Identification	O
and	O
expression	O
of	O
gene1s	ARG2
delta	ARG2
-	ARG2
isoforms	ARG2
of	ARG2
the	ARG2
multifunctional	ARG2
Ca2+/calmodulin	ARG2
-	ARG2
dependent	ARG2
protein	ARG2
kinase	ARG2
gene1e	ARG2
in	O
failing	O
and	O
nonfailing	O
arg1s	O
human	O
arg1e	O
myocardium	O
.	O
Despite	O
its	O
importance	O
for	O
the	O
regulation	O
of	O
heart	O
function	O
,	O
little	O
is	O
known	O
about	O
the	O
isoform	O
expression	O
of	O
the	O
multifunctional	O
Ca2+/calmodulin	O
-	O
dependent	O
protein	O
kinase	O
(	O
CaMKII	O
)	O
in	O
arg1s	O
human	O
arg1e	O
myocardium	O
.	O
In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
spectrum	O
of	O
gene1s	ARG2
CaMKII	ARG2
isoforms	ARG2
delta2	ARG2
,	ARG2
delta3	ARG2
,	ARG2
delta4	ARG2
,	ARG2
delta8	ARG2
,	ARG2
and	ARG2
delta9	ARG2
gene1e	ARG2
in	O
arg1s	O
human	O
arg1e	O
striated	O
muscle	O
tissue	O
.	O
Isoform	O
delta3	O
is	O
characteristically	O
expressed	O
in	O
cardiac	O
muscle	O
.	O
In	O
skeletal	O
muscle	O
,	O
specific	O
expression	O
of	O
a	O
new	O
isoform	O
termed	O
delta11	O
is	O
demonstrated	O
.	O
Complete	O
sequencing	O
of	O
arg1s	O
human	O
arg1e	O
delta2	O
cDNA	O
,	O
representing	O
all	O
common	O
features	O
of	O
the	O
investigated	O
CaMKII	O
subclass	O
,	O
revealed	O
its	O
high	O
homology	O
to	O
the	O
corresponding	O
species1s	O
rat	O
species1e	O
cDNA	O
.	O
Comparative	O
semiquantitative	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
analyses	O
from	O
left	O
ventricular	O
tissues	O
of	O
normal	O
hearts	O
and	O
from	O
arg1s	O
patients	O
arg1e	O
suffering	O
from	O
dilated	O
cardiomyopathy	O
showed	O
a	O
significant	O
increase	O
in	O
transcript	O
levels	O
of	O
isoform	O
delta3	O
relative	O
to	O
the	O
expression	O
of	O
gene1s	ARG2
glyceraldehyde-3-phosphate	ARG2
dehydrogenase	ARG2
gene1e	ARG2
in	O
diseased	O
hearts	O
(	O
101	O
.	O
6+/-11.0	O
%	O
versus	O
64.9+/-9.9	O
%	O
in	O
the	O
nonfailing	O
group	O
;	O
P	O
<	O
0.05	O
,	O
n=6	O
)	O
.	O
Transcript	O
levels	O
of	O
the	O
other	O
investigated	O
cardiac	O
CaMKII	O
isoforms	O
remained	O
unchanged	O
.	O
At	O
the	O
protein	O
level	O
,	O
by	O
using	O
a	O
subclass	O
-	O
specific	O
antibody	O
,	O
we	O
observed	O
a	O
similar	O
increase	O
of	O
a	O
gene1s	ARG2
delta	ARG2
-	ARG2
CaMKII	ARG2
gene1e	ARG2
-	O
specific	O
signal	O
(	O
7.2+/-1.0	O
versus	O
3.8+/-0.7	O
optical	O
density	O
units	O
in	O
the	O
nonfailing	O
group	O
;	O
P	O
<	O
0.05	O
,	O
n=4	O
through	O
6	O
)	O
.	O
The	O
diseased	O
state	O
of	O
the	O
failing	O
hearts	O
was	O
confirmed	O
by	O
a	O
significant	O
increase	O
in	O
transcript	O
levels	O
for	O
atrial	O
natriuretic	O
peptide	O
(	O
292	O
.	O
9+/-76.4	O
%	O
versus	O
40.1+/-3.2	O
%	O
in	O
the	O
nonfailing	O
group	O
;	O
P	O
<	O
0.05	O
,	O
n=3	O
through	O
6	O
)	O
.	O
Our	O
data	O
characterize	O
for	O
the	O
first	O
time	O
the	O
gene1s	ARG2
delta	ARG2
-	ARG2
CaMKII	ARG2
gene1e	ARG2
isoform	O
expression	O
pattern	O
in	O
arg1s	O
human	O
arg1e	O
hearts	O
and	O
demonstrate	O
changes	O
in	O
this	O
expression	O
pattern	O
in	O
heart	O
failure	O
.	O

Identification	O
and	O
expression	O
of	O
gene1s	O
delta	O
-	O
isoforms	O
of	O
the	O
multifunctional	O
Ca2+/calmodulin	O
-	O
dependent	O
protein	O
kinase	O
gene1e	O
in	O
failing	O
and	O
nonfailing	O
species1s	O
human	O
species1e	O
myocardium	O
.	O
Despite	O
its	O
importance	O
for	O
the	O
regulation	O
of	O
heart	O
function	O
,	O
little	O
is	O
known	O
about	O
the	O
isoform	O
expression	O
of	O
the	O
multifunctional	O
Ca2+/calmodulin	O
-	O
dependent	O
protein	O
kinase	O
(	O
CaMKII	O
)	O
in	O
species1s	O
human	O
species1e	O
myocardium	O
.	O
In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
spectrum	O
of	O
gene1s	O
CaMKII	O
isoforms	O
delta2	O
,	O
delta3	O
,	O
delta4	O
,	O
delta8	O
,	O
and	O
delta9	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
striated	O
muscle	O
tissue	O
.	O
Isoform	O
delta3	O
is	O
characteristically	O
expressed	O
in	O
cardiac	O
muscle	O
.	O
In	O
skeletal	O
muscle	O
,	O
specific	O
expression	O
of	O
a	O
new	O
isoform	O
termed	O
delta11	O
is	O
demonstrated	O
.	O
Complete	O
sequencing	O
of	O
species1s	O
human	O
species1e	O
delta2	O
cDNA	O
,	O
representing	O
all	O
common	O
features	O
of	O
the	O
investigated	O
CaMKII	O
subclass	O
,	O
revealed	O
its	O
high	O
homology	O
to	O
the	O
corresponding	O
arg1s	O
rat	O
arg1e	O
cDNA	O
.	O
Comparative	O
semiquantitative	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
analyses	O
from	O
left	O
ventricular	O
tissues	O
of	O
normal	O
hearts	O
and	O
from	O
species1s	O
patients	O
species1e	O
suffering	O
from	O
dilated	O
cardiomyopathy	O
showed	O
a	O
significant	O
increase	O
in	O
transcript	O
levels	O
of	O
isoform	O
delta3	O
relative	O
to	O
the	O
expression	O
of	O
gene1s	O
glyceraldehyde-3-phosphate	O
dehydrogenase	O
gene1e	O
in	O
diseased	O
hearts	O
(	O
101	O
.	O
6+/-11.0	O
%	O
versus	O
64.9+/-9.9	O
%	O
in	O
the	O
nonfailing	O
group	O
;	O
P	O
<	O
0.05	O
,	O
n=6	O
)	O
.	O
Transcript	O
levels	O
of	O
the	O
other	O
investigated	O
cardiac	O
CaMKII	O
isoforms	O
remained	O
unchanged	O
.	O
At	O
the	O
protein	O
level	O
,	O
by	O
using	O
a	O
subclass	O
-	O
specific	O
antibody	O
,	O
we	O
observed	O
a	O
similar	O
increase	O
of	O
a	O
gene1s	O
delta	O
-	O
CaMKII	O
gene1e	O
-	O
specific	O
signal	O
(	O
7.2+/-1.0	O
versus	O
3.8+/-0.7	O
optical	O
density	O
units	O
in	O
the	O
nonfailing	O
group	O
;	O
P	O
<	O
0.05	O
,	O
n=4	O
through	O
6	O
)	O
.	O
The	O
diseased	O
state	O
of	O
the	O
failing	O
hearts	O
was	O
confirmed	O
by	O
a	O
significant	O
increase	O
in	O
transcript	O
levels	O
for	O
atrial	O
natriuretic	O
peptide	O
(	O
292	O
.	O
9+/-76.4	O
%	O
versus	O
40.1+/-3.2	O
%	O
in	O
the	O
nonfailing	O
group	O
;	O
P	O
<	O
0.05	O
,	O
n=3	O
through	O
6	O
)	O
.	O
Our	O
data	O
characterize	O
for	O
the	O
first	O
time	O
the	O
gene1s	O
delta	O
-	O
CaMKII	O
gene1e	O
isoform	O
expression	O
pattern	O
in	O
species1s	O
human	O
species1e	O
hearts	O
and	O
demonstrate	O
changes	O
in	O
this	O
expression	O
pattern	O
in	O
heart	O
failure	O
.	O

Cloning	O
and	O
sequencing	O
of	O
the	O
complete	O
cDNA	O
encoding	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
insulin	ARG2
receptor	ARG2
related	ARG2
receptor	ARG2
gene1e	ARG2
.	O
The	O
gene1s	ARG2
insulin	ARG2
receptor	ARG2
related	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IRR	ARG2
gene1e	ARG2
)	O
is	O
a	O
heterotetrameric	O
transmembrane	O
receptor	O
with	O
intrinsic	O
tyrosine	O
kinase	O
activity	O
.	O
The	O
gene1s	ARG2
IRR	ARG2
gene1e	ARG2
shares	O
large	O
homology	O
with	O
the	O
gene1s	ARG2
insulin	ARG2
and	ARG2
the	ARG2
insulin	ARG2
-	ARG2
like	ARG2
growth	ARG2
factor-1	ARG2
(	ARG2
IGF	ARG2
-	ARG2
I	ARG2
)	ARG2
receptor	ARG2
gene1e	ARG2
with	O
regard	O
to	O
amino	O
acid	O
sequence	O
and	O
protein	O
structure	O
.	O
So	O
far	O
,	O
only	O
a	O
partial	O
arg1s	O
human	O
arg1e	O
sequence	O
containing	O
the	O
complete	O
3	O
'	O
end	O
has	O
been	O
reported	O
,	O
although	O
the	O
full	O
-	O
length	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
IRR	ARG2
gene1e	ARG2
cDNA	O
had	O
been	O
used	O
for	O
transfection	O
studies	O
and	O
functional	O
analysis	O
of	O
the	O
receptor	O
.	O
We	O
have	O
isolated	O
a	O
full	O
-	O
length	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
IRR	ARG2
gene1e	ARG2
cDNA	O
and	O
report	O
on	O
the	O
5	O
'	O
translated	O
and	O
untranslated	O
region	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
IRR	ARG2
gene1e	ARG2
gene	O
.	O
The	O
full	O
length	O
gene1s	ARG2
IRR	ARG2
gene1e	ARG2
sequence	O
contains	O
4150	O
bases	O
and	O
shares	O
a	O
high	O
degree	O
of	O
homology	O
with	O
the	O
species1s	O
guinea	O
pig	O
species1e	O
gene1s	O
IRR	O
gene1e	O
cDNA	O
sequence	O
and	O
species1s	O
rat	O
species1e	O
gene1s	O
IRR	O
gene1e	O
sequences	O
that	O
had	O
been	O
reported	O
earlier	O
on	O
by	O
others	O
.	O
Sequencing	O
of	O
the	O
gene1s	ARG2
IRR	ARG2
gene1e	ARG2
cDNA	O
revealed	O
that	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
IRR	ARG2
gene1e	ARG2
cDNA	O
contains	O
341	O
bases	O
corresponding	O
to	O
the	O
gene1s	ARG2
IRR	ARG2
gene1e	ARG2
5	O
'	O
end	O
in	O
addition	O
to	O
the	O
bases	O
that	O
had	O
been	O
reported	O
on	O
before	O
.	O
Also	O
,	O
this	O
sequence	O
contains	O
the	O
start	O
codon	O
of	O
translation	O
.	O
The	O
full	O
length	O
cDNA	O
for	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
IRR	ARG2
gene1e	ARG2
can	O
now	O
be	O
used	O
for	O
functional	O
expression	O
studies	O
and	O
to	O
elucidate	O
the	O
nature	O
of	O
the	O
ligand	O
for	O
this	O
receptor	O
type	O
.	O

Cloning	O
and	O
sequencing	O
of	O
the	O
complete	O
cDNA	O
encoding	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
insulin	O
receptor	O
related	O
receptor	O
gene1e	O
.	O
The	O
gene1s	O
insulin	O
receptor	O
related	O
receptor	O
gene1e	O
(	O
gene1s	O
IRR	O
gene1e	O
)	O
is	O
a	O
heterotetrameric	O
transmembrane	O
receptor	O
with	O
intrinsic	O
tyrosine	O
kinase	O
activity	O
.	O
The	O
gene1s	O
IRR	O
gene1e	O
shares	O
large	O
homology	O
with	O
the	O
gene1s	O
insulin	O
and	O
the	O
insulin	O
-	O
like	O
growth	O
factor-1	O
(	O
IGF	O
-	O
I	O
)	O
receptor	O
gene1e	O
with	O
regard	O
to	O
amino	O
acid	O
sequence	O
and	O
protein	O
structure	O
.	O
So	O
far	O
,	O
only	O
a	O
partial	O
species1s	O
human	O
species1e	O
sequence	O
containing	O
the	O
complete	O
3	O
'	O
end	O
has	O
been	O
reported	O
,	O
although	O
the	O
full	O
-	O
length	O
species1s	O
human	O
species1e	O
gene1s	O
IRR	O
gene1e	O
cDNA	O
had	O
been	O
used	O
for	O
transfection	O
studies	O
and	O
functional	O
analysis	O
of	O
the	O
receptor	O
.	O
We	O
have	O
isolated	O
a	O
full	O
-	O
length	O
species1s	O
human	O
species1e	O
gene1s	O
IRR	O
gene1e	O
cDNA	O
and	O
report	O
on	O
the	O
5	O
'	O
translated	O
and	O
untranslated	O
region	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
IRR	O
gene1e	O
gene	O
.	O
The	O
full	O
length	O
gene1s	O
IRR	O
gene1e	O
sequence	O
contains	O
4150	O
bases	O
and	O
shares	O
a	O
high	O
degree	O
of	O
homology	O
with	O
the	O
arg1s	O
guinea	O
pig	O
arg1e	O
gene1s	ARG2
IRR	ARG2
gene1e	ARG2
cDNA	O
sequence	O
and	O
species1s	O
rat	O
species1e	O
gene1s	O
IRR	O
gene1e	O
sequences	O
that	O
had	O
been	O
reported	O
earlier	O
on	O
by	O
others	O
.	O
Sequencing	O
of	O
the	O
gene1s	O
IRR	O
gene1e	O
cDNA	O
revealed	O
that	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
IRR	O
gene1e	O
cDNA	O
contains	O
341	O
bases	O
corresponding	O
to	O
the	O
gene1s	O
IRR	O
gene1e	O
5	O
'	O
end	O
in	O
addition	O
to	O
the	O
bases	O
that	O
had	O
been	O
reported	O
on	O
before	O
.	O
Also	O
,	O
this	O
sequence	O
contains	O
the	O
start	O
codon	O
of	O
translation	O
.	O
The	O
full	O
length	O
cDNA	O
for	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
IRR	O
gene1e	O
can	O
now	O
be	O
used	O
for	O
functional	O
expression	O
studies	O
and	O
to	O
elucidate	O
the	O
nature	O
of	O
the	O
ligand	O
for	O
this	O
receptor	O
type	O
.	O

Cloning	O
and	O
sequencing	O
of	O
the	O
complete	O
cDNA	O
encoding	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
insulin	O
receptor	O
related	O
receptor	O
gene1e	O
.	O
The	O
gene1s	O
insulin	O
receptor	O
related	O
receptor	O
gene1e	O
(	O
gene1s	O
IRR	O
gene1e	O
)	O
is	O
a	O
heterotetrameric	O
transmembrane	O
receptor	O
with	O
intrinsic	O
tyrosine	O
kinase	O
activity	O
.	O
The	O
gene1s	O
IRR	O
gene1e	O
shares	O
large	O
homology	O
with	O
the	O
gene1s	O
insulin	O
and	O
the	O
insulin	O
-	O
like	O
growth	O
factor-1	O
(	O
IGF	O
-	O
I	O
)	O
receptor	O
gene1e	O
with	O
regard	O
to	O
amino	O
acid	O
sequence	O
and	O
protein	O
structure	O
.	O
So	O
far	O
,	O
only	O
a	O
partial	O
species1s	O
human	O
species1e	O
sequence	O
containing	O
the	O
complete	O
3	O
'	O
end	O
has	O
been	O
reported	O
,	O
although	O
the	O
full	O
-	O
length	O
species1s	O
human	O
species1e	O
gene1s	O
IRR	O
gene1e	O
cDNA	O
had	O
been	O
used	O
for	O
transfection	O
studies	O
and	O
functional	O
analysis	O
of	O
the	O
receptor	O
.	O
We	O
have	O
isolated	O
a	O
full	O
-	O
length	O
species1s	O
human	O
species1e	O
gene1s	O
IRR	O
gene1e	O
cDNA	O
and	O
report	O
on	O
the	O
5	O
'	O
translated	O
and	O
untranslated	O
region	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
IRR	O
gene1e	O
gene	O
.	O
The	O
full	O
length	O
gene1s	O
IRR	O
gene1e	O
sequence	O
contains	O
4150	O
bases	O
and	O
shares	O
a	O
high	O
degree	O
of	O
homology	O
with	O
the	O
species1s	O
guinea	O
pig	O
species1e	O
gene1s	O
IRR	O
gene1e	O
cDNA	O
sequence	O
and	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
IRR	ARG2
gene1e	ARG2
sequences	O
that	O
had	O
been	O
reported	O
earlier	O
on	O
by	O
others	O
.	O
Sequencing	O
of	O
the	O
gene1s	O
IRR	O
gene1e	O
cDNA	O
revealed	O
that	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
IRR	O
gene1e	O
cDNA	O
contains	O
341	O
bases	O
corresponding	O
to	O
the	O
gene1s	O
IRR	O
gene1e	O
5	O
'	O
end	O
in	O
addition	O
to	O
the	O
bases	O
that	O
had	O
been	O
reported	O
on	O
before	O
.	O
Also	O
,	O
this	O
sequence	O
contains	O
the	O
start	O
codon	O
of	O
translation	O
.	O
The	O
full	O
length	O
cDNA	O
for	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
IRR	O
gene1e	O
can	O
now	O
be	O
used	O
for	O
functional	O
expression	O
studies	O
and	O
to	O
elucidate	O
the	O
nature	O
of	O
the	O
ligand	O
for	O
this	O
receptor	O
type	O
.	O

Identification	O
and	O
characterization	O
of	O
gene1s	ARG2
PKNbeta	ARG2
gene1e	ARG2
,	O
a	O
novel	O
isoform	O
of	O
protein	O
kinase	O
PKN	O
:	O
expression	O
and	O
arachidonic	O
acid	O
dependency	O
are	O
different	O
from	O
those	O
of	O
gene1s	ARG2
PKNalpha	ARG2
gene1e	ARG2
.	O
The	O
cDNA	O
clone	O
encoding	O
a	O
novel	O
isoform	O
of	O
protein	O
kinase	O
PKN	O
,	O
termed	O
gene1s	ARG2
PKNbeta	ARG2
gene1e	ARG2
,	O
was	O
isolated	O
from	O
a	O
HeLa	O
cDNA	O
library	O
.	O
gene1s	ARG2
PKNbeta	ARG2
gene1e	ARG2
had	O
high	O
sequence	O
homology	O
with	O
gene1s	ARG2
PKNalpha	ARG2
gene1e	ARG2
,	O
originally	O
isolated	O
PKN	O
,	O
especially	O
in	O
the	O
repeats	O
of	O
charged	O
amino	O
acid	O
-	O
rich	O
region	O
with	O
leucine	O
-	O
zipper	O
like	O
sequences	O
(	O
CZ	O
region	O
/	O
HR1	O
)	O
,	O
in	O
the	O
carboxyl	O
-	O
terminal	O
catalytic	O
domain	O
,	O
and	O
in	O
approximately	O
130	O
amino	O
acid	O
stretch	O
(	O
D	O
region	O
/	O
HR2	O
)	O
,	O
located	O
between	O
CZ	O
region	O
/	O
HR1	O
and	O
the	O
catalytic	O
domain	O
.	O
However	O
,	O
the	O
amino	O
acid	O
sequence	O
of	O
gene1s	ARG2
PKNbeta	ARG2
gene1e	ARG2
differed	O
from	O
that	O
of	O
gene1s	ARG2
PKNalpha	ARG2
gene1e	ARG2
in	O
the	O
region	O
immediately	O
amino	O
-	O
terminal	O
to	O
the	O
catalytic	O
domain	O
,	O
which	O
contained	O
two	O
distinct	O
proline	O
-	O
rich	O
sequences	O
consistent	O
with	O
the	O
class	O
II	O
consensus	O
sequence	O
,	O
PXXPXR	O
,	O
for	O
binding	O
to	O
SH3	O
domain	O
.	O
Distribution	O
of	O
gene1s	ARG2
PKNbeta	ARG2
gene1e	ARG2
differed	O
from	O
that	O
of	O
gene1s	ARG2
PKNalpha	ARG2
gene1e	ARG2
in	O
the	O
following	O
two	O
respects	O
:	O
(	O
1	O
)	O
Northern	O
blotting	O
indicated	O
that	O
gene1s	ARG2
PKNbeta	ARG2
gene1e	ARG2
mRNA	O
could	O
not	O
be	O
detected	O
in	O
arg1s	O
human	O
arg1e	O
adult	O
tissues	O
,	O
but	O
was	O
expressed	O
abundantly	O
in	O
arg1s	O
human	O
arg1e	O
cancer	O
cell	O
lines	O
;	O
(	O
2	O
)	O
immunochemical	O
analysis	O
indicated	O
that	O
gene1s	ARG2
PKNbeta	ARG2
gene1e	ARG2
localized	O
in	O
nucleus	O
and	O
perinuclear	O
Golgi	O
apparatus	O
,	O
and	O
was	O
almost	O
absent	O
in	O
cytoplasmic	O
region	O
in	O
species1s	O
NIH3T3	O
species1e	O
cells	O
.	O
Recombinant	O
gene1s	ARG2
PKNbeta	ARG2
gene1e	ARG2
expressed	O
in	O
species1s	O
COS7	O
species1e	O
cells	O
displayed	O
autophosphorylation	O
and	O
peptide	O
kinase	O
activity	O
,	O
but	O
was	O
found	O
to	O
be	O
significantly	O
less	O
responsive	O
to	O
arachidonic	O
acid	O
than	O
gene1s	ARG2
PKNalpha	ARG2
gene1e	ARG2
.	O
The	O
identification	O
of	O
this	O
novel	O
isoform	O
underscores	O
the	O
diversity	O
of	O
PKN	O
signaling	O
pathway	O
.	O

Identification	O
and	O
characterization	O
of	O
gene1s	O
PKNbeta	O
gene1e	O
,	O
a	O
novel	O
isoform	O
of	O
protein	O
kinase	O
PKN	O
:	O
expression	O
and	O
arachidonic	O
acid	O
dependency	O
are	O
different	O
from	O
those	O
of	O
gene1s	O
PKNalpha	O
gene1e	O
.	O
The	O
cDNA	O
clone	O
encoding	O
a	O
novel	O
isoform	O
of	O
protein	O
kinase	O
PKN	O
,	O
termed	O
gene1s	O
PKNbeta	O
gene1e	O
,	O
was	O
isolated	O
from	O
a	O
HeLa	O
cDNA	O
library	O
.	O
gene1s	O
PKNbeta	O
gene1e	O
had	O
high	O
sequence	O
homology	O
with	O
gene1s	O
PKNalpha	O
gene1e	O
,	O
originally	O
isolated	O
PKN	O
,	O
especially	O
in	O
the	O
repeats	O
of	O
charged	O
amino	O
acid	O
-	O
rich	O
region	O
with	O
leucine	O
-	O
zipper	O
like	O
sequences	O
(	O
CZ	O
region	O
/	O
HR1	O
)	O
,	O
in	O
the	O
carboxyl	O
-	O
terminal	O
catalytic	O
domain	O
,	O
and	O
in	O
approximately	O
130	O
amino	O
acid	O
stretch	O
(	O
D	O
region	O
/	O
HR2	O
)	O
,	O
located	O
between	O
CZ	O
region	O
/	O
HR1	O
and	O
the	O
catalytic	O
domain	O
.	O
However	O
,	O
the	O
amino	O
acid	O
sequence	O
of	O
gene1s	O
PKNbeta	O
gene1e	O
differed	O
from	O
that	O
of	O
gene1s	O
PKNalpha	O
gene1e	O
in	O
the	O
region	O
immediately	O
amino	O
-	O
terminal	O
to	O
the	O
catalytic	O
domain	O
,	O
which	O
contained	O
two	O
distinct	O
proline	O
-	O
rich	O
sequences	O
consistent	O
with	O
the	O
class	O
II	O
consensus	O
sequence	O
,	O
PXXPXR	O
,	O
for	O
binding	O
to	O
SH3	O
domain	O
.	O
Distribution	O
of	O
gene1s	O
PKNbeta	O
gene1e	O
differed	O
from	O
that	O
of	O
gene1s	O
PKNalpha	O
gene1e	O
in	O
the	O
following	O
two	O
respects	O
:	O
(	O
1	O
)	O
Northern	O
blotting	O
indicated	O
that	O
gene1s	O
PKNbeta	O
gene1e	O
mRNA	O
could	O
not	O
be	O
detected	O
in	O
species1s	O
human	O
species1e	O
adult	O
tissues	O
,	O
but	O
was	O
expressed	O
abundantly	O
in	O
species1s	O
human	O
species1e	O
cancer	O
cell	O
lines	O
;	O
(	O
2	O
)	O
immunochemical	O
analysis	O
indicated	O
that	O
gene1s	O
PKNbeta	O
gene1e	O
localized	O
in	O
nucleus	O
and	O
perinuclear	O
Golgi	O
apparatus	O
,	O
and	O
was	O
almost	O
absent	O
in	O
cytoplasmic	O
region	O
in	O
arg1s	O
NIH3T3	O
arg1e	O
cells	O
.	O
Recombinant	O
gene1s	O
PKNbeta	O
gene1e	O
expressed	O
in	O
species1s	O
COS7	O
species1e	O
cells	O
displayed	O
autophosphorylation	O
and	O
peptide	O
kinase	O
activity	O
,	O
but	O
was	O
found	O
to	O
be	O
significantly	O
less	O
responsive	O
to	O
arachidonic	O
acid	O
than	O
gene1s	O
PKNalpha	O
gene1e	O
.	O
The	O
identification	O
of	O
this	O
novel	O
isoform	O
underscores	O
the	O
diversity	O
of	O
PKN	O
signaling	O
pathway	O
.	O

Identification	O
and	O
characterization	O
of	O
gene1s	O
PKNbeta	O
gene1e	O
,	O
a	O
novel	O
isoform	O
of	O
protein	O
kinase	O
PKN	O
:	O
expression	O
and	O
arachidonic	O
acid	O
dependency	O
are	O
different	O
from	O
those	O
of	O
gene1s	O
PKNalpha	O
gene1e	O
.	O
The	O
cDNA	O
clone	O
encoding	O
a	O
novel	O
isoform	O
of	O
protein	O
kinase	O
PKN	O
,	O
termed	O
gene1s	O
PKNbeta	O
gene1e	O
,	O
was	O
isolated	O
from	O
a	O
HeLa	O
cDNA	O
library	O
.	O
gene1s	O
PKNbeta	O
gene1e	O
had	O
high	O
sequence	O
homology	O
with	O
gene1s	O
PKNalpha	O
gene1e	O
,	O
originally	O
isolated	O
PKN	O
,	O
especially	O
in	O
the	O
repeats	O
of	O
charged	O
amino	O
acid	O
-	O
rich	O
region	O
with	O
leucine	O
-	O
zipper	O
like	O
sequences	O
(	O
CZ	O
region	O
/	O
HR1	O
)	O
,	O
in	O
the	O
carboxyl	O
-	O
terminal	O
catalytic	O
domain	O
,	O
and	O
in	O
approximately	O
130	O
amino	O
acid	O
stretch	O
(	O
D	O
region	O
/	O
HR2	O
)	O
,	O
located	O
between	O
CZ	O
region	O
/	O
HR1	O
and	O
the	O
catalytic	O
domain	O
.	O
However	O
,	O
the	O
amino	O
acid	O
sequence	O
of	O
gene1s	O
PKNbeta	O
gene1e	O
differed	O
from	O
that	O
of	O
gene1s	O
PKNalpha	O
gene1e	O
in	O
the	O
region	O
immediately	O
amino	O
-	O
terminal	O
to	O
the	O
catalytic	O
domain	O
,	O
which	O
contained	O
two	O
distinct	O
proline	O
-	O
rich	O
sequences	O
consistent	O
with	O
the	O
class	O
II	O
consensus	O
sequence	O
,	O
PXXPXR	O
,	O
for	O
binding	O
to	O
SH3	O
domain	O
.	O
Distribution	O
of	O
gene1s	O
PKNbeta	O
gene1e	O
differed	O
from	O
that	O
of	O
gene1s	O
PKNalpha	O
gene1e	O
in	O
the	O
following	O
two	O
respects	O
:	O
(	O
1	O
)	O
Northern	O
blotting	O
indicated	O
that	O
gene1s	O
PKNbeta	O
gene1e	O
mRNA	O
could	O
not	O
be	O
detected	O
in	O
species1s	O
human	O
species1e	O
adult	O
tissues	O
,	O
but	O
was	O
expressed	O
abundantly	O
in	O
species1s	O
human	O
species1e	O
cancer	O
cell	O
lines	O
;	O
(	O
2	O
)	O
immunochemical	O
analysis	O
indicated	O
that	O
gene1s	O
PKNbeta	O
gene1e	O
localized	O
in	O
nucleus	O
and	O
perinuclear	O
Golgi	O
apparatus	O
,	O
and	O
was	O
almost	O
absent	O
in	O
cytoplasmic	O
region	O
in	O
species1s	O
NIH3T3	O
species1e	O
cells	O
.	O
Recombinant	O
gene1s	O
PKNbeta	O
gene1e	O
expressed	O
in	O
arg1s	O
COS7	O
arg1e	O
cells	O
displayed	O
autophosphorylation	O
and	O
peptide	O
kinase	O
activity	O
,	O
but	O
was	O
found	O
to	O
be	O
significantly	O
less	O
responsive	O
to	O
arachidonic	O
acid	O
than	O
gene1s	O
PKNalpha	O
gene1e	O
.	O
The	O
identification	O
of	O
this	O
novel	O
isoform	O
underscores	O
the	O
diversity	O
of	O
PKN	O
signaling	O
pathway	O
.	O

A	O
common	O
polymorphic	O
allele	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
luteinizing	ARG2
hormone	ARG2
beta	ARG2
-	ARG2
subunit	ARG2
gene1e	ARG2
gene	O
:	O
additional	O
mutations	O
and	O
differential	O
function	O
of	O
the	O
promoter	O
sequence	O
.	O
A	O
common	O
genetic	O
variant	O
(	O
V	O
)	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
luteinizing	ARG2
hormone	ARG2
(	ARG2
LH	ARG2
)	ARG2
beta	ARG2
-	ARG2
subunit	ARG2
gene1e	ARG2
gene	O
was	O
recently	O
discovered	O
.	O
The	O
V	O
-	O
LH	O
molecules	O
have	O
higher	O
bioactivity	O
in	O
vitro	O
,	O
but	O
shorter	O
half	O
-	O
life	O
in	O
circulation	O
,	O
which	O
apparently	O
is	O
related	O
to	O
the	O
alterations	O
of	O
LH	O
function	O
observed	O
in	O
individuals	O
homo-	O
and	O
heterozygous	O
for	O
the	O
V	O
-	O
gene1s	ARG2
LHbeta	ARG2
gene1e	ARG2
allele	O
.	O
We	O
have	O
now	O
studied	O
whether	O
additional	O
mutations	O
in	O
the	O
V	O
-	O
gene1s	ARG2
LHbeta	ARG2
gene1e	ARG2
promoter	O
sequence	O
could	O
contribute	O
to	O
the	O
altered	O
physiology	O
of	O
the	O
LH	O
variant	O
molecules	O
.	O
The	O
661	O
bp	O
5'-flanking	O
region	O
of	O
the	O
V	O
-	O
gene1s	ARG2
LHbeta	ARG2
gene1e	ARG2
gene	O
,	O
retrieved	O
from	O
arg1s	O
human	O
arg1e	O
genomic	O
DNA	O
by	O
PCR	O
,	O
contained	O
eight	O
single	O
-	O
nucleotide	O
changes	O
,	O
as	O
compared	O
with	O
the	O
wild	O
-	O
type	O
(	O
wt	O
)	O
gene1s	ARG2
LHbeta	ARG2
gene1e	ARG2
promoter	O
.	O
The	O
finding	O
was	O
consistent	O
in	O
DNA	O
samples	O
of	O
different	O
ethnic	O
groups	O
.	O
Reporter	O
constructs	O
with	O
various	O
lengths	O
of	O
the	O
wt-	O
and	O
V	O
-	O
LH	O
promoter	O
sequences	O
,	O
driving	O
the	O
firefly	O
luciferase	O
reporter	O
gene	O
,	O
were	O
transfected	O
into	O
an	O
immortalized	O
species1s	O
mouse	O
species1e	O
pituitary	O
cell	O
line	O
,	O
LbetaT(2	O
)	O
,	O
known	O
to	O
express	O
the	O
endogenous	O
gene1s	ARG2
LHbeta	ARG2
gene1e	ARG2
gene	O
,	O
and	O
into	O
a	O
non	O
-	O
endocrine	O
arg1s	O
human	O
arg1e	O
embryonic	O
kidney	O
cell	O
line	O
,	O
HEK	O
293	O
.	O
Basal	O
expression	O
levels	O
of	O
the	O
V	O
-	O
gene1s	ARG2
LHbeta	ARG2
gene1e	ARG2
promoter	O
constructs	O
were	O
on	O
average	O
36	O
%	O
higher	O
in	O
LbetaT(2)cells	O
(	O
P	O
<	O
0.001	O
;	O
n	O
=	O
29	O
)	O
,	O
and	O
40	O
%	O
higher	O
in	O
arg1s	O
HEK	O
293	O
arg1e	O
cells	O
(	O
P	O
<	O
0.001	O
;	O
n	O
=	O
16	O
)	O
,	O
as	O
compared	O
with	O
the	O
respective	O
wt	O
sequences	O
.	O
Numerous	O
qualitative	O
and	O
quantitative	O
differences	O
were	O
found	O
between	O
the	O
two	O
cell	O
lines	O
in	O
responses	O
of	O
the	O
two	O
promoter	O
sequences	O
to	O
stimulation	O
with	O
12-	O
O	O
-tetradecanoylphorbol-13-acetate	O
,	O
forskolin	O
,	O
8-bromo	O
-	O
cAMP	O
,	O
progesterone	O
and	O
gene1s	ARG2
gonado-	ARG2
tropin	ARG2
-	ARG2
releasing	ARG2
hormone	ARG2
gene1e	ARG2
.	O
In	O
conclusion	O
,	O
the	O
V	O
-	O
gene1s	ARG2
LHbeta	ARG2
gene1e	ARG2
promoter	O
has	O
higher	O
basal	O
activity	O
,	O
and	O
differs	O
in	O
response	O
to	O
hormonal	O
stimulation	O
,	O
as	O
compared	O
with	O
the	O
wt	O
-	O
gene1s	ARG2
LHbeta	ARG2
gene1e	ARG2
promoter	O
.	O
The	O
altered	O
promoter	O
function	O
of	O
the	O
V	O
-	O
gene1s	ARG2
LHbeta	ARG2
gene1e	ARG2
gene	O
provides	O
evidence	O
for	O
differences	O
in	O
regulation	O
of	O
the	O
wt-	O
and	O
V	O
-	O
gene1s	ARG2
LHbeta	ARG2
gene1e	ARG2
genes	O
,	O
which	O
may	O
contribute	O
to	O
the	O
differences	O
observed	O
in	O
pituitary	O
-	O
gonadal	O
function	O
between	O
carriers	O
of	O
the	O
two	O
gene1s	ARG2
LHbeta	ARG2
gene1e	ARG2
alleles	O
.	O
The	O
findings	O
also	O
suggest	O
a	O
novel	O
evolutionary	O
mechanism	O
whereby	O
polymorphic	O
changes	O
resulting	O
in	O
altered	O
bioactivity	O
of	O
a	O
gene	O
product	O
may	O
be	O
compensated	O
for	O
by	O
additional	O
mutations	O
in	O
the	O
cognate	O
promoter	O
sequence	O
,	O
changing	O
transcription	O
of	O
the	O
same	O
gene	O
.	O

A	O
common	O
polymorphic	O
allele	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
luteinizing	O
hormone	O
beta	O
-	O
subunit	O
gene1e	O
gene	O
:	O
additional	O
mutations	O
and	O
differential	O
function	O
of	O
the	O
promoter	O
sequence	O
.	O
A	O
common	O
genetic	O
variant	O
(	O
V	O
)	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
luteinizing	O
hormone	O
(	O
LH	O
)	O
beta	O
-	O
subunit	O
gene1e	O
gene	O
was	O
recently	O
discovered	O
.	O
The	O
V	O
-	O
LH	O
molecules	O
have	O
higher	O
bioactivity	O
in	O
vitro	O
,	O
but	O
shorter	O
half	O
-	O
life	O
in	O
circulation	O
,	O
which	O
apparently	O
is	O
related	O
to	O
the	O
alterations	O
of	O
LH	O
function	O
observed	O
in	O
individuals	O
homo-	O
and	O
heterozygous	O
for	O
the	O
V	O
-	O
gene1s	O
LHbeta	O
gene1e	O
allele	O
.	O
We	O
have	O
now	O
studied	O
whether	O
additional	O
mutations	O
in	O
the	O
V	O
-	O
gene1s	O
LHbeta	O
gene1e	O
promoter	O
sequence	O
could	O
contribute	O
to	O
the	O
altered	O
physiology	O
of	O
the	O
LH	O
variant	O
molecules	O
.	O
The	O
661	O
bp	O
5'-flanking	O
region	O
of	O
the	O
V	O
-	O
gene1s	O
LHbeta	O
gene1e	O
gene	O
,	O
retrieved	O
from	O
species1s	O
human	O
species1e	O
genomic	O
DNA	O
by	O
PCR	O
,	O
contained	O
eight	O
single	O
-	O
nucleotide	O
changes	O
,	O
as	O
compared	O
with	O
the	O
wild	O
-	O
type	O
(	O
wt	O
)	O
gene1s	O
LHbeta	O
gene1e	O
promoter	O
.	O
The	O
finding	O
was	O
consistent	O
in	O
DNA	O
samples	O
of	O
different	O
ethnic	O
groups	O
.	O
Reporter	O
constructs	O
with	O
various	O
lengths	O
of	O
the	O
wt-	O
and	O
V	O
-	O
LH	O
promoter	O
sequences	O
,	O
driving	O
the	O
firefly	O
luciferase	O
reporter	O
gene	O
,	O
were	O
transfected	O
into	O
an	O
immortalized	O
arg1s	O
mouse	O
arg1e	O
pituitary	O
cell	O
line	O
,	O
LbetaT(2	O
)	O
,	O
known	O
to	O
express	O
the	O
endogenous	O
gene1s	O
LHbeta	O
gene1e	O
gene	O
,	O
and	O
into	O
a	O
non	O
-	O
endocrine	O
species1s	O
human	O
species1e	O
embryonic	O
kidney	O
cell	O
line	O
,	O
HEK	O
293	O
.	O
Basal	O
expression	O
levels	O
of	O
the	O
V	O
-	O
gene1s	O
LHbeta	O
gene1e	O
promoter	O
constructs	O
were	O
on	O
average	O
36	O
%	O
higher	O
in	O
LbetaT(2)cells	O
(	O
P	O
<	O
0.001	O
;	O
n	O
=	O
29	O
)	O
,	O
and	O
40	O
%	O
higher	O
in	O
species1s	O
HEK	O
293	O
species1e	O
cells	O
(	O
P	O
<	O
0.001	O
;	O
n	O
=	O
16	O
)	O
,	O
as	O
compared	O
with	O
the	O
respective	O
wt	O
sequences	O
.	O
Numerous	O
qualitative	O
and	O
quantitative	O
differences	O
were	O
found	O
between	O
the	O
two	O
cell	O
lines	O
in	O
responses	O
of	O
the	O
two	O
promoter	O
sequences	O
to	O
stimulation	O
with	O
12-	O
O	O
-tetradecanoylphorbol-13-acetate	O
,	O
forskolin	O
,	O
8-bromo	O
-	O
cAMP	O
,	O
progesterone	O
and	O
gene1s	O
gonado-	O
tropin	O
-	O
releasing	O
hormone	O
gene1e	O
.	O
In	O
conclusion	O
,	O
the	O
V	O
-	O
gene1s	O
LHbeta	O
gene1e	O
promoter	O
has	O
higher	O
basal	O
activity	O
,	O
and	O
differs	O
in	O
response	O
to	O
hormonal	O
stimulation	O
,	O
as	O
compared	O
with	O
the	O
wt	O
-	O
gene1s	O
LHbeta	O
gene1e	O
promoter	O
.	O
The	O
altered	O
promoter	O
function	O
of	O
the	O
V	O
-	O
gene1s	O
LHbeta	O
gene1e	O
gene	O
provides	O
evidence	O
for	O
differences	O
in	O
regulation	O
of	O
the	O
wt-	O
and	O
V	O
-	O
gene1s	O
LHbeta	O
gene1e	O
genes	O
,	O
which	O
may	O
contribute	O
to	O
the	O
differences	O
observed	O
in	O
pituitary	O
-	O
gonadal	O
function	O
between	O
carriers	O
of	O
the	O
two	O
gene1s	O
LHbeta	O
gene1e	O
alleles	O
.	O
The	O
findings	O
also	O
suggest	O
a	O
novel	O
evolutionary	O
mechanism	O
whereby	O
polymorphic	O
changes	O
resulting	O
in	O
altered	O
bioactivity	O
of	O
a	O
gene	O
product	O
may	O
be	O
compensated	O
for	O
by	O
additional	O
mutations	O
in	O
the	O
cognate	O
promoter	O
sequence	O
,	O
changing	O
transcription	O
of	O
the	O
same	O
gene	O
.	O

gene1s	ARG2
Ectodysplasin	ARG2
gene1e	ARG2
is	O
a	O
collagenous	O
trimeric	O
type	O
II	O
membrane	O
protein	O
with	O
a	O
tumor	O
necrosis	O
factor	O
-	O
like	O
domain	O
and	O
co	O
-	O
localizes	O
with	O
cytoskeletal	O
structures	O
at	O
lateral	O
and	O
apical	O
surfaces	O
of	O
cells	O
.	O
Anhidrotic	O
gene1s	ARG2
ectodermal	ARG2
dysplasia	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
EDA	ARG2
gene1e	ARG2
)	O
is	O
a	O
arg1s	O
human	O
arg1e	O
genetic	O
disorder	O
of	O
impaired	O
ectodermal	O
appendage	O
development	O
.	O
The	O
gene1s	ARG2
EDA	ARG2
gene1e	ARG2
gene	O
encodes	O
isoforms	O
of	O
a	O
novel	O
transmembrane	O
protein	O
,	O
gene1s	ARG2
ectodysplasin	ARG2
gene1e	ARG2
.	O
The	O
sequence	O
of	O
the	O
longest	O
isoform	O
includes	O
an	O
interrupted	O
collagenous	O
domain	O
of	O
19	O
Gly	O
-	O
X	O
-	O
Y	O
repeats	O
and	O
a	O
motif	O
conserved	O
in	O
the	O
tumor	O
necrosis	O
factor	O
(	O
TNF)-related	O
ligand	O
family	O
.	O
In	O
order	O
to	O
understand	O
better	O
the	O
function	O
of	O
the	O
gene1s	ARG2
ectodysplasin	ARG2
gene1e	ARG2
protein	O
molecule	O
and	O
its	O
domains	O
,	O
we	O
have	O
studied	O
the	O
processing	O
and	O
localization	O
of	O
wild	O
-	O
type	O
and	O
mutated	O
isoforms	O
in	O
transfected	O
arg1s	O
human	O
arg1e	O
fetal	O
kidney	O
arg1s	O
293	O
arg1e	O
and	O
monkey	O
kidney	O
species1s	O
COS-1	O
species1e	O
cells	O
.	O
Similar	O
to	O
other	O
members	O
of	O
collagenous	O
membrane	O
proteins	O
and	O
members	O
of	O
TNF	O
-	O
related	O
ligands	O
,	O
gene1s	ARG2
ectodysplasin	ARG2
gene1e	ARG2
is	O
a	O
type	O
II	O
membrane	O
protein	O
and	O
it	O
forms	O
trimers	O
.	O
The	O
membrane	O
localization	O
of	O
gene1s	ARG2
ectodysplasin	ARG2
gene1e	ARG2
is	O
asymmetrical	O
:	O
it	O
is	O
found	O
on	O
the	O
apical	O
and	O
lateral	O
surfaces	O
of	O
the	O
cells	O
where	O
it	O
co	O
-	O
localizes	O
with	O
cytoskeletal	O
structures	O
.	O
The	O
TNF	O
-	O
like	O
motif	O
and	O
cysteines	O
found	O
near	O
the	O
C	O
-	O
terminus	O
are	O
necessary	O
for	O
correct	O
transport	O
to	O
the	O
cell	O
membrane	O
,	O
but	O
the	O
intracellular	O
and	O
collagenous	O
domains	O
are	O
not	O
required	O
for	O
the	O
localization	O
pattern	O
.	O
Our	O
results	O
suggest	O
that	O
gene1s	ARG2
ectodysplasin	ARG2
gene1e	ARG2
is	O
a	O
new	O
member	O
in	O
the	O
TNF	O
-	O
related	O
ligand	O
family	O
involved	O
in	O
the	O
early	O
epithelial	O
-	O
mesenchymal	O
interaction	O
that	O
regulates	O
ectodermal	O
appendage	O
formation	O
.	O

gene1s	O
Ectodysplasin	O
gene1e	O
is	O
a	O
collagenous	O
trimeric	O
type	O
II	O
membrane	O
protein	O
with	O
a	O
tumor	O
necrosis	O
factor	O
-	O
like	O
domain	O
and	O
co	O
-	O
localizes	O
with	O
cytoskeletal	O
structures	O
at	O
lateral	O
and	O
apical	O
surfaces	O
of	O
cells	O
.	O
Anhidrotic	O
gene1s	O
ectodermal	O
dysplasia	O
gene1e	O
(	O
gene1s	O
EDA	O
gene1e	O
)	O
is	O
a	O
species1s	O
human	O
species1e	O
genetic	O
disorder	O
of	O
impaired	O
ectodermal	O
appendage	O
development	O
.	O
The	O
gene1s	O
EDA	O
gene1e	O
gene	O
encodes	O
isoforms	O
of	O
a	O
novel	O
transmembrane	O
protein	O
,	O
gene1s	O
ectodysplasin	O
gene1e	O
.	O
The	O
sequence	O
of	O
the	O
longest	O
isoform	O
includes	O
an	O
interrupted	O
collagenous	O
domain	O
of	O
19	O
Gly	O
-	O
X	O
-	O
Y	O
repeats	O
and	O
a	O
motif	O
conserved	O
in	O
the	O
tumor	O
necrosis	O
factor	O
(	O
TNF)-related	O
ligand	O
family	O
.	O
In	O
order	O
to	O
understand	O
better	O
the	O
function	O
of	O
the	O
gene1s	O
ectodysplasin	O
gene1e	O
protein	O
molecule	O
and	O
its	O
domains	O
,	O
we	O
have	O
studied	O
the	O
processing	O
and	O
localization	O
of	O
wild	O
-	O
type	O
and	O
mutated	O
isoforms	O
in	O
transfected	O
species1s	O
human	O
species1e	O
fetal	O
kidney	O
species1s	O
293	O
species1e	O
and	O
monkey	O
kidney	O
arg1s	O
COS-1	O
arg1e	O
cells	O
.	O
Similar	O
to	O
other	O
members	O
of	O
collagenous	O
membrane	O
proteins	O
and	O
members	O
of	O
TNF	O
-	O
related	O
ligands	O
,	O
gene1s	O
ectodysplasin	O
gene1e	O
is	O
a	O
type	O
II	O
membrane	O
protein	O
and	O
it	O
forms	O
trimers	O
.	O
The	O
membrane	O
localization	O
of	O
gene1s	O
ectodysplasin	O
gene1e	O
is	O
asymmetrical	O
:	O
it	O
is	O
found	O
on	O
the	O
apical	O
and	O
lateral	O
surfaces	O
of	O
the	O
cells	O
where	O
it	O
co	O
-	O
localizes	O
with	O
cytoskeletal	O
structures	O
.	O
The	O
TNF	O
-	O
like	O
motif	O
and	O
cysteines	O
found	O
near	O
the	O
C	O
-	O
terminus	O
are	O
necessary	O
for	O
correct	O
transport	O
to	O
the	O
cell	O
membrane	O
,	O
but	O
the	O
intracellular	O
and	O
collagenous	O
domains	O
are	O
not	O
required	O
for	O
the	O
localization	O
pattern	O
.	O
Our	O
results	O
suggest	O
that	O
gene1s	O
ectodysplasin	O
gene1e	O
is	O
a	O
new	O
member	O
in	O
the	O
TNF	O
-	O
related	O
ligand	O
family	O
involved	O
in	O
the	O
early	O
epithelial	O
-	O
mesenchymal	O
interaction	O
that	O
regulates	O
ectodermal	O
appendage	O
formation	O
.	O

gene1s	ARG2
BCAR1	ARG2
gene1e	ARG2
,	O
a	O
arg1s	O
human	O
arg1e	O
homologue	O
of	O
the	O
adapter	O
protein	O
gene1s	ARG2
p130Cas	ARG2
gene1e	ARG2
,	O
and	O
antiestrogen	O
resistance	O
in	O
breast	O
cancer	O
cells	O
.	O
BACKGROUND	O
:	O
Treatment	O
of	O
breast	O
cancer	O
with	O
the	O
antiestrogen	O
tamoxifen	O
is	O
effective	O
in	O
approximately	O
one	O
half	O
of	O
the	O
arg1s	O
patients	O
arg1e	O
with	O
estrogen	O
receptor	O
-	O
positive	O
disease	O
,	O
but	O
tumors	O
recur	O
frequently	O
because	O
of	O
the	O
development	O
of	O
metastases	O
that	O
are	O
resistant	O
to	O
tamoxifen	O
.	O
We	O
have	O
previously	O
shown	O
that	O
mutagenesis	O
of	O
arg1s	O
human	O
arg1e	O
estrogen	O
-	O
dependent	O
arg1s	O
ZR-75	O
-	O
1	O
arg1e	O
breast	O
cancer	O
cells	O
by	O
insertion	O
of	O
a	O
defective	O
retrovirus	O
genome	O
caused	O
the	O
cells	O
to	O
become	O
antiestrogen	O
resistant	O
.	O
In	O
this	O
study	O
,	O
we	O
isolated	O
and	O
characterized	O
the	O
crucial	O
gene	O
at	O
the	O
gene1s	ARG2
breast	ARG2
cancer	ARG2
antiestrogen	ARG2
resistance	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
BCAR1	ARG2
gene1e	ARG2
)	O
locus	O
.	O
METHODS	O
/	O
RESULTS	O
:	O
Transfer	O
of	O
the	O
gene1s	ARG2
BCAR1	ARG2
gene1e	ARG2
locus	O
from	O
retrovirus	O
-	O
mutated	O
,	O
antiestrogen	O
-	O
resistant	O
cells	O
to	O
estrogen	O
-	O
dependent	O
arg1s	O
ZR-75	O
-	O
1	O
arg1e	O
cells	O
by	O
cell	O
fusion	O
conferred	O
an	O
antiestrogen	O
-	O
resistant	O
phenotype	O
on	O
the	O
recipient	O
cells	O
.	O
The	O
complete	O
coding	O
sequence	O
of	O
gene1s	ARG2
BCAR1	ARG2
gene1e	ARG2
was	O
isolated	O
by	O
use	O
of	O
exon	O
-	O
trapping	O
and	O
complementary	O
DNA	O
(	O
cDNA	O
)	O
library	O
screening	O
.	O
Sequence	O
analysis	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
BCAR1	ARG2
gene1e	ARG2
cDNA	O
predicted	O
a	O
protein	O
of	O
870	O
amino	O
acids	O
that	O
was	O
strongly	O
homologous	O
to	O
species1s	O
rat	O
species1e	O
gene1s	O
p130Cas	O
-	O
adapter	O
protein	O
gene1e	O
.	O
Genomic	O
analysis	O
revealed	O
that	O
gene1s	ARG2
BCAR1	ARG2
gene1e	ARG2
consists	O
of	O
seven	O
exons	O
and	O
is	O
located	O
at	O
chromosome	O
16q23.1	O
.	O
gene1s	ARG2
BCAR1	ARG2
gene1e	ARG2
transcripts	O
were	O
detected	O
in	O
multiple	O
arg1s	O
human	O
arg1e	O
tissues	O
and	O
were	O
similar	O
in	O
size	O
to	O
transcripts	O
produced	O
by	O
retrovirus	O
-	O
mutated	O
arg1s	O
ZR-75	O
-	O
1	O
arg1e	O
cells	O
.	O
Transfection	O
of	O
gene1s	ARG2
BCAR1	ARG2
gene1e	ARG2
cDNA	O
into	O
arg1s	O
ZR-75	O
-	O
1	O
arg1e	O
cells	O
again	O
resulted	O
in	O
sustained	O
cell	O
proliferation	O
in	O
the	O
presence	O
of	O
antiestrogens	O
,	O
confirming	O
that	O
gene1s	ARG2
BCAR1	ARG2
gene1e	ARG2
was	O
the	O
responsible	O
gene	O
in	O
the	O
locus	O
.	O
CONCLUSIONS	O
:	O
Overexpression	O
of	O
the	O
gene1s	ARG2
BCAR1	ARG2
gene1e	ARG2
gene	O
confers	O
antiestrogen	O
resistance	O
on	O
arg1s	O
human	O
arg1e	O
arg1s	O
ZR-75	O
-	O
1	O
arg1e	O
breast	O
cancer	O
cells	O
.	O
Overexpression	O
of	O
gene1s	ARG2
BCAR1	ARG2
gene1e	ARG2
in	O
retrovirus	O
-	O
mutated	O
cells	O
appears	O
to	O
result	O
from	O
activation	O
of	O
the	O
gene	O
's	O
promoter	O
.	O
The	O
isolation	O
and	O
characterization	O
of	O
this	O
gene	O
open	O
new	O
avenues	O
to	O
elucidating	O
mechanisms	O
by	O
which	O
the	O
growth	O
of	O
arg1s	O
human	O
arg1e	O
breast	O
cancer	O
becomes	O
independent	O
of	O
estrogen	O
.	O

gene1s	O
BCAR1	O
gene1e	O
,	O
a	O
species1s	O
human	O
species1e	O
homologue	O
of	O
the	O
adapter	O
protein	O
gene1s	O
p130Cas	O
gene1e	O
,	O
and	O
antiestrogen	O
resistance	O
in	O
breast	O
cancer	O
cells	O
.	O
BACKGROUND	O
:	O
Treatment	O
of	O
breast	O
cancer	O
with	O
the	O
antiestrogen	O
tamoxifen	O
is	O
effective	O
in	O
approximately	O
one	O
half	O
of	O
the	O
species1s	O
patients	O
species1e	O
with	O
estrogen	O
receptor	O
-	O
positive	O
disease	O
,	O
but	O
tumors	O
recur	O
frequently	O
because	O
of	O
the	O
development	O
of	O
metastases	O
that	O
are	O
resistant	O
to	O
tamoxifen	O
.	O
We	O
have	O
previously	O
shown	O
that	O
mutagenesis	O
of	O
species1s	O
human	O
species1e	O
estrogen	O
-	O
dependent	O
species1s	O
ZR-75	O
-	O
1	O
species1e	O
breast	O
cancer	O
cells	O
by	O
insertion	O
of	O
a	O
defective	O
retrovirus	O
genome	O
caused	O
the	O
cells	O
to	O
become	O
antiestrogen	O
resistant	O
.	O
In	O
this	O
study	O
,	O
we	O
isolated	O
and	O
characterized	O
the	O
crucial	O
gene	O
at	O
the	O
gene1s	O
breast	O
cancer	O
antiestrogen	O
resistance	O
1	O
gene1e	O
(	O
gene1s	O
BCAR1	O
gene1e	O
)	O
locus	O
.	O
METHODS	O
/	O
RESULTS	O
:	O
Transfer	O
of	O
the	O
gene1s	O
BCAR1	O
gene1e	O
locus	O
from	O
retrovirus	O
-	O
mutated	O
,	O
antiestrogen	O
-	O
resistant	O
cells	O
to	O
estrogen	O
-	O
dependent	O
species1s	O
ZR-75	O
-	O
1	O
species1e	O
cells	O
by	O
cell	O
fusion	O
conferred	O
an	O
antiestrogen	O
-	O
resistant	O
phenotype	O
on	O
the	O
recipient	O
cells	O
.	O
The	O
complete	O
coding	O
sequence	O
of	O
gene1s	O
BCAR1	O
gene1e	O
was	O
isolated	O
by	O
use	O
of	O
exon	O
-	O
trapping	O
and	O
complementary	O
DNA	O
(	O
cDNA	O
)	O
library	O
screening	O
.	O
Sequence	O
analysis	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
BCAR1	O
gene1e	O
cDNA	O
predicted	O
a	O
protein	O
of	O
870	O
amino	O
acids	O
that	O
was	O
strongly	O
homologous	O
to	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
p130Cas	ARG2
-	ARG2
adapter	ARG2
protein	ARG2
gene1e	ARG2
.	O
Genomic	O
analysis	O
revealed	O
that	O
gene1s	O
BCAR1	O
gene1e	O
consists	O
of	O
seven	O
exons	O
and	O
is	O
located	O
at	O
chromosome	O
16q23.1	O
.	O
gene1s	O
BCAR1	O
gene1e	O
transcripts	O
were	O
detected	O
in	O
multiple	O
species1s	O
human	O
species1e	O
tissues	O
and	O
were	O
similar	O
in	O
size	O
to	O
transcripts	O
produced	O
by	O
retrovirus	O
-	O
mutated	O
species1s	O
ZR-75	O
-	O
1	O
species1e	O
cells	O
.	O
Transfection	O
of	O
gene1s	O
BCAR1	O
gene1e	O
cDNA	O
into	O
species1s	O
ZR-75	O
-	O
1	O
species1e	O
cells	O
again	O
resulted	O
in	O
sustained	O
cell	O
proliferation	O
in	O
the	O
presence	O
of	O
antiestrogens	O
,	O
confirming	O
that	O
gene1s	O
BCAR1	O
gene1e	O
was	O
the	O
responsible	O
gene	O
in	O
the	O
locus	O
.	O
CONCLUSIONS	O
:	O
Overexpression	O
of	O
the	O
gene1s	O
BCAR1	O
gene1e	O
gene	O
confers	O
antiestrogen	O
resistance	O
on	O
species1s	O
human	O
species1e	O
species1s	O
ZR-75	O
-	O
1	O
species1e	O
breast	O
cancer	O
cells	O
.	O
Overexpression	O
of	O
gene1s	O
BCAR1	O
gene1e	O
in	O
retrovirus	O
-	O
mutated	O
cells	O
appears	O
to	O
result	O
from	O
activation	O
of	O
the	O
gene	O
's	O
promoter	O
.	O
The	O
isolation	O
and	O
characterization	O
of	O
this	O
gene	O
open	O
new	O
avenues	O
to	O
elucidating	O
mechanisms	O
by	O
which	O
the	O
growth	O
of	O
species1s	O
human	O
species1e	O
breast	O
cancer	O
becomes	O
independent	O
of	O
estrogen	O
.	O

Cloning	O
and	O
characterisation	O
of	O
the	O
Sry	O
-	O
related	O
transcription	O
factor	O
gene	O
gene1s	ARG2
Sox8	ARG2
gene1e	ARG2
.	O
SOX	O
proteins	O
form	O
a	O
large	O
family	O
of	O
transcription	O
factors	O
related	O
by	O
a	O
DNA	O
-	O
binding	O
domain	O
known	O
as	O
the	O
HMG	O
box	O
.	O
Some	O
30	O
Sox	O
genes	O
have	O
been	O
identified	O
in	O
mammals	O
and	O
orthologues	O
have	O
been	O
found	O
in	O
a	O
wide	O
range	O
of	O
other	O
metazoans	O
.	O
Sox	O
genes	O
are	O
highly	O
conserved	O
and	O
are	O
known	O
to	O
play	O
important	O
roles	O
in	O
embryonic	O
development	O
,	O
including	O
roles	O
in	O
gonadal	O
,	O
central	O
nervous	O
system	O
,	O
neural	O
crest	O
and	O
skeletal	O
development	O
.	O
Several	O
SOX	O
genes	O
have	O
been	O
implicated	O
in	O
arg1s	O
human	O
arg1e	O
congenital	O
diseases	O
.	O
We	O
report	O
here	O
the	O
isolation	O
of	O
gene1s	ARG2
Sox8	ARG2
gene1e	ARG2
and	O
its	O
characterisation	O
in	O
species1s	O
mice	O
species1e	O
and	O
arg1s	O
humans	O
arg1e	O
.	O
This	O
gene	O
has	O
a	O
remarkably	O
similar	O
primary	O
structure	O
and	O
genomic	O
organisation	O
to	O
the	O
campomelic	O
dysplasia	O
gene	O
gene1s	ARG2
SOX9	ARG2
gene1e	ARG2
and	O
the	O
Waardenburg	O
-	O
Shah	O
syndrome	O
gene	O
gene1s	ARG2
SOX10	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
SOX8	ARG2
gene1e	ARG2
protein	O
is	O
able	O
to	O
bind	O
to	O
canonical	O
SOX	O
target	O
DNA	O
sequences	O
and	O
activate	O
transcription	O
in	O
vitro	O
through	O
two	O
separate	O
trans	O
-activation	O
regions	O
.	O
Further	O
,	O
gene1s	ARG2
Sox8	ARG2
gene1e	ARG2
is	O
expressed	O
in	O
the	O
central	O
nervous	O
system	O
,	O
limbs	O
,	O
kidneys	O
,	O
gonads	O
and	O
craniofacial	O
structures	O
during	O
species1s	O
mouse	O
species1e	O
embryo	O
development	O
.	O
gene1s	ARG2
Sox8	ARG2
gene1e	ARG2
maps	O
to	O
the	O
t	O
complex	O
on	O
species1s	O
mouse	O
species1e	O
chromosome	O
17	O
and	O
to	O
arg1s	O
human	O
arg1e	O
chromosome	O
16p13.3	O
,	O
a	O
region	O
associated	O
with	O
the	O
microphthalmia	O
-	O
cataract	O
syndrome	O
CATM	O
and	O
the	O
alpha	O
-	O
thalassemia	O
/	O
mental	O
retardation	O
syndrome	O
ATR-16	O
.	O

Cloning	O
and	O
characterisation	O
of	O
the	O
Sry	O
-	O
related	O
transcription	O
factor	O
gene	O
gene1s	O
Sox8	O
gene1e	O
.	O
SOX	O
proteins	O
form	O
a	O
large	O
family	O
of	O
transcription	O
factors	O
related	O
by	O
a	O
DNA	O
-	O
binding	O
domain	O
known	O
as	O
the	O
HMG	O
box	O
.	O
Some	O
30	O
Sox	O
genes	O
have	O
been	O
identified	O
in	O
mammals	O
and	O
orthologues	O
have	O
been	O
found	O
in	O
a	O
wide	O
range	O
of	O
other	O
metazoans	O
.	O
Sox	O
genes	O
are	O
highly	O
conserved	O
and	O
are	O
known	O
to	O
play	O
important	O
roles	O
in	O
embryonic	O
development	O
,	O
including	O
roles	O
in	O
gonadal	O
,	O
central	O
nervous	O
system	O
,	O
neural	O
crest	O
and	O
skeletal	O
development	O
.	O
Several	O
SOX	O
genes	O
have	O
been	O
implicated	O
in	O
species1s	O
human	O
species1e	O
congenital	O
diseases	O
.	O
We	O
report	O
here	O
the	O
isolation	O
of	O
gene1s	O
Sox8	O
gene1e	O
and	O
its	O
characterisation	O
in	O
arg1s	O
mice	O
arg1e	O
and	O
species1s	O
humans	O
species1e	O
.	O
This	O
gene	O
has	O
a	O
remarkably	O
similar	O
primary	O
structure	O
and	O
genomic	O
organisation	O
to	O
the	O
campomelic	O
dysplasia	O
gene	O
gene1s	O
SOX9	O
gene1e	O
and	O
the	O
Waardenburg	O
-	O
Shah	O
syndrome	O
gene	O
gene1s	O
SOX10	O
gene1e	O
.	O
gene1s	O
SOX8	O
gene1e	O
protein	O
is	O
able	O
to	O
bind	O
to	O
canonical	O
SOX	O
target	O
DNA	O
sequences	O
and	O
activate	O
transcription	O
in	O
vitro	O
through	O
two	O
separate	O
trans	O
-activation	O
regions	O
.	O
Further	O
,	O
gene1s	O
Sox8	O
gene1e	O
is	O
expressed	O
in	O
the	O
central	O
nervous	O
system	O
,	O
limbs	O
,	O
kidneys	O
,	O
gonads	O
and	O
craniofacial	O
structures	O
during	O
arg1s	O
mouse	O
arg1e	O
embryo	O
development	O
.	O
gene1s	O
Sox8	O
gene1e	O
maps	O
to	O
the	O
t	O
complex	O
on	O
arg1s	O
mouse	O
arg1e	O
chromosome	O
17	O
and	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
16p13.3	O
,	O
a	O
region	O
associated	O
with	O
the	O
microphthalmia	O
-	O
cataract	O
syndrome	O
CATM	O
and	O
the	O
alpha	O
-	O
thalassemia	O
/	O
mental	O
retardation	O
syndrome	O
ATR-16	O
.	O

gene1s	ARG2
Human	ARG2
follicle	ARG2
stimulating	ARG2
hormone	ARG2
receptor	ARG2
gene1e	ARG2
variants	O
lacking	O
transmembrane	O
domains	O
display	O
altered	O
post	O
-	O
translational	O
conformations	O
.	O
Variant	O
splicing	O
of	O
gonadotropin	O
receptor	O
mRNA	O
commonly	O
occurs	O
,	O
however	O
expression	O
of	O
receptor	O
protein	O
variants	O
and	O
their	O
trafficking	O
has	O
yet	O
to	O
be	O
studied	O
in	O
detail	O
.	O
To	O
determine	O
receptor	O
variant	O
trafficking	O
and	O
intracellular	O
processing	O
in	O
arg1s	O
mammalian	O
arg1e	O
cells	O
,	O
the	O
intracellular	O
fate	O
of	O
intentionally	O
truncated	O
variants	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
follicle	ARG2
stimulating	ARG2
hormone	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
hFSH	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
)	O
expressed	O
in	O
species1s	O
CHO	O
species1e	O
cells	O
was	O
examined	O
.	O
Monoclonal	O
antibodies	O
(	O
mAbs	O
)	O
were	O
made	O
against	O
the	O
hFSH	O
-	O
R	O
's	O
extracellular	O
domain	O
(	O
ECD	O
)	O
expressed	O
in	O
insect	O
cells	O
.	O
Four	O
mAbs	O
106.156	O
,	O
106.290	O
,	O
106.318	O
,	O
and	O
106.263	O
were	O
chosen	O
as	O
probes	O
.	O
Epitope	O
mapping	O
using	O
synthetic	O
peptides	O
,	O
and	O
truncated	O
gene1s	ARG2
hFSH	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
variants	O
revealed	O
that	O
mAb	O
106.156	O
bound	O
to	O
ECD	O
residues	O
183	O
-	O
220	O
,	O
while	O
mAbs	O
106.318	O
,	O
106.290	O
,	O
106.263	O
bound	O
ECD	O
residues	O
300	O
-	O
331	O
.	O
Immunofluorescence	O
microscopy	O
showed	O
that	O
mAbs	O
106.318	O
and	O
106.156	O
stained	O
the	O
surface	O
of	O
fixed	O
,	O
intact	O
species1s	O
CHO	O
species1e	O
cells	O
expressing	O
wild	O
type	O
gene1s	ARG2
hFSH	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
.	O
However	O
,	O
following	O
cell	O
permeabilization	O
all	O
four	O
antibodies	O
stained	O
gene1s	ARG2
hFSH	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
in	O
Golgi	O
and	O
endoplasmic	O
reticulum	O
.	O
Permeabilized	O
cells	O
expressing	O
truncated	O
variants	O
ECD213	O
and	O
ECD254	O
showed	O
staining	O
accumulated	O
in	O
the	O
endoplasmic	O
reticulum	O
/	O
nuclear	O
envelope	O
continuum	O
.	O
ECD335	O
/	O
His	O
was	O
found	O
to	O
accumulate	O
in	O
extended	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
.	O
The	O
ER	O
location	O
of	O
ECD335	O
/	O
His	O
was	O
confirmed	O
by	O
double	O
labeling	O
experiments	O
with	O
concanavalin	O
A	O
and	O
ECD	O
mAb	O
.	O
Glycosidase	O
digestion	O
followed	O
by	O
Western	O
blot	O
analysis	O
show	O
ECD213	O
and	O
ECD335	O
/	O
His	O
to	O
be	O
glycosylated	O
,	O
but	O
not	O
ECD254	O
.	O
Both	O
glycosylated	O
truncated	O
gene1s	ARG2
hFSH	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
variants	O
were	O
sensitive	O
to	O
peptide	O
-	O
N	O
-	O
glycanase	O
F	O
and	O
endoglycosidase	O
H	O
but	O
insensitive	O
to	O
gene1s	ARG2
neuraminidase	ARG2
gene1e	ARG2
indicating	O
that	O
these	O
variants	O
possess	O
high	O
mannose	O
type	O
oligosaccharides	O
.	O
Thus	O
truncated	O
gene1s	ARG2
hFSH	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
variants	O
do	O
not	O
reach	O
the	O
medial	O
or	O
trans	O
Golgi	O
where	O
high	O
mannose	O
oligosaccharides	O
are	O
trimmed	O
and	O
sialic	O
acid	O
is	O
added	O
.	O
These	O
data	O
suggest	O
that	O
the	O
conformation	O
the	O
ECD	O
of	O
the	O
wild	O
type	O
receptor	O
is	O
different	O
from	O
the	O
ECD	O
alone	O
expressed	O
in	O
the	O
endoplasmic	O
reticulum	O
.	O
This	O
information	O
suggests	O
that	O
the	O
ECD	O
serves	O
two	O
distinct	O
roles	O
;	O
the	O
first	O
is	O
to	O
bind	O
FSH	O
and	O
the	O
other	O
is	O
likely	O
to	O
contact	O
the	O
endodomain	O
of	O
the	O
receptor	O
,	O
which	O
presumably	O
leads	O
to	O
activation	O
of	O
the	O
endodomain	O
for	O
signal	O
transduction	O
.	O

gene1s	O
Human	O
follicle	O
stimulating	O
hormone	O
receptor	O
gene1e	O
variants	O
lacking	O
transmembrane	O
domains	O
display	O
altered	O
post	O
-	O
translational	O
conformations	O
.	O
Variant	O
splicing	O
of	O
gonadotropin	O
receptor	O
mRNA	O
commonly	O
occurs	O
,	O
however	O
expression	O
of	O
receptor	O
protein	O
variants	O
and	O
their	O
trafficking	O
has	O
yet	O
to	O
be	O
studied	O
in	O
detail	O
.	O
To	O
determine	O
receptor	O
variant	O
trafficking	O
and	O
intracellular	O
processing	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
,	O
the	O
intracellular	O
fate	O
of	O
intentionally	O
truncated	O
variants	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
follicle	O
stimulating	O
hormone	O
receptor	O
gene1e	O
(	O
gene1s	O
hFSH	O
-	O
R	O
gene1e	O
)	O
expressed	O
in	O
arg1s	O
CHO	O
arg1e	O
cells	O
was	O
examined	O
.	O
Monoclonal	O
antibodies	O
(	O
mAbs	O
)	O
were	O
made	O
against	O
the	O
hFSH	O
-	O
R	O
's	O
extracellular	O
domain	O
(	O
ECD	O
)	O
expressed	O
in	O
insect	O
cells	O
.	O
Four	O
mAbs	O
106.156	O
,	O
106.290	O
,	O
106.318	O
,	O
and	O
106.263	O
were	O
chosen	O
as	O
probes	O
.	O
Epitope	O
mapping	O
using	O
synthetic	O
peptides	O
,	O
and	O
truncated	O
gene1s	O
hFSH	O
-	O
R	O
gene1e	O
variants	O
revealed	O
that	O
mAb	O
106.156	O
bound	O
to	O
ECD	O
residues	O
183	O
-	O
220	O
,	O
while	O
mAbs	O
106.318	O
,	O
106.290	O
,	O
106.263	O
bound	O
ECD	O
residues	O
300	O
-	O
331	O
.	O
Immunofluorescence	O
microscopy	O
showed	O
that	O
mAbs	O
106.318	O
and	O
106.156	O
stained	O
the	O
surface	O
of	O
fixed	O
,	O
intact	O
arg1s	O
CHO	O
arg1e	O
cells	O
expressing	O
wild	O
type	O
gene1s	O
hFSH	O
-	O
R	O
gene1e	O
.	O
However	O
,	O
following	O
cell	O
permeabilization	O
all	O
four	O
antibodies	O
stained	O
gene1s	O
hFSH	O
-	O
R	O
gene1e	O
in	O
Golgi	O
and	O
endoplasmic	O
reticulum	O
.	O
Permeabilized	O
cells	O
expressing	O
truncated	O
variants	O
ECD213	O
and	O
ECD254	O
showed	O
staining	O
accumulated	O
in	O
the	O
endoplasmic	O
reticulum	O
/	O
nuclear	O
envelope	O
continuum	O
.	O
ECD335	O
/	O
His	O
was	O
found	O
to	O
accumulate	O
in	O
extended	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
.	O
The	O
ER	O
location	O
of	O
ECD335	O
/	O
His	O
was	O
confirmed	O
by	O
double	O
labeling	O
experiments	O
with	O
concanavalin	O
A	O
and	O
ECD	O
mAb	O
.	O
Glycosidase	O
digestion	O
followed	O
by	O
Western	O
blot	O
analysis	O
show	O
ECD213	O
and	O
ECD335	O
/	O
His	O
to	O
be	O
glycosylated	O
,	O
but	O
not	O
ECD254	O
.	O
Both	O
glycosylated	O
truncated	O
gene1s	O
hFSH	O
-	O
R	O
gene1e	O
variants	O
were	O
sensitive	O
to	O
peptide	O
-	O
N	O
-	O
glycanase	O
F	O
and	O
endoglycosidase	O
H	O
but	O
insensitive	O
to	O
gene1s	O
neuraminidase	O
gene1e	O
indicating	O
that	O
these	O
variants	O
possess	O
high	O
mannose	O
type	O
oligosaccharides	O
.	O
Thus	O
truncated	O
gene1s	O
hFSH	O
-	O
R	O
gene1e	O
variants	O
do	O
not	O
reach	O
the	O
medial	O
or	O
trans	O
Golgi	O
where	O
high	O
mannose	O
oligosaccharides	O
are	O
trimmed	O
and	O
sialic	O
acid	O
is	O
added	O
.	O
These	O
data	O
suggest	O
that	O
the	O
conformation	O
the	O
ECD	O
of	O
the	O
wild	O
type	O
receptor	O
is	O
different	O
from	O
the	O
ECD	O
alone	O
expressed	O
in	O
the	O
endoplasmic	O
reticulum	O
.	O
This	O
information	O
suggests	O
that	O
the	O
ECD	O
serves	O
two	O
distinct	O
roles	O
;	O
the	O
first	O
is	O
to	O
bind	O
FSH	O
and	O
the	O
other	O
is	O
likely	O
to	O
contact	O
the	O
endodomain	O
of	O
the	O
receptor	O
,	O
which	O
presumably	O
leads	O
to	O
activation	O
of	O
the	O
endodomain	O
for	O
signal	O
transduction	O
.	O

The	O
gene1s	ARG2
pro	ARG2
-	ARG2
alpha3(V	ARG2
)	ARG2
collagen	ARG2
gene1e	ARG2
chain	O
.	O
Complete	O
primary	O
structure	O
,	O
expression	O
domains	O
in	O
adult	O
and	O
developing	O
tissues	O
,	O
and	O
comparison	O
to	O
the	O
structures	O
and	O
expression	O
domains	O
of	O
the	O
other	O
types	O
V	O
and	O
XI	O
procollagen	O
chains	O
.	O
The	O
low	O
abundance	O
fibrillar	O
collagen	O
type	O
V	O
is	O
widely	O
distributed	O
in	O
tissues	O
as	O
an	O
gene1s	ARG2
alpha1(V)	ARG2
gene1e	ARG2
(2)	O
gene1s	ARG2
alpha2(V	ARG2
)	ARG2
gene1e	ARG2
heterotrimer	O
that	O
helps	O
regulate	O
the	O
diameters	O
of	O
fibrils	O
of	O
the	O
abundant	O
collagen	O
type	O
I.	O
Mutations	O
in	O
the	O
gene1s	ARG2
alpha1(V	ARG2
)	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
alpha2(V	ARG2
)	ARG2
gene1e	ARG2
chain	O
genes	O
have	O
been	O
identified	O
in	O
some	O
cases	O
of	O
classical	O
Ehlers	O
-	O
Danlos	O
syndrome	O
(	O
EDS	O
)	O
,	O
in	O
which	O
aberrant	O
collagen	O
fibrils	O
are	O
associated	O
with	O
connective	O
tissue	O
fragility	O
,	O
particularly	O
in	O
skin	O
and	O
joints	O
.	O
Type	O
V	O
collagen	O
also	O
exists	O
as	O
an	O
alpha1(V)alpha2(V)	O
gene1s	ARG2
alpha3(V	ARG2
)	ARG2
gene1e	ARG2
heterotrimer	O
that	O
has	O
remained	O
poorly	O
characterized	O
chiefly	O
due	O
to	O
inability	O
to	O
obtain	O
the	O
complete	O
primary	O
structure	O
or	O
nucleic	O
acid	O
probes	O
for	O
the	O
gene1s	ARG2
alpha3(V	ARG2
)	ARG2
gene1e	ARG2
chain	O
or	O
its	O
biosynthetic	O
precursor	O
,	O
gene1s	ARG2
pro	ARG2
-	ARG2
alpha3(V	ARG2
)	ARG2
gene1e	ARG2
.	O
Here	O
we	O
provide	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
mouse	O
species1e	O
full	O
-	O
length	O
gene1s	ARG2
pro	ARG2
-	ARG2
alpha3(V	ARG2
)	ARG2
gene1e	ARG2
sequences	O
.	O
gene1s	ARG2
Pro	ARG2
-	ARG2
alpha3(V	ARG2
)	ARG2
gene1e	ARG2
is	O
shown	O
to	O
be	O
closely	O
related	O
to	O
the	O
gene1s	ARG2
alpha1(V	ARG2
)	ARG2
gene1e	ARG2
precursor	O
,	O
gene1s	ARG2
pro	ARG2
-	ARG2
alpha1(V	ARG2
)	ARG2
gene1e	ARG2
,	O
but	O
with	O
marked	O
differences	O
in	O
N	O
-	O
propeptide	O
sequences	O
,	O
and	O
collagenous	O
domain	O
features	O
that	O
provide	O
insights	O
into	O
the	O
low	O
melting	O
temperature	O
of	O
alpha1(V)alpha2(V)	O
gene1s	ARG2
alpha3(V	ARG2
)	ARG2
gene1e	ARG2
heterotrimers	O
,	O
lack	O
of	O
heparin	O
binding	O
by	O
gene1s	ARG2
alpha3(V	ARG2
)	ARG2
gene1e	ARG2
chains	O
and	O
the	O
possibility	O
that	O
alpha1(V)alpha2(V)	O
gene1s	ARG2
alpha3(V	ARG2
)	ARG2
gene1e	ARG2
heterotrimers	O
are	O
incorporated	O
into	O
heterotypic	O
fibrils	O
.	O
In	O
situ	O
hybridization	O
of	O
species1s	O
mouse	O
species1e	O
embryos	O
detects	O
gene1s	O
alpha3(V	O
)	O
gene1e	O
expression	O
primarily	O
in	O
the	O
epimysial	O
sheaths	O
of	O
developing	O
muscles	O
and	O
within	O
nascent	O
ligaments	O
adjacent	O
to	O
forming	O
bones	O
and	O
in	O
joints	O
.	O
This	O
distribution	O
,	O
and	O
the	O
association	O
of	O
gene1s	ARG2
alpha1(V	ARG2
)	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
alpha2(V	ARG2
)	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
alpha3(V	ARG2
)	ARG2
gene1e	ARG2
chains	O
in	O
heterotrimers	O
,	O
suggests	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
alpha3(V	ARG2
)	ARG2
gene1e	ARG2
gene	O
gene1s	ARG2
COL5A3	ARG2
gene1e	ARG2
as	O
a	O
candidate	O
locus	O
for	O
at	O
least	O
some	O
cases	O
of	O
classical	O
EDS	O
in	O
which	O
the	O
gene1s	ARG2
alpha1(V	ARG2
)	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
alpha2(V	ARG2
)	ARG2
gene1e	ARG2
genes	O
have	O
been	O
excluded	O
,	O
and	O
for	O
at	O
least	O
some	O
cases	O
of	O
the	O
hypermobility	O
type	O
of	O
EDS	O
,	O
a	O
condition	O
marked	O
by	O
gross	O
joint	O
laxity	O
and	O
chronic	O
musculoskeletal	O
pain	O
.	O
gene1s	ARG2
COL5A3	ARG2
gene1e	ARG2
is	O
mapped	O
to	O
19p13.2	O
near	O
a	O
polymorphic	O
marker	O
that	O
should	O
be	O
useful	O
in	O
analyzing	O
linkage	O
with	O
EDS	O
and	O
other	O
disease	O
phenotypes	O
.	O

The	O
gene1s	O
pro	O
-	O
alpha3(V	O
)	O
collagen	O
gene1e	O
chain	O
.	O
Complete	O
primary	O
structure	O
,	O
expression	O
domains	O
in	O
adult	O
and	O
developing	O
tissues	O
,	O
and	O
comparison	O
to	O
the	O
structures	O
and	O
expression	O
domains	O
of	O
the	O
other	O
types	O
V	O
and	O
XI	O
procollagen	O
chains	O
.	O
The	O
low	O
abundance	O
fibrillar	O
collagen	O
type	O
V	O
is	O
widely	O
distributed	O
in	O
tissues	O
as	O
an	O
gene1s	O
alpha1(V)	O
gene1e	O
(2)	O
gene1s	O
alpha2(V	O
)	O
gene1e	O
heterotrimer	O
that	O
helps	O
regulate	O
the	O
diameters	O
of	O
fibrils	O
of	O
the	O
abundant	O
collagen	O
type	O
I.	O
Mutations	O
in	O
the	O
gene1s	O
alpha1(V	O
)	O
gene1e	O
and	O
gene1s	O
alpha2(V	O
)	O
gene1e	O
chain	O
genes	O
have	O
been	O
identified	O
in	O
some	O
cases	O
of	O
classical	O
Ehlers	O
-	O
Danlos	O
syndrome	O
(	O
EDS	O
)	O
,	O
in	O
which	O
aberrant	O
collagen	O
fibrils	O
are	O
associated	O
with	O
connective	O
tissue	O
fragility	O
,	O
particularly	O
in	O
skin	O
and	O
joints	O
.	O
Type	O
V	O
collagen	O
also	O
exists	O
as	O
an	O
alpha1(V)alpha2(V)	O
gene1s	O
alpha3(V	O
)	O
gene1e	O
heterotrimer	O
that	O
has	O
remained	O
poorly	O
characterized	O
chiefly	O
due	O
to	O
inability	O
to	O
obtain	O
the	O
complete	O
primary	O
structure	O
or	O
nucleic	O
acid	O
probes	O
for	O
the	O
gene1s	O
alpha3(V	O
)	O
gene1e	O
chain	O
or	O
its	O
biosynthetic	O
precursor	O
,	O
gene1s	O
pro	O
-	O
alpha3(V	O
)	O
gene1e	O
.	O
Here	O
we	O
provide	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
mouse	O
arg1e	O
full	O
-	O
length	O
gene1s	ARG2
pro	ARG2
-	ARG2
alpha3(V	ARG2
)	ARG2
gene1e	ARG2
sequences	O
.	O
gene1s	O
Pro	O
-	O
alpha3(V	O
)	O
gene1e	O
is	O
shown	O
to	O
be	O
closely	O
related	O
to	O
the	O
gene1s	O
alpha1(V	O
)	O
gene1e	O
precursor	O
,	O
gene1s	O
pro	O
-	O
alpha1(V	O
)	O
gene1e	O
,	O
but	O
with	O
marked	O
differences	O
in	O
N	O
-	O
propeptide	O
sequences	O
,	O
and	O
collagenous	O
domain	O
features	O
that	O
provide	O
insights	O
into	O
the	O
low	O
melting	O
temperature	O
of	O
alpha1(V)alpha2(V)	O
gene1s	O
alpha3(V	O
)	O
gene1e	O
heterotrimers	O
,	O
lack	O
of	O
heparin	O
binding	O
by	O
gene1s	O
alpha3(V	O
)	O
gene1e	O
chains	O
and	O
the	O
possibility	O
that	O
alpha1(V)alpha2(V)	O
gene1s	O
alpha3(V	O
)	O
gene1e	O
heterotrimers	O
are	O
incorporated	O
into	O
heterotypic	O
fibrils	O
.	O
In	O
situ	O
hybridization	O
of	O
arg1s	O
mouse	O
arg1e	O
embryos	O
detects	O
gene1s	ARG2
alpha3(V	ARG2
)	ARG2
gene1e	ARG2
expression	O
primarily	O
in	O
the	O
epimysial	O
sheaths	O
of	O
developing	O
muscles	O
and	O
within	O
nascent	O
ligaments	O
adjacent	O
to	O
forming	O
bones	O
and	O
in	O
joints	O
.	O
This	O
distribution	O
,	O
and	O
the	O
association	O
of	O
gene1s	O
alpha1(V	O
)	O
gene1e	O
,	O
gene1s	O
alpha2(V	O
)	O
gene1e	O
,	O
and	O
gene1s	O
alpha3(V	O
)	O
gene1e	O
chains	O
in	O
heterotrimers	O
,	O
suggests	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
alpha3(V	O
)	O
gene1e	O
gene	O
gene1s	O
COL5A3	O
gene1e	O
as	O
a	O
candidate	O
locus	O
for	O
at	O
least	O
some	O
cases	O
of	O
classical	O
EDS	O
in	O
which	O
the	O
gene1s	O
alpha1(V	O
)	O
gene1e	O
and	O
gene1s	O
alpha2(V	O
)	O
gene1e	O
genes	O
have	O
been	O
excluded	O
,	O
and	O
for	O
at	O
least	O
some	O
cases	O
of	O
the	O
hypermobility	O
type	O
of	O
EDS	O
,	O
a	O
condition	O
marked	O
by	O
gross	O
joint	O
laxity	O
and	O
chronic	O
musculoskeletal	O
pain	O
.	O
gene1s	O
COL5A3	O
gene1e	O
is	O
mapped	O
to	O
19p13.2	O
near	O
a	O
polymorphic	O
marker	O
that	O
should	O
be	O
useful	O
in	O
analyzing	O
linkage	O
with	O
EDS	O
and	O
other	O
disease	O
phenotypes	O
.	O

A	O
G	O
protein	O
-	O
coupled	O
receptor	O
for	O
UDP	O
-	O
glucose	O
.	O
Uridine	O
5'-diphosphoglucose	O
(	O
UDP	O
-	O
glucose	O
)	O
has	O
a	O
well	O
established	O
biochemical	O
role	O
as	O
a	O
glycosyl	O
donor	O
in	O
the	O
enzymatic	O
biosynthesis	O
of	O
carbohydrates	O
.	O
It	O
is	O
less	O
well	O
known	O
that	O
UDP	O
-	O
glucose	O
may	O
possess	O
pharmacological	O
activity	O
,	O
suggesting	O
that	O
a	O
receptor	O
for	O
this	O
molecule	O
may	O
exist	O
.	O
Here	O
,	O
we	O
show	O
that	O
UDP	O
-	O
glucose	O
,	O
and	O
some	O
closely	O
related	O
molecules	O
,	O
potently	O
activate	O
the	O
orphan	O
G	O
protein	O
-	O
coupled	O
receptor	O
gene1s	O
KIAA0001	O
gene1e	O
heterologously	O
expressed	O
in	O
arg1s	O
yeast	O
arg1e	O
or	O
species1s	O
mammalian	O
species1e	O
cells	O
.	O
Nucleotides	O
known	O
to	O
activate	O
P2Y	O
receptors	O
were	O
inactive	O
,	O
indicating	O
the	O
distinctly	O
novel	O
pharmacology	O
of	O
this	O
receptor	O
.	O
The	O
receptor	O
is	O
expressed	O
in	O
a	O
wide	O
variety	O
of	O
species1s	O
human	O
species1e	O
tissues	O
,	O
including	O
many	O
regions	O
of	O
the	O
brain	O
.	O
These	O
data	O
suggest	O
that	O
some	O
sugar	O
-	O
nucleotides	O
may	O
serve	O
important	O
physiological	O
roles	O
as	O
extracellular	O
signaling	O
molecules	O
in	O
addition	O
to	O
their	O
familiar	O
role	O
in	O
intermediary	O
metabolism	O
.	O

A	O
G	O
protein	O
-	O
coupled	O
receptor	O
for	O
UDP	O
-	O
glucose	O
.	O
Uridine	O
5'-diphosphoglucose	O
(	O
UDP	O
-	O
glucose	O
)	O
has	O
a	O
well	O
established	O
biochemical	O
role	O
as	O
a	O
glycosyl	O
donor	O
in	O
the	O
enzymatic	O
biosynthesis	O
of	O
carbohydrates	O
.	O
It	O
is	O
less	O
well	O
known	O
that	O
UDP	O
-	O
glucose	O
may	O
possess	O
pharmacological	O
activity	O
,	O
suggesting	O
that	O
a	O
receptor	O
for	O
this	O
molecule	O
may	O
exist	O
.	O
Here	O
,	O
we	O
show	O
that	O
UDP	O
-	O
glucose	O
,	O
and	O
some	O
closely	O
related	O
molecules	O
,	O
potently	O
activate	O
the	O
orphan	O
G	O
protein	O
-	O
coupled	O
receptor	O
gene1s	ARG2
KIAA0001	ARG2
gene1e	ARG2
heterologously	O
expressed	O
in	O
species1s	O
yeast	O
species1e	O
or	O
arg1s	O
mammalian	O
arg1e	O
cells	O
.	O
Nucleotides	O
known	O
to	O
activate	O
P2Y	O
receptors	O
were	O
inactive	O
,	O
indicating	O
the	O
distinctly	O
novel	O
pharmacology	O
of	O
this	O
receptor	O
.	O
The	O
receptor	O
is	O
expressed	O
in	O
a	O
wide	O
variety	O
of	O
arg1s	O
human	O
arg1e	O
tissues	O
,	O
including	O
many	O
regions	O
of	O
the	O
brain	O
.	O
These	O
data	O
suggest	O
that	O
some	O
sugar	O
-	O
nucleotides	O
may	O
serve	O
important	O
physiological	O
roles	O
as	O
extracellular	O
signaling	O
molecules	O
in	O
addition	O
to	O
their	O
familiar	O
role	O
in	O
intermediary	O
metabolism	O
.	O

Spinocerebellar	O
ataxia	O
type	O
6	O
mutation	O
alters	O
P	O
-	O
type	O
calcium	O
channel	O
function	O
.	O
Abnormal	O
CAG	O
repeat	O
expansion	O
in	O
the	O
gene1s	O
alpha1A	O
voltage	O
-	O
dependent	O
calcium	O
channel	O
gene1e	O
gene	O
is	O
associated	O
with	O
spinocerebellar	O
ataxia	O
type	O
6	O
,	O
an	O
autosomal	O
dominant	O
cerebellar	O
ataxia	O
with	O
a	O
predominant	O
loss	O
of	O
the	O
Purkinje	O
cell	O
.	O
A	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
analysis	O
of	O
mRNA	O
from	O
arg1s	O
mouse	O
arg1e	O
Purkinje	O
cells	O
revealed	O
a	O
predominant	O
expression	O
of	O
the	O
gene1s	O
alpha1A	O
gene1e	O
channel	O
lacking	O
an	O
asparagine	O
-	O
proline	O
(	O
NP	O
)	O
stretch	O
in	O
the	O
domain	O
IV	O
(	O
gene1s	O
alpha1A	O
gene1e	O
(-NP	O
)	O
)	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
alpha1A	O
gene1e	O
channels	O
carrying	O
various	O
polyglutamine	O
length	O
with	O
or	O
without	O
NP	O
were	O
expressed	O
in	O
species1s	O
HEK293	O
species1e	O
cells	O
,	O
and	O
channel	O
properties	O
were	O
compared	O
using	O
a	O
whole	O
-	O
cell	O
voltage	O
clamp	O
technique	O
.	O
gene1s	O
alpha1A	O
gene1e	O
(-NP	O
)	O
,	O
corresponding	O
to	O
P	O
-	O
type	O
channel	O
,	O
with	O
24	O
and	O
28	O
polyglutamines	O
found	O
in	O
species1s	O
patients	O
species1e	O
showed	O
the	O
voltage	O
dependence	O
of	O
inactivation	O
shifting	O
negatively	O
by	O
6	O
and	O
11	O
mV	O
,	O
respectively	O
,	O
from	O
the	O
13	O
polyglutamine	O
control	O
.	O
Contrarily	O
,	O
the	O
gene1s	O
alpha1A	O
gene1e	O
channel	O
with	O
NP	O
(	O
gene1s	O
alpha1A	O
gene1e	O
(+NP	O
)	O
)	O
,	O
corresponding	O
to	O
Q	O
-	O
type	O
channel	O
,	O
with	O
28	O
polyglutamines	O
exhibited	O
a	O
positive	O
shift	O
of	O
5	O
mV.	O
These	O
results	O
suggest	O
that	O
altered	O
function	O
of	O
gene1s	O
alpha1A	O
gene1e	O
(-NP	O
)	O
may	O
contribute	O
to	O
degeneration	O
of	O
Purkinje	O
cells	O
,	O
which	O
express	O
predominantly	O
gene1s	O
alpha1A	O
gene1e	O
(-NP	O
)	O
,	O
due	O
to	O
the	O
reduced	O
Ca(2	O
+	O
)	O
influx	O
resulting	O
from	O
the	O
negative	O
shift	O
of	O
voltage	O
-	O
dependent	O
inactivation	O
.	O
On	O
the	O
other	O
hand	O
,	O
other	O
types	O
of	O
neurons	O
,	O
expressing	O
both	O
gene1s	O
alpha1A	O
gene1e	O
(-NP	O
)	O
and	O
gene1s	O
alpha1A	O
gene1e	O
(+NP	O
)	O
,	O
may	O
survive	O
because	O
the	O
positive	O
shift	O
of	O
voltage	O
-	O
dependent	O
inactivation	O
of	O
gene1s	O
alpha1A	O
gene1e	O
(+NP	O
)	O
compensates	O
Ca(2	O
+	O
)	O
influx	O
.	O

Spinocerebellar	O
ataxia	O
type	O
6	O
mutation	O
alters	O
P	O
-	O
type	O
calcium	O
channel	O
function	O
.	O
Abnormal	O
CAG	O
repeat	O
expansion	O
in	O
the	O
gene1s	ARG2
alpha1A	ARG2
voltage	ARG2
-	ARG2
dependent	ARG2
calcium	ARG2
channel	ARG2
gene1e	ARG2
gene	O
is	O
associated	O
with	O
spinocerebellar	O
ataxia	O
type	O
6	O
,	O
an	O
autosomal	O
dominant	O
cerebellar	O
ataxia	O
with	O
a	O
predominant	O
loss	O
of	O
the	O
Purkinje	O
cell	O
.	O
A	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
analysis	O
of	O
mRNA	O
from	O
species1s	O
mouse	O
species1e	O
Purkinje	O
cells	O
revealed	O
a	O
predominant	O
expression	O
of	O
the	O
gene1s	ARG2
alpha1A	ARG2
gene1e	ARG2
channel	O
lacking	O
an	O
asparagine	O
-	O
proline	O
(	O
NP	O
)	O
stretch	O
in	O
the	O
domain	O
IV	O
(	O
gene1s	ARG2
alpha1A	ARG2
gene1e	ARG2
(-NP	O
)	O
)	O
.	O
arg1s	O
Human	O
arg1e	O
gene1s	ARG2
alpha1A	ARG2
gene1e	ARG2
channels	O
carrying	O
various	O
polyglutamine	O
length	O
with	O
or	O
without	O
NP	O
were	O
expressed	O
in	O
arg1s	O
HEK293	O
arg1e	O
cells	O
,	O
and	O
channel	O
properties	O
were	O
compared	O
using	O
a	O
whole	O
-	O
cell	O
voltage	O
clamp	O
technique	O
.	O
gene1s	ARG2
alpha1A	ARG2
gene1e	ARG2
(-NP	O
)	O
,	O
corresponding	O
to	O
P	O
-	O
type	O
channel	O
,	O
with	O
24	O
and	O
28	O
polyglutamines	O
found	O
in	O
arg1s	O
patients	O
arg1e	O
showed	O
the	O
voltage	O
dependence	O
of	O
inactivation	O
shifting	O
negatively	O
by	O
6	O
and	O
11	O
mV	O
,	O
respectively	O
,	O
from	O
the	O
13	O
polyglutamine	O
control	O
.	O
Contrarily	O
,	O
the	O
gene1s	ARG2
alpha1A	ARG2
gene1e	ARG2
channel	O
with	O
NP	O
(	O
gene1s	ARG2
alpha1A	ARG2
gene1e	ARG2
(+NP	O
)	O
)	O
,	O
corresponding	O
to	O
Q	O
-	O
type	O
channel	O
,	O
with	O
28	O
polyglutamines	O
exhibited	O
a	O
positive	O
shift	O
of	O
5	O
mV.	O
These	O
results	O
suggest	O
that	O
altered	O
function	O
of	O
gene1s	ARG2
alpha1A	ARG2
gene1e	ARG2
(-NP	O
)	O
may	O
contribute	O
to	O
degeneration	O
of	O
Purkinje	O
cells	O
,	O
which	O
express	O
predominantly	O
gene1s	ARG2
alpha1A	ARG2
gene1e	ARG2
(-NP	O
)	O
,	O
due	O
to	O
the	O
reduced	O
Ca(2	O
+	O
)	O
influx	O
resulting	O
from	O
the	O
negative	O
shift	O
of	O
voltage	O
-	O
dependent	O
inactivation	O
.	O
On	O
the	O
other	O
hand	O
,	O
other	O
types	O
of	O
neurons	O
,	O
expressing	O
both	O
gene1s	ARG2
alpha1A	ARG2
gene1e	ARG2
(-NP	O
)	O
and	O
gene1s	ARG2
alpha1A	ARG2
gene1e	ARG2
(+NP	O
)	O
,	O
may	O
survive	O
because	O
the	O
positive	O
shift	O
of	O
voltage	O
-	O
dependent	O
inactivation	O
of	O
gene1s	ARG2
alpha1A	ARG2
gene1e	ARG2
(+NP	O
)	O
compensates	O
Ca(2	O
+	O
)	O
influx	O
.	O

Structure	O
,	O
mapping	O
and	O
expression	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene	O
encoding	O
the	O
homeodomain	O
protein	O
,	O
gene1s	ARG2
SIX2	ARG2
gene1e	ARG2
.	O
Vertebrate	O
genes	O
with	O
sequence	O
similarity	O
to	O
the	O
species1s	O
Drosophila	O
species1e	O
homeobox	O
gene	O
,	O
gene1s	O
sine	O
oculis	O
gene1e	O
(	O
gene1s	O
so	O
gene1e	O
)	O
,	O
constitute	O
the	O
SIX	O
family	O
.	O
There	O
is	O
notable	O
expression	O
of	O
members	O
of	O
this	O
family	O
in	O
anterior	O
neural	O
structures	O
,	O
and	O
several	O
SIX	O
genes	O
have	O
been	O
shown	O
to	O
play	O
roles	O
in	O
vertebrate	O
and	O
insect	O
development	O
,	O
or	O
have	O
been	O
implicated	O
in	O
maintenance	O
of	O
the	O
differentiated	O
state	O
of	O
tissues	O
.	O
Mutations	O
in	O
three	O
of	O
these	O
genes	O
in	O
man	O
(	O
gene1s	ARG2
SIX5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SIX6	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
SIX3	ARG2
gene1e	ARG2
)	O
are	O
associated	O
with	O
severe	O
phenotypes	O
,	O
and	O
therefore	O
,	O
the	O
cloning	O
of	O
other	O
arg1s	O
human	O
arg1e	O
genes	O
from	O
this	O
family	O
is	O
of	O
interest	O
.	O
We	O
have	O
cloned	O
and	O
characterised	O
the	O
gene	O
that	O
encodes	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
SIX2	ARG2
gene1e	ARG2
,	O
elucidated	O
its	O
gene	O
structure	O
and	O
conducted	O
expression	O
studies	O
in	O
a	O
range	O
of	O
tissues	O
.	O
gene1s	ARG2
SIX2	ARG2
gene1e	ARG2
is	O
widely	O
expressed	O
in	O
the	O
late	O
first	O
-	O
trimester	O
fetus	O
,	O
but	O
has	O
a	O
limited	O
range	O
of	O
expression	O
sites	O
in	O
the	O
adult	O
.	O
The	O
expression	O
pattern	O
of	O
gene1s	ARG2
SIX2	ARG2
gene1e	ARG2
and	O
its	O
localisation	O
to	O
chromosome	O
2p15-p16	O
will	O
be	O
of	O
use	O
in	O
assessing	O
its	O
candidacy	O
in	O
arg1s	O
human	O
arg1e	O
developmental	O
disorders	O
.	O

Structure	O
,	O
mapping	O
and	O
expression	O
of	O
the	O
species1s	O
human	O
species1e	O
gene	O
encoding	O
the	O
homeodomain	O
protein	O
,	O
gene1s	O
SIX2	O
gene1e	O
.	O
Vertebrate	O
genes	O
with	O
sequence	O
similarity	O
to	O
the	O
arg1s	O
Drosophila	O
arg1e	O
homeobox	O
gene	O
,	O
gene1s	ARG2
sine	ARG2
oculis	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
so	ARG2
gene1e	ARG2
)	O
,	O
constitute	O
the	O
SIX	O
family	O
.	O
There	O
is	O
notable	O
expression	O
of	O
members	O
of	O
this	O
family	O
in	O
anterior	O
neural	O
structures	O
,	O
and	O
several	O
SIX	O
genes	O
have	O
been	O
shown	O
to	O
play	O
roles	O
in	O
vertebrate	O
and	O
insect	O
development	O
,	O
or	O
have	O
been	O
implicated	O
in	O
maintenance	O
of	O
the	O
differentiated	O
state	O
of	O
tissues	O
.	O
Mutations	O
in	O
three	O
of	O
these	O
genes	O
in	O
man	O
(	O
gene1s	O
SIX5	O
gene1e	O
,	O
gene1s	O
SIX6	O
gene1e	O
and	O
gene1s	O
SIX3	O
gene1e	O
)	O
are	O
associated	O
with	O
severe	O
phenotypes	O
,	O
and	O
therefore	O
,	O
the	O
cloning	O
of	O
other	O
species1s	O
human	O
species1e	O
genes	O
from	O
this	O
family	O
is	O
of	O
interest	O
.	O
We	O
have	O
cloned	O
and	O
characterised	O
the	O
gene	O
that	O
encodes	O
species1s	O
human	O
species1e	O
gene1s	O
SIX2	O
gene1e	O
,	O
elucidated	O
its	O
gene	O
structure	O
and	O
conducted	O
expression	O
studies	O
in	O
a	O
range	O
of	O
tissues	O
.	O
gene1s	O
SIX2	O
gene1e	O
is	O
widely	O
expressed	O
in	O
the	O
late	O
first	O
-	O
trimester	O
fetus	O
,	O
but	O
has	O
a	O
limited	O
range	O
of	O
expression	O
sites	O
in	O
the	O
adult	O
.	O
The	O
expression	O
pattern	O
of	O
gene1s	O
SIX2	O
gene1e	O
and	O
its	O
localisation	O
to	O
chromosome	O
2p15-p16	O
will	O
be	O
of	O
use	O
in	O
assessing	O
its	O
candidacy	O
in	O
species1s	O
human	O
species1e	O
developmental	O
disorders	O
.	O

Expression	O
,	O
purification	O
,	O
and	O
functional	O
analysis	O
of	O
the	O
arg1s	O
human	O
arg1e	O
serine	O
protease	O
gene1s	ARG2
HtrA2	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
HumHtrA2	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
Omi	ARG2
gene1e	ARG2
is	O
a	O
recently	O
described	O
member	O
of	O
a	O
novel	O
family	O
of	O
arg1s	O
mammalian	O
arg1e	O
serine	O
proteases	O
homologous	O
to	O
the	O
species1s	O
Escherichia	O
coli	O
species1e	O
htrA	O
gene	O
product	O
.	O
Although	O
the	O
physiological	O
function	O
of	O
members	O
of	O
this	O
new	O
family	O
is	O
unclear	O
,	O
the	O
current	O
understanding	O
is	O
that	O
as	O
well	O
as	O
being	O
involved	O
with	O
the	O
degradation	O
aberrantly	O
folded	O
proteins	O
during	O
conditions	O
of	O
cellular	O
stress	O
,	O
they	O
may	O
possess	O
a	O
chaperone	O
-	O
like	O
role	O
under	O
normal	O
conditions	O
.	O
In	O
this	O
report	O
we	O
describe	O
the	O
overexpression	O
of	O
gene1s	ARG2
humHtrA2	ARG2
gene1e	ARG2
in	O
two	O
heterologous	O
systems	O
comparing	O
the	O
merits	O
of	O
each	O
.	O
We	O
found	O
that	O
molecular	O
analysis	O
of	O
processing	O
events	O
in	O
species1s	O
Sf9	O
species1e	O
cells	O
allowed	O
us	O
to	O
revisit	O
species1s	O
E.	O
coli	O
species1e	O
expression	O
systems	O
which	O
were	O
initially	O
unsuccessful	O
.	O
Using	O
species1s	O
E.	O
coli	O
species1e	O
we	O
were	O
able	O
to	O
produce	O
milligram	O
amounts	O
of	O
>	O
90	O
%	O
pure	O
recombinant	O
enzyme	O
as	O
determined	O
by	O
SDS	O
-	O
PAGE	O
gels	O
.	O
By	O
means	O
of	O
fluorescently	O
labeled	O
substrates	O
alpha-	O
and	O
beta	O
-	O
casein	O
and	O
zymography	O
,	O
the	O
proteolytic	O
activity	O
of	O
recombinant	O
gene1s	ARG2
HumHtrA2	ARG2
gene1e	ARG2
was	O
also	O
demonstrated	O
.	O

Expression	O
,	O
purification	O
,	O
and	O
functional	O
analysis	O
of	O
the	O
species1s	O
human	O
species1e	O
serine	O
protease	O
gene1s	O
HtrA2	O
gene1e	O
.	O
gene1s	O
HumHtrA2	O
gene1e	O
or	O
gene1s	O
Omi	O
gene1e	O
is	O
a	O
recently	O
described	O
member	O
of	O
a	O
novel	O
family	O
of	O
species1s	O
mammalian	O
species1e	O
serine	O
proteases	O
homologous	O
to	O
the	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
htrA	O
gene	O
product	O
.	O
Although	O
the	O
physiological	O
function	O
of	O
members	O
of	O
this	O
new	O
family	O
is	O
unclear	O
,	O
the	O
current	O
understanding	O
is	O
that	O
as	O
well	O
as	O
being	O
involved	O
with	O
the	O
degradation	O
aberrantly	O
folded	O
proteins	O
during	O
conditions	O
of	O
cellular	O
stress	O
,	O
they	O
may	O
possess	O
a	O
chaperone	O
-	O
like	O
role	O
under	O
normal	O
conditions	O
.	O
In	O
this	O
report	O
we	O
describe	O
the	O
overexpression	O
of	O
gene1s	O
humHtrA2	O
gene1e	O
in	O
two	O
heterologous	O
systems	O
comparing	O
the	O
merits	O
of	O
each	O
.	O
We	O
found	O
that	O
molecular	O
analysis	O
of	O
processing	O
events	O
in	O
species1s	O
Sf9	O
species1e	O
cells	O
allowed	O
us	O
to	O
revisit	O
arg1s	O
E.	O
coli	O
arg1e	O
expression	O
systems	O
which	O
were	O
initially	O
unsuccessful	O
.	O
Using	O
arg1s	O
E.	O
coli	O
arg1e	O
we	O
were	O
able	O
to	O
produce	O
milligram	O
amounts	O
of	O
>	O
90	O
%	O
pure	O
recombinant	O
enzyme	O
as	O
determined	O
by	O
SDS	O
-	O
PAGE	O
gels	O
.	O
By	O
means	O
of	O
fluorescently	O
labeled	O
substrates	O
alpha-	O
and	O
beta	O
-	O
casein	O
and	O
zymography	O
,	O
the	O
proteolytic	O
activity	O
of	O
recombinant	O
gene1s	O
HumHtrA2	O
gene1e	O
was	O
also	O
demonstrated	O
.	O

Expression	O
,	O
purification	O
,	O
and	O
functional	O
analysis	O
of	O
the	O
species1s	O
human	O
species1e	O
serine	O
protease	O
gene1s	O
HtrA2	O
gene1e	O
.	O
gene1s	O
HumHtrA2	O
gene1e	O
or	O
gene1s	O
Omi	O
gene1e	O
is	O
a	O
recently	O
described	O
member	O
of	O
a	O
novel	O
family	O
of	O
species1s	O
mammalian	O
species1e	O
serine	O
proteases	O
homologous	O
to	O
the	O
species1s	O
Escherichia	O
coli	O
species1e	O
htrA	O
gene	O
product	O
.	O
Although	O
the	O
physiological	O
function	O
of	O
members	O
of	O
this	O
new	O
family	O
is	O
unclear	O
,	O
the	O
current	O
understanding	O
is	O
that	O
as	O
well	O
as	O
being	O
involved	O
with	O
the	O
degradation	O
aberrantly	O
folded	O
proteins	O
during	O
conditions	O
of	O
cellular	O
stress	O
,	O
they	O
may	O
possess	O
a	O
chaperone	O
-	O
like	O
role	O
under	O
normal	O
conditions	O
.	O
In	O
this	O
report	O
we	O
describe	O
the	O
overexpression	O
of	O
gene1s	O
humHtrA2	O
gene1e	O
in	O
two	O
heterologous	O
systems	O
comparing	O
the	O
merits	O
of	O
each	O
.	O
We	O
found	O
that	O
molecular	O
analysis	O
of	O
processing	O
events	O
in	O
arg1s	O
Sf9	O
arg1e	O
cells	O
allowed	O
us	O
to	O
revisit	O
species1s	O
E.	O
coli	O
species1e	O
expression	O
systems	O
which	O
were	O
initially	O
unsuccessful	O
.	O
Using	O
species1s	O
E.	O
coli	O
species1e	O
we	O
were	O
able	O
to	O
produce	O
milligram	O
amounts	O
of	O
>	O
90	O
%	O
pure	O
recombinant	O
enzyme	O
as	O
determined	O
by	O
SDS	O
-	O
PAGE	O
gels	O
.	O
By	O
means	O
of	O
fluorescently	O
labeled	O
substrates	O
alpha-	O
and	O
beta	O
-	O
casein	O
and	O
zymography	O
,	O
the	O
proteolytic	O
activity	O
of	O
recombinant	O
gene1s	O
HumHtrA2	O
gene1e	O
was	O
also	O
demonstrated	O
.	O

The	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
GRAF	ARG2
gene1e	ARG2
gene	O
is	O
fused	O
to	O
gene1s	ARG2
MLL	ARG2
gene1e	ARG2
in	O
a	O
unique	O
t(5;11)(q31;q23	O
)	O
and	O
both	O
alleles	O
are	O
disrupted	O
in	O
three	O
cases	O
of	O
myelodysplastic	O
syndrome	O
/	O
acute	O
myeloid	O
leukemia	O
with	O
a	O
deletion	O
5q	O
.	O
We	O
have	O
isolated	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
GRAF	ARG2
gene1e	ARG2
gene	O
(	O
for	O
GTPase	O
regulator	O
associated	O
with	O
the	O
focal	O
adhesion	O
kinase	O
pp125(FAK	O
)	O
)	O
.	O
This	O
gene	O
was	O
fused	O
with	O
gene1s	ARG2
MLL	ARG2
gene1e	ARG2
in	O
a	O
unique	O
t(5;11)(q31;q23	O
)	O
that	O
occurred	O
in	O
an	O
infant	O
with	O
juvenile	O
myelomonocytic	O
leukemia	O
.	O
gene1s	ARG2
GRAF	ARG2
gene1e	ARG2
encodes	O
a	O
member	O
of	O
the	O
Rho	O
family	O
of	O
the	O
GTPase	O
-	O
activating	O
protein	O
(	O
GAP	O
)	O
family	O
.	O
On	O
the	O
protein	O
level	O
,	O
it	O
is	O
90	O
%	O
homologous	O
to	O
the	O
recently	O
described	O
species1s	O
chicken	O
species1e	O
gene1s	O
GRAF	O
gene1e	O
gene	O
that	O
functions	O
as	O
a	O
GAP	O
of	O
gene1s	O
RhoA	O
gene1e	O
in	O
vivo	O
and	O
is	O
thus	O
a	O
critical	O
component	O
of	O
the	O
integrin	O
signaling	O
transduction	O
pathway	O
.	O
The	O
particular	O
position	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
GRAF	ARG2
gene1e	ARG2
gene	O
at	O
5q31	O
and	O
the	O
proposed	O
antiproliferative	O
and	O
tumor	O
suppressor	O
properties	O
of	O
its	O
avian	O
homologue	O
suggest	O
that	O
it	O
also	O
might	O
be	O
pathogenetically	O
relevant	O
for	O
hematologic	O
malignancies	O
with	O
deletions	O
of	O
5q	O
.	O
To	O
investigate	O
this	O
possibility	O
,	O
we	O
sequenced	O
4	O
-	O
5	O
individual	O
cDNA	O
clones	O
from	O
13	O
cases	O
in	O
which	O
one	O
allele	O
of	O
gene1s	ARG2
GRAF	ARG2
gene1e	ARG2
was	O
deleted	O
.	O
We	O
found	O
point	O
mutations	O
within	O
the	O
GAP	O
domain	O
of	O
the	O
second	O
gene1s	ARG2
GRAF	ARG2
gene1e	ARG2
allele	O
in	O
one	O
arg1s	O
patient	O
arg1e	O
.	O
In	O
two	O
additional	O
arg1s	O
patients	O
arg1e	O
we	O
found	O
an	O
insertion	O
of	O
52	O
or	O
74	O
bp	O
within	O
the	O
gene1s	ARG2
GRAF	ARG2
gene1e	ARG2
cDNA	O
that	O
generates	O
a	O
reading	O
frame	O
shift	O
followed	O
by	O
a	O
premature	O
stop	O
codon	O
.	O
gene1s	ARG2
GRAF	ARG2
gene1e	ARG2
maps	O
outside	O
the	O
previously	O
defined	O
commonly	O
deleted	O
5q31	O
region	O
.	O
Nevertheless	O
,	O
inactivation	O
of	O
both	O
alleles	O
in	O
at	O
least	O
some	O
cases	O
suggests	O
that	O
deletions	O
and	O
mutations	O
of	O
the	O
gene1s	ARG2
GRAF	ARG2
gene1e	ARG2
gene	O
may	O
be	O
instrumental	O
in	O
the	O
development	O
and	O
progression	O
of	O
hematopoeitic	O
disorders	O
with	O
a	O
del(5q	O
)	O
.	O

The	O
species1s	O
human	O
species1e	O
gene1s	O
GRAF	O
gene1e	O
gene	O
is	O
fused	O
to	O
gene1s	O
MLL	O
gene1e	O
in	O
a	O
unique	O
t(5;11)(q31;q23	O
)	O
and	O
both	O
alleles	O
are	O
disrupted	O
in	O
three	O
cases	O
of	O
myelodysplastic	O
syndrome	O
/	O
acute	O
myeloid	O
leukemia	O
with	O
a	O
deletion	O
5q	O
.	O
We	O
have	O
isolated	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
GRAF	O
gene1e	O
gene	O
(	O
for	O
GTPase	O
regulator	O
associated	O
with	O
the	O
focal	O
adhesion	O
kinase	O
pp125(FAK	O
)	O
)	O
.	O
This	O
gene	O
was	O
fused	O
with	O
gene1s	O
MLL	O
gene1e	O
in	O
a	O
unique	O
t(5;11)(q31;q23	O
)	O
that	O
occurred	O
in	O
an	O
infant	O
with	O
juvenile	O
myelomonocytic	O
leukemia	O
.	O
gene1s	O
GRAF	O
gene1e	O
encodes	O
a	O
member	O
of	O
the	O
Rho	O
family	O
of	O
the	O
GTPase	O
-	O
activating	O
protein	O
(	O
GAP	O
)	O
family	O
.	O
On	O
the	O
protein	O
level	O
,	O
it	O
is	O
90	O
%	O
homologous	O
to	O
the	O
recently	O
described	O
arg1s	O
chicken	O
arg1e	O
gene1s	ARG2
GRAF	ARG2
gene1e	ARG2
gene	O
that	O
functions	O
as	O
a	O
GAP	O
of	O
gene1s	ARG2
RhoA	ARG2
gene1e	ARG2
in	O
vivo	O
and	O
is	O
thus	O
a	O
critical	O
component	O
of	O
the	O
integrin	O
signaling	O
transduction	O
pathway	O
.	O
The	O
particular	O
position	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
GRAF	O
gene1e	O
gene	O
at	O
5q31	O
and	O
the	O
proposed	O
antiproliferative	O
and	O
tumor	O
suppressor	O
properties	O
of	O
its	O
avian	O
homologue	O
suggest	O
that	O
it	O
also	O
might	O
be	O
pathogenetically	O
relevant	O
for	O
hematologic	O
malignancies	O
with	O
deletions	O
of	O
5q	O
.	O
To	O
investigate	O
this	O
possibility	O
,	O
we	O
sequenced	O
4	O
-	O
5	O
individual	O
cDNA	O
clones	O
from	O
13	O
cases	O
in	O
which	O
one	O
allele	O
of	O
gene1s	O
GRAF	O
gene1e	O
was	O
deleted	O
.	O
We	O
found	O
point	O
mutations	O
within	O
the	O
GAP	O
domain	O
of	O
the	O
second	O
gene1s	O
GRAF	O
gene1e	O
allele	O
in	O
one	O
species1s	O
patient	O
species1e	O
.	O
In	O
two	O
additional	O
species1s	O
patients	O
species1e	O
we	O
found	O
an	O
insertion	O
of	O
52	O
or	O
74	O
bp	O
within	O
the	O
gene1s	O
GRAF	O
gene1e	O
cDNA	O
that	O
generates	O
a	O
reading	O
frame	O
shift	O
followed	O
by	O
a	O
premature	O
stop	O
codon	O
.	O
gene1s	O
GRAF	O
gene1e	O
maps	O
outside	O
the	O
previously	O
defined	O
commonly	O
deleted	O
5q31	O
region	O
.	O
Nevertheless	O
,	O
inactivation	O
of	O
both	O
alleles	O
in	O
at	O
least	O
some	O
cases	O
suggests	O
that	O
deletions	O
and	O
mutations	O
of	O
the	O
gene1s	O
GRAF	O
gene1e	O
gene	O
may	O
be	O
instrumental	O
in	O
the	O
development	O
and	O
progression	O
of	O
hematopoeitic	O
disorders	O
with	O
a	O
del(5q	O
)	O
.	O

gene1s	ARG2
Ataxin-3	ARG2
gene1e	ARG2
,	O
the	O
gene1s	ARG2
MJD1	ARG2
gene1e	ARG2
gene	O
product	O
,	O
interacts	O
with	O
the	O
two	O
arg1s	O
human	O
arg1e	O
homologs	O
of	O
species1s	O
yeast	O
species1e	O
DNA	O
repair	O
protein	O
RAD23	O
,	O
gene1s	ARG2
HHR23A	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
HHR23B	ARG2
gene1e	ARG2
.	O
Machado	O
-	O
Joseph	O
disease	O
(	O
MJD	O
)	O
is	O
an	O
autosomal	O
dominant	O
neurodegenerative	O
disorder	O
caused	O
by	O
an	O
expansion	O
of	O
the	O
polyglutamine	O
tract	O
near	O
the	O
C	O
-	O
terminus	O
of	O
the	O
gene1s	ARG2
MJD1	ARG2
gene1e	ARG2
gene	O
product	O
,	O
gene1s	ARG2
ataxin-3	ARG2
gene1e	ARG2
.	O
The	O
mutant	O
gene1s	ARG2
ataxin-3	ARG2
gene1e	ARG2
forms	O
intranuclear	O
inclusions	O
in	O
cultured	O
cells	O
as	O
well	O
as	O
in	O
diseased	O
arg1s	O
human	O
arg1e	O
brain	O
and	O
also	O
causes	O
cell	O
death	O
in	O
transfected	O
cells	O
.	O
However	O
,	O
the	O
normal	O
function	O
of	O
gene1s	ARG2
ataxin-3	ARG2
gene1e	ARG2
remains	O
unknown	O
.	O
To	O
explore	O
the	O
function	O
of	O
gene1s	ARG2
ataxin-3	ARG2
gene1e	ARG2
,	O
we	O
used	O
the	O
two	O
-	O
hybrid	O
system	O
to	O
screen	O
for	O
the	O
protein(s	O
)	O
that	O
interacts	O
with	O
gene1s	ARG2
ataxin-3	ARG2
gene1e	ARG2
.	O
We	O
found	O
that	O
gene1s	ARG2
ataxin-3	ARG2
gene1e	ARG2
interacts	O
with	O
two	O
arg1s	O
human	O
arg1e	O
homologs	O
of	O
the	O
species1s	O
yeast	O
species1e	O
DNA	O
repair	O
protein	O
gene1s	O
RAD23	O
gene1e	O
,	O
gene1s	ARG2
HHR23A	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
HHR23B	ARG2
gene1e	ARG2
.	O
Furthermore	O
,	O
we	O
confirmed	O
that	O
gene1s	ARG2
ataxin-3	ARG2
gene1e	ARG2
interacts	O
with	O
the	O
-ubiquitin	O
-	O
like	O
domain	O
at	O
the	O
N	O
-	O
terminus	O
of	O
the	O
HHR23	O
proteins	O
,	O
which	O
is	O
important	O
for	O
nucleotide	O
excision	O
repair	O
;	O
however	O
,	O
gene1s	ARG2
ataxin-3	ARG2
gene1e	ARG2
does	O
not	O
interact	O
with	O
-ubiquitin	O
,	O
implying	O
that	O
gene1s	ARG2
ataxin-3	ARG2
gene1e	ARG2
might	O
be	O
functionally	O
associated	O
with	O
the	O
HHR23	O
proteins	O
through	O
this	O
specific	O
interaction	O
.	O
The	O
normal	O
and	O
mutant	O
gene1s	ARG2
ataxin-3	ARG2
gene1e	ARG2
proteins	O
show	O
no	O
difference	O
in	O
their	O
ability	O
to	O
bind	O
to	O
the	O
HHR23	O
proteins	O
.	O
However	O
,	O
in	O
arg1s	O
293	O
arg1e	O
cells	O
gene1s	ARG2
HHR23A	ARG2
gene1e	ARG2
is	O
recruited	O
to	O
intranuclear	O
inclusions	O
formed	O
by	O
the	O
mutant	O
gene1s	ARG2
ataxin-3	ARG2
gene1e	ARG2
through	O
its	O
interaction	O
with	O
gene1s	ARG2
ataxin-3	ARG2
gene1e	ARG2
.	O
These	O
results	O
suggest	O
that	O
this	O
interaction	O
is	O
associated	O
with	O
the	O
normal	O
function	O
of	O
gene1s	ARG2
ataxin-3	ARG2
gene1e	ARG2
and	O
that	O
some	O
functional	O
abnormality	O
of	O
the	O
HHR23	O
proteins	O
might	O
exist	O
in	O
MJD	O
.	O

gene1s	O
Ataxin-3	O
gene1e	O
,	O
the	O
gene1s	O
MJD1	O
gene1e	O
gene	O
product	O
,	O
interacts	O
with	O
the	O
two	O
species1s	O
human	O
species1e	O
homologs	O
of	O
arg1s	O
yeast	O
arg1e	O
DNA	O
repair	O
protein	O
RAD23	O
,	O
gene1s	O
HHR23A	O
gene1e	O
and	O
gene1s	O
HHR23B	O
gene1e	O
.	O
Machado	O
-	O
Joseph	O
disease	O
(	O
MJD	O
)	O
is	O
an	O
autosomal	O
dominant	O
neurodegenerative	O
disorder	O
caused	O
by	O
an	O
expansion	O
of	O
the	O
polyglutamine	O
tract	O
near	O
the	O
C	O
-	O
terminus	O
of	O
the	O
gene1s	O
MJD1	O
gene1e	O
gene	O
product	O
,	O
gene1s	O
ataxin-3	O
gene1e	O
.	O
The	O
mutant	O
gene1s	O
ataxin-3	O
gene1e	O
forms	O
intranuclear	O
inclusions	O
in	O
cultured	O
cells	O
as	O
well	O
as	O
in	O
diseased	O
species1s	O
human	O
species1e	O
brain	O
and	O
also	O
causes	O
cell	O
death	O
in	O
transfected	O
cells	O
.	O
However	O
,	O
the	O
normal	O
function	O
of	O
gene1s	O
ataxin-3	O
gene1e	O
remains	O
unknown	O
.	O
To	O
explore	O
the	O
function	O
of	O
gene1s	O
ataxin-3	O
gene1e	O
,	O
we	O
used	O
the	O
two	O
-	O
hybrid	O
system	O
to	O
screen	O
for	O
the	O
protein(s	O
)	O
that	O
interacts	O
with	O
gene1s	O
ataxin-3	O
gene1e	O
.	O
We	O
found	O
that	O
gene1s	O
ataxin-3	O
gene1e	O
interacts	O
with	O
two	O
species1s	O
human	O
species1e	O
homologs	O
of	O
the	O
arg1s	O
yeast	O
arg1e	O
DNA	O
repair	O
protein	O
gene1s	ARG2
RAD23	ARG2
gene1e	ARG2
,	O
gene1s	O
HHR23A	O
gene1e	O
and	O
gene1s	O
HHR23B	O
gene1e	O
.	O
Furthermore	O
,	O
we	O
confirmed	O
that	O
gene1s	O
ataxin-3	O
gene1e	O
interacts	O
with	O
the	O
-ubiquitin	O
-	O
like	O
domain	O
at	O
the	O
N	O
-	O
terminus	O
of	O
the	O
HHR23	O
proteins	O
,	O
which	O
is	O
important	O
for	O
nucleotide	O
excision	O
repair	O
;	O
however	O
,	O
gene1s	O
ataxin-3	O
gene1e	O
does	O
not	O
interact	O
with	O
-ubiquitin	O
,	O
implying	O
that	O
gene1s	O
ataxin-3	O
gene1e	O
might	O
be	O
functionally	O
associated	O
with	O
the	O
HHR23	O
proteins	O
through	O
this	O
specific	O
interaction	O
.	O
The	O
normal	O
and	O
mutant	O
gene1s	O
ataxin-3	O
gene1e	O
proteins	O
show	O
no	O
difference	O
in	O
their	O
ability	O
to	O
bind	O
to	O
the	O
HHR23	O
proteins	O
.	O
However	O
,	O
in	O
species1s	O
293	O
species1e	O
cells	O
gene1s	O
HHR23A	O
gene1e	O
is	O
recruited	O
to	O
intranuclear	O
inclusions	O
formed	O
by	O
the	O
mutant	O
gene1s	O
ataxin-3	O
gene1e	O
through	O
its	O
interaction	O
with	O
gene1s	O
ataxin-3	O
gene1e	O
.	O
These	O
results	O
suggest	O
that	O
this	O
interaction	O
is	O
associated	O
with	O
the	O
normal	O
function	O
of	O
gene1s	O
ataxin-3	O
gene1e	O
and	O
that	O
some	O
functional	O
abnormality	O
of	O
the	O
HHR23	O
proteins	O
might	O
exist	O
in	O
MJD	O
.	O

gene1s	ARG2
Retinoschisin	ARG2
gene1e	ARG2
,	O
the	O
gene1s	ARG2
X	ARG2
-	ARG2
linked	ARG2
retinoschisis	ARG2
protein	ARG2
gene1e	ARG2
,	O
is	O
a	O
secreted	O
photoreceptor	O
protein	O
,	O
and	O
is	O
expressed	O
and	O
released	O
by	O
arg1s	O
Weri	O
-	O
Rb1	O
arg1e	O
cells	O
.	O
gene1s	ARG2
X	ARG2
-	ARG2
linked	ARG2
retinoschisis	ARG2
gene1e	ARG2
is	O
characterized	O
by	O
microcystic	O
-	O
like	O
changes	O
of	O
the	O
macular	O
region	O
and	O
schisis	O
within	O
the	O
inner	O
retinal	O
layers	O
,	O
leading	O
to	O
visual	O
deterioration	O
in	O
males	O
.	O
Many	O
missense	O
and	O
protein	O
-	O
truncating	O
mutations	O
of	O
the	O
causative	O
gene	O
gene1s	ARG2
RS1	ARG2
gene1e	ARG2
have	O
now	O
been	O
identified	O
and	O
are	O
thought	O
to	O
be	O
inactivating	O
.	O
gene1s	ARG2
RS1	ARG2
gene1e	ARG2
encodes	O
a	O
224	O
amino	O
acid	O
protein	O
,	O
gene1s	ARG2
retinoschisin	ARG2
gene1e	ARG2
,	O
which	O
contains	O
a	O
discoidin	O
domain	O
but	O
is	O
of	O
unknown	O
function	O
.	O
We	O
have	O
generated	O
a	O
polyclonal	O
antibody	O
against	O
a	O
peptide	O
from	O
a	O
unique	O
region	O
within	O
gene1s	ARG2
retinoschisin	ARG2
gene1e	ARG2
,	O
which	O
detects	O
a	O
protein	O
of	O
approximately	O
28	O
kDa	O
in	O
retinal	O
samples	O
reduced	O
with	O
dithiothreitol	O
,	O
but	O
multimers	O
sized	O
>	O
40	O
kDa	O
under	O
non	O
-	O
reducing	O
conditions	O
.	O
A	O
screen	O
of	O
arg1s	O
human	O
arg1e	O
tissues	O
with	O
this	O
antibody	O
reveals	O
gene1s	ARG2
retinoschisin	ARG2
gene1e	ARG2
to	O
be	O
retina	O
specific	O
and	O
the	O
antibody	O
detects	O
a	O
protein	O
of	O
similar	O
size	O
in	O
species1s	O
bovine	O
species1e	O
and	O
species1s	O
murine	O
species1e	O
retinae	O
.	O
We	O
investigated	O
the	O
expression	O
pattern	O
in	O
the	O
retina	O
of	O
both	O
gene1s	ARG2
RS1	ARG2
gene1e	ARG2
mRNA	O
(	O
using	O
in	O
situ	O
hybridization	O
with	O
riboprobes	O
)	O
and	O
gene1s	ARG2
retinoschisin	ARG2
gene1e	ARG2
(	O
using	O
immunohistochemistry	O
)	O
.	O
The	O
antisense	O
riboprobe	O
detected	O
gene1s	ARG2
RS1	ARG2
gene1e	ARG2
mRNA	O
only	O
in	O
the	O
photoreceptor	O
layer	O
but	O
the	O
protein	O
product	O
of	O
the	O
gene	O
was	O
present	O
both	O
in	O
the	O
photoreceptors	O
and	O
within	O
the	O
inner	O
portions	O
of	O
the	O
retina	O
.	O
Furthermore	O
,	O
differentiated	O
retinoblastoma	O
cells	O
(	O
arg1s	O
Weri	O
-	O
Rb1	O
arg1e	O
cells	O
)	O
were	O
found	O
to	O
express	O
gene1s	ARG2
RS1	ARG2
gene1e	ARG2
mRNA	O
and	O
to	O
release	O
gene1s	ARG2
retinoschisin	ARG2
gene1e	ARG2
.	O
These	O
results	O
suggest	O
that	O
gene1s	ARG2
retinoschisin	ARG2
gene1e	ARG2
is	O
released	O
by	O
photo	O
-	O
receptors	O
and	O
has	O
functions	O
within	O
the	O
inner	O
retinal	O
layers	O
.	O
Thus	O
,	O
gene1s	ARG2
X	ARG2
-	ARG2
linked	ARG2
retinoschisis	ARG2
gene1e	ARG2
is	O
caused	O
by	O
abnormalities	O
in	O
a	O
putative	O
secreted	O
photoreceptor	O
protein	O
and	O
is	O
the	O
first	O
example	O
of	O
a	O
secreted	O
photo	O
-	O
receptor	O
protein	O
associated	O
with	O
a	O
retinal	O
dystrophy	O
.	O

gene1s	O
Retinoschisin	O
gene1e	O
,	O
the	O
gene1s	O
X	O
-	O
linked	O
retinoschisis	O
protein	O
gene1e	O
,	O
is	O
a	O
secreted	O
photoreceptor	O
protein	O
,	O
and	O
is	O
expressed	O
and	O
released	O
by	O
species1s	O
Weri	O
-	O
Rb1	O
species1e	O
cells	O
.	O
gene1s	O
X	O
-	O
linked	O
retinoschisis	O
gene1e	O
is	O
characterized	O
by	O
microcystic	O
-	O
like	O
changes	O
of	O
the	O
macular	O
region	O
and	O
schisis	O
within	O
the	O
inner	O
retinal	O
layers	O
,	O
leading	O
to	O
visual	O
deterioration	O
in	O
males	O
.	O
Many	O
missense	O
and	O
protein	O
-	O
truncating	O
mutations	O
of	O
the	O
causative	O
gene	O
gene1s	O
RS1	O
gene1e	O
have	O
now	O
been	O
identified	O
and	O
are	O
thought	O
to	O
be	O
inactivating	O
.	O
gene1s	O
RS1	O
gene1e	O
encodes	O
a	O
224	O
amino	O
acid	O
protein	O
,	O
gene1s	O
retinoschisin	O
gene1e	O
,	O
which	O
contains	O
a	O
discoidin	O
domain	O
but	O
is	O
of	O
unknown	O
function	O
.	O
We	O
have	O
generated	O
a	O
polyclonal	O
antibody	O
against	O
a	O
peptide	O
from	O
a	O
unique	O
region	O
within	O
gene1s	O
retinoschisin	O
gene1e	O
,	O
which	O
detects	O
a	O
protein	O
of	O
approximately	O
28	O
kDa	O
in	O
retinal	O
samples	O
reduced	O
with	O
dithiothreitol	O
,	O
but	O
multimers	O
sized	O
>	O
40	O
kDa	O
under	O
non	O
-	O
reducing	O
conditions	O
.	O
A	O
screen	O
of	O
species1s	O
human	O
species1e	O
tissues	O
with	O
this	O
antibody	O
reveals	O
gene1s	O
retinoschisin	O
gene1e	O
to	O
be	O
retina	O
specific	O
and	O
the	O
antibody	O
detects	O
a	O
protein	O
of	O
similar	O
size	O
in	O
arg1s	O
bovine	O
arg1e	O
and	O
species1s	O
murine	O
species1e	O
retinae	O
.	O
We	O
investigated	O
the	O
expression	O
pattern	O
in	O
the	O
retina	O
of	O
both	O
gene1s	O
RS1	O
gene1e	O
mRNA	O
(	O
using	O
in	O
situ	O
hybridization	O
with	O
riboprobes	O
)	O
and	O
gene1s	O
retinoschisin	O
gene1e	O
(	O
using	O
immunohistochemistry	O
)	O
.	O
The	O
antisense	O
riboprobe	O
detected	O
gene1s	O
RS1	O
gene1e	O
mRNA	O
only	O
in	O
the	O
photoreceptor	O
layer	O
but	O
the	O
protein	O
product	O
of	O
the	O
gene	O
was	O
present	O
both	O
in	O
the	O
photoreceptors	O
and	O
within	O
the	O
inner	O
portions	O
of	O
the	O
retina	O
.	O
Furthermore	O
,	O
differentiated	O
retinoblastoma	O
cells	O
(	O
species1s	O
Weri	O
-	O
Rb1	O
species1e	O
cells	O
)	O
were	O
found	O
to	O
express	O
gene1s	O
RS1	O
gene1e	O
mRNA	O
and	O
to	O
release	O
gene1s	O
retinoschisin	O
gene1e	O
.	O
These	O
results	O
suggest	O
that	O
gene1s	O
retinoschisin	O
gene1e	O
is	O
released	O
by	O
photo	O
-	O
receptors	O
and	O
has	O
functions	O
within	O
the	O
inner	O
retinal	O
layers	O
.	O
Thus	O
,	O
gene1s	O
X	O
-	O
linked	O
retinoschisis	O
gene1e	O
is	O
caused	O
by	O
abnormalities	O
in	O
a	O
putative	O
secreted	O
photoreceptor	O
protein	O
and	O
is	O
the	O
first	O
example	O
of	O
a	O
secreted	O
photo	O
-	O
receptor	O
protein	O
associated	O
with	O
a	O
retinal	O
dystrophy	O
.	O

gene1s	O
Retinoschisin	O
gene1e	O
,	O
the	O
gene1s	O
X	O
-	O
linked	O
retinoschisis	O
protein	O
gene1e	O
,	O
is	O
a	O
secreted	O
photoreceptor	O
protein	O
,	O
and	O
is	O
expressed	O
and	O
released	O
by	O
species1s	O
Weri	O
-	O
Rb1	O
species1e	O
cells	O
.	O
gene1s	O
X	O
-	O
linked	O
retinoschisis	O
gene1e	O
is	O
characterized	O
by	O
microcystic	O
-	O
like	O
changes	O
of	O
the	O
macular	O
region	O
and	O
schisis	O
within	O
the	O
inner	O
retinal	O
layers	O
,	O
leading	O
to	O
visual	O
deterioration	O
in	O
males	O
.	O
Many	O
missense	O
and	O
protein	O
-	O
truncating	O
mutations	O
of	O
the	O
causative	O
gene	O
gene1s	O
RS1	O
gene1e	O
have	O
now	O
been	O
identified	O
and	O
are	O
thought	O
to	O
be	O
inactivating	O
.	O
gene1s	O
RS1	O
gene1e	O
encodes	O
a	O
224	O
amino	O
acid	O
protein	O
,	O
gene1s	O
retinoschisin	O
gene1e	O
,	O
which	O
contains	O
a	O
discoidin	O
domain	O
but	O
is	O
of	O
unknown	O
function	O
.	O
We	O
have	O
generated	O
a	O
polyclonal	O
antibody	O
against	O
a	O
peptide	O
from	O
a	O
unique	O
region	O
within	O
gene1s	O
retinoschisin	O
gene1e	O
,	O
which	O
detects	O
a	O
protein	O
of	O
approximately	O
28	O
kDa	O
in	O
retinal	O
samples	O
reduced	O
with	O
dithiothreitol	O
,	O
but	O
multimers	O
sized	O
>	O
40	O
kDa	O
under	O
non	O
-	O
reducing	O
conditions	O
.	O
A	O
screen	O
of	O
species1s	O
human	O
species1e	O
tissues	O
with	O
this	O
antibody	O
reveals	O
gene1s	O
retinoschisin	O
gene1e	O
to	O
be	O
retina	O
specific	O
and	O
the	O
antibody	O
detects	O
a	O
protein	O
of	O
similar	O
size	O
in	O
species1s	O
bovine	O
species1e	O
and	O
arg1s	O
murine	O
arg1e	O
retinae	O
.	O
We	O
investigated	O
the	O
expression	O
pattern	O
in	O
the	O
retina	O
of	O
both	O
gene1s	O
RS1	O
gene1e	O
mRNA	O
(	O
using	O
in	O
situ	O
hybridization	O
with	O
riboprobes	O
)	O
and	O
gene1s	O
retinoschisin	O
gene1e	O
(	O
using	O
immunohistochemistry	O
)	O
.	O
The	O
antisense	O
riboprobe	O
detected	O
gene1s	O
RS1	O
gene1e	O
mRNA	O
only	O
in	O
the	O
photoreceptor	O
layer	O
but	O
the	O
protein	O
product	O
of	O
the	O
gene	O
was	O
present	O
both	O
in	O
the	O
photoreceptors	O
and	O
within	O
the	O
inner	O
portions	O
of	O
the	O
retina	O
.	O
Furthermore	O
,	O
differentiated	O
retinoblastoma	O
cells	O
(	O
species1s	O
Weri	O
-	O
Rb1	O
species1e	O
cells	O
)	O
were	O
found	O
to	O
express	O
gene1s	O
RS1	O
gene1e	O
mRNA	O
and	O
to	O
release	O
gene1s	O
retinoschisin	O
gene1e	O
.	O
These	O
results	O
suggest	O
that	O
gene1s	O
retinoschisin	O
gene1e	O
is	O
released	O
by	O
photo	O
-	O
receptors	O
and	O
has	O
functions	O
within	O
the	O
inner	O
retinal	O
layers	O
.	O
Thus	O
,	O
gene1s	O
X	O
-	O
linked	O
retinoschisis	O
gene1e	O
is	O
caused	O
by	O
abnormalities	O
in	O
a	O
putative	O
secreted	O
photoreceptor	O
protein	O
and	O
is	O
the	O
first	O
example	O
of	O
a	O
secreted	O
photo	O
-	O
receptor	O
protein	O
associated	O
with	O
a	O
retinal	O
dystrophy	O
.	O

arg1s	O
HIV-1	O
arg1e	O
gene1s	ARG2
gp120	ARG2
gene1e	ARG2
-	O
and	O
gene1s	ARG2
gp160	ARG2
gene1e	ARG2
-induced	O
apoptosis	O
in	O
cultured	O
endothelial	O
cells	O
is	O
mediated	O
by	O
caspases	O
.	O
The	O
immune	O
dysfunction	O
and	O
cell	O
destruction	O
that	O
occur	O
in	O
the	O
species1s	O
human	O
immunodeficiency	O
virus	O
species1e	O
(	O
species1s	O
HIV	O
species1e	O
)-infected	O
host	O
appear	O
to	O
result	O
from	O
the	O
direct	O
cytopathic	O
effects	O
of	O
viral	O
infection	O
and	O
the	O
effects	O
of	O
viral	O
proteins	O
on	O
uninfected	O
bystander	O
cells	O
.	O
Recently	O
,	O
the	O
gene1s	O
alpha	O
-	O
chemokine	O
receptor	O
CXCR4	O
gene1e	O
has	O
been	O
reported	O
to	O
mediate	O
apoptosis	O
in	O
neuronal	O
cells	O
and	O
in	O
CD4(+	O
)	O
and	O
CD8(+	O
)	O
T	O
cells	O
after	O
its	O
binding	O
to	O
arg1s	O
HIV-1	O
arg1e	O
envelope	O
proteins	O
.	O
In	O
the	O
current	O
study	O
,	O
it	O
was	O
observed	O
that	O
species1s	O
human	O
species1e	O
umbilical	O
vein	O
endothelial	O
cells	O
(	O
HUVEC	O
)	O
undergo	O
apoptosis	O
after	O
their	O
treatment	O
with	O
the	O
arg1s	O
HIV-1	O
arg1e	O
envelope	O
proteins	O
gene1s	ARG2
gp120/160	ARG2
gene1e	ARG2
.	O
Anti	O
-	O
gene1s	O
CXCR4	O
gene1e	O
monoclonal	O
antibody	O
decreased	O
arg1s	O
HIV-1	O
arg1e	O
gene1s	ARG2
gp120/160	ARG2
gene1e	ARG2
-induced	O
apoptosis	O
,	O
suggesting	O
that	O
the	O
gene1s	O
CXCR4	O
gene1e	O
chemokine	O
receptor	O
mediates	O
the	O
apoptotic	O
effects	O
of	O
these	O
species1s	O
HIV	O
species1e	O
envelope	O
glycoproteins	O
.	O
Further	O
studies	O
revealed	O
that	O
caspases	O
play	O
an	O
important	O
role	O
in	O
this	O
process	O
because	O
the	O
pretreatment	O
of	O
cells	O
with	O
a	O
general	O
caspase	O
enzyme	O
inhibitor	O
decreased	O
the	O
extent	O
of	O
HUVEC	O
apoptosis	O
induced	O
by	O
gene1s	ARG2
gp120/160	ARG2
gene1e	ARG2
.	O
In	O
addition	O
,	O
it	O
was	O
found	O
that	O
gene1s	O
caspase-3	O
gene1e	O
was	O
activated	O
on	O
arg1s	O
HIV-1	O
arg1e	O
gene1s	ARG2
gp120/160	ARG2
gene1e	ARG2
treatment	O
of	O
these	O
cells	O
.	O
It	O
was	O
also	O
observed	O
that	O
gene1s	ARG2
gp120/160	ARG2
gene1e	ARG2
treatment	O
slightly	O
increased	O
the	O
expression	O
of	O
the	O
pro	O
-	O
apoptotic	O
molecule	O
gene1s	O
Bax	O
gene1e	O
.	O
These	O
results	O
suggest	O
that	O
arg1s	O
HIV-1	O
arg1e	O
envelope	O
glycoproteins	O
can	O
disrupt	O
endothelial	O
integrity	O
through	O
the	O
interaction	O
with	O
gene1s	O
CXCR4	O
gene1e	O
,	O
thereby	O
facilitating	O
virus	O
transit	O
out	O
of	O
the	O
bloodstream	O
and	O
contributing	O
to	O
the	O
vascular	O
injury	O
syndromes	O
seen	O
in	O
acquired	O
immunodeficiency	O
syndrome	O
.	O
(	O
Blood	O
.	O
2000;96:1438	O
-	O
1442	O
)	O

species1s	O
HIV-1	O
species1e	O
gene1s	O
gp120	O
gene1e	O
-	O
and	O
gene1s	O
gp160	O
gene1e	O
-induced	O
apoptosis	O
in	O
cultured	O
endothelial	O
cells	O
is	O
mediated	O
by	O
caspases	O
.	O
The	O
immune	O
dysfunction	O
and	O
cell	O
destruction	O
that	O
occur	O
in	O
the	O
arg1s	O
human	O
immunodeficiency	O
virus	O
arg1e	O
(	O
arg1s	O
HIV	O
arg1e	O
)-infected	O
host	O
appear	O
to	O
result	O
from	O
the	O
direct	O
cytopathic	O
effects	O
of	O
viral	O
infection	O
and	O
the	O
effects	O
of	O
viral	O
proteins	O
on	O
uninfected	O
bystander	O
cells	O
.	O
Recently	O
,	O
the	O
gene1s	O
alpha	O
-	O
chemokine	O
receptor	O
CXCR4	O
gene1e	O
has	O
been	O
reported	O
to	O
mediate	O
apoptosis	O
in	O
neuronal	O
cells	O
and	O
in	O
CD4(+	O
)	O
and	O
CD8(+	O
)	O
T	O
cells	O
after	O
its	O
binding	O
to	O
species1s	O
HIV-1	O
species1e	O
envelope	O
proteins	O
.	O
In	O
the	O
current	O
study	O
,	O
it	O
was	O
observed	O
that	O
species1s	O
human	O
species1e	O
umbilical	O
vein	O
endothelial	O
cells	O
(	O
HUVEC	O
)	O
undergo	O
apoptosis	O
after	O
their	O
treatment	O
with	O
the	O
species1s	O
HIV-1	O
species1e	O
envelope	O
proteins	O
gene1s	O
gp120/160	O
gene1e	O
.	O
Anti	O
-	O
gene1s	O
CXCR4	O
gene1e	O
monoclonal	O
antibody	O
decreased	O
species1s	O
HIV-1	O
species1e	O
gene1s	O
gp120/160	O
gene1e	O
-induced	O
apoptosis	O
,	O
suggesting	O
that	O
the	O
gene1s	O
CXCR4	O
gene1e	O
chemokine	O
receptor	O
mediates	O
the	O
apoptotic	O
effects	O
of	O
these	O
arg1s	O
HIV	O
arg1e	O
envelope	O
glycoproteins	O
.	O
Further	O
studies	O
revealed	O
that	O
caspases	O
play	O
an	O
important	O
role	O
in	O
this	O
process	O
because	O
the	O
pretreatment	O
of	O
cells	O
with	O
a	O
general	O
caspase	O
enzyme	O
inhibitor	O
decreased	O
the	O
extent	O
of	O
HUVEC	O
apoptosis	O
induced	O
by	O
gene1s	O
gp120/160	O
gene1e	O
.	O
In	O
addition	O
,	O
it	O
was	O
found	O
that	O
gene1s	O
caspase-3	O
gene1e	O
was	O
activated	O
on	O
species1s	O
HIV-1	O
species1e	O
gene1s	O
gp120/160	O
gene1e	O
treatment	O
of	O
these	O
cells	O
.	O
It	O
was	O
also	O
observed	O
that	O
gene1s	O
gp120/160	O
gene1e	O
treatment	O
slightly	O
increased	O
the	O
expression	O
of	O
the	O
pro	O
-	O
apoptotic	O
molecule	O
gene1s	O
Bax	O
gene1e	O
.	O
These	O
results	O
suggest	O
that	O
species1s	O
HIV-1	O
species1e	O
envelope	O
glycoproteins	O
can	O
disrupt	O
endothelial	O
integrity	O
through	O
the	O
interaction	O
with	O
gene1s	O
CXCR4	O
gene1e	O
,	O
thereby	O
facilitating	O
virus	O
transit	O
out	O
of	O
the	O
bloodstream	O
and	O
contributing	O
to	O
the	O
vascular	O
injury	O
syndromes	O
seen	O
in	O
acquired	O
immunodeficiency	O
syndrome	O
.	O
(	O
Blood	O
.	O
2000;96:1438	O
-	O
1442	O
)	O

species1s	O
HIV-1	O
species1e	O
gene1s	O
gp120	O
gene1e	O
-	O
and	O
gene1s	O
gp160	O
gene1e	O
-induced	O
apoptosis	O
in	O
cultured	O
endothelial	O
cells	O
is	O
mediated	O
by	O
caspases	O
.	O
The	O
immune	O
dysfunction	O
and	O
cell	O
destruction	O
that	O
occur	O
in	O
the	O
species1s	O
human	O
immunodeficiency	O
virus	O
species1e	O
(	O
species1s	O
HIV	O
species1e	O
)-infected	O
host	O
appear	O
to	O
result	O
from	O
the	O
direct	O
cytopathic	O
effects	O
of	O
viral	O
infection	O
and	O
the	O
effects	O
of	O
viral	O
proteins	O
on	O
uninfected	O
bystander	O
cells	O
.	O
Recently	O
,	O
the	O
gene1s	ARG2
alpha	ARG2
-	ARG2
chemokine	ARG2
receptor	ARG2
CXCR4	ARG2
gene1e	ARG2
has	O
been	O
reported	O
to	O
mediate	O
apoptosis	O
in	O
neuronal	O
cells	O
and	O
in	O
CD4(+	O
)	O
and	O
CD8(+	O
)	O
T	O
cells	O
after	O
its	O
binding	O
to	O
species1s	O
HIV-1	O
species1e	O
envelope	O
proteins	O
.	O
In	O
the	O
current	O
study	O
,	O
it	O
was	O
observed	O
that	O
arg1s	O
human	O
arg1e	O
umbilical	O
vein	O
endothelial	O
cells	O
(	O
HUVEC	O
)	O
undergo	O
apoptosis	O
after	O
their	O
treatment	O
with	O
the	O
species1s	O
HIV-1	O
species1e	O
envelope	O
proteins	O
gene1s	O
gp120/160	O
gene1e	O
.	O
Anti	O
-	O
gene1s	ARG2
CXCR4	ARG2
gene1e	ARG2
monoclonal	O
antibody	O
decreased	O
species1s	O
HIV-1	O
species1e	O
gene1s	O
gp120/160	O
gene1e	O
-induced	O
apoptosis	O
,	O
suggesting	O
that	O
the	O
gene1s	ARG2
CXCR4	ARG2
gene1e	ARG2
chemokine	O
receptor	O
mediates	O
the	O
apoptotic	O
effects	O
of	O
these	O
species1s	O
HIV	O
species1e	O
envelope	O
glycoproteins	O
.	O
Further	O
studies	O
revealed	O
that	O
caspases	O
play	O
an	O
important	O
role	O
in	O
this	O
process	O
because	O
the	O
pretreatment	O
of	O
cells	O
with	O
a	O
general	O
caspase	O
enzyme	O
inhibitor	O
decreased	O
the	O
extent	O
of	O
HUVEC	O
apoptosis	O
induced	O
by	O
gene1s	O
gp120/160	O
gene1e	O
.	O
In	O
addition	O
,	O
it	O
was	O
found	O
that	O
gene1s	ARG2
caspase-3	ARG2
gene1e	ARG2
was	O
activated	O
on	O
species1s	O
HIV-1	O
species1e	O
gene1s	O
gp120/160	O
gene1e	O
treatment	O
of	O
these	O
cells	O
.	O
It	O
was	O
also	O
observed	O
that	O
gene1s	O
gp120/160	O
gene1e	O
treatment	O
slightly	O
increased	O
the	O
expression	O
of	O
the	O
pro	O
-	O
apoptotic	O
molecule	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
.	O
These	O
results	O
suggest	O
that	O
species1s	O
HIV-1	O
species1e	O
envelope	O
glycoproteins	O
can	O
disrupt	O
endothelial	O
integrity	O
through	O
the	O
interaction	O
with	O
gene1s	ARG2
CXCR4	ARG2
gene1e	ARG2
,	O
thereby	O
facilitating	O
virus	O
transit	O
out	O
of	O
the	O
bloodstream	O
and	O
contributing	O
to	O
the	O
vascular	O
injury	O
syndromes	O
seen	O
in	O
acquired	O
immunodeficiency	O
syndrome	O
.	O
(	O
Blood	O
.	O
2000;96:1438	O
-	O
1442	O
)	O

A	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
BRCA2	ARG2
gene1e	ARG2
complex	O
containing	O
a	O
structural	O
DNA	O
binding	O
component	O
influences	O
cell	O
cycle	O
progression	O
.	O
Germline	O
mutations	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
BRCA2	ARG2
gene1e	ARG2
gene	O
confer	O
susceptibility	O
to	O
breast	O
cancer	O
.	O
Although	O
the	O
function	O
of	O
the	O
gene1s	ARG2
BRCA2	ARG2
gene1e	ARG2
protein	O
remains	O
to	O
be	O
determined	O
,	O
species1s	O
murine	O
species1e	O
cells	O
homozygous	O
for	O
gene1s	O
BRCA2	O
gene1e	O
inactivation	O
display	O
chromosomal	O
aberrations	O
.	O
We	O
have	O
isolated	O
a	O
2	O
MDa	O
BRCA2-containing	O
complex	O
and	O
identified	O
a	O
structural	O
DNA	O
binding	O
component	O
,	O
designated	O
as	O
gene1s	ARG2
BRCA2-Associated	ARG2
Factor	ARG2
35	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
BRAF35	ARG2
gene1e	ARG2
)	O
.	O
gene1s	ARG2
BRAF35	ARG2
gene1e	ARG2
contains	O
a	O
nonspecific	O
DNA	O
binding	O
HMG	O
domain	O
and	O
a	O
kinesin	O
-	O
like	O
coiled	O
coil	O
domain	O
.	O
Similar	O
to	O
gene1s	ARG2
BRCA2	ARG2
gene1e	ARG2
,	O
gene1s	O
BRAF35	O
gene1e	O
mRNA	O
expression	O
levels	O
in	O
species1s	O
mouse	O
species1e	O
embryos	O
are	O
highest	O
in	O
proliferating	O
tissues	O
with	O
high	O
mitotic	O
index	O
.	O
Strikingly	O
,	O
nuclear	O
staining	O
revealed	O
a	O
close	O
association	O
of	O
gene1s	ARG2
BRAF35	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
BRCA2	ARG2
gene1e	ARG2
complex	O
with	O
condensed	O
chromatin	O
coincident	O
with	O
histone	O
H3	O
phosphorylation	O
.	O
Importantly	O
,	O
antibody	O
microinjection	O
experiments	O
suggest	O
a	O
role	O
for	O
gene1s	ARG2
BRCA2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
BRAF35	ARG2
gene1e	ARG2
complex	O
in	O
modulation	O
of	O
cell	O
cycle	O
progression	O
.	O

A	O
species1s	O
human	O
species1e	O
gene1s	O
BRCA2	O
gene1e	O
complex	O
containing	O
a	O
structural	O
DNA	O
binding	O
component	O
influences	O
cell	O
cycle	O
progression	O
.	O
Germline	O
mutations	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
BRCA2	O
gene1e	O
gene	O
confer	O
susceptibility	O
to	O
breast	O
cancer	O
.	O
Although	O
the	O
function	O
of	O
the	O
gene1s	O
BRCA2	O
gene1e	O
protein	O
remains	O
to	O
be	O
determined	O
,	O
arg1s	O
murine	O
arg1e	O
cells	O
homozygous	O
for	O
gene1s	ARG2
BRCA2	ARG2
gene1e	ARG2
inactivation	O
display	O
chromosomal	O
aberrations	O
.	O
We	O
have	O
isolated	O
a	O
2	O
MDa	O
BRCA2-containing	O
complex	O
and	O
identified	O
a	O
structural	O
DNA	O
binding	O
component	O
,	O
designated	O
as	O
gene1s	O
BRCA2-Associated	O
Factor	O
35	O
gene1e	O
(	O
gene1s	O
BRAF35	O
gene1e	O
)	O
.	O
gene1s	O
BRAF35	O
gene1e	O
contains	O
a	O
nonspecific	O
DNA	O
binding	O
HMG	O
domain	O
and	O
a	O
kinesin	O
-	O
like	O
coiled	O
coil	O
domain	O
.	O
Similar	O
to	O
gene1s	O
BRCA2	O
gene1e	O
,	O
gene1s	ARG2
BRAF35	ARG2
gene1e	ARG2
mRNA	O
expression	O
levels	O
in	O
arg1s	O
mouse	O
arg1e	O
embryos	O
are	O
highest	O
in	O
proliferating	O
tissues	O
with	O
high	O
mitotic	O
index	O
.	O
Strikingly	O
,	O
nuclear	O
staining	O
revealed	O
a	O
close	O
association	O
of	O
gene1s	O
BRAF35	O
gene1e	O
/	O
gene1s	O
BRCA2	O
gene1e	O
complex	O
with	O
condensed	O
chromatin	O
coincident	O
with	O
histone	O
H3	O
phosphorylation	O
.	O
Importantly	O
,	O
antibody	O
microinjection	O
experiments	O
suggest	O
a	O
role	O
for	O
gene1s	O
BRCA2	O
gene1e	O
/	O
gene1s	O
BRAF35	O
gene1e	O
complex	O
in	O
modulation	O
of	O
cell	O
cycle	O
progression	O
.	O

Cloning	O
,	O
expression	O
and	O
chromosomal	O
location	O
of	O
gene1s	O
NKX6B	O
gene1e	O
TO	O
10Q26	O
,	O
a	O
region	O
frequently	O
deleted	O
in	O
brain	O
tumors	O
.	O
gene1s	ARG2
Nkx6	ARG2
-	ARG2
2	ARG2
gene1e	ARG2
(	O
former	O
gene1s	ARG2
Gtx	ARG2
gene1e	ARG2
)	O
is	O
a	O
arg1s	O
murine	O
arg1e	O
-	O
homeobox	O
-	O
containing	O
gene	O
localized	O
distally	O
on	O
Chromosome	O
(	O
Chr	O
)	O
7	O
.	O
Analysis	O
of	O
the	O
expression	O
pattern	O
,	O
together	O
with	O
DNA	O
binding	O
assays	O
,	O
suggests	O
that	O
this	O
gene	O
product	O
might	O
be	O
important	O
for	O
differentiated	O
oligodendrocyte	O
function	O
and	O
in	O
the	O
regulation	O
of	O
myelin	O
gene	O
expression	O
.	O
We	O
now	O
report	O
on	O
the	O
cloning	O
and	O
characterization	O
of	O
the	O
species1s	O
human	O
species1e	O
homolog	O
(	O
gene1s	O
NKX6B	O
gene1e	O
)	O
.	O
DNA	O
sequence	O
analysis	O
of	O
an	O
11-kb	O
genomic	O
fragment	O
revealed	O
that	O
the	O
complete	O
species1s	O
human	O
species1e	O
gene	O
spans	O
1.2	O
kb	O
and	O
is	O
composed	O
of	O
three	O
exons	O
.	O
gene1s	O
NKX6B	O
gene1e	O
is	O
predicted	O
to	O
encode	O
a	O
polypeptide	O
of	O
277	O
amino	O
acids	O
with	O
97	O
%	O
identity	O
to	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
Nkx6	ARG2
-	ARG2
2	ARG2
gene1e	ARG2
.	O
Northern	O
blot	O
experiments	O
showed	O
that	O
gene1s	O
NKX6B	O
gene1e	O
expression	O
is	O
tightly	O
controlled	O
in	O
a	O
tissue	O
-	O
specific	O
fashion	O
with	O
the	O
highest	O
site	O
of	O
expression	O
being	O
the	O
brain	O
.	O
Finally	O
,	O
using	O
STS	O
content	O
mapping	O
and	O
RH	O
analyis	O
,	O
we	O
demonstrated	O
that	O
gene1s	O
NKX6B	O
gene1e	O
maps	O
to	O
the	O
10q26	O
,	O
a	O
region	O
where	O
frequent	O
loss	O
of	O
heterozygosity	O
has	O
been	O
observed	O
in	O
various	O
malignant	O
brain	O
tumors	O
.	O
These	O
results	O
may	O
implicate	O
gene1s	O
NKX6B	O
gene1e	O
as	O
a	O
candidate	O
tumor	O
suppressor	O
gene	O
for	O
brain	O
tumors	O
,	O
particularly	O
for	O
oligodendrogliomas	O
.	O

Cloning	O
,	O
expression	O
and	O
chromosomal	O
location	O
of	O
gene1s	ARG2
NKX6B	ARG2
gene1e	ARG2
TO	O
10Q26	O
,	O
a	O
region	O
frequently	O
deleted	O
in	O
brain	O
tumors	O
.	O
gene1s	O
Nkx6	O
-	O
2	O
gene1e	O
(	O
former	O
gene1s	O
Gtx	O
gene1e	O
)	O
is	O
a	O
species1s	O
murine	O
species1e	O
-	O
homeobox	O
-	O
containing	O
gene	O
localized	O
distally	O
on	O
Chromosome	O
(	O
Chr	O
)	O
7	O
.	O
Analysis	O
of	O
the	O
expression	O
pattern	O
,	O
together	O
with	O
DNA	O
binding	O
assays	O
,	O
suggests	O
that	O
this	O
gene	O
product	O
might	O
be	O
important	O
for	O
differentiated	O
oligodendrocyte	O
function	O
and	O
in	O
the	O
regulation	O
of	O
myelin	O
gene	O
expression	O
.	O
We	O
now	O
report	O
on	O
the	O
cloning	O
and	O
characterization	O
of	O
the	O
arg1s	O
human	O
arg1e	O
homolog	O
(	O
gene1s	ARG2
NKX6B	ARG2
gene1e	ARG2
)	O
.	O
DNA	O
sequence	O
analysis	O
of	O
an	O
11-kb	O
genomic	O
fragment	O
revealed	O
that	O
the	O
complete	O
arg1s	O
human	O
arg1e	O
gene	O
spans	O
1.2	O
kb	O
and	O
is	O
composed	O
of	O
three	O
exons	O
.	O
gene1s	ARG2
NKX6B	ARG2
gene1e	ARG2
is	O
predicted	O
to	O
encode	O
a	O
polypeptide	O
of	O
277	O
amino	O
acids	O
with	O
97	O
%	O
identity	O
to	O
species1s	O
mouse	O
species1e	O
gene1s	O
Nkx6	O
-	O
2	O
gene1e	O
.	O
Northern	O
blot	O
experiments	O
showed	O
that	O
gene1s	ARG2
NKX6B	ARG2
gene1e	ARG2
expression	O
is	O
tightly	O
controlled	O
in	O
a	O
tissue	O
-	O
specific	O
fashion	O
with	O
the	O
highest	O
site	O
of	O
expression	O
being	O
the	O
brain	O
.	O
Finally	O
,	O
using	O
STS	O
content	O
mapping	O
and	O
RH	O
analyis	O
,	O
we	O
demonstrated	O
that	O
gene1s	ARG2
NKX6B	ARG2
gene1e	ARG2
maps	O
to	O
the	O
10q26	O
,	O
a	O
region	O
where	O
frequent	O
loss	O
of	O
heterozygosity	O
has	O
been	O
observed	O
in	O
various	O
malignant	O
brain	O
tumors	O
.	O
These	O
results	O
may	O
implicate	O
gene1s	ARG2
NKX6B	ARG2
gene1e	ARG2
as	O
a	O
candidate	O
tumor	O
suppressor	O
gene	O
for	O
brain	O
tumors	O
,	O
particularly	O
for	O
oligodendrogliomas	O
.	O

gene1s	ARG2
Vascular	ARG2
endothelial	ARG2
growth	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
)	O
upregulates	O
gene1s	ARG2
BCL-2	ARG2
gene1e	ARG2
and	O
inhibits	O
apoptosis	O
in	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
murine	O
species1e	O
mammary	O
adenocarcinoma	O
cells	O
.	O
Tumour	O
progression	O
is	O
regulated	O
by	O
the	O
balance	O
of	O
proliferation	O
and	O
apoptosis	O
in	O
the	O
tumour	O
cell	O
population	O
.	O
To	O
date	O
,	O
the	O
role	O
of	O
gene1s	ARG2
vascular	ARG2
endothelial	ARG2
growth	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
)	O
in	O
tumour	O
growth	O
has	O
been	O
attributed	O
to	O
the	O
induction	O
of	O
angiogenesis	O
.	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
has	O
been	O
shown	O
to	O
be	O
a	O
survival	O
factor	O
for	O
endothelial	O
cells	O
,	O
preventing	O
apoptosis	O
by	O
inducing	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
expression	O
.	O
In	O
both	O
species1s	O
murine	O
species1e	O
(	O
4T1	O
)	O
and	O
arg1s	O
human	O
arg1e	O
(	O
arg1s	O
MDA	O
-	O
MB-231	O
arg1e	O
)	O
metastatic	O
mammary	O
carcinoma	O
cell	O
lines	O
,	O
we	O
found	O
that	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
upregulated	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
expression	O
and	O
anti	O
-	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
antibodies	O
reduced	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
expression	O
.	O
These	O
alterations	O
in	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
expression	O
were	O
reflected	O
by	O
the	O
levels	O
of	O
tumour	O
cell	O
apoptosis	O
.	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
resulted	O
in	O
reduced	O
tumour	O
cell	O
apoptosis	O
,	O
whereas	O
its	O
inhibition	O
with	O
anti	O
-	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
neutralizing	O
antibodies	O
induced	O
apoptosis	O
directly	O
in	O
tumour	O
cells	O
.	O
Therefore	O
,	O
in	O
addition	O
to	O
its	O
role	O
in	O
angiogenesis	O
and	O
vessel	O
permeability	O
,	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
acts	O
as	O
a	O
survival	O
factor	O
for	O
tumour	O
cells	O
,	O
inducing	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
expression	O
and	O
inhibiting	O
tumour	O
cell	O
apoptosis	O
.	O

gene1s	ARG2
Vascular	ARG2
endothelial	ARG2
growth	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
)	O
upregulates	O
gene1s	ARG2
BCL-2	ARG2
gene1e	ARG2
and	O
inhibits	O
apoptosis	O
in	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
murine	O
arg1e	O
mammary	O
adenocarcinoma	O
cells	O
.	O
Tumour	O
progression	O
is	O
regulated	O
by	O
the	O
balance	O
of	O
proliferation	O
and	O
apoptosis	O
in	O
the	O
tumour	O
cell	O
population	O
.	O
To	O
date	O
,	O
the	O
role	O
of	O
gene1s	ARG2
vascular	ARG2
endothelial	ARG2
growth	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
)	O
in	O
tumour	O
growth	O
has	O
been	O
attributed	O
to	O
the	O
induction	O
of	O
angiogenesis	O
.	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
has	O
been	O
shown	O
to	O
be	O
a	O
survival	O
factor	O
for	O
endothelial	O
cells	O
,	O
preventing	O
apoptosis	O
by	O
inducing	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
expression	O
.	O
In	O
both	O
arg1s	O
murine	O
arg1e	O
(	O
4T1	O
)	O
and	O
species1s	O
human	O
species1e	O
(	O
species1s	O
MDA	O
-	O
MB-231	O
species1e	O
)	O
metastatic	O
mammary	O
carcinoma	O
cell	O
lines	O
,	O
we	O
found	O
that	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
upregulated	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
expression	O
and	O
anti	O
-	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
antibodies	O
reduced	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
expression	O
.	O
These	O
alterations	O
in	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
expression	O
were	O
reflected	O
by	O
the	O
levels	O
of	O
tumour	O
cell	O
apoptosis	O
.	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
resulted	O
in	O
reduced	O
tumour	O
cell	O
apoptosis	O
,	O
whereas	O
its	O
inhibition	O
with	O
anti	O
-	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
neutralizing	O
antibodies	O
induced	O
apoptosis	O
directly	O
in	O
tumour	O
cells	O
.	O
Therefore	O
,	O
in	O
addition	O
to	O
its	O
role	O
in	O
angiogenesis	O
and	O
vessel	O
permeability	O
,	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
acts	O
as	O
a	O
survival	O
factor	O
for	O
tumour	O
cells	O
,	O
inducing	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
expression	O
and	O
inhibiting	O
tumour	O
cell	O
apoptosis	O
.	O

gene1s	ARG2
Protocadherin	ARG2
LKC	ARG2
gene1e	ARG2
,	O
a	O
new	O
candidate	O
for	O
a	O
tumor	O
suppressor	O
of	O
colon	O
and	O
liver	O
cancers	O
,	O
its	O
association	O
with	O
contact	O
inhibition	O
of	O
cell	O
proliferation	O
.	O
Protocadherins	O
are	O
a	O
major	O
subfamily	O
of	O
the	O
cadherin	O
superfamily	O
,	O
but	O
little	O
is	O
known	O
about	O
their	O
functions	O
and	O
intracellular	O
signal	O
transduction	O
.	O
We	O
cloned	O
a	O
novel	O
arg1s	O
human	O
arg1e	O
protocadherin	O
gene	O
,	O
containing	O
seven	O
EC	O
domains	O
,	O
and	O
identified	O
functional	O
aspects	O
of	O
this	O
gene	O
.	O
The	O
gene	O
was	O
predominantly	O
expressed	O
in	O
liver	O
,	O
kidney	O
and	O
colon	O
tissues	O
,	O
and	O
was	O
thus	O
designated	O
gene1s	ARG2
Protocadherin	ARG2
LKC	ARG2
gene1e	ARG2
.	O
The	O
expression	O
of	O
gene1s	ARG2
Protocadherin	ARG2
LKC	ARG2
gene1e	ARG2
is	O
markedly	O
reduced	O
in	O
cancers	O
arising	O
from	O
these	O
tissues	O
at	O
both	O
transcriptional	O
and	O
protein	O
levels	O
.	O
To	O
investigate	O
the	O
effects	O
of	O
gene1s	ARG2
Protocadherin	ARG2
LKC	ARG2
gene1e	ARG2
expression	O
in	O
colon	O
cancer	O
,	O
we	O
introduced	O
the	O
gene	O
into	O
colon	O
cancer	O
cell	O
line	O
HCT116	O
,	O
which	O
does	O
not	O
express	O
this	O
gene	O
.	O
Significantly	O
,	O
gene1s	ARG2
Protocadherin	ARG2
LKC	ARG2
gene1e	ARG2
expression	O
induced	O
contact	O
inhibition	O
of	O
cell	O
proliferation	O
although	O
it	O
did	O
not	O
affect	O
growth	O
rate	O
.	O
When	O
grown	O
to	O
post	O
-	O
confluence	O
in	O
monolayer	O
cells	O
cultures	O
,	O
gene1s	ARG2
Protocadherin	ARG2
LKC	ARG2
gene1e	ARG2
-	O
expressing	O
arg1s	O
HCT116	O
arg1e	O
no	O
longer	O
formed	O
multiple	O
cell	O
layers	O
and	O
showed	O
the	O
typical	O
paving	O
stone	O
morphology	O
of	O
normal	O
epithelial	O
cells	O
.	O
Furthermore	O
,	O
expression	O
of	O
gene1s	ARG2
Protocadherin	ARG2
LKC	ARG2
gene1e	ARG2
suppressed	O
tumor	O
formation	O
of	O
arg1s	O
HCT116	O
arg1e	O
cells	O
in	O
a	O
nude	O
species1s	O
mouse	O
species1e	O
model	O
.	O
In	O
addition	O
,	O
we	O
identified	O
a	O
protein	O
,	O
gene1s	ARG2
hMAST205	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
microtubule	ARG2
-	ARG2
associated	ARG2
serine	ARG2
/	ARG2
threonine	ARG2
kinase-205	ARG2
kDa	ARG2
gene1e	ARG2
)	O
,	O
which	O
interacted	O
with	O
gene1s	ARG2
Protocadherin	ARG2
LKC	ARG2
gene1e	ARG2
;	O
the	O
interaction	O
occurring	O
between	O
the	O
PDZ	O
domain	O
of	O
gene1s	ARG2
hMAST205	ARG2
gene1e	ARG2
and	O
C	O
-	O
terminal	O
tail	O
of	O
gene1s	ARG2
Protocadherin	ARG2
LKC	ARG2
gene1e	ARG2
.	O
Our	O
results	O
suggest	O
that	O
gene1s	ARG2
Protocadherin	ARG2
LKC	ARG2
gene1e	ARG2
,	O
which	O
directly	O
binds	O
gene1s	ARG2
PDZ	ARG2
protein	ARG2
gene1e	ARG2
,	O
is	O
a	O
molecular	O
switch	O
for	O
contact	O
inhibition	O
of	O
epithelial	O
cells	O
in	O
the	O
liver	O
,	O
kidney	O
and	O
colon	O
tissues	O
.	O

gene1s	O
Protocadherin	O
LKC	O
gene1e	O
,	O
a	O
new	O
candidate	O
for	O
a	O
tumor	O
suppressor	O
of	O
colon	O
and	O
liver	O
cancers	O
,	O
its	O
association	O
with	O
contact	O
inhibition	O
of	O
cell	O
proliferation	O
.	O
Protocadherins	O
are	O
a	O
major	O
subfamily	O
of	O
the	O
cadherin	O
superfamily	O
,	O
but	O
little	O
is	O
known	O
about	O
their	O
functions	O
and	O
intracellular	O
signal	O
transduction	O
.	O
We	O
cloned	O
a	O
novel	O
species1s	O
human	O
species1e	O
protocadherin	O
gene	O
,	O
containing	O
seven	O
EC	O
domains	O
,	O
and	O
identified	O
functional	O
aspects	O
of	O
this	O
gene	O
.	O
The	O
gene	O
was	O
predominantly	O
expressed	O
in	O
liver	O
,	O
kidney	O
and	O
colon	O
tissues	O
,	O
and	O
was	O
thus	O
designated	O
gene1s	O
Protocadherin	O
LKC	O
gene1e	O
.	O
The	O
expression	O
of	O
gene1s	O
Protocadherin	O
LKC	O
gene1e	O
is	O
markedly	O
reduced	O
in	O
cancers	O
arising	O
from	O
these	O
tissues	O
at	O
both	O
transcriptional	O
and	O
protein	O
levels	O
.	O
To	O
investigate	O
the	O
effects	O
of	O
gene1s	O
Protocadherin	O
LKC	O
gene1e	O
expression	O
in	O
colon	O
cancer	O
,	O
we	O
introduced	O
the	O
gene	O
into	O
colon	O
cancer	O
cell	O
line	O
HCT116	O
,	O
which	O
does	O
not	O
express	O
this	O
gene	O
.	O
Significantly	O
,	O
gene1s	O
Protocadherin	O
LKC	O
gene1e	O
expression	O
induced	O
contact	O
inhibition	O
of	O
cell	O
proliferation	O
although	O
it	O
did	O
not	O
affect	O
growth	O
rate	O
.	O
When	O
grown	O
to	O
post	O
-	O
confluence	O
in	O
monolayer	O
cells	O
cultures	O
,	O
gene1s	O
Protocadherin	O
LKC	O
gene1e	O
-	O
expressing	O
species1s	O
HCT116	O
species1e	O
no	O
longer	O
formed	O
multiple	O
cell	O
layers	O
and	O
showed	O
the	O
typical	O
paving	O
stone	O
morphology	O
of	O
normal	O
epithelial	O
cells	O
.	O
Furthermore	O
,	O
expression	O
of	O
gene1s	O
Protocadherin	O
LKC	O
gene1e	O
suppressed	O
tumor	O
formation	O
of	O
species1s	O
HCT116	O
species1e	O
cells	O
in	O
a	O
nude	O
arg1s	O
mouse	O
arg1e	O
model	O
.	O
In	O
addition	O
,	O
we	O
identified	O
a	O
protein	O
,	O
gene1s	O
hMAST205	O
gene1e	O
(	O
gene1s	O
microtubule	O
-	O
associated	O
serine	O
/	O
threonine	O
kinase-205	O
kDa	O
gene1e	O
)	O
,	O
which	O
interacted	O
with	O
gene1s	O
Protocadherin	O
LKC	O
gene1e	O
;	O
the	O
interaction	O
occurring	O
between	O
the	O
PDZ	O
domain	O
of	O
gene1s	O
hMAST205	O
gene1e	O
and	O
C	O
-	O
terminal	O
tail	O
of	O
gene1s	O
Protocadherin	O
LKC	O
gene1e	O
.	O
Our	O
results	O
suggest	O
that	O
gene1s	O
Protocadherin	O
LKC	O
gene1e	O
,	O
which	O
directly	O
binds	O
gene1s	O
PDZ	O
protein	O
gene1e	O
,	O
is	O
a	O
molecular	O
switch	O
for	O
contact	O
inhibition	O
of	O
epithelial	O
cells	O
in	O
the	O
liver	O
,	O
kidney	O
and	O
colon	O
tissues	O
.	O

Expression	O
cloning	O
of	O
a	O
arg1s	O
human	O
arg1e	O
dual	O
-	O
specificity	O
phosphatase	O
.	O
Using	O
an	O
expression	O
cloning	O
strategy	O
,	O
we	O
isolated	O
a	O
cDNA	O
encoding	O
a	O
arg1s	O
human	O
arg1e	O
protein	O
-	O
tyrosine	O
-	O
phosphatase	O
.	O
Bacteria	O
expressing	O
the	O
kinase	O
domain	O
of	O
the	O
gene1s	ARG2
keratinocyte	ARG2
growth	ARG2
factor	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
bek	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
fibroblast	ARG2
growth	ARG2
factor	ARG2
receptor	ARG2
2	ARG2
gene1e	ARG2
)	O
were	O
infected	O
with	O
a	O
fibroblast	O
cDNA	O
library	O
in	O
a	O
phagemid	O
prokaryotic	O
expression	O
vector	O
and	O
screened	O
with	O
a	O
monoclonal	O
anti	O
-	O
phosphotyrosine	O
antibody	O
.	O
Among	O
several	O
clones	O
showing	O
decreased	O
anti	O
-	O
phosphotyrosine	O
recognition	O
,	O
one	O
displayed	O
phosphatase	O
activity	O
toward	O
the	O
kinase	O
in	O
vitro	O
.	O
The	O
4.1-kilobase	O
cDNA	O
encoded	O
a	O
deduced	O
protein	O
of	O
185	O
amino	O
acids	O
with	O
limited	O
sequence	O
similarity	O
to	O
the	O
species1s	O
vaccinia	O
virus	O
species1e	O
phosphatase	O
VH1	O
.	O
The	O
purified	O
recombinant	O
protein	O
dephosphorylated	O
several	O
activated	O
growth	O
factor	O
receptors	O
,	O
as	O
well	O
as	O
serine	O
-	O
phosphorylated	O
casein	O
,	O
in	O
vitro	O
.	O
Both	O
serine	O
and	O
tyrosine	O
phosphatase	O
activities	O
were	O
completely	O
abolished	O
by	O
mutagenesis	O
of	O
a	O
single	O
cysteine	O
residue	O
conserved	O
in	O
VH1	O
and	O
the	O
gene1s	ARG2
VH1-related	ARG2
(	ARG2
VHR	ARG2
)	ARG2
human	ARG2
protein	ARG2
gene1e	ARG2
.	O
These	O
properties	O
suggest	O
that	O
gene1s	ARG2
VHR	ARG2
gene1e	ARG2
is	O
capable	O
of	O
regulating	O
intracellular	O
events	O
mediated	O
by	O
both	O
tyrosine	O
and	O
serine	O
phosphorylation	O
.	O

Expression	O
cloning	O
of	O
a	O
species1s	O
human	O
species1e	O
dual	O
-	O
specificity	O
phosphatase	O
.	O
Using	O
an	O
expression	O
cloning	O
strategy	O
,	O
we	O
isolated	O
a	O
cDNA	O
encoding	O
a	O
species1s	O
human	O
species1e	O
protein	O
-	O
tyrosine	O
-	O
phosphatase	O
.	O
Bacteria	O
expressing	O
the	O
kinase	O
domain	O
of	O
the	O
gene1s	O
keratinocyte	O
growth	O
factor	O
receptor	O
gene1e	O
(	O
gene1s	O
bek	O
gene1e	O
/	O
gene1s	O
fibroblast	O
growth	O
factor	O
receptor	O
2	O
gene1e	O
)	O
were	O
infected	O
with	O
a	O
fibroblast	O
cDNA	O
library	O
in	O
a	O
phagemid	O
prokaryotic	O
expression	O
vector	O
and	O
screened	O
with	O
a	O
monoclonal	O
anti	O
-	O
phosphotyrosine	O
antibody	O
.	O
Among	O
several	O
clones	O
showing	O
decreased	O
anti	O
-	O
phosphotyrosine	O
recognition	O
,	O
one	O
displayed	O
phosphatase	O
activity	O
toward	O
the	O
kinase	O
in	O
vitro	O
.	O
The	O
4.1-kilobase	O
cDNA	O
encoded	O
a	O
deduced	O
protein	O
of	O
185	O
amino	O
acids	O
with	O
limited	O
sequence	O
similarity	O
to	O
the	O
arg1s	O
vaccinia	O
virus	O
arg1e	O
phosphatase	O
VH1	O
.	O
The	O
purified	O
recombinant	O
protein	O
dephosphorylated	O
several	O
activated	O
growth	O
factor	O
receptors	O
,	O
as	O
well	O
as	O
serine	O
-	O
phosphorylated	O
casein	O
,	O
in	O
vitro	O
.	O
Both	O
serine	O
and	O
tyrosine	O
phosphatase	O
activities	O
were	O
completely	O
abolished	O
by	O
mutagenesis	O
of	O
a	O
single	O
cysteine	O
residue	O
conserved	O
in	O
VH1	O
and	O
the	O
gene1s	O
VH1-related	O
(	O
VHR	O
)	O
human	O
protein	O
gene1e	O
.	O
These	O
properties	O
suggest	O
that	O
gene1s	O
VHR	O
gene1e	O
is	O
capable	O
of	O
regulating	O
intracellular	O
events	O
mediated	O
by	O
both	O
tyrosine	O
and	O
serine	O
phosphorylation	O
.	O

Characterization	O
of	O
gene1s	ARG2
SAF	ARG2
-	ARG2
A	ARG2
gene1e	ARG2
,	O
a	O
novel	O
nuclear	O
DNA	O
binding	O
protein	O
from	O
arg1s	O
HeLa	O
arg1e	O
cells	O
with	O
high	O
affinity	O
for	O
nuclear	O
matrix	O
/	O
scaffold	O
attachment	O
DNA	O
elements	O
.	O
We	O
identified	O
four	O
proteins	O
in	O
nuclear	O
extracts	O
from	O
arg1s	O
HeLa	O
arg1e	O
cells	O
which	O
specifically	O
bind	O
to	O
a	O
gene1s	ARG2
scaffold	ARG2
attachment	ARG2
region	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SAR	ARG2
gene1e	ARG2
)	O
element	O
from	O
the	O
arg1s	O
human	O
arg1e	O
genome	O
.	O
Of	O
these	O
four	O
proteins	O
,	O
gene1s	ARG2
SAF	ARG2
-	ARG2
A	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
scaffold	ARG2
attachment	ARG2
factor	ARG2
A	ARG2
gene1e	ARG2
)	O
,	O
shows	O
the	O
highest	O
affinity	O
for	O
several	O
homologous	O
and	O
heterologous	O
gene1s	ARG2
SAR	ARG2
gene1e	ARG2
elements	O
from	O
vertebrate	O
cells	O
.	O
gene1s	ARG2
SAF	ARG2
-	ARG2
A	ARG2
gene1e	ARG2
is	O
an	O
abundant	O
nuclear	O
protein	O
and	O
a	O
constituent	O
of	O
the	O
nuclear	O
matrix	O
and	O
scaffold	O
.	O
The	O
homogeneously	O
purified	O
protein	O
is	O
a	O
novel	O
double	O
stranded	O
DNA	O
binding	O
protein	O
with	O
an	O
apparent	O
molecular	O
weight	O
of	O
120	O
kDa	O
.	O
gene1s	ARG2
SAF	ARG2
-	ARG2
A	ARG2
gene1e	ARG2
binds	O
at	O
multiple	O
sites	O
to	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
SAR	ARG2
gene1e	ARG2
element	O
;	O
competition	O
studies	O
with	O
synthetic	O
polynucleotides	O
indicate	O
that	O
these	O
sites	O
most	O
probably	O
reside	O
in	O
the	O
multitude	O
of	O
A	O
/	O
T	O
-	O
stretches	O
which	O
are	O
distributed	O
throughout	O
this	O
element	O
.	O
In	O
addition	O
we	O
show	O
by	O
electron	O
microscopy	O
that	O
the	O
protein	O
forms	O
large	O
aggregates	O
and	O
mediates	O
the	O
formation	O
of	O
looped	O
DNA	O
structures	O
.	O

Expression	O
cloning	O
of	O
a	O
cDNA	O
encoding	O
gene1s	O
UDP	O
-	O
GlcNAc	O
:	O
Gal	O
beta	O
1	O
-	O
3-GalNAc	O
-	O
R	O
(	O
GlcNAc	O
to	O
GalNAc	O
)	O
beta	O
1	O
-	O
6GlcNAc	O
transferase	O
gene1e	O
by	O
gene	O
transfer	O
into	O
arg1s	O
CHO	O
arg1e	O
cells	O
expressing	O
polyoma	O
large	O
tumor	O
antigen	O
.	O
A	O
cDNA	O
encoding	O
gene1s	O
UDP	O
-	O
GlcNAc	O
:	O
Gal	O
beta	O
1	O
-	O
3GalNAc	O
-	O
R	O
(	O
GlcNAc	O
to	O
GalNAc	O
)	O
beta	O
1	O
-	O
6GlcNAc	O
transferase	O
gene1e	O
(	O
EC	O
2.4.1.102	O
)	O
,	O
which	O
forms	O
critical	O
branches	O
in	O
O	O
-	O
glycans	O
,	O
has	O
been	O
isolated	O
by	O
an	O
expression	O
cloning	O
approach	O
using	O
arg1s	O
Chinese	O
hamster	O
arg1e	O
ovary	O
(	O
arg1s	O
CHO	O
arg1e	O
)	O
cells	O
.	O
Increased	O
activity	O
of	O
this	O
enzyme	O
and	O
the	O
concomitant	O
occurrence	O
of	O
the	O
O	O
-	O
glycan	O
core	O
2	O
structure	O
[	O
Gal	O
beta	O
1	O
-	O
3(GlcNAc	O
beta	O
1	O
-	O
6)GalNAc	O
]	O
has	O
been	O
observed	O
in	O
a	O
variety	O
of	O
biological	O
processes	O
,	O
such	O
as	O
T	O
-	O
cell	O
activation	O
and	O
immunodeficiency	O
due	O
to	O
the	O
Wiskott	O
-	O
Aldrich	O
syndrome	O
and	O
AIDS	O
.	O
Since	O
arg1s	O
CHO	O
arg1e	O
cells	O
do	O
not	O
express	O
this	O
enzyme	O
,	O
arg1s	O
CHO	O
cell	O
lines	O
arg1e	O
were	O
established	O
to	O
stably	O
express	O
polyoma	O
large	O
tumor	O
(	O
T	O
)	O
antigen	O
,	O
which	O
enables	O
transient	O
expression	O
cloning	O
.	O
Because	O
the	O
antibody	O
used	O
was	O
found	O
to	O
detect	O
most	O
efficiently	O
the	O
oligosaccharide	O
products	O
attached	O
to	O
gene1s	O
leukosialin	O
gene1e	O
,	O
the	O
arg1s	O
CHO	O
arg1e	O
cells	O
were	O
also	O
stably	O
transfected	O
with	O
gene1s	O
leukosialin	O
gene1e	O
cDNA	O
.	O
By	O
using	O
this	O
particular	O
arg1s	O
CHO	O
arg1e	O
cell	O
line	O
,	O
a	O
cDNA	O
that	O
encodes	O
a	O
protein	O
determining	O
the	O
formation	O
of	O
the	O
core	O
2	O
structure	O
was	O
isolated	O
from	O
an	O
HL-60	O
cDNA	O
library	O
.	O
The	O
cDNA	O
sequence	O
predicts	O
a	O
protein	O
with	O
type	O
II	O
membrane	O
topology	O
,	O
as	O
has	O
been	O
found	O
for	O
all	O
other	O
species1s	O
mammalian	O
species1e	O
glycosyltransferases	O
cloned	O
to	O
date	O
.	O
The	O
expression	O
of	O
the	O
presumed	O
catalytic	O
domain	O
as	O
a	O
fusion	O
protein	O
with	O
the	O
IgG	O
binding	O
domain	O
of	O
protein	O
A	O
enabled	O
us	O
to	O
demonstrate	O
unequivocally	O
that	O
the	O
cDNA	O
encodes	O
the	O
gene1s	O
core	O
2	O
beta-1,6-N	O
-	O
acetylglucosaminyltransferase	O
gene1e	O
,	O
the	O
enzyme	O
responsible	O
for	O
the	O
formation	O
of	O
Gal	O
beta	O
1	O
-	O
3(GlcNAc	O
beta	O
1	O
-	O
6)GalNAc	O
structures	O
.	O
No	O
activity	O
with	O
this	O
enzyme	O
was	O
detected	O
toward	O
the	O
acceptors	O
for	O
other	O
beta	O
1	O
-	O
6GlcNAc	O
transferases	O
.	O

Expression	O
cloning	O
of	O
a	O
cDNA	O
encoding	O
gene1s	ARG2
UDP	ARG2
-	ARG2
GlcNAc	ARG2
:	ARG2
Gal	ARG2
beta	ARG2
1	ARG2
-	ARG2
3-GalNAc	ARG2
-	ARG2
R	ARG2
(	ARG2
GlcNAc	ARG2
to	ARG2
GalNAc	ARG2
)	ARG2
beta	ARG2
1	ARG2
-	ARG2
6GlcNAc	ARG2
transferase	ARG2
gene1e	ARG2
by	O
gene	O
transfer	O
into	O
species1s	O
CHO	O
species1e	O
cells	O
expressing	O
polyoma	O
large	O
tumor	O
antigen	O
.	O
A	O
cDNA	O
encoding	O
gene1s	ARG2
UDP	ARG2
-	ARG2
GlcNAc	ARG2
:	ARG2
Gal	ARG2
beta	ARG2
1	ARG2
-	ARG2
3GalNAc	ARG2
-	ARG2
R	ARG2
(	ARG2
GlcNAc	ARG2
to	ARG2
GalNAc	ARG2
)	ARG2
beta	ARG2
1	ARG2
-	ARG2
6GlcNAc	ARG2
transferase	ARG2
gene1e	ARG2
(	O
EC	O
2.4.1.102	O
)	O
,	O
which	O
forms	O
critical	O
branches	O
in	O
O	O
-	O
glycans	O
,	O
has	O
been	O
isolated	O
by	O
an	O
expression	O
cloning	O
approach	O
using	O
species1s	O
Chinese	O
hamster	O
species1e	O
ovary	O
(	O
species1s	O
CHO	O
species1e	O
)	O
cells	O
.	O
Increased	O
activity	O
of	O
this	O
enzyme	O
and	O
the	O
concomitant	O
occurrence	O
of	O
the	O
O	O
-	O
glycan	O
core	O
2	O
structure	O
[	O
Gal	O
beta	O
1	O
-	O
3(GlcNAc	O
beta	O
1	O
-	O
6)GalNAc	O
]	O
has	O
been	O
observed	O
in	O
a	O
variety	O
of	O
biological	O
processes	O
,	O
such	O
as	O
T	O
-	O
cell	O
activation	O
and	O
immunodeficiency	O
due	O
to	O
the	O
Wiskott	O
-	O
Aldrich	O
syndrome	O
and	O
AIDS	O
.	O
Since	O
species1s	O
CHO	O
species1e	O
cells	O
do	O
not	O
express	O
this	O
enzyme	O
,	O
species1s	O
CHO	O
cell	O
lines	O
species1e	O
were	O
established	O
to	O
stably	O
express	O
polyoma	O
large	O
tumor	O
(	O
T	O
)	O
antigen	O
,	O
which	O
enables	O
transient	O
expression	O
cloning	O
.	O
Because	O
the	O
antibody	O
used	O
was	O
found	O
to	O
detect	O
most	O
efficiently	O
the	O
oligosaccharide	O
products	O
attached	O
to	O
gene1s	ARG2
leukosialin	ARG2
gene1e	ARG2
,	O
the	O
species1s	O
CHO	O
species1e	O
cells	O
were	O
also	O
stably	O
transfected	O
with	O
gene1s	ARG2
leukosialin	ARG2
gene1e	ARG2
cDNA	O
.	O
By	O
using	O
this	O
particular	O
species1s	O
CHO	O
species1e	O
cell	O
line	O
,	O
a	O
cDNA	O
that	O
encodes	O
a	O
protein	O
determining	O
the	O
formation	O
of	O
the	O
core	O
2	O
structure	O
was	O
isolated	O
from	O
an	O
HL-60	O
cDNA	O
library	O
.	O
The	O
cDNA	O
sequence	O
predicts	O
a	O
protein	O
with	O
type	O
II	O
membrane	O
topology	O
,	O
as	O
has	O
been	O
found	O
for	O
all	O
other	O
arg1s	O
mammalian	O
arg1e	O
glycosyltransferases	O
cloned	O
to	O
date	O
.	O
The	O
expression	O
of	O
the	O
presumed	O
catalytic	O
domain	O
as	O
a	O
fusion	O
protein	O
with	O
the	O
IgG	O
binding	O
domain	O
of	O
protein	O
A	O
enabled	O
us	O
to	O
demonstrate	O
unequivocally	O
that	O
the	O
cDNA	O
encodes	O
the	O
gene1s	ARG2
core	ARG2
2	ARG2
beta-1,6-N	ARG2
-	ARG2
acetylglucosaminyltransferase	ARG2
gene1e	ARG2
,	O
the	O
enzyme	O
responsible	O
for	O
the	O
formation	O
of	O
Gal	O
beta	O
1	O
-	O
3(GlcNAc	O
beta	O
1	O
-	O
6)GalNAc	O
structures	O
.	O
No	O
activity	O
with	O
this	O
enzyme	O
was	O
detected	O
toward	O
the	O
acceptors	O
for	O
other	O
beta	O
1	O
-	O
6GlcNAc	O
transferases	O
.	O

Cloning	O
of	O
a	O
novel	O
gene1s	ARG2
tumor	ARG2
necrosis	ARG2
factor	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
-	O
inducible	O
primary	O
response	O
gene	O
that	O
is	O
differentially	O
expressed	O
in	O
development	O
and	O
capillary	O
tube	O
-	O
like	O
formation	O
in	O
vitro	O
.	O
gene1s	ARG2
TNF	ARG2
gene1e	ARG2
is	O
a	O
proinflammatory	O
cytokine	O
that	O
has	O
pleiotropic	O
effects	O
on	O
cells	O
and	O
tissues	O
,	O
mediated	O
in	O
large	O
part	O
by	O
alterations	O
in	O
target	O
tissue	O
gene	O
expression	O
.	O
We	O
have	O
used	O
the	O
technique	O
of	O
differential	O
hybridization	O
to	O
identify	O
several	O
primary	O
response	O
genes	O
induced	O
by	O
gene1s	ARG2
TNF	ARG2
gene1e	ARG2
in	O
arg1s	O
human	O
arg1e	O
umbilical	O
vein	O
endothelial	O
(	O
HUVE	O
)	O
cells	O
,	O
a	O
cell	O
type	O
that	O
is	O
profoundly	O
activated	O
by	O
cytokine	O
treatment	O
.	O
One	O
of	O
these	O
cDNA	O
,	O
designated	O
gene1s	ARG2
B94	ARG2
gene1e	ARG2
,	O
detects	O
a	O
rapidly	O
and	O
transiently	O
induced	O
4-kb	O
transcript	O
in	O
gene1s	ARG2
TNF	ARG2
gene1e	ARG2
-	O
treated	O
HUVE	O
cells	O
,	O
and	O
this	O
transcript	O
is	O
superinduced	O
in	O
the	O
concomitant	O
presence	O
of	O
cycloheximide	O
.	O
Other	O
proinflammatory	O
stimuli	O
including	O
gene1s	ARG2
IL-1	ARG2
beta	ARG2
gene1e	ARG2
and	O
LPS	O
are	O
also	O
able	O
to	O
induce	O
gene1s	ARG2
B94	ARG2
gene1e	ARG2
mRNA	O
expression	O
.	O
Nuclear	O
run	O
-	O
on	O
experiments	O
demonstrate	O
that	O
gene1s	ARG2
TNF	ARG2
gene1e	ARG2
induction	O
of	O
gene1s	ARG2
B94	ARG2
gene1e	ARG2
transcript	O
occurs	O
primarily	O
at	O
the	O
level	O
of	O
transcriptional	O
activation	O
.	O
Further	O
,	O
gene1s	ARG2
B94	ARG2
gene1e	ARG2
is	O
shown	O
to	O
be	O
a	O
single	O
copy	O
gene	O
that	O
is	O
evolutionarily	O
conserved	O
.	O
The	O
gene	O
is	O
localized	O
to	O
the	O
q32	O
region	O
of	O
chromosome	O
14	O
,	O
a	O
region	O
that	O
is	O
often	O
rearranged	O
in	O
lymphoid	O
neoplasms	O
.	O
gene1s	ARG2
B94	ARG2
gene1e	ARG2
transcript	O
expression	O
is	O
also	O
found	O
to	O
be	O
regulated	O
during	O
species1s	O
mouse	O
species1e	O
development	O
and	O
in	O
an	O
in	O
vitro	O
model	O
of	O
endothelial	O
capillary	O
tube	O
formation	O
.	O
Developmental	O
regulation	O
occurs	O
most	O
prominently	O
in	O
species1s	O
mouse	O
species1e	O
embryonic	O
liver	O
and	O
kidney	O
,	O
and	O
a	O
second	O
smaller	O
form	O
of	O
gene1s	ARG2
B94	ARG2
gene1e	ARG2
transcript	O
is	O
detected	O
in	O
the	O
placenta	O
and	O
testes	O
.	O
gene1s	ARG2
B94	ARG2
gene1e	ARG2
and	O
other	O
gene1s	ARG2
TNF	ARG2
gene1e	ARG2
-	O
responsive	O
transcripts	O
are	O
also	O
induced	O
during	O
capillary	O
tube	O
formation	O
suggesting	O
overlap	O
between	O
genes	O
induced	O
by	O
gene1s	ARG2
TNF	ARG2
gene1e	ARG2
and	O
those	O
induced	O
during	O
angiogenesis	O
.	O
Sequence	O
analysis	O
of	O
the	O
gene1s	ARG2
B94	ARG2
gene1e	ARG2
cDNA	O
reveals	O
an	O
open	O
reading	O
frame	O
encoding	O
a	O
73-kDa	O
polypeptide	O
that	O
has	O
no	O
homology	O
to	O
any	O
known	O
protein	O
.	O
Polyclonal	O
antisera	O
directed	O
against	O
the	O
carboxyl	O
-	O
terminal	O
portion	O
of	O
the	O
gene1s	ARG2
B94	ARG2
gene1e	ARG2
protein	O
immunoprecipitates	O
a	O
protein	O
of	O
the	O
predicted	O
molecular	O
mass	O
both	O
from	O
COS	O
cells	O
transfected	O
with	O
a	O
gene1s	ARG2
B94	ARG2
gene1e	ARG2
expression	O
vector	O
and	O
from	O
gene1s	ARG2
TNF	ARG2
gene1e	ARG2
-	O
treated	O
HUVE	O
cells	O
.	O

Cloning	O
of	O
a	O
novel	O
gene1s	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
gene1e	O
-	O
inducible	O
primary	O
response	O
gene	O
that	O
is	O
differentially	O
expressed	O
in	O
development	O
and	O
capillary	O
tube	O
-	O
like	O
formation	O
in	O
vitro	O
.	O
gene1s	O
TNF	O
gene1e	O
is	O
a	O
proinflammatory	O
cytokine	O
that	O
has	O
pleiotropic	O
effects	O
on	O
cells	O
and	O
tissues	O
,	O
mediated	O
in	O
large	O
part	O
by	O
alterations	O
in	O
target	O
tissue	O
gene	O
expression	O
.	O
We	O
have	O
used	O
the	O
technique	O
of	O
differential	O
hybridization	O
to	O
identify	O
several	O
primary	O
response	O
genes	O
induced	O
by	O
gene1s	O
TNF	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
umbilical	O
vein	O
endothelial	O
(	O
HUVE	O
)	O
cells	O
,	O
a	O
cell	O
type	O
that	O
is	O
profoundly	O
activated	O
by	O
cytokine	O
treatment	O
.	O
One	O
of	O
these	O
cDNA	O
,	O
designated	O
gene1s	O
B94	O
gene1e	O
,	O
detects	O
a	O
rapidly	O
and	O
transiently	O
induced	O
4-kb	O
transcript	O
in	O
gene1s	O
TNF	O
gene1e	O
-	O
treated	O
HUVE	O
cells	O
,	O
and	O
this	O
transcript	O
is	O
superinduced	O
in	O
the	O
concomitant	O
presence	O
of	O
cycloheximide	O
.	O
Other	O
proinflammatory	O
stimuli	O
including	O
gene1s	O
IL-1	O
beta	O
gene1e	O
and	O
LPS	O
are	O
also	O
able	O
to	O
induce	O
gene1s	O
B94	O
gene1e	O
mRNA	O
expression	O
.	O
Nuclear	O
run	O
-	O
on	O
experiments	O
demonstrate	O
that	O
gene1s	O
TNF	O
gene1e	O
induction	O
of	O
gene1s	O
B94	O
gene1e	O
transcript	O
occurs	O
primarily	O
at	O
the	O
level	O
of	O
transcriptional	O
activation	O
.	O
Further	O
,	O
gene1s	O
B94	O
gene1e	O
is	O
shown	O
to	O
be	O
a	O
single	O
copy	O
gene	O
that	O
is	O
evolutionarily	O
conserved	O
.	O
The	O
gene	O
is	O
localized	O
to	O
the	O
q32	O
region	O
of	O
chromosome	O
14	O
,	O
a	O
region	O
that	O
is	O
often	O
rearranged	O
in	O
lymphoid	O
neoplasms	O
.	O
gene1s	ARG2
B94	ARG2
gene1e	ARG2
transcript	O
expression	O
is	O
also	O
found	O
to	O
be	O
regulated	O
during	O
arg1s	O
mouse	O
arg1e	O
development	O
and	O
in	O
an	O
in	O
vitro	O
model	O
of	O
endothelial	O
capillary	O
tube	O
formation	O
.	O
Developmental	O
regulation	O
occurs	O
most	O
prominently	O
in	O
arg1s	O
mouse	O
arg1e	O
embryonic	O
liver	O
and	O
kidney	O
,	O
and	O
a	O
second	O
smaller	O
form	O
of	O
gene1s	O
B94	O
gene1e	O
transcript	O
is	O
detected	O
in	O
the	O
placenta	O
and	O
testes	O
.	O
gene1s	O
B94	O
gene1e	O
and	O
other	O
gene1s	O
TNF	O
gene1e	O
-	O
responsive	O
transcripts	O
are	O
also	O
induced	O
during	O
capillary	O
tube	O
formation	O
suggesting	O
overlap	O
between	O
genes	O
induced	O
by	O
gene1s	O
TNF	O
gene1e	O
and	O
those	O
induced	O
during	O
angiogenesis	O
.	O
Sequence	O
analysis	O
of	O
the	O
gene1s	O
B94	O
gene1e	O
cDNA	O
reveals	O
an	O
open	O
reading	O
frame	O
encoding	O
a	O
73-kDa	O
polypeptide	O
that	O
has	O
no	O
homology	O
to	O
any	O
known	O
protein	O
.	O
Polyclonal	O
antisera	O
directed	O
against	O
the	O
carboxyl	O
-	O
terminal	O
portion	O
of	O
the	O
gene1s	O
B94	O
gene1e	O
protein	O
immunoprecipitates	O
a	O
protein	O
of	O
the	O
predicted	O
molecular	O
mass	O
both	O
from	O
COS	O
cells	O
transfected	O
with	O
a	O
gene1s	O
B94	O
gene1e	O
expression	O
vector	O
and	O
from	O
gene1s	O
TNF	O
gene1e	O
-	O
treated	O
HUVE	O
cells	O
.	O

Cloning	O
and	O
expression	O
of	O
a	O
cell	O
surface	O
receptor	O
for	O
advanced	O
glycosylation	O
end	O
products	O
of	O
proteins	O
.	O
Advanced	O
glycosylation	O
end	O
products	O
of	O
proteins	O
(	O
AGEs	O
)	O
are	O
nonenzymatically	O
glycosylated	O
proteins	O
which	O
accumulate	O
in	O
vascular	O
tissue	O
in	O
aging	O
and	O
at	O
an	O
accelerated	O
rate	O
in	O
diabetes	O
.	O
A	O
approximately	O
35-kDa	O
polypeptide	O
with	O
a	O
unique	O
NH2-terminal	O
sequence	O
has	O
been	O
isolated	O
from	O
arg1s	O
bovine	O
arg1e	O
lung	O
and	O
found	O
to	O
be	O
present	O
on	O
the	O
surface	O
of	O
endothelial	O
cells	O
where	O
it	O
mediates	O
the	O
binding	O
of	O
AGEs	O
(	O
receptor	O
for	O
advanced	O
glycosylation	O
end	O
product	O
or	O
gene1s	O
RAGE	O
gene1e	O
)	O
.	O
Using	O
an	O
oligonucleotide	O
probe	O
based	O
on	O
the	O
amino	O
-	O
terminal	O
sequence	O
of	O
gene1s	O
RAGE	O
gene1e	O
,	O
an	O
apparently	O
full	O
-	O
length	O
cDNA	O
of	O
1.5	O
kilobases	O
was	O
isolated	O
from	O
a	O
arg1s	O
bovine	O
arg1e	O
lung	O
cDNA	O
library	O
.	O
This	O
cDNA	O
encoded	O
a	O
394	O
amino	O
acid	O
mature	O
protein	O
comprised	O
of	O
the	O
following	O
putative	O
domains	O
:	O
an	O
extracellular	O
domain	O
of	O
332	O
amino	O
acids	O
,	O
a	O
single	O
hydrophobic	O
membrane	O
spanning	O
domain	O
of	O
19	O
amino	O
acids	O
,	O
and	O
a	O
carboxyl	O
-	O
terminal	O
domain	O
of	O
43	O
amino	O
acids	O
.	O
A	O
partial	O
clone	O
encoding	O
the	O
species1s	O
human	O
species1e	O
counterpart	O
of	O
gene1s	O
RAGE	O
gene1e	O
,	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
lung	O
library	O
,	O
was	O
found	O
to	O
be	O
approximately	O
90	O
%	O
homologous	O
to	O
the	O
arg1s	O
bovine	O
arg1e	O
molecule	O
.	O
Based	O
on	O
computer	O
analysis	O
of	O
the	O
amino	O
acid	O
sequence	O
of	O
gene1s	O
RAGE	O
gene1e	O
and	O
comparison	O
with	O
databases	O
,	O
gene1s	O
RAGE	O
gene1e	O
is	O
a	O
new	O
member	O
of	O
the	O
immunoglobulin	O
superfamily	O
of	O
cell	O
surface	O
molecules	O
and	O
shares	O
significant	O
homology	O
with	O
gene1s	O
MUC	O
18	O
gene1e	O
,	O
gene1s	O
NCAM	O
gene1e	O
,	O
and	O
the	O
cytoplasmic	O
domain	O
of	O
gene1s	O
CD20	O
gene1e	O
.	O
Expression	O
of	O
the	O
gene1s	O
RAGE	O
gene1e	O
cDNA	O
in	O
species1s	O
293	O
species1e	O
cells	O
allowed	O
them	O
to	O
bind	O
125I	O
-	O
AGE	O
-	O
albumin	O
in	O
a	O
saturable	O
and	O
dose	O
-	O
dependent	O
manner	O
(	O
Kd	O
approximately	O
100	O
nM	O
)	O
,	O
blocked	O
by	O
antibody	O
to	O
gene1s	O
RAGE	O
gene1e	O
.	O
Western	O
blots	O
of	O
species1s	O
293	O
species1e	O
cells	O
transfected	O
with	O
gene1s	O
RAGE	O
gene1e	O
cDNA	O
probed	O
with	O
anti	O
-	O
gene1s	O
RAGE	O
gene1e	O
IgG	O
demonstrated	O
expression	O
of	O
immunoreactive	O
protein	O
compared	O
to	O
its	O
absence	O
in	O
mock	O
-	O
transfected	O
cells	O
.	O
These	O
results	O
suggest	O
that	O
gene1s	O
RAGE	O
gene1e	O
functions	O
as	O
a	O
cell	O
surface	O
receptor	O
for	O
AGEs	O
,	O
which	O
could	O
potentially	O
mediate	O
cellular	O
effects	O
of	O
this	O
class	O
of	O
glycosylated	O
proteins	O
.	O

Cloning	O
and	O
expression	O
of	O
a	O
cell	O
surface	O
receptor	O
for	O
advanced	O
glycosylation	O
end	O
products	O
of	O
proteins	O
.	O
Advanced	O
glycosylation	O
end	O
products	O
of	O
proteins	O
(	O
AGEs	O
)	O
are	O
nonenzymatically	O
glycosylated	O
proteins	O
which	O
accumulate	O
in	O
vascular	O
tissue	O
in	O
aging	O
and	O
at	O
an	O
accelerated	O
rate	O
in	O
diabetes	O
.	O
A	O
approximately	O
35-kDa	O
polypeptide	O
with	O
a	O
unique	O
NH2-terminal	O
sequence	O
has	O
been	O
isolated	O
from	O
species1s	O
bovine	O
species1e	O
lung	O
and	O
found	O
to	O
be	O
present	O
on	O
the	O
surface	O
of	O
endothelial	O
cells	O
where	O
it	O
mediates	O
the	O
binding	O
of	O
AGEs	O
(	O
receptor	O
for	O
advanced	O
glycosylation	O
end	O
product	O
or	O
gene1s	ARG2
RAGE	ARG2
gene1e	ARG2
)	O
.	O
Using	O
an	O
oligonucleotide	O
probe	O
based	O
on	O
the	O
amino	O
-	O
terminal	O
sequence	O
of	O
gene1s	ARG2
RAGE	ARG2
gene1e	ARG2
,	O
an	O
apparently	O
full	O
-	O
length	O
cDNA	O
of	O
1.5	O
kilobases	O
was	O
isolated	O
from	O
a	O
species1s	O
bovine	O
species1e	O
lung	O
cDNA	O
library	O
.	O
This	O
cDNA	O
encoded	O
a	O
394	O
amino	O
acid	O
mature	O
protein	O
comprised	O
of	O
the	O
following	O
putative	O
domains	O
:	O
an	O
extracellular	O
domain	O
of	O
332	O
amino	O
acids	O
,	O
a	O
single	O
hydrophobic	O
membrane	O
spanning	O
domain	O
of	O
19	O
amino	O
acids	O
,	O
and	O
a	O
carboxyl	O
-	O
terminal	O
domain	O
of	O
43	O
amino	O
acids	O
.	O
A	O
partial	O
clone	O
encoding	O
the	O
arg1s	O
human	O
arg1e	O
counterpart	O
of	O
gene1s	ARG2
RAGE	ARG2
gene1e	ARG2
,	O
isolated	O
from	O
a	O
arg1s	O
human	O
arg1e	O
lung	O
library	O
,	O
was	O
found	O
to	O
be	O
approximately	O
90	O
%	O
homologous	O
to	O
the	O
species1s	O
bovine	O
species1e	O
molecule	O
.	O
Based	O
on	O
computer	O
analysis	O
of	O
the	O
amino	O
acid	O
sequence	O
of	O
gene1s	ARG2
RAGE	ARG2
gene1e	ARG2
and	O
comparison	O
with	O
databases	O
,	O
gene1s	ARG2
RAGE	ARG2
gene1e	ARG2
is	O
a	O
new	O
member	O
of	O
the	O
immunoglobulin	O
superfamily	O
of	O
cell	O
surface	O
molecules	O
and	O
shares	O
significant	O
homology	O
with	O
gene1s	ARG2
MUC	ARG2
18	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NCAM	ARG2
gene1e	ARG2
,	O
and	O
the	O
cytoplasmic	O
domain	O
of	O
gene1s	ARG2
CD20	ARG2
gene1e	ARG2
.	O
Expression	O
of	O
the	O
gene1s	ARG2
RAGE	ARG2
gene1e	ARG2
cDNA	O
in	O
arg1s	O
293	O
arg1e	O
cells	O
allowed	O
them	O
to	O
bind	O
125I	O
-	O
AGE	O
-	O
albumin	O
in	O
a	O
saturable	O
and	O
dose	O
-	O
dependent	O
manner	O
(	O
Kd	O
approximately	O
100	O
nM	O
)	O
,	O
blocked	O
by	O
antibody	O
to	O
gene1s	ARG2
RAGE	ARG2
gene1e	ARG2
.	O
Western	O
blots	O
of	O
arg1s	O
293	O
arg1e	O
cells	O
transfected	O
with	O
gene1s	ARG2
RAGE	ARG2
gene1e	ARG2
cDNA	O
probed	O
with	O
anti	O
-	O
gene1s	ARG2
RAGE	ARG2
gene1e	ARG2
IgG	O
demonstrated	O
expression	O
of	O
immunoreactive	O
protein	O
compared	O
to	O
its	O
absence	O
in	O
mock	O
-	O
transfected	O
cells	O
.	O
These	O
results	O
suggest	O
that	O
gene1s	ARG2
RAGE	ARG2
gene1e	ARG2
functions	O
as	O
a	O
cell	O
surface	O
receptor	O
for	O
AGEs	O
,	O
which	O
could	O
potentially	O
mediate	O
cellular	O
effects	O
of	O
this	O
class	O
of	O
glycosylated	O
proteins	O
.	O

Structure	O
of	O
the	O
gene1s	O
CD59	O
gene1e	O
-encoding	O
gene	O
:	O
further	O
evidence	O
of	O
a	O
relationship	O
to	O
arg1s	O
murine	O
arg1e	O
lymphocyte	O
antigen	O
gene1s	ARG2
Ly-6	ARG2
gene1e	ARG2
protein	O
.	O
The	O
gene	O
for	O
gene1s	O
CD59	O
gene1e	O
[	O
gene1s	O
membrane	O
inhibitor	O
of	O
reactive	O
lysis	O
gene1e	O
(	O
gene1s	O
MIRL	O
gene1e	O
)	O
,	O
gene1s	O
protectin	O
gene1e	O
]	O
,	O
a	O
phosphatidylinositol	O
-	O
linked	O
surface	O
glycoprotein	O
that	O
regulates	O
the	O
formation	O
of	O
the	O
polymeric	O
C9	O
complex	O
of	O
complement	O
and	O
that	O
is	O
deficient	O
on	O
the	O
abnormal	O
hematopoietic	O
cells	O
of	O
species1s	O
patients	O
species1e	O
with	O
paroxysmal	O
nocturnal	O
hemoglobinuria	O
,	O
consists	O
of	O
four	O
exons	O
spanning	O
20	O
kilobases	O
.	O
The	O
untranslated	O
first	O
exon	O
is	O
preceded	O
by	O
a	O
G+C	O
-	O
rich	O
promoter	O
region	O
that	O
lacks	O
a	O
consensus	O
TATA	O
or	O
CAAT	O
motif	O
.	O
The	O
second	O
exon	O
encodes	O
the	O
hydrophobic	O
leader	O
sequence	O
of	O
the	O
protein	O
,	O
and	O
the	O
third	O
exon	O
encodes	O
the	O
amino	O
-	O
terminal	O
portion	O
of	O
the	O
mature	O
protein	O
.	O
The	O
fourth	O
exon	O
encodes	O
the	O
remainder	O
of	O
the	O
mature	O
protein	O
,	O
including	O
the	O
hydrophobic	O
sequence	O
necessary	O
for	O
glycosyl	O
-	O
phosphatidylinositol	O
anchor	O
attachment	O
.	O
The	O
structure	O
of	O
the	O
gene1s	O
CD59	O
gene1e	O
gene	O
is	O
very	O
similar	O
to	O
that	O
encoding	O
gene1s	ARG2
Ly-6	ARG2
gene1e	ARG2
,	O
a	O
arg1s	O
murine	O
arg1e	O
glycoprotein	O
with	O
which	O
gene1s	O
CD59	O
gene1e	O
has	O
some	O
structural	O
similarity	O
.	O
The	O
striking	O
similarity	O
in	O
gene	O
structure	O
is	O
further	O
evidence	O
that	O
the	O
two	O
proteins	O
belong	O
to	O
a	O
superfamily	O
of	O
proteins	O
that	O
may	O
also	O
include	O
the	O
gene1s	O
urokinase	O
plasminogen	O
-	O
activator	O
receptor	O
gene1e	O
and	O
a	O
squid	O
glycoprotein	O
of	O
unknown	O
function	O
.	O

Structure	O
of	O
the	O
gene1s	ARG2
CD59	ARG2
gene1e	ARG2
-encoding	O
gene	O
:	O
further	O
evidence	O
of	O
a	O
relationship	O
to	O
species1s	O
murine	O
species1e	O
lymphocyte	O
antigen	O
gene1s	O
Ly-6	O
gene1e	O
protein	O
.	O
The	O
gene	O
for	O
gene1s	ARG2
CD59	ARG2
gene1e	ARG2
[	O
gene1s	ARG2
membrane	ARG2
inhibitor	ARG2
of	ARG2
reactive	ARG2
lysis	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MIRL	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
protectin	ARG2
gene1e	ARG2
]	O
,	O
a	O
phosphatidylinositol	O
-	O
linked	O
surface	O
glycoprotein	O
that	O
regulates	O
the	O
formation	O
of	O
the	O
polymeric	O
C9	O
complex	O
of	O
complement	O
and	O
that	O
is	O
deficient	O
on	O
the	O
abnormal	O
hematopoietic	O
cells	O
of	O
arg1s	O
patients	O
arg1e	O
with	O
paroxysmal	O
nocturnal	O
hemoglobinuria	O
,	O
consists	O
of	O
four	O
exons	O
spanning	O
20	O
kilobases	O
.	O
The	O
untranslated	O
first	O
exon	O
is	O
preceded	O
by	O
a	O
G+C	O
-	O
rich	O
promoter	O
region	O
that	O
lacks	O
a	O
consensus	O
TATA	O
or	O
CAAT	O
motif	O
.	O
The	O
second	O
exon	O
encodes	O
the	O
hydrophobic	O
leader	O
sequence	O
of	O
the	O
protein	O
,	O
and	O
the	O
third	O
exon	O
encodes	O
the	O
amino	O
-	O
terminal	O
portion	O
of	O
the	O
mature	O
protein	O
.	O
The	O
fourth	O
exon	O
encodes	O
the	O
remainder	O
of	O
the	O
mature	O
protein	O
,	O
including	O
the	O
hydrophobic	O
sequence	O
necessary	O
for	O
glycosyl	O
-	O
phosphatidylinositol	O
anchor	O
attachment	O
.	O
The	O
structure	O
of	O
the	O
gene1s	ARG2
CD59	ARG2
gene1e	ARG2
gene	O
is	O
very	O
similar	O
to	O
that	O
encoding	O
gene1s	O
Ly-6	O
gene1e	O
,	O
a	O
species1s	O
murine	O
species1e	O
glycoprotein	O
with	O
which	O
gene1s	ARG2
CD59	ARG2
gene1e	ARG2
has	O
some	O
structural	O
similarity	O
.	O
The	O
striking	O
similarity	O
in	O
gene	O
structure	O
is	O
further	O
evidence	O
that	O
the	O
two	O
proteins	O
belong	O
to	O
a	O
superfamily	O
of	O
proteins	O
that	O
may	O
also	O
include	O
the	O
gene1s	ARG2
urokinase	ARG2
plasminogen	ARG2
-	ARG2
activator	ARG2
receptor	ARG2
gene1e	ARG2
and	O
a	O
squid	O
glycoprotein	O
of	O
unknown	O
function	O
.	O

A	O
tissue	O
-	O
specific	O
MAR	O
/	O
arg1s	O
SAR	O
arg1e	O
DNA	O
-	O
binding	O
protein	O
with	O
unusual	O
binding	O
site	O
recognition	O
.	O
A	O
species1s	O
human	O
species1e	O
cDNA	O
was	O
cloned	O
that	O
encodes	O
a	O
DNA	O
-	O
binding	O
protein	O
(	O
gene1s	O
SATB1	O
gene1e	O
)	O
that	O
is	O
expressed	O
predominantly	O
in	O
thymus	O
and	O
binds	O
selectively	O
to	O
the	O
nuclear	O
matrix	O
/	O
scaffold	O
-	O
associating	O
DNAs	O
(	O
MARs	O
/	O
SARs	O
)	O
.	O
Missing	O
nucleoside	O
experiments	O
showed	O
that	O
gene1s	O
SATB1	O
gene1e	O
selectively	O
binds	O
in	O
a	O
special	O
AT	O
-	O
rich	O
sequence	O
context	O
where	O
one	O
strand	O
consists	O
of	O
mixed	O
A	O
's	O
,	O
T	O
's	O
,	O
and	O
C	O
's	O
,	O
excluding	O
G	O
's	O
(	O
ATC	O
sequences	O
)	O
.	O
When	O
this	O
feature	O
is	O
destroyed	O
by	O
mutation	O
,	O
gene1s	O
SATB1	O
gene1e	O
binding	O
is	O
greatly	O
reduced	O
even	O
if	O
the	O
direct	O
contact	O
sequence	O
remains	O
intact	O
.	O
Conjunctional	O
gene1s	O
SATB1	O
gene1e	O
-binding	O
sequences	O
become	O
stably	O
unpaired	O
in	O
supercoiled	O
DNA	O
.	O
Specific	O
mutations	O
that	O
diminish	O
the	O
unwinding	O
potential	O
greatly	O
reduce	O
gene1s	O
SATB1	O
gene1e	O
binding	O
.	O
However	O
,	O
gene1s	O
SATB1	O
gene1e	O
does	O
not	O
bind	O
single	O
-	O
stranded	O
DNA	O
.	O
Chemical	O
interference	O
assays	O
show	O
that	O
gene1s	O
SATB1	O
gene1e	O
binds	O
along	O
the	O
minor	O
groove	O
with	O
very	O
little	O
contact	O
with	O
the	O
bases	O
.	O
This	O
suggests	O
that	O
gene1s	O
SATB1	O
gene1e	O
recognizes	O
the	O
ATC	O
sequence	O
indirectly	O
through	O
the	O
altered	O
sugar	O
-	O
phosphate	O
backbone	O
structure	O
present	O
in	O
the	O
double	O
-	O
stranded	O
DNA	O
.	O

A	O
tissue	O
-	O
specific	O
MAR	O
/	O
species1s	O
SAR	O
species1e	O
DNA	O
-	O
binding	O
protein	O
with	O
unusual	O
binding	O
site	O
recognition	O
.	O
A	O
arg1s	O
human	O
arg1e	O
cDNA	O
was	O
cloned	O
that	O
encodes	O
a	O
DNA	O
-	O
binding	O
protein	O
(	O
gene1s	ARG2
SATB1	ARG2
gene1e	ARG2
)	O
that	O
is	O
expressed	O
predominantly	O
in	O
thymus	O
and	O
binds	O
selectively	O
to	O
the	O
nuclear	O
matrix	O
/	O
scaffold	O
-	O
associating	O
DNAs	O
(	O
MARs	O
/	O
SARs	O
)	O
.	O
Missing	O
nucleoside	O
experiments	O
showed	O
that	O
gene1s	ARG2
SATB1	ARG2
gene1e	ARG2
selectively	O
binds	O
in	O
a	O
special	O
AT	O
-	O
rich	O
sequence	O
context	O
where	O
one	O
strand	O
consists	O
of	O
mixed	O
A	O
's	O
,	O
T	O
's	O
,	O
and	O
C	O
's	O
,	O
excluding	O
G	O
's	O
(	O
ATC	O
sequences	O
)	O
.	O
When	O
this	O
feature	O
is	O
destroyed	O
by	O
mutation	O
,	O
gene1s	ARG2
SATB1	ARG2
gene1e	ARG2
binding	O
is	O
greatly	O
reduced	O
even	O
if	O
the	O
direct	O
contact	O
sequence	O
remains	O
intact	O
.	O
Conjunctional	O
gene1s	ARG2
SATB1	ARG2
gene1e	ARG2
-binding	O
sequences	O
become	O
stably	O
unpaired	O
in	O
supercoiled	O
DNA	O
.	O
Specific	O
mutations	O
that	O
diminish	O
the	O
unwinding	O
potential	O
greatly	O
reduce	O
gene1s	ARG2
SATB1	ARG2
gene1e	ARG2
binding	O
.	O
However	O
,	O
gene1s	ARG2
SATB1	ARG2
gene1e	ARG2
does	O
not	O
bind	O
single	O
-	O
stranded	O
DNA	O
.	O
Chemical	O
interference	O
assays	O
show	O
that	O
gene1s	ARG2
SATB1	ARG2
gene1e	ARG2
binds	O
along	O
the	O
minor	O
groove	O
with	O
very	O
little	O
contact	O
with	O
the	O
bases	O
.	O
This	O
suggests	O
that	O
gene1s	ARG2
SATB1	ARG2
gene1e	ARG2
recognizes	O
the	O
ATC	O
sequence	O
indirectly	O
through	O
the	O
altered	O
sugar	O
-	O
phosphate	O
backbone	O
structure	O
present	O
in	O
the	O
double	O
-	O
stranded	O
DNA	O
.	O

Cloning	O
and	O
characterization	O
of	O
a	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
angiotensin	ARG2
II	ARG2
type	ARG2
1	ARG2
receptor	ARG2
gene1e	ARG2
.	O
A	O
arg1s	O
human	O
arg1e	O
liver	O
cDNA	O
library	O
was	O
screened	O
using	O
a	O
species1s	O
rat	O
species1e	O
gene1s	O
type	O
1	O
angiotensin	O
II	O
receptor	O
gene1e	O
cDNA	O
coding	O
sequence	O
as	O
a	O
probe	O
.	O
cDNA	O
clones	O
were	O
isolated	O
which	O
encoded	O
a	O
protein	O
of	O
359	O
amino	O
acids	O
that	O
shared	O
94.4	O
%	O
and	O
95.3	O
%	O
identify	O
to	O
species1s	O
rat	O
species1e	O
and	O
species1s	O
bovine	O
species1e	O
gene1s	O
type	O
1	O
angiotensin	O
II	O
receptors	O
gene1e	O
,	O
respectively	O
.	O
Ligand	O
binding	O
studies	O
of	O
the	O
cloned	O
receptor	O
expressed	O
in	O
COS	O
cells	O
suggested	O
that	O
it	O
is	O
pharmacologically	O
a	O
gene1s	ARG2
type	ARG2
1	ARG2
angiotensin	ARG2
II	ARG2
receptor	ARG2
gene1e	ARG2
subtype	O
.	O
Electrophysiological	O
studies	O
of	O
the	O
receptor	O
expressed	O
in	O
species1s	O
Xenopus	O
laevis	O
species1e	O
oocytes	O
revealed	O
that	O
it	O
could	O
functionally	O
couple	O
to	O
a	O
second	O
messenger	O
system	O
leading	O
to	O
the	O
mobilization	O
of	O
intracellular	O
stores	O
of	O
calcium	O
.	O
Southern	O
and	O
Northern	O
blot	O
analyses	O
indicated	O
that	O
the	O
cloned	O
receptor	O
is	O
represented	O
as	O
a	O
single	O
copy	O
in	O
the	O
arg1s	O
human	O
arg1e	O
genome	O
and	O
is	O
expressed	O
in	O
many	O
tissues	O
of	O
different	O
histogenic	O
origin	O
with	O
the	O
exception	O
of	O
brain	O
,	O
where	O
mRNA	O
transcripts	O
were	O
barely	O
detectable	O
.	O

Cloning	O
and	O
characterization	O
of	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
angiotensin	O
II	O
type	O
1	O
receptor	O
gene1e	O
.	O
A	O
species1s	O
human	O
species1e	O
liver	O
cDNA	O
library	O
was	O
screened	O
using	O
a	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
type	ARG2
1	ARG2
angiotensin	ARG2
II	ARG2
receptor	ARG2
gene1e	ARG2
cDNA	O
coding	O
sequence	O
as	O
a	O
probe	O
.	O
cDNA	O
clones	O
were	O
isolated	O
which	O
encoded	O
a	O
protein	O
of	O
359	O
amino	O
acids	O
that	O
shared	O
94.4	O
%	O
and	O
95.3	O
%	O
identify	O
to	O
arg1s	O
rat	O
arg1e	O
and	O
species1s	O
bovine	O
species1e	O
gene1s	ARG2
type	ARG2
1	ARG2
angiotensin	ARG2
II	ARG2
receptors	ARG2
gene1e	ARG2
,	O
respectively	O
.	O
Ligand	O
binding	O
studies	O
of	O
the	O
cloned	O
receptor	O
expressed	O
in	O
COS	O
cells	O
suggested	O
that	O
it	O
is	O
pharmacologically	O
a	O
gene1s	O
type	O
1	O
angiotensin	O
II	O
receptor	O
gene1e	O
subtype	O
.	O
Electrophysiological	O
studies	O
of	O
the	O
receptor	O
expressed	O
in	O
species1s	O
Xenopus	O
laevis	O
species1e	O
oocytes	O
revealed	O
that	O
it	O
could	O
functionally	O
couple	O
to	O
a	O
second	O
messenger	O
system	O
leading	O
to	O
the	O
mobilization	O
of	O
intracellular	O
stores	O
of	O
calcium	O
.	O
Southern	O
and	O
Northern	O
blot	O
analyses	O
indicated	O
that	O
the	O
cloned	O
receptor	O
is	O
represented	O
as	O
a	O
single	O
copy	O
in	O
the	O
species1s	O
human	O
species1e	O
genome	O
and	O
is	O
expressed	O
in	O
many	O
tissues	O
of	O
different	O
histogenic	O
origin	O
with	O
the	O
exception	O
of	O
brain	O
,	O
where	O
mRNA	O
transcripts	O
were	O
barely	O
detectable	O
.	O

Cloning	O
and	O
characterization	O
of	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
angiotensin	O
II	O
type	O
1	O
receptor	O
gene1e	O
.	O
A	O
species1s	O
human	O
species1e	O
liver	O
cDNA	O
library	O
was	O
screened	O
using	O
a	O
species1s	O
rat	O
species1e	O
gene1s	O
type	O
1	O
angiotensin	O
II	O
receptor	O
gene1e	O
cDNA	O
coding	O
sequence	O
as	O
a	O
probe	O
.	O
cDNA	O
clones	O
were	O
isolated	O
which	O
encoded	O
a	O
protein	O
of	O
359	O
amino	O
acids	O
that	O
shared	O
94.4	O
%	O
and	O
95.3	O
%	O
identify	O
to	O
species1s	O
rat	O
species1e	O
and	O
arg1s	O
bovine	O
arg1e	O
gene1s	ARG2
type	ARG2
1	ARG2
angiotensin	ARG2
II	ARG2
receptors	ARG2
gene1e	ARG2
,	O
respectively	O
.	O
Ligand	O
binding	O
studies	O
of	O
the	O
cloned	O
receptor	O
expressed	O
in	O
COS	O
cells	O
suggested	O
that	O
it	O
is	O
pharmacologically	O
a	O
gene1s	O
type	O
1	O
angiotensin	O
II	O
receptor	O
gene1e	O
subtype	O
.	O
Electrophysiological	O
studies	O
of	O
the	O
receptor	O
expressed	O
in	O
species1s	O
Xenopus	O
laevis	O
species1e	O
oocytes	O
revealed	O
that	O
it	O
could	O
functionally	O
couple	O
to	O
a	O
second	O
messenger	O
system	O
leading	O
to	O
the	O
mobilization	O
of	O
intracellular	O
stores	O
of	O
calcium	O
.	O
Southern	O
and	O
Northern	O
blot	O
analyses	O
indicated	O
that	O
the	O
cloned	O
receptor	O
is	O
represented	O
as	O
a	O
single	O
copy	O
in	O
the	O
species1s	O
human	O
species1e	O
genome	O
and	O
is	O
expressed	O
in	O
many	O
tissues	O
of	O
different	O
histogenic	O
origin	O
with	O
the	O
exception	O
of	O
brain	O
,	O
where	O
mRNA	O
transcripts	O
were	O
barely	O
detectable	O
.	O

Cloning	O
and	O
characterization	O
of	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
angiotensin	O
II	O
type	O
1	O
receptor	O
gene1e	O
.	O
A	O
species1s	O
human	O
species1e	O
liver	O
cDNA	O
library	O
was	O
screened	O
using	O
a	O
species1s	O
rat	O
species1e	O
gene1s	O
type	O
1	O
angiotensin	O
II	O
receptor	O
gene1e	O
cDNA	O
coding	O
sequence	O
as	O
a	O
probe	O
.	O
cDNA	O
clones	O
were	O
isolated	O
which	O
encoded	O
a	O
protein	O
of	O
359	O
amino	O
acids	O
that	O
shared	O
94.4	O
%	O
and	O
95.3	O
%	O
identify	O
to	O
species1s	O
rat	O
species1e	O
and	O
species1s	O
bovine	O
species1e	O
gene1s	O
type	O
1	O
angiotensin	O
II	O
receptors	O
gene1e	O
,	O
respectively	O
.	O
Ligand	O
binding	O
studies	O
of	O
the	O
cloned	O
receptor	O
expressed	O
in	O
COS	O
cells	O
suggested	O
that	O
it	O
is	O
pharmacologically	O
a	O
gene1s	O
type	O
1	O
angiotensin	O
II	O
receptor	O
gene1e	O
subtype	O
.	O
Electrophysiological	O
studies	O
of	O
the	O
receptor	O
expressed	O
in	O
arg1s	O
Xenopus	O
laevis	O
arg1e	O
oocytes	O
revealed	O
that	O
it	O
could	O
functionally	O
couple	O
to	O
a	O
second	O
messenger	O
system	O
leading	O
to	O
the	O
mobilization	O
of	O
intracellular	O
stores	O
of	O
calcium	O
.	O
Southern	O
and	O
Northern	O
blot	O
analyses	O
indicated	O
that	O
the	O
cloned	O
receptor	O
is	O
represented	O
as	O
a	O
single	O
copy	O
in	O
the	O
species1s	O
human	O
species1e	O
genome	O
and	O
is	O
expressed	O
in	O
many	O
tissues	O
of	O
different	O
histogenic	O
origin	O
with	O
the	O
exception	O
of	O
brain	O
,	O
where	O
mRNA	O
transcripts	O
were	O
barely	O
detectable	O
.	O

Cloning	O
,	O
expression	O
and	O
localization	O
of	O
an	O
RNA	O
helicase	O
gene	O
from	O
a	O
arg1s	O
human	O
arg1e	O
lymphoid	O
cell	O
line	O
with	O
chromosomal	O
breakpoint	O
11q23.3	O
.	O
A	O
gene	O
encoding	O
a	O
putative	O
arg1s	O
human	O
arg1e	O
RNA	O
helicase	O
,	O
gene1s	ARG2
p54	ARG2
gene1e	ARG2
,	O
has	O
been	O
cloned	O
and	O
mapped	O
to	O
the	O
band	O
q23.3	O
of	O
chromosome	O
11	O
.	O
The	O
predicted	O
amino	O
acid	O
sequence	O
shares	O
a	O
striking	O
homology	O
(	O
75	O
%	O
identical	O
)	O
with	O
the	O
female	O
germline	O
-	O
specific	O
RNA	O
helicase	O
gene1s	O
ME31B	O
gene1e	O
gene	O
of	O
species1s	O
Drosophila	O
species1e	O
.	O
Unlike	O
gene1s	O
ME31B	O
gene1e	O
,	O
however	O
,	O
the	O
new	O
gene	O
expresses	O
an	O
abundant	O
transcript	O
in	O
a	O
large	O
number	O
of	O
adult	O
tissues	O
and	O
its	O
5	O
'	O
non	O
-	O
coding	O
region	O
was	O
found	O
split	O
in	O
a	O
t(11;14)(q23.3;q32.3	O
)	O
cell	O
line	O
from	O
a	O
diffuse	O
large	O
B	O
-	O
cell	O
lymphoma	O
.	O

Cloning	O
,	O
expression	O
and	O
localization	O
of	O
an	O
RNA	O
helicase	O
gene	O
from	O
a	O
species1s	O
human	O
species1e	O
lymphoid	O
cell	O
line	O
with	O
chromosomal	O
breakpoint	O
11q23.3	O
.	O
A	O
gene	O
encoding	O
a	O
putative	O
species1s	O
human	O
species1e	O
RNA	O
helicase	O
,	O
gene1s	O
p54	O
gene1e	O
,	O
has	O
been	O
cloned	O
and	O
mapped	O
to	O
the	O
band	O
q23.3	O
of	O
chromosome	O
11	O
.	O
The	O
predicted	O
amino	O
acid	O
sequence	O
shares	O
a	O
striking	O
homology	O
(	O
75	O
%	O
identical	O
)	O
with	O
the	O
female	O
germline	O
-	O
specific	O
RNA	O
helicase	O
gene1s	ARG2
ME31B	ARG2
gene1e	ARG2
gene	O
of	O
arg1s	O
Drosophila	O
arg1e	O
.	O
Unlike	O
gene1s	ARG2
ME31B	ARG2
gene1e	ARG2
,	O
however	O
,	O
the	O
new	O
gene	O
expresses	O
an	O
abundant	O
transcript	O
in	O
a	O
large	O
number	O
of	O
adult	O
tissues	O
and	O
its	O
5	O
'	O
non	O
-	O
coding	O
region	O
was	O
found	O
split	O
in	O
a	O
t(11;14)(q23.3;q32.3	O
)	O
cell	O
line	O
from	O
a	O
diffuse	O
large	O
B	O
-	O
cell	O
lymphoma	O
.	O

Mutually	O
exclusive	O
expression	O
of	O
a	O
helix	O
-	O
loop	O
-	O
helix	O
gene	O
and	O
gene1s	ARG2
N	ARG2
-	ARG2
myc	ARG2
gene1e	ARG2
in	O
arg1s	O
human	O
arg1e	O
neuroblastomas	O
and	O
in	O
normal	O
development	O
.	O
We	O
have	O
isolated	O
a	O
novel	O
arg1s	O
human	O
arg1e	O
gene	O
encoding	O
a	O
helix	O
-	O
loop	O
-	O
helix	O
(	O
HLH	O
)	O
protein	O
by	O
molecularly	O
cloning	O
chromosome	O
1p36-specific	O
CpG	O
islands	O
.	O
The	O
gene	O
termed	O
gene1s	ARG2
heir-1	ARG2
gene1e	ARG2
was	O
localized	O
to	O
the	O
neuroblastoma	O
consensus	O
deletion	O
at	O
1p36.2-p36.12	O
.	O
Its	O
predicted	O
protein	O
is	O
95.8	O
%	O
identical	O
to	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
HLH462	O
gene1e	O
protein	O
and	O
has	O
clear	O
homology	O
to	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
I	O
d	O
gene1e	O
and	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
emc	O
gene1e	O
proteins	O
.	O
gene1s	ARG2
Heir-1	ARG2
gene1e	ARG2
does	O
not	O
encode	O
a	O
basic	O
DNA	O
binding	O
domain	O
as	O
found	O
in	O
basic	O
HLH	O
proteins	O
.	O
The	O
gene	O
is	O
expressed	O
specifically	O
at	O
high	O
abundance	O
in	O
adult	O
lung	O
,	O
kidney	O
and	O
adrenal	O
medulla	O
,	O
but	O
not	O
in	O
adult	O
brain	O
.	O
Despite	O
prominent	O
gene1s	ARG2
heir-1	ARG2
gene1e	ARG2
expression	O
in	O
adrenal	O
medulla	O
,	O
which	O
is	O
a	O
prime	O
target	O
for	O
neuroblastomas	O
,	O
10	O
out	O
of	O
12	O
neuroblastoma	O
-	O
derived	O
cell	O
lines	O
revealed	O
very	O
low	O
levels	O
of	O
gene1s	ARG2
heir-1	ARG2
gene1e	ARG2
mRNA	O
.	O
Low	O
gene1s	ARG2
heir-1	ARG2
gene1e	ARG2
expression	O
was	O
generally	O
found	O
in	O
tumor	O
cell	O
lines	O
with	O
gene1s	ARG2
N	ARG2
-	ARG2
myc	ARG2
gene1e	ARG2
overexpression	O
,	O
whereas	O
the	O
two	O
cell	O
lines	O
displaying	O
high	O
gene1s	ARG2
heir-1	ARG2
gene1e	ARG2
levels	O
did	O
not	O
overexpress	O
gene1s	ARG2
N	ARG2
-	ARG2
myc	ARG2
gene1e	ARG2
.	O
Mutually	O
exclusive	O
expression	O
of	O
both	O
genes	O
was	O
also	O
found	O
by	O
in	O
situ	O
hybridization	O
in	O
developing	O
species1s	O
mouse	O
species1e	O
tissues	O
,	O
particularly	O
in	O
the	O
forebrain	O
neuroectoderm	O
.	O
We	O
conclude	O
that	O
gene1s	ARG2
heir-1	ARG2
gene1e	ARG2
expression	O
is	O
reduced	O
specifically	O
in	O
the	O
majority	O
of	O
neuroblastomas	O
and	O
suggest	O
an	O
inverse	O
correlation	O
between	O
gene1s	ARG2
heir-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
N	ARG2
-	ARG2
myc	ARG2
gene1e	ARG2
expression	O
in	O
neuroblastoma	O
tumors	O
and	O
in	O
embryonic	O
development	O
.	O

Mutually	O
exclusive	O
expression	O
of	O
a	O
helix	O
-	O
loop	O
-	O
helix	O
gene	O
and	O
gene1s	O
N	O
-	O
myc	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
neuroblastomas	O
and	O
in	O
normal	O
development	O
.	O
We	O
have	O
isolated	O
a	O
novel	O
species1s	O
human	O
species1e	O
gene	O
encoding	O
a	O
helix	O
-	O
loop	O
-	O
helix	O
(	O
HLH	O
)	O
protein	O
by	O
molecularly	O
cloning	O
chromosome	O
1p36-specific	O
CpG	O
islands	O
.	O
The	O
gene	O
termed	O
gene1s	O
heir-1	O
gene1e	O
was	O
localized	O
to	O
the	O
neuroblastoma	O
consensus	O
deletion	O
at	O
1p36.2-p36.12	O
.	O
Its	O
predicted	O
protein	O
is	O
95.8	O
%	O
identical	O
to	O
the	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
HLH462	ARG2
gene1e	ARG2
protein	O
and	O
has	O
clear	O
homology	O
to	O
the	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
I	ARG2
d	ARG2
gene1e	ARG2
and	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
emc	O
gene1e	O
proteins	O
.	O
gene1s	O
Heir-1	O
gene1e	O
does	O
not	O
encode	O
a	O
basic	O
DNA	O
binding	O
domain	O
as	O
found	O
in	O
basic	O
HLH	O
proteins	O
.	O
The	O
gene	O
is	O
expressed	O
specifically	O
at	O
high	O
abundance	O
in	O
adult	O
lung	O
,	O
kidney	O
and	O
adrenal	O
medulla	O
,	O
but	O
not	O
in	O
adult	O
brain	O
.	O
Despite	O
prominent	O
gene1s	O
heir-1	O
gene1e	O
expression	O
in	O
adrenal	O
medulla	O
,	O
which	O
is	O
a	O
prime	O
target	O
for	O
neuroblastomas	O
,	O
10	O
out	O
of	O
12	O
neuroblastoma	O
-	O
derived	O
cell	O
lines	O
revealed	O
very	O
low	O
levels	O
of	O
gene1s	O
heir-1	O
gene1e	O
mRNA	O
.	O
Low	O
gene1s	O
heir-1	O
gene1e	O
expression	O
was	O
generally	O
found	O
in	O
tumor	O
cell	O
lines	O
with	O
gene1s	O
N	O
-	O
myc	O
gene1e	O
overexpression	O
,	O
whereas	O
the	O
two	O
cell	O
lines	O
displaying	O
high	O
gene1s	O
heir-1	O
gene1e	O
levels	O
did	O
not	O
overexpress	O
gene1s	O
N	O
-	O
myc	O
gene1e	O
.	O
Mutually	O
exclusive	O
expression	O
of	O
both	O
genes	O
was	O
also	O
found	O
by	O
in	O
situ	O
hybridization	O
in	O
developing	O
arg1s	O
mouse	O
arg1e	O
tissues	O
,	O
particularly	O
in	O
the	O
forebrain	O
neuroectoderm	O
.	O
We	O
conclude	O
that	O
gene1s	O
heir-1	O
gene1e	O
expression	O
is	O
reduced	O
specifically	O
in	O
the	O
majority	O
of	O
neuroblastomas	O
and	O
suggest	O
an	O
inverse	O
correlation	O
between	O
gene1s	O
heir-1	O
gene1e	O
and	O
gene1s	O
N	O
-	O
myc	O
gene1e	O
expression	O
in	O
neuroblastoma	O
tumors	O
and	O
in	O
embryonic	O
development	O
.	O

Mutually	O
exclusive	O
expression	O
of	O
a	O
helix	O
-	O
loop	O
-	O
helix	O
gene	O
and	O
gene1s	O
N	O
-	O
myc	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
neuroblastomas	O
and	O
in	O
normal	O
development	O
.	O
We	O
have	O
isolated	O
a	O
novel	O
species1s	O
human	O
species1e	O
gene	O
encoding	O
a	O
helix	O
-	O
loop	O
-	O
helix	O
(	O
HLH	O
)	O
protein	O
by	O
molecularly	O
cloning	O
chromosome	O
1p36-specific	O
CpG	O
islands	O
.	O
The	O
gene	O
termed	O
gene1s	O
heir-1	O
gene1e	O
was	O
localized	O
to	O
the	O
neuroblastoma	O
consensus	O
deletion	O
at	O
1p36.2-p36.12	O
.	O
Its	O
predicted	O
protein	O
is	O
95.8	O
%	O
identical	O
to	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
HLH462	O
gene1e	O
protein	O
and	O
has	O
clear	O
homology	O
to	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
I	O
d	O
gene1e	O
and	O
arg1s	O
Drosophila	O
arg1e	O
gene1s	ARG2
emc	ARG2
gene1e	ARG2
proteins	O
.	O
gene1s	O
Heir-1	O
gene1e	O
does	O
not	O
encode	O
a	O
basic	O
DNA	O
binding	O
domain	O
as	O
found	O
in	O
basic	O
HLH	O
proteins	O
.	O
The	O
gene	O
is	O
expressed	O
specifically	O
at	O
high	O
abundance	O
in	O
adult	O
lung	O
,	O
kidney	O
and	O
adrenal	O
medulla	O
,	O
but	O
not	O
in	O
adult	O
brain	O
.	O
Despite	O
prominent	O
gene1s	O
heir-1	O
gene1e	O
expression	O
in	O
adrenal	O
medulla	O
,	O
which	O
is	O
a	O
prime	O
target	O
for	O
neuroblastomas	O
,	O
10	O
out	O
of	O
12	O
neuroblastoma	O
-	O
derived	O
cell	O
lines	O
revealed	O
very	O
low	O
levels	O
of	O
gene1s	O
heir-1	O
gene1e	O
mRNA	O
.	O
Low	O
gene1s	O
heir-1	O
gene1e	O
expression	O
was	O
generally	O
found	O
in	O
tumor	O
cell	O
lines	O
with	O
gene1s	O
N	O
-	O
myc	O
gene1e	O
overexpression	O
,	O
whereas	O
the	O
two	O
cell	O
lines	O
displaying	O
high	O
gene1s	O
heir-1	O
gene1e	O
levels	O
did	O
not	O
overexpress	O
gene1s	O
N	O
-	O
myc	O
gene1e	O
.	O
Mutually	O
exclusive	O
expression	O
of	O
both	O
genes	O
was	O
also	O
found	O
by	O
in	O
situ	O
hybridization	O
in	O
developing	O
species1s	O
mouse	O
species1e	O
tissues	O
,	O
particularly	O
in	O
the	O
forebrain	O
neuroectoderm	O
.	O
We	O
conclude	O
that	O
gene1s	O
heir-1	O
gene1e	O
expression	O
is	O
reduced	O
specifically	O
in	O
the	O
majority	O
of	O
neuroblastomas	O
and	O
suggest	O
an	O
inverse	O
correlation	O
between	O
gene1s	O
heir-1	O
gene1e	O
and	O
gene1s	O
N	O
-	O
myc	O
gene1e	O
expression	O
in	O
neuroblastoma	O
tumors	O
and	O
in	O
embryonic	O
development	O
.	O

Identification	O
,	O
cloning	O
,	O
and	O
expression	O
of	O
a	O
cytosolic	O
megakaryocyte	O
protein	O
-	O
tyrosine	O
-	O
phosphatase	O
with	O
sequence	O
homology	O
to	O
gene1s	ARG2
cytoskeletal	ARG2
protein	ARG2
4.1	ARG2
gene1e	ARG2
.	O
We	O
have	O
isolated	O
a	O
cDNA	O
encoding	O
a	O
third	O
type	O
of	O
protein	O
-	O
tyrosine	O
-	O
phosphatase	O
.	O
We	O
screened	O
arg1s	O
human	O
arg1e	O
megakaryoblastic	O
cell	O
line	O
(	O
arg1s	O
MEG-01	O
arg1e	O
)	O
an	O
umbilical	O
vein	O
endothelial	O
cell	O
cDNA	O
libraries	O
to	O
obtain	O
a	O
3.7-kilobase	O
cDNA	O
designated	O
gene1s	ARG2
PTPase	ARG2
MEG	ARG2
gene1e	ARG2
.	O
Northern	O
blot	O
analysis	O
of	O
MEG-01	O
RNA	O
detected	O
a	O
3.7-kilobase	O
transcript	O
,	O
suggesting	O
that	O
a	O
full	O
-	O
length	O
cDNA	O
has	O
been	O
identified	O
.	O
gene1s	ARG2
PTPase	ARG2
MEG	ARG2
gene1e	ARG2
cDNA	O
contains	O
an	O
open	O
reading	O
frame	O
of	O
926	O
amino	O
acids	O
.	O
The	O
cDNA	O
has	O
a	O
G+C	O
-	O
rich	O
5	O
'	O
untranslated	O
region	O
of	O
771	O
nucleotides	O
that	O
has	O
the	O
potential	O
to	O
form	O
stable	O
stem	O
-	O
loop	O
structures	O
and	O
has	O
two	O
upstream	O
ATG	O
codons	O
.	O
The	O
predicted	O
protein	O
(	O
Mr	O
=	O
105,910	O
)	O
has	O
no	O
apparent	O
membrane	O
-	O
spanning	O
region	O
and	O
contains	O
a	O
single	O
protein	O
-	O
tyrosine	O
-	O
phosphatase	O
domain	O
(	O
amino	O
acids	O
659	O
-	O
909	O
)	O
that	O
is	O
35	O
-	O
40	O
%	O
identical	O
to	O
previously	O
described	O
tyrosine	O
-	O
phosphatase	O
domains	O
.	O
The	O
recombinant	O
phosphatase	O
domain	O
possesses	O
protein	O
-	O
tyrosine	O
-	O
phosphatase	O
activity	O
when	O
expressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
.	O
The	O
amino	O
-	O
terminal	O
region	O
(	O
amino	O
acids	O
31	O
-	O
367	O
)	O
is	O
45	O
%	O
identical	O
to	O
the	O
amino	O
terminus	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
erythrocyte	ARG2
protein	ARG2
4.1	ARG2
gene1e	ARG2
,	O
a	O
cytoskeletal	O
protein	O
.	O
The	O
identification	O
of	O
a	O
protein	O
-	O
tyrosine	O
-	O
phosphatase	O
that	O
is	O
related	O
to	O
cytoskeletal	O
proteins	O
implies	O
that	O
cell	O
signaling	O
activities	O
reside	O
not	O
only	O
in	O
transmembrane	O
receptors	O
but	O
in	O
cytoskeletal	O
elements	O
as	O
well	O
.	O

Identification	O
,	O
cloning	O
,	O
and	O
expression	O
of	O
a	O
cytosolic	O
megakaryocyte	O
protein	O
-	O
tyrosine	O
-	O
phosphatase	O
with	O
sequence	O
homology	O
to	O
gene1s	O
cytoskeletal	O
protein	O
4.1	O
gene1e	O
.	O
We	O
have	O
isolated	O
a	O
cDNA	O
encoding	O
a	O
third	O
type	O
of	O
protein	O
-	O
tyrosine	O
-	O
phosphatase	O
.	O
We	O
screened	O
species1s	O
human	O
species1e	O
megakaryoblastic	O
cell	O
line	O
(	O
species1s	O
MEG-01	O
species1e	O
)	O
an	O
umbilical	O
vein	O
endothelial	O
cell	O
cDNA	O
libraries	O
to	O
obtain	O
a	O
3.7-kilobase	O
cDNA	O
designated	O
gene1s	O
PTPase	O
MEG	O
gene1e	O
.	O
Northern	O
blot	O
analysis	O
of	O
MEG-01	O
RNA	O
detected	O
a	O
3.7-kilobase	O
transcript	O
,	O
suggesting	O
that	O
a	O
full	O
-	O
length	O
cDNA	O
has	O
been	O
identified	O
.	O
gene1s	O
PTPase	O
MEG	O
gene1e	O
cDNA	O
contains	O
an	O
open	O
reading	O
frame	O
of	O
926	O
amino	O
acids	O
.	O
The	O
cDNA	O
has	O
a	O
G+C	O
-	O
rich	O
5	O
'	O
untranslated	O
region	O
of	O
771	O
nucleotides	O
that	O
has	O
the	O
potential	O
to	O
form	O
stable	O
stem	O
-	O
loop	O
structures	O
and	O
has	O
two	O
upstream	O
ATG	O
codons	O
.	O
The	O
predicted	O
protein	O
(	O
Mr	O
=	O
105,910	O
)	O
has	O
no	O
apparent	O
membrane	O
-	O
spanning	O
region	O
and	O
contains	O
a	O
single	O
protein	O
-	O
tyrosine	O
-	O
phosphatase	O
domain	O
(	O
amino	O
acids	O
659	O
-	O
909	O
)	O
that	O
is	O
35	O
-	O
40	O
%	O
identical	O
to	O
previously	O
described	O
tyrosine	O
-	O
phosphatase	O
domains	O
.	O
The	O
recombinant	O
phosphatase	O
domain	O
possesses	O
protein	O
-	O
tyrosine	O
-	O
phosphatase	O
activity	O
when	O
expressed	O
in	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
.	O
The	O
amino	O
-	O
terminal	O
region	O
(	O
amino	O
acids	O
31	O
-	O
367	O
)	O
is	O
45	O
%	O
identical	O
to	O
the	O
amino	O
terminus	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
erythrocyte	O
protein	O
4.1	O
gene1e	O
,	O
a	O
cytoskeletal	O
protein	O
.	O
The	O
identification	O
of	O
a	O
protein	O
-	O
tyrosine	O
-	O
phosphatase	O
that	O
is	O
related	O
to	O
cytoskeletal	O
proteins	O
implies	O
that	O
cell	O
signaling	O
activities	O
reside	O
not	O
only	O
in	O
transmembrane	O
receptors	O
but	O
in	O
cytoskeletal	O
elements	O
as	O
well	O
.	O

Cloning	O
,	O
expression	O
and	O
chromosomal	O
localization	O
of	O
a	O
new	O
putative	O
receptor	O
-	O
like	O
protein	O
tyrosine	O
phosphatase	O
.	O
We	O
have	O
isolated	O
a	O
arg1s	O
mouse	O
arg1e	O
cDNA	O
of	O
5.7	O
kb	O
,	O
encoding	O
a	O
new	O
member	O
of	O
the	O
family	O
of	O
receptor	O
-	O
like	O
protein	O
tyrosine	O
phosphatases	O
,	O
termed	O
gene1s	ARG2
mRPTP	ARG2
mu	ARG2
gene1e	ARG2
.	O
The	O
cDNA	O
predicts	O
a	O
protein	O
of	O
1432	O
amino	O
acids	O
(	O
not	O
including	O
signal	O
peptide	O
)	O
with	O
a	O
calculated	O
Mr	O
of	O
161,636	O
.	O
In	O
addition	O
,	O
we	O
have	O
cloned	O
the	O
species1s	O
human	O
species1e	O
homologue	O
,	O
gene1s	O
hRPTP	O
mu	O
gene1e	O
,	O
which	O
shows	O
98.7	O
%	O
amino	O
acid	O
identity	O
to	O
gene1s	ARG2
mRPTP	ARG2
mu	ARG2
gene1e	ARG2
.	O
The	O
predicted	O
gene1s	ARG2
mRPTP	ARG2
mu	ARG2
gene1e	ARG2
protein	O
consists	O
of	O
a	O
722	O
amino	O
acid	O
extracellular	O
region	O
,	O
containing	O
13	O
potential	O
N	O
-	O
glycosylation	O
sites	O
,	O
a	O
single	O
transmembrane	O
domain	O
and	O
a	O
688	O
amino	O
acid	O
intracellular	O
part	O
containing	O
2	O
tandem	O
repeats	O
homologous	O
to	O
the	O
catalytic	O
domains	O
of	O
other	O
tyrosine	O
phosphatases	O
.	O
The	O
N	O
-	O
terminal	O
extracellular	O
part	O
contains	O
a	O
region	O
of	O
about	O
170	O
amino	O
acids	O
with	O
no	O
sequence	O
similarities	O
to	O
known	O
proteins	O
,	O
followed	O
by	O
one	O
Ig	O
-	O
like	O
domain	O
and	O
4	O
fibronectin	O
type	O
III	O
-	O
like	O
domains	O
.	O
The	O
intracellular	O
part	O
is	O
unique	O
in	O
that	O
the	O
region	O
between	O
the	O
transmembrane	O
domain	O
and	O
the	O
first	O
catalytic	O
domain	O
is	O
about	O
twice	O
as	O
large	O
as	O
in	O
other	O
receptor	O
-	O
like	O
protein	O
tyrosine	O
phosphatases	O
.	O
RNA	O
blot	O
analysis	O
reveals	O
a	O
single	O
transcript	O
,	O
that	O
is	O
most	O
abundant	O
in	O
lung	O
and	O
present	O
in	O
much	O
lower	O
amounts	O
in	O
brain	O
and	O
heart	O
.	O
Transfection	O
of	O
the	O
gene1s	ARG2
mRPTP	ARG2
mu	ARG2
gene1e	ARG2
cDNA	O
into	O
COS	O
cells	O
results	O
in	O
the	O
synthesis	O
of	O
a	O
protein	O
with	O
an	O
apparent	O
Mr	O
of	O
195,000	O
,	O
as	O
detected	O
in	O
immunoblots	O
using	O
an	O
antipeptide	O
antibody	O
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
RPTP	O
mu	O
gene1e	O
gene	O
is	O
localized	O
on	O
chromosome	O
18pter	O
-	O
q11	O
,	O
a	O
region	O
with	O
frequent	O
abnormalities	O
implicated	O
in	O
species1s	O
human	O
species1e	O
cancer	O
.	O

Cloning	O
,	O
expression	O
and	O
chromosomal	O
localization	O
of	O
a	O
new	O
putative	O
receptor	O
-	O
like	O
protein	O
tyrosine	O
phosphatase	O
.	O
We	O
have	O
isolated	O
a	O
species1s	O
mouse	O
species1e	O
cDNA	O
of	O
5.7	O
kb	O
,	O
encoding	O
a	O
new	O
member	O
of	O
the	O
family	O
of	O
receptor	O
-	O
like	O
protein	O
tyrosine	O
phosphatases	O
,	O
termed	O
gene1s	O
mRPTP	O
mu	O
gene1e	O
.	O
The	O
cDNA	O
predicts	O
a	O
protein	O
of	O
1432	O
amino	O
acids	O
(	O
not	O
including	O
signal	O
peptide	O
)	O
with	O
a	O
calculated	O
Mr	O
of	O
161,636	O
.	O
In	O
addition	O
,	O
we	O
have	O
cloned	O
the	O
arg1s	O
human	O
arg1e	O
homologue	O
,	O
gene1s	ARG2
hRPTP	ARG2
mu	ARG2
gene1e	ARG2
,	O
which	O
shows	O
98.7	O
%	O
amino	O
acid	O
identity	O
to	O
gene1s	O
mRPTP	O
mu	O
gene1e	O
.	O
The	O
predicted	O
gene1s	O
mRPTP	O
mu	O
gene1e	O
protein	O
consists	O
of	O
a	O
722	O
amino	O
acid	O
extracellular	O
region	O
,	O
containing	O
13	O
potential	O
N	O
-	O
glycosylation	O
sites	O
,	O
a	O
single	O
transmembrane	O
domain	O
and	O
a	O
688	O
amino	O
acid	O
intracellular	O
part	O
containing	O
2	O
tandem	O
repeats	O
homologous	O
to	O
the	O
catalytic	O
domains	O
of	O
other	O
tyrosine	O
phosphatases	O
.	O
The	O
N	O
-	O
terminal	O
extracellular	O
part	O
contains	O
a	O
region	O
of	O
about	O
170	O
amino	O
acids	O
with	O
no	O
sequence	O
similarities	O
to	O
known	O
proteins	O
,	O
followed	O
by	O
one	O
Ig	O
-	O
like	O
domain	O
and	O
4	O
fibronectin	O
type	O
III	O
-	O
like	O
domains	O
.	O
The	O
intracellular	O
part	O
is	O
unique	O
in	O
that	O
the	O
region	O
between	O
the	O
transmembrane	O
domain	O
and	O
the	O
first	O
catalytic	O
domain	O
is	O
about	O
twice	O
as	O
large	O
as	O
in	O
other	O
receptor	O
-	O
like	O
protein	O
tyrosine	O
phosphatases	O
.	O
RNA	O
blot	O
analysis	O
reveals	O
a	O
single	O
transcript	O
,	O
that	O
is	O
most	O
abundant	O
in	O
lung	O
and	O
present	O
in	O
much	O
lower	O
amounts	O
in	O
brain	O
and	O
heart	O
.	O
Transfection	O
of	O
the	O
gene1s	O
mRPTP	O
mu	O
gene1e	O
cDNA	O
into	O
COS	O
cells	O
results	O
in	O
the	O
synthesis	O
of	O
a	O
protein	O
with	O
an	O
apparent	O
Mr	O
of	O
195,000	O
,	O
as	O
detected	O
in	O
immunoblots	O
using	O
an	O
antipeptide	O
antibody	O
.	O
The	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
RPTP	ARG2
mu	ARG2
gene1e	ARG2
gene	O
is	O
localized	O
on	O
chromosome	O
18pter	O
-	O
q11	O
,	O
a	O
region	O
with	O
frequent	O
abnormalities	O
implicated	O
in	O
arg1s	O
human	O
arg1e	O
cancer	O
.	O

Structure	O
,	O
expression	O
,	O
and	O
genetic	O
linkage	O
of	O
the	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
BCM1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
OX45	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
Blast-1	ARG2
gene1e	ARG2
)	O
antigen	O
.	O
Evidence	O
for	O
genetic	O
duplication	O
giving	O
rise	O
to	O
the	O
gene1s	O
BCM1	O
gene1e	O
region	O
on	O
arg1s	O
mouse	O
arg1e	O
chromosome	O
1	O
and	O
the	O
gene1s	O
CD2	O
gene1e	O
/	O
gene1s	O
LFA3	O
gene1e	O
region	O
on	O
arg1s	O
mouse	O
arg1e	O
chromosome	O
3	O
.	O
The	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
BCM1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
OX45	ARG2
gene1e	ARG2
,	O
gene1s	O
Blast-1	O
gene1e	O
)	O
antigen	O
has	O
been	O
cDNA	O
cloned	O
and	O
sequenced	O
to	O
provide	O
data	O
supporting	O
the	O
view	O
that	O
gene1s	O
BCM1	O
gene1e	O
,	O
gene1s	O
LFA3	O
gene1e	O
,	O
and	O
gene1s	O
CD2	O
gene1e	O
constitute	O
a	O
subgroup	O
within	O
the	O
Ig	O
superfamily	O
.	O
arg1s	O
Mouse	O
arg1e	O
gene1s	O
BCM1	O
gene1e	O
is	O
widely	O
expressed	O
on	O
leukocytes	O
and	O
is	O
likely	O
to	O
be	O
anchored	O
to	O
the	O
cell	O
surface	O
by	O
a	O
glycosyl	O
-	O
phosphatidylinositol	O
anchor	O
,	O
as	O
is	O
the	O
case	O
for	O
species1s	O
rat	O
species1e	O
and	O
species1s	O
human	O
species1e	O
gene1s	O
BCM1	O
gene1e	O
antigen	O
.	O
Genetic	O
linkage	O
studies	O
by	O
recombination	O
and	O
pulse	O
field	O
analysis	O
showed	O
the	O
gene1s	ARG2
BCM1	ARG2
gene1e	ARG2
locus	O
(	O
gene1s	ARG2
Bcm-1	ARG2
gene1e	ARG2
)	O
to	O
be	O
on	O
distal	O
arg1s	O
mouse	O
arg1e	O
chromosome	O
1	O
and	O
to	O
be	O
linked	O
within	O
1,600	O
kb	O
to	O
the	O
locus	O
for	O
an	O
ATPase	O
alpha	O
chain	O
gene	O
(	O
gene1s	ARG2
Atpa-3	ARG2
gene1e	ARG2
)	O
.	O
A	O
similar	O
relationship	O
was	O
established	O
between	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
BCM1	O
gene1e	O
locus	O
(	O
gene1s	O
BCM1	O
gene1e	O
)	O
and	O
gene1s	O
ATP1A2	O
gene1e	O
,	O
and	O
other	O
markers	O
on	O
chromosome	O
1q	O
.	O
Conservation	O
of	O
genomic	O
organization	O
within	O
a	O
segment	O
of	O
species1s	O
human	O
species1e	O
chromosome	O
1q	O
and	O
arg1s	O
mouse	O
arg1e	O
chromosome	O
1	O
was	O
demonstrated	O
.	O
A	O
similar	O
situation	O
is	O
seen	O
in	O
the	O
region	O
of	O
the	O
gene1s	O
CD2	O
gene1e	O
and	O
gene1s	O
LFA3	O
gene1e	O
genes	O
between	O
arg1s	O
mouse	O
arg1e	O
chromosome	O
3	O
and	O
species1s	O
human	O
species1e	O
chromosome	O
1p	O
.	O
Furthermore	O
,	O
the	O
gene1s	O
CD2	O
gene1e	O
/	O
gene1s	O
LFA3	O
gene1e	O
genes	O
are	O
linked	O
within	O
580	O
kb	O
to	O
gene1s	ARG2
Atpa-1	ARG2
gene1e	ARG2
/	O
gene1s	O
ATP1A1	O
gene1e	O
genes	O
to	O
provide	O
a	O
parallel	O
situation	O
to	O
the	O
linkage	O
between	O
gene1s	ARG2
Bcm-1	ARG2
gene1e	ARG2
/	O
gene1s	O
BCM1	O
gene1e	O
and	O
gene1s	ARG2
Atpa-3	ARG2
gene1e	ARG2
/	O
gene1s	O
ATP1A2	O
gene1e	O
on	O
chromosomes	O
1	O
(	O
arg1s	O
mouse	O
arg1e	O
)	O
and	O
1q	O
(	O
species1s	O
human	O
species1e	O
)	O
.	O
Taken	O
together	O
,	O
the	O
data	O
suggest	O
duplication	O
of	O
a	O
chromosome	O
region	O
including	O
the	O
precursors	O
of	O
the	O
genes	O
for	O
gene1s	O
BCM1	O
gene1e	O
,	O
gene1s	O
CD2	O
gene1e	O
,	O
and	O
gene1s	O
LFA3	O
gene1e	O
,	O
and	O
the	O
ATPase	O
genes	O
to	O
give	O
rise	O
to	O
the	O
linkage	O
groups	O
now	O
observed	O
.	O
The	O
duplicated	O
regions	O
may	O
have	O
stayed	O
together	O
on	O
chromosome	O
1	O
in	O
the	O
species1s	O
human	O
species1e	O
(	O
with	O
the	O
insertion	O
of	O
a	O
centromere	O
)	O
,	O
while	O
in	O
the	O
arg1s	O
mouse	O
arg1e	O
,	O
the	O
genetic	O
regions	O
are	O
proposed	O
to	O
have	O
become	O
dispersed	O
in	O
the	O
formation	O
of	O
chromosomes	O
1	O
and	O
3	O
.	O
gene1s	O
CD2	O
gene1e	O
and	O
gene1s	O
LFA3	O
gene1e	O
are	O
more	O
dissimilar	O
in	O
sequence	O
than	O
gene1s	O
BCM1	O
gene1e	O
and	O
gene1s	O
LFA3	O
gene1e	O
,	O
and	O
if	O
the	O
precursors	O
of	O
the	O
gene1s	O
CD2	O
gene1e	O
and	O
gene1s	O
LFA3	O
gene1e	O
loci	O
formed	O
before	O
the	O
proposed	O
chromosome	O
segment	O
duplication	O
,	O
then	O
a	O
gene	O
encoding	O
a	O
recognizer	O
molecule	O
for	O
gene1s	O
BCM1	O
gene1e	O
may	O
exist	O
in	O
linkage	O
with	O
gene1s	ARG2
Bcm-1	ARG2
gene1e	ARG2
/	O
gene1s	O
BCM1	O
gene1e	O
on	O
chromosome	O
1	O
(	O
arg1s	O
mouse	O
arg1e	O
)	O
and	O
1q	O
(	O
species1s	O
human	O
species1e	O
)	O
.	O

Structure	O
,	O
expression	O
,	O
and	O
genetic	O
linkage	O
of	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
BCM1	O
gene1e	O
(	O
gene1s	O
OX45	O
gene1e	O
or	O
gene1s	O
Blast-1	O
gene1e	O
)	O
antigen	O
.	O
Evidence	O
for	O
genetic	O
duplication	O
giving	O
rise	O
to	O
the	O
gene1s	O
BCM1	O
gene1e	O
region	O
on	O
species1s	O
mouse	O
species1e	O
chromosome	O
1	O
and	O
the	O
gene1s	O
CD2	O
gene1e	O
/	O
gene1s	O
LFA3	O
gene1e	O
region	O
on	O
species1s	O
mouse	O
species1e	O
chromosome	O
3	O
.	O
The	O
species1s	O
mouse	O
species1e	O
gene1s	O
BCM1	O
gene1e	O
(	O
gene1s	O
OX45	O
gene1e	O
,	O
gene1s	O
Blast-1	O
gene1e	O
)	O
antigen	O
has	O
been	O
cDNA	O
cloned	O
and	O
sequenced	O
to	O
provide	O
data	O
supporting	O
the	O
view	O
that	O
gene1s	O
BCM1	O
gene1e	O
,	O
gene1s	O
LFA3	O
gene1e	O
,	O
and	O
gene1s	O
CD2	O
gene1e	O
constitute	O
a	O
subgroup	O
within	O
the	O
Ig	O
superfamily	O
.	O
species1s	O
Mouse	O
species1e	O
gene1s	O
BCM1	O
gene1e	O
is	O
widely	O
expressed	O
on	O
leukocytes	O
and	O
is	O
likely	O
to	O
be	O
anchored	O
to	O
the	O
cell	O
surface	O
by	O
a	O
glycosyl	O
-	O
phosphatidylinositol	O
anchor	O
,	O
as	O
is	O
the	O
case	O
for	O
arg1s	O
rat	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
gene1s	O
BCM1	O
gene1e	O
antigen	O
.	O
Genetic	O
linkage	O
studies	O
by	O
recombination	O
and	O
pulse	O
field	O
analysis	O
showed	O
the	O
gene1s	O
BCM1	O
gene1e	O
locus	O
(	O
gene1s	O
Bcm-1	O
gene1e	O
)	O
to	O
be	O
on	O
distal	O
species1s	O
mouse	O
species1e	O
chromosome	O
1	O
and	O
to	O
be	O
linked	O
within	O
1,600	O
kb	O
to	O
the	O
locus	O
for	O
an	O
ATPase	O
alpha	O
chain	O
gene	O
(	O
gene1s	O
Atpa-3	O
gene1e	O
)	O
.	O
A	O
similar	O
relationship	O
was	O
established	O
between	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
BCM1	O
gene1e	O
locus	O
(	O
gene1s	O
BCM1	O
gene1e	O
)	O
and	O
gene1s	O
ATP1A2	O
gene1e	O
,	O
and	O
other	O
markers	O
on	O
chromosome	O
1q	O
.	O
Conservation	O
of	O
genomic	O
organization	O
within	O
a	O
segment	O
of	O
species1s	O
human	O
species1e	O
chromosome	O
1q	O
and	O
species1s	O
mouse	O
species1e	O
chromosome	O
1	O
was	O
demonstrated	O
.	O
A	O
similar	O
situation	O
is	O
seen	O
in	O
the	O
region	O
of	O
the	O
gene1s	O
CD2	O
gene1e	O
and	O
gene1s	O
LFA3	O
gene1e	O
genes	O
between	O
species1s	O
mouse	O
species1e	O
chromosome	O
3	O
and	O
species1s	O
human	O
species1e	O
chromosome	O
1p	O
.	O
Furthermore	O
,	O
the	O
gene1s	O
CD2	O
gene1e	O
/	O
gene1s	O
LFA3	O
gene1e	O
genes	O
are	O
linked	O
within	O
580	O
kb	O
to	O
gene1s	O
Atpa-1	O
gene1e	O
/	O
gene1s	O
ATP1A1	O
gene1e	O
genes	O
to	O
provide	O
a	O
parallel	O
situation	O
to	O
the	O
linkage	O
between	O
gene1s	O
Bcm-1	O
gene1e	O
/	O
gene1s	O
BCM1	O
gene1e	O
and	O
gene1s	O
Atpa-3	O
gene1e	O
/	O
gene1s	O
ATP1A2	O
gene1e	O
on	O
chromosomes	O
1	O
(	O
species1s	O
mouse	O
species1e	O
)	O
and	O
1q	O
(	O
species1s	O
human	O
species1e	O
)	O
.	O
Taken	O
together	O
,	O
the	O
data	O
suggest	O
duplication	O
of	O
a	O
chromosome	O
region	O
including	O
the	O
precursors	O
of	O
the	O
genes	O
for	O
gene1s	O
BCM1	O
gene1e	O
,	O
gene1s	O
CD2	O
gene1e	O
,	O
and	O
gene1s	O
LFA3	O
gene1e	O
,	O
and	O
the	O
ATPase	O
genes	O
to	O
give	O
rise	O
to	O
the	O
linkage	O
groups	O
now	O
observed	O
.	O
The	O
duplicated	O
regions	O
may	O
have	O
stayed	O
together	O
on	O
chromosome	O
1	O
in	O
the	O
species1s	O
human	O
species1e	O
(	O
with	O
the	O
insertion	O
of	O
a	O
centromere	O
)	O
,	O
while	O
in	O
the	O
species1s	O
mouse	O
species1e	O
,	O
the	O
genetic	O
regions	O
are	O
proposed	O
to	O
have	O
become	O
dispersed	O
in	O
the	O
formation	O
of	O
chromosomes	O
1	O
and	O
3	O
.	O
gene1s	O
CD2	O
gene1e	O
and	O
gene1s	O
LFA3	O
gene1e	O
are	O
more	O
dissimilar	O
in	O
sequence	O
than	O
gene1s	O
BCM1	O
gene1e	O
and	O
gene1s	O
LFA3	O
gene1e	O
,	O
and	O
if	O
the	O
precursors	O
of	O
the	O
gene1s	O
CD2	O
gene1e	O
and	O
gene1s	O
LFA3	O
gene1e	O
loci	O
formed	O
before	O
the	O
proposed	O
chromosome	O
segment	O
duplication	O
,	O
then	O
a	O
gene	O
encoding	O
a	O
recognizer	O
molecule	O
for	O
gene1s	O
BCM1	O
gene1e	O
may	O
exist	O
in	O
linkage	O
with	O
gene1s	O
Bcm-1	O
gene1e	O
/	O
gene1s	O
BCM1	O
gene1e	O
on	O
chromosome	O
1	O
(	O
species1s	O
mouse	O
species1e	O
)	O
and	O
1q	O
(	O
species1s	O
human	O
species1e	O
)	O
.	O

Structure	O
,	O
expression	O
,	O
and	O
genetic	O
linkage	O
of	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
BCM1	O
gene1e	O
(	O
gene1s	O
OX45	O
gene1e	O
or	O
gene1s	O
Blast-1	O
gene1e	O
)	O
antigen	O
.	O
Evidence	O
for	O
genetic	O
duplication	O
giving	O
rise	O
to	O
the	O
gene1s	ARG2
BCM1	ARG2
gene1e	ARG2
region	O
on	O
species1s	O
mouse	O
species1e	O
chromosome	O
1	O
and	O
the	O
gene1s	ARG2
CD2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
LFA3	ARG2
gene1e	ARG2
region	O
on	O
species1s	O
mouse	O
species1e	O
chromosome	O
3	O
.	O
The	O
species1s	O
mouse	O
species1e	O
gene1s	O
BCM1	O
gene1e	O
(	O
gene1s	O
OX45	O
gene1e	O
,	O
gene1s	ARG2
Blast-1	ARG2
gene1e	ARG2
)	O
antigen	O
has	O
been	O
cDNA	O
cloned	O
and	O
sequenced	O
to	O
provide	O
data	O
supporting	O
the	O
view	O
that	O
gene1s	ARG2
BCM1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
LFA3	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
CD2	ARG2
gene1e	ARG2
constitute	O
a	O
subgroup	O
within	O
the	O
Ig	O
superfamily	O
.	O
species1s	O
Mouse	O
species1e	O
gene1s	ARG2
BCM1	ARG2
gene1e	ARG2
is	O
widely	O
expressed	O
on	O
leukocytes	O
and	O
is	O
likely	O
to	O
be	O
anchored	O
to	O
the	O
cell	O
surface	O
by	O
a	O
glycosyl	O
-	O
phosphatidylinositol	O
anchor	O
,	O
as	O
is	O
the	O
case	O
for	O
species1s	O
rat	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
BCM1	ARG2
gene1e	ARG2
antigen	O
.	O
Genetic	O
linkage	O
studies	O
by	O
recombination	O
and	O
pulse	O
field	O
analysis	O
showed	O
the	O
gene1s	O
BCM1	O
gene1e	O
locus	O
(	O
gene1s	O
Bcm-1	O
gene1e	O
)	O
to	O
be	O
on	O
distal	O
species1s	O
mouse	O
species1e	O
chromosome	O
1	O
and	O
to	O
be	O
linked	O
within	O
1,600	O
kb	O
to	O
the	O
locus	O
for	O
an	O
ATPase	O
alpha	O
chain	O
gene	O
(	O
gene1s	O
Atpa-3	O
gene1e	O
)	O
.	O
A	O
similar	O
relationship	O
was	O
established	O
between	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
BCM1	ARG2
gene1e	ARG2
locus	O
(	O
gene1s	ARG2
BCM1	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
ATP1A2	ARG2
gene1e	ARG2
,	O
and	O
other	O
markers	O
on	O
chromosome	O
1q	O
.	O
Conservation	O
of	O
genomic	O
organization	O
within	O
a	O
segment	O
of	O
arg1s	O
human	O
arg1e	O
chromosome	O
1q	O
and	O
species1s	O
mouse	O
species1e	O
chromosome	O
1	O
was	O
demonstrated	O
.	O
A	O
similar	O
situation	O
is	O
seen	O
in	O
the	O
region	O
of	O
the	O
gene1s	ARG2
CD2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
LFA3	ARG2
gene1e	ARG2
genes	O
between	O
species1s	O
mouse	O
species1e	O
chromosome	O
3	O
and	O
arg1s	O
human	O
arg1e	O
chromosome	O
1p	O
.	O
Furthermore	O
,	O
the	O
gene1s	ARG2
CD2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
LFA3	ARG2
gene1e	ARG2
genes	O
are	O
linked	O
within	O
580	O
kb	O
to	O
gene1s	O
Atpa-1	O
gene1e	O
/	O
gene1s	ARG2
ATP1A1	ARG2
gene1e	ARG2
genes	O
to	O
provide	O
a	O
parallel	O
situation	O
to	O
the	O
linkage	O
between	O
gene1s	O
Bcm-1	O
gene1e	O
/	O
gene1s	ARG2
BCM1	ARG2
gene1e	ARG2
and	O
gene1s	O
Atpa-3	O
gene1e	O
/	O
gene1s	ARG2
ATP1A2	ARG2
gene1e	ARG2
on	O
chromosomes	O
1	O
(	O
species1s	O
mouse	O
species1e	O
)	O
and	O
1q	O
(	O
arg1s	O
human	O
arg1e	O
)	O
.	O
Taken	O
together	O
,	O
the	O
data	O
suggest	O
duplication	O
of	O
a	O
chromosome	O
region	O
including	O
the	O
precursors	O
of	O
the	O
genes	O
for	O
gene1s	ARG2
BCM1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
LFA3	ARG2
gene1e	ARG2
,	O
and	O
the	O
ATPase	O
genes	O
to	O
give	O
rise	O
to	O
the	O
linkage	O
groups	O
now	O
observed	O
.	O
The	O
duplicated	O
regions	O
may	O
have	O
stayed	O
together	O
on	O
chromosome	O
1	O
in	O
the	O
arg1s	O
human	O
arg1e	O
(	O
with	O
the	O
insertion	O
of	O
a	O
centromere	O
)	O
,	O
while	O
in	O
the	O
species1s	O
mouse	O
species1e	O
,	O
the	O
genetic	O
regions	O
are	O
proposed	O
to	O
have	O
become	O
dispersed	O
in	O
the	O
formation	O
of	O
chromosomes	O
1	O
and	O
3	O
.	O
gene1s	ARG2
CD2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
LFA3	ARG2
gene1e	ARG2
are	O
more	O
dissimilar	O
in	O
sequence	O
than	O
gene1s	ARG2
BCM1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
LFA3	ARG2
gene1e	ARG2
,	O
and	O
if	O
the	O
precursors	O
of	O
the	O
gene1s	ARG2
CD2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
LFA3	ARG2
gene1e	ARG2
loci	O
formed	O
before	O
the	O
proposed	O
chromosome	O
segment	O
duplication	O
,	O
then	O
a	O
gene	O
encoding	O
a	O
recognizer	O
molecule	O
for	O
gene1s	ARG2
BCM1	ARG2
gene1e	ARG2
may	O
exist	O
in	O
linkage	O
with	O
gene1s	O
Bcm-1	O
gene1e	O
/	O
gene1s	ARG2
BCM1	ARG2
gene1e	ARG2
on	O
chromosome	O
1	O
(	O
species1s	O
mouse	O
species1e	O
)	O
and	O
1q	O
(	O
arg1s	O
human	O
arg1e	O
)	O
.	O

Soluble	O
forms	O
of	O
tumor	O
necrosis	O
factor	O
receptors	O
(	O
TNF	O
-	O
Rs	O
)	O
.	O
The	O
cDNA	O
for	O
the	O
gene1s	ARG2
type	ARG2
I	ARG2
TNF	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
,	O
cloned	O
using	O
amino	O
acid	O
sequence	O
data	O
of	O
its	O
soluble	O
form	O
,	O
encodes	O
both	O
the	O
cell	O
surface	O
and	O
a	O
soluble	O
form	O
of	O
the	O
receptor	O
.	O
Two	O
proteins	O
which	O
specifically	O
bind	O
gene1s	ARG2
tumor	ARG2
necrosis	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TNF	ARG2
gene1e	ARG2
)	O
have	O
recently	O
been	O
isolated	O
from	O
arg1s	O
human	O
arg1e	O
urine	O
in	O
our	O
laboratory	O
.	O
The	O
two	O
proteins	O
cross	O
-	O
react	O
immunologically	O
with	O
two	O
species	O
of	O
cell	O
surface	O
TNF	O
receptors	O
(	O
TNF	O
-	O
R	O
)	O
.	O
Antibodies	O
against	O
one	O
of	O
the	O
two	O
TNF	O
binding	O
proteins	O
(	O
TBPI	O
)	O
were	O
found	O
to	O
have	O
effects	O
characteristic	O
of	O
gene1s	ARG2
TNF	ARG2
gene1e	ARG2
,	O
including	O
stimulating	O
phosphorylation	O
of	O
specific	O
cellular	O
proteins	O
.	O
Oligonucleotide	O
probes	O
designed	O
on	O
the	O
basis	O
of	O
the	O
NH2-terminal	O
amino	O
acid	O
sequence	O
of	O
TBPI	O
were	O
used	O
to	O
clone	O
the	O
cDNA	O
for	O
the	O
structurally	O
related	O
gene1s	ARG2
cell	ARG2
surface	ARG2
type	ARG2
1	ARG2
TNF	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
.	O
It	O
is	O
notable	O
that	O
although	O
this	O
receptor	O
can	O
signal	O
the	O
phosphorylation	O
of	O
cellular	O
proteins	O
,	O
it	O
appears	O
from	O
its	O
amino	O
acid	O
sequence	O
to	O
be	O
devoid	O
of	O
intrinsic	O
protein	O
kinase	O
activity	O
.	O
The	O
extracellular	O
domain	O
of	O
the	O
receptor	O
is	O
composed	O
of	O
four	O
internal	O
cysteine	O
-	O
rich	O
repeats	O
,	O
homologous	O
to	O
structures	O
repeated	O
four	O
times	O
in	O
the	O
extracellular	O
domains	O
of	O
the	O
gene1s	ARG2
nerve	ARG2
growth	ARG2
factor	ARG2
receptor	ARG2
gene1e	ARG2
and	O
the	O
B	O
lymphocytes	O
surface	O
antigen	O
gene1s	ARG2
CDw40	ARG2
gene1e	ARG2
.	O
The	O
amino	O
acid	O
composition	O
and	O
size	O
of	O
the	O
extracellular	O
domain	O
of	O
the	O
gene1s	ARG2
type	ARG2
I	ARG2
TNF	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
closely	O
resemble	O
those	O
of	O
TBPI	O
.	O
The	O
COOH	O
-	O
terminal	O
amino	O
acid	O
sequence	O
of	O
the	O
four	O
cysteine	O
rich	O
repeats	O
within	O
the	O
extracellular	O
domain	O
of	O
the	O
gene1s	ARG2
type	ARG2
I	ARG2
TNF	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
matches	O
the	O
COOH	O
-	O
terminal	O
sequence	O
of	O
TBPI	O
.	O
Amino	O
acid	O
sequences	O
in	O
the	O
extracellular	O
domain	O
also	O
fully	O
match	O
species1s	O
other	O
sequences	O
species1e	O
found	O
in	O
TBPI	O
.	O
On	O
the	O
other	O
hand	O
,	O
amino	O
acid	O
sequences	O
in	O
the	O
soluble	O
form	O
of	O
the	O
gene1s	ARG2
type	ARG2
II	ARG2
TNF	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TBPII	ARG2
gene1e	ARG2
)	O
,	O
while	O
indicating	O
a	O
marked	O
homology	O
of	O
structure	O
,	O
did	O
not	O
suggest	O
any	O
identity	O
between	O
this	O
protein	O
and	O
the	O
extracellular	O
domain	O
of	O
the	O
gene1s	ARG2
type	ARG2
I	ARG2
TNF	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
.	O
species1s	O
CHO	O
species1e	O
cells	O
transfected	O
with	O
gene1s	ARG2
type	ARG2
I	ARG2
TNF	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
cDNA	O
produced	O
both	O
cell	O
surface	O
and	O
soluble	O
forms	O
of	O
the	O
receptor	O
.	O
The	O
receptor	O
produced	O
by	O
species1s	O
CHO	O
species1e	O
cells	O
was	O
recognized	O
by	O
several	O
monoclonal	O
antibodies	O
against	O
TBPI	O
,	O
reacting	O
with	O
several	O
distinct	O
epitopes	O
in	O
this	O
molecule	O
.	O
These	O
data	O
suggest	O
that	O
the	O
soluble	O
forms	O
of	O
the	O
TNF	O
-	O
Rs	O
are	O
structurally	O
identical	O
to	O
the	O
extracellular	O
cytokine	O
binding	O
domains	O
of	O
these	O
receptors	O
and	O
are	O
consistent	O
with	O
the	O
notion	O
that	O
the	O
soluble	O
forms	O
are	O
,	O
at	O
least	O
partly	O
,	O
derived	O
from	O
the	O
same	O
transcripts	O
that	O
encode	O
the	O
cell	O
surface	O
receptors	O
.	O

Soluble	O
forms	O
of	O
tumor	O
necrosis	O
factor	O
receptors	O
(	O
TNF	O
-	O
Rs	O
)	O
.	O
The	O
cDNA	O
for	O
the	O
gene1s	O
type	O
I	O
TNF	O
-	O
R	O
gene1e	O
,	O
cloned	O
using	O
amino	O
acid	O
sequence	O
data	O
of	O
its	O
soluble	O
form	O
,	O
encodes	O
both	O
the	O
cell	O
surface	O
and	O
a	O
soluble	O
form	O
of	O
the	O
receptor	O
.	O
Two	O
proteins	O
which	O
specifically	O
bind	O
gene1s	O
tumor	O
necrosis	O
factor	O
gene1e	O
(	O
gene1s	O
TNF	O
gene1e	O
)	O
have	O
recently	O
been	O
isolated	O
from	O
species1s	O
human	O
species1e	O
urine	O
in	O
our	O
laboratory	O
.	O
The	O
two	O
proteins	O
cross	O
-	O
react	O
immunologically	O
with	O
two	O
species	O
of	O
cell	O
surface	O
TNF	O
receptors	O
(	O
TNF	O
-	O
R	O
)	O
.	O
Antibodies	O
against	O
one	O
of	O
the	O
two	O
TNF	O
binding	O
proteins	O
(	O
TBPI	O
)	O
were	O
found	O
to	O
have	O
effects	O
characteristic	O
of	O
gene1s	O
TNF	O
gene1e	O
,	O
including	O
stimulating	O
phosphorylation	O
of	O
specific	O
cellular	O
proteins	O
.	O
Oligonucleotide	O
probes	O
designed	O
on	O
the	O
basis	O
of	O
the	O
NH2-terminal	O
amino	O
acid	O
sequence	O
of	O
TBPI	O
were	O
used	O
to	O
clone	O
the	O
cDNA	O
for	O
the	O
structurally	O
related	O
gene1s	O
cell	O
surface	O
type	O
1	O
TNF	O
-	O
R	O
gene1e	O
.	O
It	O
is	O
notable	O
that	O
although	O
this	O
receptor	O
can	O
signal	O
the	O
phosphorylation	O
of	O
cellular	O
proteins	O
,	O
it	O
appears	O
from	O
its	O
amino	O
acid	O
sequence	O
to	O
be	O
devoid	O
of	O
intrinsic	O
protein	O
kinase	O
activity	O
.	O
The	O
extracellular	O
domain	O
of	O
the	O
receptor	O
is	O
composed	O
of	O
four	O
internal	O
cysteine	O
-	O
rich	O
repeats	O
,	O
homologous	O
to	O
structures	O
repeated	O
four	O
times	O
in	O
the	O
extracellular	O
domains	O
of	O
the	O
gene1s	O
nerve	O
growth	O
factor	O
receptor	O
gene1e	O
and	O
the	O
B	O
lymphocytes	O
surface	O
antigen	O
gene1s	O
CDw40	O
gene1e	O
.	O
The	O
amino	O
acid	O
composition	O
and	O
size	O
of	O
the	O
extracellular	O
domain	O
of	O
the	O
gene1s	O
type	O
I	O
TNF	O
-	O
R	O
gene1e	O
closely	O
resemble	O
those	O
of	O
TBPI	O
.	O
The	O
COOH	O
-	O
terminal	O
amino	O
acid	O
sequence	O
of	O
the	O
four	O
cysteine	O
rich	O
repeats	O
within	O
the	O
extracellular	O
domain	O
of	O
the	O
gene1s	O
type	O
I	O
TNF	O
-	O
R	O
gene1e	O
matches	O
the	O
COOH	O
-	O
terminal	O
sequence	O
of	O
TBPI	O
.	O
Amino	O
acid	O
sequences	O
in	O
the	O
extracellular	O
domain	O
also	O
fully	O
match	O
arg1s	O
other	O
sequences	O
arg1e	O
found	O
in	O
TBPI	O
.	O
On	O
the	O
other	O
hand	O
,	O
amino	O
acid	O
sequences	O
in	O
the	O
soluble	O
form	O
of	O
the	O
gene1s	O
type	O
II	O
TNF	O
-	O
R	O
gene1e	O
(	O
gene1s	O
TBPII	O
gene1e	O
)	O
,	O
while	O
indicating	O
a	O
marked	O
homology	O
of	O
structure	O
,	O
did	O
not	O
suggest	O
any	O
identity	O
between	O
this	O
protein	O
and	O
the	O
extracellular	O
domain	O
of	O
the	O
gene1s	O
type	O
I	O
TNF	O
-	O
R	O
gene1e	O
.	O
species1s	O
CHO	O
species1e	O
cells	O
transfected	O
with	O
gene1s	O
type	O
I	O
TNF	O
-	O
R	O
gene1e	O
cDNA	O
produced	O
both	O
cell	O
surface	O
and	O
soluble	O
forms	O
of	O
the	O
receptor	O
.	O
The	O
receptor	O
produced	O
by	O
species1s	O
CHO	O
species1e	O
cells	O
was	O
recognized	O
by	O
several	O
monoclonal	O
antibodies	O
against	O
TBPI	O
,	O
reacting	O
with	O
several	O
distinct	O
epitopes	O
in	O
this	O
molecule	O
.	O
These	O
data	O
suggest	O
that	O
the	O
soluble	O
forms	O
of	O
the	O
TNF	O
-	O
Rs	O
are	O
structurally	O
identical	O
to	O
the	O
extracellular	O
cytokine	O
binding	O
domains	O
of	O
these	O
receptors	O
and	O
are	O
consistent	O
with	O
the	O
notion	O
that	O
the	O
soluble	O
forms	O
are	O
,	O
at	O
least	O
partly	O
,	O
derived	O
from	O
the	O
same	O
transcripts	O
that	O
encode	O
the	O
cell	O
surface	O
receptors	O
.	O

Soluble	O
forms	O
of	O
tumor	O
necrosis	O
factor	O
receptors	O
(	O
TNF	O
-	O
Rs	O
)	O
.	O
The	O
cDNA	O
for	O
the	O
gene1s	O
type	O
I	O
TNF	O
-	O
R	O
gene1e	O
,	O
cloned	O
using	O
amino	O
acid	O
sequence	O
data	O
of	O
its	O
soluble	O
form	O
,	O
encodes	O
both	O
the	O
cell	O
surface	O
and	O
a	O
soluble	O
form	O
of	O
the	O
receptor	O
.	O
Two	O
proteins	O
which	O
specifically	O
bind	O
gene1s	O
tumor	O
necrosis	O
factor	O
gene1e	O
(	O
gene1s	O
TNF	O
gene1e	O
)	O
have	O
recently	O
been	O
isolated	O
from	O
species1s	O
human	O
species1e	O
urine	O
in	O
our	O
laboratory	O
.	O
The	O
two	O
proteins	O
cross	O
-	O
react	O
immunologically	O
with	O
two	O
species	O
of	O
cell	O
surface	O
TNF	O
receptors	O
(	O
TNF	O
-	O
R	O
)	O
.	O
Antibodies	O
against	O
one	O
of	O
the	O
two	O
TNF	O
binding	O
proteins	O
(	O
TBPI	O
)	O
were	O
found	O
to	O
have	O
effects	O
characteristic	O
of	O
gene1s	O
TNF	O
gene1e	O
,	O
including	O
stimulating	O
phosphorylation	O
of	O
specific	O
cellular	O
proteins	O
.	O
Oligonucleotide	O
probes	O
designed	O
on	O
the	O
basis	O
of	O
the	O
NH2-terminal	O
amino	O
acid	O
sequence	O
of	O
TBPI	O
were	O
used	O
to	O
clone	O
the	O
cDNA	O
for	O
the	O
structurally	O
related	O
gene1s	O
cell	O
surface	O
type	O
1	O
TNF	O
-	O
R	O
gene1e	O
.	O
It	O
is	O
notable	O
that	O
although	O
this	O
receptor	O
can	O
signal	O
the	O
phosphorylation	O
of	O
cellular	O
proteins	O
,	O
it	O
appears	O
from	O
its	O
amino	O
acid	O
sequence	O
to	O
be	O
devoid	O
of	O
intrinsic	O
protein	O
kinase	O
activity	O
.	O
The	O
extracellular	O
domain	O
of	O
the	O
receptor	O
is	O
composed	O
of	O
four	O
internal	O
cysteine	O
-	O
rich	O
repeats	O
,	O
homologous	O
to	O
structures	O
repeated	O
four	O
times	O
in	O
the	O
extracellular	O
domains	O
of	O
the	O
gene1s	O
nerve	O
growth	O
factor	O
receptor	O
gene1e	O
and	O
the	O
B	O
lymphocytes	O
surface	O
antigen	O
gene1s	O
CDw40	O
gene1e	O
.	O
The	O
amino	O
acid	O
composition	O
and	O
size	O
of	O
the	O
extracellular	O
domain	O
of	O
the	O
gene1s	O
type	O
I	O
TNF	O
-	O
R	O
gene1e	O
closely	O
resemble	O
those	O
of	O
TBPI	O
.	O
The	O
COOH	O
-	O
terminal	O
amino	O
acid	O
sequence	O
of	O
the	O
four	O
cysteine	O
rich	O
repeats	O
within	O
the	O
extracellular	O
domain	O
of	O
the	O
gene1s	O
type	O
I	O
TNF	O
-	O
R	O
gene1e	O
matches	O
the	O
COOH	O
-	O
terminal	O
sequence	O
of	O
TBPI	O
.	O
Amino	O
acid	O
sequences	O
in	O
the	O
extracellular	O
domain	O
also	O
fully	O
match	O
species1s	O
other	O
sequences	O
species1e	O
found	O
in	O
TBPI	O
.	O
On	O
the	O
other	O
hand	O
,	O
amino	O
acid	O
sequences	O
in	O
the	O
soluble	O
form	O
of	O
the	O
gene1s	O
type	O
II	O
TNF	O
-	O
R	O
gene1e	O
(	O
gene1s	O
TBPII	O
gene1e	O
)	O
,	O
while	O
indicating	O
a	O
marked	O
homology	O
of	O
structure	O
,	O
did	O
not	O
suggest	O
any	O
identity	O
between	O
this	O
protein	O
and	O
the	O
extracellular	O
domain	O
of	O
the	O
gene1s	O
type	O
I	O
TNF	O
-	O
R	O
gene1e	O
.	O
arg1s	O
CHO	O
arg1e	O
cells	O
transfected	O
with	O
gene1s	O
type	O
I	O
TNF	O
-	O
R	O
gene1e	O
cDNA	O
produced	O
both	O
cell	O
surface	O
and	O
soluble	O
forms	O
of	O
the	O
receptor	O
.	O
The	O
receptor	O
produced	O
by	O
arg1s	O
CHO	O
arg1e	O
cells	O
was	O
recognized	O
by	O
several	O
monoclonal	O
antibodies	O
against	O
TBPI	O
,	O
reacting	O
with	O
several	O
distinct	O
epitopes	O
in	O
this	O
molecule	O
.	O
These	O
data	O
suggest	O
that	O
the	O
soluble	O
forms	O
of	O
the	O
TNF	O
-	O
Rs	O
are	O
structurally	O
identical	O
to	O
the	O
extracellular	O
cytokine	O
binding	O
domains	O
of	O
these	O
receptors	O
and	O
are	O
consistent	O
with	O
the	O
notion	O
that	O
the	O
soluble	O
forms	O
are	O
,	O
at	O
least	O
partly	O
,	O
derived	O
from	O
the	O
same	O
transcripts	O
that	O
encode	O
the	O
cell	O
surface	O
receptors	O
.	O

Cloning	O
and	O
antisense	O
oligodeoxynucleotide	O
inhibition	O
of	O
a	O
arg1s	O
human	O
arg1e	O
homolog	O
of	O
gene1s	ARG2
cdc2	ARG2
gene1e	ARG2
required	O
in	O
hematopoiesis	O
.	O
Mechanisms	O
triggering	O
the	O
commitment	O
of	O
pluripotent	O
bone	O
marrow	O
stem	O
cells	O
to	O
differentiated	O
lineages	O
such	O
as	O
mononuclear	O
macrophages	O
or	O
multinucleated	O
megakaryocytes	O
are	O
still	O
unknown	O
,	O
although	O
several	O
lines	O
of	O
evidence	O
suggested	O
correlation	O
between	O
cholinergic	O
signaling	O
and	O
hematopoietic	O
differentiation	O
.	O
We	O
now	O
present	O
cloning	O
of	O
a	O
cDNA	O
coding	O
for	O
gene1s	ARG2
CHED	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
cholinesterase	ARG2
-	ARG2
related	ARG2
cell	ARG2
division	ARG2
controller	ARG2
gene1e	ARG2
)	O
,	O
a	O
arg1s	O
human	O
arg1e	O
homolog	O
of	O
the	O
species1s	O
Schizosaccharomyces	O
pombe	O
species1e	O
cell	O
division	O
cycle	O
2	O
(	O
cdc2)-like	O
kinases	O
,	O
universal	O
controllers	O
of	O
the	O
mitotic	O
cell	O
cycle	O
.	O
Library	O
screening	O
,	O
RNA	O
blot	O
hybridization	O
,	O
and	O
direct	O
PCR	O
amplification	O
of	O
cDNA	O
reverse	O
-	O
transcribed	O
from	O
cellular	O
mRNA	O
revealed	O
that	O
gene1s	ARG2
CHED	ARG2
gene1e	ARG2
mRNA	O
is	O
expressed	O
in	O
multiple	O
tissues	O
,	O
including	O
bone	O
marrow	O
.	O
The	O
gene1s	ARG2
CHED	ARG2
gene1e	ARG2
protein	O
includes	O
the	O
consensus	O
ATP	O
binding	O
and	O
phosphorylation	O
domains	O
characteristic	O
of	O
kinases	O
,	O
displays	O
34	O
-	O
42	O
%	O
identically	O
aligned	O
amino	O
acid	O
residues	O
with	O
other	O
cdc2-related	O
kinases	O
,	O
and	O
is	O
considerably	O
longer	O
at	O
its	O
amino	O
and	O
carboxyl	O
termini	O
.	O
An	O
antisense	O
oligodeoxynucleotide	O
designed	O
to	O
interrupt	O
gene1s	ARG2
CHED	ARG2
gene1e	ARG2
's	O
expression	O
(	O
AS	O
-	O
gene1s	ARG2
CHED	ARG2
gene1e	ARG2
)	O
significantly	O
reduced	O
the	O
ratio	O
between	O
gene1s	ARG2
CHED	ARG2
gene1e	ARG2
mRNA	O
and	O
actin	O
mRNA	O
within	O
1	O
hr	O
of	O
its	O
addition	O
to	O
cultures	O
,	O
a	O
reduction	O
that	O
persisted	O
for	O
4	O
days	O
.	O
AS	O
-	O
gene1s	ARG2
CHED	ARG2
gene1e	ARG2
treatment	O
selectively	O
inhibited	O
megakaryocyte	O
development	O
in	O
species1s	O
murine	O
species1e	O
bone	O
marrow	O
cultures	O
but	O
did	O
not	O
prevent	O
other	O
hematopoietic	O
pathways	O
,	O
as	O
evidenced	O
by	O
increasing	O
numbers	O
of	O
mononuclear	O
cells	O
.	O
An	O
oligodeoxynucleotide	O
blocking	O
production	O
of	O
the	O
acetylcholine	O
-	O
hydrolyzing	O
enzyme	O
,	O
gene1s	ARG2
butyrylcholinesterase	ARG2
gene1e	ARG2
,	O
displayed	O
a	O
similar	O
inhibition	O
of	O
megakaryocytopoiesis	O
.	O
In	O
contrast	O
,	O
an	O
oligodeoxynucleotide	O
blocking	O
production	O
of	O
the	O
arg1s	O
human	O
arg1e	O
2Hs	O
gene1s	ARG2
cdc2	ARG2
gene1e	ARG2
homolog	O
interfered	O
with	O
production	O
of	O
the	O
arg1s	O
human	O
arg1e	O
2Hs	O
gene1s	ARG2
cdc2	ARG2
gene1e	ARG2
homolog	O
interfered	O
with	O
cellular	O
proliferation	O
without	O
altering	O
the	O
cell	O
-	O
type	O
composition	O
of	O
these	O
cultures	O
.	O
Therefore	O
,	O
these	O
findings	O
strengthen	O
the	O
link	O
between	O
cholinergic	O
signaling	O
and	O
cell	O
division	O
control	O
in	O
hematopoiesis	O
and	O
implicate	O
both	O
gene1s	ARG2
CHED	ARG2
gene1e	ARG2
and	O
cholinesterases	O
in	O
this	O
differentiation	O
process	O
.	O

Cloning	O
and	O
antisense	O
oligodeoxynucleotide	O
inhibition	O
of	O
a	O
species1s	O
human	O
species1e	O
homolog	O
of	O
gene1s	O
cdc2	O
gene1e	O
required	O
in	O
hematopoiesis	O
.	O
Mechanisms	O
triggering	O
the	O
commitment	O
of	O
pluripotent	O
bone	O
marrow	O
stem	O
cells	O
to	O
differentiated	O
lineages	O
such	O
as	O
mononuclear	O
macrophages	O
or	O
multinucleated	O
megakaryocytes	O
are	O
still	O
unknown	O
,	O
although	O
several	O
lines	O
of	O
evidence	O
suggested	O
correlation	O
between	O
cholinergic	O
signaling	O
and	O
hematopoietic	O
differentiation	O
.	O
We	O
now	O
present	O
cloning	O
of	O
a	O
cDNA	O
coding	O
for	O
gene1s	O
CHED	O
gene1e	O
(	O
gene1s	O
cholinesterase	O
-	O
related	O
cell	O
division	O
controller	O
gene1e	O
)	O
,	O
a	O
species1s	O
human	O
species1e	O
homolog	O
of	O
the	O
arg1s	O
Schizosaccharomyces	O
pombe	O
arg1e	O
cell	O
division	O
cycle	O
2	O
(	O
cdc2)-like	O
kinases	O
,	O
universal	O
controllers	O
of	O
the	O
mitotic	O
cell	O
cycle	O
.	O
Library	O
screening	O
,	O
RNA	O
blot	O
hybridization	O
,	O
and	O
direct	O
PCR	O
amplification	O
of	O
cDNA	O
reverse	O
-	O
transcribed	O
from	O
cellular	O
mRNA	O
revealed	O
that	O
gene1s	O
CHED	O
gene1e	O
mRNA	O
is	O
expressed	O
in	O
multiple	O
tissues	O
,	O
including	O
bone	O
marrow	O
.	O
The	O
gene1s	O
CHED	O
gene1e	O
protein	O
includes	O
the	O
consensus	O
ATP	O
binding	O
and	O
phosphorylation	O
domains	O
characteristic	O
of	O
kinases	O
,	O
displays	O
34	O
-	O
42	O
%	O
identically	O
aligned	O
amino	O
acid	O
residues	O
with	O
other	O
cdc2-related	O
kinases	O
,	O
and	O
is	O
considerably	O
longer	O
at	O
its	O
amino	O
and	O
carboxyl	O
termini	O
.	O
An	O
antisense	O
oligodeoxynucleotide	O
designed	O
to	O
interrupt	O
gene1s	O
CHED	O
gene1e	O
's	O
expression	O
(	O
AS	O
-	O
gene1s	O
CHED	O
gene1e	O
)	O
significantly	O
reduced	O
the	O
ratio	O
between	O
gene1s	O
CHED	O
gene1e	O
mRNA	O
and	O
actin	O
mRNA	O
within	O
1	O
hr	O
of	O
its	O
addition	O
to	O
cultures	O
,	O
a	O
reduction	O
that	O
persisted	O
for	O
4	O
days	O
.	O
AS	O
-	O
gene1s	O
CHED	O
gene1e	O
treatment	O
selectively	O
inhibited	O
megakaryocyte	O
development	O
in	O
species1s	O
murine	O
species1e	O
bone	O
marrow	O
cultures	O
but	O
did	O
not	O
prevent	O
other	O
hematopoietic	O
pathways	O
,	O
as	O
evidenced	O
by	O
increasing	O
numbers	O
of	O
mononuclear	O
cells	O
.	O
An	O
oligodeoxynucleotide	O
blocking	O
production	O
of	O
the	O
acetylcholine	O
-	O
hydrolyzing	O
enzyme	O
,	O
gene1s	O
butyrylcholinesterase	O
gene1e	O
,	O
displayed	O
a	O
similar	O
inhibition	O
of	O
megakaryocytopoiesis	O
.	O
In	O
contrast	O
,	O
an	O
oligodeoxynucleotide	O
blocking	O
production	O
of	O
the	O
species1s	O
human	O
species1e	O
2Hs	O
gene1s	O
cdc2	O
gene1e	O
homolog	O
interfered	O
with	O
production	O
of	O
the	O
species1s	O
human	O
species1e	O
2Hs	O
gene1s	O
cdc2	O
gene1e	O
homolog	O
interfered	O
with	O
cellular	O
proliferation	O
without	O
altering	O
the	O
cell	O
-	O
type	O
composition	O
of	O
these	O
cultures	O
.	O
Therefore	O
,	O
these	O
findings	O
strengthen	O
the	O
link	O
between	O
cholinergic	O
signaling	O
and	O
cell	O
division	O
control	O
in	O
hematopoiesis	O
and	O
implicate	O
both	O
gene1s	O
CHED	O
gene1e	O
and	O
cholinesterases	O
in	O
this	O
differentiation	O
process	O
.	O

Cloning	O
and	O
antisense	O
oligodeoxynucleotide	O
inhibition	O
of	O
a	O
species1s	O
human	O
species1e	O
homolog	O
of	O
gene1s	O
cdc2	O
gene1e	O
required	O
in	O
hematopoiesis	O
.	O
Mechanisms	O
triggering	O
the	O
commitment	O
of	O
pluripotent	O
bone	O
marrow	O
stem	O
cells	O
to	O
differentiated	O
lineages	O
such	O
as	O
mononuclear	O
macrophages	O
or	O
multinucleated	O
megakaryocytes	O
are	O
still	O
unknown	O
,	O
although	O
several	O
lines	O
of	O
evidence	O
suggested	O
correlation	O
between	O
cholinergic	O
signaling	O
and	O
hematopoietic	O
differentiation	O
.	O
We	O
now	O
present	O
cloning	O
of	O
a	O
cDNA	O
coding	O
for	O
gene1s	O
CHED	O
gene1e	O
(	O
gene1s	O
cholinesterase	O
-	O
related	O
cell	O
division	O
controller	O
gene1e	O
)	O
,	O
a	O
species1s	O
human	O
species1e	O
homolog	O
of	O
the	O
species1s	O
Schizosaccharomyces	O
pombe	O
species1e	O
cell	O
division	O
cycle	O
2	O
(	O
cdc2)-like	O
kinases	O
,	O
universal	O
controllers	O
of	O
the	O
mitotic	O
cell	O
cycle	O
.	O
Library	O
screening	O
,	O
RNA	O
blot	O
hybridization	O
,	O
and	O
direct	O
PCR	O
amplification	O
of	O
cDNA	O
reverse	O
-	O
transcribed	O
from	O
cellular	O
mRNA	O
revealed	O
that	O
gene1s	O
CHED	O
gene1e	O
mRNA	O
is	O
expressed	O
in	O
multiple	O
tissues	O
,	O
including	O
bone	O
marrow	O
.	O
The	O
gene1s	O
CHED	O
gene1e	O
protein	O
includes	O
the	O
consensus	O
ATP	O
binding	O
and	O
phosphorylation	O
domains	O
characteristic	O
of	O
kinases	O
,	O
displays	O
34	O
-	O
42	O
%	O
identically	O
aligned	O
amino	O
acid	O
residues	O
with	O
other	O
cdc2-related	O
kinases	O
,	O
and	O
is	O
considerably	O
longer	O
at	O
its	O
amino	O
and	O
carboxyl	O
termini	O
.	O
An	O
antisense	O
oligodeoxynucleotide	O
designed	O
to	O
interrupt	O
gene1s	O
CHED	O
gene1e	O
's	O
expression	O
(	O
AS	O
-	O
gene1s	O
CHED	O
gene1e	O
)	O
significantly	O
reduced	O
the	O
ratio	O
between	O
gene1s	O
CHED	O
gene1e	O
mRNA	O
and	O
actin	O
mRNA	O
within	O
1	O
hr	O
of	O
its	O
addition	O
to	O
cultures	O
,	O
a	O
reduction	O
that	O
persisted	O
for	O
4	O
days	O
.	O
AS	O
-	O
gene1s	O
CHED	O
gene1e	O
treatment	O
selectively	O
inhibited	O
megakaryocyte	O
development	O
in	O
arg1s	O
murine	O
arg1e	O
bone	O
marrow	O
cultures	O
but	O
did	O
not	O
prevent	O
other	O
hematopoietic	O
pathways	O
,	O
as	O
evidenced	O
by	O
increasing	O
numbers	O
of	O
mononuclear	O
cells	O
.	O
An	O
oligodeoxynucleotide	O
blocking	O
production	O
of	O
the	O
acetylcholine	O
-	O
hydrolyzing	O
enzyme	O
,	O
gene1s	O
butyrylcholinesterase	O
gene1e	O
,	O
displayed	O
a	O
similar	O
inhibition	O
of	O
megakaryocytopoiesis	O
.	O
In	O
contrast	O
,	O
an	O
oligodeoxynucleotide	O
blocking	O
production	O
of	O
the	O
species1s	O
human	O
species1e	O
2Hs	O
gene1s	O
cdc2	O
gene1e	O
homolog	O
interfered	O
with	O
production	O
of	O
the	O
species1s	O
human	O
species1e	O
2Hs	O
gene1s	O
cdc2	O
gene1e	O
homolog	O
interfered	O
with	O
cellular	O
proliferation	O
without	O
altering	O
the	O
cell	O
-	O
type	O
composition	O
of	O
these	O
cultures	O
.	O
Therefore	O
,	O
these	O
findings	O
strengthen	O
the	O
link	O
between	O
cholinergic	O
signaling	O
and	O
cell	O
division	O
control	O
in	O
hematopoiesis	O
and	O
implicate	O
both	O
gene1s	O
CHED	O
gene1e	O
and	O
cholinesterases	O
in	O
this	O
differentiation	O
process	O
.	O

Structural	O
analysis	O
and	O
expression	O
of	O
arg1s	O
human	O
arg1e	O
desmoglein	O
:	O
a	O
cadherin	O
-	O
like	O
component	O
of	O
the	O
desmosome	O
.	O
Desmosomes	O
are	O
adhesive	O
cell	O
junctions	O
found	O
in	O
great	O
abundance	O
in	O
tissues	O
that	O
experience	O
mechanical	O
stress	O
.	O
The	O
transmembrane	O
desmosomal	O
glycoproteins	O
have	O
been	O
proposed	O
to	O
play	O
a	O
role	O
in	O
cell	O
adhesion	O
;	O
gene1s	ARG2
desmoglein	ARG2
I	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
DGI	ARG2
gene1e	ARG2
)	O
is	O
a	O
major	O
member	O
of	O
this	O
class	O
of	O
desmosomal	O
molecules	O
.	O
However	O
,	O
evidence	O
supporting	O
a	O
role	O
for	O
gene1s	ARG2
DGI	ARG2
gene1e	ARG2
in	O
cell	O
adhesion	O
or	O
in	O
the	O
plaque	O
is	O
lacking	O
.	O
In	O
order	O
to	O
begin	O
to	O
understand	O
gene1s	ARG2
DGI	ARG2
gene1e	ARG2
function	O
we	O
have	O
identified	O
arg1s	O
human	O
arg1e	O
cDNA	O
clones	O
encoding	O
the	O
entire	O
mature	O
polypeptide	O
of	O
1000	O
amino	O
acids	O
.	O
Our	O
data	O
suggest	O
that	O
like	O
the	O
species1s	O
bovine	O
species1e	O
gene1s	O
DGI	O
gene1e	O
molecule	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
DGI	ARG2
gene1e	ARG2
is	O
highly	O
related	O
to	O
the	O
calcium	O
-	O
dependent	O
class	O
of	O
cell	O
adhesion	O
molecules	O
known	O
as	O
cadherins	O
.	O
Four	O
related	O
extracellular	O
domains	O
located	O
in	O
the	O
amino	O
-	O
terminal	O
domain	O
of	O
the	O
molecule	O
contain	O
putative	O
calcium	O
binding	O
sites	O
originally	O
identified	O
in	O
the	O
cadherins	O
.	O
The	O
highest	O
degree	O
of	O
similarity	O
between	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
N	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
and	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
DGI	ARG2
gene1e	ARG2
,	O
and	O
likewise	O
between	O
species1s	O
bovine	O
species1e	O
gene1s	O
DGI	O
gene1e	O
and	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
DGI	ARG2
gene1e	ARG2
,	O
is	O
greatest	O
in	O
the	O
most	O
amino	O
-	O
terminal	O
extracellular	O
domain	O
.	O
This	O
suggests	O
a	O
conserved	O
functional	O
role	O
for	O
the	O
extracellular	O
domains	O
,	O
perhaps	O
in	O
calcium	O
-	O
mediated	O
cell	O
adhesion	O
.	O
The	O
cytoplasmic	O
portion	O
of	O
the	O
molecule	O
contains	O
a	O
cadherin	O
-	O
like	O
region	O
and	O
,	O
like	O
species1s	O
bovine	O
species1e	O
gene1s	O
DGI	O
gene1e	O
,	O
a	O
carboxy	O
-	O
terminal	O
tail	O
that	O
is	O
not	O
present	O
in	O
the	O
cadherins	O
,	O
comprising	O
three	O
additional	O
domains	O
.	O
One	O
of	O
these	O
contains	O
a	O
novel	O
repeating	O
motif	O
of	O
29	O
+	O
/-	O
1	O
residues	O
,	O
first	O
identified	O
in	O
species1s	O
bovine	O
species1e	O
gene1s	O
DGI	O
gene1e	O
.	O
Each	O
of	O
the	O
highly	O
homologous	O
repeating	O
units	O
is	O
likely	O
to	O
consist	O
of	O
two	O
beta	O
-	O
strands	O
and	O
two	O
turns	O
with	O
special	O
characteristics	O
.	O
Five	O
amino	O
acids	O
that	O
are	O
identical	O
in	O
species1s	O
bovine	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
DGI	ARG2
gene1e	ARG2
lie	O
in	O
the	O
second	O
of	O
the	O
two	O
predicted	O
beta	O
-	O
strands	O
,	O
and	O
intriguingly	O
contain	O
putative	O
target	O
sites	O
for	O
protein	O
kinase	O
C.	O
On	O
the	O
basis	O
of	O
structural	O
analysis	O
,	O
a	O
model	O
predicting	O
the	O
disposition	O
of	O
arg1s	O
human	O
arg1e	O
DGI	O
domains	O
in	O
the	O
desmosome	O
is	O
proposed	O
.	O
Northern	O
analysis	O
suggests	O
that	O
unlike	O
species1s	O
bovine	O
species1e	O
epidermis	O
,	O
which	O
expresses	O
a	O
single	O
mRNA	O
of	O
reported	O
size	O
approximately	O
7.6	O
kb	O
,	O
arg1s	O
human	O
arg1e	O
foreskin	O
and	O
cultured	O
keratinocytes	O
display	O
a	O
complex	O
pattern	O
with	O
bands	O
of	O
approximately	O
7.2	O
,	O
4.0	O
and	O
3.0	O
kb	O
.	O
Each	O
of	O
these	O
cross	O
-	O
hybridizing	O
mRNAs	O
is	O
coordinately	O
expressed	O
in	O
normal	O
arg1s	O
human	O
arg1e	O
keratinocytes	O
in	O
response	O
to	O
long	O
-	O
term	O
culture	O
and	O
increased	O
calcium	O
.	O

Structural	O
analysis	O
and	O
expression	O
of	O
species1s	O
human	O
species1e	O
desmoglein	O
:	O
a	O
cadherin	O
-	O
like	O
component	O
of	O
the	O
desmosome	O
.	O
Desmosomes	O
are	O
adhesive	O
cell	O
junctions	O
found	O
in	O
great	O
abundance	O
in	O
tissues	O
that	O
experience	O
mechanical	O
stress	O
.	O
The	O
transmembrane	O
desmosomal	O
glycoproteins	O
have	O
been	O
proposed	O
to	O
play	O
a	O
role	O
in	O
cell	O
adhesion	O
;	O
gene1s	O
desmoglein	O
I	O
gene1e	O
(	O
gene1s	O
DGI	O
gene1e	O
)	O
is	O
a	O
major	O
member	O
of	O
this	O
class	O
of	O
desmosomal	O
molecules	O
.	O
However	O
,	O
evidence	O
supporting	O
a	O
role	O
for	O
gene1s	O
DGI	O
gene1e	O
in	O
cell	O
adhesion	O
or	O
in	O
the	O
plaque	O
is	O
lacking	O
.	O
In	O
order	O
to	O
begin	O
to	O
understand	O
gene1s	O
DGI	O
gene1e	O
function	O
we	O
have	O
identified	O
species1s	O
human	O
species1e	O
cDNA	O
clones	O
encoding	O
the	O
entire	O
mature	O
polypeptide	O
of	O
1000	O
amino	O
acids	O
.	O
Our	O
data	O
suggest	O
that	O
like	O
the	O
arg1s	O
bovine	O
arg1e	O
gene1s	ARG2
DGI	ARG2
gene1e	ARG2
molecule	O
species1s	O
human	O
species1e	O
gene1s	O
DGI	O
gene1e	O
is	O
highly	O
related	O
to	O
the	O
calcium	O
-	O
dependent	O
class	O
of	O
cell	O
adhesion	O
molecules	O
known	O
as	O
cadherins	O
.	O
Four	O
related	O
extracellular	O
domains	O
located	O
in	O
the	O
amino	O
-	O
terminal	O
domain	O
of	O
the	O
molecule	O
contain	O
putative	O
calcium	O
binding	O
sites	O
originally	O
identified	O
in	O
the	O
cadherins	O
.	O
The	O
highest	O
degree	O
of	O
similarity	O
between	O
species1s	O
human	O
species1e	O
gene1s	O
N	O
-	O
cadherin	O
gene1e	O
and	O
species1s	O
human	O
species1e	O
gene1s	O
DGI	O
gene1e	O
,	O
and	O
likewise	O
between	O
arg1s	O
bovine	O
arg1e	O
gene1s	ARG2
DGI	ARG2
gene1e	ARG2
and	O
species1s	O
human	O
species1e	O
gene1s	O
DGI	O
gene1e	O
,	O
is	O
greatest	O
in	O
the	O
most	O
amino	O
-	O
terminal	O
extracellular	O
domain	O
.	O
This	O
suggests	O
a	O
conserved	O
functional	O
role	O
for	O
the	O
extracellular	O
domains	O
,	O
perhaps	O
in	O
calcium	O
-	O
mediated	O
cell	O
adhesion	O
.	O
The	O
cytoplasmic	O
portion	O
of	O
the	O
molecule	O
contains	O
a	O
cadherin	O
-	O
like	O
region	O
and	O
,	O
like	O
arg1s	O
bovine	O
arg1e	O
gene1s	ARG2
DGI	ARG2
gene1e	ARG2
,	O
a	O
carboxy	O
-	O
terminal	O
tail	O
that	O
is	O
not	O
present	O
in	O
the	O
cadherins	O
,	O
comprising	O
three	O
additional	O
domains	O
.	O
One	O
of	O
these	O
contains	O
a	O
novel	O
repeating	O
motif	O
of	O
29	O
+	O
/-	O
1	O
residues	O
,	O
first	O
identified	O
in	O
arg1s	O
bovine	O
arg1e	O
gene1s	ARG2
DGI	ARG2
gene1e	ARG2
.	O
Each	O
of	O
the	O
highly	O
homologous	O
repeating	O
units	O
is	O
likely	O
to	O
consist	O
of	O
two	O
beta	O
-	O
strands	O
and	O
two	O
turns	O
with	O
special	O
characteristics	O
.	O
Five	O
amino	O
acids	O
that	O
are	O
identical	O
in	O
arg1s	O
bovine	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
gene1s	O
DGI	O
gene1e	O
lie	O
in	O
the	O
second	O
of	O
the	O
two	O
predicted	O
beta	O
-	O
strands	O
,	O
and	O
intriguingly	O
contain	O
putative	O
target	O
sites	O
for	O
protein	O
kinase	O
C.	O
On	O
the	O
basis	O
of	O
structural	O
analysis	O
,	O
a	O
model	O
predicting	O
the	O
disposition	O
of	O
species1s	O
human	O
species1e	O
DGI	O
domains	O
in	O
the	O
desmosome	O
is	O
proposed	O
.	O
Northern	O
analysis	O
suggests	O
that	O
unlike	O
arg1s	O
bovine	O
arg1e	O
epidermis	O
,	O
which	O
expresses	O
a	O
single	O
mRNA	O
of	O
reported	O
size	O
approximately	O
7.6	O
kb	O
,	O
species1s	O
human	O
species1e	O
foreskin	O
and	O
cultured	O
keratinocytes	O
display	O
a	O
complex	O
pattern	O
with	O
bands	O
of	O
approximately	O
7.2	O
,	O
4.0	O
and	O
3.0	O
kb	O
.	O
Each	O
of	O
these	O
cross	O
-	O
hybridizing	O
mRNAs	O
is	O
coordinately	O
expressed	O
in	O
normal	O
species1s	O
human	O
species1e	O
keratinocytes	O
in	O
response	O
to	O
long	O
-	O
term	O
culture	O
and	O
increased	O
calcium	O
.	O

Characterization	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
loricrin	ARG2
gene1e	ARG2
.	O
Structure	O
and	O
function	O
of	O
a	O
new	O
class	O
of	O
epidermal	O
cell	O
envelope	O
proteins	O
.	O
We	O
have	O
isolated	O
and	O
characterized	O
a	O
full	O
-	O
length	O
cDNA	O
clone	O
encoding	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
loricrin	ARG2
gene1e	ARG2
.	O
Curiously	O
,	O
this	O
protein	O
displays	O
major	O
differences	O
from	O
the	O
recently	O
described	O
species1s	O
mouse	O
species1e	O
gene1s	O
loricrin	O
gene1e	O
(	O
Mehrel	O
,	O
T.	O
,	O
Hohl	O
,	O
D.	O
,	O
Nakazawa	O
,	O
H.	O
,	O
Rothnagel	O
,	O
J.A.	O
,	O
Longley	O
,	O
M.A.	O
,	O
Bundman	O
,	O
D.	O
,	O
Cheng	O
,	O
C.K.	O
,	O
Lichti	O
,	O
U.	O
,	O
Bisher	O
,	O
M.E.	O
,	O
Steven	O
,	O
A.	O
C.	O
,	O
Steinert	O
,	O
P.M.	O
,	O
Yuspa	O
,	O
S.H.	O
,	O
and	O
Roop	O
,	O
D.R.	O
(	O
1990	O
)	O
Cell	O
61	O
,	O
1103	O
-	O
1112	O
)	O
.	O
Although	O
both	O
proteins	O
are	O
glycine	O
-	O
serine	O
-	O
cysteine	O
-	O
rich	O
,	O
the	O
sequences	O
have	O
not	O
been	O
conserved	O
.	O
However	O
,	O
analysis	O
of	O
the	O
sequences	O
reveals	O
a	O
common	O
motif	O
of	O
quasi	O
-	O
peptide	O
repeats	O
of	O
an	O
aliphatic	O
or	O
aromatic	O
amino	O
acid	O
residue	O
followed	O
by	O
several	O
glycine	O
and/or	O
serine	O
and	O
cysteine	O
residues	O
.	O
These	O
sequences	O
are	O
interspersed	O
and	O
flanked	O
by	O
short	O
glutamine-	O
or	O
glutamine	O
/	O
lysine	O
-	O
rich	O
peptides	O
.	O
Thus	O
loricrins	O
consist	O
of	O
a	O
family	O
of	O
cell	O
envelope	O
proteins	O
of	O
highly	O
variable	O
sequences	O
that	O
nevertheless	O
retain	O
common	O
structural	O
elements	O
.	O
We	O
show	O
that	O
unlike	O
all	O
other	O
putative	O
protein	O
components	O
of	O
the	O
cell	O
envelope	O
,	O
loricrins	O
are	O
highly	O
insoluble	O
,	O
due	O
at	O
least	O
in	O
part	O
to	O
cross	O
-	O
linking	O
by	O
disulfide	O
bonds	O
.	O
Furthermore	O
,	O
we	O
have	O
isolated	O
four	O
peptides	O
from	O
purified	O
arg1s	O
human	O
arg1e	O
cell	O
envelopes	O
that	O
contain	O
recognizable	O
gene1s	ARG2
loricrin	ARG2
gene1e	ARG2
sequences	O
and	O
which	O
are	O
cross	O
-	O
linked	O
by	O
the	O
N	O
epsilon-(gamma	O
-	O
glutamyl)lysine	O
isodipeptide	O
bond	O
.	O
The	O
presence	O
of	O
such	O
bonds	O
thus	O
affords	O
an	O
explanation	O
for	O
the	O
extraordinary	O
insolubility	O
of	O
gene1s	ARG2
loricrin	ARG2
gene1e	ARG2
by	O
cross	O
-	O
linking	O
to	O
the	O
cell	O
envelope	O
and	O
can	O
also	O
explain	O
the	O
low	O
steady	O
-	O
state	O
levels	O
of	O
monomeric	O
gene1s	ARG2
loricrin	ARG2
gene1e	ARG2
in	O
cytoskeletal	O
extracts	O
of	O
epidermis	O
.	O
This	O
study	O
represents	O
the	O
first	O
report	O
of	O
this	O
isodipeptide	O
cross	O
-	O
link	O
in	O
a	O
protein	O
component	O
of	O
the	O
cornified	O
cell	O
envelope	O
.	O
We	O
propose	O
a	O
model	O
for	O
the	O
structure	O
of	O
gene1s	ARG2
loricrin	ARG2
gene1e	ARG2
in	O
which	O
(	O
i	O
)	O
the	O
unusual	O
glycine	O
-	O
serine	O
-	O
rich	O
sequences	O
adopt	O
a	O
flexible	O
loop	O
conformation	O
,	O
indexed	O
on	O
the	O
recurrent	O
aliphatic	O
residues	O
;	O
(	O
ii	O
)	O
inter-	O
or	O
intramolecular	O
isodipeptide	O
and	O
disulfide	O
cross	O
-	O
links	O
induce	O
or	O
stabilize	O
folding	O
of	O
gene1s	ARG2
loricrin	ARG2
gene1e	ARG2
so	O
as	O
to	O
form	O
a	O
more	O
compact	O
rosette	O
-	O
like	O
structure	O
;	O
and	O
(	O
iii	O
)	O
the	O
presence	O
of	O
the	O
flexible	O
glycine	O
-	O
rich	O
loops	O
necessarily	O
will	O
impact	O
a	O
flexible	O
character	O
to	O
the	O
cell	O
envelope	O
and	O
entire	O
epithelium	O
.	O

Characterization	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
loricrin	O
gene1e	O
.	O
Structure	O
and	O
function	O
of	O
a	O
new	O
class	O
of	O
epidermal	O
cell	O
envelope	O
proteins	O
.	O
We	O
have	O
isolated	O
and	O
characterized	O
a	O
full	O
-	O
length	O
cDNA	O
clone	O
encoding	O
species1s	O
human	O
species1e	O
gene1s	O
loricrin	O
gene1e	O
.	O
Curiously	O
,	O
this	O
protein	O
displays	O
major	O
differences	O
from	O
the	O
recently	O
described	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
loricrin	ARG2
gene1e	ARG2
(	O
Mehrel	O
,	O
T.	O
,	O
Hohl	O
,	O
D.	O
,	O
Nakazawa	O
,	O
H.	O
,	O
Rothnagel	O
,	O
J.A.	O
,	O
Longley	O
,	O
M.A.	O
,	O
Bundman	O
,	O
D.	O
,	O
Cheng	O
,	O
C.K.	O
,	O
Lichti	O
,	O
U.	O
,	O
Bisher	O
,	O
M.E.	O
,	O
Steven	O
,	O
A.	O
C.	O
,	O
Steinert	O
,	O
P.M.	O
,	O
Yuspa	O
,	O
S.H.	O
,	O
and	O
Roop	O
,	O
D.R.	O
(	O
1990	O
)	O
Cell	O
61	O
,	O
1103	O
-	O
1112	O
)	O
.	O
Although	O
both	O
proteins	O
are	O
glycine	O
-	O
serine	O
-	O
cysteine	O
-	O
rich	O
,	O
the	O
sequences	O
have	O
not	O
been	O
conserved	O
.	O
However	O
,	O
analysis	O
of	O
the	O
sequences	O
reveals	O
a	O
common	O
motif	O
of	O
quasi	O
-	O
peptide	O
repeats	O
of	O
an	O
aliphatic	O
or	O
aromatic	O
amino	O
acid	O
residue	O
followed	O
by	O
several	O
glycine	O
and/or	O
serine	O
and	O
cysteine	O
residues	O
.	O
These	O
sequences	O
are	O
interspersed	O
and	O
flanked	O
by	O
short	O
glutamine-	O
or	O
glutamine	O
/	O
lysine	O
-	O
rich	O
peptides	O
.	O
Thus	O
loricrins	O
consist	O
of	O
a	O
family	O
of	O
cell	O
envelope	O
proteins	O
of	O
highly	O
variable	O
sequences	O
that	O
nevertheless	O
retain	O
common	O
structural	O
elements	O
.	O
We	O
show	O
that	O
unlike	O
all	O
other	O
putative	O
protein	O
components	O
of	O
the	O
cell	O
envelope	O
,	O
loricrins	O
are	O
highly	O
insoluble	O
,	O
due	O
at	O
least	O
in	O
part	O
to	O
cross	O
-	O
linking	O
by	O
disulfide	O
bonds	O
.	O
Furthermore	O
,	O
we	O
have	O
isolated	O
four	O
peptides	O
from	O
purified	O
species1s	O
human	O
species1e	O
cell	O
envelopes	O
that	O
contain	O
recognizable	O
gene1s	O
loricrin	O
gene1e	O
sequences	O
and	O
which	O
are	O
cross	O
-	O
linked	O
by	O
the	O
N	O
epsilon-(gamma	O
-	O
glutamyl)lysine	O
isodipeptide	O
bond	O
.	O
The	O
presence	O
of	O
such	O
bonds	O
thus	O
affords	O
an	O
explanation	O
for	O
the	O
extraordinary	O
insolubility	O
of	O
gene1s	O
loricrin	O
gene1e	O
by	O
cross	O
-	O
linking	O
to	O
the	O
cell	O
envelope	O
and	O
can	O
also	O
explain	O
the	O
low	O
steady	O
-	O
state	O
levels	O
of	O
monomeric	O
gene1s	O
loricrin	O
gene1e	O
in	O
cytoskeletal	O
extracts	O
of	O
epidermis	O
.	O
This	O
study	O
represents	O
the	O
first	O
report	O
of	O
this	O
isodipeptide	O
cross	O
-	O
link	O
in	O
a	O
protein	O
component	O
of	O
the	O
cornified	O
cell	O
envelope	O
.	O
We	O
propose	O
a	O
model	O
for	O
the	O
structure	O
of	O
gene1s	O
loricrin	O
gene1e	O
in	O
which	O
(	O
i	O
)	O
the	O
unusual	O
glycine	O
-	O
serine	O
-	O
rich	O
sequences	O
adopt	O
a	O
flexible	O
loop	O
conformation	O
,	O
indexed	O
on	O
the	O
recurrent	O
aliphatic	O
residues	O
;	O
(	O
ii	O
)	O
inter-	O
or	O
intramolecular	O
isodipeptide	O
and	O
disulfide	O
cross	O
-	O
links	O
induce	O
or	O
stabilize	O
folding	O
of	O
gene1s	O
loricrin	O
gene1e	O
so	O
as	O
to	O
form	O
a	O
more	O
compact	O
rosette	O
-	O
like	O
structure	O
;	O
and	O
(	O
iii	O
)	O
the	O
presence	O
of	O
the	O
flexible	O
glycine	O
-	O
rich	O
loops	O
necessarily	O
will	O
impact	O
a	O
flexible	O
character	O
to	O
the	O
cell	O
envelope	O
and	O
entire	O
epithelium	O
.	O

Localization	O
of	O
low	O
molecular	O
weight	O
GTP	O
binding	O
proteins	O
to	O
exocytic	O
and	O
endocytic	O
compartments	O
.	O
A	O
set	O
of	O
11	O
clones	O
encoding	O
putative	O
GTP	O
binding	O
proteins	O
highly	O
homologous	O
to	O
the	O
arg1s	O
yeast	O
arg1e	O
gene1s	ARG2
YPT1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
SEC4	ARG2
gene1e	ARG2
gene	O
products	O
have	O
been	O
isolated	O
from	O
an	O
species1s	O
MDCK	O
species1e	O
cell	O
cDNA	O
library	O
.	O
We	O
localized	O
three	O
of	O
the	O
corresponding	O
proteins	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
by	O
using	O
affinity	O
-	O
purified	O
antibodies	O
in	O
immunofluorescence	O
and	O
immunoelectron	O
microscopy	O
studies	O
.	O
One	O
,	O
the	O
MDCK	O
homolog	O
of	O
gene1s	O
rab2	O
gene1e	O
,	O
is	O
associated	O
with	O
a	O
structure	O
having	O
the	O
characteristics	O
of	O
an	O
intermediate	O
compartment	O
between	O
the	O
endoplasmic	O
reticulum	O
and	O
the	O
Golgi	O
apparatus	O
.	O
The	O
second	O
,	O
gene1s	O
rab5	O
gene1e	O
,	O
is	O
located	O
at	O
the	O
cytoplasmic	O
surface	O
of	O
the	O
plasma	O
membrane	O
and	O
on	O
early	O
endosomes	O
,	O
while	O
the	O
third	O
,	O
gene1s	O
rab7	O
gene1e	O
,	O
is	O
found	O
on	O
late	O
endosomes	O
.	O
These	O
findings	O
provide	O
evidence	O
that	O
members	O
of	O
the	O
gene1s	ARG2
YPT1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
SEC4	ARG2
gene1e	ARG2
subfamily	O
of	O
GTP	O
binding	O
proteins	O
are	O
localized	O
to	O
specific	O
exocytic	O
and	O
endocytic	O
subcompartments	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
.	O

Localization	O
of	O
low	O
molecular	O
weight	O
GTP	O
binding	O
proteins	O
to	O
exocytic	O
and	O
endocytic	O
compartments	O
.	O
A	O
set	O
of	O
11	O
clones	O
encoding	O
putative	O
GTP	O
binding	O
proteins	O
highly	O
homologous	O
to	O
the	O
species1s	O
yeast	O
species1e	O
gene1s	O
YPT1	O
gene1e	O
/	O
gene1s	O
SEC4	O
gene1e	O
gene	O
products	O
have	O
been	O
isolated	O
from	O
an	O
arg1s	O
MDCK	O
arg1e	O
cell	O
cDNA	O
library	O
.	O
We	O
localized	O
three	O
of	O
the	O
corresponding	O
proteins	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
by	O
using	O
affinity	O
-	O
purified	O
antibodies	O
in	O
immunofluorescence	O
and	O
immunoelectron	O
microscopy	O
studies	O
.	O
One	O
,	O
the	O
MDCK	O
homolog	O
of	O
gene1s	O
rab2	O
gene1e	O
,	O
is	O
associated	O
with	O
a	O
structure	O
having	O
the	O
characteristics	O
of	O
an	O
intermediate	O
compartment	O
between	O
the	O
endoplasmic	O
reticulum	O
and	O
the	O
Golgi	O
apparatus	O
.	O
The	O
second	O
,	O
gene1s	O
rab5	O
gene1e	O
,	O
is	O
located	O
at	O
the	O
cytoplasmic	O
surface	O
of	O
the	O
plasma	O
membrane	O
and	O
on	O
early	O
endosomes	O
,	O
while	O
the	O
third	O
,	O
gene1s	O
rab7	O
gene1e	O
,	O
is	O
found	O
on	O
late	O
endosomes	O
.	O
These	O
findings	O
provide	O
evidence	O
that	O
members	O
of	O
the	O
gene1s	O
YPT1	O
gene1e	O
/	O
gene1s	O
SEC4	O
gene1e	O
subfamily	O
of	O
GTP	O
binding	O
proteins	O
are	O
localized	O
to	O
specific	O
exocytic	O
and	O
endocytic	O
subcompartments	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
.	O

Localization	O
of	O
low	O
molecular	O
weight	O
GTP	O
binding	O
proteins	O
to	O
exocytic	O
and	O
endocytic	O
compartments	O
.	O
A	O
set	O
of	O
11	O
clones	O
encoding	O
putative	O
GTP	O
binding	O
proteins	O
highly	O
homologous	O
to	O
the	O
species1s	O
yeast	O
species1e	O
gene1s	O
YPT1	O
gene1e	O
/	O
gene1s	O
SEC4	O
gene1e	O
gene	O
products	O
have	O
been	O
isolated	O
from	O
an	O
species1s	O
MDCK	O
species1e	O
cell	O
cDNA	O
library	O
.	O
We	O
localized	O
three	O
of	O
the	O
corresponding	O
proteins	O
in	O
arg1s	O
mammalian	O
arg1e	O
cells	O
by	O
using	O
affinity	O
-	O
purified	O
antibodies	O
in	O
immunofluorescence	O
and	O
immunoelectron	O
microscopy	O
studies	O
.	O
One	O
,	O
the	O
MDCK	O
homolog	O
of	O
gene1s	ARG2
rab2	ARG2
gene1e	ARG2
,	O
is	O
associated	O
with	O
a	O
structure	O
having	O
the	O
characteristics	O
of	O
an	O
intermediate	O
compartment	O
between	O
the	O
endoplasmic	O
reticulum	O
and	O
the	O
Golgi	O
apparatus	O
.	O
The	O
second	O
,	O
gene1s	ARG2
rab5	ARG2
gene1e	ARG2
,	O
is	O
located	O
at	O
the	O
cytoplasmic	O
surface	O
of	O
the	O
plasma	O
membrane	O
and	O
on	O
early	O
endosomes	O
,	O
while	O
the	O
third	O
,	O
gene1s	ARG2
rab7	ARG2
gene1e	ARG2
,	O
is	O
found	O
on	O
late	O
endosomes	O
.	O
These	O
findings	O
provide	O
evidence	O
that	O
members	O
of	O
the	O
gene1s	O
YPT1	O
gene1e	O
/	O
gene1s	O
SEC4	O
gene1e	O
subfamily	O
of	O
GTP	O
binding	O
proteins	O
are	O
localized	O
to	O
specific	O
exocytic	O
and	O
endocytic	O
subcompartments	O
in	O
arg1s	O
mammalian	O
arg1e	O
cells	O
.	O

A	O
arg1s	O
human	O
arg1e	O
homologue	O
of	O
the	O
species1s	O
yeast	O
species1e	O
gene1s	O
HDEL	O
receptor	O
gene1e	O
.	O
Retention	O
of	O
resident	O
proteins	O
in	O
the	O
lumen	O
of	O
the	O
endoplasmic	O
reticulum	O
is	O
achieved	O
in	O
both	O
species1s	O
yeast	O
species1e	O
and	O
animal	O
cells	O
by	O
their	O
continual	O
retrieval	O
from	O
the	O
cis	O
-	O
Golgi	O
,	O
or	O
a	O
pre	O
-	O
Golgi	O
compartment	O
.	O
Sorting	O
of	O
these	O
proteins	O
is	O
dependent	O
on	O
a	O
C	O
-	O
terminal	O
tetrapeptide	O
signal	O
,	O
usually	O
Lys	O
-	O
Asp	O
-	O
Glu	O
-	O
Leu	O
(	O
KDEL	O
in	O
the	O
single	O
letter	O
code	O
)	O
in	O
animal	O
cells	O
,	O
His	O
-	O
Asp	O
-	O
Glu	O
-	O
Leu	O
(	O
HDEL	O
)	O
in	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
.	O
There	O
is	O
evidence	O
that	O
the	O
gene1s	O
ERD2	O
gene1e	O
gene	O
encodes	O
the	O
sorting	O
receptor	O
that	O
recognizes	O
HDEL	O
in	O
species1s	O
yeast	O
species1e	O
;	O
its	O
product	O
is	O
an	O
integral	O
membrane	O
protein	O
of	O
relative	O
molecular	O
mass	O
26,000	O
(	O
26	O
K	O
)	O
that	O
is	O
not	O
glycosylated	O
.	O
In	O
contrast	O
,	O
Vaux	O
et	O
al	O
.	O
suggest	O
that	O
the	O
arg1s	O
mammalian	O
arg1e	O
gene1s	ARG2
KDEL	ARG2
receptor	ARG2
gene1e	ARG2
is	O
a	O
72	O
K	O
glycoprotein	O
that	O
they	O
detected	O
using	O
an	O
anti	O
-	O
idiotypic	O
antibody	O
approach	O
.	O
If	O
this	O
were	O
so	O
,	O
it	O
would	O
indicate	O
a	O
surprising	O
divergence	O
of	O
the	O
retrieval	O
machinery	O
between	O
species1s	O
yeast	O
species1e	O
and	O
animal	O
cells	O
.	O
We	O
report	O
here	O
that	O
arg1s	O
human	O
arg1e	O
cells	O
express	O
a	O
protein	O
similar	O
in	O
sequence	O
,	O
size	O
and	O
properties	O
to	O
the	O
gene1s	ARG2
ERD2	ARG2
gene1e	ARG2
product	O
,	O
and	O
propose	O
that	O
this	O
protein	O
is	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
KDEL	ARG2
receptor	ARG2
gene1e	ARG2
.	O

A	O
species1s	O
human	O
species1e	O
homologue	O
of	O
the	O
arg1s	O
yeast	O
arg1e	O
gene1s	ARG2
HDEL	ARG2
receptor	ARG2
gene1e	ARG2
.	O
Retention	O
of	O
resident	O
proteins	O
in	O
the	O
lumen	O
of	O
the	O
endoplasmic	O
reticulum	O
is	O
achieved	O
in	O
both	O
arg1s	O
yeast	O
arg1e	O
and	O
animal	O
cells	O
by	O
their	O
continual	O
retrieval	O
from	O
the	O
cis	O
-	O
Golgi	O
,	O
or	O
a	O
pre	O
-	O
Golgi	O
compartment	O
.	O
Sorting	O
of	O
these	O
proteins	O
is	O
dependent	O
on	O
a	O
C	O
-	O
terminal	O
tetrapeptide	O
signal	O
,	O
usually	O
Lys	O
-	O
Asp	O
-	O
Glu	O
-	O
Leu	O
(	O
KDEL	O
in	O
the	O
single	O
letter	O
code	O
)	O
in	O
animal	O
cells	O
,	O
His	O
-	O
Asp	O
-	O
Glu	O
-	O
Leu	O
(	O
HDEL	O
)	O
in	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
.	O
There	O
is	O
evidence	O
that	O
the	O
gene1s	ARG2
ERD2	ARG2
gene1e	ARG2
gene	O
encodes	O
the	O
sorting	O
receptor	O
that	O
recognizes	O
HDEL	O
in	O
arg1s	O
yeast	O
arg1e	O
;	O
its	O
product	O
is	O
an	O
integral	O
membrane	O
protein	O
of	O
relative	O
molecular	O
mass	O
26,000	O
(	O
26	O
K	O
)	O
that	O
is	O
not	O
glycosylated	O
.	O
In	O
contrast	O
,	O
Vaux	O
et	O
al	O
.	O
suggest	O
that	O
the	O
species1s	O
mammalian	O
species1e	O
gene1s	O
KDEL	O
receptor	O
gene1e	O
is	O
a	O
72	O
K	O
glycoprotein	O
that	O
they	O
detected	O
using	O
an	O
anti	O
-	O
idiotypic	O
antibody	O
approach	O
.	O
If	O
this	O
were	O
so	O
,	O
it	O
would	O
indicate	O
a	O
surprising	O
divergence	O
of	O
the	O
retrieval	O
machinery	O
between	O
arg1s	O
yeast	O
arg1e	O
and	O
animal	O
cells	O
.	O
We	O
report	O
here	O
that	O
species1s	O
human	O
species1e	O
cells	O
express	O
a	O
protein	O
similar	O
in	O
sequence	O
,	O
size	O
and	O
properties	O
to	O
the	O
gene1s	O
ERD2	O
gene1e	O
product	O
,	O
and	O
propose	O
that	O
this	O
protein	O
is	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
KDEL	O
receptor	O
gene1e	O
.	O

Primary	O
structure	O
and	O
functional	O
expression	O
of	O
arg1s	O
rat	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
gene1s	O
stem	O
cell	O
factor	O
gene1e	O
DNAs	O
.	O
Partial	O
cDNA	O
and	O
genomic	O
clones	O
of	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
stem	ARG2
cell	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SCF	ARG2
gene1e	ARG2
)	O
have	O
been	O
isolated	O
.	O
Using	O
probes	O
based	O
on	O
the	O
arg1s	O
rat	O
arg1e	O
sequence	O
,	O
partial	O
and	O
full	O
-	O
length	O
cDNA	O
and	O
genomic	O
clones	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
SCF	O
gene1e	O
have	O
been	O
isolated	O
.	O
Based	O
on	O
the	O
primary	O
structure	O
of	O
the	O
164	O
amino	O
acid	O
protein	O
purified	O
from	O
arg1s	O
BRL-3A	O
arg1e	O
cells	O
,	O
truncated	O
forms	O
of	O
the	O
arg1s	O
rat	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
proteins	O
have	O
been	O
expressed	O
in	O
species1s	O
E.	O
coli	O
species1e	O
and	O
species1s	O
mammalian	O
species1e	O
cells	O
and	O
have	O
been	O
shown	O
to	O
possess	O
biological	O
activity	O
.	O
gene1s	O
SCF	O
gene1e	O
is	O
able	O
to	O
augment	O
the	O
proliferation	O
of	O
both	O
myeloid	O
and	O
lymphoid	O
hematopoietic	O
progenitors	O
in	O
bone	O
marrow	O
cultures	O
.	O
gene1s	O
SCF	O
gene1e	O
exhibits	O
potent	O
synergistic	O
activities	O
in	O
conjunction	O
with	O
colony	O
-	O
stimulating	O
factors	O
,	O
resulting	O
in	O
increased	O
colony	O
numbers	O
and	O
colony	O
size	O
.	O

Primary	O
structure	O
and	O
functional	O
expression	O
of	O
species1s	O
rat	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
stem	ARG2
cell	ARG2
factor	ARG2
gene1e	ARG2
DNAs	O
.	O
Partial	O
cDNA	O
and	O
genomic	O
clones	O
of	O
species1s	O
rat	O
species1e	O
gene1s	O
stem	O
cell	O
factor	O
gene1e	O
(	O
gene1s	O
SCF	O
gene1e	O
)	O
have	O
been	O
isolated	O
.	O
Using	O
probes	O
based	O
on	O
the	O
species1s	O
rat	O
species1e	O
sequence	O
,	O
partial	O
and	O
full	O
-	O
length	O
cDNA	O
and	O
genomic	O
clones	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
SCF	ARG2
gene1e	ARG2
have	O
been	O
isolated	O
.	O
Based	O
on	O
the	O
primary	O
structure	O
of	O
the	O
164	O
amino	O
acid	O
protein	O
purified	O
from	O
species1s	O
BRL-3A	O
species1e	O
cells	O
,	O
truncated	O
forms	O
of	O
the	O
species1s	O
rat	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
proteins	O
have	O
been	O
expressed	O
in	O
species1s	O
E.	O
coli	O
species1e	O
and	O
arg1s	O
mammalian	O
arg1e	O
cells	O
and	O
have	O
been	O
shown	O
to	O
possess	O
biological	O
activity	O
.	O
gene1s	ARG2
SCF	ARG2
gene1e	ARG2
is	O
able	O
to	O
augment	O
the	O
proliferation	O
of	O
both	O
myeloid	O
and	O
lymphoid	O
hematopoietic	O
progenitors	O
in	O
bone	O
marrow	O
cultures	O
.	O
gene1s	ARG2
SCF	ARG2
gene1e	ARG2
exhibits	O
potent	O
synergistic	O
activities	O
in	O
conjunction	O
with	O
colony	O
-	O
stimulating	O
factors	O
,	O
resulting	O
in	O
increased	O
colony	O
numbers	O
and	O
colony	O
size	O
.	O

Primary	O
structure	O
and	O
functional	O
expression	O
of	O
species1s	O
rat	O
species1e	O
and	O
species1s	O
human	O
species1e	O
gene1s	O
stem	O
cell	O
factor	O
gene1e	O
DNAs	O
.	O
Partial	O
cDNA	O
and	O
genomic	O
clones	O
of	O
species1s	O
rat	O
species1e	O
gene1s	O
stem	O
cell	O
factor	O
gene1e	O
(	O
gene1s	O
SCF	O
gene1e	O
)	O
have	O
been	O
isolated	O
.	O
Using	O
probes	O
based	O
on	O
the	O
species1s	O
rat	O
species1e	O
sequence	O
,	O
partial	O
and	O
full	O
-	O
length	O
cDNA	O
and	O
genomic	O
clones	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
SCF	O
gene1e	O
have	O
been	O
isolated	O
.	O
Based	O
on	O
the	O
primary	O
structure	O
of	O
the	O
164	O
amino	O
acid	O
protein	O
purified	O
from	O
species1s	O
BRL-3A	O
species1e	O
cells	O
,	O
truncated	O
forms	O
of	O
the	O
species1s	O
rat	O
species1e	O
and	O
species1s	O
human	O
species1e	O
proteins	O
have	O
been	O
expressed	O
in	O
arg1s	O
E.	O
coli	O
arg1e	O
and	O
species1s	O
mammalian	O
species1e	O
cells	O
and	O
have	O
been	O
shown	O
to	O
possess	O
biological	O
activity	O
.	O
gene1s	O
SCF	O
gene1e	O
is	O
able	O
to	O
augment	O
the	O
proliferation	O
of	O
both	O
myeloid	O
and	O
lymphoid	O
hematopoietic	O
progenitors	O
in	O
bone	O
marrow	O
cultures	O
.	O
gene1s	O
SCF	O
gene1e	O
exhibits	O
potent	O
synergistic	O
activities	O
in	O
conjunction	O
with	O
colony	O
-	O
stimulating	O
factors	O
,	O
resulting	O
in	O
increased	O
colony	O
numbers	O
and	O
colony	O
size	O
.	O

Molecular	O
cloning	O
and	O
sequence	O
analysis	O
of	O
cDNA	O
encoding	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
ferrochelatase	ARG2
gene1e	ARG2
.	O
The	O
cDNA	O
encoding	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
ferrochelatase	ARG2
gene1e	ARG2
[	O
gene1s	ARG2
EC	ARG2
4.99.1.1	ARG2
gene1e	ARG2
]	O
was	O
isolated	O
from	O
a	O
arg1s	O
human	O
arg1e	O
placenta	O
cDNA	O
library	O
in	O
species1s	O
bacteriophage	O
lambda	O
species1e	O
gt11	O
by	O
screening	O
with	O
a	O
radiolabeled	O
fragment	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	O
ferrochelatase	O
gene1e	O
cDNA	O
.	O
The	O
cDNA	O
had	O
an	O
open	O
reading	O
frame	O
of	O
1269	O
base	O
pairs	O
(	O
bp	O
)	O
encoding	O
a	O
protein	O
of	O
423	O
amino	O
acid	O
residues	O
(	O
Mr.	O
47,833	O
)	O
with	O
alternative	O
putative	O
polyadenylation	O
signals	O
in	O
the	O
3	O
'	O
non	O
-	O
coding	O
regions	O
and	O
poly	O
(	O
A	O
)	O
tails	O
.	O
Amino	O
acid	O
sequencing	O
showed	O
that	O
the	O
mature	O
protein	O
consists	O
of	O
369	O
amino	O
acid	O
residues	O
(	O
Mr.	O
42,158	O
)	O
with	O
a	O
putative	O
leader	O
sequence	O
of	O
54	O
amino	O
acid	O
residues	O
.	O
The	O
arg1s	O
human	O
arg1e	O
enzyme	O
showed	O
an	O
88	O
%	O
identity	O
to	O
species1s	O
mouse	O
species1e	O
enzyme	O
and	O
46	O
%	O
to	O
species1s	O
yeast	O
species1e	O
enzyme	O
.	O
Northern	O
blot	O
analysis	O
showed	O
two	O
mRNAs	O
of	O
about	O
2500	O
and	O
1600	O
bp	O
for	O
gene1s	ARG2
ferrochelatase	ARG2
gene1e	ARG2
in	O
arg1s	O
K562	O
arg1e	O
and	O
arg1s	O
HepG2	O
arg1e	O
cells	O
.	O
As	O
full	O
-	O
length	O
cDNA	O
for	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
ferrochelatase	ARG2
gene1e	ARG2
is	O
now	O
available	O
,	O
molecular	O
lesions	O
related	O
to	O
erythropoietic	O
protoporphyria	O
can	O
be	O
characterized	O
.	O

Molecular	O
cloning	O
and	O
sequence	O
analysis	O
of	O
cDNA	O
encoding	O
species1s	O
human	O
species1e	O
gene1s	O
ferrochelatase	O
gene1e	O
.	O
The	O
cDNA	O
encoding	O
species1s	O
human	O
species1e	O
gene1s	O
ferrochelatase	O
gene1e	O
[	O
gene1s	O
EC	O
4.99.1.1	O
gene1e	O
]	O
was	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
placenta	O
cDNA	O
library	O
in	O
arg1s	O
bacteriophage	O
lambda	O
arg1e	O
gt11	O
by	O
screening	O
with	O
a	O
radiolabeled	O
fragment	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	O
ferrochelatase	O
gene1e	O
cDNA	O
.	O
The	O
cDNA	O
had	O
an	O
open	O
reading	O
frame	O
of	O
1269	O
base	O
pairs	O
(	O
bp	O
)	O
encoding	O
a	O
protein	O
of	O
423	O
amino	O
acid	O
residues	O
(	O
Mr.	O
47,833	O
)	O
with	O
alternative	O
putative	O
polyadenylation	O
signals	O
in	O
the	O
3	O
'	O
non	O
-	O
coding	O
regions	O
and	O
poly	O
(	O
A	O
)	O
tails	O
.	O
Amino	O
acid	O
sequencing	O
showed	O
that	O
the	O
mature	O
protein	O
consists	O
of	O
369	O
amino	O
acid	O
residues	O
(	O
Mr.	O
42,158	O
)	O
with	O
a	O
putative	O
leader	O
sequence	O
of	O
54	O
amino	O
acid	O
residues	O
.	O
The	O
species1s	O
human	O
species1e	O
enzyme	O
showed	O
an	O
88	O
%	O
identity	O
to	O
species1s	O
mouse	O
species1e	O
enzyme	O
and	O
46	O
%	O
to	O
species1s	O
yeast	O
species1e	O
enzyme	O
.	O
Northern	O
blot	O
analysis	O
showed	O
two	O
mRNAs	O
of	O
about	O
2500	O
and	O
1600	O
bp	O
for	O
gene1s	O
ferrochelatase	O
gene1e	O
in	O
species1s	O
K562	O
species1e	O
and	O
species1s	O
HepG2	O
species1e	O
cells	O
.	O
As	O
full	O
-	O
length	O
cDNA	O
for	O
species1s	O
human	O
species1e	O
gene1s	O
ferrochelatase	O
gene1e	O
is	O
now	O
available	O
,	O
molecular	O
lesions	O
related	O
to	O
erythropoietic	O
protoporphyria	O
can	O
be	O
characterized	O
.	O

Molecular	O
cloning	O
and	O
sequence	O
analysis	O
of	O
cDNA	O
encoding	O
species1s	O
human	O
species1e	O
gene1s	O
ferrochelatase	O
gene1e	O
.	O
The	O
cDNA	O
encoding	O
species1s	O
human	O
species1e	O
gene1s	O
ferrochelatase	O
gene1e	O
[	O
gene1s	O
EC	O
4.99.1.1	O
gene1e	O
]	O
was	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
placenta	O
cDNA	O
library	O
in	O
species1s	O
bacteriophage	O
lambda	O
species1e	O
gt11	O
by	O
screening	O
with	O
a	O
radiolabeled	O
fragment	O
of	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
ferrochelatase	ARG2
gene1e	ARG2
cDNA	O
.	O
The	O
cDNA	O
had	O
an	O
open	O
reading	O
frame	O
of	O
1269	O
base	O
pairs	O
(	O
bp	O
)	O
encoding	O
a	O
protein	O
of	O
423	O
amino	O
acid	O
residues	O
(	O
Mr.	O
47,833	O
)	O
with	O
alternative	O
putative	O
polyadenylation	O
signals	O
in	O
the	O
3	O
'	O
non	O
-	O
coding	O
regions	O
and	O
poly	O
(	O
A	O
)	O
tails	O
.	O
Amino	O
acid	O
sequencing	O
showed	O
that	O
the	O
mature	O
protein	O
consists	O
of	O
369	O
amino	O
acid	O
residues	O
(	O
Mr.	O
42,158	O
)	O
with	O
a	O
putative	O
leader	O
sequence	O
of	O
54	O
amino	O
acid	O
residues	O
.	O
The	O
species1s	O
human	O
species1e	O
enzyme	O
showed	O
an	O
88	O
%	O
identity	O
to	O
arg1s	O
mouse	O
arg1e	O
enzyme	O
and	O
46	O
%	O
to	O
species1s	O
yeast	O
species1e	O
enzyme	O
.	O
Northern	O
blot	O
analysis	O
showed	O
two	O
mRNAs	O
of	O
about	O
2500	O
and	O
1600	O
bp	O
for	O
gene1s	O
ferrochelatase	O
gene1e	O
in	O
species1s	O
K562	O
species1e	O
and	O
species1s	O
HepG2	O
species1e	O
cells	O
.	O
As	O
full	O
-	O
length	O
cDNA	O
for	O
species1s	O
human	O
species1e	O
gene1s	O
ferrochelatase	O
gene1e	O
is	O
now	O
available	O
,	O
molecular	O
lesions	O
related	O
to	O
erythropoietic	O
protoporphyria	O
can	O
be	O
characterized	O
.	O

Molecular	O
cloning	O
and	O
sequence	O
analysis	O
of	O
cDNA	O
encoding	O
species1s	O
human	O
species1e	O
gene1s	O
ferrochelatase	O
gene1e	O
.	O
The	O
cDNA	O
encoding	O
species1s	O
human	O
species1e	O
gene1s	O
ferrochelatase	O
gene1e	O
[	O
gene1s	O
EC	O
4.99.1.1	O
gene1e	O
]	O
was	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
placenta	O
cDNA	O
library	O
in	O
species1s	O
bacteriophage	O
lambda	O
species1e	O
gt11	O
by	O
screening	O
with	O
a	O
radiolabeled	O
fragment	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	O
ferrochelatase	O
gene1e	O
cDNA	O
.	O
The	O
cDNA	O
had	O
an	O
open	O
reading	O
frame	O
of	O
1269	O
base	O
pairs	O
(	O
bp	O
)	O
encoding	O
a	O
protein	O
of	O
423	O
amino	O
acid	O
residues	O
(	O
Mr.	O
47,833	O
)	O
with	O
alternative	O
putative	O
polyadenylation	O
signals	O
in	O
the	O
3	O
'	O
non	O
-	O
coding	O
regions	O
and	O
poly	O
(	O
A	O
)	O
tails	O
.	O
Amino	O
acid	O
sequencing	O
showed	O
that	O
the	O
mature	O
protein	O
consists	O
of	O
369	O
amino	O
acid	O
residues	O
(	O
Mr.	O
42,158	O
)	O
with	O
a	O
putative	O
leader	O
sequence	O
of	O
54	O
amino	O
acid	O
residues	O
.	O
The	O
species1s	O
human	O
species1e	O
enzyme	O
showed	O
an	O
88	O
%	O
identity	O
to	O
species1s	O
mouse	O
species1e	O
enzyme	O
and	O
46	O
%	O
to	O
arg1s	O
yeast	O
arg1e	O
enzyme	O
.	O
Northern	O
blot	O
analysis	O
showed	O
two	O
mRNAs	O
of	O
about	O
2500	O
and	O
1600	O
bp	O
for	O
gene1s	O
ferrochelatase	O
gene1e	O
in	O
species1s	O
K562	O
species1e	O
and	O
species1s	O
HepG2	O
species1e	O
cells	O
.	O
As	O
full	O
-	O
length	O
cDNA	O
for	O
species1s	O
human	O
species1e	O
gene1s	O
ferrochelatase	O
gene1e	O
is	O
now	O
available	O
,	O
molecular	O
lesions	O
related	O
to	O
erythropoietic	O
protoporphyria	O
can	O
be	O
characterized	O
.	O

Sequence	O
identity	O
between	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
pancreatic	ARG2
cholesterol	ARG2
esterase	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
bile	ARG2
salt	ARG2
-	ARG2
stimulated	ARG2
milk	ARG2
lipase	ARG2
gene1e	ARG2
.	O
Three	O
overlapping	O
cDNA	O
clones	O
covering	O
the	O
entire	O
primary	O
sequence	O
of	O
the	O
bile	O
salt	O
stimulated	O
lipase	O
in	O
arg1s	O
human	O
arg1e	O
milk	O
were	O
isolated	O
from	O
a	O
arg1s	O
human	O
arg1e	O
breast	O
lambda	O
gt10	O
cDNA	O
library	O
by	O
screening	O
with	O
the	O
species1s	O
rat	O
species1e	O
gene1s	O
pancreatic	O
cholesterol	O
esterase	O
gene1e	O
cDNA	O
.	O
Nucleotide	O
sequencing	O
of	O
the	O
cDNA	O
showed	O
that	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
milk	ARG2
lipase	ARG2
gene1e	ARG2
mRNA	O
encodes	O
a	O
748-residue	O
protein	O
,	O
including	O
a	O
23-residue	O
signal	O
peptide	O
.	O
The	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
milk	ARG2
lipase	ARG2
gene1e	ARG2
cDNA	O
is	O
highly	O
homologous	O
to	O
species1s	O
rat	O
species1e	O
gene1s	O
pancreatic	O
cholesterol	O
esterase	O
gene1e	O
,	O
suggesting	O
that	O
the	O
gene1s	ARG2
milk	ARG2
lipase	ARG2
gene1e	ARG2
may	O
be	O
identical	O
to	O
the	O
gene1s	ARG2
cholesterol	ARG2
esterase	ARG2
gene1e	ARG2
in	O
arg1s	O
human	O
arg1e	O
pancreas	O
.	O
This	O
conclusion	O
was	O
confirmed	O
by	O
isolation	O
and	O
sequencing	O
of	O
the	O
cDNA	O
for	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
pancreatic	ARG2
cholesterol	ARG2
esterase	ARG2
gene1e	ARG2
.	O
Analysis	O
of	O
the	O
sequence	O
for	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
cholesterol	ARG2
esterase	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
milk	ARG2
lipase	ARG2
gene1e	ARG2
revealed	O
similarities	O
to	O
other	O
serine	O
esterases	O
in	O
three	O
distinct	O
regions	O
of	O
the	O
protein	O
.	O
These	O
domains	O
may	O
represent	O
the	O
active	O
site	O
triads	O
of	O
these	O
proteins	O
.	O

Sequence	O
identity	O
between	O
species1s	O
human	O
species1e	O
gene1s	O
pancreatic	O
cholesterol	O
esterase	O
gene1e	O
and	O
gene1s	O
bile	O
salt	O
-	O
stimulated	O
milk	O
lipase	O
gene1e	O
.	O
Three	O
overlapping	O
cDNA	O
clones	O
covering	O
the	O
entire	O
primary	O
sequence	O
of	O
the	O
bile	O
salt	O
stimulated	O
lipase	O
in	O
species1s	O
human	O
species1e	O
milk	O
were	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
breast	O
lambda	O
gt10	O
cDNA	O
library	O
by	O
screening	O
with	O
the	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
pancreatic	ARG2
cholesterol	ARG2
esterase	ARG2
gene1e	ARG2
cDNA	O
.	O
Nucleotide	O
sequencing	O
of	O
the	O
cDNA	O
showed	O
that	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
milk	O
lipase	O
gene1e	O
mRNA	O
encodes	O
a	O
748-residue	O
protein	O
,	O
including	O
a	O
23-residue	O
signal	O
peptide	O
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
milk	O
lipase	O
gene1e	O
cDNA	O
is	O
highly	O
homologous	O
to	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
pancreatic	ARG2
cholesterol	ARG2
esterase	ARG2
gene1e	ARG2
,	O
suggesting	O
that	O
the	O
gene1s	O
milk	O
lipase	O
gene1e	O
may	O
be	O
identical	O
to	O
the	O
gene1s	O
cholesterol	O
esterase	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
pancreas	O
.	O
This	O
conclusion	O
was	O
confirmed	O
by	O
isolation	O
and	O
sequencing	O
of	O
the	O
cDNA	O
for	O
species1s	O
human	O
species1e	O
gene1s	O
pancreatic	O
cholesterol	O
esterase	O
gene1e	O
.	O
Analysis	O
of	O
the	O
sequence	O
for	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
cholesterol	O
esterase	O
gene1e	O
/	O
gene1s	O
milk	O
lipase	O
gene1e	O
revealed	O
similarities	O
to	O
other	O
serine	O
esterases	O
in	O
three	O
distinct	O
regions	O
of	O
the	O
protein	O
.	O
These	O
domains	O
may	O
represent	O
the	O
active	O
site	O
triads	O
of	O
these	O
proteins	O
.	O

Maple	O
syrup	O
urine	O
disease	O
.	O
Complete	O
primary	O
structure	O
of	O
the	O
gene1s	ARG2
E1	ARG2
beta	ARG2
subunit	ARG2
gene1e	ARG2
of	O
arg1s	O
human	O
arg1e	O
branched	O
chain	O
alpha	O
-	O
ketoacid	O
dehydrogenase	O
complex	O
deduced	O
from	O
the	O
nucleotide	O
sequence	O
and	O
a	O
gene	O
analysis	O
of	O
arg1s	O
patients	O
arg1e	O
with	O
this	O
disease	O
.	O
A	O
defect	O
in	O
the	O
gene1s	ARG2
E1	ARG2
beta	ARG2
subunit	ARG2
gene1e	ARG2
of	O
the	O
branched	O
chain	O
alpha	O
-	O
ketoacid	O
dehydrogenase	O
(	O
BCKDH	O
)	O
complex	O
is	O
one	O
cause	O
of	O
maple	O
syrup	O
urine	O
disease	O
(	O
MSUD	O
)	O
.	O
In	O
an	O
attempt	O
to	O
elucidate	O
the	O
molecular	O
basis	O
of	O
MSUD	O
,	O
we	O
isolated	O
and	O
characterized	O
a	O
1.35	O
kbp	O
cDNA	O
clone	O
encoding	O
the	O
entire	O
precursor	O
of	O
the	O
gene1s	ARG2
E1	ARG2
beta	ARG2
subunit	ARG2
gene1e	ARG2
of	O
BCKDH	O
complex	O
from	O
a	O
arg1s	O
human	O
arg1e	O
placental	O
cDNA	O
library	O
.	O
Nucleotide	O
sequence	O
analysis	O
revealed	O
that	O
the	O
isolated	O
cDNA	O
clone	O
(	O
lambda	O
gene1s	ARG2
hBE1	ARG2
beta-1	ARG2
gene1e	ARG2
)	O
contained	O
a	O
5'-untranslated	O
sequence	O
of	O
four	O
nucleotides	O
,	O
the	O
translated	O
sequence	O
of	O
1,176	O
nucleotides	O
and	O
the	O
3'-untranslated	O
sequence	O
of	O
169	O
nucleotides	O
.	O
Comparison	O
of	O
the	O
amino	O
acid	O
sequence	O
predicted	O
from	O
the	O
nucleotide	O
sequence	O
of	O
the	O
cDNA	O
insert	O
of	O
the	O
clone	O
with	O
the	O
NH2-terminal	O
amino	O
acid	O
sequence	O
of	O
the	O
purified	O
mature	O
species1s	O
bovine	O
species1e	O
gene1s	O
BCKDH	O
-	O
E1	O
beta	O
subunit	O
gene1e	O
showed	O
that	O
the	O
cDNA	O
insert	O
encodes	O
for	O
a	O
342-amino	O
acid	O
subunit	O
with	O
a	O
Mr	O
=	O
37,585	O
.	O
The	O
subunit	O
is	O
synthesized	O
as	O
the	O
precursor	O
with	O
a	O
leader	O
sequence	O
of	O
50	O
amino	O
acids	O
and	O
is	O
processed	O
at	O
the	O
NH2	O
terminus	O
.	O
A	O
search	O
for	O
protein	O
homology	O
revealed	O
that	O
the	O
primary	O
structure	O
of	O
arg1s	O
human	O
arg1e	O
BCKDH	O
-	O
gene1s	ARG2
E1	ARG2
beta	ARG2
gene1e	ARG2
was	O
similar	O
to	O
the	O
species1s	O
bovine	O
species1e	O
gene1s	O
BCKDH	O
-	O
E1	O
beta	O
gene1e	O
and	O
to	O
the	O
gene1s	ARG2
E1	ARG2
beta	ARG2
subunit	ARG2
gene1e	ARG2
of	O
arg1s	O
human	O
arg1e	O
pyruvate	O
dehydrogenase	O
complex	O
,	O
in	O
all	O
regions	O
.	O
The	O
structures	O
and	O
functions	O
of	O
arg1s	O
mammalian	O
arg1e	O
alpha	O
-	O
ketoacid	O
dehydrogenase	O
complexes	O
are	O
apparently	O
highly	O
conserved	O
.	O
Genomic	O
DNA	O
from	O
lymphoblastoid	O
cell	O
lines	O
derived	O
from	O
normal	O
and	O
five	O
MSUD	O
arg1s	O
patients	O
arg1e	O
,	O
in	O
whom	O
gene1s	ARG2
E1	ARG2
beta	ARG2
gene1e	ARG2
was	O
not	O
detected	O
by	O
immunoblot	O
analysis	O
,	O
gave	O
the	O
same	O
restriction	O
maps	O
on	O
Southern	O
blot	O
analysis	O
.	O
The	O
gene	O
has	O
at	O
least	O
80	O
kbp	O
.	O

Maple	O
syrup	O
urine	O
disease	O
.	O
Complete	O
primary	O
structure	O
of	O
the	O
gene1s	O
E1	O
beta	O
subunit	O
gene1e	O
of	O
species1s	O
human	O
species1e	O
branched	O
chain	O
alpha	O
-	O
ketoacid	O
dehydrogenase	O
complex	O
deduced	O
from	O
the	O
nucleotide	O
sequence	O
and	O
a	O
gene	O
analysis	O
of	O
species1s	O
patients	O
species1e	O
with	O
this	O
disease	O
.	O
A	O
defect	O
in	O
the	O
gene1s	O
E1	O
beta	O
subunit	O
gene1e	O
of	O
the	O
branched	O
chain	O
alpha	O
-	O
ketoacid	O
dehydrogenase	O
(	O
BCKDH	O
)	O
complex	O
is	O
one	O
cause	O
of	O
maple	O
syrup	O
urine	O
disease	O
(	O
MSUD	O
)	O
.	O
In	O
an	O
attempt	O
to	O
elucidate	O
the	O
molecular	O
basis	O
of	O
MSUD	O
,	O
we	O
isolated	O
and	O
characterized	O
a	O
1.35	O
kbp	O
cDNA	O
clone	O
encoding	O
the	O
entire	O
precursor	O
of	O
the	O
gene1s	O
E1	O
beta	O
subunit	O
gene1e	O
of	O
BCKDH	O
complex	O
from	O
a	O
species1s	O
human	O
species1e	O
placental	O
cDNA	O
library	O
.	O
Nucleotide	O
sequence	O
analysis	O
revealed	O
that	O
the	O
isolated	O
cDNA	O
clone	O
(	O
lambda	O
gene1s	O
hBE1	O
beta-1	O
gene1e	O
)	O
contained	O
a	O
5'-untranslated	O
sequence	O
of	O
four	O
nucleotides	O
,	O
the	O
translated	O
sequence	O
of	O
1,176	O
nucleotides	O
and	O
the	O
3'-untranslated	O
sequence	O
of	O
169	O
nucleotides	O
.	O
Comparison	O
of	O
the	O
amino	O
acid	O
sequence	O
predicted	O
from	O
the	O
nucleotide	O
sequence	O
of	O
the	O
cDNA	O
insert	O
of	O
the	O
clone	O
with	O
the	O
NH2-terminal	O
amino	O
acid	O
sequence	O
of	O
the	O
purified	O
mature	O
arg1s	O
bovine	O
arg1e	O
gene1s	ARG2
BCKDH	ARG2
-	ARG2
E1	ARG2
beta	ARG2
subunit	ARG2
gene1e	ARG2
showed	O
that	O
the	O
cDNA	O
insert	O
encodes	O
for	O
a	O
342-amino	O
acid	O
subunit	O
with	O
a	O
Mr	O
=	O
37,585	O
.	O
The	O
subunit	O
is	O
synthesized	O
as	O
the	O
precursor	O
with	O
a	O
leader	O
sequence	O
of	O
50	O
amino	O
acids	O
and	O
is	O
processed	O
at	O
the	O
NH2	O
terminus	O
.	O
A	O
search	O
for	O
protein	O
homology	O
revealed	O
that	O
the	O
primary	O
structure	O
of	O
species1s	O
human	O
species1e	O
BCKDH	O
-	O
gene1s	O
E1	O
beta	O
gene1e	O
was	O
similar	O
to	O
the	O
arg1s	O
bovine	O
arg1e	O
gene1s	ARG2
BCKDH	ARG2
-	ARG2
E1	ARG2
beta	ARG2
gene1e	ARG2
and	O
to	O
the	O
gene1s	O
E1	O
beta	O
subunit	O
gene1e	O
of	O
species1s	O
human	O
species1e	O
pyruvate	O
dehydrogenase	O
complex	O
,	O
in	O
all	O
regions	O
.	O
The	O
structures	O
and	O
functions	O
of	O
species1s	O
mammalian	O
species1e	O
alpha	O
-	O
ketoacid	O
dehydrogenase	O
complexes	O
are	O
apparently	O
highly	O
conserved	O
.	O
Genomic	O
DNA	O
from	O
lymphoblastoid	O
cell	O
lines	O
derived	O
from	O
normal	O
and	O
five	O
MSUD	O
species1s	O
patients	O
species1e	O
,	O
in	O
whom	O
gene1s	O
E1	O
beta	O
gene1e	O
was	O
not	O
detected	O
by	O
immunoblot	O
analysis	O
,	O
gave	O
the	O
same	O
restriction	O
maps	O
on	O
Southern	O
blot	O
analysis	O
.	O
The	O
gene	O
has	O
at	O
least	O
80	O
kbp	O
.	O

Sequence	O
and	O
expression	O
of	O
a	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
type	ARG2
II	ARG2
mesothelial	ARG2
keratin	ARG2
gene1e	ARG2
.	O
Using	O
mRNA	O
from	O
cultured	O
arg1s	O
human	O
arg1e	O
mesothelial	O
cells	O
,	O
we	O
constructed	O
bacterial	O
plasmids	O
and	O
species1s	O
lambda	O
phage	O
species1e	O
vectors	O
that	O
contained	O
cDNA	O
sequences	O
specific	O
for	O
the	O
keratins	O
expressed	O
in	O
these	O
cells	O
.	O
A	O
cloned	O
cDNA	O
encoding	O
keratin	O
gene1s	ARG2
K7	ARG2
gene1e	ARG2
(	O
55	O
kD	O
)	O
was	O
identified	O
by	O
positive	O
hybrid	O
selection	O
.	O
Southern	O
Blot	O
analysis	O
indicated	O
that	O
this	O
sequence	O
is	O
represented	O
only	O
once	O
in	O
the	O
arg1s	O
human	O
arg1e	O
genome	O
,	O
and	O
Northern	O
Blot	O
analysis	O
demonstrated	O
that	O
the	O
gene	O
encoding	O
gene1s	ARG2
K7	ARG2
gene1e	ARG2
is	O
expressed	O
in	O
abundance	O
in	O
cultured	O
bronchial	O
and	O
mesothelial	O
cells	O
,	O
but	O
only	O
weakly	O
in	O
cultured	O
epidermal	O
cells	O
and	O
not	O
at	O
all	O
in	O
liver	O
,	O
colon	O
,	O
or	O
exocervical	O
tissue	O
.	O
The	O
predicted	O
amino	O
acid	O
sequence	O
of	O
this	O
keratin	O
has	O
revealed	O
a	O
striking	O
difference	O
between	O
this	O
keratin	O
and	O
the	O
type	O
II	O
keratins	O
expressed	O
in	O
epidermal	O
cells	O
:	O
whereas	O
all	O
of	O
the	O
epidermal	O
type	O
II	O
keratins	O
thus	O
far	O
sequenced	O
have	O
long	O
nonhelical	O
termini	O
rich	O
in	O
glycine	O
and	O
serine	O
,	O
this	O
gene1s	ARG2
mesothelial	ARG2
type	ARG2
II	ARG2
keratin	ARG2
gene1e	ARG2
has	O
amino	O
and	O
carboxy	O
terminal	O
regions	O
that	O
are	O
unusually	O
short	O
and	O
lack	O
the	O
inexact	O
repeats	O
of	O
glycine	O
and	O
serine	O
residues	O
.	O

Sequence	O
and	O
expression	O
of	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
type	O
II	O
mesothelial	O
keratin	O
gene1e	O
.	O
Using	O
mRNA	O
from	O
cultured	O
species1s	O
human	O
species1e	O
mesothelial	O
cells	O
,	O
we	O
constructed	O
bacterial	O
plasmids	O
and	O
arg1s	O
lambda	O
phage	O
arg1e	O
vectors	O
that	O
contained	O
cDNA	O
sequences	O
specific	O
for	O
the	O
keratins	O
expressed	O
in	O
these	O
cells	O
.	O
A	O
cloned	O
cDNA	O
encoding	O
keratin	O
gene1s	O
K7	O
gene1e	O
(	O
55	O
kD	O
)	O
was	O
identified	O
by	O
positive	O
hybrid	O
selection	O
.	O
Southern	O
Blot	O
analysis	O
indicated	O
that	O
this	O
sequence	O
is	O
represented	O
only	O
once	O
in	O
the	O
species1s	O
human	O
species1e	O
genome	O
,	O
and	O
Northern	O
Blot	O
analysis	O
demonstrated	O
that	O
the	O
gene	O
encoding	O
gene1s	O
K7	O
gene1e	O
is	O
expressed	O
in	O
abundance	O
in	O
cultured	O
bronchial	O
and	O
mesothelial	O
cells	O
,	O
but	O
only	O
weakly	O
in	O
cultured	O
epidermal	O
cells	O
and	O
not	O
at	O
all	O
in	O
liver	O
,	O
colon	O
,	O
or	O
exocervical	O
tissue	O
.	O
The	O
predicted	O
amino	O
acid	O
sequence	O
of	O
this	O
keratin	O
has	O
revealed	O
a	O
striking	O
difference	O
between	O
this	O
keratin	O
and	O
the	O
type	O
II	O
keratins	O
expressed	O
in	O
epidermal	O
cells	O
:	O
whereas	O
all	O
of	O
the	O
epidermal	O
type	O
II	O
keratins	O
thus	O
far	O
sequenced	O
have	O
long	O
nonhelical	O
termini	O
rich	O
in	O
glycine	O
and	O
serine	O
,	O
this	O
gene1s	O
mesothelial	O
type	O
II	O
keratin	O
gene1e	O
has	O
amino	O
and	O
carboxy	O
terminal	O
regions	O
that	O
are	O
unusually	O
short	O
and	O
lack	O
the	O
inexact	O
repeats	O
of	O
glycine	O
and	O
serine	O
residues	O
.	O

Isolation	O
and	O
sequence	O
of	O
a	O
cDNA	O
clone	O
for	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
calcineurin	ARG2
B	ARG2
gene1e	ARG2
,	O
the	O
Ca2	O
+	O
-binding	O
subunit	O
of	O
the	O
Ca2+/calmodulin	O
-	O
stimulated	O
protein	O
phosphatase	O
.	O
We	O
have	O
identified	O
and	O
cloned	O
arg1s	O
human	O
arg1e	O
cDNA	O
for	O
the	O
gene1s	ARG2
Ca2	ARG2
+	ARG2
-binding	ARG2
subunit	ARG2
of	ARG2
calcineurin	ARG2
gene1e	ARG2
,	O
the	O
brain	O
isozyme	O
of	O
the	O
Ca2+/calmodulin	O
-	O
stimulated	O
protein	O
phosphatase	O
.	O
The	O
2.5-kb	O
cDNA	O
has	O
an	O
open	O
reading	O
frame	O
of	O
510	O
bp	O
,	O
a	O
leader	O
sequence	O
of	O
at	O
least	O
500	O
bp	O
,	O
and	O
a	O
1,277-bp	O
3'-noncoding	O
sequence	O
.	O
The	O
deduced	O
sequence	O
of	O
the	O
arg1s	O
human	O
arg1e	O
protein	O
differs	O
from	O
species1s	O
bovine	O
species1e	O
brain	O
gene1s	ARG2
calcineurin	ARG2
B	ARG2
gene1e	ARG2
by	O
an	O
additional	O
valine	O
at	O
the	O
carboxyl	O
terminus	O
and	O
substitution	O
of	O
Met-11	O
and	O
Ser-153	O
by	O
cysteine	O
.	O
A	O
partial	O
clone	O
of	O
the	O
species1s	O
mouse	O
species1e	O
protein	O
corresponding	O
to	O
amino	O
acids	O
75	O
-	O
150	O
was	O
also	O
isolated	O
.	O
This	O
portion	O
of	O
the	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
mouse	O
species1e	O
protein	O
sequence	O
is	O
identical	O
,	O
with	O
the	O
DNA	O
sequences	O
showing	O
94	O
%	O
identity	O
.	O
The	O
respective	O
mRNAs	O
in	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
mouse	O
species1e	O
are	O
also	O
of	O
similar	O
size	O
.	O
As	O
was	O
observed	O
with	O
protein	O
levels	O
,	O
mRNA	O
abundance	O
in	O
brain	O
is	O
20	O
-	O
60	O
times	O
that	O
found	O
in	O
other	O
tissues	O
with	O
the	O
exception	O
of	O
arg1s	O
HeLa	O
arg1e	O
cells	O
which	O
,	O
like	O
brain	O
,	O
contain	O
abundant	O
gene1s	ARG2
calcineurin	ARG2
B	ARG2
gene1e	ARG2
mRNA	O
.	O

Isolation	O
and	O
sequence	O
of	O
a	O
cDNA	O
clone	O
for	O
species1s	O
human	O
species1e	O
gene1s	O
calcineurin	O
B	O
gene1e	O
,	O
the	O
Ca2	O
+	O
-binding	O
subunit	O
of	O
the	O
Ca2+/calmodulin	O
-	O
stimulated	O
protein	O
phosphatase	O
.	O
We	O
have	O
identified	O
and	O
cloned	O
species1s	O
human	O
species1e	O
cDNA	O
for	O
the	O
gene1s	O
Ca2	O
+	O
-binding	O
subunit	O
of	O
calcineurin	O
gene1e	O
,	O
the	O
brain	O
isozyme	O
of	O
the	O
Ca2+/calmodulin	O
-	O
stimulated	O
protein	O
phosphatase	O
.	O
The	O
2.5-kb	O
cDNA	O
has	O
an	O
open	O
reading	O
frame	O
of	O
510	O
bp	O
,	O
a	O
leader	O
sequence	O
of	O
at	O
least	O
500	O
bp	O
,	O
and	O
a	O
1,277-bp	O
3'-noncoding	O
sequence	O
.	O
The	O
deduced	O
sequence	O
of	O
the	O
species1s	O
human	O
species1e	O
protein	O
differs	O
from	O
arg1s	O
bovine	O
arg1e	O
brain	O
gene1s	O
calcineurin	O
B	O
gene1e	O
by	O
an	O
additional	O
valine	O
at	O
the	O
carboxyl	O
terminus	O
and	O
substitution	O
of	O
Met-11	O
and	O
Ser-153	O
by	O
cysteine	O
.	O
A	O
partial	O
clone	O
of	O
the	O
species1s	O
mouse	O
species1e	O
protein	O
corresponding	O
to	O
amino	O
acids	O
75	O
-	O
150	O
was	O
also	O
isolated	O
.	O
This	O
portion	O
of	O
the	O
species1s	O
human	O
species1e	O
and	O
species1s	O
mouse	O
species1e	O
protein	O
sequence	O
is	O
identical	O
,	O
with	O
the	O
DNA	O
sequences	O
showing	O
94	O
%	O
identity	O
.	O
The	O
respective	O
mRNAs	O
in	O
species1s	O
human	O
species1e	O
and	O
species1s	O
mouse	O
species1e	O
are	O
also	O
of	O
similar	O
size	O
.	O
As	O
was	O
observed	O
with	O
protein	O
levels	O
,	O
mRNA	O
abundance	O
in	O
brain	O
is	O
20	O
-	O
60	O
times	O
that	O
found	O
in	O
other	O
tissues	O
with	O
the	O
exception	O
of	O
species1s	O
HeLa	O
species1e	O
cells	O
which	O
,	O
like	O
brain	O
,	O
contain	O
abundant	O
gene1s	O
calcineurin	O
B	O
gene1e	O
mRNA	O
.	O

Isolation	O
and	O
sequence	O
of	O
a	O
cDNA	O
clone	O
for	O
species1s	O
human	O
species1e	O
gene1s	O
calcineurin	O
B	O
gene1e	O
,	O
the	O
Ca2	O
+	O
-binding	O
subunit	O
of	O
the	O
Ca2+/calmodulin	O
-	O
stimulated	O
protein	O
phosphatase	O
.	O
We	O
have	O
identified	O
and	O
cloned	O
species1s	O
human	O
species1e	O
cDNA	O
for	O
the	O
gene1s	O
Ca2	O
+	O
-binding	O
subunit	O
of	O
calcineurin	O
gene1e	O
,	O
the	O
brain	O
isozyme	O
of	O
the	O
Ca2+/calmodulin	O
-	O
stimulated	O
protein	O
phosphatase	O
.	O
The	O
2.5-kb	O
cDNA	O
has	O
an	O
open	O
reading	O
frame	O
of	O
510	O
bp	O
,	O
a	O
leader	O
sequence	O
of	O
at	O
least	O
500	O
bp	O
,	O
and	O
a	O
1,277-bp	O
3'-noncoding	O
sequence	O
.	O
The	O
deduced	O
sequence	O
of	O
the	O
species1s	O
human	O
species1e	O
protein	O
differs	O
from	O
species1s	O
bovine	O
species1e	O
brain	O
gene1s	O
calcineurin	O
B	O
gene1e	O
by	O
an	O
additional	O
valine	O
at	O
the	O
carboxyl	O
terminus	O
and	O
substitution	O
of	O
Met-11	O
and	O
Ser-153	O
by	O
cysteine	O
.	O
A	O
partial	O
clone	O
of	O
the	O
arg1s	O
mouse	O
arg1e	O
protein	O
corresponding	O
to	O
amino	O
acids	O
75	O
-	O
150	O
was	O
also	O
isolated	O
.	O
This	O
portion	O
of	O
the	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
mouse	O
arg1e	O
protein	O
sequence	O
is	O
identical	O
,	O
with	O
the	O
DNA	O
sequences	O
showing	O
94	O
%	O
identity	O
.	O
The	O
respective	O
mRNAs	O
in	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
mouse	O
arg1e	O
are	O
also	O
of	O
similar	O
size	O
.	O
As	O
was	O
observed	O
with	O
protein	O
levels	O
,	O
mRNA	O
abundance	O
in	O
brain	O
is	O
20	O
-	O
60	O
times	O
that	O
found	O
in	O
other	O
tissues	O
with	O
the	O
exception	O
of	O
species1s	O
HeLa	O
species1e	O
cells	O
which	O
,	O
like	O
brain	O
,	O
contain	O
abundant	O
gene1s	O
calcineurin	O
B	O
gene1e	O
mRNA	O
.	O

arg1s	O
Human	O
arg1e	O
liver	O
gene1s	ARG2
serine	ARG2
dehydratase	ARG2
gene1e	ARG2
.	O
cDNA	O
cloning	O
and	O
sequence	O
homology	O
with	O
hydroxyamino	O
acid	O
dehydratases	O
from	O
other	O
sources	O
.	O
species1s	O
Rat	O
species1e	O
liver	O
gene1s	O
serine	O
dehydratase	O
gene1e	O
cDNA	O
was	O
used	O
to	O
screen	O
a	O
arg1s	O
human	O
arg1e	O
liver	O
cDNA	O
library	O
in	O
lambda	O
gt11	O
.	O
One	O
positive	O
clone	O
occurred	O
in	O
every	O
5,000	O
clones	O
.	O
Fifteen	O
positive	O
clones	O
were	O
plaque	O
purified	O
.	O
The	O
largest	O
cDNA	O
obtained	O
contained	O
an	O
open	O
reading	O
frame	O
of	O
987	O
base	O
pairs	O
,	O
and	O
5	O
'	O
and	O
3	O
'	O
noncoding	O
regions	O
of	O
89	O
and	O
317	O
base	O
pairs	O
,	O
respectively	O
.	O
The	O
deduced	O
amino	O
acid	O
sequence	O
,	O
with	O
a	O
calculated	O
Mr	O
of	O
34,615	O
,	O
was	O
similar	O
to	O
that	O
of	O
species1s	O
rat	O
species1e	O
liver	O
gene1s	O
serine	O
dehydratase	O
gene1e	O
except	O
for	O
the	O
absence	O
of	O
a	O
segment	O
consisting	O
of	O
36	O
amino	O
acid	O
residues	O
.	O
In	O
vitro	O
transcription	O
/	O
translation	O
with	O
the	O
cDNA	O
resulted	O
in	O
the	O
formation	O
of	O
a	O
polypeptide	O
with	O
an	O
Mr	O
of	O
approximately	O
35,000	O
,	O
which	O
cross	O
-	O
reacted	O
with	O
the	O
anti	O
-	O
species1s	O
rat	O
species1e	O
gene1s	O
serine	O
dehydratase	O
gene1e	O
antibody	O
.	O
These	O
results	O
suggest	O
that	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
serine	ARG2
dehydratase	ARG2
gene1e	ARG2
is	O
structurally	O
cognate	O
with	O
the	O
species1s	O
rat	O
species1e	O
enzyme	O
.	O
Moreover	O
,	O
portions	O
of	O
the	O
sequence	O
postulated	O
to	O
be	O
essential	O
for	O
activity	O
in	O
microbial	O
threonine	O
dehydratases	O
are	O
found	O
in	O
the	O
arg1s	O
mammalian	O
arg1e	O
serine	O
dehydratases	O
,	O
suggesting	O
that	O
hydroxyamino	O
and	O
dehydratases	O
may	O
have	O
originated	O
from	O
a	O
common	O
ancestor	O
.	O

species1s	O
Human	O
species1e	O
liver	O
gene1s	O
serine	O
dehydratase	O
gene1e	O
.	O
cDNA	O
cloning	O
and	O
sequence	O
homology	O
with	O
hydroxyamino	O
acid	O
dehydratases	O
from	O
other	O
sources	O
.	O
arg1s	O
Rat	O
arg1e	O
liver	O
gene1s	ARG2
serine	ARG2
dehydratase	ARG2
gene1e	ARG2
cDNA	O
was	O
used	O
to	O
screen	O
a	O
species1s	O
human	O
species1e	O
liver	O
cDNA	O
library	O
in	O
lambda	O
gt11	O
.	O
One	O
positive	O
clone	O
occurred	O
in	O
every	O
5,000	O
clones	O
.	O
Fifteen	O
positive	O
clones	O
were	O
plaque	O
purified	O
.	O
The	O
largest	O
cDNA	O
obtained	O
contained	O
an	O
open	O
reading	O
frame	O
of	O
987	O
base	O
pairs	O
,	O
and	O
5	O
'	O
and	O
3	O
'	O
noncoding	O
regions	O
of	O
89	O
and	O
317	O
base	O
pairs	O
,	O
respectively	O
.	O
The	O
deduced	O
amino	O
acid	O
sequence	O
,	O
with	O
a	O
calculated	O
Mr	O
of	O
34,615	O
,	O
was	O
similar	O
to	O
that	O
of	O
arg1s	O
rat	O
arg1e	O
liver	O
gene1s	ARG2
serine	ARG2
dehydratase	ARG2
gene1e	ARG2
except	O
for	O
the	O
absence	O
of	O
a	O
segment	O
consisting	O
of	O
36	O
amino	O
acid	O
residues	O
.	O
In	O
vitro	O
transcription	O
/	O
translation	O
with	O
the	O
cDNA	O
resulted	O
in	O
the	O
formation	O
of	O
a	O
polypeptide	O
with	O
an	O
Mr	O
of	O
approximately	O
35,000	O
,	O
which	O
cross	O
-	O
reacted	O
with	O
the	O
anti	O
-	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
serine	ARG2
dehydratase	ARG2
gene1e	ARG2
antibody	O
.	O
These	O
results	O
suggest	O
that	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
serine	O
dehydratase	O
gene1e	O
is	O
structurally	O
cognate	O
with	O
the	O
arg1s	O
rat	O
arg1e	O
enzyme	O
.	O
Moreover	O
,	O
portions	O
of	O
the	O
sequence	O
postulated	O
to	O
be	O
essential	O
for	O
activity	O
in	O
microbial	O
threonine	O
dehydratases	O
are	O
found	O
in	O
the	O
species1s	O
mammalian	O
species1e	O
serine	O
dehydratases	O
,	O
suggesting	O
that	O
hydroxyamino	O
and	O
dehydratases	O
may	O
have	O
originated	O
from	O
a	O
common	O
ancestor	O
.	O

arg1s	O
Human	O
arg1e	O
gastric	O
gene1s	ARG2
cathepsin	ARG2
E	ARG2
gene1e	ARG2
.	O
Predicted	O
sequence	O
,	O
localization	O
to	O
chromosome	O
1	O
,	O
and	O
sequence	O
homology	O
with	O
other	O
aspartic	O
proteinases	O
.	O
The	O
predicted	O
sequence	O
of	O
arg1s	O
human	O
arg1e	O
gastric	O
gene1s	ARG2
cathepsin	ARG2
E	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CTSE	ARG2
gene1e	ARG2
)	O
was	O
determined	O
by	O
analysis	O
of	O
cDNA	O
clones	O
isolated	O
from	O
a	O
library	O
constructed	O
with	O
poly(A+	O
)	O
RNA	O
from	O
a	O
gastric	O
adenocarcinoma	O
cell	O
line	O
.	O
The	O
gene1s	ARG2
CTSE	ARG2
gene1e	ARG2
cDNA	O
clones	O
were	O
identified	O
using	O
a	O
set	O
of	O
complementary	O
18-base	O
oligonucleotide	O
probes	O
specific	O
for	O
a	O
6-residue	O
sequence	O
surrounding	O
the	O
first	O
active	O
site	O
of	O
all	O
previously	O
characterized	O
arg1s	O
human	O
arg1e	O
aspartic	O
proteinases	O
.	O
Sequence	O
analysis	O
of	O
gene1s	ARG2
CTSE	ARG2
gene1e	ARG2
cDNA	O
clones	O
revealed	O
a	O
1188-base	O
pair	O
open	O
reading	O
frame	O
that	O
exhibited	O
59	O
%	O
sequence	O
identity	O
with	O
arg1s	O
human	O
arg1e	O
pepsinogen	O
A.	O
The	O
predicted	O
gene1s	ARG2
CTSE	ARG2
gene1e	ARG2
amino	O
acid	O
sequence	O
includes	O
a	O
379-residue	O
proenzyme	O
(	O
Mr	O
=	O
40,883	O
)	O
and	O
a	O
17-residue	O
signal	O
peptide	O
.	O
The	O
predicted	O
gene1s	ARG2
CTSE	ARG2
gene1e	ARG2
amino	O
acid	O
composition	O
was	O
consistent	O
with	O
that	O
of	O
purified	O
material	O
from	O
gastric	O
mucosa	O
and	O
gastric	O
adenocarcinoma	O
cell	O
lines	O
.	O
Additional	O
evidence	O
for	O
the	O
identification	O
of	O
the	O
gene1s	ARG2
CTSE	ARG2
gene1e	ARG2
cDNA	O
clones	O
was	O
obtained	O
by	O
analysis	O
of	O
poly(A+	O
)	O
RNA	O
isolated	O
from	O
gene1s	ARG2
CTSE	ARG2
gene1e	ARG2
-	O
producing	O
and	O
-nonproducing	O
gastric	O
adenocarcinoma	O
cell	O
subclones	O
.	O
Three	O
RNA	O
transcripts	O
(	O
3.6	O
,	O
2.6	O
,	O
and	O
2.1	O
kilobases	O
)	O
were	O
identified	O
in	O
poly(A+	O
)	O
RNA	O
isolated	O
from	O
a	O
gastric	O
adenocarcinoma	O
cell	O
line	O
that	O
produced	O
gene1s	ARG2
CTSE	ARG2
gene1e	ARG2
that	O
were	O
absent	O
from	O
nonproducing	O
subclones	O
.	O
gene1s	ARG2
CTSE	ARG2
gene1e	ARG2
contains	O
7	O
cysteine	O
residues	O
,	O
of	O
which	O
6	O
were	O
localized	O
by	O
comparative	O
maximal	O
alignment	O
analysis	O
with	O
pepsinogen	O
A	O
to	O
conserved	O
residues	O
that	O
form	O
intrachain	O
disulfide	O
bonds	O
.	O
The	O
seventh	O
cysteine	O
residue	O
of	O
gene1s	ARG2
CTSE	ARG2
gene1e	ARG2
is	O
located	O
within	O
the	O
activation	O
peptide	O
region	O
of	O
the	O
proenzyme	O
.	O
We	O
suspect	O
that	O
this	O
residue	O
forms	O
an	O
interchain	O
disulfide	O
bond	O
and	O
thereby	O
determines	O
the	O
dimerization	O
of	O
gene1s	ARG2
CTSE	ARG2
gene1e	ARG2
proenzyme	O
molecules	O
that	O
is	O
observed	O
under	O
native	O
conditions	O
.	O
The	O
gene1s	ARG2
CTSE	ARG2
gene1e	ARG2
gene	O
was	O
localized	O
to	O
arg1s	O
human	O
arg1e	O
chromosome	O
1	O
by	O
concurrent	O
cytogenetic	O
and	O
cDNA	O
probe	O
analyses	O
of	O
a	O
panel	O
of	O
arg1s	O
human	O
arg1e	O
x	O
species1s	O
mouse	O
species1e	O
somatic	O
cell	O
hybrids	O
.	O

species1s	O
Human	O
species1e	O
gastric	O
gene1s	O
cathepsin	O
E	O
gene1e	O
.	O
Predicted	O
sequence	O
,	O
localization	O
to	O
chromosome	O
1	O
,	O
and	O
sequence	O
homology	O
with	O
other	O
aspartic	O
proteinases	O
.	O
The	O
predicted	O
sequence	O
of	O
species1s	O
human	O
species1e	O
gastric	O
gene1s	O
cathepsin	O
E	O
gene1e	O
(	O
gene1s	O
CTSE	O
gene1e	O
)	O
was	O
determined	O
by	O
analysis	O
of	O
cDNA	O
clones	O
isolated	O
from	O
a	O
library	O
constructed	O
with	O
poly(A+	O
)	O
RNA	O
from	O
a	O
gastric	O
adenocarcinoma	O
cell	O
line	O
.	O
The	O
gene1s	O
CTSE	O
gene1e	O
cDNA	O
clones	O
were	O
identified	O
using	O
a	O
set	O
of	O
complementary	O
18-base	O
oligonucleotide	O
probes	O
specific	O
for	O
a	O
6-residue	O
sequence	O
surrounding	O
the	O
first	O
active	O
site	O
of	O
all	O
previously	O
characterized	O
species1s	O
human	O
species1e	O
aspartic	O
proteinases	O
.	O
Sequence	O
analysis	O
of	O
gene1s	O
CTSE	O
gene1e	O
cDNA	O
clones	O
revealed	O
a	O
1188-base	O
pair	O
open	O
reading	O
frame	O
that	O
exhibited	O
59	O
%	O
sequence	O
identity	O
with	O
species1s	O
human	O
species1e	O
pepsinogen	O
A.	O
The	O
predicted	O
gene1s	O
CTSE	O
gene1e	O
amino	O
acid	O
sequence	O
includes	O
a	O
379-residue	O
proenzyme	O
(	O
Mr	O
=	O
40,883	O
)	O
and	O
a	O
17-residue	O
signal	O
peptide	O
.	O
The	O
predicted	O
gene1s	O
CTSE	O
gene1e	O
amino	O
acid	O
composition	O
was	O
consistent	O
with	O
that	O
of	O
purified	O
material	O
from	O
gastric	O
mucosa	O
and	O
gastric	O
adenocarcinoma	O
cell	O
lines	O
.	O
Additional	O
evidence	O
for	O
the	O
identification	O
of	O
the	O
gene1s	O
CTSE	O
gene1e	O
cDNA	O
clones	O
was	O
obtained	O
by	O
analysis	O
of	O
poly(A+	O
)	O
RNA	O
isolated	O
from	O
gene1s	O
CTSE	O
gene1e	O
-	O
producing	O
and	O
-nonproducing	O
gastric	O
adenocarcinoma	O
cell	O
subclones	O
.	O
Three	O
RNA	O
transcripts	O
(	O
3.6	O
,	O
2.6	O
,	O
and	O
2.1	O
kilobases	O
)	O
were	O
identified	O
in	O
poly(A+	O
)	O
RNA	O
isolated	O
from	O
a	O
gastric	O
adenocarcinoma	O
cell	O
line	O
that	O
produced	O
gene1s	O
CTSE	O
gene1e	O
that	O
were	O
absent	O
from	O
nonproducing	O
subclones	O
.	O
gene1s	O
CTSE	O
gene1e	O
contains	O
7	O
cysteine	O
residues	O
,	O
of	O
which	O
6	O
were	O
localized	O
by	O
comparative	O
maximal	O
alignment	O
analysis	O
with	O
pepsinogen	O
A	O
to	O
conserved	O
residues	O
that	O
form	O
intrachain	O
disulfide	O
bonds	O
.	O
The	O
seventh	O
cysteine	O
residue	O
of	O
gene1s	O
CTSE	O
gene1e	O
is	O
located	O
within	O
the	O
activation	O
peptide	O
region	O
of	O
the	O
proenzyme	O
.	O
We	O
suspect	O
that	O
this	O
residue	O
forms	O
an	O
interchain	O
disulfide	O
bond	O
and	O
thereby	O
determines	O
the	O
dimerization	O
of	O
gene1s	O
CTSE	O
gene1e	O
proenzyme	O
molecules	O
that	O
is	O
observed	O
under	O
native	O
conditions	O
.	O
The	O
gene1s	O
CTSE	O
gene1e	O
gene	O
was	O
localized	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
1	O
by	O
concurrent	O
cytogenetic	O
and	O
cDNA	O
probe	O
analyses	O
of	O
a	O
panel	O
of	O
species1s	O
human	O
species1e	O
x	O
arg1s	O
mouse	O
arg1e	O
somatic	O
cell	O
hybrids	O
.	O

gene1s	O
COUP	O
transcription	O
factor	O
gene1e	O
is	O
a	O
member	O
of	O
the	O
steroid	O
receptor	O
superfamily	O
.	O
The	O
gene1s	O
COUP	O
(	O
chicken	O
ovalbumin	O
upstream	O
promoter	O
)	O
transcription	O
factor	O
gene1e	O
(	O
gene1s	O
COUP	O
-	O
TF	O
gene1e	O
)	O
exists	O
in	O
a	O
number	O
of	O
different	O
tissues	O
and	O
is	O
essential	O
for	O
expression	O
of	O
the	O
arg1s	O
chicken	O
arg1e	O
ovalbumin	O
gene	O
.	O
It	O
binds	O
to	O
the	O
ovalbumin	O
promoter	O
and	O
,	O
in	O
conjunction	O
with	O
a	O
second	O
protein	O
(	O
S300-II	O
)	O
,	O
stimulates	O
initiation	O
of	O
transcription	O
in	O
vitro	O
.	O
gene1s	O
COUP	O
-	O
TF	O
gene1e	O
also	O
binds	O
specifically	O
to	O
the	O
species1s	O
rat	O
species1e	O
insulin	O
promoter	O
element	O
,	O
although	O
the	O
two	O
binding	O
sites	O
share	O
little	O
sequence	O
similarity	O
.	O
Here	O
we	O
report	O
the	O
isolation	O
of	O
a	O
species1s	O
human	O
species1e	O
complementary	O
DNA	O
clone	O
encoding	O
gene1s	O
COUP	O
-	O
TF	O
gene1e	O
.	O
Comparison	O
of	O
the	O
amino	O
-	O
acid	O
sequence	O
of	O
gene1s	O
COUP	O
-	O
TF	O
gene1e	O
with	O
known	O
sequences	O
reveals	O
that	O
it	O
is	O
a	O
member	O
of	O
the	O
steroid	O
/	O
thyroid	O
hormone	O
/	O
vitamin	O
receptor	O
superfamily	O
.	O
Consequently	O
,	O
it	O
is	O
the	O
first	O
member	O
of	O
this	O
family	O
that	O
has	O
been	O
shown	O
to	O
function	O
in	O
a	O
cell	O
-	O
free	O
transcription	O
system	O
.	O
We	O
conclude	O
that	O
this	O
superfamily	O
of	O
gene	O
regulators	O
contains	O
proteins	O
which	O
bind	O
and	O
activate	O
distal	O
promoter	O
elements	O
of	O
eukaryotic	O
genes	O
.	O

gene1s	O
COUP	O
transcription	O
factor	O
gene1e	O
is	O
a	O
member	O
of	O
the	O
steroid	O
receptor	O
superfamily	O
.	O
The	O
gene1s	O
COUP	O
(	O
chicken	O
ovalbumin	O
upstream	O
promoter	O
)	O
transcription	O
factor	O
gene1e	O
(	O
gene1s	O
COUP	O
-	O
TF	O
gene1e	O
)	O
exists	O
in	O
a	O
number	O
of	O
different	O
tissues	O
and	O
is	O
essential	O
for	O
expression	O
of	O
the	O
species1s	O
chicken	O
species1e	O
ovalbumin	O
gene	O
.	O
It	O
binds	O
to	O
the	O
ovalbumin	O
promoter	O
and	O
,	O
in	O
conjunction	O
with	O
a	O
second	O
protein	O
(	O
S300-II	O
)	O
,	O
stimulates	O
initiation	O
of	O
transcription	O
in	O
vitro	O
.	O
gene1s	O
COUP	O
-	O
TF	O
gene1e	O
also	O
binds	O
specifically	O
to	O
the	O
arg1s	O
rat	O
arg1e	O
insulin	O
promoter	O
element	O
,	O
although	O
the	O
two	O
binding	O
sites	O
share	O
little	O
sequence	O
similarity	O
.	O
Here	O
we	O
report	O
the	O
isolation	O
of	O
a	O
species1s	O
human	O
species1e	O
complementary	O
DNA	O
clone	O
encoding	O
gene1s	O
COUP	O
-	O
TF	O
gene1e	O
.	O
Comparison	O
of	O
the	O
amino	O
-	O
acid	O
sequence	O
of	O
gene1s	O
COUP	O
-	O
TF	O
gene1e	O
with	O
known	O
sequences	O
reveals	O
that	O
it	O
is	O
a	O
member	O
of	O
the	O
steroid	O
/	O
thyroid	O
hormone	O
/	O
vitamin	O
receptor	O
superfamily	O
.	O
Consequently	O
,	O
it	O
is	O
the	O
first	O
member	O
of	O
this	O
family	O
that	O
has	O
been	O
shown	O
to	O
function	O
in	O
a	O
cell	O
-	O
free	O
transcription	O
system	O
.	O
We	O
conclude	O
that	O
this	O
superfamily	O
of	O
gene	O
regulators	O
contains	O
proteins	O
which	O
bind	O
and	O
activate	O
distal	O
promoter	O
elements	O
of	O
eukaryotic	O
genes	O
.	O

gene1s	ARG2
COUP	ARG2
transcription	ARG2
factor	ARG2
gene1e	ARG2
is	O
a	O
member	O
of	O
the	O
steroid	O
receptor	O
superfamily	O
.	O
The	O
gene1s	ARG2
COUP	ARG2
(	ARG2
chicken	ARG2
ovalbumin	ARG2
upstream	ARG2
promoter	ARG2
)	ARG2
transcription	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
COUP	ARG2
-	ARG2
TF	ARG2
gene1e	ARG2
)	O
exists	O
in	O
a	O
number	O
of	O
different	O
tissues	O
and	O
is	O
essential	O
for	O
expression	O
of	O
the	O
species1s	O
chicken	O
species1e	O
ovalbumin	O
gene	O
.	O
It	O
binds	O
to	O
the	O
ovalbumin	O
promoter	O
and	O
,	O
in	O
conjunction	O
with	O
a	O
second	O
protein	O
(	O
S300-II	O
)	O
,	O
stimulates	O
initiation	O
of	O
transcription	O
in	O
vitro	O
.	O
gene1s	ARG2
COUP	ARG2
-	ARG2
TF	ARG2
gene1e	ARG2
also	O
binds	O
specifically	O
to	O
the	O
species1s	O
rat	O
species1e	O
insulin	O
promoter	O
element	O
,	O
although	O
the	O
two	O
binding	O
sites	O
share	O
little	O
sequence	O
similarity	O
.	O
Here	O
we	O
report	O
the	O
isolation	O
of	O
a	O
arg1s	O
human	O
arg1e	O
complementary	O
DNA	O
clone	O
encoding	O
gene1s	ARG2
COUP	ARG2
-	ARG2
TF	ARG2
gene1e	ARG2
.	O
Comparison	O
of	O
the	O
amino	O
-	O
acid	O
sequence	O
of	O
gene1s	ARG2
COUP	ARG2
-	ARG2
TF	ARG2
gene1e	ARG2
with	O
known	O
sequences	O
reveals	O
that	O
it	O
is	O
a	O
member	O
of	O
the	O
steroid	O
/	O
thyroid	O
hormone	O
/	O
vitamin	O
receptor	O
superfamily	O
.	O
Consequently	O
,	O
it	O
is	O
the	O
first	O
member	O
of	O
this	O
family	O
that	O
has	O
been	O
shown	O
to	O
function	O
in	O
a	O
cell	O
-	O
free	O
transcription	O
system	O
.	O
We	O
conclude	O
that	O
this	O
superfamily	O
of	O
gene	O
regulators	O
contains	O
proteins	O
which	O
bind	O
and	O
activate	O
distal	O
promoter	O
elements	O
of	O
eukaryotic	O
genes	O
.	O

Autoimmune	O
target	O
in	O
Heymann	O
nephritis	O
is	O
a	O
glycoprotein	O
with	O
homology	O
to	O
the	O
gene1s	O
LDL	O
receptor	O
gene1e	O
.	O
The	O
pathogenesis	O
of	O
Heymann	O
nephritis	O
,	O
a	O
arg1s	O
rat	O
arg1e	O
model	O
of	O
species1s	O
human	O
species1e	O
membranous	O
glomerulonephritis	O
,	O
depends	O
on	O
the	O
interaction	O
of	O
autoantibodies	O
with	O
a	O
renal	O
glycoprotein	O
(	O
gene1s	O
GP330	O
gene1e	O
)	O
on	O
glomerular	O
podocytes	O
.	O
Partial	O
complementary	O
DNAs	O
coding	O
for	O
gene1s	O
GP330	O
gene1e	O
were	O
isolated	O
and	O
sequenced	O
.	O
The	O
deduced	O
amino	O
acid	O
sequence	O
from	O
4.3	O
kilobases	O
of	O
complementary	O
DNA	O
contains	O
the	O
sequences	O
identical	O
to	O
two	O
peptides	O
derived	O
from	O
the	O
isolated	O
glycoprotein	O
.	O
The	O
deduced	O
amino	O
acid	O
sequence	O
of	O
this	O
protein	O
contains	O
regions	O
with	O
homology	O
to	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
low	O
density	O
lipoprotein	O
(	O
LDL	O
)	O
receptor	O
gene1e	O
,	O
an	O
indication	O
that	O
gene1s	O
GP330	O
gene1e	O
and	O
the	O
gene1s	O
LDL	O
receptor	O
gene1e	O
may	O
be	O
members	O
of	O
the	O
same	O
gene	O
family	O
.	O
Autoantibodies	O
from	O
the	O
kidneys	O
of	O
arg1s	O
rats	O
arg1e	O
with	O
Heymann	O
nephritis	O
reacted	O
with	O
a	O
nonglycosylated	O
segment	O
of	O
gene1s	O
GP330	O
gene1e	O
that	O
contains	O
cysteine	O
-	O
rich	O
40-amino	O
acid	O
repeats	O
,	O
which	O
are	O
also	O
features	O
of	O
the	O
gene1s	O
LDL	O
receptor	O
gene1e	O
.	O
gene1s	O
GP330	O
gene1e	O
is	O
also	O
similar	O
in	O
some	O
regions	O
to	O
the	O
species1s	O
mouse	O
species1e	O
epidermal	O
growth	O
factor	O
precursor	O
.	O

Autoimmune	O
target	O
in	O
Heymann	O
nephritis	O
is	O
a	O
glycoprotein	O
with	O
homology	O
to	O
the	O
gene1s	ARG2
LDL	ARG2
receptor	ARG2
gene1e	ARG2
.	O
The	O
pathogenesis	O
of	O
Heymann	O
nephritis	O
,	O
a	O
species1s	O
rat	O
species1e	O
model	O
of	O
arg1s	O
human	O
arg1e	O
membranous	O
glomerulonephritis	O
,	O
depends	O
on	O
the	O
interaction	O
of	O
autoantibodies	O
with	O
a	O
renal	O
glycoprotein	O
(	O
gene1s	ARG2
GP330	ARG2
gene1e	ARG2
)	O
on	O
glomerular	O
podocytes	O
.	O
Partial	O
complementary	O
DNAs	O
coding	O
for	O
gene1s	ARG2
GP330	ARG2
gene1e	ARG2
were	O
isolated	O
and	O
sequenced	O
.	O
The	O
deduced	O
amino	O
acid	O
sequence	O
from	O
4.3	O
kilobases	O
of	O
complementary	O
DNA	O
contains	O
the	O
sequences	O
identical	O
to	O
two	O
peptides	O
derived	O
from	O
the	O
isolated	O
glycoprotein	O
.	O
The	O
deduced	O
amino	O
acid	O
sequence	O
of	O
this	O
protein	O
contains	O
regions	O
with	O
homology	O
to	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
low	ARG2
density	ARG2
lipoprotein	ARG2
(	ARG2
LDL	ARG2
)	ARG2
receptor	ARG2
gene1e	ARG2
,	O
an	O
indication	O
that	O
gene1s	ARG2
GP330	ARG2
gene1e	ARG2
and	O
the	O
gene1s	ARG2
LDL	ARG2
receptor	ARG2
gene1e	ARG2
may	O
be	O
members	O
of	O
the	O
same	O
gene	O
family	O
.	O
Autoantibodies	O
from	O
the	O
kidneys	O
of	O
species1s	O
rats	O
species1e	O
with	O
Heymann	O
nephritis	O
reacted	O
with	O
a	O
nonglycosylated	O
segment	O
of	O
gene1s	ARG2
GP330	ARG2
gene1e	ARG2
that	O
contains	O
cysteine	O
-	O
rich	O
40-amino	O
acid	O
repeats	O
,	O
which	O
are	O
also	O
features	O
of	O
the	O
gene1s	ARG2
LDL	ARG2
receptor	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
GP330	ARG2
gene1e	ARG2
is	O
also	O
similar	O
in	O
some	O
regions	O
to	O
the	O
species1s	O
mouse	O
species1e	O
epidermal	O
growth	O
factor	O
precursor	O
.	O

Autoimmune	O
target	O
in	O
Heymann	O
nephritis	O
is	O
a	O
glycoprotein	O
with	O
homology	O
to	O
the	O
gene1s	O
LDL	O
receptor	O
gene1e	O
.	O
The	O
pathogenesis	O
of	O
Heymann	O
nephritis	O
,	O
a	O
species1s	O
rat	O
species1e	O
model	O
of	O
species1s	O
human	O
species1e	O
membranous	O
glomerulonephritis	O
,	O
depends	O
on	O
the	O
interaction	O
of	O
autoantibodies	O
with	O
a	O
renal	O
glycoprotein	O
(	O
gene1s	O
GP330	O
gene1e	O
)	O
on	O
glomerular	O
podocytes	O
.	O
Partial	O
complementary	O
DNAs	O
coding	O
for	O
gene1s	O
GP330	O
gene1e	O
were	O
isolated	O
and	O
sequenced	O
.	O
The	O
deduced	O
amino	O
acid	O
sequence	O
from	O
4.3	O
kilobases	O
of	O
complementary	O
DNA	O
contains	O
the	O
sequences	O
identical	O
to	O
two	O
peptides	O
derived	O
from	O
the	O
isolated	O
glycoprotein	O
.	O
The	O
deduced	O
amino	O
acid	O
sequence	O
of	O
this	O
protein	O
contains	O
regions	O
with	O
homology	O
to	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
low	O
density	O
lipoprotein	O
(	O
LDL	O
)	O
receptor	O
gene1e	O
,	O
an	O
indication	O
that	O
gene1s	O
GP330	O
gene1e	O
and	O
the	O
gene1s	O
LDL	O
receptor	O
gene1e	O
may	O
be	O
members	O
of	O
the	O
same	O
gene	O
family	O
.	O
Autoantibodies	O
from	O
the	O
kidneys	O
of	O
species1s	O
rats	O
species1e	O
with	O
Heymann	O
nephritis	O
reacted	O
with	O
a	O
nonglycosylated	O
segment	O
of	O
gene1s	O
GP330	O
gene1e	O
that	O
contains	O
cysteine	O
-	O
rich	O
40-amino	O
acid	O
repeats	O
,	O
which	O
are	O
also	O
features	O
of	O
the	O
gene1s	O
LDL	O
receptor	O
gene1e	O
.	O
gene1s	O
GP330	O
gene1e	O
is	O
also	O
similar	O
in	O
some	O
regions	O
to	O
the	O
arg1s	O
mouse	O
arg1e	O
epidermal	O
growth	O
factor	O
precursor	O
.	O

arg1s	O
Human	O
arg1e	O
gene1s	ARG2
mRNA	ARG2
polyadenylate	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
:	O
evolutionary	O
conservation	O
of	O
a	O
nucleic	O
acid	O
binding	O
motif	O
.	O
We	O
have	O
isolated	O
a	O
full	O
length	O
cDNA	O
(	O
cDNA	O
)	O
coding	O
for	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
poly(A	ARG2
)	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
.	O
The	O
cDNA	O
derived	O
73	O
kd	O
basic	O
translation	O
product	O
has	O
the	O
same	O
Mr	O
,	O
isoelectric	O
point	O
and	O
peptidic	O
map	O
as	O
the	O
gene1s	ARG2
poly(A	ARG2
)	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
.	O
DNA	O
sequence	O
analysis	O
reveals	O
a	O
70,244	O
dalton	O
protein	O
.	O
The	O
N	O
terminal	O
part	O
,	O
highly	O
homologous	O
to	O
the	O
species1s	O
yeast	O
species1e	O
gene1s	ARG2
poly(A	ARG2
)	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
,	O
is	O
sufficient	O
for	O
poly(A	O
)	O
binding	O
activity	O
.	O
This	O
domain	O
consists	O
of	O
a	O
four	O
-	O
fold	O
repeated	O
unit	O
of	O
approximately	O
80	O
amino	O
acids	O
present	O
in	O
other	O
nucleic	O
acid	O
binding	O
proteins	O
.	O
In	O
the	O
C	O
terminal	O
part	O
there	O
is	O
,	O
as	O
in	O
the	O
species1s	O
yeast	O
species1e	O
protein	O
,	O
a	O
sequence	O
of	O
approximately	O
150	O
amino	O
acids	O
,	O
rich	O
in	O
proline	O
,	O
alanine	O
and	O
glutamine	O
which	O
together	O
account	O
for	O
48	O
%	O
of	O
the	O
residues	O
.	O
A	O
2,9	O
kb	O
mRNA	O
corresponding	O
to	O
this	O
cDNA	O
has	O
been	O
detected	O
in	O
several	O
vertebrate	O
cell	O
types	O
and	O
in	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
at	O
every	O
developmental	O
stage	O
including	O
oogenesis	O
.	O

species1s	O
Human	O
species1e	O
gene1s	O
mRNA	O
polyadenylate	O
binding	O
protein	O
gene1e	O
:	O
evolutionary	O
conservation	O
of	O
a	O
nucleic	O
acid	O
binding	O
motif	O
.	O
We	O
have	O
isolated	O
a	O
full	O
length	O
cDNA	O
(	O
cDNA	O
)	O
coding	O
for	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
poly(A	O
)	O
binding	O
protein	O
gene1e	O
.	O
The	O
cDNA	O
derived	O
73	O
kd	O
basic	O
translation	O
product	O
has	O
the	O
same	O
Mr	O
,	O
isoelectric	O
point	O
and	O
peptidic	O
map	O
as	O
the	O
gene1s	O
poly(A	O
)	O
binding	O
protein	O
gene1e	O
.	O
DNA	O
sequence	O
analysis	O
reveals	O
a	O
70,244	O
dalton	O
protein	O
.	O
The	O
N	O
terminal	O
part	O
,	O
highly	O
homologous	O
to	O
the	O
arg1s	O
yeast	O
arg1e	O
gene1s	O
poly(A	O
)	O
binding	O
protein	O
gene1e	O
,	O
is	O
sufficient	O
for	O
poly(A	O
)	O
binding	O
activity	O
.	O
This	O
domain	O
consists	O
of	O
a	O
four	O
-	O
fold	O
repeated	O
unit	O
of	O
approximately	O
80	O
amino	O
acids	O
present	O
in	O
other	O
nucleic	O
acid	O
binding	O
proteins	O
.	O
In	O
the	O
C	O
terminal	O
part	O
there	O
is	O
,	O
as	O
in	O
the	O
arg1s	O
yeast	O
arg1e	O
protein	O
,	O
a	O
sequence	O
of	O
approximately	O
150	O
amino	O
acids	O
,	O
rich	O
in	O
proline	O
,	O
alanine	O
and	O
glutamine	O
which	O
together	O
account	O
for	O
48	O
%	O
of	O
the	O
residues	O
.	O
A	O
2,9	O
kb	O
mRNA	O
corresponding	O
to	O
this	O
cDNA	O
has	O
been	O
detected	O
in	O
several	O
vertebrate	O
cell	O
types	O
and	O
in	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
at	O
every	O
developmental	O
stage	O
including	O
oogenesis	O
.	O

species1s	O
Human	O
species1e	O
gene1s	O
mRNA	O
polyadenylate	O
binding	O
protein	O
gene1e	O
:	O
evolutionary	O
conservation	O
of	O
a	O
nucleic	O
acid	O
binding	O
motif	O
.	O
We	O
have	O
isolated	O
a	O
full	O
length	O
cDNA	O
(	O
cDNA	O
)	O
coding	O
for	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
poly(A	O
)	O
binding	O
protein	O
gene1e	O
.	O
The	O
cDNA	O
derived	O
73	O
kd	O
basic	O
translation	O
product	O
has	O
the	O
same	O
Mr	O
,	O
isoelectric	O
point	O
and	O
peptidic	O
map	O
as	O
the	O
gene1s	O
poly(A	O
)	O
binding	O
protein	O
gene1e	O
.	O
DNA	O
sequence	O
analysis	O
reveals	O
a	O
70,244	O
dalton	O
protein	O
.	O
The	O
N	O
terminal	O
part	O
,	O
highly	O
homologous	O
to	O
the	O
species1s	O
yeast	O
species1e	O
gene1s	O
poly(A	O
)	O
binding	O
protein	O
gene1e	O
,	O
is	O
sufficient	O
for	O
poly(A	O
)	O
binding	O
activity	O
.	O
This	O
domain	O
consists	O
of	O
a	O
four	O
-	O
fold	O
repeated	O
unit	O
of	O
approximately	O
80	O
amino	O
acids	O
present	O
in	O
other	O
nucleic	O
acid	O
binding	O
proteins	O
.	O
In	O
the	O
C	O
terminal	O
part	O
there	O
is	O
,	O
as	O
in	O
the	O
species1s	O
yeast	O
species1e	O
protein	O
,	O
a	O
sequence	O
of	O
approximately	O
150	O
amino	O
acids	O
,	O
rich	O
in	O
proline	O
,	O
alanine	O
and	O
glutamine	O
which	O
together	O
account	O
for	O
48	O
%	O
of	O
the	O
residues	O
.	O
A	O
2,9	O
kb	O
mRNA	O
corresponding	O
to	O
this	O
cDNA	O
has	O
been	O
detected	O
in	O
several	O
vertebrate	O
cell	O
types	O
and	O
in	O
arg1s	O
Drosophila	O
melanogaster	O
arg1e	O
at	O
every	O
developmental	O
stage	O
including	O
oogenesis	O
.	O

Studies	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
c	ARG2
-	ARG2
myb	ARG2
gene1e	ARG2
gene	O
and	O
its	O
product	O
in	O
arg1s	O
human	O
arg1e	O
acute	O
leukemias	O
.	O
The	O
gene1s	ARG2
myb	ARG2
gene1e	ARG2
gene	O
is	O
the	O
transforming	O
oncogene	O
of	O
the	O
species1s	O
avian	O
myeloblastosis	O
virus	O
species1e	O
(	O
species1s	O
AMV	O
species1e	O
)	O
;	O
its	O
normal	O
cellular	O
homolog	O
,	O
gene1s	ARG2
c	ARG2
-	ARG2
myb	ARG2
gene1e	ARG2
,	O
is	O
conserved	O
across	O
a	O
broad	O
span	O
of	O
evolution	O
.	O
In	O
arg1s	O
humans	O
arg1e	O
,	O
gene1s	ARG2
c	ARG2
-	ARG2
myb	ARG2
gene1e	ARG2
is	O
expressed	O
in	O
malignant	O
hematopoietic	O
cell	O
lines	O
and	O
in	O
primary	O
hematopoietic	O
tumors	O
.	O
Partial	O
complementary	O
DNA	O
clones	O
were	O
generated	O
from	O
blast	O
cells	O
of	O
arg1s	O
patients	O
arg1e	O
with	O
acute	O
myelogenous	O
leukemia	O
.	O
The	O
sequences	O
of	O
the	O
clones	O
were	O
compared	O
to	O
the	O
gene1s	ARG2
c	ARG2
-	ARG2
myb	ARG2
gene1e	ARG2
of	O
other	O
species	O
,	O
as	O
well	O
as	O
the	O
gene1s	ARG2
v	ARG2
-	ARG2
myb	ARG2
gene1e	ARG2
of	O
species1s	O
AMV	O
species1e	O
.	O
In	O
addition	O
,	O
the	O
carboxyl	O
terminal	O
region	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
c	ARG2
-	ARG2
myb	ARG2
gene1e	ARG2
was	O
placed	O
in	O
an	O
expression	O
vector	O
to	O
obtain	O
protein	O
for	O
the	O
generation	O
of	O
antiserum	O
,	O
which	O
was	O
used	O
to	O
identify	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
c	ARG2
-	ARG2
myb	ARG2
gene1e	ARG2
gene	O
product	O
.	O
Like	O
gene1s	ARG2
v	ARG2
-	ARG2
myb	ARG2
gene1e	ARG2
,	O
this	O
protein	O
was	O
found	O
within	O
the	O
nucleus	O
of	O
leukemic	O
cells	O
where	O
it	O
was	O
associated	O
with	O
the	O
nuclear	O
matrix	O
.	O
These	O
studies	O
provide	O
further	O
evidence	O
that	O
gene1s	ARG2
c	ARG2
-	ARG2
myb	ARG2
gene1e	ARG2
might	O
be	O
involved	O
in	O
arg1s	O
human	O
arg1e	O
leukemia	O
.	O

Studies	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
c	O
-	O
myb	O
gene1e	O
gene	O
and	O
its	O
product	O
in	O
species1s	O
human	O
species1e	O
acute	O
leukemias	O
.	O
The	O
gene1s	O
myb	O
gene1e	O
gene	O
is	O
the	O
transforming	O
oncogene	O
of	O
the	O
arg1s	O
avian	O
myeloblastosis	O
virus	O
arg1e	O
(	O
arg1s	O
AMV	O
arg1e	O
)	O
;	O
its	O
normal	O
cellular	O
homolog	O
,	O
gene1s	O
c	O
-	O
myb	O
gene1e	O
,	O
is	O
conserved	O
across	O
a	O
broad	O
span	O
of	O
evolution	O
.	O
In	O
species1s	O
humans	O
species1e	O
,	O
gene1s	O
c	O
-	O
myb	O
gene1e	O
is	O
expressed	O
in	O
malignant	O
hematopoietic	O
cell	O
lines	O
and	O
in	O
primary	O
hematopoietic	O
tumors	O
.	O
Partial	O
complementary	O
DNA	O
clones	O
were	O
generated	O
from	O
blast	O
cells	O
of	O
species1s	O
patients	O
species1e	O
with	O
acute	O
myelogenous	O
leukemia	O
.	O
The	O
sequences	O
of	O
the	O
clones	O
were	O
compared	O
to	O
the	O
gene1s	O
c	O
-	O
myb	O
gene1e	O
of	O
other	O
species	O
,	O
as	O
well	O
as	O
the	O
gene1s	O
v	O
-	O
myb	O
gene1e	O
of	O
arg1s	O
AMV	O
arg1e	O
.	O
In	O
addition	O
,	O
the	O
carboxyl	O
terminal	O
region	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
c	O
-	O
myb	O
gene1e	O
was	O
placed	O
in	O
an	O
expression	O
vector	O
to	O
obtain	O
protein	O
for	O
the	O
generation	O
of	O
antiserum	O
,	O
which	O
was	O
used	O
to	O
identify	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
c	O
-	O
myb	O
gene1e	O
gene	O
product	O
.	O
Like	O
gene1s	O
v	O
-	O
myb	O
gene1e	O
,	O
this	O
protein	O
was	O
found	O
within	O
the	O
nucleus	O
of	O
leukemic	O
cells	O
where	O
it	O
was	O
associated	O
with	O
the	O
nuclear	O
matrix	O
.	O
These	O
studies	O
provide	O
further	O
evidence	O
that	O
gene1s	O
c	O
-	O
myb	O
gene1e	O
might	O
be	O
involved	O
in	O
species1s	O
human	O
species1e	O
leukemia	O
.	O

Molecular	O
cloning	O
and	O
primary	O
structure	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
15-lipoxygenase	ARG2
gene1e	ARG2
.	O
A	O
full	O
-	O
length	O
cDNA	O
encoding	O
gene1s	ARG2
15-lipoxygenase	ARG2
gene1e	ARG2
has	O
been	O
isolated	O
from	O
a	O
arg1s	O
human	O
arg1e	O
reticulocyte	O
cDNA	O
library	O
.	O
The	O
predicted	O
primary	O
structure	O
of	O
the	O
enzyme	O
exhibits	O
a	O
sequence	O
similarity	O
of	O
61	O
%	O
and	O
45	O
%	O
with	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
5-lipoxygenase	ARG2
gene1e	ARG2
and	O
the	O
species1s	O
soybean	O
species1e	O
gene1s	O
lipoxygenase	O
isoenzyme	O
I	O
gene1e	O
,	O
respectively	O
.	O
When	O
all	O
three	O
lipoxygenases	O
are	O
aligned	O
,	O
there	O
are	O
two	O
distinct	O
regions	O
of	O
significant	O
sequence	O
identity	O
including	O
a	O
cluster	O
of	O
five	O
histidine	O
residues	O
conserved	O
in	O
all	O
three	O
lipoxygenases	O
.	O
Because	O
histidines	O
can	O
serve	O
as	O
ligands	O
for	O
the	O
enzymatically	O
active	O
iron	O
,	O
this	O
region	O
may	O
be	O
critical	O
to	O
enzymatic	O
function	O
.	O
These	O
results	O
provide	O
a	O
basis	O
for	O
exploring	O
functional	O
domains	O
of	O
lipoxygenases	O
.	O

Molecular	O
cloning	O
and	O
primary	O
structure	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
15-lipoxygenase	O
gene1e	O
.	O
A	O
full	O
-	O
length	O
cDNA	O
encoding	O
gene1s	O
15-lipoxygenase	O
gene1e	O
has	O
been	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
reticulocyte	O
cDNA	O
library	O
.	O
The	O
predicted	O
primary	O
structure	O
of	O
the	O
enzyme	O
exhibits	O
a	O
sequence	O
similarity	O
of	O
61	O
%	O
and	O
45	O
%	O
with	O
species1s	O
human	O
species1e	O
gene1s	O
5-lipoxygenase	O
gene1e	O
and	O
the	O
arg1s	O
soybean	O
arg1e	O
gene1s	ARG2
lipoxygenase	ARG2
isoenzyme	ARG2
I	ARG2
gene1e	ARG2
,	O
respectively	O
.	O
When	O
all	O
three	O
lipoxygenases	O
are	O
aligned	O
,	O
there	O
are	O
two	O
distinct	O
regions	O
of	O
significant	O
sequence	O
identity	O
including	O
a	O
cluster	O
of	O
five	O
histidine	O
residues	O
conserved	O
in	O
all	O
three	O
lipoxygenases	O
.	O
Because	O
histidines	O
can	O
serve	O
as	O
ligands	O
for	O
the	O
enzymatically	O
active	O
iron	O
,	O
this	O
region	O
may	O
be	O
critical	O
to	O
enzymatic	O
function	O
.	O
These	O
results	O
provide	O
a	O
basis	O
for	O
exploring	O
functional	O
domains	O
of	O
lipoxygenases	O
.	O

Isolation	O
and	O
properties	O
of	O
cDNA	O
clones	O
encoding	O
gene1s	ARG2
SRF	ARG2
gene1e	ARG2
,	O
a	O
transcription	O
factor	O
that	O
binds	O
to	O
the	O
gene1s	ARG2
c	ARG2
-	ARG2
fos	ARG2
gene1e	ARG2
serum	O
response	O
element	O
.	O
The	O
serum	O
response	O
element	O
(	O
SRE	O
)	O
is	O
a	O
sequence	O
required	O
for	O
transient	O
transcriptional	O
activation	O
of	O
genes	O
in	O
response	O
to	O
growth	O
factors	O
.	O
We	O
have	O
isolated	O
cDNA	O
clones	O
encoding	O
gene1s	ARG2
serum	ARG2
response	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SRF	ARG2
gene1e	ARG2
)	O
,	O
a	O
ubiquitous	O
nuclear	O
protein	O
that	O
binds	O
to	O
the	O
SRE	O
.	O
The	O
gene1s	ARG2
SRF	ARG2
gene1e	ARG2
gene	O
is	O
highly	O
conserved	O
through	O
evolution	O
,	O
and	O
in	O
cultured	O
cells	O
its	O
transcription	O
is	O
itself	O
transiently	O
increased	O
following	O
serum	O
stimulation	O
.	O
A	O
cDNA	O
clone	O
of	O
gene1s	ARG2
SRF	ARG2
gene1e	ARG2
expressed	O
in	O
vitro	O
generates	O
protein	O
that	O
forms	O
complexes	O
indistinguishable	O
from	O
those	O
formed	O
with	O
arg1s	O
HeLa	O
arg1e	O
cell	O
gene1s	ARG2
SRF	ARG2
gene1e	ARG2
,	O
as	O
judged	O
by	O
DNA	O
binding	O
specificity	O
and	O
the	O
ability	O
to	O
promote	O
SRE	O
-	O
dependent	O
in	O
vitro	O
transcription	O
.	O
gene1s	ARG2
SRF	ARG2
gene1e	ARG2
binds	O
DNA	O
as	O
a	O
dimer	O
,	O
and	O
the	O
DNA	O
binding	O
/	O
dimerization	O
domain	O
of	O
the	O
protein	O
exhibits	O
striking	O
homology	O
to	O
two	O
species1s	O
yeast	O
species1e	O
regulatory	O
proteins	O
.	O

Isolation	O
and	O
properties	O
of	O
cDNA	O
clones	O
encoding	O
gene1s	O
SRF	O
gene1e	O
,	O
a	O
transcription	O
factor	O
that	O
binds	O
to	O
the	O
gene1s	O
c	O
-	O
fos	O
gene1e	O
serum	O
response	O
element	O
.	O
The	O
serum	O
response	O
element	O
(	O
SRE	O
)	O
is	O
a	O
sequence	O
required	O
for	O
transient	O
transcriptional	O
activation	O
of	O
genes	O
in	O
response	O
to	O
growth	O
factors	O
.	O
We	O
have	O
isolated	O
cDNA	O
clones	O
encoding	O
gene1s	O
serum	O
response	O
factor	O
gene1e	O
(	O
gene1s	O
SRF	O
gene1e	O
)	O
,	O
a	O
ubiquitous	O
nuclear	O
protein	O
that	O
binds	O
to	O
the	O
SRE	O
.	O
The	O
gene1s	O
SRF	O
gene1e	O
gene	O
is	O
highly	O
conserved	O
through	O
evolution	O
,	O
and	O
in	O
cultured	O
cells	O
its	O
transcription	O
is	O
itself	O
transiently	O
increased	O
following	O
serum	O
stimulation	O
.	O
A	O
cDNA	O
clone	O
of	O
gene1s	O
SRF	O
gene1e	O
expressed	O
in	O
vitro	O
generates	O
protein	O
that	O
forms	O
complexes	O
indistinguishable	O
from	O
those	O
formed	O
with	O
species1s	O
HeLa	O
species1e	O
cell	O
gene1s	O
SRF	O
gene1e	O
,	O
as	O
judged	O
by	O
DNA	O
binding	O
specificity	O
and	O
the	O
ability	O
to	O
promote	O
SRE	O
-	O
dependent	O
in	O
vitro	O
transcription	O
.	O
gene1s	O
SRF	O
gene1e	O
binds	O
DNA	O
as	O
a	O
dimer	O
,	O
and	O
the	O
DNA	O
binding	O
/	O
dimerization	O
domain	O
of	O
the	O
protein	O
exhibits	O
striking	O
homology	O
to	O
two	O
arg1s	O
yeast	O
arg1e	O
regulatory	O
proteins	O
.	O

Isolation	O
of	O
cDNA	O
clones	O
coding	O
for	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
isovaleryl	ARG2
-	ARG2
CoA	ARG2
dehydrogenase	ARG2
gene1e	ARG2
and	O
assignment	O
of	O
the	O
gene	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
15	O
.	O
arg1s	O
Rat	O
arg1e	O
liver	O
mRNA	O
encoding	O
the	O
cytoplasmic	O
precursor	O
of	O
mitochondrial	O
gene1s	ARG2
isovaleryl	ARG2
-	ARG2
CoA	ARG2
dehydrogenase	ARG2
gene1e	ARG2
was	O
highly	O
enriched	O
by	O
polysome	O
immunopurification	O
using	O
a	O
polyclonal	O
monospecific	O
antibody	O
.	O
The	O
purified	O
mRNA	O
was	O
used	O
to	O
prepare	O
a	O
plasmid	O
cDNA	O
library	O
which	O
was	O
screened	O
with	O
two	O
oligonucleotide	O
mixtures	O
encoding	O
two	O
peptides	O
in	O
the	O
amino	O
-	O
terminal	O
portion	O
of	O
mature	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
isovaleryl	ARG2
-	ARG2
CoA	ARG2
dehydrogenase	ARG2
gene1e	ARG2
.	O
Thirty	O
-	O
one	O
overlapping	O
cDNA	O
clones	O
,	O
spanning	O
a	O
region	O
of	O
2.1	O
kbp	O
,	O
were	O
isolated	O
and	O
characterized	O
.	O
The	O
cDNA	O
sequence	O
of	O
a	O
5'-end	O
clone	O
,	O
rIVD-13	O
(	O
155	O
bp	O
)	O
,	O
predicts	O
a	O
mitochondrial	O
leader	O
peptide	O
of	O
30	O
amino	O
acid	O
residues	O
and	O
the	O
first	O
18	O
amino	O
acids	O
of	O
the	O
mature	O
protein	O
.	O
These	O
consecutive	O
18	O
residues	O
completely	O
matched	O
the	O
amino	O
-	O
terminal	O
peptide	O
determined	O
by	O
automated	O
Edman	O
degradation	O
of	O
the	O
arg1s	O
rat	O
arg1e	O
enzyme	O
.	O
The	O
leader	O
peptide	O
contains	O
six	O
arginines	O
,	O
has	O
no	O
acidic	O
residues	O
,	O
and	O
is	O
particularly	O
rich	O
in	O
leucine	O
,	O
alanine	O
,	O
and	O
proline	O
residues	O
.	O
Southern	O
blot	O
analysis	O
of	O
DNAs	O
from	O
species1s	O
human	O
species1e	O
-	O
rodent	O
somatic	O
cell	O
hybrids	O
with	O
an	O
isolated	O
arg1s	O
rat	O
arg1e	O
cDNA	O
(	O
2	O
kbp	O
)	O
assigned	O
the	O
gene1s	ARG2
isovaleryl	ARG2
-	ARG2
CoA	ARG2
dehydrogenase	ARG2
gene1e	ARG2
gene	O
to	O
the	O
long	O
arm	O
of	O
chromosome	O
15	O
,	O
region	O
q14	O
-	O
---qter	O
.	O
The	O
chromosomal	O
assignment	O
was	O
confirmed	O
and	O
further	O
refined	O
to	O
bands	O
q14	O
-	O
---q15	O
by	O
in	O
situ	O
hybridization	O
of	O
the	O
probe	O
to	O
species1s	O
human	O
species1e	O
metaphase	O
cells	O
.	O
This	O
location	O
differs	O
from	O
that	O
of	O
the	O
gene	O
for	O
gene1s	O
medium	O
-	O
chain	O
acyl	O
-	O
CoA	O
dehydrogenase	O
gene1e	O
,	O
a	O
closely	O
related	O
enzyme	O
,	O
which	O
has	O
been	O
previously	O
assigned	O
to	O
chromosome	O
1	O
.	O

Isolation	O
of	O
cDNA	O
clones	O
coding	O
for	O
species1s	O
rat	O
species1e	O
gene1s	O
isovaleryl	O
-	O
CoA	O
dehydrogenase	O
gene1e	O
and	O
assignment	O
of	O
the	O
gene	O
to	O
arg1s	O
human	O
arg1e	O
chromosome	O
15	O
.	O
species1s	O
Rat	O
species1e	O
liver	O
mRNA	O
encoding	O
the	O
cytoplasmic	O
precursor	O
of	O
mitochondrial	O
gene1s	O
isovaleryl	O
-	O
CoA	O
dehydrogenase	O
gene1e	O
was	O
highly	O
enriched	O
by	O
polysome	O
immunopurification	O
using	O
a	O
polyclonal	O
monospecific	O
antibody	O
.	O
The	O
purified	O
mRNA	O
was	O
used	O
to	O
prepare	O
a	O
plasmid	O
cDNA	O
library	O
which	O
was	O
screened	O
with	O
two	O
oligonucleotide	O
mixtures	O
encoding	O
two	O
peptides	O
in	O
the	O
amino	O
-	O
terminal	O
portion	O
of	O
mature	O
species1s	O
rat	O
species1e	O
gene1s	O
isovaleryl	O
-	O
CoA	O
dehydrogenase	O
gene1e	O
.	O
Thirty	O
-	O
one	O
overlapping	O
cDNA	O
clones	O
,	O
spanning	O
a	O
region	O
of	O
2.1	O
kbp	O
,	O
were	O
isolated	O
and	O
characterized	O
.	O
The	O
cDNA	O
sequence	O
of	O
a	O
5'-end	O
clone	O
,	O
rIVD-13	O
(	O
155	O
bp	O
)	O
,	O
predicts	O
a	O
mitochondrial	O
leader	O
peptide	O
of	O
30	O
amino	O
acid	O
residues	O
and	O
the	O
first	O
18	O
amino	O
acids	O
of	O
the	O
mature	O
protein	O
.	O
These	O
consecutive	O
18	O
residues	O
completely	O
matched	O
the	O
amino	O
-	O
terminal	O
peptide	O
determined	O
by	O
automated	O
Edman	O
degradation	O
of	O
the	O
species1s	O
rat	O
species1e	O
enzyme	O
.	O
The	O
leader	O
peptide	O
contains	O
six	O
arginines	O
,	O
has	O
no	O
acidic	O
residues	O
,	O
and	O
is	O
particularly	O
rich	O
in	O
leucine	O
,	O
alanine	O
,	O
and	O
proline	O
residues	O
.	O
Southern	O
blot	O
analysis	O
of	O
DNAs	O
from	O
arg1s	O
human	O
arg1e	O
-	O
rodent	O
somatic	O
cell	O
hybrids	O
with	O
an	O
isolated	O
species1s	O
rat	O
species1e	O
cDNA	O
(	O
2	O
kbp	O
)	O
assigned	O
the	O
gene1s	O
isovaleryl	O
-	O
CoA	O
dehydrogenase	O
gene1e	O
gene	O
to	O
the	O
long	O
arm	O
of	O
chromosome	O
15	O
,	O
region	O
q14	O
-	O
---qter	O
.	O
The	O
chromosomal	O
assignment	O
was	O
confirmed	O
and	O
further	O
refined	O
to	O
bands	O
q14	O
-	O
---q15	O
by	O
in	O
situ	O
hybridization	O
of	O
the	O
probe	O
to	O
arg1s	O
human	O
arg1e	O
metaphase	O
cells	O
.	O
This	O
location	O
differs	O
from	O
that	O
of	O
the	O
gene	O
for	O
gene1s	ARG2
medium	ARG2
-	ARG2
chain	ARG2
acyl	ARG2
-	ARG2
CoA	ARG2
dehydrogenase	ARG2
gene1e	ARG2
,	O
a	O
closely	O
related	O
enzyme	O
,	O
which	O
has	O
been	O
previously	O
assigned	O
to	O
chromosome	O
1	O
.	O

Molecular	O
cloning	O
of	O
a	O
cDNA	O
for	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
delta	ARG2
-	ARG2
aminolevulinate	ARG2
dehydratase	ARG2
gene1e	ARG2
.	O
A	O
cDNA	O
encoding	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
delta	ARG2
-	ARG2
aminolevulinic	ARG2
acid	ARG2
dehydratase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ALA	ARG2
-	ARG2
D	ARG2
gene1e	ARG2
;	O
EC	O
4.2.1.24	O
)	O
,	O
the	O
second	O
enzyme	O
in	O
the	O
heme	O
biosynthetic	O
pathway	O
,	O
was	O
isolated	O
from	O
a	O
arg1s	O
human	O
arg1e	O
liver	O
cDNA	O
expression	O
library	O
.	O
Of	O
the	O
original	O
17	O
clones	O
selected	O
with	O
anti	O
-	O
ALA	O
-	O
D	O
antibody	O
,	O
only	O
four	O
expressed	O
anti	O
-	O
gene1s	ARG2
ALA	ARG2
-	ARG2
D	ARG2
gene1e	ARG2
epitopes	O
as	O
assessed	O
by	O
rescreening	O
with	O
antibody	O
preabsorbed	O
with	O
purified	O
antigen	O
.	O
Subsequent	O
screening	O
of	O
the	O
antibody	O
-	O
positive	O
clones	O
with	O
mixed	O
oligodeoxynucleotide	O
(	O
oligo	O
)	O
probes	O
,	O
synthesized	O
to	O
correspond	O
to	O
arg1s	O
human	O
arg1e	O
N	O
-	O
terminal	O
and	O
species1s	O
bovine	O
species1e	O
active	O
-	O
site	O
peptide	O
sequences	O
,	O
identified	O
three	O
clones	O
which	O
hybridized	O
only	O
with	O
the	O
oligo	O
probes	O
for	O
the	O
species1s	O
bovine	O
species1e	O
amino	O
acid	O
(	O
aa	O
)	O
sequences	O
.	O
Restriction	O
endonucleases	O
analysis	O
revealed	O
that	O
these	O
three	O
clones	O
contained	O
the	O
same	O
800-bp	O
cDNA	O
insert	O
.	O
This	O
insert	O
was	O
recloned	O
into	O
species1s	O
bacteriophage	O
M13mp18	O
species1e	O
and	O
mp19	O
and	O
sequenced	O
by	O
primer	O
extension	O
.	O
The	O
aa	O
sequence	O
predicted	O
from	O
the	O
partial	O
nucleotide	O
sequence	O
was	O
found	O
to	O
be	O
essentially	O
colinear	O
with	O
the	O
sequences	O
of	O
four	O
species1s	O
bovine	O
species1e	O
gene1s	O
ALA	O
-	O
D	O
gene1e	O
peptides	O
,	O
totaling	O
35	O
non	O
-	O
overlapping	O
aa	O
residues	O
.	O

Molecular	O
cloning	O
of	O
a	O
cDNA	O
for	O
species1s	O
human	O
species1e	O
gene1s	O
delta	O
-	O
aminolevulinate	O
dehydratase	O
gene1e	O
.	O
A	O
cDNA	O
encoding	O
species1s	O
human	O
species1e	O
gene1s	O
delta	O
-	O
aminolevulinic	O
acid	O
dehydratase	O
gene1e	O
(	O
gene1s	O
ALA	O
-	O
D	O
gene1e	O
;	O
EC	O
4.2.1.24	O
)	O
,	O
the	O
second	O
enzyme	O
in	O
the	O
heme	O
biosynthetic	O
pathway	O
,	O
was	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
liver	O
cDNA	O
expression	O
library	O
.	O
Of	O
the	O
original	O
17	O
clones	O
selected	O
with	O
anti	O
-	O
ALA	O
-	O
D	O
antibody	O
,	O
only	O
four	O
expressed	O
anti	O
-	O
gene1s	O
ALA	O
-	O
D	O
gene1e	O
epitopes	O
as	O
assessed	O
by	O
rescreening	O
with	O
antibody	O
preabsorbed	O
with	O
purified	O
antigen	O
.	O
Subsequent	O
screening	O
of	O
the	O
antibody	O
-	O
positive	O
clones	O
with	O
mixed	O
oligodeoxynucleotide	O
(	O
oligo	O
)	O
probes	O
,	O
synthesized	O
to	O
correspond	O
to	O
species1s	O
human	O
species1e	O
N	O
-	O
terminal	O
and	O
arg1s	O
bovine	O
arg1e	O
active	O
-	O
site	O
peptide	O
sequences	O
,	O
identified	O
three	O
clones	O
which	O
hybridized	O
only	O
with	O
the	O
oligo	O
probes	O
for	O
the	O
arg1s	O
bovine	O
arg1e	O
amino	O
acid	O
(	O
aa	O
)	O
sequences	O
.	O
Restriction	O
endonucleases	O
analysis	O
revealed	O
that	O
these	O
three	O
clones	O
contained	O
the	O
same	O
800-bp	O
cDNA	O
insert	O
.	O
This	O
insert	O
was	O
recloned	O
into	O
species1s	O
bacteriophage	O
M13mp18	O
species1e	O
and	O
mp19	O
and	O
sequenced	O
by	O
primer	O
extension	O
.	O
The	O
aa	O
sequence	O
predicted	O
from	O
the	O
partial	O
nucleotide	O
sequence	O
was	O
found	O
to	O
be	O
essentially	O
colinear	O
with	O
the	O
sequences	O
of	O
four	O
arg1s	O
bovine	O
arg1e	O
gene1s	ARG2
ALA	ARG2
-	ARG2
D	ARG2
gene1e	ARG2
peptides	O
,	O
totaling	O
35	O
non	O
-	O
overlapping	O
aa	O
residues	O
.	O

Molecular	O
cloning	O
of	O
a	O
cDNA	O
for	O
species1s	O
human	O
species1e	O
gene1s	O
delta	O
-	O
aminolevulinate	O
dehydratase	O
gene1e	O
.	O
A	O
cDNA	O
encoding	O
species1s	O
human	O
species1e	O
gene1s	O
delta	O
-	O
aminolevulinic	O
acid	O
dehydratase	O
gene1e	O
(	O
gene1s	O
ALA	O
-	O
D	O
gene1e	O
;	O
EC	O
4.2.1.24	O
)	O
,	O
the	O
second	O
enzyme	O
in	O
the	O
heme	O
biosynthetic	O
pathway	O
,	O
was	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
liver	O
cDNA	O
expression	O
library	O
.	O
Of	O
the	O
original	O
17	O
clones	O
selected	O
with	O
anti	O
-	O
ALA	O
-	O
D	O
antibody	O
,	O
only	O
four	O
expressed	O
anti	O
-	O
gene1s	O
ALA	O
-	O
D	O
gene1e	O
epitopes	O
as	O
assessed	O
by	O
rescreening	O
with	O
antibody	O
preabsorbed	O
with	O
purified	O
antigen	O
.	O
Subsequent	O
screening	O
of	O
the	O
antibody	O
-	O
positive	O
clones	O
with	O
mixed	O
oligodeoxynucleotide	O
(	O
oligo	O
)	O
probes	O
,	O
synthesized	O
to	O
correspond	O
to	O
species1s	O
human	O
species1e	O
N	O
-	O
terminal	O
and	O
species1s	O
bovine	O
species1e	O
active	O
-	O
site	O
peptide	O
sequences	O
,	O
identified	O
three	O
clones	O
which	O
hybridized	O
only	O
with	O
the	O
oligo	O
probes	O
for	O
the	O
species1s	O
bovine	O
species1e	O
amino	O
acid	O
(	O
aa	O
)	O
sequences	O
.	O
Restriction	O
endonucleases	O
analysis	O
revealed	O
that	O
these	O
three	O
clones	O
contained	O
the	O
same	O
800-bp	O
cDNA	O
insert	O
.	O
This	O
insert	O
was	O
recloned	O
into	O
arg1s	O
bacteriophage	O
M13mp18	O
arg1e	O
and	O
mp19	O
and	O
sequenced	O
by	O
primer	O
extension	O
.	O
The	O
aa	O
sequence	O
predicted	O
from	O
the	O
partial	O
nucleotide	O
sequence	O
was	O
found	O
to	O
be	O
essentially	O
colinear	O
with	O
the	O
sequences	O
of	O
four	O
species1s	O
bovine	O
species1e	O
gene1s	O
ALA	O
-	O
D	O
gene1e	O
peptides	O
,	O
totaling	O
35	O
non	O
-	O
overlapping	O
aa	O
residues	O
.	O

arg1s	O
Human	O
arg1e	O
gene1s	ARG2
beta	ARG2
-	ARG2
nerve	ARG2
growth	ARG2
factor	ARG2
gene1e	ARG2
gene	O
sequence	O
highly	O
homologous	O
to	O
that	O
of	O
species1s	O
mouse	O
species1e	O
.	O
Nerve	O
growth	O
factor	O
(	O
NGF	O
)	O
is	O
thought	O
to	O
have	O
a	O
profound	O
effect	O
on	O
the	O
development	O
and	O
maintenance	O
of	O
sympathetic	O
and	O
embryonic	O
sensory	O
neurones	O
(	O
see	O
refs	O
1	O
-	O
3	O
for	O
review	O
)	O
.	O
NGF	O
activity	O
isolated	O
from	O
the	O
male	O
species1s	O
mouse	O
species1e	O
submaxillary	O
gland	O
(	O
MSG	O
)	O
consists	O
of	O
three	O
types	O
of	O
subunits	O
,	O
alpha	O
,	O
beta	O
and	O
gamma	O
,	O
which	O
specifically	O
interact	O
to	O
form	O
a	O
7S	O
,	O
approximately	O
130,000-molecular	O
weight	O
(	O
Mr	O
)	O
complex	O
.	O
The	O
7S	O
complex	O
contains	O
two	O
identical	O
118-amino	O
acid	O
beta	O
-	O
chains	O
,	O
which	O
are	O
solely	O
responsible	O
for	O
the	O
nerve	O
growth	O
-	O
stimulating	O
activity	O
of	O
NGF	O
.	O
While	O
NGF	O
is	O
found	O
in	O
almost	O
all	O
vertebrates	O
,	O
most	O
research	O
has	O
focused	O
on	O
species1s	O
murine	O
species1e	O
NGF	O
,	O
as	O
the	O
species1s	O
mouse	O
species1e	O
male	O
submaxillary	O
gland	O
contains	O
higher	O
levels	O
of	O
this	O
polypeptide	O
than	O
other	O
tissues	O
.	O
Even	O
so	O
,	O
gene1s	ARG2
beta	ARG2
-	ARG2
NGF	ARG2
gene1e	ARG2
comprises	O
only	O
approximately	O
0.1	O
%	O
of	O
the	O
protein	O
in	O
this	O
small	O
gland	O
,	O
which	O
has	O
made	O
the	O
study	O
of	O
this	O
polypeptide	O
difficult	O
.	O
The	O
amino	O
acid	O
sequence	O
of	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
NGF	O
beta	O
gene1e	O
-	O
chain	O
has	O
been	O
determined	O
and	O
some	O
information	O
has	O
been	O
obtained	O
regarding	O
the	O
size	O
of	O
a	O
species1s	O
mouse	O
species1e	O
precursor	O
molecule	O
,	O
pro	O
-	O
gene1s	ARG2
beta	ARG2
-	ARG2
NGF	ARG2
gene1e	ARG2
,	O
but	O
little	O
was	O
known	O
about	O
the	O
structure	O
and	O
relatedness	O
of	O
gene1s	ARG2
beta	ARG2
-	ARG2
NGF	ARG2
gene1e	ARG2
from	O
other	O
vertebrates	O
.	O
Here	O
we	O
describe	O
the	O
isolation	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	O
beta	O
-	O
NGF	O
gene1e	O
complementary	O
DNA	O
(	O
cDNA	O
)	O
and	O
present	O
its	O
nucleotide	O
sequence	O
,	O
which	O
predicts	O
a	O
prepro	O
-	O
gene1s	ARG2
beta	ARG2
-	ARG2
NGF	ARG2
gene1e	ARG2
molecule	O
of	O
Mr	O
27,000	O
(	O
27	O
K	O
)	O
and	O
a	O
pro	O
-	O
gene1s	ARG2
beta	ARG2
-	ARG2
NGF	ARG2
gene1e	ARG2
molecule	O
of	O
Mr	O
25K.	O
We	O
have	O
used	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
beta	O
-	O
NGF	O
gene1e	O
cDNA	O
clone	O
to	O
isolate	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
beta	ARG2
-	ARG2
NGF	ARG2
gene1e	ARG2
gene	O
,	O
the	O
coding	O
regions	O
of	O
which	O
are	O
highly	O
homologous	O
to	O
the	O
species1s	O
mouse	O
species1e	O
prepro	O
-	O
gene1s	O
beta	O
-	O
NGF	O
gene1e	O
nucleotide	O
and	O
amino	O
acid	O
sequences	O
.	O

species1s	O
Human	O
species1e	O
gene1s	O
beta	O
-	O
nerve	O
growth	O
factor	O
gene1e	O
gene	O
sequence	O
highly	O
homologous	O
to	O
that	O
of	O
arg1s	O
mouse	O
arg1e	O
.	O
Nerve	O
growth	O
factor	O
(	O
NGF	O
)	O
is	O
thought	O
to	O
have	O
a	O
profound	O
effect	O
on	O
the	O
development	O
and	O
maintenance	O
of	O
sympathetic	O
and	O
embryonic	O
sensory	O
neurones	O
(	O
see	O
refs	O
1	O
-	O
3	O
for	O
review	O
)	O
.	O
NGF	O
activity	O
isolated	O
from	O
the	O
male	O
arg1s	O
mouse	O
arg1e	O
submaxillary	O
gland	O
(	O
MSG	O
)	O
consists	O
of	O
three	O
types	O
of	O
subunits	O
,	O
alpha	O
,	O
beta	O
and	O
gamma	O
,	O
which	O
specifically	O
interact	O
to	O
form	O
a	O
7S	O
,	O
approximately	O
130,000-molecular	O
weight	O
(	O
Mr	O
)	O
complex	O
.	O
The	O
7S	O
complex	O
contains	O
two	O
identical	O
118-amino	O
acid	O
beta	O
-	O
chains	O
,	O
which	O
are	O
solely	O
responsible	O
for	O
the	O
nerve	O
growth	O
-	O
stimulating	O
activity	O
of	O
NGF	O
.	O
While	O
NGF	O
is	O
found	O
in	O
almost	O
all	O
vertebrates	O
,	O
most	O
research	O
has	O
focused	O
on	O
arg1s	O
murine	O
arg1e	O
NGF	O
,	O
as	O
the	O
arg1s	O
mouse	O
arg1e	O
male	O
submaxillary	O
gland	O
contains	O
higher	O
levels	O
of	O
this	O
polypeptide	O
than	O
other	O
tissues	O
.	O
Even	O
so	O
,	O
gene1s	O
beta	O
-	O
NGF	O
gene1e	O
comprises	O
only	O
approximately	O
0.1	O
%	O
of	O
the	O
protein	O
in	O
this	O
small	O
gland	O
,	O
which	O
has	O
made	O
the	O
study	O
of	O
this	O
polypeptide	O
difficult	O
.	O
The	O
amino	O
acid	O
sequence	O
of	O
the	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
NGF	ARG2
beta	ARG2
gene1e	ARG2
-	O
chain	O
has	O
been	O
determined	O
and	O
some	O
information	O
has	O
been	O
obtained	O
regarding	O
the	O
size	O
of	O
a	O
arg1s	O
mouse	O
arg1e	O
precursor	O
molecule	O
,	O
pro	O
-	O
gene1s	O
beta	O
-	O
NGF	O
gene1e	O
,	O
but	O
little	O
was	O
known	O
about	O
the	O
structure	O
and	O
relatedness	O
of	O
gene1s	O
beta	O
-	O
NGF	O
gene1e	O
from	O
other	O
vertebrates	O
.	O
Here	O
we	O
describe	O
the	O
isolation	O
of	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
beta	ARG2
-	ARG2
NGF	ARG2
gene1e	ARG2
complementary	O
DNA	O
(	O
cDNA	O
)	O
and	O
present	O
its	O
nucleotide	O
sequence	O
,	O
which	O
predicts	O
a	O
prepro	O
-	O
gene1s	O
beta	O
-	O
NGF	O
gene1e	O
molecule	O
of	O
Mr	O
27,000	O
(	O
27	O
K	O
)	O
and	O
a	O
pro	O
-	O
gene1s	O
beta	O
-	O
NGF	O
gene1e	O
molecule	O
of	O
Mr	O
25K.	O
We	O
have	O
used	O
the	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
beta	ARG2
-	ARG2
NGF	ARG2
gene1e	ARG2
cDNA	O
clone	O
to	O
isolate	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
beta	O
-	O
NGF	O
gene1e	O
gene	O
,	O
the	O
coding	O
regions	O
of	O
which	O
are	O
highly	O
homologous	O
to	O
the	O
arg1s	O
mouse	O
arg1e	O
prepro	O
-	O
gene1s	ARG2
beta	ARG2
-	ARG2
NGF	ARG2
gene1e	ARG2
nucleotide	O
and	O
amino	O
acid	O
sequences	O
.	O

Cloning	O
and	O
characterization	O
of	O
a	O
gene1s	ARG2
cellular	ARG2
apoptosis	ARG2
susceptibility	ARG2
gene	ARG2
gene1e	ARG2
,	O
the	O
arg1s	O
human	O
arg1e	O
homologue	O
to	O
the	O
species1s	O
yeast	O
species1e	O
chromosome	O
segregation	O
gene	O
gene1s	O
CSE1	O
gene1e	O
.	O
We	O
recently	O
isolated	O
arg1s	O
human	O
arg1e	O
cDNA	O
fragments	O
that	O
render	O
arg1s	O
MCF-7	O
arg1e	O
breast	O
cancer	O
cells	O
resistant	O
to	O
cell	O
death	O
caused	O
by	O
Pseudomonas	O
exotoxin	O
,	O
Pseudomonas	O
exotoxin	O
-	O
derived	O
immunotoxins	O
,	O
diphtheria	O
toxin	O
,	O
and	O
tumor	O
necrosis	O
factor	O
.	O
We	O
report	O
here	O
that	O
one	O
of	O
these	O
fragments	O
is	O
an	O
antisense	O
fragment	O
of	O
a	O
gene	O
homologous	O
to	O
the	O
essential	O
species1s	O
yeast	O
species1e	O
chromosome	O
segregation	O
gene	O
gene1s	O
CSE1	O
gene1e	O
.	O
Cloning	O
and	O
analysis	O
of	O
the	O
full	O
-	O
length	O
cDNA	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	O
CSE1	O
gene1e	O
homologue	O
,	O
which	O
we	O
name	O
gene1s	ARG2
CAS	ARG2
gene1e	ARG2
for	O
gene1s	ARG2
cellular	ARG2
apoptosis	ARG2
susceptibility	ARG2
gene	ARG2
gene1e	ARG2
,	O
reveals	O
a	O
protein	O
coding	O
region	O
with	O
similar	O
length	O
(	O
971	O
amino	O
acids	O
for	O
gene1s	ARG2
CAS	ARG2
gene1e	ARG2
,	O
960	O
amino	O
acids	O
for	O
gene1s	O
CSE1	O
gene1e	O
)	O
and	O
59	O
%	O
overall	O
protein	O
homology	O
to	O
the	O
species1s	O
yeast	O
species1e	O
gene1s	O
CSE1	O
gene1e	O
protein	O
.	O
The	O
conservation	O
of	O
this	O
gene	O
indicates	O
it	O
has	O
an	O
important	O
function	O
in	O
arg1s	O
human	O
arg1e	O
cells	O
consistent	O
with	O
the	O
essential	O
role	O
of	O
gene1s	O
CSE1	O
gene1e	O
in	O
species1s	O
yeast	O
species1e	O
.	O
gene1s	ARG2
CAS	ARG2
gene1e	ARG2
is	O
highly	O
expressed	O
in	O
arg1s	O
human	O
arg1e	O
tumor	O
cell	O
lines	O
and	O
in	O
arg1s	O
human	O
arg1e	O
testis	O
and	O
fetal	O
liver	O
,	O
tissues	O
that	O
contain	O
actively	O
dividing	O
cells	O
.	O
Furthermore	O
,	O
gene1s	ARG2
CAS	ARG2
gene1e	ARG2
expression	O
increases	O
when	O
resting	O
arg1s	O
human	O
arg1e	O
fibroblasts	O
are	O
induced	O
to	O
proliferate	O
and	O
decreases	O
when	O
they	O
are	O
growth	O
-	O
arrested	O
.	O
Thus	O
,	O
gene1s	ARG2
CAS	ARG2
gene1e	ARG2
appears	O
to	O
play	O
an	O
important	O
role	O
in	O
both	O
toxin	O
and	O
tumor	O
necrosis	O
factor	O
-	O
mediated	O
cell	O
death	O
,	O
as	O
well	O
as	O
in	O
cell	O
proliferation	O
.	O

Cloning	O
and	O
characterization	O
of	O
a	O
gene1s	O
cellular	O
apoptosis	O
susceptibility	O
gene	O
gene1e	O
,	O
the	O
species1s	O
human	O
species1e	O
homologue	O
to	O
the	O
arg1s	O
yeast	O
arg1e	O
chromosome	O
segregation	O
gene	O
gene1s	ARG2
CSE1	ARG2
gene1e	ARG2
.	O
We	O
recently	O
isolated	O
species1s	O
human	O
species1e	O
cDNA	O
fragments	O
that	O
render	O
species1s	O
MCF-7	O
species1e	O
breast	O
cancer	O
cells	O
resistant	O
to	O
cell	O
death	O
caused	O
by	O
Pseudomonas	O
exotoxin	O
,	O
Pseudomonas	O
exotoxin	O
-	O
derived	O
immunotoxins	O
,	O
diphtheria	O
toxin	O
,	O
and	O
tumor	O
necrosis	O
factor	O
.	O
We	O
report	O
here	O
that	O
one	O
of	O
these	O
fragments	O
is	O
an	O
antisense	O
fragment	O
of	O
a	O
gene	O
homologous	O
to	O
the	O
essential	O
arg1s	O
yeast	O
arg1e	O
chromosome	O
segregation	O
gene	O
gene1s	ARG2
CSE1	ARG2
gene1e	ARG2
.	O
Cloning	O
and	O
analysis	O
of	O
the	O
full	O
-	O
length	O
cDNA	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	ARG2
CSE1	ARG2
gene1e	ARG2
homologue	O
,	O
which	O
we	O
name	O
gene1s	O
CAS	O
gene1e	O
for	O
gene1s	O
cellular	O
apoptosis	O
susceptibility	O
gene	O
gene1e	O
,	O
reveals	O
a	O
protein	O
coding	O
region	O
with	O
similar	O
length	O
(	O
971	O
amino	O
acids	O
for	O
gene1s	O
CAS	O
gene1e	O
,	O
960	O
amino	O
acids	O
for	O
gene1s	ARG2
CSE1	ARG2
gene1e	ARG2
)	O
and	O
59	O
%	O
overall	O
protein	O
homology	O
to	O
the	O
arg1s	O
yeast	O
arg1e	O
gene1s	ARG2
CSE1	ARG2
gene1e	ARG2
protein	O
.	O
The	O
conservation	O
of	O
this	O
gene	O
indicates	O
it	O
has	O
an	O
important	O
function	O
in	O
species1s	O
human	O
species1e	O
cells	O
consistent	O
with	O
the	O
essential	O
role	O
of	O
gene1s	ARG2
CSE1	ARG2
gene1e	ARG2
in	O
arg1s	O
yeast	O
arg1e	O
.	O
gene1s	O
CAS	O
gene1e	O
is	O
highly	O
expressed	O
in	O
species1s	O
human	O
species1e	O
tumor	O
cell	O
lines	O
and	O
in	O
species1s	O
human	O
species1e	O
testis	O
and	O
fetal	O
liver	O
,	O
tissues	O
that	O
contain	O
actively	O
dividing	O
cells	O
.	O
Furthermore	O
,	O
gene1s	O
CAS	O
gene1e	O
expression	O
increases	O
when	O
resting	O
species1s	O
human	O
species1e	O
fibroblasts	O
are	O
induced	O
to	O
proliferate	O
and	O
decreases	O
when	O
they	O
are	O
growth	O
-	O
arrested	O
.	O
Thus	O
,	O
gene1s	O
CAS	O
gene1e	O
appears	O
to	O
play	O
an	O
important	O
role	O
in	O
both	O
toxin	O
and	O
tumor	O
necrosis	O
factor	O
-	O
mediated	O
cell	O
death	O
,	O
as	O
well	O
as	O
in	O
cell	O
proliferation	O
.	O

Molecular	O
cloning	O
of	O
the	O
arg1s	O
human	O
arg1e	O
homolog	O
of	O
a	O
gene1s	ARG2
striatum	ARG2
-	ARG2
enriched	ARG2
phosphatase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
STEP	ARG2
gene1e	ARG2
)	O
gene	O
and	O
chromosomal	O
mapping	O
of	O
the	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
murine	O
species1e	O
loci	O
.	O
A	O
gene	O
for	O
a	O
protein	O
tyrosine	O
phosphatase	O
(	O
PTPase	O
)	O
was	O
isolated	O
from	O
a	O
arg1s	O
human	O
arg1e	O
fetal	O
brain	O
cDNA	O
library	O
by	O
PCR	O
amplification	O
.	O
Sequence	O
analysis	O
revealed	O
that	O
the	O
PTPase	O
has	O
a	O
single	O
phosphatase	O
catalytic	O
domain	O
located	O
at	O
the	O
C	O
-	O
terminus	O
that	O
includes	O
the	O
highly	O
conserved	O
amino	O
acid	O
domain	O
[	O
I	O
/	O
V]HCXAGXXR[S	O
/	O
T]GX[F	O
/	O
Y	O
]	O
found	O
in	O
all	O
tyrosine	O
phosphatases	O
.	O
Two	O
proline	O
-	O
rich	O
regions	O
located	O
at	O
the	O
N	O
-	O
terminus	O
may	O
contain	O
putative	O
Src	O
homology	O
domain	O
3	O
(	O
SH3	O
)	O
binding	O
motifs	O
.	O
Comparison	O
of	O
the	O
PTPase	O
with	O
a	O
previously	O
cloned	O
gene1s	O
striatum	O
enriched	O
phosphatase	O
gene1e	O
(	O
gene1s	O
STEP	O
gene1e	O
)	O
from	O
species1s	O
rat	O
species1e	O
and	O
from	O
species1s	O
mouse	O
species1e	O
exhibited	O
a	O
high	O
degree	O
of	O
identity	O
(	O
approximately	O
85	O
-	O
90	O
%	O
)	O
at	O
both	O
the	O
nucleotide	O
and	O
the	O
amino	O
acid	O
levels	O
,	O
indicating	O
that	O
the	O
arg1s	O
human	O
arg1e	O
PTPase	O
is	O
the	O
homolog	O
of	O
the	O
species1s	O
rat	O
species1e	O
and	O
species1s	O
murine	O
species1e	O
gene1s	O
STEP	O
gene1e	O
gene	O
.	O
By	O
using	O
a	O
combination	O
of	O
somatic	O
cell	O
hybrid	O
analysis	O
and	O
fluorescence	O
in	O
situ	O
hybridization	O
,	O
we	O
have	O
mapped	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
STEP	ARG2
gene1e	ARG2
locus	O
to	O
chromosome	O
11p15.2-p15.1	O
and	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
STEP	O
gene1e	O
gene	O
to	O
chromosome	O
7B3-B5	O
.	O
These	O
are	O
two	O
regions	O
of	O
known	O
conserved	O
synteny	O
,	O
providing	O
further	O
evidence	O
that	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
STEP	ARG2
gene1e	ARG2
is	O
a	O
true	O
homolog	O
of	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
STEP	O
gene1e	O
gene	O
.	O
Candidate	O
disease	O
genes	O
in	O
the	O
vicinity	O
include	O
Usher	O
syndrome	O
type	O
1C	O
in	O
arg1s	O
human	O
arg1e	O
and	O
a	O
species1s	O
mouse	O
species1e	O
mutant	O
locus	O
,	O
species1s	O
twister	O
species1e	O
(	O
species1s	O
twt	O
species1e	O
)	O
.	O

Molecular	O
cloning	O
of	O
the	O
species1s	O
human	O
species1e	O
homolog	O
of	O
a	O
gene1s	O
striatum	O
-	O
enriched	O
phosphatase	O
gene1e	O
(	O
gene1s	O
STEP	O
gene1e	O
)	O
gene	O
and	O
chromosomal	O
mapping	O
of	O
the	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
murine	O
arg1e	O
loci	O
.	O
A	O
gene	O
for	O
a	O
protein	O
tyrosine	O
phosphatase	O
(	O
PTPase	O
)	O
was	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
fetal	O
brain	O
cDNA	O
library	O
by	O
PCR	O
amplification	O
.	O
Sequence	O
analysis	O
revealed	O
that	O
the	O
PTPase	O
has	O
a	O
single	O
phosphatase	O
catalytic	O
domain	O
located	O
at	O
the	O
C	O
-	O
terminus	O
that	O
includes	O
the	O
highly	O
conserved	O
amino	O
acid	O
domain	O
[	O
I	O
/	O
V]HCXAGXXR[S	O
/	O
T]GX[F	O
/	O
Y	O
]	O
found	O
in	O
all	O
tyrosine	O
phosphatases	O
.	O
Two	O
proline	O
-	O
rich	O
regions	O
located	O
at	O
the	O
N	O
-	O
terminus	O
may	O
contain	O
putative	O
Src	O
homology	O
domain	O
3	O
(	O
SH3	O
)	O
binding	O
motifs	O
.	O
Comparison	O
of	O
the	O
PTPase	O
with	O
a	O
previously	O
cloned	O
gene1s	ARG2
striatum	ARG2
enriched	ARG2
phosphatase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
STEP	ARG2
gene1e	ARG2
)	O
from	O
species1s	O
rat	O
species1e	O
and	O
from	O
arg1s	O
mouse	O
arg1e	O
exhibited	O
a	O
high	O
degree	O
of	O
identity	O
(	O
approximately	O
85	O
-	O
90	O
%	O
)	O
at	O
both	O
the	O
nucleotide	O
and	O
the	O
amino	O
acid	O
levels	O
,	O
indicating	O
that	O
the	O
species1s	O
human	O
species1e	O
PTPase	O
is	O
the	O
homolog	O
of	O
the	O
species1s	O
rat	O
species1e	O
and	O
arg1s	O
murine	O
arg1e	O
gene1s	ARG2
STEP	ARG2
gene1e	ARG2
gene	O
.	O
By	O
using	O
a	O
combination	O
of	O
somatic	O
cell	O
hybrid	O
analysis	O
and	O
fluorescence	O
in	O
situ	O
hybridization	O
,	O
we	O
have	O
mapped	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
STEP	O
gene1e	O
locus	O
to	O
chromosome	O
11p15.2-p15.1	O
and	O
the	O
arg1s	O
murine	O
arg1e	O
gene1s	ARG2
STEP	ARG2
gene1e	ARG2
gene	O
to	O
chromosome	O
7B3-B5	O
.	O
These	O
are	O
two	O
regions	O
of	O
known	O
conserved	O
synteny	O
,	O
providing	O
further	O
evidence	O
that	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
STEP	O
gene1e	O
is	O
a	O
true	O
homolog	O
of	O
the	O
arg1s	O
murine	O
arg1e	O
gene1s	ARG2
STEP	ARG2
gene1e	ARG2
gene	O
.	O
Candidate	O
disease	O
genes	O
in	O
the	O
vicinity	O
include	O
Usher	O
syndrome	O
type	O
1C	O
in	O
species1s	O
human	O
species1e	O
and	O
a	O
arg1s	O
mouse	O
arg1e	O
mutant	O
locus	O
,	O
species1s	O
twister	O
species1e	O
(	O
species1s	O
twt	O
species1e	O
)	O
.	O

Molecular	O
cloning	O
of	O
the	O
species1s	O
human	O
species1e	O
homolog	O
of	O
a	O
gene1s	O
striatum	O
-	O
enriched	O
phosphatase	O
gene1e	O
(	O
gene1s	O
STEP	O
gene1e	O
)	O
gene	O
and	O
chromosomal	O
mapping	O
of	O
the	O
species1s	O
human	O
species1e	O
and	O
species1s	O
murine	O
species1e	O
loci	O
.	O
A	O
gene	O
for	O
a	O
protein	O
tyrosine	O
phosphatase	O
(	O
PTPase	O
)	O
was	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
fetal	O
brain	O
cDNA	O
library	O
by	O
PCR	O
amplification	O
.	O
Sequence	O
analysis	O
revealed	O
that	O
the	O
PTPase	O
has	O
a	O
single	O
phosphatase	O
catalytic	O
domain	O
located	O
at	O
the	O
C	O
-	O
terminus	O
that	O
includes	O
the	O
highly	O
conserved	O
amino	O
acid	O
domain	O
[	O
I	O
/	O
V]HCXAGXXR[S	O
/	O
T]GX[F	O
/	O
Y	O
]	O
found	O
in	O
all	O
tyrosine	O
phosphatases	O
.	O
Two	O
proline	O
-	O
rich	O
regions	O
located	O
at	O
the	O
N	O
-	O
terminus	O
may	O
contain	O
putative	O
Src	O
homology	O
domain	O
3	O
(	O
SH3	O
)	O
binding	O
motifs	O
.	O
Comparison	O
of	O
the	O
PTPase	O
with	O
a	O
previously	O
cloned	O
gene1s	ARG2
striatum	ARG2
enriched	ARG2
phosphatase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
STEP	ARG2
gene1e	ARG2
)	O
from	O
arg1s	O
rat	O
arg1e	O
and	O
from	O
species1s	O
mouse	O
species1e	O
exhibited	O
a	O
high	O
degree	O
of	O
identity	O
(	O
approximately	O
85	O
-	O
90	O
%	O
)	O
at	O
both	O
the	O
nucleotide	O
and	O
the	O
amino	O
acid	O
levels	O
,	O
indicating	O
that	O
the	O
species1s	O
human	O
species1e	O
PTPase	O
is	O
the	O
homolog	O
of	O
the	O
arg1s	O
rat	O
arg1e	O
and	O
species1s	O
murine	O
species1e	O
gene1s	ARG2
STEP	ARG2
gene1e	ARG2
gene	O
.	O
By	O
using	O
a	O
combination	O
of	O
somatic	O
cell	O
hybrid	O
analysis	O
and	O
fluorescence	O
in	O
situ	O
hybridization	O
,	O
we	O
have	O
mapped	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
STEP	O
gene1e	O
locus	O
to	O
chromosome	O
11p15.2-p15.1	O
and	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
STEP	O
gene1e	O
gene	O
to	O
chromosome	O
7B3-B5	O
.	O
These	O
are	O
two	O
regions	O
of	O
known	O
conserved	O
synteny	O
,	O
providing	O
further	O
evidence	O
that	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
STEP	O
gene1e	O
is	O
a	O
true	O
homolog	O
of	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
STEP	O
gene1e	O
gene	O
.	O
Candidate	O
disease	O
genes	O
in	O
the	O
vicinity	O
include	O
Usher	O
syndrome	O
type	O
1C	O
in	O
species1s	O
human	O
species1e	O
and	O
a	O
species1s	O
mouse	O
species1e	O
mutant	O
locus	O
,	O
species1s	O
twister	O
species1e	O
(	O
species1s	O
twt	O
species1e	O
)	O
.	O

Molecular	O
cloning	O
of	O
the	O
species1s	O
human	O
species1e	O
homolog	O
of	O
a	O
gene1s	O
striatum	O
-	O
enriched	O
phosphatase	O
gene1e	O
(	O
gene1s	O
STEP	O
gene1e	O
)	O
gene	O
and	O
chromosomal	O
mapping	O
of	O
the	O
species1s	O
human	O
species1e	O
and	O
species1s	O
murine	O
species1e	O
loci	O
.	O
A	O
gene	O
for	O
a	O
protein	O
tyrosine	O
phosphatase	O
(	O
PTPase	O
)	O
was	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
fetal	O
brain	O
cDNA	O
library	O
by	O
PCR	O
amplification	O
.	O
Sequence	O
analysis	O
revealed	O
that	O
the	O
PTPase	O
has	O
a	O
single	O
phosphatase	O
catalytic	O
domain	O
located	O
at	O
the	O
C	O
-	O
terminus	O
that	O
includes	O
the	O
highly	O
conserved	O
amino	O
acid	O
domain	O
[	O
I	O
/	O
V]HCXAGXXR[S	O
/	O
T]GX[F	O
/	O
Y	O
]	O
found	O
in	O
all	O
tyrosine	O
phosphatases	O
.	O
Two	O
proline	O
-	O
rich	O
regions	O
located	O
at	O
the	O
N	O
-	O
terminus	O
may	O
contain	O
putative	O
Src	O
homology	O
domain	O
3	O
(	O
SH3	O
)	O
binding	O
motifs	O
.	O
Comparison	O
of	O
the	O
PTPase	O
with	O
a	O
previously	O
cloned	O
gene1s	O
striatum	O
enriched	O
phosphatase	O
gene1e	O
(	O
gene1s	O
STEP	O
gene1e	O
)	O
from	O
species1s	O
rat	O
species1e	O
and	O
from	O
species1s	O
mouse	O
species1e	O
exhibited	O
a	O
high	O
degree	O
of	O
identity	O
(	O
approximately	O
85	O
-	O
90	O
%	O
)	O
at	O
both	O
the	O
nucleotide	O
and	O
the	O
amino	O
acid	O
levels	O
,	O
indicating	O
that	O
the	O
species1s	O
human	O
species1e	O
PTPase	O
is	O
the	O
homolog	O
of	O
the	O
species1s	O
rat	O
species1e	O
and	O
species1s	O
murine	O
species1e	O
gene1s	O
STEP	O
gene1e	O
gene	O
.	O
By	O
using	O
a	O
combination	O
of	O
somatic	O
cell	O
hybrid	O
analysis	O
and	O
fluorescence	O
in	O
situ	O
hybridization	O
,	O
we	O
have	O
mapped	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
STEP	O
gene1e	O
locus	O
to	O
chromosome	O
11p15.2-p15.1	O
and	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
STEP	O
gene1e	O
gene	O
to	O
chromosome	O
7B3-B5	O
.	O
These	O
are	O
two	O
regions	O
of	O
known	O
conserved	O
synteny	O
,	O
providing	O
further	O
evidence	O
that	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
STEP	O
gene1e	O
is	O
a	O
true	O
homolog	O
of	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
STEP	O
gene1e	O
gene	O
.	O
Candidate	O
disease	O
genes	O
in	O
the	O
vicinity	O
include	O
Usher	O
syndrome	O
type	O
1C	O
in	O
species1s	O
human	O
species1e	O
and	O
a	O
species1s	O
mouse	O
species1e	O
mutant	O
locus	O
,	O
arg1s	O
twister	O
arg1e	O
(	O
arg1s	O
twt	O
arg1e	O
)	O
.	O

Cloning	O
of	O
the	O
cDNA	O
for	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
ATP	ARG2
synthase	ARG2
OSCP	ARG2
subunit	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ATP5O	ARG2
gene1e	ARG2
)	O
by	O
exon	O
trapping	O
and	O
mapping	O
to	O
chromosome	O
21q22.1-q22.2	O
.	O
Exon	O
trapping	O
was	O
used	O
to	O
clone	O
portions	O
of	O
potential	O
genes	O
from	O
arg1s	O
human	O
arg1e	O
chromosome	O
21	O
.	O
One	O
trapped	O
sequence	O
showed	O
striking	O
homology	O
with	O
the	O
species1s	O
bovine	O
species1e	O
and	O
species1s	O
rat	O
species1e	O
gene1s	O
ATP	O
synthase	O
OSCP	O
gene1e	O
(	O
oligomycin	O
sensitivity	O
conferring	O
protein	O
)	O
subunit	O
.	O
We	O
subsequently	O
cloned	O
the	O
full	O
-	O
length	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
ATP	ARG2
synthase	ARG2
OSCP	ARG2
gene1e	ARG2
cDNA	O
(	O
GDB	O
/	O
HGMW	O
approved	O
name	O
gene1s	ARG2
ATP50	ARG2
gene1e	ARG2
)	O
from	O
infant	O
brain	O
and	O
muscle	O
libraries	O
and	O
determined	O
its	O
nucleotide	O
and	O
deduced	O
amino	O
acid	O
sequence	O
(	O
EMBL	O
/	O
GenBank	O
Accession	O
No	O
.	O
X83218	O
)	O
.	O
The	O
encoded	O
polypeptide	O
contains	O
213	O
amino	O
acids	O
,	O
with	O
more	O
than	O
80	O
%	O
identity	O
to	O
species1s	O
bovine	O
species1e	O
and	O
species1s	O
murine	O
species1e	O
gene1s	O
ATPase	O
OSCP	O
gene1e	O
subunits	O
and	O
over	O
35	O
%	O
identity	O
to	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
and	O
species1s	O
sweet	O
potato	O
species1e	O
sequences	O
.	O
The	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
ATP5O	ARG2
gene1e	ARG2
gene	O
is	O
located	O
at	O
21q22.1-q22.2	O
,	O
just	O
proximal	O
to	O
D21S17	O
,	O
in	O
YACs	O
860G11	O
and	O
838C7	O
of	O
the	O
Chumakov	O
et	O
al	O
.	O
(	O
Nature	O
359:380	O
,	O
1992	O
)	O
YAC	O
contig	O
.	O
The	O
gene	O
is	O
expressed	O
in	O
all	O
arg1s	O
human	O
arg1e	O
tissues	O
examined	O
,	O
most	O
strongly	O
in	O
muscle	O
and	O
heart	O
.	O
This	O
gene1s	ARG2
ATP5O	ARG2
gene1e	ARG2
subunit	O
is	O
a	O
key	O
structural	O
component	O
of	O
the	O
stalk	O
of	O
the	O
mitochondrial	O
respiratory	O
chain	O
F1F0-ATP	O
synthase	O
and	O
as	O
such	O
may	O
contribute	O
in	O
a	O
gene	O
dosage	O
-	O
dependent	O
manner	O
to	O
the	O
phenotype	O
of	O
Down	O
syndrome	O
(	O
trisomy	O
21	O
)	O
.	O

Cloning	O
of	O
the	O
cDNA	O
for	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
ATP	O
synthase	O
OSCP	O
subunit	O
gene1e	O
(	O
gene1s	O
ATP5O	O
gene1e	O
)	O
by	O
exon	O
trapping	O
and	O
mapping	O
to	O
chromosome	O
21q22.1-q22.2	O
.	O
Exon	O
trapping	O
was	O
used	O
to	O
clone	O
portions	O
of	O
potential	O
genes	O
from	O
species1s	O
human	O
species1e	O
chromosome	O
21	O
.	O
One	O
trapped	O
sequence	O
showed	O
striking	O
homology	O
with	O
the	O
arg1s	O
bovine	O
arg1e	O
and	O
species1s	O
rat	O
species1e	O
gene1s	ARG2
ATP	ARG2
synthase	ARG2
OSCP	ARG2
gene1e	ARG2
(	O
oligomycin	O
sensitivity	O
conferring	O
protein	O
)	O
subunit	O
.	O
We	O
subsequently	O
cloned	O
the	O
full	O
-	O
length	O
species1s	O
human	O
species1e	O
gene1s	O
ATP	O
synthase	O
OSCP	O
gene1e	O
cDNA	O
(	O
GDB	O
/	O
HGMW	O
approved	O
name	O
gene1s	O
ATP50	O
gene1e	O
)	O
from	O
infant	O
brain	O
and	O
muscle	O
libraries	O
and	O
determined	O
its	O
nucleotide	O
and	O
deduced	O
amino	O
acid	O
sequence	O
(	O
EMBL	O
/	O
GenBank	O
Accession	O
No	O
.	O
X83218	O
)	O
.	O
The	O
encoded	O
polypeptide	O
contains	O
213	O
amino	O
acids	O
,	O
with	O
more	O
than	O
80	O
%	O
identity	O
to	O
arg1s	O
bovine	O
arg1e	O
and	O
species1s	O
murine	O
species1e	O
gene1s	ARG2
ATPase	ARG2
OSCP	ARG2
gene1e	ARG2
subunits	O
and	O
over	O
35	O
%	O
identity	O
to	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
and	O
species1s	O
sweet	O
potato	O
species1e	O
sequences	O
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
ATP5O	O
gene1e	O
gene	O
is	O
located	O
at	O
21q22.1-q22.2	O
,	O
just	O
proximal	O
to	O
D21S17	O
,	O
in	O
YACs	O
860G11	O
and	O
838C7	O
of	O
the	O
Chumakov	O
et	O
al	O
.	O
(	O
Nature	O
359:380	O
,	O
1992	O
)	O
YAC	O
contig	O
.	O
The	O
gene	O
is	O
expressed	O
in	O
all	O
species1s	O
human	O
species1e	O
tissues	O
examined	O
,	O
most	O
strongly	O
in	O
muscle	O
and	O
heart	O
.	O
This	O
gene1s	O
ATP5O	O
gene1e	O
subunit	O
is	O
a	O
key	O
structural	O
component	O
of	O
the	O
stalk	O
of	O
the	O
mitochondrial	O
respiratory	O
chain	O
F1F0-ATP	O
synthase	O
and	O
as	O
such	O
may	O
contribute	O
in	O
a	O
gene	O
dosage	O
-	O
dependent	O
manner	O
to	O
the	O
phenotype	O
of	O
Down	O
syndrome	O
(	O
trisomy	O
21	O
)	O
.	O

Cloning	O
of	O
the	O
cDNA	O
for	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
ATP	O
synthase	O
OSCP	O
subunit	O
gene1e	O
(	O
gene1s	O
ATP5O	O
gene1e	O
)	O
by	O
exon	O
trapping	O
and	O
mapping	O
to	O
chromosome	O
21q22.1-q22.2	O
.	O
Exon	O
trapping	O
was	O
used	O
to	O
clone	O
portions	O
of	O
potential	O
genes	O
from	O
species1s	O
human	O
species1e	O
chromosome	O
21	O
.	O
One	O
trapped	O
sequence	O
showed	O
striking	O
homology	O
with	O
the	O
species1s	O
bovine	O
species1e	O
and	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
ATP	ARG2
synthase	ARG2
OSCP	ARG2
gene1e	ARG2
(	O
oligomycin	O
sensitivity	O
conferring	O
protein	O
)	O
subunit	O
.	O
We	O
subsequently	O
cloned	O
the	O
full	O
-	O
length	O
species1s	O
human	O
species1e	O
gene1s	O
ATP	O
synthase	O
OSCP	O
gene1e	O
cDNA	O
(	O
GDB	O
/	O
HGMW	O
approved	O
name	O
gene1s	O
ATP50	O
gene1e	O
)	O
from	O
infant	O
brain	O
and	O
muscle	O
libraries	O
and	O
determined	O
its	O
nucleotide	O
and	O
deduced	O
amino	O
acid	O
sequence	O
(	O
EMBL	O
/	O
GenBank	O
Accession	O
No	O
.	O
X83218	O
)	O
.	O
The	O
encoded	O
polypeptide	O
contains	O
213	O
amino	O
acids	O
,	O
with	O
more	O
than	O
80	O
%	O
identity	O
to	O
species1s	O
bovine	O
species1e	O
and	O
species1s	O
murine	O
species1e	O
gene1s	O
ATPase	O
OSCP	O
gene1e	O
subunits	O
and	O
over	O
35	O
%	O
identity	O
to	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
and	O
species1s	O
sweet	O
potato	O
species1e	O
sequences	O
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
ATP5O	O
gene1e	O
gene	O
is	O
located	O
at	O
21q22.1-q22.2	O
,	O
just	O
proximal	O
to	O
D21S17	O
,	O
in	O
YACs	O
860G11	O
and	O
838C7	O
of	O
the	O
Chumakov	O
et	O
al	O
.	O
(	O
Nature	O
359:380	O
,	O
1992	O
)	O
YAC	O
contig	O
.	O
The	O
gene	O
is	O
expressed	O
in	O
all	O
species1s	O
human	O
species1e	O
tissues	O
examined	O
,	O
most	O
strongly	O
in	O
muscle	O
and	O
heart	O
.	O
This	O
gene1s	O
ATP5O	O
gene1e	O
subunit	O
is	O
a	O
key	O
structural	O
component	O
of	O
the	O
stalk	O
of	O
the	O
mitochondrial	O
respiratory	O
chain	O
F1F0-ATP	O
synthase	O
and	O
as	O
such	O
may	O
contribute	O
in	O
a	O
gene	O
dosage	O
-	O
dependent	O
manner	O
to	O
the	O
phenotype	O
of	O
Down	O
syndrome	O
(	O
trisomy	O
21	O
)	O
.	O

Cloning	O
of	O
the	O
cDNA	O
for	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
ATP	O
synthase	O
OSCP	O
subunit	O
gene1e	O
(	O
gene1s	O
ATP5O	O
gene1e	O
)	O
by	O
exon	O
trapping	O
and	O
mapping	O
to	O
chromosome	O
21q22.1-q22.2	O
.	O
Exon	O
trapping	O
was	O
used	O
to	O
clone	O
portions	O
of	O
potential	O
genes	O
from	O
species1s	O
human	O
species1e	O
chromosome	O
21	O
.	O
One	O
trapped	O
sequence	O
showed	O
striking	O
homology	O
with	O
the	O
species1s	O
bovine	O
species1e	O
and	O
species1s	O
rat	O
species1e	O
gene1s	O
ATP	O
synthase	O
OSCP	O
gene1e	O
(	O
oligomycin	O
sensitivity	O
conferring	O
protein	O
)	O
subunit	O
.	O
We	O
subsequently	O
cloned	O
the	O
full	O
-	O
length	O
species1s	O
human	O
species1e	O
gene1s	O
ATP	O
synthase	O
OSCP	O
gene1e	O
cDNA	O
(	O
GDB	O
/	O
HGMW	O
approved	O
name	O
gene1s	O
ATP50	O
gene1e	O
)	O
from	O
infant	O
brain	O
and	O
muscle	O
libraries	O
and	O
determined	O
its	O
nucleotide	O
and	O
deduced	O
amino	O
acid	O
sequence	O
(	O
EMBL	O
/	O
GenBank	O
Accession	O
No	O
.	O
X83218	O
)	O
.	O
The	O
encoded	O
polypeptide	O
contains	O
213	O
amino	O
acids	O
,	O
with	O
more	O
than	O
80	O
%	O
identity	O
to	O
species1s	O
bovine	O
species1e	O
and	O
arg1s	O
murine	O
arg1e	O
gene1s	ARG2
ATPase	ARG2
OSCP	ARG2
gene1e	ARG2
subunits	O
and	O
over	O
35	O
%	O
identity	O
to	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
and	O
species1s	O
sweet	O
potato	O
species1e	O
sequences	O
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
ATP5O	O
gene1e	O
gene	O
is	O
located	O
at	O
21q22.1-q22.2	O
,	O
just	O
proximal	O
to	O
D21S17	O
,	O
in	O
YACs	O
860G11	O
and	O
838C7	O
of	O
the	O
Chumakov	O
et	O
al	O
.	O
(	O
Nature	O
359:380	O
,	O
1992	O
)	O
YAC	O
contig	O
.	O
The	O
gene	O
is	O
expressed	O
in	O
all	O
species1s	O
human	O
species1e	O
tissues	O
examined	O
,	O
most	O
strongly	O
in	O
muscle	O
and	O
heart	O
.	O
This	O
gene1s	O
ATP5O	O
gene1e	O
subunit	O
is	O
a	O
key	O
structural	O
component	O
of	O
the	O
stalk	O
of	O
the	O
mitochondrial	O
respiratory	O
chain	O
F1F0-ATP	O
synthase	O
and	O
as	O
such	O
may	O
contribute	O
in	O
a	O
gene	O
dosage	O
-	O
dependent	O
manner	O
to	O
the	O
phenotype	O
of	O
Down	O
syndrome	O
(	O
trisomy	O
21	O
)	O
.	O

Cloning	O
of	O
the	O
cDNA	O
for	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
ATP	O
synthase	O
OSCP	O
subunit	O
gene1e	O
(	O
gene1s	O
ATP5O	O
gene1e	O
)	O
by	O
exon	O
trapping	O
and	O
mapping	O
to	O
chromosome	O
21q22.1-q22.2	O
.	O
Exon	O
trapping	O
was	O
used	O
to	O
clone	O
portions	O
of	O
potential	O
genes	O
from	O
species1s	O
human	O
species1e	O
chromosome	O
21	O
.	O
One	O
trapped	O
sequence	O
showed	O
striking	O
homology	O
with	O
the	O
species1s	O
bovine	O
species1e	O
and	O
species1s	O
rat	O
species1e	O
gene1s	O
ATP	O
synthase	O
OSCP	O
gene1e	O
(	O
oligomycin	O
sensitivity	O
conferring	O
protein	O
)	O
subunit	O
.	O
We	O
subsequently	O
cloned	O
the	O
full	O
-	O
length	O
species1s	O
human	O
species1e	O
gene1s	O
ATP	O
synthase	O
OSCP	O
gene1e	O
cDNA	O
(	O
GDB	O
/	O
HGMW	O
approved	O
name	O
gene1s	O
ATP50	O
gene1e	O
)	O
from	O
infant	O
brain	O
and	O
muscle	O
libraries	O
and	O
determined	O
its	O
nucleotide	O
and	O
deduced	O
amino	O
acid	O
sequence	O
(	O
EMBL	O
/	O
GenBank	O
Accession	O
No	O
.	O
X83218	O
)	O
.	O
The	O
encoded	O
polypeptide	O
contains	O
213	O
amino	O
acids	O
,	O
with	O
more	O
than	O
80	O
%	O
identity	O
to	O
species1s	O
bovine	O
species1e	O
and	O
species1s	O
murine	O
species1e	O
gene1s	O
ATPase	O
OSCP	O
gene1e	O
subunits	O
and	O
over	O
35	O
%	O
identity	O
to	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
and	O
species1s	O
sweet	O
potato	O
species1e	O
sequences	O
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
ATP5O	O
gene1e	O
gene	O
is	O
located	O
at	O
21q22.1-q22.2	O
,	O
just	O
proximal	O
to	O
D21S17	O
,	O
in	O
YACs	O
860G11	O
and	O
838C7	O
of	O
the	O
Chumakov	O
et	O
al	O
.	O
(	O
Nature	O
359:380	O
,	O
1992	O
)	O
YAC	O
contig	O
.	O
The	O
gene	O
is	O
expressed	O
in	O
all	O
species1s	O
human	O
species1e	O
tissues	O
examined	O
,	O
most	O
strongly	O
in	O
muscle	O
and	O
heart	O
.	O
This	O
gene1s	O
ATP5O	O
gene1e	O
subunit	O
is	O
a	O
key	O
structural	O
component	O
of	O
the	O
stalk	O
of	O
the	O
mitochondrial	O
respiratory	O
chain	O
F1F0-ATP	O
synthase	O
and	O
as	O
such	O
may	O
contribute	O
in	O
a	O
gene	O
dosage	O
-	O
dependent	O
manner	O
to	O
the	O
phenotype	O
of	O
Down	O
syndrome	O
(	O
trisomy	O
21	O
)	O
.	O

Cloning	O
of	O
the	O
cDNA	O
for	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
ATP	O
synthase	O
OSCP	O
subunit	O
gene1e	O
(	O
gene1s	O
ATP5O	O
gene1e	O
)	O
by	O
exon	O
trapping	O
and	O
mapping	O
to	O
chromosome	O
21q22.1-q22.2	O
.	O
Exon	O
trapping	O
was	O
used	O
to	O
clone	O
portions	O
of	O
potential	O
genes	O
from	O
species1s	O
human	O
species1e	O
chromosome	O
21	O
.	O
One	O
trapped	O
sequence	O
showed	O
striking	O
homology	O
with	O
the	O
species1s	O
bovine	O
species1e	O
and	O
species1s	O
rat	O
species1e	O
gene1s	O
ATP	O
synthase	O
OSCP	O
gene1e	O
(	O
oligomycin	O
sensitivity	O
conferring	O
protein	O
)	O
subunit	O
.	O
We	O
subsequently	O
cloned	O
the	O
full	O
-	O
length	O
species1s	O
human	O
species1e	O
gene1s	O
ATP	O
synthase	O
OSCP	O
gene1e	O
cDNA	O
(	O
GDB	O
/	O
HGMW	O
approved	O
name	O
gene1s	O
ATP50	O
gene1e	O
)	O
from	O
infant	O
brain	O
and	O
muscle	O
libraries	O
and	O
determined	O
its	O
nucleotide	O
and	O
deduced	O
amino	O
acid	O
sequence	O
(	O
EMBL	O
/	O
GenBank	O
Accession	O
No	O
.	O
X83218	O
)	O
.	O
The	O
encoded	O
polypeptide	O
contains	O
213	O
amino	O
acids	O
,	O
with	O
more	O
than	O
80	O
%	O
identity	O
to	O
species1s	O
bovine	O
species1e	O
and	O
species1s	O
murine	O
species1e	O
gene1s	O
ATPase	O
OSCP	O
gene1e	O
subunits	O
and	O
over	O
35	O
%	O
identity	O
to	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
and	O
arg1s	O
sweet	O
potato	O
arg1e	O
sequences	O
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
ATP5O	O
gene1e	O
gene	O
is	O
located	O
at	O
21q22.1-q22.2	O
,	O
just	O
proximal	O
to	O
D21S17	O
,	O
in	O
YACs	O
860G11	O
and	O
838C7	O
of	O
the	O
Chumakov	O
et	O
al	O
.	O
(	O
Nature	O
359:380	O
,	O
1992	O
)	O
YAC	O
contig	O
.	O
The	O
gene	O
is	O
expressed	O
in	O
all	O
species1s	O
human	O
species1e	O
tissues	O
examined	O
,	O
most	O
strongly	O
in	O
muscle	O
and	O
heart	O
.	O
This	O
gene1s	O
ATP5O	O
gene1e	O
subunit	O
is	O
a	O
key	O
structural	O
component	O
of	O
the	O
stalk	O
of	O
the	O
mitochondrial	O
respiratory	O
chain	O
F1F0-ATP	O
synthase	O
and	O
as	O
such	O
may	O
contribute	O
in	O
a	O
gene	O
dosage	O
-	O
dependent	O
manner	O
to	O
the	O
phenotype	O
of	O
Down	O
syndrome	O
(	O
trisomy	O
21	O
)	O
.	O

Generation	O
of	O
a	O
transcription	O
map	O
at	O
the	O
HSD17B	O
locus	O
centromeric	O
to	O
gene1s	ARG2
BRCA1	ARG2
gene1e	ARG2
at	O
17q21	O
.	O
A	O
detailed	O
transcription	O
map	O
of	O
the	O
320-kb	O
region	O
containing	O
the	O
HSD17B	O
locus	O
on	O
chromosome	O
17	O
was	O
generated	O
.	O
Thirty	O
unique	O
cDNA	O
fragments	O
,	O
retrieved	O
following	O
the	O
hybridization	O
of	O
immobilized	O
YACs	O
to	O
primary	O
pools	O
of	O
cDNAs	O
prepared	O
from	O
RNA	O
of	O
mammary	O
gland	O
,	O
ovary	O
,	O
placenta	O
,	O
and	O
the	O
arg1s	O
Caco-2	O
arg1e	O
cell	O
line	O
,	O
were	O
aligned	O
into	O
10	O
transcription	O
units	O
by	O
physical	O
mapping	O
and	O
hybridization	O
to	O
RNAs	O
of	O
a	O
series	O
of	O
tissues	O
.	O
The	O
cDNAs	O
were	O
then	O
further	O
characterized	O
by	O
sequencing	O
and	O
used	O
to	O
screen	O
mammary	O
gland	O
cDNA	O
libraries	O
.	O
Fragments	O
corresponding	O
to	O
the	O
broadly	O
expressed	O
gamma	O
-	O
tubulin	O
and	O
gene1s	ARG2
Ki	ARG2
antigen	ARG2
gene1e	ARG2
genes	O
were	O
identified	O
.	O
A	O
full	O
-	O
length	O
cDNA	O
clone	O
encoding	O
a	O
117-amino	O
-	O
acid	O
protein	O
homologous	O
to	O
the	O
species1s	O
rat	O
species1e	O
gene1s	O
ribosomal	O
protein	O
L34	O
gene1e	O
was	O
isolated	O
.	O
Portions	O
of	O
genes	O
with	O
restricted	O
patterns	O
of	O
expression	O
were	O
also	O
obtained	O
,	O
including	O
the	O
previously	O
characterized	O
gene1s	ARG2
HSD17B1	ARG2
gene1e	ARG2
.	O
One	O
new	O
gene	O
,	O
for	O
which	O
a	O
full	O
-	O
length	O
cDNA	O
was	O
isolated	O
,	O
was	O
found	O
to	O
have	O
an	O
interesting	O
tissue	O
-	O
specific	O
pattern	O
of	O
expression	O
with	O
abundant	O
mRNA	O
in	O
both	O
the	O
colon	O
and	O
the	O
testis	O
and	O
in	O
the	O
mammary	O
carcinoma	O
cell	O
line	O
BT-474	O
.	O
This	O
contrasted	O
with	O
the	O
barely	O
detectable	O
level	O
observed	O
in	O
several	O
tissues	O
including	O
normal	O
mammary	O
gland	O
.	O
Of	O
the	O
five	O
additional	O
transcription	O
units	O
identified	O
,	O
one	O
showed	O
no	O
similarity	O
,	O
two	O
showed	O
identity	O
to	O
arg1s	O
human	O
arg1e	O
expressed	O
sequences	O
,	O
and	O
two	O
displayed	O
similarity	O
to	O
genes	O
of	O
animal	O
species	O
by	O
amino	O
acid	O
alignment	O
.	O
These	O
latter	O
cDNA	O
clones	O
include	O
potential	O
homologues	O
of	O
a	O
species1s	O
rat	O
species1e	O
nuclear	O
tyrosine	O
phosphatase	O
and	O
of	O
a	O
factor	O
of	O
species1s	O
Drosophila	O
species1e	O
that	O
is	O
known	O
to	O
be	O
involved	O
in	O
the	O
negative	O
regulation	O
of	O
transcription	O
of	O
segment	O
identity	O
genes	O
.	O

Generation	O
of	O
a	O
transcription	O
map	O
at	O
the	O
HSD17B	O
locus	O
centromeric	O
to	O
gene1s	O
BRCA1	O
gene1e	O
at	O
17q21	O
.	O
A	O
detailed	O
transcription	O
map	O
of	O
the	O
320-kb	O
region	O
containing	O
the	O
HSD17B	O
locus	O
on	O
chromosome	O
17	O
was	O
generated	O
.	O
Thirty	O
unique	O
cDNA	O
fragments	O
,	O
retrieved	O
following	O
the	O
hybridization	O
of	O
immobilized	O
YACs	O
to	O
primary	O
pools	O
of	O
cDNAs	O
prepared	O
from	O
RNA	O
of	O
mammary	O
gland	O
,	O
ovary	O
,	O
placenta	O
,	O
and	O
the	O
species1s	O
Caco-2	O
species1e	O
cell	O
line	O
,	O
were	O
aligned	O
into	O
10	O
transcription	O
units	O
by	O
physical	O
mapping	O
and	O
hybridization	O
to	O
RNAs	O
of	O
a	O
series	O
of	O
tissues	O
.	O
The	O
cDNAs	O
were	O
then	O
further	O
characterized	O
by	O
sequencing	O
and	O
used	O
to	O
screen	O
mammary	O
gland	O
cDNA	O
libraries	O
.	O
Fragments	O
corresponding	O
to	O
the	O
broadly	O
expressed	O
gamma	O
-	O
tubulin	O
and	O
gene1s	O
Ki	O
antigen	O
gene1e	O
genes	O
were	O
identified	O
.	O
A	O
full	O
-	O
length	O
cDNA	O
clone	O
encoding	O
a	O
117-amino	O
-	O
acid	O
protein	O
homologous	O
to	O
the	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
ribosomal	ARG2
protein	ARG2
L34	ARG2
gene1e	ARG2
was	O
isolated	O
.	O
Portions	O
of	O
genes	O
with	O
restricted	O
patterns	O
of	O
expression	O
were	O
also	O
obtained	O
,	O
including	O
the	O
previously	O
characterized	O
gene1s	O
HSD17B1	O
gene1e	O
.	O
One	O
new	O
gene	O
,	O
for	O
which	O
a	O
full	O
-	O
length	O
cDNA	O
was	O
isolated	O
,	O
was	O
found	O
to	O
have	O
an	O
interesting	O
tissue	O
-	O
specific	O
pattern	O
of	O
expression	O
with	O
abundant	O
mRNA	O
in	O
both	O
the	O
colon	O
and	O
the	O
testis	O
and	O
in	O
the	O
mammary	O
carcinoma	O
cell	O
line	O
BT-474	O
.	O
This	O
contrasted	O
with	O
the	O
barely	O
detectable	O
level	O
observed	O
in	O
several	O
tissues	O
including	O
normal	O
mammary	O
gland	O
.	O
Of	O
the	O
five	O
additional	O
transcription	O
units	O
identified	O
,	O
one	O
showed	O
no	O
similarity	O
,	O
two	O
showed	O
identity	O
to	O
species1s	O
human	O
species1e	O
expressed	O
sequences	O
,	O
and	O
two	O
displayed	O
similarity	O
to	O
genes	O
of	O
animal	O
species	O
by	O
amino	O
acid	O
alignment	O
.	O
These	O
latter	O
cDNA	O
clones	O
include	O
potential	O
homologues	O
of	O
a	O
arg1s	O
rat	O
arg1e	O
nuclear	O
tyrosine	O
phosphatase	O
and	O
of	O
a	O
factor	O
of	O
species1s	O
Drosophila	O
species1e	O
that	O
is	O
known	O
to	O
be	O
involved	O
in	O
the	O
negative	O
regulation	O
of	O
transcription	O
of	O
segment	O
identity	O
genes	O
.	O

Generation	O
of	O
a	O
transcription	O
map	O
at	O
the	O
HSD17B	O
locus	O
centromeric	O
to	O
gene1s	O
BRCA1	O
gene1e	O
at	O
17q21	O
.	O
A	O
detailed	O
transcription	O
map	O
of	O
the	O
320-kb	O
region	O
containing	O
the	O
HSD17B	O
locus	O
on	O
chromosome	O
17	O
was	O
generated	O
.	O
Thirty	O
unique	O
cDNA	O
fragments	O
,	O
retrieved	O
following	O
the	O
hybridization	O
of	O
immobilized	O
YACs	O
to	O
primary	O
pools	O
of	O
cDNAs	O
prepared	O
from	O
RNA	O
of	O
mammary	O
gland	O
,	O
ovary	O
,	O
placenta	O
,	O
and	O
the	O
species1s	O
Caco-2	O
species1e	O
cell	O
line	O
,	O
were	O
aligned	O
into	O
10	O
transcription	O
units	O
by	O
physical	O
mapping	O
and	O
hybridization	O
to	O
RNAs	O
of	O
a	O
series	O
of	O
tissues	O
.	O
The	O
cDNAs	O
were	O
then	O
further	O
characterized	O
by	O
sequencing	O
and	O
used	O
to	O
screen	O
mammary	O
gland	O
cDNA	O
libraries	O
.	O
Fragments	O
corresponding	O
to	O
the	O
broadly	O
expressed	O
gamma	O
-	O
tubulin	O
and	O
gene1s	O
Ki	O
antigen	O
gene1e	O
genes	O
were	O
identified	O
.	O
A	O
full	O
-	O
length	O
cDNA	O
clone	O
encoding	O
a	O
117-amino	O
-	O
acid	O
protein	O
homologous	O
to	O
the	O
species1s	O
rat	O
species1e	O
gene1s	O
ribosomal	O
protein	O
L34	O
gene1e	O
was	O
isolated	O
.	O
Portions	O
of	O
genes	O
with	O
restricted	O
patterns	O
of	O
expression	O
were	O
also	O
obtained	O
,	O
including	O
the	O
previously	O
characterized	O
gene1s	O
HSD17B1	O
gene1e	O
.	O
One	O
new	O
gene	O
,	O
for	O
which	O
a	O
full	O
-	O
length	O
cDNA	O
was	O
isolated	O
,	O
was	O
found	O
to	O
have	O
an	O
interesting	O
tissue	O
-	O
specific	O
pattern	O
of	O
expression	O
with	O
abundant	O
mRNA	O
in	O
both	O
the	O
colon	O
and	O
the	O
testis	O
and	O
in	O
the	O
mammary	O
carcinoma	O
cell	O
line	O
BT-474	O
.	O
This	O
contrasted	O
with	O
the	O
barely	O
detectable	O
level	O
observed	O
in	O
several	O
tissues	O
including	O
normal	O
mammary	O
gland	O
.	O
Of	O
the	O
five	O
additional	O
transcription	O
units	O
identified	O
,	O
one	O
showed	O
no	O
similarity	O
,	O
two	O
showed	O
identity	O
to	O
species1s	O
human	O
species1e	O
expressed	O
sequences	O
,	O
and	O
two	O
displayed	O
similarity	O
to	O
genes	O
of	O
animal	O
species	O
by	O
amino	O
acid	O
alignment	O
.	O
These	O
latter	O
cDNA	O
clones	O
include	O
potential	O
homologues	O
of	O
a	O
species1s	O
rat	O
species1e	O
nuclear	O
tyrosine	O
phosphatase	O
and	O
of	O
a	O
factor	O
of	O
arg1s	O
Drosophila	O
arg1e	O
that	O
is	O
known	O
to	O
be	O
involved	O
in	O
the	O
negative	O
regulation	O
of	O
transcription	O
of	O
segment	O
identity	O
genes	O
.	O

arg1s	O
Human	O
arg1e	O
serum	O
gene1s	ARG2
biotinidase	ARG2
gene1e	ARG2
.	O
cDNA	O
cloning	O
,	O
sequence	O
,	O
and	O
characterization	O
.	O
gene1s	ARG2
Biotinidase	ARG2
gene1e	ARG2
(	O
EC	O
3.5.1.12	O
)	O
catalyzes	O
the	O
hydrolysis	O
of	O
biocytin	O
,	O
the	O
product	O
of	O
biotin	O
-	O
dependent	O
carboxylase	O
degradation	O
,	O
to	O
biotin	O
and	O
lysine	O
.	O
gene1s	ARG2
Biotinidase	ARG2
gene1e	ARG2
deficiency	O
is	O
an	O
inherited	O
metabolic	O
disorder	O
of	O
biotin	O
recycling	O
that	O
is	O
characterized	O
by	O
neurological	O
and	O
cutaneous	O
abnormalities	O
,	O
and	O
can	O
be	O
successfully	O
treated	O
with	O
biotin	O
supplementation	O
.	O
Sequences	O
of	O
tryptic	O
peptides	O
of	O
the	O
purified	O
arg1s	O
human	O
arg1e	O
serum	O
enzyme	O
were	O
used	O
to	O
design	O
oligonucleotide	O
primers	O
for	O
polymerase	O
chain	O
reaction	O
amplification	O
from	O
arg1s	O
human	O
arg1e	O
hepatic	O
total	O
RNA	O
to	O
generate	O
putative	O
gene1s	ARG2
biotinidase	ARG2
gene1e	ARG2
cDNA	O
fragments	O
.	O
Sequence	O
analysis	O
of	O
a	O
cDNA	O
isolated	O
from	O
a	O
arg1s	O
human	O
arg1e	O
liver	O
library	O
by	O
plaque	O
hybridization	O
with	O
the	O
largest	O
cDNA	O
probe	O
revealed	O
an	O
open	O
reading	O
frame	O
of	O
1629	O
bases	O
encoding	O
a	O
protein	O
of	O
543	O
amino	O
acid	O
residues	O
,	O
including	O
41	O
amino	O
acids	O
of	O
a	O
potential	O
signal	O
peptide	O
.	O
Comparison	O
of	O
the	O
open	O
reading	O
frame	O
with	O
the	O
known	O
gene1s	ARG2
biotinidase	ARG2
gene1e	ARG2
tryptic	O
peptides	O
and	O
recognition	O
of	O
the	O
expressed	O
protein	O
encoded	O
by	O
this	O
cDNA	O
by	O
monoclonal	O
antibodies	O
prepared	O
against	O
purified	O
gene1s	ARG2
biotinidase	ARG2
gene1e	ARG2
demonstrated	O
the	O
identity	O
of	O
this	O
cDNA	O
.	O
Southern	O
analyses	O
suggested	O
that	O
gene1s	ARG2
biotinidase	ARG2
gene1e	ARG2
is	O
a	O
single	O
copy	O
gene	O
and	O
revealed	O
that	O
arg1s	O
human	O
arg1e	O
cDNA	O
probes	O
hybridized	O
to	O
genomic	O
DNA	O
from	O
mammals	O
,	O
but	O
not	O
from	O
species1s	O
chicken	O
species1e	O
or	O
species1s	O
yeast	O
species1e	O
.	O
Northern	O
analysis	O
indicated	O
the	O
presence	O
of	O
gene1s	ARG2
biotinidase	ARG2
gene1e	ARG2
mRNA	O
in	O
arg1s	O
human	O
arg1e	O
heart	O
,	O
brain	O
,	O
placenta	O
,	O
liver	O
,	O
lung	O
,	O
skeletal	O
muscle	O
,	O
kidney	O
,	O
and	O
pancreas	O
.	O

species1s	O
Human	O
species1e	O
serum	O
gene1s	O
biotinidase	O
gene1e	O
.	O
cDNA	O
cloning	O
,	O
sequence	O
,	O
and	O
characterization	O
.	O
gene1s	O
Biotinidase	O
gene1e	O
(	O
EC	O
3.5.1.12	O
)	O
catalyzes	O
the	O
hydrolysis	O
of	O
biocytin	O
,	O
the	O
product	O
of	O
biotin	O
-	O
dependent	O
carboxylase	O
degradation	O
,	O
to	O
biotin	O
and	O
lysine	O
.	O
gene1s	O
Biotinidase	O
gene1e	O
deficiency	O
is	O
an	O
inherited	O
metabolic	O
disorder	O
of	O
biotin	O
recycling	O
that	O
is	O
characterized	O
by	O
neurological	O
and	O
cutaneous	O
abnormalities	O
,	O
and	O
can	O
be	O
successfully	O
treated	O
with	O
biotin	O
supplementation	O
.	O
Sequences	O
of	O
tryptic	O
peptides	O
of	O
the	O
purified	O
species1s	O
human	O
species1e	O
serum	O
enzyme	O
were	O
used	O
to	O
design	O
oligonucleotide	O
primers	O
for	O
polymerase	O
chain	O
reaction	O
amplification	O
from	O
species1s	O
human	O
species1e	O
hepatic	O
total	O
RNA	O
to	O
generate	O
putative	O
gene1s	O
biotinidase	O
gene1e	O
cDNA	O
fragments	O
.	O
Sequence	O
analysis	O
of	O
a	O
cDNA	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
liver	O
library	O
by	O
plaque	O
hybridization	O
with	O
the	O
largest	O
cDNA	O
probe	O
revealed	O
an	O
open	O
reading	O
frame	O
of	O
1629	O
bases	O
encoding	O
a	O
protein	O
of	O
543	O
amino	O
acid	O
residues	O
,	O
including	O
41	O
amino	O
acids	O
of	O
a	O
potential	O
signal	O
peptide	O
.	O
Comparison	O
of	O
the	O
open	O
reading	O
frame	O
with	O
the	O
known	O
gene1s	O
biotinidase	O
gene1e	O
tryptic	O
peptides	O
and	O
recognition	O
of	O
the	O
expressed	O
protein	O
encoded	O
by	O
this	O
cDNA	O
by	O
monoclonal	O
antibodies	O
prepared	O
against	O
purified	O
gene1s	O
biotinidase	O
gene1e	O
demonstrated	O
the	O
identity	O
of	O
this	O
cDNA	O
.	O
Southern	O
analyses	O
suggested	O
that	O
gene1s	O
biotinidase	O
gene1e	O
is	O
a	O
single	O
copy	O
gene	O
and	O
revealed	O
that	O
species1s	O
human	O
species1e	O
cDNA	O
probes	O
hybridized	O
to	O
genomic	O
DNA	O
from	O
mammals	O
,	O
but	O
not	O
from	O
arg1s	O
chicken	O
arg1e	O
or	O
species1s	O
yeast	O
species1e	O
.	O
Northern	O
analysis	O
indicated	O
the	O
presence	O
of	O
gene1s	O
biotinidase	O
gene1e	O
mRNA	O
in	O
species1s	O
human	O
species1e	O
heart	O
,	O
brain	O
,	O
placenta	O
,	O
liver	O
,	O
lung	O
,	O
skeletal	O
muscle	O
,	O
kidney	O
,	O
and	O
pancreas	O
.	O

species1s	O
Human	O
species1e	O
serum	O
gene1s	O
biotinidase	O
gene1e	O
.	O
cDNA	O
cloning	O
,	O
sequence	O
,	O
and	O
characterization	O
.	O
gene1s	O
Biotinidase	O
gene1e	O
(	O
EC	O
3.5.1.12	O
)	O
catalyzes	O
the	O
hydrolysis	O
of	O
biocytin	O
,	O
the	O
product	O
of	O
biotin	O
-	O
dependent	O
carboxylase	O
degradation	O
,	O
to	O
biotin	O
and	O
lysine	O
.	O
gene1s	O
Biotinidase	O
gene1e	O
deficiency	O
is	O
an	O
inherited	O
metabolic	O
disorder	O
of	O
biotin	O
recycling	O
that	O
is	O
characterized	O
by	O
neurological	O
and	O
cutaneous	O
abnormalities	O
,	O
and	O
can	O
be	O
successfully	O
treated	O
with	O
biotin	O
supplementation	O
.	O
Sequences	O
of	O
tryptic	O
peptides	O
of	O
the	O
purified	O
species1s	O
human	O
species1e	O
serum	O
enzyme	O
were	O
used	O
to	O
design	O
oligonucleotide	O
primers	O
for	O
polymerase	O
chain	O
reaction	O
amplification	O
from	O
species1s	O
human	O
species1e	O
hepatic	O
total	O
RNA	O
to	O
generate	O
putative	O
gene1s	O
biotinidase	O
gene1e	O
cDNA	O
fragments	O
.	O
Sequence	O
analysis	O
of	O
a	O
cDNA	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
liver	O
library	O
by	O
plaque	O
hybridization	O
with	O
the	O
largest	O
cDNA	O
probe	O
revealed	O
an	O
open	O
reading	O
frame	O
of	O
1629	O
bases	O
encoding	O
a	O
protein	O
of	O
543	O
amino	O
acid	O
residues	O
,	O
including	O
41	O
amino	O
acids	O
of	O
a	O
potential	O
signal	O
peptide	O
.	O
Comparison	O
of	O
the	O
open	O
reading	O
frame	O
with	O
the	O
known	O
gene1s	O
biotinidase	O
gene1e	O
tryptic	O
peptides	O
and	O
recognition	O
of	O
the	O
expressed	O
protein	O
encoded	O
by	O
this	O
cDNA	O
by	O
monoclonal	O
antibodies	O
prepared	O
against	O
purified	O
gene1s	O
biotinidase	O
gene1e	O
demonstrated	O
the	O
identity	O
of	O
this	O
cDNA	O
.	O
Southern	O
analyses	O
suggested	O
that	O
gene1s	O
biotinidase	O
gene1e	O
is	O
a	O
single	O
copy	O
gene	O
and	O
revealed	O
that	O
species1s	O
human	O
species1e	O
cDNA	O
probes	O
hybridized	O
to	O
genomic	O
DNA	O
from	O
mammals	O
,	O
but	O
not	O
from	O
species1s	O
chicken	O
species1e	O
or	O
arg1s	O
yeast	O
arg1e	O
.	O
Northern	O
analysis	O
indicated	O
the	O
presence	O
of	O
gene1s	O
biotinidase	O
gene1e	O
mRNA	O
in	O
species1s	O
human	O
species1e	O
heart	O
,	O
brain	O
,	O
placenta	O
,	O
liver	O
,	O
lung	O
,	O
skeletal	O
muscle	O
,	O
kidney	O
,	O
and	O
pancreas	O
.	O

gene1s	O
C3	O
G	O
gene1e	O
,	O
a	O
guanine	O
nucleotide	O
-	O
releasing	O
protein	O
expressed	O
ubiquitously	O
,	O
binds	O
to	O
the	O
Src	O
homology	O
3	O
domains	O
of	O
gene1s	O
CRK	O
gene1e	O
and	O
gene1s	O
GRB2	O
gene1e	O
/	O
gene1s	O
ASH	O
gene1e	O
proteins	O
.	O
gene1s	O
CRK	O
gene1e	O
protein	O
,	O
together	O
with	O
gene1s	O
GRB2	O
gene1e	O
/	O
gene1s	O
ASH	O
gene1e	O
and	O
Nck	O
proteins	O
,	O
belongs	O
to	O
the	O
adaptor	O
-	O
type	O
Src	O
homology	O
(	O
SH)2-containing	O
molecules	O
,	O
which	O
transduce	O
signals	O
from	O
tyrosine	O
kinases	O
.	O
Here	O
another	O
guanine	O
nucleotide	O
-	O
releasing	O
protein	O
(	O
GNRP	O
)	O
,	O
gene1s	O
C3	O
G	O
gene1e	O
,	O
has	O
been	O
identified	O
as	O
a	O
gene1s	O
CRK	O
SH3-binding	O
protein	O
gene1e	O
.	O
The	O
nucleotide	O
sequence	O
of	O
a	O
4.1-kb	O
gene1s	O
C3	O
G	O
gene1e	O
cDNA	O
contains	O
a	O
3.2-kb	O
open	O
reading	O
frame	O
encoding	O
a	O
121-kDa	O
protein	O
,	O
and	O
antibodies	O
against	O
gene1s	O
C3	O
G	O
gene1e	O
have	O
been	O
shown	O
to	O
detect	O
a	O
protein	O
of	O
130	O
-	O
140	O
kDa	O
.	O
The	O
carboxyl	O
terminus	O
of	O
gene1s	O
C3	O
G	O
gene1e	O
has	O
a	O
peptide	O
sequence	O
homologous	O
to	O
GNRPs	O
for	O
Ras	O
,	O
and	O
the	O
expression	O
of	O
this	O
carboxyl	O
terminus	O
region	O
suppresses	O
the	O
loss	O
of	O
gene1s	ARG2
CDC25	ARG2
gene1e	ARG2
function	O
in	O
the	O
arg1s	O
yeast	O
arg1e	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
.	O
The	O
gene1s	O
C3	O
G	O
gene1e	O
protein	O
expressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
binds	O
to	O
gene1s	O
CRK	O
gene1e	O
and	O
gene1s	O
GRB2	O
gene1e	O
/	O
gene1s	O
ASH	O
gene1e	O
proteins	O
.	O
Mutational	O
analysis	O
of	O
gene1s	O
C3	O
G	O
gene1e	O
assigns	O
the	O
SH3	O
binding	O
region	O
to	O
a	O
50-amino	O
acid	O
region	O
containing	O
a	O
proline	O
-	O
rich	O
sequence	O
.	O
The	O
mRNAs	O
of	O
both	O
the	O
gene1s	O
C3	O
G	O
gene1e	O
and	O
gene1s	O
CRK	O
gene1e	O
proteins	O
are	O
expressed	O
ubiquitously	O
in	O
species1s	O
human	O
species1e	O
adult	O
and	O
fetal	O
tissues	O
.	O
The	O
results	O
of	O
these	O
studies	O
suggest	O
that	O
the	O
complex	O
of	O
gene1s	O
CRK	O
gene1e	O
and	O
gene1s	O
C3	O
G	O
gene1e	O
,	O
or	O
gene1s	O
GRB2	O
gene1e	O
/	O
gene1s	O
ASH	O
gene1e	O
and	O
gene1s	O
C3	O
G	O
gene1e	O
,	O
may	O
transduce	O
the	O
signals	O
from	O
tyrosine	O
kinases	O
to	O
Ras	O
in	O
a	O
number	O
of	O
different	O
tissues	O
.	O

gene1s	O
C3	O
G	O
gene1e	O
,	O
a	O
guanine	O
nucleotide	O
-	O
releasing	O
protein	O
expressed	O
ubiquitously	O
,	O
binds	O
to	O
the	O
Src	O
homology	O
3	O
domains	O
of	O
gene1s	O
CRK	O
gene1e	O
and	O
gene1s	O
GRB2	O
gene1e	O
/	O
gene1s	O
ASH	O
gene1e	O
proteins	O
.	O
gene1s	O
CRK	O
gene1e	O
protein	O
,	O
together	O
with	O
gene1s	O
GRB2	O
gene1e	O
/	O
gene1s	O
ASH	O
gene1e	O
and	O
Nck	O
proteins	O
,	O
belongs	O
to	O
the	O
adaptor	O
-	O
type	O
Src	O
homology	O
(	O
SH)2-containing	O
molecules	O
,	O
which	O
transduce	O
signals	O
from	O
tyrosine	O
kinases	O
.	O
Here	O
another	O
guanine	O
nucleotide	O
-	O
releasing	O
protein	O
(	O
GNRP	O
)	O
,	O
gene1s	O
C3	O
G	O
gene1e	O
,	O
has	O
been	O
identified	O
as	O
a	O
gene1s	O
CRK	O
SH3-binding	O
protein	O
gene1e	O
.	O
The	O
nucleotide	O
sequence	O
of	O
a	O
4.1-kb	O
gene1s	O
C3	O
G	O
gene1e	O
cDNA	O
contains	O
a	O
3.2-kb	O
open	O
reading	O
frame	O
encoding	O
a	O
121-kDa	O
protein	O
,	O
and	O
antibodies	O
against	O
gene1s	O
C3	O
G	O
gene1e	O
have	O
been	O
shown	O
to	O
detect	O
a	O
protein	O
of	O
130	O
-	O
140	O
kDa	O
.	O
The	O
carboxyl	O
terminus	O
of	O
gene1s	O
C3	O
G	O
gene1e	O
has	O
a	O
peptide	O
sequence	O
homologous	O
to	O
GNRPs	O
for	O
Ras	O
,	O
and	O
the	O
expression	O
of	O
this	O
carboxyl	O
terminus	O
region	O
suppresses	O
the	O
loss	O
of	O
gene1s	O
CDC25	O
gene1e	O
function	O
in	O
the	O
species1s	O
yeast	O
species1e	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
.	O
The	O
gene1s	O
C3	O
G	O
gene1e	O
protein	O
expressed	O
in	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
binds	O
to	O
gene1s	O
CRK	O
gene1e	O
and	O
gene1s	O
GRB2	O
gene1e	O
/	O
gene1s	O
ASH	O
gene1e	O
proteins	O
.	O
Mutational	O
analysis	O
of	O
gene1s	O
C3	O
G	O
gene1e	O
assigns	O
the	O
SH3	O
binding	O
region	O
to	O
a	O
50-amino	O
acid	O
region	O
containing	O
a	O
proline	O
-	O
rich	O
sequence	O
.	O
The	O
mRNAs	O
of	O
both	O
the	O
gene1s	O
C3	O
G	O
gene1e	O
and	O
gene1s	O
CRK	O
gene1e	O
proteins	O
are	O
expressed	O
ubiquitously	O
in	O
species1s	O
human	O
species1e	O
adult	O
and	O
fetal	O
tissues	O
.	O
The	O
results	O
of	O
these	O
studies	O
suggest	O
that	O
the	O
complex	O
of	O
gene1s	O
CRK	O
gene1e	O
and	O
gene1s	O
C3	O
G	O
gene1e	O
,	O
or	O
gene1s	O
GRB2	O
gene1e	O
/	O
gene1s	O
ASH	O
gene1e	O
and	O
gene1s	O
C3	O
G	O
gene1e	O
,	O
may	O
transduce	O
the	O
signals	O
from	O
tyrosine	O
kinases	O
to	O
Ras	O
in	O
a	O
number	O
of	O
different	O
tissues	O
.	O

gene1s	ARG2
C3	ARG2
G	ARG2
gene1e	ARG2
,	O
a	O
guanine	O
nucleotide	O
-	O
releasing	O
protein	O
expressed	O
ubiquitously	O
,	O
binds	O
to	O
the	O
Src	O
homology	O
3	O
domains	O
of	O
gene1s	ARG2
CRK	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
GRB2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ASH	ARG2
gene1e	ARG2
proteins	O
.	O
gene1s	ARG2
CRK	ARG2
gene1e	ARG2
protein	O
,	O
together	O
with	O
gene1s	ARG2
GRB2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ASH	ARG2
gene1e	ARG2
and	O
Nck	O
proteins	O
,	O
belongs	O
to	O
the	O
adaptor	O
-	O
type	O
Src	O
homology	O
(	O
SH)2-containing	O
molecules	O
,	O
which	O
transduce	O
signals	O
from	O
tyrosine	O
kinases	O
.	O
Here	O
another	O
guanine	O
nucleotide	O
-	O
releasing	O
protein	O
(	O
GNRP	O
)	O
,	O
gene1s	ARG2
C3	ARG2
G	ARG2
gene1e	ARG2
,	O
has	O
been	O
identified	O
as	O
a	O
gene1s	ARG2
CRK	ARG2
SH3-binding	ARG2
protein	ARG2
gene1e	ARG2
.	O
The	O
nucleotide	O
sequence	O
of	O
a	O
4.1-kb	O
gene1s	ARG2
C3	ARG2
G	ARG2
gene1e	ARG2
cDNA	O
contains	O
a	O
3.2-kb	O
open	O
reading	O
frame	O
encoding	O
a	O
121-kDa	O
protein	O
,	O
and	O
antibodies	O
against	O
gene1s	ARG2
C3	ARG2
G	ARG2
gene1e	ARG2
have	O
been	O
shown	O
to	O
detect	O
a	O
protein	O
of	O
130	O
-	O
140	O
kDa	O
.	O
The	O
carboxyl	O
terminus	O
of	O
gene1s	ARG2
C3	ARG2
G	ARG2
gene1e	ARG2
has	O
a	O
peptide	O
sequence	O
homologous	O
to	O
GNRPs	O
for	O
Ras	O
,	O
and	O
the	O
expression	O
of	O
this	O
carboxyl	O
terminus	O
region	O
suppresses	O
the	O
loss	O
of	O
gene1s	O
CDC25	O
gene1e	O
function	O
in	O
the	O
species1s	O
yeast	O
species1e	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
.	O
The	O
gene1s	ARG2
C3	ARG2
G	ARG2
gene1e	ARG2
protein	O
expressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
binds	O
to	O
gene1s	ARG2
CRK	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
GRB2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ASH	ARG2
gene1e	ARG2
proteins	O
.	O
Mutational	O
analysis	O
of	O
gene1s	ARG2
C3	ARG2
G	ARG2
gene1e	ARG2
assigns	O
the	O
SH3	O
binding	O
region	O
to	O
a	O
50-amino	O
acid	O
region	O
containing	O
a	O
proline	O
-	O
rich	O
sequence	O
.	O
The	O
mRNAs	O
of	O
both	O
the	O
gene1s	ARG2
C3	ARG2
G	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CRK	ARG2
gene1e	ARG2
proteins	O
are	O
expressed	O
ubiquitously	O
in	O
arg1s	O
human	O
arg1e	O
adult	O
and	O
fetal	O
tissues	O
.	O
The	O
results	O
of	O
these	O
studies	O
suggest	O
that	O
the	O
complex	O
of	O
gene1s	ARG2
CRK	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
C3	ARG2
G	ARG2
gene1e	ARG2
,	O
or	O
gene1s	ARG2
GRB2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ASH	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
C3	ARG2
G	ARG2
gene1e	ARG2
,	O
may	O
transduce	O
the	O
signals	O
from	O
tyrosine	O
kinases	O
to	O
Ras	O
in	O
a	O
number	O
of	O
different	O
tissues	O
.	O

A	O
novel	O
arg1s	O
mammalian	O
arg1e	O
protein	O
,	O
gene1s	ARG2
p55CDC	ARG2
gene1e	ARG2
,	O
present	O
in	O
dividing	O
cells	O
is	O
associated	O
with	O
protein	O
kinase	O
activity	O
and	O
has	O
homology	O
to	O
the	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
cell	O
division	O
cycle	O
proteins	O
gene1s	O
Cdc20	O
gene1e	O
and	O
gene1s	O
Cdc4	O
gene1e	O
.	O
A	O
novel	O
protein	O
,	O
gene1s	ARG2
p55CDC	ARG2
gene1e	ARG2
,	O
has	O
been	O
identified	O
in	O
cycling	O
arg1s	O
mammalian	O
arg1e	O
cells	O
.	O
This	O
transcript	O
is	O
readily	O
detectable	O
in	O
all	O
exponentially	O
growing	O
cell	O
lines	O
but	O
disappears	O
when	O
cells	O
are	O
chemically	O
induced	O
to	O
fall	O
out	O
of	O
the	O
cell	O
cycle	O
and	O
differentiate	O
.	O
The	O
gene1s	ARG2
p55CDC	ARG2
gene1e	ARG2
protein	O
appears	O
to	O
be	O
essential	O
for	O
cell	O
division	O
,	O
since	O
transfection	O
of	O
antisense	O
gene1s	ARG2
p55CDC	ARG2
gene1e	ARG2
cDNA	O
into	O
species1s	O
CHO	O
species1e	O
cells	O
resulted	O
in	O
isolation	O
of	O
only	O
those	O
cells	O
which	O
exhibited	O
a	O
compensatory	O
increase	O
in	O
gene1s	ARG2
p55CDC	ARG2
gene1e	ARG2
transcripts	O
in	O
the	O
sense	O
orientation	O
.	O
Immunoprecipitation	O
of	O
gene1s	ARG2
p55CDC	ARG2
gene1e	ARG2
yielded	O
protein	O
complexes	O
with	O
kinase	O
activity	O
which	O
fluctuated	O
during	O
the	O
cell	O
cycle	O
.	O
Since	O
gene1s	ARG2
p55CDC	ARG2
gene1e	ARG2
does	O
not	O
have	O
the	O
conserved	O
protein	O
kinase	O
domains	O
,	O
this	O
activity	O
must	O
be	O
due	O
to	O
one	O
or	O
more	O
of	O
the	O
associated	O
proteins	O
in	O
the	O
immune	O
complex	O
.	O
The	O
highest	O
levels	O
of	O
protein	O
kinase	O
activity	O
were	O
seen	O
with	O
alpha	O
-	O
casein	O
and	O
gene1s	ARG2
myelin	ARG2
basic	ARG2
protein	ARG2
gene1e	ARG2
as	O
substrates	O
and	O
demonstrated	O
a	O
pattern	O
of	O
activity	O
distinct	O
from	O
that	O
described	O
for	O
the	O
known	O
cyclin	O
-	O
dependent	O
cell	O
division	O
kinases	O
.	O
The	O
gene1s	ARG2
p55CDC	ARG2
gene1e	ARG2
protein	O
was	O
also	O
phosphorylated	O
in	O
dividing	O
cells	O
.	O
The	O
amino	O
acid	O
sequence	O
of	O
gene1s	ARG2
p55CDC	ARG2
gene1e	ARG2
contains	O
seven	O
repeats	O
homologous	O
to	O
the	O
beta	O
subunit	O
of	O
G	O
proteins	O
,	O
and	O
the	O
highest	O
degree	O
of	O
homology	O
in	O
these	O
repeats	O
was	O
found	O
with	O
the	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
gene1s	O
Cdc20	O
gene1e	O
and	O
gene1s	O
Cdc4	O
gene1e	O
proteins	O
,	O
which	O
have	O
been	O
proposed	O
to	O
be	O
involved	O
in	O
the	O
formation	O
of	O
a	O
functional	O
bipolar	O
mitotic	O
spindle	O
in	O
species1s	O
yeast	O
species1e	O
cells	O
.	O
The	O
G	O
beta	O
repeat	O
has	O
been	O
postulated	O
to	O
mediate	O
protein	O
-	O
protein	O
interactions	O
and	O
,	O
in	O
gene1s	ARG2
p55CDC	ARG2
gene1e	ARG2
,	O
may	O
modulate	O
its	O
association	O
with	O
a	O
unique	O
cell	O
cycle	O
protein	O
kinase	O
.	O
These	O
findings	O
suggest	O
that	O
gene1s	ARG2
p55CDC	ARG2
gene1e	ARG2
is	O
a	O
component	O
of	O
the	O
arg1s	O
mammalian	O
arg1e	O
cell	O
cycle	O
mechanism	O
.	O

A	O
novel	O
species1s	O
mammalian	O
species1e	O
protein	O
,	O
gene1s	O
p55CDC	O
gene1e	O
,	O
present	O
in	O
dividing	O
cells	O
is	O
associated	O
with	O
protein	O
kinase	O
activity	O
and	O
has	O
homology	O
to	O
the	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
cell	O
division	O
cycle	O
proteins	O
gene1s	ARG2
Cdc20	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Cdc4	ARG2
gene1e	ARG2
.	O
A	O
novel	O
protein	O
,	O
gene1s	O
p55CDC	O
gene1e	O
,	O
has	O
been	O
identified	O
in	O
cycling	O
species1s	O
mammalian	O
species1e	O
cells	O
.	O
This	O
transcript	O
is	O
readily	O
detectable	O
in	O
all	O
exponentially	O
growing	O
cell	O
lines	O
but	O
disappears	O
when	O
cells	O
are	O
chemically	O
induced	O
to	O
fall	O
out	O
of	O
the	O
cell	O
cycle	O
and	O
differentiate	O
.	O
The	O
gene1s	O
p55CDC	O
gene1e	O
protein	O
appears	O
to	O
be	O
essential	O
for	O
cell	O
division	O
,	O
since	O
transfection	O
of	O
antisense	O
gene1s	O
p55CDC	O
gene1e	O
cDNA	O
into	O
species1s	O
CHO	O
species1e	O
cells	O
resulted	O
in	O
isolation	O
of	O
only	O
those	O
cells	O
which	O
exhibited	O
a	O
compensatory	O
increase	O
in	O
gene1s	O
p55CDC	O
gene1e	O
transcripts	O
in	O
the	O
sense	O
orientation	O
.	O
Immunoprecipitation	O
of	O
gene1s	O
p55CDC	O
gene1e	O
yielded	O
protein	O
complexes	O
with	O
kinase	O
activity	O
which	O
fluctuated	O
during	O
the	O
cell	O
cycle	O
.	O
Since	O
gene1s	O
p55CDC	O
gene1e	O
does	O
not	O
have	O
the	O
conserved	O
protein	O
kinase	O
domains	O
,	O
this	O
activity	O
must	O
be	O
due	O
to	O
one	O
or	O
more	O
of	O
the	O
associated	O
proteins	O
in	O
the	O
immune	O
complex	O
.	O
The	O
highest	O
levels	O
of	O
protein	O
kinase	O
activity	O
were	O
seen	O
with	O
alpha	O
-	O
casein	O
and	O
gene1s	O
myelin	O
basic	O
protein	O
gene1e	O
as	O
substrates	O
and	O
demonstrated	O
a	O
pattern	O
of	O
activity	O
distinct	O
from	O
that	O
described	O
for	O
the	O
known	O
cyclin	O
-	O
dependent	O
cell	O
division	O
kinases	O
.	O
The	O
gene1s	O
p55CDC	O
gene1e	O
protein	O
was	O
also	O
phosphorylated	O
in	O
dividing	O
cells	O
.	O
The	O
amino	O
acid	O
sequence	O
of	O
gene1s	O
p55CDC	O
gene1e	O
contains	O
seven	O
repeats	O
homologous	O
to	O
the	O
beta	O
subunit	O
of	O
G	O
proteins	O
,	O
and	O
the	O
highest	O
degree	O
of	O
homology	O
in	O
these	O
repeats	O
was	O
found	O
with	O
the	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
gene1s	ARG2
Cdc20	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Cdc4	ARG2
gene1e	ARG2
proteins	O
,	O
which	O
have	O
been	O
proposed	O
to	O
be	O
involved	O
in	O
the	O
formation	O
of	O
a	O
functional	O
bipolar	O
mitotic	O
spindle	O
in	O
arg1s	O
yeast	O
arg1e	O
cells	O
.	O
The	O
G	O
beta	O
repeat	O
has	O
been	O
postulated	O
to	O
mediate	O
protein	O
-	O
protein	O
interactions	O
and	O
,	O
in	O
gene1s	O
p55CDC	O
gene1e	O
,	O
may	O
modulate	O
its	O
association	O
with	O
a	O
unique	O
cell	O
cycle	O
protein	O
kinase	O
.	O
These	O
findings	O
suggest	O
that	O
gene1s	O
p55CDC	O
gene1e	O
is	O
a	O
component	O
of	O
the	O
species1s	O
mammalian	O
species1e	O
cell	O
cycle	O
mechanism	O
.	O

A	O
novel	O
species1s	O
mammalian	O
species1e	O
protein	O
,	O
gene1s	O
p55CDC	O
gene1e	O
,	O
present	O
in	O
dividing	O
cells	O
is	O
associated	O
with	O
protein	O
kinase	O
activity	O
and	O
has	O
homology	O
to	O
the	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
cell	O
division	O
cycle	O
proteins	O
gene1s	O
Cdc20	O
gene1e	O
and	O
gene1s	O
Cdc4	O
gene1e	O
.	O
A	O
novel	O
protein	O
,	O
gene1s	O
p55CDC	O
gene1e	O
,	O
has	O
been	O
identified	O
in	O
cycling	O
species1s	O
mammalian	O
species1e	O
cells	O
.	O
This	O
transcript	O
is	O
readily	O
detectable	O
in	O
all	O
exponentially	O
growing	O
cell	O
lines	O
but	O
disappears	O
when	O
cells	O
are	O
chemically	O
induced	O
to	O
fall	O
out	O
of	O
the	O
cell	O
cycle	O
and	O
differentiate	O
.	O
The	O
gene1s	O
p55CDC	O
gene1e	O
protein	O
appears	O
to	O
be	O
essential	O
for	O
cell	O
division	O
,	O
since	O
transfection	O
of	O
antisense	O
gene1s	O
p55CDC	O
gene1e	O
cDNA	O
into	O
arg1s	O
CHO	O
arg1e	O
cells	O
resulted	O
in	O
isolation	O
of	O
only	O
those	O
cells	O
which	O
exhibited	O
a	O
compensatory	O
increase	O
in	O
gene1s	O
p55CDC	O
gene1e	O
transcripts	O
in	O
the	O
sense	O
orientation	O
.	O
Immunoprecipitation	O
of	O
gene1s	O
p55CDC	O
gene1e	O
yielded	O
protein	O
complexes	O
with	O
kinase	O
activity	O
which	O
fluctuated	O
during	O
the	O
cell	O
cycle	O
.	O
Since	O
gene1s	O
p55CDC	O
gene1e	O
does	O
not	O
have	O
the	O
conserved	O
protein	O
kinase	O
domains	O
,	O
this	O
activity	O
must	O
be	O
due	O
to	O
one	O
or	O
more	O
of	O
the	O
associated	O
proteins	O
in	O
the	O
immune	O
complex	O
.	O
The	O
highest	O
levels	O
of	O
protein	O
kinase	O
activity	O
were	O
seen	O
with	O
alpha	O
-	O
casein	O
and	O
gene1s	O
myelin	O
basic	O
protein	O
gene1e	O
as	O
substrates	O
and	O
demonstrated	O
a	O
pattern	O
of	O
activity	O
distinct	O
from	O
that	O
described	O
for	O
the	O
known	O
cyclin	O
-	O
dependent	O
cell	O
division	O
kinases	O
.	O
The	O
gene1s	O
p55CDC	O
gene1e	O
protein	O
was	O
also	O
phosphorylated	O
in	O
dividing	O
cells	O
.	O
The	O
amino	O
acid	O
sequence	O
of	O
gene1s	O
p55CDC	O
gene1e	O
contains	O
seven	O
repeats	O
homologous	O
to	O
the	O
beta	O
subunit	O
of	O
G	O
proteins	O
,	O
and	O
the	O
highest	O
degree	O
of	O
homology	O
in	O
these	O
repeats	O
was	O
found	O
with	O
the	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
gene1s	O
Cdc20	O
gene1e	O
and	O
gene1s	O
Cdc4	O
gene1e	O
proteins	O
,	O
which	O
have	O
been	O
proposed	O
to	O
be	O
involved	O
in	O
the	O
formation	O
of	O
a	O
functional	O
bipolar	O
mitotic	O
spindle	O
in	O
species1s	O
yeast	O
species1e	O
cells	O
.	O
The	O
G	O
beta	O
repeat	O
has	O
been	O
postulated	O
to	O
mediate	O
protein	O
-	O
protein	O
interactions	O
and	O
,	O
in	O
gene1s	O
p55CDC	O
gene1e	O
,	O
may	O
modulate	O
its	O
association	O
with	O
a	O
unique	O
cell	O
cycle	O
protein	O
kinase	O
.	O
These	O
findings	O
suggest	O
that	O
gene1s	O
p55CDC	O
gene1e	O
is	O
a	O
component	O
of	O
the	O
species1s	O
mammalian	O
species1e	O
cell	O
cycle	O
mechanism	O
.	O

The	O
immunoreactive	O
region	O
in	O
a	O
novel	O
autoantigen	O
contains	O
a	O
nuclear	O
localization	O
sequence	O
.	O
Antibodies	O
in	O
the	O
serum	O
of	O
arg1s	O
patients	O
arg1e	O
with	O
autoimmune	O
diseases	O
have	O
been	O
used	O
to	O
identify	O
arg1s	O
human	O
arg1e	O
autoantigens	O
.	O
Because	O
autoantibodies	O
often	O
recognize	O
active	O
sites	O
within	O
corresponding	O
protein	O
antigens	O
,	O
autoantibodies	O
have	O
facilitated	O
the	O
functional	O
characterization	O
of	O
these	O
polypeptides	O
.	O
In	O
the	O
present	O
study	O
,	O
serum	O
from	O
a	O
arg1s	O
patient	O
arg1e	O
with	O
Sjgren	O
's	O
syndrome	O
was	O
used	O
to	O
identify	O
a	O
novel	O
autoantigen	O
which	O
was	O
designated	O
gene1s	ARG2
Ge-1	ARG2
gene1e	ARG2
.	O
Using	O
the	O
arg1s	O
patient	O
arg1e	O
's	O
serum	O
,	O
a	O
4.8-kb	O
cDNA	O
encoding	O
gene1s	ARG2
Ge-1	ARG2
gene1e	ARG2
was	O
identified	O
.	O
Fragments	O
of	O
the	O
cDNA	O
were	O
ligated	O
into	O
prokaryotic	O
species1s	O
expression	O
vectors	O
species1e	O
,	O
expressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
,	O
and	O
used	O
to	O
produce	O
recombinant	O
Ge-1	O
fusion	O
proteins	O
.	O
Fusion	O
proteins	O
containing	O
different	O
portions	O
of	O
gene1s	ARG2
Ge-1	ARG2
gene1e	ARG2
were	O
used	O
to	O
identify	O
a	O
58	O
amino	O
acid	O
immunoreactive	O
region	O
within	O
the	O
protein	O
.	O
This	O
immunoreactive	O
region	O
contained	O
the	O
protein	O
's	O
putative	O
nuclear	O
localization	O
sequence	O
(	O
NLS	O
)	O
.	O
To	O
demonstrate	O
that	O
the	O
immunoreactive	O
region	O
was	O
capable	O
of	O
functioning	O
as	O
a	O
NLS	O
,	O
a	O
eukaryotic	O
species1s	O
expression	O
species1e	O
plasmid	O
was	O
constructed	O
to	O
encode	O
the	O
immunoreactive	O
region	O
fused	O
to	O
the	O
cytoplasmic	O
protein	O
,	O
species1s	O
chicken	O
species1e	O
muscle	O
pyruvate	O
kinase	O
.	O
After	O
transfection	O
of	O
this	O
plasmid	O
into	O
species1s	O
COS-1	O
species1e	O
cells	O
,	O
the	O
fusion	O
protein	O
was	O
detected	O
in	O
the	O
nucleus	O
.	O
The	O
presence	O
of	O
the	O
NLS	O
motif	O
within	O
the	O
immunoreactive	O
region	O
of	O
gene1s	ARG2
Ge-1	ARG2
gene1e	ARG2
and	O
other	O
nuclear	O
autoantigens	O
suggests	O
that	O
the	O
NLS	O
may	O
be	O
a	O
target	O
of	O
arg1s	O
human	O
arg1e	O
autoantibodies	O
.	O

The	O
immunoreactive	O
region	O
in	O
a	O
novel	O
autoantigen	O
contains	O
a	O
nuclear	O
localization	O
sequence	O
.	O
Antibodies	O
in	O
the	O
serum	O
of	O
species1s	O
patients	O
species1e	O
with	O
autoimmune	O
diseases	O
have	O
been	O
used	O
to	O
identify	O
species1s	O
human	O
species1e	O
autoantigens	O
.	O
Because	O
autoantibodies	O
often	O
recognize	O
active	O
sites	O
within	O
corresponding	O
protein	O
antigens	O
,	O
autoantibodies	O
have	O
facilitated	O
the	O
functional	O
characterization	O
of	O
these	O
polypeptides	O
.	O
In	O
the	O
present	O
study	O
,	O
serum	O
from	O
a	O
species1s	O
patient	O
species1e	O
with	O
Sjgren	O
's	O
syndrome	O
was	O
used	O
to	O
identify	O
a	O
novel	O
autoantigen	O
which	O
was	O
designated	O
gene1s	O
Ge-1	O
gene1e	O
.	O
Using	O
the	O
species1s	O
patient	O
species1e	O
's	O
serum	O
,	O
a	O
4.8-kb	O
cDNA	O
encoding	O
gene1s	O
Ge-1	O
gene1e	O
was	O
identified	O
.	O
Fragments	O
of	O
the	O
cDNA	O
were	O
ligated	O
into	O
prokaryotic	O
arg1s	O
expression	O
vectors	O
arg1e	O
,	O
expressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
,	O
and	O
used	O
to	O
produce	O
recombinant	O
Ge-1	O
fusion	O
proteins	O
.	O
Fusion	O
proteins	O
containing	O
different	O
portions	O
of	O
gene1s	O
Ge-1	O
gene1e	O
were	O
used	O
to	O
identify	O
a	O
58	O
amino	O
acid	O
immunoreactive	O
region	O
within	O
the	O
protein	O
.	O
This	O
immunoreactive	O
region	O
contained	O
the	O
protein	O
's	O
putative	O
nuclear	O
localization	O
sequence	O
(	O
NLS	O
)	O
.	O
To	O
demonstrate	O
that	O
the	O
immunoreactive	O
region	O
was	O
capable	O
of	O
functioning	O
as	O
a	O
NLS	O
,	O
a	O
eukaryotic	O
arg1s	O
expression	O
arg1e	O
plasmid	O
was	O
constructed	O
to	O
encode	O
the	O
immunoreactive	O
region	O
fused	O
to	O
the	O
cytoplasmic	O
protein	O
,	O
species1s	O
chicken	O
species1e	O
muscle	O
pyruvate	O
kinase	O
.	O
After	O
transfection	O
of	O
this	O
plasmid	O
into	O
species1s	O
COS-1	O
species1e	O
cells	O
,	O
the	O
fusion	O
protein	O
was	O
detected	O
in	O
the	O
nucleus	O
.	O
The	O
presence	O
of	O
the	O
NLS	O
motif	O
within	O
the	O
immunoreactive	O
region	O
of	O
gene1s	O
Ge-1	O
gene1e	O
and	O
other	O
nuclear	O
autoantigens	O
suggests	O
that	O
the	O
NLS	O
may	O
be	O
a	O
target	O
of	O
species1s	O
human	O
species1e	O
autoantibodies	O
.	O

The	O
immunoreactive	O
region	O
in	O
a	O
novel	O
autoantigen	O
contains	O
a	O
nuclear	O
localization	O
sequence	O
.	O
Antibodies	O
in	O
the	O
serum	O
of	O
species1s	O
patients	O
species1e	O
with	O
autoimmune	O
diseases	O
have	O
been	O
used	O
to	O
identify	O
species1s	O
human	O
species1e	O
autoantigens	O
.	O
Because	O
autoantibodies	O
often	O
recognize	O
active	O
sites	O
within	O
corresponding	O
protein	O
antigens	O
,	O
autoantibodies	O
have	O
facilitated	O
the	O
functional	O
characterization	O
of	O
these	O
polypeptides	O
.	O
In	O
the	O
present	O
study	O
,	O
serum	O
from	O
a	O
species1s	O
patient	O
species1e	O
with	O
Sjgren	O
's	O
syndrome	O
was	O
used	O
to	O
identify	O
a	O
novel	O
autoantigen	O
which	O
was	O
designated	O
gene1s	O
Ge-1	O
gene1e	O
.	O
Using	O
the	O
species1s	O
patient	O
species1e	O
's	O
serum	O
,	O
a	O
4.8-kb	O
cDNA	O
encoding	O
gene1s	O
Ge-1	O
gene1e	O
was	O
identified	O
.	O
Fragments	O
of	O
the	O
cDNA	O
were	O
ligated	O
into	O
prokaryotic	O
species1s	O
expression	O
vectors	O
species1e	O
,	O
expressed	O
in	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
,	O
and	O
used	O
to	O
produce	O
recombinant	O
Ge-1	O
fusion	O
proteins	O
.	O
Fusion	O
proteins	O
containing	O
different	O
portions	O
of	O
gene1s	O
Ge-1	O
gene1e	O
were	O
used	O
to	O
identify	O
a	O
58	O
amino	O
acid	O
immunoreactive	O
region	O
within	O
the	O
protein	O
.	O
This	O
immunoreactive	O
region	O
contained	O
the	O
protein	O
's	O
putative	O
nuclear	O
localization	O
sequence	O
(	O
NLS	O
)	O
.	O
To	O
demonstrate	O
that	O
the	O
immunoreactive	O
region	O
was	O
capable	O
of	O
functioning	O
as	O
a	O
NLS	O
,	O
a	O
eukaryotic	O
species1s	O
expression	O
species1e	O
plasmid	O
was	O
constructed	O
to	O
encode	O
the	O
immunoreactive	O
region	O
fused	O
to	O
the	O
cytoplasmic	O
protein	O
,	O
species1s	O
chicken	O
species1e	O
muscle	O
pyruvate	O
kinase	O
.	O
After	O
transfection	O
of	O
this	O
plasmid	O
into	O
species1s	O
COS-1	O
species1e	O
cells	O
,	O
the	O
fusion	O
protein	O
was	O
detected	O
in	O
the	O
nucleus	O
.	O
The	O
presence	O
of	O
the	O
NLS	O
motif	O
within	O
the	O
immunoreactive	O
region	O
of	O
gene1s	O
Ge-1	O
gene1e	O
and	O
other	O
nuclear	O
autoantigens	O
suggests	O
that	O
the	O
NLS	O
may	O
be	O
a	O
target	O
of	O
species1s	O
human	O
species1e	O
autoantibodies	O
.	O

The	O
immunoreactive	O
region	O
in	O
a	O
novel	O
autoantigen	O
contains	O
a	O
nuclear	O
localization	O
sequence	O
.	O
Antibodies	O
in	O
the	O
serum	O
of	O
species1s	O
patients	O
species1e	O
with	O
autoimmune	O
diseases	O
have	O
been	O
used	O
to	O
identify	O
species1s	O
human	O
species1e	O
autoantigens	O
.	O
Because	O
autoantibodies	O
often	O
recognize	O
active	O
sites	O
within	O
corresponding	O
protein	O
antigens	O
,	O
autoantibodies	O
have	O
facilitated	O
the	O
functional	O
characterization	O
of	O
these	O
polypeptides	O
.	O
In	O
the	O
present	O
study	O
,	O
serum	O
from	O
a	O
species1s	O
patient	O
species1e	O
with	O
Sjgren	O
's	O
syndrome	O
was	O
used	O
to	O
identify	O
a	O
novel	O
autoantigen	O
which	O
was	O
designated	O
gene1s	O
Ge-1	O
gene1e	O
.	O
Using	O
the	O
species1s	O
patient	O
species1e	O
's	O
serum	O
,	O
a	O
4.8-kb	O
cDNA	O
encoding	O
gene1s	O
Ge-1	O
gene1e	O
was	O
identified	O
.	O
Fragments	O
of	O
the	O
cDNA	O
were	O
ligated	O
into	O
prokaryotic	O
species1s	O
expression	O
vectors	O
species1e	O
,	O
expressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
,	O
and	O
used	O
to	O
produce	O
recombinant	O
Ge-1	O
fusion	O
proteins	O
.	O
Fusion	O
proteins	O
containing	O
different	O
portions	O
of	O
gene1s	O
Ge-1	O
gene1e	O
were	O
used	O
to	O
identify	O
a	O
58	O
amino	O
acid	O
immunoreactive	O
region	O
within	O
the	O
protein	O
.	O
This	O
immunoreactive	O
region	O
contained	O
the	O
protein	O
's	O
putative	O
nuclear	O
localization	O
sequence	O
(	O
NLS	O
)	O
.	O
To	O
demonstrate	O
that	O
the	O
immunoreactive	O
region	O
was	O
capable	O
of	O
functioning	O
as	O
a	O
NLS	O
,	O
a	O
eukaryotic	O
species1s	O
expression	O
species1e	O
plasmid	O
was	O
constructed	O
to	O
encode	O
the	O
immunoreactive	O
region	O
fused	O
to	O
the	O
cytoplasmic	O
protein	O
,	O
arg1s	O
chicken	O
arg1e	O
muscle	O
pyruvate	O
kinase	O
.	O
After	O
transfection	O
of	O
this	O
plasmid	O
into	O
species1s	O
COS-1	O
species1e	O
cells	O
,	O
the	O
fusion	O
protein	O
was	O
detected	O
in	O
the	O
nucleus	O
.	O
The	O
presence	O
of	O
the	O
NLS	O
motif	O
within	O
the	O
immunoreactive	O
region	O
of	O
gene1s	O
Ge-1	O
gene1e	O
and	O
other	O
nuclear	O
autoantigens	O
suggests	O
that	O
the	O
NLS	O
may	O
be	O
a	O
target	O
of	O
species1s	O
human	O
species1e	O
autoantibodies	O
.	O

The	O
immunoreactive	O
region	O
in	O
a	O
novel	O
autoantigen	O
contains	O
a	O
nuclear	O
localization	O
sequence	O
.	O
Antibodies	O
in	O
the	O
serum	O
of	O
species1s	O
patients	O
species1e	O
with	O
autoimmune	O
diseases	O
have	O
been	O
used	O
to	O
identify	O
species1s	O
human	O
species1e	O
autoantigens	O
.	O
Because	O
autoantibodies	O
often	O
recognize	O
active	O
sites	O
within	O
corresponding	O
protein	O
antigens	O
,	O
autoantibodies	O
have	O
facilitated	O
the	O
functional	O
characterization	O
of	O
these	O
polypeptides	O
.	O
In	O
the	O
present	O
study	O
,	O
serum	O
from	O
a	O
species1s	O
patient	O
species1e	O
with	O
Sjgren	O
's	O
syndrome	O
was	O
used	O
to	O
identify	O
a	O
novel	O
autoantigen	O
which	O
was	O
designated	O
gene1s	O
Ge-1	O
gene1e	O
.	O
Using	O
the	O
species1s	O
patient	O
species1e	O
's	O
serum	O
,	O
a	O
4.8-kb	O
cDNA	O
encoding	O
gene1s	O
Ge-1	O
gene1e	O
was	O
identified	O
.	O
Fragments	O
of	O
the	O
cDNA	O
were	O
ligated	O
into	O
prokaryotic	O
species1s	O
expression	O
vectors	O
species1e	O
,	O
expressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
,	O
and	O
used	O
to	O
produce	O
recombinant	O
Ge-1	O
fusion	O
proteins	O
.	O
Fusion	O
proteins	O
containing	O
different	O
portions	O
of	O
gene1s	O
Ge-1	O
gene1e	O
were	O
used	O
to	O
identify	O
a	O
58	O
amino	O
acid	O
immunoreactive	O
region	O
within	O
the	O
protein	O
.	O
This	O
immunoreactive	O
region	O
contained	O
the	O
protein	O
's	O
putative	O
nuclear	O
localization	O
sequence	O
(	O
NLS	O
)	O
.	O
To	O
demonstrate	O
that	O
the	O
immunoreactive	O
region	O
was	O
capable	O
of	O
functioning	O
as	O
a	O
NLS	O
,	O
a	O
eukaryotic	O
species1s	O
expression	O
species1e	O
plasmid	O
was	O
constructed	O
to	O
encode	O
the	O
immunoreactive	O
region	O
fused	O
to	O
the	O
cytoplasmic	O
protein	O
,	O
species1s	O
chicken	O
species1e	O
muscle	O
pyruvate	O
kinase	O
.	O
After	O
transfection	O
of	O
this	O
plasmid	O
into	O
arg1s	O
COS-1	O
arg1e	O
cells	O
,	O
the	O
fusion	O
protein	O
was	O
detected	O
in	O
the	O
nucleus	O
.	O
The	O
presence	O
of	O
the	O
NLS	O
motif	O
within	O
the	O
immunoreactive	O
region	O
of	O
gene1s	O
Ge-1	O
gene1e	O
and	O
other	O
nuclear	O
autoantigens	O
suggests	O
that	O
the	O
NLS	O
may	O
be	O
a	O
target	O
of	O
species1s	O
human	O
species1e	O
autoantibodies	O
.	O

Molecular	O
characterization	O
of	O
an	O
aquaporin	O
cDNA	O
from	O
brain	O
:	O
candidate	O
osmoreceptor	O
and	O
regulator	O
of	O
water	O
balance	O
.	O
The	O
aquaporins	O
transport	O
water	O
through	O
membranes	O
of	O
numerous	O
tissues	O
,	O
but	O
the	O
molecular	O
mechanisms	O
for	O
sensing	O
changes	O
in	O
extracellular	O
osmolality	O
and	O
regulating	O
water	O
balance	O
in	O
brain	O
are	O
unknown	O
.	O
We	O
have	O
isolated	O
a	O
brain	O
aquaporin	O
by	O
homology	O
cloning	O
.	O
Like	O
gene1s	O
aquaporin	O
1	O
gene1e	O
(	O
gene1s	O
AQP1	O
gene1e	O
,	O
also	O
known	O
as	O
gene1s	O
CHIP	O
gene1e	O
,	O
gene1s	O
channel	O
-	O
forming	O
integral	O
membrane	O
protein	O
of	O
28	O
kDa	O
gene1e	O
)	O
,	O
the	O
deduced	O
polypeptide	O
has	O
six	O
putative	O
transmembrane	O
domains	O
but	O
lacks	O
cysteines	O
at	O
the	O
known	O
mercury	O
-	O
sensitive	O
sites	O
.	O
Two	O
initiation	O
sites	O
were	O
identified	O
encoding	O
polypeptides	O
of	O
301	O
and	O
323	O
amino	O
acids	O
;	O
expression	O
of	O
each	O
in	O
arg1s	O
Xenopus	O
arg1e	O
oocytes	O
conferred	O
a	O
20-fold	O
increase	O
in	O
osmotic	O
water	O
permeability	O
not	O
blocked	O
by	O
1	O
mM	O
HgCl2	O
,	O
even	O
after	O
substitution	O
of	O
cysteine	O
at	O
the	O
predicted	O
mercury	O
-	O
sensitive	O
site	O
.	O
Northern	O
analysis	O
and	O
RNase	O
protection	O
demonstrated	O
the	O
mRNA	O
to	O
be	O
abundant	O
in	O
mature	O
species1s	O
rat	O
species1e	O
brain	O
but	O
only	O
weakly	O
detectable	O
in	O
eye	O
,	O
kidney	O
,	O
intestine	O
,	O
and	O
lung	O
.	O
In	O
situ	O
hybridization	O
of	O
brain	O
localized	O
the	O
mRNA	O
to	O
ependymal	O
cells	O
lining	O
the	O
aqueduct	O
,	O
glial	O
cells	O
forming	O
the	O
edge	O
of	O
the	O
cerebral	O
cortex	O
and	O
brainstem	O
,	O
vasopressin	O
-	O
secretory	O
neurons	O
in	O
supraoptic	O
and	O
paraventricular	O
nuclei	O
of	O
hypothalamus	O
,	O
and	O
Purkinje	O
cells	O
of	O
cerebellum	O
.	O
Its	O
distinctive	O
expression	O
pattern	O
implicates	O
this	O
fourth	O
species1s	O
mammalian	O
species1e	O
member	O
of	O
the	O
aquaporin	O
water	O
channel	O
family	O
(	O
designated	O
gene	O
symbol	O
,	O
gene1s	O
AQP4	O
gene1e	O
)	O
as	O
the	O
osmoreceptor	O
which	O
regulates	O
body	O
water	O
balance	O
and	O
mediates	O
water	O
flow	O
within	O
the	O
central	O
nervous	O
system	O
.	O

Molecular	O
characterization	O
of	O
an	O
aquaporin	O
cDNA	O
from	O
brain	O
:	O
candidate	O
osmoreceptor	O
and	O
regulator	O
of	O
water	O
balance	O
.	O
The	O
aquaporins	O
transport	O
water	O
through	O
membranes	O
of	O
numerous	O
tissues	O
,	O
but	O
the	O
molecular	O
mechanisms	O
for	O
sensing	O
changes	O
in	O
extracellular	O
osmolality	O
and	O
regulating	O
water	O
balance	O
in	O
brain	O
are	O
unknown	O
.	O
We	O
have	O
isolated	O
a	O
brain	O
aquaporin	O
by	O
homology	O
cloning	O
.	O
Like	O
gene1s	O
aquaporin	O
1	O
gene1e	O
(	O
gene1s	O
AQP1	O
gene1e	O
,	O
also	O
known	O
as	O
gene1s	O
CHIP	O
gene1e	O
,	O
gene1s	O
channel	O
-	O
forming	O
integral	O
membrane	O
protein	O
of	O
28	O
kDa	O
gene1e	O
)	O
,	O
the	O
deduced	O
polypeptide	O
has	O
six	O
putative	O
transmembrane	O
domains	O
but	O
lacks	O
cysteines	O
at	O
the	O
known	O
mercury	O
-	O
sensitive	O
sites	O
.	O
Two	O
initiation	O
sites	O
were	O
identified	O
encoding	O
polypeptides	O
of	O
301	O
and	O
323	O
amino	O
acids	O
;	O
expression	O
of	O
each	O
in	O
species1s	O
Xenopus	O
species1e	O
oocytes	O
conferred	O
a	O
20-fold	O
increase	O
in	O
osmotic	O
water	O
permeability	O
not	O
blocked	O
by	O
1	O
mM	O
HgCl2	O
,	O
even	O
after	O
substitution	O
of	O
cysteine	O
at	O
the	O
predicted	O
mercury	O
-	O
sensitive	O
site	O
.	O
Northern	O
analysis	O
and	O
RNase	O
protection	O
demonstrated	O
the	O
mRNA	O
to	O
be	O
abundant	O
in	O
mature	O
arg1s	O
rat	O
arg1e	O
brain	O
but	O
only	O
weakly	O
detectable	O
in	O
eye	O
,	O
kidney	O
,	O
intestine	O
,	O
and	O
lung	O
.	O
In	O
situ	O
hybridization	O
of	O
brain	O
localized	O
the	O
mRNA	O
to	O
ependymal	O
cells	O
lining	O
the	O
aqueduct	O
,	O
glial	O
cells	O
forming	O
the	O
edge	O
of	O
the	O
cerebral	O
cortex	O
and	O
brainstem	O
,	O
vasopressin	O
-	O
secretory	O
neurons	O
in	O
supraoptic	O
and	O
paraventricular	O
nuclei	O
of	O
hypothalamus	O
,	O
and	O
Purkinje	O
cells	O
of	O
cerebellum	O
.	O
Its	O
distinctive	O
expression	O
pattern	O
implicates	O
this	O
fourth	O
species1s	O
mammalian	O
species1e	O
member	O
of	O
the	O
aquaporin	O
water	O
channel	O
family	O
(	O
designated	O
gene	O
symbol	O
,	O
gene1s	O
AQP4	O
gene1e	O
)	O
as	O
the	O
osmoreceptor	O
which	O
regulates	O
body	O
water	O
balance	O
and	O
mediates	O
water	O
flow	O
within	O
the	O
central	O
nervous	O
system	O
.	O

Molecular	O
characterization	O
of	O
an	O
aquaporin	O
cDNA	O
from	O
brain	O
:	O
candidate	O
osmoreceptor	O
and	O
regulator	O
of	O
water	O
balance	O
.	O
The	O
aquaporins	O
transport	O
water	O
through	O
membranes	O
of	O
numerous	O
tissues	O
,	O
but	O
the	O
molecular	O
mechanisms	O
for	O
sensing	O
changes	O
in	O
extracellular	O
osmolality	O
and	O
regulating	O
water	O
balance	O
in	O
brain	O
are	O
unknown	O
.	O
We	O
have	O
isolated	O
a	O
brain	O
aquaporin	O
by	O
homology	O
cloning	O
.	O
Like	O
gene1s	ARG2
aquaporin	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
AQP1	ARG2
gene1e	ARG2
,	O
also	O
known	O
as	O
gene1s	ARG2
CHIP	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
channel	ARG2
-	ARG2
forming	ARG2
integral	ARG2
membrane	ARG2
protein	ARG2
of	ARG2
28	ARG2
kDa	ARG2
gene1e	ARG2
)	O
,	O
the	O
deduced	O
polypeptide	O
has	O
six	O
putative	O
transmembrane	O
domains	O
but	O
lacks	O
cysteines	O
at	O
the	O
known	O
mercury	O
-	O
sensitive	O
sites	O
.	O
Two	O
initiation	O
sites	O
were	O
identified	O
encoding	O
polypeptides	O
of	O
301	O
and	O
323	O
amino	O
acids	O
;	O
expression	O
of	O
each	O
in	O
species1s	O
Xenopus	O
species1e	O
oocytes	O
conferred	O
a	O
20-fold	O
increase	O
in	O
osmotic	O
water	O
permeability	O
not	O
blocked	O
by	O
1	O
mM	O
HgCl2	O
,	O
even	O
after	O
substitution	O
of	O
cysteine	O
at	O
the	O
predicted	O
mercury	O
-	O
sensitive	O
site	O
.	O
Northern	O
analysis	O
and	O
RNase	O
protection	O
demonstrated	O
the	O
mRNA	O
to	O
be	O
abundant	O
in	O
mature	O
species1s	O
rat	O
species1e	O
brain	O
but	O
only	O
weakly	O
detectable	O
in	O
eye	O
,	O
kidney	O
,	O
intestine	O
,	O
and	O
lung	O
.	O
In	O
situ	O
hybridization	O
of	O
brain	O
localized	O
the	O
mRNA	O
to	O
ependymal	O
cells	O
lining	O
the	O
aqueduct	O
,	O
glial	O
cells	O
forming	O
the	O
edge	O
of	O
the	O
cerebral	O
cortex	O
and	O
brainstem	O
,	O
vasopressin	O
-	O
secretory	O
neurons	O
in	O
supraoptic	O
and	O
paraventricular	O
nuclei	O
of	O
hypothalamus	O
,	O
and	O
Purkinje	O
cells	O
of	O
cerebellum	O
.	O
Its	O
distinctive	O
expression	O
pattern	O
implicates	O
this	O
fourth	O
arg1s	O
mammalian	O
arg1e	O
member	O
of	O
the	O
aquaporin	O
water	O
channel	O
family	O
(	O
designated	O
gene	O
symbol	O
,	O
gene1s	ARG2
AQP4	ARG2
gene1e	ARG2
)	O
as	O
the	O
osmoreceptor	O
which	O
regulates	O
body	O
water	O
balance	O
and	O
mediates	O
water	O
flow	O
within	O
the	O
central	O
nervous	O
system	O
.	O

Functional	O
expression	O
and	O
pharmacological	O
characterization	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
EAA4	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
GluR6	ARG2
gene1e	ARG2
)	O
glutamate	O
receptor	O
:	O
a	O
kainate	O
selective	O
channel	O
subunit	O
.	O
A	O
cDNA	O
encoding	O
an	O
ionotropic	O
glutamate	O
receptor	O
subunit	O
protein	O
gene1s	ARG2
humEAA4	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
GluR6	ARG2
gene1e	ARG2
)	O
,	O
has	O
been	O
cloned	O
from	O
a	O
arg1s	O
human	O
arg1e	O
fetal	O
brain	O
library	O
.	O
This	O
cDNA	O
when	O
expressed	O
in	O
COS	O
or	O
arg1s	O
HEK-293	O
arg1e	O
cells	O
is	O
associated	O
with	O
high	O
-	O
affinity	O
kainate	O
receptor	O
binding	O
and	O
ion	O
channel	O
formation	O
.	O
We	O
have	O
successfully	O
established	O
cell	O
lines	O
stably	O
expressing	O
gene1s	ARG2
humEAA4	ARG2
gene1e	ARG2
in	O
arg1s	O
HEK-293	O
arg1e	O
cells	O
This	O
is	O
the	O
first	O
report	O
of	O
the	O
establishment	O
of	O
stable	O
cell	O
lines	O
expressing	O
a	O
glutamate	O
receptor	O
channel	O
.	O
The	O
relative	O
potency	O
of	O
compounds	O
for	O
displacing	O
[	O
3H]-kainate	O
binding	O
to	O
gene1s	ARG2
humEAA4	ARG2
gene1e	ARG2
receptors	O
expressed	O
in	O
COS	O
or	O
arg1s	O
HEK-293	O
arg1e	O
cells	O
is	O
domoate	O
>	O
kainate	O
>	O
quisqualate	O
>	O
6-cyano-7-nitroquinoxaline-2,3-dione	O
>	O
L	O
-	O
glutamate	O
=	O
6,7-	O
dinitroquinoxaline-2,3-dione	O
>	O
dihydrokainate	O
.	O
Applications	O
of	O
kainate	O
,	O
glutamate	O
,	O
and	O
domoate	O
but	O
not	O
AMPA	O
evoked	O
rapidly	O
desensitizing	O
currents	O
in	O
cells	O
expressing	O
homo	O
-	O
oligomeric	O
gene1s	ARG2
humEAA4	ARG2
gene1e	ARG2
in	O
a	O
concentration	O
dependent	O
manner	O
.	O
The	O
order	O
of	O
potency	O
was	O
:	O
domoate	O
>	O
kainate	O
>	O
L	O
-	O
glutamate	O
.	O
Although	O
AMPA	O
did	O
not	O
itself	O
activate	O
gene1s	ARG2
humEAA4	ARG2
gene1e	ARG2
receptors	O
it	O
did	O
reduce	O
,	O
to	O
a	O
limited	O
extent	O
,	O
kainate	O
-	O
evoked	O
responses	O
.	O
AMPA	O
may	O
therefore	O
be	O
a	O
weak	O
partial	O
agonist	O
for	O
this	O
receptor	O
.	O
To	O
date	O
this	O
effect	O
has	O
not	O
been	O
demonstrated	O
with	O
species1s	O
rat	O
species1e	O
gene1s	ARG2
GluR6	ARG2
gene1e	ARG2
.	O
It	O
is	O
possible	O
that	O
subtle	O
species	O
differences	O
may	O
exist	O
in	O
the	O
nature	O
of	O
agonist	O
receptor	O
interaction	O
.	O
Kainate	O
evoked	O
currents	O
were	O
attenuated	O
by	O
the	O
quinoxalinediones	O
CNQX	O
and	O
DNQX	O
but	O
not	O
by	O
DAP5	O
.	O
The	O
receptor	O
desensitization	O
was	O
attenuated	O
on	O
application	O
of	O
concanavalin	O
A.	O
Ion	O
-	O
permeability	O
studies	O
indicated	O
that	O
the	O
receptor	O
-	O
linked	O
ion	O
channel	O
is	O
permeable	O
to	O
both	O
Na+	O
and	O
Ca2	O
+	O
ions	O
.	O

Functional	O
expression	O
and	O
pharmacological	O
characterization	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
EAA4	O
gene1e	O
(	O
gene1s	O
GluR6	O
gene1e	O
)	O
glutamate	O
receptor	O
:	O
a	O
kainate	O
selective	O
channel	O
subunit	O
.	O
A	O
cDNA	O
encoding	O
an	O
ionotropic	O
glutamate	O
receptor	O
subunit	O
protein	O
gene1s	O
humEAA4	O
gene1e	O
(	O
gene1s	O
GluR6	O
gene1e	O
)	O
,	O
has	O
been	O
cloned	O
from	O
a	O
species1s	O
human	O
species1e	O
fetal	O
brain	O
library	O
.	O
This	O
cDNA	O
when	O
expressed	O
in	O
COS	O
or	O
species1s	O
HEK-293	O
species1e	O
cells	O
is	O
associated	O
with	O
high	O
-	O
affinity	O
kainate	O
receptor	O
binding	O
and	O
ion	O
channel	O
formation	O
.	O
We	O
have	O
successfully	O
established	O
cell	O
lines	O
stably	O
expressing	O
gene1s	O
humEAA4	O
gene1e	O
in	O
species1s	O
HEK-293	O
species1e	O
cells	O
This	O
is	O
the	O
first	O
report	O
of	O
the	O
establishment	O
of	O
stable	O
cell	O
lines	O
expressing	O
a	O
glutamate	O
receptor	O
channel	O
.	O
The	O
relative	O
potency	O
of	O
compounds	O
for	O
displacing	O
[	O
3H]-kainate	O
binding	O
to	O
gene1s	O
humEAA4	O
gene1e	O
receptors	O
expressed	O
in	O
COS	O
or	O
species1s	O
HEK-293	O
species1e	O
cells	O
is	O
domoate	O
>	O
kainate	O
>	O
quisqualate	O
>	O
6-cyano-7-nitroquinoxaline-2,3-dione	O
>	O
L	O
-	O
glutamate	O
=	O
6,7-	O
dinitroquinoxaline-2,3-dione	O
>	O
dihydrokainate	O
.	O
Applications	O
of	O
kainate	O
,	O
glutamate	O
,	O
and	O
domoate	O
but	O
not	O
AMPA	O
evoked	O
rapidly	O
desensitizing	O
currents	O
in	O
cells	O
expressing	O
homo	O
-	O
oligomeric	O
gene1s	O
humEAA4	O
gene1e	O
in	O
a	O
concentration	O
dependent	O
manner	O
.	O
The	O
order	O
of	O
potency	O
was	O
:	O
domoate	O
>	O
kainate	O
>	O
L	O
-	O
glutamate	O
.	O
Although	O
AMPA	O
did	O
not	O
itself	O
activate	O
gene1s	O
humEAA4	O
gene1e	O
receptors	O
it	O
did	O
reduce	O
,	O
to	O
a	O
limited	O
extent	O
,	O
kainate	O
-	O
evoked	O
responses	O
.	O
AMPA	O
may	O
therefore	O
be	O
a	O
weak	O
partial	O
agonist	O
for	O
this	O
receptor	O
.	O
To	O
date	O
this	O
effect	O
has	O
not	O
been	O
demonstrated	O
with	O
arg1s	O
rat	O
arg1e	O
gene1s	O
GluR6	O
gene1e	O
.	O
It	O
is	O
possible	O
that	O
subtle	O
species	O
differences	O
may	O
exist	O
in	O
the	O
nature	O
of	O
agonist	O
receptor	O
interaction	O
.	O
Kainate	O
evoked	O
currents	O
were	O
attenuated	O
by	O
the	O
quinoxalinediones	O
CNQX	O
and	O
DNQX	O
but	O
not	O
by	O
DAP5	O
.	O
The	O
receptor	O
desensitization	O
was	O
attenuated	O
on	O
application	O
of	O
concanavalin	O
A.	O
Ion	O
-	O
permeability	O
studies	O
indicated	O
that	O
the	O
receptor	O
-	O
linked	O
ion	O
channel	O
is	O
permeable	O
to	O
both	O
Na+	O
and	O
Ca2	O
+	O
ions	O
.	O

Expression	O
of	O
central	O
and	O
peripheral	O
cannabinoid	O
receptors	O
in	O
arg1s	O
human	O
arg1e	O
immune	O
tissues	O
and	O
leukocyte	O
subpopulations	O
.	O
Two	O
proteins	O
with	O
seven	O
transmembrane	O
-	O
spanning	O
domains	O
typical	O
of	O
guanosine	O
-	O
nucleotide	O
-	O
binding	O
-	O
protein	O
-	O
coupled	O
receptors	O
have	O
been	O
identified	O
as	O
cannabinoid	O
receptors	O
;	O
the	O
central	O
cannabinoid	O
receptor	O
,	O
gene1s	ARG2
CB1	ARG2
gene1e	ARG2
,	O
and	O
the	O
peripheral	O
cannabinoid	O
receptor	O
,	O
gene1s	ARG2
CB2	ARG2
gene1e	ARG2
,	O
initially	O
described	O
in	O
species1s	O
rat	O
species1e	O
brain	O
and	O
spleen	O
,	O
respectively	O
.	O
Here	O
,	O
we	O
report	O
the	O
distribution	O
patterns	O
for	O
both	O
gene1s	ARG2
CB1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CB2	ARG2
gene1e	ARG2
transcripts	O
in	O
arg1s	O
human	O
arg1e	O
immune	O
cells	O
and	O
in	O
several	O
arg1s	O
human	O
arg1e	O
tissues	O
,	O
as	O
analysed	O
using	O
a	O
highly	O
sensitive	O
and	O
quantitative	O
PCR	O
-	O
based	O
method	O
.	O
gene1s	ARG2
CB1	ARG2
gene1e	ARG2
was	O
mainly	O
expressed	O
in	O
the	O
central	O
nervous	O
system	O
and	O
,	O
to	O
a	O
lower	O
extent	O
,	O
in	O
several	O
peripheral	O
tissues	O
such	O
as	O
adrenal	O
gland	O
,	O
heart	O
,	O
lung	O
,	O
prostate	O
,	O
uterus	O
,	O
ovary	O
,	O
testis	O
,	O
bone	O
marrow	O
,	O
thymus	O
and	O
tonsils	O
.	O
In	O
contrast	O
,	O
the	O
gene1s	ARG2
CB2	ARG2
gene1e	ARG2
gene	O
,	O
which	O
is	O
not	O
expressed	O
in	O
the	O
brain	O
,	O
was	O
particularly	O
abundant	O
in	O
immune	O
tissues	O
,	O
with	O
an	O
expression	O
level	O
10	O
-	O
100-fold	O
higher	O
than	O
that	O
of	O
gene1s	ARG2
CB1	ARG2
gene1e	ARG2
.	O
Although	O
gene1s	ARG2
CB2	ARG2
gene1e	ARG2
mRNA	O
was	O
also	O
detected	O
in	O
some	O
other	O
peripheral	O
tissues	O
,	O
its	O
level	O
remained	O
very	O
low	O
.	O
In	O
spleen	O
and	O
tonsils	O
,	O
the	O
gene1s	ARG2
CB2	ARG2
gene1e	ARG2
mRNA	O
content	O
was	O
equivalent	O
to	O
that	O
of	O
gene1s	ARG2
CB1	ARG2
gene1e	ARG2
mRNA	O
in	O
the	O
central	O
nervous	O
system	O
.	O
Among	O
the	O
main	O
arg1s	O
human	O
arg1e	O
blood	O
cell	O
subpopulations	O
,	O
the	O
distribution	O
pattern	O
of	O
the	O
gene1s	ARG2
CB2	ARG2
gene1e	ARG2
mRNA	O
displayed	O
important	O
variations	O
.	O
The	O
rank	O
order	O
of	O
gene1s	ARG2
CB2	ARG2
gene1e	ARG2
mRNA	O
levels	O
in	O
these	O
cells	O
was	O
B	O
-	O
cells	O
>	O
natural	O
killer	O
cells	O
>	O
>	O
monocytes	O
>	O
polymorphonuclear	O
neutrophil	O
cells	O
>	O
T8	O
cells	O
>	O
T4	O
cells	O
.	O
The	O
same	O
rank	O
order	O
was	O
also	O
established	O
in	O
arg1s	O
human	O
arg1e	O
cell	O
lines	O
belonging	O
to	O
the	O
myeloid	O
,	O
monocytic	O
and	O
lymphoid	O
lineages	O
.	O
The	O
prevailing	O
expression	O
of	O
the	O
gene1s	ARG2
CB2	ARG2
gene1e	ARG2
gene	O
in	O
immune	O
tissues	O
was	O
confirmed	O
by	O
Northern	O
-	O
blot	O
analysis	O
.	O
In	O
addition	O
,	O
the	O
expression	O
of	O
the	O
gene1s	ARG2
CB2	ARG2
gene1e	ARG2
protein	O
was	O
demonstrated	O
by	O
an	O
immunohistological	O
analysis	O
performed	O
on	O
tonsil	O
sections	O
using	O
specific	O
anti-(	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
CB2	ARG2
gene1e	ARG2
)	O
IgG	O
;	O
this	O
experiment	O
showed	O
that	O
gene1s	ARG2
CB2	ARG2
gene1e	ARG2
expression	O
was	O
restricted	O
to	O
B	O
-	O
lymphocyte	O
-	O
enriched	O
areas	O
of	O
the	O
mantle	O
of	O
secondary	O
lymphoid	O
follicles	O
.	O
These	O
results	O
suggest	O
that	O
(	O
a	O
)	O
gene1s	ARG2
CB1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CB2	ARG2
gene1e	ARG2
can	O
be	O
considered	O
as	O
tissue	O
-	O
selective	O
antigens	O
of	O
the	O
central	O
nervous	O
system	O
and	O
immune	O
system	O
,	O
respectively	O
,	O
and	O
(	O
b	O
)	O
cannabinoids	O
may	O
exert	O
specific	O
receptor	O
-	O
mediated	O
actions	O
on	O
the	O
immune	O
system	O
through	O
the	O
gene1s	ARG2
CB2	ARG2
gene1e	ARG2
receptor	O
.	O

Expression	O
of	O
central	O
and	O
peripheral	O
cannabinoid	O
receptors	O
in	O
species1s	O
human	O
species1e	O
immune	O
tissues	O
and	O
leukocyte	O
subpopulations	O
.	O
Two	O
proteins	O
with	O
seven	O
transmembrane	O
-	O
spanning	O
domains	O
typical	O
of	O
guanosine	O
-	O
nucleotide	O
-	O
binding	O
-	O
protein	O
-	O
coupled	O
receptors	O
have	O
been	O
identified	O
as	O
cannabinoid	O
receptors	O
;	O
the	O
central	O
cannabinoid	O
receptor	O
,	O
gene1s	O
CB1	O
gene1e	O
,	O
and	O
the	O
peripheral	O
cannabinoid	O
receptor	O
,	O
gene1s	O
CB2	O
gene1e	O
,	O
initially	O
described	O
in	O
arg1s	O
rat	O
arg1e	O
brain	O
and	O
spleen	O
,	O
respectively	O
.	O
Here	O
,	O
we	O
report	O
the	O
distribution	O
patterns	O
for	O
both	O
gene1s	O
CB1	O
gene1e	O
and	O
gene1s	O
CB2	O
gene1e	O
transcripts	O
in	O
species1s	O
human	O
species1e	O
immune	O
cells	O
and	O
in	O
several	O
species1s	O
human	O
species1e	O
tissues	O
,	O
as	O
analysed	O
using	O
a	O
highly	O
sensitive	O
and	O
quantitative	O
PCR	O
-	O
based	O
method	O
.	O
gene1s	O
CB1	O
gene1e	O
was	O
mainly	O
expressed	O
in	O
the	O
central	O
nervous	O
system	O
and	O
,	O
to	O
a	O
lower	O
extent	O
,	O
in	O
several	O
peripheral	O
tissues	O
such	O
as	O
adrenal	O
gland	O
,	O
heart	O
,	O
lung	O
,	O
prostate	O
,	O
uterus	O
,	O
ovary	O
,	O
testis	O
,	O
bone	O
marrow	O
,	O
thymus	O
and	O
tonsils	O
.	O
In	O
contrast	O
,	O
the	O
gene1s	O
CB2	O
gene1e	O
gene	O
,	O
which	O
is	O
not	O
expressed	O
in	O
the	O
brain	O
,	O
was	O
particularly	O
abundant	O
in	O
immune	O
tissues	O
,	O
with	O
an	O
expression	O
level	O
10	O
-	O
100-fold	O
higher	O
than	O
that	O
of	O
gene1s	O
CB1	O
gene1e	O
.	O
Although	O
gene1s	O
CB2	O
gene1e	O
mRNA	O
was	O
also	O
detected	O
in	O
some	O
other	O
peripheral	O
tissues	O
,	O
its	O
level	O
remained	O
very	O
low	O
.	O
In	O
spleen	O
and	O
tonsils	O
,	O
the	O
gene1s	O
CB2	O
gene1e	O
mRNA	O
content	O
was	O
equivalent	O
to	O
that	O
of	O
gene1s	O
CB1	O
gene1e	O
mRNA	O
in	O
the	O
central	O
nervous	O
system	O
.	O
Among	O
the	O
main	O
species1s	O
human	O
species1e	O
blood	O
cell	O
subpopulations	O
,	O
the	O
distribution	O
pattern	O
of	O
the	O
gene1s	O
CB2	O
gene1e	O
mRNA	O
displayed	O
important	O
variations	O
.	O
The	O
rank	O
order	O
of	O
gene1s	O
CB2	O
gene1e	O
mRNA	O
levels	O
in	O
these	O
cells	O
was	O
B	O
-	O
cells	O
>	O
natural	O
killer	O
cells	O
>	O
>	O
monocytes	O
>	O
polymorphonuclear	O
neutrophil	O
cells	O
>	O
T8	O
cells	O
>	O
T4	O
cells	O
.	O
The	O
same	O
rank	O
order	O
was	O
also	O
established	O
in	O
species1s	O
human	O
species1e	O
cell	O
lines	O
belonging	O
to	O
the	O
myeloid	O
,	O
monocytic	O
and	O
lymphoid	O
lineages	O
.	O
The	O
prevailing	O
expression	O
of	O
the	O
gene1s	O
CB2	O
gene1e	O
gene	O
in	O
immune	O
tissues	O
was	O
confirmed	O
by	O
Northern	O
-	O
blot	O
analysis	O
.	O
In	O
addition	O
,	O
the	O
expression	O
of	O
the	O
gene1s	O
CB2	O
gene1e	O
protein	O
was	O
demonstrated	O
by	O
an	O
immunohistological	O
analysis	O
performed	O
on	O
tonsil	O
sections	O
using	O
specific	O
anti-(	O
species1s	O
human	O
species1e	O
gene1s	O
CB2	O
gene1e	O
)	O
IgG	O
;	O
this	O
experiment	O
showed	O
that	O
gene1s	O
CB2	O
gene1e	O
expression	O
was	O
restricted	O
to	O
B	O
-	O
lymphocyte	O
-	O
enriched	O
areas	O
of	O
the	O
mantle	O
of	O
secondary	O
lymphoid	O
follicles	O
.	O
These	O
results	O
suggest	O
that	O
(	O
a	O
)	O
gene1s	O
CB1	O
gene1e	O
and	O
gene1s	O
CB2	O
gene1e	O
can	O
be	O
considered	O
as	O
tissue	O
-	O
selective	O
antigens	O
of	O
the	O
central	O
nervous	O
system	O
and	O
immune	O
system	O
,	O
respectively	O
,	O
and	O
(	O
b	O
)	O
cannabinoids	O
may	O
exert	O
specific	O
receptor	O
-	O
mediated	O
actions	O
on	O
the	O
immune	O
system	O
through	O
the	O
gene1s	O
CB2	O
gene1e	O
receptor	O
.	O

Molecular	O
cloning	O
and	O
functional	O
expression	O
of	O
the	O
gene	O
encoding	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
proteinase	ARG2
-	ARG2
activated	ARG2
receptor	ARG2
2	ARG2
gene1e	ARG2
.	O
We	O
previously	O
reported	O
the	O
molecular	O
cloning	O
of	O
a	O
species1s	O
mouse	O
species1e	O
guanosine	O
-	O
nucleotide	O
-	O
binding	O
-	O
protein	O
-	O
coupled	O
receptor	O
similar	O
to	O
the	O
thrombin	O
receptor	O
.	O
Since	O
the	O
physiological	O
agonist	O
was	O
unknown	O
,	O
the	O
receptor	O
was	O
named	O
gene1s	ARG2
proteinase	ARG2
-	ARG2
activated	ARG2
receptor	ARG2
2	ARG2
gene1e	ARG2
.	O
We	O
describe	O
here	O
the	O
cloning	O
and	O
functional	O
expression	O
of	O
the	O
gene	O
encoding	O
the	O
corresponding	O
arg1s	O
human	O
arg1e	O
receptor	O
.	O
The	O
gene	O
is	O
divided	O
into	O
two	O
exons	O
separated	O
by	O
about	O
14	O
kb	O
intronic	O
DNA	O
.	O
The	O
deduced	O
protein	O
sequence	O
is	O
397	O
amino	O
acids	O
long	O
and	O
83	O
%	O
identical	O
to	O
the	O
species1s	O
mouse	O
species1e	O
receptor	O
sequence	O
.	O
Within	O
the	O
extracellular	O
amino	O
terminus	O
,	O
the	O
residues	O
predicted	O
to	O
form	O
the	O
tethered	O
agonist	O
ligand	O
differ	O
between	O
the	O
two	O
receptors	O
;	O
of	O
the	O
first	O
six	O
residues	O
only	O
four	O
are	O
conserved	O
.	O
At	O
positions	O
five	O
and	O
six	O
,	O
a	O
lysine	O
residue	O
and	O
a	O
valine	O
residue	O
,	O
respectively	O
,	O
have	O
replaced	O
arginine	O
and	O
leucine	O
residues	O
found	O
in	O
the	O
species1s	O
mouse	O
species1e	O
sequence	O
.	O
When	O
the	O
arg1s	O
human	O
arg1e	O
receptor	O
is	O
expressed	O
in	O
species1s	O
Chinese	O
hamster	O
species1e	O
ovary	O
cells	O
,	O
it	O
can	O
be	O
activated	O
by	O
low	O
nanomolar	O
concentrations	O
of	O
the	O
serine	O
proteinase	O
trypsin	O
and	O
by	O
peptides	O
made	O
from	O
the	O
receptor	O
sequence	O
.	O
Northern	O
-	O
blot	O
analysis	O
of	O
receptor	O
expression	O
showed	O
that	O
the	O
receptor	O
transcript	O
is	O
widely	O
expressed	O
in	O
arg1s	O
human	O
arg1e	O
tissues	O
with	O
especially	O
high	O
levels	O
in	O
pancreas	O
,	O
liver	O
,	O
kidney	O
,	O
small	O
intestine	O
and	O
colon	O
.	O
Moderate	O
expression	O
was	O
detected	O
in	O
many	O
organs	O
but	O
none	O
in	O
brain	O
or	O
skeletal	O
muscle	O
.	O
By	O
fluorescence	O
in	O
situ	O
hybridization	O
,	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
proteinase	ARG2
-	ARG2
activated	ARG2
receptor	ARG2
2	ARG2
gene1e	ARG2
gene	O
was	O
mapped	O
to	O
chromosomal	O
region	O
5q13	O
,	O
where	O
,	O
previously	O
,	O
the	O
related	O
thrombin	O
receptor	O
gene	O
has	O
been	O
located	O
.	O

Molecular	O
cloning	O
and	O
functional	O
expression	O
of	O
the	O
gene	O
encoding	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
proteinase	O
-	O
activated	O
receptor	O
2	O
gene1e	O
.	O
We	O
previously	O
reported	O
the	O
molecular	O
cloning	O
of	O
a	O
arg1s	O
mouse	O
arg1e	O
guanosine	O
-	O
nucleotide	O
-	O
binding	O
-	O
protein	O
-	O
coupled	O
receptor	O
similar	O
to	O
the	O
thrombin	O
receptor	O
.	O
Since	O
the	O
physiological	O
agonist	O
was	O
unknown	O
,	O
the	O
receptor	O
was	O
named	O
gene1s	O
proteinase	O
-	O
activated	O
receptor	O
2	O
gene1e	O
.	O
We	O
describe	O
here	O
the	O
cloning	O
and	O
functional	O
expression	O
of	O
the	O
gene	O
encoding	O
the	O
corresponding	O
species1s	O
human	O
species1e	O
receptor	O
.	O
The	O
gene	O
is	O
divided	O
into	O
two	O
exons	O
separated	O
by	O
about	O
14	O
kb	O
intronic	O
DNA	O
.	O
The	O
deduced	O
protein	O
sequence	O
is	O
397	O
amino	O
acids	O
long	O
and	O
83	O
%	O
identical	O
to	O
the	O
arg1s	O
mouse	O
arg1e	O
receptor	O
sequence	O
.	O
Within	O
the	O
extracellular	O
amino	O
terminus	O
,	O
the	O
residues	O
predicted	O
to	O
form	O
the	O
tethered	O
agonist	O
ligand	O
differ	O
between	O
the	O
two	O
receptors	O
;	O
of	O
the	O
first	O
six	O
residues	O
only	O
four	O
are	O
conserved	O
.	O
At	O
positions	O
five	O
and	O
six	O
,	O
a	O
lysine	O
residue	O
and	O
a	O
valine	O
residue	O
,	O
respectively	O
,	O
have	O
replaced	O
arginine	O
and	O
leucine	O
residues	O
found	O
in	O
the	O
arg1s	O
mouse	O
arg1e	O
sequence	O
.	O
When	O
the	O
species1s	O
human	O
species1e	O
receptor	O
is	O
expressed	O
in	O
species1s	O
Chinese	O
hamster	O
species1e	O
ovary	O
cells	O
,	O
it	O
can	O
be	O
activated	O
by	O
low	O
nanomolar	O
concentrations	O
of	O
the	O
serine	O
proteinase	O
trypsin	O
and	O
by	O
peptides	O
made	O
from	O
the	O
receptor	O
sequence	O
.	O
Northern	O
-	O
blot	O
analysis	O
of	O
receptor	O
expression	O
showed	O
that	O
the	O
receptor	O
transcript	O
is	O
widely	O
expressed	O
in	O
species1s	O
human	O
species1e	O
tissues	O
with	O
especially	O
high	O
levels	O
in	O
pancreas	O
,	O
liver	O
,	O
kidney	O
,	O
small	O
intestine	O
and	O
colon	O
.	O
Moderate	O
expression	O
was	O
detected	O
in	O
many	O
organs	O
but	O
none	O
in	O
brain	O
or	O
skeletal	O
muscle	O
.	O
By	O
fluorescence	O
in	O
situ	O
hybridization	O
,	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
proteinase	O
-	O
activated	O
receptor	O
2	O
gene1e	O
gene	O
was	O
mapped	O
to	O
chromosomal	O
region	O
5q13	O
,	O
where	O
,	O
previously	O
,	O
the	O
related	O
thrombin	O
receptor	O
gene	O
has	O
been	O
located	O
.	O

Molecular	O
cloning	O
and	O
functional	O
expression	O
of	O
the	O
gene	O
encoding	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
proteinase	O
-	O
activated	O
receptor	O
2	O
gene1e	O
.	O
We	O
previously	O
reported	O
the	O
molecular	O
cloning	O
of	O
a	O
species1s	O
mouse	O
species1e	O
guanosine	O
-	O
nucleotide	O
-	O
binding	O
-	O
protein	O
-	O
coupled	O
receptor	O
similar	O
to	O
the	O
thrombin	O
receptor	O
.	O
Since	O
the	O
physiological	O
agonist	O
was	O
unknown	O
,	O
the	O
receptor	O
was	O
named	O
gene1s	O
proteinase	O
-	O
activated	O
receptor	O
2	O
gene1e	O
.	O
We	O
describe	O
here	O
the	O
cloning	O
and	O
functional	O
expression	O
of	O
the	O
gene	O
encoding	O
the	O
corresponding	O
species1s	O
human	O
species1e	O
receptor	O
.	O
The	O
gene	O
is	O
divided	O
into	O
two	O
exons	O
separated	O
by	O
about	O
14	O
kb	O
intronic	O
DNA	O
.	O
The	O
deduced	O
protein	O
sequence	O
is	O
397	O
amino	O
acids	O
long	O
and	O
83	O
%	O
identical	O
to	O
the	O
species1s	O
mouse	O
species1e	O
receptor	O
sequence	O
.	O
Within	O
the	O
extracellular	O
amino	O
terminus	O
,	O
the	O
residues	O
predicted	O
to	O
form	O
the	O
tethered	O
agonist	O
ligand	O
differ	O
between	O
the	O
two	O
receptors	O
;	O
of	O
the	O
first	O
six	O
residues	O
only	O
four	O
are	O
conserved	O
.	O
At	O
positions	O
five	O
and	O
six	O
,	O
a	O
lysine	O
residue	O
and	O
a	O
valine	O
residue	O
,	O
respectively	O
,	O
have	O
replaced	O
arginine	O
and	O
leucine	O
residues	O
found	O
in	O
the	O
species1s	O
mouse	O
species1e	O
sequence	O
.	O
When	O
the	O
species1s	O
human	O
species1e	O
receptor	O
is	O
expressed	O
in	O
arg1s	O
Chinese	O
hamster	O
arg1e	O
ovary	O
cells	O
,	O
it	O
can	O
be	O
activated	O
by	O
low	O
nanomolar	O
concentrations	O
of	O
the	O
serine	O
proteinase	O
trypsin	O
and	O
by	O
peptides	O
made	O
from	O
the	O
receptor	O
sequence	O
.	O
Northern	O
-	O
blot	O
analysis	O
of	O
receptor	O
expression	O
showed	O
that	O
the	O
receptor	O
transcript	O
is	O
widely	O
expressed	O
in	O
species1s	O
human	O
species1e	O
tissues	O
with	O
especially	O
high	O
levels	O
in	O
pancreas	O
,	O
liver	O
,	O
kidney	O
,	O
small	O
intestine	O
and	O
colon	O
.	O
Moderate	O
expression	O
was	O
detected	O
in	O
many	O
organs	O
but	O
none	O
in	O
brain	O
or	O
skeletal	O
muscle	O
.	O
By	O
fluorescence	O
in	O
situ	O
hybridization	O
,	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
proteinase	O
-	O
activated	O
receptor	O
2	O
gene1e	O
gene	O
was	O
mapped	O
to	O
chromosomal	O
region	O
5q13	O
,	O
where	O
,	O
previously	O
,	O
the	O
related	O
thrombin	O
receptor	O
gene	O
has	O
been	O
located	O
.	O

Interaction	O
of	O
papillomavirus	O
E6	O
oncoproteins	O
with	O
a	O
putative	O
calcium	O
-	O
binding	O
protein	O
.	O
arg1s	O
Human	O
arg1e	O
papillomaviruses	O
(	O
HPVs	O
)	O
are	O
associated	O
with	O
the	O
majority	O
of	O
cervical	O
cancers	O
and	O
encode	O
a	O
transforming	O
protein	O
,	O
E6	O
,	O
that	O
interacts	O
with	O
the	O
tumor	O
suppressor	O
protein	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
.	O
Because	O
E6	O
has	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
-independent	O
transforming	O
activity	O
,	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
was	O
used	O
to	O
search	O
for	O
other	O
E6-binding	O
proteins	O
.	O
One	O
such	O
protein	O
,	O
gene1s	ARG2
E6BP	ARG2
gene1e	ARG2
,	O
interacted	O
with	O
cancer	O
-	O
associated	O
HPV	O
E6	O
and	O
with	O
species1s	O
bovine	O
papillomavirus	O
type	O
1	O
species1e	O
(	O
species1s	O
BPV-1	O
species1e	O
)	O
E6	O
.	O
The	O
transforming	O
activity	O
of	O
species1s	O
BPV-1	O
species1e	O
E6	O
mutants	O
correlated	O
with	O
their	O
gene1s	ARG2
E6BP	ARG2
gene1e	ARG2
-	O
binding	O
ability	O
.	O
gene1s	ARG2
E6BP	ARG2
gene1e	ARG2
is	O
identical	O
to	O
a	O
putative	O
calcium	O
-	O
binding	O
protein	O
,	O
gene1s	ARG2
ERC-55	ARG2
gene1e	ARG2
,	O
that	O
appears	O
to	O
be	O
localized	O
in	O
the	O
endoplasmic	O
reticulum	O
.	O

Interaction	O
of	O
papillomavirus	O
E6	O
oncoproteins	O
with	O
a	O
putative	O
calcium	O
-	O
binding	O
protein	O
.	O
species1s	O
Human	O
species1e	O
papillomaviruses	O
(	O
HPVs	O
)	O
are	O
associated	O
with	O
the	O
majority	O
of	O
cervical	O
cancers	O
and	O
encode	O
a	O
transforming	O
protein	O
,	O
E6	O
,	O
that	O
interacts	O
with	O
the	O
tumor	O
suppressor	O
protein	O
gene1s	O
p53	O
gene1e	O
.	O
Because	O
E6	O
has	O
gene1s	O
p53	O
gene1e	O
-independent	O
transforming	O
activity	O
,	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
was	O
used	O
to	O
search	O
for	O
other	O
E6-binding	O
proteins	O
.	O
One	O
such	O
protein	O
,	O
gene1s	O
E6BP	O
gene1e	O
,	O
interacted	O
with	O
cancer	O
-	O
associated	O
HPV	O
E6	O
and	O
with	O
arg1s	O
bovine	O
papillomavirus	O
type	O
1	O
arg1e	O
(	O
arg1s	O
BPV-1	O
arg1e	O
)	O
E6	O
.	O
The	O
transforming	O
activity	O
of	O
arg1s	O
BPV-1	O
arg1e	O
E6	O
mutants	O
correlated	O
with	O
their	O
gene1s	O
E6BP	O
gene1e	O
-	O
binding	O
ability	O
.	O
gene1s	O
E6BP	O
gene1e	O
is	O
identical	O
to	O
a	O
putative	O
calcium	O
-	O
binding	O
protein	O
,	O
gene1s	O
ERC-55	O
gene1e	O
,	O
that	O
appears	O
to	O
be	O
localized	O
in	O
the	O
endoplasmic	O
reticulum	O
.	O

Cloning	O
and	O
characterization	O
of	O
a	O
G	O
protein	O
-	O
activated	O
arg1s	O
human	O
arg1e	O
phosphoinositide-3	O
kinase	O
.	O
Phosphoinositide-3	O
kinase	O
activity	O
is	O
implicated	O
in	O
diverse	O
cellular	O
responses	O
triggered	O
by	O
arg1s	O
mammalian	O
arg1e	O
cell	O
surface	O
receptors	O
and	O
in	O
the	O
regulation	O
of	O
protein	O
sorting	O
in	O
species1s	O
yeast	O
species1e	O
.	O
Receptors	O
with	O
intrinsic	O
and	O
associated	O
tyrosine	O
kinase	O
activity	O
recruit	O
heterodimeric	O
phosphoinositide-3	O
kinases	O
that	O
consist	O
of	O
p110	O
catalytic	O
subunits	O
and	O
p85	O
adaptor	O
molecules	O
containing	O
Src	O
homology	O
2	O
(	O
SH2	O
)	O
domains	O
.	O
A	O
phosphoinositide-3	O
kinase	O
isotype	O
,	O
gene1s	ARG2
p110	ARG2
gamma	ARG2
gene1e	ARG2
,	O
was	O
cloned	O
and	O
characterized	O
.	O
The	O
gene1s	ARG2
p110	ARG2
gamma	ARG2
gene1e	ARG2
enzyme	O
was	O
activated	O
in	O
vitro	O
by	O
both	O
the	O
alpha	O
and	O
beta	O
gamma	O
subunits	O
of	O
heterotrimeric	O
guanosine	O
triphosphate	O
(	O
GTP)-binding	O
proteins	O
(	O
G	O
proteins	O
)	O
and	O
did	O
not	O
interact	O
with	O
p85	O
.	O
A	O
potential	O
pleckstrin	O
homology	O
domain	O
is	O
located	O
near	O
its	O
amino	O
terminus	O
.	O
The	O
gene1s	ARG2
p110	ARG2
gamma	ARG2
gene1e	ARG2
isotype	O
may	O
link	O
signaling	O
through	O
G	O
protein	O
-	O
coupled	O
receptors	O
to	O
the	O
generation	O
of	O
phosphoinositide	O
second	O
messengers	O
phosphorylated	O
in	O
the	O
D-3	O
position	O
.	O

Cloning	O
and	O
characterization	O
of	O
a	O
G	O
protein	O
-	O
activated	O
species1s	O
human	O
species1e	O
phosphoinositide-3	O
kinase	O
.	O
Phosphoinositide-3	O
kinase	O
activity	O
is	O
implicated	O
in	O
diverse	O
cellular	O
responses	O
triggered	O
by	O
species1s	O
mammalian	O
species1e	O
cell	O
surface	O
receptors	O
and	O
in	O
the	O
regulation	O
of	O
protein	O
sorting	O
in	O
arg1s	O
yeast	O
arg1e	O
.	O
Receptors	O
with	O
intrinsic	O
and	O
associated	O
tyrosine	O
kinase	O
activity	O
recruit	O
heterodimeric	O
phosphoinositide-3	O
kinases	O
that	O
consist	O
of	O
p110	O
catalytic	O
subunits	O
and	O
p85	O
adaptor	O
molecules	O
containing	O
Src	O
homology	O
2	O
(	O
SH2	O
)	O
domains	O
.	O
A	O
phosphoinositide-3	O
kinase	O
isotype	O
,	O
gene1s	O
p110	O
gamma	O
gene1e	O
,	O
was	O
cloned	O
and	O
characterized	O
.	O
The	O
gene1s	O
p110	O
gamma	O
gene1e	O
enzyme	O
was	O
activated	O
in	O
vitro	O
by	O
both	O
the	O
alpha	O
and	O
beta	O
gamma	O
subunits	O
of	O
heterotrimeric	O
guanosine	O
triphosphate	O
(	O
GTP)-binding	O
proteins	O
(	O
G	O
proteins	O
)	O
and	O
did	O
not	O
interact	O
with	O
p85	O
.	O
A	O
potential	O
pleckstrin	O
homology	O
domain	O
is	O
located	O
near	O
its	O
amino	O
terminus	O
.	O
The	O
gene1s	O
p110	O
gamma	O
gene1e	O
isotype	O
may	O
link	O
signaling	O
through	O
G	O
protein	O
-	O
coupled	O
receptors	O
to	O
the	O
generation	O
of	O
phosphoinositide	O
second	O
messengers	O
phosphorylated	O
in	O
the	O
D-3	O
position	O
.	O

Structure	O
and	O
functional	O
expression	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
macrophage	ARG2
inflammatory	ARG2
protein	ARG2
1	ARG2
alpha	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
RANTES	ARG2
receptor	ARG2
gene1e	ARG2
.	O
The	O
chemokine	O
beta	O
family	O
is	O
comprised	O
of	O
at	O
least	O
six	O
distinct	O
cytokines	O
that	O
regulate	O
trafficking	O
of	O
phagocytes	O
and	O
lymphocytes	O
in	O
arg1s	O
mammalian	O
arg1e	O
species	O
;	O
at	O
least	O
one	O
of	O
these	O
,	O
gene1s	ARG2
macrophage	ARG2
inflammatory	ARG2
protein	ARG2
1	ARG2
alpha	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MIP-1	ARG2
alpha	ARG2
gene1e	ARG2
)	O
,	O
also	O
regulates	O
the	O
growth	O
of	O
hematopoietic	O
stem	O
cells	O
.	O
We	O
now	O
show	O
that	O
gene1s	ARG2
MIP-1	ARG2
alpha	ARG2
gene1e	ARG2
and	O
the	O
related	O
gene1s	ARG2
beta	ARG2
chemokine	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
RANTES	ARG2
gene1e	ARG2
,	O
induce	O
transient	O
alterations	O
in	O
intracellular	O
Ca2	O
+	O
concentration	O
in	O
polymorphonuclear	O
leukocytes	O
that	O
can	O
be	O
reciprocally	O
and	O
specifically	O
desensitized	O
,	O
suggesting	O
a	O
common	O
receptor	O
.	O
Moreover	O
,	O
we	O
have	O
now	O
cloned	O
both	O
the	O
cDNA	O
and	O
the	O
gene	O
for	O
this	O
receptor	O
,	O
functionally	O
expressed	O
the	O
receptor	O
in	O
species1s	O
Xenopus	O
species1e	O
oocytes	O
,	O
and	O
mapped	O
the	O
gene	O
to	O
arg1s	O
human	O
arg1e	O
chromosome	O
3p21	O
.	O
Transcripts	O
for	O
the	O
receptor	O
were	O
found	O
in	O
mature	O
and	O
immature	O
myeloid	O
cells	O
as	O
well	O
as	O
B	O
cells	O
.	O
The	O
receptor	O
is	O
a	O
member	O
of	O
the	O
G	O
protein	O
-	O
coupled	O
receptor	O
superfamily	O
.	O
It	O
has	O
approximately	O
33	O
%	O
amino	O
acid	O
identity	O
with	O
receptors	O
for	O
the	O
gene1s	ARG2
alpha	ARG2
chemokine	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
interleukin	ARG2
8	ARG2
gene1e	ARG2
,	O
and	O
may	O
be	O
the	O
arg1s	O
human	O
arg1e	O
homologue	O
of	O
the	O
product	O
of	O
gene1s	O
US28	O
gene1e	O
,	O
an	O
open	O
reading	O
frame	O
of	O
species1s	O
human	O
cytomegalovirus	O
species1e	O
.	O

Structure	O
and	O
functional	O
expression	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
macrophage	O
inflammatory	O
protein	O
1	O
alpha	O
gene1e	O
/	O
gene1s	O
RANTES	O
receptor	O
gene1e	O
.	O
The	O
chemokine	O
beta	O
family	O
is	O
comprised	O
of	O
at	O
least	O
six	O
distinct	O
cytokines	O
that	O
regulate	O
trafficking	O
of	O
phagocytes	O
and	O
lymphocytes	O
in	O
species1s	O
mammalian	O
species1e	O
species	O
;	O
at	O
least	O
one	O
of	O
these	O
,	O
gene1s	O
macrophage	O
inflammatory	O
protein	O
1	O
alpha	O
gene1e	O
(	O
gene1s	O
MIP-1	O
alpha	O
gene1e	O
)	O
,	O
also	O
regulates	O
the	O
growth	O
of	O
hematopoietic	O
stem	O
cells	O
.	O
We	O
now	O
show	O
that	O
gene1s	O
MIP-1	O
alpha	O
gene1e	O
and	O
the	O
related	O
gene1s	O
beta	O
chemokine	O
gene1e	O
,	O
gene1s	O
RANTES	O
gene1e	O
,	O
induce	O
transient	O
alterations	O
in	O
intracellular	O
Ca2	O
+	O
concentration	O
in	O
polymorphonuclear	O
leukocytes	O
that	O
can	O
be	O
reciprocally	O
and	O
specifically	O
desensitized	O
,	O
suggesting	O
a	O
common	O
receptor	O
.	O
Moreover	O
,	O
we	O
have	O
now	O
cloned	O
both	O
the	O
cDNA	O
and	O
the	O
gene	O
for	O
this	O
receptor	O
,	O
functionally	O
expressed	O
the	O
receptor	O
in	O
arg1s	O
Xenopus	O
arg1e	O
oocytes	O
,	O
and	O
mapped	O
the	O
gene	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
3p21	O
.	O
Transcripts	O
for	O
the	O
receptor	O
were	O
found	O
in	O
mature	O
and	O
immature	O
myeloid	O
cells	O
as	O
well	O
as	O
B	O
cells	O
.	O
The	O
receptor	O
is	O
a	O
member	O
of	O
the	O
G	O
protein	O
-	O
coupled	O
receptor	O
superfamily	O
.	O
It	O
has	O
approximately	O
33	O
%	O
amino	O
acid	O
identity	O
with	O
receptors	O
for	O
the	O
gene1s	O
alpha	O
chemokine	O
gene1e	O
,	O
gene1s	O
interleukin	O
8	O
gene1e	O
,	O
and	O
may	O
be	O
the	O
species1s	O
human	O
species1e	O
homologue	O
of	O
the	O
product	O
of	O
gene1s	O
US28	O
gene1e	O
,	O
an	O
open	O
reading	O
frame	O
of	O
species1s	O
human	O
cytomegalovirus	O
species1e	O
.	O

Structure	O
and	O
functional	O
expression	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
macrophage	O
inflammatory	O
protein	O
1	O
alpha	O
gene1e	O
/	O
gene1s	O
RANTES	O
receptor	O
gene1e	O
.	O
The	O
chemokine	O
beta	O
family	O
is	O
comprised	O
of	O
at	O
least	O
six	O
distinct	O
cytokines	O
that	O
regulate	O
trafficking	O
of	O
phagocytes	O
and	O
lymphocytes	O
in	O
species1s	O
mammalian	O
species1e	O
species	O
;	O
at	O
least	O
one	O
of	O
these	O
,	O
gene1s	O
macrophage	O
inflammatory	O
protein	O
1	O
alpha	O
gene1e	O
(	O
gene1s	O
MIP-1	O
alpha	O
gene1e	O
)	O
,	O
also	O
regulates	O
the	O
growth	O
of	O
hematopoietic	O
stem	O
cells	O
.	O
We	O
now	O
show	O
that	O
gene1s	O
MIP-1	O
alpha	O
gene1e	O
and	O
the	O
related	O
gene1s	O
beta	O
chemokine	O
gene1e	O
,	O
gene1s	O
RANTES	O
gene1e	O
,	O
induce	O
transient	O
alterations	O
in	O
intracellular	O
Ca2	O
+	O
concentration	O
in	O
polymorphonuclear	O
leukocytes	O
that	O
can	O
be	O
reciprocally	O
and	O
specifically	O
desensitized	O
,	O
suggesting	O
a	O
common	O
receptor	O
.	O
Moreover	O
,	O
we	O
have	O
now	O
cloned	O
both	O
the	O
cDNA	O
and	O
the	O
gene	O
for	O
this	O
receptor	O
,	O
functionally	O
expressed	O
the	O
receptor	O
in	O
species1s	O
Xenopus	O
species1e	O
oocytes	O
,	O
and	O
mapped	O
the	O
gene	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
3p21	O
.	O
Transcripts	O
for	O
the	O
receptor	O
were	O
found	O
in	O
mature	O
and	O
immature	O
myeloid	O
cells	O
as	O
well	O
as	O
B	O
cells	O
.	O
The	O
receptor	O
is	O
a	O
member	O
of	O
the	O
G	O
protein	O
-	O
coupled	O
receptor	O
superfamily	O
.	O
It	O
has	O
approximately	O
33	O
%	O
amino	O
acid	O
identity	O
with	O
receptors	O
for	O
the	O
gene1s	O
alpha	O
chemokine	O
gene1e	O
,	O
gene1s	O
interleukin	O
8	O
gene1e	O
,	O
and	O
may	O
be	O
the	O
species1s	O
human	O
species1e	O
homologue	O
of	O
the	O
product	O
of	O
gene1s	ARG2
US28	ARG2
gene1e	ARG2
,	O
an	O
open	O
reading	O
frame	O
of	O
arg1s	O
human	O
cytomegalovirus	O
arg1e	O
.	O

gene1s	O
p57KIP2	O
gene1e	O
,	O
a	O
structurally	O
distinct	O
member	O
of	O
the	O
gene1s	O
p21CIP1	O
gene1e	O
Cdk	O
inhibitor	O
family	O
,	O
is	O
a	O
candidate	O
tumor	O
suppressor	O
gene	O
.	O
Cyclin	O
-	O
dependent	O
kinases	O
(	O
Cdks	O
)	O
are	O
positive	O
regulators	O
of	O
cell	O
proliferation	O
,	O
whereas	O
Cdk	O
inhibitors	O
(	O
CKIs	O
)	O
inhibit	O
proliferation	O
.	O
We	O
describe	O
a	O
new	O
CKI	O
,	O
gene1s	O
p57KIP2	O
gene1e	O
,	O
which	O
is	O
related	O
to	O
gene1s	O
p21CIP1	O
gene1e	O
and	O
gene1s	O
p27KIP1	O
gene1e	O
.	O
gene1s	O
p57KIP2	O
gene1e	O
is	O
a	O
potent	O
,	O
tight	O
-	O
binding	O
inhibitor	O
of	O
several	O
G1	O
cyclin	O
/	O
Cdk	O
complexes	O
,	O
and	O
its	O
binding	O
is	O
cyclin	O
dependent	O
.	O
Unlike	O
gene1s	O
CIP1	O
gene1e	O
,	O
gene1s	O
KIP2	O
gene1e	O
is	O
not	O
regulated	O
by	O
gene1s	O
p53	O
gene1e	O
.	O
Overexpression	O
of	O
gene1s	O
p57KIP2	O
gene1e	O
arrests	O
cells	O
in	O
G1	O
.	O
gene1s	O
p57KIP2	O
gene1e	O
proteins	O
have	O
a	O
complex	O
structure	O
.	O
arg1s	O
Mouse	O
arg1e	O
gene1s	O
p57KIP2	O
gene1e	O
consists	O
of	O
four	O
structurally	O
distinct	O
domains	O
:	O
an	O
amino	O
-	O
terminal	O
Cdk	O
inhibitory	O
domain	O
,	O
a	O
proline	O
-	O
rich	O
domain	O
,	O
an	O
acidic	O
-	O
repeat	O
region	O
,	O
and	O
a	O
carboxy	O
-	O
terminal	O
domain	O
conserved	O
with	O
gene1s	O
p27KIP1	O
gene1e	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
p57KIP2	O
gene1e	O
appears	O
to	O
have	O
conserved	O
the	O
amino-	O
and	O
carboxy	O
-	O
terminal	O
domains	O
but	O
has	O
replaced	O
the	O
internal	O
regions	O
with	O
sequences	O
containing	O
proline	O
-	O
alanine	O
repeats	O
.	O
In	O
situ	O
hybridization	O
during	O
arg1s	O
mouse	O
arg1e	O
embryogenesis	O
revealed	O
that	O
gene1s	O
KIP2	O
gene1e	O
mRNA	O
displays	O
a	O
striking	O
pattern	O
of	O
expression	O
during	O
development	O
,	O
showing	O
high	O
level	O
expression	O
in	O
skeletal	O
muscle	O
,	O
brain	O
,	O
heart	O
,	O
lungs	O
,	O
and	O
eye	O
.	O
Most	O
of	O
the	O
gene1s	O
KIP2	O
gene1e	O
-expressing	O
cells	O
are	O
terminally	O
differentiated	O
,	O
suggesting	O
that	O
gene1s	O
p57KIP2	O
gene1e	O
is	O
involved	O
in	O
decisions	O
to	O
exit	O
the	O
cell	O
cycle	O
during	O
development	O
and	O
differentiation	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
KIP2	O
gene1e	O
is	O
located	O
at	O
11p15.5	O
,	O
a	O
region	O
implicated	O
in	O
both	O
sporadic	O
cancers	O
and	O
Beckwith	O
-	O
Wiedemann	O
syndrome	O
,	O
a	O
familial	O
cancer	O
syndrome	O
,	O
marking	O
it	O
as	O
a	O
candidate	O
tumor	O
suppressor	O
.	O
The	O
discovery	O
of	O
a	O
new	O
member	O
of	O
the	O
gene1s	O
p21CIP1	O
gene1e	O
inhibitor	O
family	O
with	O
novel	O
structural	O
features	O
and	O
expression	O
patterns	O
suggests	O
a	O
complex	O
role	O
for	O
these	O
proteins	O
in	O
cell	O
cycle	O
control	O
and	O
development	O
.	O

gene1s	ARG2
p57KIP2	ARG2
gene1e	ARG2
,	O
a	O
structurally	O
distinct	O
member	O
of	O
the	O
gene1s	ARG2
p21CIP1	ARG2
gene1e	ARG2
Cdk	O
inhibitor	O
family	O
,	O
is	O
a	O
candidate	O
tumor	O
suppressor	O
gene	O
.	O
Cyclin	O
-	O
dependent	O
kinases	O
(	O
Cdks	O
)	O
are	O
positive	O
regulators	O
of	O
cell	O
proliferation	O
,	O
whereas	O
Cdk	O
inhibitors	O
(	O
CKIs	O
)	O
inhibit	O
proliferation	O
.	O
We	O
describe	O
a	O
new	O
CKI	O
,	O
gene1s	ARG2
p57KIP2	ARG2
gene1e	ARG2
,	O
which	O
is	O
related	O
to	O
gene1s	ARG2
p21CIP1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p27KIP1	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
p57KIP2	ARG2
gene1e	ARG2
is	O
a	O
potent	O
,	O
tight	O
-	O
binding	O
inhibitor	O
of	O
several	O
G1	O
cyclin	O
/	O
Cdk	O
complexes	O
,	O
and	O
its	O
binding	O
is	O
cyclin	O
dependent	O
.	O
Unlike	O
gene1s	ARG2
CIP1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
KIP2	ARG2
gene1e	ARG2
is	O
not	O
regulated	O
by	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
.	O
Overexpression	O
of	O
gene1s	ARG2
p57KIP2	ARG2
gene1e	ARG2
arrests	O
cells	O
in	O
G1	O
.	O
gene1s	ARG2
p57KIP2	ARG2
gene1e	ARG2
proteins	O
have	O
a	O
complex	O
structure	O
.	O
species1s	O
Mouse	O
species1e	O
gene1s	ARG2
p57KIP2	ARG2
gene1e	ARG2
consists	O
of	O
four	O
structurally	O
distinct	O
domains	O
:	O
an	O
amino	O
-	O
terminal	O
Cdk	O
inhibitory	O
domain	O
,	O
a	O
proline	O
-	O
rich	O
domain	O
,	O
an	O
acidic	O
-	O
repeat	O
region	O
,	O
and	O
a	O
carboxy	O
-	O
terminal	O
domain	O
conserved	O
with	O
gene1s	ARG2
p27KIP1	ARG2
gene1e	ARG2
.	O
arg1s	O
Human	O
arg1e	O
gene1s	ARG2
p57KIP2	ARG2
gene1e	ARG2
appears	O
to	O
have	O
conserved	O
the	O
amino-	O
and	O
carboxy	O
-	O
terminal	O
domains	O
but	O
has	O
replaced	O
the	O
internal	O
regions	O
with	O
sequences	O
containing	O
proline	O
-	O
alanine	O
repeats	O
.	O
In	O
situ	O
hybridization	O
during	O
species1s	O
mouse	O
species1e	O
embryogenesis	O
revealed	O
that	O
gene1s	ARG2
KIP2	ARG2
gene1e	ARG2
mRNA	O
displays	O
a	O
striking	O
pattern	O
of	O
expression	O
during	O
development	O
,	O
showing	O
high	O
level	O
expression	O
in	O
skeletal	O
muscle	O
,	O
brain	O
,	O
heart	O
,	O
lungs	O
,	O
and	O
eye	O
.	O
Most	O
of	O
the	O
gene1s	ARG2
KIP2	ARG2
gene1e	ARG2
-expressing	O
cells	O
are	O
terminally	O
differentiated	O
,	O
suggesting	O
that	O
gene1s	ARG2
p57KIP2	ARG2
gene1e	ARG2
is	O
involved	O
in	O
decisions	O
to	O
exit	O
the	O
cell	O
cycle	O
during	O
development	O
and	O
differentiation	O
.	O
arg1s	O
Human	O
arg1e	O
gene1s	ARG2
KIP2	ARG2
gene1e	ARG2
is	O
located	O
at	O
11p15.5	O
,	O
a	O
region	O
implicated	O
in	O
both	O
sporadic	O
cancers	O
and	O
Beckwith	O
-	O
Wiedemann	O
syndrome	O
,	O
a	O
familial	O
cancer	O
syndrome	O
,	O
marking	O
it	O
as	O
a	O
candidate	O
tumor	O
suppressor	O
.	O
The	O
discovery	O
of	O
a	O
new	O
member	O
of	O
the	O
gene1s	ARG2
p21CIP1	ARG2
gene1e	ARG2
inhibitor	O
family	O
with	O
novel	O
structural	O
features	O
and	O
expression	O
patterns	O
suggests	O
a	O
complex	O
role	O
for	O
these	O
proteins	O
in	O
cell	O
cycle	O
control	O
and	O
development	O
.	O

The	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
E48	ARG2
antigen	ARG2
gene1e	ARG2
,	O
highly	O
homologous	O
to	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
Ly-6	O
antigen	O
ThB	O
gene1e	O
,	O
is	O
a	O
GPI	O
-	O
anchored	O
molecule	O
apparently	O
involved	O
in	O
keratinocyte	O
cell	O
-	O
cell	O
adhesion	O
.	O
The	O
gene1s	ARG2
E48	ARG2
antigen	ARG2
gene1e	ARG2
,	O
a	O
putative	O
arg1s	O
human	O
arg1e	O
homologue	O
of	O
the	O
20-kD	O
protein	O
present	O
in	O
desmosomal	O
preparations	O
of	O
species1s	O
bovine	O
species1e	O
muzzle	O
,	O
and	O
formerly	O
called	O
gene1s	ARG2
desmoglein	ARG2
III	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
dg4	ARG2
gene1e	ARG2
)	O
,	O
is	O
a	O
promising	O
target	O
antigen	O
for	O
antibody	O
-	O
based	O
therapy	O
of	O
squamous	O
cell	O
carcinoma	O
in	O
man	O
.	O
To	O
anticipate	O
the	O
effect	O
of	O
high	O
antibody	O
dose	O
treatment	O
,	O
and	O
to	O
evaluate	O
the	O
possible	O
biological	O
involvement	O
of	O
the	O
antigen	O
in	O
carcinogenesis	O
,	O
we	O
set	O
out	O
to	O
molecularly	O
characterize	O
the	O
antigen	O
.	O
A	O
cDNA	O
clone	O
encoding	O
the	O
gene1s	ARG2
E48	ARG2
antigen	ARG2
gene1e	ARG2
was	O
isolated	O
by	O
expression	O
cloning	O
in	O
COS	O
cells	O
.	O
Sequence	O
analysis	O
revealed	O
that	O
the	O
clone	O
contained	O
an	O
open	O
reading	O
frame	O
of	O
128	O
amino	O
acids	O
,	O
encoding	O
a	O
core	O
protein	O
of	O
13,286	O
kD.	O
Database	O
searching	O
showed	O
that	O
the	O
gene1s	ARG2
E48	ARG2
antigen	ARG2
gene1e	ARG2
has	O
a	O
high	O
level	O
of	O
sequence	O
similarity	O
with	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
ThB	O
gene1e	O
antigen	O
,	O
a	O
member	O
of	O
the	O
Ly-6	O
antigen	O
family	O
.	O
gene1s	ARG2
Phosphatidylinositol	ARG2
-	ARG2
specific	ARG2
(	ARG2
PI	ARG2
-	ARG2
specific	ARG2
)	ARG2
phospholipase	ARG2
-	ARG2
C	ARG2
gene1e	ARG2
treatment	O
indicated	O
that	O
the	O
gene1s	ARG2
E48	ARG2
antigen	ARG2
gene1e	ARG2
is	O
glycosylphosphatidylinositol	O
-	O
anchored	O
(	O
GPI	O
-	O
anchored	O
)	O
to	O
the	O
plasma	O
membrane	O
.	O
The	O
gene	O
encoding	O
the	O
gene1s	ARG2
E48	ARG2
antigen	ARG2
gene1e	ARG2
is	O
a	O
single	O
copy	O
gene	O
,	O
located	O
on	O
arg1s	O
human	O
arg1e	O
chromosome	O
8	O
in	O
the	O
8q24-qter	O
region	O
.	O
The	O
expression	O
of	O
the	O
gene	O
is	O
confined	O
to	O
keratinocytes	O
and	O
squamous	O
tumor	O
cells	O
.	O
The	O
putative	O
species1s	O
mouse	O
species1e	O
homologue	O
,	O
the	O
gene1s	O
ThB	O
gene1e	O
antigen	O
,	O
originally	O
identified	O
as	O
an	O
antigen	O
on	O
cells	O
of	O
the	O
lymphocyte	O
lineage	O
,	O
was	O
shown	O
to	O
be	O
highly	O
expressed	O
in	O
squamous	O
species1s	O
mouse	O
species1e	O
epithelia	O
.	O
Moreover	O
,	O
the	O
gene1s	O
ThB	O
gene1e	O
expression	O
level	O
is	O
in	O
keratinocytes	O
,	O
in	O
contrast	O
to	O
that	O
in	O
lymphocytes	O
,	O
not	O
species1s	O
mouse	O
species1e	O
strain	O
related	O
.	O
Transfection	O
of	O
species1s	O
mouse	O
species1e	O
SV40-polyoma	O
transformed	O
species1s	O
mouse	O
species1e	O
species1s	O
NIH/3T3	O
species1e	O
cells	O
with	O
the	O
gene1s	ARG2
E48	ARG2
gene1e	ARG2
cDNA	O
confirmed	O
that	O
the	O
antigen	O
is	O
likely	O
to	O
be	O
involved	O
in	O
cell	O
-	O
cell	O
adhesion	O
.	O

The	O
species1s	O
human	O
species1e	O
gene1s	O
E48	O
antigen	O
gene1e	O
,	O
highly	O
homologous	O
to	O
the	O
arg1s	O
murine	O
arg1e	O
gene1s	ARG2
Ly-6	ARG2
antigen	ARG2
ThB	ARG2
gene1e	ARG2
,	O
is	O
a	O
GPI	O
-	O
anchored	O
molecule	O
apparently	O
involved	O
in	O
keratinocyte	O
cell	O
-	O
cell	O
adhesion	O
.	O
The	O
gene1s	O
E48	O
antigen	O
gene1e	O
,	O
a	O
putative	O
species1s	O
human	O
species1e	O
homologue	O
of	O
the	O
20-kD	O
protein	O
present	O
in	O
desmosomal	O
preparations	O
of	O
species1s	O
bovine	O
species1e	O
muzzle	O
,	O
and	O
formerly	O
called	O
gene1s	O
desmoglein	O
III	O
gene1e	O
(	O
gene1s	O
dg4	O
gene1e	O
)	O
,	O
is	O
a	O
promising	O
target	O
antigen	O
for	O
antibody	O
-	O
based	O
therapy	O
of	O
squamous	O
cell	O
carcinoma	O
in	O
man	O
.	O
To	O
anticipate	O
the	O
effect	O
of	O
high	O
antibody	O
dose	O
treatment	O
,	O
and	O
to	O
evaluate	O
the	O
possible	O
biological	O
involvement	O
of	O
the	O
antigen	O
in	O
carcinogenesis	O
,	O
we	O
set	O
out	O
to	O
molecularly	O
characterize	O
the	O
antigen	O
.	O
A	O
cDNA	O
clone	O
encoding	O
the	O
gene1s	O
E48	O
antigen	O
gene1e	O
was	O
isolated	O
by	O
expression	O
cloning	O
in	O
COS	O
cells	O
.	O
Sequence	O
analysis	O
revealed	O
that	O
the	O
clone	O
contained	O
an	O
open	O
reading	O
frame	O
of	O
128	O
amino	O
acids	O
,	O
encoding	O
a	O
core	O
protein	O
of	O
13,286	O
kD.	O
Database	O
searching	O
showed	O
that	O
the	O
gene1s	O
E48	O
antigen	O
gene1e	O
has	O
a	O
high	O
level	O
of	O
sequence	O
similarity	O
with	O
the	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
ThB	ARG2
gene1e	ARG2
antigen	O
,	O
a	O
member	O
of	O
the	O
Ly-6	O
antigen	O
family	O
.	O
gene1s	O
Phosphatidylinositol	O
-	O
specific	O
(	O
PI	O
-	O
specific	O
)	O
phospholipase	O
-	O
C	O
gene1e	O
treatment	O
indicated	O
that	O
the	O
gene1s	O
E48	O
antigen	O
gene1e	O
is	O
glycosylphosphatidylinositol	O
-	O
anchored	O
(	O
GPI	O
-	O
anchored	O
)	O
to	O
the	O
plasma	O
membrane	O
.	O
The	O
gene	O
encoding	O
the	O
gene1s	O
E48	O
antigen	O
gene1e	O
is	O
a	O
single	O
copy	O
gene	O
,	O
located	O
on	O
species1s	O
human	O
species1e	O
chromosome	O
8	O
in	O
the	O
8q24-qter	O
region	O
.	O
The	O
expression	O
of	O
the	O
gene	O
is	O
confined	O
to	O
keratinocytes	O
and	O
squamous	O
tumor	O
cells	O
.	O
The	O
putative	O
arg1s	O
mouse	O
arg1e	O
homologue	O
,	O
the	O
gene1s	ARG2
ThB	ARG2
gene1e	ARG2
antigen	O
,	O
originally	O
identified	O
as	O
an	O
antigen	O
on	O
cells	O
of	O
the	O
lymphocyte	O
lineage	O
,	O
was	O
shown	O
to	O
be	O
highly	O
expressed	O
in	O
squamous	O
arg1s	O
mouse	O
arg1e	O
epithelia	O
.	O
Moreover	O
,	O
the	O
gene1s	ARG2
ThB	ARG2
gene1e	ARG2
expression	O
level	O
is	O
in	O
keratinocytes	O
,	O
in	O
contrast	O
to	O
that	O
in	O
lymphocytes	O
,	O
not	O
arg1s	O
mouse	O
arg1e	O
strain	O
related	O
.	O
Transfection	O
of	O
arg1s	O
mouse	O
arg1e	O
SV40-polyoma	O
transformed	O
arg1s	O
mouse	O
arg1e	O
arg1s	O
NIH/3T3	O
arg1e	O
cells	O
with	O
the	O
gene1s	O
E48	O
gene1e	O
cDNA	O
confirmed	O
that	O
the	O
antigen	O
is	O
likely	O
to	O
be	O
involved	O
in	O
cell	O
-	O
cell	O
adhesion	O
.	O

The	O
species1s	O
human	O
species1e	O
gene1s	O
E48	O
antigen	O
gene1e	O
,	O
highly	O
homologous	O
to	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
Ly-6	O
antigen	O
ThB	O
gene1e	O
,	O
is	O
a	O
GPI	O
-	O
anchored	O
molecule	O
apparently	O
involved	O
in	O
keratinocyte	O
cell	O
-	O
cell	O
adhesion	O
.	O
The	O
gene1s	O
E48	O
antigen	O
gene1e	O
,	O
a	O
putative	O
species1s	O
human	O
species1e	O
homologue	O
of	O
the	O
20-kD	O
protein	O
present	O
in	O
desmosomal	O
preparations	O
of	O
arg1s	O
bovine	O
arg1e	O
muzzle	O
,	O
and	O
formerly	O
called	O
gene1s	O
desmoglein	O
III	O
gene1e	O
(	O
gene1s	O
dg4	O
gene1e	O
)	O
,	O
is	O
a	O
promising	O
target	O
antigen	O
for	O
antibody	O
-	O
based	O
therapy	O
of	O
squamous	O
cell	O
carcinoma	O
in	O
man	O
.	O
To	O
anticipate	O
the	O
effect	O
of	O
high	O
antibody	O
dose	O
treatment	O
,	O
and	O
to	O
evaluate	O
the	O
possible	O
biological	O
involvement	O
of	O
the	O
antigen	O
in	O
carcinogenesis	O
,	O
we	O
set	O
out	O
to	O
molecularly	O
characterize	O
the	O
antigen	O
.	O
A	O
cDNA	O
clone	O
encoding	O
the	O
gene1s	O
E48	O
antigen	O
gene1e	O
was	O
isolated	O
by	O
expression	O
cloning	O
in	O
COS	O
cells	O
.	O
Sequence	O
analysis	O
revealed	O
that	O
the	O
clone	O
contained	O
an	O
open	O
reading	O
frame	O
of	O
128	O
amino	O
acids	O
,	O
encoding	O
a	O
core	O
protein	O
of	O
13,286	O
kD.	O
Database	O
searching	O
showed	O
that	O
the	O
gene1s	O
E48	O
antigen	O
gene1e	O
has	O
a	O
high	O
level	O
of	O
sequence	O
similarity	O
with	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
ThB	O
gene1e	O
antigen	O
,	O
a	O
member	O
of	O
the	O
Ly-6	O
antigen	O
family	O
.	O
gene1s	O
Phosphatidylinositol	O
-	O
specific	O
(	O
PI	O
-	O
specific	O
)	O
phospholipase	O
-	O
C	O
gene1e	O
treatment	O
indicated	O
that	O
the	O
gene1s	O
E48	O
antigen	O
gene1e	O
is	O
glycosylphosphatidylinositol	O
-	O
anchored	O
(	O
GPI	O
-	O
anchored	O
)	O
to	O
the	O
plasma	O
membrane	O
.	O
The	O
gene	O
encoding	O
the	O
gene1s	O
E48	O
antigen	O
gene1e	O
is	O
a	O
single	O
copy	O
gene	O
,	O
located	O
on	O
species1s	O
human	O
species1e	O
chromosome	O
8	O
in	O
the	O
8q24-qter	O
region	O
.	O
The	O
expression	O
of	O
the	O
gene	O
is	O
confined	O
to	O
keratinocytes	O
and	O
squamous	O
tumor	O
cells	O
.	O
The	O
putative	O
species1s	O
mouse	O
species1e	O
homologue	O
,	O
the	O
gene1s	O
ThB	O
gene1e	O
antigen	O
,	O
originally	O
identified	O
as	O
an	O
antigen	O
on	O
cells	O
of	O
the	O
lymphocyte	O
lineage	O
,	O
was	O
shown	O
to	O
be	O
highly	O
expressed	O
in	O
squamous	O
species1s	O
mouse	O
species1e	O
epithelia	O
.	O
Moreover	O
,	O
the	O
gene1s	O
ThB	O
gene1e	O
expression	O
level	O
is	O
in	O
keratinocytes	O
,	O
in	O
contrast	O
to	O
that	O
in	O
lymphocytes	O
,	O
not	O
species1s	O
mouse	O
species1e	O
strain	O
related	O
.	O
Transfection	O
of	O
species1s	O
mouse	O
species1e	O
SV40-polyoma	O
transformed	O
species1s	O
mouse	O
species1e	O
species1s	O
NIH/3T3	O
species1e	O
cells	O
with	O
the	O
gene1s	O
E48	O
gene1e	O
cDNA	O
confirmed	O
that	O
the	O
antigen	O
is	O
likely	O
to	O
be	O
involved	O
in	O
cell	O
-	O
cell	O
adhesion	O
.	O

Molecular	O
cloning	O
of	O
the	O
cDNA	O
for	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
TrkC	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NTRK3	ARG2
gene1e	ARG2
)	O
,	O
chromosomal	O
assignment	O
,	O
and	O
evidence	O
for	O
a	O
splice	O
variant	O
.	O
gene1s	ARG2
TrkC	ARG2
gene1e	ARG2
is	O
a	O
receptor	O
tyrosine	O
kinase	O
that	O
is	O
activated	O
by	O
gene1s	ARG2
neurotrophin-3	ARG2
gene1e	ARG2
,	O
a	O
factor	O
important	O
in	O
the	O
development	O
of	O
certain	O
areas	O
of	O
the	O
central	O
nervous	O
system	O
.	O
We	O
have	O
cloned	O
and	O
sequenced	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
trkC	ARG2
gene1e	ARG2
cDNA	O
and	O
found	O
that	O
the	O
predicted	O
amino	O
acid	O
sequence	O
is	O
97	O
to	O
98	O
%	O
homologous	O
to	O
the	O
species1s	O
rat	O
species1e	O
and	O
porcine	O
gene1s	ARG2
trkC	ARG2
gene1e	ARG2
sequences	O
,	O
respectively	O
.	O
The	O
species1s	O
rat	O
species1e	O
gene1s	ARG2
trkC	ARG2
gene1e	ARG2
has	O
several	O
isoforms	O
due	O
to	O
alternative	O
splicing	O
in	O
the	O
tyrosine	O
kinase	O
domain	O
.	O
We	O
cloned	O
one	O
arg1s	O
human	O
arg1e	O
splice	O
variant	O
that	O
has	O
a	O
nucleic	O
acid	O
sequence	O
identical	O
to	O
the	O
species1s	O
rat	O
species1e	O
isoform	O
with	O
an	O
insert	O
of	O
14	O
amino	O
acids	O
.	O
The	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
trkC	ARG2
gene1e	ARG2
cDNA	O
also	O
has	O
a	O
(	O
CGG)n	O
repeat	O
in	O
the	O
5'-untranslated	O
region	O
.	O
This	O
sequence	O
was	O
not	O
highly	O
polymorphic	O
in	O
that	O
79	O
of	O
80	O
chromosomes	O
examined	O
had	O
eight	O
repeats	O
,	O
while	O
1	O
chromosome	O
had	O
four	O
repeats	O
.	O
By	O
PCR	O
analysis	O
of	O
a	O
somatic	O
cell	O
hybrid	O
panel	O
and	O
fluorescence	O
in	O
situ	O
hybridization	O
with	O
the	O
cDNA	O
clone	O
,	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
trkC	ARG2
gene1e	ARG2
was	O
mapped	O
to	O
chromosome	O
15q24-q25	O
.	O

Molecular	O
cloning	O
of	O
the	O
cDNA	O
for	O
species1s	O
human	O
species1e	O
gene1s	O
TrkC	O
gene1e	O
(	O
gene1s	O
NTRK3	O
gene1e	O
)	O
,	O
chromosomal	O
assignment	O
,	O
and	O
evidence	O
for	O
a	O
splice	O
variant	O
.	O
gene1s	O
TrkC	O
gene1e	O
is	O
a	O
receptor	O
tyrosine	O
kinase	O
that	O
is	O
activated	O
by	O
gene1s	O
neurotrophin-3	O
gene1e	O
,	O
a	O
factor	O
important	O
in	O
the	O
development	O
of	O
certain	O
areas	O
of	O
the	O
central	O
nervous	O
system	O
.	O
We	O
have	O
cloned	O
and	O
sequenced	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
trkC	O
gene1e	O
cDNA	O
and	O
found	O
that	O
the	O
predicted	O
amino	O
acid	O
sequence	O
is	O
97	O
to	O
98	O
%	O
homologous	O
to	O
the	O
arg1s	O
rat	O
arg1e	O
and	O
porcine	O
gene1s	O
trkC	O
gene1e	O
sequences	O
,	O
respectively	O
.	O
The	O
arg1s	O
rat	O
arg1e	O
gene1s	O
trkC	O
gene1e	O
has	O
several	O
isoforms	O
due	O
to	O
alternative	O
splicing	O
in	O
the	O
tyrosine	O
kinase	O
domain	O
.	O
We	O
cloned	O
one	O
species1s	O
human	O
species1e	O
splice	O
variant	O
that	O
has	O
a	O
nucleic	O
acid	O
sequence	O
identical	O
to	O
the	O
arg1s	O
rat	O
arg1e	O
isoform	O
with	O
an	O
insert	O
of	O
14	O
amino	O
acids	O
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
trkC	O
gene1e	O
cDNA	O
also	O
has	O
a	O
(	O
CGG)n	O
repeat	O
in	O
the	O
5'-untranslated	O
region	O
.	O
This	O
sequence	O
was	O
not	O
highly	O
polymorphic	O
in	O
that	O
79	O
of	O
80	O
chromosomes	O
examined	O
had	O
eight	O
repeats	O
,	O
while	O
1	O
chromosome	O
had	O
four	O
repeats	O
.	O
By	O
PCR	O
analysis	O
of	O
a	O
somatic	O
cell	O
hybrid	O
panel	O
and	O
fluorescence	O
in	O
situ	O
hybridization	O
with	O
the	O
cDNA	O
clone	O
,	O
species1s	O
human	O
species1e	O
gene1s	O
trkC	O
gene1e	O
was	O
mapped	O
to	O
chromosome	O
15q24-q25	O
.	O

gene1s	ARG2
Fibulin-2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
FBLN2	ARG2
gene1e	ARG2
)	O
:	O
arg1s	O
human	O
arg1e	O
cDNA	O
sequence	O
,	O
mRNA	O
expression	O
,	O
and	O
mapping	O
of	O
the	O
gene	O
on	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
mouse	O
species1e	O
chromosomes	O
.	O
gene1s	ARG2
Fibulin-2	ARG2
gene1e	ARG2
is	O
a	O
new	O
extracellular	O
matrix	O
protein	O
that	O
we	O
recently	O
identified	O
by	O
characterizing	O
species1s	O
mouse	O
species1e	O
cDNA	O
clones	O
.	O
gene1s	ARG2
Fibulin-2	ARG2
gene1e	ARG2
mRNA	O
is	O
prominently	O
expressed	O
in	O
species1s	O
mouse	O
species1e	O
heart	O
tissue	O
and	O
is	O
present	O
in	O
low	O
amounts	O
in	O
other	O
tissues	O
.	O
In	O
this	O
study	O
,	O
we	O
isolated	O
and	O
sequenced	O
a	O
4.1-kb	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
fibulin-2	ARG2
gene1e	ARG2
cDNA	O
,	O
which	O
encoded	O
a	O
mature	O
protein	O
of	O
1157	O
amino	O
acids	O
preceded	O
by	O
a	O
27-residue	O
signal	O
sequence	O
.	O
The	O
predicted	O
polypeptide	O
contains	O
three	O
consecutive	O
anaphylatoxin	O
-	O
related	O
segments	O
(	O
domain	O
I	O
)	O
in	O
its	O
central	O
region	O
followed	O
by	O
10	O
EGF	O
-	O
like	O
repeats	O
(	O
domain	O
II	O
)	O
,	O
9	O
of	O
which	O
have	O
a	O
consensus	O
sequence	O
for	O
calcium	O
binding	O
.	O
The	O
408-residue	O
N	O
-	O
terminal	O
region	O
consists	O
of	O
two	O
separate	O
subdomains	O
,	O
a	O
cysteine	O
-	O
rich	O
segment	O
of	O
150	O
residues	O
(	O
Na	O
subdomain	O
)	O
and	O
a	O
cysteine	O
-	O
free	O
segment	O
with	O
a	O
stretch	O
of	O
acidic	O
amino	O
acids	O
(	O
Nb	O
subdomain	O
)	O
.	O
The	O
115-residue	O
C	O
-	O
terminal	O
segment	O
(	O
domain	O
III	O
)	O
is	O
similar	O
to	O
the	O
C	O
variant	O
of	O
gene1s	ARG2
fibulin-1	ARG2
gene1e	ARG2
.	O
The	O
amino	O
acid	O
sequences	O
of	O
the	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
mouse	O
species1e	O
gene1s	ARG2
fibulin-2	ARG2
gene1e	ARG2
share	O
approximately	O
90	O
%	O
identity	O
in	O
domains	O
Na	O
,	O
I	O
,	O
II	O
,	O
and	O
III	O
but	O
only	O
62	O
%	O
identity	O
in	O
domain	O
Nb	O
.	O
The	O
arg1s	O
human	O
arg1e	O
cDNA	O
lacks	O
an	O
EGF	O
-	O
like	O
repeat	O
,	O
which	O
is	O
alternatively	O
spliced	O
in	O
the	O
species1s	O
mouse	O
species1e	O
cDNA	O
clones	O
,	O
and	O
a	O
potential	O
cell	O
-	O
binding	O
Arg	O
-	O
Gly	O
-	O
Asp	O
sequence	O
found	O
in	O
the	O
Nb	O
domain	O
of	O
the	O
species1s	O
mouse	O
species1e	O
counterpart	O
.	O
Northern	O
blot	O
analysis	O
of	O
mRNA	O
from	O
various	O
arg1s	O
human	O
arg1e	O
tissues	O
reveals	O
an	O
abundant	O
4.5-kb	O
transcript	O
in	O
heart	O
,	O
placenta	O
,	O
and	O
ovary	O
tissue	O
.	O
The	O
expression	O
pattern	O
differs	O
from	O
that	O
of	O
gene1s	ARG2
fibulin-1	ARG2
gene1e	ARG2
.	O
The	O
gene1s	ARG2
fibulin-2	ARG2
gene1e	ARG2
gene	O
was	O
localized	O
by	O
in	O
situ	O
hybridization	O
to	O
the	O
p24-p25	O
region	O
of	O
arg1s	O
human	O
arg1e	O
chromosome	O
3	O
and	O
to	O
the	O
band	O
D	O
-	O
E	O
of	O
species1s	O
mouse	O
species1e	O
chromosome	O
6	O
.	O

gene1s	O
Fibulin-2	O
gene1e	O
(	O
gene1s	O
FBLN2	O
gene1e	O
)	O
:	O
species1s	O
human	O
species1e	O
cDNA	O
sequence	O
,	O
mRNA	O
expression	O
,	O
and	O
mapping	O
of	O
the	O
gene	O
on	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
mouse	O
arg1e	O
chromosomes	O
.	O
gene1s	O
Fibulin-2	O
gene1e	O
is	O
a	O
new	O
extracellular	O
matrix	O
protein	O
that	O
we	O
recently	O
identified	O
by	O
characterizing	O
arg1s	O
mouse	O
arg1e	O
cDNA	O
clones	O
.	O
gene1s	O
Fibulin-2	O
gene1e	O
mRNA	O
is	O
prominently	O
expressed	O
in	O
arg1s	O
mouse	O
arg1e	O
heart	O
tissue	O
and	O
is	O
present	O
in	O
low	O
amounts	O
in	O
other	O
tissues	O
.	O
In	O
this	O
study	O
,	O
we	O
isolated	O
and	O
sequenced	O
a	O
4.1-kb	O
species1s	O
human	O
species1e	O
gene1s	O
fibulin-2	O
gene1e	O
cDNA	O
,	O
which	O
encoded	O
a	O
mature	O
protein	O
of	O
1157	O
amino	O
acids	O
preceded	O
by	O
a	O
27-residue	O
signal	O
sequence	O
.	O
The	O
predicted	O
polypeptide	O
contains	O
three	O
consecutive	O
anaphylatoxin	O
-	O
related	O
segments	O
(	O
domain	O
I	O
)	O
in	O
its	O
central	O
region	O
followed	O
by	O
10	O
EGF	O
-	O
like	O
repeats	O
(	O
domain	O
II	O
)	O
,	O
9	O
of	O
which	O
have	O
a	O
consensus	O
sequence	O
for	O
calcium	O
binding	O
.	O
The	O
408-residue	O
N	O
-	O
terminal	O
region	O
consists	O
of	O
two	O
separate	O
subdomains	O
,	O
a	O
cysteine	O
-	O
rich	O
segment	O
of	O
150	O
residues	O
(	O
Na	O
subdomain	O
)	O
and	O
a	O
cysteine	O
-	O
free	O
segment	O
with	O
a	O
stretch	O
of	O
acidic	O
amino	O
acids	O
(	O
Nb	O
subdomain	O
)	O
.	O
The	O
115-residue	O
C	O
-	O
terminal	O
segment	O
(	O
domain	O
III	O
)	O
is	O
similar	O
to	O
the	O
C	O
variant	O
of	O
gene1s	O
fibulin-1	O
gene1e	O
.	O
The	O
amino	O
acid	O
sequences	O
of	O
the	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
mouse	O
arg1e	O
gene1s	O
fibulin-2	O
gene1e	O
share	O
approximately	O
90	O
%	O
identity	O
in	O
domains	O
Na	O
,	O
I	O
,	O
II	O
,	O
and	O
III	O
but	O
only	O
62	O
%	O
identity	O
in	O
domain	O
Nb	O
.	O
The	O
species1s	O
human	O
species1e	O
cDNA	O
lacks	O
an	O
EGF	O
-	O
like	O
repeat	O
,	O
which	O
is	O
alternatively	O
spliced	O
in	O
the	O
arg1s	O
mouse	O
arg1e	O
cDNA	O
clones	O
,	O
and	O
a	O
potential	O
cell	O
-	O
binding	O
Arg	O
-	O
Gly	O
-	O
Asp	O
sequence	O
found	O
in	O
the	O
Nb	O
domain	O
of	O
the	O
arg1s	O
mouse	O
arg1e	O
counterpart	O
.	O
Northern	O
blot	O
analysis	O
of	O
mRNA	O
from	O
various	O
species1s	O
human	O
species1e	O
tissues	O
reveals	O
an	O
abundant	O
4.5-kb	O
transcript	O
in	O
heart	O
,	O
placenta	O
,	O
and	O
ovary	O
tissue	O
.	O
The	O
expression	O
pattern	O
differs	O
from	O
that	O
of	O
gene1s	O
fibulin-1	O
gene1e	O
.	O
The	O
gene1s	O
fibulin-2	O
gene1e	O
gene	O
was	O
localized	O
by	O
in	O
situ	O
hybridization	O
to	O
the	O
p24-p25	O
region	O
of	O
species1s	O
human	O
species1e	O
chromosome	O
3	O
and	O
to	O
the	O
band	O
D	O
-	O
E	O
of	O
arg1s	O
mouse	O
arg1e	O
chromosome	O
6	O
.	O

Cloning	O
of	O
an	O
intrinsic	O
arg1s	O
human	O
arg1e	O
TFIID	O
subunit	O
that	O
interacts	O
with	O
multiple	O
transcriptional	O
activators	O
.	O
TFIID	O
is	O
a	O
multisubunit	O
protein	O
complex	O
comprised	O
of	O
the	O
gene1s	ARG2
TATA	ARG2
-	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TBP	ARG2
gene1e	ARG2
)	O
and	O
multiple	O
TBP	O
-	O
associated	O
factors	O
(	O
TAFs	O
)	O
.	O
The	O
TAFs	O
in	O
TFIID	O
are	O
essential	O
for	O
activator	O
-	O
dependent	O
transcription	O
.	O
The	O
cloning	O
of	O
a	O
complementary	O
DNA	O
encoding	O
a	O
arg1s	O
human	O
arg1e	O
TFIID	O
TAF	O
,	O
gene1s	ARG2
TAFII55	ARG2
gene1e	ARG2
,	O
that	O
has	O
no	O
known	O
homolog	O
in	O
species1s	O
Drosophila	O
species1e	O
TFIID	O
is	O
now	O
described	O
.	O
gene1s	ARG2
TAFII55	ARG2
gene1e	ARG2
is	O
shown	O
to	O
interact	O
with	O
the	O
largest	O
subunit	O
(	O
gene1s	ARG2
TAFII230	ARG2
gene1e	ARG2
)	O
of	O
arg1s	O
human	O
arg1e	O
TFIID	O
through	O
its	O
central	O
region	O
and	O
with	O
multiple	O
activators	O
--	O
including	O
gene1s	ARG2
Sp1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
YY1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
USF	ARG2
gene1e	ARG2
,	O
CTF	O
,	O
adenoviral	O
E1A	O
,	O
and	O
species1s	O
human	O
immunodeficiency	O
virus	O
-	O
type	O
1	O
species1e	O
Tat	O
proteins	O
--	O
through	O
a	O
distinct	O
amino	O
-	O
terminal	O
domain	O
.	O
The	O
gene1s	ARG2
TAFII55	ARG2
gene1e	ARG2
-interacting	O
region	O
of	O
gene1s	ARG2
Sp1	ARG2
gene1e	ARG2
was	O
localized	O
to	O
its	O
DNA	O
-	O
binding	O
domain	O
,	O
which	O
is	O
distinct	O
from	O
the	O
glutamine	O
-	O
rich	O
activation	O
domains	O
previously	O
shown	O
to	O
interact	O
with	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
TAFII110	O
gene1e	O
.	O
Thus	O
,	O
this	O
arg1s	O
human	O
arg1e	O
TFIID	O
TAF	O
may	O
be	O
a	O
co	O
-	O
activator	O
that	O
mediates	O
a	O
response	O
to	O
multiple	O
activators	O
through	O
a	O
distinct	O
mechanism	O
.	O

Cloning	O
of	O
an	O
intrinsic	O
species1s	O
human	O
species1e	O
TFIID	O
subunit	O
that	O
interacts	O
with	O
multiple	O
transcriptional	O
activators	O
.	O
TFIID	O
is	O
a	O
multisubunit	O
protein	O
complex	O
comprised	O
of	O
the	O
gene1s	O
TATA	O
-	O
binding	O
protein	O
gene1e	O
(	O
gene1s	O
TBP	O
gene1e	O
)	O
and	O
multiple	O
TBP	O
-	O
associated	O
factors	O
(	O
TAFs	O
)	O
.	O
The	O
TAFs	O
in	O
TFIID	O
are	O
essential	O
for	O
activator	O
-	O
dependent	O
transcription	O
.	O
The	O
cloning	O
of	O
a	O
complementary	O
DNA	O
encoding	O
a	O
species1s	O
human	O
species1e	O
TFIID	O
TAF	O
,	O
gene1s	O
TAFII55	O
gene1e	O
,	O
that	O
has	O
no	O
known	O
homolog	O
in	O
arg1s	O
Drosophila	O
arg1e	O
TFIID	O
is	O
now	O
described	O
.	O
gene1s	O
TAFII55	O
gene1e	O
is	O
shown	O
to	O
interact	O
with	O
the	O
largest	O
subunit	O
(	O
gene1s	O
TAFII230	O
gene1e	O
)	O
of	O
species1s	O
human	O
species1e	O
TFIID	O
through	O
its	O
central	O
region	O
and	O
with	O
multiple	O
activators	O
--	O
including	O
gene1s	O
Sp1	O
gene1e	O
,	O
gene1s	O
YY1	O
gene1e	O
,	O
gene1s	O
USF	O
gene1e	O
,	O
CTF	O
,	O
adenoviral	O
E1A	O
,	O
and	O
species1s	O
human	O
immunodeficiency	O
virus	O
-	O
type	O
1	O
species1e	O
Tat	O
proteins	O
--	O
through	O
a	O
distinct	O
amino	O
-	O
terminal	O
domain	O
.	O
The	O
gene1s	O
TAFII55	O
gene1e	O
-interacting	O
region	O
of	O
gene1s	O
Sp1	O
gene1e	O
was	O
localized	O
to	O
its	O
DNA	O
-	O
binding	O
domain	O
,	O
which	O
is	O
distinct	O
from	O
the	O
glutamine	O
-	O
rich	O
activation	O
domains	O
previously	O
shown	O
to	O
interact	O
with	O
arg1s	O
Drosophila	O
arg1e	O
gene1s	ARG2
TAFII110	ARG2
gene1e	ARG2
.	O
Thus	O
,	O
this	O
species1s	O
human	O
species1e	O
TFIID	O
TAF	O
may	O
be	O
a	O
co	O
-	O
activator	O
that	O
mediates	O
a	O
response	O
to	O
multiple	O
activators	O
through	O
a	O
distinct	O
mechanism	O
.	O

Cloning	O
of	O
an	O
intrinsic	O
species1s	O
human	O
species1e	O
TFIID	O
subunit	O
that	O
interacts	O
with	O
multiple	O
transcriptional	O
activators	O
.	O
TFIID	O
is	O
a	O
multisubunit	O
protein	O
complex	O
comprised	O
of	O
the	O
gene1s	O
TATA	O
-	O
binding	O
protein	O
gene1e	O
(	O
gene1s	O
TBP	O
gene1e	O
)	O
and	O
multiple	O
TBP	O
-	O
associated	O
factors	O
(	O
TAFs	O
)	O
.	O
The	O
TAFs	O
in	O
TFIID	O
are	O
essential	O
for	O
activator	O
-	O
dependent	O
transcription	O
.	O
The	O
cloning	O
of	O
a	O
complementary	O
DNA	O
encoding	O
a	O
species1s	O
human	O
species1e	O
TFIID	O
TAF	O
,	O
gene1s	O
TAFII55	O
gene1e	O
,	O
that	O
has	O
no	O
known	O
homolog	O
in	O
species1s	O
Drosophila	O
species1e	O
TFIID	O
is	O
now	O
described	O
.	O
gene1s	O
TAFII55	O
gene1e	O
is	O
shown	O
to	O
interact	O
with	O
the	O
largest	O
subunit	O
(	O
gene1s	O
TAFII230	O
gene1e	O
)	O
of	O
species1s	O
human	O
species1e	O
TFIID	O
through	O
its	O
central	O
region	O
and	O
with	O
multiple	O
activators	O
--	O
including	O
gene1s	O
Sp1	O
gene1e	O
,	O
gene1s	O
YY1	O
gene1e	O
,	O
gene1s	O
USF	O
gene1e	O
,	O
CTF	O
,	O
adenoviral	O
E1A	O
,	O
and	O
arg1s	O
human	O
immunodeficiency	O
virus	O
-	O
type	O
1	O
arg1e	O
Tat	O
proteins	O
--	O
through	O
a	O
distinct	O
amino	O
-	O
terminal	O
domain	O
.	O
The	O
gene1s	O
TAFII55	O
gene1e	O
-interacting	O
region	O
of	O
gene1s	O
Sp1	O
gene1e	O
was	O
localized	O
to	O
its	O
DNA	O
-	O
binding	O
domain	O
,	O
which	O
is	O
distinct	O
from	O
the	O
glutamine	O
-	O
rich	O
activation	O
domains	O
previously	O
shown	O
to	O
interact	O
with	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
TAFII110	O
gene1e	O
.	O
Thus	O
,	O
this	O
species1s	O
human	O
species1e	O
TFIID	O
TAF	O
may	O
be	O
a	O
co	O
-	O
activator	O
that	O
mediates	O
a	O
response	O
to	O
multiple	O
activators	O
through	O
a	O
distinct	O
mechanism	O
.	O

Expression	O
and	O
kinetic	O
characterization	O
of	O
recombinant	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
stomach	ARG2
alcohol	ARG2
dehydrogenase	ARG2
gene1e	ARG2
.	O
Active	O
-	O
site	O
amino	O
acid	O
sequence	O
explains	O
substrate	O
specificity	O
compared	O
with	O
liver	O
isozymes	O
.	O
A	O
full	O
-	O
length	O
1966-base	O
pair	O
clone	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
class	ARG2
IV	ARG2
alcohol	ARG2
dehydrogenase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
sigma	ARG2
-	ARG2
ADH	ARG2
gene1e	ARG2
)	O
was	O
isolated	O
from	O
a	O
arg1s	O
human	O
arg1e	O
stomach	O
cDNA	O
library	O
.	O
The	O
373-amino	O
acid	O
gene1s	ARG2
sigma	ARG2
-	ARG2
ADH	ARG2
gene1e	ARG2
encoded	O
by	O
this	O
cDNA	O
was	O
expressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
.	O
The	O
specific	O
activity	O
of	O
the	O
recombinant	O
enzyme	O
for	O
ethanol	O
oxidation	O
at	O
pH	O
7.5	O
and	O
25	O
degrees	O
C	O
,	O
calculated	O
from	O
active	O
-	O
site	O
titration	O
of	O
NADH	O
binding	O
,	O
was	O
92	O
+	O
/-	O
9	O
units	O
/	O
mg	O
.	O
Kinetic	O
analysis	O
of	O
the	O
catalytic	O
efficiency	O
(	O
kcat	O
/	O
KM	O
)	O
of	O
recombinant	O
gene1s	ARG2
sigma	ARG2
-	ARG2
ADH	ARG2
gene1e	ARG2
for	O
oxidation	O
of	O
primary	O
alcohols	O
indicated	O
broad	O
substrate	O
specificity	O
.	O
Recombinant	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
sigma	ARG2
-	ARG2
ADH	ARG2
gene1e	ARG2
exhibited	O
high	O
catalytic	O
efficiency	O
for	O
oxidation	O
of	O
all	O
-	O
trans	O
-	O
retinol	O
to	O
all	O
-	O
trans	O
-	O
retinal	O
.	O
This	O
pathway	O
is	O
important	O
in	O
the	O
synthesis	O
of	O
the	O
transcriptional	O
regulator	O
all	O
-	O
trans	O
-	O
retinoic	O
acid	O
.	O
Secondary	O
alcohols	O
and	O
3	O
beta	O
-	O
hydroxysteroids	O
were	O
inactive	O
with	O
gene1s	ARG2
sigma	ARG2
-	ARG2
ADH	ARG2
gene1e	ARG2
or	O
were	O
oxidized	O
with	O
very	O
low	O
efficiency	O
.	O
The	O
KM	O
of	O
gene1s	ARG2
sigma	ARG2
-	ARG2
ADH	ARG2
gene1e	ARG2
for	O
ethanol	O
was	O
25	O
mM	O
,	O
and	O
the	O
KM	O
for	O
primary	O
straight	O
chain	O
alcohols	O
decreased	O
substantially	O
as	O
chain	O
length	O
increased	O
.	O
There	O
are	O
important	O
amino	O
acid	O
differences	O
in	O
the	O
alcohol	O
-	O
binding	O
site	O
between	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
class	ARG2
IV	ARG2
(	ARG2
sigma	ARG2
)	ARG2
gene1e	ARG2
and	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
class	ARG2
I	ARG2
(	ARG2
beta	ARG2
)	ARG2
alcohol	ARG2
dehydrogenases	ARG2
gene1e	ARG2
that	O
appear	O
to	O
explain	O
the	O
high	O
catalytic	O
efficiency	O
for	O
all	O
-	O
trans	O
-	O
retinol	O
,	O
the	O
high	O
kcat	O
for	O
ethanol	O
,	O
and	O
the	O
low	O
catalytic	O
efficiency	O
for	O
secondary	O
alcohols	O
of	O
gene1s	ARG2
sigma	ARG2
-	ARG2
ADH	ARG2
gene1e	ARG2
relative	O
to	O
gene1s	ARG2
beta	ARG2
1-ADH	ARG2
gene1e	ARG2
.	O
For	O
example	O
,	O
modeling	O
the	O
binding	O
of	O
all	O
-	O
trans	O
-	O
retinol	O
in	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
beta	ARG2
1-ADH	ARG2
gene1e	ARG2
structure	O
suggested	O
that	O
coordination	O
of	O
retinol	O
to	O
the	O
active	O
-	O
site	O
zinc	O
is	O
hindered	O
by	O
a	O
loop	O
from	O
residues	O
114	O
to	O
120	O
that	O
is	O
at	O
the	O
entrance	O
to	O
the	O
alcohol	O
-	O
binding	O
site	O
.	O
The	O
deletion	O
of	O
Gly-117	O
in	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
sigma	ARG2
-	ARG2
ADH	ARG2
gene1e	ARG2
and	O
a	O
substitution	O
of	O
Leu	O
for	O
the	O
bulky	O
Tyr-110	O
appear	O
to	O
facilitate	O
retinol	O
access	O
to	O
the	O
active	O
-	O
site	O
zinc	O
.	O

Expression	O
and	O
kinetic	O
characterization	O
of	O
recombinant	O
species1s	O
human	O
species1e	O
gene1s	O
stomach	O
alcohol	O
dehydrogenase	O
gene1e	O
.	O
Active	O
-	O
site	O
amino	O
acid	O
sequence	O
explains	O
substrate	O
specificity	O
compared	O
with	O
liver	O
isozymes	O
.	O
A	O
full	O
-	O
length	O
1966-base	O
pair	O
clone	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
class	O
IV	O
alcohol	O
dehydrogenase	O
gene1e	O
(	O
gene1s	O
sigma	O
-	O
ADH	O
gene1e	O
)	O
was	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
stomach	O
cDNA	O
library	O
.	O
The	O
373-amino	O
acid	O
gene1s	O
sigma	O
-	O
ADH	O
gene1e	O
encoded	O
by	O
this	O
cDNA	O
was	O
expressed	O
in	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
.	O
The	O
specific	O
activity	O
of	O
the	O
recombinant	O
enzyme	O
for	O
ethanol	O
oxidation	O
at	O
pH	O
7.5	O
and	O
25	O
degrees	O
C	O
,	O
calculated	O
from	O
active	O
-	O
site	O
titration	O
of	O
NADH	O
binding	O
,	O
was	O
92	O
+	O
/-	O
9	O
units	O
/	O
mg	O
.	O
Kinetic	O
analysis	O
of	O
the	O
catalytic	O
efficiency	O
(	O
kcat	O
/	O
KM	O
)	O
of	O
recombinant	O
gene1s	O
sigma	O
-	O
ADH	O
gene1e	O
for	O
oxidation	O
of	O
primary	O
alcohols	O
indicated	O
broad	O
substrate	O
specificity	O
.	O
Recombinant	O
species1s	O
human	O
species1e	O
gene1s	O
sigma	O
-	O
ADH	O
gene1e	O
exhibited	O
high	O
catalytic	O
efficiency	O
for	O
oxidation	O
of	O
all	O
-	O
trans	O
-	O
retinol	O
to	O
all	O
-	O
trans	O
-	O
retinal	O
.	O
This	O
pathway	O
is	O
important	O
in	O
the	O
synthesis	O
of	O
the	O
transcriptional	O
regulator	O
all	O
-	O
trans	O
-	O
retinoic	O
acid	O
.	O
Secondary	O
alcohols	O
and	O
3	O
beta	O
-	O
hydroxysteroids	O
were	O
inactive	O
with	O
gene1s	O
sigma	O
-	O
ADH	O
gene1e	O
or	O
were	O
oxidized	O
with	O
very	O
low	O
efficiency	O
.	O
The	O
KM	O
of	O
gene1s	O
sigma	O
-	O
ADH	O
gene1e	O
for	O
ethanol	O
was	O
25	O
mM	O
,	O
and	O
the	O
KM	O
for	O
primary	O
straight	O
chain	O
alcohols	O
decreased	O
substantially	O
as	O
chain	O
length	O
increased	O
.	O
There	O
are	O
important	O
amino	O
acid	O
differences	O
in	O
the	O
alcohol	O
-	O
binding	O
site	O
between	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
class	O
IV	O
(	O
sigma	O
)	O
gene1e	O
and	O
species1s	O
human	O
species1e	O
gene1s	O
class	O
I	O
(	O
beta	O
)	O
alcohol	O
dehydrogenases	O
gene1e	O
that	O
appear	O
to	O
explain	O
the	O
high	O
catalytic	O
efficiency	O
for	O
all	O
-	O
trans	O
-	O
retinol	O
,	O
the	O
high	O
kcat	O
for	O
ethanol	O
,	O
and	O
the	O
low	O
catalytic	O
efficiency	O
for	O
secondary	O
alcohols	O
of	O
gene1s	O
sigma	O
-	O
ADH	O
gene1e	O
relative	O
to	O
gene1s	O
beta	O
1-ADH	O
gene1e	O
.	O
For	O
example	O
,	O
modeling	O
the	O
binding	O
of	O
all	O
-	O
trans	O
-	O
retinol	O
in	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
beta	O
1-ADH	O
gene1e	O
structure	O
suggested	O
that	O
coordination	O
of	O
retinol	O
to	O
the	O
active	O
-	O
site	O
zinc	O
is	O
hindered	O
by	O
a	O
loop	O
from	O
residues	O
114	O
to	O
120	O
that	O
is	O
at	O
the	O
entrance	O
to	O
the	O
alcohol	O
-	O
binding	O
site	O
.	O
The	O
deletion	O
of	O
Gly-117	O
in	O
species1s	O
human	O
species1e	O
gene1s	O
sigma	O
-	O
ADH	O
gene1e	O
and	O
a	O
substitution	O
of	O
Leu	O
for	O
the	O
bulky	O
Tyr-110	O
appear	O
to	O
facilitate	O
retinol	O
access	O
to	O
the	O
active	O
-	O
site	O
zinc	O
.	O

Cloning	O
of	O
arg1s	O
human	O
arg1e	O
acetyl	O
-	O
CoA	O
carboxylase	O
cDNA	O
.	O
Acetyl	O
-	O
CoA	O
carboxylase	O
is	O
the	O
rate	O
-	O
limiting	O
enzyme	O
in	O
the	O
biogenesis	O
of	O
long	O
-	O
chain	O
fatty	O
acids	O
.	O
In	O
order	O
to	O
understand	O
the	O
mechanisms	O
that	O
regulate	O
arg1s	O
human	O
arg1e	O
acetyl	O
-	O
CoA	O
carboxylase	O
at	O
the	O
gene	O
level	O
,	O
and	O
the	O
relationship	O
between	O
its	O
structure	O
and	O
function	O
,	O
cDNA	O
clones	O
for	O
arg1s	O
human	O
arg1e	O
acetyl	O
-	O
CoA	O
carboxylase	O
have	O
been	O
isolated	O
and	O
sequenced	O
.	O
arg1s	O
Human	O
arg1e	O
acetyl	O
-	O
CoA	O
-	O
carboxylase	O
cDNA	O
contains	O
7020	O
nucleotides	O
encoding	O
a	O
protein	O
of	O
2340	O
amino	O
acids	O
with	O
a	O
calculated	O
relative	O
molecular	O
mass	O
of	O
264575	O
.	O
The	O
arg1s	O
human	O
arg1e	O
enzyme	O
shows	O
approximately	O
85	O
%	O
identity	O
in	O
nucleotide	O
sequence	O
with	O
previously	O
cloned	O
species1s	O
rat	O
species1e	O
acetyl	O
-	O
CoA	O
carboxylase	O
,	O
and	O
shows	O
90	O
%	O
identity	O
in	O
the	O
amino	O
acid	O
sequence	O
.	O
Two	O
arg1s	O
human	O
arg1e	O
acetyl	O
-	O
CoA	O
-	O
carboxylase	O
mRNA	O
species	O
,	O
which	O
differ	O
in	O
the	O
5	O
'	O
untranslated	O
region	O
with	O
the	O
same	O
coding	O
sequence	O
,	O
have	O
been	O
identified	O
.	O
The	O
sequence	O
analysis	O
reveals	O
that	O
gene1s	ARG2
type	ARG2
I	ARG2
and	ARG2
type	ARG2
II	ARG2
acetyl	ARG2
-	ARG2
CoA	ARG2
-	ARG2
carboxylase	ARG2
gene1e	ARG2
mRNA	O
contain	O
313-	O
and	O
173-base	O
-	O
long	O
5	O
'	O
untranslated	O
regions	O
,	O
respectively	O
.	O
The	O
first	O
240	O
nucleotides	O
in	O
the	O
5	O
'	O
untranslated	O
region	O
of	O
gene1s	ARG2
type	ARG2
I	ARG2
acetyl	ARG2
-	ARG2
CoA	ARG2
-	ARG2
carboxylase	ARG2
gene1e	ARG2
mRNA	O
replace	O
the	O
first	O
100	O
nucleotides	O
of	O
the	O
(	O
G	O
+	O
C)-rich	O
region	O
of	O
the	O
5	O
'	O
untranslated	O
region	O
of	O
the	O
type	O
II	O
mRNA	O
.	O
These	O
two	O
species	O
of	O
mRNAs	O
are	O
the	O
only	O
species	O
of	O
arg1s	O
human	O
arg1e	O
ACC	O
mRNA	O
which	O
have	O
been	O
detected	O
compared	O
to	O
at	O
least	O
five	O
species	O
in	O
species1s	O
rat	O
species1e	O
tissues	O
,	O
and	O
they	O
are	O
expressed	O
in	O
a	O
tissue	O
-	O
specific	O
manner	O
.	O

Cloning	O
of	O
species1s	O
human	O
species1e	O
acetyl	O
-	O
CoA	O
carboxylase	O
cDNA	O
.	O
Acetyl	O
-	O
CoA	O
carboxylase	O
is	O
the	O
rate	O
-	O
limiting	O
enzyme	O
in	O
the	O
biogenesis	O
of	O
long	O
-	O
chain	O
fatty	O
acids	O
.	O
In	O
order	O
to	O
understand	O
the	O
mechanisms	O
that	O
regulate	O
species1s	O
human	O
species1e	O
acetyl	O
-	O
CoA	O
carboxylase	O
at	O
the	O
gene	O
level	O
,	O
and	O
the	O
relationship	O
between	O
its	O
structure	O
and	O
function	O
,	O
cDNA	O
clones	O
for	O
species1s	O
human	O
species1e	O
acetyl	O
-	O
CoA	O
carboxylase	O
have	O
been	O
isolated	O
and	O
sequenced	O
.	O
species1s	O
Human	O
species1e	O
acetyl	O
-	O
CoA	O
-	O
carboxylase	O
cDNA	O
contains	O
7020	O
nucleotides	O
encoding	O
a	O
protein	O
of	O
2340	O
amino	O
acids	O
with	O
a	O
calculated	O
relative	O
molecular	O
mass	O
of	O
264575	O
.	O
The	O
species1s	O
human	O
species1e	O
enzyme	O
shows	O
approximately	O
85	O
%	O
identity	O
in	O
nucleotide	O
sequence	O
with	O
previously	O
cloned	O
arg1s	O
rat	O
arg1e	O
acetyl	O
-	O
CoA	O
carboxylase	O
,	O
and	O
shows	O
90	O
%	O
identity	O
in	O
the	O
amino	O
acid	O
sequence	O
.	O
Two	O
species1s	O
human	O
species1e	O
acetyl	O
-	O
CoA	O
-	O
carboxylase	O
mRNA	O
species	O
,	O
which	O
differ	O
in	O
the	O
5	O
'	O
untranslated	O
region	O
with	O
the	O
same	O
coding	O
sequence	O
,	O
have	O
been	O
identified	O
.	O
The	O
sequence	O
analysis	O
reveals	O
that	O
gene1s	O
type	O
I	O
and	O
type	O
II	O
acetyl	O
-	O
CoA	O
-	O
carboxylase	O
gene1e	O
mRNA	O
contain	O
313-	O
and	O
173-base	O
-	O
long	O
5	O
'	O
untranslated	O
regions	O
,	O
respectively	O
.	O
The	O
first	O
240	O
nucleotides	O
in	O
the	O
5	O
'	O
untranslated	O
region	O
of	O
gene1s	O
type	O
I	O
acetyl	O
-	O
CoA	O
-	O
carboxylase	O
gene1e	O
mRNA	O
replace	O
the	O
first	O
100	O
nucleotides	O
of	O
the	O
(	O
G	O
+	O
C)-rich	O
region	O
of	O
the	O
5	O
'	O
untranslated	O
region	O
of	O
the	O
type	O
II	O
mRNA	O
.	O
These	O
two	O
species	O
of	O
mRNAs	O
are	O
the	O
only	O
species	O
of	O
species1s	O
human	O
species1e	O
ACC	O
mRNA	O
which	O
have	O
been	O
detected	O
compared	O
to	O
at	O
least	O
five	O
species	O
in	O
arg1s	O
rat	O
arg1e	O
tissues	O
,	O
and	O
they	O
are	O
expressed	O
in	O
a	O
tissue	O
-	O
specific	O
manner	O
.	O

arg1s	O
Human	O
arg1e	O
gene1s	ARG2
mu	ARG2
opiate	ARG2
receptor	ARG2
gene1e	ARG2
.	O
cDNA	O
and	O
genomic	O
clones	O
,	O
pharmacologic	O
characterization	O
and	O
chromosomal	O
assignment	O
.	O
A	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
mu	ARG2
opiate	ARG2
receptor	ARG2
gene1e	ARG2
cDNA	O
has	O
been	O
identified	O
from	O
a	O
cerebral	O
cortical	O
cDNA	O
library	O
using	O
sequences	O
from	O
the	O
species1s	O
rat	O
species1e	O
gene1s	O
mu	O
opiate	O
receptor	O
gene1e	O
cDNA	O
.	O
The	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
mu	ARG2
opiate	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
h	ARG2
mu	ARG2
OR1	ARG2
gene1e	ARG2
)	O
shares	O
95	O
%	O
amino	O
acid	O
identity	O
with	O
the	O
species1s	O
rat	O
species1e	O
sequence	O
.	O
The	O
expressed	O
gene1s	ARG2
mu	ARG2
OR1	ARG2
gene1e	ARG2
recognized	O
tested	O
opiate	O
drugs	O
and	O
opioid	O
peptides	O
in	O
a	O
sodium-	O
and	O
GTP	O
-	O
sensitive	O
fashion	O
with	O
affinities	O
virtually	O
identical	O
to	O
those	O
displayed	O
by	O
the	O
species1s	O
rat	O
species1e	O
gene1s	O
mu	O
opiate	O
receptor	O
gene1e	O
.	O
Effects	O
on	O
cyclic	O
AMP	O
are	O
similar	O
to	O
those	O
noted	O
for	O
the	O
species1s	O
rat	O
species1e	O
gene1s	O
mu	O
opiate	O
receptor	O
gene1e	O
.	O
An	O
18	O
kb	O
genomic	O
clone	O
hybridizing	O
with	O
the	O
gene1s	ARG2
h	ARG2
mu	ARG2
OR1	ARG2
gene1e	ARG2
cDNA	O
contains	O
63	O
and	O
489	O
bp	O
exonic	O
sequences	O
flanked	O
by	O
splice	O
donor	O
/	O
acceptor	O
sequences	O
.	O
Analysis	O
of	O
hybridization	O
to	O
DNA	O
prepared	O
from	O
arg1s	O
human	O
arg1e	O
rodent	O
hybrid	O
cell	O
lines	O
and	O
chromosomal	O
in	O
situ	O
hybridization	O
studies	O
indicate	O
localization	O
to	O
6q24	O
-	O
25	O
.	O
An	O
MspI	O
polymorphism	O
,	O
producing	O
a	O
3.7	O
kb	O
band	O
,	O
may	O
prove	O
useful	O
in	O
assessing	O
this	O
gene	O
's	O
involvement	O
in	O
neuropsychiatric	O
disorders	O
involving	O
opiatergic	O
systems	O
.	O

species1s	O
Human	O
species1e	O
gene1s	O
mu	O
opiate	O
receptor	O
gene1e	O
.	O
cDNA	O
and	O
genomic	O
clones	O
,	O
pharmacologic	O
characterization	O
and	O
chromosomal	O
assignment	O
.	O
A	O
species1s	O
human	O
species1e	O
gene1s	O
mu	O
opiate	O
receptor	O
gene1e	O
cDNA	O
has	O
been	O
identified	O
from	O
a	O
cerebral	O
cortical	O
cDNA	O
library	O
using	O
sequences	O
from	O
the	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
mu	ARG2
opiate	ARG2
receptor	ARG2
gene1e	ARG2
cDNA	O
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
mu	O
opiate	O
receptor	O
gene1e	O
(	O
gene1s	O
h	O
mu	O
OR1	O
gene1e	O
)	O
shares	O
95	O
%	O
amino	O
acid	O
identity	O
with	O
the	O
arg1s	O
rat	O
arg1e	O
sequence	O
.	O
The	O
expressed	O
gene1s	O
mu	O
OR1	O
gene1e	O
recognized	O
tested	O
opiate	O
drugs	O
and	O
opioid	O
peptides	O
in	O
a	O
sodium-	O
and	O
GTP	O
-	O
sensitive	O
fashion	O
with	O
affinities	O
virtually	O
identical	O
to	O
those	O
displayed	O
by	O
the	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
mu	ARG2
opiate	ARG2
receptor	ARG2
gene1e	ARG2
.	O
Effects	O
on	O
cyclic	O
AMP	O
are	O
similar	O
to	O
those	O
noted	O
for	O
the	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
mu	ARG2
opiate	ARG2
receptor	ARG2
gene1e	ARG2
.	O
An	O
18	O
kb	O
genomic	O
clone	O
hybridizing	O
with	O
the	O
gene1s	O
h	O
mu	O
OR1	O
gene1e	O
cDNA	O
contains	O
63	O
and	O
489	O
bp	O
exonic	O
sequences	O
flanked	O
by	O
splice	O
donor	O
/	O
acceptor	O
sequences	O
.	O
Analysis	O
of	O
hybridization	O
to	O
DNA	O
prepared	O
from	O
species1s	O
human	O
species1e	O
rodent	O
hybrid	O
cell	O
lines	O
and	O
chromosomal	O
in	O
situ	O
hybridization	O
studies	O
indicate	O
localization	O
to	O
6q24	O
-	O
25	O
.	O
An	O
MspI	O
polymorphism	O
,	O
producing	O
a	O
3.7	O
kb	O
band	O
,	O
may	O
prove	O
useful	O
in	O
assessing	O
this	O
gene	O
's	O
involvement	O
in	O
neuropsychiatric	O
disorders	O
involving	O
opiatergic	O
systems	O
.	O

arg1s	O
Human	O
arg1e	O
gene1s	ARG2
cytoplasmic	ARG2
3-hydroxy-3-methylglutaryl	ARG2
coenzyme	ARG2
A	ARG2
synthase	ARG2
gene1e	ARG2
:	O
expression	O
,	O
purification	O
,	O
and	O
characterization	O
of	O
recombinant	O
wild	O
-	O
type	O
and	O
Cys129	O
mutant	O
enzymes	O
.	O
A	O
cDNA	O
for	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
cytoplasmic	ARG2
3-hydroxy-3-methylglutaryl	ARG2
coenzyme	ARG2
A	ARG2
(	ARG2
HMG	ARG2
-	ARG2
CoA	ARG2
)	ARG2
synthase	ARG2
gene1e	ARG2
(	O
EC	O
4.1.3.5	O
)	O
was	O
subcloned	O
and	O
expressed	O
from	O
a	O
T7-based	O
vector	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
.	O
The	O
over	O
-	O
produced	O
enzyme	O
was	O
purified	O
using	O
a	O
three	O
-	O
step	O
protocol	O
that	O
generated	O
20	O
to	O
30	O
mg	O
protein	O
/	O
liter	O
cell	O
culture	O
.	O
The	O
physical	O
and	O
catalytic	O
properties	O
of	O
the	O
recombinant	O
synthase	O
are	O
similar	O
to	O
those	O
reported	O
for	O
the	O
nonrecombinant	O
enzymes	O
from	O
species1s	O
chicken	O
species1e	O
liver	O
[	O
Clinkenbeard	O
et	O
al	O
.	O
(	O
1975a	O
)	O
J.	O
Biol	O
.	O
Chem	O
.	O
250	O
,	O
3124	O
-	O
3135	O
]	O
and	O
species1s	O
rat	O
species1e	O
liver	O
[	O
Mehrabian	O
et	O
al	O
.	O
(	O
1986	O
)	O
J.	O
Biol	O
.	O
Chem	O
.	O
261	O
,	O
16249	O
-	O
16255	O
]	O
.	O
Mutation	O
of	O
Cys129	O
to	O
serine	O
or	O
alanine	O
destroys	O
HMG	O
-	O
CoA	O
synthase	O
activity	O
by	O
disrupting	O
the	O
first	O
catalytic	O
step	O
in	O
HMG	O
-	O
CoA	O
synthesis	O
,	O
enzyme	O
acetylation	O
by	O
acetyl	O
coenzyme	O
A.	O
Furthermore	O
,	O
unlike	O
the	O
wild	O
-	O
type	O
enzyme	O
,	O
neither	O
mutant	O
was	O
capable	O
of	O
covalent	O
modification	O
by	O
the	O
beta	O
-	O
lactone	O
inhibitor	O
,	O
L-659,699	O
[	O
Greenspan	O
et	O
al	O
.	O
(	O
1987	O
)	O
Proc	O
.	O
Natl	O
.	O
Acad	O
.	O
Sci	O
.	O
USA	O
84	O
,	O
7488	O
-	O
7492	O
]	O
.	O
Kinetic	O
analysis	O
of	O
the	O
inhibition	O
by	O
L-659,699	O
revealed	O
that	O
this	O
compound	O
is	O
a	O
potent	O
inhibitor	O
of	O
the	O
recombinant	O
arg1s	O
human	O
arg1e	O
synthase	O
,	O
with	O
an	O
inhibition	O
constant	O
of	O
53.7	O
nM	O
and	O
an	O
inactivation	O
rate	O
constant	O
of	O
1.06	O
min-1	O
.	O

species1s	O
Human	O
species1e	O
gene1s	O
cytoplasmic	O
3-hydroxy-3-methylglutaryl	O
coenzyme	O
A	O
synthase	O
gene1e	O
:	O
expression	O
,	O
purification	O
,	O
and	O
characterization	O
of	O
recombinant	O
wild	O
-	O
type	O
and	O
Cys129	O
mutant	O
enzymes	O
.	O
A	O
cDNA	O
for	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
cytoplasmic	O
3-hydroxy-3-methylglutaryl	O
coenzyme	O
A	O
(	O
HMG	O
-	O
CoA	O
)	O
synthase	O
gene1e	O
(	O
EC	O
4.1.3.5	O
)	O
was	O
subcloned	O
and	O
expressed	O
from	O
a	O
T7-based	O
vector	O
in	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
.	O
The	O
over	O
-	O
produced	O
enzyme	O
was	O
purified	O
using	O
a	O
three	O
-	O
step	O
protocol	O
that	O
generated	O
20	O
to	O
30	O
mg	O
protein	O
/	O
liter	O
cell	O
culture	O
.	O
The	O
physical	O
and	O
catalytic	O
properties	O
of	O
the	O
recombinant	O
synthase	O
are	O
similar	O
to	O
those	O
reported	O
for	O
the	O
nonrecombinant	O
enzymes	O
from	O
species1s	O
chicken	O
species1e	O
liver	O
[	O
Clinkenbeard	O
et	O
al	O
.	O
(	O
1975a	O
)	O
J.	O
Biol	O
.	O
Chem	O
.	O
250	O
,	O
3124	O
-	O
3135	O
]	O
and	O
species1s	O
rat	O
species1e	O
liver	O
[	O
Mehrabian	O
et	O
al	O
.	O
(	O
1986	O
)	O
J.	O
Biol	O
.	O
Chem	O
.	O
261	O
,	O
16249	O
-	O
16255	O
]	O
.	O
Mutation	O
of	O
Cys129	O
to	O
serine	O
or	O
alanine	O
destroys	O
HMG	O
-	O
CoA	O
synthase	O
activity	O
by	O
disrupting	O
the	O
first	O
catalytic	O
step	O
in	O
HMG	O
-	O
CoA	O
synthesis	O
,	O
enzyme	O
acetylation	O
by	O
acetyl	O
coenzyme	O
A.	O
Furthermore	O
,	O
unlike	O
the	O
wild	O
-	O
type	O
enzyme	O
,	O
neither	O
mutant	O
was	O
capable	O
of	O
covalent	O
modification	O
by	O
the	O
beta	O
-	O
lactone	O
inhibitor	O
,	O
L-659,699	O
[	O
Greenspan	O
et	O
al	O
.	O
(	O
1987	O
)	O
Proc	O
.	O
Natl	O
.	O
Acad	O
.	O
Sci	O
.	O
USA	O
84	O
,	O
7488	O
-	O
7492	O
]	O
.	O
Kinetic	O
analysis	O
of	O
the	O
inhibition	O
by	O
L-659,699	O
revealed	O
that	O
this	O
compound	O
is	O
a	O
potent	O
inhibitor	O
of	O
the	O
recombinant	O
species1s	O
human	O
species1e	O
synthase	O
,	O
with	O
an	O
inhibition	O
constant	O
of	O
53.7	O
nM	O
and	O
an	O
inactivation	O
rate	O
constant	O
of	O
1.06	O
min-1	O
.	O

species1s	O
Human	O
species1e	O
gene1s	O
cytoplasmic	O
3-hydroxy-3-methylglutaryl	O
coenzyme	O
A	O
synthase	O
gene1e	O
:	O
expression	O
,	O
purification	O
,	O
and	O
characterization	O
of	O
recombinant	O
wild	O
-	O
type	O
and	O
Cys129	O
mutant	O
enzymes	O
.	O
A	O
cDNA	O
for	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
cytoplasmic	O
3-hydroxy-3-methylglutaryl	O
coenzyme	O
A	O
(	O
HMG	O
-	O
CoA	O
)	O
synthase	O
gene1e	O
(	O
EC	O
4.1.3.5	O
)	O
was	O
subcloned	O
and	O
expressed	O
from	O
a	O
T7-based	O
vector	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
.	O
The	O
over	O
-	O
produced	O
enzyme	O
was	O
purified	O
using	O
a	O
three	O
-	O
step	O
protocol	O
that	O
generated	O
20	O
to	O
30	O
mg	O
protein	O
/	O
liter	O
cell	O
culture	O
.	O
The	O
physical	O
and	O
catalytic	O
properties	O
of	O
the	O
recombinant	O
synthase	O
are	O
similar	O
to	O
those	O
reported	O
for	O
the	O
nonrecombinant	O
enzymes	O
from	O
arg1s	O
chicken	O
arg1e	O
liver	O
[	O
Clinkenbeard	O
et	O
al	O
.	O
(	O
1975a	O
)	O
J.	O
Biol	O
.	O
Chem	O
.	O
250	O
,	O
3124	O
-	O
3135	O
]	O
and	O
species1s	O
rat	O
species1e	O
liver	O
[	O
Mehrabian	O
et	O
al	O
.	O
(	O
1986	O
)	O
J.	O
Biol	O
.	O
Chem	O
.	O
261	O
,	O
16249	O
-	O
16255	O
]	O
.	O
Mutation	O
of	O
Cys129	O
to	O
serine	O
or	O
alanine	O
destroys	O
HMG	O
-	O
CoA	O
synthase	O
activity	O
by	O
disrupting	O
the	O
first	O
catalytic	O
step	O
in	O
HMG	O
-	O
CoA	O
synthesis	O
,	O
enzyme	O
acetylation	O
by	O
acetyl	O
coenzyme	O
A.	O
Furthermore	O
,	O
unlike	O
the	O
wild	O
-	O
type	O
enzyme	O
,	O
neither	O
mutant	O
was	O
capable	O
of	O
covalent	O
modification	O
by	O
the	O
beta	O
-	O
lactone	O
inhibitor	O
,	O
L-659,699	O
[	O
Greenspan	O
et	O
al	O
.	O
(	O
1987	O
)	O
Proc	O
.	O
Natl	O
.	O
Acad	O
.	O
Sci	O
.	O
USA	O
84	O
,	O
7488	O
-	O
7492	O
]	O
.	O
Kinetic	O
analysis	O
of	O
the	O
inhibition	O
by	O
L-659,699	O
revealed	O
that	O
this	O
compound	O
is	O
a	O
potent	O
inhibitor	O
of	O
the	O
recombinant	O
species1s	O
human	O
species1e	O
synthase	O
,	O
with	O
an	O
inhibition	O
constant	O
of	O
53.7	O
nM	O
and	O
an	O
inactivation	O
rate	O
constant	O
of	O
1.06	O
min-1	O
.	O

species1s	O
Human	O
species1e	O
gene1s	O
cytoplasmic	O
3-hydroxy-3-methylglutaryl	O
coenzyme	O
A	O
synthase	O
gene1e	O
:	O
expression	O
,	O
purification	O
,	O
and	O
characterization	O
of	O
recombinant	O
wild	O
-	O
type	O
and	O
Cys129	O
mutant	O
enzymes	O
.	O
A	O
cDNA	O
for	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
cytoplasmic	O
3-hydroxy-3-methylglutaryl	O
coenzyme	O
A	O
(	O
HMG	O
-	O
CoA	O
)	O
synthase	O
gene1e	O
(	O
EC	O
4.1.3.5	O
)	O
was	O
subcloned	O
and	O
expressed	O
from	O
a	O
T7-based	O
vector	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
.	O
The	O
over	O
-	O
produced	O
enzyme	O
was	O
purified	O
using	O
a	O
three	O
-	O
step	O
protocol	O
that	O
generated	O
20	O
to	O
30	O
mg	O
protein	O
/	O
liter	O
cell	O
culture	O
.	O
The	O
physical	O
and	O
catalytic	O
properties	O
of	O
the	O
recombinant	O
synthase	O
are	O
similar	O
to	O
those	O
reported	O
for	O
the	O
nonrecombinant	O
enzymes	O
from	O
species1s	O
chicken	O
species1e	O
liver	O
[	O
Clinkenbeard	O
et	O
al	O
.	O
(	O
1975a	O
)	O
J.	O
Biol	O
.	O
Chem	O
.	O
250	O
,	O
3124	O
-	O
3135	O
]	O
and	O
arg1s	O
rat	O
arg1e	O
liver	O
[	O
Mehrabian	O
et	O
al	O
.	O
(	O
1986	O
)	O
J.	O
Biol	O
.	O
Chem	O
.	O
261	O
,	O
16249	O
-	O
16255	O
]	O
.	O
Mutation	O
of	O
Cys129	O
to	O
serine	O
or	O
alanine	O
destroys	O
HMG	O
-	O
CoA	O
synthase	O
activity	O
by	O
disrupting	O
the	O
first	O
catalytic	O
step	O
in	O
HMG	O
-	O
CoA	O
synthesis	O
,	O
enzyme	O
acetylation	O
by	O
acetyl	O
coenzyme	O
A.	O
Furthermore	O
,	O
unlike	O
the	O
wild	O
-	O
type	O
enzyme	O
,	O
neither	O
mutant	O
was	O
capable	O
of	O
covalent	O
modification	O
by	O
the	O
beta	O
-	O
lactone	O
inhibitor	O
,	O
L-659,699	O
[	O
Greenspan	O
et	O
al	O
.	O
(	O
1987	O
)	O
Proc	O
.	O
Natl	O
.	O
Acad	O
.	O
Sci	O
.	O
USA	O
84	O
,	O
7488	O
-	O
7492	O
]	O
.	O
Kinetic	O
analysis	O
of	O
the	O
inhibition	O
by	O
L-659,699	O
revealed	O
that	O
this	O
compound	O
is	O
a	O
potent	O
inhibitor	O
of	O
the	O
recombinant	O
species1s	O
human	O
species1e	O
synthase	O
,	O
with	O
an	O
inhibition	O
constant	O
of	O
53.7	O
nM	O
and	O
an	O
inactivation	O
rate	O
constant	O
of	O
1.06	O
min-1	O
.	O

gene1s	O
Bradykinin	O
gene1e	O
induces	O
translocation	O
of	O
the	O
gene1s	O
protein	O
kinase	O
C	O
isoforms	O
alpha	O
,	O
epsilon	O
,	O
and	O
zeta	O
gene1e	O
.	O
gene1s	O
Bradykinin	O
gene1e	O
exerts	O
a	O
broad	O
spectrum	O
of	O
cellular	O
effects	O
on	O
different	O
tissues	O
.	O
It	O
is	O
believed	O
that	O
these	O
effects	O
are	O
predominantly	O
mediated	O
by	O
the	O
recently	O
cloned	O
gene1s	O
B2	O
receptor	O
gene1e	O
.	O
The	O
mechanism	O
of	O
post	O
-	O
receptor	O
signal	O
transduction	O
is	O
not	O
known	O
in	O
detail	O
.	O
Involvement	O
of	O
protein	O
kinase	O
C	O
(	O
PKC	O
)	O
was	O
suggested	O
and	O
activation	O
of	O
the	O
classical	O
gene1s	O
PKC	O
isoforms	O
alpha	O
gene1e	O
and	O
beta	O
was	O
recently	O
demonstrated	O
.	O
The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
whether	O
the	O
gene1s	O
B2	O
receptor	O
gene1e	O
also	O
activates	O
new	O
gene1s	O
(	O
delta	O
,	O
epsilon	O
)	O
and	O
atypical	O
(	O
zeta	O
)	O
PKC	O
isoforms	O
gene1e	O
.	O
To	O
investigate	O
this	O
,	O
arg1s	O
chinese	O
hamster	O
arg1e	O
ovary	O
(	O
arg1s	O
CHO	O
arg1e	O
)	O
cells	O
,	O
stably	O
transfected	O
with	O
species1s	O
human	O
species1e	O
gene1s	O
B2	O
receptor	O
gene1e	O
,	O
were	O
used	O
.	O
In	O
these	O
cells	O
the	O
gene1s	O
PKC	O
isoforms	O
alpha	O
,	O
delta	O
,	O
epsilon	O
and	O
zeta	O
gene1e	O
were	O
detected	O
by	O
immunoblotting	O
with	O
specific	O
antibodies	O
.	O
To	O
monitor	O
hormone	O
-	O
induced	O
PKC	O
translocation	O
plasma	O
membranes	O
were	O
prepared	O
.	O
Stimulation	O
of	O
the	O
cells	O
with	O
gene1s	O
bradykinin	O
gene1e	O
resulted	O
in	O
a	O
rapid	O
(	O
30	O
-	O
60	O
s	O
)	O
translocation	O
of	O
the	O
gene1s	O
PKC	O
isoforms	O
alpha	O
,	O
epsilon	O
,	O
and	O
zeta	O
gene1e	O
.	O
Translocation	O
of	O
gene1s	O
PKC	O
delta	O
gene1e	O
was	O
not	O
detected	O
.	O
The	O
effect	O
of	O
gene1s	O
bradykinin	O
gene1e	O
was	O
reduced	O
by	O
simultaneous	O
addition	O
of	O
the	O
receptor	O
antagonist	O
HOE	O
140	O
,	O
a	O
gene1s	O
bradykinin	O
gene1e	O
-	O
related	O
decapeptide	O
.	O
The	O
data	O
show	O
that	O
the	O
gene1s	O
B2	O
receptor	O
gene1e	O
in	O
this	O
cell	O
model	O
is	O
able	O
to	O
activate	O
,	O
in	O
addition	O
to	O
the	O
classical	O
gene1s	O
PKC	O
isoform	O
alpha	O
gene1e	O
,	O
the	O
new	O
gene1s	O
PKC	O
isoform	O
epsilon	O
gene1e	O
and	O
the	O
atypical	O
gene1s	O
PKC	O
isoform	O
zeta	O
gene1e	O
.	O
To	O
test	O
whether	O
these	O
effects	O
are	O
as	O
well	O
observed	O
in	O
a	O
non	O
-	O
transfected	O
cell	O
,	O
the	O
experiments	O
were	O
repeated	O
in	O
species1s	O
human	O
species1e	O
foreskin	O
fibroblasts	O
which	O
naturally	O
express	O
high	O
levels	O
of	O
B2	O
receptors	O
.	O
In	O
this	O
cell	O
system	O
similar	O
results	O
on	O
gene1s	O
PKC	O
alpha	O
,	O
epsilon	O
,	O
and	O
zeta	O
gene1e	O
were	O
observed	O
,	O
suggesting	O
that	O
all	O
three	O
PKC	O
isoforms	O
are	O
involved	O
in	O
signal	O
transduction	O
of	O
the	O
gene1s	O
B2	O
receptor	O
gene1e	O
.	O

gene1s	ARG2
Bradykinin	ARG2
gene1e	ARG2
induces	O
translocation	O
of	O
the	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
C	ARG2
isoforms	ARG2
alpha	ARG2
,	ARG2
epsilon	ARG2
,	ARG2
and	ARG2
zeta	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
Bradykinin	ARG2
gene1e	ARG2
exerts	O
a	O
broad	O
spectrum	O
of	O
cellular	O
effects	O
on	O
different	O
tissues	O
.	O
It	O
is	O
believed	O
that	O
these	O
effects	O
are	O
predominantly	O
mediated	O
by	O
the	O
recently	O
cloned	O
gene1s	ARG2
B2	ARG2
receptor	ARG2
gene1e	ARG2
.	O
The	O
mechanism	O
of	O
post	O
-	O
receptor	O
signal	O
transduction	O
is	O
not	O
known	O
in	O
detail	O
.	O
Involvement	O
of	O
protein	O
kinase	O
C	O
(	O
PKC	O
)	O
was	O
suggested	O
and	O
activation	O
of	O
the	O
classical	O
gene1s	ARG2
PKC	ARG2
isoforms	ARG2
alpha	ARG2
gene1e	ARG2
and	O
beta	O
was	O
recently	O
demonstrated	O
.	O
The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
whether	O
the	O
gene1s	ARG2
B2	ARG2
receptor	ARG2
gene1e	ARG2
also	O
activates	O
new	O
gene1s	ARG2
(	ARG2
delta	ARG2
,	ARG2
epsilon	ARG2
)	ARG2
and	ARG2
atypical	ARG2
(	ARG2
zeta	ARG2
)	ARG2
PKC	ARG2
isoforms	ARG2
gene1e	ARG2
.	O
To	O
investigate	O
this	O
,	O
species1s	O
chinese	O
hamster	O
species1e	O
ovary	O
(	O
species1s	O
CHO	O
species1e	O
)	O
cells	O
,	O
stably	O
transfected	O
with	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
B2	ARG2
receptor	ARG2
gene1e	ARG2
,	O
were	O
used	O
.	O
In	O
these	O
cells	O
the	O
gene1s	ARG2
PKC	ARG2
isoforms	ARG2
alpha	ARG2
,	ARG2
delta	ARG2
,	ARG2
epsilon	ARG2
and	ARG2
zeta	ARG2
gene1e	ARG2
were	O
detected	O
by	O
immunoblotting	O
with	O
specific	O
antibodies	O
.	O
To	O
monitor	O
hormone	O
-	O
induced	O
PKC	O
translocation	O
plasma	O
membranes	O
were	O
prepared	O
.	O
Stimulation	O
of	O
the	O
cells	O
with	O
gene1s	ARG2
bradykinin	ARG2
gene1e	ARG2
resulted	O
in	O
a	O
rapid	O
(	O
30	O
-	O
60	O
s	O
)	O
translocation	O
of	O
the	O
gene1s	ARG2
PKC	ARG2
isoforms	ARG2
alpha	ARG2
,	ARG2
epsilon	ARG2
,	ARG2
and	ARG2
zeta	ARG2
gene1e	ARG2
.	O
Translocation	O
of	O
gene1s	ARG2
PKC	ARG2
delta	ARG2
gene1e	ARG2
was	O
not	O
detected	O
.	O
The	O
effect	O
of	O
gene1s	ARG2
bradykinin	ARG2
gene1e	ARG2
was	O
reduced	O
by	O
simultaneous	O
addition	O
of	O
the	O
receptor	O
antagonist	O
HOE	O
140	O
,	O
a	O
gene1s	ARG2
bradykinin	ARG2
gene1e	ARG2
-	O
related	O
decapeptide	O
.	O
The	O
data	O
show	O
that	O
the	O
gene1s	ARG2
B2	ARG2
receptor	ARG2
gene1e	ARG2
in	O
this	O
cell	O
model	O
is	O
able	O
to	O
activate	O
,	O
in	O
addition	O
to	O
the	O
classical	O
gene1s	ARG2
PKC	ARG2
isoform	ARG2
alpha	ARG2
gene1e	ARG2
,	O
the	O
new	O
gene1s	ARG2
PKC	ARG2
isoform	ARG2
epsilon	ARG2
gene1e	ARG2
and	O
the	O
atypical	O
gene1s	ARG2
PKC	ARG2
isoform	ARG2
zeta	ARG2
gene1e	ARG2
.	O
To	O
test	O
whether	O
these	O
effects	O
are	O
as	O
well	O
observed	O
in	O
a	O
non	O
-	O
transfected	O
cell	O
,	O
the	O
experiments	O
were	O
repeated	O
in	O
arg1s	O
human	O
arg1e	O
foreskin	O
fibroblasts	O
which	O
naturally	O
express	O
high	O
levels	O
of	O
B2	O
receptors	O
.	O
In	O
this	O
cell	O
system	O
similar	O
results	O
on	O
gene1s	ARG2
PKC	ARG2
alpha	ARG2
,	ARG2
epsilon	ARG2
,	ARG2
and	ARG2
zeta	ARG2
gene1e	ARG2
were	O
observed	O
,	O
suggesting	O
that	O
all	O
three	O
PKC	O
isoforms	O
are	O
involved	O
in	O
signal	O
transduction	O
of	O
the	O
gene1s	ARG2
B2	ARG2
receptor	ARG2
gene1e	ARG2
.	O

Protein	O
structure	O
of	O
gene1s	ARG2
fetal	ARG2
antigen	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
FA1	ARG2
gene1e	ARG2
)	O
.	O
A	O
novel	O
circulating	O
arg1s	O
human	O
arg1e	O
epidermal	O
-	O
growth	O
-	O
factor	O
-	O
like	O
protein	O
expressed	O
in	O
neuroendocrine	O
tumors	O
and	O
its	O
relation	O
to	O
the	O
gene	O
products	O
of	O
gene1s	ARG2
dlk	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
pG2	ARG2
gene1e	ARG2
.	O
The	O
present	O
paper	O
describes	O
the	O
primary	O
structure	O
,	O
glycosylation	O
and	O
tissue	O
localization	O
of	O
gene1s	ARG2
fetal	ARG2
antigen	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
FA1	ARG2
gene1e	ARG2
)	O
isolated	O
from	O
second	O
-	O
trimester	O
arg1s	O
human	O
arg1e	O
amniotic	O
fluid	O
.	O
gene1s	ARG2
FA1	ARG2
gene1e	ARG2
is	O
a	O
single	O
-	O
chained	O
,	O
heterogeneous	O
glycoprotein	O
of	O
225	O
-	O
262	O
amino	O
acid	O
residues	O
.	O
gene1s	ARG2
FA1	ARG2
gene1e	ARG2
has	O
six	O
well	O
conserved	O
epidermal	O
-	O
growth	O
-	O
factor	O
motifs	O
and	O
contains	O
up	O
to	O
ten	O
O	O
-	O
glycosylation	O
and	O
N	O
-	O
glycosylation	O
sites	O
,	O
six	O
of	O
which	O
are	O
differentially	O
glycosylated	O
.	O
Alignment	O
to	O
the	O
translated	O
sequences	O
of	O
species1s	O
Mus	O
.	O
musculus	O
species1e	O
gene1s	ARG2
dlk	ARG2
gene1e	ARG2
and	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
dlk	ARG2
gene1e	ARG2
revealed	O
86	O
%	O
and	O
99	O
%	O
identity	O
,	O
respectively	O
,	O
to	O
a	O
259-amino	O
-	O
acid	O
residue	O
overlap	O
,	O
and	O
this	O
high	O
similarity	O
extends	O
with	O
minor	O
corrections	O
to	O
the	O
arg1s	O
human	O
arg1e	O
adrenal	O
-	O
specific	O
mRNA	O
,	O
gene1s	ARG2
pG2	ARG2
gene1e	ARG2
as	O
well	O
.	O
Immunohistochemical	O
analysis	O
demonstrated	O
the	O
presence	O
of	O
gene1s	ARG2
FA1	ARG2
gene1e	ARG2
in	O
10	O
out	O
of	O
14	O
lung	O
tumors	O
containing	O
neuroendocrine	O
elements	O
,	O
and	O
in	O
the	O
placental	O
villi	O
where	O
gene1s	ARG2
FA1	ARG2
gene1e	ARG2
was	O
exclusively	O
seen	O
in	O
stromal	O
cells	O
in	O
close	O
contact	O
to	O
the	O
vascular	O
structure	O
.	O
In	O
the	O
pancreas	O
,	O
gene1s	ARG2
FA1	ARG2
gene1e	ARG2
co	O
-	O
localized	O
with	O
insulin	O
in	O
the	O
insulin	O
secretory	O
granules	O
of	O
the	O
beta	O
cells	O
within	O
the	O
islets	O
of	O
Langerhans	O
.	O
Our	O
findings	O
suggest	O
that	O
gene1s	ARG2
FA1	ARG2
gene1e	ARG2
is	O
synthesized	O
as	O
a	O
membrane	O
anchored	O
protein	O
and	O
released	O
into	O
the	O
circulation	O
after	O
enzymic	O
cleavage	O
,	O
and	O
that	O
circulating	O
gene1s	ARG2
FA1	ARG2
gene1e	ARG2
represents	O
the	O
post	O
-	O
translationally	O
modified	O
gene	O
product	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
dlk	ARG2
gene1e	ARG2
which	O
,	O
in	O
turn	O
,	O
is	O
identical	O
to	O
arg1s	O
human	O
arg1e	O
adrenal	O
-	O
specific	O
mRNA	O
gene1s	ARG2
pG2	ARG2
gene1e	ARG2
.	O

Protein	O
structure	O
of	O
gene1s	O
fetal	O
antigen	O
1	O
gene1e	O
(	O
gene1s	O
FA1	O
gene1e	O
)	O
.	O
A	O
novel	O
circulating	O
species1s	O
human	O
species1e	O
epidermal	O
-	O
growth	O
-	O
factor	O
-	O
like	O
protein	O
expressed	O
in	O
neuroendocrine	O
tumors	O
and	O
its	O
relation	O
to	O
the	O
gene	O
products	O
of	O
gene1s	O
dlk	O
gene1e	O
and	O
gene1s	O
pG2	O
gene1e	O
.	O
The	O
present	O
paper	O
describes	O
the	O
primary	O
structure	O
,	O
glycosylation	O
and	O
tissue	O
localization	O
of	O
gene1s	O
fetal	O
antigen	O
1	O
gene1e	O
(	O
gene1s	O
FA1	O
gene1e	O
)	O
isolated	O
from	O
second	O
-	O
trimester	O
species1s	O
human	O
species1e	O
amniotic	O
fluid	O
.	O
gene1s	O
FA1	O
gene1e	O
is	O
a	O
single	O
-	O
chained	O
,	O
heterogeneous	O
glycoprotein	O
of	O
225	O
-	O
262	O
amino	O
acid	O
residues	O
.	O
gene1s	O
FA1	O
gene1e	O
has	O
six	O
well	O
conserved	O
epidermal	O
-	O
growth	O
-	O
factor	O
motifs	O
and	O
contains	O
up	O
to	O
ten	O
O	O
-	O
glycosylation	O
and	O
N	O
-	O
glycosylation	O
sites	O
,	O
six	O
of	O
which	O
are	O
differentially	O
glycosylated	O
.	O
Alignment	O
to	O
the	O
translated	O
sequences	O
of	O
arg1s	O
Mus	O
.	O
musculus	O
arg1e	O
gene1s	O
dlk	O
gene1e	O
and	O
species1s	O
human	O
species1e	O
gene1s	O
dlk	O
gene1e	O
revealed	O
86	O
%	O
and	O
99	O
%	O
identity	O
,	O
respectively	O
,	O
to	O
a	O
259-amino	O
-	O
acid	O
residue	O
overlap	O
,	O
and	O
this	O
high	O
similarity	O
extends	O
with	O
minor	O
corrections	O
to	O
the	O
species1s	O
human	O
species1e	O
adrenal	O
-	O
specific	O
mRNA	O
,	O
gene1s	O
pG2	O
gene1e	O
as	O
well	O
.	O
Immunohistochemical	O
analysis	O
demonstrated	O
the	O
presence	O
of	O
gene1s	O
FA1	O
gene1e	O
in	O
10	O
out	O
of	O
14	O
lung	O
tumors	O
containing	O
neuroendocrine	O
elements	O
,	O
and	O
in	O
the	O
placental	O
villi	O
where	O
gene1s	O
FA1	O
gene1e	O
was	O
exclusively	O
seen	O
in	O
stromal	O
cells	O
in	O
close	O
contact	O
to	O
the	O
vascular	O
structure	O
.	O
In	O
the	O
pancreas	O
,	O
gene1s	O
FA1	O
gene1e	O
co	O
-	O
localized	O
with	O
insulin	O
in	O
the	O
insulin	O
secretory	O
granules	O
of	O
the	O
beta	O
cells	O
within	O
the	O
islets	O
of	O
Langerhans	O
.	O
Our	O
findings	O
suggest	O
that	O
gene1s	O
FA1	O
gene1e	O
is	O
synthesized	O
as	O
a	O
membrane	O
anchored	O
protein	O
and	O
released	O
into	O
the	O
circulation	O
after	O
enzymic	O
cleavage	O
,	O
and	O
that	O
circulating	O
gene1s	O
FA1	O
gene1e	O
represents	O
the	O
post	O
-	O
translationally	O
modified	O
gene	O
product	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
dlk	O
gene1e	O
which	O
,	O
in	O
turn	O
,	O
is	O
identical	O
to	O
species1s	O
human	O
species1e	O
adrenal	O
-	O
specific	O
mRNA	O
gene1s	O
pG2	O
gene1e	O
.	O

arg1s	O
Human	O
arg1e	O
gene1s	ARG2
DNA	ARG2
helicase	ARG2
II	ARG2
gene1e	ARG2
:	O
a	O
novel	O
DNA	O
unwinding	O
enzyme	O
identified	O
as	O
the	O
Ku	O
autoantigen	O
.	O
arg1s	O
Human	O
arg1e	O
gene1s	ARG2
DNA	ARG2
helicase	ARG2
II	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
HDH	ARG2
II	ARG2
gene1e	ARG2
)	O
is	O
a	O
novel	O
ATP	O
-	O
dependent	O
DNA	O
unwinding	O
enzyme	O
,	O
purified	O
to	O
apparent	O
homogeneity	O
from	O
arg1s	O
HeLa	O
arg1e	O
cells	O
,	O
which	O
(	O
i	O
)	O
unwinds	O
exclusively	O
DNA	O
duplexes	O
,	O
(	O
ii	O
)	O
prefers	O
partially	O
unwound	O
substrates	O
and	O
(	O
iii	O
)	O
proceeds	O
in	O
the	O
3	O
'	O
to	O
5	O
'	O
direction	O
on	O
the	O
bound	O
strand	O
.	O
gene1s	ARG2
HDH	ARG2
II	ARG2
gene1e	ARG2
is	O
a	O
gene1s	ARG2
heterodimer	ARG2
of	ARG2
72	ARG2
and	ARG2
87	ARG2
kDa	ARG2
polypeptides	ARG2
gene1e	ARG2
.	O
It	O
shows	O
single	O
-	O
stranded	O
DNA	O
-	O
dependent	O
ATPase	O
activity	O
,	O
as	O
well	O
as	O
double	O
-	O
stranded	O
DNA	O
binding	O
capacity	O
.	O
All	O
these	O
activities	O
comigrate	O
in	O
gel	O
filtration	O
and	O
glycerol	O
gradients	O
,	O
giving	O
a	O
sedimentation	O
coefficient	O
of	O
7.4S	O
and	O
a	O
Stokes	O
radius	O
of	O
approximately	O
46	O
A	O
,	O
corresponding	O
to	O
a	O
native	O
molecular	O
weight	O
of	O
158	O
kDa	O
.	O
The	O
antibodies	O
raised	O
in	O
rabbit	O
against	O
either	O
polypeptide	O
can	O
remove	O
from	O
the	O
solution	O
all	O
the	O
activities	O
of	O
gene1s	ARG2
HDH	ARG2
II	ARG2
gene1e	ARG2
.	O
Photoaffinity	O
labelling	O
with	O
[	O
alpha-32P]ATP	O
labelled	O
both	O
polypeptides	O
.	O
Microsequencing	O
of	O
the	O
separate	O
polypeptides	O
of	O
gene1s	ARG2
HDH	ARG2
II	ARG2
gene1e	ARG2
and	O
cross	O
-	O
reaction	O
with	O
specific	O
antibodies	O
showed	O
that	O
this	O
enzyme	O
is	O
identical	O
to	O
Ku	O
,	O
an	O
autoantigen	O
recognized	O
by	O
the	O
sera	O
of	O
scleroderma	O
and	O
lupus	O
erythematosus	O
arg1s	O
patients	O
arg1e	O
,	O
which	O
binds	O
specifically	O
to	O
duplex	O
DNA	O
ends	O
and	O
is	O
regulator	O
of	O
a	O
DNA	O
-	O
dependent	O
protein	O
kinase	O
.	O
Recombinant	O
gene1s	ARG2
HDH	ARG2
II	ARG2
/	ARG2
Ku	ARG2
gene1e	ARG2
protein	O
expressed	O
in	O
and	O
purified	O
from	O
species1s	O
Escherichia	O
coli	O
species1e	O
cells	O
showed	O
DNA	O
binding	O
and	O
helicase	O
activities	O
indistinguishable	O
from	O
those	O
of	O
the	O
isolated	O
protein	O
.	O
The	O
exclusively	O
nuclear	O
location	O
of	O
gene1s	ARG2
HDH	ARG2
II	ARG2
/	ARG2
Ku	ARG2
gene1e	ARG2
antigen	O
,	O
its	O
highly	O
specific	O
affinity	O
for	O
double	O
-	O
stranded	O
DNA	O
,	O
its	O
abundance	O
and	O
its	O
newly	O
demonstrated	O
ability	O
to	O
unwind	O
exclusively	O
DNA	O
duplexes	O
,	O
point	O
to	O
an	O
additional	O
,	O
if	O
still	O
unclear	O
,	O
role	O
for	O
this	O
molecule	O
in	O
DNA	O
metabolism	O
.	O

species1s	O
Human	O
species1e	O
gene1s	O
DNA	O
helicase	O
II	O
gene1e	O
:	O
a	O
novel	O
DNA	O
unwinding	O
enzyme	O
identified	O
as	O
the	O
Ku	O
autoantigen	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
DNA	O
helicase	O
II	O
gene1e	O
(	O
gene1s	O
HDH	O
II	O
gene1e	O
)	O
is	O
a	O
novel	O
ATP	O
-	O
dependent	O
DNA	O
unwinding	O
enzyme	O
,	O
purified	O
to	O
apparent	O
homogeneity	O
from	O
species1s	O
HeLa	O
species1e	O
cells	O
,	O
which	O
(	O
i	O
)	O
unwinds	O
exclusively	O
DNA	O
duplexes	O
,	O
(	O
ii	O
)	O
prefers	O
partially	O
unwound	O
substrates	O
and	O
(	O
iii	O
)	O
proceeds	O
in	O
the	O
3	O
'	O
to	O
5	O
'	O
direction	O
on	O
the	O
bound	O
strand	O
.	O
gene1s	O
HDH	O
II	O
gene1e	O
is	O
a	O
gene1s	O
heterodimer	O
of	O
72	O
and	O
87	O
kDa	O
polypeptides	O
gene1e	O
.	O
It	O
shows	O
single	O
-	O
stranded	O
DNA	O
-	O
dependent	O
ATPase	O
activity	O
,	O
as	O
well	O
as	O
double	O
-	O
stranded	O
DNA	O
binding	O
capacity	O
.	O
All	O
these	O
activities	O
comigrate	O
in	O
gel	O
filtration	O
and	O
glycerol	O
gradients	O
,	O
giving	O
a	O
sedimentation	O
coefficient	O
of	O
7.4S	O
and	O
a	O
Stokes	O
radius	O
of	O
approximately	O
46	O
A	O
,	O
corresponding	O
to	O
a	O
native	O
molecular	O
weight	O
of	O
158	O
kDa	O
.	O
The	O
antibodies	O
raised	O
in	O
rabbit	O
against	O
either	O
polypeptide	O
can	O
remove	O
from	O
the	O
solution	O
all	O
the	O
activities	O
of	O
gene1s	O
HDH	O
II	O
gene1e	O
.	O
Photoaffinity	O
labelling	O
with	O
[	O
alpha-32P]ATP	O
labelled	O
both	O
polypeptides	O
.	O
Microsequencing	O
of	O
the	O
separate	O
polypeptides	O
of	O
gene1s	O
HDH	O
II	O
gene1e	O
and	O
cross	O
-	O
reaction	O
with	O
specific	O
antibodies	O
showed	O
that	O
this	O
enzyme	O
is	O
identical	O
to	O
Ku	O
,	O
an	O
autoantigen	O
recognized	O
by	O
the	O
sera	O
of	O
scleroderma	O
and	O
lupus	O
erythematosus	O
species1s	O
patients	O
species1e	O
,	O
which	O
binds	O
specifically	O
to	O
duplex	O
DNA	O
ends	O
and	O
is	O
regulator	O
of	O
a	O
DNA	O
-	O
dependent	O
protein	O
kinase	O
.	O
Recombinant	O
gene1s	O
HDH	O
II	O
/	O
Ku	O
gene1e	O
protein	O
expressed	O
in	O
and	O
purified	O
from	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
cells	O
showed	O
DNA	O
binding	O
and	O
helicase	O
activities	O
indistinguishable	O
from	O
those	O
of	O
the	O
isolated	O
protein	O
.	O
The	O
exclusively	O
nuclear	O
location	O
of	O
gene1s	O
HDH	O
II	O
/	O
Ku	O
gene1e	O
antigen	O
,	O
its	O
highly	O
specific	O
affinity	O
for	O
double	O
-	O
stranded	O
DNA	O
,	O
its	O
abundance	O
and	O
its	O
newly	O
demonstrated	O
ability	O
to	O
unwind	O
exclusively	O
DNA	O
duplexes	O
,	O
point	O
to	O
an	O
additional	O
,	O
if	O
still	O
unclear	O
,	O
role	O
for	O
this	O
molecule	O
in	O
DNA	O
metabolism	O
.	O

gene1s	ARG2
BMX	ARG2
gene1e	ARG2
,	O
a	O
novel	O
nonreceptor	O
tyrosine	O
kinase	O
gene	O
of	O
the	O
gene1s	ARG2
BTK	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ITK	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
TEC	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
TXK	ARG2
gene1e	ARG2
family	O
located	O
in	O
chromosome	O
Xp22.2	O
.	O
The	O
gene1s	ARG2
Bmx	ARG2
gene1e	ARG2
sequence	O
was	O
identified	O
and	O
cloned	O
during	O
our	O
search	O
for	O
novel	O
tyrosine	O
kinase	O
genes	O
expressed	O
in	O
arg1s	O
human	O
arg1e	O
bone	O
marrow	O
cells	O
.	O
gene1s	ARG2
Bmx	ARG2
gene1e	ARG2
cDNA	O
comprises	O
a	O
long	O
open	O
reading	O
frame	O
of	O
675	O
amino	O
acids	O
,	O
containing	O
one	O
SH3	O
,	O
one	O
SH2	O
and	O
one	O
tyrosine	O
kinase	O
domain	O
,	O
which	O
are	O
about	O
70	O
%	O
identical	O
with	O
gene1s	ARG2
Btk	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Itk	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Tec	ARG2
gene1e	ARG2
and	O
somewhat	O
less	O
with	O
gene1s	ARG2
Txk	ARG2
gene1e	ARG2
tyrosine	O
kinase	O
sequences	O
.	O
The	O
amino	O
terminal	O
sequences	O
of	O
these	O
four	O
tyrosine	O
kinases	O
are	O
about	O
40	O
%	O
identical	O
and	O
each	O
contains	O
a	O
so	O
-	O
called	O
pleckstrin	O
homology	O
domain	O
.	O
The	O
2.7	O
kb	O
gene1s	ARG2
Bmx	ARG2
gene1e	ARG2
mRNA	O
was	O
expressed	O
in	O
endothelial	O
cells	O
and	O
several	O
arg1s	O
human	O
arg1e	O
tissues	O
by	O
Northern	O
blotting	O
and	O
an	O
80	O
kD	O
gene1s	ARG2
Bmx	ARG2
gene1e	ARG2
polypeptide	O
was	O
detected	O
in	O
arg1s	O
human	O
arg1e	O
endothelial	O
cells	O
.	O
Immunoprecipitates	O
of	O
COS	O
cells	O
transfected	O
with	O
a	O
gene1s	ARG2
Bmx	ARG2
gene1e	ARG2
expression	O
vector	O
and	O
species1s	O
NIH3T3	O
species1e	O
cells	O
expressing	O
a	O
gene1s	ARG2
Bmx	ARG2
gene1e	ARG2
retrovirus	O
contained	O
a	O
tyrosyl	O
phosphorylated	O
gene1s	ARG2
Bmx	ARG2
gene1e	ARG2
polypeptide	O
of	O
similar	O
molecular	O
weight	O
.	O
The	O
gene1s	ARG2
BMX	ARG2
gene1e	ARG2
gene	O
was	O
located	O
in	O
chromosomal	O
band	O
Xp22.2	O
between	O
the	O
DXS197	O
and	O
DXS207	O
loci	O
.	O
Interestingly	O
,	O
chromosome	O
X	O
also	O
contains	O
the	O
closest	O
relative	O
of	O
gene1s	ARG2
BMX	ARG2
gene1e	ARG2
,	O
the	O
gene1s	ARG2
BTK	ARG2
gene1e	ARG2
gene	O
,	O
implicated	O
in	O
X	O
-	O
linked	O
agammaglobulinemia	O
.	O
The	O
gene1s	ARG2
BMX	ARG2
gene1e	ARG2
gene	O
thus	O
encodes	O
a	O
novel	O
nonreceptor	O
tyrosine	O
kinase	O
,	O
which	O
may	O
play	O
a	O
role	O
in	O
the	O
growth	O
and	O
differentiation	O
of	O
hematopoietic	O
cells	O
.	O

gene1s	O
BMX	O
gene1e	O
,	O
a	O
novel	O
nonreceptor	O
tyrosine	O
kinase	O
gene	O
of	O
the	O
gene1s	O
BTK	O
gene1e	O
/	O
gene1s	O
ITK	O
gene1e	O
/	O
gene1s	O
TEC	O
gene1e	O
/	O
gene1s	O
TXK	O
gene1e	O
family	O
located	O
in	O
chromosome	O
Xp22.2	O
.	O
The	O
gene1s	O
Bmx	O
gene1e	O
sequence	O
was	O
identified	O
and	O
cloned	O
during	O
our	O
search	O
for	O
novel	O
tyrosine	O
kinase	O
genes	O
expressed	O
in	O
species1s	O
human	O
species1e	O
bone	O
marrow	O
cells	O
.	O
gene1s	O
Bmx	O
gene1e	O
cDNA	O
comprises	O
a	O
long	O
open	O
reading	O
frame	O
of	O
675	O
amino	O
acids	O
,	O
containing	O
one	O
SH3	O
,	O
one	O
SH2	O
and	O
one	O
tyrosine	O
kinase	O
domain	O
,	O
which	O
are	O
about	O
70	O
%	O
identical	O
with	O
gene1s	O
Btk	O
gene1e	O
,	O
gene1s	O
Itk	O
gene1e	O
and	O
gene1s	O
Tec	O
gene1e	O
and	O
somewhat	O
less	O
with	O
gene1s	O
Txk	O
gene1e	O
tyrosine	O
kinase	O
sequences	O
.	O
The	O
amino	O
terminal	O
sequences	O
of	O
these	O
four	O
tyrosine	O
kinases	O
are	O
about	O
40	O
%	O
identical	O
and	O
each	O
contains	O
a	O
so	O
-	O
called	O
pleckstrin	O
homology	O
domain	O
.	O
The	O
2.7	O
kb	O
gene1s	O
Bmx	O
gene1e	O
mRNA	O
was	O
expressed	O
in	O
endothelial	O
cells	O
and	O
several	O
species1s	O
human	O
species1e	O
tissues	O
by	O
Northern	O
blotting	O
and	O
an	O
80	O
kD	O
gene1s	O
Bmx	O
gene1e	O
polypeptide	O
was	O
detected	O
in	O
species1s	O
human	O
species1e	O
endothelial	O
cells	O
.	O
Immunoprecipitates	O
of	O
COS	O
cells	O
transfected	O
with	O
a	O
gene1s	O
Bmx	O
gene1e	O
expression	O
vector	O
and	O
arg1s	O
NIH3T3	O
arg1e	O
cells	O
expressing	O
a	O
gene1s	O
Bmx	O
gene1e	O
retrovirus	O
contained	O
a	O
tyrosyl	O
phosphorylated	O
gene1s	O
Bmx	O
gene1e	O
polypeptide	O
of	O
similar	O
molecular	O
weight	O
.	O
The	O
gene1s	O
BMX	O
gene1e	O
gene	O
was	O
located	O
in	O
chromosomal	O
band	O
Xp22.2	O
between	O
the	O
DXS197	O
and	O
DXS207	O
loci	O
.	O
Interestingly	O
,	O
chromosome	O
X	O
also	O
contains	O
the	O
closest	O
relative	O
of	O
gene1s	O
BMX	O
gene1e	O
,	O
the	O
gene1s	O
BTK	O
gene1e	O
gene	O
,	O
implicated	O
in	O
X	O
-	O
linked	O
agammaglobulinemia	O
.	O
The	O
gene1s	O
BMX	O
gene1e	O
gene	O
thus	O
encodes	O
a	O
novel	O
nonreceptor	O
tyrosine	O
kinase	O
,	O
which	O
may	O
play	O
a	O
role	O
in	O
the	O
growth	O
and	O
differentiation	O
of	O
hematopoietic	O
cells	O
.	O

Molecular	O
cloning	O
,	O
sequencing	O
,	O
and	O
functional	O
expression	O
of	O
a	O
cDNA	O
encoding	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
coproporphyrinogen	ARG2
oxidase	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
Coproporphyrinogen	ARG2
oxidase	ARG2
gene1e	ARG2
(	O
EC	O
1.3.3.3	O
)	O
catalyzes	O
the	O
sixth	O
step	O
in	O
the	O
heme	O
biosynthetic	O
pathway	O
,	O
the	O
oxidation	O
of	O
coproporphyrinogen	O
III	O
to	O
protoporphyrinogen	O
IX	O
.	O
The	O
activity	O
of	O
this	O
enzyme	O
is	O
deficient	O
in	O
the	O
disease	O
hereditary	O
coproporphyria	O
.	O
The	O
sequence	O
of	O
the	O
cDNA	O
and	O
predicted	O
amino	O
acid	O
sequence	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
coproporphyrinogen	ARG2
oxidase	ARG2
gene1e	ARG2
are	O
presented	O
.	O
The	O
arg1s	O
human	O
arg1e	O
protein	O
sequence	O
contains	O
a	O
region	O
completely	O
homologous	O
to	O
that	O
we	O
obtained	O
by	O
sequencing	O
an	O
11-amino	O
acid	O
peptide	O
fragment	O
from	O
purified	O
species1s	O
murine	O
species1e	O
liver	O
gene1s	ARG2
coproporphyrinogen	ARG2
oxidase	ARG2
gene1e	ARG2
.	O
Results	O
of	O
Southern	O
blotting	O
were	O
consistent	O
with	O
the	O
presence	O
of	O
a	O
single	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
coproporphyrinogen	ARG2
oxidase	ARG2
gene1e	ARG2
gene	O
,	O
and	O
Northern	O
blotting	O
demonstrated	O
one	O
transcript	O
of	O
similar	O
size	O
in	O
erythroid	O
and	O
nonerythroid	O
cell	O
lines	O
.	O
Expression	O
of	O
the	O
cDNA	O
coding	O
for	O
the	O
putative	O
mature	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
coproporphyrinogen	ARG2
oxidase	ARG2
gene1e	ARG2
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
resulted	O
in	O
a	O
17-fold	O
increase	O
in	O
coproporphyrinogen	O
activity	O
over	O
endogenous	O
activity	O
.	O

Molecular	O
cloning	O
,	O
sequencing	O
,	O
and	O
functional	O
expression	O
of	O
a	O
cDNA	O
encoding	O
species1s	O
human	O
species1e	O
gene1s	O
coproporphyrinogen	O
oxidase	O
gene1e	O
.	O
gene1s	O
Coproporphyrinogen	O
oxidase	O
gene1e	O
(	O
EC	O
1.3.3.3	O
)	O
catalyzes	O
the	O
sixth	O
step	O
in	O
the	O
heme	O
biosynthetic	O
pathway	O
,	O
the	O
oxidation	O
of	O
coproporphyrinogen	O
III	O
to	O
protoporphyrinogen	O
IX	O
.	O
The	O
activity	O
of	O
this	O
enzyme	O
is	O
deficient	O
in	O
the	O
disease	O
hereditary	O
coproporphyria	O
.	O
The	O
sequence	O
of	O
the	O
cDNA	O
and	O
predicted	O
amino	O
acid	O
sequence	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
coproporphyrinogen	O
oxidase	O
gene1e	O
are	O
presented	O
.	O
The	O
species1s	O
human	O
species1e	O
protein	O
sequence	O
contains	O
a	O
region	O
completely	O
homologous	O
to	O
that	O
we	O
obtained	O
by	O
sequencing	O
an	O
11-amino	O
acid	O
peptide	O
fragment	O
from	O
purified	O
arg1s	O
murine	O
arg1e	O
liver	O
gene1s	O
coproporphyrinogen	O
oxidase	O
gene1e	O
.	O
Results	O
of	O
Southern	O
blotting	O
were	O
consistent	O
with	O
the	O
presence	O
of	O
a	O
single	O
species1s	O
human	O
species1e	O
gene1s	O
coproporphyrinogen	O
oxidase	O
gene1e	O
gene	O
,	O
and	O
Northern	O
blotting	O
demonstrated	O
one	O
transcript	O
of	O
similar	O
size	O
in	O
erythroid	O
and	O
nonerythroid	O
cell	O
lines	O
.	O
Expression	O
of	O
the	O
cDNA	O
coding	O
for	O
the	O
putative	O
mature	O
species1s	O
human	O
species1e	O
gene1s	O
coproporphyrinogen	O
oxidase	O
gene1e	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
resulted	O
in	O
a	O
17-fold	O
increase	O
in	O
coproporphyrinogen	O
activity	O
over	O
endogenous	O
activity	O
.	O

Molecular	O
cloning	O
,	O
sequencing	O
,	O
and	O
functional	O
expression	O
of	O
a	O
cDNA	O
encoding	O
species1s	O
human	O
species1e	O
gene1s	O
coproporphyrinogen	O
oxidase	O
gene1e	O
.	O
gene1s	O
Coproporphyrinogen	O
oxidase	O
gene1e	O
(	O
EC	O
1.3.3.3	O
)	O
catalyzes	O
the	O
sixth	O
step	O
in	O
the	O
heme	O
biosynthetic	O
pathway	O
,	O
the	O
oxidation	O
of	O
coproporphyrinogen	O
III	O
to	O
protoporphyrinogen	O
IX	O
.	O
The	O
activity	O
of	O
this	O
enzyme	O
is	O
deficient	O
in	O
the	O
disease	O
hereditary	O
coproporphyria	O
.	O
The	O
sequence	O
of	O
the	O
cDNA	O
and	O
predicted	O
amino	O
acid	O
sequence	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
coproporphyrinogen	O
oxidase	O
gene1e	O
are	O
presented	O
.	O
The	O
species1s	O
human	O
species1e	O
protein	O
sequence	O
contains	O
a	O
region	O
completely	O
homologous	O
to	O
that	O
we	O
obtained	O
by	O
sequencing	O
an	O
11-amino	O
acid	O
peptide	O
fragment	O
from	O
purified	O
species1s	O
murine	O
species1e	O
liver	O
gene1s	O
coproporphyrinogen	O
oxidase	O
gene1e	O
.	O
Results	O
of	O
Southern	O
blotting	O
were	O
consistent	O
with	O
the	O
presence	O
of	O
a	O
single	O
species1s	O
human	O
species1e	O
gene1s	O
coproporphyrinogen	O
oxidase	O
gene1e	O
gene	O
,	O
and	O
Northern	O
blotting	O
demonstrated	O
one	O
transcript	O
of	O
similar	O
size	O
in	O
erythroid	O
and	O
nonerythroid	O
cell	O
lines	O
.	O
Expression	O
of	O
the	O
cDNA	O
coding	O
for	O
the	O
putative	O
mature	O
species1s	O
human	O
species1e	O
gene1s	O
coproporphyrinogen	O
oxidase	O
gene1e	O
in	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
resulted	O
in	O
a	O
17-fold	O
increase	O
in	O
coproporphyrinogen	O
activity	O
over	O
endogenous	O
activity	O
.	O

arg1s	O
Human	O
arg1e	O
liver	O
gene1s	ARG2
nicotinamide	ARG2
N	ARG2
-	ARG2
methyltransferase	ARG2
gene1e	ARG2
.	O
cDNA	O
cloning	O
,	O
expression	O
,	O
and	O
biochemical	O
characterization	O
.	O
gene1s	ARG2
Nicotinamide	ARG2
N	ARG2
-	ARG2
methyltransferase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NNMT	ARG2
gene1e	ARG2
)	O
catalyzes	O
the	O
N	O
-	O
methylation	O
of	O
nicotinamide	O
and	O
other	O
pyridines	O
.	O
arg1s	O
Human	O
arg1e	O
liver	O
gene1s	ARG2
NNMT	ARG2
gene1e	ARG2
activity	O
has	O
a	O
bimodal	O
frequency	O
distribution	O
,	O
an	O
observation	O
which	O
raises	O
the	O
possibility	O
that	O
this	O
enzyme	O
activity	O
might	O
be	O
regulated	O
by	O
a	O
genetic	O
polymorphism	O
,	O
a	O
polymorphism	O
that	O
could	O
have	O
functional	O
implications	O
for	O
individual	O
differences	O
in	O
drug	O
and	O
xenobiotic	O
toxicity	O
.	O
As	O
a	O
first	O
step	O
toward	O
testing	O
that	O
hypothesis	O
,	O
we	O
set	O
out	O
to	O
clone	O
and	O
express	O
a	O
cDNA	O
for	O
arg1s	O
human	O
arg1e	O
liver	O
gene1s	ARG2
NNMT	ARG2
gene1e	ARG2
.	O
arg1s	O
Human	O
arg1e	O
liver	O
gene1s	ARG2
NNMT	ARG2
gene1e	ARG2
was	O
partially	O
purified	O
,	O
photoaffinity	O
-	O
labeled	O
,	O
subjected	O
to	O
limited	O
proteolysis	O
,	O
and	O
partial	O
amino	O
acid	O
sequence	O
information	O
was	O
obtained	O
.	O
The	O
polymerase	O
chain	O
reaction	O
was	O
then	O
used	O
to	O
amplify	O
a	O
550-nucleotide	O
sequence	O
with	O
arg1s	O
human	O
arg1e	O
liver	O
cDNA	O
as	O
template	O
and	O
primers	O
designed	O
on	O
the	O
basis	O
of	O
the	O
gene1s	ARG2
NNMT	ARG2
gene1e	ARG2
amino	O
acid	O
sequence	O
.	O
The	O
5'-	O
and	O
3'-ends	O
of	O
a	O
arg1s	O
human	O
arg1e	O
liver	O
gene1s	ARG2
NNMT	ARG2
gene1e	ARG2
cDNA	O
were	O
obtained	O
by	O
use	O
of	O
the	O
rapid	O
amplification	O
of	O
cDNA	O
ends	O
.	O
The	O
combined	O
use	O
of	O
these	O
approaches	O
resulted	O
in	O
the	O
isolation	O
of	O
a	O
arg1s	O
human	O
arg1e	O
liver	O
gene1s	ARG2
NNMT	ARG2
gene1e	ARG2
cDNA	O
that	O
was	O
969	O
nucleotides	O
in	O
length	O
,	O
with	O
a	O
792-nucleotide	O
open	O
reading	O
frame	O
that	O
encoded	O
a	O
264-amino	O
acid	O
protein	O
with	O
a	O
calculated	O
molecular	O
mass	O
of	O
29.6	O
kDa	O
.	O
The	O
arg1s	O
human	O
arg1e	O
liver	O
gene1s	ARG2
NNMT	ARG2
gene1e	ARG2
cDNA	O
was	O
transcribed	O
in	O
vitro	O
and	O
translated	O
with	O
a	O
reticulocyte	O
lysate	O
system	O
to	O
yield	O
a	O
protein	O
with	O
a	O
molecular	O
mass	O
of	O
approximately	O
29	O
kDa	O
that	O
comigrated	O
during	O
SDS	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
with	O
photoaffinity	O
-	O
labeled	O
arg1s	O
human	O
arg1e	O
liver	O
gene1s	ARG2
NNMT	ARG2
gene1e	ARG2
.	O
The	O
gene1s	ARG2
NNMT	ARG2
gene1e	ARG2
cDNA	O
was	O
also	O
subcloned	O
into	O
the	O
eukaryotic	O
expression	O
vector	O
p91023(B	O
)	O
.	O
species1s	O
COS-1	O
species1e	O
cells	O
transfected	O
with	O
this	O
construct	O
expressed	O
a	O
high	O
level	O
of	O
gene1s	ARG2
NNMT	ARG2
gene1e	ARG2
enzymatic	O
activity	O
,	O
and	O
the	O
biochemical	O
properties	O
of	O
this	O
activity	O
were	O
similar	O
to	O
those	O
of	O
arg1s	O
human	O
arg1e	O
liver	O
gene1s	ARG2
NNMT	ARG2
gene1e	ARG2
.	O
arg1s	O
Human	O
arg1e	O
liver	O
gene1s	ARG2
NNMT	ARG2
gene1e	ARG2
and	O
transfected	O
species1s	O
COS-1	O
species1e	O
cell	O
gene1s	ARG2
NNMT	ARG2
gene1e	ARG2
had	O
apparent	O
Km	O
values	O
for	O
the	O
two	O
cosubstrates	O
for	O
the	O
reaction	O
,	O
nicotinamide	O
and	O
S	O
-	O
adenosyl	O
-	O
L	O
-	O
methionine	O
,	O
of	O
0.43	O
and	O
0.38	O
mM	O
and	O
of	O
1.8	O
and	O
2.2	O
microM	O
,	O
respectively	O
.	O
IC50	O
values	O
for	O
the	O
inhibition	O
of	O
gene1s	ARG2
NNMT	ARG2
gene1e	ARG2
by	O
N1-methylnicotinamide	O
were	O
60	O
and	O
30	O
microns	O
for	O
arg1s	O
human	O
arg1e	O
liver	O
and	O
species1s	O
COS-1	O
species1e	O
cell	O
-	O
expressed	O
gene1s	ARG2
NNMT	ARG2
gene1e	ARG2
,	O
respectively	O
.	O
Cloning	O
of	O
a	O
cDNA	O
for	O
arg1s	O
human	O
arg1e	O
liver	O
gene1s	ARG2
NNMT	ARG2
gene1e	ARG2
will	O
help	O
make	O
it	O
possible	O
to	O
test	O
the	O
hypothesis	O
that	O
inheritance	O
may	O
play	O
a	O
role	O
in	O
the	O
regulation	O
of	O
individual	O
differences	O
in	O
arg1s	O
human	O
arg1e	O
liver	O
gene1s	ARG2
NNMT	ARG2
gene1e	ARG2
activity	O
.	O

species1s	O
Human	O
species1e	O
liver	O
gene1s	O
nicotinamide	O
N	O
-	O
methyltransferase	O
gene1e	O
.	O
cDNA	O
cloning	O
,	O
expression	O
,	O
and	O
biochemical	O
characterization	O
.	O
gene1s	O
Nicotinamide	O
N	O
-	O
methyltransferase	O
gene1e	O
(	O
gene1s	O
NNMT	O
gene1e	O
)	O
catalyzes	O
the	O
N	O
-	O
methylation	O
of	O
nicotinamide	O
and	O
other	O
pyridines	O
.	O
species1s	O
Human	O
species1e	O
liver	O
gene1s	O
NNMT	O
gene1e	O
activity	O
has	O
a	O
bimodal	O
frequency	O
distribution	O
,	O
an	O
observation	O
which	O
raises	O
the	O
possibility	O
that	O
this	O
enzyme	O
activity	O
might	O
be	O
regulated	O
by	O
a	O
genetic	O
polymorphism	O
,	O
a	O
polymorphism	O
that	O
could	O
have	O
functional	O
implications	O
for	O
individual	O
differences	O
in	O
drug	O
and	O
xenobiotic	O
toxicity	O
.	O
As	O
a	O
first	O
step	O
toward	O
testing	O
that	O
hypothesis	O
,	O
we	O
set	O
out	O
to	O
clone	O
and	O
express	O
a	O
cDNA	O
for	O
species1s	O
human	O
species1e	O
liver	O
gene1s	O
NNMT	O
gene1e	O
.	O
species1s	O
Human	O
species1e	O
liver	O
gene1s	O
NNMT	O
gene1e	O
was	O
partially	O
purified	O
,	O
photoaffinity	O
-	O
labeled	O
,	O
subjected	O
to	O
limited	O
proteolysis	O
,	O
and	O
partial	O
amino	O
acid	O
sequence	O
information	O
was	O
obtained	O
.	O
The	O
polymerase	O
chain	O
reaction	O
was	O
then	O
used	O
to	O
amplify	O
a	O
550-nucleotide	O
sequence	O
with	O
species1s	O
human	O
species1e	O
liver	O
cDNA	O
as	O
template	O
and	O
primers	O
designed	O
on	O
the	O
basis	O
of	O
the	O
gene1s	O
NNMT	O
gene1e	O
amino	O
acid	O
sequence	O
.	O
The	O
5'-	O
and	O
3'-ends	O
of	O
a	O
species1s	O
human	O
species1e	O
liver	O
gene1s	O
NNMT	O
gene1e	O
cDNA	O
were	O
obtained	O
by	O
use	O
of	O
the	O
rapid	O
amplification	O
of	O
cDNA	O
ends	O
.	O
The	O
combined	O
use	O
of	O
these	O
approaches	O
resulted	O
in	O
the	O
isolation	O
of	O
a	O
species1s	O
human	O
species1e	O
liver	O
gene1s	O
NNMT	O
gene1e	O
cDNA	O
that	O
was	O
969	O
nucleotides	O
in	O
length	O
,	O
with	O
a	O
792-nucleotide	O
open	O
reading	O
frame	O
that	O
encoded	O
a	O
264-amino	O
acid	O
protein	O
with	O
a	O
calculated	O
molecular	O
mass	O
of	O
29.6	O
kDa	O
.	O
The	O
species1s	O
human	O
species1e	O
liver	O
gene1s	O
NNMT	O
gene1e	O
cDNA	O
was	O
transcribed	O
in	O
vitro	O
and	O
translated	O
with	O
a	O
reticulocyte	O
lysate	O
system	O
to	O
yield	O
a	O
protein	O
with	O
a	O
molecular	O
mass	O
of	O
approximately	O
29	O
kDa	O
that	O
comigrated	O
during	O
SDS	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
with	O
photoaffinity	O
-	O
labeled	O
species1s	O
human	O
species1e	O
liver	O
gene1s	O
NNMT	O
gene1e	O
.	O
The	O
gene1s	O
NNMT	O
gene1e	O
cDNA	O
was	O
also	O
subcloned	O
into	O
the	O
eukaryotic	O
expression	O
vector	O
p91023(B	O
)	O
.	O
arg1s	O
COS-1	O
arg1e	O
cells	O
transfected	O
with	O
this	O
construct	O
expressed	O
a	O
high	O
level	O
of	O
gene1s	O
NNMT	O
gene1e	O
enzymatic	O
activity	O
,	O
and	O
the	O
biochemical	O
properties	O
of	O
this	O
activity	O
were	O
similar	O
to	O
those	O
of	O
species1s	O
human	O
species1e	O
liver	O
gene1s	O
NNMT	O
gene1e	O
.	O
species1s	O
Human	O
species1e	O
liver	O
gene1s	O
NNMT	O
gene1e	O
and	O
transfected	O
arg1s	O
COS-1	O
arg1e	O
cell	O
gene1s	O
NNMT	O
gene1e	O
had	O
apparent	O
Km	O
values	O
for	O
the	O
two	O
cosubstrates	O
for	O
the	O
reaction	O
,	O
nicotinamide	O
and	O
S	O
-	O
adenosyl	O
-	O
L	O
-	O
methionine	O
,	O
of	O
0.43	O
and	O
0.38	O
mM	O
and	O
of	O
1.8	O
and	O
2.2	O
microM	O
,	O
respectively	O
.	O
IC50	O
values	O
for	O
the	O
inhibition	O
of	O
gene1s	O
NNMT	O
gene1e	O
by	O
N1-methylnicotinamide	O
were	O
60	O
and	O
30	O
microns	O
for	O
species1s	O
human	O
species1e	O
liver	O
and	O
arg1s	O
COS-1	O
arg1e	O
cell	O
-	O
expressed	O
gene1s	O
NNMT	O
gene1e	O
,	O
respectively	O
.	O
Cloning	O
of	O
a	O
cDNA	O
for	O
species1s	O
human	O
species1e	O
liver	O
gene1s	O
NNMT	O
gene1e	O
will	O
help	O
make	O
it	O
possible	O
to	O
test	O
the	O
hypothesis	O
that	O
inheritance	O
may	O
play	O
a	O
role	O
in	O
the	O
regulation	O
of	O
individual	O
differences	O
in	O
species1s	O
human	O
species1e	O
liver	O
gene1s	O
NNMT	O
gene1e	O
activity	O
.	O

Purification	O
and	O
characterization	O
of	O
the	O
recombinant	O
arg1s	O
human	O
arg1e	O
calcium	O
-	O
binding	O
S100	O
proteins	O
gene1s	ARG2
CAPL	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CACY	ARG2
gene1e	ARG2
.	O
The	O
S100	O
proteins	O
gene1s	ARG2
CAPL	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CACY	ARG2
gene1e	ARG2
are	O
expressed	O
in	O
a	O
tissue-	O
and	O
cell	O
-	O
specific	O
manner	O
and	O
have	O
been	O
reported	O
to	O
be	O
associated	O
with	O
the	O
metastatic	O
phenotype	O
of	O
tumor	O
cells	O
.	O
In	O
order	O
to	O
study	O
the	O
biochemical	O
,	O
cation	O
-	O
binding	O
,	O
and	O
conformational	O
properties	O
,	O
we	O
produced	O
and	O
purified	O
large	O
amounts	O
of	O
the	O
recombinant	O
arg1s	O
human	O
arg1e	O
proteins	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
.	O
Several	O
characteristics	O
of	O
native	O
proteins	O
are	O
shown	O
to	O
correspond	O
to	O
those	O
of	O
the	O
bacterially	O
expressed	O
proteins	O
.	O
Both	O
are	O
able	O
to	O
form	O
homodimers	O
in	O
vitro	O
,	O
probably	O
the	O
biologically	O
active	O
species	O
,	O
but	O
not	O
heterodimers	O
.	O
The	O
Ca(2+)-binding	O
parameters	O
were	O
studied	O
by	O
flow	O
offlysis	O
at	O
physiological	O
ionic	O
strength	O
.	O
Both	O
isotherms	O
show	O
a	O
maximum	O
of	O
two	O
Ca2	O
+	O
per	O
protein	O
and	O
are	O
insensitive	O
to	O
Mg2	O
+	O
,	O
indicating	O
that	O
the	O
sites	O
are	O
of	O
the	O
Ca(2+)-specific	O
type	O
.	O
The	O
isotherms	O
show	O
slight	O
(	O
gene1s	ARG2
CAPL	ARG2
gene1e	ARG2
,	O
nH	O
=	O
1.15	O
)	O
or	O
pronounced	O
(	O
gene1s	ARG2
CACY	ARG2
gene1e	ARG2
,	O
nH	O
=	O
1.33	O
)	O
positive	O
cooperativity	O
with	O
K0.5	O
values	O
of	O
0.32	O
mM	O
(	O
gene1s	ARG2
CACY	ARG2
gene1e	ARG2
)	O
and	O
0.15	O
mM	O
(	O
gene1s	ARG2
CAPL	ARG2
gene1e	ARG2
)	O
,	O
indicating	O
that	O
the	O
sites	O
are	O
of	O
the	O
low	O
-	O
affinity	O
type	O
.	O
Conformational	O
changes	O
in	O
the	O
Tyr	O
microenvironment	O
of	O
gene1s	ARG2
CACY	ARG2
gene1e	ARG2
indicate	O
that	O
Ca2	O
+	O
binding	O
induces	O
a	O
shift	O
of	O
Tyr	O
to	O
a	O
less	O
polar	O
environment	O
.	O
Mg2	O
+	O
does	O
not	O
affect	O
the	O
fluorescence	O
properties	O
nor	O
does	O
it	O
induce	O
a	O
difference	O
spectrum	O
,	O
thus	O
suggesting	O
that	O
at	O
physiological	O
ionic	O
conditions	O
it	O
does	O
not	O
interact	O
with	O
the	O
protein	O
.	O
The	O
Ca(2+)-induced	O
difference	O
spectra	O
of	O
gene1s	ARG2
CAPL	ARG2
gene1e	ARG2
are	O
about	O
3	O
times	O
smaller	O
than	O
those	O
of	O
gene1s	ARG2
CACY	ARG2
gene1e	ARG2
,	O
suggesting	O
that	O
the	O
additional	O
Tyr84	O
in	O
gene1s	ARG2
CACY	ARG2
gene1e	ARG2
is	O
much	O
more	O
sensitive	O
to	O
Ca2	O
+	O
than	O
the	O
two	O
Tyr	O
residues	O
conserved	O
in	O
both	O
proteins	O
.	O

Purification	O
and	O
characterization	O
of	O
the	O
recombinant	O
species1s	O
human	O
species1e	O
calcium	O
-	O
binding	O
S100	O
proteins	O
gene1s	O
CAPL	O
gene1e	O
and	O
gene1s	O
CACY	O
gene1e	O
.	O
The	O
S100	O
proteins	O
gene1s	O
CAPL	O
gene1e	O
and	O
gene1s	O
CACY	O
gene1e	O
are	O
expressed	O
in	O
a	O
tissue-	O
and	O
cell	O
-	O
specific	O
manner	O
and	O
have	O
been	O
reported	O
to	O
be	O
associated	O
with	O
the	O
metastatic	O
phenotype	O
of	O
tumor	O
cells	O
.	O
In	O
order	O
to	O
study	O
the	O
biochemical	O
,	O
cation	O
-	O
binding	O
,	O
and	O
conformational	O
properties	O
,	O
we	O
produced	O
and	O
purified	O
large	O
amounts	O
of	O
the	O
recombinant	O
species1s	O
human	O
species1e	O
proteins	O
in	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
.	O
Several	O
characteristics	O
of	O
native	O
proteins	O
are	O
shown	O
to	O
correspond	O
to	O
those	O
of	O
the	O
bacterially	O
expressed	O
proteins	O
.	O
Both	O
are	O
able	O
to	O
form	O
homodimers	O
in	O
vitro	O
,	O
probably	O
the	O
biologically	O
active	O
species	O
,	O
but	O
not	O
heterodimers	O
.	O
The	O
Ca(2+)-binding	O
parameters	O
were	O
studied	O
by	O
flow	O
offlysis	O
at	O
physiological	O
ionic	O
strength	O
.	O
Both	O
isotherms	O
show	O
a	O
maximum	O
of	O
two	O
Ca2	O
+	O
per	O
protein	O
and	O
are	O
insensitive	O
to	O
Mg2	O
+	O
,	O
indicating	O
that	O
the	O
sites	O
are	O
of	O
the	O
Ca(2+)-specific	O
type	O
.	O
The	O
isotherms	O
show	O
slight	O
(	O
gene1s	O
CAPL	O
gene1e	O
,	O
nH	O
=	O
1.15	O
)	O
or	O
pronounced	O
(	O
gene1s	O
CACY	O
gene1e	O
,	O
nH	O
=	O
1.33	O
)	O
positive	O
cooperativity	O
with	O
K0.5	O
values	O
of	O
0.32	O
mM	O
(	O
gene1s	O
CACY	O
gene1e	O
)	O
and	O
0.15	O
mM	O
(	O
gene1s	O
CAPL	O
gene1e	O
)	O
,	O
indicating	O
that	O
the	O
sites	O
are	O
of	O
the	O
low	O
-	O
affinity	O
type	O
.	O
Conformational	O
changes	O
in	O
the	O
Tyr	O
microenvironment	O
of	O
gene1s	O
CACY	O
gene1e	O
indicate	O
that	O
Ca2	O
+	O
binding	O
induces	O
a	O
shift	O
of	O
Tyr	O
to	O
a	O
less	O
polar	O
environment	O
.	O
Mg2	O
+	O
does	O
not	O
affect	O
the	O
fluorescence	O
properties	O
nor	O
does	O
it	O
induce	O
a	O
difference	O
spectrum	O
,	O
thus	O
suggesting	O
that	O
at	O
physiological	O
ionic	O
conditions	O
it	O
does	O
not	O
interact	O
with	O
the	O
protein	O
.	O
The	O
Ca(2+)-induced	O
difference	O
spectra	O
of	O
gene1s	O
CAPL	O
gene1e	O
are	O
about	O
3	O
times	O
smaller	O
than	O
those	O
of	O
gene1s	O
CACY	O
gene1e	O
,	O
suggesting	O
that	O
the	O
additional	O
Tyr84	O
in	O
gene1s	O
CACY	O
gene1e	O
is	O
much	O
more	O
sensitive	O
to	O
Ca2	O
+	O
than	O
the	O
two	O
Tyr	O
residues	O
conserved	O
in	O
both	O
proteins	O
.	O

gene1s	ARG2
X	ARG2
-	ARG2
arrestin	ARG2
gene1e	ARG2
:	O
a	O
new	O
retinal	O
arrestin	O
mapping	O
to	O
the	O
X	O
chromosome	O
.	O
We	O
have	O
been	O
using	O
a	O
differential	O
cDNA	O
cloning	O
approach	O
to	O
isolate	O
arg1s	O
human	O
arg1e	O
retina	O
-	O
specific	O
and	O
retina	O
-	O
enriched	O
genes	O
[	O
1	O
]	O
.	O
A	O
1,314	O
bp	O
cDNA	O
was	O
isolated	O
by	O
this	O
approach	O
,	O
representing	O
a	O
highly	O
retina	O
-	O
specific	O
message	O
encoding	O
a	O
388	O
amino	O
acid	O
protein	O
showing	O
58	O
%	O
,	O
50	O
%	O
,	O
and	O
49	O
%	O
homology	O
to	O
species1s	O
bovine	O
species1e	O
beta	O
-	O
arrestin	O
,	O
and	O
species1s	O
bovine	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
retinal	ARG2
arrestin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
S	ARG2
-	ARG2
antigen	ARG2
gene1e	ARG2
)	O
,	O
respectively	O
.	O
Chromosomal	O
mapping	O
localized	O
this	O
new	O
arrestin	O
gene	O
to	O
the	O
proximal	O
long	O
arm	O
of	O
the	O
X	O
chromosome	O
,	O
hence	O
it	O
was	O
named	O
gene1s	ARG2
X	ARG2
-	ARG2
arrestin	ARG2
gene1e	ARG2
.	O
In	O
situ	O
hybridization	O
demonstrated	O
its	O
expression	O
in	O
the	O
inner	O
and	O
outer	O
segments	O
and	O
the	O
inner	O
plexiform	O
regions	O
of	O
the	O
retina	O
.	O

gene1s	O
X	O
-	O
arrestin	O
gene1e	O
:	O
a	O
new	O
retinal	O
arrestin	O
mapping	O
to	O
the	O
X	O
chromosome	O
.	O
We	O
have	O
been	O
using	O
a	O
differential	O
cDNA	O
cloning	O
approach	O
to	O
isolate	O
species1s	O
human	O
species1e	O
retina	O
-	O
specific	O
and	O
retina	O
-	O
enriched	O
genes	O
[	O
1	O
]	O
.	O
A	O
1,314	O
bp	O
cDNA	O
was	O
isolated	O
by	O
this	O
approach	O
,	O
representing	O
a	O
highly	O
retina	O
-	O
specific	O
message	O
encoding	O
a	O
388	O
amino	O
acid	O
protein	O
showing	O
58	O
%	O
,	O
50	O
%	O
,	O
and	O
49	O
%	O
homology	O
to	O
arg1s	O
bovine	O
arg1e	O
beta	O
-	O
arrestin	O
,	O
and	O
arg1s	O
bovine	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
gene1s	ARG2
retinal	ARG2
arrestin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
S	ARG2
-	ARG2
antigen	ARG2
gene1e	ARG2
)	O
,	O
respectively	O
.	O
Chromosomal	O
mapping	O
localized	O
this	O
new	O
arrestin	O
gene	O
to	O
the	O
proximal	O
long	O
arm	O
of	O
the	O
X	O
chromosome	O
,	O
hence	O
it	O
was	O
named	O
gene1s	O
X	O
-	O
arrestin	O
gene1e	O
.	O
In	O
situ	O
hybridization	O
demonstrated	O
its	O
expression	O
in	O
the	O
inner	O
and	O
outer	O
segments	O
and	O
the	O
inner	O
plexiform	O
regions	O
of	O
the	O
retina	O
.	O

arg1s	O
Human	O
arg1e	O
gene1s	ARG2
G(olf	ARG2
)	ARG2
alpha	ARG2
gene1e	ARG2
:	O
complementary	O
deoxyribonucleic	O
acid	O
structure	O
and	O
expression	O
in	O
pancreatic	O
islets	O
and	O
other	O
tissues	O
outside	O
the	O
olfactory	O
neuroepithelium	O
and	O
central	O
nervous	O
system	O
.	O
gene1s	ARG2
G(olf	ARG2
)	ARG2
alpha	ARG2
gene1e	ARG2
is	O
a	O
G	O
-	O
protein	O
originally	O
believed	O
to	O
mediate	O
signal	O
transduction	O
exclusively	O
within	O
the	O
olfactory	O
neuroepithelium	O
and	O
subsequently	O
found	O
to	O
be	O
a	O
major	O
stimulatory	O
G	O
-	O
protein	O
in	O
the	O
basal	O
ganglia	O
.	O
Here	O
we	O
present	O
evidence	O
that	O
gene1s	ARG2
G(olf	ARG2
)	ARG2
alpha	ARG2
gene1e	ARG2
is	O
expressed	O
in	O
several	O
other	O
tissues	O
.	O
The	O
arg1s	O
human	O
arg1e	O
isoform	O
of	O
gene1s	ARG2
G(olf	ARG2
)	ARG2
alpha	ARG2
gene1e	ARG2
was	O
isolated	O
from	O
two	O
arg1s	O
human	O
arg1e	O
insulinoma	O
cDNA	O
libraries	O
.	O
Comparison	O
of	O
the	O
arg1s	O
human	O
arg1e	O
sequence	O
with	O
species1s	O
rat	O
species1e	O
gene1s	ARG2
G(olf	ARG2
)	ARG2
alpha	ARG2
gene1e	ARG2
shows	O
91	O
%	O
nucleotide	O
identity	O
(	O
within	O
the	O
coding	O
region	O
)	O
and	O
99	O
%	O
identity	O
at	O
the	O
amino	O
acid	O
level	O
.	O
Northern	O
and	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
analyses	O
indicated	O
that	O
gene1s	ARG2
G(olf	ARG2
)	ARG2
alpha	ARG2
gene1e	ARG2
is	O
expressed	O
in	O
all	O
arg1s	O
human	O
arg1e	O
insulinomas	O
examined	O
thus	O
far	O
as	O
well	O
as	O
in	O
normal	O
pancreatic	O
islets	O
.	O
gene1s	ARG2
G(olf	ARG2
)	ARG2
alpha	ARG2
gene1e	ARG2
mRNA	O
was	O
also	O
detected	O
in	O
testis	O
,	O
retina	O
,	O
brain	O
,	O
and	O
liver	O
.	O
Western	O
blot	O
analysis	O
of	O
various	O
species1s	O
mouse	O
species1e	O
tissues	O
demonstrated	O
that	O
the	O
level	O
of	O
gene1s	ARG2
G(olf	ARG2
)	ARG2
alpha	ARG2
gene1e	ARG2
protein	O
in	O
islets	O
is	O
lower	O
than	O
that	O
in	O
the	O
olfactory	O
neuroepithelium	O
and	O
other	O
parts	O
of	O
the	O
brain	O
;	O
its	O
expression	O
in	O
retina	O
,	O
lung	O
,	O
and	O
spleen	O
was	O
moderately	O
higher	O
than	O
that	O
in	O
islets	O
,	O
and	O
its	O
expression	O
in	O
testis	O
approached	O
that	O
in	O
olfactory	O
neuroepithelium	O
.	O
gene1s	ARG2
G(olf	ARG2
)	ARG2
alpha	ARG2
gene1e	ARG2
was	O
also	O
detected	O
by	O
immunohistochemistry	O
in	O
species1s	O
mouse	O
species1e	O
islets	O
,	O
arg1s	O
human	O
arg1e	O
insulinomas	O
,	O
the	O
epithelial	O
lining	O
of	O
species1s	O
mouse	O
species1e	O
epididymis	O
,	O
photoreceptor	O
cells	O
of	O
species1s	O
mouse	O
species1e	O
retina	O
,	O
and	O
species1s	O
mouse	O
species1e	O
lung	O
alveoli	O
.	O
These	O
findings	O
suggest	O
a	O
role	O
for	O
gene1s	ARG2
G(olf	ARG2
)	ARG2
alpha	ARG2
gene1e	ARG2
in	O
a	O
diverse	O
population	O
of	O
cells	O
located	O
outside	O
the	O
olfactory	O
neuroepithelium	O
and	O
central	O
nervous	O
system	O
.	O

species1s	O
Human	O
species1e	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
:	O
complementary	O
deoxyribonucleic	O
acid	O
structure	O
and	O
expression	O
in	O
pancreatic	O
islets	O
and	O
other	O
tissues	O
outside	O
the	O
olfactory	O
neuroepithelium	O
and	O
central	O
nervous	O
system	O
.	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
is	O
a	O
G	O
-	O
protein	O
originally	O
believed	O
to	O
mediate	O
signal	O
transduction	O
exclusively	O
within	O
the	O
olfactory	O
neuroepithelium	O
and	O
subsequently	O
found	O
to	O
be	O
a	O
major	O
stimulatory	O
G	O
-	O
protein	O
in	O
the	O
basal	O
ganglia	O
.	O
Here	O
we	O
present	O
evidence	O
that	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
is	O
expressed	O
in	O
several	O
other	O
tissues	O
.	O
The	O
species1s	O
human	O
species1e	O
isoform	O
of	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
was	O
isolated	O
from	O
two	O
species1s	O
human	O
species1e	O
insulinoma	O
cDNA	O
libraries	O
.	O
Comparison	O
of	O
the	O
species1s	O
human	O
species1e	O
sequence	O
with	O
arg1s	O
rat	O
arg1e	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
shows	O
91	O
%	O
nucleotide	O
identity	O
(	O
within	O
the	O
coding	O
region	O
)	O
and	O
99	O
%	O
identity	O
at	O
the	O
amino	O
acid	O
level	O
.	O
Northern	O
and	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
analyses	O
indicated	O
that	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
is	O
expressed	O
in	O
all	O
species1s	O
human	O
species1e	O
insulinomas	O
examined	O
thus	O
far	O
as	O
well	O
as	O
in	O
normal	O
pancreatic	O
islets	O
.	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
mRNA	O
was	O
also	O
detected	O
in	O
testis	O
,	O
retina	O
,	O
brain	O
,	O
and	O
liver	O
.	O
Western	O
blot	O
analysis	O
of	O
various	O
species1s	O
mouse	O
species1e	O
tissues	O
demonstrated	O
that	O
the	O
level	O
of	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
protein	O
in	O
islets	O
is	O
lower	O
than	O
that	O
in	O
the	O
olfactory	O
neuroepithelium	O
and	O
other	O
parts	O
of	O
the	O
brain	O
;	O
its	O
expression	O
in	O
retina	O
,	O
lung	O
,	O
and	O
spleen	O
was	O
moderately	O
higher	O
than	O
that	O
in	O
islets	O
,	O
and	O
its	O
expression	O
in	O
testis	O
approached	O
that	O
in	O
olfactory	O
neuroepithelium	O
.	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
was	O
also	O
detected	O
by	O
immunohistochemistry	O
in	O
species1s	O
mouse	O
species1e	O
islets	O
,	O
species1s	O
human	O
species1e	O
insulinomas	O
,	O
the	O
epithelial	O
lining	O
of	O
species1s	O
mouse	O
species1e	O
epididymis	O
,	O
photoreceptor	O
cells	O
of	O
species1s	O
mouse	O
species1e	O
retina	O
,	O
and	O
species1s	O
mouse	O
species1e	O
lung	O
alveoli	O
.	O
These	O
findings	O
suggest	O
a	O
role	O
for	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
in	O
a	O
diverse	O
population	O
of	O
cells	O
located	O
outside	O
the	O
olfactory	O
neuroepithelium	O
and	O
central	O
nervous	O
system	O
.	O

species1s	O
Human	O
species1e	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
:	O
complementary	O
deoxyribonucleic	O
acid	O
structure	O
and	O
expression	O
in	O
pancreatic	O
islets	O
and	O
other	O
tissues	O
outside	O
the	O
olfactory	O
neuroepithelium	O
and	O
central	O
nervous	O
system	O
.	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
is	O
a	O
G	O
-	O
protein	O
originally	O
believed	O
to	O
mediate	O
signal	O
transduction	O
exclusively	O
within	O
the	O
olfactory	O
neuroepithelium	O
and	O
subsequently	O
found	O
to	O
be	O
a	O
major	O
stimulatory	O
G	O
-	O
protein	O
in	O
the	O
basal	O
ganglia	O
.	O
Here	O
we	O
present	O
evidence	O
that	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
is	O
expressed	O
in	O
several	O
other	O
tissues	O
.	O
The	O
species1s	O
human	O
species1e	O
isoform	O
of	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
was	O
isolated	O
from	O
two	O
species1s	O
human	O
species1e	O
insulinoma	O
cDNA	O
libraries	O
.	O
Comparison	O
of	O
the	O
species1s	O
human	O
species1e	O
sequence	O
with	O
species1s	O
rat	O
species1e	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
shows	O
91	O
%	O
nucleotide	O
identity	O
(	O
within	O
the	O
coding	O
region	O
)	O
and	O
99	O
%	O
identity	O
at	O
the	O
amino	O
acid	O
level	O
.	O
Northern	O
and	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
analyses	O
indicated	O
that	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
is	O
expressed	O
in	O
all	O
species1s	O
human	O
species1e	O
insulinomas	O
examined	O
thus	O
far	O
as	O
well	O
as	O
in	O
normal	O
pancreatic	O
islets	O
.	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
mRNA	O
was	O
also	O
detected	O
in	O
testis	O
,	O
retina	O
,	O
brain	O
,	O
and	O
liver	O
.	O
Western	O
blot	O
analysis	O
of	O
various	O
arg1s	O
mouse	O
arg1e	O
tissues	O
demonstrated	O
that	O
the	O
level	O
of	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
protein	O
in	O
islets	O
is	O
lower	O
than	O
that	O
in	O
the	O
olfactory	O
neuroepithelium	O
and	O
other	O
parts	O
of	O
the	O
brain	O
;	O
its	O
expression	O
in	O
retina	O
,	O
lung	O
,	O
and	O
spleen	O
was	O
moderately	O
higher	O
than	O
that	O
in	O
islets	O
,	O
and	O
its	O
expression	O
in	O
testis	O
approached	O
that	O
in	O
olfactory	O
neuroepithelium	O
.	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
was	O
also	O
detected	O
by	O
immunohistochemistry	O
in	O
arg1s	O
mouse	O
arg1e	O
islets	O
,	O
species1s	O
human	O
species1e	O
insulinomas	O
,	O
the	O
epithelial	O
lining	O
of	O
arg1s	O
mouse	O
arg1e	O
epididymis	O
,	O
photoreceptor	O
cells	O
of	O
arg1s	O
mouse	O
arg1e	O
retina	O
,	O
and	O
arg1s	O
mouse	O
arg1e	O
lung	O
alveoli	O
.	O
These	O
findings	O
suggest	O
a	O
role	O
for	O
gene1s	O
G(olf	O
)	O
alpha	O
gene1e	O
in	O
a	O
diverse	O
population	O
of	O
cells	O
located	O
outside	O
the	O
olfactory	O
neuroepithelium	O
and	O
central	O
nervous	O
system	O
.	O

cDNAs	O
encoding	O
the	O
large	O
subunit	O
of	O
arg1s	O
human	O
arg1e	O
replication	O
factor	O
C.	O
Replication	O
factor	O
C	O
(	O
RFC	O
)	O
is	O
a	O
multisubunit	O
,	O
DNA	O
polymerase	O
accessory	O
protein	O
required	O
for	O
the	O
coordinated	O
synthesis	O
of	O
both	O
DNA	O
strands	O
during	O
species1s	O
simian	O
virus	O
40	O
species1e	O
DNA	O
replication	O
in	O
vitro	O
.	O
Previous	O
studies	O
have	O
shown	O
that	O
RFC	O
is	O
a	O
DNA	O
-	O
dependent	O
ATPase	O
that	O
binds	O
in	O
a	O
structure	O
-	O
specific	O
manner	O
to	O
the	O
3	O
'	O
end	O
of	O
a	O
primer	O
hybridized	O
to	O
a	O
template	O
DNA	O
,	O
an	O
activity	O
thought	O
intrinsic	O
to	O
the	O
140-kDa	O
component	O
of	O
this	O
multisubunit	O
complex	O
.	O
Here	O
,	O
the	O
isolation	O
and	O
analysis	O
of	O
cDNAs	O
encoding	O
this	O
subunit	O
is	O
described	O
.	O
Analysis	O
of	O
the	O
full	O
-	O
length	O
coding	O
sequence	O
revealed	O
an	O
open	O
reading	O
frame	O
of	O
3.4	O
kb	O
,	O
encoding	O
an	O
1148-amino	O
acid	O
protein	O
with	O
a	O
predicted	O
molecular	O
mass	O
of	O
130	O
kDa	O
.	O
A	O
putative	O
ATP	O
-	O
binding	O
motif	O
was	O
observed	O
that	O
is	O
similar	O
to	O
a	O
motif	O
in	O
several	O
of	O
the	O
smaller	O
subunits	O
of	O
RFC	O
and	O
in	O
functionally	O
homologous	O
replication	O
factors	O
of	O
bacterial	O
and	O
viral	O
origin	O
.	O
A	O
"	O
DEAD	O
"	O
box	O
is	O
also	O
conserved	O
among	O
these	O
proteins	O
.	O
The	O
predicted	O
protein	O
shows	O
significant	O
identity	O
with	O
a	O
DNA	O
-	O
binding	O
protein	O
of	O
species1s	O
murine	O
species1e	O
origin	O
(	O
B.	O
Luckow	O
,	O
P.	O
Lichter	O
,	O
and	O
G.	O
Schtz	O
,	O
personal	O
communication	O
)	O
.	O
Regions	O
of	O
similarity	O
were	O
also	O
seen	O
between	O
the	O
amino	O
acid	O
sequences	O
of	O
the	O
gene1s	ARG2
140-kDa	ARG2
subunit	ARG2
of	ARG2
RFC	ARG2
gene1e	ARG2
,	O
poly(ADP	O
-	O
ribose	O
)	O
polymerase	O
,	O
and	O
bacterial	O
DNA	O
ligases	O
--	O
possibly	O
representing	O
a	O
conserved	O
structural	O
feature	O
of	O
these	O
proteins	O
that	O
bind	O
similar	O
DNA	O
substrates	O
.	O

cDNAs	O
encoding	O
the	O
large	O
subunit	O
of	O
species1s	O
human	O
species1e	O
replication	O
factor	O
C.	O
Replication	O
factor	O
C	O
(	O
RFC	O
)	O
is	O
a	O
multisubunit	O
,	O
DNA	O
polymerase	O
accessory	O
protein	O
required	O
for	O
the	O
coordinated	O
synthesis	O
of	O
both	O
DNA	O
strands	O
during	O
arg1s	O
simian	O
virus	O
40	O
arg1e	O
DNA	O
replication	O
in	O
vitro	O
.	O
Previous	O
studies	O
have	O
shown	O
that	O
RFC	O
is	O
a	O
DNA	O
-	O
dependent	O
ATPase	O
that	O
binds	O
in	O
a	O
structure	O
-	O
specific	O
manner	O
to	O
the	O
3	O
'	O
end	O
of	O
a	O
primer	O
hybridized	O
to	O
a	O
template	O
DNA	O
,	O
an	O
activity	O
thought	O
intrinsic	O
to	O
the	O
140-kDa	O
component	O
of	O
this	O
multisubunit	O
complex	O
.	O
Here	O
,	O
the	O
isolation	O
and	O
analysis	O
of	O
cDNAs	O
encoding	O
this	O
subunit	O
is	O
described	O
.	O
Analysis	O
of	O
the	O
full	O
-	O
length	O
coding	O
sequence	O
revealed	O
an	O
open	O
reading	O
frame	O
of	O
3.4	O
kb	O
,	O
encoding	O
an	O
1148-amino	O
acid	O
protein	O
with	O
a	O
predicted	O
molecular	O
mass	O
of	O
130	O
kDa	O
.	O
A	O
putative	O
ATP	O
-	O
binding	O
motif	O
was	O
observed	O
that	O
is	O
similar	O
to	O
a	O
motif	O
in	O
several	O
of	O
the	O
smaller	O
subunits	O
of	O
RFC	O
and	O
in	O
functionally	O
homologous	O
replication	O
factors	O
of	O
bacterial	O
and	O
viral	O
origin	O
.	O
A	O
"	O
DEAD	O
"	O
box	O
is	O
also	O
conserved	O
among	O
these	O
proteins	O
.	O
The	O
predicted	O
protein	O
shows	O
significant	O
identity	O
with	O
a	O
DNA	O
-	O
binding	O
protein	O
of	O
species1s	O
murine	O
species1e	O
origin	O
(	O
B.	O
Luckow	O
,	O
P.	O
Lichter	O
,	O
and	O
G.	O
Schtz	O
,	O
personal	O
communication	O
)	O
.	O
Regions	O
of	O
similarity	O
were	O
also	O
seen	O
between	O
the	O
amino	O
acid	O
sequences	O
of	O
the	O
gene1s	O
140-kDa	O
subunit	O
of	O
RFC	O
gene1e	O
,	O
poly(ADP	O
-	O
ribose	O
)	O
polymerase	O
,	O
and	O
bacterial	O
DNA	O
ligases	O
--	O
possibly	O
representing	O
a	O
conserved	O
structural	O
feature	O
of	O
these	O
proteins	O
that	O
bind	O
similar	O
DNA	O
substrates	O
.	O

cDNAs	O
encoding	O
the	O
large	O
subunit	O
of	O
species1s	O
human	O
species1e	O
replication	O
factor	O
C.	O
Replication	O
factor	O
C	O
(	O
RFC	O
)	O
is	O
a	O
multisubunit	O
,	O
DNA	O
polymerase	O
accessory	O
protein	O
required	O
for	O
the	O
coordinated	O
synthesis	O
of	O
both	O
DNA	O
strands	O
during	O
species1s	O
simian	O
virus	O
40	O
species1e	O
DNA	O
replication	O
in	O
vitro	O
.	O
Previous	O
studies	O
have	O
shown	O
that	O
RFC	O
is	O
a	O
DNA	O
-	O
dependent	O
ATPase	O
that	O
binds	O
in	O
a	O
structure	O
-	O
specific	O
manner	O
to	O
the	O
3	O
'	O
end	O
of	O
a	O
primer	O
hybridized	O
to	O
a	O
template	O
DNA	O
,	O
an	O
activity	O
thought	O
intrinsic	O
to	O
the	O
140-kDa	O
component	O
of	O
this	O
multisubunit	O
complex	O
.	O
Here	O
,	O
the	O
isolation	O
and	O
analysis	O
of	O
cDNAs	O
encoding	O
this	O
subunit	O
is	O
described	O
.	O
Analysis	O
of	O
the	O
full	O
-	O
length	O
coding	O
sequence	O
revealed	O
an	O
open	O
reading	O
frame	O
of	O
3.4	O
kb	O
,	O
encoding	O
an	O
1148-amino	O
acid	O
protein	O
with	O
a	O
predicted	O
molecular	O
mass	O
of	O
130	O
kDa	O
.	O
A	O
putative	O
ATP	O
-	O
binding	O
motif	O
was	O
observed	O
that	O
is	O
similar	O
to	O
a	O
motif	O
in	O
several	O
of	O
the	O
smaller	O
subunits	O
of	O
RFC	O
and	O
in	O
functionally	O
homologous	O
replication	O
factors	O
of	O
bacterial	O
and	O
viral	O
origin	O
.	O
A	O
"	O
DEAD	O
"	O
box	O
is	O
also	O
conserved	O
among	O
these	O
proteins	O
.	O
The	O
predicted	O
protein	O
shows	O
significant	O
identity	O
with	O
a	O
DNA	O
-	O
binding	O
protein	O
of	O
arg1s	O
murine	O
arg1e	O
origin	O
(	O
B.	O
Luckow	O
,	O
P.	O
Lichter	O
,	O
and	O
G.	O
Schtz	O
,	O
personal	O
communication	O
)	O
.	O
Regions	O
of	O
similarity	O
were	O
also	O
seen	O
between	O
the	O
amino	O
acid	O
sequences	O
of	O
the	O
gene1s	O
140-kDa	O
subunit	O
of	O
RFC	O
gene1e	O
,	O
poly(ADP	O
-	O
ribose	O
)	O
polymerase	O
,	O
and	O
bacterial	O
DNA	O
ligases	O
--	O
possibly	O
representing	O
a	O
conserved	O
structural	O
feature	O
of	O
these	O
proteins	O
that	O
bind	O
similar	O
DNA	O
substrates	O
.	O

Molecular	O
cloning	O
and	O
centrosomal	O
localization	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
caltractin	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
Caltractin	ARG2
gene1e	ARG2
,	O
a	O
20-kDa	O
calcium	O
-	O
binding	O
protein	O
,	O
was	O
previously	O
purified	O
and	O
cloned	O
at	O
the	O
DNA	O
level	O
from	O
the	O
unicellular	O
green	O
alga	O
Chlamydomonas	O
.	O
It	O
is	O
a	O
structural	O
component	O
of	O
the	O
basal	O
body	O
complex	O
,	O
the	O
major	O
microtubule	O
-	O
organizing	O
center	O
in	O
Chlamydomonas	O
and	O
the	O
functional	O
homolog	O
of	O
the	O
centrosome	O
in	O
the	O
animal	O
cell	O
.	O
Here	O
we	O
report	O
the	O
characterization	O
of	O
a	O
cDNA	O
encoding	O
a	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
caltractin	ARG2
gene1e	ARG2
that	O
shares	O
a	O
high	O
degree	O
of	O
amino	O
acid	O
identity	O
(	O
70	O
%	O
)	O
with	O
its	O
algal	O
counterpart	O
.	O
gene1s	ARG2
Caltractin	ARG2
gene1e	ARG2
was	O
identified	O
in	O
both	O
arg1s	O
HeLa	O
arg1e	O
and	O
species1s	O
BHK	O
species1e	O
cells	O
as	O
a	O
21-kDa	O
polypeptide	O
specifically	O
localized	O
to	O
the	O
centrosome	O
of	O
interphase	O
and	O
mitotic	O
cells	O
.	O
The	O
high	O
level	O
of	O
conservation	O
in	O
the	O
amino	O
acid	O
sequence	O
of	O
gene1s	ARG2
caltractin	ARG2
gene1e	ARG2
from	O
species1s	O
algae	O
species1e	O
to	O
arg1s	O
humans	O
arg1e	O
and	O
its	O
association	O
with	O
the	O
major	O
microtubule	O
-	O
organizing	O
center	O
in	O
the	O
cell	O
suggest	O
that	O
gene1s	ARG2
caltractin	ARG2
gene1e	ARG2
plays	O
a	O
fundamental	O
role	O
in	O
microtubule	O
-	O
organizing	O
center	O
structure	O
and	O
function	O
.	O

Molecular	O
cloning	O
and	O
centrosomal	O
localization	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
caltractin	O
gene1e	O
.	O
gene1s	O
Caltractin	O
gene1e	O
,	O
a	O
20-kDa	O
calcium	O
-	O
binding	O
protein	O
,	O
was	O
previously	O
purified	O
and	O
cloned	O
at	O
the	O
DNA	O
level	O
from	O
the	O
unicellular	O
green	O
alga	O
Chlamydomonas	O
.	O
It	O
is	O
a	O
structural	O
component	O
of	O
the	O
basal	O
body	O
complex	O
,	O
the	O
major	O
microtubule	O
-	O
organizing	O
center	O
in	O
Chlamydomonas	O
and	O
the	O
functional	O
homolog	O
of	O
the	O
centrosome	O
in	O
the	O
animal	O
cell	O
.	O
Here	O
we	O
report	O
the	O
characterization	O
of	O
a	O
cDNA	O
encoding	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
caltractin	O
gene1e	O
that	O
shares	O
a	O
high	O
degree	O
of	O
amino	O
acid	O
identity	O
(	O
70	O
%	O
)	O
with	O
its	O
algal	O
counterpart	O
.	O
gene1s	O
Caltractin	O
gene1e	O
was	O
identified	O
in	O
both	O
species1s	O
HeLa	O
species1e	O
and	O
arg1s	O
BHK	O
arg1e	O
cells	O
as	O
a	O
21-kDa	O
polypeptide	O
specifically	O
localized	O
to	O
the	O
centrosome	O
of	O
interphase	O
and	O
mitotic	O
cells	O
.	O
The	O
high	O
level	O
of	O
conservation	O
in	O
the	O
amino	O
acid	O
sequence	O
of	O
gene1s	O
caltractin	O
gene1e	O
from	O
species1s	O
algae	O
species1e	O
to	O
species1s	O
humans	O
species1e	O
and	O
its	O
association	O
with	O
the	O
major	O
microtubule	O
-	O
organizing	O
center	O
in	O
the	O
cell	O
suggest	O
that	O
gene1s	O
caltractin	O
gene1e	O
plays	O
a	O
fundamental	O
role	O
in	O
microtubule	O
-	O
organizing	O
center	O
structure	O
and	O
function	O
.	O

Molecular	O
cloning	O
and	O
centrosomal	O
localization	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
caltractin	O
gene1e	O
.	O
gene1s	O
Caltractin	O
gene1e	O
,	O
a	O
20-kDa	O
calcium	O
-	O
binding	O
protein	O
,	O
was	O
previously	O
purified	O
and	O
cloned	O
at	O
the	O
DNA	O
level	O
from	O
the	O
unicellular	O
green	O
alga	O
Chlamydomonas	O
.	O
It	O
is	O
a	O
structural	O
component	O
of	O
the	O
basal	O
body	O
complex	O
,	O
the	O
major	O
microtubule	O
-	O
organizing	O
center	O
in	O
Chlamydomonas	O
and	O
the	O
functional	O
homolog	O
of	O
the	O
centrosome	O
in	O
the	O
animal	O
cell	O
.	O
Here	O
we	O
report	O
the	O
characterization	O
of	O
a	O
cDNA	O
encoding	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
caltractin	O
gene1e	O
that	O
shares	O
a	O
high	O
degree	O
of	O
amino	O
acid	O
identity	O
(	O
70	O
%	O
)	O
with	O
its	O
algal	O
counterpart	O
.	O
gene1s	O
Caltractin	O
gene1e	O
was	O
identified	O
in	O
both	O
species1s	O
HeLa	O
species1e	O
and	O
species1s	O
BHK	O
species1e	O
cells	O
as	O
a	O
21-kDa	O
polypeptide	O
specifically	O
localized	O
to	O
the	O
centrosome	O
of	O
interphase	O
and	O
mitotic	O
cells	O
.	O
The	O
high	O
level	O
of	O
conservation	O
in	O
the	O
amino	O
acid	O
sequence	O
of	O
gene1s	O
caltractin	O
gene1e	O
from	O
arg1s	O
algae	O
arg1e	O
to	O
species1s	O
humans	O
species1e	O
and	O
its	O
association	O
with	O
the	O
major	O
microtubule	O
-	O
organizing	O
center	O
in	O
the	O
cell	O
suggest	O
that	O
gene1s	O
caltractin	O
gene1e	O
plays	O
a	O
fundamental	O
role	O
in	O
microtubule	O
-	O
organizing	O
center	O
structure	O
and	O
function	O
.	O

Cloning	O
of	O
gene1s	O
Nrf1	O
gene1e	O
,	O
an	O
NF	O
-	O
E2-related	O
transcription	O
factor	O
,	O
by	O
genetic	O
selection	O
in	O
arg1s	O
yeast	O
arg1e	O
.	O
We	O
have	O
devised	O
a	O
complementation	O
assay	O
in	O
arg1s	O
yeast	O
arg1e	O
to	O
clone	O
species1s	O
mammalian	O
species1e	O
transcriptional	O
activators	O
and	O
have	O
used	O
it	O
to	O
identify	O
a	O
species1s	O
human	O
species1e	O
basic	O
leucine	O
-	O
zipper	O
transcription	O
factor	O
that	O
we	O
have	O
designated	O
gene1s	O
Nrf1	O
gene1e	O
for	O
gene1s	O
NF	O
-	O
E2-related	O
factor	O
1	O
gene1e	O
.	O
gene1s	O
Nrf1	O
gene1e	O
potentially	O
encodes	O
a	O
742-aa	O
protein	O
and	O
displays	O
marked	O
homology	O
to	O
the	O
species1s	O
mouse	O
species1e	O
and	O
species1s	O
human	O
species1e	O
NF	O
-	O
E2	O
transcription	O
factors	O
.	O
gene1s	O
Nrf1	O
gene1e	O
activates	O
transcription	O
via	O
NF	O
-	O
E2	O
binding	O
sites	O
in	O
arg1s	O
yeast	O
arg1e	O
cells	O
.	O
The	O
ubiquitous	O
expression	O
pattern	O
of	O
gene1s	O
Nrf1	O
gene1e	O
and	O
the	O
range	O
of	O
promoters	O
containing	O
the	O
NF	O
-	O
E2	O
binding	O
motif	O
suggest	O
that	O
this	O
gene	O
may	O
play	O
a	O
role	O
in	O
the	O
regulation	O
of	O
heme	O
synthesis	O
and	O
ferritin	O
genes	O
.	O

Cloning	O
of	O
gene1s	ARG2
Nrf1	ARG2
gene1e	ARG2
,	O
an	O
NF	O
-	O
E2-related	O
transcription	O
factor	O
,	O
by	O
genetic	O
selection	O
in	O
species1s	O
yeast	O
species1e	O
.	O
We	O
have	O
devised	O
a	O
complementation	O
assay	O
in	O
species1s	O
yeast	O
species1e	O
to	O
clone	O
arg1s	O
mammalian	O
arg1e	O
transcriptional	O
activators	O
and	O
have	O
used	O
it	O
to	O
identify	O
a	O
arg1s	O
human	O
arg1e	O
basic	O
leucine	O
-	O
zipper	O
transcription	O
factor	O
that	O
we	O
have	O
designated	O
gene1s	ARG2
Nrf1	ARG2
gene1e	ARG2
for	O
gene1s	ARG2
NF	ARG2
-	ARG2
E2-related	ARG2
factor	ARG2
1	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
Nrf1	ARG2
gene1e	ARG2
potentially	O
encodes	O
a	O
742-aa	O
protein	O
and	O
displays	O
marked	O
homology	O
to	O
the	O
species1s	O
mouse	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
NF	O
-	O
E2	O
transcription	O
factors	O
.	O
gene1s	ARG2
Nrf1	ARG2
gene1e	ARG2
activates	O
transcription	O
via	O
NF	O
-	O
E2	O
binding	O
sites	O
in	O
species1s	O
yeast	O
species1e	O
cells	O
.	O
The	O
ubiquitous	O
expression	O
pattern	O
of	O
gene1s	ARG2
Nrf1	ARG2
gene1e	ARG2
and	O
the	O
range	O
of	O
promoters	O
containing	O
the	O
NF	O
-	O
E2	O
binding	O
motif	O
suggest	O
that	O
this	O
gene	O
may	O
play	O
a	O
role	O
in	O
the	O
regulation	O
of	O
heme	O
synthesis	O
and	O
ferritin	O
genes	O
.	O

Cloning	O
of	O
gene1s	O
Nrf1	O
gene1e	O
,	O
an	O
NF	O
-	O
E2-related	O
transcription	O
factor	O
,	O
by	O
genetic	O
selection	O
in	O
species1s	O
yeast	O
species1e	O
.	O
We	O
have	O
devised	O
a	O
complementation	O
assay	O
in	O
species1s	O
yeast	O
species1e	O
to	O
clone	O
species1s	O
mammalian	O
species1e	O
transcriptional	O
activators	O
and	O
have	O
used	O
it	O
to	O
identify	O
a	O
species1s	O
human	O
species1e	O
basic	O
leucine	O
-	O
zipper	O
transcription	O
factor	O
that	O
we	O
have	O
designated	O
gene1s	O
Nrf1	O
gene1e	O
for	O
gene1s	O
NF	O
-	O
E2-related	O
factor	O
1	O
gene1e	O
.	O
gene1s	O
Nrf1	O
gene1e	O
potentially	O
encodes	O
a	O
742-aa	O
protein	O
and	O
displays	O
marked	O
homology	O
to	O
the	O
arg1s	O
mouse	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
NF	O
-	O
E2	O
transcription	O
factors	O
.	O
gene1s	O
Nrf1	O
gene1e	O
activates	O
transcription	O
via	O
NF	O
-	O
E2	O
binding	O
sites	O
in	O
species1s	O
yeast	O
species1e	O
cells	O
.	O
The	O
ubiquitous	O
expression	O
pattern	O
of	O
gene1s	O
Nrf1	O
gene1e	O
and	O
the	O
range	O
of	O
promoters	O
containing	O
the	O
NF	O
-	O
E2	O
binding	O
motif	O
suggest	O
that	O
this	O
gene	O
may	O
play	O
a	O
role	O
in	O
the	O
regulation	O
of	O
heme	O
synthesis	O
and	O
ferritin	O
genes	O
.	O

Cloning	O
,	O
sequencing	O
and	O
expression	O
of	O
a	O
cDNA	O
encoding	O
arg1s	O
mammalian	O
arg1e	O
gene1s	ARG2
valyl	ARG2
-	ARG2
tRNA	ARG2
synthetase	ARG2
gene1e	ARG2
.	O
A	O
fragment	O
of	O
the	O
cDNA	O
encoding	O
a	O
species1s	O
rat	O
species1e	O
gene1s	O
valyl	O
-	O
tRNA	O
synthetase	O
gene1e	O
(	O
gene1s	O
TrsVal	O
gene1e	O
)-like	O
protein	O
was	O
cloned	O
from	O
a	O
species1s	O
rat	O
species1e	O
cDNA	O
library	O
in	O
lambda	O
gt11	O
using	O
an	O
oligodeoxyribonucleotide	O
(	O
oligo	O
)	O
probe	O
.	O
Three	O
independent	O
plaque	O
clones	O
containing	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
TrsVal	ARG2
gene1e	ARG2
cDNA	O
were	O
then	O
isolated	O
from	O
a	O
lambda	O
gt10	O
arg1s	O
human	O
arg1e	O
erythroleukemia	O
cDNA	O
library	O
using	O
the	O
species1s	O
rat	O
species1e	O
cDNA	O
fragment	O
as	O
the	O
hybridization	O
probe	O
.	O
Sequence	O
analyses	O
of	O
the	O
cDNA	O
fragments	O
provided	O
a	O
3.2-kb	O
sequence	O
with	O
an	O
open	O
reading	O
frame	O
that	O
contained	O
the	O
'	O
HIGH	O
'	O
synthetase	O
signature	O
sequence	O
and	O
the	O
tRNA	O
3'-end	O
-	O
binding	O
motif	O
,	O
KMSKS	O
,	O
and	O
putative	O
Val	O
-	O
binding	O
motif	O
,	O
EWCISRQ	O
.	O
The	O
sequence	O
was	O
extended	O
to	O
the	O
3	O
'	O
end	O
of	O
the	O
cDNA	O
by	O
the	O
polymerase	O
chain	O
reaction	O
using	O
an	O
internal	O
primer	O
and	O
an	O
oligo(dT	O
)	O
adapter	O
.	O
The	O
deduced	O
1051-amino	O
-	O
acid	O
sequence	O
shares	O
65	O
%	O
identity	O
with	O
species1s	O
yeast	O
species1e	O
gene1s	O
TrsVal	O
gene1e	O
,	O
and	O
contains	O
a	O
highly	O
basic	O
N	O
-	O
terminal	O
region	O
,	O
a	O
newly	O
evolved	O
protease	O
-	O
sensitive	O
region	O
in	O
sequence	O
close	O
to	O
the	O
C	O
terminus	O
,	O
and	O
several	O
sites	O
for	O
protein	O
kinase	O
C	O
phosphorylation	O
.	O
A	O
3-kb	O
cDNA	O
fragment	O
was	O
sub	O
-	O
cloned	O
into	O
plasmid	O
pSVL	O
and	O
expressed	O
in	O
species1s	O
COS-7	O
species1e	O
cells	O
;	O
up	O
to	O
a	O
sevenfold	O
increase	O
in	O
gene1s	ARG2
TrsVal	ARG2
gene1e	ARG2
activity	O
was	O
obtained	O
.	O
These	O
results	O
confirm	O
the	O
cloning	O
and	O
sequencing	O
of	O
a	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
TrsVal	ARG2
gene1e	ARG2
-	O
encoding	O
cDNA	O
.	O

Cloning	O
,	O
sequencing	O
and	O
expression	O
of	O
a	O
cDNA	O
encoding	O
species1s	O
mammalian	O
species1e	O
gene1s	O
valyl	O
-	O
tRNA	O
synthetase	O
gene1e	O
.	O
A	O
fragment	O
of	O
the	O
cDNA	O
encoding	O
a	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
valyl	ARG2
-	ARG2
tRNA	ARG2
synthetase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TrsVal	ARG2
gene1e	ARG2
)-like	O
protein	O
was	O
cloned	O
from	O
a	O
arg1s	O
rat	O
arg1e	O
cDNA	O
library	O
in	O
lambda	O
gt11	O
using	O
an	O
oligodeoxyribonucleotide	O
(	O
oligo	O
)	O
probe	O
.	O
Three	O
independent	O
plaque	O
clones	O
containing	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
TrsVal	O
gene1e	O
cDNA	O
were	O
then	O
isolated	O
from	O
a	O
lambda	O
gt10	O
species1s	O
human	O
species1e	O
erythroleukemia	O
cDNA	O
library	O
using	O
the	O
arg1s	O
rat	O
arg1e	O
cDNA	O
fragment	O
as	O
the	O
hybridization	O
probe	O
.	O
Sequence	O
analyses	O
of	O
the	O
cDNA	O
fragments	O
provided	O
a	O
3.2-kb	O
sequence	O
with	O
an	O
open	O
reading	O
frame	O
that	O
contained	O
the	O
'	O
HIGH	O
'	O
synthetase	O
signature	O
sequence	O
and	O
the	O
tRNA	O
3'-end	O
-	O
binding	O
motif	O
,	O
KMSKS	O
,	O
and	O
putative	O
Val	O
-	O
binding	O
motif	O
,	O
EWCISRQ	O
.	O
The	O
sequence	O
was	O
extended	O
to	O
the	O
3	O
'	O
end	O
of	O
the	O
cDNA	O
by	O
the	O
polymerase	O
chain	O
reaction	O
using	O
an	O
internal	O
primer	O
and	O
an	O
oligo(dT	O
)	O
adapter	O
.	O
The	O
deduced	O
1051-amino	O
-	O
acid	O
sequence	O
shares	O
65	O
%	O
identity	O
with	O
species1s	O
yeast	O
species1e	O
gene1s	O
TrsVal	O
gene1e	O
,	O
and	O
contains	O
a	O
highly	O
basic	O
N	O
-	O
terminal	O
region	O
,	O
a	O
newly	O
evolved	O
protease	O
-	O
sensitive	O
region	O
in	O
sequence	O
close	O
to	O
the	O
C	O
terminus	O
,	O
and	O
several	O
sites	O
for	O
protein	O
kinase	O
C	O
phosphorylation	O
.	O
A	O
3-kb	O
cDNA	O
fragment	O
was	O
sub	O
-	O
cloned	O
into	O
plasmid	O
pSVL	O
and	O
expressed	O
in	O
species1s	O
COS-7	O
species1e	O
cells	O
;	O
up	O
to	O
a	O
sevenfold	O
increase	O
in	O
gene1s	O
TrsVal	O
gene1e	O
activity	O
was	O
obtained	O
.	O
These	O
results	O
confirm	O
the	O
cloning	O
and	O
sequencing	O
of	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
TrsVal	O
gene1e	O
-	O
encoding	O
cDNA	O
.	O

Cloning	O
,	O
sequencing	O
and	O
expression	O
of	O
a	O
cDNA	O
encoding	O
species1s	O
mammalian	O
species1e	O
gene1s	O
valyl	O
-	O
tRNA	O
synthetase	O
gene1e	O
.	O
A	O
fragment	O
of	O
the	O
cDNA	O
encoding	O
a	O
species1s	O
rat	O
species1e	O
gene1s	O
valyl	O
-	O
tRNA	O
synthetase	O
gene1e	O
(	O
gene1s	O
TrsVal	O
gene1e	O
)-like	O
protein	O
was	O
cloned	O
from	O
a	O
species1s	O
rat	O
species1e	O
cDNA	O
library	O
in	O
lambda	O
gt11	O
using	O
an	O
oligodeoxyribonucleotide	O
(	O
oligo	O
)	O
probe	O
.	O
Three	O
independent	O
plaque	O
clones	O
containing	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
TrsVal	O
gene1e	O
cDNA	O
were	O
then	O
isolated	O
from	O
a	O
lambda	O
gt10	O
species1s	O
human	O
species1e	O
erythroleukemia	O
cDNA	O
library	O
using	O
the	O
species1s	O
rat	O
species1e	O
cDNA	O
fragment	O
as	O
the	O
hybridization	O
probe	O
.	O
Sequence	O
analyses	O
of	O
the	O
cDNA	O
fragments	O
provided	O
a	O
3.2-kb	O
sequence	O
with	O
an	O
open	O
reading	O
frame	O
that	O
contained	O
the	O
'	O
HIGH	O
'	O
synthetase	O
signature	O
sequence	O
and	O
the	O
tRNA	O
3'-end	O
-	O
binding	O
motif	O
,	O
KMSKS	O
,	O
and	O
putative	O
Val	O
-	O
binding	O
motif	O
,	O
EWCISRQ	O
.	O
The	O
sequence	O
was	O
extended	O
to	O
the	O
3	O
'	O
end	O
of	O
the	O
cDNA	O
by	O
the	O
polymerase	O
chain	O
reaction	O
using	O
an	O
internal	O
primer	O
and	O
an	O
oligo(dT	O
)	O
adapter	O
.	O
The	O
deduced	O
1051-amino	O
-	O
acid	O
sequence	O
shares	O
65	O
%	O
identity	O
with	O
arg1s	O
yeast	O
arg1e	O
gene1s	ARG2
TrsVal	ARG2
gene1e	ARG2
,	O
and	O
contains	O
a	O
highly	O
basic	O
N	O
-	O
terminal	O
region	O
,	O
a	O
newly	O
evolved	O
protease	O
-	O
sensitive	O
region	O
in	O
sequence	O
close	O
to	O
the	O
C	O
terminus	O
,	O
and	O
several	O
sites	O
for	O
protein	O
kinase	O
C	O
phosphorylation	O
.	O
A	O
3-kb	O
cDNA	O
fragment	O
was	O
sub	O
-	O
cloned	O
into	O
plasmid	O
pSVL	O
and	O
expressed	O
in	O
species1s	O
COS-7	O
species1e	O
cells	O
;	O
up	O
to	O
a	O
sevenfold	O
increase	O
in	O
gene1s	O
TrsVal	O
gene1e	O
activity	O
was	O
obtained	O
.	O
These	O
results	O
confirm	O
the	O
cloning	O
and	O
sequencing	O
of	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
TrsVal	O
gene1e	O
-	O
encoding	O
cDNA	O
.	O

Cloning	O
,	O
sequencing	O
and	O
expression	O
of	O
a	O
cDNA	O
encoding	O
species1s	O
mammalian	O
species1e	O
gene1s	O
valyl	O
-	O
tRNA	O
synthetase	O
gene1e	O
.	O
A	O
fragment	O
of	O
the	O
cDNA	O
encoding	O
a	O
species1s	O
rat	O
species1e	O
gene1s	O
valyl	O
-	O
tRNA	O
synthetase	O
gene1e	O
(	O
gene1s	O
TrsVal	O
gene1e	O
)-like	O
protein	O
was	O
cloned	O
from	O
a	O
species1s	O
rat	O
species1e	O
cDNA	O
library	O
in	O
lambda	O
gt11	O
using	O
an	O
oligodeoxyribonucleotide	O
(	O
oligo	O
)	O
probe	O
.	O
Three	O
independent	O
plaque	O
clones	O
containing	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
TrsVal	O
gene1e	O
cDNA	O
were	O
then	O
isolated	O
from	O
a	O
lambda	O
gt10	O
species1s	O
human	O
species1e	O
erythroleukemia	O
cDNA	O
library	O
using	O
the	O
species1s	O
rat	O
species1e	O
cDNA	O
fragment	O
as	O
the	O
hybridization	O
probe	O
.	O
Sequence	O
analyses	O
of	O
the	O
cDNA	O
fragments	O
provided	O
a	O
3.2-kb	O
sequence	O
with	O
an	O
open	O
reading	O
frame	O
that	O
contained	O
the	O
'	O
HIGH	O
'	O
synthetase	O
signature	O
sequence	O
and	O
the	O
tRNA	O
3'-end	O
-	O
binding	O
motif	O
,	O
KMSKS	O
,	O
and	O
putative	O
Val	O
-	O
binding	O
motif	O
,	O
EWCISRQ	O
.	O
The	O
sequence	O
was	O
extended	O
to	O
the	O
3	O
'	O
end	O
of	O
the	O
cDNA	O
by	O
the	O
polymerase	O
chain	O
reaction	O
using	O
an	O
internal	O
primer	O
and	O
an	O
oligo(dT	O
)	O
adapter	O
.	O
The	O
deduced	O
1051-amino	O
-	O
acid	O
sequence	O
shares	O
65	O
%	O
identity	O
with	O
species1s	O
yeast	O
species1e	O
gene1s	O
TrsVal	O
gene1e	O
,	O
and	O
contains	O
a	O
highly	O
basic	O
N	O
-	O
terminal	O
region	O
,	O
a	O
newly	O
evolved	O
protease	O
-	O
sensitive	O
region	O
in	O
sequence	O
close	O
to	O
the	O
C	O
terminus	O
,	O
and	O
several	O
sites	O
for	O
protein	O
kinase	O
C	O
phosphorylation	O
.	O
A	O
3-kb	O
cDNA	O
fragment	O
was	O
sub	O
-	O
cloned	O
into	O
plasmid	O
pSVL	O
and	O
expressed	O
in	O
arg1s	O
COS-7	O
arg1e	O
cells	O
;	O
up	O
to	O
a	O
sevenfold	O
increase	O
in	O
gene1s	O
TrsVal	O
gene1e	O
activity	O
was	O
obtained	O
.	O
These	O
results	O
confirm	O
the	O
cloning	O
and	O
sequencing	O
of	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
TrsVal	O
gene1e	O
-	O
encoding	O
cDNA	O
.	O

Localization	O
of	O
the	O
intronless	O
gene	O
coding	O
for	O
gene1s	ARG2
calmodulin	ARG2
-	ARG2
like	ARG2
protein	ARG2
CLP	ARG2
gene1e	ARG2
to	O
arg1s	O
human	O
arg1e	O
chromosome	O
10p13-ter	O
.	O
The	O
functional	O
intronless	O
gene	O
coding	O
for	O
a	O
gene1s	ARG2
calmodulin	ARG2
-	ARG2
like	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CLP	ARG2
gene1e	ARG2
)	O
has	O
been	O
localized	O
to	O
arg1s	O
human	O
arg1e	O
chromosome	O
10p13-ter	O
.	O
Chromosomal	O
assignment	O
was	O
performed	O
by	O
Southern	O
blot	O
analysis	O
of	O
DNA	O
from	O
arg1s	O
human	O
arg1e	O
-	O
rodent	O
somatic	O
cell	O
hybrids	O
and	O
amplification	O
of	O
a	O
gene1s	ARG2
CLP	ARG2
gene1e	ARG2
gene	O
-	O
specific	O
1090-bp	O
DNA	O
fragment	O
by	O
the	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
on	O
DNA	O
from	O
arg1s	O
human	O
arg1e	O
-	O
species1s	O
hamster	O
species1e	O
cell	O
hybrids	O
.	O
Chromosomal	O
sublocalization	O
was	O
carried	O
out	O
by	O
in	O
situ	O
hybridization	O
of	O
arg1s	O
human	O
arg1e	O
chromosome	O
metaphase	O
spreads	O
.	O
The	O
gene1s	ARG2
CLP	ARG2
gene1e	ARG2
gene	O
is	O
the	O
first	O
member	O
of	O
the	O
arg1s	O
human	O
arg1e	O
calmodulin	O
/	O
calmodulin	O
-	O
like	O
gene	O
family	O
to	O
be	O
chromosomally	O
sublocalized	O
.	O
Its	O
presence	O
near	O
the	O
telomeric	O
end	O
of	O
the	O
short	O
arm	O
of	O
chromosome	O
10	O
may	O
be	O
of	O
significance	O
with	O
respect	O
to	O
its	O
highly	O
(	O
epithelial	O
)	O
cell	O
-	O
type	O
restricted	O
expression	O
in	O
vivo	O
and	O
strong	O
downregulation	O
upon	O
malignant	O
transformation	O
.	O
The	O
generation	O
of	O
a	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
CLP	ARG2
gene1e	ARG2
gene	O
-	O
specific	O
sequence	O
tag	O
site	O
specified	O
by	O
the	O
two	O
primers	O
used	O
for	O
PCR	O
should	O
prove	O
useful	O
for	O
future	O
linkage	O
studies	O
.	O

Localization	O
of	O
the	O
intronless	O
gene	O
coding	O
for	O
gene1s	O
calmodulin	O
-	O
like	O
protein	O
CLP	O
gene1e	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
10p13-ter	O
.	O
The	O
functional	O
intronless	O
gene	O
coding	O
for	O
a	O
gene1s	O
calmodulin	O
-	O
like	O
protein	O
gene1e	O
(	O
gene1s	O
CLP	O
gene1e	O
)	O
has	O
been	O
localized	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
10p13-ter	O
.	O
Chromosomal	O
assignment	O
was	O
performed	O
by	O
Southern	O
blot	O
analysis	O
of	O
DNA	O
from	O
species1s	O
human	O
species1e	O
-	O
rodent	O
somatic	O
cell	O
hybrids	O
and	O
amplification	O
of	O
a	O
gene1s	O
CLP	O
gene1e	O
gene	O
-	O
specific	O
1090-bp	O
DNA	O
fragment	O
by	O
the	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
on	O
DNA	O
from	O
species1s	O
human	O
species1e	O
-	O
arg1s	O
hamster	O
arg1e	O
cell	O
hybrids	O
.	O
Chromosomal	O
sublocalization	O
was	O
carried	O
out	O
by	O
in	O
situ	O
hybridization	O
of	O
species1s	O
human	O
species1e	O
chromosome	O
metaphase	O
spreads	O
.	O
The	O
gene1s	O
CLP	O
gene1e	O
gene	O
is	O
the	O
first	O
member	O
of	O
the	O
species1s	O
human	O
species1e	O
calmodulin	O
/	O
calmodulin	O
-	O
like	O
gene	O
family	O
to	O
be	O
chromosomally	O
sublocalized	O
.	O
Its	O
presence	O
near	O
the	O
telomeric	O
end	O
of	O
the	O
short	O
arm	O
of	O
chromosome	O
10	O
may	O
be	O
of	O
significance	O
with	O
respect	O
to	O
its	O
highly	O
(	O
epithelial	O
)	O
cell	O
-	O
type	O
restricted	O
expression	O
in	O
vivo	O
and	O
strong	O
downregulation	O
upon	O
malignant	O
transformation	O
.	O
The	O
generation	O
of	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
CLP	O
gene1e	O
gene	O
-	O
specific	O
sequence	O
tag	O
site	O
specified	O
by	O
the	O
two	O
primers	O
used	O
for	O
PCR	O
should	O
prove	O
useful	O
for	O
future	O
linkage	O
studies	O
.	O

A	O
novel	O
form	O
of	O
gene1s	ARG2
cytochrome	ARG2
P-450	ARG2
family	ARG2
4	ARG2
gene1e	ARG2
in	O
arg1s	O
human	O
arg1e	O
polymorphonuclear	O
leukocytes	O
.	O
cDNA	O
cloning	O
and	O
expression	O
of	O
gene1s	ARG2
leukotriene	ARG2
B4	ARG2
omega	ARG2
-	ARG2
hydroxylase	ARG2
gene1e	ARG2
.	O
Isolation	O
of	O
cDNA	O
clones	O
for	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
leukotriene	ARG2
B4	ARG2
(	ARG2
LTB4	ARG2
)	ARG2
omega	ARG2
-	ARG2
hydroxylase	ARG2
gene1e	ARG2
clearly	O
demonstrates	O
that	O
the	O
hydroxylase	O
is	O
a	O
member	O
of	O
the	O
cytochrome	O
P-450	O
(	O
CYP	O
)	O
superfamily	O
.	O
cDNA	O
clones	O
isolated	O
from	O
a	O
arg1s	O
human	O
arg1e	O
leukocyte	O
cDNA	O
library	O
with	O
CYP4A4	O
cDNA	O
as	O
a	O
probe	O
encode	O
a	O
protein	O
of	O
520	O
amino	O
acids	O
with	O
a	O
molecular	O
weight	O
of	O
59,805	O
.	O
The	O
deduced	O
amino	O
acid	O
sequence	O
contains	O
an	O
invariant	O
cysteine	O
in	O
the	O
conserved	O
heme	O
-	O
binding	O
domain	O
near	O
the	O
C	O
terminus	O
,	O
characteristic	O
of	O
the	O
P-450	O
superfamily	O
.	O
The	O
microsomes	O
from	O
species1s	O
yeast	O
species1e	O
cells	O
transfected	O
with	O
an	O
expression	O
vector	O
pAAH5	O
carrying	O
isolated	O
cDNA	O
catalyzed	O
the	O
omega	O
-	O
hydroxylation	O
of	O
LTB4	O
with	O
a	O
Km	O
value	O
of	O
0.71	O
microM	O
,	O
and	O
its	O
activity	O
was	O
significantly	O
inhibited	O
by	O
carbon	O
monoxide	O
and	O
by	O
antisera	O
against	O
CYP4A4	O
,	O
consistent	O
with	O
the	O
properties	O
previously	O
reported	O
with	O
gene1s	ARG2
LTB4	ARG2
omega	ARG2
-	ARG2
hydroxylase	ARG2
gene1e	ARG2
in	O
arg1s	O
human	O
arg1e	O
polymorphonuclear	O
leukocytes	O
.	O
The	O
amino	O
acid	O
sequence	O
of	O
gene1s	ARG2
LTB4	ARG2
omega	ARG2
-	ARG2
hydroxylase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
P-450LTB	ARG2
omega	ARG2
gene1e	ARG2
)	O
shows	O
31	O
-	O
44	O
%	O
similarity	O
to	O
those	O
of	O
CYP4A	O
,	O
CYP4B	O
,	O
and	O
CYP4C	O
,	O
whereas	O
less	O
than	O
25	O
%	O
similarity	O
was	O
observed	O
with	O
any	O
of	O
the	O
other	O
P-450	O
families	O
.	O
According	O
to	O
the	O
systematic	O
classification	O
of	O
the	O
P-450	O
superfamily	O
,	O
gene1s	ARG2
P-450LTB	ARG2
omega	ARG2
gene1e	ARG2
is	O
classified	O
into	O
the	O
CYP4	O
family	O
but	O
does	O
not	O
belong	O
to	O
any	O
of	O
the	O
known	O
CYP4	O
subfamilies	O
.	O
This	O
P-450	O
composes	O
a	O
new	O
subfamily	O
of	O
CYP4	O
.	O
RNA	O
blot	O
analysis	O
indicated	O
that	O
mRNA	O
hybridized	O
to	O
the	O
cDNA	O
was	O
expressed	O
in	O
the	O
polymorphonuclear	O
leukocytes	O
as	O
well	O
as	O
leukocytes	O
from	O
four	O
individuals	O
.	O
Isolation	O
of	O
the	O
cDNA	O
opens	O
the	O
way	O
to	O
investigate	O
the	O
physiological	O
role	O
and	O
to	O
regulation	O
of	O
the	O
omega	O
-	O
hydroxylase	O
in	O
the	O
inflammation	O
process	O
.	O

A	O
novel	O
form	O
of	O
gene1s	O
cytochrome	O
P-450	O
family	O
4	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
polymorphonuclear	O
leukocytes	O
.	O
cDNA	O
cloning	O
and	O
expression	O
of	O
gene1s	O
leukotriene	O
B4	O
omega	O
-	O
hydroxylase	O
gene1e	O
.	O
Isolation	O
of	O
cDNA	O
clones	O
for	O
species1s	O
human	O
species1e	O
gene1s	O
leukotriene	O
B4	O
(	O
LTB4	O
)	O
omega	O
-	O
hydroxylase	O
gene1e	O
clearly	O
demonstrates	O
that	O
the	O
hydroxylase	O
is	O
a	O
member	O
of	O
the	O
cytochrome	O
P-450	O
(	O
CYP	O
)	O
superfamily	O
.	O
cDNA	O
clones	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
leukocyte	O
cDNA	O
library	O
with	O
CYP4A4	O
cDNA	O
as	O
a	O
probe	O
encode	O
a	O
protein	O
of	O
520	O
amino	O
acids	O
with	O
a	O
molecular	O
weight	O
of	O
59,805	O
.	O
The	O
deduced	O
amino	O
acid	O
sequence	O
contains	O
an	O
invariant	O
cysteine	O
in	O
the	O
conserved	O
heme	O
-	O
binding	O
domain	O
near	O
the	O
C	O
terminus	O
,	O
characteristic	O
of	O
the	O
P-450	O
superfamily	O
.	O
The	O
microsomes	O
from	O
arg1s	O
yeast	O
arg1e	O
cells	O
transfected	O
with	O
an	O
expression	O
vector	O
pAAH5	O
carrying	O
isolated	O
cDNA	O
catalyzed	O
the	O
omega	O
-	O
hydroxylation	O
of	O
LTB4	O
with	O
a	O
Km	O
value	O
of	O
0.71	O
microM	O
,	O
and	O
its	O
activity	O
was	O
significantly	O
inhibited	O
by	O
carbon	O
monoxide	O
and	O
by	O
antisera	O
against	O
CYP4A4	O
,	O
consistent	O
with	O
the	O
properties	O
previously	O
reported	O
with	O
gene1s	O
LTB4	O
omega	O
-	O
hydroxylase	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
polymorphonuclear	O
leukocytes	O
.	O
The	O
amino	O
acid	O
sequence	O
of	O
gene1s	O
LTB4	O
omega	O
-	O
hydroxylase	O
gene1e	O
(	O
gene1s	O
P-450LTB	O
omega	O
gene1e	O
)	O
shows	O
31	O
-	O
44	O
%	O
similarity	O
to	O
those	O
of	O
CYP4A	O
,	O
CYP4B	O
,	O
and	O
CYP4C	O
,	O
whereas	O
less	O
than	O
25	O
%	O
similarity	O
was	O
observed	O
with	O
any	O
of	O
the	O
other	O
P-450	O
families	O
.	O
According	O
to	O
the	O
systematic	O
classification	O
of	O
the	O
P-450	O
superfamily	O
,	O
gene1s	O
P-450LTB	O
omega	O
gene1e	O
is	O
classified	O
into	O
the	O
CYP4	O
family	O
but	O
does	O
not	O
belong	O
to	O
any	O
of	O
the	O
known	O
CYP4	O
subfamilies	O
.	O
This	O
P-450	O
composes	O
a	O
new	O
subfamily	O
of	O
CYP4	O
.	O
RNA	O
blot	O
analysis	O
indicated	O
that	O
mRNA	O
hybridized	O
to	O
the	O
cDNA	O
was	O
expressed	O
in	O
the	O
polymorphonuclear	O
leukocytes	O
as	O
well	O
as	O
leukocytes	O
from	O
four	O
individuals	O
.	O
Isolation	O
of	O
the	O
cDNA	O
opens	O
the	O
way	O
to	O
investigate	O
the	O
physiological	O
role	O
and	O
to	O
regulation	O
of	O
the	O
omega	O
-	O
hydroxylase	O
in	O
the	O
inflammation	O
process	O
.	O

Molecular	O
cloning	O
of	O
the	O
cDNA	O
for	O
the	O
gene1s	ARG2
catalytic	ARG2
subunit	ARG2
of	ARG2
human	ARG2
DNA	ARG2
polymerase	ARG2
epsilon	ARG2
gene1e	ARG2
.	O
The	O
cDNA	O
encoding	O
the	O
gene1s	ARG2
catalytic	ARG2
polypeptide	ARG2
of	ARG2
human	ARG2
DNA	ARG2
polymerase	ARG2
epsilon	ARG2
gene1e	ARG2
was	O
cloned	O
.	O
The	O
deduced	O
amino	O
acid	O
sequence	O
reveals	O
that	O
the	O
catalytic	O
polypeptide	O
is	O
2257	O
amino	O
acids	O
in	O
length	O
and	O
its	O
calculated	O
molecular	O
mass	O
is	O
258	O
kDa	O
.	O
A	O
single	O
RNA	O
message	O
of	O
7.5	O
kilobases	O
was	O
recognized	O
by	O
isolated	O
cDNA	O
clones	O
.	O
The	O
identity	O
of	O
the	O
cDNA	O
was	O
verified	O
by	O
direct	O
amino	O
acid	O
sequencing	O
of	O
tryptic	O
fragments	O
derived	O
from	O
the	O
catalytic	O
polypeptide	O
of	O
the	O
HeLa	O
DNA	O
polymerase	O
epsilon	O
.	O
The	O
primary	O
structure	O
comparison	O
with	O
multiple	O
DNA	O
polymerases	O
indicates	O
that	O
arg1s	O
human	O
arg1e	O
DNA	O
polymerase	O
epsilon	O
catalytic	O
polypeptide	O
is	O
a	O
homolog	O
of	O
the	O
species1s	O
yeast	O
species1e	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
DNA	O
polymerase	O
II	O
catalytic	O
polypeptide	O
.	O
The	O
proteins	O
are	O
39	O
%	O
identical	O
.	O
In	O
the	O
region	O
containing	O
known	O
DNA	O
polymerase	O
consensus	O
motifs	O
,	O
the	O
identity	O
is	O
63	O
%	O
.	O
The	O
expression	O
of	O
the	O
mRNA	O
encoding	O
DNA	O
polymerase	O
epsilon	O
is	O
strongly	O
dependent	O
on	O
cell	O
proliferation	O
.	O

Molecular	O
cloning	O
of	O
the	O
cDNA	O
for	O
the	O
gene1s	O
catalytic	O
subunit	O
of	O
human	O
DNA	O
polymerase	O
epsilon	O
gene1e	O
.	O
The	O
cDNA	O
encoding	O
the	O
gene1s	O
catalytic	O
polypeptide	O
of	O
human	O
DNA	O
polymerase	O
epsilon	O
gene1e	O
was	O
cloned	O
.	O
The	O
deduced	O
amino	O
acid	O
sequence	O
reveals	O
that	O
the	O
catalytic	O
polypeptide	O
is	O
2257	O
amino	O
acids	O
in	O
length	O
and	O
its	O
calculated	O
molecular	O
mass	O
is	O
258	O
kDa	O
.	O
A	O
single	O
RNA	O
message	O
of	O
7.5	O
kilobases	O
was	O
recognized	O
by	O
isolated	O
cDNA	O
clones	O
.	O
The	O
identity	O
of	O
the	O
cDNA	O
was	O
verified	O
by	O
direct	O
amino	O
acid	O
sequencing	O
of	O
tryptic	O
fragments	O
derived	O
from	O
the	O
catalytic	O
polypeptide	O
of	O
the	O
HeLa	O
DNA	O
polymerase	O
epsilon	O
.	O
The	O
primary	O
structure	O
comparison	O
with	O
multiple	O
DNA	O
polymerases	O
indicates	O
that	O
species1s	O
human	O
species1e	O
DNA	O
polymerase	O
epsilon	O
catalytic	O
polypeptide	O
is	O
a	O
homolog	O
of	O
the	O
arg1s	O
yeast	O
arg1e	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
DNA	O
polymerase	O
II	O
catalytic	O
polypeptide	O
.	O
The	O
proteins	O
are	O
39	O
%	O
identical	O
.	O
In	O
the	O
region	O
containing	O
known	O
DNA	O
polymerase	O
consensus	O
motifs	O
,	O
the	O
identity	O
is	O
63	O
%	O
.	O
The	O
expression	O
of	O
the	O
mRNA	O
encoding	O
DNA	O
polymerase	O
epsilon	O
is	O
strongly	O
dependent	O
on	O
cell	O
proliferation	O
.	O

gene1s	ARG2
LAF-4	ARG2
gene1e	ARG2
encodes	O
a	O
lymphoid	O
nuclear	O
protein	O
with	O
transactivation	O
potential	O
that	O
is	O
homologous	O
to	O
gene1s	ARG2
AF-4	ARG2
gene1e	ARG2
,	O
the	O
gene	O
fused	O
to	O
gene1s	ARG2
MLL	ARG2
gene1e	ARG2
in	O
t(4;11	O
)	O
leukemias	O
.	O
A	O
novel	O
arg1s	O
human	O
arg1e	O
gene	O
,	O
gene1s	ARG2
LAF-4	ARG2
gene1e	ARG2
,	O
was	O
isolated	O
from	O
a	O
subtracted	O
cDNA	O
library	O
that	O
showed	O
strong	O
sequence	O
similarity	O
to	O
gene1s	ARG2
AF-4	ARG2
gene1e	ARG2
,	O
a	O
gene	O
that	O
is	O
translocated	O
in	O
t(4;11)(q21;q23	O
)	O
acute	O
lymphoblastic	O
leukemias	O
(	O
ALLs	O
)	O
.	O
In	O
t(4;11	O
)	O
ALL	O
,	O
the	O
gene1s	ARG2
AF-4	ARG2
gene1e	ARG2
gene	O
at	O
4q21	O
is	O
translocated	O
into	O
the	O
gene1s	ARG2
MLL	ARG2
gene1e	ARG2
locus	O
at	O
11q23	O
,	O
resulting	O
in	O
the	O
expression	O
of	O
an	O
gene1s	ARG2
MLL	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
AF-4	ARG2
gene1e	ARG2
fusion	O
protein	O
that	O
is	O
the	O
presumptive	O
oncoprotein	O
.	O
gene1s	ARG2
AF-4	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
LAF-4	ARG2
gene1e	ARG2
are	O
homologous	O
throughout	O
their	O
coding	O
regions	O
,	O
yet	O
neither	O
protein	O
is	O
related	O
to	O
previously	O
cloned	O
genes	O
.	O
arg1s	O
Human	O
arg1e	O
gene1s	ARG2
LAF-4	ARG2
gene1e	ARG2
readily	O
hybridized	O
with	O
genes	O
in	O
species1s	O
mouse	O
species1e	O
and	O
species1s	O
chicken	O
species1e	O
,	O
thus	O
showing	O
that	O
this	O
gene	O
family	O
has	O
been	O
highly	O
conserved	O
during	O
vertebrate	O
evolution	O
.	O
In	O
species1s	O
mouse	O
species1e	O
tissues	O
,	O
gene1s	ARG2
LAF-4	ARG2
gene1e	ARG2
mRNA	O
was	O
found	O
to	O
be	O
present	O
at	O
highest	O
levels	O
in	O
lymphoid	O
tissues	O
,	O
present	O
at	O
lower	O
levels	O
in	O
brain	O
and	O
lung	O
,	O
and	O
absent	O
from	O
other	O
tissues	O
.	O
In	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
mouse	O
species1e	O
lymphoid	O
cell	O
lines	O
,	O
gene1s	ARG2
LAF-4	ARG2
gene1e	ARG2
expression	O
was	O
highest	O
in	O
pre	O
-	O
B	O
cells	O
,	O
intermediate	O
in	O
mature	O
B	O
cells	O
,	O
and	O
absent	O
in	O
plasma	O
cells	O
,	O
thus	O
pointing	O
to	O
a	O
potential	O
regulatory	O
role	O
for	O
gene1s	ARG2
LAF-4	ARG2
gene1e	ARG2
in	O
lymphoid	O
development	O
.	O
Antibodies	O
to	O
gene1s	ARG2
LAF-4	ARG2
gene1e	ARG2
showed	O
it	O
to	O
be	O
a	O
nuclear	O
protein	O
that	O
showed	O
an	O
uneven	O
,	O
granular	O
immunofluorescence	O
pattern	O
.	O
In	O
vitro	O
-	O
translated	O
gene1s	ARG2
LAF-4	ARG2
gene1e	ARG2
was	O
able	O
to	O
bind	O
strongly	O
to	O
double	O
-	O
stranded	O
DNA	O
cellulose	O
.	O
Furthermore	O
,	O
both	O
gene1s	ARG2
LAF-4	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
AF-4	ARG2
gene1e	ARG2
had	O
domains	O
that	O
activated	O
transcription	O
strongly	O
when	O
fused	O
to	O
the	O
GAL4	O
DNA	O
-	O
binding	O
domain	O
.	O
Interestingly	O
,	O
the	O
AF-4	O
transactivation	O
domain	O
is	O
retained	O
in	O
the	O
gene1s	ARG2
MLL	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
AF-4	ARG2
gene1e	ARG2
fusion	O
protein	O
;	O
thus	O
,	O
it	O
may	O
contribute	O
to	O
the	O
transforming	O
potential	O
of	O
the	O
oncoprotein	O
.	O
Therefore	O
,	O
the	O
cloning	O
of	O
gene1s	ARG2
LAF-4	ARG2
gene1e	ARG2
has	O
defined	O
a	O
new	O
family	O
of	O
potential	O
regulatory	O
proteins	O
that	O
may	O
function	O
in	O
lymphoid	O
development	O
and	O
oncogenesis	O
.	O

gene1s	O
LAF-4	O
gene1e	O
encodes	O
a	O
lymphoid	O
nuclear	O
protein	O
with	O
transactivation	O
potential	O
that	O
is	O
homologous	O
to	O
gene1s	O
AF-4	O
gene1e	O
,	O
the	O
gene	O
fused	O
to	O
gene1s	O
MLL	O
gene1e	O
in	O
t(4;11	O
)	O
leukemias	O
.	O
A	O
novel	O
species1s	O
human	O
species1e	O
gene	O
,	O
gene1s	O
LAF-4	O
gene1e	O
,	O
was	O
isolated	O
from	O
a	O
subtracted	O
cDNA	O
library	O
that	O
showed	O
strong	O
sequence	O
similarity	O
to	O
gene1s	O
AF-4	O
gene1e	O
,	O
a	O
gene	O
that	O
is	O
translocated	O
in	O
t(4;11)(q21;q23	O
)	O
acute	O
lymphoblastic	O
leukemias	O
(	O
ALLs	O
)	O
.	O
In	O
t(4;11	O
)	O
ALL	O
,	O
the	O
gene1s	O
AF-4	O
gene1e	O
gene	O
at	O
4q21	O
is	O
translocated	O
into	O
the	O
gene1s	O
MLL	O
gene1e	O
locus	O
at	O
11q23	O
,	O
resulting	O
in	O
the	O
expression	O
of	O
an	O
gene1s	O
MLL	O
gene1e	O
/	O
gene1s	O
AF-4	O
gene1e	O
fusion	O
protein	O
that	O
is	O
the	O
presumptive	O
oncoprotein	O
.	O
gene1s	O
AF-4	O
gene1e	O
and	O
gene1s	O
LAF-4	O
gene1e	O
are	O
homologous	O
throughout	O
their	O
coding	O
regions	O
,	O
yet	O
neither	O
protein	O
is	O
related	O
to	O
previously	O
cloned	O
genes	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
LAF-4	O
gene1e	O
readily	O
hybridized	O
with	O
genes	O
in	O
arg1s	O
mouse	O
arg1e	O
and	O
species1s	O
chicken	O
species1e	O
,	O
thus	O
showing	O
that	O
this	O
gene	O
family	O
has	O
been	O
highly	O
conserved	O
during	O
vertebrate	O
evolution	O
.	O
In	O
arg1s	O
mouse	O
arg1e	O
tissues	O
,	O
gene1s	O
LAF-4	O
gene1e	O
mRNA	O
was	O
found	O
to	O
be	O
present	O
at	O
highest	O
levels	O
in	O
lymphoid	O
tissues	O
,	O
present	O
at	O
lower	O
levels	O
in	O
brain	O
and	O
lung	O
,	O
and	O
absent	O
from	O
other	O
tissues	O
.	O
In	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
mouse	O
arg1e	O
lymphoid	O
cell	O
lines	O
,	O
gene1s	O
LAF-4	O
gene1e	O
expression	O
was	O
highest	O
in	O
pre	O
-	O
B	O
cells	O
,	O
intermediate	O
in	O
mature	O
B	O
cells	O
,	O
and	O
absent	O
in	O
plasma	O
cells	O
,	O
thus	O
pointing	O
to	O
a	O
potential	O
regulatory	O
role	O
for	O
gene1s	O
LAF-4	O
gene1e	O
in	O
lymphoid	O
development	O
.	O
Antibodies	O
to	O
gene1s	O
LAF-4	O
gene1e	O
showed	O
it	O
to	O
be	O
a	O
nuclear	O
protein	O
that	O
showed	O
an	O
uneven	O
,	O
granular	O
immunofluorescence	O
pattern	O
.	O
In	O
vitro	O
-	O
translated	O
gene1s	O
LAF-4	O
gene1e	O
was	O
able	O
to	O
bind	O
strongly	O
to	O
double	O
-	O
stranded	O
DNA	O
cellulose	O
.	O
Furthermore	O
,	O
both	O
gene1s	O
LAF-4	O
gene1e	O
and	O
gene1s	O
AF-4	O
gene1e	O
had	O
domains	O
that	O
activated	O
transcription	O
strongly	O
when	O
fused	O
to	O
the	O
GAL4	O
DNA	O
-	O
binding	O
domain	O
.	O
Interestingly	O
,	O
the	O
AF-4	O
transactivation	O
domain	O
is	O
retained	O
in	O
the	O
gene1s	O
MLL	O
gene1e	O
/	O
gene1s	O
AF-4	O
gene1e	O
fusion	O
protein	O
;	O
thus	O
,	O
it	O
may	O
contribute	O
to	O
the	O
transforming	O
potential	O
of	O
the	O
oncoprotein	O
.	O
Therefore	O
,	O
the	O
cloning	O
of	O
gene1s	O
LAF-4	O
gene1e	O
has	O
defined	O
a	O
new	O
family	O
of	O
potential	O
regulatory	O
proteins	O
that	O
may	O
function	O
in	O
lymphoid	O
development	O
and	O
oncogenesis	O
.	O

gene1s	O
LAF-4	O
gene1e	O
encodes	O
a	O
lymphoid	O
nuclear	O
protein	O
with	O
transactivation	O
potential	O
that	O
is	O
homologous	O
to	O
gene1s	O
AF-4	O
gene1e	O
,	O
the	O
gene	O
fused	O
to	O
gene1s	O
MLL	O
gene1e	O
in	O
t(4;11	O
)	O
leukemias	O
.	O
A	O
novel	O
species1s	O
human	O
species1e	O
gene	O
,	O
gene1s	O
LAF-4	O
gene1e	O
,	O
was	O
isolated	O
from	O
a	O
subtracted	O
cDNA	O
library	O
that	O
showed	O
strong	O
sequence	O
similarity	O
to	O
gene1s	O
AF-4	O
gene1e	O
,	O
a	O
gene	O
that	O
is	O
translocated	O
in	O
t(4;11)(q21;q23	O
)	O
acute	O
lymphoblastic	O
leukemias	O
(	O
ALLs	O
)	O
.	O
In	O
t(4;11	O
)	O
ALL	O
,	O
the	O
gene1s	O
AF-4	O
gene1e	O
gene	O
at	O
4q21	O
is	O
translocated	O
into	O
the	O
gene1s	O
MLL	O
gene1e	O
locus	O
at	O
11q23	O
,	O
resulting	O
in	O
the	O
expression	O
of	O
an	O
gene1s	O
MLL	O
gene1e	O
/	O
gene1s	O
AF-4	O
gene1e	O
fusion	O
protein	O
that	O
is	O
the	O
presumptive	O
oncoprotein	O
.	O
gene1s	O
AF-4	O
gene1e	O
and	O
gene1s	O
LAF-4	O
gene1e	O
are	O
homologous	O
throughout	O
their	O
coding	O
regions	O
,	O
yet	O
neither	O
protein	O
is	O
related	O
to	O
previously	O
cloned	O
genes	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
LAF-4	O
gene1e	O
readily	O
hybridized	O
with	O
genes	O
in	O
species1s	O
mouse	O
species1e	O
and	O
arg1s	O
chicken	O
arg1e	O
,	O
thus	O
showing	O
that	O
this	O
gene	O
family	O
has	O
been	O
highly	O
conserved	O
during	O
vertebrate	O
evolution	O
.	O
In	O
species1s	O
mouse	O
species1e	O
tissues	O
,	O
gene1s	O
LAF-4	O
gene1e	O
mRNA	O
was	O
found	O
to	O
be	O
present	O
at	O
highest	O
levels	O
in	O
lymphoid	O
tissues	O
,	O
present	O
at	O
lower	O
levels	O
in	O
brain	O
and	O
lung	O
,	O
and	O
absent	O
from	O
other	O
tissues	O
.	O
In	O
species1s	O
human	O
species1e	O
and	O
species1s	O
mouse	O
species1e	O
lymphoid	O
cell	O
lines	O
,	O
gene1s	O
LAF-4	O
gene1e	O
expression	O
was	O
highest	O
in	O
pre	O
-	O
B	O
cells	O
,	O
intermediate	O
in	O
mature	O
B	O
cells	O
,	O
and	O
absent	O
in	O
plasma	O
cells	O
,	O
thus	O
pointing	O
to	O
a	O
potential	O
regulatory	O
role	O
for	O
gene1s	O
LAF-4	O
gene1e	O
in	O
lymphoid	O
development	O
.	O
Antibodies	O
to	O
gene1s	O
LAF-4	O
gene1e	O
showed	O
it	O
to	O
be	O
a	O
nuclear	O
protein	O
that	O
showed	O
an	O
uneven	O
,	O
granular	O
immunofluorescence	O
pattern	O
.	O
In	O
vitro	O
-	O
translated	O
gene1s	O
LAF-4	O
gene1e	O
was	O
able	O
to	O
bind	O
strongly	O
to	O
double	O
-	O
stranded	O
DNA	O
cellulose	O
.	O
Furthermore	O
,	O
both	O
gene1s	O
LAF-4	O
gene1e	O
and	O
gene1s	O
AF-4	O
gene1e	O
had	O
domains	O
that	O
activated	O
transcription	O
strongly	O
when	O
fused	O
to	O
the	O
GAL4	O
DNA	O
-	O
binding	O
domain	O
.	O
Interestingly	O
,	O
the	O
AF-4	O
transactivation	O
domain	O
is	O
retained	O
in	O
the	O
gene1s	O
MLL	O
gene1e	O
/	O
gene1s	O
AF-4	O
gene1e	O
fusion	O
protein	O
;	O
thus	O
,	O
it	O
may	O
contribute	O
to	O
the	O
transforming	O
potential	O
of	O
the	O
oncoprotein	O
.	O
Therefore	O
,	O
the	O
cloning	O
of	O
gene1s	O
LAF-4	O
gene1e	O
has	O
defined	O
a	O
new	O
family	O
of	O
potential	O
regulatory	O
proteins	O
that	O
may	O
function	O
in	O
lymphoid	O
development	O
and	O
oncogenesis	O
.	O

Cloning	O
,	O
chromosomal	O
localization	O
,	O
and	O
tissue	O
expression	O
of	O
gene1s	ARG2
autotaxin	ARG2
gene1e	ARG2
from	O
arg1s	O
human	O
arg1e	O
teratocarcinoma	O
cells	O
.	O
gene1s	ARG2
Autotaxin	ARG2
gene1e	ARG2
,	O
a	O
potent	O
arg1s	O
human	O
arg1e	O
tumor	O
cell	O
motility	O
-	O
stimulating	O
exophosphodiesterase	O
,	O
was	O
isolated	O
and	O
cloned	O
from	O
the	O
arg1s	O
human	O
arg1e	O
teratocarcinoma	O
cell	O
line	O
NTera2D1	O
.	O
The	O
deduced	O
amino	O
acid	O
sequence	O
for	O
the	O
teratocarcinoma	O
gene1s	ARG2
autotaxin	ARG2
gene1e	ARG2
has	O
94	O
%	O
identity	O
to	O
the	O
melanoma	O
-	O
derived	O
protein	O
,	O
90	O
%	O
identity	O
to	O
species1s	O
rat	O
species1e	O
brain	O
phosphodiesterase	O
I	O
/	O
nucleotide	O
pyrophosphatase	O
(	O
gene1s	O
PD	O
-	O
I	O
alpha	O
gene1e	O
)	O
,	O
and	O
44	O
%	O
identity	O
to	O
the	O
plasma	O
cell	O
membrane	O
marker	O
PC	O
-	O
I.	O
Utilizing	O
polymerase	O
chain	O
reaction	O
screening	O
of	O
the	O
CEPH	O
YAC	O
library	O
,	O
we	O
localized	O
the	O
gene1s	ARG2
autotaxin	ARG2
gene1e	ARG2
gene	O
to	O
arg1s	O
human	O
arg1e	O
chromosome	O
8q23	O
-	O
24	O
.	O
Northern	O
blot	O
analysis	O
of	O
relative	O
mRNA	O
from	O
multiple	O
arg1s	O
human	O
arg1e	O
tissues	O
revealed	O
that	O
gene1s	ARG2
autotaxin	ARG2
gene1e	ARG2
mRNA	O
steady	O
state	O
expression	O
is	O
most	O
abundant	O
in	O
brain	O
,	O
placenta	O
,	O
ovary	O
,	O
and	O
small	O
intestine	O
.	O

Cloning	O
,	O
chromosomal	O
localization	O
,	O
and	O
tissue	O
expression	O
of	O
gene1s	O
autotaxin	O
gene1e	O
from	O
species1s	O
human	O
species1e	O
teratocarcinoma	O
cells	O
.	O
gene1s	O
Autotaxin	O
gene1e	O
,	O
a	O
potent	O
species1s	O
human	O
species1e	O
tumor	O
cell	O
motility	O
-	O
stimulating	O
exophosphodiesterase	O
,	O
was	O
isolated	O
and	O
cloned	O
from	O
the	O
species1s	O
human	O
species1e	O
teratocarcinoma	O
cell	O
line	O
NTera2D1	O
.	O
The	O
deduced	O
amino	O
acid	O
sequence	O
for	O
the	O
teratocarcinoma	O
gene1s	O
autotaxin	O
gene1e	O
has	O
94	O
%	O
identity	O
to	O
the	O
melanoma	O
-	O
derived	O
protein	O
,	O
90	O
%	O
identity	O
to	O
arg1s	O
rat	O
arg1e	O
brain	O
phosphodiesterase	O
I	O
/	O
nucleotide	O
pyrophosphatase	O
(	O
gene1s	ARG2
PD	ARG2
-	ARG2
I	ARG2
alpha	ARG2
gene1e	ARG2
)	O
,	O
and	O
44	O
%	O
identity	O
to	O
the	O
plasma	O
cell	O
membrane	O
marker	O
PC	O
-	O
I.	O
Utilizing	O
polymerase	O
chain	O
reaction	O
screening	O
of	O
the	O
CEPH	O
YAC	O
library	O
,	O
we	O
localized	O
the	O
gene1s	O
autotaxin	O
gene1e	O
gene	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
8q23	O
-	O
24	O
.	O
Northern	O
blot	O
analysis	O
of	O
relative	O
mRNA	O
from	O
multiple	O
species1s	O
human	O
species1e	O
tissues	O
revealed	O
that	O
gene1s	O
autotaxin	O
gene1e	O
mRNA	O
steady	O
state	O
expression	O
is	O
most	O
abundant	O
in	O
brain	O
,	O
placenta	O
,	O
ovary	O
,	O
and	O
small	O
intestine	O
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
a	O
putative	O
novel	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
osteoclast	ARG2
-	ARG2
specific	ARG2
116-kDa	ARG2
gene1e	ARG2
vacuolar	O
proton	O
pump	O
subunit	O
.	O
A	O
cDNA	O
encoding	O
a	O
possible	O
novel	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
116-kDa	ARG2
polypeptide	ARG2
subunit	ARG2
of	ARG2
the	ARG2
osteoclastic	ARG2
proton	ARG2
pump	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
OC-116KDa	ARG2
gene1e	ARG2
)	O
has	O
been	O
identified	O
by	O
differential	O
screening	O
of	O
a	O
arg1s	O
human	O
arg1e	O
osteoclastoma	O
cDNA	O
library	O
.	O
The	O
predicted	O
sequence	O
of	O
gene1s	ARG2
OC-116kDa	ARG2
gene1e	ARG2
consists	O
of	O
822	O
amino	O
acids	O
and	O
is	O
46.9	O
%	O
and	O
47.2	O
%	O
identical	O
at	O
the	O
amino	O
acid	O
level	O
to	O
the	O
116-KDa	O
polypeptide	O
of	O
the	O
vacuolar	O
proton	O
pump	O
of	O
species1s	O
rat	O
species1e	O
and	O
species1s	O
bovine	O
species1e	O
brain	O
respectively	O
.	O
gene1s	ARG2
OC-116KDa	ARG2
gene1e	ARG2
mRNA	O
was	O
found	O
at	O
high	O
levels	O
in	O
osteoclastomas	O
by	O
Northern	O
analysis	O
but	O
was	O
not	O
detected	O
in	O
tumor	O
stromal	O
cells	O
or	O
in	O
other	O
tissues	O
including	O
kidney	O
,	O
liver	O
,	O
skeletal	O
muscle	O
and	O
brain	O
.	O
gene1s	ARG2
OC-116KDa	ARG2
gene1e	ARG2
mRNA	O
was	O
localized	O
to	O
multinucleated	O
giant	O
cells	O
within	O
the	O
osteoclastoma	O
tumor	O
by	O
in	O
situ	O
hybridization	O
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
a	O
putative	O
novel	O
species1s	O
human	O
species1e	O
gene1s	O
osteoclast	O
-	O
specific	O
116-kDa	O
gene1e	O
vacuolar	O
proton	O
pump	O
subunit	O
.	O
A	O
cDNA	O
encoding	O
a	O
possible	O
novel	O
species1s	O
human	O
species1e	O
gene1s	O
116-kDa	O
polypeptide	O
subunit	O
of	O
the	O
osteoclastic	O
proton	O
pump	O
gene1e	O
(	O
gene1s	O
OC-116KDa	O
gene1e	O
)	O
has	O
been	O
identified	O
by	O
differential	O
screening	O
of	O
a	O
species1s	O
human	O
species1e	O
osteoclastoma	O
cDNA	O
library	O
.	O
The	O
predicted	O
sequence	O
of	O
gene1s	O
OC-116kDa	O
gene1e	O
consists	O
of	O
822	O
amino	O
acids	O
and	O
is	O
46.9	O
%	O
and	O
47.2	O
%	O
identical	O
at	O
the	O
amino	O
acid	O
level	O
to	O
the	O
116-KDa	O
polypeptide	O
of	O
the	O
vacuolar	O
proton	O
pump	O
of	O
arg1s	O
rat	O
arg1e	O
and	O
species1s	O
bovine	O
species1e	O
brain	O
respectively	O
.	O
gene1s	O
OC-116KDa	O
gene1e	O
mRNA	O
was	O
found	O
at	O
high	O
levels	O
in	O
osteoclastomas	O
by	O
Northern	O
analysis	O
but	O
was	O
not	O
detected	O
in	O
tumor	O
stromal	O
cells	O
or	O
in	O
other	O
tissues	O
including	O
kidney	O
,	O
liver	O
,	O
skeletal	O
muscle	O
and	O
brain	O
.	O
gene1s	O
OC-116KDa	O
gene1e	O
mRNA	O
was	O
localized	O
to	O
multinucleated	O
giant	O
cells	O
within	O
the	O
osteoclastoma	O
tumor	O
by	O
in	O
situ	O
hybridization	O
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
a	O
putative	O
novel	O
species1s	O
human	O
species1e	O
gene1s	O
osteoclast	O
-	O
specific	O
116-kDa	O
gene1e	O
vacuolar	O
proton	O
pump	O
subunit	O
.	O
A	O
cDNA	O
encoding	O
a	O
possible	O
novel	O
species1s	O
human	O
species1e	O
gene1s	O
116-kDa	O
polypeptide	O
subunit	O
of	O
the	O
osteoclastic	O
proton	O
pump	O
gene1e	O
(	O
gene1s	O
OC-116KDa	O
gene1e	O
)	O
has	O
been	O
identified	O
by	O
differential	O
screening	O
of	O
a	O
species1s	O
human	O
species1e	O
osteoclastoma	O
cDNA	O
library	O
.	O
The	O
predicted	O
sequence	O
of	O
gene1s	O
OC-116kDa	O
gene1e	O
consists	O
of	O
822	O
amino	O
acids	O
and	O
is	O
46.9	O
%	O
and	O
47.2	O
%	O
identical	O
at	O
the	O
amino	O
acid	O
level	O
to	O
the	O
116-KDa	O
polypeptide	O
of	O
the	O
vacuolar	O
proton	O
pump	O
of	O
species1s	O
rat	O
species1e	O
and	O
arg1s	O
bovine	O
arg1e	O
brain	O
respectively	O
.	O
gene1s	O
OC-116KDa	O
gene1e	O
mRNA	O
was	O
found	O
at	O
high	O
levels	O
in	O
osteoclastomas	O
by	O
Northern	O
analysis	O
but	O
was	O
not	O
detected	O
in	O
tumor	O
stromal	O
cells	O
or	O
in	O
other	O
tissues	O
including	O
kidney	O
,	O
liver	O
,	O
skeletal	O
muscle	O
and	O
brain	O
.	O
gene1s	O
OC-116KDa	O
gene1e	O
mRNA	O
was	O
localized	O
to	O
multinucleated	O
giant	O
cells	O
within	O
the	O
osteoclastoma	O
tumor	O
by	O
in	O
situ	O
hybridization	O
.	O

Cloning	O
,	O
sequencing	O
and	O
expression	O
of	O
a	O
novel	O
cDNA	O
encoding	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
vacuolar	ARG2
ATPase	ARG2
(	ARG2
14-kDa	ARG2
subunit	ARG2
)	ARG2
gene1e	ARG2
.	O
A	O
cDNA	O
encoding	O
the	O
gene1s	ARG2
14-kDa	ARG2
subunit	ARG2
of	ARG2
vacuolar	ARG2
ATPase	ARG2
gene1e	ARG2
was	O
cloned	O
from	O
arg1s	O
human	O
arg1e	O
fetal	O
brain	O
.	O
The	O
sequence	O
was	O
composed	O
of	O
680	O
nucleotides	O
containing	O
an	O
open	O
reading	O
frame	O
of	O
357	O
nucleotides	O
.	O
The	O
deduced	O
peptide	O
sequence	O
consisted	O
of	O
119	O
amino	O
acid	O
residues	O
with	O
a	O
calculated	O
molecular	O
weight	O
of	O
13,369	O
Da	O
and	O
a	O
pI	O
of	O
5.19	O
.	O
Overall	O
,	O
this	O
amino	O
-	O
acid	O
sequence	O
was	O
respectively	O
69	O
%	O
and	O
70	O
%	O
identical	O
to	O
those	O
of	O
species1s	O
Manduca	O
sexta	O
species1e	O
and	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
14-kDa	O
subunits	O
,	O
although	O
the	O
two	O
representatives	O
of	O
Class	O
Insecta	O
were	O
remarkably	O
similar	O
to	O
one	O
another	O
(	O
91	O
%	O
identity	O
)	O
.	O
Three	O
regions	O
in	O
particular	O
(	O
the	O
N	O
-	O
terminal	O
,	O
amino	O
acids	O
5	O
-	O
36	O
;	O
the	O
middle	O
,	O
residues	O
58	O
-	O
68	O
;	O
and	O
the	O
C	O
-	O
terminal	O
,	O
residues	O
88	O
-	O
118	O
)	O
were	O
highly	O
conserved	O
.	O
Hence	O
,	O
we	O
think	O
that	O
the	O
14-kDa	O
subunits	O
have	O
evolved	O
from	O
the	O
same	O
ancestral	O
gene	O
,	O
and	O
that	O
the	O
three	O
conserved	O
regions	O
are	O
important	O
for	O
the	O
structure	O
and	O
function	O
of	O
vacuolar	O
ATPase	O
.	O
A	O
single	O
0.8-kb	O
band	O
was	O
detected	O
in	O
various	O
arg1s	O
human	O
arg1e	O
tissues	O
by	O
Northern	O
blot	O
analysis	O
.	O
Since	O
the	O
arg1s	O
human	O
arg1e	O
14-kDa	O
subunit	O
is	O
expressed	O
ubiquitously	O
,	O
it	O
might	O
be	O
a	O
housekeeping	O
protein	O
.	O
A	O
separate	O
transcript	O
found	O
in	O
the	O
cDNA	O
library	O
lacked	O
a	O
6-bp	O
segment	O
in	O
the	O
5	O
'	O
non	O
-	O
coding	O
region	O
(	O
nucleotides	O
-40	O
to	O
-35	O
)	O
and	O
also	O
carried	O
a	O
23C	O
to	O
T	O
(	O
8Thr	O
to	O
Ile	O
)	O
point	O
mutation	O
in	O
the	O
coding	O
region	O
;	O
these	O
minor	O
differences	O
likely	O
reflected	O
normal	O
polymorphism	O
.	O

Cloning	O
,	O
sequencing	O
and	O
expression	O
of	O
a	O
novel	O
cDNA	O
encoding	O
species1s	O
human	O
species1e	O
gene1s	O
vacuolar	O
ATPase	O
(	O
14-kDa	O
subunit	O
)	O
gene1e	O
.	O
A	O
cDNA	O
encoding	O
the	O
gene1s	O
14-kDa	O
subunit	O
of	O
vacuolar	O
ATPase	O
gene1e	O
was	O
cloned	O
from	O
species1s	O
human	O
species1e	O
fetal	O
brain	O
.	O
The	O
sequence	O
was	O
composed	O
of	O
680	O
nucleotides	O
containing	O
an	O
open	O
reading	O
frame	O
of	O
357	O
nucleotides	O
.	O
The	O
deduced	O
peptide	O
sequence	O
consisted	O
of	O
119	O
amino	O
acid	O
residues	O
with	O
a	O
calculated	O
molecular	O
weight	O
of	O
13,369	O
Da	O
and	O
a	O
pI	O
of	O
5.19	O
.	O
Overall	O
,	O
this	O
amino	O
-	O
acid	O
sequence	O
was	O
respectively	O
69	O
%	O
and	O
70	O
%	O
identical	O
to	O
those	O
of	O
arg1s	O
Manduca	O
sexta	O
arg1e	O
and	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
14-kDa	O
subunits	O
,	O
although	O
the	O
two	O
representatives	O
of	O
Class	O
Insecta	O
were	O
remarkably	O
similar	O
to	O
one	O
another	O
(	O
91	O
%	O
identity	O
)	O
.	O
Three	O
regions	O
in	O
particular	O
(	O
the	O
N	O
-	O
terminal	O
,	O
amino	O
acids	O
5	O
-	O
36	O
;	O
the	O
middle	O
,	O
residues	O
58	O
-	O
68	O
;	O
and	O
the	O
C	O
-	O
terminal	O
,	O
residues	O
88	O
-	O
118	O
)	O
were	O
highly	O
conserved	O
.	O
Hence	O
,	O
we	O
think	O
that	O
the	O
14-kDa	O
subunits	O
have	O
evolved	O
from	O
the	O
same	O
ancestral	O
gene	O
,	O
and	O
that	O
the	O
three	O
conserved	O
regions	O
are	O
important	O
for	O
the	O
structure	O
and	O
function	O
of	O
vacuolar	O
ATPase	O
.	O
A	O
single	O
0.8-kb	O
band	O
was	O
detected	O
in	O
various	O
species1s	O
human	O
species1e	O
tissues	O
by	O
Northern	O
blot	O
analysis	O
.	O
Since	O
the	O
species1s	O
human	O
species1e	O
14-kDa	O
subunit	O
is	O
expressed	O
ubiquitously	O
,	O
it	O
might	O
be	O
a	O
housekeeping	O
protein	O
.	O
A	O
separate	O
transcript	O
found	O
in	O
the	O
cDNA	O
library	O
lacked	O
a	O
6-bp	O
segment	O
in	O
the	O
5	O
'	O
non	O
-	O
coding	O
region	O
(	O
nucleotides	O
-40	O
to	O
-35	O
)	O
and	O
also	O
carried	O
a	O
23C	O
to	O
T	O
(	O
8Thr	O
to	O
Ile	O
)	O
point	O
mutation	O
in	O
the	O
coding	O
region	O
;	O
these	O
minor	O
differences	O
likely	O
reflected	O
normal	O
polymorphism	O
.	O

Cloning	O
,	O
sequencing	O
and	O
expression	O
of	O
a	O
novel	O
cDNA	O
encoding	O
species1s	O
human	O
species1e	O
gene1s	O
vacuolar	O
ATPase	O
(	O
14-kDa	O
subunit	O
)	O
gene1e	O
.	O
A	O
cDNA	O
encoding	O
the	O
gene1s	O
14-kDa	O
subunit	O
of	O
vacuolar	O
ATPase	O
gene1e	O
was	O
cloned	O
from	O
species1s	O
human	O
species1e	O
fetal	O
brain	O
.	O
The	O
sequence	O
was	O
composed	O
of	O
680	O
nucleotides	O
containing	O
an	O
open	O
reading	O
frame	O
of	O
357	O
nucleotides	O
.	O
The	O
deduced	O
peptide	O
sequence	O
consisted	O
of	O
119	O
amino	O
acid	O
residues	O
with	O
a	O
calculated	O
molecular	O
weight	O
of	O
13,369	O
Da	O
and	O
a	O
pI	O
of	O
5.19	O
.	O
Overall	O
,	O
this	O
amino	O
-	O
acid	O
sequence	O
was	O
respectively	O
69	O
%	O
and	O
70	O
%	O
identical	O
to	O
those	O
of	O
species1s	O
Manduca	O
sexta	O
species1e	O
and	O
arg1s	O
Drosophila	O
melanogaster	O
arg1e	O
14-kDa	O
subunits	O
,	O
although	O
the	O
two	O
representatives	O
of	O
Class	O
Insecta	O
were	O
remarkably	O
similar	O
to	O
one	O
another	O
(	O
91	O
%	O
identity	O
)	O
.	O
Three	O
regions	O
in	O
particular	O
(	O
the	O
N	O
-	O
terminal	O
,	O
amino	O
acids	O
5	O
-	O
36	O
;	O
the	O
middle	O
,	O
residues	O
58	O
-	O
68	O
;	O
and	O
the	O
C	O
-	O
terminal	O
,	O
residues	O
88	O
-	O
118	O
)	O
were	O
highly	O
conserved	O
.	O
Hence	O
,	O
we	O
think	O
that	O
the	O
14-kDa	O
subunits	O
have	O
evolved	O
from	O
the	O
same	O
ancestral	O
gene	O
,	O
and	O
that	O
the	O
three	O
conserved	O
regions	O
are	O
important	O
for	O
the	O
structure	O
and	O
function	O
of	O
vacuolar	O
ATPase	O
.	O
A	O
single	O
0.8-kb	O
band	O
was	O
detected	O
in	O
various	O
species1s	O
human	O
species1e	O
tissues	O
by	O
Northern	O
blot	O
analysis	O
.	O
Since	O
the	O
species1s	O
human	O
species1e	O
14-kDa	O
subunit	O
is	O
expressed	O
ubiquitously	O
,	O
it	O
might	O
be	O
a	O
housekeeping	O
protein	O
.	O
A	O
separate	O
transcript	O
found	O
in	O
the	O
cDNA	O
library	O
lacked	O
a	O
6-bp	O
segment	O
in	O
the	O
5	O
'	O
non	O
-	O
coding	O
region	O
(	O
nucleotides	O
-40	O
to	O
-35	O
)	O
and	O
also	O
carried	O
a	O
23C	O
to	O
T	O
(	O
8Thr	O
to	O
Ile	O
)	O
point	O
mutation	O
in	O
the	O
coding	O
region	O
;	O
these	O
minor	O
differences	O
likely	O
reflected	O
normal	O
polymorphism	O
.	O

Cloning	O
and	O
characterization	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
urocortin	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
Urocortin	ARG2
gene1e	ARG2
,	O
a	O
new	O
member	O
of	O
the	O
CRF	O
peptide	O
family	O
which	O
also	O
includes	O
urotensin	O
I	O
and	O
sauvagine	O
,	O
was	O
recently	O
cloned	O
from	O
the	O
species1s	O
rat	O
species1e	O
midbrain	O
.	O
The	O
synthetic	O
replicate	O
of	O
gene1s	ARG2
urocortin	ARG2
gene1e	ARG2
was	O
found	O
to	O
bind	O
with	O
high	O
affinity	O
to	O
gene1s	ARG2
type	ARG2
1	ARG2
and	ARG2
type	ARG2
2	ARG2
CRF	ARG2
receptors	ARG2
gene1e	ARG2
and	O
,	O
based	O
upon	O
its	O
anatomic	O
localization	O
within	O
the	O
brain	O
,	O
was	O
proposed	O
to	O
be	O
a	O
natural	O
ligand	O
for	O
the	O
gene1s	ARG2
type	ARG2
2	ARG2
CRF	ARG2
receptors	ARG2
gene1e	ARG2
.	O
Using	O
a	O
genomic	O
library	O
,	O
we	O
have	O
cloned	O
the	O
arg1s	O
human	O
arg1e	O
counterpart	O
of	O
species1s	O
rat	O
species1e	O
gene1s	ARG2
urocortin	ARG2
gene1e	ARG2
and	O
localized	O
it	O
to	O
arg1s	O
human	O
arg1e	O
chromosome	O
2	O
.	O
arg1s	O
Human	O
arg1e	O
and	O
species1s	O
rat	O
species1e	O
gene1s	ARG2
urocortin	ARG2
gene1e	ARG2
share	O
95	O
%	O
identity	O
within	O
the	O
mature	O
peptide	O
region	O
.	O
Synthetic	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
urocortin	ARG2
gene1e	ARG2
binds	O
with	O
high	O
affinity	O
to	O
gene1s	ARG2
CRF	ARG2
receptor	ARG2
types	ARG2
1	ARG2
,	ARG2
2	ARG2
alpha	ARG2
,	ARG2
and	ARG2
2	ARG2
beta	ARG2
gene1e	ARG2
,	O
stimulates	O
cAMP	O
accumulation	O
from	O
cells	O
stably	O
transfected	O
with	O
these	O
receptors	O
,	O
and	O
acts	O
in	O
vitro	O
to	O
release	O
gene1s	ARG2
ACTH	ARG2
gene1e	ARG2
from	O
dispersed	O
species1s	O
rat	O
species1e	O
anterior	O
pituitary	O
cells	O
.	O
In	O
addition	O
,	O
the	O
gene1s	ARG2
CRF	ARG2
-	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
binds	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
urocortin	ARG2
gene1e	ARG2
with	O
high	O
affinity	O
and	O
can	O
prevent	O
gene1s	ARG2
urocortin	ARG2
gene1e	ARG2
-	O
stimulated	O
gene1s	ARG2
ACTH	ARG2
gene1e	ARG2
secretion	O
in	O
vitro	O
.	O
The	O
inhibitory	O
effect	O
of	O
the	O
gene1s	ARG2
CRF	ARG2
-	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
on	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
urocortin	ARG2
gene1e	ARG2
can	O
be	O
blocked	O
by	O
biologically	O
inactive	O
gene1s	ARG2
CRF	ARG2
gene1e	ARG2
fragments	O
,	O
such	O
as	O
gene1s	ARG2
CRF	ARG2
gene1e	ARG2
(9	O
-	O
33	O
)	O
.	O

Cloning	O
and	O
characterization	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
urocortin	O
gene1e	O
.	O
gene1s	O
Urocortin	O
gene1e	O
,	O
a	O
new	O
member	O
of	O
the	O
CRF	O
peptide	O
family	O
which	O
also	O
includes	O
urotensin	O
I	O
and	O
sauvagine	O
,	O
was	O
recently	O
cloned	O
from	O
the	O
arg1s	O
rat	O
arg1e	O
midbrain	O
.	O
The	O
synthetic	O
replicate	O
of	O
gene1s	O
urocortin	O
gene1e	O
was	O
found	O
to	O
bind	O
with	O
high	O
affinity	O
to	O
gene1s	O
type	O
1	O
and	O
type	O
2	O
CRF	O
receptors	O
gene1e	O
and	O
,	O
based	O
upon	O
its	O
anatomic	O
localization	O
within	O
the	O
brain	O
,	O
was	O
proposed	O
to	O
be	O
a	O
natural	O
ligand	O
for	O
the	O
gene1s	O
type	O
2	O
CRF	O
receptors	O
gene1e	O
.	O
Using	O
a	O
genomic	O
library	O
,	O
we	O
have	O
cloned	O
the	O
species1s	O
human	O
species1e	O
counterpart	O
of	O
arg1s	O
rat	O
arg1e	O
gene1s	O
urocortin	O
gene1e	O
and	O
localized	O
it	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
2	O
.	O
species1s	O
Human	O
species1e	O
and	O
arg1s	O
rat	O
arg1e	O
gene1s	O
urocortin	O
gene1e	O
share	O
95	O
%	O
identity	O
within	O
the	O
mature	O
peptide	O
region	O
.	O
Synthetic	O
species1s	O
human	O
species1e	O
gene1s	O
urocortin	O
gene1e	O
binds	O
with	O
high	O
affinity	O
to	O
gene1s	O
CRF	O
receptor	O
types	O
1	O
,	O
2	O
alpha	O
,	O
and	O
2	O
beta	O
gene1e	O
,	O
stimulates	O
cAMP	O
accumulation	O
from	O
cells	O
stably	O
transfected	O
with	O
these	O
receptors	O
,	O
and	O
acts	O
in	O
vitro	O
to	O
release	O
gene1s	O
ACTH	O
gene1e	O
from	O
dispersed	O
arg1s	O
rat	O
arg1e	O
anterior	O
pituitary	O
cells	O
.	O
In	O
addition	O
,	O
the	O
gene1s	O
CRF	O
-	O
binding	O
protein	O
gene1e	O
binds	O
species1s	O
human	O
species1e	O
gene1s	O
urocortin	O
gene1e	O
with	O
high	O
affinity	O
and	O
can	O
prevent	O
gene1s	O
urocortin	O
gene1e	O
-	O
stimulated	O
gene1s	O
ACTH	O
gene1e	O
secretion	O
in	O
vitro	O
.	O
The	O
inhibitory	O
effect	O
of	O
the	O
gene1s	O
CRF	O
-	O
binding	O
protein	O
gene1e	O
on	O
species1s	O
human	O
species1e	O
gene1s	O
urocortin	O
gene1e	O
can	O
be	O
blocked	O
by	O
biologically	O
inactive	O
gene1s	O
CRF	O
gene1e	O
fragments	O
,	O
such	O
as	O
gene1s	O
CRF	O
gene1e	O
(9	O
-	O
33	O
)	O
.	O

Molecular	O
cloning	O
,	O
expression	O
,	O
and	O
chromosomal	O
localization	O
of	O
a	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
brain	ARG2
-	ARG2
specific	ARG2
Na(+)-dependent	ARG2
inorganic	ARG2
phosphate	ARG2
cotransporter	ARG2
gene1e	ARG2
.	O
We	O
describe	O
the	O
molecular	O
cloning	O
of	O
a	O
cDNA	O
encoding	O
a	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
brain	ARG2
Na(+)-dependent	ARG2
inorganic	ARG2
phosphate	ARG2
(	ARG2
P(i	ARG2
)	ARG2
)	ARG2
cotransporter	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
hBNPI	ARG2
gene1e	ARG2
)	O
.	O
The	O
nucleotide	O
and	O
deduced	O
amino	O
acid	O
sequences	O
of	O
gene1s	ARG2
hBNPI	ARG2
gene1e	ARG2
reveal	O
a	O
protein	O
of	O
560	O
amino	O
acids	O
with	O
six	O
to	O
eight	O
putative	O
transmembrane	O
segments	O
.	O
gene1s	ARG2
hBNPI	ARG2
gene1e	ARG2
shares	O
a	O
high	O
degree	O
of	O
homology	O
with	O
other	O
Na(+)-dependent	O
inorganic	O
P(i	O
)	O
cotransporters	O
,	O
including	O
those	O
found	O
in	O
species1s	O
rat	O
species1e	O
brain	O
and	O
arg1s	O
human	O
arg1e	O
and	O
rabbit	O
kidney	O
.	O
Expression	O
of	O
gene1s	ARG2
hBNPI	ARG2
gene1e	ARG2
in	O
species1s	O
COS-1	O
species1e	O
cells	O
results	O
in	O
Na(+)-dependent	O
P(i	O
)	O
uptake	O
.	O
Northern	O
blot	O
analysis	O
demonstrates	O
that	O
gene1s	ARG2
hBNPI	ARG2
gene1e	ARG2
mRNA	O
is	O
expressed	O
predominantly	O
in	O
brain	O
and	O
most	O
abundantly	O
in	O
neuron	O
-	O
enriched	O
regions	O
such	O
as	O
the	O
amygdala	O
and	O
hippocampus	O
.	O
Moderate	O
levels	O
of	O
expression	O
are	O
also	O
observed	O
in	O
glia	O
-	O
enriched	O
areas	O
such	O
as	O
the	O
corpus	O
callosum	O
,	O
and	O
low	O
levels	O
are	O
observed	O
in	O
the	O
substantia	O
nigra	O
,	O
subthalamic	O
nuclei	O
,	O
and	O
thalamus	O
.	O
In	O
situ	O
hybridization	O
histochemistry	O
reveals	O
relatively	O
high	O
levels	O
of	O
gene1s	ARG2
hBNPI	ARG2
gene1e	ARG2
mRNA	O
in	O
pyramidal	O
neurons	O
of	O
the	O
cerebral	O
cortex	O
and	O
hippocampus	O
and	O
in	O
granule	O
neurons	O
of	O
dentate	O
gyrus	O
.	O
The	O
level	O
of	O
gene1s	ARG2
hBNPI	ARG2
gene1e	ARG2
mRNA	O
is	O
quite	O
low	O
in	O
fetal	O
compared	O
with	O
adult	O
arg1s	O
human	O
arg1e	O
brain	O
,	O
suggesting	O
developmental	O
regulation	O
of	O
gene1s	ARG2
hBNPI	ARG2
gene1e	ARG2
gene	O
expression	O
.	O
Southern	O
analyses	O
of	O
nine	O
eukaryotic	O
genomic	O
DNAs	O
probed	O
under	O
stringent	O
conditions	O
with	O
gene1s	ARG2
hBNPI	ARG2
gene1e	ARG2
cDNA	O
revealed	O
that	O
the	O
gene1s	ARG2
hBNPI	ARG2
gene1e	ARG2
gene	O
is	O
highly	O
conserved	O
during	O
vertebrate	O
evolution	O
and	O
that	O
each	O
gene	O
is	O
most	O
likely	O
present	O
as	O
a	O
single	O
copy	O
.	O
Using	O
fluorescent	O
in	O
situ	O
hybridization	O
,	O
we	O
localized	O
gene1s	ARG2
hBNPI	ARG2
gene1e	ARG2
to	O
the	O
long	O
arm	O
of	O
chromosome	O
19	O
(	O
19q13	O
)	O
in	O
close	O
proximity	O
to	O
the	O
late	O
-	O
onset	O
familial	O
Alzheimer	O
's	O
disease	O
locus	O
.	O

Molecular	O
cloning	O
,	O
expression	O
,	O
and	O
chromosomal	O
localization	O
of	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
brain	O
-	O
specific	O
Na(+)-dependent	O
inorganic	O
phosphate	O
cotransporter	O
gene1e	O
.	O
We	O
describe	O
the	O
molecular	O
cloning	O
of	O
a	O
cDNA	O
encoding	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
brain	O
Na(+)-dependent	O
inorganic	O
phosphate	O
(	O
P(i	O
)	O
)	O
cotransporter	O
gene1e	O
(	O
gene1s	O
hBNPI	O
gene1e	O
)	O
.	O
The	O
nucleotide	O
and	O
deduced	O
amino	O
acid	O
sequences	O
of	O
gene1s	O
hBNPI	O
gene1e	O
reveal	O
a	O
protein	O
of	O
560	O
amino	O
acids	O
with	O
six	O
to	O
eight	O
putative	O
transmembrane	O
segments	O
.	O
gene1s	O
hBNPI	O
gene1e	O
shares	O
a	O
high	O
degree	O
of	O
homology	O
with	O
other	O
Na(+)-dependent	O
inorganic	O
P(i	O
)	O
cotransporters	O
,	O
including	O
those	O
found	O
in	O
arg1s	O
rat	O
arg1e	O
brain	O
and	O
species1s	O
human	O
species1e	O
and	O
rabbit	O
kidney	O
.	O
Expression	O
of	O
gene1s	O
hBNPI	O
gene1e	O
in	O
species1s	O
COS-1	O
species1e	O
cells	O
results	O
in	O
Na(+)-dependent	O
P(i	O
)	O
uptake	O
.	O
Northern	O
blot	O
analysis	O
demonstrates	O
that	O
gene1s	O
hBNPI	O
gene1e	O
mRNA	O
is	O
expressed	O
predominantly	O
in	O
brain	O
and	O
most	O
abundantly	O
in	O
neuron	O
-	O
enriched	O
regions	O
such	O
as	O
the	O
amygdala	O
and	O
hippocampus	O
.	O
Moderate	O
levels	O
of	O
expression	O
are	O
also	O
observed	O
in	O
glia	O
-	O
enriched	O
areas	O
such	O
as	O
the	O
corpus	O
callosum	O
,	O
and	O
low	O
levels	O
are	O
observed	O
in	O
the	O
substantia	O
nigra	O
,	O
subthalamic	O
nuclei	O
,	O
and	O
thalamus	O
.	O
In	O
situ	O
hybridization	O
histochemistry	O
reveals	O
relatively	O
high	O
levels	O
of	O
gene1s	O
hBNPI	O
gene1e	O
mRNA	O
in	O
pyramidal	O
neurons	O
of	O
the	O
cerebral	O
cortex	O
and	O
hippocampus	O
and	O
in	O
granule	O
neurons	O
of	O
dentate	O
gyrus	O
.	O
The	O
level	O
of	O
gene1s	O
hBNPI	O
gene1e	O
mRNA	O
is	O
quite	O
low	O
in	O
fetal	O
compared	O
with	O
adult	O
species1s	O
human	O
species1e	O
brain	O
,	O
suggesting	O
developmental	O
regulation	O
of	O
gene1s	O
hBNPI	O
gene1e	O
gene	O
expression	O
.	O
Southern	O
analyses	O
of	O
nine	O
eukaryotic	O
genomic	O
DNAs	O
probed	O
under	O
stringent	O
conditions	O
with	O
gene1s	O
hBNPI	O
gene1e	O
cDNA	O
revealed	O
that	O
the	O
gene1s	O
hBNPI	O
gene1e	O
gene	O
is	O
highly	O
conserved	O
during	O
vertebrate	O
evolution	O
and	O
that	O
each	O
gene	O
is	O
most	O
likely	O
present	O
as	O
a	O
single	O
copy	O
.	O
Using	O
fluorescent	O
in	O
situ	O
hybridization	O
,	O
we	O
localized	O
gene1s	O
hBNPI	O
gene1e	O
to	O
the	O
long	O
arm	O
of	O
chromosome	O
19	O
(	O
19q13	O
)	O
in	O
close	O
proximity	O
to	O
the	O
late	O
-	O
onset	O
familial	O
Alzheimer	O
's	O
disease	O
locus	O
.	O

Molecular	O
cloning	O
,	O
expression	O
,	O
and	O
chromosomal	O
localization	O
of	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
brain	O
-	O
specific	O
Na(+)-dependent	O
inorganic	O
phosphate	O
cotransporter	O
gene1e	O
.	O
We	O
describe	O
the	O
molecular	O
cloning	O
of	O
a	O
cDNA	O
encoding	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
brain	O
Na(+)-dependent	O
inorganic	O
phosphate	O
(	O
P(i	O
)	O
)	O
cotransporter	O
gene1e	O
(	O
gene1s	O
hBNPI	O
gene1e	O
)	O
.	O
The	O
nucleotide	O
and	O
deduced	O
amino	O
acid	O
sequences	O
of	O
gene1s	O
hBNPI	O
gene1e	O
reveal	O
a	O
protein	O
of	O
560	O
amino	O
acids	O
with	O
six	O
to	O
eight	O
putative	O
transmembrane	O
segments	O
.	O
gene1s	O
hBNPI	O
gene1e	O
shares	O
a	O
high	O
degree	O
of	O
homology	O
with	O
other	O
Na(+)-dependent	O
inorganic	O
P(i	O
)	O
cotransporters	O
,	O
including	O
those	O
found	O
in	O
species1s	O
rat	O
species1e	O
brain	O
and	O
species1s	O
human	O
species1e	O
and	O
rabbit	O
kidney	O
.	O
Expression	O
of	O
gene1s	O
hBNPI	O
gene1e	O
in	O
arg1s	O
COS-1	O
arg1e	O
cells	O
results	O
in	O
Na(+)-dependent	O
P(i	O
)	O
uptake	O
.	O
Northern	O
blot	O
analysis	O
demonstrates	O
that	O
gene1s	O
hBNPI	O
gene1e	O
mRNA	O
is	O
expressed	O
predominantly	O
in	O
brain	O
and	O
most	O
abundantly	O
in	O
neuron	O
-	O
enriched	O
regions	O
such	O
as	O
the	O
amygdala	O
and	O
hippocampus	O
.	O
Moderate	O
levels	O
of	O
expression	O
are	O
also	O
observed	O
in	O
glia	O
-	O
enriched	O
areas	O
such	O
as	O
the	O
corpus	O
callosum	O
,	O
and	O
low	O
levels	O
are	O
observed	O
in	O
the	O
substantia	O
nigra	O
,	O
subthalamic	O
nuclei	O
,	O
and	O
thalamus	O
.	O
In	O
situ	O
hybridization	O
histochemistry	O
reveals	O
relatively	O
high	O
levels	O
of	O
gene1s	O
hBNPI	O
gene1e	O
mRNA	O
in	O
pyramidal	O
neurons	O
of	O
the	O
cerebral	O
cortex	O
and	O
hippocampus	O
and	O
in	O
granule	O
neurons	O
of	O
dentate	O
gyrus	O
.	O
The	O
level	O
of	O
gene1s	O
hBNPI	O
gene1e	O
mRNA	O
is	O
quite	O
low	O
in	O
fetal	O
compared	O
with	O
adult	O
species1s	O
human	O
species1e	O
brain	O
,	O
suggesting	O
developmental	O
regulation	O
of	O
gene1s	O
hBNPI	O
gene1e	O
gene	O
expression	O
.	O
Southern	O
analyses	O
of	O
nine	O
eukaryotic	O
genomic	O
DNAs	O
probed	O
under	O
stringent	O
conditions	O
with	O
gene1s	O
hBNPI	O
gene1e	O
cDNA	O
revealed	O
that	O
the	O
gene1s	O
hBNPI	O
gene1e	O
gene	O
is	O
highly	O
conserved	O
during	O
vertebrate	O
evolution	O
and	O
that	O
each	O
gene	O
is	O
most	O
likely	O
present	O
as	O
a	O
single	O
copy	O
.	O
Using	O
fluorescent	O
in	O
situ	O
hybridization	O
,	O
we	O
localized	O
gene1s	O
hBNPI	O
gene1e	O
to	O
the	O
long	O
arm	O
of	O
chromosome	O
19	O
(	O
19q13	O
)	O
in	O
close	O
proximity	O
to	O
the	O
late	O
-	O
onset	O
familial	O
Alzheimer	O
's	O
disease	O
locus	O
.	O

In	O
its	O
active	O
form	O
,	O
the	O
GTP	O
-	O
binding	O
protein	O
gene1s	O
rab8	O
gene1e	O
interacts	O
with	O
a	O
stress	O
-	O
activated	O
protein	O
kinase	O
.	O
gene1s	O
Rab8	O
gene1e	O
is	O
a	O
small	O
GTP	O
-	O
binding	O
protein	O
that	O
plays	O
a	O
role	O
in	O
vesicular	O
transport	O
from	O
the	O
trans	O
-	O
Golgi	O
network	O
to	O
the	O
basolateral	O
plasma	O
membrane	O
in	O
polarized	O
epithelial	O
cells	O
(	O
MDCK	O
)	O
,	O
and	O
to	O
the	O
dendritic	O
surface	O
in	O
hippocampal	O
neurons	O
.	O
As	O
is	O
the	O
case	O
for	O
most	O
other	O
rab	O
proteins	O
,	O
the	O
precise	O
molecular	O
interactions	O
by	O
which	O
gene1s	O
rab8	O
gene1e	O
carries	O
out	O
its	O
function	O
remain	O
to	O
be	O
elucidated	O
.	O
Here	O
we	O
report	O
the	O
identification	O
and	O
the	O
complete	O
cDNA	O
-	O
derived	O
amino	O
acid	O
sequence	O
of	O
a	O
arg1s	O
murine	O
arg1e	O
gene1s	ARG2
rab8-interacting	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
rab8ip	ARG2
gene1e	ARG2
)	O
that	O
specifically	O
interacts	O
with	O
gene1s	O
rab8	O
gene1e	O
in	O
a	O
GTP	O
-	O
dependent	O
manner	O
.	O
gene1s	ARG2
Rab8ip	ARG2
gene1e	ARG2
displays	O
93	O
%	O
identity	O
with	O
the	O
gene1s	O
GC	O
kinase	O
gene1e	O
,	O
a	O
serine	O
/	O
threonine	O
protein	O
kinase	O
recently	O
identified	O
in	O
species1s	O
human	O
species1e	O
lymphoid	O
tissue	O
that	O
is	O
activated	O
in	O
the	O
stress	O
response	O
.	O
Like	O
the	O
gene1s	O
GC	O
kinase	O
gene1e	O
,	O
gene1s	ARG2
rab8ip	ARG2
gene1e	ARG2
has	O
protein	O
kinase	O
activity	O
manifested	O
by	O
autophosphorylation	O
and	O
phosphorylation	O
of	O
the	O
classical	O
serine	O
/	O
threonine	O
protein	O
kinase	O
substrates	O
,	O
gene1s	O
myelin	O
basic	O
protein	O
gene1e	O
and	O
casein	O
.	O
When	O
coexpressed	O
in	O
transfected	O
species1s	O
293	O
T	O
species1e	O
cells	O
,	O
gene1s	O
rab8	O
gene1e	O
and	O
the	O
gene1s	ARG2
rab8ip	ARG2
gene1e	ARG2
/	O
gene1s	O
GC	O
kinase	O
gene1e	O
formed	O
a	O
complex	O
that	O
could	O
be	O
recovered	O
by	O
immunoprecipitation	O
with	O
antibodies	O
to	O
gene1s	O
rab8	O
gene1e	O
.	O
Cell	O
fractionation	O
and	O
immunofluorescence	O
analyses	O
indicate	O
that	O
in	O
species1s	O
MDCK	O
species1e	O
cells	O
endogenous	O
gene1s	ARG2
rab8ip	ARG2
gene1e	ARG2
is	O
present	O
both	O
in	O
the	O
cytosol	O
and	O
as	O
a	O
peripheral	O
membrane	O
protein	O
concentrated	O
in	O
the	O
Golgi	O
region	O
and	O
basolateral	O
plasma	O
membrane	O
domains	O
,	O
sites	O
where	O
gene1s	O
rab8	O
gene1e	O
itself	O
is	O
also	O
located	O
.	O
In	O
light	O
of	O
recent	O
evidence	O
that	O
rab	O
proteins	O
may	O
act	O
by	O
promoting	O
the	O
stabilization	O
of	O
SNARE	O
complexes	O
,	O
the	O
specific	O
GTP	O
-	O
dependent	O
association	O
of	O
gene1s	O
rab8	O
gene1e	O
with	O
the	O
gene1s	ARG2
rab8ip	ARG2
gene1e	ARG2
/	O
gene1s	O
GC	O
kinase	O
gene1e	O
raises	O
the	O
possibility	O
that	O
rab	O
-	O
regulated	O
protein	O
phosphorylation	O
is	O
important	O
for	O
vesicle	O
targeting	O
or	O
fusion	O
.	O
Moreover	O
,	O
the	O
gene1s	ARG2
rab8ip	ARG2
gene1e	ARG2
/	O
gene1s	O
GC	O
kinase	O
gene1e	O
may	O
serve	O
to	O
modulate	O
secretion	O
in	O
response	O
to	O
stress	O
stimuli	O
.	O

In	O
its	O
active	O
form	O
,	O
the	O
GTP	O
-	O
binding	O
protein	O
gene1s	ARG2
rab8	ARG2
gene1e	ARG2
interacts	O
with	O
a	O
stress	O
-	O
activated	O
protein	O
kinase	O
.	O
gene1s	ARG2
Rab8	ARG2
gene1e	ARG2
is	O
a	O
small	O
GTP	O
-	O
binding	O
protein	O
that	O
plays	O
a	O
role	O
in	O
vesicular	O
transport	O
from	O
the	O
trans	O
-	O
Golgi	O
network	O
to	O
the	O
basolateral	O
plasma	O
membrane	O
in	O
polarized	O
epithelial	O
cells	O
(	O
MDCK	O
)	O
,	O
and	O
to	O
the	O
dendritic	O
surface	O
in	O
hippocampal	O
neurons	O
.	O
As	O
is	O
the	O
case	O
for	O
most	O
other	O
rab	O
proteins	O
,	O
the	O
precise	O
molecular	O
interactions	O
by	O
which	O
gene1s	ARG2
rab8	ARG2
gene1e	ARG2
carries	O
out	O
its	O
function	O
remain	O
to	O
be	O
elucidated	O
.	O
Here	O
we	O
report	O
the	O
identification	O
and	O
the	O
complete	O
cDNA	O
-	O
derived	O
amino	O
acid	O
sequence	O
of	O
a	O
species1s	O
murine	O
species1e	O
gene1s	O
rab8-interacting	O
protein	O
gene1e	O
(	O
gene1s	O
rab8ip	O
gene1e	O
)	O
that	O
specifically	O
interacts	O
with	O
gene1s	ARG2
rab8	ARG2
gene1e	ARG2
in	O
a	O
GTP	O
-	O
dependent	O
manner	O
.	O
gene1s	O
Rab8ip	O
gene1e	O
displays	O
93	O
%	O
identity	O
with	O
the	O
gene1s	ARG2
GC	ARG2
kinase	ARG2
gene1e	ARG2
,	O
a	O
serine	O
/	O
threonine	O
protein	O
kinase	O
recently	O
identified	O
in	O
arg1s	O
human	O
arg1e	O
lymphoid	O
tissue	O
that	O
is	O
activated	O
in	O
the	O
stress	O
response	O
.	O
Like	O
the	O
gene1s	ARG2
GC	ARG2
kinase	ARG2
gene1e	ARG2
,	O
gene1s	O
rab8ip	O
gene1e	O
has	O
protein	O
kinase	O
activity	O
manifested	O
by	O
autophosphorylation	O
and	O
phosphorylation	O
of	O
the	O
classical	O
serine	O
/	O
threonine	O
protein	O
kinase	O
substrates	O
,	O
gene1s	ARG2
myelin	ARG2
basic	ARG2
protein	ARG2
gene1e	ARG2
and	O
casein	O
.	O
When	O
coexpressed	O
in	O
transfected	O
arg1s	O
293	O
T	O
arg1e	O
cells	O
,	O
gene1s	ARG2
rab8	ARG2
gene1e	ARG2
and	O
the	O
gene1s	O
rab8ip	O
gene1e	O
/	O
gene1s	ARG2
GC	ARG2
kinase	ARG2
gene1e	ARG2
formed	O
a	O
complex	O
that	O
could	O
be	O
recovered	O
by	O
immunoprecipitation	O
with	O
antibodies	O
to	O
gene1s	ARG2
rab8	ARG2
gene1e	ARG2
.	O
Cell	O
fractionation	O
and	O
immunofluorescence	O
analyses	O
indicate	O
that	O
in	O
species1s	O
MDCK	O
species1e	O
cells	O
endogenous	O
gene1s	O
rab8ip	O
gene1e	O
is	O
present	O
both	O
in	O
the	O
cytosol	O
and	O
as	O
a	O
peripheral	O
membrane	O
protein	O
concentrated	O
in	O
the	O
Golgi	O
region	O
and	O
basolateral	O
plasma	O
membrane	O
domains	O
,	O
sites	O
where	O
gene1s	ARG2
rab8	ARG2
gene1e	ARG2
itself	O
is	O
also	O
located	O
.	O
In	O
light	O
of	O
recent	O
evidence	O
that	O
rab	O
proteins	O
may	O
act	O
by	O
promoting	O
the	O
stabilization	O
of	O
SNARE	O
complexes	O
,	O
the	O
specific	O
GTP	O
-	O
dependent	O
association	O
of	O
gene1s	ARG2
rab8	ARG2
gene1e	ARG2
with	O
the	O
gene1s	O
rab8ip	O
gene1e	O
/	O
gene1s	ARG2
GC	ARG2
kinase	ARG2
gene1e	ARG2
raises	O
the	O
possibility	O
that	O
rab	O
-	O
regulated	O
protein	O
phosphorylation	O
is	O
important	O
for	O
vesicle	O
targeting	O
or	O
fusion	O
.	O
Moreover	O
,	O
the	O
gene1s	O
rab8ip	O
gene1e	O
/	O
gene1s	ARG2
GC	ARG2
kinase	ARG2
gene1e	ARG2
may	O
serve	O
to	O
modulate	O
secretion	O
in	O
response	O
to	O
stress	O
stimuli	O
.	O

In	O
its	O
active	O
form	O
,	O
the	O
GTP	O
-	O
binding	O
protein	O
gene1s	O
rab8	O
gene1e	O
interacts	O
with	O
a	O
stress	O
-	O
activated	O
protein	O
kinase	O
.	O
gene1s	O
Rab8	O
gene1e	O
is	O
a	O
small	O
GTP	O
-	O
binding	O
protein	O
that	O
plays	O
a	O
role	O
in	O
vesicular	O
transport	O
from	O
the	O
trans	O
-	O
Golgi	O
network	O
to	O
the	O
basolateral	O
plasma	O
membrane	O
in	O
polarized	O
epithelial	O
cells	O
(	O
MDCK	O
)	O
,	O
and	O
to	O
the	O
dendritic	O
surface	O
in	O
hippocampal	O
neurons	O
.	O
As	O
is	O
the	O
case	O
for	O
most	O
other	O
rab	O
proteins	O
,	O
the	O
precise	O
molecular	O
interactions	O
by	O
which	O
gene1s	O
rab8	O
gene1e	O
carries	O
out	O
its	O
function	O
remain	O
to	O
be	O
elucidated	O
.	O
Here	O
we	O
report	O
the	O
identification	O
and	O
the	O
complete	O
cDNA	O
-	O
derived	O
amino	O
acid	O
sequence	O
of	O
a	O
species1s	O
murine	O
species1e	O
gene1s	O
rab8-interacting	O
protein	O
gene1e	O
(	O
gene1s	O
rab8ip	O
gene1e	O
)	O
that	O
specifically	O
interacts	O
with	O
gene1s	O
rab8	O
gene1e	O
in	O
a	O
GTP	O
-	O
dependent	O
manner	O
.	O
gene1s	O
Rab8ip	O
gene1e	O
displays	O
93	O
%	O
identity	O
with	O
the	O
gene1s	O
GC	O
kinase	O
gene1e	O
,	O
a	O
serine	O
/	O
threonine	O
protein	O
kinase	O
recently	O
identified	O
in	O
species1s	O
human	O
species1e	O
lymphoid	O
tissue	O
that	O
is	O
activated	O
in	O
the	O
stress	O
response	O
.	O
Like	O
the	O
gene1s	O
GC	O
kinase	O
gene1e	O
,	O
gene1s	O
rab8ip	O
gene1e	O
has	O
protein	O
kinase	O
activity	O
manifested	O
by	O
autophosphorylation	O
and	O
phosphorylation	O
of	O
the	O
classical	O
serine	O
/	O
threonine	O
protein	O
kinase	O
substrates	O
,	O
gene1s	O
myelin	O
basic	O
protein	O
gene1e	O
and	O
casein	O
.	O
When	O
coexpressed	O
in	O
transfected	O
species1s	O
293	O
T	O
species1e	O
cells	O
,	O
gene1s	O
rab8	O
gene1e	O
and	O
the	O
gene1s	O
rab8ip	O
gene1e	O
/	O
gene1s	O
GC	O
kinase	O
gene1e	O
formed	O
a	O
complex	O
that	O
could	O
be	O
recovered	O
by	O
immunoprecipitation	O
with	O
antibodies	O
to	O
gene1s	O
rab8	O
gene1e	O
.	O
Cell	O
fractionation	O
and	O
immunofluorescence	O
analyses	O
indicate	O
that	O
in	O
arg1s	O
MDCK	O
arg1e	O
cells	O
endogenous	O
gene1s	O
rab8ip	O
gene1e	O
is	O
present	O
both	O
in	O
the	O
cytosol	O
and	O
as	O
a	O
peripheral	O
membrane	O
protein	O
concentrated	O
in	O
the	O
Golgi	O
region	O
and	O
basolateral	O
plasma	O
membrane	O
domains	O
,	O
sites	O
where	O
gene1s	O
rab8	O
gene1e	O
itself	O
is	O
also	O
located	O
.	O
In	O
light	O
of	O
recent	O
evidence	O
that	O
rab	O
proteins	O
may	O
act	O
by	O
promoting	O
the	O
stabilization	O
of	O
SNARE	O
complexes	O
,	O
the	O
specific	O
GTP	O
-	O
dependent	O
association	O
of	O
gene1s	O
rab8	O
gene1e	O
with	O
the	O
gene1s	O
rab8ip	O
gene1e	O
/	O
gene1s	O
GC	O
kinase	O
gene1e	O
raises	O
the	O
possibility	O
that	O
rab	O
-	O
regulated	O
protein	O
phosphorylation	O
is	O
important	O
for	O
vesicle	O
targeting	O
or	O
fusion	O
.	O
Moreover	O
,	O
the	O
gene1s	O
rab8ip	O
gene1e	O
/	O
gene1s	O
GC	O
kinase	O
gene1e	O
may	O
serve	O
to	O
modulate	O
secretion	O
in	O
response	O
to	O
stress	O
stimuli	O
.	O

Distinct	O
pharmacological	O
properties	O
and	O
distribution	O
in	O
neurons	O
and	O
endocrine	O
cells	O
of	O
two	O
isoforms	O
of	O
the	O
arg1s	O
human	O
arg1e	O
vesicular	O
monoamine	O
transporter	O
.	O
A	O
second	O
isoform	O
of	O
the	O
arg1s	O
human	O
arg1e	O
vesicular	O
monoamine	O
transporter	O
(	O
hVMAT	O
)	O
has	O
been	O
cloned	O
from	O
a	O
pheochromocytoma	O
cDNA	O
library	O
.	O
The	O
contribution	O
of	O
the	O
two	O
transporter	O
isoforms	O
to	O
monoamine	O
storage	O
in	O
arg1s	O
human	O
arg1e	O
neuroendocrine	O
tissues	O
was	O
examined	O
with	O
isoform	O
-	O
specific	O
polyclonal	O
antibodies	O
against	O
gene1s	ARG2
hVMAT1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
hVMAT2	ARG2
gene1e	ARG2
.	O
Central	O
,	O
peripheral	O
,	O
and	O
enteric	O
neurons	O
express	O
only	O
gene1s	ARG2
VMAT2	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
VMAT1	ARG2
gene1e	ARG2
is	O
expressed	O
exclusively	O
in	O
neuroendocrine	O
,	O
including	O
chromaffin	O
and	O
enterochromaffin	O
,	O
cells	O
.	O
gene1s	ARG2
VMAT1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
VMAT2	ARG2
gene1e	ARG2
are	O
coexpressed	O
in	O
all	O
chromaffin	O
cells	O
of	O
the	O
adrenal	O
medulla	O
.	O
gene1s	ARG2
VMAT2	ARG2
gene1e	ARG2
alone	O
is	O
expressed	O
in	O
histamine	O
-	O
storing	O
enterochromaffin	O
-	O
like	O
cells	O
of	O
the	O
oxyntic	O
mucosa	O
of	O
the	O
stomach	O
.	O
The	O
transport	O
characteristics	O
and	O
pharmacology	O
of	O
each	O
VMAT	O
isoform	O
have	O
been	O
directly	O
compared	O
after	O
expression	O
in	O
digitonin	O
-	O
permeabilized	O
fibroblastic	O
(	O
species1s	O
CV-1	O
species1e	O
)	O
cells	O
,	O
providing	O
information	O
about	O
substrate	O
feature	O
recognition	O
by	O
each	O
transporter	O
and	O
the	O
role	O
of	O
vesicular	O
monoamine	O
storage	O
in	O
the	O
mechanism	O
of	O
action	O
of	O
psychopharmacologic	O
and	O
neurotoxic	O
agents	O
in	O
arg1s	O
human	O
arg1e	O
.	O
Serotonin	O
has	O
a	O
similar	O
affinity	O
for	O
both	O
transporters	O
.	O
Catecholamines	O
exhibit	O
a	O
3-fold	O
higher	O
affinity	O
,	O
and	O
histamine	O
exhibits	O
a	O
30-fold	O
higher	O
affinity	O
,	O
for	O
gene1s	ARG2
VMAT2	ARG2
gene1e	ARG2
.	O
Reserpine	O
and	O
ketanserin	O
are	O
slightly	O
more	O
potent	O
inhibitors	O
of	O
gene1s	ARG2
VMAT2	ARG2
gene1e	ARG2
-mediated	O
transport	O
than	O
of	O
gene1s	ARG2
VMAT1	ARG2
gene1e	ARG2
-mediated	O
transport	O
,	O
whereas	O
tetrabenazine	O
binds	O
to	O
and	O
inhibits	O
only	O
gene1s	ARG2
VMAT2	ARG2
gene1e	ARG2
.	O
N	O
-	O
methyl-4-phenylpyridinium	O
,	O
phenylethylamine	O
,	O
amphetamine	O
,	O
and	O
methylenedioxymethamphetamine	O
are	O
all	O
more	O
potent	O
inhibitors	O
of	O
gene1s	ARG2
VMAT2	ARG2
gene1e	ARG2
than	O
of	O
gene1s	ARG2
VMAT1	ARG2
gene1e	ARG2
,	O
whereas	O
fenfluramine	O
is	O
a	O
more	O
potent	O
inhibitor	O
of	O
gene1s	ARG2
VMAT1	ARG2
gene1e	ARG2
-mediated	O
monamine	O
transport	O
than	O
of	O
gene1s	ARG2
VMAT2	ARG2
gene1e	ARG2
-mediated	O
monoamine	O
transport	O
.	O
The	O
unique	O
distributions	O
of	O
gene1s	ARG2
hVMAT1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
hVMAT2	ARG2
gene1e	ARG2
provide	O
new	O
markers	O
for	O
multiple	O
neuroendocrine	O
lineages	O
,	O
and	O
examination	O
of	O
their	O
transport	O
properties	O
provides	O
mechanistic	O
insights	O
into	O
the	O
pharmacology	O
and	O
physiology	O
of	O
amine	O
storage	O
in	O
cardiovascular	O
,	O
endocrine	O
,	O
and	O
central	O
nervous	O
system	O
function	O
.	O

Distinct	O
pharmacological	O
properties	O
and	O
distribution	O
in	O
neurons	O
and	O
endocrine	O
cells	O
of	O
two	O
isoforms	O
of	O
the	O
species1s	O
human	O
species1e	O
vesicular	O
monoamine	O
transporter	O
.	O
A	O
second	O
isoform	O
of	O
the	O
species1s	O
human	O
species1e	O
vesicular	O
monoamine	O
transporter	O
(	O
hVMAT	O
)	O
has	O
been	O
cloned	O
from	O
a	O
pheochromocytoma	O
cDNA	O
library	O
.	O
The	O
contribution	O
of	O
the	O
two	O
transporter	O
isoforms	O
to	O
monoamine	O
storage	O
in	O
species1s	O
human	O
species1e	O
neuroendocrine	O
tissues	O
was	O
examined	O
with	O
isoform	O
-	O
specific	O
polyclonal	O
antibodies	O
against	O
gene1s	O
hVMAT1	O
gene1e	O
and	O
gene1s	O
hVMAT2	O
gene1e	O
.	O
Central	O
,	O
peripheral	O
,	O
and	O
enteric	O
neurons	O
express	O
only	O
gene1s	O
VMAT2	O
gene1e	O
.	O
gene1s	O
VMAT1	O
gene1e	O
is	O
expressed	O
exclusively	O
in	O
neuroendocrine	O
,	O
including	O
chromaffin	O
and	O
enterochromaffin	O
,	O
cells	O
.	O
gene1s	O
VMAT1	O
gene1e	O
and	O
gene1s	O
VMAT2	O
gene1e	O
are	O
coexpressed	O
in	O
all	O
chromaffin	O
cells	O
of	O
the	O
adrenal	O
medulla	O
.	O
gene1s	O
VMAT2	O
gene1e	O
alone	O
is	O
expressed	O
in	O
histamine	O
-	O
storing	O
enterochromaffin	O
-	O
like	O
cells	O
of	O
the	O
oxyntic	O
mucosa	O
of	O
the	O
stomach	O
.	O
The	O
transport	O
characteristics	O
and	O
pharmacology	O
of	O
each	O
VMAT	O
isoform	O
have	O
been	O
directly	O
compared	O
after	O
expression	O
in	O
digitonin	O
-	O
permeabilized	O
fibroblastic	O
(	O
arg1s	O
CV-1	O
arg1e	O
)	O
cells	O
,	O
providing	O
information	O
about	O
substrate	O
feature	O
recognition	O
by	O
each	O
transporter	O
and	O
the	O
role	O
of	O
vesicular	O
monoamine	O
storage	O
in	O
the	O
mechanism	O
of	O
action	O
of	O
psychopharmacologic	O
and	O
neurotoxic	O
agents	O
in	O
species1s	O
human	O
species1e	O
.	O
Serotonin	O
has	O
a	O
similar	O
affinity	O
for	O
both	O
transporters	O
.	O
Catecholamines	O
exhibit	O
a	O
3-fold	O
higher	O
affinity	O
,	O
and	O
histamine	O
exhibits	O
a	O
30-fold	O
higher	O
affinity	O
,	O
for	O
gene1s	O
VMAT2	O
gene1e	O
.	O
Reserpine	O
and	O
ketanserin	O
are	O
slightly	O
more	O
potent	O
inhibitors	O
of	O
gene1s	O
VMAT2	O
gene1e	O
-mediated	O
transport	O
than	O
of	O
gene1s	O
VMAT1	O
gene1e	O
-mediated	O
transport	O
,	O
whereas	O
tetrabenazine	O
binds	O
to	O
and	O
inhibits	O
only	O
gene1s	O
VMAT2	O
gene1e	O
.	O
N	O
-	O
methyl-4-phenylpyridinium	O
,	O
phenylethylamine	O
,	O
amphetamine	O
,	O
and	O
methylenedioxymethamphetamine	O
are	O
all	O
more	O
potent	O
inhibitors	O
of	O
gene1s	O
VMAT2	O
gene1e	O
than	O
of	O
gene1s	O
VMAT1	O
gene1e	O
,	O
whereas	O
fenfluramine	O
is	O
a	O
more	O
potent	O
inhibitor	O
of	O
gene1s	O
VMAT1	O
gene1e	O
-mediated	O
monamine	O
transport	O
than	O
of	O
gene1s	O
VMAT2	O
gene1e	O
-mediated	O
monoamine	O
transport	O
.	O
The	O
unique	O
distributions	O
of	O
gene1s	O
hVMAT1	O
gene1e	O
and	O
gene1s	O
hVMAT2	O
gene1e	O
provide	O
new	O
markers	O
for	O
multiple	O
neuroendocrine	O
lineages	O
,	O
and	O
examination	O
of	O
their	O
transport	O
properties	O
provides	O
mechanistic	O
insights	O
into	O
the	O
pharmacology	O
and	O
physiology	O
of	O
amine	O
storage	O
in	O
cardiovascular	O
,	O
endocrine	O
,	O
and	O
central	O
nervous	O
system	O
function	O
.	O

gene1s	O
MDC9	O
gene1e	O
,	O
a	O
widely	O
expressed	O
cellular	O
disintegrin	O
containing	O
cytoplasmic	O
SH3	O
ligand	O
domains	O
.	O
Cellular	O
disintegrins	O
are	O
a	O
family	O
of	O
proteins	O
that	O
are	O
related	O
to	O
snake	O
venom	O
integrin	O
ligands	O
and	O
metalloproteases	O
.	O
We	O
have	O
cloned	O
and	O
sequenced	O
the	O
arg1s	O
mouse	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
homologue	O
of	O
a	O
widely	O
expressed	O
cellular	O
disintegrin	O
,	O
which	O
we	O
have	O
termed	O
gene1s	O
MDC9	O
gene1e	O
(	O
for	O
gene1s	O
metalloprotease	O
/	O
disintegrin	O
/	O
cysteine	O
-	O
rich	O
protein	O
9	O
gene1e	O
)	O
.	O
The	O
deduced	O
arg1s	O
mouse	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
protein	O
sequences	O
are	O
82	O
%	O
identical	O
.	O
gene1s	O
MDC9	O
gene1e	O
contains	O
several	O
distinct	O
protein	O
domains	O
:	O
a	O
signal	O
sequence	O
is	O
followed	O
by	O
a	O
prodomain	O
and	O
a	O
domain	O
with	O
sequence	O
similarity	O
to	O
snake	O
venom	O
metalloproteases	O
,	O
a	O
disintegrin	O
domain	O
,	O
a	O
cysteine	O
-	O
rich	O
region	O
,	O
an	O
EGF	O
repeat	O
,	O
a	O
membrane	O
anchor	O
,	O
and	O
a	O
cytoplasmic	O
tail	O
.	O
The	O
cytoplasmic	O
tail	O
of	O
gene1s	O
MDC9	O
gene1e	O
has	O
two	O
proline	O
-	O
rich	O
sequences	O
which	O
can	O
bind	O
the	O
SH3	O
domain	O
of	O
gene1s	O
Src	O
gene1e	O
,	O
and	O
may	O
therefore	O
function	O
as	O
SH3	O
ligand	O
domains	O
.	O
Western	O
blot	O
analysis	O
shows	O
that	O
gene1s	O
MDC9	O
gene1e	O
is	O
an	O
approximately	O
84-kD	O
glycoprotein	O
in	O
all	O
arg1s	O
mouse	O
arg1e	O
tissues	O
examined	O
,	O
and	O
in	O
NIH	O
3T3	O
fibroblast	O
and	O
arg1s	O
C2C12	O
arg1e	O
myoblast	O
arg1s	O
mouse	O
arg1e	O
cell	O
lines	O
.	O
gene1s	O
MDC9	O
gene1e	O
can	O
be	O
both	O
cell	O
surface	O
biotinylated	O
and	O
125I	O
-	O
labeled	O
in	O
NIH	O
3T3	O
arg1s	O
mouse	O
arg1e	O
fibroblasts	O
,	O
indicating	O
that	O
the	O
protein	O
is	O
present	O
on	O
the	O
plasma	O
membrane	O
.	O
Expression	O
of	O
gene1s	O
MDC9	O
gene1e	O
in	O
species1s	O
COS-7	O
species1e	O
cells	O
yields	O
an	O
84-kD	O
protein	O
,	O
and	O
immunofluorescence	O
analysis	O
of	O
species1s	O
COS-7	O
species1e	O
cells	O
expressing	O
gene1s	O
MDC9	O
gene1e	O
shows	O
a	O
staining	O
pattern	O
that	O
is	O
consistent	O
with	O
a	O
plasma	O
membrane	O
localization	O
.	O
The	O
apparent	O
molecular	O
mass	O
of	O
84	O
kD	O
suggests	O
that	O
gene1s	O
MDC9	O
gene1e	O
contains	O
a	O
membrane	O
-	O
anchored	O
metalloprotease	O
and	O
disintegrin	O
domain	O
.	O
We	O
propose	O
that	O
gene1s	O
MDC9	O
gene1e	O
might	O
function	O
as	O
a	O
membrane	O
-	O
anchored	O
integrin	O
ligand	O
or	O
metalloprotease	O
,	O
or	O
that	O
gene1s	O
MDC9	O
gene1e	O
may	O
combine	O
both	O
activities	O
in	O
one	O
protein	O
.	O

gene1s	ARG2
MDC9	ARG2
gene1e	ARG2
,	O
a	O
widely	O
expressed	O
cellular	O
disintegrin	O
containing	O
cytoplasmic	O
SH3	O
ligand	O
domains	O
.	O
Cellular	O
disintegrins	O
are	O
a	O
family	O
of	O
proteins	O
that	O
are	O
related	O
to	O
snake	O
venom	O
integrin	O
ligands	O
and	O
metalloproteases	O
.	O
We	O
have	O
cloned	O
and	O
sequenced	O
the	O
species1s	O
mouse	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
homologue	O
of	O
a	O
widely	O
expressed	O
cellular	O
disintegrin	O
,	O
which	O
we	O
have	O
termed	O
gene1s	ARG2
MDC9	ARG2
gene1e	ARG2
(	O
for	O
gene1s	ARG2
metalloprotease	ARG2
/	ARG2
disintegrin	ARG2
/	ARG2
cysteine	ARG2
-	ARG2
rich	ARG2
protein	ARG2
9	ARG2
gene1e	ARG2
)	O
.	O
The	O
deduced	O
species1s	O
mouse	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
protein	O
sequences	O
are	O
82	O
%	O
identical	O
.	O
gene1s	ARG2
MDC9	ARG2
gene1e	ARG2
contains	O
several	O
distinct	O
protein	O
domains	O
:	O
a	O
signal	O
sequence	O
is	O
followed	O
by	O
a	O
prodomain	O
and	O
a	O
domain	O
with	O
sequence	O
similarity	O
to	O
snake	O
venom	O
metalloproteases	O
,	O
a	O
disintegrin	O
domain	O
,	O
a	O
cysteine	O
-	O
rich	O
region	O
,	O
an	O
EGF	O
repeat	O
,	O
a	O
membrane	O
anchor	O
,	O
and	O
a	O
cytoplasmic	O
tail	O
.	O
The	O
cytoplasmic	O
tail	O
of	O
gene1s	ARG2
MDC9	ARG2
gene1e	ARG2
has	O
two	O
proline	O
-	O
rich	O
sequences	O
which	O
can	O
bind	O
the	O
SH3	O
domain	O
of	O
gene1s	ARG2
Src	ARG2
gene1e	ARG2
,	O
and	O
may	O
therefore	O
function	O
as	O
SH3	O
ligand	O
domains	O
.	O
Western	O
blot	O
analysis	O
shows	O
that	O
gene1s	ARG2
MDC9	ARG2
gene1e	ARG2
is	O
an	O
approximately	O
84-kD	O
glycoprotein	O
in	O
all	O
species1s	O
mouse	O
species1e	O
tissues	O
examined	O
,	O
and	O
in	O
NIH	O
3T3	O
fibroblast	O
and	O
species1s	O
C2C12	O
species1e	O
myoblast	O
species1s	O
mouse	O
species1e	O
cell	O
lines	O
.	O
gene1s	ARG2
MDC9	ARG2
gene1e	ARG2
can	O
be	O
both	O
cell	O
surface	O
biotinylated	O
and	O
125I	O
-	O
labeled	O
in	O
NIH	O
3T3	O
species1s	O
mouse	O
species1e	O
fibroblasts	O
,	O
indicating	O
that	O
the	O
protein	O
is	O
present	O
on	O
the	O
plasma	O
membrane	O
.	O
Expression	O
of	O
gene1s	ARG2
MDC9	ARG2
gene1e	ARG2
in	O
species1s	O
COS-7	O
species1e	O
cells	O
yields	O
an	O
84-kD	O
protein	O
,	O
and	O
immunofluorescence	O
analysis	O
of	O
species1s	O
COS-7	O
species1e	O
cells	O
expressing	O
gene1s	ARG2
MDC9	ARG2
gene1e	ARG2
shows	O
a	O
staining	O
pattern	O
that	O
is	O
consistent	O
with	O
a	O
plasma	O
membrane	O
localization	O
.	O
The	O
apparent	O
molecular	O
mass	O
of	O
84	O
kD	O
suggests	O
that	O
gene1s	ARG2
MDC9	ARG2
gene1e	ARG2
contains	O
a	O
membrane	O
-	O
anchored	O
metalloprotease	O
and	O
disintegrin	O
domain	O
.	O
We	O
propose	O
that	O
gene1s	ARG2
MDC9	ARG2
gene1e	ARG2
might	O
function	O
as	O
a	O
membrane	O
-	O
anchored	O
integrin	O
ligand	O
or	O
metalloprotease	O
,	O
or	O
that	O
gene1s	ARG2
MDC9	ARG2
gene1e	ARG2
may	O
combine	O
both	O
activities	O
in	O
one	O
protein	O
.	O

gene1s	O
MDC9	O
gene1e	O
,	O
a	O
widely	O
expressed	O
cellular	O
disintegrin	O
containing	O
cytoplasmic	O
SH3	O
ligand	O
domains	O
.	O
Cellular	O
disintegrins	O
are	O
a	O
family	O
of	O
proteins	O
that	O
are	O
related	O
to	O
snake	O
venom	O
integrin	O
ligands	O
and	O
metalloproteases	O
.	O
We	O
have	O
cloned	O
and	O
sequenced	O
the	O
species1s	O
mouse	O
species1e	O
and	O
species1s	O
human	O
species1e	O
homologue	O
of	O
a	O
widely	O
expressed	O
cellular	O
disintegrin	O
,	O
which	O
we	O
have	O
termed	O
gene1s	O
MDC9	O
gene1e	O
(	O
for	O
gene1s	O
metalloprotease	O
/	O
disintegrin	O
/	O
cysteine	O
-	O
rich	O
protein	O
9	O
gene1e	O
)	O
.	O
The	O
deduced	O
species1s	O
mouse	O
species1e	O
and	O
species1s	O
human	O
species1e	O
protein	O
sequences	O
are	O
82	O
%	O
identical	O
.	O
gene1s	O
MDC9	O
gene1e	O
contains	O
several	O
distinct	O
protein	O
domains	O
:	O
a	O
signal	O
sequence	O
is	O
followed	O
by	O
a	O
prodomain	O
and	O
a	O
domain	O
with	O
sequence	O
similarity	O
to	O
snake	O
venom	O
metalloproteases	O
,	O
a	O
disintegrin	O
domain	O
,	O
a	O
cysteine	O
-	O
rich	O
region	O
,	O
an	O
EGF	O
repeat	O
,	O
a	O
membrane	O
anchor	O
,	O
and	O
a	O
cytoplasmic	O
tail	O
.	O
The	O
cytoplasmic	O
tail	O
of	O
gene1s	O
MDC9	O
gene1e	O
has	O
two	O
proline	O
-	O
rich	O
sequences	O
which	O
can	O
bind	O
the	O
SH3	O
domain	O
of	O
gene1s	O
Src	O
gene1e	O
,	O
and	O
may	O
therefore	O
function	O
as	O
SH3	O
ligand	O
domains	O
.	O
Western	O
blot	O
analysis	O
shows	O
that	O
gene1s	O
MDC9	O
gene1e	O
is	O
an	O
approximately	O
84-kD	O
glycoprotein	O
in	O
all	O
species1s	O
mouse	O
species1e	O
tissues	O
examined	O
,	O
and	O
in	O
NIH	O
3T3	O
fibroblast	O
and	O
species1s	O
C2C12	O
species1e	O
myoblast	O
species1s	O
mouse	O
species1e	O
cell	O
lines	O
.	O
gene1s	O
MDC9	O
gene1e	O
can	O
be	O
both	O
cell	O
surface	O
biotinylated	O
and	O
125I	O
-	O
labeled	O
in	O
NIH	O
3T3	O
species1s	O
mouse	O
species1e	O
fibroblasts	O
,	O
indicating	O
that	O
the	O
protein	O
is	O
present	O
on	O
the	O
plasma	O
membrane	O
.	O
Expression	O
of	O
gene1s	O
MDC9	O
gene1e	O
in	O
arg1s	O
COS-7	O
arg1e	O
cells	O
yields	O
an	O
84-kD	O
protein	O
,	O
and	O
immunofluorescence	O
analysis	O
of	O
arg1s	O
COS-7	O
arg1e	O
cells	O
expressing	O
gene1s	O
MDC9	O
gene1e	O
shows	O
a	O
staining	O
pattern	O
that	O
is	O
consistent	O
with	O
a	O
plasma	O
membrane	O
localization	O
.	O
The	O
apparent	O
molecular	O
mass	O
of	O
84	O
kD	O
suggests	O
that	O
gene1s	O
MDC9	O
gene1e	O
contains	O
a	O
membrane	O
-	O
anchored	O
metalloprotease	O
and	O
disintegrin	O
domain	O
.	O
We	O
propose	O
that	O
gene1s	O
MDC9	O
gene1e	O
might	O
function	O
as	O
a	O
membrane	O
-	O
anchored	O
integrin	O
ligand	O
or	O
metalloprotease	O
,	O
or	O
that	O
gene1s	O
MDC9	O
gene1e	O
may	O
combine	O
both	O
activities	O
in	O
one	O
protein	O
.	O

A	O
gene1s	ARG2
GLRA1	ARG2
gene1e	ARG2
null	O
mutation	O
in	O
recessive	O
hyperekplexia	O
challenges	O
the	O
functional	O
role	O
of	O
glycine	O
receptors	O
.	O
Dominant	O
missense	O
mutations	O
in	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
glycine	ARG2
receptor	ARG2
(	ARG2
GlyR	ARG2
)	ARG2
alpha	ARG2
1	ARG2
gene1e	ARG2
subunit	O
gene	O
(	O
gene1s	ARG2
GLRA1	ARG2
gene1e	ARG2
)	O
give	O
rise	O
to	O
hereditary	O
hyperekplexia	O
.	O
These	O
mutations	O
impair	O
agonist	O
affinities	O
and	O
change	O
conductance	O
states	O
of	O
expressed	O
mutant	O
channels	O
,	O
resulting	O
in	O
a	O
partial	O
loss	O
of	O
function	O
.	O
In	O
a	O
recessive	O
case	O
of	O
hyperekplexia	O
,	O
we	O
found	O
a	O
deletion	O
of	O
exons	O
1	O
-	O
6	O
of	O
the	O
gene1s	ARG2
GLRA1	ARG2
gene1e	ARG2
gene	O
.	O
Born	O
to	O
consanguineous	O
parents	O
,	O
the	O
affected	O
arg1s	O
child	O
arg1e	O
is	O
homozygous	O
for	O
this	O
gene1s	ARG2
GLRA1	ARG2
gene1e	ARG2
(null	O
)	O
allele	O
consistent	O
with	O
a	O
complete	O
loss	O
of	O
gene	O
function	O
.	O
The	O
arg1s	O
child	O
arg1e	O
displayed	O
exaggerated	O
startle	O
responses	O
and	O
pronounced	O
head	O
-	O
retraction	O
jerks	O
reflecting	O
a	O
disinhibition	O
of	O
vestigial	O
brain	O
-	O
stem	O
reflexes	O
.	O
In	O
contrast	O
,	O
proprio-	O
and	O
exteroceptive	O
inhibition	O
of	O
muscle	O
activity	O
previously	O
correlated	O
to	O
glycinergic	O
mechanisms	O
were	O
not	O
affected	O
.	O
This	O
case	O
demonstrates	O
that	O
,	O
in	O
contrast	O
to	O
the	O
lethal	O
effect	O
of	O
a	O
null	O
allele	O
in	O
the	O
recessive	O
species1s	O
mouse	O
species1e	O
mutant	O
oscillator	O
(	O
gene1s	ARG2
Glra1	ARG2
gene1e	ARG2
gene1s	ARG2
spd	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
ot	ARG2
gene1e	ARG2
)	O
,	O
the	O
loss	O
of	O
the	O
gene1s	ARG2
GlyR	ARG2
alpha	ARG2
1	ARG2
gene1e	ARG2
subunit	O
is	O
effectively	O
compensated	O
in	O
man	O
.	O

A	O
gene1s	O
GLRA1	O
gene1e	O
null	O
mutation	O
in	O
recessive	O
hyperekplexia	O
challenges	O
the	O
functional	O
role	O
of	O
glycine	O
receptors	O
.	O
Dominant	O
missense	O
mutations	O
in	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
glycine	O
receptor	O
(	O
GlyR	O
)	O
alpha	O
1	O
gene1e	O
subunit	O
gene	O
(	O
gene1s	O
GLRA1	O
gene1e	O
)	O
give	O
rise	O
to	O
hereditary	O
hyperekplexia	O
.	O
These	O
mutations	O
impair	O
agonist	O
affinities	O
and	O
change	O
conductance	O
states	O
of	O
expressed	O
mutant	O
channels	O
,	O
resulting	O
in	O
a	O
partial	O
loss	O
of	O
function	O
.	O
In	O
a	O
recessive	O
case	O
of	O
hyperekplexia	O
,	O
we	O
found	O
a	O
deletion	O
of	O
exons	O
1	O
-	O
6	O
of	O
the	O
gene1s	O
GLRA1	O
gene1e	O
gene	O
.	O
Born	O
to	O
consanguineous	O
parents	O
,	O
the	O
affected	O
species1s	O
child	O
species1e	O
is	O
homozygous	O
for	O
this	O
gene1s	O
GLRA1	O
gene1e	O
(null	O
)	O
allele	O
consistent	O
with	O
a	O
complete	O
loss	O
of	O
gene	O
function	O
.	O
The	O
species1s	O
child	O
species1e	O
displayed	O
exaggerated	O
startle	O
responses	O
and	O
pronounced	O
head	O
-	O
retraction	O
jerks	O
reflecting	O
a	O
disinhibition	O
of	O
vestigial	O
brain	O
-	O
stem	O
reflexes	O
.	O
In	O
contrast	O
,	O
proprio-	O
and	O
exteroceptive	O
inhibition	O
of	O
muscle	O
activity	O
previously	O
correlated	O
to	O
glycinergic	O
mechanisms	O
were	O
not	O
affected	O
.	O
This	O
case	O
demonstrates	O
that	O
,	O
in	O
contrast	O
to	O
the	O
lethal	O
effect	O
of	O
a	O
null	O
allele	O
in	O
the	O
recessive	O
arg1s	O
mouse	O
arg1e	O
mutant	O
oscillator	O
(	O
gene1s	O
Glra1	O
gene1e	O
gene1s	O
spd	O
gene1e	O
-	O
gene1s	O
ot	O
gene1e	O
)	O
,	O
the	O
loss	O
of	O
the	O
gene1s	O
GlyR	O
alpha	O
1	O
gene1e	O
subunit	O
is	O
effectively	O
compensated	O
in	O
man	O
.	O

Induction	O
of	O
apoptosis	O
by	O
gene1s	ARG2
Apo-2	ARG2
ligand	ARG2
gene1e	ARG2
,	O
a	O
new	O
member	O
of	O
the	O
tumor	O
necrosis	O
factor	O
cytokine	O
family	O
.	O
Cytokines	O
in	O
the	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)	O
family	O
regulate	O
development	O
and	O
function	O
of	O
the	O
immune	O
system	O
.	O
We	O
have	O
isolated	O
a	O
new	O
member	O
of	O
this	O
family	O
,	O
designated	O
gene1s	ARG2
Apo-2	ARG2
ligand	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Apo-2L	ARG2
gene1e	ARG2
)	O
,	O
via	O
an	O
expressed	O
sequence	O
tag	O
.	O
gene1s	ARG2
Apo-2L	ARG2
gene1e	ARG2
is	O
a	O
281-amino	O
acid	O
protein	O
,	O
related	O
most	O
closely	O
to	O
gene1s	ARG2
Fas	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Apo-1	ARG2
ligand	ARG2
gene1e	ARG2
.	O
Transfected	O
gene1s	ARG2
Apo-2L	ARG2
gene1e	ARG2
is	O
expressed	O
at	O
the	O
cell	O
surface	O
with	O
its	O
C	O
terminus	O
exposed	O
,	O
indicating	O
a	O
type	O
II	O
transmembrane	O
protein	O
topology	O
.	O
Like	O
gene1s	ARG2
Fas	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Apo-1	ARG2
ligand	ARG2
gene1e	ARG2
and	O
TNF	O
,	O
the	O
C	O
-	O
terminal	O
extracellular	O
region	O
of	O
gene1s	ARG2
Apo-2L	ARG2
gene1e	ARG2
(	O
amino	O
acids	O
114	O
-	O
281	O
)	O
exhibits	O
a	O
homotrimeric	O
subunit	O
structure	O
.	O
Soluble	O
gene1s	ARG2
Apo-2L	ARG2
gene1e	ARG2
induces	O
extensive	O
apoptosis	O
in	O
lymphoid	O
as	O
well	O
as	O
non	O
-	O
lymphoid	O
tumor	O
cell	O
lines	O
.	O
The	O
effect	O
of	O
gene1s	ARG2
Apo-2L	ARG2
gene1e	ARG2
is	O
not	O
inhibited	O
by	O
soluble	O
gene1s	ARG2
Fas	ARG2
gene1e	ARG2
/	O
gene1s	O
Apo-1	O
gene1e	O
and	O
TNF	O
receptors	O
;	O
moreover	O
,	O
expression	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
Fas	ARG2
gene1e	ARG2
/	O
gene1s	O
Apo-1	O
gene1e	O
in	O
species1s	O
mouse	O
species1e	O
fibroblasts	O
,	O
which	O
confers	O
sensitivity	O
to	O
induction	O
of	O
apoptosis	O
by	O
agonistic	O
anti	O
-	O
gene1s	ARG2
Fas	ARG2
gene1e	ARG2
/	O
gene1s	O
Apo-1	O
gene1e	O
antibody	O
,	O
does	O
not	O
confer	O
sensitivity	O
to	O
gene1s	ARG2
Apo-2L	ARG2
gene1e	ARG2
.	O
Hence	O
,	O
gene1s	ARG2
Apo-2L	ARG2
gene1e	ARG2
acts	O
via	O
a	O
receptor	O
which	O
is	O
distinct	O
from	O
gene1s	ARG2
Fas	ARG2
gene1e	ARG2
/	O
gene1s	O
Apo-1	O
gene1e	O
and	O
TNF	O
receptors	O
.	O
These	O
results	O
suggest	O
that	O
,	O
along	O
with	O
other	O
family	O
members	O
such	O
as	O
gene1s	ARG2
Fas	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Apo-1	ARG2
ligand	ARG2
gene1e	ARG2
and	O
TNF	O
,	O
gene1s	ARG2
Apo-2L	ARG2
gene1e	ARG2
may	O
serve	O
as	O
an	O
extracellular	O
signal	O
that	O
triggers	O
programmed	O
cell	O
death	O
.	O

Induction	O
of	O
apoptosis	O
by	O
gene1s	O
Apo-2	O
ligand	O
gene1e	O
,	O
a	O
new	O
member	O
of	O
the	O
tumor	O
necrosis	O
factor	O
cytokine	O
family	O
.	O
Cytokines	O
in	O
the	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)	O
family	O
regulate	O
development	O
and	O
function	O
of	O
the	O
immune	O
system	O
.	O
We	O
have	O
isolated	O
a	O
new	O
member	O
of	O
this	O
family	O
,	O
designated	O
gene1s	O
Apo-2	O
ligand	O
gene1e	O
(	O
gene1s	O
Apo-2L	O
gene1e	O
)	O
,	O
via	O
an	O
expressed	O
sequence	O
tag	O
.	O
gene1s	O
Apo-2L	O
gene1e	O
is	O
a	O
281-amino	O
acid	O
protein	O
,	O
related	O
most	O
closely	O
to	O
gene1s	O
Fas	O
gene1e	O
/	O
gene1s	O
Apo-1	O
ligand	O
gene1e	O
.	O
Transfected	O
gene1s	O
Apo-2L	O
gene1e	O
is	O
expressed	O
at	O
the	O
cell	O
surface	O
with	O
its	O
C	O
terminus	O
exposed	O
,	O
indicating	O
a	O
type	O
II	O
transmembrane	O
protein	O
topology	O
.	O
Like	O
gene1s	O
Fas	O
gene1e	O
/	O
gene1s	O
Apo-1	O
ligand	O
gene1e	O
and	O
TNF	O
,	O
the	O
C	O
-	O
terminal	O
extracellular	O
region	O
of	O
gene1s	O
Apo-2L	O
gene1e	O
(	O
amino	O
acids	O
114	O
-	O
281	O
)	O
exhibits	O
a	O
homotrimeric	O
subunit	O
structure	O
.	O
Soluble	O
gene1s	O
Apo-2L	O
gene1e	O
induces	O
extensive	O
apoptosis	O
in	O
lymphoid	O
as	O
well	O
as	O
non	O
-	O
lymphoid	O
tumor	O
cell	O
lines	O
.	O
The	O
effect	O
of	O
gene1s	O
Apo-2L	O
gene1e	O
is	O
not	O
inhibited	O
by	O
soluble	O
gene1s	O
Fas	O
gene1e	O
/	O
gene1s	ARG2
Apo-1	ARG2
gene1e	ARG2
and	O
TNF	O
receptors	O
;	O
moreover	O
,	O
expression	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
Fas	O
gene1e	O
/	O
gene1s	ARG2
Apo-1	ARG2
gene1e	ARG2
in	O
arg1s	O
mouse	O
arg1e	O
fibroblasts	O
,	O
which	O
confers	O
sensitivity	O
to	O
induction	O
of	O
apoptosis	O
by	O
agonistic	O
anti	O
-	O
gene1s	O
Fas	O
gene1e	O
/	O
gene1s	ARG2
Apo-1	ARG2
gene1e	ARG2
antibody	O
,	O
does	O
not	O
confer	O
sensitivity	O
to	O
gene1s	O
Apo-2L	O
gene1e	O
.	O
Hence	O
,	O
gene1s	O
Apo-2L	O
gene1e	O
acts	O
via	O
a	O
receptor	O
which	O
is	O
distinct	O
from	O
gene1s	O
Fas	O
gene1e	O
/	O
gene1s	ARG2
Apo-1	ARG2
gene1e	ARG2
and	O
TNF	O
receptors	O
.	O
These	O
results	O
suggest	O
that	O
,	O
along	O
with	O
other	O
family	O
members	O
such	O
as	O
gene1s	O
Fas	O
gene1e	O
/	O
gene1s	O
Apo-1	O
ligand	O
gene1e	O
and	O
TNF	O
,	O
gene1s	O
Apo-2L	O
gene1e	O
may	O
serve	O
as	O
an	O
extracellular	O
signal	O
that	O
triggers	O
programmed	O
cell	O
death	O
.	O

cDNA	O
cloning	O
and	O
expression	O
of	O
a	O
novel	O
arg1s	O
human	O
arg1e	O
UDP	O
-	O
N	O
-	O
acetyl	O
-	O
alpha	O
-	O
D	O
-	O
galactosamine	O
.	O
gene1s	ARG2
Polypeptide	ARG2
N	ARG2
-	ARG2
acetylgalactosaminyltransferase	ARG2
,	ARG2
GalNAc	ARG2
-	ARG2
t3	ARG2
gene1e	ARG2
.	O
The	O
glycosylation	O
of	O
serine	O
and	O
threonine	O
residues	O
during	O
mucin	O
-	O
type	O
O	O
-	O
linked	O
protein	O
glycosylation	O
is	O
carried	O
out	O
by	O
a	O
family	O
of	O
UDP	O
-	O
GalNAc	O
:	O
polypeptide	O
N	O
-	O
acetylgalactosaminyltransferases	O
(	O
GalNAc	O
-	O
transferase	O
)	O
.	O
Previously	O
two	O
members	O
,	O
gene1s	ARG2
GalNAc	ARG2
-	ARG2
T1	ARG2
and	ARG2
-T2	ARG2
gene1e	ARG2
,	O
have	O
been	O
isolated	O
and	O
the	O
genes	O
cloned	O
and	O
characterized	O
.	O
Here	O
we	O
report	O
the	O
cDNA	O
cloning	O
and	O
expression	O
of	O
a	O
novel	O
GalNAc	O
-	O
transferase	O
termed	O
gene1s	ARG2
GalNAc	ARG2
-	ARG2
T3	ARG2
gene1e	ARG2
.	O
The	O
gene	O
was	O
isolated	O
and	O
cloned	O
based	O
on	O
the	O
identification	O
of	O
a	O
GalNAc	O
-	O
transferase	O
motif	O
(	O
61	O
amino	O
acids	O
)	O
that	O
is	O
shared	O
between	O
gene1s	ARG2
GalNAc	ARG2
-	ARG2
T1	ARG2
and	ARG2
-T2	ARG2
gene1e	ARG2
as	O
well	O
as	O
a	O
homologous	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
gene	O
.	O
The	O
cDNA	O
sequence	O
has	O
a	O
633-amino	O
acid	O
coding	O
region	O
indicating	O
a	O
protein	O
of	O
72.5	O
kDa	O
with	O
a	O
type	O
II	O
domain	O
structure	O
.	O
The	O
overall	O
amino	O
acid	O
sequence	O
similarity	O
with	O
gene1s	ARG2
GalNAc	ARG2
-	ARG2
T1	ARG2
and	ARG2
-T2	ARG2
gene1e	ARG2
is	O
approximately	O
45	O
%	O
;	O
12	O
cysteine	O
residues	O
that	O
are	O
shared	O
between	O
gene1s	ARG2
GalNAc	ARG2
-	ARG2
T1	ARG2
and	ARG2
-T2	ARG2
gene1e	ARG2
are	O
also	O
found	O
in	O
gene1s	ARG2
GalNAc	ARG2
-	ARG2
T3	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
GalNAc	ARG2
-	ARG2
T3	ARG2
gene1e	ARG2
was	O
expressed	O
as	O
a	O
soluble	O
protein	O
without	O
the	O
hydrophobic	O
transmembrane	O
domain	O
in	O
insect	O
cells	O
using	O
a	O
Baculo	O
-	O
virus	O
vector	O
,	O
and	O
the	O
expressed	O
GalNAc	O
-	O
transferase	O
activity	O
showed	O
substrate	O
specificity	O
different	O
from	O
that	O
previously	O
reported	O
for	O
gene1s	ARG2
GalNAc	ARG2
-	ARG2
T1	ARG2
and	ARG2
-T2	ARG2
gene1e	ARG2
.	O
Northern	O
analysis	O
of	O
arg1s	O
human	O
arg1e	O
organs	O
revealed	O
a	O
very	O
restricted	O
expression	O
pattern	O
of	O
gene1s	ARG2
GalNAc	ARG2
-	ARG2
T3	ARG2
gene1e	ARG2
.	O

cDNA	O
cloning	O
and	O
expression	O
of	O
a	O
novel	O
species1s	O
human	O
species1e	O
UDP	O
-	O
N	O
-	O
acetyl	O
-	O
alpha	O
-	O
D	O
-	O
galactosamine	O
.	O
gene1s	O
Polypeptide	O
N	O
-	O
acetylgalactosaminyltransferase	O
,	O
GalNAc	O
-	O
t3	O
gene1e	O
.	O
The	O
glycosylation	O
of	O
serine	O
and	O
threonine	O
residues	O
during	O
mucin	O
-	O
type	O
O	O
-	O
linked	O
protein	O
glycosylation	O
is	O
carried	O
out	O
by	O
a	O
family	O
of	O
UDP	O
-	O
GalNAc	O
:	O
polypeptide	O
N	O
-	O
acetylgalactosaminyltransferases	O
(	O
GalNAc	O
-	O
transferase	O
)	O
.	O
Previously	O
two	O
members	O
,	O
gene1s	O
GalNAc	O
-	O
T1	O
and	O
-T2	O
gene1e	O
,	O
have	O
been	O
isolated	O
and	O
the	O
genes	O
cloned	O
and	O
characterized	O
.	O
Here	O
we	O
report	O
the	O
cDNA	O
cloning	O
and	O
expression	O
of	O
a	O
novel	O
GalNAc	O
-	O
transferase	O
termed	O
gene1s	O
GalNAc	O
-	O
T3	O
gene1e	O
.	O
The	O
gene	O
was	O
isolated	O
and	O
cloned	O
based	O
on	O
the	O
identification	O
of	O
a	O
GalNAc	O
-	O
transferase	O
motif	O
(	O
61	O
amino	O
acids	O
)	O
that	O
is	O
shared	O
between	O
gene1s	O
GalNAc	O
-	O
T1	O
and	O
-T2	O
gene1e	O
as	O
well	O
as	O
a	O
homologous	O
arg1s	O
Caenorhabditis	O
elegans	O
arg1e	O
gene	O
.	O
The	O
cDNA	O
sequence	O
has	O
a	O
633-amino	O
acid	O
coding	O
region	O
indicating	O
a	O
protein	O
of	O
72.5	O
kDa	O
with	O
a	O
type	O
II	O
domain	O
structure	O
.	O
The	O
overall	O
amino	O
acid	O
sequence	O
similarity	O
with	O
gene1s	O
GalNAc	O
-	O
T1	O
and	O
-T2	O
gene1e	O
is	O
approximately	O
45	O
%	O
;	O
12	O
cysteine	O
residues	O
that	O
are	O
shared	O
between	O
gene1s	O
GalNAc	O
-	O
T1	O
and	O
-T2	O
gene1e	O
are	O
also	O
found	O
in	O
gene1s	O
GalNAc	O
-	O
T3	O
gene1e	O
.	O
gene1s	O
GalNAc	O
-	O
T3	O
gene1e	O
was	O
expressed	O
as	O
a	O
soluble	O
protein	O
without	O
the	O
hydrophobic	O
transmembrane	O
domain	O
in	O
insect	O
cells	O
using	O
a	O
Baculo	O
-	O
virus	O
vector	O
,	O
and	O
the	O
expressed	O
GalNAc	O
-	O
transferase	O
activity	O
showed	O
substrate	O
specificity	O
different	O
from	O
that	O
previously	O
reported	O
for	O
gene1s	O
GalNAc	O
-	O
T1	O
and	O
-T2	O
gene1e	O
.	O
Northern	O
analysis	O
of	O
species1s	O
human	O
species1e	O
organs	O
revealed	O
a	O
very	O
restricted	O
expression	O
pattern	O
of	O
gene1s	O
GalNAc	O
-	O
T3	O
gene1e	O
.	O

Characterization	O
of	O
multiple	O
mRNAs	O
that	O
encode	O
gene1s	ARG2
mammalian	ARG2
translation	ARG2
initiation	ARG2
factor	ARG2
5	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
eIF-5	ARG2
gene1e	ARG2
)	O
.	O
gene1s	ARG2
Eukaryotic	ARG2
translation	ARG2
initiation	ARG2
factor	ARG2
5	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
eIF-5	ARG2
gene1e	ARG2
)	O
interacts	O
with	O
the	O
40	O
S	O
initiation	O
complex	O
(	O
40S.mRNA.MettRNAf.eIF-2.GTP	O
)	O
to	O
promote	O
the	O
hydrolysis	O
of	O
bound	O
GTP	O
with	O
the	O
concomitant	O
joining	O
of	O
the	O
60	O
S	O
ribosomal	O
subunit	O
to	O
the	O
40	O
S	O
initiation	O
complex	O
to	O
form	O
a	O
functional	O
80	O
S	O
initiation	O
complex	O
.	O
In	O
this	O
paper	O
,	O
the	O
multiple	O
mRNAs	O
that	O
encode	O
arg1s	O
mammalian	O
arg1e	O
gene1s	ARG2
eIF-5	ARG2
gene1e	ARG2
have	O
been	O
characterized	O
.	O
In	O
species1s	O
rat	O
species1e	O
tissues	O
,	O
three	O
major	O
gene1s	ARG2
eIF-5	ARG2
gene1e	ARG2
mRNAs	O
of	O
3.5	O
,	O
2.8	O
,	O
and	O
2.2	O
kilobases	O
in	O
length	O
are	O
detected	O
.	O
All	O
major	O
gene1s	ARG2
eIF-5	ARG2
gene1e	ARG2
mRNAs	O
are	O
initiated	O
from	O
a	O
single	O
transcription	O
initiation	O
site	O
,	O
contain	O
identical	O
5'-untranslated	O
and	O
coding	O
regions	O
,	O
but	O
differ	O
from	O
one	O
another	O
only	O
in	O
the	O
length	O
of	O
their	O
3'-untranslated	O
regions	O
.	O
The	O
different	O
lengths	O
of	O
the	O
3'-untranslated	O
region	O
of	O
gene1s	ARG2
eIF-5	ARG2
gene1e	ARG2
mRNAs	O
are	O
generated	O
by	O
the	O
use	O
of	O
alternative	O
polyadenylation	O
signals	O
.	O
Additionally	O
,	O
we	O
demonstrate	O
tissue	O
-	O
specific	O
variations	O
in	O
gene1s	ARG2
eIF-5	ARG2
gene1e	ARG2
mRNA	O
expression	O
as	O
well	O
as	O
preference	O
for	O
polyadenylation	O
sites	O
.	O
These	O
results	O
should	O
lead	O
to	O
increased	O
understanding	O
of	O
the	O
regulation	O
of	O
gene1s	ARG2
eIF-5	ARG2
gene1e	ARG2
gene	O
expression	O
.	O

Characterization	O
of	O
multiple	O
mRNAs	O
that	O
encode	O
gene1s	O
mammalian	O
translation	O
initiation	O
factor	O
5	O
gene1e	O
(	O
gene1s	O
eIF-5	O
gene1e	O
)	O
.	O
gene1s	O
Eukaryotic	O
translation	O
initiation	O
factor	O
5	O
gene1e	O
(	O
gene1s	O
eIF-5	O
gene1e	O
)	O
interacts	O
with	O
the	O
40	O
S	O
initiation	O
complex	O
(	O
40S.mRNA.MettRNAf.eIF-2.GTP	O
)	O
to	O
promote	O
the	O
hydrolysis	O
of	O
bound	O
GTP	O
with	O
the	O
concomitant	O
joining	O
of	O
the	O
60	O
S	O
ribosomal	O
subunit	O
to	O
the	O
40	O
S	O
initiation	O
complex	O
to	O
form	O
a	O
functional	O
80	O
S	O
initiation	O
complex	O
.	O
In	O
this	O
paper	O
,	O
the	O
multiple	O
mRNAs	O
that	O
encode	O
species1s	O
mammalian	O
species1e	O
gene1s	O
eIF-5	O
gene1e	O
have	O
been	O
characterized	O
.	O
In	O
arg1s	O
rat	O
arg1e	O
tissues	O
,	O
three	O
major	O
gene1s	O
eIF-5	O
gene1e	O
mRNAs	O
of	O
3.5	O
,	O
2.8	O
,	O
and	O
2.2	O
kilobases	O
in	O
length	O
are	O
detected	O
.	O
All	O
major	O
gene1s	O
eIF-5	O
gene1e	O
mRNAs	O
are	O
initiated	O
from	O
a	O
single	O
transcription	O
initiation	O
site	O
,	O
contain	O
identical	O
5'-untranslated	O
and	O
coding	O
regions	O
,	O
but	O
differ	O
from	O
one	O
another	O
only	O
in	O
the	O
length	O
of	O
their	O
3'-untranslated	O
regions	O
.	O
The	O
different	O
lengths	O
of	O
the	O
3'-untranslated	O
region	O
of	O
gene1s	O
eIF-5	O
gene1e	O
mRNAs	O
are	O
generated	O
by	O
the	O
use	O
of	O
alternative	O
polyadenylation	O
signals	O
.	O
Additionally	O
,	O
we	O
demonstrate	O
tissue	O
-	O
specific	O
variations	O
in	O
gene1s	O
eIF-5	O
gene1e	O
mRNA	O
expression	O
as	O
well	O
as	O
preference	O
for	O
polyadenylation	O
sites	O
.	O
These	O
results	O
should	O
lead	O
to	O
increased	O
understanding	O
of	O
the	O
regulation	O
of	O
gene1s	O
eIF-5	O
gene1e	O
gene	O
expression	O
.	O

Molecular	O
cloning	O
,	O
expression	O
and	O
function	O
of	O
the	O
arg1s	O
murine	O
arg1e	O
gene1s	ARG2
CB2	ARG2
gene1e	ARG2
peripheral	O
cannabinoid	O
receptor	O
.	O
We	O
have	O
cloned	O
the	O
peripheral	O
cannabinoid	O
receptor	O
,	O
gene1s	ARG2
mCB2	ARG2
gene1e	ARG2
,	O
from	O
a	O
arg1s	O
mouse	O
arg1e	O
splenocyte	O
cDNA	O
library	O
.	O
The	O
3.7	O
kb	O
sequence	O
contains	O
an	O
open	O
reading	O
frame	O
encoding	O
a	O
protein	O
of	O
347	O
residues	O
sharing	O
82	O
%	O
overall	O
identity	O
with	O
the	O
only	O
other	O
known	O
peripheral	O
receptor	O
,	O
species1s	O
human	O
species1e	O
gene1s	O
CB2	O
gene1e	O
(	O
gene1s	O
hCB2	O
gene1e	O
)	O
and	O
shorter	O
than	O
gene1s	O
hCB2	O
gene1e	O
by	O
13	O
amino	O
acids	O
at	O
the	O
carboxyl	O
terminus	O
.	O
Binding	O
experiments	O
with	O
membranes	O
from	O
species1s	O
COS-3	O
species1e	O
cells	O
transiently	O
expressing	O
gene1s	ARG2
mCB2	ARG2
gene1e	ARG2
showed	O
that	O
the	O
synthetic	O
cannabinoid	O
WIN	O
55212	O
-	O
2	O
had	O
a	O
6-fold	O
lower	O
affinity	O
for	O
gene1s	ARG2
mCB2	ARG2
gene1e	ARG2
than	O
for	O
gene1s	O
hCB2	O
gene1e	O
,	O
whereas	O
both	O
receptors	O
showed	O
similar	O
affinities	O
for	O
the	O
agonists	O
CP	O
55,940	O
,	O
delta(9)-THC	O
and	O
anandamide	O
and	O
almost	O
no	O
affinity	O
for	O
the	O
central	O
receptor-	O
(	O
gene1s	O
CB1	O
gene1e	O
)	O
specific	O
antagonist	O
SR	O
141716A.	O
Both	O
gene1s	O
hCB2	O
gene1e	O
and	O
gene1s	ARG2
mCB2	ARG2
gene1e	ARG2
mediate	O
agonist	O
-	O
stimulated	O
inhibition	O
of	O
forskolin	O
-	O
induced	O
cAMP	O
production	O
in	O
species1s	O
CHO	O
cell	O
lines	O
species1e	O
permanently	O
expressing	O
the	O
receptors	O
.	O
SR	O
141716A	O
failed	O
to	O
antagonize	O
this	O
activity	O
in	O
either	O
cell	O
line	O
,	O
confirming	O
its	O
specificity	O
for	O
gene1s	O
CB1	O
gene1e	O
.	O

Molecular	O
cloning	O
,	O
expression	O
and	O
function	O
of	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
CB2	O
gene1e	O
peripheral	O
cannabinoid	O
receptor	O
.	O
We	O
have	O
cloned	O
the	O
peripheral	O
cannabinoid	O
receptor	O
,	O
gene1s	O
mCB2	O
gene1e	O
,	O
from	O
a	O
species1s	O
mouse	O
species1e	O
splenocyte	O
cDNA	O
library	O
.	O
The	O
3.7	O
kb	O
sequence	O
contains	O
an	O
open	O
reading	O
frame	O
encoding	O
a	O
protein	O
of	O
347	O
residues	O
sharing	O
82	O
%	O
overall	O
identity	O
with	O
the	O
only	O
other	O
known	O
peripheral	O
receptor	O
,	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
CB2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
hCB2	ARG2
gene1e	ARG2
)	O
and	O
shorter	O
than	O
gene1s	ARG2
hCB2	ARG2
gene1e	ARG2
by	O
13	O
amino	O
acids	O
at	O
the	O
carboxyl	O
terminus	O
.	O
Binding	O
experiments	O
with	O
membranes	O
from	O
species1s	O
COS-3	O
species1e	O
cells	O
transiently	O
expressing	O
gene1s	O
mCB2	O
gene1e	O
showed	O
that	O
the	O
synthetic	O
cannabinoid	O
WIN	O
55212	O
-	O
2	O
had	O
a	O
6-fold	O
lower	O
affinity	O
for	O
gene1s	O
mCB2	O
gene1e	O
than	O
for	O
gene1s	ARG2
hCB2	ARG2
gene1e	ARG2
,	O
whereas	O
both	O
receptors	O
showed	O
similar	O
affinities	O
for	O
the	O
agonists	O
CP	O
55,940	O
,	O
delta(9)-THC	O
and	O
anandamide	O
and	O
almost	O
no	O
affinity	O
for	O
the	O
central	O
receptor-	O
(	O
gene1s	ARG2
CB1	ARG2
gene1e	ARG2
)	O
specific	O
antagonist	O
SR	O
141716A.	O
Both	O
gene1s	ARG2
hCB2	ARG2
gene1e	ARG2
and	O
gene1s	O
mCB2	O
gene1e	O
mediate	O
agonist	O
-	O
stimulated	O
inhibition	O
of	O
forskolin	O
-	O
induced	O
cAMP	O
production	O
in	O
species1s	O
CHO	O
cell	O
lines	O
species1e	O
permanently	O
expressing	O
the	O
receptors	O
.	O
SR	O
141716A	O
failed	O
to	O
antagonize	O
this	O
activity	O
in	O
either	O
cell	O
line	O
,	O
confirming	O
its	O
specificity	O
for	O
gene1s	ARG2
CB1	ARG2
gene1e	ARG2
.	O

Molecular	O
cloning	O
,	O
expression	O
and	O
function	O
of	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
CB2	O
gene1e	O
peripheral	O
cannabinoid	O
receptor	O
.	O
We	O
have	O
cloned	O
the	O
peripheral	O
cannabinoid	O
receptor	O
,	O
gene1s	O
mCB2	O
gene1e	O
,	O
from	O
a	O
species1s	O
mouse	O
species1e	O
splenocyte	O
cDNA	O
library	O
.	O
The	O
3.7	O
kb	O
sequence	O
contains	O
an	O
open	O
reading	O
frame	O
encoding	O
a	O
protein	O
of	O
347	O
residues	O
sharing	O
82	O
%	O
overall	O
identity	O
with	O
the	O
only	O
other	O
known	O
peripheral	O
receptor	O
,	O
species1s	O
human	O
species1e	O
gene1s	O
CB2	O
gene1e	O
(	O
gene1s	O
hCB2	O
gene1e	O
)	O
and	O
shorter	O
than	O
gene1s	O
hCB2	O
gene1e	O
by	O
13	O
amino	O
acids	O
at	O
the	O
carboxyl	O
terminus	O
.	O
Binding	O
experiments	O
with	O
membranes	O
from	O
arg1s	O
COS-3	O
arg1e	O
cells	O
transiently	O
expressing	O
gene1s	O
mCB2	O
gene1e	O
showed	O
that	O
the	O
synthetic	O
cannabinoid	O
WIN	O
55212	O
-	O
2	O
had	O
a	O
6-fold	O
lower	O
affinity	O
for	O
gene1s	O
mCB2	O
gene1e	O
than	O
for	O
gene1s	O
hCB2	O
gene1e	O
,	O
whereas	O
both	O
receptors	O
showed	O
similar	O
affinities	O
for	O
the	O
agonists	O
CP	O
55,940	O
,	O
delta(9)-THC	O
and	O
anandamide	O
and	O
almost	O
no	O
affinity	O
for	O
the	O
central	O
receptor-	O
(	O
gene1s	O
CB1	O
gene1e	O
)	O
specific	O
antagonist	O
SR	O
141716A.	O
Both	O
gene1s	O
hCB2	O
gene1e	O
and	O
gene1s	O
mCB2	O
gene1e	O
mediate	O
agonist	O
-	O
stimulated	O
inhibition	O
of	O
forskolin	O
-	O
induced	O
cAMP	O
production	O
in	O
species1s	O
CHO	O
cell	O
lines	O
species1e	O
permanently	O
expressing	O
the	O
receptors	O
.	O
SR	O
141716A	O
failed	O
to	O
antagonize	O
this	O
activity	O
in	O
either	O
cell	O
line	O
,	O
confirming	O
its	O
specificity	O
for	O
gene1s	O
CB1	O
gene1e	O
.	O

Molecular	O
cloning	O
,	O
expression	O
and	O
function	O
of	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
CB2	O
gene1e	O
peripheral	O
cannabinoid	O
receptor	O
.	O
We	O
have	O
cloned	O
the	O
peripheral	O
cannabinoid	O
receptor	O
,	O
gene1s	O
mCB2	O
gene1e	O
,	O
from	O
a	O
species1s	O
mouse	O
species1e	O
splenocyte	O
cDNA	O
library	O
.	O
The	O
3.7	O
kb	O
sequence	O
contains	O
an	O
open	O
reading	O
frame	O
encoding	O
a	O
protein	O
of	O
347	O
residues	O
sharing	O
82	O
%	O
overall	O
identity	O
with	O
the	O
only	O
other	O
known	O
peripheral	O
receptor	O
,	O
species1s	O
human	O
species1e	O
gene1s	O
CB2	O
gene1e	O
(	O
gene1s	O
hCB2	O
gene1e	O
)	O
and	O
shorter	O
than	O
gene1s	O
hCB2	O
gene1e	O
by	O
13	O
amino	O
acids	O
at	O
the	O
carboxyl	O
terminus	O
.	O
Binding	O
experiments	O
with	O
membranes	O
from	O
species1s	O
COS-3	O
species1e	O
cells	O
transiently	O
expressing	O
gene1s	O
mCB2	O
gene1e	O
showed	O
that	O
the	O
synthetic	O
cannabinoid	O
WIN	O
55212	O
-	O
2	O
had	O
a	O
6-fold	O
lower	O
affinity	O
for	O
gene1s	O
mCB2	O
gene1e	O
than	O
for	O
gene1s	O
hCB2	O
gene1e	O
,	O
whereas	O
both	O
receptors	O
showed	O
similar	O
affinities	O
for	O
the	O
agonists	O
CP	O
55,940	O
,	O
delta(9)-THC	O
and	O
anandamide	O
and	O
almost	O
no	O
affinity	O
for	O
the	O
central	O
receptor-	O
(	O
gene1s	O
CB1	O
gene1e	O
)	O
specific	O
antagonist	O
SR	O
141716A.	O
Both	O
gene1s	O
hCB2	O
gene1e	O
and	O
gene1s	O
mCB2	O
gene1e	O
mediate	O
agonist	O
-	O
stimulated	O
inhibition	O
of	O
forskolin	O
-	O
induced	O
cAMP	O
production	O
in	O
arg1s	O
CHO	O
cell	O
lines	O
arg1e	O
permanently	O
expressing	O
the	O
receptors	O
.	O
SR	O
141716A	O
failed	O
to	O
antagonize	O
this	O
activity	O
in	O
either	O
cell	O
line	O
,	O
confirming	O
its	O
specificity	O
for	O
gene1s	O
CB1	O
gene1e	O
.	O

The	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
glycine	ARG2
receptor	ARG2
beta	ARG2
gene1e	ARG2
subunit	O
:	O
primary	O
structure	O
,	O
functional	O
characterisation	O
and	O
chromosomal	O
localisation	O
of	O
the	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
murine	O
species1e	O
genes	O
.	O
The	O
inhibitory	O
glycine	O
receptor	O
(	O
GlyR	O
)	O
is	O
a	O
pentameric	O
receptor	O
comprised	O
of	O
alpha	O
and	O
beta	O
subunits	O
,	O
of	O
which	O
the	O
beta	O
subunit	O
has	O
not	O
been	O
characterised	O
in	O
arg1s	O
humans	O
arg1e	O
.	O
A	O
2106	O
bp	O
cDNA	O
,	O
isolated	O
from	O
a	O
arg1s	O
human	O
arg1e	O
hippocampal	O
cDNA	O
library	O
,	O
contained	O
an	O
open	O
reading	O
frame	O
of	O
497	O
amino	O
acids	O
which	O
encodes	O
the	O
gene1s	ARG2
beta	ARG2
subunit	ARG2
of	ARG2
the	ARG2
human	ARG2
GlyR	ARG2
gene1e	ARG2
.	O
The	O
mature	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
GlyR	ARG2
beta	ARG2
gene1e	ARG2
polypeptide	O
displays	O
99	O
%	O
amino	O
acid	O
identity	O
with	O
the	O
species1s	O
rat	O
species1e	O
gene1s	O
GlyR	O
beta	O
gene1e	O
subunit	O
and	O
48	O
%	O
identity	O
with	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
GlyR	ARG2
alpha	ARG2
1	ARG2
gene1e	ARG2
subunit	O
.	O
Neither	O
[	O
3H]strychnine	O
binding	O
nor	O
glycine	O
-	O
gated	O
currents	O
were	O
detected	O
when	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
GlyR	ARG2
beta	ARG2
gene1e	ARG2
subunit	O
cDNA	O
was	O
expressed	O
in	O
the	O
arg1s	O
human	O
arg1e	O
embryonic	O
kidney	O
293	O
cell	O
line	O
.	O
However	O
,	O
co	O
-	O
expression	O
of	O
the	O
beta	O
subunit	O
cDNA	O
with	O
the	O
alpha	O
1	O
subunit	O
cDNA	O
resulted	O
in	O
expression	O
of	O
functional	O
GlyRs	O
which	O
showed	O
a	O
4-fold	O
reduction	O
in	O
the	O
EC50	O
values	O
when	O
compared	O
to	O
gene1s	ARG2
alpha	ARG2
1	ARG2
homomeric	ARG2
GlyRs	ARG2
gene1e	ARG2
.	O
Glycine	O
-	O
gated	O
currents	O
of	O
gene1s	ARG2
alpha	ARG2
1	ARG2
/	ARG2
beta	ARG2
GlyRs	ARG2
gene1e	ARG2
were	O
17-fold	O
less	O
sensitive	O
than	O
homomeric	O
gene1s	ARG2
alpha	ARG2
1	ARG2
GlyRs	ARG2
gene1e	ARG2
to	O
the	O
antagonists	O
picrotoxin	O
,	O
picrotoxinin	O
and	O
picrotin	O
,	O
providing	O
clear	O
evidence	O
that	O
heteromeric	O
gene1s	ARG2
alpha	ARG2
1	ARG2
/	ARG2
beta	ARG2
GlyRs	ARG2
gene1e	ARG2
were	O
expressed	O
.	O
The	O
beta	O
subunit	O
appears	O
to	O
play	O
a	O
structural	O
rather	O
than	O
ligand	O
binding	O
role	O
in	O
GlyR	O
function	O
.	O
Fluorescence	O
in	O
situ	O
hybridisation	O
was	O
used	O
to	O
localise	O
the	O
gene	O
encoding	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
GlyR	ARG2
beta	ARG2
gene1e	ARG2
subunit	O
(	O
gene1s	ARG2
GLRB	ARG2
gene1e	ARG2
)	O
to	O
chromosome	O
4q32	O
,	O
a	O
position	O
syntenic	O
with	O
species1s	O
mouse	O
species1e	O
chromosome	O
3	O
.	O
In	O
situ	O
hybridisation	O
using	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
GlyR	ARG2
beta	ARG2
gene1e	ARG2
subunit	O
cDNA	O
showed	O
that	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
GlyR	O
beta	O
gene1e	O
subunit	O
gene	O
(	O
gene1s	O
Glrb	O
gene1e	O
)	O
maps	O
to	O
the	O
gene1s	O
spastic	O
gene1e	O
(	O
gene1s	O
spa	O
gene1e	O
)	O
locus	O
on	O
species1s	O
mouse	O
species1e	O
chromosome	O
3	O
at	O
bands	O
E3-F1	O
.	O
This	O
is	O
consistent	O
with	O
the	O
recent	O
finding	O
that	O
a	O
mutation	O
in	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
GlyR	O
beta	O
gene1e	O
subunit	O
causes	O
the	O
gene1s	O
spa	O
gene1e	O
phenotype	O
.	O
It	O
also	O
raises	O
the	O
possibility	O
that	O
mutations	O
in	O
the	O
arg1s	O
human	O
arg1e	O
beta	O
subunit	O
gene	O
may	O
cause	O
inherited	O
disorders	O
of	O
the	O
startle	O
response	O
.	O

The	O
species1s	O
human	O
species1e	O
gene1s	O
glycine	O
receptor	O
beta	O
gene1e	O
subunit	O
:	O
primary	O
structure	O
,	O
functional	O
characterisation	O
and	O
chromosomal	O
localisation	O
of	O
the	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
murine	O
arg1e	O
genes	O
.	O
The	O
inhibitory	O
glycine	O
receptor	O
(	O
GlyR	O
)	O
is	O
a	O
pentameric	O
receptor	O
comprised	O
of	O
alpha	O
and	O
beta	O
subunits	O
,	O
of	O
which	O
the	O
beta	O
subunit	O
has	O
not	O
been	O
characterised	O
in	O
species1s	O
humans	O
species1e	O
.	O
A	O
2106	O
bp	O
cDNA	O
,	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
hippocampal	O
cDNA	O
library	O
,	O
contained	O
an	O
open	O
reading	O
frame	O
of	O
497	O
amino	O
acids	O
which	O
encodes	O
the	O
gene1s	O
beta	O
subunit	O
of	O
the	O
human	O
GlyR	O
gene1e	O
.	O
The	O
mature	O
species1s	O
human	O
species1e	O
gene1s	O
GlyR	O
beta	O
gene1e	O
polypeptide	O
displays	O
99	O
%	O
amino	O
acid	O
identity	O
with	O
the	O
species1s	O
rat	O
species1e	O
gene1s	O
GlyR	O
beta	O
gene1e	O
subunit	O
and	O
48	O
%	O
identity	O
with	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
GlyR	O
alpha	O
1	O
gene1e	O
subunit	O
.	O
Neither	O
[	O
3H]strychnine	O
binding	O
nor	O
glycine	O
-	O
gated	O
currents	O
were	O
detected	O
when	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
GlyR	O
beta	O
gene1e	O
subunit	O
cDNA	O
was	O
expressed	O
in	O
the	O
species1s	O
human	O
species1e	O
embryonic	O
kidney	O
293	O
cell	O
line	O
.	O
However	O
,	O
co	O
-	O
expression	O
of	O
the	O
beta	O
subunit	O
cDNA	O
with	O
the	O
alpha	O
1	O
subunit	O
cDNA	O
resulted	O
in	O
expression	O
of	O
functional	O
GlyRs	O
which	O
showed	O
a	O
4-fold	O
reduction	O
in	O
the	O
EC50	O
values	O
when	O
compared	O
to	O
gene1s	O
alpha	O
1	O
homomeric	O
GlyRs	O
gene1e	O
.	O
Glycine	O
-	O
gated	O
currents	O
of	O
gene1s	O
alpha	O
1	O
/	O
beta	O
GlyRs	O
gene1e	O
were	O
17-fold	O
less	O
sensitive	O
than	O
homomeric	O
gene1s	O
alpha	O
1	O
GlyRs	O
gene1e	O
to	O
the	O
antagonists	O
picrotoxin	O
,	O
picrotoxinin	O
and	O
picrotin	O
,	O
providing	O
clear	O
evidence	O
that	O
heteromeric	O
gene1s	O
alpha	O
1	O
/	O
beta	O
GlyRs	O
gene1e	O
were	O
expressed	O
.	O
The	O
beta	O
subunit	O
appears	O
to	O
play	O
a	O
structural	O
rather	O
than	O
ligand	O
binding	O
role	O
in	O
GlyR	O
function	O
.	O
Fluorescence	O
in	O
situ	O
hybridisation	O
was	O
used	O
to	O
localise	O
the	O
gene	O
encoding	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
GlyR	O
beta	O
gene1e	O
subunit	O
(	O
gene1s	O
GLRB	O
gene1e	O
)	O
to	O
chromosome	O
4q32	O
,	O
a	O
position	O
syntenic	O
with	O
arg1s	O
mouse	O
arg1e	O
chromosome	O
3	O
.	O
In	O
situ	O
hybridisation	O
using	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
GlyR	O
beta	O
gene1e	O
subunit	O
cDNA	O
showed	O
that	O
the	O
arg1s	O
murine	O
arg1e	O
gene1s	ARG2
GlyR	ARG2
beta	ARG2
gene1e	ARG2
subunit	O
gene	O
(	O
gene1s	ARG2
Glrb	ARG2
gene1e	ARG2
)	O
maps	O
to	O
the	O
gene1s	ARG2
spastic	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
spa	ARG2
gene1e	ARG2
)	O
locus	O
on	O
arg1s	O
mouse	O
arg1e	O
chromosome	O
3	O
at	O
bands	O
E3-F1	O
.	O
This	O
is	O
consistent	O
with	O
the	O
recent	O
finding	O
that	O
a	O
mutation	O
in	O
the	O
arg1s	O
murine	O
arg1e	O
gene1s	ARG2
GlyR	ARG2
beta	ARG2
gene1e	ARG2
subunit	O
causes	O
the	O
gene1s	ARG2
spa	ARG2
gene1e	ARG2
phenotype	O
.	O
It	O
also	O
raises	O
the	O
possibility	O
that	O
mutations	O
in	O
the	O
species1s	O
human	O
species1e	O
beta	O
subunit	O
gene	O
may	O
cause	O
inherited	O
disorders	O
of	O
the	O
startle	O
response	O
.	O

The	O
species1s	O
human	O
species1e	O
gene1s	O
glycine	O
receptor	O
beta	O
gene1e	O
subunit	O
:	O
primary	O
structure	O
,	O
functional	O
characterisation	O
and	O
chromosomal	O
localisation	O
of	O
the	O
species1s	O
human	O
species1e	O
and	O
species1s	O
murine	O
species1e	O
genes	O
.	O
The	O
inhibitory	O
glycine	O
receptor	O
(	O
GlyR	O
)	O
is	O
a	O
pentameric	O
receptor	O
comprised	O
of	O
alpha	O
and	O
beta	O
subunits	O
,	O
of	O
which	O
the	O
beta	O
subunit	O
has	O
not	O
been	O
characterised	O
in	O
species1s	O
humans	O
species1e	O
.	O
A	O
2106	O
bp	O
cDNA	O
,	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
hippocampal	O
cDNA	O
library	O
,	O
contained	O
an	O
open	O
reading	O
frame	O
of	O
497	O
amino	O
acids	O
which	O
encodes	O
the	O
gene1s	O
beta	O
subunit	O
of	O
the	O
human	O
GlyR	O
gene1e	O
.	O
The	O
mature	O
species1s	O
human	O
species1e	O
gene1s	O
GlyR	O
beta	O
gene1e	O
polypeptide	O
displays	O
99	O
%	O
amino	O
acid	O
identity	O
with	O
the	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
GlyR	ARG2
beta	ARG2
gene1e	ARG2
subunit	O
and	O
48	O
%	O
identity	O
with	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
GlyR	O
alpha	O
1	O
gene1e	O
subunit	O
.	O
Neither	O
[	O
3H]strychnine	O
binding	O
nor	O
glycine	O
-	O
gated	O
currents	O
were	O
detected	O
when	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
GlyR	O
beta	O
gene1e	O
subunit	O
cDNA	O
was	O
expressed	O
in	O
the	O
species1s	O
human	O
species1e	O
embryonic	O
kidney	O
293	O
cell	O
line	O
.	O
However	O
,	O
co	O
-	O
expression	O
of	O
the	O
beta	O
subunit	O
cDNA	O
with	O
the	O
alpha	O
1	O
subunit	O
cDNA	O
resulted	O
in	O
expression	O
of	O
functional	O
GlyRs	O
which	O
showed	O
a	O
4-fold	O
reduction	O
in	O
the	O
EC50	O
values	O
when	O
compared	O
to	O
gene1s	O
alpha	O
1	O
homomeric	O
GlyRs	O
gene1e	O
.	O
Glycine	O
-	O
gated	O
currents	O
of	O
gene1s	O
alpha	O
1	O
/	O
beta	O
GlyRs	O
gene1e	O
were	O
17-fold	O
less	O
sensitive	O
than	O
homomeric	O
gene1s	O
alpha	O
1	O
GlyRs	O
gene1e	O
to	O
the	O
antagonists	O
picrotoxin	O
,	O
picrotoxinin	O
and	O
picrotin	O
,	O
providing	O
clear	O
evidence	O
that	O
heteromeric	O
gene1s	O
alpha	O
1	O
/	O
beta	O
GlyRs	O
gene1e	O
were	O
expressed	O
.	O
The	O
beta	O
subunit	O
appears	O
to	O
play	O
a	O
structural	O
rather	O
than	O
ligand	O
binding	O
role	O
in	O
GlyR	O
function	O
.	O
Fluorescence	O
in	O
situ	O
hybridisation	O
was	O
used	O
to	O
localise	O
the	O
gene	O
encoding	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
GlyR	O
beta	O
gene1e	O
subunit	O
(	O
gene1s	O
GLRB	O
gene1e	O
)	O
to	O
chromosome	O
4q32	O
,	O
a	O
position	O
syntenic	O
with	O
species1s	O
mouse	O
species1e	O
chromosome	O
3	O
.	O
In	O
situ	O
hybridisation	O
using	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
GlyR	O
beta	O
gene1e	O
subunit	O
cDNA	O
showed	O
that	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
GlyR	O
beta	O
gene1e	O
subunit	O
gene	O
(	O
gene1s	O
Glrb	O
gene1e	O
)	O
maps	O
to	O
the	O
gene1s	O
spastic	O
gene1e	O
(	O
gene1s	O
spa	O
gene1e	O
)	O
locus	O
on	O
species1s	O
mouse	O
species1e	O
chromosome	O
3	O
at	O
bands	O
E3-F1	O
.	O
This	O
is	O
consistent	O
with	O
the	O
recent	O
finding	O
that	O
a	O
mutation	O
in	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
GlyR	O
beta	O
gene1e	O
subunit	O
causes	O
the	O
gene1s	O
spa	O
gene1e	O
phenotype	O
.	O
It	O
also	O
raises	O
the	O
possibility	O
that	O
mutations	O
in	O
the	O
species1s	O
human	O
species1e	O
beta	O
subunit	O
gene	O
may	O
cause	O
inherited	O
disorders	O
of	O
the	O
startle	O
response	O
.	O

Coding	O
sequence	O
and	O
chromosome	O
mapping	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene	O
(	O
gene1s	ARG2
CDC46	ARG2
gene1e	ARG2
)	O
for	O
replication	O
protein	O
gene1s	ARG2
hCdc46	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Mcm5	ARG2
gene1e	ARG2
.	O
We	O
have	O
isolated	O
the	O
complete	O
cDNA	O
sequence	O
encoding	O
the	O
arg1s	O
human	O
arg1e	O
homolog	O
of	O
the	O
species1s	O
yeast	O
species1e	O
replication	O
protein	O
gene1s	O
Cdc46	O
gene1e	O
/	O
gene1s	O
Mcm5	O
gene1e	O
.	O
The	O
cDNA	O
was	O
used	O
as	O
a	O
probe	O
for	O
chromosomal	O
fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
,	O
which	O
localized	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
Cdc46	ARG2
gene1e	ARG2
gene	O
(	O
gene1s	ARG2
CDC46	ARG2
gene1e	ARG2
)	O
to	O
chromosome	O
region	O
22q13.1	O
-	O
->q13.2	O
.	O
This	O
is	O
the	O
fourth	O
arg1s	O
human	O
arg1e	O
Mcm	O
gene	O
whose	O
chromosome	O
region	O
has	O
been	O
determined	O
,	O
and	O
it	O
is	O
now	O
apparent	O
that	O
arg1s	O
human	O
arg1e	O
Mcm	O
genes	O
are	O
widely	O
distributed	O
in	O
the	O
genome	O
.	O
As	O
deduced	O
from	O
the	O
cDNA	O
sequence	O
,	O
arg1s	O
human	O
arg1e	O
protein	O
gene1s	ARG2
hCdc46	ARG2
gene1e	ARG2
is	O
composed	O
of	O
734	O
amino	O
acids	O
and	O
contains	O
a	O
central	O
region	O
that	O
is	O
almost	O
80	O
%	O
identical	O
with	O
the	O
species1s	O
yeast	O
species1e	O
protein	O
.	O
Immunoprecipitation	O
experiments	O
with	O
gene1s	ARG2
hCdc46	ARG2
gene1e	ARG2
-specific	O
antibodies	O
confirm	O
that	O
essentially	O
all	O
nuclear	O
gene1s	ARG2
hCdc46	ARG2
gene1e	ARG2
proteins	O
form	O
a	O
stable	O
dimeric	O
complex	O
with	O
protein	O
gene1s	ARG2
P1Mcm3	ARG2
gene1e	ARG2
.	O

Coding	O
sequence	O
and	O
chromosome	O
mapping	O
of	O
the	O
species1s	O
human	O
species1e	O
gene	O
(	O
gene1s	O
CDC46	O
gene1e	O
)	O
for	O
replication	O
protein	O
gene1s	O
hCdc46	O
gene1e	O
/	O
gene1s	O
Mcm5	O
gene1e	O
.	O
We	O
have	O
isolated	O
the	O
complete	O
cDNA	O
sequence	O
encoding	O
the	O
species1s	O
human	O
species1e	O
homolog	O
of	O
the	O
arg1s	O
yeast	O
arg1e	O
replication	O
protein	O
gene1s	ARG2
Cdc46	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Mcm5	ARG2
gene1e	ARG2
.	O
The	O
cDNA	O
was	O
used	O
as	O
a	O
probe	O
for	O
chromosomal	O
fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
,	O
which	O
localized	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
Cdc46	O
gene1e	O
gene	O
(	O
gene1s	O
CDC46	O
gene1e	O
)	O
to	O
chromosome	O
region	O
22q13.1	O
-	O
->q13.2	O
.	O
This	O
is	O
the	O
fourth	O
species1s	O
human	O
species1e	O
Mcm	O
gene	O
whose	O
chromosome	O
region	O
has	O
been	O
determined	O
,	O
and	O
it	O
is	O
now	O
apparent	O
that	O
species1s	O
human	O
species1e	O
Mcm	O
genes	O
are	O
widely	O
distributed	O
in	O
the	O
genome	O
.	O
As	O
deduced	O
from	O
the	O
cDNA	O
sequence	O
,	O
species1s	O
human	O
species1e	O
protein	O
gene1s	O
hCdc46	O
gene1e	O
is	O
composed	O
of	O
734	O
amino	O
acids	O
and	O
contains	O
a	O
central	O
region	O
that	O
is	O
almost	O
80	O
%	O
identical	O
with	O
the	O
arg1s	O
yeast	O
arg1e	O
protein	O
.	O
Immunoprecipitation	O
experiments	O
with	O
gene1s	O
hCdc46	O
gene1e	O
-specific	O
antibodies	O
confirm	O
that	O
essentially	O
all	O
nuclear	O
gene1s	O
hCdc46	O
gene1e	O
proteins	O
form	O
a	O
stable	O
dimeric	O
complex	O
with	O
protein	O
gene1s	O
P1Mcm3	O
gene1e	O
.	O

kappa	O
opioid	O
receptors	O
in	O
arg1s	O
human	O
arg1e	O
microglia	O
downregulate	O
species1s	O
human	O
immunodeficiency	O
virus	O
1	O
species1e	O
expression	O
.	O
Microglial	O
cells	O
,	O
the	O
resident	O
macrophages	O
of	O
the	O
brain	O
,	O
play	O
an	O
important	O
role	O
in	O
the	O
neuropathogenesis	O
of	O
species1s	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
species1e	O
(	O
species1s	O
HIV-1	O
species1e	O
)	O
,	O
and	O
recent	O
studies	O
suggest	O
that	O
opioid	O
peptides	O
regulate	O
the	O
function	O
of	O
macrophages	O
from	O
somatic	O
tissues	O
.	O
We	O
report	O
herein	O
the	O
presence	O
of	O
kappa	O
opioid	O
receptors	O
(	O
KORs	O
)	O
in	O
arg1s	O
human	O
arg1e	O
fetal	O
microglia	O
and	O
inhibition	O
of	O
species1s	O
HIV-1	O
species1e	O
expression	O
in	O
acutely	O
infected	O
microglial	O
cell	O
cultures	O
treated	O
with	O
gene1s	ARG2
KOR	ARG2
gene1e	ARG2
ligands	O
.	O
Using	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
and	O
sequencing	O
analyses	O
,	O
we	O
found	O
that	O
mRNA	O
for	O
the	O
gene1s	ARG2
KOR	ARG2
gene1e	ARG2
was	O
constitutively	O
expressed	O
in	O
microglia	O
and	O
determined	O
that	O
the	O
nucleotide	O
sequence	O
of	O
the	O
open	O
reading	O
frame	O
was	O
identical	O
to	O
that	O
of	O
the	O
arg1s	O
human	O
arg1e	O
brain	O
gene1s	ARG2
KOR	ARG2
gene1e	ARG2
gene	O
.	O
The	O
expression	O
of	O
gene1s	ARG2
KOR	ARG2
gene1e	ARG2
in	O
microglial	O
cells	O
was	O
confirmed	O
by	O
membrane	O
binding	O
of	O
[	O
3H]U69,593	O
,	O
a	O
kappa	O
-	O
selective	O
ligand	O
,	O
and	O
by	O
indirect	O
immunofluorescence	O
.	O
Treatment	O
of	O
microglial	O
cell	O
cultures	O
with	O
U50,488	O
or	O
U69,593	O
resulted	O
in	O
a	O
dose	O
-	O
dependent	O
inhibition	O
of	O
expression	O
of	O
the	O
monocytotropic	O
species1s	O
HIV-1	O
species1e	O
SF162	O
strain	O
.	O
This	O
antiviral	O
effect	O
of	O
the	O
kappa	O
ligands	O
was	O
blocked	O
by	O
the	O
specific	O
gene1s	ARG2
KOR	ARG2
gene1e	ARG2
antagonist	O
,	O
nor	O
-	O
binaltrophimine	O
.	O
These	O
findings	O
suggest	O
that	O
kappa	O
opioid	O
agonists	O
have	O
immunomodulatory	O
activity	O
in	O
the	O
brain	O
,	O
and	O
that	O
these	O
compounds	O
could	O
have	O
potential	O
in	O
the	O
treatment	O
of	O
species1s	O
HIV-1	O
species1e	O
-associated	O
encephalopathy	O
.	O

kappa	O
opioid	O
receptors	O
in	O
species1s	O
human	O
species1e	O
microglia	O
downregulate	O
arg1s	O
human	O
immunodeficiency	O
virus	O
1	O
arg1e	O
expression	O
.	O
Microglial	O
cells	O
,	O
the	O
resident	O
macrophages	O
of	O
the	O
brain	O
,	O
play	O
an	O
important	O
role	O
in	O
the	O
neuropathogenesis	O
of	O
arg1s	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
arg1e	O
(	O
arg1s	O
HIV-1	O
arg1e	O
)	O
,	O
and	O
recent	O
studies	O
suggest	O
that	O
opioid	O
peptides	O
regulate	O
the	O
function	O
of	O
macrophages	O
from	O
somatic	O
tissues	O
.	O
We	O
report	O
herein	O
the	O
presence	O
of	O
kappa	O
opioid	O
receptors	O
(	O
KORs	O
)	O
in	O
species1s	O
human	O
species1e	O
fetal	O
microglia	O
and	O
inhibition	O
of	O
arg1s	O
HIV-1	O
arg1e	O
expression	O
in	O
acutely	O
infected	O
microglial	O
cell	O
cultures	O
treated	O
with	O
gene1s	O
KOR	O
gene1e	O
ligands	O
.	O
Using	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
and	O
sequencing	O
analyses	O
,	O
we	O
found	O
that	O
mRNA	O
for	O
the	O
gene1s	O
KOR	O
gene1e	O
was	O
constitutively	O
expressed	O
in	O
microglia	O
and	O
determined	O
that	O
the	O
nucleotide	O
sequence	O
of	O
the	O
open	O
reading	O
frame	O
was	O
identical	O
to	O
that	O
of	O
the	O
species1s	O
human	O
species1e	O
brain	O
gene1s	O
KOR	O
gene1e	O
gene	O
.	O
The	O
expression	O
of	O
gene1s	O
KOR	O
gene1e	O
in	O
microglial	O
cells	O
was	O
confirmed	O
by	O
membrane	O
binding	O
of	O
[	O
3H]U69,593	O
,	O
a	O
kappa	O
-	O
selective	O
ligand	O
,	O
and	O
by	O
indirect	O
immunofluorescence	O
.	O
Treatment	O
of	O
microglial	O
cell	O
cultures	O
with	O
U50,488	O
or	O
U69,593	O
resulted	O
in	O
a	O
dose	O
-	O
dependent	O
inhibition	O
of	O
expression	O
of	O
the	O
monocytotropic	O
arg1s	O
HIV-1	O
arg1e	O
SF162	O
strain	O
.	O
This	O
antiviral	O
effect	O
of	O
the	O
kappa	O
ligands	O
was	O
blocked	O
by	O
the	O
specific	O
gene1s	O
KOR	O
gene1e	O
antagonist	O
,	O
nor	O
-	O
binaltrophimine	O
.	O
These	O
findings	O
suggest	O
that	O
kappa	O
opioid	O
agonists	O
have	O
immunomodulatory	O
activity	O
in	O
the	O
brain	O
,	O
and	O
that	O
these	O
compounds	O
could	O
have	O
potential	O
in	O
the	O
treatment	O
of	O
arg1s	O
HIV-1	O
arg1e	O
-associated	O
encephalopathy	O
.	O

cDNA	O
cloning	O
and	O
functional	O
analysis	O
of	O
the	O
gene1s	ARG2
p97	ARG2
subunit	ARG2
of	ARG2
the	ARG2
26S	ARG2
proteasome	ARG2
gene1e	ARG2
,	O
a	O
polypeptide	O
identical	O
to	O
the	O
gene1s	ARG2
type-1	ARG2
tumor	ARG2
-	ARG2
necrosis	ARG2
-	ARG2
factor	ARG2
-	ARG2
receptor	ARG2
-	ARG2
associated	ARG2
protein-2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
55.11	ARG2
gene1e	ARG2
.	O
Molecular	O
cloning	O
of	O
cDNA	O
for	O
a	O
new	O
regulatory	O
subunit	O
,	O
designated	O
gene1s	ARG2
p97	ARG2
gene1e	ARG2
,	O
of	O
the	O
arg1s	O
human	O
arg1e	O
26S	O
proteasome	O
showed	O
that	O
the	O
polypeptide	O
consists	O
of	O
908	O
amino	O
acid	O
residues	O
with	O
a	O
calculated	O
molecular	O
mass	O
of	O
100184	O
Da	O
and	O
an	O
isoelectric	O
point	O
of	O
4.94	O
.	O
Computer	O
analysis	O
showed	O
that	O
gene1s	ARG2
p97	ARG2
gene1e	ARG2
is	O
very	O
similar	O
to	O
gene1s	ARG2
type-1	ARG2
tumor	ARG2
-	ARG2
necrosis	ARG2
-	ARG2
factor	ARG2
(	ARG2
TNF)-receptor	ARG2
-	ARG2
associated	ARG2
protein	ARG2
(	ARG2
TRAP)-2	ARG2
gene1e	ARG2
and	O
55.11	O
,	O
both	O
of	O
which	O
were	O
identified	O
recently	O
as	O
binding	O
proteins	O
of	O
the	O
cytoplasmic	O
domain	O
of	O
type-1	O
TNF	O
receptor	O
by	O
species1s	O
yeast	O
species1e	O
two	O
-	O
hybrid	O
screening	O
.	O
This	O
finding	O
suggests	O
that	O
the	O
26S	O
proteasome	O
might	O
serve	O
as	O
a	O
mediator	O
molecule	O
in	O
the	O
TNF	O
signaling	O
pathway	O
in	O
cells	O
.	O
Computer	O
-	O
assisted	O
similarity	O
analysis	O
also	O
revealed	O
the	O
high	O
sequence	O
similarity	O
of	O
gene1s	ARG2
p97	ARG2
gene1e	ARG2
with	O
a	O
species1s	O
yeast	O
species1e	O
protein	O
whose	O
function	O
is	O
yet	O
unknown	O
,	O
the	O
gene	O
for	O
which	O
is	O
here	O
termed	O
gene1s	O
NAS1	O
gene1e	O
(	O
gene1s	O
non	O
-	O
ATPase	O
subunit	O
1	O
gene1e	O
)	O
.	O
Disruption	O
of	O
gene1s	O
NAS1	O
gene1e	O
resulted	O
in	O
several	O
phenotypes	O
,	O
including	O
lethality	O
and	O
temperature	O
-	O
sensitive	O
growth	O
,	O
depending	O
on	O
the	O
genetic	O
background	O
of	O
the	O
cells	O
used	O
.	O
The	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
p97	ARG2
gene1e	ARG2
cDNA	O
suppressed	O
the	O
growth	O
defect	O
of	O
arg1s	O
nas1	O
arg1e	O
disruptant	O
cells	O
,	O
when	O
expressed	O
from	O
single	O
-	O
copy	O
or	O
multi	O
-	O
copy	O
vectors	O
,	O
indicating	O
that	O
gene1s	ARG2
p97	ARG2
gene1e	ARG2
is	O
functionally	O
equivalent	O
to	O
species1s	O
yeast	O
species1e	O
gene1s	O
Nas1p	O
gene1e	O
.	O
Culturing	O
of	O
the	O
temperature	O
-	O
sensitive	O
arg1s	O
nas1	O
arg1e	O
cells	O
at	O
the	O
restrictive	O
temperature	O
promoted	O
the	O
accumulation	O
polyubiquitinated	O
cellular	O
proteins	O
,	O
implying	O
that	O
the	O
26S	O
proteasome	O
requires	O
a	O
functional	O
gene1s	O
Nas1p	O
gene1e	O
subunit	O
for	O
ubiquitin	O
-	O
dependent	O
proteolysis	O
.	O
These	O
results	O
indicate	O
that	O
gene1s	ARG2
p97	ARG2
gene1e	ARG2
/	O
gene1s	O
Nas1p	O
gene1e	O
plays	O
an	O
important	O
regulatory	O
role	O
in	O
the	O
function	O
of	O
the	O
26S	O
proteasome	O
.	O

cDNA	O
cloning	O
and	O
functional	O
analysis	O
of	O
the	O
gene1s	O
p97	O
subunit	O
of	O
the	O
26S	O
proteasome	O
gene1e	O
,	O
a	O
polypeptide	O
identical	O
to	O
the	O
gene1s	O
type-1	O
tumor	O
-	O
necrosis	O
-	O
factor	O
-	O
receptor	O
-	O
associated	O
protein-2	O
gene1e	O
/	O
gene1s	O
55.11	O
gene1e	O
.	O
Molecular	O
cloning	O
of	O
cDNA	O
for	O
a	O
new	O
regulatory	O
subunit	O
,	O
designated	O
gene1s	O
p97	O
gene1e	O
,	O
of	O
the	O
species1s	O
human	O
species1e	O
26S	O
proteasome	O
showed	O
that	O
the	O
polypeptide	O
consists	O
of	O
908	O
amino	O
acid	O
residues	O
with	O
a	O
calculated	O
molecular	O
mass	O
of	O
100184	O
Da	O
and	O
an	O
isoelectric	O
point	O
of	O
4.94	O
.	O
Computer	O
analysis	O
showed	O
that	O
gene1s	O
p97	O
gene1e	O
is	O
very	O
similar	O
to	O
gene1s	O
type-1	O
tumor	O
-	O
necrosis	O
-	O
factor	O
(	O
TNF)-receptor	O
-	O
associated	O
protein	O
(	O
TRAP)-2	O
gene1e	O
and	O
55.11	O
,	O
both	O
of	O
which	O
were	O
identified	O
recently	O
as	O
binding	O
proteins	O
of	O
the	O
cytoplasmic	O
domain	O
of	O
type-1	O
TNF	O
receptor	O
by	O
arg1s	O
yeast	O
arg1e	O
two	O
-	O
hybrid	O
screening	O
.	O
This	O
finding	O
suggests	O
that	O
the	O
26S	O
proteasome	O
might	O
serve	O
as	O
a	O
mediator	O
molecule	O
in	O
the	O
TNF	O
signaling	O
pathway	O
in	O
cells	O
.	O
Computer	O
-	O
assisted	O
similarity	O
analysis	O
also	O
revealed	O
the	O
high	O
sequence	O
similarity	O
of	O
gene1s	O
p97	O
gene1e	O
with	O
a	O
arg1s	O
yeast	O
arg1e	O
protein	O
whose	O
function	O
is	O
yet	O
unknown	O
,	O
the	O
gene	O
for	O
which	O
is	O
here	O
termed	O
gene1s	ARG2
NAS1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
non	ARG2
-	ARG2
ATPase	ARG2
subunit	ARG2
1	ARG2
gene1e	ARG2
)	O
.	O
Disruption	O
of	O
gene1s	ARG2
NAS1	ARG2
gene1e	ARG2
resulted	O
in	O
several	O
phenotypes	O
,	O
including	O
lethality	O
and	O
temperature	O
-	O
sensitive	O
growth	O
,	O
depending	O
on	O
the	O
genetic	O
background	O
of	O
the	O
cells	O
used	O
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
p97	O
gene1e	O
cDNA	O
suppressed	O
the	O
growth	O
defect	O
of	O
species1s	O
nas1	O
species1e	O
disruptant	O
cells	O
,	O
when	O
expressed	O
from	O
single	O
-	O
copy	O
or	O
multi	O
-	O
copy	O
vectors	O
,	O
indicating	O
that	O
gene1s	O
p97	O
gene1e	O
is	O
functionally	O
equivalent	O
to	O
arg1s	O
yeast	O
arg1e	O
gene1s	ARG2
Nas1p	ARG2
gene1e	ARG2
.	O
Culturing	O
of	O
the	O
temperature	O
-	O
sensitive	O
species1s	O
nas1	O
species1e	O
cells	O
at	O
the	O
restrictive	O
temperature	O
promoted	O
the	O
accumulation	O
polyubiquitinated	O
cellular	O
proteins	O
,	O
implying	O
that	O
the	O
26S	O
proteasome	O
requires	O
a	O
functional	O
gene1s	ARG2
Nas1p	ARG2
gene1e	ARG2
subunit	O
for	O
ubiquitin	O
-	O
dependent	O
proteolysis	O
.	O
These	O
results	O
indicate	O
that	O
gene1s	O
p97	O
gene1e	O
/	O
gene1s	ARG2
Nas1p	ARG2
gene1e	ARG2
plays	O
an	O
important	O
regulatory	O
role	O
in	O
the	O
function	O
of	O
the	O
26S	O
proteasome	O
.	O

Receptor	O
-	O
associated	O
Mad	O
homologues	O
synergize	O
as	O
effectors	O
of	O
the	O
gene1s	O
TGF	O
-	O
beta	O
gene1e	O
response	O
.	O
gene1s	O
Transforming	O
growth	O
factor	O
-	O
beta	O
gene1e	O
gene1s	O
TGF	O
-	O
beta	O
gene1e	O
is	O
the	O
prototype	O
for	O
a	O
family	O
of	O
extracellular	O
proteins	O
that	O
affect	O
cell	O
proliferation	O
and	O
tissue	O
differentiation	O
.	O
TGF	O
-	O
beta	O
-	O
related	O
factors	O
,	O
including	O
gene1s	O
BMP-2/4	O
gene1e	O
,	O
gene1s	ARG2
Dpp	ARG2
gene1e	ARG2
and	O
activin	O
,	O
act	O
through	O
two	O
types	O
of	O
serine	O
/	O
threonine	O
kinase	O
receptors	O
which	O
can	O
form	O
a	O
heteromeric	O
complex	O
.	O
However	O
,	O
the	O
mechanism	O
of	O
signal	O
transduction	O
by	O
these	O
receptors	O
is	O
largely	O
unknown	O
.	O
In	O
arg1s	O
Drosophila	O
arg1e	O
,	O
Mad	O
is	O
required	O
for	O
signalling	O
by	O
gene1s	ARG2
Dpp	ARG2
gene1e	ARG2
.	O
We	O
have	O
isolated	O
complementary	O
DNAs	O
for	O
four	O
species1s	O
human	O
species1e	O
Mad	O
homologues	O
,	O
one	O
of	O
which	O
,	O
gene1s	O
hMAD-4	O
gene1e	O
,	O
is	O
identical	O
to	O
gene1s	O
DPC-4	O
gene1e	O
,	O
a	O
candidate	O
tumour	O
suppressor	O
.	O
gene1s	O
hMAD-3	O
and	O
-4	O
gene1e	O
synergized	O
to	O
induce	O
strong	O
ligand	O
-	O
independent	O
gene1s	O
TGF	O
-	O
beta	O
gene1e	O
-	O
like	O
responses	O
.	O
When	O
truncated	O
at	O
their	O
carboxy	O
termini	O
,	O
gene1s	O
hMAD-3	O
and	O
-4	O
gene1e	O
act	O
as	O
dominant	O
-	O
negative	O
inhibitors	O
of	O
the	O
normal	O
gene1s	O
TGF	O
-	O
beta	O
gene1e	O
response	O
.	O
The	O
activity	O
of	O
gene1s	O
hMAD-3	O
and	O
-4	O
gene1e	O
was	O
regulated	O
by	O
the	O
gene1s	O
TGF	O
-	O
beta	O
gene1e	O
receptors	O
,	O
and	O
gene1s	O
hMAD-3	O
gene1e	O
but	O
not	O
gene1s	O
hMAD-4	O
gene1e	O
was	O
phosphorylated	O
and	O
associated	O
with	O
the	O
ligand	O
-	O
bound	O
receptor	O
complex	O
.	O
These	O
results	O
define	O
gene1s	O
hMAD-3	O
and	O
-4	O
gene1e	O
as	O
effectors	O
of	O
the	O
gene1s	O
TGF	O
-	O
beta	O
gene1e	O
response	O
and	O
demonstrate	O
a	O
function	O
for	O
gene1s	O
DPCA-4	O
gene1e	O
/	O
gene1s	O
hMAD-4	O
gene1e	O
as	O
a	O
tumour	O
suppressor	O
.	O

Receptor	O
-	O
associated	O
Mad	O
homologues	O
synergize	O
as	O
effectors	O
of	O
the	O
gene1s	ARG2
TGF	ARG2
-	ARG2
beta	ARG2
gene1e	ARG2
response	O
.	O
gene1s	ARG2
Transforming	ARG2
growth	ARG2
factor	ARG2
-	ARG2
beta	ARG2
gene1e	ARG2
gene1s	ARG2
TGF	ARG2
-	ARG2
beta	ARG2
gene1e	ARG2
is	O
the	O
prototype	O
for	O
a	O
family	O
of	O
extracellular	O
proteins	O
that	O
affect	O
cell	O
proliferation	O
and	O
tissue	O
differentiation	O
.	O
TGF	O
-	O
beta	O
-	O
related	O
factors	O
,	O
including	O
gene1s	ARG2
BMP-2/4	ARG2
gene1e	ARG2
,	O
gene1s	O
Dpp	O
gene1e	O
and	O
activin	O
,	O
act	O
through	O
two	O
types	O
of	O
serine	O
/	O
threonine	O
kinase	O
receptors	O
which	O
can	O
form	O
a	O
heteromeric	O
complex	O
.	O
However	O
,	O
the	O
mechanism	O
of	O
signal	O
transduction	O
by	O
these	O
receptors	O
is	O
largely	O
unknown	O
.	O
In	O
species1s	O
Drosophila	O
species1e	O
,	O
Mad	O
is	O
required	O
for	O
signalling	O
by	O
gene1s	O
Dpp	O
gene1e	O
.	O
We	O
have	O
isolated	O
complementary	O
DNAs	O
for	O
four	O
arg1s	O
human	O
arg1e	O
Mad	O
homologues	O
,	O
one	O
of	O
which	O
,	O
gene1s	ARG2
hMAD-4	ARG2
gene1e	ARG2
,	O
is	O
identical	O
to	O
gene1s	ARG2
DPC-4	ARG2
gene1e	ARG2
,	O
a	O
candidate	O
tumour	O
suppressor	O
.	O
gene1s	ARG2
hMAD-3	ARG2
and	ARG2
-4	ARG2
gene1e	ARG2
synergized	O
to	O
induce	O
strong	O
ligand	O
-	O
independent	O
gene1s	ARG2
TGF	ARG2
-	ARG2
beta	ARG2
gene1e	ARG2
-	O
like	O
responses	O
.	O
When	O
truncated	O
at	O
their	O
carboxy	O
termini	O
,	O
gene1s	ARG2
hMAD-3	ARG2
and	ARG2
-4	ARG2
gene1e	ARG2
act	O
as	O
dominant	O
-	O
negative	O
inhibitors	O
of	O
the	O
normal	O
gene1s	ARG2
TGF	ARG2
-	ARG2
beta	ARG2
gene1e	ARG2
response	O
.	O
The	O
activity	O
of	O
gene1s	ARG2
hMAD-3	ARG2
and	ARG2
-4	ARG2
gene1e	ARG2
was	O
regulated	O
by	O
the	O
gene1s	ARG2
TGF	ARG2
-	ARG2
beta	ARG2
gene1e	ARG2
receptors	O
,	O
and	O
gene1s	ARG2
hMAD-3	ARG2
gene1e	ARG2
but	O
not	O
gene1s	ARG2
hMAD-4	ARG2
gene1e	ARG2
was	O
phosphorylated	O
and	O
associated	O
with	O
the	O
ligand	O
-	O
bound	O
receptor	O
complex	O
.	O
These	O
results	O
define	O
gene1s	ARG2
hMAD-3	ARG2
and	ARG2
-4	ARG2
gene1e	ARG2
as	O
effectors	O
of	O
the	O
gene1s	ARG2
TGF	ARG2
-	ARG2
beta	ARG2
gene1e	ARG2
response	O
and	O
demonstrate	O
a	O
function	O
for	O
gene1s	ARG2
DPCA-4	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
hMAD-4	ARG2
gene1e	ARG2
as	O
a	O
tumour	O
suppressor	O
.	O

Cell	O
-	O
cell	O
adhesion	O
mediated	O
by	O
binding	O
of	O
membrane	O
-	O
anchored	O
ligand	O
gene1s	ARG2
LERK-2	ARG2
gene1e	ARG2
to	O
the	O
gene1s	ARG2
EPH	ARG2
-	ARG2
related	ARG2
receptor	ARG2
human	ARG2
embryonal	ARG2
kinase	ARG2
2	ARG2
gene1e	ARG2
promotes	O
tyrosine	O
kinase	O
activity	O
.	O
arg1s	O
Human	O
arg1e	O
gene1s	ARG2
embryonal	ARG2
kinase	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
HEK2	ARG2
gene1e	ARG2
)	O
is	O
a	O
protein	O
-	O
tyrosine	O
kinase	O
that	O
is	O
a	O
member	O
of	O
the	O
EPH	O
family	O
of	O
receptors	O
.	O
Transcripts	O
for	O
gene1s	ARG2
HEK2	ARG2
gene1e	ARG2
have	O
a	O
wide	O
tissue	O
distribution	O
.	O
Recently	O
,	O
a	O
still	O
growing	O
family	O
of	O
ligands	O
,	O
which	O
we	O
have	O
named	O
LERKs	O
,	O
for	O
ligands	O
of	O
the	O
eph	O
-	O
related	O
kinases	O
,	O
has	O
been	O
isolated	O
.	O
In	O
order	O
to	O
analyze	O
functional	O
effects	O
between	O
the	O
LERKs	O
and	O
the	O
gene1s	ARG2
HEK2	ARG2
gene1e	ARG2
receptor	O
,	O
we	O
expressed	O
gene1s	ARG2
HEK2	ARG2
gene1e	ARG2
cDNA	O
in	O
an	O
gene1s	ARG2
interleukin-3	ARG2
gene1e	ARG2
-dependent	O
progenitor	O
cell	O
line	O
species1s	O
32D	O
species1e	O
that	O
grows	O
as	O
single	O
cells	O
in	O
culture	O
.	O
Within	O
the	O
group	O
of	O
LERKs	O
,	O
gene1s	ARG2
LERK-2	ARG2
and	ARG2
-5	ARG2
gene1e	ARG2
were	O
shown	O
to	O
bind	O
to	O
gene1s	ARG2
HEK2	ARG2
gene1e	ARG2
.	O
Membrane	O
-	O
bound	O
and	O
soluble	O
forms	O
of	O
gene1s	ARG2
LERK-2	ARG2
gene1e	ARG2
were	O
demonstrated	O
to	O
signal	O
through	O
gene1s	ARG2
HEK2	ARG2
gene1e	ARG2
as	O
judged	O
by	O
receptor	O
phosphorylation	O
.	O
Coincubation	O
of	O
gene1s	ARG2
HEK2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
LERK-2	ARG2
gene1e	ARG2
expressing	O
cells	O
induced	O
cell	O
-	O
cell	O
adhesion	O
and	O
formation	O
of	O
cell	O
aggregates	O
.	O
This	O
interaction	O
could	O
be	O
inhibited	O
by	O
preincubation	O
of	O
gene1s	ARG2
HEK2	ARG2
gene1e	ARG2
expressing	O
cells	O
with	O
soluble	O
gene1s	ARG2
LERK-2	ARG2
gene1e	ARG2
.	O
Coexpression	O
of	O
gene1s	ARG2
HEK2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
LERK-2	ARG2
gene1e	ARG2
in	O
species1s	O
32D	O
species1e	O
cells	O
showed	O
reduced	O
kinase	O
activity	O
and	O
autophosphorylation	O
of	O
gene1s	ARG2
HEK2	ARG2
gene1e	ARG2
compared	O
with	O
the	O
juxtacrine	O
stimulation	O
,	O
which	O
seems	O
to	O
be	O
due	O
to	O
a	O
reduced	O
sensitivity	O
of	O
the	O
receptor	O
.	O

Cell	O
-	O
cell	O
adhesion	O
mediated	O
by	O
binding	O
of	O
membrane	O
-	O
anchored	O
ligand	O
gene1s	O
LERK-2	O
gene1e	O
to	O
the	O
gene1s	O
EPH	O
-	O
related	O
receptor	O
human	O
embryonal	O
kinase	O
2	O
gene1e	O
promotes	O
tyrosine	O
kinase	O
activity	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
embryonal	O
kinase	O
2	O
gene1e	O
(	O
gene1s	O
HEK2	O
gene1e	O
)	O
is	O
a	O
protein	O
-	O
tyrosine	O
kinase	O
that	O
is	O
a	O
member	O
of	O
the	O
EPH	O
family	O
of	O
receptors	O
.	O
Transcripts	O
for	O
gene1s	O
HEK2	O
gene1e	O
have	O
a	O
wide	O
tissue	O
distribution	O
.	O
Recently	O
,	O
a	O
still	O
growing	O
family	O
of	O
ligands	O
,	O
which	O
we	O
have	O
named	O
LERKs	O
,	O
for	O
ligands	O
of	O
the	O
eph	O
-	O
related	O
kinases	O
,	O
has	O
been	O
isolated	O
.	O
In	O
order	O
to	O
analyze	O
functional	O
effects	O
between	O
the	O
LERKs	O
and	O
the	O
gene1s	O
HEK2	O
gene1e	O
receptor	O
,	O
we	O
expressed	O
gene1s	O
HEK2	O
gene1e	O
cDNA	O
in	O
an	O
gene1s	O
interleukin-3	O
gene1e	O
-dependent	O
progenitor	O
cell	O
line	O
arg1s	O
32D	O
arg1e	O
that	O
grows	O
as	O
single	O
cells	O
in	O
culture	O
.	O
Within	O
the	O
group	O
of	O
LERKs	O
,	O
gene1s	O
LERK-2	O
and	O
-5	O
gene1e	O
were	O
shown	O
to	O
bind	O
to	O
gene1s	O
HEK2	O
gene1e	O
.	O
Membrane	O
-	O
bound	O
and	O
soluble	O
forms	O
of	O
gene1s	O
LERK-2	O
gene1e	O
were	O
demonstrated	O
to	O
signal	O
through	O
gene1s	O
HEK2	O
gene1e	O
as	O
judged	O
by	O
receptor	O
phosphorylation	O
.	O
Coincubation	O
of	O
gene1s	O
HEK2	O
gene1e	O
and	O
gene1s	O
LERK-2	O
gene1e	O
expressing	O
cells	O
induced	O
cell	O
-	O
cell	O
adhesion	O
and	O
formation	O
of	O
cell	O
aggregates	O
.	O
This	O
interaction	O
could	O
be	O
inhibited	O
by	O
preincubation	O
of	O
gene1s	O
HEK2	O
gene1e	O
expressing	O
cells	O
with	O
soluble	O
gene1s	O
LERK-2	O
gene1e	O
.	O
Coexpression	O
of	O
gene1s	O
HEK2	O
gene1e	O
and	O
gene1s	O
LERK-2	O
gene1e	O
in	O
arg1s	O
32D	O
arg1e	O
cells	O
showed	O
reduced	O
kinase	O
activity	O
and	O
autophosphorylation	O
of	O
gene1s	O
HEK2	O
gene1e	O
compared	O
with	O
the	O
juxtacrine	O
stimulation	O
,	O
which	O
seems	O
to	O
be	O
due	O
to	O
a	O
reduced	O
sensitivity	O
of	O
the	O
receptor	O
.	O

Expression	O
of	O
the	O
receptor	O
protein	O
tyrosine	O
kinase	O
gene1s	O
myk-1	O
gene1e	O
/	O
gene1s	O
htk	O
gene1e	O
in	O
normal	O
and	O
malignant	O
mammary	O
epithelium	O
.	O
We	O
have	O
recently	O
reported	O
the	O
molecular	O
characterization	O
of	O
a	O
novel	O
arg1s	O
murine	O
arg1e	O
receptor	O
PTK	O
(	O
gene1s	O
myk-1	O
gene1e	O
)	O
,	O
belonging	O
to	O
the	O
eph	O
-	O
related	O
family	O
,	O
whose	O
expression	O
was	O
differentially	O
regulated	O
during	O
mammary	O
gland	O
development	O
and	O
elevated	O
in	O
invasive	O
arg1s	O
mouse	O
arg1e	O
mammary	O
tumours	O
.	O
In	O
this	O
communication	O
we	O
have	O
investigated	O
the	O
cellular	O
origin	O
of	O
gene1s	O
myk-1	O
gene1e	O
expression	O
by	O
in	O
situ	O
hybridisation	O
and	O
RNase	O
protection	O
.	O
arg1s	O
Murine	O
arg1e	O
antisense	O
gene1s	O
myk-1	O
gene1e	O
probe	O
specifically	O
recognised	O
ductal	O
and	O
alveolar	O
epithelium	O
in	O
the	O
resting	O
arg1s	O
mouse	O
arg1e	O
mammary	O
gland	O
.	O
In	O
normal	O
species1s	O
human	O
species1e	O
breast	O
,	O
the	O
expression	O
of	O
gene1s	O
htk	O
gene1e	O
,	O
the	O
species1s	O
human	O
species1e	O
homologue	O
,	O
was	O
also	O
confined	O
to	O
the	O
secretory	O
luminal	O
epithelial	O
cells	O
.	O
RNase	O
protection	O
analysis	O
of	O
enriched	O
luminal	O
and	O
myoepithelial	O
cells	O
prepared	O
from	O
species1s	O
human	O
species1e	O
reduction	O
mammoplasty	O
tissue	O
confirmed	O
the	O
luminal	O
specificity	O
.	O
Elevated	O
expression	O
of	O
gene1s	O
htk	O
gene1e	O
was	O
found	O
in	O
several	O
species1s	O
human	O
species1e	O
breast	O
carcinoma	O
cell	O
lines	O
as	O
well	O
as	O
in	O
primary	O
,	O
high	O
grade	O
,	O
infiltrating	O
,	O
ductal	O
carcinomas	O
of	O
the	O
breast	O
.	O
The	O
specific	O
epithelial	O
expression	O
of	O
the	O
gene1s	O
myk-1	O
gene1e	O
/	O
gene1s	O
htk	O
gene1e	O
receptor	O
PTK	O
suggest	O
a	O
specialised	O
role	O
of	O
this	O
eph	O
-	O
related	O
PTK	O
in	O
the	O
differentiation	O
and/or	O
maintenance	O
of	O
secretory	O
epithelium	O
in	O
the	O
adult	O
.	O

Expression	O
of	O
the	O
receptor	O
protein	O
tyrosine	O
kinase	O
gene1s	ARG2
myk-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
htk	ARG2
gene1e	ARG2
in	O
normal	O
and	O
malignant	O
mammary	O
epithelium	O
.	O
We	O
have	O
recently	O
reported	O
the	O
molecular	O
characterization	O
of	O
a	O
novel	O
species1s	O
murine	O
species1e	O
receptor	O
PTK	O
(	O
gene1s	ARG2
myk-1	ARG2
gene1e	ARG2
)	O
,	O
belonging	O
to	O
the	O
eph	O
-	O
related	O
family	O
,	O
whose	O
expression	O
was	O
differentially	O
regulated	O
during	O
mammary	O
gland	O
development	O
and	O
elevated	O
in	O
invasive	O
species1s	O
mouse	O
species1e	O
mammary	O
tumours	O
.	O
In	O
this	O
communication	O
we	O
have	O
investigated	O
the	O
cellular	O
origin	O
of	O
gene1s	ARG2
myk-1	ARG2
gene1e	ARG2
expression	O
by	O
in	O
situ	O
hybridisation	O
and	O
RNase	O
protection	O
.	O
species1s	O
Murine	O
species1e	O
antisense	O
gene1s	ARG2
myk-1	ARG2
gene1e	ARG2
probe	O
specifically	O
recognised	O
ductal	O
and	O
alveolar	O
epithelium	O
in	O
the	O
resting	O
species1s	O
mouse	O
species1e	O
mammary	O
gland	O
.	O
In	O
normal	O
arg1s	O
human	O
arg1e	O
breast	O
,	O
the	O
expression	O
of	O
gene1s	ARG2
htk	ARG2
gene1e	ARG2
,	O
the	O
arg1s	O
human	O
arg1e	O
homologue	O
,	O
was	O
also	O
confined	O
to	O
the	O
secretory	O
luminal	O
epithelial	O
cells	O
.	O
RNase	O
protection	O
analysis	O
of	O
enriched	O
luminal	O
and	O
myoepithelial	O
cells	O
prepared	O
from	O
arg1s	O
human	O
arg1e	O
reduction	O
mammoplasty	O
tissue	O
confirmed	O
the	O
luminal	O
specificity	O
.	O
Elevated	O
expression	O
of	O
gene1s	ARG2
htk	ARG2
gene1e	ARG2
was	O
found	O
in	O
several	O
arg1s	O
human	O
arg1e	O
breast	O
carcinoma	O
cell	O
lines	O
as	O
well	O
as	O
in	O
primary	O
,	O
high	O
grade	O
,	O
infiltrating	O
,	O
ductal	O
carcinomas	O
of	O
the	O
breast	O
.	O
The	O
specific	O
epithelial	O
expression	O
of	O
the	O
gene1s	ARG2
myk-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
htk	ARG2
gene1e	ARG2
receptor	O
PTK	O
suggest	O
a	O
specialised	O
role	O
of	O
this	O
eph	O
-	O
related	O
PTK	O
in	O
the	O
differentiation	O
and/or	O
maintenance	O
of	O
secretory	O
epithelium	O
in	O
the	O
adult	O
.	O

cDNA	O
cloning	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
allograft	ARG2
inflammatory	ARG2
factor-1	ARG2
gene1e	ARG2
:	O
tissue	O
distribution	O
,	O
cytokine	O
induction	O
,	O
and	O
mRNA	O
expression	O
in	O
injured	O
species1s	O
rat	O
species1e	O
carotid	O
arteries	O
.	O
We	O
have	O
previously	O
identified	O
a	O
partial	O
cDNA	O
fragment	O
obtained	O
from	O
species1s	O
rat	O
species1e	O
carotid	O
arteries	O
subject	O
to	O
balloon	O
angioplasty	O
which	O
is	O
increased	O
in	O
response	O
to	O
vascular	O
injury	O
.	O
We	O
now	O
report	O
the	O
isolation	O
and	O
characterization	O
of	O
a	O
full	O
length	O
arg1s	O
human	O
arg1e	O
clone	O
which	O
is	O
98	O
%	O
homologous	O
at	O
the	O
amino	O
acid	O
level	O
to	O
the	O
species1s	O
rat	O
species1e	O
.	O
gene1s	ARG2
Allograft	ARG2
Inflammatory	ARG2
Factor-1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
AIF-1	ARG2
gene1e	ARG2
)	O
,	O
a	O
gene	O
previously	O
reported	O
to	O
be	O
expressed	O
in	O
species1s	O
rat	O
species1e	O
gene1s	O
IFN	O
gamma	O
gene1e	O
-	O
activated	O
macrophages	O
.	O
This	O
transcript	O
is	O
expressed	O
in	O
low	O
levels	O
in	O
undamaged	O
,	O
and	O
increases	O
1	O
day	O
and	O
3	O
days	O
,	O
and	O
declines	O
7	O
days	O
post	O
balloon	O
angioplasty	O
.	O
This	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
AIF-1	ARG2
gene1e	ARG2
homologue	O
is	O
inducible	O
in	O
serum	O
and	O
cytokine	O
-	O
stimulated	O
arg1s	O
human	O
arg1e	O
smooth	O
muscle	O
cells	O
.	O
Interestingly	O
,	O
arg1s	O
human	O
arg1e	O
tissue	O
distribution	O
indicates	O
a	O
constitutive	O
expression	O
in	O
lymphoid	O
tissue	O
which	O
can	O
be	O
augmented	O
by	O
mitogens	O
.	O
In	O
summary	O
,	O
arg1s	O
human	O
arg1e	O
AIF	O
represents	O
a	O
cytokine	O
inducible	O
,	O
tissue	O
-	O
specific	O
,	O
and	O
highly	O
conserved	O
transcript	O
transiently	O
expressed	O
in	O
response	O
to	O
vascular	O
trauma	O
.	O

cDNA	O
cloning	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
allograft	O
inflammatory	O
factor-1	O
gene1e	O
:	O
tissue	O
distribution	O
,	O
cytokine	O
induction	O
,	O
and	O
mRNA	O
expression	O
in	O
injured	O
arg1s	O
rat	O
arg1e	O
carotid	O
arteries	O
.	O
We	O
have	O
previously	O
identified	O
a	O
partial	O
cDNA	O
fragment	O
obtained	O
from	O
arg1s	O
rat	O
arg1e	O
carotid	O
arteries	O
subject	O
to	O
balloon	O
angioplasty	O
which	O
is	O
increased	O
in	O
response	O
to	O
vascular	O
injury	O
.	O
We	O
now	O
report	O
the	O
isolation	O
and	O
characterization	O
of	O
a	O
full	O
length	O
species1s	O
human	O
species1e	O
clone	O
which	O
is	O
98	O
%	O
homologous	O
at	O
the	O
amino	O
acid	O
level	O
to	O
the	O
arg1s	O
rat	O
arg1e	O
.	O
gene1s	O
Allograft	O
Inflammatory	O
Factor-1	O
gene1e	O
(	O
gene1s	O
AIF-1	O
gene1e	O
)	O
,	O
a	O
gene	O
previously	O
reported	O
to	O
be	O
expressed	O
in	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
IFN	ARG2
gamma	ARG2
gene1e	ARG2
-	O
activated	O
macrophages	O
.	O
This	O
transcript	O
is	O
expressed	O
in	O
low	O
levels	O
in	O
undamaged	O
,	O
and	O
increases	O
1	O
day	O
and	O
3	O
days	O
,	O
and	O
declines	O
7	O
days	O
post	O
balloon	O
angioplasty	O
.	O
This	O
species1s	O
human	O
species1e	O
gene1s	O
AIF-1	O
gene1e	O
homologue	O
is	O
inducible	O
in	O
serum	O
and	O
cytokine	O
-	O
stimulated	O
species1s	O
human	O
species1e	O
smooth	O
muscle	O
cells	O
.	O
Interestingly	O
,	O
species1s	O
human	O
species1e	O
tissue	O
distribution	O
indicates	O
a	O
constitutive	O
expression	O
in	O
lymphoid	O
tissue	O
which	O
can	O
be	O
augmented	O
by	O
mitogens	O
.	O
In	O
summary	O
,	O
species1s	O
human	O
species1e	O
AIF	O
represents	O
a	O
cytokine	O
inducible	O
,	O
tissue	O
-	O
specific	O
,	O
and	O
highly	O
conserved	O
transcript	O
transiently	O
expressed	O
in	O
response	O
to	O
vascular	O
trauma	O
.	O

Functional	O
expression	O
of	O
a	O
novel	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
neurokinin-3	ARG2
receptor	ARG2
gene1e	ARG2
homolog	O
that	O
binds	O
[	O
3H]senktide	O
and	O
[	O
125I	O
-	O
MePhe7]	O
gene1s	ARG2
neurokinin	ARG2
B	ARG2
gene1e	ARG2
,	O
and	O
is	O
responsive	O
to	O
tachykinin	O
peptide	O
agonists	O
.	O
In	O
1992	O
,	O
Xie	O
et	O
al	O
.	O
identified	O
a	O
cDNA	O
sequence	O
in	O
the	O
expression	O
cloning	O
search	O
for	O
the	O
gene1s	ARG2
kappa	ARG2
opioid	ARG2
receptor	ARG2
gene1e	ARG2
.	O
When	O
the	O
cDNA	O
was	O
expressed	O
in	O
species1s	O
Cos-7	O
species1e	O
cells	O
,	O
binding	O
of	O
opioid	O
compounds	O
was	O
observed	O
to	O
be	O
of	O
low	O
affinity	O
and	O
without	O
kappa	O
,	O
mu	O
,	O
or	O
delta	O
selectivity	O
[	O
Xie	O
,	O
G.-X.	O
,	O
Miyajima	O
,	O
A.	O
and	O
Goldstein	O
,	O
A.	O
(	O
1992	O
)	O
Proc	O
.	O
Natl	O
.	O
Acad	O
.	O
Sci	O
.	O
USA	O
89	O
,	O
4124	O
-	O
4128	O
]	O
.	O
This	O
cDNA	O
was	O
highly	O
homologous	O
to	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
neurokinin-3	ARG2
(	ARG2
NK-3	ARG2
)	ARG2
receptor	ARG2
gene1e	ARG2
sequence	O
,	O
and	O
displayed	O
lower	O
homology	O
to	O
gene1s	ARG2
NK-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
NK-2	ARG2
gene1e	ARG2
sequences	O
.	O
This	O
sequence	O
was	O
stably	O
expressed	O
in	O
species1s	O
Chinese	O
hamster	O
species1e	O
ovary	O
cells	O
,	O
which	O
do	O
not	O
express	O
neurokinin	O
receptors	O
naturally	O
,	O
and	O
ligand	O
binding	O
and	O
second	O
messenger	O
characteristics	O
were	O
compared	O
with	O
a	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
NK-3	ARG2
receptor	ARG2
gene1e	ARG2
.	O
The	O
gene1s	ARG2
NK-3	ARG2
receptor	ARG2
gene1e	ARG2
homolog	O
bound	O
[	O
3H	O
]	O
senktide	O
with	O
a	O
Kd	O
of	O
39	O
nM	O
,	O
similar	O
to	O
that	O
of	O
the	O
gene1s	ARG2
NK-3	ARG2
receptor	ARG2
gene1e	ARG2
.	O
The	O
rank	O
order	O
of	O
tachykinin	O
peptides	O
competing	O
for	O
[	O
3H]senktide	O
binding	O
at	O
the	O
gene1s	ARG2
NK-3	ARG2
receptor	ARG2
gene1e	ARG2
homolog	O
was	O
[	O
MePhe7]	O
gene1s	ARG2
neurokinin	ARG2
B	ARG2
gene1e	ARG2
>	O
senktide	O
>	O
gene1s	ARG2
substance	ARG2
P	ARG2
gene1e	ARG2
=	O
gene1s	ARG2
neurokinin	ARG2
A	ARG2
gene1e	ARG2
>	O
gene1s	ARG2
neurokinin	ARG2
B	ARG2
gene1e	ARG2
.	O
This	O
cell	O
line	O
also	O
bound	O
[	O
125I	O
-	O
MePhe7]	O
gene1s	ARG2
neurokinin	ARG2
B	ARG2
gene1e	ARG2
;	O
however	O
,	O
gene1s	ARG2
neurokinin	ARG2
B	ARG2
gene1e	ARG2
was	O
an	O
effective	O
competitor	O
.	O
Tachykinin	O
peptides	O
stimulated	O
both	O
inositol	O
phospholipid	O
hydrolysis	O
and	O
arachidonic	O
acid	O
release	O
at	O
gene1s	ARG2
NK-3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
NK-3	ARG2
receptor	ARG2
gene1e	ARG2
homolog	O
cell	O
lines	O
,	O
with	O
similar	O
rank	O
orders	O
of	O
potency	O
of	O
[	O
MePhe7	O
]	O
gene1s	ARG2
neurokinin	ARG2
B	ARG2
gene1e	ARG2
=	O
gene1s	ARG2
neurokinin	ARG2
B	ARG2
gene1e	ARG2
=	O
senktide	O
>	O
gene1s	ARG2
NKA	ARG2
gene1e	ARG2
=	O
gene1s	ARG2
substance	ARG2
P	ARG2
gene1e	ARG2
.	O
These	O
results	O
indicate	O
that	O
expression	O
of	O
the	O
gene1s	ARG2
NK-3	ARG2
receptor	ARG2
gene1e	ARG2
homolog	O
cDNA	O
in	O
the	O
species1s	O
Chinese	O
hamster	O
species1e	O
ovary	O
cell	O
system	O
induces	O
the	O
expression	O
of	O
a	O
receptor	O
site	O
with	O
many	O
similarities	O
but	O
certain	O
key	O
differences	O
from	O
that	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
NK-3	ARG2
receptor	ARG2
gene1e	ARG2
.	O
The	O
results	O
are	O
discussed	O
with	O
reference	O
to	O
the	O
existence	O
of	O
a	O
novel	O
arg1s	O
human	O
arg1e	O
tachykinin	O
receptor	O
.	O

Functional	O
expression	O
of	O
a	O
novel	O
species1s	O
human	O
species1e	O
gene1s	O
neurokinin-3	O
receptor	O
gene1e	O
homolog	O
that	O
binds	O
[	O
3H]senktide	O
and	O
[	O
125I	O
-	O
MePhe7]	O
gene1s	O
neurokinin	O
B	O
gene1e	O
,	O
and	O
is	O
responsive	O
to	O
tachykinin	O
peptide	O
agonists	O
.	O
In	O
1992	O
,	O
Xie	O
et	O
al	O
.	O
identified	O
a	O
cDNA	O
sequence	O
in	O
the	O
expression	O
cloning	O
search	O
for	O
the	O
gene1s	O
kappa	O
opioid	O
receptor	O
gene1e	O
.	O
When	O
the	O
cDNA	O
was	O
expressed	O
in	O
arg1s	O
Cos-7	O
arg1e	O
cells	O
,	O
binding	O
of	O
opioid	O
compounds	O
was	O
observed	O
to	O
be	O
of	O
low	O
affinity	O
and	O
without	O
kappa	O
,	O
mu	O
,	O
or	O
delta	O
selectivity	O
[	O
Xie	O
,	O
G.-X.	O
,	O
Miyajima	O
,	O
A.	O
and	O
Goldstein	O
,	O
A.	O
(	O
1992	O
)	O
Proc	O
.	O
Natl	O
.	O
Acad	O
.	O
Sci	O
.	O
USA	O
89	O
,	O
4124	O
-	O
4128	O
]	O
.	O
This	O
cDNA	O
was	O
highly	O
homologous	O
to	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
neurokinin-3	O
(	O
NK-3	O
)	O
receptor	O
gene1e	O
sequence	O
,	O
and	O
displayed	O
lower	O
homology	O
to	O
gene1s	O
NK-1	O
gene1e	O
and	O
gene1s	O
NK-2	O
gene1e	O
sequences	O
.	O
This	O
sequence	O
was	O
stably	O
expressed	O
in	O
species1s	O
Chinese	O
hamster	O
species1e	O
ovary	O
cells	O
,	O
which	O
do	O
not	O
express	O
neurokinin	O
receptors	O
naturally	O
,	O
and	O
ligand	O
binding	O
and	O
second	O
messenger	O
characteristics	O
were	O
compared	O
with	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
NK-3	O
receptor	O
gene1e	O
.	O
The	O
gene1s	O
NK-3	O
receptor	O
gene1e	O
homolog	O
bound	O
[	O
3H	O
]	O
senktide	O
with	O
a	O
Kd	O
of	O
39	O
nM	O
,	O
similar	O
to	O
that	O
of	O
the	O
gene1s	O
NK-3	O
receptor	O
gene1e	O
.	O
The	O
rank	O
order	O
of	O
tachykinin	O
peptides	O
competing	O
for	O
[	O
3H]senktide	O
binding	O
at	O
the	O
gene1s	O
NK-3	O
receptor	O
gene1e	O
homolog	O
was	O
[	O
MePhe7]	O
gene1s	O
neurokinin	O
B	O
gene1e	O
>	O
senktide	O
>	O
gene1s	O
substance	O
P	O
gene1e	O
=	O
gene1s	O
neurokinin	O
A	O
gene1e	O
>	O
gene1s	O
neurokinin	O
B	O
gene1e	O
.	O
This	O
cell	O
line	O
also	O
bound	O
[	O
125I	O
-	O
MePhe7]	O
gene1s	O
neurokinin	O
B	O
gene1e	O
;	O
however	O
,	O
gene1s	O
neurokinin	O
B	O
gene1e	O
was	O
an	O
effective	O
competitor	O
.	O
Tachykinin	O
peptides	O
stimulated	O
both	O
inositol	O
phospholipid	O
hydrolysis	O
and	O
arachidonic	O
acid	O
release	O
at	O
gene1s	O
NK-3	O
gene1e	O
and	O
gene1s	O
NK-3	O
receptor	O
gene1e	O
homolog	O
cell	O
lines	O
,	O
with	O
similar	O
rank	O
orders	O
of	O
potency	O
of	O
[	O
MePhe7	O
]	O
gene1s	O
neurokinin	O
B	O
gene1e	O
=	O
gene1s	O
neurokinin	O
B	O
gene1e	O
=	O
senktide	O
>	O
gene1s	O
NKA	O
gene1e	O
=	O
gene1s	O
substance	O
P	O
gene1e	O
.	O
These	O
results	O
indicate	O
that	O
expression	O
of	O
the	O
gene1s	O
NK-3	O
receptor	O
gene1e	O
homolog	O
cDNA	O
in	O
the	O
species1s	O
Chinese	O
hamster	O
species1e	O
ovary	O
cell	O
system	O
induces	O
the	O
expression	O
of	O
a	O
receptor	O
site	O
with	O
many	O
similarities	O
but	O
certain	O
key	O
differences	O
from	O
that	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
NK-3	O
receptor	O
gene1e	O
.	O
The	O
results	O
are	O
discussed	O
with	O
reference	O
to	O
the	O
existence	O
of	O
a	O
novel	O
species1s	O
human	O
species1e	O
tachykinin	O
receptor	O
.	O

Functional	O
expression	O
of	O
a	O
novel	O
species1s	O
human	O
species1e	O
gene1s	O
neurokinin-3	O
receptor	O
gene1e	O
homolog	O
that	O
binds	O
[	O
3H]senktide	O
and	O
[	O
125I	O
-	O
MePhe7]	O
gene1s	O
neurokinin	O
B	O
gene1e	O
,	O
and	O
is	O
responsive	O
to	O
tachykinin	O
peptide	O
agonists	O
.	O
In	O
1992	O
,	O
Xie	O
et	O
al	O
.	O
identified	O
a	O
cDNA	O
sequence	O
in	O
the	O
expression	O
cloning	O
search	O
for	O
the	O
gene1s	O
kappa	O
opioid	O
receptor	O
gene1e	O
.	O
When	O
the	O
cDNA	O
was	O
expressed	O
in	O
species1s	O
Cos-7	O
species1e	O
cells	O
,	O
binding	O
of	O
opioid	O
compounds	O
was	O
observed	O
to	O
be	O
of	O
low	O
affinity	O
and	O
without	O
kappa	O
,	O
mu	O
,	O
or	O
delta	O
selectivity	O
[	O
Xie	O
,	O
G.-X.	O
,	O
Miyajima	O
,	O
A.	O
and	O
Goldstein	O
,	O
A.	O
(	O
1992	O
)	O
Proc	O
.	O
Natl	O
.	O
Acad	O
.	O
Sci	O
.	O
USA	O
89	O
,	O
4124	O
-	O
4128	O
]	O
.	O
This	O
cDNA	O
was	O
highly	O
homologous	O
to	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
neurokinin-3	O
(	O
NK-3	O
)	O
receptor	O
gene1e	O
sequence	O
,	O
and	O
displayed	O
lower	O
homology	O
to	O
gene1s	O
NK-1	O
gene1e	O
and	O
gene1s	O
NK-2	O
gene1e	O
sequences	O
.	O
This	O
sequence	O
was	O
stably	O
expressed	O
in	O
arg1s	O
Chinese	O
hamster	O
arg1e	O
ovary	O
cells	O
,	O
which	O
do	O
not	O
express	O
neurokinin	O
receptors	O
naturally	O
,	O
and	O
ligand	O
binding	O
and	O
second	O
messenger	O
characteristics	O
were	O
compared	O
with	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
NK-3	O
receptor	O
gene1e	O
.	O
The	O
gene1s	O
NK-3	O
receptor	O
gene1e	O
homolog	O
bound	O
[	O
3H	O
]	O
senktide	O
with	O
a	O
Kd	O
of	O
39	O
nM	O
,	O
similar	O
to	O
that	O
of	O
the	O
gene1s	O
NK-3	O
receptor	O
gene1e	O
.	O
The	O
rank	O
order	O
of	O
tachykinin	O
peptides	O
competing	O
for	O
[	O
3H]senktide	O
binding	O
at	O
the	O
gene1s	O
NK-3	O
receptor	O
gene1e	O
homolog	O
was	O
[	O
MePhe7]	O
gene1s	O
neurokinin	O
B	O
gene1e	O
>	O
senktide	O
>	O
gene1s	O
substance	O
P	O
gene1e	O
=	O
gene1s	O
neurokinin	O
A	O
gene1e	O
>	O
gene1s	O
neurokinin	O
B	O
gene1e	O
.	O
This	O
cell	O
line	O
also	O
bound	O
[	O
125I	O
-	O
MePhe7]	O
gene1s	O
neurokinin	O
B	O
gene1e	O
;	O
however	O
,	O
gene1s	O
neurokinin	O
B	O
gene1e	O
was	O
an	O
effective	O
competitor	O
.	O
Tachykinin	O
peptides	O
stimulated	O
both	O
inositol	O
phospholipid	O
hydrolysis	O
and	O
arachidonic	O
acid	O
release	O
at	O
gene1s	O
NK-3	O
gene1e	O
and	O
gene1s	O
NK-3	O
receptor	O
gene1e	O
homolog	O
cell	O
lines	O
,	O
with	O
similar	O
rank	O
orders	O
of	O
potency	O
of	O
[	O
MePhe7	O
]	O
gene1s	O
neurokinin	O
B	O
gene1e	O
=	O
gene1s	O
neurokinin	O
B	O
gene1e	O
=	O
senktide	O
>	O
gene1s	O
NKA	O
gene1e	O
=	O
gene1s	O
substance	O
P	O
gene1e	O
.	O
These	O
results	O
indicate	O
that	O
expression	O
of	O
the	O
gene1s	O
NK-3	O
receptor	O
gene1e	O
homolog	O
cDNA	O
in	O
the	O
arg1s	O
Chinese	O
hamster	O
arg1e	O
ovary	O
cell	O
system	O
induces	O
the	O
expression	O
of	O
a	O
receptor	O
site	O
with	O
many	O
similarities	O
but	O
certain	O
key	O
differences	O
from	O
that	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
NK-3	O
receptor	O
gene1e	O
.	O
The	O
results	O
are	O
discussed	O
with	O
reference	O
to	O
the	O
existence	O
of	O
a	O
novel	O
species1s	O
human	O
species1e	O
tachykinin	O
receptor	O
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
a	O
transcription	O
factor	O
for	O
the	O
gene1s	ARG2
C	ARG2
-	ARG2
type	ARG2
natriuretic	ARG2
peptide	ARG2
gene1e	ARG2
gene	O
promoter	O
.	O
Our	O
previous	O
studies	O
on	O
the	O
promoter	O
function	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
C	ARG2
-	ARG2
type	ARG2
natriuretic	ARG2
peptide	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CNP	ARG2
gene1e	ARG2
)	O
gene	O
revealed	O
the	O
existence	O
of	O
two	O
GC	O
-	O
rich	O
cis	O
elements	O
essential	O
for	O
gene	O
transcription	O
in	O
species1s	O
rat	O
species1e	O
pituitary	O
-	O
derived	O
species1s	O
GH3	O
species1e	O
cells	O
.	O
To	O
isolate	O
transcription	O
factors	O
that	O
bind	O
to	O
those	O
GC	O
-	O
rich	O
elements	O
,	O
we	O
screened	O
a	O
lambda	O
ZAP	O
cDNA	O
library	O
derived	O
from	O
species1s	O
GH3	O
species1e	O
cells	O
by	O
Southwestern	O
screening	O
.	O
Several	O
positive	O
clones	O
with	O
specific	O
binding	O
abilities	O
were	O
obtained	O
,	O
and	O
one	O
was	O
identical	O
as	O
gene1s	ARG2
TSC-22	ARG2
gene1e	ARG2
,	O
a	O
speculated	O
transcriptional	O
modulator	O
stimulated	O
by	O
transforming	O
growth	O
factor	O
beta	O
(	O
TGF	O
-	O
beta	O
)	O
of	O
unknown	O
function	O
.	O
gene1s	ARG2
TSC-22	ARG2
gene1e	ARG2
significantly	O
enhanced	O
gene1s	ARG2
CNP	ARG2
gene1e	ARG2
promoter	O
activity	O
in	O
species1s	O
GH3	O
species1e	O
cells	O
.	O
We	O
further	O
cloned	O
a	O
1.8-kb	O
full	O
-	O
length	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
TSC-22	ARG2
gene1e	ARG2
cDNA	O
from	O
a	O
fetal	O
kidney	O
cDNA	O
library	O
by	O
a	O
combination	O
of	O
polymerase	O
chain	O
reaction	O
and	O
the	O
rapid	O
amplification	O
of	O
the	O
cDNA	O
ends	O
technique	O
.	O
In	O
adults	O
,	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
TSC-22	ARG2
gene1e	ARG2
mRNA	O
was	O
highly	O
expressed	O
in	O
brain	O
,	O
lung	O
and	O
heart	O
.	O
gene1s	ARG2
TSC-22	ARG2
gene1e	ARG2
gene	O
expression	O
in	O
species1s	O
GH3	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
aortic	O
endothelial	O
cells	O
was	O
stimulated	O
by	O
cytokines	O
including	O
TGF	O
-	O
beta	O
,	O
in	O
correlation	O
with	O
the	O
gene1s	ARG2
CNP	ARG2
gene1e	ARG2
mRNA	O
increase	O
.	O
These	O
results	O
suggest	O
that	O
gene1s	ARG2
TSC-22	ARG2
gene1e	ARG2
is	O
a	O
transcriptional	O
regulator	O
of	O
the	O
gene1s	ARG2
CNP	ARG2
gene1e	ARG2
gene	O
and	O
transmits	O
signals	O
from	O
cytokines	O
,	O
such	O
as	O
TGF	O
-	O
beta	O
,	O
to	O
gene1s	ARG2
CNP	ARG2
gene1e	ARG2
gene	O
expression	O
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
a	O
transcription	O
factor	O
for	O
the	O
gene1s	O
C	O
-	O
type	O
natriuretic	O
peptide	O
gene1e	O
gene	O
promoter	O
.	O
Our	O
previous	O
studies	O
on	O
the	O
promoter	O
function	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
C	O
-	O
type	O
natriuretic	O
peptide	O
gene1e	O
(	O
gene1s	O
CNP	O
gene1e	O
)	O
gene	O
revealed	O
the	O
existence	O
of	O
two	O
GC	O
-	O
rich	O
cis	O
elements	O
essential	O
for	O
gene	O
transcription	O
in	O
arg1s	O
rat	O
arg1e	O
pituitary	O
-	O
derived	O
arg1s	O
GH3	O
arg1e	O
cells	O
.	O
To	O
isolate	O
transcription	O
factors	O
that	O
bind	O
to	O
those	O
GC	O
-	O
rich	O
elements	O
,	O
we	O
screened	O
a	O
lambda	O
ZAP	O
cDNA	O
library	O
derived	O
from	O
arg1s	O
GH3	O
arg1e	O
cells	O
by	O
Southwestern	O
screening	O
.	O
Several	O
positive	O
clones	O
with	O
specific	O
binding	O
abilities	O
were	O
obtained	O
,	O
and	O
one	O
was	O
identical	O
as	O
gene1s	O
TSC-22	O
gene1e	O
,	O
a	O
speculated	O
transcriptional	O
modulator	O
stimulated	O
by	O
transforming	O
growth	O
factor	O
beta	O
(	O
TGF	O
-	O
beta	O
)	O
of	O
unknown	O
function	O
.	O
gene1s	O
TSC-22	O
gene1e	O
significantly	O
enhanced	O
gene1s	O
CNP	O
gene1e	O
promoter	O
activity	O
in	O
arg1s	O
GH3	O
arg1e	O
cells	O
.	O
We	O
further	O
cloned	O
a	O
1.8-kb	O
full	O
-	O
length	O
species1s	O
human	O
species1e	O
gene1s	O
TSC-22	O
gene1e	O
cDNA	O
from	O
a	O
fetal	O
kidney	O
cDNA	O
library	O
by	O
a	O
combination	O
of	O
polymerase	O
chain	O
reaction	O
and	O
the	O
rapid	O
amplification	O
of	O
the	O
cDNA	O
ends	O
technique	O
.	O
In	O
adults	O
,	O
species1s	O
human	O
species1e	O
gene1s	O
TSC-22	O
gene1e	O
mRNA	O
was	O
highly	O
expressed	O
in	O
brain	O
,	O
lung	O
and	O
heart	O
.	O
gene1s	O
TSC-22	O
gene1e	O
gene	O
expression	O
in	O
arg1s	O
GH3	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
aortic	O
endothelial	O
cells	O
was	O
stimulated	O
by	O
cytokines	O
including	O
TGF	O
-	O
beta	O
,	O
in	O
correlation	O
with	O
the	O
gene1s	O
CNP	O
gene1e	O
mRNA	O
increase	O
.	O
These	O
results	O
suggest	O
that	O
gene1s	O
TSC-22	O
gene1e	O
is	O
a	O
transcriptional	O
regulator	O
of	O
the	O
gene1s	O
CNP	O
gene1e	O
gene	O
and	O
transmits	O
signals	O
from	O
cytokines	O
,	O
such	O
as	O
TGF	O
-	O
beta	O
,	O
to	O
gene1s	O
CNP	O
gene1e	O
gene	O
expression	O
.	O

Isolation	O
,	O
characterization	O
,	O
and	O
chromosomal	O
mapping	O
of	O
a	O
novel	O
cDNA	O
clone	O
encoding	O
arg1s	O
human	O
arg1e	O
selenium	O
binding	O
protein	O
.	O
We	O
have	O
isolated	O
the	O
full	O
-	O
length	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
56	ARG2
kDa	ARG2
selenium	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
hSP56	ARG2
gene1e	ARG2
)	O
cDNA	O
clone	O
,	O
which	O
is	O
the	O
arg1s	O
human	O
arg1e	O
homolog	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	O
56	O
kDa	O
selenium	O
binding	O
protein	O
gene1e	O
.	O
The	O
cDNA	O
is	O
1,668	O
bp	O
long	O
and	O
has	O
an	O
open	O
reading	O
frame	O
encoding	O
472	O
amino	O
acids	O
.	O
The	O
calculated	O
molecular	O
weight	O
is	O
52.25	O
kDa	O
and	O
the	O
estimated	O
isoelectric	O
point	O
is	O
6.13	O
.	O
Using	O
Northern	O
blot	O
hybridization	O
,	O
we	O
found	O
that	O
this	O
gene1s	ARG2
56	ARG2
kDa	ARG2
selenium	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
is	O
expressed	O
in	O
species1s	O
mouse	O
species1e	O
heart	O
with	O
an	O
intermediate	O
level	O
between	O
those	O
found	O
in	O
liver	O
/	O
lung	O
/	O
kidney	O
and	O
intestine	O
.	O
We	O
have	O
also	O
successfully	O
expressed	O
gene1s	ARG2
hSP56	ARG2
gene1e	ARG2
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
using	O
the	O
expression	O
vector	O
-	O
pAED4	O
.	O
The	O
gene1s	ARG2
hSP56	ARG2
gene1e	ARG2
gene	O
is	O
located	O
at	O
arg1s	O
human	O
arg1e	O
chromosome	O
1q21	O
-	O
22	O
)	O
.	O

Isolation	O
,	O
characterization	O
,	O
and	O
chromosomal	O
mapping	O
of	O
a	O
novel	O
cDNA	O
clone	O
encoding	O
species1s	O
human	O
species1e	O
selenium	O
binding	O
protein	O
.	O
We	O
have	O
isolated	O
the	O
full	O
-	O
length	O
species1s	O
human	O
species1e	O
gene1s	O
56	O
kDa	O
selenium	O
binding	O
protein	O
gene1e	O
(	O
gene1s	O
hSP56	O
gene1e	O
)	O
cDNA	O
clone	O
,	O
which	O
is	O
the	O
species1s	O
human	O
species1e	O
homolog	O
of	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
56	ARG2
kDa	ARG2
selenium	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
.	O
The	O
cDNA	O
is	O
1,668	O
bp	O
long	O
and	O
has	O
an	O
open	O
reading	O
frame	O
encoding	O
472	O
amino	O
acids	O
.	O
The	O
calculated	O
molecular	O
weight	O
is	O
52.25	O
kDa	O
and	O
the	O
estimated	O
isoelectric	O
point	O
is	O
6.13	O
.	O
Using	O
Northern	O
blot	O
hybridization	O
,	O
we	O
found	O
that	O
this	O
gene1s	O
56	O
kDa	O
selenium	O
binding	O
protein	O
gene1e	O
is	O
expressed	O
in	O
arg1s	O
mouse	O
arg1e	O
heart	O
with	O
an	O
intermediate	O
level	O
between	O
those	O
found	O
in	O
liver	O
/	O
lung	O
/	O
kidney	O
and	O
intestine	O
.	O
We	O
have	O
also	O
successfully	O
expressed	O
gene1s	O
hSP56	O
gene1e	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
using	O
the	O
expression	O
vector	O
-	O
pAED4	O
.	O
The	O
gene1s	O
hSP56	O
gene1e	O
gene	O
is	O
located	O
at	O
species1s	O
human	O
species1e	O
chromosome	O
1q21	O
-	O
22	O
)	O
.	O

Isolation	O
,	O
characterization	O
,	O
and	O
chromosomal	O
mapping	O
of	O
a	O
novel	O
cDNA	O
clone	O
encoding	O
species1s	O
human	O
species1e	O
selenium	O
binding	O
protein	O
.	O
We	O
have	O
isolated	O
the	O
full	O
-	O
length	O
species1s	O
human	O
species1e	O
gene1s	O
56	O
kDa	O
selenium	O
binding	O
protein	O
gene1e	O
(	O
gene1s	O
hSP56	O
gene1e	O
)	O
cDNA	O
clone	O
,	O
which	O
is	O
the	O
species1s	O
human	O
species1e	O
homolog	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	O
56	O
kDa	O
selenium	O
binding	O
protein	O
gene1e	O
.	O
The	O
cDNA	O
is	O
1,668	O
bp	O
long	O
and	O
has	O
an	O
open	O
reading	O
frame	O
encoding	O
472	O
amino	O
acids	O
.	O
The	O
calculated	O
molecular	O
weight	O
is	O
52.25	O
kDa	O
and	O
the	O
estimated	O
isoelectric	O
point	O
is	O
6.13	O
.	O
Using	O
Northern	O
blot	O
hybridization	O
,	O
we	O
found	O
that	O
this	O
gene1s	O
56	O
kDa	O
selenium	O
binding	O
protein	O
gene1e	O
is	O
expressed	O
in	O
species1s	O
mouse	O
species1e	O
heart	O
with	O
an	O
intermediate	O
level	O
between	O
those	O
found	O
in	O
liver	O
/	O
lung	O
/	O
kidney	O
and	O
intestine	O
.	O
We	O
have	O
also	O
successfully	O
expressed	O
gene1s	O
hSP56	O
gene1e	O
in	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
using	O
the	O
expression	O
vector	O
-	O
pAED4	O
.	O
The	O
gene1s	O
hSP56	O
gene1e	O
gene	O
is	O
located	O
at	O
species1s	O
human	O
species1e	O
chromosome	O
1q21	O
-	O
22	O
)	O
.	O

Cloning	O
and	O
chromosomal	O
location	O
of	O
a	O
novel	O
member	O
of	O
the	O
myotonic	O
dystrophy	O
family	O
of	O
protein	O
kinases	O
.	O
We	O
have	O
cloned	O
a	O
novel	O
serine	O
/	O
threonine	O
protein	O
kinase	O
(	O
gene1s	O
PK428	O
gene1e	O
)	O
which	O
is	O
highly	O
related	O
(	O
65	O
%	O
)	O
within	O
the	O
kinase	O
domain	O
to	O
the	O
gene1s	O
myotonic	O
dystrophy	O
protein	O
kinase	O
gene1e	O
(	O
gene1s	O
DM	O
-	O
PK	O
gene1e	O
)	O
,	O
as	O
well	O
as	O
the	O
cyclic	O
AMP	O
-	O
dependent	O
protein	O
kinase	O
(	O
33	O
%	O
)	O
.	O
Northern	O
blots	O
demonstrate	O
that	O
gene1s	O
PK428	O
gene1e	O
mRNA	O
is	O
distributed	O
widely	O
among	O
tissues	O
and	O
is	O
expressed	O
at	O
the	O
highest	O
levels	O
in	O
pancreas	O
,	O
heart	O
,	O
and	O
skeletal	O
muscle	O
,	O
with	O
lower	O
levels	O
in	O
liver	O
and	O
lung	O
.	O
Two	O
gene1s	O
PK428	O
gene1e	O
mRNAs	O
10	O
and	O
3.8	O
kilobase	O
pairs	O
in	O
size	O
are	O
seen	O
in	O
a	O
number	O
of	O
cell	O
lines	O
,	O
including	O
hematopoietic	O
and	O
breast	O
cancer	O
cells	O
.	O
An	O
antibody	O
generated	O
to	O
a	O
glutathione	O
S	O
-	O
transferase	O
-	O
PK428	O
fusion	O
protein	O
detects	O
a	O
65-kDa	O
protein	O
in	O
these	O
cell	O
lines	O
,	O
and	O
a	O
similarly	O
sized	O
protein	O
when	O
the	O
cloned	O
cDNA	O
is	O
transiently	O
expressed	O
in	O
arg1s	O
Cos	O
7	O
arg1e	O
cells	O
.	O
Immunoprecipitation	O
of	O
the	O
transiently	O
expressed	O
gene1s	O
PK428	O
gene1e	O
protein	O
and	O
incubation	O
with	O
[	O
gamma-32P]ATP	O
demonstrate	O
that	O
it	O
is	O
capable	O
of	O
autophosphorylation	O
.	O
In	O
addition	O
,	O
immunoprecipitates	O
of	O
the	O
gene1s	O
PK428	O
gene1e	O
protein	O
kinase	O
also	O
phosphorylated	O
histone	O
H1	O
and	O
a	O
peptide	O
encoding	O
a	O
cyclic	O
AMP	O
-	O
dependent	O
protein	O
kinase	O
substrate	O
.	O
The	O
gene	O
corresponding	O
to	O
the	O
3.8-kb	O
gene1s	O
PK428	O
gene1e	O
mRNA	O
,	O
and	O
its	O
corresponding	O
65-kDa	O
protein	O
,	O
was	O
isolated	O
by	O
polymerase	O
chain	O
reaction	O
screening	O
of	O
a	O
P1	O
phage	O
species1s	O
human	O
species1e	O
genomic	O
library	O
.	O
Using	O
this	O
P1	O
phage	O
clone	O
as	O
a	O
probe	O
,	O
the	O
gene1s	O
PK428	O
gene1e	O
gene	O
was	O
located	O
on	O
1q41	O
-	O
42	O
,	O
a	O
possible	O
location	O
for	O
a	O
species1s	O
human	O
species1e	O
senescence	O
gene	O
,	O
gene1s	O
a	O
gene	O
associated	O
with	O
Rippling	O
muscle	O
disease	O
gene1e	O
,	O
as	O
well	O
as	O
a	O
region	O
associated	O
with	O
genetically	O
acquired	O
mental	O
retardation	O
.	O

Cloning	O
and	O
chromosomal	O
location	O
of	O
a	O
novel	O
member	O
of	O
the	O
myotonic	O
dystrophy	O
family	O
of	O
protein	O
kinases	O
.	O
We	O
have	O
cloned	O
a	O
novel	O
serine	O
/	O
threonine	O
protein	O
kinase	O
(	O
gene1s	ARG2
PK428	ARG2
gene1e	ARG2
)	O
which	O
is	O
highly	O
related	O
(	O
65	O
%	O
)	O
within	O
the	O
kinase	O
domain	O
to	O
the	O
gene1s	ARG2
myotonic	ARG2
dystrophy	ARG2
protein	ARG2
kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
DM	ARG2
-	ARG2
PK	ARG2
gene1e	ARG2
)	O
,	O
as	O
well	O
as	O
the	O
cyclic	O
AMP	O
-	O
dependent	O
protein	O
kinase	O
(	O
33	O
%	O
)	O
.	O
Northern	O
blots	O
demonstrate	O
that	O
gene1s	ARG2
PK428	ARG2
gene1e	ARG2
mRNA	O
is	O
distributed	O
widely	O
among	O
tissues	O
and	O
is	O
expressed	O
at	O
the	O
highest	O
levels	O
in	O
pancreas	O
,	O
heart	O
,	O
and	O
skeletal	O
muscle	O
,	O
with	O
lower	O
levels	O
in	O
liver	O
and	O
lung	O
.	O
Two	O
gene1s	ARG2
PK428	ARG2
gene1e	ARG2
mRNAs	O
10	O
and	O
3.8	O
kilobase	O
pairs	O
in	O
size	O
are	O
seen	O
in	O
a	O
number	O
of	O
cell	O
lines	O
,	O
including	O
hematopoietic	O
and	O
breast	O
cancer	O
cells	O
.	O
An	O
antibody	O
generated	O
to	O
a	O
glutathione	O
S	O
-	O
transferase	O
-	O
PK428	O
fusion	O
protein	O
detects	O
a	O
65-kDa	O
protein	O
in	O
these	O
cell	O
lines	O
,	O
and	O
a	O
similarly	O
sized	O
protein	O
when	O
the	O
cloned	O
cDNA	O
is	O
transiently	O
expressed	O
in	O
species1s	O
Cos	O
7	O
species1e	O
cells	O
.	O
Immunoprecipitation	O
of	O
the	O
transiently	O
expressed	O
gene1s	ARG2
PK428	ARG2
gene1e	ARG2
protein	O
and	O
incubation	O
with	O
[	O
gamma-32P]ATP	O
demonstrate	O
that	O
it	O
is	O
capable	O
of	O
autophosphorylation	O
.	O
In	O
addition	O
,	O
immunoprecipitates	O
of	O
the	O
gene1s	ARG2
PK428	ARG2
gene1e	ARG2
protein	O
kinase	O
also	O
phosphorylated	O
histone	O
H1	O
and	O
a	O
peptide	O
encoding	O
a	O
cyclic	O
AMP	O
-	O
dependent	O
protein	O
kinase	O
substrate	O
.	O
The	O
gene	O
corresponding	O
to	O
the	O
3.8-kb	O
gene1s	ARG2
PK428	ARG2
gene1e	ARG2
mRNA	O
,	O
and	O
its	O
corresponding	O
65-kDa	O
protein	O
,	O
was	O
isolated	O
by	O
polymerase	O
chain	O
reaction	O
screening	O
of	O
a	O
P1	O
phage	O
arg1s	O
human	O
arg1e	O
genomic	O
library	O
.	O
Using	O
this	O
P1	O
phage	O
clone	O
as	O
a	O
probe	O
,	O
the	O
gene1s	ARG2
PK428	ARG2
gene1e	ARG2
gene	O
was	O
located	O
on	O
1q41	O
-	O
42	O
,	O
a	O
possible	O
location	O
for	O
a	O
arg1s	O
human	O
arg1e	O
senescence	O
gene	O
,	O
gene1s	ARG2
a	ARG2
gene	ARG2
associated	ARG2
with	ARG2
Rippling	ARG2
muscle	ARG2
disease	ARG2
gene1e	ARG2
,	O
as	O
well	O
as	O
a	O
region	O
associated	O
with	O
genetically	O
acquired	O
mental	O
retardation	O
.	O

Isolation	O
and	O
characterization	O
of	O
a	O
structural	O
homologue	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
PRK2	ARG2
gene1e	ARG2
from	O
species1s	O
rat	O
species1e	O
liver	O
.	O
Distinguishing	O
substrate	O
and	O
lipid	O
activator	O
specificities	O
.	O
A	O
homologue	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
C	ARG2
(	ARG2
PKC)-related	ARG2
kinase-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PRK2	ARG2
gene1e	ARG2
,	O
which	O
had	O
previously	O
escaped	O
identification	O
in	O
normal	O
arg1s	O
mammalian	O
arg1e	O
tissues	O
,	O
was	O
isolated	O
from	O
species1s	O
rat	O
species1e	O
liver	O
as	O
the	O
protease	O
-	O
activated	O
kinase	O
(	O
PAK	O
)	O
originally	O
named	O
gene1s	O
PAK-2	O
gene1e	O
.	O
The	O
130-kDa	O
cytosolic	O
enzyme	O
was	O
purified	O
to	O
homogeneity	O
and	O
shown	O
by	O
tryptic	O
peptide	O
and	O
reverse	O
transcriptase-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR)-amplified	O
species1s	O
rat	O
species1e	O
cDNA	O
sequence	O
analyses	O
to	O
be	O
structurally	O
related	O
to	O
the	O
116-kDa	O
species1s	O
rat	O
species1e	O
hepatic	O
gene1s	O
PAK-1	O
gene1e	O
/	O
gene1s	O
protein	O
kinase	O
N	O
gene1e	O
(	O
gene1s	O
PKN	O
gene1e	O
)	O
and	O
,	O
even	O
more	O
closely	O
(	O
95	O
%	O
sequence	O
identity	O
)	O
to	O
the	O
gene1s	ARG2
130-kDa	ARG2
human	ARG2
PKC	ARG2
-	ARG2
related	ARG2
kinase	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PRK2	ARG2
gene1e	ARG2
.	O
species1s	O
Rat	O
species1e	O
myeloma	O
RNA	O
was	O
used	O
as	O
the	O
RT	O
-	O
PCR	O
template	O
because	O
of	O
its	O
relative	O
abundance	O
in	O
gene1s	O
PAK-2	O
gene1e	O
/	O
gene1s	ARG2
PRK2	ARG2
gene1e	ARG2
mRNA	O
compared	O
with	O
liver	O
and	O
other	O
species1s	O
rat	O
species1e	O
tissues	O
.	O
The	O
catalytic	O
properties	O
of	O
gene1s	O
PAK-2	O
gene1e	O
/	O
gene1s	ARG2
PRK2	ARG2
gene1e	ARG2
in	O
many	O
respects	O
resembled	O
those	O
of	O
hepatic	O
gene1s	O
PAK-1	O
gene1e	O
/	O
gene1s	O
PKN	O
gene1e	O
,	O
but	O
were	O
distinguished	O
by	O
more	O
favorable	O
kinetics	O
with	O
several	O
peptide	O
substrates	O
,	O
and	O
greater	O
sensitivity	O
to	O
PKC	O
pseudosubstrate	O
and	O
polybasic	O
amino	O
acid	O
inhibitors	O
.	O
gene1s	O
PAK-2	O
gene1e	O
/	O
gene1s	ARG2
PRK2	ARG2
gene1e	ARG2
was	O
also	O
activated	O
by	O
lipids	O
,	O
particularly	O
cardiolipin	O
and	O
to	O
a	O
lesser	O
extent	O
by	O
other	O
acidic	O
phospholipids	O
and	O
unsaturated	O
fatty	O
acids	O
.	O
Cardiolipin	O
activation	O
was	O
most	O
evident	O
with	O
autophosphorylation	O
and	O
histone	O
H2B	O
phosphorylation	O
,	O
but	O
only	O
marginally	O
evident	O
with	O
the	O
favored	O
ribosomal	O
S6-(229	O
-	O
239	O
)	O
peptide	O
substrate	O
for	O
the	O
protease	O
-	O
activated	O
kinase	O
activity	O
.	O
It	O
was	O
concluded	O
that	O
gene1s	O
PAK-2	O
gene1e	O
is	O
the	O
species1s	O
rat	O
species1e	O
homologue	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
PRK2	ARG2
gene1e	ARG2
,	O
with	O
biochemical	O
properties	O
distinct	O
from	O
although	O
overlapping	O
those	O
of	O
the	O
gene1s	O
PAK-1	O
gene1e	O
/	O
gene1s	O
PKN	O
gene1e	O
/	O
gene1s	ARG2
PRK1	ARG2
gene1e	ARG2
isoform	O
.	O

Isolation	O
and	O
characterization	O
of	O
a	O
structural	O
homologue	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
PRK2	O
gene1e	O
from	O
arg1s	O
rat	O
arg1e	O
liver	O
.	O
Distinguishing	O
substrate	O
and	O
lipid	O
activator	O
specificities	O
.	O
A	O
homologue	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
protein	O
kinase	O
C	O
(	O
PKC)-related	O
kinase-2	O
gene1e	O
,	O
gene1s	O
PRK2	O
gene1e	O
,	O
which	O
had	O
previously	O
escaped	O
identification	O
in	O
normal	O
species1s	O
mammalian	O
species1e	O
tissues	O
,	O
was	O
isolated	O
from	O
arg1s	O
rat	O
arg1e	O
liver	O
as	O
the	O
protease	O
-	O
activated	O
kinase	O
(	O
PAK	O
)	O
originally	O
named	O
gene1s	ARG2
PAK-2	ARG2
gene1e	ARG2
.	O
The	O
130-kDa	O
cytosolic	O
enzyme	O
was	O
purified	O
to	O
homogeneity	O
and	O
shown	O
by	O
tryptic	O
peptide	O
and	O
reverse	O
transcriptase-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR)-amplified	O
arg1s	O
rat	O
arg1e	O
cDNA	O
sequence	O
analyses	O
to	O
be	O
structurally	O
related	O
to	O
the	O
116-kDa	O
arg1s	O
rat	O
arg1e	O
hepatic	O
gene1s	ARG2
PAK-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
N	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PKN	ARG2
gene1e	ARG2
)	O
and	O
,	O
even	O
more	O
closely	O
(	O
95	O
%	O
sequence	O
identity	O
)	O
to	O
the	O
gene1s	O
130-kDa	O
human	O
PKC	O
-	O
related	O
kinase	O
gene1e	O
,	O
gene1s	O
PRK2	O
gene1e	O
.	O
arg1s	O
Rat	O
arg1e	O
myeloma	O
RNA	O
was	O
used	O
as	O
the	O
RT	O
-	O
PCR	O
template	O
because	O
of	O
its	O
relative	O
abundance	O
in	O
gene1s	ARG2
PAK-2	ARG2
gene1e	ARG2
/	O
gene1s	O
PRK2	O
gene1e	O
mRNA	O
compared	O
with	O
liver	O
and	O
other	O
arg1s	O
rat	O
arg1e	O
tissues	O
.	O
The	O
catalytic	O
properties	O
of	O
gene1s	ARG2
PAK-2	ARG2
gene1e	ARG2
/	O
gene1s	O
PRK2	O
gene1e	O
in	O
many	O
respects	O
resembled	O
those	O
of	O
hepatic	O
gene1s	ARG2
PAK-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PKN	ARG2
gene1e	ARG2
,	O
but	O
were	O
distinguished	O
by	O
more	O
favorable	O
kinetics	O
with	O
several	O
peptide	O
substrates	O
,	O
and	O
greater	O
sensitivity	O
to	O
PKC	O
pseudosubstrate	O
and	O
polybasic	O
amino	O
acid	O
inhibitors	O
.	O
gene1s	ARG2
PAK-2	ARG2
gene1e	ARG2
/	O
gene1s	O
PRK2	O
gene1e	O
was	O
also	O
activated	O
by	O
lipids	O
,	O
particularly	O
cardiolipin	O
and	O
to	O
a	O
lesser	O
extent	O
by	O
other	O
acidic	O
phospholipids	O
and	O
unsaturated	O
fatty	O
acids	O
.	O
Cardiolipin	O
activation	O
was	O
most	O
evident	O
with	O
autophosphorylation	O
and	O
histone	O
H2B	O
phosphorylation	O
,	O
but	O
only	O
marginally	O
evident	O
with	O
the	O
favored	O
ribosomal	O
S6-(229	O
-	O
239	O
)	O
peptide	O
substrate	O
for	O
the	O
protease	O
-	O
activated	O
kinase	O
activity	O
.	O
It	O
was	O
concluded	O
that	O
gene1s	ARG2
PAK-2	ARG2
gene1e	ARG2
is	O
the	O
arg1s	O
rat	O
arg1e	O
homologue	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
PRK2	O
gene1e	O
,	O
with	O
biochemical	O
properties	O
distinct	O
from	O
although	O
overlapping	O
those	O
of	O
the	O
gene1s	ARG2
PAK-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PKN	ARG2
gene1e	ARG2
/	O
gene1s	O
PRK1	O
gene1e	O
isoform	O
.	O

Isolation	O
of	O
a	O
full	O
-	O
length	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
WNT7A	ARG2
gene1e	ARG2
gene	O
implicated	O
in	O
limb	O
development	O
and	O
cell	O
transformation	O
,	O
and	O
mapping	O
to	O
chromosome	O
3p25	O
.	O
The	O
Wnt	O
gene	O
family	O
has	O
a	O
role	O
in	O
development	O
as	O
well	O
as	O
tumourigenesis	O
.	O
One	O
species1s	O
mouse	O
species1e	O
member	O
,	O
gene1s	ARG2
Wnt7a	ARG2
gene1e	ARG2
,	O
is	O
vital	O
for	O
limb	O
development	O
in	O
vivo	O
and	O
also	O
possesses	O
transforming	O
ability	O
in	O
vitro	O
.	O
This	O
study	O
reports	O
the	O
isolation	O
of	O
a	O
full	O
length	O
of	O
arg1s	O
human	O
arg1e	O
homologue	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	ARG2
Wnt7a	ARG2
gene1e	ARG2
gene	O
by	O
library	O
screening	O
.	O
species1s	O
Yeast	O
species1e	O
artificial	O
chromosome	O
-	O
fluorescence	O
in	O
situ	O
hybridisation	O
(	O
YAC	O
-	O
FISH	O
)	O
mapped	O
the	O
gene1s	ARG2
WNT7A	ARG2
gene1e	ARG2
gene	O
to	O
chromosome	O
3p25	O
.	O
arg1s	O
Human	O
arg1e	O
gene1s	ARG2
WNT7A	ARG2
gene1e	ARG2
had	O
an	O
ORF	O
encoding	O
a	O
deduced	O
protein	O
of	O
349	O
aa	O
that	O
exhibited	O
97	O
%	O
and	O
92	O
%	O
identity	O
to	O
species1s	O
mouse	O
species1e	O
gene1s	ARG2
Wnt7a	ARG2
gene1e	ARG2
at	O
the	O
aa	O
and	O
nucleic	O
acid	O
levels	O
,	O
respectively	O
.	O
It	O
possessed	O
the	O
22	O
conserved	O
cysteine	O
residues	O
and	O
3	O
more	O
at	O
the	O
amino	O
terminus	O
,	O
and	O
a	O
putative	O
poly	O
A	O
tail	O
.	O
This	O
is	O
the	O
fifth	O
arg1s	O
human	O
arg1e	O
WNT	O
gene	O
in	O
which	O
a	O
complete	O
cDNA	O
sequence	O
had	O
been	O
determined	O
.	O

Isolation	O
of	O
a	O
full	O
-	O
length	O
species1s	O
human	O
species1e	O
gene1s	O
WNT7A	O
gene1e	O
gene	O
implicated	O
in	O
limb	O
development	O
and	O
cell	O
transformation	O
,	O
and	O
mapping	O
to	O
chromosome	O
3p25	O
.	O
The	O
Wnt	O
gene	O
family	O
has	O
a	O
role	O
in	O
development	O
as	O
well	O
as	O
tumourigenesis	O
.	O
One	O
arg1s	O
mouse	O
arg1e	O
member	O
,	O
gene1s	O
Wnt7a	O
gene1e	O
,	O
is	O
vital	O
for	O
limb	O
development	O
in	O
vivo	O
and	O
also	O
possesses	O
transforming	O
ability	O
in	O
vitro	O
.	O
This	O
study	O
reports	O
the	O
isolation	O
of	O
a	O
full	O
length	O
of	O
species1s	O
human	O
species1e	O
homologue	O
of	O
arg1s	O
mouse	O
arg1e	O
gene1s	O
Wnt7a	O
gene1e	O
gene	O
by	O
library	O
screening	O
.	O
species1s	O
Yeast	O
species1e	O
artificial	O
chromosome	O
-	O
fluorescence	O
in	O
situ	O
hybridisation	O
(	O
YAC	O
-	O
FISH	O
)	O
mapped	O
the	O
gene1s	O
WNT7A	O
gene1e	O
gene	O
to	O
chromosome	O
3p25	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
WNT7A	O
gene1e	O
had	O
an	O
ORF	O
encoding	O
a	O
deduced	O
protein	O
of	O
349	O
aa	O
that	O
exhibited	O
97	O
%	O
and	O
92	O
%	O
identity	O
to	O
arg1s	O
mouse	O
arg1e	O
gene1s	O
Wnt7a	O
gene1e	O
at	O
the	O
aa	O
and	O
nucleic	O
acid	O
levels	O
,	O
respectively	O
.	O
It	O
possessed	O
the	O
22	O
conserved	O
cysteine	O
residues	O
and	O
3	O
more	O
at	O
the	O
amino	O
terminus	O
,	O
and	O
a	O
putative	O
poly	O
A	O
tail	O
.	O
This	O
is	O
the	O
fifth	O
species1s	O
human	O
species1e	O
WNT	O
gene	O
in	O
which	O
a	O
complete	O
cDNA	O
sequence	O
had	O
been	O
determined	O
.	O

Isolation	O
of	O
a	O
full	O
-	O
length	O
species1s	O
human	O
species1e	O
gene1s	O
WNT7A	O
gene1e	O
gene	O
implicated	O
in	O
limb	O
development	O
and	O
cell	O
transformation	O
,	O
and	O
mapping	O
to	O
chromosome	O
3p25	O
.	O
The	O
Wnt	O
gene	O
family	O
has	O
a	O
role	O
in	O
development	O
as	O
well	O
as	O
tumourigenesis	O
.	O
One	O
species1s	O
mouse	O
species1e	O
member	O
,	O
gene1s	O
Wnt7a	O
gene1e	O
,	O
is	O
vital	O
for	O
limb	O
development	O
in	O
vivo	O
and	O
also	O
possesses	O
transforming	O
ability	O
in	O
vitro	O
.	O
This	O
study	O
reports	O
the	O
isolation	O
of	O
a	O
full	O
length	O
of	O
species1s	O
human	O
species1e	O
homologue	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	O
Wnt7a	O
gene1e	O
gene	O
by	O
library	O
screening	O
.	O
arg1s	O
Yeast	O
arg1e	O
artificial	O
chromosome	O
-	O
fluorescence	O
in	O
situ	O
hybridisation	O
(	O
YAC	O
-	O
FISH	O
)	O
mapped	O
the	O
gene1s	O
WNT7A	O
gene1e	O
gene	O
to	O
chromosome	O
3p25	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
WNT7A	O
gene1e	O
had	O
an	O
ORF	O
encoding	O
a	O
deduced	O
protein	O
of	O
349	O
aa	O
that	O
exhibited	O
97	O
%	O
and	O
92	O
%	O
identity	O
to	O
species1s	O
mouse	O
species1e	O
gene1s	O
Wnt7a	O
gene1e	O
at	O
the	O
aa	O
and	O
nucleic	O
acid	O
levels	O
,	O
respectively	O
.	O
It	O
possessed	O
the	O
22	O
conserved	O
cysteine	O
residues	O
and	O
3	O
more	O
at	O
the	O
amino	O
terminus	O
,	O
and	O
a	O
putative	O
poly	O
A	O
tail	O
.	O
This	O
is	O
the	O
fifth	O
species1s	O
human	O
species1e	O
WNT	O
gene	O
in	O
which	O
a	O
complete	O
cDNA	O
sequence	O
had	O
been	O
determined	O
.	O

Coassembly	O
of	O
TRP	O
and	O
TRPL	O
produces	O
a	O
distinct	O
store	O
-	O
operated	O
conductance	O
.	O
The	O
arg1s	O
Drosophila	O
arg1e	O
retinal	O
-	O
specific	O
protein	O
,	O
TRP	O
(	O
transient	O
receptor	O
potential	O
)	O
,	O
is	O
the	O
founding	O
member	O
of	O
a	O
family	O
of	O
store	O
-	O
operated	O
channels	O
(	O
SOCs	O
)	O
conserved	O
from	O
species1s	O
C.	O
elegans	O
species1e	O
to	O
species1s	O
humans	O
species1e	O
.	O
In	O
vitro	O
studies	O
indicate	O
that	O
TRP	O
is	O
a	O
SOC	O
,	O
but	O
that	O
the	O
related	O
retinal	O
protein	O
,	O
TRPL	O
,	O
is	O
constitutively	O
active	O
.	O
In	O
the	O
current	O
work	O
,	O
we	O
report	O
that	O
coexpression	O
of	O
TRP	O
and	O
TRPL	O
leads	O
to	O
a	O
store	O
-	O
operated	O
,	O
outwardly	O
rectifying	O
current	O
distinct	O
from	O
that	O
owing	O
to	O
either	O
TRP	O
or	O
TRPL	O
alone	O
.	O
TRP	O
and	O
TRPL	O
interact	O
directly	O
,	O
indicating	O
that	O
the	O
TRP	O
-	O
TRPL	O
-	O
dependent	O
current	O
is	O
mediated	O
by	O
heteromultimeric	O
association	O
between	O
the	O
two	O
subunits	O
.	O
We	O
propose	O
that	O
the	O
light	O
-	O
activated	O
current	O
in	O
photoreceptor	O
cells	O
is	O
produced	O
by	O
a	O
combination	O
of	O
TRP	O
homo-	O
and	O
TRP	O
-	O
TRPL	O
heteromultimers	O
.	O

Coassembly	O
of	O
TRP	O
and	O
TRPL	O
produces	O
a	O
distinct	O
store	O
-	O
operated	O
conductance	O
.	O
The	O
species1s	O
Drosophila	O
species1e	O
retinal	O
-	O
specific	O
protein	O
,	O
TRP	O
(	O
transient	O
receptor	O
potential	O
)	O
,	O
is	O
the	O
founding	O
member	O
of	O
a	O
family	O
of	O
store	O
-	O
operated	O
channels	O
(	O
SOCs	O
)	O
conserved	O
from	O
arg1s	O
C.	O
elegans	O
arg1e	O
to	O
species1s	O
humans	O
species1e	O
.	O
In	O
vitro	O
studies	O
indicate	O
that	O
TRP	O
is	O
a	O
SOC	O
,	O
but	O
that	O
the	O
related	O
retinal	O
protein	O
,	O
TRPL	O
,	O
is	O
constitutively	O
active	O
.	O
In	O
the	O
current	O
work	O
,	O
we	O
report	O
that	O
coexpression	O
of	O
TRP	O
and	O
TRPL	O
leads	O
to	O
a	O
store	O
-	O
operated	O
,	O
outwardly	O
rectifying	O
current	O
distinct	O
from	O
that	O
owing	O
to	O
either	O
TRP	O
or	O
TRPL	O
alone	O
.	O
TRP	O
and	O
TRPL	O
interact	O
directly	O
,	O
indicating	O
that	O
the	O
TRP	O
-	O
TRPL	O
-	O
dependent	O
current	O
is	O
mediated	O
by	O
heteromultimeric	O
association	O
between	O
the	O
two	O
subunits	O
.	O
We	O
propose	O
that	O
the	O
light	O
-	O
activated	O
current	O
in	O
photoreceptor	O
cells	O
is	O
produced	O
by	O
a	O
combination	O
of	O
TRP	O
homo-	O
and	O
TRP	O
-	O
TRPL	O
heteromultimers	O
.	O

Coassembly	O
of	O
TRP	O
and	O
TRPL	O
produces	O
a	O
distinct	O
store	O
-	O
operated	O
conductance	O
.	O
The	O
species1s	O
Drosophila	O
species1e	O
retinal	O
-	O
specific	O
protein	O
,	O
TRP	O
(	O
transient	O
receptor	O
potential	O
)	O
,	O
is	O
the	O
founding	O
member	O
of	O
a	O
family	O
of	O
store	O
-	O
operated	O
channels	O
(	O
SOCs	O
)	O
conserved	O
from	O
species1s	O
C.	O
elegans	O
species1e	O
to	O
arg1s	O
humans	O
arg1e	O
.	O
In	O
vitro	O
studies	O
indicate	O
that	O
TRP	O
is	O
a	O
SOC	O
,	O
but	O
that	O
the	O
related	O
retinal	O
protein	O
,	O
TRPL	O
,	O
is	O
constitutively	O
active	O
.	O
In	O
the	O
current	O
work	O
,	O
we	O
report	O
that	O
coexpression	O
of	O
TRP	O
and	O
TRPL	O
leads	O
to	O
a	O
store	O
-	O
operated	O
,	O
outwardly	O
rectifying	O
current	O
distinct	O
from	O
that	O
owing	O
to	O
either	O
TRP	O
or	O
TRPL	O
alone	O
.	O
TRP	O
and	O
TRPL	O
interact	O
directly	O
,	O
indicating	O
that	O
the	O
TRP	O
-	O
TRPL	O
-	O
dependent	O
current	O
is	O
mediated	O
by	O
heteromultimeric	O
association	O
between	O
the	O
two	O
subunits	O
.	O
We	O
propose	O
that	O
the	O
light	O
-	O
activated	O
current	O
in	O
photoreceptor	O
cells	O
is	O
produced	O
by	O
a	O
combination	O
of	O
TRP	O
homo-	O
and	O
TRP	O
-	O
TRPL	O
heteromultimers	O
.	O

A	O
novel	O
arg1s	O
human	O
arg1e	O
serine	O
-	O
threonine	O
phosphatase	O
related	O
to	O
the	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
retinal	O
degeneration	O
C	O
gene1e	O
(	O
gene1s	O
rdgC	O
gene1e	O
)	O
gene	O
is	O
selectively	O
expressed	O
in	O
sensory	O
neurons	O
of	O
neural	O
crest	O
origin	O
.	O
Through	O
our	O
transcriptional	O
mapping	O
effort	O
in	O
the	O
Xp22	O
region	O
,	O
we	O
have	O
isolated	O
by	O
exon	O
trapping	O
a	O
new	O
transcript	O
highly	O
homologous	O
to	O
the	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
retinal	O
degeneration	O
C	O
gene1e	O
(	O
gene1s	O
rdgC	O
gene1e	O
)	O
gene	O
.	O
gene1s	O
rdgC	O
gene1e	O
encodes	O
a	O
serine	O
/	O
threonine	O
phosphatase	O
protein	O
and	O
is	O
required	O
in	O
species1s	O
Drosophila	O
species1e	O
to	O
prevent	O
light	O
-	O
induced	O
retinal	O
degeneration	O
.	O
This	O
arg1s	O
human	O
arg1e	O
gene	O
is	O
the	O
first	O
arg1s	O
mammalian	O
arg1e	O
member	O
of	O
the	O
serine	O
-	O
threonine	O
phosphatase	O
with	O
EF	O
hand	O
motif	O
gene	O
family	O
,	O
and	O
was	O
thus	O
named	O
gene1s	ARG2
PPEF	ARG2
gene1e	ARG2
(	O
Protein	O
Phosphatase	O
with	O
EF	O
calcium	O
-	O
binding	O
domain	O
)	O
.	O
The	O
expression	O
pattern	O
of	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
Ppef	O
gene1e	O
gene	O
was	O
studied	O
by	O
RNA	O
in	O
situ	O
hybridization	O
on	O
embryonic	O
tissue	O
sections	O
.	O
While	O
gene1s	O
rdgC	O
gene1e	O
is	O
expressed	O
in	O
the	O
visual	O
system	O
of	O
the	O
species1s	O
fly	O
species1e	O
,	O
as	O
well	O
as	O
in	O
the	O
species1s	O
mushroom	O
species1e	O
bodies	O
of	O
the	O
central	O
brain	O
,	O
we	O
found	O
that	O
gene1s	O
Ppef	O
gene1e	O
is	O
highly	O
expressed	O
in	O
sensory	O
neurons	O
of	O
the	O
dorsal	O
root	O
ganglia	O
(	O
DRG	O
)	O
and	O
neural	O
crest	O
-	O
derived	O
cranial	O
ganglia	O
.	O
The	O
selective	O
pattern	O
of	O
expression	O
makes	O
gene1s	ARG2
PPEF	ARG2
gene1e	ARG2
an	O
important	O
marker	O
for	O
sensory	O
neuron	O
differentiation	O
and	O
suggests	O
a	O
role	O
for	O
serine	O
-	O
threonine	O
phosphatases	O
in	O
arg1s	O
mammalian	O
arg1e	O
development	O
.	O

A	O
novel	O
species1s	O
human	O
species1e	O
serine	O
-	O
threonine	O
phosphatase	O
related	O
to	O
the	O
arg1s	O
Drosophila	O
arg1e	O
gene1s	ARG2
retinal	ARG2
degeneration	ARG2
C	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
rdgC	ARG2
gene1e	ARG2
)	O
gene	O
is	O
selectively	O
expressed	O
in	O
sensory	O
neurons	O
of	O
neural	O
crest	O
origin	O
.	O
Through	O
our	O
transcriptional	O
mapping	O
effort	O
in	O
the	O
Xp22	O
region	O
,	O
we	O
have	O
isolated	O
by	O
exon	O
trapping	O
a	O
new	O
transcript	O
highly	O
homologous	O
to	O
the	O
arg1s	O
Drosophila	O
arg1e	O
gene1s	ARG2
retinal	ARG2
degeneration	ARG2
C	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
rdgC	ARG2
gene1e	ARG2
)	O
gene	O
.	O
gene1s	ARG2
rdgC	ARG2
gene1e	ARG2
encodes	O
a	O
serine	O
/	O
threonine	O
phosphatase	O
protein	O
and	O
is	O
required	O
in	O
arg1s	O
Drosophila	O
arg1e	O
to	O
prevent	O
light	O
-	O
induced	O
retinal	O
degeneration	O
.	O
This	O
species1s	O
human	O
species1e	O
gene	O
is	O
the	O
first	O
species1s	O
mammalian	O
species1e	O
member	O
of	O
the	O
serine	O
-	O
threonine	O
phosphatase	O
with	O
EF	O
hand	O
motif	O
gene	O
family	O
,	O
and	O
was	O
thus	O
named	O
gene1s	O
PPEF	O
gene1e	O
(	O
Protein	O
Phosphatase	O
with	O
EF	O
calcium	O
-	O
binding	O
domain	O
)	O
.	O
The	O
expression	O
pattern	O
of	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
Ppef	O
gene1e	O
gene	O
was	O
studied	O
by	O
RNA	O
in	O
situ	O
hybridization	O
on	O
embryonic	O
tissue	O
sections	O
.	O
While	O
gene1s	ARG2
rdgC	ARG2
gene1e	ARG2
is	O
expressed	O
in	O
the	O
visual	O
system	O
of	O
the	O
arg1s	O
fly	O
arg1e	O
,	O
as	O
well	O
as	O
in	O
the	O
species1s	O
mushroom	O
species1e	O
bodies	O
of	O
the	O
central	O
brain	O
,	O
we	O
found	O
that	O
gene1s	O
Ppef	O
gene1e	O
is	O
highly	O
expressed	O
in	O
sensory	O
neurons	O
of	O
the	O
dorsal	O
root	O
ganglia	O
(	O
DRG	O
)	O
and	O
neural	O
crest	O
-	O
derived	O
cranial	O
ganglia	O
.	O
The	O
selective	O
pattern	O
of	O
expression	O
makes	O
gene1s	O
PPEF	O
gene1e	O
an	O
important	O
marker	O
for	O
sensory	O
neuron	O
differentiation	O
and	O
suggests	O
a	O
role	O
for	O
serine	O
-	O
threonine	O
phosphatases	O
in	O
species1s	O
mammalian	O
species1e	O
development	O
.	O

A	O
novel	O
species1s	O
human	O
species1e	O
serine	O
-	O
threonine	O
phosphatase	O
related	O
to	O
the	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
retinal	O
degeneration	O
C	O
gene1e	O
(	O
gene1s	O
rdgC	O
gene1e	O
)	O
gene	O
is	O
selectively	O
expressed	O
in	O
sensory	O
neurons	O
of	O
neural	O
crest	O
origin	O
.	O
Through	O
our	O
transcriptional	O
mapping	O
effort	O
in	O
the	O
Xp22	O
region	O
,	O
we	O
have	O
isolated	O
by	O
exon	O
trapping	O
a	O
new	O
transcript	O
highly	O
homologous	O
to	O
the	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
retinal	O
degeneration	O
C	O
gene1e	O
(	O
gene1s	O
rdgC	O
gene1e	O
)	O
gene	O
.	O
gene1s	O
rdgC	O
gene1e	O
encodes	O
a	O
serine	O
/	O
threonine	O
phosphatase	O
protein	O
and	O
is	O
required	O
in	O
species1s	O
Drosophila	O
species1e	O
to	O
prevent	O
light	O
-	O
induced	O
retinal	O
degeneration	O
.	O
This	O
species1s	O
human	O
species1e	O
gene	O
is	O
the	O
first	O
species1s	O
mammalian	O
species1e	O
member	O
of	O
the	O
serine	O
-	O
threonine	O
phosphatase	O
with	O
EF	O
hand	O
motif	O
gene	O
family	O
,	O
and	O
was	O
thus	O
named	O
gene1s	O
PPEF	O
gene1e	O
(	O
Protein	O
Phosphatase	O
with	O
EF	O
calcium	O
-	O
binding	O
domain	O
)	O
.	O
The	O
expression	O
pattern	O
of	O
the	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
Ppef	ARG2
gene1e	ARG2
gene	O
was	O
studied	O
by	O
RNA	O
in	O
situ	O
hybridization	O
on	O
embryonic	O
tissue	O
sections	O
.	O
While	O
gene1s	O
rdgC	O
gene1e	O
is	O
expressed	O
in	O
the	O
visual	O
system	O
of	O
the	O
species1s	O
fly	O
species1e	O
,	O
as	O
well	O
as	O
in	O
the	O
species1s	O
mushroom	O
species1e	O
bodies	O
of	O
the	O
central	O
brain	O
,	O
we	O
found	O
that	O
gene1s	ARG2
Ppef	ARG2
gene1e	ARG2
is	O
highly	O
expressed	O
in	O
sensory	O
neurons	O
of	O
the	O
dorsal	O
root	O
ganglia	O
(	O
DRG	O
)	O
and	O
neural	O
crest	O
-	O
derived	O
cranial	O
ganglia	O
.	O
The	O
selective	O
pattern	O
of	O
expression	O
makes	O
gene1s	O
PPEF	O
gene1e	O
an	O
important	O
marker	O
for	O
sensory	O
neuron	O
differentiation	O
and	O
suggests	O
a	O
role	O
for	O
serine	O
-	O
threonine	O
phosphatases	O
in	O
species1s	O
mammalian	O
species1e	O
development	O
.	O

A	O
novel	O
species1s	O
human	O
species1e	O
serine	O
-	O
threonine	O
phosphatase	O
related	O
to	O
the	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
retinal	O
degeneration	O
C	O
gene1e	O
(	O
gene1s	O
rdgC	O
gene1e	O
)	O
gene	O
is	O
selectively	O
expressed	O
in	O
sensory	O
neurons	O
of	O
neural	O
crest	O
origin	O
.	O
Through	O
our	O
transcriptional	O
mapping	O
effort	O
in	O
the	O
Xp22	O
region	O
,	O
we	O
have	O
isolated	O
by	O
exon	O
trapping	O
a	O
new	O
transcript	O
highly	O
homologous	O
to	O
the	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
retinal	O
degeneration	O
C	O
gene1e	O
(	O
gene1s	O
rdgC	O
gene1e	O
)	O
gene	O
.	O
gene1s	O
rdgC	O
gene1e	O
encodes	O
a	O
serine	O
/	O
threonine	O
phosphatase	O
protein	O
and	O
is	O
required	O
in	O
species1s	O
Drosophila	O
species1e	O
to	O
prevent	O
light	O
-	O
induced	O
retinal	O
degeneration	O
.	O
This	O
species1s	O
human	O
species1e	O
gene	O
is	O
the	O
first	O
species1s	O
mammalian	O
species1e	O
member	O
of	O
the	O
serine	O
-	O
threonine	O
phosphatase	O
with	O
EF	O
hand	O
motif	O
gene	O
family	O
,	O
and	O
was	O
thus	O
named	O
gene1s	O
PPEF	O
gene1e	O
(	O
Protein	O
Phosphatase	O
with	O
EF	O
calcium	O
-	O
binding	O
domain	O
)	O
.	O
The	O
expression	O
pattern	O
of	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
Ppef	O
gene1e	O
gene	O
was	O
studied	O
by	O
RNA	O
in	O
situ	O
hybridization	O
on	O
embryonic	O
tissue	O
sections	O
.	O
While	O
gene1s	O
rdgC	O
gene1e	O
is	O
expressed	O
in	O
the	O
visual	O
system	O
of	O
the	O
species1s	O
fly	O
species1e	O
,	O
as	O
well	O
as	O
in	O
the	O
arg1s	O
mushroom	O
arg1e	O
bodies	O
of	O
the	O
central	O
brain	O
,	O
we	O
found	O
that	O
gene1s	O
Ppef	O
gene1e	O
is	O
highly	O
expressed	O
in	O
sensory	O
neurons	O
of	O
the	O
dorsal	O
root	O
ganglia	O
(	O
DRG	O
)	O
and	O
neural	O
crest	O
-	O
derived	O
cranial	O
ganglia	O
.	O
The	O
selective	O
pattern	O
of	O
expression	O
makes	O
gene1s	O
PPEF	O
gene1e	O
an	O
important	O
marker	O
for	O
sensory	O
neuron	O
differentiation	O
and	O
suggests	O
a	O
role	O
for	O
serine	O
-	O
threonine	O
phosphatases	O
in	O
species1s	O
mammalian	O
species1e	O
development	O
.	O

A	O
gene1s	ARG2
minK	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
HERG	ARG2
gene1e	ARG2
complex	O
regulates	O
the	O
cardiac	O
potassium	O
current	O
I(Kr	O
)	O
.	O
gene1s	ARG2
MinK	ARG2
gene1e	ARG2
is	O
a	O
widely	O
expressed	O
protein	O
of	O
relative	O
molecular	O
mass	O
approximately	O
15	O
K	O
that	O
forms	O
potassium	O
channels	O
by	O
aggregation	O
with	O
other	O
membrane	O
proteins	O
.	O
gene1s	ARG2
MinK	ARG2
gene1e	ARG2
governs	O
ion	O
channel	O
activation	O
,	O
regulation	O
by	O
second	O
messengers	O
,	O
and	O
the	O
function	O
and	O
structure	O
of	O
the	O
ion	O
conduction	O
pathway	O
.	O
Association	O
of	O
gene1s	ARG2
minK	ARG2
gene1e	ARG2
with	O
a	O
channel	O
protein	O
known	O
as	O
gene1s	ARG2
KvLQT1	ARG2
gene1e	ARG2
produces	O
a	O
voltage	O
-	O
gated	O
outward	O
K+	O
current	O
(	O
I[sK	O
]	O
)	O
resembling	O
the	O
slow	O
cardiac	O
repolarization	O
current	O
(	O
I[Ks	O
]	O
)	O
.	O
gene1s	ARG2
HERG	ARG2
gene1e	ARG2
,	O
a	O
arg1s	O
human	O
arg1e	O
homologue	O
of	O
the	O
gene1s	O
ether	O
-	O
a	O
-	O
go	O
-	O
go	O
gene1e	O
gene	O
of	O
the	O
fruitfly	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
,	O
encodes	O
a	O
protein	O
that	O
produces	O
the	O
rapidly	O
activating	O
cardiac	O
delayed	O
rectifier	O
(	O
I[Kr	O
]	O
)	O
.	O
These	O
two	O
potassium	O
currents	O
,	O
I(Ks	O
)	O
and	O
I(Kr	O
)	O
,	O
provide	O
the	O
principal	O
repolarizing	O
currents	O
in	O
cardiac	O
myocytes	O
for	O
the	O
termination	O
of	O
action	O
potentials	O
.	O
Although	O
heterologously	O
expressed	O
gene1s	ARG2
HERG	ARG2
gene1e	ARG2
channels	O
are	O
largely	O
indistinguishable	O
from	O
native	O
cardiac	O
I(Kr	O
)	O
,	O
a	O
role	O
for	O
gene1s	ARG2
minK	ARG2
gene1e	ARG2
in	O
this	O
current	O
is	O
suggested	O
by	O
the	O
diminished	O
I(Kr	O
)	O
in	O
an	O
atrial	O
tumour	O
line	O
subjected	O
to	O
gene1s	ARG2
minK	ARG2
gene1e	ARG2
antisense	O
suppression	O
.	O
Here	O
we	O
show	O
that	O
gene1s	ARG2
HERG	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
minK	ARG2
gene1e	ARG2
form	O
a	O
stable	O
complex	O
,	O
and	O
that	O
this	O
heteromultimerization	O
regulates	O
I(Kr	O
)	O
activity	O
.	O
gene1s	ARG2
MinK	ARG2
gene1e	ARG2
,	O
through	O
the	O
formation	O
of	O
heteromeric	O
channel	O
complexes	O
,	O
is	O
thus	O
central	O
to	O
the	O
control	O
of	O
the	O
heart	O
rate	O
and	O
rhythm	O
.	O

A	O
gene1s	O
minK	O
gene1e	O
-	O
gene1s	O
HERG	O
gene1e	O
complex	O
regulates	O
the	O
cardiac	O
potassium	O
current	O
I(Kr	O
)	O
.	O
gene1s	O
MinK	O
gene1e	O
is	O
a	O
widely	O
expressed	O
protein	O
of	O
relative	O
molecular	O
mass	O
approximately	O
15	O
K	O
that	O
forms	O
potassium	O
channels	O
by	O
aggregation	O
with	O
other	O
membrane	O
proteins	O
.	O
gene1s	O
MinK	O
gene1e	O
governs	O
ion	O
channel	O
activation	O
,	O
regulation	O
by	O
second	O
messengers	O
,	O
and	O
the	O
function	O
and	O
structure	O
of	O
the	O
ion	O
conduction	O
pathway	O
.	O
Association	O
of	O
gene1s	O
minK	O
gene1e	O
with	O
a	O
channel	O
protein	O
known	O
as	O
gene1s	O
KvLQT1	O
gene1e	O
produces	O
a	O
voltage	O
-	O
gated	O
outward	O
K+	O
current	O
(	O
I[sK	O
]	O
)	O
resembling	O
the	O
slow	O
cardiac	O
repolarization	O
current	O
(	O
I[Ks	O
]	O
)	O
.	O
gene1s	O
HERG	O
gene1e	O
,	O
a	O
species1s	O
human	O
species1e	O
homologue	O
of	O
the	O
gene1s	ARG2
ether	ARG2
-	ARG2
a	ARG2
-	ARG2
go	ARG2
-	ARG2
go	ARG2
gene1e	ARG2
gene	O
of	O
the	O
fruitfly	O
arg1s	O
Drosophila	O
melanogaster	O
arg1e	O
,	O
encodes	O
a	O
protein	O
that	O
produces	O
the	O
rapidly	O
activating	O
cardiac	O
delayed	O
rectifier	O
(	O
I[Kr	O
]	O
)	O
.	O
These	O
two	O
potassium	O
currents	O
,	O
I(Ks	O
)	O
and	O
I(Kr	O
)	O
,	O
provide	O
the	O
principal	O
repolarizing	O
currents	O
in	O
cardiac	O
myocytes	O
for	O
the	O
termination	O
of	O
action	O
potentials	O
.	O
Although	O
heterologously	O
expressed	O
gene1s	O
HERG	O
gene1e	O
channels	O
are	O
largely	O
indistinguishable	O
from	O
native	O
cardiac	O
I(Kr	O
)	O
,	O
a	O
role	O
for	O
gene1s	O
minK	O
gene1e	O
in	O
this	O
current	O
is	O
suggested	O
by	O
the	O
diminished	O
I(Kr	O
)	O
in	O
an	O
atrial	O
tumour	O
line	O
subjected	O
to	O
gene1s	O
minK	O
gene1e	O
antisense	O
suppression	O
.	O
Here	O
we	O
show	O
that	O
gene1s	O
HERG	O
gene1e	O
and	O
gene1s	O
minK	O
gene1e	O
form	O
a	O
stable	O
complex	O
,	O
and	O
that	O
this	O
heteromultimerization	O
regulates	O
I(Kr	O
)	O
activity	O
.	O
gene1s	O
MinK	O
gene1e	O
,	O
through	O
the	O
formation	O
of	O
heteromeric	O
channel	O
complexes	O
,	O
is	O
thus	O
central	O
to	O
the	O
control	O
of	O
the	O
heart	O
rate	O
and	O
rhythm	O
.	O

gene1s	ARG2
PHOG	ARG2
gene1e	ARG2
,	O
a	O
candidate	O
gene	O
for	O
involvement	O
in	O
the	O
short	O
stature	O
of	O
Turner	O
syndrome	O
.	O
The	O
abnormalities	O
seen	O
in	O
Turner	O
syndrome	O
(	O
monosomy	O
X	O
)	O
presumably	O
result	O
from	O
haploinsufficiency	O
of	O
certain	O
genes	O
on	O
the	O
X	O
chromosome	O
.	O
Gene	O
dosage	O
considerations	O
lead	O
to	O
the	O
prediction	O
that	O
the	O
culpable	O
genes	O
escape	O
X	O
inactivation	O
and	O
have	O
functional	O
homologs	O
on	O
the	O
Y	O
chromosome	O
.	O
Among	O
the	O
genes	O
with	O
these	O
characteristics	O
are	O
those	O
residing	O
in	O
the	O
pseudoautosomal	O
regions	O
(	O
PAR	O
)	O
of	O
the	O
sex	O
chromosomes	O
.	O
A	O
pseudoautosomal	O
location	O
for	O
a	O
dosage	O
-	O
sensitive	O
locus	O
involved	O
in	O
stature	O
has	O
been	O
suggested	O
based	O
on	O
the	O
analyses	O
of	O
arg1s	O
patients	O
arg1e	O
with	O
deletions	O
of	O
a	O
specific	O
segment	O
of	O
the	O
short	O
arm	O
PAR	O
;	O
hemizygosity	O
for	O
this	O
putative	O
locus	O
probably	O
also	O
contributes	O
to	O
the	O
short	O
stature	O
in	O
Turner	O
individuals	O
.	O
We	O
have	O
isolated	O
a	O
gene	O
from	O
the	O
critical	O
deleted	O
region	O
that	O
encodes	O
a	O
novel	O
homeodomain	O
-	O
containing	O
transcription	O
factor	O
and	O
is	O
expressed	O
at	O
highest	O
levels	O
in	O
osteogenic	O
cells	O
.	O
We	O
have	O
named	O
the	O
gene	O
gene1s	ARG2
PHOG	ARG2
gene1e	ARG2
,	O
for	O
gene1s	ARG2
pseudoautosomal	ARG2
homeobox	ARG2
-	ARG2
containing	ARG2
osteogenic	ARG2
gene	ARG2
gene1e	ARG2
.	O
Its	O
deletion	O
in	O
arg1s	O
patients	O
arg1e	O
with	O
short	O
stature	O
,	O
the	O
predicted	O
altered	O
dosage	O
in	O
45,X	O
individuals	O
,	O
along	O
with	O
the	O
nature	O
of	O
the	O
encoded	O
protein	O
and	O
its	O
expression	O
pattern	O
,	O
make	O
gene1s	ARG2
PHOG	ARG2
gene1e	ARG2
an	O
attractive	O
candidate	O
for	O
involvement	O
in	O
the	O
short	O
stature	O
of	O
Turner	O
syndrome	O
.	O
We	O
have	O
also	O
found	O
that	O
the	O
species1s	O
mouse	O
species1e	O
homolog	O
of	O
gene1s	ARG2
PHOG	ARG2
gene1e	ARG2
is	O
autosomal	O
,	O
which	O
may	O
help	O
to	O
explain	O
the	O
lack	O
of	O
a	O
growth	O
abnormality	O
in	O
species1s	O
mice	O
species1e	O
with	O
monosomy	O
X.	O

gene1s	O
PHOG	O
gene1e	O
,	O
a	O
candidate	O
gene	O
for	O
involvement	O
in	O
the	O
short	O
stature	O
of	O
Turner	O
syndrome	O
.	O
The	O
abnormalities	O
seen	O
in	O
Turner	O
syndrome	O
(	O
monosomy	O
X	O
)	O
presumably	O
result	O
from	O
haploinsufficiency	O
of	O
certain	O
genes	O
on	O
the	O
X	O
chromosome	O
.	O
Gene	O
dosage	O
considerations	O
lead	O
to	O
the	O
prediction	O
that	O
the	O
culpable	O
genes	O
escape	O
X	O
inactivation	O
and	O
have	O
functional	O
homologs	O
on	O
the	O
Y	O
chromosome	O
.	O
Among	O
the	O
genes	O
with	O
these	O
characteristics	O
are	O
those	O
residing	O
in	O
the	O
pseudoautosomal	O
regions	O
(	O
PAR	O
)	O
of	O
the	O
sex	O
chromosomes	O
.	O
A	O
pseudoautosomal	O
location	O
for	O
a	O
dosage	O
-	O
sensitive	O
locus	O
involved	O
in	O
stature	O
has	O
been	O
suggested	O
based	O
on	O
the	O
analyses	O
of	O
species1s	O
patients	O
species1e	O
with	O
deletions	O
of	O
a	O
specific	O
segment	O
of	O
the	O
short	O
arm	O
PAR	O
;	O
hemizygosity	O
for	O
this	O
putative	O
locus	O
probably	O
also	O
contributes	O
to	O
the	O
short	O
stature	O
in	O
Turner	O
individuals	O
.	O
We	O
have	O
isolated	O
a	O
gene	O
from	O
the	O
critical	O
deleted	O
region	O
that	O
encodes	O
a	O
novel	O
homeodomain	O
-	O
containing	O
transcription	O
factor	O
and	O
is	O
expressed	O
at	O
highest	O
levels	O
in	O
osteogenic	O
cells	O
.	O
We	O
have	O
named	O
the	O
gene	O
gene1s	O
PHOG	O
gene1e	O
,	O
for	O
gene1s	O
pseudoautosomal	O
homeobox	O
-	O
containing	O
osteogenic	O
gene	O
gene1e	O
.	O
Its	O
deletion	O
in	O
species1s	O
patients	O
species1e	O
with	O
short	O
stature	O
,	O
the	O
predicted	O
altered	O
dosage	O
in	O
45,X	O
individuals	O
,	O
along	O
with	O
the	O
nature	O
of	O
the	O
encoded	O
protein	O
and	O
its	O
expression	O
pattern	O
,	O
make	O
gene1s	O
PHOG	O
gene1e	O
an	O
attractive	O
candidate	O
for	O
involvement	O
in	O
the	O
short	O
stature	O
of	O
Turner	O
syndrome	O
.	O
We	O
have	O
also	O
found	O
that	O
the	O
arg1s	O
mouse	O
arg1e	O
homolog	O
of	O
gene1s	O
PHOG	O
gene1e	O
is	O
autosomal	O
,	O
which	O
may	O
help	O
to	O
explain	O
the	O
lack	O
of	O
a	O
growth	O
abnormality	O
in	O
arg1s	O
mice	O
arg1e	O
with	O
monosomy	O
X.	O

gene1s	ARG2
Glycogenin-2	ARG2
gene1e	ARG2
,	O
a	O
novel	O
self	O
-	O
glucosylating	O
protein	O
involved	O
in	O
liver	O
glycogen	O
biosynthesis	O
.	O
Glycogenin	O
is	O
a	O
self	O
-	O
glucosylating	O
protein	O
involved	O
in	O
the	O
initiation	O
phase	O
of	O
glycogen	O
biosynthesis	O
.	O
A	O
single	O
arg1s	O
mammalian	O
arg1e	O
gene	O
had	O
been	O
reported	O
to	O
account	O
for	O
glycogen	O
biogenesis	O
in	O
liver	O
and	O
muscle	O
,	O
the	O
two	O
major	O
repositories	O
of	O
glycogen	O
.	O
We	O
describe	O
the	O
characterization	O
of	O
novel	O
forms	O
of	O
glycogenin	O
,	O
designated	O
gene1s	ARG2
glycogenin-2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
GN-2	ARG2
gene1e	ARG2
)	O
,	O
encoded	O
by	O
a	O
second	O
gene	O
that	O
is	O
expressed	O
preferentially	O
in	O
certain	O
tissues	O
,	O
including	O
liver	O
,	O
heart	O
,	O
and	O
pancreas	O
.	O
Cloning	O
of	O
cDNAs	O
encoding	O
gene1s	ARG2
glycogenin-2	ARG2
gene1e	ARG2
indicated	O
the	O
existence	O
of	O
multiple	O
species	O
,	O
including	O
three	O
liver	O
forms	O
(	O
gene1s	ARG2
GN-2alpha	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
GN-2beta	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
GN-2gamma	ARG2
gene1e	ARG2
)	O
generated	O
in	O
part	O
by	O
alternative	O
splicing	O
.	O
Overall	O
,	O
gene1s	ARG2
GN-2	ARG2
gene1e	ARG2
has	O
40	O
-	O
45	O
%	O
identity	O
to	O
gene1s	ARG2
muscle	ARG2
glycogenin	ARG2
gene1e	ARG2
but	O
is	O
72	O
%	O
identical	O
over	O
a	O
200-residue	O
segment	O
thought	O
to	O
contain	O
the	O
catalytic	O
domain	O
.	O
gene1s	ARG2
GN-2	ARG2
gene1e	ARG2
expressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
or	O
COS	O
cells	O
is	O
active	O
in	O
self	O
-	O
glucosylation	O
assays	O
,	O
and	O
self	O
-	O
glucosylated	O
gene1s	ARG2
GN-2	ARG2
gene1e	ARG2
can	O
be	O
elongated	O
by	O
gene1s	ARG2
skeletal	ARG2
muscle	ARG2
glycogen	ARG2
synthase	ARG2
gene1e	ARG2
.	O
Antibodies	O
raised	O
against	O
gene1s	ARG2
GN-2	ARG2
gene1e	ARG2
produced	O
in	O
species1s	O
E.	O
coli	O
species1e	O
recognized	O
proteins	O
of	O
Mr	O
approximately	O
66,000	O
present	O
in	O
extracts	O
of	O
species1s	O
rat	O
species1e	O
liver	O
and	O
in	O
cultured	O
species1s	O
H4IIEC3	O
species1e	O
hepatoma	O
cells	O
.	O
In	O
species1s	O
H4IIEC3	O
species1e	O
cells	O
,	O
most	O
of	O
the	O
gene1s	ARG2
GN-2	ARG2
gene1e	ARG2
was	O
present	O
as	O
a	O
free	O
protein	O
but	O
some	O
was	O
covalently	O
associated	O
with	O
glycogen	O
fractions	O
and	O
was	O
only	O
released	O
by	O
treatment	O
with	O
alpha	O
-	O
amylase	O
.	O
species1s	O
H4IIEC3	O
species1e	O
cells	O
also	O
expressed	O
the	O
gene1s	ARG2
muscle	ARG2
form	ARG2
of	ARG2
glycogenin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
glycogenin-1	ARG2
gene1e	ARG2
)	O
,	O
which	O
was	O
attached	O
to	O
a	O
chromatographically	O
separable	O
glycogen	O
fraction	O
.	O

gene1s	O
Glycogenin-2	O
gene1e	O
,	O
a	O
novel	O
self	O
-	O
glucosylating	O
protein	O
involved	O
in	O
liver	O
glycogen	O
biosynthesis	O
.	O
Glycogenin	O
is	O
a	O
self	O
-	O
glucosylating	O
protein	O
involved	O
in	O
the	O
initiation	O
phase	O
of	O
glycogen	O
biosynthesis	O
.	O
A	O
single	O
species1s	O
mammalian	O
species1e	O
gene	O
had	O
been	O
reported	O
to	O
account	O
for	O
glycogen	O
biogenesis	O
in	O
liver	O
and	O
muscle	O
,	O
the	O
two	O
major	O
repositories	O
of	O
glycogen	O
.	O
We	O
describe	O
the	O
characterization	O
of	O
novel	O
forms	O
of	O
glycogenin	O
,	O
designated	O
gene1s	O
glycogenin-2	O
gene1e	O
(	O
gene1s	O
GN-2	O
gene1e	O
)	O
,	O
encoded	O
by	O
a	O
second	O
gene	O
that	O
is	O
expressed	O
preferentially	O
in	O
certain	O
tissues	O
,	O
including	O
liver	O
,	O
heart	O
,	O
and	O
pancreas	O
.	O
Cloning	O
of	O
cDNAs	O
encoding	O
gene1s	O
glycogenin-2	O
gene1e	O
indicated	O
the	O
existence	O
of	O
multiple	O
species	O
,	O
including	O
three	O
liver	O
forms	O
(	O
gene1s	O
GN-2alpha	O
gene1e	O
,	O
gene1s	O
GN-2beta	O
gene1e	O
,	O
and	O
gene1s	O
GN-2gamma	O
gene1e	O
)	O
generated	O
in	O
part	O
by	O
alternative	O
splicing	O
.	O
Overall	O
,	O
gene1s	O
GN-2	O
gene1e	O
has	O
40	O
-	O
45	O
%	O
identity	O
to	O
gene1s	O
muscle	O
glycogenin	O
gene1e	O
but	O
is	O
72	O
%	O
identical	O
over	O
a	O
200-residue	O
segment	O
thought	O
to	O
contain	O
the	O
catalytic	O
domain	O
.	O
gene1s	O
GN-2	O
gene1e	O
expressed	O
in	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
or	O
COS	O
cells	O
is	O
active	O
in	O
self	O
-	O
glucosylation	O
assays	O
,	O
and	O
self	O
-	O
glucosylated	O
gene1s	O
GN-2	O
gene1e	O
can	O
be	O
elongated	O
by	O
gene1s	O
skeletal	O
muscle	O
glycogen	O
synthase	O
gene1e	O
.	O
Antibodies	O
raised	O
against	O
gene1s	O
GN-2	O
gene1e	O
produced	O
in	O
arg1s	O
E.	O
coli	O
arg1e	O
recognized	O
proteins	O
of	O
Mr	O
approximately	O
66,000	O
present	O
in	O
extracts	O
of	O
species1s	O
rat	O
species1e	O
liver	O
and	O
in	O
cultured	O
species1s	O
H4IIEC3	O
species1e	O
hepatoma	O
cells	O
.	O
In	O
species1s	O
H4IIEC3	O
species1e	O
cells	O
,	O
most	O
of	O
the	O
gene1s	O
GN-2	O
gene1e	O
was	O
present	O
as	O
a	O
free	O
protein	O
but	O
some	O
was	O
covalently	O
associated	O
with	O
glycogen	O
fractions	O
and	O
was	O
only	O
released	O
by	O
treatment	O
with	O
alpha	O
-	O
amylase	O
.	O
species1s	O
H4IIEC3	O
species1e	O
cells	O
also	O
expressed	O
the	O
gene1s	O
muscle	O
form	O
of	O
glycogenin	O
gene1e	O
(	O
gene1s	O
glycogenin-1	O
gene1e	O
)	O
,	O
which	O
was	O
attached	O
to	O
a	O
chromatographically	O
separable	O
glycogen	O
fraction	O
.	O

gene1s	O
Glycogenin-2	O
gene1e	O
,	O
a	O
novel	O
self	O
-	O
glucosylating	O
protein	O
involved	O
in	O
liver	O
glycogen	O
biosynthesis	O
.	O
Glycogenin	O
is	O
a	O
self	O
-	O
glucosylating	O
protein	O
involved	O
in	O
the	O
initiation	O
phase	O
of	O
glycogen	O
biosynthesis	O
.	O
A	O
single	O
species1s	O
mammalian	O
species1e	O
gene	O
had	O
been	O
reported	O
to	O
account	O
for	O
glycogen	O
biogenesis	O
in	O
liver	O
and	O
muscle	O
,	O
the	O
two	O
major	O
repositories	O
of	O
glycogen	O
.	O
We	O
describe	O
the	O
characterization	O
of	O
novel	O
forms	O
of	O
glycogenin	O
,	O
designated	O
gene1s	O
glycogenin-2	O
gene1e	O
(	O
gene1s	O
GN-2	O
gene1e	O
)	O
,	O
encoded	O
by	O
a	O
second	O
gene	O
that	O
is	O
expressed	O
preferentially	O
in	O
certain	O
tissues	O
,	O
including	O
liver	O
,	O
heart	O
,	O
and	O
pancreas	O
.	O
Cloning	O
of	O
cDNAs	O
encoding	O
gene1s	O
glycogenin-2	O
gene1e	O
indicated	O
the	O
existence	O
of	O
multiple	O
species	O
,	O
including	O
three	O
liver	O
forms	O
(	O
gene1s	O
GN-2alpha	O
gene1e	O
,	O
gene1s	O
GN-2beta	O
gene1e	O
,	O
and	O
gene1s	O
GN-2gamma	O
gene1e	O
)	O
generated	O
in	O
part	O
by	O
alternative	O
splicing	O
.	O
Overall	O
,	O
gene1s	O
GN-2	O
gene1e	O
has	O
40	O
-	O
45	O
%	O
identity	O
to	O
gene1s	O
muscle	O
glycogenin	O
gene1e	O
but	O
is	O
72	O
%	O
identical	O
over	O
a	O
200-residue	O
segment	O
thought	O
to	O
contain	O
the	O
catalytic	O
domain	O
.	O
gene1s	O
GN-2	O
gene1e	O
expressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
or	O
COS	O
cells	O
is	O
active	O
in	O
self	O
-	O
glucosylation	O
assays	O
,	O
and	O
self	O
-	O
glucosylated	O
gene1s	O
GN-2	O
gene1e	O
can	O
be	O
elongated	O
by	O
gene1s	O
skeletal	O
muscle	O
glycogen	O
synthase	O
gene1e	O
.	O
Antibodies	O
raised	O
against	O
gene1s	O
GN-2	O
gene1e	O
produced	O
in	O
species1s	O
E.	O
coli	O
species1e	O
recognized	O
proteins	O
of	O
Mr	O
approximately	O
66,000	O
present	O
in	O
extracts	O
of	O
arg1s	O
rat	O
arg1e	O
liver	O
and	O
in	O
cultured	O
arg1s	O
H4IIEC3	O
arg1e	O
hepatoma	O
cells	O
.	O
In	O
arg1s	O
H4IIEC3	O
arg1e	O
cells	O
,	O
most	O
of	O
the	O
gene1s	O
GN-2	O
gene1e	O
was	O
present	O
as	O
a	O
free	O
protein	O
but	O
some	O
was	O
covalently	O
associated	O
with	O
glycogen	O
fractions	O
and	O
was	O
only	O
released	O
by	O
treatment	O
with	O
alpha	O
-	O
amylase	O
.	O
arg1s	O
H4IIEC3	O
arg1e	O
cells	O
also	O
expressed	O
the	O
gene1s	O
muscle	O
form	O
of	O
glycogenin	O
gene1e	O
(	O
gene1s	O
glycogenin-1	O
gene1e	O
)	O
,	O
which	O
was	O
attached	O
to	O
a	O
chromatographically	O
separable	O
glycogen	O
fraction	O
.	O

gene1s	ARG2
hSK4	ARG2
gene1e	ARG2
,	O
a	O
member	O
of	O
a	O
novel	O
subfamily	O
of	O
calcium	O
-	O
activated	O
potassium	O
channels	O
.	O
The	O
gene	O
for	O
gene1s	ARG2
hSK4	ARG2
gene1e	ARG2
,	O
a	O
novel	O
arg1s	O
human	O
arg1e	O
small	O
conductance	O
calcium	O
-	O
activated	O
potassium	O
channel	O
,	O
or	O
SK	O
channel	O
,	O
has	O
been	O
identified	O
and	O
expressed	O
in	O
species1s	O
Chinese	O
hamster	O
species1e	O
ovary	O
cells	O
.	O
In	O
physiological	O
saline	O
gene1s	ARG2
hSK4	ARG2
gene1e	ARG2
generates	O
a	O
conductance	O
of	O
approximately	O
12	O
pS	O
,	O
a	O
value	O
in	O
close	O
agreement	O
with	O
that	O
of	O
other	O
cloned	O
SK	O
channels	O
.	O
Like	O
other	O
members	O
of	O
this	O
family	O
,	O
the	O
polypeptide	O
encoded	O
by	O
gene1s	ARG2
hSK4	ARG2
gene1e	ARG2
contains	O
a	O
previously	O
unnoted	O
leucine	O
zipper	O
-	O
like	O
domain	O
in	O
its	O
C	O
terminus	O
of	O
unknown	O
function	O
.	O
gene1s	ARG2
hSK4	ARG2
gene1e	ARG2
appears	O
unique	O
,	O
however	O
,	O
in	O
its	O
very	O
high	O
affinity	O
for	O
Ca2	O
+	O
(	O
EC50	O
of	O
95	O
nM	O
)	O
and	O
its	O
predominant	O
expression	O
in	O
nonexcitable	O
tissues	O
of	O
adult	O
animals	O
.	O
Together	O
with	O
the	O
relatively	O
low	O
homology	O
of	O
gene1s	ARG2
hSK4	ARG2
gene1e	ARG2
to	O
other	O
SK	O
channel	O
polypeptides	O
(	O
approximately	O
40	O
%	O
identical	O
)	O
,	O
these	O
data	O
suggest	O
that	O
gene1s	ARG2
hSK4	ARG2
gene1e	ARG2
belongs	O
to	O
a	O
novel	O
subfamily	O
of	O
SK	O
channels	O
.	O

gene1s	O
hSK4	O
gene1e	O
,	O
a	O
member	O
of	O
a	O
novel	O
subfamily	O
of	O
calcium	O
-	O
activated	O
potassium	O
channels	O
.	O
The	O
gene	O
for	O
gene1s	O
hSK4	O
gene1e	O
,	O
a	O
novel	O
species1s	O
human	O
species1e	O
small	O
conductance	O
calcium	O
-	O
activated	O
potassium	O
channel	O
,	O
or	O
SK	O
channel	O
,	O
has	O
been	O
identified	O
and	O
expressed	O
in	O
arg1s	O
Chinese	O
hamster	O
arg1e	O
ovary	O
cells	O
.	O
In	O
physiological	O
saline	O
gene1s	O
hSK4	O
gene1e	O
generates	O
a	O
conductance	O
of	O
approximately	O
12	O
pS	O
,	O
a	O
value	O
in	O
close	O
agreement	O
with	O
that	O
of	O
other	O
cloned	O
SK	O
channels	O
.	O
Like	O
other	O
members	O
of	O
this	O
family	O
,	O
the	O
polypeptide	O
encoded	O
by	O
gene1s	O
hSK4	O
gene1e	O
contains	O
a	O
previously	O
unnoted	O
leucine	O
zipper	O
-	O
like	O
domain	O
in	O
its	O
C	O
terminus	O
of	O
unknown	O
function	O
.	O
gene1s	O
hSK4	O
gene1e	O
appears	O
unique	O
,	O
however	O
,	O
in	O
its	O
very	O
high	O
affinity	O
for	O
Ca2	O
+	O
(	O
EC50	O
of	O
95	O
nM	O
)	O
and	O
its	O
predominant	O
expression	O
in	O
nonexcitable	O
tissues	O
of	O
adult	O
animals	O
.	O
Together	O
with	O
the	O
relatively	O
low	O
homology	O
of	O
gene1s	O
hSK4	O
gene1e	O
to	O
other	O
SK	O
channel	O
polypeptides	O
(	O
approximately	O
40	O
%	O
identical	O
)	O
,	O
these	O
data	O
suggest	O
that	O
gene1s	O
hSK4	O
gene1e	O
belongs	O
to	O
a	O
novel	O
subfamily	O
of	O
SK	O
channels	O
.	O

arg1s	O
Human	O
arg1e	O
pulmonary	O
alveolar	O
proteinosis	O
associated	O
with	O
a	O
defect	O
in	O
gene1s	ARG2
GM	ARG2
-	ARG2
CSF	ARG2
/	ARG2
IL-3	ARG2
/	ARG2
IL-5	ARG2
receptor	ARG2
common	ARG2
beta	ARG2
chain	ARG2
gene1e	ARG2
expression	O
.	O
Pulmonary	O
alveolar	O
proteinosis	O
(	O
PAP	O
)	O
is	O
a	O
heterogeneous	O
disorder	O
of	O
genetic	O
or	O
acquired	O
etiologies	O
.	O
In	O
some	O
cases	O
congenital	O
PAP	O
is	O
associated	O
with	O
hereditary	O
gene1s	ARG2
surfactant	ARG2
protein	ARG2
(	ARG2
SP)-B	ARG2
gene1e	ARG2
deficiency	O
.	O
To	O
date	O
,	O
the	O
molecular	O
defect	O
in	O
the	O
majority	O
of	O
arg1s	O
patients	O
arg1e	O
with	O
PAP	O
has	O
not	O
been	O
identified	O
.	O
In	O
species1s	O
mice	O
species1e	O
,	O
PAP	O
has	O
been	O
generated	O
by	O
targeted	O
deletion	O
of	O
the	O
genes	O
for	O
either	O
the	O
gene1s	ARG2
GM	ARG2
-	ARG2
CSF	ARG2
/	ARG2
IL-3	ARG2
/	ARG2
IL-5	ARG2
receptor	ARG2
common	ARG2
beta	ARG2
chain	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
beta	ARG2
c	ARG2
gene1e	ARG2
)	O
or	O
GM	O
-	O
CSF	O
.	O
Here	O
,	O
we	O
describe	O
an	O
expression	O
defect	O
of	O
gene1s	ARG2
beta	ARG2
c	ARG2
gene1e	ARG2
in	O
three	O
of	O
seven	O
pediatric	O
arg1s	O
patients	O
arg1e	O
with	O
PAP	O
and	O
in	O
one	O
arg1s	O
patient	O
arg1e	O
with	O
severe	O
lung	O
disease	O
suspected	O
to	O
be	O
PAP	O
.	O
The	O
arg1s	O
patients	O
arg1e	O
failed	O
to	O
express	O
normal	O
levels	O
of	O
gene1s	ARG2
beta	ARG2
c	ARG2
gene1e	ARG2
as	O
shown	O
by	O
flow	O
cytometry	O
.	O
Strikingly	O
reduced	O
or	O
absent	O
function	O
of	O
gene1s	ARG2
beta	ARG2
c	ARG2
gene1e	ARG2
was	O
demonstrated	O
by	O
ligand	O
binding	O
studies	O
and	O
progenitor	O
clonogenic	O
assays	O
.	O
Analysis	O
of	O
gene1s	ARG2
beta	ARG2
c	ARG2
gene1e	ARG2
DNA	O
revealed	O
a	O
point	O
mutation	O
from	O
proline	O
to	O
threonine	O
at	O
codon	O
602	O
in	O
one	O
arg1s	O
patient	O
arg1e	O
.	O
Our	O
findings	O
provide	O
evidence	O
that	O
a	O
defect	O
in	O
the	O
expression	O
of	O
a	O
hematopoietic	O
cytokine	O
receptor	O
is	O
associated	O
with	O
arg1s	O
human	O
arg1e	O
PAP	O
.	O

species1s	O
Human	O
species1e	O
pulmonary	O
alveolar	O
proteinosis	O
associated	O
with	O
a	O
defect	O
in	O
gene1s	O
GM	O
-	O
CSF	O
/	O
IL-3	O
/	O
IL-5	O
receptor	O
common	O
beta	O
chain	O
gene1e	O
expression	O
.	O
Pulmonary	O
alveolar	O
proteinosis	O
(	O
PAP	O
)	O
is	O
a	O
heterogeneous	O
disorder	O
of	O
genetic	O
or	O
acquired	O
etiologies	O
.	O
In	O
some	O
cases	O
congenital	O
PAP	O
is	O
associated	O
with	O
hereditary	O
gene1s	O
surfactant	O
protein	O
(	O
SP)-B	O
gene1e	O
deficiency	O
.	O
To	O
date	O
,	O
the	O
molecular	O
defect	O
in	O
the	O
majority	O
of	O
species1s	O
patients	O
species1e	O
with	O
PAP	O
has	O
not	O
been	O
identified	O
.	O
In	O
arg1s	O
mice	O
arg1e	O
,	O
PAP	O
has	O
been	O
generated	O
by	O
targeted	O
deletion	O
of	O
the	O
genes	O
for	O
either	O
the	O
gene1s	O
GM	O
-	O
CSF	O
/	O
IL-3	O
/	O
IL-5	O
receptor	O
common	O
beta	O
chain	O
gene1e	O
(	O
gene1s	O
beta	O
c	O
gene1e	O
)	O
or	O
GM	O
-	O
CSF	O
.	O
Here	O
,	O
we	O
describe	O
an	O
expression	O
defect	O
of	O
gene1s	O
beta	O
c	O
gene1e	O
in	O
three	O
of	O
seven	O
pediatric	O
species1s	O
patients	O
species1e	O
with	O
PAP	O
and	O
in	O
one	O
species1s	O
patient	O
species1e	O
with	O
severe	O
lung	O
disease	O
suspected	O
to	O
be	O
PAP	O
.	O
The	O
species1s	O
patients	O
species1e	O
failed	O
to	O
express	O
normal	O
levels	O
of	O
gene1s	O
beta	O
c	O
gene1e	O
as	O
shown	O
by	O
flow	O
cytometry	O
.	O
Strikingly	O
reduced	O
or	O
absent	O
function	O
of	O
gene1s	O
beta	O
c	O
gene1e	O
was	O
demonstrated	O
by	O
ligand	O
binding	O
studies	O
and	O
progenitor	O
clonogenic	O
assays	O
.	O
Analysis	O
of	O
gene1s	O
beta	O
c	O
gene1e	O
DNA	O
revealed	O
a	O
point	O
mutation	O
from	O
proline	O
to	O
threonine	O
at	O
codon	O
602	O
in	O
one	O
species1s	O
patient	O
species1e	O
.	O
Our	O
findings	O
provide	O
evidence	O
that	O
a	O
defect	O
in	O
the	O
expression	O
of	O
a	O
hematopoietic	O
cytokine	O
receptor	O
is	O
associated	O
with	O
species1s	O
human	O
species1e	O
PAP	O
.	O

Triplet	O
repeat	O
-	O
containing	O
gene1s	ARG2
ribosomal	ARG2
protein	ARG2
L14	ARG2
gene1e	ARG2
gene	O
in	O
immortalized	O
arg1s	O
human	O
arg1e	O
endothelial	O
cell	O
line	O
(	O
t	O
-	O
HUE4	O
)	O
.	O
A	O
cDNA	O
encoding	O
arg1s	O
human	O
arg1e	O
60S	O
gene1s	ARG2
ribosomal	ARG2
subunit	ARG2
protein	ARG2
L14	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
hRL14	ARG2
gene1e	ARG2
)	O
was	O
isolated	O
from	O
a	O
arg1s	O
human	O
arg1e	O
immortal	O
endothelial	O
cell	O
line	O
,	O
arg1s	O
t	O
-	O
HUE4	O
arg1e	O
.	O
This	O
cell	O
line	O
was	O
established	O
via	O
a	O
series	O
of	O
cell	O
lines	O
cultured	O
in	O
a	O
serum	O
-	O
free	O
and	O
a	O
protein	O
-	O
free	O
medium	O
,	O
and	O
a	O
directional	O
cDNA	O
library	O
has	O
been	O
constructed	O
and	O
screened	O
in	O
search	O
for	O
the	O
genes	O
modulating	O
protein	O
synthesis	O
machinery	O
in	O
cell	O
proliferation	O
.	O
A	O
putative	O
full	O
-	O
length	O
clone	O
with	O
an	O
open	O
reading	O
frame	O
of	O
220	O
amino	O
acids	O
;	O
predicted	O
molecular	O
weight	O
of	O
23.6	O
kDa	O
.	O
A	O
significant	O
identity	O
for	O
gene1s	ARG2
hRL14	ARG2
gene1e	ARG2
was	O
observed	O
with	O
species1s	O
rat	O
species1e	O
gene1s	O
RL14	O
gene1e	O
(	O
85	O
%	O
identity	O
)	O
,	O
with	O
exception	O
of	O
COOH	O
-	O
terminal	O
region	O
,	O
but	O
not	O
with	O
any	O
eukaryote	O
amino	O
acid	O
sequences	O
so	O
far	O
deposited	O
to	O
database	O
.	O
The	O
typical	O
features	O
of	O
ribosomal	O
proteins	O
were	O
observed	O
in	O
gene1s	ARG2
hRL14	ARG2
gene1e	ARG2
,	O
as	O
seen	O
in	O
nuclear	O
targeting	O
sequences	O
necessary	O
for	O
the	O
transport	O
from	O
cytoplasm	O
to	O
nucleolus	O
,	O
a	O
bZIP	O
like	O
(	O
basic	O
region	O
-	O
leucine	O
zipper	O
)	O
element	O
for	O
the	O
binding	O
to	O
rRNA	O
,	O
and	O
the	O
internal	O
repeat	O
sequences	O
;	O
the	O
pentapeptide	O
QKA(A	O
/	O
S)X.	O
The	O
COOH	O
-	O
terminal	O
region	O
of	O
the	O
transcripts	O
contained	O
fifteen	O
triplet	O
repeats	O
(	O
GCT	O
;	O
alanine	O
)	O
at	O
nucleotide	O
465	O
to	O
509	O
,	O
which	O
is	O
significantly	O
expanded	O
compared	O
to	O
the	O
species1s	O
rat	O
species1e	O
gene1s	O
RL14	O
gene1e	O
.	O
However	O
,	O
the	O
repeat	O
number	O
was	O
all	O
the	O
same	O
among	O
the	O
normal	O
arg1s	O
human	O
arg1e	O
endothelial	O
cell	O
line	O
and	O
the	O
cell	O
lines	O
established	O
in	O
the	O
course	O
of	O
t	O
-	O
HUE4	O
establishment	O
.	O
A	O
single	O
band	O
with	O
about	O
800	O
bases	O
was	O
identified	O
by	O
Northern	O
blot	O
analysis	O
without	O
tissue	O
specificity	O
.	O
This	O
GCT	O
repeat	O
was	O
found	O
to	O
be	O
one	O
of	O
the	O
longest	O
uninterrupted	O
repeats	O
in	O
a	O
coding	O
sequence	O
,	O
which	O
were	O
associated	O
with	O
the	O
highest	O
degree	O
of	O
polymorphism	O
.	O

Triplet	O
repeat	O
-	O
containing	O
gene1s	O
ribosomal	O
protein	O
L14	O
gene1e	O
gene	O
in	O
immortalized	O
species1s	O
human	O
species1e	O
endothelial	O
cell	O
line	O
(	O
t	O
-	O
HUE4	O
)	O
.	O
A	O
cDNA	O
encoding	O
species1s	O
human	O
species1e	O
60S	O
gene1s	O
ribosomal	O
subunit	O
protein	O
L14	O
gene1e	O
(	O
gene1s	O
hRL14	O
gene1e	O
)	O
was	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
immortal	O
endothelial	O
cell	O
line	O
,	O
species1s	O
t	O
-	O
HUE4	O
species1e	O
.	O
This	O
cell	O
line	O
was	O
established	O
via	O
a	O
series	O
of	O
cell	O
lines	O
cultured	O
in	O
a	O
serum	O
-	O
free	O
and	O
a	O
protein	O
-	O
free	O
medium	O
,	O
and	O
a	O
directional	O
cDNA	O
library	O
has	O
been	O
constructed	O
and	O
screened	O
in	O
search	O
for	O
the	O
genes	O
modulating	O
protein	O
synthesis	O
machinery	O
in	O
cell	O
proliferation	O
.	O
A	O
putative	O
full	O
-	O
length	O
clone	O
with	O
an	O
open	O
reading	O
frame	O
of	O
220	O
amino	O
acids	O
;	O
predicted	O
molecular	O
weight	O
of	O
23.6	O
kDa	O
.	O
A	O
significant	O
identity	O
for	O
gene1s	O
hRL14	O
gene1e	O
was	O
observed	O
with	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
RL14	ARG2
gene1e	ARG2
(	O
85	O
%	O
identity	O
)	O
,	O
with	O
exception	O
of	O
COOH	O
-	O
terminal	O
region	O
,	O
but	O
not	O
with	O
any	O
eukaryote	O
amino	O
acid	O
sequences	O
so	O
far	O
deposited	O
to	O
database	O
.	O
The	O
typical	O
features	O
of	O
ribosomal	O
proteins	O
were	O
observed	O
in	O
gene1s	O
hRL14	O
gene1e	O
,	O
as	O
seen	O
in	O
nuclear	O
targeting	O
sequences	O
necessary	O
for	O
the	O
transport	O
from	O
cytoplasm	O
to	O
nucleolus	O
,	O
a	O
bZIP	O
like	O
(	O
basic	O
region	O
-	O
leucine	O
zipper	O
)	O
element	O
for	O
the	O
binding	O
to	O
rRNA	O
,	O
and	O
the	O
internal	O
repeat	O
sequences	O
;	O
the	O
pentapeptide	O
QKA(A	O
/	O
S)X.	O
The	O
COOH	O
-	O
terminal	O
region	O
of	O
the	O
transcripts	O
contained	O
fifteen	O
triplet	O
repeats	O
(	O
GCT	O
;	O
alanine	O
)	O
at	O
nucleotide	O
465	O
to	O
509	O
,	O
which	O
is	O
significantly	O
expanded	O
compared	O
to	O
the	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
RL14	ARG2
gene1e	ARG2
.	O
However	O
,	O
the	O
repeat	O
number	O
was	O
all	O
the	O
same	O
among	O
the	O
normal	O
species1s	O
human	O
species1e	O
endothelial	O
cell	O
line	O
and	O
the	O
cell	O
lines	O
established	O
in	O
the	O
course	O
of	O
t	O
-	O
HUE4	O
establishment	O
.	O
A	O
single	O
band	O
with	O
about	O
800	O
bases	O
was	O
identified	O
by	O
Northern	O
blot	O
analysis	O
without	O
tissue	O
specificity	O
.	O
This	O
GCT	O
repeat	O
was	O
found	O
to	O
be	O
one	O
of	O
the	O
longest	O
uninterrupted	O
repeats	O
in	O
a	O
coding	O
sequence	O
,	O
which	O
were	O
associated	O
with	O
the	O
highest	O
degree	O
of	O
polymorphism	O
.	O

Molecular	O
cloning	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
D	ARG2
-	ARG2
dopachrome	ARG2
tautomerase	ARG2
gene1e	ARG2
cDNA	O
:	O
N	O
-	O
terminal	O
proline	O
is	O
essential	O
for	O
enzyme	O
activation	O
.	O
gene1s	ARG2
D	ARG2
-	ARG2
Dopachrome	ARG2
tautomerase	ARG2
gene1e	ARG2
converts	O
2-carboxy-2,3-dihydroindole-5,6-quinone	O
(	O
D	O
-	O
dopachrome	O
)	O
into	O
5,6-dihydroxyindole	O
.	O
This	O
protein	O
has	O
an	O
amino	O
acid	O
sequence	O
that	O
is	O
highly	O
homologous	O
with	O
that	O
of	O
gene1s	ARG2
macrophage	ARG2
migration	ARG2
inhibitory	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MIF	ARG2
gene1e	ARG2
)	O
,	O
which	O
has	O
the	O
potential	O
to	O
catalyze	O
D	O
-	O
dopachrome	O
to	O
5,6-dihydroxyindole-2-carboxylic	O
acid	O
and	O
is	O
an	O
important	O
cytokine	O
for	O
T	O
-	O
lymphocyte	O
activation	O
.	O
We	O
isolated	O
and	O
sequenced	O
a	O
566	O
bp	O
-	O
long	O
cDNA	O
encoding	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
D	ARG2
-	ARG2
dopachrome	ARG2
tautomerase	ARG2
gene1e	ARG2
.	O
The	O
cDNA	O
contains	O
an	O
open	O
reading	O
frame	O
encoding	O
118	O
amino	O
acids	O
,	O
including	O
the	O
initiator	O
methionine	O
.	O
The	O
amino	O
acid	O
sequence	O
of	O
the	O
protein	O
shares	O
80	O
%	O
homology	O
with	O
that	O
of	O
the	O
species1s	O
rat	O
species1e	O
enzyme	O
.	O
Northern	O
blot	O
analysis	O
demonstrated	O
that	O
mRNA	O
of	O
gene1s	ARG2
D	ARG2
-	ARG2
dopachrome	ARG2
tautomerase	ARG2
gene1e	ARG2
is	O
expressed	O
in	O
a	O
large	O
amount	O
in	O
the	O
liver	O
,	O
and	O
to	O
lesser	O
extent	O
in	O
other	O
organs	O
,	O
including	O
the	O
heart	O
,	O
lung	O
and	O
pancreas	O
.	O
After	O
purification	O
of	O
gene1s	ARG2
D	ARG2
-	ARG2
dopachrome	ARG2
tautomerase	ARG2
gene1e	ARG2
expressed	O
in	O
species1s	O
E.	O
coli	O
species1e	O
,	O
we	O
confirmed	O
that	O
the	O
recombinant	O
protein	O
catalyzes	O
the	O
conversion	O
of	O
D	O
-	O
dopachrome	O
to	O
5,6-dihydroxyindole	O
.	O
Its	O
catalytic	O
mechanism	O
is	O
not	O
well	O
understood	O
.	O
We	O
found	O
that	O
the	O
protein	O
completely	O
lost	O
the	O
enzyme	O
activity	O
when	O
the	O
N	O
-	O
terminal	O
proline	O
residue	O
was	O
replaced	O
with	O
alanine	O
by	O
site	O
-	O
directed	O
mutagenesis	O
.	O
This	O
fact	O
suggests	O
that	O
the	O
N	O
-	O
terminal	O
proline	O
is	O
essential	O
for	O
the	O
catalytic	O
mechanism	O
.	O
Although	O
the	O
precise	O
pathophysiological	O
function	O
of	O
gene1s	ARG2
D	ARG2
-	ARG2
dopachrome	ARG2
tautomerase	ARG2
gene1e	ARG2
remains	O
to	O
be	O
elucidated	O
,	O
the	O
present	O
results	O
could	O
contribute	O
to	O
further	O
understanding	O
of	O
isomerase	O
activity	O
in	O
relation	O
to	O
the	O
immune	O
response	O
.	O

Molecular	O
cloning	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
D	O
-	O
dopachrome	O
tautomerase	O
gene1e	O
cDNA	O
:	O
N	O
-	O
terminal	O
proline	O
is	O
essential	O
for	O
enzyme	O
activation	O
.	O
gene1s	O
D	O
-	O
Dopachrome	O
tautomerase	O
gene1e	O
converts	O
2-carboxy-2,3-dihydroindole-5,6-quinone	O
(	O
D	O
-	O
dopachrome	O
)	O
into	O
5,6-dihydroxyindole	O
.	O
This	O
protein	O
has	O
an	O
amino	O
acid	O
sequence	O
that	O
is	O
highly	O
homologous	O
with	O
that	O
of	O
gene1s	O
macrophage	O
migration	O
inhibitory	O
factor	O
gene1e	O
(	O
gene1s	O
MIF	O
gene1e	O
)	O
,	O
which	O
has	O
the	O
potential	O
to	O
catalyze	O
D	O
-	O
dopachrome	O
to	O
5,6-dihydroxyindole-2-carboxylic	O
acid	O
and	O
is	O
an	O
important	O
cytokine	O
for	O
T	O
-	O
lymphocyte	O
activation	O
.	O
We	O
isolated	O
and	O
sequenced	O
a	O
566	O
bp	O
-	O
long	O
cDNA	O
encoding	O
species1s	O
human	O
species1e	O
gene1s	O
D	O
-	O
dopachrome	O
tautomerase	O
gene1e	O
.	O
The	O
cDNA	O
contains	O
an	O
open	O
reading	O
frame	O
encoding	O
118	O
amino	O
acids	O
,	O
including	O
the	O
initiator	O
methionine	O
.	O
The	O
amino	O
acid	O
sequence	O
of	O
the	O
protein	O
shares	O
80	O
%	O
homology	O
with	O
that	O
of	O
the	O
arg1s	O
rat	O
arg1e	O
enzyme	O
.	O
Northern	O
blot	O
analysis	O
demonstrated	O
that	O
mRNA	O
of	O
gene1s	O
D	O
-	O
dopachrome	O
tautomerase	O
gene1e	O
is	O
expressed	O
in	O
a	O
large	O
amount	O
in	O
the	O
liver	O
,	O
and	O
to	O
lesser	O
extent	O
in	O
other	O
organs	O
,	O
including	O
the	O
heart	O
,	O
lung	O
and	O
pancreas	O
.	O
After	O
purification	O
of	O
gene1s	O
D	O
-	O
dopachrome	O
tautomerase	O
gene1e	O
expressed	O
in	O
species1s	O
E.	O
coli	O
species1e	O
,	O
we	O
confirmed	O
that	O
the	O
recombinant	O
protein	O
catalyzes	O
the	O
conversion	O
of	O
D	O
-	O
dopachrome	O
to	O
5,6-dihydroxyindole	O
.	O
Its	O
catalytic	O
mechanism	O
is	O
not	O
well	O
understood	O
.	O
We	O
found	O
that	O
the	O
protein	O
completely	O
lost	O
the	O
enzyme	O
activity	O
when	O
the	O
N	O
-	O
terminal	O
proline	O
residue	O
was	O
replaced	O
with	O
alanine	O
by	O
site	O
-	O
directed	O
mutagenesis	O
.	O
This	O
fact	O
suggests	O
that	O
the	O
N	O
-	O
terminal	O
proline	O
is	O
essential	O
for	O
the	O
catalytic	O
mechanism	O
.	O
Although	O
the	O
precise	O
pathophysiological	O
function	O
of	O
gene1s	O
D	O
-	O
dopachrome	O
tautomerase	O
gene1e	O
remains	O
to	O
be	O
elucidated	O
,	O
the	O
present	O
results	O
could	O
contribute	O
to	O
further	O
understanding	O
of	O
isomerase	O
activity	O
in	O
relation	O
to	O
the	O
immune	O
response	O
.	O

Molecular	O
cloning	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
D	O
-	O
dopachrome	O
tautomerase	O
gene1e	O
cDNA	O
:	O
N	O
-	O
terminal	O
proline	O
is	O
essential	O
for	O
enzyme	O
activation	O
.	O
gene1s	O
D	O
-	O
Dopachrome	O
tautomerase	O
gene1e	O
converts	O
2-carboxy-2,3-dihydroindole-5,6-quinone	O
(	O
D	O
-	O
dopachrome	O
)	O
into	O
5,6-dihydroxyindole	O
.	O
This	O
protein	O
has	O
an	O
amino	O
acid	O
sequence	O
that	O
is	O
highly	O
homologous	O
with	O
that	O
of	O
gene1s	O
macrophage	O
migration	O
inhibitory	O
factor	O
gene1e	O
(	O
gene1s	O
MIF	O
gene1e	O
)	O
,	O
which	O
has	O
the	O
potential	O
to	O
catalyze	O
D	O
-	O
dopachrome	O
to	O
5,6-dihydroxyindole-2-carboxylic	O
acid	O
and	O
is	O
an	O
important	O
cytokine	O
for	O
T	O
-	O
lymphocyte	O
activation	O
.	O
We	O
isolated	O
and	O
sequenced	O
a	O
566	O
bp	O
-	O
long	O
cDNA	O
encoding	O
species1s	O
human	O
species1e	O
gene1s	O
D	O
-	O
dopachrome	O
tautomerase	O
gene1e	O
.	O
The	O
cDNA	O
contains	O
an	O
open	O
reading	O
frame	O
encoding	O
118	O
amino	O
acids	O
,	O
including	O
the	O
initiator	O
methionine	O
.	O
The	O
amino	O
acid	O
sequence	O
of	O
the	O
protein	O
shares	O
80	O
%	O
homology	O
with	O
that	O
of	O
the	O
species1s	O
rat	O
species1e	O
enzyme	O
.	O
Northern	O
blot	O
analysis	O
demonstrated	O
that	O
mRNA	O
of	O
gene1s	O
D	O
-	O
dopachrome	O
tautomerase	O
gene1e	O
is	O
expressed	O
in	O
a	O
large	O
amount	O
in	O
the	O
liver	O
,	O
and	O
to	O
lesser	O
extent	O
in	O
other	O
organs	O
,	O
including	O
the	O
heart	O
,	O
lung	O
and	O
pancreas	O
.	O
After	O
purification	O
of	O
gene1s	O
D	O
-	O
dopachrome	O
tautomerase	O
gene1e	O
expressed	O
in	O
arg1s	O
E.	O
coli	O
arg1e	O
,	O
we	O
confirmed	O
that	O
the	O
recombinant	O
protein	O
catalyzes	O
the	O
conversion	O
of	O
D	O
-	O
dopachrome	O
to	O
5,6-dihydroxyindole	O
.	O
Its	O
catalytic	O
mechanism	O
is	O
not	O
well	O
understood	O
.	O
We	O
found	O
that	O
the	O
protein	O
completely	O
lost	O
the	O
enzyme	O
activity	O
when	O
the	O
N	O
-	O
terminal	O
proline	O
residue	O
was	O
replaced	O
with	O
alanine	O
by	O
site	O
-	O
directed	O
mutagenesis	O
.	O
This	O
fact	O
suggests	O
that	O
the	O
N	O
-	O
terminal	O
proline	O
is	O
essential	O
for	O
the	O
catalytic	O
mechanism	O
.	O
Although	O
the	O
precise	O
pathophysiological	O
function	O
of	O
gene1s	O
D	O
-	O
dopachrome	O
tautomerase	O
gene1e	O
remains	O
to	O
be	O
elucidated	O
,	O
the	O
present	O
results	O
could	O
contribute	O
to	O
further	O
understanding	O
of	O
isomerase	O
activity	O
in	O
relation	O
to	O
the	O
immune	O
response	O
.	O

Isolation	O
of	O
full	O
-	O
length	O
cDNA	O
of	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
PAX4	ARG2
gene1e	ARG2
gene	O
and	O
identification	O
of	O
its	O
species1s	O
human	O
species1e	O
homologue	O
.	O
Recent	O
genetic	O
studies	O
have	O
suggested	O
that	O
gene1s	ARG2
PAX4	ARG2
gene1e	ARG2
,	O
a	O
member	O
of	O
the	O
paired	O
box	O
(	O
PAX	O
)	O
gene	O
family	O
,	O
is	O
involved	O
in	O
the	O
mechanism	O
regulating	O
the	O
fate	O
of	O
pancreatic	O
islet	O
endocrine	O
progenitor	O
cells	O
.	O
arg1s	O
Murine	O
arg1e	O
gene1s	ARG2
PAX4	ARG2
gene1e	ARG2
was	O
originally	O
identified	O
by	O
genomic	O
screening	O
and	O
,	O
to	O
date	O
,	O
only	O
a	O
partial	O
sequence	O
of	O
gene1s	ARG2
PAX4	ARG2
gene1e	ARG2
has	O
been	O
reported	O
.	O
In	O
this	O
study	O
,	O
we	O
cloned	O
the	O
full	O
-	O
length	O
cDNA	O
of	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
PAX4	ARG2
gene1e	ARG2
by	O
RACE	O
(	O
rapid	O
amplification	O
of	O
cDNA	O
ends	O
)	O
using	O
RNA	O
from	O
arg1s	O
MIN6	O
arg1e	O
cells	O
,	O
a	O
arg1s	O
mouse	O
arg1e	O
insulinoma	O
cell	O
line	O
.	O
The	O
full	O
length	O
of	O
cDNA	O
was	O
1.38	O
kb	O
,	O
consistent	O
with	O
the	O
estimated	O
size	O
of	O
the	O
transcript	O
by	O
Northern	O
blot	O
.	O
The	O
deduced	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
PAX4	ARG2
gene1e	ARG2
protein	O
was	O
349	O
amino	O
acids	O
and	O
had	O
the	O
predicted	O
molecular	O
weight	O
of	O
38	O
kDa	O
.	O
Two	O
DNA	O
binding	O
motifs	O
,	O
a	O
128-amino	O
acid	O
paired	O
domain	O
and	O
a	O
61-amino	O
acid	O
paired	O
-	O
type	O
homeodomain	O
exhibit	O
the	O
highest	O
amino	O
acid	O
homology	O
with	O
gene1s	O
PAX6	O
gene1e	O
(	O
71.2	O
%	O
,	O
65.0	O
%	O
,	O
respectively	O
)	O
,	O
another	O
member	O
of	O
the	O
PAX	O
gene	O
family	O
.	O
However	O
,	O
the	O
sequence	O
of	O
the	O
C	O
-	O
terminal	O
segment	O
of	O
gene1s	ARG2
PAX4	ARG2
gene1e	ARG2
diverged	O
and	O
showed	O
no	O
significant	O
homology	O
with	O
any	O
other	O
known	O
PAX	O
genes	O
.	O
As	O
to	O
the	O
genomic	O
DNA	O
,	O
the	O
coding	O
region	O
of	O
the	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
PAX4	ARG2
gene1e	ARG2
gene	O
spanned	O
approximately	O
5.5	O
kb	O
and	O
was	O
composed	O
of	O
10	O
exons	O
.	O
In	O
the	O
public	O
DNA	O
database	O
,	O
a	O
species1s	O
human	O
species1e	O
cosmid	O
(	O
g1572c264	O
)	O
,	O
which	O
was	O
localized	O
on	O
species1s	O
human	O
species1e	O
chromosome	O
7q31.3	O
,	O
was	O
found	O
to	O
contain	O
a	O
gene	O
homologous	O
to	O
gene1s	O
PAX4	O
gene1e	O
.	O
The	O
nucleotide	O
and	O
protein	O
sequence	O
homologies	O
between	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
PAX4	ARG2
gene1e	ARG2
and	O
its	O
species1s	O
human	O
species1e	O
homologue	O
were	O
83.1	O
%	O
and	O
80.0	O
%	O
,	O
respectively	O
.	O
Interestingly	O
,	O
the	O
gene1s	O
ARP5	O
gene1e	O
(	O
gene1s	O
ADP	O
-	O
ribosylation	O
factor	O
5	O
gene1e	O
)	O
gene	O
was	O
also	O
found	O
in	O
the	O
same	O
cosmid	O
g1572c264	O
,	O
suggesting	O
the	O
gene1s	O
ARP5	O
gene1e	O
gene	O
to	O
be	O
adjacent	O
to	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
PAX4	O
gene1e	O
homologue	O
.	O
The	O
species1s	O
human	O
species1e	O
cosmid	O
g1572c264	O
contains	O
at	O
least	O
four	O
SSRPs	O
(	O
simple	O
sequence	O
repeat	O
polymorphism	O
)	O
,	O
which	O
could	O
be	O
used	O
for	O
genetic	O
linkage	O
studies	O
of	O
the	O
locus	O
.	O
The	O
results	O
of	O
this	O
study	O
,	O
i.e.	O
isolation	O
of	O
the	O
full	O
-	O
length	O
cDNA	O
sequence	O
of	O
gene1s	ARG2
PAX4	ARG2
gene1e	ARG2
and	O
identification	O
of	O
the	O
homologous	O
species1s	O
human	O
species1e	O
gene	O
,	O
will	O
facilitate	O
further	O
functional	O
and	O
genetic	O
studies	O
of	O
the	O
gene1s	O
PAX4	O
gene1e	O
gene	O
.	O

Isolation	O
of	O
full	O
-	O
length	O
cDNA	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	O
PAX4	O
gene1e	O
gene	O
and	O
identification	O
of	O
its	O
arg1s	O
human	O
arg1e	O
homologue	O
.	O
Recent	O
genetic	O
studies	O
have	O
suggested	O
that	O
gene1s	O
PAX4	O
gene1e	O
,	O
a	O
member	O
of	O
the	O
paired	O
box	O
(	O
PAX	O
)	O
gene	O
family	O
,	O
is	O
involved	O
in	O
the	O
mechanism	O
regulating	O
the	O
fate	O
of	O
pancreatic	O
islet	O
endocrine	O
progenitor	O
cells	O
.	O
species1s	O
Murine	O
species1e	O
gene1s	O
PAX4	O
gene1e	O
was	O
originally	O
identified	O
by	O
genomic	O
screening	O
and	O
,	O
to	O
date	O
,	O
only	O
a	O
partial	O
sequence	O
of	O
gene1s	O
PAX4	O
gene1e	O
has	O
been	O
reported	O
.	O
In	O
this	O
study	O
,	O
we	O
cloned	O
the	O
full	O
-	O
length	O
cDNA	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	O
PAX4	O
gene1e	O
by	O
RACE	O
(	O
rapid	O
amplification	O
of	O
cDNA	O
ends	O
)	O
using	O
RNA	O
from	O
species1s	O
MIN6	O
species1e	O
cells	O
,	O
a	O
species1s	O
mouse	O
species1e	O
insulinoma	O
cell	O
line	O
.	O
The	O
full	O
length	O
of	O
cDNA	O
was	O
1.38	O
kb	O
,	O
consistent	O
with	O
the	O
estimated	O
size	O
of	O
the	O
transcript	O
by	O
Northern	O
blot	O
.	O
The	O
deduced	O
species1s	O
mouse	O
species1e	O
gene1s	O
PAX4	O
gene1e	O
protein	O
was	O
349	O
amino	O
acids	O
and	O
had	O
the	O
predicted	O
molecular	O
weight	O
of	O
38	O
kDa	O
.	O
Two	O
DNA	O
binding	O
motifs	O
,	O
a	O
128-amino	O
acid	O
paired	O
domain	O
and	O
a	O
61-amino	O
acid	O
paired	O
-	O
type	O
homeodomain	O
exhibit	O
the	O
highest	O
amino	O
acid	O
homology	O
with	O
gene1s	ARG2
PAX6	ARG2
gene1e	ARG2
(	O
71.2	O
%	O
,	O
65.0	O
%	O
,	O
respectively	O
)	O
,	O
another	O
member	O
of	O
the	O
PAX	O
gene	O
family	O
.	O
However	O
,	O
the	O
sequence	O
of	O
the	O
C	O
-	O
terminal	O
segment	O
of	O
gene1s	O
PAX4	O
gene1e	O
diverged	O
and	O
showed	O
no	O
significant	O
homology	O
with	O
any	O
other	O
known	O
PAX	O
genes	O
.	O
As	O
to	O
the	O
genomic	O
DNA	O
,	O
the	O
coding	O
region	O
of	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
PAX4	O
gene1e	O
gene	O
spanned	O
approximately	O
5.5	O
kb	O
and	O
was	O
composed	O
of	O
10	O
exons	O
.	O
In	O
the	O
public	O
DNA	O
database	O
,	O
a	O
arg1s	O
human	O
arg1e	O
cosmid	O
(	O
g1572c264	O
)	O
,	O
which	O
was	O
localized	O
on	O
arg1s	O
human	O
arg1e	O
chromosome	O
7q31.3	O
,	O
was	O
found	O
to	O
contain	O
a	O
gene	O
homologous	O
to	O
gene1s	ARG2
PAX4	ARG2
gene1e	ARG2
.	O
The	O
nucleotide	O
and	O
protein	O
sequence	O
homologies	O
between	O
species1s	O
mouse	O
species1e	O
gene1s	O
PAX4	O
gene1e	O
and	O
its	O
arg1s	O
human	O
arg1e	O
homologue	O
were	O
83.1	O
%	O
and	O
80.0	O
%	O
,	O
respectively	O
.	O
Interestingly	O
,	O
the	O
gene1s	ARG2
ARP5	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ADP	ARG2
-	ARG2
ribosylation	ARG2
factor	ARG2
5	ARG2
gene1e	ARG2
)	O
gene	O
was	O
also	O
found	O
in	O
the	O
same	O
cosmid	O
g1572c264	O
,	O
suggesting	O
the	O
gene1s	ARG2
ARP5	ARG2
gene1e	ARG2
gene	O
to	O
be	O
adjacent	O
to	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
PAX4	ARG2
gene1e	ARG2
homologue	O
.	O
The	O
arg1s	O
human	O
arg1e	O
cosmid	O
g1572c264	O
contains	O
at	O
least	O
four	O
SSRPs	O
(	O
simple	O
sequence	O
repeat	O
polymorphism	O
)	O
,	O
which	O
could	O
be	O
used	O
for	O
genetic	O
linkage	O
studies	O
of	O
the	O
locus	O
.	O
The	O
results	O
of	O
this	O
study	O
,	O
i.e.	O
isolation	O
of	O
the	O
full	O
-	O
length	O
cDNA	O
sequence	O
of	O
gene1s	O
PAX4	O
gene1e	O
and	O
identification	O
of	O
the	O
homologous	O
arg1s	O
human	O
arg1e	O
gene	O
,	O
will	O
facilitate	O
further	O
functional	O
and	O
genetic	O
studies	O
of	O
the	O
gene1s	ARG2
PAX4	ARG2
gene1e	ARG2
gene	O
.	O

Identification	O
of	O
cDNAs	O
encoding	O
two	O
arg1s	O
human	O
arg1e	O
alpha	O
class	O
glutathione	O
transferases	O
(	O
gene1s	ARG2
GSTA3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
GSTA4	ARG2
gene1e	ARG2
)	O
and	O
the	O
heterologous	O
expression	O
of	O
gene1s	ARG2
GSTA4	ARG2
-	ARG2
4	ARG2
gene1e	ARG2
.	O
The	O
Expressed	O
Sequence	O
Tag	O
database	O
has	O
been	O
searched	O
for	O
examples	O
of	O
previously	O
undescribed	O
arg1s	O
human	O
arg1e	O
Alpha	O
class	O
glutathione	O
transferases	O
.	O
An	O
incomplete	O
transcript	O
of	O
the	O
previously	O
described	O
gene1s	ARG2
GSTA3	ARG2
gene1e	ARG2
gene	O
was	O
identified	O
in	O
a	O
cDNA	O
library	O
derived	O
from	O
8	O
-	O
9	O
week	O
placenta	O
.	O
This	O
indicates	O
that	O
the	O
gene1s	ARG2
GSTA3	ARG2
gene1e	ARG2
gene	O
is	O
functional	O
and	O
is	O
possibly	O
under	O
specific	O
developmental	O
regulation	O
.	O
A	O
second	O
cDNA	O
,	O
termed	O
gene1s	ARG2
GSTA4	ARG2
gene1e	ARG2
,	O
was	O
identified	O
in	O
a	O
brain	O
cDNA	O
library	O
.	O
The	O
encoded	O
gene1s	ARG2
GSTA4	ARG2
-	ARG2
4	ARG2
gene1e	ARG2
enzyme	O
was	O
expressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
and	O
was	O
found	O
to	O
be	O
immunologically	O
distinct	O
from	O
gene1s	ARG2
GSTA1	ARG2
-	ARG2
1	ARG2
gene1e	ARG2
and	O
to	O
have	O
high	O
activity	O
with	O
alk-2-enals	O
.	O
Although	O
gene1s	ARG2
GSTA4	ARG2
-	ARG2
4	ARG2
gene1e	ARG2
appears	O
to	O
be	O
functionally	O
similar	O
to	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
GST5.7	O
gene1e	O
and	O
species1s	O
rat	O
species1e	O
gene1s	O
GST8	O
-	O
8	O
Alpha	O
gene1e	O
class	O
enzymes	O
,	O
sequence	O
comparisons	O
and	O
phylogenetic	O
analysis	O
suggest	O
that	O
gene1s	ARG2
GSTA4	ARG2
-	ARG2
4	ARG2
gene1e	ARG2
may	O
be	O
a	O
member	O
of	O
a	O
distinct	O
Alpha	O
class	O
subgroup	O
.	O

Identification	O
of	O
cDNAs	O
encoding	O
two	O
species1s	O
human	O
species1e	O
alpha	O
class	O
glutathione	O
transferases	O
(	O
gene1s	O
GSTA3	O
gene1e	O
and	O
gene1s	O
GSTA4	O
gene1e	O
)	O
and	O
the	O
heterologous	O
expression	O
of	O
gene1s	O
GSTA4	O
-	O
4	O
gene1e	O
.	O
The	O
Expressed	O
Sequence	O
Tag	O
database	O
has	O
been	O
searched	O
for	O
examples	O
of	O
previously	O
undescribed	O
species1s	O
human	O
species1e	O
Alpha	O
class	O
glutathione	O
transferases	O
.	O
An	O
incomplete	O
transcript	O
of	O
the	O
previously	O
described	O
gene1s	O
GSTA3	O
gene1e	O
gene	O
was	O
identified	O
in	O
a	O
cDNA	O
library	O
derived	O
from	O
8	O
-	O
9	O
week	O
placenta	O
.	O
This	O
indicates	O
that	O
the	O
gene1s	O
GSTA3	O
gene1e	O
gene	O
is	O
functional	O
and	O
is	O
possibly	O
under	O
specific	O
developmental	O
regulation	O
.	O
A	O
second	O
cDNA	O
,	O
termed	O
gene1s	O
GSTA4	O
gene1e	O
,	O
was	O
identified	O
in	O
a	O
brain	O
cDNA	O
library	O
.	O
The	O
encoded	O
gene1s	O
GSTA4	O
-	O
4	O
gene1e	O
enzyme	O
was	O
expressed	O
in	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
and	O
was	O
found	O
to	O
be	O
immunologically	O
distinct	O
from	O
gene1s	O
GSTA1	O
-	O
1	O
gene1e	O
and	O
to	O
have	O
high	O
activity	O
with	O
alk-2-enals	O
.	O
Although	O
gene1s	O
GSTA4	O
-	O
4	O
gene1e	O
appears	O
to	O
be	O
functionally	O
similar	O
to	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
GST5.7	O
gene1e	O
and	O
species1s	O
rat	O
species1e	O
gene1s	O
GST8	O
-	O
8	O
Alpha	O
gene1e	O
class	O
enzymes	O
,	O
sequence	O
comparisons	O
and	O
phylogenetic	O
analysis	O
suggest	O
that	O
gene1s	O
GSTA4	O
-	O
4	O
gene1e	O
may	O
be	O
a	O
member	O
of	O
a	O
distinct	O
Alpha	O
class	O
subgroup	O
.	O

Identification	O
of	O
cDNAs	O
encoding	O
two	O
species1s	O
human	O
species1e	O
alpha	O
class	O
glutathione	O
transferases	O
(	O
gene1s	O
GSTA3	O
gene1e	O
and	O
gene1s	O
GSTA4	O
gene1e	O
)	O
and	O
the	O
heterologous	O
expression	O
of	O
gene1s	O
GSTA4	O
-	O
4	O
gene1e	O
.	O
The	O
Expressed	O
Sequence	O
Tag	O
database	O
has	O
been	O
searched	O
for	O
examples	O
of	O
previously	O
undescribed	O
species1s	O
human	O
species1e	O
Alpha	O
class	O
glutathione	O
transferases	O
.	O
An	O
incomplete	O
transcript	O
of	O
the	O
previously	O
described	O
gene1s	O
GSTA3	O
gene1e	O
gene	O
was	O
identified	O
in	O
a	O
cDNA	O
library	O
derived	O
from	O
8	O
-	O
9	O
week	O
placenta	O
.	O
This	O
indicates	O
that	O
the	O
gene1s	O
GSTA3	O
gene1e	O
gene	O
is	O
functional	O
and	O
is	O
possibly	O
under	O
specific	O
developmental	O
regulation	O
.	O
A	O
second	O
cDNA	O
,	O
termed	O
gene1s	O
GSTA4	O
gene1e	O
,	O
was	O
identified	O
in	O
a	O
brain	O
cDNA	O
library	O
.	O
The	O
encoded	O
gene1s	O
GSTA4	O
-	O
4	O
gene1e	O
enzyme	O
was	O
expressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
and	O
was	O
found	O
to	O
be	O
immunologically	O
distinct	O
from	O
gene1s	O
GSTA1	O
-	O
1	O
gene1e	O
and	O
to	O
have	O
high	O
activity	O
with	O
alk-2-enals	O
.	O
Although	O
gene1s	O
GSTA4	O
-	O
4	O
gene1e	O
appears	O
to	O
be	O
functionally	O
similar	O
to	O
the	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
GST5.7	ARG2
gene1e	ARG2
and	O
species1s	O
rat	O
species1e	O
gene1s	O
GST8	O
-	O
8	O
Alpha	O
gene1e	O
class	O
enzymes	O
,	O
sequence	O
comparisons	O
and	O
phylogenetic	O
analysis	O
suggest	O
that	O
gene1s	O
GSTA4	O
-	O
4	O
gene1e	O
may	O
be	O
a	O
member	O
of	O
a	O
distinct	O
Alpha	O
class	O
subgroup	O
.	O

Identification	O
of	O
cDNAs	O
encoding	O
two	O
species1s	O
human	O
species1e	O
alpha	O
class	O
glutathione	O
transferases	O
(	O
gene1s	O
GSTA3	O
gene1e	O
and	O
gene1s	O
GSTA4	O
gene1e	O
)	O
and	O
the	O
heterologous	O
expression	O
of	O
gene1s	O
GSTA4	O
-	O
4	O
gene1e	O
.	O
The	O
Expressed	O
Sequence	O
Tag	O
database	O
has	O
been	O
searched	O
for	O
examples	O
of	O
previously	O
undescribed	O
species1s	O
human	O
species1e	O
Alpha	O
class	O
glutathione	O
transferases	O
.	O
An	O
incomplete	O
transcript	O
of	O
the	O
previously	O
described	O
gene1s	O
GSTA3	O
gene1e	O
gene	O
was	O
identified	O
in	O
a	O
cDNA	O
library	O
derived	O
from	O
8	O
-	O
9	O
week	O
placenta	O
.	O
This	O
indicates	O
that	O
the	O
gene1s	O
GSTA3	O
gene1e	O
gene	O
is	O
functional	O
and	O
is	O
possibly	O
under	O
specific	O
developmental	O
regulation	O
.	O
A	O
second	O
cDNA	O
,	O
termed	O
gene1s	O
GSTA4	O
gene1e	O
,	O
was	O
identified	O
in	O
a	O
brain	O
cDNA	O
library	O
.	O
The	O
encoded	O
gene1s	O
GSTA4	O
-	O
4	O
gene1e	O
enzyme	O
was	O
expressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
and	O
was	O
found	O
to	O
be	O
immunologically	O
distinct	O
from	O
gene1s	O
GSTA1	O
-	O
1	O
gene1e	O
and	O
to	O
have	O
high	O
activity	O
with	O
alk-2-enals	O
.	O
Although	O
gene1s	O
GSTA4	O
-	O
4	O
gene1e	O
appears	O
to	O
be	O
functionally	O
similar	O
to	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
GST5.7	O
gene1e	O
and	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
GST8	ARG2
-	ARG2
8	ARG2
Alpha	ARG2
gene1e	ARG2
class	O
enzymes	O
,	O
sequence	O
comparisons	O
and	O
phylogenetic	O
analysis	O
suggest	O
that	O
gene1s	O
GSTA4	O
-	O
4	O
gene1e	O
may	O
be	O
a	O
member	O
of	O
a	O
distinct	O
Alpha	O
class	O
subgroup	O
.	O

gene1s	O
BRCA1	O
gene1e	O
protein	O
is	O
linked	O
to	O
the	O
RNA	O
polymerase	O
II	O
holoenzyme	O
complex	O
via	O
gene1s	O
RNA	O
helicase	O
A	O
gene1e	O
.	O
The	O
gene1s	O
breast	O
cancer	O
specific	O
tumour	O
suppressor	O
protein	O
gene1e	O
,	O
gene1s	O
BRCA1	O
gene1e	O
(	O
refs	O
1,2	O
)	O
,	O
activates	O
transcription	O
when	O
linked	O
with	O
a	O
DNA	O
-	O
binding	O
domain	O
and	O
is	O
a	O
component	O
of	O
the	O
RNA	O
polymerase	O
II	O
(	O
Pol	O
II	O
)	O
holoenzyme	O
.	O
We	O
show	O
here	O
that	O
gene1s	O
RNA	O
helicase	O
A	O
gene1e	O
(	O
gene1s	O
RHA	O
gene1e	O
)	O
protein	O
links	O
gene1s	O
BRCA1	O
gene1e	O
to	O
the	O
holoenzyme	O
complex	O
.	O
The	O
region	O
of	O
gene1s	O
BRCA1	O
gene1e	O
which	O
interacts	O
with	O
gene1s	O
RHA	O
gene1e	O
and	O
,	O
thus	O
,	O
the	O
holoenzyme	O
complex	O
,	O
corresponds	O
to	O
subregions	O
of	O
the	O
BRCT	O
domain	O
of	O
gene1s	O
BRCA1	O
gene1e	O
(	O
ref	O
.	O
9	O
)	O
.	O
This	O
interaction	O
was	O
shown	O
to	O
occur	O
in	O
arg1s	O
yeast	O
arg1e	O
nuclei	O
,	O
and	O
expression	O
in	O
species1s	O
human	O
species1e	O
cells	O
of	O
a	O
truncated	O
gene1s	O
RHA	O
gene1e	O
molecule	O
which	O
retains	O
binding	O
to	O
gene1s	O
BRCA1	O
gene1e	O
inhibited	O
transcriptional	O
activation	O
mediated	O
by	O
the	O
gene1s	O
BRCA1	O
gene1e	O
carboxy	O
terminus	O
.	O
These	O
data	O
are	O
the	O
first	O
to	O
identify	O
a	O
specific	O
protein	O
interaction	O
with	O
the	O
gene1s	O
BRCA1	O
gene1e	O
C	O
-	O
terminal	O
domain	O
and	O
are	O
consistent	O
with	O
the	O
model	O
that	O
gene1s	O
BRCA1	O
gene1e	O
functions	O
as	O
a	O
transcriptional	O
coactivator	O
.	O

gene1s	ARG2
BRCA1	ARG2
gene1e	ARG2
protein	O
is	O
linked	O
to	O
the	O
RNA	O
polymerase	O
II	O
holoenzyme	O
complex	O
via	O
gene1s	ARG2
RNA	ARG2
helicase	ARG2
A	ARG2
gene1e	ARG2
.	O
The	O
gene1s	ARG2
breast	ARG2
cancer	ARG2
specific	ARG2
tumour	ARG2
suppressor	ARG2
protein	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
BRCA1	ARG2
gene1e	ARG2
(	O
refs	O
1,2	O
)	O
,	O
activates	O
transcription	O
when	O
linked	O
with	O
a	O
DNA	O
-	O
binding	O
domain	O
and	O
is	O
a	O
component	O
of	O
the	O
RNA	O
polymerase	O
II	O
(	O
Pol	O
II	O
)	O
holoenzyme	O
.	O
We	O
show	O
here	O
that	O
gene1s	ARG2
RNA	ARG2
helicase	ARG2
A	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
RHA	ARG2
gene1e	ARG2
)	O
protein	O
links	O
gene1s	ARG2
BRCA1	ARG2
gene1e	ARG2
to	O
the	O
holoenzyme	O
complex	O
.	O
The	O
region	O
of	O
gene1s	ARG2
BRCA1	ARG2
gene1e	ARG2
which	O
interacts	O
with	O
gene1s	ARG2
RHA	ARG2
gene1e	ARG2
and	O
,	O
thus	O
,	O
the	O
holoenzyme	O
complex	O
,	O
corresponds	O
to	O
subregions	O
of	O
the	O
BRCT	O
domain	O
of	O
gene1s	ARG2
BRCA1	ARG2
gene1e	ARG2
(	O
ref	O
.	O
9	O
)	O
.	O
This	O
interaction	O
was	O
shown	O
to	O
occur	O
in	O
species1s	O
yeast	O
species1e	O
nuclei	O
,	O
and	O
expression	O
in	O
arg1s	O
human	O
arg1e	O
cells	O
of	O
a	O
truncated	O
gene1s	ARG2
RHA	ARG2
gene1e	ARG2
molecule	O
which	O
retains	O
binding	O
to	O
gene1s	ARG2
BRCA1	ARG2
gene1e	ARG2
inhibited	O
transcriptional	O
activation	O
mediated	O
by	O
the	O
gene1s	ARG2
BRCA1	ARG2
gene1e	ARG2
carboxy	O
terminus	O
.	O
These	O
data	O
are	O
the	O
first	O
to	O
identify	O
a	O
specific	O
protein	O
interaction	O
with	O
the	O
gene1s	ARG2
BRCA1	ARG2
gene1e	ARG2
C	O
-	O
terminal	O
domain	O
and	O
are	O
consistent	O
with	O
the	O
model	O
that	O
gene1s	ARG2
BRCA1	ARG2
gene1e	ARG2
functions	O
as	O
a	O
transcriptional	O
coactivator	O
.	O

The	O
gene1s	ARG2
IFN	ARG2
-	ARG2
inducible	ARG2
nucleoprotein	ARG2
IFI	ARG2
16	ARG2
gene1e	ARG2
is	O
expressed	O
in	O
cells	O
of	O
the	O
monocyte	O
lineage	O
,	O
but	O
is	O
rapidly	O
and	O
markedly	O
down	O
-	O
regulated	O
in	O
other	O
myeloid	O
precursor	O
populations	O
.	O
gene1s	ARG2
IFI	ARG2
16	ARG2
gene1e	ARG2
is	O
an	O
interferon	O
-	O
inducible	O
nucleoprotein	O
expressed	O
by	O
arg1s	O
human	O
arg1e	O
monocytes	O
.	O
gene1s	ARG2
IFI	ARG2
16	ARG2
gene1e	ARG2
and	O
a	O
related	O
species1s	O
mouse	O
species1e	O
protein	O
,	O
gene1s	O
p202	O
gene1e	O
,	O
control	O
cellular	O
proliferation	O
by	O
binding	O
and	O
modulating	O
the	O
functions	O
of	O
cell	O
cycle	O
regulatory	O
factors	O
including	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
and	O
the	O
gene1s	ARG2
retinoblastoma	ARG2
gene	ARG2
product	ARG2
,	ARG2
pRb	ARG2
gene1e	ARG2
.	O
In	O
this	O
study	O
,	O
we	O
examined	O
gene1s	ARG2
IFI	ARG2
16	ARG2
gene1e	ARG2
expression	O
in	O
myeloid	O
precursor	O
cells	O
cultured	O
in	O
vitro	O
in	O
colony	O
-	O
forming	O
assays	O
using	O
gene1s	ARG2
granulocyte	ARG2
(	ARG2
G-	ARG2
)	ARG2
and	ARG2
granulocyte	ARG2
-	ARG2
macrophage	ARG2
(	ARG2
GM-	ARG2
)	ARG2
colony	ARG2
-	ARG2
stimulating	ARG2
factor	ARG2
(	ARG2
CSF	ARG2
)	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
IFI	ARG2
16	ARG2
gene1e	ARG2
was	O
expressed	O
in	O
100	O
%	O
of	O
gene1s	ARG2
CD34	ARG2
gene1e	ARG2
+	O
cells	O
isolated	O
from	O
arg1s	O
human	O
arg1e	O
bone	O
marrow	O
.	O
When	O
the	O
gene1s	ARG2
CD34	ARG2
gene1e	ARG2
+	O
cells	O
were	O
induced	O
to	O
differentiate	O
,	O
two	O
sub	O
-	O
populations	O
of	O
cells	O
were	O
identified	O
by	O
two	O
-	O
color	O
cytofluorography	O
:	O
the	O
gene1s	ARG2
CD14	ARG2
gene1e	ARG2
+	O
(	O
monocytoid	O
)	O
cells	O
all	O
expressed	O
gene1s	ARG2
IFI	ARG2
16	ARG2
gene1e	ARG2
,	O
whereas	O
the	O
gene1s	ARG2
CD14	ARG2
gene1e	ARG2
-	O
(	O
polymorphonuclear	O
precursor	O
)	O
cells	O
did	O
not	O
.	O
The	O
strongest	O
expression	O
of	O
gene1s	ARG2
IFI	ARG2
16	ARG2
gene1e	ARG2
was	O
in	O
the	O
cells	O
staining	O
brightest	O
for	O
gene1s	ARG2
CD14	ARG2
gene1e	ARG2
,	O
whereas	O
depletion	O
of	O
gene1s	ARG2
CD14	ARG2
gene1e	ARG2
+	O
monocytoid	O
cells	O
from	O
mixed	O
monocytic	O
/	O
granulocytic	O
cultures	O
largely	O
abolished	O
gene1s	ARG2
IFI	ARG2
16	ARG2
gene1e	ARG2
-stained	O
cells	O
.	O
Furthermore	O
,	O
in	O
eight	O
independent	O
colony	O
-	O
forming	O
assays	O
,	O
the	O
number	O
of	O
gene1s	ARG2
IFI	ARG2
16	ARG2
gene1e	ARG2
+	O
cells	O
correlated	O
closely	O
with	O
the	O
numbers	O
of	O
monocyte	O
precursors	O
identified	O
morphologically	O
(	O
R2	O
=	O
0.99	O
)	O
,	O
but	O
was	O
unrelated	O
to	O
the	O
numbers	O
of	O
myelocytes	O
,	O
promyelocytes	O
,	O
and	O
metamyelocytes	O
;	O
nor	O
was	O
gene1s	ARG2
IFI	ARG2
16	ARG2
gene1e	ARG2
expressed	O
by	O
erythroid	O
or	O
eosinophil	O
precursors	O
.	O
We	O
conclude	O
that	O
gene1s	ARG2
IFI	ARG2
16	ARG2
gene1e	ARG2
is	O
expressed	O
in	O
gene1s	ARG2
CD34	ARG2
gene1e	ARG2
+	O
and	O
monocytoid	O
daughter	O
cells	O
,	O
but	O
is	O
rapidly	O
and	O
markedly	O
down	O
-	O
regulated	O
at	O
the	O
corresponding	O
stages	O
of	O
polymorphonuclear	O
and	O
erythroid	O
development	O
.	O
This	O
differential	O
expression	O
of	O
gene1s	ARG2
IFI	ARG2
16	ARG2
gene1e	ARG2
in	O
myeloid	O
precursor	O
subpopulations	O
and	O
its	O
perceived	O
molecular	O
properties	O
are	O
consistent	O
with	O
a	O
possible	O
role	O
in	O
regulating	O
myelopoiesis	O
.	O

The	O
gene1s	O
IFN	O
-	O
inducible	O
nucleoprotein	O
IFI	O
16	O
gene1e	O
is	O
expressed	O
in	O
cells	O
of	O
the	O
monocyte	O
lineage	O
,	O
but	O
is	O
rapidly	O
and	O
markedly	O
down	O
-	O
regulated	O
in	O
other	O
myeloid	O
precursor	O
populations	O
.	O
gene1s	O
IFI	O
16	O
gene1e	O
is	O
an	O
interferon	O
-	O
inducible	O
nucleoprotein	O
expressed	O
by	O
species1s	O
human	O
species1e	O
monocytes	O
.	O
gene1s	O
IFI	O
16	O
gene1e	O
and	O
a	O
related	O
arg1s	O
mouse	O
arg1e	O
protein	O
,	O
gene1s	ARG2
p202	ARG2
gene1e	ARG2
,	O
control	O
cellular	O
proliferation	O
by	O
binding	O
and	O
modulating	O
the	O
functions	O
of	O
cell	O
cycle	O
regulatory	O
factors	O
including	O
gene1s	O
p53	O
gene1e	O
and	O
the	O
gene1s	O
retinoblastoma	O
gene	O
product	O
,	O
pRb	O
gene1e	O
.	O
In	O
this	O
study	O
,	O
we	O
examined	O
gene1s	O
IFI	O
16	O
gene1e	O
expression	O
in	O
myeloid	O
precursor	O
cells	O
cultured	O
in	O
vitro	O
in	O
colony	O
-	O
forming	O
assays	O
using	O
gene1s	O
granulocyte	O
(	O
G-	O
)	O
and	O
granulocyte	O
-	O
macrophage	O
(	O
GM-	O
)	O
colony	O
-	O
stimulating	O
factor	O
(	O
CSF	O
)	O
gene1e	O
.	O
gene1s	O
IFI	O
16	O
gene1e	O
was	O
expressed	O
in	O
100	O
%	O
of	O
gene1s	O
CD34	O
gene1e	O
+	O
cells	O
isolated	O
from	O
species1s	O
human	O
species1e	O
bone	O
marrow	O
.	O
When	O
the	O
gene1s	O
CD34	O
gene1e	O
+	O
cells	O
were	O
induced	O
to	O
differentiate	O
,	O
two	O
sub	O
-	O
populations	O
of	O
cells	O
were	O
identified	O
by	O
two	O
-	O
color	O
cytofluorography	O
:	O
the	O
gene1s	O
CD14	O
gene1e	O
+	O
(	O
monocytoid	O
)	O
cells	O
all	O
expressed	O
gene1s	O
IFI	O
16	O
gene1e	O
,	O
whereas	O
the	O
gene1s	O
CD14	O
gene1e	O
-	O
(	O
polymorphonuclear	O
precursor	O
)	O
cells	O
did	O
not	O
.	O
The	O
strongest	O
expression	O
of	O
gene1s	O
IFI	O
16	O
gene1e	O
was	O
in	O
the	O
cells	O
staining	O
brightest	O
for	O
gene1s	O
CD14	O
gene1e	O
,	O
whereas	O
depletion	O
of	O
gene1s	O
CD14	O
gene1e	O
+	O
monocytoid	O
cells	O
from	O
mixed	O
monocytic	O
/	O
granulocytic	O
cultures	O
largely	O
abolished	O
gene1s	O
IFI	O
16	O
gene1e	O
-stained	O
cells	O
.	O
Furthermore	O
,	O
in	O
eight	O
independent	O
colony	O
-	O
forming	O
assays	O
,	O
the	O
number	O
of	O
gene1s	O
IFI	O
16	O
gene1e	O
+	O
cells	O
correlated	O
closely	O
with	O
the	O
numbers	O
of	O
monocyte	O
precursors	O
identified	O
morphologically	O
(	O
R2	O
=	O
0.99	O
)	O
,	O
but	O
was	O
unrelated	O
to	O
the	O
numbers	O
of	O
myelocytes	O
,	O
promyelocytes	O
,	O
and	O
metamyelocytes	O
;	O
nor	O
was	O
gene1s	O
IFI	O
16	O
gene1e	O
expressed	O
by	O
erythroid	O
or	O
eosinophil	O
precursors	O
.	O
We	O
conclude	O
that	O
gene1s	O
IFI	O
16	O
gene1e	O
is	O
expressed	O
in	O
gene1s	O
CD34	O
gene1e	O
+	O
and	O
monocytoid	O
daughter	O
cells	O
,	O
but	O
is	O
rapidly	O
and	O
markedly	O
down	O
-	O
regulated	O
at	O
the	O
corresponding	O
stages	O
of	O
polymorphonuclear	O
and	O
erythroid	O
development	O
.	O
This	O
differential	O
expression	O
of	O
gene1s	O
IFI	O
16	O
gene1e	O
in	O
myeloid	O
precursor	O
subpopulations	O
and	O
its	O
perceived	O
molecular	O
properties	O
are	O
consistent	O
with	O
a	O
possible	O
role	O
in	O
regulating	O
myelopoiesis	O
.	O

Overexpression	O
and	O
functional	O
characterization	O
of	O
kinin	O
receptors	O
reveal	O
subtype	O
-	O
specific	O
phosphorylation	O
.	O
G	O
protein	O
-	O
coupled	O
receptors	O
such	O
as	O
the	O
receptors	O
for	O
gene1s	ARG2
bradykinin	ARG2
gene1e	ARG2
are	O
present	O
in	O
low	O
copy	O
numbers	O
in	O
most	O
natural	O
cells	O
.	O
To	O
overcome	O
the	O
problems	O
associated	O
with	O
the	O
analysis	O
of	O
these	O
receptors	O
at	O
the	O
protein	O
level	O
,	O
we	O
used	O
highly	O
efficient	O
expression	O
systems	O
such	O
as	O
the	O
baculovirus	O
/	O
insect	O
cell	O
system	O
.	O
However	O
,	O
the	O
structural	O
and	O
functional	O
statuses	O
of	O
recombinant	O
receptors	O
have	O
often	O
remained	O
elusive	O
.	O
We	O
have	O
expressed	O
the	O
two	O
types	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
kinin	ARG2
receptors	ARG2
,	ARG2
B1	ARG2
and	ARG2
B2	ARG2
gene1e	ARG2
,	O
in	O
species1s	O
Sf9	O
species1e	O
cells	O
.	O
Both	O
receptors	O
are	O
found	O
on	O
the	O
surface	O
of	O
infected	O
cells	O
where	O
they	O
display	O
the	O
same	O
pharmacological	O
profiles	O
as	O
their	O
cognate	O
receptors	O
of	O
native	O
cells	O
.	O
The	O
functional	O
analysis	O
of	O
kinin	O
receptors	O
coupled	O
to	O
the	O
intracellular	O
signaling	O
pathways	O
of	O
species1s	O
Sf9	O
species1e	O
cells	O
revealed	O
differential	O
patterns	O
of	O
ligand	O
-	O
induced	O
phosphorylation	O
for	O
the	O
two	O
kinin	O
receptors	O
.	O
The	O
gene1s	ARG2
B1	ARG2
receptor	ARG2
gene1e	ARG2
failed	O
to	O
undergo	O
ligand	O
-	O
induced	O
phosphorylation	O
.	O
However	O
the	O
gene1s	ARG2
B2	ARG2
receptor	ARG2
gene1e	ARG2
showed	O
selective	O
phosphorylation	O
of	O
a	O
minor	O
38	O
kDa	O
band	O
and	O
lack	O
of	O
phosphorylation	O
of	O
a	O
dominant	O
33	O
kDa	O
band	O
,	O
indicating	O
that	O
only	O
a	O
fraction	O
of	O
the	O
receptor	O
protein	O
is	O
functionally	O
linked	O
to	O
the	O
kinase	O
pathway	O
.	O
A	O
striking	O
discrepancy	O
between	O
the	O
number	O
of	O
binding	O
sites	O
and	O
the	O
amount	O
of	O
receptor	O
protein	O
per	O
cell	O
(	O
molar	O
ratio	O
of	O
1:20	O
to	O
1:1000	O
)	O
indicated	O
that	O
a	O
significant	O
portion	O
of	O
kinin	O
receptors	O
is	O
associated	O
with	O
the	O
intracellular	O
compartments	O
of	O
species1s	O
Sf9	O
species1e	O
cells	O
.	O
Pulse	O
-	O
chase	O
and	O
immunoprecipitation	O
experiments	O
demonstrated	O
that	O
the	O
heterogeneity	O
of	O
recombinant	O
receptors	O
is	O
not	O
due	O
to	O
proteolytic	O
processing	O
but	O
likely	O
reflects	O
incomplete	O
or	O
lacking	O
N	O
-	O
glycosylation	O
.	O
We	O
conclude	O
that	O
the	O
baculovirus	O
/	O
Sf9	O
system	O
is	O
suitable	O
for	O
the	O
recombinant	O
expression	O
and	O
functional	O
analysis	O
of	O
kinin	O
receptors	O
though	O
limitations	O
of	O
the	O
system	O
have	O
to	O
be	O
considered	O
.	O

Overexpression	O
and	O
functional	O
characterization	O
of	O
kinin	O
receptors	O
reveal	O
subtype	O
-	O
specific	O
phosphorylation	O
.	O
G	O
protein	O
-	O
coupled	O
receptors	O
such	O
as	O
the	O
receptors	O
for	O
gene1s	O
bradykinin	O
gene1e	O
are	O
present	O
in	O
low	O
copy	O
numbers	O
in	O
most	O
natural	O
cells	O
.	O
To	O
overcome	O
the	O
problems	O
associated	O
with	O
the	O
analysis	O
of	O
these	O
receptors	O
at	O
the	O
protein	O
level	O
,	O
we	O
used	O
highly	O
efficient	O
expression	O
systems	O
such	O
as	O
the	O
baculovirus	O
/	O
insect	O
cell	O
system	O
.	O
However	O
,	O
the	O
structural	O
and	O
functional	O
statuses	O
of	O
recombinant	O
receptors	O
have	O
often	O
remained	O
elusive	O
.	O
We	O
have	O
expressed	O
the	O
two	O
types	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
kinin	O
receptors	O
,	O
B1	O
and	O
B2	O
gene1e	O
,	O
in	O
arg1s	O
Sf9	O
arg1e	O
cells	O
.	O
Both	O
receptors	O
are	O
found	O
on	O
the	O
surface	O
of	O
infected	O
cells	O
where	O
they	O
display	O
the	O
same	O
pharmacological	O
profiles	O
as	O
their	O
cognate	O
receptors	O
of	O
native	O
cells	O
.	O
The	O
functional	O
analysis	O
of	O
kinin	O
receptors	O
coupled	O
to	O
the	O
intracellular	O
signaling	O
pathways	O
of	O
arg1s	O
Sf9	O
arg1e	O
cells	O
revealed	O
differential	O
patterns	O
of	O
ligand	O
-	O
induced	O
phosphorylation	O
for	O
the	O
two	O
kinin	O
receptors	O
.	O
The	O
gene1s	O
B1	O
receptor	O
gene1e	O
failed	O
to	O
undergo	O
ligand	O
-	O
induced	O
phosphorylation	O
.	O
However	O
the	O
gene1s	O
B2	O
receptor	O
gene1e	O
showed	O
selective	O
phosphorylation	O
of	O
a	O
minor	O
38	O
kDa	O
band	O
and	O
lack	O
of	O
phosphorylation	O
of	O
a	O
dominant	O
33	O
kDa	O
band	O
,	O
indicating	O
that	O
only	O
a	O
fraction	O
of	O
the	O
receptor	O
protein	O
is	O
functionally	O
linked	O
to	O
the	O
kinase	O
pathway	O
.	O
A	O
striking	O
discrepancy	O
between	O
the	O
number	O
of	O
binding	O
sites	O
and	O
the	O
amount	O
of	O
receptor	O
protein	O
per	O
cell	O
(	O
molar	O
ratio	O
of	O
1:20	O
to	O
1:1000	O
)	O
indicated	O
that	O
a	O
significant	O
portion	O
of	O
kinin	O
receptors	O
is	O
associated	O
with	O
the	O
intracellular	O
compartments	O
of	O
arg1s	O
Sf9	O
arg1e	O
cells	O
.	O
Pulse	O
-	O
chase	O
and	O
immunoprecipitation	O
experiments	O
demonstrated	O
that	O
the	O
heterogeneity	O
of	O
recombinant	O
receptors	O
is	O
not	O
due	O
to	O
proteolytic	O
processing	O
but	O
likely	O
reflects	O
incomplete	O
or	O
lacking	O
N	O
-	O
glycosylation	O
.	O
We	O
conclude	O
that	O
the	O
baculovirus	O
/	O
Sf9	O
system	O
is	O
suitable	O
for	O
the	O
recombinant	O
expression	O
and	O
functional	O
analysis	O
of	O
kinin	O
receptors	O
though	O
limitations	O
of	O
the	O
system	O
have	O
to	O
be	O
considered	O
.	O

Isolation	O
of	O
gene1s	O
hMRE11B	O
gene1e	O
:	O
failure	O
to	O
complement	O
arg1s	O
yeast	O
arg1e	O
gene1s	ARG2
mre11	ARG2
gene1e	ARG2
defects	O
due	O
to	O
species	O
-	O
specific	O
protein	O
interactions	O
.	O
The	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
gene1s	ARG2
MRE11	ARG2
gene1e	ARG2
gene	O
plays	O
an	O
important	O
role	O
in	O
meiotic	O
recombination	O
,	O
mitotic	O
DNA	O
repair	O
and	O
telomere	O
maintenance	O
.	O
We	O
present	O
the	O
isolation	O
of	O
gene1s	O
hMRE11B	O
gene1e	O
cDNA	O
from	O
a	O
species1s	O
human	O
species1e	O
species1s	O
HeLa	O
species1e	O
cell	O
cDNA	O
library	O
as	O
an	O
gene1s	ARG2
MRE11	ARG2
gene1e	ARG2
homolog	O
.	O
Compared	O
to	O
the	O
previously	O
identified	O
gene1s	O
hMRE11	O
gene1e	O
,	O
gene1s	O
hMRE11B	O
gene1e	O
contains	O
an	O
additional	O
84bp	O
sequence	O
that	O
results	O
in	O
a	O
28	O
amino	O
-	O
acid	O
insertion	O
close	O
to	O
the	O
C	O
-	O
terminus	O
.	O
The	O
expression	O
pattern	O
of	O
gene1s	O
hMRE11B	O
gene1e	O
in	O
different	O
tissues	O
shows	O
the	O
presence	O
of	O
two	O
mRNA	O
species	O
of	O
approx	O
.	O
2.6	O
and	O
7.5	O
kb	O
.	O
Overexpression	O
of	O
gene1s	O
hMRE11B	O
gene1e	O
does	O
not	O
complement	O
the	O
alkylation	O
sensitivity	O
of	O
the	O
gene1s	ARG2
mre11	ARG2
gene1e	ARG2
null	O
and	O
temperature	O
-	O
sensitive	O
mutant	O
strains	O
.	O
In	O
this	O
study	O
,	O
we	O
examine	O
factors	O
that	O
may	O
explain	O
this	O
lack	O
of	O
complementation	O
.	O
First	O
,	O
both	O
Northern	O
and	O
Western	O
analyses	O
rule	O
out	O
the	O
lack	O
of	O
gene1s	O
hMRE11B	O
gene1e	O
transcription	O
and/or	O
translation	O
in	O
arg1s	O
yeast	O
arg1e	O
.	O
Second	O
,	O
we	O
demonstrate	O
that	O
gene1s	O
hMre11B	O
gene1e	O
,	O
like	O
the	O
arg1s	O
yeast	O
arg1e	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
protein	O
,	O
dimerizes	O
in	O
vivo	O
in	O
a	O
arg1s	O
yeast	O
arg1e	O
two	O
-	O
hybrid	O
system	O
.	O
This	O
dimerization	O
requires	O
the	O
C	O
-	O
terminal	O
one	O
-	O
third	O
of	O
gene1s	O
hMre11B	O
gene1e	O
protein	O
,	O
which	O
includes	O
the	O
28	O
amino	O
acids	O
absent	O
in	O
gene1s	O
hMre11	O
gene1e	O
.	O
However	O
,	O
gene1s	O
hMre11B	O
gene1e	O
does	O
not	O
interact	O
with	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Rad50	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Xrs2	ARG2
gene1e	ARG2
.	O
Hence	O
,	O
the	O
lack	O
of	O
protein	O
-	O
protein	O
interaction	O
between	O
gene1s	O
hMre11B	O
gene1e	O
and	O
the	O
arg1s	O
yeast	O
arg1e	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Rad50	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Xrs2	ARG2
gene1e	ARG2
may	O
explain	O
the	O
inability	O
of	O
gene1s	O
hMRE11B	O
gene1e	O
to	O
complement	O
the	O
arg1s	O
yeast	O
arg1e	O
gene1s	ARG2
mre11	ARG2
gene1e	ARG2
mutants	O
.	O
We	O
rule	O
out	O
the	O
hypothesis	O
that	O
the	O
lack	O
of	O
interaction	O
and	O
,	O
in	O
turn	O
of	O
complementation	O
,	O
is	O
due	O
to	O
the	O
absence	O
of	O
sequence	O
homology	O
at	O
the	O
C	O
-	O
terminal	O
domain	O
of	O
gene1s	O
hMre11B	O
gene1e	O
compared	O
to	O
the	O
arg1s	O
yeast	O
arg1e	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
.	O
Instead	O
,	O
we	O
propose	O
that	O
the	O
C	O
-	O
terminus	O
of	O
gene1s	O
hMre11B	O
gene1e	O
participates	O
in	O
protein	O
-	O
protein	O
interaction	O
and	O
functions	O
in	O
a	O
species	O
-	O
specific	O
manner	O
.	O

Isolation	O
of	O
gene1s	ARG2
hMRE11B	ARG2
gene1e	ARG2
:	O
failure	O
to	O
complement	O
species1s	O
yeast	O
species1e	O
gene1s	O
mre11	O
gene1e	O
defects	O
due	O
to	O
species	O
-	O
specific	O
protein	O
interactions	O
.	O
The	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
gene1s	O
MRE11	O
gene1e	O
gene	O
plays	O
an	O
important	O
role	O
in	O
meiotic	O
recombination	O
,	O
mitotic	O
DNA	O
repair	O
and	O
telomere	O
maintenance	O
.	O
We	O
present	O
the	O
isolation	O
of	O
gene1s	ARG2
hMRE11B	ARG2
gene1e	ARG2
cDNA	O
from	O
a	O
arg1s	O
human	O
arg1e	O
arg1s	O
HeLa	O
arg1e	O
cell	O
cDNA	O
library	O
as	O
an	O
gene1s	O
MRE11	O
gene1e	O
homolog	O
.	O
Compared	O
to	O
the	O
previously	O
identified	O
gene1s	ARG2
hMRE11	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
hMRE11B	ARG2
gene1e	ARG2
contains	O
an	O
additional	O
84bp	O
sequence	O
that	O
results	O
in	O
a	O
28	O
amino	O
-	O
acid	O
insertion	O
close	O
to	O
the	O
C	O
-	O
terminus	O
.	O
The	O
expression	O
pattern	O
of	O
gene1s	ARG2
hMRE11B	ARG2
gene1e	ARG2
in	O
different	O
tissues	O
shows	O
the	O
presence	O
of	O
two	O
mRNA	O
species	O
of	O
approx	O
.	O
2.6	O
and	O
7.5	O
kb	O
.	O
Overexpression	O
of	O
gene1s	ARG2
hMRE11B	ARG2
gene1e	ARG2
does	O
not	O
complement	O
the	O
alkylation	O
sensitivity	O
of	O
the	O
gene1s	O
mre11	O
gene1e	O
null	O
and	O
temperature	O
-	O
sensitive	O
mutant	O
strains	O
.	O
In	O
this	O
study	O
,	O
we	O
examine	O
factors	O
that	O
may	O
explain	O
this	O
lack	O
of	O
complementation	O
.	O
First	O
,	O
both	O
Northern	O
and	O
Western	O
analyses	O
rule	O
out	O
the	O
lack	O
of	O
gene1s	ARG2
hMRE11B	ARG2
gene1e	ARG2
transcription	O
and/or	O
translation	O
in	O
species1s	O
yeast	O
species1e	O
.	O
Second	O
,	O
we	O
demonstrate	O
that	O
gene1s	ARG2
hMre11B	ARG2
gene1e	ARG2
,	O
like	O
the	O
species1s	O
yeast	O
species1e	O
gene1s	O
Mre11	O
gene1e	O
protein	O
,	O
dimerizes	O
in	O
vivo	O
in	O
a	O
species1s	O
yeast	O
species1e	O
two	O
-	O
hybrid	O
system	O
.	O
This	O
dimerization	O
requires	O
the	O
C	O
-	O
terminal	O
one	O
-	O
third	O
of	O
gene1s	ARG2
hMre11B	ARG2
gene1e	ARG2
protein	O
,	O
which	O
includes	O
the	O
28	O
amino	O
acids	O
absent	O
in	O
gene1s	ARG2
hMre11	ARG2
gene1e	ARG2
.	O
However	O
,	O
gene1s	ARG2
hMre11B	ARG2
gene1e	ARG2
does	O
not	O
interact	O
with	O
gene1s	O
Mre11	O
gene1e	O
,	O
gene1s	O
Rad50	O
gene1e	O
and	O
gene1s	O
Xrs2	O
gene1e	O
.	O
Hence	O
,	O
the	O
lack	O
of	O
protein	O
-	O
protein	O
interaction	O
between	O
gene1s	ARG2
hMre11B	ARG2
gene1e	ARG2
and	O
the	O
species1s	O
yeast	O
species1e	O
gene1s	O
Mre11	O
gene1e	O
,	O
gene1s	O
Rad50	O
gene1e	O
,	O
and	O
gene1s	O
Xrs2	O
gene1e	O
may	O
explain	O
the	O
inability	O
of	O
gene1s	ARG2
hMRE11B	ARG2
gene1e	ARG2
to	O
complement	O
the	O
species1s	O
yeast	O
species1e	O
gene1s	O
mre11	O
gene1e	O
mutants	O
.	O
We	O
rule	O
out	O
the	O
hypothesis	O
that	O
the	O
lack	O
of	O
interaction	O
and	O
,	O
in	O
turn	O
of	O
complementation	O
,	O
is	O
due	O
to	O
the	O
absence	O
of	O
sequence	O
homology	O
at	O
the	O
C	O
-	O
terminal	O
domain	O
of	O
gene1s	ARG2
hMre11B	ARG2
gene1e	ARG2
compared	O
to	O
the	O
species1s	O
yeast	O
species1e	O
gene1s	O
Mre11	O
gene1e	O
.	O
Instead	O
,	O
we	O
propose	O
that	O
the	O
C	O
-	O
terminus	O
of	O
gene1s	ARG2
hMre11B	ARG2
gene1e	ARG2
participates	O
in	O
protein	O
-	O
protein	O
interaction	O
and	O
functions	O
in	O
a	O
species	O
-	O
specific	O
manner	O
.	O

gene1s	O
XCE	O
gene1e	O
,	O
a	O
new	O
member	O
of	O
the	O
endothelin	O
-	O
converting	O
enzyme	O
and	O
neutral	O
endopeptidase	O
family	O
,	O
is	O
preferentially	O
expressed	O
in	O
the	O
CNS	O
.	O
In	O
the	O
present	O
study	O
,	O
we	O
have	O
isolated	O
a	O
cDNA	O
encoding	O
a	O
novel	O
member	O
of	O
the	O
family	O
of	O
zinc	O
metallopeptidases	O
that	O
includes	O
neutral	O
endopeptidase	O
and	O
endothelin	O
-	O
converting	O
enzyme	O
.	O
The	O
predicted	O
amino	O
-	O
acid	O
sequence	O
of	O
this	O
enzyme	O
,	O
termed	O
gene1s	O
XCE	O
gene1e	O
,	O
consists	O
of	O
775	O
amino	O
-	O
acids	O
with	O
a	O
single	O
putative	O
membrane	O
-	O
spanning	O
region	O
,	O
an	O
N	O
-	O
terminal	O
cytoplasmic	O
domain	O
of	O
59	O
residues	O
,	O
and	O
a	O
large	O
luminal	O
domain	O
that	O
contains	O
a	O
characteristic	O
zinc	O
-	O
binding	O
motif	O
.	O
Western	O
blot	O
analysis	O
of	O
cells	O
stably	O
expressing	O
this	O
new	O
metallopeptidase	O
revealed	O
a	O
glycosylated	O
protein	O
of	O
approximately	O
95	O
kDa	O
.	O
gene1s	O
XCE	O
gene1e	O
mRNA	O
was	O
found	O
to	O
be	O
predominantly	O
expressed	O
in	O
the	O
central	O
nervous	O
system	O
,	O
sympathetic	O
ganglia	O
and	O
in	O
uterine	O
subepithelial	O
cells	O
.	O
In	O
the	O
arg1s	O
rat	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
CNS	O
,	O
a	O
very	O
specific	O
pattern	O
of	O
neuronal	O
labelling	O
(	O
in	O
presumptive	O
cholinergic	O
interneurons	O
of	O
basal	O
ganglia	O
,	O
basal	O
forebrain	O
neurons	O
,	O
as	O
well	O
as	O
brainstem	O
and	O
spinal	O
cord	O
motoneurons	O
)	O
was	O
detected	O
by	O
in	O
situ	O
hybridization	O
histochemistry	O
.	O
The	O
enzyme	O
substrate	O
,	O
as	O
yet	O
unidentified	O
,	O
might	O
be	O
found	O
among	O
the	O
numerous	O
neuropeptide	O
transmitters	O
which	O
are	O
colocalized	O
with	O
acetylcholine	O
in	O
these	O
neurons	O
.	O

gene1s	ARG2
XCE	ARG2
gene1e	ARG2
,	O
a	O
new	O
member	O
of	O
the	O
endothelin	O
-	O
converting	O
enzyme	O
and	O
neutral	O
endopeptidase	O
family	O
,	O
is	O
preferentially	O
expressed	O
in	O
the	O
CNS	O
.	O
In	O
the	O
present	O
study	O
,	O
we	O
have	O
isolated	O
a	O
cDNA	O
encoding	O
a	O
novel	O
member	O
of	O
the	O
family	O
of	O
zinc	O
metallopeptidases	O
that	O
includes	O
neutral	O
endopeptidase	O
and	O
endothelin	O
-	O
converting	O
enzyme	O
.	O
The	O
predicted	O
amino	O
-	O
acid	O
sequence	O
of	O
this	O
enzyme	O
,	O
termed	O
gene1s	ARG2
XCE	ARG2
gene1e	ARG2
,	O
consists	O
of	O
775	O
amino	O
-	O
acids	O
with	O
a	O
single	O
putative	O
membrane	O
-	O
spanning	O
region	O
,	O
an	O
N	O
-	O
terminal	O
cytoplasmic	O
domain	O
of	O
59	O
residues	O
,	O
and	O
a	O
large	O
luminal	O
domain	O
that	O
contains	O
a	O
characteristic	O
zinc	O
-	O
binding	O
motif	O
.	O
Western	O
blot	O
analysis	O
of	O
cells	O
stably	O
expressing	O
this	O
new	O
metallopeptidase	O
revealed	O
a	O
glycosylated	O
protein	O
of	O
approximately	O
95	O
kDa	O
.	O
gene1s	ARG2
XCE	ARG2
gene1e	ARG2
mRNA	O
was	O
found	O
to	O
be	O
predominantly	O
expressed	O
in	O
the	O
central	O
nervous	O
system	O
,	O
sympathetic	O
ganglia	O
and	O
in	O
uterine	O
subepithelial	O
cells	O
.	O
In	O
the	O
species1s	O
rat	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
CNS	O
,	O
a	O
very	O
specific	O
pattern	O
of	O
neuronal	O
labelling	O
(	O
in	O
presumptive	O
cholinergic	O
interneurons	O
of	O
basal	O
ganglia	O
,	O
basal	O
forebrain	O
neurons	O
,	O
as	O
well	O
as	O
brainstem	O
and	O
spinal	O
cord	O
motoneurons	O
)	O
was	O
detected	O
by	O
in	O
situ	O
hybridization	O
histochemistry	O
.	O
The	O
enzyme	O
substrate	O
,	O
as	O
yet	O
unidentified	O
,	O
might	O
be	O
found	O
among	O
the	O
numerous	O
neuropeptide	O
transmitters	O
which	O
are	O
colocalized	O
with	O
acetylcholine	O
in	O
these	O
neurons	O
.	O

Mutations	O
in	O
the	O
gene1s	ARG2
inosine	ARG2
monophosphate	ARG2
dehydrogenase	ARG2
1	ARG2
gene1e	ARG2
gene	O
(	O
gene1s	ARG2
IMPDH1	ARG2
gene1e	ARG2
)	O
cause	O
the	O
gene1s	ARG2
RP10	ARG2
gene1e	ARG2
form	O
of	O
autosomal	O
dominant	O
retinitis	O
pigmentosa	O
.	O
Autosomal	O
dominant	O
retinitis	O
pigmentosa	O
(	O
adRP	O
)	O
is	O
a	O
heterogeneous	O
set	O
of	O
progressive	O
retinopathies	O
caused	O
by	O
several	O
distinct	O
genes	O
.	O
One	O
locus	O
,	O
the	O
gene1s	ARG2
RP10	ARG2
gene1e	ARG2
form	O
of	O
adRP	O
,	O
maps	O
to	O
arg1s	O
human	O
arg1e	O
chromosome	O
7q31.1	O
and	O
may	O
account	O
for	O
5	O
-	O
10	O
%	O
of	O
adRP	O
cases	O
among	O
Americans	O
and	O
Europeans	O
.	O
We	O
identified	O
two	O
American	O
families	O
with	O
the	O
gene1s	ARG2
RP10	ARG2
gene1e	ARG2
form	O
of	O
adRP	O
by	O
linkage	O
mapping	O
and	O
used	O
these	O
families	O
to	O
reduce	O
the	O
linkage	O
interval	O
to	O
3.45	O
Mb	O
between	O
the	O
flanking	O
markers	O
D7S686	O
and	O
RP	O
-	O
STR8	O
.	O
Sequence	O
and	O
transcript	O
analysis	O
identified	O
54	O
independent	O
genes	O
within	O
this	O
region	O
,	O
at	O
least	O
10	O
of	O
which	O
are	O
retinal	O
-	O
expressed	O
and	O
thus	O
candidates	O
for	O
the	O
gene1s	ARG2
RP10	ARG2
gene1e	ARG2
gene	O
.	O
A	O
screen	O
of	O
retinal	O
transcripts	O
comparing	O
retinas	O
from	O
normal	O
species1s	O
mice	O
species1e	O
to	O
retinas	O
from	O
gene1s	ARG2
crx	ARG2
gene1e	ARG2
-/	O
gene1s	ARG2
crx	ARG2
gene1e	ARG2
-	O
knockout	O
species1s	O
mice	O
species1e	O
(	O
with	O
poorly	O
differentiated	O
photoreceptors	O
)	O
demonstrated	O
a	O
6-fold	O
reduction	O
in	O
one	O
candidate	O
,	O
gene1s	ARG2
inosine	ARG2
monophosphate	ARG2
dehydrogenase	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IMPDH1	ARG2
gene1e	ARG2
;	O
EC	O
1.1.1.205	O
)	O
.	O
Since	O
many	O
of	O
the	O
genes	O
known	O
to	O
cause	O
retinitis	O
pigmentosa	O
are	O
under	O
gene1s	ARG2
CRX	ARG2
gene1e	ARG2
control	O
in	O
photoreceptors	O
,	O
gene1s	ARG2
IMPDH1	ARG2
gene1e	ARG2
became	O
a	O
high	O
-	O
priority	O
candidate	O
for	O
mutation	O
screening	O
.	O
DNA	O
sequencing	O
of	O
affected	O
individuals	O
from	O
the	O
two	O
American	O
gene1s	ARG2
RP10	ARG2
gene1e	ARG2
families	O
revealed	O
a	O
GAC-->AAC	O
transition	O
in	O
codon	O
226	O
substituting	O
an	O
asparagine	O
for	O
an	O
aspartic	O
acid	O
in	O
both	O
families	O
.	O
The	O
identical	O
mutation	O
was	O
also	O
found	O
in	O
a	O
British	O
gene1s	ARG2
RP10	ARG2
gene1e	ARG2
family	O
.	O
The	O
Asp226Asn	O
missense	O
mutation	O
is	O
present	O
in	O
all	O
affected	O
individuals	O
tested	O
and	O
absent	O
from	O
unaffected	O
controls	O
.	O
The	O
aspartic	O
acid	O
at	O
codon	O
226	O
is	O
conserved	O
in	O
all	O
IMPDH	O
genes	O
,	O
in	O
all	O
species	O
examined	O
,	O
including	O
bacteria	O
,	O
suggesting	O
that	O
this	O
mutation	O
is	O
highly	O
deleterious	O
.	O
Subsequent	O
screening	O
of	O
probands	O
from	O
60	O
other	O
adRP	O
families	O
revealed	O
an	O
additional	O
family	O
with	O
this	O
mutation	O
,	O
confirming	O
its	O
association	O
with	O
retinitis	O
pigmentosa	O
and	O
the	O
relatively	O
high	O
frequency	O
of	O
this	O
mutation	O
.	O
Another	O
gene1s	ARG2
IMPDH1	ARG2
gene1e	ARG2
substitution	O
,	O
Val268Ile	O
,	O
was	O
also	O
observed	O
in	O
this	O
cohort	O
of	O
arg1s	O
patients	O
arg1e	O
but	O
not	O
in	O
controls	O
.	O
gene1s	ARG2
IMPDH1	ARG2
gene1e	ARG2
is	O
a	O
ubiquitously	O
expressed	O
enzyme	O
,	O
functioning	O
as	O
a	O
homotetramer	O
,	O
which	O
catalyzed	O
the	O
rate	O
-	O
limiting	O
step	O
in	O
de	O
novo	O
synthesis	O
of	O
guanine	O
nucleotides	O
.	O
As	O
such	O
,	O
it	O
plays	O
an	O
important	O
role	O
in	O
cyclic	O
nucleoside	O
metabolism	O
within	O
photoreceptors	O
.	O
Several	O
classes	O
of	O
drugs	O
are	O
known	O
to	O
affect	O
IMPDH	O
isoenzymes	O
,	O
including	O
nucleotide	O
and	O
NAD	O
analogs	O
,	O
suggesting	O
that	O
small	O
-	O
molecule	O
therapy	O
may	O
be	O
available	O
,	O
one	O
day	O
,	O
for	O
gene1s	ARG2
RP10	ARG2
gene1e	ARG2
arg1s	O
patients	O
arg1e	O
.	O

Mutations	O
in	O
the	O
gene1s	O
inosine	O
monophosphate	O
dehydrogenase	O
1	O
gene1e	O
gene	O
(	O
gene1s	O
IMPDH1	O
gene1e	O
)	O
cause	O
the	O
gene1s	O
RP10	O
gene1e	O
form	O
of	O
autosomal	O
dominant	O
retinitis	O
pigmentosa	O
.	O
Autosomal	O
dominant	O
retinitis	O
pigmentosa	O
(	O
adRP	O
)	O
is	O
a	O
heterogeneous	O
set	O
of	O
progressive	O
retinopathies	O
caused	O
by	O
several	O
distinct	O
genes	O
.	O
One	O
locus	O
,	O
the	O
gene1s	O
RP10	O
gene1e	O
form	O
of	O
adRP	O
,	O
maps	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
7q31.1	O
and	O
may	O
account	O
for	O
5	O
-	O
10	O
%	O
of	O
adRP	O
cases	O
among	O
Americans	O
and	O
Europeans	O
.	O
We	O
identified	O
two	O
American	O
families	O
with	O
the	O
gene1s	O
RP10	O
gene1e	O
form	O
of	O
adRP	O
by	O
linkage	O
mapping	O
and	O
used	O
these	O
families	O
to	O
reduce	O
the	O
linkage	O
interval	O
to	O
3.45	O
Mb	O
between	O
the	O
flanking	O
markers	O
D7S686	O
and	O
RP	O
-	O
STR8	O
.	O
Sequence	O
and	O
transcript	O
analysis	O
identified	O
54	O
independent	O
genes	O
within	O
this	O
region	O
,	O
at	O
least	O
10	O
of	O
which	O
are	O
retinal	O
-	O
expressed	O
and	O
thus	O
candidates	O
for	O
the	O
gene1s	O
RP10	O
gene1e	O
gene	O
.	O
A	O
screen	O
of	O
retinal	O
transcripts	O
comparing	O
retinas	O
from	O
normal	O
arg1s	O
mice	O
arg1e	O
to	O
retinas	O
from	O
gene1s	O
crx	O
gene1e	O
-/	O
gene1s	O
crx	O
gene1e	O
-	O
knockout	O
arg1s	O
mice	O
arg1e	O
(	O
with	O
poorly	O
differentiated	O
photoreceptors	O
)	O
demonstrated	O
a	O
6-fold	O
reduction	O
in	O
one	O
candidate	O
,	O
gene1s	O
inosine	O
monophosphate	O
dehydrogenase	O
1	O
gene1e	O
(	O
gene1s	O
IMPDH1	O
gene1e	O
;	O
EC	O
1.1.1.205	O
)	O
.	O
Since	O
many	O
of	O
the	O
genes	O
known	O
to	O
cause	O
retinitis	O
pigmentosa	O
are	O
under	O
gene1s	O
CRX	O
gene1e	O
control	O
in	O
photoreceptors	O
,	O
gene1s	O
IMPDH1	O
gene1e	O
became	O
a	O
high	O
-	O
priority	O
candidate	O
for	O
mutation	O
screening	O
.	O
DNA	O
sequencing	O
of	O
affected	O
individuals	O
from	O
the	O
two	O
American	O
gene1s	O
RP10	O
gene1e	O
families	O
revealed	O
a	O
GAC-->AAC	O
transition	O
in	O
codon	O
226	O
substituting	O
an	O
asparagine	O
for	O
an	O
aspartic	O
acid	O
in	O
both	O
families	O
.	O
The	O
identical	O
mutation	O
was	O
also	O
found	O
in	O
a	O
British	O
gene1s	O
RP10	O
gene1e	O
family	O
.	O
The	O
Asp226Asn	O
missense	O
mutation	O
is	O
present	O
in	O
all	O
affected	O
individuals	O
tested	O
and	O
absent	O
from	O
unaffected	O
controls	O
.	O
The	O
aspartic	O
acid	O
at	O
codon	O
226	O
is	O
conserved	O
in	O
all	O
IMPDH	O
genes	O
,	O
in	O
all	O
species	O
examined	O
,	O
including	O
bacteria	O
,	O
suggesting	O
that	O
this	O
mutation	O
is	O
highly	O
deleterious	O
.	O
Subsequent	O
screening	O
of	O
probands	O
from	O
60	O
other	O
adRP	O
families	O
revealed	O
an	O
additional	O
family	O
with	O
this	O
mutation	O
,	O
confirming	O
its	O
association	O
with	O
retinitis	O
pigmentosa	O
and	O
the	O
relatively	O
high	O
frequency	O
of	O
this	O
mutation	O
.	O
Another	O
gene1s	O
IMPDH1	O
gene1e	O
substitution	O
,	O
Val268Ile	O
,	O
was	O
also	O
observed	O
in	O
this	O
cohort	O
of	O
species1s	O
patients	O
species1e	O
but	O
not	O
in	O
controls	O
.	O
gene1s	O
IMPDH1	O
gene1e	O
is	O
a	O
ubiquitously	O
expressed	O
enzyme	O
,	O
functioning	O
as	O
a	O
homotetramer	O
,	O
which	O
catalyzed	O
the	O
rate	O
-	O
limiting	O
step	O
in	O
de	O
novo	O
synthesis	O
of	O
guanine	O
nucleotides	O
.	O
As	O
such	O
,	O
it	O
plays	O
an	O
important	O
role	O
in	O
cyclic	O
nucleoside	O
metabolism	O
within	O
photoreceptors	O
.	O
Several	O
classes	O
of	O
drugs	O
are	O
known	O
to	O
affect	O
IMPDH	O
isoenzymes	O
,	O
including	O
nucleotide	O
and	O
NAD	O
analogs	O
,	O
suggesting	O
that	O
small	O
-	O
molecule	O
therapy	O
may	O
be	O
available	O
,	O
one	O
day	O
,	O
for	O
gene1s	O
RP10	O
gene1e	O
species1s	O
patients	O
species1e	O
.	O

Alternative	O
splicing	O
in	O
the	O
N	O
-	O
terminus	O
of	O
Alzheimer	O
's	O
gene1s	ARG2
presenilin	ARG2
1	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
Presenilin	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
)	O
is	O
mutated	O
in	O
the	O
majority	O
of	O
familial	O
cases	O
of	O
Alzheimer	O
disease	O
(	O
AD	O
)	O
.	O
Although	O
it	O
is	O
clear	O
that	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
is	O
involved	O
in	O
the	O
processing	O
of	O
the	O
amyloid	O
precursor	O
protein	O
(	O
APP	O
)	O
,	O
the	O
exact	O
function	O
of	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
is	O
still	O
elusive	O
.	O
arg1s	O
Human	O
arg1e	O
gene1s	ARG2
presenilin	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
)	O
is	O
alternatively	O
spliced	O
,	O
resulting	O
in	O
the	O
presence	O
or	O
absence	O
of	O
a	O
four	O
-	O
amino	O
acid	O
motif	O
,	O
VRSQ	O
,	O
in	O
the	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
N	O
-	O
terminus	O
.	O
In	O
arg1s	O
human	O
arg1e	O
tissues	O
,	O
both	O
isoforms	O
are	O
expressed	O
.	O
Here	O
we	O
report	O
that	O
species1s	O
mouse	O
species1e	O
and	O
species1s	O
rat	O
species1e	O
only	O
express	O
the	O
longer	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
isoform	O
.	O
The	O
presence	O
of	O
this	O
motif	O
introduces	O
a	O
potential	O
phosphorylation	O
site	O
for	O
protein	O
kinase	O
C.	O
Because	O
the	O
splice	O
occurs	O
in	O
the	O
region	O
of	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
that	O
we	O
have	O
previously	O
shown	O
to	O
bind	O
to	O
rabGDI	O
,	O
this	O
might	O
provide	O
a	O
regulatory	O
mechanism	O
for	O
this	O
interaction	O
.	O
Our	O
data	O
show	O
that	O
the	O
-VRSQ	O
isoform	O
binds	O
rabGDI	O
,	O
but	O
the	O
+	O
VRSQ	O
does	O
not	O
.	O
Moreover	O
,	O
mutation	O
of	O
the	O
putatively	O
phosphorylated	O
threonine	O
in	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
disrupts	O
the	O
binding	O
to	O
rabGDI	O
,	O
showing	O
its	O
importance	O
for	O
the	O
interaction	O
.	O
To	O
our	O
knowledge	O
this	O
is	O
the	O
first	O
study	O
showing	O
a	O
functional	O
difference	O
between	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
splice	O
variants	O
.	O
The	O
possible	O
consequences	O
for	O
APP	O
processing	O
and	O
the	O
pathogenesis	O
of	O
AD	O
are	O
discussed	O
.	O

Alternative	O
splicing	O
in	O
the	O
N	O
-	O
terminus	O
of	O
Alzheimer	O
's	O
gene1s	O
presenilin	O
1	O
gene1e	O
.	O
gene1s	O
Presenilin	O
1	O
gene1e	O
(	O
gene1s	O
PS1	O
gene1e	O
)	O
is	O
mutated	O
in	O
the	O
majority	O
of	O
familial	O
cases	O
of	O
Alzheimer	O
disease	O
(	O
AD	O
)	O
.	O
Although	O
it	O
is	O
clear	O
that	O
gene1s	O
PS1	O
gene1e	O
is	O
involved	O
in	O
the	O
processing	O
of	O
the	O
amyloid	O
precursor	O
protein	O
(	O
APP	O
)	O
,	O
the	O
exact	O
function	O
of	O
gene1s	O
PS1	O
gene1e	O
is	O
still	O
elusive	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
presenilin	O
1	O
gene1e	O
(	O
gene1s	O
PS1	O
gene1e	O
)	O
is	O
alternatively	O
spliced	O
,	O
resulting	O
in	O
the	O
presence	O
or	O
absence	O
of	O
a	O
four	O
-	O
amino	O
acid	O
motif	O
,	O
VRSQ	O
,	O
in	O
the	O
gene1s	O
PS1	O
gene1e	O
N	O
-	O
terminus	O
.	O
In	O
species1s	O
human	O
species1e	O
tissues	O
,	O
both	O
isoforms	O
are	O
expressed	O
.	O
Here	O
we	O
report	O
that	O
arg1s	O
mouse	O
arg1e	O
and	O
species1s	O
rat	O
species1e	O
only	O
express	O
the	O
longer	O
gene1s	O
PS1	O
gene1e	O
isoform	O
.	O
The	O
presence	O
of	O
this	O
motif	O
introduces	O
a	O
potential	O
phosphorylation	O
site	O
for	O
protein	O
kinase	O
C.	O
Because	O
the	O
splice	O
occurs	O
in	O
the	O
region	O
of	O
gene1s	O
PS1	O
gene1e	O
that	O
we	O
have	O
previously	O
shown	O
to	O
bind	O
to	O
rabGDI	O
,	O
this	O
might	O
provide	O
a	O
regulatory	O
mechanism	O
for	O
this	O
interaction	O
.	O
Our	O
data	O
show	O
that	O
the	O
-VRSQ	O
isoform	O
binds	O
rabGDI	O
,	O
but	O
the	O
+	O
VRSQ	O
does	O
not	O
.	O
Moreover	O
,	O
mutation	O
of	O
the	O
putatively	O
phosphorylated	O
threonine	O
in	O
gene1s	O
PS1	O
gene1e	O
disrupts	O
the	O
binding	O
to	O
rabGDI	O
,	O
showing	O
its	O
importance	O
for	O
the	O
interaction	O
.	O
To	O
our	O
knowledge	O
this	O
is	O
the	O
first	O
study	O
showing	O
a	O
functional	O
difference	O
between	O
gene1s	O
PS1	O
gene1e	O
splice	O
variants	O
.	O
The	O
possible	O
consequences	O
for	O
APP	O
processing	O
and	O
the	O
pathogenesis	O
of	O
AD	O
are	O
discussed	O
.	O

Alternative	O
splicing	O
in	O
the	O
N	O
-	O
terminus	O
of	O
Alzheimer	O
's	O
gene1s	O
presenilin	O
1	O
gene1e	O
.	O
gene1s	O
Presenilin	O
1	O
gene1e	O
(	O
gene1s	O
PS1	O
gene1e	O
)	O
is	O
mutated	O
in	O
the	O
majority	O
of	O
familial	O
cases	O
of	O
Alzheimer	O
disease	O
(	O
AD	O
)	O
.	O
Although	O
it	O
is	O
clear	O
that	O
gene1s	O
PS1	O
gene1e	O
is	O
involved	O
in	O
the	O
processing	O
of	O
the	O
amyloid	O
precursor	O
protein	O
(	O
APP	O
)	O
,	O
the	O
exact	O
function	O
of	O
gene1s	O
PS1	O
gene1e	O
is	O
still	O
elusive	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
presenilin	O
1	O
gene1e	O
(	O
gene1s	O
PS1	O
gene1e	O
)	O
is	O
alternatively	O
spliced	O
,	O
resulting	O
in	O
the	O
presence	O
or	O
absence	O
of	O
a	O
four	O
-	O
amino	O
acid	O
motif	O
,	O
VRSQ	O
,	O
in	O
the	O
gene1s	O
PS1	O
gene1e	O
N	O
-	O
terminus	O
.	O
In	O
species1s	O
human	O
species1e	O
tissues	O
,	O
both	O
isoforms	O
are	O
expressed	O
.	O
Here	O
we	O
report	O
that	O
species1s	O
mouse	O
species1e	O
and	O
arg1s	O
rat	O
arg1e	O
only	O
express	O
the	O
longer	O
gene1s	O
PS1	O
gene1e	O
isoform	O
.	O
The	O
presence	O
of	O
this	O
motif	O
introduces	O
a	O
potential	O
phosphorylation	O
site	O
for	O
protein	O
kinase	O
C.	O
Because	O
the	O
splice	O
occurs	O
in	O
the	O
region	O
of	O
gene1s	O
PS1	O
gene1e	O
that	O
we	O
have	O
previously	O
shown	O
to	O
bind	O
to	O
rabGDI	O
,	O
this	O
might	O
provide	O
a	O
regulatory	O
mechanism	O
for	O
this	O
interaction	O
.	O
Our	O
data	O
show	O
that	O
the	O
-VRSQ	O
isoform	O
binds	O
rabGDI	O
,	O
but	O
the	O
+	O
VRSQ	O
does	O
not	O
.	O
Moreover	O
,	O
mutation	O
of	O
the	O
putatively	O
phosphorylated	O
threonine	O
in	O
gene1s	O
PS1	O
gene1e	O
disrupts	O
the	O
binding	O
to	O
rabGDI	O
,	O
showing	O
its	O
importance	O
for	O
the	O
interaction	O
.	O
To	O
our	O
knowledge	O
this	O
is	O
the	O
first	O
study	O
showing	O
a	O
functional	O
difference	O
between	O
gene1s	O
PS1	O
gene1e	O
splice	O
variants	O
.	O
The	O
possible	O
consequences	O
for	O
APP	O
processing	O
and	O
the	O
pathogenesis	O
of	O
AD	O
are	O
discussed	O
.	O

Over	O
-	O
expression	O
of	O
gene1s	ARG2
BMP4	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
BMP5	ARG2
gene1e	ARG2
in	O
a	O
arg1s	O
child	O
arg1e	O
with	O
axial	O
skeletal	O
malformations	O
and	O
heterotopic	O
ossification	O
:	O
a	O
new	O
syndrome	O
.	O
Bone	O
morphogenetic	O
proteins	O
(	O
BMPs	O
)	O
are	O
a	O
highly	O
conserved	O
class	O
of	O
signaling	O
molecules	O
that	O
induce	O
ectopic	O
cartilage	O
and	O
bone	O
formation	O
in	O
vivo	O
.	O
Dysregulated	O
expression	O
of	O
gene1s	ARG2
bone	ARG2
morphogenetic	ARG2
protein	ARG2
4	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
BMP4	ARG2
gene1e	ARG2
)	O
is	O
found	O
in	O
the	O
cells	O
of	O
arg1s	O
patients	O
arg1e	O
who	O
have	O
fibrodysplasia	O
ossificans	O
progressiva	O
(	O
FOP	O
)	O
,	O
a	O
genetic	O
disorder	O
of	O
axial	O
and	O
appendicular	O
skeletal	O
malformation	O
and	O
progressive	O
heterotopic	O
ossification	O
.	O
Loss	O
of	O
function	O
mutations	O
in	O
the	O
gene1s	ARG2
bone	ARG2
morphogenetic	ARG2
protein	ARG2
5	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
bmp5	ARG2
gene1e	ARG2
)	O
gene	O
leading	O
to	O
under	O
-	O
expression	O
of	O
gene1s	ARG2
BMP5	ARG2
gene1e	ARG2
cause	O
the	O
species1s	O
murine	O
species1e	O
short	O
ear	O
syndrome	O
,	O
characterized	O
by	O
small	O
malformed	O
ears	O
and	O
a	O
broad	O
range	O
of	O
axial	O
skeletal	O
malformations	O
.	O
We	O
found	O
features	O
reminiscent	O
of	O
both	O
the	O
short	O
ear	O
species1s	O
mouse	O
species1e	O
and	O
FOP	O
in	O
a	O
arg1s	O
child	O
arg1e	O
with	O
malformed	O
external	O
ears	O
,	O
multiple	O
malformations	O
of	O
the	O
axial	O
skeleton	O
,	O
and	O
progressive	O
heterotopic	O
ossification	O
in	O
the	O
neck	O
and	O
back	O
.	O
We	O
examined	O
BMP	O
mRNA	O
expression	O
in	O
transformed	O
lymphocytes	O
by	O
semi	O
-	O
quantitative	O
RT	O
-	O
PCR	O
and	O
protein	O
expression	O
by	O
ELISA	O
assays	O
and	O
immunohistochemistry	O
.	O
Elevated	O
levels	O
of	O
gene1s	ARG2
BMP4	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
BMP5	ARG2
gene1e	ARG2
mRNA	O
and	O
protein	O
were	O
detected	O
in	O
the	O
arg1s	O
patient	O
arg1e	O
's	O
cells	O
while	O
levels	O
of	O
gene1s	ARG2
BMP2	ARG2
gene1e	ARG2
mRNA	O
were	O
unchanged	O
.	O
Our	O
data	O
suggest	O
that	O
dysregulated	O
expression	O
of	O
gene1s	ARG2
BMP4	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
BMP5	ARG2
gene1e	ARG2
genes	O
is	O
associated	O
with	O
an	O
array	O
of	O
arg1s	O
human	O
arg1e	O
axial	O
skeletal	O
abnormalities	O
similar	O
to	O
the	O
short	O
ear	O
species1s	O
mouse	O
species1e	O
and	O
FOP	O
.	O

Over	O
-	O
expression	O
of	O
gene1s	O
BMP4	O
gene1e	O
and	O
gene1s	O
BMP5	O
gene1e	O
in	O
a	O
species1s	O
child	O
species1e	O
with	O
axial	O
skeletal	O
malformations	O
and	O
heterotopic	O
ossification	O
:	O
a	O
new	O
syndrome	O
.	O
Bone	O
morphogenetic	O
proteins	O
(	O
BMPs	O
)	O
are	O
a	O
highly	O
conserved	O
class	O
of	O
signaling	O
molecules	O
that	O
induce	O
ectopic	O
cartilage	O
and	O
bone	O
formation	O
in	O
vivo	O
.	O
Dysregulated	O
expression	O
of	O
gene1s	O
bone	O
morphogenetic	O
protein	O
4	O
gene1e	O
(	O
gene1s	O
BMP4	O
gene1e	O
)	O
is	O
found	O
in	O
the	O
cells	O
of	O
species1s	O
patients	O
species1e	O
who	O
have	O
fibrodysplasia	O
ossificans	O
progressiva	O
(	O
FOP	O
)	O
,	O
a	O
genetic	O
disorder	O
of	O
axial	O
and	O
appendicular	O
skeletal	O
malformation	O
and	O
progressive	O
heterotopic	O
ossification	O
.	O
Loss	O
of	O
function	O
mutations	O
in	O
the	O
gene1s	O
bone	O
morphogenetic	O
protein	O
5	O
gene1e	O
(	O
gene1s	O
bmp5	O
gene1e	O
)	O
gene	O
leading	O
to	O
under	O
-	O
expression	O
of	O
gene1s	O
BMP5	O
gene1e	O
cause	O
the	O
arg1s	O
murine	O
arg1e	O
short	O
ear	O
syndrome	O
,	O
characterized	O
by	O
small	O
malformed	O
ears	O
and	O
a	O
broad	O
range	O
of	O
axial	O
skeletal	O
malformations	O
.	O
We	O
found	O
features	O
reminiscent	O
of	O
both	O
the	O
short	O
ear	O
arg1s	O
mouse	O
arg1e	O
and	O
FOP	O
in	O
a	O
species1s	O
child	O
species1e	O
with	O
malformed	O
external	O
ears	O
,	O
multiple	O
malformations	O
of	O
the	O
axial	O
skeleton	O
,	O
and	O
progressive	O
heterotopic	O
ossification	O
in	O
the	O
neck	O
and	O
back	O
.	O
We	O
examined	O
BMP	O
mRNA	O
expression	O
in	O
transformed	O
lymphocytes	O
by	O
semi	O
-	O
quantitative	O
RT	O
-	O
PCR	O
and	O
protein	O
expression	O
by	O
ELISA	O
assays	O
and	O
immunohistochemistry	O
.	O
Elevated	O
levels	O
of	O
gene1s	O
BMP4	O
gene1e	O
and	O
gene1s	O
BMP5	O
gene1e	O
mRNA	O
and	O
protein	O
were	O
detected	O
in	O
the	O
species1s	O
patient	O
species1e	O
's	O
cells	O
while	O
levels	O
of	O
gene1s	O
BMP2	O
gene1e	O
mRNA	O
were	O
unchanged	O
.	O
Our	O
data	O
suggest	O
that	O
dysregulated	O
expression	O
of	O
gene1s	O
BMP4	O
gene1e	O
and	O
gene1s	O
BMP5	O
gene1e	O
genes	O
is	O
associated	O
with	O
an	O
array	O
of	O
species1s	O
human	O
species1e	O
axial	O
skeletal	O
abnormalities	O
similar	O
to	O
the	O
short	O
ear	O
arg1s	O
mouse	O
arg1e	O
and	O
FOP	O
.	O

Novel	O
suppressors	O
of	O
gene1s	O
alpha	O
-	O
synuclein	O
gene1e	O
toxicity	O
identified	O
using	O
arg1s	O
yeast	O
arg1e	O
.	O
The	O
mechanism	O
by	O
which	O
the	O
Parkinson	O
's	O
disease	O
-	O
related	O
protein	O
gene1s	O
alpha	O
-	O
synuclein	O
gene1e	O
(	O
gene1s	O
alpha	O
-	O
syn	O
gene1e	O
)	O
causes	O
neurodegeneration	O
has	O
not	O
been	O
elucidated	O
.	O
To	O
determine	O
the	O
genes	O
that	O
protect	O
cells	O
from	O
gene1s	O
alpha	O
-	O
syn	O
gene1e	O
,	O
we	O
used	O
a	O
genetic	O
screen	O
to	O
identify	O
suppressors	O
of	O
the	O
super	O
sensitivity	O
of	O
the	O
arg1s	O
yeast	O
arg1e	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
expressing	O
gene1s	O
alpha	O
-	O
syn	O
gene1e	O
to	O
killing	O
by	O
hydrogen	O
peroxide	O
.	O
Forty	O
genes	O
in	O
ubiquitin	O
-	O
dependent	O
protein	O
catabolism	O
,	O
protein	O
biosynthesis	O
,	O
vesicle	O
trafficking	O
and	O
the	O
response	O
to	O
stress	O
were	O
identified	O
.	O
Five	O
of	O
the	O
forty	O
genes	O
--	O
gene1s	ARG2
ENT3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IDP3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
JEM1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ARG2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
HSP82	ARG2
gene1e	ARG2
-	O
-ranked	O
highest	O
in	O
their	O
ability	O
to	O
block	O
gene1s	O
alpha	O
-	O
syn	O
gene1e	O
-	O
induced	O
reactive	O
oxygen	O
species	O
accumulation	O
,	O
and	O
these	O
five	O
genes	O
were	O
characterized	O
in	O
more	O
detail	O
.	O
The	O
deletion	O
of	O
any	O
of	O
these	O
five	O
genes	O
enhanced	O
the	O
toxicity	O
of	O
gene1s	O
alpha	O
-	O
syn	O
gene1e	O
as	O
judged	O
by	O
growth	O
defects	O
compared	O
with	O
wild	O
-	O
type	O
cells	O
expressing	O
gene1s	O
alpha	O
-	O
syn	O
gene1e	O
,	O
which	O
indicates	O
that	O
these	O
genes	O
protect	O
cells	O
from	O
gene1s	O
alpha	O
-	O
syn	O
gene1e	O
.	O
Strikingly	O
,	O
four	O
of	O
the	O
five	O
genes	O
are	O
specific	O
for	O
gene1s	O
alpha	O
-	O
syn	O
gene1e	O
in	O
that	O
they	O
fail	O
to	O
protect	O
cells	O
from	O
the	O
toxicity	O
of	O
the	O
two	O
inherited	O
mutants	O
A30P	O
or	O
A53T.	O
This	O
finding	O
suggests	O
that	O
gene1s	O
alpha	O
-	O
syn	O
gene1e	O
causes	O
toxicity	O
to	O
cells	O
through	O
a	O
different	O
pathway	O
than	O
these	O
two	O
inherited	O
mutants	O
.	O
Lastly	O
,	O
overexpression	O
of	O
gene1s	ARG2
Ent3p	ARG2
gene1e	ARG2
,	O
which	O
is	O
a	O
clathrin	O
adapter	O
protein	O
involved	O
in	O
protein	O
transport	O
between	O
the	O
Golgi	O
and	O
the	O
vacuole	O
,	O
causes	O
gene1s	O
alpha	O
-	O
syn	O
gene1e	O
to	O
redistribute	O
from	O
the	O
plasma	O
membrane	O
into	O
cytoplasmic	O
vesicular	O
structures	O
.	O
Our	O
interpretation	O
is	O
that	O
gene1s	ARG2
Ent3p	ARG2
gene1e	ARG2
mediates	O
the	O
transport	O
of	O
gene1s	O
alpha	O
-	O
syn	O
gene1e	O
to	O
the	O
vacuole	O
for	O
proteolytic	O
degradation	O
.	O
A	O
similar	O
clathrin	O
adaptor	O
protein	O
,	O
gene1s	O
epsinR	O
gene1e	O
,	O
exists	O
in	O
species1s	O
humans	O
species1e	O
.	O

Novel	O
suppressors	O
of	O
gene1s	ARG2
alpha	ARG2
-	ARG2
synuclein	ARG2
gene1e	ARG2
toxicity	O
identified	O
using	O
species1s	O
yeast	O
species1e	O
.	O
The	O
mechanism	O
by	O
which	O
the	O
Parkinson	O
's	O
disease	O
-	O
related	O
protein	O
gene1s	ARG2
alpha	ARG2
-	ARG2
synuclein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
alpha	ARG2
-	ARG2
syn	ARG2
gene1e	ARG2
)	O
causes	O
neurodegeneration	O
has	O
not	O
been	O
elucidated	O
.	O
To	O
determine	O
the	O
genes	O
that	O
protect	O
cells	O
from	O
gene1s	ARG2
alpha	ARG2
-	ARG2
syn	ARG2
gene1e	ARG2
,	O
we	O
used	O
a	O
genetic	O
screen	O
to	O
identify	O
suppressors	O
of	O
the	O
super	O
sensitivity	O
of	O
the	O
species1s	O
yeast	O
species1e	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
expressing	O
gene1s	ARG2
alpha	ARG2
-	ARG2
syn	ARG2
gene1e	ARG2
to	O
killing	O
by	O
hydrogen	O
peroxide	O
.	O
Forty	O
genes	O
in	O
ubiquitin	O
-	O
dependent	O
protein	O
catabolism	O
,	O
protein	O
biosynthesis	O
,	O
vesicle	O
trafficking	O
and	O
the	O
response	O
to	O
stress	O
were	O
identified	O
.	O
Five	O
of	O
the	O
forty	O
genes	O
--	O
gene1s	O
ENT3	O
gene1e	O
,	O
gene1s	O
IDP3	O
gene1e	O
,	O
gene1s	O
JEM1	O
gene1e	O
,	O
gene1s	O
ARG2	O
gene1e	O
and	O
gene1s	O
HSP82	O
gene1e	O
-	O
-ranked	O
highest	O
in	O
their	O
ability	O
to	O
block	O
gene1s	ARG2
alpha	ARG2
-	ARG2
syn	ARG2
gene1e	ARG2
-	O
induced	O
reactive	O
oxygen	O
species	O
accumulation	O
,	O
and	O
these	O
five	O
genes	O
were	O
characterized	O
in	O
more	O
detail	O
.	O
The	O
deletion	O
of	O
any	O
of	O
these	O
five	O
genes	O
enhanced	O
the	O
toxicity	O
of	O
gene1s	ARG2
alpha	ARG2
-	ARG2
syn	ARG2
gene1e	ARG2
as	O
judged	O
by	O
growth	O
defects	O
compared	O
with	O
wild	O
-	O
type	O
cells	O
expressing	O
gene1s	ARG2
alpha	ARG2
-	ARG2
syn	ARG2
gene1e	ARG2
,	O
which	O
indicates	O
that	O
these	O
genes	O
protect	O
cells	O
from	O
gene1s	ARG2
alpha	ARG2
-	ARG2
syn	ARG2
gene1e	ARG2
.	O
Strikingly	O
,	O
four	O
of	O
the	O
five	O
genes	O
are	O
specific	O
for	O
gene1s	ARG2
alpha	ARG2
-	ARG2
syn	ARG2
gene1e	ARG2
in	O
that	O
they	O
fail	O
to	O
protect	O
cells	O
from	O
the	O
toxicity	O
of	O
the	O
two	O
inherited	O
mutants	O
A30P	O
or	O
A53T.	O
This	O
finding	O
suggests	O
that	O
gene1s	ARG2
alpha	ARG2
-	ARG2
syn	ARG2
gene1e	ARG2
causes	O
toxicity	O
to	O
cells	O
through	O
a	O
different	O
pathway	O
than	O
these	O
two	O
inherited	O
mutants	O
.	O
Lastly	O
,	O
overexpression	O
of	O
gene1s	O
Ent3p	O
gene1e	O
,	O
which	O
is	O
a	O
clathrin	O
adapter	O
protein	O
involved	O
in	O
protein	O
transport	O
between	O
the	O
Golgi	O
and	O
the	O
vacuole	O
,	O
causes	O
gene1s	ARG2
alpha	ARG2
-	ARG2
syn	ARG2
gene1e	ARG2
to	O
redistribute	O
from	O
the	O
plasma	O
membrane	O
into	O
cytoplasmic	O
vesicular	O
structures	O
.	O
Our	O
interpretation	O
is	O
that	O
gene1s	O
Ent3p	O
gene1e	O
mediates	O
the	O
transport	O
of	O
gene1s	ARG2
alpha	ARG2
-	ARG2
syn	ARG2
gene1e	ARG2
to	O
the	O
vacuole	O
for	O
proteolytic	O
degradation	O
.	O
A	O
similar	O
clathrin	O
adaptor	O
protein	O
,	O
gene1s	ARG2
epsinR	ARG2
gene1e	ARG2
,	O
exists	O
in	O
arg1s	O
humans	O
arg1e	O
.	O

Association	O
of	O
a	O
null	O
allele	O
of	O
gene1s	ARG2
SPRN	ARG2
gene1e	ARG2
with	O
variant	O
Creutzfeldt	O
-	O
Jakob	O
disease	O
.	O
BACKGROUND	O
:	O
No	O
susceptibility	O
genes	O
have	O
been	O
identified	O
in	O
arg1s	O
human	O
arg1e	O
species1s	O
prion	O
species1e	O
disase	O
,	O
apart	O
from	O
the	O
gene1s	ARG2
prion	ARG2
protein	ARG2
gene1e	ARG2
gene	O
(	O
gene1s	ARG2
PRNP	ARG2
gene1e	ARG2
)	O
.	O
The	O
gene	O
gene1s	ARG2
SPRN	ARG2
gene1e	ARG2
,	O
encodes	O
gene1s	ARG2
Shadoo	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Sho	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
shadow	ARG2
of	ARG2
prion	ARG2
protein	ARG2
gene1e	ARG2
)	O
which	O
has	O
protein	O
homology	O
and	O
possible	O
functional	O
links	O
with	O
the	O
gene1s	ARG2
prion	ARG2
protein	ARG2
gene1e	ARG2
.	O
METHODS	O
:	O
A	O
genetic	O
screen	O
was	O
carried	O
out	O
of	O
the	O
open	O
reading	O
frame	O
of	O
gene1s	ARG2
SPRN	ARG2
gene1e	ARG2
by	O
direct	O
sequencing	O
in	O
522	O
arg1s	O
patients	O
arg1e	O
with	O
species1s	O
prion	O
species1e	O
disease	O
,	O
including	O
107	O
with	O
variant	O
Creutzfeldt	O
-	O
Jakob	O
disease	O
(	O
vCJD	O
)	O
,	O
and	O
861	O
healthy	O
controls	O
.	O
RESULTS	O
:	O
A	O
common	O
coding	O
variant	O
of	O
gene1s	ARG2
SPRN	ARG2
gene1e	ARG2
,	O
two	O
further	O
single	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
and	O
three	O
rare	O
insertion	O
or	O
deletion	O
variants	O
were	O
found	O
.	O
A	O
single	O
base	O
-	O
pair	O
insertion	O
at	O
codon	O
46	O
,	O
predicted	O
to	O
cause	O
a	O
frameshift	O
and	O
potentially	O
a	O
novel	O
protein	O
,	O
was	O
found	O
in	O
two	O
arg1s	O
patients	O
arg1e	O
with	O
vCJD	O
but	O
not	O
in	O
controls	O
(	O
p	O
=	O
0.01	O
)	O
.	O
Two	O
linked	O
SNPs	O
,	O
one	O
in	O
intron	O
1	O
and	O
the	O
other	O
a	O
missense	O
variant	O
at	O
codon	O
7	O
,	O
were	O
associated	O
with	O
risk	O
of	O
sporadic	O
CJD	O
(	O
p	O
=	O
0.009	O
)	O
.	O
CONCLUSION	O
:	O
These	O
data	O
justify	O
the	O
functional	O
genetic	O
characterisation	O
of	O
gene1s	ARG2
SPRN	ARG2
gene1e	ARG2
and	O
support	O
the	O
involvement	O
of	O
gene1s	ARG2
Shadoo	ARG2
gene1e	ARG2
in	O
species1s	O
prion	O
species1e	O
pathobiology	O
.	O

Association	O
of	O
a	O
null	O
allele	O
of	O
gene1s	O
SPRN	O
gene1e	O
with	O
variant	O
Creutzfeldt	O
-	O
Jakob	O
disease	O
.	O
BACKGROUND	O
:	O
No	O
susceptibility	O
genes	O
have	O
been	O
identified	O
in	O
species1s	O
human	O
species1e	O
arg1s	O
prion	O
arg1e	O
disase	O
,	O
apart	O
from	O
the	O
gene1s	O
prion	O
protein	O
gene1e	O
gene	O
(	O
gene1s	O
PRNP	O
gene1e	O
)	O
.	O
The	O
gene	O
gene1s	O
SPRN	O
gene1e	O
,	O
encodes	O
gene1s	O
Shadoo	O
gene1e	O
(	O
gene1s	O
Sho	O
gene1e	O
,	O
gene1s	O
shadow	O
of	O
prion	O
protein	O
gene1e	O
)	O
which	O
has	O
protein	O
homology	O
and	O
possible	O
functional	O
links	O
with	O
the	O
gene1s	O
prion	O
protein	O
gene1e	O
.	O
METHODS	O
:	O
A	O
genetic	O
screen	O
was	O
carried	O
out	O
of	O
the	O
open	O
reading	O
frame	O
of	O
gene1s	O
SPRN	O
gene1e	O
by	O
direct	O
sequencing	O
in	O
522	O
species1s	O
patients	O
species1e	O
with	O
arg1s	O
prion	O
arg1e	O
disease	O
,	O
including	O
107	O
with	O
variant	O
Creutzfeldt	O
-	O
Jakob	O
disease	O
(	O
vCJD	O
)	O
,	O
and	O
861	O
healthy	O
controls	O
.	O
RESULTS	O
:	O
A	O
common	O
coding	O
variant	O
of	O
gene1s	O
SPRN	O
gene1e	O
,	O
two	O
further	O
single	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
and	O
three	O
rare	O
insertion	O
or	O
deletion	O
variants	O
were	O
found	O
.	O
A	O
single	O
base	O
-	O
pair	O
insertion	O
at	O
codon	O
46	O
,	O
predicted	O
to	O
cause	O
a	O
frameshift	O
and	O
potentially	O
a	O
novel	O
protein	O
,	O
was	O
found	O
in	O
two	O
species1s	O
patients	O
species1e	O
with	O
vCJD	O
but	O
not	O
in	O
controls	O
(	O
p	O
=	O
0.01	O
)	O
.	O
Two	O
linked	O
SNPs	O
,	O
one	O
in	O
intron	O
1	O
and	O
the	O
other	O
a	O
missense	O
variant	O
at	O
codon	O
7	O
,	O
were	O
associated	O
with	O
risk	O
of	O
sporadic	O
CJD	O
(	O
p	O
=	O
0.009	O
)	O
.	O
CONCLUSION	O
:	O
These	O
data	O
justify	O
the	O
functional	O
genetic	O
characterisation	O
of	O
gene1s	O
SPRN	O
gene1e	O
and	O
support	O
the	O
involvement	O
of	O
gene1s	O
Shadoo	O
gene1e	O
in	O
arg1s	O
prion	O
arg1e	O
pathobiology	O
.	O

Alterations	O
of	O
gene1s	ARG2
ROBO1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
DUTT1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ROBO2	ARG2
gene1e	ARG2
loci	O
in	O
early	O
dysplastic	O
lesions	O
of	O
head	O
and	O
neck	O
:	O
clinical	O
and	O
prognostic	O
implications	O
.	O
Deletion	O
of	O
chromosomal	O
3p12.3	O
was	O
suggested	O
to	O
be	O
associated	O
with	O
dysplastic	O
lesions	O
of	O
head	O
and	O
neck	O
.	O
This	O
region	O
harbors	O
two	O
candidate	O
tumor	O
suppressors	O
gene1s	ARG2
ROBO1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
DUTT1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ROBO2	ARG2
gene1e	ARG2
and	O
two	O
non	O
-	O
coding	O
RNAs	O
(	O
ncRNAs	O
)	O
located	O
at	O
intron	O
2	O
of	O
gene1s	ARG2
ROBO1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
DUTT1	ARG2
gene1e	ARG2
.	O
Aim	O
of	O
this	O
study	O
is	O
to	O
understand	O
the	O
role	O
of	O
these	O
genes	O
in	O
development	O
of	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	O
.	O
A	O
collection	O
of	O
72	O
dysplastic	O
lesions	O
and	O
116	O
HNSCC	O
samples	O
and	O
two	O
oral	O
cancer	O
cell	O
lines	O
were	O
analyzed	O
for	O
gene1s	ARG2
ROBO1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
DUTT1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ROBO2	ARG2
gene1e	ARG2
deletion	O
and	O
promoter	O
methylation	O
.	O
gene1s	ARG2
ROBO1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
DUTT1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ROBO2	ARG2
gene1e	ARG2
and	O
two	O
ncRNAs	O
mRNA	O
expression	O
were	O
analyzed	O
by	O
Q	O
-	O
PCR	O
.	O
Immunohistochemical	O
analysis	O
of	O
gene1s	ARG2
ROBO1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
DUTT1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ROBO2	ARG2
gene1e	ARG2
was	O
performed	O
.	O
Alterations	O
of	O
these	O
genes	O
were	O
correlated	O
with	O
different	O
clinicopathological	O
parameters	O
.	O
High	O
frequency	O
of	O
molecular	O
alterations	O
(	O
deletion	O
/	O
methylation	O
)	O
was	O
seen	O
in	O
gene1s	ARG2
ROBO1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
DUTT1	ARG2
gene1e	ARG2
than	O
gene1s	ARG2
ROBO2	ARG2
gene1e	ARG2
.	O
In	O
mild	O
dysplastic	O
lesions	O
both	O
of	O
these	O
genes	O
showed	O
high	O
molecular	O
alterations	O
and	O
remained	O
more	O
or	O
less	O
constant	O
in	O
subsequent	O
stages	O
.	O
Q	O
-	O
PCR	O
analysis	O
showed	O
reduced	O
expression	O
of	O
these	O
genes	O
and	O
the	O
two	O
ncRNAs	O
.	O
In	O
vitro	O
demethylation	O
experiment	O
by	O
5-aza	O
-	O
dC	O
showed	O
upregulation	O
of	O
gene1s	ARG2
ROBO1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
DUTT1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ROBO2	ARG2
gene1e	ARG2
while	O
the	O
expression	O
of	O
the	O
ncRNAs	O
remained	O
unchanged	O
.	O
Immunohistochemical	O
analysis	O
of	O
gene1s	ARG2
ROBO1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
DUTT1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ROBO2	ARG2
gene1e	ARG2
showed	O
concordance	O
with	O
their	O
mRNA	O
expression	O
and	O
molecular	O
alterations	O
.	O
Poor	O
arg1s	O
patients	O
arg1e	O
'	O
outcome	O
was	O
predicted	O
in	O
the	O
cases	O
with	O
alteration	O
of	O
gene1s	ARG2
ROBO1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
DUTT1	ARG2
gene1e	ARG2
along	O
with	O
species1s	O
tobacco	O
species1e	O
addiction	O
and	O
gene1s	ARG2
nodal	ARG2
gene1e	ARG2
involvement	O
.	O
Our	O
data	O
suggests	O
(	O
a	O
)	O
gene1s	ARG2
ROBO1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
DUTT1	ARG2
gene1e	ARG2
and	O
the	O
ncRNAs	O
are	O
transcribed	O
from	O
different	O
promoters	O
,	O
and	O
(	O
b	O
)	O
inactivation	O
of	O
gene1s	ARG2
ROBO1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
DUTT1	ARG2
gene1e	ARG2
could	O
be	O
used	O
as	O
molecular	O
signature	O
for	O
early	O
detection	O
and	O
prognosis	O
of	O
the	O
head	O
and	O
neck	O
cancer	O
.	O

Alterations	O
of	O
gene1s	O
ROBO1	O
gene1e	O
/	O
gene1s	O
DUTT1	O
gene1e	O
and	O
gene1s	O
ROBO2	O
gene1e	O
loci	O
in	O
early	O
dysplastic	O
lesions	O
of	O
head	O
and	O
neck	O
:	O
clinical	O
and	O
prognostic	O
implications	O
.	O
Deletion	O
of	O
chromosomal	O
3p12.3	O
was	O
suggested	O
to	O
be	O
associated	O
with	O
dysplastic	O
lesions	O
of	O
head	O
and	O
neck	O
.	O
This	O
region	O
harbors	O
two	O
candidate	O
tumor	O
suppressors	O
gene1s	O
ROBO1	O
gene1e	O
/	O
gene1s	O
DUTT1	O
gene1e	O
,	O
gene1s	O
ROBO2	O
gene1e	O
and	O
two	O
non	O
-	O
coding	O
RNAs	O
(	O
ncRNAs	O
)	O
located	O
at	O
intron	O
2	O
of	O
gene1s	O
ROBO1	O
gene1e	O
/	O
gene1s	O
DUTT1	O
gene1e	O
.	O
Aim	O
of	O
this	O
study	O
is	O
to	O
understand	O
the	O
role	O
of	O
these	O
genes	O
in	O
development	O
of	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	O
.	O
A	O
collection	O
of	O
72	O
dysplastic	O
lesions	O
and	O
116	O
HNSCC	O
samples	O
and	O
two	O
oral	O
cancer	O
cell	O
lines	O
were	O
analyzed	O
for	O
gene1s	O
ROBO1	O
gene1e	O
/	O
gene1s	O
DUTT1	O
gene1e	O
and	O
gene1s	O
ROBO2	O
gene1e	O
deletion	O
and	O
promoter	O
methylation	O
.	O
gene1s	O
ROBO1	O
gene1e	O
/	O
gene1s	O
DUTT1	O
gene1e	O
,	O
gene1s	O
ROBO2	O
gene1e	O
and	O
two	O
ncRNAs	O
mRNA	O
expression	O
were	O
analyzed	O
by	O
Q	O
-	O
PCR	O
.	O
Immunohistochemical	O
analysis	O
of	O
gene1s	O
ROBO1	O
gene1e	O
/	O
gene1s	O
DUTT1	O
gene1e	O
and	O
gene1s	O
ROBO2	O
gene1e	O
was	O
performed	O
.	O
Alterations	O
of	O
these	O
genes	O
were	O
correlated	O
with	O
different	O
clinicopathological	O
parameters	O
.	O
High	O
frequency	O
of	O
molecular	O
alterations	O
(	O
deletion	O
/	O
methylation	O
)	O
was	O
seen	O
in	O
gene1s	O
ROBO1	O
gene1e	O
/	O
gene1s	O
DUTT1	O
gene1e	O
than	O
gene1s	O
ROBO2	O
gene1e	O
.	O
In	O
mild	O
dysplastic	O
lesions	O
both	O
of	O
these	O
genes	O
showed	O
high	O
molecular	O
alterations	O
and	O
remained	O
more	O
or	O
less	O
constant	O
in	O
subsequent	O
stages	O
.	O
Q	O
-	O
PCR	O
analysis	O
showed	O
reduced	O
expression	O
of	O
these	O
genes	O
and	O
the	O
two	O
ncRNAs	O
.	O
In	O
vitro	O
demethylation	O
experiment	O
by	O
5-aza	O
-	O
dC	O
showed	O
upregulation	O
of	O
gene1s	O
ROBO1	O
gene1e	O
/	O
gene1s	O
DUTT1	O
gene1e	O
and	O
gene1s	O
ROBO2	O
gene1e	O
while	O
the	O
expression	O
of	O
the	O
ncRNAs	O
remained	O
unchanged	O
.	O
Immunohistochemical	O
analysis	O
of	O
gene1s	O
ROBO1	O
gene1e	O
/	O
gene1s	O
DUTT1	O
gene1e	O
and	O
gene1s	O
ROBO2	O
gene1e	O
showed	O
concordance	O
with	O
their	O
mRNA	O
expression	O
and	O
molecular	O
alterations	O
.	O
Poor	O
species1s	O
patients	O
species1e	O
'	O
outcome	O
was	O
predicted	O
in	O
the	O
cases	O
with	O
alteration	O
of	O
gene1s	O
ROBO1	O
gene1e	O
/	O
gene1s	O
DUTT1	O
gene1e	O
along	O
with	O
arg1s	O
tobacco	O
arg1e	O
addiction	O
and	O
gene1s	O
nodal	O
gene1e	O
involvement	O
.	O
Our	O
data	O
suggests	O
(	O
a	O
)	O
gene1s	O
ROBO1	O
gene1e	O
/	O
gene1s	O
DUTT1	O
gene1e	O
and	O
the	O
ncRNAs	O
are	O
transcribed	O
from	O
different	O
promoters	O
,	O
and	O
(	O
b	O
)	O
inactivation	O
of	O
gene1s	O
ROBO1	O
gene1e	O
/	O
gene1s	O
DUTT1	O
gene1e	O
could	O
be	O
used	O
as	O
molecular	O
signature	O
for	O
early	O
detection	O
and	O
prognosis	O
of	O
the	O
head	O
and	O
neck	O
cancer	O
.	O

Loss	O
of	O
gene1s	O
corneodesmosin	O
gene1e	O
leads	O
to	O
severe	O
skin	O
barrier	O
defect	O
,	O
pruritus	O
,	O
and	O
atopy	O
:	O
unraveling	O
the	O
peeling	O
skin	O
disease	O
.	O
Generalized	O
peeling	O
skin	O
disease	O
is	O
an	O
autosomal	O
-	O
recessive	O
ichthyosiform	O
erythroderma	O
characterized	O
by	O
lifelong	O
patchy	O
peeling	O
of	O
the	O
skin	O
.	O
After	O
genome	O
-	O
wide	O
linkage	O
analysis	O
,	O
we	O
have	O
identified	O
a	O
homozygous	O
nonsense	O
mutation	O
in	O
gene1s	O
CDSN	O
gene1e	O
in	O
a	O
large	O
consanguineous	O
family	O
with	O
generalized	O
peeling	O
skin	O
,	O
pruritus	O
,	O
and	O
food	O
allergies	O
,	O
which	O
leads	O
to	O
a	O
complete	O
loss	O
of	O
gene1s	O
corneodesmosin	O
gene1e	O
.	O
In	O
contrast	O
to	O
hypotrichosis	O
simplex	O
,	O
which	O
can	O
be	O
associated	O
with	O
specific	O
dominant	O
gene1s	O
CDSN	O
gene1e	O
mutations	O
,	O
peeling	O
skin	O
disease	O
is	O
characterized	O
by	O
a	O
complete	O
loss	O
of	O
gene1s	O
CDSN	O
gene1e	O
expression	O
.	O
The	O
skin	O
phenotype	O
is	O
consistent	O
with	O
a	O
recent	O
arg1s	O
murine	O
arg1e	O
gene1s	ARG2
Cdsn	ARG2
gene1e	ARG2
knockout	O
model	O
.	O
Using	O
three	O
-	O
dimensional	O
species1s	O
human	O
species1e	O
skin	O
models	O
,	O
we	O
demonstrate	O
that	O
lack	O
of	O
gene1s	O
corneodesmosin	O
gene1e	O
causes	O
an	O
epidermal	O
barrier	O
defect	O
supposed	O
to	O
account	O
for	O
the	O
predisposition	O
to	O
atopic	O
diseases	O
,	O
and	O
we	O
confirm	O
the	O
role	O
of	O
gene1s	O
corneodesmosin	O
gene1e	O
as	O
a	O
decisive	O
epidermal	O
adhesion	O
molecule	O
.	O
Therefore	O
,	O
peeling	O
skin	O
disease	O
will	O
represent	O
a	O
new	O
model	O
disorder	O
for	O
atopic	O
diseases	O
,	O
similarly	O
to	O
Netherton	O
syndrome	O
and	O
ichthyosis	O
vulgaris	O
in	O
the	O
recent	O
past	O
.	O

Loss	O
of	O
gene1s	ARG2
corneodesmosin	ARG2
gene1e	ARG2
leads	O
to	O
severe	O
skin	O
barrier	O
defect	O
,	O
pruritus	O
,	O
and	O
atopy	O
:	O
unraveling	O
the	O
peeling	O
skin	O
disease	O
.	O
Generalized	O
peeling	O
skin	O
disease	O
is	O
an	O
autosomal	O
-	O
recessive	O
ichthyosiform	O
erythroderma	O
characterized	O
by	O
lifelong	O
patchy	O
peeling	O
of	O
the	O
skin	O
.	O
After	O
genome	O
-	O
wide	O
linkage	O
analysis	O
,	O
we	O
have	O
identified	O
a	O
homozygous	O
nonsense	O
mutation	O
in	O
gene1s	ARG2
CDSN	ARG2
gene1e	ARG2
in	O
a	O
large	O
consanguineous	O
family	O
with	O
generalized	O
peeling	O
skin	O
,	O
pruritus	O
,	O
and	O
food	O
allergies	O
,	O
which	O
leads	O
to	O
a	O
complete	O
loss	O
of	O
gene1s	ARG2
corneodesmosin	ARG2
gene1e	ARG2
.	O
In	O
contrast	O
to	O
hypotrichosis	O
simplex	O
,	O
which	O
can	O
be	O
associated	O
with	O
specific	O
dominant	O
gene1s	ARG2
CDSN	ARG2
gene1e	ARG2
mutations	O
,	O
peeling	O
skin	O
disease	O
is	O
characterized	O
by	O
a	O
complete	O
loss	O
of	O
gene1s	ARG2
CDSN	ARG2
gene1e	ARG2
expression	O
.	O
The	O
skin	O
phenotype	O
is	O
consistent	O
with	O
a	O
recent	O
species1s	O
murine	O
species1e	O
gene1s	O
Cdsn	O
gene1e	O
knockout	O
model	O
.	O
Using	O
three	O
-	O
dimensional	O
arg1s	O
human	O
arg1e	O
skin	O
models	O
,	O
we	O
demonstrate	O
that	O
lack	O
of	O
gene1s	ARG2
corneodesmosin	ARG2
gene1e	ARG2
causes	O
an	O
epidermal	O
barrier	O
defect	O
supposed	O
to	O
account	O
for	O
the	O
predisposition	O
to	O
atopic	O
diseases	O
,	O
and	O
we	O
confirm	O
the	O
role	O
of	O
gene1s	ARG2
corneodesmosin	ARG2
gene1e	ARG2
as	O
a	O
decisive	O
epidermal	O
adhesion	O
molecule	O
.	O
Therefore	O
,	O
peeling	O
skin	O
disease	O
will	O
represent	O
a	O
new	O
model	O
disorder	O
for	O
atopic	O
diseases	O
,	O
similarly	O
to	O
Netherton	O
syndrome	O
and	O
ichthyosis	O
vulgaris	O
in	O
the	O
recent	O
past	O
.	O

Selection	O
of	O
cDNAs	O
encoding	O
putative	O
type	O
II	O
membrane	O
proteins	O
on	O
the	O
cell	O
surface	O
from	O
a	O
arg1s	O
human	O
arg1e	O
full	O
-	O
length	O
cDNA	O
bank	O
.	O
We	O
have	O
developed	O
a	O
simple	O
method	O
to	O
test	O
whether	O
a	O
hydrophobic	O
segment	O
near	O
the	O
N	O
-	O
terminus	O
of	O
a	O
protein	O
functions	O
as	O
a	O
type	O
II	O
signal	O
anchor	O
(	O
SA	O
)	O
in	O
which	O
the	O
N	O
-	O
terminus	O
faces	O
the	O
cytoplasm	O
.	O
A	O
cDNA	O
fragment	O
containing	O
the	O
putative	O
SA	O
sequence	O
of	O
a	O
target	O
clone	O
was	O
fused	O
in	O
-	O
frame	O
to	O
the	O
5	O
'	O
end	O
of	O
a	O
cDNA	O
fragment	O
encoding	O
the	O
protease	O
domain	O
of	O
gene1s	ARG2
urokinase	ARG2
-	ARG2
type	ARG2
plasminogen	ARG2
activator	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
u	ARG2
-	ARG2
PA	ARG2
gene1e	ARG2
)	O
.	O
The	O
resulting	O
fused	O
gene	O
was	O
expressed	O
in	O
species1s	O
COS7	O
species1e	O
cells	O
.	O
Fibrinolytic	O
activity	O
on	O
the	O
cell	O
surface	O
was	O
measured	O
by	O
placing	O
a	O
fibrin	O
sheet	O
in	O
contact	O
with	O
the	O
transfected	O
species1s	O
COS7	O
species1e	O
cells	O
after	O
removing	O
the	O
medium	O
.	O
When	O
the	O
cDNA	O
fragment	O
encoded	O
a	O
SA	O
,	O
the	O
fibrin	O
sheet	O
was	O
lysed	O
by	O
the	O
gene1s	ARG2
u	ARG2
-	ARG2
PA	ARG2
gene1e	ARG2
expressed	O
on	O
the	O
cell	O
surface	O
.	O
The	O
fibrinolytic	O
activity	O
was	O
not	O
detected	O
in	O
the	O
culture	O
medium	O
,	O
suggesting	O
that	O
the	O
gene1s	ARG2
u	ARG2
-	ARG2
PA	ARG2
gene1e	ARG2
remains	O
on	O
the	O
cell	O
surface	O
anchored	O
via	O
the	O
SA	O
in	O
the	O
membrane	O
without	O
being	O
cleaved	O
by	O
signal	O
peptidase	O
.	O
This	O
fibrin	O
sheet	O
method	O
was	O
successfully	O
applied	O
to	O
select	O
five	O
novel	O
cDNA	O
clones	O
encoding	O
putative	O
type	O
II	O
membrane	O
proteins	O
from	O
a	O
arg1s	O
human	O
arg1e	O
full	O
-	O
length	O
cDNA	O
bank	O
.	O

Selection	O
of	O
cDNAs	O
encoding	O
putative	O
type	O
II	O
membrane	O
proteins	O
on	O
the	O
cell	O
surface	O
from	O
a	O
species1s	O
human	O
species1e	O
full	O
-	O
length	O
cDNA	O
bank	O
.	O
We	O
have	O
developed	O
a	O
simple	O
method	O
to	O
test	O
whether	O
a	O
hydrophobic	O
segment	O
near	O
the	O
N	O
-	O
terminus	O
of	O
a	O
protein	O
functions	O
as	O
a	O
type	O
II	O
signal	O
anchor	O
(	O
SA	O
)	O
in	O
which	O
the	O
N	O
-	O
terminus	O
faces	O
the	O
cytoplasm	O
.	O
A	O
cDNA	O
fragment	O
containing	O
the	O
putative	O
SA	O
sequence	O
of	O
a	O
target	O
clone	O
was	O
fused	O
in	O
-	O
frame	O
to	O
the	O
5	O
'	O
end	O
of	O
a	O
cDNA	O
fragment	O
encoding	O
the	O
protease	O
domain	O
of	O
gene1s	O
urokinase	O
-	O
type	O
plasminogen	O
activator	O
gene1e	O
(	O
gene1s	O
u	O
-	O
PA	O
gene1e	O
)	O
.	O
The	O
resulting	O
fused	O
gene	O
was	O
expressed	O
in	O
arg1s	O
COS7	O
arg1e	O
cells	O
.	O
Fibrinolytic	O
activity	O
on	O
the	O
cell	O
surface	O
was	O
measured	O
by	O
placing	O
a	O
fibrin	O
sheet	O
in	O
contact	O
with	O
the	O
transfected	O
arg1s	O
COS7	O
arg1e	O
cells	O
after	O
removing	O
the	O
medium	O
.	O
When	O
the	O
cDNA	O
fragment	O
encoded	O
a	O
SA	O
,	O
the	O
fibrin	O
sheet	O
was	O
lysed	O
by	O
the	O
gene1s	O
u	O
-	O
PA	O
gene1e	O
expressed	O
on	O
the	O
cell	O
surface	O
.	O
The	O
fibrinolytic	O
activity	O
was	O
not	O
detected	O
in	O
the	O
culture	O
medium	O
,	O
suggesting	O
that	O
the	O
gene1s	O
u	O
-	O
PA	O
gene1e	O
remains	O
on	O
the	O
cell	O
surface	O
anchored	O
via	O
the	O
SA	O
in	O
the	O
membrane	O
without	O
being	O
cleaved	O
by	O
signal	O
peptidase	O
.	O
This	O
fibrin	O
sheet	O
method	O
was	O
successfully	O
applied	O
to	O
select	O
five	O
novel	O
cDNA	O
clones	O
encoding	O
putative	O
type	O
II	O
membrane	O
proteins	O
from	O
a	O
species1s	O
human	O
species1e	O
full	O
-	O
length	O
cDNA	O
bank	O
.	O

gene1s	ARG2
C1qRP	ARG2
gene1e	ARG2
is	O
a	O
heavily	O
O	O
-	O
glycosylated	O
cell	O
surface	O
protein	O
involved	O
in	O
the	O
regulation	O
of	O
phagocytic	O
activity	O
.	O
C1q	O
,	O
gene1s	ARG2
mannose	ARG2
-	ARG2
binding	ARG2
lectin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MBL	ARG2
gene1e	ARG2
)	O
,	O
and	O
gene1s	ARG2
pulmonary	ARG2
surfactant	ARG2
protein	ARG2
A	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SPA	ARG2
gene1e	ARG2
)	O
interact	O
with	O
arg1s	O
human	O
arg1e	O
monocytes	O
and	O
macrophages	O
,	O
resulting	O
in	O
the	O
enhancement	O
of	O
phagocytosis	O
of	O
suboptimally	O
opsonized	O
targets	O
.	O
mAbs	O
that	O
recognize	O
a	O
cell	O
surface	O
molecule	O
of	O
126,000	O
Mr	O
,	O
designated	O
gene1s	ARG2
C1qRP	ARG2
gene1e	ARG2
,	O
have	O
been	O
shown	O
to	O
inhibit	O
C1q-	O
and	O
gene1s	ARG2
MBL	ARG2
gene1e	ARG2
-	O
mediated	O
enhancement	O
of	O
phagocytosis	O
.	O
Similar	O
inhibition	O
of	O
the	O
gene1s	ARG2
SPA	ARG2
gene1e	ARG2
-	O
mediated	O
enhancement	O
of	O
phagocytosis	O
by	O
these	O
mAbs	O
now	O
suggests	O
that	O
gene1s	ARG2
C1qRP	ARG2
gene1e	ARG2
is	O
a	O
common	O
component	O
of	O
a	O
receptor	O
for	O
these	O
macromolecules	O
.	O
Ligation	O
of	O
arg1s	O
human	O
arg1e	O
monocytes	O
with	O
immobilized	O
R3	O
,	O
a	O
IgM	O
mAb	O
recognizing	O
gene1s	ARG2
C1qRP	ARG2
gene1e	ARG2
,	O
also	O
triggers	O
enhanced	O
phagocytic	O
capacity	O
of	O
these	O
cells	O
in	O
the	O
absence	O
of	O
ligand	O
,	O
verifying	O
the	O
direct	O
involvement	O
of	O
this	O
polypeptide	O
in	O
the	O
regulation	O
of	O
phagocytosis	O
.	O
While	O
the	O
cDNA	O
for	O
gene1s	ARG2
C1qRP	ARG2
gene1e	ARG2
encodes	O
a	O
631	O
amino	O
acid	O
membrane	O
protein	O
,	O
species1s	O
Chinese	O
hamster	O
species1e	O
ovary	O
cells	O
transfected	O
with	O
the	O
cDNA	O
of	O
the	O
gene1s	ARG2
C1qRP	ARG2
gene1e	ARG2
coding	O
region	O
express	O
a	O
surface	O
glycoprotein	O
with	O
the	O
identical	O
126,000	O
Mr	O
in	O
SDS	O
-	O
PAGE	O
as	O
the	O
native	O
gene1s	ARG2
C1qRP	ARG2
gene1e	ARG2
.	O
Use	O
of	O
glycosylation	O
inhibitors	O
,	O
cleavage	O
of	O
the	O
mature	O
gene1s	ARG2
C1qRP	ARG2
gene1e	ARG2
with	O
specific	O
glycosidases	O
,	O
and	O
in	O
vitro	O
translation	O
of	O
gene1s	ARG2
C1qRP	ARG2
gene1e	ARG2
cDNA	O
demonstrated	O
that	O
both	O
posttranslational	O
glycosylation	O
and	O
the	O
nature	O
of	O
the	O
amino	O
acid	O
sequence	O
of	O
the	O
protein	O
contribute	O
to	O
the	O
difference	O
between	O
its	O
predicted	O
m.w	O
.	O
and	O
its	O
migration	O
on	O
SDS	O
-	O
PAGE	O
.	O
These	O
results	O
verify	O
that	O
the	O
cDNA	O
cloned	O
codes	O
for	O
the	O
mature	O
gene1s	ARG2
C1qRP	ARG2
gene1e	ARG2
,	O
that	O
gene1s	ARG2
C1qRP	ARG2
gene1e	ARG2
contains	O
a	O
relatively	O
high	O
degree	O
of	O
O	O
-	O
linked	O
glycoslyation	O
,	O
and	O
that	O
gene1s	ARG2
C1qRP	ARG2
gene1e	ARG2
cross	O
-	O
linked	O
directly	O
by	O
monoclonal	O
anti	O
-	O
gene1s	ARG2
C1qRP	ARG2
gene1e	ARG2
or	O
engaged	O
as	O
a	O
result	O
of	O
cell	O
surface	O
ligation	O
of	O
gene1s	ARG2
SPA	ARG2
gene1e	ARG2
,	O
as	O
well	O
as	O
C1q	O
and	O
gene1s	ARG2
MBL	ARG2
gene1e	ARG2
,	O
enhances	O
phagocytosis	O
.	O

gene1s	O
C1qRP	O
gene1e	O
is	O
a	O
heavily	O
O	O
-	O
glycosylated	O
cell	O
surface	O
protein	O
involved	O
in	O
the	O
regulation	O
of	O
phagocytic	O
activity	O
.	O
C1q	O
,	O
gene1s	O
mannose	O
-	O
binding	O
lectin	O
gene1e	O
(	O
gene1s	O
MBL	O
gene1e	O
)	O
,	O
and	O
gene1s	O
pulmonary	O
surfactant	O
protein	O
A	O
gene1e	O
(	O
gene1s	O
SPA	O
gene1e	O
)	O
interact	O
with	O
species1s	O
human	O
species1e	O
monocytes	O
and	O
macrophages	O
,	O
resulting	O
in	O
the	O
enhancement	O
of	O
phagocytosis	O
of	O
suboptimally	O
opsonized	O
targets	O
.	O
mAbs	O
that	O
recognize	O
a	O
cell	O
surface	O
molecule	O
of	O
126,000	O
Mr	O
,	O
designated	O
gene1s	O
C1qRP	O
gene1e	O
,	O
have	O
been	O
shown	O
to	O
inhibit	O
C1q-	O
and	O
gene1s	O
MBL	O
gene1e	O
-	O
mediated	O
enhancement	O
of	O
phagocytosis	O
.	O
Similar	O
inhibition	O
of	O
the	O
gene1s	O
SPA	O
gene1e	O
-	O
mediated	O
enhancement	O
of	O
phagocytosis	O
by	O
these	O
mAbs	O
now	O
suggests	O
that	O
gene1s	O
C1qRP	O
gene1e	O
is	O
a	O
common	O
component	O
of	O
a	O
receptor	O
for	O
these	O
macromolecules	O
.	O
Ligation	O
of	O
species1s	O
human	O
species1e	O
monocytes	O
with	O
immobilized	O
R3	O
,	O
a	O
IgM	O
mAb	O
recognizing	O
gene1s	O
C1qRP	O
gene1e	O
,	O
also	O
triggers	O
enhanced	O
phagocytic	O
capacity	O
of	O
these	O
cells	O
in	O
the	O
absence	O
of	O
ligand	O
,	O
verifying	O
the	O
direct	O
involvement	O
of	O
this	O
polypeptide	O
in	O
the	O
regulation	O
of	O
phagocytosis	O
.	O
While	O
the	O
cDNA	O
for	O
gene1s	O
C1qRP	O
gene1e	O
encodes	O
a	O
631	O
amino	O
acid	O
membrane	O
protein	O
,	O
arg1s	O
Chinese	O
hamster	O
arg1e	O
ovary	O
cells	O
transfected	O
with	O
the	O
cDNA	O
of	O
the	O
gene1s	O
C1qRP	O
gene1e	O
coding	O
region	O
express	O
a	O
surface	O
glycoprotein	O
with	O
the	O
identical	O
126,000	O
Mr	O
in	O
SDS	O
-	O
PAGE	O
as	O
the	O
native	O
gene1s	O
C1qRP	O
gene1e	O
.	O
Use	O
of	O
glycosylation	O
inhibitors	O
,	O
cleavage	O
of	O
the	O
mature	O
gene1s	O
C1qRP	O
gene1e	O
with	O
specific	O
glycosidases	O
,	O
and	O
in	O
vitro	O
translation	O
of	O
gene1s	O
C1qRP	O
gene1e	O
cDNA	O
demonstrated	O
that	O
both	O
posttranslational	O
glycosylation	O
and	O
the	O
nature	O
of	O
the	O
amino	O
acid	O
sequence	O
of	O
the	O
protein	O
contribute	O
to	O
the	O
difference	O
between	O
its	O
predicted	O
m.w	O
.	O
and	O
its	O
migration	O
on	O
SDS	O
-	O
PAGE	O
.	O
These	O
results	O
verify	O
that	O
the	O
cDNA	O
cloned	O
codes	O
for	O
the	O
mature	O
gene1s	O
C1qRP	O
gene1e	O
,	O
that	O
gene1s	O
C1qRP	O
gene1e	O
contains	O
a	O
relatively	O
high	O
degree	O
of	O
O	O
-	O
linked	O
glycoslyation	O
,	O
and	O
that	O
gene1s	O
C1qRP	O
gene1e	O
cross	O
-	O
linked	O
directly	O
by	O
monoclonal	O
anti	O
-	O
gene1s	O
C1qRP	O
gene1e	O
or	O
engaged	O
as	O
a	O
result	O
of	O
cell	O
surface	O
ligation	O
of	O
gene1s	O
SPA	O
gene1e	O
,	O
as	O
well	O
as	O
C1q	O
and	O
gene1s	O
MBL	O
gene1e	O
,	O
enhances	O
phagocytosis	O
.	O

A	O
mutation	O
in	O
gene1s	ARG2
OTOF	ARG2
gene1e	ARG2
,	O
encoding	O
gene1s	ARG2
otoferlin	ARG2
gene1e	ARG2
,	O
a	O
FER-1-like	O
protein	O
,	O
causes	O
gene1s	ARG2
DFNB9	ARG2
gene1e	ARG2
,	O
a	O
nonsyndromic	O
form	O
of	O
deafness	O
.	O
Using	O
a	O
candidate	O
gene	O
approach	O
,	O
we	O
identified	O
a	O
novel	O
arg1s	O
human	O
arg1e	O
gene	O
,	O
gene1s	ARG2
OTOF	ARG2
gene1e	ARG2
,	O
underlying	O
an	O
autosomal	O
recessive	O
,	O
nonsyndromic	O
prelingual	O
deafness	O
,	O
gene1s	ARG2
DFNB9	ARG2
gene1e	ARG2
.	O
The	O
same	O
nonsense	O
mutation	O
was	O
detected	O
in	O
four	O
unrelated	O
affected	O
families	O
of	O
Lebanese	O
origin	O
.	O
gene1s	ARG2
OTOF	ARG2
gene1e	ARG2
is	O
the	O
second	O
member	O
of	O
a	O
arg1s	O
mammalian	O
arg1e	O
gene	O
family	O
related	O
to	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
gene1s	O
fer-1	O
gene1e	O
.	O
It	O
encodes	O
a	O
predicted	O
cytosolic	O
protein	O
(	O
of	O
1,230	O
aa	O
)	O
with	O
three	O
C2	O
domains	O
and	O
a	O
single	O
carboxy	O
-	O
terminal	O
transmembrane	O
domain	O
.	O
The	O
sequence	O
homologies	O
and	O
predicted	O
structure	O
of	O
gene1s	ARG2
otoferlin	ARG2
gene1e	ARG2
,	O
the	O
protein	O
encoded	O
by	O
gene1s	ARG2
OTOF	ARG2
gene1e	ARG2
,	O
suggest	O
its	O
involvement	O
in	O
vesicle	O
membrane	O
fusion	O
.	O
In	O
the	O
inner	O
ear	O
,	O
the	O
expression	O
of	O
the	O
orthologous	O
species1s	O
mouse	O
species1e	O
gene	O
,	O
mainly	O
in	O
the	O
sensory	O
hair	O
cells	O
,	O
indicates	O
that	O
such	O
a	O
role	O
could	O
apply	O
to	O
synaptic	O
vesicles	O
.	O

A	O
mutation	O
in	O
gene1s	O
OTOF	O
gene1e	O
,	O
encoding	O
gene1s	O
otoferlin	O
gene1e	O
,	O
a	O
FER-1-like	O
protein	O
,	O
causes	O
gene1s	O
DFNB9	O
gene1e	O
,	O
a	O
nonsyndromic	O
form	O
of	O
deafness	O
.	O
Using	O
a	O
candidate	O
gene	O
approach	O
,	O
we	O
identified	O
a	O
novel	O
species1s	O
human	O
species1e	O
gene	O
,	O
gene1s	O
OTOF	O
gene1e	O
,	O
underlying	O
an	O
autosomal	O
recessive	O
,	O
nonsyndromic	O
prelingual	O
deafness	O
,	O
gene1s	O
DFNB9	O
gene1e	O
.	O
The	O
same	O
nonsense	O
mutation	O
was	O
detected	O
in	O
four	O
unrelated	O
affected	O
families	O
of	O
Lebanese	O
origin	O
.	O
gene1s	O
OTOF	O
gene1e	O
is	O
the	O
second	O
member	O
of	O
a	O
species1s	O
mammalian	O
species1e	O
gene	O
family	O
related	O
to	O
arg1s	O
Caenorhabditis	O
elegans	O
arg1e	O
gene1s	ARG2
fer-1	ARG2
gene1e	ARG2
.	O
It	O
encodes	O
a	O
predicted	O
cytosolic	O
protein	O
(	O
of	O
1,230	O
aa	O
)	O
with	O
three	O
C2	O
domains	O
and	O
a	O
single	O
carboxy	O
-	O
terminal	O
transmembrane	O
domain	O
.	O
The	O
sequence	O
homologies	O
and	O
predicted	O
structure	O
of	O
gene1s	O
otoferlin	O
gene1e	O
,	O
the	O
protein	O
encoded	O
by	O
gene1s	O
OTOF	O
gene1e	O
,	O
suggest	O
its	O
involvement	O
in	O
vesicle	O
membrane	O
fusion	O
.	O
In	O
the	O
inner	O
ear	O
,	O
the	O
expression	O
of	O
the	O
orthologous	O
species1s	O
mouse	O
species1e	O
gene	O
,	O
mainly	O
in	O
the	O
sensory	O
hair	O
cells	O
,	O
indicates	O
that	O
such	O
a	O
role	O
could	O
apply	O
to	O
synaptic	O
vesicles	O
.	O

A	O
mutation	O
in	O
gene1s	O
OTOF	O
gene1e	O
,	O
encoding	O
gene1s	O
otoferlin	O
gene1e	O
,	O
a	O
FER-1-like	O
protein	O
,	O
causes	O
gene1s	O
DFNB9	O
gene1e	O
,	O
a	O
nonsyndromic	O
form	O
of	O
deafness	O
.	O
Using	O
a	O
candidate	O
gene	O
approach	O
,	O
we	O
identified	O
a	O
novel	O
species1s	O
human	O
species1e	O
gene	O
,	O
gene1s	O
OTOF	O
gene1e	O
,	O
underlying	O
an	O
autosomal	O
recessive	O
,	O
nonsyndromic	O
prelingual	O
deafness	O
,	O
gene1s	O
DFNB9	O
gene1e	O
.	O
The	O
same	O
nonsense	O
mutation	O
was	O
detected	O
in	O
four	O
unrelated	O
affected	O
families	O
of	O
Lebanese	O
origin	O
.	O
gene1s	O
OTOF	O
gene1e	O
is	O
the	O
second	O
member	O
of	O
a	O
species1s	O
mammalian	O
species1e	O
gene	O
family	O
related	O
to	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
gene1s	O
fer-1	O
gene1e	O
.	O
It	O
encodes	O
a	O
predicted	O
cytosolic	O
protein	O
(	O
of	O
1,230	O
aa	O
)	O
with	O
three	O
C2	O
domains	O
and	O
a	O
single	O
carboxy	O
-	O
terminal	O
transmembrane	O
domain	O
.	O
The	O
sequence	O
homologies	O
and	O
predicted	O
structure	O
of	O
gene1s	O
otoferlin	O
gene1e	O
,	O
the	O
protein	O
encoded	O
by	O
gene1s	O
OTOF	O
gene1e	O
,	O
suggest	O
its	O
involvement	O
in	O
vesicle	O
membrane	O
fusion	O
.	O
In	O
the	O
inner	O
ear	O
,	O
the	O
expression	O
of	O
the	O
orthologous	O
arg1s	O
mouse	O
arg1e	O
gene	O
,	O
mainly	O
in	O
the	O
sensory	O
hair	O
cells	O
,	O
indicates	O
that	O
such	O
a	O
role	O
could	O
apply	O
to	O
synaptic	O
vesicles	O
.	O

gene1s	O
Slit2	O
gene1e	O
-Mediated	O
chemorepulsion	O
and	O
collapse	O
of	O
developing	O
forebrain	O
axons	O
.	O
Diffusible	O
chemorepellents	O
play	O
a	O
major	O
role	O
in	O
guiding	O
developing	O
axons	O
toward	O
their	O
correct	O
targets	O
by	O
preventing	O
them	O
from	O
entering	O
or	O
steering	O
them	O
away	O
from	O
certain	O
regions	O
.	O
Genetic	O
studies	O
in	O
arg1s	O
Drosophila	O
arg1e	O
revealed	O
a	O
novel	O
repulsive	O
guidance	O
system	O
that	O
prevents	O
inappropriate	O
axons	O
from	O
crossing	O
the	O
CNS	O
midline	O
;	O
this	O
repulsive	O
system	O
is	O
mediated	O
by	O
the	O
Roundabout	O
(	O
Robo	O
)	O
receptor	O
and	O
its	O
secreted	O
ligand	O
Slit	O
.	O
In	O
rodents	O
,	O
Robo	O
and	O
Slit	O
are	O
expressed	O
in	O
the	O
spinal	O
cord	O
and	O
Slit	O
can	O
repel	O
spinal	O
motor	O
axons	O
in	O
vitro	O
.	O
Here	O
,	O
we	O
extend	O
these	O
findings	O
into	O
higher	O
brain	O
centers	O
by	O
showing	O
that	O
gene1s	O
Robo1	O
gene1e	O
and	O
gene1s	O
Robo2	O
gene1e	O
,	O
as	O
well	O
as	O
gene1s	O
Slit1	O
gene1e	O
and	O
gene1s	O
Slit2	O
gene1e	O
,	O
are	O
often	O
expressed	O
in	O
complementary	O
patterns	O
in	O
the	O
developing	O
forebrain	O
.	O
Furthermore	O
,	O
we	O
show	O
that	O
species1s	O
human	O
species1e	O
gene1s	O
Slit2	O
gene1e	O
can	O
repel	O
olfactory	O
and	O
hippocampal	O
axons	O
and	O
collapse	O
their	O
growth	O
cones	O
.	O

gene1s	ARG2
Slit2	ARG2
gene1e	ARG2
-Mediated	O
chemorepulsion	O
and	O
collapse	O
of	O
developing	O
forebrain	O
axons	O
.	O
Diffusible	O
chemorepellents	O
play	O
a	O
major	O
role	O
in	O
guiding	O
developing	O
axons	O
toward	O
their	O
correct	O
targets	O
by	O
preventing	O
them	O
from	O
entering	O
or	O
steering	O
them	O
away	O
from	O
certain	O
regions	O
.	O
Genetic	O
studies	O
in	O
species1s	O
Drosophila	O
species1e	O
revealed	O
a	O
novel	O
repulsive	O
guidance	O
system	O
that	O
prevents	O
inappropriate	O
axons	O
from	O
crossing	O
the	O
CNS	O
midline	O
;	O
this	O
repulsive	O
system	O
is	O
mediated	O
by	O
the	O
Roundabout	O
(	O
Robo	O
)	O
receptor	O
and	O
its	O
secreted	O
ligand	O
Slit	O
.	O
In	O
rodents	O
,	O
Robo	O
and	O
Slit	O
are	O
expressed	O
in	O
the	O
spinal	O
cord	O
and	O
Slit	O
can	O
repel	O
spinal	O
motor	O
axons	O
in	O
vitro	O
.	O
Here	O
,	O
we	O
extend	O
these	O
findings	O
into	O
higher	O
brain	O
centers	O
by	O
showing	O
that	O
gene1s	ARG2
Robo1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Robo2	ARG2
gene1e	ARG2
,	O
as	O
well	O
as	O
gene1s	ARG2
Slit1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Slit2	ARG2
gene1e	ARG2
,	O
are	O
often	O
expressed	O
in	O
complementary	O
patterns	O
in	O
the	O
developing	O
forebrain	O
.	O
Furthermore	O
,	O
we	O
show	O
that	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
Slit2	ARG2
gene1e	ARG2
can	O
repel	O
olfactory	O
and	O
hippocampal	O
axons	O
and	O
collapse	O
their	O
growth	O
cones	O
.	O

gene1s	ARG2
Metaxin	ARG2
1	ARG2
gene1e	ARG2
interacts	O
with	O
gene1s	ARG2
metaxin	ARG2
2	ARG2
gene1e	ARG2
,	O
a	O
novel	O
related	O
protein	O
associated	O
with	O
the	O
arg1s	O
mammalian	O
arg1e	O
mitochondrial	O
outer	O
membrane	O
.	O
A	O
recently	O
described	O
protein	O
,	O
gene1s	ARG2
metaxin	ARG2
1	ARG2
gene1e	ARG2
,	O
serves	O
as	O
a	O
component	O
of	O
a	O
preprotein	O
import	O
complex	O
in	O
the	O
outer	O
membrane	O
of	O
the	O
arg1s	O
mammalian	O
arg1e	O
mitochondrion	O
.	O
A	O
yeast	O
two	O
-	O
hybrid	O
screen	O
with	O
gene1s	ARG2
metaxin	ARG2
1	ARG2
gene1e	ARG2
as	O
bait	O
has	O
now	O
identified	O
a	O
novel	O
protein	O
,	O
which	O
we	O
have	O
termed	O
gene1s	ARG2
metaxin	ARG2
2	ARG2
gene1e	ARG2
,	O
as	O
a	O
metaxin	O
1-binding	O
protein	O
.	O
gene1s	ARG2
Metaxin	ARG2
2	ARG2
gene1e	ARG2
shares	O
29	O
%	O
identity	O
with	O
gene1s	ARG2
metaxin	ARG2
1	ARG2
gene1e	ARG2
at	O
the	O
amino	O
acid	O
level	O
,	O
but	O
gene1s	ARG2
metaxin	ARG2
2	ARG2
gene1e	ARG2
,	O
unlike	O
gene1s	ARG2
metaxin	ARG2
1	ARG2
gene1e	ARG2
,	O
lacks	O
a	O
C	O
-	O
terminal	O
mitochondrial	O
outer	O
membrane	O
signal	O
-	O
anchor	O
domain	O
.	O
Two	O
species1s	O
C.	O
elegans	O
species1e	O
hypothetical	O
proteins	O
,	O
gene1s	O
CelZC97.1	O
gene1e	O
and	O
gene1s	O
CelF39B2.i	O
gene1e	O
,	O
share	O
high	O
sequence	O
similarity	O
with	O
gene1s	ARG2
metaxin	ARG2
2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
metaxin	ARG2
1	ARG2
gene1e	ARG2
,	O
respectively	O
,	O
and	O
likely	O
represent	O
the	O
species1s	O
C.	O
elegans	O
species1e	O
orthologs	O
.	O
Affinity	O
-	O
purified	O
antibodies	O
against	O
gene1s	ARG2
metaxin	ARG2
2	ARG2
gene1e	ARG2
were	O
prepared	O
against	O
the	O
recombinant	O
protein	O
produced	O
in	O
species1s	O
E.	O
coli	O
species1e	O
and	O
were	O
used	O
to	O
analyze	O
the	O
subcellular	O
distribution	O
of	O
gene1s	ARG2
metaxin	ARG2
2	ARG2
gene1e	ARG2
.	O
In	O
subcellular	O
fractions	O
of	O
species1s	O
mouse	O
species1e	O
liver	O
,	O
a	O
29	O
kD	O
immunoreactive	O
protein	O
,	O
consistent	O
in	O
size	O
with	O
the	O
predicted	O
translation	O
product	O
of	O
gene1s	O
metaxin	O
2	O
gene1e	O
cDNA	O
,	O
was	O
found	O
solely	O
in	O
mitochondria	O
.	O
Alkali	O
extraction	O
of	O
mitochondria	O
indicated	O
that	O
gene1s	ARG2
metaxin	ARG2
2	ARG2
gene1e	ARG2
is	O
peripherally	O
associated	O
with	O
mitochondrial	O
membranes	O
.	O
gene1s	ARG2
Metaxin	ARG2
2	ARG2
gene1e	ARG2
in	O
intact	O
mitochondria	O
was	O
susceptible	O
to	O
digestion	O
with	O
proteinase	O
K	O
,	O
indicating	O
that	O
gene1s	ARG2
metaxin	ARG2
2	ARG2
gene1e	ARG2
is	O
located	O
on	O
the	O
cytosolic	O
face	O
of	O
the	O
mitochondrial	O
outer	O
membrane	O
.	O
Finally	O
,	O
baculoviruses	O
encoding	O
a	O
His6-tagged	O
gene1s	ARG2
metaxin	ARG2
2	ARG2
gene1e	ARG2
and	O
an	O
untagged	O
gene1s	ARG2
metaxin	ARG2
1	ARG2
gene1e	ARG2
lacking	O
its	O
C	O
-	O
terminal	O
transmembrane	O
domain	O
were	O
produced	O
and	O
used	O
separately	O
or	O
in	O
combination	O
to	O
infect	O
species1s	O
Sf21	O
species1e	O
insect	O
cells	O
.	O
gene1s	ARG2
Metaxin	ARG2
1	ARG2
gene1e	ARG2
bound	O
to	O
a	O
Ni2	O
+	O
-chelate	O
affinity	O
column	O
only	O
in	O
the	O
presence	O
of	O
gene1s	ARG2
metaxin	ARG2
2	ARG2
gene1e	ARG2
,	O
indicating	O
that	O
gene1s	ARG2
metaxin	ARG2
1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
metaxin	ARG2
2	ARG2
gene1e	ARG2
interact	O
when	O
overexpressed	O
in	O
insect	O
cells	O
.	O
These	O
results	O
suggest	O
that	O
gene1s	ARG2
metaxin	ARG2
2	ARG2
gene1e	ARG2
is	O
bound	O
to	O
the	O
cytosolic	O
face	O
of	O
the	O
mitochondrial	O
outer	O
membrane	O
by	O
means	O
of	O
its	O
interaction	O
with	O
membrane	O
-	O
bound	O
gene1s	ARG2
metaxin	ARG2
1	ARG2
gene1e	ARG2
,	O
and	O
that	O
this	O
complex	O
may	O
play	O
a	O
role	O
in	O
protein	O
import	O
into	O
arg1s	O
mammalian	O
arg1e	O
mitochondria	O
.	O

gene1s	O
Metaxin	O
1	O
gene1e	O
interacts	O
with	O
gene1s	O
metaxin	O
2	O
gene1e	O
,	O
a	O
novel	O
related	O
protein	O
associated	O
with	O
the	O
species1s	O
mammalian	O
species1e	O
mitochondrial	O
outer	O
membrane	O
.	O
A	O
recently	O
described	O
protein	O
,	O
gene1s	O
metaxin	O
1	O
gene1e	O
,	O
serves	O
as	O
a	O
component	O
of	O
a	O
preprotein	O
import	O
complex	O
in	O
the	O
outer	O
membrane	O
of	O
the	O
species1s	O
mammalian	O
species1e	O
mitochondrion	O
.	O
A	O
yeast	O
two	O
-	O
hybrid	O
screen	O
with	O
gene1s	O
metaxin	O
1	O
gene1e	O
as	O
bait	O
has	O
now	O
identified	O
a	O
novel	O
protein	O
,	O
which	O
we	O
have	O
termed	O
gene1s	O
metaxin	O
2	O
gene1e	O
,	O
as	O
a	O
metaxin	O
1-binding	O
protein	O
.	O
gene1s	O
Metaxin	O
2	O
gene1e	O
shares	O
29	O
%	O
identity	O
with	O
gene1s	O
metaxin	O
1	O
gene1e	O
at	O
the	O
amino	O
acid	O
level	O
,	O
but	O
gene1s	O
metaxin	O
2	O
gene1e	O
,	O
unlike	O
gene1s	O
metaxin	O
1	O
gene1e	O
,	O
lacks	O
a	O
C	O
-	O
terminal	O
mitochondrial	O
outer	O
membrane	O
signal	O
-	O
anchor	O
domain	O
.	O
Two	O
arg1s	O
C.	O
elegans	O
arg1e	O
hypothetical	O
proteins	O
,	O
gene1s	ARG2
CelZC97.1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CelF39B2.i	ARG2
gene1e	ARG2
,	O
share	O
high	O
sequence	O
similarity	O
with	O
gene1s	O
metaxin	O
2	O
gene1e	O
and	O
gene1s	O
metaxin	O
1	O
gene1e	O
,	O
respectively	O
,	O
and	O
likely	O
represent	O
the	O
arg1s	O
C.	O
elegans	O
arg1e	O
orthologs	O
.	O
Affinity	O
-	O
purified	O
antibodies	O
against	O
gene1s	O
metaxin	O
2	O
gene1e	O
were	O
prepared	O
against	O
the	O
recombinant	O
protein	O
produced	O
in	O
species1s	O
E.	O
coli	O
species1e	O
and	O
were	O
used	O
to	O
analyze	O
the	O
subcellular	O
distribution	O
of	O
gene1s	O
metaxin	O
2	O
gene1e	O
.	O
In	O
subcellular	O
fractions	O
of	O
species1s	O
mouse	O
species1e	O
liver	O
,	O
a	O
29	O
kD	O
immunoreactive	O
protein	O
,	O
consistent	O
in	O
size	O
with	O
the	O
predicted	O
translation	O
product	O
of	O
gene1s	O
metaxin	O
2	O
gene1e	O
cDNA	O
,	O
was	O
found	O
solely	O
in	O
mitochondria	O
.	O
Alkali	O
extraction	O
of	O
mitochondria	O
indicated	O
that	O
gene1s	O
metaxin	O
2	O
gene1e	O
is	O
peripherally	O
associated	O
with	O
mitochondrial	O
membranes	O
.	O
gene1s	O
Metaxin	O
2	O
gene1e	O
in	O
intact	O
mitochondria	O
was	O
susceptible	O
to	O
digestion	O
with	O
proteinase	O
K	O
,	O
indicating	O
that	O
gene1s	O
metaxin	O
2	O
gene1e	O
is	O
located	O
on	O
the	O
cytosolic	O
face	O
of	O
the	O
mitochondrial	O
outer	O
membrane	O
.	O
Finally	O
,	O
baculoviruses	O
encoding	O
a	O
His6-tagged	O
gene1s	O
metaxin	O
2	O
gene1e	O
and	O
an	O
untagged	O
gene1s	O
metaxin	O
1	O
gene1e	O
lacking	O
its	O
C	O
-	O
terminal	O
transmembrane	O
domain	O
were	O
produced	O
and	O
used	O
separately	O
or	O
in	O
combination	O
to	O
infect	O
species1s	O
Sf21	O
species1e	O
insect	O
cells	O
.	O
gene1s	O
Metaxin	O
1	O
gene1e	O
bound	O
to	O
a	O
Ni2	O
+	O
-chelate	O
affinity	O
column	O
only	O
in	O
the	O
presence	O
of	O
gene1s	O
metaxin	O
2	O
gene1e	O
,	O
indicating	O
that	O
gene1s	O
metaxin	O
1	O
gene1e	O
and	O
gene1s	O
metaxin	O
2	O
gene1e	O
interact	O
when	O
overexpressed	O
in	O
insect	O
cells	O
.	O
These	O
results	O
suggest	O
that	O
gene1s	O
metaxin	O
2	O
gene1e	O
is	O
bound	O
to	O
the	O
cytosolic	O
face	O
of	O
the	O
mitochondrial	O
outer	O
membrane	O
by	O
means	O
of	O
its	O
interaction	O
with	O
membrane	O
-	O
bound	O
gene1s	O
metaxin	O
1	O
gene1e	O
,	O
and	O
that	O
this	O
complex	O
may	O
play	O
a	O
role	O
in	O
protein	O
import	O
into	O
species1s	O
mammalian	O
species1e	O
mitochondria	O
.	O

gene1s	O
Metaxin	O
1	O
gene1e	O
interacts	O
with	O
gene1s	O
metaxin	O
2	O
gene1e	O
,	O
a	O
novel	O
related	O
protein	O
associated	O
with	O
the	O
species1s	O
mammalian	O
species1e	O
mitochondrial	O
outer	O
membrane	O
.	O
A	O
recently	O
described	O
protein	O
,	O
gene1s	O
metaxin	O
1	O
gene1e	O
,	O
serves	O
as	O
a	O
component	O
of	O
a	O
preprotein	O
import	O
complex	O
in	O
the	O
outer	O
membrane	O
of	O
the	O
species1s	O
mammalian	O
species1e	O
mitochondrion	O
.	O
A	O
yeast	O
two	O
-	O
hybrid	O
screen	O
with	O
gene1s	O
metaxin	O
1	O
gene1e	O
as	O
bait	O
has	O
now	O
identified	O
a	O
novel	O
protein	O
,	O
which	O
we	O
have	O
termed	O
gene1s	O
metaxin	O
2	O
gene1e	O
,	O
as	O
a	O
metaxin	O
1-binding	O
protein	O
.	O
gene1s	O
Metaxin	O
2	O
gene1e	O
shares	O
29	O
%	O
identity	O
with	O
gene1s	O
metaxin	O
1	O
gene1e	O
at	O
the	O
amino	O
acid	O
level	O
,	O
but	O
gene1s	O
metaxin	O
2	O
gene1e	O
,	O
unlike	O
gene1s	O
metaxin	O
1	O
gene1e	O
,	O
lacks	O
a	O
C	O
-	O
terminal	O
mitochondrial	O
outer	O
membrane	O
signal	O
-	O
anchor	O
domain	O
.	O
Two	O
species1s	O
C.	O
elegans	O
species1e	O
hypothetical	O
proteins	O
,	O
gene1s	O
CelZC97.1	O
gene1e	O
and	O
gene1s	O
CelF39B2.i	O
gene1e	O
,	O
share	O
high	O
sequence	O
similarity	O
with	O
gene1s	O
metaxin	O
2	O
gene1e	O
and	O
gene1s	O
metaxin	O
1	O
gene1e	O
,	O
respectively	O
,	O
and	O
likely	O
represent	O
the	O
species1s	O
C.	O
elegans	O
species1e	O
orthologs	O
.	O
Affinity	O
-	O
purified	O
antibodies	O
against	O
gene1s	O
metaxin	O
2	O
gene1e	O
were	O
prepared	O
against	O
the	O
recombinant	O
protein	O
produced	O
in	O
arg1s	O
E.	O
coli	O
arg1e	O
and	O
were	O
used	O
to	O
analyze	O
the	O
subcellular	O
distribution	O
of	O
gene1s	O
metaxin	O
2	O
gene1e	O
.	O
In	O
subcellular	O
fractions	O
of	O
species1s	O
mouse	O
species1e	O
liver	O
,	O
a	O
29	O
kD	O
immunoreactive	O
protein	O
,	O
consistent	O
in	O
size	O
with	O
the	O
predicted	O
translation	O
product	O
of	O
gene1s	O
metaxin	O
2	O
gene1e	O
cDNA	O
,	O
was	O
found	O
solely	O
in	O
mitochondria	O
.	O
Alkali	O
extraction	O
of	O
mitochondria	O
indicated	O
that	O
gene1s	O
metaxin	O
2	O
gene1e	O
is	O
peripherally	O
associated	O
with	O
mitochondrial	O
membranes	O
.	O
gene1s	O
Metaxin	O
2	O
gene1e	O
in	O
intact	O
mitochondria	O
was	O
susceptible	O
to	O
digestion	O
with	O
proteinase	O
K	O
,	O
indicating	O
that	O
gene1s	O
metaxin	O
2	O
gene1e	O
is	O
located	O
on	O
the	O
cytosolic	O
face	O
of	O
the	O
mitochondrial	O
outer	O
membrane	O
.	O
Finally	O
,	O
baculoviruses	O
encoding	O
a	O
His6-tagged	O
gene1s	O
metaxin	O
2	O
gene1e	O
and	O
an	O
untagged	O
gene1s	O
metaxin	O
1	O
gene1e	O
lacking	O
its	O
C	O
-	O
terminal	O
transmembrane	O
domain	O
were	O
produced	O
and	O
used	O
separately	O
or	O
in	O
combination	O
to	O
infect	O
species1s	O
Sf21	O
species1e	O
insect	O
cells	O
.	O
gene1s	O
Metaxin	O
1	O
gene1e	O
bound	O
to	O
a	O
Ni2	O
+	O
-chelate	O
affinity	O
column	O
only	O
in	O
the	O
presence	O
of	O
gene1s	O
metaxin	O
2	O
gene1e	O
,	O
indicating	O
that	O
gene1s	O
metaxin	O
1	O
gene1e	O
and	O
gene1s	O
metaxin	O
2	O
gene1e	O
interact	O
when	O
overexpressed	O
in	O
insect	O
cells	O
.	O
These	O
results	O
suggest	O
that	O
gene1s	O
metaxin	O
2	O
gene1e	O
is	O
bound	O
to	O
the	O
cytosolic	O
face	O
of	O
the	O
mitochondrial	O
outer	O
membrane	O
by	O
means	O
of	O
its	O
interaction	O
with	O
membrane	O
-	O
bound	O
gene1s	O
metaxin	O
1	O
gene1e	O
,	O
and	O
that	O
this	O
complex	O
may	O
play	O
a	O
role	O
in	O
protein	O
import	O
into	O
species1s	O
mammalian	O
species1e	O
mitochondria	O
.	O

gene1s	O
Metaxin	O
1	O
gene1e	O
interacts	O
with	O
gene1s	O
metaxin	O
2	O
gene1e	O
,	O
a	O
novel	O
related	O
protein	O
associated	O
with	O
the	O
species1s	O
mammalian	O
species1e	O
mitochondrial	O
outer	O
membrane	O
.	O
A	O
recently	O
described	O
protein	O
,	O
gene1s	O
metaxin	O
1	O
gene1e	O
,	O
serves	O
as	O
a	O
component	O
of	O
a	O
preprotein	O
import	O
complex	O
in	O
the	O
outer	O
membrane	O
of	O
the	O
species1s	O
mammalian	O
species1e	O
mitochondrion	O
.	O
A	O
yeast	O
two	O
-	O
hybrid	O
screen	O
with	O
gene1s	O
metaxin	O
1	O
gene1e	O
as	O
bait	O
has	O
now	O
identified	O
a	O
novel	O
protein	O
,	O
which	O
we	O
have	O
termed	O
gene1s	O
metaxin	O
2	O
gene1e	O
,	O
as	O
a	O
metaxin	O
1-binding	O
protein	O
.	O
gene1s	O
Metaxin	O
2	O
gene1e	O
shares	O
29	O
%	O
identity	O
with	O
gene1s	O
metaxin	O
1	O
gene1e	O
at	O
the	O
amino	O
acid	O
level	O
,	O
but	O
gene1s	O
metaxin	O
2	O
gene1e	O
,	O
unlike	O
gene1s	O
metaxin	O
1	O
gene1e	O
,	O
lacks	O
a	O
C	O
-	O
terminal	O
mitochondrial	O
outer	O
membrane	O
signal	O
-	O
anchor	O
domain	O
.	O
Two	O
species1s	O
C.	O
elegans	O
species1e	O
hypothetical	O
proteins	O
,	O
gene1s	O
CelZC97.1	O
gene1e	O
and	O
gene1s	O
CelF39B2.i	O
gene1e	O
,	O
share	O
high	O
sequence	O
similarity	O
with	O
gene1s	O
metaxin	O
2	O
gene1e	O
and	O
gene1s	O
metaxin	O
1	O
gene1e	O
,	O
respectively	O
,	O
and	O
likely	O
represent	O
the	O
species1s	O
C.	O
elegans	O
species1e	O
orthologs	O
.	O
Affinity	O
-	O
purified	O
antibodies	O
against	O
gene1s	O
metaxin	O
2	O
gene1e	O
were	O
prepared	O
against	O
the	O
recombinant	O
protein	O
produced	O
in	O
species1s	O
E.	O
coli	O
species1e	O
and	O
were	O
used	O
to	O
analyze	O
the	O
subcellular	O
distribution	O
of	O
gene1s	O
metaxin	O
2	O
gene1e	O
.	O
In	O
subcellular	O
fractions	O
of	O
arg1s	O
mouse	O
arg1e	O
liver	O
,	O
a	O
29	O
kD	O
immunoreactive	O
protein	O
,	O
consistent	O
in	O
size	O
with	O
the	O
predicted	O
translation	O
product	O
of	O
gene1s	ARG2
metaxin	ARG2
2	ARG2
gene1e	ARG2
cDNA	O
,	O
was	O
found	O
solely	O
in	O
mitochondria	O
.	O
Alkali	O
extraction	O
of	O
mitochondria	O
indicated	O
that	O
gene1s	O
metaxin	O
2	O
gene1e	O
is	O
peripherally	O
associated	O
with	O
mitochondrial	O
membranes	O
.	O
gene1s	O
Metaxin	O
2	O
gene1e	O
in	O
intact	O
mitochondria	O
was	O
susceptible	O
to	O
digestion	O
with	O
proteinase	O
K	O
,	O
indicating	O
that	O
gene1s	O
metaxin	O
2	O
gene1e	O
is	O
located	O
on	O
the	O
cytosolic	O
face	O
of	O
the	O
mitochondrial	O
outer	O
membrane	O
.	O
Finally	O
,	O
baculoviruses	O
encoding	O
a	O
His6-tagged	O
gene1s	O
metaxin	O
2	O
gene1e	O
and	O
an	O
untagged	O
gene1s	O
metaxin	O
1	O
gene1e	O
lacking	O
its	O
C	O
-	O
terminal	O
transmembrane	O
domain	O
were	O
produced	O
and	O
used	O
separately	O
or	O
in	O
combination	O
to	O
infect	O
species1s	O
Sf21	O
species1e	O
insect	O
cells	O
.	O
gene1s	O
Metaxin	O
1	O
gene1e	O
bound	O
to	O
a	O
Ni2	O
+	O
-chelate	O
affinity	O
column	O
only	O
in	O
the	O
presence	O
of	O
gene1s	O
metaxin	O
2	O
gene1e	O
,	O
indicating	O
that	O
gene1s	O
metaxin	O
1	O
gene1e	O
and	O
gene1s	O
metaxin	O
2	O
gene1e	O
interact	O
when	O
overexpressed	O
in	O
insect	O
cells	O
.	O
These	O
results	O
suggest	O
that	O
gene1s	O
metaxin	O
2	O
gene1e	O
is	O
bound	O
to	O
the	O
cytosolic	O
face	O
of	O
the	O
mitochondrial	O
outer	O
membrane	O
by	O
means	O
of	O
its	O
interaction	O
with	O
membrane	O
-	O
bound	O
gene1s	O
metaxin	O
1	O
gene1e	O
,	O
and	O
that	O
this	O
complex	O
may	O
play	O
a	O
role	O
in	O
protein	O
import	O
into	O
species1s	O
mammalian	O
species1e	O
mitochondria	O
.	O

gene1s	O
Metaxin	O
1	O
gene1e	O
interacts	O
with	O
gene1s	O
metaxin	O
2	O
gene1e	O
,	O
a	O
novel	O
related	O
protein	O
associated	O
with	O
the	O
species1s	O
mammalian	O
species1e	O
mitochondrial	O
outer	O
membrane	O
.	O
A	O
recently	O
described	O
protein	O
,	O
gene1s	O
metaxin	O
1	O
gene1e	O
,	O
serves	O
as	O
a	O
component	O
of	O
a	O
preprotein	O
import	O
complex	O
in	O
the	O
outer	O
membrane	O
of	O
the	O
species1s	O
mammalian	O
species1e	O
mitochondrion	O
.	O
A	O
yeast	O
two	O
-	O
hybrid	O
screen	O
with	O
gene1s	O
metaxin	O
1	O
gene1e	O
as	O
bait	O
has	O
now	O
identified	O
a	O
novel	O
protein	O
,	O
which	O
we	O
have	O
termed	O
gene1s	O
metaxin	O
2	O
gene1e	O
,	O
as	O
a	O
metaxin	O
1-binding	O
protein	O
.	O
gene1s	O
Metaxin	O
2	O
gene1e	O
shares	O
29	O
%	O
identity	O
with	O
gene1s	O
metaxin	O
1	O
gene1e	O
at	O
the	O
amino	O
acid	O
level	O
,	O
but	O
gene1s	O
metaxin	O
2	O
gene1e	O
,	O
unlike	O
gene1s	O
metaxin	O
1	O
gene1e	O
,	O
lacks	O
a	O
C	O
-	O
terminal	O
mitochondrial	O
outer	O
membrane	O
signal	O
-	O
anchor	O
domain	O
.	O
Two	O
species1s	O
C.	O
elegans	O
species1e	O
hypothetical	O
proteins	O
,	O
gene1s	O
CelZC97.1	O
gene1e	O
and	O
gene1s	O
CelF39B2.i	O
gene1e	O
,	O
share	O
high	O
sequence	O
similarity	O
with	O
gene1s	O
metaxin	O
2	O
gene1e	O
and	O
gene1s	O
metaxin	O
1	O
gene1e	O
,	O
respectively	O
,	O
and	O
likely	O
represent	O
the	O
species1s	O
C.	O
elegans	O
species1e	O
orthologs	O
.	O
Affinity	O
-	O
purified	O
antibodies	O
against	O
gene1s	O
metaxin	O
2	O
gene1e	O
were	O
prepared	O
against	O
the	O
recombinant	O
protein	O
produced	O
in	O
species1s	O
E.	O
coli	O
species1e	O
and	O
were	O
used	O
to	O
analyze	O
the	O
subcellular	O
distribution	O
of	O
gene1s	O
metaxin	O
2	O
gene1e	O
.	O
In	O
subcellular	O
fractions	O
of	O
species1s	O
mouse	O
species1e	O
liver	O
,	O
a	O
29	O
kD	O
immunoreactive	O
protein	O
,	O
consistent	O
in	O
size	O
with	O
the	O
predicted	O
translation	O
product	O
of	O
gene1s	O
metaxin	O
2	O
gene1e	O
cDNA	O
,	O
was	O
found	O
solely	O
in	O
mitochondria	O
.	O
Alkali	O
extraction	O
of	O
mitochondria	O
indicated	O
that	O
gene1s	O
metaxin	O
2	O
gene1e	O
is	O
peripherally	O
associated	O
with	O
mitochondrial	O
membranes	O
.	O
gene1s	O
Metaxin	O
2	O
gene1e	O
in	O
intact	O
mitochondria	O
was	O
susceptible	O
to	O
digestion	O
with	O
proteinase	O
K	O
,	O
indicating	O
that	O
gene1s	O
metaxin	O
2	O
gene1e	O
is	O
located	O
on	O
the	O
cytosolic	O
face	O
of	O
the	O
mitochondrial	O
outer	O
membrane	O
.	O
Finally	O
,	O
baculoviruses	O
encoding	O
a	O
His6-tagged	O
gene1s	O
metaxin	O
2	O
gene1e	O
and	O
an	O
untagged	O
gene1s	O
metaxin	O
1	O
gene1e	O
lacking	O
its	O
C	O
-	O
terminal	O
transmembrane	O
domain	O
were	O
produced	O
and	O
used	O
separately	O
or	O
in	O
combination	O
to	O
infect	O
arg1s	O
Sf21	O
arg1e	O
insect	O
cells	O
.	O
gene1s	O
Metaxin	O
1	O
gene1e	O
bound	O
to	O
a	O
Ni2	O
+	O
-chelate	O
affinity	O
column	O
only	O
in	O
the	O
presence	O
of	O
gene1s	O
metaxin	O
2	O
gene1e	O
,	O
indicating	O
that	O
gene1s	O
metaxin	O
1	O
gene1e	O
and	O
gene1s	O
metaxin	O
2	O
gene1e	O
interact	O
when	O
overexpressed	O
in	O
insect	O
cells	O
.	O
These	O
results	O
suggest	O
that	O
gene1s	O
metaxin	O
2	O
gene1e	O
is	O
bound	O
to	O
the	O
cytosolic	O
face	O
of	O
the	O
mitochondrial	O
outer	O
membrane	O
by	O
means	O
of	O
its	O
interaction	O
with	O
membrane	O
-	O
bound	O
gene1s	O
metaxin	O
1	O
gene1e	O
,	O
and	O
that	O
this	O
complex	O
may	O
play	O
a	O
role	O
in	O
protein	O
import	O
into	O
species1s	O
mammalian	O
species1e	O
mitochondria	O
.	O

Comparative	O
analysis	O
of	O
a	O
novel	O
gene	O
from	O
the	O
Wolf	O
-	O
Hirschhorn	O
/	O
Pitt	O
-	O
Rogers	O
-	O
Danks	O
syndrome	O
critical	O
region	O
.	O
Wolf	O
-	O
Hirschhorn	O
syndrome	O
(	O
WHS	O
)	O
is	O
a	O
multiple	O
malformation	O
syndrome	O
characterized	O
by	O
mental	O
and	O
developmental	O
defects	O
resulting	O
from	O
the	O
absence	O
of	O
a	O
segment	O
of	O
one	O
chromosome	O
4	O
short	O
arm	O
(	O
4p16.3	O
)	O
.	O
Recently	O
,	O
Pitt	O
-	O
Rogers	O
-	O
Danks	O
syndrome	O
(	O
PRDS	O
)	O
,	O
which	O
is	O
also	O
due	O
to	O
a	O
deletion	O
of	O
chromosome	O
4p16.3	O
,	O
has	O
been	O
shown	O
to	O
be	O
allelic	O
to	O
WHS	O
.	O
Due	O
to	O
the	O
complex	O
and	O
variable	O
expression	O
of	O
these	O
disorders	O
,	O
it	O
is	O
thought	O
that	O
WHS	O
/	O
PRDS	O
results	O
from	O
a	O
segmental	O
aneusomy	O
of	O
4p	O
resulting	O
in	O
haploinsufficieny	O
of	O
an	O
undefined	O
number	O
of	O
genes	O
that	O
contribute	O
to	O
the	O
phenotype	O
.	O
In	O
an	O
effort	O
to	O
identify	O
genes	O
that	O
contribute	O
to	O
arg1s	O
human	O
arg1e	O
development	O
and	O
whose	O
absence	O
may	O
contribute	O
to	O
the	O
phenotype	O
associated	O
with	O
these	O
syndromes	O
,	O
we	O
have	O
generated	O
a	O
transcript	O
map	O
of	O
the	O
165-kb	O
critical	O
region	O
and	O
have	O
identified	O
a	O
number	O
of	O
potential	O
genes	O
.	O
One	O
of	O
these	O
genes	O
,	O
gene1s	ARG2
WHSC2	ARG2
gene1e	ARG2
,	O
which	O
was	O
identified	O
with	O
the	O
IMAGE	O
cDNA	O
clone	O
53283	O
,	O
has	O
been	O
characterized	O
.	O
Sequence	O
analysis	O
defined	O
an	O
open	O
reading	O
frame	O
of	O
1584	O
bp	O
(	O
528	O
amino	O
acids	O
)	O
,	O
and	O
transcript	O
analysis	O
detected	O
a	O
2.4-kb	O
transcript	O
in	O
all	O
fetal	O
and	O
adult	O
tissues	O
tested	O
.	O
In	O
parallel	O
,	O
the	O
species1s	O
mouse	O
species1e	O
homologue	O
was	O
isolated	O
and	O
characterized	O
.	O
species1s	O
Mouse	O
species1e	O
sequence	O
analysis	O
and	O
the	O
pattern	O
of	O
expression	O
are	O
consistent	O
with	O
the	O
clone	O
being	O
the	O
species1s	O
murine	O
species1e	O
equivalent	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
WHSC2	ARG2
gene1e	ARG2
gene	O
(	O
designated	O
gene1s	ARG2
Whsc2h	ARG2
gene1e	ARG2
)	O
.	O
The	O
data	O
from	O
sequence	O
and	O
transcript	O
analysis	O
of	O
this	O
new	O
arg1s	O
human	O
arg1e	O
gene	O
in	O
combination	O
with	O
the	O
lack	O
of	O
significant	O
similarity	O
to	O
proteins	O
of	O
known	O
function	O
imply	O
that	O
it	O
represents	O
a	O
novel	O
gene	O
.	O
Most	O
importantly	O
,	O
its	O
location	O
within	O
the	O
WHSCR	O
suggests	O
that	O
this	O
gene	O
may	O
play	O
a	O
role	O
in	O
the	O
phenotype	O
of	O
the	O
Wolf	O
-	O
Hirschhorn	O
/	O
Pitt	O
-	O
Rogers	O
-	O
Danks	O
syndrome	O
.	O
Copyright	O
1999	O
Academic	O
Press	O
.	O

Comparative	O
analysis	O
of	O
a	O
novel	O
gene	O
from	O
the	O
Wolf	O
-	O
Hirschhorn	O
/	O
Pitt	O
-	O
Rogers	O
-	O
Danks	O
syndrome	O
critical	O
region	O
.	O
Wolf	O
-	O
Hirschhorn	O
syndrome	O
(	O
WHS	O
)	O
is	O
a	O
multiple	O
malformation	O
syndrome	O
characterized	O
by	O
mental	O
and	O
developmental	O
defects	O
resulting	O
from	O
the	O
absence	O
of	O
a	O
segment	O
of	O
one	O
chromosome	O
4	O
short	O
arm	O
(	O
4p16.3	O
)	O
.	O
Recently	O
,	O
Pitt	O
-	O
Rogers	O
-	O
Danks	O
syndrome	O
(	O
PRDS	O
)	O
,	O
which	O
is	O
also	O
due	O
to	O
a	O
deletion	O
of	O
chromosome	O
4p16.3	O
,	O
has	O
been	O
shown	O
to	O
be	O
allelic	O
to	O
WHS	O
.	O
Due	O
to	O
the	O
complex	O
and	O
variable	O
expression	O
of	O
these	O
disorders	O
,	O
it	O
is	O
thought	O
that	O
WHS	O
/	O
PRDS	O
results	O
from	O
a	O
segmental	O
aneusomy	O
of	O
4p	O
resulting	O
in	O
haploinsufficieny	O
of	O
an	O
undefined	O
number	O
of	O
genes	O
that	O
contribute	O
to	O
the	O
phenotype	O
.	O
In	O
an	O
effort	O
to	O
identify	O
genes	O
that	O
contribute	O
to	O
species1s	O
human	O
species1e	O
development	O
and	O
whose	O
absence	O
may	O
contribute	O
to	O
the	O
phenotype	O
associated	O
with	O
these	O
syndromes	O
,	O
we	O
have	O
generated	O
a	O
transcript	O
map	O
of	O
the	O
165-kb	O
critical	O
region	O
and	O
have	O
identified	O
a	O
number	O
of	O
potential	O
genes	O
.	O
One	O
of	O
these	O
genes	O
,	O
gene1s	O
WHSC2	O
gene1e	O
,	O
which	O
was	O
identified	O
with	O
the	O
IMAGE	O
cDNA	O
clone	O
53283	O
,	O
has	O
been	O
characterized	O
.	O
Sequence	O
analysis	O
defined	O
an	O
open	O
reading	O
frame	O
of	O
1584	O
bp	O
(	O
528	O
amino	O
acids	O
)	O
,	O
and	O
transcript	O
analysis	O
detected	O
a	O
2.4-kb	O
transcript	O
in	O
all	O
fetal	O
and	O
adult	O
tissues	O
tested	O
.	O
In	O
parallel	O
,	O
the	O
arg1s	O
mouse	O
arg1e	O
homologue	O
was	O
isolated	O
and	O
characterized	O
.	O
arg1s	O
Mouse	O
arg1e	O
sequence	O
analysis	O
and	O
the	O
pattern	O
of	O
expression	O
are	O
consistent	O
with	O
the	O
clone	O
being	O
the	O
arg1s	O
murine	O
arg1e	O
equivalent	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
WHSC2	O
gene1e	O
gene	O
(	O
designated	O
gene1s	O
Whsc2h	O
gene1e	O
)	O
.	O
The	O
data	O
from	O
sequence	O
and	O
transcript	O
analysis	O
of	O
this	O
new	O
species1s	O
human	O
species1e	O
gene	O
in	O
combination	O
with	O
the	O
lack	O
of	O
significant	O
similarity	O
to	O
proteins	O
of	O
known	O
function	O
imply	O
that	O
it	O
represents	O
a	O
novel	O
gene	O
.	O
Most	O
importantly	O
,	O
its	O
location	O
within	O
the	O
WHSCR	O
suggests	O
that	O
this	O
gene	O
may	O
play	O
a	O
role	O
in	O
the	O
phenotype	O
of	O
the	O
Wolf	O
-	O
Hirschhorn	O
/	O
Pitt	O
-	O
Rogers	O
-	O
Danks	O
syndrome	O
.	O
Copyright	O
1999	O
Academic	O
Press	O
.	O

Redox	O
regulation	O
of	O
cell	O
signaling	O
by	O
selenocysteine	O
in	O
arg1s	O
mammalian	O
arg1e	O
thioredoxin	O
reductases	O
.	O
The	O
intracellular	O
generation	O
of	O
reactive	O
oxygen	O
species	O
,	O
together	O
with	O
the	O
gene1s	ARG2
thioredoxin	ARG2
gene1e	ARG2
and	O
glutathione	O
systems	O
,	O
is	O
thought	O
to	O
participate	O
in	O
redox	O
signaling	O
in	O
arg1s	O
mammalian	O
arg1e	O
cells	O
.	O
The	O
activity	O
of	O
gene1s	ARG2
thioredoxin	ARG2
gene1e	ARG2
is	O
dependent	O
on	O
the	O
redox	O
status	O
of	O
thioredoxin	O
reductase	O
(	O
TR	O
)	O
,	O
the	O
activity	O
of	O
which	O
in	O
turn	O
is	O
dependent	O
on	O
a	O
selenocysteine	O
residue	O
.	O
Two	O
arg1s	O
mammalian	O
arg1e	O
TR	O
isozymes	O
(	O
gene1s	ARG2
TR2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
TR3	ARG2
gene1e	ARG2
)	O
,	O
in	O
addition	O
to	O
that	O
previously	O
characterized	O
(	O
gene1s	ARG2
TR1	ARG2
gene1e	ARG2
)	O
,	O
have	O
now	O
been	O
identified	O
in	O
arg1s	O
humans	O
arg1e	O
and	O
species1s	O
mice	O
species1e	O
.	O
All	O
three	O
TR	O
isozymes	O
contain	O
a	O
selenocysteine	O
residue	O
that	O
is	O
located	O
in	O
the	O
penultimate	O
position	O
at	O
the	O
carboxyl	O
terminus	O
and	O
which	O
is	O
encoded	O
by	O
a	O
UGA	O
codon	O
.	O
The	O
generation	O
of	O
reactive	O
oxygen	O
species	O
in	O
a	O
arg1s	O
human	O
arg1e	O
carcinoma	O
cell	O
line	O
was	O
shown	O
to	O
result	O
in	O
both	O
the	O
oxidation	O
of	O
the	O
selenocysteine	O
in	O
gene1s	ARG2
TR1	ARG2
gene1e	ARG2
and	O
a	O
subsequent	O
increase	O
in	O
the	O
expression	O
of	O
this	O
enzyme	O
.	O
These	O
observations	O
identify	O
the	O
carboxyl	O
-	O
terminal	O
selenocysteine	O
of	O
gene1s	ARG2
TR1	ARG2
gene1e	ARG2
as	O
a	O
cellular	O
redox	O
sensor	O
and	O
support	O
an	O
essential	O
role	O
for	O
arg1s	O
mammalian	O
arg1e	O
TR	O
isozymes	O
in	O
redox	O
-	O
regulated	O
cell	O
signaling	O
.	O

Redox	O
regulation	O
of	O
cell	O
signaling	O
by	O
selenocysteine	O
in	O
species1s	O
mammalian	O
species1e	O
thioredoxin	O
reductases	O
.	O
The	O
intracellular	O
generation	O
of	O
reactive	O
oxygen	O
species	O
,	O
together	O
with	O
the	O
gene1s	O
thioredoxin	O
gene1e	O
and	O
glutathione	O
systems	O
,	O
is	O
thought	O
to	O
participate	O
in	O
redox	O
signaling	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
.	O
The	O
activity	O
of	O
gene1s	O
thioredoxin	O
gene1e	O
is	O
dependent	O
on	O
the	O
redox	O
status	O
of	O
thioredoxin	O
reductase	O
(	O
TR	O
)	O
,	O
the	O
activity	O
of	O
which	O
in	O
turn	O
is	O
dependent	O
on	O
a	O
selenocysteine	O
residue	O
.	O
Two	O
species1s	O
mammalian	O
species1e	O
TR	O
isozymes	O
(	O
gene1s	O
TR2	O
gene1e	O
and	O
gene1s	O
TR3	O
gene1e	O
)	O
,	O
in	O
addition	O
to	O
that	O
previously	O
characterized	O
(	O
gene1s	O
TR1	O
gene1e	O
)	O
,	O
have	O
now	O
been	O
identified	O
in	O
species1s	O
humans	O
species1e	O
and	O
arg1s	O
mice	O
arg1e	O
.	O
All	O
three	O
TR	O
isozymes	O
contain	O
a	O
selenocysteine	O
residue	O
that	O
is	O
located	O
in	O
the	O
penultimate	O
position	O
at	O
the	O
carboxyl	O
terminus	O
and	O
which	O
is	O
encoded	O
by	O
a	O
UGA	O
codon	O
.	O
The	O
generation	O
of	O
reactive	O
oxygen	O
species	O
in	O
a	O
species1s	O
human	O
species1e	O
carcinoma	O
cell	O
line	O
was	O
shown	O
to	O
result	O
in	O
both	O
the	O
oxidation	O
of	O
the	O
selenocysteine	O
in	O
gene1s	O
TR1	O
gene1e	O
and	O
a	O
subsequent	O
increase	O
in	O
the	O
expression	O
of	O
this	O
enzyme	O
.	O
These	O
observations	O
identify	O
the	O
carboxyl	O
-	O
terminal	O
selenocysteine	O
of	O
gene1s	O
TR1	O
gene1e	O
as	O
a	O
cellular	O
redox	O
sensor	O
and	O
support	O
an	O
essential	O
role	O
for	O
species1s	O
mammalian	O
species1e	O
TR	O
isozymes	O
in	O
redox	O
-	O
regulated	O
cell	O
signaling	O
.	O

Identification	O
of	O
a	O
Wnt	O
-	O
responsive	O
signal	O
transduction	O
pathway	O
in	O
primary	O
endothelial	O
cells	O
.	O
The	O
gene1s	O
beta	O
-	O
catenin	O
gene1e	O
signal	O
transduction	O
pathway	O
,	O
which	O
can	O
be	O
activated	O
by	O
secreted	O
Wnt	O
proteins	O
,	O
plays	O
a	O
key	O
role	O
in	O
normal	O
embryonic	O
development	O
and	O
in	O
malignant	O
transformation	O
of	O
the	O
mammary	O
gland	O
and	O
colon	O
.	O
Here	O
we	O
demonstrate	O
,	O
for	O
the	O
first	O
time	O
,	O
that	O
Wnt	O
and	O
gene1s	O
beta	O
-	O
catenin	O
gene1e	O
signaling	O
also	O
function	O
in	O
cells	O
of	O
the	O
vasculature	O
.	O
RT	O
-	O
PCR	O
analysis	O
showed	O
that	O
primary	O
endothelial	O
and	O
smooth	O
muscle	O
cell	O
cultures	O
,	O
of	O
both	O
arg1s	O
mouse	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
origin	O
,	O
express	O
members	O
of	O
the	O
Wnt	O
and	O
Wnt	O
receptor	O
(	O
Frizzled	O
)	O
gene	O
families	O
.	O
Transfection	O
of	O
an	O
expression	O
vector	O
for	O
gene1s	O
Wnt-1	O
gene1e	O
into	O
primary	O
endothelial	O
cells	O
increased	O
both	O
the	O
free	O
pool	O
of	O
gene1s	O
beta	O
-	O
catenin	O
gene1e	O
and	O
the	O
transcription	O
from	O
a	O
Lef	O
/	O
tcf	O
-	O
dependent	O
reporter	O
gene	O
construct	O
.	O
Expression	O
of	O
gene1s	O
Wnt-1	O
gene1e	O
,	O
but	O
not	O
gene1s	O
Wnt-5a	O
gene1e	O
,	O
also	O
stimulated	O
proliferation	O
of	O
primary	O
endothelial	O
cell	O
cultures	O
.	O
These	O
data	O
show	O
that	O
Wnt	O
and	O
Frizzled	O
proteins	O
can	O
regulate	O
signal	O
transduction	O
,	O
via	O
gene1s	O
beta	O
-	O
catenin	O
gene1e	O
,	O
in	O
endothelial	O
cells	O
.	O
These	O
findings	O
suggest	O
that	O
Wnt	O
signaling	O
may	O
feature	O
in	O
normal	O
differentiation	O
of	O
the	O
vasculature	O
as	O
well	O
as	O
in	O
pathological	O
settings	O
where	O
endothelial	O
and	O
smooth	O
muscle	O
proliferation	O
is	O
disturbed	O
.	O
Copyright	O
1999	O
Academic	O
Press	O
.	O

Identification	O
of	O
a	O
Wnt	O
-	O
responsive	O
signal	O
transduction	O
pathway	O
in	O
primary	O
endothelial	O
cells	O
.	O
The	O
gene1s	ARG2
beta	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
signal	O
transduction	O
pathway	O
,	O
which	O
can	O
be	O
activated	O
by	O
secreted	O
Wnt	O
proteins	O
,	O
plays	O
a	O
key	O
role	O
in	O
normal	O
embryonic	O
development	O
and	O
in	O
malignant	O
transformation	O
of	O
the	O
mammary	O
gland	O
and	O
colon	O
.	O
Here	O
we	O
demonstrate	O
,	O
for	O
the	O
first	O
time	O
,	O
that	O
Wnt	O
and	O
gene1s	ARG2
beta	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
signaling	O
also	O
function	O
in	O
cells	O
of	O
the	O
vasculature	O
.	O
RT	O
-	O
PCR	O
analysis	O
showed	O
that	O
primary	O
endothelial	O
and	O
smooth	O
muscle	O
cell	O
cultures	O
,	O
of	O
both	O
species1s	O
mouse	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
origin	O
,	O
express	O
members	O
of	O
the	O
Wnt	O
and	O
Wnt	O
receptor	O
(	O
Frizzled	O
)	O
gene	O
families	O
.	O
Transfection	O
of	O
an	O
expression	O
vector	O
for	O
gene1s	ARG2
Wnt-1	ARG2
gene1e	ARG2
into	O
primary	O
endothelial	O
cells	O
increased	O
both	O
the	O
free	O
pool	O
of	O
gene1s	ARG2
beta	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
and	O
the	O
transcription	O
from	O
a	O
Lef	O
/	O
tcf	O
-	O
dependent	O
reporter	O
gene	O
construct	O
.	O
Expression	O
of	O
gene1s	ARG2
Wnt-1	ARG2
gene1e	ARG2
,	O
but	O
not	O
gene1s	ARG2
Wnt-5a	ARG2
gene1e	ARG2
,	O
also	O
stimulated	O
proliferation	O
of	O
primary	O
endothelial	O
cell	O
cultures	O
.	O
These	O
data	O
show	O
that	O
Wnt	O
and	O
Frizzled	O
proteins	O
can	O
regulate	O
signal	O
transduction	O
,	O
via	O
gene1s	ARG2
beta	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
,	O
in	O
endothelial	O
cells	O
.	O
These	O
findings	O
suggest	O
that	O
Wnt	O
signaling	O
may	O
feature	O
in	O
normal	O
differentiation	O
of	O
the	O
vasculature	O
as	O
well	O
as	O
in	O
pathological	O
settings	O
where	O
endothelial	O
and	O
smooth	O
muscle	O
proliferation	O
is	O
disturbed	O
.	O
Copyright	O
1999	O
Academic	O
Press	O
.	O

Identification	O
of	O
a	O
family	O
of	O
arg1s	O
human	O
arg1e	O
F	O
-	O
box	O
proteins	O
.	O
F	O
-	O
box	O
proteins	O
are	O
an	O
expanding	O
family	O
of	O
eukaryotic	O
proteins	O
characterized	O
by	O
an	O
approximately	O
40	O
aminoacid	O
motif	O
,	O
the	O
F	O
box	O
(	O
so	O
named	O
because	O
gene1s	ARG2
cyclin	ARG2
F	ARG2
gene1e	ARG2
was	O
one	O
of	O
the	O
first	O
proteins	O
in	O
which	O
this	O
motif	O
was	O
identified	O
)	O
.	O
Some	O
F	O
-	O
box	O
proteins	O
have	O
been	O
shown	O
to	O
be	O
critical	O
for	O
the	O
controlled	O
degradation	O
of	O
cellular	O
regulatory	O
proteins	O
.	O
In	O
fact	O
,	O
F	O
-	O
box	O
proteins	O
are	O
one	O
of	O
the	O
four	O
subunits	O
of	O
ubiquitin	O
protein	O
ligases	O
called	O
SCFs	O
.	O
The	O
other	O
three	O
subunits	O
are	O
the	O
gene1s	ARG2
Skp1	ARG2
gene1e	ARG2
protein	O
;	O
one	O
of	O
the	O
cullin	O
proteins	O
(	O
Cul1	O
in	O
metazoans	O
and	O
gene1s	O
Cdc53	O
gene1e	O
or	O
gene1s	O
Cul	O
A	O
gene1e	O
in	O
the	O
species1s	O
yeast	O
species1e	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
)	O
;	O
and	O
the	O
recently	O
identified	O
gene1s	ARG2
Roc1	ARG2
gene1e	ARG2
protein	O
(	O
also	O
called	O
gene1s	ARG2
Rbx1	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
Hrt1	ARG2
gene1e	ARG2
)	O
.	O
SCF	O
ligases	O
bring	O
ubiquitin	O
conjugating	O
enzymes	O
(	O
either	O
gene1s	ARG2
Ubc3	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
Ubc4	ARG2
gene1e	ARG2
)	O
to	O
substrates	O
that	O
are	O
specifically	O
recruited	O
by	O
the	O
different	O
F	O
-	O
box	O
proteins	O
.	O
The	O
need	O
for	O
high	O
substrate	O
specificity	O
and	O
the	O
large	O
number	O
of	O
known	O
F	O
-	O
box	O
proteins	O
in	O
species1s	O
yeast	O
species1e	O
and	O
worms	O
suggest	O
the	O
existence	O
of	O
a	O
large	O
family	O
of	O
arg1s	O
mammalian	O
arg1e	O
F	O
-	O
box	O
proteins	O
.	O
Using	O
gene1s	ARG2
Skp1	ARG2
gene1e	ARG2
as	O
a	O
bait	O
in	O
a	O
species1s	O
yeast	O
species1e	O
two	O
-	O
hybrid	O
screen	O
and	O
by	O
searching	O
DNA	O
databases	O
,	O
we	O
identified	O
a	O
family	O
of	O
26	O
arg1s	O
human	O
arg1e	O
F	O
-	O
box	O
proteins	O
,	O
25	O
of	O
which	O
were	O
novel	O
.	O
Some	O
of	O
these	O
proteins	O
contained	O
WD-40	O
domains	O
or	O
leucine	O
-	O
rich	O
repeats	O
;	O
others	O
contained	O
either	O
different	O
protein	O
-	O
protein	O
interaction	O
modules	O
or	O
no	O
recognizable	O
motifs	O
.	O
We	O
have	O
named	O
the	O
F	O
-	O
box	O
proteins	O
that	O
contain	O
WD-40	O
domains	O
Fbws	O
,	O
those	O
containing	O
leucine	O
-	O
rich	O
repeats	O
,	O
Fbls	O
,	O
and	O
the	O
remaining	O
ones	O
Fbxs	O
.	O
We	O
have	O
further	O
characterized	O
representative	O
members	O
of	O
these	O
three	O
classes	O
of	O
F	O
-	O
box	O
proteins	O
.	O

Identification	O
of	O
a	O
family	O
of	O
species1s	O
human	O
species1e	O
F	O
-	O
box	O
proteins	O
.	O
F	O
-	O
box	O
proteins	O
are	O
an	O
expanding	O
family	O
of	O
eukaryotic	O
proteins	O
characterized	O
by	O
an	O
approximately	O
40	O
aminoacid	O
motif	O
,	O
the	O
F	O
box	O
(	O
so	O
named	O
because	O
gene1s	O
cyclin	O
F	O
gene1e	O
was	O
one	O
of	O
the	O
first	O
proteins	O
in	O
which	O
this	O
motif	O
was	O
identified	O
)	O
.	O
Some	O
F	O
-	O
box	O
proteins	O
have	O
been	O
shown	O
to	O
be	O
critical	O
for	O
the	O
controlled	O
degradation	O
of	O
cellular	O
regulatory	O
proteins	O
.	O
In	O
fact	O
,	O
F	O
-	O
box	O
proteins	O
are	O
one	O
of	O
the	O
four	O
subunits	O
of	O
ubiquitin	O
protein	O
ligases	O
called	O
SCFs	O
.	O
The	O
other	O
three	O
subunits	O
are	O
the	O
gene1s	O
Skp1	O
gene1e	O
protein	O
;	O
one	O
of	O
the	O
cullin	O
proteins	O
(	O
Cul1	O
in	O
metazoans	O
and	O
gene1s	ARG2
Cdc53	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
Cul	ARG2
A	ARG2
gene1e	ARG2
in	O
the	O
arg1s	O
yeast	O
arg1e	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
)	O
;	O
and	O
the	O
recently	O
identified	O
gene1s	O
Roc1	O
gene1e	O
protein	O
(	O
also	O
called	O
gene1s	O
Rbx1	O
gene1e	O
or	O
gene1s	O
Hrt1	O
gene1e	O
)	O
.	O
SCF	O
ligases	O
bring	O
ubiquitin	O
conjugating	O
enzymes	O
(	O
either	O
gene1s	O
Ubc3	O
gene1e	O
or	O
gene1s	O
Ubc4	O
gene1e	O
)	O
to	O
substrates	O
that	O
are	O
specifically	O
recruited	O
by	O
the	O
different	O
F	O
-	O
box	O
proteins	O
.	O
The	O
need	O
for	O
high	O
substrate	O
specificity	O
and	O
the	O
large	O
number	O
of	O
known	O
F	O
-	O
box	O
proteins	O
in	O
arg1s	O
yeast	O
arg1e	O
and	O
worms	O
suggest	O
the	O
existence	O
of	O
a	O
large	O
family	O
of	O
species1s	O
mammalian	O
species1e	O
F	O
-	O
box	O
proteins	O
.	O
Using	O
gene1s	O
Skp1	O
gene1e	O
as	O
a	O
bait	O
in	O
a	O
arg1s	O
yeast	O
arg1e	O
two	O
-	O
hybrid	O
screen	O
and	O
by	O
searching	O
DNA	O
databases	O
,	O
we	O
identified	O
a	O
family	O
of	O
26	O
species1s	O
human	O
species1e	O
F	O
-	O
box	O
proteins	O
,	O
25	O
of	O
which	O
were	O
novel	O
.	O
Some	O
of	O
these	O
proteins	O
contained	O
WD-40	O
domains	O
or	O
leucine	O
-	O
rich	O
repeats	O
;	O
others	O
contained	O
either	O
different	O
protein	O
-	O
protein	O
interaction	O
modules	O
or	O
no	O
recognizable	O
motifs	O
.	O
We	O
have	O
named	O
the	O
F	O
-	O
box	O
proteins	O
that	O
contain	O
WD-40	O
domains	O
Fbws	O
,	O
those	O
containing	O
leucine	O
-	O
rich	O
repeats	O
,	O
Fbls	O
,	O
and	O
the	O
remaining	O
ones	O
Fbxs	O
.	O
We	O
have	O
further	O
characterized	O
representative	O
members	O
of	O
these	O
three	O
classes	O
of	O
F	O
-	O
box	O
proteins	O
.	O

Cloning	O
,	O
characterization	O
,	O
and	O
localization	O
of	O
arg1s	O
mouse	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
gene1s	ARG2
SPO11	ARG2
gene1e	ARG2
.	O
gene1s	O
Spo11	O
gene1e	O
is	O
a	O
meiosis	O
-	O
specific	O
protein	O
in	O
species1s	O
yeast	O
species1e	O
that	O
has	O
been	O
found	O
covalently	O
bound	O
to	O
DNA	O
double	O
-	O
strand	O
breaks	O
(	O
DSBs	O
)	O
during	O
the	O
early	O
stages	O
of	O
meiosis	O
.	O
These	O
DSBs	O
initiate	O
homologous	O
recombination	O
,	O
which	O
is	O
required	O
for	O
proper	O
segregation	O
of	O
chromosomes	O
and	O
the	O
generation	O
of	O
genetic	O
diversity	O
during	O
meiosis	O
.	O
Here	O
we	O
report	O
the	O
cloning	O
,	O
characterization	O
,	O
tissue	O
expression	O
,	O
and	O
chromosomal	O
localization	O
of	O
both	O
arg1s	O
mouse	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
homologues	O
of	O
gene1s	ARG2
Spo11	ARG2
gene1e	ARG2
.	O
The	O
putative	O
arg1s	O
mouse	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
proteins	O
are	O
82	O
%	O
identical	O
and	O
share	O
approximately	O
25	O
%	O
identity	O
with	O
other	O
family	O
members	O
.	O
Northern	O
blot	O
analysis	O
revealed	O
testis	O
-	O
specific	O
expression	O
for	O
both	O
genes	O
,	O
but	O
RT	O
-	O
PCR	O
results	O
showed	O
ubiquitous	O
expression	O
of	O
at	O
least	O
a	O
portion	O
of	O
gene1s	ARG2
Spo11	ARG2
gene1e	ARG2
in	O
arg1s	O
mouse	O
arg1e	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
SPO11	O
gene1e	O
was	O
also	O
detected	O
in	O
several	O
somatic	O
tissues	O
.	O
arg1s	O
Mouse	O
arg1e	O
gene1s	ARG2
Spo11	ARG2
gene1e	ARG2
was	O
localized	O
to	O
chromosome	O
2H4	O
,	O
and	O
species1s	O
human	O
species1e	O
gene1s	O
SPO11	O
gene1e	O
was	O
localized	O
to	O
chromosome	O
20q13.2-q13.3	O
,	O
a	O
region	O
amplified	O
in	O
some	O
breast	O
and	O
ovarian	O
tumors	O
.	O

Cloning	O
,	O
characterization	O
,	O
and	O
localization	O
of	O
species1s	O
mouse	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
SPO11	ARG2
gene1e	ARG2
.	O
gene1s	O
Spo11	O
gene1e	O
is	O
a	O
meiosis	O
-	O
specific	O
protein	O
in	O
species1s	O
yeast	O
species1e	O
that	O
has	O
been	O
found	O
covalently	O
bound	O
to	O
DNA	O
double	O
-	O
strand	O
breaks	O
(	O
DSBs	O
)	O
during	O
the	O
early	O
stages	O
of	O
meiosis	O
.	O
These	O
DSBs	O
initiate	O
homologous	O
recombination	O
,	O
which	O
is	O
required	O
for	O
proper	O
segregation	O
of	O
chromosomes	O
and	O
the	O
generation	O
of	O
genetic	O
diversity	O
during	O
meiosis	O
.	O
Here	O
we	O
report	O
the	O
cloning	O
,	O
characterization	O
,	O
tissue	O
expression	O
,	O
and	O
chromosomal	O
localization	O
of	O
both	O
species1s	O
mouse	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
homologues	O
of	O
gene1s	ARG2
Spo11	ARG2
gene1e	ARG2
.	O
The	O
putative	O
species1s	O
mouse	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
proteins	O
are	O
82	O
%	O
identical	O
and	O
share	O
approximately	O
25	O
%	O
identity	O
with	O
other	O
family	O
members	O
.	O
Northern	O
blot	O
analysis	O
revealed	O
testis	O
-	O
specific	O
expression	O
for	O
both	O
genes	O
,	O
but	O
RT	O
-	O
PCR	O
results	O
showed	O
ubiquitous	O
expression	O
of	O
at	O
least	O
a	O
portion	O
of	O
gene1s	O
Spo11	O
gene1e	O
in	O
species1s	O
mouse	O
species1e	O
.	O
arg1s	O
Human	O
arg1e	O
gene1s	ARG2
SPO11	ARG2
gene1e	ARG2
was	O
also	O
detected	O
in	O
several	O
somatic	O
tissues	O
.	O
species1s	O
Mouse	O
species1e	O
gene1s	O
Spo11	O
gene1e	O
was	O
localized	O
to	O
chromosome	O
2H4	O
,	O
and	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
SPO11	ARG2
gene1e	ARG2
was	O
localized	O
to	O
chromosome	O
20q13.2-q13.3	O
,	O
a	O
region	O
amplified	O
in	O
some	O
breast	O
and	O
ovarian	O
tumors	O
.	O

Cloning	O
,	O
characterization	O
,	O
and	O
localization	O
of	O
species1s	O
mouse	O
species1e	O
and	O
species1s	O
human	O
species1e	O
gene1s	O
SPO11	O
gene1e	O
.	O
gene1s	ARG2
Spo11	ARG2
gene1e	ARG2
is	O
a	O
meiosis	O
-	O
specific	O
protein	O
in	O
arg1s	O
yeast	O
arg1e	O
that	O
has	O
been	O
found	O
covalently	O
bound	O
to	O
DNA	O
double	O
-	O
strand	O
breaks	O
(	O
DSBs	O
)	O
during	O
the	O
early	O
stages	O
of	O
meiosis	O
.	O
These	O
DSBs	O
initiate	O
homologous	O
recombination	O
,	O
which	O
is	O
required	O
for	O
proper	O
segregation	O
of	O
chromosomes	O
and	O
the	O
generation	O
of	O
genetic	O
diversity	O
during	O
meiosis	O
.	O
Here	O
we	O
report	O
the	O
cloning	O
,	O
characterization	O
,	O
tissue	O
expression	O
,	O
and	O
chromosomal	O
localization	O
of	O
both	O
species1s	O
mouse	O
species1e	O
and	O
species1s	O
human	O
species1e	O
homologues	O
of	O
gene1s	O
Spo11	O
gene1e	O
.	O
The	O
putative	O
species1s	O
mouse	O
species1e	O
and	O
species1s	O
human	O
species1e	O
proteins	O
are	O
82	O
%	O
identical	O
and	O
share	O
approximately	O
25	O
%	O
identity	O
with	O
other	O
family	O
members	O
.	O
Northern	O
blot	O
analysis	O
revealed	O
testis	O
-	O
specific	O
expression	O
for	O
both	O
genes	O
,	O
but	O
RT	O
-	O
PCR	O
results	O
showed	O
ubiquitous	O
expression	O
of	O
at	O
least	O
a	O
portion	O
of	O
gene1s	O
Spo11	O
gene1e	O
in	O
species1s	O
mouse	O
species1e	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
SPO11	O
gene1e	O
was	O
also	O
detected	O
in	O
several	O
somatic	O
tissues	O
.	O
species1s	O
Mouse	O
species1e	O
gene1s	O
Spo11	O
gene1e	O
was	O
localized	O
to	O
chromosome	O
2H4	O
,	O
and	O
species1s	O
human	O
species1e	O
gene1s	O
SPO11	O
gene1e	O
was	O
localized	O
to	O
chromosome	O
20q13.2-q13.3	O
,	O
a	O
region	O
amplified	O
in	O
some	O
breast	O
and	O
ovarian	O
tumors	O
.	O

Purification	O
,	O
molecular	O
cloning	O
,	O
and	O
genomic	O
organization	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
brain	ARG2
long	ARG2
-	ARG2
chain	ARG2
acyl	ARG2
-	ARG2
CoA	ARG2
hydrolase	ARG2
gene1e	ARG2
.	O
An	O
acyl	O
-	O
CoA	O
hydrolase	O
,	O
referred	O
to	O
as	O
gene1s	ARG2
hBACH	ARG2
gene1e	ARG2
,	O
was	O
purified	O
from	O
arg1s	O
human	O
arg1e	O
brain	O
cytosol	O
.	O
The	O
enzyme	O
had	O
a	O
molecular	O
mass	O
of	O
100	O
kDa	O
and	O
43-kDa	O
subunits	O
,	O
and	O
was	O
highly	O
active	O
with	O
long	O
-	O
chain	O
acyl	O
-	O
CoAs	O
,	O
e.g.	O
a	O
maximal	O
velocity	O
of	O
295	O
micromol	O
/	O
min	O
/	O
mg	O
and	O
K(m	O
)	O
of	O
6.4	O
microM	O
for	O
palmitoyl	O
-	O
CoA.	O
Acyl	O
-	O
CoAs	O
with	O
carbon	O
chain	O
lengths	O
of	O
C(8	O
-	O
18	O
)	O
were	O
also	O
good	O
substrates	O
.	O
In	O
arg1s	O
human	O
arg1e	O
brain	O
cytosol	O
,	O
85	O
%	O
of	O
palmitoyl	O
-	O
CoA	O
hydrolase	O
activity	O
was	O
titrated	O
by	O
an	O
anti	O
-	O
BACH	O
antibody	O
,	O
which	O
accounted	O
for	O
over	O
75	O
%	O
of	O
the	O
enzyme	O
activity	O
found	O
in	O
the	O
brain	O
tissue	O
.	O
The	O
cDNA	O
isolated	O
for	O
gene1s	ARG2
hBACH	ARG2
gene1e	ARG2
,	O
when	O
expressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
,	O
directed	O
the	O
expression	O
of	O
palmitoyl	O
-	O
CoA	O
hydrolase	O
activity	O
and	O
a	O
44-kDa	O
protein	O
immunoreactive	O
to	O
the	O
anti	O
-	O
BACH	O
antibody	O
,	O
which	O
in	O
turn	O
neutralized	O
the	O
hydrolase	O
activity	O
.	O
The	O
gene1s	ARG2
hBACH	ARG2
gene1e	ARG2
cDNA	O
encoded	O
a	O
338-amino	O
acid	O
sequence	O
which	O
was	O
95	O
%	O
identical	O
to	O
that	O
of	O
a	O
species1s	O
rat	O
species1e	O
homolog	O
.	O
The	O
gene1s	ARG2
hBACH	ARG2
gene1e	ARG2
gene	O
spanned	O
about	O
130	O
kb	O
and	O
comprised	O
9	O
exons	O
,	O
and	O
was	O
mapped	O
to	O
1p36.2	O
on	O
the	O
cytogenetic	O
ideogram	O
.	O
These	O
findings	O
indicate	O
that	O
the	O
long	O
-	O
chain	O
acyl	O
-	O
CoA	O
hydrolase	O
present	O
in	O
the	O
brain	O
is	O
well	O
conserved	O
between	O
man	O
and	O
the	O
species1s	O
rat	O
species1e	O
,	O
suggesting	O
a	O
conserved	O
role	O
for	O
this	O
enzyme	O
in	O
the	O
arg1s	O
mammalian	O
arg1e	O
brain	O
,	O
and	O
enabling	O
genetic	O
studies	O
on	O
the	O
functional	O
analysis	O
of	O
acyl	O
-	O
CoA	O
hydrolase	O
.	O

Purification	O
,	O
molecular	O
cloning	O
,	O
and	O
genomic	O
organization	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
brain	O
long	O
-	O
chain	O
acyl	O
-	O
CoA	O
hydrolase	O
gene1e	O
.	O
An	O
acyl	O
-	O
CoA	O
hydrolase	O
,	O
referred	O
to	O
as	O
gene1s	O
hBACH	O
gene1e	O
,	O
was	O
purified	O
from	O
species1s	O
human	O
species1e	O
brain	O
cytosol	O
.	O
The	O
enzyme	O
had	O
a	O
molecular	O
mass	O
of	O
100	O
kDa	O
and	O
43-kDa	O
subunits	O
,	O
and	O
was	O
highly	O
active	O
with	O
long	O
-	O
chain	O
acyl	O
-	O
CoAs	O
,	O
e.g.	O
a	O
maximal	O
velocity	O
of	O
295	O
micromol	O
/	O
min	O
/	O
mg	O
and	O
K(m	O
)	O
of	O
6.4	O
microM	O
for	O
palmitoyl	O
-	O
CoA.	O
Acyl	O
-	O
CoAs	O
with	O
carbon	O
chain	O
lengths	O
of	O
C(8	O
-	O
18	O
)	O
were	O
also	O
good	O
substrates	O
.	O
In	O
species1s	O
human	O
species1e	O
brain	O
cytosol	O
,	O
85	O
%	O
of	O
palmitoyl	O
-	O
CoA	O
hydrolase	O
activity	O
was	O
titrated	O
by	O
an	O
anti	O
-	O
BACH	O
antibody	O
,	O
which	O
accounted	O
for	O
over	O
75	O
%	O
of	O
the	O
enzyme	O
activity	O
found	O
in	O
the	O
brain	O
tissue	O
.	O
The	O
cDNA	O
isolated	O
for	O
gene1s	O
hBACH	O
gene1e	O
,	O
when	O
expressed	O
in	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
,	O
directed	O
the	O
expression	O
of	O
palmitoyl	O
-	O
CoA	O
hydrolase	O
activity	O
and	O
a	O
44-kDa	O
protein	O
immunoreactive	O
to	O
the	O
anti	O
-	O
BACH	O
antibody	O
,	O
which	O
in	O
turn	O
neutralized	O
the	O
hydrolase	O
activity	O
.	O
The	O
gene1s	O
hBACH	O
gene1e	O
cDNA	O
encoded	O
a	O
338-amino	O
acid	O
sequence	O
which	O
was	O
95	O
%	O
identical	O
to	O
that	O
of	O
a	O
species1s	O
rat	O
species1e	O
homolog	O
.	O
The	O
gene1s	O
hBACH	O
gene1e	O
gene	O
spanned	O
about	O
130	O
kb	O
and	O
comprised	O
9	O
exons	O
,	O
and	O
was	O
mapped	O
to	O
1p36.2	O
on	O
the	O
cytogenetic	O
ideogram	O
.	O
These	O
findings	O
indicate	O
that	O
the	O
long	O
-	O
chain	O
acyl	O
-	O
CoA	O
hydrolase	O
present	O
in	O
the	O
brain	O
is	O
well	O
conserved	O
between	O
man	O
and	O
the	O
species1s	O
rat	O
species1e	O
,	O
suggesting	O
a	O
conserved	O
role	O
for	O
this	O
enzyme	O
in	O
the	O
species1s	O
mammalian	O
species1e	O
brain	O
,	O
and	O
enabling	O
genetic	O
studies	O
on	O
the	O
functional	O
analysis	O
of	O
acyl	O
-	O
CoA	O
hydrolase	O
.	O

Purification	O
,	O
molecular	O
cloning	O
,	O
and	O
genomic	O
organization	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
brain	O
long	O
-	O
chain	O
acyl	O
-	O
CoA	O
hydrolase	O
gene1e	O
.	O
An	O
acyl	O
-	O
CoA	O
hydrolase	O
,	O
referred	O
to	O
as	O
gene1s	O
hBACH	O
gene1e	O
,	O
was	O
purified	O
from	O
species1s	O
human	O
species1e	O
brain	O
cytosol	O
.	O
The	O
enzyme	O
had	O
a	O
molecular	O
mass	O
of	O
100	O
kDa	O
and	O
43-kDa	O
subunits	O
,	O
and	O
was	O
highly	O
active	O
with	O
long	O
-	O
chain	O
acyl	O
-	O
CoAs	O
,	O
e.g.	O
a	O
maximal	O
velocity	O
of	O
295	O
micromol	O
/	O
min	O
/	O
mg	O
and	O
K(m	O
)	O
of	O
6.4	O
microM	O
for	O
palmitoyl	O
-	O
CoA.	O
Acyl	O
-	O
CoAs	O
with	O
carbon	O
chain	O
lengths	O
of	O
C(8	O
-	O
18	O
)	O
were	O
also	O
good	O
substrates	O
.	O
In	O
species1s	O
human	O
species1e	O
brain	O
cytosol	O
,	O
85	O
%	O
of	O
palmitoyl	O
-	O
CoA	O
hydrolase	O
activity	O
was	O
titrated	O
by	O
an	O
anti	O
-	O
BACH	O
antibody	O
,	O
which	O
accounted	O
for	O
over	O
75	O
%	O
of	O
the	O
enzyme	O
activity	O
found	O
in	O
the	O
brain	O
tissue	O
.	O
The	O
cDNA	O
isolated	O
for	O
gene1s	O
hBACH	O
gene1e	O
,	O
when	O
expressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
,	O
directed	O
the	O
expression	O
of	O
palmitoyl	O
-	O
CoA	O
hydrolase	O
activity	O
and	O
a	O
44-kDa	O
protein	O
immunoreactive	O
to	O
the	O
anti	O
-	O
BACH	O
antibody	O
,	O
which	O
in	O
turn	O
neutralized	O
the	O
hydrolase	O
activity	O
.	O
The	O
gene1s	O
hBACH	O
gene1e	O
cDNA	O
encoded	O
a	O
338-amino	O
acid	O
sequence	O
which	O
was	O
95	O
%	O
identical	O
to	O
that	O
of	O
a	O
arg1s	O
rat	O
arg1e	O
homolog	O
.	O
The	O
gene1s	O
hBACH	O
gene1e	O
gene	O
spanned	O
about	O
130	O
kb	O
and	O
comprised	O
9	O
exons	O
,	O
and	O
was	O
mapped	O
to	O
1p36.2	O
on	O
the	O
cytogenetic	O
ideogram	O
.	O
These	O
findings	O
indicate	O
that	O
the	O
long	O
-	O
chain	O
acyl	O
-	O
CoA	O
hydrolase	O
present	O
in	O
the	O
brain	O
is	O
well	O
conserved	O
between	O
man	O
and	O
the	O
arg1s	O
rat	O
arg1e	O
,	O
suggesting	O
a	O
conserved	O
role	O
for	O
this	O
enzyme	O
in	O
the	O
species1s	O
mammalian	O
species1e	O
brain	O
,	O
and	O
enabling	O
genetic	O
studies	O
on	O
the	O
functional	O
analysis	O
of	O
acyl	O
-	O
CoA	O
hydrolase	O
.	O

Family	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
oxysterol	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
OSBP	ARG2
gene1e	ARG2
)	O
homologues	O
.	O
A	O
novel	O
member	O
implicated	O
in	O
brain	O
sterol	O
metabolism	O
.	O
gene1s	ARG2
Oxysterol	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
OSBP	ARG2
gene1e	ARG2
)	O
is	O
a	O
cytosolic	O
protein	O
that	O
undergoes	O
ligand	O
-	O
induced	O
binding	O
to	O
the	O
Golgi	O
apparatus	O
and	O
has	O
been	O
implicated	O
in	O
the	O
regulation	O
of	O
cellular	O
cholesterol	O
metabolism	O
.	O
In	O
the	O
species1s	O
yeast	O
species1e	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
an	O
gene1s	ARG2
OSBP	ARG2
gene1e	ARG2
homologue	O
is	O
involved	O
in	O
membrane	O
trafficking	O
through	O
the	O
Golgi	O
complex	O
.	O
Prompted	O
by	O
the	O
multitude	O
of	O
gene1s	ARG2
OSBP	ARG2
gene1e	ARG2
-	O
related	O
genes	O
in	O
the	O
species1s	O
yeast	O
species1e	O
genome	O
,	O
we	O
carried	O
out	O
a	O
search	O
for	O
arg1s	O
human	O
arg1e	O
expressed	O
sequence	O
tags	O
(	O
ESTs	O
)	O
displaying	O
homology	O
to	O
the	O
sterol	O
-	O
binding	O
domain	O
of	O
gene1s	ARG2
OSBP	ARG2
gene1e	ARG2
.	O
This	O
revealed	O
a	O
minimum	O
of	O
six	O
novel	O
OSBP	O
-	O
related	O
proteins	O
,	O
designated	O
gene1s	ARG2
ORP-1	ARG2
to	ARG2
ORP-6	ARG2
gene1e	ARG2
.	O
ORP	O
cDNA	O
probes	O
were	O
generated	O
by	O
reverse	O
transcription	O
-	O
PCR	O
from	O
arg1s	O
human	O
arg1e	O
liver	O
mRNA	O
,	O
and	O
used	O
for	O
Northern	O
blot	O
analysis	O
of	O
arg1s	O
human	O
arg1e	O
tissue	O
transcript	O
panels	O
.	O
This	O
verified	O
that	O
each	O
of	O
them	O
represents	O
a	O
different	O
gene	O
product	O
and	O
showed	O
that	O
they	O
display	O
distinct	O
tissue	O
-	O
specific	O
expression	O
patterns	O
.	O
The	O
gene1s	ARG2
ORP-1	ARG2
and	ARG2
-2	ARG2
gene1e	ARG2
mRNA	O
expression	O
levels	O
were	O
similar	O
to	O
or	O
higher	O
than	O
that	O
of	O
gene1s	ARG2
OSBP	ARG2
gene1e	ARG2
while	O
the	O
gene1s	ARG2
ORP-3	ARG2
to	ARG2
-6	ARG2
gene1e	ARG2
mRNAs	O
were	O
detected	O
at	O
lower	O
levels	O
in	O
specific	O
tissues	O
.	O
The	O
most	O
abundantly	O
expressed	O
new	O
gene	O
,	O
gene1s	ARG2
ORP-1	ARG2
gene1e	ARG2
,	O
was	O
transcribed	O
at	O
strikingly	O
high	O
levels	O
in	O
the	O
cortical	O
areas	O
of	O
arg1s	O
human	O
arg1e	O
brain	O
and	O
displayed	O
sterol	O
-	O
regulated	O
expression	O
in	O
a	O
cultured	O
arg1s	O
human	O
arg1e	O
neuroblastoma	O
cell	O
line	O
.	O
This	O
indicates	O
that	O
gene1s	ARG2
ORP-1	ARG2
gene1e	ARG2
may	O
play	O
an	O
important	O
role	O
in	O
maintaining	O
the	O
sterol	O
balance	O
in	O
cells	O
of	O
the	O
central	O
nervous	O
system	O
.	O
Together	O
with	O
gene1s	ARG2
OSBP	ARG2
gene1e	ARG2
,	O
the	O
identified	O
gene	O
products	O
constitute	O
a	O
novel	O
arg1s	O
human	O
arg1e	O
protein	O
family	O
that	O
may	O
provide	O
a	O
link	O
between	O
organellar	O
sterol	O
status	O
and	O
membrane	O
dynamics	O
.	O

Family	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
oxysterol	O
binding	O
protein	O
gene1e	O
(	O
gene1s	O
OSBP	O
gene1e	O
)	O
homologues	O
.	O
A	O
novel	O
member	O
implicated	O
in	O
brain	O
sterol	O
metabolism	O
.	O
gene1s	O
Oxysterol	O
binding	O
protein	O
gene1e	O
(	O
gene1s	O
OSBP	O
gene1e	O
)	O
is	O
a	O
cytosolic	O
protein	O
that	O
undergoes	O
ligand	O
-	O
induced	O
binding	O
to	O
the	O
Golgi	O
apparatus	O
and	O
has	O
been	O
implicated	O
in	O
the	O
regulation	O
of	O
cellular	O
cholesterol	O
metabolism	O
.	O
In	O
the	O
arg1s	O
yeast	O
arg1e	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
an	O
gene1s	O
OSBP	O
gene1e	O
homologue	O
is	O
involved	O
in	O
membrane	O
trafficking	O
through	O
the	O
Golgi	O
complex	O
.	O
Prompted	O
by	O
the	O
multitude	O
of	O
gene1s	O
OSBP	O
gene1e	O
-	O
related	O
genes	O
in	O
the	O
arg1s	O
yeast	O
arg1e	O
genome	O
,	O
we	O
carried	O
out	O
a	O
search	O
for	O
species1s	O
human	O
species1e	O
expressed	O
sequence	O
tags	O
(	O
ESTs	O
)	O
displaying	O
homology	O
to	O
the	O
sterol	O
-	O
binding	O
domain	O
of	O
gene1s	O
OSBP	O
gene1e	O
.	O
This	O
revealed	O
a	O
minimum	O
of	O
six	O
novel	O
OSBP	O
-	O
related	O
proteins	O
,	O
designated	O
gene1s	O
ORP-1	O
to	O
ORP-6	O
gene1e	O
.	O
ORP	O
cDNA	O
probes	O
were	O
generated	O
by	O
reverse	O
transcription	O
-	O
PCR	O
from	O
species1s	O
human	O
species1e	O
liver	O
mRNA	O
,	O
and	O
used	O
for	O
Northern	O
blot	O
analysis	O
of	O
species1s	O
human	O
species1e	O
tissue	O
transcript	O
panels	O
.	O
This	O
verified	O
that	O
each	O
of	O
them	O
represents	O
a	O
different	O
gene	O
product	O
and	O
showed	O
that	O
they	O
display	O
distinct	O
tissue	O
-	O
specific	O
expression	O
patterns	O
.	O
The	O
gene1s	O
ORP-1	O
and	O
-2	O
gene1e	O
mRNA	O
expression	O
levels	O
were	O
similar	O
to	O
or	O
higher	O
than	O
that	O
of	O
gene1s	O
OSBP	O
gene1e	O
while	O
the	O
gene1s	O
ORP-3	O
to	O
-6	O
gene1e	O
mRNAs	O
were	O
detected	O
at	O
lower	O
levels	O
in	O
specific	O
tissues	O
.	O
The	O
most	O
abundantly	O
expressed	O
new	O
gene	O
,	O
gene1s	O
ORP-1	O
gene1e	O
,	O
was	O
transcribed	O
at	O
strikingly	O
high	O
levels	O
in	O
the	O
cortical	O
areas	O
of	O
species1s	O
human	O
species1e	O
brain	O
and	O
displayed	O
sterol	O
-	O
regulated	O
expression	O
in	O
a	O
cultured	O
species1s	O
human	O
species1e	O
neuroblastoma	O
cell	O
line	O
.	O
This	O
indicates	O
that	O
gene1s	O
ORP-1	O
gene1e	O
may	O
play	O
an	O
important	O
role	O
in	O
maintaining	O
the	O
sterol	O
balance	O
in	O
cells	O
of	O
the	O
central	O
nervous	O
system	O
.	O
Together	O
with	O
gene1s	O
OSBP	O
gene1e	O
,	O
the	O
identified	O
gene	O
products	O
constitute	O
a	O
novel	O
species1s	O
human	O
species1e	O
protein	O
family	O
that	O
may	O
provide	O
a	O
link	O
between	O
organellar	O
sterol	O
status	O
and	O
membrane	O
dynamics	O
.	O

gene1s	O
Myoferlin	O
gene1e	O
,	O
a	O
candidate	O
gene	O
and	O
potential	O
modifier	O
of	O
muscular	O
dystrophy	O
.	O
gene1s	O
Dysferlin	O
gene1e	O
,	O
the	O
gene	O
product	O
of	O
the	O
limb	O
girdle	O
muscular	O
dystrophy	O
(	O
LGMD	O
)	O
2B	O
locus	O
,	O
encodes	O
a	O
membrane	O
-	O
associated	O
protein	O
with	O
homology	O
to	O
arg1s	O
Caenorhabditis	O
elegans	O
arg1e	O
gene1s	ARG2
fer-1	ARG2
gene1e	ARG2
.	O
species1s	O
Humans	O
species1e	O
with	O
mutations	O
in	O
gene1s	O
dysferlin	O
gene1e	O
(	O
gene1s	O
DYSF	O
gene1e	O
)	O
develop	O
muscle	O
weakness	O
that	O
affects	O
both	O
proximal	O
and	O
distal	O
muscles	O
.	O
Strikingly	O
,	O
the	O
phenotype	O
in	O
LGMD	O
2B	O
species1s	O
patients	O
species1e	O
is	O
highly	O
variable	O
,	O
but	O
the	O
type	O
of	O
mutation	O
in	O
gene1s	O
DYSF	O
gene1e	O
can	O
not	O
explain	O
this	O
phenotypic	O
variability	O
.	O
Through	O
electronic	O
database	O
searching	O
,	O
we	O
identified	O
a	O
protein	O
highly	O
homologous	O
to	O
gene1s	O
dysferlin	O
gene1e	O
that	O
we	O
have	O
named	O
gene1s	O
myoferlin	O
gene1e	O
.	O
gene1s	O
Myoferlin	O
gene1e	O
mRNA	O
was	O
highly	O
expressed	O
in	O
cardiac	O
muscle	O
and	O
to	O
a	O
lesser	O
degree	O
in	O
skeletal	O
muscle	O
.	O
However	O
,	O
antibodies	O
raised	O
to	O
gene1s	O
myoferlin	O
gene1e	O
showed	O
abundant	O
expression	O
of	O
gene1s	O
myoferlin	O
gene1e	O
in	O
both	O
cardiac	O
and	O
skeletal	O
muscle	O
.	O
Within	O
the	O
cell	O
,	O
gene1s	O
myoferlin	O
gene1e	O
was	O
associated	O
with	O
the	O
plasma	O
membrane	O
but	O
,	O
unlike	O
gene1s	O
dysferlin	O
gene1e	O
,	O
gene1s	O
myoferlin	O
gene1e	O
was	O
also	O
associated	O
with	O
the	O
nuclear	O
membrane	O
.	O
Ferlin	O
family	O
members	O
contain	O
C2	O
domains	O
,	O
and	O
these	O
domains	O
play	O
a	O
role	O
in	O
calcium	O
-	O
mediated	O
membrane	O
fusion	O
events	O
.	O
To	O
investigate	O
this	O
,	O
we	O
studied	O
the	O
expression	O
of	O
gene1s	O
myoferlin	O
gene1e	O
in	O
the	O
mdx	O
species1s	O
mouse	O
species1e	O
,	O
which	O
lacks	O
dystrophin	O
and	O
whose	O
muscles	O
undergo	O
repeated	O
rounds	O
of	O
degeneration	O
and	O
regeneration	O
.	O
We	O
found	O
upregulation	O
of	O
gene1s	O
myoferlin	O
gene1e	O
at	O
the	O
membrane	O
in	O
mdx	O
skeletal	O
muscle	O
.	O
Thus	O
,	O
gene1s	O
myoferlin	O
gene1e	O
(	O
gene1s	O
MYOF	O
gene1e	O
)	O
is	O
a	O
candidate	O
gene	O
for	O
muscular	O
dystrophy	O
and	O
cardiomyopathy	O
,	O
or	O
possibly	O
a	O
modifier	O
of	O
the	O
muscular	O
dystrophy	O
phenotype	O
.	O

gene1s	ARG2
Myoferlin	ARG2
gene1e	ARG2
,	O
a	O
candidate	O
gene	O
and	O
potential	O
modifier	O
of	O
muscular	O
dystrophy	O
.	O
gene1s	ARG2
Dysferlin	ARG2
gene1e	ARG2
,	O
the	O
gene	O
product	O
of	O
the	O
limb	O
girdle	O
muscular	O
dystrophy	O
(	O
LGMD	O
)	O
2B	O
locus	O
,	O
encodes	O
a	O
membrane	O
-	O
associated	O
protein	O
with	O
homology	O
to	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
gene1s	O
fer-1	O
gene1e	O
.	O
arg1s	O
Humans	O
arg1e	O
with	O
mutations	O
in	O
gene1s	ARG2
dysferlin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
DYSF	ARG2
gene1e	ARG2
)	O
develop	O
muscle	O
weakness	O
that	O
affects	O
both	O
proximal	O
and	O
distal	O
muscles	O
.	O
Strikingly	O
,	O
the	O
phenotype	O
in	O
LGMD	O
2B	O
arg1s	O
patients	O
arg1e	O
is	O
highly	O
variable	O
,	O
but	O
the	O
type	O
of	O
mutation	O
in	O
gene1s	ARG2
DYSF	ARG2
gene1e	ARG2
can	O
not	O
explain	O
this	O
phenotypic	O
variability	O
.	O
Through	O
electronic	O
database	O
searching	O
,	O
we	O
identified	O
a	O
protein	O
highly	O
homologous	O
to	O
gene1s	ARG2
dysferlin	ARG2
gene1e	ARG2
that	O
we	O
have	O
named	O
gene1s	ARG2
myoferlin	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
Myoferlin	ARG2
gene1e	ARG2
mRNA	O
was	O
highly	O
expressed	O
in	O
cardiac	O
muscle	O
and	O
to	O
a	O
lesser	O
degree	O
in	O
skeletal	O
muscle	O
.	O
However	O
,	O
antibodies	O
raised	O
to	O
gene1s	ARG2
myoferlin	ARG2
gene1e	ARG2
showed	O
abundant	O
expression	O
of	O
gene1s	ARG2
myoferlin	ARG2
gene1e	ARG2
in	O
both	O
cardiac	O
and	O
skeletal	O
muscle	O
.	O
Within	O
the	O
cell	O
,	O
gene1s	ARG2
myoferlin	ARG2
gene1e	ARG2
was	O
associated	O
with	O
the	O
plasma	O
membrane	O
but	O
,	O
unlike	O
gene1s	ARG2
dysferlin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
myoferlin	ARG2
gene1e	ARG2
was	O
also	O
associated	O
with	O
the	O
nuclear	O
membrane	O
.	O
Ferlin	O
family	O
members	O
contain	O
C2	O
domains	O
,	O
and	O
these	O
domains	O
play	O
a	O
role	O
in	O
calcium	O
-	O
mediated	O
membrane	O
fusion	O
events	O
.	O
To	O
investigate	O
this	O
,	O
we	O
studied	O
the	O
expression	O
of	O
gene1s	O
myoferlin	O
gene1e	O
in	O
the	O
mdx	O
species1s	O
mouse	O
species1e	O
,	O
which	O
lacks	O
dystrophin	O
and	O
whose	O
muscles	O
undergo	O
repeated	O
rounds	O
of	O
degeneration	O
and	O
regeneration	O
.	O
We	O
found	O
upregulation	O
of	O
gene1s	O
myoferlin	O
gene1e	O
at	O
the	O
membrane	O
in	O
mdx	O
skeletal	O
muscle	O
.	O
Thus	O
,	O
gene1s	ARG2
myoferlin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MYOF	ARG2
gene1e	ARG2
)	O
is	O
a	O
candidate	O
gene	O
for	O
muscular	O
dystrophy	O
and	O
cardiomyopathy	O
,	O
or	O
possibly	O
a	O
modifier	O
of	O
the	O
muscular	O
dystrophy	O
phenotype	O
.	O

gene1s	O
Myoferlin	O
gene1e	O
,	O
a	O
candidate	O
gene	O
and	O
potential	O
modifier	O
of	O
muscular	O
dystrophy	O
.	O
gene1s	O
Dysferlin	O
gene1e	O
,	O
the	O
gene	O
product	O
of	O
the	O
limb	O
girdle	O
muscular	O
dystrophy	O
(	O
LGMD	O
)	O
2B	O
locus	O
,	O
encodes	O
a	O
membrane	O
-	O
associated	O
protein	O
with	O
homology	O
to	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
gene1s	O
fer-1	O
gene1e	O
.	O
species1s	O
Humans	O
species1e	O
with	O
mutations	O
in	O
gene1s	O
dysferlin	O
gene1e	O
(	O
gene1s	O
DYSF	O
gene1e	O
)	O
develop	O
muscle	O
weakness	O
that	O
affects	O
both	O
proximal	O
and	O
distal	O
muscles	O
.	O
Strikingly	O
,	O
the	O
phenotype	O
in	O
LGMD	O
2B	O
species1s	O
patients	O
species1e	O
is	O
highly	O
variable	O
,	O
but	O
the	O
type	O
of	O
mutation	O
in	O
gene1s	O
DYSF	O
gene1e	O
can	O
not	O
explain	O
this	O
phenotypic	O
variability	O
.	O
Through	O
electronic	O
database	O
searching	O
,	O
we	O
identified	O
a	O
protein	O
highly	O
homologous	O
to	O
gene1s	O
dysferlin	O
gene1e	O
that	O
we	O
have	O
named	O
gene1s	O
myoferlin	O
gene1e	O
.	O
gene1s	O
Myoferlin	O
gene1e	O
mRNA	O
was	O
highly	O
expressed	O
in	O
cardiac	O
muscle	O
and	O
to	O
a	O
lesser	O
degree	O
in	O
skeletal	O
muscle	O
.	O
However	O
,	O
antibodies	O
raised	O
to	O
gene1s	O
myoferlin	O
gene1e	O
showed	O
abundant	O
expression	O
of	O
gene1s	O
myoferlin	O
gene1e	O
in	O
both	O
cardiac	O
and	O
skeletal	O
muscle	O
.	O
Within	O
the	O
cell	O
,	O
gene1s	O
myoferlin	O
gene1e	O
was	O
associated	O
with	O
the	O
plasma	O
membrane	O
but	O
,	O
unlike	O
gene1s	O
dysferlin	O
gene1e	O
,	O
gene1s	O
myoferlin	O
gene1e	O
was	O
also	O
associated	O
with	O
the	O
nuclear	O
membrane	O
.	O
Ferlin	O
family	O
members	O
contain	O
C2	O
domains	O
,	O
and	O
these	O
domains	O
play	O
a	O
role	O
in	O
calcium	O
-	O
mediated	O
membrane	O
fusion	O
events	O
.	O
To	O
investigate	O
this	O
,	O
we	O
studied	O
the	O
expression	O
of	O
gene1s	ARG2
myoferlin	ARG2
gene1e	ARG2
in	O
the	O
mdx	O
arg1s	O
mouse	O
arg1e	O
,	O
which	O
lacks	O
dystrophin	O
and	O
whose	O
muscles	O
undergo	O
repeated	O
rounds	O
of	O
degeneration	O
and	O
regeneration	O
.	O
We	O
found	O
upregulation	O
of	O
gene1s	ARG2
myoferlin	ARG2
gene1e	ARG2
at	O
the	O
membrane	O
in	O
mdx	O
skeletal	O
muscle	O
.	O
Thus	O
,	O
gene1s	O
myoferlin	O
gene1e	O
(	O
gene1s	O
MYOF	O
gene1e	O
)	O
is	O
a	O
candidate	O
gene	O
for	O
muscular	O
dystrophy	O
and	O
cardiomyopathy	O
,	O
or	O
possibly	O
a	O
modifier	O
of	O
the	O
muscular	O
dystrophy	O
phenotype	O
.	O

The	O
VacA	O
toxin	O
of	O
arg1s	O
Helicobacter	O
pylori	O
arg1e	O
identifies	O
a	O
new	O
intermediate	O
filament	O
-	O
interacting	O
protein	O
.	O
The	O
VacA	O
toxin	O
produced	O
by	O
arg1s	O
Helicobacter	O
pylori	O
arg1e	O
acts	O
inside	O
cells	O
and	O
induces	O
the	O
formation	O
of	O
vacuoles	O
arising	O
from	O
late	O
endosomal	O
/	O
lysosomal	O
compartments	O
.	O
Using	O
VacA	O
as	O
bait	O
in	O
a	O
yeast	O
two	O
-	O
hybrid	O
screening	O
of	O
a	O
species1s	O
HeLa	O
species1e	O
cell	O
library	O
,	O
we	O
have	O
identified	O
a	O
novel	O
protein	O
of	O
54	O
kDa	O
(	O
gene1s	O
VIP54	O
gene1e	O
)	O
,	O
which	O
interacts	O
specifically	O
with	O
VacA	O
,	O
as	O
indicated	O
by	O
co	O
-	O
immunoprecipitation	O
and	O
binding	O
experiments	O
.	O
gene1s	O
VIP54	O
gene1e	O
is	O
expressed	O
in	O
cultured	O
cells	O
and	O
many	O
tissues	O
,	O
with	O
higher	O
expression	O
in	O
the	O
brain	O
,	O
muscle	O
,	O
kidney	O
and	O
liver	O
.	O
Confocal	O
immunofluorescence	O
microscopy	O
with	O
anti	O
-	O
gene1s	O
VIP54	O
gene1e	O
affinity-	O
purified	O
antibodies	O
shows	O
a	O
fibrous	O
pattern	O
typical	O
of	O
intermediate	O
filaments	O
.	O
Double	O
label	O
immunofluorescence	O
performed	O
on	O
various	O
cell	O
lines	O
with	O
antibodies	O
specific	O
to	O
different	O
intermediate	O
filament	O
proteins	O
revealed	O
that	O
gene1s	O
VIP54	O
gene1e	O
largely	O
co	O
-	O
distributes	O
with	O
gene1s	O
vimentin	O
gene1e	O
.	O
In	O
contrast	O
to	O
known	O
intermediate	O
filament	O
proteins	O
,	O
gene1s	O
VIP54	O
gene1e	O
is	O
predicted	O
to	O
contain	O
approximately	O
50	O
%	O
of	O
helical	O
segments	O
,	O
but	O
no	O
extended	O
coiled	O
-	O
coil	O
regions	O
.	O
The	O
possible	O
involvement	O
of	O
this	O
novel	O
protein	O
in	O
interactions	O
between	O
intermediate	O
filaments	O
and	O
late	O
endosomal	O
compartments	O
is	O
discussed	O
.	O

The	O
VacA	O
toxin	O
of	O
species1s	O
Helicobacter	O
pylori	O
species1e	O
identifies	O
a	O
new	O
intermediate	O
filament	O
-	O
interacting	O
protein	O
.	O
The	O
VacA	O
toxin	O
produced	O
by	O
species1s	O
Helicobacter	O
pylori	O
species1e	O
acts	O
inside	O
cells	O
and	O
induces	O
the	O
formation	O
of	O
vacuoles	O
arising	O
from	O
late	O
endosomal	O
/	O
lysosomal	O
compartments	O
.	O
Using	O
VacA	O
as	O
bait	O
in	O
a	O
yeast	O
two	O
-	O
hybrid	O
screening	O
of	O
a	O
arg1s	O
HeLa	O
arg1e	O
cell	O
library	O
,	O
we	O
have	O
identified	O
a	O
novel	O
protein	O
of	O
54	O
kDa	O
(	O
gene1s	ARG2
VIP54	ARG2
gene1e	ARG2
)	O
,	O
which	O
interacts	O
specifically	O
with	O
VacA	O
,	O
as	O
indicated	O
by	O
co	O
-	O
immunoprecipitation	O
and	O
binding	O
experiments	O
.	O
gene1s	ARG2
VIP54	ARG2
gene1e	ARG2
is	O
expressed	O
in	O
cultured	O
cells	O
and	O
many	O
tissues	O
,	O
with	O
higher	O
expression	O
in	O
the	O
brain	O
,	O
muscle	O
,	O
kidney	O
and	O
liver	O
.	O
Confocal	O
immunofluorescence	O
microscopy	O
with	O
anti	O
-	O
gene1s	ARG2
VIP54	ARG2
gene1e	ARG2
affinity-	O
purified	O
antibodies	O
shows	O
a	O
fibrous	O
pattern	O
typical	O
of	O
intermediate	O
filaments	O
.	O
Double	O
label	O
immunofluorescence	O
performed	O
on	O
various	O
cell	O
lines	O
with	O
antibodies	O
specific	O
to	O
different	O
intermediate	O
filament	O
proteins	O
revealed	O
that	O
gene1s	ARG2
VIP54	ARG2
gene1e	ARG2
largely	O
co	O
-	O
distributes	O
with	O
gene1s	ARG2
vimentin	ARG2
gene1e	ARG2
.	O
In	O
contrast	O
to	O
known	O
intermediate	O
filament	O
proteins	O
,	O
gene1s	ARG2
VIP54	ARG2
gene1e	ARG2
is	O
predicted	O
to	O
contain	O
approximately	O
50	O
%	O
of	O
helical	O
segments	O
,	O
but	O
no	O
extended	O
coiled	O
-	O
coil	O
regions	O
.	O
The	O
possible	O
involvement	O
of	O
this	O
novel	O
protein	O
in	O
interactions	O
between	O
intermediate	O
filaments	O
and	O
late	O
endosomal	O
compartments	O
is	O
discussed	O
.	O

Chromosome	O
instability	O
and	O
immunodeficiency	O
syndrome	O
caused	O
by	O
mutations	O
in	O
a	O
DNA	O
methyltransferase	O
gene	O
.	O
The	O
recessive	O
autosomal	O
disorder	O
known	O
as	O
ICF	O
syndrome	O
(	O
for	O
immunodeficiency	O
,	O
centromere	O
instability	O
and	O
facial	O
anomalies	O
;	O
Mendelian	O
Inheritance	O
in	O
Man	O
number	O
242860	O
)	O
is	O
characterized	O
by	O
variable	O
reductions	O
in	O
serum	O
immunoglobulin	O
levels	O
which	O
cause	O
most	O
ICF	O
arg1s	O
patients	O
arg1e	O
to	O
succumb	O
to	O
infectious	O
diseases	O
before	O
adulthood	O
.	O
Mild	O
facial	O
anomalies	O
include	O
hypertelorism	O
,	O
low	O
-	O
set	O
ears	O
,	O
epicanthal	O
folds	O
and	O
macroglossia	O
.	O
The	O
cytogenetic	O
abnormalities	O
in	O
lymphocytes	O
are	O
exuberant	O
:	O
juxtacentromeric	O
heterochromatin	O
is	O
greatly	O
elongated	O
and	O
thread	O
-	O
like	O
in	O
metaphase	O
chromosomes	O
,	O
which	O
is	O
associated	O
with	O
the	O
formation	O
of	O
complex	O
multiradiate	O
chromosomes	O
.	O
The	O
same	O
juxtacentromeric	O
regions	O
are	O
subject	O
to	O
persistent	O
interphase	O
self	O
-	O
associations	O
and	O
are	O
extruded	O
into	O
nuclear	O
blebs	O
or	O
micronuclei	O
.	O
Abnormalities	O
are	O
largely	O
confined	O
to	O
tracts	O
of	O
classical	O
species1s	O
satellites	O
species1e	O
2	O
and	O
3	O
at	O
juxtacentromeric	O
regions	O
of	O
chromosomes	O
1	O
,	O
9	O
and	O
16	O
.	O
Classical	O
satellite	O
DNA	O
is	O
normally	O
heavily	O
methylated	O
at	O
cytosine	O
residues	O
,	O
but	O
in	O
ICF	O
syndrome	O
it	O
is	O
almost	O
completely	O
unmethylated	O
in	O
all	O
tissues	O
.	O
ICF	O
syndrome	O
is	O
the	O
only	O
genetic	O
disorder	O
known	O
to	O
involve	O
constitutive	O
abnormalities	O
of	O
genomic	O
methylation	O
patterns	O
.	O
Here	O
we	O
show	O
that	O
five	O
unrelated	O
ICF	O
arg1s	O
patients	O
arg1e	O
have	O
mutations	O
in	O
both	O
alleles	O
of	O
the	O
gene	O
that	O
encodes	O
gene1s	ARG2
DNA	ARG2
methyltransferase	ARG2
3B	ARG2
gene1e	ARG2
(	O
refs	O
5	O
,	O
6	O
)	O
.	O
Cytosine	O
methylation	O
is	O
essential	O
for	O
the	O
organization	O
and	O
stabilization	O
of	O
a	O
specific	O
type	O
of	O
heterochromatin	O
,	O
and	O
this	O
methylation	O
appears	O
to	O
be	O
carried	O
out	O
by	O
an	O
enzyme	O
specialized	O
for	O
the	O
purpose	O
.	O

Chromosome	O
instability	O
and	O
immunodeficiency	O
syndrome	O
caused	O
by	O
mutations	O
in	O
a	O
DNA	O
methyltransferase	O
gene	O
.	O
The	O
recessive	O
autosomal	O
disorder	O
known	O
as	O
ICF	O
syndrome	O
(	O
for	O
immunodeficiency	O
,	O
centromere	O
instability	O
and	O
facial	O
anomalies	O
;	O
Mendelian	O
Inheritance	O
in	O
Man	O
number	O
242860	O
)	O
is	O
characterized	O
by	O
variable	O
reductions	O
in	O
serum	O
immunoglobulin	O
levels	O
which	O
cause	O
most	O
ICF	O
species1s	O
patients	O
species1e	O
to	O
succumb	O
to	O
infectious	O
diseases	O
before	O
adulthood	O
.	O
Mild	O
facial	O
anomalies	O
include	O
hypertelorism	O
,	O
low	O
-	O
set	O
ears	O
,	O
epicanthal	O
folds	O
and	O
macroglossia	O
.	O
The	O
cytogenetic	O
abnormalities	O
in	O
lymphocytes	O
are	O
exuberant	O
:	O
juxtacentromeric	O
heterochromatin	O
is	O
greatly	O
elongated	O
and	O
thread	O
-	O
like	O
in	O
metaphase	O
chromosomes	O
,	O
which	O
is	O
associated	O
with	O
the	O
formation	O
of	O
complex	O
multiradiate	O
chromosomes	O
.	O
The	O
same	O
juxtacentromeric	O
regions	O
are	O
subject	O
to	O
persistent	O
interphase	O
self	O
-	O
associations	O
and	O
are	O
extruded	O
into	O
nuclear	O
blebs	O
or	O
micronuclei	O
.	O
Abnormalities	O
are	O
largely	O
confined	O
to	O
tracts	O
of	O
classical	O
arg1s	O
satellites	O
arg1e	O
2	O
and	O
3	O
at	O
juxtacentromeric	O
regions	O
of	O
chromosomes	O
1	O
,	O
9	O
and	O
16	O
.	O
Classical	O
satellite	O
DNA	O
is	O
normally	O
heavily	O
methylated	O
at	O
cytosine	O
residues	O
,	O
but	O
in	O
ICF	O
syndrome	O
it	O
is	O
almost	O
completely	O
unmethylated	O
in	O
all	O
tissues	O
.	O
ICF	O
syndrome	O
is	O
the	O
only	O
genetic	O
disorder	O
known	O
to	O
involve	O
constitutive	O
abnormalities	O
of	O
genomic	O
methylation	O
patterns	O
.	O
Here	O
we	O
show	O
that	O
five	O
unrelated	O
ICF	O
species1s	O
patients	O
species1e	O
have	O
mutations	O
in	O
both	O
alleles	O
of	O
the	O
gene	O
that	O
encodes	O
gene1s	O
DNA	O
methyltransferase	O
3B	O
gene1e	O
(	O
refs	O
5	O
,	O
6	O
)	O
.	O
Cytosine	O
methylation	O
is	O
essential	O
for	O
the	O
organization	O
and	O
stabilization	O
of	O
a	O
specific	O
type	O
of	O
heterochromatin	O
,	O
and	O
this	O
methylation	O
appears	O
to	O
be	O
carried	O
out	O
by	O
an	O
enzyme	O
specialized	O
for	O
the	O
purpose	O
.	O

Functional	O
expression	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
hZIP2	ARG2
gene1e	ARG2
zinc	O
transporter	O
.	O
Zinc	O
is	O
an	O
essential	O
nutrient	O
for	O
arg1s	O
humans	O
arg1e	O
,	O
yet	O
we	O
know	O
little	O
about	O
how	O
this	O
metal	O
ion	O
is	O
taken	O
up	O
by	O
arg1s	O
mammalian	O
arg1e	O
cells	O
.	O
In	O
this	O
report	O
,	O
we	O
describe	O
the	O
characterization	O
of	O
gene1s	ARG2
hZip2	ARG2
gene1e	ARG2
,	O
a	O
arg1s	O
human	O
arg1e	O
zinc	O
transporter	O
identified	O
by	O
its	O
similarity	O
to	O
zinc	O
transporters	O
recently	O
characterized	O
in	O
fungi	O
and	O
plants	O
.	O
gene1s	ARG2
hZip2	ARG2
gene1e	ARG2
is	O
a	O
member	O
of	O
the	O
ZIP	O
family	O
of	O
eukaryotic	O
metal	O
ion	O
transporters	O
that	O
includes	O
two	O
other	O
arg1s	O
human	O
arg1e	O
genes	O
,	O
gene1s	ARG2
hZIP1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
hZIP3	ARG2
gene1e	ARG2
,	O
and	O
genes	O
in	O
species1s	O
mice	O
species1e	O
and	O
species1s	O
rats	O
species1e	O
.	O
To	O
test	O
whether	O
gene1s	ARG2
hZip2	ARG2
gene1e	ARG2
is	O
a	O
zinc	O
transporter	O
,	O
we	O
examined	O
(	O
65)Zn	O
uptake	O
activity	O
in	O
transfected	O
arg1s	O
K562	O
arg1e	O
erythroleukemia	O
cells	O
expressing	O
gene1s	ARG2
hZip2	ARG2
gene1e	ARG2
from	O
the	O
CMV	O
promoter	O
.	O
gene1s	ARG2
hZip2	ARG2
gene1e	ARG2
-expressing	O
cells	O
accumulated	O
more	O
zinc	O
than	O
control	O
cells	O
because	O
of	O
an	O
increased	O
initial	O
zinc	O
uptake	O
rate	O
.	O
This	O
activity	O
was	O
time-	O
,	O
temperature-	O
,	O
and	O
concentration	O
-	O
dependent	O
and	O
saturable	O
with	O
an	O
apparent	O
K(m	O
)	O
of	O
3	O
microM.	O
gene1s	ARG2
hZip2	ARG2
gene1e	ARG2
zinc	O
uptake	O
activity	O
was	O
inhibited	O
by	O
several	O
other	O
transition	O
metals	O
,	O
suggesting	O
that	O
this	O
protein	O
may	O
transport	O
other	O
substrates	O
as	O
well	O
.	O
gene1s	ARG2
hZip2	ARG2
gene1e	ARG2
activity	O
was	O
not	O
energy	O
-	O
dependent	O
,	O
nor	O
did	O
it	O
require	O
K(+	O
)	O
or	O
Na(+	O
)	O
gradients	O
.	O
Zinc	O
uptake	O
by	O
gene1s	ARG2
hZip2	ARG2
gene1e	ARG2
was	O
stimulated	O
by	O
HCO(3)(-	O
)	O
treatment	O
,	O
suggesting	O
a	O
Zn(2+)-HCO(3)(-	O
)	O
cotransport	O
mechanism	O
.	O
Finally	O
,	O
gene1s	ARG2
hZip2	ARG2
gene1e	ARG2
was	O
exclusively	O
localized	O
in	O
the	O
plasma	O
membrane	O
.	O
These	O
results	O
indicate	O
that	O
gene1s	ARG2
hZip2	ARG2
gene1e	ARG2
is	O
a	O
zinc	O
transporter	O
,	O
and	O
its	O
identification	O
provides	O
one	O
of	O
the	O
first	O
molecular	O
tools	O
to	O
study	O
zinc	O
uptake	O
in	O
arg1s	O
mammalian	O
arg1e	O
cells	O
.	O

Functional	O
expression	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
hZIP2	O
gene1e	O
zinc	O
transporter	O
.	O
Zinc	O
is	O
an	O
essential	O
nutrient	O
for	O
species1s	O
humans	O
species1e	O
,	O
yet	O
we	O
know	O
little	O
about	O
how	O
this	O
metal	O
ion	O
is	O
taken	O
up	O
by	O
species1s	O
mammalian	O
species1e	O
cells	O
.	O
In	O
this	O
report	O
,	O
we	O
describe	O
the	O
characterization	O
of	O
gene1s	O
hZip2	O
gene1e	O
,	O
a	O
species1s	O
human	O
species1e	O
zinc	O
transporter	O
identified	O
by	O
its	O
similarity	O
to	O
zinc	O
transporters	O
recently	O
characterized	O
in	O
fungi	O
and	O
plants	O
.	O
gene1s	O
hZip2	O
gene1e	O
is	O
a	O
member	O
of	O
the	O
ZIP	O
family	O
of	O
eukaryotic	O
metal	O
ion	O
transporters	O
that	O
includes	O
two	O
other	O
species1s	O
human	O
species1e	O
genes	O
,	O
gene1s	O
hZIP1	O
gene1e	O
and	O
gene1s	O
hZIP3	O
gene1e	O
,	O
and	O
genes	O
in	O
arg1s	O
mice	O
arg1e	O
and	O
species1s	O
rats	O
species1e	O
.	O
To	O
test	O
whether	O
gene1s	O
hZip2	O
gene1e	O
is	O
a	O
zinc	O
transporter	O
,	O
we	O
examined	O
(	O
65)Zn	O
uptake	O
activity	O
in	O
transfected	O
species1s	O
K562	O
species1e	O
erythroleukemia	O
cells	O
expressing	O
gene1s	O
hZip2	O
gene1e	O
from	O
the	O
CMV	O
promoter	O
.	O
gene1s	O
hZip2	O
gene1e	O
-expressing	O
cells	O
accumulated	O
more	O
zinc	O
than	O
control	O
cells	O
because	O
of	O
an	O
increased	O
initial	O
zinc	O
uptake	O
rate	O
.	O
This	O
activity	O
was	O
time-	O
,	O
temperature-	O
,	O
and	O
concentration	O
-	O
dependent	O
and	O
saturable	O
with	O
an	O
apparent	O
K(m	O
)	O
of	O
3	O
microM.	O
gene1s	O
hZip2	O
gene1e	O
zinc	O
uptake	O
activity	O
was	O
inhibited	O
by	O
several	O
other	O
transition	O
metals	O
,	O
suggesting	O
that	O
this	O
protein	O
may	O
transport	O
other	O
substrates	O
as	O
well	O
.	O
gene1s	O
hZip2	O
gene1e	O
activity	O
was	O
not	O
energy	O
-	O
dependent	O
,	O
nor	O
did	O
it	O
require	O
K(+	O
)	O
or	O
Na(+	O
)	O
gradients	O
.	O
Zinc	O
uptake	O
by	O
gene1s	O
hZip2	O
gene1e	O
was	O
stimulated	O
by	O
HCO(3)(-	O
)	O
treatment	O
,	O
suggesting	O
a	O
Zn(2+)-HCO(3)(-	O
)	O
cotransport	O
mechanism	O
.	O
Finally	O
,	O
gene1s	O
hZip2	O
gene1e	O
was	O
exclusively	O
localized	O
in	O
the	O
plasma	O
membrane	O
.	O
These	O
results	O
indicate	O
that	O
gene1s	O
hZip2	O
gene1e	O
is	O
a	O
zinc	O
transporter	O
,	O
and	O
its	O
identification	O
provides	O
one	O
of	O
the	O
first	O
molecular	O
tools	O
to	O
study	O
zinc	O
uptake	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
.	O

Functional	O
expression	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
hZIP2	O
gene1e	O
zinc	O
transporter	O
.	O
Zinc	O
is	O
an	O
essential	O
nutrient	O
for	O
species1s	O
humans	O
species1e	O
,	O
yet	O
we	O
know	O
little	O
about	O
how	O
this	O
metal	O
ion	O
is	O
taken	O
up	O
by	O
species1s	O
mammalian	O
species1e	O
cells	O
.	O
In	O
this	O
report	O
,	O
we	O
describe	O
the	O
characterization	O
of	O
gene1s	O
hZip2	O
gene1e	O
,	O
a	O
species1s	O
human	O
species1e	O
zinc	O
transporter	O
identified	O
by	O
its	O
similarity	O
to	O
zinc	O
transporters	O
recently	O
characterized	O
in	O
fungi	O
and	O
plants	O
.	O
gene1s	O
hZip2	O
gene1e	O
is	O
a	O
member	O
of	O
the	O
ZIP	O
family	O
of	O
eukaryotic	O
metal	O
ion	O
transporters	O
that	O
includes	O
two	O
other	O
species1s	O
human	O
species1e	O
genes	O
,	O
gene1s	O
hZIP1	O
gene1e	O
and	O
gene1s	O
hZIP3	O
gene1e	O
,	O
and	O
genes	O
in	O
species1s	O
mice	O
species1e	O
and	O
arg1s	O
rats	O
arg1e	O
.	O
To	O
test	O
whether	O
gene1s	O
hZip2	O
gene1e	O
is	O
a	O
zinc	O
transporter	O
,	O
we	O
examined	O
(	O
65)Zn	O
uptake	O
activity	O
in	O
transfected	O
species1s	O
K562	O
species1e	O
erythroleukemia	O
cells	O
expressing	O
gene1s	O
hZip2	O
gene1e	O
from	O
the	O
CMV	O
promoter	O
.	O
gene1s	O
hZip2	O
gene1e	O
-expressing	O
cells	O
accumulated	O
more	O
zinc	O
than	O
control	O
cells	O
because	O
of	O
an	O
increased	O
initial	O
zinc	O
uptake	O
rate	O
.	O
This	O
activity	O
was	O
time-	O
,	O
temperature-	O
,	O
and	O
concentration	O
-	O
dependent	O
and	O
saturable	O
with	O
an	O
apparent	O
K(m	O
)	O
of	O
3	O
microM.	O
gene1s	O
hZip2	O
gene1e	O
zinc	O
uptake	O
activity	O
was	O
inhibited	O
by	O
several	O
other	O
transition	O
metals	O
,	O
suggesting	O
that	O
this	O
protein	O
may	O
transport	O
other	O
substrates	O
as	O
well	O
.	O
gene1s	O
hZip2	O
gene1e	O
activity	O
was	O
not	O
energy	O
-	O
dependent	O
,	O
nor	O
did	O
it	O
require	O
K(+	O
)	O
or	O
Na(+	O
)	O
gradients	O
.	O
Zinc	O
uptake	O
by	O
gene1s	O
hZip2	O
gene1e	O
was	O
stimulated	O
by	O
HCO(3)(-	O
)	O
treatment	O
,	O
suggesting	O
a	O
Zn(2+)-HCO(3)(-	O
)	O
cotransport	O
mechanism	O
.	O
Finally	O
,	O
gene1s	O
hZip2	O
gene1e	O
was	O
exclusively	O
localized	O
in	O
the	O
plasma	O
membrane	O
.	O
These	O
results	O
indicate	O
that	O
gene1s	O
hZip2	O
gene1e	O
is	O
a	O
zinc	O
transporter	O
,	O
and	O
its	O
identification	O
provides	O
one	O
of	O
the	O
first	O
molecular	O
tools	O
to	O
study	O
zinc	O
uptake	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
.	O

Cloning	O
and	O
functional	O
characterization	O
of	O
novel	O
large	O
conductance	O
calcium	O
-	O
activated	O
potassium	O
channel	O
beta	O
subunits	O
,	O
gene1s	O
hKCNMB3	O
gene1e	O
and	O
gene1s	O
hKCNMB4	O
gene1e	O
.	O
We	O
present	O
the	O
cloning	O
and	O
characterization	O
of	O
two	O
novel	O
calcium	O
-	O
activated	O
potassium	O
channel	O
beta	O
subunits	O
,	O
gene1s	O
hKCNMB3	O
gene1e	O
and	O
gene1s	O
hKCNMB4	O
gene1e	O
,	O
that	O
are	O
enriched	O
in	O
the	O
testis	O
and	O
brain	O
,	O
respectively	O
.	O
We	O
compare	O
and	O
contrast	O
the	O
steady	O
state	O
and	O
kinetic	O
properties	O
of	O
these	O
beta	O
subunits	O
with	O
the	O
previously	O
cloned	O
arg1s	O
mouse	O
arg1e	O
beta1	O
(	O
gene1s	ARG2
mKCNMB1	ARG2
gene1e	ARG2
)	O
and	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
beta2	O
subunit	O
gene1e	O
(	O
gene1s	O
hKCNMB2	O
gene1e	O
)	O
.	O
Once	O
inactivation	O
is	O
removed	O
,	O
we	O
find	O
that	O
gene1s	O
hKCNMB2	O
gene1e	O
has	O
properties	O
similar	O
to	O
gene1s	ARG2
mKCNMB1	ARG2
gene1e	ARG2
.	O
gene1s	O
hKCNMB2	O
gene1e	O
slows	O
Hslo1	O
channel	O
gating	O
and	O
shifts	O
the	O
current	O
-	O
voltage	O
relationship	O
to	O
more	O
negative	O
potentials	O
.	O
gene1s	O
hKCNMB3	O
gene1e	O
and	O
gene1s	O
hKCNMB4	O
gene1e	O
have	O
distinct	O
effects	O
on	O
slo	O
currents	O
not	O
observed	O
with	O
gene1s	ARG2
mKCNMB1	ARG2
gene1e	ARG2
and	O
gene1s	O
hKCNMB2	O
gene1e	O
.	O
Although	O
we	O
found	O
that	O
gene1s	O
hKCNMB3	O
gene1e	O
does	O
interact	O
with	O
Hslo	O
channels	O
,	O
its	O
effects	O
on	O
Hslo1	O
channel	O
properties	O
were	O
slight	O
,	O
increasing	O
Hslo1	O
activation	O
rates	O
.	O
In	O
contrast	O
,	O
gene1s	O
hKCNMB4	O
gene1e	O
slows	O
Hslo1	O
gating	O
kinetics	O
,	O
and	O
modulates	O
the	O
apparent	O
calcium	O
sensitivity	O
of	O
Hslo1	O
.	O
We	O
found	O
that	O
the	O
different	O
effects	O
of	O
the	O
beta	O
subunits	O
on	O
some	O
Hslo1	O
channel	O
properties	O
are	O
calcium	O
-	O
dependent	O
.	O
gene1s	ARG2
mKCNMB1	ARG2
gene1e	ARG2
and	O
gene1s	O
hKCNMB2	O
gene1e	O
slow	O
activation	O
at	O
1	O
microM	O
but	O
not	O
at	O
10	O
microM	O
free	O
calcium	O
concentrations	O
.	O
gene1s	O
hKCNMB4	O
gene1e	O
decreases	O
Hslo1	O
channel	O
openings	O
at	O
low	O
calcium	O
concentrations	O
but	O
increases	O
channel	O
openings	O
at	O
high	O
calcium	O
concentrations	O
.	O
These	O
results	O
suggest	O
that	O
beta	O
subunits	O
in	O
diverse	O
tissue	O
types	O
fine	O
-	O
tune	O
slo	O
channel	O
properties	O
to	O
the	O
needs	O
of	O
a	O
particular	O
cell	O
.	O

Cloning	O
and	O
functional	O
characterization	O
of	O
novel	O
large	O
conductance	O
calcium	O
-	O
activated	O
potassium	O
channel	O
beta	O
subunits	O
,	O
gene1s	ARG2
hKCNMB3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
hKCNMB4	ARG2
gene1e	ARG2
.	O
We	O
present	O
the	O
cloning	O
and	O
characterization	O
of	O
two	O
novel	O
calcium	O
-	O
activated	O
potassium	O
channel	O
beta	O
subunits	O
,	O
gene1s	ARG2
hKCNMB3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
hKCNMB4	ARG2
gene1e	ARG2
,	O
that	O
are	O
enriched	O
in	O
the	O
testis	O
and	O
brain	O
,	O
respectively	O
.	O
We	O
compare	O
and	O
contrast	O
the	O
steady	O
state	O
and	O
kinetic	O
properties	O
of	O
these	O
beta	O
subunits	O
with	O
the	O
previously	O
cloned	O
species1s	O
mouse	O
species1e	O
beta1	O
(	O
gene1s	O
mKCNMB1	O
gene1e	O
)	O
and	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
beta2	ARG2
subunit	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
hKCNMB2	ARG2
gene1e	ARG2
)	O
.	O
Once	O
inactivation	O
is	O
removed	O
,	O
we	O
find	O
that	O
gene1s	ARG2
hKCNMB2	ARG2
gene1e	ARG2
has	O
properties	O
similar	O
to	O
gene1s	O
mKCNMB1	O
gene1e	O
.	O
gene1s	ARG2
hKCNMB2	ARG2
gene1e	ARG2
slows	O
Hslo1	O
channel	O
gating	O
and	O
shifts	O
the	O
current	O
-	O
voltage	O
relationship	O
to	O
more	O
negative	O
potentials	O
.	O
gene1s	ARG2
hKCNMB3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
hKCNMB4	ARG2
gene1e	ARG2
have	O
distinct	O
effects	O
on	O
slo	O
currents	O
not	O
observed	O
with	O
gene1s	O
mKCNMB1	O
gene1e	O
and	O
gene1s	ARG2
hKCNMB2	ARG2
gene1e	ARG2
.	O
Although	O
we	O
found	O
that	O
gene1s	ARG2
hKCNMB3	ARG2
gene1e	ARG2
does	O
interact	O
with	O
Hslo	O
channels	O
,	O
its	O
effects	O
on	O
Hslo1	O
channel	O
properties	O
were	O
slight	O
,	O
increasing	O
Hslo1	O
activation	O
rates	O
.	O
In	O
contrast	O
,	O
gene1s	ARG2
hKCNMB4	ARG2
gene1e	ARG2
slows	O
Hslo1	O
gating	O
kinetics	O
,	O
and	O
modulates	O
the	O
apparent	O
calcium	O
sensitivity	O
of	O
Hslo1	O
.	O
We	O
found	O
that	O
the	O
different	O
effects	O
of	O
the	O
beta	O
subunits	O
on	O
some	O
Hslo1	O
channel	O
properties	O
are	O
calcium	O
-	O
dependent	O
.	O
gene1s	O
mKCNMB1	O
gene1e	O
and	O
gene1s	ARG2
hKCNMB2	ARG2
gene1e	ARG2
slow	O
activation	O
at	O
1	O
microM	O
but	O
not	O
at	O
10	O
microM	O
free	O
calcium	O
concentrations	O
.	O
gene1s	ARG2
hKCNMB4	ARG2
gene1e	ARG2
decreases	O
Hslo1	O
channel	O
openings	O
at	O
low	O
calcium	O
concentrations	O
but	O
increases	O
channel	O
openings	O
at	O
high	O
calcium	O
concentrations	O
.	O
These	O
results	O
suggest	O
that	O
beta	O
subunits	O
in	O
diverse	O
tissue	O
types	O
fine	O
-	O
tune	O
slo	O
channel	O
properties	O
to	O
the	O
needs	O
of	O
a	O
particular	O
cell	O
.	O

Positional	O
cloning	O
of	O
arg1s	O
zebrafish	O
arg1e	O
gene1s	ARG2
ferroportin1	ARG2
gene1e	ARG2
identifies	O
a	O
conserved	O
vertebrate	O
iron	O
exporter	O
.	O
Defects	O
in	O
iron	O
absorption	O
and	O
utilization	O
lead	O
to	O
iron	O
deficiency	O
and	O
overload	O
disorders	O
.	O
Adult	O
mammals	O
absorb	O
iron	O
through	O
the	O
duodenum	O
,	O
whereas	O
embryos	O
obtain	O
iron	O
through	O
placental	O
transport	O
.	O
Iron	O
uptake	O
from	O
the	O
intestinal	O
lumen	O
through	O
the	O
apical	O
surface	O
of	O
polarized	O
duodenal	O
enterocytes	O
is	O
mediated	O
by	O
the	O
divalent	O
metal	O
transporter	O
,	O
DMTi	O
.	O
A	O
second	O
transporter	O
has	O
been	O
postulated	O
to	O
export	O
iron	O
across	O
the	O
basolateral	O
surface	O
to	O
the	O
circulation	O
.	O
Here	O
we	O
have	O
used	O
positional	O
cloning	O
to	O
identify	O
the	O
gene	O
responsible	O
for	O
the	O
hypochromic	O
anaemia	O
of	O
the	O
arg1s	O
zebrafish	O
arg1e	O
mutant	O
weissherbst	O
.	O
The	O
gene	O
,	O
gene1s	O
ferroportin1	O
gene1e	O
,	O
encodes	O
a	O
multiple	O
-	O
transmembrane	O
domain	O
protein	O
,	O
expressed	O
in	O
the	O
yolk	O
sac	O
,	O
that	O
is	O
a	O
candidate	O
for	O
the	O
elusive	O
iron	O
exporter	O
.	O
arg1s	O
Zebrafish	O
arg1e	O
gene1s	ARG2
ferroportin1	ARG2
gene1e	ARG2
is	O
required	O
for	O
the	O
transport	O
of	O
iron	O
from	O
maternally	O
derived	O
yolk	O
stores	O
to	O
the	O
circulation	O
and	O
functions	O
as	O
an	O
iron	O
exporter	O
when	O
expressed	O
in	O
species1s	O
Xenopus	O
species1e	O
oocytes	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
Ferroportin1	O
gene1e	O
is	O
found	O
at	O
the	O
basal	O
surface	O
of	O
placental	O
syncytiotrophoblasts	O
,	O
suggesting	O
that	O
it	O
also	O
transports	O
iron	O
from	O
mother	O
to	O
embryo	O
.	O
species1s	O
Mammalian	O
species1e	O
gene1s	O
Ferroportin1	O
gene1e	O
is	O
expressed	O
at	O
the	O
basolateral	O
surface	O
of	O
duodenal	O
enterocytes	O
and	O
could	O
export	O
cellular	O
iron	O
into	O
the	O
circulation	O
.	O
We	O
propose	O
that	O
gene1s	O
Ferroportin1	O
gene1e	O
function	O
may	O
be	O
perturbed	O
in	O
species1s	O
mammalian	O
species1e	O
disorders	O
of	O
iron	O
deficiency	O
or	O
overload	O
.	O

Positional	O
cloning	O
of	O
species1s	O
zebrafish	O
species1e	O
gene1s	O
ferroportin1	O
gene1e	O
identifies	O
a	O
conserved	O
vertebrate	O
iron	O
exporter	O
.	O
Defects	O
in	O
iron	O
absorption	O
and	O
utilization	O
lead	O
to	O
iron	O
deficiency	O
and	O
overload	O
disorders	O
.	O
Adult	O
mammals	O
absorb	O
iron	O
through	O
the	O
duodenum	O
,	O
whereas	O
embryos	O
obtain	O
iron	O
through	O
placental	O
transport	O
.	O
Iron	O
uptake	O
from	O
the	O
intestinal	O
lumen	O
through	O
the	O
apical	O
surface	O
of	O
polarized	O
duodenal	O
enterocytes	O
is	O
mediated	O
by	O
the	O
divalent	O
metal	O
transporter	O
,	O
DMTi	O
.	O
A	O
second	O
transporter	O
has	O
been	O
postulated	O
to	O
export	O
iron	O
across	O
the	O
basolateral	O
surface	O
to	O
the	O
circulation	O
.	O
Here	O
we	O
have	O
used	O
positional	O
cloning	O
to	O
identify	O
the	O
gene	O
responsible	O
for	O
the	O
hypochromic	O
anaemia	O
of	O
the	O
species1s	O
zebrafish	O
species1e	O
mutant	O
weissherbst	O
.	O
The	O
gene	O
,	O
gene1s	O
ferroportin1	O
gene1e	O
,	O
encodes	O
a	O
multiple	O
-	O
transmembrane	O
domain	O
protein	O
,	O
expressed	O
in	O
the	O
yolk	O
sac	O
,	O
that	O
is	O
a	O
candidate	O
for	O
the	O
elusive	O
iron	O
exporter	O
.	O
species1s	O
Zebrafish	O
species1e	O
gene1s	O
ferroportin1	O
gene1e	O
is	O
required	O
for	O
the	O
transport	O
of	O
iron	O
from	O
maternally	O
derived	O
yolk	O
stores	O
to	O
the	O
circulation	O
and	O
functions	O
as	O
an	O
iron	O
exporter	O
when	O
expressed	O
in	O
arg1s	O
Xenopus	O
arg1e	O
oocytes	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
Ferroportin1	O
gene1e	O
is	O
found	O
at	O
the	O
basal	O
surface	O
of	O
placental	O
syncytiotrophoblasts	O
,	O
suggesting	O
that	O
it	O
also	O
transports	O
iron	O
from	O
mother	O
to	O
embryo	O
.	O
species1s	O
Mammalian	O
species1e	O
gene1s	O
Ferroportin1	O
gene1e	O
is	O
expressed	O
at	O
the	O
basolateral	O
surface	O
of	O
duodenal	O
enterocytes	O
and	O
could	O
export	O
cellular	O
iron	O
into	O
the	O
circulation	O
.	O
We	O
propose	O
that	O
gene1s	O
Ferroportin1	O
gene1e	O
function	O
may	O
be	O
perturbed	O
in	O
species1s	O
mammalian	O
species1e	O
disorders	O
of	O
iron	O
deficiency	O
or	O
overload	O
.	O

Positional	O
cloning	O
of	O
species1s	O
zebrafish	O
species1e	O
gene1s	O
ferroportin1	O
gene1e	O
identifies	O
a	O
conserved	O
vertebrate	O
iron	O
exporter	O
.	O
Defects	O
in	O
iron	O
absorption	O
and	O
utilization	O
lead	O
to	O
iron	O
deficiency	O
and	O
overload	O
disorders	O
.	O
Adult	O
mammals	O
absorb	O
iron	O
through	O
the	O
duodenum	O
,	O
whereas	O
embryos	O
obtain	O
iron	O
through	O
placental	O
transport	O
.	O
Iron	O
uptake	O
from	O
the	O
intestinal	O
lumen	O
through	O
the	O
apical	O
surface	O
of	O
polarized	O
duodenal	O
enterocytes	O
is	O
mediated	O
by	O
the	O
divalent	O
metal	O
transporter	O
,	O
DMTi	O
.	O
A	O
second	O
transporter	O
has	O
been	O
postulated	O
to	O
export	O
iron	O
across	O
the	O
basolateral	O
surface	O
to	O
the	O
circulation	O
.	O
Here	O
we	O
have	O
used	O
positional	O
cloning	O
to	O
identify	O
the	O
gene	O
responsible	O
for	O
the	O
hypochromic	O
anaemia	O
of	O
the	O
species1s	O
zebrafish	O
species1e	O
mutant	O
weissherbst	O
.	O
The	O
gene	O
,	O
gene1s	ARG2
ferroportin1	ARG2
gene1e	ARG2
,	O
encodes	O
a	O
multiple	O
-	O
transmembrane	O
domain	O
protein	O
,	O
expressed	O
in	O
the	O
yolk	O
sac	O
,	O
that	O
is	O
a	O
candidate	O
for	O
the	O
elusive	O
iron	O
exporter	O
.	O
species1s	O
Zebrafish	O
species1e	O
gene1s	O
ferroportin1	O
gene1e	O
is	O
required	O
for	O
the	O
transport	O
of	O
iron	O
from	O
maternally	O
derived	O
yolk	O
stores	O
to	O
the	O
circulation	O
and	O
functions	O
as	O
an	O
iron	O
exporter	O
when	O
expressed	O
in	O
species1s	O
Xenopus	O
species1e	O
oocytes	O
.	O
arg1s	O
Human	O
arg1e	O
gene1s	ARG2
Ferroportin1	ARG2
gene1e	ARG2
is	O
found	O
at	O
the	O
basal	O
surface	O
of	O
placental	O
syncytiotrophoblasts	O
,	O
suggesting	O
that	O
it	O
also	O
transports	O
iron	O
from	O
mother	O
to	O
embryo	O
.	O
arg1s	O
Mammalian	O
arg1e	O
gene1s	ARG2
Ferroportin1	ARG2
gene1e	ARG2
is	O
expressed	O
at	O
the	O
basolateral	O
surface	O
of	O
duodenal	O
enterocytes	O
and	O
could	O
export	O
cellular	O
iron	O
into	O
the	O
circulation	O
.	O
We	O
propose	O
that	O
gene1s	ARG2
Ferroportin1	ARG2
gene1e	ARG2
function	O
may	O
be	O
perturbed	O
in	O
arg1s	O
mammalian	O
arg1e	O
disorders	O
of	O
iron	O
deficiency	O
or	O
overload	O
.	O

arg1s	O
Human	O
arg1e	O
gene1s	ARG2
MT6-matrix	ARG2
metalloproteinase	ARG2
gene1e	ARG2
:	O
identification	O
,	O
gene1s	ARG2
progelatinase	ARG2
A	ARG2
gene1e	ARG2
activation	O
,	O
and	O
expression	O
in	O
brain	O
tumors	O
.	O
The	O
localization	O
of	O
proteolytic	O
enzymes	O
at	O
the	O
cell	O
surface	O
is	O
a	O
widely	O
used	O
strategy	O
for	O
facilitating	O
tumor	O
invasion	O
.	O
In	O
this	O
study	O
,	O
we	O
have	O
cloned	O
a	O
new	O
member	O
of	O
the	O
membrane	O
-	O
type	O
subfamily	O
of	O
matrix	O
metalloproteinases	O
(	O
MT	O
-	O
MMPs	O
)	O
,	O
a	O
group	O
of	O
enzymes	O
associated	O
with	O
tumor	O
progression	O
.	O
The	O
cloned	O
cDNA	O
encodes	O
a	O
protein	O
of	O
562	O
amino	O
acids	O
with	O
a	O
domain	O
organization	O
similar	O
to	O
that	O
of	O
other	O
MT	O
-	O
MMPs	O
,	O
including	O
a	O
prodomain	O
with	O
a	O
cysteine	O
switch	O
,	O
a	O
catalytic	O
domain	O
with	O
the	O
zinc	O
-	O
binding	O
site	O
,	O
a	O
hemopexin	O
-	O
like	O
domain	O
,	O
and	O
a	O
COOH	O
-	O
terminal	O
extension	O
rich	O
in	O
hydrophobic	O
residues	O
.	O
The	O
predicted	O
protein	O
sequence	O
also	O
contains	O
a	O
short	O
insertion	O
of	O
basic	O
residues	O
located	O
between	O
the	O
propeptide	O
and	O
the	O
catalytic	O
domain	O
and	O
involved	O
in	O
the	O
proteolytic	O
activation	O
of	O
MT	O
-	O
MMPs	O
by	O
furin	O
-	O
like	O
enzymes	O
.	O
Furthermore	O
,	O
immunofluorescence	O
and	O
Western	O
blot	O
analysis	O
of	O
species1s	O
COS-7	O
species1e	O
cells	O
transfected	O
with	O
the	O
isolated	O
cDNA	O
revealed	O
that	O
the	O
encoded	O
protein	O
is	O
localized	O
at	O
the	O
cell	O
surface	O
.	O
Based	O
on	O
these	O
properties	O
,	O
this	O
novel	O
arg1s	O
human	O
arg1e	O
matrix	O
metalloproteinase	O
has	O
been	O
called	O
gene1s	ARG2
MT6-MMP	ARG2
gene1e	ARG2
because	O
it	O
is	O
the	O
sixth	O
identified	O
member	O
of	O
this	O
subfamily	O
of	O
matrix	O
metalloproteinase	O
.	O
Cotransfection	O
of	O
expression	O
plasmids	O
encoding	O
gene1s	ARG2
MT6-MMP	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
progelatinase	ARG2
A	ARG2
gene1e	ARG2
resulted	O
in	O
activation	O
of	O
COS-7-secreted	O
gene1s	ARG2
progelatinase	ARG2
A	ARG2
gene1e	ARG2
,	O
as	O
demonstrated	O
by	O
gelatin	O
zymography	O
.	O
In	O
contrast	O
,	O
transfection	O
of	O
gene1s	ARG2
progelatinase	ARG2
A	ARG2
gene1e	ARG2
cDNA	O
alone	O
did	O
not	O
lead	O
to	O
the	O
activation	O
of	O
the	O
proenzyme	O
.	O
Northern	O
blot	O
analysis	O
of	O
polyadenylated	O
RNAs	O
isolated	O
from	O
arg1s	O
human	O
arg1e	O
tissues	O
demonstrated	O
that	O
gene1s	ARG2
MT6-MMP	ARG2
gene1e	ARG2
is	O
predominantly	O
expressed	O
in	O
leukocytes	O
,	O
lung	O
,	O
and	O
spleen	O
.	O
gene1s	ARG2
MT6-MMP	ARG2
gene1e	ARG2
was	O
also	O
detected	O
at	O
high	O
levels	O
in	O
arg1s	O
SW480	O
arg1e	O
colon	O
carcinoma	O
cells	O
as	O
well	O
as	O
in	O
some	O
anaplastic	O
astrocytomas	O
and	O
glioblastomas	O
,	O
but	O
not	O
in	O
normal	O
colon	O
or	O
brain	O
or	O
in	O
meningiomas	O
.	O
On	O
the	O
basis	O
of	O
these	O
results	O
,	O
we	O
propose	O
that	O
gene1s	ARG2
MT6-MMP	ARG2
gene1e	ARG2
may	O
facilitate	O
tumor	O
progression	O
through	O
its	O
ability	O
to	O
activate	O
gene1s	ARG2
progelatinase	ARG2
A	ARG2
gene1e	ARG2
at	O
the	O
membrane	O
of	O
cells	O
from	O
colon	O
carcinomas	O
or	O
brain	O
tumors	O
.	O

species1s	O
Human	O
species1e	O
gene1s	O
MT6-matrix	O
metalloproteinase	O
gene1e	O
:	O
identification	O
,	O
gene1s	O
progelatinase	O
A	O
gene1e	O
activation	O
,	O
and	O
expression	O
in	O
brain	O
tumors	O
.	O
The	O
localization	O
of	O
proteolytic	O
enzymes	O
at	O
the	O
cell	O
surface	O
is	O
a	O
widely	O
used	O
strategy	O
for	O
facilitating	O
tumor	O
invasion	O
.	O
In	O
this	O
study	O
,	O
we	O
have	O
cloned	O
a	O
new	O
member	O
of	O
the	O
membrane	O
-	O
type	O
subfamily	O
of	O
matrix	O
metalloproteinases	O
(	O
MT	O
-	O
MMPs	O
)	O
,	O
a	O
group	O
of	O
enzymes	O
associated	O
with	O
tumor	O
progression	O
.	O
The	O
cloned	O
cDNA	O
encodes	O
a	O
protein	O
of	O
562	O
amino	O
acids	O
with	O
a	O
domain	O
organization	O
similar	O
to	O
that	O
of	O
other	O
MT	O
-	O
MMPs	O
,	O
including	O
a	O
prodomain	O
with	O
a	O
cysteine	O
switch	O
,	O
a	O
catalytic	O
domain	O
with	O
the	O
zinc	O
-	O
binding	O
site	O
,	O
a	O
hemopexin	O
-	O
like	O
domain	O
,	O
and	O
a	O
COOH	O
-	O
terminal	O
extension	O
rich	O
in	O
hydrophobic	O
residues	O
.	O
The	O
predicted	O
protein	O
sequence	O
also	O
contains	O
a	O
short	O
insertion	O
of	O
basic	O
residues	O
located	O
between	O
the	O
propeptide	O
and	O
the	O
catalytic	O
domain	O
and	O
involved	O
in	O
the	O
proteolytic	O
activation	O
of	O
MT	O
-	O
MMPs	O
by	O
furin	O
-	O
like	O
enzymes	O
.	O
Furthermore	O
,	O
immunofluorescence	O
and	O
Western	O
blot	O
analysis	O
of	O
arg1s	O
COS-7	O
arg1e	O
cells	O
transfected	O
with	O
the	O
isolated	O
cDNA	O
revealed	O
that	O
the	O
encoded	O
protein	O
is	O
localized	O
at	O
the	O
cell	O
surface	O
.	O
Based	O
on	O
these	O
properties	O
,	O
this	O
novel	O
species1s	O
human	O
species1e	O
matrix	O
metalloproteinase	O
has	O
been	O
called	O
gene1s	O
MT6-MMP	O
gene1e	O
because	O
it	O
is	O
the	O
sixth	O
identified	O
member	O
of	O
this	O
subfamily	O
of	O
matrix	O
metalloproteinase	O
.	O
Cotransfection	O
of	O
expression	O
plasmids	O
encoding	O
gene1s	O
MT6-MMP	O
gene1e	O
and	O
gene1s	O
progelatinase	O
A	O
gene1e	O
resulted	O
in	O
activation	O
of	O
COS-7-secreted	O
gene1s	O
progelatinase	O
A	O
gene1e	O
,	O
as	O
demonstrated	O
by	O
gelatin	O
zymography	O
.	O
In	O
contrast	O
,	O
transfection	O
of	O
gene1s	O
progelatinase	O
A	O
gene1e	O
cDNA	O
alone	O
did	O
not	O
lead	O
to	O
the	O
activation	O
of	O
the	O
proenzyme	O
.	O
Northern	O
blot	O
analysis	O
of	O
polyadenylated	O
RNAs	O
isolated	O
from	O
species1s	O
human	O
species1e	O
tissues	O
demonstrated	O
that	O
gene1s	O
MT6-MMP	O
gene1e	O
is	O
predominantly	O
expressed	O
in	O
leukocytes	O
,	O
lung	O
,	O
and	O
spleen	O
.	O
gene1s	O
MT6-MMP	O
gene1e	O
was	O
also	O
detected	O
at	O
high	O
levels	O
in	O
species1s	O
SW480	O
species1e	O
colon	O
carcinoma	O
cells	O
as	O
well	O
as	O
in	O
some	O
anaplastic	O
astrocytomas	O
and	O
glioblastomas	O
,	O
but	O
not	O
in	O
normal	O
colon	O
or	O
brain	O
or	O
in	O
meningiomas	O
.	O
On	O
the	O
basis	O
of	O
these	O
results	O
,	O
we	O
propose	O
that	O
gene1s	O
MT6-MMP	O
gene1e	O
may	O
facilitate	O
tumor	O
progression	O
through	O
its	O
ability	O
to	O
activate	O
gene1s	O
progelatinase	O
A	O
gene1e	O
at	O
the	O
membrane	O
of	O
cells	O
from	O
colon	O
carcinomas	O
or	O
brain	O
tumors	O
.	O

Large	O
exons	O
encoding	O
multiple	O
ectodomains	O
are	O
a	O
characteristic	O
feature	O
of	O
protocadherin	O
genes	O
.	O
Recent	O
studies	O
revealed	O
a	O
striking	O
difference	O
in	O
the	O
genomic	O
organization	O
of	O
classic	O
cadherin	O
genes	O
and	O
one	O
family	O
of	O
"	O
nonclassic	O
cadherin	O
"	O
genes	O
designated	O
protocadherins	O
.	O
Specifically	O
,	O
the	O
DNA	O
sequences	O
encoding	O
the	O
ectodomain	O
repeats	O
of	O
classic	O
cadherins	O
are	O
interrupted	O
by	O
multiple	O
introns	O
.	O
By	O
contrast	O
,	O
all	O
of	O
the	O
encoded	O
ectodomains	O
of	O
each	O
member	O
of	O
the	O
protocadherin	O
gene	O
clusters	O
are	O
present	O
in	O
one	O
large	O
exon	O
.	O
To	O
determine	O
whether	O
large	O
ectodomain	O
exons	O
are	O
a	O
general	O
feature	O
of	O
protocadherin	O
genes	O
we	O
have	O
investigated	O
the	O
genomic	O
organization	O
of	O
several	O
additional	O
arg1s	O
human	O
arg1e	O
protocadherin	O
genes	O
by	O
using	O
DNA	O
sequence	O
information	O
in	O
GenBank	O
.	O
These	O
genes	O
include	O
gene1s	O
protocadherin	O
12	O
gene1e	O
(	O
gene1s	O
Pcdh12	O
gene1e	O
)	O
,	O
an	O
ortholog	O
of	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
vascular	O
endothelial	O
cadherin-2	O
gene1e	O
gene	O
;	O
gene1s	ARG2
hFmi1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
hFmi2	ARG2
gene1e	ARG2
,	O
homologs	O
of	O
the	O
species1s	O
Drosophila	O
species1e	O
planar	O
cell	O
polarity	O
gene	O
,	O
species1s	O
flamingo	O
species1e	O
;	O
gene1s	ARG2
hFat2	ARG2
gene1e	ARG2
,	O
a	O
homolog	O
of	O
the	O
species1s	O
Drosophila	O
species1e	O
tumor	O
suppressor	O
gene	O
gene1s	O
fat	O
gene1e	O
;	O
and	O
the	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
DN	O
-	O
cadherin	O
gene1e	O
and	O
gene1s	O
DE	O
-	O
cadherin	O
gene1e	O
genes	O
.	O
Each	O
of	O
these	O
genes	O
was	O
found	O
to	O
be	O
a	O
member	O
of	O
the	O
protocadherin	O
subfamily	O
,	O
based	O
on	O
amino	O
acid	O
sequence	O
comparisons	O
of	O
their	O
ectodomains	O
.	O
Remarkably	O
,	O
all	O
of	O
these	O
protocadherin	O
genes	O
share	O
a	O
common	O
feature	O
:	O
most	O
of	O
the	O
genomic	O
DNA	O
sequences	O
encoding	O
their	O
ectodomains	O
are	O
not	O
interrupted	O
by	O
an	O
intron	O
.	O
We	O
conclude	O
that	O
the	O
presence	O
of	O
unusually	O
large	O
exons	O
is	O
a	O
characteristic	O
feature	O
of	O
protocadherin	O
genes	O
.	O

Large	O
exons	O
encoding	O
multiple	O
ectodomains	O
are	O
a	O
characteristic	O
feature	O
of	O
protocadherin	O
genes	O
.	O
Recent	O
studies	O
revealed	O
a	O
striking	O
difference	O
in	O
the	O
genomic	O
organization	O
of	O
classic	O
cadherin	O
genes	O
and	O
one	O
family	O
of	O
"	O
nonclassic	O
cadherin	O
"	O
genes	O
designated	O
protocadherins	O
.	O
Specifically	O
,	O
the	O
DNA	O
sequences	O
encoding	O
the	O
ectodomain	O
repeats	O
of	O
classic	O
cadherins	O
are	O
interrupted	O
by	O
multiple	O
introns	O
.	O
By	O
contrast	O
,	O
all	O
of	O
the	O
encoded	O
ectodomains	O
of	O
each	O
member	O
of	O
the	O
protocadherin	O
gene	O
clusters	O
are	O
present	O
in	O
one	O
large	O
exon	O
.	O
To	O
determine	O
whether	O
large	O
ectodomain	O
exons	O
are	O
a	O
general	O
feature	O
of	O
protocadherin	O
genes	O
we	O
have	O
investigated	O
the	O
genomic	O
organization	O
of	O
several	O
additional	O
species1s	O
human	O
species1e	O
protocadherin	O
genes	O
by	O
using	O
DNA	O
sequence	O
information	O
in	O
GenBank	O
.	O
These	O
genes	O
include	O
gene1s	ARG2
protocadherin	ARG2
12	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Pcdh12	ARG2
gene1e	ARG2
)	O
,	O
an	O
ortholog	O
of	O
the	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
vascular	ARG2
endothelial	ARG2
cadherin-2	ARG2
gene1e	ARG2
gene	O
;	O
gene1s	O
hFmi1	O
gene1e	O
and	O
gene1s	O
hFmi2	O
gene1e	O
,	O
homologs	O
of	O
the	O
species1s	O
Drosophila	O
species1e	O
planar	O
cell	O
polarity	O
gene	O
,	O
species1s	O
flamingo	O
species1e	O
;	O
gene1s	O
hFat2	O
gene1e	O
,	O
a	O
homolog	O
of	O
the	O
species1s	O
Drosophila	O
species1e	O
tumor	O
suppressor	O
gene	O
gene1s	O
fat	O
gene1e	O
;	O
and	O
the	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
DN	O
-	O
cadherin	O
gene1e	O
and	O
gene1s	O
DE	O
-	O
cadherin	O
gene1e	O
genes	O
.	O
Each	O
of	O
these	O
genes	O
was	O
found	O
to	O
be	O
a	O
member	O
of	O
the	O
protocadherin	O
subfamily	O
,	O
based	O
on	O
amino	O
acid	O
sequence	O
comparisons	O
of	O
their	O
ectodomains	O
.	O
Remarkably	O
,	O
all	O
of	O
these	O
protocadherin	O
genes	O
share	O
a	O
common	O
feature	O
:	O
most	O
of	O
the	O
genomic	O
DNA	O
sequences	O
encoding	O
their	O
ectodomains	O
are	O
not	O
interrupted	O
by	O
an	O
intron	O
.	O
We	O
conclude	O
that	O
the	O
presence	O
of	O
unusually	O
large	O
exons	O
is	O
a	O
characteristic	O
feature	O
of	O
protocadherin	O
genes	O
.	O

Large	O
exons	O
encoding	O
multiple	O
ectodomains	O
are	O
a	O
characteristic	O
feature	O
of	O
protocadherin	O
genes	O
.	O
Recent	O
studies	O
revealed	O
a	O
striking	O
difference	O
in	O
the	O
genomic	O
organization	O
of	O
classic	O
cadherin	O
genes	O
and	O
one	O
family	O
of	O
"	O
nonclassic	O
cadherin	O
"	O
genes	O
designated	O
protocadherins	O
.	O
Specifically	O
,	O
the	O
DNA	O
sequences	O
encoding	O
the	O
ectodomain	O
repeats	O
of	O
classic	O
cadherins	O
are	O
interrupted	O
by	O
multiple	O
introns	O
.	O
By	O
contrast	O
,	O
all	O
of	O
the	O
encoded	O
ectodomains	O
of	O
each	O
member	O
of	O
the	O
protocadherin	O
gene	O
clusters	O
are	O
present	O
in	O
one	O
large	O
exon	O
.	O
To	O
determine	O
whether	O
large	O
ectodomain	O
exons	O
are	O
a	O
general	O
feature	O
of	O
protocadherin	O
genes	O
we	O
have	O
investigated	O
the	O
genomic	O
organization	O
of	O
several	O
additional	O
species1s	O
human	O
species1e	O
protocadherin	O
genes	O
by	O
using	O
DNA	O
sequence	O
information	O
in	O
GenBank	O
.	O
These	O
genes	O
include	O
gene1s	O
protocadherin	O
12	O
gene1e	O
(	O
gene1s	O
Pcdh12	O
gene1e	O
)	O
,	O
an	O
ortholog	O
of	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
vascular	O
endothelial	O
cadherin-2	O
gene1e	O
gene	O
;	O
gene1s	O
hFmi1	O
gene1e	O
and	O
gene1s	O
hFmi2	O
gene1e	O
,	O
homologs	O
of	O
the	O
arg1s	O
Drosophila	O
arg1e	O
planar	O
cell	O
polarity	O
gene	O
,	O
species1s	O
flamingo	O
species1e	O
;	O
gene1s	O
hFat2	O
gene1e	O
,	O
a	O
homolog	O
of	O
the	O
arg1s	O
Drosophila	O
arg1e	O
tumor	O
suppressor	O
gene	O
gene1s	ARG2
fat	ARG2
gene1e	ARG2
;	O
and	O
the	O
arg1s	O
Drosophila	O
arg1e	O
gene1s	ARG2
DN	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
DE	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
genes	O
.	O
Each	O
of	O
these	O
genes	O
was	O
found	O
to	O
be	O
a	O
member	O
of	O
the	O
protocadherin	O
subfamily	O
,	O
based	O
on	O
amino	O
acid	O
sequence	O
comparisons	O
of	O
their	O
ectodomains	O
.	O
Remarkably	O
,	O
all	O
of	O
these	O
protocadherin	O
genes	O
share	O
a	O
common	O
feature	O
:	O
most	O
of	O
the	O
genomic	O
DNA	O
sequences	O
encoding	O
their	O
ectodomains	O
are	O
not	O
interrupted	O
by	O
an	O
intron	O
.	O
We	O
conclude	O
that	O
the	O
presence	O
of	O
unusually	O
large	O
exons	O
is	O
a	O
characteristic	O
feature	O
of	O
protocadherin	O
genes	O
.	O

Large	O
exons	O
encoding	O
multiple	O
ectodomains	O
are	O
a	O
characteristic	O
feature	O
of	O
protocadherin	O
genes	O
.	O
Recent	O
studies	O
revealed	O
a	O
striking	O
difference	O
in	O
the	O
genomic	O
organization	O
of	O
classic	O
cadherin	O
genes	O
and	O
one	O
family	O
of	O
"	O
nonclassic	O
cadherin	O
"	O
genes	O
designated	O
protocadherins	O
.	O
Specifically	O
,	O
the	O
DNA	O
sequences	O
encoding	O
the	O
ectodomain	O
repeats	O
of	O
classic	O
cadherins	O
are	O
interrupted	O
by	O
multiple	O
introns	O
.	O
By	O
contrast	O
,	O
all	O
of	O
the	O
encoded	O
ectodomains	O
of	O
each	O
member	O
of	O
the	O
protocadherin	O
gene	O
clusters	O
are	O
present	O
in	O
one	O
large	O
exon	O
.	O
To	O
determine	O
whether	O
large	O
ectodomain	O
exons	O
are	O
a	O
general	O
feature	O
of	O
protocadherin	O
genes	O
we	O
have	O
investigated	O
the	O
genomic	O
organization	O
of	O
several	O
additional	O
species1s	O
human	O
species1e	O
protocadherin	O
genes	O
by	O
using	O
DNA	O
sequence	O
information	O
in	O
GenBank	O
.	O
These	O
genes	O
include	O
gene1s	O
protocadherin	O
12	O
gene1e	O
(	O
gene1s	O
Pcdh12	O
gene1e	O
)	O
,	O
an	O
ortholog	O
of	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
vascular	O
endothelial	O
cadherin-2	O
gene1e	O
gene	O
;	O
gene1s	O
hFmi1	O
gene1e	O
and	O
gene1s	O
hFmi2	O
gene1e	O
,	O
homologs	O
of	O
the	O
species1s	O
Drosophila	O
species1e	O
planar	O
cell	O
polarity	O
gene	O
,	O
arg1s	O
flamingo	O
arg1e	O
;	O
gene1s	O
hFat2	O
gene1e	O
,	O
a	O
homolog	O
of	O
the	O
species1s	O
Drosophila	O
species1e	O
tumor	O
suppressor	O
gene	O
gene1s	O
fat	O
gene1e	O
;	O
and	O
the	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
DN	O
-	O
cadherin	O
gene1e	O
and	O
gene1s	O
DE	O
-	O
cadherin	O
gene1e	O
genes	O
.	O
Each	O
of	O
these	O
genes	O
was	O
found	O
to	O
be	O
a	O
member	O
of	O
the	O
protocadherin	O
subfamily	O
,	O
based	O
on	O
amino	O
acid	O
sequence	O
comparisons	O
of	O
their	O
ectodomains	O
.	O
Remarkably	O
,	O
all	O
of	O
these	O
protocadherin	O
genes	O
share	O
a	O
common	O
feature	O
:	O
most	O
of	O
the	O
genomic	O
DNA	O
sequences	O
encoding	O
their	O
ectodomains	O
are	O
not	O
interrupted	O
by	O
an	O
intron	O
.	O
We	O
conclude	O
that	O
the	O
presence	O
of	O
unusually	O
large	O
exons	O
is	O
a	O
characteristic	O
feature	O
of	O
protocadherin	O
genes	O
.	O

Induction	O
of	O
a	O
novel	O
cellular	O
homolog	O
of	O
gene1s	O
interleukin-10	O
gene1e	O
,	O
gene1s	O
AK155	O
gene1e	O
,	O
by	O
transformation	O
of	O
T	O
lymphocytes	O
with	O
arg1s	O
herpesvirus	O
saimiri	O
arg1e	O
.	O
Although	O
arg1s	O
herpesvirus	O
saimiri	O
arg1e	O
-	O
transformed	O
T	O
lymphocytes	O
retain	O
multiple	O
normal	O
T	O
-	O
cell	O
functions	O
,	O
only	O
a	O
few	O
changes	O
have	O
been	O
described	O
.	O
By	O
subtractive	O
hybridization	O
,	O
we	O
have	O
isolated	O
a	O
novel	O
cellular	O
gene	O
,	O
gene1s	O
ak155	O
gene1e	O
,	O
a	O
sequence	O
homolog	O
of	O
the	O
gene1s	O
interleukin-10	O
gene1e	O
gene	O
.	O
Specifically	O
arg1s	O
herpesvirus	O
saimiri	O
arg1e	O
-	O
transformed	O
T	O
cells	O
overexpress	O
gene1s	O
ak155	O
gene1e	O
and	O
secrete	O
the	O
protein	O
into	O
the	O
supernatant	O
.	O
In	O
other	O
T	O
-	O
cell	O
lines	O
and	O
in	O
native	O
peripheral	O
blood	O
cells	O
,	O
but	O
not	O
in	O
B	O
cells	O
,	O
gene1s	O
ak155	O
gene1e	O
is	O
transcribed	O
at	O
low	O
levels	O
.	O
gene1s	O
AK155	O
gene1e	O
forms	O
homodimers	O
similarly	O
to	O
gene1s	O
interleukin-10	O
gene1e	O
.	O
As	O
a	O
lymphokine	O
,	O
gene1s	O
AK155	O
gene1e	O
may	O
contribute	O
to	O
the	O
transformed	O
phenotype	O
of	O
species1s	O
human	O
species1e	O
T	O
cells	O
after	O
infection	O
by	O
arg1s	O
herpesvirus	O
saimiri	O
arg1e	O
.	O

Induction	O
of	O
a	O
novel	O
cellular	O
homolog	O
of	O
gene1s	ARG2
interleukin-10	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
AK155	ARG2
gene1e	ARG2
,	O
by	O
transformation	O
of	O
T	O
lymphocytes	O
with	O
species1s	O
herpesvirus	O
saimiri	O
species1e	O
.	O
Although	O
species1s	O
herpesvirus	O
saimiri	O
species1e	O
-	O
transformed	O
T	O
lymphocytes	O
retain	O
multiple	O
normal	O
T	O
-	O
cell	O
functions	O
,	O
only	O
a	O
few	O
changes	O
have	O
been	O
described	O
.	O
By	O
subtractive	O
hybridization	O
,	O
we	O
have	O
isolated	O
a	O
novel	O
cellular	O
gene	O
,	O
gene1s	ARG2
ak155	ARG2
gene1e	ARG2
,	O
a	O
sequence	O
homolog	O
of	O
the	O
gene1s	ARG2
interleukin-10	ARG2
gene1e	ARG2
gene	O
.	O
Specifically	O
species1s	O
herpesvirus	O
saimiri	O
species1e	O
-	O
transformed	O
T	O
cells	O
overexpress	O
gene1s	ARG2
ak155	ARG2
gene1e	ARG2
and	O
secrete	O
the	O
protein	O
into	O
the	O
supernatant	O
.	O
In	O
other	O
T	O
-	O
cell	O
lines	O
and	O
in	O
native	O
peripheral	O
blood	O
cells	O
,	O
but	O
not	O
in	O
B	O
cells	O
,	O
gene1s	ARG2
ak155	ARG2
gene1e	ARG2
is	O
transcribed	O
at	O
low	O
levels	O
.	O
gene1s	ARG2
AK155	ARG2
gene1e	ARG2
forms	O
homodimers	O
similarly	O
to	O
gene1s	ARG2
interleukin-10	ARG2
gene1e	ARG2
.	O
As	O
a	O
lymphokine	O
,	O
gene1s	ARG2
AK155	ARG2
gene1e	ARG2
may	O
contribute	O
to	O
the	O
transformed	O
phenotype	O
of	O
arg1s	O
human	O
arg1e	O
T	O
cells	O
after	O
infection	O
by	O
species1s	O
herpesvirus	O
saimiri	O
species1e	O
.	O

A	O
novel	O
arg1s	O
mammalian	O
arg1e	O
iron	O
-	O
regulated	O
protein	O
involved	O
in	O
intracellular	O
iron	O
metabolism	O
.	O
We	O
have	O
isolated	O
and	O
characterized	O
a	O
novel	O
iron	O
-	O
regulated	O
gene	O
that	O
is	O
homologous	O
to	O
the	O
divalent	O
metal	O
transporter	O
1	O
family	O
of	O
metal	O
transporters	O
.	O
This	O
gene	O
,	O
termed	O
metal	O
transporter	O
protein	O
(	O
gene1s	ARG2
mtp1	ARG2
gene1e	ARG2
)	O
,	O
is	O
expressed	O
in	O
tissues	O
involved	O
in	O
body	O
iron	O
homeostasis	O
including	O
the	O
developing	O
and	O
mature	O
reticuloendothelial	O
system	O
,	O
the	O
duodenum	O
,	O
and	O
the	O
pregnant	O
uterus	O
.	O
gene1s	ARG2
MTP1	ARG2
gene1e	ARG2
is	O
also	O
expressed	O
in	O
muscle	O
and	O
central	O
nervous	O
system	O
cells	O
in	O
the	O
embryo	O
.	O
At	O
the	O
subcellular	O
level	O
,	O
gene1s	ARG2
MTP1	ARG2
gene1e	ARG2
is	O
localized	O
to	O
the	O
basolateral	O
membrane	O
of	O
the	O
duodenal	O
epithelial	O
cell	O
and	O
a	O
cytoplasmic	O
compartment	O
of	O
reticuloendothelial	O
system	O
cells	O
.	O
Overexpression	O
of	O
gene1s	ARG2
MTP1	ARG2
gene1e	ARG2
in	O
tissue	O
culture	O
cells	O
results	O
in	O
intracellular	O
iron	O
depletion	O
.	O
In	O
the	O
adult	O
species1s	O
mouse	O
species1e	O
,	O
gene1s	O
MTP1	O
gene1e	O
expression	O
in	O
the	O
liver	O
and	O
duodenum	O
are	O
reciprocally	O
regulated	O
.	O
Iron	O
deficiency	O
induces	O
gene1s	ARG2
MTP1	ARG2
gene1e	ARG2
expression	O
in	O
the	O
duodenum	O
but	O
down	O
-	O
regulates	O
expression	O
in	O
the	O
liver	O
.	O
These	O
data	O
indicate	O
that	O
gene1s	ARG2
MTP1	ARG2
gene1e	ARG2
is	O
an	O
iron	O
-	O
regulated	O
membrane	O
-	O
spanning	O
protein	O
that	O
is	O
involved	O
in	O
intracellular	O
iron	O
metabolism	O
.	O

A	O
novel	O
species1s	O
mammalian	O
species1e	O
iron	O
-	O
regulated	O
protein	O
involved	O
in	O
intracellular	O
iron	O
metabolism	O
.	O
We	O
have	O
isolated	O
and	O
characterized	O
a	O
novel	O
iron	O
-	O
regulated	O
gene	O
that	O
is	O
homologous	O
to	O
the	O
divalent	O
metal	O
transporter	O
1	O
family	O
of	O
metal	O
transporters	O
.	O
This	O
gene	O
,	O
termed	O
metal	O
transporter	O
protein	O
(	O
gene1s	O
mtp1	O
gene1e	O
)	O
,	O
is	O
expressed	O
in	O
tissues	O
involved	O
in	O
body	O
iron	O
homeostasis	O
including	O
the	O
developing	O
and	O
mature	O
reticuloendothelial	O
system	O
,	O
the	O
duodenum	O
,	O
and	O
the	O
pregnant	O
uterus	O
.	O
gene1s	O
MTP1	O
gene1e	O
is	O
also	O
expressed	O
in	O
muscle	O
and	O
central	O
nervous	O
system	O
cells	O
in	O
the	O
embryo	O
.	O
At	O
the	O
subcellular	O
level	O
,	O
gene1s	O
MTP1	O
gene1e	O
is	O
localized	O
to	O
the	O
basolateral	O
membrane	O
of	O
the	O
duodenal	O
epithelial	O
cell	O
and	O
a	O
cytoplasmic	O
compartment	O
of	O
reticuloendothelial	O
system	O
cells	O
.	O
Overexpression	O
of	O
gene1s	O
MTP1	O
gene1e	O
in	O
tissue	O
culture	O
cells	O
results	O
in	O
intracellular	O
iron	O
depletion	O
.	O
In	O
the	O
adult	O
arg1s	O
mouse	O
arg1e	O
,	O
gene1s	ARG2
MTP1	ARG2
gene1e	ARG2
expression	O
in	O
the	O
liver	O
and	O
duodenum	O
are	O
reciprocally	O
regulated	O
.	O
Iron	O
deficiency	O
induces	O
gene1s	O
MTP1	O
gene1e	O
expression	O
in	O
the	O
duodenum	O
but	O
down	O
-	O
regulates	O
expression	O
in	O
the	O
liver	O
.	O
These	O
data	O
indicate	O
that	O
gene1s	O
MTP1	O
gene1e	O
is	O
an	O
iron	O
-	O
regulated	O
membrane	O
-	O
spanning	O
protein	O
that	O
is	O
involved	O
in	O
intracellular	O
iron	O
metabolism	O
.	O

Characterization	O
of	O
gene1s	ARG2
ABCB9	ARG2
gene1e	ARG2
,	O
an	O
ATP	O
binding	O
cassette	O
protein	O
associated	O
with	O
lysosomes	O
.	O
We	O
have	O
cloned	O
full	O
-	O
length	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
mouse	O
species1e	O
cDNAs	O
of	O
gene1s	ARG2
ABCB9	ARG2
gene1e	ARG2
,	O
which	O
encodes	O
a	O
predicted	O
multiple	O
-	O
spanning	O
transmembrane	O
domain	O
and	O
a	O
nucleotide	O
-	O
binding	O
domain	O
with	O
Walker	O
motifs	O
.	O
It	O
is	O
therefore	O
designated	O
as	O
a	O
"	O
half	O
"	O
ATP	O
binding	O
cassette	O
(	O
ABC	O
)	O
transporter	O
.	O
Northern	O
analysis	O
shows	O
that	O
the	O
gene1s	ARG2
ABCB9	ARG2
gene1e	ARG2
mRNA	O
is	O
expressed	O
at	O
a	O
high	O
level	O
in	O
testes	O
and	O
moderate	O
levels	O
in	O
brain	O
and	O
spinal	O
cord	O
.	O
A	O
splice	O
variant	O
mRNA	O
deleted	O
in	O
the	O
last	O
pair	O
of	O
predicted	O
transmembrane	O
segments	O
was	O
shown	O
to	O
be	O
expressed	O
in	O
arg1s	O
human	O
arg1e	O
tissues	O
.	O
Phylogenetic	O
analysis	O
indicates	O
that	O
gene1s	ARG2
ABCB9	ARG2
gene1e	ARG2
is	O
closely	O
related	O
to	O
gene1s	ARG2
TAP1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
TAP2	ARG2
gene1e	ARG2
,	O
two	O
"	O
half	O
"	O
ABC	O
proteins	O
found	O
in	O
endoplasmic	O
reticulum	O
.	O
gene1s	ARG2
ABCB9	ARG2
gene1e	ARG2
protein	O
colocalized	O
with	O
the	O
lysosomal	O
markers	O
,	O
gene1s	ARG2
LAMP1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
LAMP2	ARG2
gene1e	ARG2
,	O
in	O
transfected	O
cells	O
.	O
gene1s	O
ABCB9	O
gene1e	O
protein	O
appears	O
to	O
be	O
most	O
highly	O
expressed	O
in	O
the	O
Sertoli	O
cells	O
of	O
the	O
seminiferous	O
tubules	O
in	O
species1s	O
mouse	O
species1e	O
and	O
species1s	O
rat	O
species1e	O
testes	O
.	O
These	O
cells	O
have	O
high	O
levels	O
of	O
phagocytosis	O
and	O
secretory	O
activities	O
.	O
These	O
findings	O
pave	O
the	O
way	O
for	O
further	O
investigation	O
into	O
the	O
potential	O
novel	O
function	O
of	O
gene1s	ARG2
ABCB9	ARG2
gene1e	ARG2
in	O
lysosomes	O
.	O

Characterization	O
of	O
gene1s	ARG2
ABCB9	ARG2
gene1e	ARG2
,	O
an	O
ATP	O
binding	O
cassette	O
protein	O
associated	O
with	O
lysosomes	O
.	O
We	O
have	O
cloned	O
full	O
-	O
length	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
mouse	O
arg1e	O
cDNAs	O
of	O
gene1s	O
ABCB9	O
gene1e	O
,	O
which	O
encodes	O
a	O
predicted	O
multiple	O
-	O
spanning	O
transmembrane	O
domain	O
and	O
a	O
nucleotide	O
-	O
binding	O
domain	O
with	O
Walker	O
motifs	O
.	O
It	O
is	O
therefore	O
designated	O
as	O
a	O
"	O
half	O
"	O
ATP	O
binding	O
cassette	O
(	O
ABC	O
)	O
transporter	O
.	O
Northern	O
analysis	O
shows	O
that	O
the	O
gene1s	O
ABCB9	O
gene1e	O
mRNA	O
is	O
expressed	O
at	O
a	O
high	O
level	O
in	O
testes	O
and	O
moderate	O
levels	O
in	O
brain	O
and	O
spinal	O
cord	O
.	O
A	O
splice	O
variant	O
mRNA	O
deleted	O
in	O
the	O
last	O
pair	O
of	O
predicted	O
transmembrane	O
segments	O
was	O
shown	O
to	O
be	O
expressed	O
in	O
species1s	O
human	O
species1e	O
tissues	O
.	O
Phylogenetic	O
analysis	O
indicates	O
that	O
gene1s	O
ABCB9	O
gene1e	O
is	O
closely	O
related	O
to	O
gene1s	O
TAP1	O
gene1e	O
and	O
gene1s	O
TAP2	O
gene1e	O
,	O
two	O
"	O
half	O
"	O
ABC	O
proteins	O
found	O
in	O
endoplasmic	O
reticulum	O
.	O
gene1s	O
ABCB9	O
gene1e	O
protein	O
colocalized	O
with	O
the	O
lysosomal	O
markers	O
,	O
gene1s	O
LAMP1	O
gene1e	O
and	O
gene1s	O
LAMP2	O
gene1e	O
,	O
in	O
transfected	O
cells	O
.	O
gene1s	ARG2
ABCB9	ARG2
gene1e	ARG2
protein	O
appears	O
to	O
be	O
most	O
highly	O
expressed	O
in	O
the	O
Sertoli	O
cells	O
of	O
the	O
seminiferous	O
tubules	O
in	O
arg1s	O
mouse	O
arg1e	O
and	O
species1s	O
rat	O
species1e	O
testes	O
.	O
These	O
cells	O
have	O
high	O
levels	O
of	O
phagocytosis	O
and	O
secretory	O
activities	O
.	O
These	O
findings	O
pave	O
the	O
way	O
for	O
further	O
investigation	O
into	O
the	O
potential	O
novel	O
function	O
of	O
gene1s	O
ABCB9	O
gene1e	O
in	O
lysosomes	O
.	O

Characterization	O
of	O
gene1s	O
ABCB9	O
gene1e	O
,	O
an	O
ATP	O
binding	O
cassette	O
protein	O
associated	O
with	O
lysosomes	O
.	O
We	O
have	O
cloned	O
full	O
-	O
length	O
species1s	O
human	O
species1e	O
and	O
species1s	O
mouse	O
species1e	O
cDNAs	O
of	O
gene1s	O
ABCB9	O
gene1e	O
,	O
which	O
encodes	O
a	O
predicted	O
multiple	O
-	O
spanning	O
transmembrane	O
domain	O
and	O
a	O
nucleotide	O
-	O
binding	O
domain	O
with	O
Walker	O
motifs	O
.	O
It	O
is	O
therefore	O
designated	O
as	O
a	O
"	O
half	O
"	O
ATP	O
binding	O
cassette	O
(	O
ABC	O
)	O
transporter	O
.	O
Northern	O
analysis	O
shows	O
that	O
the	O
gene1s	O
ABCB9	O
gene1e	O
mRNA	O
is	O
expressed	O
at	O
a	O
high	O
level	O
in	O
testes	O
and	O
moderate	O
levels	O
in	O
brain	O
and	O
spinal	O
cord	O
.	O
A	O
splice	O
variant	O
mRNA	O
deleted	O
in	O
the	O
last	O
pair	O
of	O
predicted	O
transmembrane	O
segments	O
was	O
shown	O
to	O
be	O
expressed	O
in	O
species1s	O
human	O
species1e	O
tissues	O
.	O
Phylogenetic	O
analysis	O
indicates	O
that	O
gene1s	O
ABCB9	O
gene1e	O
is	O
closely	O
related	O
to	O
gene1s	O
TAP1	O
gene1e	O
and	O
gene1s	O
TAP2	O
gene1e	O
,	O
two	O
"	O
half	O
"	O
ABC	O
proteins	O
found	O
in	O
endoplasmic	O
reticulum	O
.	O
gene1s	O
ABCB9	O
gene1e	O
protein	O
colocalized	O
with	O
the	O
lysosomal	O
markers	O
,	O
gene1s	O
LAMP1	O
gene1e	O
and	O
gene1s	O
LAMP2	O
gene1e	O
,	O
in	O
transfected	O
cells	O
.	O
gene1s	ARG2
ABCB9	ARG2
gene1e	ARG2
protein	O
appears	O
to	O
be	O
most	O
highly	O
expressed	O
in	O
the	O
Sertoli	O
cells	O
of	O
the	O
seminiferous	O
tubules	O
in	O
species1s	O
mouse	O
species1e	O
and	O
arg1s	O
rat	O
arg1e	O
testes	O
.	O
These	O
cells	O
have	O
high	O
levels	O
of	O
phagocytosis	O
and	O
secretory	O
activities	O
.	O
These	O
findings	O
pave	O
the	O
way	O
for	O
further	O
investigation	O
into	O
the	O
potential	O
novel	O
function	O
of	O
gene1s	O
ABCB9	O
gene1e	O
in	O
lysosomes	O
.	O

Localization	O
and	O
genomic	O
organization	O
of	O
a	O
new	O
hepatocellular	O
organic	O
anion	O
transporting	O
polypeptide	O
.	O
Based	O
on	O
sequence	O
homology	O
to	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
organic	ARG2
anion	ARG2
transporting	ARG2
polypeptide	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
OATP2	ARG2
gene1e	ARG2
;	O
gene1s	ARG2
SLC21A6	ARG2
gene1e	ARG2
)	O
,	O
we	O
cloned	O
a	O
new	O
member	O
of	O
the	O
SLC21A	O
superfamily	O
of	O
solute	O
carriers	O
,	O
termed	O
gene1s	ARG2
OATP8	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SLC21A8	ARG2
gene1e	ARG2
)	O
.	O
The	O
protein	O
of	O
702	O
amino	O
acids	O
showed	O
an	O
amino	O
acid	O
identity	O
of	O
80	O
%	O
with	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
OATP2	ARG2
gene1e	ARG2
.	O
Based	O
on	O
Northern	O
blotting	O
,	O
the	O
expression	O
of	O
gene1s	ARG2
OATP8	ARG2
gene1e	ARG2
was	O
restricted	O
to	O
arg1s	O
human	O
arg1e	O
liver	O
.	O
Cosmid	O
clones	O
containing	O
the	O
genes	O
encoding	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
OATP1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SLC21A3	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
OATP2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SLC21A6	ARG2
gene1e	ARG2
)	O
,	O
and	O
gene1s	ARG2
OATP8	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SLC21A8	ARG2
gene1e	ARG2
)	O
served	O
to	O
establish	O
their	O
genomic	O
organization	O
.	O
All	O
three	O
genes	O
contained	O
14	O
exons	O
with	O
13	O
identical	O
splice	O
sites	O
when	O
transferred	O
to	O
the	O
amino	O
acid	O
sequence	O
.	O
An	O
antibody	O
raised	O
against	O
the	O
carboxyl	O
terminus	O
localized	O
gene1s	ARG2
OATP8	ARG2
gene1e	ARG2
to	O
the	O
basolateral	O
membrane	O
of	O
arg1s	O
human	O
arg1e	O
hepatocytes	O
and	O
the	O
recombinant	O
glycoprotein	O
,	O
expressed	O
in	O
species1s	O
MDCKII	O
species1e	O
cells	O
,	O
to	O
the	O
lateral	O
membrane	O
.	O
Transport	O
properties	O
of	O
gene1s	ARG2
OATP8	ARG2
gene1e	ARG2
were	O
studied	O
in	O
stably	O
transfected	O
species1s	O
MDCKII	O
species1e	O
and	O
arg1s	O
HEK293	O
arg1e	O
cells	O
.	O
Organic	O
anions	O
transported	O
by	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
OATP8	ARG2
gene1e	ARG2
included	O
sulfobromophthalein	O
,	O
with	O
a	O
K(m	O
)	O
of	O
3.3	O
microm	O
,	O
and	O
17beta	O
-	O
glucuronosyl	O
estradiol	O
,	O
with	O
a	O
K(m	O
)	O
of	O
5.4	O
microm	O
.	O
Several	O
bile	O
salts	O
were	O
not	O
substrates	O
.	O
Thus	O
,	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
OATP8	ARG2
gene1e	ARG2
is	O
a	O
new	O
uptake	O
transporter	O
in	O
the	O
basolateral	O
hepatocyte	O
membrane	O
with	O
an	O
overlapping	O
but	O
distinct	O
substrate	O
specificity	O
as	O
compared	O
with	O
gene1s	ARG2
OATP2	ARG2
gene1e	ARG2
,	O
which	O
is	O
localized	O
to	O
the	O
same	O
membrane	O
domain	O
.	O

Localization	O
and	O
genomic	O
organization	O
of	O
a	O
new	O
hepatocellular	O
organic	O
anion	O
transporting	O
polypeptide	O
.	O
Based	O
on	O
sequence	O
homology	O
to	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
organic	O
anion	O
transporting	O
polypeptide	O
2	O
gene1e	O
(	O
gene1s	O
OATP2	O
gene1e	O
;	O
gene1s	O
SLC21A6	O
gene1e	O
)	O
,	O
we	O
cloned	O
a	O
new	O
member	O
of	O
the	O
SLC21A	O
superfamily	O
of	O
solute	O
carriers	O
,	O
termed	O
gene1s	O
OATP8	O
gene1e	O
(	O
gene1s	O
SLC21A8	O
gene1e	O
)	O
.	O
The	O
protein	O
of	O
702	O
amino	O
acids	O
showed	O
an	O
amino	O
acid	O
identity	O
of	O
80	O
%	O
with	O
species1s	O
human	O
species1e	O
gene1s	O
OATP2	O
gene1e	O
.	O
Based	O
on	O
Northern	O
blotting	O
,	O
the	O
expression	O
of	O
gene1s	O
OATP8	O
gene1e	O
was	O
restricted	O
to	O
species1s	O
human	O
species1e	O
liver	O
.	O
Cosmid	O
clones	O
containing	O
the	O
genes	O
encoding	O
species1s	O
human	O
species1e	O
gene1s	O
OATP1	O
gene1e	O
(	O
gene1s	O
SLC21A3	O
gene1e	O
)	O
,	O
gene1s	O
OATP2	O
gene1e	O
(	O
gene1s	O
SLC21A6	O
gene1e	O
)	O
,	O
and	O
gene1s	O
OATP8	O
gene1e	O
(	O
gene1s	O
SLC21A8	O
gene1e	O
)	O
served	O
to	O
establish	O
their	O
genomic	O
organization	O
.	O
All	O
three	O
genes	O
contained	O
14	O
exons	O
with	O
13	O
identical	O
splice	O
sites	O
when	O
transferred	O
to	O
the	O
amino	O
acid	O
sequence	O
.	O
An	O
antibody	O
raised	O
against	O
the	O
carboxyl	O
terminus	O
localized	O
gene1s	O
OATP8	O
gene1e	O
to	O
the	O
basolateral	O
membrane	O
of	O
species1s	O
human	O
species1e	O
hepatocytes	O
and	O
the	O
recombinant	O
glycoprotein	O
,	O
expressed	O
in	O
arg1s	O
MDCKII	O
arg1e	O
cells	O
,	O
to	O
the	O
lateral	O
membrane	O
.	O
Transport	O
properties	O
of	O
gene1s	O
OATP8	O
gene1e	O
were	O
studied	O
in	O
stably	O
transfected	O
arg1s	O
MDCKII	O
arg1e	O
and	O
species1s	O
HEK293	O
species1e	O
cells	O
.	O
Organic	O
anions	O
transported	O
by	O
species1s	O
human	O
species1e	O
gene1s	O
OATP8	O
gene1e	O
included	O
sulfobromophthalein	O
,	O
with	O
a	O
K(m	O
)	O
of	O
3.3	O
microm	O
,	O
and	O
17beta	O
-	O
glucuronosyl	O
estradiol	O
,	O
with	O
a	O
K(m	O
)	O
of	O
5.4	O
microm	O
.	O
Several	O
bile	O
salts	O
were	O
not	O
substrates	O
.	O
Thus	O
,	O
species1s	O
human	O
species1e	O
gene1s	O
OATP8	O
gene1e	O
is	O
a	O
new	O
uptake	O
transporter	O
in	O
the	O
basolateral	O
hepatocyte	O
membrane	O
with	O
an	O
overlapping	O
but	O
distinct	O
substrate	O
specificity	O
as	O
compared	O
with	O
gene1s	O
OATP2	O
gene1e	O
,	O
which	O
is	O
localized	O
to	O
the	O
same	O
membrane	O
domain	O
.	O

Cloning	O
,	O
characterization	O
,	O
and	O
expression	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
TIN	ARG2
-	ARG2
ag	ARG2
-	ARG2
RP	ARG2
gene1e	ARG2
gene	O
encoding	O
a	O
novel	O
putative	O
extracellular	O
matrix	O
protein	O
.	O
The	O
arg1s	O
human	O
arg1e	O
gene	O
encoding	O
a	O
novel	O
gene1s	ARG2
tubulointerstitial	ARG2
nephritis	ARG2
antigen	ARG2
(	ARG2
TIN	ARG2
-	ARG2
ag)-related	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TIN	ARG2
-	ARG2
ag	ARG2
-	ARG2
RP	ARG2
gene1e	ARG2
)	O
was	O
isolated	O
,	O
and	O
its	O
genomic	O
organization	O
was	O
determined	O
.	O
BLAST	O
searches	O
revealed	O
the	O
highest	O
degree	O
of	O
homology	O
to	O
several	O
arg1s	O
mammalian	O
arg1e	O
gene1s	ARG2
TIN	ARG2
-	ARG2
ag	ARG2
gene1e	ARG2
orthologues	O
,	O
and	O
a	O
weak	O
homology	O
to	O
cathepsin	O
B	O
-	O
like	O
proteases	O
.	O
The	O
12	O
kb	O
gene	O
was	O
mapped	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
to	O
chromosome	O
1p34.2	O
-	O
3	O
,	O
a	O
locus	O
neither	O
related	O
to	O
that	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
TIN	ARG2
-	ARG2
ag	ARG2
gene1e	ARG2
(	O
6p11.2	O
-	O
12	O
)	O
nor	O
to	O
that	O
of	O
gene1s	ARG2
cathepsin	ARG2
B	ARG2
gene1e	ARG2
(	O
8p22	O
-	O
23.1	O
)	O
.	O
The	O
gene1s	ARG2
TIN	ARG2
-	ARG2
ag	ARG2
-	ARG2
RP	ARG2
gene1e	ARG2
is	O
encoded	O
in	O
ten	O
exons	O
with	O
introns	O
ranging	O
from	O
83	O
bp	O
to	O
4	O
kb	O
.	O
In	O
addition	O
,	O
the	O
gene	O
contained	O
one	O
exon	O
in	O
the	O
5'UTR	O
,	O
but	O
none	O
in	O
the	O
3'UTR	O
.	O
Five	O
of	O
the	O
10	O
splice	O
sites	O
of	O
the	O
gene1s	ARG2
TIN	ARG2
-	ARG2
ag	ARG2
-	ARG2
RP	ARG2
gene1e	ARG2
gene	O
were	O
fully	O
conserved	O
when	O
compared	O
to	O
a	O
related	O
gene	O
of	O
species1s	O
C.	O
elegans	O
species1e	O
,	O
whereas	O
only	O
one	O
splice	O
site	O
was	O
identical	O
to	O
those	O
found	O
in	O
gene1s	ARG2
cathepsin	ARG2
B	ARG2
gene1e	ARG2
genes	O
.	O
Furthermore	O
,	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
TIN	ARG2
-	ARG2
ag	ARG2
-	ARG2
RP	ARG2
gene1e	ARG2
tagged	O
with	O
the	O
T7-epitope	O
,	O
was	O
expressed	O
in	O
arg1s	O
HeLa	O
arg1e	O
cells	O
,	O
and	O
was	O
found	O
to	O
be	O
localized	O
in	O
vesicular	O
compartments	O
as	O
well	O
as	O
secreted	O
into	O
the	O
medium	O
suggesting	O
the	O
involvement	O
of	O
the	O
endosomal	O
trafficking	O
pathway	O
.	O
Based	O
on	O
the	O
high	O
degree	O
of	O
homology	O
of	O
the	O
amino	O
acid	O
sequences	O
and	O
genomic	O
organization	O
between	O
gene1s	ARG2
TIN	ARG2
-	ARG2
ag	ARG2
-	ARG2
RP	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
TIN	ARG2
-	ARG2
ag	ARG2
gene1e	ARG2
,	O
we	O
suggest	O
that	O
both	O
molecules	O
may	O
form	O
a	O
distinct	O
group	O
or	O
family	O
of	O
TIN	O
-	O
ag	O
-	O
like	O
proteins	O
.	O
Copyright	O
2000	O
Academic	O
Press	O
.	O

Cloning	O
,	O
characterization	O
,	O
and	O
expression	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
TIN	O
-	O
ag	O
-	O
RP	O
gene1e	O
gene	O
encoding	O
a	O
novel	O
putative	O
extracellular	O
matrix	O
protein	O
.	O
The	O
species1s	O
human	O
species1e	O
gene	O
encoding	O
a	O
novel	O
gene1s	O
tubulointerstitial	O
nephritis	O
antigen	O
(	O
TIN	O
-	O
ag)-related	O
protein	O
gene1e	O
(	O
gene1s	O
TIN	O
-	O
ag	O
-	O
RP	O
gene1e	O
)	O
was	O
isolated	O
,	O
and	O
its	O
genomic	O
organization	O
was	O
determined	O
.	O
BLAST	O
searches	O
revealed	O
the	O
highest	O
degree	O
of	O
homology	O
to	O
several	O
species1s	O
mammalian	O
species1e	O
gene1s	O
TIN	O
-	O
ag	O
gene1e	O
orthologues	O
,	O
and	O
a	O
weak	O
homology	O
to	O
cathepsin	O
B	O
-	O
like	O
proteases	O
.	O
The	O
12	O
kb	O
gene	O
was	O
mapped	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
to	O
chromosome	O
1p34.2	O
-	O
3	O
,	O
a	O
locus	O
neither	O
related	O
to	O
that	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
TIN	O
-	O
ag	O
gene1e	O
(	O
6p11.2	O
-	O
12	O
)	O
nor	O
to	O
that	O
of	O
gene1s	O
cathepsin	O
B	O
gene1e	O
(	O
8p22	O
-	O
23.1	O
)	O
.	O
The	O
gene1s	O
TIN	O
-	O
ag	O
-	O
RP	O
gene1e	O
is	O
encoded	O
in	O
ten	O
exons	O
with	O
introns	O
ranging	O
from	O
83	O
bp	O
to	O
4	O
kb	O
.	O
In	O
addition	O
,	O
the	O
gene	O
contained	O
one	O
exon	O
in	O
the	O
5'UTR	O
,	O
but	O
none	O
in	O
the	O
3'UTR	O
.	O
Five	O
of	O
the	O
10	O
splice	O
sites	O
of	O
the	O
gene1s	O
TIN	O
-	O
ag	O
-	O
RP	O
gene1e	O
gene	O
were	O
fully	O
conserved	O
when	O
compared	O
to	O
a	O
related	O
gene	O
of	O
arg1s	O
C.	O
elegans	O
arg1e	O
,	O
whereas	O
only	O
one	O
splice	O
site	O
was	O
identical	O
to	O
those	O
found	O
in	O
gene1s	O
cathepsin	O
B	O
gene1e	O
genes	O
.	O
Furthermore	O
,	O
species1s	O
human	O
species1e	O
gene1s	O
TIN	O
-	O
ag	O
-	O
RP	O
gene1e	O
tagged	O
with	O
the	O
T7-epitope	O
,	O
was	O
expressed	O
in	O
species1s	O
HeLa	O
species1e	O
cells	O
,	O
and	O
was	O
found	O
to	O
be	O
localized	O
in	O
vesicular	O
compartments	O
as	O
well	O
as	O
secreted	O
into	O
the	O
medium	O
suggesting	O
the	O
involvement	O
of	O
the	O
endosomal	O
trafficking	O
pathway	O
.	O
Based	O
on	O
the	O
high	O
degree	O
of	O
homology	O
of	O
the	O
amino	O
acid	O
sequences	O
and	O
genomic	O
organization	O
between	O
gene1s	O
TIN	O
-	O
ag	O
-	O
RP	O
gene1e	O
and	O
gene1s	O
TIN	O
-	O
ag	O
gene1e	O
,	O
we	O
suggest	O
that	O
both	O
molecules	O
may	O
form	O
a	O
distinct	O
group	O
or	O
family	O
of	O
TIN	O
-	O
ag	O
-	O
like	O
proteins	O
.	O
Copyright	O
2000	O
Academic	O
Press	O
.	O

Molecular	O
cloning	O
,	O
chromosome	O
mapping	O
and	O
characterization	O
of	O
gene1s	ARG2
UBQLN3	ARG2
gene1e	ARG2
a	O
testis	O
-	O
specific	O
gene	O
that	O
contains	O
an	O
ubiquitin	O
-	O
like	O
domain	O
.	O
The	O
sequence	O
of	O
the	O
ubiquitin	O
protein	O
is	O
highly	O
conserved	O
between	O
species	O
and	O
has	O
facilitated	O
the	O
cloning	O
of	O
numerous	O
ubiquitin	O
-	O
like	O
proteins	O
.	O
In	O
the	O
present	O
study	O
,	O
we	O
report	O
the	O
cloning	O
of	O
the	O
cDNA	O
for	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
ubiquilin	ARG2
3	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
UBQLN3	ARG2
gene1e	ARG2
)	O
.	O
The	O
deduced	O
amino	O
acid	O
sequence	O
of	O
gene1s	ARG2
UBQLN3	ARG2
gene1e	ARG2
contains	O
a	O
UBQ	O
domain	O
(	O
ubiquitin	O
-	O
like	O
)	O
in	O
the	O
amino	O
terminus	O
as	O
well	O
as	O
two	O
highly	O
conserved	O
domains	O
found	O
in	O
several	O
recently	O
cloned	O
ubiquitin	O
-	O
like	O
proteins	O
.	O
One	O
of	O
these	O
domains	O
,	O
termed	O
the	O
NP	O
domain	O
,	O
is	O
a	O
highly	O
conserved	O
93	O
amino	O
acid	O
region	O
present	O
in	O
gene1s	ARG2
UBQLN3	ARG2
gene1e	ARG2
and	O
several	O
ubiquitin	O
-	O
like	O
proteins	O
.	O
The	O
last	O
conserved	O
domain	O
is	O
the	O
UBA	O
domain	O
(	O
ubiquitin	O
-	O
associated	O
)	O
found	O
in	O
a	O
variety	O
of	O
proteins	O
of	O
the	O
ubiquination	O
pathway	O
.	O
The	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
UBQLN3	ARG2
gene1e	ARG2
gene	O
was	O
mapped	O
to	O
the	O
11p15	O
region	O
of	O
chromosome	O
11	O
.	O
Northern	O
blot	O
analysis	O
of	O
multiple	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
mouse	O
species1e	O
tissues	O
demonstrated	O
gene1s	ARG2
UBQLN3	ARG2
gene1e	ARG2
mRNA	O
expression	O
specifically	O
in	O
testis	O
.	O

Molecular	O
cloning	O
,	O
chromosome	O
mapping	O
and	O
characterization	O
of	O
gene1s	O
UBQLN3	O
gene1e	O
a	O
testis	O
-	O
specific	O
gene	O
that	O
contains	O
an	O
ubiquitin	O
-	O
like	O
domain	O
.	O
The	O
sequence	O
of	O
the	O
ubiquitin	O
protein	O
is	O
highly	O
conserved	O
between	O
species	O
and	O
has	O
facilitated	O
the	O
cloning	O
of	O
numerous	O
ubiquitin	O
-	O
like	O
proteins	O
.	O
In	O
the	O
present	O
study	O
,	O
we	O
report	O
the	O
cloning	O
of	O
the	O
cDNA	O
for	O
species1s	O
human	O
species1e	O
gene1s	O
ubiquilin	O
3	O
gene1e	O
(	O
gene1s	O
UBQLN3	O
gene1e	O
)	O
.	O
The	O
deduced	O
amino	O
acid	O
sequence	O
of	O
gene1s	O
UBQLN3	O
gene1e	O
contains	O
a	O
UBQ	O
domain	O
(	O
ubiquitin	O
-	O
like	O
)	O
in	O
the	O
amino	O
terminus	O
as	O
well	O
as	O
two	O
highly	O
conserved	O
domains	O
found	O
in	O
several	O
recently	O
cloned	O
ubiquitin	O
-	O
like	O
proteins	O
.	O
One	O
of	O
these	O
domains	O
,	O
termed	O
the	O
NP	O
domain	O
,	O
is	O
a	O
highly	O
conserved	O
93	O
amino	O
acid	O
region	O
present	O
in	O
gene1s	O
UBQLN3	O
gene1e	O
and	O
several	O
ubiquitin	O
-	O
like	O
proteins	O
.	O
The	O
last	O
conserved	O
domain	O
is	O
the	O
UBA	O
domain	O
(	O
ubiquitin	O
-	O
associated	O
)	O
found	O
in	O
a	O
variety	O
of	O
proteins	O
of	O
the	O
ubiquination	O
pathway	O
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
UBQLN3	O
gene1e	O
gene	O
was	O
mapped	O
to	O
the	O
11p15	O
region	O
of	O
chromosome	O
11	O
.	O
Northern	O
blot	O
analysis	O
of	O
multiple	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
mouse	O
arg1e	O
tissues	O
demonstrated	O
gene1s	ARG2
UBQLN3	ARG2
gene1e	ARG2
mRNA	O
expression	O
specifically	O
in	O
testis	O
.	O

Excessive	O
placental	O
secretion	O
of	O
gene1s	ARG2
neurokinin	ARG2
B	ARG2
gene1e	ARG2
during	O
the	O
third	O
trimester	O
causes	O
pre	O
-	O
eclampsia	O
.	O
Pre	O
-	O
eclampsia	O
is	O
a	O
principal	O
cause	O
of	O
maternal	O
morbidity	O
and	O
mortality	O
,	O
affecting	O
5	O
-	O
10	O
%	O
of	O
first	O
pregnancies	O
worldwide	O
.	O
Manifestations	O
include	O
increased	O
blood	O
pressure	O
,	O
proteinuria	O
,	O
coagulopathy	O
and	O
peripheral	O
and	O
cerebral	O
oedema	O
.	O
Although	O
the	O
aetiology	O
and	O
pathogenesis	O
remain	O
to	O
be	O
elucidated	O
,	O
the	O
placenta	O
is	O
undoubtedly	O
involved	O
,	O
as	O
termination	O
of	O
pregnancy	O
eradicates	O
the	O
disease	O
.	O
Here	O
we	O
have	O
cloned	O
a	O
complementary	O
DNA	O
from	O
arg1s	O
human	O
arg1e	O
placental	O
messenger	O
RNA	O
encoding	O
a	O
precursor	O
protein	O
of	O
121	O
amino	O
acids	O
which	O
gives	O
rise	O
to	O
a	O
mature	O
peptide	O
identical	O
to	O
the	O
neuropeptide	O
gene1s	ARG2
neurokinin	ARG2
B	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NKB	ARG2
gene1e	ARG2
)	O
of	O
other	O
arg1s	O
mammalian	O
arg1e	O
species	O
.	O
In	O
female	O
species1s	O
rats	O
species1e	O
,	O
concentrations	O
of	O
gene1s	ARG2
NKB	ARG2
gene1e	ARG2
several	O
-	O
fold	O
above	O
that	O
of	O
an	O
animal	O
20	O
days	O
into	O
pregnancy	O
caused	O
substantial	O
pressor	O
activity	O
.	O
In	O
arg1s	O
human	O
arg1e	O
pregnancy	O
,	O
the	O
expression	O
of	O
gene1s	ARG2
NKB	ARG2
gene1e	ARG2
was	O
confined	O
to	O
the	O
outer	O
syncytiotrophoblast	O
of	O
the	O
placenta	O
,	O
significant	O
concentrations	O
of	O
gene1s	ARG2
NKB	ARG2
gene1e	ARG2
could	O
be	O
detected	O
in	O
plasma	O
as	O
early	O
as	O
week	O
9	O
,	O
and	O
plasma	O
concentrations	O
of	O
gene1s	ARG2
NKB	ARG2
gene1e	ARG2
were	O
grossly	O
elevated	O
in	O
pregnancy	O
-	O
induced	O
hypertension	O
and	O
pre	O
-	O
eclampsia	O
.	O
We	O
conclude	O
that	O
elevated	O
levels	O
of	O
gene1s	ARG2
NKB	ARG2
gene1e	ARG2
in	O
early	O
pregnancy	O
may	O
be	O
an	O
indicator	O
of	O
hypertension	O
and	O
pre	O
-	O
eclampsia	O
,	O
and	O
that	O
treatment	O
with	O
certain	O
neurokinin	O
receptor	O
antagonists	O
may	O
be	O
useful	O
in	O
alleviating	O
the	O
symptoms	O
.	O

Excessive	O
placental	O
secretion	O
of	O
gene1s	O
neurokinin	O
B	O
gene1e	O
during	O
the	O
third	O
trimester	O
causes	O
pre	O
-	O
eclampsia	O
.	O
Pre	O
-	O
eclampsia	O
is	O
a	O
principal	O
cause	O
of	O
maternal	O
morbidity	O
and	O
mortality	O
,	O
affecting	O
5	O
-	O
10	O
%	O
of	O
first	O
pregnancies	O
worldwide	O
.	O
Manifestations	O
include	O
increased	O
blood	O
pressure	O
,	O
proteinuria	O
,	O
coagulopathy	O
and	O
peripheral	O
and	O
cerebral	O
oedema	O
.	O
Although	O
the	O
aetiology	O
and	O
pathogenesis	O
remain	O
to	O
be	O
elucidated	O
,	O
the	O
placenta	O
is	O
undoubtedly	O
involved	O
,	O
as	O
termination	O
of	O
pregnancy	O
eradicates	O
the	O
disease	O
.	O
Here	O
we	O
have	O
cloned	O
a	O
complementary	O
DNA	O
from	O
species1s	O
human	O
species1e	O
placental	O
messenger	O
RNA	O
encoding	O
a	O
precursor	O
protein	O
of	O
121	O
amino	O
acids	O
which	O
gives	O
rise	O
to	O
a	O
mature	O
peptide	O
identical	O
to	O
the	O
neuropeptide	O
gene1s	O
neurokinin	O
B	O
gene1e	O
(	O
gene1s	O
NKB	O
gene1e	O
)	O
of	O
other	O
species1s	O
mammalian	O
species1e	O
species	O
.	O
In	O
female	O
arg1s	O
rats	O
arg1e	O
,	O
concentrations	O
of	O
gene1s	O
NKB	O
gene1e	O
several	O
-	O
fold	O
above	O
that	O
of	O
an	O
animal	O
20	O
days	O
into	O
pregnancy	O
caused	O
substantial	O
pressor	O
activity	O
.	O
In	O
species1s	O
human	O
species1e	O
pregnancy	O
,	O
the	O
expression	O
of	O
gene1s	O
NKB	O
gene1e	O
was	O
confined	O
to	O
the	O
outer	O
syncytiotrophoblast	O
of	O
the	O
placenta	O
,	O
significant	O
concentrations	O
of	O
gene1s	O
NKB	O
gene1e	O
could	O
be	O
detected	O
in	O
plasma	O
as	O
early	O
as	O
week	O
9	O
,	O
and	O
plasma	O
concentrations	O
of	O
gene1s	O
NKB	O
gene1e	O
were	O
grossly	O
elevated	O
in	O
pregnancy	O
-	O
induced	O
hypertension	O
and	O
pre	O
-	O
eclampsia	O
.	O
We	O
conclude	O
that	O
elevated	O
levels	O
of	O
gene1s	O
NKB	O
gene1e	O
in	O
early	O
pregnancy	O
may	O
be	O
an	O
indicator	O
of	O
hypertension	O
and	O
pre	O
-	O
eclampsia	O
,	O
and	O
that	O
treatment	O
with	O
certain	O
neurokinin	O
receptor	O
antagonists	O
may	O
be	O
useful	O
in	O
alleviating	O
the	O
symptoms	O
.	O

Isolation	O
and	O
characterization	O
of	O
the	O
novel	O
popeye	O
gene	O
family	O
expressed	O
in	O
skeletal	O
muscle	O
and	O
heart	O
.	O
We	O
identified	O
a	O
novel	O
gene	O
family	O
in	O
vertebrates	O
which	O
is	O
preferentially	O
expressed	O
in	O
developing	O
and	O
adult	O
striated	O
muscle	O
.	O
Three	O
genes	O
of	O
the	O
Popeye	O
(	O
POP	O
)	O
family	O
were	O
detected	O
in	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
mouse	O
species1e	O
and	O
two	O
in	O
species1s	O
chicken	O
species1e	O
.	O
Chromosomal	O
mapping	O
indicates	O
that	O
gene1s	O
Pop1	O
gene1e	O
and	O
gene1s	O
Pop3	O
gene1e	O
genes	O
are	O
clustered	O
on	O
species1s	O
mouse	O
species1e	O
chromosome	O
10	O
,	O
whereas	O
gene1s	O
Pop2	O
gene1e	O
maps	O
to	O
species1s	O
mouse	O
species1e	O
chromosome	O
16	O
.	O
We	O
found	O
evidence	O
that	O
gene1s	O
POP1	O
gene1e	O
and	O
gene1s	O
POP3	O
gene1e	O
in	O
species1s	O
chicken	O
species1e	O
may	O
also	O
be	O
linked	O
and	O
multiple	O
transcript	O
isoforms	O
are	O
generated	O
from	O
this	O
locus	O
.	O
The	O
POP	O
genes	O
encode	O
proteins	O
with	O
three	O
potential	O
transmembrane	O
domains	O
that	O
are	O
conserved	O
in	O
all	O
family	O
members	O
.	O
Individual	O
POP	O
genes	O
exhibit	O
specific	O
expression	O
patterns	O
during	O
development	O
and	O
postnatally	O
.	O
species1s	O
Chicken	O
species1e	O
gene1s	O
POP3	O
gene1e	O
and	O
species1s	O
mouse	O
species1e	O
gene1s	O
Pop1	O
gene1e	O
are	O
first	O
preferentially	O
expressed	O
in	O
atrium	O
and	O
later	O
also	O
in	O
the	O
subepicardial	O
compact	O
layer	O
of	O
the	O
ventricles	O
.	O
species1s	O
Chicken	O
species1e	O
gene1s	O
POP1	O
gene1e	O
and	O
species1s	O
mouse	O
species1e	O
gene1s	O
Pop2	O
gene1e	O
are	O
expressed	O
in	O
the	O
entire	O
heart	O
except	O
the	O
outflow	O
tract	O
.	O
All	O
three	O
Pop	O
genes	O
are	O
expressed	O
in	O
heart	O
and	O
skeletal	O
muscle	O
of	O
the	O
adult	O
species1s	O
mouse	O
species1e	O
and	O
lower	O
in	O
lung	O
.	O
gene1s	O
Pop1	O
gene1e	O
and	O
gene1s	O
Pop2	O
gene1e	O
expression	O
is	O
upregulated	O
in	O
uterus	O
of	O
pregnant	O
species1s	O
mice	O
species1e	O
.	O
Like	O
the	O
species1s	O
mouse	O
species1e	O
genes	O
,	O
arg1s	O
human	O
arg1e	O
POP	O
genes	O
are	O
predominantly	O
expressed	O
in	O
skeletal	O
and	O
cardiac	O
muscle	O
.	O
The	O
strong	O
conservation	O
of	O
POP	O
genes	O
during	O
evolution	O
and	O
their	O
preferential	O
expression	O
in	O
heart	O
and	O
skeletal	O
muscle	O
suggest	O
that	O
these	O
novel	O
proteins	O
may	O
have	O
an	O
important	O
function	O
in	O
these	O
tissues	O
in	O
vertebrates	O
.	O
Copyright	O
2000	O
Academic	O
Press	O
.	O

Isolation	O
and	O
characterization	O
of	O
the	O
novel	O
popeye	O
gene	O
family	O
expressed	O
in	O
skeletal	O
muscle	O
and	O
heart	O
.	O
We	O
identified	O
a	O
novel	O
gene	O
family	O
in	O
vertebrates	O
which	O
is	O
preferentially	O
expressed	O
in	O
developing	O
and	O
adult	O
striated	O
muscle	O
.	O
Three	O
genes	O
of	O
the	O
Popeye	O
(	O
POP	O
)	O
family	O
were	O
detected	O
in	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
mouse	O
arg1e	O
and	O
two	O
in	O
species1s	O
chicken	O
species1e	O
.	O
Chromosomal	O
mapping	O
indicates	O
that	O
gene1s	ARG2
Pop1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Pop3	ARG2
gene1e	ARG2
genes	O
are	O
clustered	O
on	O
arg1s	O
mouse	O
arg1e	O
chromosome	O
10	O
,	O
whereas	O
gene1s	ARG2
Pop2	ARG2
gene1e	ARG2
maps	O
to	O
arg1s	O
mouse	O
arg1e	O
chromosome	O
16	O
.	O
We	O
found	O
evidence	O
that	O
gene1s	O
POP1	O
gene1e	O
and	O
gene1s	O
POP3	O
gene1e	O
in	O
species1s	O
chicken	O
species1e	O
may	O
also	O
be	O
linked	O
and	O
multiple	O
transcript	O
isoforms	O
are	O
generated	O
from	O
this	O
locus	O
.	O
The	O
POP	O
genes	O
encode	O
proteins	O
with	O
three	O
potential	O
transmembrane	O
domains	O
that	O
are	O
conserved	O
in	O
all	O
family	O
members	O
.	O
Individual	O
POP	O
genes	O
exhibit	O
specific	O
expression	O
patterns	O
during	O
development	O
and	O
postnatally	O
.	O
species1s	O
Chicken	O
species1e	O
gene1s	O
POP3	O
gene1e	O
and	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
Pop1	ARG2
gene1e	ARG2
are	O
first	O
preferentially	O
expressed	O
in	O
atrium	O
and	O
later	O
also	O
in	O
the	O
subepicardial	O
compact	O
layer	O
of	O
the	O
ventricles	O
.	O
species1s	O
Chicken	O
species1e	O
gene1s	O
POP1	O
gene1e	O
and	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
Pop2	ARG2
gene1e	ARG2
are	O
expressed	O
in	O
the	O
entire	O
heart	O
except	O
the	O
outflow	O
tract	O
.	O
All	O
three	O
Pop	O
genes	O
are	O
expressed	O
in	O
heart	O
and	O
skeletal	O
muscle	O
of	O
the	O
adult	O
arg1s	O
mouse	O
arg1e	O
and	O
lower	O
in	O
lung	O
.	O
gene1s	ARG2
Pop1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Pop2	ARG2
gene1e	ARG2
expression	O
is	O
upregulated	O
in	O
uterus	O
of	O
pregnant	O
arg1s	O
mice	O
arg1e	O
.	O
Like	O
the	O
arg1s	O
mouse	O
arg1e	O
genes	O
,	O
species1s	O
human	O
species1e	O
POP	O
genes	O
are	O
predominantly	O
expressed	O
in	O
skeletal	O
and	O
cardiac	O
muscle	O
.	O
The	O
strong	O
conservation	O
of	O
POP	O
genes	O
during	O
evolution	O
and	O
their	O
preferential	O
expression	O
in	O
heart	O
and	O
skeletal	O
muscle	O
suggest	O
that	O
these	O
novel	O
proteins	O
may	O
have	O
an	O
important	O
function	O
in	O
these	O
tissues	O
in	O
vertebrates	O
.	O
Copyright	O
2000	O
Academic	O
Press	O
.	O

Isolation	O
and	O
characterization	O
of	O
the	O
novel	O
popeye	O
gene	O
family	O
expressed	O
in	O
skeletal	O
muscle	O
and	O
heart	O
.	O
We	O
identified	O
a	O
novel	O
gene	O
family	O
in	O
vertebrates	O
which	O
is	O
preferentially	O
expressed	O
in	O
developing	O
and	O
adult	O
striated	O
muscle	O
.	O
Three	O
genes	O
of	O
the	O
Popeye	O
(	O
POP	O
)	O
family	O
were	O
detected	O
in	O
species1s	O
human	O
species1e	O
and	O
species1s	O
mouse	O
species1e	O
and	O
two	O
in	O
arg1s	O
chicken	O
arg1e	O
.	O
Chromosomal	O
mapping	O
indicates	O
that	O
gene1s	O
Pop1	O
gene1e	O
and	O
gene1s	O
Pop3	O
gene1e	O
genes	O
are	O
clustered	O
on	O
species1s	O
mouse	O
species1e	O
chromosome	O
10	O
,	O
whereas	O
gene1s	O
Pop2	O
gene1e	O
maps	O
to	O
species1s	O
mouse	O
species1e	O
chromosome	O
16	O
.	O
We	O
found	O
evidence	O
that	O
gene1s	ARG2
POP1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
POP3	ARG2
gene1e	ARG2
in	O
arg1s	O
chicken	O
arg1e	O
may	O
also	O
be	O
linked	O
and	O
multiple	O
transcript	O
isoforms	O
are	O
generated	O
from	O
this	O
locus	O
.	O
The	O
POP	O
genes	O
encode	O
proteins	O
with	O
three	O
potential	O
transmembrane	O
domains	O
that	O
are	O
conserved	O
in	O
all	O
family	O
members	O
.	O
Individual	O
POP	O
genes	O
exhibit	O
specific	O
expression	O
patterns	O
during	O
development	O
and	O
postnatally	O
.	O
arg1s	O
Chicken	O
arg1e	O
gene1s	ARG2
POP3	ARG2
gene1e	ARG2
and	O
species1s	O
mouse	O
species1e	O
gene1s	O
Pop1	O
gene1e	O
are	O
first	O
preferentially	O
expressed	O
in	O
atrium	O
and	O
later	O
also	O
in	O
the	O
subepicardial	O
compact	O
layer	O
of	O
the	O
ventricles	O
.	O
arg1s	O
Chicken	O
arg1e	O
gene1s	ARG2
POP1	ARG2
gene1e	ARG2
and	O
species1s	O
mouse	O
species1e	O
gene1s	O
Pop2	O
gene1e	O
are	O
expressed	O
in	O
the	O
entire	O
heart	O
except	O
the	O
outflow	O
tract	O
.	O
All	O
three	O
Pop	O
genes	O
are	O
expressed	O
in	O
heart	O
and	O
skeletal	O
muscle	O
of	O
the	O
adult	O
species1s	O
mouse	O
species1e	O
and	O
lower	O
in	O
lung	O
.	O
gene1s	O
Pop1	O
gene1e	O
and	O
gene1s	O
Pop2	O
gene1e	O
expression	O
is	O
upregulated	O
in	O
uterus	O
of	O
pregnant	O
species1s	O
mice	O
species1e	O
.	O
Like	O
the	O
species1s	O
mouse	O
species1e	O
genes	O
,	O
species1s	O
human	O
species1e	O
POP	O
genes	O
are	O
predominantly	O
expressed	O
in	O
skeletal	O
and	O
cardiac	O
muscle	O
.	O
The	O
strong	O
conservation	O
of	O
POP	O
genes	O
during	O
evolution	O
and	O
their	O
preferential	O
expression	O
in	O
heart	O
and	O
skeletal	O
muscle	O
suggest	O
that	O
these	O
novel	O
proteins	O
may	O
have	O
an	O
important	O
function	O
in	O
these	O
tissues	O
in	O
vertebrates	O
.	O
Copyright	O
2000	O
Academic	O
Press	O
.	O

Identification	O
,	O
cloning	O
,	O
expression	O
,	O
and	O
biochemical	O
characterization	O
of	O
the	O
gene1s	ARG2
testis	ARG2
-	ARG2
specific	ARG2
RNA	ARG2
polymerase	ARG2
II	ARG2
elongation	ARG2
factor	ARG2
ELL3	ARG2
gene1e	ARG2
.	O
The	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
ELL	ARG2
gene1e	ARG2
gene	O
,	O
which	O
is	O
a	O
frequent	O
target	O
for	O
translocation	O
in	O
acute	O
myeloid	O
leukemia	O
,	O
was	O
initially	O
isolated	O
from	O
species1s	O
rat	O
species1e	O
liver	O
nuclei	O
and	O
found	O
to	O
be	O
an	O
RNA	O
polymerase	O
II	O
elongation	O
factor	O
.	O
Based	O
on	O
homology	O
to	O
gene1s	ARG2
ELL	ARG2
gene1e	ARG2
,	O
we	O
later	O
cloned	O
gene1s	ARG2
ELL2	ARG2
gene1e	ARG2
and	O
demonstrated	O
that	O
it	O
can	O
also	O
increase	O
the	O
catalytic	O
rate	O
of	O
transcription	O
elongation	O
by	O
RNA	O
polymerase	O
II	O
.	O
To	O
better	O
understand	O
the	O
role	O
of	O
gene1s	ARG2
ELL	ARG2
gene1e	ARG2
proteins	O
in	O
the	O
regulation	O
of	O
transcription	O
by	O
RNA	O
polymerase	O
II	O
,	O
we	O
have	O
initiated	O
a	O
search	O
for	O
proteins	O
related	O
to	O
ELLs	O
.	O
In	O
this	O
report	O
,	O
we	O
describe	O
the	O
molecular	O
cloning	O
,	O
expression	O
,	O
and	O
characterization	O
of	O
gene1s	ARG2
ELL3	ARG2
gene1e	ARG2
,	O
a	O
novel	O
RNA	O
polymerase	O
II	O
elongation	O
factor	O
approximately	O
50	O
%	O
similar	O
to	O
both	O
gene1s	ARG2
ELL	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ELL2	ARG2
gene1e	ARG2
.	O
Our	O
transcriptional	O
studies	O
have	O
demonstrated	O
that	O
gene1s	ARG2
ELL3	ARG2
gene1e	ARG2
can	O
also	O
increase	O
the	O
catalytic	O
rate	O
of	O
transcription	O
elongation	O
by	O
RNA	O
polymerase	O
II	O
.	O
The	O
C	O
-	O
terminal	O
domain	O
of	O
gene1s	ARG2
ELL	ARG2
gene1e	ARG2
,	O
which	O
we	O
recently	O
demonstrated	O
to	O
be	O
required	O
and	O
sufficient	O
for	O
the	O
immortalization	O
of	O
myeloid	O
progenitor	O
cells	O
,	O
shares	O
strong	O
similarities	O
to	O
the	O
C	O
-	O
terminal	O
domain	O
of	O
gene1s	ARG2
ELL3	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
ELL3	ARG2
gene1e	ARG2
was	O
localized	O
by	O
immunofluorescence	O
to	O
the	O
nucleus	O
of	O
cells	O
,	O
and	O
Northern	O
analysis	O
indicated	O
that	O
gene1s	ARG2
ELL3	ARG2
gene1e	ARG2
is	O
a	O
testis	O
-	O
specific	O
RNA	O
polymerase	O
II	O
elongation	O
factor	O
.	O

Identification	O
,	O
cloning	O
,	O
expression	O
,	O
and	O
biochemical	O
characterization	O
of	O
the	O
gene1s	O
testis	O
-	O
specific	O
RNA	O
polymerase	O
II	O
elongation	O
factor	O
ELL3	O
gene1e	O
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
ELL	O
gene1e	O
gene	O
,	O
which	O
is	O
a	O
frequent	O
target	O
for	O
translocation	O
in	O
acute	O
myeloid	O
leukemia	O
,	O
was	O
initially	O
isolated	O
from	O
arg1s	O
rat	O
arg1e	O
liver	O
nuclei	O
and	O
found	O
to	O
be	O
an	O
RNA	O
polymerase	O
II	O
elongation	O
factor	O
.	O
Based	O
on	O
homology	O
to	O
gene1s	O
ELL	O
gene1e	O
,	O
we	O
later	O
cloned	O
gene1s	O
ELL2	O
gene1e	O
and	O
demonstrated	O
that	O
it	O
can	O
also	O
increase	O
the	O
catalytic	O
rate	O
of	O
transcription	O
elongation	O
by	O
RNA	O
polymerase	O
II	O
.	O
To	O
better	O
understand	O
the	O
role	O
of	O
gene1s	O
ELL	O
gene1e	O
proteins	O
in	O
the	O
regulation	O
of	O
transcription	O
by	O
RNA	O
polymerase	O
II	O
,	O
we	O
have	O
initiated	O
a	O
search	O
for	O
proteins	O
related	O
to	O
ELLs	O
.	O
In	O
this	O
report	O
,	O
we	O
describe	O
the	O
molecular	O
cloning	O
,	O
expression	O
,	O
and	O
characterization	O
of	O
gene1s	O
ELL3	O
gene1e	O
,	O
a	O
novel	O
RNA	O
polymerase	O
II	O
elongation	O
factor	O
approximately	O
50	O
%	O
similar	O
to	O
both	O
gene1s	O
ELL	O
gene1e	O
and	O
gene1s	O
ELL2	O
gene1e	O
.	O
Our	O
transcriptional	O
studies	O
have	O
demonstrated	O
that	O
gene1s	O
ELL3	O
gene1e	O
can	O
also	O
increase	O
the	O
catalytic	O
rate	O
of	O
transcription	O
elongation	O
by	O
RNA	O
polymerase	O
II	O
.	O
The	O
C	O
-	O
terminal	O
domain	O
of	O
gene1s	O
ELL	O
gene1e	O
,	O
which	O
we	O
recently	O
demonstrated	O
to	O
be	O
required	O
and	O
sufficient	O
for	O
the	O
immortalization	O
of	O
myeloid	O
progenitor	O
cells	O
,	O
shares	O
strong	O
similarities	O
to	O
the	O
C	O
-	O
terminal	O
domain	O
of	O
gene1s	O
ELL3	O
gene1e	O
.	O
gene1s	O
ELL3	O
gene1e	O
was	O
localized	O
by	O
immunofluorescence	O
to	O
the	O
nucleus	O
of	O
cells	O
,	O
and	O
Northern	O
analysis	O
indicated	O
that	O
gene1s	O
ELL3	O
gene1e	O
is	O
a	O
testis	O
-	O
specific	O
RNA	O
polymerase	O
II	O
elongation	O
factor	O
.	O

The	O
gene1s	O
SCA8	O
gene1e	O
transcript	O
is	O
an	O
antisense	O
RNA	O
to	O
a	O
brain	O
-	O
specific	O
transcript	O
encoding	O
a	O
novel	O
actin	O
-	O
binding	O
protein	O
(	O
gene1s	O
KLHL1	O
gene1e	O
)	O
.	O
gene1s	O
Spinocerebellar	O
ataxia	O
type	O
8	O
gene1e	O
(	O
gene1s	O
SCA8	O
gene1e	O
)	O
is	O
a	O
neurodegenerative	O
disorder	O
caused	O
by	O
the	O
expansion	O
of	O
a	O
CTG	O
trinucleotide	O
repeat	O
that	O
is	O
transcribed	O
as	O
part	O
of	O
an	O
untranslated	O
RNA	O
.	O
As	O
a	O
step	O
towards	O
understanding	O
the	O
molecular	O
pathology	O
of	O
gene1s	O
SCA8	O
gene1e	O
,	O
we	O
have	O
defined	O
the	O
genomic	O
organization	O
of	O
the	O
gene1s	O
SCA8	O
gene1e	O
RNA	O
transcripts	O
and	O
assembled	O
a	O
166	O
kb	O
segment	O
of	O
genomic	O
sequence	O
containing	O
the	O
repeat	O
.	O
The	O
most	O
striking	O
feature	O
of	O
the	O
gene1s	O
SCA8	O
gene1e	O
transcripts	O
is	O
that	O
the	O
most	O
5	O
'	O
exon	O
is	O
transcribed	O
through	O
the	O
first	O
exon	O
of	O
another	O
gene	O
that	O
is	O
transcribed	O
in	O
the	O
opposite	O
orientation	O
.	O
This	O
gene	O
arrangement	O
suggests	O
that	O
the	O
gene1s	O
SCA8	O
gene1e	O
transcript	O
is	O
an	O
endogenous	O
antisense	O
RNA	O
that	O
overlaps	O
the	O
transcription	O
and	O
translation	O
start	O
sites	O
as	O
well	O
as	O
the	O
first	O
splice	O
donor	O
sequence	O
of	O
the	O
sense	O
gene	O
.	O
The	O
sense	O
transcript	O
encodes	O
a	O
748	O
amino	O
acid	O
protein	O
with	O
a	O
predicted	O
domain	O
structure	O
typical	O
of	O
a	O
family	O
of	O
actin	O
-	O
organizing	O
proteins	O
related	O
to	O
the	O
arg1s	O
Drosophila	O
arg1e	O
gene1s	ARG2
Kelch	ARG2
gene1e	ARG2
gene	O
,	O
and	O
so	O
has	O
been	O
given	O
the	O
name	O
gene1s	O
Kelch	O
-	O
like	O
1	O
gene1e	O
(	O
gene1s	O
KLHL1	O
gene1e	O
)	O
.	O
We	O
have	O
identified	O
the	O
full	O
-	O
length	O
cDNA	O
sequence	O
for	O
both	O
the	O
species1s	O
human	O
species1e	O
and	O
species1s	O
mouse	O
species1e	O
gene1s	O
KLHLI	O
gene1e	O
genes	O
,	O
and	O
have	O
elucidated	O
the	O
general	O
genomic	O
organization	O
of	O
the	O
species1s	O
human	O
species1e	O
gene	O
.	O
The	O
predicted	O
open	O
reading	O
frame	O
and	O
promoter	O
region	O
are	O
highly	O
conserved	O
,	O
and	O
both	O
genes	O
are	O
primarily	O
expressed	O
in	O
specific	O
brain	O
tissues	O
,	O
including	O
the	O
cerebellum	O
,	O
the	O
tissue	O
most	O
affected	O
by	O
gene1s	O
SCA8	O
gene1e	O
.	O
Transfection	O
studies	O
with	O
epitope	O
-	O
tagged	O
gene1s	O
KLHL1	O
gene1e	O
demonstrate	O
that	O
the	O
protein	O
localizes	O
to	O
the	O
cytoplasm	O
,	O
suggesting	O
that	O
it	O
may	O
play	O
a	O
role	O
in	O
organizing	O
the	O
actin	O
cytoskeleton	O
of	O
the	O
brain	O
cells	O
in	O
which	O
it	O
is	O
expressed	O
.	O

The	O
gene1s	ARG2
SCA8	ARG2
gene1e	ARG2
transcript	O
is	O
an	O
antisense	O
RNA	O
to	O
a	O
brain	O
-	O
specific	O
transcript	O
encoding	O
a	O
novel	O
actin	O
-	O
binding	O
protein	O
(	O
gene1s	ARG2
KLHL1	ARG2
gene1e	ARG2
)	O
.	O
gene1s	ARG2
Spinocerebellar	ARG2
ataxia	ARG2
type	ARG2
8	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SCA8	ARG2
gene1e	ARG2
)	O
is	O
a	O
neurodegenerative	O
disorder	O
caused	O
by	O
the	O
expansion	O
of	O
a	O
CTG	O
trinucleotide	O
repeat	O
that	O
is	O
transcribed	O
as	O
part	O
of	O
an	O
untranslated	O
RNA	O
.	O
As	O
a	O
step	O
towards	O
understanding	O
the	O
molecular	O
pathology	O
of	O
gene1s	ARG2
SCA8	ARG2
gene1e	ARG2
,	O
we	O
have	O
defined	O
the	O
genomic	O
organization	O
of	O
the	O
gene1s	ARG2
SCA8	ARG2
gene1e	ARG2
RNA	O
transcripts	O
and	O
assembled	O
a	O
166	O
kb	O
segment	O
of	O
genomic	O
sequence	O
containing	O
the	O
repeat	O
.	O
The	O
most	O
striking	O
feature	O
of	O
the	O
gene1s	ARG2
SCA8	ARG2
gene1e	ARG2
transcripts	O
is	O
that	O
the	O
most	O
5	O
'	O
exon	O
is	O
transcribed	O
through	O
the	O
first	O
exon	O
of	O
another	O
gene	O
that	O
is	O
transcribed	O
in	O
the	O
opposite	O
orientation	O
.	O
This	O
gene	O
arrangement	O
suggests	O
that	O
the	O
gene1s	ARG2
SCA8	ARG2
gene1e	ARG2
transcript	O
is	O
an	O
endogenous	O
antisense	O
RNA	O
that	O
overlaps	O
the	O
transcription	O
and	O
translation	O
start	O
sites	O
as	O
well	O
as	O
the	O
first	O
splice	O
donor	O
sequence	O
of	O
the	O
sense	O
gene	O
.	O
The	O
sense	O
transcript	O
encodes	O
a	O
748	O
amino	O
acid	O
protein	O
with	O
a	O
predicted	O
domain	O
structure	O
typical	O
of	O
a	O
family	O
of	O
actin	O
-	O
organizing	O
proteins	O
related	O
to	O
the	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
Kelch	O
gene1e	O
gene	O
,	O
and	O
so	O
has	O
been	O
given	O
the	O
name	O
gene1s	ARG2
Kelch	ARG2
-	ARG2
like	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
KLHL1	ARG2
gene1e	ARG2
)	O
.	O
We	O
have	O
identified	O
the	O
full	O
-	O
length	O
cDNA	O
sequence	O
for	O
both	O
the	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
mouse	O
species1e	O
gene1s	ARG2
KLHLI	ARG2
gene1e	ARG2
genes	O
,	O
and	O
have	O
elucidated	O
the	O
general	O
genomic	O
organization	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene	O
.	O
The	O
predicted	O
open	O
reading	O
frame	O
and	O
promoter	O
region	O
are	O
highly	O
conserved	O
,	O
and	O
both	O
genes	O
are	O
primarily	O
expressed	O
in	O
specific	O
brain	O
tissues	O
,	O
including	O
the	O
cerebellum	O
,	O
the	O
tissue	O
most	O
affected	O
by	O
gene1s	ARG2
SCA8	ARG2
gene1e	ARG2
.	O
Transfection	O
studies	O
with	O
epitope	O
-	O
tagged	O
gene1s	ARG2
KLHL1	ARG2
gene1e	ARG2
demonstrate	O
that	O
the	O
protein	O
localizes	O
to	O
the	O
cytoplasm	O
,	O
suggesting	O
that	O
it	O
may	O
play	O
a	O
role	O
in	O
organizing	O
the	O
actin	O
cytoskeleton	O
of	O
the	O
brain	O
cells	O
in	O
which	O
it	O
is	O
expressed	O
.	O

The	O
gene1s	O
SCA8	O
gene1e	O
transcript	O
is	O
an	O
antisense	O
RNA	O
to	O
a	O
brain	O
-	O
specific	O
transcript	O
encoding	O
a	O
novel	O
actin	O
-	O
binding	O
protein	O
(	O
gene1s	O
KLHL1	O
gene1e	O
)	O
.	O
gene1s	O
Spinocerebellar	O
ataxia	O
type	O
8	O
gene1e	O
(	O
gene1s	O
SCA8	O
gene1e	O
)	O
is	O
a	O
neurodegenerative	O
disorder	O
caused	O
by	O
the	O
expansion	O
of	O
a	O
CTG	O
trinucleotide	O
repeat	O
that	O
is	O
transcribed	O
as	O
part	O
of	O
an	O
untranslated	O
RNA	O
.	O
As	O
a	O
step	O
towards	O
understanding	O
the	O
molecular	O
pathology	O
of	O
gene1s	O
SCA8	O
gene1e	O
,	O
we	O
have	O
defined	O
the	O
genomic	O
organization	O
of	O
the	O
gene1s	O
SCA8	O
gene1e	O
RNA	O
transcripts	O
and	O
assembled	O
a	O
166	O
kb	O
segment	O
of	O
genomic	O
sequence	O
containing	O
the	O
repeat	O
.	O
The	O
most	O
striking	O
feature	O
of	O
the	O
gene1s	O
SCA8	O
gene1e	O
transcripts	O
is	O
that	O
the	O
most	O
5	O
'	O
exon	O
is	O
transcribed	O
through	O
the	O
first	O
exon	O
of	O
another	O
gene	O
that	O
is	O
transcribed	O
in	O
the	O
opposite	O
orientation	O
.	O
This	O
gene	O
arrangement	O
suggests	O
that	O
the	O
gene1s	O
SCA8	O
gene1e	O
transcript	O
is	O
an	O
endogenous	O
antisense	O
RNA	O
that	O
overlaps	O
the	O
transcription	O
and	O
translation	O
start	O
sites	O
as	O
well	O
as	O
the	O
first	O
splice	O
donor	O
sequence	O
of	O
the	O
sense	O
gene	O
.	O
The	O
sense	O
transcript	O
encodes	O
a	O
748	O
amino	O
acid	O
protein	O
with	O
a	O
predicted	O
domain	O
structure	O
typical	O
of	O
a	O
family	O
of	O
actin	O
-	O
organizing	O
proteins	O
related	O
to	O
the	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
Kelch	O
gene1e	O
gene	O
,	O
and	O
so	O
has	O
been	O
given	O
the	O
name	O
gene1s	O
Kelch	O
-	O
like	O
1	O
gene1e	O
(	O
gene1s	O
KLHL1	O
gene1e	O
)	O
.	O
We	O
have	O
identified	O
the	O
full	O
-	O
length	O
cDNA	O
sequence	O
for	O
both	O
the	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
KLHLI	ARG2
gene1e	ARG2
genes	O
,	O
and	O
have	O
elucidated	O
the	O
general	O
genomic	O
organization	O
of	O
the	O
species1s	O
human	O
species1e	O
gene	O
.	O
The	O
predicted	O
open	O
reading	O
frame	O
and	O
promoter	O
region	O
are	O
highly	O
conserved	O
,	O
and	O
both	O
genes	O
are	O
primarily	O
expressed	O
in	O
specific	O
brain	O
tissues	O
,	O
including	O
the	O
cerebellum	O
,	O
the	O
tissue	O
most	O
affected	O
by	O
gene1s	O
SCA8	O
gene1e	O
.	O
Transfection	O
studies	O
with	O
epitope	O
-	O
tagged	O
gene1s	O
KLHL1	O
gene1e	O
demonstrate	O
that	O
the	O
protein	O
localizes	O
to	O
the	O
cytoplasm	O
,	O
suggesting	O
that	O
it	O
may	O
play	O
a	O
role	O
in	O
organizing	O
the	O
actin	O
cytoskeleton	O
of	O
the	O
brain	O
cells	O
in	O
which	O
it	O
is	O
expressed	O
.	O

Cloning	O
and	O
characterization	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
DDX24	ARG2
gene1e	ARG2
and	O
species1s	O
mouse	O
species1e	O
gene1s	O
Ddx24	O
gene1e	O
,	O
two	O
novel	O
putative	O
DEAD	O
-	O
Box	O
proteins	O
,	O
and	O
mapping	O
gene1s	ARG2
DDX24	ARG2
gene1e	ARG2
to	O
arg1s	O
human	O
arg1e	O
chromosome	O
14q32	O
.	O
DEAD	O
-	O
box	O
proteins	O
are	O
a	O
large	O
group	O
of	O
putative	O
RNA	O
helicases	O
that	O
exist	O
ubiquitously	O
in	O
organisms	O
ranging	O
from	O
bacteria	O
to	O
arg1s	O
humans	O
arg1e	O
.	O
They	O
are	O
likely	O
to	O
play	O
important	O
roles	O
in	O
many	O
different	O
RNA	O
metabolic	O
processes	O
.	O
In	O
this	O
paper	O
,	O
we	O
report	O
the	O
cloning	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
DDX24	ARG2
gene1e	ARG2
,	O
a	O
putative	O
DEAD	O
-	O
box	O
protein	O
,	O
and	O
its	O
ortholog	O
,	O
gene1s	O
Ddx24	O
gene1e	O
in	O
species1s	O
mouse	O
species1e	O
.	O
The	O
deduced	O
proteins	O
encoded	O
by	O
these	O
two	O
cDNAs	O
share	O
78.7	O
%	O
identity	O
at	O
the	O
amino	O
acid	O
level	O
and	O
possess	O
all	O
the	O
well	O
-	O
conserved	O
motifs	O
of	O
DEAD	O
-	O
box	O
proteins	O
.	O
However	O
,	O
little	O
homology	O
can	O
be	O
found	O
between	O
them	O
and	O
other	O
DEAD	O
-	O
box	O
proteins	O
,	O
even	O
in	O
their	O
core	O
region	O
(	O
identity	O
<	O
40	O
%	O
)	O
.	O
Northern	O
blot	O
analysis	O
showed	O
that	O
a	O
3.0-kb	O
transcript	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
DDX24	ARG2
gene1e	ARG2
exists	O
ubiquitously	O
in	O
the	O
16	O
arg1s	O
human	O
arg1e	O
tissues	O
examined	O
and	O
was	O
most	O
abundant	O
in	O
heart	O
and	O
brain	O
,	O
but	O
with	O
lowest	O
levels	O
in	O
thymus	O
and	O
small	O
intestine	O
.	O
The	O
species1s	O
mouse	O
species1e	O
gene1s	O
Ddx24	O
gene1e	O
,	O
whose	O
transcript	O
is	O
4.0	O
kb	O
,	O
was	O
also	O
expressed	O
widely	O
in	O
10	O
tissues	O
tested	O
with	O
the	O
highest	O
level	O
in	O
heart	O
and	O
testis	O
.	O
By	O
radiation	O
hybrid	O
mapping	O
,	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
DDX24	ARG2
gene1e	ARG2
gene	O
was	O
localized	O
to	O
arg1s	O
human	O
arg1e	O
chromosome	O
14q32	O
between	O
the	O
markers	O
D14S81	O
and	O
D14S265	O
.	O
Moreover	O
,	O
the	O
gene	O
structure	O
of	O
gene1s	ARG2
DDX24	ARG2
gene1e	ARG2
was	O
determined	O
by	O
comparing	O
its	O
cDNA	O
and	O
genomic	O
sequence	O
from	O
BAC	O
R-1089B7	O
,	O
which	O
showed	O
that	O
the	O
gene	O
spanned	O
a	O
30-kb	O
region	O
and	O
consisted	O
of	O
at	O
least	O
nine	O
exons	O
.	O
Copyright	O
2000	O
Academic	O
Press	O
.	O

Cloning	O
and	O
characterization	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
DDX24	O
gene1e	O
and	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
Ddx24	ARG2
gene1e	ARG2
,	O
two	O
novel	O
putative	O
DEAD	O
-	O
Box	O
proteins	O
,	O
and	O
mapping	O
gene1s	O
DDX24	O
gene1e	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
14q32	O
.	O
DEAD	O
-	O
box	O
proteins	O
are	O
a	O
large	O
group	O
of	O
putative	O
RNA	O
helicases	O
that	O
exist	O
ubiquitously	O
in	O
organisms	O
ranging	O
from	O
bacteria	O
to	O
species1s	O
humans	O
species1e	O
.	O
They	O
are	O
likely	O
to	O
play	O
important	O
roles	O
in	O
many	O
different	O
RNA	O
metabolic	O
processes	O
.	O
In	O
this	O
paper	O
,	O
we	O
report	O
the	O
cloning	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
DDX24	O
gene1e	O
,	O
a	O
putative	O
DEAD	O
-	O
box	O
protein	O
,	O
and	O
its	O
ortholog	O
,	O
gene1s	ARG2
Ddx24	ARG2
gene1e	ARG2
in	O
arg1s	O
mouse	O
arg1e	O
.	O
The	O
deduced	O
proteins	O
encoded	O
by	O
these	O
two	O
cDNAs	O
share	O
78.7	O
%	O
identity	O
at	O
the	O
amino	O
acid	O
level	O
and	O
possess	O
all	O
the	O
well	O
-	O
conserved	O
motifs	O
of	O
DEAD	O
-	O
box	O
proteins	O
.	O
However	O
,	O
little	O
homology	O
can	O
be	O
found	O
between	O
them	O
and	O
other	O
DEAD	O
-	O
box	O
proteins	O
,	O
even	O
in	O
their	O
core	O
region	O
(	O
identity	O
<	O
40	O
%	O
)	O
.	O
Northern	O
blot	O
analysis	O
showed	O
that	O
a	O
3.0-kb	O
transcript	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
DDX24	O
gene1e	O
exists	O
ubiquitously	O
in	O
the	O
16	O
species1s	O
human	O
species1e	O
tissues	O
examined	O
and	O
was	O
most	O
abundant	O
in	O
heart	O
and	O
brain	O
,	O
but	O
with	O
lowest	O
levels	O
in	O
thymus	O
and	O
small	O
intestine	O
.	O
The	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
Ddx24	ARG2
gene1e	ARG2
,	O
whose	O
transcript	O
is	O
4.0	O
kb	O
,	O
was	O
also	O
expressed	O
widely	O
in	O
10	O
tissues	O
tested	O
with	O
the	O
highest	O
level	O
in	O
heart	O
and	O
testis	O
.	O
By	O
radiation	O
hybrid	O
mapping	O
,	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
DDX24	O
gene1e	O
gene	O
was	O
localized	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
14q32	O
between	O
the	O
markers	O
D14S81	O
and	O
D14S265	O
.	O
Moreover	O
,	O
the	O
gene	O
structure	O
of	O
gene1s	O
DDX24	O
gene1e	O
was	O
determined	O
by	O
comparing	O
its	O
cDNA	O
and	O
genomic	O
sequence	O
from	O
BAC	O
R-1089B7	O
,	O
which	O
showed	O
that	O
the	O
gene	O
spanned	O
a	O
30-kb	O
region	O
and	O
consisted	O
of	O
at	O
least	O
nine	O
exons	O
.	O
Copyright	O
2000	O
Academic	O
Press	O
.	O

Cloning	O
,	O
genomic	O
organization	O
,	O
and	O
tissue	O
distribution	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
Ssf-1	ARG2
gene1e	ARG2
.	O
During	O
the	O
screening	O
of	O
a	O
arg1s	O
human	O
arg1e	O
placenta	O
cDNA	O
library	O
,	O
realized	O
in	O
order	O
to	O
isolate	O
the	O
gene1s	ARG2
P2Y(11	ARG2
)	ARG2
gene1e	ARG2
coding	O
sequence	O
,	O
an	O
unrelated	O
cDNA	O
was	O
cloned	O
.	O
We	O
identified	O
a	O
1422	O
bp	O
open	O
reading	O
frame	O
encoding	O
a	O
arg1s	O
human	O
arg1e	O
protein	O
displaying	O
40	O
%	O
amino	O
acid	O
identity	O
with	O
the	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
gene1s	O
Ssf-1	O
gene1e	O
,	O
a	O
protein	O
involved	O
in	O
the	O
second	O
step	O
of	O
mRNA	O
splicing	O
.	O
Sequencing	O
of	O
the	O
corresponding	O
genomic	O
DNA	O
showed	O
that	O
the	O
gene	O
encoding	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
Ssf-1	ARG2
gene1e	ARG2
is	O
located	O
upstream	O
to	O
the	O
gene1s	ARG2
P2Y(11	ARG2
)	ARG2
gene1e	ARG2
gene	O
on	O
chromosome	O
19p31	O
.	O
Comparison	O
of	O
the	O
cDNA	O
and	O
genomic	O
DNA	O
sequences	O
revealed	O
that	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
Ssf-1	ARG2
gene1e	ARG2
gene	O
is	O
split	O
into	O
12	O
exons	O
.	O
Northern	O
blotting	O
experiments	O
showed	O
that	O
the	O
1.7	O
kb	O
gene1s	ARG2
Ssf-1	ARG2
gene1e	ARG2
mRNA	O
presents	O
an	O
ubiquitous	O
tissue	O
expression	O
.	O
We	O
also	O
show	O
that	O
,	O
in	O
arg1s	O
HL-60	O
arg1e	O
arg1s	O
human	O
arg1e	O
promyelocytic	O
leukemia	O
cells	O
,	O
gene1s	ARG2
Ssf-1	ARG2
gene1e	ARG2
mRNA	O
is	O
rapidly	O
upregulated	O
following	O
a	O
treatment	O
by	O
gene1s	ARG2
granulocyte	ARG2
-	ARG2
colony	ARG2
stimulating	ARG2
factor	ARG2
gene1e	ARG2
and	O
dibutyryl	O
-	O
cyclicAMP	O
,	O
two	O
agents	O
known	O
to	O
induce	O
the	O
granulocytic	O
differentiation	O
of	O
these	O
cells	O
.	O
Copyright	O
2000	O
Academic	O
Press	O
.	O

Cloning	O
,	O
genomic	O
organization	O
,	O
and	O
tissue	O
distribution	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
Ssf-1	O
gene1e	O
.	O
During	O
the	O
screening	O
of	O
a	O
species1s	O
human	O
species1e	O
placenta	O
cDNA	O
library	O
,	O
realized	O
in	O
order	O
to	O
isolate	O
the	O
gene1s	O
P2Y(11	O
)	O
gene1e	O
coding	O
sequence	O
,	O
an	O
unrelated	O
cDNA	O
was	O
cloned	O
.	O
We	O
identified	O
a	O
1422	O
bp	O
open	O
reading	O
frame	O
encoding	O
a	O
species1s	O
human	O
species1e	O
protein	O
displaying	O
40	O
%	O
amino	O
acid	O
identity	O
with	O
the	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
gene1s	ARG2
Ssf-1	ARG2
gene1e	ARG2
,	O
a	O
protein	O
involved	O
in	O
the	O
second	O
step	O
of	O
mRNA	O
splicing	O
.	O
Sequencing	O
of	O
the	O
corresponding	O
genomic	O
DNA	O
showed	O
that	O
the	O
gene	O
encoding	O
species1s	O
human	O
species1e	O
gene1s	O
Ssf-1	O
gene1e	O
is	O
located	O
upstream	O
to	O
the	O
gene1s	O
P2Y(11	O
)	O
gene1e	O
gene	O
on	O
chromosome	O
19p31	O
.	O
Comparison	O
of	O
the	O
cDNA	O
and	O
genomic	O
DNA	O
sequences	O
revealed	O
that	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
Ssf-1	O
gene1e	O
gene	O
is	O
split	O
into	O
12	O
exons	O
.	O
Northern	O
blotting	O
experiments	O
showed	O
that	O
the	O
1.7	O
kb	O
gene1s	O
Ssf-1	O
gene1e	O
mRNA	O
presents	O
an	O
ubiquitous	O
tissue	O
expression	O
.	O
We	O
also	O
show	O
that	O
,	O
in	O
species1s	O
HL-60	O
species1e	O
species1s	O
human	O
species1e	O
promyelocytic	O
leukemia	O
cells	O
,	O
gene1s	O
Ssf-1	O
gene1e	O
mRNA	O
is	O
rapidly	O
upregulated	O
following	O
a	O
treatment	O
by	O
gene1s	O
granulocyte	O
-	O
colony	O
stimulating	O
factor	O
gene1e	O
and	O
dibutyryl	O
-	O
cyclicAMP	O
,	O
two	O
agents	O
known	O
to	O
induce	O
the	O
granulocytic	O
differentiation	O
of	O
these	O
cells	O
.	O
Copyright	O
2000	O
Academic	O
Press	O
.	O

Isolation	O
,	O
tissue	O
distribution	O
,	O
and	O
chromosomal	O
localization	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
activation	ARG2
-	ARG2
induced	ARG2
cytidine	ARG2
deaminase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
AID	ARG2
gene1e	ARG2
)	O
gene	O
.	O
The	O
gene	O
encoding	O
gene1s	ARG2
activation	ARG2
-	ARG2
induced	ARG2
cytidine	ARG2
deaminase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
AID	ARG2
gene1e	ARG2
)	O
,	O
a	O
member	O
of	O
the	O
cytidine	O
deaminase	O
family	O
,	O
was	O
isolated	O
from	O
a	O
species1s	O
murine	O
species1e	O
B	O
cell	O
lymphoma	O
line	O
,	O
CH12F3	O
-	O
2	O
,	O
induced	O
by	O
combined	O
stimulation	O
of	O
TGF	O
-	O
beta	O
,	O
gene1s	O
IL-4	O
gene1e	O
,	O
and	O
gene1s	O
CD40L	O
gene1e	O
.	O
We	O
have	O
isolated	O
the	O
arg1s	O
human	O
arg1e	O
orthologue	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	O
AID	O
gene1e	O
cDNA	O
,	O
which	O
has	O
an	O
open	O
reading	O
frame	O
of	O
198	O
residues	O
containing	O
a	O
conserved	O
cytidine	O
deaminase	O
motif	O
.	O
The	O
amino	O
acid	O
sequence	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
AID	ARG2
gene1e	ARG2
is	O
92	O
%	O
identical	O
to	O
that	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	O
AID	O
gene1e	O
.	O
RT	O
-	O
PCR	O
analysis	O
of	O
15	O
arg1s	O
human	O
arg1e	O
tissues	O
showed	O
that	O
gene1s	ARG2
AID	ARG2
gene1e	ARG2
mRNA	O
is	O
expressed	O
strongly	O
in	O
lymph	O
nodes	O
and	O
tonsils	O
.	O
The	O
complete	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
AID	ARG2
gene1e	ARG2
gene	O
consisting	O
of	O
five	O
exons	O
was	O
isolated	O
and	O
mapped	O
to	O
chromosome	O
12p13	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
.	O
Copyright	O
2000	O
Academic	O
Press	O
.	O

Isolation	O
,	O
tissue	O
distribution	O
,	O
and	O
chromosomal	O
localization	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
activation	O
-	O
induced	O
cytidine	O
deaminase	O
gene1e	O
(	O
gene1s	O
AID	O
gene1e	O
)	O
gene	O
.	O
The	O
gene	O
encoding	O
gene1s	O
activation	O
-	O
induced	O
cytidine	O
deaminase	O
gene1e	O
(	O
gene1s	O
AID	O
gene1e	O
)	O
,	O
a	O
member	O
of	O
the	O
cytidine	O
deaminase	O
family	O
,	O
was	O
isolated	O
from	O
a	O
arg1s	O
murine	O
arg1e	O
B	O
cell	O
lymphoma	O
line	O
,	O
CH12F3	O
-	O
2	O
,	O
induced	O
by	O
combined	O
stimulation	O
of	O
TGF	O
-	O
beta	O
,	O
gene1s	ARG2
IL-4	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
CD40L	ARG2
gene1e	ARG2
.	O
We	O
have	O
isolated	O
the	O
species1s	O
human	O
species1e	O
orthologue	O
of	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
AID	ARG2
gene1e	ARG2
cDNA	O
,	O
which	O
has	O
an	O
open	O
reading	O
frame	O
of	O
198	O
residues	O
containing	O
a	O
conserved	O
cytidine	O
deaminase	O
motif	O
.	O
The	O
amino	O
acid	O
sequence	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
AID	O
gene1e	O
is	O
92	O
%	O
identical	O
to	O
that	O
of	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
AID	ARG2
gene1e	ARG2
.	O
RT	O
-	O
PCR	O
analysis	O
of	O
15	O
species1s	O
human	O
species1e	O
tissues	O
showed	O
that	O
gene1s	O
AID	O
gene1e	O
mRNA	O
is	O
expressed	O
strongly	O
in	O
lymph	O
nodes	O
and	O
tonsils	O
.	O
The	O
complete	O
species1s	O
human	O
species1e	O
gene1s	O
AID	O
gene1e	O
gene	O
consisting	O
of	O
five	O
exons	O
was	O
isolated	O
and	O
mapped	O
to	O
chromosome	O
12p13	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
.	O
Copyright	O
2000	O
Academic	O
Press	O
.	O

arg1s	O
Human	O
arg1e	O
gene1s	ARG2
interleukin-10-related	ARG2
T	ARG2
cell	ARG2
-	ARG2
derived	ARG2
inducible	ARG2
factor	ARG2
gene1e	ARG2
:	O
molecular	O
cloning	O
and	O
functional	O
characterization	O
as	O
an	O
hepatocyte	O
-	O
stimulating	O
factor	O
.	O
gene1s	O
IL-10-related	O
T	O
cell	O
-	O
derived	O
inducible	O
factor	O
gene1e	O
(	O
gene1s	O
IL	O
-	O
TIF	O
gene1e	O
or	O
gene1s	O
IL-21	O
gene1e	O
)	O
is	O
a	O
new	O
cytokine	O
structurally	O
related	O
to	O
gene1s	O
IL-10	O
gene1e	O
and	O
originally	O
identified	O
in	O
the	O
species1s	O
mouse	O
species1e	O
as	O
a	O
gene	O
induced	O
by	O
gene1s	O
IL-9	O
gene1e	O
in	O
T	O
cells	O
and	O
mast	O
cells	O
.	O
Here	O
,	O
we	O
report	O
the	O
cloning	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
IL	ARG2
-	ARG2
TIF	ARG2
gene1e	ARG2
cDNA	O
,	O
which	O
shares	O
79	O
%	O
amino	O
acid	O
identity	O
with	O
species1s	O
mouse	O
species1e	O
gene1s	O
IL	O
-	O
TIF	O
gene1e	O
and	O
25	O
%	O
identity	O
with	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
IL-10	ARG2
gene1e	ARG2
.	O
Recombinant	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
IL	ARG2
-	ARG2
TIF	ARG2
gene1e	ARG2
was	O
found	O
to	O
activate	O
gene1s	ARG2
signal	ARG2
transducer	ARG2
and	ARG2
activator	ARG2
of	ARG2
transcription	ARG2
factors-1	ARG2
and	ARG2
-3	ARG2
gene1e	ARG2
in	O
several	O
hepatoma	O
cell	O
lines	O
.	O
gene1s	ARG2
IL	ARG2
-	ARG2
TIF	ARG2
gene1e	ARG2
stimulation	O
of	O
arg1s	O
HepG2	O
arg1e	O
arg1s	O
human	O
arg1e	O
hepatoma	O
cells	O
up	O
-	O
regulated	O
the	O
production	O
of	O
acute	O
phase	O
reactants	O
such	O
as	O
serum	O
amyloid	O
A	O
,	O
gene1s	ARG2
alpha1-antichymotrypsin	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
haptoglobin	ARG2
gene1e	ARG2
.	O
Although	O
gene1s	ARG2
IL-10	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL	ARG2
-	ARG2
TIF	ARG2
gene1e	ARG2
have	O
distinct	O
activities	O
,	O
antibodies	O
directed	O
against	O
the	O
gene1s	ARG2
beta	ARG2
chain	ARG2
of	ARG2
the	ARG2
IL-10	ARG2
receptor	ARG2
gene1e	ARG2
blocked	O
the	O
induction	O
of	O
acute	O
phase	O
reactants	O
by	O
gene1s	ARG2
IL	ARG2
-	ARG2
TIF	ARG2
gene1e	ARG2
,	O
indicating	O
that	O
this	O
chain	O
is	O
a	O
common	O
component	O
of	O
the	O
gene1s	ARG2
IL-10	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL	ARG2
-	ARG2
TIF	ARG2
gene1e	ARG2
receptors	O
.	O
Similar	O
acute	O
phase	O
reactant	O
induction	O
was	O
observed	O
in	O
species1s	O
mouse	O
species1e	O
liver	O
upon	O
gene1s	O
IL	O
-	O
TIF	O
gene1e	O
injection	O
,	O
and	O
gene1s	O
IL	O
-	O
TIF	O
gene1e	O
expression	O
was	O
found	O
to	O
be	O
rapidly	O
increased	O
after	O
lipopolysaccharide	O
(	O
LPS	O
)	O
injection	O
,	O
suggesting	O
that	O
this	O
cytokine	O
contributes	O
to	O
the	O
inflammatory	O
response	O
in	O
vivo	O
.	O

species1s	O
Human	O
species1e	O
gene1s	O
interleukin-10-related	O
T	O
cell	O
-	O
derived	O
inducible	O
factor	O
gene1e	O
:	O
molecular	O
cloning	O
and	O
functional	O
characterization	O
as	O
an	O
hepatocyte	O
-	O
stimulating	O
factor	O
.	O
gene1s	ARG2
IL-10-related	ARG2
T	ARG2
cell	ARG2
-	ARG2
derived	ARG2
inducible	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IL	ARG2
-	ARG2
TIF	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
IL-21	ARG2
gene1e	ARG2
)	O
is	O
a	O
new	O
cytokine	O
structurally	O
related	O
to	O
gene1s	ARG2
IL-10	ARG2
gene1e	ARG2
and	O
originally	O
identified	O
in	O
the	O
arg1s	O
mouse	O
arg1e	O
as	O
a	O
gene	O
induced	O
by	O
gene1s	ARG2
IL-9	ARG2
gene1e	ARG2
in	O
T	O
cells	O
and	O
mast	O
cells	O
.	O
Here	O
,	O
we	O
report	O
the	O
cloning	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
IL	O
-	O
TIF	O
gene1e	O
cDNA	O
,	O
which	O
shares	O
79	O
%	O
amino	O
acid	O
identity	O
with	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
IL	ARG2
-	ARG2
TIF	ARG2
gene1e	ARG2
and	O
25	O
%	O
identity	O
with	O
species1s	O
human	O
species1e	O
gene1s	O
IL-10	O
gene1e	O
.	O
Recombinant	O
species1s	O
human	O
species1e	O
gene1s	O
IL	O
-	O
TIF	O
gene1e	O
was	O
found	O
to	O
activate	O
gene1s	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
factors-1	O
and	O
-3	O
gene1e	O
in	O
several	O
hepatoma	O
cell	O
lines	O
.	O
gene1s	O
IL	O
-	O
TIF	O
gene1e	O
stimulation	O
of	O
species1s	O
HepG2	O
species1e	O
species1s	O
human	O
species1e	O
hepatoma	O
cells	O
up	O
-	O
regulated	O
the	O
production	O
of	O
acute	O
phase	O
reactants	O
such	O
as	O
serum	O
amyloid	O
A	O
,	O
gene1s	O
alpha1-antichymotrypsin	O
gene1e	O
,	O
and	O
gene1s	O
haptoglobin	O
gene1e	O
.	O
Although	O
gene1s	O
IL-10	O
gene1e	O
and	O
gene1s	O
IL	O
-	O
TIF	O
gene1e	O
have	O
distinct	O
activities	O
,	O
antibodies	O
directed	O
against	O
the	O
gene1s	O
beta	O
chain	O
of	O
the	O
IL-10	O
receptor	O
gene1e	O
blocked	O
the	O
induction	O
of	O
acute	O
phase	O
reactants	O
by	O
gene1s	O
IL	O
-	O
TIF	O
gene1e	O
,	O
indicating	O
that	O
this	O
chain	O
is	O
a	O
common	O
component	O
of	O
the	O
gene1s	O
IL-10	O
gene1e	O
and	O
gene1s	O
IL	O
-	O
TIF	O
gene1e	O
receptors	O
.	O
Similar	O
acute	O
phase	O
reactant	O
induction	O
was	O
observed	O
in	O
arg1s	O
mouse	O
arg1e	O
liver	O
upon	O
gene1s	ARG2
IL	ARG2
-	ARG2
TIF	ARG2
gene1e	ARG2
injection	O
,	O
and	O
gene1s	ARG2
IL	ARG2
-	ARG2
TIF	ARG2
gene1e	ARG2
expression	O
was	O
found	O
to	O
be	O
rapidly	O
increased	O
after	O
lipopolysaccharide	O
(	O
LPS	O
)	O
injection	O
,	O
suggesting	O
that	O
this	O
cytokine	O
contributes	O
to	O
the	O
inflammatory	O
response	O
in	O
vivo	O
.	O

Complete	O
nucleotide	O
sequence	O
and	O
genomic	O
structure	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
NRAMP1	ARG2
gene1e	ARG2
gene	O
region	O
on	O
chromosome	O
region	O
2q35	O
.	O
Several	O
lines	O
of	O
independent	O
evidence	O
suggest	O
that	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
Natural	ARG2
Resistance	ARG2
Associated	ARG2
Macrophage	ARG2
Protein	ARG2
1	ARG2
gene1e	ARG2
gene	O
(	O
gene1s	ARG2
NRAMP1	ARG2
gene1e	ARG2
)	O
is	O
an	O
important	O
regulator	O
of	O
susceptibility	O
to	O
infectious	O
diseases	O
caused	O
by	O
certain	O
intracellular	O
pathogens	O
.	O
Here	O
,	O
we	O
report	O
the	O
nucleotide	O
sequence	O
of	O
32198	O
bp	O
of	O
genomic	O
DNA	O
overlapping	O
gene1s	ARG2
NRAMP1	ARG2
gene1e	ARG2
on	O
chromosomal	O
region	O
2q35	O
.	O
The	O
gene1s	ARG2
NRAMP1	ARG2
gene1e	ARG2
gene	O
spans	O
13604	O
bp	O
.	O
The	O
gene	O
and	O
its	O
5	O
'	O
genomic	O
region	O
are	O
highly	O
enriched	O
for	O
DNA	O
repeat	O
sequences	O
.	O
A	O
second	O
gene	O
was	O
identified	O
in	O
the	O
immediate	O
vicinity	O
of	O
gene1s	ARG2
NRAMP1	ARG2
gene1e	ARG2
and	O
was	O
tentatively	O
named	O
gene1s	ARG2
Nuclear	ARG2
LIM	ARG2
Interactor	ARG2
-	ARG2
Interacting	ARG2
Factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NLI	ARG2
-	ARG2
IF	ARG2
gene1e	ARG2
)	O
by	O
analogy	O
to	O
its	O
closest	O
ortholog	O
.	O
The	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
NLI	ARG2
-	ARG2
IF	ARG2
gene1e	ARG2
gene	O
begins	O
4721	O
bp	O
downstream	O
of	O
the	O
gene1s	ARG2
NRAMP1	ARG2
gene1e	ARG2
stop	O
codon	O
and	O
is	O
composed	O
of	O
seven	O
exons	O
varying	O
in	O
size	O
from	O
57	O
bp	O
to	O
1644	O
bp	O
.	O
The	O
gene	O
gives	O
rise	O
to	O
a	O
2655-bp	O
mRNA	O
transcript	O
that	O
contains	O
a	O
783-bp	O
open	O
reading	O
frame	O
.	O
The	O
predicted	O
molecular	O
weight	O
of	O
the	O
261-amino	O
acid	O
gene1s	ARG2
NLI	ARG2
-	ARG2
IF	ARG2
gene1e	ARG2
protein	O
is	O
29.2	O
kDa	O
.	O
Several	O
putative	O
gene	O
regulatory	O
elements	O
were	O
identified	O
in	O
the	O
5	O
'	O
upstream	O
region	O
of	O
gene1s	ARG2
NLI	ARG2
-	ARG2
IF	ARG2
gene1e	ARG2
,	O
including	O
consensus	O
binding	O
sequences	O
for	O
gene1s	ARG2
Sp1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
AP-2	ARG2
gene1e	ARG2
,	O
NF	O
-	O
kappa	O
B	O
,	O
and	O
gene1s	ARG2
PU	ARG2
1	ARG2
gene1e	ARG2
.	O
The	O
gene1s	ARG2
NLI	ARG2
-	ARG2
IF	ARG2
gene1e	ARG2
amino	O
acid	O
sequence	O
has	O
homology	O
to	O
proteins	O
that	O
have	O
a	O
high	O
degree	O
of	O
homology	O
with	O
the	O
NLI	O
-	O
interacting	O
factor	O
from	O
species1s	O
Gallus	O
gallus	O
species1e	O
and	O
are	O
found	O
in	O
divergent	O
species	O
ranging	O
from	O
species1s	O
yeast	O
species1e	O
to	O
plants	O
.	O
gene1s	ARG2
NLI	ARG2
-	ARG2
IF	ARG2
gene1e	ARG2
is	O
part	O
of	O
a	O
arg1s	O
human	O
arg1e	O
gene	O
family	O
encoding	O
four	O
related	O
proteins	O
of	O
unknown	O
function	O
.	O
Northern	O
blot	O
analysis	O
of	O
15	O
different	O
arg1s	O
human	O
arg1e	O
tissues	O
revealed	O
a	O
2.6-kb	O
gene1s	ARG2
NLI	ARG2
-	ARG2
IF	ARG2
gene1e	ARG2
mRNA	O
that	O
was	O
ubiquitously	O
expressed	O
,	O
but	O
at	O
varying	O
levels	O
.	O
A	O
second	O
transcript	O
with	O
estimated	O
size	O
of	O
7	O
kb	O
was	O
expressed	O
only	O
in	O
the	O
placenta	O
.	O
Our	O
data	O
provide	O
new	O
sequence	O
information	O
about	O
the	O
gene1s	ARG2
NRAMP1	ARG2
gene1e	ARG2
gene	O
region	O
that	O
will	O
be	O
useful	O
in	O
the	O
search	O
for	O
genetic	O
variants	O
causally	O
involved	O
in	O
altered	O
susceptibility	O
to	O
infectious	O
diseases	O
.	O

Complete	O
nucleotide	O
sequence	O
and	O
genomic	O
structure	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
NRAMP1	O
gene1e	O
gene	O
region	O
on	O
chromosome	O
region	O
2q35	O
.	O
Several	O
lines	O
of	O
independent	O
evidence	O
suggest	O
that	O
species1s	O
human	O
species1e	O
gene1s	O
Natural	O
Resistance	O
Associated	O
Macrophage	O
Protein	O
1	O
gene1e	O
gene	O
(	O
gene1s	O
NRAMP1	O
gene1e	O
)	O
is	O
an	O
important	O
regulator	O
of	O
susceptibility	O
to	O
infectious	O
diseases	O
caused	O
by	O
certain	O
intracellular	O
pathogens	O
.	O
Here	O
,	O
we	O
report	O
the	O
nucleotide	O
sequence	O
of	O
32198	O
bp	O
of	O
genomic	O
DNA	O
overlapping	O
gene1s	O
NRAMP1	O
gene1e	O
on	O
chromosomal	O
region	O
2q35	O
.	O
The	O
gene1s	O
NRAMP1	O
gene1e	O
gene	O
spans	O
13604	O
bp	O
.	O
The	O
gene	O
and	O
its	O
5	O
'	O
genomic	O
region	O
are	O
highly	O
enriched	O
for	O
DNA	O
repeat	O
sequences	O
.	O
A	O
second	O
gene	O
was	O
identified	O
in	O
the	O
immediate	O
vicinity	O
of	O
gene1s	O
NRAMP1	O
gene1e	O
and	O
was	O
tentatively	O
named	O
gene1s	O
Nuclear	O
LIM	O
Interactor	O
-	O
Interacting	O
Factor	O
gene1e	O
(	O
gene1s	O
NLI	O
-	O
IF	O
gene1e	O
)	O
by	O
analogy	O
to	O
its	O
closest	O
ortholog	O
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
NLI	O
-	O
IF	O
gene1e	O
gene	O
begins	O
4721	O
bp	O
downstream	O
of	O
the	O
gene1s	O
NRAMP1	O
gene1e	O
stop	O
codon	O
and	O
is	O
composed	O
of	O
seven	O
exons	O
varying	O
in	O
size	O
from	O
57	O
bp	O
to	O
1644	O
bp	O
.	O
The	O
gene	O
gives	O
rise	O
to	O
a	O
2655-bp	O
mRNA	O
transcript	O
that	O
contains	O
a	O
783-bp	O
open	O
reading	O
frame	O
.	O
The	O
predicted	O
molecular	O
weight	O
of	O
the	O
261-amino	O
acid	O
gene1s	O
NLI	O
-	O
IF	O
gene1e	O
protein	O
is	O
29.2	O
kDa	O
.	O
Several	O
putative	O
gene	O
regulatory	O
elements	O
were	O
identified	O
in	O
the	O
5	O
'	O
upstream	O
region	O
of	O
gene1s	O
NLI	O
-	O
IF	O
gene1e	O
,	O
including	O
consensus	O
binding	O
sequences	O
for	O
gene1s	O
Sp1	O
gene1e	O
,	O
gene1s	O
AP-2	O
gene1e	O
,	O
NF	O
-	O
kappa	O
B	O
,	O
and	O
gene1s	O
PU	O
1	O
gene1e	O
.	O
The	O
gene1s	O
NLI	O
-	O
IF	O
gene1e	O
amino	O
acid	O
sequence	O
has	O
homology	O
to	O
proteins	O
that	O
have	O
a	O
high	O
degree	O
of	O
homology	O
with	O
the	O
NLI	O
-	O
interacting	O
factor	O
from	O
arg1s	O
Gallus	O
gallus	O
arg1e	O
and	O
are	O
found	O
in	O
divergent	O
species	O
ranging	O
from	O
species1s	O
yeast	O
species1e	O
to	O
plants	O
.	O
gene1s	O
NLI	O
-	O
IF	O
gene1e	O
is	O
part	O
of	O
a	O
species1s	O
human	O
species1e	O
gene	O
family	O
encoding	O
four	O
related	O
proteins	O
of	O
unknown	O
function	O
.	O
Northern	O
blot	O
analysis	O
of	O
15	O
different	O
species1s	O
human	O
species1e	O
tissues	O
revealed	O
a	O
2.6-kb	O
gene1s	O
NLI	O
-	O
IF	O
gene1e	O
mRNA	O
that	O
was	O
ubiquitously	O
expressed	O
,	O
but	O
at	O
varying	O
levels	O
.	O
A	O
second	O
transcript	O
with	O
estimated	O
size	O
of	O
7	O
kb	O
was	O
expressed	O
only	O
in	O
the	O
placenta	O
.	O
Our	O
data	O
provide	O
new	O
sequence	O
information	O
about	O
the	O
gene1s	O
NRAMP1	O
gene1e	O
gene	O
region	O
that	O
will	O
be	O
useful	O
in	O
the	O
search	O
for	O
genetic	O
variants	O
causally	O
involved	O
in	O
altered	O
susceptibility	O
to	O
infectious	O
diseases	O
.	O

Complete	O
nucleotide	O
sequence	O
and	O
genomic	O
structure	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
NRAMP1	O
gene1e	O
gene	O
region	O
on	O
chromosome	O
region	O
2q35	O
.	O
Several	O
lines	O
of	O
independent	O
evidence	O
suggest	O
that	O
species1s	O
human	O
species1e	O
gene1s	O
Natural	O
Resistance	O
Associated	O
Macrophage	O
Protein	O
1	O
gene1e	O
gene	O
(	O
gene1s	O
NRAMP1	O
gene1e	O
)	O
is	O
an	O
important	O
regulator	O
of	O
susceptibility	O
to	O
infectious	O
diseases	O
caused	O
by	O
certain	O
intracellular	O
pathogens	O
.	O
Here	O
,	O
we	O
report	O
the	O
nucleotide	O
sequence	O
of	O
32198	O
bp	O
of	O
genomic	O
DNA	O
overlapping	O
gene1s	O
NRAMP1	O
gene1e	O
on	O
chromosomal	O
region	O
2q35	O
.	O
The	O
gene1s	O
NRAMP1	O
gene1e	O
gene	O
spans	O
13604	O
bp	O
.	O
The	O
gene	O
and	O
its	O
5	O
'	O
genomic	O
region	O
are	O
highly	O
enriched	O
for	O
DNA	O
repeat	O
sequences	O
.	O
A	O
second	O
gene	O
was	O
identified	O
in	O
the	O
immediate	O
vicinity	O
of	O
gene1s	O
NRAMP1	O
gene1e	O
and	O
was	O
tentatively	O
named	O
gene1s	O
Nuclear	O
LIM	O
Interactor	O
-	O
Interacting	O
Factor	O
gene1e	O
(	O
gene1s	O
NLI	O
-	O
IF	O
gene1e	O
)	O
by	O
analogy	O
to	O
its	O
closest	O
ortholog	O
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
NLI	O
-	O
IF	O
gene1e	O
gene	O
begins	O
4721	O
bp	O
downstream	O
of	O
the	O
gene1s	O
NRAMP1	O
gene1e	O
stop	O
codon	O
and	O
is	O
composed	O
of	O
seven	O
exons	O
varying	O
in	O
size	O
from	O
57	O
bp	O
to	O
1644	O
bp	O
.	O
The	O
gene	O
gives	O
rise	O
to	O
a	O
2655-bp	O
mRNA	O
transcript	O
that	O
contains	O
a	O
783-bp	O
open	O
reading	O
frame	O
.	O
The	O
predicted	O
molecular	O
weight	O
of	O
the	O
261-amino	O
acid	O
gene1s	O
NLI	O
-	O
IF	O
gene1e	O
protein	O
is	O
29.2	O
kDa	O
.	O
Several	O
putative	O
gene	O
regulatory	O
elements	O
were	O
identified	O
in	O
the	O
5	O
'	O
upstream	O
region	O
of	O
gene1s	O
NLI	O
-	O
IF	O
gene1e	O
,	O
including	O
consensus	O
binding	O
sequences	O
for	O
gene1s	O
Sp1	O
gene1e	O
,	O
gene1s	O
AP-2	O
gene1e	O
,	O
NF	O
-	O
kappa	O
B	O
,	O
and	O
gene1s	O
PU	O
1	O
gene1e	O
.	O
The	O
gene1s	O
NLI	O
-	O
IF	O
gene1e	O
amino	O
acid	O
sequence	O
has	O
homology	O
to	O
proteins	O
that	O
have	O
a	O
high	O
degree	O
of	O
homology	O
with	O
the	O
NLI	O
-	O
interacting	O
factor	O
from	O
species1s	O
Gallus	O
gallus	O
species1e	O
and	O
are	O
found	O
in	O
divergent	O
species	O
ranging	O
from	O
arg1s	O
yeast	O
arg1e	O
to	O
plants	O
.	O
gene1s	O
NLI	O
-	O
IF	O
gene1e	O
is	O
part	O
of	O
a	O
species1s	O
human	O
species1e	O
gene	O
family	O
encoding	O
four	O
related	O
proteins	O
of	O
unknown	O
function	O
.	O
Northern	O
blot	O
analysis	O
of	O
15	O
different	O
species1s	O
human	O
species1e	O
tissues	O
revealed	O
a	O
2.6-kb	O
gene1s	O
NLI	O
-	O
IF	O
gene1e	O
mRNA	O
that	O
was	O
ubiquitously	O
expressed	O
,	O
but	O
at	O
varying	O
levels	O
.	O
A	O
second	O
transcript	O
with	O
estimated	O
size	O
of	O
7	O
kb	O
was	O
expressed	O
only	O
in	O
the	O
placenta	O
.	O
Our	O
data	O
provide	O
new	O
sequence	O
information	O
about	O
the	O
gene1s	O
NRAMP1	O
gene1e	O
gene	O
region	O
that	O
will	O
be	O
useful	O
in	O
the	O
search	O
for	O
genetic	O
variants	O
causally	O
involved	O
in	O
altered	O
susceptibility	O
to	O
infectious	O
diseases	O
.	O

The	O
gene1s	O
WFDC1	O
gene1e	O
gene	O
encoding	O
gene1s	O
ps20	O
gene1e	O
localizes	O
to	O
16q24	O
,	O
a	O
region	O
of	O
LOH	O
in	O
multiple	O
cancers	O
.	O
We	O
previously	O
identified	O
gene1s	ARG2
ps20	ARG2
gene1e	ARG2
protein	O
as	O
a	O
secreted	O
growth	O
inhibitor	O
and	O
purified	O
the	O
protein	O
from	O
fetal	O
arg1s	O
rat	O
arg1e	O
prostate	O
urogenital	O
sinus	O
mesenchymal	O
cell	O
conditioned	O
medium	O
.	O
The	O
arg1s	O
rat	O
arg1e	O
cDNA	O
was	O
subsequently	O
cloned	O
,	O
and	O
gene1s	ARG2
ps20	ARG2
gene1e	ARG2
was	O
found	O
to	O
contain	O
a	O
WAP	O
-	O
type	O
four	O
-	O
disulfide	O
core	O
motif	O
,	O
indicating	O
it	O
may	O
function	O
as	O
a	O
protease	O
inhibitor	O
.	O
We	O
now	O
report	O
cloning	O
and	O
characterization	O
of	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
ps20	O
gene1e	O
gene	O
(	O
designated	O
gene1s	O
Wfdc1	O
gene1e	O
)	O
,	O
the	O
species1s	O
human	O
species1e	O
homolog	O
cDNA	O
,	O
and	O
the	O
species1s	O
human	O
species1e	O
gene	O
(	O
designated	O
gene1s	O
WFDC1	O
gene1e	O
)	O
.	O
Both	O
the	O
species1s	O
mouse	O
species1e	O
and	O
species1s	O
human	O
species1e	O
gene1s	O
WFDC1	O
gene1e	O
genes	O
consist	O
of	O
seven	O
exons	O
and	O
encode	O
respective	O
gene1s	O
ps20	O
gene1e	O
proteins	O
sharing	O
79.1	O
%	O
identity	O
and	O
nearly	O
identical	O
WAP	O
motifs	O
in	O
exon	O
2	O
.	O
The	O
gene1s	O
WFDC1	O
gene1e	O
gene	O
was	O
mapped	O
by	O
FISH	O
analysis	O
to	O
species1s	O
human	O
species1e	O
Chromosome	O
(	O
Chr	O
)	O
16q24	O
,	O
an	O
area	O
of	O
frequent	O
loss	O
of	O
heterozygosity	O
(	O
LOH	O
)	O
previously	O
identified	O
in	O
multiple	O
cancers	O
including	O
prostate	O
,	O
breast	O
,	O
hepatocellular	O
,	O
and	O
Wilms	O
'	O
tumor	O
.	O
Identification	O
and	O
characterization	O
of	O
the	O
gene1s	O
WFDC1	O
gene1e	O
gene	O
may	O
aid	O
in	O
better	O
understanding	O
the	O
potential	O
role	O
of	O
this	O
gene	O
and	O
gene1s	O
ps20	O
gene1e	O
in	O
prostate	O
biology	O
and	O
carcinogenesis	O
.	O

The	O
gene1s	O
WFDC1	O
gene1e	O
gene	O
encoding	O
gene1s	O
ps20	O
gene1e	O
localizes	O
to	O
16q24	O
,	O
a	O
region	O
of	O
LOH	O
in	O
multiple	O
cancers	O
.	O
We	O
previously	O
identified	O
gene1s	O
ps20	O
gene1e	O
protein	O
as	O
a	O
secreted	O
growth	O
inhibitor	O
and	O
purified	O
the	O
protein	O
from	O
fetal	O
species1s	O
rat	O
species1e	O
prostate	O
urogenital	O
sinus	O
mesenchymal	O
cell	O
conditioned	O
medium	O
.	O
The	O
species1s	O
rat	O
species1e	O
cDNA	O
was	O
subsequently	O
cloned	O
,	O
and	O
gene1s	O
ps20	O
gene1e	O
was	O
found	O
to	O
contain	O
a	O
WAP	O
-	O
type	O
four	O
-	O
disulfide	O
core	O
motif	O
,	O
indicating	O
it	O
may	O
function	O
as	O
a	O
protease	O
inhibitor	O
.	O
We	O
now	O
report	O
cloning	O
and	O
characterization	O
of	O
the	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
ps20	ARG2
gene1e	ARG2
gene	O
(	O
designated	O
gene1s	ARG2
Wfdc1	ARG2
gene1e	ARG2
)	O
,	O
the	O
species1s	O
human	O
species1e	O
homolog	O
cDNA	O
,	O
and	O
the	O
species1s	O
human	O
species1e	O
gene	O
(	O
designated	O
gene1s	O
WFDC1	O
gene1e	O
)	O
.	O
Both	O
the	O
arg1s	O
mouse	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
gene1s	ARG2
WFDC1	ARG2
gene1e	ARG2
genes	O
consist	O
of	O
seven	O
exons	O
and	O
encode	O
respective	O
gene1s	O
ps20	O
gene1e	O
proteins	O
sharing	O
79.1	O
%	O
identity	O
and	O
nearly	O
identical	O
WAP	O
motifs	O
in	O
exon	O
2	O
.	O
The	O
gene1s	O
WFDC1	O
gene1e	O
gene	O
was	O
mapped	O
by	O
FISH	O
analysis	O
to	O
species1s	O
human	O
species1e	O
Chromosome	O
(	O
Chr	O
)	O
16q24	O
,	O
an	O
area	O
of	O
frequent	O
loss	O
of	O
heterozygosity	O
(	O
LOH	O
)	O
previously	O
identified	O
in	O
multiple	O
cancers	O
including	O
prostate	O
,	O
breast	O
,	O
hepatocellular	O
,	O
and	O
Wilms	O
'	O
tumor	O
.	O
Identification	O
and	O
characterization	O
of	O
the	O
gene1s	O
WFDC1	O
gene1e	O
gene	O
may	O
aid	O
in	O
better	O
understanding	O
the	O
potential	O
role	O
of	O
this	O
gene	O
and	O
gene1s	O
ps20	O
gene1e	O
in	O
prostate	O
biology	O
and	O
carcinogenesis	O
.	O

The	O
gene1s	ARG2
WFDC1	ARG2
gene1e	ARG2
gene	O
encoding	O
gene1s	ARG2
ps20	ARG2
gene1e	ARG2
localizes	O
to	O
16q24	O
,	O
a	O
region	O
of	O
LOH	O
in	O
multiple	O
cancers	O
.	O
We	O
previously	O
identified	O
gene1s	O
ps20	O
gene1e	O
protein	O
as	O
a	O
secreted	O
growth	O
inhibitor	O
and	O
purified	O
the	O
protein	O
from	O
fetal	O
species1s	O
rat	O
species1e	O
prostate	O
urogenital	O
sinus	O
mesenchymal	O
cell	O
conditioned	O
medium	O
.	O
The	O
species1s	O
rat	O
species1e	O
cDNA	O
was	O
subsequently	O
cloned	O
,	O
and	O
gene1s	O
ps20	O
gene1e	O
was	O
found	O
to	O
contain	O
a	O
WAP	O
-	O
type	O
four	O
-	O
disulfide	O
core	O
motif	O
,	O
indicating	O
it	O
may	O
function	O
as	O
a	O
protease	O
inhibitor	O
.	O
We	O
now	O
report	O
cloning	O
and	O
characterization	O
of	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
ps20	O
gene1e	O
gene	O
(	O
designated	O
gene1s	O
Wfdc1	O
gene1e	O
)	O
,	O
the	O
arg1s	O
human	O
arg1e	O
homolog	O
cDNA	O
,	O
and	O
the	O
arg1s	O
human	O
arg1e	O
gene	O
(	O
designated	O
gene1s	ARG2
WFDC1	ARG2
gene1e	ARG2
)	O
.	O
Both	O
the	O
species1s	O
mouse	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
WFDC1	ARG2
gene1e	ARG2
genes	O
consist	O
of	O
seven	O
exons	O
and	O
encode	O
respective	O
gene1s	ARG2
ps20	ARG2
gene1e	ARG2
proteins	O
sharing	O
79.1	O
%	O
identity	O
and	O
nearly	O
identical	O
WAP	O
motifs	O
in	O
exon	O
2	O
.	O
The	O
gene1s	ARG2
WFDC1	ARG2
gene1e	ARG2
gene	O
was	O
mapped	O
by	O
FISH	O
analysis	O
to	O
arg1s	O
human	O
arg1e	O
Chromosome	O
(	O
Chr	O
)	O
16q24	O
,	O
an	O
area	O
of	O
frequent	O
loss	O
of	O
heterozygosity	O
(	O
LOH	O
)	O
previously	O
identified	O
in	O
multiple	O
cancers	O
including	O
prostate	O
,	O
breast	O
,	O
hepatocellular	O
,	O
and	O
Wilms	O
'	O
tumor	O
.	O
Identification	O
and	O
characterization	O
of	O
the	O
gene1s	ARG2
WFDC1	ARG2
gene1e	ARG2
gene	O
may	O
aid	O
in	O
better	O
understanding	O
the	O
potential	O
role	O
of	O
this	O
gene	O
and	O
gene1s	ARG2
ps20	ARG2
gene1e	ARG2
in	O
prostate	O
biology	O
and	O
carcinogenesis	O
.	O

Retrovirally	O
mediated	O
complementation	O
of	O
the	O
glyB	O
phenotype	O
.	O
Cloning	O
of	O
a	O
arg1s	O
human	O
arg1e	O
gene	O
encoding	O
the	O
carrier	O
for	O
entry	O
of	O
folates	O
into	O
mitochondria	O
.	O
The	O
transduction	O
of	O
a	O
arg1s	O
human	O
arg1e	O
placental	O
cDNA	O
retroviral	O
library	O
into	O
glyB	O
cells	O
,	O
a	O
species1s	O
Chinese	O
hamster	O
species1e	O
ovary	O
K1	O
subline	O
that	O
is	O
deficient	O
in	O
the	O
transport	O
of	O
folates	O
into	O
mitochondria	O
,	O
resulted	O
in	O
the	O
complementation	O
of	O
glycine	O
auxotrophy	O
of	O
these	O
cells	O
.	O
A	O
2.6-kilobase	O
pair	O
cDNA	O
insert	O
flanked	O
by	O
retroviral	O
sequences	O
had	O
integrated	O
into	O
genomic	O
DNA	O
in	O
rescued	O
cells	O
.	O
An	O
open	O
reading	O
frame	O
in	O
this	O
cDNA	O
encoded	O
a	O
35-kDa	O
protein	O
homologous	O
to	O
several	O
inner	O
mitochondrial	O
wall	O
transporters	O
for	O
intermediate	O
metabolites	O
.	O
The	O
subcloned	O
cDNA	O
complemented	O
the	O
glycine	O
auxotrophy	O
of	O
glyB	O
cells	O
and	O
reinstated	O
folate	O
accumulation	O
in	O
the	O
mitochondria	O
of	O
transfected	O
cells	O
.	O
The	O
arg1s	O
human	O
arg1e	O
origin	O
,	O
chromosomal	O
location	O
,	O
and	O
intron	O
-	O
exon	O
organization	O
of	O
the	O
isolated	O
mitochondrial	O
folate	O
transporter	O
gene	O
were	O
deduced	O
from	O
the	O
expressed	O
sequence	O
tag	O
database	O
and	O
arg1s	O
human	O
arg1e	O
genome	O
project	O
data	O
.	O

Retrovirally	O
mediated	O
complementation	O
of	O
the	O
glyB	O
phenotype	O
.	O
Cloning	O
of	O
a	O
species1s	O
human	O
species1e	O
gene	O
encoding	O
the	O
carrier	O
for	O
entry	O
of	O
folates	O
into	O
mitochondria	O
.	O
The	O
transduction	O
of	O
a	O
species1s	O
human	O
species1e	O
placental	O
cDNA	O
retroviral	O
library	O
into	O
glyB	O
cells	O
,	O
a	O
arg1s	O
Chinese	O
hamster	O
arg1e	O
ovary	O
K1	O
subline	O
that	O
is	O
deficient	O
in	O
the	O
transport	O
of	O
folates	O
into	O
mitochondria	O
,	O
resulted	O
in	O
the	O
complementation	O
of	O
glycine	O
auxotrophy	O
of	O
these	O
cells	O
.	O
A	O
2.6-kilobase	O
pair	O
cDNA	O
insert	O
flanked	O
by	O
retroviral	O
sequences	O
had	O
integrated	O
into	O
genomic	O
DNA	O
in	O
rescued	O
cells	O
.	O
An	O
open	O
reading	O
frame	O
in	O
this	O
cDNA	O
encoded	O
a	O
35-kDa	O
protein	O
homologous	O
to	O
several	O
inner	O
mitochondrial	O
wall	O
transporters	O
for	O
intermediate	O
metabolites	O
.	O
The	O
subcloned	O
cDNA	O
complemented	O
the	O
glycine	O
auxotrophy	O
of	O
glyB	O
cells	O
and	O
reinstated	O
folate	O
accumulation	O
in	O
the	O
mitochondria	O
of	O
transfected	O
cells	O
.	O
The	O
species1s	O
human	O
species1e	O
origin	O
,	O
chromosomal	O
location	O
,	O
and	O
intron	O
-	O
exon	O
organization	O
of	O
the	O
isolated	O
mitochondrial	O
folate	O
transporter	O
gene	O
were	O
deduced	O
from	O
the	O
expressed	O
sequence	O
tag	O
database	O
and	O
species1s	O
human	O
species1e	O
genome	O
project	O
data	O
.	O

The	O
orthologous	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
murine	O
species1e	O
semaphorin	O
6A-1	O
proteins	O
(	O
gene1s	ARG2
SEMA6A-1	ARG2
gene1e	ARG2
/	O
gene1s	O
Sema6A-1	O
gene1e	O
)	O
bind	O
to	O
the	O
gene1s	ARG2
enabled	ARG2
/	ARG2
vasodilator	ARG2
-	ARG2
stimulated	ARG2
phosphoprotein	ARG2
-	ARG2
like	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
EVL	ARG2
gene1e	ARG2
)	O
via	O
a	O
novel	O
carboxyl	O
-	O
terminal	O
zyxin	O
-	O
like	O
domain	O
.	O
Neuronal	O
development	O
and	O
apoptosis	O
critically	O
depend	O
on	O
the	O
transformation	O
of	O
extracellular	O
signals	O
to	O
intracellular	O
actions	O
resulting	O
in	O
cytoskeletal	O
rearrangements	O
.	O
Ena	O
/	O
VASP	O
(	O
enabled	O
/	O
vasodilator	O
-	O
stimulated	O
phosphoprotein	O
)	O
proteins	O
play	O
an	O
important	O
role	O
in	O
actin	O
and	O
filament	O
dynamics	O
,	O
whereas	O
members	O
of	O
the	O
semaphorin	O
protein	O
family	O
are	O
guidance	O
signals	O
in	O
embryo-	O
and	O
organogenesis	O
.	O
Here	O
,	O
we	O
report	O
the	O
identification	O
of	O
two	O
novel	O
transmembranous	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
murine	O
species1e	O
semaphorins	O
,	O
(	O
HSA)	O
gene1s	ARG2
SEMA6A-1	ARG2
gene1e	ARG2
and	O
(	O
MMU)	O
gene1s	O
Sema6A-1	O
gene1e	O
.	O
These	O
semaphorin	O
6	O
variants	O
directly	O
link	O
the	O
Ena	O
/	O
VASP	O
and	O
the	O
semaphorin	O
protein	O
family	O
,	O
since	O
gene1s	ARG2
SEMA6A-1	ARG2
gene1e	ARG2
/	O
gene1s	O
Sema6A-1	O
gene1e	O
is	O
capable	O
of	O
a	O
selective	O
binding	O
to	O
the	O
protein	O
gene1s	ARG2
EVL	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Ena	ARG2
/	ARG2
VASP	ARG2
-	ARG2
like	ARG2
protein	ARG2
gene1e	ARG2
)	O
.	O
gene1s	ARG2
EVL	ARG2
gene1e	ARG2
is	O
the	O
third	O
member	O
of	O
the	O
Ena	O
/	O
VASP	O
family	O
of	O
proteins	O
that	O
was	O
identified	O
sharing	O
the	O
same	O
structural	O
features	O
as	O
gene1s	ARG2
Mena	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
mammalian	ARG2
enabled	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
VASP	ARG2
gene1e	ARG2
,	O
although	O
its	O
functionality	O
seems	O
to	O
be	O
different	O
from	O
that	O
of	O
the	O
other	O
members	O
.	O
Here	O
we	O
demonstrate	O
that	O
gene1s	ARG2
SEMA6A-1	ARG2
gene1e	ARG2
/	O
gene1s	O
Sema6A-1	O
gene1e	O
is	O
colocalized	O
with	O
gene1s	ARG2
EVL	ARG2
gene1e	ARG2
via	O
its	O
zyxin	O
-	O
like	O
carboxyl	O
-	O
terminal	O
domain	O
that	O
contains	O
a	O
modified	O
binding	O
motif	O
,	O
which	O
further	O
stresses	O
the	O
existence	O
of	O
functional	O
differences	O
between	O
gene1s	ARG2
EVL	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Mena	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
VASP	ARG2
gene1e	ARG2
.	O
In	O
addition	O
these	O
findings	O
suggest	O
a	O
completely	O
new	O
role	O
for	O
transmembranous	O
semaphorins	O
such	O
as	O
gene1s	ARG2
SEMA6A-1	ARG2
gene1e	ARG2
/	O
gene1s	O
Sema6A-1	O
gene1e	O
in	O
retrograde	O
signaling	O
.	O

The	O
orthologous	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
murine	O
arg1e	O
semaphorin	O
6A-1	O
proteins	O
(	O
gene1s	O
SEMA6A-1	O
gene1e	O
/	O
gene1s	ARG2
Sema6A-1	ARG2
gene1e	ARG2
)	O
bind	O
to	O
the	O
gene1s	O
enabled	O
/	O
vasodilator	O
-	O
stimulated	O
phosphoprotein	O
-	O
like	O
protein	O
gene1e	O
(	O
gene1s	ARG2
EVL	ARG2
gene1e	ARG2
)	O
via	O
a	O
novel	O
carboxyl	O
-	O
terminal	O
zyxin	O
-	O
like	O
domain	O
.	O
Neuronal	O
development	O
and	O
apoptosis	O
critically	O
depend	O
on	O
the	O
transformation	O
of	O
extracellular	O
signals	O
to	O
intracellular	O
actions	O
resulting	O
in	O
cytoskeletal	O
rearrangements	O
.	O
Ena	O
/	O
VASP	O
(	O
enabled	O
/	O
vasodilator	O
-	O
stimulated	O
phosphoprotein	O
)	O
proteins	O
play	O
an	O
important	O
role	O
in	O
actin	O
and	O
filament	O
dynamics	O
,	O
whereas	O
members	O
of	O
the	O
semaphorin	O
protein	O
family	O
are	O
guidance	O
signals	O
in	O
embryo-	O
and	O
organogenesis	O
.	O
Here	O
,	O
we	O
report	O
the	O
identification	O
of	O
two	O
novel	O
transmembranous	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
murine	O
arg1e	O
semaphorins	O
,	O
(	O
HSA)	O
gene1s	O
SEMA6A-1	O
gene1e	O
and	O
(	O
MMU)	O
gene1s	ARG2
Sema6A-1	ARG2
gene1e	ARG2
.	O
These	O
semaphorin	O
6	O
variants	O
directly	O
link	O
the	O
Ena	O
/	O
VASP	O
and	O
the	O
semaphorin	O
protein	O
family	O
,	O
since	O
gene1s	O
SEMA6A-1	O
gene1e	O
/	O
gene1s	ARG2
Sema6A-1	ARG2
gene1e	ARG2
is	O
capable	O
of	O
a	O
selective	O
binding	O
to	O
the	O
protein	O
gene1s	O
EVL	O
gene1e	O
(	O
gene1s	O
Ena	O
/	O
VASP	O
-	O
like	O
protein	O
gene1e	O
)	O
.	O
gene1s	O
EVL	O
gene1e	O
is	O
the	O
third	O
member	O
of	O
the	O
Ena	O
/	O
VASP	O
family	O
of	O
proteins	O
that	O
was	O
identified	O
sharing	O
the	O
same	O
structural	O
features	O
as	O
gene1s	O
Mena	O
gene1e	O
(	O
gene1s	O
mammalian	O
enabled	O
gene1e	O
)	O
and	O
gene1s	O
VASP	O
gene1e	O
,	O
although	O
its	O
functionality	O
seems	O
to	O
be	O
different	O
from	O
that	O
of	O
the	O
other	O
members	O
.	O
Here	O
we	O
demonstrate	O
that	O
gene1s	O
SEMA6A-1	O
gene1e	O
/	O
gene1s	ARG2
Sema6A-1	ARG2
gene1e	ARG2
is	O
colocalized	O
with	O
gene1s	O
EVL	O
gene1e	O
via	O
its	O
zyxin	O
-	O
like	O
carboxyl	O
-	O
terminal	O
domain	O
that	O
contains	O
a	O
modified	O
binding	O
motif	O
,	O
which	O
further	O
stresses	O
the	O
existence	O
of	O
functional	O
differences	O
between	O
gene1s	O
EVL	O
gene1e	O
and	O
gene1s	O
Mena	O
gene1e	O
/	O
gene1s	O
VASP	O
gene1e	O
.	O
In	O
addition	O
these	O
findings	O
suggest	O
a	O
completely	O
new	O
role	O
for	O
transmembranous	O
semaphorins	O
such	O
as	O
gene1s	O
SEMA6A-1	O
gene1e	O
/	O
gene1s	ARG2
Sema6A-1	ARG2
gene1e	ARG2
in	O
retrograde	O
signaling	O
.	O

gene1s	O
Activation	O
-	O
induced	O
cytidine	O
deaminase	O
gene1e	O
(	O
gene1s	O
AID	O
gene1e	O
)	O
deficiency	O
causes	O
the	O
autosomal	O
recessive	O
form	O
of	O
the	O
Hyper	O
-	O
IgM	O
syndrome	O
(	O
HIGM2	O
)	O
.	O
The	O
gene1s	ARG2
activation	ARG2
-	ARG2
induced	ARG2
cytidine	ARG2
deaminase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
AID	ARG2
gene1e	ARG2
)	O
gene	O
,	O
specifically	O
expressed	O
in	O
germinal	O
center	O
B	O
cells	O
in	O
arg1s	O
mice	O
arg1e	O
,	O
is	O
a	O
member	O
of	O
the	O
cytidine	O
deaminase	O
family	O
.	O
We	O
herein	O
report	O
mutations	O
in	O
the	O
species1s	O
human	O
species1e	O
counterpart	O
of	O
gene1s	O
AID	O
gene1e	O
in	O
species1s	O
patients	O
species1e	O
with	O
the	O
autosomal	O
recessive	O
form	O
of	O
hyper	O
-	O
IgM	O
syndrome	O
(	O
HIGM2	O
)	O
.	O
Three	O
major	O
abnormalities	O
characterize	O
gene1s	O
AID	O
gene1e	O
deficiency	O
:	O
(	O
1	O
)	O
the	O
absence	O
of	O
immunoglobulin	O
class	O
switch	O
recombination	O
,	O
(	O
2	O
)	O
the	O
lack	O
of	O
immunoglobulin	O
somatic	O
hypermutations	O
,	O
and	O
(	O
3	O
)	O
lymph	O
node	O
hyperplasia	O
caused	O
by	O
the	O
presence	O
of	O
giant	O
germinal	O
centers	O
.	O
The	O
phenotype	O
observed	O
in	O
HIGM2	O
species1s	O
patients	O
species1e	O
(	O
and	O
in	O
gene1s	ARG2
AID	ARG2
gene1e	ARG2
-/-	O
arg1s	O
mice	O
arg1e	O
)	O
demonstrates	O
the	O
absolute	O
requirement	O
for	O
gene1s	O
AID	O
gene1e	O
in	O
several	O
crucial	O
steps	O
of	O
B	O
cell	O
terminal	O
differentiation	O
necessary	O
for	O
efficient	O
antibody	O
responses	O
.	O

gene1s	ARG2
Activation	ARG2
-	ARG2
induced	ARG2
cytidine	ARG2
deaminase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
AID	ARG2
gene1e	ARG2
)	O
deficiency	O
causes	O
the	O
autosomal	O
recessive	O
form	O
of	O
the	O
Hyper	O
-	O
IgM	O
syndrome	O
(	O
HIGM2	O
)	O
.	O
The	O
gene1s	O
activation	O
-	O
induced	O
cytidine	O
deaminase	O
gene1e	O
(	O
gene1s	O
AID	O
gene1e	O
)	O
gene	O
,	O
specifically	O
expressed	O
in	O
germinal	O
center	O
B	O
cells	O
in	O
species1s	O
mice	O
species1e	O
,	O
is	O
a	O
member	O
of	O
the	O
cytidine	O
deaminase	O
family	O
.	O
We	O
herein	O
report	O
mutations	O
in	O
the	O
arg1s	O
human	O
arg1e	O
counterpart	O
of	O
gene1s	ARG2
AID	ARG2
gene1e	ARG2
in	O
arg1s	O
patients	O
arg1e	O
with	O
the	O
autosomal	O
recessive	O
form	O
of	O
hyper	O
-	O
IgM	O
syndrome	O
(	O
HIGM2	O
)	O
.	O
Three	O
major	O
abnormalities	O
characterize	O
gene1s	ARG2
AID	ARG2
gene1e	ARG2
deficiency	O
:	O
(	O
1	O
)	O
the	O
absence	O
of	O
immunoglobulin	O
class	O
switch	O
recombination	O
,	O
(	O
2	O
)	O
the	O
lack	O
of	O
immunoglobulin	O
somatic	O
hypermutations	O
,	O
and	O
(	O
3	O
)	O
lymph	O
node	O
hyperplasia	O
caused	O
by	O
the	O
presence	O
of	O
giant	O
germinal	O
centers	O
.	O
The	O
phenotype	O
observed	O
in	O
HIGM2	O
arg1s	O
patients	O
arg1e	O
(	O
and	O
in	O
gene1s	O
AID	O
gene1e	O
-/-	O
species1s	O
mice	O
species1e	O
)	O
demonstrates	O
the	O
absolute	O
requirement	O
for	O
gene1s	ARG2
AID	ARG2
gene1e	ARG2
in	O
several	O
crucial	O
steps	O
of	O
B	O
cell	O
terminal	O
differentiation	O
necessary	O
for	O
efficient	O
antibody	O
responses	O
.	O

Molecular	O
cloning	O
of	O
a	O
arg1s	O
human	O
arg1e	O
,	O
hemicholinium-3-sensitive	O
choline	O
transporter	O
.	O
Under	O
many	O
physiological	O
circumstances	O
,	O
Na(+)-	O
and	O
Cl(-)-dependent	O
,	O
hemicholinium-3	O
(	O
HC-3)-sensitive	O
,	O
high	O
-	O
affinity	O
choline	O
uptake	O
(	O
HACU	O
)	O
in	O
cholinergic	O
neurons	O
is	O
thought	O
to	O
be	O
rate	O
-	O
limiting	O
in	O
the	O
biosynthesis	O
of	O
acetylcholine	O
(	O
ACh	O
)	O
.	O
Based	O
on	O
sequence	O
information	O
provided	O
by	O
the	O
arg1s	O
Human	O
arg1e	O
Genome	O
Project	O
and	O
the	O
recently	O
reported	O
species1s	O
rat	O
species1e	O
gene1s	O
CHT1	O
gene1e	O
(	O
gene1s	O
rCHT1	O
gene1e	O
)	O
,	O
we	O
cloned	O
a	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
CHT	ARG2
gene1e	ARG2
cDNA	O
from	O
spinal	O
cord	O
.	O
The	O
gene1s	ARG2
hCHT	ARG2
gene1e	ARG2
cDNA	O
encodes	O
a	O
protein	O
of	O
580	O
amino	O
acids	O
having	O
93	O
%	O
identity	O
to	O
gene1s	O
rCHT1	O
gene1e	O
and	O
51	O
%	O
identity	O
to	O
the	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
homolog	O
gene1s	O
CHO-1	O
gene1e	O
,	O
and	O
is	O
distantly	O
related	O
to	O
members	O
of	O
the	O
Na(+)-coupled	O
glucose	O
transporter	O
(	O
SGLT	O
)	O
gene	O
family	O
of	O
Na(+)-coupled	O
glucose	O
(	O
SGLT	O
)	O
,	O
nucleoside	O
and	O
iodide	O
transporters	O
.	O
Northern	O
blot	O
analysis	O
reveals	O
the	O
expression	O
of	O
a	O
approximately	O
5	O
kb	O
transcript	O
in	O
arg1s	O
human	O
arg1e	O
brain	O
regions	O
rich	O
in	O
cholinergic	O
neurons	O
including	O
the	O
putamen	O
,	O
spinal	O
cord	O
,	O
and	O
medulla	O
.	O
Expression	O
of	O
gene1s	ARG2
hCHT	ARG2
gene1e	ARG2
cDNA	O
in	O
species1s	O
COS-7	O
species1e	O
cells	O
results	O
in	O
saturable	O
,	O
Na(+)/Cl(-)-dependent	O
choline	O
uptake	O
(	O
K(m	O
)	O
=	O
1.2	O
microM	O
)	O
in	O
membrane	O
vesicles	O
and	O
HC-3	O
binding	O
(	O
K(d	O
)	O
=	O
4	O
nM	O
)	O
in	O
membrane	O
fractions	O
,	O
consistent	O
with	O
characteristics	O
reported	O
in	O
arg1s	O
mammalian	O
arg1e	O
cholinergic	O
neurons	O
.	O
Using	O
radiation	O
hybrid	O
mapping	O
techniques	O
,	O
we	O
localized	O
the	O
gene1s	ARG2
hCHT	ARG2
gene1e	ARG2
gene	O
to	O
arg1s	O
human	O
arg1e	O
chromosome	O
2q12	O
.	O
These	O
studies	O
elucidate	O
the	O
primary	O
structure	O
and	O
chromosomal	O
localization	O
of	O
gene1s	ARG2
hCHT	ARG2
gene1e	ARG2
and	O
provide	O
a	O
basis	O
for	O
mechanistic	O
analysis	O
of	O
HACU	O
regulation	O
and	O
an	O
investigation	O
of	O
the	O
role	O
of	O
gene1s	ARG2
hCHT	ARG2
gene1e	ARG2
in	O
disease	O
states	O
.	O
Copyright	O
2000	O
Academic	O
Press	O
.	O

Molecular	O
cloning	O
of	O
a	O
species1s	O
human	O
species1e	O
,	O
hemicholinium-3-sensitive	O
choline	O
transporter	O
.	O
Under	O
many	O
physiological	O
circumstances	O
,	O
Na(+)-	O
and	O
Cl(-)-dependent	O
,	O
hemicholinium-3	O
(	O
HC-3)-sensitive	O
,	O
high	O
-	O
affinity	O
choline	O
uptake	O
(	O
HACU	O
)	O
in	O
cholinergic	O
neurons	O
is	O
thought	O
to	O
be	O
rate	O
-	O
limiting	O
in	O
the	O
biosynthesis	O
of	O
acetylcholine	O
(	O
ACh	O
)	O
.	O
Based	O
on	O
sequence	O
information	O
provided	O
by	O
the	O
species1s	O
Human	O
species1e	O
Genome	O
Project	O
and	O
the	O
recently	O
reported	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
CHT1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
rCHT1	ARG2
gene1e	ARG2
)	O
,	O
we	O
cloned	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
CHT	O
gene1e	O
cDNA	O
from	O
spinal	O
cord	O
.	O
The	O
gene1s	O
hCHT	O
gene1e	O
cDNA	O
encodes	O
a	O
protein	O
of	O
580	O
amino	O
acids	O
having	O
93	O
%	O
identity	O
to	O
gene1s	ARG2
rCHT1	ARG2
gene1e	ARG2
and	O
51	O
%	O
identity	O
to	O
the	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
homolog	O
gene1s	O
CHO-1	O
gene1e	O
,	O
and	O
is	O
distantly	O
related	O
to	O
members	O
of	O
the	O
Na(+)-coupled	O
glucose	O
transporter	O
(	O
SGLT	O
)	O
gene	O
family	O
of	O
Na(+)-coupled	O
glucose	O
(	O
SGLT	O
)	O
,	O
nucleoside	O
and	O
iodide	O
transporters	O
.	O
Northern	O
blot	O
analysis	O
reveals	O
the	O
expression	O
of	O
a	O
approximately	O
5	O
kb	O
transcript	O
in	O
species1s	O
human	O
species1e	O
brain	O
regions	O
rich	O
in	O
cholinergic	O
neurons	O
including	O
the	O
putamen	O
,	O
spinal	O
cord	O
,	O
and	O
medulla	O
.	O
Expression	O
of	O
gene1s	O
hCHT	O
gene1e	O
cDNA	O
in	O
species1s	O
COS-7	O
species1e	O
cells	O
results	O
in	O
saturable	O
,	O
Na(+)/Cl(-)-dependent	O
choline	O
uptake	O
(	O
K(m	O
)	O
=	O
1.2	O
microM	O
)	O
in	O
membrane	O
vesicles	O
and	O
HC-3	O
binding	O
(	O
K(d	O
)	O
=	O
4	O
nM	O
)	O
in	O
membrane	O
fractions	O
,	O
consistent	O
with	O
characteristics	O
reported	O
in	O
species1s	O
mammalian	O
species1e	O
cholinergic	O
neurons	O
.	O
Using	O
radiation	O
hybrid	O
mapping	O
techniques	O
,	O
we	O
localized	O
the	O
gene1s	O
hCHT	O
gene1e	O
gene	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
2q12	O
.	O
These	O
studies	O
elucidate	O
the	O
primary	O
structure	O
and	O
chromosomal	O
localization	O
of	O
gene1s	O
hCHT	O
gene1e	O
and	O
provide	O
a	O
basis	O
for	O
mechanistic	O
analysis	O
of	O
HACU	O
regulation	O
and	O
an	O
investigation	O
of	O
the	O
role	O
of	O
gene1s	O
hCHT	O
gene1e	O
in	O
disease	O
states	O
.	O
Copyright	O
2000	O
Academic	O
Press	O
.	O

Molecular	O
cloning	O
of	O
a	O
species1s	O
human	O
species1e	O
,	O
hemicholinium-3-sensitive	O
choline	O
transporter	O
.	O
Under	O
many	O
physiological	O
circumstances	O
,	O
Na(+)-	O
and	O
Cl(-)-dependent	O
,	O
hemicholinium-3	O
(	O
HC-3)-sensitive	O
,	O
high	O
-	O
affinity	O
choline	O
uptake	O
(	O
HACU	O
)	O
in	O
cholinergic	O
neurons	O
is	O
thought	O
to	O
be	O
rate	O
-	O
limiting	O
in	O
the	O
biosynthesis	O
of	O
acetylcholine	O
(	O
ACh	O
)	O
.	O
Based	O
on	O
sequence	O
information	O
provided	O
by	O
the	O
species1s	O
Human	O
species1e	O
Genome	O
Project	O
and	O
the	O
recently	O
reported	O
species1s	O
rat	O
species1e	O
gene1s	O
CHT1	O
gene1e	O
(	O
gene1s	O
rCHT1	O
gene1e	O
)	O
,	O
we	O
cloned	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
CHT	O
gene1e	O
cDNA	O
from	O
spinal	O
cord	O
.	O
The	O
gene1s	O
hCHT	O
gene1e	O
cDNA	O
encodes	O
a	O
protein	O
of	O
580	O
amino	O
acids	O
having	O
93	O
%	O
identity	O
to	O
gene1s	O
rCHT1	O
gene1e	O
and	O
51	O
%	O
identity	O
to	O
the	O
arg1s	O
Caenorhabditis	O
elegans	O
arg1e	O
homolog	O
gene1s	ARG2
CHO-1	ARG2
gene1e	ARG2
,	O
and	O
is	O
distantly	O
related	O
to	O
members	O
of	O
the	O
Na(+)-coupled	O
glucose	O
transporter	O
(	O
SGLT	O
)	O
gene	O
family	O
of	O
Na(+)-coupled	O
glucose	O
(	O
SGLT	O
)	O
,	O
nucleoside	O
and	O
iodide	O
transporters	O
.	O
Northern	O
blot	O
analysis	O
reveals	O
the	O
expression	O
of	O
a	O
approximately	O
5	O
kb	O
transcript	O
in	O
species1s	O
human	O
species1e	O
brain	O
regions	O
rich	O
in	O
cholinergic	O
neurons	O
including	O
the	O
putamen	O
,	O
spinal	O
cord	O
,	O
and	O
medulla	O
.	O
Expression	O
of	O
gene1s	O
hCHT	O
gene1e	O
cDNA	O
in	O
species1s	O
COS-7	O
species1e	O
cells	O
results	O
in	O
saturable	O
,	O
Na(+)/Cl(-)-dependent	O
choline	O
uptake	O
(	O
K(m	O
)	O
=	O
1.2	O
microM	O
)	O
in	O
membrane	O
vesicles	O
and	O
HC-3	O
binding	O
(	O
K(d	O
)	O
=	O
4	O
nM	O
)	O
in	O
membrane	O
fractions	O
,	O
consistent	O
with	O
characteristics	O
reported	O
in	O
species1s	O
mammalian	O
species1e	O
cholinergic	O
neurons	O
.	O
Using	O
radiation	O
hybrid	O
mapping	O
techniques	O
,	O
we	O
localized	O
the	O
gene1s	O
hCHT	O
gene1e	O
gene	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
2q12	O
.	O
These	O
studies	O
elucidate	O
the	O
primary	O
structure	O
and	O
chromosomal	O
localization	O
of	O
gene1s	O
hCHT	O
gene1e	O
and	O
provide	O
a	O
basis	O
for	O
mechanistic	O
analysis	O
of	O
HACU	O
regulation	O
and	O
an	O
investigation	O
of	O
the	O
role	O
of	O
gene1s	O
hCHT	O
gene1e	O
in	O
disease	O
states	O
.	O
Copyright	O
2000	O
Academic	O
Press	O
.	O

Molecular	O
cloning	O
of	O
a	O
species1s	O
human	O
species1e	O
,	O
hemicholinium-3-sensitive	O
choline	O
transporter	O
.	O
Under	O
many	O
physiological	O
circumstances	O
,	O
Na(+)-	O
and	O
Cl(-)-dependent	O
,	O
hemicholinium-3	O
(	O
HC-3)-sensitive	O
,	O
high	O
-	O
affinity	O
choline	O
uptake	O
(	O
HACU	O
)	O
in	O
cholinergic	O
neurons	O
is	O
thought	O
to	O
be	O
rate	O
-	O
limiting	O
in	O
the	O
biosynthesis	O
of	O
acetylcholine	O
(	O
ACh	O
)	O
.	O
Based	O
on	O
sequence	O
information	O
provided	O
by	O
the	O
species1s	O
Human	O
species1e	O
Genome	O
Project	O
and	O
the	O
recently	O
reported	O
species1s	O
rat	O
species1e	O
gene1s	O
CHT1	O
gene1e	O
(	O
gene1s	O
rCHT1	O
gene1e	O
)	O
,	O
we	O
cloned	O
a	O
species1s	O
human	O
species1e	O
gene1s	O
CHT	O
gene1e	O
cDNA	O
from	O
spinal	O
cord	O
.	O
The	O
gene1s	O
hCHT	O
gene1e	O
cDNA	O
encodes	O
a	O
protein	O
of	O
580	O
amino	O
acids	O
having	O
93	O
%	O
identity	O
to	O
gene1s	O
rCHT1	O
gene1e	O
and	O
51	O
%	O
identity	O
to	O
the	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
homolog	O
gene1s	O
CHO-1	O
gene1e	O
,	O
and	O
is	O
distantly	O
related	O
to	O
members	O
of	O
the	O
Na(+)-coupled	O
glucose	O
transporter	O
(	O
SGLT	O
)	O
gene	O
family	O
of	O
Na(+)-coupled	O
glucose	O
(	O
SGLT	O
)	O
,	O
nucleoside	O
and	O
iodide	O
transporters	O
.	O
Northern	O
blot	O
analysis	O
reveals	O
the	O
expression	O
of	O
a	O
approximately	O
5	O
kb	O
transcript	O
in	O
species1s	O
human	O
species1e	O
brain	O
regions	O
rich	O
in	O
cholinergic	O
neurons	O
including	O
the	O
putamen	O
,	O
spinal	O
cord	O
,	O
and	O
medulla	O
.	O
Expression	O
of	O
gene1s	O
hCHT	O
gene1e	O
cDNA	O
in	O
arg1s	O
COS-7	O
arg1e	O
cells	O
results	O
in	O
saturable	O
,	O
Na(+)/Cl(-)-dependent	O
choline	O
uptake	O
(	O
K(m	O
)	O
=	O
1.2	O
microM	O
)	O
in	O
membrane	O
vesicles	O
and	O
HC-3	O
binding	O
(	O
K(d	O
)	O
=	O
4	O
nM	O
)	O
in	O
membrane	O
fractions	O
,	O
consistent	O
with	O
characteristics	O
reported	O
in	O
species1s	O
mammalian	O
species1e	O
cholinergic	O
neurons	O
.	O
Using	O
radiation	O
hybrid	O
mapping	O
techniques	O
,	O
we	O
localized	O
the	O
gene1s	O
hCHT	O
gene1e	O
gene	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
2q12	O
.	O
These	O
studies	O
elucidate	O
the	O
primary	O
structure	O
and	O
chromosomal	O
localization	O
of	O
gene1s	O
hCHT	O
gene1e	O
and	O
provide	O
a	O
basis	O
for	O
mechanistic	O
analysis	O
of	O
HACU	O
regulation	O
and	O
an	O
investigation	O
of	O
the	O
role	O
of	O
gene1s	O
hCHT	O
gene1e	O
in	O
disease	O
states	O
.	O
Copyright	O
2000	O
Academic	O
Press	O
.	O

Cloning	O
,	O
localisation	O
and	O
functional	O
expression	O
of	O
a	O
novel	O
arg1s	O
human	O
arg1e	O
,	O
cerebellum	O
specific	O
,	O
two	O
pore	O
domain	O
potassium	O
channel	O
.	O
We	O
have	O
isolated	O
,	O
by	O
degenerate	O
PCR	O
,	O
a	O
complementary	O
DNA	O
encoding	O
a	O
novel	O
two	O
pore	O
domain	O
potassium	O
channel	O
.	O
This	O
is	O
the	O
7th	O
functional	O
member	O
of	O
the	O
arg1s	O
human	O
arg1e	O
tandem	O
pore	O
domain	O
potassium	O
channel	O
family	O
to	O
be	O
reported	O
.	O
It	O
has	O
an	O
open	O
reading	O
frame	O
of	O
1.125	O
kb	O
and	O
encodes	O
a	O
374	O
amino	O
acid	O
protein	O
which	O
shows	O
62	O
%	O
identity	O
to	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
TASK-1	ARG2
gene1e	ARG2
gene	O
:	O
identity	O
to	O
other	O
arg1s	O
human	O
arg1e	O
members	O
of	O
the	O
family	O
is	O
31	O
-	O
35	O
%	O
at	O
the	O
amino	O
acid	O
level	O
.	O
We	O
believe	O
this	O
gene	O
to	O
be	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
TASK-3	ARG2
gene1e	ARG2
,	O
the	O
ortholog	O
of	O
the	O
recently	O
reported	O
species1s	O
rat	O
species1e	O
gene1s	O
TASK-3	O
gene1e	O
gene	O
:	O
amino	O
acid	O
identity	O
between	O
the	O
two	O
is	O
74	O
%	O
.	O
'	O
Taqman	O
'	O
mRNA	O
analysis	O
demonstrated	O
a	O
very	O
specific	O
tissue	O
distribution	O
pattern	O
,	O
showing	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
TASK-3	ARG2
gene1e	ARG2
mRNA	O
to	O
be	O
localised	O
largely	O
in	O
the	O
cerebellum	O
,	O
in	O
contrast	O
species1s	O
rat	O
species1e	O
gene1s	O
TASK-3	O
gene1e	O
was	O
reported	O
to	O
be	O
widely	O
distributed	O
.	O
We	O
have	O
shown	O
by	O
radiation	O
hybrid	O
mapping	O
that	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
TASK-3	ARG2
gene1e	ARG2
can	O
be	O
assigned	O
to	O
chromosome	O
8q24.3	O
.	O
arg1s	O
Human	O
arg1e	O
gene1s	ARG2
TASK-3	ARG2
gene1e	ARG2
was	O
demonstrated	O
to	O
endow	O
species1s	O
Xenopus	O
species1e	O
oocytes	O
with	O
a	O
negative	O
resting	O
membrane	O
potential	O
through	O
the	O
presence	O
of	O
a	O
large	O
K(+	O
)	O
selective	O
conductance	O
.	O
gene1s	ARG2
TASK-3	ARG2
gene1e	ARG2
is	O
inhibited	O
by	O
extracellular	O
acidosis	O
with	O
a	O
mid	O
-	O
point	O
of	O
inhibition	O
around	O
pH	O
6	O
.	O
5	O
,	O
supporting	O
the	O
predictions	O
from	O
the	O
sequence	O
data	O
that	O
this	O
is	O
a	O
third	O
arg1s	O
human	O
arg1e	O
TASK	O
(	O
TWIK	O
-	O
related	O
acid	O
sensitive	O
K(+	O
)	O
channel	O
)	O
gene	O
.	O

Cloning	O
,	O
localisation	O
and	O
functional	O
expression	O
of	O
a	O
novel	O
species1s	O
human	O
species1e	O
,	O
cerebellum	O
specific	O
,	O
two	O
pore	O
domain	O
potassium	O
channel	O
.	O
We	O
have	O
isolated	O
,	O
by	O
degenerate	O
PCR	O
,	O
a	O
complementary	O
DNA	O
encoding	O
a	O
novel	O
two	O
pore	O
domain	O
potassium	O
channel	O
.	O
This	O
is	O
the	O
7th	O
functional	O
member	O
of	O
the	O
species1s	O
human	O
species1e	O
tandem	O
pore	O
domain	O
potassium	O
channel	O
family	O
to	O
be	O
reported	O
.	O
It	O
has	O
an	O
open	O
reading	O
frame	O
of	O
1.125	O
kb	O
and	O
encodes	O
a	O
374	O
amino	O
acid	O
protein	O
which	O
shows	O
62	O
%	O
identity	O
to	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
TASK-1	O
gene1e	O
gene	O
:	O
identity	O
to	O
other	O
species1s	O
human	O
species1e	O
members	O
of	O
the	O
family	O
is	O
31	O
-	O
35	O
%	O
at	O
the	O
amino	O
acid	O
level	O
.	O
We	O
believe	O
this	O
gene	O
to	O
be	O
species1s	O
human	O
species1e	O
gene1s	O
TASK-3	O
gene1e	O
,	O
the	O
ortholog	O
of	O
the	O
recently	O
reported	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
TASK-3	ARG2
gene1e	ARG2
gene	O
:	O
amino	O
acid	O
identity	O
between	O
the	O
two	O
is	O
74	O
%	O
.	O
'	O
Taqman	O
'	O
mRNA	O
analysis	O
demonstrated	O
a	O
very	O
specific	O
tissue	O
distribution	O
pattern	O
,	O
showing	O
species1s	O
human	O
species1e	O
gene1s	O
TASK-3	O
gene1e	O
mRNA	O
to	O
be	O
localised	O
largely	O
in	O
the	O
cerebellum	O
,	O
in	O
contrast	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
TASK-3	ARG2
gene1e	ARG2
was	O
reported	O
to	O
be	O
widely	O
distributed	O
.	O
We	O
have	O
shown	O
by	O
radiation	O
hybrid	O
mapping	O
that	O
species1s	O
human	O
species1e	O
gene1s	O
TASK-3	O
gene1e	O
can	O
be	O
assigned	O
to	O
chromosome	O
8q24.3	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
TASK-3	O
gene1e	O
was	O
demonstrated	O
to	O
endow	O
species1s	O
Xenopus	O
species1e	O
oocytes	O
with	O
a	O
negative	O
resting	O
membrane	O
potential	O
through	O
the	O
presence	O
of	O
a	O
large	O
K(+	O
)	O
selective	O
conductance	O
.	O
gene1s	O
TASK-3	O
gene1e	O
is	O
inhibited	O
by	O
extracellular	O
acidosis	O
with	O
a	O
mid	O
-	O
point	O
of	O
inhibition	O
around	O
pH	O
6	O
.	O
5	O
,	O
supporting	O
the	O
predictions	O
from	O
the	O
sequence	O
data	O
that	O
this	O
is	O
a	O
third	O
species1s	O
human	O
species1e	O
TASK	O
(	O
TWIK	O
-	O
related	O
acid	O
sensitive	O
K(+	O
)	O
channel	O
)	O
gene	O
.	O

Cloning	O
,	O
localisation	O
and	O
functional	O
expression	O
of	O
a	O
novel	O
species1s	O
human	O
species1e	O
,	O
cerebellum	O
specific	O
,	O
two	O
pore	O
domain	O
potassium	O
channel	O
.	O
We	O
have	O
isolated	O
,	O
by	O
degenerate	O
PCR	O
,	O
a	O
complementary	O
DNA	O
encoding	O
a	O
novel	O
two	O
pore	O
domain	O
potassium	O
channel	O
.	O
This	O
is	O
the	O
7th	O
functional	O
member	O
of	O
the	O
species1s	O
human	O
species1e	O
tandem	O
pore	O
domain	O
potassium	O
channel	O
family	O
to	O
be	O
reported	O
.	O
It	O
has	O
an	O
open	O
reading	O
frame	O
of	O
1.125	O
kb	O
and	O
encodes	O
a	O
374	O
amino	O
acid	O
protein	O
which	O
shows	O
62	O
%	O
identity	O
to	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
TASK-1	O
gene1e	O
gene	O
:	O
identity	O
to	O
other	O
species1s	O
human	O
species1e	O
members	O
of	O
the	O
family	O
is	O
31	O
-	O
35	O
%	O
at	O
the	O
amino	O
acid	O
level	O
.	O
We	O
believe	O
this	O
gene	O
to	O
be	O
species1s	O
human	O
species1e	O
gene1s	O
TASK-3	O
gene1e	O
,	O
the	O
ortholog	O
of	O
the	O
recently	O
reported	O
species1s	O
rat	O
species1e	O
gene1s	O
TASK-3	O
gene1e	O
gene	O
:	O
amino	O
acid	O
identity	O
between	O
the	O
two	O
is	O
74	O
%	O
.	O
'	O
Taqman	O
'	O
mRNA	O
analysis	O
demonstrated	O
a	O
very	O
specific	O
tissue	O
distribution	O
pattern	O
,	O
showing	O
species1s	O
human	O
species1e	O
gene1s	O
TASK-3	O
gene1e	O
mRNA	O
to	O
be	O
localised	O
largely	O
in	O
the	O
cerebellum	O
,	O
in	O
contrast	O
species1s	O
rat	O
species1e	O
gene1s	O
TASK-3	O
gene1e	O
was	O
reported	O
to	O
be	O
widely	O
distributed	O
.	O
We	O
have	O
shown	O
by	O
radiation	O
hybrid	O
mapping	O
that	O
species1s	O
human	O
species1e	O
gene1s	O
TASK-3	O
gene1e	O
can	O
be	O
assigned	O
to	O
chromosome	O
8q24.3	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
TASK-3	O
gene1e	O
was	O
demonstrated	O
to	O
endow	O
arg1s	O
Xenopus	O
arg1e	O
oocytes	O
with	O
a	O
negative	O
resting	O
membrane	O
potential	O
through	O
the	O
presence	O
of	O
a	O
large	O
K(+	O
)	O
selective	O
conductance	O
.	O
gene1s	O
TASK-3	O
gene1e	O
is	O
inhibited	O
by	O
extracellular	O
acidosis	O
with	O
a	O
mid	O
-	O
point	O
of	O
inhibition	O
around	O
pH	O
6	O
.	O
5	O
,	O
supporting	O
the	O
predictions	O
from	O
the	O
sequence	O
data	O
that	O
this	O
is	O
a	O
third	O
species1s	O
human	O
species1e	O
TASK	O
(	O
TWIK	O
-	O
related	O
acid	O
sensitive	O
K(+	O
)	O
channel	O
)	O
gene	O
.	O

arg1s	O
Human	O
arg1e	O
gene1s	ARG2
serine	ARG2
racemase	ARG2
gene1e	ARG2
:	O
moleular	O
cloning	O
,	O
genomic	O
organization	O
and	O
functional	O
analysis	O
.	O
High	O
levels	O
of	O
D	O
-	O
serine	O
are	O
found	O
in	O
arg1s	O
mammalian	O
arg1e	O
brain	O
,	O
where	O
it	O
is	O
an	O
endogenous	O
agonist	O
of	O
the	O
strichinine	O
-	O
insensitive	O
site	O
of	O
N	O
-	O
methyl	O
D	O
-	O
aspartate	O
type	O
of	O
glutamate	O
receptors	O
.	O
D	O
-	O
serine	O
is	O
enriched	O
in	O
protoplasmic	O
astrocytes	O
that	O
occur	O
in	O
gray	O
matter	O
areas	O
of	O
the	O
brain	O
and	O
was	O
shown	O
to	O
be	O
synthesized	O
from	O
L	O
-	O
serine	O
.	O
We	O
now	O
report	O
cloning	O
and	O
expression	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
serine	ARG2
racemase	ARG2
gene1e	ARG2
,	O
an	O
enzyme	O
that	O
catalyses	O
the	O
synthesis	O
of	O
D	O
-	O
serine	O
from	O
L	O
-	O
serine	O
.	O
The	O
enzyme	O
displays	O
a	O
high	O
homology	O
to	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
serine	O
racemase	O
gene1e	O
.	O
It	O
contains	O
a	O
pyridoxal	O
5'-phosphate	O
attachment	O
sequence	O
similar	O
to	O
bacterial	O
biosynthetic	O
threonine	O
dehydratase	O
.	O
Northern	O
-	O
blot	O
analysis	O
show	O
high	O
levels	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
serine	ARG2
racemase	ARG2
gene1e	ARG2
in	O
areas	O
known	O
to	O
contain	O
large	O
amounts	O
of	O
endogenous	O
D	O
-	O
serine	O
,	O
such	O
as	O
hippocampus	O
and	O
corpus	O
callosum	O
.	O
Robust	O
synthesis	O
of	O
D	O
-	O
serine	O
was	O
detected	O
in	O
cells	O
transfected	O
with	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
serine	ARG2
racemase	ARG2
gene1e	ARG2
,	O
demonstrating	O
the	O
conservation	O
of	O
D	O
-	O
amino	O
acid	O
metabolism	O
in	O
arg1s	O
humans	O
arg1e	O
.	O
gene1s	ARG2
Serine	ARG2
racemase	ARG2
gene1e	ARG2
may	O
be	O
a	O
therapeutic	O
target	O
in	O
psychiatric	O
diseases	O
as	O
supplementation	O
of	O
D	O
-	O
serine	O
greatly	O
improves	O
schizophrenia	O
symptoms	O
.	O
We	O
identify	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
serine	ARG2
racemase	ARG2
gene1e	ARG2
genomic	O
structure	O
and	O
show	O
that	O
the	O
gene	O
encompasses	O
seven	O
exons	O
and	O
localizes	O
to	O
chromosome	O
17q13.3	O
.	O
Identification	O
of	O
the	O
intron	O
-	O
exon	O
boundaries	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
serine	ARG2
racemase	ARG2
gene1e	ARG2
gene	O
will	O
be	O
useful	O
to	O
search	O
for	O
mutations	O
in	O
neuropsychiatric	O
disorders	O
.	O

species1s	O
Human	O
species1e	O
gene1s	O
serine	O
racemase	O
gene1e	O
:	O
moleular	O
cloning	O
,	O
genomic	O
organization	O
and	O
functional	O
analysis	O
.	O
High	O
levels	O
of	O
D	O
-	O
serine	O
are	O
found	O
in	O
species1s	O
mammalian	O
species1e	O
brain	O
,	O
where	O
it	O
is	O
an	O
endogenous	O
agonist	O
of	O
the	O
strichinine	O
-	O
insensitive	O
site	O
of	O
N	O
-	O
methyl	O
D	O
-	O
aspartate	O
type	O
of	O
glutamate	O
receptors	O
.	O
D	O
-	O
serine	O
is	O
enriched	O
in	O
protoplasmic	O
astrocytes	O
that	O
occur	O
in	O
gray	O
matter	O
areas	O
of	O
the	O
brain	O
and	O
was	O
shown	O
to	O
be	O
synthesized	O
from	O
L	O
-	O
serine	O
.	O
We	O
now	O
report	O
cloning	O
and	O
expression	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
serine	O
racemase	O
gene1e	O
,	O
an	O
enzyme	O
that	O
catalyses	O
the	O
synthesis	O
of	O
D	O
-	O
serine	O
from	O
L	O
-	O
serine	O
.	O
The	O
enzyme	O
displays	O
a	O
high	O
homology	O
to	O
the	O
arg1s	O
murine	O
arg1e	O
gene1s	ARG2
serine	ARG2
racemase	ARG2
gene1e	ARG2
.	O
It	O
contains	O
a	O
pyridoxal	O
5'-phosphate	O
attachment	O
sequence	O
similar	O
to	O
bacterial	O
biosynthetic	O
threonine	O
dehydratase	O
.	O
Northern	O
-	O
blot	O
analysis	O
show	O
high	O
levels	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
serine	O
racemase	O
gene1e	O
in	O
areas	O
known	O
to	O
contain	O
large	O
amounts	O
of	O
endogenous	O
D	O
-	O
serine	O
,	O
such	O
as	O
hippocampus	O
and	O
corpus	O
callosum	O
.	O
Robust	O
synthesis	O
of	O
D	O
-	O
serine	O
was	O
detected	O
in	O
cells	O
transfected	O
with	O
species1s	O
human	O
species1e	O
gene1s	O
serine	O
racemase	O
gene1e	O
,	O
demonstrating	O
the	O
conservation	O
of	O
D	O
-	O
amino	O
acid	O
metabolism	O
in	O
species1s	O
humans	O
species1e	O
.	O
gene1s	O
Serine	O
racemase	O
gene1e	O
may	O
be	O
a	O
therapeutic	O
target	O
in	O
psychiatric	O
diseases	O
as	O
supplementation	O
of	O
D	O
-	O
serine	O
greatly	O
improves	O
schizophrenia	O
symptoms	O
.	O
We	O
identify	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
serine	O
racemase	O
gene1e	O
genomic	O
structure	O
and	O
show	O
that	O
the	O
gene	O
encompasses	O
seven	O
exons	O
and	O
localizes	O
to	O
chromosome	O
17q13.3	O
.	O
Identification	O
of	O
the	O
intron	O
-	O
exon	O
boundaries	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
serine	O
racemase	O
gene1e	O
gene	O
will	O
be	O
useful	O
to	O
search	O
for	O
mutations	O
in	O
neuropsychiatric	O
disorders	O
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
D2	ARG2
gene1e	ARG2
.	O
A	O
novel	O
member	O
of	O
the	O
protein	O
kinase	O
D	O
family	O
of	O
serine	O
threonine	O
kinases	O
.	O
We	O
have	O
isolated	O
the	O
full	O
-	O
length	O
cDNA	O
of	O
a	O
novel	O
arg1s	O
human	O
arg1e	O
serine	O
threonine	O
protein	O
kinase	O
gene	O
.	O
The	O
deduced	O
protein	O
sequence	O
contains	O
two	O
cysteine	O
-	O
rich	O
motifs	O
at	O
the	O
N	O
terminus	O
,	O
a	O
pleckstrin	O
homology	O
domain	O
,	O
and	O
a	O
catalytic	O
domain	O
containing	O
all	O
the	O
characteristic	O
sequence	O
motifs	O
of	O
serine	O
protein	O
kinases	O
.	O
It	O
exhibits	O
the	O
strongest	O
homology	O
to	O
the	O
serine	O
threonine	O
protein	O
kinases	O
gene1s	ARG2
PKD	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PKCmicro	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
PKCnu	ARG2
gene1e	ARG2
,	O
particularly	O
in	O
the	O
duplex	O
zinc	O
finger	O
-	O
like	O
cysteine	O
-	O
rich	O
motif	O
,	O
in	O
the	O
pleckstrin	O
homology	O
domain	O
and	O
in	O
the	O
protein	O
kinase	O
domain	O
.	O
In	O
contrast	O
,	O
it	O
shows	O
only	O
a	O
low	O
degree	O
of	O
sequence	O
similarity	O
to	O
other	O
members	O
of	O
the	O
PKC	O
family	O
.	O
Therefore	O
,	O
the	O
new	O
protein	O
has	O
been	O
termed	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
D2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PKD2	ARG2
gene1e	ARG2
)	O
.	O
The	O
mRNA	O
of	O
gene1s	ARG2
PKD2	ARG2
gene1e	ARG2
is	O
widely	O
expressed	O
in	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
murine	O
species1e	O
tissues	O
.	O
It	O
encodes	O
a	O
protein	O
with	O
a	O
molecular	O
mass	O
of	O
105	O
kDa	O
in	O
SDS	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
,	O
which	O
is	O
expressed	O
in	O
various	O
arg1s	O
human	O
arg1e	O
cell	O
lines	O
,	O
including	O
arg1s	O
HL60	O
arg1e	O
cells	O
,	O
which	O
do	O
not	O
express	O
gene1s	ARG2
PKCmicro	ARG2
gene1e	ARG2
.	O
In	O
vivo	O
phorbol	O
ester	O
binding	O
studies	O
demonstrated	O
a	O
concentration	O
-	O
dependent	O
binding	O
of	O
phorbol	O
12,13-dibutyrate	O
to	O
gene1s	ARG2
PKD2	ARG2
gene1e	ARG2
.	O
The	O
addition	O
of	O
phorbol	O
12,13-dibutyrate	O
in	O
the	O
presence	O
of	O
dioleoylphosphatidylserine	O
stimulated	O
the	O
autophosphorylation	O
of	O
gene1s	ARG2
PKD2	ARG2
gene1e	ARG2
in	O
a	O
synergistic	O
fashion	O
.	O
Phorbol	O
esters	O
also	O
stimulated	O
autophosphorylation	O
of	O
gene1s	ARG2
PKD2	ARG2
gene1e	ARG2
in	O
intact	O
cells	O
.	O
gene1s	ARG2
PKD2	ARG2
gene1e	ARG2
activated	O
by	O
phorbol	O
esters	O
efficiently	O
phosphorylated	O
the	O
exogenous	O
substrate	O
histone	O
H1	O
.	O
In	O
addition	O
,	O
we	O
could	O
identify	O
the	O
C	O
-	O
terminal	O
Ser(876	O
)	O
residue	O
as	O
an	O
in	O
vivo	O
phosphorylation	O
site	O
within	O
gene1s	ARG2
PKD2	ARG2
gene1e	ARG2
.	O
Phosphorylation	O
of	O
Ser(876	O
)	O
of	O
gene1s	ARG2
PKD2	ARG2
gene1e	ARG2
correlated	O
with	O
the	O
activation	O
status	O
of	O
the	O
kinase	O
.	O
Finally	O
,	O
gene1s	ARG2
gastrin	ARG2
gene1e	ARG2
was	O
found	O
to	O
be	O
a	O
physiological	O
activator	O
of	O
gene1s	ARG2
PKD2	ARG2
gene1e	ARG2
in	O
arg1s	O
human	O
arg1e	O
AGS	O
-	O
B	O
cells	O
stably	O
transfected	O
with	O
the	O
gene1s	ARG2
CCK(B)	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
gastrin	ARG2
receptor	ARG2
gene1e	ARG2
.	O
Thus	O
,	O
gene1s	ARG2
PKD2	ARG2
gene1e	ARG2
is	O
a	O
novel	O
phorbol	O
ester-	O
and	O
growth	O
factor	O
-	O
stimulated	O
protein	O
kinase	O
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
protein	O
kinase	O
D2	O
gene1e	O
.	O
A	O
novel	O
member	O
of	O
the	O
protein	O
kinase	O
D	O
family	O
of	O
serine	O
threonine	O
kinases	O
.	O
We	O
have	O
isolated	O
the	O
full	O
-	O
length	O
cDNA	O
of	O
a	O
novel	O
species1s	O
human	O
species1e	O
serine	O
threonine	O
protein	O
kinase	O
gene	O
.	O
The	O
deduced	O
protein	O
sequence	O
contains	O
two	O
cysteine	O
-	O
rich	O
motifs	O
at	O
the	O
N	O
terminus	O
,	O
a	O
pleckstrin	O
homology	O
domain	O
,	O
and	O
a	O
catalytic	O
domain	O
containing	O
all	O
the	O
characteristic	O
sequence	O
motifs	O
of	O
serine	O
protein	O
kinases	O
.	O
It	O
exhibits	O
the	O
strongest	O
homology	O
to	O
the	O
serine	O
threonine	O
protein	O
kinases	O
gene1s	O
PKD	O
gene1e	O
/	O
gene1s	O
PKCmicro	O
gene1e	O
and	O
gene1s	O
PKCnu	O
gene1e	O
,	O
particularly	O
in	O
the	O
duplex	O
zinc	O
finger	O
-	O
like	O
cysteine	O
-	O
rich	O
motif	O
,	O
in	O
the	O
pleckstrin	O
homology	O
domain	O
and	O
in	O
the	O
protein	O
kinase	O
domain	O
.	O
In	O
contrast	O
,	O
it	O
shows	O
only	O
a	O
low	O
degree	O
of	O
sequence	O
similarity	O
to	O
other	O
members	O
of	O
the	O
PKC	O
family	O
.	O
Therefore	O
,	O
the	O
new	O
protein	O
has	O
been	O
termed	O
gene1s	O
protein	O
kinase	O
D2	O
gene1e	O
(	O
gene1s	O
PKD2	O
gene1e	O
)	O
.	O
The	O
mRNA	O
of	O
gene1s	O
PKD2	O
gene1e	O
is	O
widely	O
expressed	O
in	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
murine	O
arg1e	O
tissues	O
.	O
It	O
encodes	O
a	O
protein	O
with	O
a	O
molecular	O
mass	O
of	O
105	O
kDa	O
in	O
SDS	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
,	O
which	O
is	O
expressed	O
in	O
various	O
species1s	O
human	O
species1e	O
cell	O
lines	O
,	O
including	O
species1s	O
HL60	O
species1e	O
cells	O
,	O
which	O
do	O
not	O
express	O
gene1s	O
PKCmicro	O
gene1e	O
.	O
In	O
vivo	O
phorbol	O
ester	O
binding	O
studies	O
demonstrated	O
a	O
concentration	O
-	O
dependent	O
binding	O
of	O
phorbol	O
12,13-dibutyrate	O
to	O
gene1s	O
PKD2	O
gene1e	O
.	O
The	O
addition	O
of	O
phorbol	O
12,13-dibutyrate	O
in	O
the	O
presence	O
of	O
dioleoylphosphatidylserine	O
stimulated	O
the	O
autophosphorylation	O
of	O
gene1s	O
PKD2	O
gene1e	O
in	O
a	O
synergistic	O
fashion	O
.	O
Phorbol	O
esters	O
also	O
stimulated	O
autophosphorylation	O
of	O
gene1s	O
PKD2	O
gene1e	O
in	O
intact	O
cells	O
.	O
gene1s	O
PKD2	O
gene1e	O
activated	O
by	O
phorbol	O
esters	O
efficiently	O
phosphorylated	O
the	O
exogenous	O
substrate	O
histone	O
H1	O
.	O
In	O
addition	O
,	O
we	O
could	O
identify	O
the	O
C	O
-	O
terminal	O
Ser(876	O
)	O
residue	O
as	O
an	O
in	O
vivo	O
phosphorylation	O
site	O
within	O
gene1s	O
PKD2	O
gene1e	O
.	O
Phosphorylation	O
of	O
Ser(876	O
)	O
of	O
gene1s	O
PKD2	O
gene1e	O
correlated	O
with	O
the	O
activation	O
status	O
of	O
the	O
kinase	O
.	O
Finally	O
,	O
gene1s	O
gastrin	O
gene1e	O
was	O
found	O
to	O
be	O
a	O
physiological	O
activator	O
of	O
gene1s	O
PKD2	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
AGS	O
-	O
B	O
cells	O
stably	O
transfected	O
with	O
the	O
gene1s	O
CCK(B)	O
gene1e	O
/	O
gene1s	O
gastrin	O
receptor	O
gene1e	O
.	O
Thus	O
,	O
gene1s	O
PKD2	O
gene1e	O
is	O
a	O
novel	O
phorbol	O
ester-	O
and	O
growth	O
factor	O
-	O
stimulated	O
protein	O
kinase	O
.	O

gene1s	O
Interleukin	O
21	O
gene1e	O
and	O
its	O
receptor	O
are	O
involved	O
in	O
NK	O
cell	O
expansion	O
and	O
regulation	O
of	O
lymphocyte	O
function	O
.	O
Cytokines	O
are	O
important	O
in	O
the	O
regulation	O
of	O
haematopoiesis	O
and	O
immune	O
responses	O
,	O
and	O
can	O
influence	O
lymphocyte	O
development	O
.	O
Here	O
we	O
have	O
identified	O
a	O
class	O
I	O
cytokine	O
receptor	O
that	O
is	O
selectively	O
expressed	O
in	O
lymphoid	O
tissues	O
and	O
is	O
capable	O
of	O
signal	O
transduction	O
.	O
The	O
full	O
-	O
length	O
receptor	O
was	O
expressed	O
in	O
arg1s	O
BaF3	O
arg1e	O
cells	O
,	O
which	O
created	O
a	O
functional	O
assay	O
for	O
ligand	O
detection	O
and	O
cloning	O
.	O
Conditioned	O
media	O
from	O
activated	O
species1s	O
human	O
species1e	O
CD3	O
+	O
T	O
cells	O
supported	O
proliferation	O
of	O
the	O
assay	O
cell	O
line	O
.	O
We	O
constructed	O
a	O
complementary	O
DNA	O
expression	O
library	O
from	O
activated	O
species1s	O
human	O
species1e	O
CD3	O
+	O
T	O
cells	O
,	O
and	O
identified	O
a	O
cytokine	O
with	O
a	O
four	O
-	O
helix	O
-	O
bundle	O
structure	O
using	O
functional	O
cloning	O
.	O
This	O
cytokine	O
is	O
most	O
closely	O
related	O
to	O
gene1s	O
IL2	O
gene1e	O
and	O
gene1s	O
IL15	O
gene1e	O
,	O
and	O
has	O
been	O
designated	O
gene1s	O
IL21	O
gene1e	O
with	O
the	O
receptor	O
designated	O
gene1s	O
IL21	O
R	O
gene1e	O
.	O
In	O
vitro	O
assays	O
suggest	O
that	O
gene1s	O
IL21	O
gene1e	O
has	O
a	O
role	O
in	O
the	O
proliferation	O
and	O
maturation	O
of	O
natural	O
killer	O
(	O
NK	O
)	O
cell	O
populations	O
from	O
bone	O
marrow	O
,	O
in	O
the	O
proliferation	O
of	O
mature	O
B	O
-	O
cell	O
populations	O
co	O
-	O
stimulated	O
with	O
anti	O
-	O
CD40	O
,	O
and	O
in	O
the	O
proliferation	O
of	O
T	O
cells	O
co	O
-	O
stimulated	O
with	O
anti	O
-	O
CD3	O
.	O

gene1s	ARG2
Interleukin	ARG2
21	ARG2
gene1e	ARG2
and	O
its	O
receptor	O
are	O
involved	O
in	O
NK	O
cell	O
expansion	O
and	O
regulation	O
of	O
lymphocyte	O
function	O
.	O
Cytokines	O
are	O
important	O
in	O
the	O
regulation	O
of	O
haematopoiesis	O
and	O
immune	O
responses	O
,	O
and	O
can	O
influence	O
lymphocyte	O
development	O
.	O
Here	O
we	O
have	O
identified	O
a	O
class	O
I	O
cytokine	O
receptor	O
that	O
is	O
selectively	O
expressed	O
in	O
lymphoid	O
tissues	O
and	O
is	O
capable	O
of	O
signal	O
transduction	O
.	O
The	O
full	O
-	O
length	O
receptor	O
was	O
expressed	O
in	O
species1s	O
BaF3	O
species1e	O
cells	O
,	O
which	O
created	O
a	O
functional	O
assay	O
for	O
ligand	O
detection	O
and	O
cloning	O
.	O
Conditioned	O
media	O
from	O
activated	O
arg1s	O
human	O
arg1e	O
CD3	O
+	O
T	O
cells	O
supported	O
proliferation	O
of	O
the	O
assay	O
cell	O
line	O
.	O
We	O
constructed	O
a	O
complementary	O
DNA	O
expression	O
library	O
from	O
activated	O
arg1s	O
human	O
arg1e	O
CD3	O
+	O
T	O
cells	O
,	O
and	O
identified	O
a	O
cytokine	O
with	O
a	O
four	O
-	O
helix	O
-	O
bundle	O
structure	O
using	O
functional	O
cloning	O
.	O
This	O
cytokine	O
is	O
most	O
closely	O
related	O
to	O
gene1s	ARG2
IL2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL15	ARG2
gene1e	ARG2
,	O
and	O
has	O
been	O
designated	O
gene1s	ARG2
IL21	ARG2
gene1e	ARG2
with	O
the	O
receptor	O
designated	O
gene1s	ARG2
IL21	ARG2
R	ARG2
gene1e	ARG2
.	O
In	O
vitro	O
assays	O
suggest	O
that	O
gene1s	ARG2
IL21	ARG2
gene1e	ARG2
has	O
a	O
role	O
in	O
the	O
proliferation	O
and	O
maturation	O
of	O
natural	O
killer	O
(	O
NK	O
)	O
cell	O
populations	O
from	O
bone	O
marrow	O
,	O
in	O
the	O
proliferation	O
of	O
mature	O
B	O
-	O
cell	O
populations	O
co	O
-	O
stimulated	O
with	O
anti	O
-	O
CD40	O
,	O
and	O
in	O
the	O
proliferation	O
of	O
T	O
cells	O
co	O
-	O
stimulated	O
with	O
anti	O
-	O
CD3	O
.	O

gene1s	ARG2
betaIV	ARG2
spectrin	ARG2
gene1e	ARG2
,	O
a	O
new	O
spectrin	O
localized	O
at	O
axon	O
initial	O
segments	O
and	O
nodes	O
of	O
ranvier	O
in	O
the	O
central	O
and	O
peripheral	O
nervous	O
system	O
.	O
We	O
report	O
the	O
identification	O
of	O
gene1s	ARG2
betaIV	ARG2
spectrin	ARG2
gene1e	ARG2
,	O
a	O
novel	O
spectrin	O
isolated	O
as	O
an	O
interactor	O
of	O
the	O
receptor	O
tyrosine	O
phosphatase	O
-	O
like	O
protein	O
gene1s	ARG2
ICA512	ARG2
gene1e	ARG2
.	O
The	O
gene1s	ARG2
betaIV	ARG2
spectrin	ARG2
gene1e	ARG2
gene	O
is	O
located	O
on	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
mouse	O
species1e	O
chromosomes	O
19q13.13	O
and	O
7b2	O
,	O
respectively	O
.	O
Alternative	O
splicing	O
of	O
gene1s	ARG2
betaIV	ARG2
spectrin	ARG2
gene1e	ARG2
generates	O
at	O
least	O
four	O
distinct	O
isoforms	O
,	O
numbered	O
gene1s	ARG2
betaIVSigma1-betaIVSigma4	ARG2
spectrin	ARG2
gene1e	ARG2
.	O
The	O
longest	O
isoform	O
(	O
gene1s	ARG2
betaIVSigma1	ARG2
spectrin	ARG2
gene1e	ARG2
)	O
includes	O
an	O
actin	O
-	O
binding	O
domain	O
,	O
followed	O
by	O
17	O
spectrin	O
repeats	O
,	O
a	O
specific	O
domain	O
in	O
which	O
the	O
amino	O
acid	O
sequence	O
ERQES	O
is	O
repeated	O
four	O
times	O
,	O
several	O
putative	O
SH3-binding	O
sites	O
and	O
a	O
pleckstrin	O
homology	O
domain	O
.	O
gene1s	ARG2
betaIVSigma2	ARG2
and	ARG2
betaIVSigma3	ARG2
spectrin	ARG2
gene1e	ARG2
encompass	O
the	O
NH(2)-	O
and	O
COOH	O
-	O
terminal	O
halves	O
of	O
gene1s	ARG2
betaIVSigma1	ARG2
spectrin	ARG2
gene1e	ARG2
,	O
respectively	O
,	O
while	O
gene1s	ARG2
betaIVSigma4	ARG2
spectrin	ARG2
gene1e	ARG2
lacks	O
the	O
ERQES	O
and	O
the	O
pleckstrin	O
homology	O
domain	O
.	O
Northern	O
blots	O
revealed	O
an	O
abundant	O
expression	O
of	O
gene1s	ARG2
betaIV	ARG2
spectrin	ARG2
gene1e	ARG2
transcripts	O
in	O
brain	O
and	O
pancreatic	O
islets	O
.	O
By	O
immunoblotting	O
,	O
gene1s	ARG2
betaIVSigma1	ARG2
spectrin	ARG2
gene1e	ARG2
is	O
recognized	O
as	O
a	O
protein	O
of	O
250	O
kD.	O
Anti	O
-	O
gene1s	ARG2
betaIV	ARG2
spectrin	ARG2
gene1e	ARG2
antibodies	O
also	O
react	O
with	O
two	O
additional	O
isoforms	O
of	O
160	O
and	O
140	O
kD.	O
These	O
isoforms	O
differ	O
from	O
gene1s	ARG2
betaIVSigma1	ARG2
spectrin	ARG2
gene1e	ARG2
in	O
terms	O
of	O
their	O
distribution	O
on	O
subcellular	O
fractionation	O
,	O
detergent	O
extractability	O
,	O
and	O
phosphorylation	O
.	O
In	O
islets	O
,	O
the	O
immunoreactivity	O
for	O
gene1s	ARG2
betaIV	ARG2
spectrin	ARG2
gene1e	ARG2
is	O
more	O
prominent	O
in	O
alpha	O
than	O
in	O
beta	O
cells	O
.	O
In	O
brain	O
,	O
gene1s	ARG2
betaIV	ARG2
spectrin	ARG2
gene1e	ARG2
is	O
enriched	O
in	O
myelinated	O
neurons	O
,	O
where	O
it	O
colocalizes	O
with	O
gene1s	ARG2
ankyrin(G	ARG2
)	ARG2
gene1e	ARG2
480/270-kD	O
at	O
axon	O
initial	O
segments	O
and	O
nodes	O
of	O
Ranvier	O
.	O
Likewise	O
,	O
gene1s	ARG2
betaIV	ARG2
spectrin	ARG2
gene1e	ARG2
is	O
concentrated	O
at	O
the	O
nodes	O
of	O
Ranvier	O
in	O
the	O
species1s	O
rat	O
species1e	O
sciatic	O
nerve	O
.	O
In	O
the	O
species1s	O
rat	O
species1e	O
hippocampus	O
,	O
gene1s	ARG2
betaIVSigma1	ARG2
spectrin	ARG2
gene1e	ARG2
is	O
detectable	O
from	O
embryonic	O
day	O
19	O
,	O
concomitantly	O
with	O
the	O
appearance	O
of	O
immunoreactivity	O
at	O
the	O
initial	O
segments	O
.	O
Thus	O
,	O
we	O
suggest	O
that	O
gene1s	ARG2
betaIVSigma1	ARG2
spectrin	ARG2
gene1e	ARG2
interacts	O
with	O
gene1s	ARG2
ankyrin(G	ARG2
)	ARG2
gene1e	ARG2
480/270-kD	O
and	O
participates	O
in	O
the	O
clustering	O
of	O
voltage	O
-	O
gated	O
Na(+	O
)	O
channels	O
and	O
cell	O
-	O
adhesion	O
molecules	O
at	O
initial	O
segments	O
and	O
nodes	O
of	O
Ranvier	O
.	O

gene1s	O
betaIV	O
spectrin	O
gene1e	O
,	O
a	O
new	O
spectrin	O
localized	O
at	O
axon	O
initial	O
segments	O
and	O
nodes	O
of	O
ranvier	O
in	O
the	O
central	O
and	O
peripheral	O
nervous	O
system	O
.	O
We	O
report	O
the	O
identification	O
of	O
gene1s	O
betaIV	O
spectrin	O
gene1e	O
,	O
a	O
novel	O
spectrin	O
isolated	O
as	O
an	O
interactor	O
of	O
the	O
receptor	O
tyrosine	O
phosphatase	O
-	O
like	O
protein	O
gene1s	O
ICA512	O
gene1e	O
.	O
The	O
gene1s	O
betaIV	O
spectrin	O
gene1e	O
gene	O
is	O
located	O
on	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
mouse	O
arg1e	O
chromosomes	O
19q13.13	O
and	O
7b2	O
,	O
respectively	O
.	O
Alternative	O
splicing	O
of	O
gene1s	O
betaIV	O
spectrin	O
gene1e	O
generates	O
at	O
least	O
four	O
distinct	O
isoforms	O
,	O
numbered	O
gene1s	O
betaIVSigma1-betaIVSigma4	O
spectrin	O
gene1e	O
.	O
The	O
longest	O
isoform	O
(	O
gene1s	O
betaIVSigma1	O
spectrin	O
gene1e	O
)	O
includes	O
an	O
actin	O
-	O
binding	O
domain	O
,	O
followed	O
by	O
17	O
spectrin	O
repeats	O
,	O
a	O
specific	O
domain	O
in	O
which	O
the	O
amino	O
acid	O
sequence	O
ERQES	O
is	O
repeated	O
four	O
times	O
,	O
several	O
putative	O
SH3-binding	O
sites	O
and	O
a	O
pleckstrin	O
homology	O
domain	O
.	O
gene1s	O
betaIVSigma2	O
and	O
betaIVSigma3	O
spectrin	O
gene1e	O
encompass	O
the	O
NH(2)-	O
and	O
COOH	O
-	O
terminal	O
halves	O
of	O
gene1s	O
betaIVSigma1	O
spectrin	O
gene1e	O
,	O
respectively	O
,	O
while	O
gene1s	O
betaIVSigma4	O
spectrin	O
gene1e	O
lacks	O
the	O
ERQES	O
and	O
the	O
pleckstrin	O
homology	O
domain	O
.	O
Northern	O
blots	O
revealed	O
an	O
abundant	O
expression	O
of	O
gene1s	O
betaIV	O
spectrin	O
gene1e	O
transcripts	O
in	O
brain	O
and	O
pancreatic	O
islets	O
.	O
By	O
immunoblotting	O
,	O
gene1s	O
betaIVSigma1	O
spectrin	O
gene1e	O
is	O
recognized	O
as	O
a	O
protein	O
of	O
250	O
kD.	O
Anti	O
-	O
gene1s	O
betaIV	O
spectrin	O
gene1e	O
antibodies	O
also	O
react	O
with	O
two	O
additional	O
isoforms	O
of	O
160	O
and	O
140	O
kD.	O
These	O
isoforms	O
differ	O
from	O
gene1s	O
betaIVSigma1	O
spectrin	O
gene1e	O
in	O
terms	O
of	O
their	O
distribution	O
on	O
subcellular	O
fractionation	O
,	O
detergent	O
extractability	O
,	O
and	O
phosphorylation	O
.	O
In	O
islets	O
,	O
the	O
immunoreactivity	O
for	O
gene1s	O
betaIV	O
spectrin	O
gene1e	O
is	O
more	O
prominent	O
in	O
alpha	O
than	O
in	O
beta	O
cells	O
.	O
In	O
brain	O
,	O
gene1s	O
betaIV	O
spectrin	O
gene1e	O
is	O
enriched	O
in	O
myelinated	O
neurons	O
,	O
where	O
it	O
colocalizes	O
with	O
gene1s	O
ankyrin(G	O
)	O
gene1e	O
480/270-kD	O
at	O
axon	O
initial	O
segments	O
and	O
nodes	O
of	O
Ranvier	O
.	O
Likewise	O
,	O
gene1s	O
betaIV	O
spectrin	O
gene1e	O
is	O
concentrated	O
at	O
the	O
nodes	O
of	O
Ranvier	O
in	O
the	O
species1s	O
rat	O
species1e	O
sciatic	O
nerve	O
.	O
In	O
the	O
species1s	O
rat	O
species1e	O
hippocampus	O
,	O
gene1s	O
betaIVSigma1	O
spectrin	O
gene1e	O
is	O
detectable	O
from	O
embryonic	O
day	O
19	O
,	O
concomitantly	O
with	O
the	O
appearance	O
of	O
immunoreactivity	O
at	O
the	O
initial	O
segments	O
.	O
Thus	O
,	O
we	O
suggest	O
that	O
gene1s	O
betaIVSigma1	O
spectrin	O
gene1e	O
interacts	O
with	O
gene1s	O
ankyrin(G	O
)	O
gene1e	O
480/270-kD	O
and	O
participates	O
in	O
the	O
clustering	O
of	O
voltage	O
-	O
gated	O
Na(+	O
)	O
channels	O
and	O
cell	O
-	O
adhesion	O
molecules	O
at	O
initial	O
segments	O
and	O
nodes	O
of	O
Ranvier	O
.	O

gene1s	O
betaIV	O
spectrin	O
gene1e	O
,	O
a	O
new	O
spectrin	O
localized	O
at	O
axon	O
initial	O
segments	O
and	O
nodes	O
of	O
ranvier	O
in	O
the	O
central	O
and	O
peripheral	O
nervous	O
system	O
.	O
We	O
report	O
the	O
identification	O
of	O
gene1s	O
betaIV	O
spectrin	O
gene1e	O
,	O
a	O
novel	O
spectrin	O
isolated	O
as	O
an	O
interactor	O
of	O
the	O
receptor	O
tyrosine	O
phosphatase	O
-	O
like	O
protein	O
gene1s	O
ICA512	O
gene1e	O
.	O
The	O
gene1s	O
betaIV	O
spectrin	O
gene1e	O
gene	O
is	O
located	O
on	O
species1s	O
human	O
species1e	O
and	O
species1s	O
mouse	O
species1e	O
chromosomes	O
19q13.13	O
and	O
7b2	O
,	O
respectively	O
.	O
Alternative	O
splicing	O
of	O
gene1s	O
betaIV	O
spectrin	O
gene1e	O
generates	O
at	O
least	O
four	O
distinct	O
isoforms	O
,	O
numbered	O
gene1s	O
betaIVSigma1-betaIVSigma4	O
spectrin	O
gene1e	O
.	O
The	O
longest	O
isoform	O
(	O
gene1s	O
betaIVSigma1	O
spectrin	O
gene1e	O
)	O
includes	O
an	O
actin	O
-	O
binding	O
domain	O
,	O
followed	O
by	O
17	O
spectrin	O
repeats	O
,	O
a	O
specific	O
domain	O
in	O
which	O
the	O
amino	O
acid	O
sequence	O
ERQES	O
is	O
repeated	O
four	O
times	O
,	O
several	O
putative	O
SH3-binding	O
sites	O
and	O
a	O
pleckstrin	O
homology	O
domain	O
.	O
gene1s	O
betaIVSigma2	O
and	O
betaIVSigma3	O
spectrin	O
gene1e	O
encompass	O
the	O
NH(2)-	O
and	O
COOH	O
-	O
terminal	O
halves	O
of	O
gene1s	O
betaIVSigma1	O
spectrin	O
gene1e	O
,	O
respectively	O
,	O
while	O
gene1s	O
betaIVSigma4	O
spectrin	O
gene1e	O
lacks	O
the	O
ERQES	O
and	O
the	O
pleckstrin	O
homology	O
domain	O
.	O
Northern	O
blots	O
revealed	O
an	O
abundant	O
expression	O
of	O
gene1s	O
betaIV	O
spectrin	O
gene1e	O
transcripts	O
in	O
brain	O
and	O
pancreatic	O
islets	O
.	O
By	O
immunoblotting	O
,	O
gene1s	O
betaIVSigma1	O
spectrin	O
gene1e	O
is	O
recognized	O
as	O
a	O
protein	O
of	O
250	O
kD.	O
Anti	O
-	O
gene1s	O
betaIV	O
spectrin	O
gene1e	O
antibodies	O
also	O
react	O
with	O
two	O
additional	O
isoforms	O
of	O
160	O
and	O
140	O
kD.	O
These	O
isoforms	O
differ	O
from	O
gene1s	O
betaIVSigma1	O
spectrin	O
gene1e	O
in	O
terms	O
of	O
their	O
distribution	O
on	O
subcellular	O
fractionation	O
,	O
detergent	O
extractability	O
,	O
and	O
phosphorylation	O
.	O
In	O
islets	O
,	O
the	O
immunoreactivity	O
for	O
gene1s	O
betaIV	O
spectrin	O
gene1e	O
is	O
more	O
prominent	O
in	O
alpha	O
than	O
in	O
beta	O
cells	O
.	O
In	O
brain	O
,	O
gene1s	O
betaIV	O
spectrin	O
gene1e	O
is	O
enriched	O
in	O
myelinated	O
neurons	O
,	O
where	O
it	O
colocalizes	O
with	O
gene1s	O
ankyrin(G	O
)	O
gene1e	O
480/270-kD	O
at	O
axon	O
initial	O
segments	O
and	O
nodes	O
of	O
Ranvier	O
.	O
Likewise	O
,	O
gene1s	O
betaIV	O
spectrin	O
gene1e	O
is	O
concentrated	O
at	O
the	O
nodes	O
of	O
Ranvier	O
in	O
the	O
arg1s	O
rat	O
arg1e	O
sciatic	O
nerve	O
.	O
In	O
the	O
arg1s	O
rat	O
arg1e	O
hippocampus	O
,	O
gene1s	O
betaIVSigma1	O
spectrin	O
gene1e	O
is	O
detectable	O
from	O
embryonic	O
day	O
19	O
,	O
concomitantly	O
with	O
the	O
appearance	O
of	O
immunoreactivity	O
at	O
the	O
initial	O
segments	O
.	O
Thus	O
,	O
we	O
suggest	O
that	O
gene1s	O
betaIVSigma1	O
spectrin	O
gene1e	O
interacts	O
with	O
gene1s	O
ankyrin(G	O
)	O
gene1e	O
480/270-kD	O
and	O
participates	O
in	O
the	O
clustering	O
of	O
voltage	O
-	O
gated	O
Na(+	O
)	O
channels	O
and	O
cell	O
-	O
adhesion	O
molecules	O
at	O
initial	O
segments	O
and	O
nodes	O
of	O
Ranvier	O
.	O

arg1s	O
Human	O
arg1e	O
orthologs	O
of	O
species1s	O
yeast	O
species1e	O
vacuolar	O
protein	O
sorting	O
proteins	O
gene1s	O
Vps26	O
,	O
29	O
,	O
and	O
35	O
gene1e	O
:	O
assembly	O
into	O
multimeric	O
complexes	O
.	O
gene1s	ARG2
Sorting	ARG2
nexin	ARG2
(	ARG2
SNX	ARG2
)	ARG2
1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
SNX2	ARG2
gene1e	ARG2
are	O
arg1s	O
mammalian	O
arg1e	O
orthologs	O
of	O
gene1s	O
Vps5p	O
gene1e	O
,	O
a	O
species1s	O
yeast	O
species1e	O
protein	O
that	O
is	O
a	O
subunit	O
of	O
a	O
large	O
multimeric	O
complex	O
,	O
termed	O
the	O
retromer	O
complex	O
,	O
involved	O
in	O
retrograde	O
transport	O
of	O
proteins	O
from	O
endosomes	O
to	O
the	O
trans	O
-	O
Golgi	O
network	O
.	O
We	O
report	O
the	O
cloning	O
and	O
characterization	O
of	O
arg1s	O
human	O
arg1e	O
orthologs	O
of	O
three	O
additional	O
components	O
of	O
the	O
complex	O
:	O
gene1s	ARG2
Vps26p	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Vps29p	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Vps35p	ARG2
gene1e	ARG2
.	O
The	O
close	O
structural	O
similarity	O
between	O
the	O
species1s	O
yeast	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
proteins	O
suggests	O
a	O
similarity	O
in	O
function	O
.	O
We	O
used	O
both	O
species1s	O
yeast	O
species1e	O
two	O
-	O
hybrid	O
assays	O
and	O
expression	O
in	O
arg1s	O
mammalian	O
arg1e	O
cells	O
to	O
define	O
the	O
binding	O
interactions	O
among	O
these	O
proteins	O
.	O
The	O
data	O
suggest	O
a	O
model	O
in	O
which	O
gene1s	ARG2
hVps35	ARG2
gene1e	ARG2
serves	O
as	O
the	O
core	O
of	O
a	O
multimeric	O
complex	O
by	O
binding	O
directly	O
to	O
gene1s	ARG2
hVps26	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
hVps29	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
SNX1	ARG2
gene1e	ARG2
.	O
Deletional	O
analyses	O
of	O
gene1s	ARG2
hVps35	ARG2
gene1e	ARG2
demonstrate	O
that	O
amino	O
acid	O
residues	O
1	O
-	O
53	O
and	O
307	O
-	O
796	O
of	O
gene1s	ARG2
hVps35	ARG2
gene1e	ARG2
bind	O
to	O
the	O
coiled	O
coil	O
-	O
containing	O
domain	O
of	O
gene1s	ARG2
SNX1	ARG2
gene1e	ARG2
.	O
In	O
contrast	O
,	O
gene1s	ARG2
hVps26	ARG2
gene1e	ARG2
binds	O
to	O
amino	O
acid	O
residues	O
1	O
-	O
172	O
of	O
gene1s	ARG2
hVps35	ARG2
gene1e	ARG2
,	O
whereas	O
gene1s	ARG2
hVps29	ARG2
gene1e	ARG2
binds	O
to	O
amino	O
acid	O
residues	O
307	O
-	O
796	O
of	O
gene1s	ARG2
hVps35	ARG2
gene1e	ARG2
.	O
Furthermore	O
,	O
gene1s	ARG2
hVps35	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
hVps29	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
hVps26	ARG2
gene1e	ARG2
have	O
been	O
found	O
in	O
membrane	O
-	O
associated	O
and	O
cytosolic	O
compartments	O
.	O
Gel	O
filtration	O
chromatography	O
of	O
species1s	O
COS7	O
species1e	O
cell	O
cytosol	O
showed	O
that	O
both	O
recombinant	O
and	O
endogenous	O
gene1s	ARG2
hVps35	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
hVps29	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
hVps26	ARG2
gene1e	ARG2
coelute	O
as	O
a	O
large	O
complex	O
(	O
approximately	O
220	O
-	O
440	O
kDa	O
)	O
.	O
In	O
the	O
absence	O
of	O
gene1s	ARG2
hVps35	ARG2
gene1e	ARG2
,	O
neither	O
gene1s	ARG2
hVps26	ARG2
gene1e	ARG2
nor	O
gene1s	ARG2
hVps29	ARG2
gene1e	ARG2
is	O
found	O
in	O
the	O
large	O
complex	O
.	O
These	O
data	O
provide	O
the	O
first	O
insights	O
into	O
the	O
binding	O
interactions	O
among	O
subunits	O
of	O
a	O
putative	O
arg1s	O
mammalian	O
arg1e	O
retromer	O
complex	O
.	O

species1s	O
Human	O
species1e	O
orthologs	O
of	O
arg1s	O
yeast	O
arg1e	O
vacuolar	O
protein	O
sorting	O
proteins	O
gene1s	ARG2
Vps26	ARG2
,	ARG2
29	ARG2
,	ARG2
and	ARG2
35	ARG2
gene1e	ARG2
:	O
assembly	O
into	O
multimeric	O
complexes	O
.	O
gene1s	O
Sorting	O
nexin	O
(	O
SNX	O
)	O
1	O
gene1e	O
and	O
gene1s	O
SNX2	O
gene1e	O
are	O
species1s	O
mammalian	O
species1e	O
orthologs	O
of	O
gene1s	ARG2
Vps5p	ARG2
gene1e	ARG2
,	O
a	O
arg1s	O
yeast	O
arg1e	O
protein	O
that	O
is	O
a	O
subunit	O
of	O
a	O
large	O
multimeric	O
complex	O
,	O
termed	O
the	O
retromer	O
complex	O
,	O
involved	O
in	O
retrograde	O
transport	O
of	O
proteins	O
from	O
endosomes	O
to	O
the	O
trans	O
-	O
Golgi	O
network	O
.	O
We	O
report	O
the	O
cloning	O
and	O
characterization	O
of	O
species1s	O
human	O
species1e	O
orthologs	O
of	O
three	O
additional	O
components	O
of	O
the	O
complex	O
:	O
gene1s	O
Vps26p	O
gene1e	O
,	O
gene1s	O
Vps29p	O
gene1e	O
,	O
and	O
gene1s	O
Vps35p	O
gene1e	O
.	O
The	O
close	O
structural	O
similarity	O
between	O
the	O
arg1s	O
yeast	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
proteins	O
suggests	O
a	O
similarity	O
in	O
function	O
.	O
We	O
used	O
both	O
arg1s	O
yeast	O
arg1e	O
two	O
-	O
hybrid	O
assays	O
and	O
expression	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
to	O
define	O
the	O
binding	O
interactions	O
among	O
these	O
proteins	O
.	O
The	O
data	O
suggest	O
a	O
model	O
in	O
which	O
gene1s	O
hVps35	O
gene1e	O
serves	O
as	O
the	O
core	O
of	O
a	O
multimeric	O
complex	O
by	O
binding	O
directly	O
to	O
gene1s	O
hVps26	O
gene1e	O
,	O
gene1s	O
hVps29	O
gene1e	O
,	O
and	O
gene1s	O
SNX1	O
gene1e	O
.	O
Deletional	O
analyses	O
of	O
gene1s	O
hVps35	O
gene1e	O
demonstrate	O
that	O
amino	O
acid	O
residues	O
1	O
-	O
53	O
and	O
307	O
-	O
796	O
of	O
gene1s	O
hVps35	O
gene1e	O
bind	O
to	O
the	O
coiled	O
coil	O
-	O
containing	O
domain	O
of	O
gene1s	O
SNX1	O
gene1e	O
.	O
In	O
contrast	O
,	O
gene1s	O
hVps26	O
gene1e	O
binds	O
to	O
amino	O
acid	O
residues	O
1	O
-	O
172	O
of	O
gene1s	O
hVps35	O
gene1e	O
,	O
whereas	O
gene1s	O
hVps29	O
gene1e	O
binds	O
to	O
amino	O
acid	O
residues	O
307	O
-	O
796	O
of	O
gene1s	O
hVps35	O
gene1e	O
.	O
Furthermore	O
,	O
gene1s	O
hVps35	O
gene1e	O
,	O
gene1s	O
hVps29	O
gene1e	O
,	O
and	O
gene1s	O
hVps26	O
gene1e	O
have	O
been	O
found	O
in	O
membrane	O
-	O
associated	O
and	O
cytosolic	O
compartments	O
.	O
Gel	O
filtration	O
chromatography	O
of	O
species1s	O
COS7	O
species1e	O
cell	O
cytosol	O
showed	O
that	O
both	O
recombinant	O
and	O
endogenous	O
gene1s	O
hVps35	O
gene1e	O
,	O
gene1s	O
hVps29	O
gene1e	O
,	O
and	O
gene1s	O
hVps26	O
gene1e	O
coelute	O
as	O
a	O
large	O
complex	O
(	O
approximately	O
220	O
-	O
440	O
kDa	O
)	O
.	O
In	O
the	O
absence	O
of	O
gene1s	O
hVps35	O
gene1e	O
,	O
neither	O
gene1s	O
hVps26	O
gene1e	O
nor	O
gene1s	O
hVps29	O
gene1e	O
is	O
found	O
in	O
the	O
large	O
complex	O
.	O
These	O
data	O
provide	O
the	O
first	O
insights	O
into	O
the	O
binding	O
interactions	O
among	O
subunits	O
of	O
a	O
putative	O
species1s	O
mammalian	O
species1e	O
retromer	O
complex	O
.	O

species1s	O
Human	O
species1e	O
orthologs	O
of	O
species1s	O
yeast	O
species1e	O
vacuolar	O
protein	O
sorting	O
proteins	O
gene1s	O
Vps26	O
,	O
29	O
,	O
and	O
35	O
gene1e	O
:	O
assembly	O
into	O
multimeric	O
complexes	O
.	O
gene1s	O
Sorting	O
nexin	O
(	O
SNX	O
)	O
1	O
gene1e	O
and	O
gene1s	O
SNX2	O
gene1e	O
are	O
species1s	O
mammalian	O
species1e	O
orthologs	O
of	O
gene1s	O
Vps5p	O
gene1e	O
,	O
a	O
species1s	O
yeast	O
species1e	O
protein	O
that	O
is	O
a	O
subunit	O
of	O
a	O
large	O
multimeric	O
complex	O
,	O
termed	O
the	O
retromer	O
complex	O
,	O
involved	O
in	O
retrograde	O
transport	O
of	O
proteins	O
from	O
endosomes	O
to	O
the	O
trans	O
-	O
Golgi	O
network	O
.	O
We	O
report	O
the	O
cloning	O
and	O
characterization	O
of	O
species1s	O
human	O
species1e	O
orthologs	O
of	O
three	O
additional	O
components	O
of	O
the	O
complex	O
:	O
gene1s	O
Vps26p	O
gene1e	O
,	O
gene1s	O
Vps29p	O
gene1e	O
,	O
and	O
gene1s	O
Vps35p	O
gene1e	O
.	O
The	O
close	O
structural	O
similarity	O
between	O
the	O
species1s	O
yeast	O
species1e	O
and	O
species1s	O
human	O
species1e	O
proteins	O
suggests	O
a	O
similarity	O
in	O
function	O
.	O
We	O
used	O
both	O
species1s	O
yeast	O
species1e	O
two	O
-	O
hybrid	O
assays	O
and	O
expression	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
to	O
define	O
the	O
binding	O
interactions	O
among	O
these	O
proteins	O
.	O
The	O
data	O
suggest	O
a	O
model	O
in	O
which	O
gene1s	O
hVps35	O
gene1e	O
serves	O
as	O
the	O
core	O
of	O
a	O
multimeric	O
complex	O
by	O
binding	O
directly	O
to	O
gene1s	O
hVps26	O
gene1e	O
,	O
gene1s	O
hVps29	O
gene1e	O
,	O
and	O
gene1s	O
SNX1	O
gene1e	O
.	O
Deletional	O
analyses	O
of	O
gene1s	O
hVps35	O
gene1e	O
demonstrate	O
that	O
amino	O
acid	O
residues	O
1	O
-	O
53	O
and	O
307	O
-	O
796	O
of	O
gene1s	O
hVps35	O
gene1e	O
bind	O
to	O
the	O
coiled	O
coil	O
-	O
containing	O
domain	O
of	O
gene1s	O
SNX1	O
gene1e	O
.	O
In	O
contrast	O
,	O
gene1s	O
hVps26	O
gene1e	O
binds	O
to	O
amino	O
acid	O
residues	O
1	O
-	O
172	O
of	O
gene1s	O
hVps35	O
gene1e	O
,	O
whereas	O
gene1s	O
hVps29	O
gene1e	O
binds	O
to	O
amino	O
acid	O
residues	O
307	O
-	O
796	O
of	O
gene1s	O
hVps35	O
gene1e	O
.	O
Furthermore	O
,	O
gene1s	O
hVps35	O
gene1e	O
,	O
gene1s	O
hVps29	O
gene1e	O
,	O
and	O
gene1s	O
hVps26	O
gene1e	O
have	O
been	O
found	O
in	O
membrane	O
-	O
associated	O
and	O
cytosolic	O
compartments	O
.	O
Gel	O
filtration	O
chromatography	O
of	O
arg1s	O
COS7	O
arg1e	O
cell	O
cytosol	O
showed	O
that	O
both	O
recombinant	O
and	O
endogenous	O
gene1s	O
hVps35	O
gene1e	O
,	O
gene1s	O
hVps29	O
gene1e	O
,	O
and	O
gene1s	O
hVps26	O
gene1e	O
coelute	O
as	O
a	O
large	O
complex	O
(	O
approximately	O
220	O
-	O
440	O
kDa	O
)	O
.	O
In	O
the	O
absence	O
of	O
gene1s	O
hVps35	O
gene1e	O
,	O
neither	O
gene1s	O
hVps26	O
gene1e	O
nor	O
gene1s	O
hVps29	O
gene1e	O
is	O
found	O
in	O
the	O
large	O
complex	O
.	O
These	O
data	O
provide	O
the	O
first	O
insights	O
into	O
the	O
binding	O
interactions	O
among	O
subunits	O
of	O
a	O
putative	O
species1s	O
mammalian	O
species1e	O
retromer	O
complex	O
.	O

Three	O
novel	O
components	O
of	O
the	O
arg1s	O
human	O
arg1e	O
exosome	O
.	O
The	O
species1s	O
yeast	O
species1e	O
exosome	O
is	O
a	O
complex	O
of	O
3	O
'	O
--	O
>	O
5	O
'	O
exoribonucleases	O
.	O
Sequence	O
analysis	O
identified	O
putative	O
arg1s	O
human	O
arg1e	O
homologues	O
for	O
exosome	O
components	O
,	O
although	O
several	O
were	O
found	O
only	O
as	O
expressed	O
sequence	O
tags	O
.	O
Here	O
we	O
report	O
the	O
cloning	O
of	O
full	O
-	O
length	O
cDNAs	O
,	O
which	O
encode	O
putative	O
arg1s	O
human	O
arg1e	O
homologues	O
of	O
the	O
gene1s	ARG2
Rrp40p	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Rrp41p	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Rrp46p	ARG2
gene1e	ARG2
components	O
of	O
the	O
exosome	O
.	O
Recombinant	O
proteins	O
were	O
expressed	O
and	O
used	O
to	O
raise	O
rabbit	O
antisera	O
.	O
In	O
Western	O
blotting	O
experiments	O
,	O
these	O
decorated	O
arg1s	O
HeLa	O
arg1e	O
cell	O
proteins	O
of	O
the	O
predicted	O
sizes	O
.	O
All	O
three	O
arg1s	O
human	O
arg1e	O
proteins	O
were	O
enriched	O
in	O
the	O
arg1s	O
HeLa	O
arg1e	O
cells	O
nucleus	O
and	O
nucleolus	O
,	O
but	O
were	O
also	O
clearly	O
detected	O
in	O
the	O
cytoplasm	O
.	O
Size	O
exclusion	O
chromatography	O
revealed	O
that	O
gene1s	ARG2
hRrp40p	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
hRrp41p	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
hRrp46p	ARG2
gene1e	ARG2
were	O
present	O
in	O
a	O
large	O
complex	O
.	O
This	O
cofractionated	O
with	O
the	O
arg1s	O
human	O
arg1e	O
homologues	O
of	O
other	O
exosome	O
components	O
,	O
gene1s	ARG2
hRrp4p	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
PM	ARG2
/	ARG2
Scl-100	ARG2
gene1e	ARG2
.	O
Anti	O
-	O
PM	O
/	O
Scl	O
-	O
positive	O
arg1s	O
patient	O
arg1e	O
sera	O
coimmunoprecipitated	O
gene1s	ARG2
hRrp40p	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
hRrp41p	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
hRrp46p	ARG2
gene1e	ARG2
demonstrating	O
their	O
physical	O
association	O
.	O
The	O
immunoprecipitated	O
complex	O
exhibited	O
3	O
'	O
--	O
>	O
5	O
'	O
exoribonuclease	O
activity	O
in	O
vitro	O
.	O
gene1s	ARG2
hRrp41p	ARG2
gene1e	ARG2
was	O
expressed	O
in	O
species1s	O
yeast	O
species1e	O
and	O
shown	O
to	O
suppress	O
the	O
lethality	O
of	O
genetic	O
depletion	O
of	O
species1s	O
yeast	O
species1e	O
gene1s	O
Rrp41p	O
gene1e	O
.	O
We	O
conclude	O
that	O
gene1s	ARG2
hRrp40p	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
hRrp41p	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
hRrp46p	ARG2
gene1e	ARG2
represent	O
novel	O
components	O
of	O
the	O
arg1s	O
human	O
arg1e	O
exosome	O
complex	O
.	O

Three	O
novel	O
components	O
of	O
the	O
species1s	O
human	O
species1e	O
exosome	O
.	O
The	O
arg1s	O
yeast	O
arg1e	O
exosome	O
is	O
a	O
complex	O
of	O
3	O
'	O
--	O
>	O
5	O
'	O
exoribonucleases	O
.	O
Sequence	O
analysis	O
identified	O
putative	O
species1s	O
human	O
species1e	O
homologues	O
for	O
exosome	O
components	O
,	O
although	O
several	O
were	O
found	O
only	O
as	O
expressed	O
sequence	O
tags	O
.	O
Here	O
we	O
report	O
the	O
cloning	O
of	O
full	O
-	O
length	O
cDNAs	O
,	O
which	O
encode	O
putative	O
species1s	O
human	O
species1e	O
homologues	O
of	O
the	O
gene1s	O
Rrp40p	O
gene1e	O
,	O
gene1s	O
Rrp41p	O
gene1e	O
,	O
and	O
gene1s	O
Rrp46p	O
gene1e	O
components	O
of	O
the	O
exosome	O
.	O
Recombinant	O
proteins	O
were	O
expressed	O
and	O
used	O
to	O
raise	O
rabbit	O
antisera	O
.	O
In	O
Western	O
blotting	O
experiments	O
,	O
these	O
decorated	O
species1s	O
HeLa	O
species1e	O
cell	O
proteins	O
of	O
the	O
predicted	O
sizes	O
.	O
All	O
three	O
species1s	O
human	O
species1e	O
proteins	O
were	O
enriched	O
in	O
the	O
species1s	O
HeLa	O
species1e	O
cells	O
nucleus	O
and	O
nucleolus	O
,	O
but	O
were	O
also	O
clearly	O
detected	O
in	O
the	O
cytoplasm	O
.	O
Size	O
exclusion	O
chromatography	O
revealed	O
that	O
gene1s	O
hRrp40p	O
gene1e	O
,	O
gene1s	O
hRrp41p	O
gene1e	O
,	O
and	O
gene1s	O
hRrp46p	O
gene1e	O
were	O
present	O
in	O
a	O
large	O
complex	O
.	O
This	O
cofractionated	O
with	O
the	O
species1s	O
human	O
species1e	O
homologues	O
of	O
other	O
exosome	O
components	O
,	O
gene1s	O
hRrp4p	O
gene1e	O
and	O
gene1s	O
PM	O
/	O
Scl-100	O
gene1e	O
.	O
Anti	O
-	O
PM	O
/	O
Scl	O
-	O
positive	O
species1s	O
patient	O
species1e	O
sera	O
coimmunoprecipitated	O
gene1s	O
hRrp40p	O
gene1e	O
,	O
gene1s	O
hRrp41p	O
gene1e	O
,	O
and	O
gene1s	O
hRrp46p	O
gene1e	O
demonstrating	O
their	O
physical	O
association	O
.	O
The	O
immunoprecipitated	O
complex	O
exhibited	O
3	O
'	O
--	O
>	O
5	O
'	O
exoribonuclease	O
activity	O
in	O
vitro	O
.	O
gene1s	O
hRrp41p	O
gene1e	O
was	O
expressed	O
in	O
arg1s	O
yeast	O
arg1e	O
and	O
shown	O
to	O
suppress	O
the	O
lethality	O
of	O
genetic	O
depletion	O
of	O
arg1s	O
yeast	O
arg1e	O
gene1s	ARG2
Rrp41p	ARG2
gene1e	ARG2
.	O
We	O
conclude	O
that	O
gene1s	O
hRrp40p	O
gene1e	O
,	O
gene1s	O
hRrp41p	O
gene1e	O
,	O
and	O
gene1s	O
hRrp46p	O
gene1e	O
represent	O
novel	O
components	O
of	O
the	O
species1s	O
human	O
species1e	O
exosome	O
complex	O
.	O

Comparative	O
structural	O
and	O
functional	O
analysis	O
of	O
the	O
olfactory	O
receptor	O
genes	O
flanking	O
the	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
mouse	O
species1e	O
beta	O
-	O
globin	O
gene	O
clusters	O
.	O
By	O
sequencing	O
regions	O
flanking	O
the	O
beta	O
-	O
globin	O
gene	O
complex	O
in	O
species1s	O
mouse	O
species1e	O
(	O
Hbbc	O
)	O
and	O
arg1s	O
human	O
arg1e	O
(	O
HBBC	O
)	O
,	O
we	O
have	O
shown	O
that	O
the	O
beta	O
-	O
globin	O
gene	O
cluster	O
is	O
surrounded	O
by	O
a	O
larger	O
cluster	O
of	O
olfactory	O
receptor	O
genes	O
(	O
ORGs	O
)	O
.	O
To	O
facilitate	O
sequence	O
comparisons	O
and	O
to	O
investigate	O
the	O
regulation	O
of	O
ORG	O
expression	O
,	O
we	O
have	O
mapped	O
5	O
'	O
sequences	O
of	O
mRNA	O
from	O
olfactory	O
epithelium	O
encoding	O
beta	O
-	O
globin	O
-	O
proximal	O
ORGs	O
.	O
We	O
have	O
found	O
that	O
several	O
of	O
these	O
genes	O
contain	O
multiple	O
noncoding	O
exons	O
that	O
can	O
be	O
alternatively	O
spliced	O
.	O
Surprisingly	O
,	O
the	O
only	O
common	O
motifs	O
found	O
in	O
the	O
promoters	O
of	O
these	O
genes	O
are	O
a	O
"	O
TATA	O
"	O
box	O
and	O
a	O
purine	O
-	O
rich	O
motif	O
.	O
Sequence	O
comparisons	O
between	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
mouse	O
species1e	O
reveal	O
that	O
most	O
of	O
the	O
conserved	O
regions	O
are	O
confined	O
to	O
the	O
coding	O
regions	O
and	O
transcription	O
units	O
of	O
the	O
genes	O
themselves	O
,	O
but	O
a	O
few	O
blocks	O
of	O
conserved	O
sequence	O
also	O
are	O
found	O
outside	O
of	O
ORG	O
transcription	O
units	O
.	O
The	O
possible	O
influence	O
of	O
beta	O
-	O
globin	O
regulatory	O
sequences	O
on	O
ORG	O
expression	O
in	O
olfactory	O
epithelium	O
was	O
tested	O
in	O
species1s	O
mice	O
species1e	O
containing	O
a	O
deletion	O
of	O
the	O
endogenous	O
beta	O
-	O
globin	O
locus	O
control	O
region	O
,	O
but	O
no	O
change	O
in	O
expression	O
of	O
the	O
neighboring	O
ORGs	O
was	O
detected	O
.	O
We	O
evaluate	O
the	O
implications	O
of	O
these	O
results	O
for	O
possible	O
mechanisms	O
of	O
regulation	O
of	O
ORG	O
transcription	O
.	O

Comparative	O
structural	O
and	O
functional	O
analysis	O
of	O
the	O
olfactory	O
receptor	O
genes	O
flanking	O
the	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
mouse	O
arg1e	O
beta	O
-	O
globin	O
gene	O
clusters	O
.	O
By	O
sequencing	O
regions	O
flanking	O
the	O
beta	O
-	O
globin	O
gene	O
complex	O
in	O
arg1s	O
mouse	O
arg1e	O
(	O
Hbbc	O
)	O
and	O
species1s	O
human	O
species1e	O
(	O
HBBC	O
)	O
,	O
we	O
have	O
shown	O
that	O
the	O
beta	O
-	O
globin	O
gene	O
cluster	O
is	O
surrounded	O
by	O
a	O
larger	O
cluster	O
of	O
olfactory	O
receptor	O
genes	O
(	O
ORGs	O
)	O
.	O
To	O
facilitate	O
sequence	O
comparisons	O
and	O
to	O
investigate	O
the	O
regulation	O
of	O
ORG	O
expression	O
,	O
we	O
have	O
mapped	O
5	O
'	O
sequences	O
of	O
mRNA	O
from	O
olfactory	O
epithelium	O
encoding	O
beta	O
-	O
globin	O
-	O
proximal	O
ORGs	O
.	O
We	O
have	O
found	O
that	O
several	O
of	O
these	O
genes	O
contain	O
multiple	O
noncoding	O
exons	O
that	O
can	O
be	O
alternatively	O
spliced	O
.	O
Surprisingly	O
,	O
the	O
only	O
common	O
motifs	O
found	O
in	O
the	O
promoters	O
of	O
these	O
genes	O
are	O
a	O
"	O
TATA	O
"	O
box	O
and	O
a	O
purine	O
-	O
rich	O
motif	O
.	O
Sequence	O
comparisons	O
between	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
mouse	O
arg1e	O
reveal	O
that	O
most	O
of	O
the	O
conserved	O
regions	O
are	O
confined	O
to	O
the	O
coding	O
regions	O
and	O
transcription	O
units	O
of	O
the	O
genes	O
themselves	O
,	O
but	O
a	O
few	O
blocks	O
of	O
conserved	O
sequence	O
also	O
are	O
found	O
outside	O
of	O
ORG	O
transcription	O
units	O
.	O
The	O
possible	O
influence	O
of	O
beta	O
-	O
globin	O
regulatory	O
sequences	O
on	O
ORG	O
expression	O
in	O
olfactory	O
epithelium	O
was	O
tested	O
in	O
arg1s	O
mice	O
arg1e	O
containing	O
a	O
deletion	O
of	O
the	O
endogenous	O
beta	O
-	O
globin	O
locus	O
control	O
region	O
,	O
but	O
no	O
change	O
in	O
expression	O
of	O
the	O
neighboring	O
ORGs	O
was	O
detected	O
.	O
We	O
evaluate	O
the	O
implications	O
of	O
these	O
results	O
for	O
possible	O
mechanisms	O
of	O
regulation	O
of	O
ORG	O
transcription	O
.	O

Characterization	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
sialoadhesin	ARG2
gene1e	ARG2
,	O
a	O
sialic	O
acid	O
binding	O
receptor	O
expressed	O
by	O
resident	O
and	O
inflammatory	O
macrophage	O
populations	O
.	O
gene1s	ARG2
Sialoadhesin	ARG2
gene1e	ARG2
is	O
a	O
macrophage	O
-	O
restricted	O
cellular	O
interaction	O
molecule	O
and	O
a	O
prototypic	O
member	O
of	O
the	O
Siglec	O
family	O
of	O
sialic	O
acid	O
binding	O
immunoglobulin	O
(	O
Ig)-like	O
lectins	O
.	O
So	O
far	O
,	O
it	O
has	O
only	O
been	O
characterized	O
in	O
rodents	O
.	O
Here	O
,	O
we	O
report	O
the	O
molecular	O
cloning	O
,	O
binding	O
properties	O
,	O
and	O
expression	O
pattern	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
sialoadhesin	ARG2
gene1e	ARG2
.	O
The	O
predicted	O
protein	O
sequences	O
of	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
mouse	O
species1e	O
gene1s	ARG2
sialoadhesin	ARG2
gene1e	ARG2
are	O
about	O
72	O
%	O
identical	O
,	O
with	O
the	O
greatest	O
similarity	O
in	O
the	O
extracellular	O
region	O
,	O
which	O
comprises	O
17	O
Ig	O
domains	O
in	O
both	O
species	O
.	O
A	O
recombinant	O
protein	O
consisting	O
of	O
the	O
first	O
4	O
N	O
-	O
terminal	O
domains	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
sialoadhesin	ARG2
gene1e	ARG2
fused	O
to	O
the	O
Fc	O
region	O
of	O
arg1s	O
human	O
arg1e	O
IgG1	O
mediated	O
sialic	O
acid	O
-	O
dependent	O
binding	O
with	O
a	O
specificity	O
similar	O
to	O
its	O
species1s	O
mouse	O
species1e	O
counterpart	O
,	O
preferring	O
sialic	O
acid	O
in	O
the	O
alpha2,3	O
glycosidic	O
linkage	O
over	O
the	O
alpha2,6	O
linkage	O
.	O
By	O
flow	O
cytometry	O
with	O
peripheral	O
blood	O
leukocytes	O
,	O
recombinant	O
gene1s	ARG2
sialoadhesin	ARG2
gene1e	ARG2
bound	O
strongly	O
to	O
granulocytes	O
with	O
intermediate	O
binding	O
to	O
monocytes	O
,	O
natural	O
killer	O
cells	O
,	O
B	O
cells	O
,	O
and	O
a	O
subset	O
of	O
CD8	O
T	O
cells	O
.	O
Using	O
antibodies	O
raised	O
to	O
the	O
recombinant	O
protein	O
,	O
gene1s	ARG2
sialoadhesin	ARG2
gene1e	ARG2
was	O
immunoprecipitated	O
from	O
the	O
arg1s	O
THP-1	O
arg1e	O
arg1s	O
human	O
arg1e	O
monocytic	O
cell	O
line	O
as	O
an	O
approximate	O
200-kd	O
glycoprotein	O
.	O
The	O
expression	O
pattern	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
sialoadhesin	ARG2
gene1e	ARG2
was	O
found	O
to	O
be	O
similar	O
to	O
that	O
of	O
the	O
species1s	O
mouse	O
species1e	O
receptor	O
,	O
being	O
absent	O
from	O
monocytes	O
and	O
other	O
peripheral	O
blood	O
leukocytes	O
,	O
but	O
expressed	O
strongly	O
by	O
tissue	O
macrophages	O
in	O
the	O
spleen	O
,	O
lymph	O
node	O
,	O
bone	O
marrow	O
,	O
liver	O
,	O
colon	O
,	O
and	O
lungs	O
.	O
High	O
expression	O
was	O
also	O
found	O
on	O
inflammatory	O
macrophages	O
present	O
in	O
affected	O
tissues	O
from	O
arg1s	O
patients	O
arg1e	O
with	O
rheumatoid	O
arthritis	O
.	O

Characterization	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
sialoadhesin	O
gene1e	O
,	O
a	O
sialic	O
acid	O
binding	O
receptor	O
expressed	O
by	O
resident	O
and	O
inflammatory	O
macrophage	O
populations	O
.	O
gene1s	O
Sialoadhesin	O
gene1e	O
is	O
a	O
macrophage	O
-	O
restricted	O
cellular	O
interaction	O
molecule	O
and	O
a	O
prototypic	O
member	O
of	O
the	O
Siglec	O
family	O
of	O
sialic	O
acid	O
binding	O
immunoglobulin	O
(	O
Ig)-like	O
lectins	O
.	O
So	O
far	O
,	O
it	O
has	O
only	O
been	O
characterized	O
in	O
rodents	O
.	O
Here	O
,	O
we	O
report	O
the	O
molecular	O
cloning	O
,	O
binding	O
properties	O
,	O
and	O
expression	O
pattern	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
sialoadhesin	O
gene1e	O
.	O
The	O
predicted	O
protein	O
sequences	O
of	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
sialoadhesin	ARG2
gene1e	ARG2
are	O
about	O
72	O
%	O
identical	O
,	O
with	O
the	O
greatest	O
similarity	O
in	O
the	O
extracellular	O
region	O
,	O
which	O
comprises	O
17	O
Ig	O
domains	O
in	O
both	O
species	O
.	O
A	O
recombinant	O
protein	O
consisting	O
of	O
the	O
first	O
4	O
N	O
-	O
terminal	O
domains	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
sialoadhesin	O
gene1e	O
fused	O
to	O
the	O
Fc	O
region	O
of	O
species1s	O
human	O
species1e	O
IgG1	O
mediated	O
sialic	O
acid	O
-	O
dependent	O
binding	O
with	O
a	O
specificity	O
similar	O
to	O
its	O
arg1s	O
mouse	O
arg1e	O
counterpart	O
,	O
preferring	O
sialic	O
acid	O
in	O
the	O
alpha2,3	O
glycosidic	O
linkage	O
over	O
the	O
alpha2,6	O
linkage	O
.	O
By	O
flow	O
cytometry	O
with	O
peripheral	O
blood	O
leukocytes	O
,	O
recombinant	O
gene1s	O
sialoadhesin	O
gene1e	O
bound	O
strongly	O
to	O
granulocytes	O
with	O
intermediate	O
binding	O
to	O
monocytes	O
,	O
natural	O
killer	O
cells	O
,	O
B	O
cells	O
,	O
and	O
a	O
subset	O
of	O
CD8	O
T	O
cells	O
.	O
Using	O
antibodies	O
raised	O
to	O
the	O
recombinant	O
protein	O
,	O
gene1s	O
sialoadhesin	O
gene1e	O
was	O
immunoprecipitated	O
from	O
the	O
species1s	O
THP-1	O
species1e	O
species1s	O
human	O
species1e	O
monocytic	O
cell	O
line	O
as	O
an	O
approximate	O
200-kd	O
glycoprotein	O
.	O
The	O
expression	O
pattern	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
sialoadhesin	O
gene1e	O
was	O
found	O
to	O
be	O
similar	O
to	O
that	O
of	O
the	O
arg1s	O
mouse	O
arg1e	O
receptor	O
,	O
being	O
absent	O
from	O
monocytes	O
and	O
other	O
peripheral	O
blood	O
leukocytes	O
,	O
but	O
expressed	O
strongly	O
by	O
tissue	O
macrophages	O
in	O
the	O
spleen	O
,	O
lymph	O
node	O
,	O
bone	O
marrow	O
,	O
liver	O
,	O
colon	O
,	O
and	O
lungs	O
.	O
High	O
expression	O
was	O
also	O
found	O
on	O
inflammatory	O
macrophages	O
present	O
in	O
affected	O
tissues	O
from	O
species1s	O
patients	O
species1e	O
with	O
rheumatoid	O
arthritis	O
.	O

The	O
neural	O
cell	O
recognition	O
molecule	O
gene1s	O
neurofascin	O
gene1e	O
interacts	O
with	O
gene1s	O
syntenin-1	O
gene1e	O
but	O
not	O
with	O
gene1s	O
syntenin-2	O
gene1e	O
,	O
both	O
of	O
which	O
reveal	O
self	O
-	O
associating	O
activity	O
.	O
gene1s	O
Neurofascin	O
gene1e	O
belongs	O
to	O
the	O
L1	O
subgroup	O
of	O
the	O
immunoglobulin	O
superfamily	O
of	O
cell	O
adhesion	O
molecules	O
and	O
is	O
implicated	O
in	O
axonal	O
growth	O
and	O
fasciculation	O
.	O
We	O
used	O
yeast	O
two	O
-	O
hybrid	O
screening	O
to	O
identify	O
proteins	O
that	O
interact	O
with	O
gene1s	O
neurofascin	O
gene1e	O
intracellularly	O
and	O
therefore	O
might	O
link	O
it	O
to	O
trafficking	O
,	O
spatial	O
targeting	O
,	O
or	O
signaling	O
pathways	O
.	O
Here	O
,	O
we	O
demonstrate	O
that	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
syntenin-1	ARG2
gene1e	ARG2
,	O
previously	O
published	O
as	O
gene1s	O
syntenin	O
gene1e	O
,	O
gene1s	O
mda-9	O
gene1e	O
,	O
or	O
gene1s	O
TACIP18	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
,	O
is	O
a	O
gene1s	O
neurofascin	O
gene1e	O
-	O
binding	O
protein	O
that	O
exhibits	O
a	O
wide	O
-	O
spread	O
tissue	O
expression	O
pattern	O
with	O
a	O
relative	O
maximum	O
in	O
brain	O
.	O
gene1s	ARG2
Syntenin-1	ARG2
gene1e	ARG2
was	O
found	O
not	O
to	O
interact	O
with	O
other	O
vertebrate	O
members	O
of	O
the	O
L1	O
subgroup	O
such	O
as	O
L1	O
itself	O
or	O
gene1s	O
NrCAM	O
gene1e	O
.	O
We	O
confirmed	O
the	O
specificity	O
of	O
the	O
gene1s	O
neurofascin	O
gene1e	O
-	O
gene1s	O
syntenin-1	O
gene1e	O
interaction	O
by	O
ligand	O
-	O
overlay	O
assay	O
,	O
surface	O
plasmon	O
resonance	O
analysis	O
,	O
and	O
colocalization	O
of	O
both	O
proteins	O
in	O
heterologous	O
cells	O
.	O
The	O
COOH	O
terminus	O
of	O
gene1s	O
neurofascin	O
gene1e	O
was	O
mapped	O
to	O
interact	O
with	O
the	O
second	O
PDZ	O
domain	O
of	O
gene1s	O
syntenin-1	O
gene1e	O
.	O
Furthermore	O
,	O
we	O
isolated	O
gene1s	O
syntenin-2	O
gene1e	O
that	O
may	O
be	O
expressed	O
in	O
two	O
isoforms	O
.	O
Despite	O
their	O
high	O
sequence	O
similarity	O
to	O
gene1s	O
syntenin-1	O
gene1e	O
,	O
gene1s	O
syntenin-2alpha	O
gene1e	O
,	O
which	O
interacts	O
with	O
gene1s	O
neurexin	O
I	O
gene1e	O
,	O
and	O
gene1s	O
syntenin-2beta	O
gene1e	O
do	O
not	O
bind	O
to	O
gene1s	O
neurofascin	O
gene1e	O
or	O
several	O
other	O
transmembrane	O
proteins	O
that	O
are	O
binding	O
partners	O
of	O
gene1s	O
syntenin-1	O
gene1e	O
.	O
Finally	O
,	O
we	O
report	O
that	O
gene1s	O
syntenin-1	O
and	O
-2	O
gene1e	O
both	O
form	O
homodimers	O
and	O
can	O
interact	O
with	O
each	O
other	O
.	O

The	O
neural	O
cell	O
recognition	O
molecule	O
gene1s	ARG2
neurofascin	ARG2
gene1e	ARG2
interacts	O
with	O
gene1s	ARG2
syntenin-1	ARG2
gene1e	ARG2
but	O
not	O
with	O
gene1s	ARG2
syntenin-2	ARG2
gene1e	ARG2
,	O
both	O
of	O
which	O
reveal	O
self	O
-	O
associating	O
activity	O
.	O
gene1s	ARG2
Neurofascin	ARG2
gene1e	ARG2
belongs	O
to	O
the	O
L1	O
subgroup	O
of	O
the	O
immunoglobulin	O
superfamily	O
of	O
cell	O
adhesion	O
molecules	O
and	O
is	O
implicated	O
in	O
axonal	O
growth	O
and	O
fasciculation	O
.	O
We	O
used	O
yeast	O
two	O
-	O
hybrid	O
screening	O
to	O
identify	O
proteins	O
that	O
interact	O
with	O
gene1s	ARG2
neurofascin	ARG2
gene1e	ARG2
intracellularly	O
and	O
therefore	O
might	O
link	O
it	O
to	O
trafficking	O
,	O
spatial	O
targeting	O
,	O
or	O
signaling	O
pathways	O
.	O
Here	O
,	O
we	O
demonstrate	O
that	O
species1s	O
rat	O
species1e	O
gene1s	O
syntenin-1	O
gene1e	O
,	O
previously	O
published	O
as	O
gene1s	ARG2
syntenin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
mda-9	ARG2
gene1e	ARG2
,	O
or	O
gene1s	ARG2
TACIP18	ARG2
gene1e	ARG2
in	O
arg1s	O
human	O
arg1e	O
,	O
is	O
a	O
gene1s	ARG2
neurofascin	ARG2
gene1e	ARG2
-	O
binding	O
protein	O
that	O
exhibits	O
a	O
wide	O
-	O
spread	O
tissue	O
expression	O
pattern	O
with	O
a	O
relative	O
maximum	O
in	O
brain	O
.	O
gene1s	O
Syntenin-1	O
gene1e	O
was	O
found	O
not	O
to	O
interact	O
with	O
other	O
vertebrate	O
members	O
of	O
the	O
L1	O
subgroup	O
such	O
as	O
L1	O
itself	O
or	O
gene1s	ARG2
NrCAM	ARG2
gene1e	ARG2
.	O
We	O
confirmed	O
the	O
specificity	O
of	O
the	O
gene1s	ARG2
neurofascin	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
syntenin-1	ARG2
gene1e	ARG2
interaction	O
by	O
ligand	O
-	O
overlay	O
assay	O
,	O
surface	O
plasmon	O
resonance	O
analysis	O
,	O
and	O
colocalization	O
of	O
both	O
proteins	O
in	O
heterologous	O
cells	O
.	O
The	O
COOH	O
terminus	O
of	O
gene1s	ARG2
neurofascin	ARG2
gene1e	ARG2
was	O
mapped	O
to	O
interact	O
with	O
the	O
second	O
PDZ	O
domain	O
of	O
gene1s	ARG2
syntenin-1	ARG2
gene1e	ARG2
.	O
Furthermore	O
,	O
we	O
isolated	O
gene1s	ARG2
syntenin-2	ARG2
gene1e	ARG2
that	O
may	O
be	O
expressed	O
in	O
two	O
isoforms	O
.	O
Despite	O
their	O
high	O
sequence	O
similarity	O
to	O
gene1s	ARG2
syntenin-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
syntenin-2alpha	ARG2
gene1e	ARG2
,	O
which	O
interacts	O
with	O
gene1s	ARG2
neurexin	ARG2
I	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
syntenin-2beta	ARG2
gene1e	ARG2
do	O
not	O
bind	O
to	O
gene1s	ARG2
neurofascin	ARG2
gene1e	ARG2
or	O
several	O
other	O
transmembrane	O
proteins	O
that	O
are	O
binding	O
partners	O
of	O
gene1s	ARG2
syntenin-1	ARG2
gene1e	ARG2
.	O
Finally	O
,	O
we	O
report	O
that	O
gene1s	ARG2
syntenin-1	ARG2
and	ARG2
-2	ARG2
gene1e	ARG2
both	O
form	O
homodimers	O
and	O
can	O
interact	O
with	O
each	O
other	O
.	O

Identification	O
of	O
a	O
novel	O
thioredoxin	O
-	O
related	O
transmembrane	O
protein	O
.	O
We	O
recently	O
identified	O
a	O
series	O
of	O
transforming	O
growth	O
factor	O
-	O
beta	O
-	O
responsive	O
genes	O
in	O
A549	O
arg1s	O
human	O
arg1e	O
adenocarcinoma	O
cell	O
line	O
by	O
a	O
gene	O
trap	O
screening	O
method	O
.	O
Here	O
we	O
report	O
the	O
molecular	O
cloning	O
and	O
characterization	O
of	O
one	O
of	O
these	O
genes	O
,	O
designated	O
gene1s	ARG2
TMX	ARG2
gene1e	ARG2
,	O
that	O
encodes	O
a	O
novel	O
protein	O
of	O
280	O
amino	O
acid	O
residues	O
.	O
The	O
gene1s	ARG2
TMX	ARG2
gene1e	ARG2
protein	O
possesses	O
an	O
N	O
-	O
terminal	O
signal	O
peptide	O
followed	O
by	O
one	O
thioredoxin	O
(	O
Trx)-like	O
domain	O
with	O
a	O
unique	O
active	O
site	O
sequence	O
,	O
Cys	O
-	O
Pro	O
-	O
Ala	O
-	O
Cys	O
,	O
and	O
a	O
potential	O
transmembrane	O
domain	O
.	O
There	O
are	O
putative	O
gene1s	ARG2
TMX	ARG2
gene1e	ARG2
homologs	O
with	O
identical	O
active	O
site	O
sequences	O
in	O
the	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
and	O
species1s	O
Drosophila	O
species1e	O
genomes	O
.	O
Using	O
recombinant	O
proteins	O
expressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
,	O
we	O
demonstrated	O
the	O
activity	O
of	O
the	O
Trx	O
domain	O
of	O
gene1s	ARG2
TMX	ARG2
gene1e	ARG2
to	O
cleave	O
the	O
interchain	O
disulfide	O
bridges	O
in	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
in	O
vitro	O
.	O
The	O
gene1s	ARG2
TMX	ARG2
gene1e	ARG2
transcript	O
is	O
widely	O
expressed	O
in	O
normal	O
arg1s	O
human	O
arg1e	O
tissues	O
,	O
and	O
subcellular	O
fractionation	O
and	O
immunostaining	O
for	O
an	O
epitope	O
-	O
tagged	O
gene1s	ARG2
TMX	ARG2
gene1e	ARG2
protein	O
suggest	O
that	O
gene1s	ARG2
TMX	ARG2
gene1e	ARG2
is	O
predominantly	O
localized	O
in	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
.	O
When	O
gene1s	ARG2
TMX	ARG2
gene1e	ARG2
was	O
expressed	O
in	O
arg1s	O
HEK293	O
arg1e	O
cells	O
,	O
it	O
significantly	O
suppressed	O
the	O
apoptosis	O
induced	O
by	O
brefeldin	O
A	O
,	O
an	O
inhibitor	O
of	O
ER	O
-	O
Golgi	O
transport	O
.	O
This	O
activity	O
was	O
abolished	O
when	O
two	O
Cys	O
residues	O
in	O
the	O
active	O
site	O
sequence	O
were	O
mutated	O
to	O
Ser	O
,	O
suggesting	O
that	O
the	O
gene1s	ARG2
Trx	ARG2
gene1e	ARG2
-	O
like	O
activity	O
of	O
gene1s	ARG2
TMX	ARG2
gene1e	ARG2
may	O
help	O
relieve	O
ER	O
stress	O
caused	O
by	O
brefeldin	O
A.	O

Identification	O
of	O
a	O
novel	O
thioredoxin	O
-	O
related	O
transmembrane	O
protein	O
.	O
We	O
recently	O
identified	O
a	O
series	O
of	O
transforming	O
growth	O
factor	O
-	O
beta	O
-	O
responsive	O
genes	O
in	O
A549	O
species1s	O
human	O
species1e	O
adenocarcinoma	O
cell	O
line	O
by	O
a	O
gene	O
trap	O
screening	O
method	O
.	O
Here	O
we	O
report	O
the	O
molecular	O
cloning	O
and	O
characterization	O
of	O
one	O
of	O
these	O
genes	O
,	O
designated	O
gene1s	O
TMX	O
gene1e	O
,	O
that	O
encodes	O
a	O
novel	O
protein	O
of	O
280	O
amino	O
acid	O
residues	O
.	O
The	O
gene1s	O
TMX	O
gene1e	O
protein	O
possesses	O
an	O
N	O
-	O
terminal	O
signal	O
peptide	O
followed	O
by	O
one	O
thioredoxin	O
(	O
Trx)-like	O
domain	O
with	O
a	O
unique	O
active	O
site	O
sequence	O
,	O
Cys	O
-	O
Pro	O
-	O
Ala	O
-	O
Cys	O
,	O
and	O
a	O
potential	O
transmembrane	O
domain	O
.	O
There	O
are	O
putative	O
gene1s	O
TMX	O
gene1e	O
homologs	O
with	O
identical	O
active	O
site	O
sequences	O
in	O
the	O
arg1s	O
Caenorhabditis	O
elegans	O
arg1e	O
and	O
species1s	O
Drosophila	O
species1e	O
genomes	O
.	O
Using	O
recombinant	O
proteins	O
expressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
,	O
we	O
demonstrated	O
the	O
activity	O
of	O
the	O
Trx	O
domain	O
of	O
gene1s	O
TMX	O
gene1e	O
to	O
cleave	O
the	O
interchain	O
disulfide	O
bridges	O
in	O
gene1s	O
insulin	O
gene1e	O
in	O
vitro	O
.	O
The	O
gene1s	O
TMX	O
gene1e	O
transcript	O
is	O
widely	O
expressed	O
in	O
normal	O
species1s	O
human	O
species1e	O
tissues	O
,	O
and	O
subcellular	O
fractionation	O
and	O
immunostaining	O
for	O
an	O
epitope	O
-	O
tagged	O
gene1s	O
TMX	O
gene1e	O
protein	O
suggest	O
that	O
gene1s	O
TMX	O
gene1e	O
is	O
predominantly	O
localized	O
in	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
.	O
When	O
gene1s	O
TMX	O
gene1e	O
was	O
expressed	O
in	O
species1s	O
HEK293	O
species1e	O
cells	O
,	O
it	O
significantly	O
suppressed	O
the	O
apoptosis	O
induced	O
by	O
brefeldin	O
A	O
,	O
an	O
inhibitor	O
of	O
ER	O
-	O
Golgi	O
transport	O
.	O
This	O
activity	O
was	O
abolished	O
when	O
two	O
Cys	O
residues	O
in	O
the	O
active	O
site	O
sequence	O
were	O
mutated	O
to	O
Ser	O
,	O
suggesting	O
that	O
the	O
gene1s	O
Trx	O
gene1e	O
-	O
like	O
activity	O
of	O
gene1s	O
TMX	O
gene1e	O
may	O
help	O
relieve	O
ER	O
stress	O
caused	O
by	O
brefeldin	O
A.	O

Identification	O
of	O
a	O
novel	O
thioredoxin	O
-	O
related	O
transmembrane	O
protein	O
.	O
We	O
recently	O
identified	O
a	O
series	O
of	O
transforming	O
growth	O
factor	O
-	O
beta	O
-	O
responsive	O
genes	O
in	O
A549	O
species1s	O
human	O
species1e	O
adenocarcinoma	O
cell	O
line	O
by	O
a	O
gene	O
trap	O
screening	O
method	O
.	O
Here	O
we	O
report	O
the	O
molecular	O
cloning	O
and	O
characterization	O
of	O
one	O
of	O
these	O
genes	O
,	O
designated	O
gene1s	O
TMX	O
gene1e	O
,	O
that	O
encodes	O
a	O
novel	O
protein	O
of	O
280	O
amino	O
acid	O
residues	O
.	O
The	O
gene1s	O
TMX	O
gene1e	O
protein	O
possesses	O
an	O
N	O
-	O
terminal	O
signal	O
peptide	O
followed	O
by	O
one	O
thioredoxin	O
(	O
Trx)-like	O
domain	O
with	O
a	O
unique	O
active	O
site	O
sequence	O
,	O
Cys	O
-	O
Pro	O
-	O
Ala	O
-	O
Cys	O
,	O
and	O
a	O
potential	O
transmembrane	O
domain	O
.	O
There	O
are	O
putative	O
gene1s	O
TMX	O
gene1e	O
homologs	O
with	O
identical	O
active	O
site	O
sequences	O
in	O
the	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
and	O
arg1s	O
Drosophila	O
arg1e	O
genomes	O
.	O
Using	O
recombinant	O
proteins	O
expressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
,	O
we	O
demonstrated	O
the	O
activity	O
of	O
the	O
Trx	O
domain	O
of	O
gene1s	O
TMX	O
gene1e	O
to	O
cleave	O
the	O
interchain	O
disulfide	O
bridges	O
in	O
gene1s	O
insulin	O
gene1e	O
in	O
vitro	O
.	O
The	O
gene1s	O
TMX	O
gene1e	O
transcript	O
is	O
widely	O
expressed	O
in	O
normal	O
species1s	O
human	O
species1e	O
tissues	O
,	O
and	O
subcellular	O
fractionation	O
and	O
immunostaining	O
for	O
an	O
epitope	O
-	O
tagged	O
gene1s	O
TMX	O
gene1e	O
protein	O
suggest	O
that	O
gene1s	O
TMX	O
gene1e	O
is	O
predominantly	O
localized	O
in	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
.	O
When	O
gene1s	O
TMX	O
gene1e	O
was	O
expressed	O
in	O
species1s	O
HEK293	O
species1e	O
cells	O
,	O
it	O
significantly	O
suppressed	O
the	O
apoptosis	O
induced	O
by	O
brefeldin	O
A	O
,	O
an	O
inhibitor	O
of	O
ER	O
-	O
Golgi	O
transport	O
.	O
This	O
activity	O
was	O
abolished	O
when	O
two	O
Cys	O
residues	O
in	O
the	O
active	O
site	O
sequence	O
were	O
mutated	O
to	O
Ser	O
,	O
suggesting	O
that	O
the	O
gene1s	O
Trx	O
gene1e	O
-	O
like	O
activity	O
of	O
gene1s	O
TMX	O
gene1e	O
may	O
help	O
relieve	O
ER	O
stress	O
caused	O
by	O
brefeldin	O
A.	O

Identification	O
of	O
a	O
novel	O
thioredoxin	O
-	O
related	O
transmembrane	O
protein	O
.	O
We	O
recently	O
identified	O
a	O
series	O
of	O
transforming	O
growth	O
factor	O
-	O
beta	O
-	O
responsive	O
genes	O
in	O
A549	O
species1s	O
human	O
species1e	O
adenocarcinoma	O
cell	O
line	O
by	O
a	O
gene	O
trap	O
screening	O
method	O
.	O
Here	O
we	O
report	O
the	O
molecular	O
cloning	O
and	O
characterization	O
of	O
one	O
of	O
these	O
genes	O
,	O
designated	O
gene1s	O
TMX	O
gene1e	O
,	O
that	O
encodes	O
a	O
novel	O
protein	O
of	O
280	O
amino	O
acid	O
residues	O
.	O
The	O
gene1s	O
TMX	O
gene1e	O
protein	O
possesses	O
an	O
N	O
-	O
terminal	O
signal	O
peptide	O
followed	O
by	O
one	O
thioredoxin	O
(	O
Trx)-like	O
domain	O
with	O
a	O
unique	O
active	O
site	O
sequence	O
,	O
Cys	O
-	O
Pro	O
-	O
Ala	O
-	O
Cys	O
,	O
and	O
a	O
potential	O
transmembrane	O
domain	O
.	O
There	O
are	O
putative	O
gene1s	O
TMX	O
gene1e	O
homologs	O
with	O
identical	O
active	O
site	O
sequences	O
in	O
the	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
and	O
species1s	O
Drosophila	O
species1e	O
genomes	O
.	O
Using	O
recombinant	O
proteins	O
expressed	O
in	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
,	O
we	O
demonstrated	O
the	O
activity	O
of	O
the	O
Trx	O
domain	O
of	O
gene1s	O
TMX	O
gene1e	O
to	O
cleave	O
the	O
interchain	O
disulfide	O
bridges	O
in	O
gene1s	O
insulin	O
gene1e	O
in	O
vitro	O
.	O
The	O
gene1s	O
TMX	O
gene1e	O
transcript	O
is	O
widely	O
expressed	O
in	O
normal	O
species1s	O
human	O
species1e	O
tissues	O
,	O
and	O
subcellular	O
fractionation	O
and	O
immunostaining	O
for	O
an	O
epitope	O
-	O
tagged	O
gene1s	O
TMX	O
gene1e	O
protein	O
suggest	O
that	O
gene1s	O
TMX	O
gene1e	O
is	O
predominantly	O
localized	O
in	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
.	O
When	O
gene1s	O
TMX	O
gene1e	O
was	O
expressed	O
in	O
species1s	O
HEK293	O
species1e	O
cells	O
,	O
it	O
significantly	O
suppressed	O
the	O
apoptosis	O
induced	O
by	O
brefeldin	O
A	O
,	O
an	O
inhibitor	O
of	O
ER	O
-	O
Golgi	O
transport	O
.	O
This	O
activity	O
was	O
abolished	O
when	O
two	O
Cys	O
residues	O
in	O
the	O
active	O
site	O
sequence	O
were	O
mutated	O
to	O
Ser	O
,	O
suggesting	O
that	O
the	O
gene1s	O
Trx	O
gene1e	O
-	O
like	O
activity	O
of	O
gene1s	O
TMX	O
gene1e	O
may	O
help	O
relieve	O
ER	O
stress	O
caused	O
by	O
brefeldin	O
A.	O

Identification	O
of	O
two	O
prokineticin	O
cDNAs	O
:	O
recombinant	O
proteins	O
potently	O
contract	O
gastrointestinal	O
smooth	O
muscle	O
.	O
The	O
motility	O
of	O
gastrointestinal	O
tract	O
is	O
regulated	O
by	O
classical	O
neurotransmitters	O
,	O
neuropeptides	O
,	O
and	O
humoral	O
agents	O
.	O
Two	O
novel	O
arg1s	O
human	O
arg1e	O
cDNAs	O
have	O
been	O
cloned	O
based	O
on	O
their	O
sequence	O
similarity	O
to	O
a	O
frog	O
skin	O
secretion	O
protein	O
,	O
gene1s	ARG2
Bv8	ARG2
gene1e	ARG2
,	O
and	O
a	O
nontoxic	O
protein	O
of	O
mamba	O
snake	O
venom	O
.	O
These	O
arg1s	O
human	O
arg1e	O
cDNAs	O
encode	O
two	O
secreted	O
proteins	O
of	O
86	O
and	O
81	O
amino	O
acids	O
.	O
Northern	O
blot	O
hybridization	O
has	O
revealed	O
that	O
these	O
cDNAs	O
are	O
expressed	O
in	O
gastrointestinal	O
tract	O
,	O
particularly	O
the	O
stomach	O
.	O
Recombinant	O
proteins	O
with	O
authentic	O
N	O
-	O
terminal	O
sequences	O
have	O
been	O
produced	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
and	O
refolded	O
into	O
functional	O
proteins	O
by	O
careful	O
control	O
of	O
protein	O
aggregation	O
.	O
Mass	O
spectrometry	O
has	O
confirmed	O
the	O
formation	O
of	O
five	O
pairs	O
of	O
disulfide	O
bonds	O
.	O
The	O
refolded	O
recombinant	O
proteins	O
potently	O
contract	O
gastrointestinal	O
smooth	O
muscle	O
with	O
EC(50	O
)	O
values	O
in	O
the	O
subnanomolar	O
range	O
.	O
The	O
contractile	O
effects	O
of	O
the	O
recombinant	O
proteins	O
are	O
specific	O
for	O
gastrointestinal	O
smooth	O
muscle	O
,	O
because	O
they	O
have	O
no	O
effect	O
on	O
vascular	O
or	O
respiratory	O
smooth	O
muscle	O
.	O
To	O
reflect	O
their	O
potent	O
and	O
specific	O
effects	O
on	O
gastrointestinal	O
smooth	O
muscle	O
cells	O
,	O
we	O
have	O
named	O
these	O
recombinant	O
proteins	O
prokineticins	O
.	O
Ligand	O
binding	O
studies	O
with	O
iodinated	O
prokineticin	O
revealed	O
the	O
presence	O
of	O
a	O
high	O
-	O
affinity	O
site	O
in	O
ileal	O
smooth	O
muscle	O
.	O
The	O
displacement	O
of	O
specific	O
binding	O
by	O
GTP	O
gamma	O
S	O
suggests	O
that	O
the	O
prokineticin	O
receptor	O
may	O
belong	O
to	O
the	O
family	O
of	O
G	O
protein	O
-	O
coupled	O
receptors	O
.	O
Experiments	O
with	O
verapamil	O
and	O
nifedipine	O
revealed	O
that	O
calcium	O
influx	O
is	O
essential	O
for	O
the	O
contractile	O
activity	O
of	O
prokineticins	O
on	O
gastrointestinal	O
smooth	O
muscle	O
.	O
In	O
summary	O
,	O
we	O
have	O
identified	O
two	O
novel	O
endogenous	O
regulators	O
of	O
gastrointestinal	O
motility	O
.	O
The	O
availability	O
of	O
recombinant	O
prokineticins	O
should	O
provide	O
novel	O
therapeutic	O
agents	O
for	O
disorders	O
involving	O
impaired	O
gastrointestinal	O
motility	O
.	O

Identification	O
of	O
two	O
prokineticin	O
cDNAs	O
:	O
recombinant	O
proteins	O
potently	O
contract	O
gastrointestinal	O
smooth	O
muscle	O
.	O
The	O
motility	O
of	O
gastrointestinal	O
tract	O
is	O
regulated	O
by	O
classical	O
neurotransmitters	O
,	O
neuropeptides	O
,	O
and	O
humoral	O
agents	O
.	O
Two	O
novel	O
species1s	O
human	O
species1e	O
cDNAs	O
have	O
been	O
cloned	O
based	O
on	O
their	O
sequence	O
similarity	O
to	O
a	O
frog	O
skin	O
secretion	O
protein	O
,	O
gene1s	O
Bv8	O
gene1e	O
,	O
and	O
a	O
nontoxic	O
protein	O
of	O
mamba	O
snake	O
venom	O
.	O
These	O
species1s	O
human	O
species1e	O
cDNAs	O
encode	O
two	O
secreted	O
proteins	O
of	O
86	O
and	O
81	O
amino	O
acids	O
.	O
Northern	O
blot	O
hybridization	O
has	O
revealed	O
that	O
these	O
cDNAs	O
are	O
expressed	O
in	O
gastrointestinal	O
tract	O
,	O
particularly	O
the	O
stomach	O
.	O
Recombinant	O
proteins	O
with	O
authentic	O
N	O
-	O
terminal	O
sequences	O
have	O
been	O
produced	O
in	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
and	O
refolded	O
into	O
functional	O
proteins	O
by	O
careful	O
control	O
of	O
protein	O
aggregation	O
.	O
Mass	O
spectrometry	O
has	O
confirmed	O
the	O
formation	O
of	O
five	O
pairs	O
of	O
disulfide	O
bonds	O
.	O
The	O
refolded	O
recombinant	O
proteins	O
potently	O
contract	O
gastrointestinal	O
smooth	O
muscle	O
with	O
EC(50	O
)	O
values	O
in	O
the	O
subnanomolar	O
range	O
.	O
The	O
contractile	O
effects	O
of	O
the	O
recombinant	O
proteins	O
are	O
specific	O
for	O
gastrointestinal	O
smooth	O
muscle	O
,	O
because	O
they	O
have	O
no	O
effect	O
on	O
vascular	O
or	O
respiratory	O
smooth	O
muscle	O
.	O
To	O
reflect	O
their	O
potent	O
and	O
specific	O
effects	O
on	O
gastrointestinal	O
smooth	O
muscle	O
cells	O
,	O
we	O
have	O
named	O
these	O
recombinant	O
proteins	O
prokineticins	O
.	O
Ligand	O
binding	O
studies	O
with	O
iodinated	O
prokineticin	O
revealed	O
the	O
presence	O
of	O
a	O
high	O
-	O
affinity	O
site	O
in	O
ileal	O
smooth	O
muscle	O
.	O
The	O
displacement	O
of	O
specific	O
binding	O
by	O
GTP	O
gamma	O
S	O
suggests	O
that	O
the	O
prokineticin	O
receptor	O
may	O
belong	O
to	O
the	O
family	O
of	O
G	O
protein	O
-	O
coupled	O
receptors	O
.	O
Experiments	O
with	O
verapamil	O
and	O
nifedipine	O
revealed	O
that	O
calcium	O
influx	O
is	O
essential	O
for	O
the	O
contractile	O
activity	O
of	O
prokineticins	O
on	O
gastrointestinal	O
smooth	O
muscle	O
.	O
In	O
summary	O
,	O
we	O
have	O
identified	O
two	O
novel	O
endogenous	O
regulators	O
of	O
gastrointestinal	O
motility	O
.	O
The	O
availability	O
of	O
recombinant	O
prokineticins	O
should	O
provide	O
novel	O
therapeutic	O
agents	O
for	O
disorders	O
involving	O
impaired	O
gastrointestinal	O
motility	O
.	O

Expression	O
of	O
CaT	O
-	O
like	O
,	O
a	O
novel	O
calcium	O
-	O
selective	O
channel	O
,	O
correlates	O
with	O
the	O
malignancy	O
of	O
prostate	O
cancer	O
.	O
The	O
regulation	O
of	O
intracellular	O
Ca(2	O
+	O
)	O
plays	O
a	O
key	O
role	O
in	O
the	O
development	O
and	O
growth	O
of	O
cells	O
.	O
Here	O
we	O
report	O
the	O
cloning	O
and	O
functional	O
expression	O
of	O
a	O
highly	O
calcium	O
-	O
selective	O
channel	O
localized	O
on	O
the	O
arg1s	O
human	O
arg1e	O
chromosome	O
7	O
.	O
The	O
sequence	O
of	O
the	O
new	O
channel	O
is	O
structurally	O
related	O
to	O
the	O
gene	O
product	O
of	O
the	O
gene1s	O
CaT1	O
gene1e	O
protein	O
cloned	O
from	O
species1s	O
rat	O
species1e	O
duodenum	O
and	O
is	O
therefore	O
called	O
gene1s	O
CaT	O
-	O
like	O
gene1e	O
(	O
gene1s	O
CaT	O
-	O
L	O
gene1e	O
)	O
.	O
gene1s	ARG2
CaT	ARG2
-	ARG2
L	ARG2
gene1e	ARG2
is	O
expressed	O
in	O
locally	O
advanced	O
prostate	O
cancer	O
,	O
metastatic	O
and	O
androgen	O
-	O
insensitive	O
prostatic	O
lesions	O
but	O
is	O
undetectable	O
in	O
healthy	O
prostate	O
tissue	O
and	O
benign	O
prostatic	O
hyperplasia	O
.	O
Additionally	O
,	O
gene1s	ARG2
CaT	ARG2
-	ARG2
L	ARG2
gene1e	ARG2
is	O
expressed	O
in	O
normal	O
placenta	O
,	O
exocrine	O
pancreas	O
,	O
and	O
salivary	O
glands	O
.	O
New	O
markers	O
with	O
well	O
defined	O
biological	O
function	O
that	O
correlate	O
with	O
aberrant	O
cell	O
growth	O
are	O
needed	O
for	O
the	O
molecular	O
staging	O
of	O
cancer	O
and	O
to	O
predict	O
the	O
clinical	O
outcome	O
.	O
The	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
CaT	ARG2
-	ARG2
L	ARG2
gene1e	ARG2
channel	O
represents	O
a	O
marker	O
for	O
prostate	O
cancer	O
progression	O
and	O
may	O
serve	O
as	O
a	O
target	O
for	O
therapeutic	O
strategies	O
.	O

Expression	O
of	O
CaT	O
-	O
like	O
,	O
a	O
novel	O
calcium	O
-	O
selective	O
channel	O
,	O
correlates	O
with	O
the	O
malignancy	O
of	O
prostate	O
cancer	O
.	O
The	O
regulation	O
of	O
intracellular	O
Ca(2	O
+	O
)	O
plays	O
a	O
key	O
role	O
in	O
the	O
development	O
and	O
growth	O
of	O
cells	O
.	O
Here	O
we	O
report	O
the	O
cloning	O
and	O
functional	O
expression	O
of	O
a	O
highly	O
calcium	O
-	O
selective	O
channel	O
localized	O
on	O
the	O
species1s	O
human	O
species1e	O
chromosome	O
7	O
.	O
The	O
sequence	O
of	O
the	O
new	O
channel	O
is	O
structurally	O
related	O
to	O
the	O
gene	O
product	O
of	O
the	O
gene1s	ARG2
CaT1	ARG2
gene1e	ARG2
protein	O
cloned	O
from	O
arg1s	O
rat	O
arg1e	O
duodenum	O
and	O
is	O
therefore	O
called	O
gene1s	ARG2
CaT	ARG2
-	ARG2
like	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CaT	ARG2
-	ARG2
L	ARG2
gene1e	ARG2
)	O
.	O
gene1s	O
CaT	O
-	O
L	O
gene1e	O
is	O
expressed	O
in	O
locally	O
advanced	O
prostate	O
cancer	O
,	O
metastatic	O
and	O
androgen	O
-	O
insensitive	O
prostatic	O
lesions	O
but	O
is	O
undetectable	O
in	O
healthy	O
prostate	O
tissue	O
and	O
benign	O
prostatic	O
hyperplasia	O
.	O
Additionally	O
,	O
gene1s	O
CaT	O
-	O
L	O
gene1e	O
is	O
expressed	O
in	O
normal	O
placenta	O
,	O
exocrine	O
pancreas	O
,	O
and	O
salivary	O
glands	O
.	O
New	O
markers	O
with	O
well	O
defined	O
biological	O
function	O
that	O
correlate	O
with	O
aberrant	O
cell	O
growth	O
are	O
needed	O
for	O
the	O
molecular	O
staging	O
of	O
cancer	O
and	O
to	O
predict	O
the	O
clinical	O
outcome	O
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
CaT	O
-	O
L	O
gene1e	O
channel	O
represents	O
a	O
marker	O
for	O
prostate	O
cancer	O
progression	O
and	O
may	O
serve	O
as	O
a	O
target	O
for	O
therapeutic	O
strategies	O
.	O

arg1s	O
Human	O
arg1e	O
gene1s	ARG2
corneal	ARG2
GlcNac	ARG2
6-O	ARG2
-	ARG2
sulfotransferase	ARG2
gene1e	ARG2
and	O
species1s	O
mouse	O
species1e	O
gene1s	O
intestinal	O
GlcNac	O
6-O	O
-	O
sulfotransferase	O
gene1e	O
both	O
produce	O
keratan	O
sulfate	O
.	O
arg1s	O
Human	O
arg1e	O
gene1s	ARG2
corneal	ARG2
N	ARG2
-	ARG2
acetylglucosamine	ARG2
6-O	ARG2
-	ARG2
sulfotransferase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
hCGn6ST	ARG2
gene1e	ARG2
)	O
has	O
been	O
identified	O
by	O
the	O
positional	O
candidate	O
approach	O
as	O
the	O
gene	O
responsible	O
for	O
macular	O
corneal	O
dystrophy	O
(	O
MCD	O
)	O
.	O
Because	O
of	O
its	O
high	O
homology	O
to	O
carbohydrate	O
sulfotransferases	O
and	O
the	O
presence	O
of	O
mutations	O
of	O
this	O
gene	O
in	O
MCD	O
arg1s	O
patients	O
arg1e	O
who	O
lack	O
sulfated	O
keratan	O
sulfate	O
in	O
the	O
cornea	O
and	O
serum	O
,	O
gene1s	ARG2
hCGn6ST	ARG2
gene1e	ARG2
protein	O
is	O
thought	O
to	O
be	O
a	O
sulfotransferase	O
that	O
catalyzes	O
sulfation	O
of	O
GlcNAc	O
in	O
keratan	O
sulfate	O
.	O
In	O
this	O
report	O
,	O
we	O
analyzed	O
the	O
enzymatic	O
activity	O
of	O
gene1s	ARG2
hCGn6ST	ARG2
gene1e	ARG2
by	O
expressing	O
it	O
in	O
cultured	O
cells	O
.	O
A	O
lysate	O
prepared	O
from	O
arg1s	O
HeLa	O
arg1e	O
cells	O
transfected	O
with	O
an	O
intact	O
form	O
of	O
gene1s	ARG2
hCGn6ST	ARG2
gene1e	ARG2
cDNA	O
or	O
culture	O
medium	O
from	O
cells	O
transfected	O
with	O
a	O
secreted	O
form	O
of	O
gene1s	ARG2
hCGn6ST	ARG2
gene1e	ARG2
cDNA	O
showed	O
an	O
activity	O
of	O
transferring	O
sulfate	O
to	O
C-6	O
of	O
GlcNAc	O
of	O
synthetic	O
oligosaccharide	O
substrates	O
in	O
vitro	O
.	O
When	O
gene1s	ARG2
hCGn6ST	ARG2
gene1e	ARG2
was	O
expressed	O
together	O
with	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
keratan	ARG2
sulfate	ARG2
Gal-6-sulfotransferase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
hKSG6ST	ARG2
gene1e	ARG2
)	O
,	O
arg1s	O
HeLa	O
arg1e	O
cells	O
produced	O
highly	O
sulfated	O
carbohydrate	O
detected	O
by	O
an	O
anti	O
-	O
keratan	O
sulfate	O
antibody	O
5D4	O
.	O
These	O
results	O
indicate	O
that	O
gene1s	ARG2
hCGn6ST	ARG2
gene1e	ARG2
transfers	O
sulfate	O
to	O
C-6	O
of	O
GlcNAc	O
in	O
keratan	O
sulfate	O
.	O
Amino	O
acid	O
substitutions	O
in	O
gene1s	ARG2
hCGn6ST	ARG2
gene1e	ARG2
identical	O
to	O
changes	O
resulting	O
from	O
missense	O
mutations	O
found	O
in	O
MCD	O
arg1s	O
patients	O
arg1e	O
abolished	O
enzymatic	O
activity	O
.	O
Moreover	O
,	O
species1s	O
mouse	O
species1e	O
gene1s	O
intestinal	O
GlcNAc	O
6-O	O
-	O
sulfotransferase	O
gene1e	O
had	O
the	O
same	O
activity	O
as	O
gene1s	ARG2
hCGn6ST	ARG2
gene1e	ARG2
.	O
This	O
observation	O
suggests	O
that	O
species1s	O
mouse	O
species1e	O
gene1s	O
intestinal	O
GlcNAc	O
6-O	O
-	O
sulfotransferase	O
gene1e	O
is	O
the	O
orthologue	O
of	O
gene1s	ARG2
hCGn6ST	ARG2
gene1e	ARG2
and	O
functions	O
as	O
a	O
sulfotransferase	O
to	O
produce	O
keratan	O
sulfate	O
in	O
the	O
cornea	O
.	O

species1s	O
Human	O
species1e	O
gene1s	O
corneal	O
GlcNac	O
6-O	O
-	O
sulfotransferase	O
gene1e	O
and	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
intestinal	ARG2
GlcNac	ARG2
6-O	ARG2
-	ARG2
sulfotransferase	ARG2
gene1e	ARG2
both	O
produce	O
keratan	O
sulfate	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
corneal	O
N	O
-	O
acetylglucosamine	O
6-O	O
-	O
sulfotransferase	O
gene1e	O
(	O
gene1s	O
hCGn6ST	O
gene1e	O
)	O
has	O
been	O
identified	O
by	O
the	O
positional	O
candidate	O
approach	O
as	O
the	O
gene	O
responsible	O
for	O
macular	O
corneal	O
dystrophy	O
(	O
MCD	O
)	O
.	O
Because	O
of	O
its	O
high	O
homology	O
to	O
carbohydrate	O
sulfotransferases	O
and	O
the	O
presence	O
of	O
mutations	O
of	O
this	O
gene	O
in	O
MCD	O
species1s	O
patients	O
species1e	O
who	O
lack	O
sulfated	O
keratan	O
sulfate	O
in	O
the	O
cornea	O
and	O
serum	O
,	O
gene1s	O
hCGn6ST	O
gene1e	O
protein	O
is	O
thought	O
to	O
be	O
a	O
sulfotransferase	O
that	O
catalyzes	O
sulfation	O
of	O
GlcNAc	O
in	O
keratan	O
sulfate	O
.	O
In	O
this	O
report	O
,	O
we	O
analyzed	O
the	O
enzymatic	O
activity	O
of	O
gene1s	O
hCGn6ST	O
gene1e	O
by	O
expressing	O
it	O
in	O
cultured	O
cells	O
.	O
A	O
lysate	O
prepared	O
from	O
species1s	O
HeLa	O
species1e	O
cells	O
transfected	O
with	O
an	O
intact	O
form	O
of	O
gene1s	O
hCGn6ST	O
gene1e	O
cDNA	O
or	O
culture	O
medium	O
from	O
cells	O
transfected	O
with	O
a	O
secreted	O
form	O
of	O
gene1s	O
hCGn6ST	O
gene1e	O
cDNA	O
showed	O
an	O
activity	O
of	O
transferring	O
sulfate	O
to	O
C-6	O
of	O
GlcNAc	O
of	O
synthetic	O
oligosaccharide	O
substrates	O
in	O
vitro	O
.	O
When	O
gene1s	O
hCGn6ST	O
gene1e	O
was	O
expressed	O
together	O
with	O
species1s	O
human	O
species1e	O
gene1s	O
keratan	O
sulfate	O
Gal-6-sulfotransferase	O
gene1e	O
(	O
gene1s	O
hKSG6ST	O
gene1e	O
)	O
,	O
species1s	O
HeLa	O
species1e	O
cells	O
produced	O
highly	O
sulfated	O
carbohydrate	O
detected	O
by	O
an	O
anti	O
-	O
keratan	O
sulfate	O
antibody	O
5D4	O
.	O
These	O
results	O
indicate	O
that	O
gene1s	O
hCGn6ST	O
gene1e	O
transfers	O
sulfate	O
to	O
C-6	O
of	O
GlcNAc	O
in	O
keratan	O
sulfate	O
.	O
Amino	O
acid	O
substitutions	O
in	O
gene1s	O
hCGn6ST	O
gene1e	O
identical	O
to	O
changes	O
resulting	O
from	O
missense	O
mutations	O
found	O
in	O
MCD	O
species1s	O
patients	O
species1e	O
abolished	O
enzymatic	O
activity	O
.	O
Moreover	O
,	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
intestinal	ARG2
GlcNAc	ARG2
6-O	ARG2
-	ARG2
sulfotransferase	ARG2
gene1e	ARG2
had	O
the	O
same	O
activity	O
as	O
gene1s	O
hCGn6ST	O
gene1e	O
.	O
This	O
observation	O
suggests	O
that	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
intestinal	ARG2
GlcNAc	ARG2
6-O	ARG2
-	ARG2
sulfotransferase	ARG2
gene1e	ARG2
is	O
the	O
orthologue	O
of	O
gene1s	O
hCGn6ST	O
gene1e	O
and	O
functions	O
as	O
a	O
sulfotransferase	O
to	O
produce	O
keratan	O
sulfate	O
in	O
the	O
cornea	O
.	O

A	O
new	O
gene1s	ARG2
spectrin	ARG2
,	ARG2
beta	ARG2
IV	ARG2
gene1e	ARG2
,	O
has	O
a	O
major	O
truncated	O
isoform	O
that	O
associates	O
with	O
gene1s	ARG2
promyelocytic	ARG2
leukemia	ARG2
protein	ARG2
gene1e	ARG2
nuclear	O
bodies	O
and	O
the	O
nuclear	O
matrix	O
.	O
We	O
isolated	O
cDNAs	O
that	O
encode	O
a	O
77-kDa	O
peptide	O
similar	O
to	O
repeats	O
10	O
-	O
16	O
of	O
beta	O
-	O
spectrins	O
.	O
Its	O
gene	O
localizes	O
to	O
arg1s	O
human	O
arg1e	O
chromosome	O
19q13.13-q13.2	O
and	O
species1s	O
mouse	O
species1e	O
chromosome	O
7	O
,	O
at	O
7.5	O
centimorgans	O
.	O
A	O
289-kDa	O
isoform	O
,	O
similar	O
to	O
full	O
-	O
length	O
beta	O
-	O
spectrins	O
,	O
was	O
partially	O
assembled	O
from	O
sequences	O
in	O
the	O
arg1s	O
human	O
arg1e	O
genomic	O
DNA	O
data	O
base	O
and	O
completely	O
cloned	O
and	O
sequenced	O
.	O
RNA	O
transcripts	O
are	O
seen	O
predominantly	O
in	O
the	O
brain	O
,	O
and	O
Western	O
analysis	O
shows	O
a	O
major	O
peptide	O
that	O
migrates	O
as	O
a	O
72-kDa	O
band	O
.	O
This	O
new	O
gene	O
,	O
gene1s	ARG2
spectrin	ARG2
betaIV	ARG2
gene1e	ARG2
,	O
thus	O
encodes	O
a	O
full	O
-	O
length	O
minor	O
isoform	O
(	O
gene1s	ARG2
SpbetaIVSigma1	ARG2
gene1e	ARG2
)	O
and	O
a	O
truncated	O
major	O
isoform	O
(	O
gene1s	ARG2
SpbetaIVSigma5	ARG2
gene1e	ARG2
)	O
.	O
Immunostaining	O
of	O
cells	O
shows	O
a	O
micropunctate	O
pattern	O
in	O
the	O
cytoplasm	O
and	O
nucleus	O
.	O
In	O
mesenchymal	O
stem	O
cells	O
,	O
the	O
staining	O
concentrates	O
at	O
nuclear	O
dots	O
that	O
stain	O
positively	O
for	O
the	O
gene1s	ARG2
promyelocytic	ARG2
leukemia	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PML	ARG2
gene1e	ARG2
)	O
.	O
Expression	O
of	O
gene1s	ARG2
SpbetaIVSigma5	ARG2
gene1e	ARG2
fused	O
to	O
green	O
fluorescence	O
protein	O
in	O
cells	O
produces	O
nuclear	O
dots	O
that	O
include	O
all	O
gene1s	ARG2
PML	ARG2
gene1e	ARG2
bodies	O
,	O
which	O
double	O
in	O
number	O
in	O
transfected	O
cells	O
.	O
Deletion	O
analysis	O
shows	O
that	O
partial	O
repeats	O
10	O
and	O
16	O
of	O
gene1s	ARG2
SpbetaIVSigma5	ARG2
gene1e	ARG2
are	O
necessary	O
for	O
nuclear	O
dot	O
formation	O
.	O
Immunostaining	O
of	O
whole	O
-	O
mount	O
nuclear	O
matrices	O
reveals	O
diffuse	O
positivity	O
with	O
accentuation	O
at	O
gene1s	ARG2
PML	ARG2
gene1e	ARG2
bodies	O
.	O
gene1s	ARG2
Spectrin	ARG2
betaIV	ARG2
gene1e	ARG2
is	O
the	O
first	O
beta	O
-	O
spectrin	O
associated	O
with	O
a	O
subnuclear	O
structure	O
and	O
may	O
be	O
part	O
of	O
a	O
nuclear	O
scaffold	O
to	O
which	O
gene	O
regulatory	O
machinery	O
binds	O
.	O

A	O
new	O
gene1s	O
spectrin	O
,	O
beta	O
IV	O
gene1e	O
,	O
has	O
a	O
major	O
truncated	O
isoform	O
that	O
associates	O
with	O
gene1s	O
promyelocytic	O
leukemia	O
protein	O
gene1e	O
nuclear	O
bodies	O
and	O
the	O
nuclear	O
matrix	O
.	O
We	O
isolated	O
cDNAs	O
that	O
encode	O
a	O
77-kDa	O
peptide	O
similar	O
to	O
repeats	O
10	O
-	O
16	O
of	O
beta	O
-	O
spectrins	O
.	O
Its	O
gene	O
localizes	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
19q13.13-q13.2	O
and	O
arg1s	O
mouse	O
arg1e	O
chromosome	O
7	O
,	O
at	O
7.5	O
centimorgans	O
.	O
A	O
289-kDa	O
isoform	O
,	O
similar	O
to	O
full	O
-	O
length	O
beta	O
-	O
spectrins	O
,	O
was	O
partially	O
assembled	O
from	O
sequences	O
in	O
the	O
species1s	O
human	O
species1e	O
genomic	O
DNA	O
data	O
base	O
and	O
completely	O
cloned	O
and	O
sequenced	O
.	O
RNA	O
transcripts	O
are	O
seen	O
predominantly	O
in	O
the	O
brain	O
,	O
and	O
Western	O
analysis	O
shows	O
a	O
major	O
peptide	O
that	O
migrates	O
as	O
a	O
72-kDa	O
band	O
.	O
This	O
new	O
gene	O
,	O
gene1s	O
spectrin	O
betaIV	O
gene1e	O
,	O
thus	O
encodes	O
a	O
full	O
-	O
length	O
minor	O
isoform	O
(	O
gene1s	O
SpbetaIVSigma1	O
gene1e	O
)	O
and	O
a	O
truncated	O
major	O
isoform	O
(	O
gene1s	O
SpbetaIVSigma5	O
gene1e	O
)	O
.	O
Immunostaining	O
of	O
cells	O
shows	O
a	O
micropunctate	O
pattern	O
in	O
the	O
cytoplasm	O
and	O
nucleus	O
.	O
In	O
mesenchymal	O
stem	O
cells	O
,	O
the	O
staining	O
concentrates	O
at	O
nuclear	O
dots	O
that	O
stain	O
positively	O
for	O
the	O
gene1s	O
promyelocytic	O
leukemia	O
protein	O
gene1e	O
(	O
gene1s	O
PML	O
gene1e	O
)	O
.	O
Expression	O
of	O
gene1s	O
SpbetaIVSigma5	O
gene1e	O
fused	O
to	O
green	O
fluorescence	O
protein	O
in	O
cells	O
produces	O
nuclear	O
dots	O
that	O
include	O
all	O
gene1s	O
PML	O
gene1e	O
bodies	O
,	O
which	O
double	O
in	O
number	O
in	O
transfected	O
cells	O
.	O
Deletion	O
analysis	O
shows	O
that	O
partial	O
repeats	O
10	O
and	O
16	O
of	O
gene1s	O
SpbetaIVSigma5	O
gene1e	O
are	O
necessary	O
for	O
nuclear	O
dot	O
formation	O
.	O
Immunostaining	O
of	O
whole	O
-	O
mount	O
nuclear	O
matrices	O
reveals	O
diffuse	O
positivity	O
with	O
accentuation	O
at	O
gene1s	O
PML	O
gene1e	O
bodies	O
.	O
gene1s	O
Spectrin	O
betaIV	O
gene1e	O
is	O
the	O
first	O
beta	O
-	O
spectrin	O
associated	O
with	O
a	O
subnuclear	O
structure	O
and	O
may	O
be	O
part	O
of	O
a	O
nuclear	O
scaffold	O
to	O
which	O
gene	O
regulatory	O
machinery	O
binds	O
.	O

Extensive	O
repertoire	O
of	O
membrane	O
-	O
bound	O
and	O
soluble	O
gene1s	O
dendritic	O
cell	O
-	O
specific	O
ICAM-3-grabbing	O
nonintegrin	O
1	O
gene1e	O
(	O
gene1s	O
DC	O
-	O
SIGN1	O
gene1e	O
)	O
and	O
gene1s	O
DC	O
-	O
SIGN2	O
gene1e	O
isoforms	O
.	O
Inter	O
-	O
individual	O
variation	O
in	O
expression	O
of	O
DC	O
-	O
SIGN	O
transcripts	O
.	O
Expression	O
in	O
dendritic	O
cells	O
(	O
DCs	O
)	O
of	O
DC	O
-	O
SIGN	O
,	O
a	O
type	O
II	O
membrane	O
protein	O
with	O
a	O
C	O
-	O
type	O
lectin	O
ectodomain	O
,	O
is	O
thought	O
to	O
play	O
an	O
important	O
role	O
in	O
establishing	O
the	O
initial	O
contact	O
between	O
DCs	O
and	O
resting	O
T	O
cells	O
.	O
DC	O
-	O
SIGN	O
is	O
also	O
a	O
unique	O
type	O
of	O
arg1s	O
human	O
immunodeficiency	O
virus-1	O
arg1e	O
(	O
arg1s	O
HIV-1	O
arg1e	O
)	O
attachment	O
factor	O
and	O
promotes	O
efficient	O
infection	O
in	O
trans	O
of	O
cells	O
that	O
express	O
gene1s	O
CD4	O
gene1e	O
and	O
chemokine	O
receptors	O
.	O
We	O
have	O
identified	O
another	O
gene	O
,	O
designated	O
here	O
as	O
gene1s	O
DC	O
-	O
SIGN2	O
gene1e	O
,	O
that	O
exhibits	O
high	O
sequence	O
homology	O
with	O
DC	O
-	O
SIGN	O
.	O
Here	O
we	O
demonstrate	O
that	O
alternative	O
splicing	O
of	O
gene1s	O
DC	O
-	O
SIGN1	O
gene1e	O
(	O
original	O
version	O
)	O
and	O
gene1s	O
DC	O
-	O
SIGN2	O
gene1e	O
pre	O
-	O
mRNA	O
generates	O
a	O
large	O
repertoire	O
of	O
DC	O
-	O
SIGN	O
-	O
like	O
transcripts	O
that	O
are	O
predicted	O
to	O
encode	O
membrane	O
-	O
associated	O
and	O
soluble	O
isoforms	O
.	O
The	O
range	O
of	O
gene1s	O
DC	O
-	O
SIGN1	O
gene1e	O
mRNA	O
expression	O
was	O
significantly	O
broader	O
than	O
previously	O
reported	O
and	O
included	O
species1s	O
THP-1	O
species1e	O
monocytic	O
cells	O
,	O
placenta	O
,	O
and	O
peripheral	O
blood	O
mononuclear	O
cells	O
(	O
PBMCs	O
)	O
,	O
and	O
there	O
was	O
cell	O
maturation	O
/	O
activation	O
-	O
induced	O
differences	O
in	O
mRNA	O
expression	O
levels	O
.	O
Immunostaining	O
of	O
term	O
placenta	O
with	O
a	O
gene1s	O
DC	O
-	O
SIGN1	O
gene1e	O
-specific	O
antiserum	O
showed	O
that	O
gene1s	O
DC	O
-	O
SIGN1	O
gene1e	O
is	O
expressed	O
on	O
endothelial	O
cells	O
and	O
gene1s	O
CC	O
chemokine	O
receptor	O
5	O
gene1e	O
(	O
gene1s	O
CCR5	O
gene1e	O
)-positive	O
macrophage	O
-	O
like	O
cells	O
in	O
the	O
villi	O
.	O
gene1s	O
DC	O
-	O
SIGN2	O
gene1e	O
mRNA	O
expression	O
was	O
high	O
in	O
the	O
placenta	O
and	O
not	O
detectable	O
in	O
PBMCs	O
.	O
In	O
DCs	O
,	O
the	O
expression	O
of	O
gene1s	O
DC	O
-	O
SIGN2	O
gene1e	O
transcripts	O
was	O
significantly	O
lower	O
than	O
that	O
of	O
gene1s	O
DC	O
-	O
SIGN1	O
gene1e	O
.	O
Notably	O
,	O
there	O
was	O
significant	O
inter	O
-	O
individual	O
heterogeneity	O
in	O
the	O
repertoire	O
of	O
gene1s	O
DC	O
-	O
SIGN1	O
gene1e	O
and	O
gene1s	O
DC	O
-	O
SIGN2	O
gene1e	O
transcripts	O
expressed	O
.	O
The	O
genes	O
for	O
gene1s	O
DC	O
-	O
SIGN1	O
gene1e	O
,	O
gene1s	O
DC	O
-	O
SIGN2	O
gene1e	O
,	O
and	O
gene1s	O
CD23	O
gene1e	O
,	O
another	O
Type	O
II	O
lectin	O
,	O
colocalize	O
to	O
an	O
approximately	O
85	O
kilobase	O
pair	O
region	O
on	O
chromosome	O
19p13.3	O
,	O
forming	O
a	O
cluster	O
of	O
related	O
genes	O
that	O
undergo	O
highly	O
complex	O
alternative	O
splicing	O
events	O
.	O
The	O
molecular	O
diversity	O
of	O
gene1s	O
DC	O
-	O
SIGN-1	O
and	O
-2	O
gene1e	O
is	O
reminiscent	O
of	O
that	O
observed	O
for	O
certain	O
other	O
adhesive	O
cell	O
surface	O
proteins	O
involved	O
in	O
cell	O
-	O
cell	O
connectivity	O
.	O
The	O
generation	O
of	O
this	O
large	O
collection	O
of	O
polymorphic	O
cell	O
surface	O
and	O
soluble	O
variants	O
that	O
exhibit	O
inter	O
-	O
individual	O
variation	O
in	O
expression	O
levels	O
has	O
important	O
implications	O
for	O
the	O
pathogenesis	O
of	O
arg1s	O
HIV-1	O
arg1e	O
infection	O
,	O
as	O
well	O
as	O
for	O
the	O
molecular	O
code	O
required	O
to	O
establish	O
complex	O
interactions	O
between	O
antigen	O
-	O
presenting	O
cells	O
and	O
T	O
cells	O
,	O
i.e.	O
the	O
immunological	O
synapse	O
.	O

Extensive	O
repertoire	O
of	O
membrane	O
-	O
bound	O
and	O
soluble	O
gene1s	ARG2
dendritic	ARG2
cell	ARG2
-	ARG2
specific	ARG2
ICAM-3-grabbing	ARG2
nonintegrin	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
DC	ARG2
-	ARG2
SIGN1	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
DC	ARG2
-	ARG2
SIGN2	ARG2
gene1e	ARG2
isoforms	O
.	O
Inter	O
-	O
individual	O
variation	O
in	O
expression	O
of	O
DC	O
-	O
SIGN	O
transcripts	O
.	O
Expression	O
in	O
dendritic	O
cells	O
(	O
DCs	O
)	O
of	O
DC	O
-	O
SIGN	O
,	O
a	O
type	O
II	O
membrane	O
protein	O
with	O
a	O
C	O
-	O
type	O
lectin	O
ectodomain	O
,	O
is	O
thought	O
to	O
play	O
an	O
important	O
role	O
in	O
establishing	O
the	O
initial	O
contact	O
between	O
DCs	O
and	O
resting	O
T	O
cells	O
.	O
DC	O
-	O
SIGN	O
is	O
also	O
a	O
unique	O
type	O
of	O
species1s	O
human	O
immunodeficiency	O
virus-1	O
species1e	O
(	O
species1s	O
HIV-1	O
species1e	O
)	O
attachment	O
factor	O
and	O
promotes	O
efficient	O
infection	O
in	O
trans	O
of	O
cells	O
that	O
express	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
and	O
chemokine	O
receptors	O
.	O
We	O
have	O
identified	O
another	O
gene	O
,	O
designated	O
here	O
as	O
gene1s	ARG2
DC	ARG2
-	ARG2
SIGN2	ARG2
gene1e	ARG2
,	O
that	O
exhibits	O
high	O
sequence	O
homology	O
with	O
DC	O
-	O
SIGN	O
.	O
Here	O
we	O
demonstrate	O
that	O
alternative	O
splicing	O
of	O
gene1s	ARG2
DC	ARG2
-	ARG2
SIGN1	ARG2
gene1e	ARG2
(	O
original	O
version	O
)	O
and	O
gene1s	ARG2
DC	ARG2
-	ARG2
SIGN2	ARG2
gene1e	ARG2
pre	O
-	O
mRNA	O
generates	O
a	O
large	O
repertoire	O
of	O
DC	O
-	O
SIGN	O
-	O
like	O
transcripts	O
that	O
are	O
predicted	O
to	O
encode	O
membrane	O
-	O
associated	O
and	O
soluble	O
isoforms	O
.	O
The	O
range	O
of	O
gene1s	ARG2
DC	ARG2
-	ARG2
SIGN1	ARG2
gene1e	ARG2
mRNA	O
expression	O
was	O
significantly	O
broader	O
than	O
previously	O
reported	O
and	O
included	O
arg1s	O
THP-1	O
arg1e	O
monocytic	O
cells	O
,	O
placenta	O
,	O
and	O
peripheral	O
blood	O
mononuclear	O
cells	O
(	O
PBMCs	O
)	O
,	O
and	O
there	O
was	O
cell	O
maturation	O
/	O
activation	O
-	O
induced	O
differences	O
in	O
mRNA	O
expression	O
levels	O
.	O
Immunostaining	O
of	O
term	O
placenta	O
with	O
a	O
gene1s	ARG2
DC	ARG2
-	ARG2
SIGN1	ARG2
gene1e	ARG2
-specific	O
antiserum	O
showed	O
that	O
gene1s	ARG2
DC	ARG2
-	ARG2
SIGN1	ARG2
gene1e	ARG2
is	O
expressed	O
on	O
endothelial	O
cells	O
and	O
gene1s	ARG2
CC	ARG2
chemokine	ARG2
receptor	ARG2
5	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CCR5	ARG2
gene1e	ARG2
)-positive	O
macrophage	O
-	O
like	O
cells	O
in	O
the	O
villi	O
.	O
gene1s	ARG2
DC	ARG2
-	ARG2
SIGN2	ARG2
gene1e	ARG2
mRNA	O
expression	O
was	O
high	O
in	O
the	O
placenta	O
and	O
not	O
detectable	O
in	O
PBMCs	O
.	O
In	O
DCs	O
,	O
the	O
expression	O
of	O
gene1s	ARG2
DC	ARG2
-	ARG2
SIGN2	ARG2
gene1e	ARG2
transcripts	O
was	O
significantly	O
lower	O
than	O
that	O
of	O
gene1s	ARG2
DC	ARG2
-	ARG2
SIGN1	ARG2
gene1e	ARG2
.	O
Notably	O
,	O
there	O
was	O
significant	O
inter	O
-	O
individual	O
heterogeneity	O
in	O
the	O
repertoire	O
of	O
gene1s	ARG2
DC	ARG2
-	ARG2
SIGN1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
DC	ARG2
-	ARG2
SIGN2	ARG2
gene1e	ARG2
transcripts	O
expressed	O
.	O
The	O
genes	O
for	O
gene1s	ARG2
DC	ARG2
-	ARG2
SIGN1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
DC	ARG2
-	ARG2
SIGN2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
CD23	ARG2
gene1e	ARG2
,	O
another	O
Type	O
II	O
lectin	O
,	O
colocalize	O
to	O
an	O
approximately	O
85	O
kilobase	O
pair	O
region	O
on	O
chromosome	O
19p13.3	O
,	O
forming	O
a	O
cluster	O
of	O
related	O
genes	O
that	O
undergo	O
highly	O
complex	O
alternative	O
splicing	O
events	O
.	O
The	O
molecular	O
diversity	O
of	O
gene1s	ARG2
DC	ARG2
-	ARG2
SIGN-1	ARG2
and	ARG2
-2	ARG2
gene1e	ARG2
is	O
reminiscent	O
of	O
that	O
observed	O
for	O
certain	O
other	O
adhesive	O
cell	O
surface	O
proteins	O
involved	O
in	O
cell	O
-	O
cell	O
connectivity	O
.	O
The	O
generation	O
of	O
this	O
large	O
collection	O
of	O
polymorphic	O
cell	O
surface	O
and	O
soluble	O
variants	O
that	O
exhibit	O
inter	O
-	O
individual	O
variation	O
in	O
expression	O
levels	O
has	O
important	O
implications	O
for	O
the	O
pathogenesis	O
of	O
species1s	O
HIV-1	O
species1e	O
infection	O
,	O
as	O
well	O
as	O
for	O
the	O
molecular	O
code	O
required	O
to	O
establish	O
complex	O
interactions	O
between	O
antigen	O
-	O
presenting	O
cells	O
and	O
T	O
cells	O
,	O
i.e.	O
the	O
immunological	O
synapse	O
.	O

Identification	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
crooked	ARG2
neck	ARG2
gene1e	ARG2
gene	O
by	O
comparative	O
gene	O
identification	O
.	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
serves	O
as	O
a	O
useful	O
model	O
organism	O
for	O
functional	O
genomic	O
studies	O
,	O
and	O
its	O
genome	O
project	O
was	O
recently	O
completed	O
.	O
We	O
previously	O
described	O
a	O
comparative	O
-	O
gene	O
-	O
identification	O
approach	O
to	O
assist	O
arg1s	O
human	O
arg1e	O
ortholog	O
gene	O
identification	O
that	O
involves	O
applying	O
an	O
entire	O
proteome	O
as	O
an	O
alignment	O
template	O
.	O
Analysis	O
of	O
the	O
available	O
14100	O
species1s	O
Drosophila	O
species1e	O
protein	O
sequences	O
revealed	O
that	O
37	O
%	O
of	O
them	O
(	O
5228	O
sequences	O
)	O
might	O
lead	O
to	O
discoveries	O
of	O
novel	O
arg1s	O
human	O
arg1e	O
genes	O
.	O
Upon	O
further	O
database	O
interrogations	O
,	O
we	O
found	O
several	O
putative	O
full	O
-	O
length	O
arg1s	O
human	O
arg1e	O
gene	O
transcripts	O
,	O
including	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
crooked	ARG2
neck	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
crn	ARG2
gene1e	ARG2
)	O
gene	O
.	O
Based	O
on	O
sequence	O
gap	O
-	O
closure	O
experiments	O
using	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
as	O
well	O
as	O
bioinformatic	O
analysis	O
,	O
we	O
found	O
that	O
the	O
assembled	O
arg1s	O
human	O
arg1e	O
cDNA	O
contig	O
of	O
gene1s	ARG2
crooked	ARG2
neck	ARG2
gene1e	ARG2
gene	O
was	O
at	O
least	O
3903	O
base	O
pairs	O
in	O
length	O
with	O
alternative	O
splicing	O
variations	O
which	O
encoded	O
mainly	O
for	O
a	O
687-amino	O
-	O
acid	O
residue	O
protein	O
.	O
The	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
crooked	ARG2
neck	ARG2
gene1e	ARG2
gene	O
was	O
located	O
on	O
chromosome	O
20	O
with	O
at	O
least	O
15	O
exons	O
.	O
The	O
unique	O
features	O
of	O
the	O
16	O
copies	O
of	O
the	O
tetratrico	O
peptide	O
repeat	O
(	O
TPR	O
)	O
motif	O
were	O
conserved	O
in	O
the	O
species1s	O
yeast	O
species1e	O
,	O
species1s	O
fly	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
crooked	ARG2
neck	ARG2
gene1e	ARG2
orthologous	O
proteins	O
,	O
which	O
were	O
important	O
for	O
spliceosome	O
assembly	O
in	O
cells	O
.	O

Identification	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
crooked	O
neck	O
gene1e	O
gene	O
by	O
comparative	O
gene	O
identification	O
.	O
arg1s	O
Drosophila	O
melanogaster	O
arg1e	O
serves	O
as	O
a	O
useful	O
model	O
organism	O
for	O
functional	O
genomic	O
studies	O
,	O
and	O
its	O
genome	O
project	O
was	O
recently	O
completed	O
.	O
We	O
previously	O
described	O
a	O
comparative	O
-	O
gene	O
-	O
identification	O
approach	O
to	O
assist	O
species1s	O
human	O
species1e	O
ortholog	O
gene	O
identification	O
that	O
involves	O
applying	O
an	O
entire	O
proteome	O
as	O
an	O
alignment	O
template	O
.	O
Analysis	O
of	O
the	O
available	O
14100	O
arg1s	O
Drosophila	O
arg1e	O
protein	O
sequences	O
revealed	O
that	O
37	O
%	O
of	O
them	O
(	O
5228	O
sequences	O
)	O
might	O
lead	O
to	O
discoveries	O
of	O
novel	O
species1s	O
human	O
species1e	O
genes	O
.	O
Upon	O
further	O
database	O
interrogations	O
,	O
we	O
found	O
several	O
putative	O
full	O
-	O
length	O
species1s	O
human	O
species1e	O
gene	O
transcripts	O
,	O
including	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
crooked	O
neck	O
gene1e	O
(	O
gene1s	O
crn	O
gene1e	O
)	O
gene	O
.	O
Based	O
on	O
sequence	O
gap	O
-	O
closure	O
experiments	O
using	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
as	O
well	O
as	O
bioinformatic	O
analysis	O
,	O
we	O
found	O
that	O
the	O
assembled	O
species1s	O
human	O
species1e	O
cDNA	O
contig	O
of	O
gene1s	O
crooked	O
neck	O
gene1e	O
gene	O
was	O
at	O
least	O
3903	O
base	O
pairs	O
in	O
length	O
with	O
alternative	O
splicing	O
variations	O
which	O
encoded	O
mainly	O
for	O
a	O
687-amino	O
-	O
acid	O
residue	O
protein	O
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
crooked	O
neck	O
gene1e	O
gene	O
was	O
located	O
on	O
chromosome	O
20	O
with	O
at	O
least	O
15	O
exons	O
.	O
The	O
unique	O
features	O
of	O
the	O
16	O
copies	O
of	O
the	O
tetratrico	O
peptide	O
repeat	O
(	O
TPR	O
)	O
motif	O
were	O
conserved	O
in	O
the	O
species1s	O
yeast	O
species1e	O
,	O
arg1s	O
fly	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
gene1s	O
crooked	O
neck	O
gene1e	O
orthologous	O
proteins	O
,	O
which	O
were	O
important	O
for	O
spliceosome	O
assembly	O
in	O
cells	O
.	O

Identification	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
crooked	O
neck	O
gene1e	O
gene	O
by	O
comparative	O
gene	O
identification	O
.	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
serves	O
as	O
a	O
useful	O
model	O
organism	O
for	O
functional	O
genomic	O
studies	O
,	O
and	O
its	O
genome	O
project	O
was	O
recently	O
completed	O
.	O
We	O
previously	O
described	O
a	O
comparative	O
-	O
gene	O
-	O
identification	O
approach	O
to	O
assist	O
species1s	O
human	O
species1e	O
ortholog	O
gene	O
identification	O
that	O
involves	O
applying	O
an	O
entire	O
proteome	O
as	O
an	O
alignment	O
template	O
.	O
Analysis	O
of	O
the	O
available	O
14100	O
species1s	O
Drosophila	O
species1e	O
protein	O
sequences	O
revealed	O
that	O
37	O
%	O
of	O
them	O
(	O
5228	O
sequences	O
)	O
might	O
lead	O
to	O
discoveries	O
of	O
novel	O
species1s	O
human	O
species1e	O
genes	O
.	O
Upon	O
further	O
database	O
interrogations	O
,	O
we	O
found	O
several	O
putative	O
full	O
-	O
length	O
species1s	O
human	O
species1e	O
gene	O
transcripts	O
,	O
including	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
crooked	O
neck	O
gene1e	O
(	O
gene1s	O
crn	O
gene1e	O
)	O
gene	O
.	O
Based	O
on	O
sequence	O
gap	O
-	O
closure	O
experiments	O
using	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
as	O
well	O
as	O
bioinformatic	O
analysis	O
,	O
we	O
found	O
that	O
the	O
assembled	O
species1s	O
human	O
species1e	O
cDNA	O
contig	O
of	O
gene1s	O
crooked	O
neck	O
gene1e	O
gene	O
was	O
at	O
least	O
3903	O
base	O
pairs	O
in	O
length	O
with	O
alternative	O
splicing	O
variations	O
which	O
encoded	O
mainly	O
for	O
a	O
687-amino	O
-	O
acid	O
residue	O
protein	O
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
crooked	O
neck	O
gene1e	O
gene	O
was	O
located	O
on	O
chromosome	O
20	O
with	O
at	O
least	O
15	O
exons	O
.	O
The	O
unique	O
features	O
of	O
the	O
16	O
copies	O
of	O
the	O
tetratrico	O
peptide	O
repeat	O
(	O
TPR	O
)	O
motif	O
were	O
conserved	O
in	O
the	O
arg1s	O
yeast	O
arg1e	O
,	O
species1s	O
fly	O
species1e	O
and	O
species1s	O
human	O
species1e	O
gene1s	O
crooked	O
neck	O
gene1e	O
orthologous	O
proteins	O
,	O
which	O
were	O
important	O
for	O
spliceosome	O
assembly	O
in	O
cells	O
.	O

Identification	O
of	O
a	O
novel	O
fibroblast	O
growth	O
factor	O
,	O
gene1s	ARG2
FGF-22	ARG2
gene1e	ARG2
,	O
preferentially	O
expressed	O
in	O
the	O
inner	O
root	O
sheath	O
of	O
the	O
hair	O
follicle	O
.	O
We	O
isolated	O
cDNA	O
encoding	O
a	O
novel	O
fibroblast	O
growth	O
factor	O
(	O
gene1s	ARG2
FGF-22	ARG2
gene1e	ARG2
)	O
(	O
170	O
amino	O
acids	O
)	O
from	O
arg1s	O
human	O
arg1e	O
placenta	O
.	O
Of	O
the	O
FGF	O
family	O
members	O
,	O
gene1s	ARG2
FGF-22	ARG2
gene1e	ARG2
,	O
which	O
appears	O
to	O
be	O
a	O
secreted	O
protein	O
,	O
is	O
most	O
similar	O
to	O
gene1s	ARG2
FGF-10	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
FGF-7	ARG2
gene1e	ARG2
(	O
approximately	O
46	O
%	O
and	O
approximately	O
40	O
%	O
amino	O
acid	O
identities	O
,	O
respectively	O
)	O
.	O
The	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
FGF-22	ARG2
gene1e	ARG2
gene	O
was	O
localized	O
on	O
chromosome	O
19p13.3	O
.	O
We	O
also	O
isolated	O
species1s	O
mouse	O
species1e	O
cDNA	O
encoding	O
gene1s	O
FGF-22	O
gene1e	O
(	O
162	O
amino	O
acids	O
)	O
from	O
the	O
skin	O
.	O
species1s	O
Mouse	O
species1e	O
gene1s	O
FGF-22	O
gene1e	O
shows	O
high	O
homology	O
(	O
87	O
%	O
amino	O
acid	O
identity	O
)	O
to	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
FGF-22	ARG2
gene1e	ARG2
.	O
species1s	O
Mouse	O
species1e	O
gene1s	O
FGF-22	O
gene1e	O
mRNA	O
was	O
found	O
to	O
be	O
preferentially	O
expressed	O
in	O
the	O
skin	O
among	O
the	O
species1s	O
mouse	O
species1e	O
adult	O
tissues	O
examined	O
by	O
Northern	O
blotting	O
analysis	O
.	O
By	O
in	O
situ	O
hybridization	O
,	O
gene1s	ARG2
FGF-22	ARG2
gene1e	ARG2
mRNA	O
in	O
the	O
skin	O
was	O
found	O
to	O
be	O
preferentially	O
expressed	O
in	O
the	O
inner	O
root	O
sheath	O
of	O
the	O
hair	O
follicle	O
.	O
Therefore	O
,	O
gene1s	ARG2
FGF-22	ARG2
gene1e	ARG2
is	O
expected	O
to	O
be	O
a	O
unique	O
FGF	O
that	O
plays	O
a	O
role	O
in	O
hair	O
development	O
.	O

Identification	O
of	O
a	O
novel	O
fibroblast	O
growth	O
factor	O
,	O
gene1s	O
FGF-22	O
gene1e	O
,	O
preferentially	O
expressed	O
in	O
the	O
inner	O
root	O
sheath	O
of	O
the	O
hair	O
follicle	O
.	O
We	O
isolated	O
cDNA	O
encoding	O
a	O
novel	O
fibroblast	O
growth	O
factor	O
(	O
gene1s	O
FGF-22	O
gene1e	O
)	O
(	O
170	O
amino	O
acids	O
)	O
from	O
species1s	O
human	O
species1e	O
placenta	O
.	O
Of	O
the	O
FGF	O
family	O
members	O
,	O
gene1s	O
FGF-22	O
gene1e	O
,	O
which	O
appears	O
to	O
be	O
a	O
secreted	O
protein	O
,	O
is	O
most	O
similar	O
to	O
gene1s	O
FGF-10	O
gene1e	O
and	O
gene1s	O
FGF-7	O
gene1e	O
(	O
approximately	O
46	O
%	O
and	O
approximately	O
40	O
%	O
amino	O
acid	O
identities	O
,	O
respectively	O
)	O
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
FGF-22	O
gene1e	O
gene	O
was	O
localized	O
on	O
chromosome	O
19p13.3	O
.	O
We	O
also	O
isolated	O
arg1s	O
mouse	O
arg1e	O
cDNA	O
encoding	O
gene1s	ARG2
FGF-22	ARG2
gene1e	ARG2
(	O
162	O
amino	O
acids	O
)	O
from	O
the	O
skin	O
.	O
arg1s	O
Mouse	O
arg1e	O
gene1s	ARG2
FGF-22	ARG2
gene1e	ARG2
shows	O
high	O
homology	O
(	O
87	O
%	O
amino	O
acid	O
identity	O
)	O
to	O
species1s	O
human	O
species1e	O
gene1s	O
FGF-22	O
gene1e	O
.	O
arg1s	O
Mouse	O
arg1e	O
gene1s	ARG2
FGF-22	ARG2
gene1e	ARG2
mRNA	O
was	O
found	O
to	O
be	O
preferentially	O
expressed	O
in	O
the	O
skin	O
among	O
the	O
arg1s	O
mouse	O
arg1e	O
adult	O
tissues	O
examined	O
by	O
Northern	O
blotting	O
analysis	O
.	O
By	O
in	O
situ	O
hybridization	O
,	O
gene1s	O
FGF-22	O
gene1e	O
mRNA	O
in	O
the	O
skin	O
was	O
found	O
to	O
be	O
preferentially	O
expressed	O
in	O
the	O
inner	O
root	O
sheath	O
of	O
the	O
hair	O
follicle	O
.	O
Therefore	O
,	O
gene1s	O
FGF-22	O
gene1e	O
is	O
expected	O
to	O
be	O
a	O
unique	O
FGF	O
that	O
plays	O
a	O
role	O
in	O
hair	O
development	O
.	O

Molecular	O
cloning	O
and	O
mapping	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
nicotinic	ARG2
acetylcholine	ARG2
receptor	ARG2
alpha10	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CHRNA10	ARG2
gene1e	ARG2
)	O
.	O
We	O
report	O
the	O
isolation	O
and	O
initial	O
characterization	O
of	O
a	O
new	O
member	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
nicotinic	ARG2
acetylcholine	ARG2
receptor	ARG2
(	ARG2
nAChR	ARG2
)	ARG2
subunit	ARG2
family	ARG2
,	ARG2
alpha10	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CHRNA10	ARG2
gene1e	ARG2
)	O
,	O
from	O
both	O
inner	O
-	O
ear	O
neuroepithelium	O
and	O
lymphoid	O
tissue	O
.	O
The	O
cDNA	O
is	O
1959	O
nucleotides	O
in	O
length	O
,	O
with	O
a	O
coding	O
region	O
predicting	O
a	O
protein	O
of	O
451	O
amino	O
acids	O
that	O
is	O
90	O
%	O
identical	O
to	O
species1s	O
rat	O
species1e	O
alpha10	O
.	O
The	O
alpha10	O
gene	O
was	O
localized	O
to	O
chromosome	O
11p15.5	O
.	O
arg1s	O
Human	O
arg1e	O
alpha10	O
was	O
detected	O
in	O
arg1s	O
human	O
arg1e	O
inner	O
-	O
ear	O
tissue	O
,	O
tonsil	O
,	O
immortalized	O
B	O
-	O
cells	O
,	O
cultured	O
T	O
-	O
cells	O
and	O
peripheral	O
blood	O
lymphocytes	O
using	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
,	O
Northern	O
blot	O
hybridization	O
,	O
and	O
immunohistochemistry	O
.	O
We	O
also	O
detected	O
the	O
expression	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
nAChR	ARG2
alpha9	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CHRNA9	ARG2
gene1e	ARG2
)	O
mRNA	O
in	O
these	O
same	O
tissues	O
using	O
RT	O
-	O
PCR	O
and	O
Northern	O
blot	O
hybridization	O
.	O
Copyright	O
2001	O
Academic	O
Press	O
.	O

Molecular	O
cloning	O
and	O
mapping	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
nicotinic	O
acetylcholine	O
receptor	O
alpha10	O
gene1e	O
(	O
gene1s	O
CHRNA10	O
gene1e	O
)	O
.	O
We	O
report	O
the	O
isolation	O
and	O
initial	O
characterization	O
of	O
a	O
new	O
member	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
nicotinic	O
acetylcholine	O
receptor	O
(	O
nAChR	O
)	O
subunit	O
family	O
,	O
alpha10	O
gene1e	O
(	O
gene1s	O
CHRNA10	O
gene1e	O
)	O
,	O
from	O
both	O
inner	O
-	O
ear	O
neuroepithelium	O
and	O
lymphoid	O
tissue	O
.	O
The	O
cDNA	O
is	O
1959	O
nucleotides	O
in	O
length	O
,	O
with	O
a	O
coding	O
region	O
predicting	O
a	O
protein	O
of	O
451	O
amino	O
acids	O
that	O
is	O
90	O
%	O
identical	O
to	O
arg1s	O
rat	O
arg1e	O
alpha10	O
.	O
The	O
alpha10	O
gene	O
was	O
localized	O
to	O
chromosome	O
11p15.5	O
.	O
species1s	O
Human	O
species1e	O
alpha10	O
was	O
detected	O
in	O
species1s	O
human	O
species1e	O
inner	O
-	O
ear	O
tissue	O
,	O
tonsil	O
,	O
immortalized	O
B	O
-	O
cells	O
,	O
cultured	O
T	O
-	O
cells	O
and	O
peripheral	O
blood	O
lymphocytes	O
using	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
,	O
Northern	O
blot	O
hybridization	O
,	O
and	O
immunohistochemistry	O
.	O
We	O
also	O
detected	O
the	O
expression	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
nAChR	O
alpha9	O
gene1e	O
(	O
gene1s	O
CHRNA9	O
gene1e	O
)	O
mRNA	O
in	O
these	O
same	O
tissues	O
using	O
RT	O
-	O
PCR	O
and	O
Northern	O
blot	O
hybridization	O
.	O
Copyright	O
2001	O
Academic	O
Press	O
.	O

Large	O
-	O
scale	O
identification	O
of	O
arg1s	O
mammalian	O
arg1e	O
proteins	O
localized	O
to	O
nuclear	O
sub	O
-	O
compartments	O
.	O
Many	O
nuclear	O
components	O
participating	O
in	O
related	O
pathways	O
appear	O
concentrated	O
in	O
specific	O
areas	O
of	O
the	O
arg1s	O
mammalian	O
arg1e	O
nucleus	O
.	O
The	O
importance	O
of	O
this	O
organization	O
is	O
attested	O
to	O
by	O
the	O
dysfunction	O
that	O
correlates	O
with	O
mis	O
-	O
localization	O
of	O
nuclear	O
proteins	O
in	O
arg1s	O
human	O
arg1e	O
disease	O
and	O
cancer	O
.	O
Determining	O
the	O
sub	O
-	O
nuclear	O
localization	O
of	O
proteins	O
is	O
therefore	O
important	O
for	O
understanding	O
genome	O
regulation	O
and	O
function	O
,	O
and	O
it	O
also	O
provides	O
clues	O
to	O
function	O
for	O
novel	O
proteins	O
.	O
However	O
,	O
the	O
complexity	O
of	O
proteins	O
in	O
the	O
arg1s	O
mammalian	O
arg1e	O
nucleus	O
is	O
too	O
large	O
to	O
tackle	O
this	O
on	O
a	O
protein	O
by	O
protein	O
basis	O
.	O
Large	O
-	O
scale	O
approaches	O
to	O
determining	O
protein	O
function	O
and	O
sub	O
-	O
cellular	O
localization	O
are	O
required	O
.	O
We	O
have	O
used	O
a	O
visual	O
gene	O
trap	O
screen	O
to	O
identify	O
more	O
than	O
100	O
proteins	O
,	O
many	O
of	O
which	O
are	O
normal	O
,	O
located	O
within	O
compartments	O
of	O
the	O
species1s	O
mouse	O
species1e	O
nucleus	O
.	O
The	O
most	O
common	O
discrete	O
localizations	O
detected	O
are	O
at	O
the	O
nucleolus	O
and	O
the	O
splicing	O
speckles	O
and	O
on	O
chromosomes	O
.	O
Proteins	O
at	O
the	O
nuclear	O
periphery	O
,	O
or	O
in	O
other	O
nuclear	O
foci	O
,	O
have	O
also	O
been	O
identified	O
.	O
Several	O
of	O
the	O
proteins	O
have	O
been	O
implicated	O
in	O
arg1s	O
human	O
arg1e	O
disease	O
or	O
cancer	O
,	O
e.g.	O
gene1s	ARG2
ATRX	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HMGI	ARG2
-	ARG2
C	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NBS1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
EWS	ARG2
gene1e	ARG2
,	O
and	O
the	O
gene	O
-	O
trapped	O
proteins	O
provide	O
a	O
route	O
into	O
further	O
understanding	O
their	O
function	O
.	O
We	O
find	O
that	O
sequence	O
motifs	O
are	O
often	O
shared	O
amongst	O
proteins	O
co	O
-	O
localized	O
within	O
the	O
same	O
sub	O
-	O
nuclear	O
compartment	O
.	O
Conversely	O
,	O
some	O
generally	O
abundant	O
motifs	O
are	O
lacking	O
from	O
the	O
proteins	O
concentrated	O
in	O
specific	O
areas	O
of	O
the	O
nucleus	O
.	O
This	O
suggests	O
that	O
we	O
may	O
be	O
able	O
to	O
predict	O
sub	O
-	O
nuclear	O
localization	O
for	O
proteins	O
in	O
databases	O
based	O
on	O
their	O
sequence	O
.	O

Large	O
-	O
scale	O
identification	O
of	O
species1s	O
mammalian	O
species1e	O
proteins	O
localized	O
to	O
nuclear	O
sub	O
-	O
compartments	O
.	O
Many	O
nuclear	O
components	O
participating	O
in	O
related	O
pathways	O
appear	O
concentrated	O
in	O
specific	O
areas	O
of	O
the	O
species1s	O
mammalian	O
species1e	O
nucleus	O
.	O
The	O
importance	O
of	O
this	O
organization	O
is	O
attested	O
to	O
by	O
the	O
dysfunction	O
that	O
correlates	O
with	O
mis	O
-	O
localization	O
of	O
nuclear	O
proteins	O
in	O
species1s	O
human	O
species1e	O
disease	O
and	O
cancer	O
.	O
Determining	O
the	O
sub	O
-	O
nuclear	O
localization	O
of	O
proteins	O
is	O
therefore	O
important	O
for	O
understanding	O
genome	O
regulation	O
and	O
function	O
,	O
and	O
it	O
also	O
provides	O
clues	O
to	O
function	O
for	O
novel	O
proteins	O
.	O
However	O
,	O
the	O
complexity	O
of	O
proteins	O
in	O
the	O
species1s	O
mammalian	O
species1e	O
nucleus	O
is	O
too	O
large	O
to	O
tackle	O
this	O
on	O
a	O
protein	O
by	O
protein	O
basis	O
.	O
Large	O
-	O
scale	O
approaches	O
to	O
determining	O
protein	O
function	O
and	O
sub	O
-	O
cellular	O
localization	O
are	O
required	O
.	O
We	O
have	O
used	O
a	O
visual	O
gene	O
trap	O
screen	O
to	O
identify	O
more	O
than	O
100	O
proteins	O
,	O
many	O
of	O
which	O
are	O
normal	O
,	O
located	O
within	O
compartments	O
of	O
the	O
arg1s	O
mouse	O
arg1e	O
nucleus	O
.	O
The	O
most	O
common	O
discrete	O
localizations	O
detected	O
are	O
at	O
the	O
nucleolus	O
and	O
the	O
splicing	O
speckles	O
and	O
on	O
chromosomes	O
.	O
Proteins	O
at	O
the	O
nuclear	O
periphery	O
,	O
or	O
in	O
other	O
nuclear	O
foci	O
,	O
have	O
also	O
been	O
identified	O
.	O
Several	O
of	O
the	O
proteins	O
have	O
been	O
implicated	O
in	O
species1s	O
human	O
species1e	O
disease	O
or	O
cancer	O
,	O
e.g.	O
gene1s	O
ATRX	O
gene1e	O
,	O
gene1s	O
HMGI	O
-	O
C	O
gene1e	O
,	O
gene1s	O
NBS1	O
gene1e	O
and	O
gene1s	O
EWS	O
gene1e	O
,	O
and	O
the	O
gene	O
-	O
trapped	O
proteins	O
provide	O
a	O
route	O
into	O
further	O
understanding	O
their	O
function	O
.	O
We	O
find	O
that	O
sequence	O
motifs	O
are	O
often	O
shared	O
amongst	O
proteins	O
co	O
-	O
localized	O
within	O
the	O
same	O
sub	O
-	O
nuclear	O
compartment	O
.	O
Conversely	O
,	O
some	O
generally	O
abundant	O
motifs	O
are	O
lacking	O
from	O
the	O
proteins	O
concentrated	O
in	O
specific	O
areas	O
of	O
the	O
nucleus	O
.	O
This	O
suggests	O
that	O
we	O
may	O
be	O
able	O
to	O
predict	O
sub	O
-	O
nuclear	O
localization	O
for	O
proteins	O
in	O
databases	O
based	O
on	O
their	O
sequence	O
.	O

gene1s	ARG2
CHMP1	ARG2
gene1e	ARG2
is	O
a	O
novel	O
nuclear	O
matrix	O
protein	O
affecting	O
chromatin	O
structure	O
and	O
cell	O
-	O
cycle	O
progression	O
.	O
The	O
Polycomb	O
-	O
group	O
(	O
PcG	O
)	O
is	O
a	O
diverse	O
set	O
of	O
proteins	O
required	O
for	O
maintenance	O
of	O
gene	O
silencing	O
during	O
development	O
.	O
In	O
a	O
screen	O
for	O
conserved	O
partners	O
of	O
the	O
PcG	O
protein	O
gene1s	ARG2
Polycomblike	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Pcl	ARG2
gene1e	ARG2
)	O
,	O
we	O
have	O
identified	O
a	O
new	O
protein	O
,	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
CHMP1	ARG2
gene1e	ARG2
(	O
CHromatin	O
Modifying	O
Protein	O
;	O
CHarged	O
Multivesicular	O
body	O
Protein	O
)	O
,	O
which	O
is	O
encoded	O
by	O
an	O
alternative	O
open	O
reading	O
frame	O
in	O
the	O
gene1s	ARG2
PRSM1	ARG2
gene1e	ARG2
gene	O
and	O
is	O
conserved	O
in	O
both	O
complex	O
and	O
simple	O
eukaryotes	O
.	O
gene1s	ARG2
CHMP1	ARG2
gene1e	ARG2
contains	O
a	O
predicted	O
bipartite	O
nuclear	O
localization	O
signal	O
and	O
distributes	O
as	O
distinct	O
forms	O
to	O
the	O
cytoplasm	O
and	O
the	O
nuclear	O
matrix	O
in	O
all	O
cell	O
lines	O
tested	O
.	O
We	O
have	O
constructed	O
a	O
stable	O
arg1s	O
HEK293	O
arg1e	O
cell	O
line	O
that	O
inducibly	O
overexpresses	O
gene1s	ARG2
CHMP1	ARG2
gene1e	ARG2
under	O
ecdysone	O
control	O
.	O
Overexpressed	O
gene1s	ARG2
CHMP1	ARG2
gene1e	ARG2
localizes	O
to	O
a	O
punctate	O
subnuclear	O
pattern	O
,	O
encapsulating	O
regions	O
of	O
nuclease	O
-	O
resistant	O
,	O
condensed	O
chromatin	O
.	O
These	O
novel	O
structures	O
are	O
also	O
frequently	O
surrounded	O
by	O
increased	O
histone	O
H3	O
phosphorylation	O
and	O
acetylation	O
.	O
gene1s	ARG2
CHMP1	ARG2
gene1e	ARG2
can	O
recruit	O
a	O
PcG	O
protein	O
,	O
gene1s	O
BMI1	O
gene1e	O
,	O
to	O
these	O
regions	O
of	O
condensed	O
chromatin	O
and	O
can	O
cooperate	O
with	O
co	O
-	O
expressed	O
vertebrate	O
gene1s	O
Pcl	O
gene1e	O
in	O
a	O
species1s	O
Xenopus	O
species1e	O
embryo	O
PcG	O
assay	O
;	O
this	O
is	O
consistent	O
with	O
a	O
role	O
in	O
PcG	O
function	O
.	O
In	O
combination	O
,	O
these	O
observations	O
suggest	O
that	O
gene1s	ARG2
CHMP1	ARG2
gene1e	ARG2
plays	O
a	O
role	O
in	O
stable	O
gene	O
silencing	O
within	O
the	O
nucleus	O
.	O

gene1s	O
CHMP1	O
gene1e	O
is	O
a	O
novel	O
nuclear	O
matrix	O
protein	O
affecting	O
chromatin	O
structure	O
and	O
cell	O
-	O
cycle	O
progression	O
.	O
The	O
Polycomb	O
-	O
group	O
(	O
PcG	O
)	O
is	O
a	O
diverse	O
set	O
of	O
proteins	O
required	O
for	O
maintenance	O
of	O
gene	O
silencing	O
during	O
development	O
.	O
In	O
a	O
screen	O
for	O
conserved	O
partners	O
of	O
the	O
PcG	O
protein	O
gene1s	O
Polycomblike	O
gene1e	O
(	O
gene1s	O
Pcl	O
gene1e	O
)	O
,	O
we	O
have	O
identified	O
a	O
new	O
protein	O
,	O
species1s	O
human	O
species1e	O
gene1s	O
CHMP1	O
gene1e	O
(	O
CHromatin	O
Modifying	O
Protein	O
;	O
CHarged	O
Multivesicular	O
body	O
Protein	O
)	O
,	O
which	O
is	O
encoded	O
by	O
an	O
alternative	O
open	O
reading	O
frame	O
in	O
the	O
gene1s	O
PRSM1	O
gene1e	O
gene	O
and	O
is	O
conserved	O
in	O
both	O
complex	O
and	O
simple	O
eukaryotes	O
.	O
gene1s	O
CHMP1	O
gene1e	O
contains	O
a	O
predicted	O
bipartite	O
nuclear	O
localization	O
signal	O
and	O
distributes	O
as	O
distinct	O
forms	O
to	O
the	O
cytoplasm	O
and	O
the	O
nuclear	O
matrix	O
in	O
all	O
cell	O
lines	O
tested	O
.	O
We	O
have	O
constructed	O
a	O
stable	O
species1s	O
HEK293	O
species1e	O
cell	O
line	O
that	O
inducibly	O
overexpresses	O
gene1s	O
CHMP1	O
gene1e	O
under	O
ecdysone	O
control	O
.	O
Overexpressed	O
gene1s	O
CHMP1	O
gene1e	O
localizes	O
to	O
a	O
punctate	O
subnuclear	O
pattern	O
,	O
encapsulating	O
regions	O
of	O
nuclease	O
-	O
resistant	O
,	O
condensed	O
chromatin	O
.	O
These	O
novel	O
structures	O
are	O
also	O
frequently	O
surrounded	O
by	O
increased	O
histone	O
H3	O
phosphorylation	O
and	O
acetylation	O
.	O
gene1s	O
CHMP1	O
gene1e	O
can	O
recruit	O
a	O
PcG	O
protein	O
,	O
gene1s	ARG2
BMI1	ARG2
gene1e	ARG2
,	O
to	O
these	O
regions	O
of	O
condensed	O
chromatin	O
and	O
can	O
cooperate	O
with	O
co	O
-	O
expressed	O
vertebrate	O
gene1s	ARG2
Pcl	ARG2
gene1e	ARG2
in	O
a	O
arg1s	O
Xenopus	O
arg1e	O
embryo	O
PcG	O
assay	O
;	O
this	O
is	O
consistent	O
with	O
a	O
role	O
in	O
PcG	O
function	O
.	O
In	O
combination	O
,	O
these	O
observations	O
suggest	O
that	O
gene1s	O
CHMP1	O
gene1e	O
plays	O
a	O
role	O
in	O
stable	O
gene	O
silencing	O
within	O
the	O
nucleus	O
.	O

gene1s	ARG2
CHMP1	ARG2
gene1e	ARG2
functions	O
as	O
a	O
member	O
of	O
a	O
newly	O
defined	O
family	O
of	O
vesicle	O
trafficking	O
proteins	O
.	O
A	O
multivesicular	O
body	O
is	O
a	O
vesicle	O
-	O
filled	O
endosome	O
that	O
targets	O
proteins	O
to	O
the	O
interior	O
of	O
lysosomes	O
.	O
We	O
have	O
identified	O
a	O
conserved	O
eukaryotic	O
protein	O
,	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
CHMP1	ARG2
gene1e	ARG2
,	O
which	O
is	O
strongly	O
implicated	O
in	O
multivesicular	O
body	O
formation	O
.	O
Immunocytochemistry	O
and	O
biochemical	O
fractionation	O
localize	O
gene1s	ARG2
CHMP1	ARG2
gene1e	ARG2
to	O
early	O
endosomes	O
and	O
gene1s	ARG2
CHMP1	ARG2
gene1e	ARG2
physically	O
interacts	O
with	O
gene1s	ARG2
SKD1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
VPS4	ARG2
gene1e	ARG2
,	O
a	O
highly	O
conserved	O
protein	O
directly	O
linked	O
to	O
multivesicular	O
body	O
sorting	O
in	O
species1s	O
yeast	O
species1e	O
.	O
Similar	O
to	O
the	O
action	O
of	O
a	O
mutant	O
gene1s	ARG2
SKD1	ARG2
gene1e	ARG2
protein	O
,	O
overexpression	O
of	O
a	O
fusion	O
derivative	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
CHMP1	ARG2
gene1e	ARG2
dilates	O
endosomal	O
compartments	O
and	O
disrupts	O
the	O
normal	O
distribution	O
of	O
several	O
endosomal	O
markers	O
.	O
Genetic	O
studies	O
in	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
further	O
support	O
a	O
conserved	O
role	O
of	O
gene1s	ARG2
CHMP1	ARG2
gene1e	ARG2
in	O
vesicle	O
trafficking	O
.	O
Deletion	O
of	O
gene1s	O
CHM1	O
gene1e	O
,	O
the	O
budding	O
species1s	O
yeast	O
species1e	O
homolog	O
of	O
gene1s	ARG2
CHMP1	ARG2
gene1e	ARG2
,	O
results	O
in	O
defective	O
sorting	O
of	O
carboxypeptidases	O
S	O
and	O
Y	O
and	O
produces	O
abnormal	O
,	O
multi	O
-	O
lamellar	O
prevacuolar	O
compartments	O
.	O
This	O
phenotype	O
classifies	O
gene1s	O
CHM1	O
gene1e	O
as	O
a	O
member	O
of	O
the	O
class	O
E	O
vacuolar	O
protein	O
sorting	O
genes	O
.	O
species1s	O
Yeast	O
species1e	O
gene1s	O
Chm1p	O
gene1e	O
belongs	O
to	O
a	O
structurally	O
-	O
related	O
,	O
but	O
rather	O
divergent	O
family	O
of	O
proteins	O
,	O
including	O
gene1s	O
Vps24p	O
gene1e	O
and	O
gene1s	O
Snf7p	O
gene1e	O
and	O
three	O
novel	O
proteins	O
,	O
gene1s	O
Chm2p	O
gene1e	O
,	O
gene1s	O
Chm5p	O
gene1e	O
and	O
gene1s	O
Chm6p	O
gene1e	O
,	O
which	O
are	O
all	O
essential	O
for	O
multivesicular	O
body	O
sorting	O
.	O
These	O
observations	O
identify	O
the	O
conserved	O
CHMP	O
/	O
Chmp	O
family	O
as	O
a	O
set	O
of	O
proteins	O
fundamental	O
to	O
understanding	O
multivesicular	O
body	O
sorting	O
in	O
eukaryotic	O
organisms	O
.	O

gene1s	O
CHMP1	O
gene1e	O
functions	O
as	O
a	O
member	O
of	O
a	O
newly	O
defined	O
family	O
of	O
vesicle	O
trafficking	O
proteins	O
.	O
A	O
multivesicular	O
body	O
is	O
a	O
vesicle	O
-	O
filled	O
endosome	O
that	O
targets	O
proteins	O
to	O
the	O
interior	O
of	O
lysosomes	O
.	O
We	O
have	O
identified	O
a	O
conserved	O
eukaryotic	O
protein	O
,	O
species1s	O
human	O
species1e	O
gene1s	O
CHMP1	O
gene1e	O
,	O
which	O
is	O
strongly	O
implicated	O
in	O
multivesicular	O
body	O
formation	O
.	O
Immunocytochemistry	O
and	O
biochemical	O
fractionation	O
localize	O
gene1s	O
CHMP1	O
gene1e	O
to	O
early	O
endosomes	O
and	O
gene1s	O
CHMP1	O
gene1e	O
physically	O
interacts	O
with	O
gene1s	O
SKD1	O
gene1e	O
/	O
gene1s	O
VPS4	O
gene1e	O
,	O
a	O
highly	O
conserved	O
protein	O
directly	O
linked	O
to	O
multivesicular	O
body	O
sorting	O
in	O
arg1s	O
yeast	O
arg1e	O
.	O
Similar	O
to	O
the	O
action	O
of	O
a	O
mutant	O
gene1s	O
SKD1	O
gene1e	O
protein	O
,	O
overexpression	O
of	O
a	O
fusion	O
derivative	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
CHMP1	O
gene1e	O
dilates	O
endosomal	O
compartments	O
and	O
disrupts	O
the	O
normal	O
distribution	O
of	O
several	O
endosomal	O
markers	O
.	O
Genetic	O
studies	O
in	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
further	O
support	O
a	O
conserved	O
role	O
of	O
gene1s	O
CHMP1	O
gene1e	O
in	O
vesicle	O
trafficking	O
.	O
Deletion	O
of	O
gene1s	ARG2
CHM1	ARG2
gene1e	ARG2
,	O
the	O
budding	O
arg1s	O
yeast	O
arg1e	O
homolog	O
of	O
gene1s	O
CHMP1	O
gene1e	O
,	O
results	O
in	O
defective	O
sorting	O
of	O
carboxypeptidases	O
S	O
and	O
Y	O
and	O
produces	O
abnormal	O
,	O
multi	O
-	O
lamellar	O
prevacuolar	O
compartments	O
.	O
This	O
phenotype	O
classifies	O
gene1s	ARG2
CHM1	ARG2
gene1e	ARG2
as	O
a	O
member	O
of	O
the	O
class	O
E	O
vacuolar	O
protein	O
sorting	O
genes	O
.	O
arg1s	O
Yeast	O
arg1e	O
gene1s	ARG2
Chm1p	ARG2
gene1e	ARG2
belongs	O
to	O
a	O
structurally	O
-	O
related	O
,	O
but	O
rather	O
divergent	O
family	O
of	O
proteins	O
,	O
including	O
gene1s	ARG2
Vps24p	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Snf7p	ARG2
gene1e	ARG2
and	O
three	O
novel	O
proteins	O
,	O
gene1s	ARG2
Chm2p	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Chm5p	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Chm6p	ARG2
gene1e	ARG2
,	O
which	O
are	O
all	O
essential	O
for	O
multivesicular	O
body	O
sorting	O
.	O
These	O
observations	O
identify	O
the	O
conserved	O
CHMP	O
/	O
Chmp	O
family	O
as	O
a	O
set	O
of	O
proteins	O
fundamental	O
to	O
understanding	O
multivesicular	O
body	O
sorting	O
in	O
eukaryotic	O
organisms	O
.	O

gene1s	ARG2
NXF5	ARG2
gene1e	ARG2
,	O
a	O
novel	O
member	O
of	O
the	O
nuclear	O
RNA	O
export	O
factor	O
family	O
,	O
is	O
lost	O
in	O
a	O
male	O
arg1s	O
patient	O
arg1e	O
with	O
a	O
syndromic	O
form	O
of	O
mental	O
retardation	O
.	O
Although	O
X	O
-	O
linked	O
mental	O
retardation	O
(	O
XLMR	O
)	O
affects	O
2%-3	O
%	O
of	O
the	O
arg1s	O
human	O
arg1e	O
population	O
,	O
little	O
is	O
known	O
about	O
the	O
underlying	O
molecular	O
mechanisms	O
.	O
Recent	O
interest	O
in	O
this	O
topic	O
led	O
to	O
the	O
identification	O
of	O
several	O
genes	O
for	O
which	O
mutations	O
result	O
in	O
the	O
disturbance	O
of	O
cognitive	O
development	O
.	O
We	O
identified	O
a	O
novel	O
gene	O
that	O
is	O
interrupted	O
by	O
an	O
inv(X)(p21.1;q22	O
)	O
in	O
a	O
male	O
arg1s	O
patient	O
arg1e	O
with	O
a	O
syndromic	O
form	O
of	O
mental	O
retardation	O
.	O
Molecular	O
analysis	O
of	O
both	O
breakpoint	O
regions	O
did	O
not	O
reveal	O
an	O
interrupted	O
gene	O
on	O
Xp	O
,	O
but	O
identified	O
a	O
novel	O
nuclear	O
RNA	O
export	O
factor	O
(	O
NXF	O
)	O
gene	O
cluster	O
,	O
Xcen	O
-	O
gene1s	ARG2
NXF5	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
NXF2	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
NXF4	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
NXF3	ARG2
gene1e	ARG2
-Xqter	O
,	O
in	O
which	O
gene1s	ARG2
NXF5	ARG2
gene1e	ARG2
is	O
split	O
by	O
the	O
breakpoint	O
,	O
leading	O
to	O
its	O
functional	O
nullisomy	O
.	O
The	O
predicted	O
gene1s	ARG2
NXF5	ARG2
gene1e	ARG2
protein	O
shows	O
high	O
similarity	O
with	O
the	O
central	O
part	O
of	O
the	O
presumed	O
mRNA	O
nuclear	O
export	O
factor	O
gene1s	ARG2
TAP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
NXF1	ARG2
gene1e	ARG2
.	O
Functional	O
analysis	O
of	O
gene1s	ARG2
NXF5	ARG2
gene1e	ARG2
demonstrates	O
binding	O
to	O
RNA	O
as	O
well	O
as	O
to	O
the	O
RNA	O
nuclear	O
export	O
-	O
associated	O
protein	O
gene1s	ARG2
p15	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
NXT	ARG2
gene1e	ARG2
.	O
In	O
contrast	O
to	O
gene1s	ARG2
TAP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
NXF1	ARG2
gene1e	ARG2
,	O
overexpression	O
studies	O
localized	O
gene1s	ARG2
NXF5	ARG2
gene1e	ARG2
in	O
the	O
form	O
of	O
granules	O
in	O
the	O
cell	O
body	O
and	O
neurites	O
of	O
mature	O
hippocampal	O
neurons	O
,	O
suggesting	O
a	O
role	O
in	O
mRNA	O
transport	O
.	O
The	O
two	O
newly	O
identified	O
species1s	O
mouse	O
species1e	O
nxf	O
homologs	O
,	O
gene1s	O
nxf	O
-	O
a	O
gene1e	O
and	O
gene1s	O
nxf	O
-	O
b	O
gene1e	O
,	O
which	O
also	O
map	O
on	O
X	O
,	O
show	O
highest	O
mRNA	O
levels	O
in	O
the	O
brain	O
.	O
A	O
novel	O
member	O
of	O
the	O
nuclear	O
RNA	O
export	O
factor	O
family	O
is	O
absent	O
in	O
a	O
male	O
arg1s	O
patient	O
arg1e	O
with	O
a	O
syndromic	O
form	O
of	O
mental	O
retardation	O
.	O
Although	O
we	O
did	O
not	O
find	O
direct	O
evidence	O
for	O
the	O
involvement	O
of	O
gene1s	ARG2
NXF5	ARG2
gene1e	ARG2
in	O
MR	O
,	O
the	O
gene	O
could	O
be	O
involved	O
in	O
development	O
,	O
possibly	O
through	O
a	O
process	O
in	O
mRNA	O
metabolism	O
in	O
neurons	O
.	O

gene1s	O
NXF5	O
gene1e	O
,	O
a	O
novel	O
member	O
of	O
the	O
nuclear	O
RNA	O
export	O
factor	O
family	O
,	O
is	O
lost	O
in	O
a	O
male	O
species1s	O
patient	O
species1e	O
with	O
a	O
syndromic	O
form	O
of	O
mental	O
retardation	O
.	O
Although	O
X	O
-	O
linked	O
mental	O
retardation	O
(	O
XLMR	O
)	O
affects	O
2%-3	O
%	O
of	O
the	O
species1s	O
human	O
species1e	O
population	O
,	O
little	O
is	O
known	O
about	O
the	O
underlying	O
molecular	O
mechanisms	O
.	O
Recent	O
interest	O
in	O
this	O
topic	O
led	O
to	O
the	O
identification	O
of	O
several	O
genes	O
for	O
which	O
mutations	O
result	O
in	O
the	O
disturbance	O
of	O
cognitive	O
development	O
.	O
We	O
identified	O
a	O
novel	O
gene	O
that	O
is	O
interrupted	O
by	O
an	O
inv(X)(p21.1;q22	O
)	O
in	O
a	O
male	O
species1s	O
patient	O
species1e	O
with	O
a	O
syndromic	O
form	O
of	O
mental	O
retardation	O
.	O
Molecular	O
analysis	O
of	O
both	O
breakpoint	O
regions	O
did	O
not	O
reveal	O
an	O
interrupted	O
gene	O
on	O
Xp	O
,	O
but	O
identified	O
a	O
novel	O
nuclear	O
RNA	O
export	O
factor	O
(	O
NXF	O
)	O
gene	O
cluster	O
,	O
Xcen	O
-	O
gene1s	O
NXF5	O
gene1e	O
-	O
gene1s	O
NXF2	O
gene1e	O
-	O
gene1s	O
NXF4	O
gene1e	O
-	O
gene1s	O
NXF3	O
gene1e	O
-Xqter	O
,	O
in	O
which	O
gene1s	O
NXF5	O
gene1e	O
is	O
split	O
by	O
the	O
breakpoint	O
,	O
leading	O
to	O
its	O
functional	O
nullisomy	O
.	O
The	O
predicted	O
gene1s	O
NXF5	O
gene1e	O
protein	O
shows	O
high	O
similarity	O
with	O
the	O
central	O
part	O
of	O
the	O
presumed	O
mRNA	O
nuclear	O
export	O
factor	O
gene1s	O
TAP	O
gene1e	O
/	O
gene1s	O
NXF1	O
gene1e	O
.	O
Functional	O
analysis	O
of	O
gene1s	O
NXF5	O
gene1e	O
demonstrates	O
binding	O
to	O
RNA	O
as	O
well	O
as	O
to	O
the	O
RNA	O
nuclear	O
export	O
-	O
associated	O
protein	O
gene1s	O
p15	O
gene1e	O
/	O
gene1s	O
NXT	O
gene1e	O
.	O
In	O
contrast	O
to	O
gene1s	O
TAP	O
gene1e	O
/	O
gene1s	O
NXF1	O
gene1e	O
,	O
overexpression	O
studies	O
localized	O
gene1s	O
NXF5	O
gene1e	O
in	O
the	O
form	O
of	O
granules	O
in	O
the	O
cell	O
body	O
and	O
neurites	O
of	O
mature	O
hippocampal	O
neurons	O
,	O
suggesting	O
a	O
role	O
in	O
mRNA	O
transport	O
.	O
The	O
two	O
newly	O
identified	O
arg1s	O
mouse	O
arg1e	O
nxf	O
homologs	O
,	O
gene1s	ARG2
nxf	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
nxf	ARG2
-	ARG2
b	ARG2
gene1e	ARG2
,	O
which	O
also	O
map	O
on	O
X	O
,	O
show	O
highest	O
mRNA	O
levels	O
in	O
the	O
brain	O
.	O
A	O
novel	O
member	O
of	O
the	O
nuclear	O
RNA	O
export	O
factor	O
family	O
is	O
absent	O
in	O
a	O
male	O
species1s	O
patient	O
species1e	O
with	O
a	O
syndromic	O
form	O
of	O
mental	O
retardation	O
.	O
Although	O
we	O
did	O
not	O
find	O
direct	O
evidence	O
for	O
the	O
involvement	O
of	O
gene1s	O
NXF5	O
gene1e	O
in	O
MR	O
,	O
the	O
gene	O
could	O
be	O
involved	O
in	O
development	O
,	O
possibly	O
through	O
a	O
process	O
in	O
mRNA	O
metabolism	O
in	O
neurons	O
.	O

The	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
family	O
member	O
genes	O
are	O
involved	O
in	O
the	O
Notch	O
signal	O
pathway	O
.	O
The	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
tumor	O
suppressor	O
is	O
a	O
transcription	O
factor	O
that	O
regulates	O
cell	O
growth	O
and	O
death	O
in	O
response	O
to	O
environmental	O
stimuli	O
such	O
as	O
DNA	O
damage	O
.	O
gene1s	ARG2
p63	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
p51	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p73	ARG2
gene1e	ARG2
were	O
recently	O
identified	O
as	O
members	O
of	O
the	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
gene	O
family	O
.	O
In	O
contrast	O
to	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
however	O
,	O
gene1s	ARG2
p63	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p73	ARG2
gene1e	ARG2
are	O
rarely	O
mutated	O
in	O
arg1s	O
human	O
arg1e	O
cancers	O
.	O
species1s	O
Mice	O
species1e	O
that	O
lack	O
gene1s	O
p53	O
gene1e	O
are	O
developmentally	O
normal	O
,	O
while	O
gene1s	O
p63	O
gene1e	O
and	O
gene1s	O
p73	O
gene1e	O
appear	O
to	O
play	O
critical	O
roles	O
in	O
normal	O
development	O
.	O
To	O
determine	O
how	O
gene1s	ARG2
p63	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p73	ARG2
gene1e	ARG2
are	O
involved	O
in	O
normal	O
development	O
,	O
we	O
attempted	O
to	O
identify	O
target	O
genes	O
that	O
are	O
specifically	O
regulated	O
by	O
gene1s	ARG2
p63	ARG2
gene1e	ARG2
and/or	O
gene1s	ARG2
p73	ARG2
gene1e	ARG2
but	O
not	O
by	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
.	O
We	O
found	O
that	O
the	O
gene1s	ARG2
Jagged1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
JAG1	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
Jagged2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
JAG2	ARG2
gene1e	ARG2
)	O
genes	O
,	O
encoding	O
ligands	O
for	O
the	O
Notch	O
receptors	O
,	O
are	O
up	O
-	O
regulated	O
by	O
gene1s	ARG2
p63	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p73	ARG2
gene1e	ARG2
.	O
Furthermore	O
,	O
we	O
identified	O
a	O
p63-binding	O
site	O
in	O
the	O
second	O
intron	O
of	O
the	O
gene1s	ARG2
JAG1	ARG2
gene1e	ARG2
gene	O
,	O
which	O
can	O
directly	O
interact	O
with	O
the	O
gene1s	ARG2
p63	ARG2
gene1e	ARG2
protein	O
in	O
vivo	O
,	O
as	O
assessed	O
by	O
a	O
chromatin	O
immunoprecipitation	O
assay	O
.	O
A	O
heterologous	O
reporter	O
assay	O
revealed	O
that	O
this	O
p63-binding	O
site	O
is	O
a	O
functional	O
response	O
element	O
and	O
is	O
specific	O
for	O
gene1s	ARG2
p63	ARG2
gene1e	ARG2
.	O
We	O
also	O
found	O
a	O
target	O
of	O
Notch	O
signaling	O
,	O
gene1s	ARG2
HES-1	ARG2
gene1e	ARG2
was	O
up	O
-	O
regulated	O
in	O
arg1s	O
Jurkat	O
arg1e	O
cells	O
,	O
in	O
which	O
gene1s	ARG2
Notch1	ARG2
gene1e	ARG2
is	O
highly	O
expressed	O
,	O
when	O
co	O
-	O
cultured	O
with	O
gene1s	ARG2
p63	ARG2
gene1e	ARG2
-transfected	O
cells	O
,	O
suggesting	O
that	O
gene1s	ARG2
p63	ARG2
gene1e	ARG2
can	O
trigger	O
the	O
Notch	O
signal	O
pathway	O
in	O
neighboring	O
cells	O
.	O
Our	O
findings	O
show	O
an	O
association	O
between	O
the	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
family	O
genes	O
and	O
Notch	O
signaling	O
and	O
suggest	O
a	O
potential	O
molecular	O
mechanism	O
for	O
the	O
involvement	O
of	O
the	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
family	O
genes	O
in	O
normal	O
development	O
.	O

The	O
gene1s	O
p53	O
gene1e	O
family	O
member	O
genes	O
are	O
involved	O
in	O
the	O
Notch	O
signal	O
pathway	O
.	O
The	O
gene1s	O
p53	O
gene1e	O
tumor	O
suppressor	O
is	O
a	O
transcription	O
factor	O
that	O
regulates	O
cell	O
growth	O
and	O
death	O
in	O
response	O
to	O
environmental	O
stimuli	O
such	O
as	O
DNA	O
damage	O
.	O
gene1s	O
p63	O
gene1e	O
/	O
gene1s	O
p51	O
gene1e	O
and	O
gene1s	O
p73	O
gene1e	O
were	O
recently	O
identified	O
as	O
members	O
of	O
the	O
gene1s	O
p53	O
gene1e	O
gene	O
family	O
.	O
In	O
contrast	O
to	O
gene1s	O
p53	O
gene1e	O
however	O
,	O
gene1s	O
p63	O
gene1e	O
and	O
gene1s	O
p73	O
gene1e	O
are	O
rarely	O
mutated	O
in	O
species1s	O
human	O
species1e	O
cancers	O
.	O
arg1s	O
Mice	O
arg1e	O
that	O
lack	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
are	O
developmentally	O
normal	O
,	O
while	O
gene1s	ARG2
p63	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p73	ARG2
gene1e	ARG2
appear	O
to	O
play	O
critical	O
roles	O
in	O
normal	O
development	O
.	O
To	O
determine	O
how	O
gene1s	O
p63	O
gene1e	O
and	O
gene1s	O
p73	O
gene1e	O
are	O
involved	O
in	O
normal	O
development	O
,	O
we	O
attempted	O
to	O
identify	O
target	O
genes	O
that	O
are	O
specifically	O
regulated	O
by	O
gene1s	O
p63	O
gene1e	O
and/or	O
gene1s	O
p73	O
gene1e	O
but	O
not	O
by	O
gene1s	O
p53	O
gene1e	O
.	O
We	O
found	O
that	O
the	O
gene1s	O
Jagged1	O
gene1e	O
(	O
gene1s	O
JAG1	O
gene1e	O
)	O
and	O
gene1s	O
Jagged2	O
gene1e	O
(	O
gene1s	O
JAG2	O
gene1e	O
)	O
genes	O
,	O
encoding	O
ligands	O
for	O
the	O
Notch	O
receptors	O
,	O
are	O
up	O
-	O
regulated	O
by	O
gene1s	O
p63	O
gene1e	O
and	O
gene1s	O
p73	O
gene1e	O
.	O
Furthermore	O
,	O
we	O
identified	O
a	O
p63-binding	O
site	O
in	O
the	O
second	O
intron	O
of	O
the	O
gene1s	O
JAG1	O
gene1e	O
gene	O
,	O
which	O
can	O
directly	O
interact	O
with	O
the	O
gene1s	O
p63	O
gene1e	O
protein	O
in	O
vivo	O
,	O
as	O
assessed	O
by	O
a	O
chromatin	O
immunoprecipitation	O
assay	O
.	O
A	O
heterologous	O
reporter	O
assay	O
revealed	O
that	O
this	O
p63-binding	O
site	O
is	O
a	O
functional	O
response	O
element	O
and	O
is	O
specific	O
for	O
gene1s	O
p63	O
gene1e	O
.	O
We	O
also	O
found	O
a	O
target	O
of	O
Notch	O
signaling	O
,	O
gene1s	O
HES-1	O
gene1e	O
was	O
up	O
-	O
regulated	O
in	O
species1s	O
Jurkat	O
species1e	O
cells	O
,	O
in	O
which	O
gene1s	O
Notch1	O
gene1e	O
is	O
highly	O
expressed	O
,	O
when	O
co	O
-	O
cultured	O
with	O
gene1s	O
p63	O
gene1e	O
-transfected	O
cells	O
,	O
suggesting	O
that	O
gene1s	O
p63	O
gene1e	O
can	O
trigger	O
the	O
Notch	O
signal	O
pathway	O
in	O
neighboring	O
cells	O
.	O
Our	O
findings	O
show	O
an	O
association	O
between	O
the	O
gene1s	O
p53	O
gene1e	O
family	O
genes	O
and	O
Notch	O
signaling	O
and	O
suggest	O
a	O
potential	O
molecular	O
mechanism	O
for	O
the	O
involvement	O
of	O
the	O
gene1s	O
p53	O
gene1e	O
family	O
genes	O
in	O
normal	O
development	O
.	O

Composition	O
of	O
arg1s	O
Drosophila	O
melanogaster	O
arg1e	O
proteome	O
involved	O
in	O
fucosylated	O
glycan	O
metabolism	O
.	O
The	O
whole	O
genome	O
approach	O
enables	O
the	O
characterization	O
of	O
all	O
components	O
of	O
any	O
given	O
biological	O
pathway	O
.	O
Moreover	O
,	O
it	O
can	O
help	O
to	O
uncover	O
all	O
the	O
metabolic	O
routes	O
for	O
any	O
molecule	O
.	O
Here	O
we	O
have	O
used	O
the	O
genome	O
of	O
arg1s	O
Drosophila	O
melanogaster	O
arg1e	O
to	O
search	O
for	O
enzymes	O
involved	O
in	O
the	O
metabolism	O
of	O
fucosylated	O
glycans	O
.	O
Our	O
results	O
suggest	O
that	O
in	O
the	O
arg1s	O
fruit	O
fly	O
arg1e	O
GDP	O
-	O
fucose	O
,	O
the	O
donor	O
for	O
fucosyltransferase	O
reactions	O
,	O
is	O
formed	O
exclusively	O
via	O
the	O
de	O
novo	O
pathway	O
from	O
GDP	O
-	O
mannose	O
through	O
enzymatic	O
reactions	O
catalyzed	O
by	O
gene1s	ARG2
GDP	ARG2
-	ARG2
D	ARG2
-	ARG2
mannose	ARG2
4,6-dehydratase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
GMD	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
GDP-4-keto-6-deoxy	ARG2
-	ARG2
D	ARG2
-	ARG2
mannose	ARG2
3,5-epimerase/4-reductase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
GMER	ARG2
gene1e	ARG2
,	O
also	O
known	O
as	O
gene1s	O
FX	O
gene1e	O
in	O
man	O
)	O
.	O
The	O
arg1s	O
Drosophila	O
arg1e	O
genome	O
does	O
not	O
have	O
orthologs	O
for	O
the	O
salvage	O
pathway	O
enzymes	O
,	O
i.e.	O
gene1s	O
fucokinase	O
gene1e	O
and	O
gene1s	O
GDP	O
-	O
fucose	O
pyrophosphorylase	O
gene1e	O
synthesizing	O
GDP	O
-	O
fucose	O
from	O
fucose	O
.	O
In	O
addition	O
we	O
identified	O
two	O
novel	O
fucosyltransferases	O
predicted	O
to	O
catalyze	O
alpha1,3-	O
and	O
alpha1,6-specific	O
linkages	O
to	O
the	O
GlcNAc	O
residues	O
on	O
glycans	O
.	O
No	O
genes	O
with	O
the	O
capacity	O
to	O
encode	O
alpha1,2-specific	O
fucosyltransferases	O
were	O
found	O
.	O
We	O
also	O
identified	O
two	O
novel	O
genes	O
coding	O
for	O
O	O
-	O
fucosyltransferases	O
and	O
a	O
gene	O
responsible	O
for	O
a	O
fucosidase	O
enzyme	O
in	O
the	O
arg1s	O
Drosophila	O
arg1e	O
genome	O
.	O
Finally	O
,	O
using	O
the	O
arg1s	O
Drosophila	O
arg1e	O
gene1s	ARG2
CG4435	ARG2
gene1e	ARG2
gene	O
,	O
we	O
identified	O
two	O
novel	O
species1s	O
human	O
species1e	O
genes	O
putatively	O
coding	O
for	O
fucosyltransferases	O
.	O
This	O
work	O
can	O
serve	O
as	O
a	O
basis	O
for	O
further	O
whole	O
-	O
genome	O
approaches	O
in	O
mapping	O
all	O
possible	O
glycosylation	O
pathways	O
and	O
as	O
a	O
basic	O
analysis	O
leading	O
to	O
subsequent	O
experimental	O
studies	O
to	O
verify	O
the	O
predictions	O
made	O
in	O
this	O
work	O
.	O

Composition	O
of	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
proteome	O
involved	O
in	O
fucosylated	O
glycan	O
metabolism	O
.	O
The	O
whole	O
genome	O
approach	O
enables	O
the	O
characterization	O
of	O
all	O
components	O
of	O
any	O
given	O
biological	O
pathway	O
.	O
Moreover	O
,	O
it	O
can	O
help	O
to	O
uncover	O
all	O
the	O
metabolic	O
routes	O
for	O
any	O
molecule	O
.	O
Here	O
we	O
have	O
used	O
the	O
genome	O
of	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
to	O
search	O
for	O
enzymes	O
involved	O
in	O
the	O
metabolism	O
of	O
fucosylated	O
glycans	O
.	O
Our	O
results	O
suggest	O
that	O
in	O
the	O
species1s	O
fruit	O
fly	O
species1e	O
GDP	O
-	O
fucose	O
,	O
the	O
donor	O
for	O
fucosyltransferase	O
reactions	O
,	O
is	O
formed	O
exclusively	O
via	O
the	O
de	O
novo	O
pathway	O
from	O
GDP	O
-	O
mannose	O
through	O
enzymatic	O
reactions	O
catalyzed	O
by	O
gene1s	O
GDP	O
-	O
D	O
-	O
mannose	O
4,6-dehydratase	O
gene1e	O
(	O
gene1s	O
GMD	O
gene1e	O
)	O
and	O
gene1s	O
GDP-4-keto-6-deoxy	O
-	O
D	O
-	O
mannose	O
3,5-epimerase/4-reductase	O
gene1e	O
(	O
gene1s	O
GMER	O
gene1e	O
,	O
also	O
known	O
as	O
gene1s	ARG2
FX	ARG2
gene1e	ARG2
in	O
man	O
)	O
.	O
The	O
species1s	O
Drosophila	O
species1e	O
genome	O
does	O
not	O
have	O
orthologs	O
for	O
the	O
salvage	O
pathway	O
enzymes	O
,	O
i.e.	O
gene1s	ARG2
fucokinase	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
GDP	ARG2
-	ARG2
fucose	ARG2
pyrophosphorylase	ARG2
gene1e	ARG2
synthesizing	O
GDP	O
-	O
fucose	O
from	O
fucose	O
.	O
In	O
addition	O
we	O
identified	O
two	O
novel	O
fucosyltransferases	O
predicted	O
to	O
catalyze	O
alpha1,3-	O
and	O
alpha1,6-specific	O
linkages	O
to	O
the	O
GlcNAc	O
residues	O
on	O
glycans	O
.	O
No	O
genes	O
with	O
the	O
capacity	O
to	O
encode	O
alpha1,2-specific	O
fucosyltransferases	O
were	O
found	O
.	O
We	O
also	O
identified	O
two	O
novel	O
genes	O
coding	O
for	O
O	O
-	O
fucosyltransferases	O
and	O
a	O
gene	O
responsible	O
for	O
a	O
fucosidase	O
enzyme	O
in	O
the	O
species1s	O
Drosophila	O
species1e	O
genome	O
.	O
Finally	O
,	O
using	O
the	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
CG4435	O
gene1e	O
gene	O
,	O
we	O
identified	O
two	O
novel	O
arg1s	O
human	O
arg1e	O
genes	O
putatively	O
coding	O
for	O
fucosyltransferases	O
.	O
This	O
work	O
can	O
serve	O
as	O
a	O
basis	O
for	O
further	O
whole	O
-	O
genome	O
approaches	O
in	O
mapping	O
all	O
possible	O
glycosylation	O
pathways	O
and	O
as	O
a	O
basic	O
analysis	O
leading	O
to	O
subsequent	O
experimental	O
studies	O
to	O
verify	O
the	O
predictions	O
made	O
in	O
this	O
work	O
.	O

Identification	O
of	O
two	O
novel	O
arg1s	O
human	O
arg1e	O
dynein	O
light	O
chain	O
genes	O
,	O
gene1s	ARG2
DNLC2A	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
DNLC2B	ARG2
gene1e	ARG2
,	O
and	O
their	O
expression	O
changes	O
in	O
hepatocellular	O
carcinoma	O
tissues	O
from	O
68	O
Chinese	O
arg1s	O
patients	O
arg1e	O
.	O
Two	O
full	O
-	O
length	O
cDNAs	O
,	O
gene1s	ARG2
DNLC2A	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
DNLC2B	ARG2
gene1e	ARG2
,	O
were	O
cloned	O
and	O
characterized	O
.	O
Their	O
open	O
reading	O
frames	O
respectively	O
encode	O
96	O
amino	O
acids	O
which	O
are	O
most	O
closely	O
homologous	O
to	O
gene1s	O
roadblock	O
/	O
LC7	O
gene1e	O
,	O
one	O
member	O
of	O
an	O
ancient	O
dynein	O
light	O
chain	O
protein	O
family	O
,	O
conserved	O
in	O
nematode	O
,	O
species1s	O
fruit	O
fly	O
species1e	O
,	O
species1s	O
mouse	O
species1e	O
and	O
species1s	O
rat	O
species1e	O
.	O
The	O
gene1s	ARG2
DNLC2A	ARG2
gene1e	ARG2
was	O
expressed	O
in	O
12	O
of	O
16	O
arg1s	O
human	O
arg1e	O
tissues	O
examined	O
,	O
with	O
especially	O
strong	O
expression	O
in	O
heart	O
,	O
liver	O
and	O
brain	O
,	O
whereas	O
there	O
was	O
weak	O
expression	O
in	O
lung	O
,	O
prostate	O
,	O
testis	O
,	O
small	O
intestine	O
and	O
colon	O
.	O
The	O
expression	O
of	O
gene1s	ARG2
DNLC2B	ARG2
gene1e	ARG2
was	O
generally	O
high	O
compared	O
with	O
that	O
of	O
gene1s	ARG2
DNLC2A	ARG2
gene1e	ARG2
except	O
in	O
liver	O
.	O
Northern	O
blotting	O
and/or	O
semi	O
-	O
quantitative	O
RT	O
-	O
PCR	O
analysis	O
examined	O
the	O
expression	O
changes	O
of	O
gene1s	ARG2
DNLC2A	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
DNLC2B	ARG2
gene1e	ARG2
in	O
68	O
hepatocellular	O
carcinoma	O
tissue	O
samples	O
.	O
It	O
was	O
revealed	O
that	O
gene1s	ARG2
DNLC2A	ARG2
gene1e	ARG2
was	O
up	O
-	O
regulated	O
(	O
45	O
out	O
of	O
the	O
68	O
cases	O
)	O
while	O
gene1s	ARG2
DNLC2B	ARG2
gene1e	ARG2
was	O
down	O
-	O
regulated	O
(	O
44	O
out	O
of	O
68	O
cases	O
)	O
,	O
compared	O
with	O
their	O
adjacent	O
tumor	O
-	O
free	O
liver	O
tissues	O
.	O
Interestingly	O
,	O
among	O
the	O
total	O
68	O
liver	O
cancer	O
samples	O
tested	O
,	O
gene1s	ARG2
DNLC2A	ARG2
gene1e	ARG2
was	O
up	O
-	O
regulated	O
while	O
gene1s	ARG2
DNLC2B	ARG2
gene1e	ARG2
was	O
down	O
-	O
regulated	O
in	O
28	O
cases	O
;	O
gene1s	ARG2
DNLC2A	ARG2
gene1e	ARG2
was	O
up	O
-	O
regulated	O
while	O
no	O
obvious	O
change	O
was	O
observed	O
for	O
gene1s	ARG2
DNLC2B	ARG2
gene1e	ARG2
in	O
10	O
cases	O
;	O
no	O
obvious	O
change	O
was	O
observed	O
for	O
gene1s	ARG2
DNLC2A	ARG2
gene1e	ARG2
while	O
gene1s	ARG2
DNLC2B	ARG2
gene1e	ARG2
was	O
down	O
-	O
regulated	O
in	O
14	O
cases	O
.	O
Although	O
the	O
underlying	O
mechanism	O
is	O
not	O
clear	O
to	O
date	O
,	O
the	O
apparent	O
up	O
-	O
regulation	O
of	O
gene1s	ARG2
DNLC2A	ARG2
gene1e	ARG2
and	O
down	O
-	O
regulation	O
of	O
gene1s	ARG2
DNLC2B	ARG2
gene1e	ARG2
suggest	O
that	O
these	O
genes	O
might	O
be	O
involved	O
in	O
tumor	O
progression	O
.	O
On	O
the	O
other	O
hand	O
,	O
the	O
different	O
expression	O
changes	O
of	O
the	O
two	O
homologous	O
genes	O
indicate	O
that	O
hepatocellular	O
carcinomas	O
are	O
caused	O
by	O
different	O
pathological	O
mechanisms	O
.	O
In	O
addition	O
,	O
gene1s	ARG2
DNLC2A	ARG2
gene1e	ARG2
was	O
assigned	O
to	O
arg1s	O
human	O
arg1e	O
chromosome	O
20q12-q13.11	O
near	O
the	O
marker	O
D20S106	O
by	O
radiation	O
hybrid	O
mapping	O
.	O

Identification	O
of	O
two	O
novel	O
species1s	O
human	O
species1e	O
dynein	O
light	O
chain	O
genes	O
,	O
gene1s	O
DNLC2A	O
gene1e	O
and	O
gene1s	O
DNLC2B	O
gene1e	O
,	O
and	O
their	O
expression	O
changes	O
in	O
hepatocellular	O
carcinoma	O
tissues	O
from	O
68	O
Chinese	O
species1s	O
patients	O
species1e	O
.	O
Two	O
full	O
-	O
length	O
cDNAs	O
,	O
gene1s	O
DNLC2A	O
gene1e	O
and	O
gene1s	O
DNLC2B	O
gene1e	O
,	O
were	O
cloned	O
and	O
characterized	O
.	O
Their	O
open	O
reading	O
frames	O
respectively	O
encode	O
96	O
amino	O
acids	O
which	O
are	O
most	O
closely	O
homologous	O
to	O
gene1s	ARG2
roadblock	ARG2
/	ARG2
LC7	ARG2
gene1e	ARG2
,	O
one	O
member	O
of	O
an	O
ancient	O
dynein	O
light	O
chain	O
protein	O
family	O
,	O
conserved	O
in	O
nematode	O
,	O
arg1s	O
fruit	O
fly	O
arg1e	O
,	O
species1s	O
mouse	O
species1e	O
and	O
species1s	O
rat	O
species1e	O
.	O
The	O
gene1s	O
DNLC2A	O
gene1e	O
was	O
expressed	O
in	O
12	O
of	O
16	O
species1s	O
human	O
species1e	O
tissues	O
examined	O
,	O
with	O
especially	O
strong	O
expression	O
in	O
heart	O
,	O
liver	O
and	O
brain	O
,	O
whereas	O
there	O
was	O
weak	O
expression	O
in	O
lung	O
,	O
prostate	O
,	O
testis	O
,	O
small	O
intestine	O
and	O
colon	O
.	O
The	O
expression	O
of	O
gene1s	O
DNLC2B	O
gene1e	O
was	O
generally	O
high	O
compared	O
with	O
that	O
of	O
gene1s	O
DNLC2A	O
gene1e	O
except	O
in	O
liver	O
.	O
Northern	O
blotting	O
and/or	O
semi	O
-	O
quantitative	O
RT	O
-	O
PCR	O
analysis	O
examined	O
the	O
expression	O
changes	O
of	O
gene1s	O
DNLC2A	O
gene1e	O
and	O
gene1s	O
DNLC2B	O
gene1e	O
in	O
68	O
hepatocellular	O
carcinoma	O
tissue	O
samples	O
.	O
It	O
was	O
revealed	O
that	O
gene1s	O
DNLC2A	O
gene1e	O
was	O
up	O
-	O
regulated	O
(	O
45	O
out	O
of	O
the	O
68	O
cases	O
)	O
while	O
gene1s	O
DNLC2B	O
gene1e	O
was	O
down	O
-	O
regulated	O
(	O
44	O
out	O
of	O
68	O
cases	O
)	O
,	O
compared	O
with	O
their	O
adjacent	O
tumor	O
-	O
free	O
liver	O
tissues	O
.	O
Interestingly	O
,	O
among	O
the	O
total	O
68	O
liver	O
cancer	O
samples	O
tested	O
,	O
gene1s	O
DNLC2A	O
gene1e	O
was	O
up	O
-	O
regulated	O
while	O
gene1s	O
DNLC2B	O
gene1e	O
was	O
down	O
-	O
regulated	O
in	O
28	O
cases	O
;	O
gene1s	O
DNLC2A	O
gene1e	O
was	O
up	O
-	O
regulated	O
while	O
no	O
obvious	O
change	O
was	O
observed	O
for	O
gene1s	O
DNLC2B	O
gene1e	O
in	O
10	O
cases	O
;	O
no	O
obvious	O
change	O
was	O
observed	O
for	O
gene1s	O
DNLC2A	O
gene1e	O
while	O
gene1s	O
DNLC2B	O
gene1e	O
was	O
down	O
-	O
regulated	O
in	O
14	O
cases	O
.	O
Although	O
the	O
underlying	O
mechanism	O
is	O
not	O
clear	O
to	O
date	O
,	O
the	O
apparent	O
up	O
-	O
regulation	O
of	O
gene1s	O
DNLC2A	O
gene1e	O
and	O
down	O
-	O
regulation	O
of	O
gene1s	O
DNLC2B	O
gene1e	O
suggest	O
that	O
these	O
genes	O
might	O
be	O
involved	O
in	O
tumor	O
progression	O
.	O
On	O
the	O
other	O
hand	O
,	O
the	O
different	O
expression	O
changes	O
of	O
the	O
two	O
homologous	O
genes	O
indicate	O
that	O
hepatocellular	O
carcinomas	O
are	O
caused	O
by	O
different	O
pathological	O
mechanisms	O
.	O
In	O
addition	O
,	O
gene1s	O
DNLC2A	O
gene1e	O
was	O
assigned	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
20q12-q13.11	O
near	O
the	O
marker	O
D20S106	O
by	O
radiation	O
hybrid	O
mapping	O
.	O

Identification	O
of	O
two	O
novel	O
species1s	O
human	O
species1e	O
dynein	O
light	O
chain	O
genes	O
,	O
gene1s	O
DNLC2A	O
gene1e	O
and	O
gene1s	O
DNLC2B	O
gene1e	O
,	O
and	O
their	O
expression	O
changes	O
in	O
hepatocellular	O
carcinoma	O
tissues	O
from	O
68	O
Chinese	O
species1s	O
patients	O
species1e	O
.	O
Two	O
full	O
-	O
length	O
cDNAs	O
,	O
gene1s	O
DNLC2A	O
gene1e	O
and	O
gene1s	O
DNLC2B	O
gene1e	O
,	O
were	O
cloned	O
and	O
characterized	O
.	O
Their	O
open	O
reading	O
frames	O
respectively	O
encode	O
96	O
amino	O
acids	O
which	O
are	O
most	O
closely	O
homologous	O
to	O
gene1s	O
roadblock	O
/	O
LC7	O
gene1e	O
,	O
one	O
member	O
of	O
an	O
ancient	O
dynein	O
light	O
chain	O
protein	O
family	O
,	O
conserved	O
in	O
nematode	O
,	O
species1s	O
fruit	O
fly	O
species1e	O
,	O
arg1s	O
mouse	O
arg1e	O
and	O
species1s	O
rat	O
species1e	O
.	O
The	O
gene1s	O
DNLC2A	O
gene1e	O
was	O
expressed	O
in	O
12	O
of	O
16	O
species1s	O
human	O
species1e	O
tissues	O
examined	O
,	O
with	O
especially	O
strong	O
expression	O
in	O
heart	O
,	O
liver	O
and	O
brain	O
,	O
whereas	O
there	O
was	O
weak	O
expression	O
in	O
lung	O
,	O
prostate	O
,	O
testis	O
,	O
small	O
intestine	O
and	O
colon	O
.	O
The	O
expression	O
of	O
gene1s	O
DNLC2B	O
gene1e	O
was	O
generally	O
high	O
compared	O
with	O
that	O
of	O
gene1s	O
DNLC2A	O
gene1e	O
except	O
in	O
liver	O
.	O
Northern	O
blotting	O
and/or	O
semi	O
-	O
quantitative	O
RT	O
-	O
PCR	O
analysis	O
examined	O
the	O
expression	O
changes	O
of	O
gene1s	O
DNLC2A	O
gene1e	O
and	O
gene1s	O
DNLC2B	O
gene1e	O
in	O
68	O
hepatocellular	O
carcinoma	O
tissue	O
samples	O
.	O
It	O
was	O
revealed	O
that	O
gene1s	O
DNLC2A	O
gene1e	O
was	O
up	O
-	O
regulated	O
(	O
45	O
out	O
of	O
the	O
68	O
cases	O
)	O
while	O
gene1s	O
DNLC2B	O
gene1e	O
was	O
down	O
-	O
regulated	O
(	O
44	O
out	O
of	O
68	O
cases	O
)	O
,	O
compared	O
with	O
their	O
adjacent	O
tumor	O
-	O
free	O
liver	O
tissues	O
.	O
Interestingly	O
,	O
among	O
the	O
total	O
68	O
liver	O
cancer	O
samples	O
tested	O
,	O
gene1s	O
DNLC2A	O
gene1e	O
was	O
up	O
-	O
regulated	O
while	O
gene1s	O
DNLC2B	O
gene1e	O
was	O
down	O
-	O
regulated	O
in	O
28	O
cases	O
;	O
gene1s	O
DNLC2A	O
gene1e	O
was	O
up	O
-	O
regulated	O
while	O
no	O
obvious	O
change	O
was	O
observed	O
for	O
gene1s	O
DNLC2B	O
gene1e	O
in	O
10	O
cases	O
;	O
no	O
obvious	O
change	O
was	O
observed	O
for	O
gene1s	O
DNLC2A	O
gene1e	O
while	O
gene1s	O
DNLC2B	O
gene1e	O
was	O
down	O
-	O
regulated	O
in	O
14	O
cases	O
.	O
Although	O
the	O
underlying	O
mechanism	O
is	O
not	O
clear	O
to	O
date	O
,	O
the	O
apparent	O
up	O
-	O
regulation	O
of	O
gene1s	O
DNLC2A	O
gene1e	O
and	O
down	O
-	O
regulation	O
of	O
gene1s	O
DNLC2B	O
gene1e	O
suggest	O
that	O
these	O
genes	O
might	O
be	O
involved	O
in	O
tumor	O
progression	O
.	O
On	O
the	O
other	O
hand	O
,	O
the	O
different	O
expression	O
changes	O
of	O
the	O
two	O
homologous	O
genes	O
indicate	O
that	O
hepatocellular	O
carcinomas	O
are	O
caused	O
by	O
different	O
pathological	O
mechanisms	O
.	O
In	O
addition	O
,	O
gene1s	O
DNLC2A	O
gene1e	O
was	O
assigned	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
20q12-q13.11	O
near	O
the	O
marker	O
D20S106	O
by	O
radiation	O
hybrid	O
mapping	O
.	O

Identification	O
of	O
two	O
novel	O
species1s	O
human	O
species1e	O
dynein	O
light	O
chain	O
genes	O
,	O
gene1s	O
DNLC2A	O
gene1e	O
and	O
gene1s	O
DNLC2B	O
gene1e	O
,	O
and	O
their	O
expression	O
changes	O
in	O
hepatocellular	O
carcinoma	O
tissues	O
from	O
68	O
Chinese	O
species1s	O
patients	O
species1e	O
.	O
Two	O
full	O
-	O
length	O
cDNAs	O
,	O
gene1s	O
DNLC2A	O
gene1e	O
and	O
gene1s	O
DNLC2B	O
gene1e	O
,	O
were	O
cloned	O
and	O
characterized	O
.	O
Their	O
open	O
reading	O
frames	O
respectively	O
encode	O
96	O
amino	O
acids	O
which	O
are	O
most	O
closely	O
homologous	O
to	O
gene1s	O
roadblock	O
/	O
LC7	O
gene1e	O
,	O
one	O
member	O
of	O
an	O
ancient	O
dynein	O
light	O
chain	O
protein	O
family	O
,	O
conserved	O
in	O
nematode	O
,	O
species1s	O
fruit	O
fly	O
species1e	O
,	O
species1s	O
mouse	O
species1e	O
and	O
arg1s	O
rat	O
arg1e	O
.	O
The	O
gene1s	O
DNLC2A	O
gene1e	O
was	O
expressed	O
in	O
12	O
of	O
16	O
species1s	O
human	O
species1e	O
tissues	O
examined	O
,	O
with	O
especially	O
strong	O
expression	O
in	O
heart	O
,	O
liver	O
and	O
brain	O
,	O
whereas	O
there	O
was	O
weak	O
expression	O
in	O
lung	O
,	O
prostate	O
,	O
testis	O
,	O
small	O
intestine	O
and	O
colon	O
.	O
The	O
expression	O
of	O
gene1s	O
DNLC2B	O
gene1e	O
was	O
generally	O
high	O
compared	O
with	O
that	O
of	O
gene1s	O
DNLC2A	O
gene1e	O
except	O
in	O
liver	O
.	O
Northern	O
blotting	O
and/or	O
semi	O
-	O
quantitative	O
RT	O
-	O
PCR	O
analysis	O
examined	O
the	O
expression	O
changes	O
of	O
gene1s	O
DNLC2A	O
gene1e	O
and	O
gene1s	O
DNLC2B	O
gene1e	O
in	O
68	O
hepatocellular	O
carcinoma	O
tissue	O
samples	O
.	O
It	O
was	O
revealed	O
that	O
gene1s	O
DNLC2A	O
gene1e	O
was	O
up	O
-	O
regulated	O
(	O
45	O
out	O
of	O
the	O
68	O
cases	O
)	O
while	O
gene1s	O
DNLC2B	O
gene1e	O
was	O
down	O
-	O
regulated	O
(	O
44	O
out	O
of	O
68	O
cases	O
)	O
,	O
compared	O
with	O
their	O
adjacent	O
tumor	O
-	O
free	O
liver	O
tissues	O
.	O
Interestingly	O
,	O
among	O
the	O
total	O
68	O
liver	O
cancer	O
samples	O
tested	O
,	O
gene1s	O
DNLC2A	O
gene1e	O
was	O
up	O
-	O
regulated	O
while	O
gene1s	O
DNLC2B	O
gene1e	O
was	O
down	O
-	O
regulated	O
in	O
28	O
cases	O
;	O
gene1s	O
DNLC2A	O
gene1e	O
was	O
up	O
-	O
regulated	O
while	O
no	O
obvious	O
change	O
was	O
observed	O
for	O
gene1s	O
DNLC2B	O
gene1e	O
in	O
10	O
cases	O
;	O
no	O
obvious	O
change	O
was	O
observed	O
for	O
gene1s	O
DNLC2A	O
gene1e	O
while	O
gene1s	O
DNLC2B	O
gene1e	O
was	O
down	O
-	O
regulated	O
in	O
14	O
cases	O
.	O
Although	O
the	O
underlying	O
mechanism	O
is	O
not	O
clear	O
to	O
date	O
,	O
the	O
apparent	O
up	O
-	O
regulation	O
of	O
gene1s	O
DNLC2A	O
gene1e	O
and	O
down	O
-	O
regulation	O
of	O
gene1s	O
DNLC2B	O
gene1e	O
suggest	O
that	O
these	O
genes	O
might	O
be	O
involved	O
in	O
tumor	O
progression	O
.	O
On	O
the	O
other	O
hand	O
,	O
the	O
different	O
expression	O
changes	O
of	O
the	O
two	O
homologous	O
genes	O
indicate	O
that	O
hepatocellular	O
carcinomas	O
are	O
caused	O
by	O
different	O
pathological	O
mechanisms	O
.	O
In	O
addition	O
,	O
gene1s	O
DNLC2A	O
gene1e	O
was	O
assigned	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
20q12-q13.11	O
near	O
the	O
marker	O
D20S106	O
by	O
radiation	O
hybrid	O
mapping	O
.	O

Isolation	O
and	O
characterization	O
of	O
a	O
new	O
nucleolar	O
protein	O
,	O
gene1s	O
Nrap	O
gene1e	O
,	O
that	O
is	O
conserved	O
from	O
arg1s	O
yeast	O
arg1e	O
to	O
species1s	O
humans	O
species1e	O
.	O
The	O
nucleolus	O
is	O
the	O
site	O
of	O
rRNA	O
synthesis	O
and	O
processing	O
in	O
eukaryotic	O
cells	O
,	O
but	O
its	O
composition	O
remains	O
poorly	O
understood	O
.	O
We	O
have	O
identified	O
a	O
novel	O
gene1s	O
nucleolar	O
RNA	O
-	O
associated	O
protein	O
gene1e	O
(	O
gene1s	O
Nrap	O
gene1e	O
)	O
which	O
is	O
highly	O
conserved	O
from	O
arg1s	O
yeast	O
arg1e	O
(	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
)	O
to	O
species1s	O
human	O
species1e	O
,	O
with	O
homologues	O
in	O
species1s	O
mouse	O
species1e	O
,	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
,	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
,	O
species1s	O
Arabidopsis	O
thaliana	O
species1e	O
,	O
species1s	O
Schizosaccharomyces	O
pombe	O
species1e	O
,	O
and	O
other	O
species	O
.	O
In	O
the	O
species1s	O
mouse	O
species1e	O
,	O
we	O
have	O
found	O
that	O
gene1s	O
Nrap	O
gene1e	O
is	O
ubiquitously	O
expressed	O
and	O
is	O
specifically	O
localized	O
in	O
the	O
nucleolus	O
.	O
We	O
have	O
also	O
identified	O
splice	O
variants	O
in	O
species1s	O
human	O
species1e	O
and	O
species1s	O
mouse	O
species1e	O
,	O
and	O
defined	O
the	O
intron	O
-	O
exon	O
structure	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
Nrap	O
gene1e	O
gene	O
.	O
gene1s	O
Nrap	O
gene1e	O
is	O
inherited	O
into	O
daughter	O
nuclei	O
by	O
associating	O
with	O
the	O
condensed	O
chromosomes	O
during	O
mitosis	O
.	O
RNase	O
treatment	O
of	O
permeabilized	O
cells	O
indicated	O
that	O
the	O
nucleolar	O
localization	O
of	O
gene1s	O
Nrap	O
gene1e	O
is	O
RNA	O
dependent	O
.	O
The	O
effects	O
of	O
actinomycin	O
D	O
,	O
cycloheximide	O
and	O
5,6-dichloro	O
-	O
beta	O
-	O
d	O
-	O
ribofuranosyl	O
-	O
benzimidazole	O
on	O
gene1s	O
Nrap	O
gene1e	O
expression	O
and	O
distribution	O
in	O
cultured	O
cells	O
suggest	O
that	O
gene1s	O
Nrap	O
gene1e	O
is	O
associated	O
with	O
the	O
pre	O
-	O
rRNA	O
transcript	O
.	O
gene1s	O
Nrap	O
gene1e	O
is	O
a	O
large	O
nucleolar	O
protein	O
(	O
of	O
more	O
than	O
1000	O
amino	O
acids	O
)	O
,	O
and	O
is	O
a	O
new	O
class	O
of	O
protein	O
with	O
new	O
structural	O
and	O
functional	O
motifs	O
.	O
gene1s	O
Nrap	O
gene1e	O
appears	O
to	O
be	O
associated	O
with	O
ribosome	O
biogenesis	O
by	O
interacting	O
with	O
pre	O
-	O
rRNA	O
primary	O
transcript	O
.	O

Isolation	O
and	O
characterization	O
of	O
a	O
new	O
nucleolar	O
protein	O
,	O
gene1s	ARG2
Nrap	ARG2
gene1e	ARG2
,	O
that	O
is	O
conserved	O
from	O
species1s	O
yeast	O
species1e	O
to	O
arg1s	O
humans	O
arg1e	O
.	O
The	O
nucleolus	O
is	O
the	O
site	O
of	O
rRNA	O
synthesis	O
and	O
processing	O
in	O
eukaryotic	O
cells	O
,	O
but	O
its	O
composition	O
remains	O
poorly	O
understood	O
.	O
We	O
have	O
identified	O
a	O
novel	O
gene1s	ARG2
nucleolar	ARG2
RNA	ARG2
-	ARG2
associated	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Nrap	ARG2
gene1e	ARG2
)	O
which	O
is	O
highly	O
conserved	O
from	O
species1s	O
yeast	O
species1e	O
(	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
)	O
to	O
arg1s	O
human	O
arg1e	O
,	O
with	O
homologues	O
in	O
species1s	O
mouse	O
species1e	O
,	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
,	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
,	O
species1s	O
Arabidopsis	O
thaliana	O
species1e	O
,	O
species1s	O
Schizosaccharomyces	O
pombe	O
species1e	O
,	O
and	O
other	O
species	O
.	O
In	O
the	O
species1s	O
mouse	O
species1e	O
,	O
we	O
have	O
found	O
that	O
gene1s	O
Nrap	O
gene1e	O
is	O
ubiquitously	O
expressed	O
and	O
is	O
specifically	O
localized	O
in	O
the	O
nucleolus	O
.	O
We	O
have	O
also	O
identified	O
splice	O
variants	O
in	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
mouse	O
species1e	O
,	O
and	O
defined	O
the	O
intron	O
-	O
exon	O
structure	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
Nrap	ARG2
gene1e	ARG2
gene	O
.	O
gene1s	ARG2
Nrap	ARG2
gene1e	ARG2
is	O
inherited	O
into	O
daughter	O
nuclei	O
by	O
associating	O
with	O
the	O
condensed	O
chromosomes	O
during	O
mitosis	O
.	O
RNase	O
treatment	O
of	O
permeabilized	O
cells	O
indicated	O
that	O
the	O
nucleolar	O
localization	O
of	O
gene1s	ARG2
Nrap	ARG2
gene1e	ARG2
is	O
RNA	O
dependent	O
.	O
The	O
effects	O
of	O
actinomycin	O
D	O
,	O
cycloheximide	O
and	O
5,6-dichloro	O
-	O
beta	O
-	O
d	O
-	O
ribofuranosyl	O
-	O
benzimidazole	O
on	O
gene1s	ARG2
Nrap	ARG2
gene1e	ARG2
expression	O
and	O
distribution	O
in	O
cultured	O
cells	O
suggest	O
that	O
gene1s	ARG2
Nrap	ARG2
gene1e	ARG2
is	O
associated	O
with	O
the	O
pre	O
-	O
rRNA	O
transcript	O
.	O
gene1s	ARG2
Nrap	ARG2
gene1e	ARG2
is	O
a	O
large	O
nucleolar	O
protein	O
(	O
of	O
more	O
than	O
1000	O
amino	O
acids	O
)	O
,	O
and	O
is	O
a	O
new	O
class	O
of	O
protein	O
with	O
new	O
structural	O
and	O
functional	O
motifs	O
.	O
gene1s	ARG2
Nrap	ARG2
gene1e	ARG2
appears	O
to	O
be	O
associated	O
with	O
ribosome	O
biogenesis	O
by	O
interacting	O
with	O
pre	O
-	O
rRNA	O
primary	O
transcript	O
.	O

Isolation	O
and	O
characterization	O
of	O
a	O
new	O
nucleolar	O
protein	O
,	O
gene1s	O
Nrap	O
gene1e	O
,	O
that	O
is	O
conserved	O
from	O
species1s	O
yeast	O
species1e	O
to	O
species1s	O
humans	O
species1e	O
.	O
The	O
nucleolus	O
is	O
the	O
site	O
of	O
rRNA	O
synthesis	O
and	O
processing	O
in	O
eukaryotic	O
cells	O
,	O
but	O
its	O
composition	O
remains	O
poorly	O
understood	O
.	O
We	O
have	O
identified	O
a	O
novel	O
gene1s	O
nucleolar	O
RNA	O
-	O
associated	O
protein	O
gene1e	O
(	O
gene1s	O
Nrap	O
gene1e	O
)	O
which	O
is	O
highly	O
conserved	O
from	O
species1s	O
yeast	O
species1e	O
(	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
)	O
to	O
species1s	O
human	O
species1e	O
,	O
with	O
homologues	O
in	O
arg1s	O
mouse	O
arg1e	O
,	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
,	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
,	O
species1s	O
Arabidopsis	O
thaliana	O
species1e	O
,	O
species1s	O
Schizosaccharomyces	O
pombe	O
species1e	O
,	O
and	O
other	O
species	O
.	O
In	O
the	O
arg1s	O
mouse	O
arg1e	O
,	O
we	O
have	O
found	O
that	O
gene1s	ARG2
Nrap	ARG2
gene1e	ARG2
is	O
ubiquitously	O
expressed	O
and	O
is	O
specifically	O
localized	O
in	O
the	O
nucleolus	O
.	O
We	O
have	O
also	O
identified	O
splice	O
variants	O
in	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
mouse	O
arg1e	O
,	O
and	O
defined	O
the	O
intron	O
-	O
exon	O
structure	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
Nrap	O
gene1e	O
gene	O
.	O
gene1s	O
Nrap	O
gene1e	O
is	O
inherited	O
into	O
daughter	O
nuclei	O
by	O
associating	O
with	O
the	O
condensed	O
chromosomes	O
during	O
mitosis	O
.	O
RNase	O
treatment	O
of	O
permeabilized	O
cells	O
indicated	O
that	O
the	O
nucleolar	O
localization	O
of	O
gene1s	O
Nrap	O
gene1e	O
is	O
RNA	O
dependent	O
.	O
The	O
effects	O
of	O
actinomycin	O
D	O
,	O
cycloheximide	O
and	O
5,6-dichloro	O
-	O
beta	O
-	O
d	O
-	O
ribofuranosyl	O
-	O
benzimidazole	O
on	O
gene1s	O
Nrap	O
gene1e	O
expression	O
and	O
distribution	O
in	O
cultured	O
cells	O
suggest	O
that	O
gene1s	O
Nrap	O
gene1e	O
is	O
associated	O
with	O
the	O
pre	O
-	O
rRNA	O
transcript	O
.	O
gene1s	O
Nrap	O
gene1e	O
is	O
a	O
large	O
nucleolar	O
protein	O
(	O
of	O
more	O
than	O
1000	O
amino	O
acids	O
)	O
,	O
and	O
is	O
a	O
new	O
class	O
of	O
protein	O
with	O
new	O
structural	O
and	O
functional	O
motifs	O
.	O
gene1s	O
Nrap	O
gene1e	O
appears	O
to	O
be	O
associated	O
with	O
ribosome	O
biogenesis	O
by	O
interacting	O
with	O
pre	O
-	O
rRNA	O
primary	O
transcript	O
.	O

Isolation	O
and	O
characterization	O
of	O
a	O
new	O
nucleolar	O
protein	O
,	O
gene1s	O
Nrap	O
gene1e	O
,	O
that	O
is	O
conserved	O
from	O
species1s	O
yeast	O
species1e	O
to	O
species1s	O
humans	O
species1e	O
.	O
The	O
nucleolus	O
is	O
the	O
site	O
of	O
rRNA	O
synthesis	O
and	O
processing	O
in	O
eukaryotic	O
cells	O
,	O
but	O
its	O
composition	O
remains	O
poorly	O
understood	O
.	O
We	O
have	O
identified	O
a	O
novel	O
gene1s	O
nucleolar	O
RNA	O
-	O
associated	O
protein	O
gene1e	O
(	O
gene1s	O
Nrap	O
gene1e	O
)	O
which	O
is	O
highly	O
conserved	O
from	O
species1s	O
yeast	O
species1e	O
(	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
)	O
to	O
species1s	O
human	O
species1e	O
,	O
with	O
homologues	O
in	O
species1s	O
mouse	O
species1e	O
,	O
arg1s	O
Drosophila	O
melanogaster	O
arg1e	O
,	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
,	O
species1s	O
Arabidopsis	O
thaliana	O
species1e	O
,	O
species1s	O
Schizosaccharomyces	O
pombe	O
species1e	O
,	O
and	O
other	O
species	O
.	O
In	O
the	O
species1s	O
mouse	O
species1e	O
,	O
we	O
have	O
found	O
that	O
gene1s	O
Nrap	O
gene1e	O
is	O
ubiquitously	O
expressed	O
and	O
is	O
specifically	O
localized	O
in	O
the	O
nucleolus	O
.	O
We	O
have	O
also	O
identified	O
splice	O
variants	O
in	O
species1s	O
human	O
species1e	O
and	O
species1s	O
mouse	O
species1e	O
,	O
and	O
defined	O
the	O
intron	O
-	O
exon	O
structure	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
Nrap	O
gene1e	O
gene	O
.	O
gene1s	O
Nrap	O
gene1e	O
is	O
inherited	O
into	O
daughter	O
nuclei	O
by	O
associating	O
with	O
the	O
condensed	O
chromosomes	O
during	O
mitosis	O
.	O
RNase	O
treatment	O
of	O
permeabilized	O
cells	O
indicated	O
that	O
the	O
nucleolar	O
localization	O
of	O
gene1s	O
Nrap	O
gene1e	O
is	O
RNA	O
dependent	O
.	O
The	O
effects	O
of	O
actinomycin	O
D	O
,	O
cycloheximide	O
and	O
5,6-dichloro	O
-	O
beta	O
-	O
d	O
-	O
ribofuranosyl	O
-	O
benzimidazole	O
on	O
gene1s	O
Nrap	O
gene1e	O
expression	O
and	O
distribution	O
in	O
cultured	O
cells	O
suggest	O
that	O
gene1s	O
Nrap	O
gene1e	O
is	O
associated	O
with	O
the	O
pre	O
-	O
rRNA	O
transcript	O
.	O
gene1s	O
Nrap	O
gene1e	O
is	O
a	O
large	O
nucleolar	O
protein	O
(	O
of	O
more	O
than	O
1000	O
amino	O
acids	O
)	O
,	O
and	O
is	O
a	O
new	O
class	O
of	O
protein	O
with	O
new	O
structural	O
and	O
functional	O
motifs	O
.	O
gene1s	O
Nrap	O
gene1e	O
appears	O
to	O
be	O
associated	O
with	O
ribosome	O
biogenesis	O
by	O
interacting	O
with	O
pre	O
-	O
rRNA	O
primary	O
transcript	O
.	O

Isolation	O
and	O
characterization	O
of	O
a	O
new	O
nucleolar	O
protein	O
,	O
gene1s	O
Nrap	O
gene1e	O
,	O
that	O
is	O
conserved	O
from	O
species1s	O
yeast	O
species1e	O
to	O
species1s	O
humans	O
species1e	O
.	O
The	O
nucleolus	O
is	O
the	O
site	O
of	O
rRNA	O
synthesis	O
and	O
processing	O
in	O
eukaryotic	O
cells	O
,	O
but	O
its	O
composition	O
remains	O
poorly	O
understood	O
.	O
We	O
have	O
identified	O
a	O
novel	O
gene1s	O
nucleolar	O
RNA	O
-	O
associated	O
protein	O
gene1e	O
(	O
gene1s	O
Nrap	O
gene1e	O
)	O
which	O
is	O
highly	O
conserved	O
from	O
species1s	O
yeast	O
species1e	O
(	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
)	O
to	O
species1s	O
human	O
species1e	O
,	O
with	O
homologues	O
in	O
species1s	O
mouse	O
species1e	O
,	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
,	O
arg1s	O
Caenorhabditis	O
elegans	O
arg1e	O
,	O
species1s	O
Arabidopsis	O
thaliana	O
species1e	O
,	O
species1s	O
Schizosaccharomyces	O
pombe	O
species1e	O
,	O
and	O
other	O
species	O
.	O
In	O
the	O
species1s	O
mouse	O
species1e	O
,	O
we	O
have	O
found	O
that	O
gene1s	O
Nrap	O
gene1e	O
is	O
ubiquitously	O
expressed	O
and	O
is	O
specifically	O
localized	O
in	O
the	O
nucleolus	O
.	O
We	O
have	O
also	O
identified	O
splice	O
variants	O
in	O
species1s	O
human	O
species1e	O
and	O
species1s	O
mouse	O
species1e	O
,	O
and	O
defined	O
the	O
intron	O
-	O
exon	O
structure	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
Nrap	O
gene1e	O
gene	O
.	O
gene1s	O
Nrap	O
gene1e	O
is	O
inherited	O
into	O
daughter	O
nuclei	O
by	O
associating	O
with	O
the	O
condensed	O
chromosomes	O
during	O
mitosis	O
.	O
RNase	O
treatment	O
of	O
permeabilized	O
cells	O
indicated	O
that	O
the	O
nucleolar	O
localization	O
of	O
gene1s	O
Nrap	O
gene1e	O
is	O
RNA	O
dependent	O
.	O
The	O
effects	O
of	O
actinomycin	O
D	O
,	O
cycloheximide	O
and	O
5,6-dichloro	O
-	O
beta	O
-	O
d	O
-	O
ribofuranosyl	O
-	O
benzimidazole	O
on	O
gene1s	O
Nrap	O
gene1e	O
expression	O
and	O
distribution	O
in	O
cultured	O
cells	O
suggest	O
that	O
gene1s	O
Nrap	O
gene1e	O
is	O
associated	O
with	O
the	O
pre	O
-	O
rRNA	O
transcript	O
.	O
gene1s	O
Nrap	O
gene1e	O
is	O
a	O
large	O
nucleolar	O
protein	O
(	O
of	O
more	O
than	O
1000	O
amino	O
acids	O
)	O
,	O
and	O
is	O
a	O
new	O
class	O
of	O
protein	O
with	O
new	O
structural	O
and	O
functional	O
motifs	O
.	O
gene1s	O
Nrap	O
gene1e	O
appears	O
to	O
be	O
associated	O
with	O
ribosome	O
biogenesis	O
by	O
interacting	O
with	O
pre	O
-	O
rRNA	O
primary	O
transcript	O
.	O

Isolation	O
and	O
characterization	O
of	O
a	O
new	O
nucleolar	O
protein	O
,	O
gene1s	O
Nrap	O
gene1e	O
,	O
that	O
is	O
conserved	O
from	O
species1s	O
yeast	O
species1e	O
to	O
species1s	O
humans	O
species1e	O
.	O
The	O
nucleolus	O
is	O
the	O
site	O
of	O
rRNA	O
synthesis	O
and	O
processing	O
in	O
eukaryotic	O
cells	O
,	O
but	O
its	O
composition	O
remains	O
poorly	O
understood	O
.	O
We	O
have	O
identified	O
a	O
novel	O
gene1s	O
nucleolar	O
RNA	O
-	O
associated	O
protein	O
gene1e	O
(	O
gene1s	O
Nrap	O
gene1e	O
)	O
which	O
is	O
highly	O
conserved	O
from	O
species1s	O
yeast	O
species1e	O
(	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
)	O
to	O
species1s	O
human	O
species1e	O
,	O
with	O
homologues	O
in	O
species1s	O
mouse	O
species1e	O
,	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
,	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
,	O
arg1s	O
Arabidopsis	O
thaliana	O
arg1e	O
,	O
species1s	O
Schizosaccharomyces	O
pombe	O
species1e	O
,	O
and	O
other	O
species	O
.	O
In	O
the	O
species1s	O
mouse	O
species1e	O
,	O
we	O
have	O
found	O
that	O
gene1s	O
Nrap	O
gene1e	O
is	O
ubiquitously	O
expressed	O
and	O
is	O
specifically	O
localized	O
in	O
the	O
nucleolus	O
.	O
We	O
have	O
also	O
identified	O
splice	O
variants	O
in	O
species1s	O
human	O
species1e	O
and	O
species1s	O
mouse	O
species1e	O
,	O
and	O
defined	O
the	O
intron	O
-	O
exon	O
structure	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
Nrap	O
gene1e	O
gene	O
.	O
gene1s	O
Nrap	O
gene1e	O
is	O
inherited	O
into	O
daughter	O
nuclei	O
by	O
associating	O
with	O
the	O
condensed	O
chromosomes	O
during	O
mitosis	O
.	O
RNase	O
treatment	O
of	O
permeabilized	O
cells	O
indicated	O
that	O
the	O
nucleolar	O
localization	O
of	O
gene1s	O
Nrap	O
gene1e	O
is	O
RNA	O
dependent	O
.	O
The	O
effects	O
of	O
actinomycin	O
D	O
,	O
cycloheximide	O
and	O
5,6-dichloro	O
-	O
beta	O
-	O
d	O
-	O
ribofuranosyl	O
-	O
benzimidazole	O
on	O
gene1s	O
Nrap	O
gene1e	O
expression	O
and	O
distribution	O
in	O
cultured	O
cells	O
suggest	O
that	O
gene1s	O
Nrap	O
gene1e	O
is	O
associated	O
with	O
the	O
pre	O
-	O
rRNA	O
transcript	O
.	O
gene1s	O
Nrap	O
gene1e	O
is	O
a	O
large	O
nucleolar	O
protein	O
(	O
of	O
more	O
than	O
1000	O
amino	O
acids	O
)	O
,	O
and	O
is	O
a	O
new	O
class	O
of	O
protein	O
with	O
new	O
structural	O
and	O
functional	O
motifs	O
.	O
gene1s	O
Nrap	O
gene1e	O
appears	O
to	O
be	O
associated	O
with	O
ribosome	O
biogenesis	O
by	O
interacting	O
with	O
pre	O
-	O
rRNA	O
primary	O
transcript	O
.	O

Isolation	O
and	O
characterization	O
of	O
a	O
new	O
nucleolar	O
protein	O
,	O
gene1s	O
Nrap	O
gene1e	O
,	O
that	O
is	O
conserved	O
from	O
species1s	O
yeast	O
species1e	O
to	O
species1s	O
humans	O
species1e	O
.	O
The	O
nucleolus	O
is	O
the	O
site	O
of	O
rRNA	O
synthesis	O
and	O
processing	O
in	O
eukaryotic	O
cells	O
,	O
but	O
its	O
composition	O
remains	O
poorly	O
understood	O
.	O
We	O
have	O
identified	O
a	O
novel	O
gene1s	O
nucleolar	O
RNA	O
-	O
associated	O
protein	O
gene1e	O
(	O
gene1s	O
Nrap	O
gene1e	O
)	O
which	O
is	O
highly	O
conserved	O
from	O
species1s	O
yeast	O
species1e	O
(	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
)	O
to	O
species1s	O
human	O
species1e	O
,	O
with	O
homologues	O
in	O
species1s	O
mouse	O
species1e	O
,	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
,	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
,	O
species1s	O
Arabidopsis	O
thaliana	O
species1e	O
,	O
arg1s	O
Schizosaccharomyces	O
pombe	O
arg1e	O
,	O
and	O
other	O
species	O
.	O
In	O
the	O
species1s	O
mouse	O
species1e	O
,	O
we	O
have	O
found	O
that	O
gene1s	O
Nrap	O
gene1e	O
is	O
ubiquitously	O
expressed	O
and	O
is	O
specifically	O
localized	O
in	O
the	O
nucleolus	O
.	O
We	O
have	O
also	O
identified	O
splice	O
variants	O
in	O
species1s	O
human	O
species1e	O
and	O
species1s	O
mouse	O
species1e	O
,	O
and	O
defined	O
the	O
intron	O
-	O
exon	O
structure	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
Nrap	O
gene1e	O
gene	O
.	O
gene1s	O
Nrap	O
gene1e	O
is	O
inherited	O
into	O
daughter	O
nuclei	O
by	O
associating	O
with	O
the	O
condensed	O
chromosomes	O
during	O
mitosis	O
.	O
RNase	O
treatment	O
of	O
permeabilized	O
cells	O
indicated	O
that	O
the	O
nucleolar	O
localization	O
of	O
gene1s	O
Nrap	O
gene1e	O
is	O
RNA	O
dependent	O
.	O
The	O
effects	O
of	O
actinomycin	O
D	O
,	O
cycloheximide	O
and	O
5,6-dichloro	O
-	O
beta	O
-	O
d	O
-	O
ribofuranosyl	O
-	O
benzimidazole	O
on	O
gene1s	O
Nrap	O
gene1e	O
expression	O
and	O
distribution	O
in	O
cultured	O
cells	O
suggest	O
that	O
gene1s	O
Nrap	O
gene1e	O
is	O
associated	O
with	O
the	O
pre	O
-	O
rRNA	O
transcript	O
.	O
gene1s	O
Nrap	O
gene1e	O
is	O
a	O
large	O
nucleolar	O
protein	O
(	O
of	O
more	O
than	O
1000	O
amino	O
acids	O
)	O
,	O
and	O
is	O
a	O
new	O
class	O
of	O
protein	O
with	O
new	O
structural	O
and	O
functional	O
motifs	O
.	O
gene1s	O
Nrap	O
gene1e	O
appears	O
to	O
be	O
associated	O
with	O
ribosome	O
biogenesis	O
by	O
interacting	O
with	O
pre	O
-	O
rRNA	O
primary	O
transcript	O
.	O

Identification	O
of	O
the	O
gene1s	ARG2
mitochondrial	ARG2
glutamate	ARG2
transporter	ARG2
gene1e	ARG2
.	O
Bacterial	O
expression	O
,	O
reconstitution	O
,	O
functional	O
characterization	O
,	O
and	O
tissue	O
distribution	O
of	O
two	O
arg1s	O
human	O
arg1e	O
isoforms	O
.	O
The	O
mitochondrial	O
carriers	O
are	O
a	O
family	O
of	O
transport	O
proteins	O
in	O
the	O
inner	O
membranes	O
of	O
mitochondria	O
.	O
They	O
shuttle	O
substrates	O
,	O
metabolites	O
,	O
and	O
cofactors	O
through	O
this	O
membrane	O
and	O
connect	O
cytoplasm	O
functions	O
with	O
others	O
in	O
the	O
matrix	O
.	O
Glutamate	O
is	O
co	O
-	O
transported	O
with	O
H(+	O
)	O
(	O
or	O
exchanged	O
for	O
OH(-	O
)	O
)	O
,	O
but	O
no	O
protein	O
has	O
ever	O
been	O
associated	O
with	O
this	O
activity	O
.	O
Two	O
arg1s	O
human	O
arg1e	O
expressed	O
sequence	O
tags	O
encode	O
proteins	O
of	O
323	O
and	O
315	O
amino	O
acids	O
with	O
63	O
%	O
identity	O
that	O
are	O
related	O
to	O
the	O
aspartate	O
-	O
glutamate	O
carrier	O
,	O
a	O
member	O
of	O
the	O
carrier	O
family	O
.	O
They	O
have	O
been	O
overexpressed	O
in	O
species1s	O
Escherichia	O
coli	O
species1e	O
and	O
reconstituted	O
into	O
phospholipid	O
vesicles	O
.	O
Their	O
transport	O
properties	O
demonstrate	O
that	O
the	O
two	O
proteins	O
are	O
isoforms	O
of	O
the	O
gene1s	ARG2
glutamate	ARG2
/	ARG2
H(+	ARG2
)	ARG2
symporter	ARG2
gene1e	ARG2
described	O
in	O
the	O
past	O
in	O
whole	O
mitochondria	O
.	O
Isoform	O
1	O
is	O
expressed	O
at	O
higher	O
levels	O
than	O
isoform	O
2	O
in	O
all	O
the	O
tissues	O
except	O
in	O
brain	O
,	O
where	O
the	O
two	O
isoforms	O
are	O
expressed	O
at	O
comparable	O
levels	O
.	O
The	O
differences	O
in	O
expression	O
levels	O
and	O
kinetic	O
parameters	O
of	O
the	O
two	O
isoforms	O
suggest	O
that	O
isoform	O
2	O
matches	O
the	O
basic	O
requirement	O
of	O
all	O
tissues	O
especially	O
with	O
respect	O
to	O
amino	O
acid	O
degradation	O
,	O
and	O
isoform	O
1	O
becomes	O
operative	O
to	O
accommodate	O
higher	O
demands	O
associated	O
with	O
specific	O
metabolic	O
functions	O
such	O
as	O
ureogenesis	O
.	O

Identification	O
of	O
the	O
gene1s	O
mitochondrial	O
glutamate	O
transporter	O
gene1e	O
.	O
Bacterial	O
expression	O
,	O
reconstitution	O
,	O
functional	O
characterization	O
,	O
and	O
tissue	O
distribution	O
of	O
two	O
species1s	O
human	O
species1e	O
isoforms	O
.	O
The	O
mitochondrial	O
carriers	O
are	O
a	O
family	O
of	O
transport	O
proteins	O
in	O
the	O
inner	O
membranes	O
of	O
mitochondria	O
.	O
They	O
shuttle	O
substrates	O
,	O
metabolites	O
,	O
and	O
cofactors	O
through	O
this	O
membrane	O
and	O
connect	O
cytoplasm	O
functions	O
with	O
others	O
in	O
the	O
matrix	O
.	O
Glutamate	O
is	O
co	O
-	O
transported	O
with	O
H(+	O
)	O
(	O
or	O
exchanged	O
for	O
OH(-	O
)	O
)	O
,	O
but	O
no	O
protein	O
has	O
ever	O
been	O
associated	O
with	O
this	O
activity	O
.	O
Two	O
species1s	O
human	O
species1e	O
expressed	O
sequence	O
tags	O
encode	O
proteins	O
of	O
323	O
and	O
315	O
amino	O
acids	O
with	O
63	O
%	O
identity	O
that	O
are	O
related	O
to	O
the	O
aspartate	O
-	O
glutamate	O
carrier	O
,	O
a	O
member	O
of	O
the	O
carrier	O
family	O
.	O
They	O
have	O
been	O
overexpressed	O
in	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
and	O
reconstituted	O
into	O
phospholipid	O
vesicles	O
.	O
Their	O
transport	O
properties	O
demonstrate	O
that	O
the	O
two	O
proteins	O
are	O
isoforms	O
of	O
the	O
gene1s	O
glutamate	O
/	O
H(+	O
)	O
symporter	O
gene1e	O
described	O
in	O
the	O
past	O
in	O
whole	O
mitochondria	O
.	O
Isoform	O
1	O
is	O
expressed	O
at	O
higher	O
levels	O
than	O
isoform	O
2	O
in	O
all	O
the	O
tissues	O
except	O
in	O
brain	O
,	O
where	O
the	O
two	O
isoforms	O
are	O
expressed	O
at	O
comparable	O
levels	O
.	O
The	O
differences	O
in	O
expression	O
levels	O
and	O
kinetic	O
parameters	O
of	O
the	O
two	O
isoforms	O
suggest	O
that	O
isoform	O
2	O
matches	O
the	O
basic	O
requirement	O
of	O
all	O
tissues	O
especially	O
with	O
respect	O
to	O
amino	O
acid	O
degradation	O
,	O
and	O
isoform	O
1	O
becomes	O
operative	O
to	O
accommodate	O
higher	O
demands	O
associated	O
with	O
specific	O
metabolic	O
functions	O
such	O
as	O
ureogenesis	O
.	O

Identification	O
of	O
arg1s	O
mammalian	O
arg1e	O
gene1s	ARG2
Sds3	ARG2
gene1e	ARG2
as	O
an	O
integral	O
component	O
of	O
the	O
Sin3	O
/	O
histone	O
deacetylase	O
corepressor	O
complex	O
.	O
Silencing	O
of	O
gene	O
transcription	O
involves	O
local	O
chromatin	O
modification	O
achieved	O
through	O
the	O
local	O
recruitment	O
of	O
large	O
multiprotein	O
complexes	O
containing	O
histone	O
deacetylase	O
(	O
HDAC	O
)	O
activity	O
.	O
The	O
arg1s	O
mammalian	O
arg1e	O
corepressors	O
gene1s	ARG2
mSin3A	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
mSin3B	ARG2
gene1e	ARG2
have	O
been	O
shown	O
to	O
play	O
a	O
key	O
role	O
in	O
this	O
process	O
by	O
tethering	O
gene1s	ARG2
HDACs	ARG2
1	ARG2
and	ARG2
2	ARG2
gene1e	ARG2
to	O
promoter	O
-	O
bound	O
transcription	O
factors	O
.	O
Similar	O
mechanisms	O
appear	O
to	O
be	O
operative	O
in	O
species1s	O
yeast	O
species1e	O
,	O
in	O
which	O
epistasis	O
experiments	O
have	O
established	O
that	O
the	O
mSin3	O
and	O
HDAC	O
orthologs	O
(	O
gene1s	O
SIN3	O
gene1e	O
and	O
gene1s	O
RPD3	O
gene1e	O
)	O
,	O
along	O
with	O
a	O
novel	O
protein	O
,	O
gene1s	O
SDS3	O
gene1e	O
,	O
function	O
in	O
the	O
same	O
repressor	O
pathway	O
.	O
Here	O
,	O
we	O
report	O
the	O
identification	O
of	O
a	O
component	O
of	O
the	O
mSin3-HDAC	O
complex	O
that	O
bears	O
homology	O
to	O
species1s	O
yeast	O
species1e	O
gene1s	O
SDS3	O
gene1e	O
,	O
physically	O
associates	O
with	O
mSin3	O
proteins	O
in	O
vivo	O
,	O
represses	O
transcription	O
in	O
a	O
manner	O
that	O
is	O
partially	O
dependent	O
on	O
HDAC	O
activity	O
,	O
and	O
enables	O
gene1s	ARG2
HDAC1	ARG2
gene1e	ARG2
catalytic	O
activity	O
in	O
vivo	O
.	O
That	O
key	O
physical	O
and	O
functional	O
properties	O
are	O
also	O
shared	O
by	O
species1s	O
yeast	O
species1e	O
gene1s	O
SDS3	O
gene1e	O
underscores	O
the	O
central	O
role	O
of	O
the	O
Sin3-HDAC	O
-	O
gene1s	ARG2
Sds3	ARG2
gene1e	ARG2
complex	O
in	O
eukaryotic	O
cell	O
biology	O
,	O
and	O
the	O
discovery	O
of	O
mSds3	O
in	O
arg1s	O
mammalian	O
arg1e	O
cells	O
provides	O
a	O
new	O
avenue	O
for	O
modulating	O
the	O
activity	O
of	O
this	O
complex	O
in	O
arg1s	O
human	O
arg1e	O
disease	O
.	O

Identification	O
of	O
species1s	O
mammalian	O
species1e	O
gene1s	O
Sds3	O
gene1e	O
as	O
an	O
integral	O
component	O
of	O
the	O
Sin3	O
/	O
histone	O
deacetylase	O
corepressor	O
complex	O
.	O
Silencing	O
of	O
gene	O
transcription	O
involves	O
local	O
chromatin	O
modification	O
achieved	O
through	O
the	O
local	O
recruitment	O
of	O
large	O
multiprotein	O
complexes	O
containing	O
histone	O
deacetylase	O
(	O
HDAC	O
)	O
activity	O
.	O
The	O
species1s	O
mammalian	O
species1e	O
corepressors	O
gene1s	O
mSin3A	O
gene1e	O
and	O
gene1s	O
mSin3B	O
gene1e	O
have	O
been	O
shown	O
to	O
play	O
a	O
key	O
role	O
in	O
this	O
process	O
by	O
tethering	O
gene1s	O
HDACs	O
1	O
and	O
2	O
gene1e	O
to	O
promoter	O
-	O
bound	O
transcription	O
factors	O
.	O
Similar	O
mechanisms	O
appear	O
to	O
be	O
operative	O
in	O
arg1s	O
yeast	O
arg1e	O
,	O
in	O
which	O
epistasis	O
experiments	O
have	O
established	O
that	O
the	O
mSin3	O
and	O
HDAC	O
orthologs	O
(	O
gene1s	ARG2
SIN3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
RPD3	ARG2
gene1e	ARG2
)	O
,	O
along	O
with	O
a	O
novel	O
protein	O
,	O
gene1s	ARG2
SDS3	ARG2
gene1e	ARG2
,	O
function	O
in	O
the	O
same	O
repressor	O
pathway	O
.	O
Here	O
,	O
we	O
report	O
the	O
identification	O
of	O
a	O
component	O
of	O
the	O
mSin3-HDAC	O
complex	O
that	O
bears	O
homology	O
to	O
arg1s	O
yeast	O
arg1e	O
gene1s	ARG2
SDS3	ARG2
gene1e	ARG2
,	O
physically	O
associates	O
with	O
mSin3	O
proteins	O
in	O
vivo	O
,	O
represses	O
transcription	O
in	O
a	O
manner	O
that	O
is	O
partially	O
dependent	O
on	O
HDAC	O
activity	O
,	O
and	O
enables	O
gene1s	O
HDAC1	O
gene1e	O
catalytic	O
activity	O
in	O
vivo	O
.	O
That	O
key	O
physical	O
and	O
functional	O
properties	O
are	O
also	O
shared	O
by	O
arg1s	O
yeast	O
arg1e	O
gene1s	ARG2
SDS3	ARG2
gene1e	ARG2
underscores	O
the	O
central	O
role	O
of	O
the	O
Sin3-HDAC	O
-	O
gene1s	O
Sds3	O
gene1e	O
complex	O
in	O
eukaryotic	O
cell	O
biology	O
,	O
and	O
the	O
discovery	O
of	O
mSds3	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
provides	O
a	O
new	O
avenue	O
for	O
modulating	O
the	O
activity	O
of	O
this	O
complex	O
in	O
species1s	O
human	O
species1e	O
disease	O
.	O

Isolation	O
of	O
a	O
genomic	O
clone	O
containing	O
the	O
promoter	O
region	O
of	O
the	O
arg1s	O
human	O
arg1e	O
ATP	O
binding	O
cassette	O
(	O
ABC	O
)	O
transporter	O
,	O
gene1s	ARG2
ABCB6	ARG2
gene1e	ARG2
.	O
We	O
previously	O
reported	O
on	O
the	O
isolation	O
of	O
a	O
new	O
species1s	O
rat	O
species1e	O
ATP	O
binding	O
cassette	O
(	O
ABC	O
)	O
transporter	O
,	O
gene1s	O
ABCB6	O
gene1e	O
.	O
We	O
now	O
report	O
the	O
isolation	O
of	O
the	O
full	O
-	O
length	O
cDNA	O
and	O
genomic	O
clones	O
containing	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
ABCB6	ARG2
gene1e	ARG2
gene	O
.	O
gene1s	ARG2
ABCB6	ARG2
gene1e	ARG2
is	O
100	O
%	O
identical	O
to	O
the	O
cloned	O
gene1s	ARG2
MTABC3	ARG2
gene1e	ARG2
arg1s	O
human	O
arg1e	O
ABC	O
transporter	O
and	O
contains	O
the	O
typical	O
ABC	O
signature	O
,	O
Walker	O
A	O
and	O
B	O
motifs	O
.	O
We	O
found	O
that	O
gene1s	ARG2
HuABCB6	ARG2
gene1e	ARG2
is	O
expressed	O
at	O
low	O
levels	O
in	O
normal	O
arg1s	O
human	O
arg1e	O
liver	O
.	O
We	O
found	O
that	O
gene1s	ARG2
ABCB6	ARG2
gene1e	ARG2
was	O
overexpressed	O
in	O
arg1s	O
human	O
arg1e	O
hepatocellular	O
carcinomas	O
compared	O
to	O
paired	O
surrounding	O
non	O
-	O
malignant	O
tissue	O
.	O
We	O
found	O
that	O
there	O
was	O
no	O
difference	O
in	O
gene1s	ARG2
ABCB6	ARG2
gene1e	ARG2
gene	O
copy	O
between	O
arg1s	O
human	O
arg1e	O
liver	O
cancer	O
and	O
its	O
paired	O
non	O
-	O
malignant	O
tissue	O
.	O
Because	O
gene1s	ARG2
HuABCB6	ARG2
gene1e	ARG2
was	O
overexpressed	O
in	O
arg1s	O
human	O
arg1e	O
cancers	O
compared	O
to	O
peri	O
-	O
tumoral	O
tissue	O
in	O
the	O
absence	O
of	O
gene	O
amplification	O
,	O
transcriptional	O
regulation	O
may	O
play	O
an	O
important	O
role	O
in	O
its	O
expression	O
.	O
Therefore	O
,	O
we	O
isolated	O
a	O
14	O
kb	O
genomic	O
DNA	O
clone	O
containing	O
the	O
HuABCB6	O
promoter	O
and	O
5'-flanking	O
region	O
.	O
The	O
5'-flanking	O
region	O
contains	O
a	O
CpG	O
island	O
,	O
lacks	O
an	O
appropriately	O
positioned	O
TATA	O
element	O
and	O
contains	O
a	O
number	O
of	O
putative	O
transcription	O
factor	O
binding	O
sites	O
.	O
Two	O
transcription	O
start	O
sites	O
were	O
identified	O
by	O
S1	O
nuclease	O
mapping	O
at	O
-274	O
and	O
-296	O
bp	O
from	O
the	O
start	O
codon	O
.	O
Transient	O
transfection	O
of	O
the	O
gene1s	ARG2
HuABCB6	ARG2
gene1e	ARG2
promoter	O
constructs	O
(	O
gene1s	ARG2
HuABCB6	ARG2
gene1e	ARG2
/1.68	O
,	O
1.39	O
,	O
1.13	O
,	O
0.90	O
,	O
0.52	O
)	O
containing	O
the	O
luciferase	O
reporter	O
gene	O
resulted	O
in	O
a	O
1100	O
-	O
2300-fold	O
increase	O
in	O
luciferase	O
activity	O
compared	O
to	O
the	O
empty	O
vector	O
control	O
whereas	O
gene1s	ARG2
HuABCB6	ARG2
gene1e	ARG2
/1.68	O
subcloned	O
in	O
the	O
reverse	O
orientation	O
resulted	O
in	O
no	O
activity	O
.	O
We	O
observed	O
a	O
significant	O
decrease	O
in	O
luciferase	O
activity	O
with	O
the	O
promoter	O
constructs	O
,	O
gene1s	ARG2
HuABCB6	ARG2
gene1e	ARG2
/0.25	O
,	O
0.15	O
and	O
0.06	O
,	O
which	O
indicates	O
that	O
an	O
orientation	O
-	O
dependent	O
functional	O
promoter	O
is	O
contained	O
within	O
our	O
previously	O
predicted	O
promoter	O
region	O
of	O
-315	O
bp	O
to	O
-565	O
bp	O
as	O
deletion	O
of	O
this	O
250	O
bp	O
sequence	O
resulted	O
in	O
a	O
loss	O
of	O
promoter	O
activity	O
.	O

Isolation	O
of	O
a	O
genomic	O
clone	O
containing	O
the	O
promoter	O
region	O
of	O
the	O
species1s	O
human	O
species1e	O
ATP	O
binding	O
cassette	O
(	O
ABC	O
)	O
transporter	O
,	O
gene1s	O
ABCB6	O
gene1e	O
.	O
We	O
previously	O
reported	O
on	O
the	O
isolation	O
of	O
a	O
new	O
arg1s	O
rat	O
arg1e	O
ATP	O
binding	O
cassette	O
(	O
ABC	O
)	O
transporter	O
,	O
gene1s	ARG2
ABCB6	ARG2
gene1e	ARG2
.	O
We	O
now	O
report	O
the	O
isolation	O
of	O
the	O
full	O
-	O
length	O
cDNA	O
and	O
genomic	O
clones	O
containing	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
ABCB6	O
gene1e	O
gene	O
.	O
gene1s	O
ABCB6	O
gene1e	O
is	O
100	O
%	O
identical	O
to	O
the	O
cloned	O
gene1s	O
MTABC3	O
gene1e	O
species1s	O
human	O
species1e	O
ABC	O
transporter	O
and	O
contains	O
the	O
typical	O
ABC	O
signature	O
,	O
Walker	O
A	O
and	O
B	O
motifs	O
.	O
We	O
found	O
that	O
gene1s	O
HuABCB6	O
gene1e	O
is	O
expressed	O
at	O
low	O
levels	O
in	O
normal	O
species1s	O
human	O
species1e	O
liver	O
.	O
We	O
found	O
that	O
gene1s	O
ABCB6	O
gene1e	O
was	O
overexpressed	O
in	O
species1s	O
human	O
species1e	O
hepatocellular	O
carcinomas	O
compared	O
to	O
paired	O
surrounding	O
non	O
-	O
malignant	O
tissue	O
.	O
We	O
found	O
that	O
there	O
was	O
no	O
difference	O
in	O
gene1s	O
ABCB6	O
gene1e	O
gene	O
copy	O
between	O
species1s	O
human	O
species1e	O
liver	O
cancer	O
and	O
its	O
paired	O
non	O
-	O
malignant	O
tissue	O
.	O
Because	O
gene1s	O
HuABCB6	O
gene1e	O
was	O
overexpressed	O
in	O
species1s	O
human	O
species1e	O
cancers	O
compared	O
to	O
peri	O
-	O
tumoral	O
tissue	O
in	O
the	O
absence	O
of	O
gene	O
amplification	O
,	O
transcriptional	O
regulation	O
may	O
play	O
an	O
important	O
role	O
in	O
its	O
expression	O
.	O
Therefore	O
,	O
we	O
isolated	O
a	O
14	O
kb	O
genomic	O
DNA	O
clone	O
containing	O
the	O
HuABCB6	O
promoter	O
and	O
5'-flanking	O
region	O
.	O
The	O
5'-flanking	O
region	O
contains	O
a	O
CpG	O
island	O
,	O
lacks	O
an	O
appropriately	O
positioned	O
TATA	O
element	O
and	O
contains	O
a	O
number	O
of	O
putative	O
transcription	O
factor	O
binding	O
sites	O
.	O
Two	O
transcription	O
start	O
sites	O
were	O
identified	O
by	O
S1	O
nuclease	O
mapping	O
at	O
-274	O
and	O
-296	O
bp	O
from	O
the	O
start	O
codon	O
.	O
Transient	O
transfection	O
of	O
the	O
gene1s	O
HuABCB6	O
gene1e	O
promoter	O
constructs	O
(	O
gene1s	O
HuABCB6	O
gene1e	O
/1.68	O
,	O
1.39	O
,	O
1.13	O
,	O
0.90	O
,	O
0.52	O
)	O
containing	O
the	O
luciferase	O
reporter	O
gene	O
resulted	O
in	O
a	O
1100	O
-	O
2300-fold	O
increase	O
in	O
luciferase	O
activity	O
compared	O
to	O
the	O
empty	O
vector	O
control	O
whereas	O
gene1s	O
HuABCB6	O
gene1e	O
/1.68	O
subcloned	O
in	O
the	O
reverse	O
orientation	O
resulted	O
in	O
no	O
activity	O
.	O
We	O
observed	O
a	O
significant	O
decrease	O
in	O
luciferase	O
activity	O
with	O
the	O
promoter	O
constructs	O
,	O
gene1s	O
HuABCB6	O
gene1e	O
/0.25	O
,	O
0.15	O
and	O
0.06	O
,	O
which	O
indicates	O
that	O
an	O
orientation	O
-	O
dependent	O
functional	O
promoter	O
is	O
contained	O
within	O
our	O
previously	O
predicted	O
promoter	O
region	O
of	O
-315	O
bp	O
to	O
-565	O
bp	O
as	O
deletion	O
of	O
this	O
250	O
bp	O
sequence	O
resulted	O
in	O
a	O
loss	O
of	O
promoter	O
activity	O
.	O

arg1s	O
Human	O
arg1e	O
gene1s	ARG2
sprouty	ARG2
4	ARG2
gene1e	ARG2
,	O
a	O
new	O
ras	O
antagonist	O
on	O
5q31	O
,	O
interacts	O
with	O
the	O
dual	O
specificity	O
kinase	O
gene1s	ARG2
TESK1	ARG2
gene1e	ARG2
.	O
The	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
protein	O
sprouty	O
is	O
induced	O
upon	O
fibroblast	O
growth	O
factor	O
(	O
FGF)-	O
and	O
gene1s	ARG2
epidermal	ARG2
growth	ARG2
factor	ARG2
(	ARG2
EGF)-receptor	ARG2
gene1e	ARG2
tyrosine	O
kinase	O
activation	O
and	O
acts	O
as	O
an	O
inhibitor	O
of	O
the	O
ras	O
/	O
MAP	O
kinase	O
pathway	O
downstream	O
of	O
these	O
receptors	O
.	O
By	O
differential	O
display	O
RT	O
-	O
PCR	O
of	O
activated	O
vs.	O
resting	O
umbilical	O
artery	O
smooth	O
muscle	O
cells	O
(	O
SMCs	O
)	O
we	O
detected	O
a	O
new	O
arg1s	O
human	O
arg1e	O
sprouty	O
gene	O
,	O
which	O
we	O
designated	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
sprouty	ARG2
4	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
hspry4	ARG2
gene1e	ARG2
)	O
based	O
on	O
its	O
homology	O
with	O
species1s	O
murine	O
species1e	O
gene1s	O
sprouty	O
4	O
gene1e	O
.	O
gene1s	ARG2
Hspry4	ARG2
gene1e	ARG2
is	O
widely	O
expressed	O
and	O
Northern	O
blots	O
indicate	O
that	O
different	O
isoforms	O
of	O
gene1s	ARG2
hspry4	ARG2
gene1e	ARG2
are	O
induced	O
upon	O
cellular	O
activation	O
.	O
The	O
gene1s	ARG2
hspry4	ARG2
gene1e	ARG2
gene	O
maps	O
to	O
5q31.3	O
.	O
It	O
encodes	O
a	O
protein	O
of	O
322	O
amino	O
acids	O
,	O
which	O
,	O
in	O
support	O
of	O
a	O
modulating	O
role	O
in	O
signal	O
transduction	O
,	O
contains	O
a	O
prototypic	O
cysteine	O
-	O
rich	O
region	O
,	O
three	O
,	O
potentially	O
Src	O
homology	O
3	O
(	O
SH3	O
)	O
binding	O
,	O
proline	O
-	O
rich	O
regions	O
and	O
a	O
PEST	O
sequence	O
.	O
This	O
new	O
sprouty	O
orthologue	O
can	O
suppress	O
the	O
gene1s	ARG2
insulin-	ARG2
and	ARG2
EGF	ARG2
-	ARG2
receptor	ARG2
gene1e	ARG2
transduced	O
MAP	O
kinase	O
signaling	O
pathway	O
,	O
but	O
fails	O
to	O
inhibit	O
MAP	O
kinase	O
activation	O
by	O
constitutively	O
active	O
V12	O
ras	O
.	O
gene1s	ARG2
Hspry4	ARG2
gene1e	ARG2
appears	O
to	O
impair	O
the	O
formation	O
of	O
active	O
GTP	O
-	O
ras	O
and	O
exert	O
its	O
activity	O
at	O
the	O
level	O
of	O
wild	O
-	O
type	O
ras	O
or	O
upstream	O
thereof	O
.	O
In	O
a	O
yeast	O
two	O
-	O
hybrid	O
screen	O
,	O
using	O
gene1s	ARG2
hspry4	ARG2
gene1e	ARG2
as	O
bait	O
,	O
gene1s	ARG2
testicular	ARG2
protein	ARG2
kinase	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TESK1	ARG2
gene1e	ARG2
)	O
was	O
identified	O
from	O
a	O
arg1s	O
human	O
arg1e	O
fetal	O
liver	O
cDNA	O
library	O
as	O
a	O
partner	O
of	O
gene1s	ARG2
hspry4	ARG2
gene1e	ARG2
.	O
The	O
gene1s	ARG2
hspry4	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
TESK1	ARG2
gene1e	ARG2
interaction	O
was	O
confirmed	O
by	O
coimmunoprecipitation	O
experiments	O
and	O
increases	O
by	O
growth	O
factor	O
stimulation	O
.	O
The	O
two	O
proteins	O
colocalize	O
in	O
apparent	O
cytoplasmic	O
vesicles	O
and	O
do	O
not	O
show	O
substantial	O
translocation	O
to	O
the	O
plasma	O
membrane	O
upon	O
receptor	O
tyrosine	O
kinase	O
stimulation	O
.	O

species1s	O
Human	O
species1e	O
gene1s	O
sprouty	O
4	O
gene1e	O
,	O
a	O
new	O
ras	O
antagonist	O
on	O
5q31	O
,	O
interacts	O
with	O
the	O
dual	O
specificity	O
kinase	O
gene1s	O
TESK1	O
gene1e	O
.	O
The	O
arg1s	O
Drosophila	O
melanogaster	O
arg1e	O
protein	O
sprouty	O
is	O
induced	O
upon	O
fibroblast	O
growth	O
factor	O
(	O
FGF)-	O
and	O
gene1s	O
epidermal	O
growth	O
factor	O
(	O
EGF)-receptor	O
gene1e	O
tyrosine	O
kinase	O
activation	O
and	O
acts	O
as	O
an	O
inhibitor	O
of	O
the	O
ras	O
/	O
MAP	O
kinase	O
pathway	O
downstream	O
of	O
these	O
receptors	O
.	O
By	O
differential	O
display	O
RT	O
-	O
PCR	O
of	O
activated	O
vs.	O
resting	O
umbilical	O
artery	O
smooth	O
muscle	O
cells	O
(	O
SMCs	O
)	O
we	O
detected	O
a	O
new	O
species1s	O
human	O
species1e	O
sprouty	O
gene	O
,	O
which	O
we	O
designated	O
species1s	O
human	O
species1e	O
gene1s	O
sprouty	O
4	O
gene1e	O
(	O
gene1s	O
hspry4	O
gene1e	O
)	O
based	O
on	O
its	O
homology	O
with	O
species1s	O
murine	O
species1e	O
gene1s	O
sprouty	O
4	O
gene1e	O
.	O
gene1s	O
Hspry4	O
gene1e	O
is	O
widely	O
expressed	O
and	O
Northern	O
blots	O
indicate	O
that	O
different	O
isoforms	O
of	O
gene1s	O
hspry4	O
gene1e	O
are	O
induced	O
upon	O
cellular	O
activation	O
.	O
The	O
gene1s	O
hspry4	O
gene1e	O
gene	O
maps	O
to	O
5q31.3	O
.	O
It	O
encodes	O
a	O
protein	O
of	O
322	O
amino	O
acids	O
,	O
which	O
,	O
in	O
support	O
of	O
a	O
modulating	O
role	O
in	O
signal	O
transduction	O
,	O
contains	O
a	O
prototypic	O
cysteine	O
-	O
rich	O
region	O
,	O
three	O
,	O
potentially	O
Src	O
homology	O
3	O
(	O
SH3	O
)	O
binding	O
,	O
proline	O
-	O
rich	O
regions	O
and	O
a	O
PEST	O
sequence	O
.	O
This	O
new	O
sprouty	O
orthologue	O
can	O
suppress	O
the	O
gene1s	O
insulin-	O
and	O
EGF	O
-	O
receptor	O
gene1e	O
transduced	O
MAP	O
kinase	O
signaling	O
pathway	O
,	O
but	O
fails	O
to	O
inhibit	O
MAP	O
kinase	O
activation	O
by	O
constitutively	O
active	O
V12	O
ras	O
.	O
gene1s	O
Hspry4	O
gene1e	O
appears	O
to	O
impair	O
the	O
formation	O
of	O
active	O
GTP	O
-	O
ras	O
and	O
exert	O
its	O
activity	O
at	O
the	O
level	O
of	O
wild	O
-	O
type	O
ras	O
or	O
upstream	O
thereof	O
.	O
In	O
a	O
yeast	O
two	O
-	O
hybrid	O
screen	O
,	O
using	O
gene1s	O
hspry4	O
gene1e	O
as	O
bait	O
,	O
gene1s	O
testicular	O
protein	O
kinase	O
1	O
gene1e	O
(	O
gene1s	O
TESK1	O
gene1e	O
)	O
was	O
identified	O
from	O
a	O
species1s	O
human	O
species1e	O
fetal	O
liver	O
cDNA	O
library	O
as	O
a	O
partner	O
of	O
gene1s	O
hspry4	O
gene1e	O
.	O
The	O
gene1s	O
hspry4	O
gene1e	O
-	O
gene1s	O
TESK1	O
gene1e	O
interaction	O
was	O
confirmed	O
by	O
coimmunoprecipitation	O
experiments	O
and	O
increases	O
by	O
growth	O
factor	O
stimulation	O
.	O
The	O
two	O
proteins	O
colocalize	O
in	O
apparent	O
cytoplasmic	O
vesicles	O
and	O
do	O
not	O
show	O
substantial	O
translocation	O
to	O
the	O
plasma	O
membrane	O
upon	O
receptor	O
tyrosine	O
kinase	O
stimulation	O
.	O

species1s	O
Human	O
species1e	O
gene1s	O
sprouty	O
4	O
gene1e	O
,	O
a	O
new	O
ras	O
antagonist	O
on	O
5q31	O
,	O
interacts	O
with	O
the	O
dual	O
specificity	O
kinase	O
gene1s	O
TESK1	O
gene1e	O
.	O
The	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
protein	O
sprouty	O
is	O
induced	O
upon	O
fibroblast	O
growth	O
factor	O
(	O
FGF)-	O
and	O
gene1s	O
epidermal	O
growth	O
factor	O
(	O
EGF)-receptor	O
gene1e	O
tyrosine	O
kinase	O
activation	O
and	O
acts	O
as	O
an	O
inhibitor	O
of	O
the	O
ras	O
/	O
MAP	O
kinase	O
pathway	O
downstream	O
of	O
these	O
receptors	O
.	O
By	O
differential	O
display	O
RT	O
-	O
PCR	O
of	O
activated	O
vs.	O
resting	O
umbilical	O
artery	O
smooth	O
muscle	O
cells	O
(	O
SMCs	O
)	O
we	O
detected	O
a	O
new	O
species1s	O
human	O
species1e	O
sprouty	O
gene	O
,	O
which	O
we	O
designated	O
species1s	O
human	O
species1e	O
gene1s	O
sprouty	O
4	O
gene1e	O
(	O
gene1s	O
hspry4	O
gene1e	O
)	O
based	O
on	O
its	O
homology	O
with	O
arg1s	O
murine	O
arg1e	O
gene1s	ARG2
sprouty	ARG2
4	ARG2
gene1e	ARG2
.	O
gene1s	O
Hspry4	O
gene1e	O
is	O
widely	O
expressed	O
and	O
Northern	O
blots	O
indicate	O
that	O
different	O
isoforms	O
of	O
gene1s	O
hspry4	O
gene1e	O
are	O
induced	O
upon	O
cellular	O
activation	O
.	O
The	O
gene1s	O
hspry4	O
gene1e	O
gene	O
maps	O
to	O
5q31.3	O
.	O
It	O
encodes	O
a	O
protein	O
of	O
322	O
amino	O
acids	O
,	O
which	O
,	O
in	O
support	O
of	O
a	O
modulating	O
role	O
in	O
signal	O
transduction	O
,	O
contains	O
a	O
prototypic	O
cysteine	O
-	O
rich	O
region	O
,	O
three	O
,	O
potentially	O
Src	O
homology	O
3	O
(	O
SH3	O
)	O
binding	O
,	O
proline	O
-	O
rich	O
regions	O
and	O
a	O
PEST	O
sequence	O
.	O
This	O
new	O
sprouty	O
orthologue	O
can	O
suppress	O
the	O
gene1s	O
insulin-	O
and	O
EGF	O
-	O
receptor	O
gene1e	O
transduced	O
MAP	O
kinase	O
signaling	O
pathway	O
,	O
but	O
fails	O
to	O
inhibit	O
MAP	O
kinase	O
activation	O
by	O
constitutively	O
active	O
V12	O
ras	O
.	O
gene1s	O
Hspry4	O
gene1e	O
appears	O
to	O
impair	O
the	O
formation	O
of	O
active	O
GTP	O
-	O
ras	O
and	O
exert	O
its	O
activity	O
at	O
the	O
level	O
of	O
wild	O
-	O
type	O
ras	O
or	O
upstream	O
thereof	O
.	O
In	O
a	O
yeast	O
two	O
-	O
hybrid	O
screen	O
,	O
using	O
gene1s	O
hspry4	O
gene1e	O
as	O
bait	O
,	O
gene1s	O
testicular	O
protein	O
kinase	O
1	O
gene1e	O
(	O
gene1s	O
TESK1	O
gene1e	O
)	O
was	O
identified	O
from	O
a	O
species1s	O
human	O
species1e	O
fetal	O
liver	O
cDNA	O
library	O
as	O
a	O
partner	O
of	O
gene1s	O
hspry4	O
gene1e	O
.	O
The	O
gene1s	O
hspry4	O
gene1e	O
-	O
gene1s	O
TESK1	O
gene1e	O
interaction	O
was	O
confirmed	O
by	O
coimmunoprecipitation	O
experiments	O
and	O
increases	O
by	O
growth	O
factor	O
stimulation	O
.	O
The	O
two	O
proteins	O
colocalize	O
in	O
apparent	O
cytoplasmic	O
vesicles	O
and	O
do	O
not	O
show	O
substantial	O
translocation	O
to	O
the	O
plasma	O
membrane	O
upon	O
receptor	O
tyrosine	O
kinase	O
stimulation	O
.	O

Molecular	O
,	O
functional	O
,	O
and	O
genomic	O
characterization	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
KCC2	ARG2
gene1e	ARG2
,	O
the	O
neuronal	O
K	O
-	O
Cl	O
cotransporter	O
.	O
The	O
expression	O
level	O
of	O
the	O
neuronal	O
-	O
specific	O
K	O
-	O
Cl	O
cotransporter	O
gene1s	ARG2
KCC2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SLC12A5	ARG2
gene1e	ARG2
)	O
is	O
a	O
major	O
determinant	O
of	O
whether	O
neurons	O
will	O
respond	O
to	O
GABA	O
with	O
a	O
depolarizing	O
,	O
excitatory	O
response	O
or	O
a	O
hyperpolarizing	O
,	O
inhibitory	O
response	O
.	O
In	O
view	O
of	O
the	O
potential	O
role	O
in	O
arg1s	O
human	O
arg1e	O
neuronal	O
excitability	O
we	O
have	O
characterized	O
the	O
gene1s	ARG2
hKCC2	ARG2
gene1e	ARG2
cDNA	O
and	O
gene	O
.	O
The	O
5.9	O
kb	O
gene1s	ARG2
hKCC2	ARG2
gene1e	ARG2
transcript	O
is	O
specific	O
to	O
brain	O
,	O
and	O
is	O
induced	O
during	O
in	O
vitro	O
differentiation	O
of	O
arg1s	O
NT2	O
arg1e	O
teratocarcinoma	O
cells	O
into	O
neuronal	O
arg1s	O
NT2-N	O
arg1e	O
cells	O
.	O
The	O
24-exon	O
gene1s	ARG2
SLC12A5	ARG2
gene1e	ARG2
gene	O
is	O
on	O
arg1s	O
human	O
arg1e	O
chromosome	O
20q13	O
,	O
and	O
contains	O
a	O
polymorphic	O
dinucleotide	O
repeat	O
within	O
intron	O
1	O
near	O
a	O
potential	O
binding	O
site	O
for	O
neuron	O
-	O
restrictive	O
silencing	O
factor	O
.	O
Expression	O
of	O
gene1s	ARG2
hKCC2	ARG2
gene1e	ARG2
cRNA	O
in	O
species1s	O
Xenopus	O
laevis	O
species1e	O
oocytes	O
results	O
in	O
significant	O
Cl(-)-dependent	O
(	O
86)Rb(+	O
)	O
uptake	O
under	O
isotonic	O
conditions	O
;	O
cell	O
swelling	O
under	O
hypotonic	O
conditions	O
causes	O
a	O
20-fold	O
activation	O
,	O
which	O
is	O
blocked	O
by	O
the	O
protein	O
phosphatase	O
inhibitor	O
calyculin	O
-	O
A.	O
In	O
contrast	O
,	O
oocytes	O
expressing	O
species1s	O
mouse	O
species1e	O
gene1s	O
KCC4	O
gene1e	O
do	O
not	O
mediate	O
isotonic	O
K	O
-	O
Cl	O
cotransport	O
but	O
express	O
much	O
higher	O
absolute	O
transport	O
activity	O
than	O
gene1s	O
KCC2	O
gene1e	O
oocytes	O
under	O
hypotonic	O
conditions	O
.	O
Initial	O
and	O
steady	O
state	O
kinetics	O
of	O
gene1s	ARG2
hKCC2	ARG2
gene1e	ARG2
-injected	O
oocytes	O
were	O
performed	O
in	O
both	O
isotonic	O
and	O
hypotonic	O
conditions	O
,	O
revealing	O
K(m)s	O
for	O
K(+	O
)	O
and	O
Cl(-	O
)	O
of	O
9.3+/-1.8	O
mM	O
and	O
6.8+/-0.9	O
mM	O
,	O
respectively	O
;	O
both	O
affinities	O
are	O
significantly	O
higher	O
than	O
gene1s	ARG2
KCC1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
KCC4	ARG2
gene1e	ARG2
.	O
The	O
K(m	O
)	O
for	O
Cl(-	O
)	O
is	O
close	O
to	O
the	O
intracellular	O
Cl(-	O
)	O
activity	O
of	O
mature	O
neurons	O
,	O
as	O
befits	O
a	O
neuronal	O
efflux	O
mechanism	O
.	O
Copyright	O
2002	O
Elsevier	O
Science	O
B.V.	O

Molecular	O
,	O
functional	O
,	O
and	O
genomic	O
characterization	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
KCC2	O
gene1e	O
,	O
the	O
neuronal	O
K	O
-	O
Cl	O
cotransporter	O
.	O
The	O
expression	O
level	O
of	O
the	O
neuronal	O
-	O
specific	O
K	O
-	O
Cl	O
cotransporter	O
gene1s	O
KCC2	O
gene1e	O
(	O
gene1s	O
SLC12A5	O
gene1e	O
)	O
is	O
a	O
major	O
determinant	O
of	O
whether	O
neurons	O
will	O
respond	O
to	O
GABA	O
with	O
a	O
depolarizing	O
,	O
excitatory	O
response	O
or	O
a	O
hyperpolarizing	O
,	O
inhibitory	O
response	O
.	O
In	O
view	O
of	O
the	O
potential	O
role	O
in	O
species1s	O
human	O
species1e	O
neuronal	O
excitability	O
we	O
have	O
characterized	O
the	O
gene1s	O
hKCC2	O
gene1e	O
cDNA	O
and	O
gene	O
.	O
The	O
5.9	O
kb	O
gene1s	O
hKCC2	O
gene1e	O
transcript	O
is	O
specific	O
to	O
brain	O
,	O
and	O
is	O
induced	O
during	O
in	O
vitro	O
differentiation	O
of	O
species1s	O
NT2	O
species1e	O
teratocarcinoma	O
cells	O
into	O
neuronal	O
species1s	O
NT2-N	O
species1e	O
cells	O
.	O
The	O
24-exon	O
gene1s	O
SLC12A5	O
gene1e	O
gene	O
is	O
on	O
species1s	O
human	O
species1e	O
chromosome	O
20q13	O
,	O
and	O
contains	O
a	O
polymorphic	O
dinucleotide	O
repeat	O
within	O
intron	O
1	O
near	O
a	O
potential	O
binding	O
site	O
for	O
neuron	O
-	O
restrictive	O
silencing	O
factor	O
.	O
Expression	O
of	O
gene1s	O
hKCC2	O
gene1e	O
cRNA	O
in	O
arg1s	O
Xenopus	O
laevis	O
arg1e	O
oocytes	O
results	O
in	O
significant	O
Cl(-)-dependent	O
(	O
86)Rb(+	O
)	O
uptake	O
under	O
isotonic	O
conditions	O
;	O
cell	O
swelling	O
under	O
hypotonic	O
conditions	O
causes	O
a	O
20-fold	O
activation	O
,	O
which	O
is	O
blocked	O
by	O
the	O
protein	O
phosphatase	O
inhibitor	O
calyculin	O
-	O
A.	O
In	O
contrast	O
,	O
oocytes	O
expressing	O
species1s	O
mouse	O
species1e	O
gene1s	O
KCC4	O
gene1e	O
do	O
not	O
mediate	O
isotonic	O
K	O
-	O
Cl	O
cotransport	O
but	O
express	O
much	O
higher	O
absolute	O
transport	O
activity	O
than	O
gene1s	O
KCC2	O
gene1e	O
oocytes	O
under	O
hypotonic	O
conditions	O
.	O
Initial	O
and	O
steady	O
state	O
kinetics	O
of	O
gene1s	O
hKCC2	O
gene1e	O
-injected	O
oocytes	O
were	O
performed	O
in	O
both	O
isotonic	O
and	O
hypotonic	O
conditions	O
,	O
revealing	O
K(m)s	O
for	O
K(+	O
)	O
and	O
Cl(-	O
)	O
of	O
9.3+/-1.8	O
mM	O
and	O
6.8+/-0.9	O
mM	O
,	O
respectively	O
;	O
both	O
affinities	O
are	O
significantly	O
higher	O
than	O
gene1s	O
KCC1	O
gene1e	O
and	O
gene1s	O
KCC4	O
gene1e	O
.	O
The	O
K(m	O
)	O
for	O
Cl(-	O
)	O
is	O
close	O
to	O
the	O
intracellular	O
Cl(-	O
)	O
activity	O
of	O
mature	O
neurons	O
,	O
as	O
befits	O
a	O
neuronal	O
efflux	O
mechanism	O
.	O
Copyright	O
2002	O
Elsevier	O
Science	O
B.V.	O

Molecular	O
,	O
functional	O
,	O
and	O
genomic	O
characterization	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
KCC2	O
gene1e	O
,	O
the	O
neuronal	O
K	O
-	O
Cl	O
cotransporter	O
.	O
The	O
expression	O
level	O
of	O
the	O
neuronal	O
-	O
specific	O
K	O
-	O
Cl	O
cotransporter	O
gene1s	O
KCC2	O
gene1e	O
(	O
gene1s	O
SLC12A5	O
gene1e	O
)	O
is	O
a	O
major	O
determinant	O
of	O
whether	O
neurons	O
will	O
respond	O
to	O
GABA	O
with	O
a	O
depolarizing	O
,	O
excitatory	O
response	O
or	O
a	O
hyperpolarizing	O
,	O
inhibitory	O
response	O
.	O
In	O
view	O
of	O
the	O
potential	O
role	O
in	O
species1s	O
human	O
species1e	O
neuronal	O
excitability	O
we	O
have	O
characterized	O
the	O
gene1s	O
hKCC2	O
gene1e	O
cDNA	O
and	O
gene	O
.	O
The	O
5.9	O
kb	O
gene1s	O
hKCC2	O
gene1e	O
transcript	O
is	O
specific	O
to	O
brain	O
,	O
and	O
is	O
induced	O
during	O
in	O
vitro	O
differentiation	O
of	O
species1s	O
NT2	O
species1e	O
teratocarcinoma	O
cells	O
into	O
neuronal	O
species1s	O
NT2-N	O
species1e	O
cells	O
.	O
The	O
24-exon	O
gene1s	O
SLC12A5	O
gene1e	O
gene	O
is	O
on	O
species1s	O
human	O
species1e	O
chromosome	O
20q13	O
,	O
and	O
contains	O
a	O
polymorphic	O
dinucleotide	O
repeat	O
within	O
intron	O
1	O
near	O
a	O
potential	O
binding	O
site	O
for	O
neuron	O
-	O
restrictive	O
silencing	O
factor	O
.	O
Expression	O
of	O
gene1s	O
hKCC2	O
gene1e	O
cRNA	O
in	O
species1s	O
Xenopus	O
laevis	O
species1e	O
oocytes	O
results	O
in	O
significant	O
Cl(-)-dependent	O
(	O
86)Rb(+	O
)	O
uptake	O
under	O
isotonic	O
conditions	O
;	O
cell	O
swelling	O
under	O
hypotonic	O
conditions	O
causes	O
a	O
20-fold	O
activation	O
,	O
which	O
is	O
blocked	O
by	O
the	O
protein	O
phosphatase	O
inhibitor	O
calyculin	O
-	O
A.	O
In	O
contrast	O
,	O
oocytes	O
expressing	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
KCC4	ARG2
gene1e	ARG2
do	O
not	O
mediate	O
isotonic	O
K	O
-	O
Cl	O
cotransport	O
but	O
express	O
much	O
higher	O
absolute	O
transport	O
activity	O
than	O
gene1s	ARG2
KCC2	ARG2
gene1e	ARG2
oocytes	O
under	O
hypotonic	O
conditions	O
.	O
Initial	O
and	O
steady	O
state	O
kinetics	O
of	O
gene1s	O
hKCC2	O
gene1e	O
-injected	O
oocytes	O
were	O
performed	O
in	O
both	O
isotonic	O
and	O
hypotonic	O
conditions	O
,	O
revealing	O
K(m)s	O
for	O
K(+	O
)	O
and	O
Cl(-	O
)	O
of	O
9.3+/-1.8	O
mM	O
and	O
6.8+/-0.9	O
mM	O
,	O
respectively	O
;	O
both	O
affinities	O
are	O
significantly	O
higher	O
than	O
gene1s	O
KCC1	O
gene1e	O
and	O
gene1s	O
KCC4	O
gene1e	O
.	O
The	O
K(m	O
)	O
for	O
Cl(-	O
)	O
is	O
close	O
to	O
the	O
intracellular	O
Cl(-	O
)	O
activity	O
of	O
mature	O
neurons	O
,	O
as	O
befits	O
a	O
neuronal	O
efflux	O
mechanism	O
.	O
Copyright	O
2002	O
Elsevier	O
Science	O
B.V.	O

K+	O
channel	O
activation	O
by	O
all	O
three	O
isoforms	O
of	O
serum-	O
and	O
glucocorticoid	O
-	O
dependent	O
protein	O
kinase	O
SGK	O
.	O
The	O
serum-	O
and	O
glucocorticoid	O
-	O
dependent	O
kinase	O
gene1s	ARG2
SGK1	ARG2
gene1e	ARG2
was	O
originally	O
identified	O
as	O
a	O
glucocorticoid	O
-	O
sensitive	O
gene	O
.	O
Subsequently	O
,	O
the	O
two	O
homologous	O
kinases	O
gene1s	ARG2
SGK2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
SGK3	ARG2
gene1e	ARG2
have	O
been	O
cloned	O
,	O
being	O
products	O
of	O
distinct	O
genes	O
,	O
which	O
are	O
differentially	O
expressed	O
and	O
share	O
80	O
%	O
identity	O
in	O
amino	O
acid	O
sequence	O
in	O
their	O
catalytic	O
domains	O
.	O
While	O
gene1s	ARG2
SGK1	ARG2
gene1e	ARG2
has	O
been	O
shown	O
to	O
activate	O
ion	O
channels	O
,	O
including	O
K(+	O
)	O
channels	O
,	O
the	O
functions	O
of	O
gene1s	ARG2
SGK2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
SGK3	ARG2
gene1e	ARG2
have	O
not	O
been	O
examined	O
.	O
The	O
present	O
study	O
was	O
therefore	O
performed	O
to	O
elucidate	O
the	O
effect	O
of	O
gene1s	ARG2
SGK1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SGK2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
SGK3	ARG2
gene1e	ARG2
on	O
electrical	O
properties	O
of	O
renal	O
epithelial	O
cells	O
.	O
To	O
this	O
end	O
arg1s	O
human	O
arg1e	O
embryonic	O
kidney	O
(	O
arg1s	O
HEK293	O
arg1e	O
)	O
cells	O
were	O
transfected	O
with	O
the	O
kinases	O
and	O
ion	O
-	O
channel	O
activity	O
determined	O
using	O
the	O
patch	O
-	O
clamp	O
technique	O
.	O
In	O
non	O
-	O
transfected	O
cells	O
and	O
in	O
cells	O
transfected	O
with	O
the	O
empty	O
GFP	O
construct	O
a	O
voltage	O
-	O
gated	O
K(+	O
)	O
current	O
was	O
observed	O
amounting	O
to	O
303+/-19	O
pA	O
(	O
n=13	O
)	O
and	O
299+/-29	O
pA	O
(	O
n=23	O
)	O
,	O
respectively	O
.	O
Transfection	O
with	O
gene1s	ARG2
SGK1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SGK2	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
SGK3	ARG2
gene1e	ARG2
increased	O
the	O
voltage	O
-	O
gated	O
K(+	O
)	O
current	O
to	O
1056+/-152	O
pA	O
(	O
n=17	O
)	O
,	O
555+/-47	O
pA	O
(	O
n=17	O
)	O
,	O
and	O
775+/-98	O
pA	O
(	O
n=16	O
)	O
,	O
respectively	O
.	O
The	O
K(+	O
)	O
current	O
was	O
fully	O
blocked	O
by	O
3	O
mM	O
tetraethylammonium	O
chloride	O
and	O
inhibited	O
45	O
%	O
by	O
the	O
Kv1	O
channel	O
blocker	O
margatoxin	O
(	O
10	O
nM	O
)	O
.	O
In	O
dual	O
electrode	O
voltage	O
-	O
clamp	O
experiments	O
SGK	O
isoforms	O
up	O
-	O
regulated	O
Kv1	O
voltage	O
-	O
gated	O
K(+)channels	O
expressed	O
in	O
species1s	O
Xenopus	O
laevis	O
species1e	O
oocytes	O
.	O
The	O
present	O
observations	O
thus	O
reveal	O
a	O
powerful	O
stimulating	O
effect	O
of	O
all	O
three	O
isoforms	O
of	O
SGK	O
on	O
K(+	O
)	O
channels	O
.	O
Those	O
effects	O
may	O
participate	O
in	O
regulation	O
of	O
epithelial	O
transport	O
,	O
cell	O
proliferation	O
,	O
and	O
neuromuscular	O
excitability	O
.	O

K+	O
channel	O
activation	O
by	O
all	O
three	O
isoforms	O
of	O
serum-	O
and	O
glucocorticoid	O
-	O
dependent	O
protein	O
kinase	O
SGK	O
.	O
The	O
serum-	O
and	O
glucocorticoid	O
-	O
dependent	O
kinase	O
gene1s	O
SGK1	O
gene1e	O
was	O
originally	O
identified	O
as	O
a	O
glucocorticoid	O
-	O
sensitive	O
gene	O
.	O
Subsequently	O
,	O
the	O
two	O
homologous	O
kinases	O
gene1s	O
SGK2	O
gene1e	O
and	O
gene1s	O
SGK3	O
gene1e	O
have	O
been	O
cloned	O
,	O
being	O
products	O
of	O
distinct	O
genes	O
,	O
which	O
are	O
differentially	O
expressed	O
and	O
share	O
80	O
%	O
identity	O
in	O
amino	O
acid	O
sequence	O
in	O
their	O
catalytic	O
domains	O
.	O
While	O
gene1s	O
SGK1	O
gene1e	O
has	O
been	O
shown	O
to	O
activate	O
ion	O
channels	O
,	O
including	O
K(+	O
)	O
channels	O
,	O
the	O
functions	O
of	O
gene1s	O
SGK2	O
gene1e	O
and	O
gene1s	O
SGK3	O
gene1e	O
have	O
not	O
been	O
examined	O
.	O
The	O
present	O
study	O
was	O
therefore	O
performed	O
to	O
elucidate	O
the	O
effect	O
of	O
gene1s	O
SGK1	O
gene1e	O
,	O
gene1s	O
SGK2	O
gene1e	O
,	O
and	O
gene1s	O
SGK3	O
gene1e	O
on	O
electrical	O
properties	O
of	O
renal	O
epithelial	O
cells	O
.	O
To	O
this	O
end	O
species1s	O
human	O
species1e	O
embryonic	O
kidney	O
(	O
species1s	O
HEK293	O
species1e	O
)	O
cells	O
were	O
transfected	O
with	O
the	O
kinases	O
and	O
ion	O
-	O
channel	O
activity	O
determined	O
using	O
the	O
patch	O
-	O
clamp	O
technique	O
.	O
In	O
non	O
-	O
transfected	O
cells	O
and	O
in	O
cells	O
transfected	O
with	O
the	O
empty	O
GFP	O
construct	O
a	O
voltage	O
-	O
gated	O
K(+	O
)	O
current	O
was	O
observed	O
amounting	O
to	O
303+/-19	O
pA	O
(	O
n=13	O
)	O
and	O
299+/-29	O
pA	O
(	O
n=23	O
)	O
,	O
respectively	O
.	O
Transfection	O
with	O
gene1s	O
SGK1	O
gene1e	O
,	O
gene1s	O
SGK2	O
gene1e	O
or	O
gene1s	O
SGK3	O
gene1e	O
increased	O
the	O
voltage	O
-	O
gated	O
K(+	O
)	O
current	O
to	O
1056+/-152	O
pA	O
(	O
n=17	O
)	O
,	O
555+/-47	O
pA	O
(	O
n=17	O
)	O
,	O
and	O
775+/-98	O
pA	O
(	O
n=16	O
)	O
,	O
respectively	O
.	O
The	O
K(+	O
)	O
current	O
was	O
fully	O
blocked	O
by	O
3	O
mM	O
tetraethylammonium	O
chloride	O
and	O
inhibited	O
45	O
%	O
by	O
the	O
Kv1	O
channel	O
blocker	O
margatoxin	O
(	O
10	O
nM	O
)	O
.	O
In	O
dual	O
electrode	O
voltage	O
-	O
clamp	O
experiments	O
SGK	O
isoforms	O
up	O
-	O
regulated	O
Kv1	O
voltage	O
-	O
gated	O
K(+)channels	O
expressed	O
in	O
arg1s	O
Xenopus	O
laevis	O
arg1e	O
oocytes	O
.	O
The	O
present	O
observations	O
thus	O
reveal	O
a	O
powerful	O
stimulating	O
effect	O
of	O
all	O
three	O
isoforms	O
of	O
SGK	O
on	O
K(+	O
)	O
channels	O
.	O
Those	O
effects	O
may	O
participate	O
in	O
regulation	O
of	O
epithelial	O
transport	O
,	O
cell	O
proliferation	O
,	O
and	O
neuromuscular	O
excitability	O
.	O

Physical	O
interaction	O
between	O
arg1s	O
hepatitis	O
C	O
virus	O
arg1e	O
gene1s	ARG2
NS4B	ARG2
gene1e	ARG2
protein	O
and	O
gene1s	O
CREB	O
-	O
RP	O
gene1e	O
/	O
gene1s	O
ATF6beta	O
gene1e	O
.	O
By	O
using	O
a	O
species1s	O
yeast	O
species1e	O
two	O
-	O
hybrid	O
assay	O
,	O
gene1s	O
cyclic	O
AMP	O
-	O
response	O
-	O
element	O
-	O
binding	O
protein	O
-	O
related	O
protein	O
gene1e	O
(	O
gene1s	O
CREB	O
-	O
RP	O
gene1e	O
)	O
,	O
also	O
called	O
gene1s	O
activating	O
transcription	O
factor	O
6beta	O
gene1e	O
(	O
gene1s	O
ATF6beta	O
gene1e	O
)	O
,	O
was	O
identified	O
as	O
a	O
cellular	O
protein	O
that	O
interacts	O
with	O
the	O
gene1s	ARG2
NS4B	ARG2
gene1e	ARG2
protein	O
of	O
arg1s	O
hepatitis	O
C	O
virus	O
arg1e	O
.	O
An	O
N	O
-	O
terminal	O
half	O
of	O
gene1s	ARG2
NS4B	ARG2
gene1e	ARG2
and	O
a	O
central	O
portion	O
of	O
gene1s	O
CREB	O
-	O
RP	O
gene1e	O
/	O
gene1s	O
ATF6beta	O
gene1e	O
containing	O
the	O
basic	O
leucine	O
zipper	O
(	O
bZIP	O
)	O
domain	O
were	O
involved	O
in	O
the	O
interaction	O
.	O
The	O
interaction	O
between	O
gene1s	ARG2
NS4B	ARG2
gene1e	ARG2
and	O
gene1s	O
CREB	O
-	O
RP	O
gene1e	O
/	O
gene1s	O
ATF6beta	O
gene1e	O
was	O
demonstrated	O
also	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
by	O
co	O
-	O
immunoprecipitation	O
and	O
confocal	O
microscopic	O
analyses	O
using	O
specific	O
antibodies	O
.	O
The	O
bZIP	O
domain	O
of	O
gene1s	O
ATF6alpha	O
gene1e	O
,	O
which	O
shares	O
high	O
sequence	O
similarity	O
with	O
gene1s	O
CREB	O
-	O
RP	O
gene1e	O
/	O
gene1s	O
ATF6beta	O
gene1e	O
,	O
was	O
also	O
shown	O
to	O
interact	O
with	O
gene1s	ARG2
NS4B	ARG2
gene1e	ARG2
in	O
species1s	O
yeast	O
species1e	O
although	O
the	O
interaction	O
was	O
weaker	O
than	O
that	O
between	O
gene1s	ARG2
NS4B	ARG2
gene1e	ARG2
and	O
gene1s	O
CREB	O
-	O
RP	O
gene1e	O
/	O
gene1s	O
ATF6beta	O
gene1e	O
.	O
gene1s	O
CREB	O
-	O
RP	O
gene1e	O
/	O
gene1s	O
ATF6beta	O
gene1e	O
and	O
gene1s	O
ATF6alpha	O
gene1e	O
are	O
known	O
as	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
stress	O
-	O
induced	O
transcription	O
factors	O
.	O
Collectively	O
,	O
our	O
results	O
imply	O
the	O
possibility	O
that	O
gene1s	ARG2
NS4B	ARG2
gene1e	ARG2
modulates	O
certain	O
cellular	O
responses	O
upon	O
ER	O
stress	O
through	O
the	O
physical	O
interaction	O
with	O
gene1s	O
CREB	O
-	O
RP	O
gene1e	O
/	O
gene1s	O
ATF6beta	O
gene1e	O
and	O
gene1s	O
ATF6alpha	O
gene1e	O
.	O

Physical	O
interaction	O
between	O
species1s	O
hepatitis	O
C	O
virus	O
species1e	O
gene1s	O
NS4B	O
gene1e	O
protein	O
and	O
gene1s	O
CREB	O
-	O
RP	O
gene1e	O
/	O
gene1s	O
ATF6beta	O
gene1e	O
.	O
By	O
using	O
a	O
arg1s	O
yeast	O
arg1e	O
two	O
-	O
hybrid	O
assay	O
,	O
gene1s	O
cyclic	O
AMP	O
-	O
response	O
-	O
element	O
-	O
binding	O
protein	O
-	O
related	O
protein	O
gene1e	O
(	O
gene1s	O
CREB	O
-	O
RP	O
gene1e	O
)	O
,	O
also	O
called	O
gene1s	O
activating	O
transcription	O
factor	O
6beta	O
gene1e	O
(	O
gene1s	O
ATF6beta	O
gene1e	O
)	O
,	O
was	O
identified	O
as	O
a	O
cellular	O
protein	O
that	O
interacts	O
with	O
the	O
gene1s	O
NS4B	O
gene1e	O
protein	O
of	O
species1s	O
hepatitis	O
C	O
virus	O
species1e	O
.	O
An	O
N	O
-	O
terminal	O
half	O
of	O
gene1s	O
NS4B	O
gene1e	O
and	O
a	O
central	O
portion	O
of	O
gene1s	O
CREB	O
-	O
RP	O
gene1e	O
/	O
gene1s	O
ATF6beta	O
gene1e	O
containing	O
the	O
basic	O
leucine	O
zipper	O
(	O
bZIP	O
)	O
domain	O
were	O
involved	O
in	O
the	O
interaction	O
.	O
The	O
interaction	O
between	O
gene1s	O
NS4B	O
gene1e	O
and	O
gene1s	O
CREB	O
-	O
RP	O
gene1e	O
/	O
gene1s	O
ATF6beta	O
gene1e	O
was	O
demonstrated	O
also	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
by	O
co	O
-	O
immunoprecipitation	O
and	O
confocal	O
microscopic	O
analyses	O
using	O
specific	O
antibodies	O
.	O
The	O
bZIP	O
domain	O
of	O
gene1s	O
ATF6alpha	O
gene1e	O
,	O
which	O
shares	O
high	O
sequence	O
similarity	O
with	O
gene1s	O
CREB	O
-	O
RP	O
gene1e	O
/	O
gene1s	O
ATF6beta	O
gene1e	O
,	O
was	O
also	O
shown	O
to	O
interact	O
with	O
gene1s	O
NS4B	O
gene1e	O
in	O
arg1s	O
yeast	O
arg1e	O
although	O
the	O
interaction	O
was	O
weaker	O
than	O
that	O
between	O
gene1s	O
NS4B	O
gene1e	O
and	O
gene1s	O
CREB	O
-	O
RP	O
gene1e	O
/	O
gene1s	O
ATF6beta	O
gene1e	O
.	O
gene1s	O
CREB	O
-	O
RP	O
gene1e	O
/	O
gene1s	O
ATF6beta	O
gene1e	O
and	O
gene1s	O
ATF6alpha	O
gene1e	O
are	O
known	O
as	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
stress	O
-	O
induced	O
transcription	O
factors	O
.	O
Collectively	O
,	O
our	O
results	O
imply	O
the	O
possibility	O
that	O
gene1s	O
NS4B	O
gene1e	O
modulates	O
certain	O
cellular	O
responses	O
upon	O
ER	O
stress	O
through	O
the	O
physical	O
interaction	O
with	O
gene1s	O
CREB	O
-	O
RP	O
gene1e	O
/	O
gene1s	O
ATF6beta	O
gene1e	O
and	O
gene1s	O
ATF6alpha	O
gene1e	O
.	O

Physical	O
interaction	O
between	O
species1s	O
hepatitis	O
C	O
virus	O
species1e	O
gene1s	O
NS4B	O
gene1e	O
protein	O
and	O
gene1s	ARG2
CREB	ARG2
-	ARG2
RP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ATF6beta	ARG2
gene1e	ARG2
.	O
By	O
using	O
a	O
species1s	O
yeast	O
species1e	O
two	O
-	O
hybrid	O
assay	O
,	O
gene1s	ARG2
cyclic	ARG2
AMP	ARG2
-	ARG2
response	ARG2
-	ARG2
element	ARG2
-	ARG2
binding	ARG2
protein	ARG2
-	ARG2
related	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CREB	ARG2
-	ARG2
RP	ARG2
gene1e	ARG2
)	O
,	O
also	O
called	O
gene1s	ARG2
activating	ARG2
transcription	ARG2
factor	ARG2
6beta	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ATF6beta	ARG2
gene1e	ARG2
)	O
,	O
was	O
identified	O
as	O
a	O
cellular	O
protein	O
that	O
interacts	O
with	O
the	O
gene1s	O
NS4B	O
gene1e	O
protein	O
of	O
species1s	O
hepatitis	O
C	O
virus	O
species1e	O
.	O
An	O
N	O
-	O
terminal	O
half	O
of	O
gene1s	O
NS4B	O
gene1e	O
and	O
a	O
central	O
portion	O
of	O
gene1s	ARG2
CREB	ARG2
-	ARG2
RP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ATF6beta	ARG2
gene1e	ARG2
containing	O
the	O
basic	O
leucine	O
zipper	O
(	O
bZIP	O
)	O
domain	O
were	O
involved	O
in	O
the	O
interaction	O
.	O
The	O
interaction	O
between	O
gene1s	O
NS4B	O
gene1e	O
and	O
gene1s	ARG2
CREB	ARG2
-	ARG2
RP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ATF6beta	ARG2
gene1e	ARG2
was	O
demonstrated	O
also	O
in	O
arg1s	O
mammalian	O
arg1e	O
cells	O
by	O
co	O
-	O
immunoprecipitation	O
and	O
confocal	O
microscopic	O
analyses	O
using	O
specific	O
antibodies	O
.	O
The	O
bZIP	O
domain	O
of	O
gene1s	ARG2
ATF6alpha	ARG2
gene1e	ARG2
,	O
which	O
shares	O
high	O
sequence	O
similarity	O
with	O
gene1s	ARG2
CREB	ARG2
-	ARG2
RP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ATF6beta	ARG2
gene1e	ARG2
,	O
was	O
also	O
shown	O
to	O
interact	O
with	O
gene1s	O
NS4B	O
gene1e	O
in	O
species1s	O
yeast	O
species1e	O
although	O
the	O
interaction	O
was	O
weaker	O
than	O
that	O
between	O
gene1s	O
NS4B	O
gene1e	O
and	O
gene1s	ARG2
CREB	ARG2
-	ARG2
RP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ATF6beta	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
CREB	ARG2
-	ARG2
RP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ATF6beta	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ATF6alpha	ARG2
gene1e	ARG2
are	O
known	O
as	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
stress	O
-	O
induced	O
transcription	O
factors	O
.	O
Collectively	O
,	O
our	O
results	O
imply	O
the	O
possibility	O
that	O
gene1s	O
NS4B	O
gene1e	O
modulates	O
certain	O
cellular	O
responses	O
upon	O
ER	O
stress	O
through	O
the	O
physical	O
interaction	O
with	O
gene1s	ARG2
CREB	ARG2
-	ARG2
RP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ATF6beta	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ATF6alpha	ARG2
gene1e	ARG2
.	O

Nociceptive	O
sensitization	O
by	O
the	O
secretory	O
protein	O
gene1s	O
Bv8	O
gene1e	O
.	O
1	O
The	O
small	O
protein	O
gene1s	ARG2
Bv8	ARG2
gene1e	ARG2
,	O
isolated	O
from	O
amphibian	O
skin	O
,	O
belongs	O
to	O
a	O
novel	O
family	O
of	O
secretory	O
proteins	O
(	O
Bv8-Prokineticin	O
family	O
,	O
SWISS	O
-	O
PROT	O
:	O
gene1s	ARG2
Q9PW66	ARG2
gene1e	ARG2
)	O
whose	O
orthologues	O
have	O
been	O
conserved	O
throughout	O
evolution	O
,	O
from	O
invertebrates	O
to	O
arg1s	O
humans	O
arg1e	O
.	O
2	O
When	O
injected	O
intravenously	O
or	O
subcutaneously	O
(	O
from	O
0.06	O
to	O
500	O
pmol	O
kg(-1	O
)	O
)	O
or	O
intrathecally	O
(	O
from	O
6	O
fmol	O
to	O
250	O
pmol	O
)	O
in	O
rats	O
,	O
gene1s	O
Bv8	O
gene1e	O
produced	O
an	O
intense	O
systemic	O
nociceptive	O
sensitization	O
to	O
mechanical	O
and	O
thermal	O
stimuli	O
applied	O
to	O
the	O
tail	O
and	O
paws	O
.	O
3	O
Topically	O
delivered	O
into	O
one	O
species1s	O
rat	O
species1e	O
paw	O
,	O
50	O
fmol	O
of	O
gene1s	O
Bv8	O
gene1e	O
decreased	O
by	O
50	O
%	O
the	O
nociceptive	O
threshold	O
to	O
pressure	O
in	O
the	O
injected	O
paw	O
without	O
affecting	O
the	O
threshold	O
in	O
the	O
contralateral	O
paw	O
.	O
4	O
The	O
two	O
G	O
-	O
protein	O
coupled	O
prokineticin	O
receptors	O
,	O
gene1s	O
PK	O
-	O
R1	O
gene1e	O
and	O
gene1s	O
PK	O
-	O
R2	O
gene1e	O
,	O
were	O
expressed	O
in	O
species1s	O
rat	O
species1e	O
dorsal	O
root	O
ganglia	O
(	O
DRG	O
)	O
and	O
in	O
dorsal	O
quadrants	O
of	O
spinal	O
cord	O
(	O
DSC	O
)	O
and	O
bound	O
gene1s	O
Bv8	O
gene1e	O
and	O
the	O
arg1s	O
mammalian	O
arg1e	O
orthologue	O
,	O
gene1s	ARG2
EG	ARG2
-	ARG2
VEGF	ARG2
gene1e	ARG2
,	O
with	O
high	O
affinity	O
.	O
In	O
DSC	O
,	O
gene1s	O
PK	O
-	O
R1	O
gene1e	O
was	O
more	O
abundant	O
than	O
gene1s	O
PK	O
-	O
R2	O
gene1e	O
,	O
whereas	O
both	O
receptors	O
were	O
equally	O
expressed	O
in	O
DRG	O
.	O
IC(50	O
)	O
of	O
gene1s	O
Bv8	O
gene1e	O
and	O
gene1s	O
EG	O
-	O
VEGF	O
gene1e	O
to	O
inhibit	O
-	O
gene1s	O
Bv8	O
gene1e	O
binding	O
to	O
species1s	O
rat	O
species1e	O
DRG	O
and	O
DSC	O
were	O
4.1+/-0.4	O
nM	O
gene1s	O
Bv8	O
gene1e	O
and	O
76.4+/-7.6	O
nM	O
gene1s	O
EG	O
-	O
VEGF	O
gene1e	O
,	O
in	O
DRG	O
;	O
7.3+/-0.9	O
nM	O
gene1s	O
Bv8	O
gene1e	O
and	O
330+/-41	O
nM	O
gene1s	O
EG	O
-	O
VEGF	O
gene1e	O
,	O
in	O
DSC	O
.	O
5	O
In	O
the	O
small	O
diameter	O
neurons	O
(	O
<	O
30	O
microm	O
)	O
of	O
species1s	O
rat	O
species1e	O
DRG	O
cultures	O
,	O
gene1s	O
Bv8	O
gene1e	O
concentrations	O
,	O
ranging	O
from	O
0.2	O
to	O
10	O
nM	O
,	O
raised	O
(	O
i	O
)	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O
6	O
These	O
data	O
suggest	O
that	O
gene1s	O
Bv8	O
gene1e	O
,	O
through	O
binding	O
to	O
PK	O
receptors	O
of	O
DSC	O
and	O
primary	O
sensitive	O
neurons	O
,	O
results	O
in	O
intense	O
sensitization	O
of	O
peripheral	O
nociceptors	O
to	O
thermal	O
and	O
mechanical	O
stimuli	O
.	O

Nociceptive	O
sensitization	O
by	O
the	O
secretory	O
protein	O
gene1s	ARG2
Bv8	ARG2
gene1e	ARG2
.	O
1	O
The	O
small	O
protein	O
gene1s	O
Bv8	O
gene1e	O
,	O
isolated	O
from	O
amphibian	O
skin	O
,	O
belongs	O
to	O
a	O
novel	O
family	O
of	O
secretory	O
proteins	O
(	O
Bv8-Prokineticin	O
family	O
,	O
SWISS	O
-	O
PROT	O
:	O
gene1s	O
Q9PW66	O
gene1e	O
)	O
whose	O
orthologues	O
have	O
been	O
conserved	O
throughout	O
evolution	O
,	O
from	O
invertebrates	O
to	O
species1s	O
humans	O
species1e	O
.	O
2	O
When	O
injected	O
intravenously	O
or	O
subcutaneously	O
(	O
from	O
0.06	O
to	O
500	O
pmol	O
kg(-1	O
)	O
)	O
or	O
intrathecally	O
(	O
from	O
6	O
fmol	O
to	O
250	O
pmol	O
)	O
in	O
rats	O
,	O
gene1s	ARG2
Bv8	ARG2
gene1e	ARG2
produced	O
an	O
intense	O
systemic	O
nociceptive	O
sensitization	O
to	O
mechanical	O
and	O
thermal	O
stimuli	O
applied	O
to	O
the	O
tail	O
and	O
paws	O
.	O
3	O
Topically	O
delivered	O
into	O
one	O
arg1s	O
rat	O
arg1e	O
paw	O
,	O
50	O
fmol	O
of	O
gene1s	ARG2
Bv8	ARG2
gene1e	ARG2
decreased	O
by	O
50	O
%	O
the	O
nociceptive	O
threshold	O
to	O
pressure	O
in	O
the	O
injected	O
paw	O
without	O
affecting	O
the	O
threshold	O
in	O
the	O
contralateral	O
paw	O
.	O
4	O
The	O
two	O
G	O
-	O
protein	O
coupled	O
prokineticin	O
receptors	O
,	O
gene1s	ARG2
PK	ARG2
-	ARG2
R1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
PK	ARG2
-	ARG2
R2	ARG2
gene1e	ARG2
,	O
were	O
expressed	O
in	O
arg1s	O
rat	O
arg1e	O
dorsal	O
root	O
ganglia	O
(	O
DRG	O
)	O
and	O
in	O
dorsal	O
quadrants	O
of	O
spinal	O
cord	O
(	O
DSC	O
)	O
and	O
bound	O
gene1s	ARG2
Bv8	ARG2
gene1e	ARG2
and	O
the	O
species1s	O
mammalian	O
species1e	O
orthologue	O
,	O
gene1s	O
EG	O
-	O
VEGF	O
gene1e	O
,	O
with	O
high	O
affinity	O
.	O
In	O
DSC	O
,	O
gene1s	ARG2
PK	ARG2
-	ARG2
R1	ARG2
gene1e	ARG2
was	O
more	O
abundant	O
than	O
gene1s	ARG2
PK	ARG2
-	ARG2
R2	ARG2
gene1e	ARG2
,	O
whereas	O
both	O
receptors	O
were	O
equally	O
expressed	O
in	O
DRG	O
.	O
IC(50	O
)	O
of	O
gene1s	ARG2
Bv8	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
EG	ARG2
-	ARG2
VEGF	ARG2
gene1e	ARG2
to	O
inhibit	O
-	O
gene1s	ARG2
Bv8	ARG2
gene1e	ARG2
binding	O
to	O
arg1s	O
rat	O
arg1e	O
DRG	O
and	O
DSC	O
were	O
4.1+/-0.4	O
nM	O
gene1s	ARG2
Bv8	ARG2
gene1e	ARG2
and	O
76.4+/-7.6	O
nM	O
gene1s	ARG2
EG	ARG2
-	ARG2
VEGF	ARG2
gene1e	ARG2
,	O
in	O
DRG	O
;	O
7.3+/-0.9	O
nM	O
gene1s	ARG2
Bv8	ARG2
gene1e	ARG2
and	O
330+/-41	O
nM	O
gene1s	ARG2
EG	ARG2
-	ARG2
VEGF	ARG2
gene1e	ARG2
,	O
in	O
DSC	O
.	O
5	O
In	O
the	O
small	O
diameter	O
neurons	O
(	O
<	O
30	O
microm	O
)	O
of	O
arg1s	O
rat	O
arg1e	O
DRG	O
cultures	O
,	O
gene1s	ARG2
Bv8	ARG2
gene1e	ARG2
concentrations	O
,	O
ranging	O
from	O
0.2	O
to	O
10	O
nM	O
,	O
raised	O
(	O
i	O
)	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O
6	O
These	O
data	O
suggest	O
that	O
gene1s	ARG2
Bv8	ARG2
gene1e	ARG2
,	O
through	O
binding	O
to	O
PK	O
receptors	O
of	O
DSC	O
and	O
primary	O
sensitive	O
neurons	O
,	O
results	O
in	O
intense	O
sensitization	O
of	O
peripheral	O
nociceptors	O
to	O
thermal	O
and	O
mechanical	O
stimuli	O
.	O

gene1s	O
Robo1	O
gene1e	O
and	O
gene1s	O
Robo2	O
gene1e	O
are	O
homophilic	O
binding	O
molecules	O
that	O
promote	O
axonal	O
growth	O
.	O
In	O
the	O
present	O
study	O
we	O
show	O
that	O
following	O
transfection	O
in	O
arg1s	O
3T3	O
arg1e	O
cells	O
,	O
species1s	O
human	O
species1e	O
gene1s	O
Robo1	O
gene1e	O
and	O
gene1s	O
Robo2	O
gene1e	O
stimulate	O
neurite	O
outgrowth	O
from	O
Robo	O
-	O
positive	O
neurons	O
(	O
retinal	O
neurons	O
and	O
olfactory	O
neurons	O
)	O
,	O
but	O
have	O
no	O
effect	O
on	O
Robo	O
-	O
negative	O
neurons	O
(	O
cerebellar	O
granule	O
cells	O
)	O
.	O
The	O
neurite	O
outgrowth	O
response	O
was	O
inhibited	O
by	O
an	O
antibody	O
raised	O
against	O
the	O
first	O
Ig	O
domain	O
of	O
gene1s	O
Robo1/2	O
gene1e	O
or	O
by	O
soluble	O
Robo	O
-	O
Fc	O
chimera	O
.	O
Furthermore	O
,	O
we	O
show	O
that	O
the	O
extracellular	O
domains	O
of	O
gene1s	O
Robo1	O
gene1e	O
and	O
gene1s	O
Robo2	O
gene1e	O
are	O
homophilic	O
adhesion	O
molecules	O
that	O
can	O
also	O
interact	O
with	O
each	O
other	O
.	O
These	O
data	O
suggest	O
a	O
wider	O
range	O
of	O
functions	O
for	O
the	O
Robo	O
family	O
in	O
the	O
development	O
of	O
the	O
nervous	O
system	O
and	O
provide	O
novel	O
insights	O
into	O
the	O
molecular	O
basis	O
for	O
the	O
phenotypes	O
observed	O
in	O
Robo	O
mutants	O
in	O
species1s	O
Drosophila	O
species1e	O
,	O
species1s	O
C.	O
elegans	O
species1e	O
,	O
and	O
species1s	O
zebrafish	O
species1e	O
.	O

gene1s	ARG2
Robo1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Robo2	ARG2
gene1e	ARG2
are	O
homophilic	O
binding	O
molecules	O
that	O
promote	O
axonal	O
growth	O
.	O
In	O
the	O
present	O
study	O
we	O
show	O
that	O
following	O
transfection	O
in	O
species1s	O
3T3	O
species1e	O
cells	O
,	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
Robo1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Robo2	ARG2
gene1e	ARG2
stimulate	O
neurite	O
outgrowth	O
from	O
Robo	O
-	O
positive	O
neurons	O
(	O
retinal	O
neurons	O
and	O
olfactory	O
neurons	O
)	O
,	O
but	O
have	O
no	O
effect	O
on	O
Robo	O
-	O
negative	O
neurons	O
(	O
cerebellar	O
granule	O
cells	O
)	O
.	O
The	O
neurite	O
outgrowth	O
response	O
was	O
inhibited	O
by	O
an	O
antibody	O
raised	O
against	O
the	O
first	O
Ig	O
domain	O
of	O
gene1s	ARG2
Robo1/2	ARG2
gene1e	ARG2
or	O
by	O
soluble	O
Robo	O
-	O
Fc	O
chimera	O
.	O
Furthermore	O
,	O
we	O
show	O
that	O
the	O
extracellular	O
domains	O
of	O
gene1s	ARG2
Robo1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Robo2	ARG2
gene1e	ARG2
are	O
homophilic	O
adhesion	O
molecules	O
that	O
can	O
also	O
interact	O
with	O
each	O
other	O
.	O
These	O
data	O
suggest	O
a	O
wider	O
range	O
of	O
functions	O
for	O
the	O
Robo	O
family	O
in	O
the	O
development	O
of	O
the	O
nervous	O
system	O
and	O
provide	O
novel	O
insights	O
into	O
the	O
molecular	O
basis	O
for	O
the	O
phenotypes	O
observed	O
in	O
Robo	O
mutants	O
in	O
species1s	O
Drosophila	O
species1e	O
,	O
species1s	O
C.	O
elegans	O
species1e	O
,	O
and	O
species1s	O
zebrafish	O
species1e	O
.	O

gene1s	O
Robo1	O
gene1e	O
and	O
gene1s	O
Robo2	O
gene1e	O
are	O
homophilic	O
binding	O
molecules	O
that	O
promote	O
axonal	O
growth	O
.	O
In	O
the	O
present	O
study	O
we	O
show	O
that	O
following	O
transfection	O
in	O
species1s	O
3T3	O
species1e	O
cells	O
,	O
species1s	O
human	O
species1e	O
gene1s	O
Robo1	O
gene1e	O
and	O
gene1s	O
Robo2	O
gene1e	O
stimulate	O
neurite	O
outgrowth	O
from	O
Robo	O
-	O
positive	O
neurons	O
(	O
retinal	O
neurons	O
and	O
olfactory	O
neurons	O
)	O
,	O
but	O
have	O
no	O
effect	O
on	O
Robo	O
-	O
negative	O
neurons	O
(	O
cerebellar	O
granule	O
cells	O
)	O
.	O
The	O
neurite	O
outgrowth	O
response	O
was	O
inhibited	O
by	O
an	O
antibody	O
raised	O
against	O
the	O
first	O
Ig	O
domain	O
of	O
gene1s	O
Robo1/2	O
gene1e	O
or	O
by	O
soluble	O
Robo	O
-	O
Fc	O
chimera	O
.	O
Furthermore	O
,	O
we	O
show	O
that	O
the	O
extracellular	O
domains	O
of	O
gene1s	O
Robo1	O
gene1e	O
and	O
gene1s	O
Robo2	O
gene1e	O
are	O
homophilic	O
adhesion	O
molecules	O
that	O
can	O
also	O
interact	O
with	O
each	O
other	O
.	O
These	O
data	O
suggest	O
a	O
wider	O
range	O
of	O
functions	O
for	O
the	O
Robo	O
family	O
in	O
the	O
development	O
of	O
the	O
nervous	O
system	O
and	O
provide	O
novel	O
insights	O
into	O
the	O
molecular	O
basis	O
for	O
the	O
phenotypes	O
observed	O
in	O
Robo	O
mutants	O
in	O
arg1s	O
Drosophila	O
arg1e	O
,	O
species1s	O
C.	O
elegans	O
species1e	O
,	O
and	O
species1s	O
zebrafish	O
species1e	O
.	O

gene1s	O
Robo1	O
gene1e	O
and	O
gene1s	O
Robo2	O
gene1e	O
are	O
homophilic	O
binding	O
molecules	O
that	O
promote	O
axonal	O
growth	O
.	O
In	O
the	O
present	O
study	O
we	O
show	O
that	O
following	O
transfection	O
in	O
species1s	O
3T3	O
species1e	O
cells	O
,	O
species1s	O
human	O
species1e	O
gene1s	O
Robo1	O
gene1e	O
and	O
gene1s	O
Robo2	O
gene1e	O
stimulate	O
neurite	O
outgrowth	O
from	O
Robo	O
-	O
positive	O
neurons	O
(	O
retinal	O
neurons	O
and	O
olfactory	O
neurons	O
)	O
,	O
but	O
have	O
no	O
effect	O
on	O
Robo	O
-	O
negative	O
neurons	O
(	O
cerebellar	O
granule	O
cells	O
)	O
.	O
The	O
neurite	O
outgrowth	O
response	O
was	O
inhibited	O
by	O
an	O
antibody	O
raised	O
against	O
the	O
first	O
Ig	O
domain	O
of	O
gene1s	O
Robo1/2	O
gene1e	O
or	O
by	O
soluble	O
Robo	O
-	O
Fc	O
chimera	O
.	O
Furthermore	O
,	O
we	O
show	O
that	O
the	O
extracellular	O
domains	O
of	O
gene1s	O
Robo1	O
gene1e	O
and	O
gene1s	O
Robo2	O
gene1e	O
are	O
homophilic	O
adhesion	O
molecules	O
that	O
can	O
also	O
interact	O
with	O
each	O
other	O
.	O
These	O
data	O
suggest	O
a	O
wider	O
range	O
of	O
functions	O
for	O
the	O
Robo	O
family	O
in	O
the	O
development	O
of	O
the	O
nervous	O
system	O
and	O
provide	O
novel	O
insights	O
into	O
the	O
molecular	O
basis	O
for	O
the	O
phenotypes	O
observed	O
in	O
Robo	O
mutants	O
in	O
species1s	O
Drosophila	O
species1e	O
,	O
arg1s	O
C.	O
elegans	O
arg1e	O
,	O
and	O
species1s	O
zebrafish	O
species1e	O
.	O

gene1s	O
Robo1	O
gene1e	O
and	O
gene1s	O
Robo2	O
gene1e	O
are	O
homophilic	O
binding	O
molecules	O
that	O
promote	O
axonal	O
growth	O
.	O
In	O
the	O
present	O
study	O
we	O
show	O
that	O
following	O
transfection	O
in	O
species1s	O
3T3	O
species1e	O
cells	O
,	O
species1s	O
human	O
species1e	O
gene1s	O
Robo1	O
gene1e	O
and	O
gene1s	O
Robo2	O
gene1e	O
stimulate	O
neurite	O
outgrowth	O
from	O
Robo	O
-	O
positive	O
neurons	O
(	O
retinal	O
neurons	O
and	O
olfactory	O
neurons	O
)	O
,	O
but	O
have	O
no	O
effect	O
on	O
Robo	O
-	O
negative	O
neurons	O
(	O
cerebellar	O
granule	O
cells	O
)	O
.	O
The	O
neurite	O
outgrowth	O
response	O
was	O
inhibited	O
by	O
an	O
antibody	O
raised	O
against	O
the	O
first	O
Ig	O
domain	O
of	O
gene1s	O
Robo1/2	O
gene1e	O
or	O
by	O
soluble	O
Robo	O
-	O
Fc	O
chimera	O
.	O
Furthermore	O
,	O
we	O
show	O
that	O
the	O
extracellular	O
domains	O
of	O
gene1s	O
Robo1	O
gene1e	O
and	O
gene1s	O
Robo2	O
gene1e	O
are	O
homophilic	O
adhesion	O
molecules	O
that	O
can	O
also	O
interact	O
with	O
each	O
other	O
.	O
These	O
data	O
suggest	O
a	O
wider	O
range	O
of	O
functions	O
for	O
the	O
Robo	O
family	O
in	O
the	O
development	O
of	O
the	O
nervous	O
system	O
and	O
provide	O
novel	O
insights	O
into	O
the	O
molecular	O
basis	O
for	O
the	O
phenotypes	O
observed	O
in	O
Robo	O
mutants	O
in	O
species1s	O
Drosophila	O
species1e	O
,	O
species1s	O
C.	O
elegans	O
species1e	O
,	O
and	O
arg1s	O
zebrafish	O
arg1e	O
.	O

The	O
AVIT	O
protein	O
family	O
.	O
Secreted	O
cysteine	O
-	O
rich	O
vertebrate	O
proteins	O
with	O
diverse	O
functions	O
.	O
Homologues	O
of	O
a	O
protein	O
originally	O
isolated	O
from	O
snake	O
venom	O
and	O
frog	O
skin	O
secretions	O
are	O
present	O
in	O
many	O
vertebrate	O
species	O
.	O
They	O
contain	O
80	O
-	O
90	O
amino	O
acids	O
,	O
10	O
of	O
which	O
are	O
cysteines	O
with	O
identical	O
spacing	O
.	O
Various	O
names	O
have	O
been	O
given	O
to	O
these	O
proteins	O
,	O
such	O
as	O
gene1s	ARG2
mamba	ARG2
intestinal	ARG2
protein	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MIT1	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
Bv8	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Bombina	ARG2
variegata	ARG2
molecular	ARG2
mass	ARG2
approximately	ARG2
8	ARG2
kDa	ARG2
gene1e	ARG2
)	O
,	O
prokineticins	O
and	O
gene1s	ARG2
endocrine	ARG2
-	ARG2
gland	ARG2
vascular	ARG2
endothelial	ARG2
growth	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
EG	ARG2
-	ARG2
VEGF	ARG2
gene1e	ARG2
)	O
.	O
Their	O
amino	O
-	O
terminal	O
sequences	O
are	O
identical	O
,	O
and	O
so	O
we	O
propose	O
that	O
the	O
sequence	O
of	O
their	O
first	O
four	O
residues	O
,	O
AVIT	O
,	O
is	O
used	O
as	O
a	O
name	O
for	O
this	O
family	O
.	O
From	O
a	O
comparison	O
of	O
the	O
sequences	O
,	O
two	O
types	O
of	O
AVIT	O
proteins	O
can	O
be	O
discerned	O
.	O
These	O
proteins	O
seem	O
to	O
be	O
distributed	O
widely	O
in	O
arg1s	O
mammalian	O
arg1e	O
tissues	O
and	O
are	O
known	O
to	O
bind	O
to	O
G	O
-	O
protein	O
-	O
coupled	O
receptors	O
.	O
Members	O
of	O
this	O
family	O
have	O
been	O
shown	O
to	O
stimulate	O
contraction	O
of	O
the	O
species1s	O
guinea	O
pig	O
species1e	O
ileum	O
,	O
to	O
cause	O
hyperalgesia	O
after	O
injection	O
into	O
species1s	O
rats	O
species1e	O
and	O
to	O
be	O
active	O
as	O
specific	O
growth	O
factors	O
.	O
Moreover	O
,	O
the	O
messenger	O
RNA	O
level	O
of	O
one	O
of	O
these	O
AVIT	O
proteins	O
changes	O
rhythmically	O
in	O
the	O
region	O
of	O
the	O
brain	O
known	O
as	O
the	O
suprachiasmatic	O
nucleus	O
.	O
This	O
shows	O
that	O
members	O
of	O
this	O
new	O
family	O
of	O
small	O
proteins	O
are	O
involved	O
in	O
diverse	O
biological	O
processes	O
.	O

The	O
AVIT	O
protein	O
family	O
.	O
Secreted	O
cysteine	O
-	O
rich	O
vertebrate	O
proteins	O
with	O
diverse	O
functions	O
.	O
Homologues	O
of	O
a	O
protein	O
originally	O
isolated	O
from	O
snake	O
venom	O
and	O
frog	O
skin	O
secretions	O
are	O
present	O
in	O
many	O
vertebrate	O
species	O
.	O
They	O
contain	O
80	O
-	O
90	O
amino	O
acids	O
,	O
10	O
of	O
which	O
are	O
cysteines	O
with	O
identical	O
spacing	O
.	O
Various	O
names	O
have	O
been	O
given	O
to	O
these	O
proteins	O
,	O
such	O
as	O
gene1s	O
mamba	O
intestinal	O
protein	O
1	O
gene1e	O
(	O
gene1s	O
MIT1	O
gene1e	O
)	O
,	O
gene1s	O
Bv8	O
gene1e	O
(	O
gene1s	O
Bombina	O
variegata	O
molecular	O
mass	O
approximately	O
8	O
kDa	O
gene1e	O
)	O
,	O
prokineticins	O
and	O
gene1s	O
endocrine	O
-	O
gland	O
vascular	O
endothelial	O
growth	O
factor	O
gene1e	O
(	O
gene1s	O
EG	O
-	O
VEGF	O
gene1e	O
)	O
.	O
Their	O
amino	O
-	O
terminal	O
sequences	O
are	O
identical	O
,	O
and	O
so	O
we	O
propose	O
that	O
the	O
sequence	O
of	O
their	O
first	O
four	O
residues	O
,	O
AVIT	O
,	O
is	O
used	O
as	O
a	O
name	O
for	O
this	O
family	O
.	O
From	O
a	O
comparison	O
of	O
the	O
sequences	O
,	O
two	O
types	O
of	O
AVIT	O
proteins	O
can	O
be	O
discerned	O
.	O
These	O
proteins	O
seem	O
to	O
be	O
distributed	O
widely	O
in	O
species1s	O
mammalian	O
species1e	O
tissues	O
and	O
are	O
known	O
to	O
bind	O
to	O
G	O
-	O
protein	O
-	O
coupled	O
receptors	O
.	O
Members	O
of	O
this	O
family	O
have	O
been	O
shown	O
to	O
stimulate	O
contraction	O
of	O
the	O
arg1s	O
guinea	O
pig	O
arg1e	O
ileum	O
,	O
to	O
cause	O
hyperalgesia	O
after	O
injection	O
into	O
species1s	O
rats	O
species1e	O
and	O
to	O
be	O
active	O
as	O
specific	O
growth	O
factors	O
.	O
Moreover	O
,	O
the	O
messenger	O
RNA	O
level	O
of	O
one	O
of	O
these	O
AVIT	O
proteins	O
changes	O
rhythmically	O
in	O
the	O
region	O
of	O
the	O
brain	O
known	O
as	O
the	O
suprachiasmatic	O
nucleus	O
.	O
This	O
shows	O
that	O
members	O
of	O
this	O
new	O
family	O
of	O
small	O
proteins	O
are	O
involved	O
in	O
diverse	O
biological	O
processes	O
.	O

The	O
AVIT	O
protein	O
family	O
.	O
Secreted	O
cysteine	O
-	O
rich	O
vertebrate	O
proteins	O
with	O
diverse	O
functions	O
.	O
Homologues	O
of	O
a	O
protein	O
originally	O
isolated	O
from	O
snake	O
venom	O
and	O
frog	O
skin	O
secretions	O
are	O
present	O
in	O
many	O
vertebrate	O
species	O
.	O
They	O
contain	O
80	O
-	O
90	O
amino	O
acids	O
,	O
10	O
of	O
which	O
are	O
cysteines	O
with	O
identical	O
spacing	O
.	O
Various	O
names	O
have	O
been	O
given	O
to	O
these	O
proteins	O
,	O
such	O
as	O
gene1s	O
mamba	O
intestinal	O
protein	O
1	O
gene1e	O
(	O
gene1s	O
MIT1	O
gene1e	O
)	O
,	O
gene1s	O
Bv8	O
gene1e	O
(	O
gene1s	O
Bombina	O
variegata	O
molecular	O
mass	O
approximately	O
8	O
kDa	O
gene1e	O
)	O
,	O
prokineticins	O
and	O
gene1s	O
endocrine	O
-	O
gland	O
vascular	O
endothelial	O
growth	O
factor	O
gene1e	O
(	O
gene1s	O
EG	O
-	O
VEGF	O
gene1e	O
)	O
.	O
Their	O
amino	O
-	O
terminal	O
sequences	O
are	O
identical	O
,	O
and	O
so	O
we	O
propose	O
that	O
the	O
sequence	O
of	O
their	O
first	O
four	O
residues	O
,	O
AVIT	O
,	O
is	O
used	O
as	O
a	O
name	O
for	O
this	O
family	O
.	O
From	O
a	O
comparison	O
of	O
the	O
sequences	O
,	O
two	O
types	O
of	O
AVIT	O
proteins	O
can	O
be	O
discerned	O
.	O
These	O
proteins	O
seem	O
to	O
be	O
distributed	O
widely	O
in	O
species1s	O
mammalian	O
species1e	O
tissues	O
and	O
are	O
known	O
to	O
bind	O
to	O
G	O
-	O
protein	O
-	O
coupled	O
receptors	O
.	O
Members	O
of	O
this	O
family	O
have	O
been	O
shown	O
to	O
stimulate	O
contraction	O
of	O
the	O
species1s	O
guinea	O
pig	O
species1e	O
ileum	O
,	O
to	O
cause	O
hyperalgesia	O
after	O
injection	O
into	O
arg1s	O
rats	O
arg1e	O
and	O
to	O
be	O
active	O
as	O
specific	O
growth	O
factors	O
.	O
Moreover	O
,	O
the	O
messenger	O
RNA	O
level	O
of	O
one	O
of	O
these	O
AVIT	O
proteins	O
changes	O
rhythmically	O
in	O
the	O
region	O
of	O
the	O
brain	O
known	O
as	O
the	O
suprachiasmatic	O
nucleus	O
.	O
This	O
shows	O
that	O
members	O
of	O
this	O
new	O
family	O
of	O
small	O
proteins	O
are	O
involved	O
in	O
diverse	O
biological	O
processes	O
.	O

Expression	O
and	O
localization	O
of	O
VCX	O
/	O
Y	O
proteins	O
and	O
their	O
possible	O
involvement	O
in	O
regulation	O
of	O
ribosome	O
assembly	O
during	O
spermatogenesis	O
.	O
Variable	O
Charge	O
X	O
/	O
Y	O
(	O
VCX	O
/	O
Y	O
)	O
is	O
a	O
arg1s	O
human	O
arg1e	O
testis	O
-	O
specific	O
gene	O
family	O
that	O
localized	O
on	O
X	O
and	O
Y	O
chromosomes	O
.	O
In	O
this	O
study	O
,	O
VCY	O
protein	O
was	O
expressed	O
in	O
species1s	O
E.	O
coli	O
species1e	O
in	O
the	O
form	O
of	O
glutathione	O
-	O
S	O
-	O
transferase	O
(	O
GST	O
)	O
fusion	O
protein	O
.	O
With	O
the	O
purified	O
fusion	O
protein	O
as	O
antigen	O
,	O
the	O
anti	O
-	O
GST	O
-	O
gene1s	ARG2
VCY	ARG2
gene1e	ARG2
antibody	O
was	O
generated	O
and	O
the	O
localization	O
of	O
gene1s	ARG2
VCY	ARG2
gene1e	ARG2
protein	O
in	O
arg1s	O
human	O
arg1e	O
testis	O
was	O
determined	O
by	O
immunohistochemistry	O
.	O
In	O
the	O
testis	O
seminiferous	O
epithelium	O
,	O
gene1s	ARG2
VCY	ARG2
gene1e	ARG2
proteins	O
were	O
highly	O
expressed	O
in	O
nuclei	O
of	O
germ	O
cells	O
.	O
Using	O
propidium	O
iodide	O
staining	O
and	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
)	O
tag	O
technologies	O
,	O
gene1s	ARG2
VCY	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
VCX-8r	ARG2
gene1e	ARG2
proteins	O
were	O
mainly	O
localized	O
in	O
the	O
nucleoli	O
of	O
species1s	O
COS7	O
species1e	O
cells	O
.	O
In	O
addition	O
,	O
the	O
colocalization	O
for	O
gene1s	ARG2
VCY	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
VCX-8r	ARG2
gene1e	ARG2
in	O
species1s	O
COS7	O
species1e	O
cells	O
was	O
also	O
observed	O
.	O
With	O
gene1s	ARG2
VCY	ARG2
gene1e	ARG2
cDNA	O
as	O
bait	O
,	O
a	O
cDNA	O
fragment	O
of	O
gene1s	ARG2
acidic	ARG2
ribosomal	ARG2
protein	ARG2
PO	ARG2
gene1e	ARG2
was	O
obtained	O
using	O
yeast	O
two	O
-	O
hybrid	O
system	O
.	O
All	O
the	O
information	O
above	O
indicates	O
that	O
VCX	O
/	O
Y	O
protein	O
family	O
might	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
ribosome	O
assembly	O
during	O
spermatogenesis	O
.	O

Expression	O
and	O
localization	O
of	O
VCX	O
/	O
Y	O
proteins	O
and	O
their	O
possible	O
involvement	O
in	O
regulation	O
of	O
ribosome	O
assembly	O
during	O
spermatogenesis	O
.	O
Variable	O
Charge	O
X	O
/	O
Y	O
(	O
VCX	O
/	O
Y	O
)	O
is	O
a	O
species1s	O
human	O
species1e	O
testis	O
-	O
specific	O
gene	O
family	O
that	O
localized	O
on	O
X	O
and	O
Y	O
chromosomes	O
.	O
In	O
this	O
study	O
,	O
VCY	O
protein	O
was	O
expressed	O
in	O
arg1s	O
E.	O
coli	O
arg1e	O
in	O
the	O
form	O
of	O
glutathione	O
-	O
S	O
-	O
transferase	O
(	O
GST	O
)	O
fusion	O
protein	O
.	O
With	O
the	O
purified	O
fusion	O
protein	O
as	O
antigen	O
,	O
the	O
anti	O
-	O
GST	O
-	O
gene1s	O
VCY	O
gene1e	O
antibody	O
was	O
generated	O
and	O
the	O
localization	O
of	O
gene1s	O
VCY	O
gene1e	O
protein	O
in	O
species1s	O
human	O
species1e	O
testis	O
was	O
determined	O
by	O
immunohistochemistry	O
.	O
In	O
the	O
testis	O
seminiferous	O
epithelium	O
,	O
gene1s	O
VCY	O
gene1e	O
proteins	O
were	O
highly	O
expressed	O
in	O
nuclei	O
of	O
germ	O
cells	O
.	O
Using	O
propidium	O
iodide	O
staining	O
and	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
)	O
tag	O
technologies	O
,	O
gene1s	O
VCY	O
gene1e	O
and	O
gene1s	O
VCX-8r	O
gene1e	O
proteins	O
were	O
mainly	O
localized	O
in	O
the	O
nucleoli	O
of	O
species1s	O
COS7	O
species1e	O
cells	O
.	O
In	O
addition	O
,	O
the	O
colocalization	O
for	O
gene1s	O
VCY	O
gene1e	O
and	O
gene1s	O
VCX-8r	O
gene1e	O
in	O
species1s	O
COS7	O
species1e	O
cells	O
was	O
also	O
observed	O
.	O
With	O
gene1s	O
VCY	O
gene1e	O
cDNA	O
as	O
bait	O
,	O
a	O
cDNA	O
fragment	O
of	O
gene1s	O
acidic	O
ribosomal	O
protein	O
PO	O
gene1e	O
was	O
obtained	O
using	O
yeast	O
two	O
-	O
hybrid	O
system	O
.	O
All	O
the	O
information	O
above	O
indicates	O
that	O
VCX	O
/	O
Y	O
protein	O
family	O
might	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
ribosome	O
assembly	O
during	O
spermatogenesis	O
.	O

Expression	O
and	O
localization	O
of	O
VCX	O
/	O
Y	O
proteins	O
and	O
their	O
possible	O
involvement	O
in	O
regulation	O
of	O
ribosome	O
assembly	O
during	O
spermatogenesis	O
.	O
Variable	O
Charge	O
X	O
/	O
Y	O
(	O
VCX	O
/	O
Y	O
)	O
is	O
a	O
species1s	O
human	O
species1e	O
testis	O
-	O
specific	O
gene	O
family	O
that	O
localized	O
on	O
X	O
and	O
Y	O
chromosomes	O
.	O
In	O
this	O
study	O
,	O
VCY	O
protein	O
was	O
expressed	O
in	O
species1s	O
E.	O
coli	O
species1e	O
in	O
the	O
form	O
of	O
glutathione	O
-	O
S	O
-	O
transferase	O
(	O
GST	O
)	O
fusion	O
protein	O
.	O
With	O
the	O
purified	O
fusion	O
protein	O
as	O
antigen	O
,	O
the	O
anti	O
-	O
GST	O
-	O
gene1s	O
VCY	O
gene1e	O
antibody	O
was	O
generated	O
and	O
the	O
localization	O
of	O
gene1s	O
VCY	O
gene1e	O
protein	O
in	O
species1s	O
human	O
species1e	O
testis	O
was	O
determined	O
by	O
immunohistochemistry	O
.	O
In	O
the	O
testis	O
seminiferous	O
epithelium	O
,	O
gene1s	O
VCY	O
gene1e	O
proteins	O
were	O
highly	O
expressed	O
in	O
nuclei	O
of	O
germ	O
cells	O
.	O
Using	O
propidium	O
iodide	O
staining	O
and	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
)	O
tag	O
technologies	O
,	O
gene1s	O
VCY	O
gene1e	O
and	O
gene1s	O
VCX-8r	O
gene1e	O
proteins	O
were	O
mainly	O
localized	O
in	O
the	O
nucleoli	O
of	O
arg1s	O
COS7	O
arg1e	O
cells	O
.	O
In	O
addition	O
,	O
the	O
colocalization	O
for	O
gene1s	O
VCY	O
gene1e	O
and	O
gene1s	O
VCX-8r	O
gene1e	O
in	O
arg1s	O
COS7	O
arg1e	O
cells	O
was	O
also	O
observed	O
.	O
With	O
gene1s	O
VCY	O
gene1e	O
cDNA	O
as	O
bait	O
,	O
a	O
cDNA	O
fragment	O
of	O
gene1s	O
acidic	O
ribosomal	O
protein	O
PO	O
gene1e	O
was	O
obtained	O
using	O
yeast	O
two	O
-	O
hybrid	O
system	O
.	O
All	O
the	O
information	O
above	O
indicates	O
that	O
VCX	O
/	O
Y	O
protein	O
family	O
might	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
ribosome	O
assembly	O
during	O
spermatogenesis	O
.	O

gene1s	O
DACH1	O
gene1e	O
inhibits	O
transforming	O
growth	O
factor	O
-	O
beta	O
signaling	O
through	O
binding	O
gene1s	O
Smad4	O
gene1e	O
.	O
The	O
vertebrate	O
homologues	O
of	O
arg1s	O
Drosophila	O
arg1e	O
gene1s	ARG2
dachsund	ARG2
gene1e	ARG2
,	O
gene1s	O
DACH1	O
gene1e	O
and	O
gene1s	O
DACH2	O
gene1e	O
,	O
have	O
been	O
implicated	O
as	O
important	O
regulatory	O
genes	O
in	O
development	O
.	O
gene1s	O
DACH1	O
gene1e	O
plays	O
a	O
role	O
in	O
retinal	O
and	O
pituitary	O
precursor	O
cell	O
proliferation	O
and	O
gene1s	O
DACH2	O
gene1e	O
plays	O
a	O
specific	O
role	O
in	O
myogenesis	O
.	O
DACH	O
proteins	O
contain	O
a	O
domain	O
(	O
DS	O
domain	O
)	O
that	O
is	O
conserved	O
with	O
the	O
proto	O
-	O
oncogenes	O
gene1s	O
Ski	O
gene1e	O
and	O
gene1s	O
Sno	O
gene1e	O
.	O
Since	O
the	O
gene1s	O
Ski	O
gene1e	O
/	O
gene1s	O
Sno	O
gene1e	O
proto	O
-	O
oncogenes	O
repress	O
AP-1	O
and	O
SMAD	O
signaling	O
,	O
we	O
hypothesized	O
that	O
gene1s	O
DACH1	O
gene1e	O
might	O
play	O
a	O
similar	O
cellular	O
function	O
.	O
Herein	O
,	O
gene1s	O
DACH1	O
gene1e	O
was	O
found	O
to	O
be	O
expressed	O
in	O
breast	O
cancer	O
cell	O
lines	O
and	O
to	O
inhibit	O
transforming	O
growth	O
factor	O
-	O
beta	O
(	O
TGF	O
-	O
beta)-induced	O
apoptosis	O
.	O
gene1s	O
DACH1	O
gene1e	O
repressed	O
TGF	O
-	O
beta	O
induction	O
of	O
AP-1	O
and	O
Smad	O
signaling	O
in	O
gene	O
reporter	O
assays	O
and	O
repressed	O
endogenous	O
TGF	O
-	O
beta	O
-	O
responsive	O
genes	O
by	O
microarray	O
analyses	O
.	O
gene1s	O
DACH1	O
gene1e	O
bound	O
to	O
endogenous	O
gene1s	O
NCoR	O
gene1e	O
and	O
gene1s	O
Smad4	O
gene1e	O
in	O
cultured	O
cells	O
and	O
gene1s	O
DACH1	O
gene1e	O
co	O
-	O
localized	O
with	O
gene1s	O
NCoR	O
gene1e	O
in	O
nuclear	O
dotlike	O
structures	O
.	O
gene1s	O
NCoR	O
gene1e	O
enhanced	O
gene1s	O
DACH1	O
gene1e	O
repression	O
,	O
and	O
the	O
repression	O
of	O
TGF	O
-	O
beta	O
-	O
induced	O
AP-1	O
or	O
Smad	O
signaling	O
by	O
gene1s	O
DACH1	O
gene1e	O
required	O
the	O
gene1s	O
DACH1	O
gene1e	O
DS	O
domain	O
.	O
The	O
DS	O
domain	O
of	O
DACH	O
was	O
sufficient	O
for	O
gene1s	O
NCoR	O
gene1e	O
binding	O
at	O
a	O
Smad4-binding	O
site	O
.	O
gene1s	O
Smad4	O
gene1e	O
was	O
required	O
for	O
gene1s	O
DACH1	O
gene1e	O
repression	O
of	O
Smad	O
signaling	O
.	O
In	O
gene1s	O
Smad4	O
gene1e	O
null	O
species1s	O
HTB-134	O
species1e	O
cells	O
,	O
gene1s	O
DACH1	O
gene1e	O
inhibited	O
the	O
activation	O
of	O
SBE-4	O
reporter	O
activity	O
induced	O
by	O
gene1s	O
Smad2	O
gene1e	O
or	O
gene1s	O
Smad3	O
gene1e	O
only	O
in	O
the	O
presence	O
of	O
gene1s	O
Smad4	O
gene1e	O
.	O
gene1s	O
DACH1	O
gene1e	O
participates	O
in	O
the	O
negative	O
regulation	O
of	O
TGF	O
-	O
beta	O
signaling	O
by	O
interacting	O
with	O
gene1s	O
NCoR	O
gene1e	O
and	O
gene1s	O
Smad4	O
gene1e	O
.	O

gene1s	ARG2
DACH1	ARG2
gene1e	ARG2
inhibits	O
transforming	O
growth	O
factor	O
-	O
beta	O
signaling	O
through	O
binding	O
gene1s	ARG2
Smad4	ARG2
gene1e	ARG2
.	O
The	O
vertebrate	O
homologues	O
of	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
dachsund	O
gene1e	O
,	O
gene1s	ARG2
DACH1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
DACH2	ARG2
gene1e	ARG2
,	O
have	O
been	O
implicated	O
as	O
important	O
regulatory	O
genes	O
in	O
development	O
.	O
gene1s	ARG2
DACH1	ARG2
gene1e	ARG2
plays	O
a	O
role	O
in	O
retinal	O
and	O
pituitary	O
precursor	O
cell	O
proliferation	O
and	O
gene1s	ARG2
DACH2	ARG2
gene1e	ARG2
plays	O
a	O
specific	O
role	O
in	O
myogenesis	O
.	O
DACH	O
proteins	O
contain	O
a	O
domain	O
(	O
DS	O
domain	O
)	O
that	O
is	O
conserved	O
with	O
the	O
proto	O
-	O
oncogenes	O
gene1s	ARG2
Ski	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Sno	ARG2
gene1e	ARG2
.	O
Since	O
the	O
gene1s	ARG2
Ski	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Sno	ARG2
gene1e	ARG2
proto	O
-	O
oncogenes	O
repress	O
AP-1	O
and	O
SMAD	O
signaling	O
,	O
we	O
hypothesized	O
that	O
gene1s	ARG2
DACH1	ARG2
gene1e	ARG2
might	O
play	O
a	O
similar	O
cellular	O
function	O
.	O
Herein	O
,	O
gene1s	ARG2
DACH1	ARG2
gene1e	ARG2
was	O
found	O
to	O
be	O
expressed	O
in	O
breast	O
cancer	O
cell	O
lines	O
and	O
to	O
inhibit	O
transforming	O
growth	O
factor	O
-	O
beta	O
(	O
TGF	O
-	O
beta)-induced	O
apoptosis	O
.	O
gene1s	ARG2
DACH1	ARG2
gene1e	ARG2
repressed	O
TGF	O
-	O
beta	O
induction	O
of	O
AP-1	O
and	O
Smad	O
signaling	O
in	O
gene	O
reporter	O
assays	O
and	O
repressed	O
endogenous	O
TGF	O
-	O
beta	O
-	O
responsive	O
genes	O
by	O
microarray	O
analyses	O
.	O
gene1s	ARG2
DACH1	ARG2
gene1e	ARG2
bound	O
to	O
endogenous	O
gene1s	ARG2
NCoR	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Smad4	ARG2
gene1e	ARG2
in	O
cultured	O
cells	O
and	O
gene1s	ARG2
DACH1	ARG2
gene1e	ARG2
co	O
-	O
localized	O
with	O
gene1s	ARG2
NCoR	ARG2
gene1e	ARG2
in	O
nuclear	O
dotlike	O
structures	O
.	O
gene1s	ARG2
NCoR	ARG2
gene1e	ARG2
enhanced	O
gene1s	ARG2
DACH1	ARG2
gene1e	ARG2
repression	O
,	O
and	O
the	O
repression	O
of	O
TGF	O
-	O
beta	O
-	O
induced	O
AP-1	O
or	O
Smad	O
signaling	O
by	O
gene1s	ARG2
DACH1	ARG2
gene1e	ARG2
required	O
the	O
gene1s	ARG2
DACH1	ARG2
gene1e	ARG2
DS	O
domain	O
.	O
The	O
DS	O
domain	O
of	O
DACH	O
was	O
sufficient	O
for	O
gene1s	ARG2
NCoR	ARG2
gene1e	ARG2
binding	O
at	O
a	O
Smad4-binding	O
site	O
.	O
gene1s	ARG2
Smad4	ARG2
gene1e	ARG2
was	O
required	O
for	O
gene1s	ARG2
DACH1	ARG2
gene1e	ARG2
repression	O
of	O
Smad	O
signaling	O
.	O
In	O
gene1s	ARG2
Smad4	ARG2
gene1e	ARG2
null	O
arg1s	O
HTB-134	O
arg1e	O
cells	O
,	O
gene1s	ARG2
DACH1	ARG2
gene1e	ARG2
inhibited	O
the	O
activation	O
of	O
SBE-4	O
reporter	O
activity	O
induced	O
by	O
gene1s	ARG2
Smad2	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
Smad3	ARG2
gene1e	ARG2
only	O
in	O
the	O
presence	O
of	O
gene1s	ARG2
Smad4	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
DACH1	ARG2
gene1e	ARG2
participates	O
in	O
the	O
negative	O
regulation	O
of	O
TGF	O
-	O
beta	O
signaling	O
by	O
interacting	O
with	O
gene1s	ARG2
NCoR	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Smad4	ARG2
gene1e	ARG2
.	O

A	O
arg1s	O
mammalian	O
arg1e	O
homolog	O
of	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
transcriptional	O
coactivator	O
gene1s	O
intersex	O
gene1e	O
is	O
a	O
subunit	O
of	O
the	O
arg1s	O
mammalian	O
arg1e	O
Mediator	O
complex	O
.	O
The	O
multiprotein	O
Mediator	O
complex	O
is	O
a	O
coactivator	O
required	O
for	O
transcriptional	O
activation	O
of	O
RNA	O
polymerase	O
II	O
transcribed	O
genes	O
by	O
DNA	O
binding	O
transcription	O
factors	O
.	O
We	O
previously	O
partially	O
purified	O
a	O
Med8-containing	O
Mediator	O
complex	O
from	O
species1s	O
rat	O
species1e	O
liver	O
nuclei	O
(	O
Brower	O
,	O
C.	O
S.	O
,	O
Sato	O
,	O
S.	O
,	O
Tomomori	O
-	O
Sato	O
,	O
C.	O
,	O
Kamura	O
,	O
T.	O
,	O
Pause	O
,	O
A.	O
,	O
Stearman	O
,	O
R.	O
,	O
Klausner	O
,	O
R.	O
D.	O
,	O
Malik	O
,	O
S.	O
,	O
Lane	O
,	O
W.	O
S.	O
,	O
Sorokina	O
,	O
I.	O
,	O
Roeder	O
,	O
R.	O
G.	O
,	O
Conaway	O
,	O
J.	O
W.	O
,	O
and	O
Conaway	O
,	O
R.	O
C.	O
(	O
2002	O
)	O
Proc	O
.	O
Natl	O
.	O
Acad	O
.	O
Sci	O
.	O
U.	O
S.	O
A.	O
99	O
,	O
10353	O
-	O
10358	O
)	O
.	O
Analysis	O
of	O
proteins	O
present	O
in	O
the	O
most	O
highly	O
enriched	O
Mediator	O
fractions	O
by	O
tandem	O
mass	O
spectrometry	O
led	O
to	O
the	O
identification	O
of	O
several	O
new	O
arg1s	O
mammalian	O
arg1e	O
Mediator	O
subunits	O
,	O
as	O
well	O
as	O
several	O
potential	O
Mediator	O
subunits	O
.	O
Here	O
we	O
identify	O
one	O
of	O
these	O
proteins	O
,	O
encoded	O
by	O
the	O
previously	O
uncharacterized	O
gene1s	ARG2
AK000411	ARG2
gene1e	ARG2
open	O
reading	O
frame	O
,	O
as	O
a	O
new	O
subunit	O
of	O
the	O
arg1s	O
mammalian	O
arg1e	O
Mediator	O
complex	O
.	O
The	O
gene1s	ARG2
AK000411	ARG2
gene1e	ARG2
protein	O
,	O
which	O
we	O
designate	O
gene1s	ARG2
hIntersex	ARG2
gene1e	ARG2
(	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
Intersex	ARG2
gene1e	ARG2
)	O
,	O
shares	O
significant	O
sequence	O
similarity	O
with	O
the	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
gene1s	O
intersex	O
gene1e	O
protein	O
,	O
which	O
has	O
functional	O
properties	O
expected	O
of	O
a	O
transcriptional	O
coactivator	O
specific	O
for	O
the	O
species1s	O
Drosophila	O
species1e	O
doublesex	O
transactivator	O
.	O
In	O
addition	O
,	O
we	O
show	O
that	O
gene1s	ARG2
hIntersex	ARG2
gene1e	ARG2
assembles	O
into	O
a	O
subcomplex	O
with	O
gene1s	ARG2
Mediator	ARG2
subunits	ARG2
p28b	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
TRFP	ARG2
gene1e	ARG2
.	O
Taken	O
together	O
,	O
our	O
findings	O
identify	O
a	O
new	O
subunit	O
of	O
the	O
arg1s	O
mammalian	O
arg1e	O
Mediator	O
and	O
shed	O
new	O
light	O
on	O
the	O
architecture	O
of	O
the	O
arg1s	O
mammalian	O
arg1e	O
Mediator	O
complex	O
.	O

A	O
species1s	O
mammalian	O
species1e	O
homolog	O
of	O
arg1s	O
Drosophila	O
melanogaster	O
arg1e	O
transcriptional	O
coactivator	O
gene1s	ARG2
intersex	ARG2
gene1e	ARG2
is	O
a	O
subunit	O
of	O
the	O
species1s	O
mammalian	O
species1e	O
Mediator	O
complex	O
.	O
The	O
multiprotein	O
Mediator	O
complex	O
is	O
a	O
coactivator	O
required	O
for	O
transcriptional	O
activation	O
of	O
RNA	O
polymerase	O
II	O
transcribed	O
genes	O
by	O
DNA	O
binding	O
transcription	O
factors	O
.	O
We	O
previously	O
partially	O
purified	O
a	O
Med8-containing	O
Mediator	O
complex	O
from	O
species1s	O
rat	O
species1e	O
liver	O
nuclei	O
(	O
Brower	O
,	O
C.	O
S.	O
,	O
Sato	O
,	O
S.	O
,	O
Tomomori	O
-	O
Sato	O
,	O
C.	O
,	O
Kamura	O
,	O
T.	O
,	O
Pause	O
,	O
A.	O
,	O
Stearman	O
,	O
R.	O
,	O
Klausner	O
,	O
R.	O
D.	O
,	O
Malik	O
,	O
S.	O
,	O
Lane	O
,	O
W.	O
S.	O
,	O
Sorokina	O
,	O
I.	O
,	O
Roeder	O
,	O
R.	O
G.	O
,	O
Conaway	O
,	O
J.	O
W.	O
,	O
and	O
Conaway	O
,	O
R.	O
C.	O
(	O
2002	O
)	O
Proc	O
.	O
Natl	O
.	O
Acad	O
.	O
Sci	O
.	O
U.	O
S.	O
A.	O
99	O
,	O
10353	O
-	O
10358	O
)	O
.	O
Analysis	O
of	O
proteins	O
present	O
in	O
the	O
most	O
highly	O
enriched	O
Mediator	O
fractions	O
by	O
tandem	O
mass	O
spectrometry	O
led	O
to	O
the	O
identification	O
of	O
several	O
new	O
species1s	O
mammalian	O
species1e	O
Mediator	O
subunits	O
,	O
as	O
well	O
as	O
several	O
potential	O
Mediator	O
subunits	O
.	O
Here	O
we	O
identify	O
one	O
of	O
these	O
proteins	O
,	O
encoded	O
by	O
the	O
previously	O
uncharacterized	O
gene1s	O
AK000411	O
gene1e	O
open	O
reading	O
frame	O
,	O
as	O
a	O
new	O
subunit	O
of	O
the	O
species1s	O
mammalian	O
species1e	O
Mediator	O
complex	O
.	O
The	O
gene1s	O
AK000411	O
gene1e	O
protein	O
,	O
which	O
we	O
designate	O
gene1s	O
hIntersex	O
gene1e	O
(	O
species1s	O
human	O
species1e	O
gene1s	O
Intersex	O
gene1e	O
)	O
,	O
shares	O
significant	O
sequence	O
similarity	O
with	O
the	O
arg1s	O
Drosophila	O
melanogaster	O
arg1e	O
gene1s	ARG2
intersex	ARG2
gene1e	ARG2
protein	O
,	O
which	O
has	O
functional	O
properties	O
expected	O
of	O
a	O
transcriptional	O
coactivator	O
specific	O
for	O
the	O
arg1s	O
Drosophila	O
arg1e	O
doublesex	O
transactivator	O
.	O
In	O
addition	O
,	O
we	O
show	O
that	O
gene1s	O
hIntersex	O
gene1e	O
assembles	O
into	O
a	O
subcomplex	O
with	O
gene1s	O
Mediator	O
subunits	O
p28b	O
gene1e	O
and	O
gene1s	O
TRFP	O
gene1e	O
.	O
Taken	O
together	O
,	O
our	O
findings	O
identify	O
a	O
new	O
subunit	O
of	O
the	O
species1s	O
mammalian	O
species1e	O
Mediator	O
and	O
shed	O
new	O
light	O
on	O
the	O
architecture	O
of	O
the	O
species1s	O
mammalian	O
species1e	O
Mediator	O
complex	O
.	O

A	O
species1s	O
mammalian	O
species1e	O
homolog	O
of	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
transcriptional	O
coactivator	O
gene1s	O
intersex	O
gene1e	O
is	O
a	O
subunit	O
of	O
the	O
species1s	O
mammalian	O
species1e	O
Mediator	O
complex	O
.	O
The	O
multiprotein	O
Mediator	O
complex	O
is	O
a	O
coactivator	O
required	O
for	O
transcriptional	O
activation	O
of	O
RNA	O
polymerase	O
II	O
transcribed	O
genes	O
by	O
DNA	O
binding	O
transcription	O
factors	O
.	O
We	O
previously	O
partially	O
purified	O
a	O
Med8-containing	O
Mediator	O
complex	O
from	O
arg1s	O
rat	O
arg1e	O
liver	O
nuclei	O
(	O
Brower	O
,	O
C.	O
S.	O
,	O
Sato	O
,	O
S.	O
,	O
Tomomori	O
-	O
Sato	O
,	O
C.	O
,	O
Kamura	O
,	O
T.	O
,	O
Pause	O
,	O
A.	O
,	O
Stearman	O
,	O
R.	O
,	O
Klausner	O
,	O
R.	O
D.	O
,	O
Malik	O
,	O
S.	O
,	O
Lane	O
,	O
W.	O
S.	O
,	O
Sorokina	O
,	O
I.	O
,	O
Roeder	O
,	O
R.	O
G.	O
,	O
Conaway	O
,	O
J.	O
W.	O
,	O
and	O
Conaway	O
,	O
R.	O
C.	O
(	O
2002	O
)	O
Proc	O
.	O
Natl	O
.	O
Acad	O
.	O
Sci	O
.	O
U.	O
S.	O
A.	O
99	O
,	O
10353	O
-	O
10358	O
)	O
.	O
Analysis	O
of	O
proteins	O
present	O
in	O
the	O
most	O
highly	O
enriched	O
Mediator	O
fractions	O
by	O
tandem	O
mass	O
spectrometry	O
led	O
to	O
the	O
identification	O
of	O
several	O
new	O
species1s	O
mammalian	O
species1e	O
Mediator	O
subunits	O
,	O
as	O
well	O
as	O
several	O
potential	O
Mediator	O
subunits	O
.	O
Here	O
we	O
identify	O
one	O
of	O
these	O
proteins	O
,	O
encoded	O
by	O
the	O
previously	O
uncharacterized	O
gene1s	O
AK000411	O
gene1e	O
open	O
reading	O
frame	O
,	O
as	O
a	O
new	O
subunit	O
of	O
the	O
species1s	O
mammalian	O
species1e	O
Mediator	O
complex	O
.	O
The	O
gene1s	O
AK000411	O
gene1e	O
protein	O
,	O
which	O
we	O
designate	O
gene1s	O
hIntersex	O
gene1e	O
(	O
species1s	O
human	O
species1e	O
gene1s	O
Intersex	O
gene1e	O
)	O
,	O
shares	O
significant	O
sequence	O
similarity	O
with	O
the	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
gene1s	O
intersex	O
gene1e	O
protein	O
,	O
which	O
has	O
functional	O
properties	O
expected	O
of	O
a	O
transcriptional	O
coactivator	O
specific	O
for	O
the	O
species1s	O
Drosophila	O
species1e	O
doublesex	O
transactivator	O
.	O
In	O
addition	O
,	O
we	O
show	O
that	O
gene1s	O
hIntersex	O
gene1e	O
assembles	O
into	O
a	O
subcomplex	O
with	O
gene1s	O
Mediator	O
subunits	O
p28b	O
gene1e	O
and	O
gene1s	O
TRFP	O
gene1e	O
.	O
Taken	O
together	O
,	O
our	O
findings	O
identify	O
a	O
new	O
subunit	O
of	O
the	O
species1s	O
mammalian	O
species1e	O
Mediator	O
and	O
shed	O
new	O
light	O
on	O
the	O
architecture	O
of	O
the	O
species1s	O
mammalian	O
species1e	O
Mediator	O
complex	O
.	O

The	O
gene1s	ARG2
netrin	ARG2
-	ARG2
G1	ARG2
ligand	ARG2
gene1e	ARG2
gene1s	ARG2
NGL-1	ARG2
gene1e	ARG2
promotes	O
the	O
outgrowth	O
of	O
thalamocortical	O
axons	O
.	O
gene1s	ARG2
Netrin	ARG2
-	ARG2
G1	ARG2
gene1e	ARG2
is	O
a	O
lipid	O
-	O
anchored	O
protein	O
that	O
is	O
structurally	O
related	O
to	O
the	O
netrin	O
family	O
of	O
axon	O
guidance	O
molecules	O
.	O
gene1s	ARG2
Netrin	ARG2
-	ARG2
G1	ARG2
gene1e	ARG2
does	O
not	O
bind	O
any	O
of	O
the	O
known	O
netrin	O
receptors	O
and	O
its	O
function	O
is	O
not	O
known	O
.	O
Here	O
we	O
identify	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
netrin	ARG2
-	ARG2
G1	ARG2
ligand	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NGL-1	ARG2
gene1e	ARG2
)	O
,	O
a	O
transmembrane	O
protein	O
containing	O
leucine	O
-	O
rich	O
repeat	O
(	O
LRR	O
)	O
and	O
immunoglobulin	O
(	O
Ig	O
)	O
domains	O
that	O
specifically	O
interacts	O
with	O
gene1s	ARG2
netrin	ARG2
-	ARG2
G1	ARG2
gene1e	ARG2
through	O
its	O
LRR	O
region	O
.	O
Whereas	O
gene1s	O
netrin	O
-	O
G1	O
gene1e	O
is	O
expressed	O
highly	O
in	O
species1s	O
mouse	O
species1e	O
thalamic	O
axons	O
,	O
gene1s	O
NGL-1	O
gene1e	O
is	O
most	O
abundant	O
in	O
the	O
striatum	O
and	O
the	O
cerebral	O
cortex	O
--	O
the	O
intermediate	O
and	O
final	O
targets	O
,	O
respectively	O
,	O
of	O
thalamocortical	O
axons	O
(	O
TCAs	O
)	O
.	O
Surface	O
-	O
bound	O
gene1s	ARG2
NGL-1	ARG2
gene1e	ARG2
stimulates	O
,	O
but	O
soluble	O
gene1s	ARG2
NGL-1	ARG2
gene1e	ARG2
disrupts	O
,	O
the	O
growth	O
of	O
embryonic	O
thalamic	O
axons	O
,	O
and	O
in	O
vitro	O
data	O
indicate	O
that	O
gene1s	ARG2
NGL-1	ARG2
gene1e	ARG2
activity	O
may	O
be	O
mediated	O
at	O
least	O
partially	O
by	O
gene1s	ARG2
netrin	ARG2
-	ARG2
G1	ARG2
gene1e	ARG2
.	O
Our	O
findings	O
provide	O
evidence	O
that	O
gene1s	ARG2
netrin	ARG2
-	ARG2
G1	ARG2
gene1e	ARG2
functions	O
as	O
an	O
important	O
component	O
of	O
the	O
gene1s	ARG2
NGL-1	ARG2
gene1e	ARG2
receptor	O
to	O
promote	O
TCA	O
outgrowth	O
and	O
that	O
membrane	O
-	O
bound	O
netrins	O
can	O
participate	O
in	O
receiving	O
axonal	O
signaling	O
pathways	O
.	O

The	O
gene1s	O
netrin	O
-	O
G1	O
ligand	O
gene1e	O
gene1s	O
NGL-1	O
gene1e	O
promotes	O
the	O
outgrowth	O
of	O
thalamocortical	O
axons	O
.	O
gene1s	O
Netrin	O
-	O
G1	O
gene1e	O
is	O
a	O
lipid	O
-	O
anchored	O
protein	O
that	O
is	O
structurally	O
related	O
to	O
the	O
netrin	O
family	O
of	O
axon	O
guidance	O
molecules	O
.	O
gene1s	O
Netrin	O
-	O
G1	O
gene1e	O
does	O
not	O
bind	O
any	O
of	O
the	O
known	O
netrin	O
receptors	O
and	O
its	O
function	O
is	O
not	O
known	O
.	O
Here	O
we	O
identify	O
species1s	O
human	O
species1e	O
gene1s	O
netrin	O
-	O
G1	O
ligand	O
gene1e	O
(	O
gene1s	O
NGL-1	O
gene1e	O
)	O
,	O
a	O
transmembrane	O
protein	O
containing	O
leucine	O
-	O
rich	O
repeat	O
(	O
LRR	O
)	O
and	O
immunoglobulin	O
(	O
Ig	O
)	O
domains	O
that	O
specifically	O
interacts	O
with	O
gene1s	O
netrin	O
-	O
G1	O
gene1e	O
through	O
its	O
LRR	O
region	O
.	O
Whereas	O
gene1s	ARG2
netrin	ARG2
-	ARG2
G1	ARG2
gene1e	ARG2
is	O
expressed	O
highly	O
in	O
arg1s	O
mouse	O
arg1e	O
thalamic	O
axons	O
,	O
gene1s	ARG2
NGL-1	ARG2
gene1e	ARG2
is	O
most	O
abundant	O
in	O
the	O
striatum	O
and	O
the	O
cerebral	O
cortex	O
--	O
the	O
intermediate	O
and	O
final	O
targets	O
,	O
respectively	O
,	O
of	O
thalamocortical	O
axons	O
(	O
TCAs	O
)	O
.	O
Surface	O
-	O
bound	O
gene1s	O
NGL-1	O
gene1e	O
stimulates	O
,	O
but	O
soluble	O
gene1s	O
NGL-1	O
gene1e	O
disrupts	O
,	O
the	O
growth	O
of	O
embryonic	O
thalamic	O
axons	O
,	O
and	O
in	O
vitro	O
data	O
indicate	O
that	O
gene1s	O
NGL-1	O
gene1e	O
activity	O
may	O
be	O
mediated	O
at	O
least	O
partially	O
by	O
gene1s	O
netrin	O
-	O
G1	O
gene1e	O
.	O
Our	O
findings	O
provide	O
evidence	O
that	O
gene1s	O
netrin	O
-	O
G1	O
gene1e	O
functions	O
as	O
an	O
important	O
component	O
of	O
the	O
gene1s	O
NGL-1	O
gene1e	O
receptor	O
to	O
promote	O
TCA	O
outgrowth	O
and	O
that	O
membrane	O
-	O
bound	O
netrins	O
can	O
participate	O
in	O
receiving	O
axonal	O
signaling	O
pathways	O
.	O

gene1s	ARG2
TACC1	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
chTOG	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Aurora	ARG2
A	ARG2
gene1e	ARG2
protein	O
complex	O
in	O
breast	O
cancer	O
.	O
The	O
three	O
arg1s	O
human	O
arg1e	O
TACC	O
(	O
transforming	O
acidic	O
coiled	O
-	O
coil	O
)	O
genes	O
encode	O
a	O
family	O
of	O
proteins	O
with	O
poorly	O
defined	O
functions	O
that	O
are	O
suspected	O
to	O
play	O
a	O
role	O
in	O
oncogenesis	O
.	O
A	O
species1s	O
Xenopus	O
species1e	O
TACC	O
homolog	O
called	O
Maskin	O
is	O
involved	O
in	O
translational	O
control	O
,	O
while	O
species1s	O
Drosophila	O
species1e	O
D	O
-	O
TACC	O
interacts	O
with	O
the	O
microtubule	O
-	O
associated	O
protein	O
gene1s	O
MSPS	O
gene1e	O
(	O
gene1s	O
Mini	O
SPindleS	O
gene1e	O
)	O
to	O
ensure	O
proper	O
dynamics	O
of	O
spindle	O
pole	O
microtubules	O
during	O
cell	O
division	O
.	O
We	O
have	O
delineated	O
here	O
the	O
interactions	O
of	O
gene1s	ARG2
TACC1	ARG2
gene1e	ARG2
with	O
four	O
proteins	O
,	O
namely	O
the	O
microtubule	O
-	O
associated	O
gene1s	ARG2
chTOG	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
colonic	ARG2
and	ARG2
hepatic	ARG2
tumor	ARG2
-	ARG2
overexpressed	ARG2
gene	ARG2
gene1e	ARG2
)	O
protein	O
(	O
ortholog	O
of	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
MSPS	O
gene1e	O
)	O
,	O
the	O
adaptor	O
protein	O
gene1s	ARG2
TRAP	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
tudor	ARG2
repeat	ARG2
associator	ARG2
with	ARG2
PCTAIRE2	ARG2
gene1e	ARG2
)	O
,	O
the	O
mitotic	O
serine	O
/	O
threonine	O
kinase	O
gene1s	ARG2
Aurora	ARG2
A	ARG2
gene1e	ARG2
and	O
the	O
mRNA	O
regulator	O
gene1s	ARG2
LSM7	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Like	ARG2
-	ARG2
Sm	ARG2
protein	ARG2
7	ARG2
gene1e	ARG2
)	O
.	O
To	O
measure	O
the	O
relevance	O
of	O
the	O
gene1s	ARG2
TACC1	ARG2
gene1e	ARG2
-associated	O
complex	O
in	O
arg1s	O
human	O
arg1e	O
cancer	O
we	O
have	O
examined	O
the	O
expression	O
of	O
the	O
three	O
TACC	O
,	O
gene1s	ARG2
chTOG	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Aurora	ARG2
A	ARG2
gene1e	ARG2
in	O
breast	O
cancer	O
using	O
immunohistochemistry	O
on	O
tissue	O
microarrays	O
.	O
We	O
show	O
that	O
expressions	O
of	O
gene1s	ARG2
TACC1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TACC2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TACC3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Aurora	ARG2
A	ARG2
gene1e	ARG2
are	O
significantly	O
correlated	O
and	O
downregulated	O
in	O
a	O
subset	O
of	O
breast	O
tumors	O
.	O
Using	O
siRNAs	O
,	O
we	O
further	O
show	O
that	O
depletion	O
of	O
gene1s	ARG2
chTOG	ARG2
gene1e	ARG2
and	O
,	O
to	O
a	O
lesser	O
extent	O
of	O
gene1s	ARG2
TACC1	ARG2
gene1e	ARG2
,	O
perturbates	O
cell	O
division	O
.	O
We	O
propose	O
that	O
TACC	O
proteins	O
,	O
which	O
we	O
also	O
named	O
'	O
Taxins	O
'	O
,	O
control	O
mRNA	O
translation	O
and	O
cell	O
division	O
in	O
conjunction	O
with	O
microtubule	O
organization	O
and	O
in	O
association	O
with	O
gene1s	ARG2
chTOG	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Aurora	ARG2
A	ARG2
gene1e	ARG2
,	O
and	O
that	O
these	O
complexes	O
and	O
cell	O
processes	O
may	O
be	O
affected	O
during	O
mammary	O
gland	O
oncogenesis	O
.	O

gene1s	O
TACC1	O
gene1e	O
-	O
gene1s	O
chTOG	O
gene1e	O
-	O
gene1s	O
Aurora	O
A	O
gene1e	O
protein	O
complex	O
in	O
breast	O
cancer	O
.	O
The	O
three	O
species1s	O
human	O
species1e	O
TACC	O
(	O
transforming	O
acidic	O
coiled	O
-	O
coil	O
)	O
genes	O
encode	O
a	O
family	O
of	O
proteins	O
with	O
poorly	O
defined	O
functions	O
that	O
are	O
suspected	O
to	O
play	O
a	O
role	O
in	O
oncogenesis	O
.	O
A	O
arg1s	O
Xenopus	O
arg1e	O
TACC	O
homolog	O
called	O
Maskin	O
is	O
involved	O
in	O
translational	O
control	O
,	O
while	O
species1s	O
Drosophila	O
species1e	O
D	O
-	O
TACC	O
interacts	O
with	O
the	O
microtubule	O
-	O
associated	O
protein	O
gene1s	O
MSPS	O
gene1e	O
(	O
gene1s	O
Mini	O
SPindleS	O
gene1e	O
)	O
to	O
ensure	O
proper	O
dynamics	O
of	O
spindle	O
pole	O
microtubules	O
during	O
cell	O
division	O
.	O
We	O
have	O
delineated	O
here	O
the	O
interactions	O
of	O
gene1s	O
TACC1	O
gene1e	O
with	O
four	O
proteins	O
,	O
namely	O
the	O
microtubule	O
-	O
associated	O
gene1s	O
chTOG	O
gene1e	O
(	O
gene1s	O
colonic	O
and	O
hepatic	O
tumor	O
-	O
overexpressed	O
gene	O
gene1e	O
)	O
protein	O
(	O
ortholog	O
of	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
MSPS	O
gene1e	O
)	O
,	O
the	O
adaptor	O
protein	O
gene1s	O
TRAP	O
gene1e	O
(	O
gene1s	O
tudor	O
repeat	O
associator	O
with	O
PCTAIRE2	O
gene1e	O
)	O
,	O
the	O
mitotic	O
serine	O
/	O
threonine	O
kinase	O
gene1s	O
Aurora	O
A	O
gene1e	O
and	O
the	O
mRNA	O
regulator	O
gene1s	O
LSM7	O
gene1e	O
(	O
gene1s	O
Like	O
-	O
Sm	O
protein	O
7	O
gene1e	O
)	O
.	O
To	O
measure	O
the	O
relevance	O
of	O
the	O
gene1s	O
TACC1	O
gene1e	O
-associated	O
complex	O
in	O
species1s	O
human	O
species1e	O
cancer	O
we	O
have	O
examined	O
the	O
expression	O
of	O
the	O
three	O
TACC	O
,	O
gene1s	O
chTOG	O
gene1e	O
and	O
gene1s	O
Aurora	O
A	O
gene1e	O
in	O
breast	O
cancer	O
using	O
immunohistochemistry	O
on	O
tissue	O
microarrays	O
.	O
We	O
show	O
that	O
expressions	O
of	O
gene1s	O
TACC1	O
gene1e	O
,	O
gene1s	O
TACC2	O
gene1e	O
,	O
gene1s	O
TACC3	O
gene1e	O
and	O
gene1s	O
Aurora	O
A	O
gene1e	O
are	O
significantly	O
correlated	O
and	O
downregulated	O
in	O
a	O
subset	O
of	O
breast	O
tumors	O
.	O
Using	O
siRNAs	O
,	O
we	O
further	O
show	O
that	O
depletion	O
of	O
gene1s	O
chTOG	O
gene1e	O
and	O
,	O
to	O
a	O
lesser	O
extent	O
of	O
gene1s	O
TACC1	O
gene1e	O
,	O
perturbates	O
cell	O
division	O
.	O
We	O
propose	O
that	O
TACC	O
proteins	O
,	O
which	O
we	O
also	O
named	O
'	O
Taxins	O
'	O
,	O
control	O
mRNA	O
translation	O
and	O
cell	O
division	O
in	O
conjunction	O
with	O
microtubule	O
organization	O
and	O
in	O
association	O
with	O
gene1s	O
chTOG	O
gene1e	O
and	O
gene1s	O
Aurora	O
A	O
gene1e	O
,	O
and	O
that	O
these	O
complexes	O
and	O
cell	O
processes	O
may	O
be	O
affected	O
during	O
mammary	O
gland	O
oncogenesis	O
.	O

gene1s	O
TACC1	O
gene1e	O
-	O
gene1s	O
chTOG	O
gene1e	O
-	O
gene1s	O
Aurora	O
A	O
gene1e	O
protein	O
complex	O
in	O
breast	O
cancer	O
.	O
The	O
three	O
species1s	O
human	O
species1e	O
TACC	O
(	O
transforming	O
acidic	O
coiled	O
-	O
coil	O
)	O
genes	O
encode	O
a	O
family	O
of	O
proteins	O
with	O
poorly	O
defined	O
functions	O
that	O
are	O
suspected	O
to	O
play	O
a	O
role	O
in	O
oncogenesis	O
.	O
A	O
species1s	O
Xenopus	O
species1e	O
TACC	O
homolog	O
called	O
Maskin	O
is	O
involved	O
in	O
translational	O
control	O
,	O
while	O
arg1s	O
Drosophila	O
arg1e	O
D	O
-	O
TACC	O
interacts	O
with	O
the	O
microtubule	O
-	O
associated	O
protein	O
gene1s	ARG2
MSPS	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Mini	ARG2
SPindleS	ARG2
gene1e	ARG2
)	O
to	O
ensure	O
proper	O
dynamics	O
of	O
spindle	O
pole	O
microtubules	O
during	O
cell	O
division	O
.	O
We	O
have	O
delineated	O
here	O
the	O
interactions	O
of	O
gene1s	O
TACC1	O
gene1e	O
with	O
four	O
proteins	O
,	O
namely	O
the	O
microtubule	O
-	O
associated	O
gene1s	O
chTOG	O
gene1e	O
(	O
gene1s	O
colonic	O
and	O
hepatic	O
tumor	O
-	O
overexpressed	O
gene	O
gene1e	O
)	O
protein	O
(	O
ortholog	O
of	O
arg1s	O
Drosophila	O
arg1e	O
gene1s	ARG2
MSPS	ARG2
gene1e	ARG2
)	O
,	O
the	O
adaptor	O
protein	O
gene1s	O
TRAP	O
gene1e	O
(	O
gene1s	O
tudor	O
repeat	O
associator	O
with	O
PCTAIRE2	O
gene1e	O
)	O
,	O
the	O
mitotic	O
serine	O
/	O
threonine	O
kinase	O
gene1s	O
Aurora	O
A	O
gene1e	O
and	O
the	O
mRNA	O
regulator	O
gene1s	O
LSM7	O
gene1e	O
(	O
gene1s	O
Like	O
-	O
Sm	O
protein	O
7	O
gene1e	O
)	O
.	O
To	O
measure	O
the	O
relevance	O
of	O
the	O
gene1s	O
TACC1	O
gene1e	O
-associated	O
complex	O
in	O
species1s	O
human	O
species1e	O
cancer	O
we	O
have	O
examined	O
the	O
expression	O
of	O
the	O
three	O
TACC	O
,	O
gene1s	O
chTOG	O
gene1e	O
and	O
gene1s	O
Aurora	O
A	O
gene1e	O
in	O
breast	O
cancer	O
using	O
immunohistochemistry	O
on	O
tissue	O
microarrays	O
.	O
We	O
show	O
that	O
expressions	O
of	O
gene1s	O
TACC1	O
gene1e	O
,	O
gene1s	O
TACC2	O
gene1e	O
,	O
gene1s	O
TACC3	O
gene1e	O
and	O
gene1s	O
Aurora	O
A	O
gene1e	O
are	O
significantly	O
correlated	O
and	O
downregulated	O
in	O
a	O
subset	O
of	O
breast	O
tumors	O
.	O
Using	O
siRNAs	O
,	O
we	O
further	O
show	O
that	O
depletion	O
of	O
gene1s	O
chTOG	O
gene1e	O
and	O
,	O
to	O
a	O
lesser	O
extent	O
of	O
gene1s	O
TACC1	O
gene1e	O
,	O
perturbates	O
cell	O
division	O
.	O
We	O
propose	O
that	O
TACC	O
proteins	O
,	O
which	O
we	O
also	O
named	O
'	O
Taxins	O
'	O
,	O
control	O
mRNA	O
translation	O
and	O
cell	O
division	O
in	O
conjunction	O
with	O
microtubule	O
organization	O
and	O
in	O
association	O
with	O
gene1s	O
chTOG	O
gene1e	O
and	O
gene1s	O
Aurora	O
A	O
gene1e	O
,	O
and	O
that	O
these	O
complexes	O
and	O
cell	O
processes	O
may	O
be	O
affected	O
during	O
mammary	O
gland	O
oncogenesis	O
.	O

gene1s	ARG2
US11	ARG2
gene1e	ARG2
of	O
arg1s	O
herpes	O
simplex	O
virus	O
type	O
1	O
arg1e	O
interacts	O
with	O
gene1s	O
HIPK2	O
gene1e	O
and	O
antagonizes	O
gene1s	O
HIPK2	O
gene1e	O
-induced	O
cell	O
growth	O
arrest	O
.	O
gene1s	O
Homeodomain	O
-	O
interacting	O
protein	O
kinase	O
2	O
gene1e	O
(	O
gene1s	O
HIPK2	O
gene1e	O
)	O
is	O
a	O
nuclear	O
serine	O
/	O
threonine	O
kinase	O
of	O
the	O
subfamily	O
of	O
dual	O
-	O
specificity	O
Yak1-related	O
kinase	O
proteins	O
.	O
gene1s	O
HIPK2	O
gene1e	O
was	O
first	O
described	O
as	O
a	O
homeodomain	O
-	O
interacting	O
protein	O
kinase	O
acting	O
as	O
a	O
corepressor	O
for	O
homeodomain	O
transcription	O
factors	O
.	O
More	O
recently	O
,	O
it	O
was	O
reported	O
that	O
gene1s	O
HIPK2	O
gene1e	O
plays	O
a	O
role	O
in	O
gene1s	O
p53	O
gene1e	O
-mediated	O
cellular	O
apoptosis	O
and	O
could	O
also	O
participate	O
in	O
the	O
regulation	O
of	O
the	O
cell	O
cycle	O
.	O
gene1s	ARG2
US11	ARG2
gene1e	ARG2
protein	O
of	O
arg1s	O
herpes	O
simplex	O
virus	O
type	O
1	O
arg1e	O
is	O
a	O
multifunctional	O
protein	O
involved	O
in	O
the	O
regulation	O
of	O
several	O
processes	O
related	O
to	O
the	O
survival	O
of	O
cells	O
submitted	O
to	O
environmental	O
stresses	O
by	O
mechanisms	O
that	O
are	O
not	O
fully	O
elucidated	O
.	O
In	O
an	O
attempt	O
to	O
better	O
understand	O
the	O
multiple	O
functions	O
of	O
gene1s	ARG2
US11	ARG2
gene1e	ARG2
,	O
we	O
identified	O
cellular	O
binding	O
partners	O
of	O
this	O
protein	O
by	O
using	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
.	O
We	O
report	O
that	O
gene1s	ARG2
US11	ARG2
gene1e	ARG2
interacts	O
with	O
gene1s	O
HIPK2	O
gene1e	O
through	O
the	O
PEST	O
domain	O
of	O
gene1s	O
HIPK2	O
gene1e	O
and	O
that	O
this	O
interaction	O
occurs	O
also	O
in	O
species1s	O
human	O
species1e	O
cells	O
.	O
This	O
interaction	O
modifies	O
the	O
subcellular	O
distribution	O
of	O
gene1s	O
HIPK2	O
gene1e	O
and	O
protects	O
the	O
cell	O
against	O
the	O
gene1s	O
HIPK2	O
gene1e	O
-induced	O
cell	O
growth	O
arrest	O
.	O

gene1s	O
US11	O
gene1e	O
of	O
species1s	O
herpes	O
simplex	O
virus	O
type	O
1	O
species1e	O
interacts	O
with	O
gene1s	ARG2
HIPK2	ARG2
gene1e	ARG2
and	O
antagonizes	O
gene1s	ARG2
HIPK2	ARG2
gene1e	ARG2
-induced	O
cell	O
growth	O
arrest	O
.	O
gene1s	ARG2
Homeodomain	ARG2
-	ARG2
interacting	ARG2
protein	ARG2
kinase	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
HIPK2	ARG2
gene1e	ARG2
)	O
is	O
a	O
nuclear	O
serine	O
/	O
threonine	O
kinase	O
of	O
the	O
subfamily	O
of	O
dual	O
-	O
specificity	O
Yak1-related	O
kinase	O
proteins	O
.	O
gene1s	ARG2
HIPK2	ARG2
gene1e	ARG2
was	O
first	O
described	O
as	O
a	O
homeodomain	O
-	O
interacting	O
protein	O
kinase	O
acting	O
as	O
a	O
corepressor	O
for	O
homeodomain	O
transcription	O
factors	O
.	O
More	O
recently	O
,	O
it	O
was	O
reported	O
that	O
gene1s	ARG2
HIPK2	ARG2
gene1e	ARG2
plays	O
a	O
role	O
in	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
-mediated	O
cellular	O
apoptosis	O
and	O
could	O
also	O
participate	O
in	O
the	O
regulation	O
of	O
the	O
cell	O
cycle	O
.	O
gene1s	O
US11	O
gene1e	O
protein	O
of	O
species1s	O
herpes	O
simplex	O
virus	O
type	O
1	O
species1e	O
is	O
a	O
multifunctional	O
protein	O
involved	O
in	O
the	O
regulation	O
of	O
several	O
processes	O
related	O
to	O
the	O
survival	O
of	O
cells	O
submitted	O
to	O
environmental	O
stresses	O
by	O
mechanisms	O
that	O
are	O
not	O
fully	O
elucidated	O
.	O
In	O
an	O
attempt	O
to	O
better	O
understand	O
the	O
multiple	O
functions	O
of	O
gene1s	O
US11	O
gene1e	O
,	O
we	O
identified	O
cellular	O
binding	O
partners	O
of	O
this	O
protein	O
by	O
using	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
.	O
We	O
report	O
that	O
gene1s	O
US11	O
gene1e	O
interacts	O
with	O
gene1s	ARG2
HIPK2	ARG2
gene1e	ARG2
through	O
the	O
PEST	O
domain	O
of	O
gene1s	ARG2
HIPK2	ARG2
gene1e	ARG2
and	O
that	O
this	O
interaction	O
occurs	O
also	O
in	O
arg1s	O
human	O
arg1e	O
cells	O
.	O
This	O
interaction	O
modifies	O
the	O
subcellular	O
distribution	O
of	O
gene1s	ARG2
HIPK2	ARG2
gene1e	ARG2
and	O
protects	O
the	O
cell	O
against	O
the	O
gene1s	ARG2
HIPK2	ARG2
gene1e	ARG2
-induced	O
cell	O
growth	O
arrest	O
.	O

A	O
novel	O
IL-1	O
receptor	O
,	O
cloned	O
from	O
B	O
cells	O
by	O
arg1s	O
mammalian	O
arg1e	O
expression	O
,	O
is	O
expressed	O
in	O
many	O
cell	O
types	O
.	O
cDNA	O
clones	O
corresponding	O
to	O
an	O
Mr	O
approximately	O
80,000	O
receptor	O
gene1s	ARG2
(	ARG2
type	ARG2
I	ARG2
receptor	ARG2
)	ARG2
for	ARG2
interleukin-1	ARG2
(	ARG2
IL-1	ARG2
)	ARG2
gene1e	ARG2
have	O
been	O
isolated	O
previously	O
by	O
arg1s	O
mammalian	O
arg1e	O
expression	O
.	O
Here	O
,	O
we	O
report	O
the	O
use	O
of	O
an	O
improved	O
expression	O
cloning	O
method	O
to	O
isolate	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
murine	O
species1e	O
cDNA	O
clones	O
encoding	O
gene1s	ARG2
a	ARG2
second	ARG2
type	ARG2
(	ARG2
Mr	ARG2
approximately	ARG2
60,000	ARG2
)	ARG2
of	ARG2
IL-1	ARG2
receptor	ARG2
(	ARG2
type	ARG2
II	ARG2
receptor	ARG2
)	ARG2
gene1e	ARG2
.	O
The	O
mature	O
gene1s	ARG2
type	ARG2
II	ARG2
IL-1	ARG2
receptor	ARG2
gene1e	ARG2
consists	O
of	O
(	O
i	O
)	O
a	O
ligand	O
binding	O
portion	O
comprised	O
of	O
three	O
immunoglobulin	O
-	O
like	O
domains	O
;	O
(	O
ii	O
)	O
a	O
single	O
transmembrane	O
region	O
;	O
and	O
(	O
iii	O
)	O
a	O
short	O
cytoplasmic	O
domain	O
of	O
29	O
amino	O
acids	O
.	O
This	O
last	O
contrasts	O
with	O
the	O
approximately	O
215	O
amino	O
acid	O
cytoplasmic	O
domain	O
of	O
the	O
type	O
I	O
receptor	O
,	O
and	O
suggests	O
that	O
the	O
two	O
IL-1	O
receptors	O
may	O
interact	O
with	O
different	O
signal	O
transduction	O
pathways	O
.	O
The	O
type	O
II	O
receptor	O
is	O
expressed	O
in	O
a	O
number	O
of	O
different	O
tissues	O
,	O
including	O
both	O
B	O
and	O
T	O
lymphocytes	O
,	O
and	O
can	O
be	O
induced	O
in	O
several	O
cell	O
types	O
by	O
treatment	O
with	O
phorbol	O
ester	O
.	O
Both	O
IL-1	O
receptors	O
appear	O
to	O
be	O
well	O
conserved	O
in	O
evolution	O
,	O
and	O
map	O
to	O
the	O
same	O
chromosomal	O
location	O
.	O
Like	O
the	O
type	O
I	O
receptor	O
,	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
type	ARG2
II	ARG2
IL-1	ARG2
receptor	ARG2
gene1e	ARG2
can	O
bind	O
all	O
three	O
forms	O
of	O
IL-1	O
(	O
gene1s	ARG2
IL-1	ARG2
alpha	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-1	ARG2
beta	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL-1ra	ARG2
gene1e	ARG2
)	O
.	O
species1s	O
Vaccinia	O
virus	O
species1e	O
contains	O
an	O
open	O
reading	O
frame	O
bearing	O
strong	O
resemblance	O
to	O
the	O
gene1s	ARG2
type	ARG2
II	ARG2
IL-1	ARG2
receptor	ARG2
gene1e	ARG2
.	O

A	O
novel	O
IL-1	O
receptor	O
,	O
cloned	O
from	O
B	O
cells	O
by	O
species1s	O
mammalian	O
species1e	O
expression	O
,	O
is	O
expressed	O
in	O
many	O
cell	O
types	O
.	O
cDNA	O
clones	O
corresponding	O
to	O
an	O
Mr	O
approximately	O
80,000	O
receptor	O
gene1s	O
(	O
type	O
I	O
receptor	O
)	O
for	O
interleukin-1	O
(	O
IL-1	O
)	O
gene1e	O
have	O
been	O
isolated	O
previously	O
by	O
species1s	O
mammalian	O
species1e	O
expression	O
.	O
Here	O
,	O
we	O
report	O
the	O
use	O
of	O
an	O
improved	O
expression	O
cloning	O
method	O
to	O
isolate	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
murine	O
arg1e	O
cDNA	O
clones	O
encoding	O
gene1s	O
a	O
second	O
type	O
(	O
Mr	O
approximately	O
60,000	O
)	O
of	O
IL-1	O
receptor	O
(	O
type	O
II	O
receptor	O
)	O
gene1e	O
.	O
The	O
mature	O
gene1s	O
type	O
II	O
IL-1	O
receptor	O
gene1e	O
consists	O
of	O
(	O
i	O
)	O
a	O
ligand	O
binding	O
portion	O
comprised	O
of	O
three	O
immunoglobulin	O
-	O
like	O
domains	O
;	O
(	O
ii	O
)	O
a	O
single	O
transmembrane	O
region	O
;	O
and	O
(	O
iii	O
)	O
a	O
short	O
cytoplasmic	O
domain	O
of	O
29	O
amino	O
acids	O
.	O
This	O
last	O
contrasts	O
with	O
the	O
approximately	O
215	O
amino	O
acid	O
cytoplasmic	O
domain	O
of	O
the	O
type	O
I	O
receptor	O
,	O
and	O
suggests	O
that	O
the	O
two	O
IL-1	O
receptors	O
may	O
interact	O
with	O
different	O
signal	O
transduction	O
pathways	O
.	O
The	O
type	O
II	O
receptor	O
is	O
expressed	O
in	O
a	O
number	O
of	O
different	O
tissues	O
,	O
including	O
both	O
B	O
and	O
T	O
lymphocytes	O
,	O
and	O
can	O
be	O
induced	O
in	O
several	O
cell	O
types	O
by	O
treatment	O
with	O
phorbol	O
ester	O
.	O
Both	O
IL-1	O
receptors	O
appear	O
to	O
be	O
well	O
conserved	O
in	O
evolution	O
,	O
and	O
map	O
to	O
the	O
same	O
chromosomal	O
location	O
.	O
Like	O
the	O
type	O
I	O
receptor	O
,	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
type	O
II	O
IL-1	O
receptor	O
gene1e	O
can	O
bind	O
all	O
three	O
forms	O
of	O
IL-1	O
(	O
gene1s	O
IL-1	O
alpha	O
gene1e	O
,	O
gene1s	O
IL-1	O
beta	O
gene1e	O
and	O
gene1s	O
IL-1ra	O
gene1e	O
)	O
.	O
species1s	O
Vaccinia	O
virus	O
species1e	O
contains	O
an	O
open	O
reading	O
frame	O
bearing	O
strong	O
resemblance	O
to	O
the	O
gene1s	O
type	O
II	O
IL-1	O
receptor	O
gene1e	O
.	O

A	O
novel	O
IL-1	O
receptor	O
,	O
cloned	O
from	O
B	O
cells	O
by	O
species1s	O
mammalian	O
species1e	O
expression	O
,	O
is	O
expressed	O
in	O
many	O
cell	O
types	O
.	O
cDNA	O
clones	O
corresponding	O
to	O
an	O
Mr	O
approximately	O
80,000	O
receptor	O
gene1s	O
(	O
type	O
I	O
receptor	O
)	O
for	O
interleukin-1	O
(	O
IL-1	O
)	O
gene1e	O
have	O
been	O
isolated	O
previously	O
by	O
species1s	O
mammalian	O
species1e	O
expression	O
.	O
Here	O
,	O
we	O
report	O
the	O
use	O
of	O
an	O
improved	O
expression	O
cloning	O
method	O
to	O
isolate	O
species1s	O
human	O
species1e	O
and	O
species1s	O
murine	O
species1e	O
cDNA	O
clones	O
encoding	O
gene1s	O
a	O
second	O
type	O
(	O
Mr	O
approximately	O
60,000	O
)	O
of	O
IL-1	O
receptor	O
(	O
type	O
II	O
receptor	O
)	O
gene1e	O
.	O
The	O
mature	O
gene1s	O
type	O
II	O
IL-1	O
receptor	O
gene1e	O
consists	O
of	O
(	O
i	O
)	O
a	O
ligand	O
binding	O
portion	O
comprised	O
of	O
three	O
immunoglobulin	O
-	O
like	O
domains	O
;	O
(	O
ii	O
)	O
a	O
single	O
transmembrane	O
region	O
;	O
and	O
(	O
iii	O
)	O
a	O
short	O
cytoplasmic	O
domain	O
of	O
29	O
amino	O
acids	O
.	O
This	O
last	O
contrasts	O
with	O
the	O
approximately	O
215	O
amino	O
acid	O
cytoplasmic	O
domain	O
of	O
the	O
type	O
I	O
receptor	O
,	O
and	O
suggests	O
that	O
the	O
two	O
IL-1	O
receptors	O
may	O
interact	O
with	O
different	O
signal	O
transduction	O
pathways	O
.	O
The	O
type	O
II	O
receptor	O
is	O
expressed	O
in	O
a	O
number	O
of	O
different	O
tissues	O
,	O
including	O
both	O
B	O
and	O
T	O
lymphocytes	O
,	O
and	O
can	O
be	O
induced	O
in	O
several	O
cell	O
types	O
by	O
treatment	O
with	O
phorbol	O
ester	O
.	O
Both	O
IL-1	O
receptors	O
appear	O
to	O
be	O
well	O
conserved	O
in	O
evolution	O
,	O
and	O
map	O
to	O
the	O
same	O
chromosomal	O
location	O
.	O
Like	O
the	O
type	O
I	O
receptor	O
,	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
type	O
II	O
IL-1	O
receptor	O
gene1e	O
can	O
bind	O
all	O
three	O
forms	O
of	O
IL-1	O
(	O
gene1s	O
IL-1	O
alpha	O
gene1e	O
,	O
gene1s	O
IL-1	O
beta	O
gene1e	O
and	O
gene1s	O
IL-1ra	O
gene1e	O
)	O
.	O
arg1s	O
Vaccinia	O
virus	O
arg1e	O
contains	O
an	O
open	O
reading	O
frame	O
bearing	O
strong	O
resemblance	O
to	O
the	O
gene1s	O
type	O
II	O
IL-1	O
receptor	O
gene1e	O
.	O

cDNA	O
cloning	O
and	O
expression	O
of	O
two	O
new	O
members	O
of	O
the	O
arg1s	O
human	O
arg1e	O
liver	O
UDP	O
-	O
glucuronosyltransferase	O
2B	O
subfamily	O
.	O
Two	O
new	O
UDP	O
-	O
glucuronosyltransferase	O
cDNAs	O
,	O
designated	O
gene1s	ARG2
UGT2B10	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
UGT2B11	ARG2
gene1e	ARG2
,	O
encoding	O
528	O
amino	O
acid	O
proteins	O
were	O
isolated	O
from	O
a	O
arg1s	O
human	O
arg1e	O
liver	O
cDNA	O
library	O
.	O
The	O
deduced	O
amino	O
acid	O
sequences	O
of	O
gene1s	ARG2
UGTs	ARG2
2B10	ARG2
and	ARG2
2B11	ARG2
gene1e	ARG2
share	O
>	O
76	O
%	O
sequence	O
similarity	O
with	O
other	O
known	O
arg1s	O
human	O
arg1e	O
liver	O
UGT2B	O
subfamily	O
isoforms	O
and	O
<	O
48	O
%	O
sequence	O
similarity	O
with	O
UGT1	O
family	O
proteins	O
.	O
species1s	O
COS-7	O
species1e	O
cells	O
transfected	O
with	O
gene1s	ARG2
UGT	ARG2
2B10	ARG2
and	ARG2
2B11	ARG2
gene1e	ARG2
synthesized	O
proteins	O
with	O
respective	O
molecular	O
masses	O
of	O
49kDa	O
and	O
51kDa	O
.	O
gene1s	ARG2
UGT2B11	ARG2
gene1e	ARG2
expressed	O
in	O
species1s	O
COS-7	O
species1e	O
cells	O
glucuronidated	O
a	O
number	O
of	O
polyhydroxylated	O
estrogens	O
(	O
estriol	O
,	O
4-hydroxyestrone	O
and	O
2-hydroxyestriol	O
)	O
and	O
xenobiotics	O
(	O
4-methylumbelliferone	O
,	O
1-naphthol	O
,	O
4-nitrophenol	O
,	O
2-aminophenol	O
,	O
4-hydroxybiphenyl	O
and	O
menthol	O
)	O
.	O
Despite	O
the	O
screening	O
of	O
more	O
than	O
forty	O
potential	O
substrates	O
,	O
glucuronidation	O
activity	O
was	O
not	O
observed	O
for	O
expressed	O
gene1s	ARG2
UGT2B10	ARG2
gene1e	ARG2
.	O

cDNA	O
cloning	O
and	O
expression	O
of	O
two	O
new	O
members	O
of	O
the	O
species1s	O
human	O
species1e	O
liver	O
UDP	O
-	O
glucuronosyltransferase	O
2B	O
subfamily	O
.	O
Two	O
new	O
UDP	O
-	O
glucuronosyltransferase	O
cDNAs	O
,	O
designated	O
gene1s	O
UGT2B10	O
gene1e	O
and	O
gene1s	O
UGT2B11	O
gene1e	O
,	O
encoding	O
528	O
amino	O
acid	O
proteins	O
were	O
isolated	O
from	O
a	O
species1s	O
human	O
species1e	O
liver	O
cDNA	O
library	O
.	O
The	O
deduced	O
amino	O
acid	O
sequences	O
of	O
gene1s	O
UGTs	O
2B10	O
and	O
2B11	O
gene1e	O
share	O
>	O
76	O
%	O
sequence	O
similarity	O
with	O
other	O
known	O
species1s	O
human	O
species1e	O
liver	O
UGT2B	O
subfamily	O
isoforms	O
and	O
<	O
48	O
%	O
sequence	O
similarity	O
with	O
UGT1	O
family	O
proteins	O
.	O
arg1s	O
COS-7	O
arg1e	O
cells	O
transfected	O
with	O
gene1s	O
UGT	O
2B10	O
and	O
2B11	O
gene1e	O
synthesized	O
proteins	O
with	O
respective	O
molecular	O
masses	O
of	O
49kDa	O
and	O
51kDa	O
.	O
gene1s	O
UGT2B11	O
gene1e	O
expressed	O
in	O
arg1s	O
COS-7	O
arg1e	O
cells	O
glucuronidated	O
a	O
number	O
of	O
polyhydroxylated	O
estrogens	O
(	O
estriol	O
,	O
4-hydroxyestrone	O
and	O
2-hydroxyestriol	O
)	O
and	O
xenobiotics	O
(	O
4-methylumbelliferone	O
,	O
1-naphthol	O
,	O
4-nitrophenol	O
,	O
2-aminophenol	O
,	O
4-hydroxybiphenyl	O
and	O
menthol	O
)	O
.	O
Despite	O
the	O
screening	O
of	O
more	O
than	O
forty	O
potential	O
substrates	O
,	O
glucuronidation	O
activity	O
was	O
not	O
observed	O
for	O
expressed	O
gene1s	O
UGT2B10	O
gene1e	O
.	O

Isolation	O
and	O
characterization	O
of	O
cDNA	O
clones	O
for	O
gene1s	ARG2
Humly9	ARG2
gene1e	ARG2
:	O
the	O
arg1s	O
human	O
arg1e	O
homologue	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	O
Ly9	O
gene1e	O
.	O
gene1s	O
Ly9	O
gene1e	O
is	O
a	O
species1s	O
mouse	O
species1e	O
cell	O
membrane	O
antigen	O
found	O
on	O
all	O
lymphocytes	O
and	O
coded	O
for	O
by	O
a	O
gene	O
that	O
maps	O
to	O
chromosome	O
1	O
.	O
We	O
previously	O
described	O
the	O
isolation	O
and	O
characterization	O
of	O
a	O
full	O
-	O
length	O
cDNA	O
clone	O
for	O
species1s	O
mouse	O
species1e	O
gene1s	O
Ly9	O
gene1e	O
.	O
Using	O
cross	O
-	O
species	O
hybridization	O
we	O
isolated	O
cDNA	O
clones	O
encoding	O
the	O
arg1s	O
human	O
arg1e	O
homologue	O
gene1s	ARG2
Humly9	ARG2
gene1e	ARG2
.	O
Analysis	O
of	O
the	O
predicted	O
protein	O
sequence	O
suggests	O
that	O
the	O
extra	O
-	O
cellular	O
portion	O
of	O
the	O
gene1s	ARG2
Humly9	ARG2
gene1e	ARG2
molecules	O
is	O
composed	O
of	O
four	O
Ig	O
-	O
like	O
domains	O
:	O
a	O
V	O
domain	O
(	O
V	O
)	O
without	O
disulphide	O
bonds	O
and	O
a	O
truncated	O
C2	O
domain	O
(	O
tC2	O
)	O
with	O
two	O
disulphide	O
bonds	O
,	O
a	O
second	O
V	O
domain	O
without	O
disulphide	O
bonds	O
and	O
a	O
second	O
tC2	O
with	O
two	O
disulphide	O
bonds	O
,	O
i.e.	O
,	O
as	O
V	O
-	O
tC2-V	O
-	O
tC2	O
.	O
The	O
gene	O
encoding	O
gene1s	ARG2
Humly9	ARG2
gene1e	ARG2
was	O
mapped	O
to	O
chromosome	O
1	O
by	O
analysis	O
of	O
arg1s	O
human	O
arg1e	O
/	O
species1s	O
hamster	O
species1e	O
hybrids	O
,	O
and	O
more	O
specifically	O
to	O
the	O
1q22	O
region	O
by	O
in	O
situ	O
hybridization	O
.	O
The	O
protein	O
sequence	O
data	O
support	O
the	O
view	O
that	O
gene1s	ARG2
Humly9	ARG2
gene1e	ARG2
belongs	O
to	O
the	O
immunoglobulin	O
-	O
superfamily	O
subgroup	O
which	O
includes	O
gene1s	ARG2
CD48	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
LFA-3	ARG2
gene1e	ARG2
.	O

Isolation	O
and	O
characterization	O
of	O
cDNA	O
clones	O
for	O
gene1s	O
Humly9	O
gene1e	O
:	O
the	O
species1s	O
human	O
species1e	O
homologue	O
of	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
Ly9	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
Ly9	ARG2
gene1e	ARG2
is	O
a	O
arg1s	O
mouse	O
arg1e	O
cell	O
membrane	O
antigen	O
found	O
on	O
all	O
lymphocytes	O
and	O
coded	O
for	O
by	O
a	O
gene	O
that	O
maps	O
to	O
chromosome	O
1	O
.	O
We	O
previously	O
described	O
the	O
isolation	O
and	O
characterization	O
of	O
a	O
full	O
-	O
length	O
cDNA	O
clone	O
for	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
Ly9	ARG2
gene1e	ARG2
.	O
Using	O
cross	O
-	O
species	O
hybridization	O
we	O
isolated	O
cDNA	O
clones	O
encoding	O
the	O
species1s	O
human	O
species1e	O
homologue	O
gene1s	O
Humly9	O
gene1e	O
.	O
Analysis	O
of	O
the	O
predicted	O
protein	O
sequence	O
suggests	O
that	O
the	O
extra	O
-	O
cellular	O
portion	O
of	O
the	O
gene1s	O
Humly9	O
gene1e	O
molecules	O
is	O
composed	O
of	O
four	O
Ig	O
-	O
like	O
domains	O
:	O
a	O
V	O
domain	O
(	O
V	O
)	O
without	O
disulphide	O
bonds	O
and	O
a	O
truncated	O
C2	O
domain	O
(	O
tC2	O
)	O
with	O
two	O
disulphide	O
bonds	O
,	O
a	O
second	O
V	O
domain	O
without	O
disulphide	O
bonds	O
and	O
a	O
second	O
tC2	O
with	O
two	O
disulphide	O
bonds	O
,	O
i.e.	O
,	O
as	O
V	O
-	O
tC2-V	O
-	O
tC2	O
.	O
The	O
gene	O
encoding	O
gene1s	O
Humly9	O
gene1e	O
was	O
mapped	O
to	O
chromosome	O
1	O
by	O
analysis	O
of	O
species1s	O
human	O
species1e	O
/	O
species1s	O
hamster	O
species1e	O
hybrids	O
,	O
and	O
more	O
specifically	O
to	O
the	O
1q22	O
region	O
by	O
in	O
situ	O
hybridization	O
.	O
The	O
protein	O
sequence	O
data	O
support	O
the	O
view	O
that	O
gene1s	O
Humly9	O
gene1e	O
belongs	O
to	O
the	O
immunoglobulin	O
-	O
superfamily	O
subgroup	O
which	O
includes	O
gene1s	O
CD48	O
gene1e	O
,	O
gene1s	O
CD2	O
gene1e	O
,	O
and	O
gene1s	O
LFA-3	O
gene1e	O
.	O

Isolation	O
and	O
characterization	O
of	O
cDNA	O
clones	O
for	O
gene1s	O
Humly9	O
gene1e	O
:	O
the	O
species1s	O
human	O
species1e	O
homologue	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	O
Ly9	O
gene1e	O
.	O
gene1s	O
Ly9	O
gene1e	O
is	O
a	O
species1s	O
mouse	O
species1e	O
cell	O
membrane	O
antigen	O
found	O
on	O
all	O
lymphocytes	O
and	O
coded	O
for	O
by	O
a	O
gene	O
that	O
maps	O
to	O
chromosome	O
1	O
.	O
We	O
previously	O
described	O
the	O
isolation	O
and	O
characterization	O
of	O
a	O
full	O
-	O
length	O
cDNA	O
clone	O
for	O
species1s	O
mouse	O
species1e	O
gene1s	O
Ly9	O
gene1e	O
.	O
Using	O
cross	O
-	O
species	O
hybridization	O
we	O
isolated	O
cDNA	O
clones	O
encoding	O
the	O
species1s	O
human	O
species1e	O
homologue	O
gene1s	O
Humly9	O
gene1e	O
.	O
Analysis	O
of	O
the	O
predicted	O
protein	O
sequence	O
suggests	O
that	O
the	O
extra	O
-	O
cellular	O
portion	O
of	O
the	O
gene1s	O
Humly9	O
gene1e	O
molecules	O
is	O
composed	O
of	O
four	O
Ig	O
-	O
like	O
domains	O
:	O
a	O
V	O
domain	O
(	O
V	O
)	O
without	O
disulphide	O
bonds	O
and	O
a	O
truncated	O
C2	O
domain	O
(	O
tC2	O
)	O
with	O
two	O
disulphide	O
bonds	O
,	O
a	O
second	O
V	O
domain	O
without	O
disulphide	O
bonds	O
and	O
a	O
second	O
tC2	O
with	O
two	O
disulphide	O
bonds	O
,	O
i.e.	O
,	O
as	O
V	O
-	O
tC2-V	O
-	O
tC2	O
.	O
The	O
gene	O
encoding	O
gene1s	O
Humly9	O
gene1e	O
was	O
mapped	O
to	O
chromosome	O
1	O
by	O
analysis	O
of	O
species1s	O
human	O
species1e	O
/	O
arg1s	O
hamster	O
arg1e	O
hybrids	O
,	O
and	O
more	O
specifically	O
to	O
the	O
1q22	O
region	O
by	O
in	O
situ	O
hybridization	O
.	O
The	O
protein	O
sequence	O
data	O
support	O
the	O
view	O
that	O
gene1s	O
Humly9	O
gene1e	O
belongs	O
to	O
the	O
immunoglobulin	O
-	O
superfamily	O
subgroup	O
which	O
includes	O
gene1s	O
CD48	O
gene1e	O
,	O
gene1s	O
CD2	O
gene1e	O
,	O
and	O
gene1s	O
LFA-3	O
gene1e	O
.	O

gene1s	ARG2
SM-20	ARG2
gene1e	ARG2
is	O
a	O
novel	O
40-kd	O
protein	O
whose	O
expression	O
in	O
the	O
arterial	O
wall	O
is	O
restricted	O
to	O
smooth	O
muscle	O
.	O
We	O
have	O
previously	O
reported	O
the	O
identification	O
of	O
a	O
novel	O
cDNA	O
,	O
gene1s	ARG2
SM-20	ARG2
gene1e	ARG2
,	O
whose	O
corresponding	O
mRNA	O
levels	O
are	O
regulated	O
by	O
growth	O
factors	O
in	O
arg1s	O
rat	O
arg1e	O
aortic	O
smooth	O
muscle	O
cell	O
(	O
SMC	O
)	O
culture	O
.	O
Affinity	O
-	O
purified	O
polyclonal	O
and	O
monoclonal	O
antibodies	O
were	O
made	O
against	O
a	O
230	O
amino	O
acid	O
region	O
of	O
the	O
gene1s	ARG2
SM-20	ARG2
gene1e	ARG2
putative	O
peptide	O
expressed	O
in	O
the	O
bacterial	O
vector	O
,	O
pET-3b	O
.	O
Western	O
blot	O
analyses	O
of	O
arg1s	O
rat	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
SMC	O
lysates	O
detected	O
a	O
single	O
protein	O
species	O
of	O
approximately	O
40	O
kd	O
.	O
gene1s	ARG2
SM-20	ARG2
gene1e	ARG2
was	O
not	O
detected	O
in	O
concentrates	O
of	O
the	O
culture	O
medium	O
.	O
By	O
immunohistochemistry	O
,	O
gene1s	ARG2
SM-20	ARG2
gene1e	ARG2
was	O
localized	O
to	O
filaments	O
in	O
the	O
cytoplasm	O
of	O
cultured	O
SMC	O
.	O
Like	O
gene1s	ARG2
SM-20	ARG2
gene1e	ARG2
mRNA	O
,	O
levels	O
of	O
gene1s	ARG2
SM-20	ARG2
gene1e	ARG2
protein	O
were	O
increased	O
1	O
-	O
3	O
hours	O
after	O
serum	O
stimulation	O
of	O
arg1s	O
rat	O
arg1e	O
aortic	O
SMC	O
.	O
In	O
arg1s	O
rat	O
arg1e	O
tissues	O
,	O
gene1s	ARG2
SM-20	ARG2
gene1e	ARG2
antigen	O
was	O
detected	O
in	O
abundance	O
in	O
smooth	O
,	O
cardiac	O
,	O
and	O
skeletal	O
muscle	O
.	O
gene1s	ARG2
SM-20	ARG2
gene1e	ARG2
was	O
also	O
detected	O
in	O
some	O
epithelial	O
cells	O
of	O
the	O
kidney	O
,	O
pancreas	O
,	O
gastrointestinal	O
tract	O
,	O
and	O
skin	O
,	O
but	O
was	O
not	O
found	O
in	O
the	O
parenchyma	O
of	O
the	O
liver	O
,	O
spleen	O
,	O
or	O
testis	O
.	O
In	O
the	O
arg1s	O
rat	O
arg1e	O
arterial	O
wall	O
,	O
gene1s	ARG2
SM-20	ARG2
gene1e	ARG2
antigen	O
was	O
restricted	O
to	O
the	O
SMC	O
of	O
the	O
media	O
and	O
,	O
after	O
balloon	O
arterial	O
injury	O
,	O
was	O
found	O
most	O
abundantly	O
in	O
the	O
neointima	O
.	O
In	O
species1s	O
human	O
species1e	O
atherosclerotic	O
coronary	O
arteries	O
,	O
gene1s	O
SM-20	O
gene1e	O
antigen	O
predominated	O
in	O
the	O
SMC	O
of	O
the	O
intimal	O
plaques	O
and	O
was	O
not	O
detected	O
in	O
macrophages	O
,	O
endothelium	O
,	O
or	O
adventitial	O
cells	O
.	O
Thus	O
,	O
gene1s	O
SM-20	O
gene1e	O
encodes	O
a	O
protein	O
which	O
serves	O
as	O
a	O
novel	O
SMC	O
-	O
specific	O
marker	O
within	O
the	O
vessel	O
wall	O
.	O

gene1s	O
SM-20	O
gene1e	O
is	O
a	O
novel	O
40-kd	O
protein	O
whose	O
expression	O
in	O
the	O
arterial	O
wall	O
is	O
restricted	O
to	O
smooth	O
muscle	O
.	O
We	O
have	O
previously	O
reported	O
the	O
identification	O
of	O
a	O
novel	O
cDNA	O
,	O
gene1s	O
SM-20	O
gene1e	O
,	O
whose	O
corresponding	O
mRNA	O
levels	O
are	O
regulated	O
by	O
growth	O
factors	O
in	O
species1s	O
rat	O
species1e	O
aortic	O
smooth	O
muscle	O
cell	O
(	O
SMC	O
)	O
culture	O
.	O
Affinity	O
-	O
purified	O
polyclonal	O
and	O
monoclonal	O
antibodies	O
were	O
made	O
against	O
a	O
230	O
amino	O
acid	O
region	O
of	O
the	O
gene1s	O
SM-20	O
gene1e	O
putative	O
peptide	O
expressed	O
in	O
the	O
bacterial	O
vector	O
,	O
pET-3b	O
.	O
Western	O
blot	O
analyses	O
of	O
species1s	O
rat	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
SMC	O
lysates	O
detected	O
a	O
single	O
protein	O
species	O
of	O
approximately	O
40	O
kd	O
.	O
gene1s	O
SM-20	O
gene1e	O
was	O
not	O
detected	O
in	O
concentrates	O
of	O
the	O
culture	O
medium	O
.	O
By	O
immunohistochemistry	O
,	O
gene1s	O
SM-20	O
gene1e	O
was	O
localized	O
to	O
filaments	O
in	O
the	O
cytoplasm	O
of	O
cultured	O
SMC	O
.	O
Like	O
gene1s	O
SM-20	O
gene1e	O
mRNA	O
,	O
levels	O
of	O
gene1s	O
SM-20	O
gene1e	O
protein	O
were	O
increased	O
1	O
-	O
3	O
hours	O
after	O
serum	O
stimulation	O
of	O
species1s	O
rat	O
species1e	O
aortic	O
SMC	O
.	O
In	O
species1s	O
rat	O
species1e	O
tissues	O
,	O
gene1s	O
SM-20	O
gene1e	O
antigen	O
was	O
detected	O
in	O
abundance	O
in	O
smooth	O
,	O
cardiac	O
,	O
and	O
skeletal	O
muscle	O
.	O
gene1s	O
SM-20	O
gene1e	O
was	O
also	O
detected	O
in	O
some	O
epithelial	O
cells	O
of	O
the	O
kidney	O
,	O
pancreas	O
,	O
gastrointestinal	O
tract	O
,	O
and	O
skin	O
,	O
but	O
was	O
not	O
found	O
in	O
the	O
parenchyma	O
of	O
the	O
liver	O
,	O
spleen	O
,	O
or	O
testis	O
.	O
In	O
the	O
species1s	O
rat	O
species1e	O
arterial	O
wall	O
,	O
gene1s	O
SM-20	O
gene1e	O
antigen	O
was	O
restricted	O
to	O
the	O
SMC	O
of	O
the	O
media	O
and	O
,	O
after	O
balloon	O
arterial	O
injury	O
,	O
was	O
found	O
most	O
abundantly	O
in	O
the	O
neointima	O
.	O
In	O
arg1s	O
human	O
arg1e	O
atherosclerotic	O
coronary	O
arteries	O
,	O
gene1s	ARG2
SM-20	ARG2
gene1e	ARG2
antigen	O
predominated	O
in	O
the	O
SMC	O
of	O
the	O
intimal	O
plaques	O
and	O
was	O
not	O
detected	O
in	O
macrophages	O
,	O
endothelium	O
,	O
or	O
adventitial	O
cells	O
.	O
Thus	O
,	O
gene1s	ARG2
SM-20	ARG2
gene1e	ARG2
encodes	O
a	O
protein	O
which	O
serves	O
as	O
a	O
novel	O
SMC	O
-	O
specific	O
marker	O
within	O
the	O
vessel	O
wall	O
.	O

gene1s	ARG2
Prk	ARG2
gene1e	ARG2
,	O
a	O
cytokine	O
-	O
inducible	O
arg1s	O
human	O
arg1e	O
protein	O
serine	O
/	O
threonine	O
kinase	O
whose	O
expression	O
appears	O
to	O
be	O
down	O
-	O
regulated	O
in	O
lung	O
carcinomas	O
.	O
We	O
have	O
cloned	O
and	O
characterized	O
a	O
putative	O
protein	O
serine	O
/	O
threonine	O
kinase	O
termed	O
gene1s	ARG2
prk	ARG2
gene1e	ARG2
through	O
a	O
combination	O
of	O
polymerase	O
chain	O
reaction	O
and	O
conventional	O
cDNA	O
library	O
screening	O
approaches	O
.	O
There	O
are	O
apparently	O
two	O
distinct	O
domains	O
within	O
gene1s	ARG2
prk	ARG2
gene1e	ARG2
protein	O
deduced	O
from	O
its	O
nucleotide	O
sequences	O
.	O
The	O
amino	O
-	O
terminal	O
portion	O
has	O
the	O
feature	O
of	O
the	O
catalytic	O
domain	O
of	O
a	O
serine	O
/	O
threonine	O
kinase	O
and	O
shows	O
strong	O
homology	O
to	O
species1s	O
mouse	O
species1e	O
gene1s	O
fnk	O
gene1e	O
and	O
other	O
polo	O
family	O
kinases	O
including	O
species1s	O
mouse	O
species1e	O
gene1s	O
snk	O
gene1e	O
,	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
murine	O
species1e	O
gene1s	ARG2
plk	ARG2
gene1e	ARG2
,	O
species1s	O
Drosophila	O
species1e	O
polo	O
,	O
and	O
species1s	O
yeast	O
species1e	O
gene1s	O
Cdc5	O
gene1e	O
.	O
The	O
carboxyl	O
-	O
terminal	O
portion	O
,	O
presumably	O
the	O
regulatory	O
domain	O
,	O
shares	O
extensive	O
homology	O
to	O
species1s	O
mouse	O
species1e	O
gene1s	O
fnk	O
gene1e	O
.	O
Northern	O
blotting	O
analyses	O
reveal	O
that	O
gene1s	ARG2
prk	ARG2
gene1e	ARG2
expression	O
is	O
restricted	O
to	O
a	O
very	O
limited	O
number	O
of	O
tissues	O
with	O
placenta	O
,	O
ovaries	O
,	O
and	O
lung	O
containing	O
detectable	O
amounts	O
of	O
gene1s	ARG2
prk	ARG2
gene1e	ARG2
mRNA	O
.	O
gene1s	ARG2
prk	ARG2
gene1e	ARG2
mRNA	O
expression	O
is	O
also	O
detected	O
at	O
a	O
low	O
level	O
in	O
the	O
megakaryocytic	O
cell	O
line	O
arg1s	O
Dami	O
arg1e	O
,	O
arg1s	O
MO7e	O
arg1e	O
,	O
and	O
three	O
brain	O
glioma	O
cell	O
lines	O
.	O
In	O
addition	O
,	O
refeeding	O
of	O
serum	O
-	O
deprived	O
arg1s	O
MO7e	O
arg1e	O
,	O
arg1s	O
Dami	O
arg1e	O
,	O
and	O
arg1s	O
K562	O
arg1e	O
cells	O
of	O
hematopoietic	O
origin	O
and	O
GMOO637D	O
of	O
lung	O
fibroblasts	O
rapidly	O
activates	O
gene1s	ARG2
prk	ARG2
gene1e	ARG2
mRNA	O
expression	O
with	O
its	O
peak	O
induction	O
around	O
2	O
h	O
after	O
serum	O
addition	O
.	O
gene1s	ARG2
prk	ARG2
gene1e	ARG2
gene	O
activation	O
by	O
the	O
serum	O
requires	O
no	O
new	O
protein	O
synthesis	O
.	O
The	O
recombinant	O
cytokines	O
such	O
as	O
gene1s	ARG2
interleukin-3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
thrombopoietin	ARG2
gene1e	ARG2
also	O
activate	O
gene1s	ARG2
prk	ARG2
gene1e	ARG2
mRNA	O
expression	O
in	O
arg1s	O
MO7e	O
arg1e	O
cells	O
.	O
Furthermore	O
,	O
a	O
survey	O
of	O
RNAs	O
isolated	O
from	O
the	O
tumor	O
and	O
the	O
uninvolved	O
tissues	O
from	O
18	O
lung	O
cancer	O
arg1s	O
patients	O
arg1e	O
reveals	O
that	O
gene1s	ARG2
prk	ARG2
gene1e	ARG2
mRNA	O
expression	O
is	O
significantly	O
down	O
-	O
regulated	O
in	O
tumor	O
tissues	O
.	O
Southern	O
blotting	O
analysis	O
indicates	O
that	O
the	O
gene1s	ARG2
prk	ARG2
gene1e	ARG2
gene	O
is	O
present	O
in	O
a	O
single	O
copy	O
in	O
the	O
genome	O
of	O
tumors	O
and	O
normal	O
cells	O
.	O
Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
gene1s	ARG2
prk	ARG2
gene1e	ARG2
expression	O
may	O
be	O
restricted	O
to	O
proliferating	O
cells	O
and	O
involved	O
in	O
the	O
regulation	O
of	O
cell	O
cycle	O
progression	O
.	O
The	O
molecular	O
cloning	O
of	O
gene1s	ARG2
prk	ARG2
gene1e	ARG2
cDNA	O
will	O
facilitate	O
the	O
study	O
of	O
its	O
biological	O
role	O
as	O
well	O
as	O
its	O
potential	O
role	O
in	O
tumorigenesis	O
.	O

gene1s	O
Prk	O
gene1e	O
,	O
a	O
cytokine	O
-	O
inducible	O
species1s	O
human	O
species1e	O
protein	O
serine	O
/	O
threonine	O
kinase	O
whose	O
expression	O
appears	O
to	O
be	O
down	O
-	O
regulated	O
in	O
lung	O
carcinomas	O
.	O
We	O
have	O
cloned	O
and	O
characterized	O
a	O
putative	O
protein	O
serine	O
/	O
threonine	O
kinase	O
termed	O
gene1s	O
prk	O
gene1e	O
through	O
a	O
combination	O
of	O
polymerase	O
chain	O
reaction	O
and	O
conventional	O
cDNA	O
library	O
screening	O
approaches	O
.	O
There	O
are	O
apparently	O
two	O
distinct	O
domains	O
within	O
gene1s	O
prk	O
gene1e	O
protein	O
deduced	O
from	O
its	O
nucleotide	O
sequences	O
.	O
The	O
amino	O
-	O
terminal	O
portion	O
has	O
the	O
feature	O
of	O
the	O
catalytic	O
domain	O
of	O
a	O
serine	O
/	O
threonine	O
kinase	O
and	O
shows	O
strong	O
homology	O
to	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
fnk	ARG2
gene1e	ARG2
and	O
other	O
polo	O
family	O
kinases	O
including	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
snk	ARG2
gene1e	ARG2
,	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
murine	O
arg1e	O
gene1s	ARG2
plk	ARG2
gene1e	ARG2
,	O
species1s	O
Drosophila	O
species1e	O
polo	O
,	O
and	O
species1s	O
yeast	O
species1e	O
gene1s	O
Cdc5	O
gene1e	O
.	O
The	O
carboxyl	O
-	O
terminal	O
portion	O
,	O
presumably	O
the	O
regulatory	O
domain	O
,	O
shares	O
extensive	O
homology	O
to	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
fnk	ARG2
gene1e	ARG2
.	O
Northern	O
blotting	O
analyses	O
reveal	O
that	O
gene1s	O
prk	O
gene1e	O
expression	O
is	O
restricted	O
to	O
a	O
very	O
limited	O
number	O
of	O
tissues	O
with	O
placenta	O
,	O
ovaries	O
,	O
and	O
lung	O
containing	O
detectable	O
amounts	O
of	O
gene1s	O
prk	O
gene1e	O
mRNA	O
.	O
gene1s	O
prk	O
gene1e	O
mRNA	O
expression	O
is	O
also	O
detected	O
at	O
a	O
low	O
level	O
in	O
the	O
megakaryocytic	O
cell	O
line	O
species1s	O
Dami	O
species1e	O
,	O
species1s	O
MO7e	O
species1e	O
,	O
and	O
three	O
brain	O
glioma	O
cell	O
lines	O
.	O
In	O
addition	O
,	O
refeeding	O
of	O
serum	O
-	O
deprived	O
species1s	O
MO7e	O
species1e	O
,	O
species1s	O
Dami	O
species1e	O
,	O
and	O
species1s	O
K562	O
species1e	O
cells	O
of	O
hematopoietic	O
origin	O
and	O
GMOO637D	O
of	O
lung	O
fibroblasts	O
rapidly	O
activates	O
gene1s	O
prk	O
gene1e	O
mRNA	O
expression	O
with	O
its	O
peak	O
induction	O
around	O
2	O
h	O
after	O
serum	O
addition	O
.	O
gene1s	O
prk	O
gene1e	O
gene	O
activation	O
by	O
the	O
serum	O
requires	O
no	O
new	O
protein	O
synthesis	O
.	O
The	O
recombinant	O
cytokines	O
such	O
as	O
gene1s	O
interleukin-3	O
gene1e	O
and	O
gene1s	O
thrombopoietin	O
gene1e	O
also	O
activate	O
gene1s	O
prk	O
gene1e	O
mRNA	O
expression	O
in	O
species1s	O
MO7e	O
species1e	O
cells	O
.	O
Furthermore	O
,	O
a	O
survey	O
of	O
RNAs	O
isolated	O
from	O
the	O
tumor	O
and	O
the	O
uninvolved	O
tissues	O
from	O
18	O
lung	O
cancer	O
species1s	O
patients	O
species1e	O
reveals	O
that	O
gene1s	O
prk	O
gene1e	O
mRNA	O
expression	O
is	O
significantly	O
down	O
-	O
regulated	O
in	O
tumor	O
tissues	O
.	O
Southern	O
blotting	O
analysis	O
indicates	O
that	O
the	O
gene1s	O
prk	O
gene1e	O
gene	O
is	O
present	O
in	O
a	O
single	O
copy	O
in	O
the	O
genome	O
of	O
tumors	O
and	O
normal	O
cells	O
.	O
Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
gene1s	O
prk	O
gene1e	O
expression	O
may	O
be	O
restricted	O
to	O
proliferating	O
cells	O
and	O
involved	O
in	O
the	O
regulation	O
of	O
cell	O
cycle	O
progression	O
.	O
The	O
molecular	O
cloning	O
of	O
gene1s	O
prk	O
gene1e	O
cDNA	O
will	O
facilitate	O
the	O
study	O
of	O
its	O
biological	O
role	O
as	O
well	O
as	O
its	O
potential	O
role	O
in	O
tumorigenesis	O
.	O

gene1s	O
Prk	O
gene1e	O
,	O
a	O
cytokine	O
-	O
inducible	O
species1s	O
human	O
species1e	O
protein	O
serine	O
/	O
threonine	O
kinase	O
whose	O
expression	O
appears	O
to	O
be	O
down	O
-	O
regulated	O
in	O
lung	O
carcinomas	O
.	O
We	O
have	O
cloned	O
and	O
characterized	O
a	O
putative	O
protein	O
serine	O
/	O
threonine	O
kinase	O
termed	O
gene1s	O
prk	O
gene1e	O
through	O
a	O
combination	O
of	O
polymerase	O
chain	O
reaction	O
and	O
conventional	O
cDNA	O
library	O
screening	O
approaches	O
.	O
There	O
are	O
apparently	O
two	O
distinct	O
domains	O
within	O
gene1s	O
prk	O
gene1e	O
protein	O
deduced	O
from	O
its	O
nucleotide	O
sequences	O
.	O
The	O
amino	O
-	O
terminal	O
portion	O
has	O
the	O
feature	O
of	O
the	O
catalytic	O
domain	O
of	O
a	O
serine	O
/	O
threonine	O
kinase	O
and	O
shows	O
strong	O
homology	O
to	O
species1s	O
mouse	O
species1e	O
gene1s	O
fnk	O
gene1e	O
and	O
other	O
polo	O
family	O
kinases	O
including	O
species1s	O
mouse	O
species1e	O
gene1s	O
snk	O
gene1e	O
,	O
species1s	O
human	O
species1e	O
and	O
species1s	O
murine	O
species1e	O
gene1s	O
plk	O
gene1e	O
,	O
arg1s	O
Drosophila	O
arg1e	O
polo	O
,	O
and	O
species1s	O
yeast	O
species1e	O
gene1s	O
Cdc5	O
gene1e	O
.	O
The	O
carboxyl	O
-	O
terminal	O
portion	O
,	O
presumably	O
the	O
regulatory	O
domain	O
,	O
shares	O
extensive	O
homology	O
to	O
species1s	O
mouse	O
species1e	O
gene1s	O
fnk	O
gene1e	O
.	O
Northern	O
blotting	O
analyses	O
reveal	O
that	O
gene1s	O
prk	O
gene1e	O
expression	O
is	O
restricted	O
to	O
a	O
very	O
limited	O
number	O
of	O
tissues	O
with	O
placenta	O
,	O
ovaries	O
,	O
and	O
lung	O
containing	O
detectable	O
amounts	O
of	O
gene1s	O
prk	O
gene1e	O
mRNA	O
.	O
gene1s	O
prk	O
gene1e	O
mRNA	O
expression	O
is	O
also	O
detected	O
at	O
a	O
low	O
level	O
in	O
the	O
megakaryocytic	O
cell	O
line	O
species1s	O
Dami	O
species1e	O
,	O
species1s	O
MO7e	O
species1e	O
,	O
and	O
three	O
brain	O
glioma	O
cell	O
lines	O
.	O
In	O
addition	O
,	O
refeeding	O
of	O
serum	O
-	O
deprived	O
species1s	O
MO7e	O
species1e	O
,	O
species1s	O
Dami	O
species1e	O
,	O
and	O
species1s	O
K562	O
species1e	O
cells	O
of	O
hematopoietic	O
origin	O
and	O
GMOO637D	O
of	O
lung	O
fibroblasts	O
rapidly	O
activates	O
gene1s	O
prk	O
gene1e	O
mRNA	O
expression	O
with	O
its	O
peak	O
induction	O
around	O
2	O
h	O
after	O
serum	O
addition	O
.	O
gene1s	O
prk	O
gene1e	O
gene	O
activation	O
by	O
the	O
serum	O
requires	O
no	O
new	O
protein	O
synthesis	O
.	O
The	O
recombinant	O
cytokines	O
such	O
as	O
gene1s	O
interleukin-3	O
gene1e	O
and	O
gene1s	O
thrombopoietin	O
gene1e	O
also	O
activate	O
gene1s	O
prk	O
gene1e	O
mRNA	O
expression	O
in	O
species1s	O
MO7e	O
species1e	O
cells	O
.	O
Furthermore	O
,	O
a	O
survey	O
of	O
RNAs	O
isolated	O
from	O
the	O
tumor	O
and	O
the	O
uninvolved	O
tissues	O
from	O
18	O
lung	O
cancer	O
species1s	O
patients	O
species1e	O
reveals	O
that	O
gene1s	O
prk	O
gene1e	O
mRNA	O
expression	O
is	O
significantly	O
down	O
-	O
regulated	O
in	O
tumor	O
tissues	O
.	O
Southern	O
blotting	O
analysis	O
indicates	O
that	O
the	O
gene1s	O
prk	O
gene1e	O
gene	O
is	O
present	O
in	O
a	O
single	O
copy	O
in	O
the	O
genome	O
of	O
tumors	O
and	O
normal	O
cells	O
.	O
Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
gene1s	O
prk	O
gene1e	O
expression	O
may	O
be	O
restricted	O
to	O
proliferating	O
cells	O
and	O
involved	O
in	O
the	O
regulation	O
of	O
cell	O
cycle	O
progression	O
.	O
The	O
molecular	O
cloning	O
of	O
gene1s	O
prk	O
gene1e	O
cDNA	O
will	O
facilitate	O
the	O
study	O
of	O
its	O
biological	O
role	O
as	O
well	O
as	O
its	O
potential	O
role	O
in	O
tumorigenesis	O
.	O

gene1s	O
Prk	O
gene1e	O
,	O
a	O
cytokine	O
-	O
inducible	O
species1s	O
human	O
species1e	O
protein	O
serine	O
/	O
threonine	O
kinase	O
whose	O
expression	O
appears	O
to	O
be	O
down	O
-	O
regulated	O
in	O
lung	O
carcinomas	O
.	O
We	O
have	O
cloned	O
and	O
characterized	O
a	O
putative	O
protein	O
serine	O
/	O
threonine	O
kinase	O
termed	O
gene1s	O
prk	O
gene1e	O
through	O
a	O
combination	O
of	O
polymerase	O
chain	O
reaction	O
and	O
conventional	O
cDNA	O
library	O
screening	O
approaches	O
.	O
There	O
are	O
apparently	O
two	O
distinct	O
domains	O
within	O
gene1s	O
prk	O
gene1e	O
protein	O
deduced	O
from	O
its	O
nucleotide	O
sequences	O
.	O
The	O
amino	O
-	O
terminal	O
portion	O
has	O
the	O
feature	O
of	O
the	O
catalytic	O
domain	O
of	O
a	O
serine	O
/	O
threonine	O
kinase	O
and	O
shows	O
strong	O
homology	O
to	O
species1s	O
mouse	O
species1e	O
gene1s	O
fnk	O
gene1e	O
and	O
other	O
polo	O
family	O
kinases	O
including	O
species1s	O
mouse	O
species1e	O
gene1s	O
snk	O
gene1e	O
,	O
species1s	O
human	O
species1e	O
and	O
species1s	O
murine	O
species1e	O
gene1s	O
plk	O
gene1e	O
,	O
species1s	O
Drosophila	O
species1e	O
polo	O
,	O
and	O
arg1s	O
yeast	O
arg1e	O
gene1s	ARG2
Cdc5	ARG2
gene1e	ARG2
.	O
The	O
carboxyl	O
-	O
terminal	O
portion	O
,	O
presumably	O
the	O
regulatory	O
domain	O
,	O
shares	O
extensive	O
homology	O
to	O
species1s	O
mouse	O
species1e	O
gene1s	O
fnk	O
gene1e	O
.	O
Northern	O
blotting	O
analyses	O
reveal	O
that	O
gene1s	O
prk	O
gene1e	O
expression	O
is	O
restricted	O
to	O
a	O
very	O
limited	O
number	O
of	O
tissues	O
with	O
placenta	O
,	O
ovaries	O
,	O
and	O
lung	O
containing	O
detectable	O
amounts	O
of	O
gene1s	O
prk	O
gene1e	O
mRNA	O
.	O
gene1s	O
prk	O
gene1e	O
mRNA	O
expression	O
is	O
also	O
detected	O
at	O
a	O
low	O
level	O
in	O
the	O
megakaryocytic	O
cell	O
line	O
species1s	O
Dami	O
species1e	O
,	O
species1s	O
MO7e	O
species1e	O
,	O
and	O
three	O
brain	O
glioma	O
cell	O
lines	O
.	O
In	O
addition	O
,	O
refeeding	O
of	O
serum	O
-	O
deprived	O
species1s	O
MO7e	O
species1e	O
,	O
species1s	O
Dami	O
species1e	O
,	O
and	O
species1s	O
K562	O
species1e	O
cells	O
of	O
hematopoietic	O
origin	O
and	O
GMOO637D	O
of	O
lung	O
fibroblasts	O
rapidly	O
activates	O
gene1s	O
prk	O
gene1e	O
mRNA	O
expression	O
with	O
its	O
peak	O
induction	O
around	O
2	O
h	O
after	O
serum	O
addition	O
.	O
gene1s	O
prk	O
gene1e	O
gene	O
activation	O
by	O
the	O
serum	O
requires	O
no	O
new	O
protein	O
synthesis	O
.	O
The	O
recombinant	O
cytokines	O
such	O
as	O
gene1s	O
interleukin-3	O
gene1e	O
and	O
gene1s	O
thrombopoietin	O
gene1e	O
also	O
activate	O
gene1s	O
prk	O
gene1e	O
mRNA	O
expression	O
in	O
species1s	O
MO7e	O
species1e	O
cells	O
.	O
Furthermore	O
,	O
a	O
survey	O
of	O
RNAs	O
isolated	O
from	O
the	O
tumor	O
and	O
the	O
uninvolved	O
tissues	O
from	O
18	O
lung	O
cancer	O
species1s	O
patients	O
species1e	O
reveals	O
that	O
gene1s	O
prk	O
gene1e	O
mRNA	O
expression	O
is	O
significantly	O
down	O
-	O
regulated	O
in	O
tumor	O
tissues	O
.	O
Southern	O
blotting	O
analysis	O
indicates	O
that	O
the	O
gene1s	O
prk	O
gene1e	O
gene	O
is	O
present	O
in	O
a	O
single	O
copy	O
in	O
the	O
genome	O
of	O
tumors	O
and	O
normal	O
cells	O
.	O
Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
gene1s	O
prk	O
gene1e	O
expression	O
may	O
be	O
restricted	O
to	O
proliferating	O
cells	O
and	O
involved	O
in	O
the	O
regulation	O
of	O
cell	O
cycle	O
progression	O
.	O
The	O
molecular	O
cloning	O
of	O
gene1s	O
prk	O
gene1e	O
cDNA	O
will	O
facilitate	O
the	O
study	O
of	O
its	O
biological	O
role	O
as	O
well	O
as	O
its	O
potential	O
role	O
in	O
tumorigenesis	O
.	O

Assignment	O
of	O
the	O
gene1s	ARG2
PSST	ARG2
gene1e	ARG2
subunit	O
gene	O
of	O
arg1s	O
human	O
arg1e	O
mitochondrial	O
complex	O
I	O
to	O
chromosome	O
19p13	O
.	O
The	O
cDNA	O
for	O
the	O
gene1s	ARG2
PSST	ARG2
gene1e	ARG2
subunit	O
of	O
arg1s	O
human	O
arg1e	O
mitochondrial	O
nicotinamide	O
adenine	O
dinucleotide	O
(	O
NADH	O
)	O
:	O
ubiquinone	O
oxidoreductase	O
was	O
generated	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
amplification	O
of	O
arg1s	O
human	O
arg1e	O
cDNA	O
.	O
The	O
sequence	O
of	O
the	O
mature	O
protein	O
deduced	O
from	O
the	O
cDNA	O
codes	O
for	O
a	O
protein	O
that	O
is	O
closely	O
related	O
to	O
the	O
species1s	O
bovine	O
species1e	O
protein	O
(	O
93	O
%	O
homology	O
)	O
.	O
Nine	O
conservative	O
substitutions	O
are	O
found	O
in	O
the	O
mature	O
protein	O
,	O
mainly	O
in	O
the	O
N	O
and	O
C	O
terminal	O
regions	O
.	O
The	O
mature	O
arg1s	O
human	O
arg1e	O
protein	O
is	O
missing	O
four	O
amino	O
acids	O
(	O
PAAL	O
)	O
close	O
to	O
the	O
N	O
terminus	O
that	O
are	O
present	O
in	O
the	O
species1s	O
bovine	O
species1e	O
protein	O
.	O
The	O
N	O
terminus	O
of	O
the	O
mature	O
protein	O
is	O
preceded	O
by	O
a	O
presequence	O
of	O
38	O
amino	O
acids	O
that	O
,	O
although	O
quite	O
different	O
from	O
its	O
species1s	O
bovine	O
species1e	O
counterpart	O
(	O
52	O
%	O
homology	O
)	O
,	O
has	O
properties	O
that	O
are	O
characteristic	O
of	O
a	O
mitochondrial	O
import	O
sequence	O
.	O
Southern	O
hybridization	O
analysis	O
predicts	O
an	O
estimated	O
gene	O
size	O
of	O
3.8	O
kb	O
.	O
Northern	O
hybridization	O
analysis	O
of	O
mRNA	O
from	O
fibroblasts	O
of	O
complex	O
I	O
-	O
deficient	O
arg1s	O
patients	O
arg1e	O
revealed	O
no	O
size	O
or	O
transcript	O
level	O
abnormalities	O
.	O
The	O
cDNA	O
of	O
the	O
gene1s	ARG2
PSST	ARG2
gene1e	ARG2
protein	O
was	O
used	O
to	O
investigate	O
tissue	O
-	O
specific	O
expression	O
and	O
to	O
localize	O
the	O
gene	O
for	O
this	O
subunit	O
to	O
chromosome	O
19p13	O
.	O

Assignment	O
of	O
the	O
gene1s	O
PSST	O
gene1e	O
subunit	O
gene	O
of	O
species1s	O
human	O
species1e	O
mitochondrial	O
complex	O
I	O
to	O
chromosome	O
19p13	O
.	O
The	O
cDNA	O
for	O
the	O
gene1s	O
PSST	O
gene1e	O
subunit	O
of	O
species1s	O
human	O
species1e	O
mitochondrial	O
nicotinamide	O
adenine	O
dinucleotide	O
(	O
NADH	O
)	O
:	O
ubiquinone	O
oxidoreductase	O
was	O
generated	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
amplification	O
of	O
species1s	O
human	O
species1e	O
cDNA	O
.	O
The	O
sequence	O
of	O
the	O
mature	O
protein	O
deduced	O
from	O
the	O
cDNA	O
codes	O
for	O
a	O
protein	O
that	O
is	O
closely	O
related	O
to	O
the	O
arg1s	O
bovine	O
arg1e	O
protein	O
(	O
93	O
%	O
homology	O
)	O
.	O
Nine	O
conservative	O
substitutions	O
are	O
found	O
in	O
the	O
mature	O
protein	O
,	O
mainly	O
in	O
the	O
N	O
and	O
C	O
terminal	O
regions	O
.	O
The	O
mature	O
species1s	O
human	O
species1e	O
protein	O
is	O
missing	O
four	O
amino	O
acids	O
(	O
PAAL	O
)	O
close	O
to	O
the	O
N	O
terminus	O
that	O
are	O
present	O
in	O
the	O
arg1s	O
bovine	O
arg1e	O
protein	O
.	O
The	O
N	O
terminus	O
of	O
the	O
mature	O
protein	O
is	O
preceded	O
by	O
a	O
presequence	O
of	O
38	O
amino	O
acids	O
that	O
,	O
although	O
quite	O
different	O
from	O
its	O
arg1s	O
bovine	O
arg1e	O
counterpart	O
(	O
52	O
%	O
homology	O
)	O
,	O
has	O
properties	O
that	O
are	O
characteristic	O
of	O
a	O
mitochondrial	O
import	O
sequence	O
.	O
Southern	O
hybridization	O
analysis	O
predicts	O
an	O
estimated	O
gene	O
size	O
of	O
3.8	O
kb	O
.	O
Northern	O
hybridization	O
analysis	O
of	O
mRNA	O
from	O
fibroblasts	O
of	O
complex	O
I	O
-	O
deficient	O
species1s	O
patients	O
species1e	O
revealed	O
no	O
size	O
or	O
transcript	O
level	O
abnormalities	O
.	O
The	O
cDNA	O
of	O
the	O
gene1s	O
PSST	O
gene1e	O
protein	O
was	O
used	O
to	O
investigate	O
tissue	O
-	O
specific	O
expression	O
and	O
to	O
localize	O
the	O
gene	O
for	O
this	O
subunit	O
to	O
chromosome	O
19p13	O
.	O

Three	O
arg1s	O
human	O
arg1e	O
RNA	O
polymerase	O
III	O
-	O
specific	O
subunits	O
form	O
a	O
subcomplex	O
with	O
a	O
selective	O
function	O
in	O
specific	O
transcription	O
initiation	O
.	O
Transcription	O
by	O
RNA	O
polymerase	O
III	O
involves	O
recruitment	O
of	O
the	O
polymerase	O
by	O
template	O
-	O
bound	O
accessory	O
factors	O
,	O
followed	O
by	O
initiation	O
,	O
elongation	O
,	O
and	O
termination	O
steps	O
.	O
An	O
immunopurification	O
approach	O
has	O
been	O
used	O
to	O
demonstrate	O
that	O
arg1s	O
human	O
arg1e	O
RNA	O
Pol	O
III	O
is	O
composed	O
of	O
16	O
subunits	O
,	O
some	O
of	O
which	O
are	O
apparently	O
modified	O
in	O
arg1s	O
HeLa	O
arg1e	O
cells	O
.	O
Partial	O
denaturing	O
conditions	O
and	O
sucrose	O
gradient	O
sedimentation	O
at	O
high	O
salt	O
result	O
in	O
the	O
dissociation	O
of	O
a	O
subcomplex	O
that	O
includes	O
gene1s	ARG2
hRPC32	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
hRPC39	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
hRPC62	ARG2
gene1e	ARG2
.	O
Cognate	O
cDNAs	O
were	O
isolated	O
and	O
shown	O
to	O
encode	O
three	O
subunits	O
that	O
are	O
specific	O
to	O
RNA	O
Pol	O
III	O
and	O
homologous	O
to	O
three	O
species1s	O
yeast	O
species1e	O
subunits	O
.	O
The	O
arg1s	O
human	O
arg1e	O
RNA	O
Pol	O
III	O
core	O
lacking	O
the	O
subcomplex	O
functions	O
in	O
transcription	O
elongation	O
and	O
termination	O
following	O
nonspecific	O
initiation	O
on	O
a	O
tailed	O
template	O
,	O
but	O
fails	O
to	O
show	O
promoter	O
-	O
dependent	O
transcription	O
initiation	O
in	O
conjunction	O
with	O
accessory	O
factors	O
.	O
The	O
capability	O
for	O
specific	O
transcription	O
initiation	O
can	O
be	O
restored	O
either	O
by	O
the	O
natural	O
subcomplex	O
or	O
by	O
a	O
stable	O
subcomplex	O
composed	O
of	O
recombinant	O
gene1s	ARG2
hRPC32	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
hRPC39	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
hRPC62	ARG2
gene1e	ARG2
polypeptides	O
.	O
One	O
component	O
(	O
gene1s	ARG2
hRPC39	ARG2
gene1e	ARG2
)	O
of	O
this	O
subcomplex	O
interacts	O
physically	O
with	O
both	O
gene1s	ARG2
hTBP	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
hTFIIIB90	ARG2
gene1e	ARG2
,	O
two	O
subunits	O
of	O
arg1s	O
human	O
arg1e	O
RNA	O
Pol	O
III	O
transcription	O
initiation	O
factor	O
IIIB	O
.	O
These	O
data	O
strongly	O
suggest	O
that	O
the	O
gene1s	ARG2
hRPC32	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
hRPC39	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
hRPC62	ARG2
gene1e	ARG2
subcomplex	O
directs	O
RNA	O
Pol	O
III	O
binding	O
to	O
the	O
TFIIIB	O
-	O
DNA	O
complex	O
via	O
the	O
interactions	O
between	O
TFIIIB	O
and	O
gene1s	ARG2
hRPC39	ARG2
gene1e	ARG2
.	O

Three	O
species1s	O
human	O
species1e	O
RNA	O
polymerase	O
III	O
-	O
specific	O
subunits	O
form	O
a	O
subcomplex	O
with	O
a	O
selective	O
function	O
in	O
specific	O
transcription	O
initiation	O
.	O
Transcription	O
by	O
RNA	O
polymerase	O
III	O
involves	O
recruitment	O
of	O
the	O
polymerase	O
by	O
template	O
-	O
bound	O
accessory	O
factors	O
,	O
followed	O
by	O
initiation	O
,	O
elongation	O
,	O
and	O
termination	O
steps	O
.	O
An	O
immunopurification	O
approach	O
has	O
been	O
used	O
to	O
demonstrate	O
that	O
species1s	O
human	O
species1e	O
RNA	O
Pol	O
III	O
is	O
composed	O
of	O
16	O
subunits	O
,	O
some	O
of	O
which	O
are	O
apparently	O
modified	O
in	O
species1s	O
HeLa	O
species1e	O
cells	O
.	O
Partial	O
denaturing	O
conditions	O
and	O
sucrose	O
gradient	O
sedimentation	O
at	O
high	O
salt	O
result	O
in	O
the	O
dissociation	O
of	O
a	O
subcomplex	O
that	O
includes	O
gene1s	O
hRPC32	O
gene1e	O
,	O
gene1s	O
hRPC39	O
gene1e	O
,	O
and	O
gene1s	O
hRPC62	O
gene1e	O
.	O
Cognate	O
cDNAs	O
were	O
isolated	O
and	O
shown	O
to	O
encode	O
three	O
subunits	O
that	O
are	O
specific	O
to	O
RNA	O
Pol	O
III	O
and	O
homologous	O
to	O
three	O
arg1s	O
yeast	O
arg1e	O
subunits	O
.	O
The	O
species1s	O
human	O
species1e	O
RNA	O
Pol	O
III	O
core	O
lacking	O
the	O
subcomplex	O
functions	O
in	O
transcription	O
elongation	O
and	O
termination	O
following	O
nonspecific	O
initiation	O
on	O
a	O
tailed	O
template	O
,	O
but	O
fails	O
to	O
show	O
promoter	O
-	O
dependent	O
transcription	O
initiation	O
in	O
conjunction	O
with	O
accessory	O
factors	O
.	O
The	O
capability	O
for	O
specific	O
transcription	O
initiation	O
can	O
be	O
restored	O
either	O
by	O
the	O
natural	O
subcomplex	O
or	O
by	O
a	O
stable	O
subcomplex	O
composed	O
of	O
recombinant	O
gene1s	O
hRPC32	O
gene1e	O
,	O
gene1s	O
hRPC39	O
gene1e	O
,	O
and	O
gene1s	O
hRPC62	O
gene1e	O
polypeptides	O
.	O
One	O
component	O
(	O
gene1s	O
hRPC39	O
gene1e	O
)	O
of	O
this	O
subcomplex	O
interacts	O
physically	O
with	O
both	O
gene1s	O
hTBP	O
gene1e	O
and	O
gene1s	O
hTFIIIB90	O
gene1e	O
,	O
two	O
subunits	O
of	O
species1s	O
human	O
species1e	O
RNA	O
Pol	O
III	O
transcription	O
initiation	O
factor	O
IIIB	O
.	O
These	O
data	O
strongly	O
suggest	O
that	O
the	O
gene1s	O
hRPC32	O
gene1e	O
-	O
gene1s	O
hRPC39	O
gene1e	O
-	O
gene1s	O
hRPC62	O
gene1e	O
subcomplex	O
directs	O
RNA	O
Pol	O
III	O
binding	O
to	O
the	O
TFIIIB	O
-	O
DNA	O
complex	O
via	O
the	O
interactions	O
between	O
TFIIIB	O
and	O
gene1s	O
hRPC39	O
gene1e	O
.	O

gene1s	O
Presenilin	O
1	O
gene1e	O
interaction	O
in	O
the	O
brain	O
with	O
a	O
novel	O
member	O
of	O
the	O
Armadillo	O
family	O
.	O
One	O
approach	O
to	O
understanding	O
the	O
function	O
of	O
gene1s	O
presenilin	O
1	O
gene1e	O
(	O
gene1s	O
PS1	O
gene1e	O
)	O
,	O
is	O
to	O
discover	O
those	O
proteins	O
with	O
which	O
it	O
interacts	O
.	O
Evidence	O
for	O
a	O
function	O
in	O
developmental	O
patterning	O
came	O
from	O
arg1s	O
C.	O
elegans	O
arg1e	O
,	O
in	O
which	O
a	O
PS	O
homologue	O
was	O
identified	O
by	O
screening	O
for	O
suppressors	O
of	O
a	O
mutation	O
in	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
lin-12	ARG2
gene1e	ARG2
,	O
a	O
gene	O
which	O
specifies	O
cell	O
fate	O
.	O
However	O
,	O
this	O
genetic	O
experiment	O
can	O
not	O
determine	O
which	O
proteins	O
directly	O
interact	O
with	O
gene1s	O
PS1	O
gene1e	O
.	O
Therefore	O
,	O
we	O
utilized	O
the	O
two	O
hybrid	O
system	O
and	O
confirmatory	O
co	O
-	O
immunoprecipitations	O
to	O
identify	O
a	O
novel	O
catenin	O
,	O
termed	O
delta	O
-	O
catenin	O
,	O
which	O
interacts	O
with	O
gene1s	O
PS1	O
gene1e	O
and	O
is	O
principally	O
expressed	O
in	O
brain	O
.	O
The	O
catenins	O
are	O
a	O
gene	O
family	O
related	O
to	O
the	O
gene1s	O
Armadillo	O
gene1e	O
gene	O
in	O
species1s	O
Drosophila	O
species1e	O
,	O
some	O
of	O
which	O
appear	O
to	O
have	O
dual	O
roles	O
-	O
they	O
are	O
components	O
of	O
cell	O
-	O
cell	O
adherens	O
junctions	O
,	O
and	O
may	O
serve	O
as	O
intermediates	O
in	O
the	O
Wingless	O
(	O
Wg	O
)	O
signaling	O
pathway	O
,	O
which	O
,	O
like	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
lin-12	ARG2
gene1e	ARG2
,	O
is	O
also	O
responsible	O
for	O
a	O
variety	O
of	O
inductive	O
signaling	O
events	O
.	O
In	O
the	O
non	O
-	O
neuronal	O
species1s	O
293	O
species1e	O
cell	O
line	O
,	O
gene1s	O
PS1	O
gene1e	O
interacted	O
with	O
gene1s	O
beta	O
-	O
catenin	O
gene1e	O
,	O
the	O
family	O
member	O
with	O
the	O
greatest	O
homology	O
to	O
gene1s	O
Armadillo	O
gene1e	O
.	O
Wg	O
and	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
interactions	O
are	O
mediated	O
by	O
the	O
Dishevelled	O
gene	O
,	O
which	O
may	O
form	O
a	O
signaling	O
complex	O
with	O
gene1s	O
PS1	O
gene1e	O
and	O
Wg	O
pathway	O
intermediates	O
to	O
regulate	O
the	O
function	O
of	O
the	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
lin-12	ARG2
gene1e	ARG2
gene	O
.	O

gene1s	O
Presenilin	O
1	O
gene1e	O
interaction	O
in	O
the	O
brain	O
with	O
a	O
novel	O
member	O
of	O
the	O
Armadillo	O
family	O
.	O
One	O
approach	O
to	O
understanding	O
the	O
function	O
of	O
gene1s	O
presenilin	O
1	O
gene1e	O
(	O
gene1s	O
PS1	O
gene1e	O
)	O
,	O
is	O
to	O
discover	O
those	O
proteins	O
with	O
which	O
it	O
interacts	O
.	O
Evidence	O
for	O
a	O
function	O
in	O
developmental	O
patterning	O
came	O
from	O
species1s	O
C.	O
elegans	O
species1e	O
,	O
in	O
which	O
a	O
PS	O
homologue	O
was	O
identified	O
by	O
screening	O
for	O
suppressors	O
of	O
a	O
mutation	O
in	O
gene1s	O
Notch	O
gene1e	O
/	O
gene1s	O
lin-12	O
gene1e	O
,	O
a	O
gene	O
which	O
specifies	O
cell	O
fate	O
.	O
However	O
,	O
this	O
genetic	O
experiment	O
can	O
not	O
determine	O
which	O
proteins	O
directly	O
interact	O
with	O
gene1s	O
PS1	O
gene1e	O
.	O
Therefore	O
,	O
we	O
utilized	O
the	O
two	O
hybrid	O
system	O
and	O
confirmatory	O
co	O
-	O
immunoprecipitations	O
to	O
identify	O
a	O
novel	O
catenin	O
,	O
termed	O
delta	O
-	O
catenin	O
,	O
which	O
interacts	O
with	O
gene1s	O
PS1	O
gene1e	O
and	O
is	O
principally	O
expressed	O
in	O
brain	O
.	O
The	O
catenins	O
are	O
a	O
gene	O
family	O
related	O
to	O
the	O
gene1s	ARG2
Armadillo	ARG2
gene1e	ARG2
gene	O
in	O
arg1s	O
Drosophila	O
arg1e	O
,	O
some	O
of	O
which	O
appear	O
to	O
have	O
dual	O
roles	O
-	O
they	O
are	O
components	O
of	O
cell	O
-	O
cell	O
adherens	O
junctions	O
,	O
and	O
may	O
serve	O
as	O
intermediates	O
in	O
the	O
Wingless	O
(	O
Wg	O
)	O
signaling	O
pathway	O
,	O
which	O
,	O
like	O
gene1s	O
Notch	O
gene1e	O
/	O
gene1s	O
lin-12	O
gene1e	O
,	O
is	O
also	O
responsible	O
for	O
a	O
variety	O
of	O
inductive	O
signaling	O
events	O
.	O
In	O
the	O
non	O
-	O
neuronal	O
species1s	O
293	O
species1e	O
cell	O
line	O
,	O
gene1s	O
PS1	O
gene1e	O
interacted	O
with	O
gene1s	O
beta	O
-	O
catenin	O
gene1e	O
,	O
the	O
family	O
member	O
with	O
the	O
greatest	O
homology	O
to	O
gene1s	ARG2
Armadillo	ARG2
gene1e	ARG2
.	O
Wg	O
and	O
gene1s	O
Notch	O
gene1e	O
interactions	O
are	O
mediated	O
by	O
the	O
Dishevelled	O
gene	O
,	O
which	O
may	O
form	O
a	O
signaling	O
complex	O
with	O
gene1s	O
PS1	O
gene1e	O
and	O
Wg	O
pathway	O
intermediates	O
to	O
regulate	O
the	O
function	O
of	O
the	O
gene1s	O
Notch	O
gene1e	O
/	O
gene1s	O
lin-12	O
gene1e	O
gene	O
.	O

gene1s	ARG2
Presenilin	ARG2
1	ARG2
gene1e	ARG2
interaction	O
in	O
the	O
brain	O
with	O
a	O
novel	O
member	O
of	O
the	O
Armadillo	O
family	O
.	O
One	O
approach	O
to	O
understanding	O
the	O
function	O
of	O
gene1s	ARG2
presenilin	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
)	O
,	O
is	O
to	O
discover	O
those	O
proteins	O
with	O
which	O
it	O
interacts	O
.	O
Evidence	O
for	O
a	O
function	O
in	O
developmental	O
patterning	O
came	O
from	O
species1s	O
C.	O
elegans	O
species1e	O
,	O
in	O
which	O
a	O
PS	O
homologue	O
was	O
identified	O
by	O
screening	O
for	O
suppressors	O
of	O
a	O
mutation	O
in	O
gene1s	O
Notch	O
gene1e	O
/	O
gene1s	O
lin-12	O
gene1e	O
,	O
a	O
gene	O
which	O
specifies	O
cell	O
fate	O
.	O
However	O
,	O
this	O
genetic	O
experiment	O
can	O
not	O
determine	O
which	O
proteins	O
directly	O
interact	O
with	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
.	O
Therefore	O
,	O
we	O
utilized	O
the	O
two	O
hybrid	O
system	O
and	O
confirmatory	O
co	O
-	O
immunoprecipitations	O
to	O
identify	O
a	O
novel	O
catenin	O
,	O
termed	O
delta	O
-	O
catenin	O
,	O
which	O
interacts	O
with	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
and	O
is	O
principally	O
expressed	O
in	O
brain	O
.	O
The	O
catenins	O
are	O
a	O
gene	O
family	O
related	O
to	O
the	O
gene1s	O
Armadillo	O
gene1e	O
gene	O
in	O
species1s	O
Drosophila	O
species1e	O
,	O
some	O
of	O
which	O
appear	O
to	O
have	O
dual	O
roles	O
-	O
they	O
are	O
components	O
of	O
cell	O
-	O
cell	O
adherens	O
junctions	O
,	O
and	O
may	O
serve	O
as	O
intermediates	O
in	O
the	O
Wingless	O
(	O
Wg	O
)	O
signaling	O
pathway	O
,	O
which	O
,	O
like	O
gene1s	O
Notch	O
gene1e	O
/	O
gene1s	O
lin-12	O
gene1e	O
,	O
is	O
also	O
responsible	O
for	O
a	O
variety	O
of	O
inductive	O
signaling	O
events	O
.	O
In	O
the	O
non	O
-	O
neuronal	O
arg1s	O
293	O
arg1e	O
cell	O
line	O
,	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
interacted	O
with	O
gene1s	ARG2
beta	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
,	O
the	O
family	O
member	O
with	O
the	O
greatest	O
homology	O
to	O
gene1s	O
Armadillo	O
gene1e	O
.	O
Wg	O
and	O
gene1s	O
Notch	O
gene1e	O
interactions	O
are	O
mediated	O
by	O
the	O
Dishevelled	O
gene	O
,	O
which	O
may	O
form	O
a	O
signaling	O
complex	O
with	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
and	O
Wg	O
pathway	O
intermediates	O
to	O
regulate	O
the	O
function	O
of	O
the	O
gene1s	O
Notch	O
gene1e	O
/	O
gene1s	O
lin-12	O
gene1e	O
gene	O
.	O

A	O
transcriptional	O
mediator	O
protein	O
that	O
is	O
required	O
for	O
activation	O
of	O
many	O
RNA	O
polymerase	O
II	O
promoters	O
and	O
is	O
conserved	O
from	O
arg1s	O
yeast	O
arg1e	O
to	O
species1s	O
humans	O
species1e	O
.	O
A	O
temperature	O
-	O
sensitive	O
mutation	O
was	O
obtained	O
in	O
gene1s	ARG2
Med6p	ARG2
gene1e	ARG2
,	O
a	O
component	O
of	O
the	O
mediator	O
complex	O
from	O
the	O
arg1s	O
yeast	O
arg1e	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
.	O
The	O
mediator	O
complex	O
has	O
been	O
shown	O
to	O
enable	O
transcriptional	O
activation	O
in	O
vitro	O
.	O
This	O
mutation	O
in	O
gene1s	ARG2
Med6p	ARG2
gene1e	ARG2
abolished	O
activation	O
of	O
transcription	O
from	O
four	O
of	O
five	O
inducible	O
promoters	O
tested	O
in	O
vivo	O
.	O
There	O
was	O
no	O
effect	O
,	O
however	O
,	O
on	O
uninduced	O
transcription	O
,	O
transcription	O
of	O
constitutively	O
expressed	O
genes	O
,	O
or	O
transcription	O
by	O
RNA	O
polymerases	O
I	O
and	O
III	O
.	O
Mediator	O
-	O
RNA	O
polymerase	O
II	O
complex	O
isolated	O
from	O
the	O
mutant	O
arg1s	O
yeast	O
arg1e	O
strain	O
was	O
temperature	O
sensitive	O
for	O
transcriptional	O
activation	O
in	O
a	O
reconstituted	O
in	O
vitro	O
system	O
due	O
to	O
a	O
defect	O
in	O
initiation	O
complex	O
formation	O
.	O
A	O
database	O
search	O
revealed	O
the	O
existence	O
of	O
gene1s	O
MED6	O
gene1e	O
-related	O
genes	O
in	O
species1s	O
humans	O
species1e	O
and	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
,	O
suggesting	O
that	O
the	O
role	O
of	O
mediator	O
in	O
transcriptional	O
activation	O
is	O
conserved	O
throughout	O
the	O
evolution	O
.	O

A	O
transcriptional	O
mediator	O
protein	O
that	O
is	O
required	O
for	O
activation	O
of	O
many	O
RNA	O
polymerase	O
II	O
promoters	O
and	O
is	O
conserved	O
from	O
species1s	O
yeast	O
species1e	O
to	O
arg1s	O
humans	O
arg1e	O
.	O
A	O
temperature	O
-	O
sensitive	O
mutation	O
was	O
obtained	O
in	O
gene1s	O
Med6p	O
gene1e	O
,	O
a	O
component	O
of	O
the	O
mediator	O
complex	O
from	O
the	O
species1s	O
yeast	O
species1e	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
.	O
The	O
mediator	O
complex	O
has	O
been	O
shown	O
to	O
enable	O
transcriptional	O
activation	O
in	O
vitro	O
.	O
This	O
mutation	O
in	O
gene1s	O
Med6p	O
gene1e	O
abolished	O
activation	O
of	O
transcription	O
from	O
four	O
of	O
five	O
inducible	O
promoters	O
tested	O
in	O
vivo	O
.	O
There	O
was	O
no	O
effect	O
,	O
however	O
,	O
on	O
uninduced	O
transcription	O
,	O
transcription	O
of	O
constitutively	O
expressed	O
genes	O
,	O
or	O
transcription	O
by	O
RNA	O
polymerases	O
I	O
and	O
III	O
.	O
Mediator	O
-	O
RNA	O
polymerase	O
II	O
complex	O
isolated	O
from	O
the	O
mutant	O
species1s	O
yeast	O
species1e	O
strain	O
was	O
temperature	O
sensitive	O
for	O
transcriptional	O
activation	O
in	O
a	O
reconstituted	O
in	O
vitro	O
system	O
due	O
to	O
a	O
defect	O
in	O
initiation	O
complex	O
formation	O
.	O
A	O
database	O
search	O
revealed	O
the	O
existence	O
of	O
gene1s	ARG2
MED6	ARG2
gene1e	ARG2
-related	O
genes	O
in	O
arg1s	O
humans	O
arg1e	O
and	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
,	O
suggesting	O
that	O
the	O
role	O
of	O
mediator	O
in	O
transcriptional	O
activation	O
is	O
conserved	O
throughout	O
the	O
evolution	O
.	O

A	O
transcriptional	O
mediator	O
protein	O
that	O
is	O
required	O
for	O
activation	O
of	O
many	O
RNA	O
polymerase	O
II	O
promoters	O
and	O
is	O
conserved	O
from	O
species1s	O
yeast	O
species1e	O
to	O
species1s	O
humans	O
species1e	O
.	O
A	O
temperature	O
-	O
sensitive	O
mutation	O
was	O
obtained	O
in	O
gene1s	O
Med6p	O
gene1e	O
,	O
a	O
component	O
of	O
the	O
mediator	O
complex	O
from	O
the	O
species1s	O
yeast	O
species1e	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
.	O
The	O
mediator	O
complex	O
has	O
been	O
shown	O
to	O
enable	O
transcriptional	O
activation	O
in	O
vitro	O
.	O
This	O
mutation	O
in	O
gene1s	O
Med6p	O
gene1e	O
abolished	O
activation	O
of	O
transcription	O
from	O
four	O
of	O
five	O
inducible	O
promoters	O
tested	O
in	O
vivo	O
.	O
There	O
was	O
no	O
effect	O
,	O
however	O
,	O
on	O
uninduced	O
transcription	O
,	O
transcription	O
of	O
constitutively	O
expressed	O
genes	O
,	O
or	O
transcription	O
by	O
RNA	O
polymerases	O
I	O
and	O
III	O
.	O
Mediator	O
-	O
RNA	O
polymerase	O
II	O
complex	O
isolated	O
from	O
the	O
mutant	O
species1s	O
yeast	O
species1e	O
strain	O
was	O
temperature	O
sensitive	O
for	O
transcriptional	O
activation	O
in	O
a	O
reconstituted	O
in	O
vitro	O
system	O
due	O
to	O
a	O
defect	O
in	O
initiation	O
complex	O
formation	O
.	O
A	O
database	O
search	O
revealed	O
the	O
existence	O
of	O
gene1s	O
MED6	O
gene1e	O
-related	O
genes	O
in	O
species1s	O
humans	O
species1e	O
and	O
arg1s	O
Caenorhabditis	O
elegans	O
arg1e	O
,	O
suggesting	O
that	O
the	O
role	O
of	O
mediator	O
in	O
transcriptional	O
activation	O
is	O
conserved	O
throughout	O
the	O
evolution	O
.	O

Isolation	O
and	O
functional	O
analysis	O
of	O
a	O
cDNA	O
for	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
Jagged2	ARG2
gene1e	ARG2
,	O
a	O
gene	O
encoding	O
a	O
ligand	O
for	O
the	O
gene1s	ARG2
Notch1	ARG2
gene1e	ARG2
receptor	O
.	O
Signaling	O
through	O
Notch	O
receptors	O
has	O
been	O
implicated	O
in	O
the	O
control	O
of	O
cellular	O
differentiation	O
in	O
animals	O
ranging	O
from	O
nematodes	O
to	O
arg1s	O
humans	O
arg1e	O
.	O
Starting	O
from	O
a	O
arg1s	O
human	O
arg1e	O
expressed	O
sequence	O
tag	O
-	O
containing	O
sequence	O
resembling	O
that	O
of	O
gene1s	ARG2
Serrate	ARG2
gene1e	ARG2
,	O
the	O
gene	O
for	O
a	O
ligand	O
of	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
Notch	O
,	O
we	O
assembled	O
a	O
full	O
-	O
length	O
cDNA	O
,	O
now	O
called	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
Jagged2	ARG2
gene1e	ARG2
,	O
from	O
overlapping	O
cDNA	O
clones	O
.	O
The	O
full	O
-	O
length	O
cDNA	O
encodes	O
a	O
polypeptide	O
having	O
extensive	O
sequence	O
homology	O
to	O
gene1s	ARG2
Serrate	ARG2
gene1e	ARG2
(	O
40.6	O
%	O
identity	O
and	O
58.7	O
%	O
similarity	O
)	O
and	O
even	O
greater	O
homology	O
to	O
several	O
putative	O
arg1s	O
mammalian	O
arg1e	O
Notch	O
ligands	O
that	O
have	O
subsequently	O
been	O
described	O
.	O
When	O
in	O
situ	O
hybridization	O
was	O
performed	O
,	O
expression	O
of	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
Jagged2	O
gene1e	O
homolog	O
was	O
found	O
to	O
be	O
highest	O
in	O
fetal	O
thymus	O
,	O
epidermis	O
,	O
foregut	O
,	O
dorsal	O
root	O
ganglia	O
,	O
and	O
inner	O
ear	O
.	O
In	O
Northern	O
blot	O
analysis	O
of	O
RNA	O
from	O
tissues	O
of	O
2-week	O
-	O
old	O
species1s	O
mice	O
species1e	O
,	O
the	O
5.0-kb	O
gene1s	O
Jagged2	O
gene1e	O
transcript	O
was	O
most	O
abundant	O
in	O
heart	O
,	O
lung	O
,	O
thymus	O
,	O
skeletal	O
muscle	O
,	O
brain	O
,	O
and	O
testis	O
.	O
Immunohistochemistry	O
revealed	O
coexpression	O
of	O
gene1s	O
Jagged2	O
gene1e	O
and	O
gene1s	O
Notch1	O
gene1e	O
within	O
thymus	O
and	O
other	O
fetal	O
species1s	O
murine	O
species1e	O
tissues	O
,	O
consistent	O
with	O
interaction	O
of	O
the	O
two	O
proteins	O
in	O
vivo	O
.	O
Coculture	O
of	O
fibroblasts	O
expressing	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
Jagged2	ARG2
gene1e	ARG2
with	O
species1s	O
murine	O
species1e	O
C2C12	O
myoblasts	O
inhibited	O
myogenic	O
differentiation	O
,	O
accompanied	O
by	O
increased	O
gene1s	ARG2
Notch1	ARG2
gene1e	ARG2
and	O
the	O
appearance	O
of	O
a	O
novel	O
115-kDa	O
gene1s	ARG2
Notch1	ARG2
gene1e	ARG2
fragment	O
.	O
Exposure	O
of	O
species1s	O
C2C12	O
species1e	O
cells	O
to	O
gene1s	O
Jagged2	O
gene1e	O
led	O
to	O
increased	O
amounts	O
of	O
Notch	O
mRNA	O
as	O
well	O
as	O
mRNAs	O
for	O
a	O
second	O
Notch	O
receptor	O
,	O
gene1s	O
Notch3	O
gene1e	O
,	O
and	O
a	O
second	O
Notch	O
ligand	O
,	O
gene1s	O
Jagged1	O
gene1e	O
.	O
Constitutively	O
active	O
forms	O
of	O
Notchl	O
in	O
species1s	O
C2C12	O
species1e	O
cells	O
also	O
induced	O
increased	O
levels	O
of	O
the	O
same	O
set	O
of	O
mRNAs	O
,	O
suggesting	O
positive	O
feedback	O
control	O
of	O
these	O
genes	O
initiated	O
by	O
binding	O
of	O
gene1s	ARG2
Jagged2	ARG2
gene1e	ARG2
to	O
gene1s	ARG2
Notch1	ARG2
gene1e	ARG2
.	O
This	O
feedback	O
control	O
may	O
function	O
in	O
vivo	O
to	O
coordinate	O
differentiation	O
across	O
certain	O
groups	O
of	O
progenitor	O
cells	O
adopting	O
identical	O
cell	O
fates	O
.	O

Isolation	O
and	O
functional	O
analysis	O
of	O
a	O
cDNA	O
for	O
species1s	O
human	O
species1e	O
gene1s	O
Jagged2	O
gene1e	O
,	O
a	O
gene	O
encoding	O
a	O
ligand	O
for	O
the	O
gene1s	O
Notch1	O
gene1e	O
receptor	O
.	O
Signaling	O
through	O
Notch	O
receptors	O
has	O
been	O
implicated	O
in	O
the	O
control	O
of	O
cellular	O
differentiation	O
in	O
animals	O
ranging	O
from	O
nematodes	O
to	O
species1s	O
humans	O
species1e	O
.	O
Starting	O
from	O
a	O
species1s	O
human	O
species1e	O
expressed	O
sequence	O
tag	O
-	O
containing	O
sequence	O
resembling	O
that	O
of	O
gene1s	O
Serrate	O
gene1e	O
,	O
the	O
gene	O
for	O
a	O
ligand	O
of	O
arg1s	O
Drosophila	O
melanogaster	O
arg1e	O
Notch	O
,	O
we	O
assembled	O
a	O
full	O
-	O
length	O
cDNA	O
,	O
now	O
called	O
species1s	O
human	O
species1e	O
gene1s	O
Jagged2	O
gene1e	O
,	O
from	O
overlapping	O
cDNA	O
clones	O
.	O
The	O
full	O
-	O
length	O
cDNA	O
encodes	O
a	O
polypeptide	O
having	O
extensive	O
sequence	O
homology	O
to	O
gene1s	O
Serrate	O
gene1e	O
(	O
40.6	O
%	O
identity	O
and	O
58.7	O
%	O
similarity	O
)	O
and	O
even	O
greater	O
homology	O
to	O
several	O
putative	O
species1s	O
mammalian	O
species1e	O
Notch	O
ligands	O
that	O
have	O
subsequently	O
been	O
described	O
.	O
When	O
in	O
situ	O
hybridization	O
was	O
performed	O
,	O
expression	O
of	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
Jagged2	O
gene1e	O
homolog	O
was	O
found	O
to	O
be	O
highest	O
in	O
fetal	O
thymus	O
,	O
epidermis	O
,	O
foregut	O
,	O
dorsal	O
root	O
ganglia	O
,	O
and	O
inner	O
ear	O
.	O
In	O
Northern	O
blot	O
analysis	O
of	O
RNA	O
from	O
tissues	O
of	O
2-week	O
-	O
old	O
species1s	O
mice	O
species1e	O
,	O
the	O
5.0-kb	O
gene1s	O
Jagged2	O
gene1e	O
transcript	O
was	O
most	O
abundant	O
in	O
heart	O
,	O
lung	O
,	O
thymus	O
,	O
skeletal	O
muscle	O
,	O
brain	O
,	O
and	O
testis	O
.	O
Immunohistochemistry	O
revealed	O
coexpression	O
of	O
gene1s	O
Jagged2	O
gene1e	O
and	O
gene1s	O
Notch1	O
gene1e	O
within	O
thymus	O
and	O
other	O
fetal	O
species1s	O
murine	O
species1e	O
tissues	O
,	O
consistent	O
with	O
interaction	O
of	O
the	O
two	O
proteins	O
in	O
vivo	O
.	O
Coculture	O
of	O
fibroblasts	O
expressing	O
species1s	O
human	O
species1e	O
gene1s	O
Jagged2	O
gene1e	O
with	O
species1s	O
murine	O
species1e	O
C2C12	O
myoblasts	O
inhibited	O
myogenic	O
differentiation	O
,	O
accompanied	O
by	O
increased	O
gene1s	O
Notch1	O
gene1e	O
and	O
the	O
appearance	O
of	O
a	O
novel	O
115-kDa	O
gene1s	O
Notch1	O
gene1e	O
fragment	O
.	O
Exposure	O
of	O
species1s	O
C2C12	O
species1e	O
cells	O
to	O
gene1s	O
Jagged2	O
gene1e	O
led	O
to	O
increased	O
amounts	O
of	O
Notch	O
mRNA	O
as	O
well	O
as	O
mRNAs	O
for	O
a	O
second	O
Notch	O
receptor	O
,	O
gene1s	O
Notch3	O
gene1e	O
,	O
and	O
a	O
second	O
Notch	O
ligand	O
,	O
gene1s	O
Jagged1	O
gene1e	O
.	O
Constitutively	O
active	O
forms	O
of	O
Notchl	O
in	O
species1s	O
C2C12	O
species1e	O
cells	O
also	O
induced	O
increased	O
levels	O
of	O
the	O
same	O
set	O
of	O
mRNAs	O
,	O
suggesting	O
positive	O
feedback	O
control	O
of	O
these	O
genes	O
initiated	O
by	O
binding	O
of	O
gene1s	O
Jagged2	O
gene1e	O
to	O
gene1s	O
Notch1	O
gene1e	O
.	O
This	O
feedback	O
control	O
may	O
function	O
in	O
vivo	O
to	O
coordinate	O
differentiation	O
across	O
certain	O
groups	O
of	O
progenitor	O
cells	O
adopting	O
identical	O
cell	O
fates	O
.	O

Isolation	O
and	O
functional	O
analysis	O
of	O
a	O
cDNA	O
for	O
species1s	O
human	O
species1e	O
gene1s	O
Jagged2	O
gene1e	O
,	O
a	O
gene	O
encoding	O
a	O
ligand	O
for	O
the	O
gene1s	O
Notch1	O
gene1e	O
receptor	O
.	O
Signaling	O
through	O
Notch	O
receptors	O
has	O
been	O
implicated	O
in	O
the	O
control	O
of	O
cellular	O
differentiation	O
in	O
animals	O
ranging	O
from	O
nematodes	O
to	O
species1s	O
humans	O
species1e	O
.	O
Starting	O
from	O
a	O
species1s	O
human	O
species1e	O
expressed	O
sequence	O
tag	O
-	O
containing	O
sequence	O
resembling	O
that	O
of	O
gene1s	O
Serrate	O
gene1e	O
,	O
the	O
gene	O
for	O
a	O
ligand	O
of	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
Notch	O
,	O
we	O
assembled	O
a	O
full	O
-	O
length	O
cDNA	O
,	O
now	O
called	O
species1s	O
human	O
species1e	O
gene1s	O
Jagged2	O
gene1e	O
,	O
from	O
overlapping	O
cDNA	O
clones	O
.	O
The	O
full	O
-	O
length	O
cDNA	O
encodes	O
a	O
polypeptide	O
having	O
extensive	O
sequence	O
homology	O
to	O
gene1s	O
Serrate	O
gene1e	O
(	O
40.6	O
%	O
identity	O
and	O
58.7	O
%	O
similarity	O
)	O
and	O
even	O
greater	O
homology	O
to	O
several	O
putative	O
species1s	O
mammalian	O
species1e	O
Notch	O
ligands	O
that	O
have	O
subsequently	O
been	O
described	O
.	O
When	O
in	O
situ	O
hybridization	O
was	O
performed	O
,	O
expression	O
of	O
the	O
arg1s	O
murine	O
arg1e	O
gene1s	ARG2
Jagged2	ARG2
gene1e	ARG2
homolog	O
was	O
found	O
to	O
be	O
highest	O
in	O
fetal	O
thymus	O
,	O
epidermis	O
,	O
foregut	O
,	O
dorsal	O
root	O
ganglia	O
,	O
and	O
inner	O
ear	O
.	O
In	O
Northern	O
blot	O
analysis	O
of	O
RNA	O
from	O
tissues	O
of	O
2-week	O
-	O
old	O
arg1s	O
mice	O
arg1e	O
,	O
the	O
5.0-kb	O
gene1s	ARG2
Jagged2	ARG2
gene1e	ARG2
transcript	O
was	O
most	O
abundant	O
in	O
heart	O
,	O
lung	O
,	O
thymus	O
,	O
skeletal	O
muscle	O
,	O
brain	O
,	O
and	O
testis	O
.	O
Immunohistochemistry	O
revealed	O
coexpression	O
of	O
gene1s	ARG2
Jagged2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Notch1	ARG2
gene1e	ARG2
within	O
thymus	O
and	O
other	O
fetal	O
arg1s	O
murine	O
arg1e	O
tissues	O
,	O
consistent	O
with	O
interaction	O
of	O
the	O
two	O
proteins	O
in	O
vivo	O
.	O
Coculture	O
of	O
fibroblasts	O
expressing	O
species1s	O
human	O
species1e	O
gene1s	O
Jagged2	O
gene1e	O
with	O
arg1s	O
murine	O
arg1e	O
C2C12	O
myoblasts	O
inhibited	O
myogenic	O
differentiation	O
,	O
accompanied	O
by	O
increased	O
gene1s	O
Notch1	O
gene1e	O
and	O
the	O
appearance	O
of	O
a	O
novel	O
115-kDa	O
gene1s	O
Notch1	O
gene1e	O
fragment	O
.	O
Exposure	O
of	O
arg1s	O
C2C12	O
arg1e	O
cells	O
to	O
gene1s	ARG2
Jagged2	ARG2
gene1e	ARG2
led	O
to	O
increased	O
amounts	O
of	O
Notch	O
mRNA	O
as	O
well	O
as	O
mRNAs	O
for	O
a	O
second	O
Notch	O
receptor	O
,	O
gene1s	ARG2
Notch3	ARG2
gene1e	ARG2
,	O
and	O
a	O
second	O
Notch	O
ligand	O
,	O
gene1s	ARG2
Jagged1	ARG2
gene1e	ARG2
.	O
Constitutively	O
active	O
forms	O
of	O
Notchl	O
in	O
arg1s	O
C2C12	O
arg1e	O
cells	O
also	O
induced	O
increased	O
levels	O
of	O
the	O
same	O
set	O
of	O
mRNAs	O
,	O
suggesting	O
positive	O
feedback	O
control	O
of	O
these	O
genes	O
initiated	O
by	O
binding	O
of	O
gene1s	O
Jagged2	O
gene1e	O
to	O
gene1s	O
Notch1	O
gene1e	O
.	O
This	O
feedback	O
control	O
may	O
function	O
in	O
vivo	O
to	O
coordinate	O
differentiation	O
across	O
certain	O
groups	O
of	O
progenitor	O
cells	O
adopting	O
identical	O
cell	O
fates	O
.	O

Isolation	O
and	O
characterization	O
of	O
a	O
novel	O
ligand	O
-	O
dependent	O
thyroid	O
hormone	O
receptor	O
-	O
coactivating	O
protein	O
.	O
The	O
thyroid	O
hormone	O
receptor	O
(	O
TR	O
)	O
regulates	O
the	O
expression	O
of	O
target	O
genes	O
upon	O
binding	O
to	O
triiodothyronine	O
(	O
T3	O
)	O
response	O
elements	O
.	O
In	O
the	O
presence	O
of	O
T3	O
,	O
the	O
TR	O
recruits	O
coactivating	O
proteins	O
that	O
both	O
modulate	O
and	O
integrate	O
the	O
ligand	O
response	O
.	O
We	O
report	O
here	O
the	O
cloning	O
of	O
a	O
novel	O
protein	O
using	O
the	O
TR	O
ligand	O
-	O
binding	O
domain	O
as	O
bait	O
in	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
.	O
Analysis	O
of	O
a	O
putative	O
full	O
-	O
length	O
clone	O
demonstrates	O
a	O
cDNA	O
sequence	O
that	O
encodes	O
a	O
protein	O
of	O
920	O
amino	O
acids	O
with	O
a	O
size	O
of	O
120	O
kDa	O
(	O
gene1s	ARG2
p120	ARG2
gene1e	ARG2
)	O
.	O
Alignment	O
with	O
known	O
sequences	O
shows	O
homology	O
to	O
a	O
previously	O
identified	O
protein	O
of	O
unknown	O
function	O
,	O
termed	O
gene1s	ARG2
skeletal	ARG2
muscle	ARG2
abundant	ARG2
protein	ARG2
gene1e	ARG2
.	O
Interaction	O
studies	O
demonstrate	O
that	O
gene1s	ARG2
p120	ARG2
gene1e	ARG2
interacts	O
with	O
the	O
TR	O
AF-2	O
domain	O
in	O
the	O
presence	O
of	O
ligand	O
through	O
a	O
111-amino	O
acid	O
region	O
.	O
Northern	O
analysis	O
demonstrates	O
widespread	O
expression	O
in	O
arg1s	O
human	O
arg1e	O
tissues	O
.	O
Cotransfection	O
assays	O
in	O
species1s	O
CV-1	O
species1e	O
cells	O
demonstrate	O
that	O
gene1s	ARG2
p120	ARG2
gene1e	ARG2
enhances	O
TR	O
-	O
mediated	O
transactivation	O
on	O
multiple	O
T3	O
response	O
elements	O
in	O
the	O
presence	O
of	O
T3	O
.	O
In	O
addition	O
,	O
gene1s	ARG2
CREB	ARG2
-	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
synergizes	O
with	O
gene1s	ARG2
p120	ARG2
gene1e	ARG2
to	O
enhance	O
this	O
effect	O
.	O
When	O
linked	O
to	O
the	O
GAL4	O
DNA	O
-	O
binding	O
domain	O
,	O
gene1s	ARG2
p120	ARG2
gene1e	ARG2
is	O
an	O
activator	O
of	O
transcription	O
alone	O
.	O
Thus	O
,	O
gene1s	ARG2
p120	ARG2
gene1e	ARG2
satisfies	O
a	O
number	O
of	O
important	O
criteria	O
as	O
a	O
nuclear	O
receptor	O
coactivator	O
.	O

Isolation	O
and	O
characterization	O
of	O
a	O
novel	O
ligand	O
-	O
dependent	O
thyroid	O
hormone	O
receptor	O
-	O
coactivating	O
protein	O
.	O
The	O
thyroid	O
hormone	O
receptor	O
(	O
TR	O
)	O
regulates	O
the	O
expression	O
of	O
target	O
genes	O
upon	O
binding	O
to	O
triiodothyronine	O
(	O
T3	O
)	O
response	O
elements	O
.	O
In	O
the	O
presence	O
of	O
T3	O
,	O
the	O
TR	O
recruits	O
coactivating	O
proteins	O
that	O
both	O
modulate	O
and	O
integrate	O
the	O
ligand	O
response	O
.	O
We	O
report	O
here	O
the	O
cloning	O
of	O
a	O
novel	O
protein	O
using	O
the	O
TR	O
ligand	O
-	O
binding	O
domain	O
as	O
bait	O
in	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
.	O
Analysis	O
of	O
a	O
putative	O
full	O
-	O
length	O
clone	O
demonstrates	O
a	O
cDNA	O
sequence	O
that	O
encodes	O
a	O
protein	O
of	O
920	O
amino	O
acids	O
with	O
a	O
size	O
of	O
120	O
kDa	O
(	O
gene1s	O
p120	O
gene1e	O
)	O
.	O
Alignment	O
with	O
known	O
sequences	O
shows	O
homology	O
to	O
a	O
previously	O
identified	O
protein	O
of	O
unknown	O
function	O
,	O
termed	O
gene1s	O
skeletal	O
muscle	O
abundant	O
protein	O
gene1e	O
.	O
Interaction	O
studies	O
demonstrate	O
that	O
gene1s	O
p120	O
gene1e	O
interacts	O
with	O
the	O
TR	O
AF-2	O
domain	O
in	O
the	O
presence	O
of	O
ligand	O
through	O
a	O
111-amino	O
acid	O
region	O
.	O
Northern	O
analysis	O
demonstrates	O
widespread	O
expression	O
in	O
species1s	O
human	O
species1e	O
tissues	O
.	O
Cotransfection	O
assays	O
in	O
arg1s	O
CV-1	O
arg1e	O
cells	O
demonstrate	O
that	O
gene1s	O
p120	O
gene1e	O
enhances	O
TR	O
-	O
mediated	O
transactivation	O
on	O
multiple	O
T3	O
response	O
elements	O
in	O
the	O
presence	O
of	O
T3	O
.	O
In	O
addition	O
,	O
gene1s	O
CREB	O
-	O
binding	O
protein	O
gene1e	O
synergizes	O
with	O
gene1s	O
p120	O
gene1e	O
to	O
enhance	O
this	O
effect	O
.	O
When	O
linked	O
to	O
the	O
GAL4	O
DNA	O
-	O
binding	O
domain	O
,	O
gene1s	O
p120	O
gene1e	O
is	O
an	O
activator	O
of	O
transcription	O
alone	O
.	O
Thus	O
,	O
gene1s	O
p120	O
gene1e	O
satisfies	O
a	O
number	O
of	O
important	O
criteria	O
as	O
a	O
nuclear	O
receptor	O
coactivator	O
.	O

Cloning	O
and	O
functional	O
expression	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
GlcNAc-1-P	ARG2
transferase	ARG2
gene1e	ARG2
,	O
the	O
enzyme	O
for	O
the	O
committed	O
step	O
of	O
the	O
dolichol	O
cycle	O
,	O
by	O
heterologous	O
complementation	O
in	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
.	O
The	O
gene	O
for	O
the	O
arg1s	O
human	O
arg1e	O
dolichol	O
cycle	O
gene1s	ARG2
GlcNAc-1-P	ARG2
transferase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ALG7	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
GPT	ARG2
gene1e	ARG2
)	O
was	O
cloned	O
by	O
screening	O
a	O
arg1s	O
human	O
arg1e	O
lung	O
fibroblast	O
cDNA	O
library	O
.	O
The	O
library	O
was	O
constructed	O
in	O
a	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
expression	O
vector	O
,	O
and	O
the	O
positive	O
clone	O
was	O
identified	O
by	O
complementation	O
of	O
the	O
conditional	O
lethal	O
species1s	O
S.cerevisiae	O
species1e	O
strain	O
YPH	O
-	O
A7-GAL	O
.	O
This	O
strain	O
was	O
constructed	O
by	O
replacing	O
the	O
endogenous	O
promoter	O
of	O
the	O
gene1s	ARG2
GPT	ARG2
gene1e	ARG2
-	O
gene	O
by	O
the	O
stringently	O
regulated	O
GAL1-promoter	O
.	O
This	O
construct	O
allows	O
to	O
specifically	O
suppress	O
the	O
endogenous	O
enzyme	O
activity	O
.	O
The	O
insert	O
of	O
the	O
positive	O
clone	O
displayed	O
an	O
open	O
reading	O
frame	O
of	O
1200	O
nucleotides	O
,	O
coding	O
for	O
a	O
putative	O
protein	O
of	O
400	O
amino	O
acids	O
with	O
a	O
calculated	O
molecular	O
weight	O
of	O
44.7	O
kDa	O
.	O
The	O
deduced	O
protein	O
sequence	O
shows	O
a	O
homology	O
of	O
over	O
90	O
%	O
when	O
compared	O
with	O
other	O
arg1s	O
mammalian	O
arg1e	O
gene1s	ARG2
GPT	ARG2
gene1e	ARG2
sequences	O
,	O
thus	O
resembling	O
the	O
close	O
phylogenetic	O
relationship	O
between	O
arg1s	O
mammalian	O
arg1e	O
species	O
.	O
This	O
homology	O
however	O
decreases	O
to	O
40	O
-	O
50	O
%	O
when	O
compared	O
to	O
more	O
distantly	O
related	O
organisms	O
such	O
as	O
species1s	O
S.cerevisiae	O
species1e	O
,	O
species1s	O
Schizosaccharomyces	O
pombe	O
species1e	O
,	O
or	O
species1s	O
Leishmania	O
amazonensis	O
species1e	O
.	O
Biochemical	O
characterization	O
of	O
the	O
recombinant	O
protein	O
showed	O
that	O
it	O
is	O
functionally	O
expressed	O
in	O
the	O
species1s	O
S.cerevisiae	O
species1e	O
strain	O
YPH	O
-	O
A7-GAL	O
.	O
GlcNAc-	O
and	O
GlcNAc2-PP	O
-	O
Dolichol	O
biosynthesis	O
could	O
be	O
shown	O
with	O
isolated	O
species1s	O
S.cerevisiae	O
species1e	O
membranes	O
from	O
cells	O
harboring	O
the	O
recombinant	O
plasmid	O
and	O
grown	O
on	O
glucose	O
thus	O
suppressing	O
transcription	O
of	O
the	O
endogenous	O
gene	O
.	O
Synthesis	O
could	O
be	O
stimulated	O
by	O
dolicholphosphate	O
and	O
was	O
inhibited	O
by	O
tunicamycin	O
.	O
These	O
results	O
show	O
that	O
we	O
have	O
cloned	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
GlcNAc-1-P	ARG2
transferase	ARG2
gene1e	ARG2
by	O
heterologous	O
complementation	O
in	O
species1s	O
S.	O
cerevisiae	O
species1e	O
,	O
a	O
strategy	O
that	O
may	O
be	O
useful	O
for	O
the	O
cloning	O
and	O
characterization	O
of	O
glycosyltransferases	O
from	O
a	O
variety	O
of	O
organisms	O
.	O

Cloning	O
and	O
functional	O
expression	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
GlcNAc-1-P	O
transferase	O
gene1e	O
,	O
the	O
enzyme	O
for	O
the	O
committed	O
step	O
of	O
the	O
dolichol	O
cycle	O
,	O
by	O
heterologous	O
complementation	O
in	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
.	O
The	O
gene	O
for	O
the	O
species1s	O
human	O
species1e	O
dolichol	O
cycle	O
gene1s	O
GlcNAc-1-P	O
transferase	O
gene1e	O
(	O
gene1s	O
ALG7	O
gene1e	O
/	O
gene1s	O
GPT	O
gene1e	O
)	O
was	O
cloned	O
by	O
screening	O
a	O
species1s	O
human	O
species1e	O
lung	O
fibroblast	O
cDNA	O
library	O
.	O
The	O
library	O
was	O
constructed	O
in	O
a	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
expression	O
vector	O
,	O
and	O
the	O
positive	O
clone	O
was	O
identified	O
by	O
complementation	O
of	O
the	O
conditional	O
lethal	O
arg1s	O
S.cerevisiae	O
arg1e	O
strain	O
YPH	O
-	O
A7-GAL	O
.	O
This	O
strain	O
was	O
constructed	O
by	O
replacing	O
the	O
endogenous	O
promoter	O
of	O
the	O
gene1s	O
GPT	O
gene1e	O
-	O
gene	O
by	O
the	O
stringently	O
regulated	O
GAL1-promoter	O
.	O
This	O
construct	O
allows	O
to	O
specifically	O
suppress	O
the	O
endogenous	O
enzyme	O
activity	O
.	O
The	O
insert	O
of	O
the	O
positive	O
clone	O
displayed	O
an	O
open	O
reading	O
frame	O
of	O
1200	O
nucleotides	O
,	O
coding	O
for	O
a	O
putative	O
protein	O
of	O
400	O
amino	O
acids	O
with	O
a	O
calculated	O
molecular	O
weight	O
of	O
44.7	O
kDa	O
.	O
The	O
deduced	O
protein	O
sequence	O
shows	O
a	O
homology	O
of	O
over	O
90	O
%	O
when	O
compared	O
with	O
other	O
species1s	O
mammalian	O
species1e	O
gene1s	O
GPT	O
gene1e	O
sequences	O
,	O
thus	O
resembling	O
the	O
close	O
phylogenetic	O
relationship	O
between	O
species1s	O
mammalian	O
species1e	O
species	O
.	O
This	O
homology	O
however	O
decreases	O
to	O
40	O
-	O
50	O
%	O
when	O
compared	O
to	O
more	O
distantly	O
related	O
organisms	O
such	O
as	O
arg1s	O
S.cerevisiae	O
arg1e	O
,	O
species1s	O
Schizosaccharomyces	O
pombe	O
species1e	O
,	O
or	O
species1s	O
Leishmania	O
amazonensis	O
species1e	O
.	O
Biochemical	O
characterization	O
of	O
the	O
recombinant	O
protein	O
showed	O
that	O
it	O
is	O
functionally	O
expressed	O
in	O
the	O
arg1s	O
S.cerevisiae	O
arg1e	O
strain	O
YPH	O
-	O
A7-GAL	O
.	O
GlcNAc-	O
and	O
GlcNAc2-PP	O
-	O
Dolichol	O
biosynthesis	O
could	O
be	O
shown	O
with	O
isolated	O
arg1s	O
S.cerevisiae	O
arg1e	O
membranes	O
from	O
cells	O
harboring	O
the	O
recombinant	O
plasmid	O
and	O
grown	O
on	O
glucose	O
thus	O
suppressing	O
transcription	O
of	O
the	O
endogenous	O
gene	O
.	O
Synthesis	O
could	O
be	O
stimulated	O
by	O
dolicholphosphate	O
and	O
was	O
inhibited	O
by	O
tunicamycin	O
.	O
These	O
results	O
show	O
that	O
we	O
have	O
cloned	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
GlcNAc-1-P	O
transferase	O
gene1e	O
by	O
heterologous	O
complementation	O
in	O
arg1s	O
S.	O
cerevisiae	O
arg1e	O
,	O
a	O
strategy	O
that	O
may	O
be	O
useful	O
for	O
the	O
cloning	O
and	O
characterization	O
of	O
glycosyltransferases	O
from	O
a	O
variety	O
of	O
organisms	O
.	O

Cloning	O
and	O
functional	O
expression	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
GlcNAc-1-P	O
transferase	O
gene1e	O
,	O
the	O
enzyme	O
for	O
the	O
committed	O
step	O
of	O
the	O
dolichol	O
cycle	O
,	O
by	O
heterologous	O
complementation	O
in	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
.	O
The	O
gene	O
for	O
the	O
species1s	O
human	O
species1e	O
dolichol	O
cycle	O
gene1s	O
GlcNAc-1-P	O
transferase	O
gene1e	O
(	O
gene1s	O
ALG7	O
gene1e	O
/	O
gene1s	O
GPT	O
gene1e	O
)	O
was	O
cloned	O
by	O
screening	O
a	O
species1s	O
human	O
species1e	O
lung	O
fibroblast	O
cDNA	O
library	O
.	O
The	O
library	O
was	O
constructed	O
in	O
a	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
expression	O
vector	O
,	O
and	O
the	O
positive	O
clone	O
was	O
identified	O
by	O
complementation	O
of	O
the	O
conditional	O
lethal	O
species1s	O
S.cerevisiae	O
species1e	O
strain	O
YPH	O
-	O
A7-GAL	O
.	O
This	O
strain	O
was	O
constructed	O
by	O
replacing	O
the	O
endogenous	O
promoter	O
of	O
the	O
gene1s	O
GPT	O
gene1e	O
-	O
gene	O
by	O
the	O
stringently	O
regulated	O
GAL1-promoter	O
.	O
This	O
construct	O
allows	O
to	O
specifically	O
suppress	O
the	O
endogenous	O
enzyme	O
activity	O
.	O
The	O
insert	O
of	O
the	O
positive	O
clone	O
displayed	O
an	O
open	O
reading	O
frame	O
of	O
1200	O
nucleotides	O
,	O
coding	O
for	O
a	O
putative	O
protein	O
of	O
400	O
amino	O
acids	O
with	O
a	O
calculated	O
molecular	O
weight	O
of	O
44.7	O
kDa	O
.	O
The	O
deduced	O
protein	O
sequence	O
shows	O
a	O
homology	O
of	O
over	O
90	O
%	O
when	O
compared	O
with	O
other	O
species1s	O
mammalian	O
species1e	O
gene1s	O
GPT	O
gene1e	O
sequences	O
,	O
thus	O
resembling	O
the	O
close	O
phylogenetic	O
relationship	O
between	O
species1s	O
mammalian	O
species1e	O
species	O
.	O
This	O
homology	O
however	O
decreases	O
to	O
40	O
-	O
50	O
%	O
when	O
compared	O
to	O
more	O
distantly	O
related	O
organisms	O
such	O
as	O
species1s	O
S.cerevisiae	O
species1e	O
,	O
arg1s	O
Schizosaccharomyces	O
pombe	O
arg1e	O
,	O
or	O
species1s	O
Leishmania	O
amazonensis	O
species1e	O
.	O
Biochemical	O
characterization	O
of	O
the	O
recombinant	O
protein	O
showed	O
that	O
it	O
is	O
functionally	O
expressed	O
in	O
the	O
species1s	O
S.cerevisiae	O
species1e	O
strain	O
YPH	O
-	O
A7-GAL	O
.	O
GlcNAc-	O
and	O
GlcNAc2-PP	O
-	O
Dolichol	O
biosynthesis	O
could	O
be	O
shown	O
with	O
isolated	O
species1s	O
S.cerevisiae	O
species1e	O
membranes	O
from	O
cells	O
harboring	O
the	O
recombinant	O
plasmid	O
and	O
grown	O
on	O
glucose	O
thus	O
suppressing	O
transcription	O
of	O
the	O
endogenous	O
gene	O
.	O
Synthesis	O
could	O
be	O
stimulated	O
by	O
dolicholphosphate	O
and	O
was	O
inhibited	O
by	O
tunicamycin	O
.	O
These	O
results	O
show	O
that	O
we	O
have	O
cloned	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
GlcNAc-1-P	O
transferase	O
gene1e	O
by	O
heterologous	O
complementation	O
in	O
species1s	O
S.	O
cerevisiae	O
species1e	O
,	O
a	O
strategy	O
that	O
may	O
be	O
useful	O
for	O
the	O
cloning	O
and	O
characterization	O
of	O
glycosyltransferases	O
from	O
a	O
variety	O
of	O
organisms	O
.	O

Cloning	O
and	O
functional	O
expression	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
GlcNAc-1-P	O
transferase	O
gene1e	O
,	O
the	O
enzyme	O
for	O
the	O
committed	O
step	O
of	O
the	O
dolichol	O
cycle	O
,	O
by	O
heterologous	O
complementation	O
in	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
.	O
The	O
gene	O
for	O
the	O
species1s	O
human	O
species1e	O
dolichol	O
cycle	O
gene1s	O
GlcNAc-1-P	O
transferase	O
gene1e	O
(	O
gene1s	O
ALG7	O
gene1e	O
/	O
gene1s	O
GPT	O
gene1e	O
)	O
was	O
cloned	O
by	O
screening	O
a	O
species1s	O
human	O
species1e	O
lung	O
fibroblast	O
cDNA	O
library	O
.	O
The	O
library	O
was	O
constructed	O
in	O
a	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
expression	O
vector	O
,	O
and	O
the	O
positive	O
clone	O
was	O
identified	O
by	O
complementation	O
of	O
the	O
conditional	O
lethal	O
species1s	O
S.cerevisiae	O
species1e	O
strain	O
YPH	O
-	O
A7-GAL	O
.	O
This	O
strain	O
was	O
constructed	O
by	O
replacing	O
the	O
endogenous	O
promoter	O
of	O
the	O
gene1s	O
GPT	O
gene1e	O
-	O
gene	O
by	O
the	O
stringently	O
regulated	O
GAL1-promoter	O
.	O
This	O
construct	O
allows	O
to	O
specifically	O
suppress	O
the	O
endogenous	O
enzyme	O
activity	O
.	O
The	O
insert	O
of	O
the	O
positive	O
clone	O
displayed	O
an	O
open	O
reading	O
frame	O
of	O
1200	O
nucleotides	O
,	O
coding	O
for	O
a	O
putative	O
protein	O
of	O
400	O
amino	O
acids	O
with	O
a	O
calculated	O
molecular	O
weight	O
of	O
44.7	O
kDa	O
.	O
The	O
deduced	O
protein	O
sequence	O
shows	O
a	O
homology	O
of	O
over	O
90	O
%	O
when	O
compared	O
with	O
other	O
species1s	O
mammalian	O
species1e	O
gene1s	O
GPT	O
gene1e	O
sequences	O
,	O
thus	O
resembling	O
the	O
close	O
phylogenetic	O
relationship	O
between	O
species1s	O
mammalian	O
species1e	O
species	O
.	O
This	O
homology	O
however	O
decreases	O
to	O
40	O
-	O
50	O
%	O
when	O
compared	O
to	O
more	O
distantly	O
related	O
organisms	O
such	O
as	O
species1s	O
S.cerevisiae	O
species1e	O
,	O
species1s	O
Schizosaccharomyces	O
pombe	O
species1e	O
,	O
or	O
arg1s	O
Leishmania	O
amazonensis	O
arg1e	O
.	O
Biochemical	O
characterization	O
of	O
the	O
recombinant	O
protein	O
showed	O
that	O
it	O
is	O
functionally	O
expressed	O
in	O
the	O
species1s	O
S.cerevisiae	O
species1e	O
strain	O
YPH	O
-	O
A7-GAL	O
.	O
GlcNAc-	O
and	O
GlcNAc2-PP	O
-	O
Dolichol	O
biosynthesis	O
could	O
be	O
shown	O
with	O
isolated	O
species1s	O
S.cerevisiae	O
species1e	O
membranes	O
from	O
cells	O
harboring	O
the	O
recombinant	O
plasmid	O
and	O
grown	O
on	O
glucose	O
thus	O
suppressing	O
transcription	O
of	O
the	O
endogenous	O
gene	O
.	O
Synthesis	O
could	O
be	O
stimulated	O
by	O
dolicholphosphate	O
and	O
was	O
inhibited	O
by	O
tunicamycin	O
.	O
These	O
results	O
show	O
that	O
we	O
have	O
cloned	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
GlcNAc-1-P	O
transferase	O
gene1e	O
by	O
heterologous	O
complementation	O
in	O
species1s	O
S.	O
cerevisiae	O
species1e	O
,	O
a	O
strategy	O
that	O
may	O
be	O
useful	O
for	O
the	O
cloning	O
and	O
characterization	O
of	O
glycosyltransferases	O
from	O
a	O
variety	O
of	O
organisms	O
.	O

Mutations	O
in	O
gene1s	ARG2
PROP1	ARG2
gene1e	ARG2
cause	O
familial	O
combined	O
pituitary	O
hormone	O
deficiency	O
.	O
Combined	O
pituitary	O
hormone	O
deficiency	O
(	O
CPHD	O
)	O
in	O
man	O
denotes	O
impaired	O
production	O
of	O
gene1s	ARG2
growth	ARG2
hormone	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
GH	ARG2
gene1e	ARG2
)	O
and	O
one	O
or	O
more	O
of	O
the	O
other	O
five	O
anterior	O
pituitary	O
hormones	O
.	O
Mutations	O
of	O
the	O
pituitary	O
transcription	O
factor	O
gene	O
gene1s	ARG2
POU1F1	ARG2
gene1e	ARG2
(	O
the	O
arg1s	O
human	O
arg1e	O
homologue	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	ARG2
Pit1	ARG2
gene1e	ARG2
)	O
are	O
responsible	O
for	O
deficiencies	O
of	O
gene1s	ARG2
GH	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
prolactin	ARG2
gene1e	ARG2
and	O
thyroid	O
stimulating	O
hormone	O
(	O
TSH	O
)	O
in	O
Snell	O
and	O
Jackson	O
dwarf	O
species1s	O
mice	O
species1e	O
and	O
in	O
man	O
,	O
while	O
the	O
production	O
of	O
adrenocorticotrophic	O
hormone	O
(	O
ACTH	O
)	O
,	O
luteinizing	O
hormone	O
(	O
LH	O
)	O
and	O
follicle	O
stimulating	O
hormone	O
(	O
FSH	O
)	O
is	O
preserved	O
.	O
The	O
gene1s	O
Ames	O
dwarf	O
gene1e	O
(	O
df	O
)	O
species1s	O
mouse	O
species1e	O
displays	O
a	O
similar	O
phenotype	O
,	O
and	O
appears	O
to	O
be	O
epistatic	O
to	O
Snell	O
and	O
Jackson	O
dwarfism	O
.	O
We	O
have	O
recently	O
positionally	O
cloned	O
the	O
putative	O
gene1s	O
Ames	O
dwarf	O
gene1e	O
gene	O
gene1s	O
Prop1	O
gene1e	O
,	O
which	O
encodes	O
a	O
paired	O
-	O
like	O
homeodomain	O
protein	O
that	O
is	O
expressed	O
specifically	O
in	O
embryonic	O
pituitary	O
and	O
is	O
necessary	O
for	O
gene1s	O
Pit1	O
gene1e	O
expression	O
.	O
In	O
this	O
report	O
,	O
we	O
have	O
identified	O
four	O
CPHD	O
families	O
with	O
homozygosity	O
or	O
compound	O
heterozygosity	O
for	O
inactivating	O
mutations	O
of	O
gene1s	ARG2
PROP1	ARG2
gene1e	ARG2
.	O
These	O
mutations	O
in	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
PROP1	ARG2
gene1e	ARG2
gene	O
result	O
in	O
a	O
gene	O
product	O
with	O
reduced	O
DNA	O
-	O
binding	O
and	O
transcriptional	O
activation	O
ability	O
in	O
comparison	O
to	O
the	O
product	O
of	O
the	O
species1s	O
murine	O
species1e	O
df	O
mutation	O
.	O
In	O
contrast	O
to	O
individuals	O
with	O
gene1s	ARG2
POU1F1	ARG2
gene1e	ARG2
mutations	O
,	O
those	O
with	O
gene1s	ARG2
PROP1	ARG2
gene1e	ARG2
mutations	O
can	O
not	O
produce	O
LH	O
and	O
FSH	O
at	O
a	O
sufficient	O
level	O
and	O
do	O
not	O
enter	O
puberty	O
spontaneously	O
.	O
Our	O
results	O
identify	O
a	O
major	O
cause	O
of	O
CPHD	O
in	O
arg1s	O
humans	O
arg1e	O
and	O
suggest	O
a	O
direct	O
or	O
indirect	O
role	O
for	O
gene1s	ARG2
PROP1	ARG2
gene1e	ARG2
in	O
the	O
ontogenesis	O
of	O
pituitary	O
gonadotropes	O
,	O
as	O
well	O
as	O
somatotropes	O
,	O
lactotropes	O
and	O
caudomedial	O
thyrotropes	O
.	O

Mutations	O
in	O
gene1s	O
PROP1	O
gene1e	O
cause	O
familial	O
combined	O
pituitary	O
hormone	O
deficiency	O
.	O
Combined	O
pituitary	O
hormone	O
deficiency	O
(	O
CPHD	O
)	O
in	O
man	O
denotes	O
impaired	O
production	O
of	O
gene1s	O
growth	O
hormone	O
gene1e	O
(	O
gene1s	O
GH	O
gene1e	O
)	O
and	O
one	O
or	O
more	O
of	O
the	O
other	O
five	O
anterior	O
pituitary	O
hormones	O
.	O
Mutations	O
of	O
the	O
pituitary	O
transcription	O
factor	O
gene	O
gene1s	O
POU1F1	O
gene1e	O
(	O
the	O
species1s	O
human	O
species1e	O
homologue	O
of	O
arg1s	O
mouse	O
arg1e	O
gene1s	O
Pit1	O
gene1e	O
)	O
are	O
responsible	O
for	O
deficiencies	O
of	O
gene1s	O
GH	O
gene1e	O
,	O
gene1s	O
prolactin	O
gene1e	O
and	O
thyroid	O
stimulating	O
hormone	O
(	O
TSH	O
)	O
in	O
Snell	O
and	O
Jackson	O
dwarf	O
arg1s	O
mice	O
arg1e	O
and	O
in	O
man	O
,	O
while	O
the	O
production	O
of	O
adrenocorticotrophic	O
hormone	O
(	O
ACTH	O
)	O
,	O
luteinizing	O
hormone	O
(	O
LH	O
)	O
and	O
follicle	O
stimulating	O
hormone	O
(	O
FSH	O
)	O
is	O
preserved	O
.	O
The	O
gene1s	ARG2
Ames	ARG2
dwarf	ARG2
gene1e	ARG2
(	O
df	O
)	O
arg1s	O
mouse	O
arg1e	O
displays	O
a	O
similar	O
phenotype	O
,	O
and	O
appears	O
to	O
be	O
epistatic	O
to	O
Snell	O
and	O
Jackson	O
dwarfism	O
.	O
We	O
have	O
recently	O
positionally	O
cloned	O
the	O
putative	O
gene1s	ARG2
Ames	ARG2
dwarf	ARG2
gene1e	ARG2
gene	O
gene1s	ARG2
Prop1	ARG2
gene1e	ARG2
,	O
which	O
encodes	O
a	O
paired	O
-	O
like	O
homeodomain	O
protein	O
that	O
is	O
expressed	O
specifically	O
in	O
embryonic	O
pituitary	O
and	O
is	O
necessary	O
for	O
gene1s	ARG2
Pit1	ARG2
gene1e	ARG2
expression	O
.	O
In	O
this	O
report	O
,	O
we	O
have	O
identified	O
four	O
CPHD	O
families	O
with	O
homozygosity	O
or	O
compound	O
heterozygosity	O
for	O
inactivating	O
mutations	O
of	O
gene1s	O
PROP1	O
gene1e	O
.	O
These	O
mutations	O
in	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
PROP1	O
gene1e	O
gene	O
result	O
in	O
a	O
gene	O
product	O
with	O
reduced	O
DNA	O
-	O
binding	O
and	O
transcriptional	O
activation	O
ability	O
in	O
comparison	O
to	O
the	O
product	O
of	O
the	O
arg1s	O
murine	O
arg1e	O
df	O
mutation	O
.	O
In	O
contrast	O
to	O
individuals	O
with	O
gene1s	O
POU1F1	O
gene1e	O
mutations	O
,	O
those	O
with	O
gene1s	O
PROP1	O
gene1e	O
mutations	O
can	O
not	O
produce	O
LH	O
and	O
FSH	O
at	O
a	O
sufficient	O
level	O
and	O
do	O
not	O
enter	O
puberty	O
spontaneously	O
.	O
Our	O
results	O
identify	O
a	O
major	O
cause	O
of	O
CPHD	O
in	O
species1s	O
humans	O
species1e	O
and	O
suggest	O
a	O
direct	O
or	O
indirect	O
role	O
for	O
gene1s	O
PROP1	O
gene1e	O
in	O
the	O
ontogenesis	O
of	O
pituitary	O
gonadotropes	O
,	O
as	O
well	O
as	O
somatotropes	O
,	O
lactotropes	O
and	O
caudomedial	O
thyrotropes	O
.	O

Discovery	O
of	O
three	O
novel	O
G	O
-	O
protein	O
-	O
coupled	O
receptor	O
genes	O
.	O
We	O
report	O
here	O
the	O
molecular	O
cloning	O
,	O
tissue	O
distribution	O
,	O
and	O
chromosomal	O
localization	O
of	O
novel	O
genes	O
encoding	O
G	O
-	O
protein	O
-	O
coupled	O
receptors	O
(	O
GPCRs	O
)	O
.	O
A	O
search	O
of	O
a	O
arg1s	O
mouse	O
arg1e	O
database	O
of	O
expressed	O
sequence	O
tags	O
revealed	O
an	O
EST	O
partially	O
encoding	O
a	O
GPCR	O
,	O
which	O
was	O
used	O
to	O
screen	O
a	O
arg1s	O
mouse	O
arg1e	O
genomic	O
library	O
to	O
obtain	O
the	O
translational	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
.	O
The	O
resultant	O
clone	O
,	O
gene1s	O
GPR27	O
gene1e	O
,	O
contained	O
an	O
intronless	O
ORF	O
,	O
encoding	O
a	O
receptor	O
of	O
379	O
amino	O
acids	O
.	O
In	O
an	O
alternate	O
strategy	O
,	O
species1s	O
human	O
species1e	O
genomic	O
DNA	O
was	O
subjected	O
to	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
amplification	O
,	O
using	O
degenerate	O
oligonucleotides	O
based	O
on	O
gene1s	O
GPR1	O
gene1e	O
.	O
Two	O
PCR	O
products	O
partially	O
encoding	O
GPCRs	O
were	O
isolated	O
and	O
used	O
to	O
screen	O
a	O
genomic	O
library	O
to	O
obtain	O
the	O
translational	O
ORF	O
.	O
One	O
of	O
the	O
resultant	O
clones	O
,	O
gene1s	O
GPR30	O
gene1e	O
,	O
contained	O
an	O
intronless	O
ORF	O
encoding	O
a	O
receptor	O
of	O
375	O
amino	O
acids	O
.	O
The	O
other	O
clone	O
,	O
gene1s	O
GPR35	O
gene1e	O
,	O
also	O
contained	O
an	O
intronless	O
ORF	O
encoding	O
a	O
receptor	O
of	O
309	O
amino	O
acids	O
.	O
Transcripts	O
corresponding	O
to	O
gene1s	O
GPR27	O
gene1e	O
and	O
gene1s	O
GPR30	O
gene1e	O
were	O
detected	O
in	O
several	O
areas	O
of	O
species1s	O
human	O
species1e	O
and	O
species1s	O
rat	O
species1e	O
CNS	O
,	O
While	O
gene1s	O
GPR35	O
gene1e	O
expression	O
was	O
detected	O
only	O
in	O
the	O
species1s	O
rat	O
species1e	O
intestine	O
.	O
Through	O
fluorescence	O
in	O
situ	O
hybridization	O
analysis	O
the	O
gene	O
encoding	O
gene1s	O
GPR30	O
gene1e	O
was	O
localized	O
to	O
chromosome	O
7p22	O
and	O
gene1s	O
GPR35	O
gene1e	O
to	O
chromosome	O
2q37.3	O
.	O

Discovery	O
of	O
three	O
novel	O
G	O
-	O
protein	O
-	O
coupled	O
receptor	O
genes	O
.	O
We	O
report	O
here	O
the	O
molecular	O
cloning	O
,	O
tissue	O
distribution	O
,	O
and	O
chromosomal	O
localization	O
of	O
novel	O
genes	O
encoding	O
G	O
-	O
protein	O
-	O
coupled	O
receptors	O
(	O
GPCRs	O
)	O
.	O
A	O
search	O
of	O
a	O
species1s	O
mouse	O
species1e	O
database	O
of	O
expressed	O
sequence	O
tags	O
revealed	O
an	O
EST	O
partially	O
encoding	O
a	O
GPCR	O
,	O
which	O
was	O
used	O
to	O
screen	O
a	O
species1s	O
mouse	O
species1e	O
genomic	O
library	O
to	O
obtain	O
the	O
translational	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
.	O
The	O
resultant	O
clone	O
,	O
gene1s	ARG2
GPR27	ARG2
gene1e	ARG2
,	O
contained	O
an	O
intronless	O
ORF	O
,	O
encoding	O
a	O
receptor	O
of	O
379	O
amino	O
acids	O
.	O
In	O
an	O
alternate	O
strategy	O
,	O
arg1s	O
human	O
arg1e	O
genomic	O
DNA	O
was	O
subjected	O
to	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
amplification	O
,	O
using	O
degenerate	O
oligonucleotides	O
based	O
on	O
gene1s	ARG2
GPR1	ARG2
gene1e	ARG2
.	O
Two	O
PCR	O
products	O
partially	O
encoding	O
GPCRs	O
were	O
isolated	O
and	O
used	O
to	O
screen	O
a	O
genomic	O
library	O
to	O
obtain	O
the	O
translational	O
ORF	O
.	O
One	O
of	O
the	O
resultant	O
clones	O
,	O
gene1s	ARG2
GPR30	ARG2
gene1e	ARG2
,	O
contained	O
an	O
intronless	O
ORF	O
encoding	O
a	O
receptor	O
of	O
375	O
amino	O
acids	O
.	O
The	O
other	O
clone	O
,	O
gene1s	ARG2
GPR35	ARG2
gene1e	ARG2
,	O
also	O
contained	O
an	O
intronless	O
ORF	O
encoding	O
a	O
receptor	O
of	O
309	O
amino	O
acids	O
.	O
Transcripts	O
corresponding	O
to	O
gene1s	ARG2
GPR27	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
GPR30	ARG2
gene1e	ARG2
were	O
detected	O
in	O
several	O
areas	O
of	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
rat	O
species1e	O
CNS	O
,	O
While	O
gene1s	O
GPR35	O
gene1e	O
expression	O
was	O
detected	O
only	O
in	O
the	O
species1s	O
rat	O
species1e	O
intestine	O
.	O
Through	O
fluorescence	O
in	O
situ	O
hybridization	O
analysis	O
the	O
gene	O
encoding	O
gene1s	ARG2
GPR30	ARG2
gene1e	ARG2
was	O
localized	O
to	O
chromosome	O
7p22	O
and	O
gene1s	ARG2
GPR35	ARG2
gene1e	ARG2
to	O
chromosome	O
2q37.3	O
.	O

Discovery	O
of	O
three	O
novel	O
G	O
-	O
protein	O
-	O
coupled	O
receptor	O
genes	O
.	O
We	O
report	O
here	O
the	O
molecular	O
cloning	O
,	O
tissue	O
distribution	O
,	O
and	O
chromosomal	O
localization	O
of	O
novel	O
genes	O
encoding	O
G	O
-	O
protein	O
-	O
coupled	O
receptors	O
(	O
GPCRs	O
)	O
.	O
A	O
search	O
of	O
a	O
species1s	O
mouse	O
species1e	O
database	O
of	O
expressed	O
sequence	O
tags	O
revealed	O
an	O
EST	O
partially	O
encoding	O
a	O
GPCR	O
,	O
which	O
was	O
used	O
to	O
screen	O
a	O
species1s	O
mouse	O
species1e	O
genomic	O
library	O
to	O
obtain	O
the	O
translational	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
.	O
The	O
resultant	O
clone	O
,	O
gene1s	O
GPR27	O
gene1e	O
,	O
contained	O
an	O
intronless	O
ORF	O
,	O
encoding	O
a	O
receptor	O
of	O
379	O
amino	O
acids	O
.	O
In	O
an	O
alternate	O
strategy	O
,	O
species1s	O
human	O
species1e	O
genomic	O
DNA	O
was	O
subjected	O
to	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
amplification	O
,	O
using	O
degenerate	O
oligonucleotides	O
based	O
on	O
gene1s	O
GPR1	O
gene1e	O
.	O
Two	O
PCR	O
products	O
partially	O
encoding	O
GPCRs	O
were	O
isolated	O
and	O
used	O
to	O
screen	O
a	O
genomic	O
library	O
to	O
obtain	O
the	O
translational	O
ORF	O
.	O
One	O
of	O
the	O
resultant	O
clones	O
,	O
gene1s	O
GPR30	O
gene1e	O
,	O
contained	O
an	O
intronless	O
ORF	O
encoding	O
a	O
receptor	O
of	O
375	O
amino	O
acids	O
.	O
The	O
other	O
clone	O
,	O
gene1s	O
GPR35	O
gene1e	O
,	O
also	O
contained	O
an	O
intronless	O
ORF	O
encoding	O
a	O
receptor	O
of	O
309	O
amino	O
acids	O
.	O
Transcripts	O
corresponding	O
to	O
gene1s	ARG2
GPR27	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
GPR30	ARG2
gene1e	ARG2
were	O
detected	O
in	O
several	O
areas	O
of	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
rat	O
arg1e	O
CNS	O
,	O
While	O
gene1s	ARG2
GPR35	ARG2
gene1e	ARG2
expression	O
was	O
detected	O
only	O
in	O
the	O
arg1s	O
rat	O
arg1e	O
intestine	O
.	O
Through	O
fluorescence	O
in	O
situ	O
hybridization	O
analysis	O
the	O
gene	O
encoding	O
gene1s	O
GPR30	O
gene1e	O
was	O
localized	O
to	O
chromosome	O
7p22	O
and	O
gene1s	O
GPR35	O
gene1e	O
to	O
chromosome	O
2q37.3	O
.	O

The	O
C	O
-	O
terminus	O
of	O
the	O
arg1s	O
HTLV-1	O
arg1e	O
gene1s	ARG2
Tax	ARG2
gene1e	ARG2
oncoprotein	O
mediates	O
interaction	O
with	O
the	O
PDZ	O
domain	O
of	O
cellular	O
proteins	O
.	O
Infection	O
by	O
arg1s	O
HTLV-1	O
arg1e	O
has	O
been	O
correlated	O
with	O
the	O
appearance	O
of	O
various	O
proliferative	O
or	O
degenerative	O
diseases	O
.	O
Some	O
of	O
these	O
disorders	O
have	O
been	O
observed	O
in	O
species1s	O
transgenic	O
mice	O
species1e	O
expressing	O
the	O
gene1s	ARG2
Tax	ARG2
gene1e	ARG2
protein	O
,	O
which	O
is	O
known	O
to	O
transactivate	O
various	O
viral	O
and	O
cellular	O
promoters	O
through	O
interactions	O
with	O
several	O
transcription	O
factors	O
.	O
In	O
this	O
study	O
we	O
show	O
that	O
the	O
C	O
-	O
terminus	O
of	O
this	O
viral	O
oncoprotein	O
represents	O
a	O
motif	O
permitting	O
binding	O
of	O
gene1s	ARG2
Tax	ARG2
gene1e	ARG2
to	O
the	O
PDZ	O
domains	O
of	O
several	O
cellular	O
proteins	O
.	O
A	O
two	O
-	O
hybrid	O
screen	O
with	O
gene1s	ARG2
Tax	ARG2
gene1e	ARG2
as	O
bait	O
indeed	O
yielded	O
complementary	O
DNAs	O
coding	O
for	O
six	O
proteins	O
including	O
PDZ	O
domains	O
.	O
Two	O
of	O
them	O
correspond	O
to	O
truncated	O
forms	O
of	O
the	O
gene1s	O
PSD-95	O
gene1e	O
and	O
gene1s	O
beta1-syntrophin	O
gene1e	O
proteins	O
,	O
another	O
clone	O
codes	O
for	O
a	O
protein	O
homologous	O
to	O
the	O
product	O
of	O
the	O
species1s	O
C.	O
elegans	O
species1e	O
gene	O
gene1s	O
lin-7	O
gene1e	O
.	O
The	O
other	O
three	O
clones	O
code	O
for	O
new	O
species1s	O
human	O
species1e	O
members	O
of	O
the	O
PDZ	O
family	O
of	O
cellular	O
proteins	O
.	O
The	O
interaction	O
of	O
gene1s	ARG2
Tax	ARG2
gene1e	ARG2
with	O
the	O
products	O
of	O
these	O
clones	O
was	O
confirmed	O
by	O
immunoprecipitation	O
assays	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
,	O
and	O
analysis	O
of	O
various	O
mutants	O
of	O
gene1s	ARG2
Tax	ARG2
gene1e	ARG2
established	O
the	O
importance	O
of	O
the	O
C	O
-	O
terminal	O
amino	O
acids	O
for	O
several	O
of	O
these	O
interactions	O
.	O
These	O
data	O
suggest	O
that	O
gene1s	ARG2
Tax	ARG2
gene1e	ARG2
could	O
perturb	O
the	O
normal	O
function	O
of	O
targeted	O
cellular	O
proteins	O
by	O
strongly	O
interacting	O
with	O
their	O
PDZ	O
domains	O
.	O

The	O
C	O
-	O
terminus	O
of	O
the	O
species1s	O
HTLV-1	O
species1e	O
gene1s	O
Tax	O
gene1e	O
oncoprotein	O
mediates	O
interaction	O
with	O
the	O
PDZ	O
domain	O
of	O
cellular	O
proteins	O
.	O
Infection	O
by	O
species1s	O
HTLV-1	O
species1e	O
has	O
been	O
correlated	O
with	O
the	O
appearance	O
of	O
various	O
proliferative	O
or	O
degenerative	O
diseases	O
.	O
Some	O
of	O
these	O
disorders	O
have	O
been	O
observed	O
in	O
arg1s	O
transgenic	O
mice	O
arg1e	O
expressing	O
the	O
gene1s	O
Tax	O
gene1e	O
protein	O
,	O
which	O
is	O
known	O
to	O
transactivate	O
various	O
viral	O
and	O
cellular	O
promoters	O
through	O
interactions	O
with	O
several	O
transcription	O
factors	O
.	O
In	O
this	O
study	O
we	O
show	O
that	O
the	O
C	O
-	O
terminus	O
of	O
this	O
viral	O
oncoprotein	O
represents	O
a	O
motif	O
permitting	O
binding	O
of	O
gene1s	O
Tax	O
gene1e	O
to	O
the	O
PDZ	O
domains	O
of	O
several	O
cellular	O
proteins	O
.	O
A	O
two	O
-	O
hybrid	O
screen	O
with	O
gene1s	O
Tax	O
gene1e	O
as	O
bait	O
indeed	O
yielded	O
complementary	O
DNAs	O
coding	O
for	O
six	O
proteins	O
including	O
PDZ	O
domains	O
.	O
Two	O
of	O
them	O
correspond	O
to	O
truncated	O
forms	O
of	O
the	O
gene1s	O
PSD-95	O
gene1e	O
and	O
gene1s	O
beta1-syntrophin	O
gene1e	O
proteins	O
,	O
another	O
clone	O
codes	O
for	O
a	O
protein	O
homologous	O
to	O
the	O
product	O
of	O
the	O
species1s	O
C.	O
elegans	O
species1e	O
gene	O
gene1s	O
lin-7	O
gene1e	O
.	O
The	O
other	O
three	O
clones	O
code	O
for	O
new	O
species1s	O
human	O
species1e	O
members	O
of	O
the	O
PDZ	O
family	O
of	O
cellular	O
proteins	O
.	O
The	O
interaction	O
of	O
gene1s	O
Tax	O
gene1e	O
with	O
the	O
products	O
of	O
these	O
clones	O
was	O
confirmed	O
by	O
immunoprecipitation	O
assays	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
,	O
and	O
analysis	O
of	O
various	O
mutants	O
of	O
gene1s	O
Tax	O
gene1e	O
established	O
the	O
importance	O
of	O
the	O
C	O
-	O
terminal	O
amino	O
acids	O
for	O
several	O
of	O
these	O
interactions	O
.	O
These	O
data	O
suggest	O
that	O
gene1s	O
Tax	O
gene1e	O
could	O
perturb	O
the	O
normal	O
function	O
of	O
targeted	O
cellular	O
proteins	O
by	O
strongly	O
interacting	O
with	O
their	O
PDZ	O
domains	O
.	O

The	O
C	O
-	O
terminus	O
of	O
the	O
species1s	O
HTLV-1	O
species1e	O
gene1s	O
Tax	O
gene1e	O
oncoprotein	O
mediates	O
interaction	O
with	O
the	O
PDZ	O
domain	O
of	O
cellular	O
proteins	O
.	O
Infection	O
by	O
species1s	O
HTLV-1	O
species1e	O
has	O
been	O
correlated	O
with	O
the	O
appearance	O
of	O
various	O
proliferative	O
or	O
degenerative	O
diseases	O
.	O
Some	O
of	O
these	O
disorders	O
have	O
been	O
observed	O
in	O
species1s	O
transgenic	O
mice	O
species1e	O
expressing	O
the	O
gene1s	O
Tax	O
gene1e	O
protein	O
,	O
which	O
is	O
known	O
to	O
transactivate	O
various	O
viral	O
and	O
cellular	O
promoters	O
through	O
interactions	O
with	O
several	O
transcription	O
factors	O
.	O
In	O
this	O
study	O
we	O
show	O
that	O
the	O
C	O
-	O
terminus	O
of	O
this	O
viral	O
oncoprotein	O
represents	O
a	O
motif	O
permitting	O
binding	O
of	O
gene1s	O
Tax	O
gene1e	O
to	O
the	O
PDZ	O
domains	O
of	O
several	O
cellular	O
proteins	O
.	O
A	O
two	O
-	O
hybrid	O
screen	O
with	O
gene1s	O
Tax	O
gene1e	O
as	O
bait	O
indeed	O
yielded	O
complementary	O
DNAs	O
coding	O
for	O
six	O
proteins	O
including	O
PDZ	O
domains	O
.	O
Two	O
of	O
them	O
correspond	O
to	O
truncated	O
forms	O
of	O
the	O
gene1s	O
PSD-95	O
gene1e	O
and	O
gene1s	O
beta1-syntrophin	O
gene1e	O
proteins	O
,	O
another	O
clone	O
codes	O
for	O
a	O
protein	O
homologous	O
to	O
the	O
product	O
of	O
the	O
arg1s	O
C.	O
elegans	O
arg1e	O
gene	O
gene1s	ARG2
lin-7	ARG2
gene1e	ARG2
.	O
The	O
other	O
three	O
clones	O
code	O
for	O
new	O
species1s	O
human	O
species1e	O
members	O
of	O
the	O
PDZ	O
family	O
of	O
cellular	O
proteins	O
.	O
The	O
interaction	O
of	O
gene1s	O
Tax	O
gene1e	O
with	O
the	O
products	O
of	O
these	O
clones	O
was	O
confirmed	O
by	O
immunoprecipitation	O
assays	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
,	O
and	O
analysis	O
of	O
various	O
mutants	O
of	O
gene1s	O
Tax	O
gene1e	O
established	O
the	O
importance	O
of	O
the	O
C	O
-	O
terminal	O
amino	O
acids	O
for	O
several	O
of	O
these	O
interactions	O
.	O
These	O
data	O
suggest	O
that	O
gene1s	O
Tax	O
gene1e	O
could	O
perturb	O
the	O
normal	O
function	O
of	O
targeted	O
cellular	O
proteins	O
by	O
strongly	O
interacting	O
with	O
their	O
PDZ	O
domains	O
.	O

The	O
C	O
-	O
terminus	O
of	O
the	O
species1s	O
HTLV-1	O
species1e	O
gene1s	O
Tax	O
gene1e	O
oncoprotein	O
mediates	O
interaction	O
with	O
the	O
PDZ	O
domain	O
of	O
cellular	O
proteins	O
.	O
Infection	O
by	O
species1s	O
HTLV-1	O
species1e	O
has	O
been	O
correlated	O
with	O
the	O
appearance	O
of	O
various	O
proliferative	O
or	O
degenerative	O
diseases	O
.	O
Some	O
of	O
these	O
disorders	O
have	O
been	O
observed	O
in	O
species1s	O
transgenic	O
mice	O
species1e	O
expressing	O
the	O
gene1s	O
Tax	O
gene1e	O
protein	O
,	O
which	O
is	O
known	O
to	O
transactivate	O
various	O
viral	O
and	O
cellular	O
promoters	O
through	O
interactions	O
with	O
several	O
transcription	O
factors	O
.	O
In	O
this	O
study	O
we	O
show	O
that	O
the	O
C	O
-	O
terminus	O
of	O
this	O
viral	O
oncoprotein	O
represents	O
a	O
motif	O
permitting	O
binding	O
of	O
gene1s	O
Tax	O
gene1e	O
to	O
the	O
PDZ	O
domains	O
of	O
several	O
cellular	O
proteins	O
.	O
A	O
two	O
-	O
hybrid	O
screen	O
with	O
gene1s	O
Tax	O
gene1e	O
as	O
bait	O
indeed	O
yielded	O
complementary	O
DNAs	O
coding	O
for	O
six	O
proteins	O
including	O
PDZ	O
domains	O
.	O
Two	O
of	O
them	O
correspond	O
to	O
truncated	O
forms	O
of	O
the	O
gene1s	ARG2
PSD-95	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
beta1-syntrophin	ARG2
gene1e	ARG2
proteins	O
,	O
another	O
clone	O
codes	O
for	O
a	O
protein	O
homologous	O
to	O
the	O
product	O
of	O
the	O
species1s	O
C.	O
elegans	O
species1e	O
gene	O
gene1s	O
lin-7	O
gene1e	O
.	O
The	O
other	O
three	O
clones	O
code	O
for	O
new	O
arg1s	O
human	O
arg1e	O
members	O
of	O
the	O
PDZ	O
family	O
of	O
cellular	O
proteins	O
.	O
The	O
interaction	O
of	O
gene1s	O
Tax	O
gene1e	O
with	O
the	O
products	O
of	O
these	O
clones	O
was	O
confirmed	O
by	O
immunoprecipitation	O
assays	O
in	O
arg1s	O
mammalian	O
arg1e	O
cells	O
,	O
and	O
analysis	O
of	O
various	O
mutants	O
of	O
gene1s	O
Tax	O
gene1e	O
established	O
the	O
importance	O
of	O
the	O
C	O
-	O
terminal	O
amino	O
acids	O
for	O
several	O
of	O
these	O
interactions	O
.	O
These	O
data	O
suggest	O
that	O
gene1s	O
Tax	O
gene1e	O
could	O
perturb	O
the	O
normal	O
function	O
of	O
targeted	O
cellular	O
proteins	O
by	O
strongly	O
interacting	O
with	O
their	O
PDZ	O
domains	O
.	O

Interaction	O
of	O
polyadenylate	O
-	O
binding	O
protein	O
with	O
the	O
gene1s	O
eIF4	O
G	O
gene1e	O
homologue	O
PAIP	O
enhances	O
translation	O
.	O
In	O
the	O
initiation	O
of	O
translation	O
in	O
eukaryotes	O
,	O
binding	O
of	O
the	O
small	O
ribosomal	O
subunit	O
to	O
the	O
messenger	O
RNA	O
results	O
from	O
recognition	O
of	O
the	O
5	O
'	O
cap	O
structure	O
(	O
m7GpppX	O
)	O
of	O
the	O
mRNA	O
by	O
the	O
cap	O
-	O
binding	O
complex	O
eIF4F.	O
eIF4F	O
is	O
itself	O
a	O
three	O
-	O
subunit	O
complex	O
comprising	O
the	O
cap	O
-	O
binding	O
protein	O
gene1s	O
eIF4E	O
gene1e	O
,	O
gene1s	O
eIF4A	O
gene1e	O
,	O
an	O
ATP	O
-	O
dependent	O
RNA	O
helicase	O
,	O
and	O
gene1s	O
eIF4	O
G	O
gene1e	O
,	O
which	O
interacts	O
with	O
both	O
gene1s	O
eIF4A	O
gene1e	O
and	O
gene1s	O
eIF4E	O
gene1e	O
and	O
enhances	O
cap	O
binding	O
by	O
gene1s	O
eIF4E	O
gene1e	O
.	O
The	O
mRNA	O
3	O
'	O
polyadenylate	O
tail	O
and	O
the	O
associated	O
gene1s	O
poly(A)-binding	O
protein	O
gene1e	O
(	O
gene1s	O
PABP	O
gene1e	O
)	O
also	O
regulate	O
translational	O
initiation	O
,	O
probably	O
by	O
interacting	O
with	O
the	O
5	O
'	O
end	O
of	O
the	O
mRNA	O
.	O
In	O
arg1s	O
yeast	O
arg1e	O
and	O
plants	O
,	O
gene1s	O
PABP	O
gene1e	O
interacts	O
with	O
gene1s	O
eIF4	O
G	O
gene1e	O
but	O
no	O
such	O
interaction	O
has	O
been	O
reported	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
.	O
Here	O
,	O
we	O
describe	O
a	O
new	O
species1s	O
human	O
species1e	O
gene1s	O
PABP	O
gene1e	O
-	O
interacting	O
protein	O
,	O
gene1s	O
PAIP	O
-	O
I	O
gene1e	O
,	O
whose	O
sequence	O
is	O
similar	O
to	O
the	O
central	O
portion	O
of	O
gene1s	O
eIF4	O
G	O
gene1e	O
and	O
which	O
interacts	O
with	O
gene1s	O
eIF4A	O
gene1e	O
.	O
Overexpression	O
of	O
gene1s	O
PAIP-1	O
gene1e	O
in	O
species1s	O
COS-7	O
species1e	O
cells	O
stimulates	O
translation	O
,	O
perhaps	O
by	O
providing	O
a	O
physical	O
link	O
between	O
the	O
mRNA	O
termini	O
.	O

Interaction	O
of	O
polyadenylate	O
-	O
binding	O
protein	O
with	O
the	O
gene1s	ARG2
eIF4	ARG2
G	ARG2
gene1e	ARG2
homologue	O
PAIP	O
enhances	O
translation	O
.	O
In	O
the	O
initiation	O
of	O
translation	O
in	O
eukaryotes	O
,	O
binding	O
of	O
the	O
small	O
ribosomal	O
subunit	O
to	O
the	O
messenger	O
RNA	O
results	O
from	O
recognition	O
of	O
the	O
5	O
'	O
cap	O
structure	O
(	O
m7GpppX	O
)	O
of	O
the	O
mRNA	O
by	O
the	O
cap	O
-	O
binding	O
complex	O
eIF4F.	O
eIF4F	O
is	O
itself	O
a	O
three	O
-	O
subunit	O
complex	O
comprising	O
the	O
cap	O
-	O
binding	O
protein	O
gene1s	ARG2
eIF4E	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
eIF4A	ARG2
gene1e	ARG2
,	O
an	O
ATP	O
-	O
dependent	O
RNA	O
helicase	O
,	O
and	O
gene1s	ARG2
eIF4	ARG2
G	ARG2
gene1e	ARG2
,	O
which	O
interacts	O
with	O
both	O
gene1s	ARG2
eIF4A	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
eIF4E	ARG2
gene1e	ARG2
and	O
enhances	O
cap	O
binding	O
by	O
gene1s	ARG2
eIF4E	ARG2
gene1e	ARG2
.	O
The	O
mRNA	O
3	O
'	O
polyadenylate	O
tail	O
and	O
the	O
associated	O
gene1s	ARG2
poly(A)-binding	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PABP	ARG2
gene1e	ARG2
)	O
also	O
regulate	O
translational	O
initiation	O
,	O
probably	O
by	O
interacting	O
with	O
the	O
5	O
'	O
end	O
of	O
the	O
mRNA	O
.	O
In	O
species1s	O
yeast	O
species1e	O
and	O
plants	O
,	O
gene1s	ARG2
PABP	ARG2
gene1e	ARG2
interacts	O
with	O
gene1s	ARG2
eIF4	ARG2
G	ARG2
gene1e	ARG2
but	O
no	O
such	O
interaction	O
has	O
been	O
reported	O
in	O
arg1s	O
mammalian	O
arg1e	O
cells	O
.	O
Here	O
,	O
we	O
describe	O
a	O
new	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
PABP	ARG2
gene1e	ARG2
-	O
interacting	O
protein	O
,	O
gene1s	ARG2
PAIP	ARG2
-	ARG2
I	ARG2
gene1e	ARG2
,	O
whose	O
sequence	O
is	O
similar	O
to	O
the	O
central	O
portion	O
of	O
gene1s	ARG2
eIF4	ARG2
G	ARG2
gene1e	ARG2
and	O
which	O
interacts	O
with	O
gene1s	ARG2
eIF4A	ARG2
gene1e	ARG2
.	O
Overexpression	O
of	O
gene1s	ARG2
PAIP-1	ARG2
gene1e	ARG2
in	O
species1s	O
COS-7	O
species1e	O
cells	O
stimulates	O
translation	O
,	O
perhaps	O
by	O
providing	O
a	O
physical	O
link	O
between	O
the	O
mRNA	O
termini	O
.	O

Interaction	O
of	O
polyadenylate	O
-	O
binding	O
protein	O
with	O
the	O
gene1s	O
eIF4	O
G	O
gene1e	O
homologue	O
PAIP	O
enhances	O
translation	O
.	O
In	O
the	O
initiation	O
of	O
translation	O
in	O
eukaryotes	O
,	O
binding	O
of	O
the	O
small	O
ribosomal	O
subunit	O
to	O
the	O
messenger	O
RNA	O
results	O
from	O
recognition	O
of	O
the	O
5	O
'	O
cap	O
structure	O
(	O
m7GpppX	O
)	O
of	O
the	O
mRNA	O
by	O
the	O
cap	O
-	O
binding	O
complex	O
eIF4F.	O
eIF4F	O
is	O
itself	O
a	O
three	O
-	O
subunit	O
complex	O
comprising	O
the	O
cap	O
-	O
binding	O
protein	O
gene1s	O
eIF4E	O
gene1e	O
,	O
gene1s	O
eIF4A	O
gene1e	O
,	O
an	O
ATP	O
-	O
dependent	O
RNA	O
helicase	O
,	O
and	O
gene1s	O
eIF4	O
G	O
gene1e	O
,	O
which	O
interacts	O
with	O
both	O
gene1s	O
eIF4A	O
gene1e	O
and	O
gene1s	O
eIF4E	O
gene1e	O
and	O
enhances	O
cap	O
binding	O
by	O
gene1s	O
eIF4E	O
gene1e	O
.	O
The	O
mRNA	O
3	O
'	O
polyadenylate	O
tail	O
and	O
the	O
associated	O
gene1s	O
poly(A)-binding	O
protein	O
gene1e	O
(	O
gene1s	O
PABP	O
gene1e	O
)	O
also	O
regulate	O
translational	O
initiation	O
,	O
probably	O
by	O
interacting	O
with	O
the	O
5	O
'	O
end	O
of	O
the	O
mRNA	O
.	O
In	O
species1s	O
yeast	O
species1e	O
and	O
plants	O
,	O
gene1s	O
PABP	O
gene1e	O
interacts	O
with	O
gene1s	O
eIF4	O
G	O
gene1e	O
but	O
no	O
such	O
interaction	O
has	O
been	O
reported	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
.	O
Here	O
,	O
we	O
describe	O
a	O
new	O
species1s	O
human	O
species1e	O
gene1s	O
PABP	O
gene1e	O
-	O
interacting	O
protein	O
,	O
gene1s	O
PAIP	O
-	O
I	O
gene1e	O
,	O
whose	O
sequence	O
is	O
similar	O
to	O
the	O
central	O
portion	O
of	O
gene1s	O
eIF4	O
G	O
gene1e	O
and	O
which	O
interacts	O
with	O
gene1s	O
eIF4A	O
gene1e	O
.	O
Overexpression	O
of	O
gene1s	O
PAIP-1	O
gene1e	O
in	O
arg1s	O
COS-7	O
arg1e	O
cells	O
stimulates	O
translation	O
,	O
perhaps	O
by	O
providing	O
a	O
physical	O
link	O
between	O
the	O
mRNA	O
termini	O
.	O

Homology	O
between	O
a	O
arg1s	O
human	O
arg1e	O
apoptosis	O
specific	O
protein	O
and	O
the	O
product	O
of	O
gene1s	O
APG5	O
gene1e	O
,	O
a	O
gene	O
involved	O
in	O
autophagy	O
in	O
species1s	O
yeast	O
species1e	O
.	O
Apoptosis	O
specific	O
proteins	O
(	O
ASP	O
)	O
are	O
expressed	O
in	O
the	O
cytoplasm	O
of	O
cultured	O
arg1s	O
mammalian	O
arg1e	O
cells	O
of	O
various	O
lineages	O
following	O
induction	O
of	O
apoptosis	O
.	O
The	O
cDNA	O
encoding	O
ASP	O
has	O
been	O
cloned	O
from	O
a	O
arg1s	O
human	O
arg1e	O
expression	O
library	O
and	O
has	O
significant	O
homology	O
to	O
the	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
gene1s	O
APG5	O
gene1e	O
gene	O
which	O
is	O
essential	O
for	O
species1s	O
yeast	O
species1e	O
autophagy	O
.	O
The	O
ASP	O
gene	O
,	O
known	O
as	O
gene1s	ARG2
hAPG5	ARG2
gene1e	ARG2
,	O
can	O
be	O
transcribed	O
to	O
give	O
mRNAs	O
of	O
3.3	O
kbp	O
,	O
2.5	O
kbp	O
and	O
1.8	O
kbp	O
which	O
are	O
present	O
at	O
comparable	O
levels	O
in	O
viable	O
and	O
apoptotic	O
cells	O
,	O
demonstrating	O
that	O
protein	O
expression	O
must	O
be	O
regulated	O
at	O
the	O
translational	O
level	O
.	O
These	O
data	O
indicate	O
a	O
possible	O
relationship	O
between	O
apoptosis	O
and	O
autophagy	O
and	O
suggest	O
evolutionary	O
conservation	O
in	O
arg1s	O
mammalian	O
arg1e	O
apoptosis	O
of	O
a	O
degradative	O
process	O
present	O
in	O
species1s	O
yeast	O
species1e	O
.	O

Homology	O
between	O
a	O
species1s	O
human	O
species1e	O
apoptosis	O
specific	O
protein	O
and	O
the	O
product	O
of	O
gene1s	ARG2
APG5	ARG2
gene1e	ARG2
,	O
a	O
gene	O
involved	O
in	O
autophagy	O
in	O
arg1s	O
yeast	O
arg1e	O
.	O
Apoptosis	O
specific	O
proteins	O
(	O
ASP	O
)	O
are	O
expressed	O
in	O
the	O
cytoplasm	O
of	O
cultured	O
species1s	O
mammalian	O
species1e	O
cells	O
of	O
various	O
lineages	O
following	O
induction	O
of	O
apoptosis	O
.	O
The	O
cDNA	O
encoding	O
ASP	O
has	O
been	O
cloned	O
from	O
a	O
species1s	O
human	O
species1e	O
expression	O
library	O
and	O
has	O
significant	O
homology	O
to	O
the	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
gene1s	ARG2
APG5	ARG2
gene1e	ARG2
gene	O
which	O
is	O
essential	O
for	O
arg1s	O
yeast	O
arg1e	O
autophagy	O
.	O
The	O
ASP	O
gene	O
,	O
known	O
as	O
gene1s	O
hAPG5	O
gene1e	O
,	O
can	O
be	O
transcribed	O
to	O
give	O
mRNAs	O
of	O
3.3	O
kbp	O
,	O
2.5	O
kbp	O
and	O
1.8	O
kbp	O
which	O
are	O
present	O
at	O
comparable	O
levels	O
in	O
viable	O
and	O
apoptotic	O
cells	O
,	O
demonstrating	O
that	O
protein	O
expression	O
must	O
be	O
regulated	O
at	O
the	O
translational	O
level	O
.	O
These	O
data	O
indicate	O
a	O
possible	O
relationship	O
between	O
apoptosis	O
and	O
autophagy	O
and	O
suggest	O
evolutionary	O
conservation	O
in	O
species1s	O
mammalian	O
species1e	O
apoptosis	O
of	O
a	O
degradative	O
process	O
present	O
in	O
arg1s	O
yeast	O
arg1e	O
.	O

Mutations	O
in	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
alpha	ARG2
-	ARG2
tectorin	ARG2
gene1e	ARG2
gene	O
cause	O
autosomal	O
dominant	O
non	O
-	O
syndromic	O
hearing	O
impairment	O
.	O
The	O
tectorial	O
membrane	O
is	O
an	O
extracellular	O
matrix	O
of	O
the	O
inner	O
ear	O
that	O
contacts	O
the	O
stereocilia	O
bundles	O
of	O
specialized	O
sensory	O
hair	O
cells	O
.	O
Sound	O
induces	O
movement	O
of	O
these	O
hair	O
cells	O
relative	O
to	O
the	O
tectorial	O
membrane	O
,	O
deflects	O
the	O
stereocilia	O
,	O
and	O
leads	O
to	O
fluctuations	O
in	O
hair	O
-	O
cell	O
membrane	O
potential	O
,	O
transducing	O
sound	O
into	O
electrical	O
signals	O
.	O
gene1s	ARG2
Alpha	ARG2
-	ARG2
tectorin	ARG2
gene1e	ARG2
is	O
one	O
of	O
the	O
major	O
non	O
-	O
collagenous	O
components	O
of	O
the	O
tectorial	O
membrane	O
.	O
Recently	O
,	O
the	O
gene	O
encoding	O
species1s	O
mouse	O
species1e	O
gene1s	O
alpha	O
-	O
tectorin	O
gene1e	O
(	O
gene1s	O
Tecta	O
gene1e	O
)	O
was	O
mapped	O
to	O
a	O
region	O
of	O
species1s	O
mouse	O
species1e	O
chromosome	O
9	O
,	O
which	O
shows	O
evolutionary	O
conservation	O
with	O
arg1s	O
human	O
arg1e	O
chromosome	O
11q	O
(	O
ref	O
.	O
3	O
)	O
,	O
where	O
linkage	O
was	O
found	O
in	O
two	O
families	O
,	O
one	O
Belgian	O
(	O
DFNA12	O
;	O
ref	O
.	O
4	O
)	O
and	O
the	O
other	O
,	O
Austrian	O
(	O
DFNA8	O
;	O
unpublished	O
data	O
)	O
,	O
with	O
autosomal	O
dominant	O
non	O
-	O
syndromic	O
hearing	O
impairment	O
.	O
We	O
determined	O
the	O
complete	O
sequence	O
and	O
the	O
intron	O
-	O
exon	O
structure	O
of	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
TECTA	ARG2
gene1e	ARG2
gene	O
.	O
In	O
both	O
families	O
,	O
mutation	O
analysis	O
revealed	O
missense	O
mutations	O
which	O
replace	O
conserved	O
amino	O
-	O
acid	O
residues	O
within	O
the	O
zona	O
pellucida	O
domain	O
of	O
gene1s	ARG2
TECTA	ARG2
gene1e	ARG2
.	O
These	O
findings	O
indicate	O
that	O
mutations	O
in	O
gene1s	ARG2
TECTA	ARG2
gene1e	ARG2
are	O
responsible	O
for	O
hearing	O
impairment	O
in	O
these	O
families	O
,	O
and	O
implicate	O
a	O
new	O
type	O
of	O
protein	O
in	O
the	O
pathogenesis	O
of	O
hearing	O
impairment	O
.	O

Mutations	O
in	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
alpha	O
-	O
tectorin	O
gene1e	O
gene	O
cause	O
autosomal	O
dominant	O
non	O
-	O
syndromic	O
hearing	O
impairment	O
.	O
The	O
tectorial	O
membrane	O
is	O
an	O
extracellular	O
matrix	O
of	O
the	O
inner	O
ear	O
that	O
contacts	O
the	O
stereocilia	O
bundles	O
of	O
specialized	O
sensory	O
hair	O
cells	O
.	O
Sound	O
induces	O
movement	O
of	O
these	O
hair	O
cells	O
relative	O
to	O
the	O
tectorial	O
membrane	O
,	O
deflects	O
the	O
stereocilia	O
,	O
and	O
leads	O
to	O
fluctuations	O
in	O
hair	O
-	O
cell	O
membrane	O
potential	O
,	O
transducing	O
sound	O
into	O
electrical	O
signals	O
.	O
gene1s	O
Alpha	O
-	O
tectorin	O
gene1e	O
is	O
one	O
of	O
the	O
major	O
non	O
-	O
collagenous	O
components	O
of	O
the	O
tectorial	O
membrane	O
.	O
Recently	O
,	O
the	O
gene	O
encoding	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
alpha	ARG2
-	ARG2
tectorin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Tecta	ARG2
gene1e	ARG2
)	O
was	O
mapped	O
to	O
a	O
region	O
of	O
arg1s	O
mouse	O
arg1e	O
chromosome	O
9	O
,	O
which	O
shows	O
evolutionary	O
conservation	O
with	O
species1s	O
human	O
species1e	O
chromosome	O
11q	O
(	O
ref	O
.	O
3	O
)	O
,	O
where	O
linkage	O
was	O
found	O
in	O
two	O
families	O
,	O
one	O
Belgian	O
(	O
DFNA12	O
;	O
ref	O
.	O
4	O
)	O
and	O
the	O
other	O
,	O
Austrian	O
(	O
DFNA8	O
;	O
unpublished	O
data	O
)	O
,	O
with	O
autosomal	O
dominant	O
non	O
-	O
syndromic	O
hearing	O
impairment	O
.	O
We	O
determined	O
the	O
complete	O
sequence	O
and	O
the	O
intron	O
-	O
exon	O
structure	O
of	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
TECTA	O
gene1e	O
gene	O
.	O
In	O
both	O
families	O
,	O
mutation	O
analysis	O
revealed	O
missense	O
mutations	O
which	O
replace	O
conserved	O
amino	O
-	O
acid	O
residues	O
within	O
the	O
zona	O
pellucida	O
domain	O
of	O
gene1s	O
TECTA	O
gene1e	O
.	O
These	O
findings	O
indicate	O
that	O
mutations	O
in	O
gene1s	O
TECTA	O
gene1e	O
are	O
responsible	O
for	O
hearing	O
impairment	O
in	O
these	O
families	O
,	O
and	O
implicate	O
a	O
new	O
type	O
of	O
protein	O
in	O
the	O
pathogenesis	O
of	O
hearing	O
impairment	O
.	O

A	O
novel	O
homeobox	O
gene	O
gene1s	ARG2
PITX3	ARG2
gene1e	ARG2
is	O
mutated	O
in	O
families	O
with	O
autosomal	O
-	O
dominant	O
cataracts	O
and	O
ASMD	O
.	O
We	O
report	O
here	O
the	O
identification	O
of	O
a	O
new	O
arg1s	O
human	O
arg1e	O
homeobox	O
gene	O
,	O
gene1s	ARG2
PITX3	ARG2
gene1e	ARG2
,	O
and	O
its	O
involvement	O
in	O
anterior	O
segment	O
mesenchymal	O
dysgenesis	O
(	O
ASMD	O
)	O
and	O
congenital	O
cataracts	O
in	O
arg1s	O
humans	O
arg1e	O
.	O
The	O
gene1s	ARG2
PITX3	ARG2
gene1e	ARG2
gene	O
is	O
the	O
arg1s	O
human	O
arg1e	O
homologue	O
of	O
the	O
species1s	O
mouse	O
species1e	O
gene1s	O
Pitx3	O
gene1e	O
gene	O
and	O
is	O
a	O
member	O
of	O
the	O
RIEG	O
/	O
PITX	O
homeobox	O
gene	O
family	O
.	O
The	O
protein	O
encoded	O
by	O
gene1s	ARG2
PITX3	ARG2
gene1e	ARG2
shows	O
99	O
%	O
amino	O
-	O
acid	O
identity	O
to	O
the	O
species1s	O
mouse	O
species1e	O
protein	O
,	O
with	O
100	O
%	O
identity	O
in	O
the	O
homeodomain	O
and	O
approximately	O
70	O
%	O
overall	O
identity	O
to	O
other	O
members	O
of	O
this	O
family	O
.	O
We	O
mapped	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
PITX3	ARG2
gene1e	ARG2
gene	O
to	O
10q25	O
using	O
a	O
radiation	O
-	O
hybrid	O
panel	O
.	O
A	O
collection	O
of	O
80	O
DNA	O
samples	O
from	O
individuals	O
with	O
various	O
eye	O
anomalies	O
was	O
screened	O
for	O
mutations	O
in	O
the	O
gene1s	ARG2
PITX3	ARG2
gene1e	ARG2
gene	O
.	O
We	O
identified	O
two	O
mutations	O
in	O
independent	O
arg1s	O
patients	O
arg1e	O
.	O
A	O
17-bp	O
insertion	O
in	O
the	O
3'-end	O
of	O
the	O
coding	O
sequence	O
,	O
resulting	O
in	O
a	O
frame	O
shift	O
,	O
occurred	O
in	O
a	O
arg1s	O
patient	O
arg1e	O
with	O
ASMD	O
and	O
cataracts	O
,	O
and	O
a	O
G-->A	O
substitution	O
,	O
changing	O
a	O
codon	O
for	O
serine	O
into	O
a	O
codon	O
for	O
asparagine	O
,	O
in	O
the	O
5'-end	O
of	O
the	O
gene	O
occurred	O
in	O
a	O
arg1s	O
patient	O
arg1e	O
with	O
congenital	O
cataracts	O
.	O
Both	O
mutations	O
cosegregate	O
with	O
the	O
disease	O
phenotype	O
in	O
families	O
,	O
and	O
neither	O
were	O
found	O
in	O
up	O
to	O
300	O
control	O
individuals	O
studied	O
.	O
Further	O
expression	O
analysis	O
of	O
gene1s	O
Pitx3	O
gene1e	O
in	O
the	O
species1s	O
mouse	O
species1e	O
supports	O
a	O
unique	O
role	O
in	O
early	O
ocular	O
development	O
,	O
with	O
later	O
expression	O
extending	O
to	O
the	O
midbrain	O
,	O
tongue	O
,	O
incisors	O
,	O
sternum	O
,	O
vertebrae	O
and	O
limbs	O
.	O
These	O
data	O
strongly	O
suggest	O
a	O
role	O
for	O
gene1s	ARG2
PITX3	ARG2
gene1e	ARG2
in	O
ASMD	O
and	O
cataracts	O
and	O
provide	O
new	O
evidence	O
of	O
the	O
contribution	O
of	O
the	O
RIEG	O
/	O
PITX	O
gene	O
family	O
to	O
the	O
developmental	O
program	O
underpinning	O
normal	O
eye	O
formation	O
.	O

A	O
novel	O
homeobox	O
gene	O
gene1s	O
PITX3	O
gene1e	O
is	O
mutated	O
in	O
families	O
with	O
autosomal	O
-	O
dominant	O
cataracts	O
and	O
ASMD	O
.	O
We	O
report	O
here	O
the	O
identification	O
of	O
a	O
new	O
species1s	O
human	O
species1e	O
homeobox	O
gene	O
,	O
gene1s	O
PITX3	O
gene1e	O
,	O
and	O
its	O
involvement	O
in	O
anterior	O
segment	O
mesenchymal	O
dysgenesis	O
(	O
ASMD	O
)	O
and	O
congenital	O
cataracts	O
in	O
species1s	O
humans	O
species1e	O
.	O
The	O
gene1s	O
PITX3	O
gene1e	O
gene	O
is	O
the	O
species1s	O
human	O
species1e	O
homologue	O
of	O
the	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
Pitx3	ARG2
gene1e	ARG2
gene	O
and	O
is	O
a	O
member	O
of	O
the	O
RIEG	O
/	O
PITX	O
homeobox	O
gene	O
family	O
.	O
The	O
protein	O
encoded	O
by	O
gene1s	O
PITX3	O
gene1e	O
shows	O
99	O
%	O
amino	O
-	O
acid	O
identity	O
to	O
the	O
arg1s	O
mouse	O
arg1e	O
protein	O
,	O
with	O
100	O
%	O
identity	O
in	O
the	O
homeodomain	O
and	O
approximately	O
70	O
%	O
overall	O
identity	O
to	O
other	O
members	O
of	O
this	O
family	O
.	O
We	O
mapped	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
PITX3	O
gene1e	O
gene	O
to	O
10q25	O
using	O
a	O
radiation	O
-	O
hybrid	O
panel	O
.	O
A	O
collection	O
of	O
80	O
DNA	O
samples	O
from	O
individuals	O
with	O
various	O
eye	O
anomalies	O
was	O
screened	O
for	O
mutations	O
in	O
the	O
gene1s	O
PITX3	O
gene1e	O
gene	O
.	O
We	O
identified	O
two	O
mutations	O
in	O
independent	O
species1s	O
patients	O
species1e	O
.	O
A	O
17-bp	O
insertion	O
in	O
the	O
3'-end	O
of	O
the	O
coding	O
sequence	O
,	O
resulting	O
in	O
a	O
frame	O
shift	O
,	O
occurred	O
in	O
a	O
species1s	O
patient	O
species1e	O
with	O
ASMD	O
and	O
cataracts	O
,	O
and	O
a	O
G-->A	O
substitution	O
,	O
changing	O
a	O
codon	O
for	O
serine	O
into	O
a	O
codon	O
for	O
asparagine	O
,	O
in	O
the	O
5'-end	O
of	O
the	O
gene	O
occurred	O
in	O
a	O
species1s	O
patient	O
species1e	O
with	O
congenital	O
cataracts	O
.	O
Both	O
mutations	O
cosegregate	O
with	O
the	O
disease	O
phenotype	O
in	O
families	O
,	O
and	O
neither	O
were	O
found	O
in	O
up	O
to	O
300	O
control	O
individuals	O
studied	O
.	O
Further	O
expression	O
analysis	O
of	O
gene1s	ARG2
Pitx3	ARG2
gene1e	ARG2
in	O
the	O
arg1s	O
mouse	O
arg1e	O
supports	O
a	O
unique	O
role	O
in	O
early	O
ocular	O
development	O
,	O
with	O
later	O
expression	O
extending	O
to	O
the	O
midbrain	O
,	O
tongue	O
,	O
incisors	O
,	O
sternum	O
,	O
vertebrae	O
and	O
limbs	O
.	O
These	O
data	O
strongly	O
suggest	O
a	O
role	O
for	O
gene1s	O
PITX3	O
gene1e	O
in	O
ASMD	O
and	O
cataracts	O
and	O
provide	O
new	O
evidence	O
of	O
the	O
contribution	O
of	O
the	O
RIEG	O
/	O
PITX	O
gene	O
family	O
to	O
the	O
developmental	O
program	O
underpinning	O
normal	O
eye	O
formation	O
.	O

A	O
stress	O
response	O
pathway	O
from	O
the	O
endoplasmic	O
reticulum	O
to	O
the	O
nucleus	O
requires	O
a	O
novel	O
bifunctional	O
protein	O
kinase	O
/	O
endoribonuclease	O
(	O
gene1s	O
Ire1p	O
gene1e	O
)	O
in	O
arg1s	O
mammalian	O
arg1e	O
cells	O
.	O
Eukaryotes	O
respond	O
to	O
the	O
presence	O
of	O
unfolded	O
protein	O
in	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
by	O
up	O
-	O
regulating	O
the	O
transcription	O
of	O
genes	O
encoding	O
ER	O
protein	O
chaperones	O
,	O
such	O
as	O
gene1s	ARG2
BiP	ARG2
gene1e	ARG2
.	O
We	O
have	O
isolated	O
a	O
novel	O
arg1s	O
human	O
arg1e	O
cDNA	O
encoding	O
a	O
homolog	O
to	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
gene1s	O
Ire1p	O
gene1e	O
,	O
a	O
proximal	O
sensor	O
for	O
this	O
signal	O
transduction	O
pathway	O
in	O
species1s	O
yeast	O
species1e	O
.	O
The	O
gene	O
product	O
gene1s	ARG2
hIre1p	ARG2
gene1e	ARG2
is	O
a	O
type	O
1	O
transmembrane	O
protein	O
containing	O
a	O
cytoplasmic	O
domain	O
that	O
is	O
highly	O
conserved	O
to	O
the	O
species1s	O
yeast	O
species1e	O
counterpart	O
having	O
a	O
Ser	O
/	O
Thr	O
protein	O
kinase	O
domain	O
and	O
a	O
domain	O
homologous	O
to	O
gene1s	ARG2
RNase	ARG2
L	ARG2
gene1e	ARG2
.	O
However	O
,	O
the	O
luminal	O
domain	O
has	O
extensively	O
diverged	O
from	O
the	O
species1s	O
yeast	O
species1e	O
gene	O
product	O
.	O
gene1s	ARG2
hIre1p	ARG2
gene1e	ARG2
expressed	O
in	O
arg1s	O
mammalian	O
arg1e	O
cells	O
displayed	O
intrinsic	O
autophosphorylation	O
activity	O
and	O
an	O
endoribonuclease	O
activity	O
that	O
cleaved	O
the	O
5	O
'	O
splice	O
site	O
of	O
species1s	O
yeast	O
species1e	O
gene1s	O
HAC1	O
gene1e	O
mRNA	O
,	O
a	O
substrate	O
for	O
the	O
endoribonuclease	O
activity	O
of	O
species1s	O
yeast	O
species1e	O
gene1s	O
Ire1p	O
gene1e	O
.	O
Overexpressed	O
gene1s	ARG2
hIre1p	ARG2
gene1e	ARG2
was	O
localized	O
to	O
the	O
ER	O
with	O
particular	O
concentration	O
around	O
the	O
nuclear	O
envelope	O
and	O
some	O
colocalization	O
with	O
the	O
nuclear	O
pore	O
complex	O
.	O
Expression	O
of	O
gene1s	O
Ire1p	O
gene1e	O
mRNA	O
was	O
autoregulated	O
through	O
a	O
process	O
that	O
required	O
a	O
functional	O
gene1s	ARG2
hIre1p	ARG2
gene1e	ARG2
kinase	O
activity	O
.	O
Finally	O
,	O
overexpression	O
of	O
wild	O
-	O
type	O
gene1s	ARG2
hIre1p	ARG2
gene1e	ARG2
constitutively	O
activated	O
a	O
reporter	O
gene	O
under	O
transcriptional	O
control	O
of	O
the	O
species1s	O
rat	O
species1e	O
gene1s	O
BiP	O
gene1e	O
promoter	O
,	O
whereas	O
expression	O
of	O
a	O
catalytically	O
inactive	O
gene1s	ARG2
hIre1p	ARG2
gene1e	ARG2
acted	O
in	O
a	O
trans	O
-	O
dominant	O
-	O
negative	O
manner	O
to	O
prevent	O
transcriptional	O
activation	O
of	O
the	O
gene1s	ARG2
BiP	ARG2
gene1e	ARG2
promoter	O
in	O
response	O
to	O
ER	O
stress	O
induced	O
by	O
inhibition	O
of	O
N	O
-	O
linked	O
glycosylation	O
.	O
These	O
results	O
demonstrate	O
that	O
gene1s	ARG2
hIre1p	ARG2
gene1e	ARG2
is	O
an	O
essential	O
proximal	O
sensor	O
of	O
the	O
unfolded	O
protein	O
response	O
pathway	O
in	O
arg1s	O
mammalian	O
arg1e	O
cells	O
.	O

A	O
stress	O
response	O
pathway	O
from	O
the	O
endoplasmic	O
reticulum	O
to	O
the	O
nucleus	O
requires	O
a	O
novel	O
bifunctional	O
protein	O
kinase	O
/	O
endoribonuclease	O
(	O
gene1s	ARG2
Ire1p	ARG2
gene1e	ARG2
)	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
.	O
Eukaryotes	O
respond	O
to	O
the	O
presence	O
of	O
unfolded	O
protein	O
in	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
by	O
up	O
-	O
regulating	O
the	O
transcription	O
of	O
genes	O
encoding	O
ER	O
protein	O
chaperones	O
,	O
such	O
as	O
gene1s	O
BiP	O
gene1e	O
.	O
We	O
have	O
isolated	O
a	O
novel	O
species1s	O
human	O
species1e	O
cDNA	O
encoding	O
a	O
homolog	O
to	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
gene1s	ARG2
Ire1p	ARG2
gene1e	ARG2
,	O
a	O
proximal	O
sensor	O
for	O
this	O
signal	O
transduction	O
pathway	O
in	O
arg1s	O
yeast	O
arg1e	O
.	O
The	O
gene	O
product	O
gene1s	O
hIre1p	O
gene1e	O
is	O
a	O
type	O
1	O
transmembrane	O
protein	O
containing	O
a	O
cytoplasmic	O
domain	O
that	O
is	O
highly	O
conserved	O
to	O
the	O
arg1s	O
yeast	O
arg1e	O
counterpart	O
having	O
a	O
Ser	O
/	O
Thr	O
protein	O
kinase	O
domain	O
and	O
a	O
domain	O
homologous	O
to	O
gene1s	O
RNase	O
L	O
gene1e	O
.	O
However	O
,	O
the	O
luminal	O
domain	O
has	O
extensively	O
diverged	O
from	O
the	O
arg1s	O
yeast	O
arg1e	O
gene	O
product	O
.	O
gene1s	O
hIre1p	O
gene1e	O
expressed	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
displayed	O
intrinsic	O
autophosphorylation	O
activity	O
and	O
an	O
endoribonuclease	O
activity	O
that	O
cleaved	O
the	O
5	O
'	O
splice	O
site	O
of	O
arg1s	O
yeast	O
arg1e	O
gene1s	ARG2
HAC1	ARG2
gene1e	ARG2
mRNA	O
,	O
a	O
substrate	O
for	O
the	O
endoribonuclease	O
activity	O
of	O
arg1s	O
yeast	O
arg1e	O
gene1s	ARG2
Ire1p	ARG2
gene1e	ARG2
.	O
Overexpressed	O
gene1s	O
hIre1p	O
gene1e	O
was	O
localized	O
to	O
the	O
ER	O
with	O
particular	O
concentration	O
around	O
the	O
nuclear	O
envelope	O
and	O
some	O
colocalization	O
with	O
the	O
nuclear	O
pore	O
complex	O
.	O
Expression	O
of	O
gene1s	ARG2
Ire1p	ARG2
gene1e	ARG2
mRNA	O
was	O
autoregulated	O
through	O
a	O
process	O
that	O
required	O
a	O
functional	O
gene1s	O
hIre1p	O
gene1e	O
kinase	O
activity	O
.	O
Finally	O
,	O
overexpression	O
of	O
wild	O
-	O
type	O
gene1s	O
hIre1p	O
gene1e	O
constitutively	O
activated	O
a	O
reporter	O
gene	O
under	O
transcriptional	O
control	O
of	O
the	O
species1s	O
rat	O
species1e	O
gene1s	O
BiP	O
gene1e	O
promoter	O
,	O
whereas	O
expression	O
of	O
a	O
catalytically	O
inactive	O
gene1s	O
hIre1p	O
gene1e	O
acted	O
in	O
a	O
trans	O
-	O
dominant	O
-	O
negative	O
manner	O
to	O
prevent	O
transcriptional	O
activation	O
of	O
the	O
gene1s	O
BiP	O
gene1e	O
promoter	O
in	O
response	O
to	O
ER	O
stress	O
induced	O
by	O
inhibition	O
of	O
N	O
-	O
linked	O
glycosylation	O
.	O
These	O
results	O
demonstrate	O
that	O
gene1s	O
hIre1p	O
gene1e	O
is	O
an	O
essential	O
proximal	O
sensor	O
of	O
the	O
unfolded	O
protein	O
response	O
pathway	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
.	O

A	O
stress	O
response	O
pathway	O
from	O
the	O
endoplasmic	O
reticulum	O
to	O
the	O
nucleus	O
requires	O
a	O
novel	O
bifunctional	O
protein	O
kinase	O
/	O
endoribonuclease	O
(	O
gene1s	O
Ire1p	O
gene1e	O
)	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
.	O
Eukaryotes	O
respond	O
to	O
the	O
presence	O
of	O
unfolded	O
protein	O
in	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
by	O
up	O
-	O
regulating	O
the	O
transcription	O
of	O
genes	O
encoding	O
ER	O
protein	O
chaperones	O
,	O
such	O
as	O
gene1s	O
BiP	O
gene1e	O
.	O
We	O
have	O
isolated	O
a	O
novel	O
species1s	O
human	O
species1e	O
cDNA	O
encoding	O
a	O
homolog	O
to	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
gene1s	O
Ire1p	O
gene1e	O
,	O
a	O
proximal	O
sensor	O
for	O
this	O
signal	O
transduction	O
pathway	O
in	O
species1s	O
yeast	O
species1e	O
.	O
The	O
gene	O
product	O
gene1s	O
hIre1p	O
gene1e	O
is	O
a	O
type	O
1	O
transmembrane	O
protein	O
containing	O
a	O
cytoplasmic	O
domain	O
that	O
is	O
highly	O
conserved	O
to	O
the	O
species1s	O
yeast	O
species1e	O
counterpart	O
having	O
a	O
Ser	O
/	O
Thr	O
protein	O
kinase	O
domain	O
and	O
a	O
domain	O
homologous	O
to	O
gene1s	O
RNase	O
L	O
gene1e	O
.	O
However	O
,	O
the	O
luminal	O
domain	O
has	O
extensively	O
diverged	O
from	O
the	O
species1s	O
yeast	O
species1e	O
gene	O
product	O
.	O
gene1s	O
hIre1p	O
gene1e	O
expressed	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
displayed	O
intrinsic	O
autophosphorylation	O
activity	O
and	O
an	O
endoribonuclease	O
activity	O
that	O
cleaved	O
the	O
5	O
'	O
splice	O
site	O
of	O
species1s	O
yeast	O
species1e	O
gene1s	O
HAC1	O
gene1e	O
mRNA	O
,	O
a	O
substrate	O
for	O
the	O
endoribonuclease	O
activity	O
of	O
species1s	O
yeast	O
species1e	O
gene1s	O
Ire1p	O
gene1e	O
.	O
Overexpressed	O
gene1s	O
hIre1p	O
gene1e	O
was	O
localized	O
to	O
the	O
ER	O
with	O
particular	O
concentration	O
around	O
the	O
nuclear	O
envelope	O
and	O
some	O
colocalization	O
with	O
the	O
nuclear	O
pore	O
complex	O
.	O
Expression	O
of	O
gene1s	O
Ire1p	O
gene1e	O
mRNA	O
was	O
autoregulated	O
through	O
a	O
process	O
that	O
required	O
a	O
functional	O
gene1s	O
hIre1p	O
gene1e	O
kinase	O
activity	O
.	O
Finally	O
,	O
overexpression	O
of	O
wild	O
-	O
type	O
gene1s	O
hIre1p	O
gene1e	O
constitutively	O
activated	O
a	O
reporter	O
gene	O
under	O
transcriptional	O
control	O
of	O
the	O
arg1s	O
rat	O
arg1e	O
gene1s	ARG2
BiP	ARG2
gene1e	ARG2
promoter	O
,	O
whereas	O
expression	O
of	O
a	O
catalytically	O
inactive	O
gene1s	O
hIre1p	O
gene1e	O
acted	O
in	O
a	O
trans	O
-	O
dominant	O
-	O
negative	O
manner	O
to	O
prevent	O
transcriptional	O
activation	O
of	O
the	O
gene1s	O
BiP	O
gene1e	O
promoter	O
in	O
response	O
to	O
ER	O
stress	O
induced	O
by	O
inhibition	O
of	O
N	O
-	O
linked	O
glycosylation	O
.	O
These	O
results	O
demonstrate	O
that	O
gene1s	O
hIre1p	O
gene1e	O
is	O
an	O
essential	O
proximal	O
sensor	O
of	O
the	O
unfolded	O
protein	O
response	O
pathway	O
in	O
species1s	O
mammalian	O
species1e	O
cells	O
.	O

cDNA	O
sequence	O
and	O
chromosomal	O
localization	O
of	O
the	O
remaining	O
three	O
arg1s	O
human	O
arg1e	O
nuclear	O
encoded	O
iron	O
sulphur	O
protein	O
(	O
IP	O
)	O
subunits	O
of	O
complex	O
I	O
:	O
the	O
arg1s	O
human	O
arg1e	O
IP	O
fraction	O
is	O
completed	O
.	O
NADH	O
:	O
ubiquinone	O
oxidoreductase	O
(	O
complex	O
I	O
)	O
of	O
the	O
mitochondrial	O
respiratory	O
chain	O
can	O
be	O
fragmented	O
in	O
a	O
flavoprotein	O
(	O
FP	O
)	O
,	O
iron	O
-	O
sulfur	O
protein	O
(	O
IP	O
)	O
,	O
and	O
hydrophobic	O
protein	O
(	O
HP	O
)	O
subfraction	O
.	O
The	O
IP	O
subfraction	O
is	O
hypothesized	O
to	O
be	O
significant	O
,	O
since	O
it	O
contains	O
important	O
prosthetic	O
groups	O
highly	O
conserved	O
among	O
species	O
.	O
We	O
cloned	O
the	O
cDNA	O
of	O
three	O
remaining	O
arg1s	O
human	O
arg1e	O
NADH	O
:	O
ubiquinone	O
oxidoreductase	O
subunits	O
of	O
this	O
IP	O
fraction	O
:	O
the	O
gene1s	ARG2
NDUFS2	ARG2
gene1e	ARG2
(	O
49	O
kDa	O
)	O
,	O
gene1s	ARG2
NDUFS3	ARG2
gene1e	ARG2
(	O
30	O
kDa	O
)	O
,	O
and	O
gene1s	ARG2
NDUFS6	ARG2
gene1e	ARG2
(	O
13	O
kDa	O
)	O
subunits	O
.	O
All	O
presented	O
cDNAs	O
include	O
the	O
complete	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
,	O
which	O
consist	O
of	O
1392	O
,	O
795	O
,	O
and	O
375	O
base	O
pairs	O
,	O
coding	O
for	O
463	O
,	O
264	O
,	O
and	O
124	O
amino	O
acids	O
,	O
respectively	O
.	O
The	O
latter	O
show	O
96	O
,	O
90	O
,	O
and	O
83	O
%	O
homology	O
with	O
the	O
corresponding	O
species1s	O
bovine	O
species1e	O
translation	O
products	O
.	O
The	O
3	O
'	O
untranslated	O
regions	O
(	O
UTR	O
)	O
are	O
complete	O
in	O
all	O
three	O
cDNAs	O
.	O
Polymerase	O
chain	O
reaction	O
performed	O
with	O
DNA	O
isolated	O
from	O
somatic	O
arg1s	O
human	O
arg1e	O
-	O
rodent	O
cell	O
hybrids	O
containing	O
defined	O
arg1s	O
human	O
arg1e	O
chromosomes	O
as	O
template	O
gave	O
a	O
arg1s	O
human	O
arg1e	O
-	O
specific	O
signal	O
which	O
mapped	O
the	O
gene1s	ARG2
NDUFS2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
NDUFS3	ARG2
gene1e	ARG2
subunits	O
to	O
chromosomes	O
1	O
and	O
11	O
,	O
respectively	O
.	O
In	O
the	O
case	O
of	O
the	O
gene1s	ARG2
NDUFS6	ARG2
gene1e	ARG2
subunit	O
a	O
pseudogene	O
may	O
be	O
present	O
since	O
signals	O
were	O
seen	O
in	O
the	O
lanes	O
containing	O
chromosomes	O
5	O
and	O
6	O
.	O
The	O
gene1s	ARG2
NDUFS2	ARG2
gene1e	ARG2
contains	O
a	O
highly	O
conserved	O
protein	O
kinase	O
C	O
phosphorylation	O
site	O
and	O
the	O
gene1s	ARG2
NDUFS3	ARG2
gene1e	ARG2
subunit	O
contains	O
a	O
highly	O
conserved	O
casein	O
kinase	O
II	O
phosphorylation	O
site	O
which	O
make	O
them	O
strong	O
candidates	O
for	O
future	O
mutation	O
detection	O
studies	O
in	O
enzymatic	O
complex	O
I	O
-	O
deficient	O
arg1s	O
patients	O
arg1e	O
.	O

cDNA	O
sequence	O
and	O
chromosomal	O
localization	O
of	O
the	O
remaining	O
three	O
species1s	O
human	O
species1e	O
nuclear	O
encoded	O
iron	O
sulphur	O
protein	O
(	O
IP	O
)	O
subunits	O
of	O
complex	O
I	O
:	O
the	O
species1s	O
human	O
species1e	O
IP	O
fraction	O
is	O
completed	O
.	O
NADH	O
:	O
ubiquinone	O
oxidoreductase	O
(	O
complex	O
I	O
)	O
of	O
the	O
mitochondrial	O
respiratory	O
chain	O
can	O
be	O
fragmented	O
in	O
a	O
flavoprotein	O
(	O
FP	O
)	O
,	O
iron	O
-	O
sulfur	O
protein	O
(	O
IP	O
)	O
,	O
and	O
hydrophobic	O
protein	O
(	O
HP	O
)	O
subfraction	O
.	O
The	O
IP	O
subfraction	O
is	O
hypothesized	O
to	O
be	O
significant	O
,	O
since	O
it	O
contains	O
important	O
prosthetic	O
groups	O
highly	O
conserved	O
among	O
species	O
.	O
We	O
cloned	O
the	O
cDNA	O
of	O
three	O
remaining	O
species1s	O
human	O
species1e	O
NADH	O
:	O
ubiquinone	O
oxidoreductase	O
subunits	O
of	O
this	O
IP	O
fraction	O
:	O
the	O
gene1s	O
NDUFS2	O
gene1e	O
(	O
49	O
kDa	O
)	O
,	O
gene1s	O
NDUFS3	O
gene1e	O
(	O
30	O
kDa	O
)	O
,	O
and	O
gene1s	O
NDUFS6	O
gene1e	O
(	O
13	O
kDa	O
)	O
subunits	O
.	O
All	O
presented	O
cDNAs	O
include	O
the	O
complete	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
,	O
which	O
consist	O
of	O
1392	O
,	O
795	O
,	O
and	O
375	O
base	O
pairs	O
,	O
coding	O
for	O
463	O
,	O
264	O
,	O
and	O
124	O
amino	O
acids	O
,	O
respectively	O
.	O
The	O
latter	O
show	O
96	O
,	O
90	O
,	O
and	O
83	O
%	O
homology	O
with	O
the	O
corresponding	O
arg1s	O
bovine	O
arg1e	O
translation	O
products	O
.	O
The	O
3	O
'	O
untranslated	O
regions	O
(	O
UTR	O
)	O
are	O
complete	O
in	O
all	O
three	O
cDNAs	O
.	O
Polymerase	O
chain	O
reaction	O
performed	O
with	O
DNA	O
isolated	O
from	O
somatic	O
species1s	O
human	O
species1e	O
-	O
rodent	O
cell	O
hybrids	O
containing	O
defined	O
species1s	O
human	O
species1e	O
chromosomes	O
as	O
template	O
gave	O
a	O
species1s	O
human	O
species1e	O
-	O
specific	O
signal	O
which	O
mapped	O
the	O
gene1s	O
NDUFS2	O
gene1e	O
and	O
gene1s	O
NDUFS3	O
gene1e	O
subunits	O
to	O
chromosomes	O
1	O
and	O
11	O
,	O
respectively	O
.	O
In	O
the	O
case	O
of	O
the	O
gene1s	O
NDUFS6	O
gene1e	O
subunit	O
a	O
pseudogene	O
may	O
be	O
present	O
since	O
signals	O
were	O
seen	O
in	O
the	O
lanes	O
containing	O
chromosomes	O
5	O
and	O
6	O
.	O
The	O
gene1s	O
NDUFS2	O
gene1e	O
contains	O
a	O
highly	O
conserved	O
protein	O
kinase	O
C	O
phosphorylation	O
site	O
and	O
the	O
gene1s	O
NDUFS3	O
gene1e	O
subunit	O
contains	O
a	O
highly	O
conserved	O
casein	O
kinase	O
II	O
phosphorylation	O
site	O
which	O
make	O
them	O
strong	O
candidates	O
for	O
future	O
mutation	O
detection	O
studies	O
in	O
enzymatic	O
complex	O
I	O
-	O
deficient	O
species1s	O
patients	O
species1e	O
.	O

gene1s	ARG2
SAP30	ARG2
gene1e	ARG2
,	O
a	O
novel	O
protein	O
conserved	O
between	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
yeast	O
species1e	O
,	O
is	O
a	O
component	O
of	O
a	O
histone	O
deacetylase	O
complex	O
.	O
Histone	O
acetylation	O
plays	O
a	O
key	O
role	O
in	O
the	O
regulation	O
of	O
eukaryotic	O
gene	O
expression	O
.	O
Recently	O
,	O
histone	O
acetylation	O
and	O
deacetylation	O
were	O
found	O
to	O
be	O
catalyzed	O
by	O
structurally	O
distinct	O
,	O
multisubunit	O
complexes	O
that	O
mediate	O
,	O
respectively	O
,	O
activation	O
and	O
repression	O
of	O
transcription	O
.	O
Here	O
,	O
we	O
identify	O
gene1s	ARG2
SAP30	ARG2
gene1e	ARG2
as	O
a	O
novel	O
component	O
of	O
the	O
arg1s	O
human	O
arg1e	O
histone	O
deacetylase	O
complex	O
that	O
includes	O
gene1s	ARG2
Sin3	ARG2
gene1e	ARG2
,	O
the	O
histone	O
deacetylases	O
gene1s	ARG2
HDAC1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
HDAC2	ARG2
gene1e	ARG2
,	O
histone	O
binding	O
proteins	O
gene1s	ARG2
RbAp46	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
RbAp48	ARG2
gene1e	ARG2
,	O
as	O
well	O
as	O
other	O
polypeptides	O
.	O
Moreover	O
,	O
we	O
describe	O
a	O
gene1s	O
SAP30	O
gene1e	O
homolog	O
in	O
species1s	O
yeast	O
species1e	O
that	O
is	O
functionally	O
related	O
to	O
gene1s	O
Sin3	O
gene1e	O
and	O
the	O
histone	O
deacetylase	O
gene1s	O
Rpd3	O
gene1e	O
.	O
The	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
SAP30	ARG2
gene1e	ARG2
complex	O
is	O
active	O
in	O
deacetylating	O
core	O
histone	O
octamers	O
,	O
but	O
inactive	O
in	O
deacetylating	O
nucleosomal	O
histones	O
due	O
to	O
the	O
inability	O
of	O
the	O
histone	O
binding	O
proteins	O
gene1s	ARG2
RbAp46	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
RbAp48	ARG2
gene1e	ARG2
to	O
gain	O
access	O
to	O
nucleosomal	O
histones	O
.	O
These	O
results	O
define	O
gene1s	ARG2
SAP30	ARG2
gene1e	ARG2
as	O
a	O
component	O
of	O
a	O
histone	O
deacetylase	O
complex	O
conserved	O
among	O
eukaryotic	O
organisms	O
.	O

gene1s	O
SAP30	O
gene1e	O
,	O
a	O
novel	O
protein	O
conserved	O
between	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
yeast	O
arg1e	O
,	O
is	O
a	O
component	O
of	O
a	O
histone	O
deacetylase	O
complex	O
.	O
Histone	O
acetylation	O
plays	O
a	O
key	O
role	O
in	O
the	O
regulation	O
of	O
eukaryotic	O
gene	O
expression	O
.	O
Recently	O
,	O
histone	O
acetylation	O
and	O
deacetylation	O
were	O
found	O
to	O
be	O
catalyzed	O
by	O
structurally	O
distinct	O
,	O
multisubunit	O
complexes	O
that	O
mediate	O
,	O
respectively	O
,	O
activation	O
and	O
repression	O
of	O
transcription	O
.	O
Here	O
,	O
we	O
identify	O
gene1s	O
SAP30	O
gene1e	O
as	O
a	O
novel	O
component	O
of	O
the	O
species1s	O
human	O
species1e	O
histone	O
deacetylase	O
complex	O
that	O
includes	O
gene1s	O
Sin3	O
gene1e	O
,	O
the	O
histone	O
deacetylases	O
gene1s	O
HDAC1	O
gene1e	O
and	O
gene1s	O
HDAC2	O
gene1e	O
,	O
histone	O
binding	O
proteins	O
gene1s	O
RbAp46	O
gene1e	O
and	O
gene1s	O
RbAp48	O
gene1e	O
,	O
as	O
well	O
as	O
other	O
polypeptides	O
.	O
Moreover	O
,	O
we	O
describe	O
a	O
gene1s	ARG2
SAP30	ARG2
gene1e	ARG2
homolog	O
in	O
arg1s	O
yeast	O
arg1e	O
that	O
is	O
functionally	O
related	O
to	O
gene1s	ARG2
Sin3	ARG2
gene1e	ARG2
and	O
the	O
histone	O
deacetylase	O
gene1s	ARG2
Rpd3	ARG2
gene1e	ARG2
.	O
The	O
species1s	O
human	O
species1e	O
gene1s	O
SAP30	O
gene1e	O
complex	O
is	O
active	O
in	O
deacetylating	O
core	O
histone	O
octamers	O
,	O
but	O
inactive	O
in	O
deacetylating	O
nucleosomal	O
histones	O
due	O
to	O
the	O
inability	O
of	O
the	O
histone	O
binding	O
proteins	O
gene1s	O
RbAp46	O
gene1e	O
and	O
gene1s	O
RbAp48	O
gene1e	O
to	O
gain	O
access	O
to	O
nucleosomal	O
histones	O
.	O
These	O
results	O
define	O
gene1s	O
SAP30	O
gene1e	O
as	O
a	O
component	O
of	O
a	O
histone	O
deacetylase	O
complex	O
conserved	O
among	O
eukaryotic	O
organisms	O
.	O

A	O
novel	O
arg1s	O
human	O
arg1e	O
actin	O
-	O
binding	O
protein	O
homologue	O
that	O
binds	O
to	O
platelet	O
gene1s	ARG2
glycoprotein	ARG2
Ibalpha	ARG2
gene1e	ARG2
.	O
Glycoprotein	O
(	O
GP)Ib	O
-	O
IX	O
-	O
V	O
is	O
one	O
of	O
the	O
major	O
transmembrane	O
complexes	O
present	O
on	O
the	O
platelet	O
surface	O
.	O
Its	O
extracellular	O
domain	O
binds	O
gene1s	ARG2
von	ARG2
Willebrand	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
vWF	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
thrombin	ARG2
gene1e	ARG2
,	O
while	O
its	O
intracellular	O
domain	O
associates	O
tightly	O
with	O
the	O
cytoskeleton	O
through	O
the	O
gene1s	ARG2
actin	ARG2
-	ARG2
binding	ARG2
protein	ARG2
(	ARG2
ABP)-280	ARG2
gene1e	ARG2
,	O
also	O
known	O
as	O
gene1s	ARG2
filamin	ARG2
gene1e	ARG2
.	O
In	O
the	O
present	O
study	O
,	O
a	O
full	O
-	O
length	O
cDNA	O
coding	O
for	O
a	O
arg1s	O
human	O
arg1e	O
ABP	O
homologue	O
has	O
been	O
cloned	O
and	O
sequenced	O
.	O
This	O
protein	O
was	O
identified	O
by	O
the	O
yeast	O
two	O
-	O
hybrid	O
screening	O
procedure	O
via	O
its	O
interaction	O
with	O
the	O
intracellular	O
domain	O
of	O
gene1s	ARG2
GPIbalpha	ARG2
gene1e	ARG2
.	O
Initially	O
,	O
a	O
1.3-kb	O
partial	O
cDNA	O
was	O
isolated	O
from	O
a	O
megakaryocyte	O
-	O
like	O
cell	O
line	O
(	O
K562	O
)	O
cDNA	O
library	O
followed	O
by	O
a	O
full	O
-	O
length	O
cDNA	O
of	O
9.4	O
kb	O
that	O
was	O
identified	O
in	O
a	O
arg1s	O
human	O
arg1e	O
placenta	O
library	O
.	O
The	O
full	O
-	O
length	O
cDNA	O
encoded	O
a	O
protein	O
of	O
2,578	O
amino	O
acids	O
with	O
a	O
calculated	O
molecular	O
weight	O
of	O
276	O
kD	O
(	O
gene1s	ARG2
ABP-276	ARG2
gene1e	ARG2
)	O
.	O
The	O
amino	O
terminal	O
248	O
amino	O
acids	O
contained	O
an	O
apparent	O
actin	O
binding	O
domain	O
followed	O
by	O
24	O
tandem	O
repeats	O
each	O
containing	O
about	O
96	O
amino	O
acids	O
.	O
The	O
amino	O
acid	O
sequence	O
of	O
the	O
protein	O
shared	O
a	O
high	O
degree	O
of	O
homology	O
with	O
arg1s	O
human	O
arg1e	O
endothelial	O
gene1s	ARG2
ABP-280	ARG2
gene1e	ARG2
(	O
70	O
%	O
identity	O
)	O
and	O
species1s	O
chicken	O
species1e	O
gene1s	ARG2
filamin	ARG2
gene1e	ARG2
(	O
83	O
%	O
identity	O
)	O
.	O
However	O
,	O
the	O
32	O
amino	O
acid	O
Hinge	O
I	O
region	O
in	O
gene1s	ARG2
ABP-280	ARG2
gene1e	ARG2
that	O
contains	O
a	O
calpain	O
cleavage	O
site	O
conferring	O
flexibility	O
on	O
the	O
molecule	O
,	O
was	O
absent	O
in	O
the	O
homologue	O
.	O
An	O
isoform	O
containing	O
a	O
24	O
amino	O
acid	O
insertion	O
with	O
a	O
unique	O
sequence	O
at	O
the	O
missing	O
Hinge	O
I	O
region	O
was	O
also	O
identified	O
(	O
gene1s	ARG2
ABP-278	ARG2
gene1e	ARG2
)	O
.	O
This	O
isoform	O
resulted	O
from	O
alternative	O
RNA	O
splicing	O
.	O
gene1s	ARG2
ABP-276	ARG2
gene1e	ARG2
and/or	O
gene1s	ARG2
ABP-278	ARG2
gene1e	ARG2
were	O
present	O
in	O
all	O
tissues	O
examined	O
,	O
but	O
the	O
relative	O
amount	O
varied	O
in	O
that	O
some	O
tissue	O
contained	O
both	O
forms	O
,	O
while	O
other	O
tissue	O
contained	O
predominately	O
one	O
or	O
the	O
other	O
.	O
Copyright	O
1998	O
by	O
The	O
American	O
Society	O
of	O
Hematology	O
.	O

A	O
novel	O
species1s	O
human	O
species1e	O
actin	O
-	O
binding	O
protein	O
homologue	O
that	O
binds	O
to	O
platelet	O
gene1s	O
glycoprotein	O
Ibalpha	O
gene1e	O
.	O
Glycoprotein	O
(	O
GP)Ib	O
-	O
IX	O
-	O
V	O
is	O
one	O
of	O
the	O
major	O
transmembrane	O
complexes	O
present	O
on	O
the	O
platelet	O
surface	O
.	O
Its	O
extracellular	O
domain	O
binds	O
gene1s	O
von	O
Willebrand	O
factor	O
gene1e	O
(	O
gene1s	O
vWF	O
gene1e	O
)	O
and	O
gene1s	O
thrombin	O
gene1e	O
,	O
while	O
its	O
intracellular	O
domain	O
associates	O
tightly	O
with	O
the	O
cytoskeleton	O
through	O
the	O
gene1s	O
actin	O
-	O
binding	O
protein	O
(	O
ABP)-280	O
gene1e	O
,	O
also	O
known	O
as	O
gene1s	O
filamin	O
gene1e	O
.	O
In	O
the	O
present	O
study	O
,	O
a	O
full	O
-	O
length	O
cDNA	O
coding	O
for	O
a	O
species1s	O
human	O
species1e	O
ABP	O
homologue	O
has	O
been	O
cloned	O
and	O
sequenced	O
.	O
This	O
protein	O
was	O
identified	O
by	O
the	O
yeast	O
two	O
-	O
hybrid	O
screening	O
procedure	O
via	O
its	O
interaction	O
with	O
the	O
intracellular	O
domain	O
of	O
gene1s	O
GPIbalpha	O
gene1e	O
.	O
Initially	O
,	O
a	O
1.3-kb	O
partial	O
cDNA	O
was	O
isolated	O
from	O
a	O
megakaryocyte	O
-	O
like	O
cell	O
line	O
(	O
K562	O
)	O
cDNA	O
library	O
followed	O
by	O
a	O
full	O
-	O
length	O
cDNA	O
of	O
9.4	O
kb	O
that	O
was	O
identified	O
in	O
a	O
species1s	O
human	O
species1e	O
placenta	O
library	O
.	O
The	O
full	O
-	O
length	O
cDNA	O
encoded	O
a	O
protein	O
of	O
2,578	O
amino	O
acids	O
with	O
a	O
calculated	O
molecular	O
weight	O
of	O
276	O
kD	O
(	O
gene1s	O
ABP-276	O
gene1e	O
)	O
.	O
The	O
amino	O
terminal	O
248	O
amino	O
acids	O
contained	O
an	O
apparent	O
actin	O
binding	O
domain	O
followed	O
by	O
24	O
tandem	O
repeats	O
each	O
containing	O
about	O
96	O
amino	O
acids	O
.	O
The	O
amino	O
acid	O
sequence	O
of	O
the	O
protein	O
shared	O
a	O
high	O
degree	O
of	O
homology	O
with	O
species1s	O
human	O
species1e	O
endothelial	O
gene1s	O
ABP-280	O
gene1e	O
(	O
70	O
%	O
identity	O
)	O
and	O
arg1s	O
chicken	O
arg1e	O
gene1s	O
filamin	O
gene1e	O
(	O
83	O
%	O
identity	O
)	O
.	O
However	O
,	O
the	O
32	O
amino	O
acid	O
Hinge	O
I	O
region	O
in	O
gene1s	O
ABP-280	O
gene1e	O
that	O
contains	O
a	O
calpain	O
cleavage	O
site	O
conferring	O
flexibility	O
on	O
the	O
molecule	O
,	O
was	O
absent	O
in	O
the	O
homologue	O
.	O
An	O
isoform	O
containing	O
a	O
24	O
amino	O
acid	O
insertion	O
with	O
a	O
unique	O
sequence	O
at	O
the	O
missing	O
Hinge	O
I	O
region	O
was	O
also	O
identified	O
(	O
gene1s	O
ABP-278	O
gene1e	O
)	O
.	O
This	O
isoform	O
resulted	O
from	O
alternative	O
RNA	O
splicing	O
.	O
gene1s	O
ABP-276	O
gene1e	O
and/or	O
gene1s	O
ABP-278	O
gene1e	O
were	O
present	O
in	O
all	O
tissues	O
examined	O
,	O
but	O
the	O
relative	O
amount	O
varied	O
in	O
that	O
some	O
tissue	O
contained	O
both	O
forms	O
,	O
while	O
other	O
tissue	O
contained	O
predominately	O
one	O
or	O
the	O
other	O
.	O
Copyright	O
1998	O
by	O
The	O
American	O
Society	O
of	O
Hematology	O
.	O

New	O
eukaryotic	O
semaphorins	O
with	O
close	O
homology	O
to	O
semaphorins	O
of	O
arg1s	O
DNA	O
viruses	O
arg1e	O
.	O
Semaphorins	O
were	O
initially	O
described	O
as	O
a	O
family	O
of	O
repulsive	O
guidance	O
molecules	O
in	O
embryonal	O
development	O
.	O
Their	O
basic	O
structure	O
consists	O
of	O
an	O
N	O
-	O
terminal	O
signal	O
sequence	O
,	O
the	O
defining	O
semaphorin	O
domain	O
ofapproximately	O
500	O
amino	O
acids	O
,	O
an	O
Ig	O
-	O
like	O
domain	O
,	O
and	O
a	O
variable	O
carboxy	O
-	O
terminus	O
.	O
We	O
recently	O
described	O
a	O
viral	O
semaphorin	O
homologue	O
encoded	O
by	O
the	O
species1s	O
alcelaphine	O
herpesvirus	O
species1e	O
type	O
1	O
.	O
Less	O
conserved	O
,	O
truncated	O
homologues	O
were	O
also	O
identified	O
in	O
poxviruses	O
.	O
Here	O
we	O
describe	O
new	O
species1s	O
human	O
species1e	O
and	O
species1s	O
murine	O
species1e	O
semaphorin	O
homologues	O
.	O
The	O
respective	O
genes	O
were	O
cloned	O
and	O
sequenced	O
,	O
and	O
they	O
were	O
termed	O
gene1s	O
H	O
-	O
Sema	O
-	O
L	O
gene1e	O
and	O
gene1s	O
M	O
-	O
Sema	O
-	O
L	O
gene1e	O
(	O
HGMW	O
-	O
approved	O
symbols	O
gene1s	O
SEMAL	O
gene1e	O
and	O
gene1s	O
Semal	O
gene1e	O
,	O
respectively	O
)	O
.	O
A	O
multiply	O
spliced	O
mRNA	O
of	O
3.2	O
kb	O
is	O
expressed	O
in	O
species1s	O
human	O
species1e	O
placenta	O
,	O
spleen	O
,	O
thymus	O
,	O
and	O
gonadal	O
tissue	O
.	O
gene1s	O
H	O
-	O
Sema	O
-	O
L	O
gene1e	O
maps	O
to	O
chromosome	O
15q22.3-q23	O
and	O
gene1s	O
M	O
-	O
Sema	O
-	O
L	O
gene1e	O
to	O
the	O
homologous	O
locus	O
9A3.3-B	O
in	O
the	O
species1s	O
mouse	O
species1e	O
genome	O
.	O
The	O
expression	O
patterns	O
and	O
the	O
presence	O
of	O
related	O
genes	O
in	O
large	O
arg1s	O
DNA	O
viruses	O
arg1e	O
suggest	O
that	O
this	O
new	O
semaphorin	O
has	O
a	O
relevant	O
function	O
in	O
the	O
immune	O
system	O
.	O
Copyright	O
1998	O
Academic	O
Press	O
.	O

New	O
eukaryotic	O
semaphorins	O
with	O
close	O
homology	O
to	O
semaphorins	O
of	O
species1s	O
DNA	O
viruses	O
species1e	O
.	O
Semaphorins	O
were	O
initially	O
described	O
as	O
a	O
family	O
of	O
repulsive	O
guidance	O
molecules	O
in	O
embryonal	O
development	O
.	O
Their	O
basic	O
structure	O
consists	O
of	O
an	O
N	O
-	O
terminal	O
signal	O
sequence	O
,	O
the	O
defining	O
semaphorin	O
domain	O
ofapproximately	O
500	O
amino	O
acids	O
,	O
an	O
Ig	O
-	O
like	O
domain	O
,	O
and	O
a	O
variable	O
carboxy	O
-	O
terminus	O
.	O
We	O
recently	O
described	O
a	O
viral	O
semaphorin	O
homologue	O
encoded	O
by	O
the	O
arg1s	O
alcelaphine	O
herpesvirus	O
arg1e	O
type	O
1	O
.	O
Less	O
conserved	O
,	O
truncated	O
homologues	O
were	O
also	O
identified	O
in	O
poxviruses	O
.	O
Here	O
we	O
describe	O
new	O
species1s	O
human	O
species1e	O
and	O
species1s	O
murine	O
species1e	O
semaphorin	O
homologues	O
.	O
The	O
respective	O
genes	O
were	O
cloned	O
and	O
sequenced	O
,	O
and	O
they	O
were	O
termed	O
gene1s	O
H	O
-	O
Sema	O
-	O
L	O
gene1e	O
and	O
gene1s	O
M	O
-	O
Sema	O
-	O
L	O
gene1e	O
(	O
HGMW	O
-	O
approved	O
symbols	O
gene1s	O
SEMAL	O
gene1e	O
and	O
gene1s	O
Semal	O
gene1e	O
,	O
respectively	O
)	O
.	O
A	O
multiply	O
spliced	O
mRNA	O
of	O
3.2	O
kb	O
is	O
expressed	O
in	O
species1s	O
human	O
species1e	O
placenta	O
,	O
spleen	O
,	O
thymus	O
,	O
and	O
gonadal	O
tissue	O
.	O
gene1s	O
H	O
-	O
Sema	O
-	O
L	O
gene1e	O
maps	O
to	O
chromosome	O
15q22.3-q23	O
and	O
gene1s	O
M	O
-	O
Sema	O
-	O
L	O
gene1e	O
to	O
the	O
homologous	O
locus	O
9A3.3-B	O
in	O
the	O
species1s	O
mouse	O
species1e	O
genome	O
.	O
The	O
expression	O
patterns	O
and	O
the	O
presence	O
of	O
related	O
genes	O
in	O
large	O
species1s	O
DNA	O
viruses	O
species1e	O
suggest	O
that	O
this	O
new	O
semaphorin	O
has	O
a	O
relevant	O
function	O
in	O
the	O
immune	O
system	O
.	O
Copyright	O
1998	O
Academic	O
Press	O
.	O

New	O
eukaryotic	O
semaphorins	O
with	O
close	O
homology	O
to	O
semaphorins	O
of	O
species1s	O
DNA	O
viruses	O
species1e	O
.	O
Semaphorins	O
were	O
initially	O
described	O
as	O
a	O
family	O
of	O
repulsive	O
guidance	O
molecules	O
in	O
embryonal	O
development	O
.	O
Their	O
basic	O
structure	O
consists	O
of	O
an	O
N	O
-	O
terminal	O
signal	O
sequence	O
,	O
the	O
defining	O
semaphorin	O
domain	O
ofapproximately	O
500	O
amino	O
acids	O
,	O
an	O
Ig	O
-	O
like	O
domain	O
,	O
and	O
a	O
variable	O
carboxy	O
-	O
terminus	O
.	O
We	O
recently	O
described	O
a	O
viral	O
semaphorin	O
homologue	O
encoded	O
by	O
the	O
species1s	O
alcelaphine	O
herpesvirus	O
species1e	O
type	O
1	O
.	O
Less	O
conserved	O
,	O
truncated	O
homologues	O
were	O
also	O
identified	O
in	O
poxviruses	O
.	O
Here	O
we	O
describe	O
new	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
murine	O
species1e	O
semaphorin	O
homologues	O
.	O
The	O
respective	O
genes	O
were	O
cloned	O
and	O
sequenced	O
,	O
and	O
they	O
were	O
termed	O
gene1s	ARG2
H	ARG2
-	ARG2
Sema	ARG2
-	ARG2
L	ARG2
gene1e	ARG2
and	O
gene1s	O
M	O
-	O
Sema	O
-	O
L	O
gene1e	O
(	O
HGMW	O
-	O
approved	O
symbols	O
gene1s	ARG2
SEMAL	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Semal	ARG2
gene1e	ARG2
,	O
respectively	O
)	O
.	O
A	O
multiply	O
spliced	O
mRNA	O
of	O
3.2	O
kb	O
is	O
expressed	O
in	O
arg1s	O
human	O
arg1e	O
placenta	O
,	O
spleen	O
,	O
thymus	O
,	O
and	O
gonadal	O
tissue	O
.	O
gene1s	ARG2
H	ARG2
-	ARG2
Sema	ARG2
-	ARG2
L	ARG2
gene1e	ARG2
maps	O
to	O
chromosome	O
15q22.3-q23	O
and	O
gene1s	O
M	O
-	O
Sema	O
-	O
L	O
gene1e	O
to	O
the	O
homologous	O
locus	O
9A3.3-B	O
in	O
the	O
species1s	O
mouse	O
species1e	O
genome	O
.	O
The	O
expression	O
patterns	O
and	O
the	O
presence	O
of	O
related	O
genes	O
in	O
large	O
species1s	O
DNA	O
viruses	O
species1e	O
suggest	O
that	O
this	O
new	O
semaphorin	O
has	O
a	O
relevant	O
function	O
in	O
the	O
immune	O
system	O
.	O
Copyright	O
1998	O
Academic	O
Press	O
.	O

New	O
eukaryotic	O
semaphorins	O
with	O
close	O
homology	O
to	O
semaphorins	O
of	O
species1s	O
DNA	O
viruses	O
species1e	O
.	O
Semaphorins	O
were	O
initially	O
described	O
as	O
a	O
family	O
of	O
repulsive	O
guidance	O
molecules	O
in	O
embryonal	O
development	O
.	O
Their	O
basic	O
structure	O
consists	O
of	O
an	O
N	O
-	O
terminal	O
signal	O
sequence	O
,	O
the	O
defining	O
semaphorin	O
domain	O
ofapproximately	O
500	O
amino	O
acids	O
,	O
an	O
Ig	O
-	O
like	O
domain	O
,	O
and	O
a	O
variable	O
carboxy	O
-	O
terminus	O
.	O
We	O
recently	O
described	O
a	O
viral	O
semaphorin	O
homologue	O
encoded	O
by	O
the	O
species1s	O
alcelaphine	O
herpesvirus	O
species1e	O
type	O
1	O
.	O
Less	O
conserved	O
,	O
truncated	O
homologues	O
were	O
also	O
identified	O
in	O
poxviruses	O
.	O
Here	O
we	O
describe	O
new	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
murine	O
arg1e	O
semaphorin	O
homologues	O
.	O
The	O
respective	O
genes	O
were	O
cloned	O
and	O
sequenced	O
,	O
and	O
they	O
were	O
termed	O
gene1s	O
H	O
-	O
Sema	O
-	O
L	O
gene1e	O
and	O
gene1s	ARG2
M	ARG2
-	ARG2
Sema	ARG2
-	ARG2
L	ARG2
gene1e	ARG2
(	O
HGMW	O
-	O
approved	O
symbols	O
gene1s	ARG2
SEMAL	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Semal	ARG2
gene1e	ARG2
,	O
respectively	O
)	O
.	O
A	O
multiply	O
spliced	O
mRNA	O
of	O
3.2	O
kb	O
is	O
expressed	O
in	O
species1s	O
human	O
species1e	O
placenta	O
,	O
spleen	O
,	O
thymus	O
,	O
and	O
gonadal	O
tissue	O
.	O
gene1s	O
H	O
-	O
Sema	O
-	O
L	O
gene1e	O
maps	O
to	O
chromosome	O
15q22.3-q23	O
and	O
gene1s	ARG2
M	ARG2
-	ARG2
Sema	ARG2
-	ARG2
L	ARG2
gene1e	ARG2
to	O
the	O
homologous	O
locus	O
9A3.3-B	O
in	O
the	O
arg1s	O
mouse	O
arg1e	O
genome	O
.	O
The	O
expression	O
patterns	O
and	O
the	O
presence	O
of	O
related	O
genes	O
in	O
large	O
species1s	O
DNA	O
viruses	O
species1e	O
suggest	O
that	O
this	O
new	O
semaphorin	O
has	O
a	O
relevant	O
function	O
in	O
the	O
immune	O
system	O
.	O
Copyright	O
1998	O
Academic	O
Press	O
.	O

gene1s	ARG2
ZK1	ARG2
gene1e	ARG2
,	O
a	O
novel	O
Kr	O
ppel	O
-	O
type	O
zinc	O
finger	O
gene	O
,	O
is	O
induced	O
following	O
exposure	O
to	O
ionizing	O
radiation	O
and	O
enhances	O
apoptotic	O
cell	O
death	O
on	O
hematopoietic	O
cells	O
.	O
To	O
identify	O
and	O
early	O
response	O
factor	O
by	O
exposure	O
to	O
ionizing	O
radiation	O
,	O
we	O
cloned	O
the	O
cDNA	O
of	O
a	O
novel	O
Kr	O
ppel	O
-	O
type	O
zinc	O
finger	O
(	O
ZNF	O
)	O
gene	O
,	O
gene1s	ARG2
ZK1	ARG2
gene1e	ARG2
,	O
from	O
a	O
cDNA	O
library	O
constructed	O
from	O
the	O
arg1s	O
human	O
arg1e	O
leukemia	O
cell	O
line	O
,	O
CMK86	O
,	O
using	O
degenerate	O
primers	O
.	O
This	O
cDNA	O
encoded	O
a	O
protein	O
of	O
671	O
amino	O
acids	O
with	O
an	O
A	O
box	O
of	O
Kr	O
ppel	O
-	O
associated	O
box	O
(	O
KRAB	O
)	O
domain	O
at	O
the	O
N	O
-	O
terminus	O
,	O
followed	O
by	O
15	O
ZNF	O
motifs	O
.	O
The	O
expression	O
level	O
of	O
the	O
gene1s	ARG2
ZK1	ARG2
gene1e	ARG2
mRNA	O
in	O
arg1s	O
human	O
arg1e	O
leukemia	O
cells	O
lines	O
,	O
CMK86	O
and	O
U937	O
,	O
was	O
increased	O
after	O
exposure	O
to	O
ionizing	O
radiation	O
.	O
Furthermore	O
,	O
species1s	O
murine	O
species1e	O
myeloid	O
precursor	O
species1s	O
32D	O
species1e	O
cells	O
that	O
were	O
stably	O
transfected	O
with	O
gene1s	O
ZK1	O
gene1e	O
cDNA	O
had	O
higher	O
sensitivity	O
to	O
ionizing	O
radiation	O
than	O
the	O
species1s	O
32D	O
species1e	O
parent	O
cells	O
.	O
These	O
data	O
suggest	O
that	O
the	O
gene1s	ARG2
ZK1	ARG2
gene1e	ARG2
gene	O
is	O
one	O
of	O
early	O
response	O
genes	O
by	O
exposure	O
to	O
ionizing	O
radiation	O
,	O
and	O
may	O
have	O
some	O
functions	O
on	O
radiation	O
-	O
induced	O
apoptotic	O
cell	O
death	O
on	O
hematopoietic	O
cells	O
.	O

gene1s	O
ZK1	O
gene1e	O
,	O
a	O
novel	O
Kr	O
ppel	O
-	O
type	O
zinc	O
finger	O
gene	O
,	O
is	O
induced	O
following	O
exposure	O
to	O
ionizing	O
radiation	O
and	O
enhances	O
apoptotic	O
cell	O
death	O
on	O
hematopoietic	O
cells	O
.	O
To	O
identify	O
and	O
early	O
response	O
factor	O
by	O
exposure	O
to	O
ionizing	O
radiation	O
,	O
we	O
cloned	O
the	O
cDNA	O
of	O
a	O
novel	O
Kr	O
ppel	O
-	O
type	O
zinc	O
finger	O
(	O
ZNF	O
)	O
gene	O
,	O
gene1s	O
ZK1	O
gene1e	O
,	O
from	O
a	O
cDNA	O
library	O
constructed	O
from	O
the	O
species1s	O
human	O
species1e	O
leukemia	O
cell	O
line	O
,	O
CMK86	O
,	O
using	O
degenerate	O
primers	O
.	O
This	O
cDNA	O
encoded	O
a	O
protein	O
of	O
671	O
amino	O
acids	O
with	O
an	O
A	O
box	O
of	O
Kr	O
ppel	O
-	O
associated	O
box	O
(	O
KRAB	O
)	O
domain	O
at	O
the	O
N	O
-	O
terminus	O
,	O
followed	O
by	O
15	O
ZNF	O
motifs	O
.	O
The	O
expression	O
level	O
of	O
the	O
gene1s	O
ZK1	O
gene1e	O
mRNA	O
in	O
species1s	O
human	O
species1e	O
leukemia	O
cells	O
lines	O
,	O
CMK86	O
and	O
U937	O
,	O
was	O
increased	O
after	O
exposure	O
to	O
ionizing	O
radiation	O
.	O
Furthermore	O
,	O
arg1s	O
murine	O
arg1e	O
myeloid	O
precursor	O
arg1s	O
32D	O
arg1e	O
cells	O
that	O
were	O
stably	O
transfected	O
with	O
gene1s	ARG2
ZK1	ARG2
gene1e	ARG2
cDNA	O
had	O
higher	O
sensitivity	O
to	O
ionizing	O
radiation	O
than	O
the	O
arg1s	O
32D	O
arg1e	O
parent	O
cells	O
.	O
These	O
data	O
suggest	O
that	O
the	O
gene1s	O
ZK1	O
gene1e	O
gene	O
is	O
one	O
of	O
early	O
response	O
genes	O
by	O
exposure	O
to	O
ionizing	O
radiation	O
,	O
and	O
may	O
have	O
some	O
functions	O
on	O
radiation	O
-	O
induced	O
apoptotic	O
cell	O
death	O
on	O
hematopoietic	O
cells	O
.	O

gene1s	ARG2
p63	ARG2
gene1e	ARG2
,	O
a	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
homolog	O
at	O
3q27	O
-	O
29	O
,	O
encodes	O
multiple	O
products	O
with	O
transactivating	O
,	O
death	O
-	O
inducing	O
,	O
and	O
dominant	O
-	O
negative	O
activities	O
.	O
We	O
describe	O
the	O
cloning	O
of	O
gene1s	ARG2
p63	ARG2
gene1e	ARG2
,	O
a	O
gene	O
at	O
chromosome	O
3q27	O
-	O
29	O
that	O
bears	O
strong	O
homology	O
to	O
the	O
tumor	O
suppressor	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
and	O
to	O
the	O
related	O
gene	O
,	O
gene1s	ARG2
p73	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
p63	ARG2
gene1e	ARG2
was	O
detected	O
in	O
a	O
variety	O
of	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
mouse	O
species1e	O
tissues	O
,	O
including	O
proliferating	O
basal	O
cells	O
of	O
epithelial	O
layers	O
in	O
the	O
epidermis	O
,	O
cervix	O
,	O
urothelium	O
,	O
and	O
prostate	O
.	O
Unlike	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
,	O
the	O
gene1s	ARG2
p63	ARG2
gene1e	ARG2
gene	O
encodes	O
multiple	O
isotypes	O
with	O
remarkably	O
divergent	O
abilities	O
to	O
transactivate	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
reporter	O
genes	O
and	O
induce	O
apoptosis	O
.	O
Importantly	O
,	O
the	O
predominant	O
gene1s	ARG2
p63	ARG2
gene1e	ARG2
isotypes	O
in	O
many	O
epithelial	O
tissues	O
lack	O
an	O
acidic	O
N	O
terminus	O
corresponding	O
to	O
the	O
transactivation	O
domain	O
of	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
.	O
We	O
demonstrate	O
that	O
these	O
truncated	O
gene1s	ARG2
p63	ARG2
gene1e	ARG2
variants	O
can	O
act	O
as	O
dominant	O
-	O
negative	O
agents	O
toward	O
transactivation	O
by	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p63	ARG2
gene1e	ARG2
,	O
and	O
we	O
suggest	O
the	O
possibility	O
of	O
physiological	O
interactions	O
among	O
members	O
of	O
the	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
family	O
.	O

gene1s	O
p63	O
gene1e	O
,	O
a	O
gene1s	O
p53	O
gene1e	O
homolog	O
at	O
3q27	O
-	O
29	O
,	O
encodes	O
multiple	O
products	O
with	O
transactivating	O
,	O
death	O
-	O
inducing	O
,	O
and	O
dominant	O
-	O
negative	O
activities	O
.	O
We	O
describe	O
the	O
cloning	O
of	O
gene1s	O
p63	O
gene1e	O
,	O
a	O
gene	O
at	O
chromosome	O
3q27	O
-	O
29	O
that	O
bears	O
strong	O
homology	O
to	O
the	O
tumor	O
suppressor	O
gene1s	O
p53	O
gene1e	O
and	O
to	O
the	O
related	O
gene	O
,	O
gene1s	O
p73	O
gene1e	O
.	O
gene1s	O
p63	O
gene1e	O
was	O
detected	O
in	O
a	O
variety	O
of	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
mouse	O
arg1e	O
tissues	O
,	O
including	O
proliferating	O
basal	O
cells	O
of	O
epithelial	O
layers	O
in	O
the	O
epidermis	O
,	O
cervix	O
,	O
urothelium	O
,	O
and	O
prostate	O
.	O
Unlike	O
gene1s	O
p53	O
gene1e	O
,	O
the	O
gene1s	O
p63	O
gene1e	O
gene	O
encodes	O
multiple	O
isotypes	O
with	O
remarkably	O
divergent	O
abilities	O
to	O
transactivate	O
gene1s	O
p53	O
gene1e	O
reporter	O
genes	O
and	O
induce	O
apoptosis	O
.	O
Importantly	O
,	O
the	O
predominant	O
gene1s	O
p63	O
gene1e	O
isotypes	O
in	O
many	O
epithelial	O
tissues	O
lack	O
an	O
acidic	O
N	O
terminus	O
corresponding	O
to	O
the	O
transactivation	O
domain	O
of	O
gene1s	O
p53	O
gene1e	O
.	O
We	O
demonstrate	O
that	O
these	O
truncated	O
gene1s	O
p63	O
gene1e	O
variants	O
can	O
act	O
as	O
dominant	O
-	O
negative	O
agents	O
toward	O
transactivation	O
by	O
gene1s	O
p53	O
gene1e	O
and	O
gene1s	O
p63	O
gene1e	O
,	O
and	O
we	O
suggest	O
the	O
possibility	O
of	O
physiological	O
interactions	O
among	O
members	O
of	O
the	O
gene1s	O
p53	O
gene1e	O
family	O
.	O

Coding	O
sequence	O
and	O
expression	O
patterns	O
of	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
chordin	ARG2
gene1e	ARG2
and	O
mapping	O
of	O
the	O
cognate	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
chrd	ARG2
gene1e	ARG2
and	O
species1s	O
human	O
species1e	O
gene1s	O
CHRD	O
gene1e	O
genes	O
.	O
gene1s	O
Chordin	O
gene1e	O
is	O
a	O
key	O
developmental	O
protein	O
that	O
dorsalizes	O
early	O
vertebrate	O
embryonic	O
tissues	O
by	O
binding	O
to	O
ventralizing	O
gene1s	O
TGF	O
-	O
beta	O
gene1e	O
-	O
like	O
bone	O
morphogenetic	O
proteins	O
and	O
sequestering	O
them	O
in	O
latent	O
complexes	O
.	O
Here	O
we	O
report	O
the	O
first	O
characterization	O
of	O
species1s	O
mammalian	O
species1e	O
gene1s	O
chordin	O
gene1e	O
.	O
The	O
full	O
-	O
length	O
cDNA	O
sequence	O
for	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
chordin	ARG2
gene1e	ARG2
is	O
given	O
,	O
and	O
RNA	O
blot	O
analysis	O
shows	O
the	O
arg1s	O
murine	O
arg1e	O
gene1s	ARG2
chordin	ARG2
gene1e	ARG2
gene	O
gene1s	ARG2
Chrd	ARG2
gene1e	ARG2
to	O
be	O
expressed	O
at	O
relatively	O
high	O
levels	O
in	O
7-day	O
postcoitum	O
arg1s	O
mouse	O
arg1e	O
embryos	O
and	O
at	O
much	O
decreased	O
levels	O
at	O
later	O
developmental	O
times	O
and	O
in	O
adult	O
tissues	O
.	O
These	O
results	O
imply	O
a	O
major	O
role	O
for	O
gene1s	O
chordin	O
gene1e	O
during	O
gastrulation	O
of	O
the	O
species1s	O
mammalian	O
species1e	O
embryo	O
.	O
Nevertheless	O
,	O
both	O
arg1s	O
murine	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
gene1s	ARG2
chordin	ARG2
gene1e	ARG2
genes	O
are	O
shown	O
to	O
be	O
expressed	O
at	O
readily	O
detectable	O
levels	O
in	O
several	O
fetal	O
and	O
adult	O
tissues	O
,	O
most	O
notably	O
liver	O
and	O
cerebellum	O
,	O
suggesting	O
additional	O
roles	O
in	O
organogenesis	O
and	O
homeostasis	O
.	O
gene1s	ARG2
Chrd	ARG2
gene1e	ARG2
was	O
mapped	O
to	O
arg1s	O
mouse	O
arg1e	O
chromosome	O
16	O
using	O
interspecific	O
crosses	O
,	O
and	O
the	O
cognate	O
species1s	O
human	O
species1e	O
gene	O
gene1s	O
CHRD	O
gene1e	O
was	O
localized	O
to	O
species1s	O
human	O
species1e	O
chromosome	O
3q27	O
by	O
radiation	O
hybrid	O
mapping	O
.	O
Copyright	O
1998	O
Academic	O
Press	O
.	O

Coding	O
sequence	O
and	O
expression	O
patterns	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	O
chordin	O
gene1e	O
and	O
mapping	O
of	O
the	O
cognate	O
species1s	O
mouse	O
species1e	O
gene1s	O
chrd	O
gene1e	O
and	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
CHRD	ARG2
gene1e	ARG2
genes	O
.	O
gene1s	ARG2
Chordin	ARG2
gene1e	ARG2
is	O
a	O
key	O
developmental	O
protein	O
that	O
dorsalizes	O
early	O
vertebrate	O
embryonic	O
tissues	O
by	O
binding	O
to	O
ventralizing	O
gene1s	ARG2
TGF	ARG2
-	ARG2
beta	ARG2
gene1e	ARG2
-	O
like	O
bone	O
morphogenetic	O
proteins	O
and	O
sequestering	O
them	O
in	O
latent	O
complexes	O
.	O
Here	O
we	O
report	O
the	O
first	O
characterization	O
of	O
arg1s	O
mammalian	O
arg1e	O
gene1s	ARG2
chordin	ARG2
gene1e	ARG2
.	O
The	O
full	O
-	O
length	O
cDNA	O
sequence	O
for	O
species1s	O
mouse	O
species1e	O
gene1s	O
chordin	O
gene1e	O
is	O
given	O
,	O
and	O
RNA	O
blot	O
analysis	O
shows	O
the	O
species1s	O
murine	O
species1e	O
gene1s	O
chordin	O
gene1e	O
gene	O
gene1s	O
Chrd	O
gene1e	O
to	O
be	O
expressed	O
at	O
relatively	O
high	O
levels	O
in	O
7-day	O
postcoitum	O
species1s	O
mouse	O
species1e	O
embryos	O
and	O
at	O
much	O
decreased	O
levels	O
at	O
later	O
developmental	O
times	O
and	O
in	O
adult	O
tissues	O
.	O
These	O
results	O
imply	O
a	O
major	O
role	O
for	O
gene1s	ARG2
chordin	ARG2
gene1e	ARG2
during	O
gastrulation	O
of	O
the	O
arg1s	O
mammalian	O
arg1e	O
embryo	O
.	O
Nevertheless	O
,	O
both	O
species1s	O
murine	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
chordin	ARG2
gene1e	ARG2
genes	O
are	O
shown	O
to	O
be	O
expressed	O
at	O
readily	O
detectable	O
levels	O
in	O
several	O
fetal	O
and	O
adult	O
tissues	O
,	O
most	O
notably	O
liver	O
and	O
cerebellum	O
,	O
suggesting	O
additional	O
roles	O
in	O
organogenesis	O
and	O
homeostasis	O
.	O
gene1s	O
Chrd	O
gene1e	O
was	O
mapped	O
to	O
species1s	O
mouse	O
species1e	O
chromosome	O
16	O
using	O
interspecific	O
crosses	O
,	O
and	O
the	O
cognate	O
arg1s	O
human	O
arg1e	O
gene	O
gene1s	ARG2
CHRD	ARG2
gene1e	ARG2
was	O
localized	O
to	O
arg1s	O
human	O
arg1e	O
chromosome	O
3q27	O
by	O
radiation	O
hybrid	O
mapping	O
.	O
Copyright	O
1998	O
Academic	O
Press	O
.	O

Cloning	O
and	O
characterization	O
of	O
a	O
novel	O
arg1s	O
human	O
arg1e	O
hepatocyte	O
transcription	O
factor	O
,	O
gene1s	ARG2
hB1F	ARG2
gene1e	ARG2
,	O
which	O
binds	O
and	O
activates	O
enhancer	O
II	O
of	O
species1s	O
hepatitis	O
B	O
virus	O
species1e	O
.	O
Enhancer	O
II	O
(	O
ENII	O
)	O
of	O
species1s	O
hepatitis	O
B	O
virus	O
species1e	O
(	O
species1s	O
HBV	O
species1e	O
)	O
is	O
one	O
of	O
the	O
essential	O
cis	O
-	O
elements	O
for	O
the	O
transcriptional	O
regulation	O
of	O
species1s	O
HBV	O
species1e	O
gene	O
expression	O
.	O
Its	O
function	O
is	O
highly	O
liver	O
-	O
specific	O
,	O
suggesting	O
that	O
liver	O
-	O
enriched	O
transcriptional	O
factors	O
play	O
critical	O
roles	O
in	O
regulating	O
the	O
activity	O
of	O
ENII	O
.	O
In	O
this	O
report	O
,	O
a	O
novel	O
hepatocyte	O
transcription	O
factor	O
,	O
which	O
binds	O
specifically	O
to	O
the	O
B1	O
region	O
(	O
AACGACCGACCTTGAG	O
)	O
within	O
the	O
major	O
functional	O
unit	O
(	O
B	O
unit	O
)	O
of	O
ENII	O
,	O
has	O
been	O
cloned	O
from	O
a	O
arg1s	O
human	O
arg1e	O
liver	O
cDNA	O
library	O
by	O
species1s	O
yeast	O
species1e	O
one	O
-	O
hybrid	O
screening	O
,	O
and	O
demonstrated	O
to	O
trans	O
-	O
activate	O
ENII	O
via	O
the	O
B1	O
region	O
.	O
We	O
named	O
this	O
factor	O
gene1s	ARG2
hB1F	ARG2
gene1e	ARG2
,	O
for	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
B1-binding	ARG2
factor	ARG2
gene1e	ARG2
.	O
Amino	O
acid	O
analysis	O
revealed	O
this	O
factor	O
structurally	O
belongs	O
to	O
nuclear	O
receptor	O
superfamily	O
.	O
Based	O
on	O
the	O
sequence	O
similarities	O
,	O
gene1s	ARG2
hB1F	ARG2
gene1e	ARG2
is	O
characterized	O
to	O
be	O
a	O
novel	O
arg1s	O
human	O
arg1e	O
homolog	O
of	O
the	O
gene1s	ARG2
orphan	ARG2
receptor	ARG2
fushi	ARG2
tarazu	ARG2
factor	ARG2
I	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
FTZ	ARG2
-	ARG2
F1	ARG2
gene1e	ARG2
)	O
.	O
Using	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
,	O
a	O
splicing	O
isoform	O
of	O
gene1s	ARG2
hB1F	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
hB1F-2	ARG2
gene1e	ARG2
)	O
was	O
identified	O
,	O
which	O
has	O
an	O
extra	O
46	O
amino	O
acid	O
residues	O
in	O
the	O
A	O
/	O
B	O
region	O
.	O
Examination	O
of	O
the	O
tissue	O
distribution	O
has	O
revealed	O
an	O
abundant	O
5.2-kilobase	O
transcript	O
of	O
gene1s	ARG2
hB1F	ARG2
gene1e	ARG2
is	O
present	O
specifically	O
in	O
arg1s	O
human	O
arg1e	O
pancreas	O
and	O
liver	O
.	O
Interestingly	O
,	O
an	O
additional	O
transcript	O
of	O
3.8	O
kilobases	O
was	O
found	O
to	O
be	O
present	O
in	O
hepatoma	O
cells	O
HepG2	O
.	O
Fluorescent	O
in	O
situ	O
hybridization	O
has	O
mapped	O
the	O
gene	O
locus	O
of	O
gene1s	ARG2
hB1F	ARG2
gene1e	ARG2
to	O
the	O
region	O
q31	O
-	O
32.1	O
of	O
arg1s	O
human	O
arg1e	O
chromosome	O
1	O
.	O
Altogether	O
,	O
this	O
study	O
provides	O
the	O
first	O
report	O
that	O
a	O
novel	O
arg1s	O
human	O
arg1e	O
homolog	O
of	O
gene1s	ARG2
FTZ	ARG2
-	ARG2
F1	ARG2
gene1e	ARG2
binds	O
and	O
regulates	O
ENII	O
of	O
species1s	O
HBV	O
species1e	O
.	O
The	O
potential	O
roles	O
of	O
this	O
gene1s	ARG2
FTZ	ARG2
-	ARG2
F1	ARG2
gene1e	ARG2
homolog	O
in	O
tissue	O
-	O
specific	O
gene	O
regulation	O
,	O
in	O
embryonic	O
development	O
,	O
as	O
well	O
as	O
in	O
liver	O
carcinogenesis	O
are	O
discussed	O
.	O

Cloning	O
and	O
characterization	O
of	O
a	O
novel	O
species1s	O
human	O
species1e	O
hepatocyte	O
transcription	O
factor	O
,	O
gene1s	O
hB1F	O
gene1e	O
,	O
which	O
binds	O
and	O
activates	O
enhancer	O
II	O
of	O
arg1s	O
hepatitis	O
B	O
virus	O
arg1e	O
.	O
Enhancer	O
II	O
(	O
ENII	O
)	O
of	O
arg1s	O
hepatitis	O
B	O
virus	O
arg1e	O
(	O
arg1s	O
HBV	O
arg1e	O
)	O
is	O
one	O
of	O
the	O
essential	O
cis	O
-	O
elements	O
for	O
the	O
transcriptional	O
regulation	O
of	O
arg1s	O
HBV	O
arg1e	O
gene	O
expression	O
.	O
Its	O
function	O
is	O
highly	O
liver	O
-	O
specific	O
,	O
suggesting	O
that	O
liver	O
-	O
enriched	O
transcriptional	O
factors	O
play	O
critical	O
roles	O
in	O
regulating	O
the	O
activity	O
of	O
ENII	O
.	O
In	O
this	O
report	O
,	O
a	O
novel	O
hepatocyte	O
transcription	O
factor	O
,	O
which	O
binds	O
specifically	O
to	O
the	O
B1	O
region	O
(	O
AACGACCGACCTTGAG	O
)	O
within	O
the	O
major	O
functional	O
unit	O
(	O
B	O
unit	O
)	O
of	O
ENII	O
,	O
has	O
been	O
cloned	O
from	O
a	O
species1s	O
human	O
species1e	O
liver	O
cDNA	O
library	O
by	O
species1s	O
yeast	O
species1e	O
one	O
-	O
hybrid	O
screening	O
,	O
and	O
demonstrated	O
to	O
trans	O
-	O
activate	O
ENII	O
via	O
the	O
B1	O
region	O
.	O
We	O
named	O
this	O
factor	O
gene1s	O
hB1F	O
gene1e	O
,	O
for	O
species1s	O
human	O
species1e	O
gene1s	O
B1-binding	O
factor	O
gene1e	O
.	O
Amino	O
acid	O
analysis	O
revealed	O
this	O
factor	O
structurally	O
belongs	O
to	O
nuclear	O
receptor	O
superfamily	O
.	O
Based	O
on	O
the	O
sequence	O
similarities	O
,	O
gene1s	O
hB1F	O
gene1e	O
is	O
characterized	O
to	O
be	O
a	O
novel	O
species1s	O
human	O
species1e	O
homolog	O
of	O
the	O
gene1s	O
orphan	O
receptor	O
fushi	O
tarazu	O
factor	O
I	O
gene1e	O
(	O
gene1s	O
FTZ	O
-	O
F1	O
gene1e	O
)	O
.	O
Using	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
,	O
a	O
splicing	O
isoform	O
of	O
gene1s	O
hB1F	O
gene1e	O
(	O
gene1s	O
hB1F-2	O
gene1e	O
)	O
was	O
identified	O
,	O
which	O
has	O
an	O
extra	O
46	O
amino	O
acid	O
residues	O
in	O
the	O
A	O
/	O
B	O
region	O
.	O
Examination	O
of	O
the	O
tissue	O
distribution	O
has	O
revealed	O
an	O
abundant	O
5.2-kilobase	O
transcript	O
of	O
gene1s	O
hB1F	O
gene1e	O
is	O
present	O
specifically	O
in	O
species1s	O
human	O
species1e	O
pancreas	O
and	O
liver	O
.	O
Interestingly	O
,	O
an	O
additional	O
transcript	O
of	O
3.8	O
kilobases	O
was	O
found	O
to	O
be	O
present	O
in	O
hepatoma	O
cells	O
HepG2	O
.	O
Fluorescent	O
in	O
situ	O
hybridization	O
has	O
mapped	O
the	O
gene	O
locus	O
of	O
gene1s	O
hB1F	O
gene1e	O
to	O
the	O
region	O
q31	O
-	O
32.1	O
of	O
species1s	O
human	O
species1e	O
chromosome	O
1	O
.	O
Altogether	O
,	O
this	O
study	O
provides	O
the	O
first	O
report	O
that	O
a	O
novel	O
species1s	O
human	O
species1e	O
homolog	O
of	O
gene1s	O
FTZ	O
-	O
F1	O
gene1e	O
binds	O
and	O
regulates	O
ENII	O
of	O
arg1s	O
HBV	O
arg1e	O
.	O
The	O
potential	O
roles	O
of	O
this	O
gene1s	O
FTZ	O
-	O
F1	O
gene1e	O
homolog	O
in	O
tissue	O
-	O
specific	O
gene	O
regulation	O
,	O
in	O
embryonic	O
development	O
,	O
as	O
well	O
as	O
in	O
liver	O
carcinogenesis	O
are	O
discussed	O
.	O

Cloning	O
and	O
characterization	O
of	O
a	O
novel	O
species1s	O
human	O
species1e	O
hepatocyte	O
transcription	O
factor	O
,	O
gene1s	O
hB1F	O
gene1e	O
,	O
which	O
binds	O
and	O
activates	O
enhancer	O
II	O
of	O
species1s	O
hepatitis	O
B	O
virus	O
species1e	O
.	O
Enhancer	O
II	O
(	O
ENII	O
)	O
of	O
species1s	O
hepatitis	O
B	O
virus	O
species1e	O
(	O
species1s	O
HBV	O
species1e	O
)	O
is	O
one	O
of	O
the	O
essential	O
cis	O
-	O
elements	O
for	O
the	O
transcriptional	O
regulation	O
of	O
species1s	O
HBV	O
species1e	O
gene	O
expression	O
.	O
Its	O
function	O
is	O
highly	O
liver	O
-	O
specific	O
,	O
suggesting	O
that	O
liver	O
-	O
enriched	O
transcriptional	O
factors	O
play	O
critical	O
roles	O
in	O
regulating	O
the	O
activity	O
of	O
ENII	O
.	O
In	O
this	O
report	O
,	O
a	O
novel	O
hepatocyte	O
transcription	O
factor	O
,	O
which	O
binds	O
specifically	O
to	O
the	O
B1	O
region	O
(	O
AACGACCGACCTTGAG	O
)	O
within	O
the	O
major	O
functional	O
unit	O
(	O
B	O
unit	O
)	O
of	O
ENII	O
,	O
has	O
been	O
cloned	O
from	O
a	O
species1s	O
human	O
species1e	O
liver	O
cDNA	O
library	O
by	O
arg1s	O
yeast	O
arg1e	O
one	O
-	O
hybrid	O
screening	O
,	O
and	O
demonstrated	O
to	O
trans	O
-	O
activate	O
ENII	O
via	O
the	O
B1	O
region	O
.	O
We	O
named	O
this	O
factor	O
gene1s	O
hB1F	O
gene1e	O
,	O
for	O
species1s	O
human	O
species1e	O
gene1s	O
B1-binding	O
factor	O
gene1e	O
.	O
Amino	O
acid	O
analysis	O
revealed	O
this	O
factor	O
structurally	O
belongs	O
to	O
nuclear	O
receptor	O
superfamily	O
.	O
Based	O
on	O
the	O
sequence	O
similarities	O
,	O
gene1s	O
hB1F	O
gene1e	O
is	O
characterized	O
to	O
be	O
a	O
novel	O
species1s	O
human	O
species1e	O
homolog	O
of	O
the	O
gene1s	O
orphan	O
receptor	O
fushi	O
tarazu	O
factor	O
I	O
gene1e	O
(	O
gene1s	O
FTZ	O
-	O
F1	O
gene1e	O
)	O
.	O
Using	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
,	O
a	O
splicing	O
isoform	O
of	O
gene1s	O
hB1F	O
gene1e	O
(	O
gene1s	O
hB1F-2	O
gene1e	O
)	O
was	O
identified	O
,	O
which	O
has	O
an	O
extra	O
46	O
amino	O
acid	O
residues	O
in	O
the	O
A	O
/	O
B	O
region	O
.	O
Examination	O
of	O
the	O
tissue	O
distribution	O
has	O
revealed	O
an	O
abundant	O
5.2-kilobase	O
transcript	O
of	O
gene1s	O
hB1F	O
gene1e	O
is	O
present	O
specifically	O
in	O
species1s	O
human	O
species1e	O
pancreas	O
and	O
liver	O
.	O
Interestingly	O
,	O
an	O
additional	O
transcript	O
of	O
3.8	O
kilobases	O
was	O
found	O
to	O
be	O
present	O
in	O
hepatoma	O
cells	O
HepG2	O
.	O
Fluorescent	O
in	O
situ	O
hybridization	O
has	O
mapped	O
the	O
gene	O
locus	O
of	O
gene1s	O
hB1F	O
gene1e	O
to	O
the	O
region	O
q31	O
-	O
32.1	O
of	O
species1s	O
human	O
species1e	O
chromosome	O
1	O
.	O
Altogether	O
,	O
this	O
study	O
provides	O
the	O
first	O
report	O
that	O
a	O
novel	O
species1s	O
human	O
species1e	O
homolog	O
of	O
gene1s	O
FTZ	O
-	O
F1	O
gene1e	O
binds	O
and	O
regulates	O
ENII	O
of	O
species1s	O
HBV	O
species1e	O
.	O
The	O
potential	O
roles	O
of	O
this	O
gene1s	O
FTZ	O
-	O
F1	O
gene1e	O
homolog	O
in	O
tissue	O
-	O
specific	O
gene	O
regulation	O
,	O
in	O
embryonic	O
development	O
,	O
as	O
well	O
as	O
in	O
liver	O
carcinogenesis	O
are	O
discussed	O
.	O

gene1s	O
Diva	O
gene1e	O
,	O
a	O
gene1s	O
Bcl-2	O
gene1e	O
homologue	O
that	O
binds	O
directly	O
to	O
gene1s	O
Apaf-1	O
gene1e	O
and	O
induces	O
BH3-independent	O
cell	O
death	O
.	O
We	O
have	O
identified	O
and	O
characterized	O
gene1s	O
Diva	O
gene1e	O
,	O
which	O
is	O
a	O
novel	O
regulator	O
of	O
apoptosis	O
.	O
Sequence	O
analysis	O
revealed	O
that	O
gene1s	O
Diva	O
gene1e	O
is	O
a	O
member	O
of	O
the	O
gene1s	O
Bcl-2	O
gene1e	O
family	O
of	O
proteins	O
containing	O
Bcl-2	O
homology	O
domain	O
1	O
,	O
2	O
,	O
3	O
,	O
and	O
4	O
(	O
BH1	O
,	O
BH2	O
,	O
BH3	O
,	O
and	O
BH4	O
)	O
regions	O
and	O
a	O
carboxyl	O
-	O
terminal	O
hydrophobic	O
domain	O
.	O
The	O
expression	O
of	O
gene1s	ARG2
Diva	ARG2
gene1e	ARG2
mRNA	O
was	O
detected	O
in	O
multiple	O
embryonic	O
tissues	O
but	O
was	O
restricted	O
to	O
the	O
ovary	O
and	O
testis	O
in	O
adult	O
arg1s	O
mice	O
arg1e	O
.	O
The	O
expression	O
of	O
gene1s	O
Diva	O
gene1e	O
promoted	O
the	O
death	O
of	O
species1s	O
293	O
T	O
species1e	O
,	O
Ramsey	O
,	O
and	O
species1s	O
T47D	O
species1e	O
cells	O
as	O
well	O
as	O
that	O
of	O
primary	O
sensory	O
neurons	O
,	O
indicating	O
that	O
gene1s	O
Diva	O
gene1e	O
is	O
a	O
proapoptotic	O
protein	O
.	O
Significantly	O
,	O
gene1s	O
Diva	O
gene1e	O
lacks	O
critical	O
residues	O
in	O
the	O
conserved	O
BH3	O
region	O
that	O
mediate	O
the	O
interaction	O
between	O
BH3-containing	O
proapoptotic	O
gene1s	O
Bcl-2	O
gene1e	O
homologues	O
and	O
their	O
prosurvival	O
binding	O
partners	O
.	O
Consistent	O
with	O
this	O
,	O
gene1s	O
Diva	O
gene1e	O
did	O
not	O
bind	O
to	O
cellular	O
gene1s	O
Bcl-2	O
gene1e	O
family	O
members	O
including	O
gene1s	O
Bcl-2	O
gene1e	O
,	O
gene1s	O
Bcl	O
-	O
XL	O
gene1e	O
,	O
gene1s	O
Bcl	O
-	O
w	O
gene1e	O
,	O
gene1s	O
Mcl-1	O
gene1e	O
,	O
and	O
gene1s	O
A1	O
gene1e	O
/	O
gene1s	O
Bfl-1	O
gene1e	O
.	O
Furthermore	O
,	O
mutants	O
of	O
gene1s	O
Diva	O
gene1e	O
lacking	O
the	O
BH3	O
region	O
fully	O
retained	O
their	O
proapoptotic	O
activity	O
,	O
confirming	O
that	O
gene1s	O
Diva	O
gene1e	O
promotes	O
apoptosis	O
in	O
a	O
BH3-independent	O
manner	O
.	O
Significantly	O
,	O
gene1s	O
Diva	O
gene1e	O
interacted	O
with	O
a	O
viral	O
gene1s	O
Bcl-2	O
gene1e	O
homologue	O
(	O
gene1s	O
vBcl-2	O
gene1e	O
)	O
encoded	O
by	O
the	O
species1s	O
Kaposi	O
's	O
sarcoma	O
-	O
associated	O
herpesvirus	O
species1e	O
.	O
Consistent	O
with	O
these	O
associations	O
,	O
apoptosis	O
induced	O
by	O
gene1s	O
Diva	O
gene1e	O
was	O
inhibited	O
by	O
gene1s	O
vBcl-2	O
gene1e	O
but	O
not	O
by	O
gene1s	O
Bcl	O
-	O
XL	O
gene1e	O
.	O
Importantly	O
,	O
gene1s	O
Diva	O
gene1e	O
interacted	O
with	O
gene1s	O
Apaf-1	O
gene1e	O
,	O
an	O
adapter	O
molecule	O
that	O
activates	O
gene1s	O
caspase-9	O
gene1e	O
,	O
a	O
central	O
death	O
protease	O
of	O
the	O
apoptotic	O
pathway	O
.	O
The	O
expression	O
of	O
gene1s	O
Diva	O
gene1e	O
inhibited	O
the	O
binding	O
of	O
gene1s	O
Bcl	O
-	O
XL	O
gene1e	O
to	O
gene1s	O
Apaf-1	O
gene1e	O
,	O
as	O
determined	O
by	O
immunoprecipitation	O
assays	O
.	O
Thus	O
,	O
gene1s	O
Diva	O
gene1e	O
represents	O
a	O
novel	O
type	O
of	O
proapoptotic	O
gene1s	O
Bcl-2	O
gene1e	O
homologue	O
that	O
promotes	O
apoptosis	O
independently	O
of	O
the	O
BH3	O
region	O
through	O
direct	O
binding	O
to	O
gene1s	O
Apaf-1	O
gene1e	O
,	O
thus	O
preventing	O
gene1s	O
Bcl	O
-	O
XL	O
gene1e	O
from	O
binding	O
to	O
the	O
gene1s	O
caspase-9	O
gene1e	O
regulator	O
gene1s	O
Apaf-1	O
gene1e	O
.	O

gene1s	ARG2
Diva	ARG2
gene1e	ARG2
,	O
a	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
homologue	O
that	O
binds	O
directly	O
to	O
gene1s	ARG2
Apaf-1	ARG2
gene1e	ARG2
and	O
induces	O
BH3-independent	O
cell	O
death	O
.	O
We	O
have	O
identified	O
and	O
characterized	O
gene1s	ARG2
Diva	ARG2
gene1e	ARG2
,	O
which	O
is	O
a	O
novel	O
regulator	O
of	O
apoptosis	O
.	O
Sequence	O
analysis	O
revealed	O
that	O
gene1s	ARG2
Diva	ARG2
gene1e	ARG2
is	O
a	O
member	O
of	O
the	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
family	O
of	O
proteins	O
containing	O
Bcl-2	O
homology	O
domain	O
1	O
,	O
2	O
,	O
3	O
,	O
and	O
4	O
(	O
BH1	O
,	O
BH2	O
,	O
BH3	O
,	O
and	O
BH4	O
)	O
regions	O
and	O
a	O
carboxyl	O
-	O
terminal	O
hydrophobic	O
domain	O
.	O
The	O
expression	O
of	O
gene1s	O
Diva	O
gene1e	O
mRNA	O
was	O
detected	O
in	O
multiple	O
embryonic	O
tissues	O
but	O
was	O
restricted	O
to	O
the	O
ovary	O
and	O
testis	O
in	O
adult	O
species1s	O
mice	O
species1e	O
.	O
The	O
expression	O
of	O
gene1s	ARG2
Diva	ARG2
gene1e	ARG2
promoted	O
the	O
death	O
of	O
arg1s	O
293	O
T	O
arg1e	O
,	O
Ramsey	O
,	O
and	O
arg1s	O
T47D	O
arg1e	O
cells	O
as	O
well	O
as	O
that	O
of	O
primary	O
sensory	O
neurons	O
,	O
indicating	O
that	O
gene1s	ARG2
Diva	ARG2
gene1e	ARG2
is	O
a	O
proapoptotic	O
protein	O
.	O
Significantly	O
,	O
gene1s	ARG2
Diva	ARG2
gene1e	ARG2
lacks	O
critical	O
residues	O
in	O
the	O
conserved	O
BH3	O
region	O
that	O
mediate	O
the	O
interaction	O
between	O
BH3-containing	O
proapoptotic	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
homologues	O
and	O
their	O
prosurvival	O
binding	O
partners	O
.	O
Consistent	O
with	O
this	O
,	O
gene1s	ARG2
Diva	ARG2
gene1e	ARG2
did	O
not	O
bind	O
to	O
cellular	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
family	O
members	O
including	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Bcl	ARG2
-	ARG2
XL	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Bcl	ARG2
-	ARG2
w	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Mcl-1	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
A1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Bfl-1	ARG2
gene1e	ARG2
.	O
Furthermore	O
,	O
mutants	O
of	O
gene1s	ARG2
Diva	ARG2
gene1e	ARG2
lacking	O
the	O
BH3	O
region	O
fully	O
retained	O
their	O
proapoptotic	O
activity	O
,	O
confirming	O
that	O
gene1s	ARG2
Diva	ARG2
gene1e	ARG2
promotes	O
apoptosis	O
in	O
a	O
BH3-independent	O
manner	O
.	O
Significantly	O
,	O
gene1s	ARG2
Diva	ARG2
gene1e	ARG2
interacted	O
with	O
a	O
viral	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
homologue	O
(	O
gene1s	O
vBcl-2	O
gene1e	O
)	O
encoded	O
by	O
the	O
species1s	O
Kaposi	O
's	O
sarcoma	O
-	O
associated	O
herpesvirus	O
species1e	O
.	O
Consistent	O
with	O
these	O
associations	O
,	O
apoptosis	O
induced	O
by	O
gene1s	ARG2
Diva	ARG2
gene1e	ARG2
was	O
inhibited	O
by	O
gene1s	O
vBcl-2	O
gene1e	O
but	O
not	O
by	O
gene1s	ARG2
Bcl	ARG2
-	ARG2
XL	ARG2
gene1e	ARG2
.	O
Importantly	O
,	O
gene1s	ARG2
Diva	ARG2
gene1e	ARG2
interacted	O
with	O
gene1s	ARG2
Apaf-1	ARG2
gene1e	ARG2
,	O
an	O
adapter	O
molecule	O
that	O
activates	O
gene1s	ARG2
caspase-9	ARG2
gene1e	ARG2
,	O
a	O
central	O
death	O
protease	O
of	O
the	O
apoptotic	O
pathway	O
.	O
The	O
expression	O
of	O
gene1s	ARG2
Diva	ARG2
gene1e	ARG2
inhibited	O
the	O
binding	O
of	O
gene1s	ARG2
Bcl	ARG2
-	ARG2
XL	ARG2
gene1e	ARG2
to	O
gene1s	ARG2
Apaf-1	ARG2
gene1e	ARG2
,	O
as	O
determined	O
by	O
immunoprecipitation	O
assays	O
.	O
Thus	O
,	O
gene1s	ARG2
Diva	ARG2
gene1e	ARG2
represents	O
a	O
novel	O
type	O
of	O
proapoptotic	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
homologue	O
that	O
promotes	O
apoptosis	O
independently	O
of	O
the	O
BH3	O
region	O
through	O
direct	O
binding	O
to	O
gene1s	ARG2
Apaf-1	ARG2
gene1e	ARG2
,	O
thus	O
preventing	O
gene1s	ARG2
Bcl	ARG2
-	ARG2
XL	ARG2
gene1e	ARG2
from	O
binding	O
to	O
the	O
gene1s	ARG2
caspase-9	ARG2
gene1e	ARG2
regulator	O
gene1s	ARG2
Apaf-1	ARG2
gene1e	ARG2
.	O

gene1s	O
Diva	O
gene1e	O
,	O
a	O
gene1s	O
Bcl-2	O
gene1e	O
homologue	O
that	O
binds	O
directly	O
to	O
gene1s	O
Apaf-1	O
gene1e	O
and	O
induces	O
BH3-independent	O
cell	O
death	O
.	O
We	O
have	O
identified	O
and	O
characterized	O
gene1s	O
Diva	O
gene1e	O
,	O
which	O
is	O
a	O
novel	O
regulator	O
of	O
apoptosis	O
.	O
Sequence	O
analysis	O
revealed	O
that	O
gene1s	O
Diva	O
gene1e	O
is	O
a	O
member	O
of	O
the	O
gene1s	O
Bcl-2	O
gene1e	O
family	O
of	O
proteins	O
containing	O
Bcl-2	O
homology	O
domain	O
1	O
,	O
2	O
,	O
3	O
,	O
and	O
4	O
(	O
BH1	O
,	O
BH2	O
,	O
BH3	O
,	O
and	O
BH4	O
)	O
regions	O
and	O
a	O
carboxyl	O
-	O
terminal	O
hydrophobic	O
domain	O
.	O
The	O
expression	O
of	O
gene1s	O
Diva	O
gene1e	O
mRNA	O
was	O
detected	O
in	O
multiple	O
embryonic	O
tissues	O
but	O
was	O
restricted	O
to	O
the	O
ovary	O
and	O
testis	O
in	O
adult	O
species1s	O
mice	O
species1e	O
.	O
The	O
expression	O
of	O
gene1s	O
Diva	O
gene1e	O
promoted	O
the	O
death	O
of	O
species1s	O
293	O
T	O
species1e	O
,	O
Ramsey	O
,	O
and	O
species1s	O
T47D	O
species1e	O
cells	O
as	O
well	O
as	O
that	O
of	O
primary	O
sensory	O
neurons	O
,	O
indicating	O
that	O
gene1s	O
Diva	O
gene1e	O
is	O
a	O
proapoptotic	O
protein	O
.	O
Significantly	O
,	O
gene1s	O
Diva	O
gene1e	O
lacks	O
critical	O
residues	O
in	O
the	O
conserved	O
BH3	O
region	O
that	O
mediate	O
the	O
interaction	O
between	O
BH3-containing	O
proapoptotic	O
gene1s	O
Bcl-2	O
gene1e	O
homologues	O
and	O
their	O
prosurvival	O
binding	O
partners	O
.	O
Consistent	O
with	O
this	O
,	O
gene1s	O
Diva	O
gene1e	O
did	O
not	O
bind	O
to	O
cellular	O
gene1s	O
Bcl-2	O
gene1e	O
family	O
members	O
including	O
gene1s	O
Bcl-2	O
gene1e	O
,	O
gene1s	O
Bcl	O
-	O
XL	O
gene1e	O
,	O
gene1s	O
Bcl	O
-	O
w	O
gene1e	O
,	O
gene1s	O
Mcl-1	O
gene1e	O
,	O
and	O
gene1s	O
A1	O
gene1e	O
/	O
gene1s	O
Bfl-1	O
gene1e	O
.	O
Furthermore	O
,	O
mutants	O
of	O
gene1s	O
Diva	O
gene1e	O
lacking	O
the	O
BH3	O
region	O
fully	O
retained	O
their	O
proapoptotic	O
activity	O
,	O
confirming	O
that	O
gene1s	O
Diva	O
gene1e	O
promotes	O
apoptosis	O
in	O
a	O
BH3-independent	O
manner	O
.	O
Significantly	O
,	O
gene1s	O
Diva	O
gene1e	O
interacted	O
with	O
a	O
viral	O
gene1s	O
Bcl-2	O
gene1e	O
homologue	O
(	O
gene1s	ARG2
vBcl-2	ARG2
gene1e	ARG2
)	O
encoded	O
by	O
the	O
arg1s	O
Kaposi	O
's	O
sarcoma	O
-	O
associated	O
herpesvirus	O
arg1e	O
.	O
Consistent	O
with	O
these	O
associations	O
,	O
apoptosis	O
induced	O
by	O
gene1s	O
Diva	O
gene1e	O
was	O
inhibited	O
by	O
gene1s	ARG2
vBcl-2	ARG2
gene1e	ARG2
but	O
not	O
by	O
gene1s	O
Bcl	O
-	O
XL	O
gene1e	O
.	O
Importantly	O
,	O
gene1s	O
Diva	O
gene1e	O
interacted	O
with	O
gene1s	O
Apaf-1	O
gene1e	O
,	O
an	O
adapter	O
molecule	O
that	O
activates	O
gene1s	O
caspase-9	O
gene1e	O
,	O
a	O
central	O
death	O
protease	O
of	O
the	O
apoptotic	O
pathway	O
.	O
The	O
expression	O
of	O
gene1s	O
Diva	O
gene1e	O
inhibited	O
the	O
binding	O
of	O
gene1s	O
Bcl	O
-	O
XL	O
gene1e	O
to	O
gene1s	O
Apaf-1	O
gene1e	O
,	O
as	O
determined	O
by	O
immunoprecipitation	O
assays	O
.	O
Thus	O
,	O
gene1s	O
Diva	O
gene1e	O
represents	O
a	O
novel	O
type	O
of	O
proapoptotic	O
gene1s	O
Bcl-2	O
gene1e	O
homologue	O
that	O
promotes	O
apoptosis	O
independently	O
of	O
the	O
BH3	O
region	O
through	O
direct	O
binding	O
to	O
gene1s	O
Apaf-1	O
gene1e	O
,	O
thus	O
preventing	O
gene1s	O
Bcl	O
-	O
XL	O
gene1e	O
from	O
binding	O
to	O
the	O
gene1s	O
caspase-9	O
gene1e	O
regulator	O
gene1s	O
Apaf-1	O
gene1e	O
.	O

Cloning	O
and	O
characterization	O
of	O
gene1s	ARG2
CRF	ARG2
gene1e	ARG2
,	O
a	O
novel	O
gene1s	ARG2
C1q	ARG2
-	ARG2
related	ARG2
factor	ARG2
gene1e	ARG2
,	O
expressed	O
in	O
areas	O
of	O
the	O
brain	O
involved	O
in	O
motor	O
function	O
.	O
We	O
have	O
isolated	O
and	O
characterized	O
a	O
novel	O
cDNA	O
,	O
gene1s	ARG2
C1q	ARG2
-	ARG2
Related	ARG2
Factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CRF	ARG2
gene1e	ARG2
)	O
,	O
that	O
is	O
predicted	O
to	O
encode	O
a	O
258	O
amino	O
acid	O
polypeptide	O
with	O
a	O
hydrophobic	O
signal	O
sequence	O
,	O
a	O
collagenous	O
region	O
,	O
and	O
a	O
globular	O
domain	O
at	O
the	O
carboxy	O
terminus	O
that	O
shares	O
homology	O
to	O
the	O
C1q	O
signature	O
domain	O
.	O
arg1s	O
Human	O
arg1e	O
gene1s	ARG2
CRF	ARG2
gene1e	ARG2
transcript	O
is	O
expressed	O
at	O
highest	O
levels	O
in	O
the	O
brain	O
,	O
particularly	O
in	O
the	O
brainstem	O
.	O
In	O
situ	O
hybridization	O
to	O
species1s	O
mouse	O
species1e	O
brain	O
sections	O
demonstrated	O
that	O
gene1s	O
CRF	O
gene1e	O
transcripts	O
are	O
most	O
abundant	O
in	O
areas	O
of	O
the	O
nervous	O
system	O
involved	O
in	O
motor	O
function	O
,	O
such	O
as	O
the	O
Purkinje	O
cells	O
of	O
the	O
cerebellum	O
,	O
the	O
accessory	O
olivary	O
nucleus	O
,	O
the	O
pons	O
and	O
the	O
red	O
nucleus	O
.	O
The	O
species1s	O
mouse	O
species1e	O
gene1s	O
CRF	O
gene1e	O
homolog	O
is	O
highly	O
similar	O
to	O
the	O
arg1s	O
human	O
arg1e	O
gene	O
at	O
both	O
the	O
nucleotide	O
and	O
protein	O
level	O
,	O
suggesting	O
an	O
important	O
conserved	O
role	O
for	O
this	O
protein	O
.	O
Copyright	O
1999	O
Elsevier	O
Science	O
B.V.	O

Cloning	O
and	O
characterization	O
of	O
gene1s	O
CRF	O
gene1e	O
,	O
a	O
novel	O
gene1s	O
C1q	O
-	O
related	O
factor	O
gene1e	O
,	O
expressed	O
in	O
areas	O
of	O
the	O
brain	O
involved	O
in	O
motor	O
function	O
.	O
We	O
have	O
isolated	O
and	O
characterized	O
a	O
novel	O
cDNA	O
,	O
gene1s	O
C1q	O
-	O
Related	O
Factor	O
gene1e	O
(	O
gene1s	O
CRF	O
gene1e	O
)	O
,	O
that	O
is	O
predicted	O
to	O
encode	O
a	O
258	O
amino	O
acid	O
polypeptide	O
with	O
a	O
hydrophobic	O
signal	O
sequence	O
,	O
a	O
collagenous	O
region	O
,	O
and	O
a	O
globular	O
domain	O
at	O
the	O
carboxy	O
terminus	O
that	O
shares	O
homology	O
to	O
the	O
C1q	O
signature	O
domain	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
CRF	O
gene1e	O
transcript	O
is	O
expressed	O
at	O
highest	O
levels	O
in	O
the	O
brain	O
,	O
particularly	O
in	O
the	O
brainstem	O
.	O
In	O
situ	O
hybridization	O
to	O
arg1s	O
mouse	O
arg1e	O
brain	O
sections	O
demonstrated	O
that	O
gene1s	ARG2
CRF	ARG2
gene1e	ARG2
transcripts	O
are	O
most	O
abundant	O
in	O
areas	O
of	O
the	O
nervous	O
system	O
involved	O
in	O
motor	O
function	O
,	O
such	O
as	O
the	O
Purkinje	O
cells	O
of	O
the	O
cerebellum	O
,	O
the	O
accessory	O
olivary	O
nucleus	O
,	O
the	O
pons	O
and	O
the	O
red	O
nucleus	O
.	O
The	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
CRF	ARG2
gene1e	ARG2
homolog	O
is	O
highly	O
similar	O
to	O
the	O
species1s	O
human	O
species1e	O
gene	O
at	O
both	O
the	O
nucleotide	O
and	O
protein	O
level	O
,	O
suggesting	O
an	O
important	O
conserved	O
role	O
for	O
this	O
protein	O
.	O
Copyright	O
1999	O
Elsevier	O
Science	O
B.V.	O

Cloning	O
,	O
gene	O
structure	O
and	O
genomic	O
localization	O
of	O
an	O
orphan	O
transporter	O
from	O
arg1s	O
mouse	O
arg1e	O
kidney	O
with	O
six	O
alternatively	O
-	O
spliced	O
isoforms	O
.	O
Two	O
genes	O
were	O
identified	O
and	O
characterized	O
that	O
express	O
cDNAs	O
related	O
to	O
previously	O
identified	O
neurotransmitter	O
and/or	O
osmolyte	O
transporters	O
,	O
but	O
which	O
are	O
expressed	O
specifically	O
in	O
the	O
kidney	O
.	O
RNA	O
transcribed	O
from	O
one	O
of	O
these	O
two	O
genes	O
(	O
gene1s	O
XT2	O
gene1e	O
)	O
was	O
found	O
to	O
undergo	O
an	O
extensive	O
degree	O
of	O
alternative	O
splicing	O
to	O
generate	O
six	O
distinct	O
isoforms	O
.	O
The	O
intron	O
-	O
exon	O
structure	O
of	O
the	O
gene1s	O
XT2	O
gene1e	O
gene	O
and	O
the	O
sites	O
of	O
alternative	O
splicing	O
were	O
identified	O
.	O
Expression	O
of	O
the	O
second	O
gene	O
(	O
gene1s	O
XT3	O
gene1e	O
)	O
was	O
found	O
to	O
be	O
conserved	O
in	O
species1s	O
human	O
species1e	O
kidney	O
,	O
and	O
partial	O
sequence	O
was	O
obtained	O
from	O
a	O
species1s	O
human	O
species1e	O
cDNA	O
library	O
.	O
The	O
expressions	O
of	O
both	O
gene1s	ARG2
XT2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
XT3	ARG2
gene1e	ARG2
RNAs	O
were	O
determined	O
in	O
arg1s	O
mouse	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
tissues	O
,	O
respectively	O
,	O
and	O
the	O
locations	O
of	O
the	O
two	O
genes	O
within	O
the	O
arg1s	O
mouse	O
arg1e	O
genome	O
were	O
identified	O
.	O
Screening	O
experiments	O
to	O
identify	O
the	O
substrate(s	O
)	O
of	O
these	O
proteins	O
failed	O
to	O
identify	O
specific	O
uptake	O
with	O
any	O
of	O
the	O
tested	O
compounds	O
;	O
however	O
,	O
immunofluorescent	O
microscopy	O
demonstrated	O
that	O
epitope	O
-	O
tagged	O
variants	O
of	O
the	O
protein	O
products	O
of	O
the	O
gene1s	O
XT2	O
gene1e	O
and	O
gene1s	O
XT3	O
gene1e	O
cDNAs	O
were	O
present	O
on	O
the	O
plasma	O
membrane	O
of	O
transfected	O
cells	O
.	O

Cloning	O
,	O
gene	O
structure	O
and	O
genomic	O
localization	O
of	O
an	O
orphan	O
transporter	O
from	O
species1s	O
mouse	O
species1e	O
kidney	O
with	O
six	O
alternatively	O
-	O
spliced	O
isoforms	O
.	O
Two	O
genes	O
were	O
identified	O
and	O
characterized	O
that	O
express	O
cDNAs	O
related	O
to	O
previously	O
identified	O
neurotransmitter	O
and/or	O
osmolyte	O
transporters	O
,	O
but	O
which	O
are	O
expressed	O
specifically	O
in	O
the	O
kidney	O
.	O
RNA	O
transcribed	O
from	O
one	O
of	O
these	O
two	O
genes	O
(	O
gene1s	ARG2
XT2	ARG2
gene1e	ARG2
)	O
was	O
found	O
to	O
undergo	O
an	O
extensive	O
degree	O
of	O
alternative	O
splicing	O
to	O
generate	O
six	O
distinct	O
isoforms	O
.	O
The	O
intron	O
-	O
exon	O
structure	O
of	O
the	O
gene1s	ARG2
XT2	ARG2
gene1e	ARG2
gene	O
and	O
the	O
sites	O
of	O
alternative	O
splicing	O
were	O
identified	O
.	O
Expression	O
of	O
the	O
second	O
gene	O
(	O
gene1s	ARG2
XT3	ARG2
gene1e	ARG2
)	O
was	O
found	O
to	O
be	O
conserved	O
in	O
arg1s	O
human	O
arg1e	O
kidney	O
,	O
and	O
partial	O
sequence	O
was	O
obtained	O
from	O
a	O
arg1s	O
human	O
arg1e	O
cDNA	O
library	O
.	O
The	O
expressions	O
of	O
both	O
gene1s	ARG2
XT2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
XT3	ARG2
gene1e	ARG2
RNAs	O
were	O
determined	O
in	O
species1s	O
mouse	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
tissues	O
,	O
respectively	O
,	O
and	O
the	O
locations	O
of	O
the	O
two	O
genes	O
within	O
the	O
species1s	O
mouse	O
species1e	O
genome	O
were	O
identified	O
.	O
Screening	O
experiments	O
to	O
identify	O
the	O
substrate(s	O
)	O
of	O
these	O
proteins	O
failed	O
to	O
identify	O
specific	O
uptake	O
with	O
any	O
of	O
the	O
tested	O
compounds	O
;	O
however	O
,	O
immunofluorescent	O
microscopy	O
demonstrated	O
that	O
epitope	O
-	O
tagged	O
variants	O
of	O
the	O
protein	O
products	O
of	O
the	O
gene1s	ARG2
XT2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
XT3	ARG2
gene1e	ARG2
cDNAs	O
were	O
present	O
on	O
the	O
plasma	O
membrane	O
of	O
transfected	O
cells	O
.	O

gene1s	ARG2
MicroRNA-20a	ARG2
gene1e	ARG2
-	O
mediated	O
loss	O
of	O
autophagy	O
contributes	O
to	O
breast	O
tumorigenesis	O
by	O
promoting	O
genomic	O
damage	O
and	O
instability	O
.	O
Gene	O
expression	O
analysis	O
of	O
The	O
Cancer	O
Genome	O
Atlas	O
(	O
TCGA	O
)	O
breast	O
cancer	O
data	O
set	O
show	O
that	O
gene1s	ARG2
miR-20a	ARG2
gene1e	ARG2
is	O
upregulated	O
in	O
arg1s	O
human	O
arg1e	O
breast	O
cancer	O
,	O
especially	O
in	O
triple	O
-	O
negative	O
subtype	O
.	O
Gene	O
Set	O
Enrichment	O
Analysis	O
suggests	O
that	O
gene1s	ARG2
miR-20a	ARG2
gene1e	ARG2
expression	O
negatively	O
correlates	O
with	O
the	O
autophagy	O
/	O
lysosome	O
pathway	O
.	O
We	O
report	O
here	O
that	O
gene1s	ARG2
miR-20a	ARG2
gene1e	ARG2
inhibits	O
the	O
basal	O
and	O
nutrient	O
starvation	O
-	O
induced	O
autophagic	O
flux	O
and	O
lysosomal	O
proteolytic	O
activity	O
,	O
increases	O
intracellular	O
reactive	O
oxygen	O
species	O
levels	O
and	O
DNA	O
damage	O
response	O
by	O
targeting	O
several	O
key	O
regulators	O
of	O
autophagy	O
,	O
including	O
gene1s	ARG2
BECN1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ATG16L1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
SQSTM1	ARG2
gene1e	ARG2
.	O
Re	O
-	O
introduction	O
of	O
exogenous	O
gene1s	ARG2
BECN1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ATG16L1	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
SQSTM1	ARG2
gene1e	ARG2
reverses	O
the	O
inhibitory	O
effect	O
of	O
gene1s	ARG2
miR-20a	ARG2
gene1e	ARG2
on	O
autophagy	O
and	O
decreases	O
DNA	O
damage	O
.	O
A	O
negative	O
correlation	O
between	O
gene1s	ARG2
miR-20a	ARG2
gene1e	ARG2
and	O
its	O
target	O
genes	O
is	O
observed	O
in	O
breast	O
cancer	O
tissues	O
.	O
Lower	O
levels	O
of	O
gene1s	ARG2
BECN1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ATG16L1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
SQSTM1	ARG2
gene1e	ARG2
are	O
more	O
common	O
in	O
triple	O
-	O
negative	O
cancers	O
than	O
in	O
other	O
subtypes	O
.	O
High	O
levels	O
of	O
gene1s	ARG2
miR-20a	ARG2
gene1e	ARG2
also	O
associate	O
with	O
higher	O
frequency	O
of	O
copy	O
-	O
number	O
alterations	O
and	O
DNA	O
mutations	O
in	O
breast	O
cancer	O
arg1s	O
patients	O
arg1e	O
.	O
Further	O
studies	O
in	O
a	O
xenograft	O
species1s	O
mouse	O
species1e	O
model	O
show	O
that	O
gene1s	ARG2
miR-20a	ARG2
gene1e	ARG2
promotes	O
tumor	O
initiation	O
and	O
tumor	O
growth	O
.	O
Collectively	O
,	O
these	O
findings	O
suggest	O
that	O
gene1s	ARG2
miR-20a	ARG2
gene1e	ARG2
-	O
mediated	O
autophagy	O
defect	O
might	O
be	O
a	O
new	O
mechanism	O
underlying	O
the	O
oncogenic	O
function	O
of	O
miRNA	O
during	O
breast	O
tumorigenesis	O
.	O
Oncogene	O
advance	O
online	O
publication	O
,	O
19	O
June	O
2017	O
;	O
doi:10.1038	O
/	O
onc.2017.193	O
.	O

gene1s	O
MicroRNA-20a	O
gene1e	O
-	O
mediated	O
loss	O
of	O
autophagy	O
contributes	O
to	O
breast	O
tumorigenesis	O
by	O
promoting	O
genomic	O
damage	O
and	O
instability	O
.	O
Gene	O
expression	O
analysis	O
of	O
The	O
Cancer	O
Genome	O
Atlas	O
(	O
TCGA	O
)	O
breast	O
cancer	O
data	O
set	O
show	O
that	O
gene1s	O
miR-20a	O
gene1e	O
is	O
upregulated	O
in	O
species1s	O
human	O
species1e	O
breast	O
cancer	O
,	O
especially	O
in	O
triple	O
-	O
negative	O
subtype	O
.	O
Gene	O
Set	O
Enrichment	O
Analysis	O
suggests	O
that	O
gene1s	O
miR-20a	O
gene1e	O
expression	O
negatively	O
correlates	O
with	O
the	O
autophagy	O
/	O
lysosome	O
pathway	O
.	O
We	O
report	O
here	O
that	O
gene1s	O
miR-20a	O
gene1e	O
inhibits	O
the	O
basal	O
and	O
nutrient	O
starvation	O
-	O
induced	O
autophagic	O
flux	O
and	O
lysosomal	O
proteolytic	O
activity	O
,	O
increases	O
intracellular	O
reactive	O
oxygen	O
species	O
levels	O
and	O
DNA	O
damage	O
response	O
by	O
targeting	O
several	O
key	O
regulators	O
of	O
autophagy	O
,	O
including	O
gene1s	O
BECN1	O
gene1e	O
,	O
gene1s	O
ATG16L1	O
gene1e	O
and	O
gene1s	O
SQSTM1	O
gene1e	O
.	O
Re	O
-	O
introduction	O
of	O
exogenous	O
gene1s	O
BECN1	O
gene1e	O
,	O
gene1s	O
ATG16L1	O
gene1e	O
or	O
gene1s	O
SQSTM1	O
gene1e	O
reverses	O
the	O
inhibitory	O
effect	O
of	O
gene1s	O
miR-20a	O
gene1e	O
on	O
autophagy	O
and	O
decreases	O
DNA	O
damage	O
.	O
A	O
negative	O
correlation	O
between	O
gene1s	O
miR-20a	O
gene1e	O
and	O
its	O
target	O
genes	O
is	O
observed	O
in	O
breast	O
cancer	O
tissues	O
.	O
Lower	O
levels	O
of	O
gene1s	O
BECN1	O
gene1e	O
,	O
gene1s	O
ATG16L1	O
gene1e	O
and	O
gene1s	O
SQSTM1	O
gene1e	O
are	O
more	O
common	O
in	O
triple	O
-	O
negative	O
cancers	O
than	O
in	O
other	O
subtypes	O
.	O
High	O
levels	O
of	O
gene1s	O
miR-20a	O
gene1e	O
also	O
associate	O
with	O
higher	O
frequency	O
of	O
copy	O
-	O
number	O
alterations	O
and	O
DNA	O
mutations	O
in	O
breast	O
cancer	O
species1s	O
patients	O
species1e	O
.	O
Further	O
studies	O
in	O
a	O
xenograft	O
arg1s	O
mouse	O
arg1e	O
model	O
show	O
that	O
gene1s	O
miR-20a	O
gene1e	O
promotes	O
tumor	O
initiation	O
and	O
tumor	O
growth	O
.	O
Collectively	O
,	O
these	O
findings	O
suggest	O
that	O
gene1s	O
miR-20a	O
gene1e	O
-	O
mediated	O
autophagy	O
defect	O
might	O
be	O
a	O
new	O
mechanism	O
underlying	O
the	O
oncogenic	O
function	O
of	O
miRNA	O
during	O
breast	O
tumorigenesis	O
.	O
Oncogene	O
advance	O
online	O
publication	O
,	O
19	O
June	O
2017	O
;	O
doi:10.1038	O
/	O
onc.2017.193	O
.	O

gene1s	O
Notch	O
gene1e	O
,	O
gene1s	O
IL-1	O
gene1e	O
and	O
gene1s	O
leptin	O
gene1e	O
crosstalk	O
outcome	O
(	O
NILCO	O
)	O
is	O
critical	O
for	O
gene1s	O
leptin	O
gene1e	O
-	O
induced	O
proliferation	O
,	O
migration	O
and	O
gene1s	O
VEGF	O
gene1e	O
/	O
gene1s	O
VEGFR-2	O
gene1e	O
expression	O
in	O
breast	O
cancer	O
.	O
High	O
levels	O
of	O
pro	O
-	O
angiogenic	O
factors	O
,	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
(	O
ligands	O
and	O
receptors	O
)	O
,	O
are	O
found	O
in	O
breast	O
cancer	O
,	O
which	O
is	O
commonly	O
correlated	O
with	O
metastasis	O
and	O
lower	O
survival	O
of	O
arg1s	O
patients	O
arg1e	O
.	O
We	O
have	O
previously	O
reported	O
that	O
gene1s	O
leptin	O
gene1e	O
induces	O
the	O
growth	O
of	O
breast	O
cancer	O
and	O
the	O
expression	O
of	O
gene1s	O
VEGF	O
gene1e	O
/	O
gene1s	O
VEGFR-2	O
gene1e	O
and	O
gene1s	O
IL-1	O
gene1e	O
system	O
.	O
We	O
hypothesized	O
that	O
gene1s	O
Notch	O
gene1e	O
,	O
gene1s	O
IL-1	O
gene1e	O
and	O
gene1s	O
leptin	O
gene1e	O
crosstalk	O
outcome	O
(	O
NILCO	O
)	O
plays	O
an	O
essential	O
role	O
in	O
the	O
regulation	O
of	O
gene1s	O
leptin	O
gene1e	O
-	O
mediated	O
induction	O
of	O
proliferation	O
/	O
migration	O
and	O
expression	O
of	O
pro	O
-	O
angiogenic	O
molecules	O
in	O
breast	O
cancer	O
.	O
To	O
test	O
this	O
hypothesis	O
,	O
gene1s	O
leptin	O
gene1e	O
's	O
effects	O
on	O
the	O
expression	O
and	O
activation	O
of	O
gene1s	O
Notch	O
gene1e	O
signaling	O
pathway	O
and	O
gene1s	O
VEGF	O
gene1e	O
/	O
gene1s	O
VEGFR-2	O
gene1e	O
/	O
gene1s	O
IL-1	O
gene1e	O
were	O
determined	O
in	O
species1s	O
mouse	O
species1e	O
(	O
species1s	O
4T1	O
species1e	O
,	O
species1s	O
EMT6	O
species1e	O
and	O
MMT	O
)	O
breast	O
cancer	O
cells	O
.	O
Remarkably	O
,	O
gene1s	O
leptin	O
gene1e	O
up	O
-	O
regulated	O
gene1s	O
Notch1	O
-	O
4	O
gene1e	O
/	O
gene1s	O
JAG1	O
gene1e	O
/	O
gene1s	O
Dll-4	O
gene1e	O
,	O
gene1s	O
Notch	O
gene1e	O
target	O
genes	O
:	O
gene1s	O
Hey2	O
gene1e	O
and	O
gene1s	O
survivin	O
gene1e	O
,	O
together	O
with	O
gene1s	O
IL-1	O
gene1e	O
and	O
gene1s	O
VEGF	O
gene1e	O
/	O
gene1s	O
VEGFR-2	O
gene1e	O
.	O
RNA	O
knockdown	O
and	O
pharmacological	O
inhibitors	O
of	O
gene1s	O
leptin	O
gene1e	O
signaling	O
significantly	O
abrogated	O
activity	O
of	O
reporter	O
gene	O
-	O
luciferase	O
gene1s	O
CSL	O
gene1e	O
(	O
gene1s	O
RBP	O
-	O
Jk	O
gene1e	O
)	O
promoter	O
,	O
showing	O
that	O
it	O
was	O
linked	O
to	O
gene1s	O
leptin	O
gene1e	O
-	O
activated	O
gene1s	O
JAK2	O
gene1e	O
/	O
gene1s	O
STAT3	O
gene1e	O
,	O
gene1s	O
MAPK	O
gene1e	O
,	O
gene1s	O
PI-3K	O
gene1e	O
/	O
gene1s	O
mTOR	O
gene1e	O
,	O
gene1s	O
p38	O
gene1e	O
and	O
gene1s	O
JNK	O
gene1e	O
signaling	O
pathways	O
.	O
Interestingly	O
,	O
gene1s	O
leptin	O
gene1e	O
upregulatory	O
effects	O
on	O
cell	O
proliferation	O
/	O
migration	O
and	O
pro	O
-	O
angiogenic	O
factors	O
gene1s	O
Notch	O
gene1e	O
,	O
gene1s	O
IL-1	O
gene1e	O
and	O
gene1s	O
VEGF	O
gene1e	O
/	O
gene1s	O
VEGFR-2	O
gene1e	O
were	O
abrogated	O
by	O
a	O
gene1s	O
gamma	O
-	O
secretase	O
gene1e	O
inhibitor	O
,	O
DAPT	O
,	O
as	O
well	O
as	O
siRNA	O
against	O
gene1s	O
CSL	O
gene1e	O
.	O
In	O
addition	O
,	O
blockade	O
of	O
gene1s	O
IL-1R	O
tI	O
gene1e	O
inhibited	O
gene1s	O
leptin	O
gene1e	O
-	O
induced	O
gene1s	O
Notch	O
gene1e	O
,	O
gene1s	O
Hey2	O
gene1e	O
and	O
gene1s	O
survivin	O
gene1e	O
as	O
well	O
as	O
gene1s	O
VEGF	O
gene1e	O
/	O
gene1s	O
VEGFR-2	O
gene1e	O
expression	O
.	O
These	O
data	O
suggest	O
gene1s	O
leptin	O
gene1e	O
is	O
an	O
inducer	O
of	O
gene1s	O
Notch	O
gene1e	O
(	O
expression	O
/	O
activation	O
)	O
and	O
gene1s	O
IL-1	O
gene1e	O
signaling	O
modulates	O
gene1s	O
leptin	O
gene1e	O
effects	O
on	O
gene1s	O
Notch	O
gene1e	O
and	O
gene1s	O
VEGF	O
gene1e	O
/	O
gene1s	O
VEGFR-2	O
gene1e	O
.	O
We	O
show	O
for	O
the	O
first	O
time	O
that	O
a	O
novel	O
unveiled	O
crosstalk	O
between	O
gene1s	O
Notch	O
gene1e	O
,	O
gene1s	O
IL-1	O
gene1e	O
and	O
gene1s	O
leptin	O
gene1e	O
(	O
NILCO	O
)	O
occurs	O
in	O
breast	O
cancer	O
.	O
gene1s	O
Leptin	O
gene1e	O
induction	O
of	O
proliferation	O
/	O
migration	O
and	O
upregulation	O
of	O
gene1s	O
VEGF	O
gene1e	O
/	O
gene1s	O
VEGFR-2	O
gene1e	O
in	O
breast	O
cancer	O
cells	O
were	O
related	O
to	O
an	O
intact	O
gene1s	O
Notch	O
gene1e	O
signaling	O
axis	O
.	O
NILCO	O
could	O
represent	O
the	O
integration	O
of	O
developmental	O
,	O
pro	O
-	O
inflammatory	O
and	O
pro	O
-	O
angiogenic	O
signals	O
critical	O
for	O
gene1s	O
leptin	O
gene1e	O
-	O
induced	O
cell	O
proliferation	O
/	O
migration	O
and	O
regulation	O
of	O
gene1s	O
VEGF	O
gene1e	O
/	O
gene1s	O
VEGFR-2	O
gene1e	O
in	O
breast	O
cancer	O
.	O
Targeting	O
NILCO	O
might	O
help	O
to	O
design	O
new	O
pharmacological	O
strategies	O
aimed	O
at	O
controlling	O
breast	O
cancer	O
growth	O
and	O
angiogenesis	O
.	O

gene1s	ARG2
Notch	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
crosstalk	O
outcome	O
(	O
NILCO	O
)	O
is	O
critical	O
for	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
-	O
induced	O
proliferation	O
,	O
migration	O
and	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
VEGFR-2	ARG2
gene1e	ARG2
expression	O
in	O
breast	O
cancer	O
.	O
High	O
levels	O
of	O
pro	O
-	O
angiogenic	O
factors	O
,	O
gene1s	O
leptin	O
gene1e	O
,	O
gene1s	O
IL-1	O
gene1e	O
,	O
gene1s	O
Notch	O
gene1e	O
and	O
gene1s	O
VEGF	O
gene1e	O
(	O
ligands	O
and	O
receptors	O
)	O
,	O
are	O
found	O
in	O
breast	O
cancer	O
,	O
which	O
is	O
commonly	O
correlated	O
with	O
metastasis	O
and	O
lower	O
survival	O
of	O
species1s	O
patients	O
species1e	O
.	O
We	O
have	O
previously	O
reported	O
that	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
induces	O
the	O
growth	O
of	O
breast	O
cancer	O
and	O
the	O
expression	O
of	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
VEGFR-2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL-1	ARG2
gene1e	ARG2
system	O
.	O
We	O
hypothesized	O
that	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
crosstalk	O
outcome	O
(	O
NILCO	O
)	O
plays	O
an	O
essential	O
role	O
in	O
the	O
regulation	O
of	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
-	O
mediated	O
induction	O
of	O
proliferation	O
/	O
migration	O
and	O
expression	O
of	O
pro	O
-	O
angiogenic	O
molecules	O
in	O
breast	O
cancer	O
.	O
To	O
test	O
this	O
hypothesis	O
,	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
's	O
effects	O
on	O
the	O
expression	O
and	O
activation	O
of	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
signaling	O
pathway	O
and	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
VEGFR-2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
IL-1	ARG2
gene1e	ARG2
were	O
determined	O
in	O
arg1s	O
mouse	O
arg1e	O
(	O
arg1s	O
4T1	O
arg1e	O
,	O
arg1s	O
EMT6	O
arg1e	O
and	O
MMT	O
)	O
breast	O
cancer	O
cells	O
.	O
Remarkably	O
,	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
up	O
-	O
regulated	O
gene1s	ARG2
Notch1	ARG2
-	ARG2
4	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
JAG1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Dll-4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
target	O
genes	O
:	O
gene1s	ARG2
Hey2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
survivin	ARG2
gene1e	ARG2
,	O
together	O
with	O
gene1s	ARG2
IL-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
VEGFR-2	ARG2
gene1e	ARG2
.	O
RNA	O
knockdown	O
and	O
pharmacological	O
inhibitors	O
of	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
signaling	O
significantly	O
abrogated	O
activity	O
of	O
reporter	O
gene	O
-	O
luciferase	O
gene1s	ARG2
CSL	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
RBP	ARG2
-	ARG2
Jk	ARG2
gene1e	ARG2
)	O
promoter	O
,	O
showing	O
that	O
it	O
was	O
linked	O
to	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
-	O
activated	O
gene1s	ARG2
JAK2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PI-3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
p38	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
signaling	O
pathways	O
.	O
Interestingly	O
,	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
upregulatory	O
effects	O
on	O
cell	O
proliferation	O
/	O
migration	O
and	O
pro	O
-	O
angiogenic	O
factors	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
VEGFR-2	ARG2
gene1e	ARG2
were	O
abrogated	O
by	O
a	O
gene1s	ARG2
gamma	ARG2
-	ARG2
secretase	ARG2
gene1e	ARG2
inhibitor	O
,	O
DAPT	O
,	O
as	O
well	O
as	O
siRNA	O
against	O
gene1s	ARG2
CSL	ARG2
gene1e	ARG2
.	O
In	O
addition	O
,	O
blockade	O
of	O
gene1s	ARG2
IL-1R	ARG2
tI	ARG2
gene1e	ARG2
inhibited	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
-	O
induced	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Hey2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
survivin	ARG2
gene1e	ARG2
as	O
well	O
as	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
VEGFR-2	ARG2
gene1e	ARG2
expression	O
.	O
These	O
data	O
suggest	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
is	O
an	O
inducer	O
of	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
(	O
expression	O
/	O
activation	O
)	O
and	O
gene1s	ARG2
IL-1	ARG2
gene1e	ARG2
signaling	O
modulates	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
effects	O
on	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
VEGFR-2	ARG2
gene1e	ARG2
.	O
We	O
show	O
for	O
the	O
first	O
time	O
that	O
a	O
novel	O
unveiled	O
crosstalk	O
between	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
(	O
NILCO	O
)	O
occurs	O
in	O
breast	O
cancer	O
.	O
gene1s	ARG2
Leptin	ARG2
gene1e	ARG2
induction	O
of	O
proliferation	O
/	O
migration	O
and	O
upregulation	O
of	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
VEGFR-2	ARG2
gene1e	ARG2
in	O
breast	O
cancer	O
cells	O
were	O
related	O
to	O
an	O
intact	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
signaling	O
axis	O
.	O
NILCO	O
could	O
represent	O
the	O
integration	O
of	O
developmental	O
,	O
pro	O
-	O
inflammatory	O
and	O
pro	O
-	O
angiogenic	O
signals	O
critical	O
for	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
-	O
induced	O
cell	O
proliferation	O
/	O
migration	O
and	O
regulation	O
of	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
VEGFR-2	ARG2
gene1e	ARG2
in	O
breast	O
cancer	O
.	O
Targeting	O
NILCO	O
might	O
help	O
to	O
design	O
new	O
pharmacological	O
strategies	O
aimed	O
at	O
controlling	O
breast	O
cancer	O
growth	O
and	O
angiogenesis	O
.	O

gene1s	ARG2
Neuregulin-1	ARG2
beta	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
neuregulin-1	ARG2
alpha	ARG2
gene1e	ARG2
differentially	O
affect	O
the	O
migration	O
and	O
invasion	O
of	O
malignant	O
peripheral	O
nerve	O
sheath	O
tumor	O
cells	O
.	O
Malignant	O
peripheral	O
nerve	O
sheath	O
tumors	O
(	O
MPNSTs	O
)	O
are	O
the	O
most	O
common	O
malignancy	O
associated	O
with	O
neurofibromatosis	O
Type	O
1	O
(	O
NF1	O
)	O
.	O
These	O
Schwann	O
cell	O
lineage	O
-	O
derived	O
sarcomas	O
aggressively	O
invade	O
adjacent	O
nerve	O
and	O
soft	O
tissue	O
,	O
frequently	O
precluding	O
surgical	O
resection	O
.	O
Little	O
is	O
known	O
regarding	O
the	O
mechanisms	O
underlying	O
this	O
invasive	O
behavior	O
.	O
We	O
have	O
shown	O
that	O
MPNSTs	O
express	O
gene1s	ARG2
neuregulin-1	ARG2
(	ARG2
NRG-1	ARG2
)	ARG2
beta	ARG2
gene1e	ARG2
isoforms	O
,	O
which	O
promote	O
Schwann	O
cell	O
migration	O
during	O
development	O
,	O
and	O
gene1s	ARG2
NRG-1	ARG2
alpha	ARG2
gene1e	ARG2
isoforms	O
,	O
whose	O
effects	O
on	O
Schwann	O
cells	O
are	O
poorly	O
understood	O
.	O
Hypothesizing	O
that	O
gene1s	ARG2
NRG-1	ARG2
beta	ARG2
gene1e	ARG2
and/or	O
gene1s	ARG2
NRG-1	ARG2
alpha	ARG2
gene1e	ARG2
promote	O
MPNST	O
invasion	O
,	O
we	O
found	O
that	O
gene1s	ARG2
NRG-1	ARG2
beta	ARG2
gene1e	ARG2
promoted	O
MPNST	O
migration	O
in	O
a	O
substrate	O
-	O
specific	O
manner	O
,	O
markedly	O
enhancing	O
migration	O
on	O
gene1s	O
laminin	O
gene1e	O
but	O
not	O
on	O
gene1s	ARG2
collagen	ARG2
type	ARG2
I	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
fibronectin	ARG2
gene1e	ARG2
.	O
The	O
NRG-1	O
receptors	O
gene1s	ARG2
erbB3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
erbB4	ARG2
gene1e	ARG2
were	O
present	O
in	O
MPNST	O
invadopodia	O
(	O
processes	O
mediating	O
invasion	O
)	O
,	O
partially	O
colocalized	O
with	O
gene1s	ARG2
focal	ARG2
adhesion	ARG2
kinase	ARG2
gene1e	ARG2
and	O
the	O
gene1s	ARG2
laminin	ARG2
receptor	ARG2
gene1e	ARG2
gene1s	ARG2
beta(1)-integrin	ARG2
gene1e	ARG2
and	O
coimmunoprecipitated	O
with	O
gene1s	ARG2
beta(1)-integrin	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
NRG-1	ARG2
beta	ARG2
gene1e	ARG2
stimulated	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
murine	O
species1e	O
MPNST	O
cell	O
migration	O
and	O
invasion	O
in	O
a	O
concentration	O
-	O
dependent	O
manner	O
in	O
three	O
-	O
dimensional	O
migration	O
assays	O
,	O
acting	O
as	O
a	O
chemotactic	O
factor	O
.	O
Both	O
baseline	O
and	O
gene1s	ARG2
NRG-1	ARG2
beta	ARG2
gene1e	ARG2
-	O
induced	O
migration	O
were	O
gene1s	ARG2
erbB	ARG2
gene1e	ARG2
-	O
dependent	O
and	O
required	O
the	O
action	O
of	O
gene1s	ARG2
MEK	ARG2
1/2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SAPK	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PI-3	ARG2
kinase	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Src	ARG2
family	ARG2
kinases	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ROCK	ARG2
-	ARG2
I	ARG2
/	ARG2
II	ARG2
gene1e	ARG2
.	O
In	O
contrast	O
,	O
gene1s	ARG2
NRG-1	ARG2
alpha	ARG2
gene1e	ARG2
had	O
no	O
effect	O
on	O
the	O
migration	O
and	O
invasion	O
of	O
some	O
MPNST	O
lines	O
and	O
inhibited	O
the	O
migration	O
of	O
others	O
.	O
While	O
gene1s	ARG2
NRG-1	ARG2
beta	ARG2
gene1e	ARG2
potently	O
and	O
persistently	O
activated	O
gene1s	ARG2
Erk	ARG2
1/2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SAPK	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Src	ARG2
family	ARG2
kinases	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NRG-1	ARG2
alpha	ARG2
gene1e	ARG2
did	O
not	O
activate	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
and	O
activated	O
these	O
other	O
kinases	O
with	O
kinetics	O
distinct	O
from	O
those	O
evident	O
in	O
gene1s	ARG2
NRG-1	ARG2
beta	ARG2
gene1e	ARG2
-	O
stimulated	O
cells	O
.	O
These	O
findings	O
suggest	O
that	O
gene1s	ARG2
NRG-1	ARG2
beta	ARG2
gene1e	ARG2
enhances	O
MPNST	O
migration	O
and	O
that	O
gene1s	ARG2
NRG-1	ARG2
beta	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
NRG-1	ARG2
alpha	ARG2
gene1e	ARG2
differentially	O
modulate	O
this	O
process	O
.	O

gene1s	O
Neuregulin-1	O
beta	O
gene1e	O
and	O
gene1s	O
neuregulin-1	O
alpha	O
gene1e	O
differentially	O
affect	O
the	O
migration	O
and	O
invasion	O
of	O
malignant	O
peripheral	O
nerve	O
sheath	O
tumor	O
cells	O
.	O
Malignant	O
peripheral	O
nerve	O
sheath	O
tumors	O
(	O
MPNSTs	O
)	O
are	O
the	O
most	O
common	O
malignancy	O
associated	O
with	O
neurofibromatosis	O
Type	O
1	O
(	O
NF1	O
)	O
.	O
These	O
Schwann	O
cell	O
lineage	O
-	O
derived	O
sarcomas	O
aggressively	O
invade	O
adjacent	O
nerve	O
and	O
soft	O
tissue	O
,	O
frequently	O
precluding	O
surgical	O
resection	O
.	O
Little	O
is	O
known	O
regarding	O
the	O
mechanisms	O
underlying	O
this	O
invasive	O
behavior	O
.	O
We	O
have	O
shown	O
that	O
MPNSTs	O
express	O
gene1s	O
neuregulin-1	O
(	O
NRG-1	O
)	O
beta	O
gene1e	O
isoforms	O
,	O
which	O
promote	O
Schwann	O
cell	O
migration	O
during	O
development	O
,	O
and	O
gene1s	O
NRG-1	O
alpha	O
gene1e	O
isoforms	O
,	O
whose	O
effects	O
on	O
Schwann	O
cells	O
are	O
poorly	O
understood	O
.	O
Hypothesizing	O
that	O
gene1s	O
NRG-1	O
beta	O
gene1e	O
and/or	O
gene1s	O
NRG-1	O
alpha	O
gene1e	O
promote	O
MPNST	O
invasion	O
,	O
we	O
found	O
that	O
gene1s	O
NRG-1	O
beta	O
gene1e	O
promoted	O
MPNST	O
migration	O
in	O
a	O
substrate	O
-	O
specific	O
manner	O
,	O
markedly	O
enhancing	O
migration	O
on	O
gene1s	ARG2
laminin	ARG2
gene1e	ARG2
but	O
not	O
on	O
gene1s	O
collagen	O
type	O
I	O
gene1e	O
or	O
gene1s	O
fibronectin	O
gene1e	O
.	O
The	O
NRG-1	O
receptors	O
gene1s	ARG2
erbB3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
erbB4	ARG2
gene1e	ARG2
were	O
present	O
in	O
MPNST	O
invadopodia	O
(	O
processes	O
mediating	O
invasion	O
)	O
,	O
partially	O
colocalized	O
with	O
gene1s	O
focal	O
adhesion	O
kinase	O
gene1e	O
and	O
the	O
gene1s	O
laminin	O
receptor	O
gene1e	O
gene1s	O
beta(1)-integrin	O
gene1e	O
and	O
coimmunoprecipitated	O
with	O
gene1s	O
beta(1)-integrin	O
gene1e	O
.	O
gene1s	O
NRG-1	O
beta	O
gene1e	O
stimulated	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
murine	O
arg1e	O
MPNST	O
cell	O
migration	O
and	O
invasion	O
in	O
a	O
concentration	O
-	O
dependent	O
manner	O
in	O
three	O
-	O
dimensional	O
migration	O
assays	O
,	O
acting	O
as	O
a	O
chemotactic	O
factor	O
.	O
Both	O
baseline	O
and	O
gene1s	O
NRG-1	O
beta	O
gene1e	O
-	O
induced	O
migration	O
were	O
gene1s	ARG2
erbB	ARG2
gene1e	ARG2
-	O
dependent	O
and	O
required	O
the	O
action	O
of	O
gene1s	ARG2
MEK	ARG2
1/2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SAPK	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PI-3	ARG2
kinase	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Src	ARG2
family	ARG2
kinases	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ROCK	ARG2
-	ARG2
I	ARG2
/	ARG2
II	ARG2
gene1e	ARG2
.	O
In	O
contrast	O
,	O
gene1s	O
NRG-1	O
alpha	O
gene1e	O
had	O
no	O
effect	O
on	O
the	O
migration	O
and	O
invasion	O
of	O
some	O
MPNST	O
lines	O
and	O
inhibited	O
the	O
migration	O
of	O
others	O
.	O
While	O
gene1s	O
NRG-1	O
beta	O
gene1e	O
potently	O
and	O
persistently	O
activated	O
gene1s	ARG2
Erk	ARG2
1/2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SAPK	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Src	ARG2
family	ARG2
kinases	ARG2
gene1e	ARG2
,	O
gene1s	O
NRG-1	O
alpha	O
gene1e	O
did	O
not	O
activate	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
and	O
activated	O
these	O
other	O
kinases	O
with	O
kinetics	O
distinct	O
from	O
those	O
evident	O
in	O
gene1s	O
NRG-1	O
beta	O
gene1e	O
-	O
stimulated	O
cells	O
.	O
These	O
findings	O
suggest	O
that	O
gene1s	O
NRG-1	O
beta	O
gene1e	O
enhances	O
MPNST	O
migration	O
and	O
that	O
gene1s	O
NRG-1	O
beta	O
gene1e	O
and	O
gene1s	O
NRG-1	O
alpha	O
gene1e	O
differentially	O
modulate	O
this	O
process	O
.	O

Arecoline	O
induces	O
arg1s	O
HA22T	O
/	O
VGH	O
arg1e	O
hepatoma	O
cells	O
to	O
undergo	O
anoikis	O
-	O
involvement	O
of	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
RhoA	ARG2
gene1e	ARG2
activation	O
.	O
BACKGROUND	O
:	O
Our	O
previous	O
study	O
showed	O
that	O
,	O
in	O
basal	O
cell	O
carcinoma	O
cells	O
,	O
arecoline	O
reduces	O
levels	O
of	O
the	O
tumor	O
cell	O
survival	O
factor	O
gene1s	ARG2
interleukin-6	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
)	O
,	O
increases	O
levels	O
of	O
tumor	O
suppressor	O
factor	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
,	O
and	O
elicits	O
cell	O
cycle	O
arrest	O
,	O
followed	O
by	O
apoptosis	O
.	O
In	O
preliminarily	O
studies	O
,	O
we	O
observed	O
that	O
arecoline	O
induces	O
detachment	O
of	O
the	O
arg1s	O
human	O
arg1e	O
-	O
derived	O
hepatoma	O
cell	O
line	O
HA22T	O
/	O
VGH	O
from	O
the	O
extracellular	O
matrix	O
.	O
In	O
the	O
present	O
study	O
,	O
we	O
explored	O
the	O
fate	O
of	O
the	O
detached	O
arg1s	O
HA22T	O
/	O
VGH	O
arg1e	O
cells	O
and	O
investigated	O
the	O
underlying	O
mechanism	O
.	O
METHODS	O
:	O
arg1s	O
HA22T	O
/	O
VGH	O
arg1e	O
cells	O
or	O
primary	O
cultured	O
species1s	O
rat	O
species1e	O
hepatocytes	O
were	O
treated	O
with	O
arecoline	O
,	O
then	O
changes	O
in	O
morphology	O
,	O
viability	O
,	O
apoptosis	O
,	O
and	O
the	O
expression	O
of	O
surface	O
gene1s	ARG2
beta1-integrin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
apoptosis	ARG2
-	ARG2
related	ARG2
proteins	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
were	O
examined	O
.	O
Furthermore	O
,	O
activation	O
of	O
the	O
gene1s	ARG2
signal	ARG2
transducer	ARG2
and	ARG2
activator	ARG2
of	ARG2
transcription	ARG2
3	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
)	O
pathway	O
and	O
the	O
gene1s	ARG2
RhoA	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Rock	ARG2
gene1e	ARG2
signaling	O
pathway	O
,	O
including	O
gene1s	ARG2
p190RhoGAP	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Src	ARG2
homology-2	ARG2
domain	ARG2
-	ARG2
containing	ARG2
phosphatase	ARG2
gene1e	ARG2
gene1s	ARG2
SHP2	ARG2
gene1e	ARG2
,	O
was	O
examined	O
.	O
RESULTS	O
:	O
A	O
low	O
concentration	O
of	O
arecoline	O
(	O
<	O
or=	O
100	O
microg	O
/	O
ml	O
)	O
caused	O
cytoskeletal	O
changes	O
in	O
arg1s	O
HA22T	O
/	O
VGH	O
arg1e	O
cells	O
,	O
but	O
not	O
hepatocytes	O
,	O
and	O
this	O
was	O
accompanied	O
by	O
decreased	O
gene1s	ARG2
beta1-integrin	ARG2
gene1e	ARG2
expression	O
and	O
followed	O
by	O
apoptosis	O
,	O
indicating	O
that	O
arg1s	O
HA22T	O
/	O
VGH	O
arg1e	O
cells	O
undergo	O
anoikis	O
after	O
arecoline	O
treatment	O
.	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
expression	O
and	O
phosphorylation	O
of	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
,	O
which	O
provides	O
protection	O
against	O
anoikis	O
,	O
were	O
inhibited	O
and	O
levels	O
of	O
downstream	O
signaling	O
proteins	O
,	O
including	O
gene1s	ARG2
Bcl	ARG2
-	ARG2
XL	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
,	O
were	O
decreased	O
,	O
while	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
expression	O
,	O
mitochondrial	O
gene1s	ARG2
cytochrome	ARG2
c	ARG2
gene1e	ARG2
release	O
,	O
and	O
gene1s	ARG2
caspase-3	ARG2
gene1e	ARG2
activity	O
were	O
increased	O
.	O
In	O
addition	O
,	O
phosphorylation	O
/	O
activation	O
of	O
gene1s	ARG2
p190RhoGAP	ARG2
gene1e	ARG2
,	O
a	O
gene1s	ARG2
RhoA	ARG2
gene1e	ARG2
inhibitor	O
,	O
and	O
of	O
its	O
upstream	O
regulator	O
,	O
gene1s	ARG2
SHP2	ARG2
gene1e	ARG2
,	O
was	O
inhibited	O
by	O
arecoline	O
treatment	O
,	O
while	O
gene1s	ARG2
Rho	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Rock	ARG2
gene1e	ARG2
activation	O
was	O
increased	O
.	O
Addition	O
of	O
the	O
gene1s	ARG2
RhoA	ARG2
gene1e	ARG2
inhibitor	O
attenuated	O
the	O
effects	O
of	O
arecoline	O
.	O
CONCLUSIONS	O
:	O
This	O
study	O
demonstrated	O
that	O
arecoline	O
induces	O
anoikis	O
of	O
arg1s	O
HA22T	O
/	O
VGH	O
arg1e	O
cells	O
involving	O
inhibition	O
of	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
and	O
increased	O
gene1s	ARG2
RhoA	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Rock	ARG2
gene1e	ARG2
activation	O
and	O
that	O
the	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
RhoA	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Rock	ARG2
gene1e	ARG2
signaling	O
pathways	O
are	O
connected	O
.	O

Arecoline	O
induces	O
species1s	O
HA22T	O
/	O
VGH	O
species1e	O
hepatoma	O
cells	O
to	O
undergo	O
anoikis	O
-	O
involvement	O
of	O
gene1s	O
STAT3	O
gene1e	O
and	O
gene1s	O
RhoA	O
gene1e	O
activation	O
.	O
BACKGROUND	O
:	O
Our	O
previous	O
study	O
showed	O
that	O
,	O
in	O
basal	O
cell	O
carcinoma	O
cells	O
,	O
arecoline	O
reduces	O
levels	O
of	O
the	O
tumor	O
cell	O
survival	O
factor	O
gene1s	O
interleukin-6	O
gene1e	O
(	O
gene1s	O
IL-6	O
gene1e	O
)	O
,	O
increases	O
levels	O
of	O
tumor	O
suppressor	O
factor	O
gene1s	O
p53	O
gene1e	O
,	O
and	O
elicits	O
cell	O
cycle	O
arrest	O
,	O
followed	O
by	O
apoptosis	O
.	O
In	O
preliminarily	O
studies	O
,	O
we	O
observed	O
that	O
arecoline	O
induces	O
detachment	O
of	O
the	O
species1s	O
human	O
species1e	O
-	O
derived	O
hepatoma	O
cell	O
line	O
HA22T	O
/	O
VGH	O
from	O
the	O
extracellular	O
matrix	O
.	O
In	O
the	O
present	O
study	O
,	O
we	O
explored	O
the	O
fate	O
of	O
the	O
detached	O
species1s	O
HA22T	O
/	O
VGH	O
species1e	O
cells	O
and	O
investigated	O
the	O
underlying	O
mechanism	O
.	O
METHODS	O
:	O
species1s	O
HA22T	O
/	O
VGH	O
species1e	O
cells	O
or	O
primary	O
cultured	O
arg1s	O
rat	O
arg1e	O
hepatocytes	O
were	O
treated	O
with	O
arecoline	O
,	O
then	O
changes	O
in	O
morphology	O
,	O
viability	O
,	O
apoptosis	O
,	O
and	O
the	O
expression	O
of	O
surface	O
gene1s	ARG2
beta1-integrin	ARG2
gene1e	ARG2
,	O
gene1s	O
apoptosis	O
-	O
related	O
proteins	O
gene1e	O
,	O
and	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
were	O
examined	O
.	O
Furthermore	O
,	O
activation	O
of	O
the	O
gene1s	ARG2
signal	ARG2
transducer	ARG2
and	ARG2
activator	ARG2
of	ARG2
transcription	ARG2
3	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
)	O
pathway	O
and	O
the	O
gene1s	ARG2
RhoA	ARG2
gene1e	ARG2
/	O
gene1s	O
Rock	O
gene1e	O
signaling	O
pathway	O
,	O
including	O
gene1s	ARG2
p190RhoGAP	ARG2
gene1e	ARG2
and	O
gene1s	O
Src	O
homology-2	O
domain	O
-	O
containing	O
phosphatase	O
gene1e	O
gene1s	ARG2
SHP2	ARG2
gene1e	ARG2
,	O
was	O
examined	O
.	O
RESULTS	O
:	O
A	O
low	O
concentration	O
of	O
arecoline	O
(	O
<	O
or=	O
100	O
microg	O
/	O
ml	O
)	O
caused	O
cytoskeletal	O
changes	O
in	O
species1s	O
HA22T	O
/	O
VGH	O
species1e	O
cells	O
,	O
but	O
not	O
hepatocytes	O
,	O
and	O
this	O
was	O
accompanied	O
by	O
decreased	O
gene1s	O
beta1-integrin	O
gene1e	O
expression	O
and	O
followed	O
by	O
apoptosis	O
,	O
indicating	O
that	O
species1s	O
HA22T	O
/	O
VGH	O
species1e	O
cells	O
undergo	O
anoikis	O
after	O
arecoline	O
treatment	O
.	O
gene1s	O
IL-6	O
gene1e	O
expression	O
and	O
phosphorylation	O
of	O
gene1s	O
STAT3	O
gene1e	O
,	O
which	O
provides	O
protection	O
against	O
anoikis	O
,	O
were	O
inhibited	O
and	O
levels	O
of	O
downstream	O
signaling	O
proteins	O
,	O
including	O
gene1s	O
Bcl	O
-	O
XL	O
gene1e	O
and	O
gene1s	O
Bcl-2	O
gene1e	O
,	O
were	O
decreased	O
,	O
while	O
gene1s	O
Bax	O
gene1e	O
expression	O
,	O
mitochondrial	O
gene1s	O
cytochrome	O
c	O
gene1e	O
release	O
,	O
and	O
gene1s	O
caspase-3	O
gene1e	O
activity	O
were	O
increased	O
.	O
In	O
addition	O
,	O
phosphorylation	O
/	O
activation	O
of	O
gene1s	O
p190RhoGAP	O
gene1e	O
,	O
a	O
gene1s	O
RhoA	O
gene1e	O
inhibitor	O
,	O
and	O
of	O
its	O
upstream	O
regulator	O
,	O
gene1s	O
SHP2	O
gene1e	O
,	O
was	O
inhibited	O
by	O
arecoline	O
treatment	O
,	O
while	O
gene1s	O
Rho	O
gene1e	O
/	O
gene1s	O
Rock	O
gene1e	O
activation	O
was	O
increased	O
.	O
Addition	O
of	O
the	O
gene1s	O
RhoA	O
gene1e	O
inhibitor	O
attenuated	O
the	O
effects	O
of	O
arecoline	O
.	O
CONCLUSIONS	O
:	O
This	O
study	O
demonstrated	O
that	O
arecoline	O
induces	O
anoikis	O
of	O
species1s	O
HA22T	O
/	O
VGH	O
species1e	O
cells	O
involving	O
inhibition	O
of	O
gene1s	O
STAT3	O
gene1e	O
and	O
increased	O
gene1s	O
RhoA	O
gene1e	O
/	O
gene1s	O
Rock	O
gene1e	O
activation	O
and	O
that	O
the	O
gene1s	O
STAT3	O
gene1e	O
and	O
gene1s	O
RhoA	O
gene1e	O
/	O
gene1s	O
Rock	O
gene1e	O
signaling	O
pathways	O
are	O
connected	O
.	O

Role	O
of	O
gene1s	ARG2
angiotensin	ARG2
II	ARG2
type	ARG2
1a	ARG2
receptor	ARG2
gene1e	ARG2
in	O
renal	O
injury	O
induced	O
by	O
deoxycorticosterone	O
acetate	O
-	O
salt	O
hypertension	O
.	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
in	O
vivo	O
role	O
of	O
gene1s	ARG2
angiotensin	ARG2
II	ARG2
type	ARG2
1a	ARG2
(	ARG2
AT1a	ARG2
)	ARG2
receptor	ARG2
gene1e	ARG2
in	O
renal	O
damage	O
as	O
a	O
result	O
of	O
hypertension	O
by	O
using	O
arg1s	O
transgenic	O
mice	O
arg1e	O
with	O
gene1s	ARG2
AT1a	ARG2
receptor	ARG2
gene1e	ARG2
gene	O
disruption	O
.	O
arg1s	O
Transgenic	O
mice	O
arg1e	O
that	O
express	O
species1s	O
human	O
species1e	O
gene1s	O
liver	O
-	O
type	O
fatty	O
acid	O
binding	O
protein	O
gene1e	O
(	O
gene1s	O
L	O
-	O
FABP	O
gene1e	O
)	O
with	O
or	O
without	O
disruption	O
of	O
the	O
gene1s	ARG2
AT1a	ARG2
receptor	ARG2
gene1e	ARG2
gene	O
(	O
gene1s	O
L	O
-	O
FABP	O
gene1e	O
(+/-	O
)	O
gene1s	ARG2
AT1a	ARG2
gene1e	ARG2
(-/-	O
)	O
,	O
and	O
gene1s	O
L	O
-	O
FABP	O
gene1e	O
(+/-	O
)	O
gene1s	ARG2
AT1a	ARG2
gene1e	ARG2
(+/+	O
)	O
,	O
respectively	O
)	O
were	O
used	O
with	O
urinary	O
gene1s	O
L	O
-	O
FABP	O
gene1e	O
as	O
an	O
indicator	O
of	O
tubulointerstitial	O
damage	O
.	O
Those	O
female	O
arg1s	O
mice	O
arg1e	O
were	O
administered	O
subcutaneously	O
deoxycorticosterone	O
acetate	O
(	O
DOCA)-salt	O
tablets	O
plus	O
drinking	O
water	O
that	O
contained	O
1	O
%	O
saline	O
for	O
28	O
d	O
after	O
uninephrectomy	O
.	O
In	O
gene1s	O
L	O
-	O
FABP	O
gene1e	O
(+/-	O
)	O
gene1s	ARG2
AT1a	ARG2
gene1e	ARG2
(+/+	O
)	O
arg1s	O
mice	O
arg1e	O
that	O
received	O
DOCA	O
-	O
salt	O
treatment	O
,	O
hypertension	O
was	O
induced	O
and	O
slight	O
expansion	O
of	O
glomerular	O
area	O
,	O
glomerular	O
sclerosis	O
,	O
and	O
tubulointerstitial	O
damage	O
were	O
observed	O
.	O
In	O
gene1s	O
L	O
-	O
FABP	O
gene1e	O
(+/-	O
)	O
gene1s	ARG2
AT1a	ARG2
gene1e	ARG2
(-/-	O
)	O
arg1s	O
mice	O
arg1e	O
that	O
received	O
DOCA	O
-	O
salt	O
treatment	O
,	O
hypertension	O
was	O
similarly	O
induced	O
and	O
the	O
degree	O
of	O
glomerular	O
damage	O
was	O
significantly	O
more	O
severe	O
than	O
in	O
gene1s	O
L	O
-	O
FABP	O
gene1e	O
(+/-	O
)	O
gene1s	ARG2
AT1a	ARG2
gene1e	ARG2
(+/+)-DOCA	O
arg1s	O
mice	O
arg1e	O
.	O
Urinary	O
gene1s	O
L	O
-	O
FABP	O
gene1e	O
levels	O
were	O
significantly	O
higher	O
in	O
gene1s	O
L	O
-	O
FABP	O
gene1e	O
(+/-	O
)	O
gene1s	ARG2
AT1a	ARG2
gene1e	ARG2
(-/-)-DOCA	O
arg1s	O
mice	O
arg1e	O
compared	O
with	O
those	O
in	O
gene1s	O
L	O
-	O
FABP	O
gene1e	O
(+/-	O
)	O
gene1s	ARG2
AT1a	ARG2
gene1e	ARG2
(+/+)-DOCA	O
arg1s	O
mice	O
arg1e	O
.	O
Hydralazine	O
treatment	O
significantly	O
attenuated	O
renal	O
damage	O
that	O
was	O
found	O
in	O
gene1s	O
L	O
-	O
FABP	O
gene1e	O
(+/-	O
)	O
gene1s	ARG2
AT1a	ARG2
gene1e	ARG2
(-/-)-DOCA	O
arg1s	O
mice	O
arg1e	O
along	O
with	O
a	O
reduction	O
in	O
blood	O
pressure	O
.	O
In	O
summary	O
,	O
activation	O
of	O
the	O
gene1s	ARG2
AT1a	ARG2
receptor	ARG2
gene1e	ARG2
may	O
contribute	O
to	O
maintenance	O
of	O
the	O
glomerular	O
structure	O
against	O
hypertensive	O
renal	O
damage.-Hisamichi	O
,	O
M.	O
,	O
Kamijo	O
-	O
Ikemori	O
,	O
A.	O
,	O
Sugaya	O
,	O
T.	O
,	O
Ichikawa	O
,	O
D.	O
,	O
Natsuki	O
,	O
T.	O
,	O
Hoshino	O
,	O
S.	O
,	O
Kimura	O
,	O
K.	O
,	O
Shibagaki	O
,	O
Y.	O
Role	O
of	O
gene1s	ARG2
angiotensin	ARG2
II	ARG2
type	ARG2
1a	ARG2
receptor	ARG2
gene1e	ARG2
in	O
renal	O
injury	O
induced	O
by	O
deoxycorticosterone	O
acetate	O
-	O
salt	O
hypertension	O
.	O

Role	O
of	O
gene1s	O
angiotensin	O
II	O
type	O
1a	O
receptor	O
gene1e	O
in	O
renal	O
injury	O
induced	O
by	O
deoxycorticosterone	O
acetate	O
-	O
salt	O
hypertension	O
.	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
in	O
vivo	O
role	O
of	O
gene1s	O
angiotensin	O
II	O
type	O
1a	O
(	O
AT1a	O
)	O
receptor	O
gene1e	O
in	O
renal	O
damage	O
as	O
a	O
result	O
of	O
hypertension	O
by	O
using	O
species1s	O
transgenic	O
mice	O
species1e	O
with	O
gene1s	O
AT1a	O
receptor	O
gene1e	O
gene	O
disruption	O
.	O
species1s	O
Transgenic	O
mice	O
species1e	O
that	O
express	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
liver	ARG2
-	ARG2
type	ARG2
fatty	ARG2
acid	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
L	ARG2
-	ARG2
FABP	ARG2
gene1e	ARG2
)	O
with	O
or	O
without	O
disruption	O
of	O
the	O
gene1s	O
AT1a	O
receptor	O
gene1e	O
gene	O
(	O
gene1s	ARG2
L	ARG2
-	ARG2
FABP	ARG2
gene1e	ARG2
(+/-	O
)	O
gene1s	O
AT1a	O
gene1e	O
(-/-	O
)	O
,	O
and	O
gene1s	ARG2
L	ARG2
-	ARG2
FABP	ARG2
gene1e	ARG2
(+/-	O
)	O
gene1s	O
AT1a	O
gene1e	O
(+/+	O
)	O
,	O
respectively	O
)	O
were	O
used	O
with	O
urinary	O
gene1s	ARG2
L	ARG2
-	ARG2
FABP	ARG2
gene1e	ARG2
as	O
an	O
indicator	O
of	O
tubulointerstitial	O
damage	O
.	O
Those	O
female	O
species1s	O
mice	O
species1e	O
were	O
administered	O
subcutaneously	O
deoxycorticosterone	O
acetate	O
(	O
DOCA)-salt	O
tablets	O
plus	O
drinking	O
water	O
that	O
contained	O
1	O
%	O
saline	O
for	O
28	O
d	O
after	O
uninephrectomy	O
.	O
In	O
gene1s	ARG2
L	ARG2
-	ARG2
FABP	ARG2
gene1e	ARG2
(+/-	O
)	O
gene1s	O
AT1a	O
gene1e	O
(+/+	O
)	O
species1s	O
mice	O
species1e	O
that	O
received	O
DOCA	O
-	O
salt	O
treatment	O
,	O
hypertension	O
was	O
induced	O
and	O
slight	O
expansion	O
of	O
glomerular	O
area	O
,	O
glomerular	O
sclerosis	O
,	O
and	O
tubulointerstitial	O
damage	O
were	O
observed	O
.	O
In	O
gene1s	ARG2
L	ARG2
-	ARG2
FABP	ARG2
gene1e	ARG2
(+/-	O
)	O
gene1s	O
AT1a	O
gene1e	O
(-/-	O
)	O
species1s	O
mice	O
species1e	O
that	O
received	O
DOCA	O
-	O
salt	O
treatment	O
,	O
hypertension	O
was	O
similarly	O
induced	O
and	O
the	O
degree	O
of	O
glomerular	O
damage	O
was	O
significantly	O
more	O
severe	O
than	O
in	O
gene1s	ARG2
L	ARG2
-	ARG2
FABP	ARG2
gene1e	ARG2
(+/-	O
)	O
gene1s	O
AT1a	O
gene1e	O
(+/+)-DOCA	O
species1s	O
mice	O
species1e	O
.	O
Urinary	O
gene1s	ARG2
L	ARG2
-	ARG2
FABP	ARG2
gene1e	ARG2
levels	O
were	O
significantly	O
higher	O
in	O
gene1s	ARG2
L	ARG2
-	ARG2
FABP	ARG2
gene1e	ARG2
(+/-	O
)	O
gene1s	O
AT1a	O
gene1e	O
(-/-)-DOCA	O
species1s	O
mice	O
species1e	O
compared	O
with	O
those	O
in	O
gene1s	ARG2
L	ARG2
-	ARG2
FABP	ARG2
gene1e	ARG2
(+/-	O
)	O
gene1s	O
AT1a	O
gene1e	O
(+/+)-DOCA	O
species1s	O
mice	O
species1e	O
.	O
Hydralazine	O
treatment	O
significantly	O
attenuated	O
renal	O
damage	O
that	O
was	O
found	O
in	O
gene1s	ARG2
L	ARG2
-	ARG2
FABP	ARG2
gene1e	ARG2
(+/-	O
)	O
gene1s	O
AT1a	O
gene1e	O
(-/-)-DOCA	O
species1s	O
mice	O
species1e	O
along	O
with	O
a	O
reduction	O
in	O
blood	O
pressure	O
.	O
In	O
summary	O
,	O
activation	O
of	O
the	O
gene1s	O
AT1a	O
receptor	O
gene1e	O
may	O
contribute	O
to	O
maintenance	O
of	O
the	O
glomerular	O
structure	O
against	O
hypertensive	O
renal	O
damage.-Hisamichi	O
,	O
M.	O
,	O
Kamijo	O
-	O
Ikemori	O
,	O
A.	O
,	O
Sugaya	O
,	O
T.	O
,	O
Ichikawa	O
,	O
D.	O
,	O
Natsuki	O
,	O
T.	O
,	O
Hoshino	O
,	O
S.	O
,	O
Kimura	O
,	O
K.	O
,	O
Shibagaki	O
,	O
Y.	O
Role	O
of	O
gene1s	O
angiotensin	O
II	O
type	O
1a	O
receptor	O
gene1e	O
in	O
renal	O
injury	O
induced	O
by	O
deoxycorticosterone	O
acetate	O
-	O
salt	O
hypertension	O
.	O

gene1s	ARG2
RBFOX1	ARG2
gene1e	ARG2
cooperates	O
with	O
gene1s	ARG2
MBNL1	ARG2
gene1e	ARG2
to	O
control	O
splicing	O
in	O
muscle	O
,	O
including	O
events	O
altered	O
in	O
myotonic	O
dystrophy	O
type	O
1	O
.	O
With	O
the	O
goal	O
of	O
identifying	O
splicing	O
alterations	O
in	O
myotonic	O
dystrophy	O
1	O
(	O
DM1	O
)	O
tissues	O
that	O
may	O
yield	O
insights	O
into	O
targets	O
or	O
mechanisms	O
,	O
we	O
have	O
surveyed	O
mis	O
-	O
splicing	O
events	O
in	O
three	O
systems	O
using	O
a	O
RT	O
-	O
PCR	O
screening	O
and	O
validation	O
platform	O
.	O
First	O
,	O
a	O
transgenic	O
arg1s	O
mouse	O
arg1e	O
model	O
expressing	O
CUG	O
-	O
repeats	O
identified	O
splicing	O
alterations	O
shared	O
with	O
other	O
arg1s	O
mouse	O
arg1e	O
models	O
of	O
species1s	O
DM1	O
species1e	O
.	O
Second	O
,	O
using	O
cell	O
cultures	O
from	O
species1s	O
human	O
species1e	O
embryonic	O
muscle	O
,	O
we	O
noted	O
that	O
DM1-associated	O
splicing	O
alterations	O
were	O
significantly	O
enriched	O
in	O
cytoskeleton	O
(	O
e.g.	O
gene1s	O
SORBS1	O
gene1e	O
,	O
gene1s	O
TACC2	O
gene1e	O
,	O
gene1s	O
TTN	O
gene1e	O
,	O
gene1s	O
ACTN1	O
gene1e	O
and	O
gene1s	O
DMD	O
gene1e	O
)	O
and	O
channel	O
(	O
e.g.	O
gene1s	O
KCND3	O
gene1e	O
and	O
gene1s	O
TRPM4	O
gene1e	O
)	O
genes	O
.	O
Third	O
,	O
of	O
the	O
splicing	O
alterations	O
occurring	O
in	O
adult	O
DM1	O
tissues	O
,	O
one	O
produced	O
a	O
dominant	O
negative	O
variant	O
of	O
the	O
splicing	O
regulator	O
gene1s	ARG2
RBFOX1	ARG2
gene1e	ARG2
.	O
Notably	O
,	O
half	O
of	O
the	O
splicing	O
events	O
controlled	O
by	O
gene1s	ARG2
MBNL1	ARG2
gene1e	ARG2
were	O
co	O
-	O
regulated	O
by	O
gene1s	ARG2
RBFOX1	ARG2
gene1e	ARG2
,	O
and	O
several	O
events	O
in	O
this	O
category	O
were	O
mis	O
-	O
spliced	O
in	O
DM1	O
tissues	O
.	O
Our	O
results	O
suggest	O
that	O
reduced	O
gene1s	ARG2
RBFOX1	ARG2
gene1e	ARG2
activity	O
in	O
DM1	O
tissues	O
may	O
amplify	O
several	O
of	O
the	O
splicing	O
alterations	O
caused	O
by	O
the	O
deficiency	O
in	O
gene1s	ARG2
MBNL1	ARG2
gene1e	ARG2
.	O

gene1s	ARG2
RBFOX1	ARG2
gene1e	ARG2
cooperates	O
with	O
gene1s	ARG2
MBNL1	ARG2
gene1e	ARG2
to	O
control	O
splicing	O
in	O
muscle	O
,	O
including	O
events	O
altered	O
in	O
myotonic	O
dystrophy	O
type	O
1	O
.	O
With	O
the	O
goal	O
of	O
identifying	O
splicing	O
alterations	O
in	O
myotonic	O
dystrophy	O
1	O
(	O
DM1	O
)	O
tissues	O
that	O
may	O
yield	O
insights	O
into	O
targets	O
or	O
mechanisms	O
,	O
we	O
have	O
surveyed	O
mis	O
-	O
splicing	O
events	O
in	O
three	O
systems	O
using	O
a	O
RT	O
-	O
PCR	O
screening	O
and	O
validation	O
platform	O
.	O
First	O
,	O
a	O
transgenic	O
species1s	O
mouse	O
species1e	O
model	O
expressing	O
CUG	O
-	O
repeats	O
identified	O
splicing	O
alterations	O
shared	O
with	O
other	O
species1s	O
mouse	O
species1e	O
models	O
of	O
arg1s	O
DM1	O
arg1e	O
.	O
Second	O
,	O
using	O
cell	O
cultures	O
from	O
arg1s	O
human	O
arg1e	O
embryonic	O
muscle	O
,	O
we	O
noted	O
that	O
DM1-associated	O
splicing	O
alterations	O
were	O
significantly	O
enriched	O
in	O
cytoskeleton	O
(	O
e.g.	O
gene1s	ARG2
SORBS1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TACC2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TTN	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ACTN1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
DMD	ARG2
gene1e	ARG2
)	O
and	O
channel	O
(	O
e.g.	O
gene1s	ARG2
KCND3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
TRPM4	ARG2
gene1e	ARG2
)	O
genes	O
.	O
Third	O
,	O
of	O
the	O
splicing	O
alterations	O
occurring	O
in	O
adult	O
DM1	O
tissues	O
,	O
one	O
produced	O
a	O
dominant	O
negative	O
variant	O
of	O
the	O
splicing	O
regulator	O
gene1s	ARG2
RBFOX1	ARG2
gene1e	ARG2
.	O
Notably	O
,	O
half	O
of	O
the	O
splicing	O
events	O
controlled	O
by	O
gene1s	ARG2
MBNL1	ARG2
gene1e	ARG2
were	O
co	O
-	O
regulated	O
by	O
gene1s	ARG2
RBFOX1	ARG2
gene1e	ARG2
,	O
and	O
several	O
events	O
in	O
this	O
category	O
were	O
mis	O
-	O
spliced	O
in	O
DM1	O
tissues	O
.	O
Our	O
results	O
suggest	O
that	O
reduced	O
gene1s	ARG2
RBFOX1	ARG2
gene1e	ARG2
activity	O
in	O
DM1	O
tissues	O
may	O
amplify	O
several	O
of	O
the	O
splicing	O
alterations	O
caused	O
by	O
the	O
deficiency	O
in	O
gene1s	ARG2
MBNL1	ARG2
gene1e	ARG2
.	O

Dioscin	O
alleviates	O
alcoholic	O
liver	O
fibrosis	O
by	O
attenuating	O
hepatic	O
stellate	O
cell	O
activation	O
via	O
the	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
signaling	O
pathway	O
.	O
The	O
present	O
work	O
aimed	O
to	O
investigate	O
the	O
activities	O
and	O
underlying	O
mechanisms	O
of	O
dioscin	O
against	O
alcoholic	O
liver	O
fibrosis	O
(	O
ALF	O
)	O
.	O
In	O
vivo	O
liver	O
fibrosis	O
in	O
arg1s	O
mice	O
arg1e	O
was	O
induced	O
by	O
an	O
alcoholic	O
liquid	O
diet	O
,	O
and	O
in	O
vitro	O
studies	O
were	O
performed	O
on	O
activated	O
species1s	O
HSC	O
-	O
T6	O
species1e	O
and	O
species1s	O
LX2	O
species1e	O
cells	O
treated	O
with	O
lipopolysaccharide	O
.	O
Our	O
results	O
showed	O
that	O
dioscin	O
significantly	O
attenuated	O
hepatic	O
stellate	O
cells	O
(	O
HSCs	O
)	O
activation	O
,	O
improved	O
gene1s	O
collagen	O
gene1e	O
accumulation	O
,	O
and	O
attenuated	O
inflammation	O
through	O
down	O
-	O
regulating	O
the	O
levels	O
of	O
gene1s	ARG2
myeloid	ARG2
differentiation	ARG2
factor	ARG2
88	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
nuclear	ARG2
factor	ARG2
kB	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
interleukin	ARG2
(	ARG2
IL)-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
tumour	ARG2
necrosis	ARG2
factor	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
by	O
decreasing	O
gene1s	ARG2
Toll	ARG2
-	ARG2
like	ARG2
receptor	ARG2
(	ARG2
TLR)4	ARG2
gene1e	ARG2
expression	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
overexpression	O
was	O
also	O
decreased	O
by	O
dioscin	O
,	O
leading	O
to	O
the	O
markedly	O
down	O
-	O
regulated	O
levels	O
of	O
gene1s	O
MyD88	O
gene1e	O
,	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
,	O
gene1s	O
transforming	O
growth	O
factor	O
-	O
b1	O
gene1e	O
(	O
gene1s	O
TGF	O
-	O
b1	O
gene1e	O
)	O
,	O
gene1s	O
a	O
-	O
smooth	O
muscle	O
actin	O
gene1e	O
(	O
gene1s	O
a	O
-	O
SMA	O
gene1e	O
)	O
and	O
gene1s	O
type	O
I	O
collagen	O
gene1e	O
(	O
gene1s	O
COL1A1	O
gene1e	O
)	O
in	O
cultured	O
HSCs	O
.	O
Suppression	O
of	O
cellular	O
gene1s	O
MyD88	O
gene1e	O
by	O
ST2825	O
or	O
abrogation	O
of	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
by	O
pyrrolidine	O
dithiocarbamate	O
eliminated	O
the	O
inhibitory	O
effects	O
of	O
dioscin	O
on	O
the	O
levels	O
of	O
gene1s	O
TGF	O
-	O
b1	O
gene1e	O
,	O
gene1s	O
a	O
-	O
SMA	O
gene1e	O
and	O
gene1s	O
COL1A1	O
gene1e	O
.	O
In	O
a	O
word	O
,	O
dioscin	O
exhibited	O
potent	O
effects	O
against	O
ALF	O
via	O
altering	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
signaling	O
pathway	O
,	O
which	O
provided	O
novel	O
insights	O
into	O
the	O
mechanisms	O
of	O
this	O
compound	O
as	O
an	O
antifibrogenic	O
candidate	O
for	O
the	O
treatment	O
of	O
ALF	O
in	O
the	O
future	O
.	O

Dioscin	O
alleviates	O
alcoholic	O
liver	O
fibrosis	O
by	O
attenuating	O
hepatic	O
stellate	O
cell	O
activation	O
via	O
the	O
gene1s	O
TLR4	O
gene1e	O
/	O
gene1s	O
MyD88	O
gene1e	O
/	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
signaling	O
pathway	O
.	O
The	O
present	O
work	O
aimed	O
to	O
investigate	O
the	O
activities	O
and	O
underlying	O
mechanisms	O
of	O
dioscin	O
against	O
alcoholic	O
liver	O
fibrosis	O
(	O
ALF	O
)	O
.	O
In	O
vivo	O
liver	O
fibrosis	O
in	O
species1s	O
mice	O
species1e	O
was	O
induced	O
by	O
an	O
alcoholic	O
liquid	O
diet	O
,	O
and	O
in	O
vitro	O
studies	O
were	O
performed	O
on	O
activated	O
arg1s	O
HSC	O
-	O
T6	O
arg1e	O
and	O
species1s	O
LX2	O
species1e	O
cells	O
treated	O
with	O
lipopolysaccharide	O
.	O
Our	O
results	O
showed	O
that	O
dioscin	O
significantly	O
attenuated	O
hepatic	O
stellate	O
cells	O
(	O
HSCs	O
)	O
activation	O
,	O
improved	O
gene1s	ARG2
collagen	ARG2
gene1e	ARG2
accumulation	O
,	O
and	O
attenuated	O
inflammation	O
through	O
down	O
-	O
regulating	O
the	O
levels	O
of	O
gene1s	ARG2
myeloid	ARG2
differentiation	ARG2
factor	ARG2
88	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
nuclear	ARG2
factor	ARG2
kB	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
interleukin	ARG2
(	ARG2
IL)-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
tumour	ARG2
necrosis	ARG2
factor	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
by	O
decreasing	O
gene1s	ARG2
Toll	ARG2
-	ARG2
like	ARG2
receptor	ARG2
(	ARG2
TLR)4	ARG2
gene1e	ARG2
expression	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O
gene1s	O
TLR4	O
gene1e	O
overexpression	O
was	O
also	O
decreased	O
by	O
dioscin	O
,	O
leading	O
to	O
the	O
markedly	O
down	O
-	O
regulated	O
levels	O
of	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
transforming	ARG2
growth	ARG2
factor	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
a	ARG2
-	ARG2
smooth	ARG2
muscle	ARG2
actin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
a	ARG2
-	ARG2
SMA	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
type	ARG2
I	ARG2
collagen	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
COL1A1	ARG2
gene1e	ARG2
)	O
in	O
cultured	O
HSCs	O
.	O
Suppression	O
of	O
cellular	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
by	O
ST2825	O
or	O
abrogation	O
of	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
by	O
pyrrolidine	O
dithiocarbamate	O
eliminated	O
the	O
inhibitory	O
effects	O
of	O
dioscin	O
on	O
the	O
levels	O
of	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
a	ARG2
-	ARG2
SMA	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
COL1A1	ARG2
gene1e	ARG2
.	O
In	O
a	O
word	O
,	O
dioscin	O
exhibited	O
potent	O
effects	O
against	O
ALF	O
via	O
altering	O
gene1s	O
TLR4	O
gene1e	O
/	O
gene1s	O
MyD88	O
gene1e	O
/	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
signaling	O
pathway	O
,	O
which	O
provided	O
novel	O
insights	O
into	O
the	O
mechanisms	O
of	O
this	O
compound	O
as	O
an	O
antifibrogenic	O
candidate	O
for	O
the	O
treatment	O
of	O
ALF	O
in	O
the	O
future	O
.	O

Dioscin	O
alleviates	O
alcoholic	O
liver	O
fibrosis	O
by	O
attenuating	O
hepatic	O
stellate	O
cell	O
activation	O
via	O
the	O
gene1s	O
TLR4	O
gene1e	O
/	O
gene1s	O
MyD88	O
gene1e	O
/	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
signaling	O
pathway	O
.	O
The	O
present	O
work	O
aimed	O
to	O
investigate	O
the	O
activities	O
and	O
underlying	O
mechanisms	O
of	O
dioscin	O
against	O
alcoholic	O
liver	O
fibrosis	O
(	O
ALF	O
)	O
.	O
In	O
vivo	O
liver	O
fibrosis	O
in	O
species1s	O
mice	O
species1e	O
was	O
induced	O
by	O
an	O
alcoholic	O
liquid	O
diet	O
,	O
and	O
in	O
vitro	O
studies	O
were	O
performed	O
on	O
activated	O
species1s	O
HSC	O
-	O
T6	O
species1e	O
and	O
arg1s	O
LX2	O
arg1e	O
cells	O
treated	O
with	O
lipopolysaccharide	O
.	O
Our	O
results	O
showed	O
that	O
dioscin	O
significantly	O
attenuated	O
hepatic	O
stellate	O
cells	O
(	O
HSCs	O
)	O
activation	O
,	O
improved	O
gene1s	ARG2
collagen	ARG2
gene1e	ARG2
accumulation	O
,	O
and	O
attenuated	O
inflammation	O
through	O
down	O
-	O
regulating	O
the	O
levels	O
of	O
gene1s	ARG2
myeloid	ARG2
differentiation	ARG2
factor	ARG2
88	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
nuclear	ARG2
factor	ARG2
kB	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
interleukin	ARG2
(	ARG2
IL)-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
tumour	ARG2
necrosis	ARG2
factor	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
by	O
decreasing	O
gene1s	ARG2
Toll	ARG2
-	ARG2
like	ARG2
receptor	ARG2
(	ARG2
TLR)4	ARG2
gene1e	ARG2
expression	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O
gene1s	O
TLR4	O
gene1e	O
overexpression	O
was	O
also	O
decreased	O
by	O
dioscin	O
,	O
leading	O
to	O
the	O
markedly	O
down	O
-	O
regulated	O
levels	O
of	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
transforming	ARG2
growth	ARG2
factor	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
a	ARG2
-	ARG2
smooth	ARG2
muscle	ARG2
actin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
a	ARG2
-	ARG2
SMA	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
type	ARG2
I	ARG2
collagen	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
COL1A1	ARG2
gene1e	ARG2
)	O
in	O
cultured	O
HSCs	O
.	O
Suppression	O
of	O
cellular	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
by	O
ST2825	O
or	O
abrogation	O
of	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
by	O
pyrrolidine	O
dithiocarbamate	O
eliminated	O
the	O
inhibitory	O
effects	O
of	O
dioscin	O
on	O
the	O
levels	O
of	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
a	ARG2
-	ARG2
SMA	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
COL1A1	ARG2
gene1e	ARG2
.	O
In	O
a	O
word	O
,	O
dioscin	O
exhibited	O
potent	O
effects	O
against	O
ALF	O
via	O
altering	O
gene1s	O
TLR4	O
gene1e	O
/	O
gene1s	O
MyD88	O
gene1e	O
/	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
signaling	O
pathway	O
,	O
which	O
provided	O
novel	O
insights	O
into	O
the	O
mechanisms	O
of	O
this	O
compound	O
as	O
an	O
antifibrogenic	O
candidate	O
for	O
the	O
treatment	O
of	O
ALF	O
in	O
the	O
future	O
.	O

gene1s	ARG2
Gammadelta	ARG2
gene1e	ARG2
T	O
lymphocyte	O
homeostasis	O
is	O
negatively	O
regulated	O
by	O
gene1s	ARG2
beta2-microglobulin	ARG2
gene1e	ARG2
.	O
Successful	O
application	O
of	O
gammadelta	O
T	O
cells	O
in	O
adoptive	O
cell	O
therapies	O
depends	O
upon	O
our	O
ability	O
to	O
maintain	O
these	O
cells	O
in	O
vivo	O
.	O
Using	O
an	O
adoptive	O
transfer	O
model	O
to	O
study	O
lymphopenia	O
-	O
induced	O
homeostatic	O
expansion	O
,	O
we	O
show	O
that	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
(+	O
)	O
and	O
gene1s	ARG2
NK1.1	ARG2
gene1e	ARG2
(+	O
)	O
gammadelta	O
T	O
cell	O
subsets	O
are	O
differentially	O
regulated	O
.	O
While	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
(+	O
)	O
gammadelta	O
T	O
cells	O
have	O
an	O
early	O
and	O
sustained	O
advantage	O
following	O
transfer	O
into	O
gene1s	ARG2
TCRbeta(-/-)/delta	ARG2
gene1e	ARG2
(-/-	O
)	O
arg1s	O
mice	O
arg1e	O
,	O
gene1s	ARG2
NK1.1	ARG2
gene1e	ARG2
(+	O
)	O
gammadelta	O
T	O
cells	O
proliferate	O
slowly	O
and	O
are	O
maintained	O
at	O
low	O
numbers	O
.	O
The	O
advantage	O
of	O
the	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
(+	O
)	O
subset	O
could	O
not	O
be	O
explained	O
by	O
increased	O
gene1s	ARG2
bcl-2	ARG2
gene1e	ARG2
or	O
cytokine	O
receptor	O
expression	O
but	O
did	O
correlate	O
with	O
gene1s	ARG2
Vgamma4	ARG2
gene1e	ARG2
(+	O
)	O
and	O
gene1s	ARG2
Vdelta5	ARG2
gene1e	ARG2
(+	O
)	O
expression	O
.	O
Despite	O
the	O
role	O
of	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
in	O
MHC	O
class	O
I	O
recognition	O
by	O
alphabeta	O
T	O
cells	O
,	O
gene1s	ARG2
beta(2)-microglobulin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
beta(2)m	ARG2
gene1e	ARG2
)-associated	O
MHC	O
class	O
I	O
molecules	O
were	O
not	O
required	O
for	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
(+	O
)	O
gene1s	ARG2
gammadelta	ARG2
gene1e	ARG2
T	O
cell	O
homeostatic	O
expansion	O
.	O
Surprisingly	O
,	O
all	O
gene1s	ARG2
gammadelta	ARG2
gene1e	ARG2
T	O
cells	O
,	O
including	O
the	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
(+	O
)	O
subset	O
,	O
exhibited	O
enhanced	O
proliferation	O
following	O
adoptive	O
transfer	O
into	O
gene1s	ARG2
Rag1	ARG2
gene1e	ARG2
(-/-)/	O
gene1s	ARG2
beta(2)m	ARG2
gene1e	ARG2
(-/-	O
)	O
compared	O
with	O
gene1s	ARG2
Rag1	ARG2
gene1e	ARG2
(-/-	O
)	O
recipients	O
.	O
This	O
effect	O
was	O
most	O
notable	O
for	O
the	O
gene1s	ARG2
NK1.1	ARG2
gene1e	ARG2
(+	O
)	O
subset	O
,	O
which	O
expresses	O
high	O
levels	O
of	O
gene1s	ARG2
NKG2A	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CD94	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Ly49	ARG2
gene1e	ARG2
.	O
Although	O
expression	O
of	O
these	O
inhibitory	O
receptors	O
correlated	O
with	O
poor	O
homeostatic	O
expansion	O
in	O
the	O
presence	O
of	O
gene1s	ARG2
beta(2)m	ARG2
gene1e	ARG2
,	O
gammadelta	O
T	O
cell	O
homeostatic	O
proliferation	O
in	O
gene1s	ARG2
TCRbeta(-/-)/delta	ARG2
gene1e	ARG2
(-/-	O
)	O
arg1s	O
mice	O
arg1e	O
was	O
not	O
altered	O
in	O
the	O
presence	O
of	O
gene1s	ARG2
Ly49C	ARG2
/	ARG2
I	ARG2
gene1e	ARG2
-	O
and	O
gene1s	ARG2
NKG2	ARG2
gene1e	ARG2
-blocking	O
Abs	O
.	O
While	O
the	O
mechanism	O
by	O
which	O
gene1s	ARG2
beta(2)m	ARG2
gene1e	ARG2
negatively	O
regulates	O
gammadelta	O
T	O
cell	O
homeostasis	O
remains	O
to	O
be	O
determined	O
,	O
this	O
observation	O
is	O
unique	O
to	O
gammadelta	O
T	O
cells	O
and	O
confirms	O
that	O
multiple	O
mechanisms	O
are	O
in	O
place	O
to	O
maintain	O
strict	O
regulation	O
of	O
both	O
the	O
size	O
and	O
the	O
composition	O
of	O
the	O
gammadelta	O
T	O
cell	O
pool	O
.	O

A	O
team	O
of	O
heterochromatin	O
factors	O
collaborates	O
with	O
small	O
RNA	O
pathways	O
to	O
combat	O
repetitive	O
elements	O
and	O
germline	O
stress	O
.	O
Repetitive	O
sequences	O
derived	O
from	O
arg1s	O
transposons	O
arg1e	O
make	O
up	O
a	O
large	O
fraction	O
of	O
eukaryotic	O
genomes	O
and	O
must	O
be	O
silenced	O
to	O
protect	O
genome	O
integrity	O
.	O
Repetitive	O
elements	O
are	O
often	O
found	O
in	O
heterochromatin	O
;	O
however	O
,	O
the	O
roles	O
and	O
interactions	O
of	O
heterochromatin	O
proteins	O
in	O
repeat	O
regulation	O
are	O
poorly	O
understood	O
.	O
Here	O
we	O
show	O
that	O
a	O
diverse	O
set	O
of	O
species1s	O
C.	O
elegans	O
species1e	O
heterochromatin	O
proteins	O
act	O
together	O
with	O
the	O
piRNA	O
and	O
nuclear	O
RNAi	O
pathways	O
to	O
silence	O
repetitive	O
elements	O
and	O
prevent	O
genotoxic	O
stress	O
in	O
the	O
germ	O
line	O
.	O
Mutants	O
in	O
genes	O
encoding	O
gene1s	O
HPL-2	O
gene1e	O
/	O
gene1s	O
HP1	O
gene1e	O
,	O
gene1s	O
LIN-13	O
gene1e	O
,	O
gene1s	O
LIN-61	O
gene1e	O
,	O
gene1s	O
LET-418	O
gene1e	O
/	O
gene1s	O
Mi-2	O
gene1e	O
,	O
and	O
H3K9me2	O
gene1s	O
histone	O
methyltransferase	O
MET-2	O
gene1e	O
/	O
gene1s	O
SETDB1	O
gene1e	O
also	O
show	O
functionally	O
redundant	O
sterility	O
,	O
increased	O
germline	O
apoptosis	O
,	O
DNA	O
repair	O
defects	O
,	O
and	O
interactions	O
with	O
small	O
RNA	O
pathways	O
.	O
Remarkably	O
,	O
fertility	O
of	O
heterochromatin	O
mutants	O
could	O
be	O
partially	O
restored	O
by	O
inhibiting	O
gene1s	O
cep-1	O
gene1e	O
/	O
gene1s	O
p53	O
gene1e	O
,	O
endogenous	O
meiotic	O
double	O
strand	O
breaks	O
,	O
or	O
the	O
expression	O
of	O
MIRAGE1	O
DNA	O
arg1s	O
transposons	O
arg1e	O
.	O
Functional	O
redundancy	O
among	O
factors	O
and	O
pathways	O
underlies	O
the	O
importance	O
of	O
safeguarding	O
the	O
genome	O
through	O
multiple	O
means	O
.	O

A	O
team	O
of	O
heterochromatin	O
factors	O
collaborates	O
with	O
small	O
RNA	O
pathways	O
to	O
combat	O
repetitive	O
elements	O
and	O
germline	O
stress	O
.	O
Repetitive	O
sequences	O
derived	O
from	O
species1s	O
transposons	O
species1e	O
make	O
up	O
a	O
large	O
fraction	O
of	O
eukaryotic	O
genomes	O
and	O
must	O
be	O
silenced	O
to	O
protect	O
genome	O
integrity	O
.	O
Repetitive	O
elements	O
are	O
often	O
found	O
in	O
heterochromatin	O
;	O
however	O
,	O
the	O
roles	O
and	O
interactions	O
of	O
heterochromatin	O
proteins	O
in	O
repeat	O
regulation	O
are	O
poorly	O
understood	O
.	O
Here	O
we	O
show	O
that	O
a	O
diverse	O
set	O
of	O
arg1s	O
C.	O
elegans	O
arg1e	O
heterochromatin	O
proteins	O
act	O
together	O
with	O
the	O
piRNA	O
and	O
nuclear	O
RNAi	O
pathways	O
to	O
silence	O
repetitive	O
elements	O
and	O
prevent	O
genotoxic	O
stress	O
in	O
the	O
germ	O
line	O
.	O
Mutants	O
in	O
genes	O
encoding	O
gene1s	ARG2
HPL-2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
HP1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
LIN-13	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
LIN-61	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
LET-418	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Mi-2	ARG2
gene1e	ARG2
,	O
and	O
H3K9me2	O
gene1s	ARG2
histone	ARG2
methyltransferase	ARG2
MET-2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
SETDB1	ARG2
gene1e	ARG2
also	O
show	O
functionally	O
redundant	O
sterility	O
,	O
increased	O
germline	O
apoptosis	O
,	O
DNA	O
repair	O
defects	O
,	O
and	O
interactions	O
with	O
small	O
RNA	O
pathways	O
.	O
Remarkably	O
,	O
fertility	O
of	O
heterochromatin	O
mutants	O
could	O
be	O
partially	O
restored	O
by	O
inhibiting	O
gene1s	ARG2
cep-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
,	O
endogenous	O
meiotic	O
double	O
strand	O
breaks	O
,	O
or	O
the	O
expression	O
of	O
MIRAGE1	O
DNA	O
species1s	O
transposons	O
species1e	O
.	O
Functional	O
redundancy	O
among	O
factors	O
and	O
pathways	O
underlies	O
the	O
importance	O
of	O
safeguarding	O
the	O
genome	O
through	O
multiple	O
means	O
.	O

Cooperative	O
Enhancer	O
Activation	O
by	O
gene1s	ARG2
TLX1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
STAT5	ARG2
gene1e	ARG2
Drives	O
Development	O
of	O
gene1s	ARG2
NUP214	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
ABL1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
TLX1	ARG2
gene1e	ARG2
-Positive	O
T	O
Cell	O
Acute	O
Lymphoblastic	O
Leukemia	O
.	O
The	O
gene1s	ARG2
NUP214	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
ABL1	ARG2
gene1e	ARG2
fusion	O
is	O
a	O
constitutively	O
activated	O
tyrosine	O
kinase	O
that	O
is	O
significantly	O
associated	O
with	O
overexpression	O
of	O
the	O
gene1s	ARG2
TLX1	ARG2
gene1e	ARG2
and	O
gene1s	O
TLX3	O
gene1e	O
transcription	O
factors	O
in	O
T	O
cell	O
acute	O
lymphoblastic	O
leukemia	O
(	O
T	O
-	O
ALL	O
)	O
.	O
Here	O
we	O
show	O
that	O
gene1s	ARG2
NUP214	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
ABL1	ARG2
gene1e	ARG2
cooperates	O
with	O
gene1s	ARG2
TLX1	ARG2
gene1e	ARG2
in	O
driving	O
T	O
-	O
ALL	O
development	O
using	O
a	O
transgenic	O
arg1s	O
mouse	O
arg1e	O
model	O
and	O
species1s	O
human	O
species1e	O
T	O
-	O
ALL	O
cells	O
.	O
Using	O
integrated	O
ChIP	O
-	O
sequencing	O
,	O
ATAC	O
-	O
sequencing	O
,	O
and	O
RNA	O
-	O
sequencing	O
data	O
,	O
we	O
demonstrate	O
that	O
gene1s	ARG2
TLX1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
STAT5	ARG2
gene1e	ARG2
,	O
the	O
downstream	O
effector	O
of	O
gene1s	ARG2
NUP214	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
ABL1	ARG2
gene1e	ARG2
,	O
co	O
-	O
bind	O
poised	O
enhancer	O
regions	O
,	O
and	O
cooperatively	O
activate	O
the	O
expression	O
of	O
key	O
proto	O
-	O
oncogenes	O
such	O
as	O
gene1s	ARG2
MYC	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
BCL2	ARG2
gene1e	ARG2
.	O
Inhibition	O
of	O
gene1s	ARG2
STAT5	ARG2
gene1e	ARG2
,	O
downregulation	O
of	O
gene1s	ARG2
TLX1	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
MYC	ARG2
gene1e	ARG2
,	O
or	O
interference	O
with	O
enhancer	O
function	O
through	O
gene1s	O
BET	O
gene1e	O
-	O
inhibitor	O
treatment	O
leads	O
to	O
reduction	O
of	O
target	O
gene	O
expression	O
and	O
induction	O
of	O
leukemia	O
cell	O
death	O
.	O

Cooperative	O
Enhancer	O
Activation	O
by	O
gene1s	ARG2
TLX1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
STAT5	ARG2
gene1e	ARG2
Drives	O
Development	O
of	O
gene1s	ARG2
NUP214	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
ABL1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
TLX1	ARG2
gene1e	ARG2
-Positive	O
T	O
Cell	O
Acute	O
Lymphoblastic	O
Leukemia	O
.	O
The	O
gene1s	ARG2
NUP214	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
ABL1	ARG2
gene1e	ARG2
fusion	O
is	O
a	O
constitutively	O
activated	O
tyrosine	O
kinase	O
that	O
is	O
significantly	O
associated	O
with	O
overexpression	O
of	O
the	O
gene1s	ARG2
TLX1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
TLX3	ARG2
gene1e	ARG2
transcription	O
factors	O
in	O
T	O
cell	O
acute	O
lymphoblastic	O
leukemia	O
(	O
T	O
-	O
ALL	O
)	O
.	O
Here	O
we	O
show	O
that	O
gene1s	ARG2
NUP214	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
ABL1	ARG2
gene1e	ARG2
cooperates	O
with	O
gene1s	ARG2
TLX1	ARG2
gene1e	ARG2
in	O
driving	O
T	O
-	O
ALL	O
development	O
using	O
a	O
transgenic	O
species1s	O
mouse	O
species1e	O
model	O
and	O
arg1s	O
human	O
arg1e	O
T	O
-	O
ALL	O
cells	O
.	O
Using	O
integrated	O
ChIP	O
-	O
sequencing	O
,	O
ATAC	O
-	O
sequencing	O
,	O
and	O
RNA	O
-	O
sequencing	O
data	O
,	O
we	O
demonstrate	O
that	O
gene1s	ARG2
TLX1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
STAT5	ARG2
gene1e	ARG2
,	O
the	O
downstream	O
effector	O
of	O
gene1s	ARG2
NUP214	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
ABL1	ARG2
gene1e	ARG2
,	O
co	O
-	O
bind	O
poised	O
enhancer	O
regions	O
,	O
and	O
cooperatively	O
activate	O
the	O
expression	O
of	O
key	O
proto	O
-	O
oncogenes	O
such	O
as	O
gene1s	ARG2
MYC	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
BCL2	ARG2
gene1e	ARG2
.	O
Inhibition	O
of	O
gene1s	ARG2
STAT5	ARG2
gene1e	ARG2
,	O
downregulation	O
of	O
gene1s	ARG2
TLX1	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
MYC	ARG2
gene1e	ARG2
,	O
or	O
interference	O
with	O
enhancer	O
function	O
through	O
gene1s	ARG2
BET	ARG2
gene1e	ARG2
-	O
inhibitor	O
treatment	O
leads	O
to	O
reduction	O
of	O
target	O
gene	O
expression	O
and	O
induction	O
of	O
leukemia	O
cell	O
death	O
.	O

Reversal	O
of	O
gene1s	ARG2
DDK	ARG2
gene1e	ARG2
-	O
Mediated	O
gene1s	ARG2
MCM	ARG2
gene1e	ARG2
Phosphorylation	O
by	O
gene1s	ARG2
Rif1	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
PP1	ARG2
gene1e	ARG2
Regulates	O
Replication	O
Initiation	O
and	O
Replisome	O
Stability	O
Independently	O
of	O
gene1s	ARG2
ATR	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Chk1	ARG2
gene1e	ARG2
.	O
gene1s	O
Dbf4-dependent	O
kinases	O
gene1e	O
(	O
gene1s	O
DDK	O
gene1e	O
s	O
)	O
are	O
required	O
for	O
the	O
initiation	O
of	O
DNA	O
replication	O
,	O
their	O
essential	O
targets	O
being	O
the	O
gene1s	O
MCM2	O
-	O
7	O
gene1e	O
proteins	O
.	O
We	O
show	O
that	O
,	O
in	O
arg1s	O
Xenopus	O
laevis	O
arg1e	O
species1s	O
egg	O
species1e	O
extracts	O
and	O
species1s	O
human	O
species1e	O
cells	O
,	O
hyper	O
-	O
phosphorylation	O
of	O
DNA	O
-	O
bound	O
gene1s	ARG2
Mcm4	ARG2
gene1e	ARG2
,	O
but	O
not	O
phosphorylation	O
of	O
gene1s	ARG2
Mcm2	ARG2
gene1e	ARG2
,	O
correlates	O
with	O
DNA	O
replication	O
.	O
These	O
phosphorylations	O
are	O
differentially	O
affected	O
by	O
the	O
gene1s	O
DDK	O
gene1e	O
inhibitors	O
PHA-767491	O
and	O
XL413	O
.	O
We	O
show	O
that	O
gene1s	ARG2
DDK	ARG2
gene1e	ARG2
-	O
dependent	O
gene1s	ARG2
MCM	ARG2
gene1e	ARG2
phosphorylation	O
is	O
reversed	O
by	O
gene1s	ARG2
protein	ARG2
phosphatase	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PP1	ARG2
gene1e	ARG2
)	O
targeted	O
to	O
chromatin	O
by	O
gene1s	ARG2
Rif1	ARG2
gene1e	ARG2
.	O
Loss	O
of	O
gene1s	ARG2
Rif1	ARG2
gene1e	ARG2
increased	O
gene1s	ARG2
MCM	ARG2
gene1e	ARG2
phosphorylation	O
and	O
the	O
rate	O
of	O
replication	O
initiation	O
and	O
also	O
compromised	O
the	O
ability	O
of	O
cells	O
to	O
block	O
initiation	O
when	O
challenged	O
with	O
replication	O
inhibitors	O
.	O
We	O
also	O
provide	O
evidence	O
that	O
gene1s	ARG2
Rif1	ARG2
gene1e	ARG2
can	O
mediate	O
gene1s	ARG2
MCM	ARG2
gene1e	ARG2
dephosphorylation	O
at	O
replication	O
forks	O
and	O
that	O
the	O
stability	O
of	O
dephosphorylated	O
replisomes	O
strongly	O
depends	O
on	O
gene1s	ARG2
Chk1	ARG2
gene1e	ARG2
activity	O
.	O
We	O
propose	O
that	O
both	O
replication	O
initiation	O
and	O
replisome	O
stability	O
depend	O
on	O
gene1s	ARG2
MCM	ARG2
gene1e	ARG2
phosphorylation	O
,	O
which	O
is	O
maintained	O
by	O
a	O
balance	O
of	O
gene1s	ARG2
DDK	ARG2
gene1e	ARG2
-	O
dependent	O
phosphorylation	O
and	O
gene1s	ARG2
Rif1	ARG2
gene1e	ARG2
-mediated	O
dephosphorylation	O
.	O

Reversal	O
of	O
gene1s	O
DDK	O
gene1e	O
-	O
Mediated	O
gene1s	O
MCM	O
gene1e	O
Phosphorylation	O
by	O
gene1s	O
Rif1	O
gene1e	O
-	O
gene1s	O
PP1	O
gene1e	O
Regulates	O
Replication	O
Initiation	O
and	O
Replisome	O
Stability	O
Independently	O
of	O
gene1s	O
ATR	O
gene1e	O
/	O
gene1s	O
Chk1	O
gene1e	O
.	O
gene1s	O
Dbf4-dependent	O
kinases	O
gene1e	O
(	O
gene1s	O
DDK	O
gene1e	O
s	O
)	O
are	O
required	O
for	O
the	O
initiation	O
of	O
DNA	O
replication	O
,	O
their	O
essential	O
targets	O
being	O
the	O
gene1s	O
MCM2	O
-	O
7	O
gene1e	O
proteins	O
.	O
We	O
show	O
that	O
,	O
in	O
species1s	O
Xenopus	O
laevis	O
species1e	O
arg1s	O
egg	O
arg1e	O
extracts	O
and	O
species1s	O
human	O
species1e	O
cells	O
,	O
hyper	O
-	O
phosphorylation	O
of	O
DNA	O
-	O
bound	O
gene1s	O
Mcm4	O
gene1e	O
,	O
but	O
not	O
phosphorylation	O
of	O
gene1s	O
Mcm2	O
gene1e	O
,	O
correlates	O
with	O
DNA	O
replication	O
.	O
These	O
phosphorylations	O
are	O
differentially	O
affected	O
by	O
the	O
gene1s	O
DDK	O
gene1e	O
inhibitors	O
PHA-767491	O
and	O
XL413	O
.	O
We	O
show	O
that	O
gene1s	O
DDK	O
gene1e	O
-	O
dependent	O
gene1s	O
MCM	O
gene1e	O
phosphorylation	O
is	O
reversed	O
by	O
gene1s	O
protein	O
phosphatase	O
1	O
gene1e	O
(	O
gene1s	O
PP1	O
gene1e	O
)	O
targeted	O
to	O
chromatin	O
by	O
gene1s	O
Rif1	O
gene1e	O
.	O
Loss	O
of	O
gene1s	O
Rif1	O
gene1e	O
increased	O
gene1s	O
MCM	O
gene1e	O
phosphorylation	O
and	O
the	O
rate	O
of	O
replication	O
initiation	O
and	O
also	O
compromised	O
the	O
ability	O
of	O
cells	O
to	O
block	O
initiation	O
when	O
challenged	O
with	O
replication	O
inhibitors	O
.	O
We	O
also	O
provide	O
evidence	O
that	O
gene1s	O
Rif1	O
gene1e	O
can	O
mediate	O
gene1s	O
MCM	O
gene1e	O
dephosphorylation	O
at	O
replication	O
forks	O
and	O
that	O
the	O
stability	O
of	O
dephosphorylated	O
replisomes	O
strongly	O
depends	O
on	O
gene1s	O
Chk1	O
gene1e	O
activity	O
.	O
We	O
propose	O
that	O
both	O
replication	O
initiation	O
and	O
replisome	O
stability	O
depend	O
on	O
gene1s	O
MCM	O
gene1e	O
phosphorylation	O
,	O
which	O
is	O
maintained	O
by	O
a	O
balance	O
of	O
gene1s	O
DDK	O
gene1e	O
-	O
dependent	O
phosphorylation	O
and	O
gene1s	O
Rif1	O
gene1e	O
-mediated	O
dephosphorylation	O
.	O

Reversal	O
of	O
gene1s	ARG2
DDK	ARG2
gene1e	ARG2
-	O
Mediated	O
gene1s	ARG2
MCM	ARG2
gene1e	ARG2
Phosphorylation	O
by	O
gene1s	ARG2
Rif1	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
PP1	ARG2
gene1e	ARG2
Regulates	O
Replication	O
Initiation	O
and	O
Replisome	O
Stability	O
Independently	O
of	O
gene1s	ARG2
ATR	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Chk1	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
Dbf4-dependent	ARG2
kinases	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
DDK	ARG2
gene1e	ARG2
s	O
)	O
are	O
required	O
for	O
the	O
initiation	O
of	O
DNA	O
replication	O
,	O
their	O
essential	O
targets	O
being	O
the	O
gene1s	ARG2
MCM2	ARG2
-	ARG2
7	ARG2
gene1e	ARG2
proteins	O
.	O
We	O
show	O
that	O
,	O
in	O
species1s	O
Xenopus	O
laevis	O
species1e	O
species1s	O
egg	O
species1e	O
extracts	O
and	O
arg1s	O
human	O
arg1e	O
cells	O
,	O
hyper	O
-	O
phosphorylation	O
of	O
DNA	O
-	O
bound	O
gene1s	ARG2
Mcm4	ARG2
gene1e	ARG2
,	O
but	O
not	O
phosphorylation	O
of	O
gene1s	ARG2
Mcm2	ARG2
gene1e	ARG2
,	O
correlates	O
with	O
DNA	O
replication	O
.	O
These	O
phosphorylations	O
are	O
differentially	O
affected	O
by	O
the	O
gene1s	ARG2
DDK	ARG2
gene1e	ARG2
inhibitors	O
PHA-767491	O
and	O
XL413	O
.	O
We	O
show	O
that	O
gene1s	ARG2
DDK	ARG2
gene1e	ARG2
-	O
dependent	O
gene1s	ARG2
MCM	ARG2
gene1e	ARG2
phosphorylation	O
is	O
reversed	O
by	O
gene1s	ARG2
protein	ARG2
phosphatase	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PP1	ARG2
gene1e	ARG2
)	O
targeted	O
to	O
chromatin	O
by	O
gene1s	ARG2
Rif1	ARG2
gene1e	ARG2
.	O
Loss	O
of	O
gene1s	ARG2
Rif1	ARG2
gene1e	ARG2
increased	O
gene1s	ARG2
MCM	ARG2
gene1e	ARG2
phosphorylation	O
and	O
the	O
rate	O
of	O
replication	O
initiation	O
and	O
also	O
compromised	O
the	O
ability	O
of	O
cells	O
to	O
block	O
initiation	O
when	O
challenged	O
with	O
replication	O
inhibitors	O
.	O
We	O
also	O
provide	O
evidence	O
that	O
gene1s	ARG2
Rif1	ARG2
gene1e	ARG2
can	O
mediate	O
gene1s	ARG2
MCM	ARG2
gene1e	ARG2
dephosphorylation	O
at	O
replication	O
forks	O
and	O
that	O
the	O
stability	O
of	O
dephosphorylated	O
replisomes	O
strongly	O
depends	O
on	O
gene1s	ARG2
Chk1	ARG2
gene1e	ARG2
activity	O
.	O
We	O
propose	O
that	O
both	O
replication	O
initiation	O
and	O
replisome	O
stability	O
depend	O
on	O
gene1s	ARG2
MCM	ARG2
gene1e	ARG2
phosphorylation	O
,	O
which	O
is	O
maintained	O
by	O
a	O
balance	O
of	O
gene1s	ARG2
DDK	ARG2
gene1e	ARG2
-	O
dependent	O
phosphorylation	O
and	O
gene1s	ARG2
Rif1	ARG2
gene1e	ARG2
-mediated	O
dephosphorylation	O
.	O

arg1s	O
Human	O
arg1e	O
wild	O
-	O
type	O
full	O
-	O
length	O
gene1s	ARG2
tau	ARG2
gene1e	ARG2
accumulation	O
disrupts	O
mitochondrial	O
dynamics	O
and	O
the	O
functions	O
via	O
increasing	O
gene1s	ARG2
mitofusins	ARG2
gene1e	ARG2
.	O
Intracellular	O
accumulation	O
of	O
gene1s	ARG2
tau	ARG2
gene1e	ARG2
protein	O
is	O
hallmark	O
of	O
sporadic	O
Alzheimer	O
's	O
disease	O
(	O
AD	O
)	O
,	O
however	O
,	O
the	O
cellular	O
mechanism	O
whereby	O
gene1s	ARG2
tau	ARG2
gene1e	ARG2
accumulation	O
causes	O
neurodegeneration	O
is	O
poorly	O
understood	O
.	O
Here	O
we	O
report	O
that	O
overexpression	O
of	O
arg1s	O
human	O
arg1e	O
wild	O
-	O
type	O
full	O
-	O
length	O
gene1s	ARG2
tau	ARG2
gene1e	ARG2
(	O
termed	O
gene1s	ARG2
htau	ARG2
gene1e	ARG2
)	O
disrupted	O
mitochondrial	O
dynamics	O
by	O
enhancing	O
fusion	O
and	O
induced	O
their	O
perinuclear	O
accumulation	O
in	O
arg1s	O
HEK293	O
arg1e	O
cells	O
and	O
species1s	O
rat	O
species1e	O
primary	O
hippocampal	O
neurons	O
.	O
The	O
gene1s	ARG2
htau	ARG2
gene1e	ARG2
accumulation	O
at	O
later	O
stage	O
inhibited	O
mitochondrial	O
functions	O
shown	O
by	O
the	O
decreased	O
ATP	O
level	O
,	O
the	O
ratio	O
of	O
ATP	O
/	O
ADP	O
and	O
complex	O
I	O
activity	O
.	O
Simultaneously	O
,	O
the	O
cell	O
viability	O
was	O
decreased	O
with	O
retraction	O
of	O
the	O
cellular	O
/	O
neuronal	O
processes	O
.	O
Further	O
studies	O
demonstrated	O
that	O
gene1s	ARG2
htau	ARG2
gene1e	ARG2
accumulation	O
increased	O
fusion	O
proteins	O
,	O
including	O
gene1s	ARG2
OPA1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
mitofusins	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Mfn1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Mfn2	ARG2
gene1e	ARG2
)	O
and	O
reduced	O
the	O
ubiquitination	O
of	O
gene1s	ARG2
Mfn2	ARG2
gene1e	ARG2
.	O
Downregulation	O
of	O
the	O
gene1s	ARG2
mitofusins	ARG2
gene1e	ARG2
by	O
shRNA	O
to	O
~45	O
%	O
or	O
~52	O
%	O
of	O
the	O
control	O
levels	O
attenuated	O
the	O
gene1s	ARG2
htau	ARG2
gene1e	ARG2
-	O
enhanced	O
mitochondrial	O
fusion	O
and	O
restored	O
the	O
functions	O
,	O
while	O
downregulation	O
of	O
gene1s	ARG2
OPA1	ARG2
gene1e	ARG2
to	O
~50	O
%	O
of	O
the	O
control	O
level	O
did	O
not	O
show	O
rescue	O
effects	O
.	O
Finally	O
,	O
abnormal	O
mitochondrial	O
accumulation	O
and	O
dysfunction	O
were	O
also	O
observed	O
in	O
the	O
brains	O
of	O
gene1s	ARG2
htau	ARG2
gene1e	ARG2
species1s	O
transgenic	O
mice	O
species1e	O
.	O
Taken	O
together	O
,	O
our	O
data	O
demonstrate	O
that	O
gene1s	ARG2
htau	ARG2
gene1e	ARG2
accumulation	O
decreases	O
cell	O
viability	O
and	O
causes	O
degeneration	O
via	O
enhancing	O
gene1s	ARG2
mitofusin	ARG2
gene1e	ARG2
-	O
associated	O
mitochondrial	O
fusion	O
,	O
which	O
provides	O
new	O
insights	O
into	O
the	O
molecular	O
mechanisms	O
underlying	O
tauopathies	O
.	O

species1s	O
Human	O
species1e	O
wild	O
-	O
type	O
full	O
-	O
length	O
gene1s	O
tau	O
gene1e	O
accumulation	O
disrupts	O
mitochondrial	O
dynamics	O
and	O
the	O
functions	O
via	O
increasing	O
gene1s	O
mitofusins	O
gene1e	O
.	O
Intracellular	O
accumulation	O
of	O
gene1s	O
tau	O
gene1e	O
protein	O
is	O
hallmark	O
of	O
sporadic	O
Alzheimer	O
's	O
disease	O
(	O
AD	O
)	O
,	O
however	O
,	O
the	O
cellular	O
mechanism	O
whereby	O
gene1s	O
tau	O
gene1e	O
accumulation	O
causes	O
neurodegeneration	O
is	O
poorly	O
understood	O
.	O
Here	O
we	O
report	O
that	O
overexpression	O
of	O
species1s	O
human	O
species1e	O
wild	O
-	O
type	O
full	O
-	O
length	O
gene1s	O
tau	O
gene1e	O
(	O
termed	O
gene1s	O
htau	O
gene1e	O
)	O
disrupted	O
mitochondrial	O
dynamics	O
by	O
enhancing	O
fusion	O
and	O
induced	O
their	O
perinuclear	O
accumulation	O
in	O
species1s	O
HEK293	O
species1e	O
cells	O
and	O
arg1s	O
rat	O
arg1e	O
primary	O
hippocampal	O
neurons	O
.	O
The	O
gene1s	O
htau	O
gene1e	O
accumulation	O
at	O
later	O
stage	O
inhibited	O
mitochondrial	O
functions	O
shown	O
by	O
the	O
decreased	O
ATP	O
level	O
,	O
the	O
ratio	O
of	O
ATP	O
/	O
ADP	O
and	O
complex	O
I	O
activity	O
.	O
Simultaneously	O
,	O
the	O
cell	O
viability	O
was	O
decreased	O
with	O
retraction	O
of	O
the	O
cellular	O
/	O
neuronal	O
processes	O
.	O
Further	O
studies	O
demonstrated	O
that	O
gene1s	O
htau	O
gene1e	O
accumulation	O
increased	O
fusion	O
proteins	O
,	O
including	O
gene1s	O
OPA1	O
gene1e	O
and	O
gene1s	O
mitofusins	O
gene1e	O
(	O
gene1s	O
Mfn1	O
gene1e	O
,	O
gene1s	O
Mfn2	O
gene1e	O
)	O
and	O
reduced	O
the	O
ubiquitination	O
of	O
gene1s	O
Mfn2	O
gene1e	O
.	O
Downregulation	O
of	O
the	O
gene1s	O
mitofusins	O
gene1e	O
by	O
shRNA	O
to	O
~45	O
%	O
or	O
~52	O
%	O
of	O
the	O
control	O
levels	O
attenuated	O
the	O
gene1s	O
htau	O
gene1e	O
-	O
enhanced	O
mitochondrial	O
fusion	O
and	O
restored	O
the	O
functions	O
,	O
while	O
downregulation	O
of	O
gene1s	O
OPA1	O
gene1e	O
to	O
~50	O
%	O
of	O
the	O
control	O
level	O
did	O
not	O
show	O
rescue	O
effects	O
.	O
Finally	O
,	O
abnormal	O
mitochondrial	O
accumulation	O
and	O
dysfunction	O
were	O
also	O
observed	O
in	O
the	O
brains	O
of	O
gene1s	O
htau	O
gene1e	O
species1s	O
transgenic	O
mice	O
species1e	O
.	O
Taken	O
together	O
,	O
our	O
data	O
demonstrate	O
that	O
gene1s	O
htau	O
gene1e	O
accumulation	O
decreases	O
cell	O
viability	O
and	O
causes	O
degeneration	O
via	O
enhancing	O
gene1s	O
mitofusin	O
gene1e	O
-	O
associated	O
mitochondrial	O
fusion	O
,	O
which	O
provides	O
new	O
insights	O
into	O
the	O
molecular	O
mechanisms	O
underlying	O
tauopathies	O
.	O

species1s	O
Human	O
species1e	O
wild	O
-	O
type	O
full	O
-	O
length	O
gene1s	O
tau	O
gene1e	O
accumulation	O
disrupts	O
mitochondrial	O
dynamics	O
and	O
the	O
functions	O
via	O
increasing	O
gene1s	O
mitofusins	O
gene1e	O
.	O
Intracellular	O
accumulation	O
of	O
gene1s	O
tau	O
gene1e	O
protein	O
is	O
hallmark	O
of	O
sporadic	O
Alzheimer	O
's	O
disease	O
(	O
AD	O
)	O
,	O
however	O
,	O
the	O
cellular	O
mechanism	O
whereby	O
gene1s	O
tau	O
gene1e	O
accumulation	O
causes	O
neurodegeneration	O
is	O
poorly	O
understood	O
.	O
Here	O
we	O
report	O
that	O
overexpression	O
of	O
species1s	O
human	O
species1e	O
wild	O
-	O
type	O
full	O
-	O
length	O
gene1s	O
tau	O
gene1e	O
(	O
termed	O
gene1s	O
htau	O
gene1e	O
)	O
disrupted	O
mitochondrial	O
dynamics	O
by	O
enhancing	O
fusion	O
and	O
induced	O
their	O
perinuclear	O
accumulation	O
in	O
species1s	O
HEK293	O
species1e	O
cells	O
and	O
species1s	O
rat	O
species1e	O
primary	O
hippocampal	O
neurons	O
.	O
The	O
gene1s	O
htau	O
gene1e	O
accumulation	O
at	O
later	O
stage	O
inhibited	O
mitochondrial	O
functions	O
shown	O
by	O
the	O
decreased	O
ATP	O
level	O
,	O
the	O
ratio	O
of	O
ATP	O
/	O
ADP	O
and	O
complex	O
I	O
activity	O
.	O
Simultaneously	O
,	O
the	O
cell	O
viability	O
was	O
decreased	O
with	O
retraction	O
of	O
the	O
cellular	O
/	O
neuronal	O
processes	O
.	O
Further	O
studies	O
demonstrated	O
that	O
gene1s	O
htau	O
gene1e	O
accumulation	O
increased	O
fusion	O
proteins	O
,	O
including	O
gene1s	O
OPA1	O
gene1e	O
and	O
gene1s	O
mitofusins	O
gene1e	O
(	O
gene1s	O
Mfn1	O
gene1e	O
,	O
gene1s	O
Mfn2	O
gene1e	O
)	O
and	O
reduced	O
the	O
ubiquitination	O
of	O
gene1s	O
Mfn2	O
gene1e	O
.	O
Downregulation	O
of	O
the	O
gene1s	O
mitofusins	O
gene1e	O
by	O
shRNA	O
to	O
~45	O
%	O
or	O
~52	O
%	O
of	O
the	O
control	O
levels	O
attenuated	O
the	O
gene1s	O
htau	O
gene1e	O
-	O
enhanced	O
mitochondrial	O
fusion	O
and	O
restored	O
the	O
functions	O
,	O
while	O
downregulation	O
of	O
gene1s	O
OPA1	O
gene1e	O
to	O
~50	O
%	O
of	O
the	O
control	O
level	O
did	O
not	O
show	O
rescue	O
effects	O
.	O
Finally	O
,	O
abnormal	O
mitochondrial	O
accumulation	O
and	O
dysfunction	O
were	O
also	O
observed	O
in	O
the	O
brains	O
of	O
gene1s	O
htau	O
gene1e	O
arg1s	O
transgenic	O
mice	O
arg1e	O
.	O
Taken	O
together	O
,	O
our	O
data	O
demonstrate	O
that	O
gene1s	O
htau	O
gene1e	O
accumulation	O
decreases	O
cell	O
viability	O
and	O
causes	O
degeneration	O
via	O
enhancing	O
gene1s	O
mitofusin	O
gene1e	O
-	O
associated	O
mitochondrial	O
fusion	O
,	O
which	O
provides	O
new	O
insights	O
into	O
the	O
molecular	O
mechanisms	O
underlying	O
tauopathies	O
.	O

Release	O
of	O
gene1s	O
Ku	O
gene1e	O
and	O
gene1s	O
MRN	O
gene1e	O
from	O
DNA	O
ends	O
by	O
gene1s	O
Mre11	O
gene1e	O
nuclease	O
activity	O
and	O
gene1s	O
Ctp1	O
gene1e	O
is	O
required	O
for	O
homologous	O
recombination	O
repair	O
of	O
double	O
-	O
strand	O
breaks	O
.	O
The	O
multifunctional	O
gene1s	O
Mre11	O
gene1e	O
-	O
gene1s	O
Rad50	O
gene1e	O
-	O
gene1s	O
Nbs1	O
gene1e	O
(	O
gene1s	O
MRN	O
gene1e	O
)	O
protein	O
complex	O
recruits	O
gene1s	O
ATM	O
/	O
Tel1	O
checkpoint	O
kinase	O
gene1e	O
and	O
gene1s	O
CtIP	O
/	O
Ctp1	O
gene1e	O
homologous	O
recombination	O
(	O
HR	O
)	O
repair	O
factor	O
to	O
double	O
-	O
strand	O
breaks	O
(	O
DSBs	O
)	O
.	O
HR	O
repair	O
commences	O
with	O
the	O
5'-to-3	O
'	O
resection	O
of	O
DNA	O
ends	O
,	O
generating	O
3	O
'	O
single	O
-	O
strand	O
DNA	O
(	O
ssDNA	O
)	O
overhangs	O
that	O
bind	O
gene1s	O
Replication	O
Protein	O
A	O
gene1e	O
(	O
gene1s	O
RPA	O
gene1e	O
)	O
complex	O
,	O
followed	O
by	O
gene1s	O
Rad51	O
recombinase	O
gene1e	O
.	O
In	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
,	O
the	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Rad50	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Xrs2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MRX	ARG2
gene1e	ARG2
)	O
complex	O
is	O
critical	O
for	O
DSB	O
resection	O
,	O
although	O
the	O
enigmatic	O
gene1s	ARG2
ssDNA	ARG2
endonuclease	ARG2
gene1e	ARG2
activity	O
of	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
and	O
the	O
DNA	O
-	O
end	O
processing	O
factor	O
gene1s	ARG2
Sae2	ARG2
gene1e	ARG2
(	O
gene1s	O
CtIP	O
/	O
Ctp1	O
gene1e	O
ortholog	O
)	O
are	O
largely	O
unnecessary	O
unless	O
the	O
resection	O
activities	O
of	O
gene1s	ARG2
Exo1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Sgs1	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Dna2	ARG2
gene1e	ARG2
are	O
also	O
eliminated	O
.	O
gene1s	O
Mre11	O
gene1e	O
nuclease	O
activity	O
and	O
gene1s	O
Ctp1	O
/	O
CtIP	O
gene1e	O
are	O
essential	O
for	O
DSB	O
repair	O
in	O
species1s	O
Schizosaccharomyces	O
pombe	O
species1e	O
and	O
mammals	O
.	O
To	O
investigate	O
DNA	O
end	O
resection	O
in	O
Schizo	O
.	O
pombe	O
,	O
we	O
adapted	O
an	O
assay	O
that	O
directly	O
measures	O
ssDNA	O
formation	O
at	O
a	O
defined	O
DSB	O
.	O
We	O
found	O
that	O
gene1s	O
Mre11	O
gene1e	O
and	O
gene1s	O
Ctp1	O
gene1e	O
are	O
essential	O
for	O
the	O
efficient	O
initiation	O
of	O
resection	O
,	O
consistent	O
with	O
their	O
equally	O
crucial	O
roles	O
in	O
DSB	O
repair	O
.	O
gene1s	O
Exo1	O
gene1e	O
is	O
largely	O
responsible	O
for	O
extended	O
resection	O
up	O
to	O
3.1	O
kb	O
from	O
a	O
DSB	O
,	O
with	O
an	O
activity	O
dependent	O
on	O
gene1s	O
Rqh1	O
(	O
Sgs1	O
)	O
DNA	O
helicase	O
gene1e	O
having	O
a	O
minor	O
role	O
.	O
Despite	O
its	O
critical	O
function	O
in	O
DSB	O
repair	O
,	O
gene1s	O
Mre11	O
gene1e	O
nuclease	O
activity	O
is	O
not	O
required	O
for	O
resection	O
in	O
species1s	O
fission	O
yeast	O
species1e	O
.	O
However	O
,	O
gene1s	O
Mre11	O
gene1e	O
nuclease	O
and	O
gene1s	O
Ctp1	O
gene1e	O
are	O
required	O
to	O
disassociate	O
the	O
gene1s	O
MRN	O
gene1e	O
complex	O
and	O
the	O
gene1s	O
Ku70	O
gene1e	O
-	O
gene1s	O
Ku80	O
gene1e	O
nonhomologous	O
end	O
-	O
joining	O
(	O
NHEJ	O
)	O
complex	O
from	O
DSBs	O
,	O
which	O
is	O
required	O
for	O
efficient	O
gene1s	O
RPA	O
gene1e	O
localization	O
.	O
Eliminating	O
gene1s	O
Ku	O
gene1e	O
makes	O
gene1s	O
Mre11	O
gene1e	O
nuclease	O
activity	O
dispensable	O
for	O
gene1s	O
MRN	O
gene1e	O
disassociation	O
and	O
gene1s	O
RPA	O
gene1e	O
localization	O
,	O
while	O
improving	O
repair	O
of	O
a	O
one	O
-	O
ended	O
DSB	O
formed	O
by	O
replication	O
fork	O
collapse	O
.	O
From	O
these	O
data	O
we	O
propose	O
that	O
release	O
of	O
the	O
gene1s	O
MRN	O
complex	O
gene1e	O
and	O
gene1s	O
Ku	O
gene1e	O
from	O
DNA	O
ends	O
by	O
gene1s	O
Mre11	O
gene1e	O
nuclease	O
activity	O
and	O
gene1s	O
Ctp1	O
gene1e	O
is	O
a	O
critical	O
step	O
required	O
to	O
expose	O
ssDNA	O
for	O
gene1s	O
RPA	O
gene1e	O
localization	O
and	O
ensuing	O
HR	O
repair	O
.	O

Release	O
of	O
gene1s	ARG2
Ku	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MRN	ARG2
gene1e	ARG2
from	O
DNA	O
ends	O
by	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
nuclease	O
activity	O
and	O
gene1s	ARG2
Ctp1	ARG2
gene1e	ARG2
is	O
required	O
for	O
homologous	O
recombination	O
repair	O
of	O
double	O
-	O
strand	O
breaks	O
.	O
The	O
multifunctional	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Rad50	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Nbs1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MRN	ARG2
gene1e	ARG2
)	O
protein	O
complex	O
recruits	O
gene1s	ARG2
ATM	ARG2
/	ARG2
Tel1	ARG2
checkpoint	ARG2
kinase	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CtIP	ARG2
/	ARG2
Ctp1	ARG2
gene1e	ARG2
homologous	O
recombination	O
(	O
HR	O
)	O
repair	O
factor	O
to	O
double	O
-	O
strand	O
breaks	O
(	O
DSBs	O
)	O
.	O
HR	O
repair	O
commences	O
with	O
the	O
5'-to-3	O
'	O
resection	O
of	O
DNA	O
ends	O
,	O
generating	O
3	O
'	O
single	O
-	O
strand	O
DNA	O
(	O
ssDNA	O
)	O
overhangs	O
that	O
bind	O
gene1s	ARG2
Replication	ARG2
Protein	ARG2
A	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
RPA	ARG2
gene1e	ARG2
)	O
complex	O
,	O
followed	O
by	O
gene1s	ARG2
Rad51	ARG2
recombinase	ARG2
gene1e	ARG2
.	O
In	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
,	O
the	O
gene1s	O
Mre11	O
gene1e	O
-	O
gene1s	O
Rad50	O
gene1e	O
-	O
gene1s	O
Xrs2	O
gene1e	O
(	O
gene1s	O
MRX	O
gene1e	O
)	O
complex	O
is	O
critical	O
for	O
DSB	O
resection	O
,	O
although	O
the	O
enigmatic	O
gene1s	O
ssDNA	O
endonuclease	O
gene1e	O
activity	O
of	O
gene1s	O
Mre11	O
gene1e	O
and	O
the	O
DNA	O
-	O
end	O
processing	O
factor	O
gene1s	O
Sae2	O
gene1e	O
(	O
gene1s	ARG2
CtIP	ARG2
/	ARG2
Ctp1	ARG2
gene1e	ARG2
ortholog	O
)	O
are	O
largely	O
unnecessary	O
unless	O
the	O
resection	O
activities	O
of	O
gene1s	O
Exo1	O
gene1e	O
and	O
gene1s	O
Sgs1	O
gene1e	O
-	O
gene1s	O
Dna2	O
gene1e	O
are	O
also	O
eliminated	O
.	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
nuclease	O
activity	O
and	O
gene1s	ARG2
Ctp1	ARG2
/	ARG2
CtIP	ARG2
gene1e	ARG2
are	O
essential	O
for	O
DSB	O
repair	O
in	O
arg1s	O
Schizosaccharomyces	O
pombe	O
arg1e	O
and	O
mammals	O
.	O
To	O
investigate	O
DNA	O
end	O
resection	O
in	O
Schizo	O
.	O
pombe	O
,	O
we	O
adapted	O
an	O
assay	O
that	O
directly	O
measures	O
ssDNA	O
formation	O
at	O
a	O
defined	O
DSB	O
.	O
We	O
found	O
that	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Ctp1	ARG2
gene1e	ARG2
are	O
essential	O
for	O
the	O
efficient	O
initiation	O
of	O
resection	O
,	O
consistent	O
with	O
their	O
equally	O
crucial	O
roles	O
in	O
DSB	O
repair	O
.	O
gene1s	ARG2
Exo1	ARG2
gene1e	ARG2
is	O
largely	O
responsible	O
for	O
extended	O
resection	O
up	O
to	O
3.1	O
kb	O
from	O
a	O
DSB	O
,	O
with	O
an	O
activity	O
dependent	O
on	O
gene1s	ARG2
Rqh1	ARG2
(	ARG2
Sgs1	ARG2
)	ARG2
DNA	ARG2
helicase	ARG2
gene1e	ARG2
having	O
a	O
minor	O
role	O
.	O
Despite	O
its	O
critical	O
function	O
in	O
DSB	O
repair	O
,	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
nuclease	O
activity	O
is	O
not	O
required	O
for	O
resection	O
in	O
arg1s	O
fission	O
yeast	O
arg1e	O
.	O
However	O
,	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
nuclease	O
and	O
gene1s	ARG2
Ctp1	ARG2
gene1e	ARG2
are	O
required	O
to	O
disassociate	O
the	O
gene1s	ARG2
MRN	ARG2
gene1e	ARG2
complex	O
and	O
the	O
gene1s	ARG2
Ku70	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Ku80	ARG2
gene1e	ARG2
nonhomologous	O
end	O
-	O
joining	O
(	O
NHEJ	O
)	O
complex	O
from	O
DSBs	O
,	O
which	O
is	O
required	O
for	O
efficient	O
gene1s	ARG2
RPA	ARG2
gene1e	ARG2
localization	O
.	O
Eliminating	O
gene1s	ARG2
Ku	ARG2
gene1e	ARG2
makes	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
nuclease	O
activity	O
dispensable	O
for	O
gene1s	ARG2
MRN	ARG2
gene1e	ARG2
disassociation	O
and	O
gene1s	ARG2
RPA	ARG2
gene1e	ARG2
localization	O
,	O
while	O
improving	O
repair	O
of	O
a	O
one	O
-	O
ended	O
DSB	O
formed	O
by	O
replication	O
fork	O
collapse	O
.	O
From	O
these	O
data	O
we	O
propose	O
that	O
release	O
of	O
the	O
gene1s	ARG2
MRN	ARG2
complex	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Ku	ARG2
gene1e	ARG2
from	O
DNA	O
ends	O
by	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
nuclease	O
activity	O
and	O
gene1s	ARG2
Ctp1	ARG2
gene1e	ARG2
is	O
a	O
critical	O
step	O
required	O
to	O
expose	O
ssDNA	O
for	O
gene1s	ARG2
RPA	ARG2
gene1e	ARG2
localization	O
and	O
ensuing	O
HR	O
repair	O
.	O

Severe	O
polyposis	O
in	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
(1322	O
T	O
)	O
arg1s	O
mice	O
arg1e	O
is	O
associated	O
with	O
submaximal	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
signalling	O
and	O
increased	O
expression	O
of	O
the	O
stem	O
cell	O
marker	O
gene1s	ARG2
Lgr5	ARG2
gene1e	ARG2
.	O
BACKGROUND	O
AND	O
AIMS	O
:	O
gene1s	O
Adenomatous	O
polyposis	O
coli	O
gene1e	O
(	O
gene1s	O
APC	O
gene1e	O
)	O
is	O
a	O
tumour	O
suppressor	O
gene	O
mutated	O
in	O
the	O
germline	O
of	O
species1s	O
patients	O
species1e	O
with	O
familial	O
adenomatous	O
polyposis	O
(	O
FAP	O
)	O
and	O
somatically	O
in	O
most	O
colorectal	O
cancers	O
.	O
gene1s	O
APC	O
gene1e	O
mutations	O
impair	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
degradation	O
,	O
resulting	O
in	O
increased	O
gene1s	O
Wnt	O
gene1e	O
signalling	O
.	O
The	O
most	O
frequent	O
gene1s	O
APC	O
gene1e	O
mutation	O
is	O
a	O
codon	O
1309	O
truncation	O
that	O
is	O
associated	O
with	O
severe	O
FAP	O
.	O
A	O
previous	O
study	O
compared	O
two	O
arg1s	O
mouse	O
arg1e	O
models	O
of	O
intestinal	O
tumorigenesis	O
,	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
(R850X	O
)	O
(	O
Min	O
)	O
and	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
(1322	O
T	O
)	O
(	O
1322	O
T	O
)	O
,	O
the	O
latter	O
a	O
model	O
of	O
species1s	O
human	O
species1e	O
codon	O
1309	O
changes	O
.	O
1322	O
T	O
arg1s	O
mice	O
arg1e	O
had	O
more	O
severe	O
polyposis	O
but	O
,	O
surprisingly	O
,	O
these	O
tumours	O
had	O
lower	O
levels	O
of	O
nuclear	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
than	O
Min	O
tumours	O
.	O
The	O
consequences	O
of	O
these	O
different	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
levels	O
were	O
investigated	O
.	O
METHODS	O
:	O
Enterocytes	O
were	O
isolated	O
from	O
1322	O
T	O
and	O
Min	O
tumours	O
by	O
microdissection	O
and	O
gene	O
expression	O
profiling	O
was	O
performed	O
.	O
Differentially	O
expressed	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
targets	O
and	O
other	O
stem	O
cell	O
markers	O
were	O
validated	O
using	O
quantitative	O
PCR	O
,	O
in	O
situ	O
hybridisation	O
and	O
immunohistochemistry	O
.	O
RESULTS	O
:	O
As	O
expected	O
,	O
lower	O
nuclear	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
levels	O
in	O
1322	O
T	O
lesions	O
were	O
associated	O
with	O
generally	O
lower	O
levels	O
of	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
target	O
expression	O
.	O
However	O
,	O
expression	O
of	O
the	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
target	O
and	O
stem	O
cell	O
marker	O
gene1s	ARG2
Lgr5	ARG2
gene1e	ARG2
was	O
significantly	O
higher	O
in	O
1322	O
T	O
tumours	O
than	O
in	O
Min	O
tumours	O
.	O
Other	O
stem	O
cell	O
markers	O
(	O
gene1s	ARG2
Musashi1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Bmi1	ARG2
gene1e	ARG2
and	O
the	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
target	O
gene1s	ARG2
Cd44	ARG2
gene1e	ARG2
)	O
were	O
also	O
at	O
higher	O
levels	O
in	O
1322	O
T	O
tumours	O
.	O
In	O
addition	O
,	O
expression	O
of	O
the	O
gene1s	ARG2
Bmp	ARG2
gene1e	ARG2
antagonist	O
gene1s	ARG2
Gremlin1	ARG2
gene1e	ARG2
was	O
higher	O
in	O
1322	O
T	O
tumours	O
,	O
together	O
with	O
lower	O
gene1s	ARG2
Bmp2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Bmp4	ARG2
gene1e	ARG2
expression	O
.	O
CONCLUSIONS	O
:	O
The	O
severe	O
phenotype	O
caused	O
by	O
truncation	O
of	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
at	O
codon	O
1322	O
is	O
associated	O
with	O
an	O
increased	O
number	O
of	O
stem	O
cells	O
.	O
Thus	O
,	O
a	O
submaximal	O
level	O
of	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
signalling	O
favours	O
the	O
stem	O
cell	O
phenotype	O
and	O
this	O
may	O
promote	O
tumorigenesis	O
.	O
A	O
level	O
of	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
signalling	O
exists	O
that	O
is	O
too	O
high	O
for	O
optimal	O
tumour	O
growth	O
.	O

Severe	O
polyposis	O
in	O
gene1s	O
Apc	O
gene1e	O
(1322	O
T	O
)	O
species1s	O
mice	O
species1e	O
is	O
associated	O
with	O
submaximal	O
gene1s	O
Wnt	O
gene1e	O
signalling	O
and	O
increased	O
expression	O
of	O
the	O
stem	O
cell	O
marker	O
gene1s	O
Lgr5	O
gene1e	O
.	O
BACKGROUND	O
AND	O
AIMS	O
:	O
gene1s	ARG2
Adenomatous	ARG2
polyposis	ARG2
coli	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
APC	ARG2
gene1e	ARG2
)	O
is	O
a	O
tumour	O
suppressor	O
gene	O
mutated	O
in	O
the	O
germline	O
of	O
arg1s	O
patients	O
arg1e	O
with	O
familial	O
adenomatous	O
polyposis	O
(	O
FAP	O
)	O
and	O
somatically	O
in	O
most	O
colorectal	O
cancers	O
.	O
gene1s	ARG2
APC	ARG2
gene1e	ARG2
mutations	O
impair	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
degradation	O
,	O
resulting	O
in	O
increased	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
signalling	O
.	O
The	O
most	O
frequent	O
gene1s	ARG2
APC	ARG2
gene1e	ARG2
mutation	O
is	O
a	O
codon	O
1309	O
truncation	O
that	O
is	O
associated	O
with	O
severe	O
FAP	O
.	O
A	O
previous	O
study	O
compared	O
two	O
species1s	O
mouse	O
species1e	O
models	O
of	O
intestinal	O
tumorigenesis	O
,	O
gene1s	O
Apc	O
gene1e	O
(R850X	O
)	O
(	O
Min	O
)	O
and	O
gene1s	O
Apc	O
gene1e	O
(1322	O
T	O
)	O
(	O
1322	O
T	O
)	O
,	O
the	O
latter	O
a	O
model	O
of	O
arg1s	O
human	O
arg1e	O
codon	O
1309	O
changes	O
.	O
1322	O
T	O
species1s	O
mice	O
species1e	O
had	O
more	O
severe	O
polyposis	O
but	O
,	O
surprisingly	O
,	O
these	O
tumours	O
had	O
lower	O
levels	O
of	O
nuclear	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
than	O
Min	O
tumours	O
.	O
The	O
consequences	O
of	O
these	O
different	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
levels	O
were	O
investigated	O
.	O
METHODS	O
:	O
Enterocytes	O
were	O
isolated	O
from	O
1322	O
T	O
and	O
Min	O
tumours	O
by	O
microdissection	O
and	O
gene	O
expression	O
profiling	O
was	O
performed	O
.	O
Differentially	O
expressed	O
gene1s	O
Wnt	O
gene1e	O
targets	O
and	O
other	O
stem	O
cell	O
markers	O
were	O
validated	O
using	O
quantitative	O
PCR	O
,	O
in	O
situ	O
hybridisation	O
and	O
immunohistochemistry	O
.	O
RESULTS	O
:	O
As	O
expected	O
,	O
lower	O
nuclear	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
levels	O
in	O
1322	O
T	O
lesions	O
were	O
associated	O
with	O
generally	O
lower	O
levels	O
of	O
gene1s	O
Wnt	O
gene1e	O
target	O
expression	O
.	O
However	O
,	O
expression	O
of	O
the	O
gene1s	O
Wnt	O
gene1e	O
target	O
and	O
stem	O
cell	O
marker	O
gene1s	O
Lgr5	O
gene1e	O
was	O
significantly	O
higher	O
in	O
1322	O
T	O
tumours	O
than	O
in	O
Min	O
tumours	O
.	O
Other	O
stem	O
cell	O
markers	O
(	O
gene1s	O
Musashi1	O
gene1e	O
,	O
gene1s	O
Bmi1	O
gene1e	O
and	O
the	O
gene1s	O
Wnt	O
gene1e	O
target	O
gene1s	O
Cd44	O
gene1e	O
)	O
were	O
also	O
at	O
higher	O
levels	O
in	O
1322	O
T	O
tumours	O
.	O
In	O
addition	O
,	O
expression	O
of	O
the	O
gene1s	O
Bmp	O
gene1e	O
antagonist	O
gene1s	O
Gremlin1	O
gene1e	O
was	O
higher	O
in	O
1322	O
T	O
tumours	O
,	O
together	O
with	O
lower	O
gene1s	O
Bmp2	O
gene1e	O
and	O
gene1s	O
Bmp4	O
gene1e	O
expression	O
.	O
CONCLUSIONS	O
:	O
The	O
severe	O
phenotype	O
caused	O
by	O
truncation	O
of	O
gene1s	O
Apc	O
gene1e	O
at	O
codon	O
1322	O
is	O
associated	O
with	O
an	O
increased	O
number	O
of	O
stem	O
cells	O
.	O
Thus	O
,	O
a	O
submaximal	O
level	O
of	O
gene1s	O
Wnt	O
gene1e	O
signalling	O
favours	O
the	O
stem	O
cell	O
phenotype	O
and	O
this	O
may	O
promote	O
tumorigenesis	O
.	O
A	O
level	O
of	O
gene1s	O
Wnt	O
gene1e	O
signalling	O
exists	O
that	O
is	O
too	O
high	O
for	O
optimal	O
tumour	O
growth	O
.	O

The	O
Innate	O
Immune	O
Receptor	O
gene1s	O
NLRX1	O
gene1e	O
Functions	O
as	O
a	O
Tumor	O
Suppressor	O
by	O
Reducing	O
Colon	O
Tumorigenesis	O
and	O
Key	O
Tumor	O
-	O
Promoting	O
Signals	O
.	O
gene1s	O
NOD	O
-	O
like	O
receptor	O
gene1e	O
(	O
gene1s	O
NLR	O
gene1e	O
)	O
proteins	O
are	O
intracellular	O
innate	O
immune	O
sensors	O
/	O
receptors	O
that	O
regulate	O
immunity	O
.	O
This	O
work	O
shows	O
that	O
gene1s	O
NLRX1	O
gene1e	O
serves	O
as	O
a	O
tumor	O
suppressor	O
in	O
colitis	O
-	O
associated	O
cancer	O
(	O
CAC	O
)	O
and	O
sporadic	O
colon	O
cancer	O
by	O
keeping	O
key	O
tumor	O
promoting	O
pathways	O
in	O
check	O
.	O
gene1s	ARG2
Nlrx1	ARG2
gene1e	ARG2
(-/-	O
)	O
arg1s	O
mice	O
arg1e	O
were	O
highly	O
susceptible	O
to	O
CAC	O
,	O
showing	O
increases	O
in	O
key	O
cancer	O
-	O
promoting	O
pathways	O
including	O
gene1s	ARG2
nuclear	ARG2
factor	ARG2
kB	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
mitogen	ARG2
-	ARG2
activated	ARG2
protein	ARG2
kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
signal	ARG2
transducer	ARG2
and	ARG2
activator	ARG2
of	ARG2
transcription	ARG2
3	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
)	O
,	O
and	O
gene1s	ARG2
interleukin	ARG2
6	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
)	O
.	O
The	O
tumor	O
-	O
suppressive	O
function	O
of	O
gene1s	O
NLRX1	O
gene1e	O
originated	O
primarily	O
from	O
the	O
non	O
-	O
hematopoietic	O
compartment	O
.	O
This	O
prompted	O
an	O
analysis	O
of	O
gene1s	ARG2
NLRX1	ARG2
gene1e	ARG2
function	O
in	O
the	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
(min/+	O
)	O
genetic	O
model	O
of	O
sporadic	O
gastrointestinal	O
cancer	O
.	O
gene1s	ARG2
NLRX1	ARG2
gene1e	ARG2
attenuated	O
gene1s	O
Apc	O
gene1e	O
(min/+	O
)	O
colon	O
tumorigenesis	O
,	O
cellular	O
proliferation	O
,	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
,	O
gene1s	O
STAT3	O
gene1e	O
activation	O
,	O
and	O
gene1s	O
IL-6	O
gene1e	O
levels	O
.	O
Application	O
of	O
anti	O
-	O
gene1s	O
interleukin	O
6	O
receptor	O
gene1e	O
(	O
gene1s	O
IL6R	O
gene1e	O
)	O
antibody	O
therapy	O
reduced	O
tumor	O
burden	O
,	O
increased	O
survival	O
,	O
and	O
reduced	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
activation	O
in	O
gene1s	ARG2
Nlrx1	ARG2
gene1e	ARG2
(-/-)	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
(min/+	O
)	O
arg1s	O
mice	O
arg1e	O
.	O
As	O
an	O
important	O
clinical	O
correlate	O
,	O
species1s	O
human	O
species1e	O
colon	O
cancer	O
samples	O
expressed	O
lower	O
levels	O
of	O
gene1s	O
NLRX1	O
gene1e	O
than	O
healthy	O
controls	O
in	O
multiple	O
species1s	O
patient	O
species1e	O
cohorts	O
.	O
These	O
data	O
implicate	O
anti	O
-	O
gene1s	O
IL6R	O
gene1e	O
as	O
a	O
potential	O
personalized	O
therapy	O
for	O
colon	O
cancers	O
with	O
reduced	O
gene1s	O
NLRX1	O
gene1e	O
.	O

The	O
Innate	O
Immune	O
Receptor	O
gene1s	ARG2
NLRX1	ARG2
gene1e	ARG2
Functions	O
as	O
a	O
Tumor	O
Suppressor	O
by	O
Reducing	O
Colon	O
Tumorigenesis	O
and	O
Key	O
Tumor	O
-	O
Promoting	O
Signals	O
.	O
gene1s	ARG2
NOD	ARG2
-	ARG2
like	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NLR	ARG2
gene1e	ARG2
)	O
proteins	O
are	O
intracellular	O
innate	O
immune	O
sensors	O
/	O
receptors	O
that	O
regulate	O
immunity	O
.	O
This	O
work	O
shows	O
that	O
gene1s	ARG2
NLRX1	ARG2
gene1e	ARG2
serves	O
as	O
a	O
tumor	O
suppressor	O
in	O
colitis	O
-	O
associated	O
cancer	O
(	O
CAC	O
)	O
and	O
sporadic	O
colon	O
cancer	O
by	O
keeping	O
key	O
tumor	O
promoting	O
pathways	O
in	O
check	O
.	O
gene1s	O
Nlrx1	O
gene1e	O
(-/-	O
)	O
species1s	O
mice	O
species1e	O
were	O
highly	O
susceptible	O
to	O
CAC	O
,	O
showing	O
increases	O
in	O
key	O
cancer	O
-	O
promoting	O
pathways	O
including	O
gene1s	O
nuclear	O
factor	O
kB	O
gene1e	O
(	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
)	O
,	O
gene1s	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
gene1e	O
(	O
gene1s	O
MAPK	O
gene1e	O
)	O
,	O
gene1s	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
3	O
gene1e	O
(	O
gene1s	O
STAT3	O
gene1e	O
)	O
,	O
and	O
gene1s	O
interleukin	O
6	O
gene1e	O
(	O
gene1s	O
IL-6	O
gene1e	O
)	O
.	O
The	O
tumor	O
-	O
suppressive	O
function	O
of	O
gene1s	ARG2
NLRX1	ARG2
gene1e	ARG2
originated	O
primarily	O
from	O
the	O
non	O
-	O
hematopoietic	O
compartment	O
.	O
This	O
prompted	O
an	O
analysis	O
of	O
gene1s	O
NLRX1	O
gene1e	O
function	O
in	O
the	O
gene1s	O
Apc	O
gene1e	O
(min/+	O
)	O
genetic	O
model	O
of	O
sporadic	O
gastrointestinal	O
cancer	O
.	O
gene1s	O
NLRX1	O
gene1e	O
attenuated	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
(min/+	O
)	O
colon	O
tumorigenesis	O
,	O
cellular	O
proliferation	O
,	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
,	O
gene1s	O
MAPK	O
gene1e	O
,	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
activation	O
,	O
and	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
levels	O
.	O
Application	O
of	O
anti	O
-	O
gene1s	ARG2
interleukin	ARG2
6	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IL6R	ARG2
gene1e	ARG2
)	O
antibody	O
therapy	O
reduced	O
tumor	O
burden	O
,	O
increased	O
survival	O
,	O
and	O
reduced	O
gene1s	O
STAT3	O
gene1e	O
activation	O
in	O
gene1s	O
Nlrx1	O
gene1e	O
(-/-)	O
gene1s	O
Apc	O
gene1e	O
(min/+	O
)	O
species1s	O
mice	O
species1e	O
.	O
As	O
an	O
important	O
clinical	O
correlate	O
,	O
arg1s	O
human	O
arg1e	O
colon	O
cancer	O
samples	O
expressed	O
lower	O
levels	O
of	O
gene1s	ARG2
NLRX1	ARG2
gene1e	ARG2
than	O
healthy	O
controls	O
in	O
multiple	O
arg1s	O
patient	O
arg1e	O
cohorts	O
.	O
These	O
data	O
implicate	O
anti	O
-	O
gene1s	ARG2
IL6R	ARG2
gene1e	ARG2
as	O
a	O
potential	O
personalized	O
therapy	O
for	O
colon	O
cancers	O
with	O
reduced	O
gene1s	ARG2
NLRX1	ARG2
gene1e	ARG2
.	O

gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
signaling	O
in	O
age	O
-	O
related	O
macular	O
degeneration	O
:	O
arg1s	O
human	O
arg1e	O
macular	O
tissue	O
and	O
species1s	O
mouse	O
species1e	O
model	O
.	O
BACKGROUND	O
:	O
The	O
wingless	O
-	O
type	O
species1s	O
MMTV	O
species1e	O
integration	O
site	O
(	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
)	O
signaling	O
is	O
a	O
group	O
of	O
signal	O
transduction	O
pathways	O
.	O
In	O
canonical	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
pathway	O
,	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
ligands	O
bind	O
to	O
gene1s	ARG2
low	ARG2
-	ARG2
density	ARG2
lipoprotein	ARG2
receptor	ARG2
-	ARG2
related	ARG2
protein	ARG2
5	ARG2
or	ARG2
6	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
LRP5	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
LRP6	ARG2
gene1e	ARG2
)	O
,	O
resulting	O
in	O
phosphorylation	O
and	O
activation	O
of	O
the	O
receptor	O
.	O
We	O
hypothesize	O
that	O
canonical	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
pathway	O
plays	O
a	O
role	O
in	O
the	O
retinal	O
lesion	O
of	O
age	O
-	O
related	O
macular	O
degeneration	O
(	O
AMD	O
)	O
,	O
a	O
leading	O
cause	O
of	O
irreversible	O
central	O
visual	O
loss	O
in	O
elderly	O
.	O
METHODS	O
:	O
We	O
examined	O
gene1s	ARG2
LRP6	ARG2
gene1e	ARG2
phosphorylation	O
and	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
signaling	O
cascade	O
in	O
arg1s	O
human	O
arg1e	O
retinal	O
sections	O
and	O
plasma	O
gene1s	ARG2
kallistatin	ARG2
gene1e	ARG2
,	O
an	O
endogenous	O
inhibitor	O
of	O
the	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
pathway	O
in	O
AMD	O
arg1s	O
patients	O
arg1e	O
and	O
non	O
-	O
AMD	O
subjects	O
.	O
We	O
also	O
used	O
the	O
gene1s	O
Ccl2	O
gene1e	O
(	O
-/-	O
)	O
/	O
gene1s	O
Cx3cr1	O
gene1e	O
(	O
-/-	O
)	O
/rd8	O
and	O
gene1s	O
Ccl2	O
gene1e	O
(	O
-/-	O
)	O
/	O
gene1s	O
Cx3cr1	O
gene1e	O
(	O
gfp	O
/	O
gfp	O
)	O
species1s	O
mouse	O
species1e	O
models	O
with	O
AMD	O
-	O
like	O
retinal	O
degeneration	O
to	O
further	O
explore	O
the	O
involvement	O
of	O
gene1s	O
Wnt	O
gene1e	O
signaling	O
activation	O
in	O
the	O
retinal	O
lesions	O
in	O
those	O
models	O
and	O
to	O
preclinically	O
evaluate	O
the	O
role	O
of	O
gene1s	O
Wnt	O
gene1e	O
signaling	O
suppression	O
as	O
a	O
potential	O
therapeutic	O
option	O
for	O
AMD	O
.	O
RESULTS	O
:	O
We	O
found	O
higher	O
levels	O
of	O
gene1s	ARG2
LRP6	ARG2
gene1e	ARG2
(	O
a	O
key	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
signaling	O
receptor	O
)	O
protein	O
phosphorylation	O
and	O
transcripts	O
of	O
the	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
pathway	O
-	O
targeted	O
genes	O
,	O
as	O
well	O
as	O
higher	O
gene1s	ARG2
beta	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
protein	O
in	O
AMD	O
macula	O
compared	O
to	O
controls	O
.	O
gene1s	ARG2
Kallistatin	ARG2
gene1e	ARG2
was	O
decreased	O
in	O
the	O
plasma	O
of	O
AMD	O
arg1s	O
patients	O
arg1e	O
.	O
Retinal	O
non	O
-	O
phosphorylated	O
-	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
and	O
phosphorylated	O
-	O
gene1s	O
LRP6	O
gene1e	O
were	O
higher	O
in	O
gene1s	O
Ccl2	O
gene1e	O
(	O
-/-	O
)	O
/	O
gene1s	O
Cx3cr1	O
gene1e	O
(	O
-/-	O
)	O
/rd8	O
species1s	O
mice	O
species1e	O
than	O
that	O
in	O
wild	O
type	O
.	O
Intravitreal	O
administration	O
of	O
an	O
anti	O
-	O
gene1s	O
LRP6	O
gene1e	O
antibody	O
slowed	O
the	O
progression	O
of	O
retinal	O
lesions	O
in	O
gene1s	O
Ccl2	O
gene1e	O
(	O
-/-	O
)	O
/	O
gene1s	O
Cx3cr1	O
gene1e	O
(	O
-/-	O
)	O
/rd8	O
and	O
gene1s	O
Ccl2	O
gene1e	O
(	O
-/-	O
)	O
/	O
gene1s	O
Cx3cr1	O
gene1e	O
(	O
gfp	O
/	O
gfp	O
)	O
species1s	O
mice	O
species1e	O
.	O
Electroretinography	O
of	O
treated	O
eyes	O
exhibited	O
larger	O
amplitudes	O
compared	O
to	O
controls	O
in	O
both	O
species1s	O
mouse	O
species1e	O
models	O
.	O
A2E	O
,	O
a	O
retinoid	O
byproduct	O
associated	O
with	O
AMD	O
was	O
lower	O
in	O
the	O
treated	O
eyes	O
of	O
gene1s	O
Ccl2	O
gene1e	O
(	O
-/-	O
)	O
/	O
gene1s	O
Cx3cr1	O
gene1e	O
(	O
-/-	O
)	O
/rd8	O
species1s	O
mice	O
species1e	O
.	O
Anti	O
-	O
gene1s	O
LRP6	O
gene1e	O
also	O
suppressed	O
the	O
expression	O
of	O
gene1s	O
Tnf	O
-	O
a	O
gene1e	O
and	O
gene1s	O
Icam-1	O
gene1e	O
in	O
gene1s	O
Ccl2	O
gene1e	O
(	O
-/-	O
)	O
/	O
gene1s	O
Cx3cr1	O
gene1e	O
(	O
-/-	O
)	O
/rd8	O
retinas	O
.	O
CONCLUSIONS	O
:	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
signaling	O
may	O
be	O
disturbed	O
in	O
AMD	O
arg1s	O
patients	O
arg1e	O
,	O
which	O
could	O
contribute	O
to	O
the	O
retinal	O
inflammation	O
and	O
increased	O
A2E	O
levels	O
found	O
in	O
AMD	O
.	O
Aberrant	O
activation	O
of	O
canonical	O
gene1s	O
Wnt	O
gene1e	O
signaling	O
might	O
also	O
contribute	O
to	O
the	O
focal	O
retinal	O
degenerative	O
lesions	O
of	O
species1s	O
mouse	O
species1e	O
models	O
with	O
gene1s	O
Ccl2	O
gene1e	O
and	O
gene1s	O
Cx3cr1	O
gene1e	O
deficiency	O
,	O
and	O
intravitreal	O
administration	O
of	O
anti	O
-	O
gene1s	O
LRP6	O
gene1e	O
antibody	O
could	O
be	O
beneficial	O
by	O
deactivating	O
the	O
canonical	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
pathway	O
.	O

gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
signaling	O
in	O
age	O
-	O
related	O
macular	O
degeneration	O
:	O
species1s	O
human	O
species1e	O
macular	O
tissue	O
and	O
arg1s	O
mouse	O
arg1e	O
model	O
.	O
BACKGROUND	O
:	O
The	O
wingless	O
-	O
type	O
species1s	O
MMTV	O
species1e	O
integration	O
site	O
(	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
)	O
signaling	O
is	O
a	O
group	O
of	O
signal	O
transduction	O
pathways	O
.	O
In	O
canonical	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
pathway	O
,	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
ligands	O
bind	O
to	O
gene1s	ARG2
low	ARG2
-	ARG2
density	ARG2
lipoprotein	ARG2
receptor	ARG2
-	ARG2
related	ARG2
protein	ARG2
5	ARG2
or	ARG2
6	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
LRP5	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
LRP6	ARG2
gene1e	ARG2
)	O
,	O
resulting	O
in	O
phosphorylation	O
and	O
activation	O
of	O
the	O
receptor	O
.	O
We	O
hypothesize	O
that	O
canonical	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
pathway	O
plays	O
a	O
role	O
in	O
the	O
retinal	O
lesion	O
of	O
age	O
-	O
related	O
macular	O
degeneration	O
(	O
AMD	O
)	O
,	O
a	O
leading	O
cause	O
of	O
irreversible	O
central	O
visual	O
loss	O
in	O
elderly	O
.	O
METHODS	O
:	O
We	O
examined	O
gene1s	O
LRP6	O
gene1e	O
phosphorylation	O
and	O
gene1s	O
Wnt	O
gene1e	O
signaling	O
cascade	O
in	O
species1s	O
human	O
species1e	O
retinal	O
sections	O
and	O
plasma	O
gene1s	O
kallistatin	O
gene1e	O
,	O
an	O
endogenous	O
inhibitor	O
of	O
the	O
gene1s	O
Wnt	O
gene1e	O
pathway	O
in	O
AMD	O
species1s	O
patients	O
species1e	O
and	O
non	O
-	O
AMD	O
subjects	O
.	O
We	O
also	O
used	O
the	O
gene1s	ARG2
Ccl2	ARG2
gene1e	ARG2
(	O
-/-	O
)	O
/	O
gene1s	ARG2
Cx3cr1	ARG2
gene1e	ARG2
(	O
-/-	O
)	O
/rd8	O
and	O
gene1s	ARG2
Ccl2	ARG2
gene1e	ARG2
(	O
-/-	O
)	O
/	O
gene1s	ARG2
Cx3cr1	ARG2
gene1e	ARG2
(	O
gfp	O
/	O
gfp	O
)	O
arg1s	O
mouse	O
arg1e	O
models	O
with	O
AMD	O
-	O
like	O
retinal	O
degeneration	O
to	O
further	O
explore	O
the	O
involvement	O
of	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
signaling	O
activation	O
in	O
the	O
retinal	O
lesions	O
in	O
those	O
models	O
and	O
to	O
preclinically	O
evaluate	O
the	O
role	O
of	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
signaling	O
suppression	O
as	O
a	O
potential	O
therapeutic	O
option	O
for	O
AMD	O
.	O
RESULTS	O
:	O
We	O
found	O
higher	O
levels	O
of	O
gene1s	O
LRP6	O
gene1e	O
(	O
a	O
key	O
gene1s	O
Wnt	O
gene1e	O
signaling	O
receptor	O
)	O
protein	O
phosphorylation	O
and	O
transcripts	O
of	O
the	O
gene1s	O
Wnt	O
gene1e	O
pathway	O
-	O
targeted	O
genes	O
,	O
as	O
well	O
as	O
higher	O
gene1s	O
beta	O
-	O
catenin	O
gene1e	O
protein	O
in	O
AMD	O
macula	O
compared	O
to	O
controls	O
.	O
gene1s	O
Kallistatin	O
gene1e	O
was	O
decreased	O
in	O
the	O
plasma	O
of	O
AMD	O
species1s	O
patients	O
species1e	O
.	O
Retinal	O
non	O
-	O
phosphorylated	O
-	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
and	O
phosphorylated	O
-	O
gene1s	ARG2
LRP6	ARG2
gene1e	ARG2
were	O
higher	O
in	O
gene1s	ARG2
Ccl2	ARG2
gene1e	ARG2
(	O
-/-	O
)	O
/	O
gene1s	ARG2
Cx3cr1	ARG2
gene1e	ARG2
(	O
-/-	O
)	O
/rd8	O
arg1s	O
mice	O
arg1e	O
than	O
that	O
in	O
wild	O
type	O
.	O
Intravitreal	O
administration	O
of	O
an	O
anti	O
-	O
gene1s	ARG2
LRP6	ARG2
gene1e	ARG2
antibody	O
slowed	O
the	O
progression	O
of	O
retinal	O
lesions	O
in	O
gene1s	ARG2
Ccl2	ARG2
gene1e	ARG2
(	O
-/-	O
)	O
/	O
gene1s	ARG2
Cx3cr1	ARG2
gene1e	ARG2
(	O
-/-	O
)	O
/rd8	O
and	O
gene1s	ARG2
Ccl2	ARG2
gene1e	ARG2
(	O
-/-	O
)	O
/	O
gene1s	ARG2
Cx3cr1	ARG2
gene1e	ARG2
(	O
gfp	O
/	O
gfp	O
)	O
arg1s	O
mice	O
arg1e	O
.	O
Electroretinography	O
of	O
treated	O
eyes	O
exhibited	O
larger	O
amplitudes	O
compared	O
to	O
controls	O
in	O
both	O
arg1s	O
mouse	O
arg1e	O
models	O
.	O
A2E	O
,	O
a	O
retinoid	O
byproduct	O
associated	O
with	O
AMD	O
was	O
lower	O
in	O
the	O
treated	O
eyes	O
of	O
gene1s	ARG2
Ccl2	ARG2
gene1e	ARG2
(	O
-/-	O
)	O
/	O
gene1s	ARG2
Cx3cr1	ARG2
gene1e	ARG2
(	O
-/-	O
)	O
/rd8	O
arg1s	O
mice	O
arg1e	O
.	O
Anti	O
-	O
gene1s	ARG2
LRP6	ARG2
gene1e	ARG2
also	O
suppressed	O
the	O
expression	O
of	O
gene1s	ARG2
Tnf	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Icam-1	ARG2
gene1e	ARG2
in	O
gene1s	ARG2
Ccl2	ARG2
gene1e	ARG2
(	O
-/-	O
)	O
/	O
gene1s	ARG2
Cx3cr1	ARG2
gene1e	ARG2
(	O
-/-	O
)	O
/rd8	O
retinas	O
.	O
CONCLUSIONS	O
:	O
gene1s	O
Wnt	O
gene1e	O
signaling	O
may	O
be	O
disturbed	O
in	O
AMD	O
species1s	O
patients	O
species1e	O
,	O
which	O
could	O
contribute	O
to	O
the	O
retinal	O
inflammation	O
and	O
increased	O
A2E	O
levels	O
found	O
in	O
AMD	O
.	O
Aberrant	O
activation	O
of	O
canonical	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
signaling	O
might	O
also	O
contribute	O
to	O
the	O
focal	O
retinal	O
degenerative	O
lesions	O
of	O
arg1s	O
mouse	O
arg1e	O
models	O
with	O
gene1s	ARG2
Ccl2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Cx3cr1	ARG2
gene1e	ARG2
deficiency	O
,	O
and	O
intravitreal	O
administration	O
of	O
anti	O
-	O
gene1s	ARG2
LRP6	ARG2
gene1e	ARG2
antibody	O
could	O
be	O
beneficial	O
by	O
deactivating	O
the	O
canonical	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
pathway	O
.	O

gene1s	O
Wnt	O
gene1e	O
signaling	O
in	O
age	O
-	O
related	O
macular	O
degeneration	O
:	O
species1s	O
human	O
species1e	O
macular	O
tissue	O
and	O
species1s	O
mouse	O
species1e	O
model	O
.	O
BACKGROUND	O
:	O
The	O
wingless	O
-	O
type	O
arg1s	O
MMTV	O
arg1e	O
integration	O
site	O
(	O
gene1s	O
Wnt	O
gene1e	O
)	O
signaling	O
is	O
a	O
group	O
of	O
signal	O
transduction	O
pathways	O
.	O
In	O
canonical	O
gene1s	O
Wnt	O
gene1e	O
pathway	O
,	O
gene1s	O
Wnt	O
gene1e	O
ligands	O
bind	O
to	O
gene1s	O
low	O
-	O
density	O
lipoprotein	O
receptor	O
-	O
related	O
protein	O
5	O
or	O
6	O
gene1e	O
(	O
gene1s	O
LRP5	O
gene1e	O
or	O
gene1s	O
LRP6	O
gene1e	O
)	O
,	O
resulting	O
in	O
phosphorylation	O
and	O
activation	O
of	O
the	O
receptor	O
.	O
We	O
hypothesize	O
that	O
canonical	O
gene1s	O
Wnt	O
gene1e	O
pathway	O
plays	O
a	O
role	O
in	O
the	O
retinal	O
lesion	O
of	O
age	O
-	O
related	O
macular	O
degeneration	O
(	O
AMD	O
)	O
,	O
a	O
leading	O
cause	O
of	O
irreversible	O
central	O
visual	O
loss	O
in	O
elderly	O
.	O
METHODS	O
:	O
We	O
examined	O
gene1s	O
LRP6	O
gene1e	O
phosphorylation	O
and	O
gene1s	O
Wnt	O
gene1e	O
signaling	O
cascade	O
in	O
species1s	O
human	O
species1e	O
retinal	O
sections	O
and	O
plasma	O
gene1s	O
kallistatin	O
gene1e	O
,	O
an	O
endogenous	O
inhibitor	O
of	O
the	O
gene1s	O
Wnt	O
gene1e	O
pathway	O
in	O
AMD	O
species1s	O
patients	O
species1e	O
and	O
non	O
-	O
AMD	O
subjects	O
.	O
We	O
also	O
used	O
the	O
gene1s	O
Ccl2	O
gene1e	O
(	O
-/-	O
)	O
/	O
gene1s	O
Cx3cr1	O
gene1e	O
(	O
-/-	O
)	O
/rd8	O
and	O
gene1s	O
Ccl2	O
gene1e	O
(	O
-/-	O
)	O
/	O
gene1s	O
Cx3cr1	O
gene1e	O
(	O
gfp	O
/	O
gfp	O
)	O
species1s	O
mouse	O
species1e	O
models	O
with	O
AMD	O
-	O
like	O
retinal	O
degeneration	O
to	O
further	O
explore	O
the	O
involvement	O
of	O
gene1s	O
Wnt	O
gene1e	O
signaling	O
activation	O
in	O
the	O
retinal	O
lesions	O
in	O
those	O
models	O
and	O
to	O
preclinically	O
evaluate	O
the	O
role	O
of	O
gene1s	O
Wnt	O
gene1e	O
signaling	O
suppression	O
as	O
a	O
potential	O
therapeutic	O
option	O
for	O
AMD	O
.	O
RESULTS	O
:	O
We	O
found	O
higher	O
levels	O
of	O
gene1s	O
LRP6	O
gene1e	O
(	O
a	O
key	O
gene1s	O
Wnt	O
gene1e	O
signaling	O
receptor	O
)	O
protein	O
phosphorylation	O
and	O
transcripts	O
of	O
the	O
gene1s	O
Wnt	O
gene1e	O
pathway	O
-	O
targeted	O
genes	O
,	O
as	O
well	O
as	O
higher	O
gene1s	O
beta	O
-	O
catenin	O
gene1e	O
protein	O
in	O
AMD	O
macula	O
compared	O
to	O
controls	O
.	O
gene1s	O
Kallistatin	O
gene1e	O
was	O
decreased	O
in	O
the	O
plasma	O
of	O
AMD	O
species1s	O
patients	O
species1e	O
.	O
Retinal	O
non	O
-	O
phosphorylated	O
-	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
and	O
phosphorylated	O
-	O
gene1s	O
LRP6	O
gene1e	O
were	O
higher	O
in	O
gene1s	O
Ccl2	O
gene1e	O
(	O
-/-	O
)	O
/	O
gene1s	O
Cx3cr1	O
gene1e	O
(	O
-/-	O
)	O
/rd8	O
species1s	O
mice	O
species1e	O
than	O
that	O
in	O
wild	O
type	O
.	O
Intravitreal	O
administration	O
of	O
an	O
anti	O
-	O
gene1s	O
LRP6	O
gene1e	O
antibody	O
slowed	O
the	O
progression	O
of	O
retinal	O
lesions	O
in	O
gene1s	O
Ccl2	O
gene1e	O
(	O
-/-	O
)	O
/	O
gene1s	O
Cx3cr1	O
gene1e	O
(	O
-/-	O
)	O
/rd8	O
and	O
gene1s	O
Ccl2	O
gene1e	O
(	O
-/-	O
)	O
/	O
gene1s	O
Cx3cr1	O
gene1e	O
(	O
gfp	O
/	O
gfp	O
)	O
species1s	O
mice	O
species1e	O
.	O
Electroretinography	O
of	O
treated	O
eyes	O
exhibited	O
larger	O
amplitudes	O
compared	O
to	O
controls	O
in	O
both	O
species1s	O
mouse	O
species1e	O
models	O
.	O
A2E	O
,	O
a	O
retinoid	O
byproduct	O
associated	O
with	O
AMD	O
was	O
lower	O
in	O
the	O
treated	O
eyes	O
of	O
gene1s	O
Ccl2	O
gene1e	O
(	O
-/-	O
)	O
/	O
gene1s	O
Cx3cr1	O
gene1e	O
(	O
-/-	O
)	O
/rd8	O
species1s	O
mice	O
species1e	O
.	O
Anti	O
-	O
gene1s	O
LRP6	O
gene1e	O
also	O
suppressed	O
the	O
expression	O
of	O
gene1s	O
Tnf	O
-	O
a	O
gene1e	O
and	O
gene1s	O
Icam-1	O
gene1e	O
in	O
gene1s	O
Ccl2	O
gene1e	O
(	O
-/-	O
)	O
/	O
gene1s	O
Cx3cr1	O
gene1e	O
(	O
-/-	O
)	O
/rd8	O
retinas	O
.	O
CONCLUSIONS	O
:	O
gene1s	O
Wnt	O
gene1e	O
signaling	O
may	O
be	O
disturbed	O
in	O
AMD	O
species1s	O
patients	O
species1e	O
,	O
which	O
could	O
contribute	O
to	O
the	O
retinal	O
inflammation	O
and	O
increased	O
A2E	O
levels	O
found	O
in	O
AMD	O
.	O
Aberrant	O
activation	O
of	O
canonical	O
gene1s	O
Wnt	O
gene1e	O
signaling	O
might	O
also	O
contribute	O
to	O
the	O
focal	O
retinal	O
degenerative	O
lesions	O
of	O
species1s	O
mouse	O
species1e	O
models	O
with	O
gene1s	O
Ccl2	O
gene1e	O
and	O
gene1s	O
Cx3cr1	O
gene1e	O
deficiency	O
,	O
and	O
intravitreal	O
administration	O
of	O
anti	O
-	O
gene1s	O
LRP6	O
gene1e	O
antibody	O
could	O
be	O
beneficial	O
by	O
deactivating	O
the	O
canonical	O
gene1s	O
Wnt	O
gene1e	O
pathway	O
.	O

gene1s	ARG2
PD-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PD	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
Blockade	O
Enhances	O
T	O
-	O
cell	O
Activity	O
and	O
Antitumor	O
Efficacy	O
of	O
Imatinib	O
in	O
Gastrointestinal	O
Stromal	O
Tumors	O
.	O
PURPOSE	O
:	O
gene1s	ARG2
Tyrosine	ARG2
kinase	ARG2
gene1e	ARG2
inhibitors	O
are	O
effective	O
in	O
gastrointestinal	O
stromal	O
tumors	O
(	O
GISTs	O
)	O
but	O
often	O
are	O
of	O
transient	O
benefit	O
as	O
resistance	O
commonly	O
develops	O
.	O
Immunotherapy	O
,	O
particularly	O
blockade	O
of	O
the	O
inhibitory	O
receptor	O
gene1s	ARG2
programmed	ARG2
death	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PD-1	ARG2
gene1e	ARG2
)	O
or	O
the	O
ligand	O
gene1s	ARG2
programmed	ARG2
death	ARG2
ligand	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PD	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
)	O
,	O
has	O
shown	O
effectiveness	O
in	O
a	O
variety	O
of	O
cancers	O
.	O
The	O
functional	O
effects	O
of	O
gene1s	ARG2
PD-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PD	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
blockade	O
are	O
unknown	O
in	O
GISTs	O
.	O
EXPERIMENTAL	O
DESIGN	O
:	O
We	O
analyzed	O
tumor	O
and	O
matched	O
blood	O
samples	O
from	O
85	O
arg1s	O
patients	O
arg1e	O
with	O
GISTs	O
and	O
determined	O
the	O
expression	O
of	O
immune	O
checkpoint	O
molecules	O
using	O
flow	O
cytometry	O
.	O
We	O
investigated	O
the	O
combination	O
of	O
imatinib	O
with	O
gene1s	O
PD-1	O
gene1e	O
/	O
gene1s	O
PD	O
-	O
L1	O
gene1e	O
blockade	O
in	O
KitV558Delta/+	O
species1s	O
mice	O
species1e	O
that	O
develop	O
GISTs	O
.	O
RESULTS	O
:	O
The	O
inhibitory	O
receptors	O
gene1s	ARG2
PD-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
lymphocyte	ARG2
activation	ARG2
gene	ARG2
3	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
T	ARG2
-	ARG2
cell	ARG2
immunoglobulin	ARG2
mucin-3	ARG2
gene1e	ARG2
were	O
upregulated	O
on	O
tumor	O
-	O
infiltrating	O
T	O
cells	O
compared	O
with	O
T	O
cells	O
from	O
matched	O
blood	O
.	O
gene1s	ARG2
PD-1	ARG2
gene1e	ARG2
expression	O
on	O
T	O
cells	O
was	O
highest	O
in	O
imatinib	O
-	O
treated	O
arg1s	O
human	O
arg1e	O
GISTs	O
.	O
Meanwhile	O
,	O
intratumoral	O
gene1s	ARG2
PD	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
expression	O
was	O
variable	O
.	O
In	O
arg1s	O
human	O
arg1e	O
GIST	O
cell	O
lines	O
,	O
treatment	O
with	O
imatinib	O
abrogated	O
the	O
gene1s	ARG2
IFNgamma	ARG2
gene1e	ARG2
-	O
induced	O
upregulation	O
of	O
gene1s	ARG2
PD	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
via	O
gene1s	ARG2
STAT1	ARG2
gene1e	ARG2
inhibition	O
.	O
In	O
KitV558Delta/+	O
species1s	O
mice	O
species1e	O
,	O
imatinib	O
downregulated	O
gene1s	O
IFNgamma	O
gene1e	O
-	O
related	O
genes	O
and	O
reduced	O
gene1s	O
PD	O
-	O
L1	O
gene1e	O
expression	O
on	O
tumor	O
cells	O
.	O
gene1s	O
PD-1	O
gene1e	O
and	O
gene1s	O
PD	O
-	O
L1	O
gene1e	O
blockade	O
in	O
vivo	O
each	O
had	O
no	O
efficacy	O
alone	O
but	O
enhanced	O
the	O
antitumor	O
effects	O
of	O
imatinib	O
by	O
increasing	O
T	O
-	O
cell	O
effector	O
function	O
in	O
the	O
presence	O
of	O
gene1s	O
KIT	O
gene1e	O
and	O
gene1s	O
IDO	O
gene1e	O
inhibition	O
.	O
CONCLUSIONS	O
:	O
gene1s	ARG2
PD-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PD	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
blockade	O
is	O
a	O
promising	O
strategy	O
to	O
improve	O
the	O
effects	O
of	O
targeted	O
therapy	O
in	O
GISTs	O
.	O
Collectively	O
,	O
our	O
results	O
provide	O
the	O
rationale	O
to	O
combine	O
these	O
agents	O
in	O
arg1s	O
human	O
arg1e	O
GISTs	O
.	O
Clin	O
Cancer	O
Res	O
;	O
23(2	O
)	O
;	O
454	O
-	O
65	O
.	O
2016	O
AACR	O
.	O

gene1s	ARG2
PD-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PD	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
Blockade	O
Enhances	O
T	O
-	O
cell	O
Activity	O
and	O
Antitumor	O
Efficacy	O
of	O
Imatinib	O
in	O
Gastrointestinal	O
Stromal	O
Tumors	O
.	O
PURPOSE	O
:	O
gene1s	O
Tyrosine	O
kinase	O
gene1e	O
inhibitors	O
are	O
effective	O
in	O
gastrointestinal	O
stromal	O
tumors	O
(	O
GISTs	O
)	O
but	O
often	O
are	O
of	O
transient	O
benefit	O
as	O
resistance	O
commonly	O
develops	O
.	O
Immunotherapy	O
,	O
particularly	O
blockade	O
of	O
the	O
inhibitory	O
receptor	O
gene1s	O
programmed	O
death	O
1	O
gene1e	O
(	O
gene1s	O
PD-1	O
gene1e	O
)	O
or	O
the	O
ligand	O
gene1s	O
programmed	O
death	O
ligand	O
1	O
gene1e	O
(	O
gene1s	O
PD	O
-	O
L1	O
gene1e	O
)	O
,	O
has	O
shown	O
effectiveness	O
in	O
a	O
variety	O
of	O
cancers	O
.	O
The	O
functional	O
effects	O
of	O
gene1s	O
PD-1	O
gene1e	O
/	O
gene1s	O
PD	O
-	O
L1	O
gene1e	O
blockade	O
are	O
unknown	O
in	O
GISTs	O
.	O
EXPERIMENTAL	O
DESIGN	O
:	O
We	O
analyzed	O
tumor	O
and	O
matched	O
blood	O
samples	O
from	O
85	O
species1s	O
patients	O
species1e	O
with	O
GISTs	O
and	O
determined	O
the	O
expression	O
of	O
immune	O
checkpoint	O
molecules	O
using	O
flow	O
cytometry	O
.	O
We	O
investigated	O
the	O
combination	O
of	O
imatinib	O
with	O
gene1s	ARG2
PD-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PD	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
blockade	O
in	O
KitV558Delta/+	O
arg1s	O
mice	O
arg1e	O
that	O
develop	O
GISTs	O
.	O
RESULTS	O
:	O
The	O
inhibitory	O
receptors	O
gene1s	O
PD-1	O
gene1e	O
,	O
gene1s	O
lymphocyte	O
activation	O
gene	O
3	O
gene1e	O
,	O
and	O
gene1s	O
T	O
-	O
cell	O
immunoglobulin	O
mucin-3	O
gene1e	O
were	O
upregulated	O
on	O
tumor	O
-	O
infiltrating	O
T	O
cells	O
compared	O
with	O
T	O
cells	O
from	O
matched	O
blood	O
.	O
gene1s	O
PD-1	O
gene1e	O
expression	O
on	O
T	O
cells	O
was	O
highest	O
in	O
imatinib	O
-	O
treated	O
species1s	O
human	O
species1e	O
GISTs	O
.	O
Meanwhile	O
,	O
intratumoral	O
gene1s	O
PD	O
-	O
L1	O
gene1e	O
expression	O
was	O
variable	O
.	O
In	O
species1s	O
human	O
species1e	O
GIST	O
cell	O
lines	O
,	O
treatment	O
with	O
imatinib	O
abrogated	O
the	O
gene1s	O
IFNgamma	O
gene1e	O
-	O
induced	O
upregulation	O
of	O
gene1s	O
PD	O
-	O
L1	O
gene1e	O
via	O
gene1s	O
STAT1	O
gene1e	O
inhibition	O
.	O
In	O
KitV558Delta/+	O
arg1s	O
mice	O
arg1e	O
,	O
imatinib	O
downregulated	O
gene1s	ARG2
IFNgamma	ARG2
gene1e	ARG2
-	O
related	O
genes	O
and	O
reduced	O
gene1s	ARG2
PD	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
expression	O
on	O
tumor	O
cells	O
.	O
gene1s	ARG2
PD-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
PD	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
blockade	O
in	O
vivo	O
each	O
had	O
no	O
efficacy	O
alone	O
but	O
enhanced	O
the	O
antitumor	O
effects	O
of	O
imatinib	O
by	O
increasing	O
T	O
-	O
cell	O
effector	O
function	O
in	O
the	O
presence	O
of	O
gene1s	ARG2
KIT	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IDO	ARG2
gene1e	ARG2
inhibition	O
.	O
CONCLUSIONS	O
:	O
gene1s	O
PD-1	O
gene1e	O
/	O
gene1s	O
PD	O
-	O
L1	O
gene1e	O
blockade	O
is	O
a	O
promising	O
strategy	O
to	O
improve	O
the	O
effects	O
of	O
targeted	O
therapy	O
in	O
GISTs	O
.	O
Collectively	O
,	O
our	O
results	O
provide	O
the	O
rationale	O
to	O
combine	O
these	O
agents	O
in	O
species1s	O
human	O
species1e	O
GISTs	O
.	O
Clin	O
Cancer	O
Res	O
;	O
23(2	O
)	O
;	O
454	O
-	O
65	O
.	O
2016	O
AACR	O
.	O

gene1s	O
FLT3	O
gene1e	O
-ITD	O
confers	O
resistance	O
to	O
the	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
pathway	O
inhibitors	O
by	O
protecting	O
the	O
gene1s	O
mTOR	O
gene1e	O
/	O
gene1s	O
4EBP1	O
gene1e	O
/	O
gene1s	O
Mcl-1	O
gene1e	O
pathway	O
through	O
gene1s	O
STAT5	O
gene1e	O
activation	O
in	O
acute	O
myeloid	O
leukemia	O
.	O
gene1s	O
FLT3	O
gene1e	O
-ITD	O
and	O
gene1s	O
FLT3	O
gene1e	O
-TKD	O
are	O
the	O
most	O
frequent	O
gene1s	O
tyrosine	O
kinase	O
gene1e	O
mutations	O
in	O
acute	O
myeloid	O
leukemia	O
(	O
AML	O
)	O
,	O
with	O
the	O
former	O
associated	O
with	O
poor	O
prognosis	O
.	O
Here	O
,	O
we	O
show	O
that	O
the	O
gene1s	O
PI3	O
K	O
gene1e	O
inhibitor	O
GDC-0941	O
or	O
the	O
gene1s	O
Akt	O
gene1e	O
inhibitor	O
MK-2206	O
induced	O
apoptosis	O
through	O
the	O
mitochondria	O
-	O
mediated	O
intrinsic	O
pathway	O
more	O
efficiently	O
in	O
hematopoietic	O
arg1s	O
32D	O
arg1e	O
cells	O
driven	O
by	O
gene1s	O
FLT3	O
gene1e	O
-TKD	O
(	O
32D	O
/	O
TKD	O
)	O
than	O
gene1s	O
FLT3	O
gene1e	O
-ITD	O
(	O
32D	O
/	O
ITD	O
)	O
,	O
which	O
robustly	O
activated	O
gene1s	ARG2
STAT5	ARG2
gene1e	ARG2
.	O
The	O
resistance	O
to	O
GDC-0941	O
and	O
MK-2206	O
was	O
gained	O
by	O
expression	O
of	O
the	O
constitutively	O
activated	O
gene1s	O
STAT5	O
gene1e	O
mutant	O
STAT	O
species1s	O
5A1	O
species1e	O
*	O
6	O
in	O
arg1s	O
32D	O
arg1e	O
/	O
TKD	O
cells	O
,	O
while	O
it	O
was	O
abrogated	O
by	O
the	O
gene1s	O
STAT5	O
gene1e	O
inhibitor	O
pimozide	O
in	O
arg1s	O
32D	O
arg1e	O
/	O
ITD	O
cells	O
or	O
gene1s	O
FLT3	O
gene1e	O
-ITD	O
-	O
expressing	O
species1s	O
human	O
species1e	O
leukemic	O
species1s	O
MV4	O
-	O
11	O
species1e	O
cells	O
.	O
GDC-0941	O
or	O
MK-2206	O
induced	O
dephosphorylation	O
of	O
gene1s	ARG2
4EBP1	ARG2
gene1e	ARG2
more	O
conspicuously	O
in	O
32D	O
/	O
TKD	O
than	O
in	O
32D	O
/	O
ITD	O
,	O
which	O
was	O
prevented	O
or	O
augmented	O
by	O
gene1s	ARG2
STAT5A	ARG2
gene1e	ARG2
1	O
*	O
6	O
or	O
pimozide	O
,	O
respectively	O
,	O
and	O
correlated	O
with	O
downregulation	O
of	O
the	O
gene1s	ARG2
eIF4E	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
eIF4	ARG2
G	ARG2
gene1e	ARG2
complex	O
formation	O
and	O
gene1s	ARG2
Mcl-1	ARG2
gene1e	ARG2
expression	O
.	O
Furthermore	O
,	O
exogenous	O
expression	O
of	O
gene1s	ARG2
Mcl-1	ARG2
gene1e	ARG2
endowed	O
resistance	O
to	O
GDC-0941	O
and	O
MK-2206	O
on	O
arg1s	O
32D	O
arg1e	O
/	O
TKD	O
cells	O
.	O
Finally	O
,	O
it	O
was	O
confirmed	O
in	O
primary	O
AML	O
cells	O
with	O
gene1s	O
FLT3	O
gene1e	O
-ITD	O
that	O
pimozide	O
enhanced	O
gene1s	O
4EBP1	O
gene1e	O
dephosphorylation	O
and	O
gene1s	O
Mcl-1	O
gene1e	O
downregulation	O
to	O
augment	O
cytotoxicity	O
of	O
GDC-0941	O
.	O
These	O
data	O
suggest	O
that	O
the	O
robust	O
gene1s	O
STAT5	O
gene1e	O
activation	O
by	O
gene1s	O
FLT3	O
gene1e	O
-ITD	O
protects	O
cells	O
treated	O
with	O
the	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
pathway	O
inhibitors	O
from	O
apoptosis	O
by	O
maintaining	O
gene1s	O
Mcl-1	O
gene1e	O
expression	O
through	O
the	O
gene1s	O
mTORC1	O
gene1e	O
/	O
gene1s	O
4EBP1	O
gene1e	O
/	O
gene1s	O
eIF4E	O
gene1e	O
pathway	O
.	O

gene1s	O
FLT3	O
gene1e	O
-ITD	O
confers	O
resistance	O
to	O
the	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
pathway	O
inhibitors	O
by	O
protecting	O
the	O
gene1s	O
mTOR	O
gene1e	O
/	O
gene1s	O
4EBP1	O
gene1e	O
/	O
gene1s	O
Mcl-1	O
gene1e	O
pathway	O
through	O
gene1s	O
STAT5	O
gene1e	O
activation	O
in	O
acute	O
myeloid	O
leukemia	O
.	O
gene1s	O
FLT3	O
gene1e	O
-ITD	O
and	O
gene1s	O
FLT3	O
gene1e	O
-TKD	O
are	O
the	O
most	O
frequent	O
gene1s	O
tyrosine	O
kinase	O
gene1e	O
mutations	O
in	O
acute	O
myeloid	O
leukemia	O
(	O
AML	O
)	O
,	O
with	O
the	O
former	O
associated	O
with	O
poor	O
prognosis	O
.	O
Here	O
,	O
we	O
show	O
that	O
the	O
gene1s	O
PI3	O
K	O
gene1e	O
inhibitor	O
GDC-0941	O
or	O
the	O
gene1s	O
Akt	O
gene1e	O
inhibitor	O
MK-2206	O
induced	O
apoptosis	O
through	O
the	O
mitochondria	O
-	O
mediated	O
intrinsic	O
pathway	O
more	O
efficiently	O
in	O
hematopoietic	O
species1s	O
32D	O
species1e	O
cells	O
driven	O
by	O
gene1s	O
FLT3	O
gene1e	O
-TKD	O
(	O
32D	O
/	O
TKD	O
)	O
than	O
gene1s	O
FLT3	O
gene1e	O
-ITD	O
(	O
32D	O
/	O
ITD	O
)	O
,	O
which	O
robustly	O
activated	O
gene1s	O
STAT5	O
gene1e	O
.	O
The	O
resistance	O
to	O
GDC-0941	O
and	O
MK-2206	O
was	O
gained	O
by	O
expression	O
of	O
the	O
constitutively	O
activated	O
gene1s	O
STAT5	O
gene1e	O
mutant	O
STAT	O
arg1s	O
5A1	O
arg1e	O
*	O
6	O
in	O
species1s	O
32D	O
species1e	O
/	O
TKD	O
cells	O
,	O
while	O
it	O
was	O
abrogated	O
by	O
the	O
gene1s	O
STAT5	O
gene1e	O
inhibitor	O
pimozide	O
in	O
species1s	O
32D	O
species1e	O
/	O
ITD	O
cells	O
or	O
gene1s	O
FLT3	O
gene1e	O
-ITD	O
-	O
expressing	O
species1s	O
human	O
species1e	O
leukemic	O
species1s	O
MV4	O
-	O
11	O
species1e	O
cells	O
.	O
GDC-0941	O
or	O
MK-2206	O
induced	O
dephosphorylation	O
of	O
gene1s	O
4EBP1	O
gene1e	O
more	O
conspicuously	O
in	O
32D	O
/	O
TKD	O
than	O
in	O
32D	O
/	O
ITD	O
,	O
which	O
was	O
prevented	O
or	O
augmented	O
by	O
gene1s	O
STAT5A	O
gene1e	O
1	O
*	O
6	O
or	O
pimozide	O
,	O
respectively	O
,	O
and	O
correlated	O
with	O
downregulation	O
of	O
the	O
gene1s	O
eIF4E	O
gene1e	O
/	O
gene1s	O
eIF4	O
G	O
gene1e	O
complex	O
formation	O
and	O
gene1s	O
Mcl-1	O
gene1e	O
expression	O
.	O
Furthermore	O
,	O
exogenous	O
expression	O
of	O
gene1s	O
Mcl-1	O
gene1e	O
endowed	O
resistance	O
to	O
GDC-0941	O
and	O
MK-2206	O
on	O
species1s	O
32D	O
species1e	O
/	O
TKD	O
cells	O
.	O
Finally	O
,	O
it	O
was	O
confirmed	O
in	O
primary	O
AML	O
cells	O
with	O
gene1s	O
FLT3	O
gene1e	O
-ITD	O
that	O
pimozide	O
enhanced	O
gene1s	O
4EBP1	O
gene1e	O
dephosphorylation	O
and	O
gene1s	O
Mcl-1	O
gene1e	O
downregulation	O
to	O
augment	O
cytotoxicity	O
of	O
GDC-0941	O
.	O
These	O
data	O
suggest	O
that	O
the	O
robust	O
gene1s	O
STAT5	O
gene1e	O
activation	O
by	O
gene1s	O
FLT3	O
gene1e	O
-ITD	O
protects	O
cells	O
treated	O
with	O
the	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
pathway	O
inhibitors	O
from	O
apoptosis	O
by	O
maintaining	O
gene1s	O
Mcl-1	O
gene1e	O
expression	O
through	O
the	O
gene1s	O
mTORC1	O
gene1e	O
/	O
gene1s	O
4EBP1	O
gene1e	O
/	O
gene1s	O
eIF4E	O
gene1e	O
pathway	O
.	O

gene1s	ARG2
FLT3	ARG2
gene1e	ARG2
-ITD	O
confers	O
resistance	O
to	O
the	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
pathway	O
inhibitors	O
by	O
protecting	O
the	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
4EBP1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Mcl-1	ARG2
gene1e	ARG2
pathway	O
through	O
gene1s	ARG2
STAT5	ARG2
gene1e	ARG2
activation	O
in	O
acute	O
myeloid	O
leukemia	O
.	O
gene1s	ARG2
FLT3	ARG2
gene1e	ARG2
-ITD	O
and	O
gene1s	ARG2
FLT3	ARG2
gene1e	ARG2
-TKD	O
are	O
the	O
most	O
frequent	O
gene1s	ARG2
tyrosine	ARG2
kinase	ARG2
gene1e	ARG2
mutations	O
in	O
acute	O
myeloid	O
leukemia	O
(	O
AML	O
)	O
,	O
with	O
the	O
former	O
associated	O
with	O
poor	O
prognosis	O
.	O
Here	O
,	O
we	O
show	O
that	O
the	O
gene1s	ARG2
PI3	ARG2
K	ARG2
gene1e	ARG2
inhibitor	O
GDC-0941	O
or	O
the	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
inhibitor	O
MK-2206	O
induced	O
apoptosis	O
through	O
the	O
mitochondria	O
-	O
mediated	O
intrinsic	O
pathway	O
more	O
efficiently	O
in	O
hematopoietic	O
species1s	O
32D	O
species1e	O
cells	O
driven	O
by	O
gene1s	ARG2
FLT3	ARG2
gene1e	ARG2
-TKD	O
(	O
32D	O
/	O
TKD	O
)	O
than	O
gene1s	ARG2
FLT3	ARG2
gene1e	ARG2
-ITD	O
(	O
32D	O
/	O
ITD	O
)	O
,	O
which	O
robustly	O
activated	O
gene1s	O
STAT5	O
gene1e	O
.	O
The	O
resistance	O
to	O
GDC-0941	O
and	O
MK-2206	O
was	O
gained	O
by	O
expression	O
of	O
the	O
constitutively	O
activated	O
gene1s	ARG2
STAT5	ARG2
gene1e	ARG2
mutant	O
STAT	O
species1s	O
5A1	O
species1e	O
*	O
6	O
in	O
species1s	O
32D	O
species1e	O
/	O
TKD	O
cells	O
,	O
while	O
it	O
was	O
abrogated	O
by	O
the	O
gene1s	ARG2
STAT5	ARG2
gene1e	ARG2
inhibitor	O
pimozide	O
in	O
species1s	O
32D	O
species1e	O
/	O
ITD	O
cells	O
or	O
gene1s	ARG2
FLT3	ARG2
gene1e	ARG2
-ITD	O
-	O
expressing	O
arg1s	O
human	O
arg1e	O
leukemic	O
arg1s	O
MV4	O
-	O
11	O
arg1e	O
cells	O
.	O
GDC-0941	O
or	O
MK-2206	O
induced	O
dephosphorylation	O
of	O
gene1s	O
4EBP1	O
gene1e	O
more	O
conspicuously	O
in	O
32D	O
/	O
TKD	O
than	O
in	O
32D	O
/	O
ITD	O
,	O
which	O
was	O
prevented	O
or	O
augmented	O
by	O
gene1s	O
STAT5A	O
gene1e	O
1	O
*	O
6	O
or	O
pimozide	O
,	O
respectively	O
,	O
and	O
correlated	O
with	O
downregulation	O
of	O
the	O
gene1s	O
eIF4E	O
gene1e	O
/	O
gene1s	O
eIF4	O
G	O
gene1e	O
complex	O
formation	O
and	O
gene1s	O
Mcl-1	O
gene1e	O
expression	O
.	O
Furthermore	O
,	O
exogenous	O
expression	O
of	O
gene1s	O
Mcl-1	O
gene1e	O
endowed	O
resistance	O
to	O
GDC-0941	O
and	O
MK-2206	O
on	O
species1s	O
32D	O
species1e	O
/	O
TKD	O
cells	O
.	O
Finally	O
,	O
it	O
was	O
confirmed	O
in	O
primary	O
AML	O
cells	O
with	O
gene1s	ARG2
FLT3	ARG2
gene1e	ARG2
-ITD	O
that	O
pimozide	O
enhanced	O
gene1s	ARG2
4EBP1	ARG2
gene1e	ARG2
dephosphorylation	O
and	O
gene1s	ARG2
Mcl-1	ARG2
gene1e	ARG2
downregulation	O
to	O
augment	O
cytotoxicity	O
of	O
GDC-0941	O
.	O
These	O
data	O
suggest	O
that	O
the	O
robust	O
gene1s	ARG2
STAT5	ARG2
gene1e	ARG2
activation	O
by	O
gene1s	ARG2
FLT3	ARG2
gene1e	ARG2
-ITD	O
protects	O
cells	O
treated	O
with	O
the	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
pathway	O
inhibitors	O
from	O
apoptosis	O
by	O
maintaining	O
gene1s	ARG2
Mcl-1	ARG2
gene1e	ARG2
expression	O
through	O
the	O
gene1s	ARG2
mTORC1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
4EBP1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
eIF4E	ARG2
gene1e	ARG2
pathway	O
.	O

gene1s	ARG2
Oxidized	ARG2
LDL	ARG2
receptor	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
OLR1	ARG2
gene1e	ARG2
)	O
as	O
a	O
possible	O
link	O
between	O
obesity	O
,	O
dyslipidemia	O
and	O
cancer	O
.	O
Recent	O
studies	O
have	O
linked	O
expression	O
of	O
gene1s	ARG2
lectin	ARG2
-	ARG2
like	ARG2
ox	ARG2
-	ARG2
LDL	ARG2
receptor	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
OLR1	ARG2
gene1e	ARG2
)	O
to	O
tumorigenesis	O
.	O
We	O
analyzed	O
microarray	O
data	O
from	O
gene1s	ARG2
Olr1	ARG2
gene1e	ARG2
knockout	O
(	O
KO	O
)	O
and	O
wild	O
type	O
(	O
WT	O
)	O
arg1s	O
mice	O
arg1e	O
for	O
genes	O
involved	O
in	O
cellular	O
transformation	O
and	O
evaluated	O
effects	O
of	O
gene1s	ARG2
OLR1	ARG2
gene1e	ARG2
over	O
-	O
expression	O
in	O
normal	O
mammary	O
epithelial	O
cells	O
(	O
species1s	O
MCF10A	O
species1e	O
)	O
and	O
breast	O
cancer	O
cells	O
(	O
HCC1143	O
)	O
in	O
terms	O
of	O
gene	O
expression	O
,	O
migration	O
,	O
adhesion	O
and	O
transendothelial	O
migration	O
.	O
Twenty	O
-	O
six	O
out	O
of	O
238	O
genes	O
were	O
inhibited	O
in	O
tissues	O
of	O
gene1s	ARG2
OLR1	ARG2
gene1e	ARG2
KO	O
arg1s	O
mice	O
arg1e	O
;	O
the	O
vast	O
majority	O
of	O
gene1s	ARG2
OLR1	ARG2
gene1e	ARG2
sensitive	O
genes	O
contained	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
binding	O
sites	O
in	O
their	O
promoters	O
.	O
Further	O
studies	O
revealed	O
broad	O
inhibition	O
of	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
target	O
genes	O
outside	O
of	O
the	O
transformation	O
-	O
associated	O
gene	O
pool	O
,	O
with	O
enrichment	O
themes	O
of	O
defense	O
response	O
,	O
immune	O
response	O
,	O
apoptosis	O
,	O
proliferation	O
,	O
and	O
wound	O
healing	O
.	O
Transcriptome	O
of	O
gene1s	O
Olr1	O
gene1e	O
KO	O
arg1s	O
mice	O
arg1e	O
also	O
revealed	O
inhibition	O
of	O
de	O
novo	O
lipogenesis	O
,	O
rate	O
-	O
limiting	O
enzymes	O
gene1s	ARG2
fatty	ARG2
acid	ARG2
synthase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Fasn	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
stearoyl	ARG2
-	ARG2
CoA	ARG2
desaturase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Scd1	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
ELOVL	ARG2
family	ARG2
member	ARG2
6	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Elovl6	ARG2
gene1e	ARG2
)	O
,	O
as	O
well	O
as	O
lipolytic	O
gene1s	ARG2
phospholipase	ARG2
A2	ARG2
group	ARG2
IVB	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Pla2g4b	ARG2
gene1e	ARG2
)	O
.	O
In	O
studies	O
comparing	O
MCF10A	O
and	O
HCC1143	O
,	O
the	O
latter	O
displayed	O
60	O
%	O
higher	O
gene1s	O
OLR1	O
gene1e	O
expression	O
.	O
Forced	O
over	O
-	O
expression	O
of	O
gene1s	O
OLR1	O
gene1e	O
resulted	O
in	O
upregulation	O
of	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
(	O
gene1s	O
p65	O
gene1e	O
)	O
and	O
its	O
target	O
pro	O
-	O
oncogenes	O
involved	O
in	O
inhibition	O
of	O
apoptosis	O
(	O
gene1s	O
BCL2	O
gene1e	O
,	O
gene1s	O
BCL2A1	O
gene1e	O
,	O
gene1s	O
TNFAIP3	O
gene1e	O
)	O
and	O
regulation	O
of	O
cell	O
cycle	O
(	O
gene1s	O
CCND2	O
gene1e	O
)	O
in	O
both	O
cell	O
lines	O
.	O
Basal	O
expression	O
of	O
gene1s	O
FASN	O
gene1e	O
,	O
gene1s	O
SCD1	O
gene1e	O
and	O
gene1s	O
PLA2G4B	O
gene1e	O
,	O
as	O
well	O
as	O
lipogenesis	O
gene1s	O
transcription	O
factors	O
gene1e	O
gene1s	O
PPARA	O
gene1e	O
,	O
gene1s	O
SREBF2	O
gene1e	O
and	O
gene1s	O
CREM	O
gene1e	O
,	O
was	O
higher	O
in	O
species1s	O
HCC1143	O
species1e	O
cells	O
.	O
Over	O
-	O
expression	O
of	O
gene1s	O
OLR1	O
gene1e	O
in	O
species1s	O
HCC1143	O
species1e	O
cells	O
also	O
enhanced	O
cell	O
migration	O
,	O
without	O
affecting	O
their	O
adherence	O
to	O
gene1s	O
TNFa	O
gene1e	O
-	O
activated	O
endothelium	O
or	O
transendothelial	O
migration	O
.	O
On	O
the	O
other	O
hand	O
,	O
gene1s	O
OLR1	O
gene1e	O
neutralizing	O
antibody	O
inhibited	O
both	O
adhesion	O
and	O
transmigration	O
of	O
untreated	O
species1s	O
HCC1143	O
species1e	O
cells	O
.	O
We	O
conclude	O
that	O
gene1s	O
OLR1	O
gene1e	O
may	O
act	O
as	O
an	O
oncogene	O
by	O
activation	O
of	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
target	O
genes	O
responsible	O
for	O
proliferation	O
,	O
migration	O
and	O
inhibition	O
of	O
apoptosis	O
and	O
de	O
novo	O
lipogenesis	O
genes	O
.	O

gene1s	ARG2
Oxidized	ARG2
LDL	ARG2
receptor	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
OLR1	ARG2
gene1e	ARG2
)	O
as	O
a	O
possible	O
link	O
between	O
obesity	O
,	O
dyslipidemia	O
and	O
cancer	O
.	O
Recent	O
studies	O
have	O
linked	O
expression	O
of	O
gene1s	ARG2
lectin	ARG2
-	ARG2
like	ARG2
ox	ARG2
-	ARG2
LDL	ARG2
receptor	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
OLR1	ARG2
gene1e	ARG2
)	O
to	O
tumorigenesis	O
.	O
We	O
analyzed	O
microarray	O
data	O
from	O
gene1s	O
Olr1	O
gene1e	O
knockout	O
(	O
KO	O
)	O
and	O
wild	O
type	O
(	O
WT	O
)	O
species1s	O
mice	O
species1e	O
for	O
genes	O
involved	O
in	O
cellular	O
transformation	O
and	O
evaluated	O
effects	O
of	O
gene1s	O
OLR1	O
gene1e	O
over	O
-	O
expression	O
in	O
normal	O
mammary	O
epithelial	O
cells	O
(	O
arg1s	O
MCF10A	O
arg1e	O
)	O
and	O
breast	O
cancer	O
cells	O
(	O
HCC1143	O
)	O
in	O
terms	O
of	O
gene	O
expression	O
,	O
migration	O
,	O
adhesion	O
and	O
transendothelial	O
migration	O
.	O
Twenty	O
-	O
six	O
out	O
of	O
238	O
genes	O
were	O
inhibited	O
in	O
tissues	O
of	O
gene1s	O
OLR1	O
gene1e	O
KO	O
species1s	O
mice	O
species1e	O
;	O
the	O
vast	O
majority	O
of	O
gene1s	O
OLR1	O
gene1e	O
sensitive	O
genes	O
contained	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
binding	O
sites	O
in	O
their	O
promoters	O
.	O
Further	O
studies	O
revealed	O
broad	O
inhibition	O
of	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
target	O
genes	O
outside	O
of	O
the	O
transformation	O
-	O
associated	O
gene	O
pool	O
,	O
with	O
enrichment	O
themes	O
of	O
defense	O
response	O
,	O
immune	O
response	O
,	O
apoptosis	O
,	O
proliferation	O
,	O
and	O
wound	O
healing	O
.	O
Transcriptome	O
of	O
gene1s	ARG2
Olr1	ARG2
gene1e	ARG2
KO	O
species1s	O
mice	O
species1e	O
also	O
revealed	O
inhibition	O
of	O
de	O
novo	O
lipogenesis	O
,	O
rate	O
-	O
limiting	O
enzymes	O
gene1s	O
fatty	O
acid	O
synthase	O
gene1e	O
(	O
gene1s	O
Fasn	O
gene1e	O
)	O
,	O
gene1s	O
stearoyl	O
-	O
CoA	O
desaturase	O
gene1e	O
(	O
gene1s	O
Scd1	O
gene1e	O
)	O
and	O
gene1s	O
ELOVL	O
family	O
member	O
6	O
gene1e	O
(	O
gene1s	O
Elovl6	O
gene1e	O
)	O
,	O
as	O
well	O
as	O
lipolytic	O
gene1s	O
phospholipase	O
A2	O
group	O
IVB	O
gene1e	O
(	O
gene1s	O
Pla2g4b	O
gene1e	O
)	O
.	O
In	O
studies	O
comparing	O
MCF10A	O
and	O
HCC1143	O
,	O
the	O
latter	O
displayed	O
60	O
%	O
higher	O
gene1s	ARG2
OLR1	ARG2
gene1e	ARG2
expression	O
.	O
Forced	O
over	O
-	O
expression	O
of	O
gene1s	ARG2
OLR1	ARG2
gene1e	ARG2
resulted	O
in	O
upregulation	O
of	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
p65	ARG2
gene1e	ARG2
)	O
and	O
its	O
target	O
pro	O
-	O
oncogenes	O
involved	O
in	O
inhibition	O
of	O
apoptosis	O
(	O
gene1s	ARG2
BCL2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
BCL2A1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TNFAIP3	ARG2
gene1e	ARG2
)	O
and	O
regulation	O
of	O
cell	O
cycle	O
(	O
gene1s	ARG2
CCND2	ARG2
gene1e	ARG2
)	O
in	O
both	O
cell	O
lines	O
.	O
Basal	O
expression	O
of	O
gene1s	ARG2
FASN	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SCD1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
PLA2G4B	ARG2
gene1e	ARG2
,	O
as	O
well	O
as	O
lipogenesis	O
gene1s	ARG2
transcription	ARG2
factors	ARG2
gene1e	ARG2
gene1s	ARG2
PPARA	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SREBF2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CREM	ARG2
gene1e	ARG2
,	O
was	O
higher	O
in	O
arg1s	O
HCC1143	O
arg1e	O
cells	O
.	O
Over	O
-	O
expression	O
of	O
gene1s	ARG2
OLR1	ARG2
gene1e	ARG2
in	O
arg1s	O
HCC1143	O
arg1e	O
cells	O
also	O
enhanced	O
cell	O
migration	O
,	O
without	O
affecting	O
their	O
adherence	O
to	O
gene1s	ARG2
TNFa	ARG2
gene1e	ARG2
-	O
activated	O
endothelium	O
or	O
transendothelial	O
migration	O
.	O
On	O
the	O
other	O
hand	O
,	O
gene1s	ARG2
OLR1	ARG2
gene1e	ARG2
neutralizing	O
antibody	O
inhibited	O
both	O
adhesion	O
and	O
transmigration	O
of	O
untreated	O
arg1s	O
HCC1143	O
arg1e	O
cells	O
.	O
We	O
conclude	O
that	O
gene1s	ARG2
OLR1	ARG2
gene1e	ARG2
may	O
act	O
as	O
an	O
oncogene	O
by	O
activation	O
of	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
target	O
genes	O
responsible	O
for	O
proliferation	O
,	O
migration	O
and	O
inhibition	O
of	O
apoptosis	O
and	O
de	O
novo	O
lipogenesis	O
genes	O
.	O

gene1s	ARG2
miR-21	ARG2
gene1e	ARG2
ablation	O
and	O
obeticholic	O
acid	O
ameliorate	O
nonalcoholic	O
steatohepatitis	O
in	O
arg1s	O
mice	O
arg1e	O
.	O
microRNAs	O
were	O
recently	O
suggested	O
to	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
nonalcoholic	O
fatty	O
liver	O
disease	O
(	O
NAFLD	O
)	O
,	O
a	O
disease	O
lacking	O
specific	O
pharmacological	O
treatments	O
.	O
In	O
that	O
regard	O
,	O
nuclear	O
receptors	O
are	O
arising	O
as	O
key	O
molecular	O
targets	O
for	O
the	O
treatment	O
of	O
nonalcoholic	O
steatohepatitis	O
(	O
NASH	O
)	O
.	O
Here	O
we	O
show	O
that	O
,	O
in	O
a	O
typical	O
model	O
of	O
NASH	O
-	O
associated	O
liver	O
damage	O
,	O
gene1s	ARG2
microRNA-21	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
miR-21	ARG2
gene1e	ARG2
)	O
ablation	O
results	O
in	O
a	O
progressive	O
decrease	O
in	O
steatosis	O
,	O
inflammation	O
and	O
lipoapoptosis	O
,	O
with	O
impairment	O
of	O
fibrosis	O
.	O
In	O
a	O
complementary	O
fast	O
food	O
(	O
FF	O
)	O
diet	O
NASH	O
model	O
,	O
mimicking	O
features	O
of	O
the	O
metabolic	O
syndrome	O
,	O
gene1s	ARG2
miR-21	ARG2
gene1e	ARG2
levels	O
increase	O
in	O
both	O
liver	O
and	O
muscle	O
,	O
concomitantly	O
with	O
decreased	O
expression	O
of	O
gene1s	ARG2
peroxisome	ARG2
proliferator	ARG2
-	ARG2
activated	ARG2
receptor	ARG2
a	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
)	O
,	O
a	O
key	O
gene1s	ARG2
miR-21	ARG2
gene1e	ARG2
target	O
.	O
Strikingly	O
,	O
gene1s	ARG2
miR-21	ARG2
gene1e	ARG2
knockout	O
arg1s	O
mice	O
arg1e	O
fed	O
the	O
FF	O
diet	O
supplemented	O
with	O
gene1s	ARG2
farnesoid	ARG2
X	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
FXR	ARG2
gene1e	ARG2
)	O
agonist	O
obeticholic	O
acid	O
(	O
OCA	O
)	O
display	O
minimal	O
steatosis	O
,	O
inflammation	O
,	O
oxidative	O
stress	O
and	O
cholesterol	O
accumulation	O
.	O
In	O
addition	O
,	O
lipoprotein	O
metabolism	O
was	O
restored	O
,	O
including	O
decreased	O
fatty	O
acid	O
uptake	O
and	O
polyunsaturation	O
,	O
and	O
liver	O
and	O
muscle	O
insulin	O
sensitivity	O
fully	O
reinstated	O
.	O
Finally	O
,	O
the	O
gene1s	O
miR-21	O
gene1e	O
/	O
gene1s	O
PPARa	O
gene1e	O
axis	O
was	O
found	O
amplified	O
in	O
liver	O
and	O
muscle	O
biopsies	O
,	O
and	O
in	O
serum	O
,	O
of	O
NAFLD	O
species1s	O
patients	O
species1e	O
,	O
co	O
-	O
substantiating	O
its	O
role	O
in	O
the	O
development	O
of	O
the	O
metabolic	O
syndrome	O
.	O
By	O
unveiling	O
that	O
gene1s	ARG2
miR-21	ARG2
gene1e	ARG2
abrogation	O
,	O
together	O
with	O
gene1s	ARG2
FXR	ARG2
gene1e	ARG2
activation	O
by	O
OCA	O
,	O
significantly	O
improves	O
whole	O
body	O
metabolic	O
parameters	O
in	O
NASH	O
,	O
our	O
results	O
highlight	O
the	O
therapeutic	O
potential	O
of	O
nuclear	O
receptor	O
multi	O
-	O
targeting	O
therapies	O
for	O
NAFLD	O
.	O

gene1s	O
miR-21	O
gene1e	O
ablation	O
and	O
obeticholic	O
acid	O
ameliorate	O
nonalcoholic	O
steatohepatitis	O
in	O
species1s	O
mice	O
species1e	O
.	O
microRNAs	O
were	O
recently	O
suggested	O
to	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
nonalcoholic	O
fatty	O
liver	O
disease	O
(	O
NAFLD	O
)	O
,	O
a	O
disease	O
lacking	O
specific	O
pharmacological	O
treatments	O
.	O
In	O
that	O
regard	O
,	O
nuclear	O
receptors	O
are	O
arising	O
as	O
key	O
molecular	O
targets	O
for	O
the	O
treatment	O
of	O
nonalcoholic	O
steatohepatitis	O
(	O
NASH	O
)	O
.	O
Here	O
we	O
show	O
that	O
,	O
in	O
a	O
typical	O
model	O
of	O
NASH	O
-	O
associated	O
liver	O
damage	O
,	O
gene1s	O
microRNA-21	O
gene1e	O
(	O
gene1s	O
miR-21	O
gene1e	O
)	O
ablation	O
results	O
in	O
a	O
progressive	O
decrease	O
in	O
steatosis	O
,	O
inflammation	O
and	O
lipoapoptosis	O
,	O
with	O
impairment	O
of	O
fibrosis	O
.	O
In	O
a	O
complementary	O
fast	O
food	O
(	O
FF	O
)	O
diet	O
NASH	O
model	O
,	O
mimicking	O
features	O
of	O
the	O
metabolic	O
syndrome	O
,	O
gene1s	O
miR-21	O
gene1e	O
levels	O
increase	O
in	O
both	O
liver	O
and	O
muscle	O
,	O
concomitantly	O
with	O
decreased	O
expression	O
of	O
gene1s	O
peroxisome	O
proliferator	O
-	O
activated	O
receptor	O
a	O
gene1e	O
(	O
gene1s	O
PPARa	O
gene1e	O
)	O
,	O
a	O
key	O
gene1s	O
miR-21	O
gene1e	O
target	O
.	O
Strikingly	O
,	O
gene1s	O
miR-21	O
gene1e	O
knockout	O
species1s	O
mice	O
species1e	O
fed	O
the	O
FF	O
diet	O
supplemented	O
with	O
gene1s	O
farnesoid	O
X	O
receptor	O
gene1e	O
(	O
gene1s	O
FXR	O
gene1e	O
)	O
agonist	O
obeticholic	O
acid	O
(	O
OCA	O
)	O
display	O
minimal	O
steatosis	O
,	O
inflammation	O
,	O
oxidative	O
stress	O
and	O
cholesterol	O
accumulation	O
.	O
In	O
addition	O
,	O
lipoprotein	O
metabolism	O
was	O
restored	O
,	O
including	O
decreased	O
fatty	O
acid	O
uptake	O
and	O
polyunsaturation	O
,	O
and	O
liver	O
and	O
muscle	O
insulin	O
sensitivity	O
fully	O
reinstated	O
.	O
Finally	O
,	O
the	O
gene1s	ARG2
miR-21	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
axis	O
was	O
found	O
amplified	O
in	O
liver	O
and	O
muscle	O
biopsies	O
,	O
and	O
in	O
serum	O
,	O
of	O
NAFLD	O
arg1s	O
patients	O
arg1e	O
,	O
co	O
-	O
substantiating	O
its	O
role	O
in	O
the	O
development	O
of	O
the	O
metabolic	O
syndrome	O
.	O
By	O
unveiling	O
that	O
gene1s	O
miR-21	O
gene1e	O
abrogation	O
,	O
together	O
with	O
gene1s	O
FXR	O
gene1e	O
activation	O
by	O
OCA	O
,	O
significantly	O
improves	O
whole	O
body	O
metabolic	O
parameters	O
in	O
NASH	O
,	O
our	O
results	O
highlight	O
the	O
therapeutic	O
potential	O
of	O
nuclear	O
receptor	O
multi	O
-	O
targeting	O
therapies	O
for	O
NAFLD	O
.	O

gene1s	ARG2
Miz1	ARG2
gene1e	ARG2
deficiency	O
in	O
the	O
mammary	O
gland	O
causes	O
a	O
lactation	O
defect	O
by	O
attenuated	O
gene1s	ARG2
Stat5	ARG2
gene1e	ARG2
expression	O
and	O
phosphorylation	O
.	O
gene1s	ARG2
Miz1	ARG2
gene1e	ARG2
is	O
a	O
gene1s	ARG2
zinc	ARG2
finger	ARG2
transcription	ARG2
factor	ARG2
gene1e	ARG2
with	O
an	O
N	O
-	O
terminal	O
POZ	O
domain	O
.	O
Complexes	O
with	O
gene1s	ARG2
Myc	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Bcl-6	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
Gfi-1	ARG2
gene1e	ARG2
repress	O
expression	O
of	O
genes	O
like	O
gene1s	ARG2
Cdkn2b	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
p15(Ink4	ARG2
)	ARG2
gene1e	ARG2
)	O
or	O
gene1s	ARG2
Cdkn1a	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
p21(Cip1	ARG2
)	ARG2
gene1e	ARG2
)	O
.	O
The	O
role	O
of	O
gene1s	ARG2
Miz1	ARG2
gene1e	ARG2
in	O
normal	O
mammary	O
gland	O
development	O
has	O
not	O
been	O
addressed	O
so	O
far	O
.	O
Conditional	O
knockout	O
of	O
the	O
gene1s	ARG2
Miz1	ARG2
gene1e	ARG2
POZ	O
domain	O
in	O
luminal	O
cells	O
during	O
pregnancy	O
caused	O
a	O
lactation	O
defect	O
with	O
a	O
transient	O
reduction	O
of	O
glandular	O
tissue	O
,	O
reduced	O
proliferation	O
and	O
attenuated	O
differentiation	O
.	O
This	O
was	O
recapitulated	O
in	O
vitro	O
using	O
arg1s	O
mouse	O
arg1e	O
mammary	O
gland	O
derived	O
HC11	O
cells	O
.	O
Further	O
analysis	O
revealed	O
decreased	O
gene1s	ARG2
Stat5	ARG2
gene1e	ARG2
activity	O
in	O
Miz1DPOZ	O
mammary	O
glands	O
and	O
an	O
attenuated	O
expression	O
of	O
gene1s	ARG2
Stat5	ARG2
gene1e	ARG2
targets	O
.	O
Gene	O
expression	O
of	O
the	O
gene1s	ARG2
Prolactin	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PrlR	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
ErbB4	ARG2
gene1e	ARG2
,	O
both	O
critical	O
for	O
gene1s	ARG2
Stat5	ARG2
gene1e	ARG2
phosphorylation	O
(	O
gene1s	ARG2
pStat5	ARG2
)	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
pStat5	ARG2
gene1e	ARG2
nuclear	O
translocation	O
,	O
was	O
decreased	O
in	O
Miz1DPOZ	O
females	O
.	O
Microarray	O
,	O
ChIP	O
-	O
Seq	O
and	O
gene	O
set	O
enrichment	O
analysis	O
revealed	O
a	O
down	O
-	O
regulation	O
of	O
gene1s	ARG2
Miz1	ARG2
gene1e	ARG2
target	O
genes	O
being	O
involved	O
in	O
vesicular	O
transport	O
processes	O
.	O
Our	O
data	O
suggest	O
that	O
deranged	O
intracellular	O
transport	O
and	O
localization	O
of	O
gene1s	ARG2
PrlR	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ErbB4	ARG2
gene1e	ARG2
disrupt	O
the	O
gene1s	ARG2
Stat5	ARG2
gene1e	ARG2
signalling	O
pathway	O
in	O
mutant	O
glands	O
and	O
cause	O
the	O
observed	O
lactation	O
phenotype	O
.	O

Over	O
-	O
expression	O
of	O
gene1s	O
ubiquitin	O
carboxy	O
terminal	O
hydrolase	O
-	O
L1	O
gene1e	O
induces	O
apoptosis	O
in	O
breast	O
cancer	O
cells	O
.	O
gene1s	O
Ubiquitin	O
carboxy	O
terminal	O
hydrolase	O
-	O
L1	O
gene1e	O
(	O
gene1s	O
UCH	O
-	O
L1	O
gene1e	O
)	O
belongs	O
to	O
the	O
gene1s	O
UCH	O
proteases	O
family	O
gene1e	O
that	O
deubiquitinates	O
gene1s	O
ubiquitin	O
gene1e	O
-	O
protein	O
conjugates	O
in	O
the	O
gene1s	O
ubiquitin	O
gene1e	O
-	O
proteasome	O
system	O
.	O
Previous	O
research	O
showed	O
that	O
gene1s	O
UCH	O
-	O
L1	O
gene1e	O
was	O
expressed	O
in	O
arg1s	O
mouse	O
arg1e	O
retinal	O
cells	O
and	O
testicular	O
germ	O
cells	O
,	O
and	O
its	O
function	O
was	O
associated	O
with	O
apoptosis	O
.	O
But	O
it	O
is	O
still	O
unclear	O
whether	O
gene1s	O
UCH	O
-	O
L1	O
gene1e	O
is	O
concerned	O
with	O
apoptosis	O
in	O
tumor	O
cells	O
.	O
In	O
order	O
to	O
clarify	O
the	O
role	O
of	O
gene1s	O
UCH	O
-	O
L1	O
gene1e	O
in	O
tumor	O
cells	O
,	O
multi	O
-	O
drug	O
resistance	O
(	O
MDR	O
)	O
species1s	O
human	O
species1e	O
breast	O
carcinoma	O
cell	O
line	O
MCF7	O
/	O
Adr	O
,	O
that	O
expresses	O
relatively	O
high	O
gene1s	O
UCH	O
-	O
L1	O
gene1e	O
,	O
and	O
its	O
parental	O
cell	O
line	O
MCF7	O
,	O
that	O
expresses	O
relatively	O
low	O
gene1s	O
UCH	O
-	O
L1	O
gene1e	O
,	O
were	O
chosen	O
for	O
this	O
study	O
.	O
We	O
transfected	O
pcDNA3.1-	O
gene1s	O
UCH	O
-	O
L1	O
gene1e	O
plasmid	O
and	O
gene1s	O
UCH	O
-	O
L1	O
gene1e	O
siRNA	O
into	O
species1s	O
MCF7	O
species1e	O
and	O
species1s	O
MCF7	O
/	O
Adr	O
species1e	O
cells	O
,	O
respectively	O
.	O
Using	O
3-(4,5-dimethylthiazol-2-yl)-2	O
,	O
5-diphenyltetrazolium	O
bromide	O
(	O
MTT	O
)	O
assay	O
,	O
western	O
blot	O
,	O
Hoechst	O
33258	O
staining	O
assay	O
and	O
flow	O
cytometry	O
,	O
we	O
found	O
that	O
over	O
-	O
expression	O
of	O
gene1s	O
UCH	O
-	O
L1	O
gene1e	O
in	O
species1s	O
MCF7	O
species1e	O
cells	O
induced	O
apoptosis	O
.	O
On	O
the	O
other	O
hand	O
,	O
silencing	O
of	O
gene1s	O
UCH	O
-	O
L1	O
gene1e	O
in	O
species1s	O
MCF7	O
/	O
Adr	O
species1e	O
cells	O
led	O
to	O
the	O
opposite	O
effect	O
.	O
Moreover	O
,	O
to	O
explore	O
the	O
mechanism	O
underling	O
these	O
observations	O
,	O
we	O
further	O
investigated	O
the	O
expression	O
of	O
phospho	O
-	O
gene1s	O
Akt	O
gene1e	O
and	O
its	O
downstream	O
signal	O
phospho	O
-	O
IkB	O
-	O
alpha	O
and	O
other	O
signal	O
molecules	O
including	O
gene1s	O
Fas	O
gene1e	O
,	O
gene1s	O
Fas	O
-	O
L	O
gene1e	O
,	O
gene1s	O
Trail	O
gene1e	O
,	O
gene1s	O
DR4	O
gene1e	O
,	O
gene1s	O
DR5	O
gene1e	O
,	O
gene1s	O
Bax	O
gene1e	O
,	O
gene1s	O
cytochrome	O
C	O
gene1e	O
,	O
active	O
gene1s	O
caspase-3	O
gene1e	O
,	O
phospho	O
-	O
gene1s	O
p53	O
gene1e	O
,	O
phospho	O
-	O
gene1s	O
Mdm-2	O
gene1e	O
,	O
gene1s	O
Bcl-2	O
gene1e	O
,	O
gene1s	O
Bcl	O
-	O
xL	O
gene1e	O
,	O
gene1s	O
p21	O
gene1e	O
and	O
gene1s	O
p27	O
gene1e	O
.	O
The	O
results	O
indicated	O
that	O
the	O
process	O
of	O
apoptosis	O
triggered	O
by	O
gene1s	O
UCH	O
-	O
L1	O
gene1e	O
is	O
,	O
at	O
least	O
in	O
part	O
,	O
probably	O
through	O
gene1s	O
Phosphoinositide	O
3-kinase	O
gene1e	O
(	O
gene1s	O
PI3K	O
gene1e	O
)/	O
gene1s	O
Akt	O
gene1e	O
signal	O
pathway	O
.	O
Our	O
findings	O
suggest	O
that	O
modulating	O
the	O
ubiquitination	O
and	O
deubiquitination	O
pathway	O
could	O
be	O
a	O
novel	O
method	O
for	O
tumor	O
therapy	O
.	O

Over	O
-	O
expression	O
of	O
gene1s	ARG2
ubiquitin	ARG2
carboxy	ARG2
terminal	ARG2
hydrolase	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
induces	O
apoptosis	O
in	O
breast	O
cancer	O
cells	O
.	O
gene1s	ARG2
Ubiquitin	ARG2
carboxy	ARG2
terminal	ARG2
hydrolase	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
UCH	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
)	O
belongs	O
to	O
the	O
gene1s	ARG2
UCH	ARG2
proteases	ARG2
family	ARG2
gene1e	ARG2
that	O
deubiquitinates	O
gene1s	ARG2
ubiquitin	ARG2
gene1e	ARG2
-	O
protein	O
conjugates	O
in	O
the	O
gene1s	ARG2
ubiquitin	ARG2
gene1e	ARG2
-	O
proteasome	O
system	O
.	O
Previous	O
research	O
showed	O
that	O
gene1s	ARG2
UCH	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
was	O
expressed	O
in	O
species1s	O
mouse	O
species1e	O
retinal	O
cells	O
and	O
testicular	O
germ	O
cells	O
,	O
and	O
its	O
function	O
was	O
associated	O
with	O
apoptosis	O
.	O
But	O
it	O
is	O
still	O
unclear	O
whether	O
gene1s	ARG2
UCH	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
is	O
concerned	O
with	O
apoptosis	O
in	O
tumor	O
cells	O
.	O
In	O
order	O
to	O
clarify	O
the	O
role	O
of	O
gene1s	ARG2
UCH	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
in	O
tumor	O
cells	O
,	O
multi	O
-	O
drug	O
resistance	O
(	O
MDR	O
)	O
arg1s	O
human	O
arg1e	O
breast	O
carcinoma	O
cell	O
line	O
MCF7	O
/	O
Adr	O
,	O
that	O
expresses	O
relatively	O
high	O
gene1s	ARG2
UCH	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
,	O
and	O
its	O
parental	O
cell	O
line	O
MCF7	O
,	O
that	O
expresses	O
relatively	O
low	O
gene1s	ARG2
UCH	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
,	O
were	O
chosen	O
for	O
this	O
study	O
.	O
We	O
transfected	O
pcDNA3.1-	O
gene1s	ARG2
UCH	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
plasmid	O
and	O
gene1s	ARG2
UCH	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
siRNA	O
into	O
arg1s	O
MCF7	O
arg1e	O
and	O
arg1s	O
MCF7	O
/	O
Adr	O
arg1e	O
cells	O
,	O
respectively	O
.	O
Using	O
3-(4,5-dimethylthiazol-2-yl)-2	O
,	O
5-diphenyltetrazolium	O
bromide	O
(	O
MTT	O
)	O
assay	O
,	O
western	O
blot	O
,	O
Hoechst	O
33258	O
staining	O
assay	O
and	O
flow	O
cytometry	O
,	O
we	O
found	O
that	O
over	O
-	O
expression	O
of	O
gene1s	ARG2
UCH	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
in	O
arg1s	O
MCF7	O
arg1e	O
cells	O
induced	O
apoptosis	O
.	O
On	O
the	O
other	O
hand	O
,	O
silencing	O
of	O
gene1s	ARG2
UCH	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
in	O
arg1s	O
MCF7	O
/	O
Adr	O
arg1e	O
cells	O
led	O
to	O
the	O
opposite	O
effect	O
.	O
Moreover	O
,	O
to	O
explore	O
the	O
mechanism	O
underling	O
these	O
observations	O
,	O
we	O
further	O
investigated	O
the	O
expression	O
of	O
phospho	O
-	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
and	O
its	O
downstream	O
signal	O
phospho	O
-	O
IkB	O
-	O
alpha	O
and	O
other	O
signal	O
molecules	O
including	O
gene1s	ARG2
Fas	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Fas	ARG2
-	ARG2
L	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Trail	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
DR4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
DR5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
cytochrome	ARG2
C	ARG2
gene1e	ARG2
,	O
active	O
gene1s	ARG2
caspase-3	ARG2
gene1e	ARG2
,	O
phospho	O
-	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
,	O
phospho	O
-	O
gene1s	ARG2
Mdm-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Bcl	ARG2
-	ARG2
xL	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
p21	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p27	ARG2
gene1e	ARG2
.	O
The	O
results	O
indicated	O
that	O
the	O
process	O
of	O
apoptosis	O
triggered	O
by	O
gene1s	ARG2
UCH	ARG2
-	ARG2
L1	ARG2
gene1e	ARG2
is	O
,	O
at	O
least	O
in	O
part	O
,	O
probably	O
through	O
gene1s	ARG2
Phosphoinositide	ARG2
3-kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
)/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
signal	O
pathway	O
.	O
Our	O
findings	O
suggest	O
that	O
modulating	O
the	O
ubiquitination	O
and	O
deubiquitination	O
pathway	O
could	O
be	O
a	O
novel	O
method	O
for	O
tumor	O
therapy	O
.	O

Identification	O
of	O
a	O
unique	O
hepatocellular	O
carcinoma	O
line	O
,	O
arg1s	O
Li-7	O
arg1e	O
,	O
with	O
gene1s	ARG2
CD13	ARG2
gene1e	ARG2
(+	O
)	O
cancer	O
stem	O
cells	O
hierarchy	O
and	O
population	O
change	O
upon	O
its	O
differentiation	O
during	O
culture	O
and	O
effects	O
of	O
sorafenib	O
.	O
BACKGROUNDS	O
:	O
Cancer	O
stem	O
cell	O
(	O
CSC	O
)	O
research	O
has	O
highlighted	O
the	O
necessity	O
of	O
developing	O
drugs	O
targeting	O
CSCs	O
.	O
We	O
investigated	O
a	O
hepatocellular	O
carcinoma	O
(	O
HCC	O
)	O
cell	O
line	O
that	O
not	O
only	O
has	O
CSC	O
hierarchy	O
but	O
also	O
shows	O
phenotypic	O
changes	O
(	O
population	O
changes	O
)	O
upon	O
differentiation	O
of	O
CSC	O
during	O
culture	O
and	O
can	O
be	O
used	O
for	O
screening	O
drugs	O
targeting	O
CSC	O
.	O
METHODS	O
:	O
Based	O
on	O
a	O
hypothesis	O
that	O
the	O
CSC	O
proportion	O
should	O
decrease	O
upon	O
its	O
differentiation	O
into	O
progenitors	O
(	O
population	O
change	O
)	O
,	O
we	O
tested	O
HCC	O
cell	O
lines	O
(	O
HuH-7	O
,	O
Li-7	O
,	O
PLC	O
/	O
PRF/5	O
,	O
HLF	O
,	O
HLE	O
)	O
before	O
and	O
after	O
2	O
months	O
culture	O
for	O
several	O
markers	O
(	O
gene1s	ARG2
CD13	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
EpCAM	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD133	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD44	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD90	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD24	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD166	ARG2
gene1e	ARG2
)	O
.	O
Tumorigenicity	O
was	O
tested	O
using	O
species1s	O
nude	O
mice	O
species1e	O
.	O
To	O
evaluate	O
the	O
CSC	O
hierarchy	O
,	O
we	O
investigated	O
reconstructivity	O
,	O
proliferation	O
,	O
gene1s	ARG2
ALDH	ARG2
gene1e	ARG2
activity	O
,	O
spheroid	O
formation	O
,	O
chemosensitivity	O
and	O
microarray	O
analysis	O
of	O
the	O
cell	O
populations	O
sorted	O
by	O
FACS	O
.	O
RESULTS	O
:	O
Only	O
arg1s	O
Li-7	O
arg1e	O
cells	O
showed	O
a	O
population	O
change	O
during	O
culture	O
:	O
the	O
proportion	O
of	O
gene1s	ARG2
CD13	ARG2
gene1e	ARG2
positive	O
cells	O
decreased	O
,	O
while	O
that	O
of	O
gene1s	ARG2
CD166	ARG2
gene1e	ARG2
positive	O
cells	O
increased	O
.	O
The	O
high	O
tumorigenicity	O
of	O
the	O
Li-7	O
was	O
lost	O
after	O
the	O
population	O
change	O
.	O
gene1s	ARG2
CD13	ARG2
gene1e	ARG2
(+)/	O
gene1s	ARG2
CD166	ARG2
gene1e	ARG2
(-	O
)	O
cells	O
showed	O
slow	O
growth	O
and	O
reconstructed	O
the	O
bulk	O
Li-7	O
populations	O
composed	O
of	O
gene1s	ARG2
CD13	ARG2
gene1e	ARG2
(+)/	O
gene1s	ARG2
CD166	ARG2
gene1e	ARG2
(-	O
)	O
,	O
gene1s	ARG2
CD13	ARG2
gene1e	ARG2
(-)/	O
gene1s	ARG2
CD166	ARG2
gene1e	ARG2
(-	O
)	O
and	O
gene1s	ARG2
CD13	ARG2
gene1e	ARG2
(-)/	O
gene1s	ARG2
CD166	ARG2
gene1e	ARG2
(+	O
)	O
fractions	O
,	O
whereas	O
gene1s	ARG2
CD13	ARG2
gene1e	ARG2
(-)/	O
gene1s	ARG2
CD166	ARG2
gene1e	ARG2
(+	O
)	O
cells	O
showed	O
rapid	O
growth	O
but	O
could	O
not	O
reproduce	O
any	O
other	O
population	O
.	O
gene1s	ARG2
CD13	ARG2
gene1e	ARG2
(+)/	O
gene1s	ARG2
CD166	ARG2
gene1e	ARG2
(-	O
)	O
cells	O
showed	O
high	O
gene1s	ARG2
ALDH	ARG2
gene1e	ARG2
activity	O
,	O
spheroid	O
forming	O
ability	O
and	O
resistance	O
to	O
5-fluorouracil	O
.	O
Microarray	O
analysis	O
demonstrated	O
higher	O
expression	O
of	O
stemness	O
-	O
related	O
genes	O
in	O
gene1s	ARG2
CD166	ARG2
gene1e	ARG2
(-	O
)	O
than	O
gene1s	ARG2
CD166	ARG2
gene1e	ARG2
(+	O
)	O
fraction	O
.	O
These	O
results	O
indicated	O
a	O
hierarchy	O
in	O
arg1s	O
Li-7	O
arg1e	O
cells	O
,	O
in	O
which	O
gene1s	ARG2
CD13	ARG2
gene1e	ARG2
(+)/	O
gene1s	ARG2
CD166	ARG2
gene1e	ARG2
(-	O
)	O
and	O
gene1s	ARG2
CD13	ARG2
gene1e	ARG2
(-)/	O
gene1s	ARG2
CD166	ARG2
gene1e	ARG2
(+	O
)	O
cells	O
serve	O
as	O
slow	O
growing	O
CSCs	O
and	O
rapid	O
growing	O
progenitors	O
,	O
respectively	O
.	O
Sorafenib	O
selectively	O
targeted	O
the	O
gene1s	ARG2
CD166	ARG2
gene1e	ARG2
(-	O
)	O
fraction	O
,	O
including	O
gene1s	ARG2
CD13	ARG2
gene1e	ARG2
(+	O
)	O
CSCs	O
,	O
which	O
exhibited	O
higher	O
mRNA	O
expression	O
for	O
gene1s	ARG2
FGF3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
FGF4	ARG2
gene1e	ARG2
,	O
candidate	O
biomarkers	O
for	O
sorafenib	O
.	O
5-fluorouracil	O
followed	O
by	O
sorafenib	O
inhibited	O
the	O
growth	O
of	O
bulk	O
arg1s	O
Li-7	O
arg1e	O
cells	O
more	O
effectively	O
than	O
the	O
reverse	O
sequence	O
or	O
either	O
alone	O
.	O
CONCLUSIONS	O
:	O
We	O
identified	O
a	O
unique	O
HCC	O
line	O
,	O
Li-7	O
,	O
which	O
not	O
only	O
shows	O
heterogeneity	O
for	O
a	O
gene1s	ARG2
CD13	ARG2
gene1e	ARG2
(+	O
)	O
CSC	O
hierarchy	O
,	O
but	O
also	O
undergoes	O
a	O
"	O
population	O
change	O
"	O
upon	O
CSC	O
differentiation	O
.	O
Sorafenib	O
targeted	O
the	O
CSC	O
in	O
vitro	O
,	O
supporting	O
the	O
use	O
of	O
this	O
model	O
for	O
screening	O
drugs	O
targeting	O
the	O
CSC	O
.	O
This	O
type	O
of	O
"	O
heterogeneous	O
,	O
unstable	O
"	O
cell	O
line	O
may	O
prove	O
more	O
useful	O
in	O
the	O
CSC	O
era	O
than	O
conventional	O
"	O
homogeneous	O
,	O
stable	O
"	O
cell	O
lines	O
.	O

Identification	O
of	O
a	O
unique	O
hepatocellular	O
carcinoma	O
line	O
,	O
species1s	O
Li-7	O
species1e	O
,	O
with	O
gene1s	O
CD13	O
gene1e	O
(+	O
)	O
cancer	O
stem	O
cells	O
hierarchy	O
and	O
population	O
change	O
upon	O
its	O
differentiation	O
during	O
culture	O
and	O
effects	O
of	O
sorafenib	O
.	O
BACKGROUNDS	O
:	O
Cancer	O
stem	O
cell	O
(	O
CSC	O
)	O
research	O
has	O
highlighted	O
the	O
necessity	O
of	O
developing	O
drugs	O
targeting	O
CSCs	O
.	O
We	O
investigated	O
a	O
hepatocellular	O
carcinoma	O
(	O
HCC	O
)	O
cell	O
line	O
that	O
not	O
only	O
has	O
CSC	O
hierarchy	O
but	O
also	O
shows	O
phenotypic	O
changes	O
(	O
population	O
changes	O
)	O
upon	O
differentiation	O
of	O
CSC	O
during	O
culture	O
and	O
can	O
be	O
used	O
for	O
screening	O
drugs	O
targeting	O
CSC	O
.	O
METHODS	O
:	O
Based	O
on	O
a	O
hypothesis	O
that	O
the	O
CSC	O
proportion	O
should	O
decrease	O
upon	O
its	O
differentiation	O
into	O
progenitors	O
(	O
population	O
change	O
)	O
,	O
we	O
tested	O
HCC	O
cell	O
lines	O
(	O
HuH-7	O
,	O
Li-7	O
,	O
PLC	O
/	O
PRF/5	O
,	O
HLF	O
,	O
HLE	O
)	O
before	O
and	O
after	O
2	O
months	O
culture	O
for	O
several	O
markers	O
(	O
gene1s	O
CD13	O
gene1e	O
,	O
gene1s	O
EpCAM	O
gene1e	O
,	O
gene1s	O
CD133	O
gene1e	O
,	O
gene1s	O
CD44	O
gene1e	O
,	O
gene1s	O
CD90	O
gene1e	O
,	O
gene1s	O
CD24	O
gene1e	O
,	O
gene1s	O
CD166	O
gene1e	O
)	O
.	O
Tumorigenicity	O
was	O
tested	O
using	O
arg1s	O
nude	O
mice	O
arg1e	O
.	O
To	O
evaluate	O
the	O
CSC	O
hierarchy	O
,	O
we	O
investigated	O
reconstructivity	O
,	O
proliferation	O
,	O
gene1s	O
ALDH	O
gene1e	O
activity	O
,	O
spheroid	O
formation	O
,	O
chemosensitivity	O
and	O
microarray	O
analysis	O
of	O
the	O
cell	O
populations	O
sorted	O
by	O
FACS	O
.	O
RESULTS	O
:	O
Only	O
species1s	O
Li-7	O
species1e	O
cells	O
showed	O
a	O
population	O
change	O
during	O
culture	O
:	O
the	O
proportion	O
of	O
gene1s	O
CD13	O
gene1e	O
positive	O
cells	O
decreased	O
,	O
while	O
that	O
of	O
gene1s	O
CD166	O
gene1e	O
positive	O
cells	O
increased	O
.	O
The	O
high	O
tumorigenicity	O
of	O
the	O
Li-7	O
was	O
lost	O
after	O
the	O
population	O
change	O
.	O
gene1s	O
CD13	O
gene1e	O
(+)/	O
gene1s	O
CD166	O
gene1e	O
(-	O
)	O
cells	O
showed	O
slow	O
growth	O
and	O
reconstructed	O
the	O
bulk	O
Li-7	O
populations	O
composed	O
of	O
gene1s	O
CD13	O
gene1e	O
(+)/	O
gene1s	O
CD166	O
gene1e	O
(-	O
)	O
,	O
gene1s	O
CD13	O
gene1e	O
(-)/	O
gene1s	O
CD166	O
gene1e	O
(-	O
)	O
and	O
gene1s	O
CD13	O
gene1e	O
(-)/	O
gene1s	O
CD166	O
gene1e	O
(+	O
)	O
fractions	O
,	O
whereas	O
gene1s	O
CD13	O
gene1e	O
(-)/	O
gene1s	O
CD166	O
gene1e	O
(+	O
)	O
cells	O
showed	O
rapid	O
growth	O
but	O
could	O
not	O
reproduce	O
any	O
other	O
population	O
.	O
gene1s	O
CD13	O
gene1e	O
(+)/	O
gene1s	O
CD166	O
gene1e	O
(-	O
)	O
cells	O
showed	O
high	O
gene1s	O
ALDH	O
gene1e	O
activity	O
,	O
spheroid	O
forming	O
ability	O
and	O
resistance	O
to	O
5-fluorouracil	O
.	O
Microarray	O
analysis	O
demonstrated	O
higher	O
expression	O
of	O
stemness	O
-	O
related	O
genes	O
in	O
gene1s	O
CD166	O
gene1e	O
(-	O
)	O
than	O
gene1s	O
CD166	O
gene1e	O
(+	O
)	O
fraction	O
.	O
These	O
results	O
indicated	O
a	O
hierarchy	O
in	O
species1s	O
Li-7	O
species1e	O
cells	O
,	O
in	O
which	O
gene1s	O
CD13	O
gene1e	O
(+)/	O
gene1s	O
CD166	O
gene1e	O
(-	O
)	O
and	O
gene1s	O
CD13	O
gene1e	O
(-)/	O
gene1s	O
CD166	O
gene1e	O
(+	O
)	O
cells	O
serve	O
as	O
slow	O
growing	O
CSCs	O
and	O
rapid	O
growing	O
progenitors	O
,	O
respectively	O
.	O
Sorafenib	O
selectively	O
targeted	O
the	O
gene1s	O
CD166	O
gene1e	O
(-	O
)	O
fraction	O
,	O
including	O
gene1s	O
CD13	O
gene1e	O
(+	O
)	O
CSCs	O
,	O
which	O
exhibited	O
higher	O
mRNA	O
expression	O
for	O
gene1s	O
FGF3	O
gene1e	O
and	O
gene1s	O
FGF4	O
gene1e	O
,	O
candidate	O
biomarkers	O
for	O
sorafenib	O
.	O
5-fluorouracil	O
followed	O
by	O
sorafenib	O
inhibited	O
the	O
growth	O
of	O
bulk	O
species1s	O
Li-7	O
species1e	O
cells	O
more	O
effectively	O
than	O
the	O
reverse	O
sequence	O
or	O
either	O
alone	O
.	O
CONCLUSIONS	O
:	O
We	O
identified	O
a	O
unique	O
HCC	O
line	O
,	O
Li-7	O
,	O
which	O
not	O
only	O
shows	O
heterogeneity	O
for	O
a	O
gene1s	O
CD13	O
gene1e	O
(+	O
)	O
CSC	O
hierarchy	O
,	O
but	O
also	O
undergoes	O
a	O
"	O
population	O
change	O
"	O
upon	O
CSC	O
differentiation	O
.	O
Sorafenib	O
targeted	O
the	O
CSC	O
in	O
vitro	O
,	O
supporting	O
the	O
use	O
of	O
this	O
model	O
for	O
screening	O
drugs	O
targeting	O
the	O
CSC	O
.	O
This	O
type	O
of	O
"	O
heterogeneous	O
,	O
unstable	O
"	O
cell	O
line	O
may	O
prove	O
more	O
useful	O
in	O
the	O
CSC	O
era	O
than	O
conventional	O
"	O
homogeneous	O
,	O
stable	O
"	O
cell	O
lines	O
.	O

Sex	O
-	O
differences	O
in	O
renal	O
expression	O
of	O
selected	O
transporters	O
and	O
transcription	O
factors	O
in	O
lean	O
and	O
obese	O
Zucker	O
spontaneously	O
hypertensive	O
fatty	O
arg1s	O
rats	O
arg1e	O
.	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
identify	O
sex	O
-	O
dependent	O
expression	O
of	O
renal	O
transporter	O
mRNA	O
in	O
lean	O
and	O
obese	O
Zucker	O
spontaneously	O
hypertensive	O
fatty	O
(	O
ZSF1	O
)	O
arg1s	O
rats	O
arg1e	O
and	O
to	O
investigate	O
the	O
interaction	O
of	O
the	O
most	O
altered	O
transporter	O
,	O
gene1s	ARG2
organic	ARG2
anion	ARG2
transporter	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Oat2	ARG2
gene1e	ARG2
)	O
,	O
with	O
diabetes	O
-	O
relevant	O
metabolites	O
and	O
drugs	O
.	O
Higher	O
incidence	O
of	O
glomerulosclerosis	O
,	O
tubulointerstitial	O
fibrosis	O
,	O
and	O
protein	O
casts	O
in	O
Bowman	O
's	O
space	O
and	O
tubular	O
lumen	O
was	O
detected	O
by	O
PAS	O
staining	O
in	O
obese	O
male	O
compared	O
to	O
female	O
ZSF1	O
arg1s	O
rats	O
arg1e	O
.	O
Real	O
-	O
time	O
PCR	O
on	O
RNA	O
isolated	O
from	O
kidney	O
cortex	O
revealed	O
that	O
gene1s	ARG2
Sglt1	ARG2
-	ARG2
2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Oat1	ARG2
-	ARG2
3	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Oct1	ARG2
gene1e	ARG2
were	O
higher	O
expressed	O
in	O
kidneys	O
of	O
lean	O
females	O
.	O
gene1s	ARG2
Oct2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Mrp2	ARG2
gene1e	ARG2
were	O
higher	O
expressed	O
in	O
obese	O
males	O
.	O
Renal	O
mRNA	O
levels	O
of	O
transporters	O
were	O
reduced	O
with	O
diabetic	O
nephropathy	O
in	O
females	O
and	O
the	O
expression	O
of	O
transcription	O
factors	O
gene1s	ARG2
Hnf1beta	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Hnf4alpha	ARG2
gene1e	ARG2
in	O
both	O
sexes	O
.	O
The	O
highest	O
difference	O
between	O
lean	O
and	O
obese	O
ZSF1	O
arg1s	O
rats	O
arg1e	O
was	O
found	O
for	O
gene1s	ARG2
Oat2	ARG2
gene1e	ARG2
.	O
Therefore	O
,	O
we	O
have	O
tested	O
the	O
interaction	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
OAT2	O
gene1e	O
with	O
various	O
substances	O
using	O
tritium	O
-	O
labeled	O
cGMP	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
OAT2	O
gene1e	O
showed	O
no	O
interaction	O
with	O
diabetes	O
-	O
related	O
metabolites	O
,	O
diabetic	O
drugs	O
,	O
and	O
ACE	O
-	O
inhibitors	O
.	O
However	O
,	O
gene1s	O
OAT2	O
gene1e	O
-dependent	O
uptake	O
of	O
cGMP	O
was	O
inhibited	O
by	O
furosemide	O
.	O
The	O
strongly	O
decreased	O
expression	O
of	O
gene1s	ARG2
Oat2	ARG2
gene1e	ARG2
and	O
other	O
transporters	O
in	O
female	O
diabetic	O
ZSF1	O
arg1s	O
rats	O
arg1e	O
could	O
possibly	O
impair	O
renal	O
drug	O
excretion	O
,	O
for	O
example	O
,	O
of	O
furosemide	O
.	O

Sex	O
-	O
differences	O
in	O
renal	O
expression	O
of	O
selected	O
transporters	O
and	O
transcription	O
factors	O
in	O
lean	O
and	O
obese	O
Zucker	O
spontaneously	O
hypertensive	O
fatty	O
species1s	O
rats	O
species1e	O
.	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
identify	O
sex	O
-	O
dependent	O
expression	O
of	O
renal	O
transporter	O
mRNA	O
in	O
lean	O
and	O
obese	O
Zucker	O
spontaneously	O
hypertensive	O
fatty	O
(	O
ZSF1	O
)	O
species1s	O
rats	O
species1e	O
and	O
to	O
investigate	O
the	O
interaction	O
of	O
the	O
most	O
altered	O
transporter	O
,	O
gene1s	O
organic	O
anion	O
transporter	O
2	O
gene1e	O
(	O
gene1s	O
Oat2	O
gene1e	O
)	O
,	O
with	O
diabetes	O
-	O
relevant	O
metabolites	O
and	O
drugs	O
.	O
Higher	O
incidence	O
of	O
glomerulosclerosis	O
,	O
tubulointerstitial	O
fibrosis	O
,	O
and	O
protein	O
casts	O
in	O
Bowman	O
's	O
space	O
and	O
tubular	O
lumen	O
was	O
detected	O
by	O
PAS	O
staining	O
in	O
obese	O
male	O
compared	O
to	O
female	O
ZSF1	O
species1s	O
rats	O
species1e	O
.	O
Real	O
-	O
time	O
PCR	O
on	O
RNA	O
isolated	O
from	O
kidney	O
cortex	O
revealed	O
that	O
gene1s	O
Sglt1	O
-	O
2	O
gene1e	O
,	O
gene1s	O
Oat1	O
-	O
3	O
gene1e	O
,	O
and	O
gene1s	O
Oct1	O
gene1e	O
were	O
higher	O
expressed	O
in	O
kidneys	O
of	O
lean	O
females	O
.	O
gene1s	O
Oct2	O
gene1e	O
and	O
gene1s	O
Mrp2	O
gene1e	O
were	O
higher	O
expressed	O
in	O
obese	O
males	O
.	O
Renal	O
mRNA	O
levels	O
of	O
transporters	O
were	O
reduced	O
with	O
diabetic	O
nephropathy	O
in	O
females	O
and	O
the	O
expression	O
of	O
transcription	O
factors	O
gene1s	O
Hnf1beta	O
gene1e	O
and	O
gene1s	O
Hnf4alpha	O
gene1e	O
in	O
both	O
sexes	O
.	O
The	O
highest	O
difference	O
between	O
lean	O
and	O
obese	O
ZSF1	O
species1s	O
rats	O
species1e	O
was	O
found	O
for	O
gene1s	O
Oat2	O
gene1e	O
.	O
Therefore	O
,	O
we	O
have	O
tested	O
the	O
interaction	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
OAT2	ARG2
gene1e	ARG2
with	O
various	O
substances	O
using	O
tritium	O
-	O
labeled	O
cGMP	O
.	O
arg1s	O
Human	O
arg1e	O
gene1s	ARG2
OAT2	ARG2
gene1e	ARG2
showed	O
no	O
interaction	O
with	O
diabetes	O
-	O
related	O
metabolites	O
,	O
diabetic	O
drugs	O
,	O
and	O
ACE	O
-	O
inhibitors	O
.	O
However	O
,	O
gene1s	ARG2
OAT2	ARG2
gene1e	ARG2
-dependent	O
uptake	O
of	O
cGMP	O
was	O
inhibited	O
by	O
furosemide	O
.	O
The	O
strongly	O
decreased	O
expression	O
of	O
gene1s	O
Oat2	O
gene1e	O
and	O
other	O
transporters	O
in	O
female	O
diabetic	O
ZSF1	O
species1s	O
rats	O
species1e	O
could	O
possibly	O
impair	O
renal	O
drug	O
excretion	O
,	O
for	O
example	O
,	O
of	O
furosemide	O
.	O

arg1s	O
Zebrafish	O
arg1e	O
gene1s	ARG2
chordin	ARG2
-	ARG2
like	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
chordin	ARG2
gene1e	ARG2
are	O
functionally	O
redundant	O
in	O
regulating	O
patterning	O
of	O
the	O
dorsoventral	O
axis	O
.	O
gene1s	ARG2
Chordin	ARG2
gene1e	ARG2
is	O
the	O
prototype	O
of	O
a	O
group	O
of	O
gene1s	ARG2
cysteine	ARG2
-	ARG2
rich	ARG2
domain	ARG2
-	ARG2
containing	ARG2
proteins	ARG2
gene1e	ARG2
that	O
bind	O
and	O
modulate	O
signaling	O
of	O
various	O
gene1s	ARG2
TGFbeta	ARG2
gene1e	ARG2
-	O
like	O
ligands	O
.	O
gene1s	O
Chordin	O
-	O
like	O
1	O
and	O
2	O
gene1e	O
(	O
gene1s	O
CHL1	O
and	O
2	O
gene1e	O
)	O
are	O
two	O
members	O
of	O
this	O
group	O
that	O
have	O
been	O
described	O
in	O
species1s	O
human	O
species1e	O
,	O
species1s	O
mouse	O
species1e	O
,	O
and	O
species1s	O
chick	O
species1e	O
.	O
However	O
,	O
in	O
vivo	O
roles	O
for	O
gene1s	O
CHL1	O
and	O
2	O
gene1e	O
in	O
early	O
development	O
are	O
unknown	O
due	O
to	O
lack	O
of	O
loss	O
-	O
of	O
-	O
function	O
analysis	O
.	O
Here	O
we	O
identify	O
and	O
characterize	O
arg1s	O
zebrafish	O
arg1e	O
,	O
arg1s	O
Danio	O
rerio	O
arg1e	O
,	O
gene1s	ARG2
CHL	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Chl	ARG2
gene1e	ARG2
)	O
.	O
The	O
gene1s	ARG2
chl	ARG2
gene1e	ARG2
gene	O
is	O
on	O
a	O
region	O
of	O
chromosome	O
21	O
syntenic	O
with	O
the	O
area	O
of	O
species1s	O
murine	O
species1e	O
chromosome	O
7	O
bearing	O
the	O
gene1s	O
CHL2	O
gene1e	O
gene	O
.	O
Inability	O
to	O
identify	O
a	O
separate	O
arg1s	O
zebrafish	O
arg1e	O
gene	O
corresponding	O
to	O
the	O
species1s	O
mammalian	O
species1e	O
gene1s	O
CHL1	O
gene1e	O
gene	O
suggests	O
that	O
gene1s	ARG2
Chl	ARG2
gene1e	ARG2
may	O
serve	O
roles	O
in	O
arg1s	O
zebrafish	O
arg1e	O
distributed	O
between	O
gene1s	O
CHL1	O
gene1e	O
and	O
gene1s	O
CHL2	O
gene1e	O
in	O
other	O
species	O
.	O
gene1s	ARG2
Chl	ARG2
gene1e	ARG2
is	O
a	O
maternal	O
factor	O
that	O
is	O
also	O
zygotically	O
expressed	O
later	O
in	O
development	O
and	O
has	O
spatiotemporal	O
expression	O
patterns	O
that	O
differ	O
from	O
but	O
overlap	O
those	O
of	O
arg1s	O
zebrafish	O
arg1e	O
gene1s	ARG2
chordin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Chd	ARG2
gene1e	ARG2
)	O
,	O
suggesting	O
differences	O
but	O
also	O
possible	O
overlap	O
in	O
developmental	O
roles	O
of	O
the	O
two	O
proteins	O
.	O
gene1s	ARG2
Chl	ARG2
gene1e	ARG2
,	O
like	O
gene1s	ARG2
Chd	ARG2
gene1e	ARG2
,	O
dorsalizes	O
embryos	O
upon	O
overexpression	O
and	O
is	O
cleaved	O
by	O
gene1s	ARG2
BMP1	ARG2
gene1e	ARG2
,	O
which	O
antagonizes	O
this	O
activity	O
.	O
Loss	O
-	O
of	O
-	O
function	O
experiments	O
demonstrate	O
that	O
gene1s	ARG2
Chl	ARG2
gene1e	ARG2
serves	O
as	O
a	O
gene1s	ARG2
BMP	ARG2
gene1e	ARG2
antagonist	O
with	O
functions	O
that	O
overlap	O
and	O
are	O
redundant	O
with	O
those	O
of	O
gene1s	ARG2
Chd	ARG2
gene1e	ARG2
in	O
forming	O
the	O
dorsoventral	O
axis	O
.	O

species1s	O
Zebrafish	O
species1e	O
gene1s	O
chordin	O
-	O
like	O
gene1e	O
and	O
gene1s	O
chordin	O
gene1e	O
are	O
functionally	O
redundant	O
in	O
regulating	O
patterning	O
of	O
the	O
dorsoventral	O
axis	O
.	O
gene1s	O
Chordin	O
gene1e	O
is	O
the	O
prototype	O
of	O
a	O
group	O
of	O
gene1s	ARG2
cysteine	ARG2
-	ARG2
rich	ARG2
domain	ARG2
-	ARG2
containing	ARG2
proteins	ARG2
gene1e	ARG2
that	O
bind	O
and	O
modulate	O
signaling	O
of	O
various	O
gene1s	O
TGFbeta	O
gene1e	O
-	O
like	O
ligands	O
.	O
gene1s	ARG2
Chordin	ARG2
-	ARG2
like	ARG2
1	ARG2
and	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CHL1	ARG2
and	ARG2
2	ARG2
gene1e	ARG2
)	O
are	O
two	O
members	O
of	O
this	O
group	O
that	O
have	O
been	O
described	O
in	O
arg1s	O
human	O
arg1e	O
,	O
species1s	O
mouse	O
species1e	O
,	O
and	O
species1s	O
chick	O
species1e	O
.	O
However	O
,	O
in	O
vivo	O
roles	O
for	O
gene1s	ARG2
CHL1	ARG2
and	ARG2
2	ARG2
gene1e	ARG2
in	O
early	O
development	O
are	O
unknown	O
due	O
to	O
lack	O
of	O
loss	O
-	O
of	O
-	O
function	O
analysis	O
.	O
Here	O
we	O
identify	O
and	O
characterize	O
species1s	O
zebrafish	O
species1e	O
,	O
species1s	O
Danio	O
rerio	O
species1e	O
,	O
gene1s	O
CHL	O
gene1e	O
(	O
gene1s	O
Chl	O
gene1e	O
)	O
.	O
The	O
gene1s	O
chl	O
gene1e	O
gene	O
is	O
on	O
a	O
region	O
of	O
chromosome	O
21	O
syntenic	O
with	O
the	O
area	O
of	O
species1s	O
murine	O
species1e	O
chromosome	O
7	O
bearing	O
the	O
gene1s	O
CHL2	O
gene1e	O
gene	O
.	O
Inability	O
to	O
identify	O
a	O
separate	O
species1s	O
zebrafish	O
species1e	O
gene	O
corresponding	O
to	O
the	O
arg1s	O
mammalian	O
arg1e	O
gene1s	ARG2
CHL1	ARG2
gene1e	ARG2
gene	O
suggests	O
that	O
gene1s	O
Chl	O
gene1e	O
may	O
serve	O
roles	O
in	O
species1s	O
zebrafish	O
species1e	O
distributed	O
between	O
gene1s	ARG2
CHL1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CHL2	ARG2
gene1e	ARG2
in	O
other	O
species	O
.	O
gene1s	O
Chl	O
gene1e	O
is	O
a	O
maternal	O
factor	O
that	O
is	O
also	O
zygotically	O
expressed	O
later	O
in	O
development	O
and	O
has	O
spatiotemporal	O
expression	O
patterns	O
that	O
differ	O
from	O
but	O
overlap	O
those	O
of	O
species1s	O
zebrafish	O
species1e	O
gene1s	O
chordin	O
gene1e	O
(	O
gene1s	O
Chd	O
gene1e	O
)	O
,	O
suggesting	O
differences	O
but	O
also	O
possible	O
overlap	O
in	O
developmental	O
roles	O
of	O
the	O
two	O
proteins	O
.	O
gene1s	O
Chl	O
gene1e	O
,	O
like	O
gene1s	O
Chd	O
gene1e	O
,	O
dorsalizes	O
embryos	O
upon	O
overexpression	O
and	O
is	O
cleaved	O
by	O
gene1s	O
BMP1	O
gene1e	O
,	O
which	O
antagonizes	O
this	O
activity	O
.	O
Loss	O
-	O
of	O
-	O
function	O
experiments	O
demonstrate	O
that	O
gene1s	O
Chl	O
gene1e	O
serves	O
as	O
a	O
gene1s	O
BMP	O
gene1e	O
antagonist	O
with	O
functions	O
that	O
overlap	O
and	O
are	O
redundant	O
with	O
those	O
of	O
gene1s	O
Chd	O
gene1e	O
in	O
forming	O
the	O
dorsoventral	O
axis	O
.	O

species1s	O
Zebrafish	O
species1e	O
gene1s	O
chordin	O
-	O
like	O
gene1e	O
and	O
gene1s	O
chordin	O
gene1e	O
are	O
functionally	O
redundant	O
in	O
regulating	O
patterning	O
of	O
the	O
dorsoventral	O
axis	O
.	O
gene1s	O
Chordin	O
gene1e	O
is	O
the	O
prototype	O
of	O
a	O
group	O
of	O
gene1s	ARG2
cysteine	ARG2
-	ARG2
rich	ARG2
domain	ARG2
-	ARG2
containing	ARG2
proteins	ARG2
gene1e	ARG2
that	O
bind	O
and	O
modulate	O
signaling	O
of	O
various	O
gene1s	O
TGFbeta	O
gene1e	O
-	O
like	O
ligands	O
.	O
gene1s	ARG2
Chordin	ARG2
-	ARG2
like	ARG2
1	ARG2
and	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CHL1	ARG2
and	ARG2
2	ARG2
gene1e	ARG2
)	O
are	O
two	O
members	O
of	O
this	O
group	O
that	O
have	O
been	O
described	O
in	O
species1s	O
human	O
species1e	O
,	O
arg1s	O
mouse	O
arg1e	O
,	O
and	O
species1s	O
chick	O
species1e	O
.	O
However	O
,	O
in	O
vivo	O
roles	O
for	O
gene1s	ARG2
CHL1	ARG2
and	ARG2
2	ARG2
gene1e	ARG2
in	O
early	O
development	O
are	O
unknown	O
due	O
to	O
lack	O
of	O
loss	O
-	O
of	O
-	O
function	O
analysis	O
.	O
Here	O
we	O
identify	O
and	O
characterize	O
species1s	O
zebrafish	O
species1e	O
,	O
species1s	O
Danio	O
rerio	O
species1e	O
,	O
gene1s	O
CHL	O
gene1e	O
(	O
gene1s	O
Chl	O
gene1e	O
)	O
.	O
The	O
gene1s	O
chl	O
gene1e	O
gene	O
is	O
on	O
a	O
region	O
of	O
chromosome	O
21	O
syntenic	O
with	O
the	O
area	O
of	O
arg1s	O
murine	O
arg1e	O
chromosome	O
7	O
bearing	O
the	O
gene1s	ARG2
CHL2	ARG2
gene1e	ARG2
gene	O
.	O
Inability	O
to	O
identify	O
a	O
separate	O
species1s	O
zebrafish	O
species1e	O
gene	O
corresponding	O
to	O
the	O
species1s	O
mammalian	O
species1e	O
gene1s	O
CHL1	O
gene1e	O
gene	O
suggests	O
that	O
gene1s	O
Chl	O
gene1e	O
may	O
serve	O
roles	O
in	O
species1s	O
zebrafish	O
species1e	O
distributed	O
between	O
gene1s	O
CHL1	O
gene1e	O
and	O
gene1s	O
CHL2	O
gene1e	O
in	O
other	O
species	O
.	O
gene1s	O
Chl	O
gene1e	O
is	O
a	O
maternal	O
factor	O
that	O
is	O
also	O
zygotically	O
expressed	O
later	O
in	O
development	O
and	O
has	O
spatiotemporal	O
expression	O
patterns	O
that	O
differ	O
from	O
but	O
overlap	O
those	O
of	O
species1s	O
zebrafish	O
species1e	O
gene1s	O
chordin	O
gene1e	O
(	O
gene1s	O
Chd	O
gene1e	O
)	O
,	O
suggesting	O
differences	O
but	O
also	O
possible	O
overlap	O
in	O
developmental	O
roles	O
of	O
the	O
two	O
proteins	O
.	O
gene1s	O
Chl	O
gene1e	O
,	O
like	O
gene1s	O
Chd	O
gene1e	O
,	O
dorsalizes	O
embryos	O
upon	O
overexpression	O
and	O
is	O
cleaved	O
by	O
gene1s	O
BMP1	O
gene1e	O
,	O
which	O
antagonizes	O
this	O
activity	O
.	O
Loss	O
-	O
of	O
-	O
function	O
experiments	O
demonstrate	O
that	O
gene1s	O
Chl	O
gene1e	O
serves	O
as	O
a	O
gene1s	O
BMP	O
gene1e	O
antagonist	O
with	O
functions	O
that	O
overlap	O
and	O
are	O
redundant	O
with	O
those	O
of	O
gene1s	O
Chd	O
gene1e	O
in	O
forming	O
the	O
dorsoventral	O
axis	O
.	O

species1s	O
Zebrafish	O
species1e	O
gene1s	O
chordin	O
-	O
like	O
gene1e	O
and	O
gene1s	O
chordin	O
gene1e	O
are	O
functionally	O
redundant	O
in	O
regulating	O
patterning	O
of	O
the	O
dorsoventral	O
axis	O
.	O
gene1s	O
Chordin	O
gene1e	O
is	O
the	O
prototype	O
of	O
a	O
group	O
of	O
gene1s	ARG2
cysteine	ARG2
-	ARG2
rich	ARG2
domain	ARG2
-	ARG2
containing	ARG2
proteins	ARG2
gene1e	ARG2
that	O
bind	O
and	O
modulate	O
signaling	O
of	O
various	O
gene1s	O
TGFbeta	O
gene1e	O
-	O
like	O
ligands	O
.	O
gene1s	ARG2
Chordin	ARG2
-	ARG2
like	ARG2
1	ARG2
and	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CHL1	ARG2
and	ARG2
2	ARG2
gene1e	ARG2
)	O
are	O
two	O
members	O
of	O
this	O
group	O
that	O
have	O
been	O
described	O
in	O
species1s	O
human	O
species1e	O
,	O
species1s	O
mouse	O
species1e	O
,	O
and	O
arg1s	O
chick	O
arg1e	O
.	O
However	O
,	O
in	O
vivo	O
roles	O
for	O
gene1s	ARG2
CHL1	ARG2
and	ARG2
2	ARG2
gene1e	ARG2
in	O
early	O
development	O
are	O
unknown	O
due	O
to	O
lack	O
of	O
loss	O
-	O
of	O
-	O
function	O
analysis	O
.	O
Here	O
we	O
identify	O
and	O
characterize	O
species1s	O
zebrafish	O
species1e	O
,	O
species1s	O
Danio	O
rerio	O
species1e	O
,	O
gene1s	O
CHL	O
gene1e	O
(	O
gene1s	O
Chl	O
gene1e	O
)	O
.	O
The	O
gene1s	O
chl	O
gene1e	O
gene	O
is	O
on	O
a	O
region	O
of	O
chromosome	O
21	O
syntenic	O
with	O
the	O
area	O
of	O
species1s	O
murine	O
species1e	O
chromosome	O
7	O
bearing	O
the	O
gene1s	O
CHL2	O
gene1e	O
gene	O
.	O
Inability	O
to	O
identify	O
a	O
separate	O
species1s	O
zebrafish	O
species1e	O
gene	O
corresponding	O
to	O
the	O
species1s	O
mammalian	O
species1e	O
gene1s	O
CHL1	O
gene1e	O
gene	O
suggests	O
that	O
gene1s	O
Chl	O
gene1e	O
may	O
serve	O
roles	O
in	O
species1s	O
zebrafish	O
species1e	O
distributed	O
between	O
gene1s	O
CHL1	O
gene1e	O
and	O
gene1s	O
CHL2	O
gene1e	O
in	O
other	O
species	O
.	O
gene1s	O
Chl	O
gene1e	O
is	O
a	O
maternal	O
factor	O
that	O
is	O
also	O
zygotically	O
expressed	O
later	O
in	O
development	O
and	O
has	O
spatiotemporal	O
expression	O
patterns	O
that	O
differ	O
from	O
but	O
overlap	O
those	O
of	O
species1s	O
zebrafish	O
species1e	O
gene1s	O
chordin	O
gene1e	O
(	O
gene1s	O
Chd	O
gene1e	O
)	O
,	O
suggesting	O
differences	O
but	O
also	O
possible	O
overlap	O
in	O
developmental	O
roles	O
of	O
the	O
two	O
proteins	O
.	O
gene1s	O
Chl	O
gene1e	O
,	O
like	O
gene1s	O
Chd	O
gene1e	O
,	O
dorsalizes	O
embryos	O
upon	O
overexpression	O
and	O
is	O
cleaved	O
by	O
gene1s	O
BMP1	O
gene1e	O
,	O
which	O
antagonizes	O
this	O
activity	O
.	O
Loss	O
-	O
of	O
-	O
function	O
experiments	O
demonstrate	O
that	O
gene1s	O
Chl	O
gene1e	O
serves	O
as	O
a	O
gene1s	O
BMP	O
gene1e	O
antagonist	O
with	O
functions	O
that	O
overlap	O
and	O
are	O
redundant	O
with	O
those	O
of	O
gene1s	O
Chd	O
gene1e	O
in	O
forming	O
the	O
dorsoventral	O
axis	O
.	O

Nitrogen	O
regulates	O
gene1s	ARG2
AMPK	ARG2
gene1e	ARG2
to	O
control	O
gene1s	ARG2
TORC1	ARG2
gene1e	ARG2
signaling	O
.	O
BACKGROUND	O
:	O
Cell	O
growth	O
and	O
cell	O
-	O
cycle	O
progression	O
are	O
tightly	O
coordinated	O
to	O
enable	O
cells	O
to	O
adjust	O
their	O
size	O
(	O
timing	O
of	O
division	O
)	O
to	O
the	O
demands	O
of	O
proliferation	O
in	O
varying	O
nutritional	O
environments	O
.	O
In	O
arg1s	O
fission	O
yeast	O
arg1e	O
,	O
nitrogen	O
stress	O
results	O
in	O
sustained	O
proliferation	O
at	O
a	O
reduced	O
size	O
.	O
RESULTS	O
:	O
Here	O
,	O
we	O
show	O
that	O
cells	O
can	O
sense	O
nitrogen	O
stress	O
to	O
reduce	O
gene1s	ARG2
target	ARG2
of	ARG2
rapamycin	ARG2
complex-1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TORC1	ARG2
gene1e	ARG2
)	O
activity	O
.	O
Nitrogen	O
-	O
stress	O
-	O
induced	O
gene1s	ARG2
TORC1	ARG2
gene1e	ARG2
inhibition	O
differs	O
from	O
amino	O
-	O
acid	O
-	O
dependent	O
control	O
of	O
gene1s	ARG2
TORC1	ARG2
gene1e	ARG2
and	O
requires	O
the	O
gene1s	ARG2
Ssp2	ARG2
(	ARG2
AMPKalpha	ARG2
)	ARG2
kinase	ARG2
gene1e	ARG2
,	O
the	O
gene1s	ARG2
Tsc1/2	ARG2
gene1e	ARG2
complex	O
,	O
and	O
gene1s	ARG2
Rhb1	ARG2
GTPase	ARG2
gene1e	ARG2
.	O
Importantly	O
,	O
the	O
gene1s	ARG2
beta	ARG2
and	ARG2
gamma	ARG2
regulatory	ARG2
subunits	ARG2
of	ARG2
AMPK	ARG2
gene1e	ARG2
are	O
not	O
required	O
to	O
control	O
cell	O
division	O
in	O
response	O
to	O
nitrogen	O
stress	O
,	O
providing	O
evidence	O
for	O
a	O
nitrogen	O
-	O
sensing	O
mechanism	O
that	O
is	O
independent	O
of	O
changes	O
in	O
intracellular	O
ATP	O
/	O
AMP	O
levels	O
.	O
The	O
gene1s	ARG2
CaMKK	ARG2
gene1e	ARG2
homolog	O
gene1s	ARG2
Ssp1	ARG2
gene1e	ARG2
is	O
constitutively	O
required	O
for	O
phosphorylation	O
of	O
the	O
gene1s	ARG2
AMPKalpha(Ssp2	ARG2
)	ARG2
gene1e	ARG2
T	O
loop	O
.	O
However	O
,	O
we	O
find	O
that	O
a	O
second	O
homolog	O
gene1s	ARG2
CaMKK(Ppk34	ARG2
)	ARG2
gene1e	ARG2
is	O
specifically	O
required	O
to	O
stimulate	O
gene1s	ARG2
AMPKalpha(Ssp2	ARG2
)	ARG2
gene1e	ARG2
activation	O
in	O
response	O
to	O
nitrogen	O
stress	O
.	O
Finally	O
,	O
ammonia	O
also	O
controls	O
gene1s	O
mTORC1	O
gene1e	O
activity	O
in	O
species1s	O
human	O
species1e	O
cells	O
;	O
gene1s	O
mTORC1	O
gene1e	O
is	O
activated	O
upon	O
the	O
addition	O
of	O
ammonium	O
to	O
glutamine	O
-	O
starved	O
species1s	O
Hep3B	O
species1e	O
cancer	O
cells	O
.	O
CONCLUSIONS	O
:	O
The	O
alternative	O
nitrogen	O
source	O
ammonia	O
can	O
simulate	O
gene1s	ARG2
TORC1	ARG2
gene1e	ARG2
activity	O
to	O
support	O
growth	O
and	O
division	O
under	O
challenging	O
nutrient	O
settings	O
,	O
a	O
situation	O
often	O
seen	O
in	O
cancer	O
.	O

Nitrogen	O
regulates	O
gene1s	O
AMPK	O
gene1e	O
to	O
control	O
gene1s	O
TORC1	O
gene1e	O
signaling	O
.	O
BACKGROUND	O
:	O
Cell	O
growth	O
and	O
cell	O
-	O
cycle	O
progression	O
are	O
tightly	O
coordinated	O
to	O
enable	O
cells	O
to	O
adjust	O
their	O
size	O
(	O
timing	O
of	O
division	O
)	O
to	O
the	O
demands	O
of	O
proliferation	O
in	O
varying	O
nutritional	O
environments	O
.	O
In	O
species1s	O
fission	O
yeast	O
species1e	O
,	O
nitrogen	O
stress	O
results	O
in	O
sustained	O
proliferation	O
at	O
a	O
reduced	O
size	O
.	O
RESULTS	O
:	O
Here	O
,	O
we	O
show	O
that	O
cells	O
can	O
sense	O
nitrogen	O
stress	O
to	O
reduce	O
gene1s	O
target	O
of	O
rapamycin	O
complex-1	O
gene1e	O
(	O
gene1s	O
TORC1	O
gene1e	O
)	O
activity	O
.	O
Nitrogen	O
-	O
stress	O
-	O
induced	O
gene1s	O
TORC1	O
gene1e	O
inhibition	O
differs	O
from	O
amino	O
-	O
acid	O
-	O
dependent	O
control	O
of	O
gene1s	O
TORC1	O
gene1e	O
and	O
requires	O
the	O
gene1s	O
Ssp2	O
(	O
AMPKalpha	O
)	O
kinase	O
gene1e	O
,	O
the	O
gene1s	O
Tsc1/2	O
gene1e	O
complex	O
,	O
and	O
gene1s	O
Rhb1	O
GTPase	O
gene1e	O
.	O
Importantly	O
,	O
the	O
gene1s	O
beta	O
and	O
gamma	O
regulatory	O
subunits	O
of	O
AMPK	O
gene1e	O
are	O
not	O
required	O
to	O
control	O
cell	O
division	O
in	O
response	O
to	O
nitrogen	O
stress	O
,	O
providing	O
evidence	O
for	O
a	O
nitrogen	O
-	O
sensing	O
mechanism	O
that	O
is	O
independent	O
of	O
changes	O
in	O
intracellular	O
ATP	O
/	O
AMP	O
levels	O
.	O
The	O
gene1s	O
CaMKK	O
gene1e	O
homolog	O
gene1s	O
Ssp1	O
gene1e	O
is	O
constitutively	O
required	O
for	O
phosphorylation	O
of	O
the	O
gene1s	O
AMPKalpha(Ssp2	O
)	O
gene1e	O
T	O
loop	O
.	O
However	O
,	O
we	O
find	O
that	O
a	O
second	O
homolog	O
gene1s	O
CaMKK(Ppk34	O
)	O
gene1e	O
is	O
specifically	O
required	O
to	O
stimulate	O
gene1s	O
AMPKalpha(Ssp2	O
)	O
gene1e	O
activation	O
in	O
response	O
to	O
nitrogen	O
stress	O
.	O
Finally	O
,	O
ammonia	O
also	O
controls	O
gene1s	ARG2
mTORC1	ARG2
gene1e	ARG2
activity	O
in	O
arg1s	O
human	O
arg1e	O
cells	O
;	O
gene1s	ARG2
mTORC1	ARG2
gene1e	ARG2
is	O
activated	O
upon	O
the	O
addition	O
of	O
ammonium	O
to	O
glutamine	O
-	O
starved	O
arg1s	O
Hep3B	O
arg1e	O
cancer	O
cells	O
.	O
CONCLUSIONS	O
:	O
The	O
alternative	O
nitrogen	O
source	O
ammonia	O
can	O
simulate	O
gene1s	ARG2
TORC1	ARG2
gene1e	ARG2
activity	O
to	O
support	O
growth	O
and	O
division	O
under	O
challenging	O
nutrient	O
settings	O
,	O
a	O
situation	O
often	O
seen	O
in	O
cancer	O
.	O

Protective	O
roles	O
of	O
gene1s	O
interferon	O
-	O
induced	O
protein	O
with	O
tetratricopeptide	O
repeats	O
3	O
gene1e	O
(	O
gene1s	O
IFIT3	O
gene1e	O
)	O
in	O
arg1s	O
dengue	O
virus	O
arg1e	O
infection	O
of	O
species1s	O
human	O
species1e	O
lung	O
epithelial	O
cells	O
.	O
gene1s	O
Interferons	O
gene1e	O
(	O
gene1s	O
IFNs	O
gene1e	O
)	O
are	O
critical	O
gene1s	O
cytokines	O
gene1e	O
that	O
regulate	O
immune	O
response	O
against	O
virus	O
infections	O
.	O
arg1s	O
Dengue	O
virus	O
arg1e	O
(	O
arg1s	O
DV	O
arg1e	O
)	O
infections	O
are	O
a	O
major	O
public	O
health	O
concern	O
worldwide	O
,	O
and	O
especially	O
in	O
Asia	O
.	O
In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
effects	O
and	O
mechanisms	O
of	O
action	O
of	O
gene1s	O
IFN	O
-	O
induced	O
protein	O
with	O
tetratricopeptide	O
repeats	O
3	O
gene1e	O
(	O
gene1s	O
IFIT3	O
gene1e	O
)	O
in	O
species1s	O
human	O
species1e	O
lung	O
epithelial	O
cells	O
.	O
The	O
results	O
demonstrated	O
that	O
arg1s	O
DV	O
arg1e	O
infection	O
induced	O
expression	O
of	O
several	O
gene1s	O
IFITs	O
gene1e	O
,	O
including	O
gene1s	O
IFIT1	O
gene1e	O
,	O
gene1s	O
IFIT2	O
gene1e	O
,	O
gene1s	O
IFIT3	O
gene1e	O
,	O
and	O
gene1s	O
IFIT5	O
gene1e	O
in	O
A549	O
cells	O
.	O
Induction	O
of	O
gene1s	O
IFIT3	O
gene1e	O
by	O
arg1s	O
DV	O
arg1e	O
infection	O
was	O
also	O
observed	O
in	O
species1s	O
human	O
species1e	O
dendritic	O
cells	O
.	O
In	O
a	O
knockdown	O
study	O
,	O
we	O
showed	O
that	O
a	O
gene1s	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
2	O
gene1e	O
(	O
gene1s	O
STAT2	O
gene1e	O
)	O
,	O
but	O
not	O
gene1s	O
STAT1	O
gene1e	O
or	O
gene1s	O
STAT3	O
gene1e	O
,	O
regulated	O
arg1s	O
DV	O
arg1e	O
-	O
induced	O
gene1s	O
IFIT3	O
gene1e	O
production	O
.	O
By	O
using	O
several	O
different	O
methods	O
to	O
evaluate	O
cell	O
death	O
,	O
we	O
demonstrated	O
that	O
knockdown	O
of	O
gene1s	O
IFIT3	O
gene1e	O
led	O
to	O
cellular	O
apoptosis	O
.	O
Furthermore	O
,	O
knockdown	O
of	O
gene1s	O
IFIT3	O
gene1e	O
induced	O
the	O
expression	O
of	O
several	O
apoptotic	O
regulators	O
such	O
as	O
gene1s	O
caspase	O
3	O
gene1e	O
,	O
gene1s	O
caspase	O
8	O
gene1e	O
,	O
gene1s	O
caspase	O
9	O
gene1e	O
,	O
and	O
gene1s	O
Bcl-2-associated	O
X	O
protein	O
gene1e	O
(	O
gene1s	O
BAX	O
gene1e	O
)	O
.	O
Such	O
apoptotic	O
effects	O
and	O
mechanisms	O
were	O
synergistically	O
enhanced	O
after	O
arg1s	O
DV	O
arg1e	O
infection	O
.	O
Moreover	O
,	O
under	O
conditions	O
of	O
gene1s	O
IFIT3	O
gene1e	O
deficiency	O
,	O
viral	O
production	O
increased	O
,	O
suggesting	O
an	O
anti	O
-	O
viral	O
effect	O
of	O
gene1s	O
IFIT3	O
gene1e	O
.	O
Interestingly	O
,	O
arg1s	O
DV	O
arg1e	O
could	O
suppress	O
gene1s	O
IFN	O
-	O
a	O
gene1e	O
-	O
induced	O
but	O
not	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
-	O
induced	O
gene1s	O
IFIT3	O
gene1e	O
expression	O
,	O
a	O
phenomenon	O
similar	O
to	O
the	O
regulation	O
of	O
STATs	O
by	O
arg1s	O
DV	O
arg1e	O
.	O
In	O
conclusion	O
,	O
this	O
study	O
revealed	O
some	O
mechanisms	O
of	O
gene1s	O
IFIT3	O
gene1e	O
induction	O
,	O
and	O
also	O
demonstrated	O
the	O
protective	O
roles	O
of	O
gene1s	O
IFIT3	O
gene1e	O
following	O
gene1s	O
IFN	O
-	O
a	O
gene1e	O
production	O
in	O
arg1s	O
DV	O
arg1e	O
infection	O
of	O
species1s	O
human	O
species1e	O
lung	O
epithelial	O
cells	O
.	O

Protective	O
roles	O
of	O
gene1s	ARG2
interferon	ARG2
-	ARG2
induced	ARG2
protein	ARG2
with	ARG2
tetratricopeptide	ARG2
repeats	ARG2
3	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IFIT3	ARG2
gene1e	ARG2
)	O
in	O
species1s	O
dengue	O
virus	O
species1e	O
infection	O
of	O
arg1s	O
human	O
arg1e	O
lung	O
epithelial	O
cells	O
.	O
gene1s	ARG2
Interferons	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IFNs	ARG2
gene1e	ARG2
)	O
are	O
critical	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
that	O
regulate	O
immune	O
response	O
against	O
virus	O
infections	O
.	O
species1s	O
Dengue	O
virus	O
species1e	O
(	O
species1s	O
DV	O
species1e	O
)	O
infections	O
are	O
a	O
major	O
public	O
health	O
concern	O
worldwide	O
,	O
and	O
especially	O
in	O
Asia	O
.	O
In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
effects	O
and	O
mechanisms	O
of	O
action	O
of	O
gene1s	ARG2
IFN	ARG2
-	ARG2
induced	ARG2
protein	ARG2
with	ARG2
tetratricopeptide	ARG2
repeats	ARG2
3	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IFIT3	ARG2
gene1e	ARG2
)	O
in	O
arg1s	O
human	O
arg1e	O
lung	O
epithelial	O
cells	O
.	O
The	O
results	O
demonstrated	O
that	O
species1s	O
DV	O
species1e	O
infection	O
induced	O
expression	O
of	O
several	O
gene1s	ARG2
IFITs	ARG2
gene1e	ARG2
,	O
including	O
gene1s	ARG2
IFIT1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IFIT2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IFIT3	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
IFIT5	ARG2
gene1e	ARG2
in	O
A549	O
cells	O
.	O
Induction	O
of	O
gene1s	ARG2
IFIT3	ARG2
gene1e	ARG2
by	O
species1s	O
DV	O
species1e	O
infection	O
was	O
also	O
observed	O
in	O
arg1s	O
human	O
arg1e	O
dendritic	O
cells	O
.	O
In	O
a	O
knockdown	O
study	O
,	O
we	O
showed	O
that	O
a	O
gene1s	ARG2
signal	ARG2
transducer	ARG2
and	ARG2
activator	ARG2
of	ARG2
transcription	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
STAT2	ARG2
gene1e	ARG2
)	O
,	O
but	O
not	O
gene1s	ARG2
STAT1	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
,	O
regulated	O
species1s	O
DV	O
species1e	O
-	O
induced	O
gene1s	ARG2
IFIT3	ARG2
gene1e	ARG2
production	O
.	O
By	O
using	O
several	O
different	O
methods	O
to	O
evaluate	O
cell	O
death	O
,	O
we	O
demonstrated	O
that	O
knockdown	O
of	O
gene1s	ARG2
IFIT3	ARG2
gene1e	ARG2
led	O
to	O
cellular	O
apoptosis	O
.	O
Furthermore	O
,	O
knockdown	O
of	O
gene1s	ARG2
IFIT3	ARG2
gene1e	ARG2
induced	O
the	O
expression	O
of	O
several	O
apoptotic	O
regulators	O
such	O
as	O
gene1s	ARG2
caspase	ARG2
3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
caspase	ARG2
8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
caspase	ARG2
9	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Bcl-2-associated	ARG2
X	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
BAX	ARG2
gene1e	ARG2
)	O
.	O
Such	O
apoptotic	O
effects	O
and	O
mechanisms	O
were	O
synergistically	O
enhanced	O
after	O
species1s	O
DV	O
species1e	O
infection	O
.	O
Moreover	O
,	O
under	O
conditions	O
of	O
gene1s	ARG2
IFIT3	ARG2
gene1e	ARG2
deficiency	O
,	O
viral	O
production	O
increased	O
,	O
suggesting	O
an	O
anti	O
-	O
viral	O
effect	O
of	O
gene1s	ARG2
IFIT3	ARG2
gene1e	ARG2
.	O
Interestingly	O
,	O
species1s	O
DV	O
species1e	O
could	O
suppress	O
gene1s	ARG2
IFN	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
-	O
induced	O
but	O
not	O
gene1s	ARG2
IFN	ARG2
-	ARG2
g	ARG2
gene1e	ARG2
-	O
induced	O
gene1s	ARG2
IFIT3	ARG2
gene1e	ARG2
expression	O
,	O
a	O
phenomenon	O
similar	O
to	O
the	O
regulation	O
of	O
STATs	O
by	O
species1s	O
DV	O
species1e	O
.	O
In	O
conclusion	O
,	O
this	O
study	O
revealed	O
some	O
mechanisms	O
of	O
gene1s	ARG2
IFIT3	ARG2
gene1e	ARG2
induction	O
,	O
and	O
also	O
demonstrated	O
the	O
protective	O
roles	O
of	O
gene1s	ARG2
IFIT3	ARG2
gene1e	ARG2
following	O
gene1s	ARG2
IFN	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
production	O
in	O
species1s	O
DV	O
species1e	O
infection	O
of	O
arg1s	O
human	O
arg1e	O
lung	O
epithelial	O
cells	O
.	O

Ca2	O
+	O
-dependent	O
endoplasmic	O
reticulum	O
stress	O
correlation	O
with	O
astrogliosis	O
involves	O
upregulation	O
of	O
gene1s	ARG2
KCa3.1	ARG2
gene1e	ARG2
and	O
inhibition	O
of	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
signaling	O
.	O
BACKGROUND	O
:	O
The	O
gene1s	ARG2
intermediate	ARG2
-	ARG2
conductance	ARG2
Ca2	ARG2
+	ARG2
-activated	ARG2
K+	ARG2
channel	ARG2
gene1e	ARG2
gene1s	O
KCa3.1	O
gene1e	O
was	O
recently	O
shown	O
to	O
control	O
the	O
phenotype	O
switch	O
of	O
reactive	O
astrogliosis	O
(	O
RA	O
)	O
in	O
Alzheimer	O
's	O
disease	O
(	O
AD	O
)	O
.	O
METHODS	O
:	O
gene1s	ARG2
KCa3.1	ARG2
gene1e	ARG2
channels	O
expression	O
and	O
cell	O
localization	O
in	O
the	O
brains	O
of	O
AD	O
arg1s	O
patients	O
arg1e	O
and	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
species1s	O
mice	O
species1e	O
model	O
were	O
measured	O
by	O
immunoblotting	O
and	O
immunostaining	O
.	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
species1s	O
mice	O
species1e	O
and	O
gene1s	O
KCa3.1	O
gene1e	O
-/-/	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
species1s	O
mice	O
species1e	O
were	O
subjected	O
to	O
Morris	O
water	O
maze	O
test	O
to	O
evaluate	O
the	O
spatial	O
memory	O
deficits	O
.	O
Glia	O
activation	O
and	O
neuron	O
loss	O
was	O
measured	O
by	O
immunostaining	O
.	O
Fluo-4AM	O
was	O
used	O
to	O
measure	O
cytosolic	O
Ca2	O
+	O
level	O
in	O
beta	O
-	O
amyloid	O
(	O
Abeta	O
)	O
induced	O
reactive	O
astrocytes	O
in	O
vitro	O
.	O
RESULTS	O
:	O
gene1s	ARG2
KCa3.1	ARG2
gene1e	ARG2
expression	O
was	O
markedly	O
associated	O
with	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
stress	O
and	O
unfolded	O
protein	O
response	O
(	O
UPR	O
)	O
in	O
both	O
Abeta	O
-	O
stimulated	O
primary	O
astrocytes	O
and	O
brain	O
lysates	O
of	O
AD	O
arg1s	O
patients	O
arg1e	O
and	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
AD	O
species1s	O
mice	O
species1e	O
.	O
The	O
gene1s	O
KCa3.1	O
gene1e	O
channel	O
was	O
shown	O
to	O
regulate	O
store	O
-	O
operated	O
Ca2	O
+	O
entry	O
(	O
SOCE	O
)	O
through	O
an	O
interaction	O
with	O
the	O
gene1s	O
Ca2	O
+	O
channel	O
gene1e	O
gene1s	O
Orai1	O
gene1e	O
in	O
primary	O
astrocytes	O
.	O
Gene	O
deletion	O
or	O
pharmacological	O
blockade	O
of	O
gene1s	O
KCa3.1	O
gene1e	O
protected	O
against	O
SOCE	O
-	O
induced	O
Ca2	O
+	O
overload	O
and	O
ER	O
stress	O
via	O
the	O
gene1s	O
protein	O
kinase	O
B	O
gene1e	O
(	O
gene1s	O
AKT	O
gene1e	O
)	O
signaling	O
pathway	O
in	O
astrocytes	O
.	O
Importantly	O
,	O
gene	O
deletion	O
or	O
blockade	O
of	O
gene1s	O
KCa3.1	O
gene1e	O
restored	O
gene1s	O
AKT	O
gene1e	O
/	O
gene1s	O
mechanistic	O
target	O
of	O
rapamycin	O
gene1e	O
signaling	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O
Consistent	O
with	O
these	O
in	O
vitro	O
data	O
,	O
expression	O
levels	O
of	O
the	O
ER	O
stress	O
markers	O
gene1s	O
78-kDa	O
glucose	O
-	O
regulated	O
protein	O
gene1e	O
and	O
gene1s	O
CCAAT	O
/	O
enhancer	O
-	O
binding	O
protein	O
homologous	O
protein	O
gene1e	O
,	O
as	O
well	O
as	O
that	O
of	O
the	O
RA	O
marker	O
gene1s	O
glial	O
fibrillary	O
acidic	O
protein	O
gene1e	O
were	O
increased	O
in	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
AD	O
species1s	O
mouse	O
species1e	O
model	O
.	O
Elimination	O
of	O
gene1s	O
KCa3.1	O
gene1e	O
in	O
gene1s	O
KCa3.1	O
gene1e	O
-/-/	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
species1s	O
mice	O
species1e	O
corrected	O
these	O
abnormal	O
responses	O
.	O
Moreover	O
,	O
glial	O
activation	O
and	O
neuroinflammation	O
were	O
attenuated	O
in	O
the	O
hippocampi	O
of	O
gene1s	O
KCa3.1	O
gene1e	O
-/-/	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
species1s	O
mice	O
species1e	O
,	O
as	O
compared	O
with	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
species1s	O
mice	O
species1e	O
.	O
In	O
addition	O
,	O
memory	O
deficits	O
and	O
neuronal	O
loss	O
in	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
species1s	O
mice	O
species1e	O
were	O
reversed	O
in	O
gene1s	O
KCa3.1	O
gene1e	O
-/-/	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PS1	ARG2
gene1e	ARG2
species1s	O
mice	O
species1e	O
.	O
CONCLUSIONS	O
:	O
Overall	O
,	O
these	O
results	O
suggest	O
that	O
gene1s	ARG2
KCa3.1	ARG2
gene1e	ARG2
is	O
involved	O
in	O
the	O
regulation	O
of	O
Ca2	O
+	O
homeostasis	O
in	O
astrocytes	O
and	O
attenuation	O
of	O
the	O
UPR	O
and	O
ER	O
stress	O
,	O
thus	O
contributing	O
to	O
memory	O
deficits	O
and	O
neuronal	O
loss	O
.	O

Ca2	O
+	O
-dependent	O
endoplasmic	O
reticulum	O
stress	O
correlation	O
with	O
astrogliosis	O
involves	O
upregulation	O
of	O
gene1s	ARG2
KCa3.1	ARG2
gene1e	ARG2
and	O
inhibition	O
of	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
signaling	O
.	O
BACKGROUND	O
:	O
The	O
gene1s	ARG2
intermediate	ARG2
-	ARG2
conductance	ARG2
Ca2	ARG2
+	ARG2
-activated	ARG2
K+	ARG2
channel	ARG2
gene1e	ARG2
gene1s	ARG2
KCa3.1	ARG2
gene1e	ARG2
was	O
recently	O
shown	O
to	O
control	O
the	O
phenotype	O
switch	O
of	O
reactive	O
astrogliosis	O
(	O
RA	O
)	O
in	O
Alzheimer	O
's	O
disease	O
(	O
AD	O
)	O
.	O
METHODS	O
:	O
gene1s	ARG2
KCa3.1	ARG2
gene1e	ARG2
channels	O
expression	O
and	O
cell	O
localization	O
in	O
the	O
brains	O
of	O
AD	O
species1s	O
patients	O
species1e	O
and	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	O
PS1	O
gene1e	O
arg1s	O
mice	O
arg1e	O
model	O
were	O
measured	O
by	O
immunoblotting	O
and	O
immunostaining	O
.	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	O
PS1	O
gene1e	O
arg1s	O
mice	O
arg1e	O
and	O
gene1s	ARG2
KCa3.1	ARG2
gene1e	ARG2
-/-/	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	O
PS1	O
gene1e	O
arg1s	O
mice	O
arg1e	O
were	O
subjected	O
to	O
Morris	O
water	O
maze	O
test	O
to	O
evaluate	O
the	O
spatial	O
memory	O
deficits	O
.	O
Glia	O
activation	O
and	O
neuron	O
loss	O
was	O
measured	O
by	O
immunostaining	O
.	O
Fluo-4AM	O
was	O
used	O
to	O
measure	O
cytosolic	O
Ca2	O
+	O
level	O
in	O
beta	O
-	O
amyloid	O
(	O
Abeta	O
)	O
induced	O
reactive	O
astrocytes	O
in	O
vitro	O
.	O
RESULTS	O
:	O
gene1s	ARG2
KCa3.1	ARG2
gene1e	ARG2
expression	O
was	O
markedly	O
associated	O
with	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
stress	O
and	O
unfolded	O
protein	O
response	O
(	O
UPR	O
)	O
in	O
both	O
Abeta	O
-	O
stimulated	O
primary	O
astrocytes	O
and	O
brain	O
lysates	O
of	O
AD	O
species1s	O
patients	O
species1e	O
and	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	O
PS1	O
gene1e	O
AD	O
arg1s	O
mice	O
arg1e	O
.	O
The	O
gene1s	ARG2
KCa3.1	ARG2
gene1e	ARG2
channel	O
was	O
shown	O
to	O
regulate	O
store	O
-	O
operated	O
Ca2	O
+	O
entry	O
(	O
SOCE	O
)	O
through	O
an	O
interaction	O
with	O
the	O
gene1s	ARG2
Ca2	ARG2
+	ARG2
channel	ARG2
gene1e	ARG2
gene1s	ARG2
Orai1	ARG2
gene1e	ARG2
in	O
primary	O
astrocytes	O
.	O
Gene	O
deletion	O
or	O
pharmacological	O
blockade	O
of	O
gene1s	ARG2
KCa3.1	ARG2
gene1e	ARG2
protected	O
against	O
SOCE	O
-	O
induced	O
Ca2	O
+	O
overload	O
and	O
ER	O
stress	O
via	O
the	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
B	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
)	O
signaling	O
pathway	O
in	O
astrocytes	O
.	O
Importantly	O
,	O
gene	O
deletion	O
or	O
blockade	O
of	O
gene1s	ARG2
KCa3.1	ARG2
gene1e	ARG2
restored	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
mechanistic	ARG2
target	ARG2
of	ARG2
rapamycin	ARG2
gene1e	ARG2
signaling	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O
Consistent	O
with	O
these	O
in	O
vitro	O
data	O
,	O
expression	O
levels	O
of	O
the	O
ER	O
stress	O
markers	O
gene1s	ARG2
78-kDa	ARG2
glucose	ARG2
-	ARG2
regulated	ARG2
protein	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CCAAT	ARG2
/	ARG2
enhancer	ARG2
-	ARG2
binding	ARG2
protein	ARG2
homologous	ARG2
protein	ARG2
gene1e	ARG2
,	O
as	O
well	O
as	O
that	O
of	O
the	O
RA	O
marker	O
gene1s	ARG2
glial	ARG2
fibrillary	ARG2
acidic	ARG2
protein	ARG2
gene1e	ARG2
were	O
increased	O
in	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	O
PS1	O
gene1e	O
AD	O
arg1s	O
mouse	O
arg1e	O
model	O
.	O
Elimination	O
of	O
gene1s	ARG2
KCa3.1	ARG2
gene1e	ARG2
in	O
gene1s	ARG2
KCa3.1	ARG2
gene1e	ARG2
-/-/	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	O
PS1	O
gene1e	O
arg1s	O
mice	O
arg1e	O
corrected	O
these	O
abnormal	O
responses	O
.	O
Moreover	O
,	O
glial	O
activation	O
and	O
neuroinflammation	O
were	O
attenuated	O
in	O
the	O
hippocampi	O
of	O
gene1s	ARG2
KCa3.1	ARG2
gene1e	ARG2
-/-/	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	O
PS1	O
gene1e	O
arg1s	O
mice	O
arg1e	O
,	O
as	O
compared	O
with	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	O
PS1	O
gene1e	O
arg1s	O
mice	O
arg1e	O
.	O
In	O
addition	O
,	O
memory	O
deficits	O
and	O
neuronal	O
loss	O
in	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	O
PS1	O
gene1e	O
arg1s	O
mice	O
arg1e	O
were	O
reversed	O
in	O
gene1s	ARG2
KCa3.1	ARG2
gene1e	ARG2
-/-/	O
gene1s	ARG2
APP	ARG2
gene1e	ARG2
/	O
gene1s	O
PS1	O
gene1e	O
arg1s	O
mice	O
arg1e	O
.	O
CONCLUSIONS	O
:	O
Overall	O
,	O
these	O
results	O
suggest	O
that	O
gene1s	ARG2
KCa3.1	ARG2
gene1e	ARG2
is	O
involved	O
in	O
the	O
regulation	O
of	O
Ca2	O
+	O
homeostasis	O
in	O
astrocytes	O
and	O
attenuation	O
of	O
the	O
UPR	O
and	O
ER	O
stress	O
,	O
thus	O
contributing	O
to	O
memory	O
deficits	O
and	O
neuronal	O
loss	O
.	O

A	O
point	O
mutation	O
in	O
gene1s	ARG2
translation	ARG2
initiation	ARG2
factor	ARG2
2B	ARG2
gene1e	ARG2
leads	O
to	O
a	O
continuous	O
hyper	O
stress	O
state	O
in	O
oligodendroglial	O
-	O
derived	O
cells	O
.	O
BACKGROUND	O
:	O
Mutations	O
in	O
gene1s	ARG2
eukaryotic	ARG2
translation	ARG2
initiation	ARG2
factor	ARG2
2B	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
eIF2B	ARG2
gene1e	ARG2
)	O
cause	O
Childhood	O
Ataxia	O
with	O
CNS	O
Hypomyelination	O
(	O
CACH	O
)	O
,	O
also	O
known	O
as	O
Vanishing	O
White	O
Matter	O
disease	O
(	O
VWM	O
)	O
.	O
The	O
disease	O
is	O
manifested	O
by	O
loss	O
of	O
brain	O
myelin	O
upon	O
physiological	O
stress	O
.	O
In	O
a	O
previous	O
study	O
,	O
we	O
showed	O
that	O
fibroblasts	O
isolated	O
from	O
CACH	O
/	O
VWM	O
arg1s	O
patients	O
arg1e	O
are	O
hypersensitive	O
to	O
pharmacologically	O
-	O
induced	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
stress	O
.	O
Since	O
brain	O
cells	O
from	O
affected	O
individuals	O
are	O
not	O
available	O
for	O
research	O
,	O
we	O
wished	O
to	O
assess	O
the	O
effect	O
of	O
gene1s	ARG2
eIF2B	ARG2
gene1e	ARG2
mutation	O
on	O
oligodendroglial	O
-	O
derived	O
cells	O
.	O
METHODOLOGY	O
/	O
PRINCIPAL	O
FINDINGS	O
:	O
A	O
species1s	O
rat	O
species1e	O
oligodendroglial	O
-	O
derived	O
cell	O
line	O
was	O
used	O
for	O
a	O
stable	O
knock	O
-	O
down	O
of	O
gene1s	O
eIF2B5	O
gene1e	O
followed	O
by	O
stable	O
expression	O
of	O
mutated	O
gene1s	ARG2
eIF2B5	ARG2
gene1e	ARG2
(R195H	O
)	O
cDNA	O
.	O
In	O
response	O
to	O
a	O
pharmacological	O
ER	O
-	O
stress	O
agent	O
,	O
gene1s	ARG2
eIF2B5	ARG2
gene1e	ARG2
(R195H	O
)	O
expressing	O
cells	O
exhibited	O
heightened	O
ER	O
-	O
stress	O
response	O
demonstrated	O
by	O
hyper	O
induction	O
of	O
gene1s	O
ATF4	O
gene1e	O
,	O
gene1s	O
GADD34	O
gene1e	O
,	O
gene1s	O
Bip	O
gene1e	O
,	O
gene1s	O
PDIA1	O
gene1e	O
,	O
gene1s	O
PDIA3	O
gene1e	O
,	O
gene1s	O
PDIA4	O
gene1e	O
and	O
gene1s	O
PDIA6	O
gene1e	O
proteins	O
.	O
Moreover	O
,	O
even	O
in	O
the	O
absence	O
of	O
a	O
pharmacological	O
stress	O
agent	O
,	O
gene1s	ARG2
eIF2B5	ARG2
gene1e	ARG2
(R195H)-expressing	O
cells	O
exhibited	O
high	O
basal	O
levels	O
of	O
gene1s	O
ATF4	O
gene1e	O
,	O
gene1s	O
GADD34	O
gene1e	O
and	O
ER	O
-	O
associated	O
gene1s	O
Bip	O
gene1e	O
,	O
gene1s	O
PDIA1	O
gene1e	O
and	O
gene1s	O
PDIA3	O
gene1e	O
.	O
SIGNIFICANCE	O
:	O
The	O
data	O
provide	O
evidence	O
that	O
oligodendroglial	O
-	O
derived	O
cells	O
expressing	O
a	O
mutated	O
gene1s	ARG2
eIF2B	ARG2
gene1e	ARG2
constantly	O
use	O
their	O
stress	O
response	O
mechanism	O
as	O
an	O
adaptation	O
mean	O
in	O
order	O
to	O
survive	O
.	O
The	O
current	O
study	O
is	O
the	O
first	O
to	O
demonstrate	O
the	O
effects	O
of	O
gene1s	ARG2
eIF2B5	ARG2
gene1e	ARG2
mutation	O
on	O
ER	O
homeostasis	O
in	O
oligodendroglial	O
-	O
derived	O
cells	O
.	O

A	O
point	O
mutation	O
in	O
gene1s	O
translation	O
initiation	O
factor	O
2B	O
gene1e	O
leads	O
to	O
a	O
continuous	O
hyper	O
stress	O
state	O
in	O
oligodendroglial	O
-	O
derived	O
cells	O
.	O
BACKGROUND	O
:	O
Mutations	O
in	O
gene1s	O
eukaryotic	O
translation	O
initiation	O
factor	O
2B	O
gene1e	O
(	O
gene1s	O
eIF2B	O
gene1e	O
)	O
cause	O
Childhood	O
Ataxia	O
with	O
CNS	O
Hypomyelination	O
(	O
CACH	O
)	O
,	O
also	O
known	O
as	O
Vanishing	O
White	O
Matter	O
disease	O
(	O
VWM	O
)	O
.	O
The	O
disease	O
is	O
manifested	O
by	O
loss	O
of	O
brain	O
myelin	O
upon	O
physiological	O
stress	O
.	O
In	O
a	O
previous	O
study	O
,	O
we	O
showed	O
that	O
fibroblasts	O
isolated	O
from	O
CACH	O
/	O
VWM	O
species1s	O
patients	O
species1e	O
are	O
hypersensitive	O
to	O
pharmacologically	O
-	O
induced	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
stress	O
.	O
Since	O
brain	O
cells	O
from	O
affected	O
individuals	O
are	O
not	O
available	O
for	O
research	O
,	O
we	O
wished	O
to	O
assess	O
the	O
effect	O
of	O
gene1s	O
eIF2B	O
gene1e	O
mutation	O
on	O
oligodendroglial	O
-	O
derived	O
cells	O
.	O
METHODOLOGY	O
/	O
PRINCIPAL	O
FINDINGS	O
:	O
A	O
arg1s	O
rat	O
arg1e	O
oligodendroglial	O
-	O
derived	O
cell	O
line	O
was	O
used	O
for	O
a	O
stable	O
knock	O
-	O
down	O
of	O
gene1s	ARG2
eIF2B5	ARG2
gene1e	ARG2
followed	O
by	O
stable	O
expression	O
of	O
mutated	O
gene1s	O
eIF2B5	O
gene1e	O
(R195H	O
)	O
cDNA	O
.	O
In	O
response	O
to	O
a	O
pharmacological	O
ER	O
-	O
stress	O
agent	O
,	O
gene1s	O
eIF2B5	O
gene1e	O
(R195H	O
)	O
expressing	O
cells	O
exhibited	O
heightened	O
ER	O
-	O
stress	O
response	O
demonstrated	O
by	O
hyper	O
induction	O
of	O
gene1s	ARG2
ATF4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
GADD34	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Bip	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PDIA1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PDIA3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PDIA4	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
PDIA6	ARG2
gene1e	ARG2
proteins	O
.	O
Moreover	O
,	O
even	O
in	O
the	O
absence	O
of	O
a	O
pharmacological	O
stress	O
agent	O
,	O
gene1s	O
eIF2B5	O
gene1e	O
(R195H)-expressing	O
cells	O
exhibited	O
high	O
basal	O
levels	O
of	O
gene1s	ARG2
ATF4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
GADD34	ARG2
gene1e	ARG2
and	O
ER	O
-	O
associated	O
gene1s	ARG2
Bip	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PDIA1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
PDIA3	ARG2
gene1e	ARG2
.	O
SIGNIFICANCE	O
:	O
The	O
data	O
provide	O
evidence	O
that	O
oligodendroglial	O
-	O
derived	O
cells	O
expressing	O
a	O
mutated	O
gene1s	O
eIF2B	O
gene1e	O
constantly	O
use	O
their	O
stress	O
response	O
mechanism	O
as	O
an	O
adaptation	O
mean	O
in	O
order	O
to	O
survive	O
.	O
The	O
current	O
study	O
is	O
the	O
first	O
to	O
demonstrate	O
the	O
effects	O
of	O
gene1s	O
eIF2B5	O
gene1e	O
mutation	O
on	O
ER	O
homeostasis	O
in	O
oligodendroglial	O
-	O
derived	O
cells	O
.	O

An	O
inducible	O
arg1s	O
mouse	O
arg1e	O
model	O
of	O
gene1s	ARG2
podocin	ARG2
gene1e	ARG2
-	O
mutation	O
-	O
related	O
nephrotic	O
syndrome	O
.	O
Mutations	O
in	O
the	O
gene1s	O
NPHS2	O
gene1e	O
gene	O
,	O
encoding	O
gene1s	O
podocin	O
gene1e	O
,	O
cause	O
hereditary	O
nephrotic	O
syndrome	O
.	O
The	O
most	O
common	O
gene1s	O
podocin	O
gene1e	O
mutation	O
,	O
R138Q	O
,	O
is	O
associated	O
with	O
early	O
disease	O
onset	O
and	O
rapid	O
progression	O
to	O
end	O
-	O
stage	O
renal	O
disease	O
.	O
Knock	O
-	O
in	O
arg1s	O
mice	O
arg1e	O
carrying	O
a	O
R140Q	O
mutation	O
,	O
the	O
arg1s	O
mouse	O
arg1e	O
analogue	O
of	O
species1s	O
human	O
species1e	O
R138Q	O
,	O
show	O
developmental	O
arrest	O
of	O
podocytes	O
and	O
lethal	O
renal	O
failure	O
at	O
neonatal	O
age	O
.	O
Here	O
we	O
created	O
a	O
conditional	O
gene1s	ARG2
podocin	ARG2
gene1e	ARG2
knock	O
-	O
in	O
model	O
named	O
gene1s	ARG2
NPHS2	ARG2
gene1e	ARG2
R140Q/-	O
,	O
using	O
a	O
tamoxifen	O
-	O
inducible	O
Cre	O
recombinase	O
,	O
which	O
permits	O
to	O
study	O
the	O
effects	O
of	O
the	O
mutation	O
in	O
postnatal	O
life	O
.	O
Within	O
the	O
first	O
week	O
of	O
R140Q	O
hemizygosity	O
induction	O
the	O
animals	O
developed	O
proteinuria	O
,	O
which	O
peaked	O
after	O
4	O
-	O
5	O
weeks	O
.	O
Subsequently	O
the	O
animals	O
developed	O
progressive	O
renal	O
failure	O
,	O
with	O
a	O
median	O
survival	O
time	O
of	O
12	O
(	O
95	O
%	O
CI	O
:	O
11	O
-	O
13	O
)	O
weeks	O
.	O
Foot	O
process	O
fusion	O
was	O
observed	O
within	O
one	O
week	O
,	O
progressing	O
to	O
severe	O
and	O
global	O
effacement	O
in	O
the	O
course	O
of	O
the	O
disease	O
.	O
The	O
number	O
of	O
podocytes	O
per	O
glomerulus	O
gradually	O
diminished	O
to	O
18	O
%	O
compared	O
to	O
healthy	O
controls	O
12	O
-	O
16	O
weeks	O
after	O
induction	O
.	O
The	O
fraction	O
of	O
segmentally	O
sclerosed	O
glomeruli	O
was	O
25	O
%	O
,	O
85	O
%	O
and	O
97	O
%	O
at	O
2	O
,	O
4	O
and	O
8	O
weeks	O
,	O
respectively	O
.	O
Severe	O
tubulointerstitial	O
fibrosis	O
was	O
present	O
at	O
later	O
disease	O
stage	O
and	O
was	O
correlated	O
quantitatively	O
with	O
the	O
level	O
of	O
proteinuria	O
at	O
early	O
disease	O
stages	O
.	O
While	O
R140Q	O
gene1s	ARG2
podocin	ARG2
gene1e	ARG2
mRNA	O
expression	O
was	O
elevated	O
,	O
protein	O
abundance	O
was	O
reduced	O
by	O
more	O
than	O
50	O
%	O
within	O
one	O
week	O
following	O
induction	O
.	O
Whereas	O
gene1s	O
miRNA21	O
gene1e	O
expression	O
persistently	O
increased	O
during	O
the	O
first	O
4	O
weeks	O
,	O
gene1s	O
miRNA-193a	O
gene1e	O
expression	O
peaked	O
2	O
weeks	O
after	O
induction	O
.	O
In	O
conclusion	O
,	O
the	O
inducible	O
R140Q	O
-	O
gene1s	ARG2
podocin	ARG2
gene1e	ARG2
arg1s	O
mouse	O
arg1e	O
model	O
is	O
an	O
auspicious	O
model	O
of	O
the	O
most	O
common	O
genetic	O
cause	O
of	O
species1s	O
human	O
species1e	O
nephrotic	O
syndrome	O
,	O
with	O
a	O
spontaneous	O
disease	O
course	O
strongly	O
reminiscent	O
of	O
the	O
species1s	O
human	O
species1e	O
disorder	O
.	O
This	O
model	O
constitutes	O
a	O
valuable	O
tool	O
to	O
test	O
the	O
efficacy	O
of	O
novel	O
pharmacological	O
interventions	O
aimed	O
to	O
improve	O
podocyte	O
function	O
and	O
viability	O
and	O
attenuate	O
proteinuria	O
,	O
glomerulosclerosis	O
and	O
progressive	O
renal	O
failure	O
.	O

An	O
inducible	O
species1s	O
mouse	O
species1e	O
model	O
of	O
gene1s	O
podocin	O
gene1e	O
-	O
mutation	O
-	O
related	O
nephrotic	O
syndrome	O
.	O
Mutations	O
in	O
the	O
gene1s	ARG2
NPHS2	ARG2
gene1e	ARG2
gene	O
,	O
encoding	O
gene1s	ARG2
podocin	ARG2
gene1e	ARG2
,	O
cause	O
hereditary	O
nephrotic	O
syndrome	O
.	O
The	O
most	O
common	O
gene1s	ARG2
podocin	ARG2
gene1e	ARG2
mutation	O
,	O
R138Q	O
,	O
is	O
associated	O
with	O
early	O
disease	O
onset	O
and	O
rapid	O
progression	O
to	O
end	O
-	O
stage	O
renal	O
disease	O
.	O
Knock	O
-	O
in	O
species1s	O
mice	O
species1e	O
carrying	O
a	O
R140Q	O
mutation	O
,	O
the	O
species1s	O
mouse	O
species1e	O
analogue	O
of	O
arg1s	O
human	O
arg1e	O
R138Q	O
,	O
show	O
developmental	O
arrest	O
of	O
podocytes	O
and	O
lethal	O
renal	O
failure	O
at	O
neonatal	O
age	O
.	O
Here	O
we	O
created	O
a	O
conditional	O
gene1s	O
podocin	O
gene1e	O
knock	O
-	O
in	O
model	O
named	O
gene1s	O
NPHS2	O
gene1e	O
R140Q/-	O
,	O
using	O
a	O
tamoxifen	O
-	O
inducible	O
Cre	O
recombinase	O
,	O
which	O
permits	O
to	O
study	O
the	O
effects	O
of	O
the	O
mutation	O
in	O
postnatal	O
life	O
.	O
Within	O
the	O
first	O
week	O
of	O
R140Q	O
hemizygosity	O
induction	O
the	O
animals	O
developed	O
proteinuria	O
,	O
which	O
peaked	O
after	O
4	O
-	O
5	O
weeks	O
.	O
Subsequently	O
the	O
animals	O
developed	O
progressive	O
renal	O
failure	O
,	O
with	O
a	O
median	O
survival	O
time	O
of	O
12	O
(	O
95	O
%	O
CI	O
:	O
11	O
-	O
13	O
)	O
weeks	O
.	O
Foot	O
process	O
fusion	O
was	O
observed	O
within	O
one	O
week	O
,	O
progressing	O
to	O
severe	O
and	O
global	O
effacement	O
in	O
the	O
course	O
of	O
the	O
disease	O
.	O
The	O
number	O
of	O
podocytes	O
per	O
glomerulus	O
gradually	O
diminished	O
to	O
18	O
%	O
compared	O
to	O
healthy	O
controls	O
12	O
-	O
16	O
weeks	O
after	O
induction	O
.	O
The	O
fraction	O
of	O
segmentally	O
sclerosed	O
glomeruli	O
was	O
25	O
%	O
,	O
85	O
%	O
and	O
97	O
%	O
at	O
2	O
,	O
4	O
and	O
8	O
weeks	O
,	O
respectively	O
.	O
Severe	O
tubulointerstitial	O
fibrosis	O
was	O
present	O
at	O
later	O
disease	O
stage	O
and	O
was	O
correlated	O
quantitatively	O
with	O
the	O
level	O
of	O
proteinuria	O
at	O
early	O
disease	O
stages	O
.	O
While	O
R140Q	O
gene1s	O
podocin	O
gene1e	O
mRNA	O
expression	O
was	O
elevated	O
,	O
protein	O
abundance	O
was	O
reduced	O
by	O
more	O
than	O
50	O
%	O
within	O
one	O
week	O
following	O
induction	O
.	O
Whereas	O
gene1s	ARG2
miRNA21	ARG2
gene1e	ARG2
expression	O
persistently	O
increased	O
during	O
the	O
first	O
4	O
weeks	O
,	O
gene1s	ARG2
miRNA-193a	ARG2
gene1e	ARG2
expression	O
peaked	O
2	O
weeks	O
after	O
induction	O
.	O
In	O
conclusion	O
,	O
the	O
inducible	O
R140Q	O
-	O
gene1s	O
podocin	O
gene1e	O
species1s	O
mouse	O
species1e	O
model	O
is	O
an	O
auspicious	O
model	O
of	O
the	O
most	O
common	O
genetic	O
cause	O
of	O
arg1s	O
human	O
arg1e	O
nephrotic	O
syndrome	O
,	O
with	O
a	O
spontaneous	O
disease	O
course	O
strongly	O
reminiscent	O
of	O
the	O
arg1s	O
human	O
arg1e	O
disorder	O
.	O
This	O
model	O
constitutes	O
a	O
valuable	O
tool	O
to	O
test	O
the	O
efficacy	O
of	O
novel	O
pharmacological	O
interventions	O
aimed	O
to	O
improve	O
podocyte	O
function	O
and	O
viability	O
and	O
attenuate	O
proteinuria	O
,	O
glomerulosclerosis	O
and	O
progressive	O
renal	O
failure	O
.	O

The	O
arg1s	O
Drosophila	O
arg1e	O
gene1s	ARG2
fussel	ARG2
gene1e	ARG2
gene	O
is	O
required	O
for	O
bitter	O
gustatory	O
neuron	O
differentiation	O
acting	O
within	O
an	O
gene1s	ARG2
Rpd3	ARG2
gene1e	ARG2
dependent	O
chromatin	O
modifying	O
complex	O
.	O
Members	O
of	O
the	O
gene1s	ARG2
Ski	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Sno	ARG2
gene1e	ARG2
protein	O
family	O
are	O
classified	O
as	O
proto	O
-	O
oncogenes	O
and	O
act	O
as	O
negative	O
regulators	O
of	O
the	O
gene1s	ARG2
TGF	ARG2
-	ARG2
ss	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
BMP	ARG2
gene1e	ARG2
-	O
pathways	O
in	O
vertebrates	O
and	O
invertebrates	O
.	O
A	O
newly	O
identified	O
member	O
of	O
this	O
protein	O
family	O
is	O
gene1s	ARG2
fussel	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
fuss	ARG2
gene1e	ARG2
)	O
,	O
the	O
arg1s	O
Drosophila	O
arg1e	O
homologue	O
of	O
the	O
species1s	O
human	O
species1e	O
functional	O
gene1s	O
Smad	O
suppressing	O
elements	O
gene1e	O
(	O
gene1s	O
fussel-15	O
gene1e	O
and	O
gene1s	O
fussel-18	O
gene1e	O
)	O
.	O
We	O
and	O
others	O
have	O
shown	O
that	O
gene1s	ARG2
Fuss	ARG2
gene1e	ARG2
interacts	O
with	O
gene1s	ARG2
SMAD4	ARG2
gene1e	ARG2
and	O
that	O
overexpression	O
leads	O
to	O
a	O
strong	O
inhibition	O
of	O
gene1s	ARG2
Dpp	ARG2
gene1e	ARG2
signaling	O
.	O
However	O
,	O
to	O
be	O
able	O
to	O
characterize	O
the	O
endogenous	O
gene1s	ARG2
Fuss	ARG2
gene1e	ARG2
function	O
in	O
arg1s	O
Drosophila	O
melanogaster	O
arg1e	O
,	O
we	O
have	O
generated	O
a	O
number	O
of	O
state	O
of	O
the	O
art	O
tools	O
including	O
anti	O
-	O
gene1s	ARG2
Fuss	ARG2
gene1e	ARG2
antibodies	O
,	O
specific	O
gene1s	ARG2
fuss	ARG2
gene1e	ARG2
-	O
Gal4	O
lines	O
and	O
gene1s	ARG2
fuss	ARG2
gene1e	ARG2
mutant	O
arg1s	O
fly	O
arg1e	O
lines	O
via	O
the	O
CRISPR	O
/	O
Cas9	O
system	O
.	O
gene1s	ARG2
Fuss	ARG2
gene1e	ARG2
is	O
a	O
predominantly	O
nuclear	O
,	O
postmitotic	O
protein	O
,	O
mainly	O
expressed	O
in	O
interneurons	O
and	O
gene1s	ARG2
fuss	ARG2
gene1e	ARG2
mutants	O
are	O
fully	O
viable	O
without	O
any	O
obvious	O
developmental	O
phenotype	O
.	O
To	O
identify	O
potential	O
target	O
genes	O
or	O
cells	O
affected	O
in	O
gene1s	ARG2
fuss	ARG2
gene1e	ARG2
mutants	O
,	O
we	O
conducted	O
targeted	O
DamID	O
experiments	O
in	O
adult	O
flies	O
,	O
which	O
revealed	O
the	O
function	O
of	O
gene1s	ARG2
fuss	ARG2
gene1e	ARG2
in	O
bitter	O
gustatory	O
neurons	O
.	O
We	O
fully	O
characterized	O
gene1s	ARG2
fuss	ARG2
gene1e	ARG2
expression	O
in	O
the	O
adult	O
proboscis	O
and	O
by	O
using	O
food	O
choice	O
assays	O
we	O
were	O
able	O
to	O
show	O
that	O
gene1s	ARG2
fuss	ARG2
gene1e	ARG2
mutants	O
display	O
defects	O
in	O
detecting	O
bitter	O
compounds	O
.	O
This	O
correlated	O
with	O
a	O
reduction	O
of	O
gustatory	O
receptor	O
gene	O
expression	O
(	O
gene1s	ARG2
Gr33a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Gr66a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Gr93a	ARG2
gene1e	ARG2
)	O
providing	O
a	O
molecular	O
link	O
to	O
the	O
behavioral	O
phenotype	O
.	O
In	O
addition	O
,	O
gene1s	ARG2
Fuss	ARG2
gene1e	ARG2
interacts	O
with	O
gene1s	ARG2
Rpd3	ARG2
gene1e	ARG2
,	O
and	O
downregulation	O
of	O
gene1s	ARG2
rpd3	ARG2
gene1e	ARG2
in	O
gustatory	O
neurons	O
phenocopies	O
the	O
loss	O
of	O
gene1s	ARG2
Fuss	ARG2
gene1e	ARG2
expression	O
.	O
Surprisingly	O
,	O
there	O
is	O
no	O
colocalization	O
of	O
gene1s	ARG2
Fuss	ARG2
gene1e	ARG2
with	O
phosphorylated	O
gene1s	ARG2
Mad	ARG2
gene1e	ARG2
in	O
the	O
larval	O
central	O
nervous	O
system	O
,	O
excluding	O
a	O
direct	O
involvement	O
of	O
gene1s	ARG2
Fuss	ARG2
gene1e	ARG2
in	O
gene1s	ARG2
Dpp	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
BMP	ARG2
gene1e	ARG2
signaling	O
.	O
Here	O
we	O
provide	O
a	O
first	O
and	O
exciting	O
link	O
of	O
gene1s	ARG2
Fuss	ARG2
gene1e	ARG2
function	O
in	O
gustatory	O
bitter	O
neurons	O
.	O
Although	O
gustatory	O
receptors	O
have	O
been	O
well	O
characterized	O
,	O
little	O
is	O
known	O
regarding	O
the	O
differentiation	O
and	O
maturation	O
of	O
gustatory	O
neurons	O
.	O
This	O
work	O
therefore	O
reveals	O
gene1s	ARG2
Fuss	ARG2
gene1e	ARG2
as	O
a	O
pivotal	O
element	O
for	O
the	O
proper	O
differentiation	O
of	O
bitter	O
gustatory	O
neurons	O
acting	O
within	O
a	O
chromatin	O
modifying	O
complex	O
.	O

The	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
fussel	O
gene1e	O
gene	O
is	O
required	O
for	O
bitter	O
gustatory	O
neuron	O
differentiation	O
acting	O
within	O
an	O
gene1s	O
Rpd3	O
gene1e	O
dependent	O
chromatin	O
modifying	O
complex	O
.	O
Members	O
of	O
the	O
gene1s	O
Ski	O
gene1e	O
/	O
gene1s	O
Sno	O
gene1e	O
protein	O
family	O
are	O
classified	O
as	O
proto	O
-	O
oncogenes	O
and	O
act	O
as	O
negative	O
regulators	O
of	O
the	O
gene1s	O
TGF	O
-	O
ss	O
gene1e	O
/	O
gene1s	O
BMP	O
gene1e	O
-	O
pathways	O
in	O
vertebrates	O
and	O
invertebrates	O
.	O
A	O
newly	O
identified	O
member	O
of	O
this	O
protein	O
family	O
is	O
gene1s	O
fussel	O
gene1e	O
(	O
gene1s	O
fuss	O
gene1e	O
)	O
,	O
the	O
species1s	O
Drosophila	O
species1e	O
homologue	O
of	O
the	O
arg1s	O
human	O
arg1e	O
functional	O
gene1s	ARG2
Smad	ARG2
suppressing	ARG2
elements	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
fussel-15	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
fussel-18	ARG2
gene1e	ARG2
)	O
.	O
We	O
and	O
others	O
have	O
shown	O
that	O
gene1s	O
Fuss	O
gene1e	O
interacts	O
with	O
gene1s	O
SMAD4	O
gene1e	O
and	O
that	O
overexpression	O
leads	O
to	O
a	O
strong	O
inhibition	O
of	O
gene1s	O
Dpp	O
gene1e	O
signaling	O
.	O
However	O
,	O
to	O
be	O
able	O
to	O
characterize	O
the	O
endogenous	O
gene1s	O
Fuss	O
gene1e	O
function	O
in	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
,	O
we	O
have	O
generated	O
a	O
number	O
of	O
state	O
of	O
the	O
art	O
tools	O
including	O
anti	O
-	O
gene1s	O
Fuss	O
gene1e	O
antibodies	O
,	O
specific	O
gene1s	O
fuss	O
gene1e	O
-	O
Gal4	O
lines	O
and	O
gene1s	O
fuss	O
gene1e	O
mutant	O
species1s	O
fly	O
species1e	O
lines	O
via	O
the	O
CRISPR	O
/	O
Cas9	O
system	O
.	O
gene1s	O
Fuss	O
gene1e	O
is	O
a	O
predominantly	O
nuclear	O
,	O
postmitotic	O
protein	O
,	O
mainly	O
expressed	O
in	O
interneurons	O
and	O
gene1s	O
fuss	O
gene1e	O
mutants	O
are	O
fully	O
viable	O
without	O
any	O
obvious	O
developmental	O
phenotype	O
.	O
To	O
identify	O
potential	O
target	O
genes	O
or	O
cells	O
affected	O
in	O
gene1s	O
fuss	O
gene1e	O
mutants	O
,	O
we	O
conducted	O
targeted	O
DamID	O
experiments	O
in	O
adult	O
flies	O
,	O
which	O
revealed	O
the	O
function	O
of	O
gene1s	O
fuss	O
gene1e	O
in	O
bitter	O
gustatory	O
neurons	O
.	O
We	O
fully	O
characterized	O
gene1s	O
fuss	O
gene1e	O
expression	O
in	O
the	O
adult	O
proboscis	O
and	O
by	O
using	O
food	O
choice	O
assays	O
we	O
were	O
able	O
to	O
show	O
that	O
gene1s	O
fuss	O
gene1e	O
mutants	O
display	O
defects	O
in	O
detecting	O
bitter	O
compounds	O
.	O
This	O
correlated	O
with	O
a	O
reduction	O
of	O
gustatory	O
receptor	O
gene	O
expression	O
(	O
gene1s	O
Gr33a	O
gene1e	O
,	O
gene1s	O
Gr66a	O
gene1e	O
,	O
gene1s	O
Gr93a	O
gene1e	O
)	O
providing	O
a	O
molecular	O
link	O
to	O
the	O
behavioral	O
phenotype	O
.	O
In	O
addition	O
,	O
gene1s	O
Fuss	O
gene1e	O
interacts	O
with	O
gene1s	O
Rpd3	O
gene1e	O
,	O
and	O
downregulation	O
of	O
gene1s	O
rpd3	O
gene1e	O
in	O
gustatory	O
neurons	O
phenocopies	O
the	O
loss	O
of	O
gene1s	O
Fuss	O
gene1e	O
expression	O
.	O
Surprisingly	O
,	O
there	O
is	O
no	O
colocalization	O
of	O
gene1s	O
Fuss	O
gene1e	O
with	O
phosphorylated	O
gene1s	O
Mad	O
gene1e	O
in	O
the	O
larval	O
central	O
nervous	O
system	O
,	O
excluding	O
a	O
direct	O
involvement	O
of	O
gene1s	O
Fuss	O
gene1e	O
in	O
gene1s	O
Dpp	O
gene1e	O
/	O
gene1s	O
BMP	O
gene1e	O
signaling	O
.	O
Here	O
we	O
provide	O
a	O
first	O
and	O
exciting	O
link	O
of	O
gene1s	O
Fuss	O
gene1e	O
function	O
in	O
gustatory	O
bitter	O
neurons	O
.	O
Although	O
gustatory	O
receptors	O
have	O
been	O
well	O
characterized	O
,	O
little	O
is	O
known	O
regarding	O
the	O
differentiation	O
and	O
maturation	O
of	O
gustatory	O
neurons	O
.	O
This	O
work	O
therefore	O
reveals	O
gene1s	O
Fuss	O
gene1e	O
as	O
a	O
pivotal	O
element	O
for	O
the	O
proper	O
differentiation	O
of	O
bitter	O
gustatory	O
neurons	O
acting	O
within	O
a	O
chromatin	O
modifying	O
complex	O
.	O

Whole	O
-	O
Organism	O
Developmental	O
Expression	O
Profiling	O
Identifies	O
gene1s	O
RAB-28	O
gene1e	O
as	O
a	O
Novel	O
Ciliary	O
gene1s	O
GTPase	O
gene1e	O
Associated	O
with	O
the	O
gene1s	O
BBSome	O
gene1e	O
and	O
Intraflagellar	O
Transport	O
.	O
Primary	O
cilia	O
are	O
specialised	O
sensory	O
and	O
developmental	O
signalling	O
devices	O
extending	O
from	O
the	O
surface	O
of	O
most	O
eukaryotic	O
cells	O
.	O
Defects	O
in	O
these	O
organelles	O
cause	O
inherited	O
arg1s	O
human	O
arg1e	O
disorders	O
(	O
ciliopathies	O
)	O
such	O
as	O
retinitis	O
pigmentosa	O
and	O
Bardet	O
-	O
Biedl	O
syndrome	O
(	O
BBS	O
)	O
,	O
frequently	O
affecting	O
many	O
physiological	O
and	O
developmental	O
processes	O
across	O
multiple	O
organs	O
.	O
Cilium	O
formation	O
,	O
maintenance	O
and	O
function	O
depend	O
on	O
intracellular	O
transport	O
systems	O
such	O
as	O
intraflagellar	O
transport	O
(	O
IFT	O
)	O
,	O
which	O
is	O
driven	O
by	O
gene1s	O
kinesin-2	O
gene1e	O
and	O
IFT	O
-	O
gene1s	O
dynein	O
gene1e	O
motors	O
and	O
regulated	O
by	O
the	O
gene1s	O
Bardet	O
-	O
Biedl	O
syndrome	O
(	O
BBS	O
)	O
cargo	O
-	O
adaptor	O
protein	O
complex	O
gene1e	O
,	O
or	O
gene1s	O
BBSome	O
gene1e	O
.	O
To	O
identify	O
new	O
cilium	O
-	O
associated	O
genes	O
,	O
we	O
employed	O
the	O
nematode	O
species1s	O
C.	O
elegans	O
species1e	O
,	O
where	O
ciliogenesis	O
occurs	O
within	O
a	O
short	O
timespan	O
during	O
late	O
embryogenesis	O
when	O
most	O
sensory	O
neurons	O
differentiate	O
.	O
Using	O
whole	O
-	O
organism	O
RNA	O
-	O
Seq	O
libraries	O
,	O
we	O
discovered	O
a	O
signature	O
expression	O
profile	O
highly	O
enriched	O
for	O
transcripts	O
of	O
known	O
ciliary	O
proteins	O
,	O
including	O
gene1s	O
FAM-161	O
gene1e	O
(	O
gene1s	ARG2
FAM161A	ARG2
gene1e	ARG2
orthologue	O
)	O
,	O
gene1s	ARG2
CCDC-104	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CCDC104	ARG2
gene1e	ARG2
)	O
,	O
and	O
gene1s	O
RPI-1	O
gene1e	O
(	O
gene1s	ARG2
RP1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
RP1L1	ARG2
gene1e	ARG2
)	O
,	O
which	O
we	O
confirm	O
are	O
cilium	O
-	O
localised	O
in	O
worms	O
.	O
From	O
a	O
list	O
of	O
185	O
candidate	O
ciliary	O
genes	O
,	O
we	O
uncover	O
orthologues	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
MAP9	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
YAP	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CCDC149	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
RAB28	ARG2
gene1e	ARG2
as	O
conserved	O
cilium	O
-	O
associated	O
components	O
.	O
Further	O
analyses	O
of	O
species1s	O
C.	O
elegans	O
species1e	O
gene1s	O
RAB-28	O
gene1e	O
,	O
recently	O
associated	O
with	O
autosomal	O
-	O
recessive	O
cone	O
-	O
rod	O
dystrophy	O
,	O
reveal	O
that	O
this	O
small	O
gene1s	O
GTPase	O
gene1e	O
is	O
exclusively	O
expressed	O
in	O
ciliated	O
neurons	O
where	O
it	O
dynamically	O
associates	O
with	O
IFT	O
trains	O
.	O
Whereas	O
inactive	O
GDP	O
-	O
bound	O
gene1s	O
RAB-28	O
gene1e	O
displays	O
no	O
IFT	O
movement	O
and	O
diffuse	O
localisation	O
,	O
GTP	O
-	O
bound	O
(	O
activated	O
)	O
gene1s	O
RAB-28	O
gene1e	O
concentrates	O
at	O
the	O
periciliary	O
membrane	O
in	O
a	O
gene1s	O
BBSome	O
gene1e	O
-	O
dependent	O
manner	O
and	O
undergoes	O
bidirectional	O
IFT	O
.	O
Functional	O
analyses	O
reveal	O
that	O
whilst	O
cilium	O
structure	O
,	O
sensory	O
function	O
and	O
IFT	O
are	O
seemingly	O
normal	O
in	O
a	O
gene1s	O
rab-28	O
gene1e	O
null	O
allele	O
,	O
overexpression	O
of	O
predicted	O
GDP	O
or	O
GTP	O
locked	O
variants	O
of	O
gene1s	O
RAB-28	O
gene1e	O
perturbs	O
cilium	O
and	O
sensory	O
pore	O
morphogenesis	O
and	O
function	O
.	O
Collectively	O
,	O
our	O
findings	O
present	O
a	O
new	O
approach	O
for	O
identifying	O
ciliary	O
proteins	O
,	O
and	O
unveil	O
gene1s	ARG2
RAB28	ARG2
gene1e	ARG2
,	O
a	O
gene1s	ARG2
GTPase	ARG2
gene1e	ARG2
most	O
closely	O
related	O
to	O
the	O
BBS	O
protein	O
gene1s	ARG2
RABL4	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
IFT27	ARG2
gene1e	ARG2
,	O
as	O
an	O
IFT	O
-	O
associated	O
cargo	O
with	O
gene1s	ARG2
BBSome	ARG2
gene1e	ARG2
-	O
dependent	O
cell	O
autonomous	O
and	O
non	O
-	O
autonomous	O
functions	O
at	O
the	O
ciliary	O
base	O
.	O

Whole	O
-	O
Organism	O
Developmental	O
Expression	O
Profiling	O
Identifies	O
gene1s	ARG2
RAB-28	ARG2
gene1e	ARG2
as	O
a	O
Novel	O
Ciliary	O
gene1s	ARG2
GTPase	ARG2
gene1e	ARG2
Associated	O
with	O
the	O
gene1s	ARG2
BBSome	ARG2
gene1e	ARG2
and	O
Intraflagellar	O
Transport	O
.	O
Primary	O
cilia	O
are	O
specialised	O
sensory	O
and	O
developmental	O
signalling	O
devices	O
extending	O
from	O
the	O
surface	O
of	O
most	O
eukaryotic	O
cells	O
.	O
Defects	O
in	O
these	O
organelles	O
cause	O
inherited	O
species1s	O
human	O
species1e	O
disorders	O
(	O
ciliopathies	O
)	O
such	O
as	O
retinitis	O
pigmentosa	O
and	O
Bardet	O
-	O
Biedl	O
syndrome	O
(	O
BBS	O
)	O
,	O
frequently	O
affecting	O
many	O
physiological	O
and	O
developmental	O
processes	O
across	O
multiple	O
organs	O
.	O
Cilium	O
formation	O
,	O
maintenance	O
and	O
function	O
depend	O
on	O
intracellular	O
transport	O
systems	O
such	O
as	O
intraflagellar	O
transport	O
(	O
IFT	O
)	O
,	O
which	O
is	O
driven	O
by	O
gene1s	ARG2
kinesin-2	ARG2
gene1e	ARG2
and	O
IFT	O
-	O
gene1s	ARG2
dynein	ARG2
gene1e	ARG2
motors	O
and	O
regulated	O
by	O
the	O
gene1s	ARG2
Bardet	ARG2
-	ARG2
Biedl	ARG2
syndrome	ARG2
(	ARG2
BBS	ARG2
)	ARG2
cargo	ARG2
-	ARG2
adaptor	ARG2
protein	ARG2
complex	ARG2
gene1e	ARG2
,	O
or	O
gene1s	ARG2
BBSome	ARG2
gene1e	ARG2
.	O
To	O
identify	O
new	O
cilium	O
-	O
associated	O
genes	O
,	O
we	O
employed	O
the	O
nematode	O
arg1s	O
C.	O
elegans	O
arg1e	O
,	O
where	O
ciliogenesis	O
occurs	O
within	O
a	O
short	O
timespan	O
during	O
late	O
embryogenesis	O
when	O
most	O
sensory	O
neurons	O
differentiate	O
.	O
Using	O
whole	O
-	O
organism	O
RNA	O
-	O
Seq	O
libraries	O
,	O
we	O
discovered	O
a	O
signature	O
expression	O
profile	O
highly	O
enriched	O
for	O
transcripts	O
of	O
known	O
ciliary	O
proteins	O
,	O
including	O
gene1s	ARG2
FAM-161	ARG2
gene1e	ARG2
(	O
gene1s	O
FAM161A	O
gene1e	O
orthologue	O
)	O
,	O
gene1s	O
CCDC-104	O
gene1e	O
(	O
gene1s	O
CCDC104	O
gene1e	O
)	O
,	O
and	O
gene1s	ARG2
RPI-1	ARG2
gene1e	ARG2
(	O
gene1s	O
RP1	O
gene1e	O
/	O
gene1s	O
RP1L1	O
gene1e	O
)	O
,	O
which	O
we	O
confirm	O
are	O
cilium	O
-	O
localised	O
in	O
worms	O
.	O
From	O
a	O
list	O
of	O
185	O
candidate	O
ciliary	O
genes	O
,	O
we	O
uncover	O
orthologues	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
MAP9	O
gene1e	O
,	O
gene1s	O
YAP	O
gene1e	O
,	O
gene1s	O
CCDC149	O
gene1e	O
,	O
and	O
gene1s	O
RAB28	O
gene1e	O
as	O
conserved	O
cilium	O
-	O
associated	O
components	O
.	O
Further	O
analyses	O
of	O
arg1s	O
C.	O
elegans	O
arg1e	O
gene1s	ARG2
RAB-28	ARG2
gene1e	ARG2
,	O
recently	O
associated	O
with	O
autosomal	O
-	O
recessive	O
cone	O
-	O
rod	O
dystrophy	O
,	O
reveal	O
that	O
this	O
small	O
gene1s	ARG2
GTPase	ARG2
gene1e	ARG2
is	O
exclusively	O
expressed	O
in	O
ciliated	O
neurons	O
where	O
it	O
dynamically	O
associates	O
with	O
IFT	O
trains	O
.	O
Whereas	O
inactive	O
GDP	O
-	O
bound	O
gene1s	ARG2
RAB-28	ARG2
gene1e	ARG2
displays	O
no	O
IFT	O
movement	O
and	O
diffuse	O
localisation	O
,	O
GTP	O
-	O
bound	O
(	O
activated	O
)	O
gene1s	ARG2
RAB-28	ARG2
gene1e	ARG2
concentrates	O
at	O
the	O
periciliary	O
membrane	O
in	O
a	O
gene1s	ARG2
BBSome	ARG2
gene1e	ARG2
-	O
dependent	O
manner	O
and	O
undergoes	O
bidirectional	O
IFT	O
.	O
Functional	O
analyses	O
reveal	O
that	O
whilst	O
cilium	O
structure	O
,	O
sensory	O
function	O
and	O
IFT	O
are	O
seemingly	O
normal	O
in	O
a	O
gene1s	ARG2
rab-28	ARG2
gene1e	ARG2
null	O
allele	O
,	O
overexpression	O
of	O
predicted	O
GDP	O
or	O
GTP	O
locked	O
variants	O
of	O
gene1s	ARG2
RAB-28	ARG2
gene1e	ARG2
perturbs	O
cilium	O
and	O
sensory	O
pore	O
morphogenesis	O
and	O
function	O
.	O
Collectively	O
,	O
our	O
findings	O
present	O
a	O
new	O
approach	O
for	O
identifying	O
ciliary	O
proteins	O
,	O
and	O
unveil	O
gene1s	O
RAB28	O
gene1e	O
,	O
a	O
gene1s	O
GTPase	O
gene1e	O
most	O
closely	O
related	O
to	O
the	O
BBS	O
protein	O
gene1s	O
RABL4	O
gene1e	O
/	O
gene1s	O
IFT27	O
gene1e	O
,	O
as	O
an	O
IFT	O
-	O
associated	O
cargo	O
with	O
gene1s	O
BBSome	O
gene1e	O
-	O
dependent	O
cell	O
autonomous	O
and	O
non	O
-	O
autonomous	O
functions	O
at	O
the	O
ciliary	O
base	O
.	O

gene1s	ARG2
HEB	ARG2
gene1e	ARG2
is	O
required	O
for	O
the	O
specification	O
of	O
fetal	O
gene1s	ARG2
IL-17	ARG2
gene1e	ARG2
-producing	O
gd	O
T	O
cells	O
.	O
gene1s	ARG2
IL-17	ARG2
gene1e	ARG2
-producing	O
gd	O
T	O
(	O
gdT17	O
)	O
cells	O
are	O
critical	O
components	O
of	O
the	O
innate	O
immune	O
system	O
.	O
However	O
,	O
the	O
gene	O
networks	O
that	O
control	O
their	O
development	O
are	O
unclear	O
.	O
Here	O
we	O
show	O
that	O
gene1s	ARG2
HEB	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
HeLa	ARG2
E	ARG2
-	ARG2
box	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
,	O
encoded	O
by	O
gene1s	ARG2
Tcf12	ARG2
gene1e	ARG2
)	O
is	O
required	O
for	O
the	O
generation	O
of	O
a	O
newly	O
defined	O
subset	O
of	O
fetal	O
-	O
derived	O
gene1s	ARG2
CD73	ARG2
gene1e	ARG2
-	O
gdT17	O
cells	O
.	O
gene1s	ARG2
HEB	ARG2
gene1e	ARG2
is	O
required	O
in	O
immature	O
gene1s	ARG2
CD24	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
CD73	ARG2
gene1e	ARG2
-	O
gd	O
T	O
cells	O
for	O
the	O
expression	O
of	O
gene1s	ARG2
Sox4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Sox13	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Rorc	ARG2
gene1e	ARG2
,	O
and	O
these	O
genes	O
are	O
repressed	O
by	O
acute	O
expression	O
of	O
the	O
gene1s	ARG2
HEB	ARG2
gene1e	ARG2
antagonist	O
gene1s	ARG2
Id3	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
HEB	ARG2
gene1e	ARG2
-	O
deficiency	O
also	O
affects	O
mature	O
gene1s	ARG2
CD73	ARG2
gene1e	ARG2
+	O
gd	O
T	O
cells	O
,	O
which	O
are	O
defective	O
in	O
gene1s	ARG2
RORgt	ARG2
gene1e	ARG2
expression	O
and	O
gene1s	ARG2
IL-17	ARG2
gene1e	ARG2
production	O
.	O
Additionally	O
,	O
the	O
fetal	O
gene1s	ARG2
TCRg	ARG2
gene1e	ARG2
chain	O
repertoire	O
is	O
altered	O
,	O
and	O
peripheral	O
gene1s	ARG2
Vg4	ARG2
gene1e	ARG2
gd	O
T	O
cells	O
are	O
mostly	O
restricted	O
to	O
the	O
gene1s	ARG2
IFNg	ARG2
gene1e	ARG2
-	O
producing	O
phenotype	O
in	O
gene1s	ARG2
HEB	ARG2
gene1e	ARG2
-	O
deficient	O
arg1s	O
mice	O
arg1e	O
.	O
Therefore	O
,	O
our	O
work	O
identifies	O
gene1s	ARG2
HEB	ARG2
gene1e	ARG2
-	O
dependent	O
pathways	O
for	O
the	O
development	O
of	O
gene1s	ARG2
CD73	ARG2
gene1e	ARG2
+	O
and	O
gene1s	ARG2
CD73	ARG2
gene1e	ARG2
-	O
gdT17	O
cells	O
,	O
and	O
provides	O
mechanistic	O
evidence	O
for	O
control	O
of	O
the	O
gdT17	O
gene	O
network	O
by	O
gene1s	ARG2
HEB	ARG2
gene1e	ARG2
.	O

Protective	O
effect	O
of	O
naringin	O
against	O
the	O
LPS	O
-	O
induced	O
apoptosis	O
of	O
arg1s	O
PC12	O
arg1e	O
cells	O
:	O
Implications	O
for	O
the	O
treatment	O
of	O
neurodegenerative	O
disorders	O
.	O
Several	O
studies	O
have	O
demonstrated	O
that	O
increased	O
apoptosis	O
plays	O
an	O
essential	O
role	O
in	O
neurodegenerative	O
disorders	O
.	O
It	O
has	O
been	O
demonstrated	O
that	O
lipopolysaccharide	O
(	O
LPS	O
)	O
induces	O
apoptosis	O
largely	O
through	O
the	O
production	O
of	O
intracellular	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
and	O
inflammatory	O
mediators	O
.	O
In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
potential	O
protective	O
mechanisms	O
of	O
naringin	O
(	O
Nar	O
)	O
,	O
a	O
species1s	O
pummelo	O
species1e	O
peel	O
extract	O
,	O
on	O
LPS	O
-	O
induced	O
arg1s	O
PC12	O
arg1e	O
cell	O
apoptosis	O
.	O
Nar	O
pre	O
-	O
conditioning	O
prior	O
to	O
stimulation	O
with	O
LPS	O
for	O
18	O
h	O
was	O
a	O
prerequisite	O
for	O
evaluating	O
arg1s	O
PC12	O
arg1e	O
cell	O
viability	O
and	O
the	O
protective	O
mechanisms	O
of	O
Nar	O
.	O
Nar	O
significantly	O
improved	O
cell	O
survival	O
in	O
a	O
time-	O
and	O
concentration	O
-	O
dependent	O
manner	O
.	O
On	O
the	O
one	O
hand	O
,	O
Nar	O
downregulated	O
gene1s	ARG2
cytochrome	ARG2
P450	ARG2
2E1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CYP2E1	ARG2
gene1e	ARG2
)	O
,	O
inhibited	O
the	O
release	O
of	O
ROS	O
,	O
mitigated	O
the	O
stimulation	O
of	O
oxidative	O
stress	O
,	O
and	O
rectified	O
the	O
antioxidant	O
protein	O
contents	O
of	O
gene1s	ARG2
nuclear	ARG2
factor	ARG2
erythroid	ARG2
2-related	ARG2
factor	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Nrf2	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
heme	ARG2
oxygenase-1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
HO-1	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
superoxide	ARG2
dismutase	ARG2
(	ARG2
SOD)2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
glutathione	ARG2
synthetase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
GSS	ARG2
gene1e	ARG2
)	O
.	O
On	O
the	O
other	O
hand	O
,	O
Nar	O
downregulated	O
inflammatory	O
gene	O
and	O
protein	O
expression	O
,	O
including	O
gene1s	ARG2
interleukin	ARG2
(	ARG2
IL)-1b	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
tumor	ARG2
necrosis	ARG2
factor	ARG2
(	ARG2
TNF)-a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HMGB1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
high	ARG2
mobility	ARG2
group	ARG2
box	ARG2
1	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
HMGB1	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
cyclooxygenase-2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
COX-2	ARG2
gene1e	ARG2
)	O
,	O
the	O
gene1s	ARG2
Toll	ARG2
-	ARG2
like	ARG2
receptor	ARG2
4	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
)-	O
gene1s	ARG2
myeloid	ARG2
differentiation	ARG2
factor	ARG2
88	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
)-	O
gene1s	ARG2
TNF	ARG2
receptor	ARG2
-	ARG2
associated	ARG2
factor	ARG2
6	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TRAF6	ARG2
gene1e	ARG2
)	O
path	O
-	O
way	O
and	O
downstream	O
gene1s	ARG2
mitogen	ARG2
activated	ARG2
protein	ARG2
kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
)	O
phosphorylation	O
,	O
gene1s	ARG2
activator	ARG2
protein	ARG2
transcription	ARG2
factor-1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
AP-1	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
nuclear	ARG2
factor	ARG2
(	ARG2
NF)-kB	ARG2
gene1e	ARG2
.	O
Moroever	O
,	O
Nar	O
markedly	O
attenuated	O
the	O
gene1s	ARG2
cytochrome	ARG2
c	ARG2
gene1e	ARG2
shift	O
from	O
the	O
mitochondria	O
to	O
the	O
cytosol	O
and	O
regulated	O
gene1s	ARG2
caspase-3	ARG2
gene1e	ARG2
-related	O
protein	O
expression	O
.	O
To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
study	O
to	O
report	O
the	O
antioxidant	O
,	O
anti	O
-	O
inflammatory	O
and	O
anti	O
-	O
apoptotic	O
effects	O
of	O
Nar	O
in	O
neuronal	O
-	O
like	O
arg1s	O
PC12	O
arg1e	O
cells	O
.	O
These	O
results	O
suggest	O
that	O
Nar	O
can	O
be	O
utilized	O
as	O
a	O
potential	O
drug	O
for	O
the	O
treatment	O
of	O
neurodegenerative	O
disorders	O
.	O

Protective	O
effect	O
of	O
naringin	O
against	O
the	O
LPS	O
-	O
induced	O
apoptosis	O
of	O
species1s	O
PC12	O
species1e	O
cells	O
:	O
Implications	O
for	O
the	O
treatment	O
of	O
neurodegenerative	O
disorders	O
.	O
Several	O
studies	O
have	O
demonstrated	O
that	O
increased	O
apoptosis	O
plays	O
an	O
essential	O
role	O
in	O
neurodegenerative	O
disorders	O
.	O
It	O
has	O
been	O
demonstrated	O
that	O
lipopolysaccharide	O
(	O
LPS	O
)	O
induces	O
apoptosis	O
largely	O
through	O
the	O
production	O
of	O
intracellular	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
and	O
inflammatory	O
mediators	O
.	O
In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
potential	O
protective	O
mechanisms	O
of	O
naringin	O
(	O
Nar	O
)	O
,	O
a	O
arg1s	O
pummelo	O
arg1e	O
peel	O
extract	O
,	O
on	O
LPS	O
-	O
induced	O
species1s	O
PC12	O
species1e	O
cell	O
apoptosis	O
.	O
Nar	O
pre	O
-	O
conditioning	O
prior	O
to	O
stimulation	O
with	O
LPS	O
for	O
18	O
h	O
was	O
a	O
prerequisite	O
for	O
evaluating	O
species1s	O
PC12	O
species1e	O
cell	O
viability	O
and	O
the	O
protective	O
mechanisms	O
of	O
Nar	O
.	O
Nar	O
significantly	O
improved	O
cell	O
survival	O
in	O
a	O
time-	O
and	O
concentration	O
-	O
dependent	O
manner	O
.	O
On	O
the	O
one	O
hand	O
,	O
Nar	O
downregulated	O
gene1s	O
cytochrome	O
P450	O
2E1	O
gene1e	O
(	O
gene1s	O
CYP2E1	O
gene1e	O
)	O
,	O
inhibited	O
the	O
release	O
of	O
ROS	O
,	O
mitigated	O
the	O
stimulation	O
of	O
oxidative	O
stress	O
,	O
and	O
rectified	O
the	O
antioxidant	O
protein	O
contents	O
of	O
gene1s	O
nuclear	O
factor	O
erythroid	O
2-related	O
factor	O
2	O
gene1e	O
(	O
gene1s	O
Nrf2	O
gene1e	O
)	O
,	O
gene1s	O
heme	O
oxygenase-1	O
gene1e	O
(	O
gene1s	O
HO-1	O
gene1e	O
)	O
,	O
gene1s	O
superoxide	O
dismutase	O
(	O
SOD)2	O
gene1e	O
and	O
gene1s	O
glutathione	O
synthetase	O
gene1e	O
(	O
gene1s	O
GSS	O
gene1e	O
)	O
.	O
On	O
the	O
other	O
hand	O
,	O
Nar	O
downregulated	O
inflammatory	O
gene	O
and	O
protein	O
expression	O
,	O
including	O
gene1s	O
interleukin	O
(	O
IL)-1b	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
gene1s	O
tumor	O
necrosis	O
factor	O
(	O
TNF)-a	O
gene1e	O
,	O
gene1s	O
HMGB1	O
gene1e	O
,	O
gene1s	O
high	O
mobility	O
group	O
box	O
1	O
protein	O
gene1e	O
(	O
gene1s	O
HMGB1	O
gene1e	O
)	O
,	O
gene1s	O
cyclooxygenase-2	O
gene1e	O
(	O
gene1s	O
COX-2	O
gene1e	O
)	O
,	O
the	O
gene1s	O
Toll	O
-	O
like	O
receptor	O
4	O
gene1e	O
(	O
gene1s	O
TLR4	O
gene1e	O
)-	O
gene1s	O
myeloid	O
differentiation	O
factor	O
88	O
gene1e	O
(	O
gene1s	O
MyD88	O
gene1e	O
)-	O
gene1s	O
TNF	O
receptor	O
-	O
associated	O
factor	O
6	O
gene1e	O
(	O
gene1s	O
TRAF6	O
gene1e	O
)	O
path	O
-	O
way	O
and	O
downstream	O
gene1s	O
mitogen	O
activated	O
protein	O
kinase	O
gene1e	O
(	O
gene1s	O
MAPK	O
gene1e	O
)	O
phosphorylation	O
,	O
gene1s	O
activator	O
protein	O
transcription	O
factor-1	O
gene1e	O
(	O
gene1s	O
AP-1	O
gene1e	O
)	O
and	O
gene1s	O
nuclear	O
factor	O
(	O
NF)-kB	O
gene1e	O
.	O
Moroever	O
,	O
Nar	O
markedly	O
attenuated	O
the	O
gene1s	O
cytochrome	O
c	O
gene1e	O
shift	O
from	O
the	O
mitochondria	O
to	O
the	O
cytosol	O
and	O
regulated	O
gene1s	O
caspase-3	O
gene1e	O
-related	O
protein	O
expression	O
.	O
To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
study	O
to	O
report	O
the	O
antioxidant	O
,	O
anti	O
-	O
inflammatory	O
and	O
anti	O
-	O
apoptotic	O
effects	O
of	O
Nar	O
in	O
neuronal	O
-	O
like	O
species1s	O
PC12	O
species1e	O
cells	O
.	O
These	O
results	O
suggest	O
that	O
Nar	O
can	O
be	O
utilized	O
as	O
a	O
potential	O
drug	O
for	O
the	O
treatment	O
of	O
neurodegenerative	O
disorders	O
.	O

gene1s	ARG2
Melatonin	ARG2
receptor	ARG2
gene1e	ARG2
depletion	O
suppressed	O
gene1s	O
hCG	O
gene1e	O
-	O
induced	O
testosterone	O
expression	O
in	O
arg1s	O
mouse	O
arg1e	O
Leydig	O
cells	O
.	O
gene1s	ARG2
Melatonin	ARG2
receptors	ARG2
gene1e	ARG2
gene1s	ARG2
MT1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MT2	ARG2
gene1e	ARG2
(	O
genes	O
officially	O
named	O
gene1s	ARG2
MTNR1A	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MTNR1B	ARG2
gene1e	ARG2
,	O
respectively	O
)	O
play	O
crucial	O
roles	O
in	O
melatonin	O
-	O
mediated	O
regulation	O
of	O
circadian	O
rhythms	O
,	O
the	O
immune	O
system	O
,	O
and	O
control	O
of	O
reproduction	O
in	O
seasonally	O
breeding	O
animals	O
.	O
In	O
this	O
study	O
,	O
immunolocalization	O
assay	O
showed	O
that	O
gene1s	ARG2
MT1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MT2	ARG2
gene1e	ARG2
are	O
highly	O
expressed	O
in	O
Leydig	O
cell	O
membrane	O
.	O
To	O
understand	O
the	O
biological	O
function	O
of	O
gene1s	ARG2
melatonin	ARG2
receptors	ARG2
gene1e	ARG2
in	O
gene1s	O
hCG	O
gene1e	O
-	O
induced	O
testosterone	O
synthesis	O
,	O
we	O
generated	O
gene1s	ARG2
melatonin	ARG2
receptor	ARG2
gene1e	ARG2
knockdown	O
cells	O
using	O
specific	O
siRNA	O
and	O
performed	O
testosterone	O
detection	O
after	O
gene1s	O
hCG	O
gene1e	O
treatment	O
.	O
We	O
found	O
that	O
knockdown	O
of	O
gene1s	ARG2
melatonin	ARG2
receptors	ARG2
gene1e	ARG2
,	O
especially	O
gene1s	ARG2
MTNR1A	ARG2
gene1e	ARG2
,	O
led	O
to	O
an	O
obvious	O
decrease	O
(	O
>	O
60	O
%	O
)	O
of	O
testosterone	O
level	O
.	O
Our	O
further	O
study	O
revealed	O
that	O
knockdown	O
of	O
gene1s	ARG2
melatonin	ARG2
receptors	ARG2
gene1e	ARG2
repressed	O
expression	O
,	O
at	O
both	O
the	O
mRNA	O
level	O
and	O
the	O
protein	O
level	O
,	O
of	O
key	O
gene1s	ARG2
steroidogenic	ARG2
genes	ARG2
gene1e	ARG2
,	O
such	O
as	O
gene1s	ARG2
p450scc	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
p450c17	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
StAR	ARG2
gene1e	ARG2
,	O
which	O
are	O
essential	O
for	O
testosterone	O
synthesis	O
.	O
gene1s	O
hCG	O
gene1e	O
triggered	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
stress	O
to	O
regulate	O
gene1s	ARG2
steroidogenic	ARG2
genes	ARG2
gene1e	ARG2
'	O
expression	O
and	O
apoptosis	O
.	O
To	O
further	O
investigate	O
the	O
potential	O
roles	O
of	O
gene1s	ARG2
melatonin	ARG2
receptors	ARG2
gene1e	ARG2
in	O
gene1s	O
hCG	O
gene1e	O
-	O
induced	O
regulation	O
of	O
ER	O
stress	O
and	O
apoptosis	O
,	O
we	O
examined	O
expression	O
of	O
some	O
crucial	O
ER	O
stress	O
markers	O
,	O
including	O
gene1s	ARG2
Grp78	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Chop	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ATF4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Xbp1	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
IRE1	ARG2
gene1e	ARG2
.	O
We	O
found	O
that	O
inhibition	O
of	O
gene1s	ARG2
melatonin	ARG2
receptors	ARG2
gene1e	ARG2
increased	O
gene1s	O
hCG	O
gene1e	O
-	O
induced	O
expression	O
of	O
gene1s	ARG2
Grp78	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Chop	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ATF4	ARG2
gene1e	ARG2
,	O
but	O
not	O
gene1s	ARG2
Xbp1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IRE1	ARG2
gene1e	ARG2
,	O
suggesting	O
that	O
gene1s	O
hCG	O
gene1e	O
may	O
modulate	O
gene1s	ARG2
IRE1	ARG2
gene1e	ARG2
signaling	O
pathways	O
in	O
a	O
melatonin	O
receptor	O
-	O
dependent	O
manner	O
.	O
In	O
addition	O
,	O
our	O
further	O
data	O
showed	O
that	O
knockdown	O
of	O
gene1s	ARG2
MTNR1A	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MTNR1B	ARG2
gene1e	ARG2
promoted	O
gene1s	O
hCG	O
gene1e	O
-	O
induced	O
expression	O
of	O
apoptosis	O
markers	O
,	O
including	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
caspase-3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
.	O
These	O
results	O
suggested	O
that	O
the	O
gene1s	ARG2
melatonin	ARG2
receptors	ARG2
gene1e	ARG2
gene1s	ARG2
MTNR1A	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MTNR1B	ARG2
gene1e	ARG2
are	O
essential	O
to	O
repress	O
gene1s	O
hCG	O
gene1e	O
-	O
induced	O
ER	O
stress	O
and	O
cell	O
apoptosis	O
.	O
Our	O
studies	O
demonstrated	O
that	O
the	O
species1s	O
mammalian	O
species1e	O
gene1s	ARG2
melatonin	ARG2
receptors	ARG2
gene1e	ARG2
gene1s	ARG2
MT1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MT2	ARG2
gene1e	ARG2
are	O
involved	O
in	O
testosterone	O
synthesis	O
via	O
mediating	O
multiple	O
cell	O
pathways	O
.	O

gene1s	O
Melatonin	O
receptor	O
gene1e	O
depletion	O
suppressed	O
gene1s	ARG2
hCG	ARG2
gene1e	ARG2
-	O
induced	O
testosterone	O
expression	O
in	O
species1s	O
mouse	O
species1e	O
Leydig	O
cells	O
.	O
gene1s	O
Melatonin	O
receptors	O
gene1e	O
gene1s	O
MT1	O
gene1e	O
and	O
gene1s	O
MT2	O
gene1e	O
(	O
genes	O
officially	O
named	O
gene1s	O
MTNR1A	O
gene1e	O
and	O
gene1s	O
MTNR1B	O
gene1e	O
,	O
respectively	O
)	O
play	O
crucial	O
roles	O
in	O
melatonin	O
-	O
mediated	O
regulation	O
of	O
circadian	O
rhythms	O
,	O
the	O
immune	O
system	O
,	O
and	O
control	O
of	O
reproduction	O
in	O
seasonally	O
breeding	O
animals	O
.	O
In	O
this	O
study	O
,	O
immunolocalization	O
assay	O
showed	O
that	O
gene1s	O
MT1	O
gene1e	O
and	O
gene1s	O
MT2	O
gene1e	O
are	O
highly	O
expressed	O
in	O
Leydig	O
cell	O
membrane	O
.	O
To	O
understand	O
the	O
biological	O
function	O
of	O
gene1s	O
melatonin	O
receptors	O
gene1e	O
in	O
gene1s	ARG2
hCG	ARG2
gene1e	ARG2
-	O
induced	O
testosterone	O
synthesis	O
,	O
we	O
generated	O
gene1s	O
melatonin	O
receptor	O
gene1e	O
knockdown	O
cells	O
using	O
specific	O
siRNA	O
and	O
performed	O
testosterone	O
detection	O
after	O
gene1s	ARG2
hCG	ARG2
gene1e	ARG2
treatment	O
.	O
We	O
found	O
that	O
knockdown	O
of	O
gene1s	O
melatonin	O
receptors	O
gene1e	O
,	O
especially	O
gene1s	O
MTNR1A	O
gene1e	O
,	O
led	O
to	O
an	O
obvious	O
decrease	O
(	O
>	O
60	O
%	O
)	O
of	O
testosterone	O
level	O
.	O
Our	O
further	O
study	O
revealed	O
that	O
knockdown	O
of	O
gene1s	O
melatonin	O
receptors	O
gene1e	O
repressed	O
expression	O
,	O
at	O
both	O
the	O
mRNA	O
level	O
and	O
the	O
protein	O
level	O
,	O
of	O
key	O
gene1s	O
steroidogenic	O
genes	O
gene1e	O
,	O
such	O
as	O
gene1s	O
p450scc	O
gene1e	O
,	O
gene1s	O
p450c17	O
gene1e	O
and	O
gene1s	O
StAR	O
gene1e	O
,	O
which	O
are	O
essential	O
for	O
testosterone	O
synthesis	O
.	O
gene1s	ARG2
hCG	ARG2
gene1e	ARG2
triggered	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
stress	O
to	O
regulate	O
gene1s	O
steroidogenic	O
genes	O
gene1e	O
'	O
expression	O
and	O
apoptosis	O
.	O
To	O
further	O
investigate	O
the	O
potential	O
roles	O
of	O
gene1s	O
melatonin	O
receptors	O
gene1e	O
in	O
gene1s	ARG2
hCG	ARG2
gene1e	ARG2
-	O
induced	O
regulation	O
of	O
ER	O
stress	O
and	O
apoptosis	O
,	O
we	O
examined	O
expression	O
of	O
some	O
crucial	O
ER	O
stress	O
markers	O
,	O
including	O
gene1s	O
Grp78	O
gene1e	O
,	O
gene1s	O
Chop	O
gene1e	O
,	O
gene1s	O
ATF4	O
gene1e	O
,	O
gene1s	O
Xbp1	O
gene1e	O
,	O
and	O
gene1s	O
IRE1	O
gene1e	O
.	O
We	O
found	O
that	O
inhibition	O
of	O
gene1s	O
melatonin	O
receptors	O
gene1e	O
increased	O
gene1s	ARG2
hCG	ARG2
gene1e	ARG2
-	O
induced	O
expression	O
of	O
gene1s	O
Grp78	O
gene1e	O
,	O
gene1s	O
Chop	O
gene1e	O
and	O
gene1s	O
ATF4	O
gene1e	O
,	O
but	O
not	O
gene1s	O
Xbp1	O
gene1e	O
and	O
gene1s	O
IRE1	O
gene1e	O
,	O
suggesting	O
that	O
gene1s	ARG2
hCG	ARG2
gene1e	ARG2
may	O
modulate	O
gene1s	O
IRE1	O
gene1e	O
signaling	O
pathways	O
in	O
a	O
melatonin	O
receptor	O
-	O
dependent	O
manner	O
.	O
In	O
addition	O
,	O
our	O
further	O
data	O
showed	O
that	O
knockdown	O
of	O
gene1s	O
MTNR1A	O
gene1e	O
and	O
gene1s	O
MTNR1B	O
gene1e	O
promoted	O
gene1s	ARG2
hCG	ARG2
gene1e	ARG2
-	O
induced	O
expression	O
of	O
apoptosis	O
markers	O
,	O
including	O
gene1s	O
p53	O
gene1e	O
,	O
gene1s	O
caspase-3	O
gene1e	O
and	O
gene1s	O
Bcl-2	O
gene1e	O
.	O
These	O
results	O
suggested	O
that	O
the	O
gene1s	O
melatonin	O
receptors	O
gene1e	O
gene1s	O
MTNR1A	O
gene1e	O
and	O
gene1s	O
MTNR1B	O
gene1e	O
are	O
essential	O
to	O
repress	O
gene1s	ARG2
hCG	ARG2
gene1e	ARG2
-	O
induced	O
ER	O
stress	O
and	O
cell	O
apoptosis	O
.	O
Our	O
studies	O
demonstrated	O
that	O
the	O
arg1s	O
mammalian	O
arg1e	O
gene1s	O
melatonin	O
receptors	O
gene1e	O
gene1s	O
MT1	O
gene1e	O
and	O
gene1s	O
MT2	O
gene1e	O
are	O
involved	O
in	O
testosterone	O
synthesis	O
via	O
mediating	O
multiple	O
cell	O
pathways	O
.	O

gene1s	ARG2
Nebulette	ARG2
gene1e	ARG2
is	O
a	O
powerful	O
cytolinker	O
organizing	O
gene1s	ARG2
desmin	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
actin	ARG2
gene1e	ARG2
in	O
arg1s	O
mouse	O
arg1e	O
hearts	O
.	O
In	O
the	O
hearts	O
of	O
species1s	O
patients	O
species1e	O
bearing	O
gene1s	O
nebulette	O
gene1e	O
mutations	O
,	O
a	O
severe	O
general	O
disorganization	O
in	O
cardiomyocytes	O
of	O
the	O
extrasarcomeric	O
gene1s	O
desmin	O
gene1e	O
intermediate	O
filament	O
system	O
is	O
frequently	O
observed	O
.	O
However	O
,	O
the	O
molecular	O
and	O
functional	O
relationship	O
between	O
the	O
gene1s	ARG2
desmin	ARG2
gene1e	ARG2
cytoskeleton	O
and	O
gene1s	ARG2
nebulette	ARG2
gene1e	ARG2
-	O
containing	O
sarcomeres	O
is	O
still	O
unclear	O
.	O
Here	O
we	O
report	O
a	O
high	O
-	O
affinity	O
in	O
vitro	O
interaction	O
between	O
gene1s	ARG2
nebulette	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
desmin	ARG2
gene1e	ARG2
filaments	O
.	O
A	O
major	O
interaction	O
site	O
has	O
been	O
mapped	O
to	O
the	O
gene1s	O
desmin	O
gene1e	O
a	O
-	O
helical	O
rod	O
domain	O
,	O
indicating	O
that	O
the	O
filament	O
core	O
is	O
directly	O
involved	O
in	O
the	O
binding	O
of	O
gene1s	O
nebulette	O
gene1e	O
.	O
The	O
disease	O
-	O
mutant	O
gene1s	O
desmin	O
gene1e	O
variants	O
E245D	O
and	O
T453I	O
exhibited	O
increased	O
binding	O
affinity	O
for	O
gene1s	O
nebulette	O
gene1e	O
,	O
delayed	O
filament	O
assembly	O
kinetics	O
,	O
and	O
caused	O
significant	O
weakening	O
of	O
networks	O
.	O
In	O
isolated	O
species1s	O
chick	O
species1e	O
cardiomyocytes	O
and	O
sections	O
from	O
species1s	O
canine	O
species1e	O
heart	O
,	O
we	O
revealed	O
by	O
ground	O
-	O
state	O
depletion	O
and	O
confocal	O
microscopies	O
that	O
module	O
5	O
of	O
gene1s	O
nebulette	O
gene1e	O
extends	O
outward	O
from	O
Z	O
-	O
disk	O
-	O
associated	O
gene1s	O
desmin	O
gene1e	O
filaments	O
toward	O
the	O
center	O
of	O
the	O
sarcomere	O
.	O
Accordingly	O
,	O
in	O
the	O
myocardium	O
of	O
gene1s	ARG2
Des	ARG2
gene1e	ARG2
(-/-	O
)	O
arg1s	O
mice	O
arg1e	O
,	O
elevated	O
levels	O
of	O
gene1s	ARG2
cardiac	ARG2
actin	ARG2
gene1e	ARG2
correlated	O
with	O
alterations	O
in	O
the	O
distribution	O
of	O
gene1s	ARG2
nebulette	ARG2
gene1e	ARG2
.	O
Our	O
data	O
suggest	O
that	O
a	O
well	O
-	O
organized	O
gene1s	ARG2
desmin	ARG2
gene1e	ARG2
network	O
is	O
required	O
to	O
accommodate	O
an	O
optimal	O
conformation	O
of	O
gene1s	ARG2
nebulette	ARG2
gene1e	ARG2
on	O
sarcomeres	O
to	O
bind	O
and	O
recruit	O
gene1s	ARG2
cardiac	ARG2
a	ARG2
-	ARG2
actin	ARG2
gene1e	ARG2
.	O
Hence	O
we	O
propose	O
that	O
gene1s	ARG2
nebulette	ARG2
gene1e	ARG2
acts	O
in	O
synergy	O
with	O
gene1s	ARG2
nebulin	ARG2
gene1e	ARG2
to	O
reinforce	O
and	O
temporally	O
fine	O
-	O
tune	O
striated	O
muscle	O
relaxation	O
-	O
contraction	O
cycles	O
.	O

gene1s	O
Nebulette	O
gene1e	O
is	O
a	O
powerful	O
cytolinker	O
organizing	O
gene1s	O
desmin	O
gene1e	O
and	O
gene1s	O
actin	O
gene1e	O
in	O
species1s	O
mouse	O
species1e	O
hearts	O
.	O
In	O
the	O
hearts	O
of	O
arg1s	O
patients	O
arg1e	O
bearing	O
gene1s	ARG2
nebulette	ARG2
gene1e	ARG2
mutations	O
,	O
a	O
severe	O
general	O
disorganization	O
in	O
cardiomyocytes	O
of	O
the	O
extrasarcomeric	O
gene1s	ARG2
desmin	ARG2
gene1e	ARG2
intermediate	O
filament	O
system	O
is	O
frequently	O
observed	O
.	O
However	O
,	O
the	O
molecular	O
and	O
functional	O
relationship	O
between	O
the	O
gene1s	O
desmin	O
gene1e	O
cytoskeleton	O
and	O
gene1s	O
nebulette	O
gene1e	O
-	O
containing	O
sarcomeres	O
is	O
still	O
unclear	O
.	O
Here	O
we	O
report	O
a	O
high	O
-	O
affinity	O
in	O
vitro	O
interaction	O
between	O
gene1s	O
nebulette	O
gene1e	O
and	O
gene1s	O
desmin	O
gene1e	O
filaments	O
.	O
A	O
major	O
interaction	O
site	O
has	O
been	O
mapped	O
to	O
the	O
gene1s	ARG2
desmin	ARG2
gene1e	ARG2
a	O
-	O
helical	O
rod	O
domain	O
,	O
indicating	O
that	O
the	O
filament	O
core	O
is	O
directly	O
involved	O
in	O
the	O
binding	O
of	O
gene1s	ARG2
nebulette	ARG2
gene1e	ARG2
.	O
The	O
disease	O
-	O
mutant	O
gene1s	ARG2
desmin	ARG2
gene1e	ARG2
variants	O
E245D	O
and	O
T453I	O
exhibited	O
increased	O
binding	O
affinity	O
for	O
gene1s	ARG2
nebulette	ARG2
gene1e	ARG2
,	O
delayed	O
filament	O
assembly	O
kinetics	O
,	O
and	O
caused	O
significant	O
weakening	O
of	O
networks	O
.	O
In	O
isolated	O
species1s	O
chick	O
species1e	O
cardiomyocytes	O
and	O
sections	O
from	O
species1s	O
canine	O
species1e	O
heart	O
,	O
we	O
revealed	O
by	O
ground	O
-	O
state	O
depletion	O
and	O
confocal	O
microscopies	O
that	O
module	O
5	O
of	O
gene1s	O
nebulette	O
gene1e	O
extends	O
outward	O
from	O
Z	O
-	O
disk	O
-	O
associated	O
gene1s	O
desmin	O
gene1e	O
filaments	O
toward	O
the	O
center	O
of	O
the	O
sarcomere	O
.	O
Accordingly	O
,	O
in	O
the	O
myocardium	O
of	O
gene1s	O
Des	O
gene1e	O
(-/-	O
)	O
species1s	O
mice	O
species1e	O
,	O
elevated	O
levels	O
of	O
gene1s	O
cardiac	O
actin	O
gene1e	O
correlated	O
with	O
alterations	O
in	O
the	O
distribution	O
of	O
gene1s	O
nebulette	O
gene1e	O
.	O
Our	O
data	O
suggest	O
that	O
a	O
well	O
-	O
organized	O
gene1s	O
desmin	O
gene1e	O
network	O
is	O
required	O
to	O
accommodate	O
an	O
optimal	O
conformation	O
of	O
gene1s	O
nebulette	O
gene1e	O
on	O
sarcomeres	O
to	O
bind	O
and	O
recruit	O
gene1s	O
cardiac	O
a	O
-	O
actin	O
gene1e	O
.	O
Hence	O
we	O
propose	O
that	O
gene1s	O
nebulette	O
gene1e	O
acts	O
in	O
synergy	O
with	O
gene1s	O
nebulin	O
gene1e	O
to	O
reinforce	O
and	O
temporally	O
fine	O
-	O
tune	O
striated	O
muscle	O
relaxation	O
-	O
contraction	O
cycles	O
.	O

gene1s	O
Nebulette	O
gene1e	O
is	O
a	O
powerful	O
cytolinker	O
organizing	O
gene1s	O
desmin	O
gene1e	O
and	O
gene1s	O
actin	O
gene1e	O
in	O
species1s	O
mouse	O
species1e	O
hearts	O
.	O
In	O
the	O
hearts	O
of	O
species1s	O
patients	O
species1e	O
bearing	O
gene1s	O
nebulette	O
gene1e	O
mutations	O
,	O
a	O
severe	O
general	O
disorganization	O
in	O
cardiomyocytes	O
of	O
the	O
extrasarcomeric	O
gene1s	O
desmin	O
gene1e	O
intermediate	O
filament	O
system	O
is	O
frequently	O
observed	O
.	O
However	O
,	O
the	O
molecular	O
and	O
functional	O
relationship	O
between	O
the	O
gene1s	O
desmin	O
gene1e	O
cytoskeleton	O
and	O
gene1s	O
nebulette	O
gene1e	O
-	O
containing	O
sarcomeres	O
is	O
still	O
unclear	O
.	O
Here	O
we	O
report	O
a	O
high	O
-	O
affinity	O
in	O
vitro	O
interaction	O
between	O
gene1s	O
nebulette	O
gene1e	O
and	O
gene1s	O
desmin	O
gene1e	O
filaments	O
.	O
A	O
major	O
interaction	O
site	O
has	O
been	O
mapped	O
to	O
the	O
gene1s	O
desmin	O
gene1e	O
a	O
-	O
helical	O
rod	O
domain	O
,	O
indicating	O
that	O
the	O
filament	O
core	O
is	O
directly	O
involved	O
in	O
the	O
binding	O
of	O
gene1s	O
nebulette	O
gene1e	O
.	O
The	O
disease	O
-	O
mutant	O
gene1s	O
desmin	O
gene1e	O
variants	O
E245D	O
and	O
T453I	O
exhibited	O
increased	O
binding	O
affinity	O
for	O
gene1s	O
nebulette	O
gene1e	O
,	O
delayed	O
filament	O
assembly	O
kinetics	O
,	O
and	O
caused	O
significant	O
weakening	O
of	O
networks	O
.	O
In	O
isolated	O
arg1s	O
chick	O
arg1e	O
cardiomyocytes	O
and	O
sections	O
from	O
species1s	O
canine	O
species1e	O
heart	O
,	O
we	O
revealed	O
by	O
ground	O
-	O
state	O
depletion	O
and	O
confocal	O
microscopies	O
that	O
module	O
5	O
of	O
gene1s	ARG2
nebulette	ARG2
gene1e	ARG2
extends	O
outward	O
from	O
Z	O
-	O
disk	O
-	O
associated	O
gene1s	O
desmin	O
gene1e	O
filaments	O
toward	O
the	O
center	O
of	O
the	O
sarcomere	O
.	O
Accordingly	O
,	O
in	O
the	O
myocardium	O
of	O
gene1s	O
Des	O
gene1e	O
(-/-	O
)	O
species1s	O
mice	O
species1e	O
,	O
elevated	O
levels	O
of	O
gene1s	O
cardiac	O
actin	O
gene1e	O
correlated	O
with	O
alterations	O
in	O
the	O
distribution	O
of	O
gene1s	O
nebulette	O
gene1e	O
.	O
Our	O
data	O
suggest	O
that	O
a	O
well	O
-	O
organized	O
gene1s	O
desmin	O
gene1e	O
network	O
is	O
required	O
to	O
accommodate	O
an	O
optimal	O
conformation	O
of	O
gene1s	O
nebulette	O
gene1e	O
on	O
sarcomeres	O
to	O
bind	O
and	O
recruit	O
gene1s	O
cardiac	O
a	O
-	O
actin	O
gene1e	O
.	O
Hence	O
we	O
propose	O
that	O
gene1s	O
nebulette	O
gene1e	O
acts	O
in	O
synergy	O
with	O
gene1s	O
nebulin	O
gene1e	O
to	O
reinforce	O
and	O
temporally	O
fine	O
-	O
tune	O
striated	O
muscle	O
relaxation	O
-	O
contraction	O
cycles	O
.	O

gene1s	O
Nebulette	O
gene1e	O
is	O
a	O
powerful	O
cytolinker	O
organizing	O
gene1s	O
desmin	O
gene1e	O
and	O
gene1s	O
actin	O
gene1e	O
in	O
species1s	O
mouse	O
species1e	O
hearts	O
.	O
In	O
the	O
hearts	O
of	O
species1s	O
patients	O
species1e	O
bearing	O
gene1s	O
nebulette	O
gene1e	O
mutations	O
,	O
a	O
severe	O
general	O
disorganization	O
in	O
cardiomyocytes	O
of	O
the	O
extrasarcomeric	O
gene1s	O
desmin	O
gene1e	O
intermediate	O
filament	O
system	O
is	O
frequently	O
observed	O
.	O
However	O
,	O
the	O
molecular	O
and	O
functional	O
relationship	O
between	O
the	O
gene1s	O
desmin	O
gene1e	O
cytoskeleton	O
and	O
gene1s	O
nebulette	O
gene1e	O
-	O
containing	O
sarcomeres	O
is	O
still	O
unclear	O
.	O
Here	O
we	O
report	O
a	O
high	O
-	O
affinity	O
in	O
vitro	O
interaction	O
between	O
gene1s	O
nebulette	O
gene1e	O
and	O
gene1s	O
desmin	O
gene1e	O
filaments	O
.	O
A	O
major	O
interaction	O
site	O
has	O
been	O
mapped	O
to	O
the	O
gene1s	O
desmin	O
gene1e	O
a	O
-	O
helical	O
rod	O
domain	O
,	O
indicating	O
that	O
the	O
filament	O
core	O
is	O
directly	O
involved	O
in	O
the	O
binding	O
of	O
gene1s	O
nebulette	O
gene1e	O
.	O
The	O
disease	O
-	O
mutant	O
gene1s	O
desmin	O
gene1e	O
variants	O
E245D	O
and	O
T453I	O
exhibited	O
increased	O
binding	O
affinity	O
for	O
gene1s	O
nebulette	O
gene1e	O
,	O
delayed	O
filament	O
assembly	O
kinetics	O
,	O
and	O
caused	O
significant	O
weakening	O
of	O
networks	O
.	O
In	O
isolated	O
species1s	O
chick	O
species1e	O
cardiomyocytes	O
and	O
sections	O
from	O
arg1s	O
canine	O
arg1e	O
heart	O
,	O
we	O
revealed	O
by	O
ground	O
-	O
state	O
depletion	O
and	O
confocal	O
microscopies	O
that	O
module	O
5	O
of	O
gene1s	O
nebulette	O
gene1e	O
extends	O
outward	O
from	O
Z	O
-	O
disk	O
-	O
associated	O
gene1s	ARG2
desmin	ARG2
gene1e	ARG2
filaments	O
toward	O
the	O
center	O
of	O
the	O
sarcomere	O
.	O
Accordingly	O
,	O
in	O
the	O
myocardium	O
of	O
gene1s	O
Des	O
gene1e	O
(-/-	O
)	O
species1s	O
mice	O
species1e	O
,	O
elevated	O
levels	O
of	O
gene1s	O
cardiac	O
actin	O
gene1e	O
correlated	O
with	O
alterations	O
in	O
the	O
distribution	O
of	O
gene1s	O
nebulette	O
gene1e	O
.	O
Our	O
data	O
suggest	O
that	O
a	O
well	O
-	O
organized	O
gene1s	O
desmin	O
gene1e	O
network	O
is	O
required	O
to	O
accommodate	O
an	O
optimal	O
conformation	O
of	O
gene1s	O
nebulette	O
gene1e	O
on	O
sarcomeres	O
to	O
bind	O
and	O
recruit	O
gene1s	O
cardiac	O
a	O
-	O
actin	O
gene1e	O
.	O
Hence	O
we	O
propose	O
that	O
gene1s	O
nebulette	O
gene1e	O
acts	O
in	O
synergy	O
with	O
gene1s	O
nebulin	O
gene1e	O
to	O
reinforce	O
and	O
temporally	O
fine	O
-	O
tune	O
striated	O
muscle	O
relaxation	O
-	O
contraction	O
cycles	O
.	O

arg1s	O
Caenorhabditis	O
elegans	O
arg1e	O
gene1s	ARG2
protein	ARG2
arginine	ARG2
methyltransferase	ARG2
gene1e	ARG2
gene1s	ARG2
PRMT-5	ARG2
gene1e	ARG2
negatively	O
regulates	O
DNA	O
damage	O
-	O
induced	O
apoptosis	O
.	O
Arginine	O
methylation	O
of	O
gene1s	ARG2
histone	ARG2
gene1e	ARG2
and	O
non	O
-	O
gene1s	ARG2
histone	ARG2
gene1e	ARG2
proteins	O
is	O
involved	O
in	O
transcription	O
regulation	O
and	O
many	O
other	O
cellular	O
processes	O
.	O
Nevertheless	O
,	O
whether	O
such	O
protein	O
modification	O
plays	O
a	O
regulatory	O
role	O
during	O
apoptosis	O
remains	O
largely	O
unknown	O
.	O
Here	O
we	O
report	O
that	O
the	O
arg1s	O
Caenorhabditis	O
elegans	O
arg1e	O
homolog	O
of	O
species1s	O
mammalian	O
species1e	O
gene1s	O
type	O
II	O
arginine	O
methyltransferase	O
gene1e	O
gene1s	O
PRMT5	O
gene1e	O
negatively	O
regulates	O
DNA	O
damage	O
-	O
induced	O
apoptosis	O
.	O
We	O
show	O
that	O
inactivation	O
of	O
arg1s	O
C.	O
elegans	O
arg1e	O
gene1s	ARG2
prmt-5	ARG2
gene1e	ARG2
leads	O
to	O
excessive	O
apoptosis	O
in	O
germline	O
following	O
ionizing	O
irradiation	O
,	O
which	O
is	O
due	O
to	O
a	O
gene1s	ARG2
CEP-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
-dependent	O
up	O
-	O
regulation	O
of	O
the	O
cell	O
death	O
initiator	O
gene1s	ARG2
EGL-1	ARG2
gene1e	ARG2
.	O
Moreover	O
,	O
we	O
provide	O
evidence	O
that	O
gene1s	ARG2
CBP-1	ARG2
gene1e	ARG2
,	O
the	O
worm	O
ortholog	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
p300	O
gene1e	O
/	O
gene1s	O
CBP	O
gene1e	O
,	O
functions	O
as	O
a	O
cofactor	O
of	O
gene1s	ARG2
CEP-1	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
PRMT-5	ARG2
gene1e	ARG2
forms	O
a	O
complex	O
with	O
both	O
gene1s	ARG2
CEP-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CBP-1	ARG2
gene1e	ARG2
and	O
can	O
methylate	O
the	O
latter	O
.	O
Importantly	O
,	O
down	O
-	O
regulation	O
of	O
gene1s	ARG2
cbp-1	ARG2
gene1e	ARG2
significantly	O
suppresses	O
DNA	O
damage	O
-	O
induced	O
gene1s	ARG2
egl-1	ARG2
gene1e	ARG2
expression	O
and	O
apoptosis	O
in	O
gene1s	ARG2
prmt-5	ARG2
gene1e	ARG2
mutant	O
worms	O
.	O
These	O
findings	O
suggest	O
that	O
gene1s	ARG2
PRMT-5	ARG2
gene1e	ARG2
likely	O
represses	O
gene1s	ARG2
CEP-1	ARG2
gene1e	ARG2
transcriptional	O
activity	O
through	O
gene1s	ARG2
CBP-1	ARG2
gene1e	ARG2
,	O
which	O
represents	O
a	O
novel	O
regulatory	O
mechanism	O
of	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
-dependent	O
apoptosis	O
.	O

species1s	O
Caenorhabditis	O
elegans	O
species1e	O
gene1s	O
protein	O
arginine	O
methyltransferase	O
gene1e	O
gene1s	O
PRMT-5	O
gene1e	O
negatively	O
regulates	O
DNA	O
damage	O
-	O
induced	O
apoptosis	O
.	O
Arginine	O
methylation	O
of	O
gene1s	O
histone	O
gene1e	O
and	O
non	O
-	O
gene1s	O
histone	O
gene1e	O
proteins	O
is	O
involved	O
in	O
transcription	O
regulation	O
and	O
many	O
other	O
cellular	O
processes	O
.	O
Nevertheless	O
,	O
whether	O
such	O
protein	O
modification	O
plays	O
a	O
regulatory	O
role	O
during	O
apoptosis	O
remains	O
largely	O
unknown	O
.	O
Here	O
we	O
report	O
that	O
the	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
homolog	O
of	O
arg1s	O
mammalian	O
arg1e	O
gene1s	ARG2
type	ARG2
II	ARG2
arginine	ARG2
methyltransferase	ARG2
gene1e	ARG2
gene1s	ARG2
PRMT5	ARG2
gene1e	ARG2
negatively	O
regulates	O
DNA	O
damage	O
-	O
induced	O
apoptosis	O
.	O
We	O
show	O
that	O
inactivation	O
of	O
species1s	O
C.	O
elegans	O
species1e	O
gene1s	O
prmt-5	O
gene1e	O
leads	O
to	O
excessive	O
apoptosis	O
in	O
germline	O
following	O
ionizing	O
irradiation	O
,	O
which	O
is	O
due	O
to	O
a	O
gene1s	O
CEP-1	O
gene1e	O
/	O
gene1s	O
p53	O
gene1e	O
-dependent	O
up	O
-	O
regulation	O
of	O
the	O
cell	O
death	O
initiator	O
gene1s	O
EGL-1	O
gene1e	O
.	O
Moreover	O
,	O
we	O
provide	O
evidence	O
that	O
gene1s	O
CBP-1	O
gene1e	O
,	O
the	O
worm	O
ortholog	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
p300	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CBP	ARG2
gene1e	ARG2
,	O
functions	O
as	O
a	O
cofactor	O
of	O
gene1s	O
CEP-1	O
gene1e	O
.	O
gene1s	O
PRMT-5	O
gene1e	O
forms	O
a	O
complex	O
with	O
both	O
gene1s	O
CEP-1	O
gene1e	O
and	O
gene1s	O
CBP-1	O
gene1e	O
and	O
can	O
methylate	O
the	O
latter	O
.	O
Importantly	O
,	O
down	O
-	O
regulation	O
of	O
gene1s	O
cbp-1	O
gene1e	O
significantly	O
suppresses	O
DNA	O
damage	O
-	O
induced	O
gene1s	O
egl-1	O
gene1e	O
expression	O
and	O
apoptosis	O
in	O
gene1s	O
prmt-5	O
gene1e	O
mutant	O
worms	O
.	O
These	O
findings	O
suggest	O
that	O
gene1s	O
PRMT-5	O
gene1e	O
likely	O
represses	O
gene1s	O
CEP-1	O
gene1e	O
transcriptional	O
activity	O
through	O
gene1s	O
CBP-1	O
gene1e	O
,	O
which	O
represents	O
a	O
novel	O
regulatory	O
mechanism	O
of	O
gene1s	O
p53	O
gene1e	O
-dependent	O
apoptosis	O
.	O

gene1s	ARG2
HMGB1	ARG2
gene1e	ARG2
promotes	O
HCC	O
progression	O
partly	O
by	O
downregulating	O
gene1s	ARG2
p21	ARG2
gene1e	ARG2
via	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
c	ARG2
-	ARG2
Myc	ARG2
gene1e	ARG2
pathway	O
and	O
upregulating	O
gene1s	ARG2
MMP-2	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
High	ARG2
-	ARG2
mobility	ARG2
group	ARG2
box	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
HMGB1	ARG2
gene1e	ARG2
)	O
was	O
found	O
to	O
be	O
over	O
-	O
expressed	O
in	O
many	O
kinds	O
of	O
arg1s	O
human	O
arg1e	O
cancer	O
,	O
which	O
binds	O
with	O
several	O
receptors	O
and	O
activates	O
gene1s	ARG2
RAGE	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
-	O
gene1s	O
MAPK	O
gene1e	O
,	O
gene1s	ARG2
Toll	ARG2
-	ARG2
like	ARG2
receptors	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Src	ARG2
family	ARG2
kinase	ARG2
gene1e	ARG2
signaling	O
pathways	O
and	O
plays	O
a	O
crucial	O
role	O
in	O
tumorigenesis	O
and	O
cancer	O
progression	O
.	O
However	O
,	O
the	O
function	O
and	O
mechanism	O
of	O
gene1s	ARG2
HMGB1	ARG2
gene1e	ARG2
in	O
hepatocellular	O
carcinoma	O
(	O
HCC	O
)	O
remain	O
unclear	O
.	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effect	O
of	O
gene1s	ARG2
HMGB1	ARG2
gene1e	ARG2
on	O
HCC	O
progression	O
and	O
explore	O
new	O
molecular	O
mechanism	O
.	O
gene1s	ARG2
HMGB1	ARG2
gene1e	ARG2
transient	O
knockdown	O
,	O
stable	O
knockdown	O
,	O
and	O
re	O
-	O
expression	O
were	O
performed	O
by	O
transfection	O
with	O
specific	O
siRNA	O
,	O
shRNA	O
,	O
or	O
expression	O
vector	O
in	O
arg1s	O
HCCLM3	O
arg1e	O
cells	O
.	O
Results	O
showed	O
that	O
transient	O
knockdown	O
gene1s	ARG2
HMGB1	ARG2
gene1e	ARG2
prevented	O
cell	O
proliferation	O
,	O
promoted	O
apoptosis	O
,	O
induced	O
S	O
phase	O
arrest	O
,	O
and	O
inhibited	O
migration	O
and	O
invasion	O
in	O
vitro	O
,	O
and	O
stable	O
knockdown	O
gene1s	ARG2
HMGB1	ARG2
gene1e	ARG2
inhibited	O
xenograft	O
growth	O
in	O
Balb	O
/	O
c	O
athymic	O
species1s	O
mice	O
species1e	O
in	O
vivo	O
.	O
Molecular	O
mechanism	O
investigation	O
revealed	O
that	O
knockdown	O
gene1s	ARG2
HMGB1	ARG2
gene1e	ARG2
significantly	O
reduced	O
the	O
activation	O
of	O
gene1s	ARG2
MAPKs	ARG2
gene1e	ARG2
,	O
including	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
p38	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SAPK	ARG2
/	ARG2
JNK	ARG2
gene1e	ARG2
,	O
as	O
well	O
as	O
gene1s	ARG2
MAPKKs	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MEK1/2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SEK1	ARG2
gene1e	ARG2
)	O
and	O
its	O
substrates	O
(	O
gene1s	ARG2
c	ARG2
-	ARG2
Jun	ARG2
gene1e	ARG2
,	O
gene1s	O
c	O
-	O
Myc	O
)	O
gene1e	O
;	O
downregulated	O
gene1s	O
NF	O
-	O
kB	O
/	O
p65	O
gene1e	O
expression	O
and	O
phosphorylation	O
level	O
;	O
decreased	O
gene1s	ARG2
MMP-2	ARG2
gene1e	ARG2
expression	O
and	O
activity	O
;	O
and	O
upregulated	O
gene1s	ARG2
p21	ARG2
gene1e	ARG2
expression	O
.	O
Interestingly	O
,	O
gene1s	ARG2
c	ARG2
-	ARG2
Myc	ARG2
gene1e	ARG2
was	O
firstly	O
found	O
to	O
be	O
involved	O
in	O
the	O
promoting	O
function	O
of	O
gene1s	ARG2
HMGB1	ARG2
gene1e	ARG2
on	O
HCC	O
progression	O
,	O
which	O
provided	O
a	O
novel	O
clue	O
for	O
the	O
inhibitory	O
effect	O
of	O
gene1s	ARG2
HMGB1	ARG2
gene1e	ARG2
on	O
gene1s	ARG2
p21	ARG2
gene1e	ARG2
expression	O
by	O
a	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
-independent	O
pathway	O
.	O
Collectively	O
,	O
these	O
findings	O
indicated	O
that	O
gene1s	ARG2
HMGB1	ARG2
gene1e	ARG2
promoted	O
HCC	O
progression	O
partly	O
by	O
enhancing	O
the	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
pathways	O
,	O
upregulating	O
gene1s	ARG2
MMP-2	ARG2
gene1e	ARG2
,	O
and	O
downregulating	O
gene1s	ARG2
p21	ARG2
gene1e	ARG2
via	O
an	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
c	ARG2
-	ARG2
Myc	ARG2
gene1e	ARG2
pathway	O
.	O

gene1s	O
HMGB1	O
gene1e	O
promotes	O
HCC	O
progression	O
partly	O
by	O
downregulating	O
gene1s	O
p21	O
gene1e	O
via	O
gene1s	O
ERK	O
gene1e	O
/	O
gene1s	O
c	O
-	O
Myc	O
gene1e	O
pathway	O
and	O
upregulating	O
gene1s	O
MMP-2	O
gene1e	O
.	O
gene1s	O
High	O
-	O
mobility	O
group	O
box	O
1	O
gene1e	O
(	O
gene1s	O
HMGB1	O
gene1e	O
)	O
was	O
found	O
to	O
be	O
over	O
-	O
expressed	O
in	O
many	O
kinds	O
of	O
species1s	O
human	O
species1e	O
cancer	O
,	O
which	O
binds	O
with	O
several	O
receptors	O
and	O
activates	O
gene1s	O
RAGE	O
gene1e	O
-	O
gene1s	O
Ras	O
gene1e	O
-	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
,	O
gene1s	O
Toll	O
-	O
like	O
receptors	O
gene1e	O
,	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
,	O
and	O
gene1s	O
Src	O
family	O
kinase	O
gene1e	O
signaling	O
pathways	O
and	O
plays	O
a	O
crucial	O
role	O
in	O
tumorigenesis	O
and	O
cancer	O
progression	O
.	O
However	O
,	O
the	O
function	O
and	O
mechanism	O
of	O
gene1s	O
HMGB1	O
gene1e	O
in	O
hepatocellular	O
carcinoma	O
(	O
HCC	O
)	O
remain	O
unclear	O
.	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effect	O
of	O
gene1s	O
HMGB1	O
gene1e	O
on	O
HCC	O
progression	O
and	O
explore	O
new	O
molecular	O
mechanism	O
.	O
gene1s	O
HMGB1	O
gene1e	O
transient	O
knockdown	O
,	O
stable	O
knockdown	O
,	O
and	O
re	O
-	O
expression	O
were	O
performed	O
by	O
transfection	O
with	O
specific	O
siRNA	O
,	O
shRNA	O
,	O
or	O
expression	O
vector	O
in	O
species1s	O
HCCLM3	O
species1e	O
cells	O
.	O
Results	O
showed	O
that	O
transient	O
knockdown	O
gene1s	O
HMGB1	O
gene1e	O
prevented	O
cell	O
proliferation	O
,	O
promoted	O
apoptosis	O
,	O
induced	O
S	O
phase	O
arrest	O
,	O
and	O
inhibited	O
migration	O
and	O
invasion	O
in	O
vitro	O
,	O
and	O
stable	O
knockdown	O
gene1s	O
HMGB1	O
gene1e	O
inhibited	O
xenograft	O
growth	O
in	O
Balb	O
/	O
c	O
athymic	O
arg1s	O
mice	O
arg1e	O
in	O
vivo	O
.	O
Molecular	O
mechanism	O
investigation	O
revealed	O
that	O
knockdown	O
gene1s	O
HMGB1	O
gene1e	O
significantly	O
reduced	O
the	O
activation	O
of	O
gene1s	O
MAPKs	O
gene1e	O
,	O
including	O
gene1s	O
ERK1/2	O
gene1e	O
,	O
gene1s	O
p38	O
gene1e	O
,	O
gene1s	O
SAPK	O
/	O
JNK	O
gene1e	O
,	O
as	O
well	O
as	O
gene1s	O
MAPKKs	O
gene1e	O
(	O
gene1s	O
MEK1/2	O
gene1e	O
,	O
gene1s	O
SEK1	O
gene1e	O
)	O
and	O
its	O
substrates	O
(	O
gene1s	O
c	O
-	O
Jun	O
gene1e	O
,	O
gene1s	ARG2
c	ARG2
-	ARG2
Myc	ARG2
)	ARG2
gene1e	ARG2
;	O
downregulated	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
/	ARG2
p65	ARG2
gene1e	ARG2
expression	O
and	O
phosphorylation	O
level	O
;	O
decreased	O
gene1s	O
MMP-2	O
gene1e	O
expression	O
and	O
activity	O
;	O
and	O
upregulated	O
gene1s	O
p21	O
gene1e	O
expression	O
.	O
Interestingly	O
,	O
gene1s	O
c	O
-	O
Myc	O
gene1e	O
was	O
firstly	O
found	O
to	O
be	O
involved	O
in	O
the	O
promoting	O
function	O
of	O
gene1s	O
HMGB1	O
gene1e	O
on	O
HCC	O
progression	O
,	O
which	O
provided	O
a	O
novel	O
clue	O
for	O
the	O
inhibitory	O
effect	O
of	O
gene1s	O
HMGB1	O
gene1e	O
on	O
gene1s	O
p21	O
gene1e	O
expression	O
by	O
a	O
gene1s	O
p53	O
gene1e	O
-independent	O
pathway	O
.	O
Collectively	O
,	O
these	O
findings	O
indicated	O
that	O
gene1s	O
HMGB1	O
gene1e	O
promoted	O
HCC	O
progression	O
partly	O
by	O
enhancing	O
the	O
gene1s	O
ERK1/2	O
gene1e	O
and	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
pathways	O
,	O
upregulating	O
gene1s	O
MMP-2	O
gene1e	O
,	O
and	O
downregulating	O
gene1s	O
p21	O
gene1e	O
via	O
an	O
gene1s	O
ERK	O
gene1e	O
/	O
gene1s	O
c	O
-	O
Myc	O
gene1e	O
pathway	O
.	O

Differential	O
gene1s	ARG2
cytokine	ARG2
gene1e	ARG2
regulation	O
by	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
AP-1	ARG2
gene1e	ARG2
in	O
arg1s	O
Jurkat	O
arg1e	O
T	O
-	O
cells	O
.	O
BACKGROUND	O
:	O
gene1s	ARG2
Activator	ARG2
protein	ARG2
(	ARG2
AP)-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
nuclear	ARG2
factor	ARG2
(	ARG2
NF)-kappaB	ARG2
gene1e	ARG2
largely	O
control	O
T	O
-	O
cell	O
activation	O
,	O
following	O
binding	O
of	O
foreign	O
antigens	O
to	O
the	O
gene1s	ARG2
T	ARG2
-	ARG2
cell	ARG2
receptor	ARG2
gene1e	ARG2
leading	O
to	O
gene1s	ARG2
cytokine	ARG2
gene1e	ARG2
secretion	O
.	O
Elevated	O
levels	O
of	O
pro	O
-	O
inflammatory	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
chemokines	ARG2
gene1e	ARG2
such	O
as	O
gene1s	ARG2
TNF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CXCL8	ARG2
gene1e	ARG2
are	O
associated	O
with	O
several	O
arg1s	O
human	O
arg1e	O
diseases	O
including	O
cystic	O
fibrosis	O
,	O
pulmonary	O
fibrosis	O
and	O
AIDS	O
.	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
role	O
of	O
the	O
gene1s	ARG2
transcription	ARG2
factors	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
AP-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
,	O
in	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CXCL8	ARG2
gene1e	ARG2
regulation	O
in	O
arg1s	O
Jurkat	O
arg1e	O
T	O
-	O
cells	O
.	O
RESULTS	O
:	O
Phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
exposure	O
resulted	O
in	O
an	O
up	O
-	O
regulation	O
of	O
gene1s	ARG2
AP-1	ARG2
gene1e	ARG2
and	O
down	O
-	O
regulation	O
of	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
activity	O
,	O
however	O
,	O
exposure	O
to	O
heat	O
killed	O
(	O
HK	O
)	O
species1s	O
Escherichia	O
.	O
coli	O
MG1655	O
species1e	O
resulted	O
in	O
a	O
dose	O
-	O
dependent	O
increase	O
in	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
activity	O
without	O
affecting	O
gene1s	ARG2
AP-1	ARG2
gene1e	ARG2
.	O
The	O
gene1s	ARG2
cytokine	ARG2
gene1e	ARG2
profile	O
revealed	O
an	O
up	O
-	O
regulation	O
of	O
the	O
gene1s	ARG2
chemokine	ARG2
gene1e	ARG2
gene1s	ARG2
CXCL8	ARG2
gene1e	ARG2
and	O
the	O
pro	O
-	O
inflammatory	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
gene1s	ARG2
TNF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
following	O
treatment	O
with	O
both	O
PMA	O
and	O
HK	O
species1s	O
E.	O
coli	O
species1e	O
,	O
while	O
the	O
levels	O
of	O
the	O
anti	O
-	O
inflammatory	O
gene1s	ARG2
cytokine	ARG2
gene1e	ARG2
gene1s	ARG2
IL-10	ARG2
gene1e	ARG2
were	O
not	O
affected	O
by	O
PMA	O
but	O
were	O
significantly	O
down	O
-	O
regulated	O
by	O
HK	O
species1s	O
E.	O
coli	O
species1e	O
.	O
gene1s	ARG2
AP-1	ARG2
gene1e	ARG2
activation	O
was	O
significantly	O
increased	O
2	O
h	O
after	O
PMA	O
exposure	O
and	O
continued	O
to	O
increase	O
thereafter	O
.	O
In	O
contrast	O
,	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
responded	O
to	O
PMA	O
exposure	O
by	O
a	O
rapid	O
up	O
-	O
regulation	O
followed	O
by	O
a	O
subsequent	O
down	O
-	O
regulation	O
.	O
Increased	O
intracellular	O
Ca2	O
+	O
concentrations	O
countered	O
the	O
down	O
-	O
regulation	O
of	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
by	O
PMA	O
,	O
while	O
similar	O
treatment	O
with	O
calcium	O
ionophore	O
resulted	O
in	O
a	O
reduced	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
activity	O
following	O
induction	O
with	O
HK	O
species1s	O
E.	O
coli	O
species1e	O
.	O
In	O
order	O
to	O
further	O
study	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
activation	O
,	O
we	O
considered	O
two	O
up	O
-	O
stream	O
signalling	O
proteins	O
,	O
gene1s	ARG2
PKC	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Bcl10	ARG2
gene1e	ARG2
.	O
Phosphorylated	O
-	O
gene1s	ARG2
PKC	ARG2
gene1e	ARG2
levels	O
increased	O
in	O
response	O
to	O
PMA	O
and	O
HK	O
species1s	O
E.	O
coli	O
species1e	O
,	O
while	O
gene1s	ARG2
Bcl10	ARG2
gene1e	ARG2
levels	O
significantly	O
decreased	O
following	O
PMA	O
treatment	O
.	O
Using	O
an	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
activation	O
inhibitor	O
,	O
we	O
observed	O
complete	O
inhibition	O
of	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
expression	O
while	O
gene1s	ARG2
CXCL8	ARG2
gene1e	ARG2
levels	O
only	O
decreased	O
by	O
40	O
%	O
at	O
the	O
highest	O
concentration	O
.	O
Treatment	O
of	O
arg1s	O
Jurkat	O
arg1e	O
T	O
-	O
cells	O
with	O
PMA	O
in	O
the	O
presence	O
of	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
-	O
inhibitor	O
suppressed	O
both	O
gene1s	ARG2
CXCL8	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
while	O
gene1s	ARG2
PKC	ARG2
gene1e	ARG2
-	O
inhibitor	O
primarily	O
decreased	O
gene1s	ARG2
CXCL8	ARG2
gene1e	ARG2
expression	O
.	O
CONCLUSION	O
:	O
The	O
present	O
study	O
shows	O
that	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
regulated	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
but	O
not	O
gene1s	ARG2
CXCL8	ARG2
gene1e	ARG2
.	O
This	O
complex	O
regulation	O
of	O
gene1s	ARG2
CXCL8	ARG2
gene1e	ARG2
suggests	O
that	O
there	O
is	O
a	O
need	O
to	O
further	O
evaluate	O
the	O
signalling	O
pathways	O
in	O
order	O
to	O
develop	O
new	O
treatment	O
for	O
diseases	O
with	O
elevated	O
gene1s	ARG2
CXCL8	ARG2
gene1e	ARG2
levels	O
,	O
such	O
as	O
AIDS	O
and	O
autoimmune	O
diseases	O
.	O

Differential	O
gene1s	O
cytokine	O
gene1e	O
regulation	O
by	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
and	O
gene1s	O
AP-1	O
gene1e	O
in	O
species1s	O
Jurkat	O
species1e	O
T	O
-	O
cells	O
.	O
BACKGROUND	O
:	O
gene1s	O
Activator	O
protein	O
(	O
AP)-1	O
gene1e	O
and	O
gene1s	O
nuclear	O
factor	O
(	O
NF)-kappaB	O
gene1e	O
largely	O
control	O
T	O
-	O
cell	O
activation	O
,	O
following	O
binding	O
of	O
foreign	O
antigens	O
to	O
the	O
gene1s	O
T	O
-	O
cell	O
receptor	O
gene1e	O
leading	O
to	O
gene1s	O
cytokine	O
gene1e	O
secretion	O
.	O
Elevated	O
levels	O
of	O
pro	O
-	O
inflammatory	O
gene1s	O
cytokines	O
gene1e	O
and	O
gene1s	O
chemokines	O
gene1e	O
such	O
as	O
gene1s	O
TNF	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
and	O
gene1s	O
CXCL8	O
gene1e	O
are	O
associated	O
with	O
several	O
species1s	O
human	O
species1e	O
diseases	O
including	O
cystic	O
fibrosis	O
,	O
pulmonary	O
fibrosis	O
and	O
AIDS	O
.	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
role	O
of	O
the	O
gene1s	O
transcription	O
factors	O
gene1e	O
,	O
gene1s	O
AP-1	O
gene1e	O
and	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
,	O
in	O
gene1s	O
IL-6	O
gene1e	O
and	O
gene1s	O
CXCL8	O
gene1e	O
regulation	O
in	O
species1s	O
Jurkat	O
species1e	O
T	O
-	O
cells	O
.	O
RESULTS	O
:	O
Phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
exposure	O
resulted	O
in	O
an	O
up	O
-	O
regulation	O
of	O
gene1s	O
AP-1	O
gene1e	O
and	O
down	O
-	O
regulation	O
of	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
activity	O
,	O
however	O
,	O
exposure	O
to	O
heat	O
killed	O
(	O
HK	O
)	O
arg1s	O
Escherichia	O
.	O
coli	O
MG1655	O
arg1e	O
resulted	O
in	O
a	O
dose	O
-	O
dependent	O
increase	O
in	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
activity	O
without	O
affecting	O
gene1s	O
AP-1	O
gene1e	O
.	O
The	O
gene1s	O
cytokine	O
gene1e	O
profile	O
revealed	O
an	O
up	O
-	O
regulation	O
of	O
the	O
gene1s	O
chemokine	O
gene1e	O
gene1s	O
CXCL8	O
gene1e	O
and	O
the	O
pro	O
-	O
inflammatory	O
gene1s	O
cytokines	O
gene1e	O
gene1s	O
TNF	O
gene1e	O
,	O
gene1s	O
IL-2	O
gene1e	O
and	O
gene1s	O
IL-6	O
gene1e	O
following	O
treatment	O
with	O
both	O
PMA	O
and	O
HK	O
species1s	O
E.	O
coli	O
species1e	O
,	O
while	O
the	O
levels	O
of	O
the	O
anti	O
-	O
inflammatory	O
gene1s	O
cytokine	O
gene1e	O
gene1s	O
IL-10	O
gene1e	O
were	O
not	O
affected	O
by	O
PMA	O
but	O
were	O
significantly	O
down	O
-	O
regulated	O
by	O
HK	O
species1s	O
E.	O
coli	O
species1e	O
.	O
gene1s	O
AP-1	O
gene1e	O
activation	O
was	O
significantly	O
increased	O
2	O
h	O
after	O
PMA	O
exposure	O
and	O
continued	O
to	O
increase	O
thereafter	O
.	O
In	O
contrast	O
,	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
responded	O
to	O
PMA	O
exposure	O
by	O
a	O
rapid	O
up	O
-	O
regulation	O
followed	O
by	O
a	O
subsequent	O
down	O
-	O
regulation	O
.	O
Increased	O
intracellular	O
Ca2	O
+	O
concentrations	O
countered	O
the	O
down	O
-	O
regulation	O
of	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
by	O
PMA	O
,	O
while	O
similar	O
treatment	O
with	O
calcium	O
ionophore	O
resulted	O
in	O
a	O
reduced	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
activity	O
following	O
induction	O
with	O
HK	O
species1s	O
E.	O
coli	O
species1e	O
.	O
In	O
order	O
to	O
further	O
study	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
activation	O
,	O
we	O
considered	O
two	O
up	O
-	O
stream	O
signalling	O
proteins	O
,	O
gene1s	O
PKC	O
gene1e	O
and	O
gene1s	O
Bcl10	O
gene1e	O
.	O
Phosphorylated	O
-	O
gene1s	O
PKC	O
gene1e	O
levels	O
increased	O
in	O
response	O
to	O
PMA	O
and	O
HK	O
species1s	O
E.	O
coli	O
species1e	O
,	O
while	O
gene1s	O
Bcl10	O
gene1e	O
levels	O
significantly	O
decreased	O
following	O
PMA	O
treatment	O
.	O
Using	O
an	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
activation	O
inhibitor	O
,	O
we	O
observed	O
complete	O
inhibition	O
of	O
gene1s	O
IL-6	O
gene1e	O
expression	O
while	O
gene1s	O
CXCL8	O
gene1e	O
levels	O
only	O
decreased	O
by	O
40	O
%	O
at	O
the	O
highest	O
concentration	O
.	O
Treatment	O
of	O
species1s	O
Jurkat	O
species1e	O
T	O
-	O
cells	O
with	O
PMA	O
in	O
the	O
presence	O
of	O
gene1s	O
JNK	O
gene1e	O
-	O
inhibitor	O
suppressed	O
both	O
gene1s	O
CXCL8	O
gene1e	O
and	O
gene1s	O
IL-6	O
gene1e	O
while	O
gene1s	O
PKC	O
gene1e	O
-	O
inhibitor	O
primarily	O
decreased	O
gene1s	O
CXCL8	O
gene1e	O
expression	O
.	O
CONCLUSION	O
:	O
The	O
present	O
study	O
shows	O
that	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
regulated	O
gene1s	O
IL-6	O
gene1e	O
but	O
not	O
gene1s	O
CXCL8	O
gene1e	O
.	O
This	O
complex	O
regulation	O
of	O
gene1s	O
CXCL8	O
gene1e	O
suggests	O
that	O
there	O
is	O
a	O
need	O
to	O
further	O
evaluate	O
the	O
signalling	O
pathways	O
in	O
order	O
to	O
develop	O
new	O
treatment	O
for	O
diseases	O
with	O
elevated	O
gene1s	O
CXCL8	O
gene1e	O
levels	O
,	O
such	O
as	O
AIDS	O
and	O
autoimmune	O
diseases	O
.	O

Differential	O
gene1s	O
cytokine	O
gene1e	O
regulation	O
by	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
and	O
gene1s	O
AP-1	O
gene1e	O
in	O
species1s	O
Jurkat	O
species1e	O
T	O
-	O
cells	O
.	O
BACKGROUND	O
:	O
gene1s	O
Activator	O
protein	O
(	O
AP)-1	O
gene1e	O
and	O
gene1s	O
nuclear	O
factor	O
(	O
NF)-kappaB	O
gene1e	O
largely	O
control	O
T	O
-	O
cell	O
activation	O
,	O
following	O
binding	O
of	O
foreign	O
antigens	O
to	O
the	O
gene1s	O
T	O
-	O
cell	O
receptor	O
gene1e	O
leading	O
to	O
gene1s	O
cytokine	O
gene1e	O
secretion	O
.	O
Elevated	O
levels	O
of	O
pro	O
-	O
inflammatory	O
gene1s	O
cytokines	O
gene1e	O
and	O
gene1s	O
chemokines	O
gene1e	O
such	O
as	O
gene1s	O
TNF	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
and	O
gene1s	O
CXCL8	O
gene1e	O
are	O
associated	O
with	O
several	O
species1s	O
human	O
species1e	O
diseases	O
including	O
cystic	O
fibrosis	O
,	O
pulmonary	O
fibrosis	O
and	O
AIDS	O
.	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
role	O
of	O
the	O
gene1s	O
transcription	O
factors	O
gene1e	O
,	O
gene1s	O
AP-1	O
gene1e	O
and	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
,	O
in	O
gene1s	O
IL-6	O
gene1e	O
and	O
gene1s	O
CXCL8	O
gene1e	O
regulation	O
in	O
species1s	O
Jurkat	O
species1e	O
T	O
-	O
cells	O
.	O
RESULTS	O
:	O
Phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
exposure	O
resulted	O
in	O
an	O
up	O
-	O
regulation	O
of	O
gene1s	O
AP-1	O
gene1e	O
and	O
down	O
-	O
regulation	O
of	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
activity	O
,	O
however	O
,	O
exposure	O
to	O
heat	O
killed	O
(	O
HK	O
)	O
species1s	O
Escherichia	O
.	O
coli	O
MG1655	O
species1e	O
resulted	O
in	O
a	O
dose	O
-	O
dependent	O
increase	O
in	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
activity	O
without	O
affecting	O
gene1s	O
AP-1	O
gene1e	O
.	O
The	O
gene1s	O
cytokine	O
gene1e	O
profile	O
revealed	O
an	O
up	O
-	O
regulation	O
of	O
the	O
gene1s	O
chemokine	O
gene1e	O
gene1s	O
CXCL8	O
gene1e	O
and	O
the	O
pro	O
-	O
inflammatory	O
gene1s	O
cytokines	O
gene1e	O
gene1s	O
TNF	O
gene1e	O
,	O
gene1s	O
IL-2	O
gene1e	O
and	O
gene1s	O
IL-6	O
gene1e	O
following	O
treatment	O
with	O
both	O
PMA	O
and	O
HK	O
arg1s	O
E.	O
coli	O
arg1e	O
,	O
while	O
the	O
levels	O
of	O
the	O
anti	O
-	O
inflammatory	O
gene1s	O
cytokine	O
gene1e	O
gene1s	O
IL-10	O
gene1e	O
were	O
not	O
affected	O
by	O
PMA	O
but	O
were	O
significantly	O
down	O
-	O
regulated	O
by	O
HK	O
arg1s	O
E.	O
coli	O
arg1e	O
.	O
gene1s	O
AP-1	O
gene1e	O
activation	O
was	O
significantly	O
increased	O
2	O
h	O
after	O
PMA	O
exposure	O
and	O
continued	O
to	O
increase	O
thereafter	O
.	O
In	O
contrast	O
,	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
responded	O
to	O
PMA	O
exposure	O
by	O
a	O
rapid	O
up	O
-	O
regulation	O
followed	O
by	O
a	O
subsequent	O
down	O
-	O
regulation	O
.	O
Increased	O
intracellular	O
Ca2	O
+	O
concentrations	O
countered	O
the	O
down	O
-	O
regulation	O
of	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
by	O
PMA	O
,	O
while	O
similar	O
treatment	O
with	O
calcium	O
ionophore	O
resulted	O
in	O
a	O
reduced	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
activity	O
following	O
induction	O
with	O
HK	O
arg1s	O
E.	O
coli	O
arg1e	O
.	O
In	O
order	O
to	O
further	O
study	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
activation	O
,	O
we	O
considered	O
two	O
up	O
-	O
stream	O
signalling	O
proteins	O
,	O
gene1s	O
PKC	O
gene1e	O
and	O
gene1s	O
Bcl10	O
gene1e	O
.	O
Phosphorylated	O
-	O
gene1s	O
PKC	O
gene1e	O
levels	O
increased	O
in	O
response	O
to	O
PMA	O
and	O
HK	O
arg1s	O
E.	O
coli	O
arg1e	O
,	O
while	O
gene1s	O
Bcl10	O
gene1e	O
levels	O
significantly	O
decreased	O
following	O
PMA	O
treatment	O
.	O
Using	O
an	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
activation	O
inhibitor	O
,	O
we	O
observed	O
complete	O
inhibition	O
of	O
gene1s	O
IL-6	O
gene1e	O
expression	O
while	O
gene1s	O
CXCL8	O
gene1e	O
levels	O
only	O
decreased	O
by	O
40	O
%	O
at	O
the	O
highest	O
concentration	O
.	O
Treatment	O
of	O
species1s	O
Jurkat	O
species1e	O
T	O
-	O
cells	O
with	O
PMA	O
in	O
the	O
presence	O
of	O
gene1s	O
JNK	O
gene1e	O
-	O
inhibitor	O
suppressed	O
both	O
gene1s	O
CXCL8	O
gene1e	O
and	O
gene1s	O
IL-6	O
gene1e	O
while	O
gene1s	O
PKC	O
gene1e	O
-	O
inhibitor	O
primarily	O
decreased	O
gene1s	O
CXCL8	O
gene1e	O
expression	O
.	O
CONCLUSION	O
:	O
The	O
present	O
study	O
shows	O
that	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
regulated	O
gene1s	O
IL-6	O
gene1e	O
but	O
not	O
gene1s	O
CXCL8	O
gene1e	O
.	O
This	O
complex	O
regulation	O
of	O
gene1s	O
CXCL8	O
gene1e	O
suggests	O
that	O
there	O
is	O
a	O
need	O
to	O
further	O
evaluate	O
the	O
signalling	O
pathways	O
in	O
order	O
to	O
develop	O
new	O
treatment	O
for	O
diseases	O
with	O
elevated	O
gene1s	O
CXCL8	O
gene1e	O
levels	O
,	O
such	O
as	O
AIDS	O
and	O
autoimmune	O
diseases	O
.	O

Crucial	O
role	O
of	O
calbindin	O
-	O
D28k	O
in	O
the	O
pathogenesis	O
of	O
Alzheimer	O
's	O
disease	O
arg1s	O
mouse	O
arg1e	O
model	O
.	O
gene1s	ARG2
Calbindin	ARG2
-	ARG2
D28k	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CB	ARG2
gene1e	ARG2
)	O
,	O
one	O
of	O
the	O
major	O
calcium	O
-	O
binding	O
and	O
buffering	O
proteins	O
,	O
has	O
a	O
critical	O
role	O
in	O
preventing	O
a	O
neuronal	O
death	O
as	O
well	O
as	O
maintaining	O
calcium	O
homeostasis	O
.	O
Although	O
marked	O
reductions	O
of	O
gene1s	ARG2
CB	ARG2
gene1e	ARG2
expression	O
have	O
been	O
observed	O
in	O
the	O
brains	O
of	O
arg1s	O
mice	O
arg1e	O
and	O
species1s	O
humans	O
species1e	O
with	O
Alzheimer	O
disease	O
(	O
AD	O
)	O
,	O
it	O
is	O
unknown	O
whether	O
these	O
changes	O
contribute	O
to	O
AD	O
-	O
related	O
dysfunction	O
.	O
To	O
determine	O
the	O
pathogenic	O
importance	O
of	O
CB	O
depletions	O
in	O
AD	O
models	O
,	O
we	O
crossed	O
5	O
familial	O
AD	O
mutations	O
(	O
5XFAD	O
;	O
Tg	O
)	O
arg1s	O
mice	O
arg1e	O
with	O
CB	O
knock	O
-	O
out	O
(	O
CBKO	O
)	O
arg1s	O
mice	O
arg1e	O
and	O
generated	O
a	O
novel	O
line	O
CBKO.5XFAD	O
(	O
CBKOTg	O
)	O
arg1s	O
mice	O
arg1e	O
.	O
We	O
first	O
identified	O
the	O
change	O
of	O
signaling	O
pathways	O
and	O
differentially	O
expressed	O
proteins	O
globally	O
by	O
removing	O
CB	O
in	O
Tg	O
arg1s	O
mice	O
arg1e	O
using	O
mass	O
spectrometry	O
and	O
antibody	O
microarray	O
.	O
Immunohistochemistry	O
showed	O
that	O
CBKOTg	O
arg1s	O
mice	O
arg1e	O
had	O
significant	O
neuronal	O
loss	O
in	O
the	O
subiculum	O
area	O
without	O
changing	O
the	O
magnitude	O
(	O
number	O
)	O
of	O
gene1s	ARG2
amyloid	ARG2
b	ARG2
-	ARG2
peptide	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Ab	ARG2
gene1e	ARG2
)	O
plaques	O
deposition	O
and	O
elicited	O
significant	O
apoptotic	O
features	O
and	O
mitochondrial	O
dysfunction	O
compared	O
with	O
Tg	O
arg1s	O
mice	O
arg1e	O
.	O
Moreover	O
,	O
CBKOTg	O
arg1s	O
mice	O
arg1e	O
reduced	O
levels	O
of	O
phosphorylated	O
gene1s	ARG2
mitogen	ARG2
-	ARG2
activated	ARG2
protein	ARG2
kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
extracellular	ARG2
signal	ARG2
-	ARG2
regulated	ARG2
kinase	ARG2
)	ARG2
1/2	ARG2
gene1e	ARG2
and	O
cAMP	O
response	O
element	O
-	O
binding	O
protein	O
at	O
Ser-133	O
and	O
synaptic	O
molecules	O
such	O
as	O
gene1s	ARG2
N	ARG2
-	ARG2
methyl	ARG2
-	ARG2
D	ARG2
-	ARG2
aspartate	ARG2
receptor	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NMDA	ARG2
receptor	ARG2
1	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
NMDA	ARG2
receptor	ARG2
2A	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PSD-95	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
synaptophysin	ARG2
gene1e	ARG2
in	O
the	O
subiculum	O
compared	O
with	O
Tg	O
arg1s	O
mice	O
arg1e	O
.	O
Importantly	O
,	O
this	O
is	O
the	O
first	O
experimental	O
evidence	O
that	O
removal	O
of	O
CB	O
from	O
gene1s	ARG2
amyloid	ARG2
precursor	ARG2
protein	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
presenilin	ARG2
gene1e	ARG2
arg1s	O
transgenic	O
mice	O
arg1e	O
aggravates	O
AD	O
pathogenesis	O
,	O
suggesting	O
that	O
CB	O
has	O
a	O
critical	O
role	O
in	O
AD	O
pathogenesis	O
.	O

Crucial	O
role	O
of	O
calbindin	O
-	O
D28k	O
in	O
the	O
pathogenesis	O
of	O
Alzheimer	O
's	O
disease	O
species1s	O
mouse	O
species1e	O
model	O
.	O
gene1s	O
Calbindin	O
-	O
D28k	O
gene1e	O
(	O
gene1s	O
CB	O
gene1e	O
)	O
,	O
one	O
of	O
the	O
major	O
calcium	O
-	O
binding	O
and	O
buffering	O
proteins	O
,	O
has	O
a	O
critical	O
role	O
in	O
preventing	O
a	O
neuronal	O
death	O
as	O
well	O
as	O
maintaining	O
calcium	O
homeostasis	O
.	O
Although	O
marked	O
reductions	O
of	O
gene1s	ARG2
CB	ARG2
gene1e	ARG2
expression	O
have	O
been	O
observed	O
in	O
the	O
brains	O
of	O
species1s	O
mice	O
species1e	O
and	O
arg1s	O
humans	O
arg1e	O
with	O
Alzheimer	O
disease	O
(	O
AD	O
)	O
,	O
it	O
is	O
unknown	O
whether	O
these	O
changes	O
contribute	O
to	O
AD	O
-	O
related	O
dysfunction	O
.	O
To	O
determine	O
the	O
pathogenic	O
importance	O
of	O
CB	O
depletions	O
in	O
AD	O
models	O
,	O
we	O
crossed	O
5	O
familial	O
AD	O
mutations	O
(	O
5XFAD	O
;	O
Tg	O
)	O
species1s	O
mice	O
species1e	O
with	O
CB	O
knock	O
-	O
out	O
(	O
CBKO	O
)	O
species1s	O
mice	O
species1e	O
and	O
generated	O
a	O
novel	O
line	O
CBKO.5XFAD	O
(	O
CBKOTg	O
)	O
species1s	O
mice	O
species1e	O
.	O
We	O
first	O
identified	O
the	O
change	O
of	O
signaling	O
pathways	O
and	O
differentially	O
expressed	O
proteins	O
globally	O
by	O
removing	O
CB	O
in	O
Tg	O
species1s	O
mice	O
species1e	O
using	O
mass	O
spectrometry	O
and	O
antibody	O
microarray	O
.	O
Immunohistochemistry	O
showed	O
that	O
CBKOTg	O
species1s	O
mice	O
species1e	O
had	O
significant	O
neuronal	O
loss	O
in	O
the	O
subiculum	O
area	O
without	O
changing	O
the	O
magnitude	O
(	O
number	O
)	O
of	O
gene1s	O
amyloid	O
b	O
-	O
peptide	O
gene1e	O
(	O
gene1s	O
Ab	O
gene1e	O
)	O
plaques	O
deposition	O
and	O
elicited	O
significant	O
apoptotic	O
features	O
and	O
mitochondrial	O
dysfunction	O
compared	O
with	O
Tg	O
species1s	O
mice	O
species1e	O
.	O
Moreover	O
,	O
CBKOTg	O
species1s	O
mice	O
species1e	O
reduced	O
levels	O
of	O
phosphorylated	O
gene1s	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
gene1e	O
(	O
gene1s	O
extracellular	O
signal	O
-	O
regulated	O
kinase	O
)	O
1/2	O
gene1e	O
and	O
cAMP	O
response	O
element	O
-	O
binding	O
protein	O
at	O
Ser-133	O
and	O
synaptic	O
molecules	O
such	O
as	O
gene1s	O
N	O
-	O
methyl	O
-	O
D	O
-	O
aspartate	O
receptor	O
1	O
gene1e	O
(	O
gene1s	O
NMDA	O
receptor	O
1	O
gene1e	O
)	O
,	O
gene1s	O
NMDA	O
receptor	O
2A	O
gene1e	O
,	O
gene1s	O
PSD-95	O
gene1e	O
and	O
gene1s	O
synaptophysin	O
gene1e	O
in	O
the	O
subiculum	O
compared	O
with	O
Tg	O
species1s	O
mice	O
species1e	O
.	O
Importantly	O
,	O
this	O
is	O
the	O
first	O
experimental	O
evidence	O
that	O
removal	O
of	O
CB	O
from	O
gene1s	O
amyloid	O
precursor	O
protein	O
gene1e	O
/	O
gene1s	O
presenilin	O
gene1e	O
species1s	O
transgenic	O
mice	O
species1e	O
aggravates	O
AD	O
pathogenesis	O
,	O
suggesting	O
that	O
CB	O
has	O
a	O
critical	O
role	O
in	O
AD	O
pathogenesis	O
.	O

gene1s	ARG2
Minibrain	ARG2
gene1e	ARG2
/	O
gene1s	O
Dyrk1a	O
gene1e	O
regulates	O
food	O
intake	O
through	O
the	O
gene1s	ARG2
Sir2	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
FOXO	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
sNPF	ARG2
gene1e	ARG2
/	O
gene1s	O
NPY	O
gene1e	O
pathway	O
in	O
arg1s	O
Drosophila	O
arg1e	O
and	O
mammals	O
.	O
Feeding	O
behavior	O
is	O
one	O
of	O
the	O
most	O
essential	O
activities	O
in	O
animals	O
,	O
which	O
is	O
tightly	O
regulated	O
by	O
neuroendocrine	O
factors	O
.	O
arg1s	O
Drosophila	O
melanogaster	O
arg1e	O
gene1s	ARG2
short	ARG2
neuropeptide	ARG2
F	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
sNPF	ARG2
gene1e	ARG2
)	O
and	O
the	O
species1s	O
mammalian	O
species1e	O
functional	O
homolog	O
gene1s	O
neuropeptide	O
Y	O
gene1e	O
(	O
gene1s	O
NPY	O
gene1e	O
)	O
regulate	O
food	O
intake	O
.	O
Understanding	O
the	O
molecular	O
mechanism	O
of	O
gene1s	ARG2
sNPF	ARG2
gene1e	ARG2
and	O
gene1s	O
NPY	O
gene1e	O
signaling	O
is	O
critical	O
to	O
elucidate	O
feeding	O
regulation	O
.	O
Here	O
,	O
we	O
found	O
that	O
gene1s	ARG2
minibrain	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
mnb	ARG2
gene1e	ARG2
)	O
and	O
the	O
species1s	O
mammalian	O
species1e	O
ortholog	O
gene1s	O
Dyrk1a	O
gene1e	O
,	O
target	O
genes	O
of	O
gene1s	ARG2
sNPF	ARG2
gene1e	ARG2
and	O
gene1s	O
NPY	O
gene1e	O
signaling	O
,	O
[	O
corrected	O
]	O
regulate	O
food	O
intake	O
in	O
arg1s	O
Drosophila	O
melanogaster	O
arg1e	O
and	O
species1s	O
mice	O
species1e	O
.	O
In	O
arg1s	O
Drosophila	O
melanogaster	O
arg1e	O
neuronal	O
cells	O
and	O
species1s	O
mouse	O
species1e	O
hypothalamic	O
cells	O
,	O
gene1s	ARG2
sNPF	ARG2
gene1e	ARG2
and	O
gene1s	O
NPY	O
gene1e	O
modulated	O
the	O
gene1s	ARG2
mnb	ARG2
gene1e	ARG2
and	O
gene1s	O
Dyrk1a	O
gene1e	O
expression	O
through	O
the	O
gene1s	ARG2
PKA	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
CREB	ARG2
gene1e	ARG2
pathway	O
.	O
Increased	O
gene1s	O
Dyrk1a	O
gene1e	O
activated	O
gene1s	O
Sirt1	O
gene1e	O
to	O
regulate	O
the	O
deacetylation	O
of	O
gene1s	O
FOXO	O
gene1e	O
,	O
which	O
potentiated	O
gene1s	ARG2
FOXO	ARG2
gene1e	ARG2
-	O
induced	O
gene1s	ARG2
sNPF	ARG2
gene1e	ARG2
/	O
gene1s	O
NPY	O
gene1e	O
expression	O
and	O
in	O
turn	O
promoted	O
food	O
intake	O
.	O
Conversely	O
,	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
-	O
mediated	O
insulin	O
signaling	O
suppressed	O
gene1s	ARG2
FOXO	ARG2
gene1e	ARG2
-	O
mediated	O
gene1s	ARG2
sNPF	ARG2
gene1e	ARG2
/	O
gene1s	O
NPY	O
gene1e	O
expression	O
,	O
which	O
resulted	O
in	O
decreasing	O
food	O
intake	O
.	O
Furthermore	O
,	O
species1s	O
human	O
species1e	O
gene1s	O
Dyrk1a	O
gene1e	O
species1s	O
transgenic	O
mice	O
species1e	O
exhibited	O
decreased	O
gene1s	O
FOXO	O
gene1e	O
acetylation	O
and	O
increased	O
gene1s	O
NPY	O
gene1e	O
expression	O
in	O
the	O
hypothalamus	O
,	O
and	O
[	O
corrected	O
]	O
increased	O
food	O
intake	O
.	O
Our	O
findings	O
demonstrate	O
that	O
gene1s	ARG2
Mnb	ARG2
gene1e	ARG2
/	O
gene1s	O
Dyrk1a	O
gene1e	O
regulates	O
food	O
intake	O
through	O
the	O
evolutionary	O
conserved	O
gene1s	ARG2
Sir2	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
FOXO	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
sNPF	ARG2
gene1e	ARG2
/	O
gene1s	O
NPY	O
gene1e	O
pathway	O
in	O
arg1s	O
Drosophila	O
melanogaster	O
arg1e	O
and	O
mammals	O
.	O

gene1s	O
Minibrain	O
gene1e	O
/	O
gene1s	ARG2
Dyrk1a	ARG2
gene1e	ARG2
regulates	O
food	O
intake	O
through	O
the	O
gene1s	O
Sir2	O
gene1e	O
-	O
gene1s	O
FOXO	O
gene1e	O
-	O
gene1s	O
sNPF	O
gene1e	O
/	O
gene1s	O
NPY	O
gene1e	O
pathway	O
in	O
species1s	O
Drosophila	O
species1e	O
and	O
mammals	O
.	O
Feeding	O
behavior	O
is	O
one	O
of	O
the	O
most	O
essential	O
activities	O
in	O
animals	O
,	O
which	O
is	O
tightly	O
regulated	O
by	O
neuroendocrine	O
factors	O
.	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
gene1s	O
short	O
neuropeptide	O
F	O
gene1e	O
(	O
gene1s	O
sNPF	O
gene1e	O
)	O
and	O
the	O
arg1s	O
mammalian	O
arg1e	O
functional	O
homolog	O
gene1s	O
neuropeptide	O
Y	O
gene1e	O
(	O
gene1s	O
NPY	O
gene1e	O
)	O
regulate	O
food	O
intake	O
.	O
Understanding	O
the	O
molecular	O
mechanism	O
of	O
gene1s	O
sNPF	O
gene1e	O
and	O
gene1s	O
NPY	O
gene1e	O
signaling	O
is	O
critical	O
to	O
elucidate	O
feeding	O
regulation	O
.	O
Here	O
,	O
we	O
found	O
that	O
gene1s	O
minibrain	O
gene1e	O
(	O
gene1s	O
mnb	O
gene1e	O
)	O
and	O
the	O
arg1s	O
mammalian	O
arg1e	O
ortholog	O
gene1s	ARG2
Dyrk1a	ARG2
gene1e	ARG2
,	O
target	O
genes	O
of	O
gene1s	O
sNPF	O
gene1e	O
and	O
gene1s	O
NPY	O
gene1e	O
signaling	O
,	O
[	O
corrected	O
]	O
regulate	O
food	O
intake	O
in	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
and	O
species1s	O
mice	O
species1e	O
.	O
In	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
neuronal	O
cells	O
and	O
species1s	O
mouse	O
species1e	O
hypothalamic	O
cells	O
,	O
gene1s	O
sNPF	O
gene1e	O
and	O
gene1s	O
NPY	O
gene1e	O
modulated	O
the	O
gene1s	O
mnb	O
gene1e	O
and	O
gene1s	ARG2
Dyrk1a	ARG2
gene1e	ARG2
expression	O
through	O
the	O
gene1s	O
PKA	O
gene1e	O
-	O
gene1s	O
CREB	O
gene1e	O
pathway	O
.	O
Increased	O
gene1s	ARG2
Dyrk1a	ARG2
gene1e	ARG2
activated	O
gene1s	O
Sirt1	O
gene1e	O
to	O
regulate	O
the	O
deacetylation	O
of	O
gene1s	O
FOXO	O
gene1e	O
,	O
which	O
potentiated	O
gene1s	O
FOXO	O
gene1e	O
-	O
induced	O
gene1s	O
sNPF	O
gene1e	O
/	O
gene1s	O
NPY	O
gene1e	O
expression	O
and	O
in	O
turn	O
promoted	O
food	O
intake	O
.	O
Conversely	O
,	O
gene1s	O
AKT	O
gene1e	O
-	O
mediated	O
insulin	O
signaling	O
suppressed	O
gene1s	O
FOXO	O
gene1e	O
-	O
mediated	O
gene1s	O
sNPF	O
gene1e	O
/	O
gene1s	O
NPY	O
gene1e	O
expression	O
,	O
which	O
resulted	O
in	O
decreasing	O
food	O
intake	O
.	O
Furthermore	O
,	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
Dyrk1a	ARG2
gene1e	ARG2
species1s	O
transgenic	O
mice	O
species1e	O
exhibited	O
decreased	O
gene1s	O
FOXO	O
gene1e	O
acetylation	O
and	O
increased	O
gene1s	O
NPY	O
gene1e	O
expression	O
in	O
the	O
hypothalamus	O
,	O
and	O
[	O
corrected	O
]	O
increased	O
food	O
intake	O
.	O
Our	O
findings	O
demonstrate	O
that	O
gene1s	O
Mnb	O
gene1e	O
/	O
gene1s	ARG2
Dyrk1a	ARG2
gene1e	ARG2
regulates	O
food	O
intake	O
through	O
the	O
evolutionary	O
conserved	O
gene1s	O
Sir2	O
gene1e	O
-	O
gene1s	O
FOXO	O
gene1e	O
-	O
gene1s	O
sNPF	O
gene1e	O
/	O
gene1s	O
NPY	O
gene1e	O
pathway	O
in	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
and	O
mammals	O
.	O

gene1s	O
Minibrain	O
gene1e	O
/	O
gene1s	O
Dyrk1a	O
gene1e	O
regulates	O
food	O
intake	O
through	O
the	O
gene1s	ARG2
Sir2	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
FOXO	ARG2
gene1e	ARG2
-	O
gene1s	O
sNPF	O
gene1e	O
/	O
gene1s	ARG2
NPY	ARG2
gene1e	ARG2
pathway	O
in	O
species1s	O
Drosophila	O
species1e	O
and	O
mammals	O
.	O
Feeding	O
behavior	O
is	O
one	O
of	O
the	O
most	O
essential	O
activities	O
in	O
animals	O
,	O
which	O
is	O
tightly	O
regulated	O
by	O
neuroendocrine	O
factors	O
.	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
gene1s	O
short	O
neuropeptide	O
F	O
gene1e	O
(	O
gene1s	O
sNPF	O
gene1e	O
)	O
and	O
the	O
species1s	O
mammalian	O
species1e	O
functional	O
homolog	O
gene1s	ARG2
neuropeptide	ARG2
Y	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NPY	ARG2
gene1e	ARG2
)	O
regulate	O
food	O
intake	O
.	O
Understanding	O
the	O
molecular	O
mechanism	O
of	O
gene1s	O
sNPF	O
gene1e	O
and	O
gene1s	ARG2
NPY	ARG2
gene1e	ARG2
signaling	O
is	O
critical	O
to	O
elucidate	O
feeding	O
regulation	O
.	O
Here	O
,	O
we	O
found	O
that	O
gene1s	O
minibrain	O
gene1e	O
(	O
gene1s	O
mnb	O
gene1e	O
)	O
and	O
the	O
species1s	O
mammalian	O
species1e	O
ortholog	O
gene1s	O
Dyrk1a	O
gene1e	O
,	O
target	O
genes	O
of	O
gene1s	O
sNPF	O
gene1e	O
and	O
gene1s	ARG2
NPY	ARG2
gene1e	ARG2
signaling	O
,	O
[	O
corrected	O
]	O
regulate	O
food	O
intake	O
in	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
and	O
arg1s	O
mice	O
arg1e	O
.	O
In	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
neuronal	O
cells	O
and	O
arg1s	O
mouse	O
arg1e	O
hypothalamic	O
cells	O
,	O
gene1s	O
sNPF	O
gene1e	O
and	O
gene1s	ARG2
NPY	ARG2
gene1e	ARG2
modulated	O
the	O
gene1s	O
mnb	O
gene1e	O
and	O
gene1s	O
Dyrk1a	O
gene1e	O
expression	O
through	O
the	O
gene1s	ARG2
PKA	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
CREB	ARG2
gene1e	ARG2
pathway	O
.	O
Increased	O
gene1s	O
Dyrk1a	O
gene1e	O
activated	O
gene1s	ARG2
Sirt1	ARG2
gene1e	ARG2
to	O
regulate	O
the	O
deacetylation	O
of	O
gene1s	ARG2
FOXO	ARG2
gene1e	ARG2
,	O
which	O
potentiated	O
gene1s	ARG2
FOXO	ARG2
gene1e	ARG2
-	O
induced	O
gene1s	O
sNPF	O
gene1e	O
/	O
gene1s	ARG2
NPY	ARG2
gene1e	ARG2
expression	O
and	O
in	O
turn	O
promoted	O
food	O
intake	O
.	O
Conversely	O
,	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
-	O
mediated	O
insulin	O
signaling	O
suppressed	O
gene1s	ARG2
FOXO	ARG2
gene1e	ARG2
-	O
mediated	O
gene1s	O
sNPF	O
gene1e	O
/	O
gene1s	ARG2
NPY	ARG2
gene1e	ARG2
expression	O
,	O
which	O
resulted	O
in	O
decreasing	O
food	O
intake	O
.	O
Furthermore	O
,	O
species1s	O
human	O
species1e	O
gene1s	O
Dyrk1a	O
gene1e	O
arg1s	O
transgenic	O
mice	O
arg1e	O
exhibited	O
decreased	O
gene1s	ARG2
FOXO	ARG2
gene1e	ARG2
acetylation	O
and	O
increased	O
gene1s	ARG2
NPY	ARG2
gene1e	ARG2
expression	O
in	O
the	O
hypothalamus	O
,	O
and	O
[	O
corrected	O
]	O
increased	O
food	O
intake	O
.	O
Our	O
findings	O
demonstrate	O
that	O
gene1s	O
Mnb	O
gene1e	O
/	O
gene1s	O
Dyrk1a	O
gene1e	O
regulates	O
food	O
intake	O
through	O
the	O
evolutionary	O
conserved	O
gene1s	ARG2
Sir2	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
FOXO	ARG2
gene1e	ARG2
-	O
gene1s	O
sNPF	O
gene1e	O
/	O
gene1s	ARG2
NPY	ARG2
gene1e	ARG2
pathway	O
in	O
species1s	O
Drosophila	O
melanogaster	O
species1e	O
and	O
mammals	O
.	O

Artery	O
Tertiary	O
Lymphoid	O
Organs	O
Control	O
Multilayered	O
Territorialized	O
Atherosclerosis	O
B	O
-	O
Cell	O
Responses	O
in	O
Aged	O
gene1s	ARG2
ApoE	ARG2
gene1e	ARG2
-/-	O
arg1s	O
Mice	O
arg1e	O
.	O
OBJECTIVE	O
:	O
Explore	O
aorta	O
B	O
-	O
cell	O
immunity	O
in	O
aged	O
gene1s	ARG2
apolipoprotein	ARG2
E	ARG2
gene1e	ARG2
-	O
deficient	O
(	O
gene1s	ARG2
ApoE	ARG2
gene1e	ARG2
(-/-	O
)	O
)	O
arg1s	O
mice	O
arg1e	O
.	O
APPROACH	O
AND	O
RESULTS	O
:	O
Transcript	O
maps	O
,	O
fluorescence	O
-	O
activated	O
cell	O
sorting	O
,	O
immunofluorescence	O
analyses	O
,	O
cell	O
transfers	O
,	O
and	O
Ig	O
-	O
ELISPOT	O
(	O
enzyme	O
-	O
linked	O
immunospot	O
)	O
assays	O
showed	O
multilayered	O
atherosclerosis	O
B	O
-	O
cell	O
responses	O
in	O
artery	O
tertiary	O
lymphoid	O
organs	O
(	O
ATLOs	O
)	O
.	O
Aging	O
-	O
associated	O
aorta	O
B	O
-	O
cell	O
-	O
related	O
transcriptomes	O
were	O
identified	O
,	O
and	O
transcript	O
atlases	O
revealed	O
highly	O
territorialized	O
B	O
-	O
cell	O
responses	O
in	O
ATLOs	O
versus	O
atherosclerotic	O
lesions	O
:	O
ATLOs	O
showed	O
upregulation	O
of	O
species1s	O
bona	O
species1e	O
fide	O
B	O
-	O
cell	O
genes	O
,	O
including	O
gene1s	ARG2
Cd19	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Ms4a1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Cd20	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
Cd79a	ARG2
/	ARG2
b	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Ighm	ARG2
gene1e	ARG2
although	O
intima	O
plaques	O
preferentially	O
expressed	O
molecules	O
involved	O
in	O
non	O
-	O
B	O
effector	O
responses	O
toward	O
B	O
-	O
cell	O
-	O
derived	O
mediators	O
,	O
that	O
is	O
,	O
gene1s	ARG2
Fcgr3	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Cd16	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
Fcer1	ARG2
g	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Cd23	ARG2
gene1e	ARG2
)	O
,	O
and	O
the	O
gene1s	ARG2
C1q	ARG2
gene1e	ARG2
family	O
.	O
ATLOs	O
promoted	O
B	O
-	O
cell	O
recruitment	O
.	O
ATLO	O
B-2	O
B	O
cells	O
included	O
naive	O
,	O
transitional	O
,	O
follicular	O
,	O
germinal	O
center	O
,	O
switched	O
gene1s	ARG2
IgG1	ARG2
gene1e	ARG2
(+	O
)	O
,	O
gene1s	ARG2
IgA	ARG2
gene1e	ARG2
(+	O
)	O
,	O
and	O
gene1s	ARG2
IgE	ARG2
gene1e	ARG2
(+	O
)	O
memory	O
cells	O
,	O
plasmablasts	O
,	O
and	O
long	O
-	O
lived	O
plasma	O
cells	O
.	O
ATLOs	O
recruited	O
large	O
numbers	O
of	O
B-1	O
cells	O
whose	O
subtypes	O
were	O
skewed	O
toward	O
gene1s	ARG2
interleukin-10	ARG2
gene1e	ARG2
(+	O
)	O
B-1b	O
cells	O
versus	O
gene1s	ARG2
interleukin-10	ARG2
gene1e	ARG2
(-	O
)	O
B-1a	O
cells	O
.	O
ATLO	O
B-1	O
cells	O
and	O
plasma	O
cells	O
constitutively	O
produced	O
gene1s	ARG2
IgM	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IgG	ARG2
gene1e	ARG2
and	O
a	O
fraction	O
of	O
plasma	O
cells	O
expressed	O
gene1s	ARG2
interleukin-10	ARG2
gene1e	ARG2
.	O
Moreover	O
,	O
gene1s	ARG2
ApoE	ARG2
gene1e	ARG2
(-/-	O
)	O
arg1s	O
mice	O
arg1e	O
showed	O
increased	O
germinal	O
center	O
B	O
cells	O
in	O
renal	O
lymph	O
nodes	O
,	O
gene1s	ARG2
IgM	ARG2
gene1e	ARG2
-	O
producing	O
plasma	O
cells	O
in	O
the	O
bone	O
marrow	O
,	O
and	O
higher	O
gene1s	ARG2
IgM	ARG2
gene1e	ARG2
and	O
anti	O
-	O
MDA	O
-	O
LDL	O
(	O
malondialdehyde	O
-	O
modified	O
low	O
-	O
density	O
lipoprotein	O
)	O
gene1s	ARG2
IgG	ARG2
gene1e	ARG2
serum	O
titers	O
.	O
CONCLUSIONS	O
:	O
ATLOs	O
orchestrate	O
dichotomic	O
,	O
territorialized	O
,	O
and	O
multilayered	O
B	O
-	O
cell	O
responses	O
in	O
the	O
diseased	O
aorta	O
;	O
germinal	O
center	O
reactions	O
indicate	O
generation	O
of	O
autoimmune	O
B	O
cells	O
within	O
the	O
diseased	O
arterial	O
wall	O
during	O
aging	O
.	O

Artery	O
Tertiary	O
Lymphoid	O
Organs	O
Control	O
Multilayered	O
Territorialized	O
Atherosclerosis	O
B	O
-	O
Cell	O
Responses	O
in	O
Aged	O
gene1s	O
ApoE	O
gene1e	O
-/-	O
species1s	O
Mice	O
species1e	O
.	O
OBJECTIVE	O
:	O
Explore	O
aorta	O
B	O
-	O
cell	O
immunity	O
in	O
aged	O
gene1s	O
apolipoprotein	O
E	O
gene1e	O
-	O
deficient	O
(	O
gene1s	O
ApoE	O
gene1e	O
(-/-	O
)	O
)	O
species1s	O
mice	O
species1e	O
.	O
APPROACH	O
AND	O
RESULTS	O
:	O
Transcript	O
maps	O
,	O
fluorescence	O
-	O
activated	O
cell	O
sorting	O
,	O
immunofluorescence	O
analyses	O
,	O
cell	O
transfers	O
,	O
and	O
Ig	O
-	O
ELISPOT	O
(	O
enzyme	O
-	O
linked	O
immunospot	O
)	O
assays	O
showed	O
multilayered	O
atherosclerosis	O
B	O
-	O
cell	O
responses	O
in	O
artery	O
tertiary	O
lymphoid	O
organs	O
(	O
ATLOs	O
)	O
.	O
Aging	O
-	O
associated	O
aorta	O
B	O
-	O
cell	O
-	O
related	O
transcriptomes	O
were	O
identified	O
,	O
and	O
transcript	O
atlases	O
revealed	O
highly	O
territorialized	O
B	O
-	O
cell	O
responses	O
in	O
ATLOs	O
versus	O
atherosclerotic	O
lesions	O
:	O
ATLOs	O
showed	O
upregulation	O
of	O
arg1s	O
bona	O
arg1e	O
fide	O
B	O
-	O
cell	O
genes	O
,	O
including	O
gene1s	O
Cd19	O
gene1e	O
,	O
gene1s	O
Ms4a1	O
gene1e	O
(	O
gene1s	O
Cd20	O
gene1e	O
)	O
,	O
gene1s	O
Cd79a	O
/	O
b	O
gene1e	O
,	O
and	O
gene1s	O
Ighm	O
gene1e	O
although	O
intima	O
plaques	O
preferentially	O
expressed	O
molecules	O
involved	O
in	O
non	O
-	O
B	O
effector	O
responses	O
toward	O
B	O
-	O
cell	O
-	O
derived	O
mediators	O
,	O
that	O
is	O
,	O
gene1s	O
Fcgr3	O
gene1e	O
(	O
gene1s	O
Cd16	O
gene1e	O
)	O
,	O
gene1s	O
Fcer1	O
g	O
gene1e	O
(	O
gene1s	O
Cd23	O
gene1e	O
)	O
,	O
and	O
the	O
gene1s	O
C1q	O
gene1e	O
family	O
.	O
ATLOs	O
promoted	O
B	O
-	O
cell	O
recruitment	O
.	O
ATLO	O
B-2	O
B	O
cells	O
included	O
naive	O
,	O
transitional	O
,	O
follicular	O
,	O
germinal	O
center	O
,	O
switched	O
gene1s	O
IgG1	O
gene1e	O
(+	O
)	O
,	O
gene1s	O
IgA	O
gene1e	O
(+	O
)	O
,	O
and	O
gene1s	O
IgE	O
gene1e	O
(+	O
)	O
memory	O
cells	O
,	O
plasmablasts	O
,	O
and	O
long	O
-	O
lived	O
plasma	O
cells	O
.	O
ATLOs	O
recruited	O
large	O
numbers	O
of	O
B-1	O
cells	O
whose	O
subtypes	O
were	O
skewed	O
toward	O
gene1s	O
interleukin-10	O
gene1e	O
(+	O
)	O
B-1b	O
cells	O
versus	O
gene1s	O
interleukin-10	O
gene1e	O
(-	O
)	O
B-1a	O
cells	O
.	O
ATLO	O
B-1	O
cells	O
and	O
plasma	O
cells	O
constitutively	O
produced	O
gene1s	O
IgM	O
gene1e	O
and	O
gene1s	O
IgG	O
gene1e	O
and	O
a	O
fraction	O
of	O
plasma	O
cells	O
expressed	O
gene1s	O
interleukin-10	O
gene1e	O
.	O
Moreover	O
,	O
gene1s	O
ApoE	O
gene1e	O
(-/-	O
)	O
species1s	O
mice	O
species1e	O
showed	O
increased	O
germinal	O
center	O
B	O
cells	O
in	O
renal	O
lymph	O
nodes	O
,	O
gene1s	O
IgM	O
gene1e	O
-	O
producing	O
plasma	O
cells	O
in	O
the	O
bone	O
marrow	O
,	O
and	O
higher	O
gene1s	O
IgM	O
gene1e	O
and	O
anti	O
-	O
MDA	O
-	O
LDL	O
(	O
malondialdehyde	O
-	O
modified	O
low	O
-	O
density	O
lipoprotein	O
)	O
gene1s	O
IgG	O
gene1e	O
serum	O
titers	O
.	O
CONCLUSIONS	O
:	O
ATLOs	O
orchestrate	O
dichotomic	O
,	O
territorialized	O
,	O
and	O
multilayered	O
B	O
-	O
cell	O
responses	O
in	O
the	O
diseased	O
aorta	O
;	O
germinal	O
center	O
reactions	O
indicate	O
generation	O
of	O
autoimmune	O
B	O
cells	O
within	O
the	O
diseased	O
arterial	O
wall	O
during	O
aging	O
.	O

Characterization	O
and	O
identification	O
of	O
subpopulations	O
of	O
mononuclear	O
preosteoclasts	O
induced	O
by	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
in	O
combination	O
with	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b	ARG2
gene1e	ARG2
in	O
arg1s	O
rats	O
arg1e	O
.	O
Osteoclasts	O
are	O
unique	O
multinucleated	O
cells	O
formed	O
by	O
fusion	O
of	O
preosteoclasts	O
derived	O
from	O
cells	O
of	O
the	O
monocyte	O
/	O
macrophage	O
lineage	O
,	O
which	O
are	O
induced	O
by	O
gene1s	ARG2
RANKL	ARG2
gene1e	ARG2
.	O
However	O
,	O
characteristics	O
and	O
subpopulations	O
of	O
osteoclast	O
precursor	O
cells	O
are	O
poorly	O
understood	O
.	O
We	O
show	O
here	O
that	O
a	O
combination	O
of	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
M	ARG2
-	ARG2
CSF	ARG2
gene1e	ARG2
efficiently	O
generates	O
mononuclear	O
preosteoclasts	O
but	O
not	O
multinucleate	O
gene1s	ARG2
d	ARG2
gene1e	ARG2
osteoclasts	O
(	O
MNCs	O
)	O
in	O
arg1s	O
rat	O
arg1e	O
bone	O
marrow	O
cultures	O
depleted	O
of	O
stromal	O
cells	O
.	O
Using	O
a	O
arg1s	O
rat	O
arg1e	O
osteoclast	O
-	O
specific	O
mAb	O
,	O
gene1s	ARG2
Kat1	ARG2
gene1e	ARG2
,	O
we	O
found	O
that	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b	ARG2
gene1e	ARG2
specifically	O
increased	O
gene1s	ARG2
Kat1	ARG2
gene1e	ARG2
(+)	O
gene1s	ARG2
c	ARG2
-	ARG2
fms	ARG2
gene1e	ARG2
(+	O
)	O
and	O
gene1s	ARG2
Kat1	ARG2
gene1e	ARG2
(+)	O
gene1s	ARG2
c	ARG2
-	ARG2
fms	ARG2
gene1e	ARG2
(-	O
)	O
cells	O
but	O
not	O
gene1s	ARG2
Kat1	ARG2
gene1e	ARG2
(-)	O
gene1s	ARG2
c	ARG2
-	ARG2
fms	ARG2
gene1e	ARG2
(+	O
)	O
cells	O
.	O
gene1s	ARG2
Kat1	ARG2
gene1e	ARG2
(-)	O
gene1s	ARG2
c	ARG2
-	ARG2
fms	ARG2
gene1e	ARG2
(+	O
)	O
cells	O
appeared	O
in	O
early	O
stages	O
of	O
culture	O
,	O
but	O
gene1s	ARG2
Kat1	ARG2
gene1e	ARG2
(+)	O
gene1s	ARG2
c	ARG2
-	ARG2
fms	ARG2
gene1e	ARG2
(+	O
)	O
and	O
gene1s	ARG2
Kat1	ARG2
gene1e	ARG2
(+)	O
gene1s	ARG2
c	ARG2
-	ARG2
fms	ARG2
gene1e	ARG2
(-	O
)	O
cells	O
increased	O
later	O
.	O
Preosteoclasts	O
induced	O
by	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
M	ARG2
-	ARG2
CSF	ARG2
gene1e	ARG2
rapidly	O
differentiated	O
into	O
osteoclasts	O
in	O
the	O
presence	O
of	O
gene1s	ARG2
RANKL	ARG2
gene1e	ARG2
and	O
hydroxyurea	O
,	O
an	O
inhibitor	O
of	O
DNA	O
synthesis	O
,	O
suggesting	O
that	O
preosteoclasts	O
are	O
terminally	O
differentiated	O
cells	O
.	O
We	O
further	O
analyzed	O
the	O
expression	O
levels	O
of	O
genes	O
encoding	O
surface	O
proteins	O
in	O
bone	O
marrow	O
macrophages	O
(	O
BMM	O
)	O
,	O
preosteoclasts	O
,	O
and	O
MNCs	O
.	O
Preosteoclasts	O
expressed	O
gene1s	ARG2
itgam	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CD11b	ARG2
gene1e	ARG2
)	O
and	O
chemokine	O
receptors	O
gene1s	ARG2
CCR1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CCR2	ARG2
gene1e	ARG2
;	O
however	O
,	O
in	O
preosteoclasts	O
the	O
expression	O
of	O
gene1s	ARG2
chemokine	ARG2
receptors	ARG2
gene1e	ARG2
gene1s	ARG2
CCR1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CCR2	ARG2
gene1e	ARG2
was	O
not	O
up	O
-	O
regulated	O
compared	O
to	O
their	O
expression	O
in	O
BMM	O
.	O
However	O
,	O
addition	O
of	O
gene1s	ARG2
RANKL	ARG2
gene1e	ARG2
to	O
preosteoclasts	O
markedly	O
increased	O
the	O
expression	O
of	O
gene1s	ARG2
CCR1	ARG2
gene1e	ARG2
.	O
In	O
contrast	O
,	O
expression	O
of	O
macrophage	O
antigen	O
gene1s	ARG2
emr-1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
F4/80	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
chemokine	ARG2
receptor	ARG2
gene1e	ARG2
gene1s	ARG2
CCR5	ARG2
gene1e	ARG2
was	O
down	O
-	O
regulated	O
in	O
preosteoclasts	O
.	O
The	O
combination	O
of	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
M	ARG2
-	ARG2
CSF	ARG2
gene1e	ARG2
induced	O
gene1s	ARG2
Kat1	ARG2
gene1e	ARG2
(+)	O
gene1s	ARG2
CD11b	ARG2
gene1e	ARG2
(+	O
)	O
cells	O
,	O
but	O
these	O
cells	O
were	O
also	O
induced	O
by	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
alone	O
.	O
In	O
addition	O
,	O
gene1s	ARG2
MIP-1a	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MCP-1	ARG2
gene1e	ARG2
,	O
which	O
are	O
ligands	O
for	O
gene1s	ARG2
CCR1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CCR2	ARG2
gene1e	ARG2
,	O
were	O
chemotactic	O
for	O
preosteoclasts	O
,	O
and	O
promoted	O
multinucleation	O
of	O
preosteoclasts	O
.	O
Finally	O
,	O
we	O
found	O
that	O
gene1s	ARG2
Kat1	ARG2
gene1e	ARG2
(+)	O
gene1s	ARG2
c	ARG2
-	ARG2
fms	ARG2
gene1e	ARG2
(+	O
)	O
cells	O
were	O
present	O
in	O
bone	O
tissues	O
of	O
arg1s	O
rats	O
arg1e	O
with	O
adjuvant	O
arthritis	O
.	O
These	O
data	O
demonstrate	O
that	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
in	O
combination	O
with	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b	ARG2
gene1e	ARG2
efficiently	O
generates	O
preosteoclasts	O
in	O
vitro	O
.	O
We	O
delineated	O
characteristics	O
that	O
are	O
useful	O
for	O
identifying	O
and	O
isolating	O
arg1s	O
rat	O
arg1e	O
preosteoclasts	O
,	O
and	O
found	O
that	O
gene1s	ARG2
CCR1	ARG2
gene1e	ARG2
expression	O
was	O
regulated	O
in	O
the	O
fusion	O
step	O
in	O
osteoclastogenesis	O
.	O

gene1s	ARG2
NK1.1	ARG2
gene1e	ARG2
(-	O
)	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
(+	O
)	O
gene1s	ARG2
NKG2D	ARG2
gene1e	ARG2
(+	O
)	O
T	O
cells	O
suppress	O
DSS	O
-	O
induced	O
colitis	O
in	O
arg1s	O
mice	O
arg1e	O
through	O
production	O
of	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
(+	O
)	O
gene1s	ARG2
NKG2D	ARG2
gene1e	ARG2
(+	O
)	O
T	O
cells	O
are	O
associated	O
with	O
tumour	O
,	O
infection	O
and	O
autoimmune	O
diseases	O
.	O
Some	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
(+	O
)	O
gene1s	ARG2
NKG2D	ARG2
gene1e	ARG2
(+	O
)	O
T	O
cells	O
secrete	O
gene1s	ARG2
IFN	ARG2
-	ARG2
g	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
to	O
promote	O
inflammation	O
,	O
but	O
others	O
produce	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
FasL	ARG2
gene1e	ARG2
to	O
facilitate	O
tumour	O
evasion	O
.	O
Here	O
,	O
arg1s	O
murine	O
arg1e	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
(+	O
)	O
gene1s	ARG2
NKG2D	ARG2
gene1e	ARG2
(+	O
)	O
T	O
cells	O
were	O
further	O
classified	O
into	O
gene1s	ARG2
NK1.1	ARG2
gene1e	ARG2
(-	O
)	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
(+	O
)	O
gene1s	ARG2
NKG2D	ARG2
gene1e	ARG2
(+	O
)	O
and	O
gene1s	ARG2
NK1.1	ARG2
gene1e	ARG2
(+	O
)	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
(+	O
)	O
gene1s	ARG2
NKG2D	ARG2
gene1e	ARG2
(+	O
)	O
subpopulations	O
.	O
The	O
frequency	O
of	O
gene1s	ARG2
NK1.1	ARG2
gene1e	ARG2
(-	O
)	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
(+	O
)	O
gene1s	ARG2
NKG2D	ARG2
gene1e	ARG2
(+	O
)	O
cells	O
decreased	O
in	O
inflamed	O
colons	O
,	O
whereas	O
more	O
gene1s	ARG2
NK1.1	ARG2
gene1e	ARG2
(+	O
)	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
(+	O
)	O
gene1s	ARG2
NKG2D	ARG2
gene1e	ARG2
(+	O
)	O
cells	O
infiltrated	O
into	O
colons	O
of	O
arg1s	O
mice	O
arg1e	O
with	O
DSS	O
-	O
induced	O
colitis	O
.	O
gene1s	ARG2
NK1.1	ARG2
gene1e	ARG2
(-	O
)	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
(+	O
)	O
gene1s	ARG2
NKG2D	ARG2
gene1e	ARG2
(+	O
)	O
cells	O
expressed	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
FasL	ARG2
gene1e	ARG2
without	O
secreting	O
gene1s	ARG2
IFN	ARG2
-	ARG2
g	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-21	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL-17	ARG2
gene1e	ARG2
and	O
displayed	O
no	O
cytotoxicity	O
.	O
The	O
adoptive	O
transfer	O
of	O
gene1s	ARG2
NK1.1	ARG2
gene1e	ARG2
(-	O
)	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
(+	O
)	O
gene1s	ARG2
NKG2D	ARG2
gene1e	ARG2
(+	O
)	O
cells	O
suppressed	O
DSS	O
-	O
induced	O
colitis	O
largely	O
dependent	O
on	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
NK1.1	ARG2
gene1e	ARG2
(-	O
)	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
(+	O
)	O
gene1s	ARG2
NKG2D	ARG2
gene1e	ARG2
(+	O
)	O
cells	O
did	O
not	O
expressed	O
gene1s	ARG2
Foxp3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD223	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
LAG-3	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
GITR	ARG2
gene1e	ARG2
.	O
The	O
subpopulation	O
was	O
distinct	O
from	O
gene1s	ARG2
NK1.1	ARG2
gene1e	ARG2
(+	O
)	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
(+	O
)	O
gene1s	ARG2
NKG2D	ARG2
gene1e	ARG2
(+	O
)	O
cells	O
in	O
terms	O
of	O
surface	O
markers	O
and	O
RNA	O
transcription	O
.	O
gene1s	ARG2
NK1.1	ARG2
gene1e	ARG2
(-	O
)	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
(+	O
)	O
gene1s	ARG2
NKG2D	ARG2
gene1e	ARG2
(+	O
)	O
cells	O
also	O
differed	O
from	O
Th2	O
or	O
Th17	O
cells	O
because	O
the	O
former	O
did	O
not	O
express	O
gene1s	ARG2
GATA-3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ROR	ARG2
-	ARG2
gt	ARG2
gene1e	ARG2
.	O
Thus	O
,	O
gene1s	ARG2
NK1.1	ARG2
gene1e	ARG2
(-	O
)	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
(+	O
)	O
gene1s	ARG2
NKG2D	ARG2
gene1e	ARG2
(+	O
)	O
cells	O
exhibited	O
immune	O
regulatory	O
functions	O
,	O
and	O
this	O
T	O
cell	O
subset	O
could	O
be	O
developed	O
to	O
suppress	O
inflammation	O
in	O
clinics	O
.	O

Autophagy	O
suppresses	O
gene1s	O
Ras	O
gene1e	O
-	O
driven	O
epithelial	O
tumourigenesis	O
by	O
limiting	O
the	O
accumulation	O
of	O
reactive	O
oxygen	O
species	O
.	O
Activation	O
of	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
signalling	O
occurs	O
in	O
~30	O
%	O
of	O
arg1s	O
human	O
arg1e	O
cancers	O
;	O
however	O
,	O
activated	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
alone	O
is	O
not	O
sufficient	O
for	O
tumourigenesis	O
.	O
In	O
a	O
screen	O
for	O
tumour	O
suppressors	O
that	O
cooperate	O
with	O
oncogenic	O
gene1s	O
Ras	O
gene1e	O
(	O
gene1s	ARG2
Ras(V12	ARG2
)	ARG2
gene1e	ARG2
)	O
in	O
species1s	O
Drosophila	O
species1e	O
,	O
we	O
identified	O
genes	O
involved	O
in	O
the	O
autophagy	O
pathway	O
.	O
Bioinformatic	O
analysis	O
of	O
arg1s	O
human	O
arg1e	O
tumours	O
revealed	O
that	O
several	O
core	O
autophagy	O
genes	O
,	O
including	O
gene1s	ARG2
GABARAP	ARG2
gene1e	ARG2
,	O
correlate	O
with	O
oncogenic	O
gene1s	ARG2
KRAS	ARG2
gene1e	ARG2
mutations	O
and	O
poor	O
prognosis	O
in	O
arg1s	O
human	O
arg1e	O
pancreatic	O
cancer	O
,	O
supporting	O
a	O
potential	O
tumour	O
-	O
suppressive	O
effect	O
of	O
the	O
pathway	O
in	O
gene1s	O
Ras	O
gene1e	O
-	O
driven	O
arg1s	O
human	O
arg1e	O
cancers	O
.	O
In	O
species1s	O
Drosophila	O
species1e	O
,	O
we	O
demonstrate	O
that	O
blocking	O
autophagy	O
at	O
any	O
step	O
of	O
the	O
pathway	O
enhances	O
gene1s	O
Ras(V12)	O
gene1e	O
-driven	O
epithelial	O
tissue	O
overgrowth	O
via	O
the	O
accumulation	O
of	O
reactive	O
oxygen	O
species	O
and	O
activation	O
of	O
the	O
gene1s	O
Jun	O
kinase	O
gene1e	O
stress	O
response	O
pathway	O
.	O
Blocking	O
autophagy	O
in	O
gene1s	O
Ras(V12	O
)	O
gene1e	O
clones	O
also	O
results	O
in	O
non	O
-	O
cell	O
-	O
autonomous	O
effects	O
with	O
autophagy	O
,	O
cell	O
proliferation	O
and	O
caspase	O
activation	O
induced	O
in	O
adjacent	O
wild	O
-	O
type	O
cells	O
.	O
Our	O
study	O
has	O
implications	O
for	O
understanding	O
the	O
interplay	O
between	O
perturbations	O
in	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
signalling	O
and	O
autophagy	O
in	O
tumourigenesis	O
,	O
which	O
might	O
inform	O
the	O
development	O
of	O
novel	O
therapeutics	O
targeting	O
gene1s	O
Ras	O
gene1e	O
-	O
driven	O
cancers	O
.	O
Oncogene	O
advance	O
online	O
publication	O
,	O
5	O
June	O
2017	O
;	O
doi:10.1038	O
/	O
onc.2017.175	O
.	O

Autophagy	O
suppresses	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
-	O
driven	O
epithelial	O
tumourigenesis	O
by	O
limiting	O
the	O
accumulation	O
of	O
reactive	O
oxygen	O
species	O
.	O
Activation	O
of	O
gene1s	O
Ras	O
gene1e	O
signalling	O
occurs	O
in	O
~30	O
%	O
of	O
species1s	O
human	O
species1e	O
cancers	O
;	O
however	O
,	O
activated	O
gene1s	O
Ras	O
gene1e	O
alone	O
is	O
not	O
sufficient	O
for	O
tumourigenesis	O
.	O
In	O
a	O
screen	O
for	O
tumour	O
suppressors	O
that	O
cooperate	O
with	O
oncogenic	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Ras(V12	ARG2
)	ARG2
gene1e	ARG2
)	O
in	O
arg1s	O
Drosophila	O
arg1e	O
,	O
we	O
identified	O
genes	O
involved	O
in	O
the	O
autophagy	O
pathway	O
.	O
Bioinformatic	O
analysis	O
of	O
species1s	O
human	O
species1e	O
tumours	O
revealed	O
that	O
several	O
core	O
autophagy	O
genes	O
,	O
including	O
gene1s	O
GABARAP	O
gene1e	O
,	O
correlate	O
with	O
oncogenic	O
gene1s	O
KRAS	O
gene1e	O
mutations	O
and	O
poor	O
prognosis	O
in	O
species1s	O
human	O
species1e	O
pancreatic	O
cancer	O
,	O
supporting	O
a	O
potential	O
tumour	O
-	O
suppressive	O
effect	O
of	O
the	O
pathway	O
in	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
-	O
driven	O
species1s	O
human	O
species1e	O
cancers	O
.	O
In	O
arg1s	O
Drosophila	O
arg1e	O
,	O
we	O
demonstrate	O
that	O
blocking	O
autophagy	O
at	O
any	O
step	O
of	O
the	O
pathway	O
enhances	O
gene1s	ARG2
Ras(V12)	ARG2
gene1e	ARG2
-driven	O
epithelial	O
tissue	O
overgrowth	O
via	O
the	O
accumulation	O
of	O
reactive	O
oxygen	O
species	O
and	O
activation	O
of	O
the	O
gene1s	ARG2
Jun	ARG2
kinase	ARG2
gene1e	ARG2
stress	O
response	O
pathway	O
.	O
Blocking	O
autophagy	O
in	O
gene1s	ARG2
Ras(V12	ARG2
)	ARG2
gene1e	ARG2
clones	O
also	O
results	O
in	O
non	O
-	O
cell	O
-	O
autonomous	O
effects	O
with	O
autophagy	O
,	O
cell	O
proliferation	O
and	O
caspase	O
activation	O
induced	O
in	O
adjacent	O
wild	O
-	O
type	O
cells	O
.	O
Our	O
study	O
has	O
implications	O
for	O
understanding	O
the	O
interplay	O
between	O
perturbations	O
in	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
signalling	O
and	O
autophagy	O
in	O
tumourigenesis	O
,	O
which	O
might	O
inform	O
the	O
development	O
of	O
novel	O
therapeutics	O
targeting	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
-	O
driven	O
cancers	O
.	O
Oncogene	O
advance	O
online	O
publication	O
,	O
5	O
June	O
2017	O
;	O
doi:10.1038	O
/	O
onc.2017.175	O
.	O

Mesenchymal	O
stromal	O
cells	O
express	O
gene1s	ARG2
GARP	ARG2
gene1e	ARG2
/	O
gene1s	O
LRRC32	O
gene1e	O
on	O
their	O
surface	O
:	O
effects	O
on	O
their	O
biology	O
and	O
immunomodulatory	O
capacity	O
.	O
Mesenchymal	O
stromal	O
cells	O
(	O
MSCs	O
)	O
represent	O
a	O
promising	O
tool	O
for	O
therapy	O
in	O
regenerative	O
medicine	O
,	O
transplantation	O
,	O
and	O
autoimmune	O
disease	O
due	O
to	O
their	O
trophic	O
and	O
immunomodulatory	O
activities	O
.	O
However	O
,	O
we	O
are	O
still	O
far	O
from	O
understanding	O
the	O
mechanisms	O
of	O
action	O
of	O
MSCs	O
in	O
these	O
processes	O
.	O
gene1s	ARG2
Transforming	ARG2
growth	ARG2
factor	ARG2
(	ARG2
TGF)-b1	ARG2
gene1e	ARG2
is	O
a	O
pleiotropic	O
cytokine	O
involved	O
in	O
MSC	O
migration	O
,	O
differentiation	O
,	O
and	O
immunomodulation	O
.	O
Recently	O
,	O
gene1s	ARG2
glycoprotein	ARG2
A	ARG2
repetitions	ARG2
predominant	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
GARP	ARG2
gene1e	ARG2
)	O
was	O
shown	O
to	O
bind	O
gene1s	ARG2
latency	ARG2
-	ARG2
associated	ARG2
peptide	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
LAP	ARG2
gene1e	ARG2
)/	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
to	O
the	O
cell	O
surface	O
of	O
activated	O
gene1s	ARG2
Foxp3	ARG2
gene1e	ARG2
(+	O
)	O
regulatory	O
T	O
cells	O
(	O
Tregs	O
)	O
and	O
megakaryocytes	O
/	O
platelets	O
.	O
In	O
this	O
manuscript	O
,	O
we	O
show	O
that	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
mouse	O
species1e	O
MSCs	O
express	O
gene1s	ARG2
GARP	ARG2
gene1e	ARG2
which	O
presents	O
gene1s	O
LAP	O
gene1e	O
/	O
gene1s	O
TGF	O
-	O
b1	O
gene1e	O
on	O
their	O
cell	O
surface	O
.	O
Silencing	O
gene1s	ARG2
GARP	ARG2
gene1e	ARG2
expression	O
in	O
MSCs	O
increased	O
their	O
secretion	O
and	O
activation	O
of	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
and	O
reduced	O
their	O
proliferative	O
capacity	O
in	O
a	O
gene1s	O
TGF	O
-	O
b1	O
gene1e	O
-independent	O
manner	O
.	O
Importantly	O
,	O
we	O
showed	O
that	O
gene1s	O
GARP	O
gene1e	O
expression	O
on	O
MSCs	O
contributed	O
to	O
their	O
ability	O
to	O
inhibit	O
T	O
-	O
cell	O
responses	O
in	O
vitro	O
.	O
In	O
summary	O
,	O
we	O
have	O
found	O
that	O
gene1s	O
GARP	O
gene1e	O
is	O
an	O
essential	O
molecule	O
for	O
MSC	O
biology	O
,	O
regulating	O
their	O
immunomodulatory	O
and	O
proliferative	O
activities	O
.	O
We	O
envision	O
gene1s	ARG2
GARP	ARG2
gene1e	ARG2
as	O
a	O
new	O
target	O
for	O
improving	O
the	O
therapeutic	O
efficacy	O
of	O
MSCs	O
and	O
also	O
as	O
a	O
novel	O
MSC	O
marker	O
.	O

Mesenchymal	O
stromal	O
cells	O
express	O
gene1s	O
GARP	O
gene1e	O
/	O
gene1s	ARG2
LRRC32	ARG2
gene1e	ARG2
on	O
their	O
surface	O
:	O
effects	O
on	O
their	O
biology	O
and	O
immunomodulatory	O
capacity	O
.	O
Mesenchymal	O
stromal	O
cells	O
(	O
MSCs	O
)	O
represent	O
a	O
promising	O
tool	O
for	O
therapy	O
in	O
regenerative	O
medicine	O
,	O
transplantation	O
,	O
and	O
autoimmune	O
disease	O
due	O
to	O
their	O
trophic	O
and	O
immunomodulatory	O
activities	O
.	O
However	O
,	O
we	O
are	O
still	O
far	O
from	O
understanding	O
the	O
mechanisms	O
of	O
action	O
of	O
MSCs	O
in	O
these	O
processes	O
.	O
gene1s	O
Transforming	O
growth	O
factor	O
(	O
TGF)-b1	O
gene1e	O
is	O
a	O
pleiotropic	O
cytokine	O
involved	O
in	O
MSC	O
migration	O
,	O
differentiation	O
,	O
and	O
immunomodulation	O
.	O
Recently	O
,	O
gene1s	O
glycoprotein	O
A	O
repetitions	O
predominant	O
gene1e	O
(	O
gene1s	O
GARP	O
gene1e	O
)	O
was	O
shown	O
to	O
bind	O
gene1s	O
latency	O
-	O
associated	O
peptide	O
gene1e	O
(	O
gene1s	O
LAP	O
gene1e	O
)/	O
gene1s	O
TGF	O
-	O
b1	O
gene1e	O
to	O
the	O
cell	O
surface	O
of	O
activated	O
gene1s	O
Foxp3	O
gene1e	O
(+	O
)	O
regulatory	O
T	O
cells	O
(	O
Tregs	O
)	O
and	O
megakaryocytes	O
/	O
platelets	O
.	O
In	O
this	O
manuscript	O
,	O
we	O
show	O
that	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
mouse	O
arg1e	O
MSCs	O
express	O
gene1s	O
GARP	O
gene1e	O
which	O
presents	O
gene1s	ARG2
LAP	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
on	O
their	O
cell	O
surface	O
.	O
Silencing	O
gene1s	O
GARP	O
gene1e	O
expression	O
in	O
MSCs	O
increased	O
their	O
secretion	O
and	O
activation	O
of	O
gene1s	O
TGF	O
-	O
b1	O
gene1e	O
and	O
reduced	O
their	O
proliferative	O
capacity	O
in	O
a	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
-independent	O
manner	O
.	O
Importantly	O
,	O
we	O
showed	O
that	O
gene1s	ARG2
GARP	ARG2
gene1e	ARG2
expression	O
on	O
MSCs	O
contributed	O
to	O
their	O
ability	O
to	O
inhibit	O
T	O
-	O
cell	O
responses	O
in	O
vitro	O
.	O
In	O
summary	O
,	O
we	O
have	O
found	O
that	O
gene1s	ARG2
GARP	ARG2
gene1e	ARG2
is	O
an	O
essential	O
molecule	O
for	O
MSC	O
biology	O
,	O
regulating	O
their	O
immunomodulatory	O
and	O
proliferative	O
activities	O
.	O
We	O
envision	O
gene1s	O
GARP	O
gene1e	O
as	O
a	O
new	O
target	O
for	O
improving	O
the	O
therapeutic	O
efficacy	O
of	O
MSCs	O
and	O
also	O
as	O
a	O
novel	O
MSC	O
marker	O
.	O

gene1s	O
RABL2	O
gene1e	O
interacts	O
with	O
the	O
gene1s	O
intraflagellar	O
transport	O
-	O
B	O
complex	O
gene1e	O
and	O
gene1s	O
CEP19	O
gene1e	O
and	O
participates	O
in	O
ciliary	O
assembly	O
.	O
Proteins	O
localized	O
to	O
the	O
basal	O
body	O
and	O
the	O
centrosome	O
play	O
crucial	O
roles	O
in	O
ciliary	O
assembly	O
and	O
function	O
.	O
Although	O
gene1s	O
RABL2	O
gene1e	O
and	O
gene1s	O
CEP19	O
gene1e	O
are	O
conserved	O
in	O
ciliated	O
organisms	O
and	O
have	O
been	O
implicated	O
in	O
ciliary	O
/	O
flagellar	O
functions	O
,	O
their	O
roles	O
are	O
poorly	O
understood	O
.	O
Here	O
we	O
show	O
that	O
gene1s	O
RABL2	O
gene1e	O
interacts	O
with	O
gene1s	O
CEP19	O
gene1e	O
and	O
is	O
recruited	O
to	O
the	O
mother	O
centriole	O
and	O
basal	O
body	O
in	O
a	O
gene1s	O
CEP19	O
gene1e	O
-dependent	O
manner	O
and	O
that	O
gene1s	O
CEP19	O
gene1e	O
is	O
recruited	O
to	O
the	O
centriole	O
probably	O
via	O
its	O
binding	O
to	O
the	O
centrosomal	O
protein	O
gene1s	O
FGFR1OP	O
gene1e	O
.	O
Disruption	O
of	O
the	O
gene1s	ARG2
RABL2	ARG2
gene1e	ARG2
gene	O
in	O
arg1s	O
Chlamydomonas	O
reinhardtii	O
arg1e	O
results	O
in	O
the	O
nonflagellated	O
phenotype	O
,	O
suggesting	O
a	O
crucial	O
role	O
of	O
gene1s	O
RABL2	O
gene1e	O
in	O
ciliary	O
/	O
flagellar	O
assembly	O
.	O
We	O
also	O
show	O
that	O
gene1s	O
RABL2	O
gene1e	O
interacts	O
,	O
in	O
its	O
GTP	O
-	O
bound	O
state	O
,	O
with	O
the	O
gene1s	O
intraflagellar	O
transport	O
(	O
IFT)-B	O
complex	O
gene1e	O
via	O
the	O
gene1s	O
IFT74	O
gene1e	O
-	O
gene1s	O
IFT81	O
gene1e	O
heterodimer	O
and	O
that	O
the	O
interaction	O
is	O
disrupted	O
by	O
a	O
mutation	O
found	O
in	O
male	O
infertile	O
species1s	O
mice	O
species1e	O
(	O
Mot	O
species1s	O
mice	O
species1e	O
)	O
with	O
a	O
sperm	O
flagella	O
motility	O
defect	O
.	O
Intriguingly	O
,	O
gene1s	O
RABL2	O
gene1e	O
binds	O
to	O
gene1s	O
CEP19	O
gene1e	O
and	O
the	O
gene1s	O
IFT74	O
gene1e	O
-	O
gene1s	O
IFT81	O
gene1e	O
heterodimer	O
in	O
a	O
mutually	O
exclusive	O
manner	O
.	O
Furthermore	O
,	O
exogenous	O
expression	O
of	O
the	O
GDP	O
-	O
locked	O
or	O
Mot	O
-	O
type	O
gene1s	O
RABL2	O
gene1e	O
mutant	O
in	O
species1s	O
human	O
species1e	O
cells	O
results	O
in	O
mild	O
defects	O
in	O
ciliary	O
assembly	O
.	O
These	O
results	O
indicate	O
that	O
gene1s	O
RABL2	O
gene1e	O
localized	O
to	O
the	O
basal	O
body	O
plays	O
crucial	O
roles	O
in	O
ciliary	O
/	O
flagellar	O
assembly	O
via	O
its	O
interaction	O
with	O
the	O
gene1s	O
IFT	O
-	O
B	O
complex	O
gene1e	O
.	O

gene1s	O
RABL2	O
gene1e	O
interacts	O
with	O
the	O
gene1s	O
intraflagellar	O
transport	O
-	O
B	O
complex	O
gene1e	O
and	O
gene1s	O
CEP19	O
gene1e	O
and	O
participates	O
in	O
ciliary	O
assembly	O
.	O
Proteins	O
localized	O
to	O
the	O
basal	O
body	O
and	O
the	O
centrosome	O
play	O
crucial	O
roles	O
in	O
ciliary	O
assembly	O
and	O
function	O
.	O
Although	O
gene1s	O
RABL2	O
gene1e	O
and	O
gene1s	O
CEP19	O
gene1e	O
are	O
conserved	O
in	O
ciliated	O
organisms	O
and	O
have	O
been	O
implicated	O
in	O
ciliary	O
/	O
flagellar	O
functions	O
,	O
their	O
roles	O
are	O
poorly	O
understood	O
.	O
Here	O
we	O
show	O
that	O
gene1s	O
RABL2	O
gene1e	O
interacts	O
with	O
gene1s	O
CEP19	O
gene1e	O
and	O
is	O
recruited	O
to	O
the	O
mother	O
centriole	O
and	O
basal	O
body	O
in	O
a	O
gene1s	O
CEP19	O
gene1e	O
-dependent	O
manner	O
and	O
that	O
gene1s	O
CEP19	O
gene1e	O
is	O
recruited	O
to	O
the	O
centriole	O
probably	O
via	O
its	O
binding	O
to	O
the	O
centrosomal	O
protein	O
gene1s	O
FGFR1OP	O
gene1e	O
.	O
Disruption	O
of	O
the	O
gene1s	O
RABL2	O
gene1e	O
gene	O
in	O
species1s	O
Chlamydomonas	O
reinhardtii	O
species1e	O
results	O
in	O
the	O
nonflagellated	O
phenotype	O
,	O
suggesting	O
a	O
crucial	O
role	O
of	O
gene1s	O
RABL2	O
gene1e	O
in	O
ciliary	O
/	O
flagellar	O
assembly	O
.	O
We	O
also	O
show	O
that	O
gene1s	O
RABL2	O
gene1e	O
interacts	O
,	O
in	O
its	O
GTP	O
-	O
bound	O
state	O
,	O
with	O
the	O
gene1s	O
intraflagellar	O
transport	O
(	O
IFT)-B	O
complex	O
gene1e	O
via	O
the	O
gene1s	O
IFT74	O
gene1e	O
-	O
gene1s	O
IFT81	O
gene1e	O
heterodimer	O
and	O
that	O
the	O
interaction	O
is	O
disrupted	O
by	O
a	O
mutation	O
found	O
in	O
male	O
infertile	O
arg1s	O
mice	O
arg1e	O
(	O
Mot	O
arg1s	O
mice	O
arg1e	O
)	O
with	O
a	O
sperm	O
flagella	O
motility	O
defect	O
.	O
Intriguingly	O
,	O
gene1s	O
RABL2	O
gene1e	O
binds	O
to	O
gene1s	O
CEP19	O
gene1e	O
and	O
the	O
gene1s	O
IFT74	O
gene1e	O
-	O
gene1s	O
IFT81	O
gene1e	O
heterodimer	O
in	O
a	O
mutually	O
exclusive	O
manner	O
.	O
Furthermore	O
,	O
exogenous	O
expression	O
of	O
the	O
GDP	O
-	O
locked	O
or	O
Mot	O
-	O
type	O
gene1s	O
RABL2	O
gene1e	O
mutant	O
in	O
species1s	O
human	O
species1e	O
cells	O
results	O
in	O
mild	O
defects	O
in	O
ciliary	O
assembly	O
.	O
These	O
results	O
indicate	O
that	O
gene1s	O
RABL2	O
gene1e	O
localized	O
to	O
the	O
basal	O
body	O
plays	O
crucial	O
roles	O
in	O
ciliary	O
/	O
flagellar	O
assembly	O
via	O
its	O
interaction	O
with	O
the	O
gene1s	O
IFT	O
-	O
B	O
complex	O
gene1e	O
.	O

gene1s	ARG2
RABL2	ARG2
gene1e	ARG2
interacts	O
with	O
the	O
gene1s	ARG2
intraflagellar	ARG2
transport	ARG2
-	ARG2
B	ARG2
complex	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CEP19	ARG2
gene1e	ARG2
and	O
participates	O
in	O
ciliary	O
assembly	O
.	O
Proteins	O
localized	O
to	O
the	O
basal	O
body	O
and	O
the	O
centrosome	O
play	O
crucial	O
roles	O
in	O
ciliary	O
assembly	O
and	O
function	O
.	O
Although	O
gene1s	ARG2
RABL2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CEP19	ARG2
gene1e	ARG2
are	O
conserved	O
in	O
ciliated	O
organisms	O
and	O
have	O
been	O
implicated	O
in	O
ciliary	O
/	O
flagellar	O
functions	O
,	O
their	O
roles	O
are	O
poorly	O
understood	O
.	O
Here	O
we	O
show	O
that	O
gene1s	ARG2
RABL2	ARG2
gene1e	ARG2
interacts	O
with	O
gene1s	ARG2
CEP19	ARG2
gene1e	ARG2
and	O
is	O
recruited	O
to	O
the	O
mother	O
centriole	O
and	O
basal	O
body	O
in	O
a	O
gene1s	ARG2
CEP19	ARG2
gene1e	ARG2
-dependent	O
manner	O
and	O
that	O
gene1s	ARG2
CEP19	ARG2
gene1e	ARG2
is	O
recruited	O
to	O
the	O
centriole	O
probably	O
via	O
its	O
binding	O
to	O
the	O
centrosomal	O
protein	O
gene1s	ARG2
FGFR1OP	ARG2
gene1e	ARG2
.	O
Disruption	O
of	O
the	O
gene1s	O
RABL2	O
gene1e	O
gene	O
in	O
species1s	O
Chlamydomonas	O
reinhardtii	O
species1e	O
results	O
in	O
the	O
nonflagellated	O
phenotype	O
,	O
suggesting	O
a	O
crucial	O
role	O
of	O
gene1s	ARG2
RABL2	ARG2
gene1e	ARG2
in	O
ciliary	O
/	O
flagellar	O
assembly	O
.	O
We	O
also	O
show	O
that	O
gene1s	ARG2
RABL2	ARG2
gene1e	ARG2
interacts	O
,	O
in	O
its	O
GTP	O
-	O
bound	O
state	O
,	O
with	O
the	O
gene1s	ARG2
intraflagellar	ARG2
transport	ARG2
(	ARG2
IFT)-B	ARG2
complex	ARG2
gene1e	ARG2
via	O
the	O
gene1s	ARG2
IFT74	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
IFT81	ARG2
gene1e	ARG2
heterodimer	O
and	O
that	O
the	O
interaction	O
is	O
disrupted	O
by	O
a	O
mutation	O
found	O
in	O
male	O
infertile	O
species1s	O
mice	O
species1e	O
(	O
Mot	O
species1s	O
mice	O
species1e	O
)	O
with	O
a	O
sperm	O
flagella	O
motility	O
defect	O
.	O
Intriguingly	O
,	O
gene1s	ARG2
RABL2	ARG2
gene1e	ARG2
binds	O
to	O
gene1s	ARG2
CEP19	ARG2
gene1e	ARG2
and	O
the	O
gene1s	ARG2
IFT74	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
IFT81	ARG2
gene1e	ARG2
heterodimer	O
in	O
a	O
mutually	O
exclusive	O
manner	O
.	O
Furthermore	O
,	O
exogenous	O
expression	O
of	O
the	O
GDP	O
-	O
locked	O
or	O
Mot	O
-	O
type	O
gene1s	ARG2
RABL2	ARG2
gene1e	ARG2
mutant	O
in	O
arg1s	O
human	O
arg1e	O
cells	O
results	O
in	O
mild	O
defects	O
in	O
ciliary	O
assembly	O
.	O
These	O
results	O
indicate	O
that	O
gene1s	ARG2
RABL2	ARG2
gene1e	ARG2
localized	O
to	O
the	O
basal	O
body	O
plays	O
crucial	O
roles	O
in	O
ciliary	O
/	O
flagellar	O
assembly	O
via	O
its	O
interaction	O
with	O
the	O
gene1s	ARG2
IFT	ARG2
-	ARG2
B	ARG2
complex	ARG2
gene1e	ARG2
.	O

Overexpression	O
of	O
gene1s	ARG2
small	ARG2
ubiquitin	ARG2
-	ARG2
like	ARG2
modifier	ARG2
2	ARG2
gene1e	ARG2
ameliorates	O
high	O
glucose	O
-	O
induced	O
reductions	O
in	O
cardiomyocyte	O
proliferation	O
via	O
the	O
gene1s	ARG2
transforming	ARG2
growth	ARG2
factor	ARG2
-	ARG2
beta	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Smad	ARG2
gene1e	ARG2
pathway	O
.	O
Hyperglycemia	O
may	O
induce	O
diabetic	O
cardiomyopathy	O
(	O
DC	O
)	O
.	O
In	O
the	O
current	O
study	O
,	O
the	O
mechanism	O
underlying	O
the	O
alleviation	O
of	O
high	O
glucose	O
(	O
HG)-induced	O
impairments	O
in	O
the	O
proliferation	O
of	O
H9c2	O
embryo	O
cardiomyocyte	O
proliferation	O
by	O
gene1s	ARG2
small	ARG2
ubiquitin	ARG2
-	ARG2
like	ARG2
modifier	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SUMO2	ARG2
gene1e	ARG2
)	O
overexpression	O
was	O
investigated	O
.	O
arg1s	O
H9c2	O
arg1e	O
cell	O
morphology	O
was	O
identified	O
as	O
classical	O
long	O
shuttle	O
type	O
by	O
optical	O
microscopy	O
.	O
The	O
viability	O
of	O
HG	O
-	O
injured	O
arg1s	O
H9c2	O
arg1e	O
cells	O
was	O
evaluated	O
by	O
a	O
Cell	O
Counting	O
Kit-8	O
assay	O
and	O
the	O
results	O
indicated	O
that	O
viability	O
was	O
inhibited	O
in	O
a	O
dose	O
-	O
dependent	O
(	O
5.6	O
,	O
10	O
,	O
20	O
and	O
30	O
mmol	O
/	O
l	O
)	O
and	O
time	O
-	O
dependent	O
(	O
6	O
,	O
12	O
and	O
24	O
h	O
)	O
manner	O
.	O
arg1s	O
H9c2	O
arg1e	O
cells	O
treated	O
with	O
20	O
mmol	O
/	O
l	O
HG	O
for	O
24	O
h	O
were	O
selected	O
for	O
subsequent	O
experiments	O
due	O
to	O
the	O
extent	O
of	O
injury	O
caused	O
at	O
a	O
low	O
density	O
.	O
Flow	O
cytometry	O
was	O
conducted	O
to	O
confirm	O
cell	O
cycle	O
arrest	O
between	O
G1	O
/	O
S	O
phases	O
and	O
apoptosis	O
promotion	O
in	O
HG	O
-	O
injured	O
arg1s	O
H9c2	O
arg1e	O
cells	O
,	O
and	O
the	O
subsequent	O
alleviating	O
effect	O
of	O
gene1s	ARG2
SUMO2	ARG2
gene1e	ARG2
overexpression	O
on	O
these	O
HG	O
-	O
induced	O
effects	O
.	O
Reverse	O
transcription	O
-	O
quantitative	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
qPCR	O
)	O
and	O
western	O
blot	O
analysis	O
were	O
performed	O
to	O
detect	O
mRNA	O
and	O
protein	O
expression	O
levels	O
of	O
cell	O
cycle	O
-	O
and	O
apoptosis	O
-	O
associated	O
factors	O
.	O
The	O
results	O
indicated	O
that	O
the	O
expression	O
ofthe	O
cell	O
cycle	O
-	O
associated	O
factors	O
gene1s	ARG2
CyclinA2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
C	ARG2
-	ARG2
Myc	ARG2
gene1e	ARG2
was	O
upregulated	O
,	O
and	O
gene1s	ARG2
cyclin	ARG2
-	ARG2
dependent	ARG2
kinase	ARG2
inhibitor	ARG2
1a	ARG2
gene1e	ARG2
was	O
downregulated	O
.	O
The	O
expression	O
of	O
the	O
apoptosis	O
-	O
associated	O
factor	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
was	O
upregulated	O
,	O
while	O
gene1s	ARG2
Bcl-2-associated	ARG2
X	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
caspase-3	ARG2
gene1e	ARG2
expression	O
was	O
downregulated	O
,	O
by	O
gene1s	ARG2
SUMO2	ARG2
gene1e	ARG2
overexpression	O
.	O
Furthermore	O
,	O
the	O
effect	O
of	O
gene1s	ARG2
SUMO2	ARG2
gene1e	ARG2
overexpression	O
on	O
the	O
gene1s	ARG2
transforming	ARG2
growth	ARG2
factor	ARG2
(	ARG2
TGF)-beta	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Smad	ARG2
gene1e	ARG2
pathway	O
was	O
also	O
determined	O
using	O
RT	O
-	O
qPCR	O
and	O
western	O
blot	O
analysis	O
.	O
The	O
results	O
indicated	O
the	O
mRNA	O
and	O
protein	O
levels	O
of	O
gene1s	ARG2
TGF	ARG2
-	ARG2
beta1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Smad3	ARG2
gene1e	ARG2
in	O
HG	O
-	O
injured	O
arg1s	O
H9c2	O
arg1e	O
cells	O
were	O
significantly	O
decreased	O
following	O
gene1s	ARG2
SUMO2	ARG2
gene1e	ARG2
overexpression	O
.	O
Thus	O
,	O
the	O
results	O
demonstrated	O
that	O
overexpression	O
of	O
gene1s	ARG2
SUMO2	ARG2
gene1e	ARG2
may	O
alleviate	O
arg1s	O
H9c2	O
arg1e	O
cardiomyocyte	O
cell	O
cycle	O
arrest	O
and	O
apoptosis	O
promotion	O
induced	O
by	O
HG	O
via	O
regulation	O
of	O
cell	O
cycle-	O
and	O
apoptosis	O
-	O
associated	O
factors	O
,	O
as	O
well	O
as	O
inhibition	O
of	O
the	O
gene1s	ARG2
TGF	ARG2
-	ARG2
beta	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Smad	ARG2
gene1e	ARG2
pathway	O
.	O
These	O
results	O
may	O
therefore	O
provide	O
a	O
novel	O
strategy	O
for	O
the	O
protection	O
of	O
cardiomyocytes	O
and	O
may	O
aid	O
the	O
diagnosis	O
and	O
prognosis	O
of	O
species1s	O
patients	O
species1e	O
with	O
DC	O
.	O

Overexpression	O
of	O
gene1s	O
small	O
ubiquitin	O
-	O
like	O
modifier	O
2	O
gene1e	O
ameliorates	O
high	O
glucose	O
-	O
induced	O
reductions	O
in	O
cardiomyocyte	O
proliferation	O
via	O
the	O
gene1s	O
transforming	O
growth	O
factor	O
-	O
beta	O
gene1e	O
/	O
gene1s	O
Smad	O
gene1e	O
pathway	O
.	O
Hyperglycemia	O
may	O
induce	O
diabetic	O
cardiomyopathy	O
(	O
DC	O
)	O
.	O
In	O
the	O
current	O
study	O
,	O
the	O
mechanism	O
underlying	O
the	O
alleviation	O
of	O
high	O
glucose	O
(	O
HG)-induced	O
impairments	O
in	O
the	O
proliferation	O
of	O
H9c2	O
embryo	O
cardiomyocyte	O
proliferation	O
by	O
gene1s	O
small	O
ubiquitin	O
-	O
like	O
modifier	O
2	O
gene1e	O
(	O
gene1s	O
SUMO2	O
gene1e	O
)	O
overexpression	O
was	O
investigated	O
.	O
species1s	O
H9c2	O
species1e	O
cell	O
morphology	O
was	O
identified	O
as	O
classical	O
long	O
shuttle	O
type	O
by	O
optical	O
microscopy	O
.	O
The	O
viability	O
of	O
HG	O
-	O
injured	O
species1s	O
H9c2	O
species1e	O
cells	O
was	O
evaluated	O
by	O
a	O
Cell	O
Counting	O
Kit-8	O
assay	O
and	O
the	O
results	O
indicated	O
that	O
viability	O
was	O
inhibited	O
in	O
a	O
dose	O
-	O
dependent	O
(	O
5.6	O
,	O
10	O
,	O
20	O
and	O
30	O
mmol	O
/	O
l	O
)	O
and	O
time	O
-	O
dependent	O
(	O
6	O
,	O
12	O
and	O
24	O
h	O
)	O
manner	O
.	O
species1s	O
H9c2	O
species1e	O
cells	O
treated	O
with	O
20	O
mmol	O
/	O
l	O
HG	O
for	O
24	O
h	O
were	O
selected	O
for	O
subsequent	O
experiments	O
due	O
to	O
the	O
extent	O
of	O
injury	O
caused	O
at	O
a	O
low	O
density	O
.	O
Flow	O
cytometry	O
was	O
conducted	O
to	O
confirm	O
cell	O
cycle	O
arrest	O
between	O
G1	O
/	O
S	O
phases	O
and	O
apoptosis	O
promotion	O
in	O
HG	O
-	O
injured	O
species1s	O
H9c2	O
species1e	O
cells	O
,	O
and	O
the	O
subsequent	O
alleviating	O
effect	O
of	O
gene1s	O
SUMO2	O
gene1e	O
overexpression	O
on	O
these	O
HG	O
-	O
induced	O
effects	O
.	O
Reverse	O
transcription	O
-	O
quantitative	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
qPCR	O
)	O
and	O
western	O
blot	O
analysis	O
were	O
performed	O
to	O
detect	O
mRNA	O
and	O
protein	O
expression	O
levels	O
of	O
cell	O
cycle	O
-	O
and	O
apoptosis	O
-	O
associated	O
factors	O
.	O
The	O
results	O
indicated	O
that	O
the	O
expression	O
ofthe	O
cell	O
cycle	O
-	O
associated	O
factors	O
gene1s	O
CyclinA2	O
gene1e	O
and	O
gene1s	O
C	O
-	O
Myc	O
gene1e	O
was	O
upregulated	O
,	O
and	O
gene1s	O
cyclin	O
-	O
dependent	O
kinase	O
inhibitor	O
1a	O
gene1e	O
was	O
downregulated	O
.	O
The	O
expression	O
of	O
the	O
apoptosis	O
-	O
associated	O
factor	O
gene1s	O
Bcl-2	O
gene1e	O
was	O
upregulated	O
,	O
while	O
gene1s	O
Bcl-2-associated	O
X	O
gene1e	O
and	O
gene1s	O
caspase-3	O
gene1e	O
expression	O
was	O
downregulated	O
,	O
by	O
gene1s	O
SUMO2	O
gene1e	O
overexpression	O
.	O
Furthermore	O
,	O
the	O
effect	O
of	O
gene1s	O
SUMO2	O
gene1e	O
overexpression	O
on	O
the	O
gene1s	O
transforming	O
growth	O
factor	O
(	O
TGF)-beta	O
gene1e	O
/	O
gene1s	O
Smad	O
gene1e	O
pathway	O
was	O
also	O
determined	O
using	O
RT	O
-	O
qPCR	O
and	O
western	O
blot	O
analysis	O
.	O
The	O
results	O
indicated	O
the	O
mRNA	O
and	O
protein	O
levels	O
of	O
gene1s	O
TGF	O
-	O
beta1	O
gene1e	O
and	O
gene1s	O
Smad3	O
gene1e	O
in	O
HG	O
-	O
injured	O
species1s	O
H9c2	O
species1e	O
cells	O
were	O
significantly	O
decreased	O
following	O
gene1s	O
SUMO2	O
gene1e	O
overexpression	O
.	O
Thus	O
,	O
the	O
results	O
demonstrated	O
that	O
overexpression	O
of	O
gene1s	O
SUMO2	O
gene1e	O
may	O
alleviate	O
species1s	O
H9c2	O
species1e	O
cardiomyocyte	O
cell	O
cycle	O
arrest	O
and	O
apoptosis	O
promotion	O
induced	O
by	O
HG	O
via	O
regulation	O
of	O
cell	O
cycle-	O
and	O
apoptosis	O
-	O
associated	O
factors	O
,	O
as	O
well	O
as	O
inhibition	O
of	O
the	O
gene1s	O
TGF	O
-	O
beta	O
gene1e	O
/	O
gene1s	O
Smad	O
gene1e	O
pathway	O
.	O
These	O
results	O
may	O
therefore	O
provide	O
a	O
novel	O
strategy	O
for	O
the	O
protection	O
of	O
cardiomyocytes	O
and	O
may	O
aid	O
the	O
diagnosis	O
and	O
prognosis	O
of	O
arg1s	O
patients	O
arg1e	O
with	O
DC	O
.	O

A	O
steroid	O
like	O
phytochemical	O
Antcin	O
M	O
is	O
an	O
anti	O
-	O
aging	O
reagent	O
that	O
eliminates	O
hyperglycemia	O
-	O
accelerated	O
premature	O
senescence	O
in	O
dermal	O
fibroblasts	O
by	O
direct	O
activation	O
of	O
gene1s	ARG2
Nrf2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
SIRT-1	ARG2
gene1e	ARG2
.	O
The	O
present	O
study	O
revealed	O
the	O
anti	O
-	O
aging	O
properties	O
of	O
antcin	O
M	O
(	O
ANM	O
)	O
and	O
elucidated	O
the	O
molecular	O
mechanism	O
underlying	O
the	O
effects	O
.	O
We	O
found	O
that	O
exposure	O
of	O
arg1s	O
human	O
arg1e	O
normal	O
dermal	O
fibroblasts	O
(	O
HNDFs	O
)	O
to	O
high	O
-	O
glucose	O
(	O
HG	O
,	O
30	O
mM	O
)	O
for	O
3	O
days	O
,	O
accelerated	O
G0	O
/	O
G1	O
phase	O
arrest	O
and	O
senescence	O
.	O
Indeed	O
,	O
co	O
-	O
treatment	O
with	O
ANM	O
(	O
10	O
microM	O
)	O
significantly	O
attenuated	O
HG	O
-	O
induced	O
growth	O
arrest	O
and	O
promoted	O
cell	O
proliferation	O
.	O
Further	O
molecular	O
analysis	O
revealed	O
that	O
ANM	O
blocked	O
the	O
HG	O
-	O
induced	O
reduction	O
in	O
G1-S	O
transition	O
regulatory	O
proteins	O
such	O
as	O
gene1s	ARG2
cyclin	ARG2
D	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
cyclin	ARG2
E	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CDK4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CDK6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CDK2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
protein	ARG2
retinoblastoma	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
pRb	ARG2
gene1e	ARG2
)	O
.	O
In	O
addition	O
,	O
treatment	O
with	O
ANM	O
eliminated	O
HG	O
-	O
induced	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
through	O
the	O
induction	O
of	O
anti	O
-	O
oxidant	O
genes	O
,	O
gene1s	ARG2
HO-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
NQO-1	ARG2
gene1e	ARG2
via	O
transcriptional	O
activation	O
of	O
gene1s	ARG2
Nrf2	ARG2
gene1e	ARG2
.	O
Moreover	O
,	O
treatment	O
with	O
ANM	O
abolished	O
HG	O
-	O
induced	O
SIPS	O
as	O
evidenced	O
by	O
reduced	O
senescence	O
-	O
associated	O
beta	O
-	O
galactosidase	O
(	O
SA	O
-	O
beta	O
-	O
gal	O
)	O
activity	O
.	O
This	O
effect	O
was	O
further	O
confirmed	O
by	O
reduction	O
in	O
senescence	O
-	O
associated	O
marker	O
proteins	O
including	O
,	O
gene1s	ARG2
p21CIP1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
p16INK4A	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
FoxO1	ARG2
gene1e	ARG2
acetylation	O
.	O
Also	O
,	O
the	O
HG	O
-	O
induced	O
decline	O
in	O
aging	O
-	O
related	O
marker	O
protein	O
gene1s	ARG2
SMP30	ARG2
gene1e	ARG2
was	O
rescued	O
by	O
ANM	O
.	O
Furthermore	O
,	O
treatment	O
with	O
ANM	O
increased	O
gene1s	ARG2
SIRT-1	ARG2
gene1e	ARG2
expression	O
,	O
and	O
prevented	O
gene1s	ARG2
SIRT-1	ARG2
gene1e	ARG2
depletion	O
.	O
This	O
protection	O
was	O
consistent	O
with	O
inhibition	O
of	O
gene1s	ARG2
SIRT-1	ARG2
gene1e	ARG2
phosphorylation	O
at	O
Ser47	O
followed	O
by	O
blocking	O
its	O
upstream	O
kinases	O
,	O
gene1s	ARG2
p38	ARG2
MAPK	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
JNK	ARG2
/	ARG2
SAPK	ARG2
gene1e	ARG2
.	O
Further	O
analysis	O
revealed	O
that	O
ANM	O
partially	O
protected	O
HG	O
-	O
induced	O
senescence	O
in	O
gene1s	ARG2
SIRT-1	ARG2
gene1e	ARG2
silenced	O
cells	O
.	O
A	O
similar	O
effect	O
was	O
also	O
observed	O
in	O
gene1s	ARG2
Nrf2	ARG2
gene1e	ARG2
silenced	O
cells	O
.	O
However	O
,	O
a	O
complete	O
loss	O
of	O
protection	O
was	O
observed	O
in	O
both	O
gene1s	ARG2
Nrf2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
SIRT-1	ARG2
gene1e	ARG2
knockdown	O
cells	O
suggesting	O
that	O
both	O
induction	O
of	O
gene1s	ARG2
Nrf2	ARG2
gene1e	ARG2
-mediated	O
anti	O
-	O
oxidant	O
defense	O
and	O
gene1s	ARG2
SIRT-1	ARG2
gene1e	ARG2
-mediated	O
deacetylation	O
activity	O
contribute	O
to	O
the	O
anti	O
-	O
aging	O
properties	O
of	O
ANM	O
in	O
vitro	O
.	O
Result	O
of	O
in	O
vivo	O
studies	O
shows	O
that	O
ANM	O
-	O
treated	O
C.	O
elegens	O
exhibits	O
an	O
increased	O
survival	O
rate	O
during	O
HG	O
-	O
induced	O
oxidative	O
stress	O
insult	O
.	O
Furthermore	O
,	O
ANM	O
significantly	O
extended	O
the	O
life	O
span	O
of	O
species1s	O
C.	O
elegans	O
species1e	O
.	O
Taken	O
together	O
,	O
our	O
results	O
suggest	O
the	O
potential	O
application	O
of	O
ANM	O
in	O
age	O
-	O
related	O
diseases	O
or	O
as	O
a	O
preventive	O
reagent	O
against	O
aging	O
process	O
.	O

A	O
steroid	O
like	O
phytochemical	O
Antcin	O
M	O
is	O
an	O
anti	O
-	O
aging	O
reagent	O
that	O
eliminates	O
hyperglycemia	O
-	O
accelerated	O
premature	O
senescence	O
in	O
dermal	O
fibroblasts	O
by	O
direct	O
activation	O
of	O
gene1s	O
Nrf2	O
gene1e	O
and	O
gene1s	O
SIRT-1	O
gene1e	O
.	O
The	O
present	O
study	O
revealed	O
the	O
anti	O
-	O
aging	O
properties	O
of	O
antcin	O
M	O
(	O
ANM	O
)	O
and	O
elucidated	O
the	O
molecular	O
mechanism	O
underlying	O
the	O
effects	O
.	O
We	O
found	O
that	O
exposure	O
of	O
species1s	O
human	O
species1e	O
normal	O
dermal	O
fibroblasts	O
(	O
HNDFs	O
)	O
to	O
high	O
-	O
glucose	O
(	O
HG	O
,	O
30	O
mM	O
)	O
for	O
3	O
days	O
,	O
accelerated	O
G0	O
/	O
G1	O
phase	O
arrest	O
and	O
senescence	O
.	O
Indeed	O
,	O
co	O
-	O
treatment	O
with	O
ANM	O
(	O
10	O
microM	O
)	O
significantly	O
attenuated	O
HG	O
-	O
induced	O
growth	O
arrest	O
and	O
promoted	O
cell	O
proliferation	O
.	O
Further	O
molecular	O
analysis	O
revealed	O
that	O
ANM	O
blocked	O
the	O
HG	O
-	O
induced	O
reduction	O
in	O
G1-S	O
transition	O
regulatory	O
proteins	O
such	O
as	O
gene1s	O
cyclin	O
D	O
gene1e	O
,	O
gene1s	O
cyclin	O
E	O
gene1e	O
,	O
gene1s	O
CDK4	O
gene1e	O
,	O
gene1s	O
CDK6	O
gene1e	O
,	O
gene1s	O
CDK2	O
gene1e	O
and	O
gene1s	O
protein	O
retinoblastoma	O
gene1e	O
(	O
gene1s	O
pRb	O
gene1e	O
)	O
.	O
In	O
addition	O
,	O
treatment	O
with	O
ANM	O
eliminated	O
HG	O
-	O
induced	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
through	O
the	O
induction	O
of	O
anti	O
-	O
oxidant	O
genes	O
,	O
gene1s	O
HO-1	O
gene1e	O
and	O
gene1s	O
NQO-1	O
gene1e	O
via	O
transcriptional	O
activation	O
of	O
gene1s	O
Nrf2	O
gene1e	O
.	O
Moreover	O
,	O
treatment	O
with	O
ANM	O
abolished	O
HG	O
-	O
induced	O
SIPS	O
as	O
evidenced	O
by	O
reduced	O
senescence	O
-	O
associated	O
beta	O
-	O
galactosidase	O
(	O
SA	O
-	O
beta	O
-	O
gal	O
)	O
activity	O
.	O
This	O
effect	O
was	O
further	O
confirmed	O
by	O
reduction	O
in	O
senescence	O
-	O
associated	O
marker	O
proteins	O
including	O
,	O
gene1s	O
p21CIP1	O
gene1e	O
,	O
gene1s	O
p16INK4A	O
gene1e	O
,	O
and	O
gene1s	O
p53	O
gene1e	O
/	O
gene1s	O
FoxO1	O
gene1e	O
acetylation	O
.	O
Also	O
,	O
the	O
HG	O
-	O
induced	O
decline	O
in	O
aging	O
-	O
related	O
marker	O
protein	O
gene1s	O
SMP30	O
gene1e	O
was	O
rescued	O
by	O
ANM	O
.	O
Furthermore	O
,	O
treatment	O
with	O
ANM	O
increased	O
gene1s	O
SIRT-1	O
gene1e	O
expression	O
,	O
and	O
prevented	O
gene1s	O
SIRT-1	O
gene1e	O
depletion	O
.	O
This	O
protection	O
was	O
consistent	O
with	O
inhibition	O
of	O
gene1s	O
SIRT-1	O
gene1e	O
phosphorylation	O
at	O
Ser47	O
followed	O
by	O
blocking	O
its	O
upstream	O
kinases	O
,	O
gene1s	O
p38	O
MAPK	O
gene1e	O
and	O
gene1s	O
JNK	O
/	O
SAPK	O
gene1e	O
.	O
Further	O
analysis	O
revealed	O
that	O
ANM	O
partially	O
protected	O
HG	O
-	O
induced	O
senescence	O
in	O
gene1s	O
SIRT-1	O
gene1e	O
silenced	O
cells	O
.	O
A	O
similar	O
effect	O
was	O
also	O
observed	O
in	O
gene1s	O
Nrf2	O
gene1e	O
silenced	O
cells	O
.	O
However	O
,	O
a	O
complete	O
loss	O
of	O
protection	O
was	O
observed	O
in	O
both	O
gene1s	O
Nrf2	O
gene1e	O
and	O
gene1s	O
SIRT-1	O
gene1e	O
knockdown	O
cells	O
suggesting	O
that	O
both	O
induction	O
of	O
gene1s	O
Nrf2	O
gene1e	O
-mediated	O
anti	O
-	O
oxidant	O
defense	O
and	O
gene1s	O
SIRT-1	O
gene1e	O
-mediated	O
deacetylation	O
activity	O
contribute	O
to	O
the	O
anti	O
-	O
aging	O
properties	O
of	O
ANM	O
in	O
vitro	O
.	O
Result	O
of	O
in	O
vivo	O
studies	O
shows	O
that	O
ANM	O
-	O
treated	O
C.	O
elegens	O
exhibits	O
an	O
increased	O
survival	O
rate	O
during	O
HG	O
-	O
induced	O
oxidative	O
stress	O
insult	O
.	O
Furthermore	O
,	O
ANM	O
significantly	O
extended	O
the	O
life	O
span	O
of	O
arg1s	O
C.	O
elegans	O
arg1e	O
.	O
Taken	O
together	O
,	O
our	O
results	O
suggest	O
the	O
potential	O
application	O
of	O
ANM	O
in	O
age	O
-	O
related	O
diseases	O
or	O
as	O
a	O
preventive	O
reagent	O
against	O
aging	O
process	O
.	O

gene1s	ARG2
Hematopoietic-	ARG2
and	ARG2
neurologic	ARG2
-	ARG2
expressed	ARG2
sequence	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Hn1	ARG2
gene1e	ARG2
)	O
depletion	O
in	O
arg1s	O
B16.F10	O
arg1e	O
melanoma	O
cells	O
promotes	O
a	O
differentiated	O
phenotype	O
that	O
includes	O
increased	O
melanogenesis	O
and	O
cell	O
cycle	O
arrest	O
.	O
The	O
gene1s	ARG2
Hematopoietic-	ARG2
and	ARG2
neurologic	ARG2
-	ARG2
expressed	ARG2
sequence	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Hn1	ARG2
gene1e	ARG2
)	O
gene	O
encodes	O
a	O
small	O
protein	O
that	O
is	O
highly	O
conserved	O
among	O
species	O
.	O
gene1s	ARG2
Hn1	ARG2
gene1e	ARG2
expression	O
is	O
upregulated	O
in	O
regenerating	O
neural	O
tissues	O
,	O
including	O
the	O
axotomized	O
adult	O
rodent	O
facial	O
motor	O
nerve	O
and	O
dedifferentiating	O
retinal	O
pigment	O
epithelial	O
cells	O
of	O
the	O
Japanese	O
newt	O
.	O
It	O
is	O
also	O
expressed	O
in	O
numerous	O
tissues	O
during	O
embryonic	O
development	O
as	O
well	O
as	O
in	O
regions	O
of	O
the	O
adult	O
brain	O
that	O
exhibit	O
high	O
plasticity	O
.	O
gene1s	O
Hn1	O
gene1e	O
has	O
also	O
been	O
reported	O
as	O
a	O
marker	O
for	O
species1s	O
human	O
species1e	O
ovarian	O
carcinoma	O
and	O
it	O
is	O
expressed	O
in	O
high	O
-	O
grade	O
species1s	O
human	O
species1e	O
gliomas	O
.	O
This	O
study	O
was	O
directed	O
toward	O
understanding	O
the	O
function	O
of	O
gene1s	ARG2
Hn1	ARG2
gene1e	ARG2
in	O
a	O
arg1s	O
murine	O
arg1e	O
melanoma	O
cell	O
line	O
.	O
gene1s	ARG2
Hn1	ARG2
gene1e	ARG2
mRNA	O
and	O
protein	O
were	O
identified	O
in	O
arg1s	O
B16.F10	O
arg1e	O
cells	O
and	O
in	O
tumors	O
formed	O
from	O
these	O
cells	O
.	O
Inhibition	O
of	O
gene1s	ARG2
Hn1	ARG2
gene1e	ARG2
protein	O
expression	O
with	O
siRNA	O
increased	O
melanogenesis	O
.	O
gene1s	ARG2
Hn1	ARG2
gene1e	ARG2
-depleted	O
cells	O
expressed	O
higher	O
levels	O
of	O
the	O
gene1s	ARG2
melanogenic	ARG2
proteins	ARG2
gene1e	ARG2
gene1s	ARG2
tyrosinase	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Trp2	ARG2
gene1e	ARG2
and	O
an	O
increased	O
interaction	O
between	O
gene1s	ARG2
actin	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Rab27a	ARG2
gene1e	ARG2
.	O
The	O
in	O
vitro	O
cell	O
growth	O
rate	O
of	O
gene1s	ARG2
Hn1	ARG2
gene1e	ARG2
-depleted	O
cells	O
was	O
significantly	O
reduced	O
due	O
to	O
G1	O
/	O
S	O
cell	O
cycle	O
arrest	O
.	O
This	O
was	O
consistent	O
with	O
a	O
reduction	O
in	O
the	O
phosphorylation	O
of	O
gene1s	ARG2
retinoblastoma	ARG2
protein	ARG2
gene1e	ARG2
as	O
well	O
as	O
lower	O
levels	O
of	O
gene1s	ARG2
p27	ARG2
gene1e	ARG2
and	O
increased	O
expression	O
of	O
gene1s	ARG2
p21	ARG2
gene1e	ARG2
.	O
Decreased	O
expression	O
of	O
gene1s	ARG2
c	ARG2
-	ARG2
Met	ARG2
gene1e	ARG2
,	O
the	O
receptor	O
for	O
gene1s	ARG2
hepatocyte	ARG2
growth	ARG2
factor	ARG2
gene1e	ARG2
,	O
was	O
also	O
detected	O
in	O
the	O
gene1s	ARG2
Hn1	ARG2
gene1e	ARG2
-depleted	O
cells	O
,	O
however	O
gene1s	ARG2
HGF	ARG2
gene1e	ARG2
-	O
dependent	O
stimulation	O
of	O
phosphorylated	O
-	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
was	O
unaffected	O
.	O
gene1s	ARG2
Hn1	ARG2
gene1e	ARG2
depletion	O
also	O
led	O
to	O
increased	O
basal	O
levels	O
of	O
phosphorylated	O
gene1s	ARG2
p38	ARG2
MAPK	ARG2
gene1e	ARG2
,	O
while	O
basal	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
phosphorylation	O
was	O
reduced	O
.	O
Moreover	O
,	O
gene1s	ARG2
Hn1	ARG2
gene1e	ARG2
-depleted	O
cells	O
had	O
reduced	O
expression	O
of	O
transcription	O
factors	O
gene1s	ARG2
MITF	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
USF-1	ARG2
gene1e	ARG2
,	O
and	O
increased	O
expression	O
of	O
gene1s	ARG2
TFE3	ARG2
gene1e	ARG2
.	O
These	O
data	O
,	O
coupled	O
with	O
reports	O
on	O
gene1s	ARG2
Hn1	ARG2
gene1e	ARG2
expression	O
in	O
regeneration	O
and	O
development	O
,	O
suggest	O
that	O
gene1s	ARG2
Hn1	ARG2
gene1e	ARG2
functions	O
as	O
a	O
suppressor	O
of	O
differentiation	O
in	O
cells	O
undergoing	O
repair	O
or	O
proliferation	O
.	O

gene1s	O
Hematopoietic-	O
and	O
neurologic	O
-	O
expressed	O
sequence	O
1	O
gene1e	O
(	O
gene1s	O
Hn1	O
gene1e	O
)	O
depletion	O
in	O
species1s	O
B16.F10	O
species1e	O
melanoma	O
cells	O
promotes	O
a	O
differentiated	O
phenotype	O
that	O
includes	O
increased	O
melanogenesis	O
and	O
cell	O
cycle	O
arrest	O
.	O
The	O
gene1s	O
Hematopoietic-	O
and	O
neurologic	O
-	O
expressed	O
sequence	O
1	O
gene1e	O
(	O
gene1s	O
Hn1	O
gene1e	O
)	O
gene	O
encodes	O
a	O
small	O
protein	O
that	O
is	O
highly	O
conserved	O
among	O
species	O
.	O
gene1s	O
Hn1	O
gene1e	O
expression	O
is	O
upregulated	O
in	O
regenerating	O
neural	O
tissues	O
,	O
including	O
the	O
axotomized	O
adult	O
rodent	O
facial	O
motor	O
nerve	O
and	O
dedifferentiating	O
retinal	O
pigment	O
epithelial	O
cells	O
of	O
the	O
Japanese	O
newt	O
.	O
It	O
is	O
also	O
expressed	O
in	O
numerous	O
tissues	O
during	O
embryonic	O
development	O
as	O
well	O
as	O
in	O
regions	O
of	O
the	O
adult	O
brain	O
that	O
exhibit	O
high	O
plasticity	O
.	O
gene1s	ARG2
Hn1	ARG2
gene1e	ARG2
has	O
also	O
been	O
reported	O
as	O
a	O
marker	O
for	O
arg1s	O
human	O
arg1e	O
ovarian	O
carcinoma	O
and	O
it	O
is	O
expressed	O
in	O
high	O
-	O
grade	O
arg1s	O
human	O
arg1e	O
gliomas	O
.	O
This	O
study	O
was	O
directed	O
toward	O
understanding	O
the	O
function	O
of	O
gene1s	O
Hn1	O
gene1e	O
in	O
a	O
species1s	O
murine	O
species1e	O
melanoma	O
cell	O
line	O
.	O
gene1s	O
Hn1	O
gene1e	O
mRNA	O
and	O
protein	O
were	O
identified	O
in	O
species1s	O
B16.F10	O
species1e	O
cells	O
and	O
in	O
tumors	O
formed	O
from	O
these	O
cells	O
.	O
Inhibition	O
of	O
gene1s	O
Hn1	O
gene1e	O
protein	O
expression	O
with	O
siRNA	O
increased	O
melanogenesis	O
.	O
gene1s	O
Hn1	O
gene1e	O
-depleted	O
cells	O
expressed	O
higher	O
levels	O
of	O
the	O
gene1s	O
melanogenic	O
proteins	O
gene1e	O
gene1s	O
tyrosinase	O
gene1e	O
and	O
gene1s	O
Trp2	O
gene1e	O
and	O
an	O
increased	O
interaction	O
between	O
gene1s	O
actin	O
gene1e	O
and	O
gene1s	O
Rab27a	O
gene1e	O
.	O
The	O
in	O
vitro	O
cell	O
growth	O
rate	O
of	O
gene1s	O
Hn1	O
gene1e	O
-depleted	O
cells	O
was	O
significantly	O
reduced	O
due	O
to	O
G1	O
/	O
S	O
cell	O
cycle	O
arrest	O
.	O
This	O
was	O
consistent	O
with	O
a	O
reduction	O
in	O
the	O
phosphorylation	O
of	O
gene1s	O
retinoblastoma	O
protein	O
gene1e	O
as	O
well	O
as	O
lower	O
levels	O
of	O
gene1s	O
p27	O
gene1e	O
and	O
increased	O
expression	O
of	O
gene1s	O
p21	O
gene1e	O
.	O
Decreased	O
expression	O
of	O
gene1s	O
c	O
-	O
Met	O
gene1e	O
,	O
the	O
receptor	O
for	O
gene1s	O
hepatocyte	O
growth	O
factor	O
gene1e	O
,	O
was	O
also	O
detected	O
in	O
the	O
gene1s	O
Hn1	O
gene1e	O
-depleted	O
cells	O
,	O
however	O
gene1s	O
HGF	O
gene1e	O
-	O
dependent	O
stimulation	O
of	O
phosphorylated	O
-	O
gene1s	O
ERK	O
gene1e	O
was	O
unaffected	O
.	O
gene1s	O
Hn1	O
gene1e	O
depletion	O
also	O
led	O
to	O
increased	O
basal	O
levels	O
of	O
phosphorylated	O
gene1s	O
p38	O
MAPK	O
gene1e	O
,	O
while	O
basal	O
gene1s	O
ERK	O
gene1e	O
phosphorylation	O
was	O
reduced	O
.	O
Moreover	O
,	O
gene1s	O
Hn1	O
gene1e	O
-depleted	O
cells	O
had	O
reduced	O
expression	O
of	O
transcription	O
factors	O
gene1s	O
MITF	O
gene1e	O
and	O
gene1s	O
USF-1	O
gene1e	O
,	O
and	O
increased	O
expression	O
of	O
gene1s	O
TFE3	O
gene1e	O
.	O
These	O
data	O
,	O
coupled	O
with	O
reports	O
on	O
gene1s	O
Hn1	O
gene1e	O
expression	O
in	O
regeneration	O
and	O
development	O
,	O
suggest	O
that	O
gene1s	O
Hn1	O
gene1e	O
functions	O
as	O
a	O
suppressor	O
of	O
differentiation	O
in	O
cells	O
undergoing	O
repair	O
or	O
proliferation	O
.	O

gene1s	ARG2
MiR-155	ARG2
gene1e	ARG2
has	O
a	O
protective	O
role	O
in	O
the	O
development	O
of	O
non	O
-	O
alcoholic	O
hepatosteatosis	O
in	O
arg1s	O
mice	O
arg1e	O
.	O
Hepatic	O
steatosis	O
is	O
a	O
global	O
epidemic	O
that	O
is	O
thought	O
to	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
type	O
2	O
diabetes	O
.	O
MicroRNAs	O
(	O
miRs	O
)	O
are	O
regulators	O
that	O
can	O
functionally	O
integrate	O
a	O
range	O
of	O
metabolic	O
and	O
inflammatory	O
pathways	O
in	O
liver	O
.	O
We	O
aimed	O
to	O
investigate	O
the	O
functional	O
role	O
of	O
gene1s	ARG2
miR-155	ARG2
gene1e	ARG2
in	O
hepatic	O
steatosis	O
.	O
Male	O
C57BL/6	O
wild	O
-	O
type	O
(	O
WT	O
)	O
and	O
gene1s	ARG2
miR-155	ARG2
gene1e	ARG2
(-/-	O
)	O
arg1s	O
mice	O
arg1e	O
were	O
fed	O
either	O
normal	O
chow	O
or	O
high	O
fat	O
diet	O
(	O
HFD	O
)	O
for	O
6	O
months	O
then	O
lipid	O
levels	O
,	O
metabolic	O
and	O
inflammatory	O
parameters	O
were	O
assessed	O
in	O
livers	O
and	O
serum	O
of	O
the	O
arg1s	O
mice	O
arg1e	O
.	O
arg1s	O
Mice	O
arg1e	O
lacking	O
endogenous	O
gene1s	ARG2
miR-155	ARG2
gene1e	ARG2
that	O
were	O
fed	O
HFD	O
for	O
6	O
months	O
developed	O
increased	O
hepatic	O
steatosis	O
compared	O
to	O
WT	O
controls	O
.	O
This	O
was	O
associated	O
with	O
increased	O
liver	O
weight	O
and	O
serum	O
VLDL	O
/	O
LDL	O
cholesterol	O
and	O
gene1s	ARG2
alanine	ARG2
transaminase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ALT	ARG2
gene1e	ARG2
)	O
levels	O
,	O
as	O
well	O
as	O
increased	O
hepatic	O
expression	O
of	O
genes	O
involved	O
in	O
glucose	O
regulation	O
(	O
gene1s	ARG2
Pck1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Cebpa	ARG2
gene1e	ARG2
)	O
,	O
fatty	O
acid	O
uptake	O
(	O
gene1s	ARG2
Cd36	ARG2
gene1e	ARG2
)	O
and	O
lipid	O
metabolism	O
(	O
gene1s	ARG2
Fasn	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Fabp4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Lpl	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Abcd2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Pla2g7	ARG2
gene1e	ARG2
)	O
.	O
Using	O
miRNA	O
target	O
prediction	O
algorithms	O
and	O
the	O
microarray	O
transcriptomic	O
profile	O
of	O
gene1s	ARG2
miR-155	ARG2
gene1e	ARG2
(-/-	O
)	O
livers	O
,	O
we	O
identified	O
and	O
validated	O
that	O
gene1s	ARG2
Nr1h3	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
LXRa	ARG2
gene1e	ARG2
)	O
as	O
a	O
direct	O
gene1s	ARG2
miR-155	ARG2
gene1e	ARG2
target	O
gene	O
that	O
is	O
potentially	O
responsible	O
for	O
the	O
liver	O
phenotype	O
of	O
gene1s	ARG2
miR-155	ARG2
gene1e	ARG2
(-/-	O
)	O
arg1s	O
mice	O
arg1e	O
.	O
Together	O
these	O
data	O
indicate	O
that	O
gene1s	ARG2
miR-155	ARG2
gene1e	ARG2
plays	O
a	O
pivotal	O
role	O
regulating	O
lipid	O
metabolism	O
in	O
liver	O
and	O
that	O
its	O
deregulation	O
may	O
lead	O
to	O
hepatic	O
steatosis	O
in	O
species1s	O
patients	O
species1e	O
with	O
diabetes	O
.	O

gene1s	O
MiR-155	O
gene1e	O
has	O
a	O
protective	O
role	O
in	O
the	O
development	O
of	O
non	O
-	O
alcoholic	O
hepatosteatosis	O
in	O
species1s	O
mice	O
species1e	O
.	O
Hepatic	O
steatosis	O
is	O
a	O
global	O
epidemic	O
that	O
is	O
thought	O
to	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
type	O
2	O
diabetes	O
.	O
MicroRNAs	O
(	O
miRs	O
)	O
are	O
regulators	O
that	O
can	O
functionally	O
integrate	O
a	O
range	O
of	O
metabolic	O
and	O
inflammatory	O
pathways	O
in	O
liver	O
.	O
We	O
aimed	O
to	O
investigate	O
the	O
functional	O
role	O
of	O
gene1s	O
miR-155	O
gene1e	O
in	O
hepatic	O
steatosis	O
.	O
Male	O
C57BL/6	O
wild	O
-	O
type	O
(	O
WT	O
)	O
and	O
gene1s	O
miR-155	O
gene1e	O
(-/-	O
)	O
species1s	O
mice	O
species1e	O
were	O
fed	O
either	O
normal	O
chow	O
or	O
high	O
fat	O
diet	O
(	O
HFD	O
)	O
for	O
6	O
months	O
then	O
lipid	O
levels	O
,	O
metabolic	O
and	O
inflammatory	O
parameters	O
were	O
assessed	O
in	O
livers	O
and	O
serum	O
of	O
the	O
species1s	O
mice	O
species1e	O
.	O
species1s	O
Mice	O
species1e	O
lacking	O
endogenous	O
gene1s	O
miR-155	O
gene1e	O
that	O
were	O
fed	O
HFD	O
for	O
6	O
months	O
developed	O
increased	O
hepatic	O
steatosis	O
compared	O
to	O
WT	O
controls	O
.	O
This	O
was	O
associated	O
with	O
increased	O
liver	O
weight	O
and	O
serum	O
VLDL	O
/	O
LDL	O
cholesterol	O
and	O
gene1s	O
alanine	O
transaminase	O
gene1e	O
(	O
gene1s	O
ALT	O
gene1e	O
)	O
levels	O
,	O
as	O
well	O
as	O
increased	O
hepatic	O
expression	O
of	O
genes	O
involved	O
in	O
glucose	O
regulation	O
(	O
gene1s	O
Pck1	O
gene1e	O
,	O
gene1s	O
Cebpa	O
gene1e	O
)	O
,	O
fatty	O
acid	O
uptake	O
(	O
gene1s	O
Cd36	O
gene1e	O
)	O
and	O
lipid	O
metabolism	O
(	O
gene1s	O
Fasn	O
gene1e	O
,	O
gene1s	O
Fabp4	O
gene1e	O
,	O
gene1s	O
Lpl	O
gene1e	O
,	O
gene1s	O
Abcd2	O
gene1e	O
,	O
gene1s	O
Pla2g7	O
gene1e	O
)	O
.	O
Using	O
miRNA	O
target	O
prediction	O
algorithms	O
and	O
the	O
microarray	O
transcriptomic	O
profile	O
of	O
gene1s	O
miR-155	O
gene1e	O
(-/-	O
)	O
livers	O
,	O
we	O
identified	O
and	O
validated	O
that	O
gene1s	O
Nr1h3	O
gene1e	O
(	O
gene1s	O
LXRa	O
gene1e	O
)	O
as	O
a	O
direct	O
gene1s	O
miR-155	O
gene1e	O
target	O
gene	O
that	O
is	O
potentially	O
responsible	O
for	O
the	O
liver	O
phenotype	O
of	O
gene1s	O
miR-155	O
gene1e	O
(-/-	O
)	O
species1s	O
mice	O
species1e	O
.	O
Together	O
these	O
data	O
indicate	O
that	O
gene1s	ARG2
miR-155	ARG2
gene1e	ARG2
plays	O
a	O
pivotal	O
role	O
regulating	O
lipid	O
metabolism	O
in	O
liver	O
and	O
that	O
its	O
deregulation	O
may	O
lead	O
to	O
hepatic	O
steatosis	O
in	O
arg1s	O
patients	O
arg1e	O
with	O
diabetes	O
.	O

A	O
Type	O
2	O
Diabetes	O
-	O
Associated	O
Functional	O
Regulatory	O
Variant	O
in	O
a	O
Pancreatic	O
Islet	O
Enhancer	O
at	O
the	O
gene1s	ARG2
ADCY5	ARG2
gene1e	ARG2
Locus	O
.	O
Molecular	O
mechanisms	O
remain	O
unknown	O
for	O
most	O
type	O
2	O
diabetes	O
genome	O
-	O
wide	O
association	O
study	O
identified	O
loci	O
.	O
Variants	O
associated	O
with	O
type	O
2	O
diabetes	O
and	O
fasting	O
glucose	O
levels	O
reside	O
in	O
introns	O
of	O
gene1s	ARG2
ADCY5	ARG2
gene1e	ARG2
,	O
a	O
gene	O
that	O
encodes	O
gene1s	ARG2
adenylate	ARG2
cyclase	ARG2
5	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
Adenylate	ARG2
cyclase	ARG2
5	ARG2
gene1e	ARG2
catalyzes	O
the	O
production	O
of	O
cyclic	O
AMP	O
,	O
which	O
is	O
a	O
second	O
messenger	O
molecule	O
involved	O
in	O
cell	O
signaling	O
and	O
pancreatic	O
b	O
-	O
cell	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
secretion	O
.	O
We	O
demonstrated	O
that	O
type	O
2	O
diabetes	O
risk	O
alleles	O
are	O
associated	O
with	O
decreased	O
gene1s	ARG2
ADCY5	ARG2
gene1e	ARG2
expression	O
in	O
arg1s	O
human	O
arg1e	O
islets	O
and	O
examined	O
candidate	O
variants	O
for	O
regulatory	O
function	O
.	O
rs11708067	O
overlaps	O
a	O
predicted	O
enhancer	O
region	O
in	O
pancreatic	O
islets	O
.	O
The	O
type	O
2	O
diabetes	O
risk	O
rs11708067-A	O
allele	O
showed	O
fewer	O
H3K27ac	O
ChIP	O
-	O
seq	O
reads	O
in	O
arg1s	O
human	O
arg1e	O
islets	O
,	O
lower	O
transcriptional	O
activity	O
in	O
reporter	O
assays	O
in	O
rodent	O
b	O
-	O
cells	O
(	O
species1s	O
rat	O
species1e	O
832/13	O
and	O
species1s	O
mouse	O
species1e	O
MIN6	O
)	O
,	O
and	O
increased	O
nuclear	O
protein	O
binding	O
compared	O
with	O
the	O
rs11708067-G	O
allele	O
.	O
Homozygous	O
deletion	O
of	O
the	O
orthologous	O
enhancer	O
region	O
in	O
832/13	O
cells	O
resulted	O
in	O
a	O
64	O
%	O
reduction	O
in	O
expression	O
level	O
of	O
gene1s	O
Adcy5	O
gene1e	O
,	O
but	O
not	O
adjacent	O
gene	O
gene1s	O
Sec22a	O
gene1e	O
,	O
and	O
a	O
39	O
%	O
reduction	O
in	O
gene1s	O
insulin	O
gene1e	O
secretion	O
.	O
Together	O
,	O
these	O
data	O
suggest	O
that	O
rs11708067-A	O
risk	O
allele	O
contributes	O
to	O
type	O
2	O
diabetes	O
by	O
disrupting	O
an	O
islet	O
enhancer	O
,	O
which	O
results	O
in	O
reduced	O
gene1s	ARG2
ADCY5	ARG2
gene1e	ARG2
expression	O
and	O
impaired	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
secretion	O
.	O

A	O
Type	O
2	O
Diabetes	O
-	O
Associated	O
Functional	O
Regulatory	O
Variant	O
in	O
a	O
Pancreatic	O
Islet	O
Enhancer	O
at	O
the	O
gene1s	O
ADCY5	O
gene1e	O
Locus	O
.	O
Molecular	O
mechanisms	O
remain	O
unknown	O
for	O
most	O
type	O
2	O
diabetes	O
genome	O
-	O
wide	O
association	O
study	O
identified	O
loci	O
.	O
Variants	O
associated	O
with	O
type	O
2	O
diabetes	O
and	O
fasting	O
glucose	O
levels	O
reside	O
in	O
introns	O
of	O
gene1s	O
ADCY5	O
gene1e	O
,	O
a	O
gene	O
that	O
encodes	O
gene1s	O
adenylate	O
cyclase	O
5	O
gene1e	O
.	O
gene1s	O
Adenylate	O
cyclase	O
5	O
gene1e	O
catalyzes	O
the	O
production	O
of	O
cyclic	O
AMP	O
,	O
which	O
is	O
a	O
second	O
messenger	O
molecule	O
involved	O
in	O
cell	O
signaling	O
and	O
pancreatic	O
b	O
-	O
cell	O
gene1s	O
insulin	O
gene1e	O
secretion	O
.	O
We	O
demonstrated	O
that	O
type	O
2	O
diabetes	O
risk	O
alleles	O
are	O
associated	O
with	O
decreased	O
gene1s	O
ADCY5	O
gene1e	O
expression	O
in	O
species1s	O
human	O
species1e	O
islets	O
and	O
examined	O
candidate	O
variants	O
for	O
regulatory	O
function	O
.	O
rs11708067	O
overlaps	O
a	O
predicted	O
enhancer	O
region	O
in	O
pancreatic	O
islets	O
.	O
The	O
type	O
2	O
diabetes	O
risk	O
rs11708067-A	O
allele	O
showed	O
fewer	O
H3K27ac	O
ChIP	O
-	O
seq	O
reads	O
in	O
species1s	O
human	O
species1e	O
islets	O
,	O
lower	O
transcriptional	O
activity	O
in	O
reporter	O
assays	O
in	O
rodent	O
b	O
-	O
cells	O
(	O
arg1s	O
rat	O
arg1e	O
832/13	O
and	O
species1s	O
mouse	O
species1e	O
MIN6	O
)	O
,	O
and	O
increased	O
nuclear	O
protein	O
binding	O
compared	O
with	O
the	O
rs11708067-G	O
allele	O
.	O
Homozygous	O
deletion	O
of	O
the	O
orthologous	O
enhancer	O
region	O
in	O
832/13	O
cells	O
resulted	O
in	O
a	O
64	O
%	O
reduction	O
in	O
expression	O
level	O
of	O
gene1s	ARG2
Adcy5	ARG2
gene1e	ARG2
,	O
but	O
not	O
adjacent	O
gene	O
gene1s	ARG2
Sec22a	ARG2
gene1e	ARG2
,	O
and	O
a	O
39	O
%	O
reduction	O
in	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
secretion	O
.	O
Together	O
,	O
these	O
data	O
suggest	O
that	O
rs11708067-A	O
risk	O
allele	O
contributes	O
to	O
type	O
2	O
diabetes	O
by	O
disrupting	O
an	O
islet	O
enhancer	O
,	O
which	O
results	O
in	O
reduced	O
gene1s	O
ADCY5	O
gene1e	O
expression	O
and	O
impaired	O
gene1s	O
insulin	O
gene1e	O
secretion	O
.	O

A	O
Type	O
2	O
Diabetes	O
-	O
Associated	O
Functional	O
Regulatory	O
Variant	O
in	O
a	O
Pancreatic	O
Islet	O
Enhancer	O
at	O
the	O
gene1s	O
ADCY5	O
gene1e	O
Locus	O
.	O
Molecular	O
mechanisms	O
remain	O
unknown	O
for	O
most	O
type	O
2	O
diabetes	O
genome	O
-	O
wide	O
association	O
study	O
identified	O
loci	O
.	O
Variants	O
associated	O
with	O
type	O
2	O
diabetes	O
and	O
fasting	O
glucose	O
levels	O
reside	O
in	O
introns	O
of	O
gene1s	O
ADCY5	O
gene1e	O
,	O
a	O
gene	O
that	O
encodes	O
gene1s	O
adenylate	O
cyclase	O
5	O
gene1e	O
.	O
gene1s	O
Adenylate	O
cyclase	O
5	O
gene1e	O
catalyzes	O
the	O
production	O
of	O
cyclic	O
AMP	O
,	O
which	O
is	O
a	O
second	O
messenger	O
molecule	O
involved	O
in	O
cell	O
signaling	O
and	O
pancreatic	O
b	O
-	O
cell	O
gene1s	O
insulin	O
gene1e	O
secretion	O
.	O
We	O
demonstrated	O
that	O
type	O
2	O
diabetes	O
risk	O
alleles	O
are	O
associated	O
with	O
decreased	O
gene1s	O
ADCY5	O
gene1e	O
expression	O
in	O
species1s	O
human	O
species1e	O
islets	O
and	O
examined	O
candidate	O
variants	O
for	O
regulatory	O
function	O
.	O
rs11708067	O
overlaps	O
a	O
predicted	O
enhancer	O
region	O
in	O
pancreatic	O
islets	O
.	O
The	O
type	O
2	O
diabetes	O
risk	O
rs11708067-A	O
allele	O
showed	O
fewer	O
H3K27ac	O
ChIP	O
-	O
seq	O
reads	O
in	O
species1s	O
human	O
species1e	O
islets	O
,	O
lower	O
transcriptional	O
activity	O
in	O
reporter	O
assays	O
in	O
rodent	O
b	O
-	O
cells	O
(	O
species1s	O
rat	O
species1e	O
832/13	O
and	O
arg1s	O
mouse	O
arg1e	O
MIN6	O
)	O
,	O
and	O
increased	O
nuclear	O
protein	O
binding	O
compared	O
with	O
the	O
rs11708067-G	O
allele	O
.	O
Homozygous	O
deletion	O
of	O
the	O
orthologous	O
enhancer	O
region	O
in	O
832/13	O
cells	O
resulted	O
in	O
a	O
64	O
%	O
reduction	O
in	O
expression	O
level	O
of	O
gene1s	O
Adcy5	O
gene1e	O
,	O
but	O
not	O
adjacent	O
gene	O
gene1s	O
Sec22a	O
gene1e	O
,	O
and	O
a	O
39	O
%	O
reduction	O
in	O
gene1s	O
insulin	O
gene1e	O
secretion	O
.	O
Together	O
,	O
these	O
data	O
suggest	O
that	O
rs11708067-A	O
risk	O
allele	O
contributes	O
to	O
type	O
2	O
diabetes	O
by	O
disrupting	O
an	O
islet	O
enhancer	O
,	O
which	O
results	O
in	O
reduced	O
gene1s	O
ADCY5	O
gene1e	O
expression	O
and	O
impaired	O
gene1s	O
insulin	O
gene1e	O
secretion	O
.	O

gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
signaling	O
downstream	O
to	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
contributes	O
to	O
paclitaxel	O
-	O
induced	O
peripheral	O
neuropathy	O
.	O
gene1s	ARG2
Toll	ARG2
-	ARG2
like	ARG2
receptor	ARG2
4	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
)	O
has	O
been	O
implicated	O
as	O
a	O
locus	O
for	O
initiation	O
of	O
paclitaxel	O
related	O
chemotherapy	O
induced	O
peripheral	O
neuropathy	O
(	O
CIPN	O
)	O
.	O
This	O
project	O
explores	O
the	O
involvement	O
of	O
the	O
immediate	O
down	O
-	O
stream	O
signal	O
molecules	O
in	O
inducing	O
paclitaxel	O
CIPN	O
.	O
gene1s	ARG2
Mitogen	ARG2
-	ARG2
activated	ARG2
protein	ARG2
kinases	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MAPKs	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
nuclear	ARG2
factor	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NFkappaB	ARG2
gene1e	ARG2
)	O
were	O
measured	O
in	O
dorsal	O
root	O
ganglia	O
(	O
DRG	O
)	O
and	O
the	O
spinal	O
cord	O
over	O
time	O
using	O
Western	O
blot	O
and	O
immunohistochemistry	O
in	O
a	O
arg1s	O
rat	O
arg1e	O
model	O
of	O
paclitaxel	O
CIPN	O
.	O
The	O
effects	O
of	O
MAPK	O
inhibitors	O
in	O
preventing	O
and	O
reversing	O
behavioral	O
signs	O
of	O
CIPN	O
were	O
also	O
measured	O
(	O
group	O
sizes	O
4	O
-	O
9	O
)	O
.	O
gene1s	ARG2
Extracellular	ARG2
signal	ARG2
related	ARG2
kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
P38	ARG2
gene1e	ARG2
but	O
not	O
gene1s	ARG2
c	ARG2
-	ARG2
Jun	ARG2
N	ARG2
terminal	ARG2
kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
)	O
or	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
signaling	O
expression	O
was	O
increased	O
in	O
DRG	O
.	O
Phospho	O
-	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
staining	O
was	O
co	O
-	O
localized	O
to	O
small	O
gene1s	ARG2
CGRP	ARG2
gene1e	ARG2
-	O
positive	O
DRG	O
neurons	O
in	O
cell	O
profiles	O
surrounding	O
large	O
DRG	O
neurons	O
consistent	O
with	O
satellite	O
glial	O
cells	O
.	O
The	O
expression	O
of	O
phospho	O
-	O
gene1s	ARG2
P38	ARG2
gene1e	ARG2
was	O
co	O
-	O
localized	O
to	O
small	O
IB4-positive	O
and	O
gene1s	ARG2
CGRP	ARG2
gene1e	ARG2
-	O
positive	O
DRG	O
neurons	O
.	O
The	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
antagonist	O
LPS	O
derived	O
from	O
species1s	O
Rhodobacter	O
sphaeroides	O
species1e	O
(	O
LPS	O
-	O
RS	O
)	O
inhibited	O
paclitaxel	O
-	O
induced	O
phosphorylation	O
of	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
P38	ARG2
gene1e	ARG2
.	O
The	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
inhibitors	O
PD98059	O
(	O
gene1s	ARG2
MEK1/2	ARG2
gene1e	ARG2
)	O
,	O
U0126	O
(	O
gene1s	ARG2
MEK1/2	ARG2
gene1e	ARG2
)	O
and	O
SB203580	O
(	O
gene1s	ARG2
P38	ARG2
gene1e	ARG2
)	O
prevented	O
but	O
did	O
not	O
reverse	O
paclitaxel	O
-	O
induced	O
behavioral	O
hypersensitivity	O
.	O
Paclitaxel	O
treatment	O
resulted	O
in	O
phosphorylation	O
of	O
gene1s	ARG2
Inhibitor	ARG2
alpha	ARG2
of	ARG2
NFkappaB	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IkappaBalpha	ARG2
gene1e	ARG2
)	O
in	O
DRG	O
resulting	O
in	O
an	O
apparent	O
release	O
of	O
gene1s	ARG2
NFkappaB	ARG2
gene1e	ARG2
from	O
the	O
gene1s	ARG2
IkappaBalpha	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
NFkappaB	ARG2
gene1e	ARG2
complex	O
as	O
increased	O
expression	O
of	O
nuclear	O
gene1s	ARG2
NFkappaB	ARG2
gene1e	ARG2
was	O
also	O
observed	O
.	O
LPS	O
-	O
RS	O
inhibited	O
paclitaxel	O
-	O
induced	O
translocation	O
of	O
gene1s	ARG2
NFkappaB	ARG2
gene1e	ARG2
in	O
DRG	O
.	O
No	O
change	O
was	O
observed	O
in	O
spinal	O
gene1s	ARG2
NFkappaB	ARG2
gene1e	ARG2
.	O
These	O
results	O
implicate	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
signaling	O
via	O
gene1s	ARG2
MAP	ARG2
kinases	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
NFkappaB	ARG2
gene1e	ARG2
in	O
the	O
induction	O
and	O
maintenance	O
of	O
paclitaxel	O
-	O
related	O
CIPN	O
.	O

gene1s	O
MAPK	O
gene1e	O
signaling	O
downstream	O
to	O
gene1s	O
TLR4	O
gene1e	O
contributes	O
to	O
paclitaxel	O
-	O
induced	O
peripheral	O
neuropathy	O
.	O
gene1s	O
Toll	O
-	O
like	O
receptor	O
4	O
gene1e	O
(	O
gene1s	O
TLR4	O
gene1e	O
)	O
has	O
been	O
implicated	O
as	O
a	O
locus	O
for	O
initiation	O
of	O
paclitaxel	O
related	O
chemotherapy	O
induced	O
peripheral	O
neuropathy	O
(	O
CIPN	O
)	O
.	O
This	O
project	O
explores	O
the	O
involvement	O
of	O
the	O
immediate	O
down	O
-	O
stream	O
signal	O
molecules	O
in	O
inducing	O
paclitaxel	O
CIPN	O
.	O
gene1s	O
Mitogen	O
-	O
activated	O
protein	O
kinases	O
gene1e	O
(	O
gene1s	O
MAPKs	O
gene1e	O
)	O
and	O
gene1s	O
nuclear	O
factor	O
-	O
kappaB	O
gene1e	O
(	O
gene1s	O
NFkappaB	O
gene1e	O
)	O
were	O
measured	O
in	O
dorsal	O
root	O
ganglia	O
(	O
DRG	O
)	O
and	O
the	O
spinal	O
cord	O
over	O
time	O
using	O
Western	O
blot	O
and	O
immunohistochemistry	O
in	O
a	O
species1s	O
rat	O
species1e	O
model	O
of	O
paclitaxel	O
CIPN	O
.	O
The	O
effects	O
of	O
MAPK	O
inhibitors	O
in	O
preventing	O
and	O
reversing	O
behavioral	O
signs	O
of	O
CIPN	O
were	O
also	O
measured	O
(	O
group	O
sizes	O
4	O
-	O
9	O
)	O
.	O
gene1s	O
Extracellular	O
signal	O
related	O
kinase	O
gene1e	O
(	O
gene1s	O
ERK1/2	O
gene1e	O
)	O
and	O
gene1s	O
P38	O
gene1e	O
but	O
not	O
gene1s	O
c	O
-	O
Jun	O
N	O
terminal	O
kinase	O
gene1e	O
(	O
gene1s	O
JNK	O
gene1e	O
)	O
or	O
gene1s	O
PI3K	O
gene1e	O
-	O
gene1s	O
Akt	O
gene1e	O
signaling	O
expression	O
was	O
increased	O
in	O
DRG	O
.	O
Phospho	O
-	O
gene1s	O
ERK1/2	O
gene1e	O
staining	O
was	O
co	O
-	O
localized	O
to	O
small	O
gene1s	O
CGRP	O
gene1e	O
-	O
positive	O
DRG	O
neurons	O
in	O
cell	O
profiles	O
surrounding	O
large	O
DRG	O
neurons	O
consistent	O
with	O
satellite	O
glial	O
cells	O
.	O
The	O
expression	O
of	O
phospho	O
-	O
gene1s	O
P38	O
gene1e	O
was	O
co	O
-	O
localized	O
to	O
small	O
IB4-positive	O
and	O
gene1s	O
CGRP	O
gene1e	O
-	O
positive	O
DRG	O
neurons	O
.	O
The	O
gene1s	O
TLR4	O
gene1e	O
antagonist	O
LPS	O
derived	O
from	O
arg1s	O
Rhodobacter	O
sphaeroides	O
arg1e	O
(	O
LPS	O
-	O
RS	O
)	O
inhibited	O
paclitaxel	O
-	O
induced	O
phosphorylation	O
of	O
gene1s	O
ERK1/2	O
gene1e	O
and	O
gene1s	O
P38	O
gene1e	O
.	O
The	O
gene1s	O
MAPK	O
gene1e	O
inhibitors	O
PD98059	O
(	O
gene1s	O
MEK1/2	O
gene1e	O
)	O
,	O
U0126	O
(	O
gene1s	O
MEK1/2	O
gene1e	O
)	O
and	O
SB203580	O
(	O
gene1s	O
P38	O
gene1e	O
)	O
prevented	O
but	O
did	O
not	O
reverse	O
paclitaxel	O
-	O
induced	O
behavioral	O
hypersensitivity	O
.	O
Paclitaxel	O
treatment	O
resulted	O
in	O
phosphorylation	O
of	O
gene1s	O
Inhibitor	O
alpha	O
of	O
NFkappaB	O
gene1e	O
(	O
gene1s	O
IkappaBalpha	O
gene1e	O
)	O
in	O
DRG	O
resulting	O
in	O
an	O
apparent	O
release	O
of	O
gene1s	O
NFkappaB	O
gene1e	O
from	O
the	O
gene1s	O
IkappaBalpha	O
gene1e	O
-	O
gene1s	O
NFkappaB	O
gene1e	O
complex	O
as	O
increased	O
expression	O
of	O
nuclear	O
gene1s	O
NFkappaB	O
gene1e	O
was	O
also	O
observed	O
.	O
LPS	O
-	O
RS	O
inhibited	O
paclitaxel	O
-	O
induced	O
translocation	O
of	O
gene1s	O
NFkappaB	O
gene1e	O
in	O
DRG	O
.	O
No	O
change	O
was	O
observed	O
in	O
spinal	O
gene1s	O
NFkappaB	O
gene1e	O
.	O
These	O
results	O
implicate	O
gene1s	O
TLR4	O
gene1e	O
signaling	O
via	O
gene1s	O
MAP	O
kinases	O
gene1e	O
and	O
gene1s	O
NFkappaB	O
gene1e	O
in	O
the	O
induction	O
and	O
maintenance	O
of	O
paclitaxel	O
-	O
related	O
CIPN	O
.	O

Developmental	O
Role	O
of	O
Macrophage	O
gene1s	ARG2
Cannabinoid-1	ARG2
Receptor	ARG2
gene1e	ARG2
Signaling	O
in	O
Type-2	O
Diabetes	O
.	O
Islet	O
inflammation	O
promotes	O
b	O
-	O
cell	O
loss	O
and	O
type-2	O
diabetes	O
(	O
T2D	O
)	O
,	O
a	O
process	O
replicated	O
in	O
Zucker	O
Diabetic	O
Fatty	O
(	O
ZDF	O
)	O
arg1s	O
rats	O
arg1e	O
in	O
which	O
b	O
-	O
cell	O
loss	O
has	O
been	O
linked	O
to	O
gene1s	ARG2
cannabinoid-1	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CB1R	ARG2
gene1e	ARG2
)-induced	O
pro	O
-	O
inflammatory	O
signaling	O
in	O
macrophages	O
infiltrating	O
pancreatic	O
islets	O
.	O
Here	O
,	O
we	O
analyzed	O
gene1s	ARG2
CB1R	ARG2
gene1e	ARG2
signaling	O
in	O
macrophages	O
and	O
its	O
developmental	O
role	O
in	O
T2Da	O
.	O
ZDF	O
arg1s	O
rats	O
arg1e	O
with	O
global	O
deletion	O
of	O
gene1s	ARG2
CB1R	ARG2
gene1e	ARG2
are	O
protected	O
from	O
b	O
-	O
cell	O
loss	O
,	O
hyperglycemia	O
and	O
nephropathy	O
present	O
in	O
ZDF	O
littermates	O
.	O
Adoptive	O
transfer	O
of	O
gene1s	ARG2
CB1R	ARG2
gene1e	ARG2
(-/-	O
)	O
bone	O
marrow	O
to	O
ZDF	O
arg1s	O
rats	O
arg1e	O
also	O
prevents	O
b	O
-	O
cell	O
loss	O
and	O
hyperglycemia	O
,	O
but	O
not	O
nephropathy	O
.	O
ZDF	O
islets	O
contain	O
elevated	O
levels	O
of	O
gene1s	ARG2
CB1R	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-1b	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
,	O
the	O
gene1s	ARG2
chemokine	ARG2
gene1e	ARG2
gene1s	ARG2
CCL2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
interferon	ARG2
regulatory	ARG2
factor-5	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IRF5	ARG2
gene1e	ARG2
)	O
,	O
a	O
marker	O
of	O
M1	O
inflammatory	O
macrophage	O
polarization	O
.	O
In	O
primary	O
cultured	O
rodent	O
and	O
species1s	O
human	O
species1e	O
macrophages	O
,	O
gene1s	O
CB1R	O
gene1e	O
activation	O
increased	O
gene1s	ARG2
Irf5	ARG2
gene1e	ARG2
expression	O
,	O
whereas	O
knockdown	O
of	O
gene1s	O
Irf5	O
gene1e	O
blunted	O
gene1s	O
CB1R	O
gene1e	O
-	O
induced	O
secretion	O
of	O
inflammatory	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
without	O
affecting	O
gene1s	ARG2
CCL2	ARG2
gene1e	ARG2
expression	O
,	O
which	O
was	O
gene1s	ARG2
p38MAPKa	ARG2
gene1e	ARG2
-	O
dependent	O
.	O
Macrophage	O
-	O
specific	O
in	O
vivo	O
knockdown	O
of	O
gene1s	ARG2
Irf5	ARG2
gene1e	ARG2
protected	O
ZDF	O
arg1s	O
rats	O
arg1e	O
from	O
b	O
-	O
cell	O
loss	O
and	O
hyperglycemia	O
.	O
Thus	O
,	O
gene1s	ARG2
IRF5	ARG2
gene1e	ARG2
is	O
a	O
crucial	O
downstream	O
mediator	O
of	O
diabetogenic	O
gene1s	ARG2
CB1R	ARG2
gene1e	ARG2
signaling	O
in	O
macrophages	O
and	O
a	O
potential	O
therapeutic	O
target	O
.	O

Developmental	O
Role	O
of	O
Macrophage	O
gene1s	O
Cannabinoid-1	O
Receptor	O
gene1e	O
Signaling	O
in	O
Type-2	O
Diabetes	O
.	O
Islet	O
inflammation	O
promotes	O
b	O
-	O
cell	O
loss	O
and	O
type-2	O
diabetes	O
(	O
T2D	O
)	O
,	O
a	O
process	O
replicated	O
in	O
Zucker	O
Diabetic	O
Fatty	O
(	O
ZDF	O
)	O
species1s	O
rats	O
species1e	O
in	O
which	O
b	O
-	O
cell	O
loss	O
has	O
been	O
linked	O
to	O
gene1s	O
cannabinoid-1	O
receptor	O
gene1e	O
(	O
gene1s	O
CB1R	O
gene1e	O
)-induced	O
pro	O
-	O
inflammatory	O
signaling	O
in	O
macrophages	O
infiltrating	O
pancreatic	O
islets	O
.	O
Here	O
,	O
we	O
analyzed	O
gene1s	O
CB1R	O
gene1e	O
signaling	O
in	O
macrophages	O
and	O
its	O
developmental	O
role	O
in	O
T2Da	O
.	O
ZDF	O
species1s	O
rats	O
species1e	O
with	O
global	O
deletion	O
of	O
gene1s	O
CB1R	O
gene1e	O
are	O
protected	O
from	O
b	O
-	O
cell	O
loss	O
,	O
hyperglycemia	O
and	O
nephropathy	O
present	O
in	O
ZDF	O
littermates	O
.	O
Adoptive	O
transfer	O
of	O
gene1s	O
CB1R	O
gene1e	O
(-/-	O
)	O
bone	O
marrow	O
to	O
ZDF	O
species1s	O
rats	O
species1e	O
also	O
prevents	O
b	O
-	O
cell	O
loss	O
and	O
hyperglycemia	O
,	O
but	O
not	O
nephropathy	O
.	O
ZDF	O
islets	O
contain	O
elevated	O
levels	O
of	O
gene1s	O
CB1R	O
gene1e	O
,	O
gene1s	O
IL-1b	O
gene1e	O
,	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
,	O
the	O
gene1s	O
chemokine	O
gene1e	O
gene1s	O
CCL2	O
gene1e	O
and	O
gene1s	O
interferon	O
regulatory	O
factor-5	O
gene1e	O
(	O
gene1s	O
IRF5	O
gene1e	O
)	O
,	O
a	O
marker	O
of	O
M1	O
inflammatory	O
macrophage	O
polarization	O
.	O
In	O
primary	O
cultured	O
rodent	O
and	O
arg1s	O
human	O
arg1e	O
macrophages	O
,	O
gene1s	ARG2
CB1R	ARG2
gene1e	ARG2
activation	O
increased	O
gene1s	O
Irf5	O
gene1e	O
expression	O
,	O
whereas	O
knockdown	O
of	O
gene1s	ARG2
Irf5	ARG2
gene1e	ARG2
blunted	O
gene1s	ARG2
CB1R	ARG2
gene1e	ARG2
-	O
induced	O
secretion	O
of	O
inflammatory	O
gene1s	O
cytokines	O
gene1e	O
without	O
affecting	O
gene1s	O
CCL2	O
gene1e	O
expression	O
,	O
which	O
was	O
gene1s	O
p38MAPKa	O
gene1e	O
-	O
dependent	O
.	O
Macrophage	O
-	O
specific	O
in	O
vivo	O
knockdown	O
of	O
gene1s	O
Irf5	O
gene1e	O
protected	O
ZDF	O
species1s	O
rats	O
species1e	O
from	O
b	O
-	O
cell	O
loss	O
and	O
hyperglycemia	O
.	O
Thus	O
,	O
gene1s	O
IRF5	O
gene1e	O
is	O
a	O
crucial	O
downstream	O
mediator	O
of	O
diabetogenic	O
gene1s	O
CB1R	O
gene1e	O
signaling	O
in	O
macrophages	O
and	O
a	O
potential	O
therapeutic	O
target	O
.	O

Selective	O
Targeting	O
of	O
SH2	O
Domain	O
-	O
Phosphotyrosine	O
Interactions	O
of	O
gene1s	ARG2
Src	ARG2
Family	ARG2
Tyrosine	ARG2
Kinases	ARG2
gene1e	ARG2
with	O
Monobodies	O
.	O
The	O
binding	O
of	O
Src	O
-	O
homology	O
2	O
(	O
SH2	O
)	O
domains	O
to	O
phosphotyrosine	O
(	O
pY	O
)	O
sites	O
is	O
critical	O
for	O
the	O
autoinhibition	O
and	O
substrate	O
recognition	O
of	O
the	O
eight	O
gene1s	ARG2
Src	ARG2
family	ARG2
kinases	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SFKs	ARG2
gene1e	ARG2
)	O
.	O
The	O
high	O
sequence	O
conservation	O
of	O
the	O
120	O
arg1s	O
human	O
arg1e	O
SH2	O
domains	O
poses	O
a	O
significant	O
challenge	O
to	O
selectively	O
perturb	O
the	O
interactions	O
of	O
even	O
the	O
gene1s	ARG2
SFK	ARG2
gene1e	ARG2
SH2	O
family	O
against	O
the	O
rest	O
of	O
the	O
SH2	O
domains	O
.	O
We	O
have	O
developed	O
synthetic	O
binding	O
proteins	O
,	O
termed	O
monobodies	O
,	O
for	O
six	O
of	O
the	O
gene1s	ARG2
SFK	ARG2
gene1e	ARG2
SH2	O
domains	O
with	O
nanomolar	O
affinity	O
.	O
Most	O
of	O
these	O
monobodies	O
competed	O
with	O
pY	O
ligand	O
binding	O
and	O
showed	O
strong	O
selectivity	O
for	O
either	O
the	O
gene1s	ARG2
SrcA	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Yes	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Src	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Fyn	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Fgr	ARG2
gene1e	ARG2
)	O
or	O
gene1s	ARG2
SrcB	ARG2
gene1e	ARG2
subgroup	O
(	O
gene1s	ARG2
Lck	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Lyn	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Blk	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Hck	ARG2
gene1e	ARG2
)	O
.	O
Interactome	O
analysis	O
of	O
intracellularly	O
expressed	O
monobodies	O
revealed	O
that	O
they	O
bind	O
gene1s	ARG2
SFKs	ARG2
gene1e	ARG2
but	O
no	O
other	O
SH2-containing	O
proteins	O
.	O
Three	O
crystal	O
structures	O
of	O
monobody	O
-	O
SH2	O
complexes	O
unveiled	O
different	O
and	O
only	O
partly	O
overlapping	O
binding	O
modes	O
,	O
which	O
rationalized	O
the	O
observed	O
selectivity	O
and	O
enabled	O
structure	O
-	O
based	O
mutagenesis	O
to	O
modulate	O
inhibition	O
mode	O
and	O
selectivity	O
.	O
In	O
line	O
with	O
the	O
critical	O
roles	O
of	O
gene1s	ARG2
SFK	ARG2
gene1e	ARG2
SH2	O
domains	O
in	O
kinase	O
autoinhibition	O
and	O
gene1s	ARG2
T	ARG2
-	ARG2
cell	ARG2
receptor	ARG2
gene1e	ARG2
signaling	O
,	O
monobodies	O
binding	O
the	O
gene1s	ARG2
Src	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Hck	ARG2
gene1e	ARG2
SH2	O
domains	O
selectively	O
activated	O
respective	O
recombinant	O
kinases	O
,	O
whereas	O
an	O
gene1s	ARG2
Lck	ARG2
gene1e	ARG2
SH2-binding	O
monobody	O
inhibited	O
proximal	O
signaling	O
events	O
downstream	O
of	O
the	O
gene1s	ARG2
T	ARG2
-	ARG2
cell	ARG2
receptor	ARG2
gene1e	ARG2
complex	O
.	O
Our	O
results	O
show	O
that	O
gene1s	ARG2
SFK	ARG2
gene1e	ARG2
SH2	O
domains	O
can	O
be	O
targeted	O
with	O
unprecedented	O
potency	O
and	O
selectivity	O
using	O
monobodies	O
.	O
They	O
are	O
excellent	O
tools	O
for	O
dissecting	O
gene1s	ARG2
SFK	ARG2
gene1e	ARG2
functions	O
in	O
normal	O
development	O
and	O
signaling	O
and	O
to	O
interfere	O
with	O
aberrant	O
gene1s	ARG2
SFK	ARG2
gene1e	ARG2
signaling	O
networks	O
in	O
cancer	O
cells	O
.	O

gene1s	O
Rac1	O
gene1e	O
signaling	O
is	O
critical	O
to	O
cardiomyocyte	O
polarity	O
and	O
embryonic	O
heart	O
development	O
.	O
BACKGROUND	O
:	O
Defects	O
in	O
cardiac	O
septation	O
are	O
the	O
most	O
common	O
form	O
of	O
congenital	O
heart	O
disease	O
,	O
but	O
the	O
mechanisms	O
underlying	O
these	O
defects	O
are	O
still	O
poorly	O
understood	O
.	O
The	O
gene1s	ARG2
small	ARG2
GTPase	ARG2
gene1e	ARG2
gene1s	ARG2
Rac1	ARG2
gene1e	ARG2
is	O
implicated	O
in	O
planar	O
cell	O
polarity	O
of	O
epithelial	O
cells	O
in	O
arg1s	O
Drosophila	O
arg1e	O
;	O
however	O
,	O
its	O
role	O
in	O
species1s	O
mammalian	O
species1e	O
cardiomyocyte	O
polarity	O
is	O
not	O
clear	O
.	O
We	O
tested	O
the	O
hypothesis	O
that	O
gene1s	O
Rac1	O
gene1e	O
signaling	O
in	O
the	O
second	O
heart	O
field	O
regulates	O
cardiomyocyte	O
polarity	O
,	O
chamber	O
septation	O
,	O
and	O
right	O
ventricle	O
development	O
during	O
embryonic	O
heart	O
development	O
.	O
METHODS	O
AND	O
RESULTS	O
:	O
species1s	O
Mice	O
species1e	O
with	O
second	O
heart	O
field	O
-	O
specific	O
deficiency	O
of	O
gene1s	O
Rac1	O
gene1e	O
(	O
gene1s	O
Rac1	O
gene1e	O
(SHF	O
)	O
)	O
exhibited	O
ventricular	O
and	O
atrial	O
septal	O
defects	O
,	O
a	O
thinner	O
right	O
ventricle	O
myocardium	O
,	O
and	O
a	O
bifid	O
cardiac	O
apex	O
.	O
Fate	O
-	O
mapping	O
analysis	O
showed	O
that	O
second	O
heart	O
field	O
contribution	O
to	O
the	O
interventricular	O
septum	O
and	O
right	O
ventricle	O
was	O
deficient	O
in	O
gene1s	O
Rac1	O
gene1e	O
(SHF	O
)	O
hearts	O
.	O
Notably	O
,	O
cardiomyocytes	O
had	O
a	O
spherical	O
shape	O
with	O
disrupted	O
gene1s	O
F	O
-	O
actin	O
gene1e	O
filaments	O
in	O
gene1s	O
Rac1	O
gene1e	O
(SHF	O
)	O
compared	O
with	O
elongated	O
and	O
well	O
-	O
aligned	O
cardiomyocytes	O
in	O
littermate	O
controls	O
.	O
Expression	O
of	O
gene1s	O
Scrib	O
gene1e	O
,	O
a	O
core	O
protein	O
in	O
planar	O
cell	O
polarity	O
,	O
was	O
lost	O
in	O
gene1s	O
Rac1	O
gene1e	O
(SHF	O
)	O
hearts	O
with	O
decreased	O
expression	O
of	O
gene1s	O
WAVE	O
gene1e	O
and	O
gene1s	O
Arp2/3	O
gene1e	O
,	O
leading	O
to	O
decreased	O
migratory	O
ability	O
.	O
In	O
addition	O
,	O
gene1s	O
Rac1	O
gene1e	O
-deficient	O
neonatal	O
cardiomyocytes	O
displayed	O
defects	O
in	O
cell	O
projections	O
,	O
lamellipodia	O
formation	O
,	O
and	O
cell	O
elongation	O
.	O
Furthermore	O
,	O
apoptosis	O
was	O
increased	O
and	O
the	O
expression	O
of	O
gene1s	O
Gata4	O
gene1e	O
,	O
gene1s	O
Tbx5	O
gene1e	O
,	O
gene1s	O
Nkx2.5	O
gene1e	O
,	O
and	O
gene1s	O
Hand2	O
gene1e	O
transcription	O
factors	O
was	O
decreased	O
in	O
the	O
gene1s	O
Rac1	O
gene1e	O
(SHF	O
)	O
right	O
ventricle	O
myocardium	O
.	O
CONCLUSIONS	O
:	O
Deficiency	O
of	O
gene1s	O
Rac1	O
gene1e	O
in	O
the	O
second	O
heart	O
field	O
impairs	O
elongation	O
and	O
cytoskeleton	O
organization	O
of	O
cardiomyocytes	O
and	O
results	O
in	O
congenital	O
septal	O
defects	O
,	O
thin	O
right	O
ventricle	O
myocardium	O
,	O
and	O
a	O
bifid	O
cardiac	O
apex	O
.	O
Our	O
study	O
suggests	O
that	O
gene1s	O
Rac1	O
gene1e	O
signaling	O
is	O
critical	O
to	O
cardiomyocyte	O
polarity	O
and	O
embryonic	O
heart	O
development	O
.	O

gene1s	O
Rac1	O
gene1e	O
signaling	O
is	O
critical	O
to	O
cardiomyocyte	O
polarity	O
and	O
embryonic	O
heart	O
development	O
.	O
BACKGROUND	O
:	O
Defects	O
in	O
cardiac	O
septation	O
are	O
the	O
most	O
common	O
form	O
of	O
congenital	O
heart	O
disease	O
,	O
but	O
the	O
mechanisms	O
underlying	O
these	O
defects	O
are	O
still	O
poorly	O
understood	O
.	O
The	O
gene1s	O
small	O
GTPase	O
gene1e	O
gene1s	O
Rac1	O
gene1e	O
is	O
implicated	O
in	O
planar	O
cell	O
polarity	O
of	O
epithelial	O
cells	O
in	O
species1s	O
Drosophila	O
species1e	O
;	O
however	O
,	O
its	O
role	O
in	O
arg1s	O
mammalian	O
arg1e	O
cardiomyocyte	O
polarity	O
is	O
not	O
clear	O
.	O
We	O
tested	O
the	O
hypothesis	O
that	O
gene1s	O
Rac1	O
gene1e	O
signaling	O
in	O
the	O
second	O
heart	O
field	O
regulates	O
cardiomyocyte	O
polarity	O
,	O
chamber	O
septation	O
,	O
and	O
right	O
ventricle	O
development	O
during	O
embryonic	O
heart	O
development	O
.	O
METHODS	O
AND	O
RESULTS	O
:	O
species1s	O
Mice	O
species1e	O
with	O
second	O
heart	O
field	O
-	O
specific	O
deficiency	O
of	O
gene1s	O
Rac1	O
gene1e	O
(	O
gene1s	O
Rac1	O
gene1e	O
(SHF	O
)	O
)	O
exhibited	O
ventricular	O
and	O
atrial	O
septal	O
defects	O
,	O
a	O
thinner	O
right	O
ventricle	O
myocardium	O
,	O
and	O
a	O
bifid	O
cardiac	O
apex	O
.	O
Fate	O
-	O
mapping	O
analysis	O
showed	O
that	O
second	O
heart	O
field	O
contribution	O
to	O
the	O
interventricular	O
septum	O
and	O
right	O
ventricle	O
was	O
deficient	O
in	O
gene1s	O
Rac1	O
gene1e	O
(SHF	O
)	O
hearts	O
.	O
Notably	O
,	O
cardiomyocytes	O
had	O
a	O
spherical	O
shape	O
with	O
disrupted	O
gene1s	O
F	O
-	O
actin	O
gene1e	O
filaments	O
in	O
gene1s	O
Rac1	O
gene1e	O
(SHF	O
)	O
compared	O
with	O
elongated	O
and	O
well	O
-	O
aligned	O
cardiomyocytes	O
in	O
littermate	O
controls	O
.	O
Expression	O
of	O
gene1s	O
Scrib	O
gene1e	O
,	O
a	O
core	O
protein	O
in	O
planar	O
cell	O
polarity	O
,	O
was	O
lost	O
in	O
gene1s	O
Rac1	O
gene1e	O
(SHF	O
)	O
hearts	O
with	O
decreased	O
expression	O
of	O
gene1s	O
WAVE	O
gene1e	O
and	O
gene1s	O
Arp2/3	O
gene1e	O
,	O
leading	O
to	O
decreased	O
migratory	O
ability	O
.	O
In	O
addition	O
,	O
gene1s	O
Rac1	O
gene1e	O
-deficient	O
neonatal	O
cardiomyocytes	O
displayed	O
defects	O
in	O
cell	O
projections	O
,	O
lamellipodia	O
formation	O
,	O
and	O
cell	O
elongation	O
.	O
Furthermore	O
,	O
apoptosis	O
was	O
increased	O
and	O
the	O
expression	O
of	O
gene1s	O
Gata4	O
gene1e	O
,	O
gene1s	O
Tbx5	O
gene1e	O
,	O
gene1s	O
Nkx2.5	O
gene1e	O
,	O
and	O
gene1s	O
Hand2	O
gene1e	O
transcription	O
factors	O
was	O
decreased	O
in	O
the	O
gene1s	O
Rac1	O
gene1e	O
(SHF	O
)	O
right	O
ventricle	O
myocardium	O
.	O
CONCLUSIONS	O
:	O
Deficiency	O
of	O
gene1s	O
Rac1	O
gene1e	O
in	O
the	O
second	O
heart	O
field	O
impairs	O
elongation	O
and	O
cytoskeleton	O
organization	O
of	O
cardiomyocytes	O
and	O
results	O
in	O
congenital	O
septal	O
defects	O
,	O
thin	O
right	O
ventricle	O
myocardium	O
,	O
and	O
a	O
bifid	O
cardiac	O
apex	O
.	O
Our	O
study	O
suggests	O
that	O
gene1s	O
Rac1	O
gene1e	O
signaling	O
is	O
critical	O
to	O
cardiomyocyte	O
polarity	O
and	O
embryonic	O
heart	O
development	O
.	O

gene1s	ARG2
Rac1	ARG2
gene1e	ARG2
signaling	O
is	O
critical	O
to	O
cardiomyocyte	O
polarity	O
and	O
embryonic	O
heart	O
development	O
.	O
BACKGROUND	O
:	O
Defects	O
in	O
cardiac	O
septation	O
are	O
the	O
most	O
common	O
form	O
of	O
congenital	O
heart	O
disease	O
,	O
but	O
the	O
mechanisms	O
underlying	O
these	O
defects	O
are	O
still	O
poorly	O
understood	O
.	O
The	O
gene1s	O
small	O
GTPase	O
gene1e	O
gene1s	O
Rac1	O
gene1e	O
is	O
implicated	O
in	O
planar	O
cell	O
polarity	O
of	O
epithelial	O
cells	O
in	O
species1s	O
Drosophila	O
species1e	O
;	O
however	O
,	O
its	O
role	O
in	O
species1s	O
mammalian	O
species1e	O
cardiomyocyte	O
polarity	O
is	O
not	O
clear	O
.	O
We	O
tested	O
the	O
hypothesis	O
that	O
gene1s	ARG2
Rac1	ARG2
gene1e	ARG2
signaling	O
in	O
the	O
second	O
heart	O
field	O
regulates	O
cardiomyocyte	O
polarity	O
,	O
chamber	O
septation	O
,	O
and	O
right	O
ventricle	O
development	O
during	O
embryonic	O
heart	O
development	O
.	O
METHODS	O
AND	O
RESULTS	O
:	O
arg1s	O
Mice	O
arg1e	O
with	O
second	O
heart	O
field	O
-	O
specific	O
deficiency	O
of	O
gene1s	ARG2
Rac1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Rac1	ARG2
gene1e	ARG2
(SHF	O
)	O
)	O
exhibited	O
ventricular	O
and	O
atrial	O
septal	O
defects	O
,	O
a	O
thinner	O
right	O
ventricle	O
myocardium	O
,	O
and	O
a	O
bifid	O
cardiac	O
apex	O
.	O
Fate	O
-	O
mapping	O
analysis	O
showed	O
that	O
second	O
heart	O
field	O
contribution	O
to	O
the	O
interventricular	O
septum	O
and	O
right	O
ventricle	O
was	O
deficient	O
in	O
gene1s	ARG2
Rac1	ARG2
gene1e	ARG2
(SHF	O
)	O
hearts	O
.	O
Notably	O
,	O
cardiomyocytes	O
had	O
a	O
spherical	O
shape	O
with	O
disrupted	O
gene1s	ARG2
F	ARG2
-	ARG2
actin	ARG2
gene1e	ARG2
filaments	O
in	O
gene1s	ARG2
Rac1	ARG2
gene1e	ARG2
(SHF	O
)	O
compared	O
with	O
elongated	O
and	O
well	O
-	O
aligned	O
cardiomyocytes	O
in	O
littermate	O
controls	O
.	O
Expression	O
of	O
gene1s	ARG2
Scrib	ARG2
gene1e	ARG2
,	O
a	O
core	O
protein	O
in	O
planar	O
cell	O
polarity	O
,	O
was	O
lost	O
in	O
gene1s	ARG2
Rac1	ARG2
gene1e	ARG2
(SHF	O
)	O
hearts	O
with	O
decreased	O
expression	O
of	O
gene1s	ARG2
WAVE	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Arp2/3	ARG2
gene1e	ARG2
,	O
leading	O
to	O
decreased	O
migratory	O
ability	O
.	O
In	O
addition	O
,	O
gene1s	ARG2
Rac1	ARG2
gene1e	ARG2
-deficient	O
neonatal	O
cardiomyocytes	O
displayed	O
defects	O
in	O
cell	O
projections	O
,	O
lamellipodia	O
formation	O
,	O
and	O
cell	O
elongation	O
.	O
Furthermore	O
,	O
apoptosis	O
was	O
increased	O
and	O
the	O
expression	O
of	O
gene1s	ARG2
Gata4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Tbx5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Nkx2.5	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Hand2	ARG2
gene1e	ARG2
transcription	O
factors	O
was	O
decreased	O
in	O
the	O
gene1s	ARG2
Rac1	ARG2
gene1e	ARG2
(SHF	O
)	O
right	O
ventricle	O
myocardium	O
.	O
CONCLUSIONS	O
:	O
Deficiency	O
of	O
gene1s	ARG2
Rac1	ARG2
gene1e	ARG2
in	O
the	O
second	O
heart	O
field	O
impairs	O
elongation	O
and	O
cytoskeleton	O
organization	O
of	O
cardiomyocytes	O
and	O
results	O
in	O
congenital	O
septal	O
defects	O
,	O
thin	O
right	O
ventricle	O
myocardium	O
,	O
and	O
a	O
bifid	O
cardiac	O
apex	O
.	O
Our	O
study	O
suggests	O
that	O
gene1s	ARG2
Rac1	ARG2
gene1e	ARG2
signaling	O
is	O
critical	O
to	O
cardiomyocyte	O
polarity	O
and	O
embryonic	O
heart	O
development	O
.	O

The	O
-930A	O
>	O
G	O
polymorphism	O
of	O
the	O
gene1s	ARG2
CYBA	ARG2
gene1e	ARG2
gene	O
is	O
associated	O
with	O
premature	O
coronary	O
artery	O
disease	O
.	O
A	O
case	O
-	O
control	O
study	O
and	O
gene	O
-	O
risk	O
factors	O
interactions	O
.	O
Reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
are	O
involved	O
in	O
the	O
pathogenesis	O
of	O
atherosclerosis	O
and	O
coronary	O
artery	O
disease	O
(	O
CAD	O
)	O
.	O
gene1s	ARG2
NADPH	ARG2
oxidases	ARG2
gene1e	ARG2
are	O
the	O
main	O
source	O
of	O
ROS	O
in	O
the	O
vasculature	O
.	O
gene1s	ARG2
p22phox	ARG2
gene1e	ARG2
is	O
a	O
critical	O
component	O
of	O
vascular	O
gene1s	ARG2
NADPH	ARG2
oxidases	ARG2
gene1e	ARG2
and	O
is	O
encoded	O
by	O
the	O
gene1s	ARG2
CYBA	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
cytochrome	ARG2
b245	ARG2
alpha	ARG2
gene1e	ARG2
)	O
gene	O
.	O
The	O
-930A	O
>	O
G	O
gene1s	ARG2
CYBA	ARG2
gene1e	ARG2
polymorphism	O
(	O
rs9932581	O
:	O
A	O
>	O
G	O
)	O
modulates	O
the	O
activity	O
of	O
the	O
gene1s	ARG2
CYBA	ARG2
gene1e	ARG2
promoter	O
,	O
and	O
influences	O
gene1s	ARG2
CYBA	ARG2
gene1e	ARG2
transcriptional	O
activity	O
.	O
The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
analyze	O
a	O
possible	O
association	O
between	O
the	O
-930A	O
>	O
G	O
polymorphism	O
and	O
CAD	O
and	O
to	O
search	O
for	O
gene	O
-	O
traditional	O
risk	O
factors	O
interactions	O
.	O
480	O
subjects	O
were	O
studied	O
:	O
240	O
arg1s	O
patients	O
arg1e	O
with	O
premature	O
CAD	O
,	O
240	O
age	O
and	O
sex	O
matched	O
blood	O
donors	O
.	O
The	O
-930A	O
>	O
G	O
polymorphism	O
was	O
genotyped	O
using	O
the	O
TaqMan	O
-	O
Pre	O
-	O
designed	O
SNP	O
Genotyping	O
Assay	O
(	O
Applied	O
Biosystems	O
)	O
.	O
The	O
-930	O
G	O
allele	O
carrier	O
state	O
was	O
a	O
risk	O
factor	O
for	O
CAD	O
(	O
OR	O
2.03	O
,	O
95	O
%	O
CI	O
1.21	O
-	O
3.44	O
,	O
P=0.007	O
)	O
.	O
A	O
synergistic	O
effect	O
of	O
the	O
-930	O
G	O
allele	O
with	O
overweight	O
/	O
obesity	O
(	O
BMI	O
--25	O
)	O
and	O
cigarette	O
smoking	O
was	O
found	O
.	O
The	O
estimated	O
CAD	O
risk	O
for	O
BMI	O
--25	O
and	O
the	O
-930	O
G	O
allele	O
interaction	O
was	O
about	O
160	O
%	O
greater	O
than	O
that	O
predicted	O
by	O
assuming	O
additivity	O
of	O
the	O
effects	O
,	O
and	O
about	O
40	O
%	O
greater	O
for	O
interaction	O
of	O
cigarette	O
smoking	O
and	O
the	O
-930	O
G	O
allele	O
.	O
Overweight	O
/	O
obesity	O
was	O
a	O
risk	O
factor	O
for	O
CAD	O
only	O
in	O
the	O
-930	O
G	O
allele	O
carriers	O
(	O
P<10(-10	O
)	O
)	O
but	O
not	O
in	O
the	O
AA	O
homozygotes	O
(	O
P=1.00	O
)	O
.	O
In	O
conclusion	O
the	O
-930A	O
>	O
G	O
gene1s	ARG2
CYBA	ARG2
gene1e	ARG2
polymorphism	O
is	O
associated	O
with	O
CAD	O
in	O
the	O
Polish	O
population	O
.	O
The	O
-930	O
G	O
allele	O
carriers	O
are	O
particularly	O
at	O
risk	O
of	O
consequences	O
of	O
obesity	O
and	O
species1s	O
tobacco	O
species1e	O
smoke	O
exposure	O
.	O

The	O
-930A	O
>	O
G	O
polymorphism	O
of	O
the	O
gene1s	O
CYBA	O
gene1e	O
gene	O
is	O
associated	O
with	O
premature	O
coronary	O
artery	O
disease	O
.	O
A	O
case	O
-	O
control	O
study	O
and	O
gene	O
-	O
risk	O
factors	O
interactions	O
.	O
Reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
are	O
involved	O
in	O
the	O
pathogenesis	O
of	O
atherosclerosis	O
and	O
coronary	O
artery	O
disease	O
(	O
CAD	O
)	O
.	O
gene1s	O
NADPH	O
oxidases	O
gene1e	O
are	O
the	O
main	O
source	O
of	O
ROS	O
in	O
the	O
vasculature	O
.	O
gene1s	O
p22phox	O
gene1e	O
is	O
a	O
critical	O
component	O
of	O
vascular	O
gene1s	O
NADPH	O
oxidases	O
gene1e	O
and	O
is	O
encoded	O
by	O
the	O
gene1s	O
CYBA	O
gene1e	O
(	O
gene1s	O
cytochrome	O
b245	O
alpha	O
gene1e	O
)	O
gene	O
.	O
The	O
-930A	O
>	O
G	O
gene1s	O
CYBA	O
gene1e	O
polymorphism	O
(	O
rs9932581	O
:	O
A	O
>	O
G	O
)	O
modulates	O
the	O
activity	O
of	O
the	O
gene1s	O
CYBA	O
gene1e	O
promoter	O
,	O
and	O
influences	O
gene1s	O
CYBA	O
gene1e	O
transcriptional	O
activity	O
.	O
The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
analyze	O
a	O
possible	O
association	O
between	O
the	O
-930A	O
>	O
G	O
polymorphism	O
and	O
CAD	O
and	O
to	O
search	O
for	O
gene	O
-	O
traditional	O
risk	O
factors	O
interactions	O
.	O
480	O
subjects	O
were	O
studied	O
:	O
240	O
species1s	O
patients	O
species1e	O
with	O
premature	O
CAD	O
,	O
240	O
age	O
and	O
sex	O
matched	O
blood	O
donors	O
.	O
The	O
-930A	O
>	O
G	O
polymorphism	O
was	O
genotyped	O
using	O
the	O
TaqMan	O
-	O
Pre	O
-	O
designed	O
SNP	O
Genotyping	O
Assay	O
(	O
Applied	O
Biosystems	O
)	O
.	O
The	O
-930	O
G	O
allele	O
carrier	O
state	O
was	O
a	O
risk	O
factor	O
for	O
CAD	O
(	O
OR	O
2.03	O
,	O
95	O
%	O
CI	O
1.21	O
-	O
3.44	O
,	O
P=0.007	O
)	O
.	O
A	O
synergistic	O
effect	O
of	O
the	O
-930	O
G	O
allele	O
with	O
overweight	O
/	O
obesity	O
(	O
BMI	O
--25	O
)	O
and	O
cigarette	O
smoking	O
was	O
found	O
.	O
The	O
estimated	O
CAD	O
risk	O
for	O
BMI	O
--25	O
and	O
the	O
-930	O
G	O
allele	O
interaction	O
was	O
about	O
160	O
%	O
greater	O
than	O
that	O
predicted	O
by	O
assuming	O
additivity	O
of	O
the	O
effects	O
,	O
and	O
about	O
40	O
%	O
greater	O
for	O
interaction	O
of	O
cigarette	O
smoking	O
and	O
the	O
-930	O
G	O
allele	O
.	O
Overweight	O
/	O
obesity	O
was	O
a	O
risk	O
factor	O
for	O
CAD	O
only	O
in	O
the	O
-930	O
G	O
allele	O
carriers	O
(	O
P<10(-10	O
)	O
)	O
but	O
not	O
in	O
the	O
AA	O
homozygotes	O
(	O
P=1.00	O
)	O
.	O
In	O
conclusion	O
the	O
-930A	O
>	O
G	O
gene1s	O
CYBA	O
gene1e	O
polymorphism	O
is	O
associated	O
with	O
CAD	O
in	O
the	O
Polish	O
population	O
.	O
The	O
-930	O
G	O
allele	O
carriers	O
are	O
particularly	O
at	O
risk	O
of	O
consequences	O
of	O
obesity	O
and	O
arg1s	O
tobacco	O
arg1e	O
smoke	O
exposure	O
.	O

Aberrant	O
gene1s	ARG2
Mer	ARG2
receptor	ARG2
tyrosine	ARG2
kinase	ARG2
gene1e	ARG2
expression	O
contributes	O
to	O
leukemogenesis	O
in	O
acute	O
myeloid	O
leukemia	O
.	O
Acute	O
myeloid	O
leukemia	O
(	O
AML	O
)	O
continues	O
to	O
be	O
extremely	O
difficult	O
to	O
treat	O
successfully	O
,	O
and	O
the	O
unacceptably	O
low	O
overall	O
survival	O
rates	O
mandate	O
that	O
we	O
assess	O
new	O
potential	O
therapies	O
to	O
ameliorate	O
poor	O
clinical	O
response	O
to	O
conventional	O
therapy	O
.	O
Abnormal	O
gene1s	ARG2
tyrosine	ARG2
kinase	ARG2
gene1e	ARG2
activation	O
in	O
AML	O
has	O
been	O
associated	O
with	O
poor	O
prognosis	O
and	O
provides	O
strategic	O
targets	O
for	O
novel	O
therapy	O
development	O
.	O
We	O
found	O
that	O
gene1s	ARG2
Mer	ARG2
receptor	ARG2
tyrosine	ARG2
kinase	ARG2
gene1e	ARG2
was	O
over	O
-	O
expressed	O
in	O
a	O
majority	O
of	O
pediatric	O
(	O
29/36	O
,	O
80	O
%	O
)	O
and	O
adult	O
(	O
10/10	O
,	O
100	O
%	O
)	O
primary	O
AML	O
arg1s	O
patient	O
arg1e	O
blasts	O
at	O
the	O
time	O
of	O
diagnosis	O
,	O
and	O
100	O
%	O
of	O
arg1s	O
patient	O
arg1e	O
samples	O
at	O
the	O
time	O
of	O
relapse	O
.	O
gene1s	ARG2
Mer	ARG2
gene1e	ARG2
was	O
also	O
found	O
to	O
be	O
expressed	O
in	O
12	O
of	O
14	O
AML	O
cell	O
lines	O
(	O
86	O
%	O
)	O
.	O
In	O
contrast	O
,	O
normal	O
bone	O
marrow	O
myeloid	O
precursors	O
expressed	O
little	O
to	O
no	O
gene1s	ARG2
Mer	ARG2
gene1e	ARG2
.	O
Following	O
AML	O
cell	O
line	O
stimulation	O
with	O
gene1s	ARG2
Gas6	ARG2
gene1e	ARG2
,	O
a	O
gene1s	ARG2
Mer	ARG2
ligand	ARG2
gene1e	ARG2
,	O
we	O
observed	O
activation	O
of	O
prosurvival	O
and	O
proliferative	O
signaling	O
pathways	O
,	O
including	O
phosphorylation	O
of	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
p38	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MSK1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CREB	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ATF1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
STAT6	ARG2
gene1e	ARG2
.	O
To	O
assess	O
the	O
phenotypic	O
role	O
of	O
gene1s	ARG2
Mer	ARG2
gene1e	ARG2
in	O
AML	O
,	O
two	O
independent	O
short	O
-	O
hairpin	O
RNA	O
(	O
shRNA	O
)	O
constructs	O
were	O
used	O
to	O
decrease	O
gene1s	ARG2
Mer	ARG2
gene1e	ARG2
expression	O
in	O
the	O
AML	O
cell	O
lines	O
Nomo-1	O
and	O
Kasumi-1	O
.	O
Reduction	O
of	O
gene1s	ARG2
Mer	ARG2
gene1e	ARG2
protein	O
levels	O
significantly	O
increased	O
rates	O
of	O
myeloblast	O
apoptosis	O
two	O
to	O
threefold	O
in	O
response	O
to	O
serum	O
starvation	O
.	O
Furthermore	O
,	O
myeloblasts	O
with	O
knocked	O
-	O
down	O
gene1s	ARG2
Mer	ARG2
gene1e	ARG2
demonstrated	O
decreased	O
colony	O
formation	O
by	O
67	O
-	O
87	O
%	O
,	O
relative	O
to	O
control	O
cell	O
lines	O
(	O
P<0.01	O
)	O
.	O
NOD	O
-	O
SCID	O
-	O
gamma	O
species1s	O
mice	O
species1e	O
transplanted	O
with	O
Nomo-1	O
myeloblasts	O
with	O
reduced	O
levels	O
of	O
gene1s	ARG2
Mer	ARG2
gene1e	ARG2
had	O
a	O
significant	O
prolongation	O
in	O
survival	O
compared	O
with	O
species1s	O
mice	O
species1e	O
transplanted	O
with	O
the	O
parental	O
or	O
control	O
cell	O
lines	O
(	O
median	O
survival	O
17	O
days	O
in	O
parental	O
and	O
control	O
cell	O
lines	O
,	O
versus	O
32	O
-	O
36	O
days	O
in	O
gene1s	ARG2
Mer	ARG2
gene1e	ARG2
knockdown	O
cell	O
lines	O
,	O
P<0.0001	O
)	O
.	O
These	O
data	O
suggest	O
a	O
role	O
for	O
gene1s	ARG2
Mer	ARG2
gene1e	ARG2
in	O
acute	O
myeloid	O
leukemogenesis	O
and	O
indicate	O
that	O
targeted	O
inhibition	O
of	O
gene1s	ARG2
Mer	ARG2
gene1e	ARG2
may	O
be	O
an	O
effective	O
therapeutic	O
strategy	O
in	O
pediatric	O
and	O
adult	O
AML	O
.	O

Aberrant	O
gene1s	O
Mer	O
receptor	O
tyrosine	O
kinase	O
gene1e	O
expression	O
contributes	O
to	O
leukemogenesis	O
in	O
acute	O
myeloid	O
leukemia	O
.	O
Acute	O
myeloid	O
leukemia	O
(	O
AML	O
)	O
continues	O
to	O
be	O
extremely	O
difficult	O
to	O
treat	O
successfully	O
,	O
and	O
the	O
unacceptably	O
low	O
overall	O
survival	O
rates	O
mandate	O
that	O
we	O
assess	O
new	O
potential	O
therapies	O
to	O
ameliorate	O
poor	O
clinical	O
response	O
to	O
conventional	O
therapy	O
.	O
Abnormal	O
gene1s	O
tyrosine	O
kinase	O
gene1e	O
activation	O
in	O
AML	O
has	O
been	O
associated	O
with	O
poor	O
prognosis	O
and	O
provides	O
strategic	O
targets	O
for	O
novel	O
therapy	O
development	O
.	O
We	O
found	O
that	O
gene1s	O
Mer	O
receptor	O
tyrosine	O
kinase	O
gene1e	O
was	O
over	O
-	O
expressed	O
in	O
a	O
majority	O
of	O
pediatric	O
(	O
29/36	O
,	O
80	O
%	O
)	O
and	O
adult	O
(	O
10/10	O
,	O
100	O
%	O
)	O
primary	O
AML	O
species1s	O
patient	O
species1e	O
blasts	O
at	O
the	O
time	O
of	O
diagnosis	O
,	O
and	O
100	O
%	O
of	O
species1s	O
patient	O
species1e	O
samples	O
at	O
the	O
time	O
of	O
relapse	O
.	O
gene1s	O
Mer	O
gene1e	O
was	O
also	O
found	O
to	O
be	O
expressed	O
in	O
12	O
of	O
14	O
AML	O
cell	O
lines	O
(	O
86	O
%	O
)	O
.	O
In	O
contrast	O
,	O
normal	O
bone	O
marrow	O
myeloid	O
precursors	O
expressed	O
little	O
to	O
no	O
gene1s	O
Mer	O
gene1e	O
.	O
Following	O
AML	O
cell	O
line	O
stimulation	O
with	O
gene1s	O
Gas6	O
gene1e	O
,	O
a	O
gene1s	O
Mer	O
ligand	O
gene1e	O
,	O
we	O
observed	O
activation	O
of	O
prosurvival	O
and	O
proliferative	O
signaling	O
pathways	O
,	O
including	O
phosphorylation	O
of	O
gene1s	O
ERK1/2	O
gene1e	O
,	O
gene1s	O
p38	O
gene1e	O
,	O
gene1s	O
MSK1	O
gene1e	O
,	O
gene1s	O
CREB	O
gene1e	O
,	O
gene1s	O
ATF1	O
gene1e	O
,	O
gene1s	O
AKT	O
gene1e	O
and	O
gene1s	O
STAT6	O
gene1e	O
.	O
To	O
assess	O
the	O
phenotypic	O
role	O
of	O
gene1s	O
Mer	O
gene1e	O
in	O
AML	O
,	O
two	O
independent	O
short	O
-	O
hairpin	O
RNA	O
(	O
shRNA	O
)	O
constructs	O
were	O
used	O
to	O
decrease	O
gene1s	O
Mer	O
gene1e	O
expression	O
in	O
the	O
AML	O
cell	O
lines	O
Nomo-1	O
and	O
Kasumi-1	O
.	O
Reduction	O
of	O
gene1s	O
Mer	O
gene1e	O
protein	O
levels	O
significantly	O
increased	O
rates	O
of	O
myeloblast	O
apoptosis	O
two	O
to	O
threefold	O
in	O
response	O
to	O
serum	O
starvation	O
.	O
Furthermore	O
,	O
myeloblasts	O
with	O
knocked	O
-	O
down	O
gene1s	O
Mer	O
gene1e	O
demonstrated	O
decreased	O
colony	O
formation	O
by	O
67	O
-	O
87	O
%	O
,	O
relative	O
to	O
control	O
cell	O
lines	O
(	O
P<0.01	O
)	O
.	O
NOD	O
-	O
SCID	O
-	O
gamma	O
arg1s	O
mice	O
arg1e	O
transplanted	O
with	O
Nomo-1	O
myeloblasts	O
with	O
reduced	O
levels	O
of	O
gene1s	O
Mer	O
gene1e	O
had	O
a	O
significant	O
prolongation	O
in	O
survival	O
compared	O
with	O
arg1s	O
mice	O
arg1e	O
transplanted	O
with	O
the	O
parental	O
or	O
control	O
cell	O
lines	O
(	O
median	O
survival	O
17	O
days	O
in	O
parental	O
and	O
control	O
cell	O
lines	O
,	O
versus	O
32	O
-	O
36	O
days	O
in	O
gene1s	O
Mer	O
gene1e	O
knockdown	O
cell	O
lines	O
,	O
P<0.0001	O
)	O
.	O
These	O
data	O
suggest	O
a	O
role	O
for	O
gene1s	O
Mer	O
gene1e	O
in	O
acute	O
myeloid	O
leukemogenesis	O
and	O
indicate	O
that	O
targeted	O
inhibition	O
of	O
gene1s	O
Mer	O
gene1e	O
may	O
be	O
an	O
effective	O
therapeutic	O
strategy	O
in	O
pediatric	O
and	O
adult	O
AML	O
.	O

Blocking	O
of	O
gene1s	ARG2
ERK1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ERK2	ARG2
gene1e	ARG2
sensitizes	O
arg1s	O
human	O
arg1e	O
mesothelioma	O
cells	O
to	O
doxorubicin	O
.	O
BACKGROUND	O
:	O
Malignant	O
mesotheliomas	O
(	O
MM	O
)	O
have	O
a	O
poor	O
prognosis	O
,	O
largely	O
because	O
of	O
their	O
chemoresistance	O
to	O
anti	O
-	O
cancer	O
drugs	O
such	O
as	O
doxorubicin	O
(	O
Dox	O
)	O
.	O
Here	O
we	O
show	O
using	O
arg1s	O
human	O
arg1e	O
MM	O
lines	O
that	O
Dox	O
activates	O
gene1s	ARG2
extracellular	ARG2
signal	ARG2
-	ARG2
regulated	ARG2
kinases	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ERK1	ARG2
and	ARG2
2	ARG2
gene1e	ARG2
)	O
,	O
causally	O
linked	O
to	O
increased	O
expression	O
of	O
ABC	O
transporter	O
genes	O
,	O
decreased	O
accumulation	O
of	O
Dox	O
,	O
and	O
enhanced	O
MM	O
growth	O
.	O
Using	O
the	O
gene1s	ARG2
MEK1/2	ARG2
gene1e	ARG2
inhibitor	O
,	O
U0126	O
and	O
stably	O
transfected	O
gene1s	ARG2
shERK1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
shERK2	ARG2
gene1e	ARG2
MM	O
cell	O
lines	O
,	O
we	O
show	O
that	O
inhibition	O
of	O
both	O
gene1s	ARG2
ERK1	ARG2
and	ARG2
2	ARG2
gene1e	ARG2
sensitizes	O
MM	O
cells	O
to	O
Dox	O
.	O
RESULTS	O
:	O
U0126	O
significantly	O
modulated	O
endogenous	O
expression	O
of	O
several	O
important	O
drug	O
resistance	O
(	O
gene1s	ARG2
BCL2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ABCB1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ABCC3	ARG2
gene1e	ARG2
)	O
,	O
prosurvival	O
(	O
gene1s	ARG2
BCL2	ARG2
gene1e	ARG2
)	O
,	O
DNA	O
repair	O
(	O
gene1s	ARG2
BRCA1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
BRCA2	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
hormone	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
AR	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ESR2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PPARgamma	ARG2
gene1e	ARG2
)	O
and	O
drug	O
metabolism	O
(	O
gene1s	ARG2
CYP3A4	ARG2
gene1e	ARG2
)	O
genes	O
newly	O
identified	O
in	O
MM	O
cells	O
.	O
In	O
comparison	O
to	O
shControl	O
lines	O
,	O
MM	O
cell	O
lines	O
stably	O
transfected	O
with	O
gene1s	ARG2
shERK1	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
shERK2	ARG2
gene1e	ARG2
exhibited	O
significant	O
increases	O
in	O
intracellular	O
accumulation	O
of	O
Dox	O
and	O
decreases	O
in	O
cell	O
viability	O
.	O
Affymetrix	O
microarray	O
analysis	O
on	O
stable	O
gene1s	ARG2
shERK1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
shERK2	ARG2
gene1e	ARG2
MM	O
lines	O
showed	O
more	O
than	O
2-fold	O
inhibition	O
(	O
p	O
<	O
=	O
0.05	O
)	O
of	O
expression	O
of	O
gene1s	ARG2
ATP	ARG2
binding	ARG2
cassette	ARG2
gene1e	ARG2
genes	O
(	O
gene1s	ARG2
ABCG1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ABCA5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ABCA2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MDR	ARG2
/	ARG2
TAP	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ABCA1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ABCA8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ABCC2	ARG2
gene1e	ARG2
)	O
in	O
comparison	O
to	O
shControl	O
lines	O
.	O
Moreover	O
,	O
injection	O
of	O
arg1s	O
human	O
arg1e	O
MM	O
lines	O
into	O
SCID	O
species1s	O
mice	O
species1e	O
showed	O
that	O
stable	O
gene1s	ARG2
shERK1	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
shERK2	ARG2
gene1e	ARG2
lines	O
had	O
significantly	O
slower	O
tumor	O
growth	O
rates	O
in	O
comparison	O
to	O
shControl	O
lines	O
after	O
Dox	O
treatment	O
.	O
CONCLUSIONS	O
:	O
These	O
studies	O
suggest	O
that	O
blocking	O
gene1s	ARG2
ERK1	ARG2
and	ARG2
2	ARG2
gene1e	ARG2
,	O
which	O
play	O
critical	O
roles	O
in	O
multi	O
-	O
drug	O
resistance	O
and	O
survival	O
,	O
may	O
be	O
beneficial	O
in	O
combination	O
with	O
chemotherapeutic	O
drugs	O
in	O
the	O
treatment	O
of	O
MMs	O
and	O
other	O
tumors	O
.	O

Blocking	O
of	O
gene1s	O
ERK1	O
gene1e	O
and	O
gene1s	O
ERK2	O
gene1e	O
sensitizes	O
species1s	O
human	O
species1e	O
mesothelioma	O
cells	O
to	O
doxorubicin	O
.	O
BACKGROUND	O
:	O
Malignant	O
mesotheliomas	O
(	O
MM	O
)	O
have	O
a	O
poor	O
prognosis	O
,	O
largely	O
because	O
of	O
their	O
chemoresistance	O
to	O
anti	O
-	O
cancer	O
drugs	O
such	O
as	O
doxorubicin	O
(	O
Dox	O
)	O
.	O
Here	O
we	O
show	O
using	O
species1s	O
human	O
species1e	O
MM	O
lines	O
that	O
Dox	O
activates	O
gene1s	O
extracellular	O
signal	O
-	O
regulated	O
kinases	O
gene1e	O
(	O
gene1s	O
ERK1	O
and	O
2	O
gene1e	O
)	O
,	O
causally	O
linked	O
to	O
increased	O
expression	O
of	O
ABC	O
transporter	O
genes	O
,	O
decreased	O
accumulation	O
of	O
Dox	O
,	O
and	O
enhanced	O
MM	O
growth	O
.	O
Using	O
the	O
gene1s	O
MEK1/2	O
gene1e	O
inhibitor	O
,	O
U0126	O
and	O
stably	O
transfected	O
gene1s	O
shERK1	O
gene1e	O
and	O
gene1s	O
shERK2	O
gene1e	O
MM	O
cell	O
lines	O
,	O
we	O
show	O
that	O
inhibition	O
of	O
both	O
gene1s	O
ERK1	O
and	O
2	O
gene1e	O
sensitizes	O
MM	O
cells	O
to	O
Dox	O
.	O
RESULTS	O
:	O
U0126	O
significantly	O
modulated	O
endogenous	O
expression	O
of	O
several	O
important	O
drug	O
resistance	O
(	O
gene1s	O
BCL2	O
gene1e	O
,	O
gene1s	O
ABCB1	O
gene1e	O
,	O
gene1s	O
ABCC3	O
gene1e	O
)	O
,	O
prosurvival	O
(	O
gene1s	O
BCL2	O
gene1e	O
)	O
,	O
DNA	O
repair	O
(	O
gene1s	O
BRCA1	O
gene1e	O
,	O
gene1s	O
BRCA2	O
gene1e	O
)	O
,	O
gene1s	O
hormone	O
receptor	O
gene1e	O
(	O
gene1s	O
AR	O
gene1e	O
,	O
gene1s	O
ESR2	O
gene1e	O
,	O
gene1s	O
PPARgamma	O
gene1e	O
)	O
and	O
drug	O
metabolism	O
(	O
gene1s	O
CYP3A4	O
gene1e	O
)	O
genes	O
newly	O
identified	O
in	O
MM	O
cells	O
.	O
In	O
comparison	O
to	O
shControl	O
lines	O
,	O
MM	O
cell	O
lines	O
stably	O
transfected	O
with	O
gene1s	O
shERK1	O
gene1e	O
or	O
gene1s	O
shERK2	O
gene1e	O
exhibited	O
significant	O
increases	O
in	O
intracellular	O
accumulation	O
of	O
Dox	O
and	O
decreases	O
in	O
cell	O
viability	O
.	O
Affymetrix	O
microarray	O
analysis	O
on	O
stable	O
gene1s	O
shERK1	O
gene1e	O
and	O
gene1s	O
shERK2	O
gene1e	O
MM	O
lines	O
showed	O
more	O
than	O
2-fold	O
inhibition	O
(	O
p	O
<	O
=	O
0.05	O
)	O
of	O
expression	O
of	O
gene1s	O
ATP	O
binding	O
cassette	O
gene1e	O
genes	O
(	O
gene1s	O
ABCG1	O
gene1e	O
,	O
gene1s	O
ABCA5	O
gene1e	O
,	O
gene1s	O
ABCA2	O
gene1e	O
,	O
gene1s	O
MDR	O
/	O
TAP	O
gene1e	O
,	O
gene1s	O
ABCA1	O
gene1e	O
,	O
gene1s	O
ABCA8	O
gene1e	O
,	O
gene1s	O
ABCC2	O
gene1e	O
)	O
in	O
comparison	O
to	O
shControl	O
lines	O
.	O
Moreover	O
,	O
injection	O
of	O
species1s	O
human	O
species1e	O
MM	O
lines	O
into	O
SCID	O
arg1s	O
mice	O
arg1e	O
showed	O
that	O
stable	O
gene1s	O
shERK1	O
gene1e	O
or	O
gene1s	O
shERK2	O
gene1e	O
lines	O
had	O
significantly	O
slower	O
tumor	O
growth	O
rates	O
in	O
comparison	O
to	O
shControl	O
lines	O
after	O
Dox	O
treatment	O
.	O
CONCLUSIONS	O
:	O
These	O
studies	O
suggest	O
that	O
blocking	O
gene1s	O
ERK1	O
and	O
2	O
gene1e	O
,	O
which	O
play	O
critical	O
roles	O
in	O
multi	O
-	O
drug	O
resistance	O
and	O
survival	O
,	O
may	O
be	O
beneficial	O
in	O
combination	O
with	O
chemotherapeutic	O
drugs	O
in	O
the	O
treatment	O
of	O
MMs	O
and	O
other	O
tumors	O
.	O

gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
inhibitor	O
PF-04691502	O
antitumor	O
activity	O
is	O
enhanced	O
with	O
induction	O
of	O
wild	O
-	O
type	O
gene1s	ARG2
TP53	ARG2
gene1e	ARG2
in	O
arg1s	O
human	O
arg1e	O
xenograft	O
and	O
species1s	O
murine	O
species1e	O
knockout	O
models	O
of	O
head	O
and	O
neck	O
cancer	O
.	O
PURPOSE	O
:	O
gene1s	ARG2
Phosphoinositide	ARG2
3-kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
)/	O
gene1s	ARG2
mammalian	ARG2
target	ARG2
of	ARG2
rapamycin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
)	O
pathway	O
activation	O
is	O
often	O
associated	O
with	O
altered	O
expression	O
or	O
mutations	O
of	O
gene1s	ARG2
PIK3CA	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TP53	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
p73	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PTEN	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
TGF	ARG2
-	ARG2
beta	ARG2
receptors	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TGFBR	ARG2
gene1e	ARG2
)	O
in	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinomas	O
(	O
HNSCC	O
)	O
.	O
However	O
,	O
little	O
is	O
known	O
about	O
how	O
these	O
alterations	O
affect	O
response	O
to	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
-	O
targeted	O
agents	O
.	O
EXPERIMENTAL	O
DESIGN	O
:	O
In	O
this	O
preclinical	O
study	O
,	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
signaling	O
was	O
characterized	O
in	O
nine	O
HNSCC	O
(	O
UM	O
-	O
SCC	O
)	O
cell	O
lines	O
and	O
arg1s	O
human	O
arg1e	O
oral	O
keratinocytes	O
.	O
We	O
investigated	O
the	O
molecular	O
and	O
anticancer	O
effects	O
of	O
dual	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
inhibitor	O
PF-04691502(PF-502	O
)	O
in	O
UM	O
-	O
SCC	O
expressing	O
gene1s	ARG2
PIK3CA	ARG2
gene1e	ARG2
with	O
decreased	O
wild	O
-	O
type	O
gene1s	ARG2
TP53	ARG2
gene1e	ARG2
,	O
mutant	O
gene1s	ARG2
TP53	ARG2
gene1e	ARG2
-/+	O
mutant	O
gene1s	ARG2
TGFBR2	ARG2
gene1e	ARG2
,	O
and	O
in	O
HNSCC	O
of	O
a	O
conditional	O
gene1s	O
Pten	O
gene1e	O
/	O
gene1s	O
Tgfbr1	O
gene1e	O
double	O
knockout	O
species1s	O
mouse	O
species1e	O
model	O
displaying	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
/	O
gene1s	O
mTOR	O
gene1e	O
activation	O
.	O
RESULTS	O
:	O
UM	O
-	O
SCC	O
showed	O
increased	O
gene1s	ARG2
PIK3CA	ARG2
gene1e	ARG2
expression	O
and	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
activation	O
,	O
and	O
PF-502	O
inhibited	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
mTORC1/2	ARG2
gene1e	ARG2
targets	O
.	O
In	O
arg1s	O
human	O
arg1e	O
HNSCC	O
expressing	O
gene1s	ARG2
PIK3CA	ARG2
gene1e	ARG2
and	O
decreased	O
wt	O
gene1s	ARG2
TP53	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p73	ARG2
gene1e	ARG2
,	O
PF-502	O
reciprocally	O
enhanced	O
gene1s	ARG2
TP53	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
p73	ARG2
gene1e	ARG2
expression	O
and	O
growth	O
inhibition	O
,	O
which	O
was	O
partially	O
reversible	O
by	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
inhibitor	O
pifithrin	O
-	O
alpha	O
.	O
Most	O
UM	O
-	O
SCC	O
with	O
wt	O
gene1s	ARG2
TP53	ARG2
gene1e	ARG2
exhibited	O
a	O
lower	O
IC50	O
than	O
those	O
with	O
mt	O
gene1s	ARG2
TP53	ARG2
gene1e	ARG2
status	O
.	O
PF-502	O
blocked	O
growth	O
in	O
G0-G1	O
and	O
increased	O
apoptotic	O
sub	O
-	O
G0	O
DNA	O
.	O
PF-502	O
suppressed	O
tumorigenesis	O
and	O
showed	O
combinatorial	O
activity	O
with	O
radiation	O
in	O
a	O
wild	O
-	O
type	O
gene1s	ARG2
TP53	ARG2
gene1e	ARG2
UM	O
-	O
SCC	O
xenograft	O
model	O
.	O
PF-502	O
also	O
significantly	O
delayed	O
HNSCC	O
tumorigenesis	O
and	O
prolonged	O
survival	O
of	O
gene1s	O
Pten	O
gene1e	O
/	O
gene1s	O
Tgfbr1	O
gene1e	O
-deficient	O
species1s	O
mice	O
species1e	O
.	O
Significant	O
inhibition	O
of	O
p	O
-	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
,	O
p-	O
gene1s	ARG2
4EBP1	ARG2
gene1e	ARG2
,	O
p	O
-	O
gene1s	ARG2
S6	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Ki67	ARG2
gene1e	ARG2
,	O
as	O
well	O
as	O
increased	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
and	O
TUNEL	O
were	O
observed	O
in	O
tumor	O
specimens	O
.	O
CONCLUSIONS	O
:	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
inhibition	O
can	O
enhance	O
gene1s	ARG2
TP53	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
p73	ARG2
gene1e	ARG2
expression	O
and	O
significantly	O
inhibit	O
tumor	O
growth	O
alone	O
or	O
when	O
combined	O
with	O
radiation	O
in	O
HNSCC	O
with	O
wild	O
-	O
type	O
gene1s	ARG2
TP53	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
PIK3CA	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TP53	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
p73	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PTEN	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
TGF	ARG2
-	ARG2
beta	ARG2
gene1e	ARG2
alterations	O
are	O
potential	O
modifiers	O
of	O
response	O
and	O
merit	O
investigation	O
in	O
future	O
clinical	O
trials	O
with	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
inhibitors	O
.	O

gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
mTOR	O
gene1e	O
inhibitor	O
PF-04691502	O
antitumor	O
activity	O
is	O
enhanced	O
with	O
induction	O
of	O
wild	O
-	O
type	O
gene1s	O
TP53	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
xenograft	O
and	O
arg1s	O
murine	O
arg1e	O
knockout	O
models	O
of	O
head	O
and	O
neck	O
cancer	O
.	O
PURPOSE	O
:	O
gene1s	O
Phosphoinositide	O
3-kinase	O
gene1e	O
(	O
gene1s	O
PI3K	O
gene1e	O
)/	O
gene1s	O
mammalian	O
target	O
of	O
rapamycin	O
gene1e	O
(	O
gene1s	O
mTOR	O
gene1e	O
)	O
pathway	O
activation	O
is	O
often	O
associated	O
with	O
altered	O
expression	O
or	O
mutations	O
of	O
gene1s	O
PIK3CA	O
gene1e	O
,	O
gene1s	O
TP53	O
gene1e	O
/	O
gene1s	O
p73	O
gene1e	O
,	O
gene1s	O
PTEN	O
gene1e	O
,	O
and	O
gene1s	ARG2
TGF	ARG2
-	ARG2
beta	ARG2
receptors	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TGFBR	ARG2
gene1e	ARG2
)	O
in	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinomas	O
(	O
HNSCC	O
)	O
.	O
However	O
,	O
little	O
is	O
known	O
about	O
how	O
these	O
alterations	O
affect	O
response	O
to	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
mTOR	O
gene1e	O
-	O
targeted	O
agents	O
.	O
EXPERIMENTAL	O
DESIGN	O
:	O
In	O
this	O
preclinical	O
study	O
,	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
/	O
gene1s	O
mTOR	O
gene1e	O
signaling	O
was	O
characterized	O
in	O
nine	O
HNSCC	O
(	O
UM	O
-	O
SCC	O
)	O
cell	O
lines	O
and	O
species1s	O
human	O
species1e	O
oral	O
keratinocytes	O
.	O
We	O
investigated	O
the	O
molecular	O
and	O
anticancer	O
effects	O
of	O
dual	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
mTOR	O
gene1e	O
inhibitor	O
PF-04691502(PF-502	O
)	O
in	O
UM	O
-	O
SCC	O
expressing	O
gene1s	O
PIK3CA	O
gene1e	O
with	O
decreased	O
wild	O
-	O
type	O
gene1s	O
TP53	O
gene1e	O
,	O
mutant	O
gene1s	O
TP53	O
gene1e	O
-/+	O
mutant	O
gene1s	O
TGFBR2	O
gene1e	O
,	O
and	O
in	O
HNSCC	O
of	O
a	O
conditional	O
gene1s	ARG2
Pten	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Tgfbr1	ARG2
gene1e	ARG2
double	O
knockout	O
arg1s	O
mouse	O
arg1e	O
model	O
displaying	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
activation	O
.	O
RESULTS	O
:	O
UM	O
-	O
SCC	O
showed	O
increased	O
gene1s	O
PIK3CA	O
gene1e	O
expression	O
and	O
gene1s	O
Akt	O
gene1e	O
/	O
gene1s	O
mTOR	O
gene1e	O
activation	O
,	O
and	O
PF-502	O
inhibited	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
mTORC1/2	O
gene1e	O
targets	O
.	O
In	O
species1s	O
human	O
species1e	O
HNSCC	O
expressing	O
gene1s	O
PIK3CA	O
gene1e	O
and	O
decreased	O
wt	O
gene1s	O
TP53	O
gene1e	O
and	O
gene1s	O
p73	O
gene1e	O
,	O
PF-502	O
reciprocally	O
enhanced	O
gene1s	O
TP53	O
gene1e	O
/	O
gene1s	O
p73	O
gene1e	O
expression	O
and	O
growth	O
inhibition	O
,	O
which	O
was	O
partially	O
reversible	O
by	O
gene1s	O
p53	O
gene1e	O
inhibitor	O
pifithrin	O
-	O
alpha	O
.	O
Most	O
UM	O
-	O
SCC	O
with	O
wt	O
gene1s	O
TP53	O
gene1e	O
exhibited	O
a	O
lower	O
IC50	O
than	O
those	O
with	O
mt	O
gene1s	O
TP53	O
gene1e	O
status	O
.	O
PF-502	O
blocked	O
growth	O
in	O
G0-G1	O
and	O
increased	O
apoptotic	O
sub	O
-	O
G0	O
DNA	O
.	O
PF-502	O
suppressed	O
tumorigenesis	O
and	O
showed	O
combinatorial	O
activity	O
with	O
radiation	O
in	O
a	O
wild	O
-	O
type	O
gene1s	O
TP53	O
gene1e	O
UM	O
-	O
SCC	O
xenograft	O
model	O
.	O
PF-502	O
also	O
significantly	O
delayed	O
HNSCC	O
tumorigenesis	O
and	O
prolonged	O
survival	O
of	O
gene1s	ARG2
Pten	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Tgfbr1	ARG2
gene1e	ARG2
-deficient	O
arg1s	O
mice	O
arg1e	O
.	O
Significant	O
inhibition	O
of	O
p	O
-	O
gene1s	O
Akt	O
gene1e	O
,	O
p-	O
gene1s	O
4EBP1	O
gene1e	O
,	O
p	O
-	O
gene1s	O
S6	O
gene1e	O
,	O
and	O
gene1s	O
Ki67	O
gene1e	O
,	O
as	O
well	O
as	O
increased	O
gene1s	O
p53	O
gene1e	O
and	O
TUNEL	O
were	O
observed	O
in	O
tumor	O
specimens	O
.	O
CONCLUSIONS	O
:	O
gene1s	O
PI3K	O
gene1e	O
-	O
gene1s	O
mTOR	O
gene1e	O
inhibition	O
can	O
enhance	O
gene1s	O
TP53	O
gene1e	O
/	O
gene1s	O
p73	O
gene1e	O
expression	O
and	O
significantly	O
inhibit	O
tumor	O
growth	O
alone	O
or	O
when	O
combined	O
with	O
radiation	O
in	O
HNSCC	O
with	O
wild	O
-	O
type	O
gene1s	O
TP53	O
gene1e	O
.	O
gene1s	O
PIK3CA	O
gene1e	O
,	O
gene1s	O
TP53	O
gene1e	O
/	O
gene1s	O
p73	O
gene1e	O
,	O
gene1s	O
PTEN	O
gene1e	O
,	O
and	O
gene1s	O
TGF	O
-	O
beta	O
gene1e	O
alterations	O
are	O
potential	O
modifiers	O
of	O
response	O
and	O
merit	O
investigation	O
in	O
future	O
clinical	O
trials	O
with	O
gene1s	O
PI3K	O
gene1e	O
-	O
gene1s	O
mTOR	O
gene1e	O
inhibitors	O
.	O

gene1s	O
NOTCH1	O
gene1e	O
and	O
gene1s	O
SOX10	O
gene1e	O
are	O
Essential	O
for	O
Proliferation	O
and	O
Radiation	O
Resistance	O
of	O
Cancer	O
Stem	O
-	O
Like	O
Cells	O
in	O
Adenoid	O
Cystic	O
Carcinoma	O
.	O
PURPOSE	O
:	O
Although	O
the	O
existence	O
of	O
cancer	O
stem	O
cells	O
(	O
CSC	O
)	O
in	O
adenoid	O
cystic	O
carcinoma	O
(	O
ACC	O
)	O
has	O
been	O
proposed	O
,	O
lack	O
of	O
assays	O
for	O
their	O
propagation	O
and	O
uncertainty	O
about	O
molecular	O
markers	O
prevented	O
their	O
characterization	O
.	O
Our	O
objective	O
was	O
to	O
isolate	O
CSC	O
from	O
ACC	O
and	O
provide	O
insight	O
into	O
signaling	O
pathways	O
that	O
support	O
their	O
propagation	O
.	O
EXPERIMENTAL	O
DESIGN	O
:	O
To	O
isolate	O
CSC	O
from	O
ACC	O
and	O
characterize	O
them	O
,	O
we	O
used	O
gene1s	O
ROCK	O
gene1e	O
inhibitor	O
-	O
supplemented	O
cell	O
culture	O
,	O
immunomagnetic	O
cell	O
sorting	O
,	O
andin	O
vitro	O
/	O
in	O
vivoassays	O
for	O
CSC	O
viability	O
and	O
tumorigenicity	O
.	O
RESULTS	O
:	O
We	O
identified	O
in	O
ACC	O
gene1s	O
CD133	O
gene1e	O
-positive	O
CSC	O
that	O
expressed	O
gene1s	O
NOTCH1	O
gene1e	O
and	O
gene1s	O
SOX10	O
gene1e	O
,	O
formed	O
spheroids	O
,	O
and	O
initiated	O
tumors	O
in	O
arg1s	O
nude	O
mice	O
arg1e	O
.	O
gene1s	O
CD133	O
gene1e	O
(+)ACC	O
cells	O
produced	O
activated	O
gene1s	O
NOTCH1	O
gene1e	O
(	O
gene1s	O
N1ICD	O
gene1e	O
)	O
and	O
generated	O
gene1s	O
CD133	O
gene1e	O
(-)cells	O
that	O
expressed	O
gene1s	O
JAG1	O
gene1e	O
as	O
well	O
as	O
neural	O
differentiation	O
factors	O
gene1s	O
NR2F1	O
gene1e	O
,	O
gene1s	O
NR2F2	O
gene1e	O
,	O
and	O
gene1s	O
p27Kip1	O
gene1e	O
.	O
Knockdowns	O
of	O
gene1s	O
NOTCH1	O
gene1e	O
,	O
gene1s	O
SOX10	O
gene1e	O
,	O
and	O
their	O
common	O
effector	O
gene1s	O
FABP7	O
gene1e	O
had	O
negative	O
effects	O
on	O
each	O
other	O
,	O
inhibited	O
spheroidogenesis	O
,	O
and	O
induced	O
cell	O
death	O
pointing	O
at	O
their	O
essential	O
roles	O
in	O
CSC	O
maintenance	O
.	O
Downstream	O
effects	O
of	O
gene1s	O
FABP7	O
gene1e	O
knockdown	O
included	O
suppression	O
of	O
a	O
broad	O
spectrum	O
of	O
genes	O
involved	O
in	O
proliferation	O
,	O
ribosome	O
biogenesis	O
,	O
and	O
metabolism	O
.	O
Among	O
proliferation	O
-	O
linked	O
gene1s	O
NOTCH1	O
gene1e	O
/	O
gene1s	O
FABP7	O
gene1e	O
targets	O
,	O
we	O
identified	O
gene1s	O
SKP2	O
gene1e	O
and	O
its	O
substrate	O
gene1s	O
p27Kip1	O
gene1e	O
.	O
A	O
gene1s	O
g	O
-	O
secretase	O
gene1e	O
inhibitor	O
,	O
species1s	O
DAPT	O
species1e	O
,	O
selectively	O
depleted	O
gene1s	O
CD133	O
gene1e	O
(+)cells	O
,	O
suppressed	O
gene1s	O
N1ICD	O
gene1e	O
and	O
gene1s	O
SKP2	O
gene1e	O
,	O
induced	O
gene1s	O
p27Kip1	O
gene1e	O
,	O
inhibited	O
ACC	O
growthin	O
vivo	O
,	O
and	O
sensitized	O
gene1s	O
CD133	O
gene1e	O
(+)cells	O
to	O
radiation	O
.	O
CONCLUSIONS	O
:	O
These	O
results	O
establish	O
in	O
the	O
majority	O
of	O
ACC	O
the	O
presence	O
of	O
a	O
previously	O
uncharacterized	O
population	O
of	O
gene1s	O
CD133	O
gene1e	O
(+)cells	O
with	O
neural	O
stem	O
properties	O
,	O
which	O
are	O
driven	O
by	O
gene1s	O
SOX10	O
gene1e	O
,	O
gene1s	O
NOTCH1	O
gene1e	O
,	O
and	O
gene1s	O
FABP7	O
gene1e	O
.	O
Sensitivity	O
of	O
these	O
cells	O
to	O
gene1s	O
Notch	O
gene1e	O
inhibition	O
and	O
their	O
dependence	O
on	O
gene1s	O
SKP2	O
gene1e	O
offer	O
new	O
opportunities	O
for	O
targeted	O
ACC	O
therapies	O
.	O

gene1s	ARG2
NOTCH1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
SOX10	ARG2
gene1e	ARG2
are	O
Essential	O
for	O
Proliferation	O
and	O
Radiation	O
Resistance	O
of	O
Cancer	O
Stem	O
-	O
Like	O
Cells	O
in	O
Adenoid	O
Cystic	O
Carcinoma	O
.	O
PURPOSE	O
:	O
Although	O
the	O
existence	O
of	O
cancer	O
stem	O
cells	O
(	O
CSC	O
)	O
in	O
adenoid	O
cystic	O
carcinoma	O
(	O
ACC	O
)	O
has	O
been	O
proposed	O
,	O
lack	O
of	O
assays	O
for	O
their	O
propagation	O
and	O
uncertainty	O
about	O
molecular	O
markers	O
prevented	O
their	O
characterization	O
.	O
Our	O
objective	O
was	O
to	O
isolate	O
CSC	O
from	O
ACC	O
and	O
provide	O
insight	O
into	O
signaling	O
pathways	O
that	O
support	O
their	O
propagation	O
.	O
EXPERIMENTAL	O
DESIGN	O
:	O
To	O
isolate	O
CSC	O
from	O
ACC	O
and	O
characterize	O
them	O
,	O
we	O
used	O
gene1s	ARG2
ROCK	ARG2
gene1e	ARG2
inhibitor	O
-	O
supplemented	O
cell	O
culture	O
,	O
immunomagnetic	O
cell	O
sorting	O
,	O
andin	O
vitro	O
/	O
in	O
vivoassays	O
for	O
CSC	O
viability	O
and	O
tumorigenicity	O
.	O
RESULTS	O
:	O
We	O
identified	O
in	O
ACC	O
gene1s	ARG2
CD133	ARG2
gene1e	ARG2
-positive	O
CSC	O
that	O
expressed	O
gene1s	ARG2
NOTCH1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
SOX10	ARG2
gene1e	ARG2
,	O
formed	O
spheroids	O
,	O
and	O
initiated	O
tumors	O
in	O
species1s	O
nude	O
mice	O
species1e	O
.	O
gene1s	ARG2
CD133	ARG2
gene1e	ARG2
(+)ACC	O
cells	O
produced	O
activated	O
gene1s	ARG2
NOTCH1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
N1ICD	ARG2
gene1e	ARG2
)	O
and	O
generated	O
gene1s	ARG2
CD133	ARG2
gene1e	ARG2
(-)cells	O
that	O
expressed	O
gene1s	ARG2
JAG1	ARG2
gene1e	ARG2
as	O
well	O
as	O
neural	O
differentiation	O
factors	O
gene1s	ARG2
NR2F1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NR2F2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
p27Kip1	ARG2
gene1e	ARG2
.	O
Knockdowns	O
of	O
gene1s	ARG2
NOTCH1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SOX10	ARG2
gene1e	ARG2
,	O
and	O
their	O
common	O
effector	O
gene1s	ARG2
FABP7	ARG2
gene1e	ARG2
had	O
negative	O
effects	O
on	O
each	O
other	O
,	O
inhibited	O
spheroidogenesis	O
,	O
and	O
induced	O
cell	O
death	O
pointing	O
at	O
their	O
essential	O
roles	O
in	O
CSC	O
maintenance	O
.	O
Downstream	O
effects	O
of	O
gene1s	ARG2
FABP7	ARG2
gene1e	ARG2
knockdown	O
included	O
suppression	O
of	O
a	O
broad	O
spectrum	O
of	O
genes	O
involved	O
in	O
proliferation	O
,	O
ribosome	O
biogenesis	O
,	O
and	O
metabolism	O
.	O
Among	O
proliferation	O
-	O
linked	O
gene1s	ARG2
NOTCH1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
FABP7	ARG2
gene1e	ARG2
targets	O
,	O
we	O
identified	O
gene1s	ARG2
SKP2	ARG2
gene1e	ARG2
and	O
its	O
substrate	O
gene1s	ARG2
p27Kip1	ARG2
gene1e	ARG2
.	O
A	O
gene1s	ARG2
g	ARG2
-	ARG2
secretase	ARG2
gene1e	ARG2
inhibitor	O
,	O
arg1s	O
DAPT	O
arg1e	O
,	O
selectively	O
depleted	O
gene1s	ARG2
CD133	ARG2
gene1e	ARG2
(+)cells	O
,	O
suppressed	O
gene1s	ARG2
N1ICD	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
SKP2	ARG2
gene1e	ARG2
,	O
induced	O
gene1s	ARG2
p27Kip1	ARG2
gene1e	ARG2
,	O
inhibited	O
ACC	O
growthin	O
vivo	O
,	O
and	O
sensitized	O
gene1s	ARG2
CD133	ARG2
gene1e	ARG2
(+)cells	O
to	O
radiation	O
.	O
CONCLUSIONS	O
:	O
These	O
results	O
establish	O
in	O
the	O
majority	O
of	O
ACC	O
the	O
presence	O
of	O
a	O
previously	O
uncharacterized	O
population	O
of	O
gene1s	ARG2
CD133	ARG2
gene1e	ARG2
(+)cells	O
with	O
neural	O
stem	O
properties	O
,	O
which	O
are	O
driven	O
by	O
gene1s	ARG2
SOX10	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NOTCH1	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
FABP7	ARG2
gene1e	ARG2
.	O
Sensitivity	O
of	O
these	O
cells	O
to	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
inhibition	O
and	O
their	O
dependence	O
on	O
gene1s	ARG2
SKP2	ARG2
gene1e	ARG2
offer	O
new	O
opportunities	O
for	O
targeted	O
ACC	O
therapies	O
.	O

Cultured	O
mycelium	O
arg1s	O
Cordyceps	O
sinensis	O
arg1e	O
protects	O
liver	O
sinusoidal	O
endothelial	O
cells	O
in	O
acute	O
liver	O
injured	O
species1s	O
mice	O
species1e	O
.	O
Cultured	O
mycelium	O
arg1s	O
Cordyceps	O
sinensis	O
arg1e	O
(	O
CMCS	O
)	O
was	O
widely	O
used	O
for	O
a	O
variety	O
of	O
diseases	O
including	O
liver	O
injury	O
,	O
the	O
current	O
study	O
aims	O
to	O
investigate	O
the	O
protective	O
effects	O
of	O
CMCS	O
on	O
liver	O
sinusoidal	O
endothelial	O
cells	O
(	O
LSECs	O
)	O
in	O
acute	O
injury	O
liver	O
and	O
related	O
action	O
mechanisms	O
.	O
The	O
species1s	O
mice	O
species1e	O
were	O
injected	O
intraperitoneally	O
with	O
lipopolysaccharide	O
(	O
LPS	O
)	O
and	O
D	O
-	O
galactosamine	O
(	O
D	O
-	O
GalN	O
)	O
.	O
39	O
male	O
BABL	O
/	O
c	O
species1s	O
mice	O
species1e	O
were	O
randomly	O
divided	O
into	O
four	O
groups	O
:	O
normal	O
control	O
,	O
model	O
control	O
,	O
CMCS	O
treatment	O
and	O
1,10-phenanthroline	O
treatment	O
groups	O
.	O
The	O
Serum	O
liver	O
function	O
parameters	O
including	O
gene1s	O
alanine	O
aminotransferase	O
gene1e	O
(	O
gene1s	O
ALT	O
gene1e	O
)	O
and	O
gene1s	O
aspartate	O
aminotransferase	O
gene1e	O
(	O
gene1s	O
AST	O
gene1e	O
)	O
levels	O
were	O
assayed	O
with	O
the	O
commercial	O
kit	O
.	O
The	O
inflammation	O
and	O
scaffold	O
structure	O
in	O
liver	O
were	O
stained	O
with	O
hematoxylin	O
and	O
eosin	O
and	O
silver	O
staining	O
respectively	O
.	O
The	O
LSECs	O
and	O
sub	O
-	O
endothelial	O
basement	O
membrane	O
were	O
observed	O
with	O
the	O
scanning	O
and	O
transmission	O
electronic	O
microscope	O
.	O
The	O
protein	O
expressions	O
of	O
gene1s	O
intercellular	O
adhesion	O
molecule-1	O
gene1e	O
(	O
gene1s	O
ICAM-1	O
gene1e	O
)	O
and	O
gene1s	O
vascular	O
cell	O
adhesion	O
molecule-1	O
gene1e	O
(	O
gene1s	O
VCAM-1	O
gene1e	O
)	O
in	O
liver	O
were	O
analyzed	O
with	O
Western	O
blotting	O
.	O
Expression	O
of	O
gene1s	O
von	O
Willebrand	O
factor	O
gene1e	O
(	O
gene1s	O
vWF	O
gene1e	O
)	O
was	O
investigated	O
with	O
immunofluorescence	O
staining	O
.	O
The	O
lipid	O
peroxidation	O
indicators	O
including	O
antisuperoxideanion	O
(	O
ASAFR	O
)	O
,	O
hydroxyl	O
free	O
radical	O
(	O
.OH	O
)	O
,	O
gene1s	O
superoxide	O
dismutase	O
gene1e	O
(	O
gene1s	O
SOD	O
gene1e	O
)	O
,	O
malondialdehyde	O
and	O
gene1s	O
glutathione	O
S	O
-	O
transferase	O
gene1e	O
(	O
gene1s	O
GST	O
gene1e	O
)	O
were	O
determined	O
with	O
kits	O
,	O
and	O
gene1s	O
matrix	O
metalloproteinase-2	O
and	O
9	O
gene1e	O
(	O
gene1s	O
MMP-2/9	O
gene1e	O
)	O
activities	O
in	O
liver	O
were	O
analyzed	O
with	O
gelatin	O
zymography	O
and	O
in	O
situ	O
fluorescent	O
zymography	O
respectively	O
.	O
The	O
model	O
species1s	O
mice	O
species1e	O
had	O
much	O
higher	O
serum	O
levels	O
of	O
gene1s	O
ALT	O
gene1e	O
and	O
gene1s	O
AST	O
gene1e	O
than	O
the	O
normal	O
species1s	O
mice	O
species1e	O
.	O
Compared	O
to	O
that	O
in	O
the	O
normal	O
control	O
,	O
more	O
severe	O
liver	O
inflammation	O
and	O
hepatocyte	O
apoptosis	O
,	O
worse	O
hepatic	O
lipid	O
peroxidation	O
demonstrated	O
by	O
the	O
increased	O
ASAFR	O
,	O
.OH	O
and	O
MDA	O
,	O
but	O
decreased	O
gene1s	O
SOD	O
gene1e	O
and	O
gene1s	O
GST	O
gene1e	O
,	O
increased	O
gene1s	O
MMP-2/9	O
gene1e	O
activities	O
and	O
gene1s	O
VCAM-1	O
gene1e	O
,	O
gene1s	O
ICAM-1	O
gene1e	O
and	O
gene1s	O
vWF	O
gene1e	O
expressions	O
,	O
which	O
revealed	O
obvious	O
LSEC	O
injury	O
and	O
scaffold	O
structure	O
broken	O
,	O
were	O
shown	O
in	O
the	O
model	O
control	O
.	O
Compared	O
with	O
the	O
model	O
group	O
,	O
CMCS	O
and	O
1,10-phenanthroline	O
significantly	O
improved	O
serum	O
gene1s	O
ALT	O
gene1e	O
/	O
gene1s	O
AST	O
gene1e	O
,	O
attenuated	O
hepatic	O
inflammation	O
and	O
improved	O
peroxidative	O
injury	O
in	O
liver	O
,	O
decreased	O
gene1s	O
MMP-2/9	O
gene1e	O
activities	O
in	O
liver	O
tissue	O
,	O
improved	O
integration	O
of	O
scaffold	O
structure	O
,	O
and	O
decreased	O
protein	O
expression	O
of	O
gene1s	O
VCAM-1	O
gene1e	O
and	O
gene1s	O
ICAM-1	O
gene1e	O
.	O
CMCS	O
could	O
protect	O
LSECs	O
from	O
injury	O
and	O
maintain	O
the	O
microvasculature	O
integration	O
in	O
acute	O
injured	O
liver	O
of	O
species1s	O
mice	O
species1e	O
induced	O
by	O
LPS	O
/	O
D	O
-	O
GalN.	O
Its	O
action	O
mechanism	O
was	O
associated	O
with	O
the	O
down	O
-	O
regulation	O
of	O
gene1s	O
MMP-2/9	O
gene1e	O
activities	O
and	O
inhibition	O
of	O
peroxidation	O
in	O
injured	O
liver	O
.	O

Cultured	O
mycelium	O
species1s	O
Cordyceps	O
sinensis	O
species1e	O
protects	O
liver	O
sinusoidal	O
endothelial	O
cells	O
in	O
acute	O
liver	O
injured	O
arg1s	O
mice	O
arg1e	O
.	O
Cultured	O
mycelium	O
species1s	O
Cordyceps	O
sinensis	O
species1e	O
(	O
CMCS	O
)	O
was	O
widely	O
used	O
for	O
a	O
variety	O
of	O
diseases	O
including	O
liver	O
injury	O
,	O
the	O
current	O
study	O
aims	O
to	O
investigate	O
the	O
protective	O
effects	O
of	O
CMCS	O
on	O
liver	O
sinusoidal	O
endothelial	O
cells	O
(	O
LSECs	O
)	O
in	O
acute	O
injury	O
liver	O
and	O
related	O
action	O
mechanisms	O
.	O
The	O
arg1s	O
mice	O
arg1e	O
were	O
injected	O
intraperitoneally	O
with	O
lipopolysaccharide	O
(	O
LPS	O
)	O
and	O
D	O
-	O
galactosamine	O
(	O
D	O
-	O
GalN	O
)	O
.	O
39	O
male	O
BABL	O
/	O
c	O
arg1s	O
mice	O
arg1e	O
were	O
randomly	O
divided	O
into	O
four	O
groups	O
:	O
normal	O
control	O
,	O
model	O
control	O
,	O
CMCS	O
treatment	O
and	O
1,10-phenanthroline	O
treatment	O
groups	O
.	O
The	O
Serum	O
liver	O
function	O
parameters	O
including	O
gene1s	ARG2
alanine	ARG2
aminotransferase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ALT	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
aspartate	ARG2
aminotransferase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
AST	ARG2
gene1e	ARG2
)	O
levels	O
were	O
assayed	O
with	O
the	O
commercial	O
kit	O
.	O
The	O
inflammation	O
and	O
scaffold	O
structure	O
in	O
liver	O
were	O
stained	O
with	O
hematoxylin	O
and	O
eosin	O
and	O
silver	O
staining	O
respectively	O
.	O
The	O
LSECs	O
and	O
sub	O
-	O
endothelial	O
basement	O
membrane	O
were	O
observed	O
with	O
the	O
scanning	O
and	O
transmission	O
electronic	O
microscope	O
.	O
The	O
protein	O
expressions	O
of	O
gene1s	ARG2
intercellular	ARG2
adhesion	ARG2
molecule-1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ICAM-1	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
vascular	ARG2
cell	ARG2
adhesion	ARG2
molecule-1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
VCAM-1	ARG2
gene1e	ARG2
)	O
in	O
liver	O
were	O
analyzed	O
with	O
Western	O
blotting	O
.	O
Expression	O
of	O
gene1s	ARG2
von	ARG2
Willebrand	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
vWF	ARG2
gene1e	ARG2
)	O
was	O
investigated	O
with	O
immunofluorescence	O
staining	O
.	O
The	O
lipid	O
peroxidation	O
indicators	O
including	O
antisuperoxideanion	O
(	O
ASAFR	O
)	O
,	O
hydroxyl	O
free	O
radical	O
(	O
.OH	O
)	O
,	O
gene1s	ARG2
superoxide	ARG2
dismutase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SOD	ARG2
gene1e	ARG2
)	O
,	O
malondialdehyde	O
and	O
gene1s	ARG2
glutathione	ARG2
S	ARG2
-	ARG2
transferase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
GST	ARG2
gene1e	ARG2
)	O
were	O
determined	O
with	O
kits	O
,	O
and	O
gene1s	ARG2
matrix	ARG2
metalloproteinase-2	ARG2
and	ARG2
9	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MMP-2/9	ARG2
gene1e	ARG2
)	O
activities	O
in	O
liver	O
were	O
analyzed	O
with	O
gelatin	O
zymography	O
and	O
in	O
situ	O
fluorescent	O
zymography	O
respectively	O
.	O
The	O
model	O
arg1s	O
mice	O
arg1e	O
had	O
much	O
higher	O
serum	O
levels	O
of	O
gene1s	ARG2
ALT	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
AST	ARG2
gene1e	ARG2
than	O
the	O
normal	O
arg1s	O
mice	O
arg1e	O
.	O
Compared	O
to	O
that	O
in	O
the	O
normal	O
control	O
,	O
more	O
severe	O
liver	O
inflammation	O
and	O
hepatocyte	O
apoptosis	O
,	O
worse	O
hepatic	O
lipid	O
peroxidation	O
demonstrated	O
by	O
the	O
increased	O
ASAFR	O
,	O
.OH	O
and	O
MDA	O
,	O
but	O
decreased	O
gene1s	ARG2
SOD	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
GST	ARG2
gene1e	ARG2
,	O
increased	O
gene1s	ARG2
MMP-2/9	ARG2
gene1e	ARG2
activities	O
and	O
gene1s	ARG2
VCAM-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ICAM-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
vWF	ARG2
gene1e	ARG2
expressions	O
,	O
which	O
revealed	O
obvious	O
LSEC	O
injury	O
and	O
scaffold	O
structure	O
broken	O
,	O
were	O
shown	O
in	O
the	O
model	O
control	O
.	O
Compared	O
with	O
the	O
model	O
group	O
,	O
CMCS	O
and	O
1,10-phenanthroline	O
significantly	O
improved	O
serum	O
gene1s	ARG2
ALT	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
AST	ARG2
gene1e	ARG2
,	O
attenuated	O
hepatic	O
inflammation	O
and	O
improved	O
peroxidative	O
injury	O
in	O
liver	O
,	O
decreased	O
gene1s	ARG2
MMP-2/9	ARG2
gene1e	ARG2
activities	O
in	O
liver	O
tissue	O
,	O
improved	O
integration	O
of	O
scaffold	O
structure	O
,	O
and	O
decreased	O
protein	O
expression	O
of	O
gene1s	ARG2
VCAM-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ICAM-1	ARG2
gene1e	ARG2
.	O
CMCS	O
could	O
protect	O
LSECs	O
from	O
injury	O
and	O
maintain	O
the	O
microvasculature	O
integration	O
in	O
acute	O
injured	O
liver	O
of	O
arg1s	O
mice	O
arg1e	O
induced	O
by	O
LPS	O
/	O
D	O
-	O
GalN.	O
Its	O
action	O
mechanism	O
was	O
associated	O
with	O
the	O
down	O
-	O
regulation	O
of	O
gene1s	ARG2
MMP-2/9	ARG2
gene1e	ARG2
activities	O
and	O
inhibition	O
of	O
peroxidation	O
in	O
injured	O
liver	O
.	O

Gene	O
expression	O
profiling	O
of	O
the	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
AhR	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
IL22	ARG2
gene1e	ARG2
axis	O
at	O
homeostasis	O
and	O
in	O
response	O
to	O
tissue	O
injury	O
.	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Interleukin-22	ARG2
gene1e	ARG2
signaling	O
are	O
known	O
to	O
regulate	O
tissue	O
homeostasis	O
and	O
response	O
to	O
injury	O
in	O
arg1s	O
humans	O
arg1e	O
and	O
species1s	O
mice	O
species1e	O
,	O
and	O
the	O
induction	O
of	O
endogenous	O
gene1s	ARG2
arylhydrocarbon	ARG2
receptor	ARG2
gene1e	ARG2
ligands	O
through	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
links	O
the	O
two	O
pathways	O
in	O
a	O
hierarchical	O
fashion	O
.	O
However	O
,	O
in	O
adults	O
the	O
species-	O
,	O
organ-	O
and	O
injury	O
-	O
specific	O
gene	O
expression	O
of	O
the	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
AhR	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
IL22	ARG2
gene1e	ARG2
axis	O
components	O
is	O
unknown	O
.	O
We	O
therefore	O
performed	O
gene	O
expression	O
profiling	O
of	O
gene1s	ARG2
DLL1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
DLL3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
DLL4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
DLK1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
DLK2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
JAG1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
JAG2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Notch1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Notch2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Notch3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Notch4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ADAM17	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
TACE	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PSEN1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
BSG	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CD147	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
RBP	ARG2
-	ARG2
J	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HES1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HES5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HEY1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HEYL	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
AHR	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ARNT	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ARNT2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CYP1A1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CYP24A1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL22	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL22RA1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL22RA2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL10RB	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
under	O
homeostatic	O
conditions	O
in	O
10	O
mature	O
species1s	O
murine	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
organs	O
.	O
Additionally	O
,	O
the	O
expression	O
of	O
these	O
genes	O
was	O
assessed	O
in	O
species1s	O
murine	O
species1e	O
models	O
of	O
acute	O
sterile	O
inflammation	O
and	O
progressive	O
fibrosis	O
.	O
We	O
show	O
that	O
there	O
are	O
organ	O
specific	O
gene	O
expression	O
profiles	O
of	O
the	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
AhR	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
IL22	ARG2
gene1e	ARG2
axis	O
in	O
arg1s	O
humans	O
arg1e	O
and	O
species1s	O
mice	O
species1e	O
.	O
Although	O
there	O
is	O
an	O
overall	O
interspecies	O
congruency	O
,	O
specific	O
differences	O
between	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
murine	O
species1e	O
expression	O
signatures	O
do	O
exist	O
.	O
In	O
species1s	O
murine	O
species1e	O
tissues	O
with	O
gene1s	O
AHR	O
gene1e	O
/	O
gene1s	O
ARNT	O
gene1e	O
expression	O
gene1s	O
CYP1A1	O
gene1e	O
and	O
gene1s	O
IL22	O
gene1e	O
were	O
correlated	O
with	O
gene1s	O
HES5	O
gene1e	O
and	O
gene1s	O
HEYL	O
gene1e	O
expression	O
,	O
while	O
in	O
arg1s	O
human	O
arg1e	O
tissues	O
no	O
such	O
correlation	O
was	O
found	O
.	O
gene1s	O
Notch	O
gene1e	O
-	O
and	O
gene1s	ARG2
AhR	ARG2
gene1e	ARG2
-	O
signaling	O
are	O
involved	O
in	O
renal	O
inflammation	O
and	O
fibrosis	O
with	O
specific	O
gene	O
expression	O
changes	O
in	O
each	O
model	O
.	O
Despite	O
the	O
presence	O
of	O
all	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
pathway	O
molecules	O
in	O
the	O
kidney	O
and	O
a	O
model	O
-	O
specific	O
induction	O
of	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
ligands	O
,	O
gene1s	ARG2
IL22	ARG2
gene1e	ARG2
was	O
only	O
upregulated	O
in	O
acute	O
inflammation	O
,	O
but	O
rapidly	O
downregulated	O
during	O
regeneration	O
.	O
This	O
implies	O
that	O
for	O
targeting	O
injury	O
responses	O
e.g.	O
via	O
gene1s	ARG2
Interleukin-22	ARG2
gene1e	ARG2
,	O
species	O
-	O
specific	O
differences	O
,	O
injury	O
-	O
type	O
and	O
timepoints	O
have	O
to	O
be	O
considered	O
.	O

Gene	O
expression	O
profiling	O
of	O
the	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
AhR	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
IL22	ARG2
gene1e	ARG2
axis	O
at	O
homeostasis	O
and	O
in	O
response	O
to	O
tissue	O
injury	O
.	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Interleukin-22	ARG2
gene1e	ARG2
signaling	O
are	O
known	O
to	O
regulate	O
tissue	O
homeostasis	O
and	O
response	O
to	O
injury	O
in	O
species1s	O
humans	O
species1e	O
and	O
arg1s	O
mice	O
arg1e	O
,	O
and	O
the	O
induction	O
of	O
endogenous	O
gene1s	ARG2
arylhydrocarbon	ARG2
receptor	ARG2
gene1e	ARG2
ligands	O
through	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
links	O
the	O
two	O
pathways	O
in	O
a	O
hierarchical	O
fashion	O
.	O
However	O
,	O
in	O
adults	O
the	O
species-	O
,	O
organ-	O
and	O
injury	O
-	O
specific	O
gene	O
expression	O
of	O
the	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
AhR	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
IL22	ARG2
gene1e	ARG2
axis	O
components	O
is	O
unknown	O
.	O
We	O
therefore	O
performed	O
gene	O
expression	O
profiling	O
of	O
gene1s	ARG2
DLL1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
DLL3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
DLL4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
DLK1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
DLK2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
JAG1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
JAG2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Notch1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Notch2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Notch3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Notch4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ADAM17	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
TACE	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PSEN1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
BSG	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CD147	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
RBP	ARG2
-	ARG2
J	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HES1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HES5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HEY1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HEYL	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
AHR	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ARNT	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ARNT2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CYP1A1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CYP24A1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL22	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL22RA1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL22RA2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL10RB	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
under	O
homeostatic	O
conditions	O
in	O
10	O
mature	O
arg1s	O
murine	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
organs	O
.	O
Additionally	O
,	O
the	O
expression	O
of	O
these	O
genes	O
was	O
assessed	O
in	O
arg1s	O
murine	O
arg1e	O
models	O
of	O
acute	O
sterile	O
inflammation	O
and	O
progressive	O
fibrosis	O
.	O
We	O
show	O
that	O
there	O
are	O
organ	O
specific	O
gene	O
expression	O
profiles	O
of	O
the	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
AhR	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
IL22	ARG2
gene1e	ARG2
axis	O
in	O
species1s	O
humans	O
species1e	O
and	O
arg1s	O
mice	O
arg1e	O
.	O
Although	O
there	O
is	O
an	O
overall	O
interspecies	O
congruency	O
,	O
specific	O
differences	O
between	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
murine	O
arg1e	O
expression	O
signatures	O
do	O
exist	O
.	O
In	O
arg1s	O
murine	O
arg1e	O
tissues	O
with	O
gene1s	ARG2
AHR	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ARNT	ARG2
gene1e	ARG2
expression	O
gene1s	ARG2
CYP1A1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL22	ARG2
gene1e	ARG2
were	O
correlated	O
with	O
gene1s	ARG2
HES5	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
HEYL	ARG2
gene1e	ARG2
expression	O
,	O
while	O
in	O
species1s	O
human	O
species1e	O
tissues	O
no	O
such	O
correlation	O
was	O
found	O
.	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
-	O
and	O
gene1s	ARG2
AhR	ARG2
gene1e	ARG2
-	O
signaling	O
are	O
involved	O
in	O
renal	O
inflammation	O
and	O
fibrosis	O
with	O
specific	O
gene	O
expression	O
changes	O
in	O
each	O
model	O
.	O
Despite	O
the	O
presence	O
of	O
all	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
pathway	O
molecules	O
in	O
the	O
kidney	O
and	O
a	O
model	O
-	O
specific	O
induction	O
of	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
ligands	O
,	O
gene1s	ARG2
IL22	ARG2
gene1e	ARG2
was	O
only	O
upregulated	O
in	O
acute	O
inflammation	O
,	O
but	O
rapidly	O
downregulated	O
during	O
regeneration	O
.	O
This	O
implies	O
that	O
for	O
targeting	O
injury	O
responses	O
e.g.	O
via	O
gene1s	ARG2
Interleukin-22	ARG2
gene1e	ARG2
,	O
species	O
-	O
specific	O
differences	O
,	O
injury	O
-	O
type	O
and	O
timepoints	O
have	O
to	O
be	O
considered	O
.	O

gene1s	O
LEM2	O
gene1e	O
recruits	O
gene1s	O
CHMP7	O
gene1e	O
for	O
gene1s	O
ESCRT	O
gene1e	O
-	O
mediated	O
nuclear	O
envelope	O
closure	O
in	O
arg1s	O
fission	O
yeast	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
cells	O
.	O
gene1s	O
Endosomal	O
sorting	O
complexes	O
required	O
for	O
transport	O
III	O
gene1e	O
(	O
gene1s	O
ESCRT	O
-	O
III	O
gene1e	O
)	O
proteins	O
have	O
been	O
implicated	O
in	O
sealing	O
the	O
nuclear	O
envelope	O
in	O
mammals	O
,	O
spindle	O
pole	O
body	O
dynamics	O
in	O
arg1s	O
fission	O
yeast	O
arg1e	O
,	O
and	O
surveillance	O
of	O
defective	O
nuclear	O
pore	O
complexes	O
in	O
budding	O
species1s	O
yeast	O
species1e	O
.	O
Here	O
,	O
we	O
report	O
that	O
gene1s	O
Lem2p	O
gene1e	O
(	O
gene1s	O
LEM2	O
gene1e	O
)	O
,	O
a	O
member	O
of	O
the	O
gene1s	O
LEM	O
gene1e	O
(	O
gene1s	O
Lap2	O
gene1e	O
-	O
gene1s	O
Emerin	O
gene1e	O
-	O
gene1s	O
Man1	O
gene1e	O
)	O
family	O
of	O
inner	O
nuclear	O
membrane	O
proteins	O
,	O
and	O
the	O
ESCRT	O
-	O
II	O
/	O
ESCRT	O
-	O
III	O
hybrid	O
protein	O
gene1s	O
Cmp7p	O
gene1e	O
(	O
gene1s	O
CHMP7	O
gene1e	O
)	O
,	O
work	O
together	O
to	O
recruit	O
additional	O
gene1s	O
ESCRT	O
-	O
III	O
gene1e	O
proteins	O
to	O
holes	O
in	O
the	O
nuclear	O
membrane	O
.	O
In	O
arg1s	O
Schizosaccharomyces	O
pombe	O
arg1e	O
,	O
deletion	O
of	O
the	O
gene1s	ARG2
ATPase	ARG2
gene1e	ARG2
gene1s	ARG2
vps4	ARG2
gene1e	ARG2
leads	O
to	O
severe	O
defects	O
in	O
nuclear	O
morphology	O
and	O
integrity	O
.	O
These	O
phenotypes	O
are	O
suppressed	O
by	O
loss	O
-	O
of	O
-	O
function	O
mutations	O
that	O
arise	O
spontaneously	O
in	O
gene1s	O
lem2	O
gene1e	O
or	O
gene1s	O
cmp7	O
gene1e	O
,	O
implying	O
that	O
these	O
proteins	O
may	O
function	O
upstream	O
in	O
the	O
same	O
pathway	O
.	O
Building	O
on	O
these	O
genetic	O
interactions	O
,	O
we	O
explored	O
the	O
role	O
of	O
gene1s	O
LEM2	O
gene1e	O
during	O
nuclear	O
envelope	O
reformation	O
in	O
species1s	O
human	O
species1e	O
cells	O
.	O
We	O
found	O
that	O
gene1s	O
CHMP7	O
gene1e	O
and	O
gene1s	O
LEM2	O
gene1e	O
enrich	O
at	O
the	O
same	O
region	O
of	O
the	O
chromatin	O
disk	O
periphery	O
during	O
this	O
window	O
of	O
cell	O
division	O
and	O
that	O
gene1s	O
CHMP7	O
gene1e	O
can	O
bind	O
directly	O
to	O
the	O
C	O
-	O
terminal	O
domain	O
of	O
gene1s	O
LEM2	O
gene1e	O
in	O
vitro	O
.	O
We	O
further	O
found	O
that	O
,	O
during	O
nuclear	O
envelope	O
formation	O
,	O
recruitment	O
of	O
the	O
gene1s	O
ESCRT	O
gene1e	O
factors	O
gene1s	O
CHMP7	O
gene1e	O
,	O
gene1s	O
CHMP2A	O
gene1e	O
,	O
and	O
gene1s	O
IST1	O
gene1e	O
/	O
gene1s	O
CHMP8	O
gene1e	O
all	O
depend	O
on	O
gene1s	O
LEM2	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
cells	O
.	O
We	O
conclude	O
that	O
gene1s	O
Lem2p	O
gene1e	O
/	O
gene1s	O
LEM2	O
gene1e	O
is	O
a	O
conserved	O
nuclear	O
site	O
-	O
specific	O
adaptor	O
that	O
recruits	O
gene1s	O
Cmp7p	O
gene1e	O
/	O
gene1s	O
CHMP7	O
gene1e	O
and	O
downstream	O
gene1s	O
ESCRT	O
gene1e	O
factors	O
to	O
the	O
nuclear	O
envelope	O
.	O

gene1s	ARG2
LEM2	ARG2
gene1e	ARG2
recruits	O
gene1s	ARG2
CHMP7	ARG2
gene1e	ARG2
for	O
gene1s	ARG2
ESCRT	ARG2
gene1e	ARG2
-	O
mediated	O
nuclear	O
envelope	O
closure	O
in	O
species1s	O
fission	O
yeast	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
cells	O
.	O
gene1s	ARG2
Endosomal	ARG2
sorting	ARG2
complexes	ARG2
required	ARG2
for	ARG2
transport	ARG2
III	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ESCRT	ARG2
-	ARG2
III	ARG2
gene1e	ARG2
)	O
proteins	O
have	O
been	O
implicated	O
in	O
sealing	O
the	O
nuclear	O
envelope	O
in	O
mammals	O
,	O
spindle	O
pole	O
body	O
dynamics	O
in	O
species1s	O
fission	O
yeast	O
species1e	O
,	O
and	O
surveillance	O
of	O
defective	O
nuclear	O
pore	O
complexes	O
in	O
budding	O
species1s	O
yeast	O
species1e	O
.	O
Here	O
,	O
we	O
report	O
that	O
gene1s	ARG2
Lem2p	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
LEM2	ARG2
gene1e	ARG2
)	O
,	O
a	O
member	O
of	O
the	O
gene1s	ARG2
LEM	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Lap2	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Emerin	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Man1	ARG2
gene1e	ARG2
)	O
family	O
of	O
inner	O
nuclear	O
membrane	O
proteins	O
,	O
and	O
the	O
ESCRT	O
-	O
II	O
/	O
ESCRT	O
-	O
III	O
hybrid	O
protein	O
gene1s	ARG2
Cmp7p	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CHMP7	ARG2
gene1e	ARG2
)	O
,	O
work	O
together	O
to	O
recruit	O
additional	O
gene1s	ARG2
ESCRT	ARG2
-	ARG2
III	ARG2
gene1e	ARG2
proteins	O
to	O
holes	O
in	O
the	O
nuclear	O
membrane	O
.	O
In	O
species1s	O
Schizosaccharomyces	O
pombe	O
species1e	O
,	O
deletion	O
of	O
the	O
gene1s	O
ATPase	O
gene1e	O
gene1s	O
vps4	O
gene1e	O
leads	O
to	O
severe	O
defects	O
in	O
nuclear	O
morphology	O
and	O
integrity	O
.	O
These	O
phenotypes	O
are	O
suppressed	O
by	O
loss	O
-	O
of	O
-	O
function	O
mutations	O
that	O
arise	O
spontaneously	O
in	O
gene1s	ARG2
lem2	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
cmp7	ARG2
gene1e	ARG2
,	O
implying	O
that	O
these	O
proteins	O
may	O
function	O
upstream	O
in	O
the	O
same	O
pathway	O
.	O
Building	O
on	O
these	O
genetic	O
interactions	O
,	O
we	O
explored	O
the	O
role	O
of	O
gene1s	ARG2
LEM2	ARG2
gene1e	ARG2
during	O
nuclear	O
envelope	O
reformation	O
in	O
arg1s	O
human	O
arg1e	O
cells	O
.	O
We	O
found	O
that	O
gene1s	ARG2
CHMP7	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
LEM2	ARG2
gene1e	ARG2
enrich	O
at	O
the	O
same	O
region	O
of	O
the	O
chromatin	O
disk	O
periphery	O
during	O
this	O
window	O
of	O
cell	O
division	O
and	O
that	O
gene1s	ARG2
CHMP7	ARG2
gene1e	ARG2
can	O
bind	O
directly	O
to	O
the	O
C	O
-	O
terminal	O
domain	O
of	O
gene1s	ARG2
LEM2	ARG2
gene1e	ARG2
in	O
vitro	O
.	O
We	O
further	O
found	O
that	O
,	O
during	O
nuclear	O
envelope	O
formation	O
,	O
recruitment	O
of	O
the	O
gene1s	ARG2
ESCRT	ARG2
gene1e	ARG2
factors	O
gene1s	ARG2
CHMP7	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CHMP2A	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
IST1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CHMP8	ARG2
gene1e	ARG2
all	O
depend	O
on	O
gene1s	ARG2
LEM2	ARG2
gene1e	ARG2
in	O
arg1s	O
human	O
arg1e	O
cells	O
.	O
We	O
conclude	O
that	O
gene1s	ARG2
Lem2p	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
LEM2	ARG2
gene1e	ARG2
is	O
a	O
conserved	O
nuclear	O
site	O
-	O
specific	O
adaptor	O
that	O
recruits	O
gene1s	ARG2
Cmp7p	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CHMP7	ARG2
gene1e	ARG2
and	O
downstream	O
gene1s	ARG2
ESCRT	ARG2
gene1e	ARG2
factors	O
to	O
the	O
nuclear	O
envelope	O
.	O

gene1s	O
LEM2	O
gene1e	O
recruits	O
gene1s	O
CHMP7	O
gene1e	O
for	O
gene1s	O
ESCRT	O
gene1e	O
-	O
mediated	O
nuclear	O
envelope	O
closure	O
in	O
species1s	O
fission	O
yeast	O
species1e	O
and	O
species1s	O
human	O
species1e	O
cells	O
.	O
gene1s	O
Endosomal	O
sorting	O
complexes	O
required	O
for	O
transport	O
III	O
gene1e	O
(	O
gene1s	O
ESCRT	O
-	O
III	O
gene1e	O
)	O
proteins	O
have	O
been	O
implicated	O
in	O
sealing	O
the	O
nuclear	O
envelope	O
in	O
mammals	O
,	O
spindle	O
pole	O
body	O
dynamics	O
in	O
species1s	O
fission	O
yeast	O
species1e	O
,	O
and	O
surveillance	O
of	O
defective	O
nuclear	O
pore	O
complexes	O
in	O
budding	O
arg1s	O
yeast	O
arg1e	O
.	O
Here	O
,	O
we	O
report	O
that	O
gene1s	O
Lem2p	O
gene1e	O
(	O
gene1s	O
LEM2	O
gene1e	O
)	O
,	O
a	O
member	O
of	O
the	O
gene1s	O
LEM	O
gene1e	O
(	O
gene1s	O
Lap2	O
gene1e	O
-	O
gene1s	O
Emerin	O
gene1e	O
-	O
gene1s	O
Man1	O
gene1e	O
)	O
family	O
of	O
inner	O
nuclear	O
membrane	O
proteins	O
,	O
and	O
the	O
ESCRT	O
-	O
II	O
/	O
ESCRT	O
-	O
III	O
hybrid	O
protein	O
gene1s	O
Cmp7p	O
gene1e	O
(	O
gene1s	O
CHMP7	O
gene1e	O
)	O
,	O
work	O
together	O
to	O
recruit	O
additional	O
gene1s	O
ESCRT	O
-	O
III	O
gene1e	O
proteins	O
to	O
holes	O
in	O
the	O
nuclear	O
membrane	O
.	O
In	O
species1s	O
Schizosaccharomyces	O
pombe	O
species1e	O
,	O
deletion	O
of	O
the	O
gene1s	O
ATPase	O
gene1e	O
gene1s	O
vps4	O
gene1e	O
leads	O
to	O
severe	O
defects	O
in	O
nuclear	O
morphology	O
and	O
integrity	O
.	O
These	O
phenotypes	O
are	O
suppressed	O
by	O
loss	O
-	O
of	O
-	O
function	O
mutations	O
that	O
arise	O
spontaneously	O
in	O
gene1s	O
lem2	O
gene1e	O
or	O
gene1s	O
cmp7	O
gene1e	O
,	O
implying	O
that	O
these	O
proteins	O
may	O
function	O
upstream	O
in	O
the	O
same	O
pathway	O
.	O
Building	O
on	O
these	O
genetic	O
interactions	O
,	O
we	O
explored	O
the	O
role	O
of	O
gene1s	O
LEM2	O
gene1e	O
during	O
nuclear	O
envelope	O
reformation	O
in	O
species1s	O
human	O
species1e	O
cells	O
.	O
We	O
found	O
that	O
gene1s	O
CHMP7	O
gene1e	O
and	O
gene1s	O
LEM2	O
gene1e	O
enrich	O
at	O
the	O
same	O
region	O
of	O
the	O
chromatin	O
disk	O
periphery	O
during	O
this	O
window	O
of	O
cell	O
division	O
and	O
that	O
gene1s	O
CHMP7	O
gene1e	O
can	O
bind	O
directly	O
to	O
the	O
C	O
-	O
terminal	O
domain	O
of	O
gene1s	O
LEM2	O
gene1e	O
in	O
vitro	O
.	O
We	O
further	O
found	O
that	O
,	O
during	O
nuclear	O
envelope	O
formation	O
,	O
recruitment	O
of	O
the	O
gene1s	O
ESCRT	O
gene1e	O
factors	O
gene1s	O
CHMP7	O
gene1e	O
,	O
gene1s	O
CHMP2A	O
gene1e	O
,	O
and	O
gene1s	O
IST1	O
gene1e	O
/	O
gene1s	O
CHMP8	O
gene1e	O
all	O
depend	O
on	O
gene1s	O
LEM2	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
cells	O
.	O
We	O
conclude	O
that	O
gene1s	O
Lem2p	O
gene1e	O
/	O
gene1s	O
LEM2	O
gene1e	O
is	O
a	O
conserved	O
nuclear	O
site	O
-	O
specific	O
adaptor	O
that	O
recruits	O
gene1s	O
Cmp7p	O
gene1e	O
/	O
gene1s	O
CHMP7	O
gene1e	O
and	O
downstream	O
gene1s	O
ESCRT	O
gene1e	O
factors	O
to	O
the	O
nuclear	O
envelope	O
.	O

Telocytes	O
:	O
a	O
potential	O
defender	O
in	O
the	O
spleen	O
of	O
gene1s	ARG2
Npc1	ARG2
gene1e	ARG2
mutant	O
arg1s	O
mice	O
arg1e	O
.	O
Niemann	O
-	O
Pick	O
disease	O
,	O
type	O
C1	O
(	O
Npc1	O
)	O
,	O
is	O
an	O
atypical	O
lysosomal	O
storage	O
disorder	O
caused	O
by	O
autosomal	O
recessive	O
inheritance	O
of	O
mutations	O
in	O
gene1s	ARG2
Npc1	ARG2
gene1e	ARG2
gene	O
.	O
In	O
the	O
gene1s	ARG2
Npc1	ARG2
gene1e	ARG2
mutant	O
arg1s	O
mice	O
arg1e	O
(	O
gene1s	ARG2
Npc1	ARG2
gene1e	ARG2
(-/-	O
)	O
)	O
,	O
the	O
initial	O
manifestation	O
is	O
enlarged	O
spleen	O
,	O
concomitant	O
with	O
free	O
cholesterol	O
accumulation	O
.	O
Telocytes	O
(	O
species1s	O
TCs	O
species1e	O
)	O
,	O
a	O
novel	O
type	O
of	O
interstitial	O
cell	O
,	O
exist	O
in	O
a	O
variety	O
of	O
tissues	O
including	O
spleen	O
,	O
presumably	O
thought	O
to	O
be	O
involved	O
in	O
many	O
biological	O
processes	O
such	O
as	O
nursing	O
stem	O
cells	O
and	O
recruiting	O
inflammatory	O
cells	O
.	O
In	O
this	O
study	O
,	O
we	O
found	O
that	O
the	O
spleen	O
is	O
significantly	O
enlarged	O
in	O
gene1s	ARG2
Npc1	ARG2
gene1e	ARG2
(-/-	O
)	O
arg1s	O
mice	O
arg1e	O
,	O
and	O
the	O
results	O
from	O
transmission	O
electron	O
microscopy	O
examination	O
and	O
immunostaining	O
using	O
three	O
different	O
TCs	O
markers	O
,	O
gene1s	ARG2
c	ARG2
-	ARG2
Kit	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD34	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Vimentin	ARG2
gene1e	ARG2
revealed	O
significantly	O
increased	O
splenic	O
TCs	O
in	O
gene1s	ARG2
Npc1	ARG2
gene1e	ARG2
(-/-	O
)	O
arg1s	O
mice	O
arg1e	O
.	O
Furthermore	O
,	O
hematopoietic	O
stem	O
cells	O
and	O
macrophages	O
were	O
also	O
elevated	O
in	O
gene1s	ARG2
Npc1	ARG2
gene1e	ARG2
(-/-	O
)	O
spleen	O
.	O
Taken	O
together	O
,	O
our	O
data	O
indicate	O
that	O
splenic	O
TCs	O
might	O
alleviate	O
the	O
progress	O
of	O
splenic	O
malfunction	O
via	O
recruiting	O
hematopoietic	O
stem	O
cells	O
and	O
macrophages	O
.	O

Telocytes	O
:	O
a	O
potential	O
defender	O
in	O
the	O
spleen	O
of	O
gene1s	O
Npc1	O
gene1e	O
mutant	O
species1s	O
mice	O
species1e	O
.	O
Niemann	O
-	O
Pick	O
disease	O
,	O
type	O
C1	O
(	O
Npc1	O
)	O
,	O
is	O
an	O
atypical	O
lysosomal	O
storage	O
disorder	O
caused	O
by	O
autosomal	O
recessive	O
inheritance	O
of	O
mutations	O
in	O
gene1s	O
Npc1	O
gene1e	O
gene	O
.	O
In	O
the	O
gene1s	O
Npc1	O
gene1e	O
mutant	O
species1s	O
mice	O
species1e	O
(	O
gene1s	O
Npc1	O
gene1e	O
(-/-	O
)	O
)	O
,	O
the	O
initial	O
manifestation	O
is	O
enlarged	O
spleen	O
,	O
concomitant	O
with	O
free	O
cholesterol	O
accumulation	O
.	O
Telocytes	O
(	O
arg1s	O
TCs	O
arg1e	O
)	O
,	O
a	O
novel	O
type	O
of	O
interstitial	O
cell	O
,	O
exist	O
in	O
a	O
variety	O
of	O
tissues	O
including	O
spleen	O
,	O
presumably	O
thought	O
to	O
be	O
involved	O
in	O
many	O
biological	O
processes	O
such	O
as	O
nursing	O
stem	O
cells	O
and	O
recruiting	O
inflammatory	O
cells	O
.	O
In	O
this	O
study	O
,	O
we	O
found	O
that	O
the	O
spleen	O
is	O
significantly	O
enlarged	O
in	O
gene1s	O
Npc1	O
gene1e	O
(-/-	O
)	O
species1s	O
mice	O
species1e	O
,	O
and	O
the	O
results	O
from	O
transmission	O
electron	O
microscopy	O
examination	O
and	O
immunostaining	O
using	O
three	O
different	O
TCs	O
markers	O
,	O
gene1s	O
c	O
-	O
Kit	O
gene1e	O
,	O
gene1s	O
CD34	O
gene1e	O
and	O
gene1s	O
Vimentin	O
gene1e	O
revealed	O
significantly	O
increased	O
splenic	O
TCs	O
in	O
gene1s	O
Npc1	O
gene1e	O
(-/-	O
)	O
species1s	O
mice	O
species1e	O
.	O
Furthermore	O
,	O
hematopoietic	O
stem	O
cells	O
and	O
macrophages	O
were	O
also	O
elevated	O
in	O
gene1s	O
Npc1	O
gene1e	O
(-/-	O
)	O
spleen	O
.	O
Taken	O
together	O
,	O
our	O
data	O
indicate	O
that	O
splenic	O
TCs	O
might	O
alleviate	O
the	O
progress	O
of	O
splenic	O
malfunction	O
via	O
recruiting	O
hematopoietic	O
stem	O
cells	O
and	O
macrophages	O
.	O

Renal	O
gene1s	ARG2
pro	ARG2
-	ARG2
apoptotic	ARG2
proteins	ARG2
gene1e	ARG2
are	O
reduced	O
by	O
gene1s	ARG2
growth	ARG2
hormone	ARG2
gene1e	ARG2
resistance	O
but	O
not	O
by	O
visceral	O
fat	O
removal	O
.	O
gene1s	ARG2
Growth	ARG2
hormone	ARG2
(	ARG2
GH	ARG2
)	ARG2
receptor	ARG2
gene1e	ARG2
knockout	O
(	O
GHRKO	O
)	O
arg1s	O
mice	O
arg1e	O
are	O
highly	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
sensitive	O
and	O
long	O
-	O
lived	O
.	O
Surgical	O
visceral	O
fat	O
removal	O
(	O
VFR	O
)	O
improves	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
signaling	O
in	O
normal	O
arg1s	O
mice	O
arg1e	O
and	O
species1s	O
rats	O
species1e	O
and	O
extends	O
longevity	O
in	O
species1s	O
rats	O
species1e	O
.	O
We	O
have	O
previously	O
demonstrated	O
decreased	O
expression	O
of	O
certain	O
gene1s	ARG2
pro	ARG2
-	ARG2
apoptotic	ARG2
genes	ARG2
gene1e	ARG2
in	O
kidneys	O
of	O
GHRKO	O
arg1s	O
mice	O
arg1e	O
and	O
suggested	O
that	O
this	O
could	O
contribute	O
to	O
the	O
increased	O
longevity	O
of	O
these	O
animals	O
.	O
The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
examine	O
the	O
level	O
of	O
the	O
following	O
proteins	O
:	O
gene1s	ARG2
caspase-3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
caspase-9	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
caspase-8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
bax	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
bad	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
phospho	ARG2
-	ARG2
bad	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
bcl-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Smac	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
DIABLO	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Apaf-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
phospho	ARG2
-	ARG2
p53	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
pp53	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
cytochrome	ARG2
c	ARG2
gene1e	ARG2
in	O
male	O
GHRKO	O
and	O
normal	O
(	O
N	O
)	O
arg1s	O
mice	O
arg1e	O
subjected	O
to	O
VFR	O
or	O
sham	O
surgery	O
,	O
at	O
approximately	O
six	O
months	O
of	O
age	O
.	O
The	O
kidneys	O
were	O
collected	O
two	O
months	O
after	O
VFR	O
.	O
gene1s	ARG2
Caspase-3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
caspase-8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
bax	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
bad	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Smac	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
DIABLO	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Apaf-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
pp53	ARG2
gene1e	ARG2
levels	O
were	O
decreased	O
in	O
GHRKO	O
arg1s	O
mice	O
arg1e	O
as	O
compared	O
to	O
N	O
animals	O
.	O
VFR	O
did	O
not	O
change	O
the	O
level	O
of	O
any	O
of	O
the	O
examined	O
proteins	O
.	O
The	O
decreased	O
renal	O
levels	O
of	O
gene1s	ARG2
pro	ARG2
-	ARG2
apoptotic	ARG2
proteins	ARG2
gene1e	ARG2
could	O
contribute	O
to	O
the	O
extended	O
life	O
-	O
span	O
caused	O
by	O
targeted	O
disruption	O
of	O
the	O
gene1s	ARG2
GH	ARG2
receptor	ARG2
gene1e	ARG2
gene	O
but	O
are	O
apparently	O
not	O
involved	O
in	O
mediating	O
the	O
effects	O
of	O
VFR	O
.	O

Renal	O
gene1s	O
pro	O
-	O
apoptotic	O
proteins	O
gene1e	O
are	O
reduced	O
by	O
gene1s	O
growth	O
hormone	O
gene1e	O
resistance	O
but	O
not	O
by	O
visceral	O
fat	O
removal	O
.	O
gene1s	O
Growth	O
hormone	O
(	O
GH	O
)	O
receptor	O
gene1e	O
knockout	O
(	O
GHRKO	O
)	O
species1s	O
mice	O
species1e	O
are	O
highly	O
gene1s	O
insulin	O
gene1e	O
sensitive	O
and	O
long	O
-	O
lived	O
.	O
Surgical	O
visceral	O
fat	O
removal	O
(	O
VFR	O
)	O
improves	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
signaling	O
in	O
normal	O
species1s	O
mice	O
species1e	O
and	O
arg1s	O
rats	O
arg1e	O
and	O
extends	O
longevity	O
in	O
arg1s	O
rats	O
arg1e	O
.	O
We	O
have	O
previously	O
demonstrated	O
decreased	O
expression	O
of	O
certain	O
gene1s	O
pro	O
-	O
apoptotic	O
genes	O
gene1e	O
in	O
kidneys	O
of	O
GHRKO	O
species1s	O
mice	O
species1e	O
and	O
suggested	O
that	O
this	O
could	O
contribute	O
to	O
the	O
increased	O
longevity	O
of	O
these	O
animals	O
.	O
The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
examine	O
the	O
level	O
of	O
the	O
following	O
proteins	O
:	O
gene1s	O
caspase-3	O
gene1e	O
,	O
gene1s	O
caspase-9	O
gene1e	O
,	O
gene1s	O
caspase-8	O
gene1e	O
,	O
gene1s	O
bax	O
gene1e	O
,	O
gene1s	O
bad	O
gene1e	O
,	O
gene1s	O
phospho	O
-	O
bad	O
gene1e	O
,	O
gene1s	O
bcl-2	O
gene1e	O
,	O
gene1s	O
Smac	O
gene1e	O
/	O
gene1s	O
DIABLO	O
gene1e	O
,	O
gene1s	O
Apaf-1	O
gene1e	O
,	O
gene1s	O
phospho	O
-	O
p53	O
gene1e	O
(	O
gene1s	O
pp53	O
gene1e	O
)	O
and	O
gene1s	O
cytochrome	O
c	O
gene1e	O
in	O
male	O
GHRKO	O
and	O
normal	O
(	O
N	O
)	O
species1s	O
mice	O
species1e	O
subjected	O
to	O
VFR	O
or	O
sham	O
surgery	O
,	O
at	O
approximately	O
six	O
months	O
of	O
age	O
.	O
The	O
kidneys	O
were	O
collected	O
two	O
months	O
after	O
VFR	O
.	O
gene1s	O
Caspase-3	O
gene1e	O
,	O
gene1s	O
caspase-8	O
gene1e	O
,	O
gene1s	O
bax	O
gene1e	O
,	O
gene1s	O
bad	O
gene1e	O
,	O
gene1s	O
Smac	O
gene1e	O
/	O
gene1s	O
DIABLO	O
gene1e	O
,	O
gene1s	O
Apaf-1	O
gene1e	O
and	O
gene1s	O
pp53	O
gene1e	O
levels	O
were	O
decreased	O
in	O
GHRKO	O
species1s	O
mice	O
species1e	O
as	O
compared	O
to	O
N	O
animals	O
.	O
VFR	O
did	O
not	O
change	O
the	O
level	O
of	O
any	O
of	O
the	O
examined	O
proteins	O
.	O
The	O
decreased	O
renal	O
levels	O
of	O
gene1s	O
pro	O
-	O
apoptotic	O
proteins	O
gene1e	O
could	O
contribute	O
to	O
the	O
extended	O
life	O
-	O
span	O
caused	O
by	O
targeted	O
disruption	O
of	O
the	O
gene1s	O
GH	O
receptor	O
gene1e	O
gene	O
but	O
are	O
apparently	O
not	O
involved	O
in	O
mediating	O
the	O
effects	O
of	O
VFR	O
.	O

gene1s	O
TPL-2	O
gene1e	O
restricts	O
gene1s	O
Ccl24	O
gene1e	O
-dependent	O
immunity	O
to	O
arg1s	O
Heligmosomoides	O
polygyrus	O
arg1e	O
.	O
gene1s	O
TPL-2	O
gene1e	O
(	O
gene1s	O
COT	O
gene1e	O
,	O
gene1s	O
MAP3K8	O
gene1e	O
)	O
kinase	O
activates	O
the	O
gene1s	O
MEK1/2	O
gene1e	O
-	O
gene1s	O
ERK1/2	O
gene1e	O
gene1s	O
MAPK	O
gene1e	O
signaling	O
pathway	O
in	O
innate	O
immune	O
responses	O
following	O
gene1s	O
TLR	O
gene1e	O
,	O
gene1s	O
TNFR1	O
gene1e	O
and	O
gene1s	O
IL-1R	O
gene1e	O
stimulation	O
.	O
gene1s	O
TPL-2	O
gene1e	O
contributes	O
to	O
type-1	O
/	O
Th17-mediated	O
autoimmunity	O
and	O
control	O
of	O
intracellular	O
pathogens	O
.	O
We	O
recently	O
demonstrated	O
gene1s	O
TPL-2	O
gene1e	O
reduces	O
severe	O
airway	O
allergy	O
to	O
house	O
dust	O
mite	O
by	O
negatively	O
regulating	O
type-2	O
responses	O
.	O
In	O
the	O
present	O
study	O
,	O
we	O
found	O
that	O
gene1s	O
TPL-2	O
gene1e	O
deficiency	O
resulted	O
in	O
resistance	O
to	O
arg1s	O
Heligmosomoides	O
polygyrus	O
arg1e	O
infection	O
,	O
with	O
accelerated	O
worm	O
expulsion	O
,	O
reduced	O
fecal	O
egg	O
burden	O
and	O
reduced	O
worm	O
fitness	O
.	O
Using	O
co	O
-	O
housing	O
experiments	O
,	O
we	O
found	O
resistance	O
to	O
infection	O
in	O
gene1s	O
TPL-2	O
gene1e	O
deficient	O
species1s	O
mice	O
species1e	O
(	O
gene1s	O
Map3k8	O
gene1e	O
-/-	O
)	O
was	O
independent	O
of	O
microbiota	O
alterations	O
in	O
arg1s	O
H.	O
polygyrus	O
arg1e	O
infected	O
WT	O
and	O
gene1s	O
Map3k8	O
gene1e	O
-/-	O
species1s	O
mice	O
species1e	O
.	O
Additionally	O
,	O
our	O
data	O
demonstrated	O
immunity	O
to	O
arg1s	O
H.	O
polygyrus	O
arg1e	O
infection	O
in	O
gene1s	O
TPL-2	O
gene1e	O
deficient	O
species1s	O
mice	O
species1e	O
was	O
not	O
due	O
to	O
dysregulated	O
type-2	O
immune	O
responses	O
.	O
Genome	O
-	O
wide	O
analysis	O
of	O
intestinal	O
tissue	O
from	O
infected	O
gene1s	O
TPL-2	O
gene1e	O
-deficient	O
species1s	O
mice	O
species1e	O
identified	O
elevated	O
expression	O
of	O
genes	O
involved	O
in	O
chemotaxis	O
and	O
homing	O
of	O
leukocytes	O
and	O
cells	O
,	O
including	O
gene1s	O
Ccl24	O
gene1e	O
and	O
alternatively	O
activated	O
genes	O
.	O
Indeed	O
,	O
gene1s	O
Map3k8	O
gene1e	O
-/-	O
species1s	O
mice	O
species1e	O
had	O
a	O
significant	O
influx	O
of	O
eosinophils	O
,	O
neutrophils	O
,	O
monocytes	O
and	O
Il4GFP+	O
T	O
cells	O
.	O
Conditional	O
knockout	O
experiments	O
demonstrated	O
that	O
specific	O
deletion	O
of	O
gene1s	O
TPL-2	O
gene1e	O
in	O
gene1s	O
CD11c	O
gene1e	O
+	O
cells	O
,	O
but	O
not	O
gene1s	O
Villin	O
gene1e	O
+	O
epithelial	O
cells	O
,	O
gene1s	O
LysM	O
gene1e	O
+	O
myeloid	O
cells	O
or	O
gene1s	O
CD4	O
gene1e	O
+	O
T	O
cells	O
,	O
led	O
to	O
accelerated	O
resistance	O
to	O
arg1s	O
H.	O
polygyrus	O
arg1e	O
.	O
In	O
line	O
with	O
a	O
central	O
role	O
of	O
gene1s	O
CD11c	O
gene1e	O
+	O
cells	O
,	O
gene1s	O
CD11c	O
gene1e	O
+	O
gene1s	O
CD11b	O
gene1e	O
+	O
cells	O
isolated	O
from	O
gene1s	O
TPL-2	O
gene1e	O
-deficient	O
species1s	O
mice	O
species1e	O
had	O
elevated	O
gene1s	O
Ccl24	O
gene1e	O
.	O
Finally	O
,	O
gene1s	O
Ccl24	O
gene1e	O
neutralization	O
in	O
gene1s	O
TPL-2	O
gene1e	O
deficient	O
species1s	O
mice	O
species1e	O
significantly	O
decreased	O
the	O
expression	O
of	O
gene1s	O
Arg1	O
gene1e	O
,	O
gene1s	O
Retnla	O
gene1e	O
,	O
gene1s	O
Chil3	O
gene1e	O
and	O
gene1s	O
Ear11	O
gene1e	O
correlating	O
with	O
a	O
loss	O
of	O
resistance	O
to	O
arg1s	O
H.	O
polygyrus	O
arg1e	O
.	O
These	O
observations	O
suggest	O
that	O
gene1s	O
TPL-2	O
gene1e	O
-regulated	O
gene1s	O
Ccl24	O
gene1e	O
in	O
gene1s	O
CD11c	O
gene1e	O
+	O
gene1s	O
CD11b	O
gene1e	O
+	O
cells	O
prevents	O
accelerated	O
type-2	O
mediated	O
immunity	O
to	O
arg1s	O
H.	O
polygyrus	O
arg1e	O
.	O
Collectively	O
,	O
this	O
study	O
identifies	O
a	O
previously	O
unappreciated	O
role	O
for	O
gene1s	O
TPL-2	O
gene1e	O
controlling	O
immune	O
responses	O
to	O
arg1s	O
H.	O
polygyrus	O
arg1e	O
infection	O
by	O
restricting	O
gene1s	O
Ccl24	O
gene1e	O
production	O
.	O

gene1s	ARG2
TPL-2	ARG2
gene1e	ARG2
restricts	O
gene1s	ARG2
Ccl24	ARG2
gene1e	ARG2
-dependent	O
immunity	O
to	O
species1s	O
Heligmosomoides	O
polygyrus	O
species1e	O
.	O
gene1s	ARG2
TPL-2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
COT	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MAP3K8	ARG2
gene1e	ARG2
)	O
kinase	O
activates	O
the	O
gene1s	ARG2
MEK1/2	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
signaling	O
pathway	O
in	O
innate	O
immune	O
responses	O
following	O
gene1s	ARG2
TLR	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TNFR1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL-1R	ARG2
gene1e	ARG2
stimulation	O
.	O
gene1s	ARG2
TPL-2	ARG2
gene1e	ARG2
contributes	O
to	O
type-1	O
/	O
Th17-mediated	O
autoimmunity	O
and	O
control	O
of	O
intracellular	O
pathogens	O
.	O
We	O
recently	O
demonstrated	O
gene1s	ARG2
TPL-2	ARG2
gene1e	ARG2
reduces	O
severe	O
airway	O
allergy	O
to	O
house	O
dust	O
mite	O
by	O
negatively	O
regulating	O
type-2	O
responses	O
.	O
In	O
the	O
present	O
study	O
,	O
we	O
found	O
that	O
gene1s	ARG2
TPL-2	ARG2
gene1e	ARG2
deficiency	O
resulted	O
in	O
resistance	O
to	O
species1s	O
Heligmosomoides	O
polygyrus	O
species1e	O
infection	O
,	O
with	O
accelerated	O
worm	O
expulsion	O
,	O
reduced	O
fecal	O
egg	O
burden	O
and	O
reduced	O
worm	O
fitness	O
.	O
Using	O
co	O
-	O
housing	O
experiments	O
,	O
we	O
found	O
resistance	O
to	O
infection	O
in	O
gene1s	ARG2
TPL-2	ARG2
gene1e	ARG2
deficient	O
arg1s	O
mice	O
arg1e	O
(	O
gene1s	ARG2
Map3k8	ARG2
gene1e	ARG2
-/-	O
)	O
was	O
independent	O
of	O
microbiota	O
alterations	O
in	O
species1s	O
H.	O
polygyrus	O
species1e	O
infected	O
WT	O
and	O
gene1s	ARG2
Map3k8	ARG2
gene1e	ARG2
-/-	O
arg1s	O
mice	O
arg1e	O
.	O
Additionally	O
,	O
our	O
data	O
demonstrated	O
immunity	O
to	O
species1s	O
H.	O
polygyrus	O
species1e	O
infection	O
in	O
gene1s	ARG2
TPL-2	ARG2
gene1e	ARG2
deficient	O
arg1s	O
mice	O
arg1e	O
was	O
not	O
due	O
to	O
dysregulated	O
type-2	O
immune	O
responses	O
.	O
Genome	O
-	O
wide	O
analysis	O
of	O
intestinal	O
tissue	O
from	O
infected	O
gene1s	ARG2
TPL-2	ARG2
gene1e	ARG2
-deficient	O
arg1s	O
mice	O
arg1e	O
identified	O
elevated	O
expression	O
of	O
genes	O
involved	O
in	O
chemotaxis	O
and	O
homing	O
of	O
leukocytes	O
and	O
cells	O
,	O
including	O
gene1s	ARG2
Ccl24	ARG2
gene1e	ARG2
and	O
alternatively	O
activated	O
genes	O
.	O
Indeed	O
,	O
gene1s	ARG2
Map3k8	ARG2
gene1e	ARG2
-/-	O
arg1s	O
mice	O
arg1e	O
had	O
a	O
significant	O
influx	O
of	O
eosinophils	O
,	O
neutrophils	O
,	O
monocytes	O
and	O
Il4GFP+	O
T	O
cells	O
.	O
Conditional	O
knockout	O
experiments	O
demonstrated	O
that	O
specific	O
deletion	O
of	O
gene1s	ARG2
TPL-2	ARG2
gene1e	ARG2
in	O
gene1s	ARG2
CD11c	ARG2
gene1e	ARG2
+	O
cells	O
,	O
but	O
not	O
gene1s	ARG2
Villin	ARG2
gene1e	ARG2
+	O
epithelial	O
cells	O
,	O
gene1s	ARG2
LysM	ARG2
gene1e	ARG2
+	O
myeloid	O
cells	O
or	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
+	O
T	O
cells	O
,	O
led	O
to	O
accelerated	O
resistance	O
to	O
species1s	O
H.	O
polygyrus	O
species1e	O
.	O
In	O
line	O
with	O
a	O
central	O
role	O
of	O
gene1s	ARG2
CD11c	ARG2
gene1e	ARG2
+	O
cells	O
,	O
gene1s	ARG2
CD11c	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
CD11b	ARG2
gene1e	ARG2
+	O
cells	O
isolated	O
from	O
gene1s	ARG2
TPL-2	ARG2
gene1e	ARG2
-deficient	O
arg1s	O
mice	O
arg1e	O
had	O
elevated	O
gene1s	ARG2
Ccl24	ARG2
gene1e	ARG2
.	O
Finally	O
,	O
gene1s	ARG2
Ccl24	ARG2
gene1e	ARG2
neutralization	O
in	O
gene1s	ARG2
TPL-2	ARG2
gene1e	ARG2
deficient	O
arg1s	O
mice	O
arg1e	O
significantly	O
decreased	O
the	O
expression	O
of	O
gene1s	ARG2
Arg1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Retnla	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Chil3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Ear11	ARG2
gene1e	ARG2
correlating	O
with	O
a	O
loss	O
of	O
resistance	O
to	O
species1s	O
H.	O
polygyrus	O
species1e	O
.	O
These	O
observations	O
suggest	O
that	O
gene1s	ARG2
TPL-2	ARG2
gene1e	ARG2
-regulated	O
gene1s	ARG2
Ccl24	ARG2
gene1e	ARG2
in	O
gene1s	ARG2
CD11c	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
CD11b	ARG2
gene1e	ARG2
+	O
cells	O
prevents	O
accelerated	O
type-2	O
mediated	O
immunity	O
to	O
species1s	O
H.	O
polygyrus	O
species1e	O
.	O
Collectively	O
,	O
this	O
study	O
identifies	O
a	O
previously	O
unappreciated	O
role	O
for	O
gene1s	ARG2
TPL-2	ARG2
gene1e	ARG2
controlling	O
immune	O
responses	O
to	O
species1s	O
H.	O
polygyrus	O
species1e	O
infection	O
by	O
restricting	O
gene1s	ARG2
Ccl24	ARG2
gene1e	ARG2
production	O
.	O

Defining	O
a	O
Novel	O
Role	O
for	O
the	O
gene1s	O
Coxsackievirus	O
and	O
Adenovirus	O
Receptor	O
gene1e	O
in	O
arg1s	O
Human	O
Adenovirus	O
arg1e	O
Serotype	O
5	O
Transduction	O
In	O
Vitro	O
in	O
the	O
Presence	O
of	O
species1s	O
Mouse	O
species1e	O
Serum	O
.	O
species1s	O
Human	O
species1e	O
adenoviral	O
serotype	O
5	O
(	O
HAdV-5	O
)	O
vectors	O
have	O
predominantly	O
hepatic	O
tropism	O
when	O
delivered	O
intravascularly	O
,	O
resulting	O
in	O
immune	O
activation	O
and	O
toxicity	O
.	O
gene1s	O
Coagulation	O
factor	O
X	O
gene1e	O
(	O
gene1s	O
FX	O
gene1e	O
)	O
binding	O
to	O
HAdV-5	O
mediates	O
liver	O
transduction	O
and	O
provides	O
protection	O
from	O
virion	O
neutralization	O
in	O
species1s	O
mice	O
species1e	O
.	O
gene1s	O
FX	O
gene1e	O
is	O
dispensable	O
for	O
liver	O
transduction	O
in	O
species1s	O
mice	O
species1e	O
lacking	O
gene1s	O
IgM	O
gene1e	O
antibodies	O
or	O
gene1s	O
complement	O
gene1e	O
,	O
suggesting	O
that	O
alternative	O
transduction	O
pathways	O
exist	O
.	O
To	O
identify	O
novel	O
factor(s	O
)	O
mediating	O
HAdV-5	O
gene1s	O
FX	O
gene1e	O
-	O
independent	O
entry	O
,	O
we	O
investigated	O
HAdV-5	O
transduction	O
in	O
vitro	O
in	O
the	O
presence	O
of	O
serum	O
from	O
immunocompetent	O
C57BL/6	O
or	O
immunocompromised	O
species1s	O
mice	O
species1e	O
lacking	O
gene1s	O
IgM	O
gene1e	O
antibodies	O
(	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
and	O
NOD	O
-	O
scid	O
-	O
gamma	O
[	O
NSG	O
]	O
)	O
.	O
Sera	O
from	O
all	O
three	O
species1s	O
mouse	O
species1e	O
strains	O
enhanced	O
HAdV-5	O
transduction	O
of	O
A549	O
cells	O
.	O
While	O
inhibition	O
of	O
HAdV-5-	O
gene1s	O
FX	O
gene1e	O
interaction	O
with	O
gene1s	O
FX	O
gene1e	O
-	O
binding	O
protein	O
(	O
X	O
-	O
bp	O
)	O
inhibited	O
transduction	O
in	O
the	O
presence	O
of	O
C57BL/6	O
serum	O
,	O
it	O
had	O
negligible	O
effect	O
on	O
the	O
enhanced	O
transduction	O
observed	O
in	O
the	O
presence	O
of	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
or	O
NSG	O
serum	O
.	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
serum	O
also	O
enhanced	O
transduction	O
of	O
the	O
gene1s	O
FX	O
gene1e	O
binding	O
-	O
deficient	O
HAdV-5HVR5*HVR7*E451Q	O
(	O
AdT	O
*	O
)	O
.	O
Interestingly	O
,	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
serum	O
enhanced	O
HAdV-5	O
transduction	O
in	O
a	O
gene1s	O
FX	O
gene1e	O
-	O
independent	O
manner	O
in	O
CHO	O
-	O
gene1s	O
CAR	O
gene1e	O
and	O
SKOV3-	O
gene1s	O
CAR	O
gene1e	O
cells	O
(	O
species1s	O
CHO	O
species1e	O
or	O
species1s	O
SKOV3	O
species1e	O
cells	O
transfected	O
to	O
stably	O
express	O
species1s	O
human	O
species1e	O
gene1s	O
coxsackievirus	O
and	O
adenovirus	O
receptor	O
gene1e	O
[	O
gene1s	O
CAR	O
gene1e	O
]	O
)	O
.	O
Additionally	O
,	O
blockade	O
of	O
gene1s	O
CAR	O
gene1e	O
with	O
soluble	O
HAdV-5	O
fiber	O
knob	O
inhibited	O
species1s	O
mouse	O
species1e	O
serum	O
-	O
enhanced	O
transduction	O
in	O
A549	O
cells	O
,	O
suggesting	O
a	O
potential	O
role	O
for	O
gene1s	O
CAR	O
gene1e	O
.	O
Transduction	O
of	O
HAdV-5	O
KO1	O
and	O
HAdV-5	O
/	O
F35	O
(	O
gene1s	O
CAR	O
gene1e	O
binding	O
deficient	O
)	O
in	O
the	O
presence	O
of	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
serum	O
was	O
equivalent	O
to	O
that	O
of	O
HAdV-5	O
,	O
indicating	O
that	O
direct	O
interaction	O
between	O
HAdV-5	O
and	O
gene1s	O
CAR	O
gene1e	O
is	O
not	O
required	O
.	O
These	O
data	O
suggest	O
that	O
gene1s	O
FX	O
gene1e	O
may	O
protect	O
HAdV-5	O
from	O
neutralization	O
but	O
has	O
minimal	O
contribution	O
to	O
HAdV-5	O
transduction	O
in	O
the	O
presence	O
of	O
immunocompromised	O
species1s	O
mouse	O
species1e	O
serum	O
.	O
Alternatively	O
,	O
transduction	O
occurs	O
via	O
an	O
unidentified	O
species1s	O
mouse	O
species1e	O
serum	O
protein	O
capable	O
of	O
bridging	O
HAdV-5	O
to	O
gene1s	O
CAR	O
gene1e	O
.IMPORTANCE	O
The	O
intravascular	O
administration	O
of	O
HAdV-5	O
vectors	O
can	O
result	O
in	O
acute	O
liver	O
toxicity	O
,	O
transaminitis	O
,	O
thrombocytopenia	O
,	O
and	O
injury	O
to	O
the	O
vascular	O
endothelium	O
,	O
illustrating	O
challenges	O
yet	O
to	O
overcome	O
for	O
HAdV-5-mediated	O
systemic	O
gene	O
therapy	O
.	O
The	O
finding	O
that	O
gene1s	O
CAR	O
gene1e	O
and	O
potentially	O
an	O
unidentified	O
factor	O
present	O
in	O
species1s	O
mouse	O
species1e	O
serum	O
might	O
be	O
important	O
mediators	O
of	O
HAdV-5	O
transduction	O
highlights	O
that	O
a	O
better	O
understanding	O
of	O
the	O
complex	O
biology	O
defining	O
the	O
interplay	O
between	O
species1s	O
adenovirus	O
species1e	O
immune	O
recognition	O
and	O
cellular	O
uptake	O
mechanisms	O
is	O
still	O
required	O
.	O
These	O
findings	O
are	O
important	O
to	O
inform	O
future	O
optimization	O
and	O
development	O
of	O
HAdV-5-based	O
adenoviral	O
vectors	O
for	O
gene	O
therapy	O
.	O

Defining	O
a	O
Novel	O
Role	O
for	O
the	O
gene1s	O
Coxsackievirus	O
and	O
Adenovirus	O
Receptor	O
gene1e	O
in	O
species1s	O
Human	O
Adenovirus	O
species1e	O
Serotype	O
5	O
Transduction	O
In	O
Vitro	O
in	O
the	O
Presence	O
of	O
arg1s	O
Mouse	O
arg1e	O
Serum	O
.	O
species1s	O
Human	O
species1e	O
adenoviral	O
serotype	O
5	O
(	O
HAdV-5	O
)	O
vectors	O
have	O
predominantly	O
hepatic	O
tropism	O
when	O
delivered	O
intravascularly	O
,	O
resulting	O
in	O
immune	O
activation	O
and	O
toxicity	O
.	O
gene1s	ARG2
Coagulation	ARG2
factor	ARG2
X	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
FX	ARG2
gene1e	ARG2
)	O
binding	O
to	O
HAdV-5	O
mediates	O
liver	O
transduction	O
and	O
provides	O
protection	O
from	O
virion	O
neutralization	O
in	O
arg1s	O
mice	O
arg1e	O
.	O
gene1s	ARG2
FX	ARG2
gene1e	ARG2
is	O
dispensable	O
for	O
liver	O
transduction	O
in	O
arg1s	O
mice	O
arg1e	O
lacking	O
gene1s	ARG2
IgM	ARG2
gene1e	ARG2
antibodies	O
or	O
gene1s	ARG2
complement	ARG2
gene1e	ARG2
,	O
suggesting	O
that	O
alternative	O
transduction	O
pathways	O
exist	O
.	O
To	O
identify	O
novel	O
factor(s	O
)	O
mediating	O
HAdV-5	O
gene1s	O
FX	O
gene1e	O
-	O
independent	O
entry	O
,	O
we	O
investigated	O
HAdV-5	O
transduction	O
in	O
vitro	O
in	O
the	O
presence	O
of	O
serum	O
from	O
immunocompetent	O
C57BL/6	O
or	O
immunocompromised	O
arg1s	O
mice	O
arg1e	O
lacking	O
gene1s	ARG2
IgM	ARG2
gene1e	ARG2
antibodies	O
(	O
gene1s	ARG2
Rag	ARG2
2	ARG2
gene1e	ARG2
(-/-	O
)	O
and	O
NOD	O
-	O
scid	O
-	O
gamma	O
[	O
NSG	O
]	O
)	O
.	O
Sera	O
from	O
all	O
three	O
arg1s	O
mouse	O
arg1e	O
strains	O
enhanced	O
HAdV-5	O
transduction	O
of	O
A549	O
cells	O
.	O
While	O
inhibition	O
of	O
HAdV-5-	O
gene1s	O
FX	O
gene1e	O
interaction	O
with	O
gene1s	O
FX	O
gene1e	O
-	O
binding	O
protein	O
(	O
X	O
-	O
bp	O
)	O
inhibited	O
transduction	O
in	O
the	O
presence	O
of	O
C57BL/6	O
serum	O
,	O
it	O
had	O
negligible	O
effect	O
on	O
the	O
enhanced	O
transduction	O
observed	O
in	O
the	O
presence	O
of	O
gene1s	ARG2
Rag	ARG2
2	ARG2
gene1e	ARG2
(-/-	O
)	O
or	O
NSG	O
serum	O
.	O
gene1s	ARG2
Rag	ARG2
2	ARG2
gene1e	ARG2
(-/-	O
)	O
serum	O
also	O
enhanced	O
transduction	O
of	O
the	O
gene1s	O
FX	O
gene1e	O
binding	O
-	O
deficient	O
HAdV-5HVR5*HVR7*E451Q	O
(	O
AdT	O
*	O
)	O
.	O
Interestingly	O
,	O
gene1s	ARG2
Rag	ARG2
2	ARG2
gene1e	ARG2
(-/-	O
)	O
serum	O
enhanced	O
HAdV-5	O
transduction	O
in	O
a	O
gene1s	O
FX	O
gene1e	O
-	O
independent	O
manner	O
in	O
CHO	O
-	O
gene1s	O
CAR	O
gene1e	O
and	O
SKOV3-	O
gene1s	O
CAR	O
gene1e	O
cells	O
(	O
species1s	O
CHO	O
species1e	O
or	O
species1s	O
SKOV3	O
species1e	O
cells	O
transfected	O
to	O
stably	O
express	O
species1s	O
human	O
species1e	O
gene1s	O
coxsackievirus	O
and	O
adenovirus	O
receptor	O
gene1e	O
[	O
gene1s	O
CAR	O
gene1e	O
]	O
)	O
.	O
Additionally	O
,	O
blockade	O
of	O
gene1s	O
CAR	O
gene1e	O
with	O
soluble	O
HAdV-5	O
fiber	O
knob	O
inhibited	O
arg1s	O
mouse	O
arg1e	O
serum	O
-	O
enhanced	O
transduction	O
in	O
A549	O
cells	O
,	O
suggesting	O
a	O
potential	O
role	O
for	O
gene1s	O
CAR	O
gene1e	O
.	O
Transduction	O
of	O
HAdV-5	O
KO1	O
and	O
HAdV-5	O
/	O
F35	O
(	O
gene1s	O
CAR	O
gene1e	O
binding	O
deficient	O
)	O
in	O
the	O
presence	O
of	O
gene1s	ARG2
Rag	ARG2
2	ARG2
gene1e	ARG2
(-/-	O
)	O
serum	O
was	O
equivalent	O
to	O
that	O
of	O
HAdV-5	O
,	O
indicating	O
that	O
direct	O
interaction	O
between	O
HAdV-5	O
and	O
gene1s	O
CAR	O
gene1e	O
is	O
not	O
required	O
.	O
These	O
data	O
suggest	O
that	O
gene1s	O
FX	O
gene1e	O
may	O
protect	O
HAdV-5	O
from	O
neutralization	O
but	O
has	O
minimal	O
contribution	O
to	O
HAdV-5	O
transduction	O
in	O
the	O
presence	O
of	O
immunocompromised	O
arg1s	O
mouse	O
arg1e	O
serum	O
.	O
Alternatively	O
,	O
transduction	O
occurs	O
via	O
an	O
unidentified	O
arg1s	O
mouse	O
arg1e	O
serum	O
protein	O
capable	O
of	O
bridging	O
HAdV-5	O
to	O
gene1s	O
CAR	O
gene1e	O
.IMPORTANCE	O
The	O
intravascular	O
administration	O
of	O
HAdV-5	O
vectors	O
can	O
result	O
in	O
acute	O
liver	O
toxicity	O
,	O
transaminitis	O
,	O
thrombocytopenia	O
,	O
and	O
injury	O
to	O
the	O
vascular	O
endothelium	O
,	O
illustrating	O
challenges	O
yet	O
to	O
overcome	O
for	O
HAdV-5-mediated	O
systemic	O
gene	O
therapy	O
.	O
The	O
finding	O
that	O
gene1s	O
CAR	O
gene1e	O
and	O
potentially	O
an	O
unidentified	O
factor	O
present	O
in	O
arg1s	O
mouse	O
arg1e	O
serum	O
might	O
be	O
important	O
mediators	O
of	O
HAdV-5	O
transduction	O
highlights	O
that	O
a	O
better	O
understanding	O
of	O
the	O
complex	O
biology	O
defining	O
the	O
interplay	O
between	O
species1s	O
adenovirus	O
species1e	O
immune	O
recognition	O
and	O
cellular	O
uptake	O
mechanisms	O
is	O
still	O
required	O
.	O
These	O
findings	O
are	O
important	O
to	O
inform	O
future	O
optimization	O
and	O
development	O
of	O
HAdV-5-based	O
adenoviral	O
vectors	O
for	O
gene	O
therapy	O
.	O

Defining	O
a	O
Novel	O
Role	O
for	O
the	O
gene1s	ARG2
Coxsackievirus	ARG2
and	ARG2
Adenovirus	ARG2
Receptor	ARG2
gene1e	ARG2
in	O
species1s	O
Human	O
Adenovirus	O
species1e	O
Serotype	O
5	O
Transduction	O
In	O
Vitro	O
in	O
the	O
Presence	O
of	O
species1s	O
Mouse	O
species1e	O
Serum	O
.	O
arg1s	O
Human	O
arg1e	O
adenoviral	O
serotype	O
5	O
(	O
HAdV-5	O
)	O
vectors	O
have	O
predominantly	O
hepatic	O
tropism	O
when	O
delivered	O
intravascularly	O
,	O
resulting	O
in	O
immune	O
activation	O
and	O
toxicity	O
.	O
gene1s	O
Coagulation	O
factor	O
X	O
gene1e	O
(	O
gene1s	O
FX	O
gene1e	O
)	O
binding	O
to	O
HAdV-5	O
mediates	O
liver	O
transduction	O
and	O
provides	O
protection	O
from	O
virion	O
neutralization	O
in	O
species1s	O
mice	O
species1e	O
.	O
gene1s	O
FX	O
gene1e	O
is	O
dispensable	O
for	O
liver	O
transduction	O
in	O
species1s	O
mice	O
species1e	O
lacking	O
gene1s	O
IgM	O
gene1e	O
antibodies	O
or	O
gene1s	O
complement	O
gene1e	O
,	O
suggesting	O
that	O
alternative	O
transduction	O
pathways	O
exist	O
.	O
To	O
identify	O
novel	O
factor(s	O
)	O
mediating	O
HAdV-5	O
gene1s	ARG2
FX	ARG2
gene1e	ARG2
-	O
independent	O
entry	O
,	O
we	O
investigated	O
HAdV-5	O
transduction	O
in	O
vitro	O
in	O
the	O
presence	O
of	O
serum	O
from	O
immunocompetent	O
C57BL/6	O
or	O
immunocompromised	O
species1s	O
mice	O
species1e	O
lacking	O
gene1s	O
IgM	O
gene1e	O
antibodies	O
(	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
and	O
NOD	O
-	O
scid	O
-	O
gamma	O
[	O
NSG	O
]	O
)	O
.	O
Sera	O
from	O
all	O
three	O
species1s	O
mouse	O
species1e	O
strains	O
enhanced	O
HAdV-5	O
transduction	O
of	O
A549	O
cells	O
.	O
While	O
inhibition	O
of	O
HAdV-5-	O
gene1s	ARG2
FX	ARG2
gene1e	ARG2
interaction	O
with	O
gene1s	ARG2
FX	ARG2
gene1e	ARG2
-	O
binding	O
protein	O
(	O
X	O
-	O
bp	O
)	O
inhibited	O
transduction	O
in	O
the	O
presence	O
of	O
C57BL/6	O
serum	O
,	O
it	O
had	O
negligible	O
effect	O
on	O
the	O
enhanced	O
transduction	O
observed	O
in	O
the	O
presence	O
of	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
or	O
NSG	O
serum	O
.	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
serum	O
also	O
enhanced	O
transduction	O
of	O
the	O
gene1s	ARG2
FX	ARG2
gene1e	ARG2
binding	O
-	O
deficient	O
HAdV-5HVR5*HVR7*E451Q	O
(	O
AdT	O
*	O
)	O
.	O
Interestingly	O
,	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
serum	O
enhanced	O
HAdV-5	O
transduction	O
in	O
a	O
gene1s	ARG2
FX	ARG2
gene1e	ARG2
-	O
independent	O
manner	O
in	O
CHO	O
-	O
gene1s	ARG2
CAR	ARG2
gene1e	ARG2
and	O
SKOV3-	O
gene1s	ARG2
CAR	ARG2
gene1e	ARG2
cells	O
(	O
species1s	O
CHO	O
species1e	O
or	O
arg1s	O
SKOV3	O
arg1e	O
cells	O
transfected	O
to	O
stably	O
express	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
coxsackievirus	ARG2
and	ARG2
adenovirus	ARG2
receptor	ARG2
gene1e	ARG2
[	O
gene1s	ARG2
CAR	ARG2
gene1e	ARG2
]	O
)	O
.	O
Additionally	O
,	O
blockade	O
of	O
gene1s	ARG2
CAR	ARG2
gene1e	ARG2
with	O
soluble	O
HAdV-5	O
fiber	O
knob	O
inhibited	O
species1s	O
mouse	O
species1e	O
serum	O
-	O
enhanced	O
transduction	O
in	O
A549	O
cells	O
,	O
suggesting	O
a	O
potential	O
role	O
for	O
gene1s	ARG2
CAR	ARG2
gene1e	ARG2
.	O
Transduction	O
of	O
HAdV-5	O
KO1	O
and	O
HAdV-5	O
/	O
F35	O
(	O
gene1s	ARG2
CAR	ARG2
gene1e	ARG2
binding	O
deficient	O
)	O
in	O
the	O
presence	O
of	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
serum	O
was	O
equivalent	O
to	O
that	O
of	O
HAdV-5	O
,	O
indicating	O
that	O
direct	O
interaction	O
between	O
HAdV-5	O
and	O
gene1s	ARG2
CAR	ARG2
gene1e	ARG2
is	O
not	O
required	O
.	O
These	O
data	O
suggest	O
that	O
gene1s	ARG2
FX	ARG2
gene1e	ARG2
may	O
protect	O
HAdV-5	O
from	O
neutralization	O
but	O
has	O
minimal	O
contribution	O
to	O
HAdV-5	O
transduction	O
in	O
the	O
presence	O
of	O
immunocompromised	O
species1s	O
mouse	O
species1e	O
serum	O
.	O
Alternatively	O
,	O
transduction	O
occurs	O
via	O
an	O
unidentified	O
species1s	O
mouse	O
species1e	O
serum	O
protein	O
capable	O
of	O
bridging	O
HAdV-5	O
to	O
gene1s	ARG2
CAR	ARG2
gene1e	ARG2
.IMPORTANCE	O
The	O
intravascular	O
administration	O
of	O
HAdV-5	O
vectors	O
can	O
result	O
in	O
acute	O
liver	O
toxicity	O
,	O
transaminitis	O
,	O
thrombocytopenia	O
,	O
and	O
injury	O
to	O
the	O
vascular	O
endothelium	O
,	O
illustrating	O
challenges	O
yet	O
to	O
overcome	O
for	O
HAdV-5-mediated	O
systemic	O
gene	O
therapy	O
.	O
The	O
finding	O
that	O
gene1s	ARG2
CAR	ARG2
gene1e	ARG2
and	O
potentially	O
an	O
unidentified	O
factor	O
present	O
in	O
species1s	O
mouse	O
species1e	O
serum	O
might	O
be	O
important	O
mediators	O
of	O
HAdV-5	O
transduction	O
highlights	O
that	O
a	O
better	O
understanding	O
of	O
the	O
complex	O
biology	O
defining	O
the	O
interplay	O
between	O
species1s	O
adenovirus	O
species1e	O
immune	O
recognition	O
and	O
cellular	O
uptake	O
mechanisms	O
is	O
still	O
required	O
.	O
These	O
findings	O
are	O
important	O
to	O
inform	O
future	O
optimization	O
and	O
development	O
of	O
HAdV-5-based	O
adenoviral	O
vectors	O
for	O
gene	O
therapy	O
.	O

Defining	O
a	O
Novel	O
Role	O
for	O
the	O
gene1s	O
Coxsackievirus	O
and	O
Adenovirus	O
Receptor	O
gene1e	O
in	O
species1s	O
Human	O
Adenovirus	O
species1e	O
Serotype	O
5	O
Transduction	O
In	O
Vitro	O
in	O
the	O
Presence	O
of	O
species1s	O
Mouse	O
species1e	O
Serum	O
.	O
species1s	O
Human	O
species1e	O
adenoviral	O
serotype	O
5	O
(	O
HAdV-5	O
)	O
vectors	O
have	O
predominantly	O
hepatic	O
tropism	O
when	O
delivered	O
intravascularly	O
,	O
resulting	O
in	O
immune	O
activation	O
and	O
toxicity	O
.	O
gene1s	O
Coagulation	O
factor	O
X	O
gene1e	O
(	O
gene1s	O
FX	O
gene1e	O
)	O
binding	O
to	O
HAdV-5	O
mediates	O
liver	O
transduction	O
and	O
provides	O
protection	O
from	O
virion	O
neutralization	O
in	O
species1s	O
mice	O
species1e	O
.	O
gene1s	O
FX	O
gene1e	O
is	O
dispensable	O
for	O
liver	O
transduction	O
in	O
species1s	O
mice	O
species1e	O
lacking	O
gene1s	O
IgM	O
gene1e	O
antibodies	O
or	O
gene1s	O
complement	O
gene1e	O
,	O
suggesting	O
that	O
alternative	O
transduction	O
pathways	O
exist	O
.	O
To	O
identify	O
novel	O
factor(s	O
)	O
mediating	O
HAdV-5	O
gene1s	O
FX	O
gene1e	O
-	O
independent	O
entry	O
,	O
we	O
investigated	O
HAdV-5	O
transduction	O
in	O
vitro	O
in	O
the	O
presence	O
of	O
serum	O
from	O
immunocompetent	O
C57BL/6	O
or	O
immunocompromised	O
species1s	O
mice	O
species1e	O
lacking	O
gene1s	O
IgM	O
gene1e	O
antibodies	O
(	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
and	O
NOD	O
-	O
scid	O
-	O
gamma	O
[	O
NSG	O
]	O
)	O
.	O
Sera	O
from	O
all	O
three	O
species1s	O
mouse	O
species1e	O
strains	O
enhanced	O
HAdV-5	O
transduction	O
of	O
A549	O
cells	O
.	O
While	O
inhibition	O
of	O
HAdV-5-	O
gene1s	O
FX	O
gene1e	O
interaction	O
with	O
gene1s	O
FX	O
gene1e	O
-	O
binding	O
protein	O
(	O
X	O
-	O
bp	O
)	O
inhibited	O
transduction	O
in	O
the	O
presence	O
of	O
C57BL/6	O
serum	O
,	O
it	O
had	O
negligible	O
effect	O
on	O
the	O
enhanced	O
transduction	O
observed	O
in	O
the	O
presence	O
of	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
or	O
NSG	O
serum	O
.	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
serum	O
also	O
enhanced	O
transduction	O
of	O
the	O
gene1s	O
FX	O
gene1e	O
binding	O
-	O
deficient	O
HAdV-5HVR5*HVR7*E451Q	O
(	O
AdT	O
*	O
)	O
.	O
Interestingly	O
,	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
serum	O
enhanced	O
HAdV-5	O
transduction	O
in	O
a	O
gene1s	O
FX	O
gene1e	O
-	O
independent	O
manner	O
in	O
CHO	O
-	O
gene1s	O
CAR	O
gene1e	O
and	O
SKOV3-	O
gene1s	O
CAR	O
gene1e	O
cells	O
(	O
arg1s	O
CHO	O
arg1e	O
or	O
species1s	O
SKOV3	O
species1e	O
cells	O
transfected	O
to	O
stably	O
express	O
species1s	O
human	O
species1e	O
gene1s	O
coxsackievirus	O
and	O
adenovirus	O
receptor	O
gene1e	O
[	O
gene1s	O
CAR	O
gene1e	O
]	O
)	O
.	O
Additionally	O
,	O
blockade	O
of	O
gene1s	O
CAR	O
gene1e	O
with	O
soluble	O
HAdV-5	O
fiber	O
knob	O
inhibited	O
species1s	O
mouse	O
species1e	O
serum	O
-	O
enhanced	O
transduction	O
in	O
A549	O
cells	O
,	O
suggesting	O
a	O
potential	O
role	O
for	O
gene1s	O
CAR	O
gene1e	O
.	O
Transduction	O
of	O
HAdV-5	O
KO1	O
and	O
HAdV-5	O
/	O
F35	O
(	O
gene1s	O
CAR	O
gene1e	O
binding	O
deficient	O
)	O
in	O
the	O
presence	O
of	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
serum	O
was	O
equivalent	O
to	O
that	O
of	O
HAdV-5	O
,	O
indicating	O
that	O
direct	O
interaction	O
between	O
HAdV-5	O
and	O
gene1s	O
CAR	O
gene1e	O
is	O
not	O
required	O
.	O
These	O
data	O
suggest	O
that	O
gene1s	O
FX	O
gene1e	O
may	O
protect	O
HAdV-5	O
from	O
neutralization	O
but	O
has	O
minimal	O
contribution	O
to	O
HAdV-5	O
transduction	O
in	O
the	O
presence	O
of	O
immunocompromised	O
species1s	O
mouse	O
species1e	O
serum	O
.	O
Alternatively	O
,	O
transduction	O
occurs	O
via	O
an	O
unidentified	O
species1s	O
mouse	O
species1e	O
serum	O
protein	O
capable	O
of	O
bridging	O
HAdV-5	O
to	O
gene1s	O
CAR	O
gene1e	O
.IMPORTANCE	O
The	O
intravascular	O
administration	O
of	O
HAdV-5	O
vectors	O
can	O
result	O
in	O
acute	O
liver	O
toxicity	O
,	O
transaminitis	O
,	O
thrombocytopenia	O
,	O
and	O
injury	O
to	O
the	O
vascular	O
endothelium	O
,	O
illustrating	O
challenges	O
yet	O
to	O
overcome	O
for	O
HAdV-5-mediated	O
systemic	O
gene	O
therapy	O
.	O
The	O
finding	O
that	O
gene1s	O
CAR	O
gene1e	O
and	O
potentially	O
an	O
unidentified	O
factor	O
present	O
in	O
species1s	O
mouse	O
species1e	O
serum	O
might	O
be	O
important	O
mediators	O
of	O
HAdV-5	O
transduction	O
highlights	O
that	O
a	O
better	O
understanding	O
of	O
the	O
complex	O
biology	O
defining	O
the	O
interplay	O
between	O
species1s	O
adenovirus	O
species1e	O
immune	O
recognition	O
and	O
cellular	O
uptake	O
mechanisms	O
is	O
still	O
required	O
.	O
These	O
findings	O
are	O
important	O
to	O
inform	O
future	O
optimization	O
and	O
development	O
of	O
HAdV-5-based	O
adenoviral	O
vectors	O
for	O
gene	O
therapy	O
.	O

Defining	O
a	O
Novel	O
Role	O
for	O
the	O
gene1s	O
Coxsackievirus	O
and	O
Adenovirus	O
Receptor	O
gene1e	O
in	O
species1s	O
Human	O
Adenovirus	O
species1e	O
Serotype	O
5	O
Transduction	O
In	O
Vitro	O
in	O
the	O
Presence	O
of	O
species1s	O
Mouse	O
species1e	O
Serum	O
.	O
species1s	O
Human	O
species1e	O
adenoviral	O
serotype	O
5	O
(	O
HAdV-5	O
)	O
vectors	O
have	O
predominantly	O
hepatic	O
tropism	O
when	O
delivered	O
intravascularly	O
,	O
resulting	O
in	O
immune	O
activation	O
and	O
toxicity	O
.	O
gene1s	O
Coagulation	O
factor	O
X	O
gene1e	O
(	O
gene1s	O
FX	O
gene1e	O
)	O
binding	O
to	O
HAdV-5	O
mediates	O
liver	O
transduction	O
and	O
provides	O
protection	O
from	O
virion	O
neutralization	O
in	O
species1s	O
mice	O
species1e	O
.	O
gene1s	O
FX	O
gene1e	O
is	O
dispensable	O
for	O
liver	O
transduction	O
in	O
species1s	O
mice	O
species1e	O
lacking	O
gene1s	O
IgM	O
gene1e	O
antibodies	O
or	O
gene1s	O
complement	O
gene1e	O
,	O
suggesting	O
that	O
alternative	O
transduction	O
pathways	O
exist	O
.	O
To	O
identify	O
novel	O
factor(s	O
)	O
mediating	O
HAdV-5	O
gene1s	O
FX	O
gene1e	O
-	O
independent	O
entry	O
,	O
we	O
investigated	O
HAdV-5	O
transduction	O
in	O
vitro	O
in	O
the	O
presence	O
of	O
serum	O
from	O
immunocompetent	O
C57BL/6	O
or	O
immunocompromised	O
species1s	O
mice	O
species1e	O
lacking	O
gene1s	O
IgM	O
gene1e	O
antibodies	O
(	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
and	O
NOD	O
-	O
scid	O
-	O
gamma	O
[	O
NSG	O
]	O
)	O
.	O
Sera	O
from	O
all	O
three	O
species1s	O
mouse	O
species1e	O
strains	O
enhanced	O
HAdV-5	O
transduction	O
of	O
A549	O
cells	O
.	O
While	O
inhibition	O
of	O
HAdV-5-	O
gene1s	O
FX	O
gene1e	O
interaction	O
with	O
gene1s	O
FX	O
gene1e	O
-	O
binding	O
protein	O
(	O
X	O
-	O
bp	O
)	O
inhibited	O
transduction	O
in	O
the	O
presence	O
of	O
C57BL/6	O
serum	O
,	O
it	O
had	O
negligible	O
effect	O
on	O
the	O
enhanced	O
transduction	O
observed	O
in	O
the	O
presence	O
of	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
or	O
NSG	O
serum	O
.	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
serum	O
also	O
enhanced	O
transduction	O
of	O
the	O
gene1s	O
FX	O
gene1e	O
binding	O
-	O
deficient	O
HAdV-5HVR5*HVR7*E451Q	O
(	O
AdT	O
*	O
)	O
.	O
Interestingly	O
,	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
serum	O
enhanced	O
HAdV-5	O
transduction	O
in	O
a	O
gene1s	O
FX	O
gene1e	O
-	O
independent	O
manner	O
in	O
CHO	O
-	O
gene1s	O
CAR	O
gene1e	O
and	O
SKOV3-	O
gene1s	O
CAR	O
gene1e	O
cells	O
(	O
species1s	O
CHO	O
species1e	O
or	O
species1s	O
SKOV3	O
species1e	O
cells	O
transfected	O
to	O
stably	O
express	O
species1s	O
human	O
species1e	O
gene1s	O
coxsackievirus	O
and	O
adenovirus	O
receptor	O
gene1e	O
[	O
gene1s	O
CAR	O
gene1e	O
]	O
)	O
.	O
Additionally	O
,	O
blockade	O
of	O
gene1s	O
CAR	O
gene1e	O
with	O
soluble	O
HAdV-5	O
fiber	O
knob	O
inhibited	O
species1s	O
mouse	O
species1e	O
serum	O
-	O
enhanced	O
transduction	O
in	O
A549	O
cells	O
,	O
suggesting	O
a	O
potential	O
role	O
for	O
gene1s	O
CAR	O
gene1e	O
.	O
Transduction	O
of	O
HAdV-5	O
KO1	O
and	O
HAdV-5	O
/	O
F35	O
(	O
gene1s	O
CAR	O
gene1e	O
binding	O
deficient	O
)	O
in	O
the	O
presence	O
of	O
gene1s	O
Rag	O
2	O
gene1e	O
(-/-	O
)	O
serum	O
was	O
equivalent	O
to	O
that	O
of	O
HAdV-5	O
,	O
indicating	O
that	O
direct	O
interaction	O
between	O
HAdV-5	O
and	O
gene1s	O
CAR	O
gene1e	O
is	O
not	O
required	O
.	O
These	O
data	O
suggest	O
that	O
gene1s	O
FX	O
gene1e	O
may	O
protect	O
HAdV-5	O
from	O
neutralization	O
but	O
has	O
minimal	O
contribution	O
to	O
HAdV-5	O
transduction	O
in	O
the	O
presence	O
of	O
immunocompromised	O
species1s	O
mouse	O
species1e	O
serum	O
.	O
Alternatively	O
,	O
transduction	O
occurs	O
via	O
an	O
unidentified	O
species1s	O
mouse	O
species1e	O
serum	O
protein	O
capable	O
of	O
bridging	O
HAdV-5	O
to	O
gene1s	O
CAR	O
gene1e	O
.IMPORTANCE	O
The	O
intravascular	O
administration	O
of	O
HAdV-5	O
vectors	O
can	O
result	O
in	O
acute	O
liver	O
toxicity	O
,	O
transaminitis	O
,	O
thrombocytopenia	O
,	O
and	O
injury	O
to	O
the	O
vascular	O
endothelium	O
,	O
illustrating	O
challenges	O
yet	O
to	O
overcome	O
for	O
HAdV-5-mediated	O
systemic	O
gene	O
therapy	O
.	O
The	O
finding	O
that	O
gene1s	O
CAR	O
gene1e	O
and	O
potentially	O
an	O
unidentified	O
factor	O
present	O
in	O
species1s	O
mouse	O
species1e	O
serum	O
might	O
be	O
important	O
mediators	O
of	O
HAdV-5	O
transduction	O
highlights	O
that	O
a	O
better	O
understanding	O
of	O
the	O
complex	O
biology	O
defining	O
the	O
interplay	O
between	O
arg1s	O
adenovirus	O
arg1e	O
immune	O
recognition	O
and	O
cellular	O
uptake	O
mechanisms	O
is	O
still	O
required	O
.	O
These	O
findings	O
are	O
important	O
to	O
inform	O
future	O
optimization	O
and	O
development	O
of	O
HAdV-5-based	O
adenoviral	O
vectors	O
for	O
gene	O
therapy	O
.	O

gene1s	ARG2
Thymosin	ARG2
beta4	ARG2
gene1e	ARG2
mediated	O
gene1s	ARG2
PKC	ARG2
gene1e	ARG2
activation	O
is	O
essential	O
to	O
initiate	O
the	O
embryonic	O
coronary	O
developmental	O
program	O
and	O
epicardial	O
progenitor	O
cell	O
activation	O
in	O
adult	O
arg1s	O
mice	O
arg1e	O
in	O
vivo	O
.	O
Hypoxic	O
heart	O
disease	O
is	O
a	O
predominant	O
cause	O
of	O
disability	O
and	O
death	O
worldwide	O
.	O
Since	O
adult	O
species1s	O
mammalian	O
species1e	O
hearts	O
are	O
incapable	O
of	O
regeneration	O
after	O
hypoxia	O
,	O
attempts	O
to	O
modify	O
this	O
deficiency	O
are	O
critical	O
.	O
As	O
demonstrated	O
in	O
species1s	O
zebrafish	O
species1e	O
,	O
recall	O
of	O
the	O
embryonic	O
developmental	O
program	O
may	O
be	O
the	O
key	O
to	O
success	O
.	O
Because	O
gene1s	ARG2
thymosin	ARG2
beta4	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TB4	ARG2
gene1e	ARG2
)	O
is	O
beneficial	O
for	O
myocardial	O
cell	O
survival	O
and	O
essential	O
for	O
coronary	O
development	O
in	O
embryos	O
,	O
we	O
hypothesized	O
that	O
it	O
reactivates	O
the	O
embryonic	O
developmental	O
program	O
and	O
initiates	O
epicardial	O
progenitor	O
mobilization	O
in	O
adult	O
mammals	O
.	O
We	O
found	O
that	O
gene1s	ARG2
TB4	ARG2
gene1e	ARG2
stimulates	O
capillary	O
-	O
like	O
tube	O
formation	O
of	O
adult	O
coronary	O
endothelial	O
cells	O
and	O
increases	O
embryonic	O
endothelial	O
cell	O
migration	O
and	O
proliferation	O
in	O
vitro	O
.	O
The	O
increase	O
of	O
gene1s	ARG2
blood	ARG2
vessel	ARG2
/	ARG2
epicardial	ARG2
substance	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Bves	ARG2
gene1e	ARG2
)	O
expressing	O
cells	O
accompanied	O
by	O
elevated	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Flk-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TGF	ARG2
-	ARG2
beta	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Fgfr-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Fgfr-4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Fgf-17	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
beta	ARG2
-	ARG2
Catenin	ARG2
gene1e	ARG2
expression	O
and	O
increase	O
of	O
gene1s	ARG2
Tbx-18	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Wt-1	ARG2
gene1e	ARG2
positive	O
myocardial	O
progenitors	O
suggested	O
organ	O
-	O
wide	O
recall	O
of	O
the	O
embryonic	O
program	O
in	O
the	O
adult	O
epicardium	O
.	O
gene1s	ARG2
TB4	ARG2
gene1e	ARG2
also	O
positively	O
regulated	O
the	O
expression	O
and	O
phosphorylation	O
of	O
gene1s	ARG2
myristoylated	ARG2
alanine	ARG2
-	ARG2
rich	ARG2
C	ARG2
-	ARG2
kinase	ARG2
substrate	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Marcks	ARG2
gene1e	ARG2
)	O
,	O
a	O
direct	O
substrate	O
and	O
indicator	O
of	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
C	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PKC	ARG2
gene1e	ARG2
)	O
activity	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O
gene1s	ARG2
PKC	ARG2
gene1e	ARG2
inhibition	O
significantly	O
reduced	O
gene1s	ARG2
TB4	ARG2
gene1e	ARG2
initiated	O
epicardial	O
thickening	O
,	O
capillary	O
growth	O
and	O
the	O
number	O
of	O
myocardial	O
progenitors	O
.	O
Our	O
results	O
demonstrate	O
that	O
gene1s	ARG2
TB4	ARG2
gene1e	ARG2
is	O
the	O
first	O
known	O
molecule	O
capable	O
of	O
organ	O
-	O
wide	O
activation	O
of	O
the	O
embryonic	O
coronary	O
developmental	O
program	O
in	O
the	O
adult	O
species1s	O
mammalian	O
species1e	O
heart	O
after	O
systemic	O
administration	O
and	O
that	O
gene1s	ARG2
PKC	ARG2
gene1e	ARG2
plays	O
a	O
significant	O
role	O
in	O
the	O
process	O
.	O

gene1s	O
Thymosin	O
beta4	O
gene1e	O
mediated	O
gene1s	O
PKC	O
gene1e	O
activation	O
is	O
essential	O
to	O
initiate	O
the	O
embryonic	O
coronary	O
developmental	O
program	O
and	O
epicardial	O
progenitor	O
cell	O
activation	O
in	O
adult	O
species1s	O
mice	O
species1e	O
in	O
vivo	O
.	O
Hypoxic	O
heart	O
disease	O
is	O
a	O
predominant	O
cause	O
of	O
disability	O
and	O
death	O
worldwide	O
.	O
Since	O
adult	O
arg1s	O
mammalian	O
arg1e	O
hearts	O
are	O
incapable	O
of	O
regeneration	O
after	O
hypoxia	O
,	O
attempts	O
to	O
modify	O
this	O
deficiency	O
are	O
critical	O
.	O
As	O
demonstrated	O
in	O
species1s	O
zebrafish	O
species1e	O
,	O
recall	O
of	O
the	O
embryonic	O
developmental	O
program	O
may	O
be	O
the	O
key	O
to	O
success	O
.	O
Because	O
gene1s	O
thymosin	O
beta4	O
gene1e	O
(	O
gene1s	O
TB4	O
gene1e	O
)	O
is	O
beneficial	O
for	O
myocardial	O
cell	O
survival	O
and	O
essential	O
for	O
coronary	O
development	O
in	O
embryos	O
,	O
we	O
hypothesized	O
that	O
it	O
reactivates	O
the	O
embryonic	O
developmental	O
program	O
and	O
initiates	O
epicardial	O
progenitor	O
mobilization	O
in	O
adult	O
mammals	O
.	O
We	O
found	O
that	O
gene1s	O
TB4	O
gene1e	O
stimulates	O
capillary	O
-	O
like	O
tube	O
formation	O
of	O
adult	O
coronary	O
endothelial	O
cells	O
and	O
increases	O
embryonic	O
endothelial	O
cell	O
migration	O
and	O
proliferation	O
in	O
vitro	O
.	O
The	O
increase	O
of	O
gene1s	O
blood	O
vessel	O
/	O
epicardial	O
substance	O
gene1e	O
(	O
gene1s	O
Bves	O
gene1e	O
)	O
expressing	O
cells	O
accompanied	O
by	O
elevated	O
gene1s	O
VEGF	O
gene1e	O
,	O
gene1s	O
Flk-1	O
gene1e	O
,	O
gene1s	O
TGF	O
-	O
beta	O
gene1e	O
,	O
gene1s	O
Fgfr-2	O
gene1e	O
,	O
gene1s	O
Fgfr-4	O
gene1e	O
,	O
gene1s	O
Fgf-17	O
gene1e	O
and	O
gene1s	O
beta	O
-	O
Catenin	O
gene1e	O
expression	O
and	O
increase	O
of	O
gene1s	O
Tbx-18	O
gene1e	O
and	O
gene1s	O
Wt-1	O
gene1e	O
positive	O
myocardial	O
progenitors	O
suggested	O
organ	O
-	O
wide	O
recall	O
of	O
the	O
embryonic	O
program	O
in	O
the	O
adult	O
epicardium	O
.	O
gene1s	O
TB4	O
gene1e	O
also	O
positively	O
regulated	O
the	O
expression	O
and	O
phosphorylation	O
of	O
gene1s	O
myristoylated	O
alanine	O
-	O
rich	O
C	O
-	O
kinase	O
substrate	O
gene1e	O
(	O
gene1s	O
Marcks	O
gene1e	O
)	O
,	O
a	O
direct	O
substrate	O
and	O
indicator	O
of	O
gene1s	O
protein	O
kinase	O
C	O
gene1e	O
(	O
gene1s	O
PKC	O
gene1e	O
)	O
activity	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O
gene1s	O
PKC	O
gene1e	O
inhibition	O
significantly	O
reduced	O
gene1s	O
TB4	O
gene1e	O
initiated	O
epicardial	O
thickening	O
,	O
capillary	O
growth	O
and	O
the	O
number	O
of	O
myocardial	O
progenitors	O
.	O
Our	O
results	O
demonstrate	O
that	O
gene1s	O
TB4	O
gene1e	O
is	O
the	O
first	O
known	O
molecule	O
capable	O
of	O
organ	O
-	O
wide	O
activation	O
of	O
the	O
embryonic	O
coronary	O
developmental	O
program	O
in	O
the	O
adult	O
arg1s	O
mammalian	O
arg1e	O
heart	O
after	O
systemic	O
administration	O
and	O
that	O
gene1s	O
PKC	O
gene1e	O
plays	O
a	O
significant	O
role	O
in	O
the	O
process	O
.	O

gene1s	O
Thymosin	O
beta4	O
gene1e	O
mediated	O
gene1s	O
PKC	O
gene1e	O
activation	O
is	O
essential	O
to	O
initiate	O
the	O
embryonic	O
coronary	O
developmental	O
program	O
and	O
epicardial	O
progenitor	O
cell	O
activation	O
in	O
adult	O
species1s	O
mice	O
species1e	O
in	O
vivo	O
.	O
Hypoxic	O
heart	O
disease	O
is	O
a	O
predominant	O
cause	O
of	O
disability	O
and	O
death	O
worldwide	O
.	O
Since	O
adult	O
species1s	O
mammalian	O
species1e	O
hearts	O
are	O
incapable	O
of	O
regeneration	O
after	O
hypoxia	O
,	O
attempts	O
to	O
modify	O
this	O
deficiency	O
are	O
critical	O
.	O
As	O
demonstrated	O
in	O
arg1s	O
zebrafish	O
arg1e	O
,	O
recall	O
of	O
the	O
embryonic	O
developmental	O
program	O
may	O
be	O
the	O
key	O
to	O
success	O
.	O
Because	O
gene1s	O
thymosin	O
beta4	O
gene1e	O
(	O
gene1s	O
TB4	O
gene1e	O
)	O
is	O
beneficial	O
for	O
myocardial	O
cell	O
survival	O
and	O
essential	O
for	O
coronary	O
development	O
in	O
embryos	O
,	O
we	O
hypothesized	O
that	O
it	O
reactivates	O
the	O
embryonic	O
developmental	O
program	O
and	O
initiates	O
epicardial	O
progenitor	O
mobilization	O
in	O
adult	O
mammals	O
.	O
We	O
found	O
that	O
gene1s	O
TB4	O
gene1e	O
stimulates	O
capillary	O
-	O
like	O
tube	O
formation	O
of	O
adult	O
coronary	O
endothelial	O
cells	O
and	O
increases	O
embryonic	O
endothelial	O
cell	O
migration	O
and	O
proliferation	O
in	O
vitro	O
.	O
The	O
increase	O
of	O
gene1s	O
blood	O
vessel	O
/	O
epicardial	O
substance	O
gene1e	O
(	O
gene1s	O
Bves	O
gene1e	O
)	O
expressing	O
cells	O
accompanied	O
by	O
elevated	O
gene1s	O
VEGF	O
gene1e	O
,	O
gene1s	O
Flk-1	O
gene1e	O
,	O
gene1s	O
TGF	O
-	O
beta	O
gene1e	O
,	O
gene1s	O
Fgfr-2	O
gene1e	O
,	O
gene1s	O
Fgfr-4	O
gene1e	O
,	O
gene1s	O
Fgf-17	O
gene1e	O
and	O
gene1s	O
beta	O
-	O
Catenin	O
gene1e	O
expression	O
and	O
increase	O
of	O
gene1s	O
Tbx-18	O
gene1e	O
and	O
gene1s	O
Wt-1	O
gene1e	O
positive	O
myocardial	O
progenitors	O
suggested	O
organ	O
-	O
wide	O
recall	O
of	O
the	O
embryonic	O
program	O
in	O
the	O
adult	O
epicardium	O
.	O
gene1s	O
TB4	O
gene1e	O
also	O
positively	O
regulated	O
the	O
expression	O
and	O
phosphorylation	O
of	O
gene1s	O
myristoylated	O
alanine	O
-	O
rich	O
C	O
-	O
kinase	O
substrate	O
gene1e	O
(	O
gene1s	O
Marcks	O
gene1e	O
)	O
,	O
a	O
direct	O
substrate	O
and	O
indicator	O
of	O
gene1s	O
protein	O
kinase	O
C	O
gene1e	O
(	O
gene1s	O
PKC	O
gene1e	O
)	O
activity	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O
gene1s	O
PKC	O
gene1e	O
inhibition	O
significantly	O
reduced	O
gene1s	O
TB4	O
gene1e	O
initiated	O
epicardial	O
thickening	O
,	O
capillary	O
growth	O
and	O
the	O
number	O
of	O
myocardial	O
progenitors	O
.	O
Our	O
results	O
demonstrate	O
that	O
gene1s	O
TB4	O
gene1e	O
is	O
the	O
first	O
known	O
molecule	O
capable	O
of	O
organ	O
-	O
wide	O
activation	O
of	O
the	O
embryonic	O
coronary	O
developmental	O
program	O
in	O
the	O
adult	O
species1s	O
mammalian	O
species1e	O
heart	O
after	O
systemic	O
administration	O
and	O
that	O
gene1s	O
PKC	O
gene1e	O
plays	O
a	O
significant	O
role	O
in	O
the	O
process	O
.	O

gene1s	ARG2
Proteinase	ARG2
-	ARG2
activated	ARG2
receptor	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PAR2	ARG2
gene1e	ARG2
)	O
in	O
hepatic	O
stellate	O
cells	O
-	O
evidence	O
for	O
a	O
role	O
in	O
hepatocellular	O
carcinoma	O
growth	O
in	O
vivo	O
.	O
BACKGROUND	O
:	O
Previous	O
studies	O
have	O
established	O
that	O
gene1s	ARG2
proteinase	ARG2
-	ARG2
activated	ARG2
receptor	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PAR2	ARG2
gene1e	ARG2
)	O
promotes	O
migration	O
and	O
invasion	O
of	O
hepatocellular	O
carcinoma	O
(	O
HCC	O
)	O
cells	O
,	O
suggesting	O
a	O
role	O
in	O
HCC	O
progression	O
.	O
Here	O
,	O
we	O
assessed	O
the	O
impact	O
of	O
gene1s	ARG2
PAR2	ARG2
gene1e	ARG2
in	O
HCC	O
stromal	O
cells	O
on	O
HCC	O
growth	O
using	O
arg1s	O
LX-2	O
arg1e	O
hepatic	O
stellate	O
cells	O
(	O
HSCs	O
)	O
and	O
arg1s	O
Hep3B	O
arg1e	O
cells	O
as	O
model	O
.	O
METHODS	O
:	O
gene1s	ARG2
PAR2	ARG2
gene1e	ARG2
expression	O
and	O
function	O
in	O
arg1s	O
LX-2	O
arg1e	O
cells	O
was	O
analysed	O
by	O
RT	O
-	O
PCR	O
,	O
confocal	O
immunofluorescence	O
,	O
electron	O
microscopy	O
,	O
and	O
[	O
Ca(2+)]i	O
measurements	O
,	O
respectively	O
.	O
The	O
impact	O
of	O
LX-2-expressed	O
gene1s	ARG2
PAR2	ARG2
gene1e	ARG2
on	O
tumour	O
growth	O
in	O
vivo	O
was	O
monitored	O
using	O
HCC	O
xenotransplantation	O
experiments	O
in	O
SCID	O
species1s	O
mice	O
species1e	O
,	O
in	O
which	O
HCC	O
-	O
like	O
tumours	O
were	O
induced	O
by	O
coinjection	O
of	O
arg1s	O
LX-2	O
arg1e	O
cells	O
and	O
arg1s	O
Hep3B	O
arg1e	O
cells	O
.	O
To	O
characterise	O
the	O
effects	O
of	O
gene1s	ARG2
PAR2	ARG2
gene1e	ARG2
activation	O
in	O
arg1s	O
LX-2	O
arg1e	O
cells	O
,	O
various	O
signalling	O
pathways	O
were	O
analysed	O
by	O
immunoblotting	O
and	O
proteome	O
profiler	O
arrays	O
.	O
RESULTS	O
:	O
Following	O
verification	O
of	O
functional	O
gene1s	ARG2
PAR2	ARG2
gene1e	ARG2
expression	O
in	O
arg1s	O
LX-2	O
arg1e	O
cells	O
,	O
in	O
vivo	O
studies	O
showed	O
that	O
these	O
cells	O
promoted	O
tumour	O
growth	O
and	O
angiogenesis	O
of	O
HCC	O
xenografts	O
in	O
species1s	O
mice	O
species1e	O
.	O
These	O
effects	O
were	O
significantly	O
reduced	O
when	O
gene1s	ARG2
F2RL1	ARG2
gene1e	ARG2
(	O
encoding	O
gene1s	ARG2
PAR2	ARG2
gene1e	ARG2
)	O
was	O
downregulated	O
by	O
RNA	O
interference	O
(	O
RNAi	O
)	O
.	O
In	O
vitro	O
studies	O
confirmed	O
these	O
results	O
demonstrating	O
RNAi	O
mediated	O
inhibition	O
of	O
gene1s	ARG2
PAR2	ARG2
gene1e	ARG2
attenuated	O
gene1s	ARG2
Smad2/3	ARG2
gene1e	ARG2
activation	O
in	O
response	O
to	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
stimulation	O
in	O
arg1s	O
LX-2	O
arg1e	O
cells	O
and	O
blocked	O
the	O
pro	O
-	O
mitotic	O
effect	O
of	O
LX-2	O
derived	O
conditioned	O
medium	O
on	O
arg1s	O
Hep3B	O
arg1e	O
cells	O
.	O
Furthermore	O
,	O
gene1s	ARG2
PAR2	ARG2
gene1e	ARG2
stimulation	O
with	O
trypsin	O
or	O
a	O
gene1s	ARG2
PAR2	ARG2
gene1e	ARG2
-selective	O
activating	O
peptide	O
(	O
gene1s	ARG2
PAR2	ARG2
gene1e	ARG2
-AP	O
)	O
led	O
to	O
activation	O
of	O
different	O
intracellular	O
signalling	O
pathways	O
,	O
an	O
increased	O
secretion	O
of	O
pro	O
-	O
angiogenic	O
and	O
pro	O
-	O
mitotic	O
factors	O
and	O
gene1s	ARG2
proteinases	ARG2
gene1e	ARG2
,	O
and	O
an	O
enhanced	O
migration	O
rate	O
across	O
a	O
gene1s	ARG2
collagen	ARG2
gene1e	ARG2
-	O
coated	O
membrane	O
barrier	O
.	O
Silencing	O
gene1s	ARG2
F2RL1	ARG2
gene1e	ARG2
by	O
RNAi	O
or	O
pharmacological	O
inhibition	O
of	O
gene1s	ARG2
Src	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
hepatocyte	ARG2
growth	ARG2
factor	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Met	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
platelet	ARG2
-	ARG2
derived	ARG2
growth	ARG2
factor	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PDGFR	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
p42	ARG2
/	ARG2
p44	ARG2
mitogen	ARG2
activated	ARG2
protein	ARG2
kinase	ARG2
(	ARG2
MAPK	ARG2
)	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
matrix	ARG2
-	ARG2
metalloproteinases	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MMPs	ARG2
gene1e	ARG2
)	O
blocked	O
gene1s	ARG2
PAR2	ARG2
gene1e	ARG2
-AP	O
-	O
induced	O
migration	O
.	O
CONCLUSION	O
:	O
gene1s	ARG2
PAR2	ARG2
gene1e	ARG2
in	O
HSCs	O
plays	O
a	O
crucial	O
role	O
in	O
promoting	O
HCC	O
growth	O
presumably	O
by	O
mediating	O
migration	O
and	O
secretion	O
of	O
pro	O
-	O
angiogenic	O
and	O
pro	O
-	O
mitotic	O
factors	O
.	O
Therefore	O
,	O
gene1s	ARG2
PAR2	ARG2
gene1e	ARG2
in	O
stromal	O
HSCs	O
may	O
have	O
relevance	O
as	O
a	O
therapeutic	O
target	O
of	O
HCC	O
.	O

gene1s	O
Proteinase	O
-	O
activated	O
receptor	O
2	O
gene1e	O
(	O
gene1s	O
PAR2	O
gene1e	O
)	O
in	O
hepatic	O
stellate	O
cells	O
-	O
evidence	O
for	O
a	O
role	O
in	O
hepatocellular	O
carcinoma	O
growth	O
in	O
vivo	O
.	O
BACKGROUND	O
:	O
Previous	O
studies	O
have	O
established	O
that	O
gene1s	O
proteinase	O
-	O
activated	O
receptor	O
2	O
gene1e	O
(	O
gene1s	O
PAR2	O
gene1e	O
)	O
promotes	O
migration	O
and	O
invasion	O
of	O
hepatocellular	O
carcinoma	O
(	O
HCC	O
)	O
cells	O
,	O
suggesting	O
a	O
role	O
in	O
HCC	O
progression	O
.	O
Here	O
,	O
we	O
assessed	O
the	O
impact	O
of	O
gene1s	O
PAR2	O
gene1e	O
in	O
HCC	O
stromal	O
cells	O
on	O
HCC	O
growth	O
using	O
species1s	O
LX-2	O
species1e	O
hepatic	O
stellate	O
cells	O
(	O
HSCs	O
)	O
and	O
species1s	O
Hep3B	O
species1e	O
cells	O
as	O
model	O
.	O
METHODS	O
:	O
gene1s	O
PAR2	O
gene1e	O
expression	O
and	O
function	O
in	O
species1s	O
LX-2	O
species1e	O
cells	O
was	O
analysed	O
by	O
RT	O
-	O
PCR	O
,	O
confocal	O
immunofluorescence	O
,	O
electron	O
microscopy	O
,	O
and	O
[	O
Ca(2+)]i	O
measurements	O
,	O
respectively	O
.	O
The	O
impact	O
of	O
LX-2-expressed	O
gene1s	O
PAR2	O
gene1e	O
on	O
tumour	O
growth	O
in	O
vivo	O
was	O
monitored	O
using	O
HCC	O
xenotransplantation	O
experiments	O
in	O
SCID	O
arg1s	O
mice	O
arg1e	O
,	O
in	O
which	O
HCC	O
-	O
like	O
tumours	O
were	O
induced	O
by	O
coinjection	O
of	O
species1s	O
LX-2	O
species1e	O
cells	O
and	O
species1s	O
Hep3B	O
species1e	O
cells	O
.	O
To	O
characterise	O
the	O
effects	O
of	O
gene1s	O
PAR2	O
gene1e	O
activation	O
in	O
species1s	O
LX-2	O
species1e	O
cells	O
,	O
various	O
signalling	O
pathways	O
were	O
analysed	O
by	O
immunoblotting	O
and	O
proteome	O
profiler	O
arrays	O
.	O
RESULTS	O
:	O
Following	O
verification	O
of	O
functional	O
gene1s	O
PAR2	O
gene1e	O
expression	O
in	O
species1s	O
LX-2	O
species1e	O
cells	O
,	O
in	O
vivo	O
studies	O
showed	O
that	O
these	O
cells	O
promoted	O
tumour	O
growth	O
and	O
angiogenesis	O
of	O
HCC	O
xenografts	O
in	O
arg1s	O
mice	O
arg1e	O
.	O
These	O
effects	O
were	O
significantly	O
reduced	O
when	O
gene1s	O
F2RL1	O
gene1e	O
(	O
encoding	O
gene1s	O
PAR2	O
gene1e	O
)	O
was	O
downregulated	O
by	O
RNA	O
interference	O
(	O
RNAi	O
)	O
.	O
In	O
vitro	O
studies	O
confirmed	O
these	O
results	O
demonstrating	O
RNAi	O
mediated	O
inhibition	O
of	O
gene1s	O
PAR2	O
gene1e	O
attenuated	O
gene1s	O
Smad2/3	O
gene1e	O
activation	O
in	O
response	O
to	O
gene1s	O
TGF	O
-	O
b1	O
gene1e	O
stimulation	O
in	O
species1s	O
LX-2	O
species1e	O
cells	O
and	O
blocked	O
the	O
pro	O
-	O
mitotic	O
effect	O
of	O
LX-2	O
derived	O
conditioned	O
medium	O
on	O
species1s	O
Hep3B	O
species1e	O
cells	O
.	O
Furthermore	O
,	O
gene1s	O
PAR2	O
gene1e	O
stimulation	O
with	O
trypsin	O
or	O
a	O
gene1s	O
PAR2	O
gene1e	O
-selective	O
activating	O
peptide	O
(	O
gene1s	O
PAR2	O
gene1e	O
-AP	O
)	O
led	O
to	O
activation	O
of	O
different	O
intracellular	O
signalling	O
pathways	O
,	O
an	O
increased	O
secretion	O
of	O
pro	O
-	O
angiogenic	O
and	O
pro	O
-	O
mitotic	O
factors	O
and	O
gene1s	O
proteinases	O
gene1e	O
,	O
and	O
an	O
enhanced	O
migration	O
rate	O
across	O
a	O
gene1s	O
collagen	O
gene1e	O
-	O
coated	O
membrane	O
barrier	O
.	O
Silencing	O
gene1s	O
F2RL1	O
gene1e	O
by	O
RNAi	O
or	O
pharmacological	O
inhibition	O
of	O
gene1s	O
Src	O
gene1e	O
,	O
gene1s	O
hepatocyte	O
growth	O
factor	O
receptor	O
gene1e	O
(	O
gene1s	O
Met	O
gene1e	O
)	O
,	O
gene1s	O
platelet	O
-	O
derived	O
growth	O
factor	O
receptor	O
gene1e	O
(	O
gene1s	O
PDGFR	O
gene1e	O
)	O
,	O
gene1s	O
p42	O
/	O
p44	O
mitogen	O
activated	O
protein	O
kinase	O
(	O
MAPK	O
)	O
gene1e	O
or	O
gene1s	O
matrix	O
-	O
metalloproteinases	O
gene1e	O
(	O
gene1s	O
MMPs	O
gene1e	O
)	O
blocked	O
gene1s	O
PAR2	O
gene1e	O
-AP	O
-	O
induced	O
migration	O
.	O
CONCLUSION	O
:	O
gene1s	O
PAR2	O
gene1e	O
in	O
HSCs	O
plays	O
a	O
crucial	O
role	O
in	O
promoting	O
HCC	O
growth	O
presumably	O
by	O
mediating	O
migration	O
and	O
secretion	O
of	O
pro	O
-	O
angiogenic	O
and	O
pro	O
-	O
mitotic	O
factors	O
.	O
Therefore	O
,	O
gene1s	O
PAR2	O
gene1e	O
in	O
stromal	O
HSCs	O
may	O
have	O
relevance	O
as	O
a	O
therapeutic	O
target	O
of	O
HCC	O
.	O

Transforming	O
activity	O
and	O
therapeutic	O
targeting	O
of	O
gene1s	O
C	O
-	O
terminal	O
-	O
binding	O
protein	O
2	O
gene1e	O
in	O
gene1s	O
Apc	O
gene1e	O
-	O
mutated	O
neoplasia	O
.	O
Overexpression	O
of	O
the	O
transcriptional	O
coregulators	O
gene1s	ARG2
C	ARG2
-	ARG2
terminal	ARG2
binding	ARG2
proteins	ARG2
1	ARG2
and	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CtBP1	ARG2
and	ARG2
2	ARG2
gene1e	ARG2
)	O
occurs	O
in	O
many	O
arg1s	O
human	O
arg1e	O
solid	O
tumors	O
and	O
is	O
associated	O
with	O
poor	O
prognosis	O
.	O
gene1s	ARG2
CtBP	ARG2
gene1e	ARG2
modulates	O
oncogenic	O
gene	O
expression	O
programs	O
and	O
is	O
an	O
emerging	O
drug	O
target	O
,	O
but	O
its	O
oncogenic	O
role	O
is	O
unclear	O
.	O
Consistent	O
with	O
this	O
oncogenic	O
potential	O
,	O
exogenous	O
gene1s	ARG2
CtBP2	ARG2
gene1e	ARG2
transformed	O
primary	O
species1s	O
mouse	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
cells	O
to	O
anchorage	O
independence	O
similarly	O
to	O
mutant	O
gene1s	ARG2
H	ARG2
-	ARG2
Ras	ARG2
gene1e	ARG2
.	O
To	O
investigate	O
gene1s	ARG2
CtBP	ARG2
gene1e	ARG2
's	O
contribution	O
to	O
in	O
vivo	O
tumorigenesis	O
,	O
gene1s	O
Apc	O
gene1e	O
(min/+	O
)	O
species1s	O
mice	O
species1e	O
,	O
which	O
succumb	O
to	O
massive	O
intestinal	O
polyposis	O
,	O
were	O
bred	O
to	O
gene1s	O
Ctbp2	O
gene1e	O
(+/-	O
)	O
species1s	O
mice	O
species1e	O
.	O
gene1s	ARG2
CtBP	ARG2
gene1e	ARG2
interacts	O
with	O
gene1s	ARG2
adenomatous	ARG2
polyposis	ARG2
coli	ARG2
(	ARG2
APC	ARG2
)	ARG2
protein	ARG2
gene1e	ARG2
,	O
and	O
is	O
stabilized	O
in	O
both	O
gene1s	ARG2
APC	ARG2
gene1e	ARG2
-	O
mutated	O
arg1s	O
human	O
arg1e	O
colon	O
cancers	O
and	O
gene1s	O
Apc	O
gene1e	O
(min/+	O
)	O
intestinal	O
polyps	O
.	O
gene1s	O
Ctbp2	O
gene1e	O
heterozygosity	O
increased	O
the	O
median	O
survival	O
of	O
gene1s	O
Apc	O
gene1e	O
(min/+	O
)	O
species1s	O
mice	O
species1e	O
from	O
21	O
to	O
48	O
weeks	O
,	O
and	O
reduced	O
polyp	O
formation	O
by	O
90	O
%	O
,	O
with	O
gene1s	O
Ctbp2	O
gene1e	O
(+/-	O
)	O
polyps	O
exhibiting	O
reduced	O
levels	O
of	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
and	O
its	O
oncogenic	O
transcriptional	O
target	O
,	O
gene1s	O
cyclin	O
D1	O
gene1e	O
.	O
gene1s	ARG2
CtBP	ARG2
gene1e	ARG2
's	O
potential	O
as	O
a	O
therapeutic	O
target	O
was	O
studied	O
by	O
treating	O
gene1s	O
Apc	O
gene1e	O
(min/+	O
)	O
species1s	O
mice	O
species1e	O
with	O
the	O
gene1s	ARG2
CtBP	ARG2
gene1e	ARG2
small	O
-	O
molecule	O
inhibitors	O
4-methylthio-2-oxobutyric	O
acid	O
and	O
2-hydroxy	O
-	O
imino	O
phenylpyruvic	O
acid	O
,	O
both	O
of	O
which	O
reduced	O
polyposis	O
by	O
more	O
than	O
half	O
compared	O
with	O
vehicle	O
treatment	O
.	O
Phenocopying	O
gene1s	O
Ctbp2	O
gene1e	O
deletion	O
,	O
both	O
gene1s	ARG2
Ctbp	ARG2
gene1e	ARG2
inhibitors	O
caused	O
substantial	O
decreases	O
in	O
the	O
protein	O
level	O
of	O
gene1s	O
Ctbp2	O
gene1e	O
,	O
as	O
well	O
its	O
oncogenic	O
partner	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
,	O
and	O
the	O
effects	O
of	O
the	O
inhibitors	O
on	O
gene1s	ARG2
CtBP	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
levels	O
could	O
be	O
modeled	O
in	O
an	O
gene1s	ARG2
APC	ARG2
gene1e	ARG2
-	O
mutated	O
arg1s	O
human	O
arg1e	O
colon	O
cancer	O
cell	O
line	O
.	O
gene1s	O
CtBP2	O
gene1e	O
is	O
thus	O
a	O
druggable	O
transforming	O
oncoprotein	O
critical	O
for	O
the	O
evolution	O
of	O
neoplasia	O
driven	O
by	O
gene1s	O
Apc	O
gene1e	O
mutation	O
.	O

Transforming	O
activity	O
and	O
therapeutic	O
targeting	O
of	O
gene1s	ARG2
C	ARG2
-	ARG2
terminal	ARG2
-	ARG2
binding	ARG2
protein	ARG2
2	ARG2
gene1e	ARG2
in	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
-	O
mutated	O
neoplasia	O
.	O
Overexpression	O
of	O
the	O
transcriptional	O
coregulators	O
gene1s	O
C	O
-	O
terminal	O
binding	O
proteins	O
1	O
and	O
2	O
gene1e	O
(	O
gene1s	O
CtBP1	O
and	O
2	O
gene1e	O
)	O
occurs	O
in	O
many	O
species1s	O
human	O
species1e	O
solid	O
tumors	O
and	O
is	O
associated	O
with	O
poor	O
prognosis	O
.	O
gene1s	ARG2
CtBP	ARG2
gene1e	ARG2
modulates	O
oncogenic	O
gene	O
expression	O
programs	O
and	O
is	O
an	O
emerging	O
drug	O
target	O
,	O
but	O
its	O
oncogenic	O
role	O
is	O
unclear	O
.	O
Consistent	O
with	O
this	O
oncogenic	O
potential	O
,	O
exogenous	O
gene1s	ARG2
CtBP2	ARG2
gene1e	ARG2
transformed	O
primary	O
arg1s	O
mouse	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
cells	O
to	O
anchorage	O
independence	O
similarly	O
to	O
mutant	O
gene1s	ARG2
H	ARG2
-	ARG2
Ras	ARG2
gene1e	ARG2
.	O
To	O
investigate	O
gene1s	ARG2
CtBP	ARG2
gene1e	ARG2
's	O
contribution	O
to	O
in	O
vivo	O
tumorigenesis	O
,	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
(min/+	O
)	O
arg1s	O
mice	O
arg1e	O
,	O
which	O
succumb	O
to	O
massive	O
intestinal	O
polyposis	O
,	O
were	O
bred	O
to	O
gene1s	ARG2
Ctbp2	ARG2
gene1e	ARG2
(+/-	O
)	O
arg1s	O
mice	O
arg1e	O
.	O
gene1s	ARG2
CtBP	ARG2
gene1e	ARG2
interacts	O
with	O
gene1s	ARG2
adenomatous	ARG2
polyposis	ARG2
coli	ARG2
(	ARG2
APC	ARG2
)	ARG2
protein	ARG2
gene1e	ARG2
,	O
and	O
is	O
stabilized	O
in	O
both	O
gene1s	O
APC	O
gene1e	O
-	O
mutated	O
species1s	O
human	O
species1e	O
colon	O
cancers	O
and	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
(min/+	O
)	O
intestinal	O
polyps	O
.	O
gene1s	ARG2
Ctbp2	ARG2
gene1e	ARG2
heterozygosity	O
increased	O
the	O
median	O
survival	O
of	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
(min/+	O
)	O
arg1s	O
mice	O
arg1e	O
from	O
21	O
to	O
48	O
weeks	O
,	O
and	O
reduced	O
polyp	O
formation	O
by	O
90	O
%	O
,	O
with	O
gene1s	ARG2
Ctbp2	ARG2
gene1e	ARG2
(+/-	O
)	O
polyps	O
exhibiting	O
reduced	O
levels	O
of	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
and	O
its	O
oncogenic	O
transcriptional	O
target	O
,	O
gene1s	ARG2
cyclin	ARG2
D1	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
CtBP	ARG2
gene1e	ARG2
's	O
potential	O
as	O
a	O
therapeutic	O
target	O
was	O
studied	O
by	O
treating	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
(min/+	O
)	O
arg1s	O
mice	O
arg1e	O
with	O
the	O
gene1s	ARG2
CtBP	ARG2
gene1e	ARG2
small	O
-	O
molecule	O
inhibitors	O
4-methylthio-2-oxobutyric	O
acid	O
and	O
2-hydroxy	O
-	O
imino	O
phenylpyruvic	O
acid	O
,	O
both	O
of	O
which	O
reduced	O
polyposis	O
by	O
more	O
than	O
half	O
compared	O
with	O
vehicle	O
treatment	O
.	O
Phenocopying	O
gene1s	ARG2
Ctbp2	ARG2
gene1e	ARG2
deletion	O
,	O
both	O
gene1s	ARG2
Ctbp	ARG2
gene1e	ARG2
inhibitors	O
caused	O
substantial	O
decreases	O
in	O
the	O
protein	O
level	O
of	O
gene1s	ARG2
Ctbp2	ARG2
gene1e	ARG2
,	O
as	O
well	O
its	O
oncogenic	O
partner	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
,	O
and	O
the	O
effects	O
of	O
the	O
inhibitors	O
on	O
gene1s	ARG2
CtBP	ARG2
gene1e	ARG2
and	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
levels	O
could	O
be	O
modeled	O
in	O
an	O
gene1s	O
APC	O
gene1e	O
-	O
mutated	O
species1s	O
human	O
species1e	O
colon	O
cancer	O
cell	O
line	O
.	O
gene1s	ARG2
CtBP2	ARG2
gene1e	ARG2
is	O
thus	O
a	O
druggable	O
transforming	O
oncoprotein	O
critical	O
for	O
the	O
evolution	O
of	O
neoplasia	O
driven	O
by	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
mutation	O
.	O

A	O
gene1s	ARG2
TSPO	ARG2
gene1e	ARG2
ligand	O
attenuates	O
brain	O
injury	O
after	O
intracerebral	O
hemorrhage	O
.	O
Intracerebral	O
hemorrhage	O
(	O
ICH	O
)	O
is	O
a	O
devastating	O
disease	O
without	O
effective	O
treatment	O
.	O
After	O
ICH	O
,	O
the	O
immediate	O
infiltration	O
of	O
leukocytes	O
and	O
activation	O
of	O
microglia	O
are	O
accompanied	O
by	O
a	O
rapid	O
up	O
-	O
regulation	O
of	O
the	O
18-kDa	O
translocator	O
protein	O
(	O
gene1s	ARG2
TSPO	ARG2
gene1e	ARG2
)	O
.	O
gene1s	ARG2
TSPO	ARG2
gene1e	ARG2
ligands	O
have	O
shown	O
anti	O
-	O
inflammatory	O
and	O
neuroprotective	O
properties	O
in	O
models	O
of	O
CNS	O
injury	O
.	O
In	O
this	O
study	O
,	O
we	O
determined	O
the	O
impact	O
of	O
a	O
gene1s	ARG2
TSPO	ARG2
gene1e	ARG2
ligand	O
,	O
etifoxine	O
,	O
on	O
brain	O
injury	O
and	O
inflammation	O
in	O
2	O
arg1s	O
mouse	O
arg1e	O
models	O
of	O
ICH	O
.	O
gene1s	O
TSPO	O
gene1e	O
was	O
up	O
-	O
regulated	O
in	O
gene1s	O
Iba1	O
gene1e	O
(+	O
)	O
cells	O
from	O
brains	O
of	O
species1s	O
patients	O
species1e	O
with	O
ICH	O
and	O
in	O
gene1s	ARG2
CD11b	ARG2
gene1e	ARG2
(+)	O
gene1s	ARG2
CD45	ARG2
gene1e	ARG2
(int	O
)	O
cells	O
from	O
arg1s	O
mice	O
arg1e	O
subjected	O
to	O
collagenase	O
-	O
induced	O
ICH	O
.	O
Etifoxine	O
significantly	O
reduced	O
neurodeficits	O
and	O
perihematomal	O
brain	O
edema	O
after	O
ICH	O
induction	O
by	O
injection	O
of	O
either	O
autologous	O
blood	O
or	O
collagenase	O
.	O
In	O
collagenase	O
-	O
induced	O
ICH	O
arg1s	O
mice	O
arg1e	O
,	O
the	O
protection	O
of	O
etifoxine	O
was	O
associated	O
with	O
reduced	O
leukocyte	O
infiltration	O
into	O
the	O
brain	O
and	O
microglial	O
production	O
of	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
.	O
Etifoxine	O
improved	O
blood	O
-	O
brain	O
barrier	O
integrity	O
and	O
diminished	O
cell	O
death	O
.	O
Notably	O
,	O
the	O
protective	O
effect	O
of	O
etifoxine	O
was	O
abolished	O
in	O
arg1s	O
mice	O
arg1e	O
depleted	O
of	O
microglia	O
by	O
using	O
a	O
gene1s	ARG2
colony	ARG2
-	ARG2
stimulating	ARG2
factor	ARG2
1	ARG2
receptor	ARG2
gene1e	ARG2
inhibitor	O
.	O
These	O
results	O
indicate	O
that	O
the	O
gene1s	ARG2
TSPO	ARG2
gene1e	ARG2
ligand	O
etifoxine	O
attenuates	O
brain	O
injury	O
and	O
inflammation	O
after	O
ICH	O
.	O
gene1s	ARG2
TSPO	ARG2
gene1e	ARG2
may	O
be	O
a	O
viable	O
therapeutic	O
target	O
that	O
requires	O
further	O
investigations	O
in	O
ICH.-Li	O
,	O
M.	O
,	O
Ren	O
,	O
H.	O
,	O
Sheth	O
,	O
K.	O
N.	O
,	O
Shi	O
,	O
F.-D.	O
,	O
Liu	O
,	O
Q.	O
A	O
gene1s	ARG2
TSPO	ARG2
gene1e	ARG2
ligand	O
attenuates	O
brain	O
injury	O
after	O
intracerebral	O
hemorrhage	O
.	O

A	O
gene1s	O
TSPO	O
gene1e	O
ligand	O
attenuates	O
brain	O
injury	O
after	O
intracerebral	O
hemorrhage	O
.	O
Intracerebral	O
hemorrhage	O
(	O
ICH	O
)	O
is	O
a	O
devastating	O
disease	O
without	O
effective	O
treatment	O
.	O
After	O
ICH	O
,	O
the	O
immediate	O
infiltration	O
of	O
leukocytes	O
and	O
activation	O
of	O
microglia	O
are	O
accompanied	O
by	O
a	O
rapid	O
up	O
-	O
regulation	O
of	O
the	O
18-kDa	O
translocator	O
protein	O
(	O
gene1s	O
TSPO	O
gene1e	O
)	O
.	O
gene1s	O
TSPO	O
gene1e	O
ligands	O
have	O
shown	O
anti	O
-	O
inflammatory	O
and	O
neuroprotective	O
properties	O
in	O
models	O
of	O
CNS	O
injury	O
.	O
In	O
this	O
study	O
,	O
we	O
determined	O
the	O
impact	O
of	O
a	O
gene1s	O
TSPO	O
gene1e	O
ligand	O
,	O
etifoxine	O
,	O
on	O
brain	O
injury	O
and	O
inflammation	O
in	O
2	O
species1s	O
mouse	O
species1e	O
models	O
of	O
ICH	O
.	O
gene1s	ARG2
TSPO	ARG2
gene1e	ARG2
was	O
up	O
-	O
regulated	O
in	O
gene1s	ARG2
Iba1	ARG2
gene1e	ARG2
(+	O
)	O
cells	O
from	O
brains	O
of	O
arg1s	O
patients	O
arg1e	O
with	O
ICH	O
and	O
in	O
gene1s	O
CD11b	O
gene1e	O
(+)	O
gene1s	O
CD45	O
gene1e	O
(int	O
)	O
cells	O
from	O
species1s	O
mice	O
species1e	O
subjected	O
to	O
collagenase	O
-	O
induced	O
ICH	O
.	O
Etifoxine	O
significantly	O
reduced	O
neurodeficits	O
and	O
perihematomal	O
brain	O
edema	O
after	O
ICH	O
induction	O
by	O
injection	O
of	O
either	O
autologous	O
blood	O
or	O
collagenase	O
.	O
In	O
collagenase	O
-	O
induced	O
ICH	O
species1s	O
mice	O
species1e	O
,	O
the	O
protection	O
of	O
etifoxine	O
was	O
associated	O
with	O
reduced	O
leukocyte	O
infiltration	O
into	O
the	O
brain	O
and	O
microglial	O
production	O
of	O
gene1s	O
IL-6	O
gene1e	O
and	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
.	O
Etifoxine	O
improved	O
blood	O
-	O
brain	O
barrier	O
integrity	O
and	O
diminished	O
cell	O
death	O
.	O
Notably	O
,	O
the	O
protective	O
effect	O
of	O
etifoxine	O
was	O
abolished	O
in	O
species1s	O
mice	O
species1e	O
depleted	O
of	O
microglia	O
by	O
using	O
a	O
gene1s	O
colony	O
-	O
stimulating	O
factor	O
1	O
receptor	O
gene1e	O
inhibitor	O
.	O
These	O
results	O
indicate	O
that	O
the	O
gene1s	O
TSPO	O
gene1e	O
ligand	O
etifoxine	O
attenuates	O
brain	O
injury	O
and	O
inflammation	O
after	O
ICH	O
.	O
gene1s	O
TSPO	O
gene1e	O
may	O
be	O
a	O
viable	O
therapeutic	O
target	O
that	O
requires	O
further	O
investigations	O
in	O
ICH.-Li	O
,	O
M.	O
,	O
Ren	O
,	O
H.	O
,	O
Sheth	O
,	O
K.	O
N.	O
,	O
Shi	O
,	O
F.-D.	O
,	O
Liu	O
,	O
Q.	O
A	O
gene1s	O
TSPO	O
gene1e	O
ligand	O
attenuates	O
brain	O
injury	O
after	O
intracerebral	O
hemorrhage	O
.	O

A	O
single	O
amino	O
acid	O
substitution	O
confers	O
B	O
-	O
cell	O
clonogenic	O
activity	O
to	O
the	O
arg1s	O
HIV-1	O
arg1e	O
matrix	O
protein	O
gene1s	ARG2
p17	ARG2
gene1e	ARG2
.	O
Recent	O
data	O
highlight	O
the	O
presence	O
,	O
in	O
arg1s	O
HIV-1	O
arg1e	O
-seropositive	O
species1s	O
patients	O
species1e	O
with	O
lymphoma	O
,	O
of	O
gene1s	ARG2
p17	ARG2
gene1e	ARG2
variants	O
(	O
vp17s	O
)	O
endowed	O
with	O
B	O
-	O
cell	O
clonogenicity	O
,	O
suggesting	O
a	O
role	O
of	O
vp17s	O
in	O
lymphomagenesis	O
.	O
We	O
investigated	O
the	O
mechanisms	O
responsible	O
for	O
the	O
functional	O
disparity	O
on	O
B	O
cells	O
between	O
a	O
wild	O
-	O
type	O
gene1s	ARG2
p17	ARG2
gene1e	ARG2
(	O
refp17	O
)	O
and	O
a	O
vp17	O
named	O
S75X.	O
Here	O
,	O
we	O
show	O
that	O
a	O
single	O
Arginine	O
(	O
R	O
)	O
to	O
Glycine	O
(	O
G	O
)	O
mutation	O
at	O
position	O
76	O
in	O
the	O
refp17	O
backbone	O
(	O
p17R76	O
G	O
)	O
,	O
as	O
in	O
the	O
S75X	O
variant	O
,	O
is	O
per	O
se	O
sufficient	O
to	O
confer	O
a	O
B	O
-	O
cell	O
clonogenic	O
potential	O
to	O
the	O
viral	O
protein	O
and	O
modulate	O
,	O
through	O
activation	O
of	O
the	O
gene1s	O
PTEN	O
gene1e	O
/	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
signaling	O
pathway	O
,	O
different	O
molecules	O
involved	O
in	O
apoptosis	O
inhibition	O
(	O
gene1s	O
CASP-9	O
gene1e	O
,	O
gene1s	O
CASP-7	O
gene1e	O
,	O
gene1s	O
DFF-45	O
gene1e	O
,	O
gene1s	O
NPM	O
gene1e	O
,	O
gene1s	O
YWHAZ	O
gene1e	O
,	O
gene1s	O
Src	O
gene1e	O
,	O
gene1s	O
PAX2	O
gene1e	O
,	O
gene1s	O
MAPK8	O
gene1e	O
)	O
,	O
cell	O
cycle	O
promotion	O
and	O
cancer	O
progression	O
(	O
gene1s	O
CDK1	O
gene1e	O
,	O
gene1s	O
CDK2	O
gene1e	O
,	O
gene1s	O
CDK8	O
gene1e	O
,	O
gene1s	O
CHEK1	O
gene1e	O
,	O
gene1s	O
CHEK2	O
gene1e	O
,	O
gene1s	O
GSK-3	O
beta	O
gene1e	O
,	O
gene1s	O
NPM	O
gene1e	O
,	O
gene1s	O
PAK1	O
gene1e	O
,	O
gene1s	O
PP2C	O
-	O
alpha	O
gene1e	O
)	O
.	O
Moreover	O
,	O
the	O
only	O
R	O
to	O
G	O
mutation	O
at	O
position	O
76	O
was	O
found	O
to	O
strongly	O
impact	O
on	O
protein	O
folding	O
and	O
oligomerization	O
by	O
altering	O
the	O
hydrogen	O
bond	O
network	O
.	O
This	O
generates	O
a	O
conformational	O
shift	O
in	O
the	O
p17	O
R76	O
G	O
mutant	O
which	O
enables	O
a	O
functional	O
epitope(s	O
)	O
,	O
masked	O
in	O
refp17	O
,	O
to	O
elicit	O
B	O
-	O
cell	O
growth	O
-	O
promoting	O
signals	O
after	O
its	O
interaction	O
with	O
a	O
still	O
unknown	O
receptor(s	O
)	O
.	O
Our	O
findings	O
offer	O
new	O
opportunities	O
to	O
understand	O
the	O
molecular	O
mechanisms	O
accounting	O
for	O
the	O
B	O
-	O
cell	O
growth	O
-	O
promoting	O
activity	O
of	O
vp17s	O
.	O

A	O
single	O
amino	O
acid	O
substitution	O
confers	O
B	O
-	O
cell	O
clonogenic	O
activity	O
to	O
the	O
species1s	O
HIV-1	O
species1e	O
matrix	O
protein	O
gene1s	O
p17	O
gene1e	O
.	O
Recent	O
data	O
highlight	O
the	O
presence	O
,	O
in	O
species1s	O
HIV-1	O
species1e	O
-seropositive	O
arg1s	O
patients	O
arg1e	O
with	O
lymphoma	O
,	O
of	O
gene1s	O
p17	O
gene1e	O
variants	O
(	O
vp17s	O
)	O
endowed	O
with	O
B	O
-	O
cell	O
clonogenicity	O
,	O
suggesting	O
a	O
role	O
of	O
vp17s	O
in	O
lymphomagenesis	O
.	O
We	O
investigated	O
the	O
mechanisms	O
responsible	O
for	O
the	O
functional	O
disparity	O
on	O
B	O
cells	O
between	O
a	O
wild	O
-	O
type	O
gene1s	O
p17	O
gene1e	O
(	O
refp17	O
)	O
and	O
a	O
vp17	O
named	O
S75X.	O
Here	O
,	O
we	O
show	O
that	O
a	O
single	O
Arginine	O
(	O
R	O
)	O
to	O
Glycine	O
(	O
G	O
)	O
mutation	O
at	O
position	O
76	O
in	O
the	O
refp17	O
backbone	O
(	O
p17R76	O
G	O
)	O
,	O
as	O
in	O
the	O
S75X	O
variant	O
,	O
is	O
per	O
se	O
sufficient	O
to	O
confer	O
a	O
B	O
-	O
cell	O
clonogenic	O
potential	O
to	O
the	O
viral	O
protein	O
and	O
modulate	O
,	O
through	O
activation	O
of	O
the	O
gene1s	ARG2
PTEN	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
signaling	O
pathway	O
,	O
different	O
molecules	O
involved	O
in	O
apoptosis	O
inhibition	O
(	O
gene1s	ARG2
CASP-9	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CASP-7	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
DFF-45	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NPM	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
YWHAZ	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Src	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PAX2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MAPK8	ARG2
gene1e	ARG2
)	O
,	O
cell	O
cycle	O
promotion	O
and	O
cancer	O
progression	O
(	O
gene1s	ARG2
CDK1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CDK2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CDK8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CHEK1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CHEK2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
GSK-3	ARG2
beta	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NPM	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PAK1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PP2C	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
)	O
.	O
Moreover	O
,	O
the	O
only	O
R	O
to	O
G	O
mutation	O
at	O
position	O
76	O
was	O
found	O
to	O
strongly	O
impact	O
on	O
protein	O
folding	O
and	O
oligomerization	O
by	O
altering	O
the	O
hydrogen	O
bond	O
network	O
.	O
This	O
generates	O
a	O
conformational	O
shift	O
in	O
the	O
p17	O
R76	O
G	O
mutant	O
which	O
enables	O
a	O
functional	O
epitope(s	O
)	O
,	O
masked	O
in	O
refp17	O
,	O
to	O
elicit	O
B	O
-	O
cell	O
growth	O
-	O
promoting	O
signals	O
after	O
its	O
interaction	O
with	O
a	O
still	O
unknown	O
receptor(s	O
)	O
.	O
Our	O
findings	O
offer	O
new	O
opportunities	O
to	O
understand	O
the	O
molecular	O
mechanisms	O
accounting	O
for	O
the	O
B	O
-	O
cell	O
growth	O
-	O
promoting	O
activity	O
of	O
vp17s	O
.	O

Anti	O
-	O
gene1s	ARG2
IL-20	ARG2
gene1e	ARG2
monoclonal	O
antibody	O
promotes	O
bone	O
fracture	O
healing	O
through	O
regulating	O
gene1s	O
IL-20	O
gene1e	O
-mediated	O
osteoblastogenesis	O
.	O
Bone	O
loss	O
and	O
skeletal	O
fragility	O
in	O
bone	O
fracture	O
are	O
caused	O
by	O
an	O
imbalance	O
in	O
bone	O
remodeling	O
.	O
The	O
current	O
challenge	O
in	O
bone	O
fracture	O
healing	O
is	O
to	O
promote	O
osteoblastogenesis	O
and	O
bone	O
formation	O
.	O
We	O
aimed	O
to	O
explore	O
the	O
role	O
of	O
gene1s	ARG2
IL-20	ARG2
gene1e	ARG2
in	O
osteoblastogenesis	O
,	O
osteoblast	O
differentiation	O
and	O
bone	O
fracture	O
.	O
Serum	O
gene1s	ARG2
IL-20	ARG2
gene1e	ARG2
was	O
significantly	O
correlated	O
with	O
serum	O
gene1s	ARG2
sclerostin	ARG2
gene1e	ARG2
in	O
arg1s	O
patients	O
arg1e	O
with	O
bone	O
fracture	O
.	O
In	O
a	O
species1s	O
mouse	O
species1e	O
model	O
,	O
anti	O
-	O
gene1s	ARG2
IL-20	ARG2
gene1e	ARG2
monoclonal	O
antibody	O
(	O
mAb	O
)	O
7E	O
increased	O
bone	O
formation	O
during	O
fracture	O
healing	O
.	O
In	O
vitro	O
,	O
gene1s	O
IL-20	O
gene1e	O
inhibited	O
osteoblastogenesis	O
by	O
upregulating	O
gene1s	O
sclerostin	O
gene1e	O
,	O
and	O
downregulating	O
gene1s	O
osterix	O
gene1e	O
(	O
gene1s	ARG2
OSX	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
RUNX2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
osteoprotegerin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
OPG	ARG2
gene1e	ARG2
)	O
.	O
gene1s	O
IL-20R1	O
gene1e	O
deficiency	O
attenuated	O
gene1s	O
IL-20	O
gene1e	O
-mediated	O
inhibition	O
of	O
osteoblast	O
differentiation	O
and	O
maturation	O
and	O
reduced	O
the	O
healing	O
time	O
after	O
a	O
bone	O
fracture	O
.	O
We	O
conclude	O
that	O
gene1s	O
IL-20	O
gene1e	O
affects	O
bone	O
formation	O
and	O
downregulates	O
osteoblastogenesis	O
by	O
modulating	O
gene1s	O
sclerostin	O
gene1e	O
,	O
gene1s	O
OSX	O
gene1e	O
,	O
gene1s	ARG2
RUNX2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
OPG	ARG2
gene1e	ARG2
on	O
osteoblasts	O
.	O
Our	O
results	O
demonstrated	O
that	O
gene1s	O
IL-20	O
gene1e	O
is	O
involved	O
in	O
osteoregulation	O
and	O
anti	O
-	O
gene1s	ARG2
IL-20	ARG2
gene1e	ARG2
mAb	O
is	O
a	O
potential	O
therapeutic	O
for	O
treating	O
bone	O
fracture	O
or	O
metabolic	O
bone	O
diseases	O
.	O

Anti	O
-	O
gene1s	O
IL-20	O
gene1e	O
monoclonal	O
antibody	O
promotes	O
bone	O
fracture	O
healing	O
through	O
regulating	O
gene1s	ARG2
IL-20	ARG2
gene1e	ARG2
-mediated	O
osteoblastogenesis	O
.	O
Bone	O
loss	O
and	O
skeletal	O
fragility	O
in	O
bone	O
fracture	O
are	O
caused	O
by	O
an	O
imbalance	O
in	O
bone	O
remodeling	O
.	O
The	O
current	O
challenge	O
in	O
bone	O
fracture	O
healing	O
is	O
to	O
promote	O
osteoblastogenesis	O
and	O
bone	O
formation	O
.	O
We	O
aimed	O
to	O
explore	O
the	O
role	O
of	O
gene1s	O
IL-20	O
gene1e	O
in	O
osteoblastogenesis	O
,	O
osteoblast	O
differentiation	O
and	O
bone	O
fracture	O
.	O
Serum	O
gene1s	O
IL-20	O
gene1e	O
was	O
significantly	O
correlated	O
with	O
serum	O
gene1s	O
sclerostin	O
gene1e	O
in	O
species1s	O
patients	O
species1e	O
with	O
bone	O
fracture	O
.	O
In	O
a	O
arg1s	O
mouse	O
arg1e	O
model	O
,	O
anti	O
-	O
gene1s	O
IL-20	O
gene1e	O
monoclonal	O
antibody	O
(	O
mAb	O
)	O
7E	O
increased	O
bone	O
formation	O
during	O
fracture	O
healing	O
.	O
In	O
vitro	O
,	O
gene1s	ARG2
IL-20	ARG2
gene1e	ARG2
inhibited	O
osteoblastogenesis	O
by	O
upregulating	O
gene1s	ARG2
sclerostin	ARG2
gene1e	ARG2
,	O
and	O
downregulating	O
gene1s	ARG2
osterix	ARG2
gene1e	ARG2
(	O
gene1s	O
OSX	O
gene1e	O
)	O
,	O
gene1s	O
RUNX2	O
gene1e	O
,	O
and	O
gene1s	O
osteoprotegerin	O
gene1e	O
(	O
gene1s	O
OPG	O
gene1e	O
)	O
.	O
gene1s	ARG2
IL-20R1	ARG2
gene1e	ARG2
deficiency	O
attenuated	O
gene1s	ARG2
IL-20	ARG2
gene1e	ARG2
-mediated	O
inhibition	O
of	O
osteoblast	O
differentiation	O
and	O
maturation	O
and	O
reduced	O
the	O
healing	O
time	O
after	O
a	O
bone	O
fracture	O
.	O
We	O
conclude	O
that	O
gene1s	ARG2
IL-20	ARG2
gene1e	ARG2
affects	O
bone	O
formation	O
and	O
downregulates	O
osteoblastogenesis	O
by	O
modulating	O
gene1s	ARG2
sclerostin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
OSX	ARG2
gene1e	ARG2
,	O
gene1s	O
RUNX2	O
gene1e	O
,	O
and	O
gene1s	O
OPG	O
gene1e	O
on	O
osteoblasts	O
.	O
Our	O
results	O
demonstrated	O
that	O
gene1s	ARG2
IL-20	ARG2
gene1e	ARG2
is	O
involved	O
in	O
osteoregulation	O
and	O
anti	O
-	O
gene1s	O
IL-20	O
gene1e	O
mAb	O
is	O
a	O
potential	O
therapeutic	O
for	O
treating	O
bone	O
fracture	O
or	O
metabolic	O
bone	O
diseases	O
.	O

An	O
in	O
vivo	O
screen	O
to	O
identify	O
candidate	O
neurogenic	O
genes	O
in	O
the	O
developing	O
arg1s	O
Xenopus	O
arg1e	O
visual	O
system	O
.	O
Neurogenesis	O
in	O
the	O
brain	O
of	O
arg1s	O
Xenopus	O
laevis	O
arg1e	O
continues	O
throughout	O
larval	O
stages	O
of	O
development	O
.	O
We	O
developed	O
a	O
2-tier	O
screen	O
to	O
identify	O
candidate	O
genes	O
controlling	O
neurogenesis	O
in	O
arg1s	O
Xenopus	O
arg1e	O
optic	O
tectum	O
in	O
vivo	O
.	O
First	O
,	O
microarray	O
and	O
NanoString	O
analyses	O
were	O
used	O
to	O
identify	O
candidate	O
genes	O
that	O
were	O
differentially	O
expressed	O
in	O
gene1s	ARG2
Sox2	ARG2
gene1e	ARG2
-expressing	O
neural	O
progenitor	O
cells	O
or	O
their	O
neuronal	O
progeny	O
.	O
Then	O
an	O
in	O
vivo	O
,	O
time	O
-	O
lapse	O
imaging	O
-	O
based	O
screen	O
was	O
used	O
to	O
test	O
whether	O
morpholinos	O
against	O
34	O
candidate	O
genes	O
altered	O
neural	O
progenitor	O
cell	O
proliferation	O
or	O
neuronal	O
differentiation	O
over	O
3	O
days	O
in	O
the	O
optic	O
tectum	O
of	O
intact	O
arg1s	O
Xenopus	O
arg1e	O
tadpoles	O
.	O
We	O
co	O
-	O
electroporated	O
antisense	O
morpholino	O
oligonucleotides	O
against	O
each	O
of	O
the	O
candidate	O
genes	O
with	O
a	O
plasmid	O
that	O
drives	O
GFP	O
expression	O
in	O
gene1s	ARG2
Sox2	ARG2
gene1e	ARG2
-expressing	O
neural	O
progenitor	O
cells	O
and	O
quantified	O
the	O
effects	O
of	O
morpholinos	O
on	O
neurogenesis	O
.	O
Of	O
the	O
34	O
morpholinos	O
tested	O
,	O
24	O
altered	O
neural	O
progenitor	O
cell	O
proliferation	O
or	O
neuronal	O
differentiation	O
.	O
The	O
candidates	O
which	O
were	O
tagged	O
as	O
differentially	O
expressed	O
and	O
validated	O
by	O
the	O
in	O
vivo	O
imaging	O
screen	O
include	O
:	O
gene1s	ARG2
actn1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
arl9	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
eif3a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
elk4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ephb1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
fmr1-a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
fxr1	ARG2
-	ARG2
1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
fbxw7	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
fgf2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
gstp1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
hat1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
hspa5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
lsm6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
mecp2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
mmp9	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
prkaca	ARG2
gene1e	ARG2
.	O
Several	O
of	O
these	O
candidates	O
,	O
including	O
gene1s	ARG2
fgf2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
elk4	ARG2
gene1e	ARG2
,	O
have	O
known	O
or	O
proposed	O
neurogenic	O
functions	O
,	O
thereby	O
validating	O
our	O
strategy	O
to	O
identify	O
candidates	O
.	O
Genes	O
with	O
no	O
previously	O
demonstrated	O
neurogenic	O
functions	O
,	O
gene1s	ARG2
gstp1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
hspa5	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
lsm6	ARG2
gene1e	ARG2
,	O
were	O
identified	O
from	O
the	O
morpholino	O
experiments	O
,	O
suggesting	O
that	O
our	O
screen	O
successfully	O
revealed	O
unknown	O
candidates	O
.	O
Genes	O
that	O
are	O
associated	O
with	O
species1s	O
human	O
species1e	O
disease	O
,	O
such	O
as	O
such	O
as	O
gene1s	ARG2
mecp2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
fmr1-a	ARG2
gene1e	ARG2
,	O
were	O
identified	O
by	O
our	O
screen	O
,	O
providing	O
the	O
groundwork	O
for	O
using	O
arg1s	O
Xenopus	O
arg1e	O
as	O
an	O
experimental	O
system	O
to	O
probe	O
conserved	O
disease	O
mechanisms	O
.	O
Together	O
the	O
data	O
identify	O
candidate	O
neurogenic	O
regulatory	O
genes	O
and	O
demonstrate	O
that	O
arg1s	O
Xenopus	O
arg1e	O
is	O
an	O
effective	O
experimental	O
animal	O
to	O
identify	O
and	O
characterize	O
genes	O
that	O
regulate	O
neural	O
progenitor	O
cell	O
proliferation	O
and	O
differentiation	O
in	O
vivo	O
.	O

An	O
in	O
vivo	O
screen	O
to	O
identify	O
candidate	O
neurogenic	O
genes	O
in	O
the	O
developing	O
species1s	O
Xenopus	O
species1e	O
visual	O
system	O
.	O
Neurogenesis	O
in	O
the	O
brain	O
of	O
species1s	O
Xenopus	O
laevis	O
species1e	O
continues	O
throughout	O
larval	O
stages	O
of	O
development	O
.	O
We	O
developed	O
a	O
2-tier	O
screen	O
to	O
identify	O
candidate	O
genes	O
controlling	O
neurogenesis	O
in	O
species1s	O
Xenopus	O
species1e	O
optic	O
tectum	O
in	O
vivo	O
.	O
First	O
,	O
microarray	O
and	O
NanoString	O
analyses	O
were	O
used	O
to	O
identify	O
candidate	O
genes	O
that	O
were	O
differentially	O
expressed	O
in	O
gene1s	O
Sox2	O
gene1e	O
-expressing	O
neural	O
progenitor	O
cells	O
or	O
their	O
neuronal	O
progeny	O
.	O
Then	O
an	O
in	O
vivo	O
,	O
time	O
-	O
lapse	O
imaging	O
-	O
based	O
screen	O
was	O
used	O
to	O
test	O
whether	O
morpholinos	O
against	O
34	O
candidate	O
genes	O
altered	O
neural	O
progenitor	O
cell	O
proliferation	O
or	O
neuronal	O
differentiation	O
over	O
3	O
days	O
in	O
the	O
optic	O
tectum	O
of	O
intact	O
species1s	O
Xenopus	O
species1e	O
tadpoles	O
.	O
We	O
co	O
-	O
electroporated	O
antisense	O
morpholino	O
oligonucleotides	O
against	O
each	O
of	O
the	O
candidate	O
genes	O
with	O
a	O
plasmid	O
that	O
drives	O
GFP	O
expression	O
in	O
gene1s	O
Sox2	O
gene1e	O
-expressing	O
neural	O
progenitor	O
cells	O
and	O
quantified	O
the	O
effects	O
of	O
morpholinos	O
on	O
neurogenesis	O
.	O
Of	O
the	O
34	O
morpholinos	O
tested	O
,	O
24	O
altered	O
neural	O
progenitor	O
cell	O
proliferation	O
or	O
neuronal	O
differentiation	O
.	O
The	O
candidates	O
which	O
were	O
tagged	O
as	O
differentially	O
expressed	O
and	O
validated	O
by	O
the	O
in	O
vivo	O
imaging	O
screen	O
include	O
:	O
gene1s	O
actn1	O
gene1e	O
,	O
gene1s	O
arl9	O
gene1e	O
,	O
gene1s	O
eif3a	O
gene1e	O
,	O
gene1s	O
elk4	O
gene1e	O
,	O
gene1s	O
ephb1	O
gene1e	O
,	O
gene1s	O
fmr1-a	O
gene1e	O
,	O
gene1s	O
fxr1	O
-	O
1	O
gene1e	O
,	O
gene1s	O
fbxw7	O
gene1e	O
,	O
gene1s	O
fgf2	O
gene1e	O
,	O
gene1s	O
gstp1	O
gene1e	O
,	O
gene1s	O
hat1	O
gene1e	O
,	O
gene1s	O
hspa5	O
gene1e	O
,	O
gene1s	O
lsm6	O
gene1e	O
,	O
gene1s	O
mecp2	O
gene1e	O
,	O
gene1s	O
mmp9	O
gene1e	O
,	O
and	O
gene1s	O
prkaca	O
gene1e	O
.	O
Several	O
of	O
these	O
candidates	O
,	O
including	O
gene1s	O
fgf2	O
gene1e	O
and	O
gene1s	O
elk4	O
gene1e	O
,	O
have	O
known	O
or	O
proposed	O
neurogenic	O
functions	O
,	O
thereby	O
validating	O
our	O
strategy	O
to	O
identify	O
candidates	O
.	O
Genes	O
with	O
no	O
previously	O
demonstrated	O
neurogenic	O
functions	O
,	O
gene1s	O
gstp1	O
gene1e	O
,	O
gene1s	O
hspa5	O
gene1e	O
and	O
gene1s	O
lsm6	O
gene1e	O
,	O
were	O
identified	O
from	O
the	O
morpholino	O
experiments	O
,	O
suggesting	O
that	O
our	O
screen	O
successfully	O
revealed	O
unknown	O
candidates	O
.	O
Genes	O
that	O
are	O
associated	O
with	O
arg1s	O
human	O
arg1e	O
disease	O
,	O
such	O
as	O
such	O
as	O
gene1s	O
mecp2	O
gene1e	O
and	O
gene1s	O
fmr1-a	O
gene1e	O
,	O
were	O
identified	O
by	O
our	O
screen	O
,	O
providing	O
the	O
groundwork	O
for	O
using	O
species1s	O
Xenopus	O
species1e	O
as	O
an	O
experimental	O
system	O
to	O
probe	O
conserved	O
disease	O
mechanisms	O
.	O
Together	O
the	O
data	O
identify	O
candidate	O
neurogenic	O
regulatory	O
genes	O
and	O
demonstrate	O
that	O
species1s	O
Xenopus	O
species1e	O
is	O
an	O
effective	O
experimental	O
animal	O
to	O
identify	O
and	O
characterize	O
genes	O
that	O
regulate	O
neural	O
progenitor	O
cell	O
proliferation	O
and	O
differentiation	O
in	O
vivo	O
.	O

Gastric	O
expression	O
of	O
gene1s	ARG2
plasminogen	ARG2
activator	ARG2
inhibitor	ARG2
(	ARG2
PAI)-1	ARG2
gene1e	ARG2
is	O
associated	O
with	O
hyperphagia	O
and	O
obesity	O
in	O
arg1s	O
mice	O
arg1e	O
.	O
The	O
gene1s	ARG2
adipokine	ARG2
gene1e	ARG2
gene1s	ARG2
plasminogen	ARG2
activator	ARG2
inhibitor	ARG2
(	ARG2
PAI)-1	ARG2
gene1e	ARG2
is	O
increased	O
in	O
plasma	O
of	O
obese	O
individuals	O
and	O
exhibits	O
increased	O
expression	O
in	O
the	O
stomachs	O
of	O
individuals	O
infected	O
with	O
species1s	O
Helicobacter	O
species1e	O
.	O
To	O
investigate	O
the	O
relevance	O
of	O
gastric	O
gene1s	ARG2
PAI-1	ARG2
gene1e	ARG2
,	O
we	O
used	O
1.1	O
kb	O
of	O
the	O
gene1s	ARG2
H(+)/K(+)b	ARG2
subunit	ARG2
gene1e	ARG2
promoter	O
to	O
overexpress	O
gene1s	ARG2
PAI-1	ARG2
gene1e	ARG2
specifically	O
in	O
arg1s	O
mouse	O
arg1e	O
gastric	O
parietal	O
cells	O
(	O
gene1s	ARG2
PAI-1	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
H	ARG2
/	ARG2
Kb	ARG2
gene1e	ARG2
arg1s	O
mice	O
arg1e	O
)	O
.	O
We	O
studied	O
the	O
physiological	O
,	O
biochemical	O
,	O
and	O
behavioral	O
characteristics	O
of	O
these	O
and	O
arg1s	O
mice	O
arg1e	O
null	O
for	O
gene1s	ARG2
PAI-1	ARG2
gene1e	ARG2
or	O
a	O
putative	O
receptor	O
,	O
gene1s	ARG2
urokinase	ARG2
plasminogen	ARG2
activator	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
uPAR	ARG2
gene1e	ARG2
)	O
.	O
gene1s	ARG2
PAI-1	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
H	ARG2
/	ARG2
Kb	ARG2
gene1e	ARG2
arg1s	O
mice	O
arg1e	O
had	O
increased	O
plasma	O
concentrations	O
of	O
gene1s	ARG2
PAI-1	ARG2
gene1e	ARG2
and	O
increased	O
body	O
mass	O
,	O
adiposity	O
,	O
and	O
hyperphagia	O
compared	O
with	O
wild	O
-	O
type	O
arg1s	O
mice	O
arg1e	O
.	O
In	O
the	O
latter	O
,	O
food	O
intake	O
was	O
inhibited	O
by	O
gene1s	ARG2
cholecystokinin	ARG2
(	ARG2
CCK)8s	ARG2
gene1e	ARG2
,	O
but	O
gene1s	ARG2
PAI-1	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
H	ARG2
/	ARG2
Kb	ARG2
gene1e	ARG2
arg1s	O
mice	O
arg1e	O
were	O
insensitive	O
to	O
the	O
satiating	O
effects	O
of	O
gene1s	ARG2
CCK8s	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
PAI-1	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
H	ARG2
/	ARG2
Kb	ARG2
gene1e	ARG2
arg1s	O
mice	O
arg1e	O
also	O
had	O
significantly	O
reduced	O
expression	O
of	O
gene1s	ARG2
c	ARG2
-	ARG2
fos	ARG2
gene1e	ARG2
in	O
the	O
nucleus	O
tractus	O
solitarius	O
in	O
response	O
to	O
gene1s	ARG2
CCK8s	ARG2
gene1e	ARG2
and	O
refeeding	O
compared	O
with	O
wild	O
-	O
type	O
arg1s	O
mice	O
arg1e	O
.	O
Exogenous	O
gene1s	ARG2
PAI-1	ARG2
gene1e	ARG2
reversed	O
the	O
effects	O
of	O
gene1s	ARG2
CCK8s	ARG2
gene1e	ARG2
on	O
food	O
intake	O
and	O
gene1s	ARG2
c	ARG2
-	ARG2
fos	ARG2
gene1e	ARG2
levels	O
in	O
the	O
nucleus	O
tractus	O
solitarius	O
of	O
wild	O
-	O
type	O
arg1s	O
mice	O
arg1e	O
,	O
but	O
not	O
gene1s	ARG2
uPAR	ARG2
gene1e	ARG2
-	O
null	O
arg1s	O
mice	O
arg1e	O
.	O
Infection	O
of	O
C57BL/6	O
arg1s	O
mice	O
arg1e	O
with	O
species1s	O
Helicobacter	O
felis	O
species1e	O
increased	O
gastric	O
abundance	O
of	O
gene1s	ARG2
PAI-1	ARG2
gene1e	ARG2
and	O
reduced	O
the	O
satiating	O
effects	O
of	O
gene1s	ARG2
CCK8s	ARG2
gene1e	ARG2
,	O
whereas	O
the	O
response	O
to	O
gene1s	ARG2
CCK8s	ARG2
gene1e	ARG2
was	O
maintained	O
in	O
infected	O
gene1s	ARG2
PAI-1	ARG2
gene1e	ARG2
-null	O
arg1s	O
mice	O
arg1e	O
.	O
In	O
cultured	O
vagal	O
afferent	O
neurons	O
,	O
gene1s	ARG2
PAI-1	ARG2
gene1e	ARG2
inhibited	O
stimulation	O
of	O
gene1s	ARG2
neuropeptide	ARG2
Y	ARG2
type	ARG2
2	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Y2R	ARG2
gene1e	ARG2
)	O
expression	O
by	O
gene1s	ARG2
CCK8s	ARG2
gene1e	ARG2
.	O
Thus	O
,	O
gastric	O
expression	O
of	O
gene1s	ARG2
PAI-1	ARG2
gene1e	ARG2
is	O
associated	O
with	O
hyperphagia	O
,	O
moderate	O
obesity	O
,	O
and	O
resistance	O
to	O
the	O
satiating	O
effects	O
of	O
gene1s	ARG2
CCK	ARG2
gene1e	ARG2
indicating	O
a	O
new	O
role	O
in	O
suppressing	O
signals	O
from	O
the	O
upper	O
gut	O
that	O
inhibit	O
food	O
intake	O
.	O

Gastric	O
expression	O
of	O
gene1s	O
plasminogen	O
activator	O
inhibitor	O
(	O
PAI)-1	O
gene1e	O
is	O
associated	O
with	O
hyperphagia	O
and	O
obesity	O
in	O
species1s	O
mice	O
species1e	O
.	O
The	O
gene1s	O
adipokine	O
gene1e	O
gene1s	O
plasminogen	O
activator	O
inhibitor	O
(	O
PAI)-1	O
gene1e	O
is	O
increased	O
in	O
plasma	O
of	O
obese	O
individuals	O
and	O
exhibits	O
increased	O
expression	O
in	O
the	O
stomachs	O
of	O
individuals	O
infected	O
with	O
arg1s	O
Helicobacter	O
arg1e	O
.	O
To	O
investigate	O
the	O
relevance	O
of	O
gastric	O
gene1s	O
PAI-1	O
gene1e	O
,	O
we	O
used	O
1.1	O
kb	O
of	O
the	O
gene1s	O
H(+)/K(+)b	O
subunit	O
gene1e	O
promoter	O
to	O
overexpress	O
gene1s	O
PAI-1	O
gene1e	O
specifically	O
in	O
species1s	O
mouse	O
species1e	O
gastric	O
parietal	O
cells	O
(	O
gene1s	O
PAI-1	O
gene1e	O
-	O
gene1s	O
H	O
/	O
Kb	O
gene1e	O
species1s	O
mice	O
species1e	O
)	O
.	O
We	O
studied	O
the	O
physiological	O
,	O
biochemical	O
,	O
and	O
behavioral	O
characteristics	O
of	O
these	O
and	O
species1s	O
mice	O
species1e	O
null	O
for	O
gene1s	O
PAI-1	O
gene1e	O
or	O
a	O
putative	O
receptor	O
,	O
gene1s	O
urokinase	O
plasminogen	O
activator	O
receptor	O
gene1e	O
(	O
gene1s	O
uPAR	O
gene1e	O
)	O
.	O
gene1s	O
PAI-1	O
gene1e	O
-	O
gene1s	O
H	O
/	O
Kb	O
gene1e	O
species1s	O
mice	O
species1e	O
had	O
increased	O
plasma	O
concentrations	O
of	O
gene1s	O
PAI-1	O
gene1e	O
and	O
increased	O
body	O
mass	O
,	O
adiposity	O
,	O
and	O
hyperphagia	O
compared	O
with	O
wild	O
-	O
type	O
species1s	O
mice	O
species1e	O
.	O
In	O
the	O
latter	O
,	O
food	O
intake	O
was	O
inhibited	O
by	O
gene1s	O
cholecystokinin	O
(	O
CCK)8s	O
gene1e	O
,	O
but	O
gene1s	O
PAI-1	O
gene1e	O
-	O
gene1s	O
H	O
/	O
Kb	O
gene1e	O
species1s	O
mice	O
species1e	O
were	O
insensitive	O
to	O
the	O
satiating	O
effects	O
of	O
gene1s	O
CCK8s	O
gene1e	O
.	O
gene1s	O
PAI-1	O
gene1e	O
-	O
gene1s	O
H	O
/	O
Kb	O
gene1e	O
species1s	O
mice	O
species1e	O
also	O
had	O
significantly	O
reduced	O
expression	O
of	O
gene1s	O
c	O
-	O
fos	O
gene1e	O
in	O
the	O
nucleus	O
tractus	O
solitarius	O
in	O
response	O
to	O
gene1s	O
CCK8s	O
gene1e	O
and	O
refeeding	O
compared	O
with	O
wild	O
-	O
type	O
species1s	O
mice	O
species1e	O
.	O
Exogenous	O
gene1s	O
PAI-1	O
gene1e	O
reversed	O
the	O
effects	O
of	O
gene1s	O
CCK8s	O
gene1e	O
on	O
food	O
intake	O
and	O
gene1s	O
c	O
-	O
fos	O
gene1e	O
levels	O
in	O
the	O
nucleus	O
tractus	O
solitarius	O
of	O
wild	O
-	O
type	O
species1s	O
mice	O
species1e	O
,	O
but	O
not	O
gene1s	O
uPAR	O
gene1e	O
-	O
null	O
species1s	O
mice	O
species1e	O
.	O
Infection	O
of	O
C57BL/6	O
species1s	O
mice	O
species1e	O
with	O
arg1s	O
Helicobacter	O
felis	O
arg1e	O
increased	O
gastric	O
abundance	O
of	O
gene1s	O
PAI-1	O
gene1e	O
and	O
reduced	O
the	O
satiating	O
effects	O
of	O
gene1s	O
CCK8s	O
gene1e	O
,	O
whereas	O
the	O
response	O
to	O
gene1s	O
CCK8s	O
gene1e	O
was	O
maintained	O
in	O
infected	O
gene1s	O
PAI-1	O
gene1e	O
-null	O
species1s	O
mice	O
species1e	O
.	O
In	O
cultured	O
vagal	O
afferent	O
neurons	O
,	O
gene1s	O
PAI-1	O
gene1e	O
inhibited	O
stimulation	O
of	O
gene1s	O
neuropeptide	O
Y	O
type	O
2	O
receptor	O
gene1e	O
(	O
gene1s	O
Y2R	O
gene1e	O
)	O
expression	O
by	O
gene1s	O
CCK8s	O
gene1e	O
.	O
Thus	O
,	O
gastric	O
expression	O
of	O
gene1s	O
PAI-1	O
gene1e	O
is	O
associated	O
with	O
hyperphagia	O
,	O
moderate	O
obesity	O
,	O
and	O
resistance	O
to	O
the	O
satiating	O
effects	O
of	O
gene1s	O
CCK	O
gene1e	O
indicating	O
a	O
new	O
role	O
in	O
suppressing	O
signals	O
from	O
the	O
upper	O
gut	O
that	O
inhibit	O
food	O
intake	O
.	O

Identification	O
and	O
characterization	O
of	O
gene1s	O
FGF2	O
gene1e	O
-dependent	O
mRNA	O
:	O
gene1s	ARG2
microRNA	ARG2
gene1e	ARG2
networks	O
during	O
lens	O
fiber	O
cell	O
differentiation	O
.	O
gene1s	ARG2
MicroRNAs	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
miRNAs	ARG2
gene1e	ARG2
)	O
and	O
gene1s	O
fibroblast	O
growth	O
factor	O
gene1e	O
(	O
gene1s	O
FGF	O
gene1e	O
)	O
signaling	O
regulate	O
a	O
wide	O
range	O
of	O
cellular	O
functions	O
,	O
including	O
cell	O
specification	O
,	O
proliferation	O
,	O
migration	O
,	O
differentiation	O
,	O
and	O
survival	O
.	O
In	O
lens	O
,	O
both	O
these	O
systems	O
control	O
lens	O
fiber	O
cell	O
differentiation	O
;	O
however	O
,	O
a	O
possible	O
link	O
between	O
these	O
processes	O
remains	O
to	O
be	O
examined	O
.	O
Herein	O
,	O
the	O
functional	O
requirement	O
for	O
gene1s	ARG2
miRNAs	ARG2
gene1e	ARG2
in	O
differentiating	O
lens	O
fiber	O
cells	O
was	O
demonstrated	O
via	O
conditional	O
inactivation	O
of	O
gene1s	ARG2
Dicer1	ARG2
gene1e	ARG2
in	O
arg1s	O
mouse	O
arg1e	O
(	O
arg1s	O
Mus	O
musculus	O
arg1e	O
)	O
lens	O
.	O
To	O
dissect	O
the	O
gene1s	O
miRNA	O
gene1e	O
-	O
dependent	O
pathways	O
during	O
lens	O
differentiation	O
,	O
we	O
used	O
a	O
species1s	O
rat	O
species1e	O
(	O
species1s	O
Rattus	O
norvegicus	O
species1e	O
)	O
lens	O
epithelial	O
explant	O
system	O
,	O
induced	O
by	O
gene1s	O
FGF2	O
gene1e	O
to	O
differentiate	O
,	O
followed	O
by	O
mRNA	O
and	O
gene1s	O
miRNA	O
gene1e	O
expression	O
profiling	O
.	O
Transcriptome	O
and	O
miRNome	O
analysis	O
identified	O
extensive	O
gene1s	O
FGF2	O
gene1e	O
-regulated	O
cellular	O
responses	O
that	O
were	O
both	O
independent	O
and	O
dependent	O
on	O
gene1s	O
miRNAs	O
gene1e	O
.	O
We	O
identified	O
131	O
gene1s	O
FGF2	O
gene1e	O
-regulated	O
miRNAs	O
.	O
Seventy	O
-	O
six	O
of	O
these	O
gene1s	O
miRNAs	O
gene1e	O
had	O
at	O
least	O
two	O
in	O
silico	O
predicted	O
and	O
inversely	O
regulated	O
target	O
mRNAs	O
.	O
Genes	O
modulated	O
by	O
the	O
greatest	O
number	O
of	O
gene1s	O
FGF	O
gene1e	O
-	O
regulated	O
gene1s	O
miRNAs	O
gene1e	O
include	O
DNA	O
-	O
binding	O
gene1s	O
transcription	O
factors	O
gene1e	O
gene1s	O
Nfib	O
gene1e	O
,	O
gene1s	O
Nfat5	O
gene1e	O
/	O
gene1s	O
OREBP	O
gene1e	O
,	O
gene1s	O
c	O
-	O
Maf	O
gene1e	O
,	O
gene1s	O
Ets1	O
gene1e	O
,	O
and	O
gene1s	O
N	O
-	O
Myc	O
gene1e	O
.	O
Activated	O
gene1s	O
FGF	O
gene1e	O
signaling	O
influenced	O
gene1s	O
bone	O
morphogenetic	O
factor	O
gene1e	O
/	O
gene1s	O
transforming	O
growth	O
factor	O
-	O
beta	O
gene1e	O
,	O
gene1s	O
Notch	O
gene1e	O
,	O
and	O
gene1s	O
Wnt	O
gene1e	O
signaling	O
cascades	O
implicated	O
earlier	O
in	O
lens	O
differentiation	O
.	O
Specific	O
gene1s	O
miRNA	O
gene1e	O
:	O
mRNA	O
interaction	O
networks	O
were	O
predicted	O
for	O
gene1s	O
c	O
-	O
Maf	O
gene1e	O
,	O
gene1s	O
N	O
-	O
Myc	O
gene1e	O
,	O
and	O
gene1s	O
Nfib	O
gene1e	O
(	O
DNA	O
-	O
binding	O
gene1s	O
transcription	O
factors	O
gene1e	O
)	O
;	O
gene1s	O
Cnot6	O
gene1e	O
,	O
gene1s	O
Cpsf6	O
gene1e	O
,	O
gene1s	O
Dicer1	O
gene1e	O
,	O
and	O
gene1s	O
Tnrc6b	O
gene1e	O
(	O
RNA	O
to	O
gene1s	O
miRNA	O
gene1e	O
processing	O
)	O
;	O
and	O
gene1s	O
Ash1l	O
gene1e	O
,	O
gene1s	O
Med1	O
gene1e	O
/	O
gene1s	O
PBP	O
gene1e	O
,	O
and	O
gene1s	O
Kdm5b	O
gene1e	O
/	O
gene1s	O
Jarid1b	O
gene1e	O
/	O
gene1s	O
Plu1	O
gene1e	O
(	O
chromatin	O
remodeling	O
)	O
.	O
Three	O
gene1s	O
miRNAs	O
gene1e	O
,	O
including	O
gene1s	O
miR-143	O
gene1e	O
,	O
gene1s	O
miR-155	O
gene1e	O
,	O
and	O
gene1s	O
miR-301a	O
gene1e	O
,	O
down	O
-	O
regulated	O
expression	O
of	O
gene1s	O
c	O
-	O
Maf	O
gene1e	O
in	O
the	O
3'-UTR	O
luciferase	O
reporter	O
assays	O
.	O
These	O
present	O
studies	O
demonstrate	O
for	O
the	O
first	O
time	O
global	O
impact	O
of	O
activated	O
gene1s	O
FGF	O
gene1e	O
signaling	O
in	O
lens	O
cell	O
culture	O
system	O
and	O
predicted	O
novel	O
gene	O
regulatory	O
networks	O
connected	O
by	O
multiple	O
gene1s	O
miRNAs	O
gene1e	O
that	O
regulate	O
lens	O
differentiation	O
.	O

Identification	O
and	O
characterization	O
of	O
gene1s	ARG2
FGF2	ARG2
gene1e	ARG2
-dependent	O
mRNA	O
:	O
gene1s	ARG2
microRNA	ARG2
gene1e	ARG2
networks	O
during	O
lens	O
fiber	O
cell	O
differentiation	O
.	O
gene1s	ARG2
MicroRNAs	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
miRNAs	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
fibroblast	ARG2
growth	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
FGF	ARG2
gene1e	ARG2
)	O
signaling	O
regulate	O
a	O
wide	O
range	O
of	O
cellular	O
functions	O
,	O
including	O
cell	O
specification	O
,	O
proliferation	O
,	O
migration	O
,	O
differentiation	O
,	O
and	O
survival	O
.	O
In	O
lens	O
,	O
both	O
these	O
systems	O
control	O
lens	O
fiber	O
cell	O
differentiation	O
;	O
however	O
,	O
a	O
possible	O
link	O
between	O
these	O
processes	O
remains	O
to	O
be	O
examined	O
.	O
Herein	O
,	O
the	O
functional	O
requirement	O
for	O
gene1s	O
miRNAs	O
gene1e	O
in	O
differentiating	O
lens	O
fiber	O
cells	O
was	O
demonstrated	O
via	O
conditional	O
inactivation	O
of	O
gene1s	O
Dicer1	O
gene1e	O
in	O
species1s	O
mouse	O
species1e	O
(	O
species1s	O
Mus	O
musculus	O
species1e	O
)	O
lens	O
.	O
To	O
dissect	O
the	O
gene1s	ARG2
miRNA	ARG2
gene1e	ARG2
-	O
dependent	O
pathways	O
during	O
lens	O
differentiation	O
,	O
we	O
used	O
a	O
arg1s	O
rat	O
arg1e	O
(	O
arg1s	O
Rattus	O
norvegicus	O
arg1e	O
)	O
lens	O
epithelial	O
explant	O
system	O
,	O
induced	O
by	O
gene1s	ARG2
FGF2	ARG2
gene1e	ARG2
to	O
differentiate	O
,	O
followed	O
by	O
mRNA	O
and	O
gene1s	ARG2
miRNA	ARG2
gene1e	ARG2
expression	O
profiling	O
.	O
Transcriptome	O
and	O
miRNome	O
analysis	O
identified	O
extensive	O
gene1s	ARG2
FGF2	ARG2
gene1e	ARG2
-regulated	O
cellular	O
responses	O
that	O
were	O
both	O
independent	O
and	O
dependent	O
on	O
gene1s	ARG2
miRNAs	ARG2
gene1e	ARG2
.	O
We	O
identified	O
131	O
gene1s	ARG2
FGF2	ARG2
gene1e	ARG2
-regulated	O
miRNAs	O
.	O
Seventy	O
-	O
six	O
of	O
these	O
gene1s	ARG2
miRNAs	ARG2
gene1e	ARG2
had	O
at	O
least	O
two	O
in	O
silico	O
predicted	O
and	O
inversely	O
regulated	O
target	O
mRNAs	O
.	O
Genes	O
modulated	O
by	O
the	O
greatest	O
number	O
of	O
gene1s	ARG2
FGF	ARG2
gene1e	ARG2
-	O
regulated	O
gene1s	ARG2
miRNAs	ARG2
gene1e	ARG2
include	O
DNA	O
-	O
binding	O
gene1s	ARG2
transcription	ARG2
factors	ARG2
gene1e	ARG2
gene1s	ARG2
Nfib	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Nfat5	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
OREBP	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
c	ARG2
-	ARG2
Maf	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Ets1	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
N	ARG2
-	ARG2
Myc	ARG2
gene1e	ARG2
.	O
Activated	O
gene1s	ARG2
FGF	ARG2
gene1e	ARG2
signaling	O
influenced	O
gene1s	ARG2
bone	ARG2
morphogenetic	ARG2
factor	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
transforming	ARG2
growth	ARG2
factor	ARG2
-	ARG2
beta	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Notch	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
signaling	O
cascades	O
implicated	O
earlier	O
in	O
lens	O
differentiation	O
.	O
Specific	O
gene1s	ARG2
miRNA	ARG2
gene1e	ARG2
:	O
mRNA	O
interaction	O
networks	O
were	O
predicted	O
for	O
gene1s	ARG2
c	ARG2
-	ARG2
Maf	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
N	ARG2
-	ARG2
Myc	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Nfib	ARG2
gene1e	ARG2
(	O
DNA	O
-	O
binding	O
gene1s	ARG2
transcription	ARG2
factors	ARG2
gene1e	ARG2
)	O
;	O
gene1s	ARG2
Cnot6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Cpsf6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Dicer1	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Tnrc6b	ARG2
gene1e	ARG2
(	O
RNA	O
to	O
gene1s	ARG2
miRNA	ARG2
gene1e	ARG2
processing	O
)	O
;	O
and	O
gene1s	ARG2
Ash1l	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Med1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PBP	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Kdm5b	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Jarid1b	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Plu1	ARG2
gene1e	ARG2
(	O
chromatin	O
remodeling	O
)	O
.	O
Three	O
gene1s	ARG2
miRNAs	ARG2
gene1e	ARG2
,	O
including	O
gene1s	ARG2
miR-143	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-155	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
miR-301a	ARG2
gene1e	ARG2
,	O
down	O
-	O
regulated	O
expression	O
of	O
gene1s	ARG2
c	ARG2
-	ARG2
Maf	ARG2
gene1e	ARG2
in	O
the	O
3'-UTR	O
luciferase	O
reporter	O
assays	O
.	O
These	O
present	O
studies	O
demonstrate	O
for	O
the	O
first	O
time	O
global	O
impact	O
of	O
activated	O
gene1s	ARG2
FGF	ARG2
gene1e	ARG2
signaling	O
in	O
lens	O
cell	O
culture	O
system	O
and	O
predicted	O
novel	O
gene	O
regulatory	O
networks	O
connected	O
by	O
multiple	O
gene1s	ARG2
miRNAs	ARG2
gene1e	ARG2
that	O
regulate	O
lens	O
differentiation	O
.	O

Conditional	O
Inactivation	O
of	O
gene1s	ARG2
Nf1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Pten	ARG2
gene1e	ARG2
in	O
Schwann	O
Cells	O
Results	O
in	O
Abnormal	O
Neuromuscular	O
Junction	O
Maturation	O
.	O
The	O
neuromuscular	O
junction	O
(	O
NMJ	O
)	O
consists	O
of	O
three	O
components	O
,	O
namely	O
presynaptic	O
motor	O
neurons	O
,	O
postsynaptic	O
muscle	O
fibers	O
and	O
perisynaptic	O
Schwann	O
cells	O
(	O
PSCs	O
)	O
.	O
The	O
role	O
of	O
Schwann	O
cells	O
(	O
SCs	O
)	O
in	O
regulating	O
NMJ	O
structural	O
and	O
functional	O
development	O
remains	O
unclear	O
.	O
In	O
this	O
study	O
,	O
arg1s	O
mice	O
arg1e	O
with	O
conditional	O
inactivation	O
of	O
gene1s	ARG2
neurofibromin	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Nf1	ARG2
gene1e	ARG2
)	O
and	O
phosphatase	O
and	O
tensin	O
homolog	O
(	O
gene1s	ARG2
Pten	ARG2
gene1e	ARG2
)	O
,	O
specifically	O
in	O
SCs	O
,	O
resulted	O
in	O
delayed	O
NMJ	O
maturation	O
that	O
led	O
to	O
delayed	O
muscle	O
growth	O
,	O
recapitulating	O
the	O
muscular	O
dystrophy	O
condition	O
observed	O
in	O
species1s	O
human	O
species1e	O
neurofibromatosis	O
type	O
I	O
syndrome	O
(	O
NF1	O
)	O
species1s	O
patients	O
species1e	O
.	O
Expression	O
levels	O
of	O
NMJ	O
development	O
related	O
molecules	O
such	O
as	O
gene1s	ARG2
cholinergic	ARG2
receptor	ARG2
,	ARG2
nicotinic	ARG2
,	ARG2
alpha	ARG2
polypeptide	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Chrna1	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
agrin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Agrn	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
dystrophin	ARG2
,	ARG2
muscular	ARG2
dystrophy	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Dmd	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
laminin	ARG2
,	ARG2
beta	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Lamb2	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
dystroglycan	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Dag1	ARG2
gene1e	ARG2
)	O
were	O
also	O
downregulated	O
.	O
To	O
further	O
explore	O
the	O
molecular	O
alterations	O
in	O
these	O
SCs	O
,	O
gene1s	ARG2
NF1	ARG2
gene1e	ARG2
-	O
and	O
gene1s	ARG2
PTEN	ARG2
gene1e	ARG2
-	O
related	O
pathways	O
were	O
analyzed	O
in	O
mutant	O
sciatic	O
nerves	O
.	O
As	O
expected	O
,	O
hyperactive	O
gene1s	ARG2
RAS	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
signaling	O
pathways	O
were	O
identified	O
,	O
suggesting	O
the	O
importance	O
of	O
these	O
pathways	O
for	O
NMJ	O
development	O
,	O
and	O
subsequent	O
muscle	O
maturation	O
.	O

Conditional	O
Inactivation	O
of	O
gene1s	O
Nf1	O
gene1e	O
and	O
gene1s	O
Pten	O
gene1e	O
in	O
Schwann	O
Cells	O
Results	O
in	O
Abnormal	O
Neuromuscular	O
Junction	O
Maturation	O
.	O
The	O
neuromuscular	O
junction	O
(	O
NMJ	O
)	O
consists	O
of	O
three	O
components	O
,	O
namely	O
presynaptic	O
motor	O
neurons	O
,	O
postsynaptic	O
muscle	O
fibers	O
and	O
perisynaptic	O
Schwann	O
cells	O
(	O
PSCs	O
)	O
.	O
The	O
role	O
of	O
Schwann	O
cells	O
(	O
SCs	O
)	O
in	O
regulating	O
NMJ	O
structural	O
and	O
functional	O
development	O
remains	O
unclear	O
.	O
In	O
this	O
study	O
,	O
species1s	O
mice	O
species1e	O
with	O
conditional	O
inactivation	O
of	O
gene1s	O
neurofibromin	O
1	O
gene1e	O
(	O
gene1s	O
Nf1	O
gene1e	O
)	O
and	O
phosphatase	O
and	O
tensin	O
homolog	O
(	O
gene1s	O
Pten	O
gene1e	O
)	O
,	O
specifically	O
in	O
SCs	O
,	O
resulted	O
in	O
delayed	O
NMJ	O
maturation	O
that	O
led	O
to	O
delayed	O
muscle	O
growth	O
,	O
recapitulating	O
the	O
muscular	O
dystrophy	O
condition	O
observed	O
in	O
arg1s	O
human	O
arg1e	O
neurofibromatosis	O
type	O
I	O
syndrome	O
(	O
NF1	O
)	O
arg1s	O
patients	O
arg1e	O
.	O
Expression	O
levels	O
of	O
NMJ	O
development	O
related	O
molecules	O
such	O
as	O
gene1s	O
cholinergic	O
receptor	O
,	O
nicotinic	O
,	O
alpha	O
polypeptide	O
1	O
gene1e	O
(	O
gene1s	O
Chrna1	O
gene1e	O
)	O
,	O
gene1s	O
agrin	O
gene1e	O
(	O
gene1s	O
Agrn	O
gene1e	O
)	O
,	O
gene1s	O
dystrophin	O
,	O
muscular	O
dystrophy	O
gene1e	O
(	O
gene1s	O
Dmd	O
gene1e	O
)	O
,	O
gene1s	O
laminin	O
,	O
beta	O
2	O
gene1e	O
(	O
gene1s	O
Lamb2	O
gene1e	O
)	O
and	O
gene1s	O
dystroglycan	O
1	O
gene1e	O
(	O
gene1s	O
Dag1	O
gene1e	O
)	O
were	O
also	O
downregulated	O
.	O
To	O
further	O
explore	O
the	O
molecular	O
alterations	O
in	O
these	O
SCs	O
,	O
gene1s	O
NF1	O
gene1e	O
-	O
and	O
gene1s	O
PTEN	O
gene1e	O
-	O
related	O
pathways	O
were	O
analyzed	O
in	O
mutant	O
sciatic	O
nerves	O
.	O
As	O
expected	O
,	O
hyperactive	O
gene1s	O
RAS	O
gene1e	O
/	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
AKT	O
gene1e	O
/	O
gene1s	O
mTOR	O
gene1e	O
signaling	O
pathways	O
were	O
identified	O
,	O
suggesting	O
the	O
importance	O
of	O
these	O
pathways	O
for	O
NMJ	O
development	O
,	O
and	O
subsequent	O
muscle	O
maturation	O
.	O

EGCG	O
inhibits	O
growth	O
of	O
arg1s	O
human	O
arg1e	O
pancreatic	O
tumors	O
orthotopically	O
implanted	O
in	O
Balb	O
C	O
species1s	O
nude	O
mice	O
species1e	O
through	O
modulation	O
of	O
gene1s	ARG2
FKHRL1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
FOXO3a	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
neuropilin	ARG2
gene1e	ARG2
.	O
arg1s	O
Human	O
arg1e	O
pancreatic	O
cancer	O
is	O
currently	O
one	O
of	O
the	O
fourth	O
leading	O
causes	O
of	O
cancer	O
-	O
related	O
mortality	O
with	O
a	O
5-year	O
survival	O
rate	O
of	O
less	O
than	O
5	O
%	O
.	O
Since	O
pancreatic	O
carcinoma	O
is	O
largely	O
refractory	O
to	O
conventional	O
therapies	O
,	O
there	O
is	O
a	O
strong	O
medical	O
need	O
for	O
the	O
development	O
of	O
novel	O
and	O
innovative	O
cancer	O
preventive	O
strategies	O
.	O
The	O
gene1s	ARG2
forkhead	ARG2
transcription	ARG2
factors	ARG2
of	ARG2
the	ARG2
O	ARG2
class	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
FOXO	ARG2
gene1e	ARG2
)	O
play	O
a	O
major	O
role	O
in	O
cell	O
proliferation	O
,	O
angiogenesis	O
,	O
metastasis	O
,	O
and	O
tumorigenesis	O
.	O
The	O
objectives	O
of	O
this	O
study	O
were	O
to	O
examine	O
whether	O
gene1s	ARG2
FKHRL1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
FOXO3a	ARG2
gene1e	ARG2
modulates	O
antitumor	O
activity	O
of	O
(	O
-)-epigallocatechin-3-gallate	O
(	O
EGCG	O
)	O
,	O
an	O
active	O
ingredient	O
in	O
green	O
tea	O
,	O
in	O
pancreatic	O
cancer	O
model	O
in	O
vivo	O
.	O
arg1s	O
PANC-1	O
arg1e	O
cells	O
were	O
orthotopically	O
implanted	O
into	O
Balb	O
c	O
species1s	O
nude	O
mice	O
species1e	O
and	O
gavaged	O
with	O
EGCG	O
after	O
tumor	O
formation	O
.	O
Cell	O
proliferation	O
and	O
apoptosis	O
were	O
measured	O
by	O
gene1s	ARG2
Ki67	ARG2
gene1e	ARG2
and	O
TUNEL	O
staining	O
,	O
respectively	O
.	O
The	O
expression	O
of	O
gene1s	ARG2
PI3	ARG2
K	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
FOXO3a	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
FKHRL1	ARG2
gene1e	ARG2
and	O
its	O
target	O
genes	O
were	O
measured	O
by	O
the	O
western	O
blot	O
analysis	O
and/or	O
q	O
-	O
RT	O
-	O
PCR	O
.	O
gene1s	ARG2
FOXO	ARG2
gene1e	ARG2
-	O
DNA	O
binding	O
was	O
measured	O
by	O
gel	O
shift	O
assay	O
.	O
EGCG	O
-	O
treated	O
species1s	O
mice	O
species1e	O
showed	O
significant	O
inhibition	O
in	O
tumor	O
growth	O
which	O
was	O
associated	O
with	O
reduced	O
phosphorylation	O
of	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PI3	ARG2
K	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
FKHRL1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
FOXO3a	ARG2
gene1e	ARG2
,	O
and	O
modulation	O
of	O
gene1s	ARG2
FOXO	ARG2
gene1e	ARG2
target	O
genes	O
.	O
EGCG	O
induced	O
apoptosis	O
by	O
upregulating	O
gene1s	ARG2
Bim	ARG2
gene1e	ARG2
and	O
activating	O
gene1s	ARG2
caspase-3	ARG2
gene1e	ARG2
.	O
EGCG	O
modulated	O
markers	O
of	O
cell	O
cycle	O
(	O
gene1s	ARG2
p27	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
KIP1	ARG2
gene1e	ARG2
)	O
,	O
angiogenesis	O
(	O
gene1s	ARG2
CD31	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SEMA3F	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
HIF1a	ARG2
gene1e	ARG2
)	O
,	O
and	O
metastasis	O
(	O
gene1s	ARG2
MMP2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MMP7	ARG2
gene1e	ARG2
)	O
.	O
The	O
inhibition	O
of	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
by	O
EGCG	O
was	O
associated	O
with	O
suppression	O
of	O
gene1s	ARG2
neuropilin	ARG2
gene1e	ARG2
.	O
EGCG	O
inhibited	O
epithelial	O
-	O
mesenchymal	O
transition	O
by	O
upregulating	O
the	O
expression	O
of	O
gene1s	ARG2
E	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
and	O
inhibiting	O
the	O
expression	O
of	O
gene1s	ARG2
N	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Zeb1	ARG2
gene1e	ARG2
.	O
These	O
data	O
suggest	O
that	O
EGCG	O
inhibits	O
pancreatic	O
cancer	O
orthotopic	O
tumor	O
growth	O
,	O
angiogenesis	O
,	O
and	O
metastasis	O
which	O
are	O
associated	O
with	O
inhibition	O
of	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	O
AKT	O
gene1e	O
and	O
gene1s	O
ERK	O
gene1e	O
pathways	O
and	O
activation	O
of	O
gene1s	ARG2
FKHRL1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
FOXO3a	ARG2
gene1e	ARG2
.	O
As	O
a	O
conclusion	O
,	O
EGCG	O
can	O
be	O
used	O
for	O
the	O
prevention	O
and/or	O
treatment	O
of	O
pancreatic	O
cancer	O
.	O

EGCG	O
inhibits	O
growth	O
of	O
species1s	O
human	O
species1e	O
pancreatic	O
tumors	O
orthotopically	O
implanted	O
in	O
Balb	O
C	O
arg1s	O
nude	O
mice	O
arg1e	O
through	O
modulation	O
of	O
gene1s	O
FKHRL1	O
gene1e	O
/	O
gene1s	O
FOXO3a	O
gene1e	O
and	O
gene1s	O
neuropilin	O
gene1e	O
.	O
species1s	O
Human	O
species1e	O
pancreatic	O
cancer	O
is	O
currently	O
one	O
of	O
the	O
fourth	O
leading	O
causes	O
of	O
cancer	O
-	O
related	O
mortality	O
with	O
a	O
5-year	O
survival	O
rate	O
of	O
less	O
than	O
5	O
%	O
.	O
Since	O
pancreatic	O
carcinoma	O
is	O
largely	O
refractory	O
to	O
conventional	O
therapies	O
,	O
there	O
is	O
a	O
strong	O
medical	O
need	O
for	O
the	O
development	O
of	O
novel	O
and	O
innovative	O
cancer	O
preventive	O
strategies	O
.	O
The	O
gene1s	O
forkhead	O
transcription	O
factors	O
of	O
the	O
O	O
class	O
gene1e	O
(	O
gene1s	O
FOXO	O
gene1e	O
)	O
play	O
a	O
major	O
role	O
in	O
cell	O
proliferation	O
,	O
angiogenesis	O
,	O
metastasis	O
,	O
and	O
tumorigenesis	O
.	O
The	O
objectives	O
of	O
this	O
study	O
were	O
to	O
examine	O
whether	O
gene1s	O
FKHRL1	O
gene1e	O
/	O
gene1s	O
FOXO3a	O
gene1e	O
modulates	O
antitumor	O
activity	O
of	O
(	O
-)-epigallocatechin-3-gallate	O
(	O
EGCG	O
)	O
,	O
an	O
active	O
ingredient	O
in	O
green	O
tea	O
,	O
in	O
pancreatic	O
cancer	O
model	O
in	O
vivo	O
.	O
species1s	O
PANC-1	O
species1e	O
cells	O
were	O
orthotopically	O
implanted	O
into	O
Balb	O
c	O
arg1s	O
nude	O
mice	O
arg1e	O
and	O
gavaged	O
with	O
EGCG	O
after	O
tumor	O
formation	O
.	O
Cell	O
proliferation	O
and	O
apoptosis	O
were	O
measured	O
by	O
gene1s	O
Ki67	O
gene1e	O
and	O
TUNEL	O
staining	O
,	O
respectively	O
.	O
The	O
expression	O
of	O
gene1s	O
PI3	O
K	O
gene1e	O
,	O
gene1s	O
AKT	O
gene1e	O
,	O
gene1s	O
ERK	O
gene1e	O
,	O
and	O
gene1s	O
FOXO3a	O
gene1e	O
/	O
gene1s	O
FKHRL1	O
gene1e	O
and	O
its	O
target	O
genes	O
were	O
measured	O
by	O
the	O
western	O
blot	O
analysis	O
and/or	O
q	O
-	O
RT	O
-	O
PCR	O
.	O
gene1s	O
FOXO	O
gene1e	O
-	O
DNA	O
binding	O
was	O
measured	O
by	O
gel	O
shift	O
assay	O
.	O
EGCG	O
-	O
treated	O
arg1s	O
mice	O
arg1e	O
showed	O
significant	O
inhibition	O
in	O
tumor	O
growth	O
which	O
was	O
associated	O
with	O
reduced	O
phosphorylation	O
of	O
gene1s	O
ERK	O
gene1e	O
,	O
gene1s	O
PI3	O
K	O
gene1e	O
,	O
gene1s	O
AKT	O
gene1e	O
,	O
and	O
gene1s	O
FKHRL1	O
gene1e	O
/	O
gene1s	O
FOXO3a	O
gene1e	O
,	O
and	O
modulation	O
of	O
gene1s	O
FOXO	O
gene1e	O
target	O
genes	O
.	O
EGCG	O
induced	O
apoptosis	O
by	O
upregulating	O
gene1s	O
Bim	O
gene1e	O
and	O
activating	O
gene1s	O
caspase-3	O
gene1e	O
.	O
EGCG	O
modulated	O
markers	O
of	O
cell	O
cycle	O
(	O
gene1s	O
p27	O
gene1e	O
/	O
gene1s	O
KIP1	O
gene1e	O
)	O
,	O
angiogenesis	O
(	O
gene1s	O
CD31	O
gene1e	O
,	O
gene1s	O
VEGF	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
gene1s	O
IL-8	O
gene1e	O
,	O
gene1s	O
SEMA3F	O
gene1e	O
,	O
and	O
gene1s	O
HIF1a	O
gene1e	O
)	O
,	O
and	O
metastasis	O
(	O
gene1s	O
MMP2	O
gene1e	O
and	O
gene1s	O
MMP7	O
gene1e	O
)	O
.	O
The	O
inhibition	O
of	O
gene1s	O
VEGF	O
gene1e	O
by	O
EGCG	O
was	O
associated	O
with	O
suppression	O
of	O
gene1s	O
neuropilin	O
gene1e	O
.	O
EGCG	O
inhibited	O
epithelial	O
-	O
mesenchymal	O
transition	O
by	O
upregulating	O
the	O
expression	O
of	O
gene1s	O
E	O
-	O
cadherin	O
gene1e	O
and	O
inhibiting	O
the	O
expression	O
of	O
gene1s	O
N	O
-	O
cadherin	O
gene1e	O
and	O
gene1s	O
Zeb1	O
gene1e	O
.	O
These	O
data	O
suggest	O
that	O
EGCG	O
inhibits	O
pancreatic	O
cancer	O
orthotopic	O
tumor	O
growth	O
,	O
angiogenesis	O
,	O
and	O
metastasis	O
which	O
are	O
associated	O
with	O
inhibition	O
of	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
pathways	O
and	O
activation	O
of	O
gene1s	O
FKHRL1	O
gene1e	O
/	O
gene1s	O
FOXO3a	O
gene1e	O
.	O
As	O
a	O
conclusion	O
,	O
EGCG	O
can	O
be	O
used	O
for	O
the	O
prevention	O
and/or	O
treatment	O
of	O
pancreatic	O
cancer	O
.	O

gene1s	ARG2
Cyp1b1	ARG2
gene1e	ARG2
expression	O
impacts	O
the	O
angiogenic	O
and	O
inflammatory	O
properties	O
of	O
liver	O
sinusoidal	O
endothelial	O
cells	O
.	O
gene1s	ARG2
Cytochrome	ARG2
P450	ARG2
1B1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CYP1B1	ARG2
gene1e	ARG2
)	O
is	O
a	O
member	O
of	O
the	O
gene1s	ARG2
cytochrome	ARG2
p450	ARG2
gene1e	ARG2
family	O
of	O
enzymes	O
that	O
catalyze	O
gene1s	ARG2
mono	ARG2
-	ARG2
oxygenase	ARG2
gene1e	ARG2
reactions	O
.	O
Although	O
constitutive	O
gene1s	ARG2
Cyp1b1	ARG2
gene1e	ARG2
expression	O
is	O
limited	O
in	O
hepatocytes	O
,	O
its	O
expression	O
and	O
function	O
in	O
liver	O
sinusoidal	O
endothelial	O
cells	O
(	O
LSEC	O
)	O
remains	O
unknown	O
.	O
Here	O
we	O
determined	O
the	O
impact	O
of	O
gene1s	ARG2
Cyp1b1	ARG2
gene1e	ARG2
expression	O
on	O
LSEC	O
properties	O
prepared	O
from	O
gene1s	ARG2
Cyp1b1	ARG2
gene1e	ARG2
+/+	O
and	O
gene1s	ARG2
Cyp1b1	ARG2
gene1e	ARG2
-/-	O
arg1s	O
mice	O
arg1e	O
.	O
LSEC	O
expressed	O
gene1s	ARG2
PECAM-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
VE	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
B4	ARG2
lectin	ARG2
gene1e	ARG2
similar	O
to	O
EC	O
from	O
other	O
arg1s	O
mouse	O
arg1e	O
tissues	O
.	O
gene1s	ARG2
Cyp1b1	ARG2
gene1e	ARG2
+	O
/+	O
LSEC	O
constitutively	O
expressed	O
significant	O
levels	O
of	O
gene1s	ARG2
Cyp1b1	ARG2
gene1e	ARG2
,	O
while	O
gene1s	ARG2
Cyp1b1	ARG2
gene1e	ARG2
-/-	O
LSEC	O
lacked	O
gene1s	ARG2
Cyp1b1	ARG2
gene1e	ARG2
expression	O
.	O
LSEC	O
also	O
expressed	O
gene1s	ARG2
VEGFR3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PROX-1	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
LYVE-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
VEGFR1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
VEGFR2	ARG2
gene1e	ARG2
,	O
as	O
well	O
as	O
other	O
cell	O
adhesion	O
molecules	O
including	O
gene1s	ARG2
ICAM-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ICAM-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
VCAM-1	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
thrombospondin-1	ARG2
(	ARG2
TSP1	ARG2
)	ARG2
receptors	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD36	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CD47	ARG2
gene1e	ARG2
.	O
However	O
,	O
the	O
expression	O
of	O
gene1s	ARG2
PV-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
stabilin	ARG2
gene1e	ARG2
(	O
fenestration	O
markers	O
)	O
,	O
and	O
gene1s	ARG2
endoglin	ARG2
gene1e	ARG2
were	O
limited	O
in	O
these	O
cells	O
.	O
The	O
gene1s	ARG2
Cyp1b1	ARG2
gene1e	ARG2
-/-	O
LSEC	O
showed	O
limited	O
fenestration	O
,	O
and	O
decreased	O
levels	O
of	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
BMP6	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
Cyp1b1	ARG2
gene1e	ARG2
-/-	O
LSEC	O
also	O
showed	O
a	O
decrease	O
in	O
the	O
levels	O
of	O
gene1s	ARG2
VE	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ZO-1	ARG2
gene1e	ARG2
impacting	O
adherens	O
and	O
gap	O
junction	O
formation	O
.	O
gene1s	ARG2
Cyp1b1	ARG2
gene1e	ARG2
-/-	O
LSEC	O
were	O
significantly	O
more	O
apoptotic	O
,	O
proliferated	O
at	O
a	O
faster	O
rate	O
,	O
and	O
were	O
less	O
adherent	O
and	O
more	O
migratory	O
.	O
These	O
changes	O
were	O
attributed	O
,	O
in	O
part	O
,	O
to	O
decreased	O
amounts	O
of	O
gene1s	ARG2
TSP1	ARG2
gene1e	ARG2
and	O
increased	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
activation	O
.	O
The	O
expressions	O
of	O
gene1s	ARG2
integrins	ARG2
gene1e	ARG2
were	O
also	O
altered	O
by	O
the	O
lack	O
of	O
gene1s	ARG2
Cyp1b1	ARG2
gene1e	ARG2
,	O
but	O
the	O
ability	O
of	O
these	O
cells	O
to	O
undergo	O
capillary	O
morphogenesis	O
was	O
minimally	O
affected	O
.	O
Furthermore	O
,	O
gene1s	ARG2
Cyp1b1	ARG2
gene1e	ARG2
-/-	O
LSEC	O
expressed	O
lower	O
levels	O
of	O
inflammatory	O
mediators	O
gene1s	ARG2
MCP-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
.	O
Thus	O
,	O
gene1s	ARG2
Cyp1b1	ARG2
gene1e	ARG2
expression	O
has	O
a	O
significant	O
impact	O
on	O
LSEC	O
angiogenic	O
and	O
inflammatory	O
functions	O
.	O

Gartanin	O
induces	O
cell	O
cycle	O
arrest	O
and	O
autophagy	O
and	O
suppresses	O
migration	O
involving	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
signalling	O
pathway	O
in	O
arg1s	O
human	O
arg1e	O
glioma	O
cells	O
.	O
In	O
central	O
nervous	O
system	O
,	O
glioma	O
is	O
the	O
most	O
common	O
primary	O
brain	O
tumour	O
.	O
The	O
diffuse	O
migration	O
and	O
rapid	O
proliferation	O
are	O
main	O
obstacles	O
for	O
successful	O
treatment	O
.	O
Gartanin	O
,	O
a	O
natural	O
xanthone	O
of	O
species1s	O
mangosteen	O
species1e	O
,	O
suppressed	O
proliferation	O
,	O
migration	O
and	O
colony	O
formation	O
in	O
a	O
time-	O
and	O
concentration	O
-	O
dependent	O
manner	O
in	O
arg1s	O
T98	O
G	O
arg1e	O
glioma	O
cells	O
but	O
not	O
in	O
species1s	O
mouse	O
species1e	O
normal	O
neuronal	O
species1s	O
HT22	O
species1e	O
cells	O
.	O
Gartanin	O
,	O
at	O
low	O
micromole	O
,	O
led	O
to	O
cell	O
cycle	O
arrest	O
in	O
G1	O
phase	O
accompanied	O
by	O
inhibited	O
expression	O
level	O
of	O
G1	O
cell	O
cycle	O
regulatory	O
proteins	O
gene1s	ARG2
cyclin	ARG2
D1	ARG2
gene1e	ARG2
,	O
while	O
increased	O
expression	O
level	O
of	O
gene1s	ARG2
cyclin	ARG2
-	ARG2
dependent	ARG2
kinase	ARG2
inhibitor	ARG2
gene1e	ARG2
gene1s	ARG2
p27Kip1	ARG2
gene1e	ARG2
.	O
In	O
addition	O
,	O
the	O
secretion	O
and	O
activity	O
of	O
gene1s	ARG2
matrix	ARG2
metalloproteinases	ARG2
2/9	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MMP-2/-9	ARG2
gene1e	ARG2
)	O
were	O
significantly	O
suppressed	O
in	O
arg1s	O
T98	O
G	O
arg1e	O
cells	O
treated	O
with	O
gartanin	O
,	O
and	O
it	O
might	O
result	O
from	O
modulating	O
gene1s	ARG2
mitogen	ARG2
-	ARG2
activated	ARG2
protein	ARG2
kinases	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
)	O
signalling	O
pathway	O
in	O
arg1s	O
T98	O
G	O
arg1e	O
glioma	O
cells	O
.	O
Moreover	O
,	O
gartanin	O
significantly	O
induced	O
autophagy	O
in	O
arg1s	O
T98	O
G	O
arg1e	O
cells	O
and	O
increased	O
GFP	O
-	O
gene1s	ARG2
LC3	ARG2
gene1e	ARG2
punctate	O
fluorescence	O
accompanied	O
by	O
the	O
increased	O
expression	O
level	O
of	O
gene1s	ARG2
Beclin	ARG2
1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
LC3	ARG2
gene1e	ARG2
-II	O
,	O
while	O
suppressed	O
expression	O
level	O
of	O
gene1s	ARG2
p62	ARG2
gene1e	ARG2
.	O
Gartanin	O
treatment	O
resulted	O
in	O
obvious	O
inhibition	O
of	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
signalling	O
pathway	O
,	O
which	O
is	O
important	O
in	O
modulating	O
autophagy	O
.	O
Notably	O
,	O
gartanin	O
-	O
mediated	O
anti	O
-	O
viability	O
was	O
significantly	O
abrogated	O
by	O
autophagy	O
inhibitors	O
including	O
3-methyladenine	O
(	O
3-MA	O
)	O
and	O
chloroquine	O
(	O
CQ	O
)	O
.	O
These	O
results	O
indicate	O
that	O
anti	O
-	O
proliferation	O
effect	O
of	O
gartanin	O
in	O
arg1s	O
T98	O
G	O
arg1e	O
cells	O
is	O
most	O
likely	O
via	O
cell	O
cycle	O
arrest	O
modulated	O
by	O
autophagy	O
,	O
which	O
is	O
regulated	O
by	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
signalling	O
pathway	O
,	O
while	O
anti	O
-	O
migration	O
effect	O
is	O
most	O
likely	O
via	O
suppression	O
of	O
gene1s	ARG2
MMP-2/-9	ARG2
gene1e	ARG2
activity	O
which	O
is	O
involved	O
in	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
signalling	O
pathway	O
.	O

Gartanin	O
induces	O
cell	O
cycle	O
arrest	O
and	O
autophagy	O
and	O
suppresses	O
migration	O
involving	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
/	O
gene1s	O
mTOR	O
gene1e	O
and	O
gene1s	O
MAPK	O
gene1e	O
signalling	O
pathway	O
in	O
species1s	O
human	O
species1e	O
glioma	O
cells	O
.	O
In	O
central	O
nervous	O
system	O
,	O
glioma	O
is	O
the	O
most	O
common	O
primary	O
brain	O
tumour	O
.	O
The	O
diffuse	O
migration	O
and	O
rapid	O
proliferation	O
are	O
main	O
obstacles	O
for	O
successful	O
treatment	O
.	O
Gartanin	O
,	O
a	O
natural	O
xanthone	O
of	O
arg1s	O
mangosteen	O
arg1e	O
,	O
suppressed	O
proliferation	O
,	O
migration	O
and	O
colony	O
formation	O
in	O
a	O
time-	O
and	O
concentration	O
-	O
dependent	O
manner	O
in	O
species1s	O
T98	O
G	O
species1e	O
glioma	O
cells	O
but	O
not	O
in	O
species1s	O
mouse	O
species1e	O
normal	O
neuronal	O
species1s	O
HT22	O
species1e	O
cells	O
.	O
Gartanin	O
,	O
at	O
low	O
micromole	O
,	O
led	O
to	O
cell	O
cycle	O
arrest	O
in	O
G1	O
phase	O
accompanied	O
by	O
inhibited	O
expression	O
level	O
of	O
G1	O
cell	O
cycle	O
regulatory	O
proteins	O
gene1s	O
cyclin	O
D1	O
gene1e	O
,	O
while	O
increased	O
expression	O
level	O
of	O
gene1s	O
cyclin	O
-	O
dependent	O
kinase	O
inhibitor	O
gene1e	O
gene1s	O
p27Kip1	O
gene1e	O
.	O
In	O
addition	O
,	O
the	O
secretion	O
and	O
activity	O
of	O
gene1s	O
matrix	O
metalloproteinases	O
2/9	O
gene1e	O
(	O
gene1s	O
MMP-2/-9	O
gene1e	O
)	O
were	O
significantly	O
suppressed	O
in	O
species1s	O
T98	O
G	O
species1e	O
cells	O
treated	O
with	O
gartanin	O
,	O
and	O
it	O
might	O
result	O
from	O
modulating	O
gene1s	O
mitogen	O
-	O
activated	O
protein	O
kinases	O
gene1e	O
(	O
gene1s	O
MAPK	O
gene1e	O
)	O
signalling	O
pathway	O
in	O
species1s	O
T98	O
G	O
species1e	O
glioma	O
cells	O
.	O
Moreover	O
,	O
gartanin	O
significantly	O
induced	O
autophagy	O
in	O
species1s	O
T98	O
G	O
species1e	O
cells	O
and	O
increased	O
GFP	O
-	O
gene1s	O
LC3	O
gene1e	O
punctate	O
fluorescence	O
accompanied	O
by	O
the	O
increased	O
expression	O
level	O
of	O
gene1s	O
Beclin	O
1	O
gene1e	O
and	O
gene1s	O
LC3	O
gene1e	O
-II	O
,	O
while	O
suppressed	O
expression	O
level	O
of	O
gene1s	O
p62	O
gene1e	O
.	O
Gartanin	O
treatment	O
resulted	O
in	O
obvious	O
inhibition	O
of	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
/	O
gene1s	O
mTOR	O
gene1e	O
signalling	O
pathway	O
,	O
which	O
is	O
important	O
in	O
modulating	O
autophagy	O
.	O
Notably	O
,	O
gartanin	O
-	O
mediated	O
anti	O
-	O
viability	O
was	O
significantly	O
abrogated	O
by	O
autophagy	O
inhibitors	O
including	O
3-methyladenine	O
(	O
3-MA	O
)	O
and	O
chloroquine	O
(	O
CQ	O
)	O
.	O
These	O
results	O
indicate	O
that	O
anti	O
-	O
proliferation	O
effect	O
of	O
gartanin	O
in	O
species1s	O
T98	O
G	O
species1e	O
cells	O
is	O
most	O
likely	O
via	O
cell	O
cycle	O
arrest	O
modulated	O
by	O
autophagy	O
,	O
which	O
is	O
regulated	O
by	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
/	O
gene1s	O
mTOR	O
gene1e	O
signalling	O
pathway	O
,	O
while	O
anti	O
-	O
migration	O
effect	O
is	O
most	O
likely	O
via	O
suppression	O
of	O
gene1s	O
MMP-2/-9	O
gene1e	O
activity	O
which	O
is	O
involved	O
in	O
gene1s	O
MAPK	O
gene1e	O
signalling	O
pathway	O
.	O

Gartanin	O
induces	O
cell	O
cycle	O
arrest	O
and	O
autophagy	O
and	O
suppresses	O
migration	O
involving	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
/	O
gene1s	O
mTOR	O
gene1e	O
and	O
gene1s	O
MAPK	O
gene1e	O
signalling	O
pathway	O
in	O
species1s	O
human	O
species1e	O
glioma	O
cells	O
.	O
In	O
central	O
nervous	O
system	O
,	O
glioma	O
is	O
the	O
most	O
common	O
primary	O
brain	O
tumour	O
.	O
The	O
diffuse	O
migration	O
and	O
rapid	O
proliferation	O
are	O
main	O
obstacles	O
for	O
successful	O
treatment	O
.	O
Gartanin	O
,	O
a	O
natural	O
xanthone	O
of	O
species1s	O
mangosteen	O
species1e	O
,	O
suppressed	O
proliferation	O
,	O
migration	O
and	O
colony	O
formation	O
in	O
a	O
time-	O
and	O
concentration	O
-	O
dependent	O
manner	O
in	O
species1s	O
T98	O
G	O
species1e	O
glioma	O
cells	O
but	O
not	O
in	O
arg1s	O
mouse	O
arg1e	O
normal	O
neuronal	O
arg1s	O
HT22	O
arg1e	O
cells	O
.	O
Gartanin	O
,	O
at	O
low	O
micromole	O
,	O
led	O
to	O
cell	O
cycle	O
arrest	O
in	O
G1	O
phase	O
accompanied	O
by	O
inhibited	O
expression	O
level	O
of	O
G1	O
cell	O
cycle	O
regulatory	O
proteins	O
gene1s	O
cyclin	O
D1	O
gene1e	O
,	O
while	O
increased	O
expression	O
level	O
of	O
gene1s	O
cyclin	O
-	O
dependent	O
kinase	O
inhibitor	O
gene1e	O
gene1s	O
p27Kip1	O
gene1e	O
.	O
In	O
addition	O
,	O
the	O
secretion	O
and	O
activity	O
of	O
gene1s	O
matrix	O
metalloproteinases	O
2/9	O
gene1e	O
(	O
gene1s	O
MMP-2/-9	O
gene1e	O
)	O
were	O
significantly	O
suppressed	O
in	O
species1s	O
T98	O
G	O
species1e	O
cells	O
treated	O
with	O
gartanin	O
,	O
and	O
it	O
might	O
result	O
from	O
modulating	O
gene1s	O
mitogen	O
-	O
activated	O
protein	O
kinases	O
gene1e	O
(	O
gene1s	O
MAPK	O
gene1e	O
)	O
signalling	O
pathway	O
in	O
species1s	O
T98	O
G	O
species1e	O
glioma	O
cells	O
.	O
Moreover	O
,	O
gartanin	O
significantly	O
induced	O
autophagy	O
in	O
species1s	O
T98	O
G	O
species1e	O
cells	O
and	O
increased	O
GFP	O
-	O
gene1s	O
LC3	O
gene1e	O
punctate	O
fluorescence	O
accompanied	O
by	O
the	O
increased	O
expression	O
level	O
of	O
gene1s	O
Beclin	O
1	O
gene1e	O
and	O
gene1s	O
LC3	O
gene1e	O
-II	O
,	O
while	O
suppressed	O
expression	O
level	O
of	O
gene1s	O
p62	O
gene1e	O
.	O
Gartanin	O
treatment	O
resulted	O
in	O
obvious	O
inhibition	O
of	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
/	O
gene1s	O
mTOR	O
gene1e	O
signalling	O
pathway	O
,	O
which	O
is	O
important	O
in	O
modulating	O
autophagy	O
.	O
Notably	O
,	O
gartanin	O
-	O
mediated	O
anti	O
-	O
viability	O
was	O
significantly	O
abrogated	O
by	O
autophagy	O
inhibitors	O
including	O
3-methyladenine	O
(	O
3-MA	O
)	O
and	O
chloroquine	O
(	O
CQ	O
)	O
.	O
These	O
results	O
indicate	O
that	O
anti	O
-	O
proliferation	O
effect	O
of	O
gartanin	O
in	O
species1s	O
T98	O
G	O
species1e	O
cells	O
is	O
most	O
likely	O
via	O
cell	O
cycle	O
arrest	O
modulated	O
by	O
autophagy	O
,	O
which	O
is	O
regulated	O
by	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
/	O
gene1s	O
mTOR	O
gene1e	O
signalling	O
pathway	O
,	O
while	O
anti	O
-	O
migration	O
effect	O
is	O
most	O
likely	O
via	O
suppression	O
of	O
gene1s	O
MMP-2/-9	O
gene1e	O
activity	O
which	O
is	O
involved	O
in	O
gene1s	O
MAPK	O
gene1e	O
signalling	O
pathway	O
.	O

Regulation	O
of	O
gene1s	ARG2
IL-17A	ARG2
gene1e	ARG2
responses	O
in	O
arg1s	O
human	O
arg1e	O
airway	O
smooth	O
muscle	O
cells	O
by	O
gene1s	ARG2
Oncostatin	ARG2
M	ARG2
gene1e	ARG2
.	O
BACKGROUND	O
:	O
Regulation	O
of	O
arg1s	O
human	O
arg1e	O
airway	O
smooth	O
muscle	O
cells	O
(	O
HASMC	O
)	O
by	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
contributes	O
to	O
chemotactic	O
factor	O
levels	O
and	O
thus	O
to	O
inflammatory	O
cell	O
accumulation	O
in	O
lung	O
diseases	O
.	O
gene1s	ARG2
Cytokines	ARG2
gene1e	ARG2
such	O
as	O
the	O
gene1s	ARG2
gp130	ARG2
gene1e	ARG2
family	O
member	O
gene1s	ARG2
Oncostatin	ARG2
M	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
OSM	ARG2
gene1e	ARG2
)	O
can	O
act	O
synergistically	O
with	O
gene1s	ARG2
Th2	ARG2
cytokines	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IL-4	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL-13	ARG2
gene1e	ARG2
)	O
to	O
modulate	O
lung	O
cells	O
,	O
however	O
whether	O
gene1s	ARG2
IL-17A	ARG2
gene1e	ARG2
responses	O
by	O
HASMC	O
can	O
be	O
altered	O
is	O
not	O
known	O
.	O
OBJECTIVE	O
:	O
To	O
determine	O
the	O
effects	O
of	O
recombinant	O
gene1s	ARG2
OSM	ARG2
gene1e	ARG2
,	O
or	O
other	O
gene1s	ARG2
gp130	ARG2
gene1e	ARG2
cytokines	O
(	O
gene1s	ARG2
LIF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-31	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
)	O
in	O
regulating	O
HASMC	O
responses	O
to	O
gene1s	ARG2
IL-17A	ARG2
gene1e	ARG2
,	O
assessing	O
species1s	O
MCP-1	O
species1e	O
/	O
CCL2	O
and	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
expression	O
and	O
cell	O
signaling	O
pathways	O
.	O
METHODS	O
:	O
Cell	O
responses	O
of	O
primary	O
HASMC	O
cultures	O
were	O
measured	O
by	O
the	O
assessment	O
of	O
protein	O
levels	O
in	O
supernatants	O
(	O
ELISA	O
)	O
and	O
mRNA	O
levels	O
(	O
qRT	O
-	O
PCR	O
)	O
in	O
cell	O
extracts	O
.	O
Activation	O
of	O
gene1s	ARG2
STAT	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
p38	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
pathways	O
were	O
measured	O
by	O
immunoblot	O
.	O
Pharmacological	O
agents	O
were	O
used	O
to	O
assess	O
the	O
effects	O
of	O
inhibition	O
of	O
these	O
pathways	O
.	O
RESULTS	O
:	O
gene1s	ARG2
OSM	ARG2
gene1e	ARG2
but	O
not	O
gene1s	ARG2
LIF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-31	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
could	O
induce	O
detectable	O
responses	O
in	O
HASMC	O
,	O
elevating	O
gene1s	ARG2
MCP-1	ARG2
/	ARG2
CCL2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
levels	O
and	O
activation	O
of	O
gene1s	ARG2
STAT-1	ARG2
,	ARG2
3	ARG2
,	ARG2
5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
p38	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
cell	O
signaling	O
pathways	O
.	O
gene1s	ARG2
OSM	ARG2
gene1e	ARG2
induced	O
synergistic	O
action	O
with	O
gene1s	ARG2
IL-17A	ARG2
gene1e	ARG2
enhancing	O
gene1s	ARG2
MCP-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CCL-2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
mRNA	O
and	O
protein	O
expression	O
,	O
but	O
not	O
gene1s	ARG2
eotaxin-1	ARG2
gene1e	ARG2
expression	O
,	O
while	O
gene1s	ARG2
OSM	ARG2
gene1e	ARG2
in	O
combination	O
with	O
gene1s	ARG2
IL-4	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
IL-13	ARG2
gene1e	ARG2
synergistically	O
induced	O
gene1s	ARG2
eotaxin-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MCP-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CCL2	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
OSM	ARG2
gene1e	ARG2
elevated	O
steady	O
state	O
mRNA	O
levels	O
of	O
gene1s	ARG2
IL-4Ra	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
OSMRb	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
gp130	ARG2
gene1e	ARG2
,	O
but	O
not	O
gene1s	ARG2
IL-17RA	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
IL-17RC	ARG2
gene1e	ARG2
.	O
Pharmacologic	O
inhibition	O
of	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
activation	O
using	O
Stattic	O
down	O
-	O
regulated	O
gene1s	ARG2
OSM	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
OSM	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
IL-4	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
OSM	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
IL-13	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
OSM	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
IL-17A	ARG2
gene1e	ARG2
synergistic	O
responses	O
of	O
gene1s	ARG2
MCP-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CCL-2	ARG2
gene1e	ARG2
induction	O
,	O
whereas	O
,	O
inhibitors	O
of	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p38	ARG2
gene1e	ARG2
MAPK	O
resulted	O
in	O
less	O
reduction	O
in	O
gene1s	ARG2
MCP-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CCL2	ARG2
gene1e	ARG2
levels	O
.	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
expression	O
was	O
more	O
sensitive	O
to	O
inhibition	O
of	O
gene1s	ARG2
p38	ARG2
gene1e	ARG2
(	O
using	O
SB203580	O
)	O
and	O
was	O
affected	O
by	O
Stattic	O
in	O
response	O
to	O
gene1s	ARG2
IL-17A	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
OSM	ARG2
gene1e	ARG2
stimulation	O
.	O
CONCLUSIONS	O
:	O
gene1s	ARG2
Oncostatin	ARG2
M	ARG2
gene1e	ARG2
can	O
regulate	O
HASMC	O
responses	O
alone	O
or	O
in	O
synergy	O
with	O
gene1s	ARG2
IL-17A	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
OSM	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
IL-17A	ARG2
gene1e	ARG2
combinations	O
enhance	O
gene1s	ARG2
MCP-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CCL2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
but	O
not	O
gene1s	ARG2
eotaxin-1	ARG2
gene1e	ARG2
.	O
Thus	O
,	O
gene1s	ARG2
OSM	ARG2
gene1e	ARG2
through	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
activation	O
of	O
HASMC	O
may	O
participate	O
in	O
inflammatory	O
cell	O
recruitment	O
in	O
inflammatory	O
airway	O
disease	O
.	O

Regulation	O
of	O
gene1s	O
IL-17A	O
gene1e	O
responses	O
in	O
species1s	O
human	O
species1e	O
airway	O
smooth	O
muscle	O
cells	O
by	O
gene1s	O
Oncostatin	O
M	O
gene1e	O
.	O
BACKGROUND	O
:	O
Regulation	O
of	O
species1s	O
human	O
species1e	O
airway	O
smooth	O
muscle	O
cells	O
(	O
HASMC	O
)	O
by	O
gene1s	O
cytokines	O
gene1e	O
contributes	O
to	O
chemotactic	O
factor	O
levels	O
and	O
thus	O
to	O
inflammatory	O
cell	O
accumulation	O
in	O
lung	O
diseases	O
.	O
gene1s	O
Cytokines	O
gene1e	O
such	O
as	O
the	O
gene1s	O
gp130	O
gene1e	O
family	O
member	O
gene1s	O
Oncostatin	O
M	O
gene1e	O
(	O
gene1s	O
OSM	O
gene1e	O
)	O
can	O
act	O
synergistically	O
with	O
gene1s	O
Th2	O
cytokines	O
gene1e	O
(	O
gene1s	O
IL-4	O
gene1e	O
and	O
gene1s	O
IL-13	O
gene1e	O
)	O
to	O
modulate	O
lung	O
cells	O
,	O
however	O
whether	O
gene1s	O
IL-17A	O
gene1e	O
responses	O
by	O
HASMC	O
can	O
be	O
altered	O
is	O
not	O
known	O
.	O
OBJECTIVE	O
:	O
To	O
determine	O
the	O
effects	O
of	O
recombinant	O
gene1s	O
OSM	O
gene1e	O
,	O
or	O
other	O
gene1s	O
gp130	O
gene1e	O
cytokines	O
(	O
gene1s	O
LIF	O
gene1e	O
,	O
gene1s	O
IL-31	O
gene1e	O
,	O
and	O
gene1s	O
IL-6	O
gene1e	O
)	O
in	O
regulating	O
HASMC	O
responses	O
to	O
gene1s	O
IL-17A	O
gene1e	O
,	O
assessing	O
arg1s	O
MCP-1	O
arg1e	O
/	O
CCL2	O
and	O
gene1s	O
IL-6	O
gene1e	O
expression	O
and	O
cell	O
signaling	O
pathways	O
.	O
METHODS	O
:	O
Cell	O
responses	O
of	O
primary	O
HASMC	O
cultures	O
were	O
measured	O
by	O
the	O
assessment	O
of	O
protein	O
levels	O
in	O
supernatants	O
(	O
ELISA	O
)	O
and	O
mRNA	O
levels	O
(	O
qRT	O
-	O
PCR	O
)	O
in	O
cell	O
extracts	O
.	O
Activation	O
of	O
gene1s	O
STAT	O
gene1e	O
,	O
gene1s	O
MAPK	O
gene1e	O
(	O
gene1s	O
p38	O
gene1e	O
)	O
and	O
gene1s	O
Akt	O
gene1e	O
pathways	O
were	O
measured	O
by	O
immunoblot	O
.	O
Pharmacological	O
agents	O
were	O
used	O
to	O
assess	O
the	O
effects	O
of	O
inhibition	O
of	O
these	O
pathways	O
.	O
RESULTS	O
:	O
gene1s	O
OSM	O
gene1e	O
but	O
not	O
gene1s	O
LIF	O
gene1e	O
,	O
gene1s	O
IL-31	O
gene1e	O
or	O
gene1s	O
IL-6	O
gene1e	O
could	O
induce	O
detectable	O
responses	O
in	O
HASMC	O
,	O
elevating	O
gene1s	O
MCP-1	O
/	O
CCL2	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
levels	O
and	O
activation	O
of	O
gene1s	O
STAT-1	O
,	O
3	O
,	O
5	O
gene1e	O
,	O
gene1s	O
p38	O
gene1e	O
and	O
gene1s	O
Akt	O
gene1e	O
cell	O
signaling	O
pathways	O
.	O
gene1s	O
OSM	O
gene1e	O
induced	O
synergistic	O
action	O
with	O
gene1s	O
IL-17A	O
gene1e	O
enhancing	O
gene1s	O
MCP-1	O
gene1e	O
/	O
gene1s	O
CCL-2	O
gene1e	O
and	O
gene1s	O
IL-6	O
gene1e	O
mRNA	O
and	O
protein	O
expression	O
,	O
but	O
not	O
gene1s	O
eotaxin-1	O
gene1e	O
expression	O
,	O
while	O
gene1s	O
OSM	O
gene1e	O
in	O
combination	O
with	O
gene1s	O
IL-4	O
gene1e	O
or	O
gene1s	O
IL-13	O
gene1e	O
synergistically	O
induced	O
gene1s	O
eotaxin-1	O
gene1e	O
and	O
gene1s	O
MCP-1	O
gene1e	O
/	O
gene1s	O
CCL2	O
gene1e	O
.	O
gene1s	O
OSM	O
gene1e	O
elevated	O
steady	O
state	O
mRNA	O
levels	O
of	O
gene1s	O
IL-4Ra	O
gene1e	O
,	O
gene1s	O
OSMRb	O
gene1e	O
and	O
gene1s	O
gp130	O
gene1e	O
,	O
but	O
not	O
gene1s	O
IL-17RA	O
gene1e	O
or	O
gene1s	O
IL-17RC	O
gene1e	O
.	O
Pharmacologic	O
inhibition	O
of	O
gene1s	O
STAT3	O
gene1e	O
activation	O
using	O
Stattic	O
down	O
-	O
regulated	O
gene1s	O
OSM	O
gene1e	O
,	O
gene1s	O
OSM	O
gene1e	O
/	O
gene1s	O
IL-4	O
gene1e	O
or	O
gene1s	O
OSM	O
gene1e	O
/	O
gene1s	O
IL-13	O
gene1e	O
,	O
and	O
gene1s	O
OSM	O
gene1e	O
/	O
gene1s	O
IL-17A	O
gene1e	O
synergistic	O
responses	O
of	O
gene1s	O
MCP-1	O
gene1e	O
/	O
gene1s	O
CCL-2	O
gene1e	O
induction	O
,	O
whereas	O
,	O
inhibitors	O
of	O
gene1s	O
Akt	O
gene1e	O
and	O
gene1s	O
p38	O
gene1e	O
MAPK	O
resulted	O
in	O
less	O
reduction	O
in	O
gene1s	O
MCP-1	O
gene1e	O
/	O
gene1s	O
CCL2	O
gene1e	O
levels	O
.	O
gene1s	O
IL-6	O
gene1e	O
expression	O
was	O
more	O
sensitive	O
to	O
inhibition	O
of	O
gene1s	O
p38	O
gene1e	O
(	O
using	O
SB203580	O
)	O
and	O
was	O
affected	O
by	O
Stattic	O
in	O
response	O
to	O
gene1s	O
IL-17A	O
gene1e	O
/	O
gene1s	O
OSM	O
gene1e	O
stimulation	O
.	O
CONCLUSIONS	O
:	O
gene1s	O
Oncostatin	O
M	O
gene1e	O
can	O
regulate	O
HASMC	O
responses	O
alone	O
or	O
in	O
synergy	O
with	O
gene1s	O
IL-17A	O
gene1e	O
.	O
gene1s	O
OSM	O
gene1e	O
/	O
gene1s	O
IL-17A	O
gene1e	O
combinations	O
enhance	O
gene1s	O
MCP-1	O
gene1e	O
/	O
gene1s	O
CCL2	O
gene1e	O
and	O
gene1s	O
IL-6	O
gene1e	O
but	O
not	O
gene1s	O
eotaxin-1	O
gene1e	O
.	O
Thus	O
,	O
gene1s	O
OSM	O
gene1e	O
through	O
gene1s	O
STAT3	O
gene1e	O
activation	O
of	O
HASMC	O
may	O
participate	O
in	O
inflammatory	O
cell	O
recruitment	O
in	O
inflammatory	O
airway	O
disease	O
.	O

Repurposing	O
an	O
orally	O
available	O
drug	O
for	O
the	O
treatment	O
of	O
geographic	O
atrophy	O
.	O
PURPOSE	O
:	O
Chronic	O
oxidative	O
stress	O
and	O
subacute	O
inflammation	O
have	O
been	O
implicated	O
as	O
causes	O
of	O
age	O
-	O
related	O
macular	O
degeneration	O
(	O
AMD	O
)	O
.	O
In	O
this	O
study	O
,	O
we	O
tested	O
whether	O
an	O
orally	O
available	O
gene1s	ARG2
5-OH	ARG2
-	ARG2
tryptamine	ARG2
(	ARG2
5HT	ARG2
)	ARG2
1a	ARG2
receptor	ARG2
gene1e	ARG2
agonist	O
,	O
xaliproden	O
,	O
could	O
protect	O
against	O
retinal	O
pigment	O
epithelium	O
(	O
RPE	O
)	O
cell	O
damage	O
in	O
culture	O
and	O
in	O
a	O
arg1s	O
mouse	O
arg1e	O
model	O
of	O
geographic	O
atrophy	O
.	O
METHODS	O
:	O
Paraquat	O
was	O
used	O
to	O
create	O
mitochondrial	O
oxidative	O
stress	O
in	O
species1s	O
ARPE-19	O
species1e	O
cells	O
,	O
and	O
gene1s	O
tumor	O
necrosis	O
factor	O
-	O
a	O
gene1e	O
(	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
)	O
was	O
used	O
to	O
stimulate	O
the	O
production	O
of	O
gene1s	O
inflammatory	O
cytokines	O
gene1e	O
in	O
these	O
cells	O
.	O
The	O
production	O
of	O
antioxidant	O
proteins	O
,	O
gene1s	O
metallothionein	O
gene1e	O
,	O
and	O
gene1s	O
inflammatory	O
cytokines	O
gene1e	O
was	O
assayed	O
with	O
quantitative	O
real	O
-	O
time	O
PCR	O
.	O
Cell	O
survival	O
was	O
analyzed	O
with	O
microscopy	O
and	O
a	O
cell	O
titer	O
assay	O
.	O
Integrity	O
of	O
the	O
RPE	O
monolayer	O
was	O
determined	O
by	O
measuring	O
the	O
transepithelial	O
electrical	O
resistance	O
(	O
TEER	O
)	O
and	O
with	O
immunocytochemistry	O
with	O
gene1s	O
zona	O
occludens	O
protein	O
1	O
gene1e	O
(	O
gene1s	O
ZO-1	O
gene1e	O
)	O
antibody	O
.	O
RPE	O
atrophy	O
was	O
studied	O
in	O
arg1s	O
mice	O
arg1e	O
deleted	O
for	O
gene1s	ARG2
Sod2	ARG2
gene1e	ARG2
(	O
the	O
gene	O
for	O
gene1s	ARG2
mitochondrial	ARG2
superoxide	ARG2
dismutase	ARG2
gene1e	ARG2
)	O
specifically	O
in	O
the	O
RPE	O
.	O
The	O
arg1s	O
mice	O
arg1e	O
were	O
treated	O
orally	O
with	O
daily	O
doses	O
of	O
xaliproden	O
at	O
0.5	O
and	O
3	O
mg	O
/	O
kg	O
for	O
4	O
months	O
.	O
The	O
retinal	O
structure	O
was	O
analyzed	O
with	O
spectral	O
domain	O
optical	O
coherence	O
tomography	O
(	O
SD	O
-	O
OCT	O
)	O
and	O
with	O
light	O
and	O
electron	O
microscopy	O
.	O
Retinal	O
function	O
was	O
assessed	O
with	O
full	O
-	O
field	O
electroretinography	O
(	O
ERG	O
)	O
and	O
with	O
optokinetic	O
measurements	O
.	O
RESULTS	O
:	O
Xaliproden	O
led	O
to	O
a	O
dose	O
-	O
dependent	O
increase	O
in	O
cell	O
survival	O
following	O
treatment	O
with	O
paraquat	O
.	O
Synthesis	O
of	O
the	O
antioxidant	O
response	O
genes	O
gene1s	O
NqO1	O
gene1e	O
,	O
gene1s	O
GSTM1	O
gene1e	O
,	O
gene1s	O
CAT	O
gene1e	O
,	O
gene1s	O
HO-1	O
gene1e	O
,	O
and	O
gene1s	O
Nrf2	O
gene1e	O
was	O
increased	O
in	O
response	O
to	O
the	O
drug	O
,	O
as	O
was	O
the	O
zinc	O
chaperone	O
gene1s	O
metallothionein	O
gene1e	O
.	O
Treatment	O
of	O
cells	O
with	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
led	O
to	O
increased	O
production	O
of	O
gene1s	O
IL-1b	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
gene1s	O
chemokine	O
(	O
C	O
-	O
C	O
motif	O
)	O
ligand	O
20	O
gene1e	O
(	O
gene1s	O
CCL20	O
gene1e	O
)	O
,	O
and	O
gene1s	O
vascular	O
endothelial	O
growth	O
factor	O
gene1e	O
(	O
gene1s	O
VEGF	O
gene1e	O
)	O
by	O
species1s	O
ARPE-19	O
species1e	O
cells	O
,	O
and	O
this	O
response	O
was	O
attenuated	O
by	O
treatment	O
with	O
xaliproden	O
.	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
also	O
led	O
to	O
a	O
decrease	O
in	O
the	O
TEER	O
that	O
was	O
prevented	O
by	O
treatment	O
with	O
the	O
gene1s	O
5HT1a	O
gene1e	O
agonist	O
.	O
Daily	O
gavage	O
with	O
xaliproden	O
at	O
either	O
dose	O
induced	O
the	O
production	O
of	O
protective	O
enzymes	O
in	O
the	O
arg1s	O
mouse	O
arg1e	O
retina	O
,	O
and	O
treatment	O
of	O
the	O
gene1s	ARG2
Sod2	ARG2
gene1e	ARG2
-deleted	O
arg1s	O
mice	O
arg1e	O
with	O
the	O
drug	O
showed	O
improved	O
thickness	O
of	O
the	O
outer	O
nuclear	O
layer	O
and	O
improved	O
visual	O
acuity	O
relative	O
to	O
the	O
control	O
-	O
treated	O
arg1s	O
mice	O
arg1e	O
.	O
There	O
was	O
no	O
significant	O
difference	O
in	O
full	O
-	O
field	O
scotopic	O
ERG	O
among	O
the	O
treatment	O
groups	O
,	O
however	O
.	O
Vacuolization	O
of	O
the	O
RPE	O
and	O
disorganization	O
of	O
the	O
photoreceptor	O
outer	O
segments	O
were	O
reduced	O
at	O
both	O
dose	O
levels	O
of	O
xaliproden	O
.	O
CONCLUSIONS	O
:	O
Xaliproden	O
protected	O
RPE	O
cells	O
from	O
oxidative	O
and	O
inflammatory	O
insults	O
and	O
protected	O
the	O
arg1s	O
mouse	O
arg1e	O
RPE	O
and	O
retina	O
from	O
RPE	O
atrophy	O
in	O
the	O
face	O
of	O
excess	O
mitochondrial	O
oxidative	O
stress	O
.	O
These	O
results	O
suggest	O
that	O
this	O
drug	O
,	O
which	O
had	O
a	O
reasonable	O
safety	O
profile	O
in	O
clinical	O
trials	O
,	O
may	O
be	O
used	O
to	O
prevent	O
the	O
progression	O
of	O
geographic	O
atrophy	O
in	O
species1s	O
humans	O
species1e	O
.	O

Repurposing	O
an	O
orally	O
available	O
drug	O
for	O
the	O
treatment	O
of	O
geographic	O
atrophy	O
.	O
PURPOSE	O
:	O
Chronic	O
oxidative	O
stress	O
and	O
subacute	O
inflammation	O
have	O
been	O
implicated	O
as	O
causes	O
of	O
age	O
-	O
related	O
macular	O
degeneration	O
(	O
AMD	O
)	O
.	O
In	O
this	O
study	O
,	O
we	O
tested	O
whether	O
an	O
orally	O
available	O
gene1s	ARG2
5-OH	ARG2
-	ARG2
tryptamine	ARG2
(	ARG2
5HT	ARG2
)	ARG2
1a	ARG2
receptor	ARG2
gene1e	ARG2
agonist	O
,	O
xaliproden	O
,	O
could	O
protect	O
against	O
retinal	O
pigment	O
epithelium	O
(	O
RPE	O
)	O
cell	O
damage	O
in	O
culture	O
and	O
in	O
a	O
species1s	O
mouse	O
species1e	O
model	O
of	O
geographic	O
atrophy	O
.	O
METHODS	O
:	O
Paraquat	O
was	O
used	O
to	O
create	O
mitochondrial	O
oxidative	O
stress	O
in	O
arg1s	O
ARPE-19	O
arg1e	O
cells	O
,	O
and	O
gene1s	ARG2
tumor	ARG2
necrosis	ARG2
factor	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
)	O
was	O
used	O
to	O
stimulate	O
the	O
production	O
of	O
gene1s	ARG2
inflammatory	ARG2
cytokines	ARG2
gene1e	ARG2
in	O
these	O
cells	O
.	O
The	O
production	O
of	O
antioxidant	O
proteins	O
,	O
gene1s	ARG2
metallothionein	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
inflammatory	ARG2
cytokines	ARG2
gene1e	ARG2
was	O
assayed	O
with	O
quantitative	O
real	O
-	O
time	O
PCR	O
.	O
Cell	O
survival	O
was	O
analyzed	O
with	O
microscopy	O
and	O
a	O
cell	O
titer	O
assay	O
.	O
Integrity	O
of	O
the	O
RPE	O
monolayer	O
was	O
determined	O
by	O
measuring	O
the	O
transepithelial	O
electrical	O
resistance	O
(	O
TEER	O
)	O
and	O
with	O
immunocytochemistry	O
with	O
gene1s	ARG2
zona	ARG2
occludens	ARG2
protein	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ZO-1	ARG2
gene1e	ARG2
)	O
antibody	O
.	O
RPE	O
atrophy	O
was	O
studied	O
in	O
species1s	O
mice	O
species1e	O
deleted	O
for	O
gene1s	O
Sod2	O
gene1e	O
(	O
the	O
gene	O
for	O
gene1s	O
mitochondrial	O
superoxide	O
dismutase	O
gene1e	O
)	O
specifically	O
in	O
the	O
RPE	O
.	O
The	O
species1s	O
mice	O
species1e	O
were	O
treated	O
orally	O
with	O
daily	O
doses	O
of	O
xaliproden	O
at	O
0.5	O
and	O
3	O
mg	O
/	O
kg	O
for	O
4	O
months	O
.	O
The	O
retinal	O
structure	O
was	O
analyzed	O
with	O
spectral	O
domain	O
optical	O
coherence	O
tomography	O
(	O
SD	O
-	O
OCT	O
)	O
and	O
with	O
light	O
and	O
electron	O
microscopy	O
.	O
Retinal	O
function	O
was	O
assessed	O
with	O
full	O
-	O
field	O
electroretinography	O
(	O
ERG	O
)	O
and	O
with	O
optokinetic	O
measurements	O
.	O
RESULTS	O
:	O
Xaliproden	O
led	O
to	O
a	O
dose	O
-	O
dependent	O
increase	O
in	O
cell	O
survival	O
following	O
treatment	O
with	O
paraquat	O
.	O
Synthesis	O
of	O
the	O
antioxidant	O
response	O
genes	O
gene1s	ARG2
NqO1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
GSTM1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CAT	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HO-1	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Nrf2	ARG2
gene1e	ARG2
was	O
increased	O
in	O
response	O
to	O
the	O
drug	O
,	O
as	O
was	O
the	O
zinc	O
chaperone	O
gene1s	ARG2
metallothionein	ARG2
gene1e	ARG2
.	O
Treatment	O
of	O
cells	O
with	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
led	O
to	O
increased	O
production	O
of	O
gene1s	ARG2
IL-1b	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
chemokine	ARG2
(	ARG2
C	ARG2
-	ARG2
C	ARG2
motif	ARG2
)	ARG2
ligand	ARG2
20	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CCL20	ARG2
gene1e	ARG2
)	O
,	O
and	O
gene1s	ARG2
vascular	ARG2
endothelial	ARG2
growth	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
)	O
by	O
arg1s	O
ARPE-19	O
arg1e	O
cells	O
,	O
and	O
this	O
response	O
was	O
attenuated	O
by	O
treatment	O
with	O
xaliproden	O
.	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
also	O
led	O
to	O
a	O
decrease	O
in	O
the	O
TEER	O
that	O
was	O
prevented	O
by	O
treatment	O
with	O
the	O
gene1s	ARG2
5HT1a	ARG2
gene1e	ARG2
agonist	O
.	O
Daily	O
gavage	O
with	O
xaliproden	O
at	O
either	O
dose	O
induced	O
the	O
production	O
of	O
protective	O
enzymes	O
in	O
the	O
species1s	O
mouse	O
species1e	O
retina	O
,	O
and	O
treatment	O
of	O
the	O
gene1s	O
Sod2	O
gene1e	O
-deleted	O
species1s	O
mice	O
species1e	O
with	O
the	O
drug	O
showed	O
improved	O
thickness	O
of	O
the	O
outer	O
nuclear	O
layer	O
and	O
improved	O
visual	O
acuity	O
relative	O
to	O
the	O
control	O
-	O
treated	O
species1s	O
mice	O
species1e	O
.	O
There	O
was	O
no	O
significant	O
difference	O
in	O
full	O
-	O
field	O
scotopic	O
ERG	O
among	O
the	O
treatment	O
groups	O
,	O
however	O
.	O
Vacuolization	O
of	O
the	O
RPE	O
and	O
disorganization	O
of	O
the	O
photoreceptor	O
outer	O
segments	O
were	O
reduced	O
at	O
both	O
dose	O
levels	O
of	O
xaliproden	O
.	O
CONCLUSIONS	O
:	O
Xaliproden	O
protected	O
RPE	O
cells	O
from	O
oxidative	O
and	O
inflammatory	O
insults	O
and	O
protected	O
the	O
species1s	O
mouse	O
species1e	O
RPE	O
and	O
retina	O
from	O
RPE	O
atrophy	O
in	O
the	O
face	O
of	O
excess	O
mitochondrial	O
oxidative	O
stress	O
.	O
These	O
results	O
suggest	O
that	O
this	O
drug	O
,	O
which	O
had	O
a	O
reasonable	O
safety	O
profile	O
in	O
clinical	O
trials	O
,	O
may	O
be	O
used	O
to	O
prevent	O
the	O
progression	O
of	O
geographic	O
atrophy	O
in	O
arg1s	O
humans	O
arg1e	O
.	O

gene1s	ARG2
TGF	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
promotes	O
colorectal	O
cancer	O
immune	O
escape	O
by	O
elevating	O
gene1s	ARG2
B7-H3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
B7-H4	ARG2
gene1e	ARG2
via	O
the	O
gene1s	ARG2
miR-155	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
miR-143	ARG2
gene1e	ARG2
axis	O
.	O
gene1s	ARG2
Transforming	ARG2
growth	ARG2
factor	ARG2
-	ARG2
beta	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
)	O
suppresses	O
T	O
cell	O
function	O
,	O
promoting	O
tumor	O
immune	O
escape	O
.	O
Yet	O
,	O
whether	O
the	O
depression	O
of	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
on	O
T	O
cell	O
function	O
is	O
mediated	O
by	O
co	O
-	O
inhibitory	O
molecules	O
gene1s	ARG2
B7-H3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
B7-H4	ARG2
gene1e	ARG2
remains	O
largely	O
unclear	O
.	O
Here	O
,	O
we	O
demonstrated	O
that	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
elevated	O
the	O
expression	O
of	O
gene1s	ARG2
miR-155	ARG2
gene1e	ARG2
in	O
colorectal	O
cancer	O
cells	O
through	O
gene1s	ARG2
SMAD3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
SMAD4	ARG2
gene1e	ARG2
.	O
The	O
upregulated	O
gene1s	ARG2
miR-155	ARG2
gene1e	ARG2
attenuated	O
gene1s	ARG2
miR-143	ARG2
gene1e	ARG2
by	O
inhibiting	O
its	O
direct	O
target	O
,	O
the	O
gene1s	ARG2
transcription	ARG2
factor	ARG2
gene1e	ARG2
gene1s	ARG2
CEBPB	ARG2
gene1e	ARG2
.	O
Consequently	O
,	O
the	O
direct	O
target	O
genes	O
of	O
gene1s	ARG2
miR-143	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
B7-H3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
B7-H4	ARG2
gene1e	ARG2
,	O
were	O
augmented	O
in	O
the	O
cytoplasm	O
and	O
membrane	O
of	O
tumor	O
cells	O
.	O
Over	O
-	O
expression	O
of	O
gene1s	ARG2
B7-H3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
B7-H4	ARG2
gene1e	ARG2
in	O
arg1s	O
HCT-116	O
arg1e	O
cells	O
induced	O
T	O
cells	O
to	O
secrete	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
and	O
the	O
immunosuppressive	O
cytokines	O
gene1s	ARG2
IL-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
IL-17	ARG2
gene1e	ARG2
.	O
Restoration	O
of	O
gene1s	ARG2
miR-143	ARG2
gene1e	ARG2
inhibited	O
the	O
growth	O
of	O
HCT-116	O
xenograft	O
tumors	O
in	O
species1s	O
mice	O
species1e	O
,	O
and	O
also	O
repressed	O
the	O
expression	O
of	O
gene1s	ARG2
B7-H3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
B7-H4	ARG2
gene1e	ARG2
in	O
the	O
tumors	O
.	O
Thus	O
,	O
this	O
study	O
reveals	O
the	O
mechanism	O
by	O
which	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
leads	O
to	O
T	O
cell	O
-	O
mediated	O
tumor	O
evasion	O
through	O
an	O
increase	O
in	O
gene1s	ARG2
B7-H3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
B7-H4	ARG2
gene1e	ARG2
expression	O
.	O

gene1s	O
TGF	O
-	O
b1	O
gene1e	O
promotes	O
colorectal	O
cancer	O
immune	O
escape	O
by	O
elevating	O
gene1s	O
B7-H3	O
gene1e	O
and	O
gene1s	O
B7-H4	O
gene1e	O
via	O
the	O
gene1s	O
miR-155	O
gene1e	O
/	O
gene1s	O
miR-143	O
gene1e	O
axis	O
.	O
gene1s	O
Transforming	O
growth	O
factor	O
-	O
beta	O
1	O
gene1e	O
(	O
gene1s	O
TGF	O
-	O
b1	O
gene1e	O
)	O
suppresses	O
T	O
cell	O
function	O
,	O
promoting	O
tumor	O
immune	O
escape	O
.	O
Yet	O
,	O
whether	O
the	O
depression	O
of	O
gene1s	O
TGF	O
-	O
b1	O
gene1e	O
on	O
T	O
cell	O
function	O
is	O
mediated	O
by	O
co	O
-	O
inhibitory	O
molecules	O
gene1s	O
B7-H3	O
gene1e	O
and	O
gene1s	O
B7-H4	O
gene1e	O
remains	O
largely	O
unclear	O
.	O
Here	O
,	O
we	O
demonstrated	O
that	O
gene1s	O
TGF	O
-	O
b1	O
gene1e	O
elevated	O
the	O
expression	O
of	O
gene1s	O
miR-155	O
gene1e	O
in	O
colorectal	O
cancer	O
cells	O
through	O
gene1s	O
SMAD3	O
gene1e	O
and	O
gene1s	O
SMAD4	O
gene1e	O
.	O
The	O
upregulated	O
gene1s	O
miR-155	O
gene1e	O
attenuated	O
gene1s	O
miR-143	O
gene1e	O
by	O
inhibiting	O
its	O
direct	O
target	O
,	O
the	O
gene1s	O
transcription	O
factor	O
gene1e	O
gene1s	O
CEBPB	O
gene1e	O
.	O
Consequently	O
,	O
the	O
direct	O
target	O
genes	O
of	O
gene1s	O
miR-143	O
gene1e	O
,	O
gene1s	O
B7-H3	O
gene1e	O
and	O
gene1s	O
B7-H4	O
gene1e	O
,	O
were	O
augmented	O
in	O
the	O
cytoplasm	O
and	O
membrane	O
of	O
tumor	O
cells	O
.	O
Over	O
-	O
expression	O
of	O
gene1s	O
B7-H3	O
gene1e	O
and	O
gene1s	O
B7-H4	O
gene1e	O
in	O
species1s	O
HCT-116	O
species1e	O
cells	O
induced	O
T	O
cells	O
to	O
secrete	O
gene1s	O
TGF	O
-	O
b1	O
gene1e	O
and	O
the	O
immunosuppressive	O
cytokines	O
gene1s	O
IL-2	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
and	O
gene1s	O
IL-17	O
gene1e	O
.	O
Restoration	O
of	O
gene1s	O
miR-143	O
gene1e	O
inhibited	O
the	O
growth	O
of	O
HCT-116	O
xenograft	O
tumors	O
in	O
arg1s	O
mice	O
arg1e	O
,	O
and	O
also	O
repressed	O
the	O
expression	O
of	O
gene1s	O
B7-H3	O
gene1e	O
and	O
gene1s	O
B7-H4	O
gene1e	O
in	O
the	O
tumors	O
.	O
Thus	O
,	O
this	O
study	O
reveals	O
the	O
mechanism	O
by	O
which	O
gene1s	O
TGF	O
-	O
b1	O
gene1e	O
leads	O
to	O
T	O
cell	O
-	O
mediated	O
tumor	O
evasion	O
through	O
an	O
increase	O
in	O
gene1s	O
B7-H3	O
gene1e	O
and	O
gene1s	O
B7-H4	O
gene1e	O
expression	O
.	O

Thiamine	O
deficiency	O
activates	O
gene1s	ARG2
hypoxia	ARG2
inducible	ARG2
factor-1a	ARG2
gene1e	ARG2
to	O
facilitate	O
pro	O
-	O
apoptotic	O
responses	O
in	O
arg1s	O
mouse	O
arg1e	O
primary	O
astrocytes	O
.	O
Thiamine	O
is	O
an	O
essential	O
enzyme	O
cofactor	O
required	O
for	O
proper	O
metabolic	O
function	O
and	O
maintenance	O
of	O
metabolism	O
and	O
energy	O
production	O
in	O
the	O
brain	O
.	O
In	O
developed	O
countries	O
,	O
thiamine	O
deficiency	O
(	O
TD	O
)	O
is	O
most	O
often	O
manifested	O
following	O
chronic	O
alcohol	O
consumption	O
leading	O
to	O
impaired	O
mitochondrial	O
function	O
,	O
oxidative	O
stress	O
,	O
inflammation	O
and	O
excitotoxicity	O
.	O
These	O
biochemical	O
lesions	O
result	O
in	O
apoptotic	O
cell	O
death	O
in	O
both	O
neurons	O
and	O
astrocytes	O
.	O
Comparable	O
histological	O
injuries	O
in	O
species1s	O
patients	O
species1e	O
with	O
hypoxia	O
/	O
ischemia	O
and	O
TD	O
have	O
been	O
described	O
in	O
the	O
thalamus	O
and	O
mammillary	O
bodies	O
,	O
suggesting	O
a	O
congruency	O
between	O
the	O
cellular	O
responses	O
to	O
these	O
stresses	O
.	O
Consistent	O
with	O
hypoxia	O
/	O
ischemia	O
,	O
TD	O
stabilizes	O
and	O
activates	O
gene1s	ARG2
Hypoxia	ARG2
Inducible	ARG2
Factor-1a	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
HIF-1a	ARG2
gene1e	ARG2
)	O
under	O
physiological	O
oxygen	O
levels	O
.	O
However	O
,	O
the	O
role	O
of	O
TD	O
-	O
induced	O
gene1s	ARG2
HIF-1a	ARG2
gene1e	ARG2
in	O
neurological	O
injury	O
is	O
currently	O
unknown	O
.	O
Using	O
Western	O
blot	O
analysis	O
and	O
RT	O
-	O
PCR	O
,	O
we	O
have	O
demonstrated	O
that	O
TD	O
induces	O
gene1s	ARG2
HIF-1a	ARG2
gene1e	ARG2
expression	O
and	O
activity	O
in	O
primary	O
arg1s	O
mouse	O
arg1e	O
astrocytes	O
.	O
We	O
observed	O
a	O
time	O
-	O
dependent	O
increase	O
in	O
mRNA	O
and	O
protein	O
expression	O
of	O
the	O
pro	O
-	O
apoptotic	O
and	O
pro	O
-	O
inflammatory	O
gene1s	ARG2
HIF-1a	ARG2
gene1e	ARG2
target	O
genes	O
gene1s	ARG2
MCP1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
BNIP3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Nix	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Noxa	ARG2
gene1e	ARG2
during	O
TD	O
.	O
We	O
also	O
observed	O
apoptotic	O
cell	O
death	O
in	O
TD	O
as	O
demonstrated	O
by	O
PI	O
/	O
gene1s	ARG2
Annexin	ARG2
V	ARG2
gene1e	ARG2
staining	O
,	O
TUNEL	O
assay	O
,	O
and	O
Cell	O
Death	O
ELISA	O
.	O
Pharmacological	O
inhibition	O
of	O
gene1s	ARG2
HIF-1a	ARG2
gene1e	ARG2
activity	O
using	O
YC1	O
and	O
thiamine	O
repletion	O
both	O
reduced	O
expression	O
of	O
pro	O
-	O
apoptotic	O
gene1s	ARG2
HIF-1a	ARG2
gene1e	ARG2
target	O
genes	O
and	O
apoptotic	O
cell	O
death	O
in	O
TD	O
.	O
These	O
results	O
demonstrate	O
that	O
induction	O
of	O
gene1s	ARG2
HIF-1a	ARG2
gene1e	ARG2
mediated	O
transcriptional	O
up	O
-	O
regulation	O
of	O
pro	O
-	O
apoptotic	O
/	O
inflammatory	O
signaling	O
contributes	O
to	O
astrocyte	O
cell	O
death	O
during	O
thiamine	O
deficiency	O
.	O

Thiamine	O
deficiency	O
activates	O
gene1s	O
hypoxia	O
inducible	O
factor-1a	O
gene1e	O
to	O
facilitate	O
pro	O
-	O
apoptotic	O
responses	O
in	O
species1s	O
mouse	O
species1e	O
primary	O
astrocytes	O
.	O
Thiamine	O
is	O
an	O
essential	O
enzyme	O
cofactor	O
required	O
for	O
proper	O
metabolic	O
function	O
and	O
maintenance	O
of	O
metabolism	O
and	O
energy	O
production	O
in	O
the	O
brain	O
.	O
In	O
developed	O
countries	O
,	O
thiamine	O
deficiency	O
(	O
TD	O
)	O
is	O
most	O
often	O
manifested	O
following	O
chronic	O
alcohol	O
consumption	O
leading	O
to	O
impaired	O
mitochondrial	O
function	O
,	O
oxidative	O
stress	O
,	O
inflammation	O
and	O
excitotoxicity	O
.	O
These	O
biochemical	O
lesions	O
result	O
in	O
apoptotic	O
cell	O
death	O
in	O
both	O
neurons	O
and	O
astrocytes	O
.	O
Comparable	O
histological	O
injuries	O
in	O
arg1s	O
patients	O
arg1e	O
with	O
hypoxia	O
/	O
ischemia	O
and	O
TD	O
have	O
been	O
described	O
in	O
the	O
thalamus	O
and	O
mammillary	O
bodies	O
,	O
suggesting	O
a	O
congruency	O
between	O
the	O
cellular	O
responses	O
to	O
these	O
stresses	O
.	O
Consistent	O
with	O
hypoxia	O
/	O
ischemia	O
,	O
TD	O
stabilizes	O
and	O
activates	O
gene1s	O
Hypoxia	O
Inducible	O
Factor-1a	O
gene1e	O
(	O
gene1s	O
HIF-1a	O
gene1e	O
)	O
under	O
physiological	O
oxygen	O
levels	O
.	O
However	O
,	O
the	O
role	O
of	O
TD	O
-	O
induced	O
gene1s	O
HIF-1a	O
gene1e	O
in	O
neurological	O
injury	O
is	O
currently	O
unknown	O
.	O
Using	O
Western	O
blot	O
analysis	O
and	O
RT	O
-	O
PCR	O
,	O
we	O
have	O
demonstrated	O
that	O
TD	O
induces	O
gene1s	O
HIF-1a	O
gene1e	O
expression	O
and	O
activity	O
in	O
primary	O
species1s	O
mouse	O
species1e	O
astrocytes	O
.	O
We	O
observed	O
a	O
time	O
-	O
dependent	O
increase	O
in	O
mRNA	O
and	O
protein	O
expression	O
of	O
the	O
pro	O
-	O
apoptotic	O
and	O
pro	O
-	O
inflammatory	O
gene1s	O
HIF-1a	O
gene1e	O
target	O
genes	O
gene1s	O
MCP1	O
gene1e	O
,	O
gene1s	O
BNIP3	O
gene1e	O
,	O
gene1s	O
Nix	O
gene1e	O
and	O
gene1s	O
Noxa	O
gene1e	O
during	O
TD	O
.	O
We	O
also	O
observed	O
apoptotic	O
cell	O
death	O
in	O
TD	O
as	O
demonstrated	O
by	O
PI	O
/	O
gene1s	O
Annexin	O
V	O
gene1e	O
staining	O
,	O
TUNEL	O
assay	O
,	O
and	O
Cell	O
Death	O
ELISA	O
.	O
Pharmacological	O
inhibition	O
of	O
gene1s	O
HIF-1a	O
gene1e	O
activity	O
using	O
YC1	O
and	O
thiamine	O
repletion	O
both	O
reduced	O
expression	O
of	O
pro	O
-	O
apoptotic	O
gene1s	O
HIF-1a	O
gene1e	O
target	O
genes	O
and	O
apoptotic	O
cell	O
death	O
in	O
TD	O
.	O
These	O
results	O
demonstrate	O
that	O
induction	O
of	O
gene1s	O
HIF-1a	O
gene1e	O
mediated	O
transcriptional	O
up	O
-	O
regulation	O
of	O
pro	O
-	O
apoptotic	O
/	O
inflammatory	O
signaling	O
contributes	O
to	O
astrocyte	O
cell	O
death	O
during	O
thiamine	O
deficiency	O
.	O

gene1s	ARG2
Netrin-1	ARG2
gene1e	ARG2
is	O
a	O
novel	O
regulator	O
of	O
vascular	O
endothelial	O
function	O
in	O
diabetes	O
.	O
BACKGROUND	O
:	O
gene1s	ARG2
Netrin-1	ARG2
gene1e	ARG2
,	O
a	O
secreted	O
laminin	O
-	O
like	O
protein	O
identified	O
as	O
an	O
axon	O
guidance	O
molecule	O
,	O
has	O
been	O
shown	O
to	O
be	O
of	O
critical	O
importance	O
in	O
the	O
cardiovascular	O
system	O
.	O
Recent	O
studies	O
have	O
revealed	O
pro	O
-	O
angiogenic	O
,	O
anti	O
-	O
apoptotic	O
and	O
anti	O
-	O
inflammatory	O
properties	O
of	O
gene1s	ARG2
netrin-1	ARG2
gene1e	ARG2
as	O
well	O
as	O
cardioprotective	O
actions	O
against	O
myocardial	O
injury	O
in	O
diabetic	O
arg1s	O
mice	O
arg1e	O
.	O
AIM	O
:	O
To	O
examine	O
the	O
role	O
of	O
gene1s	ARG2
netrin-1	ARG2
gene1e	ARG2
in	O
diabetes	O
-	O
and	O
high	O
glucose	O
(	O
HG)-induced	O
vascular	O
endothelial	O
dysfunction	O
(	O
VED	O
)	O
using	O
gene1s	ARG2
netrin-1	ARG2
gene1e	ARG2
arg1s	O
transgenic	O
mice	O
arg1e	O
(	O
Tg3	O
)	O
and	O
cultured	O
species1s	O
bovine	O
species1e	O
aortic	O
endothelial	O
cells	O
(	O
BAEC	O
)	O
.	O
MAIN	O
OUTCOME	O
:	O
Overexpression	O
of	O
gene1s	ARG2
netrin-1	ARG2
gene1e	ARG2
prevented	O
diabetes	O
-	O
induced	O
VED	O
in	O
aorta	O
from	O
diabetic	O
arg1s	O
mice	O
arg1e	O
and	O
gene1s	ARG2
netrin-1	ARG2
gene1e	ARG2
treatment	O
attenuated	O
HG	O
-	O
induced	O
impairment	O
of	O
gene1s	O
nitric	O
oxide	O
synthase	O
gene1e	O
(	O
gene1s	O
NOS	O
gene1e	O
)	O
function	O
in	O
BAECs	O
.	O
METHODS	O
AND	O
RESULTS	O
:	O
Experiments	O
were	O
performed	O
in	O
Tg3	O
and	O
littermate	O
control	O
(	O
WT	O
)	O
arg1s	O
mice	O
arg1e	O
rendered	O
diabetic	O
with	O
streptozotocin	O
(	O
STZ	O
)	O
and	O
in	O
BAECs	O
treated	O
with	O
HG	O
(	O
25	O
mmol	O
/	O
L	O
)	O
.	O
Levels	O
of	O
gene1s	ARG2
netrin-1	ARG2
gene1e	ARG2
and	O
its	O
receptor	O
gene1s	ARG2
DCC	ARG2
gene1e	ARG2
,	O
markers	O
of	O
inflammation	O
and	O
apoptosis	O
and	O
vascular	O
function	O
were	O
assessed	O
in	O
aortas	O
from	O
diabetic	O
and	O
non	O
-	O
diabetic	O
Tg3	O
and	O
WT	O
arg1s	O
mice	O
arg1e	O
.	O
Vascular	O
gene1s	ARG2
netrin-1	ARG2
gene1e	ARG2
in	O
WT	O
arg1s	O
mice	O
arg1e	O
was	O
reduced	O
under	O
diabetic	O
conditions	O
.	O
Aortas	O
from	O
non	O
-	O
diabetic	O
Tg3	O
and	O
WT	O
arg1s	O
mice	O
arg1e	O
showed	O
similar	O
maximum	O
endothelium	O
-	O
dependent	O
relaxation	O
(	O
MEDR	O
)	O
(	O
83	O
%	O
and	O
87	O
%	O
,	O
respectively	O
)	O
.	O
MEDR	O
was	O
markedly	O
impaired	O
in	O
aorta	O
from	O
diabetic	O
WT	O
arg1s	O
mice	O
arg1e	O
(	O
51	O
%	O
)	O
.	O
This	O
effect	O
was	O
significantly	O
blunted	O
in	O
Tg3	O
diabetic	O
aortas	O
(	O
70	O
%	O
)	O
.	O
Improved	O
vascular	O
relaxation	O
in	O
Tg3	O
diabetic	O
arg1s	O
mice	O
arg1e	O
was	O
associated	O
with	O
increased	O
levels	O
of	O
gene1s	ARG2
phospho	ARG2
-	ARG2
ERK1/2	ARG2
gene1e	ARG2
and	O
reduced	O
levels	O
of	O
oxidant	O
stress	O
,	O
gene1s	ARG2
NFkB	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
COX-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
p16INK4A	ARG2
gene1e	ARG2
,	O
cleaved	O
gene1s	ARG2
caspase-3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p16	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
mRNA	O
.	O
gene1s	ARG2
Netrin-1	ARG2
gene1e	ARG2
treatment	O
prevented	O
the	O
HG	O
-	O
induced	O
decrease	O
in	O
NO	O
production	O
and	O
elevation	O
of	O
oxidative	O
stress	O
and	O
apoptosis	O
in	O
BAECs	O
.	O
CONCLUSIONS	O
:	O
Diabetes	O
decreases	O
aortic	O
levels	O
of	O
gene1s	ARG2
netrin-1	ARG2
gene1e	ARG2
.	O
However	O
,	O
overexpression	O
of	O
gene1s	ARG2
netrin-1	ARG2
gene1e	ARG2
attenuates	O
diabetes	O
-	O
induced	O
VED	O
and	O
limits	O
the	O
reduction	O
of	O
NO	O
levels	O
,	O
while	O
increasing	O
expression	O
of	O
gene1s	ARG2
p	ARG2
-	ARG2
ERK1/2	ARG2
gene1e	ARG2
,	O
and	O
suppressing	O
oxidative	O
stress	O
and	O
inflammatory	O
and	O
apoptotic	O
processes	O
.	O
Enhancement	O
of	O
gene1s	ARG2
netrin-1	ARG2
gene1e	ARG2
function	O
may	O
be	O
a	O
useful	O
therapeutic	O
means	O
for	O
preventing	O
vascular	O
dysfunction	O
in	O
diabetes	O
.	O

gene1s	O
Netrin-1	O
gene1e	O
is	O
a	O
novel	O
regulator	O
of	O
vascular	O
endothelial	O
function	O
in	O
diabetes	O
.	O
BACKGROUND	O
:	O
gene1s	O
Netrin-1	O
gene1e	O
,	O
a	O
secreted	O
laminin	O
-	O
like	O
protein	O
identified	O
as	O
an	O
axon	O
guidance	O
molecule	O
,	O
has	O
been	O
shown	O
to	O
be	O
of	O
critical	O
importance	O
in	O
the	O
cardiovascular	O
system	O
.	O
Recent	O
studies	O
have	O
revealed	O
pro	O
-	O
angiogenic	O
,	O
anti	O
-	O
apoptotic	O
and	O
anti	O
-	O
inflammatory	O
properties	O
of	O
gene1s	O
netrin-1	O
gene1e	O
as	O
well	O
as	O
cardioprotective	O
actions	O
against	O
myocardial	O
injury	O
in	O
diabetic	O
species1s	O
mice	O
species1e	O
.	O
AIM	O
:	O
To	O
examine	O
the	O
role	O
of	O
gene1s	O
netrin-1	O
gene1e	O
in	O
diabetes	O
-	O
and	O
high	O
glucose	O
(	O
HG)-induced	O
vascular	O
endothelial	O
dysfunction	O
(	O
VED	O
)	O
using	O
gene1s	O
netrin-1	O
gene1e	O
species1s	O
transgenic	O
mice	O
species1e	O
(	O
Tg3	O
)	O
and	O
cultured	O
arg1s	O
bovine	O
arg1e	O
aortic	O
endothelial	O
cells	O
(	O
BAEC	O
)	O
.	O
MAIN	O
OUTCOME	O
:	O
Overexpression	O
of	O
gene1s	O
netrin-1	O
gene1e	O
prevented	O
diabetes	O
-	O
induced	O
VED	O
in	O
aorta	O
from	O
diabetic	O
species1s	O
mice	O
species1e	O
and	O
gene1s	O
netrin-1	O
gene1e	O
treatment	O
attenuated	O
HG	O
-	O
induced	O
impairment	O
of	O
gene1s	ARG2
nitric	ARG2
oxide	ARG2
synthase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NOS	ARG2
gene1e	ARG2
)	O
function	O
in	O
BAECs	O
.	O
METHODS	O
AND	O
RESULTS	O
:	O
Experiments	O
were	O
performed	O
in	O
Tg3	O
and	O
littermate	O
control	O
(	O
WT	O
)	O
species1s	O
mice	O
species1e	O
rendered	O
diabetic	O
with	O
streptozotocin	O
(	O
STZ	O
)	O
and	O
in	O
BAECs	O
treated	O
with	O
HG	O
(	O
25	O
mmol	O
/	O
L	O
)	O
.	O
Levels	O
of	O
gene1s	O
netrin-1	O
gene1e	O
and	O
its	O
receptor	O
gene1s	O
DCC	O
gene1e	O
,	O
markers	O
of	O
inflammation	O
and	O
apoptosis	O
and	O
vascular	O
function	O
were	O
assessed	O
in	O
aortas	O
from	O
diabetic	O
and	O
non	O
-	O
diabetic	O
Tg3	O
and	O
WT	O
species1s	O
mice	O
species1e	O
.	O
Vascular	O
gene1s	O
netrin-1	O
gene1e	O
in	O
WT	O
species1s	O
mice	O
species1e	O
was	O
reduced	O
under	O
diabetic	O
conditions	O
.	O
Aortas	O
from	O
non	O
-	O
diabetic	O
Tg3	O
and	O
WT	O
species1s	O
mice	O
species1e	O
showed	O
similar	O
maximum	O
endothelium	O
-	O
dependent	O
relaxation	O
(	O
MEDR	O
)	O
(	O
83	O
%	O
and	O
87	O
%	O
,	O
respectively	O
)	O
.	O
MEDR	O
was	O
markedly	O
impaired	O
in	O
aorta	O
from	O
diabetic	O
WT	O
species1s	O
mice	O
species1e	O
(	O
51	O
%	O
)	O
.	O
This	O
effect	O
was	O
significantly	O
blunted	O
in	O
Tg3	O
diabetic	O
aortas	O
(	O
70	O
%	O
)	O
.	O
Improved	O
vascular	O
relaxation	O
in	O
Tg3	O
diabetic	O
species1s	O
mice	O
species1e	O
was	O
associated	O
with	O
increased	O
levels	O
of	O
gene1s	O
phospho	O
-	O
ERK1/2	O
gene1e	O
and	O
reduced	O
levels	O
of	O
oxidant	O
stress	O
,	O
gene1s	O
NFkB	O
gene1e	O
,	O
gene1s	O
COX-2	O
gene1e	O
,	O
gene1s	O
p16INK4A	O
gene1e	O
,	O
cleaved	O
gene1s	O
caspase-3	O
gene1e	O
and	O
gene1s	O
p16	O
gene1e	O
and	O
gene1s	O
p53	O
gene1e	O
mRNA	O
.	O
gene1s	O
Netrin-1	O
gene1e	O
treatment	O
prevented	O
the	O
HG	O
-	O
induced	O
decrease	O
in	O
NO	O
production	O
and	O
elevation	O
of	O
oxidative	O
stress	O
and	O
apoptosis	O
in	O
BAECs	O
.	O
CONCLUSIONS	O
:	O
Diabetes	O
decreases	O
aortic	O
levels	O
of	O
gene1s	O
netrin-1	O
gene1e	O
.	O
However	O
,	O
overexpression	O
of	O
gene1s	O
netrin-1	O
gene1e	O
attenuates	O
diabetes	O
-	O
induced	O
VED	O
and	O
limits	O
the	O
reduction	O
of	O
NO	O
levels	O
,	O
while	O
increasing	O
expression	O
of	O
gene1s	O
p	O
-	O
ERK1/2	O
gene1e	O
,	O
and	O
suppressing	O
oxidative	O
stress	O
and	O
inflammatory	O
and	O
apoptotic	O
processes	O
.	O
Enhancement	O
of	O
gene1s	O
netrin-1	O
gene1e	O
function	O
may	O
be	O
a	O
useful	O
therapeutic	O
means	O
for	O
preventing	O
vascular	O
dysfunction	O
in	O
diabetes	O
.	O

The	O
gene1s	O
tetraspanin	O
gene1e	O
gene1s	O
KAI1	O
gene1e	O
/	O
gene1s	O
CD82	O
gene1e	O
is	O
expressed	O
by	O
late	O
-	O
lineage	O
oligodendrocyte	O
precursors	O
and	O
may	O
function	O
to	O
restrict	O
precursor	O
migration	O
and	O
promote	O
oligodendrocyte	O
differentiation	O
and	O
myelination	O
.	O
In	O
the	O
adult	O
arg1s	O
mammalian	O
arg1e	O
brain	O
,	O
oligodendrocyte	O
progenitors	O
can	O
differentiate	O
into	O
mature	O
oligodendrocytes	O
during	O
remyelination	O
.	O
Mechanisms	O
that	O
regulate	O
migration	O
and	O
differentiation	O
of	O
progenitors	O
are	O
of	O
great	O
importance	O
in	O
understanding	O
normal	O
development	O
and	O
demyelinating	O
/	O
remyelinating	O
conditions	O
.	O
In	O
a	O
microarray	O
analysis	O
comparing	O
adult	O
and	O
neonatal	O
O4-positive	O
(	O
+	O
)	O
cells	O
,	O
we	O
found	O
that	O
the	O
gene1s	O
tetraspanin	O
gene1e	O
gene1s	O
KAI1	O
gene1e	O
/	O
gene1s	O
CD82	O
gene1e	O
is	O
far	O
more	O
highly	O
expressed	O
in	O
adult	O
O4(+	O
)	O
cells	O
than	O
in	O
neonatal	O
O4(+	O
)	O
cells	O
(	O
Lin	O
et	O
al	O
.	O
,	O
2009	O
)	O
.	O
gene1s	O
CD82	O
gene1e	O
is	O
a	O
metastasis	O
suppressor	O
,	O
and	O
its	O
expression	O
is	O
often	O
downregulated	O
or	O
lost	O
in	O
the	O
advanced	O
stages	O
of	O
metastatic	O
cancer	O
.	O
We	O
hypothesized	O
that	O
gene1s	O
CD82	O
gene1e	O
could	O
be	O
a	O
factor	O
that	O
restricts	O
migration	O
and	O
promotes	O
differentiation	O
of	O
maturing	O
oligodendrocytes	O
.	O
Western	O
blot	O
analysis	O
of	O
isolated	O
adult	O
O4(+	O
)	O
cells	O
confirms	O
the	O
elevated	O
levels	O
of	O
gene1s	O
CD82	O
gene1e	O
,	O
which	O
continues	O
to	O
be	O
expressed	O
as	O
these	O
become	O
O1(+	O
)	O
in	O
vitro	O
.	O
In	O
the	O
adult	O
species1s	O
rat	O
species1e	O
white	O
matter	O
,	O
gene1s	O
CD82	O
gene1e	O
is	O
coexpressed	O
with	O
gene1s	O
CC1	O
gene1e	O
and	O
gene1s	O
olig2	O
gene1e	O
but	O
not	O
with	O
gene1s	O
NG2	O
gene1e	O
or	O
gene1s	O
GFAP	O
gene1e	O
.	O
Immature	O
cells	O
of	O
the	O
neonatal	O
forebrain	O
subventricular	O
zone	O
(	O
SVZ	O
)	O
infected	O
in	O
vivo	O
with	O
a	O
retrovirus	O
that	O
constitutively	O
expresses	O
gene1s	O
CD82	O
gene1e	O
do	O
not	O
remain	O
immature	O
but	O
differentiate	O
into	O
either	O
gene1s	O
CC1	O
gene1e	O
(+	O
)	O
and	O
gene1s	O
MBP	O
gene1e	O
(+	O
)	O
myelinating	O
oligodendrocytes	O
in	O
the	O
white	O
matter	O
or	O
gene1s	O
zebrinII	O
gene1e	O
(+	O
)	O
astrocytes	O
in	O
the	O
cortex	O
.	O
Their	O
migration	O
from	O
the	O
SVZ	O
is	O
severely	O
restricted	O
.	O
In	O
contrast	O
,	O
downregulation	O
of	O
gene1s	O
CD82	O
gene1e	O
in	O
SVZ	O
cells	O
in	O
vivo	O
,	O
using	O
retroviral	O
-	O
expressed	O
short	O
hairpin	O
RNAs	O
(	O
shRNAs	O
)	O
,	O
prevents	O
their	O
differentiation	O
into	O
myelinating	O
oligodendrocytes	O
.	O
shRNA	O
-	O
expressing	O
cells	O
remained	O
gene1s	O
PDGF	O
receptor	O
alpha	O
gene1e	O
positive	O
,	O
gene1s	O
olig2	O
gene1e	O
(+	O
)	O
,	O
or	O
gene1s	O
NG2	O
gene1e	O
(+	O
)	O
or	O
became	O
gene1s	O
CC1	O
gene1e	O
(+	O
)	O
nonmyelinating	O
oligodendrocytes	O
or	O
gene1s	O
GFAP	O
gene1e	O
(+	O
)	O
astrocytes	O
.	O
gene1s	O
CD82	O
gene1e	O
thus	O
appears	O
to	O
be	O
a	O
critical	O
molecule	O
in	O
the	O
regulation	O
of	O
oligodendrocyte	O
progenitor	O
migration	O
and	O
myelination	O
.	O

The	O
gene1s	ARG2
tetraspanin	ARG2
gene1e	ARG2
gene1s	ARG2
KAI1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CD82	ARG2
gene1e	ARG2
is	O
expressed	O
by	O
late	O
-	O
lineage	O
oligodendrocyte	O
precursors	O
and	O
may	O
function	O
to	O
restrict	O
precursor	O
migration	O
and	O
promote	O
oligodendrocyte	O
differentiation	O
and	O
myelination	O
.	O
In	O
the	O
adult	O
species1s	O
mammalian	O
species1e	O
brain	O
,	O
oligodendrocyte	O
progenitors	O
can	O
differentiate	O
into	O
mature	O
oligodendrocytes	O
during	O
remyelination	O
.	O
Mechanisms	O
that	O
regulate	O
migration	O
and	O
differentiation	O
of	O
progenitors	O
are	O
of	O
great	O
importance	O
in	O
understanding	O
normal	O
development	O
and	O
demyelinating	O
/	O
remyelinating	O
conditions	O
.	O
In	O
a	O
microarray	O
analysis	O
comparing	O
adult	O
and	O
neonatal	O
O4-positive	O
(	O
+	O
)	O
cells	O
,	O
we	O
found	O
that	O
the	O
gene1s	ARG2
tetraspanin	ARG2
gene1e	ARG2
gene1s	ARG2
KAI1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CD82	ARG2
gene1e	ARG2
is	O
far	O
more	O
highly	O
expressed	O
in	O
adult	O
O4(+	O
)	O
cells	O
than	O
in	O
neonatal	O
O4(+	O
)	O
cells	O
(	O
Lin	O
et	O
al	O
.	O
,	O
2009	O
)	O
.	O
gene1s	ARG2
CD82	ARG2
gene1e	ARG2
is	O
a	O
metastasis	O
suppressor	O
,	O
and	O
its	O
expression	O
is	O
often	O
downregulated	O
or	O
lost	O
in	O
the	O
advanced	O
stages	O
of	O
metastatic	O
cancer	O
.	O
We	O
hypothesized	O
that	O
gene1s	ARG2
CD82	ARG2
gene1e	ARG2
could	O
be	O
a	O
factor	O
that	O
restricts	O
migration	O
and	O
promotes	O
differentiation	O
of	O
maturing	O
oligodendrocytes	O
.	O
Western	O
blot	O
analysis	O
of	O
isolated	O
adult	O
O4(+	O
)	O
cells	O
confirms	O
the	O
elevated	O
levels	O
of	O
gene1s	ARG2
CD82	ARG2
gene1e	ARG2
,	O
which	O
continues	O
to	O
be	O
expressed	O
as	O
these	O
become	O
O1(+	O
)	O
in	O
vitro	O
.	O
In	O
the	O
adult	O
arg1s	O
rat	O
arg1e	O
white	O
matter	O
,	O
gene1s	ARG2
CD82	ARG2
gene1e	ARG2
is	O
coexpressed	O
with	O
gene1s	ARG2
CC1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
olig2	ARG2
gene1e	ARG2
but	O
not	O
with	O
gene1s	ARG2
NG2	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
GFAP	ARG2
gene1e	ARG2
.	O
Immature	O
cells	O
of	O
the	O
neonatal	O
forebrain	O
subventricular	O
zone	O
(	O
SVZ	O
)	O
infected	O
in	O
vivo	O
with	O
a	O
retrovirus	O
that	O
constitutively	O
expresses	O
gene1s	ARG2
CD82	ARG2
gene1e	ARG2
do	O
not	O
remain	O
immature	O
but	O
differentiate	O
into	O
either	O
gene1s	ARG2
CC1	ARG2
gene1e	ARG2
(+	O
)	O
and	O
gene1s	ARG2
MBP	ARG2
gene1e	ARG2
(+	O
)	O
myelinating	O
oligodendrocytes	O
in	O
the	O
white	O
matter	O
or	O
gene1s	ARG2
zebrinII	ARG2
gene1e	ARG2
(+	O
)	O
astrocytes	O
in	O
the	O
cortex	O
.	O
Their	O
migration	O
from	O
the	O
SVZ	O
is	O
severely	O
restricted	O
.	O
In	O
contrast	O
,	O
downregulation	O
of	O
gene1s	ARG2
CD82	ARG2
gene1e	ARG2
in	O
SVZ	O
cells	O
in	O
vivo	O
,	O
using	O
retroviral	O
-	O
expressed	O
short	O
hairpin	O
RNAs	O
(	O
shRNAs	O
)	O
,	O
prevents	O
their	O
differentiation	O
into	O
myelinating	O
oligodendrocytes	O
.	O
shRNA	O
-	O
expressing	O
cells	O
remained	O
gene1s	ARG2
PDGF	ARG2
receptor	ARG2
alpha	ARG2
gene1e	ARG2
positive	O
,	O
gene1s	ARG2
olig2	ARG2
gene1e	ARG2
(+	O
)	O
,	O
or	O
gene1s	ARG2
NG2	ARG2
gene1e	ARG2
(+	O
)	O
or	O
became	O
gene1s	ARG2
CC1	ARG2
gene1e	ARG2
(+	O
)	O
nonmyelinating	O
oligodendrocytes	O
or	O
gene1s	ARG2
GFAP	ARG2
gene1e	ARG2
(+	O
)	O
astrocytes	O
.	O
gene1s	ARG2
CD82	ARG2
gene1e	ARG2
thus	O
appears	O
to	O
be	O
a	O
critical	O
molecule	O
in	O
the	O
regulation	O
of	O
oligodendrocyte	O
progenitor	O
migration	O
and	O
myelination	O
.	O

Loss	O
of	O
the	O
gene1s	ARG2
Protein	ARG2
Tyrosine	ARG2
Phosphatase	ARG2
gene1e	ARG2
gene1s	ARG2
PTPN22	ARG2
gene1e	ARG2
Reduces	O
Mannan	O
-	O
Induced	O
Autoimmune	O
Arthritis	O
in	O
SKG	O
arg1s	O
Mice	O
arg1e	O
.	O
The	O
cytoplasmic	O
phosphatase	O
,	O
gene1s	ARG2
protein	ARG2
tyrosine	ARG2
phosphatase	ARG2
nonreceptor	ARG2
type	ARG2
22	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PTPN22	ARG2
gene1e	ARG2
)	O
,	O
is	O
a	O
negative	O
regulator	O
of	O
T	O
cell	O
signaling	O
.	O
Genome	O
-	O
wide	O
association	O
studies	O
have	O
shown	O
that	O
single	O
-	O
nucleotide	O
polymorphisms	O
in	O
gene1s	O
PTPN22	O
gene1e	O
confer	O
an	O
increased	O
risk	O
of	O
developing	O
multiple	O
autoimmune	O
diseases	O
in	O
species1s	O
humans	O
species1e	O
.	O
The	O
precise	O
function	O
of	O
gene1s	ARG2
PTPN22	ARG2
gene1e	ARG2
and	O
how	O
the	O
variant	O
protein	O
contributes	O
to	O
autoimmunity	O
is	O
not	O
well	O
understood	O
.	O
To	O
address	O
this	O
issue	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
gene1s	ARG2
PTPN22	ARG2
gene1e	ARG2
deficiency	O
on	O
disease	O
susceptibility	O
in	O
a	O
arg1s	O
mouse	O
arg1e	O
model	O
of	O
autoimmune	O
arthritis	O
.	O
The	O
SKG	O
arg1s	O
mouse	O
arg1e	O
expresses	O
a	O
hypomorphic	O
mutant	O
allele	O
of	O
gene1s	ARG2
ZAP70	ARG2
gene1e	ARG2
,	O
which	O
,	O
upon	O
exposure	O
to	O
fungal	O
Ags	O
,	O
predisposes	O
the	O
arg1s	O
mice	O
arg1e	O
to	O
a	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
(+	O
)	O
T	O
cell	O
-	O
mediated	O
autoimmune	O
arthritis	O
that	O
closely	O
resembles	O
rheumatoid	O
arthritis	O
in	O
species1s	O
humans	O
species1e	O
.	O
Surprisingly	O
,	O
SKG	O
gene1s	ARG2
Ptpn22	ARG2
gene1e	ARG2
(-/-	O
)	O
arg1s	O
mice	O
arg1e	O
developed	O
less	O
severe	O
mannan	O
-	O
induced	O
arthritis	O
compared	O
with	O
SKG	O
arg1s	O
mice	O
arg1e	O
.	O
Diminution	O
of	O
disease	O
was	O
not	O
due	O
to	O
significant	O
alterations	O
in	O
thymocyte	O
development	O
or	O
repertoire	O
selection	O
in	O
SKG	O
gene1s	ARG2
Ptpn22	ARG2
gene1e	ARG2
(-/-	O
)	O
arg1s	O
mice	O
arg1e	O
,	O
even	O
though	O
T	O
cell	O
-	O
mediated	O
signal	O
transduction	O
was	O
improved	O
.	O
Instead	O
,	O
gene1s	ARG2
Ptpn22	ARG2
gene1e	ARG2
deficiency	O
appeared	O
to	O
bias	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
Th	O
cell	O
differentiation	O
away	O
from	O
the	O
Th17	O
lineage	O
,	O
which	O
is	O
pathogenic	O
in	O
this	O
setting	O
,	O
to	O
a	O
more	O
Th1	O
/	O
T	O
regulatory	O
-	O
focused	O
response	O
.	O
These	O
data	O
show	O
that	O
even	O
small	O
perturbations	O
in	O
TCR	O
signal	O
transduction	O
pathways	O
can	O
have	O
profound	O
consequences	O
on	O
the	O
differentiation	O
of	O
T	O
cell	O
lineages	O
and	O
thus	O
for	O
the	O
development	O
of	O
autoimmune	O
diseases	O
.	O

Loss	O
of	O
the	O
gene1s	O
Protein	O
Tyrosine	O
Phosphatase	O
gene1e	O
gene1s	O
PTPN22	O
gene1e	O
Reduces	O
Mannan	O
-	O
Induced	O
Autoimmune	O
Arthritis	O
in	O
SKG	O
species1s	O
Mice	O
species1e	O
.	O
The	O
cytoplasmic	O
phosphatase	O
,	O
gene1s	O
protein	O
tyrosine	O
phosphatase	O
nonreceptor	O
type	O
22	O
gene1e	O
(	O
gene1s	O
PTPN22	O
gene1e	O
)	O
,	O
is	O
a	O
negative	O
regulator	O
of	O
T	O
cell	O
signaling	O
.	O
Genome	O
-	O
wide	O
association	O
studies	O
have	O
shown	O
that	O
single	O
-	O
nucleotide	O
polymorphisms	O
in	O
gene1s	ARG2
PTPN22	ARG2
gene1e	ARG2
confer	O
an	O
increased	O
risk	O
of	O
developing	O
multiple	O
autoimmune	O
diseases	O
in	O
arg1s	O
humans	O
arg1e	O
.	O
The	O
precise	O
function	O
of	O
gene1s	O
PTPN22	O
gene1e	O
and	O
how	O
the	O
variant	O
protein	O
contributes	O
to	O
autoimmunity	O
is	O
not	O
well	O
understood	O
.	O
To	O
address	O
this	O
issue	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
gene1s	O
PTPN22	O
gene1e	O
deficiency	O
on	O
disease	O
susceptibility	O
in	O
a	O
species1s	O
mouse	O
species1e	O
model	O
of	O
autoimmune	O
arthritis	O
.	O
The	O
SKG	O
species1s	O
mouse	O
species1e	O
expresses	O
a	O
hypomorphic	O
mutant	O
allele	O
of	O
gene1s	O
ZAP70	O
gene1e	O
,	O
which	O
,	O
upon	O
exposure	O
to	O
fungal	O
Ags	O
,	O
predisposes	O
the	O
species1s	O
mice	O
species1e	O
to	O
a	O
gene1s	O
CD4	O
gene1e	O
(+	O
)	O
T	O
cell	O
-	O
mediated	O
autoimmune	O
arthritis	O
that	O
closely	O
resembles	O
rheumatoid	O
arthritis	O
in	O
arg1s	O
humans	O
arg1e	O
.	O
Surprisingly	O
,	O
SKG	O
gene1s	O
Ptpn22	O
gene1e	O
(-/-	O
)	O
species1s	O
mice	O
species1e	O
developed	O
less	O
severe	O
mannan	O
-	O
induced	O
arthritis	O
compared	O
with	O
SKG	O
species1s	O
mice	O
species1e	O
.	O
Diminution	O
of	O
disease	O
was	O
not	O
due	O
to	O
significant	O
alterations	O
in	O
thymocyte	O
development	O
or	O
repertoire	O
selection	O
in	O
SKG	O
gene1s	O
Ptpn22	O
gene1e	O
(-/-	O
)	O
species1s	O
mice	O
species1e	O
,	O
even	O
though	O
T	O
cell	O
-	O
mediated	O
signal	O
transduction	O
was	O
improved	O
.	O
Instead	O
,	O
gene1s	O
Ptpn22	O
gene1e	O
deficiency	O
appeared	O
to	O
bias	O
gene1s	O
CD4	O
gene1e	O
Th	O
cell	O
differentiation	O
away	O
from	O
the	O
Th17	O
lineage	O
,	O
which	O
is	O
pathogenic	O
in	O
this	O
setting	O
,	O
to	O
a	O
more	O
Th1	O
/	O
T	O
regulatory	O
-	O
focused	O
response	O
.	O
These	O
data	O
show	O
that	O
even	O
small	O
perturbations	O
in	O
TCR	O
signal	O
transduction	O
pathways	O
can	O
have	O
profound	O
consequences	O
on	O
the	O
differentiation	O
of	O
T	O
cell	O
lineages	O
and	O
thus	O
for	O
the	O
development	O
of	O
autoimmune	O
diseases	O
.	O

A	O
Critical	O
Role	O
for	O
the	O
gene1s	ARG2
Type	ARG2
I	ARG2
Interferon	ARG2
Receptor	ARG2
gene1e	ARG2
in	O
Virus	O
-	O
Induced	O
Autoimmune	O
Diabetes	O
in	O
arg1s	O
Rats	O
arg1e	O
.	O
The	O
pathogenesis	O
of	O
species1s	O
human	O
species1e	O
type	O
1	O
diabetes	O
,	O
characterized	O
by	O
immune	O
-	O
mediated	O
damage	O
of	O
gene1s	O
insulin	O
gene1e	O
-	O
producing	O
b	O
-	O
cells	O
of	O
pancreatic	O
islets	O
,	O
may	O
involve	O
viral	O
infection	O
.	O
Essential	O
components	O
of	O
the	O
innate	O
immune	O
antiviral	O
response	O
,	O
including	O
gene1s	O
type	O
I	O
interferon	O
gene1e	O
(	O
gene1s	O
IFN	O
gene1e	O
)	O
and	O
gene1s	O
IFN	O
receptor	O
gene1e	O
-	O
mediated	O
signaling	O
pathways	O
,	O
are	O
candidates	O
for	O
determining	O
susceptibility	O
to	O
species1s	O
human	O
species1e	O
type	O
1	O
diabetes	O
.	O
Numerous	O
aspects	O
of	O
species1s	O
human	O
species1e	O
type	O
1	O
diabetes	O
pathogenesis	O
are	O
recapitulated	O
in	O
the	O
LEW.1WR1	O
arg1s	O
rat	O
arg1e	O
model	O
.	O
Diabetes	O
can	O
be	O
induced	O
in	O
LEW.1WR1	O
weanling	O
arg1s	O
rats	O
arg1e	O
challenged	O
with	O
virus	O
or	O
with	O
the	O
viral	O
mimetic	O
polyinosinic	O
:	O
polycytidylic	O
acid	O
(	O
poly	O
I	O
:	O
C	O
)	O
.	O
We	O
hypothesized	O
that	O
disrupting	O
the	O
cognate	O
gene1s	ARG2
type	ARG2
I	ARG2
IFN	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
type	ARG2
I	ARG2
IFN	ARG2
a	ARG2
/	ARG2
b	ARG2
receptor	ARG2
gene1e	ARG2
[	O
gene1s	ARG2
IFNAR	ARG2
gene1e	ARG2
]	O
)	O
to	O
interrupt	O
gene1s	ARG2
IFN	ARG2
gene1e	ARG2
signaling	O
would	O
prevent	O
or	O
delay	O
the	O
development	O
of	O
virus	O
-	O
induced	O
diabetes	O
.	O
We	O
generated	O
gene1s	ARG2
IFNAR1	ARG2
gene1e	ARG2
subunit	O
-	O
deficient	O
LEW.1WR1	O
arg1s	O
rats	O
arg1e	O
using	O
CRISPR	O
-	O
Cas9	O
(	O
clustered	O
regularly	O
interspaced	O
short	O
palindromic	O
repeats	O
-	O
associated	O
protein	O
9	O
)	O
genome	O
editing	O
and	O
confirmed	O
functional	O
disruption	O
of	O
the	O
gene1s	ARG2
Ifnar1	ARG2
gene1e	ARG2
gene	O
.	O
gene1s	ARG2
IFNAR1	ARG2
gene1e	ARG2
deficiency	O
significantly	O
delayed	O
the	O
onset	O
and	O
frequency	O
of	O
diabetes	O
and	O
greatly	O
reduced	O
the	O
intensity	O
of	O
insulitis	O
after	O
poly	O
I	O
:	O
C	O
treatment	O
.	O
The	O
occurrence	O
of	O
species1s	O
Kilham	O
rat	O
virus	O
species1e	O
-	O
induced	O
diabetes	O
was	O
also	O
diminished	O
in	O
gene1s	ARG2
IFNAR1	ARG2
gene1e	ARG2
-deficient	O
animals	O
.	O
These	O
findings	O
firmly	O
establish	O
that	O
alterations	O
in	O
innate	O
immunity	O
influence	O
the	O
course	O
of	O
autoimmune	O
diabetes	O
and	O
support	O
the	O
use	O
of	O
targeted	O
strategies	O
to	O
limit	O
or	O
prevent	O
the	O
development	O
of	O
type	O
1	O
diabetes	O
.	O

A	O
Critical	O
Role	O
for	O
the	O
gene1s	O
Type	O
I	O
Interferon	O
Receptor	O
gene1e	O
in	O
Virus	O
-	O
Induced	O
Autoimmune	O
Diabetes	O
in	O
species1s	O
Rats	O
species1e	O
.	O
The	O
pathogenesis	O
of	O
arg1s	O
human	O
arg1e	O
type	O
1	O
diabetes	O
,	O
characterized	O
by	O
immune	O
-	O
mediated	O
damage	O
of	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
-	O
producing	O
b	O
-	O
cells	O
of	O
pancreatic	O
islets	O
,	O
may	O
involve	O
viral	O
infection	O
.	O
Essential	O
components	O
of	O
the	O
innate	O
immune	O
antiviral	O
response	O
,	O
including	O
gene1s	ARG2
type	ARG2
I	ARG2
interferon	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IFN	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
IFN	ARG2
receptor	ARG2
gene1e	ARG2
-	O
mediated	O
signaling	O
pathways	O
,	O
are	O
candidates	O
for	O
determining	O
susceptibility	O
to	O
arg1s	O
human	O
arg1e	O
type	O
1	O
diabetes	O
.	O
Numerous	O
aspects	O
of	O
arg1s	O
human	O
arg1e	O
type	O
1	O
diabetes	O
pathogenesis	O
are	O
recapitulated	O
in	O
the	O
LEW.1WR1	O
species1s	O
rat	O
species1e	O
model	O
.	O
Diabetes	O
can	O
be	O
induced	O
in	O
LEW.1WR1	O
weanling	O
species1s	O
rats	O
species1e	O
challenged	O
with	O
virus	O
or	O
with	O
the	O
viral	O
mimetic	O
polyinosinic	O
:	O
polycytidylic	O
acid	O
(	O
poly	O
I	O
:	O
C	O
)	O
.	O
We	O
hypothesized	O
that	O
disrupting	O
the	O
cognate	O
gene1s	O
type	O
I	O
IFN	O
receptor	O
gene1e	O
(	O
gene1s	O
type	O
I	O
IFN	O
a	O
/	O
b	O
receptor	O
gene1e	O
[	O
gene1s	O
IFNAR	O
gene1e	O
]	O
)	O
to	O
interrupt	O
gene1s	O
IFN	O
gene1e	O
signaling	O
would	O
prevent	O
or	O
delay	O
the	O
development	O
of	O
virus	O
-	O
induced	O
diabetes	O
.	O
We	O
generated	O
gene1s	O
IFNAR1	O
gene1e	O
subunit	O
-	O
deficient	O
LEW.1WR1	O
species1s	O
rats	O
species1e	O
using	O
CRISPR	O
-	O
Cas9	O
(	O
clustered	O
regularly	O
interspaced	O
short	O
palindromic	O
repeats	O
-	O
associated	O
protein	O
9	O
)	O
genome	O
editing	O
and	O
confirmed	O
functional	O
disruption	O
of	O
the	O
gene1s	O
Ifnar1	O
gene1e	O
gene	O
.	O
gene1s	O
IFNAR1	O
gene1e	O
deficiency	O
significantly	O
delayed	O
the	O
onset	O
and	O
frequency	O
of	O
diabetes	O
and	O
greatly	O
reduced	O
the	O
intensity	O
of	O
insulitis	O
after	O
poly	O
I	O
:	O
C	O
treatment	O
.	O
The	O
occurrence	O
of	O
species1s	O
Kilham	O
rat	O
virus	O
species1e	O
-	O
induced	O
diabetes	O
was	O
also	O
diminished	O
in	O
gene1s	O
IFNAR1	O
gene1e	O
-deficient	O
animals	O
.	O
These	O
findings	O
firmly	O
establish	O
that	O
alterations	O
in	O
innate	O
immunity	O
influence	O
the	O
course	O
of	O
autoimmune	O
diabetes	O
and	O
support	O
the	O
use	O
of	O
targeted	O
strategies	O
to	O
limit	O
or	O
prevent	O
the	O
development	O
of	O
type	O
1	O
diabetes	O
.	O

A	O
Critical	O
Role	O
for	O
the	O
gene1s	O
Type	O
I	O
Interferon	O
Receptor	O
gene1e	O
in	O
Virus	O
-	O
Induced	O
Autoimmune	O
Diabetes	O
in	O
species1s	O
Rats	O
species1e	O
.	O
The	O
pathogenesis	O
of	O
species1s	O
human	O
species1e	O
type	O
1	O
diabetes	O
,	O
characterized	O
by	O
immune	O
-	O
mediated	O
damage	O
of	O
gene1s	O
insulin	O
gene1e	O
-	O
producing	O
b	O
-	O
cells	O
of	O
pancreatic	O
islets	O
,	O
may	O
involve	O
viral	O
infection	O
.	O
Essential	O
components	O
of	O
the	O
innate	O
immune	O
antiviral	O
response	O
,	O
including	O
gene1s	O
type	O
I	O
interferon	O
gene1e	O
(	O
gene1s	O
IFN	O
gene1e	O
)	O
and	O
gene1s	O
IFN	O
receptor	O
gene1e	O
-	O
mediated	O
signaling	O
pathways	O
,	O
are	O
candidates	O
for	O
determining	O
susceptibility	O
to	O
species1s	O
human	O
species1e	O
type	O
1	O
diabetes	O
.	O
Numerous	O
aspects	O
of	O
species1s	O
human	O
species1e	O
type	O
1	O
diabetes	O
pathogenesis	O
are	O
recapitulated	O
in	O
the	O
LEW.1WR1	O
species1s	O
rat	O
species1e	O
model	O
.	O
Diabetes	O
can	O
be	O
induced	O
in	O
LEW.1WR1	O
weanling	O
species1s	O
rats	O
species1e	O
challenged	O
with	O
virus	O
or	O
with	O
the	O
viral	O
mimetic	O
polyinosinic	O
:	O
polycytidylic	O
acid	O
(	O
poly	O
I	O
:	O
C	O
)	O
.	O
We	O
hypothesized	O
that	O
disrupting	O
the	O
cognate	O
gene1s	O
type	O
I	O
IFN	O
receptor	O
gene1e	O
(	O
gene1s	O
type	O
I	O
IFN	O
a	O
/	O
b	O
receptor	O
gene1e	O
[	O
gene1s	O
IFNAR	O
gene1e	O
]	O
)	O
to	O
interrupt	O
gene1s	O
IFN	O
gene1e	O
signaling	O
would	O
prevent	O
or	O
delay	O
the	O
development	O
of	O
virus	O
-	O
induced	O
diabetes	O
.	O
We	O
generated	O
gene1s	O
IFNAR1	O
gene1e	O
subunit	O
-	O
deficient	O
LEW.1WR1	O
species1s	O
rats	O
species1e	O
using	O
CRISPR	O
-	O
Cas9	O
(	O
clustered	O
regularly	O
interspaced	O
short	O
palindromic	O
repeats	O
-	O
associated	O
protein	O
9	O
)	O
genome	O
editing	O
and	O
confirmed	O
functional	O
disruption	O
of	O
the	O
gene1s	O
Ifnar1	O
gene1e	O
gene	O
.	O
gene1s	O
IFNAR1	O
gene1e	O
deficiency	O
significantly	O
delayed	O
the	O
onset	O
and	O
frequency	O
of	O
diabetes	O
and	O
greatly	O
reduced	O
the	O
intensity	O
of	O
insulitis	O
after	O
poly	O
I	O
:	O
C	O
treatment	O
.	O
The	O
occurrence	O
of	O
arg1s	O
Kilham	O
rat	O
virus	O
arg1e	O
-	O
induced	O
diabetes	O
was	O
also	O
diminished	O
in	O
gene1s	O
IFNAR1	O
gene1e	O
-deficient	O
animals	O
.	O
These	O
findings	O
firmly	O
establish	O
that	O
alterations	O
in	O
innate	O
immunity	O
influence	O
the	O
course	O
of	O
autoimmune	O
diabetes	O
and	O
support	O
the	O
use	O
of	O
targeted	O
strategies	O
to	O
limit	O
or	O
prevent	O
the	O
development	O
of	O
type	O
1	O
diabetes	O
.	O

gene1s	O
Prdm1	O
gene1e	O
Regulates	O
Thymic	O
Epithelial	O
Function	O
To	O
Prevent	O
Autoimmunity	O
.	O
Autoimmunity	O
is	O
largely	O
prevented	O
by	O
medullary	O
thymic	O
epithelial	O
cells	O
(	O
TECs	O
)	O
through	O
their	O
expression	O
and	O
presentation	O
of	O
tissue	O
-	O
specific	O
Ags	O
to	O
developing	O
thymocytes	O
,	O
resulting	O
in	O
deletion	O
of	O
self	O
-	O
reactive	O
T	O
cells	O
and	O
supporting	O
regulatory	O
T	O
cell	O
development	O
.	O
The	O
transcription	O
factor	O
gene1s	ARG2
Prdm1	ARG2
gene1e	ARG2
has	O
been	O
implicated	O
in	O
autoimmune	O
diseases	O
in	O
arg1s	O
humans	O
arg1e	O
through	O
genome	O
-	O
wide	O
association	O
studies	O
and	O
in	O
species1s	O
mice	O
species1e	O
using	O
cell	O
type	O
-	O
specific	O
deletion	O
of	O
gene1s	O
Prdm1	O
gene1e	O
in	O
T	O
and	O
dendritic	O
cells	O
.	O
In	O
this	O
article	O
,	O
we	O
demonstrate	O
that	O
gene1s	O
Prdm1	O
gene1e	O
functions	O
in	O
TECs	O
to	O
prevent	O
autoimmunity	O
in	O
species1s	O
mice	O
species1e	O
.	O
gene1s	O
Prdm1	O
gene1e	O
is	O
expressed	O
by	O
a	O
subset	O
of	O
species1s	O
mouse	O
species1e	O
TECs	O
,	O
and	O
conditional	O
deletion	O
of	O
gene1s	O
Prdm1	O
gene1e	O
in	O
either	O
gene1s	O
Keratin	O
14	O
gene1e	O
-	O
or	O
gene1s	O
Foxn1	O
gene1e	O
-expressing	O
cells	O
in	O
species1s	O
mice	O
species1e	O
resulted	O
in	O
multisymptom	O
autoimmune	O
pathology	O
.	O
Notably	O
,	O
the	O
development	O
of	O
gene1s	O
Foxp3	O
gene1e	O
(+	O
)	O
regulatory	O
T	O
cells	O
occurs	O
normally	O
in	O
the	O
absence	O
of	O
gene1s	O
Blimp1	O
gene1e	O
.	O
Importantly	O
,	O
species1s	O
nude	O
mice	O
species1e	O
developed	O
anti	O
-	O
nuclear	O
Abs	O
when	O
transplanted	O
with	O
gene1s	O
Prdm1	O
gene1e	O
null	O
TECs	O
,	O
but	O
not	O
wild	O
-	O
type	O
TECs	O
,	O
indicating	O
that	O
gene1s	O
Prdm1	O
gene1e	O
functions	O
in	O
TECs	O
to	O
regulate	O
autoantibody	O
production	O
.	O
We	O
show	O
that	O
gene1s	O
Prdm1	O
gene1e	O
acts	O
independently	O
of	O
gene1s	O
Aire	O
gene1e	O
,	O
a	O
crucial	O
transcription	O
factor	O
implicated	O
in	O
medullary	O
TEC	O
function	O
.	O
Collectively	O
,	O
our	O
data	O
highlight	O
a	O
previously	O
unrecognized	O
role	O
for	O
gene1s	O
Prdm1	O
gene1e	O
in	O
regulating	O
thymic	O
epithelial	O
function	O
.	O

gene1s	ARG2
Prdm1	ARG2
gene1e	ARG2
Regulates	O
Thymic	O
Epithelial	O
Function	O
To	O
Prevent	O
Autoimmunity	O
.	O
Autoimmunity	O
is	O
largely	O
prevented	O
by	O
medullary	O
thymic	O
epithelial	O
cells	O
(	O
TECs	O
)	O
through	O
their	O
expression	O
and	O
presentation	O
of	O
tissue	O
-	O
specific	O
Ags	O
to	O
developing	O
thymocytes	O
,	O
resulting	O
in	O
deletion	O
of	O
self	O
-	O
reactive	O
T	O
cells	O
and	O
supporting	O
regulatory	O
T	O
cell	O
development	O
.	O
The	O
transcription	O
factor	O
gene1s	O
Prdm1	O
gene1e	O
has	O
been	O
implicated	O
in	O
autoimmune	O
diseases	O
in	O
species1s	O
humans	O
species1e	O
through	O
genome	O
-	O
wide	O
association	O
studies	O
and	O
in	O
arg1s	O
mice	O
arg1e	O
using	O
cell	O
type	O
-	O
specific	O
deletion	O
of	O
gene1s	ARG2
Prdm1	ARG2
gene1e	ARG2
in	O
T	O
and	O
dendritic	O
cells	O
.	O
In	O
this	O
article	O
,	O
we	O
demonstrate	O
that	O
gene1s	ARG2
Prdm1	ARG2
gene1e	ARG2
functions	O
in	O
TECs	O
to	O
prevent	O
autoimmunity	O
in	O
arg1s	O
mice	O
arg1e	O
.	O
gene1s	ARG2
Prdm1	ARG2
gene1e	ARG2
is	O
expressed	O
by	O
a	O
subset	O
of	O
arg1s	O
mouse	O
arg1e	O
TECs	O
,	O
and	O
conditional	O
deletion	O
of	O
gene1s	ARG2
Prdm1	ARG2
gene1e	ARG2
in	O
either	O
gene1s	ARG2
Keratin	ARG2
14	ARG2
gene1e	ARG2
-	O
or	O
gene1s	ARG2
Foxn1	ARG2
gene1e	ARG2
-expressing	O
cells	O
in	O
arg1s	O
mice	O
arg1e	O
resulted	O
in	O
multisymptom	O
autoimmune	O
pathology	O
.	O
Notably	O
,	O
the	O
development	O
of	O
gene1s	ARG2
Foxp3	ARG2
gene1e	ARG2
(+	O
)	O
regulatory	O
T	O
cells	O
occurs	O
normally	O
in	O
the	O
absence	O
of	O
gene1s	ARG2
Blimp1	ARG2
gene1e	ARG2
.	O
Importantly	O
,	O
arg1s	O
nude	O
mice	O
arg1e	O
developed	O
anti	O
-	O
nuclear	O
Abs	O
when	O
transplanted	O
with	O
gene1s	ARG2
Prdm1	ARG2
gene1e	ARG2
null	O
TECs	O
,	O
but	O
not	O
wild	O
-	O
type	O
TECs	O
,	O
indicating	O
that	O
gene1s	ARG2
Prdm1	ARG2
gene1e	ARG2
functions	O
in	O
TECs	O
to	O
regulate	O
autoantibody	O
production	O
.	O
We	O
show	O
that	O
gene1s	ARG2
Prdm1	ARG2
gene1e	ARG2
acts	O
independently	O
of	O
gene1s	ARG2
Aire	ARG2
gene1e	ARG2
,	O
a	O
crucial	O
transcription	O
factor	O
implicated	O
in	O
medullary	O
TEC	O
function	O
.	O
Collectively	O
,	O
our	O
data	O
highlight	O
a	O
previously	O
unrecognized	O
role	O
for	O
gene1s	ARG2
Prdm1	ARG2
gene1e	ARG2
in	O
regulating	O
thymic	O
epithelial	O
function	O
.	O

gene1s	ARG2
Paxillin	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
embryonic	ARG2
PolyAdenylation	ARG2
Binding	ARG2
Protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ePABP	ARG2
gene1e	ARG2
)	O
engage	O
to	O
regulate	O
androgen	O
-	O
dependent	O
arg1s	O
Xenopus	O
laevis	O
arg1e	O
oocyte	O
maturation	O
-	O
A	O
model	O
of	O
kinase	O
-	O
dependent	O
regulation	O
of	O
protein	O
expression	O
.	O
Steroid	O
-	O
triggered	O
arg1s	O
Xenopus	O
laevis	O
arg1e	O
oocyte	O
maturation	O
is	O
an	O
elegant	O
physiologic	O
model	O
of	O
nongenomic	O
steroid	O
signaling	O
,	O
as	O
it	O
proceeds	O
completely	O
independent	O
of	O
transcription	O
.	O
We	O
previously	O
demonstrated	O
that	O
androgens	O
are	O
the	O
main	O
physiologic	O
stimulator	O
of	O
oocyte	O
maturation	O
in	O
arg1s	O
Xenopus	O
arg1e	O
oocytes	O
,	O
and	O
that	O
the	O
adaptor	O
protein	O
gene1s	ARG2
paxillin	ARG2
gene1e	ARG2
plays	O
a	O
crucial	O
role	O
in	O
mediating	O
this	O
process	O
through	O
a	O
positive	O
feedback	O
loop	O
in	O
which	O
gene1s	ARG2
paxillin	ARG2
gene1e	ARG2
first	O
enhances	O
gene1s	ARG2
Mos	ARG2
gene1e	ARG2
protein	O
translation	O
,	O
ensued	O
by	O
gene1s	ARG2
Erk2	ARG2
gene1e	ARG2
activation	O
and	O
gene1s	ARG2
Erk	ARG2
gene1e	ARG2
-	O
dependent	O
phosphorylation	O
of	O
gene1s	ARG2
paxillin	ARG2
gene1e	ARG2
on	O
serine	O
residues	O
.	O
Phosphoserine	O
-	O
gene1s	ARG2
paxillin	ARG2
gene1e	ARG2
then	O
further	O
augments	O
gene1s	ARG2
Mos	ARG2
gene1e	ARG2
protein	O
translation	O
and	O
downstream	O
gene1s	ARG2
Erk2	ARG2
gene1e	ARG2
activation	O
,	O
resulting	O
in	O
meiotic	O
progression	O
.	O
We	O
hypothesized	O
that	O
gene1s	ARG2
paxillin	ARG2
gene1e	ARG2
enhances	O
gene1s	ARG2
Mos	ARG2
gene1e	ARG2
translation	O
by	O
interacting	O
with	O
gene1s	ARG2
embryonic	ARG2
PolyAdenylation	ARG2
Binding	ARG2
Protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ePABP	ARG2
gene1e	ARG2
)	O
on	O
polyadenylated	O
gene1s	ARG2
Mos	ARG2
gene1e	ARG2
mRNA	O
.	O
Knockdown	O
of	O
gene1s	ARG2
ePABP	ARG2
gene1e	ARG2
phenocopied	O
gene1s	ARG2
paxillin	ARG2
gene1e	ARG2
knockdown	O
,	O
with	O
reduced	O
gene1s	ARG2
Mos	ARG2
gene1e	ARG2
protein	O
expression	O
,	O
gene1s	ARG2
Erk2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Cdk1	ARG2
gene1e	ARG2
activation	O
,	O
as	O
well	O
as	O
oocyte	O
maturation	O
.	O
In	O
both	O
arg1s	O
Xenopus	O
arg1e	O
oocytes	O
and	O
species1s	O
mammalian	O
species1e	O
cells	O
(	O
HEK-293	O
)	O
,	O
gene1s	ARG2
paxillin	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ePABP	ARG2
gene1e	ARG2
constitutively	O
interacted	O
.	O
Testosterone	O
(	O
arg1s	O
Xenopus	O
arg1e	O
)	O
or	O
EGF	O
(	O
HEK-293	O
)	O
augmented	O
gene1s	ARG2
ePABP	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
paxillin	ARG2
gene1e	ARG2
binding	O
,	O
as	O
well	O
as	O
gene1s	ARG2
ePABP	ARG2
gene1e	ARG2
binding	O
to	O
gene1s	ARG2
Mos	ARG2
gene1e	ARG2
mRNA	O
(	O
arg1s	O
Xenopus	O
arg1e	O
)	O
,	O
in	O
an	O
gene1s	ARG2
Erk	ARG2
gene1e	ARG2
-	O
dependent	O
fashion	O
.	O
Thus	O
,	O
gene1s	ARG2
ePABP	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
paxillin	ARG2
gene1e	ARG2
work	O
together	O
in	O
an	O
gene1s	ARG2
Erk	ARG2
gene1e	ARG2
-	O
dependent	O
fashion	O
to	O
enhance	O
gene1s	ARG2
Mos	ARG2
gene1e	ARG2
protein	O
translation	O
and	O
promote	O
oocyte	O
maturation	O
.	O

gene1s	O
Paxillin	O
gene1e	O
and	O
gene1s	O
embryonic	O
PolyAdenylation	O
Binding	O
Protein	O
gene1e	O
(	O
gene1s	O
ePABP	O
gene1e	O
)	O
engage	O
to	O
regulate	O
androgen	O
-	O
dependent	O
species1s	O
Xenopus	O
laevis	O
species1e	O
oocyte	O
maturation	O
-	O
A	O
model	O
of	O
kinase	O
-	O
dependent	O
regulation	O
of	O
protein	O
expression	O
.	O
Steroid	O
-	O
triggered	O
species1s	O
Xenopus	O
laevis	O
species1e	O
oocyte	O
maturation	O
is	O
an	O
elegant	O
physiologic	O
model	O
of	O
nongenomic	O
steroid	O
signaling	O
,	O
as	O
it	O
proceeds	O
completely	O
independent	O
of	O
transcription	O
.	O
We	O
previously	O
demonstrated	O
that	O
androgens	O
are	O
the	O
main	O
physiologic	O
stimulator	O
of	O
oocyte	O
maturation	O
in	O
species1s	O
Xenopus	O
species1e	O
oocytes	O
,	O
and	O
that	O
the	O
adaptor	O
protein	O
gene1s	O
paxillin	O
gene1e	O
plays	O
a	O
crucial	O
role	O
in	O
mediating	O
this	O
process	O
through	O
a	O
positive	O
feedback	O
loop	O
in	O
which	O
gene1s	O
paxillin	O
gene1e	O
first	O
enhances	O
gene1s	O
Mos	O
gene1e	O
protein	O
translation	O
,	O
ensued	O
by	O
gene1s	O
Erk2	O
gene1e	O
activation	O
and	O
gene1s	O
Erk	O
gene1e	O
-	O
dependent	O
phosphorylation	O
of	O
gene1s	O
paxillin	O
gene1e	O
on	O
serine	O
residues	O
.	O
Phosphoserine	O
-	O
gene1s	O
paxillin	O
gene1e	O
then	O
further	O
augments	O
gene1s	O
Mos	O
gene1e	O
protein	O
translation	O
and	O
downstream	O
gene1s	O
Erk2	O
gene1e	O
activation	O
,	O
resulting	O
in	O
meiotic	O
progression	O
.	O
We	O
hypothesized	O
that	O
gene1s	O
paxillin	O
gene1e	O
enhances	O
gene1s	O
Mos	O
gene1e	O
translation	O
by	O
interacting	O
with	O
gene1s	O
embryonic	O
PolyAdenylation	O
Binding	O
Protein	O
gene1e	O
(	O
gene1s	O
ePABP	O
gene1e	O
)	O
on	O
polyadenylated	O
gene1s	O
Mos	O
gene1e	O
mRNA	O
.	O
Knockdown	O
of	O
gene1s	O
ePABP	O
gene1e	O
phenocopied	O
gene1s	O
paxillin	O
gene1e	O
knockdown	O
,	O
with	O
reduced	O
gene1s	O
Mos	O
gene1e	O
protein	O
expression	O
,	O
gene1s	O
Erk2	O
gene1e	O
and	O
gene1s	O
Cdk1	O
gene1e	O
activation	O
,	O
as	O
well	O
as	O
oocyte	O
maturation	O
.	O
In	O
both	O
species1s	O
Xenopus	O
species1e	O
oocytes	O
and	O
arg1s	O
mammalian	O
arg1e	O
cells	O
(	O
HEK-293	O
)	O
,	O
gene1s	O
paxillin	O
gene1e	O
and	O
gene1s	O
ePABP	O
gene1e	O
constitutively	O
interacted	O
.	O
Testosterone	O
(	O
species1s	O
Xenopus	O
species1e	O
)	O
or	O
EGF	O
(	O
HEK-293	O
)	O
augmented	O
gene1s	O
ePABP	O
gene1e	O
-	O
gene1s	O
paxillin	O
gene1e	O
binding	O
,	O
as	O
well	O
as	O
gene1s	O
ePABP	O
gene1e	O
binding	O
to	O
gene1s	O
Mos	O
gene1e	O
mRNA	O
(	O
species1s	O
Xenopus	O
species1e	O
)	O
,	O
in	O
an	O
gene1s	O
Erk	O
gene1e	O
-	O
dependent	O
fashion	O
.	O
Thus	O
,	O
gene1s	O
ePABP	O
gene1e	O
and	O
gene1s	O
paxillin	O
gene1e	O
work	O
together	O
in	O
an	O
gene1s	O
Erk	O
gene1e	O
-	O
dependent	O
fashion	O
to	O
enhance	O
gene1s	O
Mos	O
gene1e	O
protein	O
translation	O
and	O
promote	O
oocyte	O
maturation	O
.	O

gene1s	ARG2
Endothelial	ARG2
NADPH	ARG2
oxidase	ARG2
4	ARG2
gene1e	ARG2
mediates	O
gene1s	ARG2
vascular	ARG2
endothelial	ARG2
growth	ARG2
factor	ARG2
receptor	ARG2
2	ARG2
gene1e	ARG2
-induced	O
intravitreal	O
neovascularization	O
in	O
a	O
arg1s	O
rat	O
arg1e	O
model	O
of	O
retinopathy	O
of	O
prematurity	O
.	O
PURPOSE	O
:	O
gene1s	ARG2
NADPH	ARG2
oxidase	ARG2
gene1e	ARG2
-	O
generated	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
are	O
implicated	O
in	O
angiogenesis	O
.	O
Isoforms	O
of	O
gene1s	ARG2
NADPH	ARG2
oxidase	ARG2
gene1e	ARG2
gene1s	ARG2
NOX1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NOX2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
NOX4	ARG2
gene1e	ARG2
are	O
reported	O
to	O
be	O
expressed	O
in	O
endothelial	O
cells	O
(	O
ECs	O
)	O
.	O
Of	O
these	O
,	O
gene1s	ARG2
NOX1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
NOX2	ARG2
gene1e	ARG2
have	O
been	O
reported	O
to	O
contribute	O
to	O
intravitreal	O
neovascularization	O
(	O
IVNV	O
)	O
in	O
oxygen	O
-	O
induced	O
retinopathy	O
(	O
OIR	O
)	O
models	O
.	O
In	O
this	O
study	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
the	O
isoform	O
gene1s	ARG2
NOX4	ARG2
gene1e	ARG2
in	O
ECs	O
contributed	O
to	O
gene1s	ARG2
vascular	ARG2
endothelial	ARG2
growth	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
)-induced	O
angiogenesis	O
and	O
IVNV	O
.	O
METHODS	O
:	O
Isoforms	O
of	O
gene1s	ARG2
NADPH	ARG2
oxidase	ARG2
gene1e	ARG2
MRNA	O
were	O
measured	O
in	O
several	O
types	O
of	O
cultured	O
vascular	O
ecs	O
:	O
species1s	O
human	O
species1e	O
retinal	O
microvascular	O
ECs	O
(	O
hRMVECs	O
)	O
,	O
choroidal	O
ECs	O
(	O
CECs	O
)	O
,	O
and	O
species1s	O
human	O
species1e	O
umbilical	O
vascular	O
ECs	O
(	O
HUVECs	O
)	O
using	O
real	O
-	O
time	O
PCR	O
.	O
Newborn	O
arg1s	O
rat	O
arg1e	O
pups	O
and	O
dams	O
were	O
placed	O
into	O
an	O
OIR	O
model	O
that	O
cycled	O
oxygen	O
concentration	O
between	O
50	O
%	O
and	O
10	O
%	O
every	O
24	O
h	O
for	O
14	O
days	O
,	O
and	O
then	O
were	O
placed	O
in	O
room	O
air	O
(	O
RA	O
)	O
for	O
an	O
additional	O
4	O
days	O
(	O
arg1s	O
rat	O
arg1e	O
OIR	O
model	O
)	O
.	O
gene1s	ARG2
NOX4	ARG2
gene1e	ARG2
expression	O
in	O
retinal	O
lysates	O
from	O
the	O
RA	O
-	O
raised	O
pups	O
at	O
postnatal	O
day	O
0	O
(	O
P0	O
)	O
,	O
P14	O
,	O
and	O
P18	O
was	O
determined	O
with	O
western	O
blots	O
.	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
activation	O
was	O
determined	O
as	O
the	O
ratio	O
of	O
phosphorylated	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
to	O
total	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
with	O
western	O
blot	O
analysis	O
of	O
retinal	O
lysates	O
from	O
pups	O
raised	O
in	O
RA	O
or	O
from	O
the	O
arg1s	O
rat	O
arg1e	O
OIR	O
model	O
at	O
P18	O
.	O
Semiquantitative	O
assessment	O
of	O
the	O
density	O
of	O
gene1s	ARG2
NOX4	ARG2
gene1e	ARG2
colabeling	O
with	O
lectin	O
-	O
stained	O
retinal	O
ECs	O
was	O
determined	O
by	O
immunolabeling	O
of	O
retinal	O
cryosections	O
from	O
P18	O
pups	O
in	O
OIR	O
or	O
in	O
RA	O
.	O
In	O
hRMVECs	O
transfected	O
with	O
gene1s	O
NOX4	O
gene1e	O
siRNA	O
and	O
treated	O
with	O
gene1s	O
VEGF	O
gene1e	O
or	O
control	O
,	O
1	O
)	O
ROS	O
generation	O
was	O
measured	O
using	O
the	O
5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein	O
diacetate	O
,	O
acetyl	O
ester	O
fluorescence	O
assay	O
and	O
2	O
)	O
phosphorylated	O
gene1s	O
VEGF	O
receptor	O
2	O
gene1e	O
and	O
gene1s	O
STAT3	O
gene1e	O
,	O
and	O
total	O
gene1s	O
VEGFR2	O
gene1e	O
and	O
gene1s	O
STAT3	O
gene1e	O
were	O
measured	O
in	O
western	O
blot	O
analyses	O
.	O
gene1s	O
VEGF	O
gene1e	O
-	O
stimulated	O
hRMVEC	O
proliferation	O
was	O
measured	O
following	O
transfection	O
with	O
gene1s	O
NOX4	O
gene1e	O
siRNA	O
or	O
gene1s	O
STAT3	O
gene1e	O
siRNA	O
,	O
or	O
respective	O
controls	O
.	O
RESULTS	O
:	O
gene1s	O
NOX4	O
gene1e	O
was	O
the	O
most	O
prevalent	O
isoform	O
of	O
gene1s	ARG2
NADPH	ARG2
oxidase	ARG2
gene1e	ARG2
in	O
vascular	O
ECs	O
.	O
gene1s	ARG2
NOX4	ARG2
gene1e	ARG2
expression	O
in	O
retinal	O
lysates	O
was	O
significantly	O
decreased	O
during	O
development	O
in	O
RA	O
.	O
Compared	O
to	O
RA	O
,	O
the	O
expression	O
of	O
retinal	O
gene1s	ARG2
NOX4	ARG2
gene1e	ARG2
increased	O
at	O
P18	O
.	O
At	O
p18	O
OIR	O
,	O
semiquantitative	O
assessment	O
of	O
the	O
density	O
of	O
lectin	O
and	O
gene1s	ARG2
NOX4	ARG2
gene1e	ARG2
colabeling	O
in	O
retinal	O
vascular	O
ECs	O
was	O
greater	O
in	O
retinal	O
cryosections	O
and	O
activated	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
was	O
greater	O
in	O
retinal	O
lysates	O
when	O
compared	O
to	O
the	O
RA	O
-	O
raised	O
pups	O
.	O
In	O
cultured	O
hRMVECs	O
,	O
knockdown	O
of	O
gene1s	O
NOX4	O
gene1e	O
by	O
siRNA	O
transfection	O
inhibited	O
gene1s	O
VEGF	O
gene1e	O
-	O
induced	O
ROS	O
generation	O
.	O
gene1s	O
VEGF	O
gene1e	O
induced	O
a	O
physical	O
interaction	O
of	O
phosphorylated	O
-	O
gene1s	O
VEGFR2	O
gene1e	O
and	O
gene1s	O
NOX4	O
gene1e	O
.	O
Knockdown	O
of	O
gene1s	O
NOX4	O
gene1e	O
:	O
1	O
)	O
reduced	O
gene1s	O
VEGFR2	O
gene1e	O
activation	O
but	O
did	O
not	O
abolish	O
it	O
and	O
2	O
)	O
abolished	O
gene1s	O
STAT3	O
gene1e	O
activation	O
in	O
response	O
to	O
gene1s	O
VEGF	O
gene1e	O
.	O
Knockdown	O
of	O
either	O
gene1s	O
NOX4	O
gene1e	O
or	O
gene1s	O
STAT3	O
gene1e	O
inhibited	O
gene1s	O
VEGF	O
gene1e	O
-	O
induced	O
EC	O
proliferation	O
.	O
CONCLUSIONS	O
:	O
Our	O
data	O
suggest	O
that	O
in	O
a	O
model	O
representative	O
of	O
species1s	O
human	O
species1e	O
retinopathy	O
of	O
prematurity	O
,	O
gene1s	ARG2
NOX4	ARG2
gene1e	ARG2
was	O
increased	O
at	O
a	O
time	O
point	O
when	O
IVNV	O
developed	O
.	O
gene1s	O
VEGF	O
gene1e	O
-	O
activated	O
gene1s	O
NOX4	O
gene1e	O
led	O
to	O
an	O
interaction	O
between	O
gene1s	O
VEGF	O
gene1e	O
-	O
activated	O
gene1s	O
VEGFR2	O
gene1e	O
and	O
gene1s	O
NOX4	O
gene1e	O
that	O
mediated	O
EC	O
proliferation	O
via	O
activation	O
of	O
gene1s	O
STAT3	O
gene1e	O
.	O
Altogether	O
,	O
our	O
results	O
suggest	O
that	O
gene1s	ARG2
NOX4	ARG2
gene1e	ARG2
may	O
regulate	O
gene1s	ARG2
VEGFR2	ARG2
gene1e	ARG2
-mediated	O
IVNV	O
through	O
activated	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
.	O

gene1s	O
Endothelial	O
NADPH	O
oxidase	O
4	O
gene1e	O
mediates	O
gene1s	O
vascular	O
endothelial	O
growth	O
factor	O
receptor	O
2	O
gene1e	O
-induced	O
intravitreal	O
neovascularization	O
in	O
a	O
species1s	O
rat	O
species1e	O
model	O
of	O
retinopathy	O
of	O
prematurity	O
.	O
PURPOSE	O
:	O
gene1s	ARG2
NADPH	ARG2
oxidase	ARG2
gene1e	ARG2
-	O
generated	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
are	O
implicated	O
in	O
angiogenesis	O
.	O
Isoforms	O
of	O
gene1s	ARG2
NADPH	ARG2
oxidase	ARG2
gene1e	ARG2
gene1s	O
NOX1	O
gene1e	O
,	O
gene1s	O
NOX2	O
gene1e	O
,	O
and	O
gene1s	O
NOX4	O
gene1e	O
are	O
reported	O
to	O
be	O
expressed	O
in	O
endothelial	O
cells	O
(	O
ECs	O
)	O
.	O
Of	O
these	O
,	O
gene1s	O
NOX1	O
gene1e	O
and	O
gene1s	O
NOX2	O
gene1e	O
have	O
been	O
reported	O
to	O
contribute	O
to	O
intravitreal	O
neovascularization	O
(	O
IVNV	O
)	O
in	O
oxygen	O
-	O
induced	O
retinopathy	O
(	O
OIR	O
)	O
models	O
.	O
In	O
this	O
study	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
the	O
isoform	O
gene1s	O
NOX4	O
gene1e	O
in	O
ECs	O
contributed	O
to	O
gene1s	O
vascular	O
endothelial	O
growth	O
factor	O
gene1e	O
(	O
gene1s	O
VEGF	O
gene1e	O
)-induced	O
angiogenesis	O
and	O
IVNV	O
.	O
METHODS	O
:	O
Isoforms	O
of	O
gene1s	ARG2
NADPH	ARG2
oxidase	ARG2
gene1e	ARG2
MRNA	O
were	O
measured	O
in	O
several	O
types	O
of	O
cultured	O
vascular	O
ecs	O
:	O
arg1s	O
human	O
arg1e	O
retinal	O
microvascular	O
ECs	O
(	O
hRMVECs	O
)	O
,	O
choroidal	O
ECs	O
(	O
CECs	O
)	O
,	O
and	O
arg1s	O
human	O
arg1e	O
umbilical	O
vascular	O
ECs	O
(	O
HUVECs	O
)	O
using	O
real	O
-	O
time	O
PCR	O
.	O
Newborn	O
species1s	O
rat	O
species1e	O
pups	O
and	O
dams	O
were	O
placed	O
into	O
an	O
OIR	O
model	O
that	O
cycled	O
oxygen	O
concentration	O
between	O
50	O
%	O
and	O
10	O
%	O
every	O
24	O
h	O
for	O
14	O
days	O
,	O
and	O
then	O
were	O
placed	O
in	O
room	O
air	O
(	O
RA	O
)	O
for	O
an	O
additional	O
4	O
days	O
(	O
species1s	O
rat	O
species1e	O
OIR	O
model	O
)	O
.	O
gene1s	O
NOX4	O
gene1e	O
expression	O
in	O
retinal	O
lysates	O
from	O
the	O
RA	O
-	O
raised	O
pups	O
at	O
postnatal	O
day	O
0	O
(	O
P0	O
)	O
,	O
P14	O
,	O
and	O
P18	O
was	O
determined	O
with	O
western	O
blots	O
.	O
gene1s	O
STAT3	O
gene1e	O
activation	O
was	O
determined	O
as	O
the	O
ratio	O
of	O
phosphorylated	O
gene1s	O
STAT3	O
gene1e	O
to	O
total	O
gene1s	O
STAT3	O
gene1e	O
with	O
western	O
blot	O
analysis	O
of	O
retinal	O
lysates	O
from	O
pups	O
raised	O
in	O
RA	O
or	O
from	O
the	O
species1s	O
rat	O
species1e	O
OIR	O
model	O
at	O
P18	O
.	O
Semiquantitative	O
assessment	O
of	O
the	O
density	O
of	O
gene1s	O
NOX4	O
gene1e	O
colabeling	O
with	O
lectin	O
-	O
stained	O
retinal	O
ECs	O
was	O
determined	O
by	O
immunolabeling	O
of	O
retinal	O
cryosections	O
from	O
P18	O
pups	O
in	O
OIR	O
or	O
in	O
RA	O
.	O
In	O
hRMVECs	O
transfected	O
with	O
gene1s	ARG2
NOX4	ARG2
gene1e	ARG2
siRNA	O
and	O
treated	O
with	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
or	O
control	O
,	O
1	O
)	O
ROS	O
generation	O
was	O
measured	O
using	O
the	O
5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein	O
diacetate	O
,	O
acetyl	O
ester	O
fluorescence	O
assay	O
and	O
2	O
)	O
phosphorylated	O
gene1s	ARG2
VEGF	ARG2
receptor	ARG2
2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
,	O
and	O
total	O
gene1s	ARG2
VEGFR2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
were	O
measured	O
in	O
western	O
blot	O
analyses	O
.	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
-	O
stimulated	O
hRMVEC	O
proliferation	O
was	O
measured	O
following	O
transfection	O
with	O
gene1s	ARG2
NOX4	ARG2
gene1e	ARG2
siRNA	O
or	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
siRNA	O
,	O
or	O
respective	O
controls	O
.	O
RESULTS	O
:	O
gene1s	ARG2
NOX4	ARG2
gene1e	ARG2
was	O
the	O
most	O
prevalent	O
isoform	O
of	O
gene1s	ARG2
NADPH	ARG2
oxidase	ARG2
gene1e	ARG2
in	O
vascular	O
ECs	O
.	O
gene1s	O
NOX4	O
gene1e	O
expression	O
in	O
retinal	O
lysates	O
was	O
significantly	O
decreased	O
during	O
development	O
in	O
RA	O
.	O
Compared	O
to	O
RA	O
,	O
the	O
expression	O
of	O
retinal	O
gene1s	O
NOX4	O
gene1e	O
increased	O
at	O
P18	O
.	O
At	O
p18	O
OIR	O
,	O
semiquantitative	O
assessment	O
of	O
the	O
density	O
of	O
lectin	O
and	O
gene1s	O
NOX4	O
gene1e	O
colabeling	O
in	O
retinal	O
vascular	O
ECs	O
was	O
greater	O
in	O
retinal	O
cryosections	O
and	O
activated	O
gene1s	O
STAT3	O
gene1e	O
was	O
greater	O
in	O
retinal	O
lysates	O
when	O
compared	O
to	O
the	O
RA	O
-	O
raised	O
pups	O
.	O
In	O
cultured	O
hRMVECs	O
,	O
knockdown	O
of	O
gene1s	ARG2
NOX4	ARG2
gene1e	ARG2
by	O
siRNA	O
transfection	O
inhibited	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
-	O
induced	O
ROS	O
generation	O
.	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
induced	O
a	O
physical	O
interaction	O
of	O
phosphorylated	O
-	O
gene1s	ARG2
VEGFR2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
NOX4	ARG2
gene1e	ARG2
.	O
Knockdown	O
of	O
gene1s	ARG2
NOX4	ARG2
gene1e	ARG2
:	O
1	O
)	O
reduced	O
gene1s	ARG2
VEGFR2	ARG2
gene1e	ARG2
activation	O
but	O
did	O
not	O
abolish	O
it	O
and	O
2	O
)	O
abolished	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
activation	O
in	O
response	O
to	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
.	O
Knockdown	O
of	O
either	O
gene1s	ARG2
NOX4	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
inhibited	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
-	O
induced	O
EC	O
proliferation	O
.	O
CONCLUSIONS	O
:	O
Our	O
data	O
suggest	O
that	O
in	O
a	O
model	O
representative	O
of	O
arg1s	O
human	O
arg1e	O
retinopathy	O
of	O
prematurity	O
,	O
gene1s	O
NOX4	O
gene1e	O
was	O
increased	O
at	O
a	O
time	O
point	O
when	O
IVNV	O
developed	O
.	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
-	O
activated	O
gene1s	ARG2
NOX4	ARG2
gene1e	ARG2
led	O
to	O
an	O
interaction	O
between	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
-	O
activated	O
gene1s	ARG2
VEGFR2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
NOX4	ARG2
gene1e	ARG2
that	O
mediated	O
EC	O
proliferation	O
via	O
activation	O
of	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
.	O
Altogether	O
,	O
our	O
results	O
suggest	O
that	O
gene1s	O
NOX4	O
gene1e	O
may	O
regulate	O
gene1s	O
VEGFR2	O
gene1e	O
-mediated	O
IVNV	O
through	O
activated	O
gene1s	O
STAT3	O
gene1e	O
.	O

Two	O
Distinct	O
gene1s	ARG2
Cdc2	ARG2
gene1e	ARG2
Pools	O
Regulate	O
Cell	O
Cycle	O
Progression	O
and	O
the	O
DNA	O
Damage	O
Response	O
in	O
the	O
arg1s	O
Fission	O
Yeast	O
arg1e	O
arg1s	O
S.pombe	O
arg1e	O
.	O
The	O
activity	O
of	O
gene1s	ARG2
Cdc2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CDK1	ARG2
gene1e	ARG2
)	O
kinase	O
,	O
which	O
coordinates	O
cell	O
cycle	O
progression	O
and	O
DNA	O
break	O
repair	O
,	O
is	O
blocked	O
upon	O
its	O
phosphorylation	O
at	O
tyrosine	O
15	O
(	O
Y15	O
)	O
by	O
gene1s	ARG2
Wee1	ARG2
gene1e	ARG2
kinase	O
in	O
the	O
presence	O
of	O
DNA	O
damage	O
.	O
How	O
gene1s	ARG2
Cdc2	ARG2
gene1e	ARG2
can	O
support	O
DNA	O
repair	O
whilst	O
being	O
inactivated	O
by	O
the	O
DNA	O
damage	O
checkpoint	O
remains	O
to	O
be	O
explained	O
.	O
species1s	O
Human	O
species1e	O
gene1s	O
CDK1	O
gene1e	O
is	O
phosphorylated	O
by	O
gene1s	O
Myt1	O
gene1e	O
kinase	O
at	O
threonine	O
14	O
(	O
T14	O
)	O
close	O
to	O
its	O
ATP	O
binding	O
site	O
before	O
being	O
modified	O
at	O
threonine	O
161	O
(	O
T167Sp	O
)	O
in	O
its	O
T	O
-	O
loop	O
by	O
the	O
gene1s	O
CDK	O
-	O
activating	O
kinase	O
gene1e	O
(	O
gene1s	O
CAK	O
gene1e	O
)	O
.	O
While	O
modification	O
of	O
T161	O
promotes	O
association	O
with	O
the	O
cyclin	O
partner	O
,	O
phosphorylation	O
of	O
T14	O
inhibits	O
the	O
gene1s	O
CDK1	O
gene1e	O
-	O
gene1s	O
cyclin	O
gene1e	O
complex	O
.	O
This	O
inhibition	O
is	O
further	O
enforced	O
by	O
the	O
modification	O
of	O
Y15	O
by	O
gene1s	O
Wee1	O
gene1e	O
in	O
the	O
presence	O
of	O
DNA	O
lesions	O
.	O
In	O
arg1s	O
S.pombe	O
arg1e	O
,	O
the	O
dominant	O
inhibition	O
of	O
gene1s	ARG2
Cdc2	ARG2
gene1e	ARG2
is	O
provided	O
by	O
the	O
phosphorylation	O
of	O
Y15	O
and	O
only	O
a	O
small	O
amount	O
of	O
gene1s	ARG2
Cdc2	ARG2
gene1e	ARG2
is	O
modified	O
at	O
T14	O
when	O
cells	O
are	O
in	O
S	O
phase	O
.	O
Unlike	O
species1s	O
human	O
species1e	O
cells	O
,	O
both	O
inhibitory	O
modifications	O
are	O
executed	O
by	O
gene1s	ARG2
Wee1	ARG2
gene1e	ARG2
.	O
Using	O
the	O
novel	O
IEFPT	O
technology	O
,	O
which	O
combines	O
isoelectric	O
focusing	O
(	O
IEF	O
)	O
with	O
Phos	O
-	O
tag	O
SDS	O
electrophoresis	O
(	O
PT	O
)	O
,	O
we	O
report	O
here	O
that	O
arg1s	O
S.pombe	O
arg1e	O
gene1s	ARG2
Cdc2	ARG2
gene1e	ARG2
kinase	O
exists	O
in	O
seven	O
forms	O
.	O
While	O
five	O
forms	O
are	O
phosphorylated	O
,	O
two	O
species	O
are	O
not	O
.	O
Four	O
phospho	O
-	O
forms	O
associate	O
with	O
gene1s	ARG2
cyclin	ARG2
B	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Cdc13	ARG2
gene1e	ARG2
)	O
of	O
which	O
only	O
two	O
are	O
modified	O
at	O
Y15	O
by	O
gene1s	ARG2
Wee1	ARG2
gene1e	ARG2
.	O
Interestingly	O
,	O
only	O
one	O
Y15-modified	O
species	O
carries	O
also	O
the	O
T14	O
modification	O
.	O
The	O
fifth	O
phospho	O
-	O
form	O
has	O
a	O
low	O
affinity	O
for	O
gene1s	ARG2
cyclin	ARG2
B	ARG2
gene1e	ARG2
and	O
is	O
neither	O
Y15	O
nor	O
T14	O
modified	O
.	O
The	O
two	O
unphosphorylated	O
forms	O
may	O
contribute	O
directly	O
to	O
the	O
DNA	O
damage	O
response	O
as	O
only	O
they	O
associate	O
with	O
the	O
DNA	O
damage	O
gene1s	ARG2
checkpoint	ARG2
kinase	ARG2
gene1e	ARG2
gene1s	ARG2
Chk1	ARG2
gene1e	ARG2
.	O
Interestingly	O
,	O
gene1s	ARG2
cyclin	ARG2
B	ARG2
gene1e	ARG2
is	O
also	O
present	O
in	O
the	O
unphosphorylated	O
pool	O
.	O
We	O
also	O
show	O
that	O
the	O
G146D	O
mutation	O
in	O
gene1s	ARG2
Cdc2	ARG2
gene1e	ARG2
.1w	O
,	O
which	O
renders	O
gene1s	ARG2
Cdc2	ARG2
gene1e	ARG2
insensitive	O
to	O
gene1s	ARG2
Wee1	ARG2
gene1e	ARG2
inhibition	O
,	O
is	O
aberrantly	O
modified	O
in	O
a	O
gene1s	ARG2
Wee1	ARG2
gene1e	ARG2
-dependent	O
manner	O
.	O
In	O
conclusion	O
,	O
our	O
work	O
adds	O
support	O
to	O
the	O
idea	O
that	O
two	O
distinct	O
gene1s	ARG2
Cdc2	ARG2
gene1e	ARG2
pools	O
regulate	O
cell	O
cycle	O
progression	O
and	O
the	O
response	O
to	O
DNA	O
damage	O
.	O

Two	O
Distinct	O
gene1s	O
Cdc2	O
gene1e	O
Pools	O
Regulate	O
Cell	O
Cycle	O
Progression	O
and	O
the	O
DNA	O
Damage	O
Response	O
in	O
the	O
species1s	O
Fission	O
Yeast	O
species1e	O
species1s	O
S.pombe	O
species1e	O
.	O
The	O
activity	O
of	O
gene1s	O
Cdc2	O
gene1e	O
(	O
gene1s	O
CDK1	O
gene1e	O
)	O
kinase	O
,	O
which	O
coordinates	O
cell	O
cycle	O
progression	O
and	O
DNA	O
break	O
repair	O
,	O
is	O
blocked	O
upon	O
its	O
phosphorylation	O
at	O
tyrosine	O
15	O
(	O
Y15	O
)	O
by	O
gene1s	O
Wee1	O
gene1e	O
kinase	O
in	O
the	O
presence	O
of	O
DNA	O
damage	O
.	O
How	O
gene1s	O
Cdc2	O
gene1e	O
can	O
support	O
DNA	O
repair	O
whilst	O
being	O
inactivated	O
by	O
the	O
DNA	O
damage	O
checkpoint	O
remains	O
to	O
be	O
explained	O
.	O
arg1s	O
Human	O
arg1e	O
gene1s	ARG2
CDK1	ARG2
gene1e	ARG2
is	O
phosphorylated	O
by	O
gene1s	ARG2
Myt1	ARG2
gene1e	ARG2
kinase	O
at	O
threonine	O
14	O
(	O
T14	O
)	O
close	O
to	O
its	O
ATP	O
binding	O
site	O
before	O
being	O
modified	O
at	O
threonine	O
161	O
(	O
T167Sp	O
)	O
in	O
its	O
T	O
-	O
loop	O
by	O
the	O
gene1s	ARG2
CDK	ARG2
-	ARG2
activating	ARG2
kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CAK	ARG2
gene1e	ARG2
)	O
.	O
While	O
modification	O
of	O
T161	O
promotes	O
association	O
with	O
the	O
cyclin	O
partner	O
,	O
phosphorylation	O
of	O
T14	O
inhibits	O
the	O
gene1s	ARG2
CDK1	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
cyclin	ARG2
gene1e	ARG2
complex	O
.	O
This	O
inhibition	O
is	O
further	O
enforced	O
by	O
the	O
modification	O
of	O
Y15	O
by	O
gene1s	ARG2
Wee1	ARG2
gene1e	ARG2
in	O
the	O
presence	O
of	O
DNA	O
lesions	O
.	O
In	O
species1s	O
S.pombe	O
species1e	O
,	O
the	O
dominant	O
inhibition	O
of	O
gene1s	O
Cdc2	O
gene1e	O
is	O
provided	O
by	O
the	O
phosphorylation	O
of	O
Y15	O
and	O
only	O
a	O
small	O
amount	O
of	O
gene1s	O
Cdc2	O
gene1e	O
is	O
modified	O
at	O
T14	O
when	O
cells	O
are	O
in	O
S	O
phase	O
.	O
Unlike	O
arg1s	O
human	O
arg1e	O
cells	O
,	O
both	O
inhibitory	O
modifications	O
are	O
executed	O
by	O
gene1s	O
Wee1	O
gene1e	O
.	O
Using	O
the	O
novel	O
IEFPT	O
technology	O
,	O
which	O
combines	O
isoelectric	O
focusing	O
(	O
IEF	O
)	O
with	O
Phos	O
-	O
tag	O
SDS	O
electrophoresis	O
(	O
PT	O
)	O
,	O
we	O
report	O
here	O
that	O
species1s	O
S.pombe	O
species1e	O
gene1s	O
Cdc2	O
gene1e	O
kinase	O
exists	O
in	O
seven	O
forms	O
.	O
While	O
five	O
forms	O
are	O
phosphorylated	O
,	O
two	O
species	O
are	O
not	O
.	O
Four	O
phospho	O
-	O
forms	O
associate	O
with	O
gene1s	O
cyclin	O
B	O
gene1e	O
(	O
gene1s	O
Cdc13	O
gene1e	O
)	O
of	O
which	O
only	O
two	O
are	O
modified	O
at	O
Y15	O
by	O
gene1s	O
Wee1	O
gene1e	O
.	O
Interestingly	O
,	O
only	O
one	O
Y15-modified	O
species	O
carries	O
also	O
the	O
T14	O
modification	O
.	O
The	O
fifth	O
phospho	O
-	O
form	O
has	O
a	O
low	O
affinity	O
for	O
gene1s	O
cyclin	O
B	O
gene1e	O
and	O
is	O
neither	O
Y15	O
nor	O
T14	O
modified	O
.	O
The	O
two	O
unphosphorylated	O
forms	O
may	O
contribute	O
directly	O
to	O
the	O
DNA	O
damage	O
response	O
as	O
only	O
they	O
associate	O
with	O
the	O
DNA	O
damage	O
gene1s	O
checkpoint	O
kinase	O
gene1e	O
gene1s	O
Chk1	O
gene1e	O
.	O
Interestingly	O
,	O
gene1s	O
cyclin	O
B	O
gene1e	O
is	O
also	O
present	O
in	O
the	O
unphosphorylated	O
pool	O
.	O
We	O
also	O
show	O
that	O
the	O
G146D	O
mutation	O
in	O
gene1s	O
Cdc2	O
gene1e	O
.1w	O
,	O
which	O
renders	O
gene1s	O
Cdc2	O
gene1e	O
insensitive	O
to	O
gene1s	O
Wee1	O
gene1e	O
inhibition	O
,	O
is	O
aberrantly	O
modified	O
in	O
a	O
gene1s	O
Wee1	O
gene1e	O
-dependent	O
manner	O
.	O
In	O
conclusion	O
,	O
our	O
work	O
adds	O
support	O
to	O
the	O
idea	O
that	O
two	O
distinct	O
gene1s	O
Cdc2	O
gene1e	O
pools	O
regulate	O
cell	O
cycle	O
progression	O
and	O
the	O
response	O
to	O
DNA	O
damage	O
.	O

gene1s	ARG2
CD38	ARG2
gene1e	ARG2
promotes	O
gene1s	ARG2
angiotensin	ARG2
II	ARG2
gene1e	ARG2
-	O
induced	O
cardiac	O
hypertrophy	O
.	O
Cardiac	O
hypertrophy	O
is	O
an	O
early	O
hallmark	O
during	O
the	O
clinical	O
course	O
of	O
heart	O
failure	O
and	O
regulated	O
by	O
various	O
signalling	O
pathways	O
.	O
Recently	O
,	O
we	O
observed	O
that	O
arg1s	O
mouse	O
arg1e	O
embryonic	O
fibroblasts	O
from	O
gene1s	ARG2
CD38	ARG2
gene1e	ARG2
knockout	O
arg1s	O
mice	O
arg1e	O
were	O
significantly	O
resistant	O
to	O
oxidative	O
stress	O
such	O
as	O
H2	O
O2	O
-induced	O
injury	O
and	O
hypoxia	O
/	O
reoxygenation	O
-	O
induced	O
injury	O
.	O
In	O
addition	O
,	O
we	O
also	O
found	O
that	O
gene1s	ARG2
CD38	ARG2
gene1e	ARG2
knockout	O
arg1s	O
mice	O
arg1e	O
protected	O
heart	O
from	O
ischaemia	O
reperfusion	O
injury	O
through	O
activating	O
gene1s	ARG2
SIRT1	ARG2
gene1e	ARG2
/	O
FOXOs	O
-	O
mediated	O
antioxidative	O
stress	O
pathway	O
.	O
However	O
,	O
the	O
role	O
of	O
gene1s	ARG2
CD38	ARG2
gene1e	ARG2
in	O
cardiac	O
hypertrophy	O
is	O
not	O
explored	O
.	O
Here	O
,	O
we	O
investigated	O
the	O
roles	O
and	O
mechanisms	O
of	O
gene1s	ARG2
CD38	ARG2
gene1e	ARG2
in	O
gene1s	ARG2
angiotensin	ARG2
II	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Ang	ARG2
-	ARG2
II	ARG2
gene1e	ARG2
)-induced	O
cardiac	O
hypertrophy	O
.	O
Following	O
14	O
days	O
of	O
gene1s	ARG2
Ang	ARG2
-	ARG2
II	ARG2
gene1e	ARG2
infusion	O
with	O
osmotic	O
mini	O
-	O
pumps	O
,	O
a	O
comparable	O
hypertension	O
was	O
generated	O
in	O
both	O
of	O
gene1s	ARG2
CD38	ARG2
gene1e	ARG2
knockout	O
and	O
wild	O
-	O
type	O
arg1s	O
mice	O
arg1e	O
.	O
However	O
,	O
the	O
cardiac	O
hypertrophy	O
and	O
fibrosis	O
were	O
much	O
more	O
severe	O
in	O
wild	O
-	O
type	O
arg1s	O
mice	O
arg1e	O
compared	O
with	O
gene1s	ARG2
CD38	ARG2
gene1e	ARG2
knockout	O
arg1s	O
mice	O
arg1e	O
.	O
Consistently	O
,	O
RNAi	O
-	O
induced	O
knockdown	O
of	O
gene1s	O
CD38	O
gene1e	O
decreased	O
the	O
gene	O
expressions	O
of	O
gene1s	O
atrial	O
natriuretic	O
factor	O
gene1e	O
(	O
gene1s	O
ANF	O
gene1e	O
)	O
and	O
gene1s	O
brain	O
natriuretic	O
peptide	O
gene1e	O
(	O
gene1s	O
BNP	O
gene1e	O
)	O
and	O
reactive	O
oxygen	O
species	O
generation	O
in	O
gene1s	ARG2
Ang	ARG2
-	ARG2
II	ARG2
gene1e	ARG2
-	O
stimulated	O
species1s	O
H9c2	O
species1e	O
cells	O
.	O
In	O
addition	O
,	O
the	O
expression	O
of	O
gene1s	O
SIRT3	O
gene1e	O
was	O
elevated	O
in	O
gene1s	O
CD38	O
gene1e	O
knockdown	O
species1s	O
H9c2	O
species1e	O
cells	O
,	O
in	O
which	O
gene1s	O
SIRT3	O
gene1e	O
may	O
further	O
activate	O
the	O
gene1s	O
FOXO3	O
gene1e	O
antioxidant	O
pathway	O
.	O
The	O
intracellular	O
Ca(2	O
+	O
)	O
release	O
induced	O
by	O
gene1s	ARG2
Ang	ARG2
-	ARG2
II	ARG2
gene1e	ARG2
markedly	O
decreased	O
in	O
gene1s	O
CD38	O
gene1e	O
knockdown	O
species1s	O
H9c2	O
species1e	O
cells	O
,	O
which	O
might	O
be	O
associated	O
with	O
the	O
decrease	O
of	O
nuclear	O
translocation	O
of	O
gene1s	O
NFATc4	O
gene1e	O
and	O
inhibition	O
of	O
gene1s	O
ERK	O
gene1e	O
/	O
AKT	O
phosphorylation	O
.	O
We	O
concluded	O
that	O
gene1s	ARG2
CD38	ARG2
gene1e	ARG2
plays	O
an	O
essential	O
role	O
in	O
cardiac	O
hypertrophy	O
probably	O
via	O
inhibition	O
of	O
gene1s	O
SIRT3	O
gene1e	O
expression	O
and	O
activation	O
of	O
Ca(2	O
+	O
)	O
-	O
gene1s	O
NFAT	O
gene1e	O
signalling	O
pathway	O
.	O
Thus	O
,	O
gene1s	ARG2
CD38	ARG2
gene1e	ARG2
may	O
be	O
a	O
novel	O
target	O
for	O
treating	O
cardiac	O
hypertrophy	O
.	O

gene1s	ARG2
CD38	ARG2
gene1e	ARG2
promotes	O
gene1s	O
angiotensin	O
II	O
gene1e	O
-	O
induced	O
cardiac	O
hypertrophy	O
.	O
Cardiac	O
hypertrophy	O
is	O
an	O
early	O
hallmark	O
during	O
the	O
clinical	O
course	O
of	O
heart	O
failure	O
and	O
regulated	O
by	O
various	O
signalling	O
pathways	O
.	O
Recently	O
,	O
we	O
observed	O
that	O
species1s	O
mouse	O
species1e	O
embryonic	O
fibroblasts	O
from	O
gene1s	O
CD38	O
gene1e	O
knockout	O
species1s	O
mice	O
species1e	O
were	O
significantly	O
resistant	O
to	O
oxidative	O
stress	O
such	O
as	O
H2	O
O2	O
-induced	O
injury	O
and	O
hypoxia	O
/	O
reoxygenation	O
-	O
induced	O
injury	O
.	O
In	O
addition	O
,	O
we	O
also	O
found	O
that	O
gene1s	O
CD38	O
gene1e	O
knockout	O
species1s	O
mice	O
species1e	O
protected	O
heart	O
from	O
ischaemia	O
reperfusion	O
injury	O
through	O
activating	O
gene1s	O
SIRT1	O
gene1e	O
/	O
FOXOs	O
-	O
mediated	O
antioxidative	O
stress	O
pathway	O
.	O
However	O
,	O
the	O
role	O
of	O
gene1s	O
CD38	O
gene1e	O
in	O
cardiac	O
hypertrophy	O
is	O
not	O
explored	O
.	O
Here	O
,	O
we	O
investigated	O
the	O
roles	O
and	O
mechanisms	O
of	O
gene1s	ARG2
CD38	ARG2
gene1e	ARG2
in	O
gene1s	O
angiotensin	O
II	O
gene1e	O
(	O
gene1s	O
Ang	O
-	O
II	O
gene1e	O
)-induced	O
cardiac	O
hypertrophy	O
.	O
Following	O
14	O
days	O
of	O
gene1s	O
Ang	O
-	O
II	O
gene1e	O
infusion	O
with	O
osmotic	O
mini	O
-	O
pumps	O
,	O
a	O
comparable	O
hypertension	O
was	O
generated	O
in	O
both	O
of	O
gene1s	O
CD38	O
gene1e	O
knockout	O
and	O
wild	O
-	O
type	O
species1s	O
mice	O
species1e	O
.	O
However	O
,	O
the	O
cardiac	O
hypertrophy	O
and	O
fibrosis	O
were	O
much	O
more	O
severe	O
in	O
wild	O
-	O
type	O
species1s	O
mice	O
species1e	O
compared	O
with	O
gene1s	O
CD38	O
gene1e	O
knockout	O
species1s	O
mice	O
species1e	O
.	O
Consistently	O
,	O
RNAi	O
-	O
induced	O
knockdown	O
of	O
gene1s	ARG2
CD38	ARG2
gene1e	ARG2
decreased	O
the	O
gene	O
expressions	O
of	O
gene1s	ARG2
atrial	ARG2
natriuretic	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ANF	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
brain	ARG2
natriuretic	ARG2
peptide	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
BNP	ARG2
gene1e	ARG2
)	O
and	O
reactive	O
oxygen	O
species	O
generation	O
in	O
gene1s	O
Ang	O
-	O
II	O
gene1e	O
-	O
stimulated	O
arg1s	O
H9c2	O
arg1e	O
cells	O
.	O
In	O
addition	O
,	O
the	O
expression	O
of	O
gene1s	ARG2
SIRT3	ARG2
gene1e	ARG2
was	O
elevated	O
in	O
gene1s	ARG2
CD38	ARG2
gene1e	ARG2
knockdown	O
arg1s	O
H9c2	O
arg1e	O
cells	O
,	O
in	O
which	O
gene1s	ARG2
SIRT3	ARG2
gene1e	ARG2
may	O
further	O
activate	O
the	O
gene1s	ARG2
FOXO3	ARG2
gene1e	ARG2
antioxidant	O
pathway	O
.	O
The	O
intracellular	O
Ca(2	O
+	O
)	O
release	O
induced	O
by	O
gene1s	O
Ang	O
-	O
II	O
gene1e	O
markedly	O
decreased	O
in	O
gene1s	ARG2
CD38	ARG2
gene1e	ARG2
knockdown	O
arg1s	O
H9c2	O
arg1e	O
cells	O
,	O
which	O
might	O
be	O
associated	O
with	O
the	O
decrease	O
of	O
nuclear	O
translocation	O
of	O
gene1s	ARG2
NFATc4	ARG2
gene1e	ARG2
and	O
inhibition	O
of	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
/	O
AKT	O
phosphorylation	O
.	O
We	O
concluded	O
that	O
gene1s	O
CD38	O
gene1e	O
plays	O
an	O
essential	O
role	O
in	O
cardiac	O
hypertrophy	O
probably	O
via	O
inhibition	O
of	O
gene1s	ARG2
SIRT3	ARG2
gene1e	ARG2
expression	O
and	O
activation	O
of	O
Ca(2	O
+	O
)	O
-	O
gene1s	ARG2
NFAT	ARG2
gene1e	ARG2
signalling	O
pathway	O
.	O
Thus	O
,	O
gene1s	O
CD38	O
gene1e	O
may	O
be	O
a	O
novel	O
target	O
for	O
treating	O
cardiac	O
hypertrophy	O
.	O

DDA	O
suppresses	O
angiogenesis	O
and	O
tumor	O
growth	O
of	O
colorectal	O
cancer	O
in	O
vivo	O
through	O
decreasing	O
gene1s	ARG2
VEGFR2	ARG2
gene1e	ARG2
signaling	O
.	O
As	O
angiogenesis	O
is	O
required	O
for	O
tumor	O
growth	O
and	O
metastasis	O
,	O
suppressing	O
angiogenesis	O
is	O
a	O
promising	O
strategy	O
in	O
limiting	O
tumor	O
progression	O
.	O
gene1s	ARG2
Vascular	ARG2
endothelial	ARG2
growth	ARG2
factor	ARG2
(	ARG2
VEGF)-A	ARG2
gene1e	ARG2
,	O
a	O
critical	O
pro	O
-	O
angiogenic	O
factor	O
,	O
has	O
thus	O
become	O
an	O
attractive	O
target	O
for	O
therapeutic	O
interventions	O
in	O
cancer	O
.	O
In	O
this	O
study	O
,	O
we	O
explored	O
the	O
underlying	O
mechanisms	O
of	O
a	O
novel	O
anthraquinone	O
derivative	O
DDA	O
in	O
suppressing	O
angiogenesis	O
.	O
DDA	O
inhibited	O
gene1s	ARG2
VEGF	ARG2
-	ARG2
A	ARG2
gene1e	ARG2
-	O
induced	O
proliferation	O
,	O
migration	O
and	O
tube	O
formation	O
of	O
arg1s	O
human	O
arg1e	O
umbilical	O
vein	O
endothelial	O
cells	O
(	O
HUVECs	O
)	O
.	O
DDA	O
also	O
reduced	O
gene1s	ARG2
VEGF	ARG2
-	ARG2
A	ARG2
gene1e	ARG2
-	O
induced	O
microvessel	O
sprouting	O
from	O
aortic	O
rings	O
ex	O
vivo	O
and	O
suppressed	O
neovascularization	O
in	O
vivo	O
.	O
gene1s	ARG2
VEGF	ARG2
-	ARG2
A	ARG2
gene1e	ARG2
-	O
induced	O
gene1s	ARG2
VEGFR1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
VEGFR2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
FAK	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
phosphorylation	O
was	O
reduced	O
in	O
the	O
presence	O
of	O
DDA	O
.	O
In	O
addition	O
,	O
gene1s	ARG2
NRP-1	ARG2
gene1e	ARG2
siRNA	O
reduced	O
gene1s	ARG2
VEGF	ARG2
-	ARG2
A	ARG2
gene1e	ARG2
's	O
enhancing	O
effects	O
in	O
gene1s	ARG2
VEGFR2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
FAK	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
phosphorylation	O
and	O
cell	O
proliferation	O
in	O
HUVECs	O
.	O
DDA	O
disrupted	O
gene1s	ARG2
VEGF	ARG2
-	ARG2
A	ARG2
gene1e	ARG2
-	O
induced	O
complex	O
formation	O
between	O
gene1s	ARG2
NRP-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
VEGFR2	ARG2
gene1e	ARG2
.	O
Furthermore	O
,	O
systemic	O
administration	O
of	O
DDA	O
was	O
shown	O
to	O
suppress	O
tumor	O
angiogenesis	O
and	O
growth	O
in	O
in	O
vivo	O
species1s	O
mouse	O
species1e	O
xenograft	O
models	O
.	O
Taken	O
together	O
,	O
we	O
demonstrated	O
in	O
this	O
study	O
that	O
DDA	O
exhibits	O
anti	O
-	O
angiogenic	O
properties	O
through	O
suppressing	O
gene1s	ARG2
VEGF	ARG2
-	ARG2
A	ARG2
gene1e	ARG2
signaling	O
.	O
These	O
observations	O
also	O
suggest	O
that	O
DDA	O
might	O
be	O
a	O
potential	O
drug	O
candidate	O
for	O
developing	O
anti	O
-	O
angiogenic	O
agent	O
in	O
the	O
field	O
of	O
cancer	O
and	O
angiogenesis	O
-	O
related	O
diseases	O
.	O

DDA	O
suppresses	O
angiogenesis	O
and	O
tumor	O
growth	O
of	O
colorectal	O
cancer	O
in	O
vivo	O
through	O
decreasing	O
gene1s	O
VEGFR2	O
gene1e	O
signaling	O
.	O
As	O
angiogenesis	O
is	O
required	O
for	O
tumor	O
growth	O
and	O
metastasis	O
,	O
suppressing	O
angiogenesis	O
is	O
a	O
promising	O
strategy	O
in	O
limiting	O
tumor	O
progression	O
.	O
gene1s	O
Vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF)-A	O
gene1e	O
,	O
a	O
critical	O
pro	O
-	O
angiogenic	O
factor	O
,	O
has	O
thus	O
become	O
an	O
attractive	O
target	O
for	O
therapeutic	O
interventions	O
in	O
cancer	O
.	O
In	O
this	O
study	O
,	O
we	O
explored	O
the	O
underlying	O
mechanisms	O
of	O
a	O
novel	O
anthraquinone	O
derivative	O
DDA	O
in	O
suppressing	O
angiogenesis	O
.	O
DDA	O
inhibited	O
gene1s	O
VEGF	O
-	O
A	O
gene1e	O
-	O
induced	O
proliferation	O
,	O
migration	O
and	O
tube	O
formation	O
of	O
species1s	O
human	O
species1e	O
umbilical	O
vein	O
endothelial	O
cells	O
(	O
HUVECs	O
)	O
.	O
DDA	O
also	O
reduced	O
gene1s	O
VEGF	O
-	O
A	O
gene1e	O
-	O
induced	O
microvessel	O
sprouting	O
from	O
aortic	O
rings	O
ex	O
vivo	O
and	O
suppressed	O
neovascularization	O
in	O
vivo	O
.	O
gene1s	O
VEGF	O
-	O
A	O
gene1e	O
-	O
induced	O
gene1s	O
VEGFR1	O
gene1e	O
,	O
gene1s	O
VEGFR2	O
gene1e	O
,	O
gene1s	O
FAK	O
gene1e	O
,	O
gene1s	O
Akt	O
gene1e	O
,	O
gene1s	O
ERK1/2	O
gene1e	O
or	O
gene1s	O
STAT3	O
gene1e	O
phosphorylation	O
was	O
reduced	O
in	O
the	O
presence	O
of	O
DDA	O
.	O
In	O
addition	O
,	O
gene1s	O
NRP-1	O
gene1e	O
siRNA	O
reduced	O
gene1s	O
VEGF	O
-	O
A	O
gene1e	O
's	O
enhancing	O
effects	O
in	O
gene1s	O
VEGFR2	O
gene1e	O
,	O
gene1s	O
FAK	O
gene1e	O
and	O
gene1s	O
Akt	O
gene1e	O
phosphorylation	O
and	O
cell	O
proliferation	O
in	O
HUVECs	O
.	O
DDA	O
disrupted	O
gene1s	O
VEGF	O
-	O
A	O
gene1e	O
-	O
induced	O
complex	O
formation	O
between	O
gene1s	O
NRP-1	O
gene1e	O
and	O
gene1s	O
VEGFR2	O
gene1e	O
.	O
Furthermore	O
,	O
systemic	O
administration	O
of	O
DDA	O
was	O
shown	O
to	O
suppress	O
tumor	O
angiogenesis	O
and	O
growth	O
in	O
in	O
vivo	O
arg1s	O
mouse	O
arg1e	O
xenograft	O
models	O
.	O
Taken	O
together	O
,	O
we	O
demonstrated	O
in	O
this	O
study	O
that	O
DDA	O
exhibits	O
anti	O
-	O
angiogenic	O
properties	O
through	O
suppressing	O
gene1s	O
VEGF	O
-	O
A	O
gene1e	O
signaling	O
.	O
These	O
observations	O
also	O
suggest	O
that	O
DDA	O
might	O
be	O
a	O
potential	O
drug	O
candidate	O
for	O
developing	O
anti	O
-	O
angiogenic	O
agent	O
in	O
the	O
field	O
of	O
cancer	O
and	O
angiogenesis	O
-	O
related	O
diseases	O
.	O

gene1s	ARG2
MicroRNA-451a	ARG2
gene1e	ARG2
overexpression	O
induces	O
accelerated	O
neuronal	O
differentiation	O
of	O
arg1s	O
Ntera2	O
/	O
D1	O
arg1e	O
cells	O
and	O
ablation	O
affects	O
neurogenesis	O
in	O
gene1s	O
microRNA-451a	O
gene1e	O
-/-	O
species1s	O
mice	O
species1e	O
.	O
gene1s	O
MiR-451a	O
gene1e	O
is	O
best	O
known	O
for	O
its	O
role	O
in	O
erythropoiesis	O
and	O
for	O
its	O
tumour	O
suppressor	O
features	O
.	O
Here	O
we	O
show	O
a	O
role	O
for	O
gene1s	O
miR-451a	O
gene1e	O
in	O
neuronal	O
differentiation	O
through	O
analysis	O
of	O
endogenous	O
and	O
ectopically	O
expressed	O
or	O
silenced	O
gene1s	O
miR-451a	O
gene1e	O
in	O
arg1s	O
Ntera2	O
/	O
D1	O
arg1e	O
cells	O
during	O
neuronal	O
differentiation	O
.	O
Furthermore	O
,	O
we	O
compared	O
neuronal	O
differentiation	O
in	O
the	O
dentate	O
gyrus	O
of	O
hippocampus	O
of	O
gene1s	O
miR-451a	O
gene1e	O
-/-	O
and	O
wild	O
type	O
species1s	O
mice	O
species1e	O
.	O
gene1s	O
MiR-451a	O
gene1e	O
overexpression	O
in	O
lentiviral	O
transduced	O
arg1s	O
Ntera2	O
/	O
D1	O
arg1e	O
cells	O
was	O
associated	O
with	O
a	O
significant	O
shifting	O
of	O
mRNA	O
expression	O
of	O
the	O
developmental	O
markers	O
gene1s	O
Nestin	O
gene1e	O
,	O
gene1s	O
betaIII	O
Tubulin	O
gene1e	O
,	O
gene1s	O
NF200	O
gene1e	O
,	O
gene1s	O
DCX	O
gene1e	O
and	O
gene1s	O
MAP2	O
gene1e	O
to	O
earlier	O
developmental	O
time	O
points	O
,	O
compared	O
to	O
control	O
vector	O
transduced	O
cells	O
.	O
In	O
line	O
with	O
this	O
,	O
accelerated	O
neuronal	O
network	O
formation	O
in	O
AB.G.	O
gene1s	O
miR-451a	O
gene1e	O
transduced	O
cells	O
,	O
as	O
well	O
as	O
an	O
increase	O
in	O
neurite	O
outgrowth	O
both	O
in	O
number	O
and	O
length	O
was	O
observed	O
.	O
gene1s	O
MiR-451a	O
gene1e	O
targets	O
genes	O
gene1s	O
MIF	O
gene1e	O
,	O
gene1s	O
AKT1	O
gene1e	O
,	O
gene1s	O
CAB39	O
gene1e	O
,	O
gene1s	O
YWHAZ	O
gene1e	O
,	O
gene1s	O
RAB14	O
gene1e	O
,	O
gene1s	O
TSC1	O
gene1e	O
,	O
gene1s	O
OSR1	O
gene1e	O
,	O
gene1s	O
POU3F2	O
gene1e	O
,	O
gene1s	O
TNS4	O
gene1e	O
,	O
gene1s	O
PSMB8	O
gene1e	O
,	O
gene1s	O
CXCL16	O
gene1e	O
,	O
gene1s	O
CDKN2D	O
gene1e	O
and	O
gene1s	O
IL6R	O
gene1e	O
were	O
,	O
moreover	O
,	O
either	O
constantly	O
downregulated	O
or	O
exhibited	O
shifted	O
expression	O
profiles	O
in	O
AB.G.	O
gene1s	O
miR-451a	O
gene1e	O
transduced	O
cells	O
.	O
Lentiviral	O
knockdown	O
of	O
endogenous	O
gene1s	O
miR-451a	O
gene1e	O
expression	O
in	O
arg1s	O
Ntera2	O
/	O
D1	O
arg1e	O
cells	O
resulted	O
in	O
decelerated	O
differentiation	O
.	O
Endogenous	O
gene1s	O
miR-451a	O
gene1e	O
expression	O
was	O
upregulated	O
during	O
development	O
in	O
the	O
hippocampus	O
of	O
wildtype	O
species1s	O
mice	O
species1e	O
.	O
In	O
situ	O
hybridization	O
revealed	O
intensively	O
stained	O
single	O
cells	O
in	O
the	O
subgranular	O
zone	O
and	O
the	O
hilus	O
of	O
the	O
dentate	O
gyrus	O
of	O
wild	O
type	O
species1s	O
mice	O
species1e	O
,	O
while	O
genetic	O
ablation	O
of	O
gene1s	O
miR-451a	O
gene1e	O
was	O
observed	O
to	O
promote	O
an	O
imbalance	O
between	O
proliferation	O
and	O
neuronal	O
differentiation	O
in	O
neurogenic	O
brain	O
regions	O
,	O
suggested	O
by	O
gene1s	O
Ki67	O
gene1e	O
and	O
gene1s	O
DCX	O
gene1e	O
staining	O
.	O
Taken	O
together	O
,	O
these	O
results	O
provide	O
strong	O
support	O
for	O
a	O
role	O
of	O
gene1s	O
miR-451a	O
gene1e	O
in	O
neuronal	O
maturation	O
processes	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

gene1s	O
MicroRNA-451a	O
gene1e	O
overexpression	O
induces	O
accelerated	O
neuronal	O
differentiation	O
of	O
species1s	O
Ntera2	O
/	O
D1	O
species1e	O
cells	O
and	O
ablation	O
affects	O
neurogenesis	O
in	O
gene1s	ARG2
microRNA-451a	ARG2
gene1e	ARG2
-/-	O
arg1s	O
mice	O
arg1e	O
.	O
gene1s	ARG2
MiR-451a	ARG2
gene1e	ARG2
is	O
best	O
known	O
for	O
its	O
role	O
in	O
erythropoiesis	O
and	O
for	O
its	O
tumour	O
suppressor	O
features	O
.	O
Here	O
we	O
show	O
a	O
role	O
for	O
gene1s	ARG2
miR-451a	ARG2
gene1e	ARG2
in	O
neuronal	O
differentiation	O
through	O
analysis	O
of	O
endogenous	O
and	O
ectopically	O
expressed	O
or	O
silenced	O
gene1s	ARG2
miR-451a	ARG2
gene1e	ARG2
in	O
species1s	O
Ntera2	O
/	O
D1	O
species1e	O
cells	O
during	O
neuronal	O
differentiation	O
.	O
Furthermore	O
,	O
we	O
compared	O
neuronal	O
differentiation	O
in	O
the	O
dentate	O
gyrus	O
of	O
hippocampus	O
of	O
gene1s	ARG2
miR-451a	ARG2
gene1e	ARG2
-/-	O
and	O
wild	O
type	O
arg1s	O
mice	O
arg1e	O
.	O
gene1s	ARG2
MiR-451a	ARG2
gene1e	ARG2
overexpression	O
in	O
lentiviral	O
transduced	O
species1s	O
Ntera2	O
/	O
D1	O
species1e	O
cells	O
was	O
associated	O
with	O
a	O
significant	O
shifting	O
of	O
mRNA	O
expression	O
of	O
the	O
developmental	O
markers	O
gene1s	ARG2
Nestin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
betaIII	ARG2
Tubulin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NF200	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
DCX	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MAP2	ARG2
gene1e	ARG2
to	O
earlier	O
developmental	O
time	O
points	O
,	O
compared	O
to	O
control	O
vector	O
transduced	O
cells	O
.	O
In	O
line	O
with	O
this	O
,	O
accelerated	O
neuronal	O
network	O
formation	O
in	O
AB.G.	O
gene1s	ARG2
miR-451a	ARG2
gene1e	ARG2
transduced	O
cells	O
,	O
as	O
well	O
as	O
an	O
increase	O
in	O
neurite	O
outgrowth	O
both	O
in	O
number	O
and	O
length	O
was	O
observed	O
.	O
gene1s	ARG2
MiR-451a	ARG2
gene1e	ARG2
targets	O
genes	O
gene1s	ARG2
MIF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
AKT1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CAB39	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
YWHAZ	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
RAB14	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TSC1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
OSR1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
POU3F2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TNS4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PSMB8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CXCL16	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CDKN2D	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL6R	ARG2
gene1e	ARG2
were	O
,	O
moreover	O
,	O
either	O
constantly	O
downregulated	O
or	O
exhibited	O
shifted	O
expression	O
profiles	O
in	O
AB.G.	O
gene1s	ARG2
miR-451a	ARG2
gene1e	ARG2
transduced	O
cells	O
.	O
Lentiviral	O
knockdown	O
of	O
endogenous	O
gene1s	ARG2
miR-451a	ARG2
gene1e	ARG2
expression	O
in	O
species1s	O
Ntera2	O
/	O
D1	O
species1e	O
cells	O
resulted	O
in	O
decelerated	O
differentiation	O
.	O
Endogenous	O
gene1s	ARG2
miR-451a	ARG2
gene1e	ARG2
expression	O
was	O
upregulated	O
during	O
development	O
in	O
the	O
hippocampus	O
of	O
wildtype	O
arg1s	O
mice	O
arg1e	O
.	O
In	O
situ	O
hybridization	O
revealed	O
intensively	O
stained	O
single	O
cells	O
in	O
the	O
subgranular	O
zone	O
and	O
the	O
hilus	O
of	O
the	O
dentate	O
gyrus	O
of	O
wild	O
type	O
arg1s	O
mice	O
arg1e	O
,	O
while	O
genetic	O
ablation	O
of	O
gene1s	ARG2
miR-451a	ARG2
gene1e	ARG2
was	O
observed	O
to	O
promote	O
an	O
imbalance	O
between	O
proliferation	O
and	O
neuronal	O
differentiation	O
in	O
neurogenic	O
brain	O
regions	O
,	O
suggested	O
by	O
gene1s	ARG2
Ki67	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
DCX	ARG2
gene1e	ARG2
staining	O
.	O
Taken	O
together	O
,	O
these	O
results	O
provide	O
strong	O
support	O
for	O
a	O
role	O
of	O
gene1s	ARG2
miR-451a	ARG2
gene1e	ARG2
in	O
neuronal	O
maturation	O
processes	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

A	O
homozygous	O
mutation	O
in	O
gene1s	ARG2
LYRM7	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
MZM1L	ARG2
gene1e	ARG2
associated	O
with	O
early	O
onset	O
encephalopathy	O
,	O
lactic	O
acidosis	O
,	O
and	O
severe	O
reduction	O
of	O
mitochondrial	O
complex	O
III	O
activity	O
.	O
Mutations	O
in	O
nuclear	O
genes	O
associated	O
with	O
defective	O
complex	O
III	O
(	O
cIII	O
)	O
of	O
the	O
mitochondrial	O
respiratory	O
chain	O
are	O
rare	O
,	O
having	O
been	O
found	O
in	O
only	O
two	O
cIII	O
assembly	O
factors	O
and	O
,	O
as	O
private	O
changes	O
in	O
single	O
families	O
,	O
three	O
cIII	O
structural	O
subunits	O
.	O
Recently	O
,	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
LYRM7	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
MZM1L	ARG2
gene1e	ARG2
,	O
the	O
ortholog	O
of	O
species1s	O
yeast	O
species1e	O
gene1s	O
MZM1	O
gene1e	O
,	O
has	O
been	O
identified	O
as	O
a	O
new	O
assembly	O
factor	O
for	O
cIII	O
.	O
In	O
a	O
baby	O
arg1s	O
patient	O
arg1e	O
with	O
early	O
onset	O
,	O
severe	O
encephalopathy	O
,	O
lactic	O
acidosis	O
and	O
profound	O
,	O
isolated	O
cIII	O
deficiency	O
in	O
skeletal	O
muscle	O
,	O
we	O
identified	O
a	O
disease	O
-	O
segregating	O
homozygous	O
mutation	O
(	O
c.73G	O
>	O
A	O
)	O
in	O
gene1s	ARG2
LYRM7	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
MZM1L	ARG2
gene1e	ARG2
,	O
predicting	O
a	O
drastic	O
change	O
in	O
a	O
highly	O
conserved	O
amino	O
-	O
acid	O
residue	O
(	O
p	O
.	O
Asp25Asn	O
)	O
.	O
In	O
a	O
gene1s	O
mzm1D	O
gene1e	O
species1s	O
yeast	O
species1e	O
strain	O
,	O
the	O
expression	O
of	O
a	O
gene1s	O
mzm1	O
gene1e	O
(D25N	O
)	O
mutant	O
allele	O
caused	O
temperature	O
-	O
sensitive	O
respiratory	O
growth	O
defect	O
,	O
decreased	O
oxygen	O
consumption	O
,	O
impaired	O
maturation	O
/	O
stabilization	O
of	O
the	O
gene1s	O
Rieske	O
Fe	O
-	O
S	O
protein	O
gene1e	O
,	O
and	O
reduced	O
complex	O
III	O
activity	O
and	O
amount	O
.	O
gene1s	ARG2
LYRM7	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
MZM1L	ARG2
gene1e	ARG2
is	O
a	O
novel	O
disease	O
gene	O
,	O
causing	O
cIII	O
-	O
defective	O
,	O
early	O
onset	O
,	O
severe	O
mitochondrial	O
encephalopathy	O
.	O

A	O
homozygous	O
mutation	O
in	O
gene1s	O
LYRM7	O
gene1e	O
/	O
gene1s	O
MZM1L	O
gene1e	O
associated	O
with	O
early	O
onset	O
encephalopathy	O
,	O
lactic	O
acidosis	O
,	O
and	O
severe	O
reduction	O
of	O
mitochondrial	O
complex	O
III	O
activity	O
.	O
Mutations	O
in	O
nuclear	O
genes	O
associated	O
with	O
defective	O
complex	O
III	O
(	O
cIII	O
)	O
of	O
the	O
mitochondrial	O
respiratory	O
chain	O
are	O
rare	O
,	O
having	O
been	O
found	O
in	O
only	O
two	O
cIII	O
assembly	O
factors	O
and	O
,	O
as	O
private	O
changes	O
in	O
single	O
families	O
,	O
three	O
cIII	O
structural	O
subunits	O
.	O
Recently	O
,	O
species1s	O
human	O
species1e	O
gene1s	O
LYRM7	O
gene1e	O
/	O
gene1s	O
MZM1L	O
gene1e	O
,	O
the	O
ortholog	O
of	O
arg1s	O
yeast	O
arg1e	O
gene1s	ARG2
MZM1	ARG2
gene1e	ARG2
,	O
has	O
been	O
identified	O
as	O
a	O
new	O
assembly	O
factor	O
for	O
cIII	O
.	O
In	O
a	O
baby	O
species1s	O
patient	O
species1e	O
with	O
early	O
onset	O
,	O
severe	O
encephalopathy	O
,	O
lactic	O
acidosis	O
and	O
profound	O
,	O
isolated	O
cIII	O
deficiency	O
in	O
skeletal	O
muscle	O
,	O
we	O
identified	O
a	O
disease	O
-	O
segregating	O
homozygous	O
mutation	O
(	O
c.73G	O
>	O
A	O
)	O
in	O
gene1s	O
LYRM7	O
gene1e	O
/	O
gene1s	O
MZM1L	O
gene1e	O
,	O
predicting	O
a	O
drastic	O
change	O
in	O
a	O
highly	O
conserved	O
amino	O
-	O
acid	O
residue	O
(	O
p	O
.	O
Asp25Asn	O
)	O
.	O
In	O
a	O
gene1s	ARG2
mzm1D	ARG2
gene1e	ARG2
arg1s	O
yeast	O
arg1e	O
strain	O
,	O
the	O
expression	O
of	O
a	O
gene1s	ARG2
mzm1	ARG2
gene1e	ARG2
(D25N	O
)	O
mutant	O
allele	O
caused	O
temperature	O
-	O
sensitive	O
respiratory	O
growth	O
defect	O
,	O
decreased	O
oxygen	O
consumption	O
,	O
impaired	O
maturation	O
/	O
stabilization	O
of	O
the	O
gene1s	ARG2
Rieske	ARG2
Fe	ARG2
-	ARG2
S	ARG2
protein	ARG2
gene1e	ARG2
,	O
and	O
reduced	O
complex	O
III	O
activity	O
and	O
amount	O
.	O
gene1s	O
LYRM7	O
gene1e	O
/	O
gene1s	O
MZM1L	O
gene1e	O
is	O
a	O
novel	O
disease	O
gene	O
,	O
causing	O
cIII	O
-	O
defective	O
,	O
early	O
onset	O
,	O
severe	O
mitochondrial	O
encephalopathy	O
.	O

Impaired	O
musculoskeletal	O
response	O
to	O
age	O
and	O
exercise	O
in	O
gene1s	ARG2
PPARb	ARG2
gene1e	ARG2
(-/-	O
)	O
diabetic	O
arg1s	O
mice	O
arg1e	O
.	O
Fragility	O
fractures	O
are	O
recognized	O
complication	O
of	O
diabetes	O
,	O
but	O
yet	O
the	O
underlying	O
mechanisms	O
remain	O
poorly	O
understood	O
.	O
This	O
is	O
particularly	O
pronounced	O
in	O
type	O
2	O
diabetes	O
in	O
which	O
the	O
propensity	O
to	O
fall	O
is	O
increased	O
but	O
bone	O
mass	O
is	O
not	O
necessarily	O
low	O
.	O
Thus	O
,	O
whether	O
factors	O
implicated	O
in	O
the	O
development	O
of	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
resistance	O
and	O
diabetes	O
directly	O
impact	O
on	O
the	O
musculoskeletal	O
system	O
remains	O
to	O
be	O
investigated	O
.	O
gene1s	ARG2
PPARb	ARG2
gene1e	ARG2
(-/-	O
)	O
arg1s	O
mice	O
arg1e	O
have	O
reduced	O
metabolic	O
activity	O
and	O
are	O
glucose	O
intolerant	O
.	O
We	O
examined	O
changes	O
in	O
bone	O
and	O
muscle	O
in	O
gene1s	ARG2
PPARb	ARG2
gene1e	ARG2
(-/-	O
)	O
arg1s	O
mice	O
arg1e	O
and	O
investigated	O
both	O
the	O
mechanism	O
behind	O
those	O
changes	O
with	O
age	O
as	O
well	O
as	O
their	O
response	O
to	O
exercise	O
.	O
Compared	O
with	O
their	O
wild	O
type	O
,	O
gene1s	ARG2
PPARb	ARG2
gene1e	ARG2
(-/-	O
)	O
arg1s	O
mice	O
arg1e	O
had	O
an	O
accelerated	O
and	O
parallel	O
decline	O
in	O
both	O
muscle	O
and	O
bone	O
strength	O
with	O
age	O
.	O
These	O
changes	O
were	O
accompanied	O
by	O
increased	O
gene1s	ARG2
myostatin	ARG2
gene1e	ARG2
expression	O
,	O
low	O
bone	O
formation	O
,	O
and	O
increased	O
resorption	O
.	O
In	O
addition	O
,	O
mesenchymal	O
cells	O
from	O
gene1s	ARG2
PPARb	ARG2
gene1e	ARG2
(-/-	O
)	O
had	O
a	O
reduced	O
proliferation	O
capacity	O
and	O
appeared	O
to	O
differentiate	O
into	O
more	O
of	O
an	O
adipogenic	O
phenotype	O
.	O
Concomitantly	O
we	O
observed	O
an	O
increased	O
expression	O
of	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
,	O
characteristic	O
of	O
adipocytes	O
.	O
The	O
anabolic	O
responses	O
of	O
muscle	O
and	O
bone	O
to	O
exercise	O
were	O
also	O
diminished	O
in	O
gene1s	ARG2
PPARb	ARG2
gene1e	ARG2
(-/-	O
)	O
arg1s	O
mice	O
arg1e	O
.	O
The	O
periosteal	O
bone	O
formation	O
response	O
to	O
direct	O
bone	O
compression	O
was	O
,	O
however	O
,	O
maintained	O
,	O
indicating	O
that	O
gene1s	ARG2
PPARb	ARG2
gene1e	ARG2
controls	O
periosteal	O
bone	O
formation	O
through	O
muscle	O
contraction	O
and/or	O
metabolism	O
.	O
Taken	O
together	O
,	O
these	O
data	O
indicate	O
that	O
gene1s	ARG2
PPARb	ARG2
gene1e	ARG2
deficiency	O
leads	O
to	O
glucose	O
intolerance	O
,	O
decreased	O
muscle	O
function	O
,	O
and	O
reduced	O
bone	O
strength	O
.	O
On	O
a	O
molecular	O
level	O
,	O
gene1s	ARG2
PPARb	ARG2
gene1e	ARG2
appears	O
to	O
regulate	O
gene1s	ARG2
myostatin	ARG2
gene1e	ARG2
and	O
gene1s	O
PPARg	O
gene1e	O
expression	O
in	O
muscle	O
and	O
bone	O
,	O
thereby	O
providing	O
potential	O
new	O
targets	O
to	O
reverse	O
bone	O
fragility	O
in	O
species1s	O
patients	O
species1e	O
with	O
metabolic	O
disturbances	O
.	O

Impaired	O
musculoskeletal	O
response	O
to	O
age	O
and	O
exercise	O
in	O
gene1s	O
PPARb	O
gene1e	O
(-/-	O
)	O
diabetic	O
species1s	O
mice	O
species1e	O
.	O
Fragility	O
fractures	O
are	O
recognized	O
complication	O
of	O
diabetes	O
,	O
but	O
yet	O
the	O
underlying	O
mechanisms	O
remain	O
poorly	O
understood	O
.	O
This	O
is	O
particularly	O
pronounced	O
in	O
type	O
2	O
diabetes	O
in	O
which	O
the	O
propensity	O
to	O
fall	O
is	O
increased	O
but	O
bone	O
mass	O
is	O
not	O
necessarily	O
low	O
.	O
Thus	O
,	O
whether	O
factors	O
implicated	O
in	O
the	O
development	O
of	O
gene1s	O
insulin	O
gene1e	O
resistance	O
and	O
diabetes	O
directly	O
impact	O
on	O
the	O
musculoskeletal	O
system	O
remains	O
to	O
be	O
investigated	O
.	O
gene1s	O
PPARb	O
gene1e	O
(-/-	O
)	O
species1s	O
mice	O
species1e	O
have	O
reduced	O
metabolic	O
activity	O
and	O
are	O
glucose	O
intolerant	O
.	O
We	O
examined	O
changes	O
in	O
bone	O
and	O
muscle	O
in	O
gene1s	O
PPARb	O
gene1e	O
(-/-	O
)	O
species1s	O
mice	O
species1e	O
and	O
investigated	O
both	O
the	O
mechanism	O
behind	O
those	O
changes	O
with	O
age	O
as	O
well	O
as	O
their	O
response	O
to	O
exercise	O
.	O
Compared	O
with	O
their	O
wild	O
type	O
,	O
gene1s	O
PPARb	O
gene1e	O
(-/-	O
)	O
species1s	O
mice	O
species1e	O
had	O
an	O
accelerated	O
and	O
parallel	O
decline	O
in	O
both	O
muscle	O
and	O
bone	O
strength	O
with	O
age	O
.	O
These	O
changes	O
were	O
accompanied	O
by	O
increased	O
gene1s	O
myostatin	O
gene1e	O
expression	O
,	O
low	O
bone	O
formation	O
,	O
and	O
increased	O
resorption	O
.	O
In	O
addition	O
,	O
mesenchymal	O
cells	O
from	O
gene1s	O
PPARb	O
gene1e	O
(-/-	O
)	O
had	O
a	O
reduced	O
proliferation	O
capacity	O
and	O
appeared	O
to	O
differentiate	O
into	O
more	O
of	O
an	O
adipogenic	O
phenotype	O
.	O
Concomitantly	O
we	O
observed	O
an	O
increased	O
expression	O
of	O
gene1s	O
PPARg	O
gene1e	O
,	O
characteristic	O
of	O
adipocytes	O
.	O
The	O
anabolic	O
responses	O
of	O
muscle	O
and	O
bone	O
to	O
exercise	O
were	O
also	O
diminished	O
in	O
gene1s	O
PPARb	O
gene1e	O
(-/-	O
)	O
species1s	O
mice	O
species1e	O
.	O
The	O
periosteal	O
bone	O
formation	O
response	O
to	O
direct	O
bone	O
compression	O
was	O
,	O
however	O
,	O
maintained	O
,	O
indicating	O
that	O
gene1s	O
PPARb	O
gene1e	O
controls	O
periosteal	O
bone	O
formation	O
through	O
muscle	O
contraction	O
and/or	O
metabolism	O
.	O
Taken	O
together	O
,	O
these	O
data	O
indicate	O
that	O
gene1s	O
PPARb	O
gene1e	O
deficiency	O
leads	O
to	O
glucose	O
intolerance	O
,	O
decreased	O
muscle	O
function	O
,	O
and	O
reduced	O
bone	O
strength	O
.	O
On	O
a	O
molecular	O
level	O
,	O
gene1s	O
PPARb	O
gene1e	O
appears	O
to	O
regulate	O
gene1s	O
myostatin	O
gene1e	O
and	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
expression	O
in	O
muscle	O
and	O
bone	O
,	O
thereby	O
providing	O
potential	O
new	O
targets	O
to	O
reverse	O
bone	O
fragility	O
in	O
arg1s	O
patients	O
arg1e	O
with	O
metabolic	O
disturbances	O
.	O

gene1s	ARG2
Calreticulin	ARG2
gene1e	ARG2
-	O
mutant	O
proteins	O
induce	O
megakaryocytic	O
signaling	O
to	O
transform	O
hematopoietic	O
cells	O
and	O
undergo	O
accelerated	O
degradation	O
and	O
Golgi	O
-	O
mediated	O
secretion	O
.	O
BACKGROUND	O
:	O
Somatic	O
gene1s	ARG2
calreticulin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
)	O
,	O
gene1s	O
Janus	O
kinase	O
2	O
gene1e	O
(	O
gene1s	O
JAK2	O
gene1e	O
)	O
,	O
and	O
gene1s	ARG2
thrombopoietin	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	O
MPL	O
gene1e	O
)	O
mutations	O
essentially	O
show	O
mutual	O
exclusion	O
in	O
myeloproliferative	O
neoplasms	O
(	O
MPN	O
)	O
,	O
suggesting	O
that	O
they	O
activate	O
common	O
oncogenic	O
pathways	O
.	O
Recent	O
data	O
have	O
shown	O
that	O
gene1s	ARG2
MPL	ARG2
gene1e	ARG2
function	O
is	O
essential	O
for	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
mutant	O
-	O
driven	O
MPN	O
.	O
However	O
,	O
the	O
exact	O
role	O
and	O
the	O
mechanisms	O
of	O
action	O
of	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
mutants	O
have	O
not	O
been	O
fully	O
elucidated	O
.	O
METHODS	O
:	O
The	O
arg1s	O
murine	O
arg1e	O
myeloid	O
cell	O
line	O
arg1s	O
32D	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
species1s	O
HL60	O
species1e	O
cells	O
overexpressing	O
the	O
most	O
frequent	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
type	O
1	O
and	O
type	O
2	O
frameshift	O
mutants	O
were	O
generated	O
to	O
analyze	O
the	O
first	O
steps	O
of	O
cellular	O
transformation	O
,	O
in	O
the	O
presence	O
and	O
absence	O
of	O
gene1s	ARG2
MPL	ARG2
gene1e	ARG2
expression	O
.	O
Furthermore	O
,	O
mutant	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
protein	O
stability	O
and	O
secretion	O
were	O
examined	O
using	O
brefeldin	O
A	O
,	O
MG132	O
,	O
spautin-1	O
,	O
and	O
tunicamycin	O
treatment	O
.	O
RESULTS	O
:	O
The	O
present	O
study	O
demonstrates	O
that	O
the	O
expression	O
of	O
endogenous	O
gene1s	ARG2
Mpl	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD41	ARG2
gene1e	ARG2
,	O
and	O
the	O
key	O
megakaryocytic	O
transcription	O
factor	O
gene1s	ARG2
NF	ARG2
-	ARG2
E2	ARG2
gene1e	ARG2
is	O
stimulated	O
by	O
type	O
1	O
and	O
type	O
2	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
mutants	O
,	O
even	O
in	O
the	O
absence	O
of	O
exogenous	O
gene1s	ARG2
MPL	ARG2
gene1e	ARG2
.	O
Mutant	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
expressing	O
arg1s	O
32D	O
arg1e	O
cells	O
spontaneously	O
acquired	O
cytokine	O
independence	O
,	O
and	O
this	O
was	O
associated	O
with	O
increased	O
gene1s	ARG2
Mpl	ARG2
gene1e	ARG2
mRNA	O
expression	O
,	O
gene1s	ARG2
CD41	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
NF	ARG2
-	ARG2
E2	ARG2
gene1e	ARG2
protein	O
as	O
well	O
as	O
constitutive	O
activation	O
of	O
downstream	O
signaling	O
and	O
response	O
to	O
gene1s	ARG2
JAK	ARG2
gene1e	ARG2
inhibitor	O
treatment	O
.	O
Exogenous	O
expression	O
of	O
gene1s	ARG2
MPL	ARG2
gene1e	ARG2
led	O
to	O
constitutive	O
activation	O
of	O
gene1s	ARG2
STAT3	ARG2
and	ARG2
5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
,	O
cytokine	O
-	O
independent	O
growth	O
,	O
and	O
reduction	O
of	O
apoptosis	O
similar	O
to	O
the	O
effects	O
seen	O
in	O
the	O
spontaneously	O
outgrown	O
cells	O
.	O
We	O
observed	O
low	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
-	O
mutant	O
protein	O
amounts	O
in	O
cellular	O
lysates	O
of	O
stably	O
transduced	O
cells	O
,	O
and	O
this	O
was	O
due	O
to	O
accelerated	O
protein	O
degradation	O
that	O
occurred	O
independently	O
from	O
the	O
ubiquitin	O
-	O
proteasome	O
system	O
as	O
well	O
as	O
autophagy	O
.	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
-	O
mutant	O
degradation	O
was	O
attenuated	O
by	O
gene1s	ARG2
MPL	ARG2
gene1e	ARG2
expression	O
.	O
Interestingly	O
,	O
we	O
found	O
high	O
levels	O
of	O
mutated	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
and	O
loss	O
of	O
downstream	O
signaling	O
after	O
blockage	O
of	O
the	O
secretory	O
pathway	O
and	O
protein	O
glycosylation	O
.	O
CONCLUSIONS	O
:	O
These	O
findings	O
demonstrate	O
the	O
potency	O
of	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
mutants	O
to	O
drive	O
expression	O
of	O
megakaryocytic	O
differentiation	O
markers	O
such	O
as	O
gene1s	ARG2
NF	ARG2
-	ARG2
E2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CD41	ARG2
gene1e	ARG2
as	O
well	O
as	O
gene1s	ARG2
Mpl	ARG2
gene1e	ARG2
.	O
Furthermore	O
,	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
mutants	O
undergo	O
accelerated	O
protein	O
degradation	O
that	O
involves	O
the	O
secretory	O
pathway	O
and/or	O
protein	O
glycosylation	O
.	O

gene1s	ARG2
Calreticulin	ARG2
gene1e	ARG2
-	O
mutant	O
proteins	O
induce	O
megakaryocytic	O
signaling	O
to	O
transform	O
hematopoietic	O
cells	O
and	O
undergo	O
accelerated	O
degradation	O
and	O
Golgi	O
-	O
mediated	O
secretion	O
.	O
BACKGROUND	O
:	O
Somatic	O
gene1s	ARG2
calreticulin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
Janus	ARG2
kinase	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
JAK2	ARG2
gene1e	ARG2
)	O
,	O
and	O
gene1s	ARG2
thrombopoietin	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MPL	ARG2
gene1e	ARG2
)	O
mutations	O
essentially	O
show	O
mutual	O
exclusion	O
in	O
myeloproliferative	O
neoplasms	O
(	O
MPN	O
)	O
,	O
suggesting	O
that	O
they	O
activate	O
common	O
oncogenic	O
pathways	O
.	O
Recent	O
data	O
have	O
shown	O
that	O
gene1s	ARG2
MPL	ARG2
gene1e	ARG2
function	O
is	O
essential	O
for	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
mutant	O
-	O
driven	O
MPN	O
.	O
However	O
,	O
the	O
exact	O
role	O
and	O
the	O
mechanisms	O
of	O
action	O
of	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
mutants	O
have	O
not	O
been	O
fully	O
elucidated	O
.	O
METHODS	O
:	O
The	O
species1s	O
murine	O
species1e	O
myeloid	O
cell	O
line	O
species1s	O
32D	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
arg1s	O
HL60	O
arg1e	O
cells	O
overexpressing	O
the	O
most	O
frequent	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
type	O
1	O
and	O
type	O
2	O
frameshift	O
mutants	O
were	O
generated	O
to	O
analyze	O
the	O
first	O
steps	O
of	O
cellular	O
transformation	O
,	O
in	O
the	O
presence	O
and	O
absence	O
of	O
gene1s	ARG2
MPL	ARG2
gene1e	ARG2
expression	O
.	O
Furthermore	O
,	O
mutant	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
protein	O
stability	O
and	O
secretion	O
were	O
examined	O
using	O
brefeldin	O
A	O
,	O
MG132	O
,	O
spautin-1	O
,	O
and	O
tunicamycin	O
treatment	O
.	O
RESULTS	O
:	O
The	O
present	O
study	O
demonstrates	O
that	O
the	O
expression	O
of	O
endogenous	O
gene1s	ARG2
Mpl	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD41	ARG2
gene1e	ARG2
,	O
and	O
the	O
key	O
megakaryocytic	O
transcription	O
factor	O
gene1s	ARG2
NF	ARG2
-	ARG2
E2	ARG2
gene1e	ARG2
is	O
stimulated	O
by	O
type	O
1	O
and	O
type	O
2	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
mutants	O
,	O
even	O
in	O
the	O
absence	O
of	O
exogenous	O
gene1s	ARG2
MPL	ARG2
gene1e	ARG2
.	O
Mutant	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
expressing	O
species1s	O
32D	O
species1e	O
cells	O
spontaneously	O
acquired	O
cytokine	O
independence	O
,	O
and	O
this	O
was	O
associated	O
with	O
increased	O
gene1s	O
Mpl	O
gene1e	O
mRNA	O
expression	O
,	O
gene1s	O
CD41	O
gene1e	O
,	O
and	O
gene1s	O
NF	O
-	O
E2	O
gene1e	O
protein	O
as	O
well	O
as	O
constitutive	O
activation	O
of	O
downstream	O
signaling	O
and	O
response	O
to	O
gene1s	O
JAK	O
gene1e	O
inhibitor	O
treatment	O
.	O
Exogenous	O
expression	O
of	O
gene1s	ARG2
MPL	ARG2
gene1e	ARG2
led	O
to	O
constitutive	O
activation	O
of	O
gene1s	ARG2
STAT3	ARG2
and	ARG2
5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
,	O
cytokine	O
-	O
independent	O
growth	O
,	O
and	O
reduction	O
of	O
apoptosis	O
similar	O
to	O
the	O
effects	O
seen	O
in	O
the	O
spontaneously	O
outgrown	O
cells	O
.	O
We	O
observed	O
low	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
-	O
mutant	O
protein	O
amounts	O
in	O
cellular	O
lysates	O
of	O
stably	O
transduced	O
cells	O
,	O
and	O
this	O
was	O
due	O
to	O
accelerated	O
protein	O
degradation	O
that	O
occurred	O
independently	O
from	O
the	O
ubiquitin	O
-	O
proteasome	O
system	O
as	O
well	O
as	O
autophagy	O
.	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
-	O
mutant	O
degradation	O
was	O
attenuated	O
by	O
gene1s	ARG2
MPL	ARG2
gene1e	ARG2
expression	O
.	O
Interestingly	O
,	O
we	O
found	O
high	O
levels	O
of	O
mutated	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
and	O
loss	O
of	O
downstream	O
signaling	O
after	O
blockage	O
of	O
the	O
secretory	O
pathway	O
and	O
protein	O
glycosylation	O
.	O
CONCLUSIONS	O
:	O
These	O
findings	O
demonstrate	O
the	O
potency	O
of	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
mutants	O
to	O
drive	O
expression	O
of	O
megakaryocytic	O
differentiation	O
markers	O
such	O
as	O
gene1s	ARG2
NF	ARG2
-	ARG2
E2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CD41	ARG2
gene1e	ARG2
as	O
well	O
as	O
gene1s	ARG2
Mpl	ARG2
gene1e	ARG2
.	O
Furthermore	O
,	O
gene1s	ARG2
CALR	ARG2
gene1e	ARG2
mutants	O
undergo	O
accelerated	O
protein	O
degradation	O
that	O
involves	O
the	O
secretory	O
pathway	O
and/or	O
protein	O
glycosylation	O
.	O

gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
functions	O
as	O
a	O
molecular	O
link	O
between	O
tumor	O
cells	O
and	O
Th1	O
/	O
Tc1	O
T	O
cells	O
in	O
the	O
tumor	O
microenvironment	O
to	O
exert	O
radiation	O
-	O
mediated	O
tumor	O
suppression	O
.	O
Radiation	O
modulates	O
both	O
tumor	O
cells	O
and	O
immune	O
cells	O
in	O
the	O
tumor	O
microenvironment	O
to	O
exert	O
its	O
anti	O
-	O
tumor	O
activity	O
;	O
however	O
,	O
the	O
molecular	O
connection	O
between	O
tumor	O
cells	O
and	O
immune	O
cells	O
that	O
mediates	O
radiation	O
-	O
exerted	O
tumor	O
suppression	O
activity	O
in	O
the	O
tumor	O
microenvironment	O
is	O
largely	O
unknown	O
.	O
We	O
report	O
here	O
that	O
radiation	O
induces	O
rapid	O
activation	O
of	O
the	O
gene1s	ARG2
p65	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
p50	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p50	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
p50	ARG2
gene1e	ARG2
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
complexes	O
in	O
arg1s	O
human	O
arg1e	O
soft	O
tissue	O
sarcoma	O
(	O
STS	O
)	O
cells	O
.	O
Radiation	O
-	O
activated	O
gene1s	ARG2
p65	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
p50	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p50	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
p50	ARG2
gene1e	ARG2
bind	O
to	O
the	O
gene1s	ARG2
TNFa	ARG2
gene1e	ARG2
promoter	O
to	O
activate	O
its	O
transcription	O
in	O
STS	O
cells	O
.	O
Radiation	O
-	O
induced	O
gene1s	ARG2
TNFa	ARG2
gene1e	ARG2
induces	O
tumor	O
cell	O
death	O
in	O
an	O
autocrine	O
manner	O
.	O
A	O
sublethal	O
dose	O
of	O
Smac	O
mimetic	O
BV6	O
induces	O
gene1s	ARG2
cIAP1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
cIAP2	ARG2
gene1e	ARG2
degradation	O
to	O
increase	O
tumor	O
cell	O
sensitivity	O
to	O
radiation	O
-	O
induced	O
cell	O
death	O
in	O
vitro	O
and	O
to	O
enhance	O
radiation	O
-	O
mediated	O
suppression	O
of	O
STS	O
xenografts	O
in	O
vivo	O
.	O
Inhibition	O
of	O
gene1s	ARG2
caspases	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
RIP1	ARG2
gene1e	ARG2
,	O
or	O
gene1s	ARG2
RIP3	ARG2
gene1e	ARG2
blocks	O
radiation	O
/	O
gene1s	ARG2
TNFa	ARG2
gene1e	ARG2
-	O
induced	O
cell	O
death	O
,	O
whereas	O
inhibition	O
of	O
gene1s	ARG2
RIP1	ARG2
gene1e	ARG2
blocks	O
gene1s	ARG2
TNFa	ARG2
gene1e	ARG2
-	O
induced	O
gene1s	ARG2
caspase	ARG2
gene1e	ARG2
activation	O
,	O
suggesting	O
that	O
gene1s	ARG2
caspases	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
RIP1	ARG2
gene1e	ARG2
act	O
sequentially	O
to	O
mediate	O
the	O
non	O
-	O
compensatory	O
cell	O
death	O
pathways	O
.	O
Furthermore	O
,	O
we	O
determined	O
in	O
a	O
syngeneic	O
sarcoma	O
species1s	O
mouse	O
species1e	O
model	O
that	O
radiation	O
up	O
-	O
regulates	O
gene1s	O
IRF3	O
gene1e	O
,	O
gene1s	O
IFNb	O
gene1e	O
,	O
and	O
the	O
T	O
cell	O
chemokines	O
gene1s	O
CCL2	O
gene1e	O
and	O
gene1s	O
CCL5	O
gene1e	O
in	O
the	O
tumor	O
microenvironment	O
,	O
which	O
are	O
associated	O
with	O
activation	O
and	O
increased	O
infiltration	O
of	O
Th1	O
/	O
Tc1	O
T	O
cells	O
in	O
the	O
tumor	O
microenvironment	O
.	O
Moreover	O
,	O
tumor	O
-	O
infiltrating	O
T	O
cells	O
are	O
in	O
their	O
active	O
form	O
since	O
both	O
the	O
gene1s	O
perforin	O
gene1e	O
and	O
gene1s	O
FasL	O
gene1e	O
pathways	O
are	O
activated	O
in	O
irradiated	O
tumor	O
tissues	O
.	O
Consequently	O
,	O
combined	O
BV6	O
and	O
radiation	O
completely	O
suppressed	O
tumor	O
growth	O
in	O
vivo	O
.	O
Therefore	O
,	O
radiation	O
-	O
induced	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
functions	O
as	O
a	O
molecular	O
link	O
between	O
tumor	O
cells	O
and	O
immune	O
cells	O
in	O
the	O
tumor	O
microenvironment	O
for	O
radiation	O
-	O
mediated	O
tumor	O
suppression	O
.	O

gene1s	O
NF	O
-	O
kB	O
gene1e	O
functions	O
as	O
a	O
molecular	O
link	O
between	O
tumor	O
cells	O
and	O
Th1	O
/	O
Tc1	O
T	O
cells	O
in	O
the	O
tumor	O
microenvironment	O
to	O
exert	O
radiation	O
-	O
mediated	O
tumor	O
suppression	O
.	O
Radiation	O
modulates	O
both	O
tumor	O
cells	O
and	O
immune	O
cells	O
in	O
the	O
tumor	O
microenvironment	O
to	O
exert	O
its	O
anti	O
-	O
tumor	O
activity	O
;	O
however	O
,	O
the	O
molecular	O
connection	O
between	O
tumor	O
cells	O
and	O
immune	O
cells	O
that	O
mediates	O
radiation	O
-	O
exerted	O
tumor	O
suppression	O
activity	O
in	O
the	O
tumor	O
microenvironment	O
is	O
largely	O
unknown	O
.	O
We	O
report	O
here	O
that	O
radiation	O
induces	O
rapid	O
activation	O
of	O
the	O
gene1s	O
p65	O
gene1e	O
/	O
gene1s	O
p50	O
gene1e	O
and	O
gene1s	O
p50	O
gene1e	O
/	O
gene1s	O
p50	O
gene1e	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
complexes	O
in	O
species1s	O
human	O
species1e	O
soft	O
tissue	O
sarcoma	O
(	O
STS	O
)	O
cells	O
.	O
Radiation	O
-	O
activated	O
gene1s	O
p65	O
gene1e	O
/	O
gene1s	O
p50	O
gene1e	O
and	O
gene1s	O
p50	O
gene1e	O
/	O
gene1s	O
p50	O
gene1e	O
bind	O
to	O
the	O
gene1s	O
TNFa	O
gene1e	O
promoter	O
to	O
activate	O
its	O
transcription	O
in	O
STS	O
cells	O
.	O
Radiation	O
-	O
induced	O
gene1s	O
TNFa	O
gene1e	O
induces	O
tumor	O
cell	O
death	O
in	O
an	O
autocrine	O
manner	O
.	O
A	O
sublethal	O
dose	O
of	O
Smac	O
mimetic	O
BV6	O
induces	O
gene1s	O
cIAP1	O
gene1e	O
and	O
gene1s	O
cIAP2	O
gene1e	O
degradation	O
to	O
increase	O
tumor	O
cell	O
sensitivity	O
to	O
radiation	O
-	O
induced	O
cell	O
death	O
in	O
vitro	O
and	O
to	O
enhance	O
radiation	O
-	O
mediated	O
suppression	O
of	O
STS	O
xenografts	O
in	O
vivo	O
.	O
Inhibition	O
of	O
gene1s	O
caspases	O
gene1e	O
,	O
gene1s	O
RIP1	O
gene1e	O
,	O
or	O
gene1s	O
RIP3	O
gene1e	O
blocks	O
radiation	O
/	O
gene1s	O
TNFa	O
gene1e	O
-	O
induced	O
cell	O
death	O
,	O
whereas	O
inhibition	O
of	O
gene1s	O
RIP1	O
gene1e	O
blocks	O
gene1s	O
TNFa	O
gene1e	O
-	O
induced	O
gene1s	O
caspase	O
gene1e	O
activation	O
,	O
suggesting	O
that	O
gene1s	O
caspases	O
gene1e	O
and	O
gene1s	O
RIP1	O
gene1e	O
act	O
sequentially	O
to	O
mediate	O
the	O
non	O
-	O
compensatory	O
cell	O
death	O
pathways	O
.	O
Furthermore	O
,	O
we	O
determined	O
in	O
a	O
syngeneic	O
sarcoma	O
arg1s	O
mouse	O
arg1e	O
model	O
that	O
radiation	O
up	O
-	O
regulates	O
gene1s	ARG2
IRF3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IFNb	ARG2
gene1e	ARG2
,	O
and	O
the	O
T	O
cell	O
chemokines	O
gene1s	ARG2
CCL2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CCL5	ARG2
gene1e	ARG2
in	O
the	O
tumor	O
microenvironment	O
,	O
which	O
are	O
associated	O
with	O
activation	O
and	O
increased	O
infiltration	O
of	O
Th1	O
/	O
Tc1	O
T	O
cells	O
in	O
the	O
tumor	O
microenvironment	O
.	O
Moreover	O
,	O
tumor	O
-	O
infiltrating	O
T	O
cells	O
are	O
in	O
their	O
active	O
form	O
since	O
both	O
the	O
gene1s	ARG2
perforin	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
FasL	ARG2
gene1e	ARG2
pathways	O
are	O
activated	O
in	O
irradiated	O
tumor	O
tissues	O
.	O
Consequently	O
,	O
combined	O
BV6	O
and	O
radiation	O
completely	O
suppressed	O
tumor	O
growth	O
in	O
vivo	O
.	O
Therefore	O
,	O
radiation	O
-	O
induced	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
functions	O
as	O
a	O
molecular	O
link	O
between	O
tumor	O
cells	O
and	O
immune	O
cells	O
in	O
the	O
tumor	O
microenvironment	O
for	O
radiation	O
-	O
mediated	O
tumor	O
suppression	O
.	O

Mutation	O
of	O
the	O
gene1s	O
a	O
-	O
tubulin	O
gene1e	O
gene1s	O
Tuba1a	O
gene1e	O
leads	O
to	O
straighter	O
microtubules	O
and	O
perturbs	O
neuronal	O
migration	O
.	O
Brain	O
development	O
involves	O
extensive	O
migration	O
of	O
neurons	O
.	O
Microtubules	O
(	O
MTs	O
)	O
are	O
key	O
cellular	O
effectors	O
of	O
neuronal	O
displacement	O
that	O
are	O
assembled	O
from	O
gene1s	O
a	O
/	O
b	O
-	O
tubulin	O
gene1e	O
heterodimers	O
.	O
Mutation	O
of	O
the	O
gene1s	ARG2
a	ARG2
-	ARG2
tubulin	ARG2
gene1e	ARG2
isotype	O
gene1s	ARG2
TUBA1A	ARG2
gene1e	ARG2
is	O
associated	O
with	O
cortical	O
malformations	O
in	O
arg1s	O
humans	O
arg1e	O
.	O
In	O
this	O
study	O
,	O
we	O
provide	O
detailed	O
in	O
vivo	O
and	O
in	O
vitro	O
analyses	O
of	O
gene1s	O
Tuba1a	O
gene1e	O
mutants	O
.	O
In	O
species1s	O
mice	O
species1e	O
carrying	O
a	O
gene1s	O
Tuba1a	O
gene1e	O
missense	O
mutation	O
(	O
S140	O
G	O
)	O
,	O
neurons	O
accumulate	O
,	O
and	O
glial	O
cells	O
are	O
dispersed	O
along	O
the	O
rostral	O
migratory	O
stream	O
in	O
postnatal	O
and	O
adult	O
brains	O
.	O
Live	O
imaging	O
of	O
gene1s	O
Tuba1a	O
gene1e	O
-	O
mutant	O
neurons	O
revealed	O
slowed	O
migration	O
and	O
increased	O
neuronal	O
branching	O
,	O
which	O
correlated	O
with	O
directionality	O
alterations	O
and	O
perturbed	O
nucleus	O
-	O
centrosome	O
(	O
N	O
-	O
C	O
)	O
coupling	O
.	O
gene1s	O
Tuba1a	O
gene1e	O
mutation	O
led	O
to	O
increased	O
straightness	O
of	O
newly	O
polymerized	O
MTs	O
,	O
and	O
structural	O
modeling	O
data	O
suggest	O
a	O
conformational	O
change	O
in	O
the	O
gene1s	O
a	O
/	O
b	O
-	O
tubulin	O
gene1e	O
heterodimer	O
.	O
We	O
show	O
that	O
gene1s	O
Tuba8	O
gene1e	O
,	O
another	O
gene1s	O
a	O
-	O
tubulin	O
gene1e	O
isotype	O
previously	O
associated	O
with	O
cortical	O
malformations	O
,	O
has	O
altered	O
function	O
compared	O
with	O
gene1s	O
Tuba1a	O
gene1e	O
.	O
Our	O
work	O
shows	O
that	O
gene1s	O
Tuba1a	O
gene1e	O
plays	O
an	O
essential	O
,	O
noncompensated	O
role	O
in	O
neuronal	O
saltatory	O
migration	O
in	O
vivo	O
and	O
highlights	O
the	O
importance	O
of	O
MT	O
flexibility	O
in	O
N	O
-	O
C	O
coupling	O
and	O
neuronal	O
-	O
branching	O
regulation	O
during	O
neuronal	O
migration	O
.	O

Mutation	O
of	O
the	O
gene1s	ARG2
a	ARG2
-	ARG2
tubulin	ARG2
gene1e	ARG2
gene1s	ARG2
Tuba1a	ARG2
gene1e	ARG2
leads	O
to	O
straighter	O
microtubules	O
and	O
perturbs	O
neuronal	O
migration	O
.	O
Brain	O
development	O
involves	O
extensive	O
migration	O
of	O
neurons	O
.	O
Microtubules	O
(	O
MTs	O
)	O
are	O
key	O
cellular	O
effectors	O
of	O
neuronal	O
displacement	O
that	O
are	O
assembled	O
from	O
gene1s	ARG2
a	ARG2
/	ARG2
b	ARG2
-	ARG2
tubulin	ARG2
gene1e	ARG2
heterodimers	O
.	O
Mutation	O
of	O
the	O
gene1s	O
a	O
-	O
tubulin	O
gene1e	O
isotype	O
gene1s	O
TUBA1A	O
gene1e	O
is	O
associated	O
with	O
cortical	O
malformations	O
in	O
species1s	O
humans	O
species1e	O
.	O
In	O
this	O
study	O
,	O
we	O
provide	O
detailed	O
in	O
vivo	O
and	O
in	O
vitro	O
analyses	O
of	O
gene1s	ARG2
Tuba1a	ARG2
gene1e	ARG2
mutants	O
.	O
In	O
arg1s	O
mice	O
arg1e	O
carrying	O
a	O
gene1s	ARG2
Tuba1a	ARG2
gene1e	ARG2
missense	O
mutation	O
(	O
S140	O
G	O
)	O
,	O
neurons	O
accumulate	O
,	O
and	O
glial	O
cells	O
are	O
dispersed	O
along	O
the	O
rostral	O
migratory	O
stream	O
in	O
postnatal	O
and	O
adult	O
brains	O
.	O
Live	O
imaging	O
of	O
gene1s	ARG2
Tuba1a	ARG2
gene1e	ARG2
-	O
mutant	O
neurons	O
revealed	O
slowed	O
migration	O
and	O
increased	O
neuronal	O
branching	O
,	O
which	O
correlated	O
with	O
directionality	O
alterations	O
and	O
perturbed	O
nucleus	O
-	O
centrosome	O
(	O
N	O
-	O
C	O
)	O
coupling	O
.	O
gene1s	ARG2
Tuba1a	ARG2
gene1e	ARG2
mutation	O
led	O
to	O
increased	O
straightness	O
of	O
newly	O
polymerized	O
MTs	O
,	O
and	O
structural	O
modeling	O
data	O
suggest	O
a	O
conformational	O
change	O
in	O
the	O
gene1s	ARG2
a	ARG2
/	ARG2
b	ARG2
-	ARG2
tubulin	ARG2
gene1e	ARG2
heterodimer	O
.	O
We	O
show	O
that	O
gene1s	ARG2
Tuba8	ARG2
gene1e	ARG2
,	O
another	O
gene1s	ARG2
a	ARG2
-	ARG2
tubulin	ARG2
gene1e	ARG2
isotype	O
previously	O
associated	O
with	O
cortical	O
malformations	O
,	O
has	O
altered	O
function	O
compared	O
with	O
gene1s	ARG2
Tuba1a	ARG2
gene1e	ARG2
.	O
Our	O
work	O
shows	O
that	O
gene1s	ARG2
Tuba1a	ARG2
gene1e	ARG2
plays	O
an	O
essential	O
,	O
noncompensated	O
role	O
in	O
neuronal	O
saltatory	O
migration	O
in	O
vivo	O
and	O
highlights	O
the	O
importance	O
of	O
MT	O
flexibility	O
in	O
N	O
-	O
C	O
coupling	O
and	O
neuronal	O
-	O
branching	O
regulation	O
during	O
neuronal	O
migration	O
.	O

gene1s	O
IGFBP1	O
gene1e	O
increases	O
b	O
-	O
cell	O
regeneration	O
by	O
promoting	O
a-	O
to	O
b	O
-	O
cell	O
transdifferentiation	O
.	O
There	O
is	O
great	O
interest	O
in	O
therapeutically	O
harnessing	O
endogenous	O
regenerative	O
mechanisms	O
to	O
increase	O
the	O
number	O
of	O
b	O
cells	O
in	O
arg1s	O
people	O
arg1e	O
with	O
diabetes	O
.	O
By	O
performing	O
whole	O
-	O
genome	O
expression	O
profiling	O
of	O
species1s	O
zebrafish	O
species1e	O
islets	O
,	O
we	O
identified	O
11	O
secreted	O
proteins	O
that	O
are	O
upregulated	O
during	O
b	O
-	O
cell	O
regeneration	O
.	O
We	O
then	O
tested	O
the	O
proteins	O
'	O
ability	O
to	O
potentiate	O
b	O
-	O
cell	O
regeneration	O
in	O
species1s	O
zebrafish	O
species1e	O
at	O
supraphysiological	O
levels	O
.	O
One	O
protein	O
,	O
gene1s	O
insulin	O
-	O
like	O
growth	O
factor	O
(	O
Igf	O
)	O
binding	O
-	O
protein	O
1	O
gene1e	O
(	O
gene1s	O
Igfbp1	O
gene1e	O
)	O
,	O
potently	O
promoted	O
b	O
-	O
cell	O
regeneration	O
by	O
potentiating	O
a-	O
to	O
b	O
-	O
cell	O
transdifferentiation	O
.	O
Using	O
various	O
inhibitors	O
and	O
activators	O
of	O
the	O
gene1s	O
Igf	O
gene1e	O
pathway	O
,	O
we	O
show	O
that	O
gene1s	O
Igfbp1	O
gene1e	O
exerts	O
its	O
regenerative	O
effect	O
,	O
at	O
least	O
partly	O
,	O
by	O
inhibiting	O
gene1s	O
Igf	O
gene1e	O
signaling	O
.	O
gene1s	O
Igfbp1	O
gene1e	O
's	O
effect	O
on	O
transdifferentiation	O
appears	O
conserved	O
across	O
species	O
:	O
Treating	O
species1s	O
mouse	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
islets	O
with	O
recombinant	O
gene1s	ARG2
IGFBP1	ARG2
gene1e	ARG2
in	O
vitro	O
increased	O
the	O
number	O
of	O
cells	O
co	O
-	O
expressing	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
glucagon	ARG2
gene1e	ARG2
threefold	O
.	O
Moreover	O
,	O
a	O
prospective	O
arg1s	O
human	O
arg1e	O
study	O
showed	O
that	O
having	O
high	O
gene1s	ARG2
IGFBP1	ARG2
gene1e	ARG2
levels	O
reduces	O
the	O
risk	O
of	O
developing	O
type-2	O
diabetes	O
by	O
more	O
than	O
85	O
%	O
.	O
Thus	O
,	O
we	O
identify	O
gene1s	O
IGFBP1	O
gene1e	O
as	O
an	O
endogenous	O
promoter	O
of	O
b	O
-	O
cell	O
regeneration	O
and	O
highlight	O
its	O
clinical	O
importance	O
in	O
diabetes	O
.	O

gene1s	ARG2
IGFBP1	ARG2
gene1e	ARG2
increases	O
b	O
-	O
cell	O
regeneration	O
by	O
promoting	O
a-	O
to	O
b	O
-	O
cell	O
transdifferentiation	O
.	O
There	O
is	O
great	O
interest	O
in	O
therapeutically	O
harnessing	O
endogenous	O
regenerative	O
mechanisms	O
to	O
increase	O
the	O
number	O
of	O
b	O
cells	O
in	O
species1s	O
people	O
species1e	O
with	O
diabetes	O
.	O
By	O
performing	O
whole	O
-	O
genome	O
expression	O
profiling	O
of	O
arg1s	O
zebrafish	O
arg1e	O
islets	O
,	O
we	O
identified	O
11	O
secreted	O
proteins	O
that	O
are	O
upregulated	O
during	O
b	O
-	O
cell	O
regeneration	O
.	O
We	O
then	O
tested	O
the	O
proteins	O
'	O
ability	O
to	O
potentiate	O
b	O
-	O
cell	O
regeneration	O
in	O
arg1s	O
zebrafish	O
arg1e	O
at	O
supraphysiological	O
levels	O
.	O
One	O
protein	O
,	O
gene1s	ARG2
insulin	ARG2
-	ARG2
like	ARG2
growth	ARG2
factor	ARG2
(	ARG2
Igf	ARG2
)	ARG2
binding	ARG2
-	ARG2
protein	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Igfbp1	ARG2
gene1e	ARG2
)	O
,	O
potently	O
promoted	O
b	O
-	O
cell	O
regeneration	O
by	O
potentiating	O
a-	O
to	O
b	O
-	O
cell	O
transdifferentiation	O
.	O
Using	O
various	O
inhibitors	O
and	O
activators	O
of	O
the	O
gene1s	ARG2
Igf	ARG2
gene1e	ARG2
pathway	O
,	O
we	O
show	O
that	O
gene1s	ARG2
Igfbp1	ARG2
gene1e	ARG2
exerts	O
its	O
regenerative	O
effect	O
,	O
at	O
least	O
partly	O
,	O
by	O
inhibiting	O
gene1s	ARG2
Igf	ARG2
gene1e	ARG2
signaling	O
.	O
gene1s	ARG2
Igfbp1	ARG2
gene1e	ARG2
's	O
effect	O
on	O
transdifferentiation	O
appears	O
conserved	O
across	O
species	O
:	O
Treating	O
species1s	O
mouse	O
species1e	O
and	O
species1s	O
human	O
species1e	O
islets	O
with	O
recombinant	O
gene1s	O
IGFBP1	O
gene1e	O
in	O
vitro	O
increased	O
the	O
number	O
of	O
cells	O
co	O
-	O
expressing	O
gene1s	O
insulin	O
gene1e	O
and	O
gene1s	O
glucagon	O
gene1e	O
threefold	O
.	O
Moreover	O
,	O
a	O
prospective	O
species1s	O
human	O
species1e	O
study	O
showed	O
that	O
having	O
high	O
gene1s	O
IGFBP1	O
gene1e	O
levels	O
reduces	O
the	O
risk	O
of	O
developing	O
type-2	O
diabetes	O
by	O
more	O
than	O
85	O
%	O
.	O
Thus	O
,	O
we	O
identify	O
gene1s	ARG2
IGFBP1	ARG2
gene1e	ARG2
as	O
an	O
endogenous	O
promoter	O
of	O
b	O
-	O
cell	O
regeneration	O
and	O
highlight	O
its	O
clinical	O
importance	O
in	O
diabetes	O
.	O

gene1s	O
IGFBP1	O
gene1e	O
increases	O
b	O
-	O
cell	O
regeneration	O
by	O
promoting	O
a-	O
to	O
b	O
-	O
cell	O
transdifferentiation	O
.	O
There	O
is	O
great	O
interest	O
in	O
therapeutically	O
harnessing	O
endogenous	O
regenerative	O
mechanisms	O
to	O
increase	O
the	O
number	O
of	O
b	O
cells	O
in	O
species1s	O
people	O
species1e	O
with	O
diabetes	O
.	O
By	O
performing	O
whole	O
-	O
genome	O
expression	O
profiling	O
of	O
species1s	O
zebrafish	O
species1e	O
islets	O
,	O
we	O
identified	O
11	O
secreted	O
proteins	O
that	O
are	O
upregulated	O
during	O
b	O
-	O
cell	O
regeneration	O
.	O
We	O
then	O
tested	O
the	O
proteins	O
'	O
ability	O
to	O
potentiate	O
b	O
-	O
cell	O
regeneration	O
in	O
species1s	O
zebrafish	O
species1e	O
at	O
supraphysiological	O
levels	O
.	O
One	O
protein	O
,	O
gene1s	O
insulin	O
-	O
like	O
growth	O
factor	O
(	O
Igf	O
)	O
binding	O
-	O
protein	O
1	O
gene1e	O
(	O
gene1s	O
Igfbp1	O
gene1e	O
)	O
,	O
potently	O
promoted	O
b	O
-	O
cell	O
regeneration	O
by	O
potentiating	O
a-	O
to	O
b	O
-	O
cell	O
transdifferentiation	O
.	O
Using	O
various	O
inhibitors	O
and	O
activators	O
of	O
the	O
gene1s	O
Igf	O
gene1e	O
pathway	O
,	O
we	O
show	O
that	O
gene1s	O
Igfbp1	O
gene1e	O
exerts	O
its	O
regenerative	O
effect	O
,	O
at	O
least	O
partly	O
,	O
by	O
inhibiting	O
gene1s	O
Igf	O
gene1e	O
signaling	O
.	O
gene1s	O
Igfbp1	O
gene1e	O
's	O
effect	O
on	O
transdifferentiation	O
appears	O
conserved	O
across	O
species	O
:	O
Treating	O
arg1s	O
mouse	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
islets	O
with	O
recombinant	O
gene1s	ARG2
IGFBP1	ARG2
gene1e	ARG2
in	O
vitro	O
increased	O
the	O
number	O
of	O
cells	O
co	O
-	O
expressing	O
gene1s	O
insulin	O
gene1e	O
and	O
gene1s	O
glucagon	O
gene1e	O
threefold	O
.	O
Moreover	O
,	O
a	O
prospective	O
species1s	O
human	O
species1e	O
study	O
showed	O
that	O
having	O
high	O
gene1s	O
IGFBP1	O
gene1e	O
levels	O
reduces	O
the	O
risk	O
of	O
developing	O
type-2	O
diabetes	O
by	O
more	O
than	O
85	O
%	O
.	O
Thus	O
,	O
we	O
identify	O
gene1s	O
IGFBP1	O
gene1e	O
as	O
an	O
endogenous	O
promoter	O
of	O
b	O
-	O
cell	O
regeneration	O
and	O
highlight	O
its	O
clinical	O
importance	O
in	O
diabetes	O
.	O

Atorvastatin	O
protects	O
against	O
contrast	O
-	O
induced	O
nephropathy	O
via	O
anti	O
-	O
apoptosis	O
by	O
the	O
upregulation	O
of	O
gene1s	ARG2
Hsp27	ARG2
gene1e	ARG2
in	O
vivo	O
and	O
in	O
vitro	O
.	O
Contrast	O
-	O
induced	O
nephropathy	O
(	O
CIN	O
)	O
is	O
an	O
iatrogenic	O
acute	O
renal	O
failure	O
occurring	O
following	O
the	O
intravascular	O
injection	O
of	O
iodinated	O
radiographic	O
contrast	O
medium	O
.	O
However	O
,	O
the	O
regulatory	O
mechanisms	O
for	O
CIN	O
remain	O
to	O
be	O
fully	O
elucidated	O
.	O
The	O
present	O
study	O
aimed	O
to	O
investigate	O
whether	O
atorvastatin	O
protects	O
against	O
CIN	O
via	O
anti	O
-	O
apoptotic	O
effects	O
by	O
the	O
upregulation	O
of	O
gene1s	ARG2
Hsp27	ARG2
gene1e	ARG2
in	O
vivo	O
and	O
in	O
vitro	O
.	O
To	O
determine	O
whether	O
atorvastatin	O
attenuated	O
CIN	O
,	O
the	O
inflammatory	O
response	O
and	O
apoptosis	O
in	O
vivo	O
and	O
in	O
vitro	O
,	O
a	O
arg1s	O
rat	O
arg1e	O
model	O
of	O
iopamidol	O
-	O
induced	O
CIN	O
was	O
used	O
,	O
and	O
species1s	O
human	O
species1e	O
embryonic	O
proximal	O
tubule	O
(	O
HK2	O
)	O
cell	O
damage	O
was	O
assessed	O
.	O
The	O
arg1s	O
rats	O
arg1e	O
were	O
assigned	O
into	O
four	O
groups	O
(	O
n=10	O
per	O
group	O
)	O
,	O
as	O
follows	O
:	O
Control	O
arg1s	O
rats	O
arg1e	O
;	O
arg1s	O
rats	O
arg1e	O
+atorvastatin	O
;	O
arg1s	O
rats	O
arg1e	O
+	O
iopamidol	O
;	O
arg1s	O
rats	O
arg1e	O
+iopamidol+atorvastatin	O
.	O
In	O
vitro	O
,	O
the	O
HK2	O
cells	O
were	O
treated	O
with	O
iopamidol	O
in	O
the	O
presence	O
or	O
absence	O
of	O
atorvastatin	O
,	O
gene1s	O
heat	O
shock	O
protein	O
(	O
Hsp)27	O
gene1e	O
small	O
interfering	O
(	O
si)RNA	O
or	O
pcDNA3.1-	O
gene1s	O
Hsp27	O
gene1e	O
.	O
The	O
renal	O
tissues	O
were	O
examined	O
histopathologically	O
and	O
collected	O
for	O
western	O
blot	O
analysis	O
.	O
The	O
results	O
showed	O
that	O
atorvastatin	O
ameliorated	O
the	O
apoptosis	O
and	O
deterioration	O
of	O
renal	O
function	O
(	O
P<0.05	O
)	O
.	O
Furthermore	O
,	O
atorvastatin	O
reduced	O
the	O
iopamidol	O
-	O
induced	O
activity	O
of	O
gene1s	ARG2
B	ARG2
cell	ARG2
lymphoma-2	ARG2
gene1e	ARG2
gene1s	ARG2
(	ARG2
Bcl-2)-associated	ARG2
X	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
)/	O
gene1s	ARG2
caspase-3	ARG2
gene1e	ARG2
and	O
increased	O
the	O
expression	O
of	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
in	O
vivo	O
and	O
in	O
vitro	O
.	O
Notably	O
,	O
following	O
treatment	O
with	O
gene1s	O
Hsp27	O
gene1e	O
siRNA	O
or	O
pcDNA3.1-	O
gene1s	O
Hsp27	O
gene1e	O
,	O
it	O
was	O
found	O
that	O
iopamidol	O
enhanced	O
or	O
weakened	O
the	O
upregulation	O
of	O
gene1s	O
Bax	O
gene1e	O
/	O
gene1s	O
caspase-3	O
gene1e	O
and	O
downregulation	O
of	O
gene1s	O
Bcl-2	O
gene1e	O
in	O
the	O
HK2	O
cells	O
,	O
respectively	O
.	O
The	O
results	O
of	O
the	O
present	O
study	O
suggested	O
that	O
atorvastatin	O
protected	O
against	O
contrast	O
-	O
induced	O
renal	O
tubular	O
cell	O
apoptosis	O
through	O
the	O
upregulation	O
of	O
gene1s	ARG2
Hsp27	ARG2
gene1e	ARG2
in	O
vivo	O
and	O
in	O
vitro	O
.	O

Atorvastatin	O
protects	O
against	O
contrast	O
-	O
induced	O
nephropathy	O
via	O
anti	O
-	O
apoptosis	O
by	O
the	O
upregulation	O
of	O
gene1s	O
Hsp27	O
gene1e	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O
Contrast	O
-	O
induced	O
nephropathy	O
(	O
CIN	O
)	O
is	O
an	O
iatrogenic	O
acute	O
renal	O
failure	O
occurring	O
following	O
the	O
intravascular	O
injection	O
of	O
iodinated	O
radiographic	O
contrast	O
medium	O
.	O
However	O
,	O
the	O
regulatory	O
mechanisms	O
for	O
CIN	O
remain	O
to	O
be	O
fully	O
elucidated	O
.	O
The	O
present	O
study	O
aimed	O
to	O
investigate	O
whether	O
atorvastatin	O
protects	O
against	O
CIN	O
via	O
anti	O
-	O
apoptotic	O
effects	O
by	O
the	O
upregulation	O
of	O
gene1s	O
Hsp27	O
gene1e	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O
To	O
determine	O
whether	O
atorvastatin	O
attenuated	O
CIN	O
,	O
the	O
inflammatory	O
response	O
and	O
apoptosis	O
in	O
vivo	O
and	O
in	O
vitro	O
,	O
a	O
species1s	O
rat	O
species1e	O
model	O
of	O
iopamidol	O
-	O
induced	O
CIN	O
was	O
used	O
,	O
and	O
arg1s	O
human	O
arg1e	O
embryonic	O
proximal	O
tubule	O
(	O
HK2	O
)	O
cell	O
damage	O
was	O
assessed	O
.	O
The	O
species1s	O
rats	O
species1e	O
were	O
assigned	O
into	O
four	O
groups	O
(	O
n=10	O
per	O
group	O
)	O
,	O
as	O
follows	O
:	O
Control	O
species1s	O
rats	O
species1e	O
;	O
species1s	O
rats	O
species1e	O
+atorvastatin	O
;	O
species1s	O
rats	O
species1e	O
+	O
iopamidol	O
;	O
species1s	O
rats	O
species1e	O
+iopamidol+atorvastatin	O
.	O
In	O
vitro	O
,	O
the	O
HK2	O
cells	O
were	O
treated	O
with	O
iopamidol	O
in	O
the	O
presence	O
or	O
absence	O
of	O
atorvastatin	O
,	O
gene1s	ARG2
heat	ARG2
shock	ARG2
protein	ARG2
(	ARG2
Hsp)27	ARG2
gene1e	ARG2
small	O
interfering	O
(	O
si)RNA	O
or	O
pcDNA3.1-	O
gene1s	ARG2
Hsp27	ARG2
gene1e	ARG2
.	O
The	O
renal	O
tissues	O
were	O
examined	O
histopathologically	O
and	O
collected	O
for	O
western	O
blot	O
analysis	O
.	O
The	O
results	O
showed	O
that	O
atorvastatin	O
ameliorated	O
the	O
apoptosis	O
and	O
deterioration	O
of	O
renal	O
function	O
(	O
P<0.05	O
)	O
.	O
Furthermore	O
,	O
atorvastatin	O
reduced	O
the	O
iopamidol	O
-	O
induced	O
activity	O
of	O
gene1s	O
B	O
cell	O
lymphoma-2	O
gene1e	O
gene1s	O
(	O
Bcl-2)-associated	O
X	O
protein	O
gene1e	O
(	O
gene1s	O
Bax	O
gene1e	O
)/	O
gene1s	O
caspase-3	O
gene1e	O
and	O
increased	O
the	O
expression	O
of	O
gene1s	O
Bcl-2	O
gene1e	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O
Notably	O
,	O
following	O
treatment	O
with	O
gene1s	ARG2
Hsp27	ARG2
gene1e	ARG2
siRNA	O
or	O
pcDNA3.1-	O
gene1s	ARG2
Hsp27	ARG2
gene1e	ARG2
,	O
it	O
was	O
found	O
that	O
iopamidol	O
enhanced	O
or	O
weakened	O
the	O
upregulation	O
of	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
caspase-3	ARG2
gene1e	ARG2
and	O
downregulation	O
of	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
in	O
the	O
HK2	O
cells	O
,	O
respectively	O
.	O
The	O
results	O
of	O
the	O
present	O
study	O
suggested	O
that	O
atorvastatin	O
protected	O
against	O
contrast	O
-	O
induced	O
renal	O
tubular	O
cell	O
apoptosis	O
through	O
the	O
upregulation	O
of	O
gene1s	O
Hsp27	O
gene1e	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O

Curcumin	O
decreases	O
gene1s	ARG2
specificity	ARG2
protein	ARG2
gene1e	ARG2
expression	O
in	O
bladder	O
cancer	O
cells	O
.	O
Curcumin	O
is	O
the	O
active	O
component	O
of	O
tumeric	O
,	O
and	O
this	O
polyphenolic	O
compound	O
has	O
been	O
extensively	O
investigated	O
as	O
an	O
anticancer	O
drug	O
that	O
modulates	O
multiple	O
pathways	O
and	O
genes	O
.	O
In	O
this	O
study	O
,	O
10	O
to	O
25	O
micromol	O
/	O
L	O
curcumin	O
inhibited	O
arg1s	O
253JB	O
-	O
V	O
arg1e	O
and	O
arg1s	O
KU7	O
arg1e	O
bladder	O
cancer	O
cell	O
growth	O
,	O
and	O
this	O
was	O
accompanied	O
by	O
induction	O
of	O
apoptosis	O
and	O
decreased	O
expression	O
of	O
the	O
gene1s	ARG2
proapoptotic	ARG2
protein	ARG2
gene1e	ARG2
gene1s	ARG2
survivin	ARG2
gene1e	ARG2
and	O
the	O
gene1s	ARG2
angiogenic	ARG2
proteins	ARG2
gene1e	ARG2
gene1s	ARG2
vascular	ARG2
endothelial	ARG2
growth	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
VEGF	ARG2
receptor	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
VEGFR1	ARG2
gene1e	ARG2
)	O
.	O
Because	O
expression	O
of	O
gene1s	ARG2
survivin	ARG2
,	ARG2
gene1e	ARG2
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
VEGFR1	ARG2
gene1e	ARG2
are	O
dependent	O
on	O
gene1s	ARG2
specificity	ARG2
protein	ARG2
(	ARG2
Sp	ARG2
)	ARG2
transcription	ARG2
factors	ARG2
gene1e	ARG2
,	O
we	O
also	O
investigated	O
the	O
effects	O
of	O
curcumin	O
on	O
gene1s	ARG2
Sp	ARG2
protein	ARG2
gene1e	ARG2
expression	O
as	O
an	O
underlying	O
mechanism	O
for	O
the	O
apoptotic	O
and	O
antiangiogenic	O
activity	O
of	O
this	O
compound	O
.	O
The	O
results	O
show	O
that	O
curcumin	O
induced	O
gene1s	ARG2
proteasome	ARG2
gene1e	ARG2
-	O
dependent	O
down	O
-	O
regulation	O
of	O
gene1s	ARG2
Sp1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Sp3	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Sp4	ARG2
gene1e	ARG2
in	O
arg1s	O
253JB	O
-	O
V	O
arg1e	O
and	O
arg1s	O
KU7	O
arg1e	O
cells	O
.	O
Moreover	O
,	O
using	O
RNA	O
interference	O
with	O
small	O
inhibitory	O
RNAs	O
for	O
gene1s	ARG2
Sp1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Sp3	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Sp4	ARG2
gene1e	ARG2
,	O
we	O
observed	O
that	O
curcumin	O
-	O
dependent	O
inhibition	O
of	O
gene1s	ARG2
nuclear	ARG2
factor	ARG2
kappaB	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
)-dependent	O
genes	O
,	O
such	O
as	O
gene1s	ARG2
bcl-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
survivin	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
cyclin	ARG2
D1	ARG2
gene1e	ARG2
,	O
was	O
also	O
due	O
,	O
in	O
part	O
,	O
to	O
loss	O
of	O
gene1s	ARG2
Sp	ARG2
gene1e	ARG2
proteins	O
.	O
Curcumin	O
also	O
decreased	O
bladder	O
tumor	O
growth	O
in	O
athymic	O
species1s	O
nude	O
mice	O
species1e	O
bearing	O
arg1s	O
KU7	O
arg1e	O
cells	O
as	O
xenografts	O
and	O
this	O
was	O
accompanied	O
by	O
decreased	O
gene1s	O
Sp1	O
gene1e	O
,	O
gene1s	ARG2
Sp3	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Sp4	ARG2
gene1e	ARG2
protein	O
levels	O
in	O
tumors	O
.	O
These	O
results	O
show	O
for	O
the	O
first	O
time	O
that	O
one	O
of	O
the	O
underlying	O
mechanisms	O
of	O
action	O
of	O
curcumin	O
as	O
a	O
cancer	O
chemotherapeutic	O
agent	O
is	O
due	O
,	O
in	O
part	O
,	O
to	O
decreased	O
expression	O
of	O
gene1s	ARG2
Sp	ARG2
transcription	ARG2
factors	ARG2
gene1e	ARG2
in	O
bladder	O
cancer	O
cells	O
.	O

Curcumin	O
decreases	O
gene1s	O
specificity	O
protein	O
gene1e	O
expression	O
in	O
bladder	O
cancer	O
cells	O
.	O
Curcumin	O
is	O
the	O
active	O
component	O
of	O
tumeric	O
,	O
and	O
this	O
polyphenolic	O
compound	O
has	O
been	O
extensively	O
investigated	O
as	O
an	O
anticancer	O
drug	O
that	O
modulates	O
multiple	O
pathways	O
and	O
genes	O
.	O
In	O
this	O
study	O
,	O
10	O
to	O
25	O
micromol	O
/	O
L	O
curcumin	O
inhibited	O
species1s	O
253JB	O
-	O
V	O
species1e	O
and	O
species1s	O
KU7	O
species1e	O
bladder	O
cancer	O
cell	O
growth	O
,	O
and	O
this	O
was	O
accompanied	O
by	O
induction	O
of	O
apoptosis	O
and	O
decreased	O
expression	O
of	O
the	O
gene1s	O
proapoptotic	O
protein	O
gene1e	O
gene1s	O
survivin	O
gene1e	O
and	O
the	O
gene1s	O
angiogenic	O
proteins	O
gene1e	O
gene1s	O
vascular	O
endothelial	O
growth	O
factor	O
gene1e	O
(	O
gene1s	O
VEGF	O
gene1e	O
)	O
and	O
gene1s	O
VEGF	O
receptor	O
1	O
gene1e	O
(	O
gene1s	O
VEGFR1	O
gene1e	O
)	O
.	O
Because	O
expression	O
of	O
gene1s	O
survivin	O
,	O
gene1e	O
gene1s	O
VEGF	O
gene1e	O
,	O
and	O
gene1s	O
VEGFR1	O
gene1e	O
are	O
dependent	O
on	O
gene1s	O
specificity	O
protein	O
(	O
Sp	O
)	O
transcription	O
factors	O
gene1e	O
,	O
we	O
also	O
investigated	O
the	O
effects	O
of	O
curcumin	O
on	O
gene1s	O
Sp	O
protein	O
gene1e	O
expression	O
as	O
an	O
underlying	O
mechanism	O
for	O
the	O
apoptotic	O
and	O
antiangiogenic	O
activity	O
of	O
this	O
compound	O
.	O
The	O
results	O
show	O
that	O
curcumin	O
induced	O
gene1s	O
proteasome	O
gene1e	O
-	O
dependent	O
down	O
-	O
regulation	O
of	O
gene1s	O
Sp1	O
gene1e	O
,	O
gene1s	O
Sp3	O
gene1e	O
,	O
and	O
gene1s	O
Sp4	O
gene1e	O
in	O
species1s	O
253JB	O
-	O
V	O
species1e	O
and	O
species1s	O
KU7	O
species1e	O
cells	O
.	O
Moreover	O
,	O
using	O
RNA	O
interference	O
with	O
small	O
inhibitory	O
RNAs	O
for	O
gene1s	O
Sp1	O
gene1e	O
,	O
gene1s	O
Sp3	O
gene1e	O
,	O
and	O
gene1s	O
Sp4	O
gene1e	O
,	O
we	O
observed	O
that	O
curcumin	O
-	O
dependent	O
inhibition	O
of	O
gene1s	O
nuclear	O
factor	O
kappaB	O
gene1e	O
(	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
)-dependent	O
genes	O
,	O
such	O
as	O
gene1s	O
bcl-2	O
gene1e	O
,	O
gene1s	O
survivin	O
gene1e	O
,	O
and	O
gene1s	O
cyclin	O
D1	O
gene1e	O
,	O
was	O
also	O
due	O
,	O
in	O
part	O
,	O
to	O
loss	O
of	O
gene1s	O
Sp	O
gene1e	O
proteins	O
.	O
Curcumin	O
also	O
decreased	O
bladder	O
tumor	O
growth	O
in	O
athymic	O
arg1s	O
nude	O
mice	O
arg1e	O
bearing	O
species1s	O
KU7	O
species1e	O
cells	O
as	O
xenografts	O
and	O
this	O
was	O
accompanied	O
by	O
decreased	O
gene1s	ARG2
Sp1	ARG2
gene1e	ARG2
,	O
gene1s	O
Sp3	O
gene1e	O
,	O
and	O
gene1s	O
Sp4	O
gene1e	O
protein	O
levels	O
in	O
tumors	O
.	O
These	O
results	O
show	O
for	O
the	O
first	O
time	O
that	O
one	O
of	O
the	O
underlying	O
mechanisms	O
of	O
action	O
of	O
curcumin	O
as	O
a	O
cancer	O
chemotherapeutic	O
agent	O
is	O
due	O
,	O
in	O
part	O
,	O
to	O
decreased	O
expression	O
of	O
gene1s	O
Sp	O
transcription	O
factors	O
gene1e	O
in	O
bladder	O
cancer	O
cells	O
.	O

A	O
Role	O
for	O
Androgens	O
in	O
Epithelial	O
Proliferation	O
and	O
Formation	O
of	O
Glands	O
in	O
the	O
arg1s	O
Mouse	O
arg1e	O
Uterus	O
.	O
The	O
endometrium	O
consists	O
of	O
stromal	O
and	O
epithelial	O
compartments	O
(	O
luminal	O
and	O
glandular	O
)	O
with	O
distinct	O
functions	O
in	O
the	O
regulation	O
of	O
uterine	O
homeostasis	O
.	O
Ovarian	O
sex	O
steroids	O
,	O
namely	O
17b	O
-	O
estradiol	O
and	O
progesterone	O
,	O
play	O
essential	O
roles	O
in	O
modulating	O
uterine	O
cell	O
proliferation	O
,	O
stromal	O
-	O
epithelial	O
cross	O
-	O
talk	O
and	O
differentiation	O
in	O
preparation	O
for	O
pregnancy	O
.	O
The	O
effect	O
of	O
androgens	O
on	O
uterine	O
function	O
remains	O
poorly	O
understood	O
.	O
The	O
current	O
study	O
investigated	O
the	O
effect	O
of	O
the	O
non	O
-	O
aromatizable	O
androgen	O
dihydrotestosterone	O
(	O
DHT	O
)	O
on	O
arg1s	O
mouse	O
arg1e	O
endometrial	O
function	O
.	O
Ovx	O
female	O
arg1s	O
mice	O
arg1e	O
were	O
given	O
a	O
single	O
sc	O
injection	O
(	O
short	O
treatment	O
)	O
or	O
7	O
daily	O
injections	O
(	O
long	O
treatment	O
)	O
of	O
vehicle	O
alone	O
(	O
5	O
%	O
ethanol	O
,	O
0.4	O
%	O
methylcellulose	O
)	O
or	O
vehicle	O
with	O
the	O
addition	O
of	O
0.2	O
mg	O
DHT	O
(	O
n=8	O
/	O
group	O
)	O
and	O
a	O
single	O
injection	O
of	O
bromodeoxyuridine	O
2	O
hours	O
prior	O
to	O
tissue	O
recovery	O
.	O
Treatment	O
with	O
DHT	O
increased	O
uterine	O
weight	O
,	O
the	O
area	O
of	O
the	O
endometrial	O
compartment	O
and	O
immunoexpression	O
of	O
the	O
gene1s	ARG2
androgen	ARG2
receptor	ARG2
gene1e	ARG2
in	O
the	O
luminal	O
and	O
glandular	O
epithelium	O
.	O
Treatment	O
-	O
dependent	O
proliferation	O
of	O
epithelial	O
cells	O
was	O
identified	O
by	O
immunostaining	O
for	O
gene1s	ARG2
MKi67	ARG2
gene1e	ARG2
and	O
bromodeoxyuridine	O
.	O
Real	O
-	O
time	O
PCR	O
identified	O
significant	O
DHT	O
-	O
dependent	O
changes	O
in	O
the	O
concentrations	O
of	O
mRNAs	O
encoded	O
by	O
genes	O
implicated	O
in	O
the	O
regulation	O
of	O
the	O
cell	O
cycle	O
(	O
gene1s	ARG2
Wee1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Ccnd1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Rb1	ARG2
gene1e	ARG2
)	O
and	O
stromal	O
-	O
epithelial	O
interactions	O
(	O
gene1s	ARG2
Wnt4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Wnt5a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Wnt7a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Cdh1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Vcl	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Igf1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Prl8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Prlr	ARG2
gene1e	ARG2
)	O
as	O
well	O
as	O
a	O
striking	O
effect	O
on	O
the	O
number	O
of	O
endometrial	O
glands	O
.	O
This	O
study	O
has	O
revealed	O
a	O
novel	O
role	O
for	O
androgens	O
in	O
regulating	O
uterine	O
function	O
with	O
an	O
effect	O
on	O
the	O
glandular	O
compartment	O
of	O
the	O
endometrium	O
.	O
This	O
previously	O
unrecognized	O
role	O
for	O
androgens	O
has	O
implications	O
for	O
our	O
understanding	O
of	O
the	O
role	O
of	O
androgens	O
in	O
regulation	O
of	O
endometrial	O
function	O
and	O
fertility	O
in	O
species1s	O
women	O
species1e	O
.	O

A	O
Role	O
for	O
Androgens	O
in	O
Epithelial	O
Proliferation	O
and	O
Formation	O
of	O
Glands	O
in	O
the	O
species1s	O
Mouse	O
species1e	O
Uterus	O
.	O
The	O
endometrium	O
consists	O
of	O
stromal	O
and	O
epithelial	O
compartments	O
(	O
luminal	O
and	O
glandular	O
)	O
with	O
distinct	O
functions	O
in	O
the	O
regulation	O
of	O
uterine	O
homeostasis	O
.	O
Ovarian	O
sex	O
steroids	O
,	O
namely	O
17b	O
-	O
estradiol	O
and	O
progesterone	O
,	O
play	O
essential	O
roles	O
in	O
modulating	O
uterine	O
cell	O
proliferation	O
,	O
stromal	O
-	O
epithelial	O
cross	O
-	O
talk	O
and	O
differentiation	O
in	O
preparation	O
for	O
pregnancy	O
.	O
The	O
effect	O
of	O
androgens	O
on	O
uterine	O
function	O
remains	O
poorly	O
understood	O
.	O
The	O
current	O
study	O
investigated	O
the	O
effect	O
of	O
the	O
non	O
-	O
aromatizable	O
androgen	O
dihydrotestosterone	O
(	O
DHT	O
)	O
on	O
species1s	O
mouse	O
species1e	O
endometrial	O
function	O
.	O
Ovx	O
female	O
species1s	O
mice	O
species1e	O
were	O
given	O
a	O
single	O
sc	O
injection	O
(	O
short	O
treatment	O
)	O
or	O
7	O
daily	O
injections	O
(	O
long	O
treatment	O
)	O
of	O
vehicle	O
alone	O
(	O
5	O
%	O
ethanol	O
,	O
0.4	O
%	O
methylcellulose	O
)	O
or	O
vehicle	O
with	O
the	O
addition	O
of	O
0.2	O
mg	O
DHT	O
(	O
n=8	O
/	O
group	O
)	O
and	O
a	O
single	O
injection	O
of	O
bromodeoxyuridine	O
2	O
hours	O
prior	O
to	O
tissue	O
recovery	O
.	O
Treatment	O
with	O
DHT	O
increased	O
uterine	O
weight	O
,	O
the	O
area	O
of	O
the	O
endometrial	O
compartment	O
and	O
immunoexpression	O
of	O
the	O
gene1s	O
androgen	O
receptor	O
gene1e	O
in	O
the	O
luminal	O
and	O
glandular	O
epithelium	O
.	O
Treatment	O
-	O
dependent	O
proliferation	O
of	O
epithelial	O
cells	O
was	O
identified	O
by	O
immunostaining	O
for	O
gene1s	O
MKi67	O
gene1e	O
and	O
bromodeoxyuridine	O
.	O
Real	O
-	O
time	O
PCR	O
identified	O
significant	O
DHT	O
-	O
dependent	O
changes	O
in	O
the	O
concentrations	O
of	O
mRNAs	O
encoded	O
by	O
genes	O
implicated	O
in	O
the	O
regulation	O
of	O
the	O
cell	O
cycle	O
(	O
gene1s	O
Wee1	O
gene1e	O
,	O
gene1s	O
Ccnd1	O
gene1e	O
,	O
gene1s	O
Rb1	O
gene1e	O
)	O
and	O
stromal	O
-	O
epithelial	O
interactions	O
(	O
gene1s	O
Wnt4	O
gene1e	O
,	O
gene1s	O
Wnt5a	O
gene1e	O
,	O
gene1s	O
Wnt7a	O
gene1e	O
,	O
gene1s	O
Cdh1	O
gene1e	O
,	O
gene1s	O
Vcl	O
gene1e	O
,	O
gene1s	O
Igf1	O
gene1e	O
,	O
gene1s	O
Prl8	O
gene1e	O
,	O
gene1s	O
Prlr	O
gene1e	O
)	O
as	O
well	O
as	O
a	O
striking	O
effect	O
on	O
the	O
number	O
of	O
endometrial	O
glands	O
.	O
This	O
study	O
has	O
revealed	O
a	O
novel	O
role	O
for	O
androgens	O
in	O
regulating	O
uterine	O
function	O
with	O
an	O
effect	O
on	O
the	O
glandular	O
compartment	O
of	O
the	O
endometrium	O
.	O
This	O
previously	O
unrecognized	O
role	O
for	O
androgens	O
has	O
implications	O
for	O
our	O
understanding	O
of	O
the	O
role	O
of	O
androgens	O
in	O
regulation	O
of	O
endometrial	O
function	O
and	O
fertility	O
in	O
arg1s	O
women	O
arg1e	O
.	O

arg1s	O
S.	O
cerevisiae	O
arg1e	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
recruits	O
conjugated	O
gene1s	ARG2
SUMO	ARG2
gene1e	ARG2
moieties	O
to	O
facilitate	O
the	O
assembly	O
and	O
function	O
of	O
the	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Rad50	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Xrs2	ARG2
gene1e	ARG2
complex	O
.	O
Double	O
-	O
strand	O
breaks	O
(	O
DSBs	O
)	O
in	O
chromosomes	O
are	O
the	O
most	O
challenging	O
type	O
of	O
DNA	O
damage	O
.	O
The	O
arg1s	O
yeast	O
arg1e	O
and	O
species1s	O
mammalian	O
species1e	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Rad50	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Xrs2	ARG2
gene1e	ARG2
/	O
gene1s	O
Nbs1	O
gene1e	O
(	O
gene1s	ARG2
MRX	ARG2
/	ARG2
N	ARG2
gene1e	ARG2
)-	O
gene1s	ARG2
Sae2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Ctp1	ARG2
gene1e	ARG2
complex	O
catalyzes	O
the	O
resection	O
of	O
DSBs	O
induced	O
by	O
secondary	O
structures	O
,	O
chemical	O
adducts	O
or	O
covalently	O
-	O
attached	O
proteins	O
.	O
gene1s	ARG2
MRX	ARG2
/	ARG2
N	ARG2
gene1e	ARG2
also	O
initiates	O
two	O
parallel	O
DNA	O
damage	O
responses	O
-	O
checkpoint	O
phosphorylation	O
and	O
global	O
SUMOylation	O
-	O
to	O
boost	O
a	O
cell	O
's	O
ability	O
to	O
repair	O
DSBs	O
.	O
However	O
,	O
the	O
molecular	O
mechanism	O
of	O
this	O
gene1s	ARG2
SUMO	ARG2
gene1e	ARG2
-	O
mediated	O
response	O
is	O
not	O
completely	O
known	O
.	O
In	O
this	O
study	O
,	O
we	O
report	O
that	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
can	O
non	O
-	O
covalently	O
recruit	O
the	O
conjugated	O
gene1s	ARG2
SUMO	ARG2
gene1e	ARG2
moieties	O
,	O
particularly	O
the	O
poly	O
-	O
gene1s	ARG2
SUMO	ARG2
gene1e	ARG2
chain	O
.	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
has	O
two	O
evolutionarily	O
-	O
conserved	O
gene1s	ARG2
SUMO	ARG2
gene1e	ARG2
-	O
interacting	O
motifs	O
,	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
(SIM1	O
)	O
and	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
(SIM2	O
)	O
,	O
which	O
reside	O
on	O
the	O
outermost	O
surface	O
of	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
(SIM1	O
)	O
is	O
indispensable	O
for	O
gene1s	ARG2
MRX	ARG2
gene1e	ARG2
assembly	O
.	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
(SIM2	O
)	O
non	O
-	O
covalently	O
links	O
gene1s	ARG2
MRX	ARG2
gene1e	ARG2
with	O
the	O
gene1s	ARG2
SUMO	ARG2
enzymes	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
E2	ARG2
/	ARG2
Ubc9	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
E3	ARG2
/	ARG2
Siz2	ARG2
gene1e	ARG2
)	O
to	O
promote	O
global	O
SUMOylation	O
of	O
DNA	O
repair	O
proteins	O
.	O
gene1s	ARG2
Mre11	ARG2
gene1e	ARG2
(SIM2	O
)	O
acts	O
independently	O
of	O
checkpoint	O
phosphorylation	O
.	O
During	O
meiosis	O
,	O
the	O
gene1s	ARG2
mre11	ARG2
gene1e	ARG2
(SIM2	O
)	O
mutant	O
,	O
as	O
for	O
gene1s	ARG2
mre11S	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
rad50S	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
sae2Delta	ARG2
gene1e	ARG2
,	O
allows	O
initiation	O
but	O
not	O
processing	O
of	O
gene1s	ARG2
Spo11	ARG2
gene1e	ARG2
-induced	O
DSBs	O
.	O
Using	O
gene1s	ARG2
MRX	ARG2
gene1e	ARG2
and	O
DSB	O
repair	O
as	O
a	O
model	O
,	O
our	O
work	O
reveals	O
a	O
general	O
principle	O
in	O
which	O
the	O
conjugated	O
gene1s	ARG2
SUMO	ARG2
gene1e	ARG2
moieties	O
non	O
-	O
covalently	O
facilitate	O
the	O
assembly	O
and	O
functions	O
of	O
multi	O
-	O
subunit	O
protein	O
complexes	O
.	O

species1s	O
S.	O
cerevisiae	O
species1e	O
gene1s	O
Mre11	O
gene1e	O
recruits	O
conjugated	O
gene1s	O
SUMO	O
gene1e	O
moieties	O
to	O
facilitate	O
the	O
assembly	O
and	O
function	O
of	O
the	O
gene1s	O
Mre11	O
gene1e	O
-	O
gene1s	O
Rad50	O
gene1e	O
-	O
gene1s	O
Xrs2	O
gene1e	O
complex	O
.	O
Double	O
-	O
strand	O
breaks	O
(	O
DSBs	O
)	O
in	O
chromosomes	O
are	O
the	O
most	O
challenging	O
type	O
of	O
DNA	O
damage	O
.	O
The	O
species1s	O
yeast	O
species1e	O
and	O
arg1s	O
mammalian	O
arg1e	O
gene1s	O
Mre11	O
gene1e	O
-	O
gene1s	O
Rad50	O
gene1e	O
-	O
gene1s	O
Xrs2	O
gene1e	O
/	O
gene1s	ARG2
Nbs1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MRX	ARG2
/	ARG2
N	ARG2
gene1e	ARG2
)-	O
gene1s	O
Sae2	O
gene1e	O
/	O
gene1s	O
Ctp1	O
gene1e	O
complex	O
catalyzes	O
the	O
resection	O
of	O
DSBs	O
induced	O
by	O
secondary	O
structures	O
,	O
chemical	O
adducts	O
or	O
covalently	O
-	O
attached	O
proteins	O
.	O
gene1s	ARG2
MRX	ARG2
/	ARG2
N	ARG2
gene1e	ARG2
also	O
initiates	O
two	O
parallel	O
DNA	O
damage	O
responses	O
-	O
checkpoint	O
phosphorylation	O
and	O
global	O
SUMOylation	O
-	O
to	O
boost	O
a	O
cell	O
's	O
ability	O
to	O
repair	O
DSBs	O
.	O
However	O
,	O
the	O
molecular	O
mechanism	O
of	O
this	O
gene1s	O
SUMO	O
gene1e	O
-	O
mediated	O
response	O
is	O
not	O
completely	O
known	O
.	O
In	O
this	O
study	O
,	O
we	O
report	O
that	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
gene1s	O
Mre11	O
gene1e	O
can	O
non	O
-	O
covalently	O
recruit	O
the	O
conjugated	O
gene1s	O
SUMO	O
gene1e	O
moieties	O
,	O
particularly	O
the	O
poly	O
-	O
gene1s	O
SUMO	O
gene1e	O
chain	O
.	O
gene1s	O
Mre11	O
gene1e	O
has	O
two	O
evolutionarily	O
-	O
conserved	O
gene1s	O
SUMO	O
gene1e	O
-	O
interacting	O
motifs	O
,	O
gene1s	O
Mre11	O
gene1e	O
(SIM1	O
)	O
and	O
gene1s	O
Mre11	O
gene1e	O
(SIM2	O
)	O
,	O
which	O
reside	O
on	O
the	O
outermost	O
surface	O
of	O
gene1s	O
Mre11	O
gene1e	O
.	O
gene1s	O
Mre11	O
gene1e	O
(SIM1	O
)	O
is	O
indispensable	O
for	O
gene1s	O
MRX	O
gene1e	O
assembly	O
.	O
gene1s	O
Mre11	O
gene1e	O
(SIM2	O
)	O
non	O
-	O
covalently	O
links	O
gene1s	O
MRX	O
gene1e	O
with	O
the	O
gene1s	O
SUMO	O
enzymes	O
gene1e	O
(	O
gene1s	O
E2	O
/	O
Ubc9	O
gene1e	O
and	O
gene1s	O
E3	O
/	O
Siz2	O
gene1e	O
)	O
to	O
promote	O
global	O
SUMOylation	O
of	O
DNA	O
repair	O
proteins	O
.	O
gene1s	O
Mre11	O
gene1e	O
(SIM2	O
)	O
acts	O
independently	O
of	O
checkpoint	O
phosphorylation	O
.	O
During	O
meiosis	O
,	O
the	O
gene1s	O
mre11	O
gene1e	O
(SIM2	O
)	O
mutant	O
,	O
as	O
for	O
gene1s	O
mre11S	O
gene1e	O
,	O
gene1s	O
rad50S	O
gene1e	O
and	O
gene1s	O
sae2Delta	O
gene1e	O
,	O
allows	O
initiation	O
but	O
not	O
processing	O
of	O
gene1s	O
Spo11	O
gene1e	O
-induced	O
DSBs	O
.	O
Using	O
gene1s	O
MRX	O
gene1e	O
and	O
DSB	O
repair	O
as	O
a	O
model	O
,	O
our	O
work	O
reveals	O
a	O
general	O
principle	O
in	O
which	O
the	O
conjugated	O
gene1s	O
SUMO	O
gene1e	O
moieties	O
non	O
-	O
covalently	O
facilitate	O
the	O
assembly	O
and	O
functions	O
of	O
multi	O
-	O
subunit	O
protein	O
complexes	O
.	O

gene1s	O
AP4	O
gene1e	O
is	O
a	O
mediator	O
of	O
epithelial	O
-	O
mesenchymal	O
transition	O
and	O
metastasis	O
in	O
colorectal	O
cancer	O
.	O
The	O
gene1s	O
basic	O
helix	O
-	O
loop	O
-	O
helix	O
transcription	O
factor	O
gene1e	O
gene1s	O
AP4	O
gene1e	O
/	O
gene1s	O
TFAP4	O
gene1e	O
/	O
gene1s	O
AP-4	O
gene1e	O
is	O
encoded	O
by	O
a	O
gene1s	O
c	O
-	O
MYC	O
gene1e	O
target	O
gene	O
and	O
displays	O
up	O
-	O
regulation	O
concomitantly	O
with	O
gene1s	O
c	O
-	O
MYC	O
gene1e	O
in	O
colorectal	O
cancer	O
(	O
CRC	O
)	O
and	O
numerous	O
other	O
tumor	O
types	O
.	O
Here	O
a	O
genome	O
-	O
wide	O
characterization	O
of	O
gene1s	O
AP4	O
gene1e	O
DNA	O
binding	O
and	O
mRNA	O
expression	O
was	O
performed	O
using	O
a	O
combination	O
of	O
microarray	O
,	O
genome	O
-	O
wide	O
chromatin	O
immunoprecipitation	O
,	O
next	O
-	O
generation	O
sequencing	O
,	O
and	O
bioinformatic	O
analyses	O
.	O
Thereby	O
,	O
hundreds	O
of	O
induced	O
and	O
repressed	O
gene1s	O
AP4	O
gene1e	O
target	O
genes	O
were	O
identified	O
.	O
Besides	O
many	O
genes	O
involved	O
in	O
the	O
control	O
of	O
proliferation	O
,	O
the	O
gene1s	O
AP4	O
gene1e	O
target	O
genes	O
included	O
markers	O
of	O
stemness	O
(	O
gene1s	O
LGR5	O
gene1e	O
and	O
gene1s	O
CD44	O
gene1e	O
)	O
and	O
epithelial	O
-	O
mesenchymal	O
transition	O
(	O
EMT	O
)	O
such	O
as	O
gene1s	O
SNAIL	O
gene1e	O
,	O
gene1s	O
E	O
-	O
cadherin	O
gene1e	O
/	O
gene1s	O
CDH1	O
gene1e	O
,	O
gene1s	O
OCLN	O
gene1e	O
,	O
gene1s	O
VIM	O
gene1e	O
,	O
gene1s	O
FN1	O
gene1e	O
,	O
and	O
the	O
gene1s	O
Claudins	O
1	O
,	O
4	O
,	O
and	O
7	O
gene1e	O
.	O
Accordingly	O
,	O
activation	O
of	O
gene1s	O
AP4	O
gene1e	O
induced	O
EMT	O
and	O
enhanced	O
migration	O
and	O
invasion	O
of	O
CRC	O
cells	O
.	O
Conversely	O
,	O
down	O
-	O
regulation	O
of	O
gene1s	O
AP4	O
gene1e	O
resulted	O
in	O
mesenchymal	O
-	O
epithelial	O
transition	O
and	O
inhibited	O
migration	O
and	O
invasion	O
.	O
In	O
addition	O
,	O
gene1s	O
AP4	O
gene1e	O
induction	O
was	O
required	O
for	O
EMT	O
,	O
migration	O
,	O
and	O
invasion	O
caused	O
by	O
ectopic	O
expression	O
of	O
gene1s	O
c	O
-	O
MYC	O
gene1e	O
.	O
Inhibition	O
of	O
gene1s	O
AP4	O
gene1e	O
in	O
CRC	O
cells	O
resulted	O
in	O
decreased	O
lung	O
metastasis	O
in	O
arg1s	O
mice	O
arg1e	O
.	O
Elevated	O
gene1s	O
AP4	O
gene1e	O
expression	O
in	O
primary	O
CRC	O
significantly	O
correlated	O
with	O
liver	O
metastasis	O
and	O
poor	O
species1s	O
patient	O
species1e	O
survival	O
.	O
These	O
findings	O
imply	O
gene1s	O
AP4	O
gene1e	O
as	O
a	O
new	O
regulator	O
of	O
EMT	O
that	O
contributes	O
to	O
metastatic	O
processes	O
in	O
CRC	O
and	O
presumably	O
other	O
carcinomas	O
.	O

gene1s	ARG2
AP4	ARG2
gene1e	ARG2
is	O
a	O
mediator	O
of	O
epithelial	O
-	O
mesenchymal	O
transition	O
and	O
metastasis	O
in	O
colorectal	O
cancer	O
.	O
The	O
gene1s	ARG2
basic	ARG2
helix	ARG2
-	ARG2
loop	ARG2
-	ARG2
helix	ARG2
transcription	ARG2
factor	ARG2
gene1e	ARG2
gene1s	ARG2
AP4	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
TFAP4	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
AP-4	ARG2
gene1e	ARG2
is	O
encoded	O
by	O
a	O
gene1s	ARG2
c	ARG2
-	ARG2
MYC	ARG2
gene1e	ARG2
target	O
gene	O
and	O
displays	O
up	O
-	O
regulation	O
concomitantly	O
with	O
gene1s	ARG2
c	ARG2
-	ARG2
MYC	ARG2
gene1e	ARG2
in	O
colorectal	O
cancer	O
(	O
CRC	O
)	O
and	O
numerous	O
other	O
tumor	O
types	O
.	O
Here	O
a	O
genome	O
-	O
wide	O
characterization	O
of	O
gene1s	ARG2
AP4	ARG2
gene1e	ARG2
DNA	O
binding	O
and	O
mRNA	O
expression	O
was	O
performed	O
using	O
a	O
combination	O
of	O
microarray	O
,	O
genome	O
-	O
wide	O
chromatin	O
immunoprecipitation	O
,	O
next	O
-	O
generation	O
sequencing	O
,	O
and	O
bioinformatic	O
analyses	O
.	O
Thereby	O
,	O
hundreds	O
of	O
induced	O
and	O
repressed	O
gene1s	ARG2
AP4	ARG2
gene1e	ARG2
target	O
genes	O
were	O
identified	O
.	O
Besides	O
many	O
genes	O
involved	O
in	O
the	O
control	O
of	O
proliferation	O
,	O
the	O
gene1s	ARG2
AP4	ARG2
gene1e	ARG2
target	O
genes	O
included	O
markers	O
of	O
stemness	O
(	O
gene1s	ARG2
LGR5	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CD44	ARG2
gene1e	ARG2
)	O
and	O
epithelial	O
-	O
mesenchymal	O
transition	O
(	O
EMT	O
)	O
such	O
as	O
gene1s	ARG2
SNAIL	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
E	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CDH1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
OCLN	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
VIM	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
FN1	ARG2
gene1e	ARG2
,	O
and	O
the	O
gene1s	ARG2
Claudins	ARG2
1	ARG2
,	ARG2
4	ARG2
,	ARG2
and	ARG2
7	ARG2
gene1e	ARG2
.	O
Accordingly	O
,	O
activation	O
of	O
gene1s	ARG2
AP4	ARG2
gene1e	ARG2
induced	O
EMT	O
and	O
enhanced	O
migration	O
and	O
invasion	O
of	O
CRC	O
cells	O
.	O
Conversely	O
,	O
down	O
-	O
regulation	O
of	O
gene1s	ARG2
AP4	ARG2
gene1e	ARG2
resulted	O
in	O
mesenchymal	O
-	O
epithelial	O
transition	O
and	O
inhibited	O
migration	O
and	O
invasion	O
.	O
In	O
addition	O
,	O
gene1s	ARG2
AP4	ARG2
gene1e	ARG2
induction	O
was	O
required	O
for	O
EMT	O
,	O
migration	O
,	O
and	O
invasion	O
caused	O
by	O
ectopic	O
expression	O
of	O
gene1s	ARG2
c	ARG2
-	ARG2
MYC	ARG2
gene1e	ARG2
.	O
Inhibition	O
of	O
gene1s	ARG2
AP4	ARG2
gene1e	ARG2
in	O
CRC	O
cells	O
resulted	O
in	O
decreased	O
lung	O
metastasis	O
in	O
species1s	O
mice	O
species1e	O
.	O
Elevated	O
gene1s	ARG2
AP4	ARG2
gene1e	ARG2
expression	O
in	O
primary	O
CRC	O
significantly	O
correlated	O
with	O
liver	O
metastasis	O
and	O
poor	O
arg1s	O
patient	O
arg1e	O
survival	O
.	O
These	O
findings	O
imply	O
gene1s	ARG2
AP4	ARG2
gene1e	ARG2
as	O
a	O
new	O
regulator	O
of	O
EMT	O
that	O
contributes	O
to	O
metastatic	O
processes	O
in	O
CRC	O
and	O
presumably	O
other	O
carcinomas	O
.	O

Acute	O
myeloid	O
leukemia	O
of	O
donor	O
origin	O
after	O
allogeneic	O
stem	O
cell	O
transplantation	O
from	O
a	O
sibling	O
who	O
harbors	O
germline	O
gene1s	ARG2
XPD	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
XRCC3	ARG2
gene1e	ARG2
homozygous	O
polymorphisms	O
.	O
A	O
54-year	O
-	O
old	O
arg1s	O
woman	O
arg1e	O
was	O
diagnosed	O
with	O
infiltrative	O
ductal	O
breast	O
carcinoma	O
.	O
Two	O
years	O
after	O
treatment	O
,	O
the	O
arg1s	O
patient	O
arg1e	O
developed	O
an	O
acute	O
myeloid	O
leukemia	O
(	O
AML	O
)	O
which	O
harbored	O
arg1s	O
del	O
arg1e	O
(11q23	O
)	O
in	O
8	O
%	O
of	O
the	O
blast	O
cells	O
.	O
The	O
arg1s	O
patient	O
arg1e	O
was	O
submitted	O
for	O
allogeneic	O
stem	O
cell	O
transplantation	O
(	O
aSCT	O
)	O
from	O
her	O
HLA	O
-	O
compatible	O
sister	O
.	O
Ten	O
months	O
after	O
transplantation	O
,	O
she	O
relapsed	O
with	O
an	O
AML	O
with	O
basophilic	O
maturation	O
characterized	O
by	O
gene1s	ARG2
CD45	ARG2
gene1e	ARG2
(low	O
)	O
gene1s	ARG2
CD33	ARG2
gene1e	ARG2
(high	O
)	O
,	O
gene1s	ARG2
CD117	ARG2
gene1e	ARG2
+	O
,	O
gene1s	ARG2
CD13	ARG2
gene1e	ARG2
(-/+	O
)	O
,	O
gene1s	ARG2
HLA	ARG2
Dr	ARG2
gene1e	ARG2
(high	O
)	O
,	O
gene1s	ARG2
CD123	ARG2
gene1e	ARG2
(high	O
)	O
,	O
and	O
gene1s	ARG2
CD203c	ARG2
gene1e	ARG2
+	O
blast	O
cells	O
lacking	O
expression	O
of	O
gene1s	ARG2
CD7	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD10	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD34	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD15	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD14	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD56	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD36	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD64	ARG2
gene1e	ARG2
,	O
and	O
cytoplasmic	O
tryptase	O
.	O
Karyotype	O
analysis	O
showed	O
the	O
emergence	O
of	O
a	O
new	O
clone	O
with	O
t(2;14	O
)	O
and	O
FISH	O
analysis	O
indicated	O
the	O
presence	O
of	O
gene1s	ARG2
MLL	ARG2
gene1e	ARG2
gene	O
rearrangement	O
consistent	O
with	O
arg1s	O
del	O
arg1e	O
(11q23	O
)	O
.	O
Interestingly	O
,	O
AML	O
blast	O
cell	O
DNA	O
tested	O
with	O
microsatellite	O
markers	O
showed	O
the	O
same	O
pattern	O
as	O
the	O
donor	O
's	O
,	O
suggesting	O
that	O
this	O
AML	O
emerged	O
from	O
donor	O
cells	O
.	O
Additionally	O
,	O
polymorphisms	O
of	O
the	O
gene1s	ARG2
XPA	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
XPD	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
XRCC1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
XRCC3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
RAD51	ARG2
gene1e	ARG2
DNA	O
repair	O
genes	O
revealed	O
three	O
unfavorable	O
alleles	O
with	O
low	O
DNA	O
repair	O
capacity	O
.	O
In	O
summary	O
,	O
we	O
report	O
the	O
first	O
case	O
of	O
AML	O
involving	O
gene1s	ARG2
XPD	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
XRCC3	ARG2
gene1e	ARG2
polymorphisms	O
from	O
donor	O
origin	O
following	O
allogeneic	O
stem	O
cell	O
transplantation	O
and	O
highlight	O
the	O
potential	O
need	O
for	O
careful	O
analysis	O
of	O
DNA	O
repair	O
gene	O
polymorphisms	O
in	O
selecting	O
candidate	O
donors	O
prior	O
to	O
allogeneic	O
stem	O
cell	O
transplantation	O
.	O

gene1s	ARG2
XB130	ARG2
gene1e	ARG2
promotes	O
proliferation	O
and	O
invasion	O
of	O
gastric	O
cancer	O
cells	O
.	O
BACKGROUND	O
:	O
gene1s	ARG2
XB130	ARG2
gene1e	ARG2
has	O
been	O
reported	O
to	O
be	O
expressed	O
by	O
various	O
types	O
of	O
cells	O
such	O
as	O
thyroid	O
cancer	O
and	O
esophageal	O
cancer	O
cells	O
,	O
and	O
it	O
promotes	O
the	O
proliferation	O
and	O
invasion	O
of	O
thyroid	O
cancer	O
cells	O
.	O
Our	O
previous	O
study	O
demonstrated	O
that	O
gene1s	ARG2
XB130	ARG2
gene1e	ARG2
is	O
also	O
expressed	O
in	O
gastric	O
cancer	O
(	O
GC	O
)	O
,	O
and	O
that	O
its	O
expression	O
is	O
associated	O
with	O
the	O
prognosis	O
,	O
but	O
the	O
role	O
of	O
gene1s	ARG2
XB130	ARG2
gene1e	ARG2
in	O
GC	O
has	O
not	O
been	O
well	O
characterized	O
.	O
METHODS	O
:	O
In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
influence	O
of	O
gene1s	ARG2
XB130	ARG2
gene1e	ARG2
on	O
gastric	O
tumorigenesis	O
and	O
metastasis	O
in	O
vivo	O
and	O
in	O
vitro	O
using	O
the	O
MTT	O
assay	O
,	O
clonogenic	O
assay	O
,	O
BrdU	O
incorporation	O
assay	O
,	O
3D	O
culture	O
,	O
immunohistochemistry	O
and	O
immunofluorescence	O
.	O
Western	O
blot	O
analysis	O
was	O
also	O
performed	O
to	O
identify	O
the	O
potential	O
mechanisms	O
involved	O
.	O
RESULTS	O
:	O
The	O
proliferation	O
,	O
migration	O
,	O
and	O
invasion	O
of	O
arg1s	O
SGC7901	O
arg1e	O
and	O
MNK45	O
gastric	O
adenocarcinoma	O
cell	O
lines	O
were	O
all	O
significantly	O
inhibited	O
by	O
knockdown	O
of	O
gene1s	ARG2
XB130	ARG2
gene1e	ARG2
using	O
small	O
hairpin	O
RNA	O
.	O
In	O
a	O
xenograft	O
model	O
,	O
tumor	O
growth	O
was	O
markedly	O
inhibited	O
after	O
sh	O
gene1s	ARG2
XB130	ARG2
gene1e	ARG2
-transfected	O
GC	O
cells	O
were	O
implanted	O
into	O
species1s	O
nude	O
mice	O
species1e	O
.	O
After	O
gene1s	ARG2
XB130	ARG2
gene1e	ARG2
knockdown	O
,	O
GC	O
cells	O
showed	O
a	O
more	O
epithelial	O
-	O
like	O
phenotype	O
,	O
suggesting	O
an	O
inhibition	O
of	O
the	O
epithelial	O
-	O
mesenchymal	O
transition	O
(	O
EMT	O
)	O
process	O
.	O
In	O
addition	O
,	O
silencing	O
of	O
gene1s	ARG2
XB130	ARG2
gene1e	ARG2
reduced	O
the	O
expression	O
of	O
p	O
-	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
,	O
upregulated	O
expression	O
of	O
epithelial	O
markers	O
including	O
gene1s	ARG2
E	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
a	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
,	O
and	O
downregulated	O
mesenchymal	O
markers	O
including	O
gene1s	ARG2
fibronectin	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
vimentin	ARG2
gene1e	ARG2
.	O
Expression	O
of	O
oncoproteins	O
related	O
to	O
tumor	O
metastasis	O
,	O
such	O
as	O
gene1s	ARG2
MMP2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MMP9	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
CD44	ARG2
gene1e	ARG2
,	O
was	O
also	O
significantly	O
reduced	O
.	O
CONCLUSIONS	O
:	O
These	O
findings	O
indicate	O
that	O
gene1s	ARG2
XB130	ARG2
gene1e	ARG2
enhances	O
cell	O
motility	O
and	O
invasiveness	O
by	O
modulating	O
the	O
EMT	O
-	O
like	O
process	O
,	O
while	O
silencing	O
gene1s	ARG2
XB130	ARG2
gene1e	ARG2
in	O
GC	O
suppresses	O
tumorigenesis	O
and	O
metastasis	O
,	O
suggesting	O
that	O
it	O
may	O
be	O
a	O
potential	O
therapeutic	O
target	O
.	O

gene1s	O
XB130	O
gene1e	O
promotes	O
proliferation	O
and	O
invasion	O
of	O
gastric	O
cancer	O
cells	O
.	O
BACKGROUND	O
:	O
gene1s	O
XB130	O
gene1e	O
has	O
been	O
reported	O
to	O
be	O
expressed	O
by	O
various	O
types	O
of	O
cells	O
such	O
as	O
thyroid	O
cancer	O
and	O
esophageal	O
cancer	O
cells	O
,	O
and	O
it	O
promotes	O
the	O
proliferation	O
and	O
invasion	O
of	O
thyroid	O
cancer	O
cells	O
.	O
Our	O
previous	O
study	O
demonstrated	O
that	O
gene1s	O
XB130	O
gene1e	O
is	O
also	O
expressed	O
in	O
gastric	O
cancer	O
(	O
GC	O
)	O
,	O
and	O
that	O
its	O
expression	O
is	O
associated	O
with	O
the	O
prognosis	O
,	O
but	O
the	O
role	O
of	O
gene1s	O
XB130	O
gene1e	O
in	O
GC	O
has	O
not	O
been	O
well	O
characterized	O
.	O
METHODS	O
:	O
In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
influence	O
of	O
gene1s	O
XB130	O
gene1e	O
on	O
gastric	O
tumorigenesis	O
and	O
metastasis	O
in	O
vivo	O
and	O
in	O
vitro	O
using	O
the	O
MTT	O
assay	O
,	O
clonogenic	O
assay	O
,	O
BrdU	O
incorporation	O
assay	O
,	O
3D	O
culture	O
,	O
immunohistochemistry	O
and	O
immunofluorescence	O
.	O
Western	O
blot	O
analysis	O
was	O
also	O
performed	O
to	O
identify	O
the	O
potential	O
mechanisms	O
involved	O
.	O
RESULTS	O
:	O
The	O
proliferation	O
,	O
migration	O
,	O
and	O
invasion	O
of	O
species1s	O
SGC7901	O
species1e	O
and	O
MNK45	O
gastric	O
adenocarcinoma	O
cell	O
lines	O
were	O
all	O
significantly	O
inhibited	O
by	O
knockdown	O
of	O
gene1s	O
XB130	O
gene1e	O
using	O
small	O
hairpin	O
RNA	O
.	O
In	O
a	O
xenograft	O
model	O
,	O
tumor	O
growth	O
was	O
markedly	O
inhibited	O
after	O
sh	O
gene1s	O
XB130	O
gene1e	O
-transfected	O
GC	O
cells	O
were	O
implanted	O
into	O
arg1s	O
nude	O
mice	O
arg1e	O
.	O
After	O
gene1s	O
XB130	O
gene1e	O
knockdown	O
,	O
GC	O
cells	O
showed	O
a	O
more	O
epithelial	O
-	O
like	O
phenotype	O
,	O
suggesting	O
an	O
inhibition	O
of	O
the	O
epithelial	O
-	O
mesenchymal	O
transition	O
(	O
EMT	O
)	O
process	O
.	O
In	O
addition	O
,	O
silencing	O
of	O
gene1s	O
XB130	O
gene1e	O
reduced	O
the	O
expression	O
of	O
p	O
-	O
gene1s	O
Akt	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
,	O
upregulated	O
expression	O
of	O
epithelial	O
markers	O
including	O
gene1s	O
E	O
-	O
cadherin	O
gene1e	O
,	O
gene1s	O
a	O
-	O
catenin	O
gene1e	O
and	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
,	O
and	O
downregulated	O
mesenchymal	O
markers	O
including	O
gene1s	O
fibronectin	O
gene1e	O
and	O
gene1s	O
vimentin	O
gene1e	O
.	O
Expression	O
of	O
oncoproteins	O
related	O
to	O
tumor	O
metastasis	O
,	O
such	O
as	O
gene1s	O
MMP2	O
gene1e	O
,	O
gene1s	O
MMP9	O
gene1e	O
,	O
and	O
gene1s	O
CD44	O
gene1e	O
,	O
was	O
also	O
significantly	O
reduced	O
.	O
CONCLUSIONS	O
:	O
These	O
findings	O
indicate	O
that	O
gene1s	O
XB130	O
gene1e	O
enhances	O
cell	O
motility	O
and	O
invasiveness	O
by	O
modulating	O
the	O
EMT	O
-	O
like	O
process	O
,	O
while	O
silencing	O
gene1s	O
XB130	O
gene1e	O
in	O
GC	O
suppresses	O
tumorigenesis	O
and	O
metastasis	O
,	O
suggesting	O
that	O
it	O
may	O
be	O
a	O
potential	O
therapeutic	O
target	O
.	O

Use	O
of	O
Physcion	O
to	O
Improve	O
Atopic	O
Dermatitis	O
-	O
Like	O
Skin	O
Lesions	O
through	O
Blocking	O
of	O
gene1s	ARG2
Thymic	ARG2
Stromal	ARG2
Lymphopoietin	ARG2
gene1e	ARG2
.	O
Physcion	O
is	O
well	O
known	O
for	O
the	O
treatment	O
of	O
carcinoma	O
.	O
However	O
,	O
the	O
therapeutic	O
effect	O
of	O
physcion	O
on	O
atopic	O
dermatitis	O
(	O
AD	O
)	O
through	O
the	O
inhibition	O
of	O
gene1s	ARG2
thymic	ARG2
stromal	ARG2
lymphopoietin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TSLP	ARG2
gene1e	ARG2
)	O
level	O
remains	O
largely	O
unknown	O
.	O
In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
anti	O
-	O
AD	O
effect	O
of	O
physcion	O
using	O
arg1s	O
HMC-1	O
arg1e	O
cells	O
,	O
splenocytes	O
,	O
and	O
a	O
species1s	O
murine	O
species1e	O
model	O
.	O
Treatment	O
with	O
physcion	O
decreased	O
production	O
and	O
mRNA	O
expression	O
levels	O
of	O
gene1s	ARG2
TSLP	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
IL-1beta	ARG2
gene1e	ARG2
in	O
activated	O
arg1s	O
HMC-1	O
arg1e	O
cells	O
.	O
Physcion	O
reduced	O
the	O
expression	O
levels	O
of	O
gene1s	ARG2
RIP2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
caspase-1	ARG2
gene1e	ARG2
and	O
phospho	O
(	O
p)	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
pJNK	ARG2
gene1e	ARG2
/	O
pp38	O
in	O
activated	O
arg1s	O
HMC-1	O
arg1e	O
cells	O
.	O
Physcion	O
suppressed	O
the	O
expression	O
levels	O
of	O
p	O
gene1s	ARG2
IKKbeta	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
/	O
p	O
gene1s	ARG2
IkB	ARG2
gene1e	ARG2
in	O
activated	O
arg1s	O
HMC-1	O
arg1e	O
cells	O
.	O
Moreover	O
,	O
physcion	O
attenuated	O
the	O
production	O
levels	O
of	O
gene1s	O
TSLP	O
gene1e	O
,	O
gene1s	O
IL-4	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
gene1s	O
TNF	O
gene1e	O
-	O
,	O
and	O
gene1s	O
IFN	O
-	O
gamma	O
gene1e	O
from	O
activated	O
splenocytes	O
.	O
Oral	O
administration	O
of	O
physcion	O
improved	O
the	O
severity	O
of	O
2,4-dinitrochlorobenzene	O
-	O
induced	O
AD	O
-	O
like	O
lesional	O
skin	O
through	O
reducing	O
infiltration	O
of	O
inflammatory	O
cells	O
and	O
mast	O
cells	O
,	O
and	O
the	O
protein	O
and	O
mRNA	O
levels	O
of	O
gene1s	O
TSLP	O
gene1e	O
,	O
gene1s	O
IL-4	O
gene1e	O
,	O
and	O
gene1s	O
IL-6	O
gene1e	O
in	O
the	O
lesional	O
skin	O
tissues	O
.	O
Physcion	O
attenuated	O
histamine	O
,	O
IgE	O
,	O
gene1s	O
TSLP	O
gene1e	O
,	O
gene1s	O
IL-4	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
and	O
gene1s	O
TNF	O
gene1e	O
-	O
levels	O
in	O
serum	O
.	O
In	O
addition	O
,	O
physcion	O
inhibited	O
gene1s	O
caspase-1	O
gene1e	O
activation	O
in	O
the	O
lesional	O
skin	O
tissues	O
.	O
These	O
findings	O
indicate	O
that	O
physcion	O
could	O
ameliorate	O
AD	O
-	O
like	O
skin	O
lesions	O
by	O
inhibiting	O
gene1s	O
TSLP	O
gene1e	O
levels	O
via	O
gene1s	O
caspase-1	O
gene1e	O
/	O
gene1s	O
MAPK	O
gene1e	O
s	O
/	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
signalings	O
,	O
which	O
would	O
provide	O
experimental	O
evidence	O
of	O
the	O
therapeutic	O
potential	O
of	O
physcion	O
for	O
AD	O
.	O

Use	O
of	O
Physcion	O
to	O
Improve	O
Atopic	O
Dermatitis	O
-	O
Like	O
Skin	O
Lesions	O
through	O
Blocking	O
of	O
gene1s	ARG2
Thymic	ARG2
Stromal	ARG2
Lymphopoietin	ARG2
gene1e	ARG2
.	O
Physcion	O
is	O
well	O
known	O
for	O
the	O
treatment	O
of	O
carcinoma	O
.	O
However	O
,	O
the	O
therapeutic	O
effect	O
of	O
physcion	O
on	O
atopic	O
dermatitis	O
(	O
AD	O
)	O
through	O
the	O
inhibition	O
of	O
gene1s	O
thymic	O
stromal	O
lymphopoietin	O
gene1e	O
(	O
gene1s	O
TSLP	O
gene1e	O
)	O
level	O
remains	O
largely	O
unknown	O
.	O
In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
anti	O
-	O
AD	O
effect	O
of	O
physcion	O
using	O
species1s	O
HMC-1	O
species1e	O
cells	O
,	O
splenocytes	O
,	O
and	O
a	O
arg1s	O
murine	O
arg1e	O
model	O
.	O
Treatment	O
with	O
physcion	O
decreased	O
production	O
and	O
mRNA	O
expression	O
levels	O
of	O
gene1s	O
TSLP	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
gene1s	O
TNF	O
-	O
alpha	O
gene1e	O
,	O
and	O
gene1s	O
IL-1beta	O
gene1e	O
in	O
activated	O
species1s	O
HMC-1	O
species1e	O
cells	O
.	O
Physcion	O
reduced	O
the	O
expression	O
levels	O
of	O
gene1s	O
RIP2	O
gene1e	O
/	O
gene1s	O
caspase-1	O
gene1e	O
and	O
phospho	O
(	O
p)	O
gene1s	O
ERK	O
gene1e	O
/	O
gene1s	O
pJNK	O
gene1e	O
/	O
pp38	O
in	O
activated	O
species1s	O
HMC-1	O
species1e	O
cells	O
.	O
Physcion	O
suppressed	O
the	O
expression	O
levels	O
of	O
p	O
gene1s	O
IKKbeta	O
gene1e	O
/	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
/	O
p	O
gene1s	O
IkB	O
gene1e	O
in	O
activated	O
species1s	O
HMC-1	O
species1e	O
cells	O
.	O
Moreover	O
,	O
physcion	O
attenuated	O
the	O
production	O
levels	O
of	O
gene1s	ARG2
TSLP	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TNF	ARG2
gene1e	ARG2
-	O
,	O
and	O
gene1s	ARG2
IFN	ARG2
-	ARG2
gamma	ARG2
gene1e	ARG2
from	O
activated	O
splenocytes	O
.	O
Oral	O
administration	O
of	O
physcion	O
improved	O
the	O
severity	O
of	O
2,4-dinitrochlorobenzene	O
-	O
induced	O
AD	O
-	O
like	O
lesional	O
skin	O
through	O
reducing	O
infiltration	O
of	O
inflammatory	O
cells	O
and	O
mast	O
cells	O
,	O
and	O
the	O
protein	O
and	O
mRNA	O
levels	O
of	O
gene1s	ARG2
TSLP	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-4	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
in	O
the	O
lesional	O
skin	O
tissues	O
.	O
Physcion	O
attenuated	O
histamine	O
,	O
IgE	O
,	O
gene1s	ARG2
TSLP	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
TNF	ARG2
gene1e	ARG2
-	O
levels	O
in	O
serum	O
.	O
In	O
addition	O
,	O
physcion	O
inhibited	O
gene1s	ARG2
caspase-1	ARG2
gene1e	ARG2
activation	O
in	O
the	O
lesional	O
skin	O
tissues	O
.	O
These	O
findings	O
indicate	O
that	O
physcion	O
could	O
ameliorate	O
AD	O
-	O
like	O
skin	O
lesions	O
by	O
inhibiting	O
gene1s	ARG2
TSLP	ARG2
gene1e	ARG2
levels	O
via	O
gene1s	ARG2
caspase-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
s	O
/	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
signalings	O
,	O
which	O
would	O
provide	O
experimental	O
evidence	O
of	O
the	O
therapeutic	O
potential	O
of	O
physcion	O
for	O
AD	O
.	O

arg1s	O
Mycobacterium	O
massiliense	O
arg1e	O
induces	O
inflammatory	O
responses	O
in	O
macrophages	O
through	O
gene1s	O
Toll	O
-	O
like	O
receptor	O
2	O
gene1e	O
and	O
gene1s	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
gene1e	O
.	O
arg1s	O
Mycobacterium	O
massiliense	O
arg1e	O
(	O
arg1s	O
Mmass	O
arg1e	O
)	O
is	O
an	O
emerging	O
,	O
rapidly	O
growing	O
species1s	O
mycobacterium	O
species1e	O
(	O
RGM	O
)	O
that	O
belongs	O
to	O
the	O
species1s	O
M.	O
abscessus	O
species1e	O
(	O
species1s	O
Mabc	O
species1e	O
)	O
group	O
,	O
albeit	O
clearly	O
differentiated	O
from	O
species1s	O
Mabc	O
species1e	O
.	O
Compared	O
with	O
species1s	O
M.	O
tuberculosis	O
species1e	O
,	O
a	O
well	O
-	O
characterized	O
species1s	O
human	O
species1e	O
pathogen	O
,	O
the	O
host	O
innate	O
immune	O
response	O
against	O
arg1s	O
Mmass	O
arg1e	O
infection	O
is	O
largely	O
unknown	O
.	O
In	O
this	O
study	O
,	O
we	O
show	O
that	O
arg1s	O
Mmass	O
arg1e	O
robustly	O
activates	O
mRNA	O
and	O
protein	O
expression	O
of	O
gene1s	O
tumor	O
necrosis	O
factor	O
(	O
TNF)-a	O
gene1e	O
and	O
gene1s	O
interleukin	O
(	O
IL)-6	O
gene1e	O
in	O
species1s	O
murine	O
species1e	O
bone	O
marrow	O
-	O
derived	O
macrophages	O
(	O
BMDMs	O
)	O
.	O
gene1s	O
Toll	O
-	O
like	O
receptor	O
(	O
TLR)-2	O
gene1e	O
and	O
gene1s	O
myeloid	O
differentiation	O
primary	O
response	O
gene	O
88	O
gene1e	O
(	O
gene1s	O
MyD88	O
gene1e	O
)	O
,	O
but	O
neither	O
gene1s	O
TLR4	O
gene1e	O
nor	O
gene1s	O
Dectin-1	O
gene1e	O
,	O
are	O
involved	O
in	O
arg1s	O
Mmass	O
arg1e	O
-	O
induced	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
or	O
gene1s	O
IL-6	O
gene1e	O
production	O
in	O
BMDMs	O
.	O
arg1s	O
Mmass	O
arg1e	O
infection	O
also	O
activates	O
the	O
gene1s	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
gene1e	O
(	O
gene1s	O
MAPKs	O
gene1e	O
;	O
gene1s	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
gene1e	O
(	O
gene1s	O
JNK	O
gene1e	O
)	O
,	O
gene1s	O
ERK1/2	O
gene1e	O
and	O
gene1s	O
p38	O
MAPK	O
gene1e	O
)	O
pathway	O
.	O
arg1s	O
Mmass	O
arg1e	O
-	O
induced	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
and	O
gene1s	O
IL-6	O
gene1e	O
production	O
was	O
dependent	O
on	O
gene1s	O
JNK	O
gene1e	O
activation	O
,	O
while	O
they	O
were	O
unaffected	O
by	O
either	O
the	O
gene1s	O
ERK1/2	O
gene1e	O
or	O
gene1s	O
p38	O
gene1e	O
pathway	O
in	O
BMDMs	O
.	O
Additionally	O
,	O
intracellular	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
,	O
gene1s	O
NADPH	O
oxidase-2	O
gene1e	O
,	O
and	O
gene1s	O
nuclear	O
factor	O
-	O
kB	O
gene1e	O
are	O
required	O
for	O
arg1s	O
Mmass	O
arg1e	O
-	O
induced	O
proinflammatory	O
gene1s	O
cytokine	O
gene1e	O
generation	O
in	O
macrophages	O
.	O
Furthermore	O
,	O
the	O
S	O
morphotype	O
of	O
arg1s	O
Mmass	O
arg1e	O
showed	O
lower	O
overall	O
induction	O
of	O
pro	O
-	O
inflammatory	O
(	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
and	O
gene1s	O
IL-1b	O
gene1e	O
)	O
and	O
anti	O
-	O
inflammatory	O
(	O
gene1s	O
IL-10	O
gene1e	O
)	O
gene1s	O
cytokines	O
gene1e	O
than	O
the	O
R	O
morphotype	O
,	O
suggesting	O
fewer	O
immunogenic	O
characteristics	O
for	O
this	O
clinical	O
strain	O
.	O
Together	O
,	O
these	O
results	O
suggest	O
that	O
arg1s	O
Mmass	O
arg1e	O
-	O
induced	O
activation	O
of	O
host	O
proinflammatory	O
gene1s	O
cytokines	O
gene1e	O
is	O
mediated	O
through	O
gene1s	O
TLR2	O
gene1e	O
-dependent	O
gene1s	O
JNK	O
gene1e	O
and	O
ROS	O
signaling	O
pathways	O
.	O

species1s	O
Mycobacterium	O
massiliense	O
species1e	O
induces	O
inflammatory	O
responses	O
in	O
macrophages	O
through	O
gene1s	O
Toll	O
-	O
like	O
receptor	O
2	O
gene1e	O
and	O
gene1s	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
gene1e	O
.	O
species1s	O
Mycobacterium	O
massiliense	O
species1e	O
(	O
species1s	O
Mmass	O
species1e	O
)	O
is	O
an	O
emerging	O
,	O
rapidly	O
growing	O
arg1s	O
mycobacterium	O
arg1e	O
(	O
RGM	O
)	O
that	O
belongs	O
to	O
the	O
arg1s	O
M.	O
abscessus	O
arg1e	O
(	O
arg1s	O
Mabc	O
arg1e	O
)	O
group	O
,	O
albeit	O
clearly	O
differentiated	O
from	O
arg1s	O
Mabc	O
arg1e	O
.	O
Compared	O
with	O
species1s	O
M.	O
tuberculosis	O
species1e	O
,	O
a	O
well	O
-	O
characterized	O
species1s	O
human	O
species1e	O
pathogen	O
,	O
the	O
host	O
innate	O
immune	O
response	O
against	O
species1s	O
Mmass	O
species1e	O
infection	O
is	O
largely	O
unknown	O
.	O
In	O
this	O
study	O
,	O
we	O
show	O
that	O
species1s	O
Mmass	O
species1e	O
robustly	O
activates	O
mRNA	O
and	O
protein	O
expression	O
of	O
gene1s	O
tumor	O
necrosis	O
factor	O
(	O
TNF)-a	O
gene1e	O
and	O
gene1s	O
interleukin	O
(	O
IL)-6	O
gene1e	O
in	O
species1s	O
murine	O
species1e	O
bone	O
marrow	O
-	O
derived	O
macrophages	O
(	O
BMDMs	O
)	O
.	O
gene1s	O
Toll	O
-	O
like	O
receptor	O
(	O
TLR)-2	O
gene1e	O
and	O
gene1s	O
myeloid	O
differentiation	O
primary	O
response	O
gene	O
88	O
gene1e	O
(	O
gene1s	O
MyD88	O
gene1e	O
)	O
,	O
but	O
neither	O
gene1s	O
TLR4	O
gene1e	O
nor	O
gene1s	O
Dectin-1	O
gene1e	O
,	O
are	O
involved	O
in	O
species1s	O
Mmass	O
species1e	O
-	O
induced	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
or	O
gene1s	O
IL-6	O
gene1e	O
production	O
in	O
BMDMs	O
.	O
species1s	O
Mmass	O
species1e	O
infection	O
also	O
activates	O
the	O
gene1s	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
gene1e	O
(	O
gene1s	O
MAPKs	O
gene1e	O
;	O
gene1s	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
gene1e	O
(	O
gene1s	O
JNK	O
gene1e	O
)	O
,	O
gene1s	O
ERK1/2	O
gene1e	O
and	O
gene1s	O
p38	O
MAPK	O
gene1e	O
)	O
pathway	O
.	O
species1s	O
Mmass	O
species1e	O
-	O
induced	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
and	O
gene1s	O
IL-6	O
gene1e	O
production	O
was	O
dependent	O
on	O
gene1s	O
JNK	O
gene1e	O
activation	O
,	O
while	O
they	O
were	O
unaffected	O
by	O
either	O
the	O
gene1s	O
ERK1/2	O
gene1e	O
or	O
gene1s	O
p38	O
gene1e	O
pathway	O
in	O
BMDMs	O
.	O
Additionally	O
,	O
intracellular	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
,	O
gene1s	O
NADPH	O
oxidase-2	O
gene1e	O
,	O
and	O
gene1s	O
nuclear	O
factor	O
-	O
kB	O
gene1e	O
are	O
required	O
for	O
species1s	O
Mmass	O
species1e	O
-	O
induced	O
proinflammatory	O
gene1s	O
cytokine	O
gene1e	O
generation	O
in	O
macrophages	O
.	O
Furthermore	O
,	O
the	O
S	O
morphotype	O
of	O
species1s	O
Mmass	O
species1e	O
showed	O
lower	O
overall	O
induction	O
of	O
pro	O
-	O
inflammatory	O
(	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
and	O
gene1s	O
IL-1b	O
gene1e	O
)	O
and	O
anti	O
-	O
inflammatory	O
(	O
gene1s	O
IL-10	O
gene1e	O
)	O
gene1s	O
cytokines	O
gene1e	O
than	O
the	O
R	O
morphotype	O
,	O
suggesting	O
fewer	O
immunogenic	O
characteristics	O
for	O
this	O
clinical	O
strain	O
.	O
Together	O
,	O
these	O
results	O
suggest	O
that	O
species1s	O
Mmass	O
species1e	O
-	O
induced	O
activation	O
of	O
host	O
proinflammatory	O
gene1s	O
cytokines	O
gene1e	O
is	O
mediated	O
through	O
gene1s	O
TLR2	O
gene1e	O
-dependent	O
gene1s	O
JNK	O
gene1e	O
and	O
ROS	O
signaling	O
pathways	O
.	O

species1s	O
Mycobacterium	O
massiliense	O
species1e	O
induces	O
inflammatory	O
responses	O
in	O
macrophages	O
through	O
gene1s	O
Toll	O
-	O
like	O
receptor	O
2	O
gene1e	O
and	O
gene1s	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
gene1e	O
.	O
species1s	O
Mycobacterium	O
massiliense	O
species1e	O
(	O
species1s	O
Mmass	O
species1e	O
)	O
is	O
an	O
emerging	O
,	O
rapidly	O
growing	O
species1s	O
mycobacterium	O
species1e	O
(	O
RGM	O
)	O
that	O
belongs	O
to	O
the	O
species1s	O
M.	O
abscessus	O
species1e	O
(	O
species1s	O
Mabc	O
species1e	O
)	O
group	O
,	O
albeit	O
clearly	O
differentiated	O
from	O
species1s	O
Mabc	O
species1e	O
.	O
Compared	O
with	O
arg1s	O
M.	O
tuberculosis	O
arg1e	O
,	O
a	O
well	O
-	O
characterized	O
species1s	O
human	O
species1e	O
pathogen	O
,	O
the	O
host	O
innate	O
immune	O
response	O
against	O
species1s	O
Mmass	O
species1e	O
infection	O
is	O
largely	O
unknown	O
.	O
In	O
this	O
study	O
,	O
we	O
show	O
that	O
species1s	O
Mmass	O
species1e	O
robustly	O
activates	O
mRNA	O
and	O
protein	O
expression	O
of	O
gene1s	O
tumor	O
necrosis	O
factor	O
(	O
TNF)-a	O
gene1e	O
and	O
gene1s	O
interleukin	O
(	O
IL)-6	O
gene1e	O
in	O
species1s	O
murine	O
species1e	O
bone	O
marrow	O
-	O
derived	O
macrophages	O
(	O
BMDMs	O
)	O
.	O
gene1s	O
Toll	O
-	O
like	O
receptor	O
(	O
TLR)-2	O
gene1e	O
and	O
gene1s	O
myeloid	O
differentiation	O
primary	O
response	O
gene	O
88	O
gene1e	O
(	O
gene1s	O
MyD88	O
gene1e	O
)	O
,	O
but	O
neither	O
gene1s	O
TLR4	O
gene1e	O
nor	O
gene1s	O
Dectin-1	O
gene1e	O
,	O
are	O
involved	O
in	O
species1s	O
Mmass	O
species1e	O
-	O
induced	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
or	O
gene1s	O
IL-6	O
gene1e	O
production	O
in	O
BMDMs	O
.	O
species1s	O
Mmass	O
species1e	O
infection	O
also	O
activates	O
the	O
gene1s	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
gene1e	O
(	O
gene1s	O
MAPKs	O
gene1e	O
;	O
gene1s	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
gene1e	O
(	O
gene1s	O
JNK	O
gene1e	O
)	O
,	O
gene1s	O
ERK1/2	O
gene1e	O
and	O
gene1s	O
p38	O
MAPK	O
gene1e	O
)	O
pathway	O
.	O
species1s	O
Mmass	O
species1e	O
-	O
induced	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
and	O
gene1s	O
IL-6	O
gene1e	O
production	O
was	O
dependent	O
on	O
gene1s	O
JNK	O
gene1e	O
activation	O
,	O
while	O
they	O
were	O
unaffected	O
by	O
either	O
the	O
gene1s	O
ERK1/2	O
gene1e	O
or	O
gene1s	O
p38	O
gene1e	O
pathway	O
in	O
BMDMs	O
.	O
Additionally	O
,	O
intracellular	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
,	O
gene1s	O
NADPH	O
oxidase-2	O
gene1e	O
,	O
and	O
gene1s	O
nuclear	O
factor	O
-	O
kB	O
gene1e	O
are	O
required	O
for	O
species1s	O
Mmass	O
species1e	O
-	O
induced	O
proinflammatory	O
gene1s	O
cytokine	O
gene1e	O
generation	O
in	O
macrophages	O
.	O
Furthermore	O
,	O
the	O
S	O
morphotype	O
of	O
species1s	O
Mmass	O
species1e	O
showed	O
lower	O
overall	O
induction	O
of	O
pro	O
-	O
inflammatory	O
(	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
and	O
gene1s	O
IL-1b	O
gene1e	O
)	O
and	O
anti	O
-	O
inflammatory	O
(	O
gene1s	O
IL-10	O
gene1e	O
)	O
gene1s	O
cytokines	O
gene1e	O
than	O
the	O
R	O
morphotype	O
,	O
suggesting	O
fewer	O
immunogenic	O
characteristics	O
for	O
this	O
clinical	O
strain	O
.	O
Together	O
,	O
these	O
results	O
suggest	O
that	O
species1s	O
Mmass	O
species1e	O
-	O
induced	O
activation	O
of	O
host	O
proinflammatory	O
gene1s	O
cytokines	O
gene1e	O
is	O
mediated	O
through	O
gene1s	O
TLR2	O
gene1e	O
-dependent	O
gene1s	O
JNK	O
gene1e	O
and	O
ROS	O
signaling	O
pathways	O
.	O

species1s	O
Mycobacterium	O
massiliense	O
species1e	O
induces	O
inflammatory	O
responses	O
in	O
macrophages	O
through	O
gene1s	O
Toll	O
-	O
like	O
receptor	O
2	O
gene1e	O
and	O
gene1s	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
gene1e	O
.	O
species1s	O
Mycobacterium	O
massiliense	O
species1e	O
(	O
species1s	O
Mmass	O
species1e	O
)	O
is	O
an	O
emerging	O
,	O
rapidly	O
growing	O
species1s	O
mycobacterium	O
species1e	O
(	O
RGM	O
)	O
that	O
belongs	O
to	O
the	O
species1s	O
M.	O
abscessus	O
species1e	O
(	O
species1s	O
Mabc	O
species1e	O
)	O
group	O
,	O
albeit	O
clearly	O
differentiated	O
from	O
species1s	O
Mabc	O
species1e	O
.	O
Compared	O
with	O
species1s	O
M.	O
tuberculosis	O
species1e	O
,	O
a	O
well	O
-	O
characterized	O
arg1s	O
human	O
arg1e	O
pathogen	O
,	O
the	O
host	O
innate	O
immune	O
response	O
against	O
species1s	O
Mmass	O
species1e	O
infection	O
is	O
largely	O
unknown	O
.	O
In	O
this	O
study	O
,	O
we	O
show	O
that	O
species1s	O
Mmass	O
species1e	O
robustly	O
activates	O
mRNA	O
and	O
protein	O
expression	O
of	O
gene1s	O
tumor	O
necrosis	O
factor	O
(	O
TNF)-a	O
gene1e	O
and	O
gene1s	O
interleukin	O
(	O
IL)-6	O
gene1e	O
in	O
species1s	O
murine	O
species1e	O
bone	O
marrow	O
-	O
derived	O
macrophages	O
(	O
BMDMs	O
)	O
.	O
gene1s	O
Toll	O
-	O
like	O
receptor	O
(	O
TLR)-2	O
gene1e	O
and	O
gene1s	O
myeloid	O
differentiation	O
primary	O
response	O
gene	O
88	O
gene1e	O
(	O
gene1s	O
MyD88	O
gene1e	O
)	O
,	O
but	O
neither	O
gene1s	O
TLR4	O
gene1e	O
nor	O
gene1s	O
Dectin-1	O
gene1e	O
,	O
are	O
involved	O
in	O
species1s	O
Mmass	O
species1e	O
-	O
induced	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
or	O
gene1s	O
IL-6	O
gene1e	O
production	O
in	O
BMDMs	O
.	O
species1s	O
Mmass	O
species1e	O
infection	O
also	O
activates	O
the	O
gene1s	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
gene1e	O
(	O
gene1s	O
MAPKs	O
gene1e	O
;	O
gene1s	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
gene1e	O
(	O
gene1s	O
JNK	O
gene1e	O
)	O
,	O
gene1s	O
ERK1/2	O
gene1e	O
and	O
gene1s	O
p38	O
MAPK	O
gene1e	O
)	O
pathway	O
.	O
species1s	O
Mmass	O
species1e	O
-	O
induced	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
and	O
gene1s	O
IL-6	O
gene1e	O
production	O
was	O
dependent	O
on	O
gene1s	O
JNK	O
gene1e	O
activation	O
,	O
while	O
they	O
were	O
unaffected	O
by	O
either	O
the	O
gene1s	O
ERK1/2	O
gene1e	O
or	O
gene1s	O
p38	O
gene1e	O
pathway	O
in	O
BMDMs	O
.	O
Additionally	O
,	O
intracellular	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
,	O
gene1s	O
NADPH	O
oxidase-2	O
gene1e	O
,	O
and	O
gene1s	O
nuclear	O
factor	O
-	O
kB	O
gene1e	O
are	O
required	O
for	O
species1s	O
Mmass	O
species1e	O
-	O
induced	O
proinflammatory	O
gene1s	O
cytokine	O
gene1e	O
generation	O
in	O
macrophages	O
.	O
Furthermore	O
,	O
the	O
S	O
morphotype	O
of	O
species1s	O
Mmass	O
species1e	O
showed	O
lower	O
overall	O
induction	O
of	O
pro	O
-	O
inflammatory	O
(	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
and	O
gene1s	O
IL-1b	O
gene1e	O
)	O
and	O
anti	O
-	O
inflammatory	O
(	O
gene1s	O
IL-10	O
gene1e	O
)	O
gene1s	O
cytokines	O
gene1e	O
than	O
the	O
R	O
morphotype	O
,	O
suggesting	O
fewer	O
immunogenic	O
characteristics	O
for	O
this	O
clinical	O
strain	O
.	O
Together	O
,	O
these	O
results	O
suggest	O
that	O
species1s	O
Mmass	O
species1e	O
-	O
induced	O
activation	O
of	O
host	O
proinflammatory	O
gene1s	O
cytokines	O
gene1e	O
is	O
mediated	O
through	O
gene1s	O
TLR2	O
gene1e	O
-dependent	O
gene1s	O
JNK	O
gene1e	O
and	O
ROS	O
signaling	O
pathways	O
.	O

species1s	O
Mycobacterium	O
massiliense	O
species1e	O
induces	O
inflammatory	O
responses	O
in	O
macrophages	O
through	O
gene1s	ARG2
Toll	ARG2
-	ARG2
like	ARG2
receptor	ARG2
2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
c	ARG2
-	ARG2
Jun	ARG2
N	ARG2
-	ARG2
terminal	ARG2
kinase	ARG2
gene1e	ARG2
.	O
species1s	O
Mycobacterium	O
massiliense	O
species1e	O
(	O
species1s	O
Mmass	O
species1e	O
)	O
is	O
an	O
emerging	O
,	O
rapidly	O
growing	O
species1s	O
mycobacterium	O
species1e	O
(	O
RGM	O
)	O
that	O
belongs	O
to	O
the	O
species1s	O
M.	O
abscessus	O
species1e	O
(	O
species1s	O
Mabc	O
species1e	O
)	O
group	O
,	O
albeit	O
clearly	O
differentiated	O
from	O
species1s	O
Mabc	O
species1e	O
.	O
Compared	O
with	O
species1s	O
M.	O
tuberculosis	O
species1e	O
,	O
a	O
well	O
-	O
characterized	O
species1s	O
human	O
species1e	O
pathogen	O
,	O
the	O
host	O
innate	O
immune	O
response	O
against	O
species1s	O
Mmass	O
species1e	O
infection	O
is	O
largely	O
unknown	O
.	O
In	O
this	O
study	O
,	O
we	O
show	O
that	O
species1s	O
Mmass	O
species1e	O
robustly	O
activates	O
mRNA	O
and	O
protein	O
expression	O
of	O
gene1s	ARG2
tumor	ARG2
necrosis	ARG2
factor	ARG2
(	ARG2
TNF)-a	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
interleukin	ARG2
(	ARG2
IL)-6	ARG2
gene1e	ARG2
in	O
arg1s	O
murine	O
arg1e	O
bone	O
marrow	O
-	O
derived	O
macrophages	O
(	O
BMDMs	O
)	O
.	O
gene1s	ARG2
Toll	ARG2
-	ARG2
like	ARG2
receptor	ARG2
(	ARG2
TLR)-2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
myeloid	ARG2
differentiation	ARG2
primary	ARG2
response	ARG2
gene	ARG2
88	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
)	O
,	O
but	O
neither	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
nor	O
gene1s	ARG2
Dectin-1	ARG2
gene1e	ARG2
,	O
are	O
involved	O
in	O
species1s	O
Mmass	O
species1e	O
-	O
induced	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
production	O
in	O
BMDMs	O
.	O
species1s	O
Mmass	O
species1e	O
infection	O
also	O
activates	O
the	O
gene1s	ARG2
mitogen	ARG2
-	ARG2
activated	ARG2
protein	ARG2
kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MAPKs	ARG2
gene1e	ARG2
;	O
gene1s	ARG2
c	ARG2
-	ARG2
Jun	ARG2
N	ARG2
-	ARG2
terminal	ARG2
kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p38	ARG2
MAPK	ARG2
gene1e	ARG2
)	O
pathway	O
.	O
species1s	O
Mmass	O
species1e	O
-	O
induced	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
production	O
was	O
dependent	O
on	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
activation	O
,	O
while	O
they	O
were	O
unaffected	O
by	O
either	O
the	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
p38	ARG2
gene1e	ARG2
pathway	O
in	O
BMDMs	O
.	O
Additionally	O
,	O
intracellular	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
,	O
gene1s	ARG2
NADPH	ARG2
oxidase-2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
nuclear	ARG2
factor	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
are	O
required	O
for	O
species1s	O
Mmass	O
species1e	O
-	O
induced	O
proinflammatory	O
gene1s	ARG2
cytokine	ARG2
gene1e	ARG2
generation	O
in	O
macrophages	O
.	O
Furthermore	O
,	O
the	O
S	O
morphotype	O
of	O
species1s	O
Mmass	O
species1e	O
showed	O
lower	O
overall	O
induction	O
of	O
pro	O
-	O
inflammatory	O
(	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
IL-1b	ARG2
gene1e	ARG2
)	O
and	O
anti	O
-	O
inflammatory	O
(	O
gene1s	ARG2
IL-10	ARG2
gene1e	ARG2
)	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
than	O
the	O
R	O
morphotype	O
,	O
suggesting	O
fewer	O
immunogenic	O
characteristics	O
for	O
this	O
clinical	O
strain	O
.	O
Together	O
,	O
these	O
results	O
suggest	O
that	O
species1s	O
Mmass	O
species1e	O
-	O
induced	O
activation	O
of	O
host	O
proinflammatory	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
is	O
mediated	O
through	O
gene1s	ARG2
TLR2	ARG2
gene1e	ARG2
-dependent	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
and	O
ROS	O
signaling	O
pathways	O
.	O

Keratinocyte	O
overexpression	O
of	O
gene1s	O
IL-17C	O
gene1e	O
promotes	O
psoriasiform	O
skin	O
inflammation	O
.	O
gene1s	ARG2
IL-17C	ARG2
gene1e	ARG2
is	O
a	O
functionally	O
distinct	O
member	O
of	O
the	O
gene1s	ARG2
IL-17	ARG2
gene1e	ARG2
family	O
that	O
binds	O
gene1s	ARG2
IL-17	ARG2
receptor	ARG2
E	ARG2
/	ARG2
A	ARG2
gene1e	ARG2
to	O
promote	O
innate	O
defense	O
in	O
epithelial	O
cells	O
and	O
regulate	O
Th17	O
cell	O
differentiation	O
.	O
We	O
demonstrate	O
that	O
gene1s	ARG2
IL-17C	ARG2
gene1e	ARG2
(	O
not	O
gene1s	ARG2
IL-17A	ARG2
gene1e	ARG2
)	O
is	O
the	O
most	O
abundant	O
gene1s	ARG2
IL-17	ARG2
gene1e	ARG2
isoform	O
in	O
lesional	O
psoriasis	O
skin	O
(	O
1058	O
versus	O
8	O
pg	O
/	O
ml	O
;	O
p	O
<	O
0.006	O
)	O
and	O
localizes	O
to	O
keratinocytes	O
(	O
KCs	O
)	O
,	O
endothelial	O
cells	O
(	O
ECs	O
)	O
,	O
and	O
leukocytes	O
.	O
ECs	O
stimulated	O
with	O
gene1s	ARG2
IL-17C	ARG2
gene1e	ARG2
produce	O
increased	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
and	O
KCs	O
stimulated	O
with	O
gene1s	ARG2
IL-17C	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
produce	O
similar	O
inflammatory	O
gene	O
response	O
patterns	O
as	O
those	O
elicited	O
by	O
gene1s	ARG2
IL-17A	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
,	O
including	O
increases	O
in	O
gene1s	ARG2
IL-17C	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-1alpha	ARG2
/	ARG2
beta	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-1F5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-1F9	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-19	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CCL20	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
S100A7	ARG2
/	ARG2
A8	ARG2
/	ARG2
A9	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
DEFB4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
lipocalin	ARG2
2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
peptidase	ARG2
inhibitor	ARG2
3	ARG2
gene1e	ARG2
(	O
p	O
<	O
0.05	O
)	O
,	O
indicating	O
a	O
positive	O
proinflammatory	O
feedback	O
loop	O
between	O
the	O
epidermis	O
and	O
ECs	O
.	O
Psoriasis	O
arg1s	O
patients	O
arg1e	O
treated	O
with	O
etanercept	O
rapidly	O
decrease	O
cutaneous	O
gene1s	ARG2
IL-17C	ARG2
gene1e	ARG2
levels	O
,	O
suggesting	O
gene1s	ARG2
IL-17C	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
-	O
mediated	O
inflammatory	O
signaling	O
is	O
critical	O
for	O
psoriasis	O
pathogenesis	O
.	O
species1s	O
Mice	O
species1e	O
genetically	O
engineered	O
to	O
overexpress	O
gene1s	O
IL-17C	O
gene1e	O
in	O
KCs	O
develop	O
well	O
-	O
demarcated	O
areas	O
of	O
erythematous	O
,	O
flakey	O
involved	O
skin	O
adjacent	O
to	O
areas	O
of	O
normal	O
-	O
appearing	O
uninvolved	O
skin	O
despite	O
increased	O
gene1s	O
IL-17C	O
gene1e	O
expression	O
in	O
both	O
areas	O
(	O
p	O
<	O
0.05	O
)	O
.	O
Uninvolved	O
skin	O
displays	O
increased	O
angiogenesis	O
and	O
elevated	O
gene1s	O
S100A8	O
/	O
A9	O
gene1e	O
expression	O
(	O
p	O
<	O
0.05	O
)	O
but	O
no	O
epidermal	O
hyperplasia	O
,	O
whereas	O
involved	O
skin	O
exhibits	O
robust	O
epidermal	O
hyperplasia	O
,	O
increased	O
angiogenesis	O
and	O
leukocyte	O
infiltration	O
,	O
and	O
upregulated	O
gene1s	O
TNF	O
-	O
alpha	O
gene1e	O
,	O
gene1s	O
IL-1alpha	O
/	O
beta	O
gene1e	O
,	O
gene1s	O
IL-17A	O
/	O
F	O
gene1e	O
,	O
gene1s	O
IL-23p19	O
gene1e	O
,	O
gene1s	O
vascular	O
endothelial	O
growth	O
factor	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
and	O
gene1s	O
CCL20	O
gene1e	O
(	O
p	O
<	O
0.05	O
)	O
,	O
suggesting	O
that	O
gene1s	O
IL-17C	O
gene1e	O
,	O
when	O
coupled	O
with	O
other	O
proinflammatory	O
signals	O
,	O
initiates	O
the	O
development	O
of	O
psoriasiform	O
dermatitis	O
.	O
This	O
skin	O
phenotype	O
was	O
significantly	O
improved	O
following	O
8	O
wk	O
of	O
gene1s	O
TNF	O
-	O
alpha	O
gene1e	O
inhibition	O
.	O
These	O
findings	O
identify	O
a	O
role	O
for	O
gene1s	ARG2
IL-17C	ARG2
gene1e	ARG2
in	O
skin	O
inflammation	O
and	O
suggest	O
a	O
pathogenic	O
function	O
for	O
the	O
elevated	O
gene1s	ARG2
IL-17C	ARG2
gene1e	ARG2
observed	O
in	O
lesional	O
psoriasis	O
skin	O
.	O

Keratinocyte	O
overexpression	O
of	O
gene1s	ARG2
IL-17C	ARG2
gene1e	ARG2
promotes	O
psoriasiform	O
skin	O
inflammation	O
.	O
gene1s	ARG2
IL-17C	ARG2
gene1e	ARG2
is	O
a	O
functionally	O
distinct	O
member	O
of	O
the	O
gene1s	ARG2
IL-17	ARG2
gene1e	ARG2
family	O
that	O
binds	O
gene1s	ARG2
IL-17	ARG2
receptor	ARG2
E	ARG2
/	ARG2
A	ARG2
gene1e	ARG2
to	O
promote	O
innate	O
defense	O
in	O
epithelial	O
cells	O
and	O
regulate	O
Th17	O
cell	O
differentiation	O
.	O
We	O
demonstrate	O
that	O
gene1s	O
IL-17C	O
gene1e	O
(	O
not	O
gene1s	O
IL-17A	O
gene1e	O
)	O
is	O
the	O
most	O
abundant	O
gene1s	ARG2
IL-17	ARG2
gene1e	ARG2
isoform	O
in	O
lesional	O
psoriasis	O
skin	O
(	O
1058	O
versus	O
8	O
pg	O
/	O
ml	O
;	O
p	O
<	O
0.006	O
)	O
and	O
localizes	O
to	O
keratinocytes	O
(	O
KCs	O
)	O
,	O
endothelial	O
cells	O
(	O
ECs	O
)	O
,	O
and	O
leukocytes	O
.	O
ECs	O
stimulated	O
with	O
gene1s	O
IL-17C	O
gene1e	O
produce	O
increased	O
gene1s	O
TNF	O
-	O
alpha	O
gene1e	O
and	O
KCs	O
stimulated	O
with	O
gene1s	O
IL-17C	O
gene1e	O
/	O
gene1s	O
TNF	O
-	O
alpha	O
gene1e	O
produce	O
similar	O
inflammatory	O
gene	O
response	O
patterns	O
as	O
those	O
elicited	O
by	O
gene1s	O
IL-17A	O
gene1e	O
/	O
gene1s	O
TNF	O
-	O
alpha	O
gene1e	O
,	O
including	O
increases	O
in	O
gene1s	O
IL-17C	O
gene1e	O
,	O
gene1s	O
TNF	O
-	O
alpha	O
gene1e	O
,	O
gene1s	O
IL-8	O
gene1e	O
,	O
gene1s	O
IL-1alpha	O
/	O
beta	O
gene1e	O
,	O
gene1s	O
IL-1F5	O
gene1e	O
,	O
gene1s	O
IL-1F9	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
gene1s	O
IL-19	O
gene1e	O
,	O
gene1s	O
CCL20	O
gene1e	O
,	O
gene1s	O
S100A7	O
/	O
A8	O
/	O
A9	O
gene1e	O
,	O
gene1s	O
DEFB4	O
gene1e	O
,	O
gene1s	O
lipocalin	O
2	O
gene1e	O
,	O
and	O
gene1s	O
peptidase	O
inhibitor	O
3	O
gene1e	O
(	O
p	O
<	O
0.05	O
)	O
,	O
indicating	O
a	O
positive	O
proinflammatory	O
feedback	O
loop	O
between	O
the	O
epidermis	O
and	O
ECs	O
.	O
Psoriasis	O
species1s	O
patients	O
species1e	O
treated	O
with	O
etanercept	O
rapidly	O
decrease	O
cutaneous	O
gene1s	O
IL-17C	O
gene1e	O
levels	O
,	O
suggesting	O
gene1s	O
IL-17C	O
gene1e	O
/	O
gene1s	O
TNF	O
-	O
alpha	O
gene1e	O
-	O
mediated	O
inflammatory	O
signaling	O
is	O
critical	O
for	O
psoriasis	O
pathogenesis	O
.	O
arg1s	O
Mice	O
arg1e	O
genetically	O
engineered	O
to	O
overexpress	O
gene1s	ARG2
IL-17C	ARG2
gene1e	ARG2
in	O
KCs	O
develop	O
well	O
-	O
demarcated	O
areas	O
of	O
erythematous	O
,	O
flakey	O
involved	O
skin	O
adjacent	O
to	O
areas	O
of	O
normal	O
-	O
appearing	O
uninvolved	O
skin	O
despite	O
increased	O
gene1s	ARG2
IL-17C	ARG2
gene1e	ARG2
expression	O
in	O
both	O
areas	O
(	O
p	O
<	O
0.05	O
)	O
.	O
Uninvolved	O
skin	O
displays	O
increased	O
angiogenesis	O
and	O
elevated	O
gene1s	ARG2
S100A8	ARG2
/	ARG2
A9	ARG2
gene1e	ARG2
expression	O
(	O
p	O
<	O
0.05	O
)	O
but	O
no	O
epidermal	O
hyperplasia	O
,	O
whereas	O
involved	O
skin	O
exhibits	O
robust	O
epidermal	O
hyperplasia	O
,	O
increased	O
angiogenesis	O
and	O
leukocyte	O
infiltration	O
,	O
and	O
upregulated	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-1alpha	ARG2
/	ARG2
beta	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-17A	ARG2
/	ARG2
F	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-23p19	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
vascular	ARG2
endothelial	ARG2
growth	ARG2
factor	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
CCL20	ARG2
gene1e	ARG2
(	O
p	O
<	O
0.05	O
)	O
,	O
suggesting	O
that	O
gene1s	ARG2
IL-17C	ARG2
gene1e	ARG2
,	O
when	O
coupled	O
with	O
other	O
proinflammatory	O
signals	O
,	O
initiates	O
the	O
development	O
of	O
psoriasiform	O
dermatitis	O
.	O
This	O
skin	O
phenotype	O
was	O
significantly	O
improved	O
following	O
8	O
wk	O
of	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
inhibition	O
.	O
These	O
findings	O
identify	O
a	O
role	O
for	O
gene1s	ARG2
IL-17C	ARG2
gene1e	ARG2
in	O
skin	O
inflammation	O
and	O
suggest	O
a	O
pathogenic	O
function	O
for	O
the	O
elevated	O
gene1s	ARG2
IL-17C	ARG2
gene1e	ARG2
observed	O
in	O
lesional	O
psoriasis	O
skin	O
.	O

Telomere	O
Replication	O
Stress	O
Induced	O
by	O
gene1s	ARG2
POT1	ARG2
gene1e	ARG2
Inactivation	O
Accelerates	O
Tumorigenesis	O
.	O
Genome	O
sequencing	O
studies	O
have	O
revealed	O
a	O
number	O
of	O
cancer	O
-	O
associated	O
mutations	O
in	O
the	O
telomere	O
-	O
binding	O
factor	O
gene1s	O
POT1	O
gene1e	O
.	O
Here	O
,	O
we	O
show	O
that	O
when	O
combined	O
with	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
deficiency	O
,	O
depletion	O
of	O
arg1s	O
murine	O
arg1e	O
gene1s	ARG2
POT1a	ARG2
gene1e	ARG2
in	O
common	O
lymphoid	O
progenitor	O
cells	O
fosters	O
genetic	O
instability	O
,	O
accelerates	O
the	O
onset	O
,	O
and	O
increases	O
the	O
severity	O
of	O
T	O
cell	O
lymphomas	O
.	O
In	O
parallel	O
,	O
we	O
examined	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
mouse	O
arg1e	O
cells	O
carrying	O
gene1s	ARG2
POT1	ARG2
gene1e	ARG2
mutations	O
found	O
in	O
cutaneous	O
T	O
cell	O
lymphoma	O
(	O
CTCL	O
)	O
species1s	O
patients	O
species1e	O
.	O
Inhibition	O
of	O
gene1s	ARG2
POT1	ARG2
gene1e	ARG2
activates	O
gene1s	O
ATR	O
gene1e	O
-	O
dependent	O
DNA	O
damage	O
signaling	O
and	O
induces	O
telomere	O
fragility	O
,	O
replication	O
fork	O
stalling	O
,	O
and	O
telomere	O
elongation	O
.	O
Our	O
data	O
suggest	O
that	O
these	O
phenotypes	O
are	O
linked	O
to	O
impaired	O
gene1s	O
CST	O
gene1e	O
(	O
gene1s	O
CTC1	O
gene1e	O
-	O
gene1s	O
STN1	O
gene1e	O
-	O
gene1s	O
TEN1	O
gene1e	O
)	O
function	O
at	O
telomeres	O
.	O
Lastly	O
,	O
we	O
show	O
that	O
proliferation	O
of	O
cancer	O
cells	O
lacking	O
gene1s	ARG2
POT1	ARG2
gene1e	ARG2
is	O
enabled	O
by	O
the	O
attenuation	O
of	O
the	O
gene1s	ARG2
ATR	ARG2
kinase	ARG2
gene1e	ARG2
pathway	O
.	O
These	O
results	O
uncover	O
a	O
role	O
for	O
defective	O
telomere	O
replication	O
during	O
tumorigenesis	O
.	O

Telomere	O
Replication	O
Stress	O
Induced	O
by	O
gene1s	O
POT1	O
gene1e	O
Inactivation	O
Accelerates	O
Tumorigenesis	O
.	O
Genome	O
sequencing	O
studies	O
have	O
revealed	O
a	O
number	O
of	O
cancer	O
-	O
associated	O
mutations	O
in	O
the	O
telomere	O
-	O
binding	O
factor	O
gene1s	ARG2
POT1	ARG2
gene1e	ARG2
.	O
Here	O
,	O
we	O
show	O
that	O
when	O
combined	O
with	O
gene1s	O
p53	O
gene1e	O
deficiency	O
,	O
depletion	O
of	O
species1s	O
murine	O
species1e	O
gene1s	O
POT1a	O
gene1e	O
in	O
common	O
lymphoid	O
progenitor	O
cells	O
fosters	O
genetic	O
instability	O
,	O
accelerates	O
the	O
onset	O
,	O
and	O
increases	O
the	O
severity	O
of	O
T	O
cell	O
lymphomas	O
.	O
In	O
parallel	O
,	O
we	O
examined	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
mouse	O
species1e	O
cells	O
carrying	O
gene1s	O
POT1	O
gene1e	O
mutations	O
found	O
in	O
cutaneous	O
T	O
cell	O
lymphoma	O
(	O
CTCL	O
)	O
arg1s	O
patients	O
arg1e	O
.	O
Inhibition	O
of	O
gene1s	O
POT1	O
gene1e	O
activates	O
gene1s	ARG2
ATR	ARG2
gene1e	ARG2
-	O
dependent	O
DNA	O
damage	O
signaling	O
and	O
induces	O
telomere	O
fragility	O
,	O
replication	O
fork	O
stalling	O
,	O
and	O
telomere	O
elongation	O
.	O
Our	O
data	O
suggest	O
that	O
these	O
phenotypes	O
are	O
linked	O
to	O
impaired	O
gene1s	ARG2
CST	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CTC1	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
STN1	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
TEN1	ARG2
gene1e	ARG2
)	O
function	O
at	O
telomeres	O
.	O
Lastly	O
,	O
we	O
show	O
that	O
proliferation	O
of	O
cancer	O
cells	O
lacking	O
gene1s	O
POT1	O
gene1e	O
is	O
enabled	O
by	O
the	O
attenuation	O
of	O
the	O
gene1s	O
ATR	O
kinase	O
gene1e	O
pathway	O
.	O
These	O
results	O
uncover	O
a	O
role	O
for	O
defective	O
telomere	O
replication	O
during	O
tumorigenesis	O
.	O

A	O
small	O
peptide	O
modeled	O
after	O
the	O
gene1s	O
NRAGE	O
gene1e	O
repeat	O
domain	O
inhibits	O
gene1s	O
XIAP	O
gene1e	O
-	O
gene1s	O
TAB1	O
gene1e	O
-	O
gene1s	O
TAK1	O
gene1e	O
signaling	O
for	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
activation	O
and	O
apoptosis	O
in	O
P19	O
cells	O
.	O
In	O
normal	O
growth	O
and	O
development	O
,	O
apoptosis	O
is	O
necessary	O
to	O
shape	O
the	O
central	O
nervous	O
system	O
and	O
to	O
eliminate	O
excess	O
neurons	O
which	O
are	O
not	O
required	O
for	O
innervation	O
.	O
In	O
some	O
diseases	O
,	O
however	O
,	O
apoptosis	O
can	O
be	O
either	O
overactive	O
as	O
in	O
some	O
neurodegenerative	O
disorders	O
or	O
severely	O
attenuated	O
as	O
in	O
the	O
spread	O
of	O
certain	O
cancers	O
.	O
gene1s	O
Bone	O
morphogenetic	O
proteins	O
gene1e	O
(	O
gene1s	O
BMPs	O
gene1e	O
)	O
transmit	O
signals	O
for	O
regulating	O
cell	O
growth	O
,	O
differentiation	O
,	O
and	O
apoptosis	O
.	O
Responding	O
to	O
gene1s	O
BMP	O
receptors	O
gene1e	O
stimulated	O
from	O
gene1s	O
BMP	O
gene1e	O
ligands	O
,	O
gene1s	O
neurotrophin	O
receptor	O
-	O
mediated	O
MAGE	O
homolog	O
gene1e	O
(	O
gene1s	O
NRAGE	O
gene1e	O
)	O
binds	O
and	O
functions	O
with	O
the	O
gene1s	O
XIAP	O
gene1e	O
-	O
gene1s	O
TAK1	O
gene1e	O
-	O
gene1s	O
TAB1	O
gene1e	O
complex	O
to	O
activate	O
gene1s	O
p38(MAPK	O
)	O
gene1e	O
and	O
induces	O
apoptosis	O
in	O
cortical	O
neural	O
progenitors	O
.	O
gene1s	ARG2
NRAGE	ARG2
gene1e	ARG2
contains	O
a	O
unique	O
repeat	O
domain	O
that	O
is	O
only	O
found	O
in	O
arg1s	O
human	O
arg1e	O
,	O
species1s	O
mouse	O
species1e	O
,	O
and	O
species1s	O
rat	O
species1e	O
homologs	O
that	O
we	O
theorize	O
is	O
pivotal	O
in	O
its	O
gene1s	ARG2
BMP	ARG2
gene1e	ARG2
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
role	O
.	O
Previously	O
,	O
we	O
showed	O
that	O
deletion	O
of	O
the	O
repeat	O
domain	O
inhibits	O
apoptosis	O
,	O
gene1s	O
p38(MAPK	O
)	O
gene1e	O
phosphorylation	O
,	O
and	O
gene1s	O
caspase-3	O
gene1e	O
cleavage	O
in	O
P19	O
neural	O
progenitor	O
cells	O
.	O
We	O
also	O
showed	O
that	O
the	O
gene1s	O
XIAP	O
gene1e	O
-	O
gene1s	O
TAB1	O
gene1e	O
-	O
gene1s	O
TAK1	O
gene1e	O
complex	O
is	O
dependent	O
on	O
gene1s	O
NRAGE	O
gene1e	O
for	O
gene1s	O
IKK	O
-	O
a	O
/	O
b	O
gene1e	O
phosphorylation	O
and	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
activation	O
.	O
gene1s	O
XIAP	O
gene1e	O
is	O
a	O
major	O
inhibitor	O
of	O
gene1s	O
caspases	O
gene1e	O
,	O
the	O
main	O
executioners	O
of	O
apoptosis	O
.	O
Although	O
it	O
has	O
been	O
shown	O
previously	O
that	O
gene1s	O
NRAGE	O
gene1e	O
binds	O
to	O
the	O
RING	O
domain	O
of	O
gene1s	O
XIAP	O
gene1e	O
,	O
it	O
has	O
not	O
been	O
determined	O
which	O
gene1s	O
NRAGE	O
gene1e	O
domain	O
binds	O
to	O
gene1s	O
XIAP	O
gene1e	O
.	O
Here	O
,	O
we	O
used	O
fluorescence	O
resonance	O
energy	O
transfer	O
(	O
FRET	O
)	O
to	O
determine	O
that	O
there	O
is	O
a	O
strong	O
likelihood	O
of	O
a	O
direct	O
interaction	O
between	O
gene1s	O
NRAGE	O
gene1e	O
and	O
gene1s	O
XIAP	O
gene1e	O
occurring	O
at	O
gene1s	O
NRAGE	O
gene1e	O
's	O
unique	O
repeat	O
domain	O
which	O
we	O
also	O
attribute	O
to	O
be	O
the	O
domain	O
responsible	O
for	O
downstream	O
signaling	O
of	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
and	O
activating	O
gene1s	O
IKK	O
subunits	O
gene1e	O
.	O
From	O
these	O
results	O
,	O
we	O
designed	O
a	O
small	O
peptide	O
modeled	O
after	O
the	O
gene1s	O
NRAGE	O
gene1e	O
repeat	O
domain	O
which	O
we	O
have	O
determined	O
inhibits	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
activation	O
and	O
apoptosis	O
in	O
P19	O
cells	O
.	O
These	O
intriguing	O
results	O
illustrate	O
that	O
the	O
paradigm	O
of	O
the	O
gene1s	O
NRAGE	O
gene1e	O
repeat	O
domain	O
may	O
hold	O
promising	O
therapeutic	O
strategies	O
in	O
developing	O
pharmaceutical	O
solutions	O
for	O
combating	O
harmful	O
diseases	O
involving	O
excessive	O
downstream	O
gene1s	O
BMP	O
gene1e	O
signaling	O
,	O
including	O
apoptosis	O
.	O

A	O
small	O
peptide	O
modeled	O
after	O
the	O
gene1s	ARG2
NRAGE	ARG2
gene1e	ARG2
repeat	O
domain	O
inhibits	O
gene1s	ARG2
XIAP	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
TAB1	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
TAK1	ARG2
gene1e	ARG2
signaling	O
for	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
activation	O
and	O
apoptosis	O
in	O
P19	O
cells	O
.	O
In	O
normal	O
growth	O
and	O
development	O
,	O
apoptosis	O
is	O
necessary	O
to	O
shape	O
the	O
central	O
nervous	O
system	O
and	O
to	O
eliminate	O
excess	O
neurons	O
which	O
are	O
not	O
required	O
for	O
innervation	O
.	O
In	O
some	O
diseases	O
,	O
however	O
,	O
apoptosis	O
can	O
be	O
either	O
overactive	O
as	O
in	O
some	O
neurodegenerative	O
disorders	O
or	O
severely	O
attenuated	O
as	O
in	O
the	O
spread	O
of	O
certain	O
cancers	O
.	O
gene1s	ARG2
Bone	ARG2
morphogenetic	ARG2
proteins	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
BMPs	ARG2
gene1e	ARG2
)	O
transmit	O
signals	O
for	O
regulating	O
cell	O
growth	O
,	O
differentiation	O
,	O
and	O
apoptosis	O
.	O
Responding	O
to	O
gene1s	ARG2
BMP	ARG2
receptors	ARG2
gene1e	ARG2
stimulated	O
from	O
gene1s	ARG2
BMP	ARG2
gene1e	ARG2
ligands	O
,	O
gene1s	ARG2
neurotrophin	ARG2
receptor	ARG2
-	ARG2
mediated	ARG2
MAGE	ARG2
homolog	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NRAGE	ARG2
gene1e	ARG2
)	O
binds	O
and	O
functions	O
with	O
the	O
gene1s	ARG2
XIAP	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
TAK1	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
TAB1	ARG2
gene1e	ARG2
complex	O
to	O
activate	O
gene1s	ARG2
p38(MAPK	ARG2
)	ARG2
gene1e	ARG2
and	O
induces	O
apoptosis	O
in	O
cortical	O
neural	O
progenitors	O
.	O
gene1s	ARG2
NRAGE	ARG2
gene1e	ARG2
contains	O
a	O
unique	O
repeat	O
domain	O
that	O
is	O
only	O
found	O
in	O
species1s	O
human	O
species1e	O
,	O
arg1s	O
mouse	O
arg1e	O
,	O
and	O
species1s	O
rat	O
species1e	O
homologs	O
that	O
we	O
theorize	O
is	O
pivotal	O
in	O
its	O
gene1s	ARG2
BMP	ARG2
gene1e	ARG2
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
role	O
.	O
Previously	O
,	O
we	O
showed	O
that	O
deletion	O
of	O
the	O
repeat	O
domain	O
inhibits	O
apoptosis	O
,	O
gene1s	ARG2
p38(MAPK	ARG2
)	ARG2
gene1e	ARG2
phosphorylation	O
,	O
and	O
gene1s	ARG2
caspase-3	ARG2
gene1e	ARG2
cleavage	O
in	O
P19	O
neural	O
progenitor	O
cells	O
.	O
We	O
also	O
showed	O
that	O
the	O
gene1s	ARG2
XIAP	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
TAB1	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
TAK1	ARG2
gene1e	ARG2
complex	O
is	O
dependent	O
on	O
gene1s	ARG2
NRAGE	ARG2
gene1e	ARG2
for	O
gene1s	ARG2
IKK	ARG2
-	ARG2
a	ARG2
/	ARG2
b	ARG2
gene1e	ARG2
phosphorylation	O
and	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
activation	O
.	O
gene1s	ARG2
XIAP	ARG2
gene1e	ARG2
is	O
a	O
major	O
inhibitor	O
of	O
gene1s	ARG2
caspases	ARG2
gene1e	ARG2
,	O
the	O
main	O
executioners	O
of	O
apoptosis	O
.	O
Although	O
it	O
has	O
been	O
shown	O
previously	O
that	O
gene1s	ARG2
NRAGE	ARG2
gene1e	ARG2
binds	O
to	O
the	O
RING	O
domain	O
of	O
gene1s	ARG2
XIAP	ARG2
gene1e	ARG2
,	O
it	O
has	O
not	O
been	O
determined	O
which	O
gene1s	ARG2
NRAGE	ARG2
gene1e	ARG2
domain	O
binds	O
to	O
gene1s	ARG2
XIAP	ARG2
gene1e	ARG2
.	O
Here	O
,	O
we	O
used	O
fluorescence	O
resonance	O
energy	O
transfer	O
(	O
FRET	O
)	O
to	O
determine	O
that	O
there	O
is	O
a	O
strong	O
likelihood	O
of	O
a	O
direct	O
interaction	O
between	O
gene1s	ARG2
NRAGE	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
XIAP	ARG2
gene1e	ARG2
occurring	O
at	O
gene1s	ARG2
NRAGE	ARG2
gene1e	ARG2
's	O
unique	O
repeat	O
domain	O
which	O
we	O
also	O
attribute	O
to	O
be	O
the	O
domain	O
responsible	O
for	O
downstream	O
signaling	O
of	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
and	O
activating	O
gene1s	ARG2
IKK	ARG2
subunits	ARG2
gene1e	ARG2
.	O
From	O
these	O
results	O
,	O
we	O
designed	O
a	O
small	O
peptide	O
modeled	O
after	O
the	O
gene1s	ARG2
NRAGE	ARG2
gene1e	ARG2
repeat	O
domain	O
which	O
we	O
have	O
determined	O
inhibits	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
activation	O
and	O
apoptosis	O
in	O
P19	O
cells	O
.	O
These	O
intriguing	O
results	O
illustrate	O
that	O
the	O
paradigm	O
of	O
the	O
gene1s	ARG2
NRAGE	ARG2
gene1e	ARG2
repeat	O
domain	O
may	O
hold	O
promising	O
therapeutic	O
strategies	O
in	O
developing	O
pharmaceutical	O
solutions	O
for	O
combating	O
harmful	O
diseases	O
involving	O
excessive	O
downstream	O
gene1s	ARG2
BMP	ARG2
gene1e	ARG2
signaling	O
,	O
including	O
apoptosis	O
.	O

A	O
small	O
peptide	O
modeled	O
after	O
the	O
gene1s	O
NRAGE	O
gene1e	O
repeat	O
domain	O
inhibits	O
gene1s	O
XIAP	O
gene1e	O
-	O
gene1s	O
TAB1	O
gene1e	O
-	O
gene1s	O
TAK1	O
gene1e	O
signaling	O
for	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
activation	O
and	O
apoptosis	O
in	O
P19	O
cells	O
.	O
In	O
normal	O
growth	O
and	O
development	O
,	O
apoptosis	O
is	O
necessary	O
to	O
shape	O
the	O
central	O
nervous	O
system	O
and	O
to	O
eliminate	O
excess	O
neurons	O
which	O
are	O
not	O
required	O
for	O
innervation	O
.	O
In	O
some	O
diseases	O
,	O
however	O
,	O
apoptosis	O
can	O
be	O
either	O
overactive	O
as	O
in	O
some	O
neurodegenerative	O
disorders	O
or	O
severely	O
attenuated	O
as	O
in	O
the	O
spread	O
of	O
certain	O
cancers	O
.	O
gene1s	O
Bone	O
morphogenetic	O
proteins	O
gene1e	O
(	O
gene1s	O
BMPs	O
gene1e	O
)	O
transmit	O
signals	O
for	O
regulating	O
cell	O
growth	O
,	O
differentiation	O
,	O
and	O
apoptosis	O
.	O
Responding	O
to	O
gene1s	O
BMP	O
receptors	O
gene1e	O
stimulated	O
from	O
gene1s	O
BMP	O
gene1e	O
ligands	O
,	O
gene1s	O
neurotrophin	O
receptor	O
-	O
mediated	O
MAGE	O
homolog	O
gene1e	O
(	O
gene1s	O
NRAGE	O
gene1e	O
)	O
binds	O
and	O
functions	O
with	O
the	O
gene1s	O
XIAP	O
gene1e	O
-	O
gene1s	O
TAK1	O
gene1e	O
-	O
gene1s	O
TAB1	O
gene1e	O
complex	O
to	O
activate	O
gene1s	O
p38(MAPK	O
)	O
gene1e	O
and	O
induces	O
apoptosis	O
in	O
cortical	O
neural	O
progenitors	O
.	O
gene1s	ARG2
NRAGE	ARG2
gene1e	ARG2
contains	O
a	O
unique	O
repeat	O
domain	O
that	O
is	O
only	O
found	O
in	O
species1s	O
human	O
species1e	O
,	O
species1s	O
mouse	O
species1e	O
,	O
and	O
arg1s	O
rat	O
arg1e	O
homologs	O
that	O
we	O
theorize	O
is	O
pivotal	O
in	O
its	O
gene1s	ARG2
BMP	ARG2
gene1e	ARG2
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
role	O
.	O
Previously	O
,	O
we	O
showed	O
that	O
deletion	O
of	O
the	O
repeat	O
domain	O
inhibits	O
apoptosis	O
,	O
gene1s	O
p38(MAPK	O
)	O
gene1e	O
phosphorylation	O
,	O
and	O
gene1s	O
caspase-3	O
gene1e	O
cleavage	O
in	O
P19	O
neural	O
progenitor	O
cells	O
.	O
We	O
also	O
showed	O
that	O
the	O
gene1s	O
XIAP	O
gene1e	O
-	O
gene1s	O
TAB1	O
gene1e	O
-	O
gene1s	O
TAK1	O
gene1e	O
complex	O
is	O
dependent	O
on	O
gene1s	O
NRAGE	O
gene1e	O
for	O
gene1s	O
IKK	O
-	O
a	O
/	O
b	O
gene1e	O
phosphorylation	O
and	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
activation	O
.	O
gene1s	O
XIAP	O
gene1e	O
is	O
a	O
major	O
inhibitor	O
of	O
gene1s	O
caspases	O
gene1e	O
,	O
the	O
main	O
executioners	O
of	O
apoptosis	O
.	O
Although	O
it	O
has	O
been	O
shown	O
previously	O
that	O
gene1s	O
NRAGE	O
gene1e	O
binds	O
to	O
the	O
RING	O
domain	O
of	O
gene1s	O
XIAP	O
gene1e	O
,	O
it	O
has	O
not	O
been	O
determined	O
which	O
gene1s	O
NRAGE	O
gene1e	O
domain	O
binds	O
to	O
gene1s	O
XIAP	O
gene1e	O
.	O
Here	O
,	O
we	O
used	O
fluorescence	O
resonance	O
energy	O
transfer	O
(	O
FRET	O
)	O
to	O
determine	O
that	O
there	O
is	O
a	O
strong	O
likelihood	O
of	O
a	O
direct	O
interaction	O
between	O
gene1s	O
NRAGE	O
gene1e	O
and	O
gene1s	O
XIAP	O
gene1e	O
occurring	O
at	O
gene1s	O
NRAGE	O
gene1e	O
's	O
unique	O
repeat	O
domain	O
which	O
we	O
also	O
attribute	O
to	O
be	O
the	O
domain	O
responsible	O
for	O
downstream	O
signaling	O
of	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
and	O
activating	O
gene1s	O
IKK	O
subunits	O
gene1e	O
.	O
From	O
these	O
results	O
,	O
we	O
designed	O
a	O
small	O
peptide	O
modeled	O
after	O
the	O
gene1s	O
NRAGE	O
gene1e	O
repeat	O
domain	O
which	O
we	O
have	O
determined	O
inhibits	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
activation	O
and	O
apoptosis	O
in	O
P19	O
cells	O
.	O
These	O
intriguing	O
results	O
illustrate	O
that	O
the	O
paradigm	O
of	O
the	O
gene1s	O
NRAGE	O
gene1e	O
repeat	O
domain	O
may	O
hold	O
promising	O
therapeutic	O
strategies	O
in	O
developing	O
pharmaceutical	O
solutions	O
for	O
combating	O
harmful	O
diseases	O
involving	O
excessive	O
downstream	O
gene1s	O
BMP	O
gene1e	O
signaling	O
,	O
including	O
apoptosis	O
.	O

gene1s	ARG2
MIG-7	ARG2
gene1e	ARG2
and	O
phosphorylated	O
gene1s	ARG2
prohibitin	ARG2
gene1e	ARG2
coordinately	O
regulate	O
lung	O
cancer	O
invasion	O
/	O
metastasis	O
.	O
gene1s	ARG2
Growth	ARG2
factors	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
COX-2	ARG2
gene1e	ARG2
/	O
PGE2	O
enhance	O
lung	O
cancer	O
invasion	O
/	O
metastasis	O
via	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
RAS	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Raf	ARG2
gene1e	ARG2
.	O
Here	O
,	O
we	O
explored	O
their	O
mechanism	O
of	O
action	O
further	O
.	O
We	O
found	O
first	O
that	O
higher	O
levels	O
of	O
gene1s	ARG2
migration	ARG2
inducting	ARG2
gene-7	ARG2
gene1e	ARG2
protein	O
(	O
gene1s	ARG2
MIG-7	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
PHB	ARG2
gene1e	ARG2
phosphorylated	O
at	O
threonine	O
258	O
(	O
phospho	O
-	O
gene1s	ARG2
PHB	ARG2
gene1e	ARG2
T258	O
)	O
are	O
positively	O
correlated	O
with	O
advanced	O
stages	O
of	O
arg1s	O
human	O
arg1e	O
lung	O
cancer	O
in	O
tissue	O
microarray	O
.	O
PGE2	O
or	O
gene1s	ARG2
growth	ARG2
factors	ARG2
gene1e	ARG2
such	O
as	O
gene1s	ARG2
EGF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HGF	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IGF-1	ARG2
gene1e	ARG2
increased	O
complex	O
formation	O
of	O
phospho	O
-	O
gene1s	ARG2
PHB	ARG2
gene1e	ARG2
T258	O
with	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
,	O
phospho	O
-	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
S473	O
,	O
phospho	O
-	O
gene1s	ARG2
Raf-1	ARG2
gene1e	ARG2
S338	O
,	O
gene1s	ARG2
MEKK1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IKKalpha	ARG2
/	ARG2
beta	ARG2
gene1e	ARG2
S176/180	O
in	O
the	O
raft	O
domain	O
transiently	O
within	O
1	O
hour	O
and	O
gene1s	ARG2
MIG-7	ARG2
gene1e	ARG2
in	O
the	O
cytosol	O
12	O
-	O
24	O
hours	O
later	O
.	O
Association	O
of	O
phospho	O
-	O
gene1s	ARG2
PHB	ARG2
gene1e	ARG2
T258	O
with	O
gene1s	ARG2
MEKK1	ARG2
gene1e	ARG2
but	O
not	O
gene1s	ARG2
MEKK3	ARG2
gene1e	ARG2
activates	O
gene1s	ARG2
IKK	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
IkappaB	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MEK	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
to	O
increase	O
cellular	O
COX-2	O
/	O
PGE2	O
and	O
an	O
gene1s	ARG2
E	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
suppressor	O
gene1s	ARG2
Snail	ARG2
gene1e	ARG2
leading	O
to	O
enhancement	O
of	O
epithelial	O
-	O
mesenchymal	O
transition	O
(	O
EMT	O
)	O
and	O
lung	O
cancer	O
migration	O
/	O
invasion	O
.	O
gene1s	ARG2
MIG-7	ARG2
gene1e	ARG2
,	O
on	O
the	O
other	O
hand	O
,	O
was	O
induced	O
by	O
growth	O
factors	O
and	O
PGE2	O
via	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
GSK-3beta	ARG2
gene1e	ARG2
in	O
a	O
phospho	O
-	O
gene1s	ARG2
PHB	ARG2
gene1e	ARG2
T258	O
independent	O
manner	O
.	O
gene1s	ARG2
MIG-7	ARG2
gene1e	ARG2
increased	O
two	O
gene1s	ARG2
E	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
suppressors	O
gene1s	ARG2
ZEB-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Twist	ARG2
gene1e	ARG2
to	O
enhance	O
EMT	O
and	O
cancer	O
migration	O
/	O
invasion	O
.	O
Downregulating	O
phospho	O
-	O
gene1s	ARG2
PHB	ARG2
gene1e	ARG2
T258	O
and	O
gene1s	ARG2
MIG-7	ARG2
gene1e	ARG2
had	O
an	O
additive	O
effect	O
on	O
attenuating	O
lung	O
cancer	O
invasion	O
/	O
metastasis	O
and	O
prolonging	O
the	O
survival	O
of	O
xenograft	O
species1s	O
mice	O
species1e	O
.	O
Phospho	O
-	O
gene1s	ARG2
PHB	ARG2
gene1e	ARG2
T258	O
and	O
gene1s	ARG2
MIG-7	ARG2
gene1e	ARG2
may	O
thus	O
play	O
complementary	O
roles	O
in	O
the	O
initiation	O
and	O
sustainment	O
of	O
the	O
effects	O
of	O
growth	O
factors	O
and	O
COX-2	O
/	O
PGE2	O
on	O
cancer	O
invasion	O
/	O
metastasis	O
.	O

gene1s	O
MIG-7	O
gene1e	O
and	O
phosphorylated	O
gene1s	O
prohibitin	O
gene1e	O
coordinately	O
regulate	O
lung	O
cancer	O
invasion	O
/	O
metastasis	O
.	O
gene1s	O
Growth	O
factors	O
gene1e	O
and	O
gene1s	O
COX-2	O
gene1e	O
/	O
PGE2	O
enhance	O
lung	O
cancer	O
invasion	O
/	O
metastasis	O
via	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
and	O
gene1s	O
RAS	O
gene1e	O
/	O
gene1s	O
Raf	O
gene1e	O
.	O
Here	O
,	O
we	O
explored	O
their	O
mechanism	O
of	O
action	O
further	O
.	O
We	O
found	O
first	O
that	O
higher	O
levels	O
of	O
gene1s	O
migration	O
inducting	O
gene-7	O
gene1e	O
protein	O
(	O
gene1s	O
MIG-7	O
gene1e	O
)	O
and	O
gene1s	O
PHB	O
gene1e	O
phosphorylated	O
at	O
threonine	O
258	O
(	O
phospho	O
-	O
gene1s	O
PHB	O
gene1e	O
T258	O
)	O
are	O
positively	O
correlated	O
with	O
advanced	O
stages	O
of	O
species1s	O
human	O
species1e	O
lung	O
cancer	O
in	O
tissue	O
microarray	O
.	O
PGE2	O
or	O
gene1s	O
growth	O
factors	O
gene1e	O
such	O
as	O
gene1s	O
EGF	O
gene1e	O
,	O
gene1s	O
HGF	O
gene1e	O
and	O
gene1s	O
IGF-1	O
gene1e	O
increased	O
complex	O
formation	O
of	O
phospho	O
-	O
gene1s	O
PHB	O
gene1e	O
T258	O
with	O
gene1s	O
Ras	O
gene1e	O
,	O
phospho	O
-	O
gene1s	O
Akt	O
gene1e	O
S473	O
,	O
phospho	O
-	O
gene1s	O
Raf-1	O
gene1e	O
S338	O
,	O
gene1s	O
MEKK1	O
gene1e	O
and	O
gene1s	O
IKKalpha	O
/	O
beta	O
gene1e	O
S176/180	O
in	O
the	O
raft	O
domain	O
transiently	O
within	O
1	O
hour	O
and	O
gene1s	O
MIG-7	O
gene1e	O
in	O
the	O
cytosol	O
12	O
-	O
24	O
hours	O
later	O
.	O
Association	O
of	O
phospho	O
-	O
gene1s	O
PHB	O
gene1e	O
T258	O
with	O
gene1s	O
MEKK1	O
gene1e	O
but	O
not	O
gene1s	O
MEKK3	O
gene1e	O
activates	O
gene1s	O
IKK	O
gene1e	O
/	O
gene1s	O
IkappaB	O
gene1e	O
/	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
and	O
gene1s	O
MEK	O
gene1e	O
/	O
gene1s	O
ERK	O
gene1e	O
to	O
increase	O
cellular	O
COX-2	O
/	O
PGE2	O
and	O
an	O
gene1s	O
E	O
-	O
cadherin	O
gene1e	O
suppressor	O
gene1s	O
Snail	O
gene1e	O
leading	O
to	O
enhancement	O
of	O
epithelial	O
-	O
mesenchymal	O
transition	O
(	O
EMT	O
)	O
and	O
lung	O
cancer	O
migration	O
/	O
invasion	O
.	O
gene1s	O
MIG-7	O
gene1e	O
,	O
on	O
the	O
other	O
hand	O
,	O
was	O
induced	O
by	O
growth	O
factors	O
and	O
PGE2	O
via	O
gene1s	O
Akt	O
gene1e	O
/	O
gene1s	O
GSK-3beta	O
gene1e	O
in	O
a	O
phospho	O
-	O
gene1s	O
PHB	O
gene1e	O
T258	O
independent	O
manner	O
.	O
gene1s	O
MIG-7	O
gene1e	O
increased	O
two	O
gene1s	O
E	O
-	O
cadherin	O
gene1e	O
suppressors	O
gene1s	O
ZEB-1	O
gene1e	O
and	O
gene1s	O
Twist	O
gene1e	O
to	O
enhance	O
EMT	O
and	O
cancer	O
migration	O
/	O
invasion	O
.	O
Downregulating	O
phospho	O
-	O
gene1s	O
PHB	O
gene1e	O
T258	O
and	O
gene1s	O
MIG-7	O
gene1e	O
had	O
an	O
additive	O
effect	O
on	O
attenuating	O
lung	O
cancer	O
invasion	O
/	O
metastasis	O
and	O
prolonging	O
the	O
survival	O
of	O
xenograft	O
arg1s	O
mice	O
arg1e	O
.	O
Phospho	O
-	O
gene1s	O
PHB	O
gene1e	O
T258	O
and	O
gene1s	O
MIG-7	O
gene1e	O
may	O
thus	O
play	O
complementary	O
roles	O
in	O
the	O
initiation	O
and	O
sustainment	O
of	O
the	O
effects	O
of	O
growth	O
factors	O
and	O
COX-2	O
/	O
PGE2	O
on	O
cancer	O
invasion	O
/	O
metastasis	O
.	O

gene1s	ARG2
Melanocortin-4	ARG2
receptor	ARG2
gene1e	ARG2
activation	O
inhibits	O
gene1s	ARG2
c	ARG2
-	ARG2
Jun	ARG2
N	ARG2
-	ARG2
terminal	ARG2
kinase	ARG2
gene1e	ARG2
activity	O
and	O
promotes	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
signaling	O
.	O
The	O
gene1s	ARG2
melanocortin	ARG2
gene1e	ARG2
system	O
is	O
crucial	O
to	O
regulation	O
of	O
energy	O
homeostasis	O
.	O
The	O
gene1s	ARG2
melanocortin	ARG2
receptor	ARG2
type	ARG2
4	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MC4R	ARG2
gene1e	ARG2
)	O
modulates	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
signaling	O
via	O
effects	O
on	O
gene1s	ARG2
c	ARG2
-	ARG2
Jun	ARG2
N	ARG2
-	ARG2
terminal	ARG2
kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
)	O
.	O
The	O
gene1s	ARG2
melanocortin	ARG2
gene1e	ARG2
agonist	O
NDP	O
-	O
MSH	O
dose	O
-	O
dependently	O
inhibited	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
activity	O
in	O
arg1s	O
HEK293	O
arg1e	O
cells	O
stably	O
expressing	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
MC4R	ARG2
gene1e	ARG2
;	O
effects	O
were	O
reversed	O
by	O
gene1s	ARG2
melanocortin	ARG2
receptor	ARG2
gene1e	ARG2
antagonist	O
.	O
NDP	O
-	O
MSH	O
time-	O
and	O
dose	O
-	O
dependently	O
inhibited	O
gene1s	ARG2
IRS-1	ARG2
gene1e	ARG2
(ser307	O
)	O
phosphorylation	O
,	O
effects	O
also	O
reversed	O
by	O
a	O
specific	O
gene1s	ARG2
melanocortin	ARG2
receptor	ARG2
gene1e	ARG2
antagonist	O
.	O
NDP	O
-	O
MSH	O
augmented	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
-	O
stimulated	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
phosphorylation	O
in	O
vitro	O
.	O
The	O
gene1s	ARG2
melanocortin	ARG2
gene1e	ARG2
agonist	O
melanotan	O
II	O
increased	O
gene1s	O
insulin	O
gene1e	O
-	O
stimulated	O
gene1s	O
AKT	O
gene1e	O
phosphorylation	O
in	O
the	O
species1s	O
rat	O
species1e	O
hypothalamus	O
in	O
vivo	O
.	O
NDP	O
-	O
MSH	O
increased	O
gene1s	O
insulin	O
gene1e	O
-	O
stimulated	O
glucose	O
uptake	O
in	O
hypothalamic	O
species1s	O
GT1	O
-	O
1	O
species1e	O
cells	O
.	O
The	O
current	O
study	O
shows	O
that	O
the	O
melanocortinergic	O
system	O
interacts	O
with	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
signaling	O
via	O
novel	O
effects	O
on	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
activity	O
.	O

gene1s	ARG2
Melanocortin-4	ARG2
receptor	ARG2
gene1e	ARG2
activation	O
inhibits	O
gene1s	ARG2
c	ARG2
-	ARG2
Jun	ARG2
N	ARG2
-	ARG2
terminal	ARG2
kinase	ARG2
gene1e	ARG2
activity	O
and	O
promotes	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
signaling	O
.	O
The	O
gene1s	O
melanocortin	O
gene1e	O
system	O
is	O
crucial	O
to	O
regulation	O
of	O
energy	O
homeostasis	O
.	O
The	O
gene1s	O
melanocortin	O
receptor	O
type	O
4	O
gene1e	O
(	O
gene1s	O
MC4R	O
gene1e	O
)	O
modulates	O
gene1s	O
insulin	O
gene1e	O
signaling	O
via	O
effects	O
on	O
gene1s	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
gene1e	O
(	O
gene1s	O
JNK	O
gene1e	O
)	O
.	O
The	O
gene1s	O
melanocortin	O
gene1e	O
agonist	O
NDP	O
-	O
MSH	O
dose	O
-	O
dependently	O
inhibited	O
gene1s	O
JNK	O
gene1e	O
activity	O
in	O
species1s	O
HEK293	O
species1e	O
cells	O
stably	O
expressing	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
MC4R	O
gene1e	O
;	O
effects	O
were	O
reversed	O
by	O
gene1s	O
melanocortin	O
receptor	O
gene1e	O
antagonist	O
.	O
NDP	O
-	O
MSH	O
time-	O
and	O
dose	O
-	O
dependently	O
inhibited	O
gene1s	O
IRS-1	O
gene1e	O
(ser307	O
)	O
phosphorylation	O
,	O
effects	O
also	O
reversed	O
by	O
a	O
specific	O
gene1s	O
melanocortin	O
receptor	O
gene1e	O
antagonist	O
.	O
NDP	O
-	O
MSH	O
augmented	O
gene1s	O
insulin	O
gene1e	O
-	O
stimulated	O
gene1s	O
AKT	O
gene1e	O
phosphorylation	O
in	O
vitro	O
.	O
The	O
gene1s	O
melanocortin	O
gene1e	O
agonist	O
melanotan	O
II	O
increased	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
-	O
stimulated	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
phosphorylation	O
in	O
the	O
arg1s	O
rat	O
arg1e	O
hypothalamus	O
in	O
vivo	O
.	O
NDP	O
-	O
MSH	O
increased	O
gene1s	O
insulin	O
gene1e	O
-	O
stimulated	O
glucose	O
uptake	O
in	O
hypothalamic	O
species1s	O
GT1	O
-	O
1	O
species1e	O
cells	O
.	O
The	O
current	O
study	O
shows	O
that	O
the	O
melanocortinergic	O
system	O
interacts	O
with	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
signaling	O
via	O
novel	O
effects	O
on	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
activity	O
.	O

gene1s	ARG2
Melanocortin-4	ARG2
receptor	ARG2
gene1e	ARG2
activation	O
inhibits	O
gene1s	ARG2
c	ARG2
-	ARG2
Jun	ARG2
N	ARG2
-	ARG2
terminal	ARG2
kinase	ARG2
gene1e	ARG2
activity	O
and	O
promotes	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
signaling	O
.	O
The	O
gene1s	O
melanocortin	O
gene1e	O
system	O
is	O
crucial	O
to	O
regulation	O
of	O
energy	O
homeostasis	O
.	O
The	O
gene1s	O
melanocortin	O
receptor	O
type	O
4	O
gene1e	O
(	O
gene1s	O
MC4R	O
gene1e	O
)	O
modulates	O
gene1s	O
insulin	O
gene1e	O
signaling	O
via	O
effects	O
on	O
gene1s	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
gene1e	O
(	O
gene1s	O
JNK	O
gene1e	O
)	O
.	O
The	O
gene1s	O
melanocortin	O
gene1e	O
agonist	O
NDP	O
-	O
MSH	O
dose	O
-	O
dependently	O
inhibited	O
gene1s	O
JNK	O
gene1e	O
activity	O
in	O
species1s	O
HEK293	O
species1e	O
cells	O
stably	O
expressing	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
MC4R	O
gene1e	O
;	O
effects	O
were	O
reversed	O
by	O
gene1s	O
melanocortin	O
receptor	O
gene1e	O
antagonist	O
.	O
NDP	O
-	O
MSH	O
time-	O
and	O
dose	O
-	O
dependently	O
inhibited	O
gene1s	O
IRS-1	O
gene1e	O
(ser307	O
)	O
phosphorylation	O
,	O
effects	O
also	O
reversed	O
by	O
a	O
specific	O
gene1s	O
melanocortin	O
receptor	O
gene1e	O
antagonist	O
.	O
NDP	O
-	O
MSH	O
augmented	O
gene1s	O
insulin	O
gene1e	O
-	O
stimulated	O
gene1s	O
AKT	O
gene1e	O
phosphorylation	O
in	O
vitro	O
.	O
The	O
gene1s	O
melanocortin	O
gene1e	O
agonist	O
melanotan	O
II	O
increased	O
gene1s	O
insulin	O
gene1e	O
-	O
stimulated	O
gene1s	O
AKT	O
gene1e	O
phosphorylation	O
in	O
the	O
species1s	O
rat	O
species1e	O
hypothalamus	O
in	O
vivo	O
.	O
NDP	O
-	O
MSH	O
increased	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
-	O
stimulated	O
glucose	O
uptake	O
in	O
hypothalamic	O
arg1s	O
GT1	O
-	O
1	O
arg1e	O
cells	O
.	O
The	O
current	O
study	O
shows	O
that	O
the	O
melanocortinergic	O
system	O
interacts	O
with	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
signaling	O
via	O
novel	O
effects	O
on	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
activity	O
.	O

gene1s	O
Tryptophan	O
hydroxylase	O
1	O
gene1e	O
and	O
gene1s	O
5-HT7	O
receptor	O
gene1e	O
preferentially	O
expressed	O
in	O
triple	O
-	O
negative	O
breast	O
cancer	O
promote	O
cancer	O
progression	O
through	O
autocrine	O
serotonin	O
signaling	O
.	O
BACKGROUND	O
:	O
Triple	O
-	O
negative	O
breast	O
cancer	O
(	O
TNBC	O
)	O
has	O
a	O
high	O
risk	O
of	O
relapse	O
and	O
there	O
are	O
few	O
chemotherapy	O
options	O
.	O
Although	O
5-hydroxytryptamine	O
(	O
5-HT	O
,	O
serotonin	O
)	O
signaling	O
pathways	O
have	O
been	O
suggested	O
as	O
potential	O
targets	O
for	O
anti	O
-	O
cancer	O
drug	O
development	O
,	O
the	O
mechanism	O
responsible	O
for	O
the	O
action	O
of	O
5-HT	O
in	O
TNBC	O
remains	O
unknown	O
.	O
METHODS	O
:	O
Quantitative	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
(	O
qRT	O
-	O
PCR	O
)	O
and	O
Western	O
blotting	O
were	O
used	O
to	O
measure	O
mRNA	O
and	O
protein	O
levels	O
,	O
respectively	O
.	O
Cell	O
proliferation	O
was	O
measured	O
using	O
CellTiter	O
96	O
Aqueous	O
One	O
Solution	O
.	O
siRNA	O
transfection	O
was	O
used	O
to	O
assess	O
involvement	O
of	O
genes	O
in	O
cancer	O
invasion	O
,	O
which	O
were	O
identified	O
by	O
Matrigel	O
transwell	O
invasion	O
assay	O
.	O
Levels	O
of	O
5-HT	O
and	O
gene1s	O
vascular	O
endothelial	O
growth	O
factor	O
gene1e	O
(	O
gene1s	O
VEGF	O
gene1e	O
)	O
were	O
measured	O
using	O
ELISA	O
kits	O
.	O
arg1s	O
Chick	O
arg1e	O
chorioallantoic	O
membrane	O
(	O
CAM	O
)	O
assay	O
and	O
species1s	O
mouse	O
species1e	O
tumor	O
model	O
were	O
used	O
to	O
investigate	O
the	O
in	O
vivo	O
effects	O
of	O
SB269970	O
,	O
a	O
gene1s	O
5-HT7	O
receptor	O
gene1e	O
antagonist	O
,	O
and	O
BJ-1113	O
,	O
a	O
novel	O
synthetic	O
compound	O
.	O
RESULTS	O
:	O
TNBC	O
cell	O
lines	O
(	O
MDA	O
-	O
MB-231	O
,	O
HCC-1395	O
,	O
and	O
Hs578	O
T	O
)	O
expressed	O
higher	O
levels	O
of	O
gene1s	O
tryptophan	O
hydroxylase	O
1	O
gene1e	O
(	O
gene1s	O
TPH1	O
gene1e	O
)	O
than	O
hormone	O
-	O
responsive	O
breast	O
cancer	O
cell	O
lines	O
(	O
species1s	O
MCF-7	O
species1e	O
and	O
species1s	O
T47D	O
species1e	O
)	O
.	O
In	O
species1s	O
MDA	O
-	O
MB-231	O
species1e	O
cells	O
,	O
5-HT	O
promoted	O
invasion	O
and	O
proliferation	O
via	O
gene1s	O
5-HT7	O
receptor	O
gene1e	O
,	O
and	O
interestingly	O
,	O
the	O
stimulatory	O
effect	O
of	O
5-HT	O
on	O
species1s	O
MDA	O
-	O
MB-231	O
species1e	O
cell	O
invasion	O
was	O
stronger	O
than	O
its	O
effect	O
on	O
proliferation	O
.	O
Likewise	O
,	O
downstream	O
signaling	O
pathways	O
of	O
5-HT7	O
differed	O
during	O
invasion	O
and	O
proliferation	O
,	O
that	O
is	O
,	O
Ga	O
-	O
activated	O
cAMP	O
and	O
gene1s	O
Gbg	O
-	O
activated	O
kinase	O
gene1e	O
signaling	O
during	O
invasion	O
,	O
and	O
gene1s	O
Gbg	O
gene1e	O
-	O
activated	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
signaling	O
during	O
proliferation	O
.	O
Also	O
,	O
5-HT	O
increased	O
the	O
protein	O
expressions	O
of	O
gene1s	O
TPH1	O
gene1e	O
and	O
gene1s	O
VEGF	O
gene1e	O
in	O
species1s	O
MDA	O
-	O
MB-231	O
species1e	O
cells	O
.	O
These	O
results	O
provide	O
insight	O
of	O
the	O
stimulatory	O
effect	O
of	O
5-HT	O
on	O
breast	O
cancer	O
progression	O
;	O
5-HT	O
was	O
found	O
to	O
act	O
more	O
strongly	O
during	O
the	O
first	O
stage	O
of	O
metastasis	O
(	O
during	O
invasion	O
and	O
migration	O
)	O
than	O
during	O
the	O
later	O
proliferative	O
phase	O
after	O
local	O
invasion	O
.	O
Interestingly	O
,	O
these	O
actions	O
of	O
5-HT	O
were	O
inhibited	O
by	O
BJ-1113	O
,	O
a	O
6-amino-2,4,5-trimethylpyridin-3-ol	O
analog	O
.	O
BJ-1113	O
blocked	O
intracellular	O
signaling	O
pathways	O
initiated	O
by	O
gene1s	O
5-HT7	O
receptor	O
gene1e	O
activation	O
,	O
and	O
exhibited	O
anti	O
-	O
proliferative	O
and	O
anti	O
-	O
invasive	O
activities	O
against	O
species1s	O
MDA	O
-	O
MB-231	O
species1e	O
cells	O
.	O
Furthermore	O
,	O
the	O
inhibitory	O
effect	O
of	O
BJ-1113	O
against	O
MDA	O
-	O
MB-231	O
tumor	O
growth	O
was	O
greater	O
than	O
that	O
of	O
SB269970	O
,	O
a	O
gene1s	O
5-HT7	O
receptor	O
gene1e	O
antagonist	O
.	O
CONCLUSIONS	O
:	O
gene1s	O
5-HT7	O
receptor	O
gene1e	O
which	O
mediates	O
5-HT	O
-	O
induced	O
cancer	O
progression	O
is	O
a	O
potential	O
therapeutic	O
target	O
in	O
TNBC	O
,	O
and	O
BJ-1113	O
offers	O
a	O
novel	O
scaffold	O
for	O
the	O
development	O
of	O
anti	O
-	O
cancer	O
agents	O
against	O
TNBC	O
.	O

gene1s	O
Tryptophan	O
hydroxylase	O
1	O
gene1e	O
and	O
gene1s	O
5-HT7	O
receptor	O
gene1e	O
preferentially	O
expressed	O
in	O
triple	O
-	O
negative	O
breast	O
cancer	O
promote	O
cancer	O
progression	O
through	O
autocrine	O
serotonin	O
signaling	O
.	O
BACKGROUND	O
:	O
Triple	O
-	O
negative	O
breast	O
cancer	O
(	O
TNBC	O
)	O
has	O
a	O
high	O
risk	O
of	O
relapse	O
and	O
there	O
are	O
few	O
chemotherapy	O
options	O
.	O
Although	O
5-hydroxytryptamine	O
(	O
5-HT	O
,	O
serotonin	O
)	O
signaling	O
pathways	O
have	O
been	O
suggested	O
as	O
potential	O
targets	O
for	O
anti	O
-	O
cancer	O
drug	O
development	O
,	O
the	O
mechanism	O
responsible	O
for	O
the	O
action	O
of	O
5-HT	O
in	O
TNBC	O
remains	O
unknown	O
.	O
METHODS	O
:	O
Quantitative	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
(	O
qRT	O
-	O
PCR	O
)	O
and	O
Western	O
blotting	O
were	O
used	O
to	O
measure	O
mRNA	O
and	O
protein	O
levels	O
,	O
respectively	O
.	O
Cell	O
proliferation	O
was	O
measured	O
using	O
CellTiter	O
96	O
Aqueous	O
One	O
Solution	O
.	O
siRNA	O
transfection	O
was	O
used	O
to	O
assess	O
involvement	O
of	O
genes	O
in	O
cancer	O
invasion	O
,	O
which	O
were	O
identified	O
by	O
Matrigel	O
transwell	O
invasion	O
assay	O
.	O
Levels	O
of	O
5-HT	O
and	O
gene1s	O
vascular	O
endothelial	O
growth	O
factor	O
gene1e	O
(	O
gene1s	O
VEGF	O
gene1e	O
)	O
were	O
measured	O
using	O
ELISA	O
kits	O
.	O
species1s	O
Chick	O
species1e	O
chorioallantoic	O
membrane	O
(	O
CAM	O
)	O
assay	O
and	O
arg1s	O
mouse	O
arg1e	O
tumor	O
model	O
were	O
used	O
to	O
investigate	O
the	O
in	O
vivo	O
effects	O
of	O
SB269970	O
,	O
a	O
gene1s	O
5-HT7	O
receptor	O
gene1e	O
antagonist	O
,	O
and	O
BJ-1113	O
,	O
a	O
novel	O
synthetic	O
compound	O
.	O
RESULTS	O
:	O
TNBC	O
cell	O
lines	O
(	O
MDA	O
-	O
MB-231	O
,	O
HCC-1395	O
,	O
and	O
Hs578	O
T	O
)	O
expressed	O
higher	O
levels	O
of	O
gene1s	O
tryptophan	O
hydroxylase	O
1	O
gene1e	O
(	O
gene1s	O
TPH1	O
gene1e	O
)	O
than	O
hormone	O
-	O
responsive	O
breast	O
cancer	O
cell	O
lines	O
(	O
species1s	O
MCF-7	O
species1e	O
and	O
species1s	O
T47D	O
species1e	O
)	O
.	O
In	O
species1s	O
MDA	O
-	O
MB-231	O
species1e	O
cells	O
,	O
5-HT	O
promoted	O
invasion	O
and	O
proliferation	O
via	O
gene1s	O
5-HT7	O
receptor	O
gene1e	O
,	O
and	O
interestingly	O
,	O
the	O
stimulatory	O
effect	O
of	O
5-HT	O
on	O
species1s	O
MDA	O
-	O
MB-231	O
species1e	O
cell	O
invasion	O
was	O
stronger	O
than	O
its	O
effect	O
on	O
proliferation	O
.	O
Likewise	O
,	O
downstream	O
signaling	O
pathways	O
of	O
5-HT7	O
differed	O
during	O
invasion	O
and	O
proliferation	O
,	O
that	O
is	O
,	O
Ga	O
-	O
activated	O
cAMP	O
and	O
gene1s	O
Gbg	O
-	O
activated	O
kinase	O
gene1e	O
signaling	O
during	O
invasion	O
,	O
and	O
gene1s	O
Gbg	O
gene1e	O
-	O
activated	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
signaling	O
during	O
proliferation	O
.	O
Also	O
,	O
5-HT	O
increased	O
the	O
protein	O
expressions	O
of	O
gene1s	O
TPH1	O
gene1e	O
and	O
gene1s	O
VEGF	O
gene1e	O
in	O
species1s	O
MDA	O
-	O
MB-231	O
species1e	O
cells	O
.	O
These	O
results	O
provide	O
insight	O
of	O
the	O
stimulatory	O
effect	O
of	O
5-HT	O
on	O
breast	O
cancer	O
progression	O
;	O
5-HT	O
was	O
found	O
to	O
act	O
more	O
strongly	O
during	O
the	O
first	O
stage	O
of	O
metastasis	O
(	O
during	O
invasion	O
and	O
migration	O
)	O
than	O
during	O
the	O
later	O
proliferative	O
phase	O
after	O
local	O
invasion	O
.	O
Interestingly	O
,	O
these	O
actions	O
of	O
5-HT	O
were	O
inhibited	O
by	O
BJ-1113	O
,	O
a	O
6-amino-2,4,5-trimethylpyridin-3-ol	O
analog	O
.	O
BJ-1113	O
blocked	O
intracellular	O
signaling	O
pathways	O
initiated	O
by	O
gene1s	O
5-HT7	O
receptor	O
gene1e	O
activation	O
,	O
and	O
exhibited	O
anti	O
-	O
proliferative	O
and	O
anti	O
-	O
invasive	O
activities	O
against	O
species1s	O
MDA	O
-	O
MB-231	O
species1e	O
cells	O
.	O
Furthermore	O
,	O
the	O
inhibitory	O
effect	O
of	O
BJ-1113	O
against	O
MDA	O
-	O
MB-231	O
tumor	O
growth	O
was	O
greater	O
than	O
that	O
of	O
SB269970	O
,	O
a	O
gene1s	O
5-HT7	O
receptor	O
gene1e	O
antagonist	O
.	O
CONCLUSIONS	O
:	O
gene1s	O
5-HT7	O
receptor	O
gene1e	O
which	O
mediates	O
5-HT	O
-	O
induced	O
cancer	O
progression	O
is	O
a	O
potential	O
therapeutic	O
target	O
in	O
TNBC	O
,	O
and	O
BJ-1113	O
offers	O
a	O
novel	O
scaffold	O
for	O
the	O
development	O
of	O
anti	O
-	O
cancer	O
agents	O
against	O
TNBC	O
.	O

gene1s	ARG2
Tryptophan	ARG2
hydroxylase	ARG2
1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
5-HT7	ARG2
receptor	ARG2
gene1e	ARG2
preferentially	O
expressed	O
in	O
triple	O
-	O
negative	O
breast	O
cancer	O
promote	O
cancer	O
progression	O
through	O
autocrine	O
serotonin	O
signaling	O
.	O
BACKGROUND	O
:	O
Triple	O
-	O
negative	O
breast	O
cancer	O
(	O
TNBC	O
)	O
has	O
a	O
high	O
risk	O
of	O
relapse	O
and	O
there	O
are	O
few	O
chemotherapy	O
options	O
.	O
Although	O
5-hydroxytryptamine	O
(	O
5-HT	O
,	O
serotonin	O
)	O
signaling	O
pathways	O
have	O
been	O
suggested	O
as	O
potential	O
targets	O
for	O
anti	O
-	O
cancer	O
drug	O
development	O
,	O
the	O
mechanism	O
responsible	O
for	O
the	O
action	O
of	O
5-HT	O
in	O
TNBC	O
remains	O
unknown	O
.	O
METHODS	O
:	O
Quantitative	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
(	O
qRT	O
-	O
PCR	O
)	O
and	O
Western	O
blotting	O
were	O
used	O
to	O
measure	O
mRNA	O
and	O
protein	O
levels	O
,	O
respectively	O
.	O
Cell	O
proliferation	O
was	O
measured	O
using	O
CellTiter	O
96	O
Aqueous	O
One	O
Solution	O
.	O
siRNA	O
transfection	O
was	O
used	O
to	O
assess	O
involvement	O
of	O
genes	O
in	O
cancer	O
invasion	O
,	O
which	O
were	O
identified	O
by	O
Matrigel	O
transwell	O
invasion	O
assay	O
.	O
Levels	O
of	O
5-HT	O
and	O
gene1s	ARG2
vascular	ARG2
endothelial	ARG2
growth	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
)	O
were	O
measured	O
using	O
ELISA	O
kits	O
.	O
species1s	O
Chick	O
species1e	O
chorioallantoic	O
membrane	O
(	O
CAM	O
)	O
assay	O
and	O
species1s	O
mouse	O
species1e	O
tumor	O
model	O
were	O
used	O
to	O
investigate	O
the	O
in	O
vivo	O
effects	O
of	O
SB269970	O
,	O
a	O
gene1s	ARG2
5-HT7	ARG2
receptor	ARG2
gene1e	ARG2
antagonist	O
,	O
and	O
BJ-1113	O
,	O
a	O
novel	O
synthetic	O
compound	O
.	O
RESULTS	O
:	O
TNBC	O
cell	O
lines	O
(	O
MDA	O
-	O
MB-231	O
,	O
HCC-1395	O
,	O
and	O
Hs578	O
T	O
)	O
expressed	O
higher	O
levels	O
of	O
gene1s	ARG2
tryptophan	ARG2
hydroxylase	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TPH1	ARG2
gene1e	ARG2
)	O
than	O
hormone	O
-	O
responsive	O
breast	O
cancer	O
cell	O
lines	O
(	O
arg1s	O
MCF-7	O
arg1e	O
and	O
arg1s	O
T47D	O
arg1e	O
)	O
.	O
In	O
arg1s	O
MDA	O
-	O
MB-231	O
arg1e	O
cells	O
,	O
5-HT	O
promoted	O
invasion	O
and	O
proliferation	O
via	O
gene1s	ARG2
5-HT7	ARG2
receptor	ARG2
gene1e	ARG2
,	O
and	O
interestingly	O
,	O
the	O
stimulatory	O
effect	O
of	O
5-HT	O
on	O
arg1s	O
MDA	O
-	O
MB-231	O
arg1e	O
cell	O
invasion	O
was	O
stronger	O
than	O
its	O
effect	O
on	O
proliferation	O
.	O
Likewise	O
,	O
downstream	O
signaling	O
pathways	O
of	O
5-HT7	O
differed	O
during	O
invasion	O
and	O
proliferation	O
,	O
that	O
is	O
,	O
Ga	O
-	O
activated	O
cAMP	O
and	O
gene1s	ARG2
Gbg	ARG2
-	ARG2
activated	ARG2
kinase	ARG2
gene1e	ARG2
signaling	O
during	O
invasion	O
,	O
and	O
gene1s	ARG2
Gbg	ARG2
gene1e	ARG2
-	O
activated	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
signaling	O
during	O
proliferation	O
.	O
Also	O
,	O
5-HT	O
increased	O
the	O
protein	O
expressions	O
of	O
gene1s	ARG2
TPH1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
in	O
arg1s	O
MDA	O
-	O
MB-231	O
arg1e	O
cells	O
.	O
These	O
results	O
provide	O
insight	O
of	O
the	O
stimulatory	O
effect	O
of	O
5-HT	O
on	O
breast	O
cancer	O
progression	O
;	O
5-HT	O
was	O
found	O
to	O
act	O
more	O
strongly	O
during	O
the	O
first	O
stage	O
of	O
metastasis	O
(	O
during	O
invasion	O
and	O
migration	O
)	O
than	O
during	O
the	O
later	O
proliferative	O
phase	O
after	O
local	O
invasion	O
.	O
Interestingly	O
,	O
these	O
actions	O
of	O
5-HT	O
were	O
inhibited	O
by	O
BJ-1113	O
,	O
a	O
6-amino-2,4,5-trimethylpyridin-3-ol	O
analog	O
.	O
BJ-1113	O
blocked	O
intracellular	O
signaling	O
pathways	O
initiated	O
by	O
gene1s	ARG2
5-HT7	ARG2
receptor	ARG2
gene1e	ARG2
activation	O
,	O
and	O
exhibited	O
anti	O
-	O
proliferative	O
and	O
anti	O
-	O
invasive	O
activities	O
against	O
arg1s	O
MDA	O
-	O
MB-231	O
arg1e	O
cells	O
.	O
Furthermore	O
,	O
the	O
inhibitory	O
effect	O
of	O
BJ-1113	O
against	O
MDA	O
-	O
MB-231	O
tumor	O
growth	O
was	O
greater	O
than	O
that	O
of	O
SB269970	O
,	O
a	O
gene1s	ARG2
5-HT7	ARG2
receptor	ARG2
gene1e	ARG2
antagonist	O
.	O
CONCLUSIONS	O
:	O
gene1s	ARG2
5-HT7	ARG2
receptor	ARG2
gene1e	ARG2
which	O
mediates	O
5-HT	O
-	O
induced	O
cancer	O
progression	O
is	O
a	O
potential	O
therapeutic	O
target	O
in	O
TNBC	O
,	O
and	O
BJ-1113	O
offers	O
a	O
novel	O
scaffold	O
for	O
the	O
development	O
of	O
anti	O
-	O
cancer	O
agents	O
against	O
TNBC	O
.	O

gene1s	ARG2
TLR1/2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TLR7	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
TLR9	ARG2
gene1e	ARG2
signals	O
directly	O
activate	O
arg1s	O
human	O
arg1e	O
peripheral	O
blood	O
naive	O
and	O
memory	O
B	O
cell	O
subsets	O
to	O
produce	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
chemokines	ARG2
gene1e	ARG2
,	O
and	O
hematopoietic	O
growth	O
factors	O
.	O
Recently	O
,	O
it	O
has	O
been	O
reported	O
that	O
using	O
multiple	O
signals	O
,	O
species1s	O
murine	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
B	O
cells	O
secrete	O
several	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
with	O
pro	O
-	O
inflammatory	O
and	O
immunoregulatory	O
properties	O
.	O
We	O
present	O
the	O
first	O
comprehensive	O
analysis	O
of	O
24	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
chemokines	ARG2
gene1e	ARG2
,	O
and	O
hematopoietic	O
growth	O
factors	O
production	O
by	O
purified	O
arg1s	O
human	O
arg1e	O
peripheral	O
blood	O
B	O
cells	O
(	O
gene1s	ARG2
CD19	ARG2
gene1e	ARG2
+	O
)	O
,	O
and	O
naive	O
(	O
gene1s	ARG2
CD19	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
CD27	ARG2
gene1e	ARG2
-	O
)	O
and	O
memory	O
(	O
gene1s	ARG2
CD19	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
CD27	ARG2
gene1e	ARG2
+	O
)	O
B	O
cells	O
in	O
response	O
to	O
direct	O
and	O
exclusive	O
signaling	O
provided	O
by	O
gene1s	ARG2
toll	ARG2
-	ARG2
like	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TLR	ARG2
gene1e	ARG2
)	O
ligands	O
Pam3CSK	O
(	O
gene1s	ARG2
TLR1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
TLR2	ARG2
gene1e	ARG2
)	O
,	O
Imiquimod	O
(	O
gene1s	ARG2
TLR7	ARG2
gene1e	ARG2
)	O
,	O
and	O
GpG	O
-	O
ODN2006	O
(	O
gene1s	ARG2
TLR9	ARG2
gene1e	ARG2
)	O
.	O
All	O
three	O
TLR	O
ligands	O
stimulated	O
B	O
cells	O
(	O
gene1s	ARG2
CD19	ARG2
gene1e	ARG2
+	O
)	O
to	O
produce	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
gene1s	ARG2
IL-1a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-1b	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-13	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
IL-10	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
chemokines	ARG2
gene1e	ARG2
gene1s	ARG2
MIP-1a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MIP-1b	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MCP-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IP-10	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
IL-8	ARG2
gene1e	ARG2
.	O
However	O
,	O
gene1s	ARG2
GM	ARG2
-	ARG2
CSF	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
G	ARG2
-	ARG2
CSF	ARG2
gene1e	ARG2
production	O
was	O
predominantly	O
induced	O
by	O
gene1s	ARG2
TLR2	ARG2
gene1e	ARG2
agonist	O
.	O
Most	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
chemokines	ARG2
gene1e	ARG2
/	O
hematopoietic	O
growth	O
factors	O
were	O
predominantly	O
or	O
exclusively	O
produced	O
by	O
memory	O
B	O
cells	O
,	O
and	O
in	O
general	O
,	O
gene1s	ARG2
TLR2	ARG2
gene1e	ARG2
signal	O
was	O
more	O
powerful	O
than	O
signal	O
provided	O
via	O
gene1s	ARG2
TLR7	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
TLR9	ARG2
gene1e	ARG2
.	O
No	O
significant	O
secretion	O
of	O
gene1s	ARG2
eotaxin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IFN	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IFN	ARG2
-	ARG2
g	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-7	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-15	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-17	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-12p40	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-12p70	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
TNF	ARG2
-	ARG2
b	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
lymphotoxin	ARG2
gene1e	ARG2
)	O
was	O
observed	O
.	O
These	O
data	O
demonstrate	O
that	O
arg1s	O
human	O
arg1e	O
B	O
cells	O
can	O
be	O
directly	O
activated	O
via	O
gene1s	ARG2
TLR1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
TLR2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TLR7	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
TLR9	ARG2
gene1e	ARG2
to	O
induce	O
secretion	O
of	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
chemokines	ARG2
gene1e	ARG2
,	O
and	O
hematopoietic	O
growth	O
factors	O
and	O
suggest	O
a	O
role	O
of	O
B	O
cells	O
in	O
immune	O
response	O
against	O
microbial	O
pathogenesis	O
and	O
immune	O
homeostasis	O
.	O

gene1s	O
TLR1/2	O
gene1e	O
,	O
gene1s	O
TLR7	O
gene1e	O
,	O
and	O
gene1s	O
TLR9	O
gene1e	O
signals	O
directly	O
activate	O
species1s	O
human	O
species1e	O
peripheral	O
blood	O
naive	O
and	O
memory	O
B	O
cell	O
subsets	O
to	O
produce	O
gene1s	O
cytokines	O
gene1e	O
,	O
gene1s	O
chemokines	O
gene1e	O
,	O
and	O
hematopoietic	O
growth	O
factors	O
.	O
Recently	O
,	O
it	O
has	O
been	O
reported	O
that	O
using	O
multiple	O
signals	O
,	O
arg1s	O
murine	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
B	O
cells	O
secrete	O
several	O
gene1s	O
cytokines	O
gene1e	O
with	O
pro	O
-	O
inflammatory	O
and	O
immunoregulatory	O
properties	O
.	O
We	O
present	O
the	O
first	O
comprehensive	O
analysis	O
of	O
24	O
gene1s	O
cytokines	O
gene1e	O
,	O
gene1s	O
chemokines	O
gene1e	O
,	O
and	O
hematopoietic	O
growth	O
factors	O
production	O
by	O
purified	O
species1s	O
human	O
species1e	O
peripheral	O
blood	O
B	O
cells	O
(	O
gene1s	O
CD19	O
gene1e	O
+	O
)	O
,	O
and	O
naive	O
(	O
gene1s	O
CD19	O
gene1e	O
+	O
gene1s	O
CD27	O
gene1e	O
-	O
)	O
and	O
memory	O
(	O
gene1s	O
CD19	O
gene1e	O
+	O
gene1s	O
CD27	O
gene1e	O
+	O
)	O
B	O
cells	O
in	O
response	O
to	O
direct	O
and	O
exclusive	O
signaling	O
provided	O
by	O
gene1s	O
toll	O
-	O
like	O
receptor	O
gene1e	O
(	O
gene1s	O
TLR	O
gene1e	O
)	O
ligands	O
Pam3CSK	O
(	O
gene1s	O
TLR1	O
gene1e	O
/	O
gene1s	O
TLR2	O
gene1e	O
)	O
,	O
Imiquimod	O
(	O
gene1s	O
TLR7	O
gene1e	O
)	O
,	O
and	O
GpG	O
-	O
ODN2006	O
(	O
gene1s	O
TLR9	O
gene1e	O
)	O
.	O
All	O
three	O
TLR	O
ligands	O
stimulated	O
B	O
cells	O
(	O
gene1s	O
CD19	O
gene1e	O
+	O
)	O
to	O
produce	O
gene1s	O
cytokines	O
gene1e	O
gene1s	O
IL-1a	O
gene1e	O
,	O
gene1s	O
IL-1b	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
,	O
gene1s	O
IL-13	O
gene1e	O
,	O
and	O
gene1s	O
IL-10	O
gene1e	O
,	O
and	O
gene1s	O
chemokines	O
gene1e	O
gene1s	O
MIP-1a	O
gene1e	O
,	O
gene1s	O
MIP-1b	O
gene1e	O
,	O
gene1s	O
MCP-1	O
gene1e	O
,	O
gene1s	O
IP-10	O
gene1e	O
,	O
and	O
gene1s	O
IL-8	O
gene1e	O
.	O
However	O
,	O
gene1s	O
GM	O
-	O
CSF	O
gene1e	O
and	O
gene1s	O
G	O
-	O
CSF	O
gene1e	O
production	O
was	O
predominantly	O
induced	O
by	O
gene1s	O
TLR2	O
gene1e	O
agonist	O
.	O
Most	O
gene1s	O
cytokines	O
gene1e	O
/	O
gene1s	O
chemokines	O
gene1e	O
/	O
hematopoietic	O
growth	O
factors	O
were	O
predominantly	O
or	O
exclusively	O
produced	O
by	O
memory	O
B	O
cells	O
,	O
and	O
in	O
general	O
,	O
gene1s	O
TLR2	O
gene1e	O
signal	O
was	O
more	O
powerful	O
than	O
signal	O
provided	O
via	O
gene1s	O
TLR7	O
gene1e	O
and	O
gene1s	O
TLR9	O
gene1e	O
.	O
No	O
significant	O
secretion	O
of	O
gene1s	O
eotaxin	O
gene1e	O
,	O
gene1s	O
IFN	O
-	O
a	O
gene1e	O
,	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
,	O
gene1s	O
IL-2	O
gene1e	O
,	O
gene1s	O
IL-3	O
gene1e	O
,	O
gene1s	O
IL-4	O
gene1e	O
,	O
gene1s	O
IL-5	O
gene1e	O
,	O
gene1s	O
IL-7	O
gene1e	O
,	O
gene1s	O
IL-15	O
gene1e	O
,	O
gene1s	O
IL-17	O
gene1e	O
,	O
gene1s	O
IL-12p40	O
gene1e	O
,	O
gene1s	O
IL-12p70	O
gene1e	O
,	O
and	O
gene1s	O
TNF	O
-	O
b	O
gene1e	O
(	O
gene1s	O
lymphotoxin	O
gene1e	O
)	O
was	O
observed	O
.	O
These	O
data	O
demonstrate	O
that	O
species1s	O
human	O
species1e	O
B	O
cells	O
can	O
be	O
directly	O
activated	O
via	O
gene1s	O
TLR1	O
gene1e	O
/	O
gene1s	O
TLR2	O
gene1e	O
,	O
gene1s	O
TLR7	O
gene1e	O
,	O
and	O
gene1s	O
TLR9	O
gene1e	O
to	O
induce	O
secretion	O
of	O
gene1s	O
cytokines	O
gene1e	O
,	O
gene1s	O
chemokines	O
gene1e	O
,	O
and	O
hematopoietic	O
growth	O
factors	O
and	O
suggest	O
a	O
role	O
of	O
B	O
cells	O
in	O
immune	O
response	O
against	O
microbial	O
pathogenesis	O
and	O
immune	O
homeostasis	O
.	O

The	O
arg1s	O
Yeast	O
arg1e	O
DNA	O
Damage	O
Checkpoint	O
Kinase	O
gene1s	ARG2
Rad53	ARG2
gene1e	ARG2
Targets	O
the	O
Exoribonuclease	O
,	O
gene1s	ARG2
Xrn1	ARG2
gene1e	ARG2
.	O
The	O
highly	O
conserved	O
DNA	O
damage	O
response	O
(	O
DDR	O
)	O
pathway	O
monitors	O
the	O
genomic	O
integrity	O
of	O
the	O
cell	O
and	O
protects	O
against	O
genotoxic	O
stresses	O
.	O
The	O
gene1s	ARG2
apical	ARG2
kinases	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Mec1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Tel1	ARG2
gene1e	ARG2
(	O
gene1s	O
ATR	O
gene1e	O
and	O
gene1s	O
ATM	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
,	O
respectively	O
)	O
,	O
initiate	O
the	O
DNA	O
damage	O
signaling	O
cascade	O
through	O
the	O
gene1s	ARG2
effector	ARG2
kinases	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Rad53	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Chk1	ARG2
gene1e	ARG2
,	O
to	O
regulate	O
a	O
variety	O
of	O
cellular	O
processes	O
including	O
cell	O
cycle	O
progression	O
,	O
DNA	O
damage	O
repair	O
,	O
chromatin	O
remodeling	O
,	O
and	O
transcription	O
.	O
The	O
DDR	O
also	O
regulates	O
other	O
cellular	O
pathways	O
,	O
but	O
direct	O
substrates	O
and	O
mechanisms	O
are	O
still	O
lacking	O
.	O
Using	O
a	O
mass	O
spectrometry	O
-	O
based	O
phosphoproteomic	O
screen	O
in	O
arg1s	O
Saccharomyces	O
cerevisiae	O
arg1e	O
,	O
we	O
identified	O
novel	O
targets	O
of	O
gene1s	ARG2
Rad53	ARG2
gene1e	ARG2
,	O
many	O
of	O
which	O
are	O
proteins	O
that	O
are	O
involved	O
in	O
RNA	O
metabolism	O
.	O
Of	O
the	O
33	O
novel	O
substrates	O
identified	O
,	O
we	O
verified	O
that	O
12	O
are	O
directly	O
phosphorylated	O
by	O
gene1s	ARG2
Rad53	ARG2
gene1e	ARG2
in	O
vitro	O
:	O
gene1s	ARG2
Xrn1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Gcd11	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Rps7b	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Ded1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Cho2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Pus1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Hst1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Srv2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Set3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Snu23	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Alb1	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Scp160	ARG2
gene1e	ARG2
.	O
We	O
further	O
characterized	O
gene1s	ARG2
Xrn1	ARG2
gene1e	ARG2
,	O
a	O
highly	O
conserved	O
gene1s	ARG2
5	ARG2
'	ARG2
exoribonuclease	ARG2
gene1e	ARG2
that	O
functions	O
in	O
RNA	O
degradation	O
and	O
the	O
most	O
enriched	O
in	O
our	O
phosphoproteomics	O
screen	O
.	O
Phosphorylation	O
of	O
gene1s	ARG2
Xrn1	ARG2
gene1e	ARG2
by	O
gene1s	ARG2
Rad53	ARG2
gene1e	ARG2
does	O
not	O
appear	O
to	O
affect	O
gene1s	ARG2
Xrn1	ARG2
gene1e	ARG2
's	O
intrinsic	O
nuclease	O
activity	O
in	O
vitro	O
,	O
but	O
may	O
affect	O
its	O
activity	O
or	O
specificity	O
in	O
vivo	O
.	O

The	O
species1s	O
Yeast	O
species1e	O
DNA	O
Damage	O
Checkpoint	O
Kinase	O
gene1s	O
Rad53	O
gene1e	O
Targets	O
the	O
Exoribonuclease	O
,	O
gene1s	O
Xrn1	O
gene1e	O
.	O
The	O
highly	O
conserved	O
DNA	O
damage	O
response	O
(	O
DDR	O
)	O
pathway	O
monitors	O
the	O
genomic	O
integrity	O
of	O
the	O
cell	O
and	O
protects	O
against	O
genotoxic	O
stresses	O
.	O
The	O
gene1s	ARG2
apical	ARG2
kinases	ARG2
gene1e	ARG2
,	O
gene1s	O
Mec1	O
gene1e	O
and	O
gene1s	O
Tel1	O
gene1e	O
(	O
gene1s	ARG2
ATR	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ATM	ARG2
gene1e	ARG2
in	O
arg1s	O
human	O
arg1e	O
,	O
respectively	O
)	O
,	O
initiate	O
the	O
DNA	O
damage	O
signaling	O
cascade	O
through	O
the	O
gene1s	O
effector	O
kinases	O
gene1e	O
,	O
gene1s	O
Rad53	O
gene1e	O
and	O
gene1s	O
Chk1	O
gene1e	O
,	O
to	O
regulate	O
a	O
variety	O
of	O
cellular	O
processes	O
including	O
cell	O
cycle	O
progression	O
,	O
DNA	O
damage	O
repair	O
,	O
chromatin	O
remodeling	O
,	O
and	O
transcription	O
.	O
The	O
DDR	O
also	O
regulates	O
other	O
cellular	O
pathways	O
,	O
but	O
direct	O
substrates	O
and	O
mechanisms	O
are	O
still	O
lacking	O
.	O
Using	O
a	O
mass	O
spectrometry	O
-	O
based	O
phosphoproteomic	O
screen	O
in	O
species1s	O
Saccharomyces	O
cerevisiae	O
species1e	O
,	O
we	O
identified	O
novel	O
targets	O
of	O
gene1s	O
Rad53	O
gene1e	O
,	O
many	O
of	O
which	O
are	O
proteins	O
that	O
are	O
involved	O
in	O
RNA	O
metabolism	O
.	O
Of	O
the	O
33	O
novel	O
substrates	O
identified	O
,	O
we	O
verified	O
that	O
12	O
are	O
directly	O
phosphorylated	O
by	O
gene1s	O
Rad53	O
gene1e	O
in	O
vitro	O
:	O
gene1s	O
Xrn1	O
gene1e	O
,	O
gene1s	O
Gcd11	O
gene1e	O
,	O
gene1s	O
Rps7b	O
gene1e	O
,	O
gene1s	O
Ded1	O
gene1e	O
,	O
gene1s	O
Cho2	O
gene1e	O
,	O
gene1s	O
Pus1	O
gene1e	O
,	O
gene1s	O
Hst1	O
gene1e	O
,	O
gene1s	O
Srv2	O
gene1e	O
,	O
gene1s	O
Set3	O
gene1e	O
,	O
gene1s	O
Snu23	O
gene1e	O
,	O
gene1s	O
Alb1	O
gene1e	O
,	O
and	O
gene1s	O
Scp160	O
gene1e	O
.	O
We	O
further	O
characterized	O
gene1s	O
Xrn1	O
gene1e	O
,	O
a	O
highly	O
conserved	O
gene1s	O
5	O
'	O
exoribonuclease	O
gene1e	O
that	O
functions	O
in	O
RNA	O
degradation	O
and	O
the	O
most	O
enriched	O
in	O
our	O
phosphoproteomics	O
screen	O
.	O
Phosphorylation	O
of	O
gene1s	O
Xrn1	O
gene1e	O
by	O
gene1s	O
Rad53	O
gene1e	O
does	O
not	O
appear	O
to	O
affect	O
gene1s	O
Xrn1	O
gene1e	O
's	O
intrinsic	O
nuclease	O
activity	O
in	O
vitro	O
,	O
but	O
may	O
affect	O
its	O
activity	O
or	O
specificity	O
in	O
vivo	O
.	O

Independent	O
and	O
cooperative	O
roles	O
of	O
gene1s	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
gene1e	O
,	O
gene1s	ARG2
nuclear	ARG2
factor	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
bone	ARG2
morphogenetic	ARG2
protein-2	ARG2
gene1e	ARG2
in	O
regulation	O
of	O
metastasis	O
and	O
osteomimicry	O
of	O
prostate	O
cancer	O
cells	O
and	O
differentiation	O
and	O
mineralization	O
of	O
arg1s	O
MC3T3-E1	O
arg1e	O
osteoblast	O
-	O
like	O
cells	O
.	O
The	O
molecular	O
mechanisms	O
involved	O
in	O
prostate	O
cancer	O
(	O
PC	O
)	O
metastasis	O
and	O
bone	O
remodeling	O
are	O
poorly	O
understood	O
.	O
We	O
recently	O
reported	O
that	O
gene1s	O
phosphoinositide	O
3-kinase	O
(	O
PI3K)/protein	O
kinase	O
B	O
gene1e	O
(	O
gene1s	O
Akt	O
gene1e	O
)	O
mediates	O
transcriptional	O
regulation	O
and	O
activation	O
of	O
gene1s	O
bone	O
morphogenetic	O
protein	O
(	O
BMP)-2	O
gene1e	O
signaling	O
by	O
gene1s	O
nuclear	O
factor	O
(	O
NF)-kappaB	O
gene1e	O
in	O
bone	O
metastatic	O
prostate	O
cancer	O
cells	O
.	O
In	O
the	O
present	O
study	O
,	O
we	O
demonstrate	O
that	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
,	O
whether	O
activated	O
by	O
recombinant	O
species1s	O
human	O
species1e	O
gene1s	O
tumor	O
necrosis	O
factor	O
(	O
TNF)-alpha	O
gene1e	O
or	O
by	O
ectopic	O
expression	O
of	O
the	O
gene1s	O
p65	O
gene1e	O
subunit	O
,	O
is	O
involved	O
in	O
extracellular	O
matrix	O
adhesion	O
and	O
invasion	O
of	O
osteotropic	O
PC-3	O
and	O
species1s	O
C4	O
-	O
2B	O
species1e	O
,	O
but	O
not	O
species1s	O
LNCaP	O
species1e	O
,	O
cells	O
.	O
The	O
enhanced	O
metastatic	O
potential	O
was	O
associated	O
with	O
transcriptional	O
upregulation	O
of	O
gene1s	O
osteopontin	O
gene1e	O
,	O
gene1s	O
osteocalcin	O
gene1e	O
,	O
and	O
gene1s	O
collagen	O
IA1	O
gene1e	O
in	O
osteotropic	O
PC	O
cells	O
,	O
suggesting	O
their	O
role	O
in	O
osteomimicry	O
of	O
PC	O
cells	O
.	O
Unlike	O
gene1s	O
BMP-4	O
gene1e	O
,	O
gene1s	O
BMP-2	O
gene1e	O
protein	O
enhanced	O
the	O
invasive	O
properties	O
of	O
species1s	O
C4	O
-	O
2B	O
species1e	O
cells	O
,	O
but	O
not	O
in	O
species1s	O
LNCaP	O
species1e	O
cells	O
.	O
Also	O
,	O
this	O
effect	O
was	O
nullified	O
by	O
gene1s	O
Noggin	O
gene1e	O
.	O
In	O
addition	O
,	O
gene1s	O
BMP-2	O
gene1e	O
mediates	O
gene1s	O
TNF	O
-	O
alpha	O
gene1e	O
-	O
induced	O
invasion	O
of	O
species1s	O
C4	O
-	O
2B	O
species1e	O
cells	O
in	O
a	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
-	O
dependent	O
fashion	O
.	O
gene1s	O
TNF	O
-	O
alpha	O
gene1e	O
or	O
conditioned	O
media	O
(	O
CM	O
)	O
of	O
gene1s	O
TNF	O
-	O
alpha	O
gene1e	O
-	O
stimulated	O
species1s	O
C4	O
-	O
2B	O
species1e	O
cells	O
upregulated	O
gene1s	ARG2
BMP-2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
BMP	ARG2
gene1e	ARG2
-	O
dependent	O
gene1s	ARG2
Smad	ARG2
gene1e	ARG2
transcripts	O
and	O
inhibited	O
gene1s	ARG2
receptor	ARG2
activator	ARG2
of	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
ligand	ARG2
gene1e	ARG2
transcripts	O
in	O
arg1s	O
RAW	O
264.7	O
arg1e	O
preosteoclast	O
cells	O
,	O
respectively	O
,	O
implying	O
that	O
this	O
factor	O
may	O
contribute	O
to	O
suppression	O
of	O
osteoclastogenesis	O
via	O
direct	O
and	O
paracrine	O
mechanisms	O
.	O
In	O
contrast	O
,	O
CM	O
of	O
gene1s	O
TNF	O
-	O
alpha	O
gene1e	O
-	O
stimulate	O
or	O
gene1s	O
BMP2	O
gene1e	O
-stimulated	O
species1s	O
C4	O
-	O
2B	O
species1e	O
cells	O
induced	O
in	O
vitro	O
mineralization	O
of	O
arg1s	O
MC3T3-E1	O
arg1e	O
osteoblast	O
cells	O
in	O
a	O
gene1s	ARG2
BMP-2	ARG2
gene1e	ARG2
-dependent	O
and	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
-	O
dependent	O
manner	O
,	O
respectively	O
.	O
Taken	O
together	O
,	O
the	O
results	O
suggest	O
that	O
mutual	O
interactions	O
between	O
these	O
factors	O
may	O
be	O
pivotal	O
not	O
only	O
in	O
enhancing	O
the	O
osteomimicry	O
and	O
metastatic	O
potential	O
of	O
PC	O
cells	O
,	O
but	O
also	O
in	O
bone	O
remodeling	O
and	O
in	O
shifting	O
the	O
balance	O
from	O
osteoclastogenesis	O
towards	O
osteoblastogenesis	O
.	O

Independent	O
and	O
cooperative	O
roles	O
of	O
gene1s	ARG2
tumor	ARG2
necrosis	ARG2
factor	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
nuclear	ARG2
factor	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
bone	ARG2
morphogenetic	ARG2
protein-2	ARG2
gene1e	ARG2
in	O
regulation	O
of	O
metastasis	O
and	O
osteomimicry	O
of	O
prostate	O
cancer	O
cells	O
and	O
differentiation	O
and	O
mineralization	O
of	O
species1s	O
MC3T3-E1	O
species1e	O
osteoblast	O
-	O
like	O
cells	O
.	O
The	O
molecular	O
mechanisms	O
involved	O
in	O
prostate	O
cancer	O
(	O
PC	O
)	O
metastasis	O
and	O
bone	O
remodeling	O
are	O
poorly	O
understood	O
.	O
We	O
recently	O
reported	O
that	O
gene1s	ARG2
phosphoinositide	ARG2
3-kinase	ARG2
(	ARG2
PI3K)/protein	ARG2
kinase	ARG2
B	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
)	O
mediates	O
transcriptional	O
regulation	O
and	O
activation	O
of	O
gene1s	ARG2
bone	ARG2
morphogenetic	ARG2
protein	ARG2
(	ARG2
BMP)-2	ARG2
gene1e	ARG2
signaling	O
by	O
gene1s	ARG2
nuclear	ARG2
factor	ARG2
(	ARG2
NF)-kappaB	ARG2
gene1e	ARG2
in	O
bone	O
metastatic	O
prostate	O
cancer	O
cells	O
.	O
In	O
the	O
present	O
study	O
,	O
we	O
demonstrate	O
that	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
,	O
whether	O
activated	O
by	O
recombinant	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
tumor	ARG2
necrosis	ARG2
factor	ARG2
(	ARG2
TNF)-alpha	ARG2
gene1e	ARG2
or	O
by	O
ectopic	O
expression	O
of	O
the	O
gene1s	ARG2
p65	ARG2
gene1e	ARG2
subunit	O
,	O
is	O
involved	O
in	O
extracellular	O
matrix	O
adhesion	O
and	O
invasion	O
of	O
osteotropic	O
PC-3	O
and	O
arg1s	O
C4	O
-	O
2B	O
arg1e	O
,	O
but	O
not	O
arg1s	O
LNCaP	O
arg1e	O
,	O
cells	O
.	O
The	O
enhanced	O
metastatic	O
potential	O
was	O
associated	O
with	O
transcriptional	O
upregulation	O
of	O
gene1s	ARG2
osteopontin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
osteocalcin	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
collagen	ARG2
IA1	ARG2
gene1e	ARG2
in	O
osteotropic	O
PC	O
cells	O
,	O
suggesting	O
their	O
role	O
in	O
osteomimicry	O
of	O
PC	O
cells	O
.	O
Unlike	O
gene1s	ARG2
BMP-4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
BMP-2	ARG2
gene1e	ARG2
protein	O
enhanced	O
the	O
invasive	O
properties	O
of	O
arg1s	O
C4	O
-	O
2B	O
arg1e	O
cells	O
,	O
but	O
not	O
in	O
arg1s	O
LNCaP	O
arg1e	O
cells	O
.	O
Also	O
,	O
this	O
effect	O
was	O
nullified	O
by	O
gene1s	ARG2
Noggin	ARG2
gene1e	ARG2
.	O
In	O
addition	O
,	O
gene1s	ARG2
BMP-2	ARG2
gene1e	ARG2
mediates	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
-	O
induced	O
invasion	O
of	O
arg1s	O
C4	O
-	O
2B	O
arg1e	O
cells	O
in	O
a	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
-	O
dependent	O
fashion	O
.	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
or	O
conditioned	O
media	O
(	O
CM	O
)	O
of	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
-	O
stimulated	O
arg1s	O
C4	O
-	O
2B	O
arg1e	O
cells	O
upregulated	O
gene1s	O
BMP-2	O
gene1e	O
and	O
gene1s	O
BMP	O
gene1e	O
-	O
dependent	O
gene1s	O
Smad	O
gene1e	O
transcripts	O
and	O
inhibited	O
gene1s	O
receptor	O
activator	O
of	O
NF	O
-	O
kappaB	O
ligand	O
gene1e	O
transcripts	O
in	O
species1s	O
RAW	O
264.7	O
species1e	O
preosteoclast	O
cells	O
,	O
respectively	O
,	O
implying	O
that	O
this	O
factor	O
may	O
contribute	O
to	O
suppression	O
of	O
osteoclastogenesis	O
via	O
direct	O
and	O
paracrine	O
mechanisms	O
.	O
In	O
contrast	O
,	O
CM	O
of	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
-	O
stimulate	O
or	O
gene1s	ARG2
BMP2	ARG2
gene1e	ARG2
-stimulated	O
arg1s	O
C4	O
-	O
2B	O
arg1e	O
cells	O
induced	O
in	O
vitro	O
mineralization	O
of	O
species1s	O
MC3T3-E1	O
species1e	O
osteoblast	O
cells	O
in	O
a	O
gene1s	O
BMP-2	O
gene1e	O
-dependent	O
and	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
-	O
dependent	O
manner	O
,	O
respectively	O
.	O
Taken	O
together	O
,	O
the	O
results	O
suggest	O
that	O
mutual	O
interactions	O
between	O
these	O
factors	O
may	O
be	O
pivotal	O
not	O
only	O
in	O
enhancing	O
the	O
osteomimicry	O
and	O
metastatic	O
potential	O
of	O
PC	O
cells	O
,	O
but	O
also	O
in	O
bone	O
remodeling	O
and	O
in	O
shifting	O
the	O
balance	O
from	O
osteoclastogenesis	O
towards	O
osteoblastogenesis	O
.	O

What	O
can	O
naturally	O
occurring	O
mutations	O
tell	O
us	O
about	O
gene1s	ARG2
Ca(v)1.x	ARG2
channel	ARG2
gene1e	ARG2
function	O
?	O
gene1s	ARG2
Voltage	ARG2
-	ARG2
gated	ARG2
Ca2	ARG2
+	ARG2
channels	ARG2
gene1e	ARG2
allow	O
for	O
Ca2	O
+	O
-dependent	O
intracellular	O
signaling	O
by	O
directly	O
mediating	O
Ca2	O
+	O
ion	O
influx	O
,	O
by	O
physical	O
coupling	O
to	O
intracellular	O
gene1s	ARG2
Ca2	ARG2
+	ARG2
release	ARG2
channels	ARG2
gene1e	ARG2
or	O
functional	O
coupling	O
to	O
other	O
gene1s	ARG2
ion	ARG2
channels	ARG2
gene1e	ARG2
such	O
as	O
gene1s	ARG2
Ca2	ARG2
+	ARG2
activated	ARG2
potassium	ARG2
channels	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
L	ARG2
-	ARG2
type	ARG2
Ca2	ARG2
+	ARG2
channels	ARG2
gene1e	ARG2
that	O
comprise	O
the	O
family	O
of	O
gene1s	ARG2
Ca(v)1	ARG2
channels	ARG2
gene1e	ARG2
are	O
expressed	O
in	O
many	O
electrically	O
excitable	O
tissues	O
and	O
are	O
characterized	O
by	O
their	O
unique	O
sensitivity	O
to	O
dihydropyridines	O
.	O
In	O
this	O
issue	O
,	O
we	O
summarize	O
genetic	O
defects	O
in	O
gene1s	ARG2
L	ARG2
-	ARG2
type	ARG2
Ca2	ARG2
+	ARG2
channels	ARG2
gene1e	ARG2
and	O
analyze	O
their	O
role	O
in	O
arg1s	O
human	O
arg1e	O
diseases	O
(	O
Ca2	O
+	O
channelopathies	O
)	O
;	O
e.g.	O
mutations	O
in	O
gene1s	ARG2
Ca(v)1.2	ARG2
a1	ARG2
gene1e	ARG2
cause	O
species1s	O
Timothy	O
species1e	O
and	O
Brugada	O
syndrome	O
,	O
mutations	O
in	O
gene1s	ARG2
Ca(v)1.3	ARG2
a1	ARG2
gene1e	ARG2
are	O
linked	O
to	O
sinoatrial	O
node	O
dysfunction	O
and	O
deafness	O
while	O
mutations	O
in	O
gene1s	ARG2
Ca(v)1.4	ARG2
a1	ARG2
gene1e	ARG2
are	O
associated	O
with	O
X	O
-	O
linked	O
retinal	O
disorders	O
such	O
as	O
an	O
incomplete	O
form	O
of	O
congenital	O
stationary	O
night	O
blindness	O
.	O
Herein	O
,	O
we	O
also	O
put	O
the	O
mutations	O
underlying	O
the	O
channel	O
's	O
dysfunction	O
into	O
the	O
structural	O
context	O
of	O
the	O
pore	O
-	O
forming	O
a1	O
subunit	O
.	O
This	O
analysis	O
highlights	O
the	O
importance	O
of	O
combining	O
functional	O
data	O
with	O
structural	O
analysis	O
to	O
gain	O
a	O
deeper	O
understanding	O
for	O
the	O
disease	O
pathophysiology	O
as	O
well	O
as	O
for	O
physiological	O
channel	O
function	O
.	O
This	O
article	O
is	O
part	O
of	O
a	O
Special	O
Issue	O
entitled	O
:	O
gene1s	ARG2
Calcium	ARG2
channels	ARG2
gene1e	ARG2
.	O

What	O
can	O
naturally	O
occurring	O
mutations	O
tell	O
us	O
about	O
gene1s	O
Ca(v)1.x	O
channel	O
gene1e	O
function	O
?	O
gene1s	O
Voltage	O
-	O
gated	O
Ca2	O
+	O
channels	O
gene1e	O
allow	O
for	O
Ca2	O
+	O
-dependent	O
intracellular	O
signaling	O
by	O
directly	O
mediating	O
Ca2	O
+	O
ion	O
influx	O
,	O
by	O
physical	O
coupling	O
to	O
intracellular	O
gene1s	O
Ca2	O
+	O
release	O
channels	O
gene1e	O
or	O
functional	O
coupling	O
to	O
other	O
gene1s	O
ion	O
channels	O
gene1e	O
such	O
as	O
gene1s	O
Ca2	O
+	O
activated	O
potassium	O
channels	O
gene1e	O
.	O
gene1s	O
L	O
-	O
type	O
Ca2	O
+	O
channels	O
gene1e	O
that	O
comprise	O
the	O
family	O
of	O
gene1s	O
Ca(v)1	O
channels	O
gene1e	O
are	O
expressed	O
in	O
many	O
electrically	O
excitable	O
tissues	O
and	O
are	O
characterized	O
by	O
their	O
unique	O
sensitivity	O
to	O
dihydropyridines	O
.	O
In	O
this	O
issue	O
,	O
we	O
summarize	O
genetic	O
defects	O
in	O
gene1s	O
L	O
-	O
type	O
Ca2	O
+	O
channels	O
gene1e	O
and	O
analyze	O
their	O
role	O
in	O
species1s	O
human	O
species1e	O
diseases	O
(	O
Ca2	O
+	O
channelopathies	O
)	O
;	O
e.g.	O
mutations	O
in	O
gene1s	O
Ca(v)1.2	O
a1	O
gene1e	O
cause	O
arg1s	O
Timothy	O
arg1e	O
and	O
Brugada	O
syndrome	O
,	O
mutations	O
in	O
gene1s	O
Ca(v)1.3	O
a1	O
gene1e	O
are	O
linked	O
to	O
sinoatrial	O
node	O
dysfunction	O
and	O
deafness	O
while	O
mutations	O
in	O
gene1s	O
Ca(v)1.4	O
a1	O
gene1e	O
are	O
associated	O
with	O
X	O
-	O
linked	O
retinal	O
disorders	O
such	O
as	O
an	O
incomplete	O
form	O
of	O
congenital	O
stationary	O
night	O
blindness	O
.	O
Herein	O
,	O
we	O
also	O
put	O
the	O
mutations	O
underlying	O
the	O
channel	O
's	O
dysfunction	O
into	O
the	O
structural	O
context	O
of	O
the	O
pore	O
-	O
forming	O
a1	O
subunit	O
.	O
This	O
analysis	O
highlights	O
the	O
importance	O
of	O
combining	O
functional	O
data	O
with	O
structural	O
analysis	O
to	O
gain	O
a	O
deeper	O
understanding	O
for	O
the	O
disease	O
pathophysiology	O
as	O
well	O
as	O
for	O
physiological	O
channel	O
function	O
.	O
This	O
article	O
is	O
part	O
of	O
a	O
Special	O
Issue	O
entitled	O
:	O
gene1s	O
Calcium	O
channels	O
gene1e	O
.	O

Knockdown	O
of	O
gene1s	ARG2
cathepsin	ARG2
B	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
uPAR	ARG2
gene1e	ARG2
inhibits	O
gene1s	ARG2
CD151	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
a3b1	ARG2
integrin	ARG2
gene1e	ARG2
-	O
mediated	O
cell	O
adhesion	O
and	O
invasion	O
in	O
glioma	O
.	O
Glioma	O
is	O
a	O
highly	O
complex	O
brain	O
tumor	O
characterized	O
by	O
the	O
dysregulation	O
of	O
proteins	O
and	O
genes	O
that	O
leads	O
to	O
tumor	O
metastasis	O
.	O
gene1s	ARG2
Cathepsin	ARG2
B	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
uPAR	ARG2
gene1e	ARG2
are	O
overexpressed	O
in	O
gliomas	O
and	O
they	O
are	O
postulated	O
to	O
play	O
central	O
roles	O
in	O
glioma	O
metastasis	O
.	O
In	O
this	O
study	O
,	O
efficient	O
downregulation	O
of	O
gene1s	ARG2
cathepsin	ARG2
B	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
uPAR	ARG2
gene1e	ARG2
by	O
siRNA	O
treatments	O
significantly	O
reduced	O
glioma	O
cell	O
adhesion	O
to	O
gene1s	ARG2
laminin	ARG2
gene1e	ARG2
as	O
compared	O
to	O
gene1s	ARG2
vitronectin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
fibronectin	ARG2
gene1e	ARG2
,	O
or	O
gene1s	ARG2
collagen	ARG2
I	ARG2
gene1e	ARG2
in	O
arg1s	O
U251	O
arg1e	O
and	O
4910	O
glioma	O
cell	O
lines	O
.	O
Brain	O
glioma	O
tissue	O
array	O
analysis	O
showed	O
high	O
expression	O
of	O
gene1s	ARG2
CD151	ARG2
gene1e	ARG2
in	O
clinical	O
samples	O
when	O
compared	O
with	O
normal	O
brain	O
tissue	O
.	O
gene1s	ARG2
Cathepsin	ARG2
B	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
uPAR	ARG2
gene1e	ARG2
siRNA	O
treatment	O
led	O
to	O
the	O
downregulation	O
of	O
gene1s	ARG2
CD151	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
laminin	ARG2
-	ARG2
binding	ARG2
integrins	ARG2
a3	ARG2
and	ARG2
b1	ARG2
gene1e	ARG2
.	O
Co	O
-	O
immunoprecipitation	O
experiments	O
revealed	O
that	O
downregulation	O
of	O
gene1s	ARG2
cathepsin	ARG2
B	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
uPAR	ARG2
gene1e	ARG2
decreased	O
the	O
interaction	O
of	O
gene1s	ARG2
CD151	ARG2
gene1e	ARG2
with	O
gene1s	ARG2
uPAR	ARG2
gene1e	ARG2
gene1s	ARG2
cathepsin	ARG2
B	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
a3b1	ARG2
integrin	ARG2
gene1e	ARG2
.	O
Studies	O
on	O
the	O
downstream	O
signaling	O
cascade	O
of	O
gene1s	ARG2
uPAR	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CD151	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
a3b1	ARG2
integrin	ARG2
gene1e	ARG2
have	O
shown	O
that	O
phosphorylation	O
of	O
gene1s	ARG2
FAK	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SRC	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
paxillin	ARG2
gene1e	ARG2
,	O
and	O
expression	O
of	O
adaptor	O
gene1s	ARG2
cytoskeletal	ARG2
proteins	ARG2
gene1e	ARG2
gene1s	ARG2
talin	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
vinculin	ARG2
gene1e	ARG2
were	O
reduced	O
with	O
knockdown	O
of	O
gene1s	ARG2
cathepsin	ARG2
B	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
uPAR	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
CD151	ARG2
gene1e	ARG2
.	O
Treatment	O
with	O
the	O
bicistronic	O
construct	O
reduced	O
interactions	O
between	O
gene1s	ARG2
uPAR	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CD151	ARG2
gene1e	ARG2
as	O
well	O
as	O
lowering	O
gene1s	ARG2
a3b1	ARG2
integrin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
talin	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
vinculin	ARG2
gene1e	ARG2
expression	O
levels	O
in	O
pre	O
-	O
established	O
glioma	O
tumors	O
of	O
species1s	O
nude	O
mice	O
species1e	O
.	O
In	O
conclusion	O
,	O
our	O
results	O
show	O
that	O
downregulation	O
of	O
gene1s	ARG2
cathepsin	ARG2
B	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
uPAR	ARG2
gene1e	ARG2
alone	O
and	O
in	O
combination	O
inhibit	O
glioma	O
cell	O
adhesion	O
by	O
downregulating	O
gene1s	ARG2
CD151	ARG2
gene1e	ARG2
and	O
its	O
associated	O
signaling	O
molecules	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O
Taken	O
together	O
,	O
the	O
results	O
of	O
the	O
present	O
study	O
show	O
that	O
targeting	O
the	O
gene1s	ARG2
uPAR	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
cathepsin	ARG2
B	ARG2
gene1e	ARG2
system	O
has	O
possible	O
therapeutic	O
potential	O
.	O

Knockdown	O
of	O
gene1s	O
cathepsin	O
B	O
gene1e	O
and	O
gene1s	O
uPAR	O
gene1e	O
inhibits	O
gene1s	O
CD151	O
gene1e	O
and	O
gene1s	O
a3b1	O
integrin	O
gene1e	O
-	O
mediated	O
cell	O
adhesion	O
and	O
invasion	O
in	O
glioma	O
.	O
Glioma	O
is	O
a	O
highly	O
complex	O
brain	O
tumor	O
characterized	O
by	O
the	O
dysregulation	O
of	O
proteins	O
and	O
genes	O
that	O
leads	O
to	O
tumor	O
metastasis	O
.	O
gene1s	O
Cathepsin	O
B	O
gene1e	O
and	O
gene1s	O
uPAR	O
gene1e	O
are	O
overexpressed	O
in	O
gliomas	O
and	O
they	O
are	O
postulated	O
to	O
play	O
central	O
roles	O
in	O
glioma	O
metastasis	O
.	O
In	O
this	O
study	O
,	O
efficient	O
downregulation	O
of	O
gene1s	O
cathepsin	O
B	O
gene1e	O
and	O
gene1s	O
uPAR	O
gene1e	O
by	O
siRNA	O
treatments	O
significantly	O
reduced	O
glioma	O
cell	O
adhesion	O
to	O
gene1s	O
laminin	O
gene1e	O
as	O
compared	O
to	O
gene1s	O
vitronectin	O
gene1e	O
,	O
gene1s	O
fibronectin	O
gene1e	O
,	O
or	O
gene1s	O
collagen	O
I	O
gene1e	O
in	O
species1s	O
U251	O
species1e	O
and	O
4910	O
glioma	O
cell	O
lines	O
.	O
Brain	O
glioma	O
tissue	O
array	O
analysis	O
showed	O
high	O
expression	O
of	O
gene1s	O
CD151	O
gene1e	O
in	O
clinical	O
samples	O
when	O
compared	O
with	O
normal	O
brain	O
tissue	O
.	O
gene1s	O
Cathepsin	O
B	O
gene1e	O
and	O
gene1s	O
uPAR	O
gene1e	O
siRNA	O
treatment	O
led	O
to	O
the	O
downregulation	O
of	O
gene1s	O
CD151	O
gene1e	O
and	O
gene1s	O
laminin	O
-	O
binding	O
integrins	O
a3	O
and	O
b1	O
gene1e	O
.	O
Co	O
-	O
immunoprecipitation	O
experiments	O
revealed	O
that	O
downregulation	O
of	O
gene1s	O
cathepsin	O
B	O
gene1e	O
and	O
gene1s	O
uPAR	O
gene1e	O
decreased	O
the	O
interaction	O
of	O
gene1s	O
CD151	O
gene1e	O
with	O
gene1s	O
uPAR	O
gene1e	O
gene1s	O
cathepsin	O
B	O
gene1e	O
,	O
and	O
gene1s	O
a3b1	O
integrin	O
gene1e	O
.	O
Studies	O
on	O
the	O
downstream	O
signaling	O
cascade	O
of	O
gene1s	O
uPAR	O
gene1e	O
/	O
gene1s	O
CD151	O
gene1e	O
/	O
gene1s	O
a3b1	O
integrin	O
gene1e	O
have	O
shown	O
that	O
phosphorylation	O
of	O
gene1s	O
FAK	O
gene1e	O
,	O
gene1s	O
SRC	O
gene1e	O
,	O
gene1s	O
paxillin	O
gene1e	O
,	O
and	O
expression	O
of	O
adaptor	O
gene1s	O
cytoskeletal	O
proteins	O
gene1e	O
gene1s	O
talin	O
gene1e	O
and	O
gene1s	O
vinculin	O
gene1e	O
were	O
reduced	O
with	O
knockdown	O
of	O
gene1s	O
cathepsin	O
B	O
gene1e	O
,	O
gene1s	O
uPAR	O
gene1e	O
,	O
and	O
gene1s	O
CD151	O
gene1e	O
.	O
Treatment	O
with	O
the	O
bicistronic	O
construct	O
reduced	O
interactions	O
between	O
gene1s	O
uPAR	O
gene1e	O
and	O
gene1s	O
CD151	O
gene1e	O
as	O
well	O
as	O
lowering	O
gene1s	O
a3b1	O
integrin	O
gene1e	O
,	O
gene1s	O
talin	O
gene1e	O
,	O
and	O
gene1s	O
vinculin	O
gene1e	O
expression	O
levels	O
in	O
pre	O
-	O
established	O
glioma	O
tumors	O
of	O
arg1s	O
nude	O
mice	O
arg1e	O
.	O
In	O
conclusion	O
,	O
our	O
results	O
show	O
that	O
downregulation	O
of	O
gene1s	O
cathepsin	O
B	O
gene1e	O
and	O
gene1s	O
uPAR	O
gene1e	O
alone	O
and	O
in	O
combination	O
inhibit	O
glioma	O
cell	O
adhesion	O
by	O
downregulating	O
gene1s	O
CD151	O
gene1e	O
and	O
its	O
associated	O
signaling	O
molecules	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O
Taken	O
together	O
,	O
the	O
results	O
of	O
the	O
present	O
study	O
show	O
that	O
targeting	O
the	O
gene1s	O
uPAR	O
gene1e	O
-	O
gene1s	O
cathepsin	O
B	O
gene1e	O
system	O
has	O
possible	O
therapeutic	O
potential	O
.	O

Spirulina	O
lipopolysaccharides	O
inhibit	O
tumor	O
growth	O
in	O
a	O
gene1s	O
Toll	O
-	O
like	O
receptor	O
4	O
gene1e	O
-dependent	O
manner	O
by	O
altering	O
the	O
gene1s	O
cytokine	O
gene1e	O
milieu	O
from	O
gene1s	O
interleukin-17	O
gene1e	O
/	O
gene1s	O
interleukin-23	O
gene1e	O
to	O
gene1s	O
interferon	O
-	O
g	O
gene1e	O
.	O
Th17	O
cells	O
and	O
the	O
gene1s	ARG2
cytokine	ARG2
gene1e	ARG2
they	O
produce	O
,	O
gene1s	ARG2
interleukin	ARG2
(	ARG2
IL)-17	ARG2
gene1e	ARG2
,	O
play	O
an	O
important	O
role	O
in	O
tumor	O
progression	O
in	O
arg1s	O
humans	O
arg1e	O
and	O
in	O
species1s	O
mice	O
species1e	O
.	O
gene1s	O
IL-6	O
gene1e	O
and	O
gene1s	O
IL-23	O
gene1e	O
are	O
critical	O
gene1s	O
cytokines	O
gene1e	O
for	O
the	O
differentiation	O
and	O
propagation	O
of	O
Th17	O
cells	O
,	O
respectively	O
.	O
Bacterial	O
lipopolysaccharides	O
(	O
LPS	O
)	O
are	O
known	O
to	O
stimulate	O
immune	O
cells	O
to	O
produce	O
such	O
inflammatory	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
.	O
Contrary	O
to	O
species1s	O
Escherichia	O
coli	O
species1e	O
(	O
species1s	O
E.	O
coli	O
species1e	O
)	O
LPS	O
,	O
LPS	O
from	O
Spirulina	O
has	O
low	O
toxicity	O
and	O
barely	O
induces	O
in	O
vivo	O
production	O
of	O
gene1s	O
IL-6	O
gene1e	O
and	O
gene1s	O
IL-23	O
gene1e	O
in	O
species1s	O
mice	O
species1e	O
.	O
We	O
examined	O
the	O
antitumor	O
effects	O
of	O
Spirulina	O
LPS	O
compared	O
to	O
species1s	O
E.	O
coli	O
species1e	O
LPS	O
in	O
an	O
MH134	O
hepatoma	O
model	O
.	O
Administration	O
of	O
Spirulina	O
LPS	O
suppressed	O
tumor	O
growth	O
in	O
C3H	O
/	O
HeN	O
species1s	O
mice	O
species1e	O
,	O
but	O
not	O
in	O
gene1s	O
Toll	O
-	O
like	O
receptor	O
4	O
gene1e	O
(	O
gene1s	O
TLR4	O
gene1e	O
)-mutant	O
C3H	O
/	O
HeJ	O
species1s	O
mice	O
species1e	O
,	O
by	O
reducing	O
serum	O
levels	O
of	O
gene1s	O
IL-17	O
gene1e	O
and	O
gene1s	O
IL-23	O
gene1e	O
,	O
while	O
increasing	O
gene1s	O
interferon	O
(	O
IFN)-g	O
gene1e	O
levels	O
.	O
The	O
antitumor	O
activity	O
and	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
production	O
were	O
mediated	O
by	O
T	O
cells	O
.	O
Moreover	O
,	O
in	O
vitro	O
experiments	O
showed	O
that	O
Spirulina	O
LPS	O
impaired	O
the	O
antigen	O
-	O
presenting	O
function	O
that	O
supports	O
the	O
generation	O
of	O
gene1s	O
IL-17	O
gene1e	O
-producing	O
cells	O
in	O
a	O
gene1s	O
toll	O
-	O
like	O
receptor	O
(	O
TLR)4	O
gene1e	O
-dependent	O
manner	O
.	O
Of	O
note	O
,	O
injection	O
of	O
anti	O
-	O
gene1s	O
IL-17	O
gene1e	O
antibody	O
in	O
tumor	O
-	O
bearing	O
C3H	O
/	O
HeN	O
species1s	O
mice	O
species1e	O
in	O
the	O
absence	O
of	O
Spirulina	O
LPS	O
markedly	O
suppressed	O
tumor	O
growth	O
and	O
augmented	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
responses	O
.	O
Thus	O
,	O
our	O
results	O
support	O
the	O
notion	O
that	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
and	O
gene1s	O
IL-17	O
gene1e	O
/	O
gene1s	O
IL-23	O
gene1e	O
mutually	O
regulate	O
Th17	O
and	O
Th1	O
responses	O
in	O
tumor	O
-	O
bearing	O
hosts	O
,	O
and	O
Spirulina	O
LPS	O
modulates	O
the	O
balance	O
of	O
the	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
-	O
gene1s	O
IL-17	O
gene1e	O
/	O
gene1s	O
IL-23	O
gene1e	O
axis	O
towards	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
production	O
,	O
which	O
leads	O
to	O
tumor	O
inhibition	O
.	O
Furthermore	O
,	O
Spirulina	O
LPS	O
effectively	O
inhibited	O
the	O
spontaneous	O
development	O
of	O
mammary	O
tumors	O
.	O
This	O
study	O
has	O
important	O
implications	O
for	O
the	O
exploitation	O
of	O
TLR	O
-	O
based	O
immunomodulators	O
for	O
cancer	O
immunotherapy	O
.	O

Spirulina	O
lipopolysaccharides	O
inhibit	O
tumor	O
growth	O
in	O
a	O
gene1s	ARG2
Toll	ARG2
-	ARG2
like	ARG2
receptor	ARG2
4	ARG2
gene1e	ARG2
-dependent	O
manner	O
by	O
altering	O
the	O
gene1s	ARG2
cytokine	ARG2
gene1e	ARG2
milieu	O
from	O
gene1s	ARG2
interleukin-17	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
interleukin-23	ARG2
gene1e	ARG2
to	O
gene1s	ARG2
interferon	ARG2
-	ARG2
g	ARG2
gene1e	ARG2
.	O
Th17	O
cells	O
and	O
the	O
gene1s	ARG2
cytokine	ARG2
gene1e	ARG2
they	O
produce	O
,	O
gene1s	ARG2
interleukin	ARG2
(	ARG2
IL)-17	ARG2
gene1e	ARG2
,	O
play	O
an	O
important	O
role	O
in	O
tumor	O
progression	O
in	O
species1s	O
humans	O
species1e	O
and	O
in	O
arg1s	O
mice	O
arg1e	O
.	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL-23	ARG2
gene1e	ARG2
are	O
critical	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
for	O
the	O
differentiation	O
and	O
propagation	O
of	O
Th17	O
cells	O
,	O
respectively	O
.	O
Bacterial	O
lipopolysaccharides	O
(	O
LPS	O
)	O
are	O
known	O
to	O
stimulate	O
immune	O
cells	O
to	O
produce	O
such	O
inflammatory	O
gene1s	O
cytokines	O
gene1e	O
.	O
Contrary	O
to	O
species1s	O
Escherichia	O
coli	O
species1e	O
(	O
species1s	O
E.	O
coli	O
species1e	O
)	O
LPS	O
,	O
LPS	O
from	O
Spirulina	O
has	O
low	O
toxicity	O
and	O
barely	O
induces	O
in	O
vivo	O
production	O
of	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL-23	ARG2
gene1e	ARG2
in	O
arg1s	O
mice	O
arg1e	O
.	O
We	O
examined	O
the	O
antitumor	O
effects	O
of	O
Spirulina	O
LPS	O
compared	O
to	O
species1s	O
E.	O
coli	O
species1e	O
LPS	O
in	O
an	O
MH134	O
hepatoma	O
model	O
.	O
Administration	O
of	O
Spirulina	O
LPS	O
suppressed	O
tumor	O
growth	O
in	O
C3H	O
/	O
HeN	O
arg1s	O
mice	O
arg1e	O
,	O
but	O
not	O
in	O
gene1s	ARG2
Toll	ARG2
-	ARG2
like	ARG2
receptor	ARG2
4	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
)-mutant	O
C3H	O
/	O
HeJ	O
arg1s	O
mice	O
arg1e	O
,	O
by	O
reducing	O
serum	O
levels	O
of	O
gene1s	ARG2
IL-17	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL-23	ARG2
gene1e	ARG2
,	O
while	O
increasing	O
gene1s	ARG2
interferon	ARG2
(	ARG2
IFN)-g	ARG2
gene1e	ARG2
levels	O
.	O
The	O
antitumor	O
activity	O
and	O
gene1s	ARG2
IFN	ARG2
-	ARG2
g	ARG2
gene1e	ARG2
production	O
were	O
mediated	O
by	O
T	O
cells	O
.	O
Moreover	O
,	O
in	O
vitro	O
experiments	O
showed	O
that	O
Spirulina	O
LPS	O
impaired	O
the	O
antigen	O
-	O
presenting	O
function	O
that	O
supports	O
the	O
generation	O
of	O
gene1s	ARG2
IL-17	ARG2
gene1e	ARG2
-producing	O
cells	O
in	O
a	O
gene1s	ARG2
toll	ARG2
-	ARG2
like	ARG2
receptor	ARG2
(	ARG2
TLR)4	ARG2
gene1e	ARG2
-dependent	O
manner	O
.	O
Of	O
note	O
,	O
injection	O
of	O
anti	O
-	O
gene1s	ARG2
IL-17	ARG2
gene1e	ARG2
antibody	O
in	O
tumor	O
-	O
bearing	O
C3H	O
/	O
HeN	O
arg1s	O
mice	O
arg1e	O
in	O
the	O
absence	O
of	O
Spirulina	O
LPS	O
markedly	O
suppressed	O
tumor	O
growth	O
and	O
augmented	O
gene1s	ARG2
IFN	ARG2
-	ARG2
g	ARG2
gene1e	ARG2
responses	O
.	O
Thus	O
,	O
our	O
results	O
support	O
the	O
notion	O
that	O
gene1s	ARG2
IFN	ARG2
-	ARG2
g	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL-17	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
IL-23	ARG2
gene1e	ARG2
mutually	O
regulate	O
Th17	O
and	O
Th1	O
responses	O
in	O
tumor	O
-	O
bearing	O
hosts	O
,	O
and	O
Spirulina	O
LPS	O
modulates	O
the	O
balance	O
of	O
the	O
gene1s	ARG2
IFN	ARG2
-	ARG2
g	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
IL-17	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
IL-23	ARG2
gene1e	ARG2
axis	O
towards	O
gene1s	ARG2
IFN	ARG2
-	ARG2
g	ARG2
gene1e	ARG2
production	O
,	O
which	O
leads	O
to	O
tumor	O
inhibition	O
.	O
Furthermore	O
,	O
Spirulina	O
LPS	O
effectively	O
inhibited	O
the	O
spontaneous	O
development	O
of	O
mammary	O
tumors	O
.	O
This	O
study	O
has	O
important	O
implications	O
for	O
the	O
exploitation	O
of	O
TLR	O
-	O
based	O
immunomodulators	O
for	O
cancer	O
immunotherapy	O
.	O

Spirulina	O
lipopolysaccharides	O
inhibit	O
tumor	O
growth	O
in	O
a	O
gene1s	O
Toll	O
-	O
like	O
receptor	O
4	O
gene1e	O
-dependent	O
manner	O
by	O
altering	O
the	O
gene1s	O
cytokine	O
gene1e	O
milieu	O
from	O
gene1s	O
interleukin-17	O
gene1e	O
/	O
gene1s	O
interleukin-23	O
gene1e	O
to	O
gene1s	O
interferon	O
-	O
g	O
gene1e	O
.	O
Th17	O
cells	O
and	O
the	O
gene1s	O
cytokine	O
gene1e	O
they	O
produce	O
,	O
gene1s	O
interleukin	O
(	O
IL)-17	O
gene1e	O
,	O
play	O
an	O
important	O
role	O
in	O
tumor	O
progression	O
in	O
species1s	O
humans	O
species1e	O
and	O
in	O
species1s	O
mice	O
species1e	O
.	O
gene1s	O
IL-6	O
gene1e	O
and	O
gene1s	O
IL-23	O
gene1e	O
are	O
critical	O
gene1s	O
cytokines	O
gene1e	O
for	O
the	O
differentiation	O
and	O
propagation	O
of	O
Th17	O
cells	O
,	O
respectively	O
.	O
Bacterial	O
lipopolysaccharides	O
(	O
LPS	O
)	O
are	O
known	O
to	O
stimulate	O
immune	O
cells	O
to	O
produce	O
such	O
inflammatory	O
gene1s	O
cytokines	O
gene1e	O
.	O
Contrary	O
to	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
(	O
arg1s	O
E.	O
coli	O
arg1e	O
)	O
LPS	O
,	O
LPS	O
from	O
Spirulina	O
has	O
low	O
toxicity	O
and	O
barely	O
induces	O
in	O
vivo	O
production	O
of	O
gene1s	O
IL-6	O
gene1e	O
and	O
gene1s	O
IL-23	O
gene1e	O
in	O
species1s	O
mice	O
species1e	O
.	O
We	O
examined	O
the	O
antitumor	O
effects	O
of	O
Spirulina	O
LPS	O
compared	O
to	O
arg1s	O
E.	O
coli	O
arg1e	O
LPS	O
in	O
an	O
MH134	O
hepatoma	O
model	O
.	O
Administration	O
of	O
Spirulina	O
LPS	O
suppressed	O
tumor	O
growth	O
in	O
C3H	O
/	O
HeN	O
species1s	O
mice	O
species1e	O
,	O
but	O
not	O
in	O
gene1s	O
Toll	O
-	O
like	O
receptor	O
4	O
gene1e	O
(	O
gene1s	O
TLR4	O
gene1e	O
)-mutant	O
C3H	O
/	O
HeJ	O
species1s	O
mice	O
species1e	O
,	O
by	O
reducing	O
serum	O
levels	O
of	O
gene1s	O
IL-17	O
gene1e	O
and	O
gene1s	O
IL-23	O
gene1e	O
,	O
while	O
increasing	O
gene1s	O
interferon	O
(	O
IFN)-g	O
gene1e	O
levels	O
.	O
The	O
antitumor	O
activity	O
and	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
production	O
were	O
mediated	O
by	O
T	O
cells	O
.	O
Moreover	O
,	O
in	O
vitro	O
experiments	O
showed	O
that	O
Spirulina	O
LPS	O
impaired	O
the	O
antigen	O
-	O
presenting	O
function	O
that	O
supports	O
the	O
generation	O
of	O
gene1s	O
IL-17	O
gene1e	O
-producing	O
cells	O
in	O
a	O
gene1s	O
toll	O
-	O
like	O
receptor	O
(	O
TLR)4	O
gene1e	O
-dependent	O
manner	O
.	O
Of	O
note	O
,	O
injection	O
of	O
anti	O
-	O
gene1s	O
IL-17	O
gene1e	O
antibody	O
in	O
tumor	O
-	O
bearing	O
C3H	O
/	O
HeN	O
species1s	O
mice	O
species1e	O
in	O
the	O
absence	O
of	O
Spirulina	O
LPS	O
markedly	O
suppressed	O
tumor	O
growth	O
and	O
augmented	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
responses	O
.	O
Thus	O
,	O
our	O
results	O
support	O
the	O
notion	O
that	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
and	O
gene1s	O
IL-17	O
gene1e	O
/	O
gene1s	O
IL-23	O
gene1e	O
mutually	O
regulate	O
Th17	O
and	O
Th1	O
responses	O
in	O
tumor	O
-	O
bearing	O
hosts	O
,	O
and	O
Spirulina	O
LPS	O
modulates	O
the	O
balance	O
of	O
the	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
-	O
gene1s	O
IL-17	O
gene1e	O
/	O
gene1s	O
IL-23	O
gene1e	O
axis	O
towards	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
production	O
,	O
which	O
leads	O
to	O
tumor	O
inhibition	O
.	O
Furthermore	O
,	O
Spirulina	O
LPS	O
effectively	O
inhibited	O
the	O
spontaneous	O
development	O
of	O
mammary	O
tumors	O
.	O
This	O
study	O
has	O
important	O
implications	O
for	O
the	O
exploitation	O
of	O
TLR	O
-	O
based	O
immunomodulators	O
for	O
cancer	O
immunotherapy	O
.	O

gene1s	ARG2
Bach1	ARG2
gene1e	ARG2
siRNA	O
attenuates	O
bleomycin	O
-	O
induced	O
pulmonary	O
fibrosis	O
by	O
modulating	O
oxidative	O
stress	O
in	O
arg1s	O
mice	O
arg1e	O
.	O
Oxidative	O
stress	O
plays	O
an	O
essential	O
role	O
in	O
inflammation	O
and	O
fibrosis	O
.	O
gene1s	ARG2
Bach1	ARG2
gene1e	ARG2
is	O
an	O
important	O
transcriptional	O
repressor	O
that	O
acts	O
by	O
modulating	O
oxidative	O
stress	O
and	O
represents	O
a	O
potential	O
target	O
in	O
the	O
treatment	O
of	O
pulmonary	O
fibrosis	O
(	O
PF	O
)	O
.	O
In	O
this	O
study	O
,	O
we	O
knocked	O
down	O
gene1s	ARG2
Bach1	ARG2
gene1e	ARG2
using	O
species1s	O
adenovirus	O
species1e	O
-	O
mediated	O
small	O
interfering	O
RNA	O
(	O
siRNA	O
)	O
to	O
determine	O
whether	O
the	O
use	O
of	O
gene1s	ARG2
Bach1	ARG2
gene1e	ARG2
siRNA	O
is	O
an	O
effective	O
therapeutic	O
strategy	O
in	O
arg1s	O
mice	O
arg1e	O
with	O
bleomycin	O
(	O
BLM)-induced	O
PF	O
.	O
arg1s	O
Mouse	O
arg1e	O
lung	O
fibroblasts	O
(	O
MLFs	O
)	O
were	O
incubated	O
with	O
gene1s	ARG2
transforming	ARG2
growth	ARG2
factor	ARG2
(	ARG2
TGF)-b1	ARG2
gene1e	ARG2
(	O
5	O
ng	O
/	O
ml	O
)	O
and	O
subsequently	O
infected	O
with	O
recombined	O
species1s	O
adenovirus	O
species1e	O
-	O
like	O
gene1s	ARG2
Bach1	ARG2
gene1e	ARG2
siRNA1	O
and	O
gene1s	ARG2
Bach1	ARG2
gene1e	ARG2
siRNA2	O
,	O
while	O
an	O
empty	O
species1s	O
adenovirus	O
species1e	O
vector	O
was	O
used	O
as	O
the	O
negative	O
control	O
.	O
The	O
selected	O
gene1s	ARG2
Bach1	ARG2
gene1e	ARG2
siRNA	O
with	O
higher	O
interference	O
efficiency	O
was	O
used	O
for	O
the	O
animal	O
experiments	O
.	O
A	O
arg1s	O
mouse	O
arg1e	O
model	O
of	O
BLM	O
-	O
induced	O
PF	O
was	O
established	O
,	O
and	O
gene1s	ARG2
Bach1	ARG2
gene1e	ARG2
siRNA	O
(	O
1x109	O
pfu	O
)	O
was	O
administered	O
to	O
the	O
arg1s	O
mice	O
arg1e	O
via	O
the	O
tail	O
vein	O
.	O
The	O
results	O
revealed	O
that	O
the	O
gene1s	ARG2
Bach1	ARG2
gene1e	ARG2
mRNA	O
and	O
protein	O
levels	O
were	O
significantly	O
downregulated	O
by	O
gene1s	ARG2
Bach1	ARG2
gene1e	ARG2
siRNA	O
.	O
Furthermore	O
,	O
the	O
MLFs	O
infected	O
with	O
gene1s	ARG2
Bach1	ARG2
gene1e	ARG2
siRNA	O
exhibited	O
increased	O
mRNA	O
and	O
protein	O
expression	O
levels	O
of	O
gene1s	ARG2
heme	ARG2
oxygenase-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
glutathione	ARG2
peroxidase	ARG2
1	ARG2
gene1e	ARG2
,	O
but	O
decreased	O
levels	O
of	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
interleukin-6	ARG2
gene1e	ARG2
in	O
the	O
cell	O
supernatants	O
compared	O
with	O
the	O
cells	O
exposed	O
to	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b1	ARG2
gene1e	ARG2
alone	O
.	O
gene1s	ARG2
Bach1	ARG2
gene1e	ARG2
knockdown	O
by	O
siRNA	O
also	O
enhanced	O
the	O
expression	O
of	O
antioxidant	O
factors	O
,	O
but	O
suppressed	O
that	O
of	O
fibrosis	O
-	O
related	O
cytokines	O
in	O
arg1s	O
mice	O
arg1e	O
compared	O
with	O
the	O
BLM	O
group	O
.	O
Finally	O
,	O
the	O
inflammatory	O
infiltration	O
of	O
alveolar	O
and	O
interstitial	O
cells	O
and	O
the	O
destruction	O
of	O
lung	O
structure	O
were	O
significantly	O
attenuated	O
in	O
the	O
mide	O
administered	O
gene1s	ARG2
Bach1	ARG2
gene1e	ARG2
siRNA	O
compared	O
with	O
those	O
in	O
the	O
BLM	O
group	O
.	O
On	O
the	O
whole	O
,	O
our	O
findings	O
demonstrate	O
that	O
gene1s	ARG2
Bach1	ARG2
gene1e	ARG2
siRNA	O
exerts	O
protective	O
effects	O
against	O
BLM	O
-	O
induced	O
PF	O
in	O
arg1s	O
mice	O
arg1e	O
.	O
Our	O
data	O
may	O
provide	O
the	O
basis	O
for	O
the	O
development	O
of	O
novel	O
targeted	O
therapeutic	O
strategies	O
for	O
PF	O
.	O

gene1s	O
Bach1	O
gene1e	O
siRNA	O
attenuates	O
bleomycin	O
-	O
induced	O
pulmonary	O
fibrosis	O
by	O
modulating	O
oxidative	O
stress	O
in	O
species1s	O
mice	O
species1e	O
.	O
Oxidative	O
stress	O
plays	O
an	O
essential	O
role	O
in	O
inflammation	O
and	O
fibrosis	O
.	O
gene1s	O
Bach1	O
gene1e	O
is	O
an	O
important	O
transcriptional	O
repressor	O
that	O
acts	O
by	O
modulating	O
oxidative	O
stress	O
and	O
represents	O
a	O
potential	O
target	O
in	O
the	O
treatment	O
of	O
pulmonary	O
fibrosis	O
(	O
PF	O
)	O
.	O
In	O
this	O
study	O
,	O
we	O
knocked	O
down	O
gene1s	O
Bach1	O
gene1e	O
using	O
arg1s	O
adenovirus	O
arg1e	O
-	O
mediated	O
small	O
interfering	O
RNA	O
(	O
siRNA	O
)	O
to	O
determine	O
whether	O
the	O
use	O
of	O
gene1s	O
Bach1	O
gene1e	O
siRNA	O
is	O
an	O
effective	O
therapeutic	O
strategy	O
in	O
species1s	O
mice	O
species1e	O
with	O
bleomycin	O
(	O
BLM)-induced	O
PF	O
.	O
species1s	O
Mouse	O
species1e	O
lung	O
fibroblasts	O
(	O
MLFs	O
)	O
were	O
incubated	O
with	O
gene1s	O
transforming	O
growth	O
factor	O
(	O
TGF)-b1	O
gene1e	O
(	O
5	O
ng	O
/	O
ml	O
)	O
and	O
subsequently	O
infected	O
with	O
recombined	O
arg1s	O
adenovirus	O
arg1e	O
-	O
like	O
gene1s	O
Bach1	O
gene1e	O
siRNA1	O
and	O
gene1s	O
Bach1	O
gene1e	O
siRNA2	O
,	O
while	O
an	O
empty	O
arg1s	O
adenovirus	O
arg1e	O
vector	O
was	O
used	O
as	O
the	O
negative	O
control	O
.	O
The	O
selected	O
gene1s	O
Bach1	O
gene1e	O
siRNA	O
with	O
higher	O
interference	O
efficiency	O
was	O
used	O
for	O
the	O
animal	O
experiments	O
.	O
A	O
species1s	O
mouse	O
species1e	O
model	O
of	O
BLM	O
-	O
induced	O
PF	O
was	O
established	O
,	O
and	O
gene1s	O
Bach1	O
gene1e	O
siRNA	O
(	O
1x109	O
pfu	O
)	O
was	O
administered	O
to	O
the	O
species1s	O
mice	O
species1e	O
via	O
the	O
tail	O
vein	O
.	O
The	O
results	O
revealed	O
that	O
the	O
gene1s	O
Bach1	O
gene1e	O
mRNA	O
and	O
protein	O
levels	O
were	O
significantly	O
downregulated	O
by	O
gene1s	O
Bach1	O
gene1e	O
siRNA	O
.	O
Furthermore	O
,	O
the	O
MLFs	O
infected	O
with	O
gene1s	O
Bach1	O
gene1e	O
siRNA	O
exhibited	O
increased	O
mRNA	O
and	O
protein	O
expression	O
levels	O
of	O
gene1s	O
heme	O
oxygenase-1	O
gene1e	O
and	O
gene1s	O
glutathione	O
peroxidase	O
1	O
gene1e	O
,	O
but	O
decreased	O
levels	O
of	O
gene1s	O
TGF	O
-	O
b1	O
gene1e	O
and	O
gene1s	O
interleukin-6	O
gene1e	O
in	O
the	O
cell	O
supernatants	O
compared	O
with	O
the	O
cells	O
exposed	O
to	O
gene1s	O
TGF	O
-	O
b1	O
gene1e	O
alone	O
.	O
gene1s	O
Bach1	O
gene1e	O
knockdown	O
by	O
siRNA	O
also	O
enhanced	O
the	O
expression	O
of	O
antioxidant	O
factors	O
,	O
but	O
suppressed	O
that	O
of	O
fibrosis	O
-	O
related	O
cytokines	O
in	O
species1s	O
mice	O
species1e	O
compared	O
with	O
the	O
BLM	O
group	O
.	O
Finally	O
,	O
the	O
inflammatory	O
infiltration	O
of	O
alveolar	O
and	O
interstitial	O
cells	O
and	O
the	O
destruction	O
of	O
lung	O
structure	O
were	O
significantly	O
attenuated	O
in	O
the	O
mide	O
administered	O
gene1s	O
Bach1	O
gene1e	O
siRNA	O
compared	O
with	O
those	O
in	O
the	O
BLM	O
group	O
.	O
On	O
the	O
whole	O
,	O
our	O
findings	O
demonstrate	O
that	O
gene1s	O
Bach1	O
gene1e	O
siRNA	O
exerts	O
protective	O
effects	O
against	O
BLM	O
-	O
induced	O
PF	O
in	O
species1s	O
mice	O
species1e	O
.	O
Our	O
data	O
may	O
provide	O
the	O
basis	O
for	O
the	O
development	O
of	O
novel	O
targeted	O
therapeutic	O
strategies	O
for	O
PF	O
.	O

Reversal	O
of	O
ischemic	O
cardiomyopathy	O
with	O
gene1s	ARG2
Sca-1	ARG2
gene1e	ARG2
+	O
stem	O
cells	O
modified	O
with	O
multiple	O
gene1s	O
growth	O
factors	O
gene1e	O
.	O
BACKGROUND	O
:	O
We	O
hypothesized	O
that	O
bone	O
marrow	O
derived	O
gene1s	ARG2
Sca-1	ARG2
gene1e	ARG2
+	O
stem	O
cells	O
(	O
BM	O
gene1s	ARG2
Sca-1	ARG2
gene1e	ARG2
+	O
)	O
transduced	O
with	O
multiple	O
therapeutic	O
cytokines	O
with	O
diverse	O
effects	O
will	O
induce	O
faster	O
angiomyogenic	O
differentiation	O
in	O
the	O
infarcted	O
myocardium	O
.	O
METHODS	O
AND	O
RESULTS	O
:	O
BM	O
gene1s	ARG2
Sca-1	ARG2
gene1e	ARG2
+	O
were	O
purified	O
from	O
transgenic	O
male	O
arg1s	O
mice	O
arg1e	O
expressing	O
GFP	O
.	O
Plasmids	O
encoding	O
for	O
select	O
quartet	O
of	O
growth	O
factors	O
,	O
i.e.	O
,	O
species1s	O
human	O
species1e	O
gene1s	O
IGF-1	O
gene1e	O
,	O
gene1s	O
VEGF	O
gene1e	O
,	O
gene1s	O
SDF-1a	O
gene1e	O
and	O
gene1s	O
HGF	O
gene1e	O
were	O
prepared	O
and	O
used	O
for	O
genetic	O
modification	O
of	O
gene1s	ARG2
Sca-1	ARG2
gene1e	ARG2
+	O
cells	O
(	O
GF	O
gene1s	ARG2
Sca-1	ARG2
+	ARG2
gene1e	ARG2
)	O
.	O
Scramble	O
transfected	O
cells	O
(	O
Sc	O
gene1s	ARG2
Sca-1	ARG2
+	ARG2
gene1e	ARG2
)	O
were	O
used	O
as	O
a	O
control	O
.	O
RT	O
-	O
PCR	O
and	O
western	O
blotting	O
showed	O
significantly	O
higher	O
expression	O
of	O
the	O
growth	O
factors	O
in	O
GF	O
gene1s	ARG2
Sca-1	ARG2
+	ARG2
gene1e	ARG2
.	O
Besides	O
the	O
quartet	O
of	O
the	O
therapeutic	O
growth	O
factors	O
,	O
PCR	O
based	O
growth	O
factor	O
array	O
showed	O
upregulation	O
of	O
multiple	O
angiogenic	O
and	O
prosurvival	O
factors	O
such	O
as	O
gene1s	ARG2
Ang-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Ang-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MMP9	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Cx43	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
BMP2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
BMP5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
FGF2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
NGF	ARG2
gene1e	ARG2
in	O
GF	O
gene1s	ARG2
Sca-1	ARG2
+	ARG2
gene1e	ARG2
(	O
p<0.01	O
vs	O
Sc	O
gene1s	ARG2
Sca-1	ARG2
+	ARG2
gene1e	ARG2
)	O
.	O
LDH	O
and	O
TUNEL	O
assays	O
showed	O
enhanced	O
survival	O
of	O
GF	O
gene1s	ARG2
Sca-1	ARG2
+	ARG2
gene1e	ARG2
under	O
lethal	O
anoxia	O
(	O
p<0.01	O
vs	O
Sc	O
gene1s	ARG2
Sca-1	ARG2
+	ARG2
gene1e	ARG2
)	O
.	O
MTS	O
assay	O
showed	O
significant	O
increased	O
cell	O
proliferation	O
in	O
GF	O
gene1s	ARG2
Sca-1	ARG2
+	ARG2
gene1e	ARG2
(	O
p<0.05	O
vs	O
Sc	O
gene1s	ARG2
Sca-1	ARG2
+	ARG2
gene1e	ARG2
)	O
.	O
For	O
in	O
vivo	O
study	O
,	O
female	O
arg1s	O
mice	O
arg1e	O
were	O
grouped	O
to	O
receive	O
the	O
intramyocardial	O
injection	O
of	O
15	O
ul	O
DMEM	O
without	O
cells	O
(	O
group-1	O
)	O
or	O
containing	O
2.5	O
x	O
10(5	O
)	O
Sc	O
gene1s	ARG2
Sca-1	ARG2
+	ARG2
gene1e	ARG2
(	O
group-2	O
)	O
or	O
GF	O
gene1s	ARG2
Sca-1	ARG2
+	ARG2
gene1e	ARG2
(	O
group-3	O
)	O
immediately	O
after	O
coronary	O
artery	O
ligation	O
.	O
As	O
indicated	O
by	O
gene1s	ARG2
Sry	ARG2
gene1e	ARG2
gene	O
,	O
a	O
higher	O
survival	O
of	O
GF	O
gene1s	ARG2
Sca-1	ARG2
+	ARG2
gene1e	ARG2
in	O
group-3	O
on	O
day	O
4	O
(	O
2.3	O
fold	O
higher	O
vs	O
group-2	O
)	O
was	O
observed	O
with	O
massive	O
mobilization	O
of	O
stem	O
and	O
progenitor	O
cells	O
(	O
gene1s	ARG2
cKit	ARG2
gene1e	ARG2
+	O
,	O
gene1s	ARG2
Mdr1	ARG2
gene1e	ARG2
+	O
,	O
gene1s	ARG2
Cxcr4	ARG2
gene1e	ARG2
+	O
cells	O
)	O
.	O
Heart	O
tissue	O
sections	O
immunostained	O
for	O
gene1s	ARG2
actinin	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Cx43	ARG2
gene1e	ARG2
at	O
4	O
weeks	O
post	O
engraftment	O
showed	O
extensive	O
myofiber	O
formation	O
and	O
expression	O
of	O
gap	O
junctions	O
.	O
Immunostaining	O
for	O
gene1s	ARG2
vWF	ARG2
gene1e	ARG2
showed	O
increased	O
blood	O
vessel	O
density	O
in	O
both	O
peri	O
-	O
infarct	O
and	O
infarct	O
regions	O
in	O
group-3	O
.	O
Infarct	O
size	O
was	O
attenuated	O
and	O
the	O
global	O
heart	O
function	O
was	O
improved	O
in	O
group-3	O
as	O
compared	O
to	O
group-2	O
.	O
CONCLUSIONS	O
:	O
Administration	O
of	O
BM	O
gene1s	ARG2
Sca-1	ARG2
gene1e	ARG2
+	O
transduced	O
with	O
multiple	O
genes	O
is	O
a	O
novel	O
approach	O
to	O
treat	O
infarcted	O
heart	O
for	O
its	O
regeneration	O
.	O

Reversal	O
of	O
ischemic	O
cardiomyopathy	O
with	O
gene1s	O
Sca-1	O
gene1e	O
+	O
stem	O
cells	O
modified	O
with	O
multiple	O
gene1s	ARG2
growth	ARG2
factors	ARG2
gene1e	ARG2
.	O
BACKGROUND	O
:	O
We	O
hypothesized	O
that	O
bone	O
marrow	O
derived	O
gene1s	O
Sca-1	O
gene1e	O
+	O
stem	O
cells	O
(	O
BM	O
gene1s	O
Sca-1	O
gene1e	O
+	O
)	O
transduced	O
with	O
multiple	O
therapeutic	O
cytokines	O
with	O
diverse	O
effects	O
will	O
induce	O
faster	O
angiomyogenic	O
differentiation	O
in	O
the	O
infarcted	O
myocardium	O
.	O
METHODS	O
AND	O
RESULTS	O
:	O
BM	O
gene1s	O
Sca-1	O
gene1e	O
+	O
were	O
purified	O
from	O
transgenic	O
male	O
species1s	O
mice	O
species1e	O
expressing	O
GFP	O
.	O
Plasmids	O
encoding	O
for	O
select	O
quartet	O
of	O
growth	O
factors	O
,	O
i.e.	O
,	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
IGF-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SDF-1a	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
HGF	ARG2
gene1e	ARG2
were	O
prepared	O
and	O
used	O
for	O
genetic	O
modification	O
of	O
gene1s	O
Sca-1	O
gene1e	O
+	O
cells	O
(	O
GF	O
gene1s	O
Sca-1	O
+	O
gene1e	O
)	O
.	O
Scramble	O
transfected	O
cells	O
(	O
Sc	O
gene1s	O
Sca-1	O
+	O
gene1e	O
)	O
were	O
used	O
as	O
a	O
control	O
.	O
RT	O
-	O
PCR	O
and	O
western	O
blotting	O
showed	O
significantly	O
higher	O
expression	O
of	O
the	O
growth	O
factors	O
in	O
GF	O
gene1s	O
Sca-1	O
+	O
gene1e	O
.	O
Besides	O
the	O
quartet	O
of	O
the	O
therapeutic	O
growth	O
factors	O
,	O
PCR	O
based	O
growth	O
factor	O
array	O
showed	O
upregulation	O
of	O
multiple	O
angiogenic	O
and	O
prosurvival	O
factors	O
such	O
as	O
gene1s	O
Ang-1	O
gene1e	O
,	O
gene1s	O
Ang-2	O
gene1e	O
,	O
gene1s	O
MMP9	O
gene1e	O
,	O
gene1s	O
Cx43	O
gene1e	O
,	O
gene1s	O
BMP2	O
gene1e	O
,	O
gene1s	O
BMP5	O
gene1e	O
,	O
gene1s	O
FGF2	O
gene1e	O
,	O
and	O
gene1s	O
NGF	O
gene1e	O
in	O
GF	O
gene1s	O
Sca-1	O
+	O
gene1e	O
(	O
p<0.01	O
vs	O
Sc	O
gene1s	O
Sca-1	O
+	O
gene1e	O
)	O
.	O
LDH	O
and	O
TUNEL	O
assays	O
showed	O
enhanced	O
survival	O
of	O
GF	O
gene1s	O
Sca-1	O
+	O
gene1e	O
under	O
lethal	O
anoxia	O
(	O
p<0.01	O
vs	O
Sc	O
gene1s	O
Sca-1	O
+	O
gene1e	O
)	O
.	O
MTS	O
assay	O
showed	O
significant	O
increased	O
cell	O
proliferation	O
in	O
GF	O
gene1s	O
Sca-1	O
+	O
gene1e	O
(	O
p<0.05	O
vs	O
Sc	O
gene1s	O
Sca-1	O
+	O
gene1e	O
)	O
.	O
For	O
in	O
vivo	O
study	O
,	O
female	O
species1s	O
mice	O
species1e	O
were	O
grouped	O
to	O
receive	O
the	O
intramyocardial	O
injection	O
of	O
15	O
ul	O
DMEM	O
without	O
cells	O
(	O
group-1	O
)	O
or	O
containing	O
2.5	O
x	O
10(5	O
)	O
Sc	O
gene1s	O
Sca-1	O
+	O
gene1e	O
(	O
group-2	O
)	O
or	O
GF	O
gene1s	O
Sca-1	O
+	O
gene1e	O
(	O
group-3	O
)	O
immediately	O
after	O
coronary	O
artery	O
ligation	O
.	O
As	O
indicated	O
by	O
gene1s	O
Sry	O
gene1e	O
gene	O
,	O
a	O
higher	O
survival	O
of	O
GF	O
gene1s	O
Sca-1	O
+	O
gene1e	O
in	O
group-3	O
on	O
day	O
4	O
(	O
2.3	O
fold	O
higher	O
vs	O
group-2	O
)	O
was	O
observed	O
with	O
massive	O
mobilization	O
of	O
stem	O
and	O
progenitor	O
cells	O
(	O
gene1s	O
cKit	O
gene1e	O
+	O
,	O
gene1s	O
Mdr1	O
gene1e	O
+	O
,	O
gene1s	O
Cxcr4	O
gene1e	O
+	O
cells	O
)	O
.	O
Heart	O
tissue	O
sections	O
immunostained	O
for	O
gene1s	O
actinin	O
gene1e	O
and	O
gene1s	O
Cx43	O
gene1e	O
at	O
4	O
weeks	O
post	O
engraftment	O
showed	O
extensive	O
myofiber	O
formation	O
and	O
expression	O
of	O
gap	O
junctions	O
.	O
Immunostaining	O
for	O
gene1s	O
vWF	O
gene1e	O
showed	O
increased	O
blood	O
vessel	O
density	O
in	O
both	O
peri	O
-	O
infarct	O
and	O
infarct	O
regions	O
in	O
group-3	O
.	O
Infarct	O
size	O
was	O
attenuated	O
and	O
the	O
global	O
heart	O
function	O
was	O
improved	O
in	O
group-3	O
as	O
compared	O
to	O
group-2	O
.	O
CONCLUSIONS	O
:	O
Administration	O
of	O
BM	O
gene1s	O
Sca-1	O
gene1e	O
+	O
transduced	O
with	O
multiple	O
genes	O
is	O
a	O
novel	O
approach	O
to	O
treat	O
infarcted	O
heart	O
for	O
its	O
regeneration	O
.	O

Deletion	O
of	O
gene1s	ARG2
growth	ARG2
hormone	ARG2
receptor	ARG2
gene1e	ARG2
gene	O
but	O
not	O
visceral	O
fat	O
removal	O
decreases	O
expression	O
of	O
gene1s	ARG2
apoptosis	ARG2
-	ARG2
related	ARG2
genes	ARG2
gene1e	ARG2
in	O
the	O
kidney	O
-	O
potential	O
mechanism	O
of	O
lifespan	O
extension	O
.	O
arg1s	O
Mice	O
arg1e	O
homozygous	O
for	O
the	O
targeted	O
disruption	O
of	O
the	O
gene1s	ARG2
growth	ARG2
hormone	ARG2
(	ARG2
GH	ARG2
)	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Ghr	ARG2
gene1e	ARG2
)	O
gene	O
(	O
gene1s	ARG2
GH	ARG2
receptor	ARG2
gene1e	ARG2
knockout	O
;	O
GHRKO	O
;	O
KO	O
)	O
are	O
hypoinsulinemic	O
,	O
highly	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
sensitive	O
,	O
normoglycemic	O
,	O
and	O
long	O
-	O
lived	O
.	O
Visceral	O
fat	O
removal	O
(	O
VFR	O
)	O
is	O
a	O
surgical	O
intervention	O
which	O
improves	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
signaling	O
in	O
normal	O
(	O
N	O
)	O
arg1s	O
mice	O
arg1e	O
and	O
species1s	O
rats	O
species1e	O
and	O
extends	O
longevity	O
in	O
species1s	O
rats	O
species1e	O
.	O
We	O
have	O
previously	O
demonstrated	O
decreased	O
expression	O
level	O
of	O
certain	O
gene1s	ARG2
pro	ARG2
-	ARG2
apoptotic	ARG2
genes	ARG2
gene1e	ARG2
in	O
skeletal	O
muscles	O
and	O
suggested	O
that	O
this	O
may	O
contribute	O
to	O
the	O
regulation	O
of	O
longevity	O
in	O
GHRKO	O
arg1s	O
mice	O
arg1e	O
.	O
Alterations	O
in	O
gene1s	ARG2
apoptosis	ARG2
-	ARG2
related	ARG2
genes	ARG2
gene1e	ARG2
expression	O
in	O
the	O
kidneys	O
also	O
may	O
potentially	O
lead	O
to	O
lifespan	O
extension	O
.	O
In	O
this	O
context	O
,	O
we	O
decided	O
to	O
examine	O
the	O
renal	O
expression	O
of	O
the	O
following	O
genes	O
:	O
gene1s	ARG2
caspase-3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
caspase-9	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
caspase-8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
bax	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
bad	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
bcl-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Smac	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
DIABLO	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Apaf-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
cytochrome	ARG2
c1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
cyc1	ARG2
gene1e	ARG2
)	O
in	O
male	O
GHRKO	O
and	O
N	O
arg1s	O
mice	O
arg1e	O
subjected	O
to	O
VFR	O
or	O
sham	O
surgery	O
,	O
at	O
approximately	O
6	O
months	O
of	O
age	O
.	O
The	O
kidneys	O
were	O
collected	O
2	O
months	O
after	O
VFR	O
.	O
As	O
a	O
result	O
,	O
gene1s	ARG2
caspase-3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
caspase-9	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
bax	ARG2
gene1e	ARG2
expressions	O
were	O
decreased	O
in	O
KO	O
arg1s	O
mice	O
arg1e	O
as	O
compared	O
to	O
N	O
animals	O
.	O
Expressions	O
of	O
gene1s	ARG2
Smac	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
DIABLO	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
caspase-8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
bcl-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
bad	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
did	O
not	O
differ	O
between	O
KOs	O
and	O
N	O
arg1s	O
mice	O
arg1e	O
.	O
VFR	O
did	O
not	O
change	O
the	O
expression	O
of	O
the	O
examined	O
genes	O
in	O
KO	O
or	O
N	O
arg1s	O
mice	O
arg1e	O
.	O
In	O
conclusion	O
,	O
endocrine	O
abnormalities	O
in	O
gene1s	ARG2
GHR	ARG2
gene1e	ARG2
KO	O
arg1s	O
mice	O
arg1e	O
result	O
in	O
decreased	O
expression	O
of	O
gene1s	ARG2
pro	ARG2
-	ARG2
apoptotic	ARG2
genes	ARG2
gene1e	ARG2
and	O
VFR	O
did	O
not	O
alter	O
the	O
examined	O
genes	O
expression	O
in	O
N	O
and	O
KO	O
arg1s	O
mice	O
arg1e	O
.	O
These	O
data	O
are	O
consistent	O
with	O
a	O
model	O
in	O
which	O
alterations	O
of	O
gene1s	ARG2
GH	ARG2
gene1e	ARG2
signaling	O
and/or	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
sensitivity	O
lead	O
to	O
increased	O
lifespan	O
mediated	O
by	O
decreased	O
renal	O
expression	O
of	O
gene1s	ARG2
pro	ARG2
-	ARG2
apoptotic	ARG2
genes	ARG2
gene1e	ARG2
.	O

Deletion	O
of	O
gene1s	O
growth	O
hormone	O
receptor	O
gene1e	O
gene	O
but	O
not	O
visceral	O
fat	O
removal	O
decreases	O
expression	O
of	O
gene1s	O
apoptosis	O
-	O
related	O
genes	O
gene1e	O
in	O
the	O
kidney	O
-	O
potential	O
mechanism	O
of	O
lifespan	O
extension	O
.	O
species1s	O
Mice	O
species1e	O
homozygous	O
for	O
the	O
targeted	O
disruption	O
of	O
the	O
gene1s	O
growth	O
hormone	O
(	O
GH	O
)	O
receptor	O
gene1e	O
(	O
gene1s	O
Ghr	O
gene1e	O
)	O
gene	O
(	O
gene1s	O
GH	O
receptor	O
gene1e	O
knockout	O
;	O
GHRKO	O
;	O
KO	O
)	O
are	O
hypoinsulinemic	O
,	O
highly	O
gene1s	O
insulin	O
gene1e	O
sensitive	O
,	O
normoglycemic	O
,	O
and	O
long	O
-	O
lived	O
.	O
Visceral	O
fat	O
removal	O
(	O
VFR	O
)	O
is	O
a	O
surgical	O
intervention	O
which	O
improves	O
gene1s	O
insulin	O
gene1e	O
signaling	O
in	O
normal	O
(	O
N	O
)	O
species1s	O
mice	O
species1e	O
and	O
arg1s	O
rats	O
arg1e	O
and	O
extends	O
longevity	O
in	O
arg1s	O
rats	O
arg1e	O
.	O
We	O
have	O
previously	O
demonstrated	O
decreased	O
expression	O
level	O
of	O
certain	O
gene1s	O
pro	O
-	O
apoptotic	O
genes	O
gene1e	O
in	O
skeletal	O
muscles	O
and	O
suggested	O
that	O
this	O
may	O
contribute	O
to	O
the	O
regulation	O
of	O
longevity	O
in	O
GHRKO	O
species1s	O
mice	O
species1e	O
.	O
Alterations	O
in	O
gene1s	O
apoptosis	O
-	O
related	O
genes	O
gene1e	O
expression	O
in	O
the	O
kidneys	O
also	O
may	O
potentially	O
lead	O
to	O
lifespan	O
extension	O
.	O
In	O
this	O
context	O
,	O
we	O
decided	O
to	O
examine	O
the	O
renal	O
expression	O
of	O
the	O
following	O
genes	O
:	O
gene1s	O
caspase-3	O
gene1e	O
,	O
gene1s	O
caspase-9	O
gene1e	O
,	O
gene1s	O
caspase-8	O
gene1e	O
,	O
gene1s	O
bax	O
gene1e	O
,	O
gene1s	O
bad	O
gene1e	O
,	O
gene1s	O
bcl-2	O
gene1e	O
,	O
gene1s	O
Smac	O
gene1e	O
/	O
gene1s	O
DIABLO	O
gene1e	O
,	O
gene1s	O
Apaf-1	O
gene1e	O
,	O
gene1s	O
p53	O
gene1e	O
,	O
and	O
gene1s	O
cytochrome	O
c1	O
gene1e	O
(	O
gene1s	O
cyc1	O
gene1e	O
)	O
in	O
male	O
GHRKO	O
and	O
N	O
species1s	O
mice	O
species1e	O
subjected	O
to	O
VFR	O
or	O
sham	O
surgery	O
,	O
at	O
approximately	O
6	O
months	O
of	O
age	O
.	O
The	O
kidneys	O
were	O
collected	O
2	O
months	O
after	O
VFR	O
.	O
As	O
a	O
result	O
,	O
gene1s	O
caspase-3	O
gene1e	O
,	O
gene1s	O
caspase-9	O
gene1e	O
,	O
and	O
gene1s	O
bax	O
gene1e	O
expressions	O
were	O
decreased	O
in	O
KO	O
species1s	O
mice	O
species1e	O
as	O
compared	O
to	O
N	O
animals	O
.	O
Expressions	O
of	O
gene1s	O
Smac	O
gene1e	O
/	O
gene1s	O
DIABLO	O
gene1e	O
,	O
gene1s	O
caspase-8	O
gene1e	O
,	O
gene1s	O
bcl-2	O
gene1e	O
,	O
gene1s	O
bad	O
gene1e	O
,	O
and	O
gene1s	O
p53	O
gene1e	O
did	O
not	O
differ	O
between	O
KOs	O
and	O
N	O
species1s	O
mice	O
species1e	O
.	O
VFR	O
did	O
not	O
change	O
the	O
expression	O
of	O
the	O
examined	O
genes	O
in	O
KO	O
or	O
N	O
species1s	O
mice	O
species1e	O
.	O
In	O
conclusion	O
,	O
endocrine	O
abnormalities	O
in	O
gene1s	O
GHR	O
gene1e	O
KO	O
species1s	O
mice	O
species1e	O
result	O
in	O
decreased	O
expression	O
of	O
gene1s	O
pro	O
-	O
apoptotic	O
genes	O
gene1e	O
and	O
VFR	O
did	O
not	O
alter	O
the	O
examined	O
genes	O
expression	O
in	O
N	O
and	O
KO	O
species1s	O
mice	O
species1e	O
.	O
These	O
data	O
are	O
consistent	O
with	O
a	O
model	O
in	O
which	O
alterations	O
of	O
gene1s	O
GH	O
gene1e	O
signaling	O
and/or	O
gene1s	O
insulin	O
gene1e	O
sensitivity	O
lead	O
to	O
increased	O
lifespan	O
mediated	O
by	O
decreased	O
renal	O
expression	O
of	O
gene1s	O
pro	O
-	O
apoptotic	O
genes	O
gene1e	O
.	O

Subtilase	O
cytotoxin	O
induces	O
apoptosis	O
in	O
arg1s	O
HeLa	O
arg1e	O
cells	O
by	O
mitochondrial	O
permeabilization	O
via	O
activation	O
of	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Bak	ARG2
gene1e	ARG2
,	O
independent	O
of	O
gene1s	ARG2
C	ARG2
/	ARG2
EBF	ARG2
-	ARG2
homologue	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CHOP	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
Ire1alpha	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
signaling	O
.	O
Subtilase	O
cytotoxin	O
(	O
SubAB	O
)	O
is	O
an	O
AB(5	O
)	O
cytotoxin	O
produced	O
by	O
some	O
strains	O
of	O
Shiga	O
-	O
toxigenic	O
species1s	O
Escherichia	O
coli	O
species1e	O
.	O
The	O
gene1s	O
A	O
subunit	O
gene1e	O
is	O
a	O
gene1s	O
subtilase	O
-	O
like	O
serine	O
protease	O
gene1e	O
and	O
cleaves	O
an	O
gene1s	ARG2
endoplasmic	ARG2
reticulum	ARG2
(	ARG2
ER	ARG2
)	ARG2
chaperone	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
BiP	ARG2
gene1e	ARG2
,	O
leading	O
to	O
transient	O
inhibition	O
of	O
protein	O
synthesis	O
and	O
cell	O
cycle	O
arrest	O
at	O
G(1	O
)	O
phase	O
,	O
and	O
inducing	O
gene1s	ARG2
caspase	ARG2
gene1e	ARG2
-	O
dependent	O
apoptosis	O
via	O
mitochondrial	O
membrane	O
damage	O
in	O
species1s	O
Vero	O
species1e	O
cells	O
.	O
Here	O
we	O
investigated	O
the	O
mechanism	O
of	O
mitochondrial	O
permeabilization	O
in	O
arg1s	O
HeLa	O
arg1e	O
cells	O
.	O
SubAB	O
-	O
induced	O
gene1s	ARG2
cytochrome	ARG2
c	ARG2
gene1e	ARG2
release	O
into	O
cytosol	O
did	O
not	O
depend	O
on	O
mitochondrial	O
permeability	O
transition	O
pore	O
(	O
PTP	O
)	O
,	O
since	O
cyclosporine	O
A	O
did	O
not	O
suppress	O
gene1s	ARG2
cytochrome	ARG2
c	ARG2
gene1e	ARG2
release	O
.	O
SubAB	O
did	O
not	O
change	O
the	O
expression	O
of	O
anti	O
-	O
apoptotic	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
Bcl	ARG2
-	ARG2
XL	ARG2
gene1e	ARG2
and	O
pro	O
-	O
apoptotic	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
Bak	ARG2
gene1e	ARG2
,	O
but	O
triggered	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Bak	ARG2
gene1e	ARG2
conformational	O
changes	O
and	O
association	O
of	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
with	O
gene1s	ARG2
Bak	ARG2
gene1e	ARG2
.	O
Silencing	O
using	O
siRNA	O
of	O
both	O
gene1s	ARG2
bax	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
bak	ARG2
gene1e	ARG2
genes	O
,	O
but	O
not	O
gene1s	ARG2
bax	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
bak	ARG2
gene1e	ARG2
,	O
or	O
bim	O
alone	O
,	O
resulted	O
in	O
reduction	O
of	O
gene1s	ARG2
cytochrome	ARG2
c	ARG2
gene1e	ARG2
release	O
,	O
gene1s	ARG2
caspase-3	ARG2
gene1e	ARG2
activation	O
,	O
DNA	O
ladder	O
formation	O
and	O
cytotoxicity	O
,	O
indicating	O
that	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Bak	ARG2
gene1e	ARG2
were	O
involved	O
in	O
apoptosis	O
.	O
SubAB	O
activated	O
ER	O
transmembrane	O
transducers	O
,	O
gene1s	ARG2
Ire1alpha	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
cJun	ARG2
N	ARG2
-	ARG2
terminal	ARG2
kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
)	O
,	O
and	O
induced	O
gene1s	ARG2
C	ARG2
/	ARG2
EBF	ARG2
-	ARG2
homologue	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CHOP	ARG2
gene1e	ARG2
)	O
.	O
To	O
investigate	O
whether	O
these	O
signals	O
were	O
involved	O
in	O
gene1s	ARG2
cytochrome	ARG2
c	ARG2
gene1e	ARG2
release	O
by	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
activation	O
,	O
we	O
silenced	O
gene1s	ARG2
ire1alpha	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
jnk	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
chop	ARG2
gene1e	ARG2
;	O
however	O
,	O
silencing	O
did	O
not	O
decrease	O
SubAB	O
-	O
induced	O
gene1s	ARG2
cytochrome	ARG2
c	ARG2
gene1e	ARG2
release	O
,	O
suggesting	O
that	O
these	O
signals	O
were	O
not	O
necessary	O
for	O
SubAB	O
-	O
induced	O
mitochondrial	O
permeabilization	O
by	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
activation	O
.	O

Subtilase	O
cytotoxin	O
induces	O
apoptosis	O
in	O
species1s	O
HeLa	O
species1e	O
cells	O
by	O
mitochondrial	O
permeabilization	O
via	O
activation	O
of	O
gene1s	O
Bax	O
gene1e	O
/	O
gene1s	O
Bak	O
gene1e	O
,	O
independent	O
of	O
gene1s	O
C	O
/	O
EBF	O
-	O
homologue	O
protein	O
gene1e	O
(	O
gene1s	O
CHOP	O
gene1e	O
)	O
,	O
gene1s	O
Ire1alpha	O
gene1e	O
or	O
gene1s	O
JNK	O
gene1e	O
signaling	O
.	O
Subtilase	O
cytotoxin	O
(	O
SubAB	O
)	O
is	O
an	O
AB(5	O
)	O
cytotoxin	O
produced	O
by	O
some	O
strains	O
of	O
Shiga	O
-	O
toxigenic	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
.	O
The	O
gene1s	ARG2
A	ARG2
subunit	ARG2
gene1e	ARG2
is	O
a	O
gene1s	ARG2
subtilase	ARG2
-	ARG2
like	ARG2
serine	ARG2
protease	ARG2
gene1e	ARG2
and	O
cleaves	O
an	O
gene1s	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
chaperone	O
gene1e	O
,	O
gene1s	O
BiP	O
gene1e	O
,	O
leading	O
to	O
transient	O
inhibition	O
of	O
protein	O
synthesis	O
and	O
cell	O
cycle	O
arrest	O
at	O
G(1	O
)	O
phase	O
,	O
and	O
inducing	O
gene1s	O
caspase	O
gene1e	O
-	O
dependent	O
apoptosis	O
via	O
mitochondrial	O
membrane	O
damage	O
in	O
species1s	O
Vero	O
species1e	O
cells	O
.	O
Here	O
we	O
investigated	O
the	O
mechanism	O
of	O
mitochondrial	O
permeabilization	O
in	O
species1s	O
HeLa	O
species1e	O
cells	O
.	O
SubAB	O
-	O
induced	O
gene1s	O
cytochrome	O
c	O
gene1e	O
release	O
into	O
cytosol	O
did	O
not	O
depend	O
on	O
mitochondrial	O
permeability	O
transition	O
pore	O
(	O
PTP	O
)	O
,	O
since	O
cyclosporine	O
A	O
did	O
not	O
suppress	O
gene1s	O
cytochrome	O
c	O
gene1e	O
release	O
.	O
SubAB	O
did	O
not	O
change	O
the	O
expression	O
of	O
anti	O
-	O
apoptotic	O
gene1s	O
Bcl-2	O
gene1e	O
or	O
gene1s	O
Bcl	O
-	O
XL	O
gene1e	O
and	O
pro	O
-	O
apoptotic	O
gene1s	O
Bax	O
gene1e	O
or	O
gene1s	O
Bak	O
gene1e	O
,	O
but	O
triggered	O
gene1s	O
Bax	O
gene1e	O
and	O
gene1s	O
Bak	O
gene1e	O
conformational	O
changes	O
and	O
association	O
of	O
gene1s	O
Bax	O
gene1e	O
with	O
gene1s	O
Bak	O
gene1e	O
.	O
Silencing	O
using	O
siRNA	O
of	O
both	O
gene1s	O
bax	O
gene1e	O
and	O
gene1s	O
bak	O
gene1e	O
genes	O
,	O
but	O
not	O
gene1s	O
bax	O
gene1e	O
,	O
gene1s	O
bak	O
gene1e	O
,	O
or	O
bim	O
alone	O
,	O
resulted	O
in	O
reduction	O
of	O
gene1s	O
cytochrome	O
c	O
gene1e	O
release	O
,	O
gene1s	O
caspase-3	O
gene1e	O
activation	O
,	O
DNA	O
ladder	O
formation	O
and	O
cytotoxicity	O
,	O
indicating	O
that	O
gene1s	O
Bax	O
gene1e	O
and	O
gene1s	O
Bak	O
gene1e	O
were	O
involved	O
in	O
apoptosis	O
.	O
SubAB	O
activated	O
ER	O
transmembrane	O
transducers	O
,	O
gene1s	O
Ire1alpha	O
gene1e	O
,	O
and	O
gene1s	O
cJun	O
N	O
-	O
terminal	O
kinase	O
gene1e	O
(	O
gene1s	O
JNK	O
gene1e	O
)	O
,	O
and	O
induced	O
gene1s	O
C	O
/	O
EBF	O
-	O
homologue	O
protein	O
gene1e	O
(	O
gene1s	O
CHOP	O
gene1e	O
)	O
.	O
To	O
investigate	O
whether	O
these	O
signals	O
were	O
involved	O
in	O
gene1s	O
cytochrome	O
c	O
gene1e	O
release	O
by	O
gene1s	O
Bax	O
gene1e	O
activation	O
,	O
we	O
silenced	O
gene1s	O
ire1alpha	O
gene1e	O
,	O
gene1s	O
jnk	O
gene1e	O
or	O
gene1s	O
chop	O
gene1e	O
;	O
however	O
,	O
silencing	O
did	O
not	O
decrease	O
SubAB	O
-	O
induced	O
gene1s	O
cytochrome	O
c	O
gene1e	O
release	O
,	O
suggesting	O
that	O
these	O
signals	O
were	O
not	O
necessary	O
for	O
SubAB	O
-	O
induced	O
mitochondrial	O
permeabilization	O
by	O
gene1s	O
Bax	O
gene1e	O
activation	O
.	O

Subtilase	O
cytotoxin	O
induces	O
apoptosis	O
in	O
species1s	O
HeLa	O
species1e	O
cells	O
by	O
mitochondrial	O
permeabilization	O
via	O
activation	O
of	O
gene1s	O
Bax	O
gene1e	O
/	O
gene1s	O
Bak	O
gene1e	O
,	O
independent	O
of	O
gene1s	O
C	O
/	O
EBF	O
-	O
homologue	O
protein	O
gene1e	O
(	O
gene1s	O
CHOP	O
gene1e	O
)	O
,	O
gene1s	O
Ire1alpha	O
gene1e	O
or	O
gene1s	O
JNK	O
gene1e	O
signaling	O
.	O
Subtilase	O
cytotoxin	O
(	O
SubAB	O
)	O
is	O
an	O
AB(5	O
)	O
cytotoxin	O
produced	O
by	O
some	O
strains	O
of	O
Shiga	O
-	O
toxigenic	O
species1s	O
Escherichia	O
coli	O
species1e	O
.	O
The	O
gene1s	O
A	O
subunit	O
gene1e	O
is	O
a	O
gene1s	O
subtilase	O
-	O
like	O
serine	O
protease	O
gene1e	O
and	O
cleaves	O
an	O
gene1s	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
chaperone	O
gene1e	O
,	O
gene1s	O
BiP	O
gene1e	O
,	O
leading	O
to	O
transient	O
inhibition	O
of	O
protein	O
synthesis	O
and	O
cell	O
cycle	O
arrest	O
at	O
G(1	O
)	O
phase	O
,	O
and	O
inducing	O
gene1s	O
caspase	O
gene1e	O
-	O
dependent	O
apoptosis	O
via	O
mitochondrial	O
membrane	O
damage	O
in	O
arg1s	O
Vero	O
arg1e	O
cells	O
.	O
Here	O
we	O
investigated	O
the	O
mechanism	O
of	O
mitochondrial	O
permeabilization	O
in	O
species1s	O
HeLa	O
species1e	O
cells	O
.	O
SubAB	O
-	O
induced	O
gene1s	O
cytochrome	O
c	O
gene1e	O
release	O
into	O
cytosol	O
did	O
not	O
depend	O
on	O
mitochondrial	O
permeability	O
transition	O
pore	O
(	O
PTP	O
)	O
,	O
since	O
cyclosporine	O
A	O
did	O
not	O
suppress	O
gene1s	O
cytochrome	O
c	O
gene1e	O
release	O
.	O
SubAB	O
did	O
not	O
change	O
the	O
expression	O
of	O
anti	O
-	O
apoptotic	O
gene1s	O
Bcl-2	O
gene1e	O
or	O
gene1s	O
Bcl	O
-	O
XL	O
gene1e	O
and	O
pro	O
-	O
apoptotic	O
gene1s	O
Bax	O
gene1e	O
or	O
gene1s	O
Bak	O
gene1e	O
,	O
but	O
triggered	O
gene1s	O
Bax	O
gene1e	O
and	O
gene1s	O
Bak	O
gene1e	O
conformational	O
changes	O
and	O
association	O
of	O
gene1s	O
Bax	O
gene1e	O
with	O
gene1s	O
Bak	O
gene1e	O
.	O
Silencing	O
using	O
siRNA	O
of	O
both	O
gene1s	O
bax	O
gene1e	O
and	O
gene1s	O
bak	O
gene1e	O
genes	O
,	O
but	O
not	O
gene1s	O
bax	O
gene1e	O
,	O
gene1s	O
bak	O
gene1e	O
,	O
or	O
bim	O
alone	O
,	O
resulted	O
in	O
reduction	O
of	O
gene1s	O
cytochrome	O
c	O
gene1e	O
release	O
,	O
gene1s	O
caspase-3	O
gene1e	O
activation	O
,	O
DNA	O
ladder	O
formation	O
and	O
cytotoxicity	O
,	O
indicating	O
that	O
gene1s	O
Bax	O
gene1e	O
and	O
gene1s	O
Bak	O
gene1e	O
were	O
involved	O
in	O
apoptosis	O
.	O
SubAB	O
activated	O
ER	O
transmembrane	O
transducers	O
,	O
gene1s	O
Ire1alpha	O
gene1e	O
,	O
and	O
gene1s	O
cJun	O
N	O
-	O
terminal	O
kinase	O
gene1e	O
(	O
gene1s	O
JNK	O
gene1e	O
)	O
,	O
and	O
induced	O
gene1s	O
C	O
/	O
EBF	O
-	O
homologue	O
protein	O
gene1e	O
(	O
gene1s	O
CHOP	O
gene1e	O
)	O
.	O
To	O
investigate	O
whether	O
these	O
signals	O
were	O
involved	O
in	O
gene1s	O
cytochrome	O
c	O
gene1e	O
release	O
by	O
gene1s	O
Bax	O
gene1e	O
activation	O
,	O
we	O
silenced	O
gene1s	O
ire1alpha	O
gene1e	O
,	O
gene1s	O
jnk	O
gene1e	O
or	O
gene1s	O
chop	O
gene1e	O
;	O
however	O
,	O
silencing	O
did	O
not	O
decrease	O
SubAB	O
-	O
induced	O
gene1s	O
cytochrome	O
c	O
gene1e	O
release	O
,	O
suggesting	O
that	O
these	O
signals	O
were	O
not	O
necessary	O
for	O
SubAB	O
-	O
induced	O
mitochondrial	O
permeabilization	O
by	O
gene1s	O
Bax	O
gene1e	O
activation	O
.	O

A	O
major	O
role	O
for	O
gene1s	ARG2
Scar	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
WAVE-1	ARG2
gene1e	ARG2
downstream	O
of	O
gene1s	ARG2
GPVI	ARG2
gene1e	ARG2
in	O
platelets	O
.	O
BACKGROUND	O
:	O
The	O
gene1s	ARG2
small	ARG2
GTPase	ARG2
gene1e	ARG2
gene1s	ARG2
Rac1	ARG2
gene1e	ARG2
plays	O
a	O
critical	O
role	O
in	O
lamellipodia	O
assembly	O
in	O
platelets	O
on	O
matrix	O
proteins	O
in	O
the	O
absence	O
or	O
presence	O
of	O
gene1s	ARG2
G	ARG2
protein	ARG2
-	ARG2
coupled	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
GPCR	ARG2
gene1e	ARG2
)	O
agonists	O
.	O
gene1s	ARG2
Rac	ARG2
gene1e	ARG2
mediates	O
actin	O
assembly	O
via	O
gene1s	ARG2
Scar	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
WAVE	ARG2
gene1e	ARG2
,	O
a	O
family	O
of	O
scaffolding	O
proteins	O
that	O
direct	O
gene1s	ARG2
actin	ARG2
gene1e	ARG2
reorganization	O
by	O
relaying	O
signals	O
from	O
gene1s	ARG2
Rac	ARG2
gene1e	ARG2
to	O
the	O
gene1s	ARG2
Arp2/3	ARG2
gene1e	ARG2
complex	O
.	O
OBJECTIVE	O
:	O
To	O
evaluate	O
the	O
role	O
of	O
gene1s	ARG2
Scar	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
WAVE-1	ARG2
gene1e	ARG2
in	O
mediating	O
platelet	O
activation	O
and	O
cytoskeletal	O
reorganization	O
.	O
METHODS	O
AND	O
RESULTS	O
:	O
Using	O
specific	O
antibodies	O
,	O
we	O
demonstrate	O
that	O
arg1s	O
murine	O
arg1e	O
platelets	O
,	O
like	O
species1s	O
human	O
species1e	O
platelets	O
,	O
express	O
gene1s	ARG2
Scar	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
WAVE-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Scar	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
WAVE-2	ARG2
gene1e	ARG2
.	O
Lamellipodia	O
formation	O
in	O
gene1s	ARG2
Scar	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
WAVE-1	ARG2
gene1e	ARG2
(-/-	O
)	O
platelets	O
is	O
markedly	O
inhibited	O
on	O
immobilized	O
gene1s	ARG2
collagen	ARG2
gene1e	ARG2
-	O
related	O
peptide	O
(	O
CRP	O
)	O
and	O
on	O
gene1s	ARG2
laminin	ARG2
gene1e	ARG2
,	O
both	O
of	O
which	O
signal	O
through	O
the	O
gene1s	ARG2
collagen	ARG2
receptor	ARG2
gene1e	ARG2
gene1s	ARG2
GPVI	ARG2
gene1e	ARG2
.	O
In	O
contrast	O
,	O
lamellipodia	O
formation	O
on	O
gene1s	ARG2
collagen	ARG2
gene1e	ARG2
,	O
which	O
requires	O
release	O
of	O
the	O
gene1s	ARG2
GPCR	ARG2
gene1e	ARG2
agonists	O
ADP	O
and	O
thromboxane	O
A(2	O
)	O
,	O
is	O
not	O
altered	O
.	O
Immobilized	O
gene1s	ARG2
fibrinogen	ARG2
gene1e	ARG2
supports	O
limited	O
formation	O
of	O
lamellipodia	O
in	O
arg1s	O
murine	O
arg1e	O
platelets	O
,	O
which	O
is	O
not	O
altered	O
in	O
gene1s	ARG2
Scar	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
WAVE-1	ARG2
gene1e	ARG2
(-/-	O
)	O
platelets	O
.	O
As	O
with	O
gene1s	ARG2
Rac1	ARG2
gene1e	ARG2
(-/-	O
)	O
platelets	O
,	O
gene1s	ARG2
Scar	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
WAVE-1	ARG2
gene1e	ARG2
(-/-	O
)	O
platelets	O
exhibit	O
a	O
marked	O
inhibition	O
of	O
aggregation	O
in	O
response	O
to	O
CRP	O
,	O
whereas	O
the	O
response	O
to	O
the	O
gene1s	ARG2
GPCR	ARG2
gene1e	ARG2
agonist	O
gene1s	ARG2
thrombin	ARG2
gene1e	ARG2
is	O
not	O
altered	O
.	O
Platelet	O
aggregation	O
on	O
immobilized	O
gene1s	ARG2
collagen	ARG2
gene1e	ARG2
under	O
shear	O
,	O
which	O
is	O
dependent	O
on	O
signaling	O
by	O
matrix	O
and	O
gene1s	ARG2
GPCR	ARG2
gene1e	ARG2
agonists	O
,	O
was	O
unaltered	O
in	O
the	O
absence	O
of	O
gene1s	ARG2
Scar	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
WAVE-1	ARG2
gene1e	ARG2
.	O
CONCLUSION	O
:	O
This	O
study	O
demonstrates	O
a	O
major	O
role	O
for	O
gene1s	ARG2
Scar	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
WAVE-1	ARG2
gene1e	ARG2
in	O
mediating	O
platelet	O
cytoskeletal	O
reorganization	O
and	O
aggregate	O
formation	O
downstream	O
of	O
activation	O
by	O
gene1s	ARG2
GPVI	ARG2
gene1e	ARG2
but	O
not	O
by	O
gene1s	ARG2
GPCR	ARG2
gene1e	ARG2
agonists	O
.	O

A	O
major	O
role	O
for	O
gene1s	O
Scar	O
gene1e	O
/	O
gene1s	O
WAVE-1	O
gene1e	O
downstream	O
of	O
gene1s	O
GPVI	O
gene1e	O
in	O
platelets	O
.	O
BACKGROUND	O
:	O
The	O
gene1s	O
small	O
GTPase	O
gene1e	O
gene1s	O
Rac1	O
gene1e	O
plays	O
a	O
critical	O
role	O
in	O
lamellipodia	O
assembly	O
in	O
platelets	O
on	O
matrix	O
proteins	O
in	O
the	O
absence	O
or	O
presence	O
of	O
gene1s	O
G	O
protein	O
-	O
coupled	O
receptor	O
gene1e	O
(	O
gene1s	O
GPCR	O
gene1e	O
)	O
agonists	O
.	O
gene1s	O
Rac	O
gene1e	O
mediates	O
actin	O
assembly	O
via	O
gene1s	O
Scar	O
gene1e	O
/	O
gene1s	O
WAVE	O
gene1e	O
,	O
a	O
family	O
of	O
scaffolding	O
proteins	O
that	O
direct	O
gene1s	O
actin	O
gene1e	O
reorganization	O
by	O
relaying	O
signals	O
from	O
gene1s	O
Rac	O
gene1e	O
to	O
the	O
gene1s	O
Arp2/3	O
gene1e	O
complex	O
.	O
OBJECTIVE	O
:	O
To	O
evaluate	O
the	O
role	O
of	O
gene1s	O
Scar	O
gene1e	O
/	O
gene1s	O
WAVE-1	O
gene1e	O
in	O
mediating	O
platelet	O
activation	O
and	O
cytoskeletal	O
reorganization	O
.	O
METHODS	O
AND	O
RESULTS	O
:	O
Using	O
specific	O
antibodies	O
,	O
we	O
demonstrate	O
that	O
species1s	O
murine	O
species1e	O
platelets	O
,	O
like	O
arg1s	O
human	O
arg1e	O
platelets	O
,	O
express	O
gene1s	O
Scar	O
gene1e	O
/	O
gene1s	O
WAVE-1	O
gene1e	O
and	O
gene1s	O
Scar	O
gene1e	O
/	O
gene1s	O
WAVE-2	O
gene1e	O
.	O
Lamellipodia	O
formation	O
in	O
gene1s	O
Scar	O
gene1e	O
/	O
gene1s	O
WAVE-1	O
gene1e	O
(-/-	O
)	O
platelets	O
is	O
markedly	O
inhibited	O
on	O
immobilized	O
gene1s	O
collagen	O
gene1e	O
-	O
related	O
peptide	O
(	O
CRP	O
)	O
and	O
on	O
gene1s	O
laminin	O
gene1e	O
,	O
both	O
of	O
which	O
signal	O
through	O
the	O
gene1s	O
collagen	O
receptor	O
gene1e	O
gene1s	O
GPVI	O
gene1e	O
.	O
In	O
contrast	O
,	O
lamellipodia	O
formation	O
on	O
gene1s	O
collagen	O
gene1e	O
,	O
which	O
requires	O
release	O
of	O
the	O
gene1s	O
GPCR	O
gene1e	O
agonists	O
ADP	O
and	O
thromboxane	O
A(2	O
)	O
,	O
is	O
not	O
altered	O
.	O
Immobilized	O
gene1s	O
fibrinogen	O
gene1e	O
supports	O
limited	O
formation	O
of	O
lamellipodia	O
in	O
species1s	O
murine	O
species1e	O
platelets	O
,	O
which	O
is	O
not	O
altered	O
in	O
gene1s	O
Scar	O
gene1e	O
/	O
gene1s	O
WAVE-1	O
gene1e	O
(-/-	O
)	O
platelets	O
.	O
As	O
with	O
gene1s	O
Rac1	O
gene1e	O
(-/-	O
)	O
platelets	O
,	O
gene1s	O
Scar	O
gene1e	O
/	O
gene1s	O
WAVE-1	O
gene1e	O
(-/-	O
)	O
platelets	O
exhibit	O
a	O
marked	O
inhibition	O
of	O
aggregation	O
in	O
response	O
to	O
CRP	O
,	O
whereas	O
the	O
response	O
to	O
the	O
gene1s	O
GPCR	O
gene1e	O
agonist	O
gene1s	O
thrombin	O
gene1e	O
is	O
not	O
altered	O
.	O
Platelet	O
aggregation	O
on	O
immobilized	O
gene1s	O
collagen	O
gene1e	O
under	O
shear	O
,	O
which	O
is	O
dependent	O
on	O
signaling	O
by	O
matrix	O
and	O
gene1s	O
GPCR	O
gene1e	O
agonists	O
,	O
was	O
unaltered	O
in	O
the	O
absence	O
of	O
gene1s	O
Scar	O
gene1e	O
/	O
gene1s	O
WAVE-1	O
gene1e	O
.	O
CONCLUSION	O
:	O
This	O
study	O
demonstrates	O
a	O
major	O
role	O
for	O
gene1s	O
Scar	O
gene1e	O
/	O
gene1s	O
WAVE-1	O
gene1e	O
in	O
mediating	O
platelet	O
cytoskeletal	O
reorganization	O
and	O
aggregate	O
formation	O
downstream	O
of	O
activation	O
by	O
gene1s	O
GPVI	O
gene1e	O
but	O
not	O
by	O
gene1s	O
GPCR	O
gene1e	O
agonists	O
.	O

gene1s	ARG2
Tcf19	ARG2
gene1e	ARG2
is	O
a	O
novel	O
islet	O
factor	O
necessary	O
for	O
proliferation	O
and	O
survival	O
in	O
the	O
arg1s	O
INS-1	O
arg1e	O
b	O
-	O
cell	O
line	O
.	O
Recently	O
,	O
a	O
novel	O
type	O
1	O
diabetes	O
association	O
locus	O
was	O
identified	O
at	O
species1s	O
human	O
species1e	O
chromosome	O
6p31.3	O
,	O
and	O
gene1s	O
transcription	O
factor	O
19	O
gene1e	O
(	O
gene1s	O
TCF19	O
gene1e	O
)	O
is	O
a	O
likely	O
causal	O
gene	O
.	O
Little	O
is	O
known	O
about	O
gene1s	ARG2
Tcf19	ARG2
gene1e	ARG2
,	O
and	O
we	O
now	O
show	O
that	O
it	O
plays	O
a	O
role	O
in	O
both	O
proliferation	O
and	O
apoptosis	O
in	O
insulinoma	O
cells	O
.	O
gene1s	O
Tcf19	O
gene1e	O
is	O
expressed	O
in	O
species1s	O
mouse	O
species1e	O
and	O
species1s	O
human	O
species1e	O
islets	O
,	O
with	O
increasing	O
mRNA	O
expression	O
in	O
nondiabetic	O
obesity	O
.	O
The	O
expression	O
of	O
gene1s	ARG2
Tcf19	ARG2
gene1e	ARG2
is	O
correlated	O
with	O
b	O
-	O
cell	O
mass	O
expansion	O
,	O
suggesting	O
that	O
it	O
may	O
be	O
a	O
transcriptional	O
regulator	O
of	O
b	O
-	O
cell	O
mass	O
.	O
Increasing	O
proliferation	O
and	O
decreasing	O
apoptotic	O
cell	O
death	O
are	O
two	O
strategies	O
to	O
increase	O
pancreatic	O
b	O
-	O
cell	O
mass	O
and	O
prevent	O
or	O
delay	O
diabetes	O
.	O
siRNA	O
-	O
mediated	O
knockdown	O
of	O
gene1s	ARG2
Tcf19	ARG2
gene1e	ARG2
in	O
the	O
arg1s	O
INS-1	O
arg1e	O
insulinoma	O
cell	O
line	O
,	O
a	O
b	O
-	O
cell	O
model	O
,	O
results	O
in	O
a	O
decrease	O
in	O
proliferation	O
and	O
an	O
increase	O
in	O
apoptosis	O
.	O
There	O
was	O
a	O
significant	O
reduction	O
in	O
the	O
expression	O
of	O
numerous	O
cell	O
cycle	O
genes	O
from	O
the	O
late	O
G1	O
phase	O
through	O
the	O
M	O
phase	O
,	O
and	O
cells	O
were	O
arrested	O
at	O
the	O
G1	O
/	O
S	O
checkpoint	O
.	O
We	O
also	O
observed	O
increased	O
apoptosis	O
and	O
susceptibility	O
to	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
stress	O
after	O
gene1s	ARG2
Tcf19	ARG2
gene1e	ARG2
knockdown	O
.	O
There	O
was	O
a	O
reduction	O
in	O
expression	O
of	O
genes	O
important	O
for	O
the	O
maintenance	O
of	O
ER	O
homeostasis	O
(	O
gene1s	ARG2
Bip	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
p58(IPK	ARG2
)	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Edem1	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
calreticulin	ARG2
gene1e	ARG2
)	O
and	O
an	O
increase	O
in	O
proapoptotic	O
genes	O
(	O
gene1s	ARG2
Bim	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Bid	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Nix	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Gadd34	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Pdia2	ARG2
gene1e	ARG2
)	O
.	O
Therefore	O
,	O
gene1s	ARG2
Tcf19	ARG2
gene1e	ARG2
is	O
necessary	O
for	O
both	O
proliferation	O
and	O
survival	O
and	O
is	O
a	O
novel	O
regulator	O
of	O
these	O
pathways	O
.	O

gene1s	O
Tcf19	O
gene1e	O
is	O
a	O
novel	O
islet	O
factor	O
necessary	O
for	O
proliferation	O
and	O
survival	O
in	O
the	O
species1s	O
INS-1	O
species1e	O
b	O
-	O
cell	O
line	O
.	O
Recently	O
,	O
a	O
novel	O
type	O
1	O
diabetes	O
association	O
locus	O
was	O
identified	O
at	O
arg1s	O
human	O
arg1e	O
chromosome	O
6p31.3	O
,	O
and	O
gene1s	ARG2
transcription	ARG2
factor	ARG2
19	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TCF19	ARG2
gene1e	ARG2
)	O
is	O
a	O
likely	O
causal	O
gene	O
.	O
Little	O
is	O
known	O
about	O
gene1s	O
Tcf19	O
gene1e	O
,	O
and	O
we	O
now	O
show	O
that	O
it	O
plays	O
a	O
role	O
in	O
both	O
proliferation	O
and	O
apoptosis	O
in	O
insulinoma	O
cells	O
.	O
gene1s	ARG2
Tcf19	ARG2
gene1e	ARG2
is	O
expressed	O
in	O
species1s	O
mouse	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
islets	O
,	O
with	O
increasing	O
mRNA	O
expression	O
in	O
nondiabetic	O
obesity	O
.	O
The	O
expression	O
of	O
gene1s	O
Tcf19	O
gene1e	O
is	O
correlated	O
with	O
b	O
-	O
cell	O
mass	O
expansion	O
,	O
suggesting	O
that	O
it	O
may	O
be	O
a	O
transcriptional	O
regulator	O
of	O
b	O
-	O
cell	O
mass	O
.	O
Increasing	O
proliferation	O
and	O
decreasing	O
apoptotic	O
cell	O
death	O
are	O
two	O
strategies	O
to	O
increase	O
pancreatic	O
b	O
-	O
cell	O
mass	O
and	O
prevent	O
or	O
delay	O
diabetes	O
.	O
siRNA	O
-	O
mediated	O
knockdown	O
of	O
gene1s	O
Tcf19	O
gene1e	O
in	O
the	O
species1s	O
INS-1	O
species1e	O
insulinoma	O
cell	O
line	O
,	O
a	O
b	O
-	O
cell	O
model	O
,	O
results	O
in	O
a	O
decrease	O
in	O
proliferation	O
and	O
an	O
increase	O
in	O
apoptosis	O
.	O
There	O
was	O
a	O
significant	O
reduction	O
in	O
the	O
expression	O
of	O
numerous	O
cell	O
cycle	O
genes	O
from	O
the	O
late	O
G1	O
phase	O
through	O
the	O
M	O
phase	O
,	O
and	O
cells	O
were	O
arrested	O
at	O
the	O
G1	O
/	O
S	O
checkpoint	O
.	O
We	O
also	O
observed	O
increased	O
apoptosis	O
and	O
susceptibility	O
to	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
stress	O
after	O
gene1s	O
Tcf19	O
gene1e	O
knockdown	O
.	O
There	O
was	O
a	O
reduction	O
in	O
expression	O
of	O
genes	O
important	O
for	O
the	O
maintenance	O
of	O
ER	O
homeostasis	O
(	O
gene1s	O
Bip	O
gene1e	O
,	O
gene1s	O
p58(IPK	O
)	O
gene1e	O
,	O
gene1s	O
Edem1	O
gene1e	O
,	O
and	O
gene1s	O
calreticulin	O
gene1e	O
)	O
and	O
an	O
increase	O
in	O
proapoptotic	O
genes	O
(	O
gene1s	O
Bim	O
gene1e	O
,	O
gene1s	O
Bid	O
gene1e	O
,	O
gene1s	O
Nix	O
gene1e	O
,	O
gene1s	O
Gadd34	O
gene1e	O
,	O
and	O
gene1s	O
Pdia2	O
gene1e	O
)	O
.	O
Therefore	O
,	O
gene1s	O
Tcf19	O
gene1e	O
is	O
necessary	O
for	O
both	O
proliferation	O
and	O
survival	O
and	O
is	O
a	O
novel	O
regulator	O
of	O
these	O
pathways	O
.	O

gene1s	O
Tcf19	O
gene1e	O
is	O
a	O
novel	O
islet	O
factor	O
necessary	O
for	O
proliferation	O
and	O
survival	O
in	O
the	O
species1s	O
INS-1	O
species1e	O
b	O
-	O
cell	O
line	O
.	O
Recently	O
,	O
a	O
novel	O
type	O
1	O
diabetes	O
association	O
locus	O
was	O
identified	O
at	O
species1s	O
human	O
species1e	O
chromosome	O
6p31.3	O
,	O
and	O
gene1s	O
transcription	O
factor	O
19	O
gene1e	O
(	O
gene1s	O
TCF19	O
gene1e	O
)	O
is	O
a	O
likely	O
causal	O
gene	O
.	O
Little	O
is	O
known	O
about	O
gene1s	O
Tcf19	O
gene1e	O
,	O
and	O
we	O
now	O
show	O
that	O
it	O
plays	O
a	O
role	O
in	O
both	O
proliferation	O
and	O
apoptosis	O
in	O
insulinoma	O
cells	O
.	O
gene1s	ARG2
Tcf19	ARG2
gene1e	ARG2
is	O
expressed	O
in	O
arg1s	O
mouse	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
islets	O
,	O
with	O
increasing	O
mRNA	O
expression	O
in	O
nondiabetic	O
obesity	O
.	O
The	O
expression	O
of	O
gene1s	O
Tcf19	O
gene1e	O
is	O
correlated	O
with	O
b	O
-	O
cell	O
mass	O
expansion	O
,	O
suggesting	O
that	O
it	O
may	O
be	O
a	O
transcriptional	O
regulator	O
of	O
b	O
-	O
cell	O
mass	O
.	O
Increasing	O
proliferation	O
and	O
decreasing	O
apoptotic	O
cell	O
death	O
are	O
two	O
strategies	O
to	O
increase	O
pancreatic	O
b	O
-	O
cell	O
mass	O
and	O
prevent	O
or	O
delay	O
diabetes	O
.	O
siRNA	O
-	O
mediated	O
knockdown	O
of	O
gene1s	O
Tcf19	O
gene1e	O
in	O
the	O
species1s	O
INS-1	O
species1e	O
insulinoma	O
cell	O
line	O
,	O
a	O
b	O
-	O
cell	O
model	O
,	O
results	O
in	O
a	O
decrease	O
in	O
proliferation	O
and	O
an	O
increase	O
in	O
apoptosis	O
.	O
There	O
was	O
a	O
significant	O
reduction	O
in	O
the	O
expression	O
of	O
numerous	O
cell	O
cycle	O
genes	O
from	O
the	O
late	O
G1	O
phase	O
through	O
the	O
M	O
phase	O
,	O
and	O
cells	O
were	O
arrested	O
at	O
the	O
G1	O
/	O
S	O
checkpoint	O
.	O
We	O
also	O
observed	O
increased	O
apoptosis	O
and	O
susceptibility	O
to	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
stress	O
after	O
gene1s	O
Tcf19	O
gene1e	O
knockdown	O
.	O
There	O
was	O
a	O
reduction	O
in	O
expression	O
of	O
genes	O
important	O
for	O
the	O
maintenance	O
of	O
ER	O
homeostasis	O
(	O
gene1s	O
Bip	O
gene1e	O
,	O
gene1s	O
p58(IPK	O
)	O
gene1e	O
,	O
gene1s	O
Edem1	O
gene1e	O
,	O
and	O
gene1s	O
calreticulin	O
gene1e	O
)	O
and	O
an	O
increase	O
in	O
proapoptotic	O
genes	O
(	O
gene1s	O
Bim	O
gene1e	O
,	O
gene1s	O
Bid	O
gene1e	O
,	O
gene1s	O
Nix	O
gene1e	O
,	O
gene1s	O
Gadd34	O
gene1e	O
,	O
and	O
gene1s	O
Pdia2	O
gene1e	O
)	O
.	O
Therefore	O
,	O
gene1s	O
Tcf19	O
gene1e	O
is	O
necessary	O
for	O
both	O
proliferation	O
and	O
survival	O
and	O
is	O
a	O
novel	O
regulator	O
of	O
these	O
pathways	O
.	O

An	O
gene1s	ARG2
Ag	ARG2
-	ARG2
globin	ARG2
gene1e	ARG2
G->A	O
gene	O
polymorphism	O
associated	O
with	O
gene1s	ARG2
b(0)39	ARG2
thalassemia	ARG2
globin	ARG2
gene1e	ARG2
gene	O
and	O
high	O
gene1s	ARG2
fetal	ARG2
hemoglobin	ARG2
gene1e	ARG2
production	O
.	O
BACKGROUND	O
:	O
Increase	O
of	O
the	O
expression	O
of	O
gene1s	ARG2
g	ARG2
-	ARG2
globin	ARG2
gene1e	ARG2
gene	O
and	O
high	O
production	O
of	O
gene1s	ARG2
fetal	ARG2
hemoglobin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
HbF	ARG2
gene1e	ARG2
)	O
in	O
b	O
-	O
thalassemia	O
arg1s	O
patients	O
arg1e	O
is	O
widely	O
accepted	O
as	O
associated	O
with	O
a	O
milder	O
or	O
even	O
asymptomatic	O
disease	O
.	O
The	O
search	O
for	O
gene1s	ARG2
HbF	ARG2
gene1e	ARG2
-	O
associated	O
polymorphisms	O
(	O
such	O
as	O
the	O
XmnI	O
,	O
gene1s	ARG2
BCL11A	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MYB	ARG2
gene1e	ARG2
polymorphisms	O
)	O
has	O
recently	O
gained	O
great	O
attention	O
,	O
in	O
order	O
to	O
stratify	O
b	O
-	O
thalassemia	O
arg1s	O
patients	O
arg1e	O
with	O
respect	O
to	O
expectancy	O
of	O
the	O
first	O
transfusion	O
,	O
need	O
for	O
annual	O
intake	O
of	O
blood	O
,	O
response	O
to	O
gene1s	ARG2
HbF	ARG2
gene1e	ARG2
inducers	O
(	O
the	O
most	O
studied	O
of	O
which	O
is	O
hydroxyurea	O
)	O
.	O
METHODS	O
:	O
gene1s	ARG2
Ag	ARG2
-	ARG2
globin	ARG2
gene1e	ARG2
gene	O
sequencing	O
was	O
performed	O
on	O
genomic	O
DNA	O
isolated	O
from	O
a	O
total	O
of	O
75	O
b	O
-	O
thalassemia	O
arg1s	O
patients	O
arg1e	O
,	O
including	O
31	O
b(0)39	O
/	O
b(0)39	O
,	O
33	O
b(0)39	O
/	O
b(+)IVSI-110	O
,	O
9	O
b(+)IVSI-110	O
/	O
b(+)IVSI-110	O
,	O
one	O
b(0)IVSI-1	O
/	O
b(+)IVSI-6	O
and	O
one	O
b(0)39	O
/	O
b(+)IVSI-6	O
.	O
RESULTS	O
:	O
The	O
results	O
show	O
that	O
the	O
rs368698783	O
polymorphism	O
is	O
present	O
in	O
b	O
-	O
thalassemia	O
arg1s	O
patients	O
arg1e	O
in	O
the	O
5'UTR	O
sequence	O
(	O
+25	O
)	O
of	O
the	O
gene1s	ARG2
Ag	ARG2
-	ARG2
globin	ARG2
gene1e	ARG2
gene	O
,	O
known	O
to	O
affect	O
the	O
gene1s	ARG2
LYAR	ARG2
gene1e	ARG2
(	O
arg1s	O
human	O
arg1e	O
homologue	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	O
Ly-1	O
antibody	O
reactive	O
clone	O
gene1e	O
)	O
binding	O
site	O
5'-GGTTAT-3	O
'	O
.	O
This	O
Ag(+25	O
G->A	O
)	O
polymorphism	O
is	O
associated	O
with	O
the	O
gene1s	ARG2
Gg	ARG2
-	ARG2
globin	ARG2
gene1e	ARG2
-	O
XmnI	O
polymorphism	O
and	O
both	O
are	O
linked	O
with	O
the	O
gene1s	ARG2
b(0)39-globin	ARG2
gene1e	ARG2
gene	O
,	O
but	O
not	O
with	O
the	O
gene1s	ARG2
b(+)IVSI-110-globin	ARG2
gene1e	ARG2
gene	O
.	O
In	O
agreement	O
with	O
the	O
expectation	O
that	O
this	O
mutation	O
alters	O
the	O
gene1s	ARG2
LYAR	ARG2
gene1e	ARG2
binding	O
activity	O
,	O
we	O
found	O
that	O
the	O
Ag(+25	O
G->A	O
)	O
and	O
gene1s	ARG2
Gg	ARG2
-	ARG2
globin	ARG2
gene1e	ARG2
-	O
XmnI	O
polymorphisms	O
are	O
associated	O
with	O
high	O
gene1s	ARG2
HbF	ARG2
gene1e	ARG2
in	O
erythroid	O
precursor	O
cells	O
isolated	O
from	O
b(0)39	O
/	O
b(0)39	O
thalassemia	O
arg1s	O
patients	O
arg1e	O
.	O
CONCLUSIONS	O
:	O
As	O
a	O
potential	O
explanation	O
of	O
our	O
findings	O
,	O
we	O
hypothesize	O
that	O
in	O
b	O
-	O
thalassemia	O
the	O
gene1s	ARG2
Gg	ARG2
-	ARG2
globin	ARG2
gene1e	ARG2
-	O
XmnI	O
/	O
gene1s	ARG2
Ag	ARG2
-	ARG2
globin	ARG2
gene1e	ARG2
-(G->A	O
)	O
genotype	O
is	O
frequently	O
under	O
genetic	O
linkage	O
with	O
b(0)-thalassemia	O
mutations	O
,	O
but	O
not	O
with	O
the	O
b(+)-thalassemia	O
mutation	O
here	O
studied	O
(	O
i.e.	O
b(+)IVSI-110	O
)	O
and	O
that	O
this	O
genetic	O
combination	O
has	O
been	O
selected	O
within	O
the	O
population	O
of	O
b(0)-thalassemia	O
arg1s	O
patients	O
arg1e	O
,	O
due	O
to	O
functional	O
association	O
with	O
high	O
gene1s	ARG2
HbF	ARG2
gene1e	ARG2
.	O
Here	O
we	O
describe	O
the	O
characterization	O
of	O
the	O
rs368698783	O
(	O
+25	O
G->A	O
)	O
polymorphism	O
of	O
the	O
gene1s	ARG2
Ag	ARG2
-	ARG2
globin	ARG2
gene1e	ARG2
gene	O
associated	O
in	O
b(0)39	O
thalassemia	O
arg1s	O
patients	O
arg1e	O
with	O
high	O
gene1s	ARG2
HbF	ARG2
gene1e	ARG2
in	O
erythroid	O
precursor	O
cells	O
.	O

An	O
gene1s	O
Ag	O
-	O
globin	O
gene1e	O
G->A	O
gene	O
polymorphism	O
associated	O
with	O
gene1s	O
b(0)39	O
thalassemia	O
globin	O
gene1e	O
gene	O
and	O
high	O
gene1s	O
fetal	O
hemoglobin	O
gene1e	O
production	O
.	O
BACKGROUND	O
:	O
Increase	O
of	O
the	O
expression	O
of	O
gene1s	O
g	O
-	O
globin	O
gene1e	O
gene	O
and	O
high	O
production	O
of	O
gene1s	O
fetal	O
hemoglobin	O
gene1e	O
(	O
gene1s	O
HbF	O
gene1e	O
)	O
in	O
b	O
-	O
thalassemia	O
species1s	O
patients	O
species1e	O
is	O
widely	O
accepted	O
as	O
associated	O
with	O
a	O
milder	O
or	O
even	O
asymptomatic	O
disease	O
.	O
The	O
search	O
for	O
gene1s	O
HbF	O
gene1e	O
-	O
associated	O
polymorphisms	O
(	O
such	O
as	O
the	O
XmnI	O
,	O
gene1s	O
BCL11A	O
gene1e	O
and	O
gene1s	O
MYB	O
gene1e	O
polymorphisms	O
)	O
has	O
recently	O
gained	O
great	O
attention	O
,	O
in	O
order	O
to	O
stratify	O
b	O
-	O
thalassemia	O
species1s	O
patients	O
species1e	O
with	O
respect	O
to	O
expectancy	O
of	O
the	O
first	O
transfusion	O
,	O
need	O
for	O
annual	O
intake	O
of	O
blood	O
,	O
response	O
to	O
gene1s	O
HbF	O
gene1e	O
inducers	O
(	O
the	O
most	O
studied	O
of	O
which	O
is	O
hydroxyurea	O
)	O
.	O
METHODS	O
:	O
gene1s	O
Ag	O
-	O
globin	O
gene1e	O
gene	O
sequencing	O
was	O
performed	O
on	O
genomic	O
DNA	O
isolated	O
from	O
a	O
total	O
of	O
75	O
b	O
-	O
thalassemia	O
species1s	O
patients	O
species1e	O
,	O
including	O
31	O
b(0)39	O
/	O
b(0)39	O
,	O
33	O
b(0)39	O
/	O
b(+)IVSI-110	O
,	O
9	O
b(+)IVSI-110	O
/	O
b(+)IVSI-110	O
,	O
one	O
b(0)IVSI-1	O
/	O
b(+)IVSI-6	O
and	O
one	O
b(0)39	O
/	O
b(+)IVSI-6	O
.	O
RESULTS	O
:	O
The	O
results	O
show	O
that	O
the	O
rs368698783	O
polymorphism	O
is	O
present	O
in	O
b	O
-	O
thalassemia	O
species1s	O
patients	O
species1e	O
in	O
the	O
5'UTR	O
sequence	O
(	O
+25	O
)	O
of	O
the	O
gene1s	O
Ag	O
-	O
globin	O
gene1e	O
gene	O
,	O
known	O
to	O
affect	O
the	O
gene1s	O
LYAR	O
gene1e	O
(	O
species1s	O
human	O
species1e	O
homologue	O
of	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
Ly-1	ARG2
antibody	ARG2
reactive	ARG2
clone	ARG2
gene1e	ARG2
)	O
binding	O
site	O
5'-GGTTAT-3	O
'	O
.	O
This	O
Ag(+25	O
G->A	O
)	O
polymorphism	O
is	O
associated	O
with	O
the	O
gene1s	O
Gg	O
-	O
globin	O
gene1e	O
-	O
XmnI	O
polymorphism	O
and	O
both	O
are	O
linked	O
with	O
the	O
gene1s	O
b(0)39-globin	O
gene1e	O
gene	O
,	O
but	O
not	O
with	O
the	O
gene1s	O
b(+)IVSI-110-globin	O
gene1e	O
gene	O
.	O
In	O
agreement	O
with	O
the	O
expectation	O
that	O
this	O
mutation	O
alters	O
the	O
gene1s	O
LYAR	O
gene1e	O
binding	O
activity	O
,	O
we	O
found	O
that	O
the	O
Ag(+25	O
G->A	O
)	O
and	O
gene1s	O
Gg	O
-	O
globin	O
gene1e	O
-	O
XmnI	O
polymorphisms	O
are	O
associated	O
with	O
high	O
gene1s	O
HbF	O
gene1e	O
in	O
erythroid	O
precursor	O
cells	O
isolated	O
from	O
b(0)39	O
/	O
b(0)39	O
thalassemia	O
species1s	O
patients	O
species1e	O
.	O
CONCLUSIONS	O
:	O
As	O
a	O
potential	O
explanation	O
of	O
our	O
findings	O
,	O
we	O
hypothesize	O
that	O
in	O
b	O
-	O
thalassemia	O
the	O
gene1s	O
Gg	O
-	O
globin	O
gene1e	O
-	O
XmnI	O
/	O
gene1s	O
Ag	O
-	O
globin	O
gene1e	O
-(G->A	O
)	O
genotype	O
is	O
frequently	O
under	O
genetic	O
linkage	O
with	O
b(0)-thalassemia	O
mutations	O
,	O
but	O
not	O
with	O
the	O
b(+)-thalassemia	O
mutation	O
here	O
studied	O
(	O
i.e.	O
b(+)IVSI-110	O
)	O
and	O
that	O
this	O
genetic	O
combination	O
has	O
been	O
selected	O
within	O
the	O
population	O
of	O
b(0)-thalassemia	O
species1s	O
patients	O
species1e	O
,	O
due	O
to	O
functional	O
association	O
with	O
high	O
gene1s	O
HbF	O
gene1e	O
.	O
Here	O
we	O
describe	O
the	O
characterization	O
of	O
the	O
rs368698783	O
(	O
+25	O
G->A	O
)	O
polymorphism	O
of	O
the	O
gene1s	O
Ag	O
-	O
globin	O
gene1e	O
gene	O
associated	O
in	O
b(0)39	O
thalassemia	O
species1s	O
patients	O
species1e	O
with	O
high	O
gene1s	O
HbF	O
gene1e	O
in	O
erythroid	O
precursor	O
cells	O
.	O

gene1s	O
Transgelin	O
gene1e	O
increases	O
metastatic	O
potential	O
of	O
colorectal	O
cancer	O
cells	O
in	O
vivo	O
and	O
alters	O
expression	O
of	O
genes	O
involved	O
in	O
cell	O
motility	O
.	O
BACKGROUND	O
:	O
gene1s	O
Transgelin	O
gene1e	O
is	O
an	O
gene1s	ARG2
actin	ARG2
-	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
that	O
promotes	O
motility	O
in	O
normal	O
cells	O
.	O
Although	O
the	O
role	O
of	O
gene1s	O
transgelin	O
gene1e	O
in	O
cancer	O
is	O
controversial	O
,	O
a	O
number	O
of	O
studies	O
have	O
shown	O
that	O
elevated	O
levels	O
correlate	O
with	O
aggressive	O
tumor	O
behavior	O
,	O
advanced	O
stage	O
,	O
and	O
poor	O
prognosis	O
.	O
Here	O
we	O
sought	O
to	O
determine	O
the	O
role	O
of	O
gene1s	O
transgelin	O
gene1e	O
more	O
directly	O
by	O
determining	O
whether	O
experimental	O
manipulation	O
of	O
gene1s	O
transgelin	O
gene1e	O
levels	O
in	O
colorectal	O
cancer	O
(	O
CRC	O
)	O
cells	O
led	O
to	O
changes	O
in	O
metastatic	O
potential	O
in	O
vivo	O
.	O
METHODS	O
:	O
Isogenic	O
CRC	O
cell	O
lines	O
that	O
differ	O
in	O
gene1s	O
transgelin	O
gene1e	O
expression	O
were	O
characterized	O
using	O
in	O
vitro	O
assays	O
of	O
growth	O
and	O
invasiveness	O
and	O
a	O
arg1s	O
mouse	O
arg1e	O
tail	O
vein	O
assay	O
of	O
experimental	O
metastasis	O
.	O
Downstream	O
effects	O
of	O
gene1s	O
transgelin	O
gene1e	O
overexpression	O
were	O
investigated	O
by	O
gene	O
expression	O
profiling	O
and	O
quantitative	O
PCR	O
.	O
RESULTS	O
:	O
Stable	O
overexpression	O
of	O
gene1s	O
transgelin	O
gene1e	O
in	O
species1s	O
RKO	O
species1e	O
cells	O
,	O
which	O
have	O
low	O
endogenous	O
levels	O
,	O
led	O
to	O
increased	O
invasiveness	O
,	O
growth	O
at	O
low	O
density	O
,	O
and	O
growth	O
in	O
soft	O
agar	O
.	O
Overexpression	O
also	O
led	O
to	O
an	O
increase	O
in	O
the	O
number	O
and	O
size	O
of	O
lung	O
metastases	O
in	O
the	O
arg1s	O
mouse	O
arg1e	O
tail	O
vein	O
injection	O
model	O
.	O
Similarly	O
,	O
attenuation	O
of	O
gene1s	O
transgelin	O
gene1e	O
expression	O
in	O
species1s	O
HCT116	O
species1e	O
cells	O
,	O
which	O
have	O
high	O
endogenous	O
levels	O
,	O
decreased	O
metastases	O
in	O
the	O
same	O
model	O
.	O
Investigation	O
of	O
mRNA	O
expression	O
patterns	O
showed	O
that	O
gene1s	O
transgelin	O
gene1e	O
overexpression	O
altered	O
the	O
levels	O
of	O
approximately	O
250	O
other	O
transcripts	O
,	O
with	O
over	O
-	O
representation	O
of	O
genes	O
that	O
affect	O
function	O
of	O
gene1s	O
actin	O
gene1e	O
or	O
other	O
gene1s	O
cytoskeletal	O
proteins	O
gene1e	O
.	O
Changes	O
included	O
increases	O
in	O
gene1s	O
HOOK1	O
gene1e	O
,	O
gene1s	O
SDCCAG8	O
gene1e	O
,	O
gene1s	O
ENAH	O
gene1e	O
/	O
gene1s	O
Mena	O
gene1e	O
,	O
and	O
gene1s	O
TNS1	O
gene1e	O
and	O
decreases	O
in	O
gene1s	O
EMB	O
gene1e	O
,	O
gene1s	O
BCL11B	O
gene1e	O
,	O
and	O
gene1s	O
PTPRD	O
gene1e	O
.	O
CONCLUSIONS	O
:	O
Increases	O
or	O
decreases	O
in	O
gene1s	O
transgelin	O
gene1e	O
levels	O
have	O
reciprocal	O
effects	O
on	O
tumor	O
cell	O
behavior	O
,	O
with	O
higher	O
expression	O
promoting	O
metastasis	O
.	O
Chronic	O
overexpression	O
influences	O
steady	O
-	O
state	O
levels	O
of	O
mRNAs	O
for	O
metastasis	O
-	O
related	O
genes	O
.	O

gene1s	ARG2
Transgelin	ARG2
gene1e	ARG2
increases	O
metastatic	O
potential	O
of	O
colorectal	O
cancer	O
cells	O
in	O
vivo	O
and	O
alters	O
expression	O
of	O
genes	O
involved	O
in	O
cell	O
motility	O
.	O
BACKGROUND	O
:	O
gene1s	ARG2
Transgelin	ARG2
gene1e	ARG2
is	O
an	O
gene1s	ARG2
actin	ARG2
-	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
that	O
promotes	O
motility	O
in	O
normal	O
cells	O
.	O
Although	O
the	O
role	O
of	O
gene1s	ARG2
transgelin	ARG2
gene1e	ARG2
in	O
cancer	O
is	O
controversial	O
,	O
a	O
number	O
of	O
studies	O
have	O
shown	O
that	O
elevated	O
levels	O
correlate	O
with	O
aggressive	O
tumor	O
behavior	O
,	O
advanced	O
stage	O
,	O
and	O
poor	O
prognosis	O
.	O
Here	O
we	O
sought	O
to	O
determine	O
the	O
role	O
of	O
gene1s	ARG2
transgelin	ARG2
gene1e	ARG2
more	O
directly	O
by	O
determining	O
whether	O
experimental	O
manipulation	O
of	O
gene1s	ARG2
transgelin	ARG2
gene1e	ARG2
levels	O
in	O
colorectal	O
cancer	O
(	O
CRC	O
)	O
cells	O
led	O
to	O
changes	O
in	O
metastatic	O
potential	O
in	O
vivo	O
.	O
METHODS	O
:	O
Isogenic	O
CRC	O
cell	O
lines	O
that	O
differ	O
in	O
gene1s	ARG2
transgelin	ARG2
gene1e	ARG2
expression	O
were	O
characterized	O
using	O
in	O
vitro	O
assays	O
of	O
growth	O
and	O
invasiveness	O
and	O
a	O
species1s	O
mouse	O
species1e	O
tail	O
vein	O
assay	O
of	O
experimental	O
metastasis	O
.	O
Downstream	O
effects	O
of	O
gene1s	ARG2
transgelin	ARG2
gene1e	ARG2
overexpression	O
were	O
investigated	O
by	O
gene	O
expression	O
profiling	O
and	O
quantitative	O
PCR	O
.	O
RESULTS	O
:	O
Stable	O
overexpression	O
of	O
gene1s	ARG2
transgelin	ARG2
gene1e	ARG2
in	O
arg1s	O
RKO	O
arg1e	O
cells	O
,	O
which	O
have	O
low	O
endogenous	O
levels	O
,	O
led	O
to	O
increased	O
invasiveness	O
,	O
growth	O
at	O
low	O
density	O
,	O
and	O
growth	O
in	O
soft	O
agar	O
.	O
Overexpression	O
also	O
led	O
to	O
an	O
increase	O
in	O
the	O
number	O
and	O
size	O
of	O
lung	O
metastases	O
in	O
the	O
species1s	O
mouse	O
species1e	O
tail	O
vein	O
injection	O
model	O
.	O
Similarly	O
,	O
attenuation	O
of	O
gene1s	ARG2
transgelin	ARG2
gene1e	ARG2
expression	O
in	O
arg1s	O
HCT116	O
arg1e	O
cells	O
,	O
which	O
have	O
high	O
endogenous	O
levels	O
,	O
decreased	O
metastases	O
in	O
the	O
same	O
model	O
.	O
Investigation	O
of	O
mRNA	O
expression	O
patterns	O
showed	O
that	O
gene1s	ARG2
transgelin	ARG2
gene1e	ARG2
overexpression	O
altered	O
the	O
levels	O
of	O
approximately	O
250	O
other	O
transcripts	O
,	O
with	O
over	O
-	O
representation	O
of	O
genes	O
that	O
affect	O
function	O
of	O
gene1s	ARG2
actin	ARG2
gene1e	ARG2
or	O
other	O
gene1s	ARG2
cytoskeletal	ARG2
proteins	ARG2
gene1e	ARG2
.	O
Changes	O
included	O
increases	O
in	O
gene1s	ARG2
HOOK1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SDCCAG8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ENAH	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Mena	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
TNS1	ARG2
gene1e	ARG2
and	O
decreases	O
in	O
gene1s	ARG2
EMB	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
BCL11B	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
PTPRD	ARG2
gene1e	ARG2
.	O
CONCLUSIONS	O
:	O
Increases	O
or	O
decreases	O
in	O
gene1s	ARG2
transgelin	ARG2
gene1e	ARG2
levels	O
have	O
reciprocal	O
effects	O
on	O
tumor	O
cell	O
behavior	O
,	O
with	O
higher	O
expression	O
promoting	O
metastasis	O
.	O
Chronic	O
overexpression	O
influences	O
steady	O
-	O
state	O
levels	O
of	O
mRNAs	O
for	O
metastasis	O
-	O
related	O
genes	O
.	O

Embelin	O
suppresses	O
growth	O
of	O
arg1s	O
human	O
arg1e	O
pancreatic	O
cancer	O
xenografts	O
,	O
and	O
pancreatic	O
cancer	O
cells	O
isolated	O
from	O
KrasG12D	O
species1s	O
mice	O
species1e	O
by	O
inhibiting	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Sonic	ARG2
hedgehog	ARG2
gene1e	ARG2
pathways	O
.	O
Pancreatic	O
cancer	O
is	O
a	O
deadly	O
disease	O
,	O
and	O
therefore	O
effective	O
treatment	O
and/or	O
prevention	O
strategies	O
are	O
urgently	O
needed	O
.	O
The	O
objectives	O
of	O
this	O
study	O
were	O
to	O
examine	O
the	O
molecular	O
mechanisms	O
by	O
which	O
embelin	O
inhibited	O
arg1s	O
human	O
arg1e	O
pancreatic	O
cancer	O
cell	O
growth	O
in	O
vitro	O
,	O
and	O
xenografts	O
in	O
Balb	O
C	O
species1s	O
nude	O
mice	O
species1e	O
,	O
and	O
pancreatic	O
cancer	O
cell	O
growth	O
isolated	O
from	O
KrasG12D	O
species1s	O
transgenic	O
mice	O
species1e	O
.	O
XTT	O
assays	O
were	O
performed	O
to	O
measure	O
cell	O
viability	O
.	O
arg1s	O
AsPC-1	O
arg1e	O
cells	O
were	O
injected	O
subcutaneously	O
into	O
Balb	O
c	O
species1s	O
nude	O
mice	O
species1e	O
and	O
treated	O
with	O
embelin	O
.	O
Cell	O
proliferation	O
and	O
apoptosis	O
were	O
measured	O
by	O
gene1s	ARG2
Ki67	ARG2
gene1e	ARG2
and	O
TUNEL	O
staining	O
,	O
respectively	O
.	O
The	O
expression	O
of	O
gene1s	O
Akt	O
gene1e	O
,	O
and	O
gene1s	ARG2
Sonic	ARG2
Hedgehog	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
)	O
and	O
their	O
target	O
gene	O
products	O
were	O
measured	O
by	O
the	O
immunohistochemistry	O
,	O
and	O
Western	O
blot	O
analysis	O
.	O
The	O
effects	O
of	O
embelin	O
on	O
pancreatic	O
cancer	O
cells	O
isolated	O
from	O
10-months	O
old	O
KrasG12D	O
species1s	O
mice	O
species1e	O
were	O
also	O
examined	O
.	O
Embelin	O
inhibited	O
cell	O
viability	O
in	O
pancreatic	O
cancer	O
arg1s	O
AsPC-1	O
arg1e	O
,	O
arg1s	O
PANC-1	O
arg1e	O
,	O
arg1s	O
MIA	O
PaCa-2	O
arg1e	O
and	O
arg1s	O
Hs	O
766	O
T	O
arg1e	O
cell	O
lines	O
,	O
and	O
these	O
inhibitory	O
effects	O
were	O
blocked	O
either	O
by	O
constitutively	O
active	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
protein	O
.	O
Embelin	O
-	O
treated	O
species1s	O
mice	O
species1e	O
showed	O
significant	O
inhibition	O
in	O
tumor	O
growth	O
which	O
was	O
associated	O
with	O
reduced	O
expression	O
of	O
markers	O
of	O
cell	O
proliferation	O
(	O
gene1s	ARG2
Ki67	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PCNA	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
)	O
and	O
cell	O
cycle	O
(	O
gene1s	ARG2
cyclin	ARG2
D1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CDK2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
CDK6	ARG2
gene1e	ARG2
)	O
,	O
and	O
induction	O
of	O
apoptosis	O
(	O
activation	O
of	O
gene1s	ARG2
caspase-3	ARG2
gene1e	ARG2
and	O
cleavage	O
of	O
gene1s	ARG2
PARP	ARG2
gene1e	ARG2
,	O
and	O
increased	O
expression	O
of	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
)	O
.	O
In	O
addition	O
,	O
embelin	O
inhibited	O
the	O
expression	O
of	O
markers	O
of	O
angiogenesis	O
(	O
gene1s	ARG2
COX-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
VEGFR	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
IL-8	ARG2
gene1e	ARG2
)	O
,	O
and	O
metastasis	O
(	O
gene1s	ARG2
MMP-2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MMP-9	ARG2
gene1e	ARG2
)	O
in	O
tumor	O
tissues	O
.	O
Antitumor	O
activity	O
of	O
embelin	O
was	O
associated	O
with	O
inhibition	O
of	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
pathways	O
in	O
xenografts	O
,	O
and	O
pancreatic	O
cancer	O
cells	O
isolated	O
from	O
KrasG12D	O
species1s	O
mice	O
species1e	O
.	O
Furthermore	O
,	O
embelin	O
also	O
inhibited	O
epithelial	O
-	O
to	O
-	O
mesenchymal	O
transition	O
(	O
EMT	O
)	O
by	O
up	O
-	O
regulating	O
gene1s	ARG2
E	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
and	O
inhibiting	O
the	O
expression	O
of	O
gene1s	ARG2
Snail	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Slug	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
ZEB1	ARG2
gene1e	ARG2
.	O
These	O
data	O
suggest	O
that	O
embelin	O
can	O
inhibit	O
pancreatic	O
cancer	O
growth	O
,	O
angiogenesis	O
and	O
metastasis	O
by	O
suppressing	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
pathways	O
,	O
and	O
can	O
be	O
developed	O
for	O
the	O
treatment	O
and/or	O
prevention	O
of	O
pancreatic	O
cancer	O
.	O

Embelin	O
suppresses	O
growth	O
of	O
species1s	O
human	O
species1e	O
pancreatic	O
cancer	O
xenografts	O
,	O
and	O
pancreatic	O
cancer	O
cells	O
isolated	O
from	O
KrasG12D	O
arg1s	O
mice	O
arg1e	O
by	O
inhibiting	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Sonic	ARG2
hedgehog	ARG2
gene1e	ARG2
pathways	O
.	O
Pancreatic	O
cancer	O
is	O
a	O
deadly	O
disease	O
,	O
and	O
therefore	O
effective	O
treatment	O
and/or	O
prevention	O
strategies	O
are	O
urgently	O
needed	O
.	O
The	O
objectives	O
of	O
this	O
study	O
were	O
to	O
examine	O
the	O
molecular	O
mechanisms	O
by	O
which	O
embelin	O
inhibited	O
species1s	O
human	O
species1e	O
pancreatic	O
cancer	O
cell	O
growth	O
in	O
vitro	O
,	O
and	O
xenografts	O
in	O
Balb	O
C	O
arg1s	O
nude	O
mice	O
arg1e	O
,	O
and	O
pancreatic	O
cancer	O
cell	O
growth	O
isolated	O
from	O
KrasG12D	O
arg1s	O
transgenic	O
mice	O
arg1e	O
.	O
XTT	O
assays	O
were	O
performed	O
to	O
measure	O
cell	O
viability	O
.	O
species1s	O
AsPC-1	O
species1e	O
cells	O
were	O
injected	O
subcutaneously	O
into	O
Balb	O
c	O
arg1s	O
nude	O
mice	O
arg1e	O
and	O
treated	O
with	O
embelin	O
.	O
Cell	O
proliferation	O
and	O
apoptosis	O
were	O
measured	O
by	O
gene1s	O
Ki67	O
gene1e	O
and	O
TUNEL	O
staining	O
,	O
respectively	O
.	O
The	O
expression	O
of	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Sonic	ARG2
Hedgehog	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
)	O
and	O
their	O
target	O
gene	O
products	O
were	O
measured	O
by	O
the	O
immunohistochemistry	O
,	O
and	O
Western	O
blot	O
analysis	O
.	O
The	O
effects	O
of	O
embelin	O
on	O
pancreatic	O
cancer	O
cells	O
isolated	O
from	O
10-months	O
old	O
KrasG12D	O
arg1s	O
mice	O
arg1e	O
were	O
also	O
examined	O
.	O
Embelin	O
inhibited	O
cell	O
viability	O
in	O
pancreatic	O
cancer	O
species1s	O
AsPC-1	O
species1e	O
,	O
species1s	O
PANC-1	O
species1e	O
,	O
species1s	O
MIA	O
PaCa-2	O
species1e	O
and	O
species1s	O
Hs	O
766	O
T	O
species1e	O
cell	O
lines	O
,	O
and	O
these	O
inhibitory	O
effects	O
were	O
blocked	O
either	O
by	O
constitutively	O
active	O
gene1s	O
Akt	O
gene1e	O
or	O
gene1s	O
Shh	O
gene1e	O
protein	O
.	O
Embelin	O
-	O
treated	O
arg1s	O
mice	O
arg1e	O
showed	O
significant	O
inhibition	O
in	O
tumor	O
growth	O
which	O
was	O
associated	O
with	O
reduced	O
expression	O
of	O
markers	O
of	O
cell	O
proliferation	O
(	O
gene1s	O
Ki67	O
gene1e	O
,	O
gene1s	O
PCNA	O
gene1e	O
and	O
gene1s	O
Bcl-2	O
gene1e	O
)	O
and	O
cell	O
cycle	O
(	O
gene1s	O
cyclin	O
D1	O
gene1e	O
,	O
gene1s	O
CDK2	O
gene1e	O
,	O
and	O
gene1s	O
CDK6	O
gene1e	O
)	O
,	O
and	O
induction	O
of	O
apoptosis	O
(	O
activation	O
of	O
gene1s	O
caspase-3	O
gene1e	O
and	O
cleavage	O
of	O
gene1s	O
PARP	O
gene1e	O
,	O
and	O
increased	O
expression	O
of	O
gene1s	O
Bax	O
gene1e	O
)	O
.	O
In	O
addition	O
,	O
embelin	O
inhibited	O
the	O
expression	O
of	O
markers	O
of	O
angiogenesis	O
(	O
gene1s	O
COX-2	O
gene1e	O
,	O
gene1s	O
VEGF	O
gene1e	O
,	O
gene1s	O
VEGFR	O
gene1e	O
,	O
and	O
gene1s	O
IL-8	O
gene1e	O
)	O
,	O
and	O
metastasis	O
(	O
gene1s	O
MMP-2	O
gene1e	O
and	O
gene1s	O
MMP-9	O
gene1e	O
)	O
in	O
tumor	O
tissues	O
.	O
Antitumor	O
activity	O
of	O
embelin	O
was	O
associated	O
with	O
inhibition	O
of	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
pathways	O
in	O
xenografts	O
,	O
and	O
pancreatic	O
cancer	O
cells	O
isolated	O
from	O
KrasG12D	O
arg1s	O
mice	O
arg1e	O
.	O
Furthermore	O
,	O
embelin	O
also	O
inhibited	O
epithelial	O
-	O
to	O
-	O
mesenchymal	O
transition	O
(	O
EMT	O
)	O
by	O
up	O
-	O
regulating	O
gene1s	O
E	O
-	O
cadherin	O
gene1e	O
and	O
inhibiting	O
the	O
expression	O
of	O
gene1s	O
Snail	O
gene1e	O
,	O
gene1s	O
Slug	O
gene1e	O
,	O
and	O
gene1s	O
ZEB1	O
gene1e	O
.	O
These	O
data	O
suggest	O
that	O
embelin	O
can	O
inhibit	O
pancreatic	O
cancer	O
growth	O
,	O
angiogenesis	O
and	O
metastasis	O
by	O
suppressing	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
pathways	O
,	O
and	O
can	O
be	O
developed	O
for	O
the	O
treatment	O
and/or	O
prevention	O
of	O
pancreatic	O
cancer	O
.	O

Activated	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
alters	O
lens	O
and	O
corneal	O
development	O
through	O
induction	O
of	O
distinct	O
downstream	O
targets	O
.	O
BACKGROUND	O
:	O
arg1s	O
Mammalian	O
arg1e	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
genes	O
regulate	O
diverse	O
cellular	O
processes	O
including	O
proliferation	O
and	O
differentiation	O
and	O
are	O
frequently	O
mutated	O
in	O
arg1s	O
human	O
arg1e	O
cancers	O
.	O
Tumor	O
development	O
in	O
response	O
to	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
activation	O
varies	O
between	O
different	O
tissues	O
and	O
the	O
molecular	O
basis	O
for	O
these	O
variations	O
are	O
poorly	O
understood	O
.	O
The	O
species1s	O
murine	O
species1e	O
lens	O
and	O
cornea	O
have	O
a	O
common	O
embryonic	O
origin	O
and	O
arise	O
from	O
adjacent	O
regions	O
of	O
the	O
surface	O
ectoderm	O
.	O
Activation	O
of	O
the	O
gene1s	O
fibroblast	O
growth	O
factor	O
gene1e	O
(	O
gene1s	O
FGF	O
gene1e	O
)	O
signaling	O
pathway	O
induces	O
the	O
corneal	O
epithelial	O
cells	O
to	O
proliferate	O
and	O
the	O
lens	O
epithelial	O
cells	O
to	O
exit	O
the	O
cell	O
cycle	O
.	O
The	O
molecular	O
mechanisms	O
that	O
regulate	O
the	O
differential	O
responses	O
of	O
these	O
two	O
related	O
tissues	O
have	O
not	O
been	O
defined	O
.	O
We	O
have	O
generated	O
species1s	O
transgenic	O
mice	O
species1e	O
that	O
express	O
a	O
constitutively	O
active	O
version	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
H	ARG2
-	ARG2
Ras	ARG2
gene1e	ARG2
in	O
their	O
lenses	O
and	O
corneas	O
.	O
RESULTS	O
:	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
species1s	O
transgenic	O
species1e	O
lenses	O
and	O
corneal	O
epithelial	O
cells	O
showed	O
increased	O
proliferation	O
with	O
concomitant	O
increases	O
in	O
gene1s	O
cyclin	O
D1	O
and	O
D2	O
gene1e	O
expression	O
.	O
This	O
initial	O
increase	O
in	O
proliferation	O
is	O
sustained	O
in	O
the	O
cornea	O
but	O
not	O
in	O
the	O
lens	O
epithelial	O
cells	O
.	O
Coincidentally	O
,	O
gene1s	O
cdk	O
inhibitors	O
gene1e	O
gene1s	O
p27Kip1	O
gene1e	O
and	O
gene1s	O
p57Kip2	O
gene1e	O
were	O
upregulated	O
in	O
the	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
species1s	O
transgenic	O
species1e	O
lenses	O
but	O
not	O
in	O
the	O
corneas	O
.	O
Phospho	O
-	O
gene1s	O
Erk1	O
gene1e	O
and	O
gene1s	O
Erk2	O
gene1e	O
levels	O
were	O
elevated	O
in	O
the	O
lens	O
but	O
not	O
in	O
the	O
cornea	O
and	O
gene1s	O
Spry	O
1	O
gene1e	O
and	O
gene1s	O
Spry	O
2	O
gene1e	O
,	O
negative	O
regulators	O
of	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
-	O
gene1s	O
Raf	O
gene1e	O
-	O
gene1s	O
Erk	O
gene1e	O
signaling	O
,	O
were	O
upregulated	O
more	O
in	O
the	O
corneal	O
than	O
in	O
the	O
lens	O
epithelial	O
cells	O
.	O
Both	O
lens	O
and	O
corneal	O
differentiation	O
programs	O
were	O
sensitive	O
to	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
activation	O
.	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
species1s	O
transgenic	O
species1e	O
embryos	O
showed	O
a	O
distinctive	O
alteration	O
in	O
the	O
architecture	O
of	O
the	O
lens	O
pit	O
.	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
activation	O
,	O
though	O
sufficient	O
for	O
upregulation	O
of	O
gene1s	O
Prox1	O
gene1e	O
,	O
a	O
transcription	O
factor	O
critical	O
for	O
cell	O
cycle	O
exit	O
and	O
initiation	O
of	O
fiber	O
differentiation	O
,	O
is	O
not	O
sufficient	O
for	O
induction	O
of	O
terminal	O
fiber	O
differentiation	O
.	O
Expression	O
of	O
gene1s	O
Keratin	O
12	O
gene1e	O
,	O
a	O
marker	O
of	O
corneal	O
epithelial	O
differentiation	O
,	O
was	O
reduced	O
in	O
the	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
species1s	O
transgenic	O
species1e	O
corneas	O
.	O
CONCLUSIONS	O
:	O
Collectively	O
,	O
these	O
results	O
suggest	O
that	O
gene1s	ARG2
Ras	ARG2
gene1e	ARG2
activation	O
a	O
)	O
induces	O
distinct	O
sets	O
of	O
downstream	O
targets	O
in	O
the	O
lens	O
and	O
cornea	O
resulting	O
in	O
distinct	O
cellular	O
responses	O
and	O
b	O
)	O
is	O
sufficient	O
for	O
initiation	O
but	O
not	O
completion	O
of	O
lens	O
fiber	O
differentiation	O
.	O

Activated	O
gene1s	O
Ras	O
gene1e	O
alters	O
lens	O
and	O
corneal	O
development	O
through	O
induction	O
of	O
distinct	O
downstream	O
targets	O
.	O
BACKGROUND	O
:	O
species1s	O
Mammalian	O
species1e	O
gene1s	O
Ras	O
gene1e	O
genes	O
regulate	O
diverse	O
cellular	O
processes	O
including	O
proliferation	O
and	O
differentiation	O
and	O
are	O
frequently	O
mutated	O
in	O
species1s	O
human	O
species1e	O
cancers	O
.	O
Tumor	O
development	O
in	O
response	O
to	O
gene1s	O
Ras	O
gene1e	O
activation	O
varies	O
between	O
different	O
tissues	O
and	O
the	O
molecular	O
basis	O
for	O
these	O
variations	O
are	O
poorly	O
understood	O
.	O
The	O
arg1s	O
murine	O
arg1e	O
lens	O
and	O
cornea	O
have	O
a	O
common	O
embryonic	O
origin	O
and	O
arise	O
from	O
adjacent	O
regions	O
of	O
the	O
surface	O
ectoderm	O
.	O
Activation	O
of	O
the	O
gene1s	ARG2
fibroblast	ARG2
growth	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
FGF	ARG2
gene1e	ARG2
)	O
signaling	O
pathway	O
induces	O
the	O
corneal	O
epithelial	O
cells	O
to	O
proliferate	O
and	O
the	O
lens	O
epithelial	O
cells	O
to	O
exit	O
the	O
cell	O
cycle	O
.	O
The	O
molecular	O
mechanisms	O
that	O
regulate	O
the	O
differential	O
responses	O
of	O
these	O
two	O
related	O
tissues	O
have	O
not	O
been	O
defined	O
.	O
We	O
have	O
generated	O
arg1s	O
transgenic	O
mice	O
arg1e	O
that	O
express	O
a	O
constitutively	O
active	O
version	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
H	O
-	O
Ras	O
gene1e	O
in	O
their	O
lenses	O
and	O
corneas	O
.	O
RESULTS	O
:	O
gene1s	O
Ras	O
gene1e	O
arg1s	O
transgenic	O
arg1e	O
lenses	O
and	O
corneal	O
epithelial	O
cells	O
showed	O
increased	O
proliferation	O
with	O
concomitant	O
increases	O
in	O
gene1s	ARG2
cyclin	ARG2
D1	ARG2
and	ARG2
D2	ARG2
gene1e	ARG2
expression	O
.	O
This	O
initial	O
increase	O
in	O
proliferation	O
is	O
sustained	O
in	O
the	O
cornea	O
but	O
not	O
in	O
the	O
lens	O
epithelial	O
cells	O
.	O
Coincidentally	O
,	O
gene1s	ARG2
cdk	ARG2
inhibitors	ARG2
gene1e	ARG2
gene1s	ARG2
p27Kip1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p57Kip2	ARG2
gene1e	ARG2
were	O
upregulated	O
in	O
the	O
gene1s	O
Ras	O
gene1e	O
arg1s	O
transgenic	O
arg1e	O
lenses	O
but	O
not	O
in	O
the	O
corneas	O
.	O
Phospho	O
-	O
gene1s	ARG2
Erk1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Erk2	ARG2
gene1e	ARG2
levels	O
were	O
elevated	O
in	O
the	O
lens	O
but	O
not	O
in	O
the	O
cornea	O
and	O
gene1s	ARG2
Spry	ARG2
1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Spry	ARG2
2	ARG2
gene1e	ARG2
,	O
negative	O
regulators	O
of	O
gene1s	O
Ras	O
gene1e	O
-	O
gene1s	ARG2
Raf	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Erk	ARG2
gene1e	ARG2
signaling	O
,	O
were	O
upregulated	O
more	O
in	O
the	O
corneal	O
than	O
in	O
the	O
lens	O
epithelial	O
cells	O
.	O
Both	O
lens	O
and	O
corneal	O
differentiation	O
programs	O
were	O
sensitive	O
to	O
gene1s	O
Ras	O
gene1e	O
activation	O
.	O
gene1s	O
Ras	O
gene1e	O
arg1s	O
transgenic	O
arg1e	O
embryos	O
showed	O
a	O
distinctive	O
alteration	O
in	O
the	O
architecture	O
of	O
the	O
lens	O
pit	O
.	O
gene1s	O
Ras	O
gene1e	O
activation	O
,	O
though	O
sufficient	O
for	O
upregulation	O
of	O
gene1s	ARG2
Prox1	ARG2
gene1e	ARG2
,	O
a	O
transcription	O
factor	O
critical	O
for	O
cell	O
cycle	O
exit	O
and	O
initiation	O
of	O
fiber	O
differentiation	O
,	O
is	O
not	O
sufficient	O
for	O
induction	O
of	O
terminal	O
fiber	O
differentiation	O
.	O
Expression	O
of	O
gene1s	ARG2
Keratin	ARG2
12	ARG2
gene1e	ARG2
,	O
a	O
marker	O
of	O
corneal	O
epithelial	O
differentiation	O
,	O
was	O
reduced	O
in	O
the	O
gene1s	O
Ras	O
gene1e	O
arg1s	O
transgenic	O
arg1e	O
corneas	O
.	O
CONCLUSIONS	O
:	O
Collectively	O
,	O
these	O
results	O
suggest	O
that	O
gene1s	O
Ras	O
gene1e	O
activation	O
a	O
)	O
induces	O
distinct	O
sets	O
of	O
downstream	O
targets	O
in	O
the	O
lens	O
and	O
cornea	O
resulting	O
in	O
distinct	O
cellular	O
responses	O
and	O
b	O
)	O
is	O
sufficient	O
for	O
initiation	O
but	O
not	O
completion	O
of	O
lens	O
fiber	O
differentiation	O
.	O

Knockdown	O
of	O
gene1s	ARG2
Carboxypeptidase	ARG2
A6	ARG2
gene1e	ARG2
in	O
arg1s	O
Zebrafish	O
arg1e	O
Larvae	O
Reduces	O
Response	O
to	O
Seizure	O
-	O
Inducing	O
Drugs	O
and	O
Causes	O
Changes	O
in	O
the	O
Level	O
of	O
mRNAs	O
Encoding	O
Signaling	O
Molecules	O
.	O
gene1s	ARG2
Carboxypeptidase	ARG2
A6	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CPA6	ARG2
gene1e	ARG2
)	O
is	O
an	O
extracellular	O
matrix	O
metallocarboxypeptidase	O
that	O
modulates	O
peptide	O
and	O
protein	O
function	O
by	O
removal	O
of	O
hydrophobic	O
C	O
-	O
terminal	O
amino	O
acids	O
.	O
Mutations	O
in	O
the	O
species1s	O
human	O
species1e	O
gene1s	O
CPA6	O
gene1e	O
gene	O
that	O
reduce	O
enzymatic	O
activity	O
in	O
the	O
extracellular	O
matrix	O
are	O
associated	O
with	O
febrile	O
seizures	O
,	O
temporal	O
lobe	O
epilepsy	O
,	O
and	O
juvenile	O
myoclonic	O
epilepsy	O
.	O
The	O
characterization	O
of	O
these	O
species1s	O
human	O
species1e	O
mutations	O
suggests	O
a	O
dominant	O
mode	O
of	O
inheritance	O
by	O
haploinsufficiency	O
through	O
loss	O
of	O
function	O
mutations	O
,	O
however	O
the	O
total	O
number	O
of	O
species1s	O
humans	O
species1e	O
with	O
pathologic	O
mutations	O
in	O
gene1s	O
CPA6	O
gene1e	O
identified	O
to	O
date	O
remains	O
small	O
.	O
To	O
better	O
understand	O
the	O
relationship	O
between	O
gene1s	ARG2
CPA6	ARG2
gene1e	ARG2
and	O
seizures	O
we	O
investigated	O
the	O
effects	O
of	O
morpholino	O
knockdown	O
of	O
gene1s	ARG2
cpa6	ARG2
gene1e	ARG2
mRNA	O
in	O
arg1s	O
zebrafish	O
arg1e	O
(	O
arg1s	O
Danio	O
rerio	O
arg1e	O
)	O
larvae	O
.	O
Knockdown	O
of	O
gene1s	ARG2
cpa6	ARG2
gene1e	ARG2
mRNA	O
resulted	O
in	O
resistance	O
to	O
the	O
effect	O
of	O
seizure	O
-	O
inducing	O
drugs	O
pentylenetetrazole	O
and	O
pilocarpine	O
on	O
swimming	O
behaviors	O
.	O
Knockdown	O
of	O
gene1s	ARG2
cpa6	ARG2
gene1e	ARG2
mRNA	O
also	O
reduced	O
the	O
levels	O
of	O
mRNAs	O
encoding	O
neuropeptide	O
precursors	O
(	O
gene1s	ARG2
bdnf	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
npy	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
chga	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
pcsk1nl	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
tac1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
nts	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
edn1	ARG2
gene1e	ARG2
)	O
,	O
a	O
gene1s	ARG2
neuropeptide	ARG2
processing	ARG2
enzyme	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
cpe	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
transcription	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
c	ARG2
-	ARG2
fos	ARG2
gene1e	ARG2
)	O
,	O
and	O
molecules	O
implicated	O
in	O
glutamatergic	O
signaling	O
(	O
gene1s	ARG2
grin1a	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
slc1a2b	ARG2
gene1e	ARG2
)	O
.	O
Treatment	O
of	O
arg1s	O
zebrafish	O
arg1e	O
embryos	O
with	O
60	O
mM	O
pilocarpine	O
for	O
1	O
hour	O
led	O
to	O
reductions	O
in	O
levels	O
of	O
many	O
of	O
the	O
same	O
mRNAs	O
when	O
measured	O
1	O
day	O
after	O
pilocarpine	O
exposure	O
,	O
except	O
for	O
gene1s	ARG2
c	ARG2
-	ARG2
fos	ARG2
gene1e	ARG2
which	O
was	O
elevated	O
1	O
day	O
after	O
pilocarpine	O
treatment	O
.	O
Pilocarpine	O
treatment	O
,	O
like	O
gene1s	ARG2
cpa6	ARG2
gene1e	ARG2
knockdown	O
,	O
led	O
to	O
a	O
reduced	O
sensitivity	O
to	O
pentylenetetrazole	O
when	O
tested	O
1	O
day	O
after	O
pilocarpine	O
treatment	O
.	O
Taken	O
together	O
,	O
these	O
results	O
add	O
to	O
mounting	O
evidence	O
that	O
peptidergic	O
systems	O
participate	O
in	O
the	O
biological	O
effects	O
of	O
seizure	O
-	O
inducing	O
drugs	O
,	O
and	O
are	O
the	O
first	O
in	O
vivo	O
demonstration	O
of	O
the	O
molecular	O
and	O
behavioral	O
consequences	O
of	O
gene1s	ARG2
cpa6	ARG2
gene1e	ARG2
insufficiency	O
.	O

Knockdown	O
of	O
gene1s	O
Carboxypeptidase	O
A6	O
gene1e	O
in	O
species1s	O
Zebrafish	O
species1e	O
Larvae	O
Reduces	O
Response	O
to	O
Seizure	O
-	O
Inducing	O
Drugs	O
and	O
Causes	O
Changes	O
in	O
the	O
Level	O
of	O
mRNAs	O
Encoding	O
Signaling	O
Molecules	O
.	O
gene1s	O
Carboxypeptidase	O
A6	O
gene1e	O
(	O
gene1s	O
CPA6	O
gene1e	O
)	O
is	O
an	O
extracellular	O
matrix	O
metallocarboxypeptidase	O
that	O
modulates	O
peptide	O
and	O
protein	O
function	O
by	O
removal	O
of	O
hydrophobic	O
C	O
-	O
terminal	O
amino	O
acids	O
.	O
Mutations	O
in	O
the	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
CPA6	ARG2
gene1e	ARG2
gene	O
that	O
reduce	O
enzymatic	O
activity	O
in	O
the	O
extracellular	O
matrix	O
are	O
associated	O
with	O
febrile	O
seizures	O
,	O
temporal	O
lobe	O
epilepsy	O
,	O
and	O
juvenile	O
myoclonic	O
epilepsy	O
.	O
The	O
characterization	O
of	O
these	O
arg1s	O
human	O
arg1e	O
mutations	O
suggests	O
a	O
dominant	O
mode	O
of	O
inheritance	O
by	O
haploinsufficiency	O
through	O
loss	O
of	O
function	O
mutations	O
,	O
however	O
the	O
total	O
number	O
of	O
arg1s	O
humans	O
arg1e	O
with	O
pathologic	O
mutations	O
in	O
gene1s	ARG2
CPA6	ARG2
gene1e	ARG2
identified	O
to	O
date	O
remains	O
small	O
.	O
To	O
better	O
understand	O
the	O
relationship	O
between	O
gene1s	O
CPA6	O
gene1e	O
and	O
seizures	O
we	O
investigated	O
the	O
effects	O
of	O
morpholino	O
knockdown	O
of	O
gene1s	O
cpa6	O
gene1e	O
mRNA	O
in	O
species1s	O
zebrafish	O
species1e	O
(	O
species1s	O
Danio	O
rerio	O
species1e	O
)	O
larvae	O
.	O
Knockdown	O
of	O
gene1s	O
cpa6	O
gene1e	O
mRNA	O
resulted	O
in	O
resistance	O
to	O
the	O
effect	O
of	O
seizure	O
-	O
inducing	O
drugs	O
pentylenetetrazole	O
and	O
pilocarpine	O
on	O
swimming	O
behaviors	O
.	O
Knockdown	O
of	O
gene1s	O
cpa6	O
gene1e	O
mRNA	O
also	O
reduced	O
the	O
levels	O
of	O
mRNAs	O
encoding	O
neuropeptide	O
precursors	O
(	O
gene1s	O
bdnf	O
gene1e	O
,	O
gene1s	O
npy	O
gene1e	O
,	O
gene1s	O
chga	O
gene1e	O
,	O
gene1s	O
pcsk1nl	O
gene1e	O
,	O
gene1s	O
tac1	O
gene1e	O
,	O
gene1s	O
nts	O
gene1e	O
,	O
gene1s	O
edn1	O
gene1e	O
)	O
,	O
a	O
gene1s	O
neuropeptide	O
processing	O
enzyme	O
gene1e	O
(	O
gene1s	O
cpe	O
gene1e	O
)	O
,	O
gene1s	O
transcription	O
factor	O
gene1e	O
(	O
gene1s	O
c	O
-	O
fos	O
gene1e	O
)	O
,	O
and	O
molecules	O
implicated	O
in	O
glutamatergic	O
signaling	O
(	O
gene1s	O
grin1a	O
gene1e	O
and	O
gene1s	O
slc1a2b	O
gene1e	O
)	O
.	O
Treatment	O
of	O
species1s	O
zebrafish	O
species1e	O
embryos	O
with	O
60	O
mM	O
pilocarpine	O
for	O
1	O
hour	O
led	O
to	O
reductions	O
in	O
levels	O
of	O
many	O
of	O
the	O
same	O
mRNAs	O
when	O
measured	O
1	O
day	O
after	O
pilocarpine	O
exposure	O
,	O
except	O
for	O
gene1s	O
c	O
-	O
fos	O
gene1e	O
which	O
was	O
elevated	O
1	O
day	O
after	O
pilocarpine	O
treatment	O
.	O
Pilocarpine	O
treatment	O
,	O
like	O
gene1s	O
cpa6	O
gene1e	O
knockdown	O
,	O
led	O
to	O
a	O
reduced	O
sensitivity	O
to	O
pentylenetetrazole	O
when	O
tested	O
1	O
day	O
after	O
pilocarpine	O
treatment	O
.	O
Taken	O
together	O
,	O
these	O
results	O
add	O
to	O
mounting	O
evidence	O
that	O
peptidergic	O
systems	O
participate	O
in	O
the	O
biological	O
effects	O
of	O
seizure	O
-	O
inducing	O
drugs	O
,	O
and	O
are	O
the	O
first	O
in	O
vivo	O
demonstration	O
of	O
the	O
molecular	O
and	O
behavioral	O
consequences	O
of	O
gene1s	O
cpa6	O
gene1e	O
insufficiency	O
.	O

Aberrant	O
expression	O
of	O
costimulatory	O
molecules	O
in	O
splenocytes	O
of	O
the	O
gene1s	ARG2
mevalonate	ARG2
kinase	ARG2
gene1e	ARG2
-	O
deficient	O
arg1s	O
mouse	O
arg1e	O
model	O
of	O
species1s	O
human	O
species1e	O
hyper	O
-	O
gene1s	ARG2
IgD	ARG2
gene1e	ARG2
syndrome	O
(	O
HIDS	O
)	O
.	O
OBJECTIVE	O
:	O
We	O
sought	O
to	O
determine	O
the	O
activation	O
status	O
and	O
proliferative	O
capacities	O
of	O
splenic	O
lymphocyte	O
populations	O
from	O
a	O
gene1s	ARG2
mevalonate	ARG2
kinase	ARG2
gene1e	ARG2
-	O
deficient	O
arg1s	O
mouse	O
arg1e	O
model	O
of	O
hyper	O
-	O
gene1s	ARG2
IgD	ARG2
gene1e	ARG2
syndrome	O
(	O
HIDS	O
)	O
.	O
We	O
previously	O
reported	O
that	O
arg1s	O
murine	O
arg1e	O
gene1s	ARG2
mevalonate	ARG2
kinase	ARG2
gene1e	ARG2
gene	O
ablation	O
was	O
embryonic	O
lethal	O
for	O
homozygous	O
mutants	O
while	O
heterozygotes	O
(	O
gene1s	ARG2
Mvk	ARG2
gene1e	ARG2
(	O
+	O
/-	O
)	O
)	O
demonstrated	O
several	O
phenotypic	O
features	O
of	O
species1s	O
human	O
species1e	O
HIDS	O
including	O
increased	O
serum	O
levels	O
of	O
gene1s	ARG2
IgD	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IgA	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
TNFa	ARG2
gene1e	ARG2
,	O
temperature	O
dysregulation	O
,	O
hematological	O
abnormalities	O
,	O
and	O
splenomegaly	O
.	O
METHODS	O
AND	O
RESULTS	O
:	O
Flow	O
cytometric	O
analysis	O
of	O
cell	O
surface	O
activation	O
markers	O
on	O
T	O
and	O
B	O
lymphocytes	O
,	O
and	O
macrophage	O
populations	O
,	O
demonstrated	O
aberrant	O
expression	O
of	O
gene1s	ARG2
B7	ARG2
glycoproteins	ARG2
gene1e	ARG2
in	O
all	O
splenic	O
cell	O
types	O
studied	O
.	O
Differences	O
in	O
expression	O
levels	O
between	O
gene1s	ARG2
Mvk	ARG2
gene1e	ARG2
(	O
+	O
/-	O
)	O
and	O
gene1s	ARG2
Mvk	ARG2
gene1e	ARG2
(	O
+	O
/+	O
)	O
littermate	O
controls	O
were	O
observed	O
in	O
both	O
the	O
basal	O
state	O
(	O
unstimulated	O
)	O
and	O
after	O
Concanavalin	O
A	O
(	O
Con	O
-	O
A	O
)	O
stimulation	O
in	O
vitro	O
of	O
whole	O
splenocyte	O
cultures	O
.	O
In	O
gene1s	ARG2
Mvk	ARG2
gene1e	ARG2
(	O
+	O
/-	O
)	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
T	O
cells	O
,	O
alterations	O
in	O
expression	O
of	O
gene1s	ARG2
CD25	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD80	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD152	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
CD28	ARG2
gene1e	ARG2
were	O
observed	O
.	O
gene1s	ARG2
Mvk	ARG2
gene1e	ARG2
(	O
+	O
/-	O
)	O
splenic	O
macrophages	O
expressed	O
altered	O
levels	O
of	O
gene1s	ARG2
CD80	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD86	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD40	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
CD11c	ARG2
gene1e	ARG2
while	O
gene1s	ARG2
Mvk	ARG2
gene1e	ARG2
(	O
+	O
/-	O
)	O
B	O
lymphocytes	O
had	O
differential	O
expression	O
of	O
gene1s	ARG2
CD40	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD80	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
CD86	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
Mvk	ARG2
gene1e	ARG2
(	O
+	O
/-	O
)	O
splenocyte	O
subpopulations	O
also	O
exhibited	O
altered	O
proliferative	O
capacities	O
in	O
response	O
to	O
in	O
vitro	O
stimulation	O
.	O
CONCLUSION	O
:	O
We	O
postulate	O
that	O
imbalances	O
in	O
the	O
expression	O
of	O
cell	O
surface	O
proteins	O
necessary	O
for	O
activation	O
,	O
proliferation	O
,	O
and	O
regulation	O
of	O
the	O
intensity	O
and	O
duration	O
of	O
an	O
immune	O
response	O
may	O
result	O
in	O
defective	O
T	O
cell	O
activation	O
,	O
proliferation	O
,	O
and	O
effector	O
functions	O
in	O
our	O
model	O
and	O
potentially	O
in	O
species1s	O
human	O
species1e	O
HIDS	O
.	O

Aberrant	O
expression	O
of	O
costimulatory	O
molecules	O
in	O
splenocytes	O
of	O
the	O
gene1s	O
mevalonate	O
kinase	O
gene1e	O
-	O
deficient	O
species1s	O
mouse	O
species1e	O
model	O
of	O
arg1s	O
human	O
arg1e	O
hyper	O
-	O
gene1s	O
IgD	O
gene1e	O
syndrome	O
(	O
HIDS	O
)	O
.	O
OBJECTIVE	O
:	O
We	O
sought	O
to	O
determine	O
the	O
activation	O
status	O
and	O
proliferative	O
capacities	O
of	O
splenic	O
lymphocyte	O
populations	O
from	O
a	O
gene1s	O
mevalonate	O
kinase	O
gene1e	O
-	O
deficient	O
species1s	O
mouse	O
species1e	O
model	O
of	O
hyper	O
-	O
gene1s	O
IgD	O
gene1e	O
syndrome	O
(	O
HIDS	O
)	O
.	O
We	O
previously	O
reported	O
that	O
species1s	O
murine	O
species1e	O
gene1s	O
mevalonate	O
kinase	O
gene1e	O
gene	O
ablation	O
was	O
embryonic	O
lethal	O
for	O
homozygous	O
mutants	O
while	O
heterozygotes	O
(	O
gene1s	O
Mvk	O
gene1e	O
(	O
+	O
/-	O
)	O
)	O
demonstrated	O
several	O
phenotypic	O
features	O
of	O
arg1s	O
human	O
arg1e	O
HIDS	O
including	O
increased	O
serum	O
levels	O
of	O
gene1s	O
IgD	O
gene1e	O
,	O
gene1s	O
IgA	O
gene1e	O
,	O
and	O
gene1s	O
TNFa	O
gene1e	O
,	O
temperature	O
dysregulation	O
,	O
hematological	O
abnormalities	O
,	O
and	O
splenomegaly	O
.	O
METHODS	O
AND	O
RESULTS	O
:	O
Flow	O
cytometric	O
analysis	O
of	O
cell	O
surface	O
activation	O
markers	O
on	O
T	O
and	O
B	O
lymphocytes	O
,	O
and	O
macrophage	O
populations	O
,	O
demonstrated	O
aberrant	O
expression	O
of	O
gene1s	O
B7	O
glycoproteins	O
gene1e	O
in	O
all	O
splenic	O
cell	O
types	O
studied	O
.	O
Differences	O
in	O
expression	O
levels	O
between	O
gene1s	O
Mvk	O
gene1e	O
(	O
+	O
/-	O
)	O
and	O
gene1s	O
Mvk	O
gene1e	O
(	O
+	O
/+	O
)	O
littermate	O
controls	O
were	O
observed	O
in	O
both	O
the	O
basal	O
state	O
(	O
unstimulated	O
)	O
and	O
after	O
Concanavalin	O
A	O
(	O
Con	O
-	O
A	O
)	O
stimulation	O
in	O
vitro	O
of	O
whole	O
splenocyte	O
cultures	O
.	O
In	O
gene1s	O
Mvk	O
gene1e	O
(	O
+	O
/-	O
)	O
gene1s	O
CD4	O
gene1e	O
and	O
gene1s	O
CD8	O
gene1e	O
T	O
cells	O
,	O
alterations	O
in	O
expression	O
of	O
gene1s	O
CD25	O
gene1e	O
,	O
gene1s	O
CD80	O
gene1e	O
,	O
gene1s	O
CD152	O
gene1e	O
,	O
and	O
gene1s	O
CD28	O
gene1e	O
were	O
observed	O
.	O
gene1s	O
Mvk	O
gene1e	O
(	O
+	O
/-	O
)	O
splenic	O
macrophages	O
expressed	O
altered	O
levels	O
of	O
gene1s	O
CD80	O
gene1e	O
,	O
gene1s	O
CD86	O
gene1e	O
,	O
gene1s	O
CD40	O
gene1e	O
,	O
and	O
gene1s	O
CD11c	O
gene1e	O
while	O
gene1s	O
Mvk	O
gene1e	O
(	O
+	O
/-	O
)	O
B	O
lymphocytes	O
had	O
differential	O
expression	O
of	O
gene1s	O
CD40	O
gene1e	O
,	O
gene1s	O
CD80	O
gene1e	O
,	O
and	O
gene1s	O
CD86	O
gene1e	O
.	O
gene1s	O
Mvk	O
gene1e	O
(	O
+	O
/-	O
)	O
splenocyte	O
subpopulations	O
also	O
exhibited	O
altered	O
proliferative	O
capacities	O
in	O
response	O
to	O
in	O
vitro	O
stimulation	O
.	O
CONCLUSION	O
:	O
We	O
postulate	O
that	O
imbalances	O
in	O
the	O
expression	O
of	O
cell	O
surface	O
proteins	O
necessary	O
for	O
activation	O
,	O
proliferation	O
,	O
and	O
regulation	O
of	O
the	O
intensity	O
and	O
duration	O
of	O
an	O
immune	O
response	O
may	O
result	O
in	O
defective	O
T	O
cell	O
activation	O
,	O
proliferation	O
,	O
and	O
effector	O
functions	O
in	O
our	O
model	O
and	O
potentially	O
in	O
arg1s	O
human	O
arg1e	O
HIDS	O
.	O

Salidroside	O
Ameliorates	O
Renal	O
Interstitial	O
Fibrosis	O
by	O
Inhibiting	O
the	O
gene1s	O
TLR4	O
gene1e	O
/	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
and	O
gene1s	O
MAPK	O
gene1e	O
Signaling	O
Pathways	O
.	O
Salidroside	O
(	O
Sal	O
)	O
is	O
an	O
active	O
ingredient	O
that	O
is	O
isolated	O
from	O
arg1s	O
Rhodiola	O
rosea	O
arg1e	O
,	O
which	O
has	O
been	O
reported	O
to	O
have	O
anti	O
-	O
inflammatory	O
activities	O
and	O
a	O
renal	O
protective	O
effect	O
.	O
However	O
,	O
the	O
role	O
of	O
Sal	O
on	O
renal	O
fibrosis	O
has	O
not	O
yet	O
been	O
elucidated	O
.	O
Here	O
,	O
the	O
purpose	O
of	O
the	O
current	O
study	O
is	O
to	O
test	O
the	O
protective	O
effects	O
of	O
Sal	O
against	O
renal	O
interstitial	O
fibrosis	O
(	O
RIF	O
)	O
,	O
and	O
to	O
explore	O
the	O
underlying	O
mechanisms	O
using	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
models	O
.	O
In	O
this	O
study	O
,	O
we	O
establish	O
the	O
unilateral	O
ureteric	O
obstruction	O
(	O
UUO	O
)	O
or	O
folic	O
acid	O
(	O
FA)-induced	O
species1s	O
mice	O
species1e	O
renal	O
interstitial	O
fibrosis	O
in	O
vivo	O
and	O
the	O
transforming	O
growth	O
factor	O
(	O
TGF)-beta1-stimulated	O
species1s	O
human	O
species1e	O
proximal	O
tubular	O
epithelial	O
cell	O
(	O
HK-2	O
)	O
model	O
in	O
vitro	O
.	O
The	O
levels	O
of	O
kidney	O
functional	O
parameters	O
and	O
inflammatory	O
cytokines	O
in	O
serum	O
are	O
examined	O
.	O
The	O
degree	O
of	O
renal	O
damage	O
and	O
fibrosis	O
is	O
determined	O
by	O
histological	O
assessment	O
.	O
Immunohistochemistry	O
and	O
western	O
blotting	O
are	O
used	O
to	O
determine	O
the	O
mechanisms	O
of	O
Sal	O
against	O
RIF	O
.	O
Our	O
results	O
show	O
that	O
treatment	O
with	O
Sal	O
can	O
ameliorate	O
tubular	O
injury	O
and	O
deposition	O
of	O
the	O
extracellular	O
matrix	O
(	O
ECM	O
)	O
components	O
(	O
including	O
gene1s	O
collagen	O
SH	O
gene1e	O
and	O
gene1s	O
collagen	O
I	O
gene1e	O
)	O
.	O
Furthermore	O
,	O
Sal	O
administration	O
significantly	O
suppresses	O
epithelial	O
-	O
mesenchymal	O
transition	O
(	O
EMT	O
)	O
,	O
as	O
evidenced	O
by	O
a	O
decreased	O
expression	O
of	O
gene1s	O
alpha	O
-	O
SMA	O
gene1e	O
,	O
gene1s	O
vimentin	O
gene1e	O
,	O
gene1s	O
TGF	O
-	O
beta1	O
gene1e	O
,	O
gene1s	O
snail	O
gene1e	O
,	O
gene1s	O
slug	O
gene1e	O
,	O
and	O
a	O
largely	O
restored	O
expression	O
of	O
gene1s	O
E	O
-	O
cadherin	O
gene1e	O
.	O
Additionally	O
,	O
Sal	O
also	O
reduces	O
the	O
levels	O
of	O
serum	O
biochemical	O
markers	O
(	O
serum	O
creatinine	O
,	O
Scr	O
;	O
blood	O
urea	O
nitrogen	O
,	O
BUN	O
;	O
and	O
uric	O
acid	O
,	O
UA	O
)	O
and	O
decreases	O
the	O
release	O
of	O
inflammatory	O
gene1s	O
cytokines	O
gene1e	O
(	O
gene1s	O
IL-1beta	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
gene1s	O
TNF	O
-	O
alpha	O
gene1e	O
)	O
.	O
Further	O
study	O
revealed	O
that	O
the	O
effect	O
of	O
Sal	O
on	O
renal	O
interstitial	O
fibrosis	O
is	O
associated	O
with	O
the	O
lower	O
expression	O
of	O
gene1s	O
TLR4	O
gene1e	O
,	O
p	O
-	O
gene1s	O
IkappaBalpha	O
gene1e	O
,	O
p	O
-	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
and	O
gene1s	O
mitogen	O
-	O
activated	O
protein	O
kinases	O
gene1e	O
(	O
gene1s	O
MAPK	O
gene1e	O
)	O
,	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O
In	O
conclusion	O
,	O
Sal	O
treatment	O
improves	O
kidney	O
function	O
,	O
ameliorates	O
the	O
deposition	O
of	O
the	O
ECM	O
components	O
and	O
relieves	O
the	O
protein	O
levels	O
of	O
EMT	O
markers	O
in	O
species1s	O
mouse	O
species1e	O
kidneys	O
and	O
HK-2	O
cells	O
.	O
Furthermore	O
,	O
Sal	O
treatment	O
significantly	O
decreases	O
the	O
release	O
of	O
inflammatory	O
cytokines	O
and	O
inhibits	O
the	O
gene1s	O
TLR4	O
gene1e	O
/	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
and	O
gene1s	O
MAPK	O
gene1e	O
signaling	O
pathways	O
.	O
Collectively	O
,	O
these	O
results	O
suggest	O
that	O
the	O
administration	O
of	O
Sal	O
could	O
be	O
a	O
novel	O
therapeutic	O
strategy	O
in	O
treating	O
renal	O
fibrosis	O
.	O

Salidroside	O
Ameliorates	O
Renal	O
Interstitial	O
Fibrosis	O
by	O
Inhibiting	O
the	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
Signaling	O
Pathways	O
.	O
Salidroside	O
(	O
Sal	O
)	O
is	O
an	O
active	O
ingredient	O
that	O
is	O
isolated	O
from	O
species1s	O
Rhodiola	O
rosea	O
species1e	O
,	O
which	O
has	O
been	O
reported	O
to	O
have	O
anti	O
-	O
inflammatory	O
activities	O
and	O
a	O
renal	O
protective	O
effect	O
.	O
However	O
,	O
the	O
role	O
of	O
Sal	O
on	O
renal	O
fibrosis	O
has	O
not	O
yet	O
been	O
elucidated	O
.	O
Here	O
,	O
the	O
purpose	O
of	O
the	O
current	O
study	O
is	O
to	O
test	O
the	O
protective	O
effects	O
of	O
Sal	O
against	O
renal	O
interstitial	O
fibrosis	O
(	O
RIF	O
)	O
,	O
and	O
to	O
explore	O
the	O
underlying	O
mechanisms	O
using	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
models	O
.	O
In	O
this	O
study	O
,	O
we	O
establish	O
the	O
unilateral	O
ureteric	O
obstruction	O
(	O
UUO	O
)	O
or	O
folic	O
acid	O
(	O
FA)-induced	O
arg1s	O
mice	O
arg1e	O
renal	O
interstitial	O
fibrosis	O
in	O
vivo	O
and	O
the	O
transforming	O
growth	O
factor	O
(	O
TGF)-beta1-stimulated	O
species1s	O
human	O
species1e	O
proximal	O
tubular	O
epithelial	O
cell	O
(	O
HK-2	O
)	O
model	O
in	O
vitro	O
.	O
The	O
levels	O
of	O
kidney	O
functional	O
parameters	O
and	O
inflammatory	O
cytokines	O
in	O
serum	O
are	O
examined	O
.	O
The	O
degree	O
of	O
renal	O
damage	O
and	O
fibrosis	O
is	O
determined	O
by	O
histological	O
assessment	O
.	O
Immunohistochemistry	O
and	O
western	O
blotting	O
are	O
used	O
to	O
determine	O
the	O
mechanisms	O
of	O
Sal	O
against	O
RIF	O
.	O
Our	O
results	O
show	O
that	O
treatment	O
with	O
Sal	O
can	O
ameliorate	O
tubular	O
injury	O
and	O
deposition	O
of	O
the	O
extracellular	O
matrix	O
(	O
ECM	O
)	O
components	O
(	O
including	O
gene1s	ARG2
collagen	ARG2
SH	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
collagen	ARG2
I	ARG2
gene1e	ARG2
)	O
.	O
Furthermore	O
,	O
Sal	O
administration	O
significantly	O
suppresses	O
epithelial	O
-	O
mesenchymal	O
transition	O
(	O
EMT	O
)	O
,	O
as	O
evidenced	O
by	O
a	O
decreased	O
expression	O
of	O
gene1s	ARG2
alpha	ARG2
-	ARG2
SMA	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
vimentin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TGF	ARG2
-	ARG2
beta1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
snail	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
slug	ARG2
gene1e	ARG2
,	O
and	O
a	O
largely	O
restored	O
expression	O
of	O
gene1s	ARG2
E	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
.	O
Additionally	O
,	O
Sal	O
also	O
reduces	O
the	O
levels	O
of	O
serum	O
biochemical	O
markers	O
(	O
serum	O
creatinine	O
,	O
Scr	O
;	O
blood	O
urea	O
nitrogen	O
,	O
BUN	O
;	O
and	O
uric	O
acid	O
,	O
UA	O
)	O
and	O
decreases	O
the	O
release	O
of	O
inflammatory	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IL-1beta	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
)	O
.	O
Further	O
study	O
revealed	O
that	O
the	O
effect	O
of	O
Sal	O
on	O
renal	O
interstitial	O
fibrosis	O
is	O
associated	O
with	O
the	O
lower	O
expression	O
of	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
,	O
p	O
-	O
gene1s	ARG2
IkappaBalpha	ARG2
gene1e	ARG2
,	O
p	O
-	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
mitogen	ARG2
-	ARG2
activated	ARG2
protein	ARG2
kinases	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
)	O
,	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O
In	O
conclusion	O
,	O
Sal	O
treatment	O
improves	O
kidney	O
function	O
,	O
ameliorates	O
the	O
deposition	O
of	O
the	O
ECM	O
components	O
and	O
relieves	O
the	O
protein	O
levels	O
of	O
EMT	O
markers	O
in	O
arg1s	O
mouse	O
arg1e	O
kidneys	O
and	O
HK-2	O
cells	O
.	O
Furthermore	O
,	O
Sal	O
treatment	O
significantly	O
decreases	O
the	O
release	O
of	O
inflammatory	O
cytokines	O
and	O
inhibits	O
the	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
signaling	O
pathways	O
.	O
Collectively	O
,	O
these	O
results	O
suggest	O
that	O
the	O
administration	O
of	O
Sal	O
could	O
be	O
a	O
novel	O
therapeutic	O
strategy	O
in	O
treating	O
renal	O
fibrosis	O
.	O

Salidroside	O
Ameliorates	O
Renal	O
Interstitial	O
Fibrosis	O
by	O
Inhibiting	O
the	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
Signaling	O
Pathways	O
.	O
Salidroside	O
(	O
Sal	O
)	O
is	O
an	O
active	O
ingredient	O
that	O
is	O
isolated	O
from	O
species1s	O
Rhodiola	O
rosea	O
species1e	O
,	O
which	O
has	O
been	O
reported	O
to	O
have	O
anti	O
-	O
inflammatory	O
activities	O
and	O
a	O
renal	O
protective	O
effect	O
.	O
However	O
,	O
the	O
role	O
of	O
Sal	O
on	O
renal	O
fibrosis	O
has	O
not	O
yet	O
been	O
elucidated	O
.	O
Here	O
,	O
the	O
purpose	O
of	O
the	O
current	O
study	O
is	O
to	O
test	O
the	O
protective	O
effects	O
of	O
Sal	O
against	O
renal	O
interstitial	O
fibrosis	O
(	O
RIF	O
)	O
,	O
and	O
to	O
explore	O
the	O
underlying	O
mechanisms	O
using	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
models	O
.	O
In	O
this	O
study	O
,	O
we	O
establish	O
the	O
unilateral	O
ureteric	O
obstruction	O
(	O
UUO	O
)	O
or	O
folic	O
acid	O
(	O
FA)-induced	O
species1s	O
mice	O
species1e	O
renal	O
interstitial	O
fibrosis	O
in	O
vivo	O
and	O
the	O
transforming	O
growth	O
factor	O
(	O
TGF)-beta1-stimulated	O
arg1s	O
human	O
arg1e	O
proximal	O
tubular	O
epithelial	O
cell	O
(	O
HK-2	O
)	O
model	O
in	O
vitro	O
.	O
The	O
levels	O
of	O
kidney	O
functional	O
parameters	O
and	O
inflammatory	O
cytokines	O
in	O
serum	O
are	O
examined	O
.	O
The	O
degree	O
of	O
renal	O
damage	O
and	O
fibrosis	O
is	O
determined	O
by	O
histological	O
assessment	O
.	O
Immunohistochemistry	O
and	O
western	O
blotting	O
are	O
used	O
to	O
determine	O
the	O
mechanisms	O
of	O
Sal	O
against	O
RIF	O
.	O
Our	O
results	O
show	O
that	O
treatment	O
with	O
Sal	O
can	O
ameliorate	O
tubular	O
injury	O
and	O
deposition	O
of	O
the	O
extracellular	O
matrix	O
(	O
ECM	O
)	O
components	O
(	O
including	O
gene1s	ARG2
collagen	ARG2
SH	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
collagen	ARG2
I	ARG2
gene1e	ARG2
)	O
.	O
Furthermore	O
,	O
Sal	O
administration	O
significantly	O
suppresses	O
epithelial	O
-	O
mesenchymal	O
transition	O
(	O
EMT	O
)	O
,	O
as	O
evidenced	O
by	O
a	O
decreased	O
expression	O
of	O
gene1s	ARG2
alpha	ARG2
-	ARG2
SMA	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
vimentin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TGF	ARG2
-	ARG2
beta1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
snail	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
slug	ARG2
gene1e	ARG2
,	O
and	O
a	O
largely	O
restored	O
expression	O
of	O
gene1s	ARG2
E	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
.	O
Additionally	O
,	O
Sal	O
also	O
reduces	O
the	O
levels	O
of	O
serum	O
biochemical	O
markers	O
(	O
serum	O
creatinine	O
,	O
Scr	O
;	O
blood	O
urea	O
nitrogen	O
,	O
BUN	O
;	O
and	O
uric	O
acid	O
,	O
UA	O
)	O
and	O
decreases	O
the	O
release	O
of	O
inflammatory	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IL-1beta	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
)	O
.	O
Further	O
study	O
revealed	O
that	O
the	O
effect	O
of	O
Sal	O
on	O
renal	O
interstitial	O
fibrosis	O
is	O
associated	O
with	O
the	O
lower	O
expression	O
of	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
,	O
p	O
-	O
gene1s	ARG2
IkappaBalpha	ARG2
gene1e	ARG2
,	O
p	O
-	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
mitogen	ARG2
-	ARG2
activated	ARG2
protein	ARG2
kinases	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
)	O
,	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O
In	O
conclusion	O
,	O
Sal	O
treatment	O
improves	O
kidney	O
function	O
,	O
ameliorates	O
the	O
deposition	O
of	O
the	O
ECM	O
components	O
and	O
relieves	O
the	O
protein	O
levels	O
of	O
EMT	O
markers	O
in	O
species1s	O
mouse	O
species1e	O
kidneys	O
and	O
HK-2	O
cells	O
.	O
Furthermore	O
,	O
Sal	O
treatment	O
significantly	O
decreases	O
the	O
release	O
of	O
inflammatory	O
cytokines	O
and	O
inhibits	O
the	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
signaling	O
pathways	O
.	O
Collectively	O
,	O
these	O
results	O
suggest	O
that	O
the	O
administration	O
of	O
Sal	O
could	O
be	O
a	O
novel	O
therapeutic	O
strategy	O
in	O
treating	O
renal	O
fibrosis	O
.	O

Microparticles	O
carrying	O
gene1s	O
Sonic	O
hedgehog	O
gene1e	O
favor	O
neovascularization	O
through	O
the	O
activation	O
of	O
nitric	O
oxide	O
pathway	O
in	O
arg1s	O
mice	O
arg1e	O
.	O
BACKGROUND	O
:	O
Microparticles	O
(	O
MPs	O
)	O
are	O
vesicles	O
released	O
from	O
plasma	O
membrane	O
upon	O
cell	O
activation	O
and	O
during	O
apoptosis	O
.	O
species1s	O
Human	O
species1e	O
T	O
lymphocytes	O
undergoing	O
activation	O
and	O
apoptosis	O
generate	O
MPs	O
bearing	O
morphogen	O
gene1s	O
Shh	O
gene1e	O
(	O
MPs(	O
gene1s	O
Shh	O
gene1e	O
+	O
)	O
)	O
that	O
are	O
able	O
to	O
regulate	O
in	O
vitro	O
angiogenesis	O
.	O
METHODOLOGY	O
/	O
PRINCIPAL	O
FINDINGS	O
:	O
Here	O
,	O
we	O
investigated	O
the	O
ability	O
of	O
MPs(	O
gene1s	O
Shh	O
gene1e	O
+	O
)	O
to	O
modulate	O
neovascularization	O
in	O
a	O
model	O
of	O
arg1s	O
mouse	O
arg1e	O
hind	O
limb	O
ischemia	O
.	O
arg1s	O
Mice	O
arg1e	O
were	O
treated	O
in	O
vivo	O
for	O
21	O
days	O
with	O
vehicle	O
,	O
MPs(	O
gene1s	O
Shh	O
gene1e	O
+	O
)	O
,	O
MPs(	O
gene1s	O
Shh	O
gene1e	O
+	O
)	O
plus	O
cyclopamine	O
or	O
cyclopamine	O
alone	O
,	O
an	O
inhibitor	O
of	O
gene1s	O
Shh	O
gene1e	O
signalling	O
.	O
Laser	O
doppler	O
analysis	O
revealed	O
that	O
the	O
recovery	O
of	O
the	O
blood	O
flow	O
was	O
1.4	O
fold	O
higher	O
in	O
MPs(	O
gene1s	O
Shh	O
gene1e	O
+)-treated	O
arg1s	O
mice	O
arg1e	O
than	O
in	O
controls	O
,	O
and	O
this	O
was	O
associated	O
with	O
an	O
activation	O
of	O
gene1s	O
Shh	O
gene1e	O
pathway	O
in	O
muscles	O
and	O
an	O
increase	O
in	O
NO	O
production	O
in	O
both	O
aorta	O
and	O
muscles	O
.	O
MPs(	O
gene1s	O
Shh	O
gene1e	O
+)-mediated	O
effects	O
on	O
flow	O
recovery	O
and	O
NO	O
production	O
were	O
completely	O
prevented	O
when	O
gene1s	O
Shh	O
gene1e	O
signalling	O
was	O
inhibited	O
by	O
cyclopamine	O
.	O
In	O
aorta	O
,	O
MPs(	O
gene1s	O
Shh	O
gene1e	O
+	O
)	O
increased	O
activation	O
of	O
gene1s	ARG2
eNOS	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
pathway	O
,	O
and	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
expression	O
,	O
being	O
inhibited	O
by	O
cyclopamine	O
.	O
By	O
contrast	O
,	O
in	O
muscles	O
,	O
MPs(	O
gene1s	O
Shh	O
gene1e	O
+	O
)	O
enhanced	O
gene1s	ARG2
eNOS	ARG2
gene1e	ARG2
expression	O
and	O
phosphorylation	O
and	O
decreased	O
gene1s	ARG2
caveolin-1	ARG2
gene1e	ARG2
expression	O
,	O
but	O
cyclopamine	O
prevented	O
only	O
the	O
effects	O
of	O
MPs(	O
gene1s	O
Shh	O
gene1e	O
+	O
)	O
on	O
gene1s	ARG2
eNOS	ARG2
gene1e	ARG2
pathway	O
.	O
Quantitative	O
RT	O
-	O
PCR	O
revealed	O
that	O
MPs(	O
gene1s	O
Shh	O
gene1e	O
+	O
)	O
treatment	O
increased	O
gene1s	ARG2
FGF5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
FGF2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
VEGF	ARG2
A	ARG2
and	ARG2
C	ARG2
gene1e	ARG2
mRNA	O
levels	O
and	O
decreased	O
those	O
of	O
gene1s	ARG2
alpha5-integrin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
FLT-4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HGF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IGF-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
KDR	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MCP-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MT1-MMP	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MMP-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TGFbeta1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TGFbeta2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TSP-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
VCAM-1	ARG2
gene1e	ARG2
,	O
in	O
ischemic	O
muscles	O
.	O
CONCLUSIONS	O
/	O
SIGNIFICANCE	O
:	O
These	O
findings	O
suggest	O
that	O
MPs(	O
gene1s	O
Shh	O
gene1e	O
+	O
)	O
may	O
contribute	O
to	O
reparative	O
neovascularization	O
after	O
ischemic	O
injury	O
by	O
regulating	O
NO	O
pathway	O
and	O
genes	O
involved	O
in	O
angiogenesis	O
.	O

Microparticles	O
carrying	O
gene1s	ARG2
Sonic	ARG2
hedgehog	ARG2
gene1e	ARG2
favor	O
neovascularization	O
through	O
the	O
activation	O
of	O
nitric	O
oxide	O
pathway	O
in	O
species1s	O
mice	O
species1e	O
.	O
BACKGROUND	O
:	O
Microparticles	O
(	O
MPs	O
)	O
are	O
vesicles	O
released	O
from	O
plasma	O
membrane	O
upon	O
cell	O
activation	O
and	O
during	O
apoptosis	O
.	O
arg1s	O
Human	O
arg1e	O
T	O
lymphocytes	O
undergoing	O
activation	O
and	O
apoptosis	O
generate	O
MPs	O
bearing	O
morphogen	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
(	O
MPs(	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
+	O
)	O
)	O
that	O
are	O
able	O
to	O
regulate	O
in	O
vitro	O
angiogenesis	O
.	O
METHODOLOGY	O
/	O
PRINCIPAL	O
FINDINGS	O
:	O
Here	O
,	O
we	O
investigated	O
the	O
ability	O
of	O
MPs(	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
+	O
)	O
to	O
modulate	O
neovascularization	O
in	O
a	O
model	O
of	O
species1s	O
mouse	O
species1e	O
hind	O
limb	O
ischemia	O
.	O
species1s	O
Mice	O
species1e	O
were	O
treated	O
in	O
vivo	O
for	O
21	O
days	O
with	O
vehicle	O
,	O
MPs(	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
+	O
)	O
,	O
MPs(	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
+	O
)	O
plus	O
cyclopamine	O
or	O
cyclopamine	O
alone	O
,	O
an	O
inhibitor	O
of	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
signalling	O
.	O
Laser	O
doppler	O
analysis	O
revealed	O
that	O
the	O
recovery	O
of	O
the	O
blood	O
flow	O
was	O
1.4	O
fold	O
higher	O
in	O
MPs(	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
+)-treated	O
species1s	O
mice	O
species1e	O
than	O
in	O
controls	O
,	O
and	O
this	O
was	O
associated	O
with	O
an	O
activation	O
of	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
pathway	O
in	O
muscles	O
and	O
an	O
increase	O
in	O
NO	O
production	O
in	O
both	O
aorta	O
and	O
muscles	O
.	O
MPs(	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
+)-mediated	O
effects	O
on	O
flow	O
recovery	O
and	O
NO	O
production	O
were	O
completely	O
prevented	O
when	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
signalling	O
was	O
inhibited	O
by	O
cyclopamine	O
.	O
In	O
aorta	O
,	O
MPs(	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
+	O
)	O
increased	O
activation	O
of	O
gene1s	O
eNOS	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
pathway	O
,	O
and	O
gene1s	O
VEGF	O
gene1e	O
expression	O
,	O
being	O
inhibited	O
by	O
cyclopamine	O
.	O
By	O
contrast	O
,	O
in	O
muscles	O
,	O
MPs(	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
+	O
)	O
enhanced	O
gene1s	O
eNOS	O
gene1e	O
expression	O
and	O
phosphorylation	O
and	O
decreased	O
gene1s	O
caveolin-1	O
gene1e	O
expression	O
,	O
but	O
cyclopamine	O
prevented	O
only	O
the	O
effects	O
of	O
MPs(	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
+	O
)	O
on	O
gene1s	O
eNOS	O
gene1e	O
pathway	O
.	O
Quantitative	O
RT	O
-	O
PCR	O
revealed	O
that	O
MPs(	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
+	O
)	O
treatment	O
increased	O
gene1s	O
FGF5	O
gene1e	O
,	O
gene1s	O
FGF2	O
gene1e	O
,	O
gene1s	O
VEGF	O
A	O
and	O
C	O
gene1e	O
mRNA	O
levels	O
and	O
decreased	O
those	O
of	O
gene1s	O
alpha5-integrin	O
gene1e	O
,	O
gene1s	O
FLT-4	O
gene1e	O
,	O
gene1s	O
HGF	O
gene1e	O
,	O
gene1s	O
IGF-1	O
gene1e	O
,	O
gene1s	O
KDR	O
gene1e	O
,	O
gene1s	O
MCP-1	O
gene1e	O
,	O
gene1s	O
MT1-MMP	O
gene1e	O
,	O
gene1s	O
MMP-2	O
gene1e	O
,	O
gene1s	O
TGFbeta1	O
gene1e	O
,	O
gene1s	O
TGFbeta2	O
gene1e	O
,	O
gene1s	O
TSP-1	O
gene1e	O
and	O
gene1s	O
VCAM-1	O
gene1e	O
,	O
in	O
ischemic	O
muscles	O
.	O
CONCLUSIONS	O
/	O
SIGNIFICANCE	O
:	O
These	O
findings	O
suggest	O
that	O
MPs(	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
+	O
)	O
may	O
contribute	O
to	O
reparative	O
neovascularization	O
after	O
ischemic	O
injury	O
by	O
regulating	O
NO	O
pathway	O
and	O
genes	O
involved	O
in	O
angiogenesis	O
.	O

Establishment	O
and	O
characterization	O
of	O
a	O
novel	O
gene1s	ARG2
MYC	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
BCL2	ARG2
gene1e	ARG2
"	O
double	O
-	O
hit	O
"	O
diffuse	O
large	O
B	O
cell	O
lymphoma	O
cell	O
line	O
,	O
RC	O
.	O
BACKGROUND	O
:	O
Diffuse	O
large	O
B	O
cell	O
lymphoma	O
(	O
DLBCL	O
)	O
is	O
the	O
most	O
common	O
type	O
of	O
lymphoid	O
malignancy	O
worldwide	O
.	O
Approximately	O
5	O
%	O
of	O
cases	O
of	O
DLBCL	O
are	O
so	O
-	O
called	O
double	O
-	O
hit	O
lymphomas	O
(	O
DHL	O
)	O
,	O
defined	O
by	O
a	O
chromosomal	O
translocation	O
or	O
rearrangement	O
involving	O
gene1s	ARG2
MYC	ARG2
gene1e	ARG2
/8q24.2	O
in	O
combination	O
with	O
another	O
recurrent	O
breakpoint	O
,	O
usually	O
gene1s	ARG2
BCL2	ARG2
gene1e	ARG2
/18q21.3	O
.	O
arg1s	O
Patients	O
arg1e	O
with	O
gene1s	ARG2
MYC	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
BCL2	ARG2
gene1e	ARG2
DHL	O
are	O
resistant	O
to	O
standard	O
front	O
-	O
line	O
therapy	O
,	O
and	O
currently	O
,	O
there	O
is	O
no	O
consensus	O
for	O
a	O
therapeutic	O
strategy	O
to	O
treat	O
these	O
arg1s	O
patients	O
arg1e	O
.	O
Lack	O
of	O
clinically	O
relevant	O
or	O
validated	O
arg1s	O
human	O
arg1e	O
experimental	O
DHL	O
models	O
of	O
any	O
type	O
that	O
would	O
improve	O
our	O
understanding	O
of	O
the	O
biologic	O
basis	O
of	O
gene1s	ARG2
MYC	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
BCL2	ARG2
gene1e	ARG2
DHL	O
pathophysiology	O
continues	O
to	O
hamper	O
identification	O
of	O
valid	O
therapeutic	O
targets	O
.	O
We	O
describe	O
a	O
unique	O
gene1s	ARG2
MYC	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
BCL2	ARG2
gene1e	ARG2
DHL	O
cell	O
line	O
with	O
morphologic	O
features	O
of	O
DLBCL	O
that	O
we	O
have	O
established	O
,	O
designated	O
as	O
RC	O
.	O
METHODS	O
:	O
We	O
used	O
tissue	O
culture	O
techniques	O
to	O
establish	O
the	O
RC	O
cell	O
line	O
from	O
primary	O
DLBCL	O
cells	O
.	O
We	O
also	O
utilized	O
molecular	O
and	O
cellular	O
biological	O
techniques	O
including	O
flow	O
cytometry	O
,	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
,	O
DNA	O
fingerprinting	O
,	O
reverse	O
-	O
phase	O
protein	O
array	O
,	O
conventional	O
cytogenetics	O
,	O
and	O
fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
analysis	O
to	O
characterize	O
the	O
RC	O
cell	O
line	O
.	O
NSG	O
-	O
severe	O
combined	O
immunodeficiency	O
(	O
SCID	O
)	O
species1s	O
mice	O
species1e	O
were	O
utilized	O
as	O
a	O
model	O
for	O
xeno	O
-	O
transplantation	O
of	O
RC	O
cells	O
.	O
RESULTS	O
:	O
RC	O
cells	O
had	O
the	O
following	O
immunophenotype	O
:	O
positive	O
for	O
gene1s	ARG2
CD10	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD19	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD20	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD22	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD38	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD43	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD44	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
CD79b	ARG2
gene1e	ARG2
and	O
negative	O
for	O
gene1s	ARG2
CD3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD11c	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD14	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD30	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD56	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
CD200	ARG2
gene1e	ARG2
,	O
which	O
was	O
identical	O
to	O
the	O
primary	O
tumor	O
cells	O
.	O
Conventional	O
cytogenetic	O
analysis	O
showed	O
a	O
t(2;8)(p12;q24.2	O
)	O
and	O
t(14;18)(q32;q21.3	O
)	O
,	O
corresponding	O
to	O
gene1s	ARG2
MYC	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
BCL2	ARG2
gene1e	ARG2
gene	O
rearrangements	O
,	O
respectively	O
.	O
DNA	O
fingerprinting	O
authenticated	O
the	O
RC	O
cell	O
line	O
to	O
be	O
of	O
the	O
same	O
clone	O
as	O
the	O
primary	O
tumor	O
cells	O
.	O
In	O
addition	O
,	O
RC	O
cells	O
were	O
established	O
in	O
SCID	O
species1s	O
mice	O
species1e	O
as	O
an	O
in	O
vivo	O
model	O
for	O
translational	O
therapeutics	O
studies	O
.	O
Proteomic	O
analysis	O
showed	O
activation	O
of	O
the	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
signaling	O
pathway	O
in	O
RC	O
cells	O
that	O
can	O
be	O
targeted	O
with	O
an	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
inhibitor	O
.	O
CONCLUSION	O
:	O
The	O
data	O
presented	O
confirm	O
the	O
validity	O
of	O
the	O
RC	O
cell	O
line	O
as	O
a	O
representative	O
model	O
of	O
gene1s	ARG2
MYC	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
BCL2	ARG2
gene1e	ARG2
DHL	O
that	O
will	O
be	O
useful	O
for	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
studies	O
of	O
DHL	O
pathogenesis	O
and	O
therapeutics	O
.	O

Establishment	O
and	O
characterization	O
of	O
a	O
novel	O
gene1s	O
MYC	O
gene1e	O
/	O
gene1s	O
BCL2	O
gene1e	O
"	O
double	O
-	O
hit	O
"	O
diffuse	O
large	O
B	O
cell	O
lymphoma	O
cell	O
line	O
,	O
RC	O
.	O
BACKGROUND	O
:	O
Diffuse	O
large	O
B	O
cell	O
lymphoma	O
(	O
DLBCL	O
)	O
is	O
the	O
most	O
common	O
type	O
of	O
lymphoid	O
malignancy	O
worldwide	O
.	O
Approximately	O
5	O
%	O
of	O
cases	O
of	O
DLBCL	O
are	O
so	O
-	O
called	O
double	O
-	O
hit	O
lymphomas	O
(	O
DHL	O
)	O
,	O
defined	O
by	O
a	O
chromosomal	O
translocation	O
or	O
rearrangement	O
involving	O
gene1s	O
MYC	O
gene1e	O
/8q24.2	O
in	O
combination	O
with	O
another	O
recurrent	O
breakpoint	O
,	O
usually	O
gene1s	O
BCL2	O
gene1e	O
/18q21.3	O
.	O
species1s	O
Patients	O
species1e	O
with	O
gene1s	O
MYC	O
gene1e	O
/	O
gene1s	O
BCL2	O
gene1e	O
DHL	O
are	O
resistant	O
to	O
standard	O
front	O
-	O
line	O
therapy	O
,	O
and	O
currently	O
,	O
there	O
is	O
no	O
consensus	O
for	O
a	O
therapeutic	O
strategy	O
to	O
treat	O
these	O
species1s	O
patients	O
species1e	O
.	O
Lack	O
of	O
clinically	O
relevant	O
or	O
validated	O
species1s	O
human	O
species1e	O
experimental	O
DHL	O
models	O
of	O
any	O
type	O
that	O
would	O
improve	O
our	O
understanding	O
of	O
the	O
biologic	O
basis	O
of	O
gene1s	O
MYC	O
gene1e	O
/	O
gene1s	O
BCL2	O
gene1e	O
DHL	O
pathophysiology	O
continues	O
to	O
hamper	O
identification	O
of	O
valid	O
therapeutic	O
targets	O
.	O
We	O
describe	O
a	O
unique	O
gene1s	O
MYC	O
gene1e	O
/	O
gene1s	O
BCL2	O
gene1e	O
DHL	O
cell	O
line	O
with	O
morphologic	O
features	O
of	O
DLBCL	O
that	O
we	O
have	O
established	O
,	O
designated	O
as	O
RC	O
.	O
METHODS	O
:	O
We	O
used	O
tissue	O
culture	O
techniques	O
to	O
establish	O
the	O
RC	O
cell	O
line	O
from	O
primary	O
DLBCL	O
cells	O
.	O
We	O
also	O
utilized	O
molecular	O
and	O
cellular	O
biological	O
techniques	O
including	O
flow	O
cytometry	O
,	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
,	O
DNA	O
fingerprinting	O
,	O
reverse	O
-	O
phase	O
protein	O
array	O
,	O
conventional	O
cytogenetics	O
,	O
and	O
fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
analysis	O
to	O
characterize	O
the	O
RC	O
cell	O
line	O
.	O
NSG	O
-	O
severe	O
combined	O
immunodeficiency	O
(	O
SCID	O
)	O
arg1s	O
mice	O
arg1e	O
were	O
utilized	O
as	O
a	O
model	O
for	O
xeno	O
-	O
transplantation	O
of	O
RC	O
cells	O
.	O
RESULTS	O
:	O
RC	O
cells	O
had	O
the	O
following	O
immunophenotype	O
:	O
positive	O
for	O
gene1s	O
CD10	O
gene1e	O
,	O
gene1s	O
CD19	O
gene1e	O
,	O
gene1s	O
CD20	O
gene1e	O
,	O
gene1s	O
CD22	O
gene1e	O
,	O
gene1s	O
CD38	O
gene1e	O
,	O
gene1s	O
CD43	O
gene1e	O
,	O
gene1s	O
CD44	O
gene1e	O
,	O
and	O
gene1s	O
CD79b	O
gene1e	O
and	O
negative	O
for	O
gene1s	O
CD3	O
gene1e	O
,	O
gene1s	O
CD4	O
gene1e	O
,	O
gene1s	O
CD5	O
gene1e	O
,	O
gene1s	O
CD8	O
gene1e	O
,	O
gene1s	O
CD11c	O
gene1e	O
,	O
gene1s	O
CD14	O
gene1e	O
,	O
gene1s	O
CD30	O
gene1e	O
,	O
gene1s	O
CD56	O
gene1e	O
,	O
and	O
gene1s	O
CD200	O
gene1e	O
,	O
which	O
was	O
identical	O
to	O
the	O
primary	O
tumor	O
cells	O
.	O
Conventional	O
cytogenetic	O
analysis	O
showed	O
a	O
t(2;8)(p12;q24.2	O
)	O
and	O
t(14;18)(q32;q21.3	O
)	O
,	O
corresponding	O
to	O
gene1s	O
MYC	O
gene1e	O
and	O
gene1s	O
BCL2	O
gene1e	O
gene	O
rearrangements	O
,	O
respectively	O
.	O
DNA	O
fingerprinting	O
authenticated	O
the	O
RC	O
cell	O
line	O
to	O
be	O
of	O
the	O
same	O
clone	O
as	O
the	O
primary	O
tumor	O
cells	O
.	O
In	O
addition	O
,	O
RC	O
cells	O
were	O
established	O
in	O
SCID	O
arg1s	O
mice	O
arg1e	O
as	O
an	O
in	O
vivo	O
model	O
for	O
translational	O
therapeutics	O
studies	O
.	O
Proteomic	O
analysis	O
showed	O
activation	O
of	O
the	O
gene1s	O
mTOR	O
gene1e	O
signaling	O
pathway	O
in	O
RC	O
cells	O
that	O
can	O
be	O
targeted	O
with	O
an	O
gene1s	O
mTOR	O
gene1e	O
inhibitor	O
.	O
CONCLUSION	O
:	O
The	O
data	O
presented	O
confirm	O
the	O
validity	O
of	O
the	O
RC	O
cell	O
line	O
as	O
a	O
representative	O
model	O
of	O
gene1s	O
MYC	O
gene1e	O
/	O
gene1s	O
BCL2	O
gene1e	O
DHL	O
that	O
will	O
be	O
useful	O
for	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
studies	O
of	O
DHL	O
pathogenesis	O
and	O
therapeutics	O
.	O

Metabolic	O
Symbiosis	O
Enables	O
Adaptive	O
Resistance	O
to	O
Anti	O
-	O
angiogenic	O
Therapy	O
that	O
Is	O
Dependent	O
on	O
gene1s	O
mTOR	O
gene1e	O
Signaling	O
.	O
Therapeutic	O
targeting	O
of	O
tumor	O
angiogenesis	O
with	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
inhibitors	O
results	O
in	O
demonstrable	O
,	O
but	O
transitory	O
efficacy	O
in	O
certain	O
arg1s	O
human	O
arg1e	O
tumors	O
and	O
species1s	O
mouse	O
species1e	O
models	O
of	O
cancer	O
,	O
limited	O
by	O
unconventional	O
forms	O
of	O
adaptive	O
/	O
evasive	O
resistance	O
.	O
In	O
one	O
such	O
species1s	O
mouse	O
species1e	O
model	O
,	O
potent	O
angiogenesis	O
inhibitors	O
elicit	O
compartmental	O
reorganization	O
of	O
cancer	O
cells	O
around	O
remaining	O
blood	O
vessels	O
.	O
The	O
gene1s	O
glucose	O
and	O
lactate	O
transporters	O
gene1e	O
gene1s	O
GLUT1	O
gene1e	O
and	O
gene1s	O
MCT4	O
gene1e	O
are	O
induced	O
in	O
distal	O
hypoxic	O
cells	O
in	O
a	O
gene1s	O
HIF1a	O
gene1e	O
-	O
dependent	O
fashion	O
,	O
indicative	O
of	O
glycolysis	O
.	O
Tumor	O
cells	O
proximal	O
to	O
blood	O
vessels	O
instead	O
express	O
the	O
gene1s	O
lactate	O
transporter	O
gene1e	O
gene1s	O
MCT1	O
gene1e	O
,	O
and	O
gene1s	O
p	O
-	O
S6	O
gene1e	O
,	O
the	O
latter	O
reflecting	O
gene1s	O
mTOR	O
gene1e	O
signaling	O
.	O
Normoxic	O
cancer	O
cells	O
import	O
and	O
metabolize	O
lactate	O
,	O
resulting	O
in	O
upregulation	O
of	O
gene1s	O
mTOR	O
gene1e	O
signaling	O
via	O
glutamine	O
metabolism	O
enhanced	O
by	O
lactate	O
catabolism	O
.	O
Thus	O
,	O
metabolic	O
symbiosis	O
is	O
established	O
in	O
the	O
face	O
of	O
angiogenesis	O
inhibition	O
,	O
whereby	O
hypoxic	O
cancer	O
cells	O
import	O
glucose	O
and	O
export	O
lactate	O
,	O
while	O
normoxic	O
cells	O
import	O
and	O
catabolize	O
lactate	O
.	O
gene1s	O
mTOR	O
gene1e	O
signaling	O
inhibition	O
disrupts	O
this	O
metabolic	O
symbiosis	O
,	O
associated	O
with	O
upregulation	O
of	O
the	O
gene1s	O
glucose	O
transporter	O
gene1e	O
gene1s	O
GLUT2	O
gene1e	O
.	O

Metabolic	O
Symbiosis	O
Enables	O
Adaptive	O
Resistance	O
to	O
Anti	O
-	O
angiogenic	O
Therapy	O
that	O
Is	O
Dependent	O
on	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
Signaling	O
.	O
Therapeutic	O
targeting	O
of	O
tumor	O
angiogenesis	O
with	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
inhibitors	O
results	O
in	O
demonstrable	O
,	O
but	O
transitory	O
efficacy	O
in	O
certain	O
species1s	O
human	O
species1e	O
tumors	O
and	O
arg1s	O
mouse	O
arg1e	O
models	O
of	O
cancer	O
,	O
limited	O
by	O
unconventional	O
forms	O
of	O
adaptive	O
/	O
evasive	O
resistance	O
.	O
In	O
one	O
such	O
arg1s	O
mouse	O
arg1e	O
model	O
,	O
potent	O
angiogenesis	O
inhibitors	O
elicit	O
compartmental	O
reorganization	O
of	O
cancer	O
cells	O
around	O
remaining	O
blood	O
vessels	O
.	O
The	O
gene1s	ARG2
glucose	ARG2
and	ARG2
lactate	ARG2
transporters	ARG2
gene1e	ARG2
gene1s	ARG2
GLUT1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MCT4	ARG2
gene1e	ARG2
are	O
induced	O
in	O
distal	O
hypoxic	O
cells	O
in	O
a	O
gene1s	ARG2
HIF1a	ARG2
gene1e	ARG2
-	O
dependent	O
fashion	O
,	O
indicative	O
of	O
glycolysis	O
.	O
Tumor	O
cells	O
proximal	O
to	O
blood	O
vessels	O
instead	O
express	O
the	O
gene1s	ARG2
lactate	ARG2
transporter	ARG2
gene1e	ARG2
gene1s	ARG2
MCT1	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
p	ARG2
-	ARG2
S6	ARG2
gene1e	ARG2
,	O
the	O
latter	O
reflecting	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
signaling	O
.	O
Normoxic	O
cancer	O
cells	O
import	O
and	O
metabolize	O
lactate	O
,	O
resulting	O
in	O
upregulation	O
of	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
signaling	O
via	O
glutamine	O
metabolism	O
enhanced	O
by	O
lactate	O
catabolism	O
.	O
Thus	O
,	O
metabolic	O
symbiosis	O
is	O
established	O
in	O
the	O
face	O
of	O
angiogenesis	O
inhibition	O
,	O
whereby	O
hypoxic	O
cancer	O
cells	O
import	O
glucose	O
and	O
export	O
lactate	O
,	O
while	O
normoxic	O
cells	O
import	O
and	O
catabolize	O
lactate	O
.	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
signaling	O
inhibition	O
disrupts	O
this	O
metabolic	O
symbiosis	O
,	O
associated	O
with	O
upregulation	O
of	O
the	O
gene1s	ARG2
glucose	ARG2
transporter	ARG2
gene1e	ARG2
gene1s	ARG2
GLUT2	ARG2
gene1e	ARG2
.	O

gene1s	ARG2
Star	ARG2
-	ARG2
PAP	ARG2
gene1e	ARG2
,	O
a	O
gene1s	ARG2
poly(A	ARG2
)	ARG2
polymerase	ARG2
gene1e	ARG2
,	O
functions	O
as	O
a	O
tumor	O
suppressor	O
in	O
an	O
orthotopic	O
arg1s	O
human	O
arg1e	O
breast	O
cancer	O
model	O
.	O
gene1s	ARG2
Star	ARG2
-	ARG2
PAP	ARG2
gene1e	ARG2
is	O
a	O
noncanonical	O
gene1s	ARG2
poly(A	ARG2
)	ARG2
polymerase	ARG2
gene1e	ARG2
and	O
required	O
for	O
the	O
expression	O
of	O
a	O
select	O
set	O
of	O
mRNAs	O
.	O
However	O
,	O
the	O
pathological	O
role	O
of	O
gene1s	ARG2
Star	ARG2
-	ARG2
PAP	ARG2
gene1e	ARG2
in	O
cancer	O
largely	O
remains	O
unknown	O
.	O
In	O
this	O
study	O
,	O
we	O
observed	O
decreased	O
expression	O
of	O
gene1s	ARG2
Star	ARG2
-	ARG2
PAP	ARG2
gene1e	ARG2
in	O
breast	O
cancer	O
cell	O
lines	O
and	O
tissues	O
.	O
Ectopic	O
gene1s	ARG2
Star	ARG2
-	ARG2
PAP	ARG2
gene1e	ARG2
expression	O
inhibited	O
proliferation	O
as	O
well	O
as	O
colony	O
-	O
forming	O
ability	O
of	O
breast	O
cancer	O
cells	O
.	O
In	O
breast	O
cancer	O
arg1s	O
patients	O
arg1e	O
,	O
high	O
levels	O
of	O
gene1s	ARG2
Star	ARG2
-	ARG2
PAP	ARG2
gene1e	ARG2
correlated	O
with	O
an	O
improved	O
prognosis	O
.	O
Moreover	O
,	O
by	O
regulating	O
the	O
expression	O
of	O
gene1s	ARG2
BIK	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
BCL2-interacting	ARG2
killer	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
Star	ARG2
-	ARG2
PAP	ARG2
gene1e	ARG2
induced	O
apoptosis	O
of	O
breast	O
cancer	O
cells	O
through	O
the	O
mitochondrial	O
pathway	O
.	O
The	O
growth	O
of	O
breast	O
cancer	O
xenografts	O
in	O
NOD	O
/	O
SCID	O
species1s	O
mice	O
species1e	O
was	O
also	O
inhibited	O
by	O
the	O
doxycycline	O
-	O
induced	O
gene1s	ARG2
Star	ARG2
-	ARG2
PAP	ARG2
gene1e	ARG2
overexpression	O
.	O
Furthermore	O
,	O
gene1s	ARG2
Star	ARG2
-	ARG2
PAP	ARG2
gene1e	ARG2
sensitized	O
breast	O
cancer	O
cells	O
to	O
chemotherapy	O
drugs	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O
In	O
mammary	O
epithelial	O
cells	O
,	O
gene1s	ARG2
Star	ARG2
-	ARG2
PAP	ARG2
gene1e	ARG2
knockdown	O
partially	O
transformed	O
these	O
cells	O
and	O
induced	O
them	O
to	O
undergo	O
epithelial	O
-	O
mesenchymal	O
transition	O
(	O
EMT	O
)	O
.	O
These	O
findings	O
suggested	O
that	O
gene1s	ARG2
Star	ARG2
-	ARG2
PAP	ARG2
gene1e	ARG2
possesses	O
tumor	O
-	O
suppressing	O
activity	O
and	O
can	O
be	O
a	O
valuable	O
target	O
for	O
developing	O
new	O
cancer	O
therapeutic	O
strategies	O
.	O

gene1s	O
Star	O
-	O
PAP	O
gene1e	O
,	O
a	O
gene1s	O
poly(A	O
)	O
polymerase	O
gene1e	O
,	O
functions	O
as	O
a	O
tumor	O
suppressor	O
in	O
an	O
orthotopic	O
species1s	O
human	O
species1e	O
breast	O
cancer	O
model	O
.	O
gene1s	O
Star	O
-	O
PAP	O
gene1e	O
is	O
a	O
noncanonical	O
gene1s	O
poly(A	O
)	O
polymerase	O
gene1e	O
and	O
required	O
for	O
the	O
expression	O
of	O
a	O
select	O
set	O
of	O
mRNAs	O
.	O
However	O
,	O
the	O
pathological	O
role	O
of	O
gene1s	O
Star	O
-	O
PAP	O
gene1e	O
in	O
cancer	O
largely	O
remains	O
unknown	O
.	O
In	O
this	O
study	O
,	O
we	O
observed	O
decreased	O
expression	O
of	O
gene1s	O
Star	O
-	O
PAP	O
gene1e	O
in	O
breast	O
cancer	O
cell	O
lines	O
and	O
tissues	O
.	O
Ectopic	O
gene1s	O
Star	O
-	O
PAP	O
gene1e	O
expression	O
inhibited	O
proliferation	O
as	O
well	O
as	O
colony	O
-	O
forming	O
ability	O
of	O
breast	O
cancer	O
cells	O
.	O
In	O
breast	O
cancer	O
species1s	O
patients	O
species1e	O
,	O
high	O
levels	O
of	O
gene1s	O
Star	O
-	O
PAP	O
gene1e	O
correlated	O
with	O
an	O
improved	O
prognosis	O
.	O
Moreover	O
,	O
by	O
regulating	O
the	O
expression	O
of	O
gene1s	O
BIK	O
gene1e	O
(	O
gene1s	O
BCL2-interacting	O
killer	O
gene1e	O
)	O
,	O
gene1s	O
Star	O
-	O
PAP	O
gene1e	O
induced	O
apoptosis	O
of	O
breast	O
cancer	O
cells	O
through	O
the	O
mitochondrial	O
pathway	O
.	O
The	O
growth	O
of	O
breast	O
cancer	O
xenografts	O
in	O
NOD	O
/	O
SCID	O
arg1s	O
mice	O
arg1e	O
was	O
also	O
inhibited	O
by	O
the	O
doxycycline	O
-	O
induced	O
gene1s	O
Star	O
-	O
PAP	O
gene1e	O
overexpression	O
.	O
Furthermore	O
,	O
gene1s	O
Star	O
-	O
PAP	O
gene1e	O
sensitized	O
breast	O
cancer	O
cells	O
to	O
chemotherapy	O
drugs	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O
In	O
mammary	O
epithelial	O
cells	O
,	O
gene1s	O
Star	O
-	O
PAP	O
gene1e	O
knockdown	O
partially	O
transformed	O
these	O
cells	O
and	O
induced	O
them	O
to	O
undergo	O
epithelial	O
-	O
mesenchymal	O
transition	O
(	O
EMT	O
)	O
.	O
These	O
findings	O
suggested	O
that	O
gene1s	O
Star	O
-	O
PAP	O
gene1e	O
possesses	O
tumor	O
-	O
suppressing	O
activity	O
and	O
can	O
be	O
a	O
valuable	O
target	O
for	O
developing	O
new	O
cancer	O
therapeutic	O
strategies	O
.	O

gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
regulates	O
the	O
expression	O
of	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
during	O
hormone	O
-	O
induced	O
3T3-L1	O
preadipocyte	O
differentiation	O
:	O
a	O
possible	O
role	O
in	O
obesity	O
and	O
associated	O
diseases	O
.	O
BACKGROUND	O
:	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
is	O
highly	O
expressed	O
in	O
adipose	O
tissue	O
and	O
has	O
been	O
associated	O
with	O
obesity	O
and	O
related	O
disorders	O
.	O
However	O
,	O
the	O
molecular	O
function	O
of	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
in	O
adipose	O
tissue	O
is	O
unclear	O
.	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
has	O
been	O
implicated	O
in	O
cell	O
lineage	O
determination	O
and	O
differentiation	O
.	O
Therefore	O
,	O
we	O
investigated	O
both	O
the	O
role	O
of	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
in	O
adipocyte	O
precursor	O
mobilization	O
and	O
the	O
relationship	O
of	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
with	O
other	O
molecular	O
determinants	O
of	O
adipocyte	O
differentiation	O
.	O
METHODS	O
:	O
We	O
examined	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
mRNA	O
and	O
protein	O
expression	O
in	O
subcutaneous	O
adipose	O
tissues	O
from	O
diet	O
-	O
induced	O
obese	O
C57	O
/	O
BL6	O
arg1s	O
mice	O
arg1e	O
and	O
species1s	O
Wistar	O
rats	O
species1e	O
and	O
in	O
obese	O
species1s	O
patients	O
species1e	O
undergoing	O
liposuction	O
or	O
adipose	O
transplant	O
surgeries	O
.	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
expression	O
was	O
measured	O
on	O
days	O
0	O
,	O
2	O
,	O
4	O
,	O
8	O
,	O
and	O
12	O
of	O
3T3-L1	O
differentiation	O
in	O
vitro	O
.	O
The	O
role	O
of	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
in	O
adipogenesis	O
was	O
explored	O
using	O
retroviral	O
interference	O
of	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
expression	O
.	O
Adipokine	O
secretion	O
was	O
evaluated	O
using	O
a	O
RayBioR	O
Biotin	O
Label	O
-	O
based	O
Adipokine	O
Array	O
.	O
RESULTS	O
:	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
mRNA	O
and	O
protein	O
levels	O
were	O
reduced	O
in	O
diet	O
-	O
induced	O
obese	O
arg1s	O
mice	O
arg1e	O
and	O
species1s	O
rats	O
species1e	O
and	O
in	O
obese	O
species1s	O
humans	O
species1e	O
.	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
was	O
upregulated	O
during	O
3T3-L1	O
preadipocyte	O
differentiation	O
in	O
vitro	O
,	O
beginning	O
from	O
the	O
fourth	O
day	O
of	O
differentiation	O
induction	O
.	O
Retroviral	O
interference	O
of	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
expression	O
did	O
not	O
significantly	O
impair	O
lipid	O
formation	O
;	O
however	O
,	O
retroviral	O
interference	O
induced	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
mRNA	O
and	O
protein	O
expression	O
on	O
day	O
4	O
of	O
differentiation	O
induction	O
.	O
Adipokine	O
array	O
analyses	O
revealed	O
increased	O
secretion	O
of	O
gene1s	ARG2
CXCR4	ARG2
gene1e	ARG2
(	O
19.55-fold	O
)	O
,	O
gene1s	ARG2
VEGFR1	ARG2
gene1e	ARG2
(	O
92.13-fold	O
)	O
,	O
L-21	O
R	O
(	O
63.55-fold	O
)	O
,	O
and	O
gene1s	ARG2
IL-12	ARG2
R	ARG2
beta	ARG2
1	ARG2
gene1e	ARG2
(	O
59.66-fold	O
)	O
and	O
decreased	O
secretion	O
of	O
gene1s	ARG2
VEGFR3	ARG2
gene1e	ARG2
(	O
0.01-fold	O
)	O
,	O
gene1s	ARG2
TSLP	ARG2
gene1e	ARG2
R	O
(	O
0.071-fold	O
)	O
,	O
gene1s	ARG2
MIP-1	ARG2
gamma	ARG2
gene1e	ARG2
(	O
0.069-fold	O
)	O
,	O
gene1s	ARG2
TNF	ARG2
RI	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
TNFRSF1A	ARG2
gene1e	ARG2
(	O
0.09-fold	O
)	O
,	O
and	O
gene1s	ARG2
MFG	ARG2
-	ARG2
E8	ARG2
gene1e	ARG2
(	O
0.06-fold	O
)	O
.	O
CONCLUSIONS	O
:	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
is	O
a	O
regulator	O
of	O
adipocyte	O
gene	O
expression	O
although	O
it	O
is	O
not	O
likely	O
to	O
regulate	O
differentiation	O
.	O
We	O
identified	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
as	O
a	O
potential	O
target	O
of	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
and	O
found	O
variation	O
in	O
the	O
secretion	O
of	O
multiple	O
adipokines	O
,	O
which	O
might	O
indicate	O
a	O
prospective	O
mechanism	O
linking	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
expression	O
with	O
obesity	O
or	O
associated	O
diseases	O
.	O

gene1s	O
Twist	O
1	O
gene1e	O
regulates	O
the	O
expression	O
of	O
gene1s	O
PPARg	O
gene1e	O
during	O
hormone	O
-	O
induced	O
3T3-L1	O
preadipocyte	O
differentiation	O
:	O
a	O
possible	O
role	O
in	O
obesity	O
and	O
associated	O
diseases	O
.	O
BACKGROUND	O
:	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
is	O
highly	O
expressed	O
in	O
adipose	O
tissue	O
and	O
has	O
been	O
associated	O
with	O
obesity	O
and	O
related	O
disorders	O
.	O
However	O
,	O
the	O
molecular	O
function	O
of	O
gene1s	O
Twist	O
1	O
gene1e	O
in	O
adipose	O
tissue	O
is	O
unclear	O
.	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
has	O
been	O
implicated	O
in	O
cell	O
lineage	O
determination	O
and	O
differentiation	O
.	O
Therefore	O
,	O
we	O
investigated	O
both	O
the	O
role	O
of	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
in	O
adipocyte	O
precursor	O
mobilization	O
and	O
the	O
relationship	O
of	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
with	O
other	O
molecular	O
determinants	O
of	O
adipocyte	O
differentiation	O
.	O
METHODS	O
:	O
We	O
examined	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
mRNA	O
and	O
protein	O
expression	O
in	O
subcutaneous	O
adipose	O
tissues	O
from	O
diet	O
-	O
induced	O
obese	O
C57	O
/	O
BL6	O
species1s	O
mice	O
species1e	O
and	O
arg1s	O
Wistar	O
rats	O
arg1e	O
and	O
in	O
obese	O
species1s	O
patients	O
species1e	O
undergoing	O
liposuction	O
or	O
adipose	O
transplant	O
surgeries	O
.	O
gene1s	O
Twist	O
1	O
gene1e	O
expression	O
was	O
measured	O
on	O
days	O
0	O
,	O
2	O
,	O
4	O
,	O
8	O
,	O
and	O
12	O
of	O
3T3-L1	O
differentiation	O
in	O
vitro	O
.	O
The	O
role	O
of	O
gene1s	O
Twist	O
1	O
gene1e	O
in	O
adipogenesis	O
was	O
explored	O
using	O
retroviral	O
interference	O
of	O
gene1s	O
Twist	O
1	O
gene1e	O
expression	O
.	O
Adipokine	O
secretion	O
was	O
evaluated	O
using	O
a	O
RayBioR	O
Biotin	O
Label	O
-	O
based	O
Adipokine	O
Array	O
.	O
RESULTS	O
:	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
mRNA	O
and	O
protein	O
levels	O
were	O
reduced	O
in	O
diet	O
-	O
induced	O
obese	O
species1s	O
mice	O
species1e	O
and	O
arg1s	O
rats	O
arg1e	O
and	O
in	O
obese	O
species1s	O
humans	O
species1e	O
.	O
gene1s	O
Twist	O
1	O
gene1e	O
was	O
upregulated	O
during	O
3T3-L1	O
preadipocyte	O
differentiation	O
in	O
vitro	O
,	O
beginning	O
from	O
the	O
fourth	O
day	O
of	O
differentiation	O
induction	O
.	O
Retroviral	O
interference	O
of	O
gene1s	O
Twist	O
1	O
gene1e	O
expression	O
did	O
not	O
significantly	O
impair	O
lipid	O
formation	O
;	O
however	O
,	O
retroviral	O
interference	O
induced	O
gene1s	O
PPARg	O
gene1e	O
mRNA	O
and	O
protein	O
expression	O
on	O
day	O
4	O
of	O
differentiation	O
induction	O
.	O
Adipokine	O
array	O
analyses	O
revealed	O
increased	O
secretion	O
of	O
gene1s	O
CXCR4	O
gene1e	O
(	O
19.55-fold	O
)	O
,	O
gene1s	O
VEGFR1	O
gene1e	O
(	O
92.13-fold	O
)	O
,	O
L-21	O
R	O
(	O
63.55-fold	O
)	O
,	O
and	O
gene1s	O
IL-12	O
R	O
beta	O
1	O
gene1e	O
(	O
59.66-fold	O
)	O
and	O
decreased	O
secretion	O
of	O
gene1s	O
VEGFR3	O
gene1e	O
(	O
0.01-fold	O
)	O
,	O
gene1s	O
TSLP	O
gene1e	O
R	O
(	O
0.071-fold	O
)	O
,	O
gene1s	O
MIP-1	O
gamma	O
gene1e	O
(	O
0.069-fold	O
)	O
,	O
gene1s	O
TNF	O
RI	O
gene1e	O
/	O
gene1s	O
TNFRSF1A	O
gene1e	O
(	O
0.09-fold	O
)	O
,	O
and	O
gene1s	O
MFG	O
-	O
E8	O
gene1e	O
(	O
0.06-fold	O
)	O
.	O
CONCLUSIONS	O
:	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
is	O
a	O
regulator	O
of	O
adipocyte	O
gene	O
expression	O
although	O
it	O
is	O
not	O
likely	O
to	O
regulate	O
differentiation	O
.	O
We	O
identified	O
gene1s	O
PPARg	O
gene1e	O
as	O
a	O
potential	O
target	O
of	O
gene1s	O
Twist	O
1	O
gene1e	O
and	O
found	O
variation	O
in	O
the	O
secretion	O
of	O
multiple	O
adipokines	O
,	O
which	O
might	O
indicate	O
a	O
prospective	O
mechanism	O
linking	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
expression	O
with	O
obesity	O
or	O
associated	O
diseases	O
.	O

gene1s	O
Twist	O
1	O
gene1e	O
regulates	O
the	O
expression	O
of	O
gene1s	O
PPARg	O
gene1e	O
during	O
hormone	O
-	O
induced	O
3T3-L1	O
preadipocyte	O
differentiation	O
:	O
a	O
possible	O
role	O
in	O
obesity	O
and	O
associated	O
diseases	O
.	O
BACKGROUND	O
:	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
is	O
highly	O
expressed	O
in	O
adipose	O
tissue	O
and	O
has	O
been	O
associated	O
with	O
obesity	O
and	O
related	O
disorders	O
.	O
However	O
,	O
the	O
molecular	O
function	O
of	O
gene1s	O
Twist	O
1	O
gene1e	O
in	O
adipose	O
tissue	O
is	O
unclear	O
.	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
has	O
been	O
implicated	O
in	O
cell	O
lineage	O
determination	O
and	O
differentiation	O
.	O
Therefore	O
,	O
we	O
investigated	O
both	O
the	O
role	O
of	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
in	O
adipocyte	O
precursor	O
mobilization	O
and	O
the	O
relationship	O
of	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
with	O
other	O
molecular	O
determinants	O
of	O
adipocyte	O
differentiation	O
.	O
METHODS	O
:	O
We	O
examined	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
mRNA	O
and	O
protein	O
expression	O
in	O
subcutaneous	O
adipose	O
tissues	O
from	O
diet	O
-	O
induced	O
obese	O
C57	O
/	O
BL6	O
species1s	O
mice	O
species1e	O
and	O
species1s	O
Wistar	O
rats	O
species1e	O
and	O
in	O
obese	O
arg1s	O
patients	O
arg1e	O
undergoing	O
liposuction	O
or	O
adipose	O
transplant	O
surgeries	O
.	O
gene1s	O
Twist	O
1	O
gene1e	O
expression	O
was	O
measured	O
on	O
days	O
0	O
,	O
2	O
,	O
4	O
,	O
8	O
,	O
and	O
12	O
of	O
3T3-L1	O
differentiation	O
in	O
vitro	O
.	O
The	O
role	O
of	O
gene1s	O
Twist	O
1	O
gene1e	O
in	O
adipogenesis	O
was	O
explored	O
using	O
retroviral	O
interference	O
of	O
gene1s	O
Twist	O
1	O
gene1e	O
expression	O
.	O
Adipokine	O
secretion	O
was	O
evaluated	O
using	O
a	O
RayBioR	O
Biotin	O
Label	O
-	O
based	O
Adipokine	O
Array	O
.	O
RESULTS	O
:	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
mRNA	O
and	O
protein	O
levels	O
were	O
reduced	O
in	O
diet	O
-	O
induced	O
obese	O
species1s	O
mice	O
species1e	O
and	O
species1s	O
rats	O
species1e	O
and	O
in	O
obese	O
arg1s	O
humans	O
arg1e	O
.	O
gene1s	O
Twist	O
1	O
gene1e	O
was	O
upregulated	O
during	O
3T3-L1	O
preadipocyte	O
differentiation	O
in	O
vitro	O
,	O
beginning	O
from	O
the	O
fourth	O
day	O
of	O
differentiation	O
induction	O
.	O
Retroviral	O
interference	O
of	O
gene1s	O
Twist	O
1	O
gene1e	O
expression	O
did	O
not	O
significantly	O
impair	O
lipid	O
formation	O
;	O
however	O
,	O
retroviral	O
interference	O
induced	O
gene1s	O
PPARg	O
gene1e	O
mRNA	O
and	O
protein	O
expression	O
on	O
day	O
4	O
of	O
differentiation	O
induction	O
.	O
Adipokine	O
array	O
analyses	O
revealed	O
increased	O
secretion	O
of	O
gene1s	O
CXCR4	O
gene1e	O
(	O
19.55-fold	O
)	O
,	O
gene1s	O
VEGFR1	O
gene1e	O
(	O
92.13-fold	O
)	O
,	O
L-21	O
R	O
(	O
63.55-fold	O
)	O
,	O
and	O
gene1s	O
IL-12	O
R	O
beta	O
1	O
gene1e	O
(	O
59.66-fold	O
)	O
and	O
decreased	O
secretion	O
of	O
gene1s	O
VEGFR3	O
gene1e	O
(	O
0.01-fold	O
)	O
,	O
gene1s	O
TSLP	O
gene1e	O
R	O
(	O
0.071-fold	O
)	O
,	O
gene1s	O
MIP-1	O
gamma	O
gene1e	O
(	O
0.069-fold	O
)	O
,	O
gene1s	O
TNF	O
RI	O
gene1e	O
/	O
gene1s	O
TNFRSF1A	O
gene1e	O
(	O
0.09-fold	O
)	O
,	O
and	O
gene1s	O
MFG	O
-	O
E8	O
gene1e	O
(	O
0.06-fold	O
)	O
.	O
CONCLUSIONS	O
:	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
is	O
a	O
regulator	O
of	O
adipocyte	O
gene	O
expression	O
although	O
it	O
is	O
not	O
likely	O
to	O
regulate	O
differentiation	O
.	O
We	O
identified	O
gene1s	O
PPARg	O
gene1e	O
as	O
a	O
potential	O
target	O
of	O
gene1s	O
Twist	O
1	O
gene1e	O
and	O
found	O
variation	O
in	O
the	O
secretion	O
of	O
multiple	O
adipokines	O
,	O
which	O
might	O
indicate	O
a	O
prospective	O
mechanism	O
linking	O
gene1s	ARG2
Twist	ARG2
1	ARG2
gene1e	ARG2
expression	O
with	O
obesity	O
or	O
associated	O
diseases	O
.	O
